id|nct_id|allocation|intervention_model|observational_model|primary_purpose|time_perspective|masking|masking_description|intervention_model_description|subject_masked|caregiver_masked|investigator_masked|outcomes_assessor_masked
1285058|NCT03790657|Randomized|Parallel Assignment||Basic Science||Double|Participants will not be told which dosage group they are assigned to. Outcomes Assessors will not be told which dosage group the participant was randomized to.|Participants will randomized to one of two dosages of transcranial direct current stimulation (tDCS): Dosage A or Dosage B|t|||t
1285059|NCT03790644||Single Group Assignment||Treatment||None (Open Label)||A prospective longitudinal, self-controlled, single-case repeated measures alternating treatment, randomized and counterbalanced cross-over experimental trial design, comparing walking endurance without and with a powered exoskeleton.||||
1285060|NCT03790631|||Cohort||Prospective|||||||
1285061|NCT03790618|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1285062|NCT03790605|Randomized|Parallel Assignment||Treatment||Double|The study design follows a double blinded design where the participant and the outcome assessor are unaware of the intervention to the subject|"Total subjects = 40 INCLUSION CRITERION~Systemically healthy individuals both males and females of 20-60 years~Presence of a minimum of 20 teeth in the oral cavity~Localised periodontal pockets with probing depths greater than 4mm i.e., Periodontitis in its stages 2 and 3, as described by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions, and published by the American Academy of Periodontology (AAP) EXCLUSION CRITERION~1 Known allergy to curcumin and/ or hydroxyl propyl methyl cellulose 2 Systemic diseases and/or Inflammatory conditions, Obesity 3 Former or current tobacco users 4 Chronic consumption of alcohol 5 Use of anti-inflammatory drugs and antibiotics over the past 3 months 6 Periodontal therapy in any form, surgical or non surgical in the past 6 months 7 Pregnant and lactating mothers"|t|||t
1285063|NCT03790592||Single Group Assignment||Treatment||None (Open Label)||||||
1285064|NCT03790579|||Case-Control||Cross-Sectional|||||||
1285065|NCT03790566|Randomized|Parallel Assignment||Prevention||Single||||||t
1285066|NCT03790553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285067|NCT03790540|Randomized|Crossover Assignment||Other||None (Open Label)|The operator will not be blinded to the type of treatment. However, the statistician will be blinded to the treatment groups.|Each group will receive 2 mandibular nerve block injections with two different injection techniques, with 1-2 weeks apart as a washing out period .Mandibular nerve block injection will be either with vibration using DentalVibe at the injection side or topical analgesic (benzocaine 20%) gel will be applied before the injection of local anesthesia at first the appointment, and the alternative technique will be used at the second appointment. Injection with the aid of DentalVibe tool will act as the experimental group while the control group will be the use of topical analgesic (benzocaine 20%).||||
1285068|NCT03790527|Randomized|Parallel Assignment||Basic Science||Double|double blind: both participants and experimenters won't know which group is training group or sham control group.|The investigators assigned subjects to two training groups and collected pre - and post-test data|t||t|
1285069|NCT03790514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285070|NCT03790501|||Cohort||Prospective|||||||
1285071|NCT03790488||Single Group Assignment||Treatment||None (Open Label)||||||
1285072|NCT03790475|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1285073|NCT03790462|Randomized|Parallel Assignment||Supportive Care||Triple|It is a triple blinded study||t||t|t
1285074|NCT03790449|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Statistician is blinded|Randomized Controlled Trial (1:1)||||
1285075|NCT03790436||Single Group Assignment||Treatment||None (Open Label)||||||
1285076|NCT03790423||Single Group Assignment||Diagnostic||None (Open Label)||||||
1285077|NCT03790410|Randomized|Parallel Assignment||Treatment||Single|||||t|
1285078|NCT03790397|||Cohort||Retrospective|||||||
1285079|NCT03790384|Randomized|Parallel Assignment||Treatment||Single||The subjects will be assessed for eligibility at the screening visit (Visit 1) three weeks after TURB and re-TURB prior to randomization and only subjects who fulfil the inclusion criteria will be included: patients with a diagnosis of High risk NMIBC: T1 tumor, G3, CIS, or multiple and recurrent and large (>3 cm) Ta or patients in the last EAU recurrence category (EAU/EORTC recurrence score >/=10). Patients selected for the study, are centrally randomized (randomization is performed at the Sant'Andrea Hospital) to receive BCG induction treatment according to the standard protocol (an instillation once a week for six weeks) with ImmuCyst (81 mg Connaught strain BCG). Patients in group two received BCG treatment with the same protocol with a 40 mg mitomycin instillation the day before .|||t|
1285080|NCT03790371|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285081|NCT03790358|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1285082|NCT03790345|Randomized|Parallel Assignment||Treatment||Quadruple||Proof of concept 12-week prospective, randomized, double-blind, controlled trial|t|t|t|t
1285083|NCT03790332||Single Group Assignment||Treatment||None (Open Label)||||||
1285084|NCT03790319|||Cohort||Prospective|||||||
1285085|NCT03790306|||Cohort||Prospective|||||||
1285086|NCT03790293|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients included and treated in the RITUXIMAB 3 study (NCT00784589):~Rituximab in combination with reduced corticosteroids~Standard corticosteroid"||||
1285087|NCT03790280|Randomized|Parallel Assignment||Treatment||Double|"A double-blinded randomized control trial including children with refractory focal epilepsy who undergo surgery with intra- or extra-operative electrocorticography. Surgery is tailored by HFOs and standard ECoG interpretation (spikes on intra-operative ECoG or seizure onset on extra-operative ECoG) (arm 1), or tailored by standard ECoG alone (arm 2).~Informed consent will be obtained 1 to 7 days to up to 3 months prior to the day of surgery. Prior to surgery, the subject will be randomized into the cohort arms in a 1:1 ratio.~Blinding of the clinical neurophysiologists and neurosurgeons for treatment allocation is not feasible because of the character of the intervention. Therefore, this is a double-blinded trial as subjects will be blinded to the cohort arm to minimize bias of the follow-up results. The treating neurologist will also be blinded."|Randomization into standard arm and the treatment arm in a 1:1 ratio.|t|t||
1285088|NCT03790267|||Cohort||Prospective|||||||
1285089|NCT03790254|||Other||Retrospective|||||||
1285090|NCT03790241|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1285091|NCT03790228||Single Group Assignment||Treatment||None (Open Label)||Anlotinib combined with Pemetrexed and Carboplatin||||
1300210|NCT03593499||||||||||||
1285092|NCT03790215||Single Group Assignment||Treatment||None (Open Label)||||||
1285093|NCT03790202|||Cohort||Prospective|||||||
1285094|NCT03790189||Single Group Assignment||Treatment||None (Open Label)||||||
1285095|NCT03790176||Single Group Assignment||Other||None (Open Label)||group A - patients on automated peritoneal dialysis group B - critically ill patients with pneumonia||||
1285096|NCT03790163|Randomized|Parallel Assignment||Supportive Care||Double|Double(participant ,care provider)||t|t||
1285097|NCT03790150|||Cohort||Prospective|||||||
1285098|NCT03790137||Single Group Assignment||Treatment||None (Open Label)||||||
1285099|NCT03790124|||Other||Retrospective|||||||
1285100|NCT03790111||Single Group Assignment||Treatment||None (Open Label)||||||
1285101|NCT03790098|Randomized|Parallel Assignment||Treatment||None (Open Label)|Randomization to arm follows the baseline assessment visit.|Group 1 Participants attend Restorative-Flow Yoga classes, two times per week with a certified yoga instructor and have at-home supplemental materials. Group 2 receive the at-home supplemental materials after outcome visit corresponding to after the 24 classes.||||
1285102|NCT03790085|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1285103|NCT03790072||Sequential Assignment||Treatment||None (Open Label)||Dose escalation, 3 cohorts, x10 dose increments between cohorts (10^6, 10^7, 10^8 of cells per kg of body weight).||||
1285104|NCT03790059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285105|NCT03790046||||||||||||
1285106|NCT03790033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285107|NCT03790020|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||3 types of local anesthetic applying method will be compared||||
1285108|NCT03790007|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||3 types of local anesthetic applying method will be compared||||
1285109|NCT03789994|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1285110|NCT03789981|||Cohort||Prospective|||||||
1285111|NCT03789968|||Cohort||Retrospective|||||||
1285112|NCT03789955||Single Group Assignment||Diagnostic||None (Open Label)||||||
1285113|NCT03789942|Randomized|Parallel Assignment||Treatment||None (Open Label)||"90 patients will be randomly divided into three groups of 30 patients each. They will be given a prior consent both of the procedures to be performed and of the sedation procedure to which they will be subjected, if that is the case, without knowing what dose they will be administered. In case of being sedated, they will be informed verbally of the details concerning the procedure.~Group 1, 30 patients treated by Oral Surgery procedures exclusively with Local Anesthesia.~Group 2, 30 patients treated by procedures of Oral Surgery with Local Anesthesia and Oral Sedation with Midazolam.~Group 3, 30 patients treated by Oral Surgery procedures with Local Anesthesia and Inhalation Sedation with a mixture of Nitrous Oxide / Oxygen."||||
1285114|NCT03789929|||Cohort||Prospective|||||||
1285115|NCT03789916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285116|NCT03789903||Single Group Assignment||Diagnostic||None (Open Label)||||||
1285117|NCT03789890||Single Group Assignment||Other||None (Open Label)||||||
1285118|NCT03789877|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1285119|NCT03789864|||Cohort||Prospective|||||||
1285120|NCT03789851||Single Group Assignment||Diagnostic||None (Open Label)||||||
1285121|NCT03789838|||Cohort||Prospective|||||||
1285122|NCT03789825|||Other||Prospective|||||||
1285123|NCT03789812|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1285124|NCT03789799|Randomized|Parallel Assignment||Treatment||Quadruple|TIAGIN and placebo will be provided in identical non-distinguishable packaging and formulations. To each pack a unique random ID will be assigned based on an independently generated random scheme (www.randomization.com). Patients will blindly receive consecutively a single pack of 10 vaginal capsules. The same blinding procedure will also be present for health professionals (double-blind study) as only the manufacturer will be aware of the contents of the pack. For each enrolled patient, the patient ID will be associated to the packaging ID, the maintenance of the confidentiality of such data will be the responsibility of the Principal Investigator, to which the contents of the pack will be revealed only at the end of the study for the final data analysis.|Randomized controlled double-blind trial|t|t|t|t
1285125|NCT03789786|||Case-Control||Other|||||||
1285126|NCT03789773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1285127|NCT03789760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285128|NCT03789747|||Cohort||Prospective|||||||
1285129|NCT03789734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285130|NCT03789721|||Cohort||Prospective|||||||
1285131|NCT03789708|Randomized|Parallel Assignment||Treatment||Double|The placebo and the Gum Arabic are provided to patients in similar unlabeled packages|Randomized and controlled clinical trial with parallel design|t|t||
1285132|NCT03789695|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1285133|NCT03789682|||Cohort||Prospective|||||||
1285134|NCT03789669||||||||||||
1285135|NCT03789656||Single Group Assignment||Treatment||None (Open Label)||||||
1285136|NCT03789643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285137|NCT03789630|||Cohort||Prospective|||||||
1285138|NCT03789617||Single Group Assignment||Treatment||None (Open Label)||||||
1285139|NCT03789604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285140|NCT03789591|Randomized|Parallel Assignment||Prevention||Triple|The study is designed with a double-blind design. The clinical provider and participant/family will be aware of the absolute (mg) starting dose and could theoretically calculate the mg/kg starting dose, but the treatment assignment will not explicitly be provided to the provider or the family, and the same procedures will be used for dose escalation or reduction. Although most doses in the Alternative Arm will be different than 20 mg/kg, there are some patients on the standard arm who may have a PK-guided dose that is close to or at 20 mg/kg. Thus, although it may be possible to deduce the study arm, the study is designed technically in a double-blind fashion.||t|t|t|
1285236|NCT03788343|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1285237|NCT03788330|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1338893|NCT03089684|||Other||Other|||||||
1285141|NCT03789578|Randomized|Crossover Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.|This is a three-period cross-over trial. The treatments to be used are: Treatment A: insulin 287, Treatment B: semaglutide, and Treatment C: NNC0148-0287sema. The subjects will be randomised to one of the six treatment sequences in the trial: 1) ABC, 2) ACB, 3) BAC, 4) BCA, 5) CAB, and 6) CBA. The trial includes a screening visit followed by three 5 -week periods with pharmacokinetic sampling after single dose administration. The dose periods are separated by a 1-4 week washout period (from last pharmacokinetic sampling to next dosing). The follow-up period is 1−4 weeks after last pharmacokinetic sampling in period 3 (i.e. 6 to 9 weeks after last trial product administration). The total trial duration for the individual subjects participating in the trial will be 19 to 32 weeks (including follow-up), depending on individual visit schedules.|t|t|t|t
1285142|NCT03789565|||Case-Control||Cross-Sectional|||||||
1285143|NCT03789552|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285144|NCT03789539|Randomized|Parallel Assignment||Prevention||Quadruple||"Subjects will undergo screening procedures within 2-6 days prior to first vaccination which will include medical history, vital signs, physical examination and safety blood and urine lab tests.~On the first treatment visit, eligible subjects will undergo pre-dose physical examination, ECG, vital signs, and a blood sample for circulating IgE. They will then receive an IM injection of either vaccine or placebo, according to the above treatment assignment, into the deltoid muscle preferably of non dominant arm. The subjects will remain under medical supervision for 72 hrs at which time they will be released from the Clinical research center.~The second treatment will take place 21 days after the first vaccination. Procedures will be the same as that of Visit 1 Additional follow-up visits will take place at 4-7th,14th,24-27th and 42nd days. Blood and urine samples will be collected for safety."|t|t|t|t
1285145|NCT03789526|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance.~Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance."||||
1285146|NCT03789513||Single Group Assignment||Screening||None (Open Label)||||||
1285147|NCT03789500||Single Group Assignment||Treatment||None (Open Label)||||||
1285148|NCT03789487||Single Group Assignment||Treatment||None (Open Label)||||||
1285149|NCT03789474|Randomized|Parallel Assignment||Prevention||Triple|Draping of the legs was done in both the groups.the care observer nor investigator were blinded for the allocation.|About 60 patients of age group 25 to 50 belonging to American Society of Anesthesiologists (ASA) grade 1 and 2 were allocated to either control or sequential pneumatic compression device group .Allocation was done by sealed envelop technique.In the operating room,in the control group,the device was placed on operating table and was placed next to the patients calves.in the intervention group,the device was placed over calves and inflated during induction of General Anaesthesia (GA) and maintenance.legs were draped in both the groups.Femoral vein velocities were assessed using ultrasound in preoperative period , intraoperatively 15 minutes after induction of anaesthesia and in post-operative period.|t|t|t|
1285150|NCT03789461||Single Group Assignment||Treatment||None (Open Label)||||||
1285151|NCT03789448|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1285152|NCT03789435|||Cohort||Other|||||||
1285153|NCT03789422|Randomized|Crossover Assignment||Treatment||Double|Double blind|Multicentric controlled randomized crossover study, double-blind|t||t|
1285154|NCT03789409|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1285155|NCT03789396|||Case-Control||Prospective|||||||
1285156|NCT03789383|||Cohort||Other|||||||
1285157|NCT03789370|Randomized|Parallel Assignment||Prevention||Double|The patient and the outcomes assessor will not know what kind of anaesthetic drug was used for maintainance of anaesthesia.||t|||t
1285158|NCT03789357|||Cohort||Prospective|||||||
1285159|NCT03789344|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285160|NCT03789331|||Cohort||Cross-Sectional|||||||
1285161|NCT03789318|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285162|NCT03789305|||Cohort||Prospective|||||||
1285163|NCT03789292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285164|NCT03789279|||Cohort||Prospective|||||||
1285165|NCT03789266|Randomized|Parallel Assignment||Supportive Care||Single|patient will not know which technique will be used for drain ablation||t|||
1285166|NCT03789253|||Cohort||Prospective|||||||
1285167|NCT03789240||Single Group Assignment||Treatment||None (Open Label)||||||
1285168|NCT03789227|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1285169|NCT03789214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285170|NCT03789201|||Case-Only||Cross-Sectional|||||||
1285171|NCT03789188|||Cohort||Other|||||||
1285172|NCT03789175||Single Group Assignment||Basic Science||None (Open Label)||||||
1285173|NCT03789162|||Cohort||Prospective|||||||
1285174|NCT03789149||Single Group Assignment||Treatment||None (Open Label)||Single group assignment||||
1285175|NCT03789136|||Case-Control||Cross-Sectional|||||||
1285176|NCT03789123|Randomized|Parallel Assignment||Treatment||Single||||||t
1285177|NCT03789110||Single Group Assignment||Treatment||None (Open Label)||||||
1285178|NCT03789097||Single Group Assignment||Treatment||None (Open Label)||||||
1285179|NCT03789084|Randomized|Parallel Assignment||Treatment||Single||||||t
1285180|NCT03789071|||Other||Prospective|||||||
1285181|NCT03789058|Randomized|Parallel Assignment||Supportive Care||Double|The treatment regimens were masked for both participants and care provider (Clinical investigator)|Parallel Assignment a single-center double-blind randomized controlled trial|t|t||
1285182|NCT03789045|||Case-Only||Cross-Sectional|||||||
1285183|NCT03789032||Single Group Assignment||Treatment||None (Open Label)||This is a single arm fixed sequence study. Subjects will be administered vadadustat on day 1, rabeprazole on days 2 to 5, and vadadustat and rabeprazole on day 6.||||
1285184|NCT03789019||Single Group Assignment||Treatment||None (Open Label)||||||
1285185|NCT03789006|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized clinical trial||||
1285238|NCT03788317|||Case-Only||Prospective|||||||
1285186|NCT03788993|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a single-centre, unblinded, two-arm, parallel-group, pragmatic effectiveness RCT of differences in the mean duration of acute psychiatric hospitalization in days for individuals exposed to experimental lighting compared with normal lighting conditions.||||
1285187|NCT03788980|||Case-Only||Prospective|||||||
1285188|NCT03788967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285189|NCT03788954|Randomized|Crossover Assignment||Treatment||Double|Double|Crossover Assignment|t|||t
1285190|NCT03788941|||Cohort||Prospective|||||||
1285191|NCT03788928|||Case-Only||Cross-Sectional|||||||
1285192|NCT03788915|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1285193|NCT03788902|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1285194|NCT03788889|Randomized|Parallel Assignment||Treatment||Triple|"Each participant will be randomized according to a web-based randomization program employed by a research pharmacist once the Emergency Department provider deems the patient appropriate for inpatient treatment of alcohol withdrawal syndrome.~Each medication will be packaged by Santa Barbara Cottage Hospital pharmacy. In order to blind both the clinicians and the participants, the pharmacy will provide medication bags that are identical. Therefore, Emergency Department nursing staff and physicians will be unaware of which study drug is being provided to the patient. Normal saline will be used as a placebo to mimic study drugs (phenobarbital and ketamine). Pharmacy will remain unblinded and maintain records of which treatment assignment is prepared for each patient.~Treatment will be provided for the duration of the patient's hospitalization; therefore, treatment compliance will be documented in the electronic health record using the medication bag identifier."|prospective, randomized control trial|t|t|t|
1285195|NCT03788876|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1285196|NCT03788863|||Cohort||Retrospective|||||||
1285197|NCT03788850|||Cohort||Retrospective|||||||
1285198|NCT03788837|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285199|NCT03788824|||Cohort||Prospective|||||||
1285200|NCT03788811|||Case-Control||Prospective|||||||
1285201|NCT03788798|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1285202|NCT03788785|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is an open, controlled, randomized, parallel-group, two-arm, multicenter clinical study||||
1285203|NCT03788772||Single Group Assignment||Basic Science||None (Open Label)||||||
1285204|NCT03788759|Randomized|Parallel Assignment||Treatment||Quadruple||Proof of concept 4-month prospective, randomized, double-blind, controlled trial|t|t|t|t
1285205|NCT03788746|||Cohort||Prospective|||||||
1285206|NCT03788733|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285207|NCT03788720|Randomized|Parallel Assignment||Treatment||Triple|"Surgeons who perform the surgery will be not masked for the treatment allocation.~Evaluators (sonographers, data analyzers) will be blind for the treatment allocation."|Randomized Controlled Trial|t||t|t
1285208|NCT03788707||Single Group Assignment||Diagnostic||None (Open Label)||Volunteers will lay flat with a face mask breathing room air while expired CO2 is measured. After 30 seconds, legs will be passively raised for 3 minutes. Changes in expired CO2 before and after leg raising will be compared.||||
1285209|NCT03788694||Single Group Assignment||Treatment||None (Open Label)||||||
1285210|NCT03788681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285211|NCT03788668|Randomized|Parallel Assignment||Treatment||Double|Neither the pulmonologist or the phoniatracian or the surgeon who will befrom post operative sleep study, post operative nasopharyngoscopy and post operative sleep endoscopy will know the type of operation performed to the patients.|||t|t|
1285212|NCT03788655|||Cohort||Prospective|||||||
1285213|NCT03788642|Randomized|Parallel Assignment||Treatment||Double||"The randomised clinical trial with participants randomised1:1 to either~Control group : Patients will wear LED shoe (Placebo) 30 minutes once daily~Laser group : Patients will wear Laser shoe 30 minutes once daily"|t|||t
1285214|NCT03788629|Randomized|Parallel Assignment||Treatment||Single|Single blinded|Randomized||t||
1285215|NCT03788616|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1285216|NCT03788603||Single Group Assignment||Treatment||None (Open Label)||||||
1285217|NCT03788590||Single Group Assignment||Treatment||None (Open Label)||||||
1285218|NCT03788577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285219|NCT03788564|||Case-Control||Prospective|||||||
1285220|NCT03788551||||||||||||
1285221|NCT03788538|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1285222|NCT03788525|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1285223|NCT03788512|||Cohort||Prospective|||||||
1285224|NCT03788499|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285225|NCT03788486||Single Group Assignment||Treatment||None (Open Label)||Single site prospective study with no control group to assess the safety and clinical efficacy of a low power LED light device on the signs and symptoms of dry eye disease.||||
1285226|NCT03788473|||Case-Control||Prospective|||||||
1285227|NCT03788460|||Cohort||Other|||||||
1285228|NCT03788447|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1285229|NCT03788434|Randomized|Parallel Assignment||Prevention||Quadruple|To reduce potential bias and increase study data integrity, study participants, care providers, site investigators, and study outcomes assessors will all be masked to study treatment assignment.|"This Phase 2 study will help determine how safe and effective the study drug, VE303, is at preventing subsequent Clostridium difficile Infection (CDI)-associated diarrhea compared with placebo, following completion of at least 1 successful course of standard-of-care (SOC) antibiotics for subjects with recurrent CDI.~Patients in the study will be randomized into 3 arms in a 1:1:1 ratio of high dose VE303, low dose VE303, and placebo."|t|t|t|t
1285230|NCT03788421|Randomized|Parallel Assignment||Treatment||Single||||t||
1285231|NCT03788408|Randomized|Parallel Assignment||Treatment||Single||||||t
1285232|NCT03788395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285233|NCT03788382|||Cohort||Prospective|||||||
1285234|NCT03788369|||Cohort||Prospective|||||||
1285235|NCT03788356|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1285239|NCT03788304|Randomized|Parallel Assignment||Treatment||Quadruple|Neither the participant , care provider , the investigator nor the outcome assessor will select patients in both groups , see results of other patients till the end of the study or informed by literature opinion in this intervention|patients with acute respiratory failure will be randomly enrolled to either non invasive group or HFNC group and improvement and patient satisfaction will be assessed|t|t|t|t
1285240|NCT03788291||Single Group Assignment||Treatment||None (Open Label)||||||
1285241|NCT03788278|||Cohort||Prospective|||||||
1285242|NCT03788265||Single Group Assignment||Treatment||None (Open Label)||||||
1285243|NCT03788252|Randomized|Parallel Assignment||Prevention||None (Open Label)||Renamezin (AST-120) group or non-Renamezin group||||
1285244|NCT03788239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285245|NCT03788226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285246|NCT03788213|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised, controlled, open-label, two arm, multicenter, randomized controlled trial with two parallel groups||||
1285247|NCT03788200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285248|NCT03788187||Parallel Assignment||Other||Double|Analyzing the concentrations of 46 POPs in both adipose tissue and serum samples from breast tumor patients (benign, malignant with and without lymph node metastasis).||t||t|
1285249|NCT03788174||Single Group Assignment||Treatment||None (Open Label)||||||
1285250|NCT03788161|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1285251|NCT03788148|||Cohort||Retrospective|||||||
1285252|NCT03788135|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1285253|NCT03788122||Single Group Assignment||Other||None (Open Label)||||||
1285254|NCT03788109||Single Group Assignment||Basic Science||None (Open Label)||||||
1285255|NCT03788096|Randomized|Parallel Assignment||Supportive Care||Single||A prospective, 2-arm, single-blind, randomized controlled clinical feasibility trial design.||||t
1285256|NCT03788083|Non-Randomized|Sequential Assignment||Treatment||Single|Subjects will not know whether an active or non-active substance is being injected. The choice for TriMix or placebo will take place according to the predefined schedule and can not be influenced by the patient or the investigator. Only after the comparison of the tumour tissue before (the initial biopsy where the diagnosis was made) and after (obtained at second biopsy or surgery) the intratumoral injection, it will be known whether mRNA or non-active product was used for the injection.||t|||
1285257|NCT03788070|||Cohort||Prospective|||||||
1285258|NCT03788057||Single Group Assignment||Diagnostic||None (Open Label)|Clinician takes decision about possible change in treatment basing on clinical data only - is not aware of the results of the inflammatory parameters measurements|A prospective, observational, interventional, single blind study. Clinician takes decision about possible reduction of ICS dose basing on clinical data only - is not aware of the results of the inflammatory parameters measurement.||||
1285259|NCT03788044|Randomized|Parallel Assignment||Treatment||None (Open Label)||AF patients will be divided in four groups (AF-EduCare study and AF-EduApp substudy): one group will have application-based education (AF-EduApp substudy), the second group will have in-person education (AF-EduCare study), the third group will have online education (AF-EduCare study) and the fourth group will receive standard AF care (AF-EduCare study and not eligible for AF-EduApp substudy). NOAC adherence will be compared between these groups.||||
1285260|NCT03788031|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285261|NCT03788018|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1285262|NCT03788005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285263|NCT03787992|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1285264|NCT03787979|Randomized|Crossover Assignment||Treatment||Double|The assessor and investigator will be blinded to the random order. This process will be handled by the research manager.|Participants will be randomly assigned to either stretching exercise with lumbopelvic stiffening technique or lumbopelvic relaxing technique. They will be provided a 2-day wash-out period. Then, participants will cross-over to another technique.|||t|t
1285265|NCT03787966|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1285266|NCT03787953||Single Group Assignment||Treatment||None (Open Label)||||||
1285267|NCT03787940|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1285268|NCT03787927|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1285269|NCT03787914|Randomized|Parallel Assignment||Health Services Research||Single||The investigators conducted a two-arm, parallel design[1:1], single blind randomized control trial in 200 newly diagnosed TB patients||||t
1285270|NCT03787901|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1285271|NCT03787888|||Case-Only||Cross-Sectional|||||||
1285272|NCT03787875|||Case-Control||Prospective|||||||
1285273|NCT03787862|||Case-Only||Prospective|||||||
1285274|NCT03787849|Randomized|Parallel Assignment||Screening||Double|Participants are not aware of anesthesia technique. Outcome assessor of DNA methylation are not aware of anesthesia technique since they will analyze blood samples.||t|||t
1285275|NCT03787836|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will first be randomized as controls or exercisers. All exercisers will complete a 16 week exercise program, then be randomized into two groups. The first group will increase the exercise intensity and conduct another 12 week program. The second group will continue the original program for an additional 12 weeks.||||
1285276|NCT03787823|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285277|NCT03787810|||Cohort||Prospective|||||||
1285278|NCT03787797|||Cohort||Prospective|||||||
1285279|NCT03787784|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1285280|NCT03787771|||Cohort||Other|||||||
1285281|NCT03787758|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285282|NCT03787745|Randomized|Parallel Assignment||Treatment||Single|All study personell involved in outcome assessment will be blinded to the treatment employed|Prospective, randomized, placebo controlled||||t
1285283|NCT03787732|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285284|NCT03787719|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single center pilot study||||
1285285|NCT03787706|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1285286|NCT03787693|Randomized|Parallel Assignment||Basic Science||Double|The PI and the subject will not be aware of the group assignment of each subject.|Chronic stroke survivors will be screened and assigned to either a Symmetric or Asymmetric group based on inter-limb step length and/or step time asymmetry at baseline. Each subject will be randomly assigned to perform a split-belt adaptation protocol in either a VR or a Non-VR environment.|t||t|
1285287|NCT03787680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1285288|NCT03787667|||Cohort||Prospective|||||||
1285289|NCT03787654|Randomized|Parallel Assignment||Treatment||Double|participants in electroacupuncture and sham electroacupuncture groups are blinded, and solifenacin group is open.||||t|t
1285290|NCT03787641||Single Group Assignment||Treatment||None (Open Label)||||||
1285291|NCT03787628|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1285292|NCT03787615||Single Group Assignment||Prevention||None (Open Label)||A variety of technologies (e.g., wrist-worn sensors, smart water bottles, mobile applications) can be utilized to engage participants over time and support compliance with increasing fluid consumption.||||
1285293|NCT03787602||Single Group Assignment||Treatment||None (Open Label)||||||
1285294|NCT03787589|Randomized|Parallel Assignment||Treatment||Single||||||t
1285295|NCT03787576|||Case-Only||Prospective|||||||
1285296|NCT03787563|Randomized|Crossover Assignment||Supportive Care||Triple|Double blinded study|all the subjects will receive sequence of different study treatments.|t|t|t|
1285297|NCT03787550|||Cohort||Prospective|||||||
1285298|NCT03787537|||Cohort||Prospective|||||||
1285299|NCT03787524|||Case-Control||Prospective|||||||
1285300|NCT03787511|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1285301|NCT03787498||Sequential Assignment||Treatment||None (Open Label)||||||
1285302|NCT03787485|||Case-Control||Prospective|||||||
1285303|NCT03787472||||||||||||
1285304|NCT03787459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285305|NCT03787446|||Cohort||Cross-Sectional|||||||
1285306|NCT03787433|||Cohort||Prospective|||||||
1285307|NCT03787420|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1285308|NCT03787407|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Healthy individuals recruited through advertisement||||
1285309|NCT03787394|Randomized|Crossover Assignment||Basic Science||Single||A two-step, randomised controlled intervention study|t|||
1285310|NCT03787381||Single Group Assignment||Diagnostic||None (Open Label)||||||
1285311|NCT03787368|Randomized|Parallel Assignment||Treatment||Double|Patients, investigators, and all other site staff will remain blinded for the administered BAY1213790 or placebo, with the exception of the unblinded pharmacist or specifically dedicated site personnel.The sponsor will be not be blinded. Bioanalysis of plasma concentrations and PD parameters, as well as the evaluation of results will be performed in a non-blinded fashion.||t||t|
1285312|NCT03787355|Randomized|Parallel Assignment||Treatment||Triple||Intervention versus Control.|t||t|t
1285313|NCT03787342|Randomized|Parallel Assignment||Treatment||Double|Care provider and investigator cannot be blinded as they are involved in the surgical procedure so blinding is not feasible.|Three Groups of intervention compared to one group of comparator. Each group contains 10 patients.|t|||t
1285314|NCT03787329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||interventional group vs. historical control group||||
1285315|NCT03787316||Single Group Assignment||Treatment||None (Open Label)||||||
1285316|NCT03787303||Single Group Assignment||Treatment||None (Open Label)|N/A (not applicable)|Triiodothyronine (T3) - IND Exempt||||
1285317|NCT03787290|Randomized|Single Group Assignment||Treatment||Quadruple|The randomization list maintained by the Research Pharmacies will contain the treatment assignment, along with a letter code (A or B) corresponding to the two treatment groups. During the study period and continuing until the major hypotheses have been tested and reported, the correspondence of letter-coded treatment assignment to actual treatment (tocilizumab or placebo) will be known only by pharmacy staff. The study principal investigators (PIs), study coordinators, clinicians conducting outcome assessments, and study statistician, as well as research assistants interacting with patients or entering study data and laboratory technicians performing/reporting biomarker assays, will have no access to any subject's treatment assignment. Only after the study statistician has completed and reported analyses by coded treatment assignment for the study aims articulated in this protocol will the correspondence between letter codes and actual treatment be revealed to study personnel.|Randomization will be conducted by randomly permuted blocks of 4 with separate randomization schedules for each site. The randomization schedule for each site will be created by a statistician who has no other role in the study data collection or analysis. The randomization schedules will be sent directly from the statistician to each site's Research Pharmacy which will maintain the list. Qualifying study subjects will be assigned the next sequential treatment assignment on the randomization schedule, in the order they are randomized. Participants will be randomized on a 1-to-1 allocation to one of two study arms: 1) tocilizumab followed by whole body hyperthermia (WBH); or 2) placebo followed by whole body hyperthermia (WBH). At the time of randomization, the study coordinator will contact the Research Pharmacy at the site to complete the coded treatment assignment described below.|t|t|t|t
1285318|NCT03787277|||Case-Only||Retrospective|||||||
1285319|NCT03787264||Single Group Assignment||Treatment||None (Open Label)||||||
1285320|NCT03787251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285321|NCT03787238|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285322|NCT03787225|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.|Participants will be randomised to 1 of 6 treatment arms, in 3 receiving active NNC0174-0833 and 3 receiving placebo. For statistical analysis and reporting of results, data from the 3 placebo arms will be pooled.|t|t|t|t
1285323|NCT03787212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285440|NCT03785691|Randomized|Parallel Assignment||Treatment||Quadruple|All oral tablets will be encapsulated in gelatine to ensure identical look, smell and taste.|Randomized placebo controlled multicenter trial testing already marketed drugs on a new indication.|t|t|t|t
1285324|NCT03787199|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||"Feasibility study, including a comparison between Andago and treadmill walking conditions (as we include a heterogeneous group of participants concerning age (children/adolescents), diagnosis, walking ability, etc., we include in this feasibility study 20 participants - rather than the usual 10).~Patients participate in 3 appointments (planned within 10 days):~Appointment 1 (60 min): patient characteristics, clinical tests (Selective Control Assessment of the Lower Extremity / Manual Muscle Testing / 10 meter walk test or 10MWT); practising on treadmill and in Andago; questions to participants~Appointment 2 (45 min): determine accuracy of the unloading system; practicing on treadmill and in Andago; questions to participant~Appointment 3 (60-90 min): 10MWT at onset and end; measurement of stride length, leg muscle EMG and joint kinematics during walking on treadmill with bodyweight unloading and walking overground with Andago with 3 levels of bodyweight unloading"||||
1285325|NCT03787186|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1285326|NCT03787173|Randomized|Crossover Assignment||Treatment||Single|||t|||
1285327|NCT03787160|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1285328|NCT03787147|Randomized|Parallel Assignment||Supportive Care||Double|The sealed envelope is randomized and blinded so no one will know which group the participant falls and its revealed only after the participant opens the sealed envelope.||t||t|
1285329|NCT03787134||Single Group Assignment||Basic Science||None (Open Label)||||||
1285330|NCT03787121|||Cohort||Retrospective|||||||
1285331|NCT03787108|||Cohort||Prospective|||||||
1285332|NCT03787095|Randomized|Sequential Assignment||Treatment||Double|||t|t||
1285333|NCT03787082|Randomized|Parallel Assignment||Treatment||Double|Participants will receive open label nitrate and be randomly assigned to either chlorhexidine mouthwash or placebo mouthwash. The participant and investigator will be blinded to which mouthwash the participant is randomized.||t||t|
1285334|NCT03787069|Randomized|Parallel Assignment||Prevention||None (Open Label)||Equal allocation||||
1285335|NCT03787056||Single Group Assignment||Diagnostic||None (Open Label)||||||
1285336|NCT03787043|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1285337|NCT03787030|Randomized|Parallel Assignment||Treatment||Single|A nurse blinded to the treatment applied will evaluate the healing of chronic anal fissure and quantify pain|||||t
1285338|NCT03787017|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1285339|NCT03787004|Randomized|Parallel Assignment||Treatment||None (Open Label)|Part 1: Open Label Part 2: Double-Blind|||||
1285340|NCT03786991|||Cohort||Prospective|||||||
1285341|NCT03786978|Randomized|Parallel Assignment||Supportive Care||Single|The outcomes assessor made a blind evaluation from the study outcomes.|Randomized clinical trial study||||t
1285342|NCT03786965|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1285343|NCT03786952|Randomized|Factorial Assignment||Basic Science||Double|||t|||t
1285344|NCT03786939|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1285345|NCT03786926||Single Group Assignment||Treatment||None (Open Label)||||||
1285346|NCT03786913|||Cohort||Prospective|||||||
1285347|NCT03786900||||||||||||
1285348|NCT03786887||Sequential Assignment||Treatment||None (Open Label)||||||
1285349|NCT03786874|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"Case group:~Healthcare teams benefiting first the implementation of the coaching model other (centered round the following steps: identify, understand and act) : just after the first measure~Control group:~Healthcare teams benefiting first the implementation of the coaching model (centered round the following steps: identify, understand and act) : after the second measure (impact of the device on case group)."||||
1285350|NCT03786861|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1285351|NCT03786848||Single Group Assignment||Treatment||None (Open Label)||||||
1285352|NCT03786835|Randomized|Factorial Assignment||Prevention||Single|||||t|
1285353|NCT03786822|Randomized|Parallel Assignment||Treatment||Single|Subjects will be randomized in a 2:1 fashion|"Condition or Disease: Paroxysmal atrial fibrillation~Procedure: Cryoballoon Pulmonary Vein Isolation"||||t
1285354|NCT03786809|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285355|NCT03786796||Single Group Assignment||Treatment||None (Open Label)||||||
1285356|NCT03786783||Single Group Assignment||Treatment||None (Open Label)||||||
1285357|NCT03786770|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1285358|NCT03786757|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285359|NCT03786744|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is prospective, non-randomized (open label) with control group study. The total 20 patient will be enrolled in this study. In 10 patient with ASD will be infused with umbilical corb blood. Other 10 patient with ASD will be treated with standard therapy (control group).||||
1285360|NCT03786731|Randomized|Parallel Assignment||Treatment||Single||||||t
1285361|NCT03786718||Single Group Assignment||Health Services Research||None (Open Label)||||||
1285362|NCT03786705|||Case-Control||Retrospective|||||||
1285363|NCT03786692|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The design of this study will be an open label, randomized, phase 2 study in adult (≥ 18 years) male and female subjects with stage IV disease who have never smoked, irrespective of their driver mutation status, as well as subjects who have tumors that possess a driver mutation.~The study will be comparing the four agent treatment group (Arm A) that includes carboplatin + pemetrexed + bevacizumab + atezolizumab versus a three agent control group (Arm B) that includes carboplatin + pemetrexed + bevacizumab for 4 cycles, each cycle lasting for 3 weeks. Treatment will be followed by maintenance in both arms that will include all agents except carboplatin. There is no crossover in this study.~Arm A: Carboplatin + Pemetrexed + Bevacizumab + Atezolizumab Maintenance: Pemetrexed + Bevacizumab + Atezolizumab~Arm B: Carboplatin + Pemetrexed + Bevacizumab Maintenance: Pemetrexed + Bevacizumab"||||
1285364|NCT03786679|Randomized|Parallel Assignment||Treatment||Single|The assessors are not involved in the treatment and the radiological assessment of images will be assessed with anonymyized images.|Parallel assignment||||t
1285365|NCT03786666|||Cohort||Prospective|||||||
1285366|NCT03786653|||Case-Only||Prospective|||||||
1285367|NCT03786640|||Case-Only||Prospective|||||||
1285368|NCT03786627|Randomized|Parallel Assignment||Treatment||Triple|Physical therapist, investigator, and assessor will be blinded to the group assignment. This process will be handled by the research coordinator.|Subjects with impaired lumbopelvic control will be randomly assigned to either combined NMES with motor control training group, or motor control training alone group using randomly generated number in concealed envelopes.||t|t|t
1285369|NCT03786614|Randomized|Parallel Assignment||Treatment||Single|The person performing the data collection (rater) will be blind to the randomization of the patient for the entire duration of the study|||||t
1285370|NCT03786601|||Case-Control||Prospective|||||||
1285371|NCT03786588|||Case-Control||Prospective|||||||
1285372|NCT03786575||Single Group Assignment||Treatment||None (Open Label)||||||
1285373|NCT03786562|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1285374|NCT03786549|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1285375|NCT03786536||Single Group Assignment||Treatment||None (Open Label)||Healthy volunteer study||||
1285376|NCT03786523|Randomized|Parallel Assignment||Treatment||Single||||||t
1285377|NCT03786510|Randomized|Parallel Assignment||Prevention||Single||A single-blinded randomized controlled pilot study||||t
1285378|NCT03786497|||Cohort||Other|||||||
1285379|NCT03786484|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1285380|NCT03786471|Randomized|Parallel Assignment||Supportive Care||Double||"2150 dyads of persons with dementia and their respective primary caregiver~1000 in each intervention arm, and 150 in the usual care arm"|||t|t
1285381|NCT03786458||Single Group Assignment||Supportive Care||None (Open Label)||||||
1285382|NCT03786445|||Cohort||Retrospective|||||||
1285383|NCT03786432||Single Group Assignment||Treatment||None (Open Label)||||||
1285384|NCT03786419||Single Group Assignment||Treatment||None (Open Label)||||||
1285385|NCT03786406|||Other||Prospective|||||||
1285386|NCT03786393|||Cohort||Cross-Sectional|||||||
1285387|NCT03786380||Single Group Assignment||Treatment||None (Open Label)||||||
1285388|NCT03786367|||Case-Control||Prospective|||||||
1285389|NCT03786354|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285390|NCT03786341|Randomized|Parallel Assignment||Treatment||Double|This was a randomized-prospective study and participants were recruited to each the experimental and the control group equally. Patients in the experimental group (EG) received 30-minutes rehabilitation, consisting of 15 minutes of walking training with laser quad-cane and 15 minutes of traditional physical therapy (such as strengthening and balance training). Patients in the control group (CG) received the same rehabilitation except that the walking training was by conventional strategy without lase quad-cane. The rehabilitation lasted for 4 weeks, twice per week. Gait parameters were measured by Rehab watch as primary outcomes and Berg's balance scale (BBS), timed-up-and-go test (TUG), and Barthel index were used as secondary outcomes. Both the primary and secondary outcomes were measured before the rehabilitation (baseline), 4 weeks (week 4), and 8 weeks (week 8) after the rehabilitation.|This was a randomized-prospective study and participants were recruited to each the experimental and the control group equally. Patients in the experimental group (EG) received 30-minutes rehabilitation, consisting of 15 minutes of walking training with laser quad-cane and 15 minutes of traditional physical therapy (such as strengthening and balance training). Patients in the control group (CG) received the same rehabilitation except that the walking training was by conventional strategy without lase quad-cane. The rehabilitation lasted for 4 weeks, twice per week. Gait parameters were measured by Rehab watch as primary outcomes and Berg's balance scale (BBS), timed-up-and-go test (TUG), and Barthel index were used as secondary outcomes. Both the primary and secondary outcomes were measured before the rehabilitation (baseline), 4 weeks (week 4), and 8 weeks (week 8) after the rehabilitation.|t|||t
1285391|NCT03786328|Non-Randomized|Sequential Assignment||Screening||None (Open Label)||||||
1285392|NCT03786315|Randomized|Parallel Assignment||Supportive Care||Single|Blinding of the research team will not be possible for the purposes of this feasibility study due to resource availability. Participants will be informed via participant information sheets that their practice will either be assigned to intervention or to control. Participants will not be informed which arm of the study their practice has been randomised to, however participants in the intervention arm are likely to be aware that they are receiving more than the standard 'usual care'.|"Clusters will be defined at practice level with randomisation to usual care or to the intervention, carried out after practice recruitment. Although statistically more powerful, randomising by patient would be impractical and vulnerable to contamination. We will cluster randomise using block randomisation. Block randomisation will be stratified by site; two practices in inner city Plymouth, two practices from Exeter and two from rural Devon.~In order to reduce bias, practice randomisation on a 1:1 allocation (90 patients per arm) will be conducted using computer allocation software by an independent statistician. We will report comparisons in pre- and post-intervention data between the control and intervention groups when analysing results. The sample size if sufficient to compare standard deviations in our primary outcome between the intervention and control group."|t|||
1285393|NCT03786302|Randomized|Parallel Assignment||Treatment||Triple|The operator will not be blinded to the treatment type. However, the participants, their care givers, the expert assessing the histologic and inflammatory changes and the statistician will be blinded to the treatment groups.|Study group (assigned to TAMP bioglass), and Control group (assigned to Biodentine ™).|t|t||t
1285394|NCT03786289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285395|NCT03786276|Randomized|Crossover Assignment||Other||None (Open Label)||We will use an 8-week, randomized cross--over design trial of active VR-WMR.||||
1285396|NCT03786263|||Cohort||Prospective|||||||
1285397|NCT03786250|||Cohort||Retrospective|||||||
1285398|NCT03786237||Single Group Assignment||Treatment||None (Open Label)||||||
1285399|NCT03786224||Single Group Assignment||Other||None (Open Label)||||||
1285400|NCT03786211|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1285401|NCT03786198|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Home-based walking intervention for 24 weeks + standard adjuvant AI therapy~Physical activity according to standard recommendations for 24 weeks + standard adjuvant AI therapy"||||
1285441|NCT03785678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357012|NCT02853695|||||Cross-Sectional|||||||
1285402|NCT03786185|Randomized|Parallel Assignment||Treatment||Single|The participant is not aware of the group (intervention or control) in which s/he belongs.|This is a 2x2x2 mixed model design with between subjects factors condition (congruent and incongruent) and age group (adolescent, adults, elderlies) and within subjects factor time (pre, post).|t|||
1285403|NCT03786172|Randomized|Parallel Assignment||Prevention||Single||||||t
1285404|NCT03786159|||Cohort||Prospective|||||||
1285405|NCT03786146|||Case-Crossover||Prospective|||||||
1285406|NCT03786133|||Case-Control||Retrospective|||||||
1285407|NCT03786120|||Cohort||Prospective|||||||
1285408|NCT03786107|||Cohort||Prospective|||||||
1285409|NCT03786094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285410|NCT03786081|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285411|NCT03786068|||Cohort||Other|||||||
1285412|NCT03786055||Single Group Assignment||Treatment||None (Open Label)||Criteria for enrollment included cancer survivors age 18 or older; any type or stage of cancer, currently completed all treatment with no current evidence of disease; at least mild peripheral neuropathy symptoms (either sensory or motor) as rated on the Patient Neurotoxicity Questionnaire (PNQ), attributable to chemotherapy intervention as a component of cancer treatment. Exclusion criteria included active cancer disease or current cancer treatment; co-morbidities such a diabetes or prior history of peripheral neuropathy from any cause. All participants will be screened with the physical activity readiness questionnaire (PAR-Q) to determine the safety or possible risk of exercising based on health history, current symptoms and risk factors. Somatic yoga and meditation (SYM) will be provided during 16 sessions/8 weeks for 1.5 hours and participants will complete home-based SYM and journal entries.||||
1285413|NCT03786042|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1285414|NCT03786029|Randomized|Parallel Assignment||Treatment||Double|The participant will be blinded, the drug administrator will be blinded too, and the investigator who will give the treatment and explain the pain scale to the participant and ask him\her to point to the face that fits the degree of his pain that associated with the drug administration will also be blinded.|Blinded, randomized placebo-controlled trial, comparing three groups.|t||t|
1285415|NCT03786016||Single Group Assignment||Other||None (Open Label)||All participants will be exposed to the same condition.||||
1285416|NCT03786003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285417|NCT03785990|||Cohort||Prospective|||||||
1285418|NCT03785977|||Case-Only||Prospective|||||||
1285419|NCT03785964|Randomized|Parallel Assignment||Treatment||Quadruple|For the double-blind phase, the participant, investigator, and all other clinical site personnel will be blinded to the assigned treatment allocation. All sponsor personnel will also be blinded except for the sponsor's quality assurance designee(s), safety designee(s), and clinical supply material designee(s).||t|t|t|t
1285420|NCT03785951|Randomized|Crossover Assignment||Prevention||Triple|Coded protein products will be used.|Double-blind, randomised, controlled, 3-way, cross-over study|t||t|t
1285421|NCT03785938|Randomized|Parallel Assignment||Other||Quadruple|The liquid probiotic/placebo will be blinded by the pharmacy team and LTHT|Double blinded randomised-controlled feasibility study|t|t|t|t
1285422|NCT03785925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285423|NCT03785912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285424|NCT03785899|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1285425|NCT03785886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285426|NCT03785873||Single Group Assignment||Treatment||None (Open Label)||||||
1285427|NCT03785860|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1285428|NCT03785847|||Cohort||Cross-Sectional|||||||
1285429|NCT03785834|||Cohort||Prospective|||||||
1285430|NCT03785821|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1285431|NCT03785808|Randomized|Parallel Assignment||Supportive Care||Single|"Participants will be randomized to the low-carbohydrate diet (Diet A), the low-fat diet (Diet B), or the USDA control diet (Diet C). Participants will not be informed about the nature of the intervention diets or the hypotheses we aim to test. The participants will know the diets only as Diet A, Diet B, and Diet C. They will be de-briefed about the nature of the diets and our hypotheses by mail after the study has been completed. At that time, we will also offer them a folder with the dietary guidelines and recipes for the diets they had not been randomized to. The reason participants will be blinded about the diets is that knowing the details may create a placebo effect and/or opting into another intervention diet."||t|||
1285432|NCT03785795|||Case-Only||Prospective|||||||
1285433|NCT03785782|||Cohort||Prospective|||||||
1285434|NCT03785769|Randomized|Parallel Assignment||Treatment||Double|Double-blind (Patient and Examiner) will not be able to blinding the operator due to the obvious difference between the techniques||t|||t
1285435|NCT03785756|Randomized|Parallel Assignment||Treatment||Quadruple|This is a double-blind, double dummy study. There will be two placebo tablets designed to be comparable to each of the active products (PR and Immediate Release (IR)) in both shape, size, colour and weight. All subject packs have been designed and labelled to ensure blinding is maintained. Subjects, investigators and site staff will all be blind to the treatments.|The dental pain model used in this study is a robust and well established postsurgical pain model that produces pain that is predictable in its character, duration, and intensity. The model is widely accepted and has a proven record of assay sensitivity (i.e. separating active drugs from each other, as well as from placebo). The model is frequently used to evaluate NSAID type analgesics. Results from dental pain studies are accepted by the US Food and Drug Administration (FDA) and European authorities and have been widely extrapolated to other general pain conditions.|t|t|t|t
1285436|NCT03785743|Randomized|Parallel Assignment||Treatment||Single||||||t
1285437|NCT03785730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285438|NCT03785717|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1285439|NCT03785704|Randomized|Parallel Assignment||Treatment||None (Open Label)||Totally 60 subjects will be included in the study.Random assignment was 1:1 to Xinmailong injection group and control group.||||
1285442|NCT03785665||Single Group Assignment||Diagnostic||None (Open Label)||Multi-Center, Open, Home Monitoring, Prospective Study||||
1286504|NCT03771859|||Cohort||Prospective|||||||
1285443|NCT03785652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285444|NCT03785639|||Cohort||Prospective|||||||
1285445|NCT03785626|||Cohort||Prospective|||||||
1285446|NCT03785613|Randomized|Crossover Assignment||Treatment||None (Open Label)||3-way cross-over (three periods, three treatments and six sequence groups) with single application each. There will be a wash-out period between administrations, i.e., between removal of previous patch and application of new patch of at least 10 days.||||
1285447|NCT03785600|Randomized|Parallel Assignment||Supportive Care||Single|Participants will be blinded to the intervention by way of study personnel's description. Subjects will be told that both devices may or may not be active and thus, will be unaware that all light boxes are active and all negative ion generators are inactivated.|Subjects will be randomized to receive MBLT or a sham/no-light control. Subjects randomized to receive MBLT will be given a light box (LightPad, Aurora Light Solutions) to take home. Subjects randomized to receive the sham/no-light control will be given a negative ion generator that has been deactivated such that it still emits an audible hum but does not emit ions.|t|||
1285448|NCT03785587||Single Group Assignment||Treatment||None (Open Label)||||||
1285449|NCT03785574|Randomized|Parallel Assignment||Treatment||None (Open Label)||"A. treated with chemotherapy immediately, B. follow up until hCG level met FIGO diagnostic criteria of GTN (B1) or hCG level declined to normal spontaneously (B2).~A:B=1:2"||||
1285450|NCT03785561|||Cohort||Prospective|||||||
1285451|NCT03785548|||Cohort||Prospective|||||||
1285452|NCT03785535|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285453|NCT03785522|||Cohort||Prospective|||||||
1285454|NCT03785509|||Cohort||Retrospective|||||||
1285455|NCT03785496||Single Group Assignment||Treatment||None (Open Label)||||||
1285456|NCT03785483|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||3 groups: motivation, mindfulness, and treatment as usual||||
1285457|NCT03785470||Single Group Assignment||Other||None (Open Label)||||||
1285458|NCT03785457|Randomized|Parallel Assignment||Treatment||Triple|The primary investigator will be blinded to the measurements of spinal height using stadiometry, and to the group assignment of each participant (sustained versus repetitive extension postures)|||t|t|t
1285459|NCT03785444|||Case-Control||Prospective|||||||
1285460|NCT03785431||Single Group Assignment||Treatment||None (Open Label)||||||
1285461|NCT03785418|Randomized|Parallel Assignment||Treatment||Single|Data downloaded from the participants' implantable loop recorders will not be available to the investigators nor anyone involved in direct patient interaction in the study. A blinded event committee composed of three physicians with a specialization in cardiology, who are not directly involved in the research study, will have access to this data.|A randomization schedule will be prepared by the data coordinating centre at Queen's University, Kingston, Ontario using a computerized random number-generator. Random allocation will be determined by a patient randomization software application. Participants will be randomized on a 1:1 fashion between active intervention and control.||||t
1285462|NCT03785405||Single Group Assignment||Treatment||None (Open Label)||||||
1285463|NCT03785392|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1285464|NCT03785379|Randomized|Parallel Assignment||Treatment||None (Open Label)||After the baseline assessment, patients will be randomly assigned either to: 1) 1-year caloric restriction with an immediate start of 12-week supervised structured exercise training (SSET) (Early-SSET intervention), followed by no exercise at health centers for 3 months; or: 2) 1-year caloric restriction with no exercise at health centers for 3 months and then a 12-week SSET from month 4 to month 6 (Late-SSET intervention). During the last 6 months participants' activity will be unrestricted.||||
1285465|NCT03785366|Randomized|Parallel Assignment||Basic Science||Single|Subjects are blinded until the Day 57 Visit||t|||
1285466|NCT03785353||Single Group Assignment||Health Services Research||None (Open Label)||Participants will arrive at a location TBD on the day of data collection. Consent forms will be dispersed to participants, who will be able to ask any questions they may have before signing. A Spanish-speaking researcher will be available to answer those questions. After consent is received, each participant will draw a random number that will be used to link their responses to pre- and post-lecture surveys. After consent is received, a pre-test on pain knowledge and beliefs will be administered. A 30-minute Pain Neuroscience Education (PNE) lecture will be given to participants in Spanish. A post-test on pain knowledge and beliefs will be administered.||||
1285467|NCT03785340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285468|NCT03785327|Randomized|Crossover Assignment||Basic Science||Single||"ASD participants will complete active and sham simulation sessions in a randomized, counterbalanced order approximately one week apart~TD participants will be assigned to receive or not receive a training session."|t|||
1285469|NCT03785314|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1285470|NCT03785301|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1285471|NCT03785288|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will compare two standard of care treatments: HDR vaginal brachytherapy 3 fractions of 7Gy (Arm 1) to HDR vaginal brachytherapy 6 fractions of 4Gy (Arm 2) for early stage endometrial cancer.||||
1285472|NCT03785275|||Case-Control||Cross-Sectional|||||||
1285473|NCT03785262|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1285474|NCT03785249|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1285475|NCT03785236|||Case-Control||Cross-Sectional|||||||
1285476|NCT03785223|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1285477|NCT03785210||Single Group Assignment||Treatment||None (Open Label)||||||
1285478|NCT03785197|||Cohort||Prospective|||||||
1285479|NCT03785184||Single Group Assignment||Treatment||None (Open Label)||||||
1285480|NCT03785171|||Case-Only||Prospective|||||||
1285481|NCT03785158|Randomized|Parallel Assignment||Supportive Care||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor|This is a randomised, placebo-controlled, two arm parallel design pilot RCT|t|t|t|t
1285482|NCT03785145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285483|NCT03785132|||Cohort||Retrospective|||||||
1285484|NCT03785119|||Cohort||Prospective|||||||
1285840|NCT03780491|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1285485|NCT03785106|Randomized|Parallel Assignment||Prevention||None (Open Label)||This study is a multicenter, randomized, open-label, phase III clinical trial comparing a 4-week daily INH/RPT regimen (1HP) to a 12-weekly INH/RPT (3HP) for the treatment of LTBI in HIV-infected participants without evidence of active TB.||||
1285486|NCT03785093|||Family-Based||Prospective|||||||
1285487|NCT03785080|Randomized|Parallel Assignment||Prevention||None (Open Label)||Stratified randomization according to stroke risk level based on CHA2DS2-VASc (high risk: CHA2DS2-VASc score ≥2; average risk: CHA2DS2-VASc score <2)||||
1285488|NCT03785067|Randomized|Parallel Assignment||Screening||Quadruple|Main Study: Participants are double-blinded. Sub-Study: No blinding to neuropsychological assessments|"Main Study: Multicentre, international, double-blinded, placebo-controlled, parallel-group, randomised controlled trial.~Sub-Study: Multicentre, international, single-arm trial"|t|t|t|t
1285489|NCT03785054|Randomized|Sequential Assignment||Basic Science||Double|• Placebo capsules will be identical in appearance to the HTL0014242 capsules|Single ascending dose|t||t|
1285490|NCT03785041|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1285491|NCT03785028||Single Group Assignment||Basic Science||None (Open Label)||basic science||||
1285492|NCT03785015|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285493|NCT03785002|Non-Randomized|Parallel Assignment||Other||Single||||||t
1285494|NCT03784989|||Other||Retrospective|||||||
1285495|NCT03784976|Randomized|Parallel Assignment||Treatment||Double||||t||t
1285496|NCT03784963|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285497|NCT03784950|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1285498|NCT03784937|||Cohort||Prospective|||||||
1285499|NCT03784924|||Cohort||Prospective|||||||
1285500|NCT03784911|||Cohort||Prospective|||||||
1285501|NCT03784898||Single Group Assignment||Treatment||None (Open Label)||||||
1285502|NCT03784885|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1285503|NCT03784872||Single Group Assignment||Treatment||None (Open Label)||||||
1285504|NCT03784859|||Case-Only||Prospective|||||||
1285505|NCT03784846|Randomized|Parallel Assignment||Prevention||Single||Individually-Randomized Group Treatment||||t
1285506|NCT03784833|||Cohort||Retrospective|||||||
1285507|NCT03784820|Randomized|Parallel Assignment||Treatment||Single||Participants will be randomized to either couple therapy (UNITE) or individual therapy (CBT-E) for binge-eating disorder and will receive 16 1-hour sessions of the respective treatment. All study hypotheses will be tested using recommended Intent-To-Treat (ITT) methods. Differential treatment effects in individual functioning variables will be tested using 2 (time) x 2 (treatment) mixed-effect ANOVAs for binge-purge frequency and eating disorder outcomes and 2 (partner) x 3 (time) x 2 (treatment) mixed-effect ANOVAs for psychological outcomes. (Some variables will have 4 time points). Differential treatment effects in target relationship variables will be tested using 2 (partner) x 2 (time) x 2 (treatment) mixed-effect ANOVAs for all outcomes except vocally encoded emotional arousal. Differential treatment effects of vocally encoded emotional arousal will be tested using repeated-measures Actor Partner Interdependence Models (RM-APIMS).||||t
1285508|NCT03784807|||Case-Control||Prospective|||||||
1285509|NCT03784794|Randomized|Parallel Assignment||Treatment||None (Open Label)||Group A Fibrinogen Concentrate, Protrombin Complex Concentrate, trhromboelastometry guided Group B Cryoprecipitates, fresh frozen plasma, standard coagulation lab test||||
1285510|NCT03784781|||Case-Control||Cross-Sectional|||||||
1285511|NCT03784768|Randomized|Parallel Assignment||Treatment||None (Open Label)||30 stroke patients will be included in this study. The patients who meet the inclusion criteria will be divided randomly into 2 groups as study (n=15) and control (n=15). Patients in study group received 45-min conventional physiotherapy session for 5-days in a week, over 4-week. Each physiotherapy sessions will consist of range of motion and strengthening exercises, exercises such as activities of daily living, mobility and transfer activities. In addition after 45-min conventional physiotherapy session for 3-days in 5-days, while each patient in study group is supine position, plantar vibration will be applied to both foot of each patient with a vibration device with a frequency of 15-100 Hz over 7.5-min. Patients in the control group received 45-min conventional pysiotherapy session for 5-days in a week, over 4-week. Each physiotherapy session will consist of range of motion and strengthening exercises, exercises such as activities of daily living, mobility and transfer activities.||||
1285512|NCT03784755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285513|NCT03784742|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1285514|NCT03784729|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1285515|NCT03784716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285516|NCT03784703|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|prospective, open-label trial|seventy-five patients were randomly assigned to receive either 20 mg per day atorvastatin (Atrostat®, Delta Pharmaceutical Industries, Cairo, Egypt) tablets (ATROVA group, n= 40) or 20 mg per day Rosuvastatin (Rosuvastatin Calcium®, Chemipharm Co. Cairo, Egypt) tablets (ROSUVA group, n= 35) as recommended in NCEP ATP III (21). Twenty patients (Non-statin group, n=20), not treated with statin, were used for comparison. Patients included in the study were maintained on oral hypoglycemic agents (OHA) according to their treatment regimen.||||
1285517|NCT03784690|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1285518|NCT03784677||Single Group Assignment||Treatment||None (Open Label)||||||
1285519|NCT03784664|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1285520|NCT03784651|||Cohort||Prospective|||||||
1285521|NCT03784638|Randomized|Parallel Assignment||Treatment||None (Open Label)||lingually-based triangle flap design buccaly-based triangular flap design||||
1285522|NCT03784625|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||dose escalation model||||
1285523|NCT03784612|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1285524|NCT03784599||Single Group Assignment||Treatment||None (Open Label)||||||
1285525|NCT03784586|||Case-Control||Prospective|||||||
1285612|NCT03783455|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open, controlled, randomized and prospective study.||||
1287267|NCT03761940|||Other||Cross-Sectional|||||||
1285526|NCT03784573|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Subjects will be randomized per dog and handler availability, but subjects that are excluded due to an aversion or dogs or per the Child Life staff member, can be in the control group.||||
1285527|NCT03784560|||Cohort||Prospective|||||||
1285528|NCT03784547|||Cohort||Retrospective|||||||
1285529|NCT03784534|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Pathophysiological and longitudinal study with no therapeutic intervention||||
1285530|NCT03784521|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1285531|NCT03784508|||Cohort||Prospective|||||||
1285532|NCT03784495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285533|NCT03784482|||Cohort||Retrospective|||||||
1285534|NCT03784469|Randomized|Parallel Assignment||Other||Single||||||t
1285535|NCT03784456|Randomized|Parallel Assignment||Prevention||Single|The program is designed as a double blind test, randomized intervention. Which meant that neither the subjects nor the PI and co-PI would not know which kind of diet they're going to obtain. Only investigators and test provider would know the meals corresponding to respective groups of subjects.|This program is designed as a double blind parallel randomized intervention. The primary purpose of this program is Prevention.|t|||
1285536|NCT03784443|Randomized|Parallel Assignment||Treatment||Triple|"To maintain double-masking, participants assigned to the control arm will receive sham implantation. This will be performed with an empty Luer Lock Syringe without a needle attached to it, that will not penetrate the eye nor deliver any drug.~The Iluvien and the sham injection should be performed by the unmasked investigator. The unmasked investigator should not be involved in any patient assessment in the study."|Double masking randomized control trial with 2 parallel treatment arms: intervention (Iluvien plus Ranibizumab) vs control (Sham plus Ranibizumab)|t||t|t
1285537|NCT03784430|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1285538|NCT03784417||Single Group Assignment||Treatment||None (Open Label)||||||
1285539|NCT03784404|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1285540|NCT03784391|||Cohort||Retrospective|||||||
1285541|NCT03784378||||||||||||
1285542|NCT03784365|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285543|NCT03784352|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1285544|NCT03784339|Randomized|Parallel Assignment||Treatment||Single||||||t
1285545|NCT03784326||Single Group Assignment||Treatment||None (Open Label)||||||
1285546|NCT03784313|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1285547|NCT03784300|Randomized|Parallel Assignment||Prevention||Triple||Single center, randomized, double-blind, placebo controlled, SAD study of three escalating doses of PTI-125. A total of 24 healthy subjects enrolled in one of three dose cohorts. Each cohort will contain 8 subjects; six receive PTI-125 and two receive placebo. Three SAD does of PTI-125 oral solution (50, 100 or 200 mg) or placebo solution will be administered.|t||t|t
1285548|NCT03784287||Single Group Assignment||Treatment||None (Open Label)||||||
1285549|NCT03784274|||Other||Retrospective|||||||
1285550|NCT03784261|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285551|NCT03784248|||Ecologic or Community||Prospective|||||||
1285552|NCT03784235|Randomized|Parallel Assignment||Other||Double|Investigator and outcome assessor will remain unaware of treatment group. Physiotherapists involved in exercise instruction will not be blinded. Nor will the participants.||||t|t
1285553|NCT03784222|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285554|NCT03784209|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1285555|NCT03784196|||Case-Control||Prospective|||||||
1285556|NCT03784183|Randomized|Parallel Assignment||Treatment||Single|Single Blind: Neuropsychologists and Neurophysiologists are prevented from having knowledge of the intervention assigned to the participants.|A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group||||t
1285557|NCT03784170|Randomized|Parallel Assignment||Treatment||Quadruple||Subjects will wear a device and will be treated at 1 of 2 device settings for approximately 3 days.|t|t|t|t
1285558|NCT03784157|||Other||Prospective|||||||
1285559|NCT03784144|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Each test will be assessed in different days following a randomized order.||||
1285560|NCT03784131||Single Group Assignment||Treatment||None (Open Label)||||||
1285561|NCT03784118||Single Group Assignment||Screening||None (Open Label)||||||
1285562|NCT03784105|Randomized|Crossover Assignment||Other||Triple|Double-blind, preparation and administration of codeine or placebo conducted by an independent researcher.|Double-blind, placebo-controlled, randomized, cross-over study in healthy volunteers|t||t|t
1285563|NCT03784092|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1285564|NCT03784079|Randomized|Sequential Assignment||Treatment||Double|This will be a double blind study. Subjects and investigator will be blinded.|Eligible subjects will be randomized to receive two active doses of GSK3640254 along with placebo in Part 1 of the study. In Part 2, subjects will receive three active doses of GSK3640254 along with placebo depending upon the data obtained in Part 1.|t||t|
1285565|NCT03784066|Randomized|Parallel Assignment||Treatment||None (Open Label)||The primary objective is to evaluate the biological response in the tumor upon treatment with Durvalumab, and in parallel, with combination of Durvalumab and Tremelimumab.||||
1285566|NCT03784053|||Cohort||Prospective|||||||
1285567|NCT03784040|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285568|NCT03784027|Randomized|Crossover Assignment||Treatment||None (Open Label)||"Device: CamAPS FX~The automated closed loop system (CamAPS FX) will consist of:~Dana insulin pump (Diabecare, Sooil, Seoul, South Korea)~Dexcom G6 real-time CGM sensor (Dexcom, Northridge, CA, USA)~An Android smartphone hosting CamAPS FX app with the Cambridge model predictive control algorithm and communicating wirelessly with the insulin pump and glucose sensor~Cloud upload system to monitor CGM/insulin data."||||
1285613|NCT03783442|Randomized|Parallel Assignment||Treatment||Single|Double-blinded||t|||
1285614|NCT03783429|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind, placebo controlled|A national, multicenter, randomized, double-blind placebo controlled, clinical trial.|t|t|t|t
1286016|NCT03778203|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1285569|NCT03784014|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"MULTISARC is a randomized multicenter study assessing whether high throughput molecular analysis (next generation sequencing exome - NGS) is feasible in advanced soft tissue sarcoma participants.~In parallel, MULTISARC aims to assess efficacy of an innovative treatment strategy guided by high throughput molecular analysis, in participants with advanced soft-tissue sarcomas.~Randomization 1:1 with 1 participant randomized in experimental Arm NGS (treatment strategy based on NGS) and 1 participant randomized in standard Arm No NGS (treatment strategy not based on NGS).~At the end of first-line treatment, participant's tumor profile of experimental Arm NGS will be discussed within a multidisciplinary tumor board which aims at discussing the genomic profiles and at providing a therapeutic decision for each participant. Participants for whom a targetable genomic alteration has been identified will be proposed to enter in one of the subsequent phase II single-arm sub-trial."||||
1285570|NCT03784001|Randomized|Parallel Assignment||Other||Single|"Participants will only know they are taking part in a Mood and Writing Study and will not know which condition they are in."|Participants will be randomly assigned to one of three conditions: Gratitude, Gratitude + Expectations, or Events Control Participants in the two gratitude conditions will login to an online Google form three times a week for two weeks and make entries of up to five things they are grateful for. The form for participants in the gratitude + expectation condition will also provide information about benefits of gratitude. An everyday events control will be used to provide a neutral comparison condition. This group will be instructed to type up to five things or events of note from their day on their form.|t|||
1285571|NCT03783988||Single Group Assignment||Treatment||None (Open Label)||This is a pharmacokinetic study to study the systemic levels of DHEA, DHEAs and TRIAC, before and after application of a new topical combination gel containing DHEA and TRIAC. MS-based validated methods will be used.||||
1285572|NCT03783975||Single Group Assignment||Screening||None (Open Label)||||||
1285573|NCT03783962|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The Behavioral Weight Loss Program: Investigators have developed and implemented a theory-based group-delivered behavioral weight control program in two previous studies that incorporates the elements of current thinking and empirical data on successful weight loss programs, including restricted calorie intake and increased physical activity. In addition to attending weekly classes, participants will track their food intake, exercise, and weight. Participants will share online tracking diaries with the group facilitator who will offer individualized feedback on progress.~The Cooking Program Active Intervention. Twelve cooking classes will be run every other week after the in-person weight loss meetings.~Demonstrations. The demonstration condition will serve as an attention only control. All participants will have an opportunity to sample the prepared food at the end of class. The demonstrations will be led by the same chef as the active intervention group."||||
1285574|NCT03783949|Randomized|Parallel Assignment||Treatment||None (Open Label)||Standard arm (arm A): Carboplatin (AUC5 d1, q3w i.v.) in combination with Paclitaxel (175 mg/m² d1, q3w i.v.) or Carboplatin (AUC4 d1, q3w i.v.) in combination with Gemcitabine (1000 mg/m² d1, d8, q3w i.v.) followed by maintenance therapy with Niraparib (200/ 300 mg oral daily, q4w) First experimental arm (arm B): Ganetespib (150 mg/m2, d1, q3w) in combination with Carboplatin (AUC5 d1, q3w i.v.) followed by maintenance treatment with Niraparib (200/ 300 mg oral daily, q4w) Second experimental arm (arm C): Ganetespib (150 mg/m² d1, q3w i.v.) plus Carboplatin (AUC5 d1, q3w i.v.) followed by Ganetespib (100 mg/m² d1, d8, d15, d22, q4w i.v.) and Niraparib (200 mg oral daily, q4w)||||
1285575|NCT03783936||Single Group Assignment||Treatment||None (Open Label)||||||
1285576|NCT03783923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285577|NCT03783910|Randomized|Crossover Assignment||Treatment||Quadruple||This dose-titration study was conducted with randomized, multi-center, double-blind, placebo-controlled, crossover design and multiple administrations in 2 treatment sequences in treatment periods 1 and 2: Sequence GRT9906-Placebo and sequence Placebo-GRT9906.|t|t|t|t
1285578|NCT03783897||Single Group Assignment||Basic Science||None (Open Label)||||||
1285579|NCT03783884||||||||||||
1285580|NCT03783871||Single Group Assignment||Treatment||None (Open Label)||||||
1285581|NCT03783858||Single Group Assignment||Other||None (Open Label)||||||
1285582|NCT03783845|Randomized|Single Group Assignment||Treatment||Single|||t|||
1285583|NCT03783832|||Cohort||Other|||||||
1285584|NCT03783819|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1285585|NCT03783806|||Case-Control||Cross-Sectional|||||||
1285586|NCT03783793|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285587|NCT03783780||||||||||||
1285588|NCT03783767|Randomized|Parallel Assignment||Prevention||Single||||||t
1285589|NCT03783754|Randomized|Parallel Assignment||Screening||Triple||Main Study: Multicentre, international, double-blinded, placebo-controlled, parallel-group, randomised controlled trial|t|t|t|
1285590|NCT03783741|||Cohort||Prospective|||||||
1285591|NCT03783728|||Case-Only||Prospective|||||||
1285592|NCT03783715|||Cohort||Prospective|||||||
1285593|NCT03783702|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized into one of two groups: one will receive acetaminophen and oxycodone while the other will receive acetaminophen, ibuprofen, and oxycodone.||||
1285594|NCT03783689|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1285595|NCT03783676|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1285596|NCT03783663|Randomized|Parallel Assignment||Health Services Research||Single||parallel arm superiority, pilot feasibility randomized controlled trial|||t|
1285597|NCT03783650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285598|NCT03783637|Randomized|Crossover Assignment||Other||Double|||||t|t
1285599|NCT03783624|Randomized|Parallel Assignment||Treatment||Double|due to the nature of the treatment (Open label placebo, hypnosis)patients and care providers will be in an open label setting, however the investigators and outcomes assessors will be blinded to the conditions.||||t|t
1285600|NCT03783611|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285615|NCT03783416|Randomized|Parallel Assignment||Other||Quadruple||This is a double-blind, randomised, placebo-controlled trial. Randomisation will be stratified by disease stage, i.e. RRMS (and established on DMT) versus progressive MS (and not on DMT). The expected study duration is 36 months (a 12-month recruitment period and a 24-month treatment period). There will be 72 participants: 48 on ixazomib; 24 on placebo.|t|t|t|t
1285601|NCT03783598|Randomized|Parallel Assignment||Treatment||Single|The study population was 76 individuals whose diagnosis of type 2 diabetes. 9 volunteer individual gave up to participation without for various reasons in the process.That intervention grup (n=33) control group (n=34), between the ages of 18 to 65 years and volunteer individuals.|The problem solving therapy is an social cognitive therapy approach. And ıt used for occupational therapy intervention. We used that with person environment occupation model perspective to type 2 diabetes.|t|||
1285602|NCT03783585|Randomized|Parallel Assignment||Treatment||Single||||||t
1285603|NCT03783572|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||2 groups, one with 40 stroke patients and the control group with 40 healthy subjects prospective, longitudinal, without blinding, multicenter.||||
1285604|NCT03783559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285605|NCT03783546|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1285606|NCT03783533||Single Group Assignment||Treatment||None (Open Label)||||||
1285607|NCT03783520|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1285608|NCT03783507|Randomized|Factorial Assignment||Screening||Single||In order to examine if low-ED foods and high-ED foods substitute for each other, a 4 X 4 mixed-factor design with a between-subjects factor of order and a within-subjects factor of meal will be used. For the within-subjects factor of meal, four meal conditions will be implemented. Participants will be randomized to one of 4 orders to reduce the possibility of an order effect. During all sessions, participants will be provided with 12 ounces of water.|t|||
1285609|NCT03783494||Single Group Assignment||Supportive Care||None (Open Label)||||||
1285610|NCT03783481|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1285611|NCT03783468||Single Group Assignment||Treatment||None (Open Label)||||||
1285616|NCT03783403||Single Group Assignment||Treatment||None (Open Label)||||||
1285617|NCT03783390|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||To assess the effectiveness of a physical activity intervention on eating behavior in adolescents; OW/OB inactive adolescents will be randomly assigned to a 3-month exercise intervention (Exercise +Newsletter), or a control condition (Newsletter).||||
1285618|NCT03783377|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1285619|NCT03783364|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285620|NCT03783351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285621|NCT03783338|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will be blinded to which each child allocated to any one of the three arms.|Children will be assigned randomly using sealed envelopes into three intervention groups (A, B and C groups). Group A will receive the conventional physical therapy program (CPTP) only. Group B will receive the CPTP in addition to aerobic exercises, whereas group C will receive CPTP, aerobic exercises in addition to an oral daily dose of vitamin D3 1000 IU (Cholecalciferol). All groups will receive the treatment program for 12 weeks.||||t
1285622|NCT03783325|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Patients will have the opportunity to participate in a questionnaire and then they are given the option to participate in substudy A (wear a UV dosimeter, complete questionnaires, and receive feedback based on the UV dosimeter results), subtstudy B (wear a skin patch, participate in a UV photo analysis, answer questionnaires), and/or substudy C (give biological samples via nevi).||||
1285623|NCT03783312|Randomized|Parallel Assignment||Treatment||Single|Single (Participant)|Prospective, Randomized, Placebo-Controlled Clinical Trial|t|||
1285624|NCT03783299|Randomized|Factorial Assignment||Screening||None (Open Label)||The study is employing a split-plot community-randomized controlled trial design, with peer navigator test and treat randomized at the health center catchment level, and village-based test and treat randomized at the village level within health center catchment areas (HCCA).||||
1285625|NCT03783286|||Cohort||Prospective|||||||
1285626|NCT03783273|Randomized|Crossover Assignment||Treatment||Single|Participants will not know if they receive juice with complex-bound vitamin D3 or not.|A multiple crossover study using a balanced latin square design. Each participant will receive all five treatments with a wash-out period of 10-21 days between each treatment.|t|||
1285627|NCT03783260||Single Group Assignment||Basic Science||None (Open Label)||||||
1285628|NCT03783247|Randomized|Parallel Assignment||Treatment||Double|To achieve double blinding, patients will receive the block by the anesthetist. Another doctor not involved in the block procedure will evaluate the patients postoperatively.|randomized double-blinded|t|||t
1285629|NCT03783234|||Cohort||Prospective|||||||
1285630|NCT03783221|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1285631|NCT03783208|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1285632|NCT03783195|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants are assigned to high genetic risk score group in parallel to low genetic risk score group||||
1285633|NCT03783182|Randomized|Parallel Assignment||Treatment||Triple|Administrator gives the study number and check the randomization list and thereafter gives the drug/placebo to a Health care personnel, who does not know if it is placebo or drug.|Double-blinded, placebo controlled and randomized study|t|t|t|
1285634|NCT03783169|||Case-Control||Prospective|||||||
1285635|NCT03783156|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285636|NCT03783143|||Cohort||Prospective|||||||
1285637|NCT03783130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285638|NCT03783117||Single Group Assignment||Treatment||None (Open Label)||Subjects in second stage of hypertension: the systolic blood pressure in a range of 140-180 mmHg or diastolic blood pressure in a range 90-120 mmHg. For safety, subjects, who have a pacemaker or other metallic devices implanted, will not be admitted.||||
1285639|NCT03783104|Randomized|Parallel Assignment||Prevention||Quadruple|double-blinded|A total of 720 recruited mothers across India and Nepal will be randomly allocated to 2 equal groups (360 each). Group 1 (Intervention) will receive 250μg of vitamin B12 supplementation delivered daily to the mother from 12 weeks gestation up to 6 months post-partum. Group 2 (Control) will receive 50μg of vitamin B12 supplementation delivered daily to the mother from 12 weeks gestation up to 6 months post-partum.|t|t|t|t
1285765|NCT03781466|Randomized|Parallel Assignment||Prevention||None (Open Label)|A randomized clinical trial open label|A randomized clinical trial||||
1285640|NCT03783091|Randomized|Parallel Assignment||Treatment||Single|Vitamin B12a is bright red and excreted in the urine. Due to this, patient allocation cannot be masked for patients or individuals who may care for them.|||||t
1285641|NCT03783078||Single Group Assignment||Treatment||None (Open Label)||||||
1285642|NCT03783065|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285643|NCT03783052|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1285644|NCT03783039|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285645|NCT03783026||Single Group Assignment||Treatment||None (Open Label)||||||
1285646|NCT03783013|Randomized|Crossover Assignment||Other||Double|||||t|t
1285647|NCT03783000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1285648|NCT03782987|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1285649|NCT03782974|Randomized|Parallel Assignment||Treatment||Quadruple|All participants, on-site care-providers and investigators, and the outcome assessors will be informed that this study is placebo controlled, and that each participant has a 50/50 chance of receiving treatment or placebo. The test material will include treatment and placebo, both coated by the same coating. The code will be kept by the sponsor and disclosed after the analyses are completed.|Individuals with Protective Qi Insufficiency|t|t|t|t
1285650|NCT03782961|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1285651|NCT03782948|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1285652|NCT03782935|Randomized|Parallel Assignment||Prevention||None (Open Label)||Pregnant women assigned to 1) over-the-counter approved prenatal multivitamin mineral supplement alone provided by the study at time of enrollment, 2)over-the-counter approved prenatal multivitamin mineral supplement with additional over-the-counter approved 750 mg choline supplement provided by the study at the time of enrollment, or 3) standard of care which is recommendation to take over-the-counter prenatal multivitamin mineral supplements||||
1285653|NCT03782922|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1285654|NCT03782909||Single Group Assignment||Health Services Research||None (Open Label)||||||
1285655|NCT03782896|||Case-Only||Cross-Sectional|||||||
1285656|NCT03782883|||Ecologic or Community||Prospective|||||||
1285657|NCT03782870|||Cohort||Prospective|||||||
1285658|NCT03782857|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants were randomized 1:1 to intervention or control group||||
1285659|NCT03782844|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1285660|NCT03782831|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285661|NCT03782818||Single Group Assignment||Treatment||None (Open Label)||The design is open-label. A 4-week pre-treatment phase will allow ensuring that patients are on stable doses of medication. Patients will be given progressive doses of olaparib up to 300mg BID for 24 weeks.||||
1285662|NCT03782805|Randomized|Parallel Assignment||Treatment||Double|Neither the investigator nor the subjects were aware of the group allocation; the pharmacist (in charge of the placebo tablets as well as the packing and coding of the supplements) was the only person to know to which group each participant belonged.|In this randomized, controlled, double blind study, participants were randomized (using the simple randomization method) to receive either a supplement of 10,000 IU of cholecalciferol (Euro-Pharm International, Canada) or a placebo tablet (containing microcrystalline cellulose: 66.3%, starch: 33.2%, magnesium stearate: 0.5%, per serving) to be taken 3 times a week for a period of six months|t||t|
1285663|NCT03782792|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285664|NCT03782779|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1285665|NCT03782766|Randomized|Parallel Assignment||Treatment||||"Three models:-~Split mouth design where piezocision will be performed on the right of left side of the patient in bilateral first molar extraction space subjects.~comparison between 2 groups of subjects; one group where protraction is done with piezocision and the other group where protraction was done with no piezocision.~third part where the same side of space receives the 2 interventions. Molar protraction started with no piezocision for 3 months followed by piezocision and protraction for another 3 months,"||||
1285666|NCT03782753|||Case-Control||Other|||||||
1285667|NCT03782740|Randomized|Parallel Assignment||Treatment||Triple||Two parallel studies (dysmenorrhea and endometriosis) with 40 participants in each.|t|t|t|
1285668|NCT03782727|||Case-Only||Prospective|||||||
1285669|NCT03782714|Randomized|Parallel Assignment||Treatment||None (Open Label)||It is a split-mouth randomized controlled clinical trial||||
1285670|NCT03782701|Randomized|Parallel Assignment||Treatment||None (Open Label)|Data analysis will be conducted on clinical photographs. Analyzer will be blinded to which eye received intervention versus placebo.|Each patient will be randomized to receive medication in one eye and placebo in the other.||||
1285671|NCT03782688|||Cohort||Prospective|||||||
1285672|NCT03782675|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1285673|NCT03782662|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285674|NCT03782649||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1285675|NCT03782636|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285676|NCT03782623|||Cohort||Prospective|||||||
1285677|NCT03782610|||Cohort||Prospective|||||||
1285678|NCT03782597|||Family-Based||Prospective|||||||
1285679|NCT03782584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285680|NCT03782571|Randomized|Crossover Assignment||Treatment||Single|||t|||
1285681|NCT03782558|||Case-Control||Prospective|||||||
1285682|NCT03782545||Single Group Assignment||Treatment||None (Open Label)|This is an open label study.|A type of intervention model describing a clinical trial in which all participants receive the same intervention/treatment.||||
1285683|NCT03782532|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285684|NCT03782519|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1285685|NCT03782506|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1285766|NCT03781453|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Quasi-experimental, pre-post study design||||
1285767|NCT03781440|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1285686|NCT03782493|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessors and data coders will be blind to experimental condition|A stratified randomized clinical trial design will be used with site (Vanderbilt, Northwestern) and biological sex (boys, girls) as stratification factors and EMT-SF or business-as-usual (BAU) control as a randomization factor.||||t
1285687|NCT03782480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285688|NCT03782467||Single Group Assignment||Treatment||None (Open Label)||||||
1285689|NCT03782454|||Cohort||Prospective|||||||
1285690|NCT03782441||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1285691|NCT03782428|Randomized|Parallel Assignment||Supportive Care||Double|both probiotic and placebo product were labelled as either A or B and was given to the patients through simple randomization.|A randomized double-blind placebo controlled trial was performed in patients who were diagnosed with colorectal cancer and planned for colorectal resection. Four weeks postoperative, patients were randomized to receive either placebo or 3g X 1010 probiotic containing six viable microorganism of Lactobacillus and Bifidobacterium strains for six months.|t||t|
1285692|NCT03782415|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Phase 1b/2a Multi-center, Open-label, Dose Escalation Study||||
1285693|NCT03782402|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1285694|NCT03782389|||Cohort||Retrospective|||||||
1285695|NCT03782376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285696|NCT03782363|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose finding study for the determination of the MTD for the RP2D with cohort of 3 patients plus 3 other patients as scaling design||||
1285697|NCT03782350|Randomized|Parallel Assignment||Treatment||Quadruple|Participants, care provider, investigator and outcomes will be blinded to treatment allocation.|The subject will be assigned to either high dose regimen group or low dose regimen group of tranexamic acid in a blinded fashion|t|t|t|t
1285698|NCT03782337|||Cohort||Prospective|||||||
1285699|NCT03782324|||Case-Only||Prospective|||||||
1285700|NCT03782311|||Cohort||Prospective|||||||
1285701|NCT03782298|||Case-Only||Retrospective|||||||
1285702|NCT03782285|||Cohort||Prospective|||||||
1285703|NCT03782272|Randomized|Parallel Assignment||Other||Triple||This is a mixed-methods pilot study to assess the safety, acceptability, and feasible dosage of AA-ORS among children with mild to moderate stunting (LAZ between -1 and -3) who are at risk for EED and to assess the acceptability of this fluid supplementation for their caregivers. During the main study, child participants will be randomized to receive 14 days of AA-ORS or placebo solution daily, dosing of up to 237 ml over a 3-hour period. Study staff and participants will be blinded to the study product allocation. Caregivers will store and return unused study product. Data collection methods to include direct observation of product consumption, structured surveys with caregivers, average daily volume consumed, and measurement of plasma/serum markers of metabolism, gut dysfunction, systemic inflammation, and micro-nutrient status pre- and post-administration of product.|t|t|t|
1285704|NCT03782259|Randomized|Parallel Assignment||Screening||Quadruple||Randomized, double-blind and placebo controlled cardiac MRI study|t|t|t|t
1285705|NCT03782246|Randomized|Parallel Assignment||Treatment||Single||||||t
1285706|NCT03782233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285707|NCT03782220|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285708|NCT03782207|||Cohort||Prospective|||||||
1285709|NCT03782194|Non-Randomized|Parallel Assignment||Other||Triple|Participants will be blinded to whether or not the LIFUP transducer is on and, when on, what parameters are used. The investigator collecting the neuropsychological data will be blinded to which condition (LIFUP, sham) the participant completed during the session. The statistical analysts for both the neuropsychological and neuroimaging data will also be blinded to condition.||t||t|t
1285710|NCT03782181|Randomized|Parallel Assignment||Treatment||Double|In this clinical trial design strategy, the participants and the investigator do not know which participants have been assigned which interventions so there is a double-blind masking.|In this clinical,two groups of participants receive different interventions. One group receives a training with a whole body vibration plattform and the other is the control group.|t||t|
1285711|NCT03782168|||Case-Control||Prospective|||||||
1285712|NCT03782155|Randomized|Parallel Assignment||Treatment||Triple||A randomized clinical trial study|t||t|t
1285713|NCT03782142|||Case-Only||Cross-Sectional|||||||
1285714|NCT03782129|||Cohort||Prospective|||||||
1285715|NCT03782116||||||||||||
1285716|NCT03782103|Randomized|Parallel Assignment||Prevention||Single||||||t
1285717|NCT03782090|Randomized|Parallel Assignment||Other||Single|Patients, investigators who evaluate complication of intubation are blinded to the study group.|Patients were randomly allocated into either control group (n = 95) or experimental group (n = 95) by a computerized randomization table. In control group, endobronchial intubation is performed using conventional technique with left-sided double-lumen endotracheal tube (Shiley®, Covidien, Mansfield, MA, USA). In experimental group, patients are intubated with novel double-lumen endotracheal tube (Ankor®,Insung Medical, Wonjou, S. Korea).|t|||
1285718|NCT03782077|||Cohort||Prospective|||||||
1285719|NCT03782064||Single Group Assignment||Treatment||None (Open Label)||||||
1285720|NCT03782051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285721|NCT03782038||Single Group Assignment||Treatment||None (Open Label)||||||
1285722|NCT03782025|||Case-Crossover||Prospective|||||||
1285723|NCT03782012|Randomized|Parallel Assignment||Diagnostic||Double|Provide information about other parties who may be masked in the clinical trial,|This study will randomly select 300 from Storm Lake students in grades 5-8 (i.e., 75 students per grade) (see Table 1). Because of the short duration of the experiment (3 sessions), we estimate 20% attrition (n = 60 students). We will replace all students who exit from the sample within grade to ensure sufficiently power. Students will randomly be assigned within grade to one of two conditions: support versus no support.|t|||t
1285724|NCT03781999|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1285768|NCT03781427|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1286017|NCT03778190||Single Group Assignment||Treatment||None (Open Label)||||||
1286123|NCT03776812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285725|NCT03781986|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Part 1:~Arm A: APG-115 Monotherapy, APG-115 (PO): dose= 150 mg, Cycle length: 21 days~Arm B: APG-115 + Carboplatin, APG-115 (PO): dose= 150 mg, Cycle length: 21 days~Carboplatin (IV): dose= AUC 4.5, day= 1, cycle length: 21 days~Part 2:~One of the regimens in Arm A or Arm B based on emerging data from Part 1."||||
1285726|NCT03781973||Sequential Assignment||Health Services Research||None (Open Label)||An intervention with integrated components||||
1285727|NCT03781960||Single Group Assignment||Treatment||None (Open Label)||||||
1285728|NCT03781947|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||This Phase I clinical study is an open-label, parallel-design, single-centre study to investigate the PK, safety and PD following subcutaneous and intramuscular administration of single doses of teverelix TFA in healthy male subjects.||||
1285729|NCT03781934|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Intrapatient dose escalations continuing into interpatient dose escalations to end with dose expansion cohorts.||||
1285730|NCT03781921|||Cohort||Cross-Sectional|||||||
1285731|NCT03781908|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285732|NCT03781895|Randomized|Parallel Assignment||Supportive Care||Triple|Prospective interventional randomized double blinded study|Two groups of Vitamin D3 deficient stable COPD patients were taken, Group A was given placebo along with standard therapeutic treatment and Group B was given Vitamin D3 along with standard therapeutic treatment|t|t|t|
1285733|NCT03781882|Randomized|Parallel Assignment||Treatment||Single|Patients were not allowed to know allocations|All cases with disrupted surgical wounds admitted at Obstetrics and Gynecology departments|t|||
1285734|NCT03781869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285735|NCT03781856|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285736|NCT03781843|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1285737|NCT03781830||Single Group Assignment||Supportive Care||None (Open Label)||This is a single center prospective trial. Participants in this study will use the mHealth application to manage and track their immunosuppression medical regimen post-transplant.||||
1285738|NCT03781817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285739|NCT03781804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285740|NCT03781791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285741|NCT03781778|Randomized|Parallel Assignment||Prevention||Double|"Assignment to the active versus control group will be blinded using a computer program and will be designated as diet A and diet B. Investigators will be unblinded once the study and data analyses have been completed."|Blinded, block randomization based on sex and BMI.|t||t|
1285742|NCT03781765|Randomized|Single Group Assignment||Basic Science||None (Open Label)||This is a pilot study with no control group. All youth will be treated with MPH or ATX and receive pre and post fMRI.||||
1285743|NCT03781752||Single Group Assignment||Basic Science||None (Open Label)||Youth will NOT be randomized to drug for this PD study, but will receive MPH from their treatment providers in clinical care either before or after being invited to participate in the PK procedure. Their treatment data will be collected from their providers to augment the study team's analyses. The study team is performing a pharmacokinetic (PK) study using a single dose of methylphenidate (MPH) among youth identified as having specific variants of the CES1 gene. Youth will be identified by cheek swabs for CES1 variants. They will be provided . MPH for the PK procedure.||||
1285744|NCT03781739|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285745|NCT03781726||Single Group Assignment||Prevention||None (Open Label)||||||
1285746|NCT03781713|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"To evaluate the impact of the tool on the time of stabilization of patients, two groups will be compared: the first will be composed of patients who did not triggered triggers and the second by patients who triggered triggers and had interventions.~For the calculation of the stabilization time, the long-term risk rating of the Epimed Performance software will be used, which allows us to estimate the length of ICU stay of the patients individually using more than 60 variables."||||
1285747|NCT03781700|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized controlled trial|t|t|t|t
1285748|NCT03781687|Randomized|Crossover Assignment||Prevention||Single||||||t
1285749|NCT03781674|Randomized|Parallel Assignment||Prevention||Quadruple|a double‐blind randomized controlled trial|a double‐blind randomized controlled trial|t|t|t|t
1285750|NCT03781661|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Experimental randomized controlled trial||||
1285751|NCT03781648|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1285752|NCT03781635|Randomized|Parallel Assignment||Treatment||Quadruple|Randomization into group infusion versus boluses of ketamine will be done prior to the entrance in the OR, the day of the surgery|Two groups of patients. Randomization into group infusion versus boluses of ketamine according to a randomization list for a total number of patients of 50.|t|t|t|t
1285753|NCT03781622||Single Group Assignment||Treatment||None (Open Label)||A prospective, non-randomized, multi-center, feasibility clinical investigation to evaluate the safety and device technical performance of the WOLF Thrombectomy Device in removing thrombus from an occluded large intracranial vessel(s) in patients with acute ischemic stroke. The device may be used alone or as an adjunct to intravenous tissue plasminogen activator (tPA) and/or to other traditional, thrombectomy modalities.||||
1285754|NCT03781609|Randomized|Parallel Assignment||Treatment||Single||||||t
1285755|NCT03781596|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1285756|NCT03781583|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Testing will be done in three conditions: baseline (no HMD), sham (smartHMD worn but not active), and smartHMD (smartHMD worn and active)||||
1285757|NCT03781570|||Cohort||Prospective|||||||
1285758|NCT03781557|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1285759|NCT03781544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285760|NCT03781531|||Cohort||Prospective|||||||
1285761|NCT03781518|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285762|NCT03781505|Randomized|Parallel Assignment||Treatment||Triple||Randomized control trail|t||t|t
1285763|NCT03781492|||Cohort||Prospective|||||||
1285764|NCT03781479|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1285769|NCT03781414|Randomized|Parallel Assignment||Treatment||None (Open Label)||Study CCFZ533A2202 is a randomized, 12-month, active-controlled, multicenter, dose range finding study to evaluate the efficacy, safety, tolerability, PK and PD of CFZ533, as compared to standard of care comprised of tacrolimus, MMF and corticosteroids, with a 12-month additional follow up.||||
1285770|NCT03781401|||Cohort||Cross-Sectional|||||||
1285771|NCT03781388|Non-Randomized|Sequential Assignment||Treatment||Triple|Blinded study drugs will be prepared by an anesthesia provider not involved in the study. The anesthesia provider providing care to the patient will be blinded to the dosage of the hyperbaric bupivacaine. In order to preserve the blinding of the provider, the total volume of study drug will be maintained at a constant of 2mL. The difference in total volume based on the variation of hyperbaric bupivacaine dosing will be replaced with preservative free normal saline.|The starting dose of hyperbaric bupivacaine for the first patient in this study will be 9mg; the dose for the subsequent subject will be based on the response of the preceding subject as per the Narayana Rule, a modification of the biased-coin design (BCD) up-down sequential method (UDM).|t|t||t
1285772|NCT03781375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285773|NCT03781362||Single Group Assignment||Treatment||None (Open Label)||3 + 3 dose escalation study design||||
1285774|NCT03781349|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1285775|NCT03781336|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Participants are allocated into the mindfulness-based self-care group or a wait list group for 5 weeks. Since the group is offered during work hours, the waitlist group could be best described as treatment as usual. After group allocation, all participants complete demographic and clinical assessments at baseline, and follow-up."||||
1285776|NCT03781323||Single Group Assignment||Treatment||None (Open Label)||||||
1285777|NCT03781310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285778|NCT03781297|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1285779|NCT03781284|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1285780|NCT03781271|Non-Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||2 arms of patients will undergo standard routine brachytherapy treatment. A part of the treatment involves the placement of catheters. For both arms of the study the placement of these catheters will be assisted by an electromagnetic navigation system. The difference between the arms will be that the navigation system will be used at different times in the course of their brachytherapy treatment to eliminate bias. One group will undergo electromagnetic navigation assisted catheter placement during their first fraction of treatment while the second arm will undergo electromagnetic navigation assisted catheter placement during their third fraction of treatment.||||
1285781|NCT03781258||Single Group Assignment||Other||None (Open Label)||Patients implanted with the HeartMate 3 LVAS will be screened for participation in the study with established stability at 6 months after implantation of the device. If inclusion criteria are met, patients will be transitioned to a single anti-thrombotic therapy with Acetylsalicylic Acid (ASA) or equivalent and anticoagulation with warfarin will be withdrawn. ASA will be administered in a minimum dose of 100 mg per day with dosage adjustments based on VerifyNow testing up to a maximum of 200 mg daily. The primary endpoint will be analyzed at 90 and 180 days after initiation of the single antiplatelet therapy.||||
1285782|NCT03781245|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1285783|NCT03781232|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1285784|NCT03781219||Sequential Assignment||Treatment||None (Open Label)||If no Dose-limiting toxicity (DLT) occurs in the first three subjects in Cycle 1, the dose will be escalated to the next dose level; If a DLT occurs in one of the first three subjects, three additional subjects will be enrolled for the same dose cohort, and undergo the same procedures. Dose -escalation is performed based on the scheduled dose groups until DLT occurs in two or more subjects in a dose group which consists of 3 or 6 subjects.||||
1285785|NCT03781206|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1285786|NCT03781193|||Cohort||Prospective|||||||
1285787|NCT03781180|||Case-Only||Retrospective|||||||
1285788|NCT03781167||Single Group Assignment||Treatment||None (Open Label)||||||
1285789|NCT03781154|Randomized|Parallel Assignment||Supportive Care||Double|PI and study staff conducting assessments at study visits will be blinded to study arm assignment.|Patients will be randomized to either one on one exercise with a personal trainer or they will be randomized to Group Mediated Cognitive Behavior (GMCB) exercise|||t|t
1285790|NCT03781141|Randomized|Single Group Assignment||Treatment||Single|Blinded assessment for wound healing|||||t
1285791|NCT03781128|Randomized|Crossover Assignment||Treatment||Quadruple|double-blind|Double-blind, randomized, placebo-controlled two-phase cross-over study design.|t|t|t|t
1285792|NCT03781115|Randomized|Parallel Assignment||Diagnostic||Double|Double Blind Masking: The participant and the investigator are both blinded.|The investigators will first conduct a dose-response evaluation of the anti-psychotic drug ziprasidone (Geodon) (20, 40, or 60 mg tablet) or olanzapine (Zyprexa®) (2.5, 5, 7.5, or 10 mg tablet) in non-psychiatric ill control individuals to determine the dosage that promotes sedation in individuals versus a placebo. The evaluation will comprise of a physical examination, drug/pregnancy screenings and sleepiness questionnaires. Once the dosage of the anti-psychotic medication is determined new healthy subjects will be recruited to ingest the medication and have an electroencephalogram (EEG) recording taken. If the dosage of medication does not show an effect on the EEG the investigators will ask the individual to come back on a different day so the next higher dose of medication can be given. Once a the healthy subject's EEG shows an effect new control subjects and individuals with a diagnosis of schizophrenia will be recruited.|t||t|
1285831|NCT03780608|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1285832|NCT03780595|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285833|NCT03780582|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1285834|NCT03780569||Single Group Assignment||Treatment||None (Open Label)||||||
1285835|NCT03780556|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1285836|NCT03780543|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285837|NCT03780530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285838|NCT03780517||Sequential Assignment||Treatment||None (Open Label)||||||
1285839|NCT03780504|||Cohort||Prospective|||||||
1285793|NCT03781102|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants (60 children and their biological mothers (n=120)) will be assigned to a clinic location nearest to their home address, which will determine the order in which they will complete the 16-week intervention. Two clinics were selected to participate in this pilot study. Randomization to the intervention and wait-list control conditions will be performed *by site* (flip of a coin). Randomization by site is proposed as it has the least potential for contamination during the initial delivery period. Group A participants (n=30) will begin the 16-week face-to-face group program immediately, whereas the Group B participants (n=30) will receive normal standard of care. After 16 weeks, the Group A participants will transition to follow-up while the Group B participants begin the intervention. This design is responsive to standards of care for T2D prevention by primary care providers and will provide the opportunity to investigate all the outcome questions.||||
1285794|NCT03781089|Randomized|Parallel Assignment||Prevention||Single|The study is open-label and therefore the subjects, coordinators and investigators are not blinded to the intervention. Titration of the patiromer will require viewing of the serum potassium values. During the data analysis, however, personnel involved will remain blinded.|This is a prospective, randomized, open-label trial. Eligible ESRD patients who are on thrice weekly HD schedule will be screened from retrospective review of clinical and laboratory parameters from our clinical practice group. A total of 40 patients (randomized 1:1 study drug: usual care) will be enrolled. Duration of study medication exposure will be 4 weeks. The total duration of study, from enrollment until the end of the washout period will be 7 weeks.||||t
1285795|NCT03781076|Randomized|Parallel Assignment||Treatment||Single|The intervention explicitly involves behavior change, so the participant cannot be blinded. The outcomes assessment involves objective monitors, and therefore can be considered blind.|Note that the intervention portion of the study involves only a subset of participants. The larger bulk (planned n=108) will undergo only initial observation of sleep and concussion symptoms. The investigators plan to have 24 (those still symptomatic at 4 weeks post-concussion who do not get recommended sleep) undergo a pilot trial of a sleep intervention.||||t
1285796|NCT03781063|Randomized|Parallel Assignment||Treatment||None (Open Label)||open label, randomized, parallel-group, multicenter study||||
1285797|NCT03781050||Single Group Assignment||Treatment||None (Open Label)||||||
1285798|NCT03781037||Single Group Assignment||Treatment||None (Open Label)||open label pilot study||||
1285799|NCT03781024|||Cohort||Prospective|||||||
1285800|NCT03781011|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1285801|NCT03780998|||Cohort||Prospective|||||||
1285802|NCT03780985|Randomized|Parallel Assignment||Prevention||Single|||t|||
1285803|NCT03780972|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1285804|NCT03780959|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285805|NCT03780946|||Case-Control||Prospective|||||||
1285806|NCT03780933|Randomized|Parallel Assignment||Treatment||Single|||||t|
1285807|NCT03780920|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1285808|NCT03780907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285809|NCT03780894|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Single-center, non-randomized, open-label, two-arms, controlled pilot clinical trial.~The experimental and control arms will be determined according to the SEM units with RBC, TXA and FC administration capacity (i.e. helicopter unit, rapid intervention ambulance or advanced life support ambulance). The emergency SEM units are activated according current protocols based on distance, severity and weather conditions."||||
1285810|NCT03780881|Randomized|Parallel Assignment||Basic Science||Single|The investigator randomly assigns participants to one of the experimental conditions. Participants are not aware which experimental condition they are allocated to.|Participants are assigned to one of two experimental groups in parallel for the duration of the study|||t|
1285811|NCT03780868|Randomized|Parallel Assignment||Treatment||Single||compare external dacryocystorhinostomy versus canalicular silicone intubation with the use of Mitomycin C (MMC) in primary acquired nasolacrimal duct obstruction (NLDO).|t|||
1285812|NCT03780855|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1285813|NCT03780842|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||Prospective, interventional, exploratory study in a convenience sample||||
1285814|NCT03780829|Randomized|Crossover Assignment||Treatment||Double|participants and some research personnel will be blinded|repetitive intermittent hypoxia treatment combined with exercise and/or NMDA agonist|t||t|
1285815|NCT03780816|||Ecologic or Community||Other|||||||
1285816|NCT03780803|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1285817|NCT03780790|Randomized|Parallel Assignment||Screening||Triple||RANDOMISED DOUBLE BLINDED INTERVENTIONAL|t||t|t
1285818|NCT03780777||Single Group Assignment||Health Services Research||None (Open Label)||||||
1285819|NCT03780764|Randomized|Parallel Assignment||Treatment||None (Open Label)||A split mouth study design was applied for each patient. Two different fixed appliance brackets were used in the lower arch (self-ligating brackets on one side and conventional brackets on the other side of the same patients).||||
1285820|NCT03780751|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to one of three groups parallel for the duration of the study. 40% of participants will be assigned to one of the two immediate treatment conditions, 20% of participants will be assigned to a waitlist and will begin active treatment after a six months waiting period.||||
1285821|NCT03780738|||Case-Control||Prospective|||||||
1285822|NCT03780725|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1285823|NCT03780712|||Cohort||Prospective|||||||
1285824|NCT03780699|||Other||Cross-Sectional|||||||
1285825|NCT03780686|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1285826|NCT03780673|Randomized|Parallel Assignment||Treatment||Double|Neither the participants nor the researchers will know which group the participants has been allocated to|Phase III, multicentre, double-blind placebo-controlled, randomized clinical trial|t||t|
1285827|NCT03780660|||Cohort||Prospective|||||||
1285828|NCT03780647|||Cohort||Cross-Sectional|||||||
1285829|NCT03780634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285830|NCT03780621|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1285841|NCT03780478|Randomized|Parallel Assignment||Treatment||Single|After giving consent to participate in study, patients enrolled in study will be randomly assigned to either the experimental vs. normal standard of care. Patients will be unaware as to which group they are assigned.|"rhinoplasty/septoplasty patients will be identified by Dr. Kochhar (PI). Patients' informed consent for participation in this study will be obtained and they will subsequently be enrolled. Participants will be randomized into two arms: experimental vs. no treatment.~Study arms:~Experimental: SPG block with local anesthetic per normal methods of nerve block.~Current standard of care: no local injection at sphenopalatine ganglion."|t|||
1285842|NCT03780465|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285843|NCT03780452|||Case-Only||Prospective|||||||
1285844|NCT03780439|||Cohort||Prospective|||||||
1285845|NCT03780426|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1285846|NCT03780413|Randomized|Crossover Assignment||Treatment||Single|Blinded assessors|RCT in which participants are randomized to active group (CPS for 10 weeks) or control group (treatment as usual for 10 weeks, followed CPS for 10 weeks)||||t
1285847|NCT03780400||Single Group Assignment||Treatment||None (Open Label)||||||
1285848|NCT03780387||Single Group Assignment||Basic Science||None (Open Label)||||||
1285849|NCT03780374|Randomized|Crossover Assignment||Treatment||Single|The participant's will not know which intervention will be applied.|Each participant will be treated with sound principle 1, 2 and 3 in a crossover design.|t|||
1285850|NCT03780361||Single Group Assignment||Basic Science||None (Open Label)||||||
1285851|NCT03780348|Randomized|Parallel Assignment||Diagnostic||Triple|The caregivers of the children, the care provider linking the children to either of the groups and the investigator will not know which group each child is joining and which group is using which method.|Children will be assigned for nutrition status assessment to either of the two groups that use the 'new' or the 'existing' assessment method|t|t|t|
1285852|NCT03780335|||Case-Control||Retrospective|||||||
1285853|NCT03780322|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1285854|NCT03780309|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285855|NCT03780296||Single Group Assignment||Device Feasibility||None (Open Label)||Single group pre-test/post-test design||||
1285856|NCT03780283|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1285857|NCT03780270|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285858|NCT03780257|Randomized|Sequential Assignment||Treatment||Quadruple|The first subject in a dose cohort will receive QR-421a (open-label); subsequent subjects in the same dose cohort will be randomized to either QR-421a or sham-procedure in a double-masked approach.||t|t|t|t
1285859|NCT03780244|Randomized|Parallel Assignment||Treatment||Single||||||t
1285860|NCT03780231|||Cohort||Prospective|||||||
1285861|NCT03780218|||Case-Control||Prospective|||||||
1285862|NCT03780205|||Cohort||Prospective|||||||
1285863|NCT03780192|||Other||Prospective|||||||
1285864|NCT03780179|Randomized|Parallel Assignment||Prevention||Quadruple||Randomization to intervention: MMRvaxpro at 6 months of age, or placebo-vaccine (solvent only)|t|t|t|t
1285865|NCT03780166||Single Group Assignment||Treatment||None (Open Label)||||||
1285866|NCT03780153|||Ecologic or Community||Cross-Sectional|||||||
1285867|NCT03780140||||||||||||
1285868|NCT03780127||||||||||||
1285869|NCT03780114|||Case-Only||Cross-Sectional|||||||
1285870|NCT03780101|||Other||Prospective|||||||
1285871|NCT03780088||Single Group Assignment||Treatment||None (Open Label)||||||
1285872|NCT03780075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285873|NCT03780062||Single Group Assignment||Diagnostic||None (Open Label)||||||
1285874|NCT03780049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285875|NCT03780036|Randomized|Parallel Assignment||Treatment||Single|The participant will not know which implant was used for segmental replacement of his or hear femur.|Random assignment of patients into one of the two study arms: porous collar magaprostheses or porous collar with HA megaprostheses.|t|||
1285876|NCT03780023|||Case-Only||Prospective|||||||
1285877|NCT03780010||Single Group Assignment||Treatment||None (Open Label)||||||
1285878|NCT03779997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285879|NCT03779984||||||||||||
1285880|NCT03779971|Randomized|Crossover Assignment||Basic Science||Double|Treatments will be color coded, and samples will be labeled only by subject number and date. Investigators and outcomes assessors will not know the treatments nor the color code until after the data analyses are complete.||||t|t
1285881|NCT03779958|||Cohort||Prospective|||||||
1285882|NCT03779945|Randomized|Parallel Assignment||Treatment||Single|the person performing the statistical analysis shall be masked|single center, prospective randomized comparative trial||||t
1285883|NCT03779932|||Case-Only||Cross-Sectional|||||||
1285884|NCT03779919|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1285885|NCT03779906||Single Group Assignment||Other||None (Open Label)||||||
1285886|NCT03779893|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1285887|NCT03779880|||Case-Only||Retrospective|||||||
1285888|NCT03779867|Randomized|Parallel Assignment||Prevention||Double|All study personnel other than the statisticians and exercise physiologist will be masked to participant study arm||||t|t
1285889|NCT03779854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285890|NCT03779841|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285891|NCT03779828|||Other||Prospective|||||||
1285892|NCT03779815||Single Group Assignment||Diagnostic||None (Open Label)||||||
1285893|NCT03779802||Single Group Assignment||Treatment||None (Open Label)||||||
1285894|NCT03779789|Randomized|Parallel Assignment||Treatment||Single||Pragmatic, multicenter, open-label, parallel-group, superiority, randomized trial.||||t
1285895|NCT03779776|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1285896|NCT03779763|||Ecologic or Community||Cross-Sectional|||||||
1285897|NCT03779750|||Cohort||Prospective|||||||
1286124|NCT03776799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372173|NCT02655887||||||||||||
1285898|NCT03779737|Randomized|Parallel Assignment||Prevention||Double|The person responsible for the analyzes will be blind about the interventions. The analysis will be by intention to treat. There would be three arms of the study (strength group, aerobic exercise group and control group) of adolescents of 12 to 17 years old. A balanced randomization will be carried out using random numbers generated in software systematized form, guaranteeing the homogeneity of the number of subjects in each arm, with internal random assignment with a ratio of 1:1:1 to receive the study intervention.|The study is divided into two phases carried out in several visits: Phase I is constituted by a visit -1 and 1, which includes the selection of the sample and the randomization. Phase II includes the execution of the study with three arms, one group will be assigned to strength training and the other to aerobic capacity training, taking into account the plan of sessions per week defined for SIMAC (three sessions). The control group will be monitored passively for the detection of adverse or secondary events. At the end of this phase, anthropometric, clinical and biochemical markers will be monitored in the two intervention groups and in the control group. In Phase III a combined program of strength and aerobic capacity will be implemented, which will last six months more than will be compared with the previously defined control group.|||t|t
1285899|NCT03779724|Randomized|Parallel Assignment||Treatment||None (Open Label)||This prospective randomized controlled trial aimed to recruit 60 patients with MS from the physical medicine and rehabilitation clinic of Ankara Training and Research Hospital, Health Sciences University, Ankara, Turkey (June 2016 to June 2017). Fifty patients who met the inclusion criteria were enrolled in the study. Fifty patients were randomized to two groups: isokinetic exercise (Group 1) (n=25) and home exercise (Group 2) (n=25). Randomization was completed using sequentially numbered, opaque envelopes by the investigator. All patients gave informed consent before the assessment. The outcome measures were assessed initially and at eighth week after the treatment. Group 1 performed isokinetic concentric quadriceps and hamstring strengthening exercises under supervision and Group 2 performed lower extremity muscle strengthening and balance exercises at home.||||
1285900|NCT03779711|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285901|NCT03779698|Randomized|Parallel Assignment||Treatment||Triple|Two full-time pediatric dentistry faculty members (other than the operator) from KAU blindly evaluated all the teeth clinically and radiographically.|A double-blinded, split-mouth, randomized, controlled clinical study design was used with a sample of 37 healthy children aged 4- to 8-year-old. A total of 56 pairs (112 teeth) of carious primary teeth, 1 pair per child, were selected for treatment. One tooth from each pair was randomly assigned to either the BiodentineTM pulpotomy group or the formocresol pulpotomy group.|t||t|t
1285902|NCT03779685|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1285903|NCT03779672|Randomized|Crossover Assignment||Treatment||Quadruple|Double-blinded Placebo vs Memantine|Monocentric, Off-Label Use, Randomized, crossover, Double-blinded Placebo vs Memantine.|t|t|t|t
1285904|NCT03779659|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1285905|NCT03779646|Randomized|Parallel Assignment||Treatment||Single|The investigator, care providers and participants will know whether the participants use the trial drug（bisoprolol） or not. But the outcome assessor who will analysis the results of the cardiac MR and echocardiography images from the participants will be blinded to the grouping situation.|This is a randomized, controlled trial.Enrolled participants should receive a kind of ACEI drug for more than 1 month and the dose should be fixed. Then the participants were randomly assigned (1:1) to receive either bisoprolol or not any beta blocker.||||t
1285906|NCT03779633|Randomized|Parallel Assignment||Treatment||Double||Double-blind, Placebo-controlled|t||t|
1285907|NCT03779620||Single Group Assignment||Treatment||None (Open Label)||Ultrasound treatment of calcified aortic valve stenosis||||
1285908|NCT03779607|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1285909|NCT03779594||Single Group Assignment||Treatment||None (Open Label)||||||
1285910|NCT03779581|Randomized|Parallel Assignment||Treatment||Quadruple||Six of the 17 subjects visiting out-patient Department of our hospital met the inclusion criteria. All the subjects diagnosed with kyphoscoliosis signed the informed consent approved by the ethical committee of the hospital. The diagnosis was based on the diagnosis by an experienced radiologist. Subjects with idiopathic kyphoscoliosis and Cobb's angle greater than 60 degree and normal pulmonary function were included. The subjects with other cardiovascular pathologies, congenital disorders and inability to commute were excluded from this study.|t|t|t|t
1285911|NCT03779568||Single Group Assignment||Other||None (Open Label)||||||
1285912|NCT03779555|||Cohort||Prospective|||||||
1285913|NCT03779542|||Case-Control||Prospective|||||||
1285914|NCT03779529|Randomized|Parallel Assignment||Treatment||Quadruple|The olive oils will be administered as oil A or B with content unknown to participants, investigators and outcome assessors|The general linear model for repeated measurements will be used with multiple paired comparisons in order to assess differences between the groups.|t|t|t|t
1285915|NCT03779516|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1285916|NCT03779503|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1285917|NCT03779490|||Cohort||Prospective|||||||
1285918|NCT03779477|Randomized|Parallel Assignment||Prevention||Single||||||t
1285919|NCT03779464|Randomized|Parallel Assignment||Treatment||Single||||||t
1285920|NCT03779451|Randomized|Parallel Assignment||Prevention||None (Open Label)|An open-label randomized controlled study|A randomized controlled study||||
1285921|NCT03779438|Randomized|Parallel Assignment||Prevention||Quadruple|A Double-Blind Randomized Clinical Trial|A Double-Blind Randomized Clinical Trial|t|t|t|t
1285922|NCT03779425||Single Group Assignment||Treatment||None (Open Label)||||||
1285923|NCT03779412|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomly assigned to one of two active self-help interventions for the duration of the study.||||
1285924|NCT03779399|||Case-Control||Prospective|||||||
1285925|NCT03779386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285926|NCT03779373|Randomized|Parallel Assignment||Treatment||Single||Prospective randomized controlled trial|t|||
1285927|NCT03779360|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||An interventional, open-label, comparator controlled study to investigate the immunomodulatory effects of erythromycin and clindamycin in an LPS skin challenge model in healthy volunteers.||||
1380092|NCT02552485|||||Prospective|||||||
1285928|NCT03779347|Randomized|Factorial Assignment||Diagnostic||Double|Study assessor /investigator will be blinded from the treatment allocation. Treatment for study participants will be given under the supervision of the trained nurses at the ANC, while the study assessor will assess participants for clinical events at the research center||||t|t
1285929|NCT03779334||Single Group Assignment||Treatment||None (Open Label)||Open-label, single arm||||
1285930|NCT03779321|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1285931|NCT03779308||Single Group Assignment||Treatment||None (Open Label)||Before and after cohort study with sample size less than 20||||
1285932|NCT03779295|Randomized|Parallel Assignment||Treatment||Single|"The investigators will not remind the participant or other investigators which side of the face received laser therapy, however the investigators cannot completely blind either the participant or other investigators as they will be awake or performing the therapy, respectively."|This will be a split face prospective trial. The face will be treated in halves. The halves will be randomized to receive topical clindamycin or PDL therapy and clindamycin. Both halves of the face will be treated with topical clindamycin. Per randomization, half of the face will be treated with pulse dye laser therapy at 595 nm, using 6.5 J/cm2, 10 mm spot size and a 6 millisecond pulse width.|t|||
1285933|NCT03779282|||Case-Control||Prospective|||||||
1285934|NCT03779269|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||prospective convenience controlled study||||
1285935|NCT03779256|||Cohort||Prospective|||||||
1285936|NCT03779243|Randomized|Parallel Assignment||Treatment||Double|double-blind||t|t||
1285937|NCT03779230||Single Group Assignment||Treatment||None (Open Label)||Open label, non-randomized, mono-center Phase I/II study in subjects with IDH-wildtype WHO grade III / IV glioma at first relapse.||||
1285938|NCT03779217|||Cohort||Prospective|||||||
1285939|NCT03779204|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will employ a convergent mixed methods design (i.e., quantitative and qualitative data are collected concurrently, and the findings combined) embedded within a RCT and a CBPAR framework. 24 participants will be assessed for eligibility, and then randomized into 1 of 2 arms using covariate adaptive randomization. 12 are allocated to the intervention group (rent subsidies + mentoring), while 12 are allocated to the control group (rent subsidies only). Participants in the intervention group (n = 12) will be matched with an adult mentor recruited by one of the community partners. Mentors are selected and matched through one-on-one interviews with someone in a leadership role within the organization. A common mentoring guide will be used for all sites; these booklets cover information ranging from ideal mentor characteristics to mentor code of conduct.||||
1285940|NCT03779191||Single Group Assignment||Treatment||None (Open Label)||Phase II, single arm trial assessing Alectinib in combination with Bevacizumab in untreated and previously treated patients with Advanced or Metastatic Non-Squamous ALK-rearranged NSCLC||||
1285941|NCT03779178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285942|NCT03779165|||Cohort||Prospective|||||||
1285943|NCT03779152|||Cohort||Prospective|||||||
1285944|NCT03779139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285945|NCT03779126|Randomized|Parallel Assignment||Treatment||Double|The assessments will be conducted for a second investigator to ensure the blinding of first investigator. The subjects will be randomised in four groups (low frequency, high frequency, low and high frequency and sham stimulation) to ensure the blinding of participants.|The subjects will be randomised in four groups: 1) low frequency electrical stimulation (LF), 2) high frequency (HF), low and High frequency (LHF), and sham. The subjects will receive electrical stimulation in quadriceps bilaterally for 60 minutes , three times per week, during two months.|t||t|
1285946|NCT03779113||Single Group Assignment||Treatment||None (Open Label)||||||
1285947|NCT03779100||Single Group Assignment||Treatment||None (Open Label)||||||
1285948|NCT03779087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285949|NCT03779074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285950|NCT03779061|Randomized|Parallel Assignment||Other||Double|Single (Participant)||t|||t
1285951|NCT03779048|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Phase 1 is observational. Phase 2 is a double-blind, placebo-controlled, randomized controlled trial.|t|t|t|t
1285952|NCT03779035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285953|NCT03779022|||Cohort||Prospective|||||||
1285954|NCT03779009||Single Group Assignment||Other||None (Open Label)||||||
1285955|NCT03778996|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285956|NCT03778983|||Cohort||Prospective|||||||
1285957|NCT03778970|Randomized|Parallel Assignment||Treatment||Double|The participants will be submitted to Pain Neuroscience Education or Self-Management Education plus movement control exercises. They will not be aware of the education approach they will receive. The assessors will also not be aware whether the participant received Pain Neuroscience Education or Self-Management Education.|Randomized controlled clinical trial, superiority trial|t|||t
1285958|NCT03778957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1285959|NCT03778944|Randomized|Parallel Assignment||Supportive Care||Single||Using computer & sealed envelope randomization, patients are assigned to receive either Mannitol [M group; n=20], Dopamine [D group; n=20] or adequate hydration [C group; n=20]||||t
1285960|NCT03778931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285961|NCT03778918|||Cohort||Prospective|||||||
1285962|NCT03778905|||Other||Retrospective|||||||
1285963|NCT03778892|Randomized|Parallel Assignment||Prevention||None (Open Label)||half of study participants will receive the intervention||||
1285964|NCT03778879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1285965|NCT03778866|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1285966|NCT03778853||Single Group Assignment||Treatment||None (Open Label)||||||
1285967|NCT03778840|||Cohort||Prospective|||||||
1285968|NCT03778827|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1285969|NCT03778814||Single Group Assignment||Treatment||None (Open Label)||||||
1285970|NCT03778801|||Cohort||Cross-Sectional|||||||
1286125|NCT03776786|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285971|NCT03778788|Randomized|Parallel Assignment||Supportive Care||Triple|A computer-generated randomizer will be used to decide the random allocation. Each eligible subject will be assigned a number generated by the computer. By using random numbers, subjects will be randomly allocated to different groups. This randomization ensure equal sample size in the study groups.|A multisite randomized controlled trial with three arms : app group, booklet and leaflet||t|t|t
1285972|NCT03778775|||Cohort||Prospective|||||||
1285973|NCT03778762|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1285974|NCT03778749|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||Twenty mechanically ventilated ICU patients: the investigators will compare the mean TOF% between three different measurement techniques in 20 mechanically ventilated ICU patients: 1/electromyographic neuromuscular transmission monitoring at the hand muscle - 2/acceleromyographic neuromuscular transmission monitoring at the hand muscle - 3/acceleromyographic neuromuscular transmission monitoring at the eyebrow muscle; and the investigators will determine how the three TOF% values vary in each individual patient.||||
1285975|NCT03778736|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1285976|NCT03778723|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1285977|NCT03778710|||Cohort||Retrospective|||||||
1285978|NCT03778697||Single Group Assignment||Treatment||None (Open Label)||||||
1285979|NCT03778684|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1285980|NCT03778671|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1285981|NCT03778658|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1285982|NCT03778645|||Cohort||Retrospective|||||||
1285983|NCT03778632|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285984|NCT03778619||Single Group Assignment||Treatment||None (Open Label)||||||
1285985|NCT03778606||Single Group Assignment||Prevention||None (Open Label)||||||
1285986|NCT03778593||Single Group Assignment||Treatment||None (Open Label)||mFOLFIRINOX (5-FU, Irinotecan, oxaliplatin, Leucovorin)||||
1285987|NCT03778580|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1285988|NCT03778567||Sequential Assignment||Treatment||None (Open Label)||||||
1285989|NCT03778554|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, randomized, controlled, open-label, blinded endpoint (PROBE design)||||
1285990|NCT03778541|Randomized|Parallel Assignment||Treatment||None (Open Label)||patients were randomized to 2 parallel groups, namely the concurrent chemoradiotherapy group and radiotherapy alone group||||
1285991|NCT03778528|||Cohort||Prospective|||||||
1285992|NCT03778515|||Case-Control||Prospective|||||||
1285993|NCT03778502|||Cohort||Prospective|||||||
1285994|NCT03778489|Randomized|Parallel Assignment||Basic Science||Triple||Randomized double blinded case-control interventional study|t|t|t|
1285995|NCT03778476|Randomized|Crossover Assignment||Treatment||Single|The participant is masked to the hypotheses of the treatment.|The two groups will participate in two sessions receiving intervention or no intervention in a randomized manner.|t|||
1285996|NCT03778463|Randomized|Parallel Assignment||Treatment||Single|||t|||
1285997|NCT03778450|||Cohort||Retrospective|||||||
1285998|NCT03778437|Randomized|Parallel Assignment||Prevention||Single|||t|||
1285999|NCT03778424||||||||||||
1286000|NCT03778411|||Case-Only||Cross-Sectional|||||||
1286001|NCT03778398||Single Group Assignment||Treatment||None (Open Label)||||||
1286002|NCT03778385|Randomized|Crossover Assignment||Treatment||Single|Participants are masked to the primary hypothesis of the study.|All subjects will participate in two randomized exercise sessions. Clinical and experimental pain assessment will be performed before, during, and after each exercise task.|t|||
1286003|NCT03778372|||Case-Control||Prospective|||||||
1286004|NCT03778359|||Other||Retrospective|||||||
1286005|NCT03778346||Single Group Assignment||Treatment||None (Open Label)||||||
1286006|NCT03778333||Single Group Assignment||Treatment||None (Open Label)||Open-label phase 1, single-center, pre-post comparison study||||
1286007|NCT03778320|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1286008|NCT03778307|||Case-Control||Cross-Sectional|||||||
1286009|NCT03778294||Single Group Assignment||Treatment||None (Open Label)||||||
1286010|NCT03778281|Randomized|Crossover Assignment||Treatment||Single|Patient privacy needs to be protected||t|||
1286011|NCT03778268||Single Group Assignment||Diagnostic||None (Open Label)||"The procedure is listed as follows:~Recruiting early stage cervical cancer patients undergoing extra-fascial/sub-extensive/extensive hysterectomy, pelvic with or without aortic lymph node resection from July 2018 to June 2020.~Selecting the Standard-compliant patients according to the inclusion and exclusion criteria.~Numbering the above patients and collecting their clinical data.~Injecting carbon nanoparticles (CNP)[Not Equipped with near-infrared fluorescent vascular imager] or CNP combining Indocyanine Green(ICG)[Equipped with near-infrared fluorescent vascular imager].~Identifying and removing sentinel lymph nodes.~Completing the total hysterectomy, biadnexectomy and pelvic with or without para-aortic lymphadenectomy.~Staining all nodes using hematoxylin-eosin staining.~Calculating the sensitivity, negative predictive value, etc."||||
1286012|NCT03778255||Single Group Assignment||Diagnostic||None (Open Label)||"The procedure is listed as follows:~Recruiting endometrial cancer patients undergoing hysterectomy with or without bilateral adnexectomy, pelvic and para-aortic lymph node resection from July 2018 to June 2020.~Selecting the Standard-compliant patients according to the inclusion and exclusion criteria and letting them sign an informed consent form.~Numbering the above patients and collecting their clinical data.~Injecting carbon nanoparticles (CNP)[Not Equipped with near-infrared fluorescent vascular imager] or CNP combining Indocyanine Green(ICG)[Equipped with near-infrared fluorescent vascular imager].~Identifying and removing sentinel lymph nodes.~Completing the hysterectomy with or without bilateral adnexectomy, pelvic and para-aortic lymph node resection~Staining all nodes using hematoxylin-eosin staining.~Calculating the sensitivity, negative predictive value, etc."||||
1286013|NCT03778242|Randomized|Parallel Assignment||Prevention||Quadruple|A Double-Blind Randomized Clinical Tria|A Double-Blind Randomized Clinical Tria|t|t|t|t
1286014|NCT03778229||Single Group Assignment||Treatment||None (Open Label)||||||
1286015|NCT03778216|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286018|NCT03778177||Single Group Assignment||Treatment||None (Open Label)||The investigators will use of transcranial electrical stimulation (tES) to evaluate pain in patients with Trigeminal Neuralgia (TN).||||
1286019|NCT03778164|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This study uses a cross sectional stepped wedge cluster randomized design||||
1286020|NCT03778151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286021|NCT03778138||Single Group Assignment||Treatment||None (Open Label)||Anlotinib and Pemetrexed||||
1286022|NCT03778125|||Cohort||Prospective|||||||
1286023|NCT03778112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286024|NCT03778099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286025|NCT03778086|||Cohort||Prospective|||||||
1286026|NCT03778073||Single Group Assignment||Treatment||None (Open Label)||||||
1286027|NCT03778060||Single Group Assignment||Treatment||None (Open Label)|No other parties will be masked|||||
1286028|NCT03778047|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1286029|NCT03778034|||Other||Cross-Sectional|||||||
1286030|NCT03778021|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1286031|NCT03778008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286032|NCT03777995|||Cohort||Cross-Sectional|||||||
1286033|NCT03777982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286034|NCT03777969|||Cohort||Other|||||||
1286035|NCT03777956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286036|NCT03777943||Single Group Assignment||Other||None (Open Label)||||||
1286037|NCT03777930|Randomized|Parallel Assignment||Treatment||Single||200 patients with advanced tumors with a predicted survival period of ≥2 months were selected, including 100 patients with chemotherapy indications (50 patients were divided into chemotherapy group and 50 patients were divided into chemotherapy combined with TH and MG group according to the random principle) and 100 patients without chemotherapy indications (50 patients were randomly divided into the best supportive treatment group and 50 patients were randomly divided into the best supportive treatment group with TH and MG according to the random principle). The chemotherapy alone group and the best supportive treatment group were the control group. The thalidomide and megestrol acetate administration groups were administered with thalidomide 100 mg qn po and megestrol acetate 0.16 qd po for 8 weeks.||||t
1286038|NCT03777917|Randomized|Parallel Assignment||Treatment||Single||||||t
1286039|NCT03777904|||Cohort||Prospective|||||||
1286040|NCT03777891|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286041|NCT03777878|Randomized|Parallel Assignment||Prevention||Quadruple|A Double-Blind Randomized Clinical Trial|A Double-Blind Randomized Clinical Trial|t|t|t|t
1286042|NCT03777865||Single Group Assignment||Prevention||None (Open Label)||||||
1286043|NCT03777852|Non-Randomized|Parallel Assignment||Other||Single||A group of women will be evaluated twice, being one before the intervention and the second after the breast cancer reconstruction surgery|t|||
1286044|NCT03777839|||Cohort||Prospective|||||||
1286045|NCT03777826||Single Group Assignment||Treatment||None (Open Label)||||||
1286046|NCT03777813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286047|NCT03777800|Randomized|Parallel Assignment||Treatment||Single||||||t
1286048|NCT03777787|Randomized|Crossover Assignment||Other||Triple||Randomized, double-blind, placebo-controlled study|t||t|t
1286049|NCT03777774|Randomized|Parallel Assignment||Prevention||Double|Patients will be randomized only after the closing stage of decompressive craniectomy to avoid surgeon bias||t|t||
1286050|NCT03777761|Randomized|Crossover Assignment||Treatment||Triple|The study will be double-blind in regard to tucatinib and placebo study treatments and open-label for the positive control, moxifloxacin.||t|t|t|
1286051|NCT03777748||Single Group Assignment||Treatment||None (Open Label)||||||
1286052|NCT03777735|||Cohort||Prospective|||||||
1286053|NCT03777722|Randomized|Crossover Assignment||Treatment||Triple||Crossover placebo controlled design|t|t||t
1286054|NCT03777709|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286055|NCT03777696|Randomized|Parallel Assignment||Prevention||Quadruple|a double-blinded randomized placebo-controlled trial|A Double-Blind Randomized Clinical Trial|t|t|t|t
1286056|NCT03777683|Randomized|Parallel Assignment||Treatment||Quadruple|On enrolment, study nutritionist or clinicians take a consecutive sealed opaque envelope containing the unique patient identifier but not the study group, to which they remain masked. A paired set of sealed envelopes are kept in a locked cabinet in the study laboratory, label with the unique patient identifier and containing the study group allocation. These are opened by the nutritionist. Investigators, all study staff hospital attending clinical teams, and patients were masked to the study group allocation.||t|t|t|t
1286057|NCT03777670|||Case-Control||Prospective|||||||
1286058|NCT03777657|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286059|NCT03777644|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1286060|NCT03777631|Randomized|Parallel Assignment||Prevention||None (Open Label)||The included patients were randomly allocated to two groups: (1) Standard medical treatment group and (2) Catheter ablation additional group.||||
1286061|NCT03777618|||Cohort||Retrospective|||||||
1286062|NCT03777605||Single Group Assignment||Treatment||None (Open Label)|All tablets are processed, marked and coded by a pharmacist,|A randomized, cross over design||||
1286063|NCT03777592|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1286064|NCT03777579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286065|NCT03777566|||Cohort||Cross-Sectional|||||||
1286066|NCT03777553||Single Group Assignment||Treatment||None (Open Label)||This is a single group pre/post trial.||||
1286067|NCT03777540|||Cohort||Retrospective|||||||
1286068|NCT03777527|||Cohort||Prospective|||||||
1286121|NCT03776838|Randomized|Parallel Assignment||Prevention||Triple|Randomization into group SoC + NOL vs SoC will be done prior to the entrance in the OR, the day of the surgery|2 groups of patients. Randomization into group SoC + NOL vs SoC according to randomization list for a total number of 70 patients|t|t||t
1286122|NCT03776825|||Cohort||Prospective|||||||
1286069|NCT03777514|Randomized|Parallel Assignment||Treatment||Quadruple|"The IV bags will be opaque and patients will be asked to wear a eye mask during the infusion of iron vs. saline.~The oral tables will be identical in color and shape (iron in the form of ferrous sulphate and vitamin C)"|"The study is a randomized, comparative double blind, double dummy study to evaluate efficacy and time course of treatment response of bariatric surgical patients found to have IDA, three months or greater following bariatric surgery (Roux-en Y gastric bypass and vertical sleeve gastrectomy) over 6 weeks with a 46-week follow-up extension. Two medications and placebos will be used with equal random assignment to both groups~Ferumoxytol intravenous (IV) 1020 mg as - 2 vials of 510 mg (510 mg IV over 15 minutes) each given 2-7 days apart.~Ferrous sulfate 325 mg (oral) tabs morning and evening.~Placebo: oral vitamin C 500 mg tabs, saline infusion"|t|t|t|t
1286070|NCT03777501|Randomized|Parallel Assignment||Treatment||Double||randomized double-blinded controlled trial|||t|t
1286071|NCT03777488|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1286072|NCT03777475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286073|NCT03777462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286074|NCT03777449|||Cohort||Prospective|||||||
1286075|NCT03777436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286076|NCT03777423|Randomized|Parallel Assignment||Treatment||Single||||||t
1286077|NCT03777410|||Cohort||Prospective|||||||
1286078|NCT03777397|||Ecologic or Community||Cross-Sectional|||||||
1286079|NCT03777384|||Case-Only||Prospective|||||||
1286080|NCT03777371|||Other||Retrospective|||||||
1286081|NCT03777358|||Cohort||Prospective|||||||
1286082|NCT03777345|Randomized|Parallel Assignment||Treatment||Single||||||t
1286083|NCT03777332||Single Group Assignment||Treatment||None (Open Label)||||||
1286084|NCT03777319|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be randomly assigned to either to the spironolactone treatment group or to the standard clinical dose of corticosteroids.||||
1286085|NCT03777306|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||Multi-modality didactic education program implemented in parallel to standard cancer treatment to improve QoL for patients with MM||||
1286086|NCT03777293|Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1286087|NCT03777280|Randomized|Parallel Assignment||Treatment||Single||||||t
1286088|NCT03777267||Single Group Assignment||Supportive Care||None (Open Label)||This will be a single site, open label, pilot clinical trial, enrolling people aged 11 or older, who have self-reported symptoms of neurological, cardiovascular, and psychophysiological conditions, or who are caregivers or first responders. Up to 100 participants will be enrolled so as to gather pilot data that will help inform regarding feasibility, effect size, and dosing to support future cohort-specific randomized trials. Participants will receive between 4 and 12 intervention sessions of Cereset Research consisting of audible tones echoing current brainwave activity.||||
1286089|NCT03777254||Single Group Assignment||Treatment||None (Open Label)||||||
1286090|NCT03777241|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1286091|NCT03777228|||Case-Control||Cross-Sectional|||||||
1286092|NCT03777215|Randomized|Parallel Assignment||Other||Double|||t||t|
1286093|NCT03777202||Single Group Assignment||Treatment||None (Open Label)||||||
1286094|NCT03777189||Single Group Assignment||Treatment||None (Open Label)||||||
1286095|NCT03777176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286096|NCT03777163|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1286097|NCT03777150|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Group I: admitted into the ICU for postoperative care Group II: admitted into a standard ward for postoperative care||||
1286098|NCT03777137|||Other||Prospective|||||||
1286099|NCT03777124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286100|NCT03777111|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286101|NCT03777098|||Case-Only||Prospective|||||||
1286102|NCT03777085|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286103|NCT03777072|||Cohort||Prospective|||||||
1286104|NCT03777059|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1286105|NCT03777046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286106|NCT03777033|Randomized|Parallel Assignment||Prevention||Single||Randomized control trial - control group ( supplements of calcium and vit D on demand) vs study group ( systematic administration of oral calcium and vit D )||||t
1286107|NCT03777020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286108|NCT03777007||Single Group Assignment||Supportive Care||None (Open Label)||||||
1286109|NCT03776994|Randomized|Sequential Assignment||Prevention||Single|Subjects will be blinded to receiving the non-adjuvanted versus adjuvanted vaccines, but will not be blinded to the vaccine dosage. Vaccines will be brought into the subject rooms in a concealed container, and subjects will be asked to turn away from the dosing arm so that the SRI Clinical Trials' Unit (CTU) staff can prepare and administer the dose. Subjects may be unblinded if subject experiences a Serious Adverse Event (SAE) and upon notification to the data review team, called Protocol Safety Review Team (PSRT).|To assess the safety and immunogenicity of a monovalent Venezuelan Equine Encephalitis (VEE) Virus-like Particle (VLP) Vaccine in healthy adults for protection against exposure to VEE virus (VEEV).|t|||
1286110|NCT03776981|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286111|NCT03776968||Sequential Assignment||Treatment||None (Open Label)||||||
1286112|NCT03776955|Randomized|Parallel Assignment||Prevention||Quadruple|Placebo matched control||t|t|t|t
1286113|NCT03776942|||Case-Only||Retrospective|||||||
1286114|NCT03776929|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1286115|NCT03776916|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1286116|NCT03776903|||Cohort||Other|||||||
1286117|NCT03776890||Single Group Assignment||Prevention||None (Open Label)||||||
1286118|NCT03776877|||Cohort||Other|||||||
1286119|NCT03776864||Single Group Assignment||Treatment||None (Open Label)||||||
1286120|NCT03776851|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1286126|NCT03776773|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Prospective, open study comparing sleep quality in 2 different groups: AR patients and patients without AR during the pollen season and outside the pollen season.||||
1286127|NCT03776760|||Cohort||Prospective|||||||
1286128|NCT03776747|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1286129|NCT03776734||Single Group Assignment||Basic Science||None (Open Label)||||||
1286130|NCT03776721|Randomized|Parallel Assignment||Treatment||Quadruple|"All patients undergo the same liposuction procedure. During general anesthesia, patients are randomized to either fat grafting or sham grafting with saline injection to the axilla. After stem cell suspension, patients receive either stem cell or saline injection depending on randomization using masked syringes.~Participants are blinded, care providers postoperatively are blinded, primary investigator is blinded and all outcome assessors are blinded. The surgeon performing the liposuction and the stem-cell staff are unblinded."||t|t|t|t
1286131|NCT03776708|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286132|NCT03776695|Randomized|Sequential Assignment||Treatment||Single|||t|||
1286133|NCT03776682|||Cohort||Prospective|||||||
1286134|NCT03776669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286135|NCT03776656||Single Group Assignment||Treatment||None (Open Label)||||||
1286136|NCT03776643|Randomized|Parallel Assignment||Treatment||Double|Double Blind|Safety/Efficacy|t||t|
1286137|NCT03776630|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1286138|NCT03776617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286139|NCT03776604||Single Group Assignment||Prevention||None (Open Label)||Subjects with newly diagnosed small cell lung cancer who met the inclusion/exclusion criteria were prophylactically administered the test drug PEG-rhG-CSF 48 h after chemotherapy.||||
1286140|NCT03776591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286141|NCT03776578|||Other||Other|||||||
1286142|NCT03776565|||Case-Control||Prospective|||||||
1286143|NCT03776552|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled study||||
1286144|NCT03776539||Single Group Assignment||Treatment||None (Open Label)||"Subjects will be categorized in 4 groups:~Group 1: subjects with mild renal impairment~Group 2: subjects with moderate renal impairment~Group 3: subjects with severe renal impairment~Group 4 (control group): subjects with normal renal function"||||
1286145|NCT03776526|||Cohort||Prospective|||||||
1286146|NCT03776513|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1286147|NCT03776500|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286148|NCT03776487||Single Group Assignment||Treatment||None (Open Label)||||||
1286149|NCT03776474|||Case-Control||Prospective|||||||
1286150|NCT03776461||Single Group Assignment||Treatment||Single|Evaluator blinded assessment of photographs|Prospective, single centre, evaluator-blind study||||t
1286151|NCT03776448|Randomized|Parallel Assignment||Treatment||Double|Both participants and researchers involved directly in collecting data (ex. Measuring blood pressure or interviewing subjects) will be unaware of the allocation status and thus blinded. However, statistical analysts and those who will provide the participants with the intervention/placebo will be aware of the allocation status. All interventions (black seed oil and charcoal softgels) will be supplemented in neutral identical containers. Each participant will receive a container labeled with his or her specific identification code and containing the intervention for the arm to which he or she has been allocated.||t||t|
1286152|NCT03776435|||Cohort||Retrospective|||||||
1286153|NCT03776422||Single Group Assignment||Treatment||None (Open Label)||||||
1286154|NCT03776409|||Cohort||Retrospective|||||||
1286155|NCT03776396|||Cohort||Prospective|||||||
1286156|NCT03776383|Randomized|Parallel Assignment||Health Services Research||Single|The data for the outcome are being provided from a third party with no involvement in the study|3:3:1 for intervention 1: intervention 2: control||||t
1286157|NCT03776370|Non-Randomized|Parallel Assignment||Treatment||Single||Preservation of left colonic artery in rectal cancer surgery||||t
1286158|NCT03776357||Single Group Assignment||Health Services Research||None (Open Label)||||||
1286159|NCT03776344|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1286160|NCT03776331|||Cohort||Prospective|||||||
1286161|NCT03776318|||Cohort||Prospective|||||||
1286162|NCT03776305||Single Group Assignment||Treatment||None (Open Label)||||||
1286163|NCT03776292|||Other||Prospective|||||||
1286164|NCT03776279||Single Group Assignment||Treatment||None (Open Label)||||||
1286165|NCT03776266|||Cohort||Retrospective|||||||
1286166|NCT03776253||Single Group Assignment||Supportive Care||None (Open Label)||||||
1286167|NCT03776240|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1286168|NCT03776227|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286169|NCT03776214|||Cohort||Other|||||||
1286170|NCT03776201|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286171|NCT03776188|||Cohort||Prospective|||||||
1286172|NCT03776175|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286173|NCT03776162|Randomized|Parallel Assignment||Treatment||Triple|Treatment will be determined by intra-operative computer-generated randomization after the diagnostic arthroscopy and participant treatment assignment will not be reported to the participant until termination of the study observation period. Research Assessments by Independent Blinded Assessor for assessments of study endpoints and safety. KT-1000 knee laxity arthrometer testing, International Knee Documentation Committee (IKDC) patient-reported outcome score, Knee Injury and Osteoarthritis Outcome Score (KOOS), Marx knee activity rating scale, Anterior Knee Pain Scale, Quadriceps Strength, Hop testing, and physical examination. The physical therapist implementing the post-surgical rehabilitation will be blinded to the treatment group.|Multi-center, 2-arm, 1:1 permuted block randomized controlled clinical trial, with a blinded patient and outcome assessor.|t|t||t
1286222|NCT03775525||Sequential Assignment||Treatment||None (Open Label)||||||
1286223|NCT03775512||||||||||||
1286224|NCT03775499|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1422256|NCT02002104||||||||||||
1286174|NCT03776149|Randomized|Crossover Assignment||Supportive Care||Double|The supplement and placebo will be distributed to the individual by a member of the research team who is not involved with data collection or analysis.|This study utilizes a 7-day randomized, double-blind, placebo-controlled crossover study design, in which individuals are initially supplemented with a nitrate-rich supplement in the form of a specifically formulated beetroot juice, or nitrate-poor placebo. Individuals will then entered a 7-day washout period before entering the opposing arm of the study.|t||t|
1286175|NCT03776136||Single Group Assignment||Treatment||None (Open Label)||||||
1286176|NCT03776123|||Cohort||Prospective|||||||
1286177|NCT03776110|Randomized|Sequential Assignment||Treatment||Quadruple||Single center, multiple dose, dose escalation (within dose-group randomized, double-blind, placebo-controlled, 2-way cross-over)|t|t|t|t
1286178|NCT03776097|||Other||Prospective|||||||
1286179|NCT03776084|||Cohort||Prospective|||||||
1286180|NCT03776071|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286181|NCT03776058|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286182|NCT03776045|Randomized|Parallel Assignment||Prevention||Single|Outcome assessors and data analysts were blind to treatment allocation. It was not possible to blind participants or the intervention facilitator.|After baseline measures were collected, participants were randomly allocated (1:1) to standard care or standard care plus exercise using a randomisation sequence created by an independent researcher (nQuery, Statistical Solutions, USA). Treatment allocation was concealed from the research team until after baseline measurements were collected.||||t
1286183|NCT03776032|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286184|NCT03776019|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286185|NCT03776006|||Cohort||Prospective|||||||
1286186|NCT03775993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286187|NCT03775980|||Cohort||Prospective|||||||
1286188|NCT03775967|||Cohort||Prospective|||||||
1286189|NCT03775954|||Cohort||Prospective|||||||
1286190|NCT03775941|||Ecologic or Community||Cross-Sectional|||||||
1286191|NCT03775928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286192|NCT03775915|Randomized|Parallel Assignment||Treatment||Double||Participants are randomly allocated (1:1 ratio) to either the intervention group (Real Neurofeedback) or the control group (Sham Neurofeedback). Randomisation is done after participants undergo baseline measurements using a computer-generated minimisation method that takes into account baseline upper limb function (Action Research Arm test score) and time since stroke.|t|||t
1286193|NCT03775902|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1286194|NCT03775889||Single Group Assignment||Prevention||None (Open Label)||||||
1286195|NCT03775876|Randomized|Parallel Assignment||Supportive Care||Triple|surgeons, patients as well as the outcome assessor were blinded in regards of the drug used for sedation during surgery (Propofol vs dexmedetomidine)|randomised controlled double blind trial|t|t||t
1286196|NCT03775863|||Cohort||Prospective|||||||
1286197|NCT03775850|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be assigned to one of three cohorts based on disease condition: Cohort A (microsatellite stable colorectal cancer); Cohort B (Triple negative breast cancer); Cohort C (PD-1 relapsed tumors: non small cell lung cancer, gastroesophageal cancer, or any microsatellite unstable or renal cell carcinoma). Patients will receive monotherapy with EDP1503 for a period of 2 weeks, following which they will be dosed with a combination of EDP1503 and pembrolizumab.||||
1286198|NCT03775837|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286199|NCT03775824|||Cohort||Prospective|||||||
1286200|NCT03775811|||Cohort||Prospective|||||||
1286201|NCT03775798|||Cohort||Prospective|||||||
1286202|NCT03775785|Randomized|Parallel Assignment||Treatment||Quadruple|The decision to start fortification will be made by the attending physician blinded to the intervention allocated. An employee outside the research team will feed data into the computer in separate datasheets so that the researchers can analyse data without having access to information about the allocation.|"This is a multi-centre superiority randomised parallel group, 1:1 allocation study.~After reaching 80 ml/kg/day of enteral feeding, patients will be randomised to receive standard fortification-SF (Bebilon HMF, Nutricia) or targeted fortification -TF (proteins, lipids,carbohydrates). Allocation will be performed electronically."|t|t|t|t
1286203|NCT03775772|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286204|NCT03775759|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled, non-blinded, single center||||
1286205|NCT03775746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286206|NCT03775733|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1286207|NCT03775720|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286208|NCT03775707||Single Group Assignment||Treatment||None (Open Label)||||||
1286209|NCT03775694|||Case-Only||Retrospective|||||||
1286210|NCT03775681||Single Group Assignment||Supportive Care||None (Open Label)||||||
1286211|NCT03775668||Single Group Assignment||Treatment||None (Open Label)||||||
1286212|NCT03775655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286213|NCT03775642|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1286214|NCT03775629|Randomized|Parallel Assignment||Treatment||None (Open Label)||Group A: Tramadol hydrochloride (HCl) 75mg tablet +Polmacoxib 2mg capsule combination regimen Group B: Polmacoxib 2mg capsule Group C: Tramadol hydrochloride (HCl) 75mg tablet||||
1286215|NCT03775616||Single Group Assignment||Supportive Care||None (Open Label)||||||
1286216|NCT03775603|||Case-Only||Prospective|||||||
1286217|NCT03775590|Randomized|Parallel Assignment||Treatment||Triple||There are 3 study arms with 50 subjects in each arm. The 3 arms are: water, water + bleach, and water + vinegar||t|t|t
1286218|NCT03775577|||Cohort||Prospective|||||||
1286219|NCT03775564|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||RemedRugby program Vs TAU + TouchRugby||||
1286220|NCT03775551|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1286221|NCT03775538|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind|Randomised, Double-Blind, Active Treatment|t|t|t|t
1286225|NCT03775486|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286226|NCT03775473||Single Group Assignment||Diagnostic||None (Open Label)||Interventional Research, at Risk and Minimal Constraints, Category 2||||
1286227|NCT03775460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286228|NCT03775447|||Case-Control||Cross-Sectional|||||||
1286229|NCT03775434||Single Group Assignment||Treatment||None (Open Label)|This is a single arm open label study. Subjects will be assigned to the study treatment arm. Each participant will be scheduled to receive investigational product (IP).|All subjects will receive active product||||
1286230|NCT03775421||Single Group Assignment||Treatment||None (Open Label)||The study is designed as an open-label (OL), single-arm, multicenter long-term trial in which all adolescent (≥ 12 years) and adult male and female subjects who had previously completed in the parent RUBATO DB study (AC-055H301, NCT03153137) will enroll. The primary objective of the study is to assess the long-term safety and tolerability of macitentan. All efficacy endpoints including the ones listed below are considered as exploratory in nature.||||
1286231|NCT03775408|||Cohort||Prospective|||||||
1286232|NCT03775395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286233|NCT03775382|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1286234|NCT03775369|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1286235|NCT03775356|Randomized|Parallel Assignment||Prevention||Double|Single masked. The entropy and EEG module will be masked for the responsible anesthetist as well as the study team during the entire investigation.|||t|t|
1286236|NCT03775343|||Case-Control||Prospective|||||||
1286237|NCT03775330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286238|NCT03775317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286239|NCT03775304|||Case-Only||Retrospective|||||||
1286240|NCT03775291|||Case-Control||Prospective|||||||
1286241|NCT03775278|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1286242|NCT03775265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286243|NCT03775252||Single Group Assignment||Basic Science||None (Open Label)||||||
1286244|NCT03775239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286245|NCT03775226||Single Group Assignment||Treatment||None (Open Label)||||||
1286246|NCT03775213|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1286247|NCT03775200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286248|NCT03775187||||||||||||
1286249|NCT03775174||||||||||||
1286250|NCT03775161||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286251|NCT03775148|Randomized|Parallel Assignment||Treatment||Single||||||t
1286252|NCT03775135|||Cohort||Prospective|||||||
1286253|NCT03775122|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286254|NCT03775109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286255|NCT03775096||Single Group Assignment||Treatment||None (Open Label)||Treatment: carvedilol titration; Experimental treatment with carvedilol will be offered at stabilized medical treatment. The dosage of carvedilol will be gradually increased from the initial recommended starting dose of 3.125mg twice daily and will be doubled every week according to patient tolerability, as measured by subjective complaints, arterial blood pressure and heart rate. The target dose will be 25mg twice daily (50 mg/day). Subjects that cannot tolerate the 50 mg daily dose, will be offered to continue at the 25 mg daily dose.||||
1286256|NCT03775083|||Cohort||Prospective|||||||
1286257|NCT03775070||Single Group Assignment||Treatment||None (Open Label)||||||
1286258|NCT03775057||Single Group Assignment||Other||None (Open Label)||||||
1286259|NCT03775044||Single Group Assignment||Health Services Research||None (Open Label)|No masking is possible for this study.|This study is a stepped wedge design where all individuals receive the intervention but at different time points after enrollment in the study. Each person will have two observations before the intervention and three observations after the intervention. Health service use data will be collected for two years prior to enrollment and two years after enrollment.||||
1286260|NCT03775031|Randomized|Single Group Assignment||Prevention||None (Open Label)||Randomized-Controlled (Subjects will serve as their own control)||||
1286261|NCT03775018|Randomized|Parallel Assignment||Treatment||Double|The analgesic treatment applied will be blinded to the treatment and to the epidemiology nurse who will assess the postoperative pain||t|||t
1286262|NCT03775005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286263|NCT03774992|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286264|NCT03774979||Single Group Assignment||Treatment||None (Open Label)||||||
1286265|NCT03774966|Randomized|Parallel Assignment||Treatment||Single||||||t
1286266|NCT03774953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286267|NCT03774940|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286268|NCT03774927|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286269|NCT03774914|||Cohort||Prospective|||||||
1286270|NCT03774901||Single Group Assignment||Treatment||None (Open Label)||||||
1286271|NCT03774888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286272|NCT03774875|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286273|NCT03774862|||Cohort||Retrospective|||||||
1286274|NCT03774849|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1286275|NCT03774836|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286276|NCT03774823|Randomized|Parallel Assignment||Treatment||Single|Participant is not aware which group they will be randomized into upon entering the study|One group receives treatment with RF and PEMF while the second group receives treatment with ultrasound|t|||
1286277|NCT03774810|Randomized|Sequential Assignment||Treatment||Quadruple|Double Blinded||t|t|t|t
1286278|NCT03774797|||Other||Cross-Sectional|||||||
1286279|NCT03774784|||Cohort||Prospective|||||||
1286280|NCT03774771|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1286281|NCT03774758|||Cohort||Prospective|||||||
1287270|NCT03761901|||Cohort||Retrospective|||||||
1286282|NCT03774745|Randomized|Parallel Assignment||Treatment||Triple|placebo pills in opaque bottle|Randomized, double blind, placebo controlled trial|t|t|t|
1286283|NCT03774732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286284|NCT03774719||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286285|NCT03774706|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which will be used|double-blind placebo randomized controlled trial|t|t|t|t
1286286|NCT03774693|Randomized|Parallel Assignment||Other||Double|||t|||t
1286287|NCT03774680|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286288|NCT03774667|||Case-Control||Prospective|||||||
1286289|NCT03774654||Single Group Assignment||Treatment||None (Open Label)||||||
1286290|NCT03774641|||Case-Only||Prospective|||||||
1286291|NCT03774628|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286292|NCT03774615||Single Group Assignment||Treatment||None (Open Label)||open-label, uncontrolled, monocenter, phase IV study||||
1286293|NCT03774602||Single Group Assignment||Prevention||None (Open Label)||||||
1286294|NCT03774589|Randomized|Parallel Assignment||Treatment||Single||||||t
1286295|NCT03774576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1286296|NCT03774563|||Cohort||Prospective|||||||
1286297|NCT03774550|||Cohort||Retrospective|||||||
1286298|NCT03774537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286299|NCT03774524|Randomized|Parallel Assignment||Prevention||Quadruple|a double-blinded randomized placebo-controlled trial|A Double-Blind Randomized Clinical Trial|t|t|t|t
1286300|NCT03774511|Randomized|Parallel Assignment||Treatment||Double|HII group, each patient in this group were conducted a program of high-intensity aerobic exercise for 8 weeks, three times per week with each exercise session lasting for nearly 40 minutes morning. Each patient was instructed to not eat for 2 hours before the exercise session to avoid exercise induced airway obstruction. MIC group, each patient was received (MIC 3 times/week) for eight weeks, according to following parameters; 5 minutes warm up, followed by 30 minutes of continuous aerobic exercise on a cycle Ergometer with constant intensity at 70 to 75% of peak HR and 5 minutes cool down. Also, these measures were obtained at the beginning and the end of the intervention.||t|||t
1286301|NCT03774498|Randomized|Sequential Assignment||Prevention||Double|||t|t||
1286302|NCT03774485|||Case-Control||Prospective|||||||
1286303|NCT03774472||Single Group Assignment||Treatment||None (Open Label)||||||
1286304|NCT03774459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286305|NCT03774446||Sequential Assignment||Treatment||None (Open Label)||||||
1286306|NCT03774433||Single Group Assignment||Basic Science||None (Open Label)||||||
1286307|NCT03774420|||Cohort||Prospective|||||||
1286308|NCT03774407|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a single-group prospective repeated-measures pilot trial. Duration is 12 months,||||
1286309|NCT03774394|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286310|NCT03774381|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286311|NCT03774368|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286312|NCT03774355|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286313|NCT03774342|||Cohort||Prospective|||||||
1286314|NCT03774329|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1286315|NCT03774316|||Cohort||Prospective|||||||
1286316|NCT03774303|Randomized|Parallel Assignment||Other||None (Open Label)||RCT||||
1286317|NCT03774290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286318|NCT03774277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286319|NCT03774264||Single Group Assignment||Treatment||None (Open Label)||||||
1286320|NCT03774251|Randomized|Parallel Assignment||Treatment||Single||Randomized prospective study||||t
1286321|NCT03774238||Single Group Assignment||Basic Science||None (Open Label)||||||
1286322|NCT03774225|Randomized|Parallel Assignment||Treatment||Single|The assessments where conducting by a blind examiner (investigator) in different days of the training. The examinator wasn't know which group the participant would be performing|Prospective, single-blind, parallel-group, randomised trial|||t|
1286323|NCT03774212|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286324|NCT03774199||Single Group Assignment||Basic Science||None (Open Label)||||||
1286325|NCT03774186|Randomized|Parallel Assignment||Treatment||Single|Biostatistician is blinded to intervention assignment|Randomized clinical trial||||t
1286326|NCT03774173|Randomized|Crossover Assignment||Other||None (Open Label)||"Subjects will receive oral doses of aramchol at 300 mg twice daily (every 12 h) for 9 days in one period, with a single dose in the morning of Day 10, and 600 mg once daily (every 24 h) for 10 days in the other period.~Enrolment of 16 subjects is planned with each subject taking part in the 2 study periods. The subjects will be randomised 1:1 so that 8 subjects receive each regimen in the first period and the alternate regimen in the second period."||||
1286327|NCT03774160|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Two different districts are being used, one in which the intervention is implemented and the other is a no-intervention comparison site.||||
1286328|NCT03774147|||Case-Only||Prospective|||||||
1286329|NCT03774134|||Cohort||Prospective|||||||
1286330|NCT03774121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286331|NCT03774108|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286332|NCT03774095|Randomized|Crossover Assignment||Treatment||Single||Cross-over study of 3 interventions; 1) no oil intake, 2)6g hydrolyzed pine nut oil and 3) combined intake of 3g hydrolyzed pine nut oil and 3g olive oil 30 minutes prior to an 6-hours oral glucose tolerance test (75g glucose).|t|||
1286333|NCT03774082||Single Group Assignment||Treatment||None (Open Label)||||||
1286334|NCT03774069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286335|NCT03774056||Sequential Assignment||Treatment||None (Open Label)||||||
1286336|NCT03774043|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286337|NCT03774030||Single Group Assignment||Other||None (Open Label)||a group of hearing-impaired particpants with mild or severe hearing loss||||
1286338|NCT03774017|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1286339|NCT03774004|||Cohort||Prospective|||||||
1286340|NCT03773991|||Cohort||Prospective|||||||
1286341|NCT03773978|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1286342|NCT03773965||Single Group Assignment||Treatment||None (Open Label)||||||
1286343|NCT03773952|Randomized|Parallel Assignment||Treatment||Quadruple||randomized, double blind, placebo controlled, multicenter clinical trial|t|t|t|t
1286344|NCT03773939|||Cohort||Other|||||||
1286345|NCT03773926||Single Group Assignment||Treatment||None (Open Label)||An efficiency multicentric pilot study on a targeted population for development and use of Neuro-feedback therapy for treating tinnitus.||||
1286346|NCT03773913|||Ecologic or Community||Cross-Sectional|||||||
1286347|NCT03773900|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1286348|NCT03773887|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1286349|NCT03773874|||Cohort||Prospective|||||||
1286350|NCT03773861||Single Group Assignment||Other||None (Open Label)||||||
1286351|NCT03773848|||Cohort||Prospective|||||||
1286352|NCT03773835||Sequential Assignment||Treatment||None (Open Label)||||||
1286353|NCT03773822|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286354|NCT03773809|Randomized|Parallel Assignment||Supportive Care||Double|Both the patients and the principal investigator will remain blind to the intervention given. After the end of follow up, at the time of data analysis principal investigator will be provided with the information about which patient isgoven placebo and which patient isgivev drug.|"Baseline group:~This group will include 60 vitamin D3 deficient ACO patients.~Group A:~Group A0: Vitamin D3 deficient ACO patients with placebo at day 0. Group A90: Vitamin D3 deficient ACO patients with placebo at day 90~Group B:~Group B0: Vitamin D3 deficient ACO patients with vitamin D3 at day 0. Group B90: Vitamin D3 deficient ACO patients with vitamin D3 at day 90.~All the patients will be similar by age, sex and BMI"|t||t|
1286355|NCT03773796||Single Group Assignment||Treatment||None (Open Label)|None, open-label|open-label||||
1286356|NCT03773783|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1286357|NCT03773770||||||||||||
1286358|NCT03773757|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1286359|NCT03773744|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286360|NCT03773731|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1286361|NCT03773718|||Cohort||Prospective|||||||
1286362|NCT03773705|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1286363|NCT03773692||Single Group Assignment||Prevention||None (Open Label)|Participants were aware of the phase of the study they were in.|Each individual will take part in the study for three phases, each with a duration of one month. The first month will involve collecting baseline PA levels. The second and third months of the study will provide the participants with passive PA level feedback and just-in-time persuasive feedback about their PA levels, respectively.||||
1286364|NCT03773679|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1286365|NCT03773666|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286366|NCT03773653|Randomized|Parallel Assignment||Treatment||Single||||||t
1286367|NCT03773640|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The study group I (20 patients) and control group II (20 patients) consisted of patients, aged 19 to 45 years, of both sexes, who reported to the Consulting Room of Temporomandibular Joint Dysfunction at The Institute of Dentistry in Krakow to undertake prosthetic treatment of pain form of temporomandibular disorders, with the dominant muscle component.||||
1286368|NCT03773627|||Cohort||Prospective|||||||
1286369|NCT03773614|||Case-Only||Prospective|||||||
1286370|NCT03773601||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286371|NCT03773588|Randomized|Sequential Assignment||Treatment||Quadruple||Device: Closed-Loop propofol TCI with Entropy and SPI Device: Open-Loop propofol by Target Controlled Infusion Drug: propofol|t|t|t|t
1286372|NCT03773575|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286373|NCT03773562||Single Group Assignment||Treatment||None (Open Label)||All consented and qualifying subjects will receive erenumab treatment. Questionnaires, cognitive testing, and brain MRIs will be completed pre- and post-treatment.||||
1286374|NCT03773549|||Case-Control||Cross-Sectional|||||||
1286375|NCT03773536||Single Group Assignment||Treatment||None (Open Label)||A one-armed prospective antimalarial drug efficacy trial.||||
1286376|NCT03773523|Randomized|Parallel Assignment||Device Feasibility||Quadruple|"Participants will not be informed on their assigned protocol. During consent, they will be informed that there is a 50% chance of being assigned either to the group receiving active tDCS or the group receiving sham tDCS.~The Principal Investigator and research staff will also be blind to the condition the participant is assigned to."|This study is randomized, double-blind, and sham-controlled. Participants will be randomly assigned to either active or sham tDCS.|t|t|t|t
1286377|NCT03773510|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Randomized, open-label , two arm study All the patients who will complete 6 cycles of treatment without disease progression will be be randomized to continue Trabectedin versus treatment interruption followed by re-challenge at progression. Patients randomized to discontinue treatment will be candidate to other 6 cycles of treatment and if they do not progress, to another interruption. The treatment will be resumed again at progression for other 6 cycles and this scheme of treatment will be proposed until progression under Trabectedin."||||
1286378|NCT03773497|Randomized|Crossover Assignment||Other||Double|||||t|t
1286379|NCT03773484||Single Group Assignment||Health Services Research||None (Open Label)||||||
1286380|NCT03773471|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1286381|NCT03773458||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286382|NCT03773445|||Cohort||Cross-Sectional|||||||
1286383|NCT03773432|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286384|NCT03773419|Randomized|Parallel Assignment||Treatment||Single||||||t
1286385|NCT03773406|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1286386|NCT03773393||Single Group Assignment||Treatment||None (Open Label)||"Open-label, Phase I study designed to evaluate the safety of CK0801 in the treatment of bone marrow failure syndromes.~This study will use a Simon 3 + 3 design.~Three patients will be treated at dose level 1: 1x106/kg. If no dose limiting toxicity (DLT) is observed, then the dose will be escalated to dose level 2: 3x106/kg for the next cohort of 3 patients. If no DLT is observed, then the dose will be escalated to dose level 3: 1x107/kg.~If 1 DLT is observed at a dose level, then 3 additional patients will be treated at that level. If no additional DLTs, then that dose level will be defined as MTD.~If ≥ 2 DLTs at dose level 2 or 3, then prior dose level is defined as MTD. If ≥ 2 DLTs at dose level 1, then DSMB will review and evaluate for study continuation. MTD decided when 6 patients are treated at a dose level with < 2 DLTs."||||
1286387|NCT03773380||Single Group Assignment||Other||None (Open Label)||||||
1286388|NCT03773367||Single Group Assignment||Treatment||None (Open Label)||||||
1286389|NCT03773354||Single Group Assignment||Treatment||None (Open Label)||||||
1286390|NCT03773341|||Ecologic or Community||Prospective|||||||
1286391|NCT03773328||Single Group Assignment||Treatment||None (Open Label)||Open-label, single arm study using a Simon 3 + 3 design. Study will utilize 3 dose cohorts with a minimum of 3 patients in each cohort.||||
1286392|NCT03773315|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286393|NCT03773302|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, Open Label, Randomized, Controlled Phase 3||||
1286394|NCT03773289|||Cohort||Retrospective|||||||
1286395|NCT03773276||Single Group Assignment||Prevention||None (Open Label)||||||
1286396|NCT03773263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286397|NCT03773250|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286398|NCT03773237|Randomized|Parallel Assignment||Supportive Care||Quadruple|The randomization list will be generated using http://www.randomization.com and blinded at enrollment using supplement codes. The study coordinator will hold the randomization codes and will be revealed to the investigators only after the statistical analysis is complete.|Prospective Randomized Controlled|t|t|t|t
1286399|NCT03773224|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1286400|NCT03773211|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1286401|NCT03773198|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286402|NCT03773185|||Cohort||Cross-Sectional|||||||
1286403|NCT03773172|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1286404|NCT03773159|||Cohort||Prospective|||||||
1286405|NCT03773146|Randomized|Parallel Assignment||Other||Single||Participants were randomized to one of three airtime incentive structures: 1) no incentive; 2) a fixed 1X incentive for all participants who completed the noncommunicable disease risk factor survey; or 3) a lottery incentive (10-20 times larger than the fixed incentive) given to 1 out of every 20 participants who completed the same survey.||||t
1286406|NCT03773133||Single Group Assignment||Other||None (Open Label)||||||
1286407|NCT03773120|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1286408|NCT03773107|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1286409|NCT03773094|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1286410|NCT03773081||Single Group Assignment||Treatment||None (Open Label)||||||
1286411|NCT03773068|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1286412|NCT03773055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286413|NCT03773042|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1286414|NCT03773029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286415|NCT03773016|Non-Randomized|Crossover Assignment||Other||None (Open Label)||The intervention activity will consist of the cross-over use of two different visual art apps in touchscreen tablets with people with mild to moderate dementia that lives in care homes. The study will take place in a nursing home in Nottinghamshire and will involve 12 residents of the care home with dementia and up to 12 staff members that are involved in participants' care. Study data collection will take 8 weeks; four weeks will involve the execution of the intervention and four weeks for additional measurements (collect consent, screening and end measures). Participants will be split into two groups of 6 participants; each group will use one app for two weeks and then change to the other app for another 2 weeks. Participants will be supported to use the app twice a week, with a maximum of 8 individual sessions over the four weeks. The data collection will consist of the observation of the activity and on the use of dementia-specific instruments and questionnaires.||||
1286416|NCT03773003|Randomized|Parallel Assignment||Basic Science||Single|Blinding will be made at the probiotics manufacturer's establishment. Neither investigators nor care providers nor patients know their status til the end of the study.|"Double blinded, placebo controlled intervention with probiotics~There are three groups in the study:~Tumor disease with fatigue~Tumor disease without fatigue~Healthy control group"|||t|
1286417|NCT03772990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286418|NCT03772977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286419|NCT03772964|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Subjects will act as their own controls: data will be collect on each subject at baseline, throughout exposure and following, exposure to metformin.||||
1286420|NCT03772951|Randomized|Parallel Assignment||Treatment||Single||||||t
1286421|NCT03772938|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286422|NCT03772925||Single Group Assignment||Treatment||None (Open Label)||||||
1286423|NCT03772912|||Cohort||Prospective|||||||
1286424|NCT03772899||Single Group Assignment||Treatment||None (Open Label)||||||
1286425|NCT03772886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286426|NCT03772873|||Other||Prospective|||||||
1286427|NCT03772860|||Case-Control||Prospective|||||||
1286428|NCT03772847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286429|NCT03772834|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1286430|NCT03772821|||Cohort||Prospective|||||||
1286431|NCT03772808||Single Group Assignment||Supportive Care||None (Open Label)||||||
1286500|NCT03771911|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286432|NCT03772795|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two groups receiving 2 interventions. In the first group patients received fixed orthodontic appliance and in the second, they received clear aligner orthodontic appliance||||
1286433|NCT03772782|||Other||Other|||||||
1286434|NCT03772769||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286435|NCT03772756|Randomized|Parallel Assignment||Treatment||Single||||||t
1286436|NCT03772743|Randomized|Parallel Assignment||Treatment||None (Open Label)||All comers, prospective, randomized, multicenter, open-label trial with blinded adjudicated evaluation of outcomes (PROBE).||||
1286437|NCT03772730|||Cohort||Prospective|||||||
1286438|NCT03772717|Randomized|Parallel Assignment||Treatment||Single||Participants will be randomized to receive a device that delivers electrical neuromuscular stimulation or a sham device.|t|||
1286439|NCT03772704|||Case-Only||Prospective|||||||
1286440|NCT03772691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286441|NCT03772678|Randomized|Parallel Assignment||Basic Science||Quadruple|Pharmacist not blind||t|t|t|t
1286442|NCT03772665|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Masked|This is a multicenter, randomized, double-masked, placebo-controlled study to evaluate the efficacy and safety of emixustat compared to placebo in subjects who have Macular Atrophy secondary to Stargardt disease.|t|t|t|t
1286443|NCT03772652|||Cohort||Cross-Sectional|||||||
1286444|NCT03772639|Randomized|Parallel Assignment||Treatment||Single||||||t
1286445|NCT03772626||Single Group Assignment||Treatment||None (Open Label)||Single group non-randomized open label study of efficacy and feasibility. Comparison will be to historical controls.||||
1286446|NCT03772613|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1286447|NCT03772600|Randomized|Parallel Assignment||Other||None (Open Label)||multicenter, randomized, double arm, open label, partial cross-over, parallel group clinical trial||||
1286448|NCT03772587|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286449|NCT03772574|Randomized|Parallel Assignment||Treatment||Single||||||t
1286450|NCT03772561||Single Group Assignment||Treatment||None (Open Label)||||||
1286451|NCT03772548|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1286452|NCT03772535|Randomized|Crossover Assignment||Screening||Single|||t|||
1286453|NCT03772522|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Thirty young people (aged 18 - 26 years) who have transitioned out of homelessness within the past three years will be offered scholarships to participate in a six-week intervention that focuses on building identity capital and providing career direction. The intervention will be designed and carried out by dk Leadership - an established, highly successful leadership and counseling centre in Toronto with a track record of significantly improving the life trajectories of teens and adults. Importantly, study participants will be incorporated into the centre's current programming, meaning the intervention will be held at a location not associated with homelessness. All of the participants will be invited to attend two focus groups, which will be conducted immediately post-intervention and at six months post-intervention. Each focus group will contain approximately 8 - 10 youth. Participants in the intervention and delayed intervention will be in separate focus groups.||||
1286454|NCT03772509|Randomized|Parallel Assignment||Other||Single||Participants were randomized to one of two introduction and consent modes: 1) computer-assisted telephone interviews, or 2) interactive voice response.||||t
1286455|NCT03772496||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286456|NCT03772483|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized Intervention Model: Split-mouth assignment||||
1286457|NCT03772470|Randomized|Parallel Assignment||Other||Single||Participants will be randomized to one of four airtime incentive amounts: 1) no incentive; 2) 1X incentive; 3) 2X incentive or 4) a lottery incentive, in which one out of every 20 participants will receive the incentive. Airtime incentives were sent if participants completed the noncommunicable disease risk factor survey.||||t
1286458|NCT03772457|||Cohort||Prospective|||||||
1286459|NCT03772444|Randomized|Parallel Assignment||Prevention||None (Open Label)|Patients undergoing colorectal surgery will be randomized (n=10) to receive one week daily 70 ml of beetroot juice (~ 7 mmol inorganic nitrate) or (n=10) an equivalent volume of nitrate-depleted beetroot juice (control group 1). An additional control group (n=10) is added to the pilot study, in which patients will receive an equivalent volume of water (control group 2); this allows us to investigate whether the antioxidants present in beetroot juice contribute to the protective effect of beetroot juice in POI. Beetroot juice and nitrate-depleted beetroot juice cause discoloration of urine (beeturia) and feces from the purple betacyanin pigments in beetroot; for the control group that receives water, this will not be the case and blinding for this group is thus not possible.|||||
1286460|NCT03772431|Randomized|Parallel Assignment||Other||Single||Participants were randomized to one of four narrator/introduction combinations: 1) male voice, informational content; 2) male voice, motivational content; 3) female voice, informational content; 4) female voice, motivational content.||||t
1286461|NCT03772418|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286462|NCT03772405||Single Group Assignment||Treatment||None (Open Label)||||||
1286463|NCT03772392|||Cohort||Prospective|||||||
1286464|NCT03772379|Randomized|Parallel Assignment||Treatment||Single||||||t
1286465|NCT03772366|||Cohort||Prospective|||||||
1286466|NCT03772353||Single Group Assignment||Treatment||None (Open Label)||||||
1286467|NCT03772340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286468|NCT03772327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286469|NCT03772314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286470|NCT03772301|||Ecologic or Community||Prospective|||||||
1286471|NCT03772288|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1286472|NCT03772275|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1286473|NCT03772262|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1286501|NCT03771898||Single Group Assignment||Treatment||None (Open Label)||||||
1286502|NCT03771885|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1286503|NCT03771872|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1286474|NCT03772249|Randomized|Sequential Assignment||Treatment||Triple|This is a double-blind placebo-controlled study in which the study site team, the Sponsor, and the participants will be blinded to treatment assignment. The unblinded pharmacist will cover each syringe, prior to transport to the bedside, to ensure blinding. Participants will be centrally assigned to randomized study intervention using an Interactive Voice/Web Response System (IVRS/IWRS).|Progression from the SAD phase to the first cohort in the MAD phase is contingent upon the Safety Review Committee (SRC) review of a minimum of 14 days post-dose safety and tolerability data from all NHV in at least the first 2 SAD cohorts. The SRC will select one (or more) well-tolerated dose(s) from the SAD phase for administration in the SD and MAD phases. In all study phases, dosing will be staggered with the use of sentinel participants to allow time for the assessment of safety before additional subjects are exposed to study drug.|t|t|t|
1286475|NCT03772236|||Case-Only||Cross-Sectional|||||||
1286476|NCT03772223|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286477|NCT03772210|Randomized|Crossover Assignment||Basic Science||Single|Device used to apply stimulation can be operated in SHAM mode, where subject experiences sensation of the tDCS stimulation starting, but the device is turned off shortly after SHAM mode initiates.|"Structural (T1-weighted) and high angular resolution diffusion images of participant heads will be obtained. Current density distributions in normal participants will be imaged using an F3-F4 montage at three different current intensities. Measures will be repeated at intervals of at least one week. Each time, the montage will be reapplied and subjects re-imaged. Because the imaging method is quantitative, these measures will be used to provide an indication of baseline replicability. Both intra- and inter-subject variations in measured current and electric field distributions will be determined.~Participant performance on a 3-back/0-back memory task will be compared in both Sham and Active subjects, using either 1, 1.5 or 2 mA intensity stimulation."|t|||
1286478|NCT03772197|||Cohort||Retrospective|||||||
1286479|NCT03772184|Randomized|Parallel Assignment||Prevention||Quadruple||Using cervical inversion during cesarean section|t|t|t|t
1286480|NCT03772171|||Cohort||Prospective|||||||
1286481|NCT03772158|Randomized|Crossover Assignment||Other||Single|Blinding of the test and reference products to study subjects is not feasible, because the products are different dosage forms (chewable tablets and IR tablets) and administered in different ways (with or without water and fasted or fed). Personnel conducting the bioanalyses of samples will not know the treatment sequence. The randomization code will not be available to them until the analytical tables have been finalized and audited by the Algorithme Pharma (An Altasciences Company) Quality Assurance (QA) department.|"This is a randomized, single-dose, four-treatment crossover bioequivalence and food effect study of Cetirizine Chewable Tablets versus ZYRTEC® Immediate Release (IR) Tablets (US reference) and REACTINE® IR Tablets (EU and Australian marketed reference product).~The study will be conducted in two parts. Part 1 of the study will have a randomized, four way crossover study design in which 40 healthy subjects, ages 18 to 55 years, will be randomized to four sequences of Treatments A, B, D and E over consecutive periods. No less than approximately 40% of either gender will be represented in the study population. Part 2 of the study will assess a potential food effect in which all subjects will be administered Treatment C in the fifth period."||||t
1286482|NCT03772145|||Cohort||Prospective|||||||
1286483|NCT03772132||Single Group Assignment||Treatment||None (Open Label)||||||
1286484|NCT03772119|||Cohort||Prospective|||||||
1286485|NCT03772106|Randomized|Parallel Assignment||Other||Single|||t|||
1286486|NCT03772093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286487|NCT03772080|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286488|NCT03772067|Randomized|Parallel Assignment||Other||None (Open Label)||Parallel assignment||||
1286489|NCT03772054|Randomized|Parallel Assignment||Prevention||Single|Blood samples will be codified by the principal investigator. Laboratory team will receive all samples for biomarkers measures. Results will be analyzed by the principal investigator.|||||t
1286490|NCT03772041|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286491|NCT03772028|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized controlled, open-label, multicenter phase III trial||||
1286492|NCT03772015|||Case-Control||Prospective|||||||
1286493|NCT03772002||Single Group Assignment||Screening||None (Open Label)||||||
1286494|NCT03771989|Randomized|Parallel Assignment||Treatment||Triple|"4.4.1 Randomization Randomization is computer based, performed in blocks of twelve.~4.4.2 Blinding Blinding of the patient is secured as follows: The liposuction and microfragmentation of the fatty tissue is performed in the operating theatre. When the graft is ready for use the randomization envelope is opened by the project nurse; if the patient is allocated to active treatment syringes containing the microfragmented fatty tissue are prepared; if the patient is allocated to placebo syringes containing saline are prepared. The 10ml syringe is placed in the hand of the treating surgeon. Injection is performed with a 21G cannula. Due to the difference in viscosity of the graft and saline, the surgeon cannot be blinded.~In order to investigate if the blinding is working the patients will be asked at 6 months follow up which group he/she believe he/she was assigned to."|"The study is performed as a blinded, multicenter, randomized, controlled trial with participants individually randomized to one of two parallel groups:~The intervention group: Participants receive one intra articular injection with autologous, microfragmented adipose tissue.~The control group: Participants receive one intra articular injection with Saline (placebo)."|t||t|t
1286495|NCT03771976|||Cohort||Retrospective|||||||
1286496|NCT03771963||Single Group Assignment||Prevention||None (Open Label)||||||
1286497|NCT03771950|Randomized|Parallel Assignment||Treatment||Single|After screening for eligibility, fulfilling inclusion criteria and consenting to participation the baseline assessment will be conducted by an OT at enrolment. After this the patients will be randomised either to the intervention or control group in using lots in sealed envelopes based on a computer generated group allocation. The lots are kept in sealed envelopes prepared by a person not involved in the study. An OT will open the envelope and inform the patient about group allocation. All care providers will be blinded for baseline and post-test outcomes. A research co-worker who are involved in data management will be blinded for group allocation.|||||t
1286498|NCT03771937|Randomized|Parallel Assignment||Prevention||Single|Single blinding was provided that included inclusion criteria and agreement to participate in the study||t|||
1286499|NCT03771924|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1286505|NCT03771846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286506|NCT03771833|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286507|NCT03771820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286508|NCT03771807|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1286509|NCT03771794|Randomized|Crossover Assignment||Treatment||Double||"Active Comparator: ReguRate RR2 active. Device: ReguRate neurostimulation system~Sham Comparator: ReguRate RR2 placebo. Device: Sham ReguRate electrical stimulation - mock sham stimulation mode"|t||t|
1286510|NCT03771781|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286511|NCT03771768|Randomized|Parallel Assignment||Treatment||Double|"Double - blinded trial:~Outcome assessor (CS) and Statistician. Participants couldn't be blinded because of the difference in the nature of interventions method of application."|1:1||t|t|
1286512|NCT03771755|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1286513|NCT03771742|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1286514|NCT03771729||Single Group Assignment||Treatment||None (Open Label)||||||
1286515|NCT03771716|Randomized|Parallel Assignment||Basic Science||Double|Neither the investigator, nor outcomes assessors will know participants' group assignments. Participants will be instructed to refrain from speaking about their group's activities when visiting the lab for follow-up assessment. In addition, special care was taken to ensure that non-blinded laboratory staff (e.g., staff member notifying participants of their group assignments, staff monitoring the intervention classes) are not located in the same proximity in the laboratory, further preventing accidental unblinding.|180 African American older adults between the ages of 60-80 will be randomly assigned to one of two groups: African Dance or Africana Culture. Both groups will meet 3 times per week for 1 hour over a period of 6-months. Cognitive and brain metrics will be assessed at baseline and following the completion of the intervention.|||t|t
1286516|NCT03771703|||Cohort||Retrospective|||||||
1286517|NCT03771690|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1286518|NCT03771677|Randomized|Parallel Assignment||Treatment||None (Open Label)|"Active Comparator:nucleotide analogues(NAs) patients continue to use NAs~Experimental: peg-interferon alfa-2a patients switch to sequential peg-interferon α-2a"|"Drug: nucleotide analogues(NAs)~Drug: Peginterferon alfa-2a"||||
1286519|NCT03771664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286520|NCT03771651||Single Group Assignment||Treatment||None (Open Label)||||||
1286521|NCT03771638|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized, controlled study||||
1286522|NCT03771625|||Cohort||Prospective|||||||
1286523|NCT03771612|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1286524|NCT03771599|Randomized|Parallel Assignment||Treatment||Single|outcome assessor was kept blind about group identification of the participants before assessments at baseline, after 06 weeks and 12 weeks of intervention.|It is a RCT with two groups, control and intervention. Both groups received routine physical therapy five days a week for a period of three months. Intervention group also received traditional massage for thirty minutes before start of the routine physical therapy. Data was collected at baseline, after 06 weeks and 12 weeks of intervention||||t
1286525|NCT03771586|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1286526|NCT03771573|Randomized|Parallel Assignment||Treatment||Single|THE BLIND INVESTIGATOR, WHO WILL NOT KNOW THE GROUPS AND THE STUDY, WILL RECEIVE THE DATED NAMES WITH CODES TO CARRY OUT DATA ANALYSIS.|BLINDED AND RANDOMIZED CLINICAL TRIAL|||t|
1286527|NCT03771560||Single Group Assignment||Treatment||None (Open Label)||||||
1286528|NCT03771547|||Case-Control||Prospective|||||||
1286529|NCT03771534||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286530|NCT03771521||||||||||||
1286531|NCT03771508|||Case-Only||Prospective|||||||
1286532|NCT03771495|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1286533|NCT03771482|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1286534|NCT03771469||Single Group Assignment||Screening||None (Open Label)||This will be a prospective validation study of a sample of consecutive pediatric Down syndrome patients who are seen through the weekly Down syndrome clinic at OHSU/Doernbecher's.||||
1286535|NCT03771456|||Cohort||Prospective|||||||
1286536|NCT03771443||Single Group Assignment||Prevention||None (Open Label)||||||
1286537|NCT03771430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286538|NCT03771417|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286539|NCT03771404||Single Group Assignment||Other||None (Open Label)||||||
1286540|NCT03771391|Randomized|Crossover Assignment||Treatment||Single|At the point of randomisation every effort will be made to ensure that participants are unaware of the cluster they are randomised to; this is to help ensure that compliance is not affected by participants knowing when they will start the new treatment.|The study has a stepped wedge design, which is chosen over the alternative cross-over study as it allows that all participants start on the amino acid supplement and avoids the difficulty of the 'wash-out' period being the same as one of the treatment strategies being offered.|t|||
1286541|NCT03771378|Randomized|Parallel Assignment||Treatment||Single||This study was a randomized, double-blind trial in which patients were divided into two groups, one receiving rhTPO injection and oral placebo tablet; the other group receiving oral eltrombopag and receiving a injection placebo.|||t|
1286542|NCT03771365|||Cohort||Prospective|||||||
1286543|NCT03771352||||||||||||
1286544|NCT03771339|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1286545|NCT03771326|Randomized|Parallel Assignment||Basic Science||None (Open Label)|All the individuals were told before the use of Kp-10 administration. however, to avoid psychological effect the exact time was not disclosed.|Fourteen volunteers (aged 20-45 years), including seven adult normal weight healthy men (mean body weight and BMI 75.5±4.8 kg and 23±0.7 kg/m2, respectively) and seven obese men (mean body weight and BMI 115±15 kg and 34±2 kg/m2, respectively), participated in this clinical study||||
1286546|NCT03771313||Single Group Assignment||Treatment||None (Open Label)|Open label|Open-label, single center, prospective study||||
1286586|NCT03770793|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1287271|NCT03761888|||Other||Prospective|||||||
1286547|NCT03771300|Randomized|Parallel Assignment||Prevention||Double|The assignation of the subjects will be carried out after the evaluation by a member of the research group, who has no knowledge about the study, through a random sequence generated by computer. Participants will be assigned to one of these conditions: 1) Mindfulness condition; 2) Mindfulness condition complemented by VR environments; 3) Relaxation condition.|This is a randomized, controlled, pragmatic trial, involving three assessment time points (baseline, post-intervention and six-month follow-up).|t|||t
1286548|NCT03771287|Randomized|Parallel Assignment||Treatment||Double|Double-blinded randomized control trial of OpenSound Navigator (OSN) enabled/disabled hearing aids. Only the fitting audiologist will know if the OSN algorithm is enabled or disabled in the research hearing aids. Will be un-blinded after data collection is complete in order to carry out group comparison analysis.||t||t|
1286549|NCT03771274||Single Group Assignment||Treatment||None (Open Label)||||||
1286550|NCT03771261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286551|NCT03771248|Randomized|Parallel Assignment||Treatment||Single||||||t
1286552|NCT03771235|Randomized|Parallel Assignment||Treatment||Single||Randomized Controlled Trial||||t
1286553|NCT03771222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286554|NCT03771209||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286555|NCT03771196|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1286556|NCT03771183|||Cohort||Retrospective|||||||
1286557|NCT03771170|Randomized|Parallel Assignment||Treatment||Single|Outcomes Assessor will perform the assessment of primary, secondary efficasy and safety parameters|Assignment||||t
1286558|NCT03771157||Single Group Assignment||Treatment||None (Open Label)||||||
1286559|NCT03771144||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286560|NCT03771131|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286561|NCT03771118|||Cohort||Retrospective|||||||
1286562|NCT03771105|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|crossover parallel|||||
1286563|NCT03771092|Randomized|Parallel Assignment||Treatment||Single||||||t
1286564|NCT03771079|||Cohort||Retrospective|||||||
1286565|NCT03771066|Randomized|Parallel Assignment||Treatment||Double|This study will be a double-blinded study. Research staff collecting data and participants will not know treatment allocation.|This experimental study is a 2-group randomized, clinical trial comparing a 4-day energy balance diet plus oral BPA consumption at 50 ug/kg body weight (Diet+BPA) vs. 4-day energy balance diet plus oral placebo consumption (Diet+No BPA). Forty participants will be randomized to Diet+BPA and Diet+No BPA and will reside in a supervised environment at Cal Poly's sleep research facilities for 6 days (2-day baseline run-in, followed by 4-day treatment). Main outcome measures (muscle insulin sensitivity and hepatic glucose suppression) will be assessed at baseline and treatment periods.|t|||t
1286566|NCT03771053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286567|NCT03771040|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286568|NCT03771027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286569|NCT03771014|Randomized|Parallel Assignment||Supportive Care||Single|Outcome assessment at ICU discharge, hospital discharge and 3 month follow-up will be undertaken by an assessor, blinded to study group allocation.|Feasibility study of two-arm pilot RCT, randomised 1:1 with blinded outcome assessments||||t
1286570|NCT03771001||Single Group Assignment||Other||None (Open Label)||Feasibility study||||
1286571|NCT03770988||Single Group Assignment||Treatment||None (Open Label)||||||
1286572|NCT03770975|Randomized|Parallel Assignment||Treatment||Single||||||t
1286573|NCT03770962|Randomized|Parallel Assignment||Prevention||Single|The statistician who performs the statistical analysis will be blinded.||||t|
1286574|NCT03770949|||Cohort||Prospective|||||||
1286575|NCT03770936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286576|NCT03770923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286577|NCT03770910|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1286578|NCT03770897|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1286579|NCT03770884|||Cohort||Prospective|||||||
1286580|NCT03770871|Randomized|Parallel Assignment||Treatment||Triple|Double blinded|Parallel group with 1:1 allocation ratio|t||t|t
1286581|NCT03770858|||Cohort||Prospective|||||||
1286582|NCT03770845|||Cohort||Prospective|||||||
1286583|NCT03770832|||Cohort||Prospective|||||||
1286584|NCT03770819|Randomized|Parallel Assignment||Treatment||Double|This is a Split Mouth Double Blind Randomized Controlled Clinical Trial in which both participants and care provider are blinded.|"16 patients contributing a total of 64 sites will be selected. Recording of clinical and microbiological parameters will be done at baseline, end of 1 month, and 3 months. Oral hygiene instructions will be given. Following full mouth SRP, each quadrant will be randomly assigned by simple randomization using a computer generated randomization technique into one of the following four treatment modalities.~Group 1 (control) - Application of placebo gel followed by sham PDT (Directing the Light cure device without turning on the light beam).~Group 2 -Application of Zinc oxide gel followed by sham PDT. Group 3 - Application of placebo gel followed by PDT. Group 4 - Application of Zinc oxide gel followed by PDT. The procedure mentioned for each group will be performed on all periodontal pockets in the assigned quadrant at baseline, end of 1 week and 1 month from the first session.~Study period - 3 months"|t|t||
1286585|NCT03770806|Randomized|Parallel Assignment||Treatment||Single|The research coordinator in charge of checking in with subjects during the six month follow-up period is blind to the pain treatment condition of the subject (Groin block vs. Mid-thigh block|Subjects who choose to have medication alone with no block for their routine care will be in an observational group only with no randomization. Subjects who elect to have a nerve block placed for their routine treatment will be randomized per the research protocol to have the block placed at either the groin or the mid-thigh. Subjects in each study group will perform the same study procedures. This study will follow subjects for the first 6 months of their recovery to observe routine care pain treatments and evaluate whether the methods of pain control determine (a) severity and duration of postoperative pain, (b) the speed of recovery of muscle function, and (c) pain responses and aggressiveness of pursuing physical therapy maneuvers||||t
1287362|NCT03760705|||Cohort||Other|||||||
1286587|NCT03770780|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1286588|NCT03770767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286589|NCT03770754|Randomized|Factorial Assignment||Treatment||Double|Certified endodontists trained in the procedures, devices, and systems investigated took part in the research. All experts tracked a pre-established procedure for Rotary instrument systems and Endo vac system.|"All clinical procedures and measurements were conducted by the author. A #0 periapical radiograph was taken for each tooth in buccolingual projection to allow proper selection. The selected teeth included 7 second maxillary molars (three canals each), 9 first maxillary molars (2 canals each), 3 central incisors (one canal each), 18 first mandibular molars (2 canals each), 8 second mandibular molars (three canals each) for a total of 45 teeth with 102 canals (Table 1).~A standard session time recommended by the pedodontists was approximately 20-35 minutes in length to allow for acceptable time for completion of treatment. All treatment was performed by the author. As a novel treatment in Pedodontics, were included electronic apex locator (EAL), EndoVac system and two rotary systems: LightSpeed LSX instruments and ProTaper Next."|t||t|
1286590|NCT03770741|Randomized|Parallel Assignment||Treatment||None (Open Label)|Due to the nature of the experimental intervention, no blinding can be done for the clinical staff and the parents. Outcome assessment of mortality will not be blinded, but the diagnosis and classification of brain injury and the entry of this into the eCRF, will be done by a person that is blinded to group allocation. Principal investigators must develop a local procedure description that describe how this is done. The local procedure description must be approved by the sponsor. Furthermore, mortality will be checked by Good Clinical Practice (GCP) through source data verification in all patients. The data managers, statisticians and those drawing conclusions will be blinded to treatment allocation. Data management will be blinded.|||||
1286591|NCT03770728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286592|NCT03770715|||Cohort||Prospective|||||||
1286593|NCT03770702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286594|NCT03770689|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1286595|NCT03770676|Randomized|Parallel Assignment||Basic Science||Double|"The investigator will be blinded to which (intervention) flavour each participant is assigned to.~Both the investigator and the participant will be blinded to the participant's plasma selenium concentration."|There are three study groups (three 'test' biscuit flavours). Each study group will be assigned one test flavour ('intervention' flavour/biscuit). They begin consumption of their intervention biscuits on day 1 and finish on day 14. Plasma selenium concentration and sensory perception of biscuits will be measured on day 1 (baseline), 8 (post-7 days of intervention) and 15 (post-14 days of intervention).|t||t|
1286596|NCT03770663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286597|NCT03770650|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor will remain blinded until the final study results are released.|Patients will undergo 1:1 randomization to either IVUS-guided DKCrush stenting which will be the treatment group or Angio-guided DKCrush stenting which will be the control group based on an online Clinical Research Data Management Platform provided by King Yee,,Beijing CN. The initiation of the trial is defined as the time of randomization. After study subjects' enrollment and randomization, the study intervention will take place immediately. The follow-up visits for the primary endpoint are scheduled at 1, 6, and 12 months after the index procedure. Angiographic follow-up is scheduled at 13 months.||||t
1286598|NCT03770637|Randomized|Crossover Assignment||Treatment||Double|The sponsor, investigators/staff and subjects will be blinded to treatment assignment. Active study drug and placebo have the identical appearance (i.e., clear, colorless liquid), and both will be provided in identical vials with blinded labeling that does not reveal the contents of the vial.|A randomized, placebo-controlled, double-blind, two-treatment, 2-period, crossover in-patient phase followed by a placebo-controlled, double-blind, parallel two-treatment outpatient stage..|t||t|
1286599|NCT03770624|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1286600|NCT03770611|Randomized|Factorial Assignment||Treatment||Triple|"Patient Blinding: Patients in automated peritoneal dialysis will be blinded to the intervention they will receive. Evaluator Blinding: The principal investigator and the Doctorate program student will be blinded to the intervention that patients will receive (probiotic, prebiotic, symbiotic or placebo).~Care providers will be blinded to the intervention groups."|Parallel assignment, patients in automated peritoneal dialysis will be randomly assigned to one of the four intervention groups: probiotic, prebiotic, symbiotic and placebo|t|t|t|
1286601|NCT03770598|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Non-Distressed patients will be randomized to receive intervention or standard of care.~Distressed patients will be randomized to receive intervention or standard of care"||||
1286602|NCT03770585|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1286603|NCT03770572|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"Single Treatment Group (AAV9-CLN3) - 2 Cohort Assignment (Low-dose, High-dose)~Dose escalation in this study will begin with low-dose, determined to be the minimal efficacious dose as determined in non-clinical studies. Dose escalation to a high-dose (2x the minimally effective dose (MED) as evaluated in Cohort 1) will proceed as part of Cohort 2 of the study upon demonstration of safety of the low-dose in Cohort 1 of the study."||||
1286604|NCT03770559|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two parallel groups: laparoscopic and open surgery||||
1286605|NCT03770546|Randomized|Parallel Assignment||Treatment||Single||||||t
1286606|NCT03770533|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286607|NCT03770520|Randomized|Parallel Assignment||Treatment||Double|QFR will be masked to care providers and participants, and open to investigators, the allocation will be based on QFR.||t|t||
1286608|NCT03770507|Randomized|Crossover Assignment||Basic Science||Single||||||t
1286609|NCT03770494||Single Group Assignment||Treatment||None (Open Label)||||||
1286610|NCT03770481|Randomized|Parallel Assignment||Supportive Care||Double||randomized controlled trial|t|t||
1286611|NCT03770468|||Other||Cross-Sectional|||||||
1286612|NCT03770455||Single Group Assignment||Treatment||None (Open Label)||||||
1286663|NCT03769792||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286772|NCT03768375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286773|NCT03768362|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1286613|NCT03770442|Randomized|Parallel Assignment||Prevention||Single|"Ultrasound images will be labelled by their participant number, and not by intervention. Therefore, when image analysis takes place, the investigators will not know whether the images come from somebody who received cycling sessions or the control group.~Tissue samples will be treated in the same way.~In follow up sessions, participants will be asked not to reveal if they can remember whether they cycled or not."|||||t
1286614|NCT03770429||Single Group Assignment||Treatment||None (Open Label)||||||
1286615|NCT03770416|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286616|NCT03770403||Single Group Assignment||Treatment||None (Open Label)||||||
1286617|NCT03770390||Single Group Assignment||Treatment||None (Open Label)||This single group study documents changes before and after surgical correction of pectus excavatum.||||
1286618|NCT03770377|Randomized|Crossover Assignment||Treatment||None (Open Label)||A cross-sectional study design will be used to examine laryngeal adaptation across all study groups.||||
1286619|NCT03770364|||Cohort||Prospective|||||||
1286620|NCT03770351|||Cohort||Prospective|||||||
1286621|NCT03770338|Randomized|Parallel Assignment||Other||None (Open Label)||To detect any significant difference between control and teriparatide groups in terms of intraoperative insertional torque strength||||
1286622|NCT03770325|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1286623|NCT03770312|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286624|NCT03770299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286625|NCT03770286|Randomized|Parallel Assignment||Treatment||Single|Evaluator of the x-rays will be blinded.|||||t
1286626|NCT03770273|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286627|NCT03770260||Single Group Assignment||Treatment||None (Open Label)||||||
1286628|NCT03770247|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1286629|NCT03770234|Randomized|Crossover Assignment||Treatment||None (Open Label)||Each participant will apply Transtec 35 µg/hour transdermal patch, once for 96 hours (Treatment A) and once for 72 hours (Treatment B) in randomized order. Between removal of the first patch and application of the second patch, there will be a washout period of at least 10 days.||||
1286630|NCT03770221|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1286631|NCT03770208|Randomized|Parallel Assignment||Treatment||Triple|All parties involved until the end of trial. Pharmacy will be the only unblinded party as they need to prepare the study drugs.|RCT, single site, double blinded|t|t|t|
1286632|NCT03770195|||Cohort||Prospective|||||||
1286633|NCT03770182|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1286634|NCT03770169|||Case-Only||Prospective|||||||
1286635|NCT03770156|||Cohort||Prospective|||||||
1286636|NCT03770143|||Case-Control||Prospective|||||||
1286637|NCT03770130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286638|NCT03770117|||Case-Control||Retrospective|||||||
1286639|NCT03770104|Randomized|Parallel Assignment||Prevention||Double|Clinicians and neonatal nurses will not masked to group assignment. However, Neonatal Intensive Care Unit nurses who take care of the patient will be mask, as well as both pediatric radiologist who will determine the main outcome of the study.||t|||t
1286640|NCT03770091|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286641|NCT03770078||Single Group Assignment||Supportive Care||None (Open Label)||||||
1286642|NCT03770065|||Case-Only||Prospective|||||||
1286643|NCT03770052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286644|NCT03770039|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1286645|NCT03770026|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1286646|NCT03770013|Randomized|Parallel Assignment||Prevention||Quadruple|double-blind study.|A prospective Randomized Interventional double-blind study.|t|t|t|t
1286647|NCT03770000||Single Group Assignment||Treatment||None (Open Label)||||||
1286648|NCT03769987|||Case-Control||Prospective|||||||
1286649|NCT03769974|Randomized|Parallel Assignment||Basic Science||Double|An independent blind assessor will perform the measurements and recorded the data. Finally, the participants will also be blinded.||t||t|
1286650|NCT03769961|||Case-Control||Cross-Sectional|||||||
1286651|NCT03769948|||Cohort||Retrospective|||||||
1286652|NCT03769935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286653|NCT03769922|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286654|NCT03769909|||Cohort||Prospective|||||||
1286655|NCT03769896|Randomized|Parallel Assignment||Treatment||Quadruple|placebo-controlled, double-blind, parallel-group with 1 : 1 randomization|randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study|t|t|t|t
1286656|NCT03769883|Randomized|Parallel Assignment||Treatment||Single|Upon completion of the study and prior to breaking the allocation code, a data-collection form is generated by a statistician and the principal investigator. The data-analyst breaks the allocation code and labels the participants according to the assigned treatment and analyzes the outcomes. Following the analyses, group allocation will be concealed in all data outputs and the N per group and present the data to the writing committee in a blinded fashion. Then the writing committee will provide their blinded interpretations.|||||t
1286657|NCT03769870|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1286658|NCT03769857|Randomized|Parallel Assignment||Supportive Care||Quadruple|Quadruple Blind|treatment versus placebo|t|t|t|t
1286659|NCT03769844|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This is an open-label, sequential, dose- and route of administration-finding study that will be conducted in sequential cohorts of children with sepsis-induced MODS||||
1286660|NCT03769831|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1286661|NCT03769818|Randomized|Parallel Assignment||Prevention||Quadruple|Participating patients, surgeons, anesthesiologists and medical investigators who will be involved in the data collection will be all blinded to the patient's group assignment until the collection of data for all cases will be complete for group 1 and 2.|A prospective Randomized Interventional double-blind study.|t|t|t|t
1286662|NCT03769805||Single Group Assignment||Treatment||None (Open Label)||||||
1422560|NCT01998113|||||Retrospective|||||||
1286664|NCT03769779|Randomized|Parallel Assignment||Prevention||Quadruple|Envelopes that contain information regarding the coding of treatment and placebo will be provided to Sponsor, Site, and PI and kept in a secure location. Envelopes will be readily available for the investigator or site to open in the event that it becomes necessary to know which product a participant is taking for the sake of the participant health care. The sponsor must be notified of any unblinding by the site within 24 hours.|Randomized, Double-Blind, Placebo-Controlled, Parallel Study|t|t|t|t
1286665|NCT03769766|Randomized|Parallel Assignment||Treatment||Double||placebo/active Curcumin|t||t|
1286666|NCT03769753||Single Group Assignment||Treatment||None (Open Label)||This is a prospective, single-center phase I study.||||
1286667|NCT03769740|||Cohort||Prospective|||||||
1286668|NCT03769727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286669|NCT03769714|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1286670|NCT03769701|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286671|NCT03769688|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1286672|NCT03769675||Single Group Assignment||Treatment||None (Open Label)||||||
1286673|NCT03769662||Single Group Assignment||Treatment||None (Open Label)||Open-label, single dose study||||
1286674|NCT03769649||Single Group Assignment||Treatment||None (Open Label)||Subjects will receive the treatment and outcome will be followed||||
1286675|NCT03769636|||Cohort||Prospective|||||||
1286676|NCT03769623|Randomized|Parallel Assignment||Treatment||Single||||||t
1286677|NCT03769610|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be randomly assigned to either inpatient or outpatient cervical ripening with a Foley catheter.||||
1286678|NCT03769597||Single Group Assignment||Treatment||None (Open Label)||||||
1286679|NCT03769584|||Cohort||Retrospective|||||||
1286680|NCT03769571|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1286681|NCT03769558|||Cohort||Retrospective|||||||
1286682|NCT03769545|||Case-Only||Retrospective|||||||
1286683|NCT03769532||Single Group Assignment||Treatment||None (Open Label)||||||
1286684|NCT03769519||Single Group Assignment||Health Services Research||None (Open Label)||||||
1286685|NCT03769506||||||||||||
1286686|NCT03769493||Single Group Assignment||Treatment||None (Open Label)||An uncontrolled open trial approach will be used in which all participants receive the MACS app.||||
1286687|NCT03769480|||Cohort||Prospective|||||||
1286688|NCT03769467||Single Group Assignment||Treatment||None (Open Label)||||||
1286689|NCT03769454|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1286690|NCT03769441|Randomized|Parallel Assignment||Treatment||Quadruple|All participants, care providers and researchers will be blinded, except for the nurse who will administer the medication.|The study is designed as a 24 week, multicentre, randomized placebo-controlled clinical trial with two parallel arms to investigate the effect of ferric(III) carboxymaltose on exercise tolerance, cardiac function, skeletal muscle function, quality of life, the gut microbiota and on the immune system, to be performed at the University Medical Center Groningen (UMCG) and the Erasmus MC, University Medical Center Rotterdam.|t|t|t|t
1286691|NCT03769428|Randomized|Parallel Assignment||Treatment||Triple||Parallel Assignment|t|t|t|
1286692|NCT03769415||Single Group Assignment||Treatment||None (Open Label)||||||
1286693|NCT03769402|Randomized|Parallel Assignment||Treatment||Single||Randomized clinical trial|t|||
1286694|NCT03769389|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1286695|NCT03769376|Randomized|Parallel Assignment||Treatment||Single|Participants will be randomly assigned (1:1) to one of two treatment groups (Bio-Oss® or Salvin-Oss®) at the time of surgery through random selection of sealed envelopes. The outcome assessor for histological samples will not be aware of which group the participant was in until code unlocked.|Patients will be randomly assigned (1:1) to one of two treatment groups (Bio-Oss® or Salvin-Oss®) at the time of surgery through random selection of sealed envelopes.||||t
1286696|NCT03769363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286697|NCT03769350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286698|NCT03769337|||Other||Prospective|||||||
1286699|NCT03769324|||Cohort||Prospective|||||||
1286700|NCT03769311||Single Group Assignment||Treatment||None (Open Label)||Single site, open label, window of opportunity study||||
1286701|NCT03769298||Single Group Assignment||Treatment||None (Open Label)||This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 30 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 2 years prior, with a history of tremors following transplantation.||||
1286702|NCT03769285|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1286703|NCT03769272|||Case-Control||Prospective|||||||
1286704|NCT03769259|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1286705|NCT03769246|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1286706|NCT03769233||Single Group Assignment||Treatment||None (Open Label)||||||
1286707|NCT03769220|||Cohort||Prospective|||||||
1286708|NCT03769207||Single Group Assignment||Other||None (Open Label)||||||
1286709|NCT03769194|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1286710|NCT03769181|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286711|NCT03769168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open-label|||||
1286712|NCT03769155|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286713|NCT03769142|||Other||Prospective|||||||
1286714|NCT03769129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286715|NCT03769116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286716|NCT03769103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286717|NCT03769090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286718|NCT03769077|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286770|NCT03768401||Single Group Assignment||Health Services Research||None (Open Label)||||||
1286771|NCT03768388|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1286719|NCT03769064|Randomized|Crossover Assignment||Treatment||Triple|Double-blind, randomized|The study will consist of a 2-period crossover Qualification Phase (Part 1) to ensure subject eligibility for the treatment phase of the study, and a 4-period crossover Treatment Phase (Part 2) to determine the effect of concomitant administration of MPH and NTX on subjective pharmacodynamic (PD) measures of abuse, relative to MPH and placebo.|t|t|t|
1286720|NCT03769051|||Cohort||Prospective|||||||
1286721|NCT03769038||Single Group Assignment||Treatment||None (Open Label)||||||
1286722|NCT03769025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286723|NCT03769012|Randomized|Parallel Assignment||Other||Quadruple|A randomization schedule will be created and provided to the Investigator indicating the order of randomization. Each participant will be assigned a randomization code according to the order of the randomization list generated using www.randomization.com. Enrolled participants will be randomized to the different treatment arms at day -14. Concealment of the allocation of treatment will be employed through the use of opaque sealed envelopes, each labeled with a randomization number. Each envelope will contain information regarding the treatment associated with each randomization number.|Single-center, randomized, double-blind, placebo-controlled, parallel study|t|t|t|t
1286724|NCT03768999|||Cohort||Prospective|||||||
1286725|NCT03768986|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1286726|NCT03768973|||Case-Control||Prospective|||||||
1286727|NCT03768960||Single Group Assignment||Treatment||None (Open Label)||||||
1286728|NCT03768947||Single Group Assignment||Treatment||None (Open Label)||||||
1286729|NCT03768934|Randomized|Parallel Assignment||Other||Single||Participants will be randomized to one of four airtime amounts: 1) no incentive; 2) 1X incentive; 3) 2X incentive or 4) a lottery incentive, in which one out of every 20 participants will receive the incentive.||||t
1286730|NCT03768921||Single Group Assignment||Supportive Care||None (Open Label)|The research design is a longitudinal, quantitative and analytical clinical trial.|||||
1286731|NCT03768908|Randomized|||Treatment||None (Open Label)|No blinding was done due to the different drug formulations and regimens.|A multicentre randomised comparative clinical trial of the efficacy of ASAQ versus AL for the treatment of uncomplicated childhood Plasmodium falciparum malaria.||||
1286732|NCT03768895|||Cohort||Other|||||||
1286733|NCT03768882|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1286734|NCT03768869|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Because inpatient management and outpatient management use different treatment methods, blinding is not possible.|Patients will be stratified as high risk, where they will receive inpatient management, or low risk, where they will then be randomize to receive inpatient or outpatient management.||||
1286735|NCT03768856||Single Group Assignment||Supportive Care||None (Open Label)||||||
1286736|NCT03768843||Single Group Assignment||Treatment||None (Open Label)||||||
1286737|NCT03768830|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Participants will be randomly selected into 4 groups: MS individuals that will exercise - group (MSE), with related control group of individuals who will not exercise) (MSC).~In addition, a group of healthy control subjects without MS (HE) will also exercise and be evaluated after the study with related control individuals who will not exercise (HC).~Group of MS and healthy individuals will exercise under the guidance of a physiotherapist."||||
1286738|NCT03768817|||Case-Only||Retrospective|||||||
1286739|NCT03768804|Randomized|Crossover Assignment||Treatment||Triple||Double blind, randomised crossover study|t||t|t
1286740|NCT03768791|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1286741|NCT03768778||Single Group Assignment||Treatment||None (Open Label)||||||
1286742|NCT03768765|||Cohort||Prospective|||||||
1286743|NCT03768752|||Cohort||Prospective|||||||
1286744|NCT03768739|||Cohort||Prospective|||||||
1286745|NCT03768726||Single Group Assignment||Treatment||None (Open Label)|Subjects who participate in A1281198 will be transitioned under double blind conditions (during the first two weeks of the study) to 26 weeks of treatment with flexibly dosed opened label ziprasidone.|Subjects would completed A1281198 will be transitioned under double blind conditions to 26 weeks of treatment with flexibly dosed opened label ziprasidone.||||
1286746|NCT03768713|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1286747|NCT03768700|||Cohort||Prospective|||||||
1286748|NCT03768687|||Cohort||Prospective|||||||
1286749|NCT03768674|||Cohort||Cross-Sectional|||||||
1286750|NCT03768661|||Cohort||Retrospective|||||||
1286751|NCT03768648|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1286752|NCT03768635|||Cohort||Retrospective|||||||
1286753|NCT03768622|||Cohort||Retrospective|||||||
1286754|NCT03768609|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1286755|NCT03768596|Randomized|Parallel Assignment||Basic Science||None (Open Label)|In the first pat of the study, participants are unaware of the fact we are trying to nudge them. In the second part, they are explained and asked what they feel about nudging|one group receives a form with the nudge, one group receives the same form without nudge and another group doesn't receive any form||||
1286756|NCT03768583|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286757|NCT03768570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286758|NCT03768557|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286759|NCT03768544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286760|NCT03768531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286761|NCT03768518|||Case-Only||Prospective|||||||
1286762|NCT03768505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286763|NCT03768492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286764|NCT03768479||Single Group Assignment||Other||None (Open Label)||||||
1286765|NCT03768466||Single Group Assignment||Supportive Care||None (Open Label)||||||
1286766|NCT03768453|||Cohort||Prospective|||||||
1286767|NCT03768440|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1286768|NCT03768427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286769|NCT03768414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286774|NCT03768349||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286775|NCT03768336|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1286776|NCT03768323|Randomized|Parallel Assignment||Other||Single||Participants were randomized to one of three airtime incentive amounts: 1) no incentive; 2) 1X incentive; or 3) 2x incentive where X was equal to 50 Bangladeshi Taka ($0.60 USD) or 5000 Ugandan Shillings (UGX; $1.35 USD as of April 3, 2018). Airtime incentives were sent if participants completed the noncommunicable disease risk factor survey||||t
1286777|NCT03768310|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1286778|NCT03768297|Randomized|Parallel Assignment||Treatment||Double|double blinded||t|||t
1286779|NCT03768284|||Case-Control||Cross-Sectional|||||||
1286780|NCT03768271|||Cohort||Prospective|||||||
1286781|NCT03768258|||Cohort||Retrospective|||||||
1286782|NCT03768245|Randomized|Parallel Assignment||Treatment||None (Open Label)||The intervention program is split into two groups of participants which receive two deferments treatments (Arms); treatment (Arm 1) is applied to all participants (n=800), while treatment 2 (Arm 2) is randomly applied just in the Mestizo group (n=117), i.e. schools and grade are randomly allocated in Arm 2||||
1286783|NCT03768232|||Other||Prospective|||||||
1286784|NCT03768219|Randomized|Sequential Assignment||Treatment||Quadruple||"SAD: Randomized, double-blind, placebo-controlled, sequential cohort-group study with a sentinel subject design~MAD: Randomized, double-blind, placebo-controlled, sequential cohort-group study~Psoriasis Expansion Cohort: Randomized, double-blind, placebo-controlled study~Ulcerative Colitis Expansion Cohort: Randomized, double-blind, placebo-controlled study"|t|t|t|t
1286785|NCT03768206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286786|NCT03768193|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1286787|NCT03768180|||Cohort||Retrospective|||||||
1286788|NCT03768167||Single Group Assignment||Treatment||None (Open Label)||||||
1286789|NCT03768154||Sequential Assignment||Treatment||None (Open Label)||Measurement 1 (Supine + spontaneous effort) , Measurement 2 (Supine + paralysis) , Measurement 3 (Prone + paralysis) , Measurement 4 (Prone + spontaneous breathing)||||
1286790|NCT03768141|||Cohort||Prospective|||||||
1286791|NCT03768128|||Other||Prospective|||||||
1286792|NCT03768115|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Autologous crimped plasma segments||||
1286793|NCT03768102|||Cohort||Prospective|||||||
1286794|NCT03768089|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1286795|NCT03768076|||Case-Only||Retrospective|||||||
1286796|NCT03768063||Single Group Assignment||Treatment||None (Open Label)||||||
1286797|NCT03768050|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1286798|NCT03768037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286799|NCT03768024|Randomized|Single Group Assignment||Treatment||Quadruple||Qualified participants for the treatment phase will be randomized to 1 of 7 treatment-sequences based on a computer generated randomization schedule. Participants will receive all 7 treatments in the order specified by the treatment sequence according to a 7-sequence, 7-period balanced design.|t|t|t|t
1286800|NCT03768011|||Cohort||Prospective|||||||
1286801|NCT03767998|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1286802|NCT03767985|Randomized|Parallel Assignment||Treatment||Single|The research orthoptist that does the orthoptic examinations is masked to the randomization.|Participants are randomized to either the standard patching therapy or the dichoptic video game therapy.||t||
1286803|NCT03767972||Single Group Assignment||Treatment||None (Open Label)||This is a prospective clinical trial to compare various energy-based devices for the rejuvenation of the face, neck/décolletage, hands, upper and lower extremities and vagina. Adults seeking rejuvenation of either the face, neck/décolletage, hands, upper and lower extremities, trunk and/or vagina will be treated with appropriate energy-based device(s) based on investigators' discretion. If patients' require rejuvenation of multiple areas, per investigator assessment, they will be allowed to get treatment in multiple areas. Patients will be followed for 3 months post-treatment to determine if the procedure was efficacious for rejuvenation of the area(s) treated.||||
1286804|NCT03767959|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1286805|NCT03767946|||Cohort||Prospective|||||||
1286806|NCT03767933|Randomized|Parallel Assignment||Treatment||Quadruple|Research staff, emergency department staff, and participants will be masked with respect to the allocated treatment. The data analyst will also be masked using codes that will not identify treatment groups until analysis is complete.|This study will be comprised of two Phase 2, six-centre, randomized, double blind, placebo-controlled trials that will be run simultaneously. The investigators expect that the number of participants recruited and the time to completion of both trials will be more efficient as recruitment for both will occur simultaneously. They propose to conduct this study with a novel preference-informed complementary trial design, in which they will conduct two simultaneous 'sister' trials. Caregiver/child pairs presenting to the ED with acute MSK limb injury will decide in which trial they wish to participate: the Opioid trial or the Non-Opioid trial. The design of each trial will be informed by its sister, or complementary, trial. Once the caregiver/child pair has chosen their preferred trial, conduct within each trial will follow traditional randomized, double-blind placebo-controlled superiority trial methodology. Study endpoints will be identical for both trials within this study.|t|t|t|t
1286807|NCT03767920|Randomized|Parallel Assignment||Prevention||Quadruple|Participating patients, surgeons, anesthesiologists and medical investigators who will be involved in the data collection will be all blinded to the patient's group assignment until the collection of data for all cases will be complete.|A prospective Randomized Interventional double-blind study.|t|t|t|t
1286808|NCT03767907|Randomized|Parallel Assignment||Treatment||Single||||||t
1286809|NCT03767894||Single Group Assignment||Treatment||None (Open Label)|Subjects are assessed by an independent therapist. The therapist is not blinded to the control mechanism used during treatment.|||||
1286810|NCT03767881||Single Group Assignment||Treatment||None (Open Label)||||||
1286811|NCT03767868|||Case-Only||Prospective|||||||
1286812|NCT03767855|Randomized|Sequential Assignment||Basic Science||Triple|||t||t|t
1286813|NCT03767842|||Cohort||Prospective|||||||
1468930|NCT01390896|||||Prospective|||||||
1286814|NCT03767829|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286815|NCT03767816|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1286816|NCT03767803|||Cohort||Prospective|||||||
1286817|NCT03767790|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286818|NCT03767777||Single Group Assignment||Treatment||None (Open Label)||||||
1286819|NCT03767764|||Case-Control||Cross-Sectional|||||||
1286820|NCT03767751|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1286821|NCT03767738||Single Group Assignment||Treatment||None (Open Label)||||||
1286822|NCT03767725||Single Group Assignment||Treatment||None (Open Label)||Anti-BCMA or/and Anti-CD19 CAR Autologous T Cells||||
1286823|NCT03767712|||Cohort||Prospective|||||||
1286824|NCT03767699|||Cohort||Prospective|||||||
1286825|NCT03767686|||Cohort||Prospective|||||||
1286826|NCT03767673|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|Control group: Age and sex matched healthy volunteers.|||||
1286827|NCT03767660||Single Group Assignment||Treatment||None (Open Label)||||||
1286828|NCT03767647|Randomized|Parallel Assignment||Treatment||Single||||||t
1286829|NCT03767634|||Cohort||Retrospective|||||||
1286830|NCT03767621|||Case-Only||Prospective|||||||
1286831|NCT03767608|||Cohort||Cross-Sectional|||||||
1286832|NCT03767595||Single Group Assignment||Treatment||None (Open Label)||||||
1286833|NCT03767582|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1286834|NCT03767569|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized controlled trial|t|t|t|t
1286835|NCT03767556|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1286836|NCT03767543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286837|NCT03767530|Randomized|Parallel Assignment||Treatment||None (Open Label)|Not blinded study.|All subjects will be ophthalmologically evaluated before treatment and at weeks 8, 16 and 24. Subjects will be randomly assigned into 2 study groups. Mibo group will have 3 sessions (basal, week 2, week 4) of thermal therapy with Mibo Thermoflo in both eyes. The control group will use warm compresses and eyelid massage 2 times per day in both eyes. At the week 16 control group will also have 3 sessions of Mibo therapy at 2 weeks interval.||||
1286838|NCT03767517|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1286839|NCT03767504||Single Group Assignment||Other||None (Open Label)||Open label, single arm, ascending dose||||
1286840|NCT03767491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286841|NCT03767478|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1286842|NCT03767465|||Cohort||Other|||||||
1286843|NCT03767452||Single Group Assignment||Treatment||None (Open Label)||||||
1286844|NCT03767439||Single Group Assignment||Treatment||None (Open Label)||||||
1286845|NCT03767426|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Independent group comparison||||
1286846|NCT03767413|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||There are two group of subjects: PNF group will receive only PNF training PNFMP group: will receive PNF training and mental pracice technique||||
1286847|NCT03767400|||Case-Control||Prospective|||||||
1286848|NCT03767387|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1286849|NCT03767374|||Cohort||Cross-Sectional|||||||
1286850|NCT03767361|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1286851|NCT03767348|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286852|NCT03767335||Sequential Assignment||Treatment||None (Open Label)||Step 1 Dose escalation / Step 2 Cohort expansion in two selected breast cancer sub-populations||||
1286853|NCT03767322|Randomized|Parallel Assignment||Prevention||Double|Double blind clinical trial||t||t|
1286854|NCT03767309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286855|NCT03767296|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286856|NCT03767283|||Other||Prospective|||||||
1286857|NCT03767270|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1286858|NCT03767257||Single Group Assignment||Treatment||None (Open Label)||||||
1286859|NCT03767244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286860|NCT03767231|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1286861|NCT03767218|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label, phase 3 pilot randomized trial using a two-arm design with 1:1 allocation ratio||||
1286862|NCT03767205||Single Group Assignment||Other||None (Open Label)||||||
1286863|NCT03767192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1286864|NCT03767179|||Case-Control||Prospective|||||||
1286865|NCT03767166|||Cohort||Prospective|||||||
1286866|NCT03767153|Non-Randomized|Single Group Assignment||Treatment||Single|Blinded assessment of photographs taken at baseline and 6, 12 weeks post final treatment by independent evaluators.|||||t
1286867|NCT03767140|Randomized|Parallel Assignment||Treatment||Double|Patients didn´t know what kind of therapy they were submitted The acupuncturist was a nurse, able to do invasive procedures with no knowledge of Chinese Medicine, and totally blind in terms of the verum or sham acupuncture.|"The patients were randomized in two groups, one verum acupuncture, submitted to real acupuncture treatment, and the other sham acupuncture, treated with false acupuncture.~The method used to randomized was flipping a coin, when got heads they went to verum group and when got tails they went to sham group."|t||t|
1286868|NCT03767127|||Cohort||Prospective|||||||
1286869|NCT03767114|Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1286870|NCT03767101|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286871|NCT03767088|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective randomized controlled parallel group design||||
1286913|NCT03766542|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomized controlled trial.||||
1286914|NCT03766529|||Cohort||Prospective|||||||
1286915|NCT03766516|||Cohort||Other|||||||
1286971|NCT03765788|Randomized|Parallel Assignment||Treatment||Double|Double-blind||t||t|
1286872|NCT03767075||Single Group Assignment||Treatment||None (Open Label)|no masking is used. All involved know the identity of the intervention assignment|"Part A includes a molecular profiling program for subjects with advanced solid tumors (iPROFILER) and a molecular tumor board to select the most appropriate treatment based on the molecular alterations found in the iPROFILER.~Part B includes iBASKET, a modular investigator initiated basket study for subjects with selected molecular alterations."||||
1286873|NCT03767062|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286874|NCT03767049|||Cohort||Prospective|||||||
1286875|NCT03767036|Randomized|Crossover Assignment||Treatment||None (Open Label)||Open-label, randomized, crossover design with three treatment periods and six sequences (A3-A1-A2, A1-A2-A3, A2-A3-A1, A3-A2-A1, A1-A3-A2, A2-A1-A3) with single administration of tramadol (A1), ketorolac (A2) or tramadol and ketorolac (A3). Treatment periods were separated by a washout period of at least 4 days.||||
1286876|NCT03767023|||Case-Control||Cross-Sectional|||||||
1286877|NCT03767010|Randomized|Parallel Assignment||Other||None (Open Label)||Prospective, randomized, open-label study||||
1286878|NCT03766997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286879|NCT03766984|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Longitudinal, prospective, crossover, open, randomized, single-dose study with 3 periods, 2 sequences (ACB and BCA), and 3 treatments (A, B, and C) in healthy participants and under fasting conditions.||||
1286880|NCT03766971|Randomized|Parallel Assignment||Other||Triple|Research staff will be blind to the age of tobacco onset condition.|The effects of 7- and 21-days of tobacco cessation on cannabis relapse in daily cigarette-smoking, cannabis smokers will be compared, with half the participants in each group initiating tobacco cigarette smoking early (<16 years) and the other half later (>=16 years).|t||t|t
1286881|NCT03766958|||Cohort||Prospective|||||||
1286882|NCT03766945|||Case-Only||Other|||||||
1286883|NCT03766932|||Cohort||Prospective|||||||
1286884|NCT03766919||Single Group Assignment||Treatment||None (Open Label)||||||
1286885|NCT03766906||Single Group Assignment||Other||None (Open Label)||||||
1286886|NCT03766893||Single Group Assignment||Treatment||None (Open Label)||||||
1286887|NCT03766880||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286888|NCT03766867|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286889|NCT03766854|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1286890|NCT03766841|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1286891|NCT03766828|||Cohort||Prospective|||||||
1286892|NCT03766815|Randomized|Parallel Assignment||Other||Single|Participants will not be able to distinguish branched-chain amino acid and fiber supplement by taste, color or scent as the supplements are provided in capsules.|Participants will be supplemented for 18 days with either 200mg BCAA/kg/day, 400mg BCAA/kg/day or placebo (fiber supplement) in capsules in a single-blind fashion. Followed by a muscle damaging exercise and subsequent MVC and blood sample for force and metabolite measurements.|t|||
1286893|NCT03766802|Randomized|Parallel Assignment||Supportive Care||Triple||"Group 1: Wearable watch training group. 3 orientation session Watch notifies 3/week for exercise~Benefits of watch:~BP and movement sensors allow to validate if the patient has exercised. Videos for exercises. Trackable and notifiable if patients don't exercise. Group 2: Mobile application training group. 3 orientation session App notifies 3/week for exercise~Benefits of app:~Cheaper Trackable and notifiable if patients don't exercise. Group 3: Supervised exercise training in a fitness center for people with DM."|t|t||t
1286894|NCT03766789|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1286895|NCT03766776||Single Group Assignment||Treatment||None (Open Label)||||||
1286896|NCT03766763||Single Group Assignment||Treatment||None (Open Label)||||||
1286897|NCT03766750|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286898|NCT03766737||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286899|NCT03766724|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1286900|NCT03766711|Randomized|Crossover Assignment||Basic Science||Single|Participant intervention arm will be randomized and they will not be told which whether the treatment is being applied in the current set. However, they will be instructed of the task goal at the beginning of the session and will be told that we will be modifying visual feedback to help improve reaching symmetry in some manner.||t|||
1286901|NCT03766698|||Other||Cross-Sectional|||||||
1286902|NCT03766685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286903|NCT03766672|||Cohort||Prospective|||||||
1286904|NCT03766659|Randomized|Parallel Assignment||Diagnostic||Single||International multicenter prospective randomized comparative study.|t|||
1286905|NCT03766646|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|After recruitment, patients were randomised into one of two arms, speech or non-speech. Both the investigator and the participant were aware of the intervention assigned|Patients were assigned to either the `Speech` arm or `Non-speech` arm of the study||||
1286906|NCT03766633|||Cohort||Retrospective|||||||
1286907|NCT03766620|||Cohort||Prospective|||||||
1286908|NCT03766607||Single Group Assignment||Treatment||None (Open Label)||||||
1286909|NCT03766594|Randomized|Parallel Assignment||Treatment||Double|Patients are randomized to receive either folic acid and sildenafil citrate or folic acid and placebo. Placebo tablets were same size and appearance of the sildenafil citrate tablets.|"Patients will be randomized into two groups: Group (A) folic acid and sildenafil citrate and Group (B) folic acid and placebo.~Folic acid (0.5 mg) will be started 3 months before conception in the two groups. Sildenafil citrate (dose: 25 mg; oral tablets, 4 times/day) or placebo will be started preconception for 24 days"|t|t||
1286910|NCT03766581|Randomized|Parallel Assignment||Prevention||Double||Dose ranging study using RAR (Response Adaptive Randomization) design|t||t|
1286911|NCT03766568||Single Group Assignment||Diagnostic||None (Open Label)||Prospective observational cohort study (single arm study)||||
1286912|NCT03766555|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective randomized study to be conducted in an academic hospital with a specialized hepato-biliary team. The principal investigator and other members within the team will perform patient selection and recruitment of this study according to the inclusion and exclusion criteria.||||
1286916|NCT03766503||Single Group Assignment||Health Services Research||None (Open Label)||The main study intervention is the daily witnessing of participants while they self-administer their medications by trained pharmacy staff to ensure compliance. The staff in question will be provided by Leila pharmacy and will in addition provide support so that individuals can transition back into living independently through reminders to attend regularly scheduled medical appointments and counseling on correct use of prescribed medications.||||
1286917|NCT03766490||Single Group Assignment||Treatment||None (Open Label)||Anlotinib Hydrochloride Combined With gefitinib or Icotinib||||
1286918|NCT03766477|||Cohort||Prospective|||||||
1286919|NCT03766464|||Cohort||Prospective|||||||
1286920|NCT03766451|||Other||Prospective|||||||
1286921|NCT03766438|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1286922|NCT03766425|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286923|NCT03766412|||Case-Only||Cross-Sectional|||||||
1286924|NCT03766399|Randomized|Sequential Assignment||Treatment||Single|||t|||
1286925|NCT03766386|||Cohort||Other|||||||
1286926|NCT03766373|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1286927|NCT03766360|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1286928|NCT03766347|||Cohort||Prospective|||||||
1286929|NCT03766334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286930|NCT03766321|Randomized|Parallel Assignment||Treatment||Quadruple|placebo will be unrecognizable from active treatment because the patients will undergo endoscopic procedure with sedation|randomized double blind multicentre study on FMT in ALS, with a randomization ratio 2:1 (FMT: placebo).|t|t|t|t
1286931|NCT03766308|Randomized|Parallel Assignment||Treatment||Single|||t|||
1286932|NCT03766295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1286933|NCT03766282|||Case-Control||Prospective|||||||
1286934|NCT03766269||Single Group Assignment||Treatment||None (Open Label)||||||
1286935|NCT03766256||Single Group Assignment||Prevention||None (Open Label)||||||
1286936|NCT03766243|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1286937|NCT03766230|||Cohort||Prospective|||||||
1286938|NCT03766217|Randomized|Parallel Assignment||Treatment||Single||||||t
1286939|NCT03766204|||Case-Control||Prospective|||||||
1286940|NCT03766191|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1286941|NCT03766178||Single Group Assignment||Treatment||None (Open Label)||||||
1286942|NCT03766165|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1286943|NCT03766152||Single Group Assignment||Treatment||None (Open Label)||||||
1286944|NCT03766139|Randomized|Parallel Assignment||Treatment||Double|The sites will be randomly (computer generated tabulation method) assigned into control group (treated with PRFM alone) and test group (treated with Supercell Glue).|The study will be a Double Blinded Randomized controlled clinical trial with a split mouth design.|t||t|
1286945|NCT03766126||Single Group Assignment||Treatment||None (Open Label)||||||
1286946|NCT03766113|Randomized|Parallel Assignment||Other||Single|||||t|
1286947|NCT03766100|Randomized|Parallel Assignment||Treatment||Single|Application of PSG equipment prior to monitoring sleep efficiency and subsequent analysis of results will be conducted by neurophysiology assistants at the Danish Center for Sleep Medicine (DCSM) blinded to participants' allocation. Examination of participants' joints related to the secondary outcome of disease activity will be conducted by a project nurse specialized in rheumatology blinded to participants' allocation. Blood samples related to RA and disease activity will be taken and analysed by a medical laboratory technologist blinded to participants' allocation. Patient Reported Outcome Measures (PROMs) will be collected via questionnaires on tablets handed out by the project manager, who will also conduct the intervention of CBT-I, and therefore not able to be blinded to allocation.|||||t
1286948|NCT03766087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286949|NCT03766074|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1286950|NCT03766061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286951|NCT03766048|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1286952|NCT03766035||Single Group Assignment||Diagnostic||None (Open Label)||||||
1286953|NCT03766022|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1286954|NCT03766009|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Institutional cross-over||||
1286955|NCT03765996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286956|NCT03765983|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286957|NCT03765970|||Case-Only||Prospective|||||||
1286958|NCT03765957|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286959|NCT03765944|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1286960|NCT03765931|Randomized|Parallel Assignment||Treatment||None (Open Label)||We aimed to determine the efficacy of a single dose of doxycycline compared to a 5-day amoxicillin course for the treatment of fever.||||
1286961|NCT03765918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286962|NCT03765905|||Case-Control||Prospective|||||||
1286963|NCT03765892|||Case-Control||Cross-Sectional|||||||
1286964|NCT03765879|Randomized|Parallel Assignment||Treatment||None (Open Label)|This experiment will not be blinded. Participants will be aware if they are in the verum VGAIT or sham VGAIT group by nature of the interventions.|In this study, participants will be randomly assigned to receive one of two interventions: verum video-guided acupuncture imagery treatment (VGAIT) or sham VGAIT.||||
1286965|NCT03765866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286966|NCT03765853|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286967|NCT03765840|||Case-Control||Prospective|||||||
1286968|NCT03765827|Randomized|Parallel Assignment||Prevention||Double|The patient and the epidemiology nurse will not know the treatgment assigned.||t|||t
1286969|NCT03765814|||Cohort||Prospective|||||||
1286970|NCT03765801|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1287497|NCT03758937|Randomized|Parallel Assignment||Other||Single||||||t
1286972|NCT03765775||Single Group Assignment||Treatment||None (Open Label)||||||
1286973|NCT03765762|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1286974|NCT03765749|||Cohort||Prospective|||||||
1286975|NCT03765736|||Cohort||Prospective|||||||
1286976|NCT03765723|||Cohort||Prospective|||||||
1286977|NCT03765710|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1286978|NCT03765697||Single Group Assignment||Treatment||None (Open Label)||||||
1286979|NCT03765684|||Cohort||Prospective|||||||
1286980|NCT03765671|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1286981|NCT03765658||Single Group Assignment||Treatment||Double||During each treatment period, participants randomly received either GRT0151Y or matching placebo, in a manner that no participant received placebo in two consecutive periods.|t||t|
1286982|NCT03765645|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286983|NCT03765632||Single Group Assignment||Treatment||None (Open Label)||||||
1286984|NCT03765619|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1286985|NCT03765606|Randomized|Crossover Assignment||Prevention||Triple|Double-blinded|Randomised double-blinded crossover|t||t|t
1286986|NCT03765593|||Cohort||Prospective|||||||
1286987|NCT03765580|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286988|NCT03765567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1286989|NCT03765554|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1286990|NCT03765541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1286991|NCT03765528|||Cohort||Prospective|||||||
1286992|NCT03765515|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Trial (RCT)||||
1286993|NCT03765502|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1286994|NCT03765489|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1286995|NCT03765476|Randomized|Parallel Assignment||Treatment||None (Open Label)||"one group receives add-on- intervention SALIENCE"||||
1286996|NCT03765463||Single Group Assignment||Treatment||None (Open Label)||||||
1286997|NCT03765450|||Cohort||Prospective|||||||
1286998|NCT03765437||Single Group Assignment||Prevention||None (Open Label)||The study design is considered Phase 3 for the purpose of registration. This is a safety assessment study designed to provide safety data in Vietnamese participants.||||
1286999|NCT03765424|||Cohort||Prospective|||||||
1287000|NCT03765411|||Case-Only||Cross-Sectional|||||||
1287001|NCT03765398||Single Group Assignment||Treatment||None (Open Label)||||||
1287002|NCT03765385|Randomized|Parallel Assignment||Treatment||Double|The outcome assessors will be masked to group allocation. The participants will be given repeated instructions not to reveal their group allocation to the outcome assessors. Data set will be blinded regarding group allocation (and the code for the groups will be held by a researcher not involved in the study) when performing analyses for main outcomes.||||t|t
1287003|NCT03765372|||Other||Prospective|||||||
1287004|NCT03765359|Randomized|Parallel Assignment||Treatment||Triple|placebo controlled||t|t|t|
1287005|NCT03765346|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1287006|NCT03765333|||Ecologic or Community||Cross-Sectional|||||||
1287007|NCT03765320|||Cohort||Retrospective|||||||
1287008|NCT03765307|Randomized|Parallel Assignment||Treatment||Single|This study is conducted by an independent clinical monitoring organization, a data management and statistical center to collect and statistically analyze all relevant clinical and laboratory data.|Patients with severe asthma are assigned to the experimental or control group at a 1:1 ratio based on a central randomized system.||||t
1287009|NCT03765294|Randomized|Crossover Assignment||Treatment||Quadruple||2-way cross-over|t|t|t|t
1287010|NCT03765281|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1287011|NCT03765268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287012|NCT03765255|Randomized|Parallel Assignment||Prevention||Single|The adolescents and the staff enrolling the participants will not know of study assignment until after completing recruitment, consent, and baseline. At that point, they will open an envelope stating if it is a control or treatment cohort. The researcher conducting the outcomes analysis will not know enrollment status of an individual.|Adolescents will be randomly assigned to treatment or control by cohort (groups of 5-25 adolescents). Adolescents will consent to participation and complete baseline survey prior to randomization. Enrollment will continue by cohort for approximately 2 years. Approximately 15 sites will participate with 2-4 cohorts per site per year.||||t
1287013|NCT03765242|||Cohort||Retrospective|||||||
1287014|NCT03765229||Single Group Assignment||Treatment||None (Open Label)||||||
1287015|NCT03765216|Randomized|Parallel Assignment||Prevention||Triple||Participants are randomly assigned to group A or B. Participants of group A are given normal bowel preparation, while participants of group B are given personalized regimens according to a predictive model we have established.||t|t|t
1287016|NCT03765203|Randomized|Parallel Assignment||Other||None (Open Label)||The study is a pre-post, two round controlled trial of care practices in a nationally representative sample of practicing nephrologists randomly assigned to a control or an intervention arm. All providers will be asked to propose care for a total of 6 CPV simulated patients who are adults aged 30-75; three or more months post-transplant; and presenting with signs, symptoms and laboratory findings suggestive of allograft rejection. Each assessment round will consist of 3 simulated patients. In between assessment rounds, physicians randomized into the intervention arm will receive educational materials on the new allograft rejection test.||||
1287017|NCT03765190||Single Group Assignment||Treatment||None (Open Label)||Proton Therapy+PD-1 Ab||||
1287018|NCT03765177||Single Group Assignment||Treatment||None (Open Label)||||||
1287100|NCT03764111|Non-Randomized|Parallel Assignment||Diagnostic||Single|Four experienced sonographers will review the ultrasound images without knowledge of whether they were obtained from the inexpensive hand-held machine or the large mobile ultrasound system.|||||t
1287101|NCT03764098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287146|NCT03763513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468931|NCT01390883|||||Prospective|||||||
1287019|NCT03765164|Randomized|Parallel Assignment||Other||None (Open Label)||The study is a pre-post, two-round, randomized controlled study of a nationally representative sample of primary care physicians, including internists and family physicians, randomly assigned to a control or intervention arm. Once eligibility is determined and providers are enrolled in the study, they will be asked to complete a questionnaire describing their practice and professional background. They will then care for a total of 6 CPV® simulated patients over the two rounds (3 per round). The simulated patients are adults aged 18-75 who present with diabetes, different levels of glycemic control and various co-morbidities. The study design consists of two study arms, a control arm and an intervention-arm that receives educational materials and the 1,5-AG results.||||
1287020|NCT03765151|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1287021|NCT03765138||Single Group Assignment||Treatment||None (Open Label)||||||
1287022|NCT03765125|Randomized|Parallel Assignment||Treatment||Double|test and placebo powder contained in coded blister packages of identical shape and colour Handing out of the assigned powder by a study nurse not involved in the clinical examination and data collection|randomized, double-blind, placebo-controlled 2-arm, parallel group|t||t|
1287023|NCT03765112||Single Group Assignment||Diagnostic||None (Open Label)||||||
1287024|NCT03765099|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287025|NCT03765086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287026|NCT03765073|Randomized|Sequential Assignment||Prevention||Double|This is an observer-blinded study. Study staff dispensing and administering the vaccine will be unblinded, but all other study personnel, including the principal investigator, and the subject, will be blinded.||t||t|
1287027|NCT03765060|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1287028|NCT03765047|Randomized|Parallel Assignment||Supportive Care||Single|Parents of the children are not aware if there child is at an intervention or control school|Prospective, randomized control study|t|||
1287029|NCT03765034|Randomized|Crossover Assignment||Treatment||Single||||||t
1287030|NCT03765021|Randomized|Parallel Assignment||Treatment||Double|Method of randomization: using closed envelopes containing cards with fractional CO2 Rt and fractional CO2 Lt and the patient will draw one of them blindly.||t||t|
1287031|NCT03765008|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1287032|NCT03764995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287033|NCT03764982|||Cohort||Prospective|||||||
1287034|NCT03764969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287035|NCT03764956|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label randomized non inferiority trial with two parallel arms||||
1287036|NCT03764943||Single Group Assignment||Supportive Care||None (Open Label)||Prospective cohort study, 2 groups; alloplastic reconstruction and autologous reconstruction, same intervention||||
1287037|NCT03764930|||Case-Only||Retrospective|||||||
1287038|NCT03764917|||Cohort||Prospective|||||||
1287039|NCT03764904|||Cohort||Prospective|||||||
1287040|NCT03764891|||Case-Control||Retrospective|||||||
1287041|NCT03764878|||Cohort||Prospective|||||||
1287042|NCT03764865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287043|NCT03764852||Single Group Assignment||Treatment||None (Open Label)||||||
1287044|NCT03764839|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1287045|NCT03764826|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1287046|NCT03764813|||Cohort||Prospective|||||||
1287047|NCT03764800|||Cohort||Prospective|||||||
1287048|NCT03764787||Single Group Assignment||Treatment||None (Open Label)||||||
1287049|NCT03764774|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1287050|NCT03764761||Single Group Assignment||Device Feasibility||None (Open Label)||Within subjects alternating treatment design||||
1287051|NCT03764748||Single Group Assignment||Treatment||None (Open Label)||Participants will receive 200ml selective microbiota suspension (namely mini-FMT, mixed species of cultured bacteria) daily through the nasojejunal transendoscopic enteral tubing (TET) tube for 3 days.||||
1287052|NCT03764735|Randomized|Parallel Assignment||Treatment||Quadruple||Parallel-group study of two strengths of ophthalmic solution versus placebo solution|t|t|t|t
1287053|NCT03764722||Single Group Assignment||Treatment||None (Open Label)||||||
1287054|NCT03764709|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Prospective, randomized, controlled, open-label, monocentric study for the evaluation of two different settings of critically ill patients recovered in Internal Medicine unit (IMU) and subsequently sent to subacute managed care unit or to earlier discharge, in order to evaluate the effectiveness of a wireless monitoring of clinical conditions vs. a traditional clinical monitoring on outcomes (critical adverse events, clinical exacerbations).||||
1287055|NCT03764696|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1287056|NCT03764683|Randomized|Sequential Assignment||Treatment||Double||The investigators are proposing the use of SPCD for this study. The Sequential Parallel Comparison Design aims to reduce the impact of high placebo response and decrease sample size. The design has been accepted by and published on by FDA. The SPCD model has two relatively short phases of treatment of equal duration. Only non-responders to placebo (P) during the first phase are included in the analyses of the second phase. Randomization is unbalanced (for example, a 2:3:3 assignment of DD, PP, and PD).|t||t|
1287057|NCT03764670|||Case-Only||Retrospective|||||||
1287058|NCT03764657|||Case-Control||Prospective|||||||
1287059|NCT03764644|Randomized|Parallel Assignment||Treatment||Quadruple||Double blind, sham-controlled, randomized trial|t|t|t|t
1287060|NCT03764631|||Cohort||Prospective|||||||
1287061|NCT03764618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287102|NCT03764085|Randomized|Parallel Assignment||Treatment||Single|Outcomes Assessor will perform the assessment of primary, secondary efficasy and safety parameters|||||t
1287103|NCT03764072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287104|NCT03764059|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1287105|NCT03764046|||Cohort||Prospective|||||||
1287147|NCT03763500|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective, randomized and open study||||
1287062|NCT03764605|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Trial will enroll 150 subjects affected by Type I-truncating ADPKD. Their eligibility will be confirmed by the mean of eGFR calculated from the 2 pre-treatment serum creatinine assessments. Once eligibility is assessed, patients will undergo kidneys CTscan. Randomization visit will occur on Day -29. During this visit patients will be randomized (1:1) to each arm of treatment and will start IMP titration. Subjects not tolerating the minimum IMP dose will be considered Titration failures and will complete End of Treatment (EoTx) visit and will be followed up after 7 days by phone call. Subjects tolerating the minimum IMP dose enter the unblind run-in period during which, subjects will continue on a stable IMP dose to confirm tolerability over a longer period. At the end of the run-in period subjects not tolerating the minimum IMP dose will be considered Run-in failures and will complete EoTx visit. Subjects completing the run-in will start the open-label 24 months treatment period."||||
1287063|NCT03764592|||Cohort||Prospective|||||||
1287064|NCT03764579|Randomized|Parallel Assignment||Prevention||Single|||t|||
1287065|NCT03764566|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1287066|NCT03764553|Randomized|Parallel Assignment||Treatment||None (Open Label)||phase 2 study||||
1287067|NCT03764540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287068|NCT03764527|Randomized|Parallel Assignment||Treatment||None (Open Label)|The AQ+AS (AA) group received their drugs under direct observation once daily for 3 days. The Coartem (CO) group received their drugs twice daily, the second (evening) dose also under supervision. Drug treatment was thus not be blinded.|A comparative randomised study comparing oral treatment with AQ + AS and CO of uncomplicated falciparum malaria in children.||||
1287069|NCT03764514|||Cohort||Prospective|||||||
1287070|NCT03764501|Randomized|Parallel Assignment||Treatment||None (Open Label)||Image fusion group will utilize 3D preoperative planning and image fusion system. Control group will utilize only 3D preoperative planning.||||
1287071|NCT03764488|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1287072|NCT03764475||Single Group Assignment||Treatment||None (Open Label)||Note: Subjects that consent to enter this open-label safety study have previously completed a companion study (ARQ-151-201 Phase 2 randomized controlled trial)||||
1287073|NCT03764462|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1287074|NCT03764449|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287075|NCT03764436|Randomized|Crossover Assignment||Prevention||Double||This study uses a cluster-randomized stepped-wedge design with three steps to evaluate the impact of LEAPS-NCHD program. Ninety-nine clusters (villages) are enrolled. Thirty-three clusters per step are randomly selected to cross-over from receipt of standard services (comparison) to receipt of the LEAPS-NCHD program (intervention). Unit of randomization is at the village (cluster) level. A process evaluation will assess program rollout for fidelity, adherence, quality, and cost.|||t|t
1287076|NCT03764423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287077|NCT03764410|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1287078|NCT03764397||Single Group Assignment||Treatment||None (Open Label)||||||
1287079|NCT03764384|||Case-Crossover||Prospective|||||||
1287080|NCT03764371|||Cohort||Prospective|||||||
1287081|NCT03764358|Randomized|Parallel Assignment||Prevention||Single||||||t
1287082|NCT03764345||Single Group Assignment||Treatment||None (Open Label)||||||
1287083|NCT03764332||Single Group Assignment||Prevention||None (Open Label)||||||
1287084|NCT03764319|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparison of 2 groups||||
1287085|NCT03764306|Randomized|Parallel Assignment||Treatment||Single||Patients were randomly assigned to one of the two treatment arms: surgical endarterectomy or carotid angioplasty with stenting under proximal protection|||t|
1287086|NCT03764293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287087|NCT03764280|Randomized|Parallel Assignment||Treatment||Single||"This is an open-label, randomized, two-way, parallel study to compare the glucose control between physician adjusted basal-bolus parameters and our computer basal-bolus optimizing algorithm. Children and adolescent type 1 diabetes patients at Camp Carowanis, a camp for diabetes, will be enrolled in the study, where they will randomly undergo one of two interventions:~MDI with Physician Adjusted Basal-Bolus Parameters~MDI with Basal-Bolus Optimization Algorithm Adjusted Basal-Bolus Parameters (OA)"|t|||
1287088|NCT03764267|Randomized|Parallel Assignment||Other||Single|||||t|
1287089|NCT03764254||||||||||||
1287090|NCT03764241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287091|NCT03764228||Single Group Assignment||Prevention||None (Open Label)||||||
1287092|NCT03764215||Sequential Assignment||Treatment||None (Open Label)|We propose to perform an open label, Phase Ib, proof of concept study to evaluate the impact of low doses of Nilotinib treatment on safety, tolerability and biomarkers in participants with HD. We propose an adaptive design based on safety and tolerability of 150mg Nilotinib treatment for 3 months. We will first enroll 10 participants who will receive an oral dose of 150mg Nilotinib once daily (group 1) for 3 months. If these participants tolerate 150mg dose of Nilotinib, an additional 10 new HD participants (group 2) will be enrolled to evaluate the effects of 300 mg dose of Nilotinib for 3 months. We will then compare baseline with the effects of 3-months Nilotinib treatment within each group and between groups (1 and 2). Participants (group 1 and 2) will return for a follow up visit one month after the termination of 3-months treatment with Nilotinib and results will compared to baseline visits and end of study visits.|Ten (10) participants will receive an oral dose of 150mg Nilotinib once daily for 3 months (group 1). If this dose is tolerated another 10 participants will receive an oral dose of 300mg Nilotinib once daily (group 2) for 3 months.||||
1287093|NCT03764202|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287094|NCT03764189|Randomized|Parallel Assignment||Treatment||None (Open Label)|not possible as the subject will sign an informed consent and areas of microosteoperforation will be apparent|||||
1287095|NCT03764176|Randomized|Parallel Assignment||Treatment||Single||||||t
1287096|NCT03764163||Single Group Assignment||Basic Science||None (Open Label)||||||
1287097|NCT03764150|||Cohort||Prospective|||||||
1287098|NCT03764137||Single Group Assignment||Diagnostic||None (Open Label)||||||
1287099|NCT03764124|||Cohort||Prospective|||||||
1287106|NCT03764033|Randomized|Parallel Assignment||Treatment||Single|The clinical evaluators will be kept blind to treatment condition throughout the study period.|The investigators propose to conduct a multi-site, randomized, controlled trial to test the efficacy of an individual treatment for PTSD stemming from moral injury called IOK, compared to a present-centered therapy (PCT) control condition.||||t
1287107|NCT03764020|Randomized|Parallel Assignment||Treatment||Triple|"Triple blinding is planned. All participants, medical providers and outcome evaluators will be blinded about treatment arms.~The THC pharmacy will dispense the medication and perform the randomization. Melatonin capsule and placebo will be completely identical."|Melatonin 3 Mg or placebo associated with life style modification according to 2013ACC/ AHA guideline has been planned in parallel fashion for three weeks of follow up. Participants allocated to each group will stay at the same interventional group for entire follow up period of three weeks.|t|t||t
1287108|NCT03764007||Single Group Assignment||Diagnostic||None (Open Label)||||||
1287109|NCT03763994|||Case-Control||Prospective|||||||
1287110|NCT03763981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287111|NCT03763968|||Cohort||Retrospective|||||||
1287112|NCT03763955|||Cohort||Other|||||||
1287113|NCT03763942|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This trial will include 657 participants with 2:1 allocation for the intervention (438) and control (219) conditions. Recruitment strategies will be formulated to increase enrollment of MSM who identify as members of racial/ethnic minority groups.||||
1287114|NCT03763929|Randomized|Parallel Assignment||Treatment||Quadruple|TSC injections will be prepared and injected by unblinded personnel on each ambulance. All other study personnel will be blinded|Multicenter, randomized, placebo-controlled, double-blind, parallel group|t|t|t|t
1287115|NCT03763916|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1287116|NCT03763903|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1287117|NCT03763890|||Case-Crossover||Prospective|||||||
1287118|NCT03763877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287119|NCT03763864||Single Group Assignment||Basic Science||None (Open Label)||||||
1287120|NCT03763851|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1287121|NCT03763838|Randomized|Parallel Assignment||Supportive Care||Quadruple|"Participants in the standard of care arm will not be blinded; however, the two self-acupressure arms will be blinded as to which acupressure treatment they have been randomized. All study staff and researchers will remain blinded until after the completion of data analyses."||t|t|t|t
1287122|NCT03763825|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287123|NCT03763812|Non-Randomized|Parallel Assignment||Other||None (Open Label)|No masking since patients, doctor and researchers know if patients undergo EVAR or EVAS.|||||
1287124|NCT03763799|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287125|NCT03763786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287126|NCT03763773|||Cohort||Prospective|||||||
1287127|NCT03763760|Randomized|Parallel Assignment||Treatment||Quadruple|"All intervention drugs will be blinded by a nurse who is not a participant in the study or in the treatment of the patient in any way.~The Patient, the administrator of the drug(nurse or doctor), the assessor, the investigator and the care team will all be blinded."|A randomized double blinded controlled trial.|t|t|t|t
1287128|NCT03763747||Single Group Assignment||Treatment||None (Open Label)||||||
1287129|NCT03763734|Randomized|Parallel Assignment||Treatment||Quadruple|"All intervention drugs will be blinded by a nurse who is not a participant in the study or in the treatment of the patient in any way.~The Patient, the administrator of the drug(nurse or doctor), the assessor, the investigator and the care team will all be blinded."|A randomized double blinded controlled trial.|t|t|t|t
1287130|NCT03763721|Randomized|Parallel Assignment||Diagnostic||Single|The patient will be blinded in the study, to prevent detection bias in filling out the questionnaires|The design of the study is a prospective, international, multicenter, non-inferiority, randomized controlled interventional clinical trial to compare the outcomes after posterior lamellar surgery with an iOCT optimized surgical protocol, and current practice, where the eye is over-pressurized for a set period of time. These groups will be labelled iOCT optimized protocol (iOCT-p) and current practice protocol (CP-p). Eligible patients will be assigned to either one of the groups. The study will be conducted simultaneously at the University Medical Center Utrecht (UMCU), Maastricht University Medical Center (MUMC) and the University Hospitals Leuven (UZL, Belgium). The inclusion, preoperative and postoperative measurements and questionnaires will take place at the Ophthalmology department of the site were the surgery was conducted. The research activities will be coordinated by the UMCU.|t|||
1287131|NCT03763708||Single Group Assignment||Treatment||None (Open Label)||||||
1287132|NCT03763695|||Case-Control||Other|||||||
1287133|NCT03763682||Single Group Assignment||Treatment||None (Open Label)||prospective, open-label, 2 groups||||
1287134|NCT03763669|Randomized|Parallel Assignment||Treatment||Double|Placebo administered|Patients will be randomly assigned to receive (n. 40) diet and folic acid (400 mcg per day) alone, or (n. 40) diet, folic acid (400 mcg per day) and myoinositol (2 g. twice a day) supplementation. The insulin sensitivity index (HOMA-IR) and fetal sonographic profile will be monitor for each patient at GDM diagnosis and after 4 and 8 weeks of treatment.|t|t||
1287135|NCT03763656||Single Group Assignment||Treatment||None (Open Label)||||||
1287136|NCT03763643|Randomized|Parallel Assignment||Prevention||None (Open Label)||Control group and treatment/intervention group||||
1287137|NCT03763630|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1287138|NCT03763617|Randomized|Parallel Assignment||Prevention||Double||A d-ptfe membrane is placed between the buccal bone and periosteum of an extraction socket to prevent the precursors of the bone resorbing cells (osteoclasts) from adhering to the bone surface.|t||t|
1287139|NCT03763604||||||||||||
1287140|NCT03763591||Single Group Assignment||Prevention||None (Open Label)||||||
1287141|NCT03763578|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1287142|NCT03763565|||Cohort||Retrospective|||||||
1287143|NCT03763552|||Case-Only||Retrospective|||||||
1287144|NCT03763539|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1287145|NCT03763526|||Cohort||Prospective|||||||
1469785|NCT01379703|||||Prospective|||||||
1287148|NCT03763487|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||50 patients and 30 healthy blood donor||||
1287149|NCT03763474|Randomized|Parallel Assignment||Supportive Care||Single|Outcomes assessors were blinded as for the allocation of the patients in the 2 groups.|||||t
1287150|NCT03763461|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1287151|NCT03763448|Randomized|Parallel Assignment||Treatment||Triple|participants, outcome assessors, data analysts and chief investigators are masked during the study procedure.||t||t|t
1287152|NCT03763435|||Case-Control||Cross-Sectional|||||||
1287153|NCT03763422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287154|NCT03763409|Randomized|Parallel Assignment||Basic Science||Double|double-blind|Parallel randomised|t||t|
1287155|NCT03763396|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1287156|NCT03763383|||Case-Only||Retrospective|||||||
1287157|NCT03763370||||||||||||
1287158|NCT03763357|Randomized|Parallel Assignment||Treatment||Single||Half of the subjects in this study will receive the control/sham treatment and half of the subjects in this study will receive heat therapy.|t|||
1287159|NCT03763344|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1287160|NCT03763331|Randomized|Crossover Assignment||Treatment||Single|Subjects will not be told outright which therapy there are receiving (thermoneutral or HT).||t|||
1287161|NCT03763318|Randomized|Sequential Assignment||Treatment||Quadruple|Part B will be blinded to all study staff that has direct access to the subjects and the sponsor. The site's pharmacist or designee will be unblinded to prepare the study drug.|Part A is an open label 3+3 dose escalation Part B is blinded and randomized 2:1|t|t|t|t
1287162|NCT03763305|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1287163|NCT03763292|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1287164|NCT03763279|Randomized|Parallel Assignment||Prevention||Double|The patient and the epidemiology nurse, who will assess the presence of SSI, will be blinded to the treatment assigned.||t|||t
1287165|NCT03763266|Randomized|Parallel Assignment||Diagnostic||Triple||||t|t|t
1287166|NCT03763253|Randomized|Factorial Assignment||Treatment||None (Open Label)||Three-arm unblinded randomised controlled trial using a positive control||||
1287167|NCT03763240|Randomized|Parallel Assignment||Treatment||Quadruple|"Each participant receives the kit that corresponds to his/her study ID. The randomization is blind to both participants and the Investigator during the study.~The randomization list is kept with the local pharmacy during the entire study. Sealed envelopes with randomization information for each participant are send to investigator and may be opened in case of emergency."|Parallel arm study with placebo and intervention substance|t|t|t|t
1287168|NCT03763227|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Phase 1: Patients with best corrected visual acuity (BCVA) < 0.5 will receive carbonic anhydrase inhibitors (CAI) [oral acetazolamide 500mg/day or topical brinzolamide twice daily] and followed up for three months. Phase 2: Patients who do not show an adequate response with CAI will receive three 0.5mg IVR injection at monthly intervals.||||
1287169|NCT03763214|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, two arms||||
1287170|NCT03763201|||Cohort||Prospective|||||||
1287171|NCT03763188|||Cohort||Other|||||||
1287172|NCT03763175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287173|NCT03763162||Single Group Assignment||Treatment||None (Open Label)||||||
1287174|NCT03763149||Single Group Assignment||Treatment||None (Open Label)||||||
1287175|NCT03763136||Single Group Assignment||Treatment||None (Open Label)||||||
1287176|NCT03763123||Single Group Assignment||Treatment||None (Open Label)||||||
1287177|NCT03763110|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1287178|NCT03763097|||Cohort||Prospective|||||||
1287179|NCT03763084|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1287180|NCT03763071|||Case-Only||Cross-Sectional|||||||
1287181|NCT03763058||Single Group Assignment||Treatment||None (Open Label)||A monocentric prospective before-after study on patients carried out in chronic pain department of the CHU Sud Reunion. Patients will be evaluated for inclusion in the study, and will complete the 3-month music intervention. Participants will complete 1-2 sessions of listening to music per day, with a minimum of 15 sessions per month. Before starting the musicotherapy program, retrospective data will be collected on the month prior regarding migraine attacks (frequency, severity, duration, treatment intake).||||
1287182|NCT03763045|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blinded|"Sildenafil 25: Twenty hemodialysis patients will receive a dose of 25mg sildenafil daily for 3 months.~Sildenafil 50: Twenty hemodialysis patients will receive a dose of 50mg sildenafil daily for 3 months.~Placebo: Twenty hemodialysis patients will receive a placebo tablet daily for 3 months."|t|t|t|t
1287183|NCT03763032||Single Group Assignment||Supportive Care||None (Open Label)|Because this is a pilot study, all participants will be receiving the same intervention and no blinding will take place.|All patients will be assigned a patient navigator, who will provide a psychosocial assessment and palliative counselling||||
1287184|NCT03763019|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1287185|NCT03763006|Randomized|Parallel Assignment||Prevention||Single|Investigator will be masked|Ocudox lid wipes|||t|
1287186|NCT03762993|Randomized|Crossover Assignment||Treatment||None (Open Label)||Within Subject Design||||
1287187|NCT03762980|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1287188|NCT03762967|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The study consist 40 patients in 4 groups. Two working groups and two control groups. Each group consist 10 Males.||||
1287189|NCT03762954|||Case-Only||Prospective|||||||
1287190|NCT03762941|||Cohort||Prospective|||||||
1287191|NCT03762928|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1287192|NCT03762915|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1287193|NCT03762902|||Cohort||Prospective|||||||
1287268|NCT03761927|Randomized|Crossover Assignment||Treatment||Single|||t|||
1287269|NCT03761914|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 1/2, open-label, non-comparative, multicenter, multi-arm study||||
1470027|NCT01376518|||||Prospective|||||||
1287194|NCT03762889|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||In this cohort study, 100 preoperative patients from Jackson Memorial Hospital would be randomly assigned based on age, gender, and type of anesthesia to three samples: anesthesia with Eyeprotx™ Goggles, anesthesia with eyelid tape, and anesthesia with ointment application. Analysis of samples will be based on length of procedure, length of preventative measure application, position during operation(supine or prone), and postoperative events. Patient discomfort or pain, eye dryness intensity would be rated on numerical rating scale. Qualitative analysis will include additional comments from patients and the anesthesiologist.||||
1287195|NCT03762876|||Cohort||Prospective|||||||
1287196|NCT03762863|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1287197|NCT03762850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287198|NCT03762837|||Cohort||Prospective|||||||
1287199|NCT03762824|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1287200|NCT03762811||Single Group Assignment||Treatment||None (Open Label)||||||
1287201|NCT03762798||Single Group Assignment||Treatment||None (Open Label)||||||
1287202|NCT03762785|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1287203|NCT03762772||Single Group Assignment||Prevention||None (Open Label)||All participants will use a single combination TAF/EVG vaginal insert.||||
1287204|NCT03762759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287205|NCT03762746|Randomized|Parallel Assignment||Treatment||Triple|We apply blinding status of trial participants, care providers, and outcome assessors. We are using TMS sham-coil with similarities in appearance, sound, heavy; also we have the timing of final unblinding of all trial participants|Forty schizophrenic or schizoaffective patients with predominant audiotoric hallucinatory symptoms will be given rTMS 1 Hz intervention, 1000-pulse train, 20 min, 90% strength, 1000 pulse in left temporo-parietal cortex for 10 consecutive days (except holidays). Assessment of DN network connectivity in the brain using the results of brain wave decomposition analysis with EEGLAB. For measurement of auditor hall of hallucinations used Indonesian-Psychosis Symptom Rating Scale (INA-PSYRATS) instrument. Source monitoring capability using the INA-Source Monitoring instrument.|t|t||t
1287206|NCT03762733|||Cohort||Prospective|||||||
1287207|NCT03762720|Randomized|Parallel Assignment||Treatment||Single|Blind researcher|RANDOMIZED CLINICAL TRIAL WITH BLIND EVALUATION BY THIRD PARTIES, LONGITUDINAL AND PROSPECTIVE.|||t|
1287208|NCT03762707|||Cohort||Retrospective|||||||
1287209|NCT03762694|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1287210|NCT03762681|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1287211|NCT03762668||||||||||||
1287212|NCT03762655|Randomized|Parallel Assignment||Treatment||Single|"Subjects will be randomized in a blinded manner to one of two study arms, the Treatment or Scaffold Arm and the Standard of Care or Comparator Arm. Subjects in the Scaffold Arm will have the Scaffold implantation immediately following standard of care open spine surgery. Subjects in the Comparator Arm will have standard of care open spine surgery and will not receive the Scaffold. The subjects will be blinded to their study arm for the duration of the study."|"Subjects will be randomized in a blinded manner to one of two study arms, the Treatment or Scaffold Arm and the Standard of Care or Comparator Arm. Subjects in the Scaffold Arm will have the Scaffold implantation immediately following standard of care open spine surgery. Subjects in the Comparator Arm will have standard of care open spine surgery and will not receive the Scaffold."|t|||
1287213|NCT03762642|||Cohort||Retrospective|||||||
1287214|NCT03762629|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1287215|NCT03762616|Non-Randomized|Sequential Assignment||Diagnostic||Single|Investigator performing the micro-ultrasound biopsy will be blinded to the MRI report, and the investigator performing the MRI targeted biopsy will be blinded to the micro-ultrasound images and targets.||||t|
1287216|NCT03762603||Single Group Assignment||Supportive Care||None (Open Label)||||||
1287217|NCT03762590|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1287218|NCT03762577|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287219|NCT03762564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287220|NCT03762551|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1287221|NCT03762538|||Case-Only||Prospective|||||||
1287222|NCT03762525||Single Group Assignment||Other||None (Open Label)|The choice for the device is not part of this study and will be made by the doctor in consultation with the patient and the patients anatomy.|"This study is designed as a multicenter prospective case series.~To prospectively enroll 15 patients that are scheduled for endovascular aneurysm repair using the Gore IBE device in conjunction with its dedicated self expanding Internal Iliac component.~Tocompare 15 patients that have been treated in the period October 2006- July 2016 with the Cook IBD with a non-dedicated IIA component (Advanta-V12 or Fluency) and 15 matched patients treated with Gore IBE device."||||
1287223|NCT03762512|||Case-Only||Prospective|||||||
1287224|NCT03762499|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1287225|NCT03762486|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||"TENS was applied to around the insicion: Transcutaneous electrical nerve stimulation was applied to around the incision.~TAES was applied to acupuncture points: Transcutaneous electrical stimulation was applied to acupuncture points.~No intervention: No stimulation was performed to the patients.~A standard analgesia protocol for post-operative pain control was used in all patients included in the study. A standard antiemetic protocol was used for all patients after surgery."||||
1287226|NCT03762473|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287227|NCT03762460|||Case-Control||Prospective|||||||
1287228|NCT03762447||Single Group Assignment||Treatment||None (Open Label)||||||
1287264|NCT03761979|Non-Randomized|Sequential Assignment||Other||Double|Subjects' anonymity was maintained on electronic case report forms (eCRFs) and other documents by utilization of initials, number, or code, and not by using a subject's name. The Investigator kept a separate log showing codes, names, and addresses. All documents showing the subjects' identity were kept in strict confidence by the Investigator.|This was an unblinded, sequential, three dose study. The study consisted of one screening visit (Visit 1; day -7) and three test visits (Visits 2, 3, and 4; days 0, 7, and 14) with at least a 6-d washout between test visits.|t|||t
1287265|NCT03761966|||Cohort||Prospective|||||||
1287229|NCT03762434|Randomized|Parallel Assignment||Supportive Care||Triple|Randomisation and masking: A statistician will use computer-generated randomisation to determine random allocation. Eligible participants will be randomly allocated to either the control ( booklet group ) or the intervention group ( MetS app group) according to an allocation sequence prepared by the statistician before the start of the study. The patients will be randomised at a ratio of 1:1, with stratification by study site. Small cards indicating the group assignments will be placed in opaque sealed envelopes, which will be opened by the research assistant after each patient has completed the baseline questionnaires. In this study, the statisticians, outcome assessors and research assistant assigned to perform data input will be blinded to the allocation sequence. Given the type of intervention, however, the intervention group will be unmasked to the participants and the research nurse performing the intervention.|A multisite randomized controlled trial with two arms: MetS app group and , booklet group||t|t|t
1287230|NCT03762421|Randomized|Parallel Assignment||Prevention||Single|Fidelity of masking will be ensured by having assessors guess the condition of each participant at the end of each assessment to assess the contamination across intervention and control arm.||||t|
1287231|NCT03762408|Randomized|Parallel Assignment||Treatment||Single|Single-blinded (blind third party evaluation) The physician performing the infiltration will be different and cannot be related to the investigator evaluating the results.|||||t
1287232|NCT03762395|Randomized|Crossover Assignment||Treatment||Single||||||t
1287233|NCT03762382|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1287234|NCT03762369|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1287235|NCT03762356|||Other||Other|||||||
1287236|NCT03762343|Randomized|Parallel Assignment||Treatment||Triple|An online randomization program (http://www.randomizer.org) will be used to generate random list and to allocate patients into two study groups. Random allocation numbers will be concealed in opaque closed envelops. The patient and investigator performing the block and assessing study outcomes will all be blinded to the study group allocation. The intraoperative study outcomes will be assessed by an anesthetist who is not involved in the block performance and postoperative data will be collected by PICU trained nurses who are blinded to the study groups.||t||t|t
1287237|NCT03762330|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287238|NCT03762317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287239|NCT03762304|||Other||Prospective|||||||
1287240|NCT03762291||Single Group Assignment||Treatment||None (Open Label)||||||
1287241|NCT03762278|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1287242|NCT03762265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287243|NCT03762252|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1287244|NCT03762239|Randomized|Parallel Assignment||Prevention||Single|||t|||
1287245|NCT03762226|||Cohort||Prospective|||||||
1287246|NCT03762213|Randomized|Parallel Assignment||Treatment||None (Open Label)||The investigators propose a parallel-group pilot randomized controlled trial with a stratified block randomization and an equal allocation ratio of 1:1. The participants will be randomly allocated to Group A (VR/intervention group) or Group B (iPad/control group). The relaxation session will last for 10 minutes in each group using the same application Happy Place (© Mimerse) played on VR headsets (Oculus GO) versus iPad (Apple Inc. Cupertino CA). The randomization will be stratified on the basis of pain score on the day of intervention.||||
1287247|NCT03762200||Single Group Assignment||Treatment||None (Open Label)||||||
1287248|NCT03762187|Randomized|Factorial Assignment||Treatment||Double|Neither patients nor counselors were aware of participants' assigned condition|Participants are randomized to one of the two conditions.|t|t||
1287249|NCT03762174|||Cohort||Retrospective|||||||
1287250|NCT03762161||Single Group Assignment||Treatment||None (Open Label)||||||
1287251|NCT03762148|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1287252|NCT03762135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287253|NCT03762122||Single Group Assignment||Treatment||None (Open Label)||"This is a single-arm, multicenter phase II clinical trial. The trial uses a single-stage design based on a time-to-event rate to a specific time-point using Kaplan-Meier estimators.~Rogaratinib is given at a dose of 800 mg twice daily in continuous 28-days cycles, without treatment breaks (except for toxicity management). Trial treatment is continued until evidence of tumor progression, unacceptable toxicity, consent withdrawal or withdrawal by the investigator.~In order to include 24 patients into the trial, it is expected that 52 patients with advanced SQCLC have to be screened for tumor FGFR mRNA overexpression. Taking into account patients who are FGFR mRNA positive but cannot be enrolled (attrition rate of 20%), it is estimated that 68 patients will have to be screened in total."||||
1287254|NCT03762109|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1287255|NCT03762096|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1287256|NCT03762083||Single Group Assignment||Treatment||None (Open Label)||||||
1287257|NCT03762070|||Case-Only||Cross-Sectional|||||||
1287258|NCT03762057|||Cohort||Prospective|||||||
1287259|NCT03762044|Randomized|Parallel Assignment||Treatment||Double|In order to masking, investigator who assess the subject before and after the treatment will not know which group the subjects belong, and so the biostatistician.|After proposing to the subjects the enrollment to the study and once they accept, they will be randomly allocated to experimental TAPA treatment group or standard CDT treatment. They will be assessed 1 to 3 days before and after completing the treatment. It will be consists in a total of 10 sessions of 30 minutes of treatment, twice per week in a total 5 weeks period.|||t|t
1287260|NCT03762031|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1287261|NCT03762018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287262|NCT03762005|Randomized|Parallel Assignment||Treatment||Single||||||t
1287263|NCT03761992|Randomized|Parallel Assignment||Treatment||Double|Neither the patient nor the investigator will know which treatment that the patient is receiving.|Gingko baloba extract (GBE) versus placebo|t||t|
1287266|NCT03761953||Single Group Assignment||Treatment||None (Open Label)||This will be a pilot single-arm study consisting of 15 patients evaluating the use of oritavancin in the final consolidation phase (last two weeks of treatment) of systemic infections with Staphylococcus aureus (S. aureus) in opioid users.||||
1471773|NCT01353612|||||Prospective|||||||
1287272|NCT03761875|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1287273|NCT03761862|||Other||Retrospective|||||||
1287274|NCT03761849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287275|NCT03761836||Single Group Assignment||Treatment||None (Open Label)||||||
1287276|NCT03761823|||Cohort||Prospective|||||||
1287277|NCT03761810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287278|NCT03761797|||Cohort||Prospective|||||||
1287279|NCT03761784|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287280|NCT03761771|||Case-Only||Prospective|||||||
1287281|NCT03761758|Randomized|Parallel Assignment||Device Feasibility||Single|||t|||
1287282|NCT03761745|||Cohort||Prospective|||||||
1287283|NCT03761732||Single Group Assignment||Treatment||None (Open Label)||This is an active intervention feasibility study, using a pre-post clinical trial design; there is no randomization and no control intervention.||||
1287284|NCT03761719|||Cohort||Prospective|||||||
1287285|NCT03761706||Single Group Assignment||Prevention||None (Open Label)||||||
1287286|NCT03761693|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1287287|NCT03761680|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, controlled, open-label, clinical trial||||
1287288|NCT03761667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287289|NCT03761654|||Case-Only||Prospective|||||||
1287290|NCT03761641|||Other||Prospective|||||||
1287291|NCT03761628||Single Group Assignment||Treatment||None (Open Label)||||||
1287292|NCT03761615|||Cohort||Prospective|||||||
1287293|NCT03761602|||Cohort||Prospective|||||||
1287294|NCT03761589|Randomized|Parallel Assignment||Other||Single||Families (i.e., children and parents/primary caregivers dyads) were randomly assigned to participate in either the intervention group or a wait-list control group. The intervention (AFL) consisted of 24 structured, twice-weekly 90-min family-based, nutrition and sport/fitness-oriented sessions, and was delivered in a municipal recreation center. The wait-list control group received the intervention after all follow-up data had been collected. Data from all participants (both intervention group and wait-list group) were collected in four phases: before the intervention group started the program (week 0) and at 6, 12, and 24 weeks, thereafter.|t|||
1287295|NCT03761576|||Case-Only||Prospective|||||||
1287296|NCT03761563|||Cohort||Prospective|||||||
1287297|NCT03761550|||Case-Only||Prospective|||||||
1287298|NCT03761537|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287299|NCT03761524|Randomized|Parallel Assignment||Treatment||Single|Because the two interventions used in this trial are easily recognized by the participants and the investigator, neither the investigator nor the participant can be blinded. But, assessor and the statistician will be blinded.|||||t
1287300|NCT03761511|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287301|NCT03761498|||Cohort||Prospective|||||||
1287302|NCT03761485|Randomized|Parallel Assignment||Treatment||Quadruple|double blind|Randomized double blind clinical trial|t|t|t|t
1287303|NCT03761472|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287304|NCT03761459|||Cohort||Prospective|||||||
1287305|NCT03761446|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1287306|NCT03761433|||Case-Only||Prospective|||||||
1287307|NCT03761420|||Case-Only||Retrospective|||||||
1287308|NCT03761407|Randomized|Crossover Assignment||Treatment||Quadruple||Twelve volunteers (6 males and 6 females) per dose group will be randomly assigned to two treatment sequences (placebo-verum and verum-placebo, within dose-group randomized) in a ratio of 1:1. There will be a washout period of 7 to 11 days between the treatment sequences.|t|t|t|t
1287309|NCT03761394|Randomized|Sequential Assignment||Diagnostic||Single|||||t|
1287310|NCT03761381|||Case-Control||Prospective|||||||
1287311|NCT03761368|Randomized|Parallel Assignment||Prevention||Single|Blinded investigator, not involved in either CA or randomization procedure, performed assignment intervention.|After admission to the Department, patients were randomly assigned in 1:1 ratio to either control group or RIPC - group by means of a computerized randomization table.|||t|
1287312|NCT03761355|||Cohort||Prospective|||||||
1287313|NCT03761342|Randomized|Crossover Assignment||Other||Single|While participants will be made aware that there are different versions of NUSMart, the exact details of the arms will not be revealed to ensure validity of results. It will be deleterious to the study to reveal the differences between study arms as that would likely confound participant responses. Since there are 3 shopping conditions (unknown to participants), each participant will be randomly assigned at baseline to 1 of 6 groups that vary the sequence of shopping conditions and which shops will result in an actual food delivery.||t|||
1287314|NCT03761329|Randomized|Parallel Assignment||Treatment||Single||||||t
1287315|NCT03761316|||Case-Only||Cross-Sectional|||||||
1287363|NCT03760692|Randomized|Parallel Assignment||Treatment||Double||Prospective, multicenter, randomized|||t|t
1287364|NCT03760679|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1287365|NCT03760666||Single Group Assignment||Treatment||None (Open Label)||||||
1287366|NCT03760653|Randomized|Parallel Assignment||Treatment||Double|The probiotic and the placebo will be encapsulated in identical capsules and in identical cans that will only be identified with the letters A and B||t||t|
1287367|NCT03760640|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1287368|NCT03760627|Randomized|Crossover Assignment||Supportive Care||Single||This is a stepped wedge cluster randomized trial design. The design involves random and sequential crossover of clusters from control to intervention until all clusters are exposed. The controls from the previous session who were available for the parallel portion of the study, will later become the treatment group while another control group is recruited for them, which in turn will become an intervention group and so forth.|t|||
1287428|NCT03759834||Single Group Assignment||Treatment||None (Open Label)|"The electrode will be placed in the middle ear. The patient and investigator will be blinded to the on-off status of the device. The patient will report if they have improvement of their tinnitus while both the patient and investigator are blinded to the on-off status."|||||
1486499|NCT01160523|||||Prospective|||||||
1287316|NCT03761303|Randomized|Parallel Assignment||Treatment||Double|"The randomization of the patients is carried out by a non-medical employee. This co-worker maintains a randomly generated randomization list, indicating to the particular study code (e.g., TMS-PSD-001; TMS-PSD-002), whether to perform an active or sham treatment. The employee pulls a number from an envelope before beginning the intervention of each enrolled patient and then looks at the list to identify the particular group assignment. There will always be randomization packages of ten patients each. Once these are used up, a new list and a new envelope with study codes are prepared.~In addition, the real and the placebo coils are coded before starting studies (eg A and B). Only the uninvolved employee is the assignment to the real - or placebo coil known. The uninvolved employee randomly assigns the study code containing the information on which coil to use (A or B). In this way a blinding of performing physician, patient and the evaluating scientist is guaranteed."|"All patients will receive standard antidepressant therapy with 15 mg escitalopram (Selective Serotonin Reuptake Inhibitor) per day during the study. The dose of escitalopram is increased in all included patients from 5mg/day (day 1-3), over 10mg/day (day 4-6) to 15mg/day (from day 7).~Patients in the experimental group (active rTMS stimulation) receive active 10 Hz rTMS stimulation over the left dorsolateral prefrontal cortex (DLPFC) over a period of 20 days, seven days a week (20 sessions). The comparison group receives a duration of equal long sham-stimulation.~For transcranial magnetic stimulation, the Stimulator PowerMAG Research 100 (Mag & More, Munich, Germany) is used with a cooled double coil (PMD70-pCool)."|t||t|
1287317|NCT03761290|||Case-Control||Cross-Sectional|||||||
1287318|NCT03761277||Single Group Assignment||Treatment||None (Open Label)||||||
1287319|NCT03761264|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287320|NCT03761251||Single Group Assignment||Treatment||None (Open Label)||||||
1287321|NCT03761238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287322|NCT03761225|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287323|NCT03761212|||Cohort||Prospective|||||||
1287324|NCT03761199|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1287325|NCT03761186|Randomized|Parallel Assignment||Other||Single|Nurses that will take lab samples as well as laboratory personal that analyses the samples will be masked. Due to the nature of the study, it is not possible to mask the participants or the care providers/investigators.|||||t
1287326|NCT03761173|||Cohort||Prospective|||||||
1287327|NCT03761160|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287328|NCT03761147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287329|NCT03761134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287330|NCT03761121|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1287331|NCT03761108||Sequential Assignment||Treatment||None (Open Label)||||||
1287332|NCT03761095||Single Group Assignment||Treatment||None (Open Label)||||||
1287333|NCT03761082|||Cohort||Retrospective|||||||
1287334|NCT03761069||Single Group Assignment||Treatment||None (Open Label)||||||
1287335|NCT03761056||Single Group Assignment||Treatment||None (Open Label)||||||
1287336|NCT03761043|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1287337|NCT03761030|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t||t|
1287338|NCT03761017||Single Group Assignment||Treatment||None (Open Label)||3+3+3 dose escalation design followed by cohort expansion at MTD/MAD||||
1287339|NCT03761004|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1287340|NCT03760991||Single Group Assignment||Treatment||None (Open Label)||||||
1287341|NCT03760978|||Cohort||Prospective|||||||
1287342|NCT03760965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287343|NCT03760952|||Case-Only||Prospective|||||||
1287344|NCT03760939|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1287345|NCT03760926||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1287346|NCT03760913|Randomized|Parallel Assignment||Treatment||Triple|double-blind|This will be a double-blind, randomized, placebo-controlled, single and multiple subcutaneous dose study.|t|t|t|
1287347|NCT03760900|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1287348|NCT03760887|Randomized|Parallel Assignment||Treatment||Single|Patients were randomly assigned to one of two groups (control or experimental).|Randomized Control Trial|t|||
1287349|NCT03760874|||Cohort||Prospective|||||||
1287350|NCT03760861||Single Group Assignment||Device Feasibility||None (Open Label)||Open label pilot study||||
1287351|NCT03760848||Single Group Assignment||Other||None (Open Label)||||||
1287352|NCT03760835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287353|NCT03760822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287354|NCT03760809|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1287355|NCT03760796||Single Group Assignment||Prevention||None (Open Label)||Corrie Digital Health Platform prospective intervention group, as compared with historical standard of care comparison group||||
1287356|NCT03760783||Single Group Assignment||Other||None (Open Label)||||||
1287357|NCT03760770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287358|NCT03760757|Randomized|Parallel Assignment||Basic Science||Quadruple||Randomized controlled non-inferiority trial|t|t|t|t
1287359|NCT03760744|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1287360|NCT03760731|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor will be blind to treatment condition.|"Acceptance and Commitment Therapy for Moral Injury (ACT-MI) is a novel treatment protocol detailing the application of ACT for recovery from moral injury. ACT-MI is designed to help Veterans learn to interact differently with moral emotions and engage meaningfully in their lives. The intervention is group-based and spans twelve, 90-minute sessions. The current ACT-MI protocol was developed through an iterative process in which authors generated and refined the intervention based on clinical interactions with Veterans currently reporting moral injury.~Present Centered Therapy (PCT) will include 12 group sessions, but will focus on problem solving daily life difficulties related to moral injury rather than the experiential focus on moral emotions presented in ACT-MI."||||t
1287361|NCT03760718|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287369|NCT03760614||Sequential Assignment||Treatment||None (Open Label)||"This will be a modified 3+3 dose-escalation design with a primary endpoint of dose-limiting toxicity. All cohorts will receive the same dose of FOLFOX, once every 2 weeks. All cohorts will receive entinostat on days 1,8, 15, and 22 of 28 day cycles. Cohorts will vary in their dose of entinostat as follows:~Cohort 0: 2mg~Cohort 1: 3mg~Cohort 2: 4mg~Cohort 3: 5mg~Dosing will start with cohort 1. If no dose limiting toxicities (DLTs) are observed, the dose will be escalated directly to cohort 3. If any DLTs are experienced in cohort 1, three additional subjects will be enrolled in cohort 1. If no DLTs are experience by the additional subjects, the dose will be escalated to cohort 2. If a DLT occurs in two subjects in any dose cohort, dose escalation will be halted, and the next three subjects will be enrolled at the next lower dose cohort."||||
1287370|NCT03760601|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Single case experimental AB design with optional replication (ABAB)||||
1287371|NCT03760588|Randomized|Parallel Assignment||Prevention||Quadruple||Randomized, placebo controlled, double blind design|t|t|t|t
1287372|NCT03760575||Single Group Assignment||Treatment||None (Open Label)||||||
1287373|NCT03760562|||Cohort||Retrospective|||||||
1287374|NCT03760549|||Other||Other|||||||
1287375|NCT03760536|||Case-Only||Prospective|||||||
1287376|NCT03760523||Single Group Assignment||Treatment||None (Open Label)||||||
1287377|NCT03760510|Randomized|Parallel Assignment||Prevention||None (Open Label)||The endotracheal tube securement study was a pragmatic, single center, open-label, randomized trial comparing the effect of adhesive tape versus endotracheal tube fastener (Hollister AnchorFast Guard) among critically ill adults requiring intubation and mechanical ventilation for at least 24 hours.||||
1287378|NCT03760497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287379|NCT03760484||Single Group Assignment||Treatment||None (Open Label)||||||
1287380|NCT03760471||Single Group Assignment||Supportive Care||None (Open Label)||||||
1287381|NCT03760458|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287382|NCT03760445|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"3 parts - two different populations Part 1 - escalation - parallel dose escalation in 1L AML subjects and in R/R subjects (up to 8 dose cohorts per arm.~Part 2 - expansion - parallel expansion in 3 cohorts of 1L AML, and 1 cohort of R/R AML after recommended dose of expansion was determined.~Part 3 - DDI - parallel enrollment or R/R AML subjects into 2 DDI Cohorts (one with CYP3A4 inhibitor, one with CYP3A4 substrate)."||||
1287383|NCT03760432||Single Group Assignment||Treatment||None (Open Label)||||||
1287384|NCT03760419|Randomized|Crossover Assignment||Health Services Research||Double|"Aim 1: During intervention periods, providers caring for enrolled children will be presented with a detailed decision support strategy that emphasizes management in accordance with national guideline recommendations. During control periods, no additional decision support will be provided.~Aim2: Screening and enrollment procedures for Aim 2 will be identical to Aim 1. For children randomized to the intervention arm, providers will be presented with prognostic information regarding risk for severe disease outcomes via an electronic health record based decision support strategy that emphasizes management in accordance with national guideline recommendations. During control periods, no additional decision support will be provided."|"Aim 1: Effectiveness of the EHR-based antibiotic decision support application for promoting guideline-concordant antibiotic prescribing in children presenting for emergency care will be evaluated in a pragmatic, cluster randomized crossover study conducted over a period of 18 months that includes two respiratory seasons. Crossover will occur each month in a randomly determined sequence within each hospital. To ensure balanced representation of each arm in periods of both low and high pneumonia prevalence, randomization will occur in 3 permuted blocks (size=6).~Aim 2: The investigator will conduct a randomized controlled trial comparing our prognostic tool (intervention arm) to usual care (control arm) over a period of 24 months. Randomization will occur at the patient level. Allocation to intervention or control will be based on medical record number (even vs. odd) and will be assigned automatically once a provider confirms the diagnosis of pneumonia via the radiology alert tool."|t|t||
1287385|NCT03760406||Single Group Assignment||Basic Science||None (Open Label)||||||
1287386|NCT03760393|Randomized|Parallel Assignment||Prevention||None (Open Label)||"This study will employ a prospective, 2-group, repeated measure (2x5), randomized controlled trial (RCT) design. All participants will be randomized into either a 6-week HAPA-treatment (SB-related planning + text messages intervention) or waitlisted control (no treatment) condition.~All primary outcomes will be assessed at four time points (baseline, 2, 4, and 6 weeks), and again at a two-week follow-up (8 weeks). Action and coping planning and action control towards reducing occupational (student) sitting time will be assessed at the same time points. Secondary outcome assessments (i.e., work- and health-related outcomes) will occur pre-(baseline) and post-intervention (6 weeks)."||||
1287387|NCT03760380|Randomized|Sequential Assignment||Other||None (Open Label)||"Phase 1 All subjects will perform the same procedures with all the experimental interventions (Sole 1 - Neutral, Sole 1--Offset, Sole 2 - Neutral, Sole 2 - Offset)~Phase 2 Subjects will be assigned one of two shoes/soles (either Sole 1-Offset or Sole 2- Offset) for home use."||||
1287388|NCT03760367|Randomized|Parallel Assignment||Treatment||Triple|Participants are randomly assigned to one of the two arms and perform the treatment without knowing whether they use the blue covarine toothpaste or the control toothpaste. Treatment outcomes are assessed by a) a blinded operator and b) the blinded participants in a different room. Allocation of treatment groups will be revealed to the principal investigator after all data have been collected.|Participants are assigned to one of two groups - blue covarine toothpaste and control toothpaste group.|t||t|t
1287389|NCT03760354|Randomized|Parallel Assignment||Treatment||Single|single-blinded trial|Prospective Phase II, Bayesian, single-blinded, monocentric, randomized, prospective clinical trial|t|||
1287390|NCT03760341|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1287426|NCT03759860|Randomized|Parallel Assignment||Treatment||Double|"The participant must be masked from the information on the treatment group assignment.~The BCVA and image (OCT, Color Fundus Photography (CFP), Fundus Autofluorescence (FAF), Fluorescence Angiography (FAG)) investigator of the institution must be blinded on the participants' treatment group assignment to eliminate bias in evaluation.~Based on the images (OCT, CFP, FAF) and quantified measurement results (BCVA, OCT), the blinded principal investigator (independent evaluator) evaluates efficacy and adverse events and determines whether ranibizumab should be administered again.~An investigator not blinded performs SRT and ranibizumab administration."||t|||t
1287391|NCT03760328|Randomized|Crossover Assignment||Treatment||Triple|Neither the subject nor the investigator or Outcomes Assessor (double-blinded) will know the outcome of the randomization until after the subject has fulfilled and completed all study requirements at the end of the visit 3.|This study is a prospective, multi-center, randomized, crossover study, conducted under a common protocol. Subjects will be enrolled after they have been implanted and using the Inspire therapy (Inspire II/IV, Inspire Medical Systems, Maple Grove, USA) for at least six months. Participants will be randomized to one of two groups: therapeutic stimulation or sham stimulation. During the second phase of the study therapy settings of the stimulation system will be adjusted to crossover.|t||t|t
1287392|NCT03760315|||Cohort||Retrospective|||||||
1287393|NCT03760302|||Case-Only||Retrospective|||||||
1287394|NCT03760276||Single Group Assignment||Other||None (Open Label)||||||
1287395|NCT03760263|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287396|NCT03760250||Single Group Assignment||Prevention||None (Open Label)||||||
1287397|NCT03760237|||Cohort||Prospective|||||||
1287398|NCT03760224|Randomized|Parallel Assignment||Treatment||Single||||||t
1287399|NCT03760211|Randomized|Parallel Assignment||Prevention||Single|||t|||
1287400|NCT03760198|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287401|NCT03760185||Single Group Assignment||Treatment||None (Open Label)||This is a single arm study in which all enrolled subjects will receive eye drops to only one eye. The alternative eye will serve as the control for efficacy.||||
1287402|NCT03760172|||Cohort||Other|||||||
1287403|NCT03760159|||Cohort||Prospective|||||||
1287404|NCT03760146|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1287405|NCT03760133|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1287406|NCT03760120|Randomized|Crossover Assignment||Treatment||Triple|Technicians performing multiple-breath washout tests are blinded to treatment allocation; physiotherapists performing the treatment are blinded to multiple breath washout results; patients are blinded to the purpose of the study; the statistician will be blind to treatment allocation together with outcome assessors.|Cross-over randomized controlled trial. Procedure: two nitrogen multiple-breath washout tests, one before and one after the intervention with PEP-Mask, either standard or sham allocation, during two subsequent mornings.|t||t|t
1287407|NCT03760107|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1287408|NCT03760094||Single Group Assignment||Diagnostic||None (Open Label)||||||
1287409|NCT03760081||Single Group Assignment||Treatment||None (Open Label)||||||
1287410|NCT03760068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287411|NCT03760055|||Cohort||Prospective|||||||
1287412|NCT03760042|Randomized|Parallel Assignment||Other||Triple|"Crisaborole 2% ointment and matching crisaborole vehicle will be supplied by Pfizer to the CRU as packaged 60 gram tubes and labeled according to local regulatory requirements in an unblinded fashion.~Crisaborole and vehicle ointment doses for the 14 pre-specified application sites bilaterally will be prepared by the unblinded PCRU pharmacist and provided to the blinded investigational site staff in individual dose containers. Subjects will be blinded to side of body treated with crisaborole and side of body treated with vehicle."|Using surrogate markers of skin sensitivity (current perception threshold and lactic acid stinging test responses) to stratify risk for developing application site treatment emergent adverse events (AS-TEAEs), within-subject comparisons will quantify AS-TEAE frequency and severity in healthy participants following double-blind applications of crisaborole ointment and vehicle ointment at 7 sensitive skin anatomic locations.|t|t|t|
1287413|NCT03760029||Single Group Assignment||Other||None (Open Label)||||||
1287414|NCT03760016|Randomized|Parallel Assignment||Treatment||Single||||||t
1287415|NCT03760003|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, double blind, placebo controlled, parallel groups|t|t|t|t
1287416|NCT03759990|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1287417|NCT03759977|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||pre- posttest with control group||||
1287418|NCT03759964|Randomized|Parallel Assignment||Prevention||Triple||FCAACS will be a parallel group randomized trial, with a 2-group design and no crossover. Allocation ratio will be 1/1, in an equivalence framework.|t|t||t
1287419|NCT03759951|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1287420|NCT03759938|Randomized|Parallel Assignment||Treatment||Single|"The Event Adjudication Committee is a study group (of at least three members) responsible for the review of clinical events to ensure consistent, standardized, objective and unbiased results throughout all participating sites and minimise the likelihood of discrepant interpretations.~This group consists of a panel of experts who have the relevant therapeutic area expertise, are experienced in clinical trials, and have been trained on the specific study protocol.~The Event Adjudication Committee will centrally review events reported using all available clinical and imaging data and evaluate efficacy and/ or safety endpoints in a blinded and unbiased manner on a regular basis to ensure accurate, consistent and standardized assessments of important study events such as recurrent symptomatic ischaemic stroke, systemic embolism and death."|Patients will be randomised in a 1:1 ratio to intervention or control arms of the study. Participants and their physicians will not be blinded to study arm allocation.The exact timing of anticoagulation within the period specified for the allocated study arm is at the discretion of the treating physician, as is the choice of DOAC. Apart from the timing of DOAC initiation, the DOAC should be prescribed in accordance with usual clinical practice||||t
1287421|NCT03759925|Randomized|Parallel Assignment||Other||Double|The analyst(s) and investigator(s) conducting the analyses of the data will be masked to whether participants were in the intervention or control arm.|We aim to randomize 180 participants to the intervention (n=90) or control (n=90) groups. The intervention consists of providing home delivery of medically-appropriate food support and individual nutritional counseling over five months to patients at Zuckerberg San Francisco General admitted to the hospital with acute decompensated heart failure.|||t|t
1287422|NCT03759912|||Cohort||Prospective|||||||
1287423|NCT03759899|||Case-Only||Prospective|||||||
1287424|NCT03759886|||Case-Control||Prospective|||||||
1287425|NCT03759873|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1287427|NCT03759847||Single Group Assignment||Prevention||None (Open Label)||Comparison of interdialytic weight gain with fluid intake as recorded by fluid app||||
1287429|NCT03759821|Randomized|Factorial Assignment||Prevention||Single||Eighty villages in the Mara region of Tanzania will be randomly selected and randomly allocated with equal probability and in equal numbers to one of the 5 EFFECTS study arms. In each participating village, a sampling frame of all households in that village will be created with the help of local leaders. Households will be selected from this sampling frame using simple random sampling. The selected households will be listed in random order and visited by study staff, who will assess whether a household meets all inclusion criteria and provides informed consent. Households will be visited until 12 households are enrolled in each village.||||t
1287430|NCT03759808||Single Group Assignment||Treatment||None (Open Label)||An open trial will be conducted in patients with persistent post-concussion symptoms compared to non-injured controls in order to determine whether the intervention (controlled breathing and cognitive behavioral therapy for anxiety) improves parasympathetic, HPA axis activity and cerebral blood flow, and whether improvement in parasympathetic and HPA axis activity predicts reduction in PPCS symptoms. We will compare baseline evaluations to the evaluation conducted after brief CBT and controlled breathing training to demonstrate the feasibility of normalizing parasympathetic, and HPA axis activity via this intervention. If we obtain the predicted results in the current study we will design a much larger study to identify the mechanisms of change. Healthy, non-injured control participants will provide normative data on all measures except for concussion-relevant outcomes.||||
1287431|NCT03759795|Randomized|Parallel Assignment||Prevention||None (Open Label)|Randomised Controlled Trial. Wait-list control for half participants. Other half receive ACTr (acceptance and commitment training) intention.|||||
1287432|NCT03759782|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label||||
1287433|NCT03759769|Randomized|Parallel Assignment||Treatment||Single||||||t
1287434|NCT03759756|||Other||Other|||||||
1287435|NCT03759743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287436|NCT03759730|||Other||Prospective|||||||
1287437|NCT03759717|||Cohort||Prospective|||||||
1287438|NCT03759704||Single Group Assignment||Basic Science||None (Open Label)||Sarcoma patients and Healthy Control Subjects||||
1287439|NCT03759691|||Case-Only||Cross-Sectional|||||||
1287440|NCT03759678|Non-Randomized|Single Group Assignment||Treatment||Single|The primary evaluation of the Clinical Impression of Change in Severity (CI-CS; Primary Endpoint) will be performed by two independent neurologists whose assessments are based on videos of patient's performance on either the 9 Hole Peg Test of the Dominant Hand (9HPT-D) or the 8 Meter Walk Test (8MWT) taken at each visit.|Patients will be assessed during three study phases: a baseline period (with or without a study run-in), a treatment period, and a washout period.||||t
1287441|NCT03759665|Non-Randomized|Single Group Assignment||Treatment||Single|The primary evaluation of the Clinical Impression of Change in Severity (CI-CS; Primary Endpoint) will be performed by two independent neurologists whose assessments are based on videos of patient's performance on either the 9 Hole Peg Test of the Dominant Hand (9HPT-D) or the 8 Meter Walk Test (8MWT) taken at each visit.|Patients will be assessed during three study phases: a baseline period (with or without a study run-in), a treatment period, and a washout period.||||t
1287442|NCT03759652|||Cohort||Retrospective|||||||
1287443|NCT03759639|Non-Randomized|Single Group Assignment||Treatment||Single|The primary evaluation of the Clinical Impression of Change in Severity (CI-CS; Primary Endpoint) will be performed by two independent neurologists whose assessments are based on videos of patient's performance on either the 9 Hole Peg Test of the Dominant Hand (9HPT-D) or the 8 Meter Walk Test (8MWT) taken at each visit.|Patients will be assessed during three study phases: a baseline period (with or without a study run-in), a treatment period, and a washout period.||||t
1287444|NCT03759626|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1287445|NCT03759613|Randomized|Parallel Assignment||Screening||Double|||t|||t
1287446|NCT03759600||Single Group Assignment||Treatment||None (Open Label)||||||
1287447|NCT03759587||Single Group Assignment||Treatment||None (Open Label)||||||
1287448|NCT03759574|||Cohort||Prospective|||||||
1287449|NCT03759561|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287450|NCT03759548|||Cohort||Prospective|||||||
1287451|NCT03759535|||Case-Only||Prospective|||||||
1287452|NCT03759522|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1287453|NCT03759509|Randomized|Parallel Assignment||Other||None (Open Label)||The study will randomly sample from previously screen low sleep quality participants, then random assign to experimental (aerobic exercise) and control (routine activity) groups||||
1287454|NCT03759496||Single Group Assignment||Treatment||None (Open Label)||||||
1287455|NCT03759483|||Other||Other|||||||
1287456|NCT03759470|||Cohort||Prospective|||||||
1287457|NCT03759457||Single Group Assignment||Treatment||None (Open Label)||||||
1287458|NCT03759444|||Case-Only||Retrospective|||||||
1287459|NCT03759431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287460|NCT03759418|||Case-Only||Retrospective|||||||
1287461|NCT03759405||Single Group Assignment||Treatment||None (Open Label)||||||
1287462|NCT03759392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287463|NCT03759379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287464|NCT03759366||Single Group Assignment||Treatment||None (Open Label)||||||
1287465|NCT03759353|Randomized|Parallel Assignment||Treatment||None (Open Label)||98 pregnant women with iron deficiency will be randomized into two groups: lactoferrin group or ferrous sulfate group||||
1287466|NCT03759340||Single Group Assignment||Treatment||None (Open Label)||This Phase 2, multicenter, open-label study will evaluate the safety, tolerability, efficacy, and durability of efficacy of ATI-502 Topical Solution, 0.46% for the treatment of alopecia areata (AA), alopecia universalis (AU) and alopecia totalis (AT) in adult subjects who completed 24 weeks of treatment with ATI-501 Oral Suspension or Placebo Suspension.||||
1287467|NCT03759327|||Case-Only||Other|||||||
1287468|NCT03759314|||Other||Retrospective|||||||
1287469|NCT03759301|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1287470|NCT03759288|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1287471|NCT03759275|||Case-Only||Prospective|||||||
1287472|NCT03759262||Single Group Assignment||Supportive Care||None (Open Label)||||||
1287473|NCT03759249||Single Group Assignment||Treatment||None (Open Label)||||||
1287474|NCT03759236|Randomized|Parallel Assignment||Prevention||None (Open Label)||Two clinics are randomized to receive the health messaging via SMS and the third clinic is randomized to receive standard CDC health education materials.||||
1287475|NCT03759223|Randomized|Parallel Assignment||Treatment||None (Open Label)||Up to 12 participants will first complete an open trial of E-PST to test the feasibility, acceptability, and preliminary clinical effect. Subsequently, up to 38 participants will be randomly assigned (1:1) to E-PST or a control condition comprised of supportive contact and symptom monitoring.||||
1287476|NCT03759210|||Cohort||Retrospective|||||||
1287477|NCT03759197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287478|NCT03759184||Sequential Assignment||Treatment||None (Open Label)||||||
1287479|NCT03759171|Randomized|Crossover Assignment||Treatment||None (Open Label)||Delayed entry, randomized trial||||
1287480|NCT03759158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287481|NCT03759145|Randomized|Parallel Assignment||Treatment||Single||||||t
1287482|NCT03759132|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1287483|NCT03759119|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor investigator will be masked to all medical diagnoses of the infant|This will be a randomized controlled trial using a pretest /posttest control group design to allow for comparison between an intervention group that receives tummy time and parent education and a standard of care group that receives parent education only|||t|
1287484|NCT03759106|Randomized|Parallel Assignment||Treatment||Single||||||t
1287485|NCT03759093|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287486|NCT03759080|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||"there are two arms :1. proprioceptive neuromuscular facilitation (PNF) group ,2.proprioceptive neuromuscular facilitation with mental practice (PNFMP) group.~PNF group: 15 individuals, these subjects received only PNF training. PNFMP: 15 individuals, these subjects received PNF training combined with MP. training program has been administered for every group for 15 sessions over 5 weeks with 3 x 30 min training sessions per week."||||
1287487|NCT03759067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287488|NCT03759054|||Cohort||Prospective|||||||
1287489|NCT03759041|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1287490|NCT03759028|Randomized|Parallel Assignment||Treatment||Double|Randomization envelopes used to allocate treatment groups|double blinded, randomized trial|t||t|
1287491|NCT03759015||Single Group Assignment||Prevention||None (Open Label)||||||
1287492|NCT03759002|||Case-Control||Cross-Sectional|||||||
1287493|NCT03758989||Single Group Assignment||Treatment||None (Open Label)||||||
1287494|NCT03758976|||Cohort||Prospective|||||||
1287495|NCT03758963|Randomized|Parallel Assignment||Treatment||Double|"In this study, double-blinding will be applied for subjects and independent efficacy evaluators. It is difficult to apply blinding to the practitioner who handles the products used for therapy because of difference in the procedure of the treatment and sham, but the information related to the medical device shall not be released to subjects and independent efficacy evaluators. For blinding of independent efficacy evaluators, an independent evaluator shall conduct efficacy evaluation tests (OCT, BCVA test, contrast sensitivity test, FA).~Subjects and independent efficacy evaluators will not know which group the subjects are assigned to and whether SRT or sham procedure is used. The blinding on the test device will be maintained until the data for statistical analysis are opened."||t|||t
1287496|NCT03758950|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple blind||t|t|t|t
1287498|NCT03758924|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind, Randomized, Placebo-Controlled||t|t|t|
1287499|NCT03758911|||Case-Only||Prospective|||||||
1287500|NCT03758898|Randomized|Parallel Assignment||Treatment||Single||The patients were randomised using randomisation software and divided into two groups each comprising 74 patients. Chest physiotherapy and mobilisation was applied to the patients in the first group, and only mobilisation was applied to the patients in the second group.|||t|
1287501|NCT03758885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287502|NCT03758872||Single Group Assignment||Diagnostic||None (Open Label)||||||
1287503|NCT03758859||Single Group Assignment||Diagnostic||None (Open Label)|Randomisation is between eyes i.e. eye exposed to blinking alone vs eye exposed to lubricant drops|||||
1287504|NCT03758846|Randomized|Parallel Assignment||Other||Single|||t|||
1287505|NCT03758833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287506|NCT03758820|Randomized|Parallel Assignment||Supportive Care||Single|randomization of patients|parallel group assignment|t|||
1287507|NCT03758807|Randomized|Parallel Assignment||Treatment||Single|Patients were randomly assigned to one of two treatment groups|Randomized Control Trial|t|||
1287508|NCT03758794|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1287509|NCT03758781||Single Group Assignment||Treatment||None (Open Label)||||||
1287510|NCT03758768|Randomized|Parallel Assignment||Treatment||Double|"A third-party investigator is recruited to be present during the intervention. This third-party investigator has no knowledge of the hypotheses of the study.~Although the participants can see the type of light they receive, they have no knowledge of the study hypotheses."|Randomized, controlled, single-blinded trial.|t||t|
1287511|NCT03758755|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1287512|NCT03758742||Single Group Assignment||Treatment||None (Open Label)||||||
1287513|NCT03758729||Single Group Assignment||Treatment||None (Open Label)||||||
1287514|NCT03758716||Single Group Assignment||Treatment||None (Open Label)||||||
1287515|NCT03758703|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Because of the nature of the intervention, it is not possible to perform blinding/masking.|This study will employ a pragmatic parallel randomized-control trial design as a mixed-methods study in which approximately half of the participants will be randomized into a control and the other remaining half in the experimental group.||||
1287516|NCT03758690||Single Group Assignment||Treatment||None (Open Label)||||||
1287517|NCT03758677||Single Group Assignment||Treatment||None (Open Label)||||||
1287518|NCT03758664||Single Group Assignment||Treatment||None (Open Label)||||||
1287519|NCT03758651|||Cohort||Cross-Sectional|||||||
1287520|NCT03758638|Randomized|Parallel Assignment||Prevention||None (Open Label)||Healthy Eating & Active Living Taught at Home (HEALTH) embeds content related to healthy eating and activity within Parents as Teachers (PAT)'s existing home visits.||||
1287521|NCT03758625|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, double-blind, multi-arm|t|t|t|t
1287522|NCT03758612|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1287523|NCT03758599|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled clinical trial with three arms for the comparison of the efficacy of a climbing exercise program, an aerobic exercise program and a social contact control group on symptoms of AD/PTSD, worry symptoms, quality of life, physical activity, health-related resources and affective responses in patients with AD or PTSD.|t|||
1287524|NCT03758586|Randomized|Parallel Assignment||Other||Single|||t|||
1287525|NCT03758573|Randomized|Parallel Assignment||Treatment||Double||Compare the effectiveness of early inspiratory muscle training (IMT) versus non-IMT in patients undergoing mechanical ventilation to improve the outcome of mechanical ventilation weaning time.|||t|t
1287526|NCT03758560|||Cohort||Prospective|||||||
1287527|NCT03758547||Sequential Assignment||Treatment||None (Open Label)|patients deeply sedated and therefore not conscious|baseline (time0) application of 10 cycles of positive inspiratory and negative expiratory pressures (time1) application of percussion (time2)||||
1287528|NCT03758534|||Cohort||Retrospective|||||||
1287529|NCT03758521|||Cohort||Prospective|||||||
1287530|NCT03758508|Randomized|Parallel Assignment||Treatment||None (Open Label)||Efficacy of alternating NIV and HFO compared to HFO alone in the determination of an improvement of PaO2/FiO2 at 21 hours compared to baseline PaO2/FiO2||||
1287531|NCT03758495|||Case-Control||Cross-Sectional|||||||
1287532|NCT03758482|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1287533|NCT03758469|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1287534|NCT03758456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287535|NCT03758443|Randomized|Parallel Assignment||Treatment||Quadruple||Integrated and Adaptive Design|t|t|t|t
1287536|NCT03758430|||Cohort||Prospective|||||||
1287537|NCT03758417||Single Group Assignment||Treatment||None (Open Label)||||||
1287538|NCT03758404|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1287539|NCT03758391|Randomized|Parallel Assignment||Other||None (Open Label)||Prospective cohort study||||
1287540|NCT03758378||Single Group Assignment||Treatment||None (Open Label)||||||
1287541|NCT03758365|Randomized|Parallel Assignment||Treatment||Single|Visual assessments of potential skin blanching will be made independently by 2 trained observers, according to a grading scale (0 to 4)|Single application, intra individual comparison on mini-test sites (n=7)||||t
1287542|NCT03758352|Randomized|Parallel Assignment||Prevention||Double|The patient enrolment will be done by the on-call doctor and intervention will be performed by unblinded nurse anaesthetists who won't be involved in sample collection or data analysis. All other research personnel, including surgeons and those responsible for sample collection and assessment will remain blinded. Also, due to the properties of the active and sham procedures, the patients will be blinded to their allocation.|Patients will be allocated at random in a 1:1 ratio to either the control group (non-rIC) or intervention group (rIC).|t||t|
1287543|NCT03758339||Single Group Assignment||Treatment||None (Open Label)||||||
1287544|NCT03758326|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1287545|NCT03758313|||Cohort||Prospective|||||||
1287546|NCT03758300|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1287547|NCT03758287|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287548|NCT03758274|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1287549|NCT03758261|Randomized|Parallel Assignment||Treatment||None (Open Label)||2 groups of patients will be studied simultaneously. One group will have the intervention of the nerve block in the erector spinae approach and the other group will have the nerve block in the traditional paravertebral approach.||||
1287550|NCT03758248|||Cohort||Prospective|||||||
1287551|NCT03758235|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287552|NCT03758222|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287553|NCT03758209|Randomized|Parallel Assignment||Prevention||Triple|Investigators and assessors will be blinded regarding preoperative preparation. Both randomization process and rehabilitation process will be carried out by a trained nurse, physiotherapist and psychotherapist, neither of them will be involved in outcome assessment.|"Patients planned for elective, curative operations for colorectal cancer will be randomized into two groups: experimental group will take part in a dedicated 4-week multimodal preparation program followed by ERAS preoperative management, while control group will just participate in the ERAS program without specific physical and mental preparation.~1:1 randomization will be performed."||t|t|t
1287554|NCT03758196|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287555|NCT03758183|||Cohort||Retrospective|||||||
1287556|NCT03758170|Randomized|Parallel Assignment||Treatment||Quadruple|"All intervention drugs will be blinded by a nurse who is not a participant in the study or in the treatment of the patient in any way.~The Patient, the administrator of the drug(nurse or doctor), the assessor, the investigator and the care team will all be blinded."|A randomized doubleblinded controlled trial.|t|t|t|t
1287557|NCT03758157|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1287558|NCT03758144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287559|NCT03758131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287560|NCT03758118|Randomized|Sequential Assignment||Treatment||Double|||||t|t
1287561|NCT03758105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287562|NCT03758092|||Case-Control||Retrospective|||||||
1287563|NCT03758079|Randomized|Crossover Assignment||Treatment||Single||||||t
1287564|NCT03758066||Single Group Assignment||Health Services Research||None (Open Label)||Pre-post quasi-experimental design||||
1287565|NCT03758053|||Case-Control||Prospective|||||||
1287566|NCT03758040|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1287567|NCT03758027|Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a randomized control trial with an experimental and control group. There will be a total of 96 participants, 48 in each group. For research question, a 2 X 3 repeated measures MANOVA will be conducted.||||
1287568|NCT03758014|Randomized|Parallel Assignment||Treatment||Single|||||t|
1287569|NCT03758001|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1287570|NCT03757988||Single Group Assignment||Treatment||None (Open Label)||||||
1287571|NCT03757975|||Case-Only||Cross-Sectional|||||||
1287572|NCT03757962||Single Group Assignment||Treatment||None (Open Label)||||||
1287573|NCT03757949|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1287574|NCT03757936||Single Group Assignment||Treatment||None (Open Label)||||||
1287575|NCT03757923|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized controlled trail||||
1287576|NCT03757910|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1287577|NCT03757897||Single Group Assignment||Diagnostic||None (Open Label)||This is a preliminary interventional trial in which participants will serve as their own controls.||||
1287578|NCT03757884||Single Group Assignment||Health Services Research||None (Open Label)||Pre-posttest study design||||
1287579|NCT03757871|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1287580|NCT03757858|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1287581|NCT03757845|Randomized|Parallel Assignment||Basic Science||Double||Randomized trial of dietary intervention|||t|t
1287582|NCT03757832|||Cohort||Prospective|||||||
1287583|NCT03757819|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287584|NCT03757806|Randomized|Parallel Assignment||Treatment||None (Open Label)||"A randomized controlled trial will be conducted. Participants will be randomized to the control group or intervention group.~The control group will receive usual care only (e.g., pharmacologic treatment), whilst the experimental group will receive an individualized home-based physical activity program at home (LiFE4D) in addition to usual care."||||
1287585|NCT03757793|||Cohort||Prospective|||||||
1287586|NCT03757780|||Cohort||Retrospective|||||||
1287587|NCT03757767||Single Group Assignment||Basic Science||None (Open Label)||Research subjects are measured in the fed state and in the prolonged fasted state.||||
1287588|NCT03757754|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|open|Multiple Ascending Dose, Multiple groups, Multiple centers||||
1287589|NCT03757741|||Cohort||Prospective|||||||
1287590|NCT03757728|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1287591|NCT03757715|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1287592|NCT03757702|||Case-Control||Cross-Sectional|||||||
1287593|NCT03757689||Single Group Assignment||Treatment||None (Open Label)||||||
1287625|NCT03757273|Randomized|Parallel Assignment||Treatment||Single|Because the two interventions used in this trial are easily recognized by the participant and the investigators, neither the investigator nor the participant can be blinded. But, the assessor and the statistician will be blinded.|||||t
1287626|NCT03757260|Randomized|Parallel Assignment||Treatment||Triple|"Once selected the patient will see two clinicians: the examiner (hygienist) and operator (resident).~The examiner records the data (PPD, CAL, BOP, PI) of the teeth, and provides preliminary hygiene treatment; the operator delivers the test treatments.~The treatment assignments are concealed to the patient and the examiner. The operator is unaware of previously recorded data except for pocket depth measurements and is not involved in the post-treatment evaluations (3,6,12 months)"||t|t|t|
1287594|NCT03757676|Randomized|Parallel Assignment||Other||Single||Participants were randomly assigned into one of three experimental groups: a control group and two play groups. The two play groups consisted of a group that was asked to play Pokémon Go ad libitum (at will play) and the other group was asked to achieve a specific level within the game during the study period (goal oriented play). Participants were measured for baseline physical activity levels (2 weeks) followed by randomization to one of the three groups. The intervention period lasted 4 weeks. All participants completed a brief questionnaire and were measured for height and weight, and daily physical activity levels using a FitBit accelerometer. Locations of where individual engaged in physical activity were recorded using a GPS tracking application. During the 5th week of the study period, participants completed five (5) short surveys per day using Ecological Momentary Assessment (EMA) software to assess level of play and engagement of play.|t|||
1287595|NCT03757663||Single Group Assignment||Prevention||None (Open Label)||Each participant will self-report skin protective behaviors and attitudes before wearing a UV dosimeter for 3 weeks. After the wear period, the study team provides feedback based on UV exposure. The participant will then wear the device again for 3 weeks.||||
1287596|NCT03757650|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1287597|NCT03757637|Randomized|Parallel Assignment||Supportive Care||Triple|This study was not fully blinded; however, the group allocation was concealed from the patient and primary researcher until after baseline assessments were completed. A primary researcher obtained patient consent, collected selfreported assessments, and if the patients were randomized to intervention group, the intervention trainer explained the exercise program to participants. The study statistician and data managers remained blinded at all times.|There are various models of SCP, in general, the primary care physician model or nurse-led model are generally being recognized for effective detecting patients' distress and recurrences, effective coordination and communication, and taking SCP as standard cancer care. In Taiwan, we take a large number of advanced DTC patients, it is important to integrate the SCP but also need to concern about the limited time in busy OPD clinics and patients' differences because of various physical or psychological conditions and needs. We will build up the contents and operable programs for two interventions groups: NLSCP and ICT supported HAP.||t|t|t
1287598|NCT03757624|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1287599|NCT03757611|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1287600|NCT03757598|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||There are two study groups, each with 6 health facilities. All providers offering maternity care were trained in labor management practices and use of the partograph approved for national use in Kenya. In the intervention group only, providers were offered training and Android tablets to use the electronic partogram with clients. The 6-month intervention phase was simultaneous in both groups.||||
1287601|NCT03757585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287602|NCT03757572|Randomized|Parallel Assignment||Treatment||Double|Blinding will exist at the level of the investigator who will record the data postoperatively. There will be no blinding at the level of the surgeon or the patient.||||t|t
1287603|NCT03757559|Randomized|Crossover Assignment||Treatment||Quadruple||Nested-randomized, single site, double-blind, double-dummy, placebo- and active-controlled, crossover design with administration of a single oral dose. Based on the assigned treatment sequence, each participant was randomly allocated to receive a single oral dose of the investigational medicinal product (IMP) in each of 7 periods. One administration of placebo (Treatment G) always followed cebranopadol 800 micrograms (Treatment C). Each IMP administration was given under fasted conditions and was separated by a washout period of at least 14 days.|t|t|t|t
1287604|NCT03757546|||Cohort||Prospective|||||||
1287605|NCT03757533|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287606|NCT03757520|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||"According two Smartphone Addiction Proneness Scale (SAPS) the subjects will be divided into two groups: Regular user group with SAPS score 39 or less. Heavy user group with SAPS score 40 or more.~we have two variables to be assessed:~Pain pressure threshold for two muscles (upper fiber of trapezius and sternocleidomastoid muscle)~Hand grip force"||||
1287607|NCT03757507|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||Open label, single group||||
1287608|NCT03757494||Single Group Assignment||Device Feasibility||None (Open Label)||Using Alpha Stim||||
1287609|NCT03757481||Single Group Assignment||Other||None (Open Label)||||||
1287610|NCT03757468|Randomized|Parallel Assignment||Treatment||Single||||||t
1287611|NCT03757455|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial|t|||
1287612|NCT03757442|||Cohort||Retrospective|||||||
1287613|NCT03757429|||Cohort||Prospective|||||||
1287614|NCT03757416|||Case-Only||Prospective|||||||
1287615|NCT03757403|Randomized|Crossover Assignment||Treatment||Triple||phase 2a randomized double-blinded placebo-controlled cross-over|t|t|t|
1287616|NCT03757390|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1287617|NCT03757377|Randomized|Parallel Assignment||Treatment||Double|Double (Participant, Investigator)||t||t|
1287618|NCT03757364|||Case-Control||Retrospective|||||||
1287619|NCT03757351|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1287620|NCT03757338|Randomized|Crossover Assignment||Treatment||Single|The study was conducted as a blinded study regarding dose administration and sample collection. In addition, the blood samples from each subject were coded in a manner to make the analyst blind to the identity of the samples, allowing efficient conduct of the analytical procedure.|Single centre, single dose, blinded, two treatment, two period, two sequence, two-way crossover, randomized study.||||t
1287621|NCT03757325|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1287622|NCT03757312||Single Group Assignment||Diagnostic||None (Open Label)||||||
1287623|NCT03757299||Single Group Assignment||Prevention||None (Open Label)||||||
1287624|NCT03757286|Randomized|Parallel Assignment||Treatment||Single|Because the two interventions used in this trial are easily recognized by the participants and the investigator, neither the investigator nor the participant can be blinded. But, assessor and the statistician will be blinded.|||||t
1287627|NCT03757247|||Other||Prospective|||||||
1287628|NCT03757234|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519987|NCT00718445|||Cohort|||||||||
1287629|NCT03757221||Single Group Assignment||Treatment||None (Open Label)||We plan a single-arm non-randomized open label phase II study with a Fleming one stage hypothesis testing for the primary endpoint of VGPR (Very Good Partial Response) + CR (Complete Response) Rate during the twelve months follow-up. The efficacy of Daratumumab plus Ixazomib will be evaluated in comparison to a minimally effective lower threshold level of VGPR + CR.||||
1287630|NCT03757208|Randomized|Parallel Assignment||Treatment||Single|||||t|
1287631|NCT03757195||Single Group Assignment||Treatment||None (Open Label)||||||
1287632|NCT03757182||Single Group Assignment||Other||None (Open Label)||||||
1287633|NCT03757169|Randomized|Parallel Assignment||Treatment||None (Open Label)||There are two randomized groups.||||
1287634|NCT03757156|Randomized|Parallel Assignment||Prevention||None (Open Label)||Aspirin maintenance group versus aspirin interruption group||||
1287635|NCT03757143|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1287636|NCT03757130|Randomized|Parallel Assignment||Other||Double|Double-blind study||t||t|
1287637|NCT03757117||Single Group Assignment||Health Services Research||None (Open Label)||Twelve-month, non-randomized, single-arm, pilot cohort study to assess the feasibility, acceptability, and potential effectiveness of integrating routine HIV prevention and treatment services with gender-affirming care supported by transgender woman community peer health navigators.||||
1287638|NCT03757104|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1287639|NCT03757091|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287640|NCT03757078|||Cohort||Prospective|||||||
1287641|NCT03757065|||Cohort||Cross-Sectional|||||||
1287642|NCT03757052||Single Group Assignment||Diagnostic||None (Open Label)||||||
1287643|NCT03757039|Randomized|Parallel Assignment||Treatment||Double|This will be a double-masked trial for the contact lens wearers. The PAL wearers are not masked.||t||t|
1287644|NCT03757026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287645|NCT03757013|||Cohort||Retrospective|||||||
1287646|NCT03757000||Single Group Assignment||Treatment||None (Open Label)||dose escalation||||
1287647|NCT03756987|Randomized|Parallel Assignment||Treatment||Quadruple|The randomization sequence will be computer generated. Allocation concealment will be carried out via concealed assignments in opaque, sealed, and consecutively numbered envelopes.||t|t|t|t
1287648|NCT03756974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287649|NCT03756961|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, randomized, non-blinded, non-commercial single site study||||
1287650|NCT03756948|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1287651|NCT03756935|||Other||Prospective|||||||
1287652|NCT03756922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287653|NCT03756909|||Cohort||Cross-Sectional|||||||
1287654|NCT03756896||Single Group Assignment||Treatment||None (Open Label)||||||
1287655|NCT03756883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287656|NCT03756870|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 parallel design||||
1287657|NCT03756857|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, open, randomized, parallel, two-arm trial||||
1287658|NCT03756844||Single Group Assignment||Treatment||None (Open Label)|There was no masking. This was a single subject study. Participants allowed us to use their clinical data for research purposes.|This was a single-subject (time series design).||||
1287659|NCT03756831|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||3x3 factorial design, according to body mass index (Independent variable)subjects will be divided into three groups (Group I - normal subjects-BMI<25 kg/m2, Group II -overweight subjects-BMI, 25-30 kg/m2), Group III -obese subjects- BMI>30 kg/m2). Core stability (dependent variable) will be measured by three tests : bilateral static balance with open and close eye, uni-pedal static balance test, and dynamic balance test using Prokin System for balance||||
1287660|NCT03756818||Single Group Assignment||Treatment||None (Open Label)||||||
1287661|NCT03756805|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with moderate to severe sleep apnea (apnea-hypopnea index (AHI) between 15 / h and 65 / h) are included in the period 2014-2018. The patients are assigned to two groups: group 1, who are receiving PAP therapy and group 2, who are receiving upper airway stimulation. All patients receive polysomnography (PSG) in the sleep laboratory prior to therapy and are followed up on average 12 months after initiation of therapy by PSG or a home sleep test. This protocol is close to the daily clinical routine.||||
1287662|NCT03756792|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1287663|NCT03756779|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1287664|NCT03756766|||Case-Control||Prospective|||||||
1287665|NCT03756753|Randomized|Parallel Assignment||Other||None (Open Label)|Patients will be enrolled in the study, and will not initially know their study arm. After enrollment, the professional research assistant (PRA) will find out the study arm. Providers will be notified of the results for the intervention group. Providers are able to let patients know of their results.|Participants will be allocated 1:1 by computer-generated randomization to either the intervention group - test result available to providers, or the control group- test result not available (routine clinical care).||||
1287719|NCT03756038|Randomized|Parallel Assignment||Treatment||Quadruple||Subjects will be randomly assigned to either the experimental condition (lorazepam) or the control condition (placebo).|t|t|t|t
1287720|NCT03756025|Randomized|Parallel Assignment||Treatment||Triple|Each evaluation was performed by a different blind examiner for the type of GIC used in ART Patients did not know what material was being used on their teeth.|The study is characterized by longitudinal follow-up of a randomized, double-blind, split-mouth-type clinical trial performed in babies affected by early childhood caries|t|t||t
1287721|NCT03756012|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1287722|NCT03755999|Non-Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1287723|NCT03755986||Single Group Assignment||Diagnostic||None (Open Label)||||||
1287821|NCT03754712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287822|NCT03754699|Randomized|Parallel Assignment||Prevention||Single|||t|||
1520066|NCT00717392|||||Prospective|||||||
1287666|NCT03756740|Randomized|Parallel Assignment||Treatment||Double|"Participants will not know the intervention in other groups or the research aim in details. they will only know that it is a research for low back pain treatment.~The physical therapists performing the examination pre and post intervention will be blinded to the participants group."|"Sixty patients diagnosed with chronic LBP referred for physical therapy to one of the 5 outpatient clinics of Maccabi Health Services in the Haifa metropolitan area, Israel, will be recruited for this study. each subject will undergo a baseline examination including answering several questionnaires/self-reported outcome measures, a history of present or any past LBP and a physical examination routinely conducted during physical therapy assessment and treatments.~Following the physical examination, the physical therapist will decide on the appropriate physical therapy modalities for the specific patients. These techniques will include only manual therapy (soft tissue mobilization and vertebrae segmental mobilization) and interferential electrotherapy. Furthermore, the subject will receive an appropriate exercise program which will performed at home.~Each subject will be randomly referred to one of the research groups."|t|||t
1287667|NCT03756727|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1287668|NCT03756714|||Cohort||Retrospective|||||||
1287669|NCT03756701|Randomized|Crossover Assignment||Treatment||None (Open Label)||"There will be 2 groups of participants. Group 1 will begin the intervention immediately. Group 2 will maintain their usual lifestyle for the first 10 weeks, and begin group sessions when group 1 has completed. There will be refresher sessions for group 1 once per month, and 3, 6 12 month follow up testing after the group sessions."||||
1287670|NCT03756688|Randomized|Factorial Assignment||Treatment||Triple|The provider and outcome assessor will be blinded to the patient's study arm for all length assessments. Additionally, the assessor will be blinded to prior length measurements.|"Patients will be randomized into one of four groups:~Penile Traction Therapy (PTT) for 30 min 2x/day x 3 months, followed by no treatment x 3 months~PTT for 30 min 2x/day x 3 months, followed by once weekly (30 minutes) x 3 months~PTT for 30 min 2x/day x 6 months~Control (no treatment)"||t|t|t
1287671|NCT03756675|||Cohort||Prospective|||||||
1287672|NCT03756662||Single Group Assignment||Diagnostic||None (Open Label)||Prospective, open-label, single arm, multicenter||||
1287673|NCT03756649|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1287674|NCT03756636||Single Group Assignment||Treatment||None (Open Label)||||||
1287675|NCT03756623|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1287676|NCT03756610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287677|NCT03756597|||Case-Control||Prospective|||||||
1287678|NCT03756584|Randomized|Crossover Assignment||Basic Science||Double||single-blind parallel-group crossover design|t|||t
1287679|NCT03756571|Randomized|Crossover Assignment||Treatment||Single|Primary outcomes are GVS, GDI, gait speed from three dimensional gait analysis and community walking activity are all collected via technology (three dimensional gait lab, accelerometry, thus masked.|Study Design and Randomization. A randomized waitlist trial will be used to compare the AFO-FC to TSAFO in ambulatory children with CP.||||t
1287680|NCT03756558||Single Group Assignment||Treatment||None (Open Label)||Performance goal||||
1287681|NCT03756545|||Cohort||Prospective|||||||
1287682|NCT03756519|Randomized|Parallel Assignment||Treatment||Single||"The patient will be partially blinded by our not providing full details on the two interventions being studied. Participants will be instructed that, Participants in this study will be randomized (chosen as by a coin flip) to receive one of two different types of advice and instruction on maintaining mobility and performing exercise."|t|||
1287683|NCT03756506|Randomized|Parallel Assignment||Prevention||Single||The study will enroll 12 total research participants (6 control research participants and 6 DuraDerm® research participants) with approximately 120 pin sites (approximately 60 in the Control group and 60 in the DuraDerm® group). Each research participant undergoing Deformity Correction and/or Traumatic Provisional Surgery will be asked to participate in the study to evaluate if the topical application of DuraDerm® as an additional step in the management of post-operative pin track site care reduces the incidence of pin track infections. Investigational Review Board (IRB) approval will be obtained and informed research participant consent will be obtained from each research participant.||t||
1287684|NCT03756493|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1287685|NCT03756480|||Case-Control||Prospective|||||||
1287686|NCT03756467|Randomized|Parallel Assignment||Health Services Research||Single|The impact evaluation is a cluster-randomized controlled trial with three study arms: control (no program), GE, and GE+. GE refers to the Girl Empower program alone, while GE+ adds small cash transfers to the families of eligible girls as an incentive to increase take-up of GE attendance in weekly sessions. The study team will conduct a baseline survey of all girls age 13-14 and their caregiver in 100 communities in Nimba County, Liberia. Communities will then be randomized, blocking on number of girl in the community and % of girls enrolled in school, to one of the 3 study arms. Two years following the baseline survey (1 year following program completion), the study team will conduct an endline survey in all 100 communities with the same girls and caregivers and compare outcomes in the three study arms.|The impact evaluation study is a cluster-randomized controlled trial among 100 communities with three study arms: control (no intervention), GE, and GE+.|t|||
1287724|NCT03755973|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||All consenting subjects will first undergo an endometrial biopsy seven days after the luteinizing hormone (LH) peak in an unmedicated natural cycle. This biopsy will serve as the baseline endometrial biopsy (natural cycle biopsy) for the gene expression signature analysis. Following this baseline biopsy, the subjects will be randomly allocated to a specific type of ovarian stimulation regimen in order to later perform some second endometrial biopsy, five days after oocyte retrieval (stimulated cycle biopsy).||||
1287725|NCT03755960|Randomized|Parallel Assignment||Treatment||None (Open Label)|The statistician will be blinded to the study intervention.|multicenter, open label, randomized||||
1287726|NCT03755947||Single Group Assignment||Treatment||None (Open Label)||This is a multicenter, longitudinal, experimental, open, non-randomized and non-comparable study||||
1287727|NCT03755934|Randomized|Parallel Assignment||Treatment||Triple|Double blind||t||t|t
1287823|NCT03754686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287824|NCT03754673|||Case-Only||Cross-Sectional|||||||
1287825|NCT03754660|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1287687|NCT03756454|Randomized|Parallel Assignment||Treatment||Triple|Upon conclusion of the surgical intervention, the Anesthesia or nursing team will administer the trial medication, Bezlotoxumab, or the placebo, normal saline. Dosing is planned to be ten milligrams per kilogram, which is standard dosing for therapeutic Bezlotoxumab approved for use by the U.S. Food and Drug Administration. This dose will be administered as a one-time single-infusion dose administered over the span of one hour. The placebo administration of normal saline will be at the same dosing with a single-infusion over one hour. The patient will receive standard of care post-operative management and the information obtained from standard-of-care lab draws will be assessed throughout their hospital stay. The patient will be seen and evaluated in clinic in the post-operative period at the one month follow-up and either in clinic or via telephone at their three month and six month follow-up.|Randomization will be performed per best common practice guidelines with a computer generated randomization process and hospital investigational pharmacy blinding processes into both a therapeutic arm (Bezlotoxumab) and a placebo (normal saline) arm of the study. All current standards of care will continue to be administered in these patients, regardless of their respective study arm. To control for the antibiotics administered, the patients will need to be stratified according to the standard-of-care antibiotics and balanced in regards to this variable. Current standard of care therapy at our institution for fulminant C. difficile colitis includes Vancomycin (both oral and rectal, if needed) and intravenous Metronidazole. Fulminant C. difficile colitis is defined, per our guidelines, as proven infection with hypotension/ shock, ileus, or megacolon.|t|t|t|
1287688|NCT03756441|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287689|NCT03756428|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287690|NCT03756415|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1287691|NCT03756402|||Cohort||Prospective|||||||
1287692|NCT03756389|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|In Part A, all subjects will receive study drug and this is Open Label. When Part A is complete, Part B will start and this will be double blind to participant and investigators.|||||
1287693|NCT03756376|||Cohort||Prospective|||||||
1287694|NCT03756363|Randomized|Parallel Assignment||Treatment||Double|double-blind||t|||t
1287695|NCT03756350||Single Group Assignment||Treatment||None (Open Label)|Blinded reviewer will evaluate the pre and post photos|||||
1287696|NCT03756337|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1287697|NCT03756324|Randomized|Parallel Assignment||Treatment||Single|Due to the different numbers of interventions, the investigators can not blind the participants and the doctors. Thus, the CRF recorders, outcomes assessors and the statisticians will be blinded in the study.|Based on previous studies, considering the 20% expulsion rate, the investigators plan to recruit 306 participants with sample-size calculation formula. The sequence of randomization (1:1:1) will be generated by the statisticians with a computer program.||||t
1287698|NCT03756311||||||||||||
1287699|NCT03756298|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1287700|NCT03756285|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1287701|NCT03756272|Randomized|Parallel Assignment||Treatment||Double|In this study patient and outcome assessor are blinded|Randomized controlled trial|t|||t
1287702|NCT03756259||Single Group Assignment||Prevention||None (Open Label)||||||
1287703|NCT03756246|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Both healthy and depressed arms will receive the influenza vaccine.||||
1287704|NCT03756233|Randomized|Crossover Assignment||Supportive Care||Single||In this study, remifentanil gradually withdrawal goup (test group) and remifentanil immediately stop group (control group) were divided into two groups. In the Remifentanil gradual reduction group (test group), 20 minutes before the end of the operation, remifentanil was gradually decreased by 25% every 5 minutes. The control group stopped remifentanil 10 minutes before the end of the operation.|t|||
1287705|NCT03756220|Randomized|Parallel Assignment||Treatment||Quadruple||Multi-center, Double-blinded, Randomized, Controlled Study|t|t|t|t
1287706|NCT03756207||Single Group Assignment||Treatment||None (Open Label)||In this study, the investigators plan to prospectively recruit 80 muscle-invasive bladder cancer patients, who don't want to receive radical cystectomy or are not candidates for radical cystectomy, treated with multidisciplinary bladder-preservation therapy from Nov 2018 to Dec 2020 in Peking University Third Hospital.||||
1287707|NCT03756194|Non-Randomized|Parallel Assignment||Other||Single|The researchers and technical staff supporting the experiments are unable to be blinded. Therefore, a single blind masking strategy will be used meaning that the participants and their carers (apart from the control arm 2) will be left unaware of what group they have been allocated to and what type of the CARESSES robot they will be interacting with.||t|||
1287708|NCT03756181|Randomized|Parallel Assignment||Prevention||Double||Pilot randomized controlled trial.|t|||t
1287709|NCT03756168||Single Group Assignment||Treatment||None (Open Label)||||||
1287710|NCT03756155|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized into two different groups (Group 1 and Group 2) in 10 participant blocks, meaning after every 10 participants eligible and completing the study, there will be 5 participants assigned to each group.||||
1287711|NCT03756142|||Case-Control||Prospective|||||||
1287712|NCT03756129|Randomized|Parallel Assignment||Treatment||Double||This is a non-confirmatory, multi-center, 6-treatment arm in the EU countries and 5-treatment arm in the USA (no ketamine arm), randomized, subject and investigator blinded, parallel group, placebo controlled study in treatment-resistant depression patients. The study allows for the inclusion of subjects seeking treatment for their disease from both an 'inpatient' or 'outpatient' clinic setting.|t||t|
1287713|NCT03756116|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1287714|NCT03756103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287715|NCT03756090|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1287716|NCT03756077|||Cohort||Prospective|||||||
1287717|NCT03756064|Randomized|Parallel Assignment||Treatment||Triple||"Experimental: Pyrotinib (400mg orally daily)+Trastuzumab (8mg/kg iv load followed by 6mg/kg iv 3-weekly)+Docetaxel (75mg/m2)+ Carboplatin(AUC=5), for a total of 6 cycles.~Placebo Comparator: Placebo Oral Tablet (400mg orally daily)+Trastuzumab (8mg/kg iv load followed by 6mg/kg iv 3-weekly)+Docetaxel (75mg/m2)+ Carboplatin(AUC=5), for a total of 6 cycles."|t|t|t|
1287718|NCT03756051|||Cohort||Prospective|||||||
1287728|NCT03755921|Randomized|Parallel Assignment||Other||Double||The control group will receive speech therapy with weekly frequency, and the intervention group will participate in a brief and intensive therapy program that will take place during five days a week for three weeks, totaling fifteen sessions. The sessions will be of 40 minutes and, in both groups, the patients will receive care of individualized form, according to their needs|t||t|
1287729|NCT03755908|||Cohort||Prospective|||||||
1287730|NCT03755895|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287731|NCT03755882|Randomized|Crossover Assignment||Treatment||Single|||t|||
1287732|NCT03755869||Single Group Assignment||Treatment||None (Open Label)||||||
1287733|NCT03755856|||Cohort||Cross-Sectional|||||||
1287734|NCT03755843|||Cohort||Prospective|||||||
1287735|NCT03755830|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1287736|NCT03755817|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287737|NCT03755804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1287738|NCT03755791|Randomized|Parallel Assignment||Treatment||None (Open Label)||Approximately 640 eligible subjects with advanced HCC will be randomized in a 6:3:1 ratio. Experimental arm (approximately 384 subjects) will receive cabozantinib plus atezolizumab. Control arm (approximately 192 subjects) will receive sorafenib. Exploratory arm (approximately 64 subjects) will receive single-agent cabozantinib||||
1287739|NCT03755778|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||3-Part Single Group study||||
1287740|NCT03755765|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1287741|NCT03755752|Randomized|Crossover Assignment||Treatment||Single|Randomization was done using an envelope technique wherein, after each patient was placed on the operating bed, the surgeon opened the patient's corresponding envelope, which contained information about whether Trypan Blue should be used for anterior capsular staining or not.||||t|
1287742|NCT03755739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287743|NCT03755726|||Cohort||Prospective|||||||
1287744|NCT03755713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287745|NCT03755700|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1287746|NCT03755687||Single Group Assignment||Treatment||None (Open Label)||A prospective observational pilot study||||
1287747|NCT03755674|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1287748|NCT03755661|Randomized|Parallel Assignment||Prevention||Single|The outcomes assessor is not provided with randomization information for the subjects|Participants are randomly assigned to one of two groups||||t
1287749|NCT03755648|Randomized|Parallel Assignment||Treatment||Single||||||t
1287750|NCT03755635|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Controlled before and after interventional trial||||
1287751|NCT03755622|Randomized|Parallel Assignment||Basic Science||Single|Patients who received the Transpalatal Arch (TPA) are not aware whether the appliance is fabricated conventionally or made from 3D reconstructed study model.|"Group C : Patients who receive Transpalatal Arch (TPA) that is conventionally constructed on stone models.~Group 3D : Patients who receive Transpalatal Arch (TPA) fabricated from three dimensionally (3D) reconstructed study model."|t|||
1287752|NCT03755609|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287753|NCT03755596||Single Group Assignment||Treatment||None (Open Label)||Open-label, single-group, self-paired study||||
1287754|NCT03755583||Single Group Assignment||Treatment||None (Open Label)||||||
1287755|NCT03755570|||Cohort||Prospective|||||||
1287756|NCT03755557|Randomized|Crossover Assignment||Treatment||Quadruple|The visual aspects of the three treatment arms are identical. Identification of the treatment is achieved via a randomization code.|3-way crossover, randomized, prospective, placebo-controlled, double blinded study in a validated allergen exposure chamber setting using grass pollen allergen|t|t|t|t
1287757|NCT03755544|||Cohort||Prospective|||||||
1287758|NCT03755531|Randomized|Parallel Assignment||Prevention||Quadruple|The anesthetist was the person in charge for giving the allocated drug after labor of the baby at once. Otherwise the operating obstetricians, the care givers, investigators and the ouctcomes assessor were all blinded to the type of the injection.|Parallel Assignment|t|t|t|t
1287759|NCT03755518||Single Group Assignment||Treatment||None (Open Label)||||||
1287760|NCT03755505|||Other||Cross-Sectional|||||||
1287761|NCT03755492|Randomized|Parallel Assignment||Treatment||Double|"Patients will be randomized into either Group 1 or Group 2 depending on whether they will receive Tadalafil 4mg or Placebo to be taken every other day for 6 months after surgery. The Group receiving Tadalafil 4mg (only known by care provider) will also receive absorbent pads for urinary incontinence."|Randomized, Double-blinded, Placebo controlled trial|t||t|
1287762|NCT03755479|||Cohort||Prospective|||||||
1287763|NCT03755466|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1287764|NCT03755453|Non-Randomized|Single Group Assignment||Treatment||Single||All participants will receive a hearing aid fitted with fitting method A and afterwards fitted with fitting method B.|t|||
1287765|NCT03755440||Single Group Assignment||Treatment||None (Open Label)||PD-1 antibody, SHR-1210||||
1287766|NCT03755427|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1287767|NCT03755414||Single Group Assignment||Treatment||None (Open Label)||||||
1287768|NCT03755401|Randomized|Parallel Assignment||Treatment||Single|All assessments will be performed by blinded clinical assessors; randomization accomplished by computer algorhythm|Randomized controlled trial of psychosocial interventions||||t
1287769|NCT03755388||Single Group Assignment||Treatment||None (Open Label)||||||
1287814|NCT03754803|||Cohort||Prospective|||||||
1287815|NCT03754790||Single Group Assignment||Treatment||None (Open Label)||||||
1287816|NCT03754777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287817|NCT03754764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1287818|NCT03754751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287819|NCT03754738|Randomized|Parallel Assignment||Treatment||Double||||t||t
1287820|NCT03754725|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289037|NCT03738891||Single Group Assignment||Other||None (Open Label)||||||
1287770|NCT03755375|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter randomized control trial. All patients will be randomized by the computer (www.random.org) in 4 groups, 2 groups of treatment and 2 control groups. Then, they will be assessed by specialized physiotherapists through a medical history data; application of validated questionnaires of pain, urinary symptoms, sexual function and quality of life; postural evaluation; pelvic floor muscles physical and surface electromyographic assessment at baseline. Patients will be randomized to two different treatment groups and control group. One treatment will be consisted by 10 sessions, once a week, using Biofeedback , myofascial trigger points release and transcutaneous electrostimulation. The other group will be treated by 10 sessions, once a week, using Biofeedback , myofascial trigger points release and postural exercises.The control groups will start treatment 3 months after the assessment. All patients will be re - evaluated after treatment, at 3, 6 and 12 months' post treatment.||||
1287771|NCT03755362|Randomized|Parallel Assignment||Prevention||None (Open Label)||This study will randomize 60 subjects ≥65 years old with asymptomatic carotid artery stenosis (ACAS), mild to moderate cognitive impairment and periodontitis. These 60 patients will be randomized to two groups (intensive vs. standardized periodontal treatment). As randomization will be computer generated, the likelihood of randomization to either group is 50:50.||||
1287772|NCT03755349|Randomized|Parallel Assignment||Treatment||Single|"Patients will be blinded for allocation to the study group/side, but surgeons will not be. Patients will not be aware of the study group/side, since the operation takes place under general anesthesia. After surgery, it is not possible to see through the skin, whether or not a burr hole cover has been placed.~The fact that patients are blinded for the study group allocation will be mentioned in the discharge letter (in order to inform the family physician), and the neurosurgical team of nurses and physicians will also be informed not to unblind the patient.~Unblinding (and revealing a participant's allocated intervention) towards the patient is permissible only if the trial is suspended, prematurely terminated due to security concerns or completed."|"As the evacuation of a cSDH encompasses trepanation of the skull with 2 burr-holes per side (each one in the frontal and parietal skull region), we will perform the study as follows:~In patients with unilateral cSDH, we will cover either both (intervention group) or none of the burr holes with a burr hole cover (control group).~In patients with bilateral cSDH, we will cover one side with burr hole covers (intervention side), while on the other side no burr hole covers are applied (control side)."|t|||
1287773|NCT03755336|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1287774|NCT03755323|||Cohort||Prospective|||||||
1287775|NCT03755310|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1287776|NCT03755297|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1287777|NCT03755284|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized and controlled experimental study||||
1287778|NCT03755271|||Case-Only||Prospective|||||||
1287779|NCT03755258|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind|Multiple Ascending Dose, Multiple Groups, Multiple Centers|t|t|t|t
1287780|NCT03755245||Single Group Assignment||Other||None (Open Label)||Whole-body distribution, plasma pharmacokinetics, radiation dosimetry, safety, tolerability and performance of [68Ga]Ga-DOTA-Siglec-9||||
1287781|NCT03755232|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1287782|NCT03755219|||Cohort||Prospective|||||||
1287783|NCT03755206||Single Group Assignment||Health Services Research||None (Open Label)||||||
1287784|NCT03755193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287785|NCT03755180|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287786|NCT03755167||Single Group Assignment||Treatment||None (Open Label)||||||
1287787|NCT03755154||Single Group Assignment||Treatment||None (Open Label)||||||
1287788|NCT03755141||Single Group Assignment||Treatment||None (Open Label)||||||
1287789|NCT03755128|||Cohort||Prospective|||||||
1287790|NCT03755115||Single Group Assignment||Treatment||None (Open Label)||||||
1287791|NCT03755102|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287792|NCT03755089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287793|NCT03755076||Single Group Assignment||Basic Science||None (Open Label)||Participants will perform bilateral arm movements in a virtual reality environment under different perceptual conditions to identify a condition that improves coordination between arms.||||
1287794|NCT03755063|Randomized|Parallel Assignment||Treatment||Single||||||t
1287795|NCT03755050|||Case-Only||Retrospective|||||||
1287796|NCT03755037|Randomized|Parallel Assignment||Treatment||Double|Double blind randomisation|Women with unexplained infertility (n=150) were divided into 3 equal groups. Group 1 received estradiol and clomiphine citrate (cc), group 2 received sildenafil and cc and group 3 cc and placebo.|t||t|
1287797|NCT03755024|||Cohort||Prospective|||||||
1287798|NCT03755011|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1287799|NCT03754998|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||Quasi experimental||||
1287800|NCT03754985|||Cohort||Prospective|||||||
1287801|NCT03754972||Single Group Assignment||Diagnostic||None (Open Label)||Determine whether an objective metric for spinal stability will change the surgical treatment plan in a significant proportion of patients with lumbar spinal stenosis||||
1287802|NCT03754959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287803|NCT03754946|||Cohort||Prospective|||||||
1287804|NCT03754933||Single Group Assignment||Treatment||None (Open Label)||||||
1287805|NCT03754920||Single Group Assignment||Basic Science||None (Open Label)||||||
1287806|NCT03754907|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287807|NCT03754894|Randomized|Parallel Assignment||Treatment||Single||||||t
1287808|NCT03754881|||Cohort||Prospective|||||||
1287809|NCT03754868|||Cohort||Prospective|||||||
1287810|NCT03754855|||Case-Only||Cross-Sectional|||||||
1287811|NCT03754842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287812|NCT03754829|Randomized|Parallel Assignment||Treatment||Single||A three-armed randomized controlled trial with 2 experimental groups and 1 control group.|||t|
1287813|NCT03754816||Single Group Assignment||Prevention||None (Open Label)||||||
1525792|NCT00642057||||||||||||
1287826|NCT03754647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287827|NCT03754634||Single Group Assignment||Treatment||None (Open Label)||||||
1287828|NCT03754621|||Case-Control||Prospective|||||||
1287829|NCT03754608|||Case-Control||Prospective|||||||
1287830|NCT03754595|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two parallel groups: 2DLaparoscopic pancreatoduodenectomy and 3DLaparoscopic pancreatoduodenectomy||||
1287831|NCT03754582||Single Group Assignment||Treatment||None (Open Label)||||||
1287832|NCT03754569||Single Group Assignment||Basic Science||None (Open Label)||||||
1287833|NCT03754556|||Cohort||Retrospective|||||||
1287834|NCT03754543|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1287835|NCT03754530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287836|NCT03754517|||Case-Control||Prospective|||||||
1287837|NCT03754504|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1287838|NCT03754491|Randomized|Parallel Assignment||Treatment||None (Open Label)||Investigators will enroll 204 naïve papilla with a body temperature ≥37 °C who was diagnosed with mild to moderate cholangitis associated with choledocholithiasis. investigators will randomized to divide the patients into two groups: one-stage procedure (group A): 102 cases, and two-stage procedure (group B): 102 cases.||||
1287839|NCT03754478|||Case-Only||Prospective|||||||
1287840|NCT03754465|Randomized|Parallel Assignment||Treatment||Double|Double-Blind||t||t|
1287841|NCT03754452|||Cohort||Prospective|||||||
1287842|NCT03754439|||Cohort||Prospective|||||||
1287843|NCT03754426|||Cohort||Prospective|||||||
1287844|NCT03754413|Randomized|Parallel Assignment||Treatment||Single||||||t
1287845|NCT03754400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287846|NCT03754387|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287847|NCT03754374|||Cohort||Prospective|||||||
1287848|NCT03754361|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||the mode of urgent dialysis will choose by patient guided by nephrologist, the HD group will receive the standard traditional treatment: from induction HD to regular HD. The PD group will receive the APD daily.||||
1287849|NCT03754348|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1287850|NCT03754335|Randomized|Parallel Assignment||Supportive Care||Double|"This procedure is to be able to easily randomize half of the patients into a sham PL arm passed by independent practitioners of the investigators in charge of the patient, which allows a good double-blind study."|Randomized, double blind, prospective monocentric trial evaluating in parallel groups|t||t|
1287851|NCT03754322|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1287852|NCT03754309|Randomized|Parallel Assignment||Treatment||Triple||Primary analysis up to day 113. Long term follow up to day 365 (dependent on response).|t||t|t
1287853|NCT03754296|||Cohort||Prospective|||||||
1287854|NCT03754283|Randomized|Parallel Assignment||Treatment||Single||1:1||||t
1287855|NCT03754270|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is a randomized, open, parallel-group intervention study. The two treatment groups are:~A.Patients with moderate OSA are treated with lifestyle advice (n = 50) B. Patients with moderate OSA are treated with CC and lifestyle advice (n = 50).~Life style advice is quite subjective and it means that the patients are encouraged to stop smoking, to avoid alcohol, to lose weight, to be more physically active and to avoid sleeping on supine position."||||
1287856|NCT03754257|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1287857|NCT03754244||Single Group Assignment||Treatment||None (Open Label)||||||
1287858|NCT03754231||Single Group Assignment||Supportive Care||None (Open Label)||All patients recruited will be wearing the Aingeal device at a paediatric outpatient clinic setting.||||
1287859|NCT03754218|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287860|NCT03754205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287861|NCT03754192||Single Group Assignment||Diagnostic||None (Open Label)||Dual-energy computed tomography and perfusion computed tomography||||
1287862|NCT03754179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287863|NCT03754166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287864|NCT03754153|Randomized|Parallel Assignment||Treatment||Single|At each site, a masked orthoptist will carry out the study assessments.|Two-group parallel randomized controlled trial||||t
1287865|NCT03754140||Single Group Assignment||Treatment||None (Open Label)||Open label, single arm pilot study||||
1287866|NCT03754127|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1287867|NCT03754114|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessors will be blinded to the treatment assignment of the participant.|||||t
1287868|NCT03754101|||Cohort||Prospective|||||||
1287869|NCT03754088|||Cohort||Prospective|||||||
1287870|NCT03754075|||Cohort||Prospective|||||||
1287871|NCT03754062|Randomized|Crossover Assignment||Basic Science||Double|Double blind|Placebo x Haloperidol x LDOPA|t||t|
1287872|NCT03754049|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287873|NCT03754036|Randomized|Crossover Assignment||Prevention||None (Open Label)||Sleep restriction (-1.5 hours of sleep per day for 1 week) and Sleep extension (+1.5 hours of sleep per day for 1 week)||||
1287874|NCT03754023|||Cohort||Prospective|||||||
1287875|NCT03754010|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1287876|NCT03753997|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1287877|NCT03753984|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1287878|NCT03753971||Single Group Assignment||Treatment||None (Open Label)||||||
1287879|NCT03753958|Randomized|Parallel Assignment||Treatment||Single|For the evaluation of clinical parameters, a single trained, calibrated examiner will examine 6 sites of each implant with a 15mm North Carolina millimeter probe for measurements of plaque index, probing bleeding, probing depth, gingival recession and loss of clinical insertion. The evaluation will be performed at the beginning of treatment, 30 and 60 days after the first application of aPDT. The evaluator will not know to which group the patient belongs.|||||t
1289084|NCT03738280|||Cohort||Prospective|||||||
1287880|NCT03753945|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1287881|NCT03753932||Single Group Assignment||Treatment||None (Open Label)||Single group for the control vs. intervention group. Crossover model within the intervention group.||||
1287882|NCT03753919||Single Group Assignment||Treatment||None (Open Label)||"Cohort 1: Advanced, radioiodine-refractory differentiated thyroid carcinoma, including papillary, follicular, Hürtle. Cell and poorly-differentiated thyroid carcinoma (DTC).~Cohort 2: Advanced medullary thyroid carcinoma (MTC).~Cohort 3: Advanced anaplastic thyroid cancer (ATC)."||||
1287883|NCT03753906||Single Group Assignment||Treatment||None (Open Label)||All the patients were implanted with self-inflating hydrogel expander in subperiosteal positions using the pouch technique in the mandibular anterior region.||||
1287884|NCT03753893|||Ecologic or Community||Retrospective|||||||
1287885|NCT03753880||Single Group Assignment||Prevention||None (Open Label)||||||
1287886|NCT03753867||Single Group Assignment||Treatment||None (Open Label)||||||
1287887|NCT03753854|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1287888|NCT03753841|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287889|NCT03753828|||Cohort||Retrospective|||||||
1287890|NCT03753815|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1287891|NCT03753802|Randomized|Parallel Assignment||Treatment||Quadruple|The randomization will be performed by the study website and will be only known by the physiotherapist. The parents are not allowed to be in the room of physiotherapy during the physiotherapy session. They don't know which treatment is allocated to their child. The evaluator physician doesn't know which treatment is allocated to the child. The biostatistician doesn't know which treatment is allocated to which group during the analyses.|The treated group will receive respiratory physiotherapy treatment using slow extended and passive expiratory maneuvers. The control group will not receive physiotherapy treatment.|t|t|t|t
1287892|NCT03753789||Single Group Assignment||Treatment||None (Open Label)||||||
1287893|NCT03753776|Randomized|Parallel Assignment||Treatment||Quadruple|Neither patients receiving pills nor doctors evaluating radiodermatitis know the nature of treatment (placebo or homeopathy)|A first randomization will establish two groups : placebo versus homeopathy (Radium bromatum), and if patients develop a radiodermatitis of grade 2 or higher, a second randomization will take place, with two groups : placebo versus homeopathy (Radium bromatum, Apis mellifica, and Belladonna)|t|t|t|t
1287894|NCT03753763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287895|NCT03753750|Randomized|Parallel Assignment||Treatment||Double||Blinded sham-controlled trial|t||t|
1287896|NCT03753737|||Other||Cross-Sectional|||||||
1287897|NCT03753724|||Other||Prospective|||||||
1287898|NCT03753711||Single Group Assignment||Basic Science||None (Open Label)||||||
1287899|NCT03753698||Single Group Assignment||Treatment||None (Open Label)||||||
1287900|NCT03753685||Single Group Assignment||Treatment||None (Open Label)||||||
1287901|NCT03753672|||Cohort||Prospective|||||||
1287902|NCT03753659||Single Group Assignment||Treatment||None (Open Label)||Immunotherapy with pembrolizumab in combination with local ablation||||
1287903|NCT03753646|Randomized|Parallel Assignment||Other||Single|The Assessor who will measure children's cognitive development and behavor and other measurements will be masked|We will integrate ECD services to Bangladesh government lactating allowance to measure children's neurocognitive behavior in urban area of Bangladesh.||||t
1287904|NCT03753633|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1287905|NCT03753620||Single Group Assignment||Other||None (Open Label)||||||
1287906|NCT03753607|||Case-Control||Prospective|||||||
1287907|NCT03753594|||Cohort||Prospective|||||||
1287908|NCT03753581|Randomized|Parallel Assignment||Treatment||Triple|"Masking of the researchers: the assignment of participants to the groups will be carried out by a researcher who will not apply the interventions and will not collect the outcome variables. The interventions will be carried out by researchers different from those who will perform the evaluations of the outcome variables.~Masking of the participants: it will be done using the same electrodes and microcurrent devices in both groups. In the placebo stimulation, the device will emit a luminous signal of operation as well as the devices of the intervention group, however, it will be manipulated and tested with an oscilloscope to ensure that it does not emit microcurrents. The participants of both groups will not perceive any sensation of current, since the electrical stimulation with microcurrents is below the sensitive threshold."||t|t||t
1287909|NCT03753568||Single Group Assignment||Treatment||None (Open Label)||Subjects are monitored first before the intervention and then during the intervention.||||
1287910|NCT03753555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287911|NCT03753542|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The sample size calculated was 30 samples per group. After adjusting error in non-response of data collection 50 samples will be drown from each group. Total 100 caregivers along with their children will be selected.||||
1287912|NCT03753529|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287913|NCT03753516|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1287914|NCT03753503|Randomized|Parallel Assignment||Treatment||Single||||||t
1287915|NCT03753490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287916|NCT03753477|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1287917|NCT03753464|||Case-Control||Prospective|||||||
1287918|NCT03753451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287919|NCT03753438|||Cohort||Prospective|||||||
1287920|NCT03753425|||Cohort||Prospective|||||||
1287921|NCT03753412|||Cohort||Prospective|||||||
1287922|NCT03753399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287923|NCT03753386||Single Group Assignment||Basic Science||None (Open Label)||||||
1287924|NCT03753373|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1287925|NCT03753360|Randomized|Parallel Assignment||Other||None (Open Label)||Prospective Parallel non-blinded randomized two arms, intervention group and active control group||||
1287926|NCT03753347||Single Group Assignment||Other||None (Open Label)||||||
1287927|NCT03753334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1287928|NCT03753321|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1287929|NCT03753308|||Cohort||Prospective|||||||
1287930|NCT03753295|||Case-Control||Retrospective|||||||
1287931|NCT03753282|||Cohort||Retrospective|||||||
1287932|NCT03753269|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1287933|NCT03753256|Randomized|Parallel Assignment||Screening||Double|||t||t|
1287934|NCT03753243||Single Group Assignment||Treatment||None (Open Label)||single arm, single-stage open label Phase II of neoadjuvant immune-hormonal therapy in high-risk Localized prostate cancer.||||
1287935|NCT03753230|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1287936|NCT03753217||Single Group Assignment||Other||None (Open Label)||||||
1287937|NCT03753204||Single Group Assignment||Basic Science||None (Open Label)||Participants will be given a high salt diet and 2 liters of saline (salt loading), followed by low salt diet and furosemide or lasix (salt depletion).||||
1287938|NCT03753191|Randomized|Parallel Assignment||Treatment||Quadruple|double-blinded, with randomized case-control|double-blinded, randomized case-control interventional study|t|t|t|t
1287939|NCT03753178|||Case-Control||Other|||||||
1287940|NCT03753165|Randomized|Parallel Assignment||Treatment||Single||It is a single blinded randomised clinical trial|t|||
1287941|NCT03753152|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1287942|NCT03753139|||Case-Control||Prospective|||||||
1287943|NCT03753126||Single Group Assignment||Diagnostic||||||||
1287944|NCT03753113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287945|NCT03753100|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1287946|NCT03753087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287947|NCT03753074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287948|NCT03753061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287949|NCT03753048|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287950|NCT03753035|||Cohort||Prospective|||||||
1287951|NCT03753022|Randomized|Sequential Assignment||Treatment||Triple||The study was planned in 3 groups. Group G5 (control group: no changes will be made to the value of PEEP). Group G10 [after 30 minutes of admission (time 0) the PEEP will be raised to 10 cmH2O (time1) for 30 minutes and then returned to 5 cm H2O (time 2)]. Group G15 [after 30 minutes of admission (time 0) the PEEP will be raised to 15 cmH2O (time 1) for 30 minutes and then returned to 5 cm H2O (time 2)].|t||t|t
1287952|NCT03753009|||Cohort||Retrospective|||||||
1287953|NCT03752996||Single Group Assignment||Treatment||None (Open Label)||||||
1287954|NCT03752983|||Case-Control||Retrospective|||||||
1287955|NCT03752970|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1287956|NCT03752957|||Cohort||Prospective|||||||
1287957|NCT03752944|Randomized|Parallel Assignment||Treatment||Single|Cards will have sequential numbers one number for each card then these cards will be placed within opaque sealed envelopes. Then these envelops will be placed in a container (box), each participant will grasp one envelope the day of procedure.|Randomized|t|||
1287958|NCT03752931|Randomized|Single Group Assignment||Prevention||Single||||||t
1287959|NCT03752918|Randomized|Crossover Assignment||Treatment||Quadruple||This study will be a double-blind, placebo-controlled, within-subjects, crossover-dose neuroimaging study in which participants will initially receive either a single dose of MDMA 1.5mg/kg or a placebo (niacin 250mg), with a crossover dose to follow. Doses will be separated by 2 weeks.|t|t|t|t
1287960|NCT03752905|Randomized|Crossover Assignment||Treatment||Quadruple|Single-blind|Randomized, Saline-Controlled, Single-Blind, Multiple Ascending Dose, Dose-Escalation, Multi-Center|t|t|t|t
1287961|NCT03752892|Randomized|Parallel Assignment||Treatment||Single|assessor of the primary outcomes will be blind to the participant's group allocation|prospective, randomized controlled trial||||t
1287962|NCT03752879|||Case-Control||Prospective|||||||
1287963|NCT03752866||Single Group Assignment||Treatment||None (Open Label)||This registry will include market released Portico™ valves (23mm, 25mm, 27mm and 29mm), delivery systems and loading systems. The registry will also allow future iterations of the Portico valve and delivery system along with expanded indications to be included as they receive approval for commercial use in the country where the subject is enrolled.||||
1287964|NCT03752853|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287965|NCT03752840|Randomized|Parallel Assignment||Screening||Single||||||t
1287966|NCT03752827|Randomized|Parallel Assignment||Treatment||Triple|It is a double-blinded trial in which the subject, post-procedural investigator and imaging core laboratory radiologists are blinded.||t||t|t
1287967|NCT03752814||Single Group Assignment||Treatment||None (Open Label)||||||
1287968|NCT03752801|||Cohort||Prospective|||||||
1287969|NCT03752788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287970|NCT03752775|Randomized|Parallel Assignment||Treatment||Single||The device assisted treatment will be administrated to patients with subacute stroke and chronic stroke. The subacute stroke group will be compared in parallel with a control group receive the conventional physical and occupational therapies.||||t
1287971|NCT03752762|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1287972|NCT03752749|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1287973|NCT03752736|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1287974|NCT03752723||Sequential Assignment||Treatment||None (Open Label)||||||
1287975|NCT03752710|||Case-Control||Retrospective|||||||
1287976|NCT03752697|||Cohort||Prospective|||||||
1287977|NCT03752684|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||Evaluate urinary oxalate excretion before and after colonization with the oxalate degrading bacterium Oxalobacter formigenes||||
1287978|NCT03752671|Randomized|Parallel Assignment||Treatment||Single|The patient will be blinded to the randomisation arm. As the procedure is conducted under general anaesthesia, the patient will not be informed whether the procedure which was performed on him/her did or did not result in the implantation of the IntraSPINE® device (which is not visible on radiographs)||t|||
1287979|NCT03752658|||Cohort||Prospective|||||||
1526181|NCT00636948|||||Prospective|||||||
1287980|NCT03752645|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1287981|NCT03752632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1287982|NCT03752619|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1287983|NCT03752606|Randomized|Crossover Assignment||Treatment||Single|Allocation was communicated by telephone after informed consent had been obtained and after lymphadenectomy had been completed. Outcome assessment was performed by the independent reviewers. Outcome assessors were blinded to the treatment allocation.|A Tachosil® patch of 4.8x4.8 cm was attached to one side of the obturator fossa (study group) and the same patient constituted also control group, because no Tachosil® patch was used on the second side of lymphadenectomy. Specific drainage of the retroperitoneum was performed. Patients had to agree to participate in the study and signed informed consent at least one day before surgery. Taking into consideration the examined group the patient was allocated to, the surgeon applied either one Tachosil® patches in the study group or no Tachosil® in the control group. After placing for 4 minutes, a uniform pressure was applied to it to provide rapid haemostasis by forming a strong, fibrin clot adjacent to the tissue surface. Tachosil was placed alternately once in the left, once in the right obturator fossa, so that each of the patients participating in the study could be their own control.||||t
1287984|NCT03752593|||Cohort||Prospective|||||||
1287985|NCT03752580||Single Group Assignment||Treatment||None (Open Label)||||||
1287986|NCT03752567|||Cohort||Prospective|||||||
1287987|NCT03752554|||Other||Prospective|||||||
1287988|NCT03752541||Sequential Assignment||Treatment||None (Open Label)||0.5-1*10~6/KgBW, 1-2*10~6/KgBW,2-3*10~6/KgBW||||
1287989|NCT03752528|||Case-Only||Prospective|||||||
1287990|NCT03752515|||Cohort||Retrospective|||||||
1287991|NCT03752502|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1287992|NCT03752489|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1287993|NCT03752476|||Case-Control||Retrospective|||||||
1287994|NCT03752463|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1287995|NCT03752450|||Cohort||Prospective|||||||
1287996|NCT03752437|Randomized|Parallel Assignment||Other||Triple|Randomisation by computer, different sheet for encoding data.|One arm will receive 300 IU of heparin based on real weight, and the other arm will receive 300 IU of heparin based on ideal weight.|t|t|t|
1287997|NCT03752424|Randomized|Parallel Assignment||Treatment||Single|||t|||
1287998|NCT03752411|Randomized|Parallel Assignment||Other||Double|||t|t||
1287999|NCT03752398||Sequential Assignment||Treatment||None (Open Label)||||||
1288000|NCT03752385|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288001|NCT03752372|||Cohort||Prospective|||||||
1288002|NCT03752359|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1288003|NCT03752346|Randomized|Parallel Assignment||Other||Single|||t|||
1288004|NCT03752333||Single Group Assignment||Treatment||None (Open Label)||||||
1288005|NCT03752320|||Cohort||Prospective|||||||
1288006|NCT03752307|Randomized|Parallel Assignment||Treatment||Double|Subjects will be randomized 1:1 according to a computer-generated allocation scheme to receive either Isoxsuprine HCL 1 capsule 3 times daily for 5 days or matching placebo.|This is a proof of concept, randomized, double-blind, placebo-controlled, 2-arm, parallel group study of Isoxsuprine in MS subjects experiencing a typical relapse|t||t|
1288007|NCT03752294|Randomized|Crossover Assignment||Treatment||Quadruple|The first phase of the study is 9-month, double-blind, randomized-control treatment. All participants participants will cross-over to phase II (open label) for an additional 12 months of treatment with a 3-month non-treatment follow-up|Randomized-control, Double-blind, Multicenter, Delayed-start, Pilot|t|t|t|t
1288008|NCT03752281|||Cohort||Prospective|||||||
1288009|NCT03752268|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1288010|NCT03752255|Randomized|Parallel Assignment||Other||Single|||t|||
1288011|NCT03752242|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|In Part A, all subjects will receive study drug and this is Open Label. When Part A is complete, Part B will start and this will be double blind to participant and investigators.|||||
1288012|NCT03752229|Randomized|Parallel Assignment||Other||Single|||t|||
1288013|NCT03752216||Single Group Assignment||Treatment||None (Open Label)|Open|||||
1288014|NCT03752203||Single Group Assignment||Other||None (Open Label)|Since patients are being recruited from the investigators' practices, and there is only one form of treatment, masking will not be utilized.|The primary neurosurgeons who will perform the resections will be investigators on the study and will identify eligible patients from the established practice. At the time surgical intervention is recommended, the doctors will inform patients and parents/guardians of the existence of the study. Only those subjects with a clinical relationship to the study investigators will be recruited.||||
1288015|NCT03752190||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288016|NCT03752177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1288017|NCT03752164||Single Group Assignment||Other||None (Open Label)||||||
1288018|NCT03752151||||||||||||
1288019|NCT03752138|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1288020|NCT03752125|Randomized|Crossover Assignment||Treatment||Double|Flavonoid and placebo capsules|Randomized, crossover|t||t|
1288021|NCT03752112|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a Phase 1/2 trial to evaluate the efficacy and safety of cefixime for use in treating women with acute syphilis.~This is a randomized, non-comparative, open label study assessing the efficacy and safety of cefixime 400mg taken orally two times a day for 10 consecutive days in non-pregnant women with early syphilis infection.To benchmark the performance of benzathine penicillin in the study population being used for cefixime, The investigators will include a contemporary arm of participants that will receive standard of care treatment with benzathine penicillin according to the Brazil national STI treatment guidelines. The investigators will use a ratio of 2 patients receiving cefixime to 1 patient receiving benzathine penicillin."||||
1288022|NCT03752099|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1288023|NCT03752086|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1288024|NCT03752073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288025|NCT03752060|Randomized|Parallel Assignment||Treatment||None (Open Label)||Following enrollment, participants will complete familiarization and be randomly assigned to an aerobic training (AT; n = 20), a resistance training (RT; n = 20), or a control (CON; n = 20) group.||||
1288026|NCT03752047|||Cohort||Retrospective|||||||
1288027|NCT03752034||Single Group Assignment||Treatment||None (Open Label)||||||
1288028|NCT03752021|||Case-Only||Cross-Sectional|||||||
1288029|NCT03752008|Randomized|Parallel Assignment||Other||None (Open Label)||10 childcare centers were cluster-randomized to receive either a physical activity or outdoor free play curriculum.||||
1288030|NCT03751995|Randomized|Parallel Assignment||Supportive Care||Double||pilot pragmatic cluster randomized trial|||t|t
1288031|NCT03751982|Randomized|Single Group Assignment||Basic Science||Quadruple|The phase alignment of the treatment is set in software and not revealed to participant or experimenter. Order of treatment is randomized and counterbalanced.|Within subjects comparison of two effective treatments. Order of treatment is randomized and counterbalanced.|t|t|t|t
1288032|NCT03751969||Single Group Assignment||Treatment||None (Open Label)||||||
1288033|NCT03751956||Single Group Assignment||Treatment||None (Open Label)||||||
1288034|NCT03751943||Single Group Assignment||Treatment||None (Open Label)||||||
1288035|NCT03751930|||Cohort||Prospective|||||||
1288036|NCT03751917|||Cohort||Other|||||||
1288037|NCT03751904||Single Group Assignment||Other||None (Open Label)||||||
1288038|NCT03751891|Randomized|Crossover Assignment||Treatment||Single|Participant masking was only done for laboratory measurements. For home trial testing no masking was done.||t|||
1288039|NCT03751878|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288040|NCT03751865|Randomized|Parallel Assignment||Treatment||Single||||||t
1288041|NCT03751852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288042|NCT03751839||Single Group Assignment||Diagnostic||None (Open Label)||Identical diagnostic procedures will be performed in participants with type 1 diabetes and age- and sex-matched controls.||||
1288043|NCT03751826|Randomized|Parallel Assignment||Prevention||Double||The unit of randomisation will be pairs of peer navigators: 21 pairs of peer navigators will be randomised to 3 arms: two intervention arms, and standard of care (7 pairs per arm).|||t|t
1288044|NCT03751813|Randomized|Parallel Assignment||Treatment||Single||||||t
1288045|NCT03751800|||Cohort||Prospective|||||||
1288046|NCT03751787|Randomized|Parallel Assignment||Treatment||||||||
1288047|NCT03751774|Randomized|Parallel Assignment||Prevention||None (Open Label)||Clusters (maternity wards) are randomized to either intervention or control (standard ANC)||||
1288048|NCT03751761||Single Group Assignment||Treatment||None (Open Label)||||||
1288049|NCT03751748|Randomized|Parallel Assignment||Treatment||Triple||Multicenter, randomized, sham controlled, single blind with objective end points.|t|t||t
1288050|NCT03751735||Single Group Assignment||Treatment||None (Open Label)||||||
1288051|NCT03751722|||Cohort||Prospective|||||||
1288052|NCT03751709||Single Group Assignment||Treatment||None (Open Label)||||||
1288053|NCT03751696|Randomized|Parallel Assignment||Treatment||Single||||||t
1288054|NCT03751683|||Cohort||Prospective|||||||
1288055|NCT03751670|Randomized|Parallel Assignment||Treatment||Single|Masking: Single Blind, Outcomes Assessor|Participants are assigned to one of two groups in parallel for the duration of the study.||||t
1288056|NCT03751657|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.||t|t|t|t
1288057|NCT03751644|Randomized|Parallel Assignment||Other||Single|Patients will be randomized by non-investigator from the present study|Patients with systemic autoimmune myopathies will receive or not the periphericalneuromuscular electrical stimulation in thigh muscles|||t|
1288058|NCT03751631|Randomized|Crossover Assignment||Diagnostic||Double|There will be no differences in the presentation of study drug administered and all study personnel conducting ophthalmic assessments after study drug administration will be masked to treatment assignment.|This trial is a double-masked, active-controlled, cross-over superiority study evaluating the efficacy of the fixed combination study drug vs. the 2 individual components in the fixed combination drug.|t|||t
1288059|NCT03751618|Randomized|Parallel Assignment||Other||Double||Prospective, monocentric, randomized, double blind study|t||t|
1288060|NCT03751605|||Cohort||Prospective|||||||
1288061|NCT03751592||Single Group Assignment||Treatment||None (Open Label)||||||
1288062|NCT03751579|||Cohort||Prospective|||||||
1288063|NCT03751566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288064|NCT03751553|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1288065|NCT03751540|||Case-Control||Retrospective|||||||
1288066|NCT03751527||Single Group Assignment||Treatment||None (Open Label)||||||
1288067|NCT03751514|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Human challenge study||||
1288068|NCT03751501|Randomized|Parallel Assignment||Prevention||Double||"Eligible participants will be randomized into one of the 2 study arms groups: standard of care group with sham laser or experimental group with laser.~Both group with laser or sham laser will be performed in combination with anti VEGF treatment"|t|||t
1288069|NCT03751488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288070|NCT03751475|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1288071|NCT03751462||Single Group Assignment||Treatment||None (Open Label)||||||
1288072|NCT03751449|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1288073|NCT03751436||Single Group Assignment||Treatment||None (Open Label)||||||
1288153|NCT03750396||Single Group Assignment||Treatment||None (Open Label)||"Endocrine therapy is a standard-of-care for 1st line treatment in the patients with ER+/HER2- metastatic breast cancer.~Local treatments for metastatic lesions will be added in this group.~All patients will undergo local treatments in addition to endocrine therapies.~Local treatments include modalities described below:~i) Surgical resection: the achievement of tumor-free margin is not obligatory.~ii) Stereotactic body radiotherapy~iii) Palliative radiotherapy~iv) Radiofrequency ablation"||||
1288293|NCT03748576|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1288074|NCT03751423|Randomized|Parallel Assignment||Supportive Care||Triple|For the three treatment arms, the nurses, the study participants, and the abortion provider will be blinded to study arm assignment and will remain blinded throughout the course of the study. As such, all study personnel who will be administering questionnaires will be appropriately blinded to minimize bias. The provider of the IV medications will not be blinded. This decision was made in order to ensure participant safety in titrating medication doses, and to avoid the need to unblind all members if a reversal agent is required. The provider of the anesthetic will not disclose which study arm the participant belongs to and will not be involved in administering questionnaires or data analysis.|This study will be a randomized, controlled, double-blinded, single-centre superiority trial with three parallel groups.|t|t||t
1288075|NCT03751410|||Cohort||Prospective|||||||
1288076|NCT03751397|||Cohort||Cross-Sectional|||||||
1288077|NCT03751384|Non-Randomized|Parallel Assignment||Supportive Care||Single|pseudo-anonymized|Allocation, not randomized||||t
1288078|NCT03751371||||||||||||
1288079|NCT03751358||Single Group Assignment||Treatment||None (Open Label)||Healthy volunteers accepting to have a Unilateral ESP block with an MRI after injection of Low volume of local anesthetic||||
1288080|NCT03751345|Randomized|Parallel Assignment||Treatment||None (Open Label)||In the Open Trial, all participants will receive PW. In the RCT phase, adolescents will be randomly assigned to one of the two conditions. After completion of the baseline assessment, random assignment of adolescents using blocking and stratification will be automatically generated by the electronic data capture software REDCap. Random block sizes of assignments will be generated to prevent guessing of pending treatment assignments. Stratification will be used to ensure a balance on biological sex and disruptive behavior disorder severity (more of less than T=85), as indicated on the CBCL.||||
1288081|NCT03751332||Single Group Assignment||Treatment||None (Open Label)||||||
1288082|NCT03751319|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized Controlled Trial||||
1288083|NCT03751306|Randomized|Sequential Assignment||Treatment||Triple|||t|t||t
1288084|NCT03751293||Single Group Assignment||Treatment||None (Open Label)||||||
1288085|NCT03751280|Randomized|Parallel Assignment||Treatment||Single||||||t
1288086|NCT03751267|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1288087|NCT03751254||Single Group Assignment||Other||None (Open Label)||||||
1288088|NCT03751241||Single Group Assignment||Screening||None (Open Label)||||||
1288089|NCT03751228||Single Group Assignment||Treatment||None (Open Label)||||||
1288090|NCT03751215||Single Group Assignment||Treatment||None (Open Label)||||||
1288091|NCT03751202|Randomized|Crossover Assignment||Other||Single||One-center crossover, randomized, 2-period, 2-sequence (RT and TR), single dose, laboratory-blinded study||||t
1288092|NCT03751189|||Ecologic or Community||Retrospective|||||||
1288093|NCT03751176|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be assigned in a 3:2 ratio to receive FOLFIRI + panitumumab (Group A) or FOLFIRI alone (Group B). Randomization will be stratified by primary tumour location (left vs right).||||
1288094|NCT03751163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288095|NCT03751150|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288096|NCT03751137|||Case-Control||Cross-Sectional|||||||
1288097|NCT03751124|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized withdrawal following an open-label extension to a randomized controlled parent study|t|t|t|t
1288098|NCT03751111|Randomized|Parallel Assignment||Treatment||Single|The participants will not be informed whether the drug they received is naloxone or desloratadine. The investigators will remove the package of the drugs and use the unified package for both of the drugs. The participants only know that one arm is orally administrated and the other arm is sublingually administrated, but they do not distinguish one from the other.|Participants will be randomly assigned to two arms using a computer-generalized sequence of random numbers.|t|||
1288099|NCT03751098|Randomized|Crossover Assignment||Diagnostic||Double|There will be no differences in the presentation of study treatment administered and all study personnel conducting ophthalmic assessments after study treatment administration will be masked to treatment assignment.|This trial is a double-masked, active-controlled, cross-over superiority study evaluating the efficacy of the fixed combination study drug vs. placebo.|t|||t
1288100|NCT03751085||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288101|NCT03751072|||Case-Only||Retrospective|||||||
1288102|NCT03751059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288103|NCT03751046|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1288104|NCT03751033||Single Group Assignment||Other||None (Open Label)||||||
1288105|NCT03751020|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1288106|NCT03751007|Randomized|Sequential Assignment||Treatment||Quadruple|For the randomized participants in the combination cohorts, blinding will be accomplished by arranging for AG019 and placebo components as well as teplizumab and placebo components to have identical packaging.|"The Phase 1b part of the study will enroll 4 sequential AG019 cohorts of up to 6 Participants, in ascending dose cohorts and descending age cohorts. All participants in these cohorts will be treated with AG019 in an open label fashion.~The Phase 2a part of the study will evaluate 2 cohorts of participants administered AG019 and teplizumab. The first 2 participants will be treated with active treatment in an open label fashion. Participants 3-12 will be randomized (4:1) to receive active treatment or placebo in a double-blind fashion."|t|t|t|t
1288107|NCT03750994|||Case-Only||Prospective|||||||
1288108|NCT03750981||Single Group Assignment||Health Services Research||None (Open Label)||||||
1288109|NCT03750968|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1288110|NCT03750955|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Split-mouth||||
1288111|NCT03750942|Randomized|Parallel Assignment||Prevention||Single||Randomized controlled trial|t|||
1288112|NCT03750929|Randomized|Parallel Assignment||Other||Single|||||t|
1288113|NCT03750916||Single Group Assignment||Treatment||None (Open Label)||Anlotinib and Docetaxel||||
1288114|NCT03750903|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Two group parallel design||||
1288115|NCT03750890|||Case-Only||Prospective|||||||
1534730|NCT00522977|||||Prospective|||||||
1288116|NCT03750877|Randomized|Parallel Assignment||Other||Single|"the number of files from the volunteer participants were grouped into one group and the ones with double file numbers were included in the other group.~participants do not know which group of patients to be in. Only practitioners know about the procedure."|The aim of this study was to evaluate the success rate of median and paramedian approach in spinal anesthesia in geriatric patients, number of trials, number of attempts at another interval due to failure, duration of procedure, patient comfort, change to other method in case of failure and success rate. In the study, two groups were formed: the median approach and the paramedian approach.|t|||
1288117|NCT03750864||Single Group Assignment||Supportive Care||None (Open Label)||||||
1288118|NCT03750851|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288119|NCT03750838|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288120|NCT03750825|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1288121|NCT03750812|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1288122|NCT03750799|Randomized|Parallel Assignment||Basic Science||Double|All of the participants will be told that the vibration stimulation was performed for muscle strengthening. However, participants will have no knowledge about the characteristics of the vibration used for muscle-strength enhancement. Vibration will be applied in the experimental group, whereas sham vibration will be applied in the Control group. The WBV exercise will be performed at different days for the Control and Experimental groups to make them blind to each other's applications.All measurements will be made by an independent assessor (isokinetic test laboratory assistant) blinded to the trial allocation.|Experimental group will be exposed WBV, Control group will be exposed sham WBV|t|||t
1288123|NCT03750786|Randomized|Parallel Assignment||Treatment||Single||||||t
1288124|NCT03750773|Randomized|Parallel Assignment||Treatment||Triple|Randomized 1:1 drug:placebo in blocks of 6 stratified by the hospital, double blind study||t|t|t|
1288125|NCT03750760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288126|NCT03750747|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1288127|NCT03750734|||Cohort||Prospective|||||||
1288128|NCT03750721|||Cohort||Retrospective|||||||
1288129|NCT03750708|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288130|NCT03750695|Randomized|Crossover Assignment||Treatment||None (Open Label)||Single group crossover design of acute effects of resistance exercise, aerobic exercise or rest (control) on maternal vascular function and glucose metabolism||||
1288131|NCT03750682|Randomized|Single Group Assignment||Other||None (Open Label)|No one is blinded during this study.|The ENGAGE for Brain Health is designed as a single blind, randomized-controlled, parallel group pilot study. This study plans to enroll up to 40 participants to be randomized into the PA or HE intervention group.||||
1288132|NCT03750669|Randomized|Parallel Assignment||Treatment||Single||||||t
1288133|NCT03750656|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized open-blind clinical trial||||
1288134|NCT03750643|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1288135|NCT03750630|||Case-Only||Prospective|||||||
1288136|NCT03750617|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1288137|NCT03750604|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1288138|NCT03750591|||Cohort||Prospective|||||||
1288139|NCT03750578|Randomized|Parallel Assignment||Other||None (Open Label)||"Interventions. When venipuncture (either for IV line insertion or diagnostic venipuncture) is prescribed by a physician, a topical anesthetic cream (Maxilene® 4 - Lidocaine 4%) will be proposed to the patient, as standard of care. Usual positioning will be used by the staff nurse.~A) Virtual reality: Patients in this group will be offered virtual reality distraction through the use of OR.~B) Control intervention (standard of care): Patients in this group will receive standard care, including the proposition to use topical anesthetic cream prior to venipuncture attempt, usual distraction and positioning proposed by the treating nurse. Standard behavioural techniques to relax children will be employed."||||
1288140|NCT03750565|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1288141|NCT03750552|Randomized|Parallel Assignment||Treatment||Quadruple||Parallel assignment|t|t|t|t
1288142|NCT03750539|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase II Comparative Randomized Open-label||||
1288143|NCT03750526|Randomized|Parallel Assignment||Treatment||Single||||||t
1288144|NCT03750513||Single Group Assignment||Treatment||None (Open Label)||||||
1288145|NCT03750500|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288146|NCT03750487|Randomized|Parallel Assignment||Treatment||Single||||||t
1288147|NCT03750474|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1288148|NCT03750461||Single Group Assignment||Prevention||None (Open Label)||Modified Simon-Two Step. An initial cohort of 5 patients will be enrolled and treated sequentially with 30 day follow-up. If stopping criteria are not met, the cohort will be expanded to an additional 15 patients followed concurrently for the duration of the study period||||
1288149|NCT03750448|Randomized|Parallel Assignment||Treatment||Single|"A physiotherapist will assess the outcomes at baseline after which the patients are randomized. The same physiotherapist will then deliver the allocated intervention and no longer assess outcomes for this patient. A different physiotherapist, who is blinded to treatment allocation, will assess outcomes at the follow-up visits in this patient. At all follow-up visits, patients will be asked not to disclose any information regarding group allocation, and the physiotherapists will be instructed not to ask questions regarding group allocation.~The patients are blinded to the trial hypothesis in order to prevent ascertainment bias. The principal investigator is not an outcome assessor and will not be blinded."|"Telerehabilitation.~No intervention.~Unsupervised rehabilitation."||t||
1288150|NCT03750435||Single Group Assignment||Treatment||None (Open Label)||prospective single arm||||
1288151|NCT03750422|Randomized|Parallel Assignment||Treatment||Double|Subjects are provided with de-identified tubes of both study product and vehicle then instructed on which de-identified product is to be used for aftercare on which side of the abdomen.|double-blinded, randomized split-body study|t||t|
1288152|NCT03750409|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1288242|NCT03749239||Single Group Assignment||Basic Science||None (Open Label)||||||
1288154|NCT03750383|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||2-Part Single Group study||||
1288155|NCT03750370|||Other||Other|||||||
1288156|NCT03750357|Non-Randomized|Single Group Assignment||Treatment||Double|||t|t||
1288157|NCT03750344||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288158|NCT03750331|Randomized|Parallel Assignment||Other||None (Open Label)||Non-inferiority Randomized Controlled Trial comparing Non-inferiority Randomized Controlled Trial comparing (i) a group of renal transplant outpatients consulting their Transplant Centre following a traditional schedule (every other week up to 6 months post-transplant, once a month up to year 1, every three months up to year 2 and every 6 months thereafter) to (ii) a group of patients assisted by Ap'TELACARE and consulting their Transplant Centre following a less stringent schedule of consultations (every month up to 6 months, every other month up to year 1, every six months up to year 2 and once a year thereafter).||||
1288159|NCT03750318||Single Group Assignment||Supportive Care||None (Open Label)||All patients recruited will be wearing the Aingeal device as part of an integrated monitoring with opioid delivery system at ward setting.||||
1288160|NCT03750305|Randomized|Parallel Assignment||Treatment||None (Open Label)||Between groups, comparing Imagery-Focussed therapy with psychoeducation/TAU/within group, comparing baseline phase with treatment phase.||||
1288161|NCT03750292|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1288162|NCT03750279|Randomized|Parallel Assignment||Treatment||Quadruple|Two laser devices of the same appearance are used, i.e. one with 3x60 mW output power and one with 0 mW output power (sham). Participants in one group is treated with the sham laser device and the other group is treated with laser. The laser beam is invisible for the eye (wavelength 904 nm) and of such low power that heat is not detected. Thus, the participants, therapists and assessors are unaware of which laser device is active/inactive. The laser devices were randomly coded by a secretary who is not otherwise involved in the study.||t|t|t|t
1288163|NCT03750266|||Cohort||Prospective|||||||
1288164|NCT03750253||Single Group Assignment||Supportive Care||None (Open Label)||||||
1288165|NCT03750240||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288166|NCT03750227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288167|NCT03750214||Single Group Assignment||Screening||None (Open Label)||||||
1288168|NCT03750201|Randomized|Parallel Assignment||Treatment||Single|Intra-ocular pressure (IOP) measurements by masked investigator or masked technique (masked reading).|||||t
1288169|NCT03750188|||Case-Only||Retrospective|||||||
1288170|NCT03750175|||Cohort||Prospective|||||||
1288171|NCT03750162|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288172|NCT03750149||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288173|NCT03750136|Randomized|Parallel Assignment||Treatment||Single|||||t|
1288174|NCT03750123|||Case-Control||Cross-Sectional|||||||
1288175|NCT03750110|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study will use a pragmatic, parallel-group, open, randomized controlled trial design||||
1288176|NCT03750097||Single Group Assignment||Other||None (Open Label)||||||
1288177|NCT03750084|||Other||Prospective|||||||
1288178|NCT03750071||Single Group Assignment||Treatment||None (Open Label)||||||
1288179|NCT03750058||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1288180|NCT03750045||Single Group Assignment||Treatment||None (Open Label)||||||
1288181|NCT03750032|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking will be used in the study.|The patients will be randomized into three groups of various appendicular stump closure.||||
1288182|NCT03750019|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1288183|NCT03750006||Single Group Assignment||Treatment||None (Open Label)||The goals of this proposal are to: 1) investigate the feasibility of recruiting and administering short session HIIT to frail, pre-frail, and non-frail older Veterans and 2) to characterize the physical performance benefits and serum microRNA (miRNA) profiles in those participants.||||
1288184|NCT03749993||Single Group Assignment||Screening||None (Open Label)||||||
1288185|NCT03749980|||Cohort||Other|||||||
1288186|NCT03749967|Randomized|Parallel Assignment||Treatment||Single|All participants will be randomized to 10 different active doses of accelerated, intermittent theta burst rTMS.|Veterans will be randomized to 10 different doses of accelerated intermittent theta burst rTMS for remediation of transdiagnostic psychosocial impairment. The goal is to determine the optimal dose in terms of efficacy while minimizing burden and side effects.|t|||
1288187|NCT03749954|||Cohort||Prospective|||||||
1288188|NCT03749941|||Cohort||Retrospective|||||||
1288189|NCT03749928|Randomized|Parallel Assignment||Treatment||Single|||||t|
1288190|NCT03749915|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288191|NCT03749902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288192|NCT03749889|Randomized|Parallel Assignment||Prevention||Single||||||t
1288193|NCT03749876|Randomized|Crossover Assignment||Basic Science||Double|The research staff performing the statistical analyses of the outcomes of interest will be masked from knowing the individuals' randomized treatment assignments, as will the principal investigator.|Participants receive one of two alternative interventions during the initial phase of the study and receive the other intervention during the second phase of the study.|||t|t
1288194|NCT03749863||Single Group Assignment||Treatment||None (Open Label)||Serial monthly vocal fold injections with PRP for total of 4 injections.||||
1288195|NCT03749850||Single Group Assignment||Treatment||None (Open Label)||||||
1288196|NCT03749837|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1288197|NCT03749824|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1288291|NCT03748602|Randomized|Parallel Assignment||Treatment||None (Open Label)||"All patients diagnosed with NTOS refractory to conservative physiotherapy treatment (based on criteria produced by the reporting standards) and considered to benefit from TOD in a multidisciplinary TOS-consensus group are considered candidates for this study.~Patients will be randomized into surgery (TOD) versus conservative physiotherapy. The group randomised for conservative physiotherapy will be offered surgical therapy after 3 months if complaints persist."||||
1288292|NCT03748589|Non-Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1288198|NCT03749811|Randomized|Single Group Assignment||Treatment||Triple|"Participant does not know in which of the groups he/she is allocated. Only a care provider (an attending anesthesiologist who is responsible for the patient's anesthesia) knows the group which the patient belongs to.~Investigator and outcomes assessor does not know in which of the groups the patient is allocated, since the group name will be just recorded as A or B until data analysis of the last participant is done."|Interventional group: remifentanil infusion under pupillometry monitoring. Control group: remifentanil infusion without pupillometry monitoring (remifentanil dose is determined by conventional method, i. e., hemodynamic change probably related to noxious stimuli)|t||t|t
1288199|NCT03749798||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288200|NCT03749785|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1288201|NCT03749772|Randomized|Parallel Assignment||Treatment||Double|Randomization was performed by the principal investigator. The interventions were carried out individually, so the participants were unaware of the existence of another study arms.||t|||t
1288202|NCT03749759||Single Group Assignment||Other||None (Open Label)||||||
1288203|NCT03749746|Randomized|Parallel Assignment||Prevention||Single||||||t
1288204|NCT03749733|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1288205|NCT03749720||Single Group Assignment||Prevention||None (Open Label)||Case-control study with up to 200 case patients newly diagnosed cervical cancer and a control group of 10 healthy women with no prior cervical dysplasia and 10 women with cervical dysplasia (CIN3), respectively.||||
1288206|NCT03749707||Single Group Assignment||Prevention||None (Open Label)||Early-stage cervical cancer patients treated with radical hysterectomy and removal of SLNs.||||
1288207|NCT03749694|||Cohort||Prospective|||||||
1288208|NCT03749681|||Cohort||Retrospective|||||||
1288209|NCT03749668|||Cohort||Prospective|||||||
1288210|NCT03749655|Randomized|Parallel Assignment||Other||None (Open Label)|Principle investigator will be blinded from the randomisation as this member will conduct CBT with all patients.|Single centre feasibility, single blind, parallel, randomised controlled study.||||
1288211|NCT03749642|Randomized|Parallel Assignment||Treatment||Quadruple|The present study will be performed in double blind conditions. During the study neither the Investigator nor the patient will be aware of the treatment assigned.|Randomized, double-blind, placebo and reference controlled, placebo unbalanced, double-dummy, dose finding, parallel group, multicentre, international, prospective study|t|t|t|t
1288212|NCT03749629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Investigators will prospectively randomize 400 participants with DSM-V major depressive disorder to best practice guidelines plus PGx- guided psychiatric treatment (n=200) or best practice guidelines alone (n=200) and follow them for one year.||||
1288213|NCT03749616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288214|NCT03749603||Single Group Assignment||Diagnostic||None (Open Label)|no masking required. assessments are both done on same subjects.|Exploratory, interventional, one arm study||||
1288215|NCT03749590|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1288216|NCT03749577|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1288217|NCT03749564|Randomized|Factorial Assignment||Treatment||Double|Design precludes blinding of patients or care providers. Research personnel conducting outcomes assessments and the principal investigator are blind to participants' group assignment throughout the study.|Factorial design examining the outcomes of SMT with varying combinations of co-interventions.|||t|t
1288218|NCT03749551|||Cohort||Prospective|||||||
1288219|NCT03749538|Randomized|Parallel Assignment||Other||Double|Double-blind study to transcranial current stimulation|Prospective, randomized, double-blind, placebo-controlled study with application or not of a transcranial current stimulation session in patients with systemic autoimmune myopathies.|t||t|
1288220|NCT03749525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288221|NCT03749512|||Cohort||Retrospective|||||||
1288222|NCT03749499|Randomized|Parallel Assignment||Screening||Single|Research Assistants are blinded to study arm assignment of participant when assessing outcomes measures.|||||t
1288223|NCT03749486||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288224|NCT03749473|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1288225|NCT03749460||Single Group Assignment||Treatment||None (Open Label)||||||
1288226|NCT03749447||Single Group Assignment||Treatment||None (Open Label)||||||
1288227|NCT03749434|||Case-Only||Prospective|||||||
1288228|NCT03749421|||Other||Prospective|||||||
1288229|NCT03749408|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288230|NCT03749395|Randomized|Parallel Assignment||Prevention||Single|The practitioner and the patient are not blinded.The outcomes assessor will not know which group each patient is in.|Two parallel arms. One group will receive erector spinae plane block, and the other will receive nothing.||||t
1288231|NCT03749382|Randomized|Parallel Assignment||Other||Single|Participants will receive a brief description of both the appearance-based intervention and general stop smoking intervention. Participants will not know prior to taking part which condition they will be randomised into, on completion of the intervention it will become apparent whether they received the appearance-based intervention or general intervention. For participants randomised to the appearance intervention the instruction type will remain concealed. The investigator will not be blind throughout.|Parallel assignment|t|||
1288232|NCT03749369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288233|NCT03749356||Single Group Assignment||Treatment||None (Open Label)||||||
1288234|NCT03749343|||Cohort||Prospective|||||||
1288235|NCT03749330||Single Group Assignment||Health Services Research||None (Open Label)||||||
1288236|NCT03749317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288237|NCT03749304||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288238|NCT03749291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288239|NCT03749278|Non-Randomized|Parallel Assignment||Prevention||Double|The investigator and outcomes assessor will not have knowledge of the intervention assigned to individual participants||||t|t
1288240|NCT03749265|||Cohort||Prospective|||||||
1288241|NCT03749252||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288243|NCT03749226|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Twenty consecutive patients heavily colonized by Gram-negative bacteria will be eligible for this study. Patients will be randomized to receive either AZLI nebulized or nothing via 1:1 randomization at study or control group.~Patients assigned to study group will receive nebulized Aztreonam lysine (AZLI 75 mg-dose) three times /day during 5 days by mean of the ultrasonic nebulizer (Aeroneb solo®) plus Combihaler® spacer adapted of the ventilator. All patients will be on conventional volume-control ventilator setting during the antibiotic therapy. Systemic antibiotics will not be used in any patient. If the attending physician saw the need to administer intravenous antibiotics after the patient has entry in the study, this patients should be removed from the study"||||
1288244|NCT03749213||Single Group Assignment||Treatment||None (Open Label)||||||
1288245|NCT03749200|Randomized|Parallel Assignment||Treatment||None (Open Label)|Given the nature of the intervention participants or researchers could not be blinded.|Randomized clustered clinical trial, with treatment on obese children in 2 arms: a control group (CG) that will follow the usual recommendations of pediatricians and nurses in the primary care centres and an intervention group (IG) that will receive a structured motivation-based interview combined with group therapy and eHealth. the treatment of the two arms will last 12 (+3) months||||
1288246|NCT03749187|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288247|NCT03749174|Randomized|Factorial Assignment||Treatment||Single||Patients are subdivided into 3 groups where one group is further subdivided into 2 groups||||t
1288248|NCT03749161|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1288249|NCT03749148|Randomized|Parallel Assignment||Treatment||Quadruple|randomized, double blind, placebo controlled|Phase 2 multicenter, randomized, double blind, placebo controlled, parallel group, two-arm, investigator-initiated trial (IIT)|t|t|t|t
1288250|NCT03749135|Randomized|Parallel Assignment||Treatment||Quadruple|randomized, double blind, placebo controlled|This is a Phase 2amulticenter, randomized, double blind, placebo controlled, parallel group, two-arm, proof-of-concept investigator-initiated trial|t|t|t|t
1288251|NCT03749122|||Cohort||Retrospective|||||||
1288252|NCT03749109|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288253|NCT03749096|Randomized|Parallel Assignment||Treatment||Quadruple|Randomized double-blind||t|t|t|t
1288254|NCT03749083|||Cohort||Prospective|||||||
1288255|NCT03749070|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Clinical trial, randomized, double-blind and controlled|t|t|t|t
1288256|NCT03749057||Single Group Assignment||Treatment||None (Open Label)||||||
1288257|NCT03749044|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized Control Trial||||
1288258|NCT03749031|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1288259|NCT03749018||Single Group Assignment||Treatment||None (Open Label)||||||
1288260|NCT03749005|||Cohort||Retrospective|||||||
1288261|NCT03748992||Single Group Assignment||Treatment||None (Open Label)||||||
1288262|NCT03748979|Randomized|Sequential Assignment||Other||Double|||t||t|
1288263|NCT03748966|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Adults or children (age 6-17) with X-linked hypophosphatemia (XLH) will be enrolled the study. All research subjects will be treated with optimized doses of calcitriol alone (without phosphate supplementation) for one year.||||
1288264|NCT03748953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288265|NCT03748940|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1288266|NCT03748927|||Cohort||Prospective|||||||
1288267|NCT03748914|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1288268|NCT03748901|||Cohort||Retrospective|||||||
1288269|NCT03748888|Randomized|Parallel Assignment||Basic Science||None (Open Label)||"The present study will involve two study groups.~Exercise group (EG). Pregnant women allocated in the EG will receive and intervention based on a supervised antenatal physical activity programme during 20-24 weeks. They must be enrolled in the study between their 12-16 weeks of gestation.~Control group (CG). Pregnant women allocated in CG will not receive any intervention. They will maintain standard health care during pregnancy."||||
1288270|NCT03748875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288271|NCT03748862|||Case-Control||Retrospective|||||||
1288272|NCT03748849|||Case-Control||Prospective|||||||
1288273|NCT03748836|Randomized|Parallel Assignment||Other||Double|Double blinded, placebo-controlled|Randomized, placebo-controlled, double-blinded, dose escalation to evaluate the safety, PK, and PD of single and multiple doses of ALPN-101|t||t|
1288274|NCT03748823||||||||||||
1288275|NCT03748810|||Case-Control||Prospective|||||||
1288276|NCT03748797|Randomized|Parallel Assignment||Treatment||Single|A research assistant who was blinded for the participants grouping was responsible for data collection.|"Exercise group: Performed an 8-week, 2 times/week exercise training (moderate intensity) under physiotherapist supervision.~Control group: No supervised exercise training given. Participants were advised to continue their routine daily activities and self exercises if they have."||||t
1288277|NCT03748784|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-label, dose-escalation clinical study to evaluate the safety and tolerability of ADVM-022 in subjects with wet AMD.||||
1288278|NCT03748771||||||||||||
1288279|NCT03748758|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1288280|NCT03748745|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1288281|NCT03748732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||surgery||||
1288282|NCT03748719||Single Group Assignment||Treatment||None (Open Label)||||||
1288283|NCT03748706||Single Group Assignment||Treatment||None (Open Label)||||||
1288284|NCT03748693|||Case-Control||Prospective|||||||
1288285|NCT03748680|Randomized|Parallel Assignment||Treatment||None (Open Label)||A open label 1:1 randomized phase II exploratory study||||
1288286|NCT03748667|||Cohort||Cross-Sectional|||||||
1288287|NCT03748654||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1288288|NCT03748641|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288289|NCT03748628||Single Group Assignment||Basic Science||None (Open Label)||||||
1288290|NCT03748615||Single Group Assignment||Treatment||None (Open Label)||||||
1288294|NCT03748563||Single Group Assignment||Diagnostic||None (Open Label)||A prospective self-controlled comparative multi-center study.||||
1288295|NCT03748550|Randomized|Parallel Assignment||Prevention||Single|Clinicians interpreting the echocardiograms and stress test results will not know whether the participant is in the control group or the exercise intervention.|Participants will be randomly allocated to either the standard of care group (control) or the intervention group (standard of care + 12-weeks aerobic exercise).||||t
1288296|NCT03748537|Randomized|Parallel Assignment||Basic Science||Single||"Eligible patients for aim#3 will be randomly assigned in a 1:1 ratio of hydrocortisone and no hydrocortisone administration (control group), in a block of four patterns. Serum cortisol will be collected before administration.~Hydrocortisone will be administered intravenously at 200 mg every 24 hours for 5 days, then tapered to a 50 mg intravenous bolus every 12 hours for days 6 to 8 and 50 mg every 24 hours for days 9 to 11, and then stopped. In control group, patient will not receive any corticosteroids for seven day after inclusion."|||t|
1288297|NCT03748524||Single Group Assignment||Basic Science||None (Open Label)||||||
1288298|NCT03748511|||Cohort||Prospective|||||||
1288299|NCT03748498|Randomized|Parallel Assignment||Treatment||Single|All procedures were conducted by one clinician , and assignment was concealed from the clinician who performed the laser applications.|This study was designed as a randomized, placebo-controlled trial of 2 groups.|||t|
1288300|NCT03748485|Randomized|Parallel Assignment||Treatment||Single|||||t|
1288301|NCT03748472|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1288302|NCT03748459|||Case-Control||Prospective|||||||
1288303|NCT03748446|Non-Randomized|Crossover Assignment||Treatment||Triple|The identity of the inhalant will be blinded to all except the anesthesiologist, who will not participate in any assessment of the depressive symptoms.|A randomized, double-blind crossover model that will compare the effects of xenon-oxygen (35:65 ratio by volume) added to treatment as usual (X-TAU group) to the effects of nitrogen-oxygen (35:65 ratio by volume) added to treatment as usual (N-TAU group). A total of 20 severely depressed patients, 10 with major depressive disorder (MDD) and 10 with Bipolar Depression (BP), will be exposed in random order to N-TAU and X-TAU in a double-blind protocol.|t||t|t
1288304|NCT03748433|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomised open-label parallel group study||||
1288305|NCT03748420|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1288306|NCT03748407||Single Group Assignment||Screening||None (Open Label)||||||
1288307|NCT03748394|Randomized|Parallel Assignment||Treatment||Single||||||t
1288308|NCT03748381||Single Group Assignment||Treatment||None (Open Label)||||||
1288309|NCT03748368|Randomized|Parallel Assignment||Other||Single|||t|||
1288310|NCT03748355||Single Group Assignment||Basic Science||None (Open Label)||||||
1288311|NCT03748342|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1288312|NCT03748329|Randomized|Single Group Assignment||Device Feasibility||Single|The transducer will remain in place during the performance of the block but the monitor will be above the head of the patient in the 12 o'clock position so as to not be in direct view.|Split mouth study|t|||
1288313|NCT03748316||||||||||||
1288314|NCT03748303||Single Group Assignment||Treatment||None (Open Label)||Single-arm, open-label study||||
1288315|NCT03748290|Randomized|Parallel Assignment||Treatment||Quadruple|The placebo pills will be purchased from Trilog, which is licensed and licensed by the Ministry of Health to prepare random drug kits (the company has an agreement with Sheba). The drug will be used by the company that supplies the drug and placebo, so that the researchers in the study did not know which treatment was given to each patient. This information will be received at the end of the study, or if the subjects for any reason participate in the research||t|t|t|t
1288316|NCT03748277|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"group - decompression, MIS TLIF + Screw Fixation~group - decompression, open fusion + Screw Fixation"||||
1288317|NCT03748264||||||||||||
1288318|NCT03748251|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1288319|NCT03748238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288320|NCT03748225|||Cohort||Prospective|||||||
1288321|NCT03748212|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1288322|NCT03748199|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1288323|NCT03748186||Sequential Assignment||Treatment||None (Open Label)||Part 1: Dose escalation starting at human equivalent dose (HED) of 1/6 the highest non-severely toxic dose (HNSTD) identified in the good laboratory practice (GLP) toxicology study in cynomolgus monkeys. The second dose level increases by 100% of the initial dose, and thereafter by 80%, then 60%, 50%, 40%, 30% and then 20% of the preceding doses.||||
1288324|NCT03748173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288325|NCT03748160|Randomized|Parallel Assignment||Prevention||Quadruple||Cluster (household) RCT with three treatment arms|t|t|t|t
1288326|NCT03748147|Randomized|Single Group Assignment||Treatment||Triple|Both arms will receive identical appearing drug made by the Investigational Drug Unit of the Pharmacy.|Parallel design randomized trial. Two study groups: control (25 mcg) intervention (50 mcg)|t|t|t|
1288327|NCT03748134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288328|NCT03748121|Randomized|Parallel Assignment||Treatment||Double|Participants and Therapists (Care Provider) could not be blinded according to the nature of the intervention. However, therapists will be blinded to allocation concealment as they do not be aware of the patients' group assignment at baseline assessment until they open the opaque randomization envelope, which contains the patient randomization number and group assignment. The random sequence generation and the envelopes were prepared by the study coordinator who is not involved patient recruitment. Patients received post intervention questionnaires from a study assistant/nurse of the respective outpatient department who is also blinded to the patients' group assignment. After completing the questionnaires, the study assistant will sent them to study coordinator so that the therapist could not influence the patients' answers.||||t|t
1288373|NCT03747536|Randomized|Crossover Assignment||Treatment||Quadruple|Study drug will be dispensed as a metered-dose spray bottle of ipratropium bromide or identical placebo prepared by the Hospital Pharmacy. Clinician, investigator, care provider, as well as outcome assessor will be blinded to the treatment.||t|t|t|t
1288329|NCT03748108|Randomized|Parallel Assignment||Prevention||Quadruple|Participating patients, surgeons, anesthesiologists and medical investigators who will be involved in the data collection will be all blinded to the patient's group assignment until the collection of data for all cases will be complete.|This study will be a single-center, randomized double-blind, placebo-controlled, parallel group trial.|t|t|t|t
1288330|NCT03748095|||Other||Prospective|||||||
1288331|NCT03748082|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1288332|NCT03748069|||Cohort||Prospective|||||||
1288333|NCT03748056|Randomized|Crossover Assignment||Prevention||Single|||t|||
1288334|NCT03748043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288335|NCT03748030|||Cohort||Prospective|||||||
1288336|NCT03748017|Randomized|Parallel Assignment||Basic Science||Triple|Participants, investigators, and data evaluators will be blinded to the treatment assignments.|Subjects will be enrolled and randomized, receiving either a streptococcus-containing probiotic supplement or a placebo-control supplement.|t||t|t
1288337|NCT03748004|Randomized|Parallel Assignment||Other||Single||72 clients receiving primary care services from one DTES clinical site who are employment ready will be randomly assigned to IPS and Peer Support (experimental group) or WorkBC (control group).|||t|
1288338|NCT03747991|||Case-Control||Cross-Sectional|||||||
1288339|NCT03747978|Randomized|Parallel Assignment||Treatment||Quadruple||double blind head to head trial|t|t|t|t
1288340|NCT03747965||Single Group Assignment||Treatment||None (Open Label)||||||
1288341|NCT03747952|||Case-Control||Prospective|||||||
1288342|NCT03747939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288343|NCT03747926|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288344|NCT03747913||Single Group Assignment||Basic Science||None (Open Label)||Each participant enrolled in the study will be part of the supplementation and control condition group in a non-randomized order||||
1288345|NCT03747900|Randomized|Parallel Assignment||Treatment||Single|||||t|
1288346|NCT03747887|Randomized|Parallel Assignment||Treatment||Single||Random assignment to intervention group or business as usual group.||||t
1288347|NCT03747874||Single Group Assignment||Screening||None (Open Label)||||||
1288348|NCT03747861||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288349|NCT03747848||Single Group Assignment||Treatment||None (Open Label)||||||
1288350|NCT03747835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288351|NCT03747822|Randomized|Parallel Assignment||Treatment||Single|a third party oral surgery specialist will be asked to assess the study participate according to a standardized assessment tool|||||t
1288352|NCT03747809|||Other||Prospective|||||||
1288353|NCT03747796|Randomized|Parallel Assignment||Prevention||Double||||t||t
1288354|NCT03747783|||Cohort||Retrospective|||||||
1288355|NCT03747770|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"Age range of subjects: 13 up to 18 years of age~Vaccination - grade 8: 13 to less than 15 years of age~Behavioral questionnaire: grade 8 (as above) and 15-18 years of age for baseline (unvaccinated) and Year 2 and Year 4 cross-sectional surveys post vaccination~Urine collection: 15-18 years of age for baseline (unvaccinated) and Year 2 and Year 4 cross-sectional surveys post vaccination~Blood collection: grade 8 (as above) and 15-18 years of age for Year 2 and Year 4 cross-sectional surveys post vaccination"||||
1288356|NCT03747757||Single Group Assignment||Supportive Care||None (Open Label)||||||
1288357|NCT03747744||Single Group Assignment||Treatment||None (Open Label)||Intratumoral injection of T-VEC followed by intratumoral injection of CD1c (BDCA-1)+ myDC||||
1288358|NCT03747731|||Other||Prospective|||||||
1288359|NCT03747718|Randomized|Factorial Assignment||Treatment||Triple|Masking will be completed at the 1.5 month visit by the pharmacy.|The study will operate as a single group open label study until visit 6, at which point it will become a randomized trial.|t|t|t|
1288360|NCT03747705|||Case-Only||Prospective|||||||
1288361|NCT03747692|Randomized|Parallel Assignment||Supportive Care||Single|group 1 will be subjected to intracervical injection of mepicaine hydrochloride 3%iof a local anasthetic as Carbocaine3% and group 2 will be subjected to intracervical injection of 5 ml of normal saline|two groups will be used , 1st study group using intracervical anasthesia of a local anasthetic as Carbocaine3%,and 2nd group using NSAIDs and intracervical injection of a placebo ( saline ).Ask the patient to tell about any sense of nausea or vomiting or drowsiness.|t|||
1288362|NCT03747679|Randomized|Single Group Assignment||Other||Single|single blind|This will be a single-blind, randomized, multiple-period (dosing over 4 days) study in healthy male and/or female participants. Approximately 8 participants will assess the sensory attributes of each of the formulation options using Bosutinib Taste Assessment Questionnaire|t|||
1288363|NCT03747666|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288364|NCT03747653|||Cohort||Cross-Sectional|||||||
1288365|NCT03747640||||||||||||
1288366|NCT03747627|||Cohort||Prospective|||||||
1288367|NCT03747614|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||subjects from zhongshan ophthalmic center||||
1288368|NCT03747601||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1288369|NCT03747588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288370|NCT03747575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288371|NCT03747562|Randomized|Parallel Assignment||Treatment||Triple|"Both patient groups will receive gabapentin or a matching placebo additional to the standard analgesic therapy, and will be asked to consume the content following the predefined directions provided to them. Both the investigators and the patients will be blinded for the IMP, since gabapentin and the matching placebo will appear identical.~The clinical pharmacist responsible for clinical trials as well as Bimetra clinics will receive a sealed envelope from the statistician with the information necessary for decoding."|Randomised-controlled trial where patients are randomised to either the experimental group (E) receiving gabapentin or the control group (C) receiving a matching placebo, both in addition to standard analgesic therapy (WHO ladder steps 2 and 3).|t|t|t|
1288372|NCT03747549|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1288374|NCT03747523|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560629|NCT00177788|||||Retrospective|||||||
1288375|NCT03747510||Single Group Assignment||Treatment||None (Open Label)||||||
1288376|NCT03747497|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288377|NCT03747484||Single Group Assignment||Treatment||None (Open Label)||||||
1288378|NCT03747471|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This will be a 2 arms individual randomized controlled trial. Intervention arm will receive teaching from the nurses using diabetic conversation map with visual images and control arm will receive teaching from the nurses using the traditional diabetic counselling.||||
1288379|NCT03747458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288380|NCT03747445|||Case-Control||Prospective|||||||
1288381|NCT03747432|Randomized|Parallel Assignment||Other||Double|||t||t|
1288382|NCT03747419||Single Group Assignment||Treatment||None (Open Label)||||||
1288383|NCT03747406|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1288384|NCT03747393|Randomized|Parallel Assignment||Treatment||Single||Comparative effectiveness parallel-group randomized controlled clinical trial||||t
1288385|NCT03747380|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288386|NCT03747367|Randomized|Crossover Assignment||Basic Science||Double|Experiment 1 - none Experiment 2 - double-blind|Experiment 1 - Single group, repeated assessment Experiment 2 - Double-blind, randomized, cross-over design|t||t|
1288387|NCT03747354|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1288388|NCT03747341|Randomized|Crossover Assignment||Prevention||Single|Participants will be blinded to treatment with buprenorphine or placebo during Periods 1 and 2 in Part A only.|"Part A is a 3 period study in approximately 18 healthy subjects. Subjects will be randomized in a 1:1 ratio to 2 treatment sequences determined by the order in which they receive buprenorphine or placebo (periods 1 and 2). An optional open-label Period 3 may be conducted in which subjects will receive buprenorphine only.~Part B is an open label study of approximately 8 opioid tolerant patients. All will undergo a washout of their own opioids which will be replaced with oral oxycodone and continue at stable doses from at least 48 hours prior to Period 1 to the end of Period 2. All will receive placebo plus fentanyl during Period 1 and buprenorphine plus fentanyl during Period 2."|t|||
1288389|NCT03747328||Single Group Assignment||Treatment||None (Open Label)||||||
1288390|NCT03747315|||Case-Control||Prospective|||||||
1288391|NCT03747302|Randomized|Parallel Assignment||Health Services Research||Single|Participants are not aware of which arm of social messaging they are receiving and whether they are receiving the control message or not||t|||
1288392|NCT03747289|Non-Randomized|Parallel Assignment||Treatment||Single|the investigator will check all the participants without knowing to which group they are assigned to||||t|
1288393|NCT03747276||Single Group Assignment||Health Services Research||None (Open Label)||||||
1288394|NCT03747263|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288395|NCT03747250|Randomized|Parallel Assignment||Treatment||Single|The allocation to the group will be randomized in located in closed envelope, that will be opened in the operating theater before anesthesia induction|Randomized controlled trial|t|||
1288396|NCT03747237|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288397|NCT03747224|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1288398|NCT03747211|Randomized|Parallel Assignment||Treatment||Double|Concealed computer generated allocation via REDCap|Randomized, outcome assessor blinded, controlled trial|||t|t
1288399|NCT03747198|Randomized|Parallel Assignment||Supportive Care||Triple|MSM tablets will be packaged and labelled (intervention A or B) by Bergstrom nutrition off-site.|double blinded randomized parallel design|t||t|t
1288400|NCT03747185|Randomized|Crossover Assignment||Treatment||Double|The assessor and investigator will be blinded to the random order. This process will be handled by the research manager.|Participants will be randomly assigned to either stretching exercise with lumbopelvic stiffening technique or lumbopelvic relaxing technique. They will be provided a 2-day wash-out period. Then, participants will cross-over to another technique.|||t|t
1288401|NCT03747172|||Cohort||Prospective|||||||
1288402|NCT03747159|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single-center||||
1288403|NCT03747146|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288404|NCT03747133||Single Group Assignment||Treatment||None (Open Label)||||||
1288405|NCT03747120|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1:1 randomization||||
1288406|NCT03747107|||Ecologic or Community||Other|||||||
1288407|NCT03747094|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288408|NCT03747081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288409|NCT03747068|||Cohort||Retrospective|||||||
1288410|NCT03747055|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288411|NCT03747042||Single Group Assignment||Treatment||None (Open Label)||||||
1288412|NCT03747029|||Case-Control||Retrospective|||||||
1288413|NCT03747016|Randomized|Parallel Assignment||Other||Triple||||t|t|t
1288414|NCT03747003|||Cohort||Prospective|||||||
1288415|NCT03746990|||Ecologic or Community||Cross-Sectional|||||||
1288416|NCT03746977|Randomized|Parallel Assignment||Prevention||Double|Outcome assessors were not aware of the status of the participants and were not allowed to ask correspondingly. Each of the participants were blinded according to the treatment and intervention. Participants of the three study groups were not in contact.|Randomized controlled parallel group design with 3 study arms|t|||t
1288417|NCT03746964|||Cohort||Prospective|||||||
1288418|NCT03746951|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1288419|NCT03746938||Single Group Assignment||Treatment||None (Open Label)||||||
1288420|NCT03746925|Randomized|Parallel Assignment||Treatment||Single||It is a 2 group, parallel study where they will be randomized into one of the two groups. One will receive SuperPATH approach and the other will receive DAA.||||t
1288421|NCT03746912||||||||||||
1288422|NCT03746899||||||||||||
1288423|NCT03746886|||Case-Only||Other|||||||
1288424|NCT03746873|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1288425|NCT03746860|||Cohort||Prospective|||||||
1288426|NCT03746847|||Cohort||Prospective|||||||
1288427|NCT03746834||Single Group Assignment||Treatment||None (Open Label)||Patients are treated with injection of NASHA/Dx and act as their own Controls over time.||||
1288428|NCT03746821||Single Group Assignment||Basic Science||None (Open Label)||||||
1288429|NCT03746808|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1288430|NCT03746795|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"During the experiment, six measurements will be performed for each examined individual to calculate the spirometric parameters of FVC, FEV1 and Tiffenea's index (TI) FEV1/FVC. Spirometry measurements will be performed in a randomized order: two standard spirometric examinations, two spirometric examinations using EIT and two simultaneous measurements using both methods.~Each subject will undergo all six measurements."||||
1288431|NCT03746782|||Case-Control||Cross-Sectional|||||||
1288432|NCT03746769||Single Group Assignment||Treatment||None (Open Label)||||||
1288433|NCT03746756|Randomized|Parallel Assignment||Treatment||None (Open Label)||Compares Screening, Brief Intervention and Referral to Treatment (SBIRT) as currently practiced at federal qualified health centers (FQHC) as a practice as usual comparison group vs. SBIRT+ Recovery Management Checkups for Primary Care at the time of referral and quarterly for 12 months.||||
1288434|NCT03746743|||Cohort||Prospective|||||||
1288435|NCT03746730|||Cohort||Prospective|||||||
1288436|NCT03746717|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open 2-arm prospective randomized controlled trial||||
1288437|NCT03746704|Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1288438|NCT03746691|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1288439|NCT03746678|||Cohort||Prospective|||||||
1288440|NCT03746665|Non-Randomized|Parallel Assignment||Prevention||Single|Laboratory personnel assessing primary and secondary serological endpoints (Men A and Tetanus Toxoid) will be blinded to group allocation (i.e. MenAfriVac Group versus Control Group).|100 eligible mother-infant pairs randomized to the control group in the PROPEL trial (SCC1433, NCT02628886) who gave consent for their samples to be used for other ethically-approved research will be chosen at random and serve as controls for this study||||t
1288441|NCT03746652||Single Group Assignment||Treatment||None (Open Label)||||||
1288442|NCT03746639|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1288443|NCT03746626|||Cohort||Prospective|||||||
1288444|NCT03746613||Single Group Assignment||Treatment||None (Open Label)||||||
1288445|NCT03746600|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized waitlist-controlled trial||||
1288446|NCT03746587|Randomized|Parallel Assignment||Treatment||Triple|Double-blinded, randomized, placebo controlled|Randomized|t|t|t|
1288447|NCT03746574|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomization to intervention or control occuring at the level of clinic. All participants within a clinic are assigned to same group||||
1288448|NCT03746561|||Case-Only||Retrospective|||||||
1288449|NCT03746548|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1288450|NCT03746535|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|no masking, all subjects have endometriosis|2 cohort clinical trial||||
1288451|NCT03746522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288452|NCT03746509|Randomized|Parallel Assignment||Treatment||Single||||||t
1288453|NCT03746496|||Case-Only||Prospective|||||||
1288454|NCT03746483|Randomized|Crossover Assignment||Treatment||None (Open Label)|Unblinded|2x2 Crossover||||
1288455|NCT03746470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288456|NCT03746457|Non-Randomized|Crossover Assignment||Other||None (Open Label)||Participants in the three experimental ART Centers received three cycles of intervention, while two ART Centers served as the controls. In the first cycle, participants in the three experimental Centers each received individual counseling, group intervention (GI) and collective advocacy (CA). In Cycle 2, participants in each experimental center received a second intervention (e.g. GI + CA) and in the third cycle, participants in each experimental Center received a third intervention (GI + CA + IC). In addition, in Cycle 3, the participants in one of the Control Centers received an integrated package of IC-GI-CI.||||
1288457|NCT03746444|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1288458|NCT03746431||Single Group Assignment||Treatment||None (Open Label)||||||
1288459|NCT03746418|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1288460|NCT03746405|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1288461|NCT03746392|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1288462|NCT03746379|||Other||Cross-Sectional|||||||
1288463|NCT03746366|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||[C-11]PiB||||
1288464|NCT03746353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288465|NCT03746340|||Other||Other|||||||
1288466|NCT03746327||Single Group Assignment||Treatment||None (Open Label)||||||
1288467|NCT03746314|||Case-Only||Cross-Sectional|||||||
1288468|NCT03746301|||Cohort||Prospective|||||||
1288469|NCT03746288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288470|NCT03746275|||Cohort||Prospective|||||||
1288471|NCT03746262|||Cohort||Prospective|||||||
1288472|NCT03746249||Single Group Assignment||Treatment||None (Open Label)||||||
1288473|NCT03746236|||Case-Only||Prospective|||||||
1288474|NCT03746223||Single Group Assignment||Treatment||None (Open Label)||||||
1288475|NCT03746210|||Cohort||Prospective|||||||
1288476|NCT03746197|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1288477|NCT03746184|||Cohort||Prospective|||||||
1288478|NCT03746171|||Case-Only||Prospective|||||||
1288479|NCT03746158||Single Group Assignment||Treatment||None (Open Label)||||||
1288480|NCT03746145|Randomized|Parallel Assignment||Basic Science||Quadruple||During the entire winter over (WO) period, from arrival at COCORDIA until departure (1 year), participants receive 2g nutritional supplement powder (sachet, containing 10e11 CFU Bifidobacterium longum 1714 or placebo) once every day, to be taken in the morning with breakfast throughout the year.|t|t|t|t
1288521|NCT03745612|Randomized|Parallel Assignment||Treatment||Single||||||t
1288481|NCT03746132|Randomized|Crossover Assignment||Treatment||Double|Sham devices are not involved in this study. The surgeon will remain blinded to the subject's group assignment until after the wound is surgically closed in the operating room, and just prior to application of the dressing. A clinical professional, experienced in care of surgical wounds, will be appointed at the end of the study as a masked independent evaluator. This clinical professional will be blinded as to the treatment group of the subject.|Subjects who meet the inclusion/exclusion criteria will be randomized to receive the treatment device with Standard of Care or Standard of Care alone (1:1). At the end of the four-week study period, the cross-over will happen to those non-healed patients in the either arm of the study, after one-week wash-out period.|||t|t
1288482|NCT03746119|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1288483|NCT03746106|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Three-arm randomized crossover study design.||||
1288484|NCT03746093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288485|NCT03746080||Single Group Assignment||Treatment||None (Open Label)||||||
1288486|NCT03746067|Randomized|Parallel Assignment||Treatment||Double|Double-blind||t||t|
1288487|NCT03746054|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288488|NCT03746041||Single Group Assignment||Treatment||None (Open Label)||||||
1288489|NCT03746028|||Cohort||Prospective|||||||
1288490|NCT03746015||Single Group Assignment||Prevention||None (Open Label)||||||
1288491|NCT03746002|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, randomized, open-label, active control pilot study||||
1288492|NCT03745989||Sequential Assignment||Treatment||None (Open Label)||||||
1288493|NCT03745976|||Cohort||Prospective|||||||
1288494|NCT03745963|Randomized|Parallel Assignment||Treatment||Single|Two research assistants (RA1, RA2) who are blinded to the intervention condition will be hired to complete facial coding and calculation of infant PIPP-R scores. Each research assistant will only code data for preterm infants in the skin to skin condition (RA1) or the sucrose condition (RA2) and will not be aware of whether they are watching preterm infant responses to noxious or non-noxious stimulation. To minimize observer bias, research assistants will not be informed of the study design, will not be permitted to attend data collection sessions, and will not share datasets or communicate with the other research assistant regarding the study. During data collection, up close video recording of only the preterm infants face will be completed to attempt to keep coders blind to the nature of the intervention.|||||t
1288495|NCT03745950|Randomized|Parallel Assignment||Treatment||Triple||Olaparib vs placebo|t|t|t|
1288496|NCT03745937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288497|NCT03745924|||Cohort||Prospective|||||||
1288498|NCT03745911||Single Group Assignment||Treatment||None (Open Label)||||||
1288499|NCT03745898|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1288500|NCT03745885|Randomized|Parallel Assignment||Treatment||Triple|Only outcomes assessor is unmasked.|This study plan to set up 6 dosages (0.375 mg, 0.75 mg, 1.5 mg, 3.0 mg, 6.0 mg, 9.0 mg). The subjects in each group will be randomly assigned to Supaglutide injection group (6 cases) and placebo group (2 cases).|t|t|t|
1288501|NCT03745872||Single Group Assignment||Prevention||None (Open Label)|Participant names will be written on pre and post test to enable matching purposes, but once this has been completed, only the study ID will be used.|All students who participate in this study will be given a pre test, instruction regarding sun exposure and a post test to determine their sun exposure behaviors and knowledge of sun exposure risks.||||
1288502|NCT03745859|||Case-Only||Prospective|||||||
1288503|NCT03745846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288504|NCT03745833||Single Group Assignment||Treatment||None (Open Label)||||||
1288505|NCT03745820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288506|NCT03745807||Single Group Assignment||Treatment||None (Open Label)||||||
1288507|NCT03745794|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288508|NCT03745781|Randomized|Parallel Assignment||Treatment||None (Open Label)||Arm 1: open-label placebo Arm 2: treatment as usual control||||
1288509|NCT03745768|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized controlled clinical trial testing iTBS versus sham|t|t|t|t
1288510|NCT03745755|||Cohort||Prospective|||||||
1288511|NCT03745742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288512|NCT03745729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288513|NCT03745716|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This will be a Phase III, multicenter, randomized study to compare the rate of CR and duration of CR, in patients with TP53-mutated MDS who will receive APR-246 and azacitidine or azacitidine alone.~Treatment will be administered on an outpatient basis. No investigational or commercial agents or therapies other than those described below may be administered with the intent to treat the patient's disease.~Patients will be randomized (1:1) to one of two arms: stratified by age (< 65 years versus ≥ 65):~Experimental arm: APR-246 + azacitidine; or~Control arm: Azacitidine"||||
1288514|NCT03745703|Randomized|Crossover Assignment||Prevention||Single|Participants are randomly assigned to either the MOCHA standard arm or to the enhanced MOCHA+ arm.|The study design uses a wait-list control to test the effectiveness and relative effectiveness of a community-driven MOCHA intervention, including discussions of salient health topics (such as stress and anger management) and an enhanced version MOCHA+, which incorporates narrative communication strategies to strenghten comprehnsion, retention and motivation.|t|||
1288515|NCT03745690||Single Group Assignment||Treatment||None (Open Label)||||||
1288516|NCT03745677|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Two group pretest-posttest analysis||||
1288517|NCT03745664|Randomized|Parallel Assignment||Treatment||Quadruple|Doctors, staff and any primary care provider/s involved in the participant's non-trial management will be blinded to the group allocations. Individual participants will be not told their group allocation until the end of their involvement in the trial and after the completion of the trial|Phase 3, multicenter, double-blind, placebo-controlled, randomized, intervention trial|t|t|t|t
1288518|NCT03745651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288519|NCT03745638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288520|NCT03745625|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1288522|NCT03745599|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1288523|NCT03745586||Single Group Assignment||Treatment||None (Open Label)||||||
1288524|NCT03745573|Randomized|Parallel Assignment||Prevention||None (Open Label)|Due to the behavioural nature of the intervention, it is not possible to mask allocation to participants. Outcome assessors will not be told of allocation, but due to the nature of the intervention they should be assumed to be unmasked. The statistician performing the main trial analyses related to primary and secondary outcomes will be masked to allocation, but other investigators will not.|Schools will be randomised to receive the intervention or a wait-list control condition. Assignment will be parallel.||||
1288525|NCT03745560|||Case-Only||Prospective|||||||
1288526|NCT03745547|||Cohort||Prospective|||||||
1288527|NCT03745534|||Other||Prospective|||||||
1288528|NCT03745521|||Cohort||Prospective|||||||
1288529|NCT03745508|Randomized|Crossover Assignment||Other||Double|Double-blind||t|||t
1288530|NCT03745495|||Cohort||Prospective|||||||
1288531|NCT03745482|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1288532|NCT03745469|||Case-Only||Cross-Sectional|||||||
1288533|NCT03745456|||Case-Only||Prospective|||||||
1288534|NCT03745443|Randomized|Parallel Assignment||Other||None (Open Label)||randomized parallel controlled clinical trial||||
1288535|NCT03745430||Single Group Assignment||Treatment||None (Open Label)||||||
1288536|NCT03745417||Single Group Assignment||Treatment||None (Open Label)||||||
1288537|NCT03745404|Randomized|Sequential Assignment||Treatment||Quadruple|Open-label enriched enrolment followed by double-blind treatment for 2 weeks.|"An enriched enrolment, randomized-withdrawal, parallel-group design was applied. Only participants responding to open-label active treatment were included into the Double-blind Phase.~The study comprised:~A non-controlled, open-label enrichment phase with Lido-Patch treatment (Run-in Phase).~A double-blind, randomized-withdrawal phase (Double-blind Phase).~Upon request of the participant, treatment could be continued in the clinical study KF10004/02.~A Follow-up Phase without treatment for participants not continuing in KF10004/02."|t|t|t|t
1288538|NCT03745391|Randomized|Parallel Assignment||Diagnostic||Single|A blinded neurologist investigator (M. Gomis) will perform the clinical assesment of included patients at 90 days in outpatient clinics|Patients will be included consecutively and randomized (1:1) to Multimodal MR or Multimodal CT stratifying by age (<70, ≥70) and stroke severity (NIHSS<18, ≥18)||||t
1288539|NCT03745378|||Case-Control||Retrospective|||||||
1288540|NCT03745365|||Cohort||Prospective|||||||
1288541|NCT03745352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288542|NCT03745339|||Case-Control||Cross-Sectional|||||||
1288543|NCT03745326|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288544|NCT03745313||||||||||||
1288545|NCT03745300|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288546|NCT03745287||Single Group Assignment||Treatment||None (Open Label)||||||
1288547|NCT03745274|Randomized|Sequential Assignment||Prevention||Double|||t||t|
1288548|NCT03745261|Randomized|Parallel Assignment||Treatment||Single||||||t
1288549|NCT03745248|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will know that the participant has received balance or aerobic training, but will not be aware of which group the participant belonged|Single blind randomized control trial||||t
1288550|NCT03745235|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1288551|NCT03745222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288552|NCT03745209|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1288553|NCT03745196|Randomized|Parallel Assignment||Treatment||Quadruple|This is a double-blind study.||t|t|t|t
1288554|NCT03745183||Single Group Assignment||Treatment||None (Open Label)||This study is a preliminary open label, single arm, before and after clinical trial, that utilized Akapulko (Senna alata),a medicinal plant, leaf decoction in the treatment of tinea imbricata. Enrolled, who were recruited during the outreach mission were taught how to make a community-prepared akapulko decoction and were asked to apply it as a leave-on body wash once a day for 28+/-3 days.||||
1288555|NCT03745170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288556|NCT03745157|||Cohort||Prospective|||||||
1288557|NCT03745144|Randomized|Crossover Assignment||Other||Double|||t||t|
1288558|NCT03745131|||Cohort||Prospective|||||||
1288559|NCT03745118||Single Group Assignment||Basic Science||None (Open Label)||||||
1288560|NCT03745105|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288561|NCT03745092|Randomized|Parallel Assignment||Treatment||Single||||||t
1288562|NCT03745079|||Other||Prospective|||||||
1288563|NCT03745066|||Cohort||Prospective|||||||
1288564|NCT03745053|Randomized|Parallel Assignment||Treatment||Single|The members of the Event Adjudication Committee and the Core Lab will be blinded to the patient assignment.|Randomized multi-centre controlled trial||||t
1288565|NCT03745040|Randomized|Parallel Assignment||Treatment||Single|Subjects will be blinded and will not be informed if they received the study drug or not.|This is a prospective randomized clinical trial with two cohorts: one experimental and one control.|t|||
1288566|NCT03745027||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288567|NCT03745014|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1288568|NCT03745001|Randomized|Parallel Assignment||Treatment||Double|EHP-101 Liquid or matching placebo.|Single center, randomized, double-blind, placebo-controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study|t||t|
1288569|NCT03744988|||Cohort||Prospective|||||||
1288570|NCT03744975|Randomized|Crossover Assignment||Treatment||Double||Triple cross-over study comparing Oral Placebo/Placebo Injection with Oral Placebo/Neseritide Injection with LCZ 696 (Entresto) Oral/Placebo Injection||t|t|
1288571|NCT03744962|||Cohort||Prospective|||||||
1288572|NCT03744949|Randomized|Parallel Assignment||Treatment||Quadruple|remifentanil will be given by a dosage of 0.5-1.0-1.5-2.0 µg/kg of adjusted body weight bolus according to randomization, by an infusion pump over 30 seconds|Four groups of patients. Randomization into the dose of remifentanil given according to a randomization list for a total number of patients of 80.|t|t|t|t
1573269|NCT00001814||||||||||||
1288573|NCT03744936||Single Group Assignment||Health Services Research||None (Open Label)||||||
1288574|NCT03744923|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1288575|NCT03744910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288576|NCT03744897|Randomized|Crossover Assignment||Other||Double|Subjects are blinded to wether group they will be allocated Assessor will be blinded and the investigator not involved in subjects assessment will perform the hypnosis.|"Hypnotic analgesia + a-tDCS~Hypnotic analgesia + s-tDCS~Hypnotic analgesia~a-tDCS"|t|||t
1288577|NCT03744884|Randomized|Parallel Assignment||Diagnostic||Single|Research team members administering clinical assessments will be blinded from participant allocation. Participant's allocation will not be revealed during the course of the study.|A group of children with dystonic or spastic/dystonic cerebral palsy and a group of typical developing children will be randomly assigned to an intervention or control group. The control group will only attend assessment sessions whereas the intervention group will attend both the assessment and intervention sessions.||||t
1288578|NCT03744871||Parallel Assignment||Health Services Research||None (Open Label)||||||
1288579|NCT03744858|||Case-Control||Prospective|||||||
1288580|NCT03744845|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Trial||||
1288581|NCT03744832|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Randomized Controlled Trial.||||
1288582|NCT03744819|||Cohort||Prospective|||||||
1288583|NCT03744806|||Case-Control||Retrospective|||||||
1288584|NCT03744793||Single Group Assignment||Treatment||None (Open Label)||||||
1288585|NCT03744780||Single Group Assignment||Treatment||None (Open Label)||All participants will be assigned to the same intervention.||||
1288586|NCT03744767||Sequential Assignment||Treatment||None (Open Label)||all participants receive fixed monthly intravitreal anti-VEGF injections for 6 months, plus adjuvant treatment during 4 months, followed by 2 months without adjuvant treatment.||||
1288587|NCT03744754|||Cohort||Prospective|||||||
1288588|NCT03744741|||Cohort||Prospective|||||||
1288589|NCT03744728|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1288590|NCT03744715||Single Group Assignment||Treatment||None (Open Label)||||||
1288591|NCT03744702||Single Group Assignment||Treatment||None (Open Label)||||||
1288592|NCT03744689|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1288593|NCT03744676||Single Group Assignment||Treatment||None (Open Label)||||||
1288594|NCT03744663|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients admitted to the WFBMC Medication-Assisted-Therapy (MAT) clinic with a diagnosis of moderate/severe Opioid-Use Disorders (OUD) who are more than 18 years old will be approached for enrollment in this study. Because of the nature of a pilot study, it's proposed a total of 30 patients, 15 in each group. Subjects will be started and titrated to optimal Suboxone® SL dose for 14 days. After the 14 day, the subject will be started on the treatment to which they are randomized, either Suboxone® SL or Sublocade®. Control group -Suboxone®SL: Patients assigned to this group will continue with their already established dose of Suboxone ®SL films for 24 weeks along with weekly therapy. Study drug-Sublocade® group: Patients assigned to this group will receive the study drug (subcutaneously) every 4 weeks for a total of 6 doses along with weekly therapy. At the end of the 24-weeks subjects will continue the medication of their choice within the constraints of their insurance provider.||||
1288595|NCT03744650||Single Group Assignment||Prevention||None (Open Label)|NA.|A two-phase study design will be adopted. Phase 1 is a pilot, two-arm randomized controlled trial (RCT) study and phase 2 is a single group pretest and repeated posttest longitudinal study.||||
1288596|NCT03744637|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1288597|NCT03744624|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1288598|NCT03744611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288599|NCT03744598|||Cohort||Prospective|||||||
1288600|NCT03744585|||Cohort||Retrospective|||||||
1288601|NCT03744572|||Cohort||Prospective|||||||
1288602|NCT03744559|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288603|NCT03744546||||||||||||
1288604|NCT03744533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288605|NCT03744520||Single Group Assignment||Screening||None (Open Label)||||||
1288606|NCT03744507|||Cohort||Prospective|||||||
1288607|NCT03744494|Randomized|Parallel Assignment||Other||Single|The patient, unaware of which surgery was done, would grade the scrotal appearance three months afterwards|Three groups of patients subjected to a type of orchidectomy each|t|||
1288608|NCT03744481|||Cohort||Prospective|||||||
1288609|NCT03744468|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|This is an open-label, multicenter, nonrandomized Phase 1 and Phase 2 clinical trial. Phase 1 will determine the Recommended Phase 2 Dose (RP2D) for the combination of BGB-A425 and tislelizumab. Phase 2 will continue to evaluate the safety but also focus on the efficacy of the combination in select tumor types.||||
1288610|NCT03744455|||Cohort||Prospective|||||||
1288611|NCT03744442|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1288612|NCT03744429||Single Group Assignment||Other||None (Open Label)||||||
1288613|NCT03744416|Randomized|Parallel Assignment||Other||None (Open Label)||Cluster randomised trial.||||
1288614|NCT03744403||Single Group Assignment||Treatment||None (Open Label)||||||
1288615|NCT03744390||Single Group Assignment||Treatment||None (Open Label)||||||
1288616|NCT03744377|||Cohort||Prospective|||||||
1288617|NCT03744364|Randomized|Parallel Assignment||Treatment||Single||||||t
1288618|NCT03744351|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1288619|NCT03744338|||Other||Cross-Sectional|||||||
1288620|NCT03744325|Randomized|Crossover Assignment||Treatment||None (Open Label)||Patients are randomized 2:1 to receive active HE OIT or continue on an elimination diet after which active HE OIT is started.||||
1288621|NCT03744312|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1288622|NCT03744299||Single Group Assignment||Health Services Research||None (Open Label)||||||
1288722|NCT03742986|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573270|NCT00001812||||Treatment||||||||
1288623|NCT03744286||Single Group Assignment||Device Feasibility||None (Open Label)||This is a 2-visit clinical trial to test a novel prototype slip inducing platform device for feasibility and not health outcomes.||||
1288624|NCT03744273||||||||||||
1288625|NCT03744260|||Cohort||Prospective|||||||
1288626|NCT03744247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288627|NCT03744234|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1288628|NCT03744221|Randomized|Crossover Assignment||Basic Science||Triple|Proteins will be packed in non-transparent sealed sachets/jars and labeled with 'protein A/B/C'. Proteins will be flavored to mask taste|double blind, randomised, cross-over, short-term trial in which 36 study subject will participate. Study subjects will receive three protein interventions of 1 week with a washout period of 1 week between interventions. 12 subjects will also receive an acute postprandial digestibility test at the start of the intervention.|t||t|t
1288629|NCT03744208||Single Group Assignment||Treatment||None (Open Label)||||||
1288630|NCT03744195|Randomized|Parallel Assignment||Treatment||Single|This will be a single blinded study.Participants will be randomly allocated to Group (I)|Experimental study|||t|
1288631|NCT03744182|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288632|NCT03744169|||Case-Only||Prospective|||||||
1288633|NCT03744156|Randomized|Parallel Assignment||Treatment||Single||||||t
1288634|NCT03744143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288635|NCT03744130|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1288636|NCT03744117||Single Group Assignment||Treatment||None (Open Label)||||||
1288637|NCT03744104|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1288638|NCT03744091|Randomized|Crossover Assignment||Treatment||None (Open Label)||Participants will be randomly assigned to either 10 mg or 20mg arm||||
1288639|NCT03744078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288640|NCT03744065|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1288641|NCT03744052||Single Group Assignment||Other||None (Open Label)||||||
1288642|NCT03744039|||Cohort||Prospective|||||||
1288643|NCT03744026||Single Group Assignment||Treatment||None (Open Label)||||||
1288644|NCT03744013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||post market prospective, multi-center study||||
1288645|NCT03744000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288646|NCT03743987|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288647|NCT03743974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288648|NCT03743961|||Cohort||Prospective|||||||
1288649|NCT03743948||Single Group Assignment||Other||None (Open Label)||||||
1288650|NCT03743935||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288651|NCT03743922|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1288652|NCT03743909|||Cohort||Retrospective|||||||
1288653|NCT03743896|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|There is no possibility of subjective bias or placebo effect since the primary outcome is the drug concentration in the synovial fluid. Hence no blinding or randomization needed.|Subjects who agreed to participate in the study could decide to be part of the Control group (no intervention) or the Test group (single dose, topical application of Transdermal Glucosamine Cream)||||
1288654|NCT03743883|||Cohort||Retrospective|||||||
1288655|NCT03743870|||Cohort||Prospective|||||||
1288656|NCT03743857|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1288657|NCT03743844|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1288658|NCT03743831|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1288659|NCT03743818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288660|NCT03743805||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288661|NCT03743792|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1288662|NCT03743779|||Other||Retrospective|||||||
1288663|NCT03743766|Randomized|Parallel Assignment||Treatment||None (Open Label)||In the 4-week lead-in phase, subjects will be randomized to one of three arms for 1 cycle (4 weeks) of lead-in treatment with nivolumab, relatlimab, or the combination of nivolumab and relatlimab. Following 1 cycle of lead-in treatment, all subjects will be treated with the combination of relatlimab and nivolumab every 4 weeks.||||
1288664|NCT03743753|Randomized|Parallel Assignment||Other||Double|The plastic surgeon will be blinded to participant's group allocation. The data analyst will also be blinded. They will be presented the data without group identification (i.e., Group A and Group B).|||t||t
1288665|NCT03743740|Randomized|Crossover Assignment||Treatment||Single|||||t|
1288666|NCT03743727||Single Group Assignment||Treatment||None (Open Label)||||||
1288667|NCT03743714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288668|NCT03743701|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1288669|NCT03743688|||Cohort||Prospective|||||||
1288670|NCT03743675|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1288671|NCT03743662|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288672|NCT03743649|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1288673|NCT03743636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288674|NCT03743623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288675|NCT03743610|Randomized|Parallel Assignment||Prevention||Single|||t|||
1288676|NCT03743597|Randomized|Crossover Assignment||Treatment||None (Open Label)||"A computer generated list will allocate each participant to either one of the stockings, the innovative SOCKNLEG, or the standard Sigvaris COTTON stocking. In each participant the examinations will be conducted with both stockings.~The allocated group defines with which stocking the examinations will be conducted first."||||
1288723|NCT03742973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288724|NCT03742960||Single Group Assignment||Treatment||None (Open Label)||||||
1288771|NCT03742349|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288772|NCT03742336|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1288677|NCT03743584|Randomized|Parallel Assignment||Treatment||Triple|The clinical team responsible for the participant (physicians, nurses and others) and involved with direct patient care will not be blinded to allocation group due to the inherent difficulty in blinding the intervention and as temperature is a vital sign required for clinical care. Measures will be taken to ensure that the information about allocation will not disseminate beyond the immediate group of caregivers responsible for patient care. A blinded physician will evaluate the patient for Cardiac function at pre-specified time-Points after randomisation and make a statement on Cardiac function.||t||t|t
1288678|NCT03743571|Randomized|Parallel Assignment||Treatment||Double||Participants will be randomly assigned to receive either sham or anodal (2 mA) tDCS targeting the mPFC during exposure therapy for public speaking anxiety.|t|t||
1288679|NCT03743558||Single Group Assignment||Diagnostic||None (Open Label)||"First consultation: SHS questionnaire submission and clinical examination~Realization of PV and analysis according to the standard criteria of the American Academy of Sleep Medicine~Production of a video at home by the parents according to the following conditions, within 4 days around the PV/PSG :~Second consultation~Collection of the video and the result of the PV~Study exit."||||
1288680|NCT03743545|Randomized|Parallel Assignment||Treatment||None (Open Label)||healthy posterior mandible||||
1288681|NCT03743532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288682|NCT03743519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288683|NCT03743506||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288684|NCT03743493|||Other||Retrospective|||||||
1288685|NCT03743480|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|centralized randomization|||||
1288686|NCT03743467|||Case-Control||Other|||||||
1288687|NCT03743454|||Other||Cross-Sectional|||||||
1288688|NCT03743441|Randomized|Parallel Assignment||Treatment||Quadruple|"Two identical laser devices are used, where one is active and the other is sham. One laser device has a 3x60 mW output power and the other one has 0 mW output power (sham).~These are labelled with yellow or blue tape by a secretary who is otherwise not participating in the study.~Since the laser device has an invisible beam (904 nm wavelength) and is of such low power that heat is not detected, both the participant and the clinician will be blinded."||t|t|t|t
1288689|NCT03743428|Randomized|Parallel Assignment||Basic Science||None (Open Label)|No masking|Head-to-head comparison of apatinib versus bevacizumab plus second-line chemotherapy regimen FOLFIRI for treatment of metastatic colorectal cancer||||
1288690|NCT03743415|Randomized|Sequential Assignment||Supportive Care||Single|Follow-up data collectors will be blind to the arm of the study.|This project will determine which dyads require which intervention sequence: Handbook alone, Handbook alone stepped up with Telephone Interpersonal Counseling (TIP-C) based on demonstrated needs after giving Handbook alone 4 weeks of time, or an combined TIP-C+Handbook for the first 8 weeks then Handbook alone for 4 weeks. Dyads will be initially randomized to either Handbook alone or TIP-C+Handbook. If the survivor's depression or anxiety does not respond to Handbook alone at week 4, dyads will be re-randomized to the TIPC+Handbook or continue with Handbook alone. Outcome data will be collected at baseline, weeks 13 (post-intervention) and 17 (follow-up). Total duration is 17 weeks.||||t
1288691|NCT03743402|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessment will be conducted by Kaiser survey team which will be blind to treatment assignment.|Patients are individually randomized to pain self-management training for opioid taper or usual care. Those randomized to pain self-management training will be offered assistance with opioid taper during approximately the fourth session of pain self-management training.||||t
1288692|NCT03743389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288693|NCT03743376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288694|NCT03743363|Randomized|Parallel Assignment||Treatment||Single|||||t|
1288695|NCT03743337|||Other||Other|||||||
1288696|NCT03743324|||Cohort||Prospective|||||||
1288697|NCT03743311|||Other||Prospective|||||||
1288698|NCT03743298||Single Group Assignment||Treatment||None (Open Label)||||||
1288699|NCT03743285||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1288700|NCT03743272|||Cohort||Cross-Sectional|||||||
1288701|NCT03743259|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288702|NCT03743246||Single Group Assignment||Treatment||None (Open Label)||||||
1288703|NCT03743233|Randomized|Parallel Assignment||Treatment||Single||||||t
1288704|NCT03743220|||Cohort||Retrospective|||||||
1288705|NCT03743207|Randomized|Parallel Assignment||Supportive Care||Triple|The infants were randomly assigned using the last digit of their hospital identification number to two different groups with different feeding temperatures. Only the nurse giving the primary care was not blinded.||t||t|t
1288706|NCT03743194|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288707|NCT03743181|||Cohort||Prospective|||||||
1288708|NCT03743168|Randomized|Parallel Assignment||Treatment||Single||||||t
1288709|NCT03743155||Single Group Assignment||Treatment||None (Open Label)||single arm due to not alternative treatment exist||||
1288710|NCT03743142|||Cohort||Prospective|||||||
1288711|NCT03743129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288712|NCT03743116|||Cohort||Prospective|||||||
1288713|NCT03743103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288714|NCT03743090|||Cohort||Prospective|||||||
1288715|NCT03743077||Single Group Assignment||Supportive Care||None (Open Label)||||||
1288716|NCT03743064|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, Double-Blind, Placebo-Controlled, Multicenter Study|t|t|t|t
1288717|NCT03743051|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, Double-Blind, Placebo-Controlled, Multicenter Study|t|t|t|t
1288718|NCT03743038|Randomized|Parallel Assignment||Treatment||Double||Eligible subjects will be randomized (1:1) to treatment with Test Article A to one side of the face versus Test Article B on the contralateral side.|t|||t
1288719|NCT03743025|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective Placebo controlled randomized study||||
1288720|NCT03743012|Randomized|Parallel Assignment||Treatment||Single||||||t
1288721|NCT03742999|Randomized|Parallel Assignment||Treatment||Single||||||t
1288725|NCT03742947|Randomized|Parallel Assignment||Diagnostic||Double|Double blind|Three blood samples of 20 ml each at T0 after the anesthesia for the caesarean section and before the administration of the product (TXA or placebo), T15 fifteen minutes after the administration of the product and T120, 2 hours after the administration of TRAAP2 study IMP (tranexamic acid or placebo).|t||t|
1288726|NCT03742934|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1288727|NCT03742921|||Cohort||Retrospective|||||||
1288728|NCT03742908|Randomized|Parallel Assignment||Prevention||None (Open Label)|Treatment allocation is revealed to the surgical team intraoperatively. Treatment allocation is revealed to the patient post-op in their first followup visit in the clinics.|Block randomization is generated by one investigator that is not involved in surgery and the block size is kept hidden from other investigators and patients.||||
1288729|NCT03742895||Single Group Assignment||Treatment||None (Open Label)||||||
1288730|NCT03742882||Single Group Assignment||Treatment||None (Open Label)||||||
1288731|NCT03742869|||Case-Control||Prospective|||||||
1288732|NCT03742856|||Case-Control||Prospective|||||||
1288733|NCT03742843|||Case-Control||Prospective|||||||
1288734|NCT03742830|||Case-Only||Prospective|||||||
1288735|NCT03742817|Randomized|Crossover Assignment||Other||Single|||t|||
1288736|NCT03742804||Single Group Assignment||Treatment||None (Open Label)||||||
1288737|NCT03742791|Randomized|Parallel Assignment||Treatment||Double|Double-blind (Participant, Investigator)||t||t|
1288738|NCT03742778|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1288739|NCT03742765|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1288740|NCT03742752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288741|NCT03742739|||Cohort||Prospective|||||||
1288742|NCT03742726||Single Group Assignment||Treatment||None (Open Label)||||||
1288743|NCT03742713||Single Group Assignment||Treatment||None (Open Label)||||||
1288744|NCT03742700|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)|Subjects were divided into 4 groups (n=30 each) based on their self-declared smoking status: control (C), tobacco cigarette smokers (T-Smokers), exclusive e-cigarette users (E-Smokers) and dual users (T/E-Smokers).|This was a laboratory-based intervention study: pre-post-post||||
1288745|NCT03742687|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288746|NCT03742674|||Cohort||Prospective|||||||
1288747|NCT03742661|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Participating physicians will recruit patients meeting the inclusion and exclusion criteria. Upon completion of screening and enrollment procedures study participants will be randomly assigned to one of two groups using a randomized call-in system: treatment or standard of care.~Demographics will be obtained for both groups during this initial clinic visit. The treatment group will be prescribed the Brain Sentinel® SPEAC System for use in the home environment. Study Participants in the standard of care group will be given standard care."||||
1288748|NCT03742648|Randomized|Parallel Assignment||Prevention||None (Open Label)|There is no party who is masked|Participants are assigned to one of two or more groups in parallel for the duration of the study||||
1288749|NCT03742635||Single Group Assignment||Screening||None (Open Label)||"Conduct General Movements Assessments (GMA) both in-person/via telemedicine (real-time) and through recordings (standard of care)."||||
1288750|NCT03742622||Single Group Assignment||Treatment||None (Open Label)|no masking|||||
1288751|NCT03742609|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1288752|NCT03742596|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1288753|NCT03742583|Randomized|Parallel Assignment||Other||Single||||||t
1288754|NCT03742570|||Case-Only||Cross-Sectional|||||||
1288755|NCT03742557|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|A double-blind randomized clinical trial (initially) will be performed, followed by an open-label trial.|t|t|t|t
1288756|NCT03742544|||Cohort||Prospective|||||||
1288757|NCT03742531|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288758|NCT03742518|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1288759|NCT03742505|Randomized|Crossover Assignment||Treatment||Quadruple|The randomization lists will only be accessible to the Methods Centre at the Ottawa Hospital Research Institute and the research pharmacist(s). The active drug and placebo are identical (e.g. colour, consistency, volume, taste, smell, containers).|Pragmatic, Phase III, multi-centre, double-blinded randomized controlled trial|t|t|t|t
1288760|NCT03742492|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1288761|NCT03742479||Single Group Assignment||Treatment||None (Open Label)||Single Group, Open Label Study||||
1288762|NCT03742466|Randomized|Parallel Assignment||Treatment||Single||||||t
1288763|NCT03742453||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288764|NCT03742440||Single Group Assignment||Treatment||None (Open Label)||||||
1288765|NCT03742427||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288766|NCT03742414|Randomized|Parallel Assignment||Prevention||Double||This is a randomized, controlled trial designed for children (total n = 750) who are have already developed atopic dermatitis (AD or eczema) by 10 weeks of age. The aimis to compare the effect of proactive sequential skin care, including the twice daily use of a tri-lipid skin barrier cream (Epiceram) and proactive use of fluticasone proprionate cream, against reactive AD therapy, to reduce the occurrence and severity of AD in early infancy and thereby prevent food allergy (FA).|t||t|
1288767|NCT03742401|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a multicentrer, crossover study with cluster randomization. In the cross over design, 1/2 of the centers are randomized to start the trial with HIFU and the other 1/2 with surgery. In the cluster randomized crossover (CXRO), all participating cluster receive both the intervention and control in a sequence determined at random||||
1288768|NCT03742388|||Cohort||Prospective|||||||
1288769|NCT03742375||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288770|NCT03742362||Single Group Assignment||Other||None (Open Label)||3 groups of women: Group 1: Healthy young women Group 2: Postmenopausal women without Osteoporosis Group 3: Postmenopausal women with Osteoporosis All will undergo the same MRI scans||||
1573271|NCT00001810||||Treatment||||||||
1288773|NCT03742323||Single Group Assignment||Treatment||None (Open Label)||||||
1288774|NCT03742310|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288775|NCT03742297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288776|NCT03742284||Single Group Assignment||Other||None (Open Label)||||||
1288777|NCT03742271||Single Group Assignment||Treatment||None (Open Label)||||||
1288778|NCT03742258||Single Group Assignment||Treatment||None (Open Label)||||||
1288779|NCT03742245||Single Group Assignment||Treatment||None (Open Label)||||||
1288780|NCT03742232|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1288781|NCT03742219||Single Group Assignment||Treatment||None (Open Label)||||||
1288782|NCT03742206|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288783|NCT03742193|Randomized|Parallel Assignment||Treatment||Single|An Independent radiologic reviewing committee assess the radiological tumor response in a blinded manner. Data Safety and Monitoring Board (DSMB) access the outcome in the interim analysis and final analysis|||||t
1288784|NCT03742180|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1288785|NCT03742167|Randomized|Parallel Assignment||Health Services Research||Single|Live and video raters of paramedic performance are blinded to group allocation.|||||t
1288786|NCT03742154|Randomized|Parallel Assignment||Other||None (Open Label)||Participants will be randomized into one of the two study groups, like drawing numbers from a hat. One group will receive a mailed sample of varenicline, and the other will not. Participants have 50/50 chance of being in either group. Both groups will contain equal numbers of smokers motivated to quit and smokers not currently motivated to quit.||||
1288787|NCT03742141||Single Group Assignment||Other||None (Open Label)||All patients enrolled in the study will be in a single group.||||
1288788|NCT03742128|||Cohort||Cross-Sectional|||||||
1288789|NCT03742115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288790|NCT03742102|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Part 1: At least 20 patients will be enrolled in each treatment arm, for a total of approximately 100 patients (durvalumab + paclitaxel arm and 4 triplet combination arms). Additional patients may be enrolled in order to have 20 evaluable (i.e. dosed) patients per arm.~Part 2: Approximately 75 patients will be randomized to each treatment arm, for an anticipated total of at least 150 patients (durvalumab + paclitaxel arm and 1 or more triplet combination arms based on the treatment arm(s) from Part 1 that have met the protocol-defined efficacy criteria)."||||
1288791|NCT03742089|||Case-Only||Prospective|||||||
1288792|NCT03742076|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1288793|NCT03742063|||Cohort||Prospective|||||||
1288794|NCT03742050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288795|NCT03742037|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288796|NCT03742024|||Cohort||Prospective|||||||
1288797|NCT03742011|||Cohort||Prospective|||||||
1288798|NCT03741998|Randomized|Parallel Assignment||Treatment||Single|||t|||
1288799|NCT03741985|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1288800|NCT03741972|||Cohort||Prospective|||||||
1288801|NCT03741959|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor will be blinded. Patients will be specifically asked not to discuss their treatment during assessments. Examiner will be requested to inform the research coordinator if he will discover to which group a patient belonged, and they will periodically be questioned by the coordinator about this.|Parallel Assignment. Single-blind RCT with two parallel group||||t
1288802|NCT03741946||Single Group Assignment||Supportive Care||None (Open Label)||||||
1288803|NCT03741933||Single Group Assignment||Treatment||None (Open Label)||All participants will be patients that have been screened within the Department of Dermatology at the GW MFA. Individuals meeting inclusion and exclusion criteria will be enrolled into the study. A total of 10 patients will be enrolled in the study and each patient will be given Apremilast 30 mg twice daily to be administered for a period of 6 months. Patients will present to clinic for clinical assessments, adverse event monitoring, laboratory testing, and/or photography at the following time periods of therapy: baseline and 2 weeks, 4 weeks, and every 4 weeks thereafter until completion of the 6 month treatment period. Additionally, all patients will be required to return for a 4-week follow up visit after completing the final dose of the study medication.||||
1288804|NCT03741920|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1288805|NCT03741907|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1288806|NCT03741894|Randomized|Parallel Assignment||Prevention||Double||Randomized controlled trial|t|||t
1288807|NCT03741881|||Cohort||Prospective|||||||
1288808|NCT03741868|||Cohort||Prospective|||||||
1288809|NCT03741855|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1288810|NCT03741842|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1288811|NCT03741829|||Case-Only||Prospective|||||||
1288812|NCT03741816|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288813|NCT03741803|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288814|NCT03741790|||Cohort||Retrospective|||||||
1288815|NCT03741777|Randomized|Parallel Assignment||Treatment||None (Open Label)||The children included in this study will be randomly assigned into one of four groups by using randomization.org: Group 1 will consume 3 ml/kg of clear fluid by mouth at 2-hour period before surgical scheduled time, Group 2 will consume 5 ml/kg, Group 3 will consume 7 ml/kg, and Group 4 will consume 10 ml/kg.||||
1288816|NCT03741764||Single Group Assignment||Treatment||None (Open Label)||||||
1288817|NCT03741751|Randomized|Parallel Assignment||Treatment||Single|participants will be masked to the TMS versus sham treatment. Sham treatment will be very similar to active TMS without the active magnetic stimulation|randomized controlled trial|t|||
1288818|NCT03741738|||Case-Control||Prospective|||||||
1288819|NCT03741725|Randomized|Parallel Assignment||Screening||None (Open Label)||3-arm superiority randomized controlled||||
1288820|NCT03741712|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288821|NCT03741699|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective, interventional, randomised, unblinded and controlled study with 2 parallel groups||||
1288822|NCT03741686|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1288823|NCT03741673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288824|NCT03741660|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1288825|NCT03741647|||Case-Only||Prospective|||||||
1288826|NCT03741634|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288827|NCT03741621|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1288828|NCT03741608|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two groups will both participate in the 7-part educational series to reduce high blood pressure. One of the two groups will also be given a blood pressure cuff and will be trained to check their own blood pressure. We will track blood pressure and stress level of both groups for 6 months||||
1288829|NCT03741595||Single Group Assignment||Basic Science||None (Open Label)||||||
1288830|NCT03741582|||Other||Prospective|||||||
1288831|NCT03741569||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288832|NCT03741556|||Case-Only||Prospective|||||||
1288833|NCT03741543||Single Group Assignment||Supportive Care||None (Open Label)||a 12-week health promotion course||||
1288834|NCT03741530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288835|NCT03741517|||Cohort||Prospective|||||||
1288836|NCT03741504|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1288837|NCT03741491|||Other||Cross-Sectional|||||||
1288838|NCT03741478|Randomized|Crossover Assignment||Basic Science||Double|"Participants will be masked to:~Knowing whether they were assigned to the olanzapine or placebo conditions~Knowing whether they were assigned to the intranasal insulin or intranasal placebo conditions.~Investigators will only be masked to the randomization of placebo or olanzapine for the participants, but will know whether the participant receives intranasal insulin or intranasal placebo."|"This study will follow a single-blind, crossover design wherein each participant will participate in all of the 4 possible treatment combinations (intranasal insulin or intranasal placebo, olanzapine or placebo) including:~Intranasal placebo and placebo~Intranasal placebo and olanzapine~Intranasal insulin and placebo~Intranasal insulin and olanzapine"|t||t|
1288839|NCT03741465|Randomized|Sequential Assignment||Other||Single|The ultrasonography was made by a consultant radiologist (M.D.) Although the consultant didn't know which position was for control and which was the one the study evaluates. Although investigators were trying to mask the outcomes assessor; the consultant saw the positions because there is no way to hide the sitting positions of the participants. So there is a paradox if the consultant is masked or not.|"Systematic randomization was made from 150 volunteers, and 50 participants were chosen.~All 50 participants were planned to sit on the stretcher in both of the two positioning techniques sequentially (one after another). The two positioning techniques are 1) sitting fetal position- the SFP ( a traditional position ) and 2) sitting fetal cross-legged- the ASP ( a new position, named as  Anatolian sitting position). The investigator was planned to record all of the participants' anatomical measurements in both of those positioning techniques evaluated via ultrasonography. After each position participants were planned to evaluate each positioning technique's comfort by 5-point numerical rating scale from minimum 1 meaning poor to maximum 5 meaning excellent."||||t
1288840|NCT03741452|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1288841|NCT03741439|Randomized|Parallel Assignment||Treatment||Triple|Patients and who analyzes the data are blind to randomization.|Randomized controlled trial|t|t||t
1288842|NCT03741426|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||Bayesian Adaptive||||
1288843|NCT03741413|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1288844|NCT03741400|Randomized|Parallel Assignment||Treatment||Single|Assessor that will be performing the interval assessments will be blinded to treatment arm.|||||t
1288845|NCT03741387|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1288846|NCT03741374||Single Group Assignment||Treatment||None (Open Label)||||||
1288847|NCT03741361|||Cohort||Prospective|||||||
1288848|NCT03741348|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1288849|NCT03741335|Randomized|Parallel Assignment||Supportive Care||Single|Outcomes assessors will be masked to the participants assigned study arm. Participants will not be formally masked from knowing whether or not they are assigned to an experimental or control group, but every effort will be made not to overemphasize expected outcomes.|3-group, single-blind, parallel design randomized controlled trial||||t
1288850|NCT03741322|||Other||Prospective|||||||
1288851|NCT03741309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288852|NCT03741296|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a study is a multicentre, prospective, parallel, two-arm, randomized controlled trial aiming to assess the efficacy of single stage revision peri-prosthetic joint infection of hip arthroplasty in adult's patients, compared to the current gold standard of care, two-stage revision.||||
1288853|NCT03741283|Randomized|Parallel Assignment||Treatment||Single||||||t
1288854|NCT03741270||Single Group Assignment||Prevention||None (Open Label)||||||
1288855|NCT03741257|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1288856|NCT03741244|Randomized|Parallel Assignment||Treatment||Single||||||t
1288857|NCT03741231|||Cohort||Retrospective|||||||
1288858|NCT03741218|Randomized|Crossover Assignment||Basic Science||Double|GRAP and PLA will have the same aspect, so neither the participant and the care provider will know the received treatment at each stage.|GRAP: dried and milled grape pomaces. PLA: control period. All the subjects will pass the two periods: one half will receive the acute PLA supplementation followed by the acute GRAP supplementation, and the other half will do it inversely. The assignment to each order will be done randomly. Both period will be separated by a two weeks washing period.|t|t||
1288859|NCT03741205|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Participating physicians will recruit patients meeting the inclusion and exclusion criteria. Upon completion of screening and enrollment procedures study participants will be randomly assigned to one of two groups using a randomized call-in system: treatment or standard of care.~Demographics will be obtained for both groups during this initial clinic visit. The treatment group will be prescribed the Brain Sentinel® SPEAC System for use in the home environment. Study Participants in the standard of care group will be given standard care."||||
1288860|NCT03741192|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Participating physicians will recruit patients meeting the inclusion and exclusion criteria. Upon completion of screening and enrollment procedures study participants will be randomly assigned to one of two groups using a randomized call-in system: treatment or standard of care.~Demographics will be obtained for both groups during this initial clinic visit. The treatment group will be prescribed the Brain Sentinel® SPEAC System for use in the home environment. Study Participants in the standard of care group will be given standard care."||||
1288861|NCT03741179|Randomized|Parallel Assignment||Treatment||None (Open Label)||A phase III, multicentric, Randomized, open-label, parallel-group clinical trial||||
1288862|NCT03741166|||Cohort||Prospective|||||||
1288863|NCT03741153|||Case-Control||Prospective|||||||
1288864|NCT03741140|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1288865|NCT03741127||Single Group Assignment||Other||None (Open Label)||||||
1288866|NCT03741114|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which was used.|The study was a double-blind randomized controlled trial carried out in a tertiary University Hospital|t|t|t|t
1288867|NCT03741101||Single Group Assignment||Treatment||None (Open Label)||||||
1288868|NCT03741088||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1288869|NCT03741075|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which was used|The current study was a double-blind randomized controlled trial will be conducted at a tertiary University Hospital|t|t|t|t
1288870|NCT03741062|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1288871|NCT03741049|||Case-Only||Prospective|||||||
1288872|NCT03741036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288873|NCT03741023|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1288874|NCT03741010|||Cohort||Prospective|||||||
1288875|NCT03740997|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1288876|NCT03740984|Randomized|Parallel Assignment||Supportive Care||Triple|"Single blinded. The participant knows which group intervention is being used (music, hypnosis or standard care). This is being told while listening to the Intervention. All care Providers only know which colour mp3 player is being used (white, orange or black)."|"Prospective randomised Trial:~Intervention 1 = hypnosis (hypnotherapy), Intervention 2 = Music therapy; Intervention 3 (Standard care)"||t|t|t
1288877|NCT03740971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288878|NCT03740958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288879|NCT03740945|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288880|NCT03740932|||Other||Cross-Sectional|||||||
1288881|NCT03740919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288882|NCT03740906|||Cohort||Prospective|||||||
1288883|NCT03740893|Randomized|Parallel Assignment||Other||None (Open Label)||"Window of opportunity (WOP), open-label, multi-centre, phase IIa trial comprising multiple non-comparative treatment cohorts with patient allocation via randomisation.~The trial consists of two parts: a post-neoadjuvant chemotherapy preoperative WOP component (PART 1); and a post-operative component (PART 2)."||||
1288884|NCT03740880|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Two groups: 1 groups of patients receiving an early trigger (14mm), the other group receiving a late trigger (17mm)||||
1288885|NCT03740867|Non-Randomized|Parallel Assignment||Other||None (Open Label)||After completion of the program, patients will be divided into two groups according to their cognitive status (Group 1: those with poor cognition; Group 2: those with good cognition). The PR gains of the groups will be compared.||||
1288886|NCT03740854|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1288887|NCT03740841|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1288888|NCT03740828|||Cohort||Prospective|||||||
1288889|NCT03740815||Single Group Assignment||Treatment||None (Open Label)||||||
1288890|NCT03740802|||Cohort||Retrospective|||||||
1288891|NCT03740789|||Cohort||Retrospective|||||||
1288892|NCT03740776|||Cohort||Prospective|||||||
1288893|NCT03740763|Randomized|Parallel Assignment||Treatment||Single|Care Provider and Participants ar not masked. Data analysis of accelerometer data is masked (outcome assessor).|||||t
1288894|NCT03740750|Randomized|Parallel Assignment||Treatment||None (Open Label)||6 different interventions will be tested in parallel on 6 equivalent groups of subjects||||
1288895|NCT03740737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288896|NCT03740724||Single Group Assignment||Treatment||None (Open Label)||||||
1288897|NCT03740711|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled test||||
1288898|NCT03740698|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||"This is a 3-way crossover open-label randomized controlled trial. Description of the three interventions for comparison are as follows:~Sensor augmented pump (combination of insulin pump and continuous glucose monitoring) (open-loop system)~Bio-inspired Artificial Pancreas (closed-loop system) with a fixed bolus calculator~Bio-inspired Artificial Pancreas (closed-loop system) with the Advanced Bolus Calculator for Diabetes (ABC4D)~The intervention in each arm will be assessed over 6 weeks with a minimum 2-week break in between each intervention. During the break participants will revert back to usual pump therapy."||||
1288899|NCT03740685|||Cohort||Cross-Sectional|||||||
1288900|NCT03740672|||Cohort||Prospective|||||||
1288901|NCT03740659|Randomized|Parallel Assignment||Other||Single|Single|A randomized, assessor-blinded, parallel-group study.||||t
1288902|NCT03740646|||Cohort||Prospective|||||||
1288903|NCT03740633|Randomized|Parallel Assignment||Prevention||Single||||||t
1288904|NCT03740620|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1288905|NCT03740607|Randomized|Single Group Assignment||Treatment||Double||randomized prospective cohort|t|||t
1288906|NCT03740594|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1288907|NCT03740581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288908|NCT03740568|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288909|NCT03740555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288910|NCT03740542|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1288911|NCT03740529|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288912|NCT03740516||||||||||||
1288913|NCT03740503|||Cohort||Retrospective|||||||
1288914|NCT03740490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288915|NCT03740477||Single Group Assignment||Prevention||None (Open Label)||||||
1288916|NCT03740464|Randomized|Parallel Assignment||Treatment||Single||||||t
1288917|NCT03740451|Randomized|Parallel Assignment||Treatment||Single|Patients will be divided randomly into 3 groups, using the website www.random.org.|A randomized clinical trial will be conducted where patients will be divided randomly, through the website www.random.org, in three groups: 2 of them will be the experimental group and the other one will be the control group.||||t
1288918|NCT03740438|||Cohort||Prospective|||||||
1288919|NCT03740425|||Cohort||Retrospective|||||||
1288920|NCT03740412|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1288921|NCT03740399|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1288922|NCT03740386|Randomized|Crossover Assignment||Treatment||Double|We use a program to randomize three groups. Double blind study No sham or placebo|Three randomized groups|t||t|
1288923|NCT03740373|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1288924|NCT03740360|||Case-Only||Prospective|||||||
1288925|NCT03740347|||Cohort||Cross-Sectional|||||||
1288926|NCT03740334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288927|NCT03740321|Randomized|Parallel Assignment||Treatment||Triple||Blocked randomized, single blind, prospective study|t|t||t
1288928|NCT03740308|Randomized|Parallel Assignment||Treatment||Double|Double-blinded study (Patients blinding & Outcome-assessor blinding).||t|||t
1288929|NCT03740295|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1288930|NCT03740282||Single Group Assignment||Treatment||None (Open Label)||||||
1288931|NCT03740269|||Other||Other|||||||
1288932|NCT03740256||Single Group Assignment||Treatment||None (Open Label)||||||
1288933|NCT03740243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288934|NCT03740230|||Cohort||Prospective|||||||
1288935|NCT03740217|Randomized|Crossover Assignment||Other||None (Open Label)||Subject will be randomly allocated with different formulations of treatment or conditions (Fasting or Fed) during three periods (P1, P2 and P3).||||
1288936|NCT03740204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288937|NCT03740191||Single Group Assignment||Other||None (Open Label)||||||
1288938|NCT03740178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1288939|NCT03740165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288940|NCT03740152||Single Group Assignment||Treatment||None (Open Label)|Participant receives all three types of light: continuous, pulse, and sham. They do not know when they receive each type of light, but they do know that they will receive all three.|||||
1288941|NCT03740139|Randomized|Parallel Assignment||Health Services Research||Single|Subjects will not know the arm that they are randomized to.|"Participants will be randomized either to the intervention (the Linkage System) or to no additional intervention."|t|||
1288942|NCT03740126|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Multicenter, randomized controlled trial||||
1288943|NCT03740113|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster randomized design of schools||||
1288944|NCT03740100||Single Group Assignment||Treatment||None (Open Label)||Oral administration||||
1288945|NCT03740087|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Baseline blood samples were obtained after 12 hours overnight fast; the postprandial miRNA state was measured after intake of a meal with beef (test meal) that consisted of 200 g roast beef with salad (lettuce, tomato, lentils) and a cup of rice. The control diet consisted of the same intervention, without the roast beef. Each intervention day the meals were prepared with fresh food. Participants ate meals under control of the study staff. Postprandial samples were collected at 2, 4 and 6 hours after the diet intervention. The subjects did not eat or drink again until the end of sample collection.||||
1288946|NCT03740074||Single Group Assignment||Treatment||None (Open Label)||Prospective pilot||||
1288947|NCT03740061|||Cohort||Prospective|||||||
1288948|NCT03740048|Randomized|Parallel Assignment||Treatment||Single||||||t
1288949|NCT03740035||Single Group Assignment||Supportive Care||None (Open Label)||||||
1288950|NCT03740022|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1288951|NCT03740009||Single Group Assignment||Basic Science||None (Open Label)||||||
1288952|NCT03739996||Single Group Assignment||Treatment||None (Open Label)||||||
1288953|NCT03739983||Single Group Assignment||Supportive Care||None (Open Label)||Prospective Simon two-stage study design||||
1288954|NCT03739970|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1288955|NCT03739957||Single Group Assignment||Prevention||None (Open Label)||||||
1288956|NCT03739944|Randomized|Parallel Assignment||Treatment||Single|||||t|
1288957|NCT03739931|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288958|NCT03739918|||Other||Retrospective|||||||
1288959|NCT03739905||Single Group Assignment||Treatment||None (Open Label)||||||
1288960|NCT03739892||Single Group Assignment||Other||None (Open Label)||physiopathological study||||
1288961|NCT03739879||Single Group Assignment||Supportive Care||None (Open Label)||Patients underwent an interview about their medical history, tested spirometry using Carefusion®, and the inspiratory muscle strength was assessed using Micro RPM Carefusion®. The St George Respiratory Questionnaire (SGRQ) was used to assess the health status and the 6-minute Walking Test (6MWT) was conducted to assess functional capacity. Subject exercised using inspiratory muscle trainer (Philips Respironic®) for eight weeks.||||
1288962|NCT03739866|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1288963|NCT03739853|Randomized|Single Group Assignment||Treatment||Single|Blinded assessor will perform clinical evaluations.|||||t
1288964|NCT03739840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288965|NCT03739827|||Cohort||Prospective|||||||
1288966|NCT03739814|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288967|NCT03739801||Single Group Assignment||Treatment||None (Open Label)||||||
1288968|NCT03739788||Single Group Assignment||Treatment||None (Open Label)||||||
1288969|NCT03739775||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288970|NCT03739762|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Participants will be randomized into one of two cohorts/arms: one called i-STAND with coaching sessions focused directly on sitting less and standing more; the other called Healthy Living with coaching sessions focused on various topics related to a healthy lifestyle, but without a focus on standing more. Those randomized to the i-STAND intervention will also be re-randomized half-way through the study, with half of that cohort moving on to phase 2, which involves booster sessions on sitting less and standing more."||||
1288971|NCT03739749|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Multiple group assignment||||
1288972|NCT03739736|||Other||Other|||||||
1288973|NCT03739723|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1288974|NCT03739710|Randomized|Parallel Assignment||Treatment||None (Open Label)|The study will be open-label.|||||
1288975|NCT03739697|Randomized|Parallel Assignment||Prevention||Single|||||t|
1288976|NCT03739684||Single Group Assignment||Diagnostic||None (Open Label)||||||
1288977|NCT03739671|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1288978|NCT03739658|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1288979|NCT03739645||Single Group Assignment||Basic Science||None (Open Label)||A similar analysis will be carried out for experience to identify components with greater proportions for conditioned vs nociceptive stages. Correlation of those proportions with CS+ SCR, pain ratings and pain sensitivity will be taken as confirmatory evidence for components involved in the experience Network. Power analysis for a two-way ANOVA was conducted to determine a sufficient sample size using an alpha of 0.05, power 0.80, a high effect size (pilot data indicate η2 values for main effects > 0.5). Based on these assumptions, we conservatively use a sample size of 40.||||
1288980|NCT03739632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1288981|NCT03739619||Single Group Assignment||Treatment||None (Open Label)||||||
1288982|NCT03739606||Single Group Assignment||Treatment||None (Open Label)||||||
1288983|NCT03739593|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Single injection of AR-1105 dexamethasone intravitreal implant administered in a single eye. As soon as all 20 subjects are enrolled into Cohort 1, Cohort 2 can begin enrolling. Each subject will complete a 6-month primary evaluation period. Residual implant assessment will be performed by 3-field fundus photography at Day 7 and at Months 3, 4, 5, and 6, and if necessary at monthly visits thereafter until the subject requires retreatment, or until 1 month after the implant is no longer visible, or to Month 9, whichever comes first.||||
1288984|NCT03739580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288985|NCT03739567|||Case-Only||Cross-Sectional|||||||
1288986|NCT03739554||Single Group Assignment||Treatment||None (Open Label)||Three to 6 patients will be entered at a given CYC065 dose level. Dose escalation will be 33% until one out of 3 patients experienced a DLT at a given dose level. Dose escalation will continue at 25% if no additional DLT is observed; otherwise, dose escalation will be stopped. At least 6 patients will be treated at RD.||||
1288987|NCT03739541||Single Group Assignment||Basic Science||None (Open Label)||||||
1288988|NCT03739528|Randomized|Parallel Assignment||Prevention||Single||A randomized, parallel-group study||||t
1288989|NCT03739515|Randomized|Parallel Assignment||Health Services Research||Single|"To minimise the possibility of selection bias, a person independent of the recruitment process will complete random group allocation. Computer generated random numbers will be created and placed in sealed envelopes by this independent person. These numbers will be stored in the pre-sealed envelopes in a locked drawer in the Health Research Institute at the Clinical Education and Research Centre (CERC). Allocation will be revealed after recruitment by a telephone call from the dedicated research nurse to this independent person, who will open the next envelope in the sequence and give the randomisation information to the research nurse. Each envelope will be opened on enrolment of an eligible participant. After allocation is revealed, the appropriate intervention will be organised by the team.~In addition, the outcome assessment will be conducted by a research nurse blinded to the patient allocation in order to reduce potential detection bias."|Eligible participants will be randomly assigned to either the experimental group (ED-based HSCP intervention) or the control group (ED routine care). By assigning participants at random, it is possible to infer that any observed group differences are attributable to the independent variable (the intervention under investigation).||||t
1288990|NCT03739502|Randomized|Parallel Assignment||Treatment||None (Open Label)||A Randomized Phase II Study Evaluating the Efficacy of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplantation||||
1288991|NCT03739489|Randomized|Crossover Assignment||Treatment||None (Open Label)||The participant will be received three different sessions of rtms, with wash out 30 days between sessions.||||
1288992|NCT03739476|Randomized|Parallel Assignment||Treatment||Double|double blinded.|one arm treatment. one arm placebo.|t||t|
1288993|NCT03739463|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1289032|NCT03738956||Single Group Assignment||Treatment||None (Open Label)||Eligible patients will be given tofacitinib 5 mg BD ,at the end of 1st and 3rd months they will be assessed for safety and efficacy.At 3rd months if any patient wll not responds then they will be given tofacitinib 10 mg BD,at the end of 6th month they will be assessed for safety and efficacy.If any adverse events occur they will be treated accordingly.||||
1289033|NCT03738943|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants will be assigned to one of three arms of the study. The arms of the study are based on the vasodilators being tested in order to determine the effect of pyridoxine on vasodilation in response to intra-arterial administration of the vasodilators.||||
1289034|NCT03738930|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289035|NCT03738917|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicentre, pragmatic, parallel group, open randomized trial.||||
1573272|NCT00001805||||Treatment||||||||
1288994|NCT03739450|Randomized|Parallel Assignment||Treatment||Single|Blinding will be ensured by allocating to group assignment after baseline assessment is complete, having different staff performing assessments vs delivering the intervention, scheduling meetings with assessors and interventionists separately, and instructing participants to not discuss the intervention with the person calling to complete follow-up assessments.|Participants are randomized and allocated after baseline assessment to PST + Education or Education only via stratified, blocked randomization. Randomization is stratified by participating center and then based on whether a single care partner or multiple care partners are participating for the same patient by participating TBIMS Center. The investigators used a block size of four to ensure equal numbers across groups and to account for potentially small numbers of participants at any given TBIMS Center. Randomization is computer-generated and maintained by the TBI Model Systems National and Statistical Data Center. Allocation assignments for each center are distributed to the site PI and maintained in a password-protected electronic file. Outcome assessors are blinded to intervention allocation.||||t
1288995|NCT03739437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1288996|NCT03739424|Randomized|Single Group Assignment||Other||Double|||t||t|
1288997|NCT03739411|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1288998|NCT03739398|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"LUTRONIC GENIUS Laser is performed on one side and LASEMD Laser is performed on the other. LUTRONIC GENIUS Laser is performed on the other side without energy irradiation. Laser treatment is performed after application of EMLA cream (2.5% lidocaine 2.5% and prilocaine 2.5%) for 30 minutes or more before local anesthesia.~Measurement of hydration, transepidermal water loss, skin pigmentation, redness, and elasticity were performed using a corneometer, a vapometer, a mexameter, and a cutometer before the procedure and on the 7th day after the first operation and 3 months after the last operation. Using an Antera 3D® camera, the skin texture, wrinkles, pores, volume of depressions / elevations, skin color, redness and pigmentation were measured. The change of skin surface and extent of wrinkle were measured using a visuometer, a high-resolution camera."||||
1288999|NCT03739385|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The study is designed as a five-armed, cluster-randomized controlled trial with a 25-week (distributed over a school year) physical exercise training intervention with a 3-month follow-up period (Figure 1). After preliminary assessment (written consent, questionnaires, personal data) the institutions with their participants will be randomly assigned to either the intergenerational group (INT), the two peer-groups PGS (peer group seniors) and PGC (peer group children) or the two control groups CONS (control group seniors) or CONC (control group children). Measurements of psychological wellbeing and physical health will occur on three occasions in all five groups: before intervention start (M1), after the intervention period (M2) and after a 3-month follow-up period (M3).||||
1289000|NCT03739372|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289001|NCT03739359|Randomized|Parallel Assignment||Treatment||Double|Nebulization will be offered in a one room and pulmonary function test will be performed in the other room. Both patients and the pulmonary function test technician will be masked to the group.||t|t||
1289002|NCT03739346|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289003|NCT03739333||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289004|NCT03739320|||Case-Crossover||Prospective|||||||
1289005|NCT03739307|||Cohort||Cross-Sectional|||||||
1289006|NCT03739294|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1289007|NCT03739281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289008|NCT03739268|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1289009|NCT03739255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289010|NCT03739242|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1289011|NCT03739229|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1289012|NCT03739216|||Other||Prospective|||||||
1289013|NCT03739203|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289014|NCT03739190|Randomized|Crossover Assignment||Other||Triple|Each condom will be contained within an individual foil packet on which all branding will been masked. All the condom types will be masked in the same manner and identical boxes will be used for the test and comparator condoms A and B.|The condom types will be tested in a three-way cross-over design where couples will be randomised to use each of the three condom types in a defined order, according to the randomisation schedule.|t||t|t
1289015|NCT03739177|||Cohort||Prospective|||||||
1289016|NCT03739164|||Case-Only||Prospective|||||||
1289017|NCT03739151||Single Group Assignment||Other||None (Open Label)||All participants in this study receive gold-standard behavioral obesity treatment on an individual basis.||||
1289018|NCT03739138|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289019|NCT03739125|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1289020|NCT03739112|Randomized|Parallel Assignment||Prevention||Single|Surveillance personnel is blinded from IP injection|This is a randomized, observer-blind, active comparator-controlled, multicenter, Phase 3 efficacy study.||||t
1289021|NCT03739099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289022|NCT03739086|||Case-Only||Retrospective|||||||
1289023|NCT03739073||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289024|NCT03739060|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289025|NCT03739047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289026|NCT03739034||Single Group Assignment||Treatment||None (Open Label)||Patients are being treated with established lifestyle medicine modalities, tailored to the individual patient need and situation.||||
1289027|NCT03739021|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a randomized, open label study. A series of 60 sealed envelopes: 30 Exparel single shot and 30 Ropivacaine catheter will be blindly open for each of the 60 patients when collecting informed consent."||||
1289028|NCT03739008|||Case-Only||Retrospective|||||||
1289029|NCT03738995|||Cohort||Retrospective|||||||
1289030|NCT03738982||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1289031|NCT03738969|||Cohort||Retrospective|||||||
1289036|NCT03738904|Randomized|Parallel Assignment||Treatment||Single|||||t|
1289038|NCT03738878|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1289039|NCT03738865|Randomized|Crossover Assignment||Treatment||Single|||t|||
1289040|NCT03738852|Randomized|Parallel Assignment||Treatment||Single|blinded||t|||
1289041|NCT03738839|Randomized|Parallel Assignment||Diagnostic||Double|It was not possible for the clinicians and their interventions to be blocked. The patients and the specialists were blinded to the treatment groups when their treatment groups were aware.|Random sequence generation was performed with a computerized random 1:1 allocation using block sizes of 4.|t|||t
1289042|NCT03738826||Single Group Assignment||Health Services Research||None (Open Label)||||||
1289043|NCT03738813|Randomized|Parallel Assignment||Treatment||Single||||||t
1289044|NCT03738800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289045|NCT03738787|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289046|NCT03738774|||Cohort||Prospective|||||||
1289047|NCT03738761|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Treatment is started at Visit 1 with Amlessa® 4mg/5mg (Amlessa® Arm) or Co-Amlessa® 4mg/1,25mg/5mg (Co-Amlessa® Arm) for 4 weeks.~At each of the three follow-up visits (at week 4, week 8 and week 12) patient BP is assessed and if normal office blood pressure was achieved, the treatment with the study medication prescribed for the previous treatment period is continued. If normal office blood pressure was not achieved at any of the follow-up visits (week 4, week 8 and week 12), Amlessa® or Co-Amlessa® strength is increased in accordance with the below sequence.~Amlessa® Arm Amlessa® 4mg/5mg (initial therapy) - Amlessa® 8mg/5mg - Amlessa® 8mg/10mg - Co-Amlessa® 8mg/2,5mg/10mg~Co-Amlessa® Arm Co-Amlessa® 4mg/1,25mg/5mg - Co-Amlessa® 8mg/2,5mg/5mg - Co-Amlessa® 8mg/2,5mg/10mg - end of study no further escalation of study medication dosage~Normal office BP is defined as SBP < 140 mmHg and DBP < 90 mmHg; patients with type 2 diabetes mellitus: SBP < 140 mmHg and DBP < 85 mmHg."||||
1289048|NCT03738748|Randomized|Parallel Assignment||Treatment||Single||||||t
1289049|NCT03738735|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1289050|NCT03738722||Sequential Assignment||Treatment||None (Open Label)||||||
1289051|NCT03738709|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289052|NCT03738696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289053|NCT03738683|||Case-Only||Prospective|||||||
1289054|NCT03738670||Single Group Assignment||Prevention||None (Open Label)||||||
1289055|NCT03738657|||Other||Cross-Sectional|||||||
1289056|NCT03738644|||Cohort||Prospective|||||||
1289057|NCT03738631|||Cohort||Prospective|||||||
1289058|NCT03738618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289059|NCT03738605|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289060|NCT03738592|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1289061|NCT03738579|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study model is modified psuedo-factorial design with a parallel base. The Next Science treatment arm (using TorrentX Wound Wash and BlastX Wound Gel) is compared against 2 controls, one using a standard dressing and another using a standard dressing with an antimicrobial component.||||
1289062|NCT03738566|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized into one of 2 arms.||||
1289063|NCT03738553|||Cohort||Prospective|||||||
1289064|NCT03738540|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1289065|NCT03738527|Randomized|Parallel Assignment||Prevention||Double|"Patients will be randomized by computer generated block randomization using a specific software provided by the department of research.~Their assignment will be placed in an envelope which will be given to the OR circulating nurse who shall open it only once she is in the OR core area. She will bring the appropriate seringes (containing TXA or normal saline) in the Operating Room, will remove the identifying label and packaging, and will give them in a sterile fashion to the surgeons."|"Pilot Randomized Controlled Trial (RCT) with 2 arms: the interventional arm (receiving topical TXA) and the control arm (receiving placebo).~Intervention: Two 10 mL seringes each with 1g TXA (TXA injection solution 100mg/mL) to be applied topically to the mastectomy cavity~Placebo: Two 10 mL seringes containing 10 mL of normal saline to be applied topically to the mastectomy cavity"|t|t||
1289066|NCT03738514|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289067|NCT03738501|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1289068|NCT03738488|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||Study model: Longitudinal, prospective, experimental, multi centric on a cohort of patients diagnosed of Renal Cell Carcinoma with Vascular Involvement from 2018 in either the HUVR or the HURC||||
1289069|NCT03738475|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind|Randomized double-blind placebo-controlled|t|t|t|t
1289070|NCT03738462|||Case-Only||Prospective|||||||
1289071|NCT03738449|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1289072|NCT03738436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289073|NCT03738423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289074|NCT03738410|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||This is a qualitative/quantitative trial that utilizes a Sequential to Parallel intervention study design model. The initial 15 participants (first 5 each that speak English, Spanish, or Haitain Creole) will participate in the Qualitative arm. These participants may also be eligible to roll over into the quantitative portion of the study and randomized to either the control group or the mHealth Intervention group.||||
1289075|NCT03738397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289076|NCT03738384||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1289077|NCT03738371|||Other||Prospective|||||||
1289078|NCT03738358|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1289079|NCT03738345|Non-Randomized|Parallel Assignment||Treatment||Single|The participant will be masked by the flow setting||t|||
1289080|NCT03738332||Single Group Assignment||Supportive Care||None (Open Label)||Pre-and post design||||
1289081|NCT03738319|||Case-Control||Prospective|||||||
1289082|NCT03738306|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289083|NCT03738293|||Case-Control||Retrospective|||||||
1573273|NCT00001797||||Treatment||||||||
1289085|NCT03738267|||Cohort||Retrospective|||||||
1289086|NCT03738254|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1289087|NCT03738241|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1289088|NCT03738228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289089|NCT03738215|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289090|NCT03738202|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289091|NCT03738189|||Cohort||Prospective|||||||
1289092|NCT03738176|Randomized|Parallel Assignment||Treatment||Single||sesame oil in orabase(80 gm CMC -20 gm sesame oil)||||t
1289093|NCT03738163||Single Group Assignment||Treatment||None (Open Label)||infants (0-36 months old), children (3-18 years old) and adults (>18 years old)||||
1289094|NCT03738150||Single Group Assignment||Treatment||None (Open Label)||||||
1289095|NCT03738137|Randomized|Parallel Assignment||Other||Double|||t|t||
1289096|NCT03738124||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1289097|NCT03738111||Single Group Assignment||Treatment||None (Open Label)||||||
1289098|NCT03738098|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The overall design is a Randomized Controlled Trial (RCT), evaluating the use of a novel Communication Tool to facilitate the return of WGS genomic results and comparing it to return of results using routine genetic counseling. The RCT will occur in the context of the performing WGS and TGP for diagnostic purposes in 1,130 children in an effort to assess clinical utility. Children and young adults with specific disorders will be recruited from MS and EM. In the Traditional GC group, participants will receive traditional genetic counseling for the Baseline and Return of Results (ROR1) visits. In the Communication Tool group, they will receive traditional GC for the Baseline visit, and traditional GC plus Communication Tool for the ROR1 visit (see arm descriptions below). Based on the subjects' randomization, they will be scheduled to see a specific genetic counselor, as the genetic counselors will be assigned to a specific arm and will remain in that arm for the duration of the study.||||
1289099|NCT03738085|||Cohort||Retrospective|||||||
1289100|NCT03738072||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289101|NCT03738059|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1289102|NCT03738046||Single Group Assignment||Health Services Research||None (Open Label)||||||
1289103|NCT03738033|||Case-Control||Prospective|||||||
1289104|NCT03738020|Randomized|Parallel Assignment||Treatment||Double||IND approved from KFDA|t|||t
1289105|NCT03738007|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289106|NCT03737994|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1289107|NCT03737981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289108|NCT03737968|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1289109|NCT03737955||Single Group Assignment||Treatment||None (Open Label)||||||
1289110|NCT03737942|||Cohort||Prospective|||||||
1289111|NCT03737929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289112|NCT03737916|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289113|NCT03737903|||Cohort||Prospective|||||||
1289114|NCT03737890|Randomized|Parallel Assignment||Treatment||Single||||||t
1289115|NCT03737877||Single Group Assignment||Other||None (Open Label)||||||
1289116|NCT03737864|Randomized|Single Group Assignment||Treatment||Single||||||t
1289117|NCT03737851|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289118|NCT03737838|||Cohort||Prospective|||||||
1289119|NCT03737825|Randomized|Parallel Assignment||Treatment||Double|Masking: Triple (Participant, Investigator, Outcomes Assessor) Study assessment administrator is blinded to what digital tool the subject has been assigned.||t|||t
1289120|NCT03737812|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289121|NCT03737799|||Cohort||Prospective|||||||
1289122|NCT03737786|Randomized|Parallel Assignment||Treatment||Single||||||t
1289123|NCT03737773|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289124|NCT03737760|||Cohort||Prospective|||||||
1289125|NCT03737747|||Cohort||Retrospective|||||||
1289126|NCT03737734||Single Group Assignment||Treatment||None (Open Label)||||||
1289127|NCT03737721||Single Group Assignment||Treatment||None (Open Label)||This study has been designed as an open-label, non-randomized, single-arm phase II study to investigate the feasibility and efficacy of Avelumab in combination with radiation therapy in patients with unresectable cuSCC.||||
1289128|NCT03737708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289129|NCT03737695|||Other||Prospective|||||||
1289130|NCT03737682|||Cohort||Other|||||||
1289131|NCT03737669|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1289132|NCT03737656|Randomized|Parallel Assignment||Other||None (Open Label)||Single site, open-label, randomized, single-dose, with three groups.||||
1289133|NCT03737643|Randomized|Parallel Assignment||Treatment||Quadruple||The study consists of 2 independent cohorts: 3 double-blind treatment arms cohort for patients with no BRCA mutation, and a single open label arm cohort for patients with BRCA mutation|t|t|t|t
1289134|NCT03737630|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289135|NCT03737617|Randomized|Parallel Assignment||Treatment||None (Open Label)|1 group receiving standard care|1 Group receiving active immunoglobulin replacement therapy||||
1289136|NCT03737604|Randomized|Parallel Assignment||Treatment||None (Open Label)|Unable to mask based on physical characteristics of liposomal bupivacaine|||||
1289137|NCT03737591|||Cohort||Prospective|||||||
1289138|NCT03737578|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||this is an interventional, pragmatic study with minimal risks, exposed / unexposed, prospective, longitudinal, multicentric and national conducted in metropolitan France||||
1289139|NCT03737565|||Case-Only||Prospective|||||||
1289140|NCT03737552|||Case-Control||Prospective|||||||
1289141|NCT03737539|||Cohort||Prospective|||||||
1289142|NCT03737526|||Case-Only||Retrospective|||||||
1289143|NCT03737513|||Case-Only||Retrospective|||||||
1289144|NCT03737500|Randomized|Parallel Assignment||Treatment||Single|||t|||
1289145|NCT03737487|||Cohort||Prospective|||||||
1289146|NCT03737474||Single Group Assignment||Treatment||None (Open Label)||||||
1289147|NCT03737461|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1289148|NCT03737448|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1289149|NCT03737435|||Other||Retrospective|||||||
1289150|NCT03737422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289151|NCT03737409|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1289152|NCT03737396|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)|Patients, nurses and investigators are aware of participating patients' allocation in this cross over validation study. However, nurses would be blinded to the electronic responses of patients.|Participating patients performs self-administered preanaesthesia health screening on an electronic tablet, before receiving nurse-administered health screening using a paper questionnaire by nurses blinded to their electronic responses||||
1289153|NCT03737383||Single Group Assignment||Treatment||None (Open Label)||||||
1289154|NCT03737370|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1289155|NCT03737357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1289156|NCT03737344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289157|NCT03737331|Randomized|Parallel Assignment||Treatment||Single|Participants will be randomly assigned with a block randomization design for one of the four groups: no stimulus (i.e. control), invariant, random and variable stimuli. Subjects will be assigned to unique ID code such as 'S00NC', where S means subject, 00N refers to participant number (i.e., 001 or 100), and C the group condition (N - No stimulus; P - Periodic stimulus; V - Variant stimulus; R - Random stimulus).|Older adults at risk of a fall will participate in an 8-week training program. There will be four groups: no stimulus (i.e., control), invariant, random and variable stimuli. The training program will consist in an 8-week program, 3 sessions per week. For each training session, participants will come to the Biomechanics Research Building for a 30-minute training session (2 x 10-minute walking trials with a 10-minute resting period in between), 3 times per week. During the training session, the subjects will be instructed to walk while viewing and synchronizing the steps with the visual stimulus. In the first session of weeks 3, 5 and 7, the subjects will undergo a reassessment of the preferred stride time, wearing the footswitches. This reassessment will be needed to recalculate the preferred stride time and incorporate it in the stimulus in use, in case it has been changed as an effect of the training.|t|||
1289158|NCT03737318|Randomized|Parallel Assignment||Treatment||Single|All perceptual ratings will be obtained from blinded, naive listeners recruited through online crowdsourcing. Following protocols refined in previous published research, binary rating responses will be aggregated over at least 9 unique listeners per token.|All participants will complete a Dynamic Assessment session (Phase 0) consisting of 2 hours of traditional (non-biofeedback) instruction. Participants will be categorized into high, moderate, and low response groups based on performance in Phase 0, and the response groups will be block randomized to traditional or biofeedback speech treatment. Within the biofeedback condition, individuals will be sub-randomized in equal numbers to receive visual-acoustic or ultrasound treatment. Participants will then complete two phases of speech treatment in their randomly assigned condition. Phase 1 (Acquisition) will consist of high-intensity, highly interactive practice delivered in three 90-minute sessions over one week. Phase 2 (Generalization) will elicit structured practice of /r/ in 16 semiweekly 45-minute sessions over 8 weeks.||||t
1289159|NCT03737305|Randomized|Parallel Assignment||Treatment||Single|The Outcomes Assessor, or secondary investigator does nor have the knowlegde of the group of patients that is being evaluated.|This is a randomized controlled clinical trial, in a unique investigation center, non-blinded, parallel-group, comparative and interpretive study of the results of clinical use of a TMJ distraction device in patients with diagnosis of Articular Disorders, compared to the traditional method of treatment using manual physiotherapy.||||t
1289160|NCT03737292|Randomized|Parallel Assignment||Treatment||Triple||This is a prospective randomized controlled, double blind study.|t|t|t|
1289161|NCT03737279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289162|NCT03737266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289163|NCT03737253|Randomized|Parallel Assignment||Health Services Research||Double|Patients and care providers need to know the type of hormone provided in order to be able to instruct and treat the patient. However, all roles are masked regarding the genotype.|"Women undergoing in vitro fertilization are randomized to either menotropin (urin derivate) or recombinant follicle stimulating hormone.~Inclusion criteria are:~younger than 40 years of age~more than 12 months of unprotected intercourse~normal ovulatory cycles 26-32 days~first or second IVF treatment~indication for IVF is male factor~tubal factor or unexplained infertility.~Exclusion criteria are:~Anti müllerian hormone less than 5pmol or FSH more than 12 cycle day 2-3~Endometriosis~polycystic ovarian syndrome~pre ovarian failure~smoking~male age more than 56.~The succeeding treatment is according to normal procedures at respective clinic.~End points are: total hormonal dosage, number of retrieved oocytes, fertilization rate, rate of blastocyst transfer, pregnancy rate, live birth rate.~Adverse effects e.g overstimulation is recorded."|||t|t
1289164|NCT03737240|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized in a 1 to 1 ratio to receive the study treatment or standard of care.||||
1289165|NCT03737227||Single Group Assignment||Basic Science||None (Open Label)||Fundamental research with 11 male participants in one study arm, all performingflexion and extension of the lumbar spine during cinematographic recordings twice.||||
1289166|NCT03737214||Single Group Assignment||Treatment||None (Open Label)||Multi-center, open-label, uncontrolled, single-arm, extension study||||
1289167|NCT03737201|Randomized|Parallel Assignment||Treatment||Double||randomized, three-arm parallel, two-blinded clinical trial|t|||t
1289168|NCT03737188||Single Group Assignment||Other||None (Open Label)||||||
1289169|NCT03737175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289170|NCT03737162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289280|NCT03735719|||Cohort||Prospective|||||||
1289287|NCT03735628|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1289430|NCT03733769||Single Group Assignment||Treatment||None (Open Label)||||||
1289431|NCT03733756|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1573274|NCT00001790||||Treatment||||||||
1289171|NCT03737149|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a staged cohort study. In the first (pilot) cohort, all participating subjects will utilize the mymobility with Apple Watch platform. In the second (RCT) cohort, approximately 1,000 subjects will be randomized 1:1 to either the mymobility with Apple Watch platform or standard of care SOC. In the third (correlative analytics) cohort, all participating subjects will utilize the mymobility with Apple Watch platform.||||
1289172|NCT03737136|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1289173|NCT03737123||Single Group Assignment||Treatment||None (Open Label)||||||
1289174|NCT03737110|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1289175|NCT03737097|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Both arms will take place in the same period.||||
1289176|NCT03737084|Randomized|Parallel Assignment||Supportive Care||Double||"Intervention group: The compassion intervention (CBCT) will be performed during the period of hospitalization, in the hospital room, and will be applied simultaneously to the patient his caregiver.~Control Group: Patients and caregivers in the control group will receive standard hospital care. Patients and caregivers of the control group will receive the same compassion intervention at the end of the study."|t|t||
1289177|NCT03737071||Single Group Assignment||Basic Science||None (Open Label)||||||
1289178|NCT03737058|||Cohort||Retrospective|||||||
1289179|NCT03737045||Single Group Assignment||Other||None (Open Label)|Participants will have a choice of decision aids (web or paper) and will not be blinded. The study team will be aware of each prototype and decision aid that participants use.|Patients and providers will use a web-based or paper decision aid. They will not be assigned to specific arms or undergo randomized treatment.||||
1289180|NCT03737032|Randomized|Crossover Assignment||Basic Science||Double|The content of each TBS condition will be unknown to participants and to the research staff member conducting assessment of change neural, behavioral, and subjective response with TBS.|All participants will receive intermittent Theta Burst Stimulation (TBS), continuous TBS, and sham TBS mimicking stimulation, in randomized, double-blind order across three sessions.|t|||t
1289181|NCT03737019|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Prospective non-randomized trial with one interventional group and a parallel group without intervention||||
1289182|NCT03737006|||Cohort||Cross-Sectional|||||||
1289183|NCT03736993||Single Group Assignment||Screening||None (Open Label)||||||
1289184|NCT03736980|Randomized|Parallel Assignment||Basic Science||Double||Four independent study groups|t||t|
1289185|NCT03736967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289186|NCT03736954||Single Group Assignment||Prevention||None (Open Label)||pilot study||||
1289187|NCT03736941||Single Group Assignment||Treatment||None (Open Label)||||||
1289188|NCT03736928|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1289189|NCT03736915|Randomized|Crossover Assignment||Treatment||Double|The senior author (T.O.H.P) will perform all injection, and are given three pieces of paper before ever injection, to silently give information on tumescent technique, fingers sequence, syringe-needle combinations sequence and the solution used. Subjects are seated comfortably, behind a screen with a small opening large enough to introduce the tested hand. Both hands are placed on the supine position on the table. Seating positions and hand positions are designed somewhat ergonomics and comfort, to avoid creating bias due to positional discomfort. They could not see any of the procedure and won't know which syringe-needle combinations is used.|: A randomized single-blinded controlled trial is designed for 30 adult male healthy subjects to compare the pain from injection using syringe and needle combination i.e. 1) 1 cc syringe with 26G needle, 2) 3 cc syringe with 26 G needle, and 3) 5 cc needle with 26 G needle. The injection will be performed in any of at the second, third and fourth fingers of either subject's hand randomly. The injection will be SIMPLE block technique using 1 cc of NaCl 0.9% solution under the injection speed of 30 seconds/cc. Subjects are required to rate two check-point of VAS at the timing of needle puncture and just right after the completion of the infiltration. Upon the completion of each finger, the subject is also asked to give response to seri of questions regarding the procedures and their preferences. At the end of all injections, subject is asked to rate his preference of syringe and needle combination.|t|||t
1289190|NCT03736902|||Other||Other|||||||
1289191|NCT03736889||Single Group Assignment||Treatment||None (Open Label)||||||
1289192|NCT03736876|Randomized|Parallel Assignment||Prevention||None (Open Label)||Multi-site independent randomized group treatment trial (IGRT). 1,209 youth randomized to intervention or control conditions within schools. Sample accrues over 2.5 years (Years 2-4)||||
1289193|NCT03736863||Single Group Assignment||Treatment||None (Open Label)||||||
1289194|NCT03736850||Single Group Assignment||Treatment||None (Open Label)||||||
1289195|NCT03736837||Single Group Assignment||Treatment||None (Open Label)||||||
1289196|NCT03736824|||Other||Prospective|||||||
1289197|NCT03736811|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289198|NCT03736798||||||||||||
1289199|NCT03736785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289200|NCT03736772|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1289201|NCT03736759|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1289202|NCT03736746||Single Group Assignment||Supportive Care||None (Open Label)||||||
1289203|NCT03736733|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1289204|NCT03736720||Single Group Assignment||Treatment||None (Open Label)||||||
1289205|NCT03736707|Randomized|Parallel Assignment||Treatment||Triple||Neonates will be randomized and assigned either to selective HFOV or CMV|t||t|t
1289281|NCT03735706|Randomized|Parallel Assignment||Diagnostic||Triple|"A computer random number generator prepares the randomization schedule in a 1:1:1:1 manner, which is balanced randomization. Stratification is performed, based on age (< 60 and ≥ 60 years) and weight < 75 and ≥ 75 kg). Variable block randomization will distribute patients equally over time.~The blinding and randomization process will be conducted by Clinical Trial Centre Maastricht (CTCM, www.CTCM.nl) with a randomization program (ALEA) designed for usage of different techniques."|randomized controlled trial with 4 study arms.|t|t|t|
1289282|NCT03735693|||Cohort||Prospective|||||||
1289283|NCT03735680||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289284|NCT03735667||||||||||||
1289206|NCT03736694|Randomized|Parallel Assignment||Treatment||Double|"After recruitment and assessment for inclusion and exclusion criteria, the participants are randomly assigned with numbers generated by computer and divided equally into 3 groups managed by an independent administrator.~The participants are required to fill in online questionnaires themselves to prevent possible biases during outcome assessments.~The participants will be labelled by numbers without any personal information or intervention group allocated during data analysis."|"A prospective randomized controlled trial (RCT) will be performed to compare the effectiveness of the 3 types of therapies.~After recruitment and assessment for inclusion and exclusion criteria, the participants are randomly assigned with numbers generated by computer and divided equally into 3 groups managed by an independent administrator.~The first intervention group (Group 1) will attend one half-day cognitive behavioural therapy for insomnia (CBTI) workshop in the community setting. The second intervention group (Group 2) will receive self-help CBTI. The control group (Group 3) will receive sleep hygiene education (SHE)."|||t|t
1289207|NCT03736681|Randomized|Parallel Assignment||Treatment||Single||This is a double center, randomized, 2-arm (1:1), single blinded clinical trial comparing pain control at the time of cervical dilation with two different paracervical blocks in women undergoing D&C in the first trimester for either surgical abortion or miscarriage management.|t|||
1289208|NCT03736668||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289209|NCT03736655||Single Group Assignment||Treatment||None (Open Label)||||||
1289210|NCT03736642|||Other||Prospective|||||||
1289211|NCT03736629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289212|NCT03736616|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289213|NCT03736603|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1289214|NCT03736590|Randomized|Parallel Assignment||Prevention||Double|Pediatricians and outcomes assessors will not be aware of study arm.|Randomized controlled trial||t||t
1289215|NCT03736577|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Two-armed cluster randomized trial. As the intervention is to introduce a new way to do drug chart reviews, to prevent contamination bias within the nursing home the whole nursing home will have to be treated as a cluster. The recruited nursing homes will be randomized by a statistician to either intervention or control. Before randomization, both physicians working in the recruited facilities and selected personnel, i.e. specialized nurses, will attend a three hours lecture on dementia, depression and anxiety and psychosis on the elderly.||||
1289216|NCT03736564||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289217|NCT03736551|Randomized|Parallel Assignment||Treatment||Single|Study outcome measures performed by assessor blinded to treatment arm|Parallel arm, single blinded, randomised controlled feasibility study||||t
1289218|NCT03736538|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289219|NCT03736525|Randomized|Parallel Assignment||Other||None (Open Label)|"Participants who will be found suitable for participation and who will agree online to participate in the study, will be randomized into intervention and wait list control groups, using an online software Research Randomizer. The wait list control group will not receive any special treatment during the study. Both groups will be asked to answer the online questionnaires, and after the end of the intervention period the wait list control group will get access to the Facebook group also, to compensate them for participation."|"Participants will be randomized online to intervention and wait list control groups. Intervention group only will be exposed to a new Facebook group, opened specifically for this study. The Facebook group will have a privacy setting of closed group, meaning that only members of the group can see posts. This is to prevent possible contamination, ensuring that members of the control group will not be exposed to the intervention. The intervention period will be 3 months. Participants in both groups will fill pre, mid and post intervention questionnaires. At the end of 3 months, we will change the settings of the group and open it to all, including the wait list control group. That way the control group will get access to the treatment as well, to compensate them for participation."||||
1289220|NCT03736512|||Case-Only||Prospective|||||||
1289221|NCT03736499|||Cohort||Prospective|||||||
1289222|NCT03736486|||Cohort||Cross-Sectional|||||||
1289223|NCT03736473||Single Group Assignment||Other||None (Open Label)||||||
1289224|NCT03736460|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1289225|NCT03736447|Randomized|Parallel Assignment||Treatment||Triple|Double-Blinded|2:1 randomization|t|t|t|
1289226|NCT03736434|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1289227|NCT03736421|||Cohort||Prospective|||||||
1289228|NCT03736408|||Cohort||Prospective|||||||
1289229|NCT03736395|Randomized|Parallel Assignment||Prevention||Single|All data collectors will be masked.|A portion of participating schools will receive the Idaho Rural Implementation Model (I-RIM) intervention, designed to support implementation of schoolwide positive behavioral interventions and supports (SWPBIS). All other participating schools will only receive basic training session about SWPBIS. The process to determine which schools receive the intervention is random. Intervention is at the school level. Outcomes are at the school level, staff level, and student level (anonymous).||||t
1289230|NCT03736382|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289231|NCT03736369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289232|NCT03736356|||Cohort||Prospective|||||||
1289233|NCT03736343|Randomized|Parallel Assignment||Other||Double|||t||t|
1289234|NCT03736330||Single Group Assignment||Treatment||None (Open Label)||Autologous D-CIK (1.0-1.5*10^10 cells) will be transferred to patients via intravenous infusion. Before cell transfer, D-CIK were incubated with anti-PD-1 antibody.||||
1289235|NCT03736317|Randomized|Parallel Assignment||Treatment||Single|||t|||
1289236|NCT03736304|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1289237|NCT03736291|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289238|NCT03736278|||Cohort||Retrospective|||||||
1289239|NCT03736265|Randomized|Parallel Assignment||Prevention||Single||Parallel Assignment|t|||
1289240|NCT03736252|||Cohort||Prospective|||||||
1289241|NCT03736239|||Cohort||Prospective|||||||
1289242|NCT03736226|||Other||Prospective|||||||
1289285|NCT03735654|||Case-Only||Cross-Sectional|||||||
1289286|NCT03735641|||Case-Only||Retrospective|||||||
1573275|NCT00001789||||Treatment||||||||
1289243|NCT03736213|Randomized|Factorial Assignment||Treatment||Single|All perceptual ratings will be obtained from blinded, naive listeners recruited through online crowdsourcing. Following protocols refined in previous published research, binary rating responses will be aggregated over at least 9 unique listeners per token.|In this single-case randomization design, each participant will receive an equal number of sessions of visual-acoustic and ultrasound biofeedback, with randomized allocation of treatment types to individual sessions. Treatment will last 20 hrs (10 days) over a 5 week period. Randomization will be blocked, with each day of treatment serving as a block; within each day, one hour of treatment will be randomly assigned to feature visual-acoustic and one to feature ultrasound treatment. A congruent condition and an incongruent condition will be defined for each participant based on their sensory profile, where the congruent condition is the biofeedback type that is expected to be more effective and the incongruent condition is the type expected to be less effective. Visual-acoustic biofeedback is defined as the congruent condition for individuals with a primary auditory deficit and ultrasound biofeedback is defined as congruent for individuals with a primary somatosensory deficit.||||t
1289244|NCT03736200|Randomized|Parallel Assignment||Treatment||Single|||||t|
1289245|NCT03736187|Randomized|Parallel Assignment||Prevention||Single|Two equal groups,140 women in each group|2 Groups of obese women under elective cesarean section|t|||
1289246|NCT03736174|||Case-Control||Prospective|||||||
1289247|NCT03736161|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label randomized trial||||
1289248|NCT03736148|Randomized|Parallel Assignment||Treatment||Double|Electromyographic signal and skin conductance were assessed by blinded assessors before and immediately after the intervention. The participants were not aware of their assigned group.|Double blind randomized control placebo trial|t|||t
1289249|NCT03736135|||Cohort||Prospective|||||||
1289250|NCT03736122||Single Group Assignment||Treatment||None (Open Label)||||||
1289251|NCT03736109|||Case-Control||Prospective|||||||
1289252|NCT03736096|||Case-Only||Prospective|||||||
1289253|NCT03736083|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study team will enroll 52 consecutive new onset type 1 diabetes patients and stratify the subjects into two groups, age 4-10 vs 11-17, aiming for 26 subjects in each group. Participants will be randomized to one of the two groups using blocked randomization with random block sizes of 2 and 4, stratified by age (4-10 vs. 11-17).||||
1289254|NCT03736070|||Cohort||Prospective|||||||
1289255|NCT03736057|||Cohort||Prospective|||||||
1289256|NCT03736044|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"Group A: patients on treatment with TNF-blockers plus DMARDs~Group B: patients treated with DMARDs only (Methotrexate/Leflunomide), never treated with anti-TNF.~In addition a cohort of healthy subjects matched for sex and age used as a control."||||
1289257|NCT03736031|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1289258|NCT03736018|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1289259|NCT03736005|||Cohort||Prospective|||||||
1289260|NCT03735992|Randomized|Parallel Assignment||Treatment||Single||||||t
1289261|NCT03735979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289262|NCT03735966||Single Group Assignment||Treatment||None (Open Label)||||||
1289263|NCT03735953|Randomized|Parallel Assignment||Screening||Double|||t|||t
1289264|NCT03735940|Randomized|Parallel Assignment||Screening||None (Open Label)||"In this study ICU departments will be randomized with respect to the time they will introduce the DeltaScan following a stepped wedge cluster randomization design. All departments apply 'usual care' in combination with a harmonized delirium treatment protocol during the control phase. After this first time period, each new time period a department switches to the intervention period.~This design has a number of advantages. It is especially appropriate when the intervention encompasses the implementation of a change in logistics, procedures, or information use, which is the case in our trial comparing two diagnostic strategies in patients at risk of delirium (usual care delirium screening and the introduction of the DeltaScan). Furthermore, it allows adjusting the implementation to the local setting in each participating hospital. This ensures that the study design more closely resembles daily clinical practice, resulting in realistic effect estimates conform daily practice."||||
1289265|NCT03735927|Randomized|Parallel Assignment||Screening||None (Open Label)||"In this study hospital departments will be randomized with respect to the time they will introduce the DeltaScan following a stepped wedge cluster randomization design. All departments apply 'usual care' in combination with a harmonized delirium treatment protocol during the control phase. After this first time period, each new time period a department switches to the intervention period.~This design has a number of advantages. It is especially appropriate when the intervention encompasses the implementation of a change in logistics, procedures, or information use, which is the case in our trial comparing two diagnostic strategies in patients at risk of delirium (usual care delirium screening and the introduction of the DeltaScan). Furthermore, it allows adjusting the implementation to the local setting in each participating hospital. This ensures that the study design more closely resembles daily clinical practice, resulting in realistic effect estimates conform daily practice."||||
1289266|NCT03735914||Single Group Assignment||Other||None (Open Label)||||||
1289267|NCT03735901|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind|Study participants will be randomized 1:1|t|t|t|t
1289268|NCT03735875||Single Group Assignment||Treatment||None (Open Label)||||||
1289269|NCT03735862|||Cohort||Retrospective|||||||
1289270|NCT03735849|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289271|NCT03735836|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Randomized study with two parallel treatment arms.||||
1289272|NCT03735823|||Cohort||Prospective|||||||
1289273|NCT03735810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289274|NCT03735797|||Cohort||Prospective|||||||
1289275|NCT03735784|Randomized|Parallel Assignment||Prevention||Single|||||t|
1289276|NCT03735771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289277|NCT03735758|Randomized|Parallel Assignment||Treatment||None (Open Label)||multicentric, controlled, randomized, open Label, parallel-group, prospective||||
1289278|NCT03735745|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1289279|NCT03735732|||Case-Control||Cross-Sectional|||||||
1289288|NCT03735615|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||10 patients with stable chronic obstructive lung disease (COPD) stage 3 and 4 according to GOLD guidelines (www.goldcopd.org), recruited from outpatient ward of the Lung Department at St Olav University Hospital. Control group of 10 age-matched but otherwise healthy subjects||||
1289289|NCT03735602||Single Group Assignment||Basic Science||None (Open Label)||||||
1289290|NCT03735589||Single Group Assignment||Treatment||None (Open Label)||||||
1289291|NCT03735576|Randomized|Parallel Assignment||Treatment||Single||Randomized, multi-center, single blind (observer-blinded), active-controlled, parallel group trial (therapeutic confirmatory) in 248 patients with late-life depression of both genders at 7 trial sites in Germany. The intervention includes 8 weeks of manual-based, individual, 15-session, twice weekly, outpatient treatment for patients with late life depression in each arm of the trial.||||t
1289292|NCT03735563|Randomized|Parallel Assignment||Treatment||Quadruple|The investigators and medical staff are blinded to the fact which study medication is given. A pharmacist or a nurse not participating in treatment of the child in question prepares the drug. Preparation of the study drug is done in a different location than where the treatment takes place.||t|t|t|t
1289293|NCT03735550|||Cohort||Cross-Sectional|||||||
1289294|NCT03735537|Randomized|Parallel Assignment||Treatment||Single|Images of incident fractures and vertebral fractures will be assessed by an independent clinical adjudicator blinded to treatment allocation.|Multicentre, parallel arm, open-label, phase IV randomised controlled trial||||t
1289295|NCT03735524||Single Group Assignment||Treatment||None (Open Label)||||||
1289296|NCT03735511|||Other||Retrospective|||||||
1289297|NCT03735498||Single Group Assignment||Supportive Care||None (Open Label)||||||
1289298|NCT03735485|Randomized|Factorial Assignment||Treatment||Single|Participants did not know which treatment group they were in.|There were three study groups: 1. The control group: Participants in this group received only conventional physiotherapy treatment. 2. The shoulder mobilization group: Participants in this group received conventional physiotherapy and shoulder joint mobilization techniques as treatment. The Proprioceptive Neuromuscular Facilitation (PNF) group. Participants in this group received conventional physiotherapy and PNF exercises as treatment.|t|||
1289299|NCT03735472|||Cohort||Prospective|||||||
1289300|NCT03735459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289301|NCT03735446||Single Group Assignment||Treatment||None (Open Label)||||||
1289302|NCT03735433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289303|NCT03735420|Randomized|Parallel Assignment||Other||Double|"Randomization will occur in up to 8 blocks of 4 based on biological sex. Initial randomization series will be generated using readily available random sequence generators designed to do so. A series of sequential envelopes will be generated, each containing the allocation for one participant. Envelopes will be opaque and signed across the seal. The randomization code will be kept in a sealed envelope with a signature across the label and dated the day of creation. Study product and comparator (placebo) will be compounded and placed in identical opaque capsules outside the institution."|Participants will be randomized to receive either encapsulated xanthohumol in a rice protein vehicle, or an identical capsule containing vehicle alone.|t||t|
1289304|NCT03735407||Single Group Assignment||Diagnostic||None (Open Label)||Prospective, Multi-center, Single-arm, safety study||||
1289305|NCT03735394||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289306|NCT03735381|Randomized|Parallel Assignment||Prevention||Single|Participants know they will be selected for either a pedometer group or a not pedometer group. They wil not know if the intervention is minimum (pedometer only) or maximum (pedometer and a goal of 11000 steps/day)||t|||
1289307|NCT03735368|Randomized|Parallel Assignment||Treatment||Quadruple|The patients, the surgeons and the research team will be blinded to the randomization.||t|t|t|t
1289308|NCT03735355|Randomized|Parallel Assignment||Treatment||Single||||||t
1289309|NCT03735342|Randomized|Parallel Assignment||Health Services Research||Single|To minimize selection bias, study research assistants and enrolled discharging providers are blinded to participants' (patients') study arm allocation until after participants are enrolled in the study.||||t|
1289310|NCT03735329||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289311|NCT03735316|Randomized|Parallel Assignment||Supportive Care||Triple|Masking and blinding will be carried out by the research pharmacy with unmasking to be performed at study completion through the research pharmacy and statistician.||t|t|t|
1289312|NCT03735303|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1289313|NCT03735290|Randomized|Sequential Assignment||Treatment||None (Open Label)||Single arm phase 1b. Randomized phase 2.||||
1289314|NCT03735277||Single Group Assignment||Treatment||None (Open Label)||||||
1289315|NCT03735264||Single Group Assignment||Treatment||None (Open Label)||Anlotinib and Docetaxel||||
1289316|NCT03735251|||Cohort||Prospective|||||||
1289317|NCT03735238|||Case-Only||Other|||||||
1289318|NCT03735225|Randomized|Sequential Assignment||Treatment||Quadruple||Dose escalation|t|t|t|t
1289319|NCT03735212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289320|NCT03735199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289321|NCT03735186|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1289322|NCT03735173|Randomized|Parallel Assignment||Treatment||Single|||t|||
1289323|NCT03735160|||Case-Only||Prospective|||||||
1289324|NCT03735147||Single Group Assignment||Prevention||None (Open Label)||||||
1289325|NCT03735134|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289326|NCT03735121||Sequential Assignment||Treatment||None (Open Label)||Intervention study model can be sequential or in parallel.||||
1289327|NCT03735108|||Case-Control||Prospective|||||||
1289328|NCT03735095||Single Group Assignment||Treatment||None (Open Label)||||||
1289329|NCT03735082||Single Group Assignment||Treatment||None (Open Label)||||||
1289423|NCT03733860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289424|NCT03733847|||Cohort||Prospective|||||||
1289425|NCT03733834|||Case-Control||Prospective|||||||
1289426|NCT03733821|||Cohort||Retrospective|||||||
1289605|NCT03731494|||Cohort||Prospective|||||||
1289330|NCT03735069|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study will be a prospective case series study; VPT (IPT, partial or complete pulpotomies) will be done depending on the severity of the case (depth of caries/pulpal involvement, symptoms and response to vitality testing). The study will include about 150 hypomineralized first permanent molars, patients age will range from 6-16 years old. Sample will be divided into 3 groups according to the treatment that will be provided (IPT / Cvek pulpotomy / Cervical pulpotomy). Patients' teeth will be randomly allocated to different treatment procedures (IPT or pulpotomy) using random tables.||||
1289331|NCT03735056|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1289332|NCT03735043||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289333|NCT03735030|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1289334|NCT03735017|Randomized|Parallel Assignment||Treatment||Double|Participants and key research staff assessing outcomes will be blind to condition allocation.|Participants will be randomly assigned to one of two intervention arms. Both groups receive the same number of sessions, duration of sessions, and measures procured.|t|||t
1289335|NCT03735004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289336|NCT03734991|Randomized|Parallel Assignment||Treatment||Triple||randomized, placebo-controlled, double-blind study|t|t|t|
1289337|NCT03734978|||Cohort||Retrospective|||||||
1289338|NCT03734965|Randomized|Crossover Assignment||Treatment||Single|||||t|
1289339|NCT03734952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289340|NCT03734939|||Other||Cross-Sectional|||||||
1289341|NCT03734926|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289342|NCT03734913|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289343|NCT03734900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289344|NCT03734887|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The intervention will enroll 70 patients over a 6-month period. Investigators will provide each patient with a smart pill bottle to sync medication use data with their phones and provide real-time data about adherence to study staff. After completing a baseline survey, investigators will confirm eligibility (including confirmation of loved ones' willingness to receive text messages), and randomize eligible patients to one of the two study arms. With synced data from the smart pill box, investigators will provide biweekly feedback about adherence in the form of a brief text message, including a comparison to the patient's adherence in the preceding week. Biweekly feedback will be provided for 12 weeks and semi-structured interviews will be performed among a random subsample of participants afterward.||||
1289345|NCT03734874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289346|NCT03734861|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Patients will be randomized to one of two arms:~BreathSmart system~Standard of Care"||||
1289347|NCT03734848|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1289348|NCT03734835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289349|NCT03734822||Single Group Assignment||Other||None (Open Label)||||||
1289350|NCT03734809||Single Group Assignment||Treatment||None (Open Label)||||||
1289351|NCT03734796|||Cohort||Prospective|||||||
1289352|NCT03734783|||Case-Control||Cross-Sectional|||||||
1289353|NCT03734770|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomized trial||||
1289354|NCT03734757||Single Group Assignment||Other||None (Open Label)||||||
1289355|NCT03734744|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289356|NCT03734731||Single Group Assignment||Treatment||None (Open Label)||Individual physician patient studies with all products and services being used on FDA label. Study process being referred to in NCD 310.1 as Clinical Trial Policy (CTP), will be approved by the Principal Investigator||||
1289357|NCT03734718|Randomized|Crossover Assignment||Basic Science||Triple|The peptides/placebo is prepared, in a randomized fashion, by a laboratory assistant.|placebo-controlled, double-blinded, cross-over study|t|t|t|
1289358|NCT03734705|Randomized|Parallel Assignment||Basic Science||Single|Participants will be randomly assigned to imaginal exposure writing intervention or neutral control writing.||t|||
1289359|NCT03734692||Single Group Assignment||Treatment||None (Open Label)||||||
1289360|NCT03734679||Single Group Assignment||Treatment||None (Open Label)||||||
1289361|NCT03734666|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1289362|NCT03734653||Single Group Assignment||Treatment||None (Open Label)||This is a longitudinal pilot, single arm, interventional study.||||
1289363|NCT03734640|Randomized|Sequential Assignment||Supportive Care||Double|Guardian consent for intervention as standard of care service provision. Outcome assessed by independent researcher blind to treatment allocation|stepped wedge cluster randomized|t|||t
1289364|NCT03734627|||Case-Control||Prospective|||||||
1289365|NCT03734614|||Cohort||Prospective|||||||
1289366|NCT03734601||Single Group Assignment||Treatment||None (Open Label)||||||
1289367|NCT03734588||Single Group Assignment||Treatment||None (Open Label)||||||
1289368|NCT03734575|||Cohort||Prospective|||||||
1289369|NCT03734562|Randomized|Parallel Assignment||Treatment||Single|ICD therapy analysis and outcome adjudication is performed by physicians blinded to the study group.|||||t
1289370|NCT03734549|||Cohort||Prospective|||||||
1289371|NCT03734536|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289372|NCT03734523|||Cohort||Prospective|||||||
1289373|NCT03734510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289374|NCT03734497|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomised||||
1289375|NCT03734484|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1289376|NCT03734471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289377|NCT03734458|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1289427|NCT03733808|Randomized|Parallel Assignment||Treatment||Quadruple||Double blind, randomized, sham-controlled with a 1:1 allocation into 2 parallel arms|t|t|t|t
1289428|NCT03733795|||Other||Prospective|||||||
1289429|NCT03733782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573276|NCT00001782||||||||||||
1289378|NCT03734445|Randomized|Parallel Assignment||Treatment||Double|Vitamin Supplement and placebo will be packaged by others not including the investigators, code will be kept secret until the end of the trial or unless a secondary effect is registered and merits the opening of the code|Subjects will be randomly allocated to two groups (vitamin supplement or placebo), with a duration of 24 weeks. Dietary and compliance monthly follow-up and baseline, 12 and 24-week measurements.|t||t|
1289379|NCT03734432||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1289380|NCT03734419|||Other||Other|||||||
1289381|NCT03734406|Randomized|Parallel Assignment||Other||Double||"We designed a multicentric, pragmatic, parallel groups trial, with 1:1 randomization, that will involve patients discharged from EDs with a diagnosis of atrial fibrillation (AF) or deep vein thrombosis (DVT).~The study aims to demonstrate the superiority of the intervention in terms of efficacy of doctor-patient communication at the ED, assessed with a telephone interview that will be conducted within 48 hours from patient's discharge."|||t|t
1289382|NCT03734393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289383|NCT03734380|Randomized|Parallel Assignment||Treatment||Single||||||t
1289384|NCT03734367|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1289385|NCT03734354|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1289386|NCT03734341|Randomized|Crossover Assignment||Treatment||Single|||t|||
1289387|NCT03734328|Randomized|Parallel Assignment||Prevention||Single||Randomized controlled trial||||t
1289388|NCT03734315|||Other||Prospective|||||||
1289389|NCT03734302||Single Group Assignment||Other||None (Open Label)||||||
1289390|NCT03734289|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Caregivers will be randomized in a 1:1 ratio for immediate intervention vs. a 6 week delayed intervention||||
1289391|NCT03734276|Randomized|Parallel Assignment||Treatment||None (Open Label)||feasibility Study with randomized control trial||||
1289392|NCT03734263||Single Group Assignment||Treatment||None (Open Label)||||||
1289393|NCT03734250|||Case-Control||Prospective|||||||
1289394|NCT03734237|Randomized|Parallel Assignment||Prevention||None (Open Label)||A total of 10,650 eligible subjects (or 3,550 subject distributed evenly between the 3 study arms) will be enrolled. eligible subjects will be randomized in 1:1:1 (cell-culture-based vaccine, the recombinant vaccine, or the egg-based vaccine) over two influenza seasons (2019-2020, 2020-2021).||||
1289395|NCT03734224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289396|NCT03734211|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1289397|NCT03734198||Single Group Assignment||Treatment||None (Open Label)||Open label multicentre phase 2 study||||
1289398|NCT03734185|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1289399|NCT03734172|||Cohort||Prospective|||||||
1289400|NCT03734159|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1289401|NCT03734146|Randomized|Parallel Assignment||Basic Science||Single|The outcomes assessor was blinded to treatment group allocation.|randomized controlled trial||||t
1289402|NCT03734133||Single Group Assignment||Treatment||None (Open Label)||||||
1289403|NCT03734120|||Cohort||Prospective|||||||
1289404|NCT03734107|Randomized|Parallel Assignment||Treatment||Single||Participants are randomized in a 1:1 ratio to the intervention group or standard care comparison group||||t
1289405|NCT03734094|Randomized|Parallel Assignment||Treatment||Single|||t|||
1289406|NCT03734081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289407|NCT03734068|||Cohort||Prospective|||||||
1289408|NCT03734055|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1289409|NCT03734042|Randomized|Parallel Assignment||Treatment||Single||2 groups parallel|t|||
1289410|NCT03734029|Randomized|Parallel Assignment||Treatment||Quadruple||Parallel model, randomized at a 2:1 ratio|t|t|t|t
1289411|NCT03734016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289412|NCT03734003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289413|NCT03733990|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose-escalation, four dose levels||||
1289414|NCT03733977|||Other||Prospective|||||||
1289415|NCT03733964|Randomized|Crossover Assignment||Treatment||Triple|None of the physicians were personally involved in the preparation and the manner of performing the test. Before commencing the tests, each patient was familiarised with their course, expressed their informed written consent for participation and random assignment to a specified tested group. The author of this paper had no influence on the categorisation of patients into individual treatment groups. During the studies, the physicians performing the categorisation were not informed about the results of the used treatment. However, on request they could acquire information about the result of using the procedures for a single patient. They were also informed about the occurrence of any undesired events.|"The patients were randomly divided into four groups of 50 people: the manual therapy group (A), the PNF method group (B), the manual therapy and the PNF method group (C), as well as the traditional kinesiotherapy group (D).~Therapy in all groups proceeded for ten days during a period of two weeks. Measurements of pain intensity using visual analogue pain scale (VAS) and a modified Laitinen's pain questionnaire were carried out four times (before the start of the therapy, in the middle of it, immediately after its completion and two weeks after the end of the treatment). The clinical examination (goniometric measurements of range of motion of the spine) and the evaluation of nerve root irritation (Laseque's and Mackiewicz's signs) was done twice - before and immediately after the treatment."|t|t|t|
1289416|NCT03733951||Single Group Assignment||Treatment||None (Open Label)||||||
1289417|NCT03733938|||Cohort||Prospective|||||||
1289418|NCT03733925||Single Group Assignment||Treatment||None (Open Label)||||||
1289419|NCT03733912|||Case-Control||Cross-Sectional|||||||
1289420|NCT03733899|Randomized|Crossover Assignment||Treatment||Single|||t|||
1289421|NCT03733886|Randomized|Crossover Assignment||Treatment||Quadruple||"N-of-1-study.~Each patient will go through three treatment cycles each consisting of two weeks of active treatment and two weeks of sham in randomised order. In total the study period will be 12 weeks."|t|t|t|t
1289422|NCT03733873|Randomized|Parallel Assignment||Treatment||Single||group1 desmopressin group2 desmopressin plus Suoquan mixture|t|||
1289432|NCT03733743||Single Group Assignment||Basic Science||None (Open Label)||Standardized living protocol||||
1289433|NCT03733730|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289434|NCT03733717||Single Group Assignment||Treatment||None (Open Label)||||||
1289435|NCT03733704||Single Group Assignment||Basic Science||None (Open Label)||Spontaneous ventilation via an obstructing plastic tube||||
1289436|NCT03733691|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized, open label, Phase 2 study involving two arms evaluating the efficacy and safety of ixazomib monotherapy (with steroids if applicable) and the combination of ixazomib and lenalidomide (with steroids if applicable) as maintenance therapy for patients with MM who have achieved at least PR after receiving a bortezomib and lenalidomide (with steroids if applicable)-containing combination frontline therapy.||||
1289437|NCT03733678|Randomized|Sequential Assignment||Health Services Research||Single|Participants are masked in some interventions related to the workings of the tablet-based decision-support tool, but not to the price discounts they receive for the contraceptive methods.|"The study independently experiments with two aspects of the health provider-client relationship:~First, a tablet-based counseling app that is used by the provider gives random discounts to clients - separately for LARCs and SARCs.~Second, the tablet-based app presents recommendations to the client sequentially (i.e. the top-ranked method, followed by the next one if that recommendation is declined by the client, etc.) vs. simultaneously (i.e. presenting the top recommendations to the client all at once and asking her to choose which one to discuss further)."|t|||
1289438|NCT03733665|||Cohort||Other|||||||
1289439|NCT03733652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289440|NCT03733639|Randomized|Parallel Assignment||Prevention||Single|Patients won't know if his anastomoses has been reinforced with Tisseel®.||t|||
1289441|NCT03733626|Randomized|Parallel Assignment||Treatment||Single|Participants will be blinded to the randomization group and which bone graft is used during surgery|Subjects will be randomized to either: 1) treatment arm where the investigator will use an FDA approved/cleared DePuy Synthes spinal pedicle screw system with ViviGen® Cellular Bone Matrix mixed with cortical/cancellous allograft or the 2) control arm where the investigator use the same DePuy Synthes spinal pedicle screw system with local autologous bone graft mixed with cortical/cancellous allograft. Randomization is 1:1|t|||
1289442|NCT03733613|||Other||Other|||||||
1289443|NCT03733600|||Cohort||Retrospective|||||||
1289444|NCT03733587||Sequential Assignment||Treatment||None (Open Label)||||||
1289445|NCT03733574|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1289446|NCT03733561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289447|NCT03733548||Single Group Assignment||Treatment||None (Open Label)||Pilot trial to finish developing and refining the intervention||||
1289448|NCT03733535||Single Group Assignment||Treatment||None (Open Label)||Open-label, single arm||||
1289449|NCT03733522|Randomized|Parallel Assignment||Treatment||Single|Only the evaluator of the restorations will be blind to the type of treatment (absolute or relative isolation). As the procedures are different, it will not be possible to blind operators and patients.|||||t
1289450|NCT03733509|Randomized|Parallel Assignment||Treatment||Quadruple|Total blind (patient, physicians, outcome assessors and statistician) Closed envelope by independent randomizer is given to physician assistant. The assistant prepares randomly allocated placebo or local anesthetic. Group is coded so that statistician is also blind|Two arm, randomly assigned|t|t|t|t
1289451|NCT03733496|||Cohort||Prospective|||||||
1289452|NCT03733483||Single Group Assignment||Other||None (Open Label)||Subjects are their own controls, with baseline measurements serving as the control values prior to intervention.||||
1289453|NCT03733470|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1289454|NCT03733457||Single Group Assignment||Health Services Research||None (Open Label)||||||
1289455|NCT03733444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289456|NCT03733431|Randomized|Parallel Assignment||Other||Single|||t|||
1289457|NCT03733418|||Cohort||Prospective|||||||
1289458|NCT03733405|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289459|NCT03733392|||Other||Prospective|||||||
1289460|NCT03733379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289461|NCT03733366||Crossover Assignment||Other||None (Open Label)||||||
1289462|NCT03733353|Randomized|Sequential Assignment||Treatment||Double||The study is a double-blind dose escalation cohort study in healthy volunteers and participants with either mild to moderate psoriasis or mild to moderate atopic dermatitis. The study consists of 7 cohorts and will test doses of EDP1815 versus placebo. The safety and tolerability of EDP1815 will be tested in participants with psoriasis and atopic dermatitis alongside pharmacodynamic effects on the systemic immune system and observation of any clinical effects.|t||t|
1289463|NCT03733340|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289464|NCT03733327||Single Group Assignment||Treatment||None (Open Label)||||||
1289465|NCT03733314|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1289466|NCT03733301|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289467|NCT03733288|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1289468|NCT03733275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289469|NCT03733262|||Cohort||Prospective|||||||
1289470|NCT03733249||Single Group Assignment||Treatment||None (Open Label)||||||
1289471|NCT03733236||Single Group Assignment||Treatment||None (Open Label)||||||
1289472|NCT03733223|||Cohort||Prospective|||||||
1289473|NCT03733210|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1289474|NCT03733197|Randomized|Parallel Assignment||Prevention||Single||Mixed Methods Approach|t|||
1289475|NCT03733184|||Cohort||Retrospective|||||||
1289476|NCT03733171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289477|NCT03733158|Randomized|Crossover Assignment||Treatment||Single||||||t
1289478|NCT03733145|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289479|NCT03733132|Randomized|Parallel Assignment||Basic Science||Quadruple|Study will be a double-blind, placebo-controlled, randomized design.||t|t|t|t
1289480|NCT03733119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289481|NCT03733106|Randomized|Parallel Assignment||Screening||Single|participants blinded to type of screening scan|Prospective randomized controlled study|t|||
1289482|NCT03733093|||Cohort||Prospective|||||||
1289483|NCT03733080|||Cohort||Cross-Sectional|||||||
1289484|NCT03733067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289485|NCT03733054|||Cohort||Cross-Sectional|||||||
1289486|NCT03733041|Randomized|Parallel Assignment||Treatment||Quadruple|Subjects and the study team (staff responsible for administering treatment or rating outcomes and study physicians) will not know the coil assignment since coils are labeled 'X' or 'Y' and are identical.|Participants will be randomized to parallel groups to receive either the rTMS or sham treatment with allocation ratio of 1:1. The stratified randomization scheme will be generated by a statistician using a random block design with random block sizes, and assignments (X or Y) will be placed in sealed envelopes for sequential opening.|t|t|t|t
1289487|NCT03733028|Randomized|Parallel Assignment||Treatment||Single||||||t
1289488|NCT03733015|Randomized|Crossover Assignment||Treatment||Single|||t|||
1289489|NCT03733002|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1289490|NCT03732989|Randomized|Parallel Assignment||Prevention||Single|Participants will not be aware of the other condition, i.e., that the device could be interactive/non-interactive.||t|||
1289491|NCT03732976|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1289492|NCT03732963|Randomized|Parallel Assignment||Supportive Care||Triple|Randomization will be done via computer generated numbers and concealed by serially numbered, opaque and sealed envelopes. The details of series will be unknown to the investigators and the group assignment will be kept in a set of concealed envelopes each bearing only the case number on the outside. Prior to the start of the study, the appropriately numbered envelopes will be opened by the nurse, the card will determine the assigned intervention for each patient, which will be prepared by a clinical pharmacist with no other role in the study|(N-acetyl-5-methoxytryptamine) is a neurohormone secreted by the pineal gland. It is primarily responsible for the sleep awake cycle as its level decreases in the morning and increases by night; owing to reduced light intensity, leading to circadian rhythm. It provides circadian and seasonal timing through activation of G protein-coupled receptors (GPCRs) in target tissues. Melatonin exerts its hypnotic effects through the activation of the MT1 and MT2 melatonin receptors|t|t|t|
1289493|NCT03732950||Single Group Assignment||Treatment||None (Open Label)||||||
1289494|NCT03732937|||Case-Control||Prospective|||||||
1289495|NCT03732924|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1289496|NCT03732911||Single Group Assignment||Prevention||None (Open Label)||||||
1289497|NCT03732898||Single Group Assignment||Treatment||None (Open Label)||||||
1289498|NCT03732885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289499|NCT03732872|||Case-Control||Cross-Sectional|||||||
1289500|NCT03732859|||Case-Only||Prospective|||||||
1289501|NCT03732846||Single Group Assignment||Treatment||None (Open Label)||||||
1289502|NCT03732833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289503|NCT03732820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289504|NCT03732807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289505|NCT03732794||Single Group Assignment||Treatment||None (Open Label)||||||
1289506|NCT03732781||Single Group Assignment||Prevention||None (Open Label)||3+3 Dose escalation||||
1289507|NCT03732768||Single Group Assignment||Prevention||None (Open Label)||3+3 dose escalation study||||
1289508|NCT03732755||Single Group Assignment||Treatment||None (Open Label)||||||
1289509|NCT03732742|Non-Randomized|Parallel Assignment||Prevention||Single|||||t|
1289510|NCT03732729|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1289511|NCT03732716|||Cohort||Prospective|||||||
1289512|NCT03732703|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Six arms with 38 patients per arm||||
1289513|NCT03732690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289514|NCT03732677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289515|NCT03732664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"Nivolumab administration:~Three doses of nivolumab will be administered to enrolled patients on Day -42, Day -28, and Day-14 (+/- two days) prior to planned surgery on Day 0 or up to +10 days."||||
1289516|NCT03732651|Non-Randomized|Crossover Assignment||Basic Science||Single||Each patient served as his own control.||||t
1289517|NCT03732638|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1289518|NCT03732625||Single Group Assignment||Other||None (Open Label)||Multicenter, open, non-randomized pilot trial.||||
1289519|NCT03732612|||Cohort||Prospective|||||||
1289520|NCT03732599|Randomized|Parallel Assignment||Treatment||Single|"Technologists who do the vision testing on participants are masked as to which arm the participant was randomized"|This is a randomize study, in which half of the participants will be receiving either the standard deep anterior lamellar keratoplasty (DALK) (with a blade) technique or the femtosecond laser technique that creates the initial incisions instead of a blade.||t||
1289521|NCT03732586|Randomized|Parallel Assignment||Treatment||Single|Subjects will be randomly assigned to one of the two treatments. The randomization is done through a computer generated system. The labeling will be done by a pharmacist or similar. Envelopes with randomization listings will be stored in a secure environment within the Hospital. Blinding should be maintained throughout the study. The randomization code should not be broken during the course of the study unless it is necessary for the safety of the subjects, as judged by the investigator. The date, time and reason for unmasking must be recorded, along with the researcher's signature. The rupture of the study blind will be done once the database has been blocked. The study will be double-blind, which means that neither the patients nor the study site staff will have access to the randomization code until the code is broken.|Randomized, Double-blind clinical trial.|t|||
1289606|NCT03731481|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Comparative effectiveness research of two interventions across four cohorts||||
1289607|NCT03731468|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1573277|NCT00001777||||Treatment||||||||
1289522|NCT03732573|Randomized|Parallel Assignment||Other||Single||"After completing an online questionnaire, participants will be randomized to intervention or control condition. Participants in the intervention condition will receive text messages designed to promote goal setting in the first week, text messages designed to promote goal operating in the second week, and message designed to promote self-monitoring messages in the third week. All text messages will seek to encourage usage of shared bike schemes (e.g. How many times can you use a shared bike scheme over the next week? Set yourself a goal and challenge yourself!). Control group participants will receive no messages during the course of the study."|t|||
1289523|NCT03732560|||Cohort||Retrospective|||||||
1289524|NCT03732547||Single Group Assignment||Treatment||None (Open Label)||||||
1289525|NCT03732534||Single Group Assignment||Treatment||None (Open Label)||||||
1289526|NCT03732521|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1289527|NCT03732508||Single Group Assignment||Treatment||None (Open Label)||||||
1289528|NCT03732495||Single Group Assignment||Treatment||None (Open Label)||Patients with predominant bone metastases from Radioiodine-Refractory Differentiated Thyroid Carcinoma (RR-DTC)||||
1289529|NCT03732482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289530|NCT03732469|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1289531|NCT03732456|||Other||Prospective|||||||
1289532|NCT03732443|||Cohort||Prospective|||||||
1289533|NCT03732430||Single Group Assignment||Treatment||None (Open Label)||||||
1289534|NCT03732417|||Other||Prospective|||||||
1289535|NCT03732404|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which was used.|This is a randomized, placebo-controlled, study.|t|t|t|t
1289536|NCT03732391||Single Group Assignment||Treatment||None (Open Label)||||||
1289537|NCT03732378|Randomized|Parallel Assignment||Treatment||Single|Along with anti psychotics, one capsule of omega-3 (EPA 300mg, and 200mg DHA) were given to treatment group , and 500 mg corn oil one capsules daily along with anti psychotics were given to placebo group. Patients were unaware about treatment and placebo as plastic transparent same packing was used.|12 week Randomized, single blind, placebo-Controlled Trial (RCT) was conducted at King Edward medical university, psychiatry & behavioral sciences department Lahore. one capsule of omega-3 (EPA 300mg, and 200mg DHA) were given, or placebo (500 mg corn oil).|t|||
1289538|NCT03732365|Randomized|Parallel Assignment||Treatment||Single|"This study will be observer-blinded. Each investigational site will be required to have a Sponsor-approved plan (a site-specific Blinding Plan) that describes site-specific precautions being taken to ensure that the study is observer-blinded, taking into account the specific subject care procedures, equipment, and information accessibility at that site. At each investigational site, at least 1 blinded investigator (referred to as Blinded Observer) will not know the subject's treatment assignment and will conduct clinical assessments (including efficacy and safety. The Blinded Observer will not ask other members of the study team, the subject, or the subject's parent(s)/legally acceptable representative(s) which study treatment is being given, and will avoid all attempts to uncover treatment assignment. The Blinded Observer will see the subject during times when study treatment is NOT being administered."|Single-center, parallel-group study to compare the efficacy and safety of UDD plus standard of care with standard of care alone for the treatment of skin and soft tissue infections in chronic non-healing wounds.||||t
1289539|NCT03732352||Single Group Assignment||Treatment||None (Open Label)||||||
1289540|NCT03732339||Single Group Assignment||Treatment||None (Open Label)||||||
1289541|NCT03732326|||Cohort||Prospective|||||||
1289542|NCT03732313|Randomized|Parallel Assignment||Treatment||Single|||t|||
1289543|NCT03732300|Randomized|Parallel Assignment||Treatment||Single||Monocenter, open-label, randomized parallel two study arms (ASSIP vs control)||||t
1289544|NCT03732287|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||A dose escalation strategy of differing temperatures and duration to test safety and efficacy of cooling anesthesia for intravitreal injection||||
1289545|NCT03732274||Single Group Assignment||Treatment||None (Open Label)||||||
1289546|NCT03732261|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1289547|NCT03732248|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1289548|NCT03732235|||Case-Control||Prospective|||||||
1289549|NCT03732222|Randomized|Parallel Assignment||Treatment||Double|the masking of the evaluator has been obtained, measuring the association between the response variables at baseline and the intervention group, by means of the variance analysis (ANOVA), for each response variable separately. We have verified that there are no differences between the means of the responses at the baseline level in each assigned intervention group, so that masking at the level of the evaluator has been carried out correctly||t|||t
1289550|NCT03732209|Randomized|Parallel Assignment||Treatment||Double|Participants assigned to both groups will be masked to experimental hypotheses. Research personnel who will be conducting assessment sessions, including weight measurements, will not be informed of participants' group assignments.|Participants will engage in episodic future or control thinking in the natural environment. All participants will also receive case management regarding the Traffic Light Diet, modified for type 2 diabetes to include glycemic index of foods, as well as the Traffic Light Activity Plan and other techniques to aid in weight loss (e.g., self-monitoring).|t|||t
1289551|NCT03732196|||Cohort||Cross-Sectional|||||||
1289552|NCT03732183||Single Group Assignment||Supportive Care||None (Open Label)||||||
1289553|NCT03732170|Randomized|Parallel Assignment||Treatment||Double|Blinding will be done to the assessors to reduce bias to healing assessment. As well, participants won't know which treatment they are undergoing.|Study subject (tooth) will be randomized in a 1:1 allocation ratio between the two treatment groups.|t|||t
1289554|NCT03732157|||Cohort||Prospective|||||||
1289602|NCT03731533|Randomized|Parallel Assignment||Treatment||None (Open Label)||The intervention group will be enrolled in WellStart. The control group will continue with usual care. Study subjects from both groups will be sent commercial home lab kits to test lipid and hemoglobin A1c levels, as well as a digitally connected scale and blood pressure monitoring device.||||
1289603|NCT03731520||Single Group Assignment||Diagnostic||None (Open Label)||||||
1573278|NCT00001774||||||||||||
1289555|NCT03732144|Randomized|Parallel Assignment||Prevention||None (Open Label)||The prospective randomized controlled trial is a nested cohort design that compares two levels of the intervention, a staff-based social development PA program to a generalized ASP health curriculum control, over a 10-month (40 week) time period (16-week intervention, 6 month followup). A total of 30 ASPs serving underserved middle school (~40 youth and ~5 staff per school; N=1200 youth, 150 staff) will be randomly assigned to either receive the Connect intervention or serve as the standard ASP Health curriculum control. The project will be implemented over a 5-year period with a new cohort of 6 ASPs added each year (a total of 5 cohorts, with 6 ASPs in each cohort).||||
1289556|NCT03732131|||Cohort||Prospective|||||||
1289557|NCT03732118|||Case-Control||Cross-Sectional|||||||
1289558|NCT03732105|Randomized|Factorial Assignment||Treatment||None (Open Label)||2X2 factorial design||||
1289559|NCT03732092|||Cohort||Prospective|||||||
1289560|NCT03732079|||Cohort||Prospective|||||||
1289561|NCT03732066|Randomized|Parallel Assignment||Health Services Research||Triple|The patients (but not their care providers), research personnel, and investigators will be unaware of their allocation. Study coordinators and research assistants conducting the assessments and statisticians will also be blinded.|Randomization will be performed using a centralized, computerized randomization program in a uniform 1:1 allocation ratio.|t||t|t
1289562|NCT03732053|Randomized|Parallel Assignment||Treatment||Single||Randomized Controlled Trial||||t
1289563|NCT03732040|Randomized|Parallel Assignment||Prevention||Single||||||t
1289564|NCT03732027|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289565|NCT03732014|||Case-Only||Cross-Sectional|||||||
1289566|NCT03732001|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289567|NCT03731988|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1289568|NCT03731975|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289569|NCT03731962|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1289570|NCT03731949|||Other||Prospective|||||||
1289571|NCT03731936|||Case-Control||Cross-Sectional|||||||
1289572|NCT03731923||Single Group Assignment||Other||None (Open Label)||||||
1289573|NCT03731910||Single Group Assignment||Other||None (Open Label)||||||
1289574|NCT03731897|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289575|NCT03731884|||Cohort||Prospective|||||||
1289576|NCT03731871|||Cohort||Prospective|||||||
1289577|NCT03731858|||Cohort||Prospective|||||||
1289578|NCT03731845||Single Group Assignment||Screening||None (Open Label)||||||
1289579|NCT03731832|Non-Randomized|Sequential Assignment||Screening||None (Open Label)||All patients receive PId. Patients showing a biochemical relapse receive PICd afterwards, while patients showing a clinical relapse go off study.||||
1289580|NCT03731819||Single Group Assignment||Other||None (Open Label)||||||
1289581|NCT03731806|||Case-Only||Cross-Sectional|||||||
1289582|NCT03731793|Randomized|Parallel Assignment||Treatment||Quadruple|"Full randomization and full blind study. Intervention was named by integratore A and integratore B"|Double-blind randomized placebo controlled study. 90 days of treatment with 600 mg/d of non-animal Chondroitin Sulphate or placebo|t|t|t|t
1289583|NCT03731780|Randomized|Parallel Assignment||Prevention||Double|The recruiter will be blinded. The operator cannot be blinded because of the different in the procedures of caries prevention applied in each group. However, the assessors will be kept unaware of the treatment assigned to the patient.||t|||t
1289584|NCT03731767||Single Group Assignment||Basic Science||None (Open Label)||Pretest post test study design||||
1289585|NCT03731754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289586|NCT03731741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289587|NCT03731728|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to treatment group allocation by not involving them in discussions about study participants and not granting them access to the database which contains the randomization code. In addition, study participants will self-complete all outcome assessments on a tablet with the assessor only guiding the process. Moreover, these assessors will not be involved in data analysis.|||||t
1289588|NCT03731715|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Open-label||||
1289589|NCT03731702|||Case-Only||Cross-Sectional|||||||
1289590|NCT03731689|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289591|NCT03731676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289592|NCT03731663|Randomized|Parallel Assignment||Basic Science||Single||After receiving an explanation about the study and providing informed consent online, participants will complete questionnaires assessing demographic variables, SNS food preoccupation and disturbed eating online via Qualtrics link. Participants will then be randomly assigned to view a video clip showing pictures of either appetizing pictures of food (experimental group) or sightseeing pictures in a tourist destination (control group). After viewing the video, participants will respond to online questionnaire measuring external eating and food cravings, and will also be asked to order food they would like to eat immediately from a hypothetical menu.|t|||
1289593|NCT03731650|Randomized|Parallel Assignment||Treatment||Single|||t|||
1289594|NCT03731637|||Cohort||Prospective|||||||
1289595|NCT03731624|||Cohort||Prospective|||||||
1289596|NCT03731611|Randomized|Parallel Assignment||Treatment||Single||||||t
1289597|NCT03731598|||Cohort||Prospective|||||||
1289598|NCT03731585|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1289599|NCT03731572|Randomized|Factorial Assignment||Prevention||Double|All testing for Aims 1a and 1b will be conducted by individuals who are masked to subject intervention group assignment at baseline-testing, post-intervention testing, and retention-testing|The investigators will compare changes in protective stepping, hip abduction and adduction muscle power and neuromuscular activation, balance and mobility function, and number of prospective falls between power and strength training groups.|||t|t
1289600|NCT03731559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289601|NCT03731546|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1289604|NCT03731507||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289608|NCT03731455||Single Group Assignment||Other||None (Open Label)||"The neurosurgical intervention will be performed with both devices: investigational (Wise Cortical Strip, WCS) and comparator device. Both devices will be used during the baseline phase. During IONM phase, instead, the WCS is intended to remain on the brain surface, while the comparator device will be used according to physician's discretion (together with the WCS)."||||
1289609|NCT03731442|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1289610|NCT03731429|Randomized|Parallel Assignment||Treatment||Triple||This study was designed as a double-blind randomized controlled trial|t||t|t
1289611|NCT03731416|Randomized|Parallel Assignment||Other||Single|Each patient will be given a code by the researcher and the observers will be blind to which group this case belong.|The patients will be randomly divided into 2 equal groups|||t|
1289612|NCT03731403|Randomized|Parallel Assignment||Treatment||Single||||||t
1289613|NCT03731390|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289614|NCT03731377|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1289615|NCT03731364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289616|NCT03731351|||Case-Only||Prospective|||||||
1289617|NCT03731338|||Case-Control||Retrospective|||||||
1289618|NCT03731325|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289619|NCT03731312|||Ecologic or Community||Cross-Sectional|||||||
1289620|NCT03731299|||Case-Control||Cross-Sectional|||||||
1289621|NCT03731286|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1289622|NCT03731273||Crossover Assignment||Prevention||None (Open Label)||||||
1289623|NCT03731260|Randomized|Parallel Assignment||Treatment||Quadruple||In Part 1 of the study, patients will be randomly assigned to 1 of 3 doses of avapritinib or to placebo + BSC. Once the recommended phase 2 dose (RP2D) of avapritinib is identified in Part 1, patients in Part 2 will be randomly assigned to receive avapritinib at the RP2D + BSC or matching placebo + BSC. In Part 3, patients who have completed treatment in Part 1 or Part 2 of the study (including those initially randomized to placebo) may participate in a long-term open-label extension, receiving avapritinib at the RP2D + BSC.|t|t|t|t
1289624|NCT03731247|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||One group of skin cancer patients One group without skin cancer patients||||
1289625|NCT03731234||Single Group Assignment||Treatment||None (Open Label)||Ibrutinib in combination to rituximab-CHOP followed by ibrutinib maintenance||||
1289626|NCT03731221|Randomized|Parallel Assignment||Treatment||Double|Anesthesiologists will not be blinded to the intervention, but all outcomes will be assessed by research personnel who are blinded to the group assignment.|Patients will be randomized the day of surgery upon presentation to the operating room to either a treatment group (PECSII/SAP blocks with bupivacaine HCl plus liposomal bupivacaine) or a control group (PECSII/SAP blocks with bupivacaine HCl plus preservative free normal saline) using secure web-based randomization.|t|||t
1289627|NCT03731208||Single Group Assignment||Treatment||None (Open Label)||||||
1289628|NCT03731195|||Cohort||Prospective|||||||
1289629|NCT03731182|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1289630|NCT03731169|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1289631|NCT03731156|||Cohort||Retrospective|||||||
1289632|NCT03731143||Single Group Assignment||Treatment||None (Open Label)||||||
1289633|NCT03731130|||Cohort||Prospective|||||||
1289634|NCT03731117||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-comparative, multicenter, study||||
1289635|NCT03731104|||Cohort||Prospective|||||||
1289636|NCT03731091|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind||t|t|t|t
1289637|NCT03731078|||Cohort||Prospective|||||||
1289638|NCT03731065|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1289639|NCT03731052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289640|NCT03731039|||Cohort||Prospective|||||||
1289641|NCT03731026|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||3-Group Study||||
1289642|NCT03731013|Randomized|Factorial Assignment||Prevention||Single||Parallel group 2x2 factorial design clinical trial according to which participants will be randomly assigned to one of four 16-week intervention groups: 1- Mediterranean Diet alone; 2- Physical Activity alone ; 3- Combination of Mediterranean Diet and Physical Activity; 4- Control Group (no intervention).||||t
1289643|NCT03731000||Single Group Assignment||Treatment||None (Open Label)||Single Group||||
1289644|NCT03730987|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289645|NCT03730974|Randomized|Crossover Assignment||Treatment||None (Open Label)||The study has a randomized 2-sequence, 2-period, 2-treatment crossover design.||||
1289646|NCT03730961|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1289647|NCT03730948||Single Group Assignment||Treatment||None (Open Label)||||||
1289648|NCT03730935|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1289649|NCT03730922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289650|NCT03730909|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1289651|NCT03730896|Randomized|Parallel Assignment||Treatment||Single|Random assignment to dry needle group or control group with standard manual therapy interventions||t|||
1289652|NCT03730883|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289653|NCT03730870|Randomized|Parallel Assignment||Treatment||Double|Subjects will be blinded as to study arm participation and outcome assessments.|Participants will be randomized to have their study clinician have access to their pharmacogenomics report prior to prescribing medications (experimental group) or no access (control group) until end of the study.|t|||t
1289654|NCT03730857|Randomized|Factorial Assignment||Treatment||None (Open Label)||One hundred eleven inpatients with acutely exacerbated schizophrenia were randomized to give optimal therapy of olanzapine, risperidone, and paliperidone in one-week run-in period and 12 weeks' intervention.||||
1289655|NCT03730844|||Cohort||Prospective|||||||
1289656|NCT03730831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289697|NCT03730298|Randomized|Parallel Assignment||Prevention||Quadruple|double-blind, placebo-controlled|Randomized, double-blind, placebo-controlled|t|t|t|t
1289657|NCT03730818|Randomized|Parallel Assignment||Treatment||Single|This is an assessor-blind study. Physiotherapist in charge of performing the baseline and post-intervention assessment will be blinded to participants allocation|||||t
1289658|NCT03730805|Randomized|Factorial Assignment||Treatment||Triple||Randomized Controlled Trial||t|t|t
1289659|NCT03730792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289660|NCT03730779||Single Group Assignment||Treatment||None (Open Label)||||||
1289661|NCT03730766||Single Group Assignment||Basic Science||None (Open Label)||||||
1289662|NCT03730753|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1289663|NCT03730740||Single Group Assignment||Treatment||None (Open Label)||||||
1289664|NCT03730727|Randomized|Crossover Assignment||Basic Science||Single|Although the trial order will be randomized, it is not possible to blind the participant or the investigator to the timing between meals and physical activity. However, the trial allocation and order will be blinded to the outcomes assessor when statistical analyses are performed.|Three independent groups of participants will enter 1 of 3 studies, each of which involves a randomised, crossover, controlled trial containing 4 trials: (i) control, meal ingestion no activity; (ii) activity bout immediately prior to meal; (iii) activity bout immediately after ingestion of meal; (iv) activity bout 30-mins after ingestion of meal.||||t
1289665|NCT03730714|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1289666|NCT03730701|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289667|NCT03730688||Single Group Assignment||Diagnostic||None (Open Label)|No masking will be used in the study.|Compartment pressure will be measured in a single group of patients, using the conventional and the newly developed experimental means of measurement.||||
1289668|NCT03730675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289669|NCT03730662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289670|NCT03730649|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289671|NCT03730636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289672|NCT03730623|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Clinical Trial with118 participants. Randomization to Control group/standard care or Intervention group: 12 week exercise supervised by physiotherapist, Nurse+ dietitian, pedometer and exercise log-book, smoking cessation and text-message follow up. 6 and 12 month follow up. Primary and secondary endpoints.||||
1289673|NCT03730610||Single Group Assignment||Prevention||None (Open Label)||Exercise Training for six months||||
1289674|NCT03730597|Randomized|Parallel Assignment||Prevention||Single|blinded to purpose of study and to randomization|randomized study||||t
1289675|NCT03730584||Single Group Assignment||Treatment||None (Open Label)||||||
1289676|NCT03730571||Single Group Assignment||Health Services Research||None (Open Label)||||||
1289677|NCT03730558|||Cohort||Prospective|||||||
1289678|NCT03730545|Randomized|Parallel Assignment||Supportive Care||Double|Eligible patients were randomly assigned in equal numbers to undergo SEN or EIN according to a computer-generated randomization list managed by a dietary nurse not involved in the study. The study was double-blind: SEN and EIN feeds were identical in color and type of container, so treatment assignments were not revealed to patients or to any staff members.|Patients were randomized to receive enteral immunonutrition or standard enteral nutrition in postoperative day 1 by enteral feeding.|t||t|
1289679|NCT03730532|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patient Preference Trial||||
1289680|NCT03730519|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a post-marketing open label twin arm, single centre clinical trial of electrical carotid sinus stimulation with the Barostim Neo device to target sub-optimally controlled arterial hypertension or highly variable blood pressure in patients for whom no alternative therapies are available.||||
1289681|NCT03730506|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1289682|NCT03730493|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1289683|NCT03730480||Single Group Assignment||Other||None (Open Label)||||||
1289684|NCT03730467|||Cohort||Cross-Sectional|||||||
1289685|NCT03730454|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multisite randomized control trial.||||
1289686|NCT03730441|||Other||Retrospective|||||||
1289687|NCT03730428|||Cohort||Retrospective|||||||
1289688|NCT03730415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289689|NCT03730402|Randomized|Parallel Assignment||Other||Single|single-blind study|prospective randomized control trial|t|||
1289690|NCT03730389|Randomized|Parallel Assignment||Treatment||None (Open Label)||External Physical Vibration Lithecbole(EPVL) for ureteral stone||||
1289691|NCT03730376|Randomized|Parallel Assignment||Health Services Research||Double|The care provider and patient will not be informed as to which group the participant is in|"Participants will be randomized into 1 of 2 study arms arm 1: control arm 2: intervention.~We will use a random block generator to assign participants to their study arm."|t|t||
1289692|NCT03730363||Single Group Assignment||Treatment||None (Open Label)||||||
1289693|NCT03730350|Randomized|Parallel Assignment||Treatment||None (Open Label)|Random assignment to group will take place after baseline assessment. Patients who are randomly assigned to the clinical hypnosis group will immediately undergo their first in-person hypnosis session focused on preparing for surgery. Masking is not employed as patients will know if they are randomized to the intervention arm.|This study will conduct a 2-arm (intervention vs. treatment-as-usual) pilot RCT with patients currently undergoing oncology surgery at Toronto General Hospital. This study will recruit N = 92 patients (n = 46 psychology intervention, n = 46 control). The psychology intervention will be delivered by the TPS pain psychology team, under the supervision of Transitional Pain Service lead pain psychologist Dr. Aliza Weinrib. In addition, audio recordings developed by Dr. Weinrib will be provided to patients||||
1289694|NCT03730337||Single Group Assignment||Treatment||None (Open Label)||||||
1289695|NCT03730324|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Study subjects will be randomized in a 1:7 fashion between~Standard biopsies + biomarkers and~Biomarkers + mpMRI and Standard / mpMRI targeted biopsies."||||
1289696|NCT03730311|Randomized|Crossover Assignment||Treatment||Double|Double-blind study||t||t|
1289782|NCT03729193|||Cohort||Prospective|||||||
1289698|NCT03730285|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1289699|NCT03730272|||Cohort||Prospective|||||||
1289700|NCT03730259|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1289701|NCT03730246|||Cohort||Prospective|||||||
1289702|NCT03730233|Randomized|Parallel Assignment||Treatment||Double|The randomization process was initiated after general anesthesia had been induced and the group affiliation was determined by opening of a sealed envelope specifying the group assignment. The subsequent operation report, with information on the specific type of repair performed, was not included in the digital patient-chart. Instead, a hard copy was printed and kept in a sealed envelope, which was filed in a locked archive to maintain the patient, staff and clinical assessors blinded to the study group allocation.|repair by tension-free mesh closure or simple suturing of the diaphragmatic|t|||t
1289703|NCT03730220|||Cohort||Prospective|||||||
1289704|NCT03730207|Randomized|Parallel Assignment||Treatment||Single|||t|||
1289705|NCT03730194|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||First, participants are randomly assigned to either melatonin or The Bedtime Bank. Response (>/= 18 minute nightly increase in total sleep time [TST]) will be measured at week 4 and 8. Participants who respond remain on the assigned treatment. Participants who are non-responsive are re-randomized to a different treatment option.||||
1289706|NCT03730181||Single Group Assignment||Prevention||None (Open Label)||||||
1289707|NCT03730168||Single Group Assignment||Treatment||None (Open Label)||||||
1289708|NCT03730155|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289709|NCT03730142||Single Group Assignment||Treatment||None (Open Label)||||||
1289710|NCT03730129||Single Group Assignment||Treatment||None (Open Label)||||||
1289711|NCT03730116|||Other||Prospective|||||||
1289712|NCT03730103|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Prospective cohort study with historical controls||||
1289713|NCT03730090|||Cohort||Prospective|||||||
1289714|NCT03730077|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1289715|NCT03730064||Single Group Assignment||Other||None (Open Label)||||||
1289716|NCT03730051|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1289717|NCT03730038|Randomized|Crossover Assignment||Other||None (Open Label)||Patients who assigned to the pitavastatin treatment first group will be given the pitavastatin, followed by wash-out period and life-style modification treatment. Patients who assigned to the life-style modification treatment first group, will be treated with life-style modification treatment first, followed by wash-out period and pitavastatin treatment.||||
1289718|NCT03730025|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1289719|NCT03730012||Single Group Assignment||Treatment||None (Open Label)||||||
1289720|NCT03729999||Single Group Assignment||Other||None (Open Label)||||||
1289721|NCT03729986|||Other||Cross-Sectional|||||||
1289722|NCT03729973|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1289723|NCT03729960||Single Group Assignment||Other||Double|||t|t||
1289724|NCT03729947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289725|NCT03729934|Randomized|Crossover Assignment||Prevention||Single|||t|||
1289726|NCT03729921|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289727|NCT03729908|Randomized|Parallel Assignment||Treatment||Single||||||t
1289728|NCT03729895||Single Group Assignment||Treatment||None (Open Label)||Twenty-four patients diagnosed with OSAS in different degrees,who cannot tolerate continuous positive air pressure use and reject a surgical approach, were treated with adjustable customized oral appliances and evaluated with cone-beam computed tomography and polysomnography.||||
1289729|NCT03729882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289730|NCT03729869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289731|NCT03729856|Randomized|Sequential Assignment||Treatment||None (Open Label)||A Single Case Experimental Design (SCED) will be used to evaluate the intervention. Participants act as their own controls, and thus are exposed to both the treatment and control conditions. The study will be conducted and reported according to the Singe Case Reporting guidelines in BEhavioural Interventions (SCRIBE). A randomised, concurrent, multiple-baseline A1 (baseline control) - B (intervention)-A2 (follow-up withdrawal) design will be used to meet the methodological recommendations for SCEDs. Participants will be randomly allocated to a 5, 8 or 11 week baseline period during which they will undertake their usual activities. The baseline phase will be followed by a 16-week intervention period during which participants will participate in 12, one hour sessions with an accredited exercise physiologist. The intervention phase will be followed by a 5-week follow-up phase where participants will have no contact with the intervention personnel.||||
1289732|NCT03729843|||Other||Other|||||||
1289733|NCT03729830|||Case-Only||Prospective|||||||
1289734|NCT03729817||Single Group Assignment||Prevention||None (Open Label)||subjects will be recruited into a single arm undergoing intervention.||||
1289735|NCT03729804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289736|NCT03729791|Randomized|Parallel Assignment||Treatment||Quadruple|All researchers will conduct research with only the encrypted subject number. A separate third-party researcher will participate to encrypt the subject and adjust the active/sham direction of the tDCS device during the actual research.|"Randomized controlled trial~1 arm is active tDCS and 1 arm is sham tDCS"|t|t|t|t
1289737|NCT03729778|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1289738|NCT03729765|Randomized|Parallel Assignment||Treatment||Single||||||t
1289739|NCT03729752|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1289740|NCT03729739|Randomized|Parallel Assignment||Diagnostic||Single||Randomized clinical non-inferiority trial||||t
1289741|NCT03729726|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289742|NCT03729713|Randomized|Single Group Assignment||Treatment||Triple||Placebo controlled||t|t|t
1289743|NCT03729700|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1289783|NCT03729180|||Cohort||Prospective|||||||
1289784|NCT03729167||Single Group Assignment||Diagnostic||None (Open Label)||||||
1573279|NCT00001772||||||||||||
1289744|NCT03729687||Single Group Assignment||Treatment||None (Open Label)||Treatment with short-course radiotherapy (scRT) followed by 4 cycles of CAPOX chemotherapy and surgery in locally advanced rectal cancer while waiting for the results of the randomized phase III RAPIDO trial||||
1289745|NCT03729674|||Cohort||Prospective|||||||
1289746|NCT03729661||Single Group Assignment||Treatment||None (Open Label)||Exploratory study||||
1289747|NCT03729648|Randomized|Parallel Assignment||Treatment||Double||Parallel Randomized Controlled Trial|t||t|
1289748|NCT03729635||Single Group Assignment||Treatment||None (Open Label)||||||
1289749|NCT03729622|Randomized|Parallel Assignment||Treatment||Single||||||t
1289750|NCT03729609|||Cohort||Prospective|||||||
1289751|NCT03729596|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Following monotherapy dose escalation, MGC018 will be evaluated in combination with MGC018. Dose escalation will also proceed using a 3+3+3 design to identify an MTD for the combination, and will then be followed by a Cohort Expansion for the combination.||||
1289752|NCT03729583|Randomized|Parallel Assignment||Treatment||Single|||||t|
1289753|NCT03729570|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289754|NCT03729557|||Cohort||Prospective|||||||
1289755|NCT03729544|Randomized|Parallel Assignment||Screening||Single|The allocation ratio will be 1:1 for an EPIC BPA on-screen alert versus no notification. Investigators will be assessing the impact of the EPIC BPA on echocardiographic screening for CTEPH and the diagnosis of CTEPH in the patients enrolled in this Quality Improvement Initiative. While investigators will randomize patients by Attending Physician of Record to minimize cluster-effect, the observational unit will be the patient. The cluster-effect describes a type of confounding observed in studies of provider behavior that can result in a bias of the outcome toward the null. In such a case, a provider may carry over knowledge gained from the alert for the intervention group patient to the care of the control group patient.|400-patient single-center Quality Improvement Initiative in the form of a randomized controlled trial|t|||
1289756|NCT03729531|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1289757|NCT03729518||Single Group Assignment||Treatment||None (Open Label)||||||
1289758|NCT03729505|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1289759|NCT03729492||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289760|NCT03729479|Randomized|Factorial Assignment||Treatment||Single||2x2 full factorial||||t
1289761|NCT03729466|Randomized|Parallel Assignment||Treatment||None (Open Label)||clinical pilates and control group||||
1289762|NCT03729453||Single Group Assignment||Treatment||None (Open Label)||||||
1289763|NCT03729440|||Case-Crossover||Prospective|||||||
1289764|NCT03729427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289765|NCT03729414|Randomized|Parallel Assignment||Treatment||Single|long term outcome will be evaluated by a third observer unaware of the type of surgery performed|Prospective, multi-centre, parallel-arm randomized controlled equivalence trial. Eligible patients will be randomized to either mucopexy without Doppler guided artery ligation or mucopexy with doppler guided hemorroidal artery ligation.||||t
1289766|NCT03729401|Randomized|Parallel Assignment||Treatment||Double|Double (Investigator, Outcomes Assessor)||||t|t
1289767|NCT03729388|||Cohort||Prospective|||||||
1289768|NCT03729375|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289769|NCT03729362|Randomized|Parallel Assignment||Treatment||Double|Double-blind masking||t||t|
1289770|NCT03729349|||Cohort||Prospective|||||||
1289771|NCT03729336|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Patient spontaneously voids in the bathroom using PEEZY (research sample). Within 10 minutes, patient is catheterized during physical exam (control sample) for post-void residual.||||
1289772|NCT03729323|Randomized|Parallel Assignment||Treatment||Double|Double Blind. The person responsible for randomizing and allocating research subjects, outcome assessors and those responsible for data analysis will be blinded.|Clinical-behavioral|t|||t
1289773|NCT03729310|Randomized|Parallel Assignment||Treatment||Single|Subjects will not have access to what treatment each cavity received through randomization. The information will be available should an emergency arise that would require the treating physician to know this information in order to best treat the subject. The subjects right to access this information will be reinstated when the study period is over (12 weeks after surgery).|Each subject will have both treatments (Propel and Nasopore), with one treatment on one side and the other treatment on the opposite side. The treatment for the right and left cavity will be selected in a randomized fashion (using opaque envelopes to assign each treatment to a respective ethmoid cavity).|t|||
1289774|NCT03729297||Single Group Assignment||Treatment||None (Open Label)||"3 cohorts:~adenoid cystic carcinoma~salivary duct carcinoma~other subtypes of salivary gland cancer~sample size: The Simon two-stage design will be used, The first stage consists of 9 patients per cohort ((1) SDC, (2) ACC) evaluable for response. If 0 responses out of the first 9 evaluable patients are observed, the study will be stopped. In any other situation, the study will be continued until 17 patients are evaluable for response per cohort. If ≤2 responses are observed the study will accept the null hypothesis. If >2 responses are observed, the null hypothesis will be rejected. In the third cohort (other SGC) 9 patients will be included to evaluate the efficacy of cabozantinib in other subtypes of c-MET positive SGC. Because different subtypes are included in this cohort, these results are hypothesis forming but will not be used for statistical analysis. Therefore, this study cohort will be closed after the first stage with 9 patients."||||
1289775|NCT03729284|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1289776|NCT03729271||Single Group Assignment||Treatment||None (Open Label)|The study drug will be open label. However, the order of the breath tests that are performed (glucose and lactulose) will be blinded to the participant and the person performing the breath sample, and the results of the breath test.|||||
1289777|NCT03729258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289778|NCT03729245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289779|NCT03729232|||Case-Only||Prospective|||||||
1289780|NCT03729219|Randomized|Parallel Assignment||Prevention||Triple|Other parts will be blinded except unblinded person who prepares the doses.|A randomized, placebo-controlled phase IIb|t|t|t|
1289781|NCT03729206||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289785|NCT03729154|Randomized|Parallel Assignment||Treatment||Single||||||t
1289786|NCT03729141|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1289787|NCT03729128|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1289788|NCT03729115||Single Group Assignment||Screening||None (Open Label)||||||
1289789|NCT03729102|Non-Randomized|Parallel Assignment||Treatment||Single|The serum samples from all participants would be labelled as the codes, of which the laboratory technicians could not access to the groups or other details of the participants.|"There would be two study groups. Those who had received primary immunization would be the control group. While persons who had received primary immunization and later received booster vaccination for at least 3 times would be the study group.~All participants would be given one dose of rabies vaccine and monitored the immunological cells and cytokines before and after the rabies booster injection."||||t
1289790|NCT03729089|Randomized|Parallel Assignment||Other||None (Open Label)||Eligible pregnant women at 34 to 40 weeks gestation will be randomized to interventional group (Biophysical profile scanning) or to a control group receiving the current standard of care||||
1289791|NCT03729076|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1289792|NCT03729063|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This study is designed to compare one group of patients who had morning (6-8 am) and evening (5-7 pm) measurements of expired carbon monoxide (COexp) every day during their hospitalization (the twice-daily COexp group) versus a second group who had COexp measurements only the first morning following admission and the morning just prior to discharge (control group). A high potential for arm-contamination led the investigators to exclude a randomised design. The frequent COexp intervention was therefore deployed throughout months 1 and 3 of the four-month inclusion period, while the control intervention was deployed on months 2 and 4.||||
1289793|NCT03729050|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1289794|NCT03729037|Randomized|Parallel Assignment||Other||Single|Single (outcomes assessor)|||||t
1289795|NCT03729024||||||||||||
1289796|NCT03729011|Randomized|Parallel Assignment||Prevention||Single||Patients will be randomly allocated to receive either inhalation anaesthesia or TIVA. Permuted-block randomization will be used to allocate subjects to one of the study groups. Sequentially numbered sealed opaque envelopes will contain the treatment code, to be opened in the morning of surgery. Patients will be unaware of group assignment. All the statistical analyses will be performed by the biostatistician not involved in treatment allocation.|t|||
1289797|NCT03728998||Single Group Assignment||Screening||None (Open Label)||||||
1289798|NCT03728985||||||||||||
1289799|NCT03728972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289800|NCT03728959|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1289801|NCT03728946|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1289802|NCT03728933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289803|NCT03728920|||Cohort||Prospective|||||||
1289804|NCT03728907|Randomized|Crossover Assignment||Treatment||Double|Outcomes assessors and participants will not be aware of which hearing setting (audiologist adjusted vs. self-adjusted) they are wearing|Repeated-measures crossover design|t|||t
1289805|NCT03728894|Randomized|Crossover Assignment||Treatment||Triple|Triple (Participant, Care Provider, Outcomes Assessor) Each of the children/parents, the dentist and the outcomes assessors were blinded. To ensure the blindness of the dentist, the inhalation sedation machine was placed in a way that he could not see the flow rate panel or the type of the administered gases.|blinded, randomized controlled trial, comparing two groups.|t|t||t
1289806|NCT03728881|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289807|NCT03728868|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1289808|NCT03728855|Non-Randomized|Sequential Assignment||Health Services Research||Single|The subject, staff and investigators are aware of which method of medication administration the patient is given, SAM or standard care. Only the data analysis is blinded by anonymizing and coding all data. Furthermore, an independent person will perform the data analyses.|The intervention of this study is the implementation of self-administration of medication (SAM) by hospitalized patients. SAM will be compared to standard care.||||t
1289809|NCT03728842|||Cohort||Prospective|||||||
1289810|NCT03728829|||Cohort||Prospective|||||||
1289811|NCT03728816|||Cohort||Prospective|||||||
1289812|NCT03728803|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||A controlled before-after trial of inspiratory muscle training will be performed in patients with nemaline myopathy with respiratory muscle weakness. The 2 sequentially tested conditions are sham IMT and active IMT. Patients are not blinded to the conditions, instead patients are instructed that two training methods are tested. First the effect of breathing technique with low resistance (sham IMT) and secondly with high resistance (active IMT).||||
1289813|NCT03728790|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Randomized Control Trial with 2 arms||||
1289814|NCT03728777|Randomized|Crossover Assignment||Treatment||Double||double-blind, randomized, placebo-controlled, cross-over study.|t||t|
1289815|NCT03728764||Single Group Assignment||Other||None (Open Label)||||||
1289816|NCT03728751||Single Group Assignment||Treatment||None (Open Label)||Single group pre-test post test study design||||
1289817|NCT03728738|Randomized|Parallel Assignment||Treatment||Single|Prospective randomized open blinded endpoint (PROBE) clinical trial using clinical assessors blinded to the intervention to determine neurologic deterioration on the NIH Stroke Scale Score following positioning to either zero degree or thirty degree heights.|||||t
1289818|NCT03728725|||Cohort||Cross-Sectional|||||||
1289819|NCT03728712|||Case-Control||Prospective|||||||
1289820|NCT03728699|||Cohort||Prospective|||||||
1289821|NCT03728686|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1289822|NCT03728673||Single Group Assignment||Treatment||None (Open Label)||grade II and III glioma patients treated with SSRIs during a 3 month study period||||
1289823|NCT03728660|Randomized|Crossover Assignment||Supportive Care||Single|Baseline AI administered prior to randomization, outcomes assessor masked on intervention assignment before and after crossover|Intention to treat design; crossover with 22 week washout period between interventions; primary outcome measure is patient-reported function||||t
1573280|NCT00001768||||Treatment||||||||
1289824|NCT03728647|Randomized|Parallel Assignment||Supportive Care||Single||This study used a randomized repeated-measures experimental design. The experimental group received a multimedia health education program and the control group received a regular health education program.||||t
1289825|NCT03728634|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289826|NCT03728621|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a randomized, prospective, controlled study of 12 months a total of 170 children were consecutively recruited among those with diagnosis of obesity (in accordance with World Health Organization (WHO) criteria) by primary care pediatricians and admitted to the Department of Pediatrics, San Paolo Hospital, Milan, Italy, between January 2012 and June 2017. Inclusion criteria were: age at recruitment ≥6 years; weight at birth ≥2500 g and <4000 g; gestational age 37-42 weeks; single birth; Caucasian race; family residing in Milan or neighborhood (≤30 km). Children having syndromic, organic and hormonal conditions besides obesity were excluded.||||
1289827|NCT03728608|Randomized|Parallel Assignment||Prevention||Single||||||t
1289828|NCT03728595|||Case-Only||Cross-Sectional|||||||
1289829|NCT03728582|Randomized|Crossover Assignment||Treatment||Triple|Triple|Crossover assignment|t||t|t
1289830|NCT03728569|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Both groups, young and old, will receive the same intervention; therefore, single group study model was chosen.||||
1289831|NCT03728556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289832|NCT03728543|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel assignment||||
1289833|NCT03728530|Randomized|Parallel Assignment||Prevention||None (Open Label)||Study was to determine the effects of deep breathing exercises in smokers. It was conducted on the general population of Isra Institute of Rehabilitation Sciences, Isra University, Islamabad Campus. 30 participants were selected through Non probability Convenience Sampling and later equally divided into experimental (n=15) and control group (n=15) through lottery method. Inclusion criteria were young smokers between 20-30 years of age and without any chronic pulmonary complication, smoking for past five years. Smokers with any pulmonary disease, acute infections, other systemic disease, chest deformity or any disability were excluded from study.||||
1289834|NCT03728517|||Cohort||Prospective|||||||
1289835|NCT03728504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289836|NCT03728491|Randomized|Sequential Assignment||Other||Double|||||t|t
1289837|NCT03728478|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a a 12-month open label, randomised, actively controlled, multi-centre, prospective, superiority trial of two different treatment strategies (Step-down versus Step-up).~After signature of informed consent/assent patients will be randomized into two therapeutic arms: Step-up or Step-down. Patients in the Step-up arm will be treated according to a conventional strategy based on treatment escalation and driven by the treat-to-target strategy. Patients in the Step-Down arm will be treated with an early, combined, aggressive therapy for 6 months.~After the conclusion of the 12-month observation period of the trial, patients will be followed for up to 5 years for the evaluation of disease course, medication requirements, adverse events, and long-term disease-related morbidity."||||
1289838|NCT03728465||Single Group Assignment||Treatment||None (Open Label)||||||
1289839|NCT03728452|||Cohort||Prospective|||||||
1289840|NCT03728439|Randomized|Crossover Assignment||Treatment||Double||This is a randomized crossover (cross-over) trial. Participants will undergo an initial evaluation where they will perform the performance tests without receiving LED therapy. After the initial tests, participants will be randomized to receive LED therapy in three different moments: before (Lpré), in the interval (Lin) and after (Lpós) the performance tests. At 7, 14 and 21 days after the initial tests, the same test and evaluation protocol will be performed. In addition, 48 hours after each test protocol, functional tests, recovery questionnaire, pain threshold and creatine kinase collection will be applied.|||t|t
1289841|NCT03728426||Single Group Assignment||Treatment||None (Open Label)||||||
1289842|NCT03728413|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1289843|NCT03728400|||Cohort||Prospective|||||||
1289844|NCT03728387||Single Group Assignment||Treatment||None (Open Label)||||||
1289845|NCT03728374||Single Group Assignment||Treatment||None (Open Label)||||||
1289846|NCT03728361||Single Group Assignment||Treatment||None (Open Label)||||||
1289847|NCT03728348|||Cohort||Prospective|||||||
1289848|NCT03728335||Single Group Assignment||Treatment||None (Open Label)||||||
1289849|NCT03728322||Sequential Assignment||Treatment||None (Open Label)||||||
1289850|NCT03728309||||||||||||
1289851|NCT03728296||Sequential Assignment||Treatment||None (Open Label)||||||
1289852|NCT03728283|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, randomised, parallel-group, controlled clinical trial (Altman et al. 2001) with allocation ratio 1:1,||||
1289853|NCT03728270|Randomized|Parallel Assignment||Treatment||Single||||||t
1289854|NCT03728257|Randomized|Parallel Assignment||Supportive Care||Double||There will be two groups. The research study that will compare two methods of self-managing exercise after receiving a lung transplant. These methods are a home-based exercise program plus self-monitoring or self-monitoring alone. The investigator would also like to collect information about the patients health and ability to exercise, and the amount of physical activity the participants do per day. The length of the study will be 6 months.||t||t
1289855|NCT03728244|Randomized|Parallel Assignment||Treatment||Single||||||t
1289856|NCT03728231|||Case-Control||Other|||||||
1289857|NCT03728218|Randomized|Single Group Assignment||Other||None (Open Label)||This is a crossover study of two types of contact lenses (toric orthokeratology and soft multifocals).||||
1289858|NCT03728205||Single Group Assignment||Supportive Care||None (Open Label)||||||
1289859|NCT03728192|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The study comprised of two groups A (Hela) and group B ( H357) . Each group was further subdivided into 3 subgroups- A1 -Untreated cells, A2- mangosteen treated cells and A3- cells treated with standard drug. Group B was divided into B1- Untreated cells, B2- mangosteen treated cells and B3 -cells treated with the standard drug healthy periodontium. Test group: (Chronic periodontitis patients) comprised of 25 participants with signs of clinical inflammation and bone los||||
1289860|NCT03728179|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1289861|NCT03728166|Randomized|Parallel Assignment||Prevention||Single|"Investigators will randomize patients by Attending Physician ID# to minimize the influence of an alert effect on the care of patients not randomized to the alert group but who have the same Attending Physician (thereby reducing what is called the cluster-effect). While investigators will randomize patients by Attending Physician of Record to minimize cluster-effect, the observational unit will be the patient."|U.S.-based, single-center, randomized controlled trial|t|||
1289862|NCT03728153||Single Group Assignment||Treatment||None (Open Label)||Phase II study of one dose||||
1289863|NCT03728140|Randomized|Parallel Assignment||Screening||Single|||t|||
1289864|NCT03728127|Randomized|Parallel Assignment||Treatment||Single||||||t
1289865|NCT03728114|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1289866|NCT03728101||Sequential Assignment||Basic Science||None (Open Label)||||||
1289867|NCT03728088|||Case-Only||Cross-Sectional|||||||
1289868|NCT03728075|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1289869|NCT03728062|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1289870|NCT03728049|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter open-label randomized controlled clinical trial||||
1289871|NCT03728036|||Cohort||Prospective|||||||
1289872|NCT03728023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289873|NCT03728010|||Cohort||Prospective|||||||
1289874|NCT03727997|||Cohort||Prospective|||||||
1289875|NCT03727984|||Cohort||Retrospective|||||||
1289876|NCT03727971|Randomized|Parallel Assignment||Treatment||Triple|"All packaging and labeling of the biological drugs and placebo will be done in a way that ensures blinding for the investigator site staff. Glostrup pharmacy, the hospital pharmacy at the Capital region, will manage randomization and blinding.~Participants will be randomized in two equally big groups, one receiving omalizumab and one receiving placebo, by a computer based program, blinded to investigator. It will be randomized to blocks of 10, in total 16 blocks. It will be automated random assignment of subject numbers to randomization numbers. These randomization numbers are linked to the different treatment arms, which in turn are linked to medication numbers."|A randomized, double blinded, parallel group, study|t||t|t
1289877|NCT03727958|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Current or former heavy smoker subjects with suspected or known coronary artery disease will be randomized to undergo CT assessment of both coronary arteries and thoracic area for simultaneous coronary artery and lung cancer screening||||
1289878|NCT03727945|Randomized|Parallel Assignment||Treatment||Single|Urolog was not involved in physiotherapy treatment, randomised patients previous of treatment.|2 aleatorized groups; control group (n=21) and intervention group|t|||
1289879|NCT03727932||Single Group Assignment||Screening||None (Open Label)||||||
1289880|NCT03727919|Randomized|Parallel Assignment||Treatment||Single|A single blinded assessor will be allocated to a certain participant. This means that he/she will perform the assessment (FAC, 10-m Walk Test, FM, MI) across the different repeated measurements within the same participant, to reduce bias from inter-assessor variability in performing and evaluating a clinical test.|||||t
1289881|NCT03727906|Randomized|Crossover Assignment||Basic Science||None (Open Label)||"The experimental paradigm will consist of three in-lab counterbalanced non-consecutive (≥2 days in-between) polysomnography (PSG) nights in which we will modulate the level of pre-sleep psychophysiological arousal in a group of insomnia and non-insomnia adolescents.~no pre-sleep arousal manipulation night;~pre-sleep arousal down-regulation night (pre-sleep relaxation-driven Virtual reality ANS downregulation);~pre-sleep arousal up-regulation night (pre-sleep anticipation of stress using the Trier Social StressTest)."||||
1289882|NCT03727893|Randomized|Parallel Assignment||Treatment||Single||||||t
1289883|NCT03727880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289884|NCT03727867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289885|NCT03727854|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1289886|NCT03727841||Single Group Assignment||Treatment||None (Open Label)||||||
1289887|NCT03727828|||Cohort||Prospective|||||||
1289888|NCT03727815|Randomized|Parallel Assignment||Treatment||Double||||t||t
1289889|NCT03727802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289890|NCT03727789||Single Group Assignment||Treatment||None (Open Label)||||||
1289891|NCT03727776||Single Group Assignment||Basic Science||None (Open Label)||||||
1289892|NCT03727763||Single Group Assignment||Treatment||None (Open Label)||||||
1289893|NCT03727750||Single Group Assignment||Treatment||None (Open Label)|open-label|Single arm, open-label, interventional||||
1289894|NCT03727737|Randomized|Parallel Assignment||Treatment||Quadruple|double blind study until trial is complete|The proposed study will evaluate the safety, durability and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) as a promising non-invasive therapeutic treatment for improving memory in older adults with mild or moderate Traumatic Brain Injury (TBI) who have been experiencing residual memory or cognitive problems that affect daily functioning.|t|t|t|t
1289895|NCT03727724||Single Group Assignment||Treatment||None (Open Label)||||||
1289896|NCT03727711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289897|NCT03727698||Single Group Assignment||Treatment||None (Open Label)||To assess delivery of radiotherapy on the MR Linac for multiple tumour sites||||
1289898|NCT03727685|||Cohort||Cross-Sectional|||||||
1289899|NCT03727672|||Cohort||Cross-Sectional|||||||
1289900|NCT03727659||Single Group Assignment||Treatment||None (Open Label)||Participants will receive SHADE therapy for drug use and depression for 10 weeks plus CONNECT FaceBook social support.||||
1289901|NCT03727646|Non-Randomized|Sequential Assignment||Treatment||Single|Study biostatistician will be blinded to group (NR vs. untreated controls)|This single-center, open-label study will compare blood and myocardial NAD+ levels and other mitochondrial endpoints in participants with end-stage heart failure treated with open-label nicotinamide riboside prior to LVAD implantation to similar endpoints from untreated patients previously undergoing LVAD implantation.||||t
1290033|NCT03725917|Randomized|Parallel Assignment||Prevention||Single|All assessments will be made by an experienced Podiatrist, who will not have other functions in the study|Randomized Controlled Trial||||t
1573281|NCT00001763||||Treatment||||||||
1289902|NCT03727633||Single Group Assignment||Treatment||None (Open Label)|No masking is used. All involved know the identity of the intervention assignment.|The purpose of this study is to assess efficacy and tolerance of hepatic intra-arterial injection of an emulsion of Idarubicine and Lipiodol for treatment of non-metastatic, unresectable hepatocellular carcinoma on cirrhosis with Child-Pugh A/B7.||||
1289903|NCT03727620|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289904|NCT03727607|Randomized|Parallel Assignment||Treatment||Single||randomized control trial.|t|||
1289905|NCT03727594|||Cohort||Prospective|||||||
1289906|NCT03727581|||Case-Only||Prospective|||||||
1289907|NCT03727568|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1289908|NCT03727555||Single Group Assignment||Treatment||None (Open Label)||||||
1289909|NCT03727542||Single Group Assignment||Diagnostic||None (Open Label)||Serum level of MMP-9 will be measured initially in the blood samples collected from the patients with permanent pacemaker implantation while they were on sinus rhythm and the second samples will be collected at the end of the 3 weeks of short AVD (60 msec. shorter than patients' native PR interval) pacing to ensure wide QRS rhythm.||||
1289910|NCT03727529|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1289911|NCT03727516|||Cohort||Prospective|||||||
1289912|NCT03727503||Single Group Assignment||Diagnostic||None (Open Label)||Agreement and precision between two methods to measure pulse pressure variation (PPV)||||
1289913|NCT03727490|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289914|NCT03727477|||Cohort||Retrospective|||||||
1289915|NCT03727464|Randomized|Parallel Assignment||Basic Science||Single||||||t
1289916|NCT03727451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289917|NCT03727438|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1289918|NCT03727425||Single Group Assignment||Other||None (Open Label)||||||
1289919|NCT03727412|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1289920|NCT03727399|||Cohort||Prospective|||||||
1289921|NCT03727386|Randomized|Parallel Assignment||Other||None (Open Label)||This study will be a pilot study with an internal feasibility study that aims at evaluating the acceptance and adherence of participants to the intervention. Participants will be randomized into an intervention (coconut oil) and control group (sunflower oil) using an online randomisation software; Sealed envelope.||||
1289922|NCT03727373|||Other||Prospective|||||||
1289923|NCT03727360|Randomized|Parallel Assignment||Other||Triple|Participants and outcomes assessors are masked to APOE genotype. We do not share any data with care providers.||t|t||t
1289924|NCT03727347||Single Group Assignment||Treatment||None (Open Label)||All enrolled subjects will be treated with the InSeca Stylus||||
1289925|NCT03727334|Randomized|Parallel Assignment||Treatment||Single|The psychometrist will be blind to the arm the participant is assigned to.|This is a randomized two-armed study, comprised of a treatment arm and a control arm. Given the small numbers and the potentially slow rate of recruitment, the investigators will employ simple rather than block randomization. To minimize selection bias, allocation to group will be concealed (i.e., with assignment unpredictable and unchangeable) using software that randomizes each patient upon confirmation of eligibility. Patients will not be blind to group assignment, but the psychometrist completing behavioural outcomes will be kept blind to group assignment.||||t
1289926|NCT03727321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1289927|NCT03727308|||Cohort||Prospective|||||||
1289928|NCT03727295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289929|NCT03727282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289930|NCT03727269|Randomized|Parallel Assignment||Other||Single||Experimental group|t|||
1289931|NCT03727256|Randomized|Parallel Assignment||Treatment||Single||||||t
1289932|NCT03727243|||Cohort||Prospective|||||||
1289933|NCT03727230||Single Group Assignment||Treatment||None (Open Label)||"To identify the participators with Asia type DEL blood group and then transfused with D+ blood product rather than D- blood product."||||
1289934|NCT03727217||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289935|NCT03727204|||Cohort||Prospective|||||||
1289936|NCT03727191|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1289937|NCT03727178|||Cohort||Prospective|||||||
1289938|NCT03727165|Randomized|Parallel Assignment||Treatment||Triple|Participants will be in the intensive care unit under sedative treatment and will not know about randomization Nurses in the intensive care unit (care providers of enteral nutrition infusion) will not know about the study Outcomes evaluation will be made by one independent clinical epidemiologist|Randomized clinical trial|t|t||t
1289939|NCT03727152||Single Group Assignment||Treatment||None (Open Label)||||||
1289940|NCT03727139|||Cohort||Prospective|||||||
1289941|NCT03727126|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289942|NCT03727113|||Case-Control||Prospective|||||||
1289943|NCT03727100|Randomized|Parallel Assignment||Treatment||Triple|Double-Blinded|Clonidine Micropellet vs Sham-Control|t||t|t
1289944|NCT03727087|||Cohort||Cross-Sectional|||||||
1289945|NCT03727074|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289946|NCT03727061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289947|NCT03727048|Randomized|Parallel Assignment||Treatment||Single||||||t
1289948|NCT03727035|||Other||Other|||||||
1289949|NCT03727022|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1289950|NCT03727009|||Cohort||Cross-Sectional|||||||
1289951|NCT03726996||Single Group Assignment||Treatment||None (Open Label)||||||
1289952|NCT03726983|Randomized|Parallel Assignment||Prevention||None (Open Label)||This study was longitudinal approach and repeated testing using an experimental design to evaluate the follow-up outcomes of the e-heath management platform intervention.||||
1289953|NCT03726970|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1290034|NCT03725904||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290089|NCT03725189||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1573282|NCT00001761||||Treatment||||||||
1289954|NCT03726957|Randomized|Parallel Assignment||Basic Science||None (Open Label)||The investigators adopted a cluster randomized controlled trial with village as the unit of randomization. Villages were randomized to have participating households assigned to either a traditional biomass burning cookstove (control group) or to an improved cookstove (intervention group). A household that was willing to participate was considered eligible: 1) if it had a traditional wood burning cookstove; and 2) if the household included at least one child between the ages of 8-15. If a household had more than one child within the target age range, the oldest child within the age range was selected for study. Study participants within each household were the mother and the selected child.||||
1289955|NCT03726944|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||This study was a 4-group randomized trial design in which participants were randomly assigned to 4 unique groups that lasted for 8 weeks in total. Each group received two 4-week conditions involving one of three different conditions/arms.||||
1289956|NCT03726931||Single Group Assignment||Diagnostic||None (Open Label)||In this multicenter observational study with invasive measurements, patients with clinically ER+/HER2- LABC and LRR breast cancer will be included. All patients will undergo the current 'standard' diagnostic procedures including a histological biopsy of the primary tumor, cytology of axillary lymph nodes and imaging procedures with mammography, ultrasound of breast and axilla, magnetic resonance imaging (MRI) breast and whole body [18F]FDG PET combined with diagnostic chest/abdominal CT. In addition, all patients will undergo the 'experimental' imaging procedure with [18F]FES PET/CT. After evaluation of the obtained scans (independently for both scans), an 'experimental histological biopsy' of a lymph node metastasis will be obtained and clinically relevant [18F]FDG+ and/or [18F]FES+ lesions and/or suspicious lesions on CT will be biopsied according to standard clinical practice for pathological analyses.||||
1289957|NCT03726918|||Cohort||Prospective|||||||
1289958|NCT03726905|Randomized|Parallel Assignment||Treatment||Double|The control group will be assigned an imitation of respiratory muscles training with the help of breathing simulators, with a breathing resistance level set at 0|Parallel assignment|t|||t
1289959|NCT03726892|Randomized|Parallel Assignment||Treatment||Single|||t|||
1289960|NCT03726879|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1289961|NCT03726866|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1289962|NCT03726853|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289963|NCT03726840|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1289964|NCT03726827|||Other||Other|||||||
1289965|NCT03726814||Sequential Assignment||Treatment||None (Open Label)||||||
1289966|NCT03726801|Randomized|Parallel Assignment||Other||Single|This is a non-blinded, randomized, controlled clinical trial consisting of 64 participants, which aims to assess the effectiveness of a nursing intervention for family members and patients prior to surgery to prevent body image disorder in breast cancer operated subjects. or colon (32 participants), compared to the intervention limited only to patients (32 participants).|This is a non-blinded, randomized, controlled clinical trial consisting of 64 participants, which aims to assess the effectiveness of a nursing intervention for family members and patients prior to surgery to prevent body image disorder in breast cancer operated subjects. or colon (32 participants), compared to the intervention limited only to patients (32 participants).|||t|
1289967|NCT03726788|Randomized|Parallel Assignment||Treatment||Quadruple|Only pharmacists and radiologists know the patient's randomizing arm.||t|t|t|t
1289968|NCT03726775||Single Group Assignment||Treatment||None (Open Label)||IV infusion of durvalumab will start at fixed dose on Day1 of RT and subsequently every 3 weeks during the course of RT. Durvalumab with be continued via IV infusion at a fixed dose for an additional 6 months following RT, unless there is unacceptable toxicity, withdrawal of consent, or another discontinuation criterion is met.||||
1289969|NCT03726762|Randomized|Parallel Assignment||Treatment||Single||||||t
1289970|NCT03726749||Single Group Assignment||Treatment||None (Open Label)||||||
1289971|NCT03726736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1289972|NCT03726710||Single Group Assignment||Treatment||None (Open Label)||||||
1289973|NCT03726697|Randomized|Parallel Assignment||Prevention||Single|Parents and Statistician are blinded|||||t
1289974|NCT03726684||Single Group Assignment||Basic Science||None (Open Label)||Single center, single-armed, parallel design with four laboratory sessions for CI subjects||||
1289975|NCT03726671|Randomized|Crossover Assignment||Screening||Triple|Participant dietary arm assignment is randomized by a randomization plan created by the study coordinator at www.randomization.com. Each of the 3 hormonal related demographic groups (male, premenopausal females, and postmenopausal females) will have a list of the same order of diets created by the randomizer. Each participant will be assigned upon entry into the study into the next open diet for their group as ordered by the randomizer. No one collecting or processing data will be informed of the choline levels the participant is experiencing in their dietary arms at any given time to attempt to eliminate bias and ensure appropriate data collection. All staff who interact with participants or who are handling samples/data, will not be informed of the code linking dietary choline levels to diet order.|Healthy volunteers will consume meals, provided by the investigator, in two week intervals with 3 different levels of choline (Cho). Participants will receive 100% of the recommended daily intake (RDI) of Cho (550 mg Cho/day); 50% of the RDI of Cho (275mg/day); and 25% of the RDI of Cho (137.5 mg/day). The meal order will be randomly assigned and all participants will receive all diets at some point in the study. There will be a minimum of a two week washout between diet intervals where participants return to their regular diets. Both participants and researchers will be blinded to the diet order.|t||t|t
1289976|NCT03726658|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1289977|NCT03726645|Randomized|Parallel Assignment||Treatment||Triple|FMT type (donor/own feces) randomization is done by a study nurse.||t|t|t|
1289978|NCT03726632|||Case-Only||Prospective|||||||
1289979|NCT03726619|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1289980|NCT03726606|Randomized|Parallel Assignment||Treatment||Double|The patient and the examiner will be blinded to the arms.|Participants will be randomly allocated to one of two arms: Trifocal or extended depth of focus intraocular lenses.|t|||t
1290087|NCT03725215|Randomized|Parallel Assignment||Treatment||Single||Participants will randomly be assigned to 1 of 4 different split-belt treadmill paradigms. Assessments will be performed pre and post training on day 1 and once again on day 2.|t|||
1289981|NCT03726593|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, open-label clinical trial to evaluate the tolerability and clinical and parasitological responses after treatment of Pf and/or mixed infections (Pf/Pv) in volunteers with uncomplicated malaria. The assignment of volunteers will be 1:1:1 for ASPY (Pyramax), AP+ASPY (AP+Pyramax), and AP+ASMQ. All study drug administration will be by directly observed therapy (DOT).||||
1289982|NCT03726580|||Case-Control||Prospective|||||||
1289983|NCT03726567|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants who are undergoing bariatric surgery and control group who is having abdominal surgery for non-bariatric reasons||||
1289984|NCT03726554|||Cohort||Prospective|||||||
1289985|NCT03726541||Single Group Assignment||Screening||None (Open Label)||||||
1289986|NCT03726528||Single Group Assignment||Diagnostic||None (Open Label)||||||
1289987|NCT03726515||Single Group Assignment||Treatment||None (Open Label)||||||
1289988|NCT03726502|Randomized|Parallel Assignment||Treatment||Single||||||t
1289989|NCT03726489|Randomized|Parallel Assignment||Other||None (Open Label)||Pragmatic, randomized, active comparator effectiveness study||||
1289990|NCT03726476|Randomized|Parallel Assignment||Treatment||Single|||||t|
1289991|NCT03726463|||Cohort||Prospective|||||||
1289992|NCT03726450||Single Group Assignment||Treatment||None (Open Label)||||||
1289993|NCT03726437|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1289994|NCT03726424|||Cohort||Prospective|||||||
1289995|NCT03726411|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1289996|NCT03726398||Single Group Assignment||Prevention||None (Open Label)||||||
1289997|NCT03726385|||Cohort||Prospective|||||||
1289998|NCT03726372|Randomized|Parallel Assignment||Prevention||Triple|Muscle relaxant will be given by a specific investigator that is not involved in anesthesia and outcome assessment||t|t||t
1289999|NCT03726359||Single Group Assignment||Other||None (Open Label)||||||
1290000|NCT03726346||Single Group Assignment||Treatment||None (Open Label)||||||
1290001|NCT03726333|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients in the study will be assigned to different groups according to their liver function. Patients in each group will receive specific lorlatinib dose. Plasma samples for pharmacokinetic analysis will be collected in all patients. Safety and efficacy will also be followed in all patients until at least 28 days after the last study treatment.||||
1290002|NCT03726320|Randomized|Parallel Assignment||Screening||Double||||t|t|
1290003|NCT03726307|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-label, dose-escalation, phase 1 clinical trial.||||
1290004|NCT03726294||Single Group Assignment||Treatment||None (Open Label)||||||
1290005|NCT03726281||Single Group Assignment||Treatment||None (Open Label)||||||
1290006|NCT03726268|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1290007|NCT03726255|||Cohort||Retrospective|||||||
1290008|NCT03726242|Randomized|Crossover Assignment||Other||Quadruple||Parallel, randomized placebo controlled and crossover study|t|t|t|t
1290009|NCT03726229|||Cohort||Prospective|||||||
1290010|NCT03726216|||Cohort||Prospective|||||||
1290011|NCT03726203|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290012|NCT03726190|||Cohort||Retrospective|||||||
1290013|NCT03726177|Randomized|Parallel Assignment||Prevention||Quadruple|both participants and researchers will be blinded to the intervention given.|This will be a randomized control trial to estimate the efficacy of two doses (80 mg versus 160 mg) of aspirin for prevention of preeclampsia in High-Risk Pregnant Women identified in the first trimester to be at high risk.|t|t|t|t
1290014|NCT03726164|Randomized|Parallel Assignment||Treatment||Single||||||t
1290015|NCT03726151|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1290016|NCT03726138|||Cohort||Prospective|||||||
1290017|NCT03726125|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1290018|NCT03726112|Randomized|Parallel Assignment||Treatment||Triple||A Randomized, Double Blind, Placebo-Controlled Study followed by an open label phase|t||t|t
1290019|NCT03726099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290020|NCT03726086|||Cohort||Prospective|||||||
1290021|NCT03726073|Randomized|Parallel Assignment||Prevention||Double|transcutaneous electrical acupoint stimulation is given by an investigator who is not involved in anesthesia and outcome assessment|||t||t
1290022|NCT03726060|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290023|NCT03726047|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1290024|NCT03726034|Randomized|Parallel Assignment||Health Services Research||Single|A trained research assistant will be responsible to collect demographic data and assessing the outcomes at T0, T1, T2. The research assistant will be blinded to the grouping of participants.|Two-arm single-blinded randomized controlled feasibility trial.||||t
1290025|NCT03726021||Single Group Assignment||Treatment||None (Open Label)||"Experimental: Irinotecan,Oxaliplatin, and S1~S1 will be administered orally days 1 and 14 of a 21 day cycle~Irrinotecan 165 mg/m2 and Oxaliplatin 85mg/m2 will be administered IV days 1 of a 21 day cycle."||||
1290026|NCT03726008|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1290027|NCT03725995|Randomized|Parallel Assignment||Treatment||Double|The participant was blinded, the first assistant who explained the pain scale to the participants and asked him\her to record the score of pain associated with the drug administration was also blinded.|blinded, randomized placebo-controlled trial, comparing three groups.|t||t|
1290028|NCT03725982|Randomized|Crossover Assignment||Prevention||None (Open Label)|Subjects and experimenters will not be blinded, because it will be obvious which task will be performed by the subjects and measurements need to be tracked by the experimenter.|||||
1290029|NCT03725969|Randomized|Single Group Assignment||Other||Double|Double-blind||t||t|
1290030|NCT03725956||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290031|NCT03725943||Single Group Assignment||Diagnostic||None (Open Label)||Dreem||||
1290032|NCT03725930|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290088|NCT03725202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573283|NCT00001759||||||||||||
1290035|NCT03725891|Randomized|Parallel Assignment||Prevention||Quadruple|both participants and researchers will be blinded to the intervention given|This will be a randomized control trial to estimate the efficacy of two doses (81 mg versus 162 mg) of aspirin for prevention of preeclampsia in healthy, nulliparous obese and overweight pregnant women identified in the first trimester.|t|t|t|t
1290036|NCT03725878|Randomized|Parallel Assignment||Prevention||Single|This is a single-blind randomized controlled trial, participants are blinded from their preconceptional folate nutrition status.|cluster rondomization with average cluster size =100 pregnancies.|t|||
1290037|NCT03725865||Sequential Assignment||Treatment||None (Open Label)||||||
1290038|NCT03725852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290039|NCT03725839||Single Group Assignment||Treatment||None (Open Label)||||||
1290040|NCT03725826|||Cohort||Prospective|||||||
1290041|NCT03725813||Single Group Assignment||Health Services Research||None (Open Label)||A quasi- experimental study with non-equivalent control group design, pretest-posttest study.||||
1290042|NCT03725800|||Cohort||Prospective|||||||
1290043|NCT03725787||Single Group Assignment||Prevention||None (Open Label)||||||
1290044|NCT03725774||Single Group Assignment||Prevention||None (Open Label)||Uncontrolled before-and-after study||||
1290045|NCT03725761||Single Group Assignment||Treatment||None (Open Label)||||||
1290046|NCT03725748|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1290047|NCT03725735||Single Group Assignment||Treatment||None (Open Label)||Open label pilot study||||
1290048|NCT03725722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290049|NCT03725709|||Cohort||Prospective|||||||
1290050|NCT03725696|||Case-Only||Prospective|||||||
1290051|NCT03725683|Randomized|Parallel Assignment||Treatment||Single|||t|||
1290052|NCT03725670||Single Group Assignment||Treatment||None (Open Label)||||||
1290053|NCT03725657|||Case-Only||Prospective|||||||
1290054|NCT03725644|Randomized|Parallel Assignment||Treatment||Single||||||t
1290055|NCT03725631||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290056|NCT03725618|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290057|NCT03725605||Single Group Assignment||Treatment||None (Open Label)||LTX-315 and TILs||||
1290058|NCT03725592|Randomized|Parallel Assignment||Prevention||None (Open Label)||Recruit and prospectively follow 300 households and 600 participants (2 per household) to one of 2 study arms (150 households per arm). Each arm will receive arsenic removal devices. However the Standard Arm will only be provided with written instructions on how to use the arsenic removal device and follow-up phone calls, while the Intensive Education Arm will receive up to 5 additional in-visits and phone calls to provide support regarding the health implications of arsenic and the proper use and maintenance of the arsenic removal device.||||
1290059|NCT03725579|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1290060|NCT03725566||Sequential Assignment||Other||None (Open Label)||||||
1290061|NCT03725553|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which was used.|Patients were randomized to two groups, patients according to a two -blocked randomization list which was coded (1 or 2) at 1:1 ratio. The study drug was administered immediately after delivery, as soon as the umbilical cord was clamped. The experimental group received a bolus injection of vasopressin (4 IU) diluted to 2 mL with saline into the myometrium of the placental bed during slow (30‐s) Conversely, the placebo group received a 10‐mL bolus injection of saline into the myometrium during slow (30‐seconds).|t|t|t|t
1290062|NCT03725540|||Cohort||Prospective|||||||
1290063|NCT03725527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290064|NCT03725514|Randomized|Parallel Assignment||Treatment||Double|Sealed Opaque Envelopes||t||t|
1290065|NCT03725501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290066|NCT03725488|||Other||Prospective|||||||
1290067|NCT03725475|||Cohort||Retrospective|||||||
1290068|NCT03725462|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1290069|NCT03725449|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290070|NCT03725436||Single Group Assignment||Treatment||None (Open Label)||||||
1290071|NCT03725423||Single Group Assignment||Treatment||None (Open Label)||||||
1290072|NCT03725410|Randomized|Single Group Assignment||Treatment||Single|||t|||
1290073|NCT03725397|Randomized|Parallel Assignment||Supportive Care||Single|randomized double blinded|two cohort double blinded clinical trial|t|||
1290074|NCT03725384|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1290075|NCT03725371|||Case-Only||Prospective|||||||
1290076|NCT03725358|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||three supply-side interventions (including control condition) are being crossed with three levels of subsidies for LARCs||||
1290077|NCT03725345|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1290078|NCT03725332|Randomized|Parallel Assignment||Treatment||Single||||||t
1290079|NCT03725319|||Cohort||Retrospective|||||||
1290080|NCT03725306||Single Group Assignment||Treatment||None (Open Label)||Objective Performance Criterion||||
1290081|NCT03725293|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective single-site, parallel, two-arm, randomized investigation||||
1290082|NCT03725280|||Case-Control||Prospective|||||||
1290083|NCT03725267|Randomized|Parallel Assignment||Treatment||Triple|Melatonin and placebo pills will be manipulated in identical format. The pharmacist will provide similar packets of 7 pills each numbered from 1 to 100. Each packet will have placebo or melatonin according to a randomization list previously sent from a researcher responsible (not involved with intervention). Patients will be consecutively enrolled and receive the packet following the order of one to 100.|Randomized, double blind, placebo-controlled, 2-arm parallel trial|t|t|t|
1290084|NCT03725254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290085|NCT03725241|Randomized|Parallel Assignment||Basic Science||Double|Double blind||t||t|
1290086|NCT03725228|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1290090|NCT03725163|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized using block randomization to be assigned to a waitlist control condition or the treatment condition. Participants assigned to the waitlist control will have a 12-week waiting period prior to starting treatment. Those assigned to the treatment condition will begin therapy immediately.||||
1290091|NCT03725150|||Cohort||Prospective|||||||
1290092|NCT03725137|||Cohort||Prospective|||||||
1290093|NCT03725124|||Case-Only||Cross-Sectional|||||||
1290094|NCT03725111||Single Group Assignment||Treatment||None (Open Label)||||||
1290095|NCT03725098|Randomized|Parallel Assignment||Treatment||Single|||t|||
1290096|NCT03725085||Single Group Assignment||Basic Science||None (Open Label)||||||
1290097|NCT03725072||Single Group Assignment||Other||None (Open Label)||||||
1290098|NCT03725059|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1290099|NCT03725046|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1290100|NCT03725033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290101|NCT03725020|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1290102|NCT03725007|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1290103|NCT03724994|||Cohort||Prospective|||||||
1290104|NCT03724981|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1290105|NCT03724968|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290106|NCT03724955|Randomized|Parallel Assignment||Treatment||Double|Double Blinded|Prospective, double-blinded, randomized, placebo-controlled, interventional|t|||t
1290107|NCT03724942||Single Group Assignment||Treatment||None (Open Label)||||||
1290108|NCT03724929||Single Group Assignment||Prevention||None (Open Label)||||||
1290109|NCT03724916|Randomized|Sequential Assignment||Other||Quadruple|||t|t|t|t
1290110|NCT03724903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290111|NCT03724890|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290112|NCT03724877|||Cohort||Prospective|||||||
1290113|NCT03724864|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1290114|NCT03724851||Single Group Assignment||Treatment||None (Open Label)||||||
1290115|NCT03724838|Randomized|Parallel Assignment||Treatment||Quadruple|both participants and researchers will be blinded to the intervention given|We will conduct a randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of Esomeprazole alone or with Sildenafil Citrate in preterm pregnancies complicated by preeclampsia.|t|t|t|t
1290116|NCT03724825|||Case-Control||Cross-Sectional|||||||
1290117|NCT03724812||Single Group Assignment||Treatment||None (Open Label)||Devices under investigation in this clinical investigation include the FlexNav™ Delivery System(s) (18 F and 19 F) and FlexNav™ Loading System(s) (Small and Large), which are both approved for investigational use only. Other devices to be used in the clinical investigation include all four (4) market released St. Jude Medical (SJM) Portico™ valve sizes (23mm, 25mm, 27mm and 29mm).||||
1290118|NCT03724799||Single Group Assignment||Basic Science||None (Open Label)||||||
1290119|NCT03724786|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1290120|NCT03724773|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290121|NCT03724760|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290122|NCT03724747|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1290123|NCT03724734|Randomized|Crossover Assignment||Treatment||Double|Patients will not be told which form of stimulation is being applied and the main measures used to evaluate the outcome of the study will be video-taped performance on a number of motor tasks and the video-taping of mobility during arousals and awakenings from sleep.|Patients will be randomised as to whether they receive conventional DBS or adaptive DBS first. Thereafter they will cross-over to the second type of stimulation.|t|||t
1290124|NCT03724721||Single Group Assignment||Treatment||None (Open Label)||||||
1290125|NCT03724708|Randomized|Parallel Assignment||Prevention||Single|randomised computer generated table and closed envelope system|randomized controlled trial|t|||
1290126|NCT03724695|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1290127|NCT03724682||Single Group Assignment||Treatment||None (Open Label)||Baseline study session with standard PD therapy. Three study sessions with the Carry Life UF device at three different glucose dosages, starting with the lowest dose of 11g/h, increasing to 14g/h and finally 20g/h.||||
1290128|NCT03724669|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1290129|NCT03724656|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1290130|NCT03724643|Randomized|Parallel Assignment||Other||Quadruple||Prospective randomized controlled trial|t|t|t|t
1290131|NCT03724630|||Cohort||Prospective|||||||
1290132|NCT03724617||Single Group Assignment||Treatment||None (Open Label)||||||
1290133|NCT03724604|||Cohort||Prospective|||||||
1290134|NCT03724591|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1290135|NCT03724578|Randomized|Parallel Assignment||Prevention||Single||||||t
1290136|NCT03724565|||Ecologic or Community||Cross-Sectional|||||||
1290137|NCT03724552||Single Group Assignment||Treatment||None (Open Label)||||||
1290179|NCT03724006|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Parents will be divided in 2 study groups: INTERVENTION group (I) and CONTROL group (C).~Group I will receive a psychoeducational intervention in addition to the usual routines of the Service. Group C will receive the usual routines of the Service. The intervention will be performed as soon as possible after inclusion in the study.~Participants will be evaluated in 3 moments: M1 beginning of the study; M2 4 weeks after the intervention (I) or after enrollment (C) and M3 16 weeks after intervention/enrollment. The primary outcome will be parental QoL, which will be evaluated through the SF36v2 Health Survey. The family impact and the perception of positive contributions will be secondary outcomes. These outcome variables will be assessed by the Impact on Family Scale and the Positive Contributions Scale - Kansas Inventory of Parental Perceptions, respectively. A semi-structured interview will be performed after all quantitative data have been collected."||||
1290180|NCT03723993|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1290138|NCT03724539|Randomized|Parallel Assignment||Health Services Research||Triple|"The OPTICA study is partially blinded, with blinding being implemented as follows:~Due to the nature of the study intervention participating GPs (care providers) cannot be blinded.~Patients remain blinded. They will not be informed to which treatment arm their GP is allocated to, in order to minimize performance and other reporting biases. Despite this, they receive a high-level description of the study question and the study procedures.~Data collection for primary and secondary outcome analyses will be conducted by blinded study team members.~Outcome adjudication (MAI and AOU assessment) will be performed by blinded study team members."|"Clusters will be randomized 1:1, to either the intervention arm receiving STRIPA or to the control arm undergoing a sham intervention. Each cluster is defined by one GP.~The patients assigned to a cluster (i.e. GP) which was allocated to the intervention arm will undergo a systematic pharmacotherapy optimization by their GP using the STRIP assistant and shared decision making. Patients assigned to a cluster that was assigned to the control arm will receive a sham intervention, which consists of a usual medication review by the GP in accordance with usual care and shared decision making.~This RCT randomizes GPs instead of patients to prevent contamination, which would occur if the same GPs treated patients in the intervention and the control arm simultaneously."|t||t|t
1290139|NCT03724526|Randomized|Parallel Assignment||Treatment||Single|The study is a two-arm, parallel, randomized clinical trial. The primary outcome and secondary outcomes was measured by blinded assessors throughout the study period.|The eligible participants will be randomly allocated into intervention and control groups in a 1:1 ratio. The intervention group will receive text messages in addition to usual care for 12 months, while the control group will receive usual care.||||t
1290140|NCT03724513|||Cohort||Retrospective|||||||
1290141|NCT03724500|||Case-Only||Retrospective|||||||
1290142|NCT03724487|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290143|NCT03724474|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Pretest-Posttest Control Group Design||||
1290144|NCT03724461|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1290145|NCT03724448|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1290146|NCT03724435|||Cohort||Prospective|||||||
1290147|NCT03724422|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomized to either a treatment or control group.||||
1290148|NCT03724409|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This is a sequential early phase 1 study using Storer's phase 1 design B.||||
1290149|NCT03724396|Randomized|Parallel Assignment||Treatment||Single||||||t
1290150|NCT03724383|Randomized|Parallel Assignment||Treatment||Double|The investigators involved in analyzing test results or treating patients are blinded to the participant's study group.|This is a parallel-group randomized controlled trial. Consecutive patients meeting eligibility criteria that are seen for routine cardiology follow-up will be invited to participate in this study. Patients who accept the possibility of diet counseling and exercise program will be randomized and stratified to 'control arm' versus 'intervention arm.' The final study results will be reported after completion of one-year follow up. We will also carry out a mid-study data analysis at six-months. Forty patients will be randomized to control arm and 40 patients randomized to the intervention arm. Intervention will include Phase 1, a six month program including three months of diet counseling combined with home exercise, followed by three months (starting at week 13) of an in-hospital, Cardiac rehabilitation exercise program. Phase 2 of the intervention will include six months of home-based maintenance exercise and diet (starting at week 25). The entire intervention period will be one year.|||t|t
1290151|NCT03724370|Randomized|Parallel Assignment||Other||Single||||||t
1290152|NCT03724357||Single Group Assignment||Basic Science||None (Open Label)||Volunteers who choose to take part in this study will receive the licensed FDA-approved Oral Cholera Vaccine (Vaxchora).||||
1290153|NCT03724344|||Case-Only||Cross-Sectional|||||||
1290154|NCT03724331|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290155|NCT03724318|Randomized|Parallel Assignment||Prevention||None (Open Label)||Open-label, parallel, randomized, control trial||||
1290156|NCT03724305|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290157|NCT03724292|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1290158|NCT03724279||Single Group Assignment||Treatment||None (Open Label)||||||
1290159|NCT03724266|Randomized|Parallel Assignment||Treatment||Double|participants should be blinded|postoperative pain after intervention|t|||t
1290160|NCT03724253|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1290161|NCT03724240|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1290162|NCT03724227||||||||||||
1290163|NCT03724214|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Pre and post study design. All patients presenting with simple gastroschisis during the pre-intervention phase will receive the current care provided by the study site. All patients with simple gastroschisis presenting to a study site following implementation will receive the interventional care bundle (if consent is provided).||||
1290164|NCT03724201|||Other||Cross-Sectional|||||||
1290165|NCT03724188|||Case-Only||Prospective|||||||
1290166|NCT03724175||Single Group Assignment||Treatment||None (Open Label)||||||
1290167|NCT03724162|||Case-Only||Prospective|||||||
1290168|NCT03724149||Single Group Assignment||Treatment||None (Open Label)||||||
1290169|NCT03724136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be assigned to one of 3 arms with monitoring and retesting at 1,3,6 and 12 months following treatment.||||
1290170|NCT03724123|||Cohort||Retrospective|||||||
1290171|NCT03724110|||Cohort||Prospective|||||||
1290172|NCT03724097|||Case-Control||Prospective|||||||
1290173|NCT03724084||Single Group Assignment||Treatment||None (Open Label)||||||
1290174|NCT03724071||Single Group Assignment||Treatment||None (Open Label)||||||
1290175|NCT03724058|Randomized|Parallel Assignment||Treatment||Single|||t|||
1290176|NCT03724045||Sequential Assignment||Prevention||None (Open Label)||||||
1290177|NCT03724032|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1290178|NCT03724019|||Cohort||Prospective|||||||
1290181|NCT03723980|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1290182|NCT03723967||Single Group Assignment||Treatment||None (Open Label)||Multicenter, prospective, single arm phase II study (a run-in tolerance study will be first performed on a limited number of patients: maximum 9)||||
1290183|NCT03723954|||Cohort||Prospective|||||||
1290184|NCT03723941|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, randomized, open-label, stratified, nation-based multi-center, phase III trial for patients with ACC and Ki67≥10% after resection with curative intent||||
1290185|NCT03723928|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1290186|NCT03723915||Single Group Assignment||Treatment||None (Open Label)||||||
1290187|NCT03723902|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1290188|NCT03723889|||Case-Control||Prospective|||||||
1290189|NCT03723876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290190|NCT03723863||Single Group Assignment||Supportive Care||None (Open Label)||||||
1290191|NCT03723850|Randomized|Parallel Assignment||Basic Science||Double|Neither the participant, nor the research assistant administering tDCS will know if the participant is receiving active tDCS or sham tDCS.||t||t|
1290192|NCT03723837|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290193|NCT03723824||Single Group Assignment||Treatment||None (Open Label)||grazoprevir 100 mg/ elbasvir 50 mg, Zepatier®, 1# qd for 12 weeks||||
1290194|NCT03723811|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290195|NCT03723798|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290196|NCT03723785|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290197|NCT03723772|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1290198|NCT03723759|Randomized|Crossover Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is asked according to company standard procedures||t|t|t|t
1290199|NCT03723746|Randomized|Sequential Assignment||Other||Double|||t||t|
1290200|NCT03723733|||Cohort||Cross-Sectional|||||||
1290201|NCT03723720|||Other||Retrospective|||||||
1290202|NCT03723707|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1290203|NCT03723694|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1290204|NCT03723681|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1290205|NCT03723668|||Cohort||Other|||||||
1290206|NCT03723655|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1290207|NCT03723642|Randomized|Parallel Assignment||Basic Science||Single|"After obtaining written informed consent from patients/legal guardians the patients will be randomized 1:1 to one of the two surgical techniques. Randomization is carried out using the web-based Randomizer for Clinical Trials program at the Institute of Medical Informatics, Statistics and Documentation at the Medical University of Graz (www.randomizer.at)."|20 patients aged 6-18 years suffering from acute appendicitis are to be included. These are divided into 2 groups. Group 1 (n = 10) with laparoscopic and group 2 (n = 10) with open appendectomy.|t|||
1290208|NCT03723629|||Cohort||Prospective|||||||
1290209|NCT03723616|Randomized|Parallel Assignment||Other||Single|||t|||
1290210|NCT03723603||Single Group Assignment||Treatment||None (Open Label)||||||
1290211|NCT03723590||Single Group Assignment||Treatment||None (Open Label)||||||
1290212|NCT03723577||Single Group Assignment||Treatment||None (Open Label)||||||
1290213|NCT03723564||Single Group Assignment||Treatment||None (Open Label)||||||
1290214|NCT03723551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290215|NCT03723538|||Cohort||Prospective|||||||
1290216|NCT03723525|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1290217|NCT03723512||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290218|NCT03723499|||Cohort||Retrospective|||||||
1290219|NCT03723486|||Cohort||Prospective|||||||
1290220|NCT03723473|||Cohort||Prospective|||||||
1290221|NCT03723460|||Cohort||Prospective|||||||
1290222|NCT03723447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290223|NCT03723434|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||PAS will be applied to two cortical targets at different asynchronies to modulate connectivity. PAS may selectively increase or decrease effective connectivity depending on the asynchrony. Negative asynchronies are expected to decrease effective connectivity, whereas positive asynchronies to increase it.||||
1290224|NCT03723421|Randomized|Parallel Assignment||Prevention||Single|As the study was a single-blind trial, the pain assessment was performed by another nurse, in the second minute after the injection, using the numerical pain rating scale, in order to provide neutrality. The nurse was informed by the researcher about the use of the scale.|||||t
1290225|NCT03723408||Single Group Assignment||Prevention||None (Open Label)|Three sites - Loma Linda Medical Center, Johns Hopkins, Miami Nicklaus Children's|An observational prospective trial was conducted in operating room settings across multiple study sites. 120 surgical patients undergoing a variety of interventional and surgical procedures were selected, representing multiple patient populations, case types and anesthesia setups. The ClearLine IV, a device that detects and removes air from IV tubing, was inserted into the IV circuit. Clinicians followed standard protocols. Blood warmers were used at the practitioner's discretion. IV fluid was administered at a constant flow rate or through a bolus given over 30-60 seconds per standard of care. The volume and duration of fluid administration was recorded, along with the frequency, duration and amount of air captured by ClearLine IV.||||
1290226|NCT03723395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290227|NCT03723382|||Cohort||Other|||||||
1290228|NCT03723369||Single Group Assignment||Treatment||None (Open Label)||||||
1290229|NCT03723356|||Case-Crossover||Prospective|||||||
1290230|NCT03723343|||Case-Control||Prospective|||||||
1290231|NCT03723330|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1290232|NCT03723317|||Cohort||Retrospective|||||||
1290233|NCT03723304|||Cohort||Retrospective|||||||
1290234|NCT03723291|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicentre, parallel group, randomised controlled trial in 50 patients with radiotherapy-induced fibrosis of the head and neck.||||
1573284|NCT00001757||||Treatment||||||||
1290235|NCT03723278|||Case-Only||Cross-Sectional|||||||
1290236|NCT03723265|||Cohort||Prospective|||||||
1290237|NCT03723252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290238|NCT03723239||Single Group Assignment||Treatment||None (Open Label)||||||
1290239|NCT03723226|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1290240|NCT03723213|||Case-Control||Prospective|||||||
1290241|NCT03723200|||Other||Retrospective|||||||
1290242|NCT03723187|Randomized|Parallel Assignment||Other||None (Open Label)||"Cancer patients in need of chemotherapy~Newly accepted Port-A Implant~port maintenance:Catheter irrigation with 20 ml N/S,10 ml N/S sealing tube"||||
1290243|NCT03723174|||Other||Prospective|||||||
1290244|NCT03723161|||Case-Only||Prospective|||||||
1290245|NCT03723148||||||||||||
1290246|NCT03723135||||||||||||
1290247|NCT03723122|Randomized|Parallel Assignment||Supportive Care||Quadruple|Randomization allocation is given only at the data manager. Participant, care provider and assessor do not know in which group participants are allocated|Randomized Controlled Trial|t|t|t|t
1290248|NCT03723109|||Cohort||Prospective|||||||
1290249|NCT03723096||||||||||||
1290250|NCT03723083||||||||||||
1290251|NCT03723070||Single Group Assignment||Treatment||None (Open Label)||Non-randomized study designed to validate the safety and performance of the Cryterion Cardiac Cryoablation System when used as intended||||
1290252|NCT03723057||||||||||||
1290253|NCT03723044||Single Group Assignment||Basic Science||None (Open Label)||||||
1290254|NCT03723031|Randomized|Parallel Assignment||Prevention||Single|||t|||
1290255|NCT03723018|Randomized|Parallel Assignment||Treatment||Single|The investigator analyzing the data will be blinded to which study arm participants were assigned to.||||t|
1290256|NCT03723005|||Cohort||Prospective|||||||
1290257|NCT03722992||Single Group Assignment||Treatment||None (Open Label)||||||
1290258|NCT03722979||Single Group Assignment||Other||None (Open Label)||||||
1290259|NCT03722966|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1290260|NCT03722953||Single Group Assignment||Basic Science||None (Open Label)||||||
1290261|NCT03722940|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1290262|NCT03722927|Randomized|Parallel Assignment||Prevention||Double||Women of all races and ethnicity who meet the above-described eligibility criteria are eligible to participate in this study. Approximately 5% of study participants to be Hispanic/Latino (N=5), 10% Black or African American (N=10), 1% American Indian/Alaska Native (N=1), and 5% Asian (N=5).|t||t|
1290263|NCT03722914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290264|NCT03722901|||Cohort||Prospective|||||||
1290265|NCT03722888||Single Group Assignment||Prevention||None (Open Label)||single group study with pre-post design||||
1290266|NCT03722875||Single Group Assignment||Treatment||None (Open Label)||||||
1290267|NCT03722862|Randomized|Crossover Assignment||Prevention||Double|fiber is provided in pouches; coded to treatment|3 arm crossover, randomized|t||t|
1290268|NCT03722849|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||The experiment will consist of two sessions. The first session will involve questionnaires, followed by measures of sensitivity and behavioural responses to tussive (cough evoking) stimulation. The second session will involve functional brain imaging measures of responses to tussive stimulation.||||
1290269|NCT03722836|||Other||Prospective|||||||
1290270|NCT03722823|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290271|NCT03722810|Randomized|Parallel Assignment||Other||Single||Randomised controlled trial, with sham control.|t|||
1290272|NCT03722797|||Case-Control||Cross-Sectional|||||||
1290273|NCT03722784||||||||||||
1290274|NCT03722771|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1290275|NCT03722758|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1290276|NCT03722745|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1290277|NCT03722732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290278|NCT03722719|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1290279|NCT03722706|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290280|NCT03722693|||Case-Only||Prospective|||||||
1290281|NCT03722680|Randomized|Parallel Assignment||Prevention||Quadruple|Placebo arm: The patient will be taken on tablet (placebo :50 mg, film-coated tablet) Posology, administration and duration of treatment will be equivalent to riluzole group.|Riluzole arm: The patient will be taken one tablet (riluzole 50 mg, film-coated tablet) twice a day, in the morning and in the evening during the meal (12h interval). The medication is taken during the 14 days of each chemotherapy cycle, beginning 7 days before the start of chemotherapy and ending 2 weeks after the start of last cycle of chemotherapy (25 weeks). The treatment ends with the cessation of chemotherapy (visit V3 or anticipated stop).|t|t|t|t
1290282|NCT03722667|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The investigators hypothesize that African Americans' hypertension self-management behaviors are influenced by the ability of the individual to task differentiate between the DMN and TPN neural processing. Furthermore, such behaviors will lead to improved BP control and HRQoL. Using a two-arm RCT pilot study, investigators will compare the effects of TechSuPPorT and the Technology-based component arm on BP, HRQoL, and psychological health (affective well-being, depressive symptoms, anxiety) and cognitive task differentiation of the DMN and TPN neural networks. Data will be collected at three points: baseline, 8 weeks and 12 weeks. Brain scans (fMRIs) will be captured at baseline and following the intervention at 8 weeks.||||
1290283|NCT03722654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290284|NCT03722641|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1290285|NCT03722628|||Case-Control||Prospective|||||||
1290286|NCT03722615|||Cohort||Prospective|||||||
1290287|NCT03722602||Single Group Assignment||Treatment||None (Open Label)||||||
1290288|NCT03722589|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290289|NCT03722576||Single Group Assignment||Treatment||None (Open Label)||||||
1290290|NCT03722563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573285|NCT00001754||||||||||||
1290291|NCT03722550|Randomized|Parallel Assignment||Other||Quadruple|Unique coding of the study products||t|t|t|t
1290292|NCT03722537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290293|NCT03722524|||Other||Prospective|||||||
1290294|NCT03722511|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290295|NCT03722498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290296|NCT03722485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290297|NCT03722472|Randomized|Parallel Assignment||Prevention||Quadruple|All clinical staff and the participants are blinded to treatment, with the exception of the clinical pharmacist who prepares the vaccines and syringes.||t|t|t|t
1290298|NCT03722459||Single Group Assignment||Other||None (Open Label)||||||
1290299|NCT03722446|Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1290300|NCT03722433|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1290301|NCT03722420|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel, 2 arms||||
1290302|NCT03722407||Sequential Assignment||Treatment||None (Open Label)||||||
1290303|NCT03722394||Single Group Assignment||Treatment||None (Open Label)||Observational cohort||||
1290304|NCT03722381|||Cohort||Prospective|||||||
1290305|NCT03722368|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1290306|NCT03722355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290307|NCT03722342||Sequential Assignment||Treatment||None (Open Label)||||||
1290308|NCT03722329|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1290309|NCT03722316|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1290310|NCT03722303|Non-Randomized|Single Group Assignment||Treatment||Double|||||t|t
1290311|NCT03722290||Single Group Assignment||Treatment||None (Open Label)||Open-label trial||||
1290312|NCT03722277|Randomized|Parallel Assignment||Treatment||Single|||||t|
1290313|NCT03722264|Randomized|Single Group Assignment||Prevention||Single|"Opalseal and TransbondXT are identical in color, consistency and application allowing random assignments as well as patient blinding.~The outcomes assessor will also be blinded to the groups assignments."|Participants have at least two teeth planned for extraction on either side of the mouth. The study will use a split-mouth design with random assignments for intervention (OpalSeal) on one tooth.|t|||
1290314|NCT03722251|Randomized|Crossover Assignment||Prevention||Single||Repeated measures cross-over design.|t|||
1290315|NCT03722238||Parallel Assignment||Other||None (Open Label)||The Actual Use Trial (AUT) design utilizes a real world setting to assess the ability of consumers to use an investigational product that will be marketed in an over-the-counter setting according to the proposed product labelling. The primary objective of this AUT is to evaluate compliance with the labeled dosing directions for Advil 12 Hour and to understand why misuse occurred and if it was a conscious decision by the subject. A secondary objective is to evaluate the safety of Advil 12 Hour in unsupervised actual use and how it relates to misuse.||||
1290316|NCT03722225||Single Group Assignment||Other||None (Open Label)||This is a descriptive, single arm, non-randomized interventional study. The intervention consisted of carbohydrate loading prior to and intermittent high carbohydrate intake during physical exercise and a proactive use of Real-Time Continuous Glucose Monitoring (rtCGM) to achieve and maintain glucose control.||||
1290317|NCT03722212||Single Group Assignment||Diagnostic||None (Open Label)|The METAglut1 test is performed blindly of the reference strategy. METAglut1's result masking is maintained for the investigator on the one hand, and the glycorrhachia value masking is maintained for the centralized testing laboratory in charge of METAglut1 on the other hand.|The METAglut1 test is performed on each patient, in parallel and blindly of the reference diagnostic strategy which is performed through the current practice.||||
1290318|NCT03722199|Randomized|Crossover Assignment||Prevention||Quadruple|The different capsules are separated into 2 boxes but both sorts of capsules have the same colour and size. They just have a different number marked on the white box. During the investigation day, the participant chooses an envelope marked with number 1 or number 2 leading to the decision of the box and thus the capsules they will get.||t|t|t|t
1290319|NCT03722186||Sequential Assignment||Treatment||None (Open Label)||||||
1290320|NCT03722173||Crossover Assignment||Treatment||None (Open Label)||||||
1290321|NCT03722160||Single Group Assignment||Treatment||None (Open Label)||||||
1290322|NCT03722147||Single Group Assignment||Treatment||None (Open Label)||||||
1290323|NCT03722134|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Our study aim was to assess the applicability and safety of MOCA in short term as well as occlusion rate and disease specific quality of life one year after the procedure, and compare it with currently used thermal ablation methods of laser ablation (EVLA) and radiofrequency ablation (RFA) in a randomized controlled trial.~Randomization took place by a study nurse after the appointment, using block randomization with sealed envelopes into EVLA, RFA, or MOCA in ratio 1:1:2."||||
1290324|NCT03722121|||Cohort||Retrospective|||||||
1290325|NCT03722108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290326|NCT03722095|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1290327|NCT03722082|Randomized|Parallel Assignment||Prevention||Single|Primary outcome|||||t
1290328|NCT03722069|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1290329|NCT03722056|||Case-Only||Retrospective|||||||
1290330|NCT03722043||Single Group Assignment||Prevention||None (Open Label)||||||
1290331|NCT03722030|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Pilot/Feasibility trial - 2 arms, one strength-training intervention vs. waitlist control group||||
1290380|NCT03721393|||Cohort||Prospective|||||||
1290381|NCT03721380|Randomized|Single Group Assignment||Treatment||Single|||t|||
1290382|NCT03721367|||Other||Cross-Sectional|||||||
1290383|NCT03721354||Single Group Assignment||Treatment||None (Open Label)|the ultrasonography examiner is blind on the ventilatory mode|pilot interventional study||||
1290384|NCT03721341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290385|NCT03721328||Single Group Assignment||Treatment||None (Open Label)||||||
1290386|NCT03721315|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1290332|NCT03722017|Randomized|Parallel Assignment||Treatment||Double|The investigators and outcomes assessors (study personnel) will be masked as to which study arm patients below. The participant and providers involved in their care will not be masked to the intervention, as there is participation of both groups in the deprescribing protocol discussions.|"The investigators will ascertain for each medication: (1) Indication; (2) Deprescribing rationale (i.e., stopping or reducing dose) for each medication.~Deprescribing Recommendations will be specified as: (1) Stop prior to hospital discharge, no monitoring; (2) Stop prior to hospital discharge with monitoring; (3) Stop at specified time point following hospital discharge; (4) Reduce over time with monitoring until stopped; (5) Reduce to lower dose without monitoring; (6) Reduce to lower dose with monitoring. Deprescribing will begin prior to hospital discharge.~The investigators will incorporate Veteran preferences, communicate with all providers involved in prescribing, create final deprescribing actions, and do enhanced hospital discharge communication."|||t|t
1290333|NCT03722004|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290334|NCT03721991|Randomized|Parallel Assignment||Basic Science||Quadruple|randomised controlled with placebo tablets matching active capsules with investigational product|randomised controlled study with active compared to placebo for 12 weeks|t|t|t|t
1290335|NCT03721978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290336|NCT03721965||Single Group Assignment||Treatment||None (Open Label)||||||
1290337|NCT03721952|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290338|NCT03721939||Single Group Assignment||Treatment||None (Open Label)||||||
1290339|NCT03721926|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290340|NCT03721913|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor will be masked for assessments of family empowerment|||||t
1290341|NCT03721900|Non-Randomized|Sequential Assignment||Treatment||Single||Each subject will receive one of the following: placebo, 20 mg (low dose), or 40 mg (high dose). All subjects will receive doses in the same order during 3 study periods|t|||
1290342|NCT03721887|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1290343|NCT03721874|Randomized|Crossover Assignment||Basic Science||Double||Double-Blind, Randomized, Phase IV, Mechanistic, Placebo-Controlled, Cross-Over, Single-Center Study|t||t|
1290344|NCT03721861||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1290345|NCT03721848|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"Condition 1: an existing NCD preventive intervention consisting of 24 sessions, which are 45 minutes covering diabetes, hypertension, obesity, reproductive health, cardiovascular diseases, allergies and smoking;~Condition 2: The existing NCD preventive intervention with 4 added mental health awareness sessions covering traumatic stress reactions, individual strategies for coping with stress and traumatic events and collective strategies for coping with stress and trauma;~Condition 3: Treatment as usual"||||
1290346|NCT03721835||Single Group Assignment||Treatment||None (Open Label)||||||
1290347|NCT03721822|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290348|NCT03721809|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290349|NCT03721796|||Case-Control||Prospective|||||||
1290350|NCT03721783|||Cohort||Prospective|||||||
1290351|NCT03721770|||Cohort||Prospective|||||||
1290352|NCT03721757|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290353|NCT03721744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290354|NCT03721731|||Cohort||Prospective|||||||
1290355|NCT03721718|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290356|NCT03721705|Randomized|Parallel Assignment||Treatment||Double||Participants will be randomized to either the treatment group or the sham group.|t|||t
1290357|NCT03721692|Randomized|Parallel Assignment||Prevention||Single||||||t
1290358|NCT03721679||Sequential Assignment||Treatment||None (Open Label)||The study is largely a signal-finding exercise to determine if there is an immune and/or clinical response to the addition of poly-ICLC to aPD-1 or aPDL-1 therapy, as predicted by preclinical models.||||
1290359|NCT03721666|||Other||Retrospective|||||||
1290360|NCT03721653|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective, open-label, multicentric phase II randomized in a 1:2 ratio||||
1290361|NCT03721640|||Other||Prospective|||||||
1290362|NCT03721627||Single Group Assignment||Treatment||None (Open Label)||||||
1290363|NCT03721614|Randomized|Parallel Assignment||Treatment||None (Open Label)||Study Device :- BioMime™ Morph - Sirolimus Eluting Coronary Stent System Active Control Device :- Xience family Everolimus Coronary Stent Systems||||
1290364|NCT03721601|||Case-Control||Prospective|||||||
1290365|NCT03721588|||Case-Only||Cross-Sectional|||||||
1290366|NCT03721575|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1290367|NCT03721562|||Case-Only||Cross-Sectional|||||||
1290368|NCT03721549|Non-Randomized|Sequential Assignment||Other||None (Open Label)||A total of 16 eligible healthy young adults will be challenged with either the moderate or higher dose of norovirus inoculum||||
1290369|NCT03721536|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1290370|NCT03721523|||Cohort||Prospective|||||||
1290371|NCT03721510|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290372|NCT03721497|Randomized|Parallel Assignment||Other||Quadruple||Randomized, placebo-controlled and double-blinded study|t|t|t|t
1290373|NCT03721484||Single Group Assignment||Prevention||None (Open Label)||||||
1290374|NCT03721471|||Cohort||Prospective|||||||
1290375|NCT03721458|||Case-Only||Retrospective|||||||
1290376|NCT03721445|||Case-Control||Prospective|||||||
1290377|NCT03721432|Randomized|Parallel Assignment||Treatment||Quadruple|sealed opaque numbered envelopes indicating the group of each patient, carried out by an independent anesthesiologist and given to the ward nurse||t|t|t|t
1290378|NCT03721419|Non-Randomized|Parallel Assignment||Treatment||Single|Single blind|Crossover study between 2 medical ICUs and 1 Surgical ICU. Patients in one unit will start off with Low Flow (LF) while the other unit will start off with High Flow (HF). After one half of the required sample size is accrued we will crossover the Medicine ICUs with the Surgical ICU.||||t
1290379|NCT03721406||Single Group Assignment||Basic Science||None (Open Label)||||||
1290387|NCT03721302|||Cohort||Prospective|||||||
1290388|NCT03721289|||Cohort||Retrospective|||||||
1290389|NCT03721276|Randomized|Parallel Assignment||Treatment||None (Open Label)|Patients will either be immediately enrolled or wait listed for the intervention.|||||
1290390|NCT03721263||Single Group Assignment||Treatment||None (Open Label)||Single Ascending Dose||||
1290391|NCT03721250|||Other||Prospective|||||||
1290392|NCT03721237||Single Group Assignment||Other||None (Open Label)||||||
1290393|NCT03721224|||Case-Control||Cross-Sectional|||||||
1290394|NCT03721211||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290395|NCT03721198|Randomized|Parallel Assignment||Prevention||None (Open Label)||split mouth technique||||
1290396|NCT03721185|Randomized|Parallel Assignment||Treatment||None (Open Label)|Researchers assessed the efficacy of a lipolytic cream with hypocaloric diet and physical activity in the treatment of overweight and obesity. The control treatment was lypolitic cream with hypocaloric diet and physicial activity and hypocaloric diet and physicial activity alone. In total, 102 patients were recruited and allocated to treatment (51: lypolitic cream with hypocaloric diet and physicial activity and, 51: hypocaloric diet and physicial activity alone.|open-label, randomized, parallel-group||||
1290397|NCT03721172|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290398|NCT03721159|||Other||Other|||||||
1290399|NCT03721146|||Cohort||Prospective|||||||
1290400|NCT03721133||Single Group Assignment||Screening||None (Open Label)||"Measurement, Estimate recruitment, and risk~Study subject:~Non small lung cancer patients~Received curative intended tumor resection (ie. anatomic resection and mediastinal lymph node dissection)~age ≧ 20 yeas old~agreed to join the study after thoroughly explanations Data collection: medical record review and blood sampling for circulating tumor cell purification Risk: no increased for patients who join into the study Estimated patient number in disease severity Stage 1: 100 Stage 2: 50 Stage 3: 50"||||
1290401|NCT03721120|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1290402|NCT03721107|Randomized|Parallel Assignment||Treatment||Double|Double blind trial design||t||t|
1290403|NCT03721094|Randomized|Parallel Assignment||Other||None (Open Label)|Participants and the principal investigators were blinded to performance metrics by the simulator during the supervised procedure and the three test procedures. Participants and the data collector could not be blinded to the allocation/intervention. The investigator in charge of the statistical analysis was blinded to participants' group allocation.|A single-center randomized trial was designed according to the CONSORT statement||||
1290404|NCT03721081|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1290405|NCT03721068||Single Group Assignment||Treatment||None (Open Label)||||||
1290406|NCT03721055||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290407|NCT03721042||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290408|NCT03721029|Randomized|Parallel Assignment||Prevention||Single|||t|||
1290409|NCT03721016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290410|NCT03721003|||Cohort||Prospective|||||||
1290411|NCT03720990||Single Group Assignment||Treatment||None (Open Label)||||||
1290412|NCT03720977|||Case-Control||Retrospective|||||||
1290413|NCT03720964|||Case-Control||Prospective|||||||
1290414|NCT03720951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290415|NCT03720938|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290416|NCT03720925||Single Group Assignment||Treatment||None (Open Label)||||||
1290417|NCT03720912|Randomized|Parallel Assignment||Health Services Research||Single|The outcomes assessor will be masked to the participant's assignment. Others (participant, care provider, investigator) cannot be masked to assignment because one group will be receiving the behavioral health intervention and the other will not be receiving anything additional.|||||t
1290418|NCT03720899|Randomized|Parallel Assignment||Treatment||None (Open Label)||participants will be randomized to one of two interventions||||
1290419|NCT03720886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290420|NCT03720873||Single Group Assignment||Treatment||None (Open Label)||||||
1290421|NCT03720860|||Cohort||Prospective|||||||
1290422|NCT03720847|Randomized|Crossover Assignment||Basic Science||Triple|Identical placebos provided by the UNC investigational drug service.|Crossover 2-Condition Placebo-Controlled Trial|t||t|t
1290423|NCT03720834|||Cohort||Prospective|||||||
1290424|NCT03720821||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290425|NCT03720808|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290426|NCT03720795||Single Group Assignment||Treatment||None (Open Label)|The rater is unaware of treatment status, that is if the child continues to receive treatment after Step 1 (versus being in maintenance).|Single group observational.||||
1290427|NCT03720782|||Cohort||Other|||||||
1290428|NCT03720769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290429|NCT03720756|Non-Randomized|Parallel Assignment||Treatment||Single|The efficacy of treatment methods will be assessed by comparing GERD-Health Related Quality of Life (HRQL) questionnaires before and after implementation of a nickel-free diet.|Patients will undergo a patch test to determine if they are hypersensitive to nickel among other metabolites. Regardless of the results of the patch test, patients will be placed on a nickel-free diet for 8 weeks.|t|||
1290430|NCT03720743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290431|NCT03720730||Single Group Assignment||Prevention||None (Open Label)||||||
1290432|NCT03720717|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1290433|NCT03720704|||Cohort||Prospective|||||||
1290434|NCT03720691|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1290435|NCT03720678|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||3+3 dose escalation||||
1290480|NCT03720093|||Cohort||Prospective|||||||
1290481|NCT03720080|||Cohort||Prospective|||||||
1290482|NCT03720067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290483|NCT03720054|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290538|NCT03719339|||Case-Only||Prospective|||||||
1573286|NCT00001753||||Treatment||||||||
1290436|NCT03720665|Randomized|Crossover Assignment||Basic Science||Double|A statistician prepares a randomization list. Only pharmacist knows the medication type (caffeine or placebo) and the type of electrical stimulation. An investigator is blinded to the type of electrical stimulation and medication. In addition, all participants are naive to electrical stimulation and does not know type of medications that they receive|15 participants are assigned to caffeine group and another 15 are assigned to placebo group. Then, the participants who were initially in the caffeine group now be in placebo group and those who were in the placebo group were assigned to caffeine group. Finally, all participants received both placebo and caffeine|t||t|
1290437|NCT03720652||Single Group Assignment||Other||None (Open Label)||||||
1290438|NCT03720639|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1290439|NCT03720626||||||||||||
1290440|NCT03720613|||Cohort||Prospective|||||||
1290441|NCT03720600|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290442|NCT03720587|||Other||Prospective|||||||
1290443|NCT03720574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290444|NCT03720561|||Cohort||Prospective|||||||
1290445|NCT03720548|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1290446|NCT03720535|||Case-Only||Retrospective|||||||
1290447|NCT03720522|||Cohort||Prospective|||||||
1290448|NCT03720509|||Case-Only||Retrospective|||||||
1290449|NCT03720496||Single Group Assignment||Treatment||None (Open Label)||||||
1290450|NCT03720483|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1290451|NCT03720470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290452|NCT03720457||Single Group Assignment||Treatment||None (Open Label)||||||
1290453|NCT03720444|||Case-Only||Prospective|||||||
1290454|NCT03720431||Sequential Assignment||Treatment||None (Open Label)||||||
1290455|NCT03720418|Randomized|Sequential Assignment||Treatment||Quadruple|Study Part A open-label and Study Part B randomized, double-blind||t|t|t|t
1290456|NCT03720405|||Cohort||Cross-Sectional|||||||
1290457|NCT03720392|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290458|NCT03720379|Randomized|Parallel Assignment||Prevention||Quadruple|All participants,Care Providers, Investigators and Outcomes Assessor will be aware of the current subject's allocation and will be unconscious which product is fluoride varnish and which placebo. participants assigned to intervention(s) based on a protocol Patients will be distributed between Group A (Fluor Protector S) and group B (placebo) according to allocation for 2 types of intervention and blindness (codes for the type of intervention A and B will be assigned to patient numbers according to the reporting order and placed in opaque envelopes).|"We plan to include 168 subjects in this study.~Dental examination Qualified for the study will receive oral and written information on the causative factors of dental caries, hygienic and dietary recommendations.~Oral hygiene instruction will be provided.~Caries risk assesment~Application Fluor Protector S or Placebo~Dental examination will be performed before the intervention (preliminary), after 6 months and after 12 months. Dental exams will include an interview, a physical examination , radiological examination (bite- wing x-ray images) and Diagnodent assessment.~The applications of Fluor Protector S (intervention A) or placebo (intervention B) will be performed every three months during one year."|t|t|t|t
1290459|NCT03720366|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290460|NCT03720353|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1290461|NCT03720340|Randomized|Parallel Assignment||Treatment||Single|||t|||
1290462|NCT03720327|Randomized|Parallel Assignment||Supportive Care||Triple||"Participants will be randomized to one of two groups for the study duration (3 months):~control group (Get FIT);~intervention group (Get FIT+)."|t||t|t
1290463|NCT03720314|||Other||Prospective|||||||
1290464|NCT03720301|Randomized|Parallel Assignment||Prevention||Double|Patient and Intubating Anesthesiology provider are blinded to subjects randomization into the sham treatment or protocol treatment arm of the study|Double blinded, randomized, sham controlled prospective|t|t||
1290465|NCT03720288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290466|NCT03720275||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290467|NCT03720262|Randomized|Parallel Assignment||Treatment||Double|The patient and the surgeon performing the follow-up are masked for the allocation|Randomized controlled trial|t|||t
1290468|NCT03720249|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1290469|NCT03720236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290470|NCT03720223|Randomized|Parallel Assignment||Treatment||Triple|Patient blinded for the intraoperative intervention given (With Liposomal Bupivacaine injection to the buccal mucosal graft harvest site or not)||t||t|t
1290471|NCT03720210||Single Group Assignment||Treatment||None (Open Label)||Open label single interventional series||||
1290472|NCT03720197|||Cohort||Prospective|||||||
1290473|NCT03720184|Randomized|Parallel Assignment||Treatment||Quadruple|"Patient and neurocognitive examinator does not know the arm assigned, as well as the anaesthesiologist, surgeon and ICU team. Only the perfusionist has access to de randomization sheet before choosing and set up of the extracorporeal circuit.~In order to guarantee the blinding, the perfusionist must be hidden during the possible HAR performance, using a field blanket to isolate the oxygenator´s area. Anestesiologist´s proceed in every case as if HAR is assigned maintaining a mean arterial pressure over 60 mmHg."|"In a preliminary phase, patients are randomly assigned to 4 branches, regarding to two conditions: oxygenator´s deairing type and HAR exposure. This phase is designed as pilot study with 100 patients in order to determine precisely the sample size needed depending on the observed effects.~If there are no clinical differences between oxygenators behaviour, during the second stage, sample will be only divided in 2 groups due to HAR exposure."|t|t|t|t
1290474|NCT03720171||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-randomized, uncontrolled study.||||
1290475|NCT03720158|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1290476|NCT03720145|Randomized|Parallel Assignment||Treatment||Single||||||t
1290477|NCT03720132||Single Group Assignment||Other||None (Open Label)||||||
1290478|NCT03720119|||Cohort||Prospective|||||||
1290479|NCT03720106||Single Group Assignment||Other||None (Open Label)||feasibility study||||
1290484|NCT03720041|Randomized|Parallel Assignment||Treatment||Quadruple|Randomisation 1 is open label Randomisation 2 is double-blind, placebo-controlled|Phase III, multi-centre, randomised, parallel group trial|t|t|t|t
1290485|NCT03720028|||Cohort||Prospective|||||||
1290486|NCT03720015|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Case study||||
1290487|NCT03720002|Randomized|Parallel Assignment||Treatment||Triple|participant/care provider/investigator blinded|After an initial open-label run-in (if successful) the patients will be randomized to receive HF2 or placebo (2:1 allocation)|t|t|t|
1290488|NCT03719989||Single Group Assignment||Treatment||None (Open Label)||||||
1290489|NCT03719976||Single Group Assignment||Other||None (Open Label)||||||
1290490|NCT03719963|||Cohort||Cross-Sectional|||||||
1290491|NCT03719950|||Other||Cross-Sectional|||||||
1290492|NCT03719937||Sequential Assignment||Treatment||None (Open Label)||pilot-feasibility study||||
1290493|NCT03719924|Randomized|Parallel Assignment||Treatment||None (Open Label)||"All initial characteristics will be described in the overall population and by treatment arm. Evaluation criteria related to efficacy and safety will be described by treatment arm. Initial characteristics of best response and toxicities will be evaluated using usual statistics: for quantitative variables: mean, standard deviation, median, interquartile interval and range and for qualitative variables: frequencies and percentages.~For the primary evaluation end point, a one-sided 95% confidence interval (CI) will be calculated in the experimental arm."||||
1290494|NCT03719911||Single Group Assignment||Treatment||None (Open Label)||single-arm 24-week pre-post study||||
1290495|NCT03719898||Single Group Assignment||Treatment||None (Open Label)||Refractory or relapsed ALK positive ALCL patients who may or my not have previously received treatment with any ALK inhibitor for any indication||||
1290496|NCT03719885||Single Group Assignment||Treatment||None (Open Label)||||||
1290497|NCT03719872|||Cohort||Prospective|||||||
1290498|NCT03719859|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized to one of two groups (surgeon directed home therapy or formal physical therapy). If subjects in either group are dissatisfied with the outcome of their rehabilitation process, they will be afforded the opportunity to cross-over to the other arm of the study.||||
1290499|NCT03719846|||Other||Prospective|||||||
1290500|NCT03719833|||Case-Control||Prospective|||||||
1290501|NCT03719820|||Cohort||Prospective|||||||
1290502|NCT03719807|Randomized|Parallel Assignment||Treatment||Single||||||t
1290503|NCT03719794|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1290504|NCT03719781|||Case-Only||Prospective|||||||
1290505|NCT03719768||Single Group Assignment||Treatment||None (Open Label)||||||
1290506|NCT03719755|Randomized|Parallel Assignment||Diagnostic||Single|Subjects are blinded to distention media||t|||
1290507|NCT03719742||Single Group Assignment||Supportive Care||None (Open Label)||||||
1290508|NCT03719729||Single Group Assignment||Treatment||None (Open Label)||||||
1290509|NCT03719716|Randomized|Parallel Assignment||Supportive Care||Double|Participants will be randomised automatically by the local trials unit and allocated a study number. This will be used in all statistical analyses and other quantitative data analysis including the questionnaires. The study researcher will know the identity of the participants she interviews and the qualitative analysis cannot be blinded although all data generated will be anonymised.|Feasibility randomised controlled trial|t|||t
1290510|NCT03719703|||Cohort||Prospective|||||||
1290511|NCT03719690|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1290512|NCT03719677|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290513|NCT03719664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290514|NCT03719651|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Stepped wedge design with three cohorts||||
1290515|NCT03719638|Randomized|Crossover Assignment||Other||Single||||||t
1290516|NCT03719625|Randomized|Parallel Assignment||Prevention||Single||controlled, prospective, randomised trial comparing 2 interventions|t|||
1290517|NCT03719612||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290518|NCT03719599|||Cohort||Cross-Sectional|||||||
1290519|NCT03719586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290520|NCT03719573|Randomized|Parallel Assignment||Treatment||Single|Physiotherapist assessing function status.|||||t
1290521|NCT03719560||Single Group Assignment||Treatment||None (Open Label)||||||
1290522|NCT03719547|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label, randomized controlled trial||||
1290523|NCT03719534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290524|NCT03719521|Randomized|Parallel Assignment||Other||Single|Staff conducting the outcome survey will be masked to the arm allocation|||||t
1290525|NCT03719508|||Cohort||Prospective|||||||
1290526|NCT03719495|||Cohort||Prospective|||||||
1290527|NCT03719482||Single Group Assignment||Other||None (Open Label)||||||
1290528|NCT03719469|||Other||Retrospective|||||||
1290529|NCT03719456||Single Group Assignment||Treatment||None (Open Label)||||||
1290530|NCT03719443|Randomized|Parallel Assignment||Treatment||Quadruple|The clinical study will be performed in a double-blind manner, for clinical research unit staff interacting with study participants, with the exception of the persons involved in the preparation of the IMPs. These persons will not be involved in any other study activities.|phase 1, randomized, placebo-controlled, double-blind, single ascending dose study|t|t|t|t
1290531|NCT03719430||Single Group Assignment||Treatment||None (Open Label)||||||
1290532|NCT03719417|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290533|NCT03719404|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1290534|NCT03719391|Randomized|Crossover Assignment||Other||None (Open Label)||Randomized, Open-Label, Cross-Over||||
1290535|NCT03719378|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290536|NCT03719365||Single Group Assignment||Supportive Care||None (Open Label)||Randomized, interventional, prospective study||||
1290537|NCT03719352|Randomized|Parallel Assignment||Treatment||Double|Double (participant, outcomes Assessor||t|||t
1290539|NCT03719326|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||3+3 dose escalation||||
1290540|NCT03719313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290541|NCT03719300||Single Group Assignment||Treatment||None (Open Label)||||||
1290542|NCT03719287|||Cohort||Cross-Sectional|||||||
1290543|NCT03719274|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1290544|NCT03719261|Randomized|Parallel Assignment||Treatment||Double|Double blinded The patient is also outcome assessor will be blinded as well as data analyst person.||t|||t
1290545|NCT03719248|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290546|NCT03719235||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290547|NCT03719222|||Cohort||Retrospective|||||||
1290548|NCT03719209|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1290549|NCT03719196|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290550|NCT03719183|||Case-Only||Prospective|||||||
1290551|NCT03719170|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||A cluster-randomized (by healthcare system) pragmatic trial of the provider-centered intervention versus pragmatic control.||||
1290552|NCT03719157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290553|NCT03719144|||Case-Only||Cross-Sectional|||||||
1290554|NCT03719131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290555|NCT03719118|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290556|NCT03719105|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Cohort 1 and 2 will be based on initial diagnosis.||||
1290557|NCT03719092||Single Group Assignment||Prevention||None (Open Label)||||||
1290558|NCT03719079|||Cohort||Prospective|||||||
1290559|NCT03719066|Randomized|Parallel Assignment||Prevention||None (Open Label)||Subjects will be randomized to receive two doses of Shanchol oral cholera vaccine with dose intervals of either 2 weeks, 6 months or 11 months.||||
1290560|NCT03719053||Single Group Assignment||Other||None (Open Label)||||||
1290561|NCT03719040|||Cohort||Prospective|||||||
1290562|NCT03719027||Single Group Assignment||Diagnostic||None (Open Label)||Retrospective and prospective cohort study||||
1290563|NCT03719014||Single Group Assignment||Treatment||None (Open Label)||This is an open label, multi-center, prospective, supplemental study in which the device, NovaCross™ CTO micro-catheter, will be tested in up to 60 patients scheduled to undergo CTO-PCI using an anterograde approach||||
1290564|NCT03719001|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1290565|NCT03718988|Randomized|Crossover Assignment||Prevention||Double||SWAP-MEAT is a randomized, cross-over design among 30 adults randomly assigned to one of two diet sequences. Each diet sequence will consist of two phases: the Meat phase, which will consist of participants consuming their typical diet, and the Plant Alternative phase, which will consist of participants consuming plant-based meat alternatives instead of their typical meat products, for a predominantly vegetarian diet.|||t|t
1290566|NCT03718975|Randomized|Crossover Assignment||Treatment||Single|||t|||
1290567|NCT03718962||Single Group Assignment||Treatment||None (Open Label)||||||
1290568|NCT03718949|||Cohort||Prospective|||||||
1290569|NCT03718936|||Cohort||Cross-Sectional|||||||
1290570|NCT03718923|||Cohort||Cross-Sectional|||||||
1290571|NCT03718910|||Cohort||Cross-Sectional|||||||
1290572|NCT03718897|||Cohort||Prospective|||||||
1290573|NCT03718884|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1290574|NCT03718871|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This is a mixed methods study where Aims 1 and 2 have both qualitative and quantitative arms. Aim 3 is an unblinded intervention, with a control arm (Sept 2019-June 2020).||||
1290575|NCT03718858|Randomized|Parallel Assignment||Other||Triple|On the day of surgery, patients will be randomly assigned (1:1) to one of two groups according to a computer-generated list. The patients, the clinical care team (anesthesiologist providing intraoperative care, nurses, and surgeons), data collectors, outcome adjudicators, and the study statisticians will all remain blinded to randomization and group allocation. The anesthesiologist who will perform the intervention will be aware of group allocation, but the anesthesiologist providing intraoperative care will remain blinded. Situations such as patient refusal at any time of the study, any adverse event or complication necessitating withholding the intervention would result in voluntary un-blinding of study investigators.|This is two-arm, prospective, parallel, double blind, multi center, randomized controlled trial|t|t|t|
1290576|NCT03718845|||Cohort||Prospective|||||||
1290577|NCT03718832|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1290578|NCT03718819||Single Group Assignment||Treatment||None (Open Label)||||||
1290579|NCT03718806|Randomized|Crossover Assignment||Treatment||None (Open Label)||"It is planned to enroll 2 cohorts of 24 subjects each. Single doses of zoliflodacin (3 g and 4 g) will be assessed within each cohort in a two period cross-over design.~Cohort 1~Regimen A: 3 g zoliflodacin oral suspension; oral administration after an overnight fast~Regimen B: 3 g zoliflodacin oral suspension; oral administration with a standardized high calorie, high-fat breakfast~Cohort 2~Regimen C: 4 g zoliflodacin oral suspension; oral administration after an overnight fast~Regimen D: 4 g zoliflodacin oral suspension; oral administration with a standardized high calorie, high-fat breakfast~There will be a minimum washout of 4 days between each period."||||
1290580|NCT03718793||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290581|NCT03718780|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290582|NCT03718767||Single Group Assignment||Treatment||None (Open Label)||||||
1290583|NCT03718754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290584|NCT03718741||Single Group Assignment||Treatment||None (Open Label)||Adiuvant Radiotherapy +/- CT||||
1290585|NCT03718728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290586|NCT03718715|||Cohort||Prospective|||||||
1290673|NCT03717584|||Cohort||Prospective|||||||
1290674|NCT03717571|||Cohort||Retrospective|||||||
1290679|NCT03717506|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1573287|NCT00001752||||Treatment||||||||
1290587|NCT03718702|Randomized|Parallel Assignment||Supportive Care||Triple|Self-efficacy theory of behavioral change is adopted to guide the conceptual framework and development of the intervention. It was first introduced by Bandura in 1977. In the theory, self-efficacy would increase when a person participates actively in the activities to gain experience. There are two expectations in the model. The efficacy expectations of the person would contribute to the person's behaviour. The person performs the behaviour and would expect the outcomes and this is outcome expectations. The theory has been discussed for how to apply in health promotion. As the theory integrates self-efficacy and self-regulatory elements, people are benefited from the improved health outcomes which is resulted from the health behaviours.||t||t|t
1290588|NCT03718689|Randomized|Parallel Assignment||Prevention||Single||||||t
1290589|NCT03718676|Randomized|Parallel Assignment||Treatment||Single|||t|||
1290590|NCT03718663|||Cohort||Prospective|||||||
1290591|NCT03718650||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290592|NCT03718637|Randomized|Parallel Assignment||Treatment||Single|The study participant will not have knowledge of which treatment group he/she is randomized into for the duration of the study. Because the care provider/investigator will be required to implant the bioinductive patch, the physician will know into which treatment group each patient falls.|"Patients will be randomized into one of two groups. In the control group, patients will receive the current surgical treatment for lateral epicondylitis: tendon debridement and repair. Patients in the experimental group will receive a bio-inductive patch following the same surgical treatment. Both groups of patients will participate in preoperative and postoperative ultrasound imaging studies."|t|||
1290593|NCT03718624||Single Group Assignment||Treatment||None (Open Label)||||||
1290594|NCT03718611|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1290595|NCT03718598|||Case-Control||Prospective|||||||
1290596|NCT03718585|||Other||Cross-Sectional|||||||
1290597|NCT03718572|||Cohort||Prospective|||||||
1290598|NCT03718559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290599|NCT03718546|||Cohort||Prospective|||||||
1290600|NCT03718533||Single Group Assignment||Treatment||None (Open Label)||||||
1290601|NCT03718520|||Cohort||Prospective|||||||
1290602|NCT03718507|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290603|NCT03718494|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||This is a phase 4 intervention in a cohort of post menopausal women.||||
1290604|NCT03718481|||Other||Prospective|||||||
1290605|NCT03718468|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290606|NCT03718455||Single Group Assignment||Other||None (Open Label)||Single cohort of twenty women receiving neoadjuvant chemotherapy with breast cancer will have a Magseed inserted into a biopsy proven metastatic axillary lymph node for pre-surgical localization. The Magseed is a FDA approved device for pre-surgical localization and has been recently approved for use in the axilla and for placement longer than 30 days.||||
1290607|NCT03718442|||Case-Only||Prospective|||||||
1290608|NCT03718429|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The proposed investigation will be a prospective PD (pharmacodynamic) study conducted in cohorts of patients with CAD, PAD, or atrial fibrillation||||
1290609|NCT03718416|||Cohort||Other|||||||
1290610|NCT03718403||Single Group Assignment||Other||None (Open Label)||Open label intervention study, off label use of theophylline||||
1290611|NCT03718390|Randomized|Factorial Assignment||Basic Science||Quadruple|Sealed opaque envelopes containing simple randomization via computerized sequence generation|A total of 40 eligible subjects participate in the Dosing and Observation period. The enrollment occurs in five Dosing Groups. Within each Dosing Group, subjects are randomized to receive either one of four LYN-PLT extended release capsules or a placebo capsule (8 per formulation).|t|t|t|t
1290612|NCT03718377|Randomized|Parallel Assignment||Treatment||Single||||||t
1290613|NCT03718364|||Cohort||Prospective|||||||
1290614|NCT03718351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290615|NCT03718338||Single Group Assignment||Basic Science||None (Open Label)||||||
1290616|NCT03718325|Randomized|Crossover Assignment||Treatment||Triple|There will be two research teams. One team will be unblinded (e.g. clinical care provider/company representative, study coordinator) and will perform stimulator programming/adjustment, and the other team will be blinded (e.g. research personnel) and will perform clinical testing and collect study outcome measures.||t||t|t
1290617|NCT03718312|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290618|NCT03718299||Single Group Assignment||Treatment||None (Open Label)||||||
1290619|NCT03718286|Randomized|Parallel Assignment||Prevention||Triple||A randomized, double-blind, sham-controlled parallel group clinical trial.|t||t|t
1290620|NCT03718273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290621|NCT03718260|||Cohort||Prospective|||||||
1290622|NCT03718247|||Cohort||Prospective|||||||
1290623|NCT03718234|Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a non-randomized crossover study design.||||
1290624|NCT03718221|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1290625|NCT03718208||Single Group Assignment||Other||None (Open Label)||||||
1290626|NCT03718195||Single Group Assignment||Other||None (Open Label)||||||
1290627|NCT03718182|Randomized|Parallel Assignment||Treatment||None (Open Label)||"D-CODE is a two part trial entailing two vitamin D screening studies (winter and summer) and an interventional feasibility study.~The vitamin D screening studies will take place during the winter and summer months to determine the prevalence of vitamin D deficiency in patients with CD throughout the seasons.~In the intervention/feasibility stage D-CODE is an exploratory study for an open label, multi-site, superiority randomised controlled trial. Participants will be randomised to one of two parallel arms (A or B)"||||
1290628|NCT03718169|||Case-Only||Prospective|||||||
1290675|NCT03717558|Randomized|Crossover Assignment||Other||None (Open Label)||Open label, crossover, randomized, 5-period, 20-sequence, partial replicate, single dose design||||
1290676|NCT03717545||Single Group Assignment||Treatment||None (Open Label)||||||
1290677|NCT03717532|Randomized|Parallel Assignment||Treatment||Single||||t||
1290678|NCT03717519|||Cohort||Retrospective|||||||
1290629|NCT03718156|Randomized|Parallel Assignment||Prevention||None (Open Label)|Long-term care facilities (LTCFs) cannot be blinded, as trial arm allocation will be obvious (those in the intervention group will undergo delirium prevention protocol training before their respective follow-up periods, and those in the control group will not). Similarly, research assistants (RAs) tasked with conducting resident assessments cannot be blinded to group allocation, as they will be constantly exposed to the everyday workings of participating LTCFs. However, RAs will be blinded to resident cognitive scores. All researchers analyzing the data will be blinded to group allocation, as LTCF names will be anonymized and randomization statuses will be concealed prior to data analysis.|The PREPARED Trial is a 4-year cluster randomized intervention study. A cluster design was adopted in order to prevent contamination across the intervention and control arms by nursing staff who may provide replacement hours of employment at different units/floors within their long-term care facilities (LTCFs). Participating LTCFs (clusters) will be assigned to either the PREPARED Trial intervention or the control (usual care) arm of the study using a covariate constrained randomization procedure. In addition, given the need to assess each resident weekly for a follow-up period of 18 weeks and logistical limitations (large geographical coverage, 40-50 LTCFs included, and limited work force), the investigators will employ a sequential approach whereby sets of clusters (LTCFs) will be randomized into the two study arms in consecutive 'waves' of follow-up lasting 18 weeks each. It is estimated that 4 waves of trial follow-up, comprised of 10-12 clusters each, will be completed.||||
1290630|NCT03718143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290631|NCT03718130|Randomized|Single Group Assignment||Prevention||None (Open Label)||6 groups of 12 subjects each will receive varying vaccine dosages and vaccine canditdate combinations||||
1290632|NCT03718117|||Cohort||Prospective|||||||
1290633|NCT03718104|||Cohort||Prospective|||||||
1290634|NCT03718091|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290635|NCT03718078||Single Group Assignment||Other||None (Open Label)||||||
1290636|NCT03718065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290637|NCT03718052|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290638|NCT03718039||Single Group Assignment||Prevention||None (Open Label)||||||
1290639|NCT03718026|||Case-Control||Cross-Sectional|||||||
1290640|NCT03718013|Randomized|Parallel Assignment||Treatment||Single||||||t
1290641|NCT03718000|Randomized|Parallel Assignment||Prevention||Single|||t|||
1290642|NCT03717987|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1290643|NCT03717974|Randomized|Parallel Assignment||Other||None (Open Label)||Monocentric, randomized controlled pilot study||||
1290644|NCT03717961|Randomized|Parallel Assignment||Treatment||Quadruple|this study is double blind masking: Both participants and investigators are unaware of the intervention assignment, others including statistician|Multicenter, double-blind, randomized, placebo-controlled, parallel groups, phase III|t|t|t|t
1290645|NCT03717948|Randomized|Crossover Assignment||Basic Science||Double|Allocation concealment, assessor blinding||||t|t
1290646|NCT03717935|Randomized|Crossover Assignment||Treatment||Quadruple|Investigational drug pharmacy will performed randomization and dispense the EAA or placebo.||t|t|t|t
1290647|NCT03717922|Non-Randomized|Parallel Assignment||Other||Triple|Participants will be blinded to whether or not the LIFUP transducer is on and, when on, what parameters are used. The investigator collecting the neuropsychological data will be blinded to which condition (LIFUP, sham) the participant completed during the session. The statistical analysts for both the neuropsychological and neuroimaging data will also be blinded to condition.||t||t|t
1290648|NCT03717909|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1290649|NCT03717896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290650|NCT03717883|||Cohort||Other|||||||
1290651|NCT03717870|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Trial||||
1290652|NCT03717857|||Case-Only||Cross-Sectional|||||||
1290653|NCT03717844|||Cohort||Prospective|||||||
1290654|NCT03717831|||Cohort||Prospective|||||||
1290655|NCT03717818|Randomized|Parallel Assignment||Treatment||Single||||||t
1290656|NCT03717805|Randomized|Parallel Assignment||Supportive Care||Single||Randomized controlled trial (1/1)|||t|
1290657|NCT03717792|||Cohort||Prospective|||||||
1290658|NCT03717779|||Case-Only||Prospective|||||||
1290659|NCT03717766|||Case-Only||Prospective|||||||
1290660|NCT03717753|Non-Randomized|Sequential Assignment||Treatment||Single|||t|||
1290661|NCT03717740|Randomized|Parallel Assignment||Prevention||Quadruple|both participants and researchers will be blinded to the intervention given.|The population of interest involves women attending the study hospital for antenatal care and delivery. The intervention involves randomization to oral esomeprazole tablets40 mg or identical placebo tablet from recruitment until delivery. Randomization is achieved using computational random allocation, and both participants and researchers will be blinded to the intervention given.|t|t|t|t
1290662|NCT03717727|Randomized|Parallel Assignment||Treatment||Single||||||t
1290663|NCT03717714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290664|NCT03717701|Randomized|Parallel Assignment||Treatment||Quadruple|both participants and researchers will be blinded to the intervention given|This is a randomized double-blinded placebo-controlled intervention trial|t|t|t|t
1290665|NCT03717688|Randomized|Crossover Assignment||Treatment||None (Open Label)||The participants are on 4 study days with wash out period of minimum 2 weeks randomized to 4 intervention arms||||
1290666|NCT03717675||Single Group Assignment||Treatment||None (Open Label)||||||
1290667|NCT03717662||Single Group Assignment||Health Services Research||None (Open Label)||||||
1290668|NCT03717649|Randomized|Sequential Assignment||Treatment||Triple||A single centre, prospective, randomised, double-blind trial|t|t|t|
1290669|NCT03717636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290670|NCT03717623||Single Group Assignment||Treatment||None (Open Label)||||||
1290671|NCT03717610||Single Group Assignment||Treatment||None (Open Label)||||||
1290672|NCT03717597||Single Group Assignment||Prevention||None (Open Label)||While subjects will be enrolled in multiple groups, all subjects will receive the same intervention and will complete the same study activities.||||
1290680|NCT03717493|Randomized|Factorial Assignment||Treatment||Single|Assessors were blinded with regard to study condition|Randomized controlled trial; group x time||||t
1290681|NCT03717480||Single Group Assignment||Treatment||None (Open Label)||||||
1290682|NCT03717467|Randomized|Parallel Assignment||Prevention||Triple|Patient will be randomly assigned to one of the two groups. An independent anesthesiologist who will not be participating in the study prepares the study medications.||t|t|t|
1290683|NCT03717454|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290684|NCT03717441|||Cohort||Prospective|||||||
1290685|NCT03717428|Randomized|Single Group Assignment||Prevention||None (Open Label)||Effect of self-weighing to prevent age-related weight gain||||
1290686|NCT03717415|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1290687|NCT03717402|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||"This study is being conducted through 4 sequential activities. Activities 3 and 4 both involve human subject participants.~Activity 3 (user acceptability testing) participants will be reported under arm/group 1.~Activity 4 (pilot testing) participants will be reported under arm/group 2."||||
1290688|NCT03717389|||Other||Cross-Sectional|||||||
1290689|NCT03717376|||Cohort||Prospective|||||||
1290690|NCT03717363|Randomized|Parallel Assignment||Prevention||None (Open Label)||randomitzed interventional study with control group||||
1290691|NCT03717350|Randomized|Parallel Assignment||Treatment||Quadruple|Similar appearance of study drug of both arms||t|t|t|t
1290692|NCT03717337|Randomized|Parallel Assignment||Treatment||Single|single|The design of this randomized clinical trial is a parallel group two arms trial with 1:1 allocation ratio||||t
1290693|NCT03717324|||Cohort||Prospective|||||||
1290694|NCT03717311||Single Group Assignment||Basic Science||None (Open Label)||||||
1290695|NCT03717298||Single Group Assignment||Supportive Care||None (Open Label)||||||
1290696|NCT03717285|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290697|NCT03717272|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1290698|NCT03717259|Non-Randomized|Crossover Assignment||Treatment||Single||"This is an analytical cross-sectional study for which patients with terminal chronic kidney disease will be taken from kidney transplanted from a related live donor in a tertiary hospital. The selection of patients will be done with a non-probabilistic sampling of consecutive cases.~Kidney transplantation from a live donor will be carried out by means of kidney graft procurement techniques using open surgery, laparoscopic hand-assisted surgery or pure laparoscopic surgery.~The statistical analysis will be performed with Student´s t-test and Chi-square test. To determine if the intervening variables affected the postoperative renal function, we will perform a multivariate analysis. We will consider a significant P value when it is <0.05."||||t
1290699|NCT03717246|Randomized|Parallel Assignment||Treatment||None (Open Label)||6th to 8th grade middle school students will be enrolled then randomly assigned to one of three conditions: 1) Sleep Smart Latino intervention condition , 2) child health topics education control condition; 3) a no treatment control condition||||
1290700|NCT03717233||Single Group Assignment||Other||None (Open Label)||Participants will be evaluated as their own controls.||||
1290701|NCT03717220||Single Group Assignment||Treatment||None (Open Label)||||||
1290702|NCT03717207|||Other||Retrospective|||||||
1290703|NCT03717194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290704|NCT03717181||Single Group Assignment||Treatment||None (Open Label)||||||
1290705|NCT03717168|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290706|NCT03717155||Single Group Assignment||Treatment||None (Open Label)||||||
1290707|NCT03717142|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Dose Escalation||||
1290708|NCT03717129|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1290709|NCT03717116|||Cohort||Prospective|||||||
1290710|NCT03717103||Single Group Assignment||Treatment||None (Open Label)||||||
1290711|NCT03717090|||Cohort||Prospective|||||||
1290712|NCT03717077|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1290713|NCT03717064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1290714|NCT03717051|Randomized|Parallel Assignment||Treatment||Single||||||t
1290715|NCT03717038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290716|NCT03717025|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290717|NCT03717012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290718|NCT03716999||Single Group Assignment||Supportive Care||None (Open Label)||Palliative Care Population||||
1290719|NCT03716986||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290720|NCT03716973||Single Group Assignment||Treatment||None (Open Label)||Open label pilot study||||
1290721|NCT03716960|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1290722|NCT03716947|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1290723|NCT03716934|Randomized|Parallel Assignment||Treatment||Single||||||t
1290724|NCT03716921|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290725|NCT03716908|||Case-Control||Cross-Sectional|||||||
1290726|NCT03716895|||Cohort||Prospective|||||||
1290727|NCT03716882|||Cohort||Prospective|||||||
1290728|NCT03716869|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1290729|NCT03716856||Single Group Assignment||Treatment||None (Open Label)||||||
1290730|NCT03716843|||Case-Only||Prospective|||||||
1290731|NCT03716830|Randomized|Factorial Assignment||Treatment||Double|Both participants and study staff will be blinded to the treatment group of participants. Only the licensed acupuncturist will be aware of the type of acupuncture the participant will be receiving.|Participants will be randomized to one of four groups: 1) verum acupuncture + real tDCS, 2) sham acupuncture + real tDCS, 3) verum acupuncture + sham tDCS, and 4) sham acupuncture + sham tDCS.|t||t|
1290732|NCT03716817||Single Group Assignment||Treatment||None (Open Label)||||||
1290782|NCT03716167|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1290783|NCT03716154|Randomized|Parallel Assignment||Treatment||Single||split mouth|t|||
1290733|NCT03716804|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"Parallel assignment Intervention group: Educational intervention to prescribers and Medicine-Tab Nitrofurantoin (100 mg, 2 times daily for 7 days) to the patients.~Control group: No educational intervention to the prescribers and Medicine- of personal choice of physician(Tablet Ciprofloxacin, 500 mg/Tablet Cef 3, 200 mg/Tab Cefuroxime, 250 mg) to the patients."||||
1290734|NCT03716791|Randomized|Parallel Assignment||Prevention||Triple||Double-blind placebo controlled randomized controlled trial|t||t|t
1290735|NCT03716778|Randomized|Parallel Assignment||Treatment||Single|||t|||
1290736|NCT03716765|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1290737|NCT03716752|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290738|NCT03716739|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1290739|NCT03716726|Randomized|Parallel Assignment||Screening||None (Open Label)||Pragmatic pilot cluster RCT to examine the implementation of WE CARE as standard of care in two of the four outpatient pediatric hematology clinics.||||
1290740|NCT03716713||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1290741|NCT03716700|||Cohort||Prospective|||||||
1290742|NCT03716687|Randomized|Parallel Assignment||Prevention||None (Open Label)||50-50% randomisation into interventional (ciNPWT) and control (traditionaltreatment) groups.||||
1290743|NCT03716674||Single Group Assignment||Other||None (Open Label)|This was a cross-sectional study|A single group of 9 patients completed the 4 conditions presented in the Methods section.||||
1290744|NCT03716661|Randomized|Parallel Assignment||Treatment||Single|||||t|
1290745|NCT03716648|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized, crossover study||||
1290746|NCT03716635|Randomized|Crossover Assignment||Treatment||Single|After determining the eligibility of the patient, the assistant supervisor will be contacted to assign the participant to either the intervention (cryotherapy) or the control (normal saline) groups according to the random sequence generated.|"A random sequence will be generated by computer software, (http://www.random.org/).~The table will be kept with the assistant supervisor."|t|||
1290747|NCT03716622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290748|NCT03716609|Randomized|Sequential Assignment||Prevention||Double|||t|t||
1290749|NCT03716596||Single Group Assignment||Treatment||None (Open Label)||||||
1290750|NCT03716583|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1290751|NCT03716570|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1290752|NCT03716557|Randomized|Crossover Assignment||Treatment||Single||Single-blind crossover design|t|||
1290753|NCT03716544|Randomized|Parallel Assignment||Treatment||Single||||||t
1290754|NCT03716531||Single Group Assignment||Treatment||None (Open Label)||||||
1290755|NCT03716518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290756|NCT03716505|Randomized|Parallel Assignment||Prevention||Quadruple|Two parallel groups, gammaCore®-Sapphire (active treatment) and a gammaCore®-Sapphire sham (inactive) treatment.|Two parallel groups, gammaCore®-Sapphire (active treatment) and a sham (inactive) treatment.|t|t|t|t
1290757|NCT03716492||||||||||||
1290758|NCT03716479|Randomized|Crossover Assignment||Prevention||Double|fiber will be mixed into orange juice|subjects will consume 0, and 2 doses of acacia gum|t||t|
1290759|NCT03716466|||Other||Prospective|||||||
1290760|NCT03716453|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1290761|NCT03716440|Randomized|Parallel Assignment||Treatment||Single|||t|||
1290762|NCT03716427||Sequential Assignment||Treatment||None (Open Label)||This is Phase 1, single-center, open-label, single-sequence drug-drug interaction study to determine the effect of CT1812 (560 mg) once daily on the pharmacokinetics of 4 probe drugs (tolbutamide, midazolam, dextromethorphan and omeprazole)||||
1290763|NCT03716414|||Cohort||Prospective|||||||
1290764|NCT03716401|||Cohort||Cross-Sectional|||||||
1290765|NCT03716388|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1290766|NCT03716375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290767|NCT03716362|||Case-Crossover||Prospective|||||||
1290768|NCT03716349|Randomized|Parallel Assignment||Treatment||Triple|The statistician will prepare a randomization list of A-B and B-A pairs to be applied sequentially as subjects receive restorations. The first system listed in the randomization pair will be placed on first tooth (#4-#13), and the second system on 2nd tooth (#4-#13). The random sequence will be individually placed in opaque, consecutively numbered and sealed envelopes, which should be opened by the operator immediately before the intervention.|Simple randomization will be used for assignment of the treatment groups. Randomization: Two restorations will be placed in each subject, one using system A and one using system B.|t||t|t
1290769|NCT03716336|Randomized|Parallel Assignment||Treatment||Single|Participants were assigned randomly used sealed envelope into two groups (A&B) equally in number.|were randomly assigned to group A participated in aerobic and resistive exercise program, and group B participated in aerobic exercise and followed prescribed diet restriction program. Both of the groups (A&B) followed the treatment program 3 times per weeks for 8 weeks. Assessment of the fasting glucose, fasting insulin, and HOMA test of insulin resistance were measured for all subjects in both groups (A and B) was carried out before and after the end of the treatment program.||||t
1290770|NCT03716323||Single Group Assignment||Treatment||None (Open Label)||||||
1290771|NCT03716310|||Cohort||Prospective|||||||
1290772|NCT03716297|||Case-Control||Cross-Sectional|||||||
1290773|NCT03716284|||Cohort||Prospective|||||||
1290774|NCT03716271||Single Group Assignment||Treatment||None (Open Label)||||||
1290775|NCT03716258|||Cohort||Prospective|||||||
1290776|NCT03716245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290777|NCT03716232|Randomized|Parallel Assignment||Treatment||Single||||||t
1290778|NCT03716219|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1290779|NCT03716206|Randomized|Parallel Assignment||Treatment||Single||||||t
1290780|NCT03716193|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Four cohorts based on standard treatment will be given the same intervention||||
1290781|NCT03716180||Single Group Assignment||Treatment||None (Open Label)||||||
1290784|NCT03716141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290785|NCT03716128|||Other||Cross-Sectional|||||||
1290786|NCT03716115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290787|NCT03716102||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1290788|NCT03716089|||Case-Control||Prospective|||||||
1290789|NCT03716076|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1290790|NCT03716063|Randomized|Parallel Assignment||Prevention||Double|This study was double-blind. According to the randomized results, the experimental group was given orally therapeutic granules, while the control group was given orally low-dose granules. Random sequence was generated by professional statisticians of group leader unit by statistical software. 350 subjects were divided into experimental group and control group according to the ratio of 1:1, 175 cases in each group. Random seeds and random sequences are stored as confidential data in opaque envelopes, and emergency envelopes are handed over to a third party to ensure that patients, researchers and outcome evaluators are unaware of the patient group before blindness is uncovered. After successful screening and signing the informed consent form, the patient can open a random envelope in turn and record the subject's name, hospital number and admission time on the envelope.|This study was double-blind. According to the randomized results, the experimental group was given orally therapeutic granules, while the control group was given orally low-dose granules.|t|t||
1290791|NCT03716050|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1290792|NCT03716037|Randomized|Parallel Assignment||Other||Single|||t|||
1290793|NCT03716024|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1290794|NCT03716011||Single Group Assignment||Treatment||None (Open Label)||the EXCROSSAL stent in CAD patients with 3-month DAPT or 12-month DAPT||||
1290795|NCT03715998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290796|NCT03715985||Sequential Assignment||Treatment||None (Open Label)||Not a randomized study. 25 patients to be included. Group A) has not yet started standard treatment Group B) has begun standard treatment at least 4 months before first vaccine, and the decease development is status quo.||||
1290797|NCT03715972|||Cohort||Other|||||||
1290798|NCT03715959||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290799|NCT03715946||Single Group Assignment||Treatment||None (Open Label)||||||
1290800|NCT03715933|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1290801|NCT03715920|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1290802|NCT03715907|Randomized|Factorial Assignment||Prevention||Single||||||t
1290803|NCT03715894|||Case-Only||Prospective|||||||
1290804|NCT03715881|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1290805|NCT03715868|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1290806|NCT03715855||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290807|NCT03715842|Randomized|Parallel Assignment||Treatment||Single|||t|||
1290808|NCT03715829|Randomized|Parallel Assignment||Treatment||Triple|Dose ranging period is blinded. The partially blinded extension period includes open arms and blinded arms.|Dose ranging period is a parallel design. Extension period is a sequential design.|t||t|t
1290809|NCT03715816|Randomized|Crossover Assignment||Prevention||None (Open Label)|The study is not blinded, because the subject(s) will know which of the three experimental conditions they are exposed to (control without breaks; intervention with passive or active breaks). The same applies to the experimenter(s).|||||
1290810|NCT03715803|||Cohort||Retrospective|||||||
1290811|NCT03715790|||Other||Prospective|||||||
1290812|NCT03715777||Single Group Assignment||Treatment||None (Open Label)||||||
1290813|NCT03715764|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1290814|NCT03715751|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1290815|NCT03715738||Single Group Assignment||Other||None (Open Label)||||||
1290816|NCT03715725|||Cohort||Retrospective|||||||
1290817|NCT03715712|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1290818|NCT03715699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290819|NCT03715686||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290820|NCT03715673|||Case-Control||Prospective|||||||
1290821|NCT03715660||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290822|NCT03715647|||Cohort||Prospective|||||||
1290823|NCT03715634|Randomized|Sequential Assignment||Treatment||Single|||t|||
1290824|NCT03715621|||Cohort||Prospective|||||||
1290825|NCT03715608|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1290826|NCT03715595|Randomized|Parallel Assignment||Other||Single|||||t|
1290827|NCT03715582|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1290828|NCT03715569|||Cohort||Prospective|||||||
1290829|NCT03715556|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290830|NCT03715543||Single Group Assignment||Treatment||None (Open Label)||||||
1290831|NCT03715530|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1290832|NCT03715517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290833|NCT03715504||Single Group Assignment||Treatment||None (Open Label)||||||
1290834|NCT03715491|Randomized|Factorial Assignment||Basic Science||None (Open Label)||Phase III randomized, open label, multi-center study assessing the impact of filter ventilation.||||
1290835|NCT03715478||Sequential Assignment||Treatment||None (Open Label)||||||
1290836|NCT03715465|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1290837|NCT03715452|||Cohort||Prospective|||||||
1290838|NCT03715439|||Cohort||Prospective|||||||
1290839|NCT03715426|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290840|NCT03715413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290841|NCT03715400|Randomized|Factorial Assignment||Treatment||Single|||t|||
1290928|NCT03714269||Single Group Assignment||Other||None (Open Label)||||||
1290929|NCT03714256|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290842|NCT03715387|Randomized|Single Group Assignment||Prevention||Triple|Patients will receive a container for each cheek where the contents will be randomized between the study ointment and the control ointment. Only one investigator will have knowledge of the contents. The care providor, patient, and assessor will all be blinded.|Patients will serve as their own self matched controls with one study cheek and one control cheek.|t|t||t
1290843|NCT03715374|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1290844|NCT03715361|||Cohort||Prospective|||||||
1290845|NCT03715348|Randomized|Parallel Assignment||Other||None (Open Label)||Pragmatic pilot, open label, phase II randomised controlled trial||||
1290846|NCT03715335|Randomized|Sequential Assignment||Screening||None (Open Label)||A comparative effectiveness pragmatic trial using a stepped wedge crossover design will be conducted. A stepped wedge design involves the sequential roll-out of an intervention or a sequence of interventions to individuals or sites over multiple time periods. At the end of the study, all sites will have received all interventions, but the order in which sites are enrolled is randomly assigned. Once the final intervention is implemented, that intervention will continue until the end of the study.||||
1290847|NCT03715322|Randomized|Parallel Assignment||Treatment||Double|Both the investigators and the participants will be masked to the study allocation. The randonmization codes will be generated by a blinded medical statistician with the use of computerized program. Randomization will be achieved based on the permuted block design.|Patients will be randomized into the treatment group and control group. No cross-over of the study group will be made.|t||t|
1290848|NCT03715309||Single Group Assignment||Treatment||None (Open Label)||||||
1290849|NCT03715296|||Cohort||Prospective|||||||
1290850|NCT03715283|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1290851|NCT03715270|||Case-Only||Prospective|||||||
1290852|NCT03715257|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1290853|NCT03715244|||Cohort||Prospective|||||||
1290854|NCT03715231||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290855|NCT03715218|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1290856|NCT03715205|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290857|NCT03715192|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1290858|NCT03715179|||Cohort||Prospective|||||||
1290859|NCT03715166|Randomized|Parallel Assignment||Treatment||Quadruple||6-month, randomized, double-blind, placebo-controlled, parallel groups followed by an open label active 6-month treatment period with bumetanide.|t|t|t|t
1290860|NCT03715153|Randomized|Parallel Assignment||Treatment||Quadruple||6-month, randomized, double-blind, placebo-controlled, parallel groups followed by an open label active 6-month treatment period with bumetanide.|t|t|t|t
1290861|NCT03715140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290862|NCT03715127|Randomized|Parallel Assignment||Treatment||Triple|double-blind||t|t|t|
1290863|NCT03715114|Randomized|Sequential Assignment||Basic Science||Quadruple|||t|t|t|t
1290864|NCT03715101||Single Group Assignment||Treatment||None (Open Label)||||||
1290865|NCT03715088|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290866|NCT03715075|||Cohort||Prospective|||||||
1290867|NCT03715062|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Cluster randomized controlled study, where each Long-term care facility is one cluster.||||
1290868|NCT03715049||Single Group Assignment||Treatment||None (Open Label)||||||
1290869|NCT03715036|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1290870|NCT03715023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290871|NCT03715010|Randomized|Crossover Assignment||Treatment||Triple|Placebo|BCAA|t|t|t|
1290872|NCT03714997|Randomized|Parallel Assignment||Treatment||Single|Blinded outcomes assessment at each measures phase|Parallel design randomized controlled trial||||t
1290873|NCT03714984|Randomized|Parallel Assignment||Supportive Care||Single||Superiority trial with 1:1 allocation ratio, randomized with two-arm parallel group||||t
1290874|NCT03714971|Randomized|Parallel Assignment||Treatment||Double|The study was designed as a single-blind study. The physicians (except the first author) were blind to the allocation to intervention or control groups and they conducted their routine smoking cessation counseling work. As long as the patient did not comment on the messages, the physicians were blind throughout the follow ups as well. After the first routine counseling, participants were informed by the first author about the study, thus they were not blind to the intervention. The analysis of the study was conducted by the first author who was not blind to the intervention/ control status of the participants. The first author could not be blind as he was to send out the WhatssApp messages. However, contact numbers of the participants were labeled with numbers (I-01 to I-44) to secure anonymity and to prevent any bias.|The study was designed as a RCT including two parallel arms: an intervention group receiving messages through WhatsApp Messenger operating on smart phones and a control group not receiving these messages, with an allocation ratio of 1:2. Both groups received the standard outpatient care of the clinic including a 45-60 minutes face-to-face individual counseling at first contact ending with the decision of treatment and quit date, and a support booklet on quitting and subsequent follow-ups by the same clinician at 1st, 2nd, 4th weeks and 3rd month after quit date, either face-to-face at the clinic or by telephone if the patient does not come to the clinic for follow-up. The study was carried out in the smoking cessation clinic of Ege University Medical School's Public Health Department.|t|t||
1290875|NCT03714958||Single Group Assignment||Treatment||None (Open Label)||This study will utilize sequential and adaptive Bayesian design using the method of Time-to-event Continual Reassessment Method (CRM) to guide dose escalation and estimate the MTD||||
1290876|NCT03714945|||Cohort||Prospective|||||||
1290877|NCT03714932|||Other||Other|||||||
1290878|NCT03714919||Single Group Assignment||Treatment||None (Open Label)||||||
1290879|NCT03714906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290880|NCT03714893|||Cohort||Retrospective|||||||
1290881|NCT03714880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290930|NCT03714243||Single Group Assignment||Device Feasibility||None (Open Label)||Prospective, single arm, single center||||
1290931|NCT03714230|||Cohort||Prospective|||||||
1573288|NCT00001748||||Treatment||||||||
1290882|NCT03714867|Randomized|Parallel Assignment||Treatment||Triple|Patients, care providers, and investigators will all be blinded to patient group identity.|Intervention is single dose. Patients will be assigned to either treatment or placebo arms. No opportunity for crossing over will be present.|t|t|t|
1290883|NCT03714854|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1290884|NCT03714841|Randomized|Parallel Assignment||Treatment||Triple||Randomized Controlled Trial|t||t|t
1290885|NCT03714828||Single Group Assignment||Treatment||None (Open Label)||||||
1290886|NCT03714815||Single Group Assignment||Treatment||None (Open Label)||Subjects who remained in main study (SERENADE/AC-055G202, NCT03153111) for 52 weeks after randomization and who meet the eligibility criteria described will be eligible to enter this single-arm OL extension study. All enrolled subjects will receive macitentan 10 mg. For this OL extension study no primary efficacy endpoint has been defined and all efficacy endpoints are of exploratory nature including the ones that are listed under primary outcomes||||
1290887|NCT03714802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290888|NCT03714789|||Cohort||Prospective|||||||
1290889|NCT03714776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290890|NCT03714763|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290891|NCT03714750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290892|NCT03714737|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1290893|NCT03714724|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Intraabdominal pressure of the patients were measured on the 0. 6. 12. 18. and 24. hours and recorded.||||
1290894|NCT03714711|||Cohort||Prospective|||||||
1290895|NCT03714698|Non-Randomized|Parallel Assignment||Health Services Research||Double|Both groups received the similar medication (atypical antipsychotic drugs) during the study. Patients in the control group participated in a non-specific activity programme including conventional exercise training, hobby and social interaction activities routinely twice a week, at the community mental health center during six weeks. The PEG participated in a supervised Pilates exercise program twice per week for six weeks (totally 12 sessions).|Pilates exercise group participated in supervised Pilates-based group training twice per week for six weeks, while the control group participated in a routine non-specific activity program twice a week in Community Mental Health Center during study|t|||t
1290896|NCT03714685||Sequential Assignment||Basic Science||None (Open Label)||||||
1290897|NCT03714672|Randomized|Parallel Assignment||Treatment||Quadruple|This study will use double-blind and double-dummy methods to guarantee the blinding of all personnel involved in the study. Participants, investigators, and all persons involved in the conduct, data management, and analysis of the study will be fully blinded to the participant's treatment.||t|t|t|t
1290898|NCT03714659||Single Group Assignment||Treatment||None (Open Label)||||||
1290899|NCT03714646|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1290900|NCT03714633|Randomized|Parallel Assignment||Prevention||Single|The assessor of the parent-child interaction using the emotional availability scales is blind to if the child belongs to the intervention Group or Control Group. Several outcomes are self assessment questionnaires, with no masking.|||||t
1290901|NCT03714620|Randomized|Factorial Assignment||Treatment||Quadruple|All study investigators, patients and clinicians except the clinical pharmacist will be blinded to the study treatment allocation. Treatment will be prepared and blinded by the ED clinical pharmacist.|The sequence will be generated using randomization permuted blocks of 2 and 4 patients, with the allocated dose revealed using an online randomization module within the REDCap data management system.|t|t|t|t
1290902|NCT03714607|Randomized|Parallel Assignment||Treatment||Single||||||t
1290903|NCT03714594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290904|NCT03714581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290905|NCT03714568|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1290906|NCT03714555|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290907|NCT03714542||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290908|NCT03714529||Single Group Assignment||Treatment||None (Open Label)||||||
1290909|NCT03714516||Single Group Assignment||Prevention||None (Open Label)||non-controlled evaluation pilot study with pre-, post- and follow-up assessments||||
1290910|NCT03714503||Single Group Assignment||Health Services Research||None (Open Label)||Simon's two stage||||
1290911|NCT03714490|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized phase II trial design||||
1290912|NCT03714477|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Randomized controlled trial||||
1290913|NCT03714464|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Principal investigators and co-investigators were blinded when measuring gastric volumes, small bowel water content and colonic volumes.|"The intervention to be tested in this study is dietary intake of apples which are naturally high in fermentable carbohydrate. The investigators purchased the apples from a mainstream high street supermarket.~The test meals consisted of whole apples (Meal A), apple puree (Meal B) and apple juice (Meal C)"||||
1290914|NCT03714451|Randomized|Parallel Assignment||Other||Quadruple|double blinded|double blinded randomized|t|t|t|t
1290915|NCT03714438|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1290916|NCT03714425|Randomized|Parallel Assignment||Treatment||Double||High frequency device vs. Low frequency device|t||t|
1290917|NCT03714412||Single Group Assignment||Treatment||None (Open Label)||||||
1290918|NCT03714399|||Cohort||Prospective|||||||
1290919|NCT03714386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290920|NCT03714373||Single Group Assignment||Treatment||None (Open Label)||||||
1290921|NCT03714360|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1290922|NCT03714347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290923|NCT03714334||Single Group Assignment||Treatment||None (Open Label)||||||
1290924|NCT03714321|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized non-blinded controlled pilot study||||
1290925|NCT03714308|||Cohort||Prospective|||||||
1290926|NCT03714295|||Other||Prospective|||||||
1290927|NCT03714282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290932|NCT03714217||Single Group Assignment||Treatment||None (Open Label)||||||
1290933|NCT03714204|Randomized|Parallel Assignment||Prevention||None (Open Label)|The names of individual participants|Randomized controlled trial||||
1290934|NCT03714191|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1290935|NCT03714178||||||||||||
1290936|NCT03714165|||Other||Prospective|||||||
1290937|NCT03714152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290938|NCT03714139|Randomized|Parallel Assignment||Other||Double|One of the researchers , neither involved in the selection of the patients nor in the surgical and prosthetic treatment, will carry out electronically the randomization (randomization.com). Will be prepared sealed opaque envelopes and opened at the time of surgery.|Split mouth, At least one site will be used as a test and one as a control where experimental mini-implants will be installed.|||t|t
1290939|NCT03714126|||Case-Only||Other|||||||
1290940|NCT03714113||Single Group Assignment||Prevention||None (Open Label)||||||
1290941|NCT03714100||Single Group Assignment||Prevention||None (Open Label)||||||
1290942|NCT03714087|Non-Randomized|Parallel Assignment||Treatment||Single||One historic control group (UDEA1)comparing with intervention group (UDEA2) ( before and after)|||t|
1290943|NCT03714074|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1290944|NCT03714061|Randomized|Parallel Assignment||Treatment||Double||Single blind, randomized clinical trial, controlled|t|||t
1290945|NCT03714048|||Cohort||Prospective|||||||
1290946|NCT03714035|||Other||Cross-Sectional|||||||
1290947|NCT03714022|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290948|NCT03714009|Randomized|Parallel Assignment||Other||Single||||||t
1290949|NCT03713996|Randomized|Parallel Assignment||Treatment||Single||||||t
1290950|NCT03713983|||Cohort||Prospective|||||||
1290951|NCT03713970|Randomized|Parallel Assignment||Treatment||Double|After examining the participant for eligibility,each participant will be given a number start from one by Shafeq(the main researcher )i.e. each participant will be assigned by numbers and allocated to different groups using these numbers.(for example, the odd numbers to the intervention and the even numbers to the control group)|two groups withe different laminate veneers restorations(celtra duo press and IPS e.max press)|t||t|
1290952|NCT03713957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290953|NCT03713944||Single Group Assignment||Treatment||None (Open Label)||Single Arm Therapeutic study using historical controls||||
1290954|NCT03713931|||Other||Prospective|||||||
1290955|NCT03713918|Randomized|Parallel Assignment||Treatment||Double|Participants and outcome assessor will be blinded to avoid performance, detection and analysis bias. Only main investigator will be aware of the allocated patients in each group and the specific type of intervention given to every patient|Patients requiring posterior single crowns or endocrowns|t|||t
1290956|NCT03713905||Sequential Assignment||Treatment||None (Open Label)||1 mg per kg, Q2W; 4 mg per kg, Q2W; 10 mg per kg, Q2W; 240 mg fixed dose, Q2W||||
1290957|NCT03713892|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1290958|NCT03713879|Randomized|Parallel Assignment||Prevention||None (Open Label)||"rectal indomethacin 100 mg to be administered before or after ERCP~a PD stent to be inserted during ERCP (a 3 to 5 cm 5Fr single pigtail pancreatic duct stent without inner flap is used, the stent is inserted after deep cannulation of pancreatic duct with a .025 or .035 wire) or~a PD stent plus rectal indomethacin 100 mg before or after ERCP~In patients randomized to receive PD stenting, the number of attemtps is limited to 5."||||
1290959|NCT03713866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290960|NCT03713853|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients will be randomized two treatment groups:~Acute primary total hip arthroplasty (THA) + ORIF or~Open reduction internal fixation (ORIF) alone"||||
1290961|NCT03713840|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1290962|NCT03713827|Randomized|Factorial Assignment||Treatment||None (Open Label)||double blinded, split mouth, randomized clinical trial||||
1290963|NCT03713814|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1290964|NCT03713801|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1290965|NCT03713788|Randomized|Parallel Assignment||Basic Science||None (Open Label)||A sample of convenience was recruited for this cross-sectional study. Participants were randomly assigned to a pain group or a control group using counterbalanced block randomization. Passive knee extension range of motion was measured three consecutive times with five-minute intervals between measurements. Both groups underwent a static stretch protocol consisting of two bouts of thirty-second constant-angle static stretching of the knee flexors with a one-minute rest between bouts. Subjects were instructed to keep the limb relaxed as the lower leg was passively moved towards extension. Following stretching, the post-stretch measurement was performed. Finally, subjects in the pain group were instructed to immerse their non-dominant hand into a container with circulating water at 1˚C to 4˚C and keep it there for 2 minutes. A Biodex system 4 pro dynamometer was used to quantify range of motion and passive resistive torque. Muscle activity was recorded as surface electromyography.||||
1290966|NCT03713775|Randomized|Parallel Assignment||Treatment||Single|This is an open-label randomised controlled study and patients will be aware of their treatment allocation. Potentially subjective measurements will be undertaken by observers blinded to treatment allocation; in particular, all imaging and ECG monitoring data will be anonymised prior to post-processing, and PPT score will be assessed by a research nurse blinded to treatment allocation. All study assessments will be coded and recorded blinded to treatment allocation.|||||t
1290967|NCT03713762|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1290968|NCT03713749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290969|NCT03713736||Single Group Assignment||Diagnostic||None (Open Label)||||||
1290970|NCT03713723|||Cohort||Prospective|||||||
1290971|NCT03713710|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1290972|NCT03713697|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1290973|NCT03713684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1290974|NCT03713671|Randomized|Parallel Assignment||Screening||Single||Parallel Assignment||||t
1290975|NCT03713658|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1290976|NCT03713645||Single Group Assignment||Prevention||None (Open Label)||||||
1290977|NCT03713632||Parallel Assignment||Treatment||Triple||Multicenter, randomized, double-blind, placebo-controlled, parallel group study, with two secukinumab dose regimens in approximately 471 patients with moderate to severe HS|t|t|t|
1290978|NCT03713619||Parallel Assignment||Treatment||Triple||Multicenter, randomized, double-blind, placebo-controlled, parallel group study, with two secukinumab dose regimens in approximately 471 patients with moderate to severe HS|t|t|t|
1290979|NCT03713606|||Cohort||Prospective|||||||
1290980|NCT03713593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1290981|NCT03713580||Single Group Assignment||Treatment||None (Open Label)||||||
1290982|NCT03713567|Non-Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1290983|NCT03713554|||Other||Prospective|||||||
1290984|NCT03713541|||Cohort||Cross-Sectional|||||||
1290985|NCT03713528|Randomized|Parallel Assignment||Treatment||None (Open Label)||two-arm, multi-center, randomized, superiority clinical trial||||
1290986|NCT03713515|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1290987|NCT03713502|||Other||Cross-Sectional|||||||
1290988|NCT03713489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290989|NCT03713476|Randomized|Parallel Assignment||Treatment||Single||||||t
1290990|NCT03713463|||Cohort||Prospective|||||||
1290991|NCT03713450|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1290992|NCT03713437|||Cohort||Cross-Sectional|||||||
1290993|NCT03713424|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1290994|NCT03713411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1290995|NCT03713398|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1290996|NCT03713385|||Case-Control||Cross-Sectional|||||||
1290997|NCT03713372||Single Group Assignment||Treatment||None (Open Label)||||||
1290998|NCT03713359|Randomized|Parallel Assignment||Prevention||Single|The first two volunteers will be assigned to the MRVAC group (code named A) and coded A001 and A002. The 3rd Volunteer will be assigned to the control group (code named B) and coded as B001. Volunteers arriving later will also be coded in this order until they meet enough subjects as required.|Eligible participants will be randomized receiving either MRVAC or MR vaccine produced by Serum Institute, India, which was using in Vietnam National Expanded program on Immunization in the ratio of 2:1. The Participants will be received only 1 dose of vaccine at the age from 1 year to 45 years.|t|||
1290999|NCT03713346|Randomized|Crossover Assignment||Other||Single|||||t|
1291000|NCT03713333|Randomized|Sequential Assignment||Screening||Triple|Treating physicians and clinical practitioners will not be concealed to the randomized allocation of individual clinics or the patients that are seen in these encounters. Physicians in the interventional group will participate in conducting technology-enabled visitations before a patient encounter and therefore are not blinded to the assessment. For the standard care group handheld imaging and digital health screening will be performed after the patient-physician encounter. Principal investigators, outcome adjudicators, and statisticians are blinded to randomization, device findings, and treatment decisions.|Pragmatic, multisite, cluster randomized trial comparing technology-enabled healthcare visitations with digital health devices and handheld imaging to standard-care||t|t|t
1291001|NCT03713320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291002|NCT03713307|||Cohort||Prospective|||||||
1291003|NCT03713294||Single Group Assignment||Treatment||None (Open Label)||||||
1291004|NCT03713281||||||||||||
1291005|NCT03713268|||Cohort||Prospective|||||||
1291006|NCT03713255|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple (participant, care provider, investigator, outcomes assessor)|Prospective, randomized, quadruple-blinded, three arm parallel group clinical trial.|t|t|t|t
1291007|NCT03713242|Non-Randomized|Sequential Assignment||Other||None (Open Label)||prospective, single-center, open-label, single-dose||||
1291008|NCT03713229|||Cohort||Prospective|||||||
1291009|NCT03713216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291010|NCT03713203||Single Group Assignment||Treatment||None (Open Label)||||||
1291011|NCT03713190|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1291012|NCT03713177|||Ecologic or Community||Cross-Sectional|||||||
1291013|NCT03713164|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1291014|NCT03713151||Single Group Assignment||Treatment||None (Open Label)||Feasibility study with a pre-post comparison||||
1291015|NCT03713138|Randomized|Parallel Assignment||Treatment||Single|Single-blinded trial, Intervention and placebo given|Randomized controlled placebo trial|t|||
1291016|NCT03713125|Randomized|Parallel Assignment||Other||Single|||||t|
1291017|NCT03713112|Randomized|Parallel Assignment||Prevention||None (Open Label)||The 2 arms of rehabilitative and/or subacute care patients consist of the intervention arm (receiving weekly multidisciplinary rounds up to the point of discharge, using 5 steps of deprescribing at the bedside, targeted to deprescribe selected medications [Beers' List of inappropriate Medications 2015; selected supplements and selected symptomatic medications]) and control arm (receving usual care)||||
1291018|NCT03713099||Single Group Assignment||Treatment||None (Open Label)||||||
1291019|NCT03713086|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291020|NCT03713073|Randomized|Parallel Assignment||Treatment||Single||"The study is a split-mouth design , in which two treatments (test and control) are randomly assigned to either the right or left halves of the dentition/palate."|t|||
1291021|NCT03713060|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1291022|NCT03713047|||Cohort||Prospective|||||||
1291023|NCT03713034|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1291024|NCT03713021||Single Group Assignment||Other||None (Open Label)||||||
1291025|NCT03713008||Single Group Assignment||Diagnostic||None (Open Label)||All patients included in the study will receive 4 ml/kg fluid bolus.||||
1291026|NCT03712995||Single Group Assignment||Treatment||None (Open Label)||Retrospective review of charts of the patients enrolled||||
1291027|NCT03712982|Randomized|Factorial Assignment||Other||Single|||t|||
1291028|NCT03712969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291029|NCT03712956||Single Group Assignment||Treatment||None (Open Label)||||||
1291030|NCT03712943||Sequential Assignment||Treatment||None (Open Label)||Regorafenib and Nivolumab||||
1291031|NCT03712930||Single Group Assignment||Treatment||None (Open Label)||||||
1291032|NCT03712917|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291033|NCT03712904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291034|NCT03712891|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1291035|NCT03712878||Single Group Assignment||Treatment||None (Open Label)||||||
1291036|NCT03712865|||Cohort||Prospective|||||||
1291037|NCT03712852|Randomized|Parallel Assignment||Treatment||Triple||parallel assignment|t|t|t|
1291038|NCT03712839|||Case-Control||Retrospective|||||||
1291039|NCT03712826|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291040|NCT03712813|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients will be randomized in a 1:1 ratio to LIV or the standard of care. The total patient enrollment will be 72 patients with 36 patients in each arm. Upon registration, subjects will be randomized and given an automated sequence number.||||
1291041|NCT03712800|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are randomized to one of the three groups (rhythmical massage, HRV biofeedback or control). After the three-month intervention period, the controls receive rhythmical massage for ethical and compliance reasons. Assessments are taken before and after the intervention phase. Pain intensity is once more queried three months after the end of the intervention period.||||
1291042|NCT03712787|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291043|NCT03712774|||Cohort||Prospective|||||||
1291044|NCT03712761|||Case-Crossover||Prospective|||||||
1291045|NCT03712748||Single Group Assignment||Treatment||None (Open Label)||All participants will complete the same arm, which is four sessions of imaginal exposure across a one month time period. Each session is separated by 1 week.||||
1291046|NCT03712735|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1291047|NCT03712722|||Cohort||Prospective|||||||
1291048|NCT03712709|||Cohort||Cross-Sectional|||||||
1291049|NCT03712696||Single Group Assignment||Other||None (Open Label)||Open Label||||
1291050|NCT03712683||Single Group Assignment||Screening||None (Open Label)||||||
1291051|NCT03712670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291052|NCT03712657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291053|NCT03712644|Randomized|Parallel Assignment||Treatment||None (Open Label)||non-blinded, open-label, prospective 1:1 randomized controlled multicentric trial.||||
1291054|NCT03712631|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1291055|NCT03712618|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1291056|NCT03712605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291057|NCT03712592|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1291058|NCT03712579|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1291059|NCT03712566|||Cohort||Prospective|||||||
1291060|NCT03712553|Randomized|Parallel Assignment||Screening||Double|||||t|t
1291061|NCT03712540||Single Group Assignment||Treatment||None (Open Label)||||||
1291062|NCT03712527|Randomized|Parallel Assignment||Treatment||Single|||||t|
1291063|NCT03712514|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1291064|NCT03712501|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1291065|NCT03712488|||Cohort||Prospective|||||||
1291066|NCT03712475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291067|NCT03712462|Randomized|Parallel Assignment||Treatment||Single||The novel acceptance-based behavioral weight loss therapy is being compared to standard behavioral weight loss therapy for individuals with binge eating disorder.|t|||
1291068|NCT03712449||Single Group Assignment||Treatment||None (Open Label)||||||
1291069|NCT03712436|Randomized|Parallel Assignment||Supportive Care||Double|blinded|A randomized controlled trial of standard oncologic care versus standard oncologic care plus palliative care in a newly diagnosed oncology population.|t|t||
1291070|NCT03712423||Single Group Assignment||Treatment||None (Open Label)||Phase I, open-label, single centre immune-PET study with [89Zr]-Df-CriPec® docetaxel in patients with solid tumours to assess biodistribution and tumour accumulation of [89Zr]-Df-CriPec® docetaxel||||
1291071|NCT03712410|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291072|NCT03712397||Single Group Assignment||Treatment||None (Open Label)||||||
1291073|NCT03712384|||Cohort||Retrospective|||||||
1291074|NCT03712371||Single Group Assignment||Treatment||None (Open Label)||||||
1291075|NCT03712358|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1291076|NCT03712345|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291077|NCT03712332||Single Group Assignment||Treatment||None (Open Label)||A basic two-phase AB case series design will be used. All participants will complete a seven day baseline phase, followed by the intervention phase of up to three weeks.||||
1291078|NCT03712319|Randomized|Parallel Assignment||Supportive Care||Single|Single-blind. The type of intervention (presence-based, app or waiting list) can not be masked neither for the participant nor for the intervention provider. Thus, the masking only applies to the assessor of the results.|Randomized, prospective, controlled and single-blind trial of 16 weeks. Students of Medicine, Nutrition, Psychology and Nursing are randomly assigned to the app group, the presential-based MBSR program or a waiting list. Three evaluations take place: pre-intervention, at 8 weeks (post-intervention) and at 16 weeks.||||t
1291123|NCT03711734|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1291124|NCT03711721|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1291125|NCT03711708|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1291126|NCT03711695|||Case-Only||Prospective|||||||
1291127|NCT03711682|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1291079|NCT03712306|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Participants will be randomized intro one of the three study groups.~Stratification by gender and habitual protein intake (low protein (>=0.9 g/kg BW/day - <1.0 g/kg BW/day), very low protein (<0.9 g/kg BW/day)), since we expect a different intervention effect for participants with a very low baseline habitual protein intake (< 0.9 g/kg body weight/d) compared to participants with a low baseline habitual protein intake (≥ 0.9 g/kg body weight/d), and because of potential differences in how women and men respond to the intervention.~In case couples participate, we will make sure they will be allocated to the same intervention group. This will ensure no interference between intervention groups. We will randomly select whether the randomization for the intervention group is based on the men or the women."||||
1291080|NCT03712293||Single Group Assignment||Treatment||None (Open Label)||This study will enroll up to 10 patients who are eligible and recommended for the standard adjuvant phase of TMZ chemotherapy. The goal is for all subjects to undergo ExAblate Type 2.0 BBB disruption procedures on one of the first three days of each TMZ dosing cycle throughout the adjuvant phase (up to 6 cycles).||||
1291081|NCT03712280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291082|NCT03712267||Single Group Assignment||Supportive Care||None (Open Label)||||||
1291083|NCT03712254|||Cohort||Prospective|||||||
1291084|NCT03712241|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1291085|NCT03712228|Randomized|Parallel Assignment||Prevention||Quadruple|Double blind|Subjects are assigned to 1 of 2 or more groups in parallel for the duration of the study|t|t|t|t
1291086|NCT03712215|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291087|NCT03712202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291088|NCT03712189|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1291089|NCT03712176|||Cohort||Prospective|||||||
1291090|NCT03712163|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1291091|NCT03712150|||Cohort||Cross-Sectional|||||||
1291092|NCT03712137|Randomized|Parallel Assignment||Treatment||Single||||||t
1291093|NCT03712124|Randomized|Parallel Assignment||Treatment||Double|The Investigator, study personnel, and patients will not make any effort to determine which study drug is being received. Patients will be blinded to study drug assignment.|Parallel assignment to either CNSA-001 (sepiapterin) 20 mg/kg/day or a placebo.|t||t|
1291094|NCT03712111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291095|NCT03712098|Randomized|Parallel Assignment||Treatment||Triple||This is a randomized, double-blind, placebo-controlled, parallel arm pilot study with one between-subjects factor of medication group (liraglutide vs. placebo).|t||t|t
1291096|NCT03712085|Randomized|Sequential Assignment||Treatment||Triple|||t||t|t
1291097|NCT03712072|||Cohort||Prospective|||||||
1291098|NCT03712059|||Cohort||Prospective|||||||
1291099|NCT03712046||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291100|NCT03712033|||Cohort||Prospective|||||||
1291101|NCT03712020|||Other||Prospective|||||||
1291102|NCT03712007|Randomized|Parallel Assignment||Treatment||Single||||||t
1291103|NCT03711994|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1291104|NCT03711981|Randomized|Parallel Assignment||Treatment||Single|Participants will not know which type of injection they have received for pain control.|Patients in one arm of the study would receive a bilateral Laparoscopic Assisted TAP block with 10cc Liposomal bupivacaine, 10cc 0.25% bupivacaine and 10cc normal saline each bilaterally at the beginning of their surgery. The patients in the control arm of the study would receive pre-incisional injections at the trocar incision sites using a total of 20cc 0.25% bupivacaine.|t|||
1291105|NCT03711968|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1291106|NCT03711955|Randomized|Parallel Assignment||Health Services Research||Double|"Investigator will not engage in the 8 week training program occurring, a leading supervisor will lead every training session so that the primary investigator (myself) will be blinded to the participants and their performance throughout the 8 week training interventions.~Participants from the opposite training groups will have separate training session times. In this way, no participant from the opposite training group will have contact with each other (ex. aerobic training group's session is at 12pm; instability resistance training group's session is at 4pm)."|Participants will be randomly assigned to either the aerobic training group/intervention or the instability resistance training group/intervention|t||t|
1291107|NCT03711942|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1291108|NCT03711929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291109|NCT03711916|Randomized|Single Group Assignment||Device Feasibility||Single|||||t|
1291110|NCT03711903|Randomized|Parallel Assignment||Supportive Care||Quadruple||The treatment arm will be given CN 105 The placebo arm will be give 0/9% NaCl|t|t|t|t
1291111|NCT03711890||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291112|NCT03711877|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291113|NCT03711864||Single Group Assignment||Treatment||None (Open Label)||||||
1291114|NCT03711851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291115|NCT03711838|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1291116|NCT03711825||Single Group Assignment||Treatment||None (Open Label)||||||
1291117|NCT03711812|Randomized|Parallel Assignment||Treatment||Single||||t||
1291118|NCT03711799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291119|NCT03711786|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|"As randomization is at the clinic level and cannot be masked, participants, care providers, and investigators will not be masked to allocation.~Outcome assessors do not need to know study arm, but it will be operationally difficult to blind them to whether a clinic is receiving the basic or enhanced implementation package."|10 clinics will be randomized 1:1 to either a basic or enhanced implementation package to support integration of evidence-based depression treatment.||||
1291120|NCT03711773||Single Group Assignment||Treatment||None (Open Label)||||||
1291121|NCT03711760|Randomized|Parallel Assignment||Treatment||Single||single center, single blinded, controlled, randomized, intention to treat.||||t
1291122|NCT03711747|||Cohort||Prospective|||||||
1291128|NCT03711669|||Cohort||Prospective|||||||
1291129|NCT03711656||Single Group Assignment||Other||None (Open Label)||Longitudinal, prospective, interventional study||||
1291130|NCT03711643|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1291131|NCT03711630||Single Group Assignment||Treatment||None (Open Label)||This study is a non-randomized interventional study in which subjects with bothersome tinnitus will meditate to investigate how meditation effects the level of bother of their tinnitus.||||
1291132|NCT03711617|||Cohort||Prospective|||||||
1291133|NCT03711604||Single Group Assignment||Treatment||None (Open Label)||||||
1291134|NCT03711591|||Case-Only||Prospective|||||||
1291135|NCT03711578||Single Group Assignment||Treatment||None (Open Label)||||||
1291136|NCT03711565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291137|NCT03711552|||Cohort||Prospective|||||||
1291138|NCT03711539|||Cohort||Prospective|||||||
1291139|NCT03711526|||Cohort||Prospective|||||||
1291140|NCT03711513|Randomized|Parallel Assignment||Treatment||Single||||||t
1291141|NCT03711500|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1291142|NCT03711487|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1291143|NCT03711474|Randomized|Parallel Assignment||Prevention||Double|Double blinded (participant and investigator)|Randomized; double blinded (participant and investigator)|t||t|
1291144|NCT03711461|Randomized|Parallel Assignment||Other||Single|the swallowing function assessor is blind|intubated and nonintubated patients||||t
1291145|NCT03711448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291146|NCT03711435|||Case-Control||Prospective|||||||
1291147|NCT03711422|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291148|NCT03711409|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects are divided into soft tissue biased manual therapy group and conventional physical therapy group by two different hospitals||||
1291149|NCT03711396||Single Group Assignment||Other||None (Open Label)||We will conduct four n-of-1 group visits for advance care planning using a rapid prototyping model and input from a longitudinal focus group.||||
1291150|NCT03711383|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1291151|NCT03711370|Randomized|Parallel Assignment||Prevention||Single|The video coders will be masked during video analysis.|All participants will be randomly assigned to either the opaque bottle group or the clear bottle group. Mothers will be asked to use their assigned bottle type to feed their infant for a full 12-week period. A pre-test will be given before the 12-week period as well as a post-test after the 12-week period. During these tests, we will observe each mother using the clear bottle to feed her infant on one visit and the opaque bottle on another visit. The order of these conditions will be randomized and counterbalanced.||||t
1291152|NCT03711357|Randomized|Parallel Assignment||Prevention||Single|All the participants will be blinded, as they will not know which interventional group they belong to|A trial with two parallel groups|t|||
1291153|NCT03711344|Randomized|Parallel Assignment||Treatment||Single||East Asian youth diagnosed with Anxiety and/or depression will be randomly assigned to either the experimental group (receives the cultural adapted version of cognitive behavioral therapy) or the control group (non-culturally adapted cognitive behavioral therapy). It is a randomized control trial design.||||t
1291154|NCT03711331|Randomized|Parallel Assignment||Treatment||Single|||||t|
1291155|NCT03711318||Single Group Assignment||Treatment||None (Open Label)||||||
1291156|NCT03711305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291157|NCT03711292||Single Group Assignment||Health Services Research||None (Open Label)||Stepped wedge cluster randomized trial||||
1291158|NCT03711279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291159|NCT03711266||Single Group Assignment||Treatment||None (Open Label)||||||
1291160|NCT03711253||Single Group Assignment||Treatment||None (Open Label)||||||
1291161|NCT03711240||Single Group Assignment||Treatment||None (Open Label)||||||
1291162|NCT03711227|||Cohort||Prospective|||||||
1291163|NCT03711214|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|Clinical treatment of periodontal disease in pSS patients and healthy individuals||||
1291164|NCT03711201|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1291165|NCT03711188||Single Group Assignment||Treatment||None (Open Label)||||||
1291166|NCT03711175|Randomized|Parallel Assignment||Treatment||Single|Subject will not know which group they were randomized to until the completion of the study.|Two treatment arms. One group will have the subscapularis repaired during surgery, and one group will not have the subscapularis repaired during surgery. All subjects will receive the same device.|t|||
1291167|NCT03711162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291168|NCT03711149|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This randomized controlled trial will involve two arms: (1) and intervention arm consisting of activity monitor feedback loop and art tours and (2) control group consisting of standard of care.||||
1291169|NCT03711136|||Cohort||Retrospective|||||||
1291170|NCT03711123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291171|NCT03711110|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized, multicenter, open-label clinical trial comparing, in elderly patient with cancer under anti-tumoral treatment, two different cardiotoxicity prevention strategies||||
1291172|NCT03711097|Randomized|Parallel Assignment||Prevention||Double||Split mouth study|t|||t
1291173|NCT03711084|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1291174|NCT03711071|Randomized|Parallel Assignment||Other||Triple|All participating doctors will be blinded towards the explicit purpose and design of the study. ICE communication training will be offered to all participants: to the doctors in the intervention group as a true intervention at the beginning of the trial, and to the doctors in the control group as a pretend intervention at the end of the trial.|Cluster randomised parallel design: Randomization to ICE communication training will take place at the practice level with units of randomizations being single handed or group practices.|t|t||t
1291175|NCT03711058|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1291176|NCT03711045|||Cohort||Cross-Sectional|||||||
1291177|NCT03711032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291178|NCT03711019|Randomized|Parallel Assignment||Treatment||Triple|Individuals blinded to their acute course of treatment will continue to receive the convulsive therapy to which they responded in in a blinded fashion.|"The study will involve a parallel-group clinical trial with three treatment arms conducted at the Centre for Addiction and Mental Health (CAMH) in Toronto, ON, Parkwood Institute of St. Joseph's Healthcare in London, ON and UBC Hospital in Vancouver, BC.~The investigators plan to enroll up to 105 participants to ensure 70 participants receive a complete course of continuation therapy following MST, RUL-UB ECT, or bitemporal ECT and anticipate enrolling up to 60 participants who will receive an acute course of bitemporal ECT as part of our secondary exploratory outcome over 48 months."|t|t||t
1291179|NCT03711006||Single Group Assignment||Treatment||None (Open Label)||The trial is an open-label pilot study treating 7 patients with Ulcerative Colitis with 25 daily multi-donor FMT Capsules for 50 days with 6 months follow up including the treatment period||||
1291180|NCT03710993|||Other||Prospective|||||||
1291181|NCT03710980|||Other||Prospective|||||||
1291182|NCT03710967|Randomized|Crossover Assignment||Treatment||Double||single-blinded, randomized controlled cross-over design trial|t|||t
1291183|NCT03710954||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291184|NCT03710941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291185|NCT03710928|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291186|NCT03710915||Sequential Assignment||Treatment||None (Open Label)||"Drug: HG146 capsule HG146 capsule is a histone deacetylase inhibitor (HDAC inhibitor) for the treatment of multiple myeloma.~Other Name: HG280146, HG0146, HG280146, HG280146-P1"||||
1291187|NCT03710902|Randomized|Parallel Assignment||Prevention||Single|Clinical endpoints will be assessed according to PROBE principles, i.e. outcomes assessors are masked to treatment allocation.|||||t
1291188|NCT03710889||Single Group Assignment||Treatment||None (Open Label)||The study will consist of a Screening Period (up to 1 month), a Pretreatment Period (approximately 1 month), a Treatment Period (3 months), and a Month 4 visit one month after the last dose of study medication.||||
1291189|NCT03710876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291190|NCT03710863||Single Group Assignment||Treatment||None (Open Label)||||||
1291191|NCT03710850|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||single groups assignment||||
1291192|NCT03710837|Randomized|Parallel Assignment||Health Services Research||Triple|Participant information is pseudonymised using student numbers only. As soon is data is generated data will be fully anonymised.|Multi disciplinary randomised controlled trial|t||t|t
1291193|NCT03710824|||Cohort||Prospective|||||||
1291194|NCT03710811|||Case-Only||Prospective|||||||
1291195|NCT03710798||Single Group Assignment||Treatment||None (Open Label)||prospective observational study with a diet intervention||||
1291196|NCT03710785||Single Group Assignment||Health Services Research||None (Open Label)||||||
1291197|NCT03710772|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291198|NCT03710759||Single Group Assignment||Treatment||None (Open Label)||||||
1291199|NCT03710746|Randomized|Factorial Assignment||Prevention||Double|Participants will be masked to their response training condition. Outcomes assessors will be masked to both participant conditions.||t|||t
1291200|NCT03710733|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291201|NCT03710720|Randomized|Parallel Assignment||Prevention||Single|Urn randomization will be monitored by the Principle Investigator.|||||t
1291202|NCT03710707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291203|NCT03710694|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291204|NCT03710681|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1291205|NCT03710668|||Case-Control||Prospective|||||||
1291206|NCT03710655|Randomized|Parallel Assignment||Treatment||Triple|randomization and blinded personnel at site|1-1 in two studies of 468 patients total patients 936|t||t|t
1291207|NCT03710642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291208|NCT03710629|||Cohort||Prospective|||||||
1291209|NCT03710616|||Cohort||Retrospective|||||||
1291210|NCT03710603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291211|NCT03710590|Non-Randomized|Crossover Assignment||Basic Science||Single|Participants will be blinded to the power level and nicotine concentration used in each session.|The purpose of this study is to determine differences in nicotine delivery, use behavior (puff topography), carbon monoxide delivery, subjective effects, and physiological effects, when cigarette smokers and experienced electronic cigarette users use an electronic cigarette with different settings (different voltage and resistance settings, which together determine power levels) and different e-liquid concentrations.|t|||
1291212|NCT03710577|Randomized|Crossover Assignment||Other||None (Open Label)||The proposed study is an acute, single group, crossover pilot study where participants will complete control and experimental conditions.||||
1291213|NCT03710564||Parallel Assignment||Treatment||Double|Additionally, the care provider will be masked.|multicenter, randomized, double-masked|t||t|
1291214|NCT03710551|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1291215|NCT03710538|Randomized|Crossover Assignment||Treatment||Single|snack beverage or flavored placebo will be not recognizable|"Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women; Sedentary activities throughout the study [condition control]~Consumption of 200ml of soy beverage + 90g of carbohydrate (CHO) breakfast for men and 80g for women; Sedentary activities throughout the study [snack effect on PPG excursion]~Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5); [exercise effect on the PPG excursion]~Consumption of 200ml of soy beverage + breakfast of 90g of carbohydrate (CHO) breakfast for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5). [Combined snack and exercise effect on the PPG excursion]"|t|||
1291247|NCT03710122|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291248|NCT03710109|||Cohort||Prospective|||||||
1291249|NCT03710096|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1291216|NCT03710525|Randomized|Factorial Assignment||Other||None (Open Label)||This study will utilize a three factor design, with one between-subject factor and two within-subject factors. The between-subject factor is participation in a federal food assistance program. The within-subject factors are price change condition and price change scenario.||||
1291217|NCT03710512|||Case-Control||Prospective|||||||
1291218|NCT03710499||Single Group Assignment||Treatment||None (Open Label)||After a physical therapy evaluation, the patient underwent a booklet-guided physical exercise program that lasted two months (3 times per week with a duration of 60 minutes per session). Activities included overall stretching and strengthening (flexion, extension, adduction and abduction movements) and muscular endurance exercises (exercises involving open and closed kinetic chains), along with aerobic conditioning using a functional circuit. The patient was evaluated at 3 different timepoints (baseline, after 8 weeks of training, and after a 4-week washout period with no treatment); thus, he served as his own control. The physiotherapist contacted the patient by phone weekly to follow the progression of the treatment. Throughout the application of the protocol, the patient regularly maintained his follow-up visits with the multidisciplinary team. Moreover, there was no change in pharmacological treatment throughout this period.||||
1291219|NCT03710486|||Cohort||Retrospective|||||||
1291220|NCT03710473|||Case-Control||Prospective|||||||
1291221|NCT03710460|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291222|NCT03710447|Randomized|Parallel Assignment||Treatment||Single|Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking).|Parallel Assignment parallel-group, randomized-controlled study||||t
1291223|NCT03710434|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1291224|NCT03710421||Single Group Assignment||Treatment||None (Open Label)||||||
1291225|NCT03710408|Randomized|Parallel Assignment||Treatment||Triple|To achieve assessor/care provider blinding, all participants will receive a sham needle (opposite of the randomization). This will not pierce the skin but just lay on top of the skin. Both the randomized and the sham needle will be covered by non-woven swabs before placement of the dressing. Both the active and the sham device is connected to an infusion set. The infusion tubes will be tangled at the top, just below the roller ball and drop counter. The entanglement will be covered by opaque dressing. This way it cannot be know which infusions tube is connected to the fluid bag, while it is still possible to control the infusion speed.|||t|t|t
1291226|NCT03710395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291227|NCT03710382||Single Group Assignment||Supportive Care||None (Open Label)||Prospective pilot study with single group assignment||||
1291228|NCT03710369|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1291229|NCT03710356||Single Group Assignment||Treatment||None (Open Label)||phase ½ therapeutic trial stratified on disease (Severe Hematologic or Pulmonary Disease)||||
1291230|NCT03710343|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded. Participants and research personnel will remain masked until the completion of all study participants.||t|t|t|t
1291231|NCT03710330|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which will be used.|"Eligible participants were allocated to one of three groups after induction of general anesthesia and immediately prior to the operation and just before skin incision. Groups were labeled as follows:~Group one (120) - 5 ml of distilled water in 20 ml of 5% dextrose~Group two (120) - TA in the dose of I gm in 20 ml of 5% dextrose~Group three(120) - TA in the dose of 0.5gm in 20 ml of 5% dextrose"|t|t|t|t
1291232|NCT03710317|Randomized|Parallel Assignment||Prevention||Triple|a double-blinded randomized placebo-controlled trial|"Study drug administration Group 1 100 μg carbetocin ampoule will be diluted in 10 mL normal saline and administered slowly (over 30-60 s) intravenously by the anesthetist after the birth of the baby~Group 2 400 μg buccal misoprostol (2 tablets of 200 μg) will be given after spinal anesthesia and few minutes before skin incision in addition to 1 gm tranexamic acid in 100 mL of intravenous solution infusion over 15 min."|t|t|t|
1291233|NCT03710304|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which will be used.|"participants will be randomized via a computer-generated random number sequence into one of two groups: one group received a pre-prepared sealed and opaque packet containing 400 μg of misoprostol (2 tablets of 200 μg), 2 ampoules of TA (1 gm for infusion) and separate placebo ampoule (distilled water). The other group received similar packets containing two placebo tablets, two placebo ampoules (distilled water) and separate 2 ampoules of oxytocin (syntocinon; 10 IU in each ampoule for infusion) for slow intravenous injection. The misoprostol and placebo tablets were similar in size, shape, and color, and ampoules of oxytocin was also similar to placebo. Randomization was done by the resident doctors immediately before transfer to theater, whereas preparation of packets and confidential record maintenance was done by the labor room nursing staff.~Study drug administration"|t|t|t|t
1291234|NCT03710291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291235|NCT03710278|||Case-Only||Prospective|||||||
1291236|NCT03710265||Single Group Assignment||Treatment||None (Open Label)||||||
1291237|NCT03710252||Single Group Assignment||Treatment||None (Open Label)||This is a Phase IV, open label, single arm study.||||
1291238|NCT03710239|Randomized|Parallel Assignment||Treatment||Single|Participants will not know what type of dilator they have been assigned, however the medical care team (including investigators) will be aware.|Participants will be randomly assigned to receive one of two existing dilator times, with the remainder of care and study procedures being identical.|t|||
1291239|NCT03710226|||Case-Control||Cross-Sectional|||||||
1291240|NCT03710213|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1291241|NCT03710200|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1291242|NCT03710187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291243|NCT03710174|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will not know to which group the participants belong.|||||t
1291244|NCT03710161|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1291245|NCT03710148|||Cohort||Prospective|||||||
1291246|NCT03710135|||Case-Only||Prospective|||||||
1573289|NCT00001747||||||||||||
1291250|NCT03710083||Single Group Assignment||Treatment||None (Open Label)||||||
1291251|NCT03710070|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1291252|NCT03710057|||Cohort||Prospective|||||||
1291253|NCT03710044||Single Group Assignment||Other||None (Open Label)||||||
1291254|NCT03710031|||Cohort||Prospective|||||||
1291255|NCT03710018|||Cohort||Prospective|||||||
1291256|NCT03710005|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291257|NCT03709992|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1291258|NCT03709979|Randomized|Parallel Assignment||Other||Double|||t|||t
1291259|NCT03709966|Randomized|Parallel Assignment||Prevention||Single||The methodology used for this study consists of a pilot randomized controlled trial of 30 Type 2 diabetes patients already followed by health professionals from GMF-U Quatre-Bourgeois|t|||
1291260|NCT03709953||Single Group Assignment||Treatment||None (Open Label)||apatinib monotherapy||||
1291261|NCT03709940|Non-Randomized|Crossover Assignment||Other||Single|The first part of the study (DAY 1 and DAY 2) is conceived as a single-blind placebo-controlled cross-over experiment. Participants are blind to the order of the tablets (placebo and MPH). After the two scanning sessions, all 60 participants are started on a long-acting formulation of MPH used routinely at the Adult ADHD Clinic (open trial phase).|30 participants with Attention Deficit Hyperactivity Disorder (ADHD) undergo behavioural tests and brain scanning twice, once under placebo and once under an acute dose of methylphenidate (MPH). The order of the tablets is inverted for the second half of the sample, thus the last 30 participants undergo behavioural tests and brain scanning twice, once under an acute dose of MPH and once under placebo. All 60 participants are then treated with a long-acting formulation of MPH used routinely at the Adult ADHD Clinic.|t|||
1291262|NCT03709927|Randomized|Crossover Assignment||Treatment||Triple|Single dose study treatments will be administered in blinded, randomized sequence in separate periods with each subject in the study exposed to each of the four treatments.|4-way cross over (two doses of ZTI-01, placebo and oral moxifloxacin)|t||t|t
1291263|NCT03709914|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)|Subjects <12 years of age, are assigned by age to one of five age based cohorts. Study is open label and not masked.|multiple-center, non-comparative, open-label, PK study||||
1291264|NCT03709901|Randomized|Parallel Assignment||Treatment||Single|The assignment to treatment (active allograft, or placebo, or conservative care) is open label at Day 0 of the Active Phase to the extent that subjects receiving allograft or placebo will not be aware of what they have received, while those assigned to conservative care will be aware. All site study staff will be aware of the group to which each subject is randomized. Sites will be trained to ensure that subjects receiving the allograft or placebo treatment will remain blinded to their treatment throughout the study duration.|Multi-center, prospective, randomized, parallel-arm study.|t|||
1291265|NCT03709888|||Cohort||Prospective|||||||
1291266|NCT03709875|Randomized|Parallel Assignment||Treatment||Double||multi-center, prospective, parallel design, single-blind trial|||t|t
1291267|NCT03709862|||Case-Only||Retrospective|||||||
1291268|NCT03709849|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291269|NCT03709836|||Cohort||Retrospective|||||||
1291270|NCT03709823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291271|NCT03709810|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1291272|NCT03709797|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291273|NCT03709784|||Cohort||Prospective|||||||
1291274|NCT03709771|||Cohort||Prospective|||||||
1291275|NCT03709758||Single Group Assignment||Treatment||None (Open Label)||||||
1291276|NCT03709745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291277|NCT03709732|||Cohort||Other|||||||
1291278|NCT03709719||Single Group Assignment||Treatment||None (Open Label)||||||
1291279|NCT03709706|Randomized|Parallel Assignment||Treatment||None (Open Label)|This will be an open-label study. Hence, there will be no masking.|Subjects will receive either a single intravenous (IV) infusion of GSK3377794 as monotherapy or as combination therapy along with pembrolizumab IV infusion.||||
1291280|NCT03709693|||Cohort||Prospective|||||||
1291281|NCT03709680|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The study will be conducted of 3 parts: a dose escalation part (following a rolling 6 design), a dose expansion part, and if applicable, tumor-specific expansion part.||||
1291282|NCT03709667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291283|NCT03709654|Randomized|Parallel Assignment||Treatment||Double|Double blind|Randomized Double Blind Vehicle Controlled Trial, dual arm with 2:1 treatment to vehicle assignment|t||t|
1291284|NCT03709641||Single Group Assignment||Device Feasibility||None (Open Label)||Study is set as a single-arm, randomized, single-masked to evaluate Restylane Defyne for canalicular occlusion in participants with mild to moderate dry eye disease. Each participant will have a screening visit, it is then participants will be provided with informed consent form to review and ask questions before written informed consent is obtained. Screening visit occurs 30 days prior to 42 days and will be seen for follow-up exams at 3 , 14 and 42 days.||||
1291285|NCT03709628||Single Group Assignment||Treatment||None (Open Label)||Multicenter, open-label||||
1291286|NCT03709615|Randomized|Parallel Assignment||Treatment||Single||||||t
1291287|NCT03709602|||Cohort||Prospective|||||||
1291288|NCT03709589|||Case-Control||Prospective|||||||
1291289|NCT03709576||Single Group Assignment||Treatment||None (Open Label)||||||
1291290|NCT03709563|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1291291|NCT03709550||Single Group Assignment||Treatment||None (Open Label)||||||
1291292|NCT03709537|Randomized|Parallel Assignment||Health Services Research||Single|Data collection and analysis will occur without knowledge of participant intervention condition.|The study will draw participants from mental health sites where one or more peer supervisors and peer workers are located. These sites will be randomized to either the treatment or standard practice control group. The treatment group will receive the intervention, which consists of a Co-Learning Collaborative, several trainings, and the creation of Implementation Teams. The sites assigned as part of control group will not receive any training or additional technical assistance that is part of the intervention.||||t
1573290|NCT00001742||||||||||||
1291293|NCT03709524|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1291294|NCT03709511|Randomized|Parallel Assignment||Prevention||None (Open Label)|Both the researchers and participants know which treatment is being administered(An open-label trial).|||||
1291295|NCT03709498|||Cohort||Prospective|||||||
1291296|NCT03709485||Single Group Assignment||Basic Science||None (Open Label)||||||
1291297|NCT03709472|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Randomization will be stratified by gender, type of self-harm, trauma exposure and LGBT status. The investigators will attempt to match overall contact hours (in the experimental condition some of these hours will be with technology). During the continuing care phase the CIFFTA families will interact with the therapist via the website for a period of 8 additional weeks. To match dosage time during aftercare, Treatment As Usual (TAU) will receive check-in telephone calls with the therapist."||||
1291298|NCT03709459|||Cohort||Prospective|||||||
1291299|NCT03709446||Single Group Assignment||Treatment||None (Open Label)||||||
1291300|NCT03709433||Single Group Assignment||Treatment||None (Open Label)|No masking will be used.|All participants will receive the same active treatment (acceptance and commitment therapy groups and a mobile app)||||
1291301|NCT03709420|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1291302|NCT03709407|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1291303|NCT03709394|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomized study||||
1291304|NCT03709381||Single Group Assignment||Diagnostic||None (Open Label)||At t=0, 9 ml of blood will be collected for measurement of VEGF, ACTH, and cortisol levels. Then, 1 mcg of cosyntropin (a synthetic ACTH analog) will be administered intravenously (IV). Samples for measurement of cortisol and VEGF levels will be obtained at t=30 and 60 minutes (6 ml of blood collected at both times). After the 60 minute blood draw, 250 mcg of cosyntropin will be administered IV. At t=90, 120, 150 , and 180 minutes, samples for measurement of cortisol and VEGF levels will be obtained (6 ml of blood collected at each time).||||
1291305|NCT03709368|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1291306|NCT03709355|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1291307|NCT03709342||Single Group Assignment||Treatment||None (Open Label)||||||
1291308|NCT03709329|Randomized|Parallel Assignment||Treatment||Double|Investigator and Outcome assessors were blinded to types of treatment the patients received until the end of the study.|"Single blinded Randomized controlled study design is divided into two groups: robot-assisted walking group and conventional walking group. The random assignment is performed by Stratified Permuted Block Randomization to match Sex and Age between the two groups, and the subject is assigned using a randomly generated table before the start of the study so that the evaluator can not know what kind of treatment the subject is receiving.~Both groups undergo unassisted overground walking condition before and after treatment and after 6 weeks of treatment.~Plain gait condition at the time of evaluation: When walking, several 8-meter-long plazas are walked several times to induce a natural walk, and three natural gait cycles are selected."|||t|t
1291309|NCT03709316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291310|NCT03709303|||Case-Control||Cross-Sectional|||||||
1291311|NCT03709290|||Case-Control||Cross-Sectional|||||||
1291312|NCT03709277|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291313|NCT03709264|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291314|NCT03709251|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1291315|NCT03709238|||Cohort||Prospective|||||||
1291316|NCT03709225||Single Group Assignment||Supportive Care||None (Open Label)||||||
1291317|NCT03709212|||Cohort||Cross-Sectional|||||||
1291318|NCT03709199|||Cohort||Prospective|||||||
1291319|NCT03709186|||Cohort||Prospective|||||||
1291320|NCT03709173|||Other||Cross-Sectional|||||||
1291321|NCT03709160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291322|NCT03709147|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Single Institution, open-labeled, double arm, non-comparative, randomized, single stage phase II trial, with pick-the-winner design."||||
1291323|NCT03709134|||Cohort||Other|||||||
1291324|NCT03709121|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1291325|NCT03709108|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1291326|NCT03709095|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants were randomized to one of two groups: (A) sprint interval training (SIT) or (B) moderate intensity continuous training (MICT).||||
1291327|NCT03709082|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291328|NCT03709069|Randomized|Parallel Assignment||Treatment||Triple||One group receives routine diet while other group receives supplemental albumin along with routine diet|t|t||t
1291329|NCT03709056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291330|NCT03709043|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291331|NCT03709030|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Randomised Controlled Trial||||
1291332|NCT03709017|||Case-Only||Prospective|||||||
1291333|NCT03709004|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1291334|NCT03708991|||Other||Prospective|||||||
1291335|NCT03708978|||Cohort||Other|||||||
1291336|NCT03708965||Single Group Assignment||Treatment||None (Open Label)||||||
1291337|NCT03708952|||Cohort||Prospective|||||||
1291338|NCT03708939|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1291339|NCT03708926|Randomized|Parallel Assignment||Treatment||Double|double-blinded|placebo controlled clinical trial|t||t|
1291340|NCT03708913||Single Group Assignment||Treatment||None (Open Label)||||||
1291341|NCT03708900||Single Group Assignment||Treatment||None (Open Label)||||||
1291342|NCT03708887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291343|NCT03708874|||Other||Prospective|||||||
1291344|NCT03708861||Single Group Assignment||Treatment||None (Open Label)||||||
1291399|NCT03708146|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1291400|NCT03708133|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1291345|NCT03708848||Single Group Assignment||Treatment||None (Open Label)||After antimicrobial susceptibility testing of Helicobacter pylori from biopsy samples, according to antibiotic resistance pattern of each one, give esomeprazole 20mg bid, bismuth potassium citrate 600mg bid and two sensitive ones of clarithromycin, metronidazole,levofloxacin and tetracycline.||||
1291346|NCT03708835|Randomized|Parallel Assignment||Health Services Research||Single|The result will be evaluated by the statistician|Types of interventions that are applied to stroke patients and caregivers based on Transitional Care Model are hospital interview, home visit, telephone interview and web-based training.||||t
1291347|NCT03708822||Single Group Assignment||Treatment||None (Open Label)||||||
1291348|NCT03708809|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291349|NCT03708796|||Cohort||Prospective|||||||
1291350|NCT03708783||Single Group Assignment||Treatment||None (Open Label)||Patients with locally advanced upper and middle third gastric cancer will receive laparoscopic total gastrectomy with D2 lymphadenectomy including No. 10 lymph node dissection.||||
1291351|NCT03708770||Single Group Assignment||Treatment||None (Open Label)||||||
1291352|NCT03708757|Randomized|Parallel Assignment||Treatment||Single|This will be a single blinded study.Participants will be randomly allocated to PIRT Group (I) or EMET Group (II)|Experimental Study|t|||
1291353|NCT03708744|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized, open-label four-way crossover||||
1291354|NCT03708731|||Cohort||Prospective|||||||
1291355|NCT03708718|Randomized|Parallel Assignment||Treatment||Triple|Double-blind. The trial management team are blind to treatment allocation for the duration of the trial. The site research teams and patients are blind to treatment until code-break. At this point the on-site team and patient are unblind to allocation for continuing care. The site pharmacy personnel, PRedSS trial monitor and supervising statistician are unblind throughout.|Patients are allocated to received either prednisolone or matched placebo for the duration of the trial. The allocation is randomised 1:1.|t|t|t|
1291356|NCT03708705|||Cohort||Prospective|||||||
1291357|NCT03708692|||Other||Prospective|||||||
1291358|NCT03708679|||Other||Prospective|||||||
1291359|NCT03708666||Single Group Assignment||Prevention||None (Open Label)||||||
1291360|NCT03708653|||Cohort||Prospective|||||||
1291361|NCT03708640|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1291362|NCT03708627|Non-Randomized|Single Group Assignment||Treatment||Single|Outcomes assessor will evaluate clinical photos. Other measures such as Hertel's exophthalmometry values are objective outcomes which will be made available to the Principal Investigator|||||t
1291363|NCT03708614||Single Group Assignment||Supportive Care||None (Open Label)||Non-randomized pilot intervention study||||
1291364|NCT03708601|||Cohort||Prospective|||||||
1291365|NCT03708588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291366|NCT03708575|||Other||Retrospective|||||||
1291367|NCT03708562||Single Group Assignment||Treatment||None (Open Label)||||||
1291368|NCT03708549|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291369|NCT03708536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291370|NCT03708523|||Case-Crossover||Retrospective|||||||
1291371|NCT03708510|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1291372|NCT03708497|Randomized|Parallel Assignment||Prevention||None (Open Label)|open label study|women were allocated to one of the three study groups: group I (carbetocin group) received 100 mc carbetocin IV after delivery of the baby, group II (misoprostol group) received 600 mg buccal misoprostol after delivery of the baby, and group III (TA plus misoprostol group) received 1000mg oral TA at the end of the first stage of labor plus 600 mg buccal misoprostol after delivery of the baby. A buccal route, in which the tablets are placed in the cheek for 30 min after which any remnants are swallowed||||
1291373|NCT03708484|Randomized|Parallel Assignment||Other||Single|||||t|
1291374|NCT03708471|Randomized|Parallel Assignment||Treatment||Single||||||t
1291375|NCT03708458|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291376|NCT03708445||Single Group Assignment||Diagnostic||None (Open Label)||The conventional staining method and new staining method will be performed in cytology specimens obtained from same patient.||||
1291377|NCT03708432|||Cohort||Retrospective|||||||
1291378|NCT03708419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291379|NCT03708406|||Cohort||Prospective|||||||
1291380|NCT03708393||||||||||||
1291381|NCT03708380||Single Group Assignment||Prevention||None (Open Label)||||||
1291382|NCT03708367|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1291383|NCT03708354|Randomized|Parallel Assignment||Prevention||Triple|Placebo softgels will be of the same size/color as the active softgels.|dietary supplement|t||t|t
1291384|NCT03708341|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo, double blind|Randomized Controled Trial|t|t|t|t
1291385|NCT03708328|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1291386|NCT03708315|Randomized|Crossover Assignment||Treatment||Quadruple||The subjects will be randomized and will get either an infusion of Precedex or infusion of Normal Saline.|t|t|t|t
1291387|NCT03708302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291388|NCT03708289|||Cohort||Prospective|||||||
1291389|NCT03708276||Single Group Assignment||Health Services Research||None (Open Label)||||||
1291390|NCT03708263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291391|NCT03708250|||Case-Only||Prospective|||||||
1291392|NCT03708237|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291393|NCT03708224|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1291394|NCT03708211|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1291395|NCT03708198||Single Group Assignment||Basic Science||None (Open Label)||||||
1291396|NCT03708185|Randomized|Parallel Assignment||Treatment||Double|Doubly-blinded & randomised using an online randomisation website.||t||t|
1291397|NCT03708172|Randomized|Parallel Assignment||Treatment||Quadruple|Open Label for rTMS, Double-Blinded for Cognitive Training||t|t|t|t
1291398|NCT03708159|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1291401|NCT03708120||Single Group Assignment||Basic Science||None (Open Label)|There is no blinding employed since the outcome measures are based on tick behaviour.|This is a single group trial with the participants acting as their own controls, one arm will be treated with insect repellent, and the other left untreated.||||
1291402|NCT03708107|Randomized|Parallel Assignment||Treatment||Single|The researcher who did the algometry was masked. The researcher who did the statistical analysis was masked.|||||t
1291403|NCT03708094|||Cohort||Prospective|||||||
1291404|NCT03708081|||Case-Only||Prospective|||||||
1291405|NCT03708068|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1291406|NCT03708055||Single Group Assignment||Prevention||None (Open Label)||||||
1291407|NCT03708042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291408|NCT03708029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291409|NCT03708016|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1291410|NCT03708003||Single Group Assignment||Treatment||None (Open Label)||A multicenter, single-arm, open-label, phase-II trial.||||
1291411|NCT03707990|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.|In total, 11 cohorts are planned. Five cohorts in Part 1 (cohort 1-5), and 6 cohorts (cohort 6-11) in Part 2. Each cohort will contain 8 participants. The first 2 participants will be randomised so one participant will receive active (Part 1: NNC0165-1875; Part 2: NNC0165-1875 and semaglutide) while the other receive placebo (Part 1: placebo; Part 2: placebo and semaglutide) treatment. The participants will remain in-house for a 5 days safety observation period. The remaining 6 subjects will be dosed at least after 96 hours.|t|t|t|t
1291412|NCT03707977|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291413|NCT03707964|Randomized|Parallel Assignment||Other||Triple|"Deliberate deception (by not informing of the aim of assessing for ability to challenge authority) will be used to blind the participants. However, open disclosure and explanation of the rationale for deception will be conducted during the debriefing sessions and participants will be extensively counselled.~The confederate specialist will also be blinded to the allocation of the control or intervention arm of participants.~All sessions will be video recorded and assessed in random order by two independent raters blinded to group allocation, using the modified Advocacy-Inquiry Score (mAIS)."||t|t||t
1291414|NCT03707951|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind placebo-controlled pharmacotherapy trial|1:1 parallel group allocation randomized placebo controlled trial|t|t|t|t
1291415|NCT03707938||Single Group Assignment||Treatment||None (Open Label)||||||
1291416|NCT03707925||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291417|NCT03707912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291418|NCT03707899|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1291419|NCT03707886|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1291420|NCT03707873|Randomized|Parallel Assignment||Treatment||None (Open Label)||AF patients will be divided in three groups: one group will have in-person education, the second group will have online education and the third group will receive standard AF care. Cardiovascular outcomes will be compared between these groups.||||
1291421|NCT03707860|||Cohort||Prospective|||||||
1291422|NCT03707847||Single Group Assignment||Treatment||None (Open Label)||||||
1291423|NCT03707834|Randomized|Parallel Assignment||Treatment||Single||||||t
1291424|NCT03707821|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291425|NCT03707808||Single Group Assignment||Treatment||None (Open Label)||||||
1291426|NCT03707795|Non-Randomized|Parallel Assignment||Treatment||Single|Participants remain blinded as to their genotype.||t|||
1291427|NCT03707782|||Family-Based||Prospective|||||||
1291428|NCT03707769||Single Group Assignment||Basic Science||None (Open Label)||||||
1291429|NCT03707756|||Other||Retrospective|||||||
1291430|NCT03707743|||Cohort||Other|||||||
1291431|NCT03707730|Randomized|Crossover Assignment||Treatment||Quadruple|placebo controlled|randomized double-blind, placebo-controlled crossover trial|t|t|t|t
1291432|NCT03707717|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1291433|NCT03707704|||Cohort||Prospective|||||||
1291434|NCT03707691|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1291435|NCT03707678|Randomized|Parallel Assignment||Treatment||Double|This will be a double blind study where the investigators and subjects will be blinded and sponsor remains unblinded.|This will be a parallel-group study. Subjects will be randomized in 1:1 ratio to receive GSK2245035 or placebo once weekly for 8 weeks.|t||t|
1291436|NCT03707665|||Cohort||Prospective|||||||
1291437|NCT03707652|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1291438|NCT03707639||Single Group Assignment||Treatment||None (Open Label)||||||
1291439|NCT03707626|||Cohort||Retrospective|||||||
1291440|NCT03707613||Single Group Assignment||Prevention||None (Open Label)||||||
1291441|NCT03707600|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1291442|NCT03707587||Single Group Assignment||Treatment||None (Open Label)||||||
1291443|NCT03707574||||||||||||
1291444|NCT03707561|||Cohort||Prospective|||||||
1291445|NCT03707548||Single Group Assignment||Treatment||None (Open Label)||"Study design: The project follows the outline of a non-randomized evaluation of a weekly group BPT using a waiting-period comparator, with a nested randomized controlled trial (RCT) to evaluate the short-term efficacy of smartphone-triggered bodily interventions.~Measurement points:~Patients will be surveyed at three points in time (initial consultation, pre- and post-intervention) to explore the effects of BPT on bodily disturbances and body image in post-treatment cancer patients.~During the BPT Intervention group cohesion and bodily well-being will be assessed weekly.~The smartphone-triggered bodily and control interventions will be provided over a period of 5 consecutive weeks on 6 days per week and will be assessed pre- and post intervention."||||
1291446|NCT03707535|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291447|NCT03707522|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1291448|NCT03707509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291449|NCT03707496|||Cohort||Prospective|||||||
1291450|NCT03707483|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1291451|NCT03707470|Randomized|Parallel Assignment||Treatment||Single|Participants to be provided with 2 different types of compression garments and a sham treatment (sham ultrasound) for recovery from muscle damaging exercise|Randomised, controlled, parallel trial|t|||
1291452|NCT03707457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291453|NCT03707444||Single Group Assignment||Treatment||None (Open Label)||Single arm study of 20 patients||||
1291454|NCT03707431|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized and double-blinded controlled trial of web-based CBT (WebMAP) vs pain education (WebED).|t|t|t|t
1291455|NCT03707418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291456|NCT03707405|Randomized|Parallel Assignment||Treatment||Single||||||t
1291457|NCT03707392|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized controlled trial||||
1291458|NCT03707379|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1291459|NCT03707366|Randomized|Parallel Assignment||Prevention||Single|Research assistants who conduct the interviews are masked to condition.|Randomized controlled trial with 2 groups||||t
1291460|NCT03707353|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291461|NCT03707340|||Cohort||Prospective|||||||
1291462|NCT03707327|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291463|NCT03707314|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multi-centre parallel design||||
1291464|NCT03707301|||Cohort||Prospective|||||||
1291465|NCT03707288||Single Group Assignment||Prevention||None (Open Label)||||||
1291466|NCT03707275|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1291467|NCT03707262||Single Group Assignment||Treatment||None (Open Label)||||||
1291468|NCT03707249|Randomized|Parallel Assignment||Basic Science||Triple|Participants were blinded by the use of eye-masks during infusion and the physical covering of infusion bags and giving sets. Investigators were unaware of the allocation to iron or saline control. Outcomes assessors were also unaware of the allocation.|2 groups were randomised to receive a dose of intravenous iron or iv saline control to manipulate body iron stores. They were subsequently investigated non-invasively and with venous blood sampling during an ascent to very high altitude.|t||t|t
1291469|NCT03707236|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1291470|NCT03707223|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291471|NCT03707210|Randomized|Parallel Assignment||Other||None (Open Label)||intervention: VR training; control group: ISO document||||
1291472|NCT03707197|Randomized|Parallel Assignment||Treatment||Single|Investigator will be blind to condition throughout data accrual.|Randomization to either digital meditation condition or waitlist-control condition|||t|
1291473|NCT03707184||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291474|NCT03707171|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291475|NCT03707158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291476|NCT03707145|Randomized|Parallel Assignment||Prevention||Single|The participant is unaware of the other groups details. Assessor and investigator are not blinded due to the need for providing information to the participant about their group allocation in this pilot project|Randomised; Interventional; Design type: Treatment, Complex Intervention, Physical, Rehabilitation|t|||
1291477|NCT03707132|||Case-Control||Prospective|||||||
1291478|NCT03707119|||Cohort||Prospective|||||||
1291479|NCT03707106|Randomized|Parallel Assignment||Treatment||Single||||||t
1291480|NCT03707093||Sequential Assignment||Treatment||None (Open Label)||||||
1291481|NCT03707080|||Cohort||Other|||||||
1291482|NCT03707067|Randomized|Crossover Assignment||Treatment||Triple|Randomization carried out and compression garments allocated by a third party. All testing will be completed once athletes have removed their garments, without the knowledge of outcomes assessors or primary investigator|Crossover RCT|t||t|t
1291483|NCT03707054||Single Group Assignment||Basic Science||None (Open Label)||prospective trial||||
1291484|NCT03707041|Randomized|Parallel Assignment||Prevention||Quadruple|Placebo capsules matched to the drug product with regard to appearance and taste|In each of the three treatment cohorts, subjects will be randomly allocated to receive either P218 or placebo.|t|t|t|t
1291485|NCT03707028||Single Group Assignment||Treatment||None (Open Label)||||||
1291486|NCT03707015|||Case-Only||Retrospective|||||||
1291487|NCT03707002|Randomized|Parallel Assignment||Other||Quadruple|Identical sachets containing 5g of scFOS or placebo (maltodextrins)||t|t|t|t
1291488|NCT03706989||Single Group Assignment||Diagnostic||None (Open Label)||Only one group of cardiac patients divided in sub-groups according to their age.||||
1291489|NCT03706976||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1291490|NCT03706963|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1291491|NCT03706950|||Case-Control||Prospective|||||||
1291492|NCT03706937|||Case-Only||Prospective|||||||
1291493|NCT03706924|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1291494|NCT03706911|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1291495|NCT03706898|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1291496|NCT03706885|Randomized|Parallel Assignment||Other||Quadruple|Only the Statistician and Pharmacists are unmasked||t|t|t|t
1291497|NCT03706872|Randomized|Parallel Assignment||Prevention||Single|Care provider will not know the arm of randomization|Randomized controlled trial with 2 arms of intervention||t||
1291498|NCT03706859|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1291499|NCT03706846|Randomized|Parallel Assignment||Other||Single||||||t
1291500|NCT03706833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291501|NCT03706820|||Case-Only||Prospective|||||||
1291502|NCT03706807|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291543|NCT03706274|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1291544|NCT03706261||Single Group Assignment||Basic Science||None (Open Label)||||||
1573291|NCT00001740||||||||||||
1291503|NCT03706794|Randomized|Parallel Assignment||Treatment||Triple|"Participants will be informed that they will receive one of two educational interventions. The care provider is a smarphone application; the only person aware of the condition is the research assistant assigning participants to the smartphone application conditions. The investigator, research coordinator, and all other personnel including outcomes assessors will be unaware of condition."||t||t|t
1291504|NCT03706781|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1291505|NCT03706768||Single Group Assignment||Other||None (Open Label)||Aneurysmal Subarachnoid Hemorrhage||||
1291506|NCT03706755|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1291507|NCT03706742|Randomized|Parallel Assignment||Screening||Double||||t||t
1291508|NCT03706729||Single Group Assignment||Prevention||None (Open Label)||||||
1291509|NCT03706716|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Arm A - intervention /consultation with use of decision aid Arm B - Controls / consultation without use of decision aid||||
1291510|NCT03706703||Single Group Assignment||Treatment||None (Open Label)||||||
1291511|NCT03706690|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor, excluding supply chain management personnel and unblinded monitors of site pharmacies, will remain blinded.||t|t|t|t
1291512|NCT03706677|Randomized|Parallel Assignment||Treatment||Triple|Single-blinded; participants will be blinded to the treatment group. Investigators will be blinded on study specific diagnostics used in the trial; Endpoint Review Committee will be blinded to the treatment group.|Randomization 1:1 between Cryoballoon ablation and Radiofrequency ablation|t||t|t
1291513|NCT03706664|Randomized|Single Group Assignment||Diagnostic||None (Open Label)|Neither the Radiologists nor the Computer scientists/outcomes assessors will be masked to the image labels or if a given MR Enterography has been used in the training or validation dataset.|"Radiologists will label 226 MR Enterography images as normal or abnormal. The labelled images will be randomised between training and validation sets.~The training dataset will be used to develop machine learning algorithm to localise the terminal ileum & classify the terminal ileum as normal or abnormal.~The validation dataset will test the accuracy of the algorithm against the Radiologists labels."||||
1291514|NCT03706651|||Case-Control||Prospective|||||||
1291515|NCT03706638|Randomized|Parallel Assignment||Treatment||None (Open Label)|Treatment groups are blinded and becomes unmasked when assigning the patient to a treatment group. At this time, the patient and the investigator becomes aware of the treatment assigned.|Randomized Noninferiority Trial||||
1291516|NCT03706625|||Cohort||Prospective|||||||
1291517|NCT03706612|||Cohort||Prospective|||||||
1291518|NCT03706599|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1291519|NCT03706586|Randomized|Parallel Assignment||Prevention||Single|outcome assessed will be unaware of group allocation|||||t
1291520|NCT03706573||||||||||||
1291521|NCT03706560|||Cohort||Prospective|||||||
1291522|NCT03706547||Single Group Assignment||Treatment||None (Open Label)||||||
1291523|NCT03706534|Randomized|Sequential Assignment||Diagnostic||Double||"First, the images will be reviewed by the radiologists using Breast Imaging Reporting and Data System scheme without any assistance of an interactive deep learning (or artificial intelligence) program. The same images will be separately processed by the artificial intelligence system by Samsung. The two results, one by the radiologists and the other by artificial intelligence system, will be compared to statistically quantify equivalence (CADe).~Second, the images will be reviewed by the radiologists with the help of artificial intelligence system, which is an interactive tool automatically providing recommendations on Breast Imaging Reporting and Data System descriptor choices that can be modified by the radiologists. The radiologists, after selecting all the descriptors of Breast Imaging Reporting and Data System, will decide the assessment categories. These decisions will be compared with the ground truths generated from the biopsy results or a 24-month follow-up (CADx)."|t||t|
1291524|NCT03706521||Single Group Assignment||Treatment||None (Open Label)||||||
1291525|NCT03706508|||Case-Only||Prospective|||||||
1291526|NCT03706495|Randomized|Parallel Assignment||Treatment||Double|Participants involved in the study and the physiotherapist doing the assessment do not know which exercise group they will be involved in.|Randomized double-blind|t||t|
1291527|NCT03706482|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291528|NCT03706469|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1291529|NCT03706456||Single Group Assignment||Treatment||None (Open Label)||||||
1291530|NCT03706443|Randomized|Crossover Assignment||Treatment||Single|Investigator instills known eye drop; masked to participant|Single masked; randomized|t|||
1291531|NCT03706430||||||||||||
1291532|NCT03706417|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1291533|NCT03706404|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1291534|NCT03706391|||Case-Control||Cross-Sectional|||||||
1291535|NCT03706378|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1291536|NCT03706365|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291537|NCT03706352|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1291538|NCT03706339|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which will be used.|patients were allocated to one of three groups after induction of general anesthesia and immediately prior to the operation and just before skin incision. they received 1-gram tranexamic acid (10 ml) in 100 ml saline infusion or placebo (110 normal saline) by slow intravenous injection at an approximate rate of 1 mL per min. Throughout the operation irrigation was done by 60 ml of (2g tranexamic acid (10 ml) diluted in 100 ml of sodium chloride 0.9%) or placebo ( 60 ml of sodium chloride 0.9%.).At the end of operation another dose of 60 ml of (1g tranexamic acid (10 ml) diluted in 50 ml of sodium chloride 0.9%) or placebo ( 60 ml of sodium chloride 0.9%.) was left intraabdominal|t|t|t|t
1291539|NCT03706326|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291540|NCT03706313|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1291541|NCT03706300|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1291542|NCT03706287||Single Group Assignment||Treatment||None (Open Label)||||||
1291545|NCT03706248|||Case-Control||Prospective|||||||
1291546|NCT03706235|||Case-Control||Prospective|||||||
1291547|NCT03706222|||Case-Only||Retrospective|||||||
1291548|NCT03706209|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind|Three-arm randomized, double-blind, placebo-controlled, parallel group phase II multi-center trial|t|t|t|t
1291549|NCT03706196|||Cohort||Prospective|||||||
1291550|NCT03706183|||Case-Control||Prospective|||||||
1291551|NCT03706170|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1291552|NCT03706157|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1291553|NCT03706144|Randomized|Parallel Assignment||Basic Science||Single|"The primary outcomes are standardized, computerized assessments.~Please note that the primary outcome is on the individual student level, while the randomization and participant number below is per teacher.~Each teacher participates with 1-4 classes of on average 25 students"|"This is a randomized trial with two arms. Teachers (and their respective classes of students) have been randomized into one of two groups:~Participating in the adaptive, online Prodigy Math Training~treatment as usual (TAU) - classic math instruction in school"||||t
1291554|NCT03706131|Randomized|Parallel Assignment||Health Services Research||Single|Spasticity evaluations will be done by blind investigator.|||||t
1291555|NCT03706118||Single Group Assignment||Basic Science||None (Open Label)||Prospective, longitudinal, monocentric, interventional study||||
1291556|NCT03706105||Single Group Assignment||Treatment||None (Open Label)||||||
1291557|NCT03706092|||Cohort||Prospective|||||||
1291558|NCT03706079|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind|"Subjects previously randomized in one of the predecessor studies to tezepelumab will be assigned and remain on tezepelumab dosing in the Destination Study.~Subjects randomized to placebo arm in the predecessor studies will be re-randomized in a 1:1 ratio to either tezepelumab or placebo.~Given the randomization scheme of subjects in the predecessor studies, this will give an overall subject distribution of 3:1 (tezepelumab:placebo), assuming a similar number of subjects rollover from each arm in the predecessor studies."|t|t|t|
1291559|NCT03706066|||Case-Only||Prospective|||||||
1291560|NCT03706053|Randomized|Parallel Assignment||Treatment||Triple|Patients will be randomized to intervention or placebo by the investigational pharmacy. Care providers, investigators and participants will be blinded to study arm.||t|t|t|
1291561|NCT03706040|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291562|NCT03706027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291563|NCT03706014|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Controlled Trial involving a contact-equivalent control group||||
1291564|NCT03706001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291565|NCT03705988|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291566|NCT03705975|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1291567|NCT03705962|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291568|NCT03705949|Randomized|Parallel Assignment||Prevention||Single||||||t
1291569|NCT03705936|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1291570|NCT03705923||Single Group Assignment||Basic Science||None (Open Label)||||||
1291571|NCT03705910|Randomized|Parallel Assignment||Treatment||Single|Outcome measures will be performed by an experienced physiotherapist who will be blinded to the group allocation.|||||t
1291572|NCT03705897||Single Group Assignment||Health Services Research||None (Open Label)||||||
1291573|NCT03705884|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Patients and healthy subjects will be allocated in a non-randomised fashion to either corticosteroid or control arms, for parallel comparison within the two groups. The corticosteroid is recognised treatment for the condition and is being used to observe the impact on diagnostic imaging; no treatment effects are being studied or are endpoints of the study (i.e. the study is not a clinical trial of treatment in cardiac sarcoidosis with corticosteroid).||||
1291574|NCT03705871|Randomized|Parallel Assignment||Treatment||Single||||||t
1291575|NCT03705858||Single Group Assignment||Treatment||None (Open Label)||||||
1291576|NCT03705845|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1291577|NCT03705832|Randomized|Parallel Assignment||Treatment||Quadruple||Double blind placebo controlled|t|t|t|t
1291578|NCT03705819|Non-Randomized|Parallel Assignment||Other||None (Open Label)|Open Label Study|||||
1291579|NCT03705806|||Case-Only||Prospective|||||||
1291580|NCT03705793|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291581|NCT03705780|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1291582|NCT03705767|||Cohort||Prospective|||||||
1291583|NCT03705754|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Tattoo arm vs. control arm||||
1291584|NCT03705741|Randomized|Parallel Assignment||Prevention||Single|Opaque sealed envelopes, which are randomly picked out before the meeting with each participant|||||t
1291585|NCT03705728|Randomized|Parallel Assignment||Treatment||Double||prospective randomized|t|t||
1291586|NCT03705715|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1291587|NCT03705702|Randomized|Parallel Assignment||Treatment||Double|All the measurements will be performed by a blinded professional, who will be masked from randomization and other results. For each test, the same investigator will be maintained before and after the intervention. The participants will know what treatment they will receive, but they don't will know what intervention belongs to the control group.||t|||t
1291588|NCT03705689|||Case-Control||Prospective|||||||
1291625|NCT03705208|Randomized|Parallel Assignment||Prevention||Single|The technical advisory group constituted for this study will be presented masked results, wherein the results will be presented without identifying the study arm.|||||t
1291626|NCT03705195|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Proof-of-Concept Physiological Study||||
1291627|NCT03705182|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The 450 participants will be allocated to an intervention- or a control group, around 225 in each. The intervention group will be shown the fluorescent areas on their skin, while the control group will not have this opportunity. Work teams of approximately 40 workers with comparable work procedures, are allocated together.||||
1291628|NCT03705169|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291589|NCT03705676|Randomized|Crossover Assignment||Basic Science||Single|"Participants are aware that electrocutaneous stimulation might occur during the fear condition and never during the control condition. This is of paramount importance, as the expectancy of a painful stimulus is the main difference between both conditions.~The researcher that will perform the EMG-analysis, i.e. onset determination of the various muscles that were measured, will be blinded for participant, condition and muscle during that process. EEG-data does not have to be blinded as data processing is computer based and not subjectable to subjective bias of a researcher."|Each participant will perform both experimental conditions spread out over 2 test days in a randomized order. Between 2 test days a minimum of 5 days has to be present in order to ensure full recuperation from test day 1. Half of the participants will receive the control condition on test day 1 and the fear condition on day 2, the other half vice versa.||||t
1291590|NCT03705663|||Cohort||Prospective|||||||
1291591|NCT03705650||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291592|NCT03705637||Single Group Assignment||Other||None (Open Label)||||||
1291593|NCT03705624|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Cluster randomized trial||||
1291594|NCT03705611|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||1:1:1 randomization of primary health clinics (cluster randomized trial)||||
1291595|NCT03705598|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1291596|NCT03705585|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Volunteers who choose to take part in this study will receive the licensed FDA approved Oral Typhoid Vaccine (Vivotif) and/or the licensed FDA approved Oral Cholera Vaccine (Vaxchora). Volunteers also have the possibility of being a control participant who will not be vaccinated.||||
1291597|NCT03705572|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1291598|NCT03705559|Randomized|Sequential Assignment||Basic Science||Double|This is a randomized, double-blind, double-dummy, placebo-controlled design||t||t|
1291599|NCT03705546|||Cohort||Prospective|||||||
1291600|NCT03705533|Randomized|Crossover Assignment||Other||Single|*The randomization code will not be available to the personnel of the bioanalytical facility until the bioanalytical tables have been finalized and audited by the Quality Assurance (QA) department. Study participants will be aware they will receive different formulations of the same drug, without being informed which product (Test or Reference) is being administered.|In compliance with full replicate design there are two sequences in the study: ABAB and BABA where A = the test product, B = the reference product (see detailed description of items below).||||t
1291601|NCT03705520|||Case-Control||Cross-Sectional|||||||
1291602|NCT03705507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Group P will enrol all patients under 18 years of age and Group A will enrol all patients who are 18 years or older.||||
1291603|NCT03705494|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291604|NCT03705481||Sequential Assignment||Device Feasibility||None (Open Label)||Prospective, single-arm, single center, non-randomized feasibility study||||
1291605|NCT03705468|||Case-Only||Retrospective|||||||
1291606|NCT03705455|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291607|NCT03705442|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1291608|NCT03705429|Randomized|Parallel Assignment||Other||Single|||t|||
1291609|NCT03705416|||Cohort||Prospective|||||||
1291610|NCT03705403|Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a multicentre, randomised controlled open-label phase II trial testing if the combination of (SAB)R and immunocytokine L19-IL2 improves the progression-free survival in patients with limited metastatic non-small cell lung cancer (NSCLC). The patients included in the trial will be stratified for the metastatic load (oligo; max 3 or diffuse; 4-10 metastases). After randomisation, patients will be assigned either to the experimental arm or the standard of care (SOC) arm. Depending on the metastatic load, patients with (max 3 metastases) will receive in the experimental arm SABR to all lesions followed by L19-IL2 followed by standard of care therapy. Patients with more extensive metastatic disease (4 to up to 10 metastasis) in the experimental arm will be included following first or second line treatment with a platinum doublet and receive radiotherapy (3x8 Gy) to at least one (symptomatic) lesion, followed by L19-IL2 followed by SOC.||||
1291611|NCT03705390||Single Group Assignment||Treatment||None (Open Label)||||||
1291612|NCT03705377|||Other||Cross-Sectional|||||||
1291613|NCT03705364|Randomized|Parallel Assignment||Prevention||Single|||||t|
1291614|NCT03705351||Sequential Assignment||Treatment||None (Open Label)||The study is an open-label pilot study. Following surgery, eligible patients will start tumor treating fields therapy with the Optune device less than 2 weeks prior to radiation and temozolomide given at a dose and schedule conforming to routine treatment.||||
1291615|NCT03705338|||Case-Control||Prospective|||||||
1291616|NCT03705325||Single Group Assignment||Other||None (Open Label)||This is a prospective single arm study of 12-21 year olds with persistent asthma. Participants will be given the VitalFlo spirometer for home use and an iPhone 5S (without SIM card) loaded with the VitalFlo app. Participants will be asked to use the VitalFlo spirometer at least twice daily (in the morning between 6am and 10am and in the evening between 6am and 10pm) and whenever rescue medication (albuterol) is administered or the participant feels symptoms of asthma (such as cough, wheezing, or shortness of breath) in order to document lung function. After performing the spirometry maneuver, the user will be prompted to answer questions about their asthma symptoms. Changes in lung function will be matched to subject-reported asthma symptoms and/or albuterol use.||||
1291617|NCT03705312|Randomized|Parallel Assignment||Treatment||Single||Patients will be randomized 1:1 to medical treatment or intervention with the MitraClip device||||t
1291618|NCT03705299||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291619|NCT03705286|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1291620|NCT03705273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291621|NCT03705260|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1291622|NCT03705247|||Cohort||Prospective|||||||
1291623|NCT03705234|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1291624|NCT03705221|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291629|NCT03705156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573292|NCT00001738||||||||||||
1291630|NCT03705143|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291631|NCT03705130|||Case-Only||Prospective|||||||
1291632|NCT03705117||Single Group Assignment||Basic Science||None (Open Label)||||||
1291633|NCT03705104|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291634|NCT03705091|||Cohort||Prospective|||||||
1291635|NCT03705078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291636|NCT03705065|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1291637|NCT03705052||Single Group Assignment||Health Services Research||None (Open Label)||||||
1291638|NCT03705039|Randomized|Parallel Assignment||Treatment||Triple||randomized controlled study|t||t|t
1291639|NCT03705026|||Cohort||Prospective|||||||
1291640|NCT03705013|||Cohort||Retrospective|||||||
1291641|NCT03705000|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291642|NCT03704987|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||To compare bone mineral density of klinefelter patients and normal population||||
1291643|NCT03704974|||Cohort||Retrospective|||||||
1291644|NCT03704961|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1291645|NCT03704948|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291646|NCT03704935|||Cohort||Prospective|||||||
1291647|NCT03704922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291648|NCT03704909|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1291649|NCT03704896|||Cohort||Prospective|||||||
1291650|NCT03704883|||Case-Only||Prospective|||||||
1291651|NCT03704870|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1291652|NCT03704857|Randomized|Sequential Assignment||Treatment||Double|||t|||t
1291653|NCT03704844|||Cohort||Prospective|||||||
1291654|NCT03704831|||Other||Retrospective|||||||
1291655|NCT03704818|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1291656|NCT03704805|Randomized|Parallel Assignment||Treatment||None (Open Label)||Cluster-randomized, controlled, two-arm multicenter, superiority trial||||
1291657|NCT03704792|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1291658|NCT03704779|Randomized|Parallel Assignment||Treatment||Single|Data collectors will be masked to participant group assignment.|"Intervention will be implemented over 8 consecutive weeks and will consist of experiential mindfulness activities that can be accessed in-person and online. In-person mindfulness activities will be available twice per week and last approximately 40 minutes in length. Mindfulness meditation videos posted online will be available 24/7 and last 10-45 minutes. Students will be asked to participate in one 40-minute in-person and four 10-minute online mindfulness activities per week (total of 1 hour and 20 minutes per week).~Week 1. Progressive muscle relaxation, mindfulness meditation, guided imagery.~Week 2. Mindfulness: Zen garden, painting, craftwork.~Week 3. Active Meditation: yoga, Tai Chi.~Week 4. Aromatherapy.~Week 5. Addiction Information and Management Strategies.~Week 6. Positive Psychology Strategies: cognitive reframing techniques.~Week 7. Self-Compassion Strategies: walking meditation, nutritious snacks, self-massage.~Week 8. Pet Therapy."||||t
1291659|NCT03704766|Non-Randomized|Parallel Assignment||Diagnostic||Double|For patients with inflamed joints, the medical team will be blind to the results of the alpha-defensin assay and other experimental tests for a period of 2 weeks, after which results may be divulged to the clinical team at their request. As such, the results will not influence the physician/surgeons' decision for acute treatment of the patient, as the decision to treat suspected septic arthritis is typically made within 24 hours, and the final diagnosis is made within 2 weeks (pending culture results). As the testing of the leukocyte esterase strips will occur in the operating room, the surgeon will not be blinded to these results. A blinded team member will read the pictures of all of the leukocyte test strip results at once, after they have all been collected. The patient will be made aware of results at the physician/surgeon's discretion. For normative controls, the results of experimental testing will not be divulged to the clinical team or to the patient.|Participants are assigned as either cases of infection/inflammation, or normative controls, and receive the same diagnostic testing for the duration of the study.|t|t||
1291660|NCT03704753|Randomized|Parallel Assignment||Treatment||Quadruple||Randomised and double blinded.|t|t|t|t
1291661|NCT03704740|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1291662|NCT03704727||Single Group Assignment||Treatment||None (Open Label)||||||
1291663|NCT03704714||Single Group Assignment||Treatment||None (Open Label)||||||
1291664|NCT03704701|||Cohort||Prospective|||||||
1291665|NCT03704688|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291666|NCT03704675|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1291667|NCT03704662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291668|NCT03704649|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291669|NCT03704636||||||||||||
1291670|NCT03704623|Randomized|Parallel Assignment||Treatment||Double|The emergency department (ED) nurse will do randomization by drawing one of the sealed closed envelopes that contain the analgesic to be administered.|Eligible patients will be randomized to one of the two treatment groups.|t||t|
1291671|NCT03704610|Randomized|Parallel Assignment||Treatment||Single|"Only the two first infusions will be blinded. Treatment will be prepared by local pharmacies. The pharmacist will receive a fax with the treatment to prepare (infliximab or placebo). The placebo will be an injectable solution of 0.9% sodium chloride equivalent to the one used for infliximab reconstitution. Both treatments will be presented in an infusion bag. After reconstitution and dilution, infliximab solution is clear and limpid, similar to 0.9% sodium chloride solution.~At week 6, after evaluation of ePOST score, unblinding process will be done. All the patients will receive infliximab treatment."||||t|
1291672|NCT03704597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291673|NCT03704584|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, unblinded controlled clinical trial||||
1291674|NCT03704571|Randomized|Parallel Assignment||Other||Double|||||t|t
1291675|NCT03704558|||Case-Only||Retrospective|||||||
1291676|NCT03704545|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1291677|NCT03704532|||Cohort||Prospective|||||||
1291678|NCT03704519|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1291679|NCT03704506|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291680|NCT03704493|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The intervention consists of a video shown to the patient while exercising on the treadmill. It shows 5 amateur runners running across woods and fields. The group is film form behind giving the patient the impression of running within the group.||||
1291681|NCT03704480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291682|NCT03704467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291683|NCT03704454|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1291684|NCT03704441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291685|NCT03704428|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1291686|NCT03704415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291687|NCT03704402|||Cohort||Prospective|||||||
1291688|NCT03704389||Single Group Assignment||Health Services Research||None (Open Label)||||||
1291689|NCT03704376|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291690|NCT03704363|Randomized|Parallel Assignment||Treatment||Quadruple|A computer-generated randomised allocation sequence will be imported into an electronic case report form (eCRF) system (Viedoc) and made available exclusively to a study nurse (mixing nurse) authorised by the local principal investigator to prepare infusions. The mixing nurse is otherwise not involved in the treatment of the patient. The infusion bags containing the study medication will be prepared by the mixing nurse in identical infusion bags, and applied labels with patient number and dose such that blinding of the participants is secured. The Investigational Medicinal Products (IMPs) have the same color and will look the same. After preparing the IMP, the mixing nurse will hand over the IMP to another nurse, blinded to allocation, and authorised by the local principal investigator to administer the infusion.||t|t|t|t
1291691|NCT03704350|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291692|NCT03704337|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||A randomized, cross-over administration of supplements with approximately 7-10 days between testing sessions.||||
1291693|NCT03704324|||Cohort||Prospective|||||||
1291694|NCT03704311||Single Group Assignment||Basic Science||None (Open Label)|Assessor doing high Resolution respirometry was blinded with respect to diagnosis, location of biopsy and all Patient related data|||||
1291695|NCT03704298||Single Group Assignment||Treatment||None (Open Label)||||||
1291696|NCT03704285|||Case-Control||Prospective|||||||
1291697|NCT03704272|Randomized|Parallel Assignment||Treatment||None (Open Label)||Control group (Treatment as usual) vs. Treatment group (screening, brief intervention and referral to treatment)||||
1291698|NCT03704259|||Case-Only||Prospective|||||||
1291699|NCT03704246||Single Group Assignment||Treatment||None (Open Label)||||||
1291700|NCT03704233|||Case-Only||Prospective|||||||
1291701|NCT03704220||Single Group Assignment||Treatment||None (Open Label)||||||
1291702|NCT03704207||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291703|NCT03704194|Randomized|Parallel Assignment||Prevention||Single||randomized controlled feasibility trial||||t
1291704|NCT03704181|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291705|NCT03704168||Single Group Assignment||Treatment||None (Open Label)||||||
1291706|NCT03704155|Randomized|Parallel Assignment||Treatment||Double|Evaluator 1: triage, random draw of treatments to be performed; Evaluator 2: BoNT-A application; Evaluator 3: assessment data collection; Evaluator 4: physical therapy treatment. Evaluator 3 was blinded in relation to the groups.|A randomized controlled clinical trial|t|||t
1291707|NCT03704142|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Each participant will be tested with one of the models of devices.||||
1291708|NCT03704129|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1291709|NCT03704116|Randomized|Parallel Assignment||Treatment||Double|Double-blinded|Two groups run in parallel (active and control)|t|||t
1291710|NCT03704103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291711|NCT03704090|Randomized|Parallel Assignment||Prevention||Double|Patients were randomized in 16 blocks of 10 patients and only one investigator has the randomized information. This researcher will not have any role in the recruitment, intervention, and diagnosis of postoperative delirium. Also, the analysis of data will be performed by researchers who will be masked to the randomization information.|"Elderly patients who will undergo major surgery will be randomized to 2 prevention groups of postoperative delirium:~Control: standard non-pharmacological prevention measures for 5 days after surgery.~Intervention: occupational therapist plus standard non-pharmacological prevention measures for 5 days after surgery."||t|t|
1291712|NCT03704077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291713|NCT03704064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291714|NCT03704051||Single Group Assignment||Basic Science||None (Open Label)|The video coders will be masked during video analysis.|Every mother will come into the lab two times (separated by one day) and will breastfeed their baby during one visit and bottle-feed their baby during the other visit. The order of these conditions will be randomly assigned and counterbalanced.||||
1291715|NCT03704038|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291716|NCT03704025|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291717|NCT03704012|Non-Randomized|Factorial Assignment||Treatment||Single||The control group included all preterm infants from months 1-6 and 19-24 of the study. The intervention group included all the premature newborns from the 7-18 months of the study.|||t|
1291718|NCT03703999|||Case-Only||Prospective|||||||
1291719|NCT03703986|||Case-Control||Retrospective|||||||
1291720|NCT03703973|||Case-Control||Prospective|||||||
1291721|NCT03703960|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291722|NCT03703947|||Cohort||Prospective|||||||
1291723|NCT03703934|||Case-Control||Cross-Sectional|||||||
1291724|NCT03703921|||Case-Only||Prospective|||||||
1291725|NCT03703908||Sequential Assignment||Treatment||None (Open Label)||Open-Label, Intra-Subject, Dose Escalation||||
1291726|NCT03703895|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1291727|NCT03703882|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291728|NCT03703869|||Cohort||Prospective|||||||
1291729|NCT03703856|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1291730|NCT03703843||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1291731|NCT03703830|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1291732|NCT03703817|||Other||Cross-Sectional|||||||
1291733|NCT03703804|||Cohort||Prospective|||||||
1291734|NCT03703791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291735|NCT03703778|||Case-Crossover||Prospective|||||||
1291736|NCT03703765||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291737|NCT03703752|||Case-Only||Retrospective|||||||
1291738|NCT03703739|Randomized|Crossover Assignment||Prevention||Single|||t|||
1291739|NCT03703726|Randomized|Crossover Assignment||Prevention||Single|||t|||
1291740|NCT03703713|||Cohort||Prospective|||||||
1291741|NCT03703700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291742|NCT03703687||Single Group Assignment||Treatment||None (Open Label)||This clinical trial has a single arm: all the dyads will go through all the steps (apart from the qualitative assessment which are facultatives).||||
1291743|NCT03703674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291744|NCT03703661|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective randomized controlled trial||||
1291745|NCT03703648|||Cohort||Prospective|||||||
1291746|NCT03703635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291747|NCT03703622|Randomized|Parallel Assignment||Health Services Research||Quadruple|Cluster randomization was done by an independent statistician from the University of Bergen who is not part of the study. The health workers from randomised facilities were randomly assigned to two groups of 24 participants, each to be trained for two days. The participants and the assessors did not know the intervention groups which they belonged to until the day of training. During follow-up the assessors and the PI will not know which intervention arms the participants are in.|The AAP HBB curriculum will be used to train participants. Lectures will be delivered by the PI (Master Trainers), followed by demonstration of HBB skills using NeoNatali Mannequin. The participants will then be divided into two groups. One group for practical sessions with master trainers and the other group video-debriefing. The video-debriefing group will have their practical sessions filmed and then the film used for debriefing feedback. First the experiences of the team performing resuscitation will be obtained then positive feedback and learning points from other learners will be given in a respectful safe environment. All participants will be encouraged to contribute in the discussion. Pre- and Post-Test knowledge and skills will be assessed will be done using MCQs, and bag mask ventilation, OSCE A and B checklists from 2nd edition AAP HBB training manual.|t|t|t|t
1291748|NCT03703609|Randomized|Parallel Assignment||Supportive Care||Triple|Analyst blinded|The study is a single-blind parallel two-arm randomized controlled study with 1:1 distribution to intervention and control group. In total 150 persons with long-term conditions will be recruited from three hospitals and randomized to an intervention of medical yoga at home (tele-yoga) using a live videoconference link and a yoga-app on the participants tablet for 12 weeks or a control group receiving individual advice of physical activity. Data will be collected at baseline measurement, after 3 and 6 months.||t|t|t
1291749|NCT03703596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291750|NCT03703583|||Cohort||Cross-Sectional|||||||
1291751|NCT03703570|Randomized|Parallel Assignment||Treatment||Double||An interventional, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial|t||t|
1291752|NCT03703557|Non-Randomized|Sequential Assignment||Diagnostic||Triple||Interventional, prospective, open, monocentric study with risks and minimal constraints|t||t|t
1291753|NCT03703544|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1291754|NCT03703531|||Ecologic or Community||Retrospective|||||||
1291755|NCT03703518|Randomized|Crossover Assignment||Treatment||Single||cross-over pilot study||||t
1291756|NCT03703505||Single Group Assignment||Basic Science||None (Open Label)||||||
1291757|NCT03703492||Single Group Assignment||Diagnostic||None (Open Label)||This is a prospective, one-arm, observational study which will enroll patients with biopsy-proven DCIS scheduled for diagnostic breast MRI for preoperative staging/extent of disease evaluation as part of standard of care.||||
1291758|NCT03703479|Randomized|Parallel Assignment||Treatment||Quadruple||spilt mouth design|t|t|t|t
1291759|NCT03703466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291760|NCT03703453||Single Group Assignment||Treatment||None (Open Label)||Medical cardiac arrest patients||||
1291761|NCT03703440|Randomized|Parallel Assignment||Supportive Care||Single|Data analysts|"Active arm: Patients randomized to the active arm will be asked to attend ≥ 3 group education sessions, in addition to their usual diabetes clinic visits every 3 months, over the 12-month intervention period. Group education sessions will coincide with regularly scheduled clinic visits.~Control arm: Patients randomized to usual care will attend their usual 3-month interval diabetes clinic visits, over the 12-month intervention period, which consists of visits with their diabetes care physician."||||t
1291762|NCT03703427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291763|NCT03703414|||Cohort||Prospective|||||||
1291764|NCT03703401|||Cohort||Prospective|||||||
1291765|NCT03703388|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1291766|NCT03703375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291767|NCT03703362||Single Group Assignment||Treatment||None (Open Label)||Feasibility study||||
1291768|NCT03703349|Randomized|Parallel Assignment||Prevention||Quadruple|treatment concealment will be managed by the central pharmacy of the hospital, which will dispense treatment according to the randomization plan.|Patients will be assigned to the 2 groups of treatment by blocks of 8. The randomization list will be computer-generated, with no factors for stratification. To reduce predictability of the random sequence, blocking will be made unavailable to those who assign interventions.|t|t|t|t
1291948|NCT03701009||Single Group Assignment||Treatment||None (Open Label)||||||
1291949|NCT03700996|||Cohort||Prospective|||||||
1291769|NCT03703336|Randomized|Parallel Assignment||Prevention||Triple||Eligible infants will be randomized to receive either ROTAVIN or ROTAVIN-M1 vaccines in the ratio of 2:1. Two doses of vaccine will be administered 8 weeks apart, with the first administration given at 2-3 months (60-91 days) of age. All childhood vaccines as per the Expanded Program for Immunization of the Government of Vietnam will be allowed as per the immunization schedule.|t||t|t
1291770|NCT03703323||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291771|NCT03703310|Randomized|Parallel Assignment||Treatment||Quadruple|As a double-blinded study, the Investigators, the site staff, Sponsor, and the Clinical Monitor(s) will be blinded to the treatment assigned to individual participants.|Partcipants will be randomized 1:1 to receive Patidegib Topical Gel, 2%, or Vehicle (IP)|t|t|t|t
1291772|NCT03703297|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291773|NCT03703284|||Case-Control||Prospective|||||||
1291774|NCT03703271|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1291775|NCT03703258|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291776|NCT03703245|||Other||Retrospective|||||||
1291777|NCT03703232||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1291778|NCT03703219|||Cohort||Prospective|||||||
1291779|NCT03703206|Randomized|Parallel Assignment||Treatment||Triple||This is a prospective, randomized, blinded study with a parallel design and an allocation ratio of 1 to 1 for the treatment groups|t|t||t
1291780|NCT03703193|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1291781|NCT03703180|||Cohort||Prospective|||||||
1291782|NCT03703167||Single Group Assignment||Treatment||None (Open Label)||This is an open-label, phase Ib trial with dose expansion of the BTK inhibitor ibrutinib in combination with rituximab and lenalidomide.||||
1291783|NCT03703154|||Cohort||Prospective|||||||
1291784|NCT03703141|Randomized|Factorial Assignment||Screening||Double|||t|t||
1291785|NCT03703128|||Case-Control||Retrospective|||||||
1291786|NCT03703115|Randomized|Parallel Assignment||Treatment||Single||||||t
1291787|NCT03703102|Randomized|Parallel Assignment||Treatment||Quadruple||subcutaneous administration|t|t|t|t
1291788|NCT03703089||Single Group Assignment||Treatment||None (Open Label)||||||
1291789|NCT03703076|||Cohort||Other|||||||
1291790|NCT03703063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Resectable patients And Borderline resectable patients||||
1291791|NCT03703050|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Prospective, non-randomized, single arm phase II trial with 2 cohorts of ALK+ ALCL treated with nivolumab, according to patient status after previous treatment (patients in progression, into the Cohort 1; patients in CR, into the Cohort 2)||||
1291792|NCT03703037|||Other||Prospective|||||||
1291793|NCT03703024|Randomized|Parallel Assignment||Health Services Research||Double|Double blind model|A double-blind, randomized, placebo-controlled clinical study.|t||t|
1291794|NCT03703011||Single Group Assignment||Other||None (Open Label)||||||
1291795|NCT03702998|||Cohort||Retrospective|||||||
1291796|NCT03702985|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291797|NCT03702972|||Cohort||Prospective|||||||
1291798|NCT03702959|||Cohort||Other|||||||
1291799|NCT03702946|Randomized|Parallel Assignment||Prevention||Single|||t|||
1291800|NCT03702933|||Case-Control||Prospective|||||||
1291801|NCT03702920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291802|NCT03702907|||Cohort||Prospective|||||||
1291803|NCT03702894|Randomized|Crossover Assignment||Other||Single|The subjects and the investigator will not be blinded towards the identity of the study products. However, analysts will be blinded towards identity of the study products administered.|||||t
1291804|NCT03702881|Randomized|Parallel Assignment||Treatment||Single||||||t
1291805|NCT03702868|||Cohort||Prospective|||||||
1291806|NCT03702855|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1291807|NCT03702842|Randomized|Parallel Assignment||Treatment||Single|Participants will be randomized to receive either 16 sessions of locomotor training with lower or higher dosage tsDCS, but will be unaware of the stimulation dosage level.||t|||
1291808|NCT03702829||Single Group Assignment||Treatment||None (Open Label)||||||
1291809|NCT03702816|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|No masking|All participants will receive two Flutriciclamide (18F-GE180) PET scans. One will be done at baseline (Y1) and one will be done approximately 12 months later (Y2).||||
1291810|NCT03702803|Randomized|Parallel Assignment||Treatment||Quadruple|Both treatments have an identical appearance and are packed in hard gelatin capsules, which are packed in individual aluminum and PVC blisters with 10 doses each. Three blisters with ten doses are introduced in cardboard boxes and identified through a folio number.|Participants will be randomly assigned to one of the two groups: the experimental group receiving a phytopharmaceutical elaborated with the standardized extract from G. glauca, and a control group receiving an identical formulation containing Alprazolam|t|t|t|t
1291811|NCT03702790|||Cohort||Prospective|||||||
1291812|NCT03702777|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291813|NCT03702764|||Cohort||Prospective|||||||
1291814|NCT03702751|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1291815|NCT03702738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291816|NCT03702725|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291817|NCT03702712|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1291818|NCT03702699|||Other||Prospective|||||||
1291819|NCT03702686||Single Group Assignment||Basic Science||None (Open Label)||||||
1291820|NCT03702673|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1291821|NCT03702660|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1291950|NCT03700983||Single Group Assignment||Supportive Care||None (Open Label)||"Head and neck cancer survivors - patients who had been diagnosed with cancer of lip, oral cavity, oropharynx and nasopharynx, received treatment and the oncologists had defined them as complete remission, and having normal physical exam and blood biochemistry"||||
1573293|NCT00001736||||Treatment||||||||
1291822|NCT03702647|Randomized|Parallel Assignment||Other||Quadruple|Patients will be randomized by an independent research pharmacist to receive either 30mL 0.2% ropivacaine or 30mL of placebo (saline), both being clear, colorless solutions. These samples will be prepared by the research pharmacist 2-3 weeks prior to the procedure and stored until the procedure date as per pharmacy standards. On the morning of the procedure, the study solution will be taken to the operating room with the patient. During the POEM procedure, prior to closure of the mucosotomy, the study solution is instilled into the tunnel. The investigator, patient, care provider, and research coordinator will be blinded to the group assignment.|Patients enrolled in the study will be randomized to receive either 30mL of normal saline (placebo), or 30mL of 0.2% ropivacaine in the POEM tunnel.|t|t|t|t
1291823|NCT03702634|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Arm 1- Control group Arm 2- Intervention group||||
1291824|NCT03702621|Randomized|Parallel Assignment||Treatment||Double|Both the patients and the research staff doing assessments will be blinded to the randomization.|"LB group (Liposomal Bupivacaine)~SB group (Standard Bupivacaine)"|t||t|
1291825|NCT03702608|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1291826|NCT03702595||Single Group Assignment||Treatment||None (Open Label)||||||
1291827|NCT03702582|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statisticians performing comparative analyses of primary outcomes will be blinded as to the allocation designations of patients. Otherwise there will be no masking in the study.|Cardiac surgery patients who meet study criteria and develop recurrent or persistent atrial fibrillation post-operatively will be randomized 1:1 to receive Warfarin or Rivaroxaban for prophylaxis against stroke or other systemic arterial embolism||||
1291828|NCT03702569|||Case-Only||Prospective|||||||
1291829|NCT03702556|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1291830|NCT03702543||Single Group Assignment||Prevention||None (Open Label)||In this feasibility study, a customized electronic diary will be provided to collect data 1) from bluetooth devices, 2) from Apple Health app information, and 3) from self-reported diary information. Researchers will provide feedback via charts and reminders/text messages to encourage management of vascular risk factors.||||
1291831|NCT03702530|Randomized|Parallel Assignment||Other||Triple|Participant, clinical trial physicians and laboratory personnel are blinded for treatment allocation. Blinding is maintained by exposing the volunteers in the placebo group to a mock infection with water. During the trial clinical trial physicians are blinded to the outcome measures (i.e. Kato-Katz outcomes), laboratory staff are blinded for the study code of samples delivered.|Volunteers are randomized into either the intervention or the placebo group (2:1 allocation). The two groups run parallel in the trial. At the moments of immunization in the intervention group volunteers in the placebo group receive a mock infection with water to maintain blinding.|t||t|t
1291832|NCT03702517|Randomized|Parallel Assignment||Treatment||Single|||||t|
1291833|NCT03702504|||Cohort||Prospective|||||||
1291834|NCT03702491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291835|NCT03702478|||Other||Cross-Sectional|||||||
1291836|NCT03702465|Randomized|Parallel Assignment||Prevention||None (Open Label)||Parallel assignment with an active control||||
1291837|NCT03702452|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1291838|NCT03702439|||Other||Cross-Sectional|||||||
1291839|NCT03702426|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1291840|NCT03702413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291841|NCT03702400|Randomized|Parallel Assignment||Treatment||Triple||In a randomized, double-blinded study, 76 healthy patients having cesarean delivery under spinal anesthesia will be randomized, using an electronic system (the Randomizer App®, Version 3.2 Wisse Keizer program), to have systolic blood pressure maintained with bolus of phenylephrine at a dose of 100 mcg bolus (at a dilution containing 20 mcg / mL), or with norepinephrine at a dose of 5 mcg (at a dilution containing 1 mcg / mL).|t|t|t|
1291842|NCT03702387|Randomized|Parallel Assignment||Treatment||Single|Patients will be informed that if they participate in the study, there is a chance they might not receive the modified treatment (and instead receive standard treatment) if they are randomized into the control group. Patients will not be told if they are having the modified IVRA procedure to avoid bias.|Male and female patients aged 18-100 who need short upper extremity or hand surgery (cases lasting less than 45 minutes) in the outpatient setting will be considered for the study. Exclusion criteria: patients requesting to withdraw from the study and patients with a history of drug abuse or illicitly used controlled drugs or substances within the last year. The study population will be divided into two groups: one group receiving the standard IVRA procedure and one group receiving the modified IVRA procedure (which simply includes the reapplication of the Esmarch bandage after the local anesthetic is administered intravenously). Due to limited information from other intravenous regional anesthesia studies, at least 40 subjects in each group will be needed (at least 80 patients total). Any patient who would like to participate will be included regardless of comorbidities. Any patient who refuses participation will be excluded, and patients may withdraw from the study at any time.|t|||
1291843|NCT03702374|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1291844|NCT03702361||Single Group Assignment||Treatment||None (Open Label)||A single-center, open-label trial to assess the safety and efficacy of rapid administration of velaglucerase alfa (VPRIV) to treatment-naive patients with type I Gaucher disease.||||
1291845|NCT03702348|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1291846|NCT03702335|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1291847|NCT03702322||Single Group Assignment||Treatment||None (Open Label)|Participants in the perceptual studies rating audio and visual files will be masked.|All participants receive every intervention in randomized order||||
1291848|NCT03702309|||Cohort||Prospective|||||||
1291849|NCT03702296|Randomized|Parallel Assignment||Prevention||Single|Blinded assessors will review the patients for 3 days post-operatively and assess sleep quality using the Richard-Campbell sleep questionnaire.|||||t
1291850|NCT03702283||Single Group Assignment||Treatment||None (Open Label)||||||
1291951|NCT03700970|Randomized|Parallel Assignment||Treatment||Double|Participants and plastic surgeons will be blinded to the study treatment arm||t|t||
1291952|NCT03700957|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292040|NCT03699813|||Case-Control||Retrospective|||||||
1291851|NCT03702270|Randomized|Crossover Assignment||Treatment||None (Open Label)||During the trial, randomization will occur using a stepped wedge cluster randomized controlled trial design. Medical units at VUMC will assigned to clusters. A single cluster will be selected for intervention at the outset of the trial. Subsequent additional clusters will first contribute to the control group, and be selected to randomly cross over to the intervention group at regular intervals of 2 months.||||
1291852|NCT03702257||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291853|NCT03702244|Randomized|Parallel Assignment||Other||None (Open Label)||Participants who meet all inclusion criteria and none of the exclusion criteria will be randomized in a ratio of 1:1 within a clinical center to either a precision evaluation strategy or usual care using an interactive web or voice-based system (IXRS). Randomization will be stratified by intended first test if randomized to usual care and by classification as minimal vs. elevated risk by the minimal risk model. The randomization scheme within a clinical center will be carried out by the method of random permuted block design with variable block size||||
1291854|NCT03702231||Single Group Assignment||Prevention||None (Open Label)||||||
1291855|NCT03702218|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291856|NCT03702205|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1291857|NCT03702192||Single Group Assignment||Supportive Care||None (Open Label)||||||
1291858|NCT03702179||Sequential Assignment||Treatment||None (Open Label)||The study will be conducted using a two-stage sequential design. Using the assumption that the treatment would be considered ineffective if it had a response proportion similar to radiotherapy alone (P0: 0.5) but would be of considerable interest if it had a response proportion of 70% of more (P1: 0.7), the sample size requirement is 12 patients for the first stage and 20 additional patients for the second stage. Six or more responses in the first stage were required for continuation to second stage accrual. The study was planned to have a type I error of 0.10 and a power of 80% in a one sided test.||||
1291859|NCT03702166||Single Group Assignment||Treatment||None (Open Label)||||||
1291860|NCT03702153|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A study group submitted to abdominal wall repair with synthetic mesh in the contaminated/infected setting compared to a control group submitted to abdominal wall repair with synthetic mesh in the clean setting.||||
1291861|NCT03702140|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291862|NCT03702127||Single Group Assignment||Basic Science||None (Open Label)|Participant will receive active and sham stimulation at varying points during the study.|||||
1291863|NCT03702114|||Case-Control||Prospective|||||||
1291864|NCT03702101|||Other||Prospective|||||||
1291865|NCT03702088|||Cohort||Prospective|||||||
1291866|NCT03702075|Randomized|Parallel Assignment||Treatment||Single||||||t
1291867|NCT03702062||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291868|NCT03702049||Single Group Assignment||Prevention||None (Open Label)||||||
1291869|NCT03702036||||||||||||
1291870|NCT03702023|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1291871|NCT03702010|Randomized|Crossover Assignment||Health Services Research||Single||Single-blind, multicenter, crossover|t|||
1291872|NCT03701997|||Cohort||Prospective|||||||
1291873|NCT03701984|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1291874|NCT03701971|Randomized|Parallel Assignment||Other||None (Open Label)||evaluation of the benefit of music therapy on pruritus in patients with pruritic dermatitis compared to the application of an emollient||||
1291875|NCT03701958||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1291876|NCT03701945||Sequential Assignment||Treatment||None (Open Label)||156 patients with COPD will be followed monthly for a year and their lung microbiota and clinical data will be analysed. Community-based PR will be delivered to 56 patients. Data will be collected before, at 3 weeks, after PR and at 6 months to assess the feasibility and effects of PR.||||
1291877|NCT03701932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291878|NCT03701919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291879|NCT03701906|Randomized|Parallel Assignment||Supportive Care||Triple||This is an interventional, randomized, double-blind, placebo-controlled, parallel-group study.|t|t|t|
1291880|NCT03701893||Single Group Assignment||Screening||None (Open Label)||Open label intervention study.||||
1291881|NCT03701880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291882|NCT03701867||Single Group Assignment||Other||None (Open Label)||||||
1291883|NCT03701854|||Case-Control||Prospective|||||||
1291884|NCT03701841|||Cohort||Prospective|||||||
1291885|NCT03701828||Single Group Assignment||Diagnostic||None (Open Label)||||||
1291886|NCT03701815||Single Group Assignment||Treatment||None (Open Label)||||||
1291887|NCT03701802|||Cohort||Prospective|||||||
1291888|NCT03701789||Single Group Assignment||Other||None (Open Label)||||||
1291889|NCT03701776|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will know that the participant has received balance or aerobic training, but will not be aware of which group the participant belonged.|Single blind randomized control trial||||t
1291890|NCT03701763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291891|NCT03701750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291892|NCT03701737|||Cohort||Prospective|||||||
1291893|NCT03701724|Randomized|Parallel Assignment||Other||Triple|"Sham rTMS will be used for the arm without rTMS"||t||t|t
1291894|NCT03701711||Single Group Assignment||Other||None (Open Label)||Single arm dose escalation study||||
1291895|NCT03701698||Single Group Assignment||Prevention||None (Open Label)||||||
1291896|NCT03701685||Single Group Assignment||Treatment||None (Open Label)||||||
1291897|NCT03701672|||Cohort||Prospective|||||||
1291898|NCT03701659|Randomized|Parallel Assignment||Treatment||Single||||||t
1291899|NCT03701646|||Case-Only||Prospective|||||||
1291900|NCT03701633|||Cohort||Cross-Sectional|||||||
1291901|NCT03701620|||Cohort||Prospective|||||||
1291902|NCT03701607|||Cohort||Prospective|||||||
1292038|NCT03699839|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1573294|NCT00001735||||Treatment||||||||
1291903|NCT03701594|Randomized|Crossover Assignment||Health Services Research||Single|The people administering the self-reported outcome measures will be blinded to the condition the subject participated in.|The study will be a randomized, controlled, single-blinded, crossover design with three conditions: condition A will consist of 1 hour of yoga-based physical therapy session in a group setting; condition B will consist of 1 hour of one-on-one conventional physical therapy; condition C will consist of 1 hour of seated rest in a relaxing environment in a group setting.||||t
1291904|NCT03701581|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1291905|NCT03701568|||Case-Only||Retrospective|||||||
1291906|NCT03701555|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1291907|NCT03701542|||Case-Only||Prospective|||||||
1291908|NCT03701529|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1291909|NCT03701516|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1291910|NCT03701503|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291911|NCT03701490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291912|NCT03701477|Randomized|Parallel Assignment||Treatment||Double|The primary investigator and outcomes assessors will be masked. The care provider and participants won't be masked.|control and intervention arms|||t|t
1291913|NCT03701464|Randomized|Parallel Assignment||Treatment||Double||||t||t
1291914|NCT03701451||Single Group Assignment||Treatment||None (Open Label)||||||
1291915|NCT03701438|||Case-Only||Prospective|||||||
1291916|NCT03701425|Randomized|Parallel Assignment||Treatment||Single|Random assignment, through software, to 4 treatment groups: one, first consume the Mediterranean and exercise plan, second group will be given only nutritional plan with Mediterranean diet, the third group only exercise plan, and the fourth control group which will give a low standard low fat.||t|||
1291917|NCT03701412|||Cohort||Cross-Sectional|||||||
1291918|NCT03701399|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1291919|NCT03701386|Randomized|Parallel Assignment||Prevention||None (Open Label)|no masking|The eligible participant will be allocated to groups, group one will receive cesarean hysterectomy and group 2 will be received N&H sandwich technique||||
1291920|NCT03701373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291921|NCT03701360|||Case-Control||Prospective|||||||
1291922|NCT03701347|Randomized|Parallel Assignment||Other||Single|||t|||
1291923|NCT03701334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291924|NCT03701321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291925|NCT03701308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291926|NCT03701295||Single Group Assignment||Treatment||None (Open Label)||||||
1291927|NCT03701282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291928|NCT03701269|||Case-Only||Retrospective|||||||
1291929|NCT03701256|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1291930|NCT03701243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291931|NCT03701230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291932|NCT03701217|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291933|NCT03701204|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291934|NCT03701191|Randomized|Parallel Assignment||Treatment||Single|Two outcome assessors will be chosen: one will be a periodontist but not included within the research; and the other will be a non-periodontist. The outcome assessors will be blinded; they will not be informed by the type of intervention to be assessed.|"Included participants will be:~Gender: Male and Female~Age: >20 years~Have RT1 and RT2 gingival recession~Exclusion criteria:~Medically compromised~History of certain medications~Pregnant females~Periapical involvement in selected teeth~History of periodontal surgery involving experimental teeth~If the problem was due to orthodontic treatment"||||t
1291935|NCT03701178|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1291936|NCT03701165||Single Group Assignment||Treatment||None (Open Label)||Cohort non-randomized trial.||||
1291937|NCT03701152|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291938|NCT03701139|Randomized|Parallel Assignment||Treatment||Single||||||t
1291939|NCT03701126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291940|NCT03701113|Randomized|Parallel Assignment||Basic Science||None (Open Label)||A block randomised, controlled study among healthy, post-menopausal women with osteopenia receiving a milk-based protein supplement (MBPS) in the evening, or not (CONTROL), for a period of 24 weeks.||||
1291941|NCT03701100|Randomized|Parallel Assignment||Treatment||Double|In sham stimulation, the current was turned on for 30 sec and then ramped down to 0 mA.|Direct current (DC) generated by a Eldith DC stimulator was bilaterally delivered through a pair of saline-soaked surface sponge electrodes (35 square centimeter). One anode was placed with the middle of the electrode over a point midway between International 10-20 electrode positions F3 and Fp1 (left dorsolateral prefrontal cortex and left prefrontal cortex). The other was located over a point midway between F4 and Fp2 (right dorsolateral prefrontal cortex and left prefrontal cortex). An extracephalic positions were used for the reference electrodes (cathodes) in order to avoid confounding effects from inhibitory cathodal effects at other cortical sites. The reference electrodes were placed on bilateral forearms. Stimulation was applied at an intensity of 2 milliampere (mA) (current density=1.14 A/square meter) for 20 min, twice-daily on 5 consecutive weekdays (total charge density=2736 C/square meter).|t|||t
1291942|NCT03701087|Randomized|Single Group Assignment||Prevention||None (Open Label)||Effect of Vitamin D intake in pregnancy to prevent recurrence of gestational Diabetes||||
1291943|NCT03701074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1291944|NCT03701061|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Prospective, Exploratory study with up to 50 subjects total, who previously participated in the HIPCVAX-010 Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine with and without AS03 Adjuvant study||||
1291945|NCT03701048|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1291946|NCT03701035|Randomized|Parallel Assignment||Treatment||Single||||||t
1291947|NCT03701022||Single Group Assignment||Treatment||None (Open Label)||||||
1573295|NCT00001731||||Treatment||||||||
1291953|NCT03700944|Randomized|Parallel Assignment||Treatment||Single||Twenty-seven allergic rhinitis patients, aged 18-45 year old, were randomized into 2 groups: control group (CON; n=14) and yoga group (YOG; n=13). The control group had normal life and the yoga group was required to complete protocol with yoga training for a period of 8 weeks, 60 minutes, 3 times a week. Physiological variables, lung function variables, allergic rhinitis symptoms variables, and cytokines level in nasal secretion variables were analyzed during pre-test and post-test.||||t
1291954|NCT03700931|Randomized|Parallel Assignment||Basic Science||Single|"The experimental aim is concealed presenting it as a study on memory of daily activities"|The participants are allocated to one of the two conditions (experimental or control condition) of the study in a randomised sequence.|t|||
1291955|NCT03700918||Single Group Assignment||Device Feasibility||None (Open Label)||First in human||||
1291956|NCT03700905|Randomized|Parallel Assignment||Treatment||None (Open Label)||Arm Ia and Arm Ib are summarized in one Arm, due to central ethics committee, as they both include neoadjuvant and adjuvant treatment compared to Arm II||||
1291957|NCT03700892|Randomized|Crossover Assignment||Basic Science||Double|The e-liquids will be maintained by an individual not active in the study procedures or analysis.|Controls will not be randomized and will not receive the study intervention.|t|||t
1291958|NCT03700879|||Cohort||Prospective|||||||
1291959|NCT03700866|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1291960|NCT03700853|||Other||Prospective|||||||
1291961|NCT03700840||Single Group Assignment||Prevention||None (Open Label)||||||
1291962|NCT03700827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291963|NCT03700814|Randomized|Parallel Assignment||Treatment||Single|||t|||
1291964|NCT03700801|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||According to two different therapies, patients were divided into the study group (triple combination therapy group) and control group (premixed insulin treatment group). Each group included 65 cases.||||
1291965|NCT03700788|Randomized|Parallel Assignment||Treatment||Double|Participant will be unaware as to which medication is used in the treatment procedure and will also be self-reporting outcomes.||t|||t
1291966|NCT03700775||Single Group Assignment||Treatment||None (Open Label)||Singe center prospective cohort study||||
1291967|NCT03700762|||Case-Only||Prospective|||||||
1291968|NCT03700749|Randomized|Factorial Assignment||Treatment||Double|Patients and outcome assessors will be blinded. The operating surgeon will not perform outcome assessment.|"FALCON 2x2 factorial trial with strata: (1) clean-contaminated and (2) contaminated/dirty. Eligible patients will be randomised at the level of the individual in a 1:1:1:1 ratio between:~A. 2% alcoholic chlorhexidine and non-coated suture B. 2% alcoholic chlorhexidine and triclosan-coated suture C. 10% aqueous povidone-iodine and non-coated suture D. 10% aqueous povidone-iodine and triclosan-coated suture"|t|||t
1291969|NCT03700736|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1291970|NCT03700723|Randomized|Parallel Assignment||Treatment||Triple|Double blind|Subjects will be randomized in a 1:1 ratio to receive Resusix or FP24|t||t|t
1291971|NCT03700710|Randomized|Parallel Assignment||Treatment||Single||||||t
1291972|NCT03700697|Randomized|Parallel Assignment||Prevention||None (Open Label)||A cluster randomized quality improvement intervention trial||||
1291973|NCT03700684|Non-Randomized|Parallel Assignment||Treatment||Single|Data files are coded to mask group assignment, session ID, and testing condition.|Participants are stratified by voice severity and assigned to one of three groups: Lee Silverman Voice Treatment (intervention), SpeechVive (intervention), or non-treatment control group (control).||||t
1291974|NCT03700671|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants were randomised to either high or moderate intensity exercise||||
1291975|NCT03700658|Randomized|Crossover Assignment||Other||None (Open Label)|The study will be partially blinded due to differences in appearance and volume of the treatments. Designated unblinded study staff will conduct randomization procedures. The staff preparing and administering injections will also be unblinded to treatment sequence but will be trained to shield the syringe prior to and at the time of injection from view of the subject and study staff assessing ISRs.|||||
1291976|NCT03700645|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1291977|NCT03700632|Randomized|Parallel Assignment||Treatment||Triple|care provider, investigator and outcome assessor will be unaware the group of participants. because of the nature of study, patch therapy vs no treatment, masking of participant will not be possible.|the experimental group will be treated with part time patch therapy and control group will be observed without any treatment.||t|t|t
1291978|NCT03700619|||Other||Prospective|||||||
1291979|NCT03700606|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1291980|NCT03700593|||Cohort||Prospective|||||||
1291981|NCT03700580|Randomized|Parallel Assignment||Treatment||Quadruple||The intervention encompassed a topical application on the ulcer bed of the active fraction 0.1% P1G10 dispersed in hydrosoluble vehicle. The control group received hydrogel with the same frequency adopted for P1G10 (Three times per week during 16 weeks). Regardless the intervention prior to each application the ulcer bed was cleaned with 0.9% physiological serum without antiseptic.|t|t|t|t
1291982|NCT03700567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291983|NCT03700554|Randomized|Parallel Assignment||Treatment||Single|Method of closed envelopes|Randomised, non-blinded, actively controlled clinical trial.|||t|
1291984|NCT03700541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291985|NCT03700528||Single Group Assignment||Treatment||None (Open Label)||The psychological treatment which we will use is called Acceptance and Commitment Therapy (ACT). The ACT treatment includes treatment processes of acceptance, cognitive defusion, mindfulness, and values-based action. Methods will include practice to deal with painful experiences, to improve awareness, to identify and work on goals, and to better stick to commitments.||||
1291986|NCT03700515|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1291987|NCT03700502|||Cohort||Cross-Sectional|||||||
1291988|NCT03700489|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1291989|NCT03700476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291990|NCT03700463|||Other||Prospective|||||||
1292039|NCT03699826||Single Group Assignment||Treatment||None (Open Label)||||||
1291991|NCT03700450||Single Group Assignment||Treatment||None (Open Label)||All patients will receive on day 3 and 4 after allogeneic stem cell transplan-tation 50 mg/kg BW cyclophosphamide||||
1291992|NCT03700437|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1291993|NCT03700424|Randomized|Parallel Assignment||Treatment||Quadruple|This study will be performed double-blind||t|t|t|t
1291994|NCT03700411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291995|NCT03700398|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1291996|NCT03700385||||||||||||
1291997|NCT03700372||||||||||||
1291998|NCT03700359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1291999|NCT03700346|Non-Randomized|Parallel Assignment||Other||Single|||||t|
1292000|NCT03700333|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1292001|NCT03700320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292002|NCT03700307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292003|NCT03700294||Single Group Assignment||Treatment||None (Open Label)||||||
1292004|NCT03700281|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1292005|NCT03700268|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292006|NCT03700255|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1292007|NCT03700242|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292008|NCT03700229||Single Group Assignment||Treatment||None (Open Label)||||||
1292009|NCT03700216|||Cohort||Prospective|||||||
1292010|NCT03700203|||Case-Control||Prospective|||||||
1292011|NCT03700190|||Cohort||Prospective|||||||
1292012|NCT03700177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292013|NCT03700164|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||It is anticipated that 32 participants will enrol in the study. Specifically, 16 participants will be healthy individuals and the other 16 will be individuals with impaired fasting glucose (5.6 mM to 6.9 mM) and/or blood glucose values 7.8-11.0 mM 2h after glucose drink consumption during the OGTT in screening. Initially, the study will investigate the effect of the cold exposure on healthy individuals, and then depending on the results in these individuals, the intervention may be tested on participants with impaired glucose metabolism.||||
1292014|NCT03700151||Single Group Assignment||Treatment||None (Open Label)||A group of 20 participants with severe speech sound disorders will receive the proposed intervention. Pre- and post-test data will be collected to study the treatment efficacy||||
1292015|NCT03700138|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292016|NCT03700125||Single Group Assignment||Treatment||None (Open Label)||Single centre feasibility study of a complex intervention||||
1292017|NCT03700112|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1292018|NCT03700099||Single Group Assignment||Treatment||None (Open Label)||||||
1292019|NCT03700086|Randomized|Parallel Assignment||Prevention||None (Open Label)||1:1 randomized controlled trial||||
1292020|NCT03700073|Randomized|Parallel Assignment||Treatment||Single||||||t
1292021|NCT03700060|||Other||Prospective|||||||
1292022|NCT03700047||||||||||||
1292023|NCT03700034|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1292024|NCT03700021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292025|NCT03700008|Randomized|Parallel Assignment||Diagnostic||Single|The outcome-assessor or rater did not know which diagnosis the participant has and the participant is informed about the diagnosis after the diagnostic procedure from a physician/ psychotherapist not involved in the study.|Two randomized groups of participants, blinded to rater in relation of the diagnosis of the individual proband.||||t
1292026|NCT03699995||Single Group Assignment||Screening||None (Open Label)||||||
1292027|NCT03699982||Single Group Assignment||Treatment||None (Open Label)||||||
1292028|NCT03699969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292029|NCT03699956|Randomized|Crossover Assignment||Treatment||None (Open Label)||"In this study, patients will be randomized to 1 of 2 groups or arms. Patients in Arm 1 will receive the study drug, RRx-001, once a week for 3 weeks followed by up to 4 cycles of platinum doublet (platinum plus etoposide) chemotherapy. Patients with stable disease or better will go on to the Platinum Stacking Phase and will receive RRx-001 once a week for 2 weeks followed by 2 cycles of single agent platinum chemotherapy in a repeating pattern until such time as their cancer gets worse.. Patients in Arm 2 will receive the standard of care platinum doublet (platinum plus etoposide) chemotherapy for up to 4 cycles. . Patients in arm 2 whose cancer gets worse (as determined by imaging scans), may cross-over to the Platinum Stacking Phase of Arm 1 (see study schema below)."||||
1292030|NCT03699943|Non-Randomized|Sequential Assignment||Treatment||Single||Low dose - 30 cc High dose - 60 cc||||t
1292031|NCT03699930|Randomized|Parallel Assignment||Treatment||Triple|The only person knowing about this assignment will be the PI|double-blind randomized controlled design|t|t||t
1292032|NCT03699917|||Case-Only||Retrospective|||||||
1292033|NCT03699904|Randomized|Parallel Assignment||Treatment||Quadruple|This will be randomised, double-blind trial with matching placebo.|Parallel assignment.|t|t|t|t
1292034|NCT03699891|||Cohort||Retrospective|||||||
1292035|NCT03699878|||Cohort||Prospective|||||||
1292036|NCT03699865|Randomized|Factorial Assignment||Other||Single|Participants will be informed that they will be supplied cigarettes with low nicotine content but will be blinded to exact nicotine content and unaware that within-subject, all packages will contain the same type of low nicotine cigarette|Randomized, single-blind, 2 x 4 mixed factorial design laboratory-based study manipulating: (1) cigarette pack color (4-level within-subjects factor: own brand vs. white vs. purple vs. black color), and (2) nicotine content (2-level between-subjects factor: moderate vs. very low nicotine content). All participants will provide and smoke their preferred brand for an initial 5-day baseline period, and then will be randomly assigned to smoke either intermediate or very low LNC cigarettes for the study duration. We will supply participants with LNC cigarettes in three pack colors; each color will be used for a 10-day period, in counter-balanced order.|t|||
1292037|NCT03699852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573296|NCT00001730||||Treatment||||||||
1292041|NCT03699800|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1292042|NCT03699787|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1292043|NCT03699774||Sequential Assignment||Basic Science||None (Open Label)||Fixed sequence||||
1292044|NCT03699761|Randomized|Parallel Assignment||Treatment||Single||||||t
1292045|NCT03699748|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1292046|NCT03699735|Randomized|Crossover Assignment||Treatment||Single|Single (Participant)|Crossover Assignment Each participant will be treated with each test condition in a randomized order.|t|||
1292047|NCT03699722|Randomized|Parallel Assignment||Prevention||None (Open Label)||At the baseline visit, participants will be randomly assigned to intervention or control conditions in a 3:1 ratio, stratified by site. Participants will remain in those assigned groups for the duration of the study.||||
1292048|NCT03699709|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomization to one of two arms: intervention or control group||||
1292049|NCT03699696|||Cohort||Retrospective|||||||
1292050|NCT03699683||Sequential Assignment||Treatment||None (Open Label)||two groups (experimental and control) randomly assigned||||
1292051|NCT03699670|||Cohort||Prospective|||||||
1292052|NCT03699657|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1292053|NCT03699644|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1292054|NCT03699631||Single Group Assignment||Treatment||None (Open Label)||||||
1292055|NCT03699618|||Case-Only||Prospective|||||||
1292056|NCT03699605|Randomized|Parallel Assignment||Treatment||None (Open Label)||The two groups were included for speech therapy. For any given subject, aphasia severity evaluations were completed on the same day.includes patients that are 40+ years old, and have three months of post stroke with diagnosis of chronic Broca's Aphasias, each patient received treatment for 4 months that includes 04 VESMP sessions per week with each session being 30-45 minutes long. The measurement will be taken at 0 week (baseline) after 16 weeks.||||
1292057|NCT03699592|Non-Randomized|Sequential Assignment||Other||None (Open Label)||time series prospective cohort and comparison group design||||
1292058|NCT03699579|||Cohort||Retrospective|||||||
1292059|NCT03699566|||Other||Other|||||||
1292060|NCT03699553|Randomized|Crossover Assignment||Treatment||None (Open Label)||40 participants will be randomized to the LARKSPUR Study. 20 will receive the online intervention and 20 will report their daily emotions for the same duration as the intervention. The 20 individuals assigned to the emotion reporting (control group) arm will receive the online intervention after completing the final assessment, 12 weeks after baseline.||||
1292061|NCT03699540|Randomized|Sequential Assignment||Basic Science||Double|Double-blind, double-dummy, placebo-controlled design|Within-subject, randomized, placebo-controlled, double-dummy, double-blind study|t||t|
1292062|NCT03699527|||Cohort||Prospective|||||||
1292063|NCT03699514|||Case-Only||Prospective|||||||
1292064|NCT03699501|||Cohort||Prospective|||||||
1292065|NCT03699488|||Ecologic or Community||Prospective|||||||
1292066|NCT03699475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292067|NCT03699462|Randomized|Parallel Assignment||Prevention||Triple|"One researcher (Anesthesiologist) conducts randomized group assignment, and the researcher is not involved in other aspects of anesthesia and research.~Therefore, other researchers, and all those involved in anesthesia, surgery, and postoperative management do not know the patient's group assignment."|Groups are divided into 2 groups; those receiving balanced crystalloid solution (Plasma solution-A injection, CJ Pharma, South Korea), and those receiving 5% albumin (Albumin 5% inj, Green cross, South Korea) during surgery|t|t||t
1292068|NCT03699449|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a randomized, multi-center, open label, phase II study for HRD+ patients and a biomarker-driven multiple-arm phase II study for HRD- patients.~This study will consist of a number of study modules (substudies), each evaluating the antitumor activity of targeted agents in patients whose tumors express specific phenotype relevant to the molecules under investigation."||||
1292069|NCT03699436|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1292070|NCT03699423|Randomized|Parallel Assignment||Supportive Care||Quadruple|The study treatments will be labelled as A, B and C by one of the team member who does not involve in the assessment and follow-up. The masked study products will then be sent to the study coordinator to dispense||t|t|t|t
1292071|NCT03699410|||Case-Only||Prospective|||||||
1292072|NCT03699397||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292073|NCT03699384||Single Group Assignment||Treatment||None (Open Label)||This is an open label, phase I/II prospective clinical trial.||||
1292074|NCT03699371|Randomized|Parallel Assignment||Prevention||Single||prospective, randomised, multi-centre assessor-blinded study||||t
1292075|NCT03699358|||Case-Control||Prospective|||||||
1292076|NCT03699345|||Case-Only||Prospective|||||||
1292077|NCT03699332||Single Group Assignment||Diagnostic||None (Open Label)||Single Group Assignment||||
1292078|NCT03699319||Single Group Assignment||Treatment||None (Open Label)||Single-armed study of patients with locally advanced pancreatic cancer, evaluating combination CPI-613 with modified FOLFIRINOX||||
1292079|NCT03699306|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1292080|NCT03699293|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Qualified patients will be treated with immediate release 81mg aspirin for 4 weeks in the run-in period followed by randomization to celecoxib (200 mg bid) vs. naproxen sodium (550 mg bid) for 4 weeks and then cross over to the other drug for another 4 weeks. Blood and urine samples will be collected before the aspirin run-in period (baseline), 24±4 hrs after the last dose of aspirin in the run-in period, 24±4 hr after the last dose of the study drug in the first period and 24±4 hr after the last dose of the study drug in the second period. Assays for platelet function, biomarkers of inflammation and endothelial function will be performed at these time points||||
1292133|NCT03698604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292186|NCT03697915|Randomized|Parallel Assignment||Treatment||None (Open Label)||Thirty hospitalized patients who were immobile more than 1 week were randomised into two groups. Each group had received 15 sessions of physical therapy (ROM exercises and electrotherapy) regularly.||||
1292187|NCT03697902|||Cohort||Cross-Sectional|||||||
1292081|NCT03699280|Randomized|Parallel Assignment||Other||Single||"The study is a randomised control trial involving mixed methods of qualitative and quantitative analysis. The study will include 40 patients attending the outpatient hysteroscopy clinic and randomised to either a VR intervention group or standard procedure by computer-generated randomisation.~All patients will fill in a questionnaire before and after the procedure. Patients who have been randomised to the VR arm will have a semi-structured interview regarding their experience with VR.~The clinician performing the procedure will fill in a questionnaire per patient regarding the ease of the procedure and perceived pain levels of the patient. The Clinician performing the procedure and nursing staff's perception regarding feasibility of using the VR equipment for each patient who had the intervention was also assessed through the questionnaire."||||t
1292082|NCT03699267|||Cohort||Prospective|||||||
1292083|NCT03699254|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292084|NCT03699241|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1292085|NCT03699228|||Other||Prospective|||||||
1292086|NCT03699215|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292087|NCT03699202|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292088|NCT03699189|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||A randomised, controlled, parallel trial.||||
1292089|NCT03699176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292090|NCT03699163|||Case-Control||Cross-Sectional|||||||
1292091|NCT03699150|||Cohort||Retrospective|||||||
1292092|NCT03699137|||Other||Retrospective|||||||
1292093|NCT03699124|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1292094|NCT03699111|||Cohort||Prospective|||||||
1292095|NCT03699098||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292096|NCT03699085|Randomized|Parallel Assignment||Treatment||Single|Individuals on the study team designated to conduct follow up interviews will be blinded to which arm participants belong to.|||||t
1292097|NCT03699072||Single Group Assignment||Treatment||None (Open Label)||||||
1292098|NCT03699059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|No blinding. Purposive sampling of the 15 subjects- 5 HCP, 10 kidney transplant patients.|A small study creating a kidney transplant specific online weight gain prevention tool with qualitative data from 15 participants (5 transplant MDT members and 10 kidney transplant recipients)||||
1292099|NCT03699046|Randomized|Parallel Assignment||Treatment||Single|Patients will be randomized at the time of surgery to either the control group or the intervention group.|The control group will be patients receiving knee arthroscopy alone and the intervention group will be patients receiving subchondroplasty and knee arthroscopy.|t|||
1292100|NCT03699033||Single Group Assignment||Treatment||None (Open Label)||||||
1292101|NCT03699020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292102|NCT03699007|Randomized|Parallel Assignment||Treatment||None (Open Label)||Adolescents will be randomized to either GET Living or TPM and stratified on fear (moderate/high; FOPQ-C: moderate [35-49] high [50-96]) and disability (moderate/high; moderate [13-29] severe [30-60]), to minimize the possibility of imbalance between the two treatment arms. To allow the use of small blocks while minimizing the probability of a blinded staff member predicting the next assignment we will use blocks of size two and four and randomly choose block sizes.||||
1292103|NCT03698994||Single Group Assignment||Treatment||None (Open Label)||||||
1292104|NCT03698981|Randomized|Parallel Assignment||Other||Single|"Staff conducting primary outcome measures with mothers at baseline, post-intervention, and week 56 (in person) will be blinded to treatment assignment."|To account for expected drop out (~10%), ~220 participants will be recruited, resulting in MME and TAU groups of ~100 with complete data at week 56. For the MME arm, we will enroll 9-10 women per group on a rolling basis to comprise ~12 intervention groups total; ~1 MME group will be initiated per month.||||t
1292105|NCT03698968||Single Group Assignment||Prevention||None (Open Label)|Open|||||
1292106|NCT03698955|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292107|NCT03698942|||Case-Control||Retrospective|||||||
1292108|NCT03698929|Randomized|Crossover Assignment||Other||Double||Randomized, double-blind, crossover|t||t|
1292109|NCT03698916|||Cohort||Prospective|||||||
1292110|NCT03698903|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1292111|NCT03698890|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1292112|NCT03698877|||Cohort||Prospective|||||||
1292113|NCT03698864||Single Group Assignment||Treatment||None (Open Label)||||||
1292114|NCT03698851|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1292115|NCT03698838|||Other||Prospective|||||||
1292116|NCT03698825||Single Group Assignment||Treatment||None (Open Label)||||||
1292117|NCT03698812|||Cohort||Prospective|||||||
1292118|NCT03698799|||Cohort||Prospective|||||||
1292119|NCT03698786|||Cohort||Cross-Sectional|||||||
1292120|NCT03698773|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1292121|NCT03698760|Non-Randomized|Parallel Assignment||Other||None (Open Label)||The study is a single-center controlled study (Jewish General Hospital, Montreal, Quebec, Canada), consisting of two groups of subjects: a control group and a group of subjects with mild Alzheimer's disease.||||
1292122|NCT03698747|||Case-Control||Prospective|||||||
1292123|NCT03698734|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1292124|NCT03698721|||Other||Prospective|||||||
1292125|NCT03698708||Single Group Assignment||Treatment||None (Open Label)||||||
1292126|NCT03698695|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292127|NCT03698682|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1292128|NCT03698669|Randomized|Parallel Assignment||Treatment||Single||||||t
1292129|NCT03698656|||Case-Only||Prospective|||||||
1292130|NCT03698643|||Other||Retrospective|||||||
1292131|NCT03698630|Randomized|Parallel Assignment||Treatment||Single|The Pediatric Respiratory Assessment Measure score will be performed by a clinician blinded to treatment allocation.|Randomized, open-label, non-inferiority trial||||t
1292132|NCT03698617|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1292134|NCT03698591|Randomized|Crossover Assignment||Basic Science||Double|Neither the lead experimenter nor the subject will know which arm they will complete first. The secondary experimenter will use a randomized counter-balanced log to determine the order of sequences will take place. The secondary experimenter will set up the device while the lead experimenter is out of the room to preserve blindness to the intervention.||t||t|
1292135|NCT03698578|Non-Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1292136|NCT03698565||Single Group Assignment||Other||None (Open Label)||||||
1292137|NCT03698552||Single Group Assignment||Treatment||None (Open Label)||||||
1292138|NCT03698539|||Case-Control||Cross-Sectional|||||||
1292139|NCT03698526|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1292140|NCT03698513|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1292141|NCT03698500||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292142|NCT03698487|Non-Randomized|Single Group Assignment||Other||None (Open Label)||"This project is a prospective interventional implementation study with a pre-intervention control cohort; mixed methods will be used to explore the success and moderators of implementation.~Specifically, it consists of:~A retrospective study (NB: ethics for this part of the overall study has been sought separately and already approved, file number 1023666).~A before/after intervention~A multiple case study (a sub-study of the before/after intervention)"||||
1292143|NCT03698474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292144|NCT03698461||Single Group Assignment||Treatment||None (Open Label)||||||
1292145|NCT03698448|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo medication with identical appearance, taste and smell to the active drug|Randomised, double blind, dose-finding|t|t|t|t
1292146|NCT03698435|||Case-Only||Prospective|||||||
1292147|NCT03698422|||Other||Prospective|||||||
1292148|NCT03698409|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292149|NCT03698396||Single Group Assignment||Treatment||None (Open Label)||||||
1292150|NCT03698383||Single Group Assignment||Treatment||None (Open Label)||||||
1292151|NCT03698370|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1292152|NCT03698357|Randomized|Parallel Assignment||Treatment||Single||||||t
1292153|NCT03698344||Single Group Assignment||Basic Science||None (Open Label)||||||
1292154|NCT03698331|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292155|NCT03698318|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1292156|NCT03698305|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292157|NCT03698292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292158|NCT03698279|Randomized|Sequential Assignment||Prevention||Triple|Modified double-blind: the participant's parent / legally acceptable representative, the Investigator, and other study personnel remain unaware of the treatment assignments throughout the trial. An unblinded vaccine administrator will administer the appropriate vaccine but will not be involved in safety data collection.|The study will be divided into 13 groups and will enroll in 4 stages. The study will use a stepwise age de-escalation and dose ascension design for children 6 months to < 5 years of age.|t||t|t
1292159|NCT03698266||Single Group Assignment||Other||None (Open Label)||All patients enrolled in the study will consent to a needle knife fistulotomy as a starting technique to gain access to the biliary system.||||
1292160|NCT03698253||Single Group Assignment||Treatment||None (Open Label)||||||
1292161|NCT03698240|Randomized|Crossover Assignment||Treatment||Single||||||t
1292162|NCT03698227||Single Group Assignment||Treatment||None (Open Label)||Olaratumab and doxorubicin rechallenge in anthracycline pretreated, advanced soft tissue sarcoma patients||||
1292163|NCT03698214|||Other||Retrospective|||||||
1292164|NCT03698201|||Cohort||Prospective|||||||
1292165|NCT03698188|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292166|NCT03698175|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1292167|NCT03698162|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1292168|NCT03698149||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1292169|NCT03698136||Single Group Assignment||Treatment||None (Open Label)||Repeated measurement interventional Single Subject Design||||
1292170|NCT03698123||Single Group Assignment||Other||None (Open Label)|Researchers analyze the data will be blinded to the group assignment.|"Study participants will participate in the study 3 nights with one control night and two dietary interventions nights.The order of the 2 dietary intervention groups will be randomized per block.~There are two possible combinations and the order will be randomized using a computer-generated random-number sequence. There will be at least a 24-hour wash-out period between study nights to minimize the carry-over effects of the cross-over design as well as learning effects of the computerized cognitive tests.~A: Control- no intervention, B: intervention 1 arm, C: Intervention 2 The order of the blocks will be randomized. block a: A, B, C block b: A, C, B"||||
1292171|NCT03698110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292172|NCT03698097|||Cohort||Prospective|||||||
1292173|NCT03698084|||Cohort||Prospective|||||||
1292174|NCT03698071||Single Group Assignment||Other||None (Open Label)||||||
1292175|NCT03698058|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292176|NCT03698045||Single Group Assignment||Treatment||None (Open Label)||||||
1292177|NCT03698032|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1292178|NCT03698019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292179|NCT03698006|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292180|NCT03697993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292181|NCT03697980|||Cohort||Prospective|||||||
1292182|NCT03697967|Randomized|Parallel Assignment||Prevention||Double||Randomised two arms study|||t|t
1292183|NCT03697954|||Cohort||Prospective|||||||
1292184|NCT03697941|||Cohort||Prospective|||||||
1292185|NCT03697928|||Cohort||Cross-Sectional|||||||
1292188|NCT03697889|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292239|NCT03697226|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1292189|NCT03697876|Randomized|Parallel Assignment||Treatment||Double|"The blinding will correspond to the research subject and the principal investigator. In addition, the statistical analysis will be carried out in a blinded manner for the partial and final analysis.~The masking will be done by means of identical labels. Which, in accordance with current and applicable regulations, must contain at least:~Name, address and telephone number of the sponsor~Pharmaceutical form and route of administration~Lot Number~Legend Exclusively for clinical studies~Date of Expiry"|controlled, of parallel groups, double blind, randomized, exploratory|t||t|
1292190|NCT03697863|||Cohort||Retrospective|||||||
1292191|NCT03697850||Single Group Assignment||Treatment||None (Open Label)||||||
1292192|NCT03697837||Single Group Assignment||Treatment||None (Open Label)||Open feasibility trial||||
1292193|NCT03697824||Single Group Assignment||Treatment||None (Open Label)||This is an open-label, single arm treatment study.||||
1292194|NCT03697811||Single Group Assignment||Treatment||None (Open Label)||||||
1292195|NCT03697798|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292196|NCT03697785|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1292197|NCT03697772|||Cohort||Retrospective|||||||
1292198|NCT03697759||Single Group Assignment||Treatment||None (Open Label)|Since there is no randomization, all participants receive the intervention. Consequently, there is no blinding.|This study is a pilot study preceding a randomized controlled trial. In the pilot study all enrolled participants are offered the intervention.||||
1292199|NCT03697746|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1292200|NCT03697733|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292201|NCT03697720||Single Group Assignment||Treatment||None (Open Label)||||||
1292202|NCT03697707|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||First 10 patients will get the lowest dose and next 10 patients will receive the highest dose||||
1292203|NCT03697694|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1292204|NCT03697681|Randomized|Parallel Assignment||Prevention||Quadruple|triple blinded (Participant, Care Provider, investigator)|A Randomized, Double-Blinded, Placebo-Controlled Trial|t|t|t|t
1292205|NCT03697668|Randomized|Sequential Assignment||Treatment||None (Open Label)|"The research method will be a Phase 2 trial, 2 arms, randomized, open label (only the microscopist will be blinded), adaptive, dose de-escalation, trial conducted in adult male subjects with uncomplicated P.falciparum malaria.~In all phases, patients will be treated by a triple combination IMA-DHA-PPQ (ARM 1) or by the standard DHA-PPQ treatment (ARM 2)."|interventional||||
1292206|NCT03697655|Randomized|Parallel Assignment||Prevention||None (Open Label)||treatment arm and control (observation) arm||||
1292207|NCT03697642|Randomized|Parallel Assignment||Treatment||Single|||t|||
1292208|NCT03697629||Single Group Assignment||Treatment||None (Open Label)||||||
1292209|NCT03697616||Single Group Assignment||Treatment||None (Open Label)||||||
1292210|NCT03697603|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292211|NCT03697590|Randomized|Parallel Assignment||Treatment||Single||||||t
1292212|NCT03697577|||Other||Prospective|||||||
1292213|NCT03697564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292214|NCT03697551||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292215|NCT03697538|Randomized|Parallel Assignment||Treatment||Single|Patients, nurses on the floor and physical therapists will be blinded to the nature of the patient assignment||t|||
1292216|NCT03697525|Randomized|Parallel Assignment||Treatment||Triple|double-blind|prospective randomized double-blind sham-controlled study|t|t||t
1292217|NCT03697512||Single Group Assignment||Treatment||None (Open Label)||||||
1292218|NCT03697499|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1292219|NCT03697486|Randomized|Crossover Assignment||Treatment||Single|||t|||
1292220|NCT03697473|Randomized|Parallel Assignment||Basic Science||Single|The principal investigator responsible for the statistical analysis was blinded to the group allocation of participants|||||t
1292221|NCT03697460||Single Group Assignment||Treatment||None (Open Label)||Topical INCB018424||||
1292222|NCT03697447|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1292223|NCT03697434||Single Group Assignment||Supportive Care||None (Open Label)||||||
1292224|NCT03697421|||Cohort||Prospective|||||||
1292225|NCT03697408||Single Group Assignment||Treatment||None (Open Label)||||||
1292226|NCT03697395|||Case-Only||Prospective|||||||
1292227|NCT03697382|Randomized|Crossover Assignment||Prevention||None (Open Label)||Subjects will complete three experimental conditions which include 2 days of reduced step count (2,500, 5,000, and 7,500 steps/day) with 1-hour of exercise at 65% VO2max.||||
1292228|NCT03697369|||Case-Only||Prospective|||||||
1292229|NCT03697356||Single Group Assignment||Treatment||None (Open Label)||||||
1292230|NCT03697343|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, multicenter, Open-Label, randomized||||
1292231|NCT03697330|Randomized|Parallel Assignment||Prevention||Quadruple|Randomization will be done using computer generated table of random numbers in a 1:1 ratio and will be conducted using sequentially numbered, opaque and sealed envelope. The trial will be planned that neither the doctors (investigators) nor the patients will be aware of the group allocation and amount of fluid received. Intraoperative and postoperative data collections will be achieved by the same blinded anesthiologist.|comparing the effect of two different protocols of fluid therapy (liberal versus restrictive) in adult patients undergoing unilateral orthopedic lower limb surgery under spinal anesthesia|t|t|t|t
1292232|NCT03697317|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292233|NCT03697304|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1292234|NCT03697291|Non-Randomized|Crossover Assignment||Diagnostic||Single|unlabeled ECG print|Single center, prospective, cross over study||||t
1292235|NCT03697278|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1292236|NCT03697265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292237|NCT03697252|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292238|NCT03697239||Single Group Assignment||Treatment||None (Open Label)||Ascorbic Acid Paclitaxel Protein Bound Cisplatin Gemcitabine||||
1292240|NCT03697213|||Cohort||Cross-Sectional|||||||
1292241|NCT03697200|Randomized|Factorial Assignment||Treatment||Single|||t|||
1292242|NCT03697187|||Cohort||Prospective|||||||
1292243|NCT03697174|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1292244|NCT03697161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292245|NCT03697148||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292246|NCT03697135|||Other||Prospective|||||||
1292247|NCT03697122||Single Group Assignment||Treatment||None (Open Label)||The intervention group has only one arm. All patients will use active warming via traditional methods (ie forced air warming blankets) and Heated Humidified breathing circuits (HHBC) via ANAPOD Heated Humidification System® (ANAPOD). Those patients will be matched with a retrospective historical cohort of patients that received active warming via traditional methods only (forced air warming blankets).||||
1292248|NCT03697109|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292249|NCT03697096|Randomized|Parallel Assignment||Other||None (Open Label)||This cluster-randomized trial will assess a novel quality improvement antibiotic stewardship strategy for empiric antibiotic selection.||||
1292250|NCT03697083|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1292251|NCT03697070|Randomized|Parallel Assignment||Other||None (Open Label)||This cluster-randomized trial will assess a novel quality improvement antibiotic stewardship strategy for empiric antibiotic selection.||||
1292252|NCT03697057|||Case-Crossover||Prospective|||||||
1292253|NCT03697044|||Cohort||Prospective|||||||
1292254|NCT03697031|||Cohort||Prospective|||||||
1292255|NCT03697018|Randomized|Parallel Assignment||Treatment||Double|double blind||t|||t
1292256|NCT03697005|Randomized|Parallel Assignment||Treatment||Double|"Double blinding (trial participants and outcome assessor)~Dental colleague assessors who are blinded about the aim of the study and participant's allocation will be responsible for assessing the outcomes of this study.~The level of intra- and inter-examiner reliability will be determined for each assessor by the performance of a calibration session prior to the start of the trial. A training exercise to the assessors with the main investigator will help to standardize measurement techniques and parameters. An interactive calibration session will enable the investigator to quantitate the measurement variability among and between assessors and enable the optimization of the measurement process. The main supervisor will solve any conflict that may arise between the assessors by repeating the assessing and giving the final opinion."|patients requiring posterior single crowns.|t|||t
1292257|NCT03696992|Randomized|Parallel Assignment||Diagnostic||Single||Prospective randomized design|t|||
1292258|NCT03696979|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1292259|NCT03696966|Randomized|Parallel Assignment||Treatment||Single|||||t|
1292260|NCT03696953|Randomized|Factorial Assignment||Prevention||Triple|Double Blind Randomized Placebo Controlled Trial.|Healthy pregnant participants will be randomly assigned to one of two groups (Probiotic vs Placebo) that are blind to participants and researchers. Both groups will take one capsule daily and have the same study measures at the same times.|t|t|t|
1292261|NCT03696940|Randomized|Parallel Assignment||Treatment||Single|Simple Blinded|Longitudinal|t|||
1292262|NCT03696927||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1292263|NCT03696914|||Case-Control||Retrospective|||||||
1292264|NCT03696901|||Cohort||Other|||||||
1292265|NCT03696888|Randomized|Parallel Assignment||Treatment||Single|||t|||
1292266|NCT03696875|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 1: Matched-pair cluster randomized clinical trial. Phase 2: a quasi-experimental study.||||
1292267|NCT03696862||Single Group Assignment||Treatment||None (Open Label)||||||
1292268|NCT03696849|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292269|NCT03696836||Single Group Assignment||Treatment||None (Open Label)||||||
1292270|NCT03696823||Single Group Assignment||Treatment||None (Open Label)||||||
1292271|NCT03696810||Single Group Assignment||Other||None (Open Label)||||||
1292272|NCT03696797|Randomized|Parallel Assignment||Treatment||Single|Both groups will not know assignment as all will have a sleep mask (like a blindfold, covering the eyes, held on with an elastic band) placed so participant will not know whether blood was actually removed.||t|||
1292273|NCT03696784||Single Group Assignment||Treatment||None (Open Label)||||||
1292274|NCT03696771||Single Group Assignment||Treatment||None (Open Label)||||||
1292275|NCT03696758||Single Group Assignment||Treatment||None (Open Label)||Young adults born premature, recruited either from the National Lung Project Cohort or the general public, will undergo Cardiac Magnetic Resonance Imaging before and after medication administration. This will occur twice, on two separate visits. Subjects will be given sildenafil in between imaging scans at one visit, and will receive intravenous metoprolol in between scans at a separate visit. These visits can occur in either order.||||
1292276|NCT03696745|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292277|NCT03696732|||Cohort||Prospective|||||||
1292278|NCT03696719|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1292279|NCT03696706|Randomized|Parallel Assignment||Treatment||Double|"In the placebo group, the same procedures of the LED group will be made, but the device will be turned off. Participants will not know whether they are in the active or placebo group.~The investigator will not know to which group the participants belong, only the care provider."||t||t|
1292280|NCT03696693|||Case-Control||Retrospective|||||||
1292281|NCT03696680||Single Group Assignment||Treatment||None (Open Label)||||||
1292282|NCT03696667|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1292318|NCT03696199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292319|NCT03696186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292320|NCT03696173|||Cohort||Retrospective|||||||
1292321|NCT03696160|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1292322|NCT03696147|||Cohort||Prospective|||||||
1292323|NCT03696134|||Cohort||Prospective|||||||
1292324|NCT03696121|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292325|NCT03696108|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292283|NCT03696654|Non-Randomized|Sequential Assignment||Other||None (Open Label)||The control system of measurements will be before and after treatment on the same group of patients (children with SDB and indication for adeno-tonsillectomy). For the analysis of the main variable (mean systolic blood pressure-BP), baseline values will be obtained through ambulatory blood pressure monitoring (ABPM) and pulse transit time (PTT) in the basal visit. In order to evaluate the impact of treatment of SDB (adeno-tonsillar surgery) on BP, the measurement will be repeated just before the surgical intervention (ABPM and PTT) and six months after surgery (ABPM and PTT) in the same group. In this way, a control group will be available (measurements just before the surgery / control group) that will be compared with the measurements of those same patients six months after the surgery (treatment group). This measure allows having control values without preventing the treatment of any patient and without causing delays in the application of the same linked to the study||||
1292284|NCT03696641|Randomized|Parallel Assignment||Treatment||Single|participant, outcome assessor double blind||t|||
1292285|NCT03696628|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|Open : no masking us used. All involved know the identity of the intervention assignment.|"All participants receive the same intervention throughout the protocol, no matter if they are healthy children or cardiomyopathic children."||||
1292286|NCT03696615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292287|NCT03696602|||Other||Retrospective|||||||
1292288|NCT03696589||Single Group Assignment||Treatment||None (Open Label)||Single arm cohort study with pre and post intervention assessments||||
1292289|NCT03696576|Randomized|Parallel Assignment||Treatment||Single|Speech Language Pathologists (SLPs) will not know which group the participants have been randomized to.|||t||
1292290|NCT03696563|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a single centred prehospital multi-period cluster crossover feasibility trial||||
1292291|NCT03696550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1292292|NCT03696537||Sequential Assignment||Treatment||None (Open Label)||"Standard 3+3 phase I design of dose escalation using 3 patients per dose level cohort with an expansion to 6 patients at the MTD will be used during the phase 1 component. We will treat 3 patients at the initial dose level of TMI. If no dose-limiting toxicity [DLT] is observed, the next cohort of three patients is treated at the next higher dose level. If 1 of the 3 patients demonstrates DLT, an additional 3 patients are treated at that dose level. If only 1 of the 6 shows DLT, the next cohort of three patients is entered at the next dose level. If 2 or more of the 6 demonstrate DLT, the MTD is defined as the previous dose level. If no DLT is observed in the final dose level, the number of patients treated will be expanded to 6. The phase II component will enroll additional patients at the defined MTD level."||||
1292293|NCT03696524|Randomized|Parallel Assignment||Supportive Care||Single|The subjects and providers will not be blinded, since it will be apparent which patients received a pleurx catheter. Outcomes measured by survey and chart review will be scored and analyzed in a blinded fashion.|There will be an intervention group (receiving the tunneled pleural catheter) and a usual care group.||||t
1292294|NCT03696511|Randomized|Parallel Assignment||Treatment||Single|data sheet will be blinded for the analyses|||||t
1292295|NCT03696498|Randomized|Parallel Assignment||Treatment||Single||||||t
1292296|NCT03696485|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1292297|NCT03696472|Randomized|Parallel Assignment||Treatment||Single|||t|||
1292298|NCT03696459|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1292299|NCT03696446|Randomized|Parallel Assignment||Treatment||Single|The facilitators will not know that the participants are part of the study. Participants will know which group they are allocated to as they are aware of both groups (described in the consent form).|||t||
1292300|NCT03696433|Randomized|Crossover Assignment||Basic Science||Single||||||t
1292301|NCT03696420|||Case-Only||Prospective|||||||
1292302|NCT03696407|||Cohort||Retrospective|||||||
1292303|NCT03696394|Randomized|Parallel Assignment||Treatment||Single|This study will be single-blinded. Group I and II subjects will be blinded as to whether they have received BioCartilage® in addition to Microfracture or Microfracture alone, as per standard of care. Investigators will be aware of the assigned treatment on the patients. Subjects will be aware of their assigned treatment after their surgery.|Participants are assigned to one of two groups. Group I consists of 5 patients receiving Microfracture as per standard of care (Control Group). Group II consists of 10 patients receiving Microfracture with BioCartilage® (Investigational Group).|t|||
1292304|NCT03696381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292305|NCT03696368|||Cohort||Prospective|||||||
1292306|NCT03696355|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292307|NCT03696342|Randomized|Parallel Assignment||Treatment||Double|"In addition, the statistical analysis will be carried out in a blinded manner in the case of a partial and final analysis.~The masking will be done using boxes in the primary packaging identical in the two groups and relabelling the bottles of both interventions.~Blinding for the research subject and the researcher will be done by replacing the commercial labels in the case of the comparator in the bottles and the use of identical labels that contain the assignment number."|clinical study of non-inferiority, multicenter, double-blind, with comparative group randomized|t||t|
1292308|NCT03696329|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292309|NCT03696316||||||||||||
1292310|NCT03696303|||Case-Control||Prospective|||||||
1292311|NCT03696290|Randomized|Parallel Assignment||Treatment||Quadruple|Trail management team will also be masked. A bespoke online randomisation system will be used to generate the treatment codes for each participant|Multi-centre randomised double-blind placebo controlled parallel group trial with four treatment arms|t|t|t|t
1292312|NCT03696277||Single Group Assignment||Treatment||None (Open Label)||||||
1292313|NCT03696264||Single Group Assignment||Basic Science||None (Open Label)|Participants blinded to the protein dose consumed in a given metabolic trial|||||
1292314|NCT03696251|||Cohort||Cross-Sectional|||||||
1292315|NCT03696238|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1292316|NCT03696225|Randomized|Parallel Assignment||Treatment||Single|Assessors will be masked to participant condition.|This is a parallel randomized controlled pilot trial.||||t
1292317|NCT03696212||Single Group Assignment||Treatment||None (Open Label)||||||
1292326|NCT03696095|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292327|NCT03696082|Randomized|Sequential Assignment||Other||Single|The outcome assessors will be masked to intervention assignment.|||||t
1292328|NCT03696069|||Cohort||Retrospective|||||||
1292329|NCT03696056|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292330|NCT03696043|Non-Randomized|Parallel Assignment||Treatment||Single|Target of 100 participants - 50% freehand EVD placement and 50% image guided EVD placement. Randomization is every other patient will received image guided EVD placement|Target of 100 participants - 50% freehand EVD placement and 50% image guided EVD placement. Randomization is every other patient will received image guided EVD placement|t|||
1292331|NCT03696030||Single Group Assignment||Treatment||None (Open Label)||||||
1292332|NCT03696017|||Case-Control||Cross-Sectional|||||||
1292333|NCT03696004|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1292334|NCT03695991|||Cohort||Prospective|||||||
1292335|NCT03695978|||Cohort||Other|||||||
1292336|NCT03695965|||Other||Cross-Sectional|||||||
1292337|NCT03695952|||Cohort||Prospective|||||||
1292338|NCT03695939||Single Group Assignment||Treatment||None (Open Label)||||||
1292339|NCT03695926||Single Group Assignment||Other||None (Open Label)||||||
1292340|NCT03695913||Single Group Assignment||Treatment||None (Open Label)||||||
1292341|NCT03695900|Randomized|Crossover Assignment||Other||None (Open Label)||This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2, 93-95% vs 90-92%) on ventilatory stability in premature infants.||||
1292342|NCT03695887|Randomized|Crossover Assignment||Treatment||Double||Randomized to receive either active study article or inactive comparator then crossed over to other treatment arm on next dressing change.|t|||t
1292343|NCT03695874|||Other||Prospective|||||||
1292344|NCT03695861||Single Group Assignment||Diagnostic||None (Open Label)|The interpretation of the PET-CT will be performed by a nuclear medicine expert who is expert in cardiac imaging and infectious pathology, blinded to other imaging tests.|"Diagnostic study, prospective, delayed-type cross-sectional study (the result of the reference test is defined at 3 months of follow-up), monocentric, blinded, including consecutive patients."||||
1292345|NCT03695848|||Case-Control||Prospective|||||||
1292346|NCT03695835|||Case-Only||Other|||||||
1292347|NCT03695822||Single Group Assignment||Treatment||None (Open Label)||||||
1292348|NCT03695809|||Cohort||Retrospective|||||||
1292349|NCT03695796||Single Group Assignment||Diagnostic||None (Open Label)||biopsy-proven NAFLD patients||||
1292350|NCT03695783|Randomized|Parallel Assignment||Health Services Research||Single|"Given the study design and intervention, it is not possible to ensure the blinding of patients and physicians. However, we will attempt to address the limitations resulting from a lack of blinding:~Patients and the physicians will be informed of the study protocol, but will not be provided accurate information about the specific primary outcome (i.e. comparison between IBD&me and the Crohn's & Colitis Foundation of America (CCFA) resource). The informed consent document will keep participants blind to the study goals.~Physicians will be kept blinded of the patient's assignment group until the clinic visit.~Data will be collected by an independent researcher. Study investigators and the data analyst will remain blinded until all follow-up data is obtained and the primary analysis is finalized."|Parallel Assignment|||t|
1292351|NCT03695770||Single Group Assignment||Other||None (Open Label)||before/after study design||||
1292352|NCT03695757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Intramuscularly administrations of autologous total IgG in healthy subjects and patients with advanced solid tumor||||
1292353|NCT03695744||Single Group Assignment||Treatment||None (Open Label)||||||
1292354|NCT03695731|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1292355|NCT03695718|||Cohort||Prospective|||||||
1292356|NCT03695705|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1292357|NCT03695692|Randomized|Factorial Assignment||Treatment||Single||||||t
1292358|NCT03695679|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1292359|NCT03695666|||Other||Retrospective|||||||
1292360|NCT03695653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292361|NCT03695640|Randomized|Parallel Assignment||Treatment||Single||randomized, controlled, prospective||||t
1292362|NCT03695627|Randomized|Parallel Assignment||Treatment||Single|Investigator will be blind to condition throughout data accrual.||||t|
1292363|NCT03695614||Single Group Assignment||Treatment||None (Open Label)||||||
1292364|NCT03695601|||Cohort||Prospective|||||||
1292365|NCT03695588|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292366|NCT03695575||Single Group Assignment||Supportive Care||None (Open Label)||||||
1292367|NCT03695562|Randomized|Parallel Assignment||Treatment||Double|double blinded||t|||t
1292368|NCT03695549|Randomized|Parallel Assignment||Treatment||Single||||||t
1292369|NCT03695536|||Case-Control||Cross-Sectional|||||||
1292370|NCT03695523|Randomized|Parallel Assignment||Other||Single|Children and childcare providers will be aware of whether or not they receive the intervention. However, research assistants who are collecting data will remain blind to each centre's group assignment.|Cluster randomized controlled trial||||t
1292371|NCT03695510||Single Group Assignment||Treatment||None (Open Label)||||||
1292372|NCT03695497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292373|NCT03695484|||Case-Control||Prospective|||||||
1292374|NCT03695471||Single Group Assignment||Treatment||None (Open Label)||||||
1292375|NCT03695458|Randomized|Parallel Assignment||Treatment||Quadruple|Phototherapy pad with six clusters of 12 diodes each one will be placed in both legs. Only one researcher, that will be not involved with any procedure during data collection and analysis, will know about the phototherapy program used in which leg and randomization procedure. The light aspect is the same independent of the program (active or placebo) applied and all participants will wear a opaque glasses to protect against irradiation and also assure the blinding.|Randomized, triple-blind and placebo-controlled|t|t|t|t
1292376|NCT03695445|||Cohort||Prospective|||||||
1573297|NCT00001718||||||||||||
1292377|NCT03695432|Randomized|Factorial Assignment||Prevention||Single||||||t
1292378|NCT03695419|||Case-Only||Cross-Sectional|||||||
1292379|NCT03695406||Single Group Assignment||Other||None (Open Label)||||||
1292380|NCT03695393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292381|NCT03695380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292382|NCT03695367||Single Group Assignment||Prevention||None (Open Label)||||||
1292383|NCT03695354|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1292384|NCT03695341|||Cohort||Retrospective|||||||
1292385|NCT03695328|||Case-Crossover||Cross-Sectional|||||||
1292386|NCT03695315|||Case-Crossover||Prospective|||||||
1292387|NCT03695302|||Other||Cross-Sectional|||||||
1292388|NCT03695289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292389|NCT03695276|Randomized|Parallel Assignment||Health Services Research||Single|Investigators and the Data Safety Monitoring Board will receive data summaries that mask identification of groups.|Cluster randomized controlled trial|||t|
1292390|NCT03695263||Sequential Assignment||Treatment||None (Open Label)|The analysis will proceed automatically without knowledge of which 3-day treatment periods were associated with one of the five interventions and which were associated with the subject's usual activities.|"Each participant will enroll in a personalized (N-of-1) crossover trial."||||
1292391|NCT03695250||Single Group Assignment||Treatment||None (Open Label)||||||
1292392|NCT03695237||Single Group Assignment||Treatment||None (Open Label)||||||
1292393|NCT03695224|||Cohort||Prospective|||||||
1292394|NCT03695211|Randomized|Parallel Assignment||Treatment||Double|Participants and observers are blinded to the block position of the superficial cervical plexus|Randomize, double blind, prospective|t|||t
1292395|NCT03695198|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1292396|NCT03695185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292397|NCT03695172|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomly assigned to one of three treatment groups, TAP, QL, or ESP blocks||||
1292398|NCT03695159|||Case-Only||Other|||||||
1292399|NCT03695146|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1292400|NCT03695133|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1292401|NCT03695120|Randomized|Parallel Assignment||Treatment||None (Open Label)||The subjects will be randomized into a control group or variable group with an approximate 50/50 randomization. The control group will consist of subjects receiving ACEIs/ARBs. The variable group will consist of subjects that will not receive ACEI/ARBs during the first 72 hours of admission.||||
1292402|NCT03695107|||Other||Other|||||||
1292403|NCT03695094|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1292404|NCT03695081|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||"An intervention group is compared to a cross-sectional retrospective group.~A group of 60 patients with hip fracture will get an intervention by a clinical pharmacist who performs medication reconciliation and medication review during hospitalisation, they will receive a discharge summary where the medication part is optimised. After six weeks the patients will be get a follow-up with a second medication reconciliation and - review. This group will be compared with the last 50 patients with hip fracture who did not get the intervention."||||
1292405|NCT03695068|Randomized|Parallel Assignment||Treatment||Single|Assessors are not aware of intervention assignment.|Participants are randomly assigned to one of two arms: (1) the reading instruction for students who are English learners with reading difficulties (RISE) intervention or (2) a business as usual comparison condition.||||t
1292406|NCT03695055|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292407|NCT03695042|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292408|NCT03695029|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292409|NCT03695016|Randomized|Parallel Assignment||Prevention||Double|Participants and their referring physician will be aware of participant randomization. Only the intervention coach, who will also notify the participants of their assignment will be aware of the assignments; other study staff and the investigator will be masked.|3 month wait-listed control trial in which participants are randomized to immediate intervention or intervention after 3 months.|||t|t
1292410|NCT03695003|Randomized|Parallel Assignment||Other||Triple|Double blind. Randomized by a disinterested third party. Placebo and active capsules matched for aesthetics.|The study will follow a randomised, double-blind, placebo-controlled, parallel groups design.|t||t|t
1292411|NCT03694990|||Cohort||Prospective|||||||
1292412|NCT03694977||Single Group Assignment||Treatment||None (Open Label)||MCS110/PDR001 combination||||
1292413|NCT03694964|Randomized|Parallel Assignment||Treatment||Triple|Double blind study: treatment (experimental group) vs placebo (control group).|After signing the informed consent form, the patients will be randomized either in the experimental group (Citrulline (ProteiCIT®): 10 g / day) or in the control group (placebo).|t|t|t|
1292414|NCT03694951|Randomized|Parallel Assignment||Other||Single|Study advertisements and information provided to participants will focus on non-specific behaviour change, in order to mask participants to the purpose of the study.|Upon obtaining consent, eligible participants will complete a week-long baseline period and then will be randomly assigned to either a 1-week intervention or control group, followed by a 1-week follow-up period.|t|||
1292415|NCT03694938||Single Group Assignment||Screening||None (Open Label)||||||
1292416|NCT03694925|||Case-Control||Prospective|||||||
1292417|NCT03694912|||Cohort||Prospective|||||||
1292418|NCT03694899||Single Group Assignment||Prevention||None (Open Label)||||||
1292419|NCT03694886|Randomized|Parallel Assignment||Basic Science||Single|Participants will not be made aware if they have or have not received caffeine to not bias results.|"Participants will be randomly assigned to one of four groups:~1) 90 mg caffeine with a 1 mm diameter sucrose pillule; 2) no caffeine with the small sucrose pillule; 3) 90 mg caffeine with a 5 mm sucrose pillule; 4) no caffeine with the large sucrose pillule."|t|||
1292420|NCT03694873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292421|NCT03694860|||Other||Prospective|||||||
1292422|NCT03694847|||Case-Control||Retrospective|||||||
1292476|NCT03694145|||Other||Prospective|||||||
1292423|NCT03694834||Single Group Assignment||Basic Science||None (Open Label)||||||
1292424|NCT03694821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292425|NCT03694808|Randomized|Parallel Assignment||Treatment||Single||"A non-inferiority randomized clinical trial to enroll 500 long term care (LTC) dwellers from at least one of 40 nursing homes sites in northern Ohio.~Age 65 and older to receive either Fluad or HD vaccine at 1:1 ratio.~Blood will be sampled pre- and post-vaccine and post-influenza season and coded for blinded laboratory analysis.~Randomization by from randomizer.org software./RedCAP"||||t
1292426|NCT03694795|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292427|NCT03694782|||Case-Control||Prospective|||||||
1292428|NCT03694769|||Cohort||Cross-Sectional|||||||
1292429|NCT03694756|Non-Randomized|Parallel Assignment||Other||None (Open Label)|no need for masking, all patients will undergo TMEM-MRI|Patients will be enrolled in 2 cohorts (A and B), based on breast biopsy status.||||
1292430|NCT03694743|Randomized|Parallel Assignment||Treatment||Single|Double (Participant, Outcomes Assessor)||t|||
1292431|NCT03694730|Randomized|Parallel Assignment||Prevention||Single|The study staff responsible for collecting primary and secondary outcomes will be blinded to group allocation.|Two treatment groups receiving different activity modification instructions.||||t
1292432|NCT03694717|||Cohort||Prospective|||||||
1292433|NCT03694704||Single Group Assignment||Other||None (Open Label)||||||
1292434|NCT03694691||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292435|NCT03694678|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292436|NCT03694665||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292437|NCT03694652|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292438|NCT03694639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292439|NCT03694626|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1292440|NCT03694613||Single Group Assignment||Diagnostic||None (Open Label)|Clinical team (care provider) will be blinded to the Placental/Umbilical Cord Blood sepsis evaluation results|||||
1292441|NCT03694600|||Other||Prospective|||||||
1292442|NCT03694587|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292443|NCT03694574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292444|NCT03694561|||Cohort||Prospective|||||||
1292445|NCT03694548||Single Group Assignment||Supportive Care||None (Open Label)||Prospective single group interventional study (Part B)||||
1292446|NCT03694535||Single Group Assignment||Prevention||None (Open Label)||single group of patients composed of intermediate and high risk non muscle invasive bladder cancer||||
1292447|NCT03694522|Randomized|Parallel Assignment||Treatment||Double|Double blinded (participant, treating physician)||t||t|
1292448|NCT03694509|Randomized|Parallel Assignment||Treatment||Double|The ultrasound assessor will be blinded to group allocation. The statistician will be blinded to group allocation.|Two groups - Tea with milk group and water control group.|||t|t
1292449|NCT03694496|Randomized|Parallel Assignment||Supportive Care||Double|.An experienced fieldworker will facilitate the survey process, and she will be blind to our group allocation. Two experienced dentists will conduct the dental examinations who don't know the group allocation.||||t|t
1292450|NCT03694483|||Cohort||Prospective|||||||
1292451|NCT03694470|||Cohort||Retrospective|||||||
1292452|NCT03694457|Randomized|Parallel Assignment||Treatment||None (Open Label)|no masking|||||
1292453|NCT03694444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292454|NCT03694431|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomization of registered nurses stratified by site (n=15) to either standard or tech-supported HBPC||||
1292455|NCT03694418|Randomized|Sequential Assignment||Prevention||None (Open Label)||Stepped Wedge Design||||
1292456|NCT03694405|Randomized|Parallel Assignment||Prevention||Double||Group 1 = 3 prior doses of MenC vaccine (Alberta), Group 2 = 2 prior doses of MenC vaccine (British Columbia), Group 3 = 1 prior dose of MenC vaccine (Nova Scotia). Group A = Menveo (MenACWY-CRM), Group B = Menactra (MenACWY-DT), Group C = Nimenrix (MenACWY-TT)|t|||t
1292457|NCT03694392|||Cohort||Prospective|||||||
1292458|NCT03694379|Randomized|Parallel Assignment||Prevention||Single||||||t
1292459|NCT03694366|||Ecologic or Community||Prospective|||||||
1292460|NCT03694353||Single Group Assignment||Treatment||None (Open Label)||||||
1292461|NCT03694340||Single Group Assignment||Supportive Care||None (Open Label)||Single-case research design||||
1292462|NCT03694327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292463|NCT03694314|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1292464|NCT03694301|||Cohort||Prospective|||||||
1292465|NCT03694288|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a multicenter randomized clinical trial comparing implant retention (Retention) to scheduled removal of implants (Removal) in skeletally mature patients with previously operatively treated Lisfranc injuries requiring screw and/or plate fixation.||||
1292466|NCT03694275||Single Group Assignment||Treatment||None (Open Label)||||||
1292467|NCT03694262||Single Group Assignment||Treatment||None (Open Label)||Cycle length = 21 days Atezolizumab 1,200mg IV on day 1 Bevacizumab 15mg/kg IV on day 1 Rucaparib 600mg orally twice daily by continuous dosing||||
1292468|NCT03694249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292469|NCT03694236||Single Group Assignment||Treatment||None (Open Label)||||||
1292470|NCT03694223|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1292471|NCT03694210||Single Group Assignment||Other||None (Open Label)||A prospective, single arm, open label, multi-center, trial to evaluate the safety and effectiveness of the Interscope EndoRotor® Resection System in subjects requiring direct endoscopic necrosectomy with walled off pancreatic necrosis (WOPN).||||
1292472|NCT03694197||Single Group Assignment||Treatment||None (Open Label)||||||
1292473|NCT03694184|||Other||Retrospective|||||||
1292474|NCT03694171|||Cohort||Retrospective|||||||
1292475|NCT03694158|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind, placebo controlled.|This is a genotype stratified, double-blind, randomized, placebo-controlled, parallel-group, phase 2 clinical trial|t|t|t|t
1292477|NCT03694132|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||patients vs. health subjects||||
1292478|NCT03694119|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1292479|NCT03694106|||Case-Only||Prospective|||||||
1292480|NCT03694093|||Case-Only||Prospective|||||||
1292481|NCT03694080||Single Group Assignment||Treatment||None (Open Label)||||||
1292482|NCT03694067|||Case-Control||Retrospective|||||||
1292483|NCT03694054|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1292484|NCT03694041|Randomized|Parallel Assignment||Treatment||Double||Parallel design for SAD and MAD studies Crossover design for Food and Drug interaction studies|t||t|
1292485|NCT03694028|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1292486|NCT03694015|Randomized|Parallel Assignment||Treatment||None (Open Label)||Simple randomization with stratification will be used to randomly assign patients to either Arm 1 or Arm 2 in a 1:1 ratio using a computer-generated randomization scheme.||||
1292487|NCT03694002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292488|NCT03693989|Randomized|Parallel Assignment||Treatment||Double|"Blinding and masking The blinding will correspond to the research subject and the principal investigator. In addition, the statistical analysis will be carried out in a blinded manner in the case of a partial and final analysis.~The masking will be carried out using boxes in the identical primary packaging in the two groups and re-labeling the bottles of both interventions.~Blinding for the research subject and the researcher will be done by replacing the commercial labels in the case of the comparator in the bottles and the use of identical labels that contain the assignment number."|double-blind, controlled, parallel group, multicentre, randomized|t||t|
1292489|NCT03693976|||Other||Prospective|||||||
1292490|NCT03693963||Single Group Assignment||Treatment||None (Open Label)||||||
1292491|NCT03693950|Randomized|Parallel Assignment||Other||Double|||t|t||
1292492|NCT03693937|||Cohort||Retrospective|||||||
1292493|NCT03693924|||Cohort||Retrospective|||||||
1292494|NCT03693911|Randomized|Parallel Assignment||Prevention||None (Open Label)|No masking was carried out|Comparison between AcceptME and waitlist control group||||
1292495|NCT03693898||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292496|NCT03693885|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292497|NCT03693872|Non-Randomized|Parallel Assignment||Other||Single|open|Interventional to minimal risks and constraints, non randomized, open|t|||
1292498|NCT03693859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292499|NCT03693846||Single Group Assignment||Treatment||None (Open Label)||||||
1292500|NCT03693833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292501|NCT03693820|Randomized|Parallel Assignment||Prevention||Quadruple|the infiltration cocktail of local anesthetic will be replaced by saline in the same volume.||t|t|t|t
1292502|NCT03693807||Single Group Assignment||Treatment||None (Open Label)||Pilot non- randomized safety study.||||
1292503|NCT03693794|||Ecologic or Community||Prospective|||||||
1292504|NCT03693781|Randomized|Parallel Assignment||Treatment||Double|placebo will be unrecognizable from active treatment (both in tablets)|Three arms of 18 patients each; in two arms two colchicine dosages will be tested compared to placebo in the control arm. The three arms will undergo treatment vs placebo in parallel|t||t|
1292505|NCT03693768||Single Group Assignment||Supportive Care||None (Open Label)||||||
1292506|NCT03693755|Randomized|Parallel Assignment||Treatment||Single|The Patient will not be told in which Group he belongs|1 Group will be compared to another|t|||
1292507|NCT03693742|Randomized|Crossover Assignment||Diagnostic||Triple|For randomization, a computer generated random list will determine the order of the scans (MSG first, placebo first). Sealed envelopes will be prepared. A study coordinator or technologist not involved in measuring vital signs or collecting adverse events will prepare the tomato juice solution based on the randomization envelope. The rest of the team will not be informed of which tomato juice is used (placebo or MSG) but this information will be recorded and will be immediately accessible should a participant experience a severe adverse event.|This is a prospective double blind intra-participant comparison of [18F]-DCFPyL PET/CT scans performed after orally administered MSG or placebo. The participants will receive oral administration of MSG or placebo, in two different examination sessions, 30 minutes before [18F]-DCFPyL injection.|t|t||t
1292508|NCT03693729|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1292509|NCT03693716||Single Group Assignment||Treatment||None (Open Label)||||||
1292510|NCT03693703|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1292511|NCT03693690|||Cohort||Prospective|||||||
1292512|NCT03693677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292513|NCT03693664|||Other||Prospective|||||||
1292514|NCT03693651|||Cohort||Prospective|||||||
1292515|NCT03693638|Randomized|Parallel Assignment||Treatment||Single|||t|||
1292516|NCT03693625||Single Group Assignment||Treatment||None (Open Label)||||||
1292517|NCT03693612|Randomized|Parallel Assignment||Treatment||None (Open Label)||In Part 1, dose escalation will occur using a zone based approach. Part 2 will be randomized, parallel group study wherein the subjects will be randomized in a ratio of 2:1 to either recommended Phase 2 dose combination of GSK3359609 and tremelimumab or SOC (paclitaxel, docetaxel or cetuximab).||||
1292518|NCT03693599|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1292519|NCT03693586|||Other||Cross-Sectional|||||||
1292520|NCT03693573||Single Group Assignment||Treatment||None (Open Label)||||||
1292521|NCT03693560|Randomized|Parallel Assignment||Treatment||None (Open Label)||All enrolled patients will be mentioned as two groups; Group I (n=40) are patients who the endocrinologist prescribed them vildagliptin plus their metformin to control their blood sugar level. Group II (n=40) are patients who the endocrinologist prescribed them glimepiride plus their metformin.||||
1292522|NCT03693547||Single Group Assignment||Treatment||None (Open Label)||||||
1292523|NCT03693534|||Cohort||Prospective|||||||
1292524|NCT03693521|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1292587|NCT03692702|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573298|NCT00001717||||||||||||
1292525|NCT03693508||Single Group Assignment||Treatment||None (Open Label)||Single arm, phase 4 study. The naive patients will be treated with elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide as a first-line treatment||||
1292526|NCT03693495||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292527|NCT03693482|||Other||Other|||||||
1292528|NCT03693469|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1292529|NCT03693456|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1292530|NCT03693443|||Case-Only||Cross-Sectional|||||||
1292531|NCT03693430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292532|NCT03693417|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1292533|NCT03693404|Randomized|Parallel Assignment||Treatment||Single|||t|||
1292534|NCT03693391|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1292535|NCT03693378|||Cohort||Prospective|||||||
1292536|NCT03693365|||Case-Only||Prospective|||||||
1292537|NCT03693352|||Case-Only||Prospective|||||||
1292538|NCT03693339||Single Group Assignment||Treatment||None (Open Label)||||||
1292539|NCT03693326||Single Group Assignment||Treatment||None (Open Label)||||||
1292540|NCT03693313|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized Wait List Trial||||
1292541|NCT03693300||Single Group Assignment||Treatment||None (Open Label)||||||
1292542|NCT03693287|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1292543|NCT03693274|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1292544|NCT03693261|||Case-Crossover||Cross-Sectional|||||||
1292545|NCT03693248|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparison of clinical outcomes between two and three cycles of neoadjuvant chemotherapy followed by interval debulking surgery.||||
1292546|NCT03693235|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1292547|NCT03693222|Randomized|Parallel Assignment||Other||Triple|The investigator's study is a prospective, randomized, double-blind study.|Patients included in the study were randomly divided into 2 groups. Cases were assessed as intravenous opioid with 1 mg/kg tramadol HCl (Group O, n=20) or ultrasonography-guided quadratus lumborum block (Group B, n=20).|t||t|t
1292548|NCT03693209|Randomized|Parallel Assignment||Prevention||Double|The control condition is active and has a similar format to the intervention conditions to avoid participants knowing which condition they have been assigned to. Outcomes are assessed by self-report.|There will be one control group and two intervention groups. Each group will be independently be compared with the others, and not in combination.|t|||t
1292549|NCT03693196|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1292550|NCT03693183|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292551|NCT03693170||Single Group Assignment||Treatment||None (Open Label)|All involved know the identity of the intervention assignment.|||||
1292552|NCT03693157|||Cohort||Prospective|||||||
1292553|NCT03693144|Randomized|Parallel Assignment||Other||Single||||||t
1292554|NCT03693131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292555|NCT03693118|Randomized|Factorial Assignment||Treatment||Single|||t|||
1292556|NCT03693105|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will receive stimulation to one of two brain areas. Patients will be randomized to either stimulation site.||||
1292557|NCT03693092|||Case-Only||Prospective|||||||
1292558|NCT03693079||Single Group Assignment||Treatment||None (Open Label)||||||
1292559|NCT03693066|Randomized|Parallel Assignment||Treatment||Single||||||t
1292560|NCT03693053|||Cohort||Prospective|||||||
1292561|NCT03693040||Single Group Assignment||Prevention||None (Open Label)||||||
1292562|NCT03693027|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1292563|NCT03693014||Single Group Assignment||Treatment||None (Open Label)||This is an open label Phase 2 screening trial in subjects.||||
1292564|NCT03693001||Single Group Assignment||Screening||None (Open Label)||||||
1292565|NCT03692988|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1292566|NCT03692975|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1292567|NCT03692962|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1292568|NCT03692949|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1292569|NCT03692936|||Case-Control||Prospective|||||||
1292570|NCT03692923|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1292571|NCT03692910||Single Group Assignment||Treatment||None (Open Label)||||||
1292572|NCT03692897|||Cohort||Retrospective|||||||
1292573|NCT03692884|||Cohort||Prospective|||||||
1292574|NCT03692871|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1292575|NCT03692858|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292576|NCT03692845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292577|NCT03692832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292578|NCT03692819|Randomized|Parallel Assignment||Treatment||Triple|In addition to concealment of randomization, the investigator responsible for the procedures of periodontal therapy (periodontal debridement) and the researcher responsible for the measurements will not know which treatment each group will receive, characterizing the blindness of the study.|Parallel Assignment Prospective double-blind randomized controlled clinical study with a 180-days follow-up.||t|t|t
1292579|NCT03692806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292580|NCT03692793||Single Group Assignment||Treatment||None (Open Label)||||||
1292581|NCT03692780|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292582|NCT03692767||Sequential Assignment||Treatment||None (Open Label)||||||
1292583|NCT03692754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292584|NCT03692741||||||||||||
1292585|NCT03692728|||Other||Cross-Sectional|||||||
1292586|NCT03692715|Randomized|Parallel Assignment||Prevention||Quadruple|Patients will undergo central randomization, which will be accessed by phone or internet. Un-blinding will occur only once statistical analysis is complete.||t|t|t|t
1292588|NCT03692689||Single Group Assignment||Treatment||None (Open Label)||||||
1292589|NCT03692676|||Cohort||Cross-Sectional|||||||
1292590|NCT03692663||Sequential Assignment||Treatment||None (Open Label)||||||
1292591|NCT03692650|||Cohort||Prospective|||||||
1292592|NCT03692637||Single Group Assignment||Treatment||None (Open Label)||||||
1292593|NCT03692624|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Cancer patients will be recruited from the Cancer Institute at Greenville Health System. Random assignment to the HRV-B or control group will occur after baseline assessment. During the baseline assessment, participants will be asked to fill out a questionnaire, including information about symptoms and feelings. Participant heart rate (pulse) and breathing will be measured for 15 minutes. Baseline heart rate will be measured with a sensor loosely attached to the wrist. Breathing will be monitored by another sensor attached around the abdomen by a belt. Each weekly HRV-B training session will last 30-45 minutes. In each session, heart rate and breathing will be monitored while the participant is viewing pleasant images on a computer screen. An Intervention professional will be present throughout the session. While viewing the images, the participant will be coached on how to control their pulse.||||
1292594|NCT03692611|Randomized|Parallel Assignment||Treatment||Double||This is a randomized controlled trial to discover whether STOMP is an efficacious Pain Self-Management (PSM) intervention, mediated by the hypothesized Social Cognitive Theory (SCT) constructs.|||t|t
1292595|NCT03692598||||||||||||
1292596|NCT03692585|||Other||Other|||||||
1292597|NCT03692572|Randomized|Crossover Assignment||Prevention||Triple|Only research nurse will have an access to the randomization sheet.|2 groups of women (early and normal menopause transition) will be enrolled to crossover design study in a fashion of randomized and double-blinded.|t||t|t
1292598|NCT03692559|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1292599|NCT03692546|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1292600|NCT03692533|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||2 groups : Group A include cases and Group B includes controls||||
1292601|NCT03692520||Single Group Assignment||Treatment||None (Open Label)||||||
1292602|NCT03692507|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292603|NCT03692494|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292604|NCT03692481||Single Group Assignment||Other||None (Open Label)||||||
1292605|NCT03692468|Randomized|Parallel Assignment||Treatment||Single||||||t
1292606|NCT03692455|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1292607|NCT03692442|||Cohort||Retrospective|||||||
1292608|NCT03692429|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"st segment: The dose-escalation segment: All patients will be treated with 3 injections of CYAD-101. Three escalating dose-levels (1x10^8, 3x10^8 and 1x10^9 per injection) of CYAD-101 will be evaluated using a 3+3 design. Each CYAD-101 injection will be administered at Day 3, after 5-FU pump removal, of the chemotherapy cycles 3 to 5.~Cohort 1: 1x10^8 per injection~Cohort 2: 3x10^8 per injection~Cohort 3: 1x10^9 per injection~nd segment: The expansion segment:~Cohort 4: The Recommended dose defined in the first segment, administered concurrently with FOLFOX, in a larger number of patients."||||
1292609|NCT03692416|Randomized|Parallel Assignment||Treatment||None (Open Label)|No other parties are masked in this clinical trial.|The aim of this work is to assess the effect of various forms of treatment of vasculitis on C3, C4, C5a & ANCA levels in blood, in infants & children.||||
1292610|NCT03692403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292611|NCT03692390|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1292612|NCT03692377|||Cohort||Prospective|||||||
1292613|NCT03692364|Randomized|Parallel Assignment||Treatment||Single||Prospective randomized study||||t
1292614|NCT03692351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292615|NCT03692338|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients will be assigned to one of three cohorts: Supervised exercise, semi-supervised exercise or usual care.||||
1292616|NCT03692325||Single Group Assignment||Prevention||None (Open Label)||||||
1292617|NCT03692312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292618|NCT03692299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292619|NCT03692286|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292620|NCT03692273||Parallel Assignment||Treatment||Single|The provider and patient will know which area is randomized to the three treatments. The assessors of the primary and secondary outcomes will be blinded to which treatment was provided to each of the three areas within the study scar.|Patients will receive all three interventions (laser, 0.5mm punch biopsy, and no treatment) within their study scar.||||t
1292621|NCT03692260|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1292622|NCT03692247||Single Group Assignment||Other||None (Open Label)||This is a cohort study of one group of 60 healthy volunteers without a diagnosis of neuropathy or chronic pain.||||
1292623|NCT03692234|Randomized|Parallel Assignment||Basic Science||Double||randomized double-blind placebo controlled|t||t|
1292624|NCT03692221|Randomized|Parallel Assignment||Treatment||None (Open Label)||24 participants will be equally randomized into two groups; 12 Healthy controls subjects & 12 treatment subjects. The treatment group will then be sub-divided and randomized into 6 subjects receiving a low dosage treatment and 6 subjects receiving a high dosage treatment||||
1292625|NCT03692208|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1292626|NCT03692195|Randomized|Parallel Assignment||Other||None (Open Label)||Study participants will either wear the WHOOP strap one week before their sleep study (as well as the night of the sleep study) or one week after their sleep study (as well as the night of the sleep study).||||
1292627|NCT03692182|||Cohort||Retrospective|||||||
1292628|NCT03692169|||Cohort||Prospective|||||||
1292629|NCT03692156|||Case-Only||Cross-Sectional|||||||
1292630|NCT03692143|||Cohort||Prospective|||||||
1292631|NCT03692130|Randomized|Parallel Assignment||Treatment||Double|The participants don't know in which of the both arms they are, the outcome assessor don't know which participant of which study-arm he/she calculate|One group with new treatment, one group with known and defined treatment|t|||t
1292632|NCT03692117|||Cohort||Prospective|||||||
1292633|NCT03692104|||Cohort||Prospective|||||||
1292634|NCT03692091|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1292635|NCT03692078|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1292636|NCT03692065|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292637|NCT03692052||Single Group Assignment||Treatment||None (Open Label)||||||
1292638|NCT03692039|Randomized|Parallel Assignment||Treatment||Single|After the operator find an eligible participant, a phone call is made to the assistant supervisor to confirm the patient eligibility then to assign the participant to either group according to the generated random sequence.|Blocks of 4 are generated on a Microsoft Excel sheet where the intervention and control are denoted A & B and randomly distributed. The table is kept with the assistant supervisor.|t|||
1292639|NCT03692026|Randomized|Parallel Assignment||Treatment||Double||It's a Randomized Clinical Trial|t|||t
1292640|NCT03692013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292641|NCT03692000|||Other||Other|||||||
1292642|NCT03691987|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292643|NCT03691974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292644|NCT03691961|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Half of the patients is enrolled in each group according to the individual dose decided by the clinician in charge as the optimal dose to treat the disease. The optimized dose to treat the disease is decided independently of the participation to the study.||||
1292645|NCT03691948|Randomized|Parallel Assignment||Other||Single|||t|||
1292646|NCT03691935|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292647|NCT03691922|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1292648|NCT03691909||Single Group Assignment||Treatment||None (Open Label)||A single IV infusion of autologous adipose-derived mesenchymal stem cells (HB-adMSCs) in subjects with clinical diagnosis of RA.||||
1292649|NCT03691896|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1292650|NCT03691883|||Cohort||Prospective|||||||
1292651|NCT03691870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292652|NCT03691857||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292653|NCT03691844|Randomized|Parallel Assignment||Treatment||Double|3 treatment arms will be double-blind, the 4th (comparator) will be single-blind|placebo-controlled, double-blind, randomized, parallel study|t||t|
1292654|NCT03691831|Randomized|Parallel Assignment||Treatment||Quadruple|The blinded vehicle solution is packaged to match the active study drug and will be stored under the same conditions.|Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study|t|t|t|t
1292655|NCT03691818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292656|NCT03691805|Randomized|Parallel Assignment||Treatment||Single|Participants will be blinded as to their assigned study arm.|Half of the participants will receive transcranial direct current stimulation, while the others will receive sham stimulation.|t|||
1292657|NCT03691792|Randomized|Parallel Assignment||Treatment||Single|Outcomes are rated on a semi-structured interview by raters blind to treatment assignment.|head-to-head RCT||||t
1292658|NCT03691779|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1292659|NCT03691766|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1292660|NCT03691753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292661|NCT03691740|Randomized|Parallel Assignment||Treatment||Triple|Study group assignments will be placed in an opaque envelope which will be kept in the designated research area on Labor and Delivery. After informed consent is obtained, the coordinator will take one of the envelopes to determine the study group. The coordinator will not communicate with the care provide or the investigator regarding study group assignment.|Randomized clinical trial||t|t|t
1292662|NCT03691727|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1. All subjects will be randomized to control (standard of care) or experimental arms.||||
1292663|NCT03691714||Single Group Assignment||Treatment||None (Open Label)||||||
1292664|NCT03691701|Randomized|Parallel Assignment||Treatment||Single||||||t
1292665|NCT03691688|||Cohort||Prospective|||||||
1292666|NCT03691675||Single Group Assignment||Treatment||None (Open Label)||Patients with de novo lesion whose radiography showed that target lesion diameter stenosis is ≥50%, reference diameter is ≥2.75mm and who agreed with the Drug coated balloon dilatation therapy||||
1292667|NCT03691662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292668|NCT03691649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292669|NCT03691636|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomized clinical trial||||
1292670|NCT03691623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292671|NCT03691610|Randomized|Parallel Assignment||Prevention||Triple|The study has a modified double blind design for each group at enrollment, and thus, with the exception of the personnel administering the vaccine, everyone involved in study is blinded to avoid any bias.||t||t|t
1292672|NCT03691597|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292673|NCT03691584||Single Group Assignment||Basic Science||None (Open Label)||||||
1292674|NCT03691571|Randomized|Parallel Assignment||Prevention||Single||Randomized, blinded single center pilot study|t|||
1292675|NCT03691558|Non-Randomized|Parallel Assignment||Other||Single|Treatment and control were masked with A and B|It is single blind, parallel arms study||||t
1292676|NCT03691545||Single Group Assignment||Supportive Care||None (Open Label)||||||
1292677|NCT03691532|Randomized|Crossover Assignment||Prevention||None (Open Label)||Mixed-crossover: three separate groups (paraplegia, tetraplegia, and neurologically intact) undergo two conditions (seated control and exercise) in a randomized order.||||
1292729|NCT03690856||Single Group Assignment||Other||None (Open Label)||||||
1292730|NCT03690843|||Cohort||Other|||||||
1292731|NCT03690830|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Two case groups (Recurrent Implantation Failure and idiopathic recurrent pregnancy loss ) One control group (patients undergoing Assisted ReproductiveTechnologies (ART) for male factor infertility)||||
1292732|NCT03690817|||Case-Control||Cross-Sectional|||||||
1292733|NCT03690804||Single Group Assignment||Supportive Care||None (Open Label)||||||
1292678|NCT03691519|Randomized|Parallel Assignment||Prevention||Triple|"This study will be a double-blind trial. The packaging, presentation, and labelling of products will ensure the blinding of both the medical team and the patient. The treatment arms in this study will be differentiated only by treatment numbers. Treatment arms will be allocated treatment numbers according to the previously established randomisation table.~Neither the investigating doctors nor the patients will be aware of the treatment arm to which the patients have been allocated until the end of the study."|Subjects will be randomly assigned in a 1:1 ratio to one of the following 2 groups: (i) DHA+EPA supplement or (ii) placebo. A computer-generated randomisation procedure will be used with stratification by centre. A centralised Interactive Voice Response System will be used to identify which group to allocate and which lot number to administrate|t|t|t|
1292679|NCT03691506|Randomized|Parallel Assignment||Treatment||Single||||||t
1292680|NCT03691493||Single Group Assignment||Treatment||None (Open Label)||||||
1292681|NCT03691480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292682|NCT03691467|Randomized|Parallel Assignment||Treatment||Double||randomized clinical trial|t|||t
1292683|NCT03691454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292684|NCT03691441|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Prospective, two-arm, open label, multicenter, randomized, controlled comparative effectiveness study.~The trial is based on an event-driven design: the final analysis will be performed when all events have been observed or the study was terminated at one of the interim analyses."||||
1292685|NCT03691428|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1292686|NCT03691415|||Cohort||Prospective|||||||
1292687|NCT03691402|Randomized|Parallel Assignment||Treatment||Double|Double blind||||t|t
1292688|NCT03691389|||Family-Based||Retrospective|||||||
1292689|NCT03691376||Single Group Assignment||Treatment||None (Open Label)||||||
1292690|NCT03691363||Single Group Assignment||Treatment||None (Open Label)||All youth will receive the intervention||||
1292691|NCT03691350|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292692|NCT03691337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292693|NCT03691324|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1292694|NCT03691311|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a parallel two arms trial randomized in 2:1 proportions to intervention group vs control group. . At least 24 patients with hormone receptor negative breast cancer and 24 premenopausal patients will be included in the study so allocation of patients without any of these two characteristics will be restricted depending on the overall characteristics of the included population||||
1292695|NCT03691298|||Case-Only||Prospective|||||||
1292696|NCT03691285|Randomized|Parallel Assignment||Treatment||None (Open Label)|To avoid selection bias and ensure adequate allocation concealment, their treatment group will only be revealed for each participant after the assessment of the baseline outcomes, which will occur after the delivery and regular use of the new set of conventional dentures. Since full blinding for the two interventions is not possible for those involved with treatment management and collection of data, only those collecting and analyzing clinical data from masticatory performance tests will be unaware of the assigned treatment.|Comparative effectiveness of two competing strategies for the edentulous mandible using implants||||
1292697|NCT03691272|Randomized|Parallel Assignment||Treatment||Quadruple|Participants will be randomized with a random number generator to receive either sham or rTMS. Allocation will be concealed through the use of sequentially numbered, sealed, opaque envelopes.||t|t|t|t
1292698|NCT03691259|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1292699|NCT03691246|||Cohort||Retrospective|||||||
1292700|NCT03691233|||Case-Only||Prospective|||||||
1292701|NCT03691220|Randomized|Parallel Assignment||Treatment||Single|Study pathologists will perform masked reading of for-cause biopsy slides.|Study participants will be randomized to receive the telemetric intervention or standard of care.||||t
1292702|NCT03691207||Single Group Assignment||Treatment||None (Open Label)||Open label||||
1292703|NCT03691194|Randomized|Crossover Assignment||Other||Single|||t|||
1292704|NCT03691181||Single Group Assignment||Treatment||None (Open Label)||||||
1292705|NCT03691168|||Cohort||Prospective|||||||
1292706|NCT03691155|Non-Randomized|Single Group Assignment||Other||Single|||t|||
1292707|NCT03691142|||Other||Prospective|||||||
1292708|NCT03691129|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1292709|NCT03691116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292710|NCT03691103|||Cohort||Prospective|||||||
1292711|NCT03691090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292712|NCT03691077||Single Group Assignment||Treatment||None (Open Label)||The first dose of ocrelizumab will be administered as two 300-mg IV infusions (600 mg total) in 250 mL 0.9% sodium chloride each separated by 14 days (i.e., Days 1 and 15), followed by one 600-mg IV infusion in 500 mL 0.9% sodium chloride every subsequent doses (i.e., every 24 weeks) for 72 weeks.||||
1292713|NCT03691064|||Cohort||Other|||||||
1292714|NCT03691051||Single Group Assignment||Treatment||None (Open Label)||||||
1292715|NCT03691038|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292716|NCT03691025|||Cohort||Prospective|||||||
1292717|NCT03691012|||Cohort||Prospective|||||||
1292718|NCT03690999|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1292719|NCT03690986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292720|NCT03690973|Randomized|Parallel Assignment||Treatment||Single|single blinded|It is randomized clinical trial||||t
1292721|NCT03690960|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292722|NCT03690947|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292723|NCT03690934|Randomized|Parallel Assignment||Treatment||None (Open Label)||Assignment||||
1292724|NCT03690921||Single Group Assignment||Treatment||None (Open Label)||||||
1292725|NCT03690908|||Case-Control||Retrospective|||||||
1292726|NCT03690895|||Case-Only||Retrospective|||||||
1292727|NCT03690882|||Case-Only||Retrospective|||||||
1292728|NCT03690869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292734|NCT03690791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292735|NCT03690778|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292736|NCT03690765|||Cohort||Prospective|||||||
1292737|NCT03690752|Randomized|Parallel Assignment||Treatment||Single|||t|||
1292738|NCT03690739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292739|NCT03690726|Randomized|Parallel Assignment||Treatment||Triple||Randomized Placebo Controlled Clinical Intervention Study|t|t||t
1292740|NCT03690713|||Cohort||Prospective|||||||
1292741|NCT03690700|Randomized|Parallel Assignment||Treatment||Double|"Prior to the first training session, participants will be block-randomized to either active BFRE (n=12) or sham BFRE (n=12), (control for gender).~The outcome assessor will be blinded from the randomization."|randomized placebo controlled parallel group study|t|||t
1292742|NCT03690687|||Cohort||Cross-Sectional|||||||
1292743|NCT03690674||Single Group Assignment||Supportive Care||None (Open Label)||||||
1292744|NCT03690661|Randomized|Parallel Assignment||Basic Science||Triple|Fully blinded||t||t|t
1292745|NCT03690648|||Case-Control||Prospective|||||||
1292746|NCT03690635|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292747|NCT03690622|Randomized|Parallel Assignment||Treatment||Double|masking for the drop instilled|randomised control trial|t||t|
1292748|NCT03690609|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1292749|NCT03690596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292750|NCT03690583|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1292751|NCT03690570|||Cohort||Retrospective|||||||
1292752|NCT03690557||Single Group Assignment||Treatment||None (Open Label)||||||
1292753|NCT03690544||Single Group Assignment||Treatment||None (Open Label)||Apremilast 30mg orally twice daily for 16 weeks||||
1292754|NCT03690531|||Case-Control||Prospective|||||||
1292755|NCT03690518|Randomized|Parallel Assignment||Other||None (Open Label)||Cardiac rehabilitation||||
1292756|NCT03690505||Single Group Assignment||Supportive Care||None (Open Label)||||||
1292757|NCT03690492|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1292758|NCT03690479|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1292759|NCT03690466|Randomized|Parallel Assignment||Treatment||Quadruple||"This will be a controlled, randomized, double-blinded trial of short-term (14 days) treatment with ultrasound stimulation (therapeutic energy dose) or sham (no energy dose) delivered to the spleen.~Participants will be provided a portable ultrasound device or sham device for at home use. Participants will be trained on how to use the device and will be instructed to use it for 30 minutes per day, at approximately the same time each day for 14 days.~Participants will be assessed at several time points before, during and at the end of treatment as well as a one-week follow-up visit."|t|t|t|t
1292760|NCT03690453|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1292761|NCT03690440|||Cohort||Other|||||||
1292762|NCT03690427|Randomized|Crossover Assignment||Other||None (Open Label)||Charcoal-heated hookah vs. Electronic hookah bowl||||
1292763|NCT03690414|Randomized|Parallel Assignment||Other||Quadruple|The study treatments will be labelled as A, B and C at the Pharmacy. The masked study products will then be sent to the study coordinator to dispense|Children aged between 6 to 13 years old. Myopia with spherical equivalent of -0.50D or worse with cylinder of -2.00D or less|t|t|t|t
1292764|NCT03690401|||Cohort||Prospective|||||||
1292765|NCT03690388|Randomized|Parallel Assignment||Treatment||Triple|Study treatment assignment will be unknown to the subjects, investigators, study centers, Sponsor, and any Contract Research Organization affiliated with the study other than those authorized to access treatment assignment for regulatory safety reporting and submission processes, IRT system administration, and drug supply management. Cabozantinib-matched placebo will be packaged and color-, size-, and shape-matched to be indistinguishable from cabozantinib. Individual study treatment assignment will be unblinded and information provided to the Investigators upon request for subjects with radiographic PD per RECIST 1.1 confirmed by the blinded independent radiology committee (BIRC).|This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study of cabozantinib in subjects with RAI-refractory DTC after prior VEGFR-TKI therapy. Cabozantinib-matched placebo will be given in the control arm to blind (mask) study treatment. Approximately 300 eligible subjects will be randomized in a 2:1 ratio to receive either cabozantinib or placebo. After the primary efficacy endpoints have been analyzed and sufficient data have been collected to adequately evaluate all study endpoints to establish, for regulatory purposes, the safety and efficacy profile of the experimental drug within this study, the study will transition to an open label Maintenance Phase.|t|t|t|
1292766|NCT03690375|Randomized|Parallel Assignment||Treatment||Single||||||t
1292767|NCT03690362|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||The study will enroll approximately 32 subjects assigned to treatment groups based on renal function.||||
1292768|NCT03690349|||Case-Control||Cross-Sectional|||||||
1292769|NCT03690336|||Cohort||Retrospective|||||||
1292770|NCT03690323|Randomized|Parallel Assignment||Treatment||None (Open Label)||Radiofrequency ablation (RFA) plus chemotherapy versus chemotherapy monotherapy||||
1292771|NCT03690310||Single Group Assignment||Treatment||None (Open Label)||||||
1292772|NCT03690297|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1292773|NCT03690284|Randomized|Parallel Assignment||Other||Single|||t|||
1292774|NCT03690271|||Cohort||Prospective|||||||
1292775|NCT03690258|Randomized|Crossover Assignment||Prevention||Single|Researches collecting data will be blinded of participant allocation.|Variable load exercise, non-pharmacological intervention|||t|
1292776|NCT03690245|Randomized|Parallel Assignment||Treatment||Single||||||t
1292777|NCT03690232|Randomized|Parallel Assignment||Treatment||Double|outcomes assessor and participant do not know the treatment patient received.|The study in the first year is a prospective, randomized controlled, double-blind study. The enrolled patients were randomly divided into two groups: the intraarticular glucose group and the intraarticular HA group.|t|||t
1292778|NCT03690219|||Cohort||Retrospective|||||||
1292779|NCT03690206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573299|NCT00001714||||||||||||
1292780|NCT03690193||Single Group Assignment||Treatment||None (Open Label)||||||
1292781|NCT03690180|||Case-Control||Retrospective|||||||
1292782|NCT03690167|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292783|NCT03690154||Single Group Assignment||Treatment||None (Open Label)||||||
1292784|NCT03690141||Single Group Assignment||Treatment||None (Open Label)||tomivosertib (eFT508) will be supplied as 100-mg capsules by the Sponsor. Capsules are packaged in 200-cc high-density polyethylene wide-mouth, round, white bottles, at either 100 or 150 units per bottle, induction sealed and capped with a 38-mm child-resistant closure.||||
1292785|NCT03690128|Randomized|Parallel Assignment||Prevention||None (Open Label)||A prospective, cluster randomized, cross-over, non-inferiority study||||
1292786|NCT03690115||Single Group Assignment||Treatment||None (Open Label)||||||
1292787|NCT03690102|Randomized|Parallel Assignment||Other||None (Open Label)||"Parallel Assignment~Participants are randomized to one of three groups (stratified for course type, using computer-generated lists with variable block sizes):~Participants are given a cardiac arrest scenario test either before or after a European Resuscitation Council standardized basic life support course. Two of the groups receive instructions in cardiopulmonary resuscitation from a dispatcher when they call the Emergency Medical Services."||||
1292788|NCT03690089|Randomized|Parallel Assignment||Treatment||Quadruple|Double-masked|Multicentre, randomised, double-masked, placebo-controlled superiority trial|t|t|t|t
1292789|NCT03690076|||Case-Control||Prospective|||||||
1292790|NCT03690063|||Cohort||Prospective|||||||
1292791|NCT03690050|Randomized|Parallel Assignment||Treatment||Triple|"Ophthalmologists undertaking laser treatments for DMO at each of the participating centres will also deliver the treatment for the trial. Although, for obvious reasons, ophthalmologists delivering the treatment will not be masked with regards to the laser used, every effort will be made to ensure that participants and outcome assessors (e.g. optometrists measuring visual function, photographers/technicians/nurses obtaining OCT images and ophthalmic technicians obtaining visual fields) will be masked to the allocated treatment. Patients will not be informed before, during, and after the laser treatment about which technology of laser was used for their treatment.~Similarly, the investigators obtaining outcome measures will only have access to the CRF booklet (but not to the notes of the patients) which will contain no information with regards to the type of laser the patient had been allocated or received"||t|t||t
1292792|NCT03690037|Randomized|Parallel Assignment||Treatment||None (Open Label)|Not Blinded|A Phase IV, single centred, open label, parallel group, randomised controlled trial||||
1292793|NCT03690024|||Case-Only||Prospective|||||||
1292794|NCT03690011||Single Group Assignment||Treatment||None (Open Label)||||||
1292795|NCT03689998|Randomized|Parallel Assignment||Treatment||Double|single blinded|it is randomized clinical trial|t|||t
1292796|NCT03689985||Single Group Assignment||Prevention||None (Open Label)||||||
1292797|NCT03689972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292798|NCT03689959||Single Group Assignment||Treatment||None (Open Label)||||||
1292799|NCT03689946||Single Group Assignment||Treatment||None (Open Label)||Early development, single-arm, prospective, open-label study of evolocumab injection in patients with calcified plaque in the coronary artery detected by CCTA. Fifty-five (55) evaluable subjects will be enrolled in the study.||||
1292800|NCT03689933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292801|NCT03689920|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292802|NCT03689907|||Cohort||Prospective|||||||
1292803|NCT03689894||Single Group Assignment||Treatment||None (Open Label)||||||
1292804|NCT03689881||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292805|NCT03689868|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1292806|NCT03689855||Single Group Assignment||Treatment||None (Open Label)||||||
1292807|NCT03689842||Single Group Assignment||Treatment||None (Open Label)||||||
1292808|NCT03689829|Randomized|Parallel Assignment||Basic Science||None (Open Label)|Part I - randomized open label. Part II - randomized double blind.|||||
1292809|NCT03689816||Single Group Assignment||Treatment||None (Open Label)||||||
1292810|NCT03689803||Single Group Assignment||Treatment||None (Open Label)||||||
1292811|NCT03689790||Single Group Assignment||Treatment||None (Open Label)||||||
1292812|NCT03689777||Single Group Assignment||Prevention||None (Open Label)||||||
1292813|NCT03689764|Randomized|Crossover Assignment||Treatment||Single||||||t
1292814|NCT03689751|Randomized|Parallel Assignment||Other||Double|Patients were block randomised in groups of 10 participants to either control (no video) or intervention (video), using opaque envelopes. Both control and intervention arms received standard pre-operative face to face counseling and written information. Clinicians were blinded to allocation. A research nurse blinded to allocation performed data entry.|Two RSAV were created explaining LSCS and TVT/TOT. Participants were block-randomised in groups of 10 to either control (no video) or intervention (video). Target recruitment was 60 patients per group; 30 patients per arm.||t||t
1292815|NCT03689738|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1292816|NCT03689725|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1292817|NCT03689712|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1292818|NCT03689699|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study will include a total of approximately 30 patients per arm to achieve at least 23 evaluable patients per arm.||||
1292819|NCT03689686||Single Group Assignment||Treatment||None (Open Label)||||||
1292820|NCT03689673|||Cohort||Prospective|||||||
1292821|NCT03689660|Randomized|Parallel Assignment||Treatment||Single|Nope||t|||
1292822|NCT03689647||Single Group Assignment||Basic Science||None (Open Label)||||||
1292823|NCT03689634|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1292824|NCT03689621|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292825|NCT03689608|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1292826|NCT03689595|||Cohort||Prospective|||||||
1292827|NCT03689582||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293014|NCT03687151|||Cohort||Prospective|||||||
1292828|NCT03689569|Randomized|Parallel Assignment||Prevention||Double|This will be a double blind study. Neither the participant nor the investigator will know what substance (resistant starch or corn starch) the participants will be consuming.|An Intention-To-Treat design will be used in this study. Effects of treatment on all dependent variables will be assessed by a 2 (prebiotic supplement or control) by 2 (aerobic exercise or control) by 3 (time) mixed factor ANOVA|t||t|
1292829|NCT03689556|||Case-Only||Prospective|||||||
1292830|NCT03689543|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1292831|NCT03689530|Randomized|Parallel Assignment||Prevention||Single||||||t
1292832|NCT03689517|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1292833|NCT03689504|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292834|NCT03689491|Randomized|Parallel Assignment||Treatment||Single|Single Blind (Outcomes Assessor)|Randomized||||t
1292835|NCT03689478||Single Group Assignment||Treatment||None (Open Label)||Prospective single-arm study||||
1292836|NCT03689465|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292837|NCT03689452|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292838|NCT03689439|||Cohort||Prospective|||||||
1292839|NCT03689426|||Case-Only||Prospective|||||||
1292840|NCT03689413|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1292841|NCT03689400|||Cohort||Retrospective|||||||
1292842|NCT03689387|||Case-Only||Retrospective|||||||
1292843|NCT03689374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292844|NCT03689361|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1292845|NCT03689348|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1292846|NCT03689335|Randomized|Parallel Assignment||Treatment||None (Open Label)|There is no blinding possible in this study, as the presence or absence of a skin incision/surgical scar is obvious to both patient and clinician during follow-up assessment.|Randomised controlled trial, with 1:1 allocation into one of 2 treatment arms (operative or non-operative treatment). The randomisation is stratified by patient age (<65 years old or ≥65 years old) to ensure approximately equal numbers by age in each treatment arm.||||
1292847|NCT03689322|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292848|NCT03689309|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1292849|NCT03689296|||Cohort||Prospective|||||||
1292850|NCT03689283|Randomized|Factorial Assignment||Treatment||Double|Participants will be blinded to group allocation. Participants in the control group will receive sham needling.|Prospective randomized controlled trial|t|||t
1292851|NCT03689270|||Other||Prospective|||||||
1292852|NCT03689257|||Cohort||Prospective|||||||
1292853|NCT03689244|Randomized|Sequential Assignment||Treatment||Quadruple|The first period of the study is conducted double blind (first 52 weeks). Then, subjects who complete the 52 weeks of the double-blind period will enter an open-label treatment extension period (up to 2 years)|"This study implements an adaptive group-sequential design with early futility or efficacy stopping rules and sample size re-estimation. An interim analysis (IA) will be carried out when approximately 90 subjects in the hemodynamic cohort complete the assessments of PVR at Week 20 and 6-minute walk distance (6MWD) at Week 26. After the IA and sample size re-estimation, the number of subjects could be increased to between 150 and 400 based on conditional power considerations on the 6MWD.~During the double-blind treatment period, subjects are randomized in a 1:1 ratio to receive either selexipag or placebo. During the open-label extension period, all the subjects will receive selexipag."|t|t|t|t
1292854|NCT03689231|||Cohort||Retrospective|||||||
1292855|NCT03689218|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292856|NCT03689205|||Other||Prospective|||||||
1292857|NCT03689192||Single Group Assignment||Treatment||None (Open Label)||||||
1292858|NCT03689179|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This study uses a full-powered pilot sample (n=150) and a randomized waitlist control design to examine feasibility and initial efficacy of the TLC intervention. After an initial orientation/control period (4 weeks), group A will receive access to the TLC intervention for 8 weeks, followed by an optional 8-week control period where they can continue to use the TLC intervention if they choose. After the initial 4-week orientation period, Group B will receive 8 weeks of waitlist (no treatment) control, followed by access to the TLC intervention for 8 weeks. Primary outcomes (defined as anxiety, caregiver burden) will be assessed by electronically delivered surveys every 4 weeks; respite time-use and time-use satisfaction will be assessed using ecological momentary analysis for each respite period taken during the 20-week study period; feasibility will be assessed using fixed-choice and open-ended survey questions collected post-intervention.||||
1292859|NCT03689166|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinded RCT|"Definition and design. Prospective, double-blind randomised study.~Population Pregnant women admitted for TPL between weeks 24.0 and 34.6 of gestation at the participating centre."|t|t|t|t
1292860|NCT03689153|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1292861|NCT03689140|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292862|NCT03689127|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1292863|NCT03689114|Randomized|Parallel Assignment||Treatment||Single||This is a multicenter randomized pragmatic parallel-group single-blind non-inferiority trial.|t|||
1292864|NCT03689101||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292865|NCT03689088|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1292866|NCT03689075|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292867|NCT03689062|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292868|NCT03689049|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Blinding of participants cannot be achieved in pragmatic trials of QI interventions in primary care.|The intervention will first be tested for feasibility using a single-arm, prospective, explanatory mixed approach. What we learn from the feasibility will then be applied to a 2-arm pragmatic cluster RCT where practices enrolled in the intervention group will be compared with those enrolled in the usual care group. Randomization will be at the practice level to avoid potential contamination where physicians practicing at the same location are enrolled in different arms.||||
1292869|NCT03689036|||Cohort||Prospective|||||||
1292870|NCT03689023||Single Group Assignment||Prevention||None (Open Label)||||||
1292871|NCT03689010|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292872|NCT03688997|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Fifteen attending surgeons and 30 first year surgical residents were recruited to the study held at tertiary medical center during the years 2016-2017. The participants tied eight knots in different settings (Superficial vs. Deep) and techniques (One hand vs. two hands).||||
1292873|NCT03688984|Randomized|Parallel Assignment||Treatment||Single|Assessors will be blind to randomization condition.|||||t
1292874|NCT03688971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292875|NCT03688958|Randomized|Parallel Assignment||Treatment||Triple|double blind|two randomized clinical groups including women with early (stage II) and advanced (stage III) breast cancer. In the Early group, women were treated with I2 (5 mg/day) or placebo (colored water) for 7 to 35 days. In the Advanced group, patients received treatment (I2 or placebo) along with 4 to 6 cycles of FEC/TE treatment.|t|t|t|
1292876|NCT03688945|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1292877|NCT03688932|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292878|NCT03688919|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292879|NCT03688906|||Other||Prospective|||||||
1292880|NCT03688893|Randomized|Parallel Assignment||Treatment||Single|It was single blind; as the evaluator did not know what intervention the patient was assigned.|The investigators conducted a Randomized controlled trial (RCT) to study the effect of LASER in dental bleaching in 24 patients in Paraguay in 2015.||||t
1292881|NCT03688880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292882|NCT03688867||Single Group Assignment||Supportive Care||None (Open Label)||||||
1292883|NCT03688854|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1292884|NCT03688841|Randomized|Parallel Assignment||Treatment||Double|"Due to the obvious differences between the intervention and comparator, it is impossible to blind the participants or the care providers.~However, the investigator, the outcomes assessor and statistician are blinded to treatment received."|This is a randomised, parallel group, active-control trial, with patients randomised in a 1:1 ratio to one of two treatment arms.|||t|t
1292885|NCT03688828|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1292886|NCT03688815|||Cohort||Retrospective|||||||
1292887|NCT03688802|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292888|NCT03688789||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292889|NCT03688776|Randomized|Crossover Assignment||Other||Single|||t|||
1292890|NCT03688763||Single Group Assignment||Treatment||None (Open Label)||||||
1292891|NCT03688750|||Other||Prospective|||||||
1292892|NCT03688737|Randomized|Parallel Assignment||Treatment||Single|Single blinded study. Blinding to the patient will be ensured by masking the instruments during the follow up. The patient will be informed of the steps of the follow up (as mentioned in the consent form) without getting into details of the method of follow up.|Participants will be randomly assigned to either control or study group in the ratio of 1:1 using random number table.|t|||
1292893|NCT03688724|||Cohort||Prospective|||||||
1292894|NCT03688711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292895|NCT03688698|||Case-Control||Cross-Sectional|||||||
1292896|NCT03688685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1292897|NCT03688672||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1292898|NCT03688659||Single Group Assignment||Treatment||None (Open Label)|open|||||
1292899|NCT03688646|Randomized|||Supportive Care||||||||
1292900|NCT03688633|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1292901|NCT03688620||Single Group Assignment||Prevention||None (Open Label)||||||
1292902|NCT03688607|||Cohort||Prospective|||||||
1292903|NCT03688594||Single Group Assignment||Diagnostic||None (Open Label)||||||
1292904|NCT03688581|||Cohort||Other|||||||
1292905|NCT03688568||Single Group Assignment||Treatment||None (Open Label)||||||
1292906|NCT03688555|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292907|NCT03688542|Randomized|Parallel Assignment||Other||Single||||||t
1292908|NCT03688529|||Cohort||Prospective|||||||
1292909|NCT03688516|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1292910|NCT03688503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292911|NCT03688490|||Cohort||Prospective|||||||
1292912|NCT03688477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1292913|NCT03688464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1292914|NCT03688451||Sequential Assignment||Treatment||None (Open Label)||Sequential dose cohorts||||
1292915|NCT03688438|Randomized|Parallel Assignment||Prevention||None (Open Label)||Two study arms: (1) Standard of Care and (2) WoundVac||||
1292916|NCT03688425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292917|NCT03688412|||Cohort||Prospective|||||||
1292918|NCT03688399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292919|NCT03688386|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomization of mother infant pairs to a language curriculum with reading (intervention) or an infant bonding curriculum (control)||||
1292920|NCT03688373|Randomized|Parallel Assignment||Treatment||Single||||||t
1292921|NCT03688360|Randomized|Parallel Assignment||Treatment||Single||||||t
1292922|NCT03688347|||Other||Prospective|||||||
1292923|NCT03688334|Randomized|Crossover Assignment||Treatment||Single|||t|||
1292924|NCT03688321|Randomized|Parallel Assignment||Prevention||Triple|Labels with CMUH REC No. plus serial numbers on each bottle been completed by manufacturer and deliver to participants followed by random grouping order.|Study Group: take 2 probiotics capsules before sleep for 12 weeks after being confirmed as GBS positive on 28th gestation Placebo Group: take 2 placebo capsules before sleep for 12 weeks after being confirmed as GBS positive on 28th gestation|t|t|t|
1292976|NCT03687645|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1573300|NCT00001705||||Treatment||||||||
1292925|NCT03688308|Randomized|Parallel Assignment||Treatment||Double|Patients will not know if they received the surgical intervention that includes BMAC administration||t|||t
1292926|NCT03688295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1292927|NCT03688282|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1292928|NCT03688269|Randomized|Parallel Assignment||Treatment||Quadruple||allocation to one of the 2 arm after randomization|t|t|t|t
1292929|NCT03688256|||Cohort||Prospective|||||||
1292930|NCT03688243|||Cohort||Prospective|||||||
1292931|NCT03688230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1292932|NCT03688217|Randomized|Parallel Assignment||Prevention||Single|Since data will be entered directly into a tablet device by the participant, the outcomes assessor (ie: the tablet) will have no knowledge of the interventions assigned to individual participants. Additionally, the phone survey company performing the follow-up surveys will be blinded to the interventions assigned to individual participants.|This is a cluster-randomized controlled trial with baseline covariate adjustment and stratification.The randomization unit is the mentor-mother. The clusters are pregnant participants enrolled by each mentor-mother over the course of the trial. The randomization will be stratified by neighborhood type, to ensure balance of intervention versus control assignment by this covariate. The following baseline characteristics will be measured and adjusted for in the main analysis of the primary and secondary outcomes to increase statistical efficiency: 1. participant's number of previous children, 2. participant's age, 3. running water in the home, 4. electricity in the home, 5. participant's employment status, 6. participant's education level||||t
1292933|NCT03688204|||Case-Crossover||Prospective|||||||
1292934|NCT03688191||Single Group Assignment||Treatment||None (Open Label)||||||
1292935|NCT03688178|Randomized|Parallel Assignment||Treatment||Triple|Assignment to Groups 1 and 2 is blinded, and neither the study team nor the subject knows which pre-conditioning regimen is given. Assignment to Group 3 is not blinded, and the subject and study team know that Td preconditioning and Varlilumab is given.||t|t|t|
1292936|NCT03688165|||Cohort||Prospective|||||||
1292937|NCT03688152||Single Group Assignment||Treatment||None (Open Label)||||||
1292938|NCT03688139|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1292939|NCT03688126|Randomized|Parallel Assignment||Supportive Care||Triple|The U.S. POINTER Coordinating Center (CC) is divided into two distinct entities: the Administrative and Clinical Operations CC and the Data CC. Investigators and staff within the Administrative and Clinical Operations CC will be masked to outcomes data. Investigators and staff within the Data CC will be unmasked to intervention assignment and outcomes. In the clinic, examiners, data entry staff, and the study clinician will be masked to intervention assignment.|||t|t|t
1292940|NCT03688113|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292941|NCT03688100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292942|NCT03688087|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1292943|NCT03688074|Randomized|Parallel Assignment||Treatment||Triple|Double-blind|Subjects will be randomized in a 1:1 ratio to either tezepelumab or matching placebo both administered subcutaneously.|t|t|t|
1292944|NCT03688061|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||Each group will be sequentially recruited over a period of two months to allow for safety review.||||
1292945|NCT03688048|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1292946|NCT03688035|||Cohort||Prospective|||||||
1292947|NCT03688022|Randomized|Crossover Assignment||Other||None (Open Label)||Open Label||||
1292948|NCT03688009|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1292949|NCT03687996|||Case-Only||Retrospective|||||||
1292950|NCT03687983||Single Group Assignment||Treatment||None (Open Label)||||||
1292951|NCT03687970|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1292952|NCT03687957|Randomized|Sequential Assignment||Treatment||Triple|Phase II only: This study is triple-blinded (participant, physician, and study coordinator are all blinded; pharmacist and study statistician are not blinded)|-Phase I enrollment will be a sequential enrollment (patients will be stratified by concomitant use of steroids (yes/no)) and then Phase II portion will open with 2 arms being enrolled to in parallel.|t|t|t|
1292953|NCT03687944|||Other||Other|||||||
1292954|NCT03687931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292955|NCT03687918|||Cohort||Retrospective|||||||
1292956|NCT03687905|||Cohort||Prospective|||||||
1292957|NCT03687892|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1292958|NCT03687879|||Cohort||Prospective|||||||
1292959|NCT03687866|||Cohort||Prospective|||||||
1292960|NCT03687853|Non-Randomized|Parallel Assignment||Prevention||Single|Pancreatic cancer patients who received chemotherapy through peripheral vein after operation|Pancreatic cancer patients who received hepatic arterial perfusion chemotherapy after operation|t|||
1292961|NCT03687840|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||Parallel Assignment||||
1292962|NCT03687827|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1292963|NCT03687814|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1292964|NCT03687801|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1292965|NCT03687788|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1292966|NCT03687775|||Case-Only||Cross-Sectional|||||||
1292967|NCT03687762|Randomized|Parallel Assignment||Treatment||Single||A randomized, 3-group parallel design, 240-subject clinical trial to test the mechanisms of cognitive therapy, mindfulness meditation, and activation skills on individuals with chronic low back pain.||||t
1292968|NCT03687749|||Case-Control||Cross-Sectional|||||||
1292969|NCT03687736||Single Group Assignment||Other||None (Open Label)||||||
1292970|NCT03687723|||Cohort||Prospective|||||||
1292971|NCT03687710|||Cohort||Prospective|||||||
1292972|NCT03687697|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1292973|NCT03687684|Randomized|Sequential Assignment||Other||Triple|||t||t|t
1292974|NCT03687671|Randomized|Parallel Assignment||Treatment||Single||||||t
1292975|NCT03687658|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1292977|NCT03687632||Single Group Assignment||Treatment||None (Open Label)||This is a Phase 2, open label trial to determine if treatment with ST266 eye drops qid for 28 days heals the study eye.||||
1292978|NCT03687619|Randomized|Crossover Assignment||Treatment||Single||||||t
1292979|NCT03687606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292980|NCT03687593|||Other||Other|||||||
1292981|NCT03687580|Randomized|Parallel Assignment||Treatment||Triple|The active and sham devices are externally identical and emit the same guiding light. The only difference is that the sham does not emit the therapeutic near infrared rays. However, since near infrared laser light is invisible to the human eye, the treatment allocation cannot be determined.|Single center, Prospective, Double Blind, Randomized, Sham-Controlled, Parallel Group, Superiority comparison|t|t|t|
1292982|NCT03687567|||Cohort||Retrospective|||||||
1292983|NCT03687554||Single Group Assignment||Treatment||None (Open Label)||||||
1292984|NCT03687541|||Cohort||Retrospective|||||||
1292985|NCT03687528|||Case-Only||Prospective|||||||
1292986|NCT03687515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1292987|NCT03687502||Single Group Assignment||Diagnostic||None (Open Label)|The CEUS image will be read at a future time by a Children's Mercy Hospital radiologist blinded to the results of the gray scale ultrasound and computed tomography (CT) scan if one was obtained; these will be used for comparison.|||||
1292988|NCT03687489||Single Group Assignment||Treatment||None (Open Label)||||||
1292989|NCT03687476|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1292990|NCT03687463|||Cohort||Prospective|||||||
1292991|NCT03687450|Randomized|Parallel Assignment||Treatment||None (Open Label)||We plan to enroll up to 200 participants with a 2:1 ratio of participants randomized to the intervention arm (the yoga-based RISE program) to participants randomized to the no-treatment control arm. The control group will receive a one session of RISE after their participation in the trial is complete.||||
1292992|NCT03687437|||Case-Only||Prospective|||||||
1292993|NCT03687424|Randomized|Parallel Assignment||Treatment||Double|Anesthesiologist who interviews and examines patients scheduled for colonoscopy under analgo-sedation will enroll eligible participants and will offer procedure explanation and possibility to sign uniformed written consent. Unique personal hospital admission number (UPHAN) will be assigned to all eligible participants. After that, they will be randomized to control or intervention group by using random numbers generator. Anesthesiologist who implements anesthesia will receive nontransparent envelope with assigned intervention provided by independent investigator and will not decide which participant will receive LFNO or HFNO. However, attending anesthesiologist and participants will unavoidably be aware of type of oxygenation applied. Investigator who collects data after procedure will be unaware of study protocol and will enter data to formatted database. Participants' data will be noted under UPHAN. Outcome assessors will be unaware of intervention applied.|"We plan to conduct prospective, parallel group, randomized controlled clinical trial.~In total, 126 participants will be included in this trial. These participants are patients scheduled for outpatient colonoscopy in analgo-sedation.~This study includes 126 patients divided in 3 groups of according to BMI: 18<BMI<30 kg/m2, 30<BMI<40 kg/m2 or BMI ≥40 kg/m2. Each group will be divided in control groups of 21 patients who will receive LFNO and intervention groups of 21 patients who will receive HFNO during standardized intravenous analgo-sedation."|||t|t
1292994|NCT03687411||Single Group Assignment||Other||None (Open Label)||||||
1292995|NCT03687398|||Case-Control||Prospective|||||||
1292996|NCT03687385|Randomized|Parallel Assignment||Treatment||Double|Anesthesiologist who interviews and examines patients scheduled for colonoscopy under analgo-sedation will enroll eligible participants and will offer procedure explanation and possibility to sign uniformed written consent. Unique personal hospital admission number (UPHAN) will be assigned to all eligible participants. After that, they will be randomized to control or intervention group by using random numbers generator. Anesthesiologist who implements anesthesia will receive nontransparent envelope with assigned intervention provided by independent investigator and will not decide which participant will receive LFNO or HFNO. However, attending anesthesiologist and participants will unavoidably be aware of type of oxygenation applied. Investigator who collects data after procedure will be unaware of study protocol and will enter data to formatted database. Participants' data will be noted under UPHAN. Outcome assessors will be unaware of intervention applied.|"We plan to conduct prospective, parallel group, randomized controlled clinical trial.~In total, 126 participants will be included in this trial. These participants are patients scheduled for outpatient colonoscopy in analgo-sedation.~This study includes 126 normal weight patients of anesthesia risk ASA class I, II or III divided in three groups of 42. Each group will be divided in control subgroups of 21 patients who will receive low-flow nasal oxygenation (LFNO) and intervention subgroups of 21 patients who will receive high-flow nasal oxygenation (HFNO) during standardized intravenous analgo-sedation."|||t|t
1292997|NCT03687372|Randomized|Parallel Assignment||Treatment||Quadruple|The blinded vehicle solution is packaged to match the active study drug and will be stored under the same conditions.|Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study|t|t|t|t
1292998|NCT03687359|||Cohort||Prospective|||||||
1292999|NCT03687346|||Cohort||Prospective|||||||
1293000|NCT03687333||Single Group Assignment||Treatment||None (Open Label)||||||
1293001|NCT03687320|Randomized|Parallel Assignment||Treatment||Triple|Sham control|Single center, Prospective, Double Blind, Randomized, Sham-Controlled, Parallel Group, Superiority comparison|t|t|t|
1293002|NCT03687307|||Case-Only||Prospective|||||||
1293003|NCT03687294|||Case-Control||Prospective|||||||
1293004|NCT03687281|||Other||Prospective|||||||
1293005|NCT03687268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293006|NCT03687255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293007|NCT03687242||Single Group Assignment||Treatment||None (Open Label)||||||
1293008|NCT03687229|||Case-Control||Prospective|||||||
1293009|NCT03687216|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293010|NCT03687203|||Cohort||Prospective|||||||
1293011|NCT03687190|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293012|NCT03687177|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1293013|NCT03687164|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1293015|NCT03687138|||Case-Control||Prospective|||||||
1293016|NCT03687125||Sequential Assignment||Treatment||None (Open Label)||Phase 1 Does escalation followed by Phase 2 Expansion at MTD||||
1293017|NCT03687112|||Cohort||Prospective|||||||
1293018|NCT03687099|||Other||Retrospective|||||||
1293019|NCT03687086|Randomized|Parallel Assignment||Treatment||Single||||||t
1293020|NCT03687073|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293021|NCT03687060|Randomized|Crossover Assignment||Prevention||None (Open Label)||Stepped-wedge cluster randomized trial||||
1293022|NCT03687047||Single Group Assignment||Treatment||None (Open Label)||||||
1293023|NCT03687034||Single Group Assignment||Treatment||None (Open Label)||This study consists of dose escalations that follow the standard 3+3 design, proceeding until the maximum tolerated dose is attained. The treatment period for patients in this study at each dose will be one year.||||
1293024|NCT03687021|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1293025|NCT03687008||Single Group Assignment||Treatment||None (Open Label)||one group, pre- post-intervention design||||
1293026|NCT03686982|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1293027|NCT03686969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293028|NCT03686956|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293029|NCT03686943|||Case-Only||Prospective|||||||
1293030|NCT03686930|Randomized|Sequential Assignment||Treatment||Triple|double-blind, placebo-controlled|Multiple Dose, Dose Escalation study|t||t|t
1293031|NCT03686917|||Other||Prospective|||||||
1293032|NCT03686904|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293033|NCT03686891||Single Group Assignment||Screening||None (Open Label)||||||
1293034|NCT03686878||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293035|NCT03686865|||Cohort||Prospective|||||||
1293036|NCT03686852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293037|NCT03686839||Single Group Assignment||Prevention||None (Open Label)||no randomized, no controlled.||||
1293038|NCT03686826|||Cohort||Prospective|||||||
1293039|NCT03686813|Randomized|Crossover Assignment||Prevention||Quadruple|Placebo controlled|Double blind, randomized|t|t|t|t
1293040|NCT03686800||Single Group Assignment||Basic Science||None (Open Label)||||||
1293041|NCT03686787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Healthy, non-smoking||||
1293042|NCT03686774|Randomized|Parallel Assignment||Treatment||None (Open Label)|no masking|||||
1293043|NCT03686761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|The clinical assessment was not masked , however, the histological and biomarker examination were send to blind investigator not directly involved in the study|Surgical distraction was performed in 20 cleft lip and palate (CLP) subjects with class III malocclusion, gingival GCF were collected from teeth neighboring the osteotomy site and from premolars of the opposite arch as control.||||
1293044|NCT03686748|Randomized|Parallel Assignment||Treatment||Single|"Participant in the Chronic Pain Group are initially blinded to the intervention they will be receiving in the study.~Healthy participants under go all assessments in the study."|Two group, single blind for chronic pain patients receiving intervention, additional basic science component with baseline comparisons between patients and healthy controls.|t|||
1293045|NCT03686735|||Cohort||Prospective|||||||
1293046|NCT03686722|Randomized|Crossover Assignment||Other||Double||"Twenty Eligible Adult Subjects Will be Randomized Equally into two Groups: A and B To Receive Either:~Group (A):10 subjects will receive 500 mg Metformin twice daily on day 1-4 then 1000mg metformin twice on day 5-7 Group (B):10 subjects will receive 500 mg co-administered daily with Daclatasvir 60 mg once daily on day 1-4 then 1000mg Metformin co-administered twice daily with Daclatasvir 60 mg once daily on day 5-7"|||t|t
1293047|NCT03686709|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This is a feasibility study assessing radiation exposure and distribution of Y90 therapy agents. Two groups of 10 patients will be recruited with equal numbers in each group for each of the two types of Y90 radioembolization products commercially available in the United States.Both groups undergo the same monitoring procedures throughout the study and then will be compared. Stratification of patients into therapy groups is solely based on clinical standard of care decision making.||||
1293048|NCT03686696|Randomized|Factorial Assignment||Treatment||None (Open Label)||2 * 2 Factorial Design||||
1293049|NCT03686683|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Subjects will be randomized 2:1 to the sipuleucel-T arm or the control arm.Subjects randomized to sipuleucel-T arm will receive 3 infusions of sipuleucel-T at approximately 2-week intervals. Subjects randomized to the control arm will be followed on AS as standard of care described in the schedule of events.||||
1293050|NCT03686670|||Cohort||Prospective|||||||
1293051|NCT03686657|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1293052|NCT03686644||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293053|NCT03686631|Randomized|Parallel Assignment||Prevention||Double|The outcomes assessor / statistician will be blinded to which group each patient is in.|Patients will be enrolled randomly into either the passive arm or the smartphone arm prior to their surgery.||t||t
1293054|NCT03686618|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is not blinded and does not require any randomization codes. Ten patients each will receive one of three treatments for Days 1, 2, and 3:~No secretin - standard of care and observation (Cohort X)~32 mcg (<50kg) or 40 mcg (≥50kg)IV Bolus every 12 hours (Cohort 1)~32 mcg (<50kg) or 40 mcg (≥50kg)IV Bolus every 6 hours (Cohort 2)~32 mcg (<50kg) or 40 mcg (≥50kg)IV Bolus every 4 hours (Cohort 3)"||||
1293055|NCT03686605|||Other||Cross-Sectional|||||||
1293056|NCT03686592|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1293057|NCT03686579|||Cohort||Other|||||||
1293058|NCT03686566||Single Group Assignment||Other||None (Open Label)||||||
1293059|NCT03686553|||Cohort||Retrospective|||||||
1293060|NCT03686540|||Cohort||Retrospective|||||||
1293061|NCT03686527|||Case-Only||Prospective|||||||
1293062|NCT03686514|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293063|NCT03686501||Single Group Assignment||Other||None (Open Label)||||||
1293064|NCT03686488||Single Group Assignment||Treatment||None (Open Label)||||||
1293065|NCT03686475|Randomized|Parallel Assignment||Treatment||Triple|blinding||t|t||t
1293066|NCT03686462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293067|NCT03686449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293068|NCT03686436|||Case-Only||Prospective|||||||
1293069|NCT03686423|||Other||Prospective|||||||
1293070|NCT03686410|Randomized|Parallel Assignment||Treatment||Triple|the participants and the study researchers will not know the group assigned to each subject. In fact, the evaluations will be carried out through the website.||t|t||t
1293071|NCT03686397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293072|NCT03686384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293073|NCT03686371|||Cohort||Prospective|||||||
1293074|NCT03686358|||Case-Only||Retrospective|||||||
1293075|NCT03686345||Single Group Assignment||Treatment||None (Open Label)||Core binding factor acute myeloid leukemia (CBF-AML) patients||||
1293076|NCT03686332|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"All patients included will have unresectable advanced penile cancer. Patients will be discussed in multi-disciplinary rounds to establish this criterion. Two treatment groups will be distinguished, having a pre-specified number of patients (inclusion into the arm will be closed if this number is reached):~Arm A (n=22): Patients with locoregional lymph node disease who have not received extensive inguinal or pelvic irradiation on the involved area before. Patients in this group will concurrently be treated with locoregional radiotherapy and atezolizumab.~Arm B (n=10): Patients who are not expected to derive benefit from radiotherapeutic treatment. This group will mainly consist of patients with distant metastases or previously treated locoregional disease and will only be treated with atezolizumab."||||
1293077|NCT03686319|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1293078|NCT03686306|Randomized|Parallel Assignment||Treatment||Triple|"The preparation of the 'blinded' treatments will be undertaken by the PPRIGO hospital pharmacist's consortium (Production Pharmaceutique pour la Recherche Institutionnelle du Grand Ouest) under recommended standardised conditions. PPRIGO will provide numbered and labelled bottles each containing 33 capsules of the study drug (sildenafil or placebo) according to the randomisation order). All bottles will be identically labelled, with the study number being the only differentiating feature between different drug packs.~The un-blinding will be centralised with eCRF software in agreement with the principal investigator."|Experimental design A National, Multicentre, Prospective, Randomised, Double Blind, placebo-controlled clinical trial with two parallel groups.|t|t|t|
1293079|NCT03686293||Single Group Assignment||Basic Science||None (Open Label)||Acute meal test||||
1293080|NCT03686280|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1293081|NCT03686267|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1293082|NCT03686254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293083|NCT03686241|||Case-Only||Prospective|||||||
1293084|NCT03686228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293085|NCT03686215||Single Group Assignment||Treatment||None (Open Label)||||||
1293086|NCT03686202|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1293087|NCT03686189||Single Group Assignment||Treatment||None (Open Label)||||||
1293088|NCT03686176|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized, unblinded, controlled||||
1293089|NCT03686163|Randomized|Parallel Assignment||Treatment||Single||||||t
1293090|NCT03686150|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized, parallel arm clinical trial||||
1293091|NCT03686137|||Cohort||Prospective|||||||
1293092|NCT03686124||Single Group Assignment||Treatment||None (Open Label)||||||
1293093|NCT03686111|||Cohort||Prospective|||||||
1293094|NCT03686098|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293095|NCT03686085|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1293096|NCT03686072||Single Group Assignment||Treatment||None (Open Label)||||||
1293097|NCT03686059|Randomized|Parallel Assignment||Treatment||Single||||||t
1293098|NCT03686046|||Other||Prospective|||||||
1293099|NCT03686033|Randomized|Crossover Assignment||Treatment||Quadruple|The study consists of a randomized double-blind design in Treatment Periods 1, 2, and 3, followed by an open-label Treatment Period 4.|The study consists of a crossover design in Treatment Periods 1, 2, and 3, followed by an open-label Treatment Period 4.|t|t|t|t
1293100|NCT03686020|||Case-Control||Prospective|||||||
1293101|NCT03686007|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293102|NCT03685994|||Cohort||Prospective|||||||
1293103|NCT03685981|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1293104|NCT03685968|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1293105|NCT03685955|||Cohort||Prospective|||||||
1293106|NCT03685942|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293107|NCT03685929|||Case-Only||Cross-Sectional|||||||
1293108|NCT03685916|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1293109|NCT03685903||Single Group Assignment||Screening||None (Open Label)||||||
1293110|NCT03685890|Randomized|Parallel Assignment||Treatment||Quadruple||The study is a randomized placebo controlled double blind trial. Patients will be randomized to ILP with nivolumab or ILP with placebo. Active follow-up for 3 years.|t|t|t|t
1293111|NCT03685877|||Other||Cross-Sectional|||||||
1293112|NCT03685864|Randomized|Parallel Assignment||Treatment||Single|||||t|
1293113|NCT03685851|||Cohort||Retrospective|||||||
1293114|NCT03685838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293115|NCT03685825|||Cohort||Prospective|||||||
1293116|NCT03685812|||Case-Control||Cross-Sectional|||||||
1293117|NCT03685799|||Cohort||Retrospective|||||||
1293118|NCT03685786||Single Group Assignment||Treatment||None (Open Label)||Phase 1 Clinical Study of CD19-directed Chimeric Antigen Receptor-modified T Cells (CART19) treatment for the Patients with Minimal Residual Disease (MRD) of B Cell Malignancies and then Autologous Hematopoietic Stem Cell Transplantation(Auto-HSCT).||||
1293119|NCT03685773|Non-Randomized|Crossover Assignment||Basic Science||Single|The subject will be blinded to which study drug is received first (Drug or Placebo).||t|||
1293120|NCT03685760|Randomized|Parallel Assignment||Supportive Care||Double|Participants and outcomes assessor are masked as well as all investigators except one co-investigator.|Three Group Randomized Controlled Trial|t|||t
1293121|NCT03685747||Single Group Assignment||Basic Science||None (Open Label)||||||
1293122|NCT03685734|||Cohort||Prospective|||||||
1293123|NCT03685721|||Case-Control||Cross-Sectional|||||||
1293124|NCT03685708||Single Group Assignment||Prevention||None (Open Label)||||||
1293125|NCT03685695||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293126|NCT03685682||Single Group Assignment||Prevention||None (Open Label)||||||
1293127|NCT03685669|||Cohort||Cross-Sectional|||||||
1293128|NCT03685656|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1293129|NCT03685643|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293130|NCT03685630||Single Group Assignment||Treatment||None (Open Label)||||||
1293131|NCT03685617|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293132|NCT03685604|Randomized|Parallel Assignment||Diagnostic||Single||"The intervention will be conducted as an open-label cluster-randomized cross-over multicenter trial with an allocation ratio of 1:1.~The departments of surgery of the 3 study sites will be randomized center-wise in clusters by month to use CHX or PI. The products will be switched over according to the computer-generated randomization list."||||t
1293133|NCT03685591|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293134|NCT03685578|||Case-Only||Prospective|||||||
1293135|NCT03685565|Randomized|Parallel Assignment||Treatment||Double||Experimental group: Dermabond with underlying steristrips. Control group: Dermabond alone|||t|t
1293136|NCT03685552||Single Group Assignment||Treatment||None (Open Label)||||||
1293137|NCT03685539||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293138|NCT03685526||Single Group Assignment||Treatment||None (Open Label)||||||
1293139|NCT03685513|Randomized|Parallel Assignment||Treatment||Double|Double blind||t|||t
1293140|NCT03685500|Randomized|Parallel Assignment||Treatment||None (Open Label)||A phase IV, multicentre, randomised, open-label, pilot clinical trial.||||
1293141|NCT03685487|||Cohort||Prospective|||||||
1293142|NCT03685474|Randomized|Crossover Assignment||Treatment||None (Open Label)||"In the present study, we will use the measure entitled Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM; Glasgow, 2013) as a framework for planning and implementing FYF-SB in the school environment. The translation of research from controlled research settings to natural environments is often an exceptionally slow process, perhaps because of the emphasis on efficacy. A pragmatic framework such as RE-AIM can hasten the portability of evidenced based intervention to real-world practice by focusing on stakeholder feedback and environmental context, in conjunction with intervention development and content.~We plan to conduct a randomized controlled trial of the FYF-SB intervention across 30 schools within 3 districts. The intervention conditions occur for 1 semester within an academic year. Data will be collected in a pre-post design (before and after the condition of either Facing Your Fears - School Based or Usual Care)."||||
1293143|NCT03685461|Randomized|Parallel Assignment||Other||Double|participant blinded to condition surgeon aware by necessity data reviewers blinded|Sample of cochlear implant recipients. Half randomized for observation with ECOchG on, half randomized to ECochG off|t|||t
1293144|NCT03685448||Single Group Assignment||Treatment||None (Open Label)||||||
1293145|NCT03685435|||Case-Only||Prospective|||||||
1293146|NCT03685422||Single Group Assignment||Treatment||None (Open Label)||||||
1293147|NCT03685409|Randomized|Parallel Assignment||Prevention||Single||||||t
1293148|NCT03685396|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1293149|NCT03685383|Randomized|Parallel Assignment||Treatment||None (Open Label)||two-groups (treatment vs. control), pseudo-randomized, monocentric, nonblinded||||
1293150|NCT03685370|Randomized|Parallel Assignment||Other||Single||||||t
1293151|NCT03685357|||Case-Control||Cross-Sectional|||||||
1293152|NCT03685344||Sequential Assignment||Treatment||None (Open Label)||||||
1293153|NCT03685331|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The phase I component is a dose-escalation study. Dose escalation will follow a 3+3 design. An additional cohort of at least 36 patients (total number of patients in phase I and phase II = 54) will be included on the single-arm, non-randomized phase II portion of this clinical trial.||||
1293154|NCT03685318|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1293155|NCT03685305|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293156|NCT03685292|||Case-Only||Prospective|||||||
1293157|NCT03685279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293158|NCT03685266|||Case-Only||Prospective|||||||
1293159|NCT03685253|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1293160|NCT03685240|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1293161|NCT03685227|Randomized|Sequential Assignment||Other||None (Open Label)||||||
1293162|NCT03685214|Randomized|Parallel Assignment||Treatment||Single||One model using normal saline for resuscitation fluid,the other using balanced crystalloids.|t|||
1293163|NCT03685201|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1293164|NCT03685188|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1293165|NCT03685175|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1293166|NCT03685162|||Cohort||Prospective|||||||
1293167|NCT03685149|Randomized|Crossover Assignment||Treatment||Quadruple|This is double-blinded trial with all participants, investigators, and outcome assessors being blinded with except for DSMB members.|This is a randomized double-blinded placebo-controlled crossover trial on the effect of flecainide on the frequency of ventricular arrhythmias of 38 ARVC patients. The crossover design requires a 10-week treatment with each patient receiving flecainide 100 mg bid and placebo for 4 weeks in a blinded randomized order.|t|t|t|t
1293168|NCT03685136||||||||||||
1293169|NCT03685123|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293170|NCT03685110|||Cohort||Prospective|||||||
1293171|NCT03685097|||Cohort||Prospective|||||||
1293172|NCT03685084|Randomized|Sequential Assignment||Other||Quadruple|||t|t|t|t
1293173|NCT03685071|||Case-Only||Prospective|||||||
1293174|NCT03685058|Randomized|Parallel Assignment||Treatment||Triple|Because of the nature of the study, the investigator who will apply the treatment will not be blind to the group allocation of the lesion. Yet, the investigators who will evaluate the radiographs, DIAGNOcam images, and perform the visual examination will be blinded to which group the lesion they are evaluating belongs. In addition, the statistician will be blinded.|"The study design will be a split mouth, randomized controlled clinical trial in which the teeth will be randomly assigned to be either in the test group or control group in a 1:1 ratio.~The control group: will be treated with standard-of-care preventive measures which includes application of 5% sodium fluoride (NaF) topical varnish, oral hygiene instruction, and dietary counseling.~The test group: will be treated with light curable resin modified glass ionomer (RMGI) varnish in addition to standard-of-care preventive measures."|t||t|t
1293175|NCT03685045||Single Group Assignment||Health Services Research||None (Open Label)||The intervention is the campaign days where all participants will undergo a questionnaire, point of care and dried blood spot testing for hepatitis C, fibroscan and a clinical assessment.||||
1293176|NCT03685032|Randomized|Parallel Assignment||Treatment||Quadruple|The study drugs based on a sequentially numbered list were prepared in the same way. These drugs had similar characteristics, including clear color and no observable particles, and were loaded into syringes labeled for each group. The attending anesthesiologists, anesthetic nurses, and ward nurses, as well as the patients were blinded to the computer-generated randomization lists.|"Double-blinded randomized control trial was conducted. The investigators allocated patients into two arm.~The study group (Gr. D) received intraoperative dexamethasone 4 mg iv and ondansetron 4 mg iv, whereas the control group (Gr. N) received placebo (0.9% normal saline 1 ml iv and 0.9% normal saline 2 ml iv)"|t|t|t|t
1293177|NCT03685019|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1293178|NCT03685006|||Cohort||Prospective|||||||
1293179|NCT03684993|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1293180|NCT03684980|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is an open-label, non-randomized, pilot study of Voraxaze administered following standard of care MTX and rituximab in patients with CNS lymphoma.||||
1293181|NCT03684967||Single Group Assignment||Treatment||None (Open Label)||||||
1293182|NCT03684954|Randomized|Parallel Assignment||Treatment||Single|Single investigator|Patallel Assignment|||t|
1293183|NCT03684941|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1293184|NCT03684928|Randomized|Crossover Assignment||Treatment||Double||Prospective, double-masked, bilateral, randomized, one month cross-over dispensing study.|t||t|
1293185|NCT03684915|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1293186|NCT03684902||Single Group Assignment||Screening||None (Open Label)||||||
1293187|NCT03684889||Single Group Assignment||Treatment||None (Open Label)||||||
1293188|NCT03684876|||Cohort||Prospective|||||||
1293189|NCT03684863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293190|NCT03684850|Randomized|Parallel Assignment||Treatment||Single||||||t
1293191|NCT03684837|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1293192|NCT03684824||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293193|NCT03684811|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293194|NCT03684798|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293195|NCT03684785|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293196|NCT03684772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293197|NCT03684759|||Case-Only||Prospective|||||||
1293198|NCT03684746|||Cohort||Other|||||||
1293199|NCT03684733|||Other||Other|||||||
1293200|NCT03684720|Randomized|Parallel Assignment||Other||Single|The groups will be masked, until the day of the teaching session, so the investigator won't know, which group he assigns participants to, when enrolling them. The raters who will score the participants, will have no knowledge of which group the participant belongs to.|The study is a randomized experimental study comparing 2 groups, a control and an intervention. One group will receive traditional instructional teaching (control) and the other will receive guided-discovery-learning (intervention). Both groups will undertake the same tests after the teaching session.||||t
1293201|NCT03684707|Randomized|Parallel Assignment||Prevention||Single||Randomized clinical trials||||t
1293202|NCT03684694||Sequential Assignment||Treatment||None (Open Label)||||||
1293203|NCT03684681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293204|NCT03684668|Randomized|Parallel Assignment||Prevention||Single|All forms with the questionnaires will be consecutively numbered before the beginning of the study and randomly allocated to one of the study groups. This assignment list will be given to the secretary who will allocate the questionnaires to the corresponding group and deliver them to the corresponding researcher. After completion, all forms will be collected and merged and then delivered again to the secretary who will randomly assign number 1 or 2 to one of the groups and will write this number in the upper right edge of each completed questionnaire according to the original assignment list. The researcher that will introduce data in the database will include a field for this number but will not know to which of the groups it belongs. Statistical analysis will be then carried comparing groups 1 and 2. This will not be uncovered until all results are obtained and are ready for discussion.|"This is a behavioral intervention where 120 university students will be randomly assigned to the intervention or de control group. Intervention consists in a psychoeducational activity enhanced using meta-universes or three-dimensional virtual worlds. Each selected student will undergo a three-session educational activity before a personal computer and wearing 3D lenses. The first session is called Knowledge about STI; the second session is entitled Use of the male condom and the third session is called Talking about sexuality issues. The intervention will be carried out every 24 hours with four participants in four computers and 3D lenses available in the computer labs of the University. The control group will not receive this intervention."||||t
1293205|NCT03684655||Single Group Assignment||Diagnostic||None (Open Label)||Adults with HIV Infection taking or not taking antiretroviral therapy||||
1293261|NCT03683927|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1293206|NCT03684642|Randomized|Parallel Assignment||Treatment||None (Open Label)|The study is open-label for the tested versus comparator drug and double blind for the doses.|||||
1293207|NCT03684629|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1293208|NCT03684616|||Cohort||Retrospective|||||||
1293209|NCT03684603|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293210|NCT03684590|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293211|NCT03684577|Randomized|Parallel Assignment||Treatment||Single||||||t
1293212|NCT03684564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293213|NCT03684551|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1293214|NCT03684538|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1293215|NCT03684525|Randomized|Factorial Assignment||Treatment||Single|Two investigators unaware of the group to which the patients belong will carry out all the measurements on CBCT scan. One investigator will crop the view of the extraction site to ensure blinding of the other investigator.|"Randomized controlled clinical trial following CONSORT guidelines. Patients to be allocated equally to two groups: one treatment group and one control group as follows:~Group 1: Extraction of primary maxillary canines group (EG)~Group 2: Control group - no extraction (CG)"|||t|
1293216|NCT03684512|Randomized|Parallel Assignment||Prevention||Single||||||t
1293217|NCT03684499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293218|NCT03684486||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293219|NCT03684473|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293220|NCT03684460|Randomized|Parallel Assignment||Treatment||Single||randomized controlled trial with 2 cohorts||||t
1293221|NCT03684447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293222|NCT03684434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293223|NCT03684421|||Cohort||Prospective|||||||
1293224|NCT03684408|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1293225|NCT03684395|||Case-Crossover||Retrospective|||||||
1293226|NCT03684382|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Consenting participants are randomly allocated to either the intervention or the control group.|Participants who have completed the online consent form, affirmed their study participation and completed the baseline assessments are then randomly allocated to either the NeW-I group or the control group via the online NeW-I platform that is developed for the purpose of this study. Such random assignment reduces the potential of bias.||||
1293227|NCT03684369|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1293228|NCT03684356|Randomized|Parallel Assignment||Treatment||Single||||||t
1293229|NCT03684343|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1293230|NCT03684330|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293231|NCT03684317|||Cohort||Retrospective|||||||
1293232|NCT03684304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293233|NCT03684291|||Other||Prospective|||||||
1293234|NCT03684278|Randomized|Parallel Assignment||Treatment||Quadruple|Once the delegated research team member performs randomisation and the Pharmacist is provided with the allocation to either Arm A, B or C, the Pharmacist will prepare the infusion, which will be covered by an opaque sleeve and labelled for blinding.|RAPID-I is a randomised, placebo-controlled, double-blind, multi-centre, three-arm, phase IIb efficacy trial of infliximab in patients with AP. Patients will be randomised (1:1:1 allocation ratio) to receive an intravenous infusion of either 5 mg/kg or 10 mg/kg infliximab or placebo, initiated within 12 hours of admission to the Accident and Emergency Medicine Department. Treatment allocation will only be revealed to Pharmacy to ensure the research team administering the treatment remains blinded.|t|t|t|t
1293235|NCT03684265|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1293236|NCT03684252|Randomized|Parallel Assignment||Other||Single|||t|||
1293237|NCT03684239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293238|NCT03684226|||Cohort||Prospective|||||||
1293239|NCT03684213|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Each subject has one control site and three experimental sites concurrently tested within the same study using intradermal microdialysis on the dorsal forearm.||||
1293240|NCT03684200|Randomized|Parallel Assignment||Other||Single||||||t
1293241|NCT03684187||Single Group Assignment||Treatment||None (Open Label)||||||
1293242|NCT03684174|||Case-Control||Prospective|||||||
1293243|NCT03684161|||Case-Control||Prospective|||||||
1293244|NCT03684148|Randomized|Parallel Assignment||Supportive Care||Double||This was a randomized, controlled, parallel-group intervention trial to evaluate the benefits of adding MI practice to CPT postoperative rehabilitation program. Eligible patients were randomly assigned to either an intervention group in which MI practice was combined with CPT (MIp), or to a control group which received CPT alone (CON).|t|t||
1293245|NCT03684135||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293246|NCT03684122||Single Group Assignment||Treatment||None (Open Label)||||||
1293247|NCT03684109||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293248|NCT03684096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293249|NCT03684083|||Case-Control||Prospective|||||||
1293250|NCT03684070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293251|NCT03684057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293252|NCT03684044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293253|NCT03684031|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293254|NCT03684018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293255|NCT03684005||Single Group Assignment||Other||None (Open Label)||||||
1293256|NCT03683992|||Cohort||Prospective|||||||
1293257|NCT03683979|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293258|NCT03683966|||Cohort||Prospective|||||||
1293259|NCT03683953|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1293260|NCT03683940||Single Group Assignment||Screening||None (Open Label)||||||
1293262|NCT03683914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293263|NCT03683901|Non-Randomized|Single Group Assignment||Treatment||Triple||Cohort study; single group but with random serial allocation of treatment type|t||t|t
1293264|NCT03683888|Randomized|Parallel Assignment||Prevention||None (Open Label)||Open-label||||
1293265|NCT03683875|||Case-Control||Prospective|||||||
1293266|NCT03683862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293267|NCT03683849|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1293268|NCT03683836|||Cohort||Retrospective|||||||
1293269|NCT03683823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293270|NCT03683810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293271|NCT03683797|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1293272|NCT03683784|||Cohort||Prospective|||||||
1293273|NCT03683771|||Cohort||Prospective|||||||
1293274|NCT03683758|Non-Randomized|Parallel Assignment||Supportive Care||Single|"Participants from both teams will be aware of whether or not they received the intervention warm-up since the intervention warm-up would be a deviation from what each team typically performs for a warm-up.~Investigator, Dr. Matt Wentzell is not blinded to which group is receiving the intervention warm-up since he will be leading the warm-up over the 8-week period.~The three trained assistants will be performing the performance pre- and posttesting. They will be blinded to the group each player has been allocated to.~Any study member that is not blinded will not be performing the pre- and posttesting."|"A parallel, two-group, pre-post comparative trial is proposed for this study. Two soccer teams comprise the convenience sample. One team (Impact) will be allocated to the control group while the other team (Hearts) are allocated to the intervention group. Participant allocation is premeditated due to Dr. Matt Wentzell's regular paramedical involvement with the Hearts and therefore his ability to oversee and administer the intervention warm-up. The control warm-up will be run by the coaching staff of the control group.~Performance pre-testing will be performed by three trained assistants one week after the 2018/2019 soccer season begins. Tests will be performed three times with the best test score being recorded.~Both groups will then complete their assigned warm-up three times per week for eight weeks. Both groups will complete posttesting within three days of the trial period concluding in a fashion identical to that of the pre-testing session."||||t
1293275|NCT03683745|||Other||Cross-Sectional|||||||
1293276|NCT03683732|||Case-Only||Prospective|||||||
1293277|NCT03683719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293278|NCT03683706|Randomized|Parallel Assignment||Health Services Research||Single|Researchers doing outcome assessments will be kept blind to treatment allocations|||||t
1293279|NCT03683693|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Matched cohort: historical standard of care group (patients from the period January 2016 - April 2018) versus interventional group (patients from May 2018 on)||||
1293280|NCT03683680||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293281|NCT03683667|Randomized|Factorial Assignment||Prevention||Quadruple|Participants, care providers, investigators and outcomes assessors will be blinded to the azithromycin or placebo interventions. Neither participants nor outcomes assessors will be masked to the nutrition interventions. Investigators will be masked to the nutrition interventions.|For this 2 x 4 factorial, cluster-randomized trial, 566 previously defined clusters will be assigned independently to 8 different combinations of interventions: 1) azithromycin and protein supplementation; 2) azithromycin and isocaloric supplementation; 3) azithromycin and egg; 4) azithromycin and control (nutrition education); 5) placebo and protein supplementation; 6) placebo and isocaloric supplementation; 7) placebo and egg; 8) placebo and control (nutrition education).|t|t|t|t
1293282|NCT03683654|||Cohort||Cross-Sectional|||||||
1293283|NCT03683641|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293284|NCT03683628|Randomized|Parallel Assignment||Treatment||Single|The assessor who measure the pain free walking distance, ABI, TBI,TCOM do not know the result of randomization|||||t
1293285|NCT03683615||Single Group Assignment||Treatment||None (Open Label)||||||
1293286|NCT03683602|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293287|NCT03683589|||Cohort||Prospective|||||||
1293288|NCT03683576|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293289|NCT03683563|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293290|NCT03683550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293291|NCT03683537|||Case-Control||Prospective|||||||
1293292|NCT03683524|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Experimental group: bitherapy based on DTG (50 mg QD) plus DRV/cobi (800/150 mg QD)~Control group: continuation of their current stable ART."||||
1293293|NCT03683511|||Case-Only||Retrospective|||||||
1293294|NCT03683498||Sequential Assignment||Treatment||None (Open Label)||Initial enrollment will be at Dose-level A. Subsequent cohorts will be dose escalated.||||
1293295|NCT03683485|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293296|NCT03683472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293297|NCT03683459||Single Group Assignment||Treatment||None (Open Label)||||||
1293298|NCT03683446|||Cohort||Other|||||||
1293299|NCT03683433||Single Group Assignment||Treatment||None (Open Label)||||||
1293300|NCT03683420|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293301|NCT03683407|||Cohort||Prospective|||||||
1293302|NCT03683394|Randomized|Parallel Assignment||Prevention||Single||Participants will be randomized after baseline assessments to the SMARRT intervention arm or Health Education (HE) control arm. Randomization will be stratified by clinic, race/ethnicity (non-Hispanic white vs. non-white or Hispanic) and age (70-79, 80-89).||||t
1293303|NCT03683381|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1293304|NCT03683368|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1293305|NCT03683355|||Cohort||Prospective|||||||
1293306|NCT03683342|Randomized|Parallel Assignment||Other||Triple||||t|t|t
1293307|NCT03683329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293308|NCT03683316|||Cohort||Prospective|||||||
1573301|NCT00001699||||||||||||
1293309|NCT03683303|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1293310|NCT03683290|||Cohort||Prospective|||||||
1293311|NCT03683277||Single Group Assignment||Treatment||None (Open Label)||All the patients will receive the same treatment until progression desease||||
1293312|NCT03683264|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1293313|NCT03683251|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1293314|NCT03683238|||Case-Control||Retrospective|||||||
1293315|NCT03683225||Single Group Assignment||Treatment||None (Open Label)||"Pramipexole ER tablets will be administered with or without aprepitant, orally once daily in the morning.~During Part 1 and Part 2, pramipexole ER dosage will be adjusted in twice-weekly increments of 0.75 mg/day as guided by efficacy and tolerability (see table above).~Aprepitant:~From study Part 2 onwards, participants will also receive one 80 mg capsule of aprepitant co-administered once daily with pramipexole ER."||||
1293316|NCT03683212|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293317|NCT03683199||Single Group Assignment||Treatment||None (Open Label)||The total sample size will be 27 patients to study as calculated using G power version 3.1.3, in order to detect a significant difference in the mean of nasal ratios before and after surgery in the studied group (one of basic tools to measure the outcome). Assumed Effect size= 0.5, Power =0.80, Alpha error = 0.05.||||
1293318|NCT03683186||Single Group Assignment||Treatment||None (Open Label)||||||
1293319|NCT03683173|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293320|NCT03683160||Single Group Assignment||Treatment||None (Open Label)||Single arm design with two blocks.||||
1293321|NCT03683147|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293322|NCT03683134|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1293323|NCT03683121|||Cohort||Prospective|||||||
1293324|NCT03683108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293325|NCT03683095|||Cohort||Prospective|||||||
1293326|NCT03683082|Randomized|Crossover Assignment||Treatment||Single|||t|||
1293327|NCT03683069|Randomized|Parallel Assignment||Basic Science||Triple|The screened, eligible hypertensives will enter a two-week single blind placebo washout phase.|Parallel Design|t||t|t
1293328|NCT03683056|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293329|NCT03683043|Randomized|Parallel Assignment||Treatment||Single||||||t
1293330|NCT03683030||Single Group Assignment||Treatment||None (Open Label)||||||
1293331|NCT03683017|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293332|NCT03683004|||Cohort||Prospective|||||||
1293333|NCT03682991|Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a parallel group, open label randomized clinical trial, with blinded endpoint evaluation (PROBE design)||||
1293334|NCT03682978|Randomized|Parallel Assignment||Treatment||Quadruple|AIMS2-CT-01 is a double-blind study where participants and parent(s)/legal guardians as well as research staff will be unaware of the treatment allocation, with the exception of a dedicated unblinded pharmacist at each individual site. Blinding of the remainder of the study team members will be maintained by utilizing identical tablets, blistercards and boxes containing either Arbaclofen or placebo. Unblinded study drug and placebo supplies will be stocked at each study site pharmacy. An online randomization system will be used, by this unblinded pharmacist, to assign the study treatment. Based on the outcome of the randomisation, the pharmacist prepares the boxes containing the applicable treatment and releases these (blinded) boxes to the investigator for dispensing to the patient. In order to maintain the study blind, the dosing regimen will be consistent whether participants are randomized to Arbaclofen or placebo.||t|t|t|t
1293335|NCT03682965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293336|NCT03682952|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293337|NCT03682939||Single Group Assignment||Other||None (Open Label)||||||
1293338|NCT03682926|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293339|NCT03682913|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293340|NCT03682900|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293341|NCT03682887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293342|NCT03682874|||Cohort||Prospective|||||||
1293343|NCT03682861|Randomized|Single Group Assignment||Other||Single|Flavoured water placebo drink with no energy or carbohydrate drinks in opaque bottles to keep participant blinded|It is a repeated measure design where each participant will undergo all four treatment in a randomized fashion to prevent any order effect. Treatments (recovery drinks) include a placebo which will be similar in taste and flavour to other treatments and three carbohydrate containing drinks mixed in water at different concentrations. Design of the study is composed of three main stages: 1) glycogen lowering exercise, 2) glycogen replenishment and rest and 3) performance based, timed cycling exercise. All participants will arrive fasted to the laboratory, performing an exercise protocol that lowers their glycogen levels, followed by ingestion of different drinks (every 30 min) during 2 hours of a 4 hour rest and finally performing a 20 km stationary bike test for the time to finish to evaluate the effect of recovery drinks ingested.|t|||
1293344|NCT03682848||Single Group Assignment||Treatment||None (Open Label)|This will be an open-label study. Hence, there will be no masking.|All subjects will receive the FDC of DTG/3TC (50/300 milligrams) for once daily dosing in this single arm study.||||
1293345|NCT03682835|Randomized|Parallel Assignment||Other||Single||randomized, parallel, single-blind, placebo-controlled|t|||
1293346|NCT03682822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293347|NCT03682809|Randomized|Parallel Assignment||Treatment||Double|"The patients who are randomized to Systane Complete will be masked to the brand of the artificial tears.~There will be a masked examiner who does not know the subject's study group."|One group will be randomized Systane Complete, and one group will be randomized to no treatment.|t||t|
1293348|NCT03682796|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293349|NCT03682783|||Case-Only||Prospective|||||||
1293350|NCT03682770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293351|NCT03682757|||Cohort||Prospective|||||||
1293352|NCT03682744||Single Group Assignment||Treatment||None (Open Label)||||||
1293353|NCT03682731|||Cohort||Prospective|||||||
1293354|NCT03682718|Randomized|Parallel Assignment||Treatment||Single||||||t
1293355|NCT03682705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293356|NCT03682692|Randomized|Parallel Assignment||Treatment||Single||Randomization and treatment: Eligible patients should be monitored 24-hour blood pressure before enrollment. Then randomly divided into two groups according to the center and whether receive antihypertensive treatment, taking benazepril 10 mg/amlodipine besylate 5mg fixed-dose combination, 1 tablet once a day, or benazepril 10mg / hydrochlorothiazide 12.5mg fixed-dose combination, 1 tablet once a day. If the systolic/diastolic blood pressure is ≥140/90 mmHg during follow-up, the dose can be increased to 2 tablets once a day. If the systolic /diastolic blood pressure continues ≥140/90mmHg, bisoprolol 5mg (1 tablet once a day) or doxazosin controlled-release tablets 4mg (1 tablet once a day) or spironolactone 20mg (one tablet once a day) can be added further.|t|||
1293357|NCT03682679|||Other||Cross-Sectional|||||||
1293358|NCT03682666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293359|NCT03682653|Randomized|Parallel Assignment||Prevention||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|individually randomized trial of azithromycin versus placebo to establish the efficacy and safety of administration of a dose of azithromycin during the neonatal period|t|t|t|t
1293360|NCT03682640|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study is a 2-arm, randomized, open, clinical trial comparing the AIDIT protocol with treatment as usual.||||
1293361|NCT03682627|Randomized|Parallel Assignment||Prevention||Triple||single intuition, double blinded, randomized clinical trial.|t||t|t
1293362|NCT03682614|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1293363|NCT03682601|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blinded|Randomized, Double Blinded, Placebo Controlled|t|t|t|t
1293364|NCT03682588|Randomized|Parallel Assignment||Treatment||Single|Randomised electronically generated randomisation table. Secret allocation (sealed opaque envelopes).|Randomized controlled trial||||t
1293365|NCT03682575|||Cohort||Prospective|||||||
1293366|NCT03682562|||Case-Control||Prospective|||||||
1293367|NCT03682549|||Case-Control||Prospective|||||||
1293368|NCT03682536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293369|NCT03682523|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants will be enrolled into the control group (n=25), and complete all study procedures before any participants are enrolled in the intervention group (n=25). This approach is necessary to limit contamination of implementing the intervention on the behaviors of healthcare providers.||||
1293370|NCT03682510|Randomized|Parallel Assignment||Prevention||None (Open Label)||The participants who fulfilled the eligibility criteria were explained about the study with the beneficial and possible adverse effects of lidocaine. Informed consent was obtained from them after that participant were randomized into 3 groups: group 1 [N&H technique], group 2 [N&H technique] and group 3 stepwise devascularization||||
1293371|NCT03682497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293372|NCT03682484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293373|NCT03682471|||Cohort||Prospective|||||||
1293374|NCT03682458|||Cohort||Prospective|||||||
1293375|NCT03682445|Randomized|Parallel Assignment||Supportive Care||Double|Participants wil be making exercise. It is not possible to make participants blinded to the study.|The study has 3 arms.|||t|t
1293376|NCT03682432||||||||||||
1293377|NCT03682419|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||A performance evaluation study.||||
1293378|NCT03682406|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessors will remain blinded to the treatment condition for all participants.|Participants will be assigned in even numbers to CAMS-G or care as usual.||||t
1293379|NCT03682393|Randomized|Parallel Assignment||Prevention||Triple|The study is double blinded, neither the patients or investigators or nurses managing the drugs do not know whether the patient receives placebo (isotonic saline) or active drug (corticosteroid). In case of emergency the codes can be cracked.|half of the recruited patients will receive intravenous corticosteroid and the other half will receive intravenous isotonic saline as placebo|t|t|t|
1293380|NCT03682380|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1293381|NCT03682367|Randomized|Parallel Assignment||Supportive Care||Triple|All staff involved including nursing, surgeons, pain management, participants and PI will be blinded. Unmasked personnel only include research pharmacy staff.||t|t|t|
1293382|NCT03682354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293383|NCT03682341|||Case-Control||Prospective|||||||
1293384|NCT03682328|Randomized|Parallel Assignment||Treatment||Single||Randomized Controlled Trial|t|||
1293385|NCT03682315|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293386|NCT03682302|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293387|NCT03682289|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293388|NCT03682276||Single Group Assignment||Treatment||None (Open Label)||||||
1293389|NCT03682263|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293390|NCT03682250|||Other||Prospective|||||||
1293391|NCT03682237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293392|NCT03682224|Randomized|Parallel Assignment||Treatment||Single|The participant will not be aware of the drug group. A study statistician will generate the randomization with two arms. Statistician will be blinded and will not be aware of the treatment allocation. Researchers and clinicians will be aware of the allocation and drugs will be dispensed by the hospital pharmacy based on the allocation sequence.|Participants will be randomly assigned to receive either Exparel or Marcaine during surgery. Based on the randomization they will receive one of the two drugs. Participants are assigned one of the two groups in parallel for the duration of the study|t|||
1293393|NCT03682211|Randomized|Parallel Assignment||Treatment||Triple|All clinical and research staff, patients and parents are blinded to the treatment allocation. All study drugs will be packaged in blinded trial packs by a clinical trial pharmacist who is blinded to interventions and outcomes.The matched size and shape of the placebo ampoule is necessary to maintain blinding of intervention by the investigators.|randomised, double-blind, double-dummy active control trial|t|t|t|
1294334|NCT03669978|||Cohort||Prospective|||||||
1293394|NCT03682198||Single Group Assignment||Basic Science||None (Open Label)||||||
1293395|NCT03682185|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1293396|NCT03682172|Randomized|Parallel Assignment||Basic Science||Double||It is a blinded, randomized, placebo controlled study where 15 participants receive three different 4 hour intravenous infusions of either saline (placebo), low GLP-2 (at a rate of 1pmol/kg/min) or high GLP-2 (at a rate of 10pmol/kg/min) on three different study days.|t||t|
1293397|NCT03682159|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1293398|NCT03682146|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293399|NCT03682133|||Other||Prospective|||||||
1293400|NCT03682120|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1293401|NCT03682107|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1293402|NCT03682094||Single Group Assignment||Treatment||None (Open Label)|No masking.|||||
1293403|NCT03682081|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking.|||||
1293404|NCT03682068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293405|NCT03682055||Single Group Assignment||Treatment||None (Open Label)|Open label study|Single-arm study||||
1293406|NCT03682042|Randomized|Parallel Assignment||Prevention||Single|Neurodevelopmental providers will be blinded to the randomization of the toddler during the examination.|Neurodevelopmental assessments will be done at 2 years of age (22-26 months) for subjects who were randomized to receive either immediate cord clamping or umbilical cord milking as part of the MIDAB trial.||||t
1293407|NCT03682029|Randomized|Parallel Assignment||Prevention||Quadruple|Randomization performed by the independent provider of study medication (Glostrup Pharmacy).|Prospective, randomized, placebo-controlled trial.|t|t|t|t
1293408|NCT03682016|||Cohort||Cross-Sectional|||||||
1293409|NCT03682003|||Cohort||Prospective|||||||
1293410|NCT03681990||Single Group Assignment||Prevention||None (Open Label)||||||
1293411|NCT03681977|Randomized|Parallel Assignment||Treatment||Double|"The Participants and the researchers at the Constance Lethbridge Rehabilitation Centre responsible for collecting the kinematic and gait data (motion capture, questionnaires, performance measures) will be blinded.~For analysis purposes the Participants will be dummy coded (0 = one group, 1 = the other group). The blinded parties will know the dummy code but they will not know which group is assigned to each code."|A prospective, double-blinded, randomized control study consisting of a clinical follow-up followed by a knee kinematics assessment. Patients outcomes will be measured pre-operatively, and at 1 and 2 years post-surgery. Measures will include joint mechanics and neuromuscular activation during walking and stair stepping measured with motion capture and electromyography, and clinical/self assessment including pain in response to physical activity.|t|||t
1293412|NCT03681964|||Cohort||Prospective|||||||
1293413|NCT03681951|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Part 1 dose escalation will administer escalating doses of GSK3145095 as monotherapy only. Part 2 will combine escalating doses of GSK3145095 with 200 mg pembrolizumab. Dose escalation of GSK3145095 will begin at least one level below the highest dose shown to have an acceptable toxicity profile in at least 3 subjects in Part 1. Part 3 will enroll subjects treated with one or more dose levels of GSK3145095 in combination with 200 mg pembrolizumab. Part 4 will investigate the combination of additional anticancer agents with one or more doses of GSK3145095 identified as safe in Part 1.||||
1293414|NCT03681938|||Case-Control||Retrospective|||||||
1293415|NCT03681925|Randomized|Parallel Assignment||Screening||Single|Patient participants will be unaware of which arm their dietitian has been randomized to.|6 dietitians will be randomized in a 2:1 intervention:control fashion. Each dietitian will recruit 19 patient participants, for 114 total patient participants.|t|||
1293416|NCT03681912|||Cohort||Retrospective|||||||
1293417|NCT03681899|||Cohort||Prospective|||||||
1293418|NCT03681886||||||||||||
1293419|NCT03681873||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293420|NCT03681860|Randomized|Parallel Assignment||Treatment||None (Open Label)|This will be an open label trial as it will not be possible to blind either volunteers or clinic staff to the allocation. However, laboratory staff will be blinded to the allocation of the volunteers as they undertake the immunological assays.|||||
1293421|NCT03681847|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293422|NCT03681834|||Cohort||Prospective|||||||
1293423|NCT03681821|Randomized|Parallel Assignment||Supportive Care||Double|Potential eligible participants were identified by researchers according to medical records at the colorectal surgery unit in each hospital. They were recruited with informed consent, and researchers explained the study purposes, procedures, benefits, and risks involved orally. The participants were then randomly allocated to the intervention or the control group according to a computer-generated block randomization list. The generated random numbers were put into consecutively numbered and opaque sealed envelopes. When enrolling and randomising a new participant, the enrolling investigators opened the sealed envelope after participant's name was written on next available envelopes. A sequentially numbered and opaque , sealed envelope system was used by a non-investigator. Additionally, all data collection was conducted by another research assistant who was blind to the study design and allocation of participants.|"Patients in the intervention group had access to conventional care, in addition to receiving the follow-up TTM-based intervention sessions. The intervention was provided by trained nurses, including one researcher and one ET nurse. The researcher was regarded as primary leader of the intervention sessions. The leader informed patients of the schedule for each session using the educational manual 'we all can do the same: a pro-change program for self-management of an ostomy' (developed by psychologists, nursing managers, experienced ET nurses, and researchers).~No interventions were performed for the control group participants during the study. However, these patients received conventional care in the colorectal surgery units according to the three hospitals' similar nursing guidelines."|t|||t
1293424|NCT03681808|Randomized|Parallel Assignment||Treatment||Single|Subjects will be dispensed product according to the treatment arm corresponding to their randomization and will be unmasked. The Investigator will be masked.|Investigator/Sponsor masked, randomized, open-label, parallel-group, multicenter study|||t|
1293425|NCT03681795||Single Group Assignment||Other||None (Open Label)||||||
1293426|NCT03681782|||Cohort||Prospective|||||||
1293554|NCT03680118||Single Group Assignment||Treatment||None (Open Label)||||||
1573302|NCT00001696||||Treatment||||||||
1293427|NCT03681769|Randomized|Parallel Assignment||Treatment||Quadruple|Data for this randomized, double-blind, sham-controlled study (behavioral assessments, functional MRI measurements) will be acquired by the members of the Dr. Hanlon's lab, including graduate students and research specialists. These individuals will also perform data under the guidance of the PI. Manuscript composition will be led by the PI, with the assistance of the research team.|"This randomized, double-blind, sham-controlled study will parametrically evaluate the longitudinal effects of 16 days of rTMS to the DLPFC (Aim 1) or the MPFC (Aim 2) on self-reported pain and the brain's response to pain. This will be done in a cohort of patients recruited from Medical University of South Carolina clinics and the outer community with chronic lower back pain that have been using prescription opiates for 3 or more months without adequate pain relief. Participants will be randomized to receive TMS to the DLPFC, MPFC, or sham (50% at each site), using a Latin square randomization. Resting state connectivity will be collected along with data from a standardized thermal pain paradigm wherein individuals are exposed to pain and instructed to try to control' the pain. Quantitative Pain Testing will be collected 12 times. MRI data will be collected 3 times: before the 1st visit of TMS, before the 12th visit of TMS, and before the 16th visit of TMS."|t|t|t|t
1293428|NCT03681756|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293429|NCT03681743|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293430|NCT03681730|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293431|NCT03681717|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293432|NCT03681704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293433|NCT03681691|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Primary Objective: The primary objective is to determine whether the effects of glucose and ketone body uptake to the brain in response to 8-week administration of transdermal 17β-estradiol differ in postmenopausal women with and without type 2 diabetes.||||
1293434|NCT03681678|||Cohort||Prospective|||||||
1293435|NCT03681665|||Cohort||Prospective|||||||
1293436|NCT03681652|||Case-Control||Prospective|||||||
1293437|NCT03681639||Single Group Assignment||Treatment||None (Open Label)||||||
1293438|NCT03681626|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293439|NCT03681613|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293440|NCT03681600|||Cohort||Prospective|||||||
1293441|NCT03681587|||Cohort||Prospective|||||||
1293442|NCT03681574|Randomized|Parallel Assignment||Treatment||Single|A pharmacist will prepare the drugs under codes of numbers 1, 2 or 3. The nursing team and anesthesiologists will not know the drug formula used. Drugs will only be revealed after the statistical assessment.|Parallel Assignment||||t
1293443|NCT03681561||Single Group Assignment||Treatment||None (Open Label)||||||
1293444|NCT03681548|Randomized|Crossover Assignment||Treatment||None (Open Label)||Bioequivalence study||||
1293445|NCT03681535||Single Group Assignment||Treatment||None (Open Label)||||||
1293446|NCT03681522|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1293447|NCT03681509|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1293448|NCT03681496||||||||||||
1293449|NCT03681483||Single Group Assignment||Treatment||None (Open Label)||Single arm, open label, multi-institution study of RO5126766 (CH5127566) in patients with KRAS mutant NSCLC.||||
1293450|NCT03681470||Single Group Assignment||Treatment||None (Open Label)||||||
1293451|NCT03681457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293452|NCT03681444|Randomized|Parallel Assignment||Other||Single||||t||
1293453|NCT03681431|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||A phase II, single-centre, open, non-randomized, cross-over, clinical trial.||||
1293454|NCT03681418||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293455|NCT03681405|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1293456|NCT03681392|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Randomized open-label crossover design with 1:1 allocation of first regimen as once daily or twice daily||||
1293457|NCT03681379|||Case-Only||Prospective|||||||
1293458|NCT03681366|Randomized|Parallel Assignment||Treatment||Double|"Double masked design:~The investigator(s) who were responsible for refracting and performing relevant ocular data measurement were masked from the grouping of the subjects.~The unmasked investigator(s) were responsible for group allocation, spectacle-dispensing work, measuring lens visual performance, record keeping, data entry and compliance checking. Data input was carefully checked by the unmasked investigator and the other researchers independently.~The children and their parents were also masked to group allocation until the data analysis was completed."||t||t|
1293459|NCT03681353||Single Group Assignment||Other||None (Open Label)||||||
1293460|NCT03681340|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1293461|NCT03681327||Single Group Assignment||Basic Science||None (Open Label)||||||
1293462|NCT03681314|Randomized|Parallel Assignment||Supportive Care||Single|Neurodevelopmental providers will be blinded to the randomization of the toddler during the examination.|Neurodevelopmental assessments will be done at 2 years of age (22-26 months) for subjects who were randomized to receive either immediate cord clamping or umbilical cord milking as part of the MIDAB trial.||||t
1293463|NCT03681301|Randomized|Parallel Assignment||Other||Double|Double (Investigator, Outcomes Assessor)|Parallel Assignment|||t|t
1293464|NCT03681288||Single Group Assignment||Treatment||None (Open Label)||||||
1293465|NCT03681275|Randomized|Parallel Assignment||Prevention||Single|||t|||
1293466|NCT03681262|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized open label parallel group||||
1293467|NCT03681249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293468|NCT03681236|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1293469|NCT03681223|Randomized|Parallel Assignment||Treatment||Single|All patients will be blinded to their assignment, investigators will not be blinded.|All subjects will be predetermined by their surgeon to undergo either a laparoscopic or robotic assisted laparoscopic sacrocolpopexy depending upon their clinical evaluation. The participants will then be randomized to either Restorelle® or Vertessa® Y sacrocolpopexy according to a computer-generated randomization.|t|||
1293470|NCT03681210|||Cohort||Prospective|||||||
1293471|NCT03681197|Randomized|Parallel Assignment||Treatment||Single|Each of the consecutive women numbers will be written on sequentially numbered opaque sealed envelope that contains the assignment code.At the time of procedure,the responsible investigator will open the envelope to reveal the assignment,and she will introduce the planned method. Monitoring and follow up will be done. After enrollment,the cases will be randomly allocated into two groups.||t|||
1293472|NCT03681184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293473|NCT03681171||Single Group Assignment||Treatment||None (Open Label)||||||
1293474|NCT03681158||Single Group Assignment||Treatment||None (Open Label)||||||
1293475|NCT03681145|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1293476|NCT03681132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293477|NCT03681119||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293478|NCT03681106|Randomized|Parallel Assignment||Treatment||None (Open Label)|"Randomization list has been already generated but will not be available to the recruiters to avoid allocation bias.~Statistician that will handle the data anlysis will not know which group is the interventional and which group is the control.~We were not able to mask the using of tape to the patients or the investigators because it is an evident treatment."|||||
1293479|NCT03681093|Randomized|Parallel Assignment||Treatment||Double|Double blind, double dummy study design.||t||t|
1293480|NCT03681080|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293481|NCT03681067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293482|NCT03681054|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1293483|NCT03681041|||Cohort||Prospective|||||||
1293484|NCT03681028||Single Group Assignment||Treatment||None (Open Label)||||||
1293485|NCT03681015|||Case-Only||Prospective|||||||
1293486|NCT03681002||Single Group Assignment||Health Services Research||None (Open Label)||||||
1293487|NCT03680989|Randomized|Crossover Assignment||Treatment||Single|||t|||
1293488|NCT03680976|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1293489|NCT03680963|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1293490|NCT03680950||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293491|NCT03680937|||Case-Control||Prospective|||||||
1293492|NCT03680924|||Case-Only||Other|||||||
1293493|NCT03680911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293494|NCT03680898|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1293495|NCT03680885|Randomized|Parallel Assignment||Health Services Research||Quadruple|The scoring of the lidocaine test is masked, using the coded identity of the tastes. The tastes will be assessed in random order. Each subject will have 2 tests with lidocaine gel and 2 with a placebo gel, in random order, each on different days. The subjects and other study personnel will be told not to discuss what the subject could or couldn't taste. Scoring will be done only after all testing on the subject is complete. A person not involved in the testing will keep track of which gels the subject has had.|Half the subjects will have a self-reported history of lidocaine working for them (effective) and half will have a history of difficulty getting numb (ineffective).|t|t|t|t
1293496|NCT03680872||Single Group Assignment||Treatment||None (Open Label)||This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to three individuals with tetraplegia.||||
1293497|NCT03680859|||Cohort||Prospective|||||||
1293498|NCT03680846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293499|NCT03680833||Single Group Assignment||Diagnostic||None (Open Label)||prospective cohort study||||
1293500|NCT03680820|||Cohort||Prospective|||||||
1293501|NCT03680807|||Case-Control||Cross-Sectional|||||||
1293502|NCT03680794||Single Group Assignment||Other||None (Open Label)||||||
1293503|NCT03680781||Single Group Assignment||Treatment||None (Open Label)||||||
1293504|NCT03680768|||Cohort||Cross-Sectional|||||||
1293505|NCT03680755|Randomized|Parallel Assignment||Treatment||None (Open Label)|Given the obvious differences between those who will receive the Internet-based dental anxiety and those who will not (i.e., those who are assigned to the control condition), we will not be able to blind patients to this aspect of randomization. Patients will not be informed about the professional affiliation of therapy aides, who will dress similarly (e.g., professional dress and a lab coat) and who will be instructed not to respond to questions related to this topic.|This will be a single-center parallel groups study with randomization to one of three arms: (1) a treatment condition (Tr1) in which the dental anxiety intervention is administered by CBT personnel (n=150), (2) a treatment condition in which the dental anxiety intervention is administered by dental staff (Tr2) (n=150), or (3) an active control (AC) group (notification of the dental providers of the patient's score on a dental anxiety scale before their dental treatment appointment). In addition, control participants will be asked to view a video of nature scenes for a period of time equivalent to the dental anxiety intervention.||||
1293506|NCT03680742||Single Group Assignment||Treatment||None (Open Label)||||||
1293507|NCT03680729|Randomized|Parallel Assignment||Prevention||None (Open Label)||aBSB is the adaptation of BSB. BSB a two part intervention to improve rates of community-based HIV testing and prevention education in black young MSM (YMSM). BSB was developed on Information Motivation Behavioral Skills (IMB) theory. The first part of BSB uses Motivational Interviewing in a culturally appropriate way to encourage participants to accept testing and return for test results. The second part is conducted after the participant has received his result, assuming it was not reactive and offers prevention education.||||
1293508|NCT03680716|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1293509|NCT03680703|Randomized|Parallel Assignment||Treatment||Single||||||t
1293510|NCT03680690|||Cohort||Prospective|||||||
1293555|NCT03680105|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1293556|NCT03680092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293557|NCT03680079||Single Group Assignment||Other||None (Open Label)||The intervention being studied is a group education program||||
1293558|NCT03680066||Single Group Assignment||Other||None (Open Label)||||||
1573303|NCT00001685||||Treatment||||||||
1293511|NCT03680677|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"There will be two cohorts of patients:~Arm A will include patients 60 years of age and older with a new diagnosis of either acute leukemia or MDS who are being evaluated either in the outpatient or inpatient hematologic malignancies department at the University of Pennsylvania. These patients are routinely evaluated with a series of tests prior to initiation of chemotherapy.~Arm B will include patients 60 years of age and older with a diagnosis of any hematologic malignancy being treated with a non-myeloablative allogeneic blood or marrow transplantation.~Patients may proceed from Arm A to B, or start directly in Arm B"||||
1293512|NCT03680664|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1293513|NCT03680651|||Cohort||Retrospective|||||||
1293514|NCT03680638|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Each subject has one control site and three experimental sites concurrently tested within the same study using intradermal microdialysis on the dorsal forearm.||||
1293515|NCT03680625|Randomized|Parallel Assignment||Treatment||None (Open Label)||parallel/2 groups||||
1293516|NCT03680612|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1293517|NCT03680599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293518|NCT03680586||Single Group Assignment||Treatment||None (Open Label)||||||
1293519|NCT03680573|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Each subject has one control site and three experimental sites concurrently tested within the same study using intradermal microdialysis on the dorsal forearm.||||
1293520|NCT03680560||Single Group Assignment||Treatment||None (Open Label)||||||
1293521|NCT03680547|||Other||Cross-Sectional|||||||
1293522|NCT03680534|Randomized|Parallel Assignment||Treatment||Single||||||t
1293523|NCT03680521||Single Group Assignment||Treatment||None (Open Label)||||||
1293524|NCT03680508||Single Group Assignment||Treatment||None (Open Label)||||||
1293525|NCT03680495|||Case-Control||Other|||||||
1293526|NCT03680482|Randomized|Crossover Assignment||Screening||Single|the participant has no knowledge of the intervention assignment|The experimental design was developed 3 times. Each intervention was performed separately for a minimum period of 7 days out and a maximum of 14 days, depending on the availability of the experimental subjects. Cross treatment design (crossover) each subject serves as its own control The first intervention corresponded to the control group, in order to maintain the ignorance of the type of sweetener they were receiving, between day 7 or maximum 14 days post-intervention the order of the test of the ENN was reversed. Therefore, during the second or third intervention they were given to drink water with sucralose or stevia respectively|t|||
1293527|NCT03680469|Randomized|Parallel Assignment||Treatment||Single||||||t
1293528|NCT03680456|Randomized|Parallel Assignment||Treatment||Double||interventional randomized doubleblind, Placebo controlled|t||t|
1293529|NCT03680443|||Case-Only||Retrospective|||||||
1293530|NCT03680430||Single Group Assignment||Treatment||None (Open Label)||||||
1293531|NCT03680417|Randomized|Parallel Assignment||Prevention||Single|laboratory analyst are masked for the evaluation of antibody against measles and rubella. The immunogenicity is measured before and after vaccination.|Safety Group: open labeled, prospective intervention study, only assess the safety outcome Sub Group: open labeled, prospective intervention study, evaluate safety and protectivity outcome||||t
1293532|NCT03680404|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Each subject has one control site and three experimental sites concurrently tested within the same study using intradermal microdialysis on the dorsal forearm.||||
1293533|NCT03680391|||Case-Control||Prospective|||||||
1293534|NCT03680378||Single Group Assignment||Other||None (Open Label)||||||
1293535|NCT03680365|||Case-Only||Cross-Sectional|||||||
1293536|NCT03680352||Sequential Assignment||Other||None (Open Label)||||||
1293537|NCT03680339|Randomized|Parallel Assignment||Prevention||Single||||||t
1293538|NCT03680326|||Other||Retrospective|||||||
1293539|NCT03680313|||Case-Control||Prospective|||||||
1293540|NCT03680300|Randomized|Parallel Assignment||Prevention||None (Open Label)||60 athletes with hamstring tightness divided into 3 group.they will be Allocated by using a manual lottery system||||
1293541|NCT03680287|Non-Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1293542|NCT03680274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293543|NCT03680261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293544|NCT03680248|Randomized|Single Group Assignment||Basic Science||None (Open Label)||10 non-obese insulin-sensitive male volunteers with normal hepatic fat content (less than 5% of liver fat) and 10 non-obese non-diabetic subjects with increased hepatic fat content (more than 5% of hepatic fat) will undergo series of six experiments - changes of liver fat content will be measured at time 0, 3 and 6 hours after specific dietary interventions||||
1293545|NCT03680235|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1293546|NCT03680222|Randomized|Parallel Assignment||Treatment||Single||Different methods of protection of external branches of superior laryngeal nerve|t|||
1293547|NCT03680209|||Cohort||Prospective|||||||
1293548|NCT03680196||Single Group Assignment||Treatment||None (Open Label)||||||
1293549|NCT03680183|||Case-Control||Prospective|||||||
1293550|NCT03680170|Randomized|Parallel Assignment||Treatment||Triple|At the pre and first post test the person performing the testing is blinded to which group the participant is allocated to. The participant is blinded to which intervention he/she is participating in. At the second post-test the research assistant know which training the participant has been allocated to. Person performing the statistical analysis will be blinded to study group allocation.|Two parallel assigned intervention groups with randomized allocation.The intervention of focus is a web-based working memory updating training. The placebo condition consists of a web-based low dose short term memory training. Both groups received pretesting (pre-test) before 30 sessions (6-8 weeks) of training followed by immediate post-testing (post-test 1) and a long term follow up four months after training (post-test 2)|t||t|t
1293551|NCT03680157|||Other||Retrospective|||||||
1293552|NCT03680144||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293553|NCT03680131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573304|NCT00001681||||||||||||
1293559|NCT03680053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293560|NCT03680040|||Cohort||Prospective|||||||
1293561|NCT03680027|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293562|NCT03680014|||Cohort||Prospective|||||||
1293563|NCT03680001|||Cohort||Cross-Sectional|||||||
1293564|NCT03679988|||Ecologic or Community||Cross-Sectional|||||||
1293565|NCT03679975||Single Group Assignment||Other||None (Open Label)||Approximately 30 subjects with ALS will be enrolled and undergo an instrumental evaluation of swallowing safety before and after administration of a single dose of the ROSF formulation containing 50 mg of Riluzole.||||
1293566|NCT03679962|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Control Trial||||
1293567|NCT03679949|Randomized|Crossover Assignment||Basic Science||Double||This is a randomized, cross-over, double-blind, placebo-controlled study. All participants will partake in each arm and receive all interventions.|t||t|
1293568|NCT03679936|||Case-Control||Prospective|||||||
1293569|NCT03679923|Randomized|Parallel Assignment||Supportive Care||Quadruple||treatment versus placebo|t|t|t|t
1293570|NCT03679910|||Case-Control||Retrospective|||||||
1293571|NCT03679897|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293572|NCT03679884|Randomized|Parallel Assignment||Treatment||Quadruple||Multi-center, double-blind, parallel-group, randomized, placebo-controlled, three doses, 40-week extension study|t|t|t|t
1293573|NCT03679871||Single Group Assignment||Other||None (Open Label)||||||
1293574|NCT03679858|||Cohort||Prospective|||||||
1293575|NCT03679845||Single Group Assignment||Treatment||None (Open Label)||||||
1293576|NCT03679832|||Cohort||Prospective|||||||
1293577|NCT03679819|||Case-Only||Prospective|||||||
1293578|NCT03679806|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1293579|NCT03679793|Randomized|Parallel Assignment||Treatment||Single||||||t
1293580|NCT03679780|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Each subject has one control site and three experimental sites concurrently tested within the same study using intradermal microdialysis on the dorsal forearm.||||
1293581|NCT03679767||Single Group Assignment||Treatment||None (Open Label)||||||
1293582|NCT03679754||Single Group Assignment||Treatment||None (Open Label)||||||
1293583|NCT03679741|Randomized|Crossover Assignment||Treatment||Single|||t|||
1293584|NCT03679728|||Other||Cross-Sectional|||||||
1293585|NCT03679715|Randomized|Parallel Assignment||Prevention||Single||The design is a unicentre (Jewish General Hospital; Montreal, Quebec, Canada), clinical, randomized, controlled, single blinded (i.e.; investigators), superiority trial, with two parallel arms (Intervention and Control groups), comparative (comparison between Intervention and Control groups) and analyzed with the intention-to-treat.|||t|
1293586|NCT03679702||Single Group Assignment||Other||None (Open Label)||||||
1293587|NCT03679689|Randomized|Parallel Assignment||Prevention||Single|Nobody involved with data acquisition had access to de assignment of the subjects|A randomized, blind, controlled clinical trial|||t|
1293588|NCT03679676|Randomized|Parallel Assignment||Treatment||Triple||This is a prospective Phase 2, single-center, multi-allergen OIT in participants with proven allergies to up to 3 different foods in which one must be peanut. Our intent to treat population will be 160 participants, ages 4 to 21 years with a history of multiple food allergies of up to 3 different foods including peanut. An additional 20 multi-food allergic participants and 20 non-allergic controls that will not undergo OIT, will be followed to help interpret immune mechanisms of OIT. Allergy will be confirmed by FA-specific IgE levels and positive skin prick test (SPT). Enrolled participants must be positive at or before the 100 mg (144 mg cumulative) a dosing level of FA proteins.|t|t|t|
1293589|NCT03679663|Randomized|Parallel Assignment||Diagnostic||Single|The outcomes will be assessed by an observer who was not in the room when the puncture site was identified and was blinded to the study group. The room set up will be identical with the handheld ultrasound placed visible in all cases, including those randomized to the palpation group.|RCT||||t
1293590|NCT03679650|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293591|NCT03679637||Single Group Assignment||Treatment||None (Open Label)||||||
1293592|NCT03679624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293593|NCT03679611|Randomized|Parallel Assignment||Treatment||Quadruple|All study investigators, research coordinator, patients, surgeons, anesthesiologists, health care personnel will be blinded to the treatment arm allocation in the study.|This study is a prospective, double-blinded randomized controlled superiority trial with two parallel groups. Randomization will be performed with a 1:1 allocation into reversal of NMBD with sugammadex or neostigmine.|t|t|t|t
1293594|NCT03679598|Randomized|Parallel Assignment||Treatment||Triple|double blind|randomized (1:1), placebo-controlled|t||t|t
1293595|NCT03679585||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293596|NCT03679572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293597|NCT03679559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293598|NCT03679546|Randomized|Parallel Assignment||Treatment||Triple|"The investigator will proceed to the patient randomization as follows :~The investigator fulfill the electronic case report form (eCRF)~The randomization will be performed through the eCRF.~A mail will be sent to the pharmacy that included the inclusion number of the patient, the group allocated and the dose of infliximab or vedolizumab to be infused.~A mail will be sent to the investigator that included only the inclusion number of the patient.~The trial is conducted in a double-blind manner. The biostatistician who generated the randomization list, the person in charge of pharmacovigilance, the pharmacy of the clinical trials of the Rennes university hospital and the pharmacist of the recruiting center can have access to the arm of treatment under study.~Patients and physicians will not know the nature of the molecules administered."|A prospective, multicenter, randomized, double blind clinical trial|t|t|t|
1293599|NCT03679533|Randomized|Parallel Assignment||Prevention||Quadruple||Double-blind placebo-controlled parallel intervention|t|t|t|t
1293685|NCT03678415||Single Group Assignment||Prevention||None (Open Label)||||||
1293686|NCT03678402||Single Group Assignment||Prevention||None (Open Label)||single arm prospective non-randomized study||||
1293687|NCT03678389|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1293600|NCT03679520|Randomized|Parallel Assignment||Supportive Care||Single|Individual participant information will state that different ways of providing antenatal parental preparation will be evaluated, but will not reveal any specific information about the different types of antenatal parental preparation. Individual participants will therefore have no knowledge of allocation to control group or intervention group.|Antenatal clinics randomised to control group provide antenatal parental preparation as usual (regular programme) to expectant parents and antenatal clinics randomised to intervention group provide a new programme of antenatal parental preparation to expectant parents.|t|||
1293601|NCT03679507|Randomized|Parallel Assignment||Treatment||Triple|A Study Administrator will assign subjects to a treatment group randomly, and keep this information strictly confidential. Subjects and investigators will be blinded. The Study Administrator will assign each participant a randomly generated Patient ID number to be used in the collection of data.|This clinical trial will investigate the safety and efficacy of a new hand-held, low-intensity therapeutic ultrasound (LIPUS) device to treat chronic knee pain in osteoarthritis patients. Osteoarthritis of the knee is painful condition, and a leading cause of disability [11]. Two meta-analyses of this application indicate its efficacy in controlling pain [7,10]; one in improving function [10]. Three randomized, double blind, placebo-controlled studies have been published recently. Two demonstrate the ameliorative effects of low-intensity ultrasound therapy on pain, function and quality of life in patients with knee osteoarthritis [12,13]; one showed no significant difference from placebo [9]. Significantly, no adverse event was reported in any of these clinical trials. However subjects will have 24 hours phone access and email access to study administrator and study investigator for reporting any type of adverse event and seeking guidance if needed.|t|t|t|
1293602|NCT03679494|Randomized|Parallel Assignment||Other||Double|||t|t||
1293603|NCT03679481|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1293604|NCT03679468|Randomized|Sequential Assignment||Other||Double|In order to prevent bias in our research results, we will employ a double-blind study design in which the examiner nor the research participant will know which group membership they were assigned to.|We propose undertaking a randomized, blinded, sham controlled clinical trial investigating the effectiveness of CR and exercise, either singly or in combination, in treating cognitive dysfunction in people with progressive MS. Subjects will be randomly assigned to one of four groups: CR plus exercise; CR plus passive exercise; passive CR plus exercise and passive CR plus passive exercise. Subjects will receive one of these four treatments for 12 weeks, twice a week. One in three subjects will undergo structural and functional MRI to investigate how the brain responds to the two interventions.|t||t|
1293605|NCT03679455||Single Group Assignment||Treatment||None (Open Label)||multi-center, single-arm, open label, non-randomized||||
1293606|NCT03679442||Single Group Assignment||Basic Science||None (Open Label)||||||
1293607|NCT03679429|||Cohort||Prospective|||||||
1293608|NCT03679416|||Cohort||Retrospective|||||||
1293609|NCT03679403|||Case-Control||Cross-Sectional|||||||
1293610|NCT03679390|Randomized|Parallel Assignment||Other||Single||Use same medication for different generations, focus on the reactions.|t|||
1293611|NCT03679377||Single Group Assignment||Device Feasibility||None (Open Label)||Mandibular slotplates are placed during the osteosynthesis phase of the BSSO surgery. After clinical testing during the surgery the plates are removed and the osteotomy is fixated with bicortical screws.||||
1293612|NCT03679364|||Case-Control||Prospective|||||||
1293613|NCT03679351|||Other||Cross-Sectional|||||||
1293614|NCT03679338||Single Group Assignment||Treatment||None (Open Label)||||||
1293615|NCT03679325|Randomized|Parallel Assignment||Screening||Double|||t|||t
1293616|NCT03679312|Randomized|Crossover Assignment||Treatment||Double||Randomized double-blind cross-over design|t|||t
1293617|NCT03679299|||Cohort||Prospective|||||||
1293618|NCT03679286|||Cohort||Prospective|||||||
1293619|NCT03679273|Randomized|Parallel Assignment||Treatment||Single||||||t
1293620|NCT03679260|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1293621|NCT03679247|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||PCPs will be stratified based on two factors (size of CKD panel and measure of intent to change behavior). Within these strata, PCPs will be randomized to intervention and control arms in a 1:1 ratio. At study start, each CKD patient seen by a participating PCP will be assigned to the same arm as their PCP. The intervention will be in place for 12 months and data collection will continue for an additional 12 months. In the second phase of the study, we have embedded a one-way (unidirectional) cross-over design (i.e., the PCPs cross over in one direction only, from control to intervention). The second phase of the study will allow us to detect secular trends and contamination, which will serve as preliminary data for future trials.||||
1293622|NCT03679234||Single Group Assignment||Treatment||None (Open Label)|Subjects and their parent/caregiver will be blinded to the intervention product. Care Providers at sites, Investigators, and Outcomes Assessors are unblinded to the intervention product.|||||
1293623|NCT03679221|||Cohort||Cross-Sectional|||||||
1293624|NCT03679208|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293625|NCT03679195|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1293626|NCT03679182||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293627|NCT03679169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293628|NCT03679156|||Other||Retrospective|||||||
1293629|NCT03679143|Randomized|Parallel Assignment||Treatment||Quadruple|Masking for Participant, Investigator and Clinical Research Associate||t|t|t|t
1293678|NCT03678506|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The patients included in the study will receive a serial determination of D-dimer assay (a maximum of four determinations in case of negative results).The D-dimer measurements should be performed at the moment of patient screening, when patients still assume their anticoagulant treatment (T0), at 15±2 days (T1), 30±4 days (T2), and 60±5 (T3) days after their anticoagulant treatment has been stopped. At the first positive D-dimer result patients resume anticoagulation with apixaban 2.5 mg bis in die for the next 18 months. Patients with negative D-Dimer results at all determinations stop anticoagulation definitely and will followed up for the next 18 months.||||
1293679|NCT03678493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293680|NCT03678480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293681|NCT03678467||||||||||||
1293630|NCT03679130|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||FitMum RCT is designed as an open-labeled single-site three-arm randomized controlled trial, including 220 pregnant women no later than gestational age week 15+0 days. Included women will be randomized in a 2:2:1 ratio to receive a structured supervised exercise training (EXE) intervention, receive a motivational counseling intervention supported by health technology (MOT), or a control group receiving standard treatment (CON), respectively. The participants in the EXE and MOT groups continue in the physical activity intervention as long as their pregnancy allows and ideally until delivery, in total approximately six months. Collection of data for assessment of the primary outcome will take place from randomization (one week after inclusion) to GA week 28+0-6 and will be measured by a commercial activity tracker. Secondary outcomes will be examined at Nordsjaellands Hospital five times during the study period. Time frames and methods for assessment of outcomes are specified below.||||
1293631|NCT03679117|Randomized|Parallel Assignment||Prevention||Single||Randomized trial in which participants are assigned to mindfulness training or treatment as usual.||||t
1293632|NCT03679104|Randomized|Crossover Assignment||Treatment||Single||Patients will be allocated to the corresponding group according to a peri-procedural finding, availability of a respective closure method and endoscopist´s decision.|||t|
1293633|NCT03679091|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1293634|NCT03679078||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293635|NCT03679065|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1293636|NCT03679052|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1293637|NCT03679039|||Other||Prospective|||||||
1293638|NCT03679026|||Cohort||Retrospective|||||||
1293639|NCT03679013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293640|NCT03679000|||Cohort||Prospective|||||||
1293641|NCT03678987|||Other||Prospective|||||||
1293642|NCT03678974||Single Group Assignment||Treatment||None (Open Label)||||||
1293643|NCT03678961|||Case-Crossover||Prospective|||||||
1293644|NCT03678948|Randomized|Parallel Assignment||Treatment||Single|Study subject will not be made aware of the treatment received until after completion of the research study.||t|||
1293645|NCT03678935|Randomized|Parallel Assignment||Treatment||None (Open Label)||The intervention group receives advice on following the low-FODMAP diet, and the control group follows their regular gluten free diet.||||
1293646|NCT03678922|||Cohort||Prospective|||||||
1293647|NCT03678909|||Cohort||Prospective|||||||
1293648|NCT03678896|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293649|NCT03678883|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293650|NCT03678870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293651|NCT03678857|Randomized|Single Group Assignment||Prevention||Triple|An independent researcher will label the placebo and creatine and only reveal which group is which after data has been analyzed.||t||t|t
1293652|NCT03678844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293653|NCT03678831|||Case-Control||Prospective|||||||
1293654|NCT03678818|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1293655|NCT03678805|Randomized|Parallel Assignment||Treatment||Single||||||t
1293656|NCT03678792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293657|NCT03678779|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293658|NCT03678766|Randomized|Parallel Assignment||Treatment||Single||||||t
1293659|NCT03678753|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293660|NCT03678740|||Case-Only||Other|||||||
1293661|NCT03678727|||Cohort||Prospective|||||||
1293662|NCT03678714|Randomized|Parallel Assignment||Treatment||Single|It is not possible to mask participants or research team to the allocated intervention. Outcome assessors will be blinded to group allocation for anthropometric and fitness measures.|Participants will be randomised into either an exercise group, a lifestyle physical activity group, or a control group, for a duration of 12 weeks.||||t
1293663|NCT03678701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293664|NCT03678688|Randomized|Sequential Assignment||Treatment||None (Open Label)||"This will be a multiple-dose trial of OPC-167832 with 2 stages.~Stage 1 is a multiple ascending dose trial planned to be conducted in 4 sequential cohorts of 18 participants each. There will be 2 arms (OPC-167832, RHEZ) in each cohort.~Stage 2 will be a parallel group comparison of 4 treatment regimens: 1) low dose OPC-167832 plus delamanid 2) high dose OPC-167832 plus delamanid 3) delamanid only 4) RHEZ."||||
1293665|NCT03678675|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1293666|NCT03678662|Randomized|Parallel Assignment||Other||Double|Participants will not be aware of which group they are allocated to. The experimenter who is assessing pressure pain threshold and tolerance is blinded to the study group of the participant.||t||t|
1293667|NCT03678649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293668|NCT03678636|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||100 patients positive for BPA will be randomized to intervention or control treatment. It is anticipated approximately 200-250 patients will be tested assuming a prevalence of BPA of 40-50%.||||
1293669|NCT03678623|||Case-Only||Cross-Sectional|||||||
1293670|NCT03678610|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1293671|NCT03678597|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1293672|NCT03678584|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1293673|NCT03678571|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1293674|NCT03678558|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1293675|NCT03678545|Randomized|Parallel Assignment||Treatment||Triple||Participants are assigned to either drug or placebo, followed by an open label extension|t|t|t|
1293676|NCT03678532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293677|NCT03678519|||Other||Cross-Sectional|||||||
1293682|NCT03678454|||Other||Prospective|||||||
1293683|NCT03678441|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1293684|NCT03678428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573305|NCT00001680||||Treatment||||||||
1293688|NCT03678376||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293689|NCT03678363|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1293690|NCT03678350||Single Group Assignment||Treatment||None (Open Label)||||||
1293691|NCT03678337|||Cohort||Prospective|||||||
1293692|NCT03678324||Single Group Assignment||Basic Science||None (Open Label)||40 patients with Fabry and 40 unaffected||||
1293693|NCT03678311||Single Group Assignment||Treatment||None (Open Label)||||||
1293694|NCT03678298|||Cohort||Prospective|||||||
1293695|NCT03678285||Single Group Assignment||Screening||None (Open Label)|No other parties besides the participants will be masked.|All participants will take part in the same, single bout, exercise intervention||||
1293696|NCT03678272|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293697|NCT03678259||Single Group Assignment||Diagnostic||None (Open Label)|open-label|The first three patients enrolled in the trial (Part 1) will take part in a dose-escalation dosimetry study and will receive a single IV dose 11.1 MBq (0.3 mCi; n = 1), 37 MBq (1 mCi; n = 1) or 74 MBq (2 mCi; n = 1) of 124I-p5+14 Injection for the purpose of determining estimates of organ-related and whole body radioactive dosimetry. Thereafter, the trial will be opened to include another 40 patients who will be administered a single IV bolus injection of 124I-p5+14 Injection at a dose, to be determined in Part 1 of the study, based on the dosimetry data. Likely, 2 mCi will be used. Every patient participating will receive < 2 mg of peptide p5+14||||
1293698|NCT03678246|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Images are reviewed by an airway anaesthetist who is not directly involved in the study.|Ramped vs Supine position||||
1293699|NCT03678233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293700|NCT03678220||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293701|NCT03678207|||Cohort||Prospective|||||||
1293702|NCT03678194|Randomized|Parallel Assignment||Supportive Care||Single||200 patients with a DSM-V diagnosis of depression are recruited. Patients are randomly assigned to receive either a 6 weeks smartphone application with daily evaluations, or no application.||||t
1293703|NCT03678181|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293704|NCT03678168|Randomized|Parallel Assignment||Treatment||Single|The participants will be unaware of the type of packaging used port rhinology surgery to control pain and bleeding.||t|||
1293705|NCT03678155|Randomized|Parallel Assignment||Treatment||None (Open Label)|Patients will be informed of the condition they have been assigned to.|Two conditions. Patients will be randomly assigned to one of the two conditions.||||
1293706|NCT03678142|||Cohort||Prospective|||||||
1293707|NCT03678129|Randomized|Crossover Assignment||Basic Science||Double|Participants and investigators were blinded to the drug condition|Repeated-measures cross-over study, where each subject received each one of the three pharmacological probes in separate visits (i.e., placebo, AZD7325 low dose and AZD7325 high dose), with the order of tablet administration being pseudorandomized.|t||t|
1293708|NCT03678116|Randomized|Crossover Assignment||Other||Double||Three groups: placebo, caffeine (plus Teacrine and Cayenne) and caffeine (plus Teacrine)|t||t|
1293709|NCT03678103||||||||||||
1293710|NCT03678090|Randomized|Parallel Assignment||Treatment||Double|double blinded||t|t||
1293711|NCT03678077|||Cohort||Retrospective|||||||
1293712|NCT03678064||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1293713|NCT03678051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293714|NCT03678038|Randomized|Parallel Assignment||Treatment||Single||||||t
1293715|NCT03678025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293716|NCT03678012|Randomized|Crossover Assignment||Prevention||Triple|The study dentist, specimen/sample analysis technicians and the statistician will be blinded to the product allocation of subjects.|This will be a randomized, crossover, single blind in situ study with three test periods utilizing 16 subjects. The subjects in this study are lower partial denture wearers who have already had a study partial denture made for them as a part of a partial denture panel under 14-I-098 (IRB # 1407637739) or who will wear their own lower partial denture which was previously approved as part of the panel. The study partial dentures or personal partial dentures can house the specimen holders in two hollowed out areas of the buccal surface of two posterior denture teeth. The subjects will wear the lower partial dentures with enamel specimens in place for three consecutive 14-day study periods.||t|t|t
1293717|NCT03677999|||Case-Only||Prospective|||||||
1293718|NCT03677986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293719|NCT03677973|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1293720|NCT03677960|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293721|NCT03677947|Randomized|Parallel Assignment||Treatment||Single|The independent evaluators will be blind to the random allocation treatment conditions.|The RCT will compare the outcome of 16 sessions of Inference Based Cognitive Therapy compared to 16 sessions of Exposure and Response Prevention in Obsessive Compulsive Disorder patients. The independent evaluators will be blind to the random allocation treatment conditions with a randomization ratio of 1:1. Both treatments will be administered by trained therapists on a weekly one-on-one basis over a 16-week period with 6-month follow-up conforming to current thinking on relapse in OCD. Conditions of treatment delivery, duration and monitoring will be equivalent across all groups. Both treatments are manualized and any newly engaged therapists will receive intensive training in one therapy protocol to ensure optimal delivery of each modality.||||t
1293722|NCT03677934|Randomized|Parallel Assignment||Treatment||Single||||||t
1293723|NCT03677921|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1293724|NCT03677908|||Case-Only||Retrospective|||||||
1293725|NCT03677895||Single Group Assignment||Treatment||None (Open Label)|outcome assessor does not know the rotator cuff condition of patients|patients with rotator cuff disorders receving subacromial hyaluronic acid injection||||
1293726|NCT03677882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293727|NCT03677869||Single Group Assignment||Treatment||None (Open Label)||||||
1293728|NCT03677856|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multi-centre, parallel group, superiority, with an internal pilot, in a 1:1 ratio||||
1293729|NCT03677843|||Cohort||Prospective|||||||
1293730|NCT03677830|Randomized|Parallel Assignment||Treatment||Quadruple|The intervention (intravenous acetaminophen) and placebo (saline) will be distributed by the pharmacy and are visually indistinguishable.||t|t|t|t
1293731|NCT03677817|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293732|NCT03677804|||Cohort||Retrospective|||||||
1293733|NCT03677791|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1293734|NCT03677778|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293735|NCT03677765|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293736|NCT03677752|Randomized|Parallel Assignment||Other||Double|||||t|t
1293737|NCT03677739|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293738|NCT03677726|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to receive either a Mindfulness-based Therapy for Insomnia (MBTI) or a Sleep Hygiene Education Program (SHEP). The intervention is for 8 weeks. Measures will be administered prior to and on completion of the intervention.||||
1293739|NCT03677713|Randomized|Parallel Assignment||Treatment||None (Open Label)||A single center, non-blinded, randomized controlled trial (RCT) will be conducted as a pilot study.||||
1293740|NCT03677700|||Case-Only||Prospective|||||||
1293741|NCT03677687||Single Group Assignment||Other||None (Open Label)||||||
1293742|NCT03677674|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1293743|NCT03677661|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293744|NCT03677648|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293745|NCT03677635|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1293746|NCT03677622|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293747|NCT03677609|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1293748|NCT03677596|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study will be conducted in 2 phases: a run in phase and a randomized phase.~Run in phase: a total of up to 22 patients will be enrolled to receive the starting dose of 1.2 mg/m2/cycle (dose level 2). A Simon Two Stage optimal design will be used. If acceptable efficacy (CR/CRi and MRD negativity) is observed in the run in phase, the study will enter the randomized phase.~Randomized phase: if acceptable efficacy is observed in the run in phase, the study will enter the randomized phase. A total of approximately 80 patients will be randomized (1:1) to 1 of 2 dose levels of inotuzumab ozogamicin (40 patients per dose level)."||||
1293749|NCT03677583|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1293750|NCT03677570|||Case-Control||Prospective|||||||
1293751|NCT03677557||Single Group Assignment||Treatment||None (Open Label)||||||
1293752|NCT03677544|||Cohort||Retrospective|||||||
1293753|NCT03677531||Single Group Assignment||Other||None (Open Label)||||||
1293754|NCT03677518|||Case-Only||Retrospective|||||||
1293755|NCT03677505|Randomized|Parallel Assignment||Treatment||Single||||||t
1293756|NCT03677492|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1293757|NCT03677479|Randomized|Parallel Assignment||Other||Double|single blinded|pilot randomized clinical trial|t|||t
1293758|NCT03677466|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1293759|NCT03677453|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1293760|NCT03677440|Randomized|Parallel Assignment||Treatment||Triple|Participants will be unaware if the treadmill walking exercise training or stretching-and-toning conditions represent the experimental or control conditions; outcome assessors will be treatment-blinded; MRI data analysts will be blinded to condition||t||t|t
1293761|NCT03677427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293762|NCT03677414|||Cohort||Cross-Sectional|||||||
1293763|NCT03677401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293764|NCT03677388||||||||||||
1293765|NCT03677375||||||||||||
1293766|NCT03677362||Single Group Assignment||Treatment||None (Open Label)||||||
1293767|NCT03677349|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Comparison of primary and secondary outcomes measures between group 1 (resensitization by neurorrhaphy) and group 2 patients (No resensitization by neurorrhaphy).~Patients randomly included in the groups according to a randomization software (RedCap)"||||
1293768|NCT03677336|Randomized|Crossover Assignment||Treatment||Quadruple|Blinded and packaged medication will be provided to the investigational site and dispensed to the participants. The participants, their treating physicians and the investigators will be blinded for the randomization of subjects to the treatment groups. Of both treatment medications, OD and MVP, a placebo version will be available and administered in both oocyte donation cycles. The medication will be given in a double blind double dummy fashion. All the tablets and capsules will be identical in appearance, shape, smell and taste, and packaged in the proper proportion to assure desired dosages and maintenance of the blinding.|A randomised, cross-over, double blind double dummy study|t|t|t|t
1293769|NCT03677323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293770|NCT03677310|Randomized|Parallel Assignment||Prevention||Double|The bags of IV solution will be masked by the pharmacists before sending to the operating room.|There is no effective treatment for post-operative dysphagia. Thus crossover is not expected.|t||t|
1293771|NCT03677297|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1293810|NCT03676790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293811|NCT03676777|||Cohort||Prospective|||||||
1293812|NCT03676764|Randomized|Factorial Assignment||Prevention||Quadruple|The trial sites will be masked to outcomes, so the responsibility for monitoring interim analysis will fall on the DSMC|All eligible communities in Nouna District will be randomized in a 1:1 fashion to biannual azithromycin or placebo. Targeted treatment (vaccine visit) will be randomized 1:1 individually to azithromycin or placebo. Randomization will be conducted by T. Porco. Procedural and algorithmic details are provided in an appendix to the Statistical Analysis Plan.|t|t|t|t
1293813|NCT03676751|Randomized|Parallel Assignment||Prevention||Quadruple|Quadruple: (Participant, Care Provider, Investigator, Outcomes Assessor)|Individually randomized placebo-controlled trail of azithromycin vs. placebo to establish the efficacy and safety of azithromycin.|t|t|t|t
1293814|NCT03676738|||Cohort||Prospective|||||||
1294847|NCT03663296|Randomized|Parallel Assignment||Other||Double|||||t|t
1293772|NCT03677284|Randomized|Crossover Assignment||Health Services Research||Double|The assessments at three and six months (for intervention group t2, for control group t2 and t3) will be performed by research assistants to avoid bias from the care providers (occupational therapists giving intervention). It is anticipated that the research assistant will not be informed of what group the PwD was allocated to.|"Assessments at baseline (t1) is done for each person with dementia (PwD) with informed consent. The coding of each PwD is determined by the memory clinic (first two digits in the code, 10 - 70) and consecutive starting with 01 and on.~A stratified randomization will be prepared in advance by the researchers, in closed envelopes, for each memory clinic. When the assessment is done, the occupational therapist opens the top envelope marked with the code of the PwD to find out allocation to intervention or control.~Intervention will be provided by the occupational therapist at the memory clinic or at other out-patient service during three months. The second data collection (t2) will be done by research assistants. After the assessment (t2), the control group will be offered intervention with prescribed time assistive products, followed by a third assessment (t3) after another three months (6 months after baseline)."||t||t
1293773|NCT03677271||Single Group Assignment||Supportive Care||None (Open Label)||||||
1293774|NCT03677258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293775|NCT03677245||Single Group Assignment||Treatment||None (Open Label)||pre- post-test design with each participant serving as his or her own control||||
1293776|NCT03677232|||Case-Only||Cross-Sectional|||||||
1293777|NCT03677219|Randomized|Parallel Assignment||Supportive Care||Double|The caregiver obtaining consent for lumbar puncture does not know if the parent will be randomized to see the video; the parent is not aware they may be randomized to see a video when they respond to the first survey about their concerns.|Parents are randomized to either view an educational video or not|t|t||
1293778|NCT03677206|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1293779|NCT03677193||Single Group Assignment||Treatment||None (Open Label)||The study will be conducted a single-case experimental design (SCED). Participants will be randomly assigned to begin the intervention at staggered starting-points.||||
1293780|NCT03677180|||Cohort||Prospective|||||||
1293781|NCT03677167|Randomized|Parallel Assignment||Treatment||Single|The physiotherapist who examines patients before and after the intervention does not know which group the patient belongs to|The study will include 52 subjects with heel pain for more than 12 weeks. The subjects will be randomly assigned to one of two groups: a barefoot walking group on a treadmill and a walking group in shoes on a treadmill. The subjects will receive treatment twice a week at the Meuhedet Health Fund Institute for 4 weeks. All subjects will be instructed to walk on the treadmill until they reach level 6 on the Short Borg Scale. In addition, all subjects will receive an ultrasound treatment for 5 minutes each session. Before and after the intervention, the subjects will complete the SF-36 questionnaire, and will assess the level of pain they experience on the heel during initial treading down from the bed in the morning. In addition, the minimum pain threshold and pain tolerance will be checked with an algometer at relevant points in the heel and the speed and walking time will be documented.||||t
1293782|NCT03677154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293783|NCT03677141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293784|NCT03677128||Single Group Assignment||Other||None (Open Label)||||||
1293785|NCT03677115||Single Group Assignment||Treatment||None (Open Label)||a single-dose thoracic paravertebral analgesia for postoperative pain control after thoracoscopic lobectomy||||
1293786|NCT03677102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293787|NCT03677089||Single Group Assignment||Health Services Research||None (Open Label)||"Sites were randomized in a stepped-wedge design with 5 clusters (2 sites per cluster) and a staggered start over a 1-year period. Staggering the start allowed for some control for potential temporal trends, as well as allowing the core team to focus on working with each site to ensure smooth startup of the training program at each site.~All participants received the intervention."||||
1293788|NCT03677076||Single Group Assignment||Basic Science||None (Open Label)||||||
1293789|NCT03677063|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293790|NCT03677050|Randomized|Parallel Assignment||Diagnostic||Single|colonoscopist accessing BBPS scores will be blinded; investigator will also assess BBPS scores (not blinded)|Randomized clinical trial||||t
1293791|NCT03677037|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1293792|NCT03677024|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1293793|NCT03677011|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1293794|NCT03676998||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293795|NCT03676985|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293796|NCT03676972||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293797|NCT03676959|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293798|NCT03676946|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293799|NCT03676933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293800|NCT03676920||Single Group Assignment||Treatment||None (Open Label)|There is only one arm and patients will know they are testing the intervention. Physicians will not be told explicitly which of their patients are enrolled in the study but they may see patients with the intervention (either on an iPad or in a printed version).|"The research tests the feasibility of an application-based (app) communication intervention designed to improve the frequency and quality of patient-oncologist treatment cost discussions during clinical interactions, and associated measures."||||
1293801|NCT03676907|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1293802|NCT03676894|Randomized|Parallel Assignment||Treatment||Single||Prospective, randomized, 3-arm parallel pilot study|t|||
1293803|NCT03676881|||Cohort||Prospective|||||||
1293804|NCT03676868|||Case-Only||Prospective|||||||
1293805|NCT03676855|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1293806|NCT03676842||Single Group Assignment||Treatment||None (Open Label)||||||
1293807|NCT03676829||Single Group Assignment||Treatment||None (Open Label)||||||
1293808|NCT03676816|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1293809|NCT03676803|Randomized|Parallel Assignment||Other||Single|||||t|
1293815|NCT03676725||Single Group Assignment||Health Services Research||None (Open Label)|The scoring of the lidocaine test is masked, using the coded identity of the tastes. The tastes will be assessed in random order. The subjects and other study personnel will be told not to discuss what the subject could or couldn't taste. Scoring will not be shared with the testing site until all testing is complete.|A group of 100 subjects will be assessed.||||
1293816|NCT03676712||Single Group Assignment||Health Services Research||None (Open Label)||||||
1293817|NCT03676699|||Cohort||Prospective|||||||
1293818|NCT03676686||Single Group Assignment||Treatment||None (Open Label)||||||
1293819|NCT03676673|||Case-Control||Cross-Sectional|||||||
1293820|NCT03676660|||Case-Only||Cross-Sectional|||||||
1293821|NCT03676647||||||||||||
1293822|NCT03676634||Single Group Assignment||Other||None (Open Label)||||||
1293823|NCT03676621|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1293824|NCT03676608|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293825|NCT03676595|Randomized|Crossover Assignment||Treatment||Single||||||t
1293826|NCT03676582|||Cohort||Prospective|||||||
1293827|NCT03676569||Single Group Assignment||Treatment||None (Open Label)||Experimental clinical treatment||||
1293828|NCT03676556|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1293829|NCT03676543||Single Group Assignment||Treatment||None (Open Label)||||||
1293830|NCT03676530|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pro-Tec Shin Splints Compression Wrap||||
1293831|NCT03676517||Single Group Assignment||Treatment||None (Open Label)||Enrolled patient receive 1-week short-course radiation (5 Gy x 5) plus 6-week XELOX (capecitabine 1,000mg/m2 and oxaliplatin 130mg/m2 every 3 weeks) chemotherapy before total mesorectal excision (TME). Short-term outcomes including complications, TME completeness, and tumor response will be investigated. EORTC-QLQ-C30 questionnaire scoring will be used to evaluate QoL during the treatment period and after surgery. Cost effectiveness will be assessed using cost-utility analysis.||||
1293832|NCT03676504|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293833|NCT03676491|Randomized|Parallel Assignment||Treatment||Single||The study design is an explanatory mixed methods design in two parts. The first part is a two-arm parallel group, single center randomized controlled trial (n=120). Experimental group and waitlist control group receive standard treatment according to national guidelines. The experimental group use a sound pillow and The Music Star App at bedtime as a sleep aid in 4 weeks.The second part is an interview study (n=4). Qualitative data from a semi-structured interview on the use of music and sleep are used to discuss findings from the RCT.||||t
1293834|NCT03676478|Randomized|Parallel Assignment||Treatment||Single|The study is single blinded at the level of outcome assessment. As in the postoperative setting it will be clear which subject is in the delayed enteral feeding group, masking cannot be performed for participants, care providers and the investigators. Therefore the study is considered to be open label, but single blinded for the primary outcome analysis.|Single blinded (for outcome), open label, prospective, randomized, controlled, parallel-group designed interventional study||||t
1293835|NCT03676465|Randomized|Parallel Assignment||Other||None (Open Label)||Subjects will be randomized to either a Control Group or an Experimental Group. Both groups will use a study CGM and activity tracker. MDI users will use an inPen to dispense their insulin treatment with their personal insulin. Subjects who use an insulin pump to care for their diabetes will use their personal pump and their personal insulin during the study. All subjects will be asked to download their equipment each week. The study team will communicate with both the subject and their parent(s) each week to discuss their diabetes management. Subjects will complete questionnaires at the beginning and end of the study.||||
1293836|NCT03676452|Randomized|Crossover Assignment||Prevention||None (Open Label)||This is a two-arm randomized controlled trial with an intervention group and a usual care waitlist control group. After pre-measurement, participants of the intervention group train for four months with the Active@Home exergame. Participants of the control group are instructed to continue their usual daily business and activities. Then, post-measurement takes place. After post-measurement, participants of the control group get the Active@Home exergame for their personal use at home (for several months, no additional measurement).||||
1293837|NCT03676439|Randomized|Parallel Assignment||Treatment||Double|Patient and independent evaluator|A comparision, Randomized and double blinded study|t|||t
1293838|NCT03676426|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Patients will be blinded to the comparison being made, but not to the intervention in their arm.|||||
1293839|NCT03676413|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1293840|NCT03676400|Randomized|Parallel Assignment||Supportive Care||Double||Product group / Control(placebo) group|t||t|
1293841|NCT03676387|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1293842|NCT03676374|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293843|NCT03676361||Single Group Assignment||Other||None (Open Label)||||||
1293844|NCT03676348|||Cohort||Prospective|||||||
1293845|NCT03676335|Randomized|Parallel Assignment||Treatment||Single||||||t
1293846|NCT03676322|Randomized|Parallel Assignment||Other||Double|||t||t|
1293847|NCT03676309|Randomized|Parallel Assignment||Treatment||Double||Experimental drawing Phase II prospective, randomized, comparative, vs placebo study|t||t|
1293848|NCT03676296|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1293849|NCT03676283|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1293850|NCT03676270|||Cohort||Retrospective|||||||
1293851|NCT03676257|||Cohort||Retrospective|||||||
1293852|NCT03676244||Single Group Assignment||Treatment||None (Open Label)||||||
1293853|NCT03676231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293854|NCT03676218|||Cohort||Retrospective|||||||
1293855|NCT03676205|Randomized|Parallel Assignment||Treatment||Double|The patient doesn't know the treatment. The person who analyze the data (outcomes assessor) doesn't know the treatment.|Two homogeneus groups with 1:1 possibilities to receive PRP or a homeopathic product.|t|||t
1293856|NCT03676192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293857|NCT03676179|Non-Randomized|Parallel Assignment||Treatment||Double|unicompartment knee arthroplasty without patella denervation|unicompartment knee arthroplasty with patella denervation|||t|t
1293858|NCT03676166|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1293859|NCT03676153|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pragmatic study examining the impact of a nurse-guided self-administered integrative medicine intervention on quality-of-life outcomes in cancer care.||||
1293860|NCT03676140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293861|NCT03676127|||Other||Cross-Sectional|||||||
1293862|NCT03676114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293863|NCT03676101|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1293864|NCT03676088|Randomized|Parallel Assignment||Treatment||Single|Computer generated randomization sequence was obtained by the assistant. Allocation concealment was achieved using a sealed coded opaque envelope containing the treatment of the specific subject The sealed envelope containing treatment assignment was opened immediately prior to surgery to prevent surgeon bias|The patients were assigned into two treatment groups (test and control). The test group was treated with recombinant human Platelet Derived Growth Factor-BB and Modified Coronally Advanced Tunnel +Connective Tissue Graft whereas the control group was treated by Modified Coronally Advanced Tunnel +Connective Tissue Graft alone.||||t
1293865|NCT03676075|||Other||Prospective|||||||
1293866|NCT03676062|Randomized|Parallel Assignment||Treatment||Single||||||t
1293867|NCT03676049||||||||||||
1293868|NCT03676036|Randomized|Parallel Assignment||Treatment||Single|||t|||
1293869|NCT03676023|||Case-Only||Other|||||||
1293870|NCT03676010|||Cohort||Retrospective|||||||
1293871|NCT03675997|||Cohort||Prospective|||||||
1293872|NCT03675984||Single Group Assignment||Treatment||None (Open Label)||Annual evaluation after educating asymmetrical stabilization exercise. Cohort study.||||
1293873|NCT03675971|Randomized|Parallel Assignment||Treatment||Triple||Parallel Assignment|t||t|t
1293874|NCT03675958|Randomized|Parallel Assignment||Treatment||Single|The evaluator does not know the assignment of the participants to the intervention group.|A randomized experimental study with two intervention groups will be performed. Control group (GS): Stretching and experimental group: (GJPS + S): Johnstone´s Pressure Splint plus Stretching.|||t|
1293875|NCT03675945|||Cohort||Prospective|||||||
1293876|NCT03675932||Single Group Assignment||Treatment||None (Open Label)||||||
1293877|NCT03675919|Randomized|Parallel Assignment||Supportive Care||Single||randomized controlled trial||||t
1293878|NCT03675906|||Case-Crossover||Retrospective|||||||
1293879|NCT03675893|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293880|NCT03675880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293881|NCT03675867|||Case-Only||Retrospective|||||||
1293882|NCT03675854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293883|NCT03675841|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1293884|NCT03675828|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1293885|NCT03675815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293886|NCT03675802|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1293887|NCT03675789|||Case-Control||Cross-Sectional|||||||
1293888|NCT03675776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293889|NCT03675763|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1293890|NCT03675750|||Cohort||Prospective|||||||
1293891|NCT03675737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293892|NCT03675724|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293893|NCT03675711|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||supportive care||||
1293894|NCT03675698|||Cohort||Prospective|||||||
1293895|NCT03675685||Single Group Assignment||Treatment||None (Open Label)||||||
1293896|NCT03675672|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1293897|NCT03675659|Randomized|Parallel Assignment||Treatment||Single|||||t|
1293898|NCT03675646|Randomized|Single Group Assignment||Treatment||Single|Only ICU personnel was blinded to the method used|Patient elicited for open prostatectomy or open nephrectomy were given intrathecal morphine in normal saline before induction to general anaesthesia (GA) or GA only. After surgery, time to the first opioid request, total opioid consumption during first 24 hours and 48 hours after surgery and opioid side effects were noticed.||||t
1293899|NCT03675633|||Cohort||Prospective|||||||
1293900|NCT03675620|Randomized|Parallel Assignment||Treatment||Double|Investigators recording data and the patients physician will be blinded to group assignment.|This is a prospective, randomized control trial. After consenting, subjects will be randomized to one of two groups by using a computer generated random number generator.||t||t
1293901|NCT03675607|||Other||Cross-Sectional|||||||
1293902|NCT03675594|Randomized|Crossover Assignment||Other||Double|the participants will not be told which type they received till obtaining the final results of both types.Outcomes will be collected only by the supervisor.||t|||t
1293903|NCT03675581||Single Group Assignment||Treatment||None (Open Label)||||||
1293904|NCT03675568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293905|NCT03675555|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1293906|NCT03675542||Single Group Assignment||Treatment||None (Open Label)||open-label, singlecenter, single-arm, dose-selection, proof of-concept study||||
1293907|NCT03675529|Randomized|Parallel Assignment||Basic Science||Single||||||t
1293908|NCT03675516|||Cohort||Retrospective|||||||
1293909|NCT03675503|Randomized|Parallel Assignment||Prevention||Single||||||
1293910|NCT03675490||Single Group Assignment||Treatment||None (Open Label)||pre-post pilot feasibility||||
1293911|NCT03675477|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293912|NCT03675464|||Cohort||Prospective|||||||
1293913|NCT03675451||Single Group Assignment||Diagnostic||None (Open Label)||||||
1293914|NCT03675438||Single Group Assignment||Treatment||None (Open Label)||||||
1293915|NCT03675425|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1293959|NCT03674853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293916|NCT03675412|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||All eyes will undergo imaging to measure blood flow in the back of the eye (retina and optic nerve) using the Avanti AngioVue HD OCTA (optical coherence tomography angiography)||||
1293917|NCT03675399|Randomized|Parallel Assignment||Treatment||Single|Exercise sessions were delivered by a physiotherapist who was not involved in the assessments.||||t|
1293918|NCT03675386|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1293919|NCT03675373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293920|NCT03675360|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1293921|NCT03675347|||Case-Only||Retrospective|||||||
1293922|NCT03675334|Randomized|Parallel Assignment||Treatment||Double|The clinical parameters were screened by one single examiner that was not aware of the procedures|Randomized Controlled Split-mouth clinical trial|||t|t
1293923|NCT03675321|Randomized|Parallel Assignment||Treatment||Quadruple|All participants, investigators and study team members blinded|Randomized, double blind placebo-controlled trial|t|t|t|t
1293924|NCT03675308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293925|NCT03675295|Randomized|Parallel Assignment||Treatment||Double||Investigate if, and to what extent, hydro-dissection using Hyalase versus saline, under ultrasound guidance, can improve the clinical condition, change in nerve conduction parameters of patients with CTS and delay or avoid the surgical intervention.|t|||t
1293926|NCT03675282|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1293927|NCT03675269|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1293928|NCT03675256|Randomized|Crossover Assignment||Prevention||Quadruple|The study is blinded. The pharmacists, unblinded data manager, and unblinded statistician are the only ones who will know treatment assignment.|At the start of our study, young women will be randomly sorted into three arms. In arm 1, the women will receive the bivalent HPV vaccine. In arm 2, the women will receive the nonavalent HPV vaccine. And in arm 3, the women will receive a meningococcal vaccine. At the end of the study, those in arms 1 and 2 will receive the meningococcal vaccine, while those in arm 3 will receive either the bivalent or nonavalent HPV vaccine. The three arm study structure makes it possible to compare the women who received an HPV vaccine to those who did not receive an HPV vaccine during the study.|t|t|t|t
1293929|NCT03675243|||Cohort||Prospective|||||||
1293930|NCT03675230|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293931|NCT03675217|Randomized|Parallel Assignment||Treatment||Single|Patients evaluator and Outcomes Assessor are masked|Parallel Assignment||||t
1293932|NCT03675204|||Cohort||Other|||||||
1293933|NCT03675191|Randomized|Parallel Assignment||Treatment||Triple|"The placebo pill is given to participants who are randomly assigned to the control group.~Double-blinded"|"Randomized placebo-controlled clinical trials (12 weeks)~orlistat (120mg, three times a day, within 1hour after meal) + phentermin (37.5mg, once a day, within 1hour after meal)~placebo (120mg, three times a day, within 1hour after meal) + phentermin (37.5mg, once a day, within 1hour after meal) The patients were divided into two groups: orlistat (120mg, three times a day), phentermine (37.5 mg, once a day) combined Group (N = 57), placebo (placebo, three times a day) and phentermine (37.5 mg, once a day) Group (N=57)"|t|t|t|
1293934|NCT03675178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1293935|NCT03675165|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1293936|NCT03675152|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||patients are in two groups treated with soft spinal brace or with thoracolumbar orthosis.||||
1293937|NCT03675139|Randomized|Parallel Assignment||Treatment||Single||||||t
1293938|NCT03675126||Single Group Assignment||Treatment||None (Open Label)||||||
1293939|NCT03675113|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1293940|NCT03675100|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1293941|NCT03675087|||Case-Only||Cross-Sectional|||||||
1293942|NCT03675074||Single Group Assignment||Treatment||None (Open Label)||||||
1293943|NCT03675061|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1293944|NCT03675048|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1293945|NCT03675035||Single Group Assignment||Treatment||None (Open Label)||||||
1293946|NCT03675022||Single Group Assignment||Treatment||None (Open Label)||||||
1293947|NCT03675009|Randomized|Sequential Assignment||Health Services Research||Double|Participants and education providers will be unaware whether they are in an early or late delivery of education randomization group.|stepped wedge|t|t||
1293948|NCT03674996|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1293949|NCT03674983|Randomized|Parallel Assignment||Prevention||Double||Aim 1: discrete choice experiment (DCE) with n=200. Aim 2: randomly assign 100 HIV-negative MSW in a 1:1 ratio either to: the SoC group, or to the CEI group. MSW in the SoC group (n=50) will receive transport reimbursement at baseline, 3 and 6 months. MSW in the CEI group (n=50) will receive transport reimbursement at baseline, 3 and 6 months, and additional incentives based on sufficiently high PrEP adherence at months 3 and 6. All participants will provide hair samples and have optional brief counseling based on hair sample results. Those in the CEI group, will receive additional incentives if concentrations of TDF/FTC in hair samples corroborate that they have been sufficiently adherent in recent weeks. The final incentives (amounts, format, location, etc.) will be based on Aim 1 results. 1-2 weeks after study visits, participants will receive a grade depending on the drug level detected in their scalp hair. The CEI amounts will be distributed depending on grade.|||t|t
1293950|NCT03674970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1293951|NCT03674957|||Cohort||Other|||||||
1293952|NCT03674944|Randomized|Parallel Assignment||Treatment||Single||||||t
1293953|NCT03674931|Randomized|Parallel Assignment||Prevention||None (Open Label)||Longitudinal RCT (clinical trial) with an experimental group and an active control group||||
1293954|NCT03674918|||Cohort||Retrospective|||||||
1293955|NCT03674905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293956|NCT03674892||Single Group Assignment||Treatment||None (Open Label)||non-randomized, open-label, single arm pilot trial||||
1293957|NCT03674879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293958|NCT03674866|||Cohort||Retrospective|||||||
1293960|NCT03674840|Randomized|Parallel Assignment||Treatment||Single||Parallel Assignment. For each patient one eye was randomly selected as design group and receive a SBL-3 implantation based on angle kappa, while the other eye was included in control group and receive a SBL-3implantation of 0 to 180 degree|t|||
1293961|NCT03674827||Single Group Assignment||Treatment||None (Open Label)||||||
1293962|NCT03674814||Single Group Assignment||Treatment||None (Open Label)||Patients will be sequentially enrolled to increasing dose escalation cohorts based on safety and PK.||||
1293963|NCT03674801|||Case-Only||Prospective|||||||
1293964|NCT03674788|||Cohort||Prospective|||||||
1293965|NCT03674775|Randomized|Parallel Assignment||Treatment||None (Open Label)||cluster randomized control trial||||
1293966|NCT03674762|Randomized|Sequential Assignment||Treatment||None (Open Label)||The cases were randomly divided into two groups as two-stage/submerged, and one-stage/nonsubmerged. Thus, in each patient, the two implants (submerged and nonsubmerged) were placed randomly in the left and right hemi-mandible or in the left and right hemi-maxilla||||
1293967|NCT03674749|Randomized|Parallel Assignment||Treatment||Single||||t||
1293968|NCT03674736|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Each subject will randomly receive 4 levels of methionine or lysine provided as free amino acids, Rice, Wheat, Chickpeas or Lentils for a total of 7 studies x 3 days per study.||||
1293969|NCT03674723||Single Group Assignment||Other||None (Open Label)||Each subject will randomly receive 4 levels of methionine provided as free amino acids, Mung beans, or Mung beans combined with rice or wheat for a total of 10 studies x 3 days per study.||||
1293970|NCT03674710|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1293971|NCT03674697|Randomized|Parallel Assignment||Prevention||Single|||t|||
1293972|NCT03674684|||Other||Retrospective|||||||
1293973|NCT03674671|Randomized|Crossover Assignment||Treatment||Single||||||t
1293974|NCT03674658|Randomized|Parallel Assignment||Treatment||None (Open Label)||Group A: Rhynorm (A drug) Group B: Rytmonorm (B drug)||||
1293975|NCT03674645||Single Group Assignment||Other||None (Open Label)||||||
1293976|NCT03674632|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1293977|NCT03674619|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1293978|NCT03674606|Randomized|Parallel Assignment||Prevention||None (Open Label)||Three-armed parallel, multi-center, open-label randomised control trial||||
1293979|NCT03674593|Randomized|Parallel Assignment||Treatment||Single|Single blind masking (Participant)|Single-center, prospective, semi-open, randomized study|t|||
1293980|NCT03674580|||Cohort||Prospective|||||||
1293981|NCT03674567|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1293982|NCT03674554|Randomized|Parallel Assignment||Treatment||Double|Allocation sequence generation will be performed by the Senior supervisor. Enrolment of participants will be performed by the principle investigator where the patients will be assessed for eligibility.||t|||t
1293983|NCT03674541|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1293984|NCT03674528|||Cohort||Prospective|||||||
1293985|NCT03674515|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1293986|NCT03674502||Single Group Assignment||Treatment||None (Open Label)||Single arm study||||
1293987|NCT03674489|Randomized|Parallel Assignment||Treatment||Double||"Each subject will be randomized to one of three groups:~Neurodynamic Slider Mobilization~Neurodynamic Tensioner Mobilization~Sham Neurodynamic Mobilization~Outcomes will be assessed immediately prior to and immediately following the intervention."|t|||t
1293988|NCT03674476|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293989|NCT03674463||Single Group Assignment||Treatment||None (Open Label)||||||
1293990|NCT03674450||Single Group Assignment||Treatment||None (Open Label)||||||
1293991|NCT03674437|||Case-Control||Prospective|||||||
1293992|NCT03674424|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, randomized study. 2 cohorts possible depending on cisplatin-eligibility. Afterwards randomization between 2 arms into the cohort.||||
1293993|NCT03674411|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293994|NCT03674398|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1293995|NCT03674385|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective randomized controlled open label study||||
1293996|NCT03674372||Single Group Assignment||Treatment||None (Open Label)||||||
1293997|NCT03674359|||Cohort||Prospective|||||||
1293998|NCT03674346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1293999|NCT03674333|Randomized|Parallel Assignment||Treatment||Single|Participants of both the groups will be unaware of whether they received placebo or folic acid.|Group A receives Folic Acid and Group B receives Placebo.|t|||
1294000|NCT03674320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294001|NCT03674307|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1294002|NCT03674294|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294003|NCT03674281|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1294004|NCT03674268|||Other||Prospective|||||||
1294005|NCT03674255|||Cohort||Prospective|||||||
1294006|NCT03674242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294007|NCT03674229|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294008|NCT03674216|||Case-Only||Prospective|||||||
1294009|NCT03674203||Single Group Assignment||Treatment||None (Open Label)||A prospective cohort study with therapeutic intervention for one year. We included patients older than 18 years with a diagnosis of melanoma and a history of pregnancy with a time greater than 6 months, who were not in the period of lactation, with no history of skin cancer, with a history of liver, thyroid or injury, of acne and traumatic injuries on the face, in addition, with no work history of PRP. The patients received three sessions of PRP application, at intervals of 15 days between each of them.||||
1294010|NCT03674190|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294098|NCT03673046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294099|NCT03673033|||Cohort||Prospective|||||||
1295023|NCT03661008|||Cohort||Cross-Sectional|||||||
1294011|NCT03674177|Randomized|Parallel Assignment||Prevention||Triple|Observer-blind In this study, the subject and study site personnel involved in the clinical evaluations of the subjects are blinded while other study personnel may be aware of the treatment assignments.||t||t|t
1294012|NCT03674164||Single Group Assignment||Other||None (Open Label)||||||
1294013|NCT03674151|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294014|NCT03674138|Randomized|Crossover Assignment||Supportive Care||Single|Patients will be blinded to the genomic results for 12 weeks, with the 12 week time period starting at the time of antidepressant drug prescribing.||t|||
1294015|NCT03674125|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294016|NCT03674112|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1294017|NCT03674099|Randomized|Parallel Assignment||Treatment||Single|Treating physician not blinded, evaluating physician blinded.|Randomized, single-blinded, controlled.||||t
1294018|NCT03674086|||Case-Only||Prospective|||||||
1294019|NCT03674073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294020|NCT03674060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294021|NCT03674047|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294022|NCT03674034|||Case-Only||Retrospective|||||||
1294023|NCT03674021|Randomized|Parallel Assignment||Other||Single|The patient, attending physicians, and study team will not be blinded. Outcomes will be assessed through tracing electronic records as well as telephone calls for those whose electronic records are unobtainable. The outcome assessors will be blinded and will follow a telephone script for follow-up.|This is a randomized controlled trial where subjects are stratified by gender and then randomized 1:1 to the intervention (CPC) or control arm (usual care).||||t
1294024|NCT03674008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294025|NCT03673995||Single Group Assignment||Treatment||None (Open Label)||||||
1294026|NCT03673982||Single Group Assignment||Treatment||None (Open Label)||||||
1294027|NCT03673969|Randomized|Parallel Assignment||Treatment||Single|Participant will not know the arm prior to surgery, but will be made aware of it afterward||t|||
1294028|NCT03673956||Single Group Assignment||Treatment||None (Open Label)||||||
1294029|NCT03673943||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294030|NCT03673930|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1294031|NCT03673917|Randomized|Parallel Assignment||Other||None (Open Label)||The study design protocol is as follows: Schools of cosmetology in Arkansas are randomized using simple randomization to receive either 1) our educational video on skin cancer for cosmetologists or 2) a publicly accessible healthy lifestyle video on YouTube, which does not contain any information on skin cancer. Students view the video that was randomly assigned to the school they attended. Pre-video tests are administered at the school during classes or online at the students' convenience; the video intervention follows immediately, also during classes or online. Post-video test (in class or online) are administered 3 to 6 months after watching the video. All schools continued to also use their previous educational materials on skin cancer concurrent with our program.||||
1294032|NCT03673904|||Case-Only||Prospective|||||||
1294033|NCT03673891|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294034|NCT03673878|||Cohort||Prospective|||||||
1294035|NCT03673865|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective randomized clinical study with longitudinal follow-up||||
1294036|NCT03673852|Randomized|Sequential Assignment||Other||None (Open Label)||||||
1294037|NCT03673839|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1294038|NCT03673826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294039|NCT03673813|||Cohort||Prospective|||||||
1294040|NCT03673800|Randomized|Parallel Assignment||Treatment||Single|||t|||
1294041|NCT03673787|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1294042|NCT03673774||Single Group Assignment||Prevention||None (Open Label)||||||
1294043|NCT03673761|||Case-Control||Cross-Sectional|||||||
1294044|NCT03673748|Randomized|Parallel Assignment||Treatment||Triple|Both experimental and Control will receive a similar endovenous injection with either cells or placebo. Blind to participant, investigator ans care providers,|Control arm (placebo) and experimental arm (mesenchymal stromal cells)|t|t|t|
1294045|NCT03673735|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1294046|NCT03673722|Randomized|Parallel Assignment||Prevention||Single||RCT||||t
1294047|NCT03673709|Randomized|Parallel Assignment||Health Services Research||Single|The research team working on the effectiveness evaluation of group care is blinded to study condition and is charged with collecting the Aim 1 effectiveness data from the individuals.|||||t
1294048|NCT03673696|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1294049|NCT03673683|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Stepped wedge, cluster randomized stepped wedge clinical trial||||
1294050|NCT03673670|Randomized|Crossover Assignment||Treatment||Triple|The nebulizer cup will be obscured so the contents are not visible to the subject and the blinded study staff.||t||t|t
1294051|NCT03673657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294052|NCT03673644|||Cohort||Cross-Sectional|||||||
1294053|NCT03673631|||Cohort||Prospective|||||||
1294054|NCT03673618|Randomized|Parallel Assignment||Treatment||Quadruple|A study pharmacist will provide soluble corn fiber or a placebo (malodextrin) in identical packets to be dispensed in identical fruit-flavored beverage||t|t|t|t
1294055|NCT03673605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294056|NCT03673592|||Cohort||Prospective|||||||
1294057|NCT03673579|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Prospective control data will be collected before the study devices are installed in all the NICU rooms. At the point of clinical go-live, there will be a single intervention group that all parents/clinicians will have the opportunity to participate in.||||
1294100|NCT03673020||Single Group Assignment||Treatment||None (Open Label)||||||
1294101|NCT03673007|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1294102|NCT03672994|||Case-Control||Prospective|||||||
1294058|NCT03673566|Randomized|Parallel Assignment||Other||None (Open Label)||The NICU is divided into two floors. One floor will have the Dashboard installed and serve as the intervention floor, while the other will not have the Dashboard and thus serves as the Control floor. As patients are admitted, they are randomly assigned to a room based on availability. Therefore, intervention and control arms will run in parallel in a quasi-randomized fashion.||||
1294059|NCT03673553|||Other||Prospective|||||||
1294060|NCT03673540||Single Group Assignment||Treatment||None (Open Label)||||||
1294061|NCT03673527||Single Group Assignment||Other||None (Open Label)||||||
1294062|NCT03673514|Randomized|Parallel Assignment||Treatment||Single|However, the decision to discharge subjects was made by physiotherapists blinded to treatment and based on objective criteria. These criteria were: 1) being autonomous for transfer from bed/chair to upright position 2) being able to walk with walking aid 3) climbing stairs in a safe way 4) having a pain level contained by painkillers. No restrictions were recommended for either group. The same rehabilitation and pain protocols were used for both approaches. In addition, statistical analyses were performed by an independent consultant who remained blinded to treatment group assignment.|||||t
1294063|NCT03673501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294064|NCT03673488|||Case-Only||Prospective|||||||
1294065|NCT03673475|||Other||Prospective|||||||
1294066|NCT03673462|Randomized|Parallel Assignment||Prevention||Quadruple|A modified double blind design is used. With the exception of the personnel administering the vaccine, everyone involved in study (participants, care provider, investigator, safety outcomes assessor, Sponsor) is blinded.||t|t|t|t
1294067|NCT03673449||Single Group Assignment||Treatment||None (Open Label)||Open Label Monocentre Study||||
1294068|NCT03673436|||Cohort||Prospective|||||||
1294069|NCT03673423|||Other||Cross-Sectional|||||||
1294070|NCT03673410|Randomized|Parallel Assignment||Treatment||Triple|Once consent has been signed, the patient will be assigned to any of the two groups, using a computer-based randomization on REDCap and the patient will be assigned to the corresponding study arm.|We will randomise 60 patients between robotic (30 patients) and laparoscopic revisional bariatric surgery (30 patients) to evaluate those procedures in terms of perioperative safety, weight loss and comorbidity resolution.|t||t|t
1294071|NCT03673397|Randomized|Parallel Assignment||Treatment||Single||||||t
1294072|NCT03673384|Randomized|Parallel Assignment||Treatment||Single||The sampling method is purposive sampling. The inclusion criteria are adults between 20 and 50 year-old with a definite clinical diagnosis of allergic rhinitis. Subjects were randomly divided into experimental and control groups. Thirty persons in the experimental group received both medical and infrared-C irradiation as intervention. On the other hand, twenty persons in the control group received only medical treatment. Patients in experimental group received anti-histamine, steroid nasal spray and infrared-C irradiation by hot compress for 40 minutes per time, and more than three times per week. The regions of hot compress included head, neck and shoulder, back and lower back, which covered many acupuncture points frequently used by traditional Chinese medicine for the treatment of allergic rhinitis. In addition, patients also received hot compress over face, eyes and nose during acute stage of allergic rhinitis.|t|||
1294073|NCT03673371|||Cohort||Prospective|||||||
1294074|NCT03673358|Randomized|Parallel Assignment||Prevention||Single||Participants with operatively managed extremity fractures 6-weeks post-fracture fixation will be randomized to receive either cognitive behavioural therapy (CBT) with participants having a choice of 6 weekly one-on-one telephone or video therapy sessions OR completion of online therapy modules or standard of care (control). Outcomes will be assessed at 3 months, 6 months, 9 months, and 12 months' post-fracture||||t
1294075|NCT03673345|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294076|NCT03673332||Single Group Assignment||Treatment||None (Open Label)||This is a national prospective phase 4, multi-centre, single arm, open-label cohort study to evaluate the safety and efficacy of immune checkpoint inhibitors-based therapies in elderly patients with advanced or metastatic melanoma or NSCLC.||||
1294077|NCT03673319|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294078|NCT03673306|||Cohort||Retrospective|||||||
1294079|NCT03673293|||Cohort||Prospective|||||||
1294080|NCT03673280|Randomized|Parallel Assignment||Supportive Care||Triple||Clinical, analytical, prospective, randomized trial.|t||t|t
1294081|NCT03673267||Single Group Assignment||Prevention||None (Open Label)||||||
1294082|NCT03673254|||Cohort||Prospective|||||||
1294083|NCT03673241|Randomized|Parallel Assignment||Treatment||None (Open Label)||A prospective, non-blinded, randomized trial. This cohort will be divided into two groups: (1) The Control Group (2) The Study Group||||
1294084|NCT03673228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294085|NCT03673215|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294086|NCT03673202|||Cohort||Prospective|||||||
1294087|NCT03673189|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||Prospective, monocentric, with healthy volunteers and patients||||
1294088|NCT03673176||Single Group Assignment||Treatment||None (Open Label)||||||
1294089|NCT03673163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294090|NCT03673150|||Case-Control||Retrospective|||||||
1294091|NCT03673137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294092|NCT03673124||Single Group Assignment||Treatment||None (Open Label)||||||
1294093|NCT03673111|Randomized|Single Group Assignment||Treatment||Single|||t|||
1294094|NCT03673098|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Intervention: 10 weekly sessions of the adapted Relaxation Response Resiliency Program (3RP) Control: 10 weekly sessions of a supportive psychotherapy program||||
1294095|NCT03673085|Randomized|Sequential Assignment||Treatment||Single|||t|||
1294096|NCT03673072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294097|NCT03673059|Randomized|Parallel Assignment||Basic Science||Triple||Subjects were randomly assigned to two groups. One group was supplied with a test product containing an OTC drug monographed ingredient for treatment of eczema and the other group was supplied with a cosmetic test product which is a standard dry skin daily moisturizer. Both groups were also provided with a cosmetic test cleanser to use in place of their normal cleanser. There was a 7-day regression period following the 14 days of product use.|t||t|t
1294103|NCT03672981||Single Group Assignment||Supportive Care||None (Open Label)||||||
1294104|NCT03672968||||||||||||
1294105|NCT03672955|||Cohort||Prospective|||||||
1294106|NCT03672942|Randomized|Parallel Assignment||Basic Science||Single|couples are not informed as to what condition they are assigned|random assignment to two active conditions vs. a placebo control|t|||
1294107|NCT03672929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1294108|NCT03672916|||Cohort||Prospective|||||||
1294109|NCT03672903|Randomized|Parallel Assignment||Treatment||Single|Masking will not be publically revealed before the study ends. Subjects may be able to determine if they are in the control/placebo group or intervention group if we publically reveal our masking procedure. However, the masking procedure is pre-determined and approved by the ethic's committee.|We will use a parallel study design in which we compare the placebo group with the intervention group. In order to avoid the risk of carry-over effects, we have decided to not use a crossover design. This could have decreased the variation of the measurement values and increased the power of the study. However, we believe there could be a risk of a carry-over effect with a cross over design. As this is a completely new effect in clinical studies, we have no information about the wash-out time needed to avoid this problem.|t|||
1294110|NCT03672890|||Cohort||Prospective|||||||
1294111|NCT03672877|Randomized|Parallel Assignment||Treatment||Single|Physical therapy assessors will be blinded to the child's group assignment.|Participants will be randomly assigned to receive 3 months of intervention immediately (Immediate Group) or to be observed for 6 months (Delay Group). Participants in the Delay Group will be offered the intervention once the observation period is complete.||||t
1294112|NCT03672864|Randomized|Parallel Assignment||Treatment||Single|Assessing therapists are blinded to the child's group assignment.|Randomized, controlled trial||||t
1294113|NCT03672851||Single Group Assignment||Treatment||None (Open Label)||||||
1294114|NCT03672838|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1294115|NCT03672825||Single Group Assignment||Treatment||None (Open Label)||||||
1294116|NCT03672812|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1294117|NCT03672799|Randomized|Crossover Assignment||Supportive Care||Double|"The outcomes assessor, study investigators, and statistician will remain blinded to group allocation.~Participants and the treating therapist (Rehabilitation Consultant) will remain unblinded."|Randomized controlled trial with two arms, the experimental arm (Rehabilitation Planning Consult; RPC) and a wait list control (WLC) arm.|||t|t
1294118|NCT03672786|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1294119|NCT03672773||Single Group Assignment||Treatment||None (Open Label)||||||
1294120|NCT03672760|Randomized|Sequential Assignment||Prevention||Double|Participants will not know about other arms. Outcome assessors will not know the arms participant belong.|The participants will be randomized into 3 intervention groups as follows: IMT, IMT placebo and CardioBreath®App. The intervention will long five weeks. The exercises will be performed at home for five days/ week during 10 minute|t|||t
1294121|NCT03672747|Randomized|Crossover Assignment||Basic Science||Double|Double-blinded|Full crossover; all participants complete all conditions|t||t|
1294122|NCT03672734|||Case-Only||Other|||||||
1294123|NCT03672721||Single Group Assignment||Treatment||None (Open Label)||Dose escalation study of combined intraarterial carboplatin + radiotherapy||||
1294124|NCT03672708||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294125|NCT03672695||Sequential Assignment||Treatment||None (Open Label)||||||
1294126|NCT03672682|||Other||Retrospective|||||||
1294127|NCT03672669|Randomized|Crossover Assignment||Supportive Care||Double||patients with bilateral impacted mandibular third molar which surgically operated at different times|t|||t
1294128|NCT03672656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294129|NCT03672643||Single Group Assignment||Treatment||None (Open Label)||single arm, open label study.||||
1294130|NCT03672630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294131|NCT03672617|||Cohort||Prospective|||||||
1294132|NCT03672604|Randomized|Sequential Assignment||Treatment||Quadruple||A Phase 1, first-in-human, double-blind, randomized, placebo-controlled, single-ascending followed by multiple-dose study|t|t|t|t
1294133|NCT03672591|||Case-Control||Cross-Sectional|||||||
1294134|NCT03672578|Randomized|Factorial Assignment||Prevention||Single|||||t|
1294135|NCT03672565|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294136|NCT03672552|Randomized|Parallel Assignment||Prevention||Single|Participants may identify with the study receiving more oral care than previously but not know if they are in the intervention or control group. Clinicians performing swallowing and oral health assessments will not know which participants are randomly assigned to groups. Nursing staff will be performing daily care on all participants as specified in daily nursing protocols and may have more oral care but may not identify whether a participant is in the intervention or control group except some staff will be adding supervised brushing before plain (thin) water and between mealtimes.|All study participants will have assessments for swallowing and oral hygiene. The intervention group will have a dental hygiene cleaning and supervised tooth brushing before taking plain, thin (unmodified) water and between meals. The control group will continue with standard oral care and the agreed upon diet texture and fluid modifications.|t|||
1294137|NCT03672539||Single Group Assignment||Treatment||None (Open Label)||||||
1294138|NCT03672526||Single Group Assignment||Other||None (Open Label)||||||
1294139|NCT03672513|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1294140|NCT03672500|Randomized|Parallel Assignment||Prevention||Double|a randomized, single-masked, controlled trial|a randomized, single-masked, controlled trial|t|||t
1294141|NCT03672487|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo||t|t|t|t
1294142|NCT03672474|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1294143|NCT03672461|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1294144|NCT03672448|||Cohort||Prospective|||||||
1294145|NCT03672435|||Cohort||Prospective|||||||
1294146|NCT03672422|||Cohort||Prospective|||||||
1294147|NCT03672409||Single Group Assignment||Other||None (Open Label)||||||
1295025|NCT03660982|||Case-Control||Cross-Sectional|||||||
1294148|NCT03672396||Single Group Assignment||Health Services Research||None (Open Label)||Single-arm study with ~30 men being recruited and 20-25 who complete all aspects of the study.||||
1294149|NCT03672383|Randomized|Parallel Assignment||Treatment||Double|Observer-blind||||t|t
1294150|NCT03672370|||Cohort||Prospective|||||||
1294151|NCT03672357|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1294152|NCT03672344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294153|NCT03672331|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294154|NCT03672318||Single Group Assignment||Treatment||None (Open Label)||||||
1294155|NCT03672305||Single Group Assignment||Treatment||None (Open Label)||||||
1294156|NCT03672292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294157|NCT03672279|||Cohort||Prospective|||||||
1294158|NCT03672266|||Case-Control||Cross-Sectional|||||||
1294159|NCT03672253||Single Group Assignment||Treatment||None (Open Label)||||||
1294160|NCT03672240||Single Group Assignment||Treatment||None (Open Label)||||||
1294161|NCT03672227|Randomized|Parallel Assignment||Prevention||Single||There are two arms in this study. In the intervention arm, teachers will receive the Mealtime Matters training about child nutrition. In the control arm, the teachers do not receive the Mealtime Matters until the completion of the study.|||t|
1294162|NCT03672214|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294163|NCT03672201|Randomized|Parallel Assignment||Treatment||Double|Participants and assessors will be blind to the group assignment.||t|||t
1294164|NCT03672188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294165|NCT03672175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294166|NCT03672162|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1294167|NCT03672149|Non-Randomized|Single Group Assignment||Other||None (Open Label)||"If cefazolin is part of the empiric or definitive treatment regimen, it will be mixed in the CRRT solution(s) and administered via a continuous infusion to obtain treatment, pharmacokinetic, and safety data .~If cefazolin is not part of the empiric or definitive treatment regimen, it will be mixed in the CRRT solution(s) and administered via a continuous infusion to obtain pharmacokinetic, and safety data .~If a patient does not require any anti-microbial therapy, cefazolin will be given via the CRRT solution(s) to solely obtain pharmacokinetic and safety data."||||
1294168|NCT03672136||Single Group Assignment||Treatment||None (Open Label)||||||
1294169|NCT03672123|||Cohort||Prospective|||||||
1294170|NCT03672110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294171|NCT03672097||Single Group Assignment||Treatment||None (Open Label)||||||
1294172|NCT03672084|||Cohort||Prospective|||||||
1294173|NCT03672071|Randomized|Parallel Assignment||Other||Single||A randomized prospective controlled study|t|||
1294174|NCT03672058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294175|NCT03672045|Randomized|Parallel Assignment||Treatment||Quadruple||Biased coin up-and-down design.|t|t|t|t
1294176|NCT03672032|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1294177|NCT03672019|||Cohort||Prospective|||||||
1294178|NCT03672006|Randomized|Parallel Assignment||Prevention||Quadruple|Centralized pharmacy will prepare and blind the study drug (t-PA) and the control (heparin)||t|t|t|t
1294179|NCT03671993|Randomized|Parallel Assignment||Treatment||Single||||||t
1294180|NCT03671980||Single Group Assignment||Other||None (Open Label)||Feasibility study||||
1294181|NCT03671967|Randomized|Parallel Assignment||Treatment||None (Open Label)||open-label randomized controlled trial||||
1294182|NCT03671954|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Participant, outcome assessor|The intervention group will perform unsupervised home strengthening exercises for the hip abductors in addition to standard physical therapy, while the control group will receive standard physical therapy alone. Subjects will be assigned to one of two groups by block randomization, such that patients receiving each different implant design comprise each block.||||
1294183|NCT03671941|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1294184|NCT03671928|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1294185|NCT03671915|Randomized|Crossover Assignment||Treatment||None (Open Label)||Closed loop vs. Open loop||||
1294186|NCT03671902||||||||||||
1294187|NCT03671889||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1294188|NCT03671876|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294189|NCT03671863|||Cohort||Retrospective|||||||
1294190|NCT03671850|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1294191|NCT03671837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294192|NCT03671824|||Cohort||Prospective|||||||
1294193|NCT03671811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294194|NCT03671798|||Case-Control||Prospective|||||||
1294195|NCT03671785|Randomized|Parallel Assignment||Treatment||Single|||t|||
1294196|NCT03671772|||Case-Control||Prospective|||||||
1294197|NCT03671759||Single Group Assignment||Other||None (Open Label)||||||
1294198|NCT03671746|Randomized|Parallel Assignment||Treatment||Triple|Participant medical team will be blinded to the treatment or placebo intervention|Compare the effectiveness of a NSAID to placebo in acute trauma setting.|t|t|t|
1294199|NCT03671733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294200|NCT03671720||Single Group Assignment||Treatment||None (Open Label)||||||
1294201|NCT03671707|Randomized|Parallel Assignment||Treatment||Single||||||t
1294202|NCT03671694|Randomized|Parallel Assignment||Treatment||Triple|only the care provider (who is not involved with recruitment or evaluation of patients' outcomes) will be aware of the treatment assignments|RCT|t||t|t
1294203|NCT03671681|Randomized|Parallel Assignment||Treatment||Single||||||t
1294204|NCT03671668|Randomized|Parallel Assignment||Treatment||None (Open Label)||Completely edentulous patients||||
1294245|NCT03671135||Single Group Assignment||Treatment||None (Open Label)||Single group assignment||||
1294246|NCT03671122|||Cohort||Prospective|||||||
1573306|NCT00001679||||||||||||
1294205|NCT03671655|Randomized|Parallel Assignment||Treatment||Single|The patient and study coordinator performing patient follow-up will be blinded to the allocated treatment strategy. Angiographic and US analyses will also be done blinded to study-arm allocation. Breaking the blind will be possible for any patient who develops a complication or whose clinical care requires knowledge of the study group allocation.|This is a phase 3, multi-center, randomized controlled, parallel-group study in patients with long Superficial Femoral Artery (SFA) lesions and SFA Chronic Total Occlusion (CTO), undergoing clinically indicated stent-based percutaneous revascularization .Patients will be randomized into Drug eluting stent (DES) arm (intervention) vs. Bare Metal Stent (BMS) arm (control).|t|||
1294206|NCT03671642||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1294207|NCT03671629|Randomized|Parallel Assignment||Other||Single|A group of physicians and clinical pharmacists will asses whether readmissions are drug-related or not. This group is blinded.|||||t
1294208|NCT03671616||Single Group Assignment||Other||None (Open Label)||||||
1294209|NCT03671603|||Other||Prospective|||||||
1294210|NCT03671590|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294211|NCT03671577|Randomized|Parallel Assignment||Treatment||Single|Participants will be randomized into active treatment or waitlist control, so they will be aware of the condition they are in.|Participants will be randomized into active treatment or waitlist control.||||t
1294212|NCT03671564||Single Group Assignment||Treatment||None (Open Label)||||||
1294213|NCT03671551|||Cohort||Prospective|||||||
1294214|NCT03671538||Single Group Assignment||Treatment||None (Open Label)||||||
1294215|NCT03671525|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1294216|NCT03671512|Randomized|Parallel Assignment||Treatment||Double||For each subject, one quadrant will be randomized to PSR and the other quadrant will be randomized to conventional scaling and root planing.|t|||t
1294217|NCT03671499||Single Group Assignment||Supportive Care||None (Open Label)||||||
1294218|NCT03671486|||Cohort||Prospective|||||||
1294219|NCT03671473|Randomized|Parallel Assignment||Treatment||Single||||||t
1294220|NCT03671460||Single Group Assignment||Treatment||None (Open Label)||single-center, open-label, nonrandomized, no control, prospective clinical trial||||
1294221|NCT03671447|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||"Stepped Wedge Cluster-Randomization from 9 centers to a total of 3 clusters (switching group), i.e. 3 institutions per cluster. There will be a staggered introduction of intervention into the centers (participating houses) for each cluster (rollout of intervention at the cluster level): Cluster 1 will implement the intervention after the third month of the project, Cluster 2 will implement the intervention after the sixth month of the project, and Cluster 3 will implement the intervention after the ninth month of the project."||||
1294222|NCT03671434|Randomized|Parallel Assignment||Other||Double|"Participants: Participants will not be informed of their status as part of an intervention or control group.~Provider: No masking~Investigator: No masking~Outcome Assessor: Survey data will indicate intervention assignment; observational data will be masked such that document coders will not be aware of the condition associated with coded documents."|Participants will be randomly assigned to either a comprehensive intervention or a control group that receives minimal intervention.|t|||t
1294223|NCT03671421|Non-Randomized|Parallel Assignment||Treatment||Single|The clinical assessments will be done by someone blinded to the arm of the study the patient is in.|Prospective cohort study design||||t
1294224|NCT03671408|||Case-Only||Cross-Sectional|||||||
1294225|NCT03671395|||Cohort||Prospective|||||||
1294226|NCT03671382|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1294227|NCT03671369|||Cohort||Prospective|||||||
1294228|NCT03671356|||Cohort||Prospective|||||||
1294229|NCT03671343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294230|NCT03671330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294231|NCT03671317|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Participants are randomized to either receive medical clowning intervention or no intervention. The total length of subject participation is the participant's one visit to the blood draw clinic. Data collection involves pre then post surveys to measure anxiety and pain levels for comparison.~After screening, consent, and randomization, the participant and legal guardian assigned to both the intervention and no intervention group complete a survey. Once completed, the intervention arm is introduced to two medical clowns who accompany the participant through the blood draw process. The non intervention arm waits for the nurse to continue with usual care. Audio recording begins when participants of both arms enter the blood draw room. Once the nurse leaves the room after venipuncture, all participants and legal guardians complete a second questionnaire.~At the conclusion of the study, the medical staff are asked to answer a questionnaire rated on the Likert Scale."||||
1294232|NCT03671304||Single Group Assignment||Supportive Care||None (Open Label)||This project will enroll 50 participants receiving treatment for RCC in an eight-week study. Using a microrandomized design, participants will receive affective framing messages and intention planning prompts on a randomized schedule, such that participants will receive each message type on 50% of days.||||
1294233|NCT03671291||Single Group Assignment||Prevention||None (Open Label)||||||
1294234|NCT03671278||Single Group Assignment||Health Services Research||None (Open Label)||||||
1294235|NCT03671265||Single Group Assignment||Treatment||None (Open Label)||||||
1294236|NCT03671252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294237|NCT03671239|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1294238|NCT03671226||Single Group Assignment||Supportive Care||None (Open Label)||||||
1294239|NCT03671213||Single Group Assignment||Treatment||None (Open Label)||Single Arm Study Design||||
1294240|NCT03671200|||Case-Crossover||Cross-Sectional|||||||
1294241|NCT03671187|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294242|NCT03671174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294243|NCT03671161||Single Group Assignment||Treatment||||19 patients with type 1 diabetes, HbA1c >9% (75 mmol/mol), multi daily insulin injections ( MDI) and who perform less than 2 SMBG /day.||||
1294244|NCT03671148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573307|NCT00001677||||Treatment||||||||
1294247|NCT03671109|Randomized|Parallel Assignment||Prevention||Quadruple|Double blind placebo-controlled|Superiority clinical trial|t|t|t|t
1294248|NCT03671096||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1294249|NCT03671083|||Case-Control||Prospective|||||||
1294250|NCT03671070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294251|NCT03671057|Randomized|Parallel Assignment||Prevention||Triple|"Two sets of cartboard boxes will be prepared. The boxes are prepared and numbered by the study investigator (F.V.) (the unique randomized test number) and distributed amongst the consultation offices of the surgeons by the researchers. To blind both the researchers and the surgeons, the 2 sets of boxes will have the same weight. The weight of the ipad is simulated in the boxes of the control group by the use of a coloring book. This will prevent patient selection bias.~After the consultation and when the parent and the child has agreed to participate, the surgeon hands over a box to the parent. The surgeon writes the box number, name of the child, date of birth and the phone number of the child in an excel sheet. This document will be used during data procession.~The patients participating in the trial, the treating physicians, the surgeons dispensing the study boxes, the researchers assessing outcomes and the data-managers will be blinded for group allocation."|The design of the study will be a single blinded randomized clinical trial. Children will be divided in 2 research groups: an intervention group (children who will play the game HospiAvontuur as a non-pharmacological at home preparation prior to the hospital admission. These children will not receive any pharmacological preparation - Midazolam - at the hospital) and a control group (children who do not play the game at home and do receive a pharmacological preparation - Midazolam - at the hospital). Participants will be randomly assigned to the intervention group or the control group using a computer-generated random allocation sequence, created by the study investigator (F.V.). Each patient will receive a unique randomized test number.||t|t|t
1294252|NCT03671044|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Experimental: T1, Nanosomal Docetaxel Lipid Suspension (75 mg/m2) Experimental: NDLS for Injection, 75 mg/ m2 Nanosomal Docetaxel Lipid Suspension for Injection; Dose: 75 mg/m2; Frequency: Every 3-weeks; Duration of treatment: Patient will be dosed with drug until disease progression and/or unacceptable toxicity.~Experimental: T2, Nanosomal Docetaxel Lipid Suspension (100 mg/m2) Experimental: NDLS for Injection, 100 mg/ m2 Nanosomal Docetaxel Lipid Suspension for Injection; Dose: 100 mg/m2; Frequency: Every 3-weeks; Duration of treatment: Patient will be dosed with drug until disease progression and/or unacceptable toxicity.~Active Comparator: R, Taxotere® (100 mg/m2) Active Comparator: Taxotere® Injection Concentrate Docetaxel Injection Concentrate; Dose: 100 mg/m2; Frequency: Every 3-weeks; Duration of treatment: Patient will be dosed with drug until disease progression and/or unacceptable toxicity."||||
1294253|NCT03671031|||Cohort||Retrospective|||||||
1294254|NCT03671018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294255|NCT03671005|Randomized|Parallel Assignment||Treatment||Single|A blinded psychiatrist who works independently of the (co-) therapist conducts the rater-questionnaires. Due to the psychotherapeutic nature of the study, information about the treatment allocation has to be shared with the co-therapist and the participants. Randomization is conducted by the Random Group Generator (pubmed, 2018).|A single-centered randomized controlled trial with a parallel-groups design is utilized, comprising of mindfulness-based group therapy (MBGT) in addition to treatment as usual (TAU) in the experimental condition, and TAU in the control condition||||t
1294256|NCT03670992|||Case-Only||Retrospective|||||||
1294257|NCT03670979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294258|NCT03670966||Single Group Assignment||Treatment||None (Open Label)||||||
1294259|NCT03670953|Randomized|Parallel Assignment||Treatment||Quadruple|Double dummy, blinded drug|Multicenter, randomized, double-blind, double-dummy, active-controlled, parallel-group study.|t|t|t|t
1294260|NCT03670940|||Cohort||Retrospective|||||||
1294261|NCT03670927|||Case-Control||Prospective|||||||
1294262|NCT03670914||Single Group Assignment||Diagnostic||None (Open Label)||This is a prospective single cohort study that will evaluate the efficacy of the WatchPAT200 device by comparing it to an in-lab polysomnography.||||
1294263|NCT03670901|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294264|NCT03670888|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294265|NCT03670875|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Study groups. Agave inulin: 2.3 g twice a day by mouth during 3 months plus recommendations to decrease calories intake an do exercise.~Curcumin: 600 mg (turmeric 600 + black pepper 5 mg) by mouth daily during 3 months plus recommendations to decrease calories intake an do exercise.~Omega-3 fatty acids 600 mg (eicosapentaenoic acid 360; docosahexaenoic acid 240) Three times a day by mouth during 3 months plus recommendations to decrease calories intake an do exercise.~Control group with no intervention. Recommendations to decrease calories intake an do exercise.~Dietary recommendations to ingest 1600 calories per day Exercise: 30 minutes each day, al least 5 days a week (caloric consumption 150-200 kcal per day)"||||
1294266|NCT03670862|||Case-Only||Prospective|||||||
1294267|NCT03670849||Single Group Assignment||Supportive Care||None (Open Label)||||||
1294268|NCT03670836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294269|NCT03670823|||Case-Control||Prospective|||||||
1294270|NCT03670810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294271|NCT03670797|||Ecologic or Community||Cross-Sectional|||||||
1294272|NCT03670784|||Cohort||Retrospective|||||||
1294273|NCT03670771|||Cohort||Prospective|||||||
1294274|NCT03670758|||Case-Control||Other|||||||
1294275|NCT03670745|Randomized|Parallel Assignment||Supportive Care||Single||This project will utilize a sequential explanatory research design, with an embedded randomized controlled trial (RCT) intervention .|t|||
1294276|NCT03670732|Randomized|Crossover Assignment||Treatment||None (Open Label)||Crossover non-inferiority trial||||
1294277|NCT03670719|Randomized|Parallel Assignment||Treatment||Single|Only the evaluator is blinded|||||t
1294278|NCT03670706|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1294279|NCT03670693|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1294280|NCT03670680||Single Group Assignment||Treatment||None (Open Label)||||||
1294281|NCT03670667|||Cohort||Retrospective|||||||
1294333|NCT03669991|||Cohort||Prospective|||||||
1294282|NCT03670654|Randomized|Parallel Assignment||Treatment||Single|All the measurements will be performed by a blinded professional, who will be masked from randomization and other results. For each test, the same investigator will be maintained before and after the intervention. The participants will know what treatment (exercise) they will receive, but they don't will know what exercise belongs to the control group.|||||t
1294283|NCT03670641||Single Group Assignment||Treatment||None (Open Label)||10 participants will be recruited soon after diagnosis of type 2 diabetes and started on short term insulin therapy to achieve euglycemia with insulin doses guided by continuous glucose monitor algorithm||||
1294284|NCT03670628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294285|NCT03670615|Randomized|Parallel Assignment||Treatment||Triple|The research personnel that will be administering the cognitive assessments will be blinded to treatment allocation. The patients will be blinded to stimulation type.|This is a randomized, blinded, repeated-session, parallel-design study.|t||t|t
1294286|NCT03670602|Randomized|Parallel Assignment||Treatment||Single|Research personnel who will be conducting assessment sessions, including weight measurements, will not be informed of participant's group assignment|Participants will engage in EFT or control while using The Traffic Light Diet, The Traffic Light Activity Program, and a variety of behavioral techniques including stimulus control, self-monitoring, goal setting, problem solving, resetting rewarding mechanisms by reducing need for immediate gratification, finding behavioral substitutes for highly reinforcing food.||||t
1294287|NCT03670589|||Case-Control||Retrospective|||||||
1294288|NCT03670576|||Cohort||Prospective|||||||
1294289|NCT03670563|Randomized|Parallel Assignment||Treatment||Single|Team members collecting balance related outcomes data will not know participant allocation|||||t
1294290|NCT03670550||Single Group Assignment||Basic Science||None (Open Label)|Investigators and participants cannot be blinded as to whether or not the brace is worn.|Evaluation of knee stability with brace wear. Control is same subject without the brace.||||
1294291|NCT03670537|||Cohort||Prospective|||||||
1294292|NCT03670524|Non-Randomized|Parallel Assignment||Other||None (Open Label)||A unique pragmatic interventional trial with longitudinal follow up to assess the cardiovascular effects of increasing residential greenery.||||
1294293|NCT03670511|Non-Randomized|Parallel Assignment||Screening||Single|||||t|
1294294|NCT03670498|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1294295|NCT03670485||Single Group Assignment||Treatment||None (Open Label)||||||
1294296|NCT03670472|||Case-Control||Prospective|||||||
1294297|NCT03670459|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1294298|NCT03670446|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1294299|NCT03670433|||Cohort||Prospective|||||||
1294300|NCT03670420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294301|NCT03670407|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294302|NCT03670394|||Cohort||Prospective|||||||
1294303|NCT03670381|||Case-Control||Cross-Sectional|||||||
1294304|NCT03670368|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294305|NCT03670355|Randomized|Parallel Assignment||Prevention||Single|||t|||
1294306|NCT03670342|||Case-Only||Prospective|||||||
1294307|NCT03670329||Single Group Assignment||Treatment||None (Open Label)||Non-comparative study||||
1294308|NCT03670316|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to either the Algorithm Treatment plus referral to a quitline (AT) or the quitline alone condition (eTAU).||||
1294309|NCT03670303|Randomized|Parallel Assignment||Prevention||None (Open Label)||Study will involve two groups intervention group and no intervention (control) group. each group will include two boys and two girls schools. Educational intervention will be given to two boys and two girls schools. Remaining two boys and two girls schools will not receive educational intervention. Simultaneous follow-ups will be carried out in two groups to assess compliance towards spectacles use.||||
1294310|NCT03670290|||Cohort||Prospective|||||||
1294311|NCT03670277||||||||||||
1294312|NCT03670264|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1294313|NCT03670251||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294314|NCT03670238|Randomized|Parallel Assignment||Treatment||None (Open Label)||A cross-over randomized trial||||
1294315|NCT03670225||Single Group Assignment||Treatment||None (Open Label)||non-randomized||||
1294316|NCT03670212|Randomized|Single Group Assignment||Basic Science||Double|Double-blinded study. Subjects, the experimenter, research assistants, and MRI technician did not know if the oral doses were active (acute stress condition) or inert (placebo session).|Double-blind, placebo-controlled, and randomized cross-over study design. Each subject completed both the placebo and acute stress experimental sessions.|t||t|
1294317|NCT03670199|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294318|NCT03670186|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1294319|NCT03670173||Single Group Assignment||Treatment||None (Open Label)||multi-center, single-arm, open-label, non-blind||||
1294320|NCT03670160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294321|NCT03670147|Randomized|Parallel Assignment||Supportive Care||Single|The participant and study staff will be blinded. The study physicians will not be blinded.||t|||
1294322|NCT03670134||Single Group Assignment||Prevention||None (Open Label)||||||
1294323|NCT03670121||Single Group Assignment||Treatment||None (Open Label)||Single arm Pilot Study||||
1294324|NCT03670108|||Other||Prospective|||||||
1294325|NCT03670095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294326|NCT03670082|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1294327|NCT03670069||Single Group Assignment||Treatment||None (Open Label)||||||
1294328|NCT03670056||Single Group Assignment||Treatment||None (Open Label)||||||
1294329|NCT03670043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294330|NCT03670030||Single Group Assignment||Treatment||None (Open Label)||||||
1294331|NCT03670017||Single Group Assignment||Other||None (Open Label)||||||
1294332|NCT03670004|||Cohort||Prospective|||||||
1294335|NCT03669965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294336|NCT03669952|||Case-Only||Prospective|||||||
1294337|NCT03669939|||Other||Prospective|||||||
1294338|NCT03669926||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294339|NCT03669913|Randomized|Parallel Assignment||Prevention||None (Open Label)||A cluster randomized trial where the intervention is structured comprehensive sexuality education lesson packages||||
1294340|NCT03669900||Single Group Assignment||Treatment||None (Open Label)||||||
1294341|NCT03669887|Randomized|Parallel Assignment||Treatment||Single|||||t|
1294342|NCT03669874|||Cohort||Prospective|||||||
1294343|NCT03669861||Single Group Assignment||Treatment||None (Open Label)||||||
1294344|NCT03669848|||Other||Prospective|||||||
1294345|NCT03669835|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294346|NCT03669822|||Cohort||Prospective|||||||
1294347|NCT03669809|||Cohort||Other|||||||
1294348|NCT03669796|Randomized|Crossover Assignment||Basic Science||Double||A double-blind crossover trial, including two different study days, with 4-7 days wash-out (WO) period in between. The intervention implemented 20 mg of MPH per kg body weight (test material) or control (casein).|t||t|
1294349|NCT03669783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294350|NCT03669770|||Case-Crossover||Prospective|||||||
1294351|NCT03669757|Randomized|Parallel Assignment||Treatment||Single|The trial will be performed investigator-blind with random assignment of the 4 Investigational Medicinal Products (IMPs), the placebo and the active comparator.|Intra-individual comparison of all treatment|||t|
1294352|NCT03669744|||Case-Only||Retrospective|||||||
1294353|NCT03669731|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1294354|NCT03669718|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294355|NCT03669705|||Cohort||Prospective|||||||
1294356|NCT03669692|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open Randomized Clinical Trials||||
1294357|NCT03669679|Randomized|Parallel Assignment||Treatment||Single|||t|||
1294358|NCT03669666|||Case-Control||Prospective|||||||
1294359|NCT03669653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294360|NCT03669640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294361|NCT03669627|Randomized|Parallel Assignment||Prevention||Single|Observer-blind|Participants will be randomly assigned to one of three groups: Group 1 will receive aTIV as a primer and QIV as a booster, Group 2 will receive QIV as both primer and booster, and Group 3 will receive aTIV as both primer and booster.|||t|
1294362|NCT03669614|Randomized|Sequential Assignment||Treatment||Triple||"SAD Phase The HV cohort will include up to 24 adult subjects in 3 groups (8 per dose group). In each dose group, subjects will be randomly assigned in a 3:1 ratio to the active drug or placebo, resulting in 4 subjects receiving inhaled AR-501 and 2 receiving placebo in a double-blind manner.~The MAD phase of the study will include up to an additional 18 adult subjects in 3 dose groups (also 6 per dose group). In each dose group, subjects will be randomly assigned in a 2:1 ratio to active study drug or placebo, resulting in 4 subjects receiving inhaled AR-501 and 2 receiving placebo in a double-blind manner.~Cystic Fibrosis Cohort The CF cohort, consisting of 36 adult CF subjects, will undergo the same treatment and monitoring process as the HV cohort during the SAD phase, including the use of sentinel subjects in the first dose group."|t|t|t|
1294363|NCT03669601|Randomized|Parallel Assignment||Treatment||None (Open Label)||Continuous and intermittent administration schedule.||||
1294364|NCT03669588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294365|NCT03669575|Randomized|Crossover Assignment||Treatment||Double|The randomization block of four. Participants, research coordinators, and study clinicians are blinded.|Eligible participants are randomly assigned to one of two crossover arms, i.e verum-placebo or placebo-verum sequence. The verum groups are dosed approximately 900 mg a day omega-7 fatty acid, and placebo group contains other fatty acids except for omega-7. After the baseline assessment, a participant is on the supplement bottle for three weeks before re-assessed, and starts the second bottle without a washout period. The participant is re-assessed at the end of the six weeks before exits the study.|t||t|
1294366|NCT03669562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294367|NCT03669549||Single Group Assignment||Treatment||None (Open Label)||||||
1294368|NCT03669536|||Ecologic or Community||Cross-Sectional|||||||
1294369|NCT03669523||Single Group Assignment||Treatment||None (Open Label)||National (French), multicenter, prospective, open, single-arm phase II study||||
1294370|NCT03669510|Randomized|Single Group Assignment||Treatment||None (Open Label)||atrophic posterior mandible requiring nerve lateralization||||
1294371|NCT03669497||Single Group Assignment||Treatment||None (Open Label)||||||
1294372|NCT03669484|Randomized|Parallel Assignment||Treatment||Single|Simple blinding stipulates hiding the treatment group for a patient. In addition, the research team had a blinded anesthesiologist who did not know about a patient's therapy group throughout the trial. This anesthesiologist assessed a patient's condition by scales (modified Aldrete score, memory assessment, postoperative delirium diagnosis). Anesthesia depth assessment by bispectral index (BIS), administration and, if necessary, correction of the trial drug/reference drug dosage were carried out by another anesthesiologist.||t|||
1294373|NCT03669471|||Cohort||Cross-Sectional|||||||
1294374|NCT03669458||||||||||||
1294375|NCT03669445||Single Group Assignment||Treatment||None (Open Label)||||||
1294376|NCT03669432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294377|NCT03669419|||Cohort||Prospective|||||||
1294378|NCT03669406||Single Group Assignment||Treatment||None (Open Label)||||||
1294379|NCT03669393||Single Group Assignment||Treatment||None (Open Label)||||||
1294380|NCT03669380|||Cohort||Retrospective|||||||
1294381|NCT03669367|Randomized|Parallel Assignment||Treatment||None (Open Label)||National multi-center study, open, controlled and randomized||||
1294382|NCT03669354|||Cohort||Prospective|||||||
1294483|NCT03668028|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294484|NCT03668015|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1295026|NCT03660969|||Cohort||Prospective|||||||
1294383|NCT03669341|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||All study participants will perform both techniques of suppression of respiratory motion at 4 weekly visits. They always start with the deep-inspiration-breath- hold (DIBH) technique, extended by prior hyperventilation while breathing 100% O2, followed by the high-frequency-percussive-ventilation (HFPV) technique. Inbetween the weekly visits, participants are requested to perform a daily, short breath-hold training at home.||||
1294384|NCT03669328|||Other||Prospective|||||||
1294385|NCT03669315|Randomized|Parallel Assignment||Treatment||Triple|Outcome assessor, investigators and participants will be blinded to the type of treatment (active TMS or Placebo)|After selection and enrollment, participants will be screened at baseline with MRI and a complete diagnostic and clinical assessment, described in the following corresponding sections. Using a placebo-controlled double-blind design patients will be randomized to receive active or placebo cTBS.|t||t|t
1294386|NCT03669302|Randomized|Parallel Assignment||Treatment||None (Open Label)||Individuals with Spinal Cord Imjury will be randomly assigned to receive robotic gait training with the Lokomat, and/or Lokomat gait training combined with non-invasive thoracolumbar transspinal stimulation at 0.3 or at 30 Hz.||||
1294387|NCT03669289||Single Group Assignment||Health Services Research||None (Open Label)||Pre-post within-subject design||||
1294388|NCT03669276|||Case-Only||Retrospective|||||||
1294389|NCT03669263||Single Group Assignment||Treatment||None (Open Label)||||||
1294390|NCT03669250|Randomized|Crossover Assignment||Treatment||Quadruple|Double blind, placebo controlled.|Male and female subjects with schizophrenia, age 18 to 50 years old, inclusive, will be randomized to 1 of 6 treatment sequences to receive 1 of 3 dose regimens in each period; a single oral administration of CVN058, or a matching placebo.|t|t|t|t
1294391|NCT03669237|Randomized|Sequential Assignment||Treatment||Triple|||t||t|t
1294392|NCT03669224|Randomized|Parallel Assignment||Screening||Double|||t|||t
1294393|NCT03669211||Single Group Assignment||Other||None (Open Label)||||||
1294394|NCT03669198|Randomized|Parallel Assignment||Treatment||Single|||t|||
1294395|NCT03669185|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1294396|NCT03669172||Single Group Assignment||Treatment||None (Open Label)||||||
1294397|NCT03669146|Randomized|Parallel Assignment||Treatment||Single|A provider other than the investigator(s) will be masked to the primary outcome of the study.|||t||
1294398|NCT03669133|Randomized|Parallel Assignment||Treatment||Triple|Study biostatistician and Investigational Drug Services pharmacist will randomize subjects and will provide study drug|Group A: Vitamin E 800 IU/daily for 24 weeks. (total of 28 subjects) Group B: Matching placebo for 24 weeks (total of 28 subjects)|t|t|t|
1294399|NCT03669120|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1294400|NCT03669107|Randomized|Parallel Assignment||Treatment||Double|Double (Participant, Investigator)||t||t|
1294401|NCT03669094|Randomized|Parallel Assignment||Treatment||Quadruple||This is an interventional randomized, multicenter, double-blind, placebo-controlled, parallel-group study|t|t|t|t
1294402|NCT03669081|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1294403|NCT03669068|||Cohort||Prospective|||||||
1294404|NCT03669055||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294405|NCT03669042||Single Group Assignment||Treatment||None (Open Label)||||||
1294406|NCT03669029|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1294407|NCT03669016|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1294408|NCT03669003|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294409|NCT03668990|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1294410|NCT03668977|Randomized|Factorial Assignment||Prevention||None (Open Label)||2 x 2 factorial design.||||
1294411|NCT03668964|Randomized|Parallel Assignment||Basic Science||Quadruple||Randomized, double-blind, placebo-controlled, parallel trial|t|t|t|t
1294412|NCT03668951|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1294413|NCT03668938|Randomized|Parallel Assignment||Treatment||Single|masking of outcome assessor to T0|||||t
1294414|NCT03668925|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1294415|NCT03668912|Randomized|Parallel Assignment||Treatment||Single||||||t
1294416|NCT03668899|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294417|NCT03668886|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||intervention group: receive multimodal exercise program for half year control group: participate community activity||||
1294418|NCT03668873|Randomized|Parallel Assignment||Treatment||Single||||||t
1294419|NCT03668860|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1294420|NCT03668847||Single Group Assignment||Treatment||None (Open Label)||||||
1294421|NCT03668834|Randomized|Parallel Assignment||Treatment||None (Open Label)||All 3 methods of recipient site preparation will be done in all 36 patients.||||
1294422|NCT03668821|||Cohort||Prospective|||||||
1294423|NCT03668808|Randomized|Crossover Assignment||Treatment||None (Open Label)||Subjects will begin in Honolulu, HI (HNL), fly to Newark (EWR) where they will stay for up to 72 hours followed by a return long-haul flight back to Honolulu with up to 72 hours at this destination. This journey will be repeated after a 2 week period when subjects return to their original insulin treatment regimen and then switch to the alternative basal insulin.||||
1294424|NCT03668795|||Cohort||Retrospective|||||||
1294425|NCT03668782|||Case-Control||Prospective|||||||
1294426|NCT03668769||Single Group Assignment||Prevention||None (Open Label)||||||
1294427|NCT03668756|||Cohort||Prospective|||||||
1294428|NCT03668743|||Case-Control||Retrospective|||||||
1294429|NCT03668730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1294430|NCT03668717|||Case-Only||Retrospective|||||||
1294431|NCT03668704|||Case-Only||Retrospective|||||||
1294432|NCT03668691|||Case-Only||Prospective|||||||
1294433|NCT03668678|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1294530|NCT03667417|||Cohort||Prospective|||||||
1294676|NCT03665519|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294677|NCT03665506|||Case-Only||Prospective|||||||
1294434|NCT03668665|Randomized|Parallel Assignment||Treatment||Triple|"The images taken from the wound as a progress control during the study should be evaluated anonymously by both the surgeon and the patient using the Manchester Scar Scale and the Patient and Observer Scar Assessment Scale."|The wound is divided into two halves (top and bottom). During the in-patient stay, half of the split skin removal sites are treated with Ready Medical Post Treatment on the 1st, 4th and 7th postoperative days in addition to conventional treatment with moist dressings (Mepilex and Fixomull). The other half of the wound should only be treated with conventional dressings as a control. Half of those treated with Ready Medical Post Treatment receive a new dressing after each application.|t|t|t|
1294435|NCT03668652|Randomized|Parallel Assignment||Treatment||None (Open Label)|Focal treatment of prostate cancer using HIFU compared to Radical prostatectomy|Randomized controlled trial||||
1294436|NCT03668639||Single Group Assignment||Supportive Care||None (Open Label)||||||
1294437|NCT03668626|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1294438|NCT03668613||Parallel Assignment||Treatment||None (Open Label)||||||
1294439|NCT03668600||Single Group Assignment||Treatment||None (Open Label)||||||
1294440|NCT03668587|||Case-Control||Prospective|||||||
1294441|NCT03668574|Randomized|Parallel Assignment||Treatment||Single||||||t
1294442|NCT03668561||Single Group Assignment||Treatment||None (Open Label)||||||
1294443|NCT03668548|Randomized|Parallel Assignment||Treatment||Quadruple|All parties will be masked from the intervention.|The study will be a randomised controlled pilot trial. Participants will complete testing at baseline and after 10 weeks.|t|t|t|t
1294444|NCT03668535|Randomized|Parallel Assignment||Prevention||Double|closed envelop will be used for randomization. The patient and the investigator will be blinded.|Two groups of women with difficult Cesarean Section at risk of urinary bladder injury. Group A will receive the intervention. Group B will not receive the intervention.|t||t|
1294445|NCT03668522|||Case-Only||Cross-Sectional|||||||
1294446|NCT03668509|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1294447|NCT03668496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294448|NCT03668483||Single Group Assignment||Treatment||None (Open Label)||||||
1294449|NCT03668470|Randomized|Parallel Assignment||Treatment||Quadruple||Multicentric, investigator-initiated, randomized, double-blinded, therapeutic clinical trial, placebo-controlled, two arm parallel group intervention trial during 24 weeks, phase II.|t|t|t|t
1294450|NCT03668457|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1294451|NCT03668444|Randomized|Parallel Assignment||Supportive Care||Single|Assessors are blinded to conditions|Randomized Control Trial||||t
1294452|NCT03668431||Single Group Assignment||Treatment||None (Open Label)||||||
1294453|NCT03668418|||Cohort||Prospective|||||||
1294454|NCT03668405||Single Group Assignment||Treatment||None (Open Label)||||||
1294455|NCT03668392||Single Group Assignment||Treatment||None (Open Label)||||||
1294456|NCT03668379|Randomized|Sequential Assignment||Treatment||Double|Medical providers of the patients enrolled in the study will be notified that their patient is in a study for depression but not told what intervention arm. At all follow-up outcome points, the assessor will be blind to all intervention arms the patient were randomized to.|"The study utilizes a Sequential Multiple Assignment Randomized Trial (SMART) design in order to guide a series of adaptive behavioral interventions. In a SMART, eligible participants will be randomized at baseline and assigned to 1st-stage treatments consisting of either 1. Behavioral Activation Therapy (BAT) or 2. BAT & mHealth. During the first stage treatment, Patient Health Questionnaire-9 (PHQ-9) scores will be collected. At the follow-up period, the PHQ-9 will provide a cutoff score to determine whether a participant showed a clinically meaningful response (responder/non-responder) to the 1st stage treatment. Responder indicates that patients successfully responded to the 1st stage treatment and will continue the treatment in maintenance mode. Non-responder indicates that the patient did not respond to the 1st-stage treatment and are re-randomized to either an augmented or switched intervention."||t||t
1294457|NCT03668366||Single Group Assignment||Treatment||None (Open Label)||||||
1294458|NCT03668353|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||dose escalation||||
1294459|NCT03668340||Single Group Assignment||Treatment||None (Open Label)||||||
1294460|NCT03668327|||Cohort||Prospective|||||||
1294461|NCT03668314|Randomized|Parallel Assignment||Other||Triple||Parts 1 and 3 are parallel designs with escalating doses within each part. Part 2 is a FE cross-over study|t||t|t
1294462|NCT03668301|||Case-Control||Prospective|||||||
1294463|NCT03668288|||Cohort||Prospective|||||||
1294464|NCT03668275|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1294465|NCT03668262|||Cohort||Prospective|||||||
1294466|NCT03668249|||Cohort||Retrospective|||||||
1294467|NCT03668236|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor- and analyst-blinded trial|||||t
1294468|NCT03668223|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1294469|NCT03668210|||Case-Control||Retrospective|||||||
1294470|NCT03668197|||Cohort||Prospective|||||||
1294471|NCT03668184|||Cohort||Retrospective|||||||
1294472|NCT03668171|Randomized|Parallel Assignment||Treatment||Quadruple|Randomization will be blinded to participant, care provider, investigator and outcome assessors.||t|t|t|t
1294473|NCT03668158|||Cohort||Retrospective|||||||
1294474|NCT03668145|Randomized|Parallel Assignment||Treatment||Quadruple|Randomization will be blinded to participant, care provider, investigator and outcome assessors.||t|t|t|t
1294475|NCT03668132|||Case-Control||Prospective|||||||
1294476|NCT03668119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294477|NCT03668106|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1294478|NCT03668093|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294479|NCT03668080|||Other||Other|||||||
1294480|NCT03668067|||Cohort||Prospective|||||||
1294481|NCT03668054||Single Group Assignment||Treatment||None (Open Label)||Open label, multicenter study for evaluating the safety and clinical effectiveness of intravitreal bevacizumab||||
1294482|NCT03668041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294485|NCT03668002|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will provide preliminary data and possibly demonstrate feasibility of a large scale randomized controlled trial comparing AVF and AVG in elderly patients (defined as patients over 65 years of age) receiving hemodialysis through a TDC.||||
1294486|NCT03667989||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294487|NCT03667976|Randomized|Parallel Assignment||Prevention||Single|"The investigator will (a) screen, determine eligibility, and obtain consent from eligible peers, (b) schedule and deliver the peer training session, (c) provide support and answer questions of peers as required, (d) assist in the organization of peer meetings and discussions as required, and (e) will pair participants with the appropriate peer based on having children (peer-participant dyad) via telephone.~The outcome assessor (research assistant) will be blinded. Study participants will be assigned a unique study identification (ID) number and will use this study ID number when they electronically submit step counts to the research assistant at weeks 6 and 12. Intervention group participants will additionally submit step counts weekly until study completion. All other outcome data will be collected by the research assistant at the 12-weeks post-intervention follow-up."|A pragmatic two-arm parallel 12-week pilot randomized controlled trial.||||t
1294488|NCT03667963|Non-Randomized|Factorial Assignment||Basic Science||Double|||||t|t
1294489|NCT03667950||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294490|NCT03667937|Randomized|Parallel Assignment||Treatment||Single||||||t
1294491|NCT03667924||Single Group Assignment||Supportive Care||None (Open Label)||||||
1294492|NCT03667911|Randomized|Parallel Assignment||Screening||Double||||t||t
1294493|NCT03667898|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1294494|NCT03667885|||Cohort||Prospective|||||||
1294495|NCT03667872||Single Group Assignment||Treatment||None (Open Label)||||||
1294496|NCT03667859|||Cohort||Prospective|||||||
1294497|NCT03667846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294498|NCT03667833|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1294499|NCT03667820||Single Group Assignment||Treatment||None (Open Label)||||||
1294500|NCT03667807|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294501|NCT03667794|||Cohort||Cross-Sectional|||||||
1294502|NCT03667781|||Cohort||Prospective|||||||
1294503|NCT03667768|Randomized|Crossover Assignment||Treatment||Double||Split-mouth design|t|t||
1294504|NCT03667755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294505|NCT03667742|||Cohort||Prospective|||||||
1294506|NCT03667729|Randomized|Parallel Assignment||Supportive Care||Single|The rater did not know what interventions the participants belonged to.|"This study applied a randomized parallel case-controlled design.~Hospital-based randomized control trial . Subjects were chronic schizophrenia who were recruited from a psychotic ward complex and randomized into PMR, or control groups."||||t
1294507|NCT03667716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294508|NCT03667703|Randomized|Parallel Assignment||Other||Quadruple||Prospective, double-blinded randomized placebo-controlled pilot feasibility trial|t|t|t|t
1294509|NCT03667690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294510|NCT03667677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294511|NCT03667664||Single Group Assignment||Prevention||None (Open Label)||||||
1294512|NCT03667651|Randomized|Parallel Assignment||Prevention||Single|The outcomes assessor will be blinded to the group of allocation and will have no contact with the participants aside from the assessment of outcomes at six-weeks and 12-months|A single blinded study design will be used||||t
1294513|NCT03667638||Single Group Assignment||Treatment||None (Open Label)||||||
1294514|NCT03667625|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1294515|NCT03667612|||Cohort||Retrospective|||||||
1294516|NCT03667599|Non-Randomized|Parallel Assignment||Treatment||Double|||t|t||
1294517|NCT03667586|Randomized|Parallel Assignment||Treatment||Single||The study design will be randomized prospective with a control group. More specifically, all patients will be randomly assigned either to the psychotherapy or the control group. Randomization will be 1:1 and will be performed through the method of sealed envelopes. A group of participants will receive weekly group cognitive behavioral therapy sessions, while another group will receive care as usual with regular weekly brief follow-ups by the gastroenterologists and the nurse of the research team. In total, the psychotherapeutic intervention will last for 6 months with participants attending weekly sessions for the first 3 months and monthly follow-up sessions for the next 3 months. All patients will be re-evaluated at 6 months (treatment completion), 12 months and 18 months after study initiation.||||t
1294518|NCT03667573|Randomized|Parallel Assignment||Other||Single|Participants will be masked to the dosage of transcutaneous spinal direct current stimulation (tsDCS)|Participants will be randomized to one of four different parallel groups|t|||
1294519|NCT03667560|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294520|NCT03667547||Single Group Assignment||Treatment||None (Open Label)||||||
1294521|NCT03667534|||Cohort||Cross-Sectional|||||||
1294522|NCT03667521|||Case-Control||Prospective|||||||
1294523|NCT03667508|Randomized|Parallel Assignment||Treatment||Single||||||t
1294524|NCT03667495|||Other||Prospective|||||||
1294525|NCT03667482||Single Group Assignment||Treatment||None (Open Label)||A standard 3+3 design will be used to find the maximum tolerated dose (MTD) from 3 testing dose levels: 20, 40, and 60.||||
1294526|NCT03667469|Randomized|Parallel Assignment||Treatment||Single|sealed non-transparent envelopes|"Participants are randomly allocated to one of three groups:~Surgical bariatric procedure in the first (A) group undergo the laparoscopic band-separated mini-gastric bypass procedure: Gastric band (vascular prosthesis 8mm diameter and 7 cm length) was introduced in the abdomen and retracted through the retrogastric tunnel.~Surgical bariatric procedure in the second (B) group: Linear cutter stapler-separated mini-gastric bypass (MGB/OAGB): standard surgery.~Non-Surgical interventional in three (C) group including hypocaloric diet therapy."||||t
1294527|NCT03667456||Single Group Assignment||Treatment||None (Open Label)||||||
1294528|NCT03667443|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1294529|NCT03667430|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1294531|NCT03667404|Randomized|Parallel Assignment||Treatment||Quadruple|"participants will be blinded to condition. control condition (maltodextrin) will be used and has identical appearance.~investigator and research staff (except pharmacy) will be blinded to condition"|Double blind placebo (maltodextrin) controlled randomized trial|t|t|t|t
1294532|NCT03667391|||Cohort||Prospective|||||||
1294533|NCT03667378|||Case-Control||Prospective|||||||
1294534|NCT03667365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294535|NCT03667352|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1294536|NCT03667339|||Cohort||Prospective|||||||
1294537|NCT03667326|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1294538|NCT03667313|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294539|NCT03667300|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1294540|NCT03667287|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294541|NCT03667274|||Cohort||Retrospective|||||||
1294542|NCT03667261|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor will be blinded as well as the data analysis|cases with with hopeless mandibular molars followed by immediate implant placement||||t
1294543|NCT03667248|||Cohort||Retrospective|||||||
1294544|NCT03667235|||Cohort||Prospective|||||||
1294545|NCT03667222|Randomized|Parallel Assignment||Treatment||Triple|Vehicle control is identical to the active product in appearance||t||t|t
1294546|NCT03667209|Randomized|Parallel Assignment||Treatment||Single||||||t
1294547|NCT03667196|||Cohort||Prospective|||||||
1294548|NCT03667183||Single Group Assignment||Supportive Care||None (Open Label)||||||
1294549|NCT03667170|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294550|NCT03667157|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1294551|NCT03667144|||Cohort||Cross-Sectional|||||||
1294552|NCT03667131|Randomized|Parallel Assignment||Prevention||Quadruple|Participant, care provider, investigator and outcomes assessor.|Randomized, double blind, controlled, parallel groups clinical trial.|t|t|t|t
1294553|NCT03667118|Randomized|Parallel Assignment||Supportive Care||Single|Parents received packets of the powder to be fed from their infant directly from the manufacturer.||t|||
1294554|NCT03667105|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1294555|NCT03667092||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294556|NCT03667079|Randomized|Factorial Assignment||Prevention||None (Open Label)||Villages were allocated to one of three treatment arms: in Arm 1 villages people received deworming treatment and dogs rabies vaccination through an integrated delivery; in Arm 2 villages only deworming of people occurred; in Arm 3 only dog vaccination occurred. After the study, Arm 2 and 3 villages received rabies vaccination and deworming, respectively.||||
1294557|NCT03667066|||Cohort||Cross-Sectional|||||||
1294558|NCT03667053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294559|NCT03667040|Randomized|Parallel Assignment||Treatment||None (Open Label)||150 participants will be recruited; 75 participants into the intervention group and 75 into the control group. There will three visits, baseline and follow-up at 30 days and 60 days.||||
1294560|NCT03667027|||Case-Control||Prospective|||||||
1294561|NCT03667014||Single Group Assignment||Treatment||None (Open Label)||||||
1294562|NCT03667001|Randomized|Parallel Assignment||Treatment||Quadruple|Measures taken to minimize or avoid bias include randomization and blinding of participants after they have given their informed consent. Blinding of medical practitioner and medical personnel will be conducted by provision of equal looking and packing of IMPs, which will be fabricated individually for each patient and on request one to two days before surgery by the pharmacy.|"The investigators plan to evaluate the analgesic effect of systemic Lidocaine in Addition to general anesthesia during bariatric surgery.~Lidocaine group: perioperative application of systemic Lidocaine up to four hours from end of surgical procedures.~Control group: perioperative application of Placebo (NaCl 0.9%) up to four hours from end of surgical procedures."|t|t|t|t
1294563|NCT03666988|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|This will be an open-label study. Hence, masking will not be performed.|Eligible subjects will receive sequential doses of GSK3368715, administered orally once daily in Part 1 of the study and in Part 2, subjects will receive RP2D determined in Part 1.||||
1294564|NCT03666975|Randomized|Parallel Assignment||Other||Triple|Blinding / masking of participants investigator and assessor|Vibration therapy intervention study involving children with pre-existing LLD to be assessed monthly for 4 months and then randomised to have one of 2 vibration therapies for three months and finally 6 months leg-length measurements to assess changes in extra bone length achieved in the shorter leg during the intervention.|t||t|t
1294565|NCT03666962|||Case-Control||Other|||||||
1294566|NCT03666949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294567|NCT03666936||Single Group Assignment||Treatment||None (Open Label)||||||
1294568|NCT03666923|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1294569|NCT03666910|||Case-Control||Retrospective|||||||
1294570|NCT03666897||Single Group Assignment||Other||None (Open Label)||||||
1294571|NCT03666884|Randomized|Parallel Assignment||Treatment||Double|Participants chose their treatment regime randomly|The comparison of 50 % concentration autologous serum eye drops versus preservative free artificial eye drop plus 0.05 % cyclosporin ophthalmic emulsion in the treatment of severe dry eye syndrom|t|||t
1294572|NCT03666871|Randomized|Parallel Assignment||Treatment||Double|Double-blind|Randomized, double-blind|t||t|
1294573|NCT03666858|||Cohort||Prospective|||||||
1294574|NCT03666845|||Case-Only||Prospective|||||||
1294575|NCT03666832||Single Group Assignment||Treatment||None (Open Label)||||||
1294576|NCT03666819||Single Group Assignment||Treatment||None (Open Label)||||||
1294618|NCT03666273|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1294619|NCT03666260|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294620|NCT03666247|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294621|NCT03666234|||Cohort||Prospective|||||||
1294622|NCT03666221||Single Group Assignment||Treatment||None (Open Label)||||||
1294577|NCT03666806|Randomized|Parallel Assignment||Prevention||Quadruple|The participant and the study team will both be masked to which arm the participant will be assigned. Blinding will be achieved by use of a placebo that has similar characteristics as the influenza vaccine i.e. as the vaccine, the placebo will be formulated and packaged as an injectable placebo. In addition, on enrollment, the participants will be informed by the study team that their assignment to a study arm is completely random and unknown to the study team. The study nurse will pick the study drug from the pharmacist to be used for each participant after the randomization code has been revealed. The randomization code on the study drug will have to be the same as the code in the envelope. Lastly, the envelopes will be kept off site with the statistician who will deliver them every morning before the clinic opens.|Randomized double blinded parallel control study|t|t|t|t
1294578|NCT03666793|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294579|NCT03666780|||Cohort||Prospective|||||||
1294580|NCT03666767|||Cohort||Prospective|||||||
1294581|NCT03666754|Randomized|Parallel Assignment||Treatment||Single||"The randomised clinical trial with participants randomised1:1 to either:~'Standard' therapy consisting of multilayer elastic compression bandaging/ stockings with deferred treatment of superficial reflux (usually once the ulcer has healed) Early endovenous glue embolization of superficial venous reflux(within 2 weeks) in addition to standard therapy"||||t
1294582|NCT03666741|||Case-Only||Prospective|||||||
1294583|NCT03666728||Single Group Assignment||Treatment||None (Open Label)||||||
1294584|NCT03666715|||Cohort||Retrospective|||||||
1294585|NCT03666702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294586|NCT03666689|||Cohort||Prospective|||||||
1294587|NCT03666676|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1294588|NCT03666663|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind study|Randomized placebo controlled study|t|t|t|t
1294589|NCT03666650||Single Group Assignment||Basic Science||None (Open Label)||||||
1294590|NCT03666637|||Cohort||Retrospective|||||||
1294591|NCT03666624|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will utilize a 2-group randomized controlled trial design including 3 assessment, i.e. a pre-treatment, a post-treatment, and a follow-up assessment.||||
1294592|NCT03666611|||Other||Retrospective|||||||
1294593|NCT03666598|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294594|NCT03666585|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294595|NCT03666572|Randomized|Parallel Assignment||Basic Science||Triple||"3 treatment arms for infants with SAM~Placebo (Lactose)~B. infantis alone (Bif)~B. infantis + prebiotic Lacto-N-neotetraose [LNnT] (Bif+prebiotic)~Age at enrollment~2-3.9 months of age~4-5.9 months of age~open-label treatment arm for 18 non-malnourished primarily breastfed infants - B. infantis alone (Bif)"|t|t||t
1294596|NCT03666559||Single Group Assignment||Treatment||None (Open Label)||||||
1294597|NCT03666546|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1294598|NCT03666533|Randomized|Parallel Assignment||Treatment||Quadruple||transcranial Direct Current Stimulation|t|t|t|t
1294599|NCT03666520|||Cohort||Prospective|||||||
1294600|NCT03666507|||Case-Control||Prospective|||||||
1294601|NCT03666494|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294602|NCT03666481|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294603|NCT03666468|Randomized|Parallel Assignment||Treatment||Double||3 groups|||t|t
1294604|NCT03666455||Single Group Assignment||Treatment||None (Open Label)||Study Design: Mixed methods, intervention trial, feasibility study, with sequential and concurrent quantitative and qualitative data collection before, during, and after the intervention.||||
1294605|NCT03666442||Single Group Assignment||Treatment||None (Open Label)||a group of patients receive 4 cycle of Xelox chemotherapy, MRI,TRUS, DE,endoscopy, blood DNA test,before, between and after chemotherapy was compared to detect the effect of chemotherapy in 2 cycles.||||
1294606|NCT03666429|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294607|NCT03666416||Single Group Assignment||Treatment||None (Open Label)||This is a within-subjects design where participants complete outcome measures with and without exercise intervention.||||
1294608|NCT03666403||Single Group Assignment||Diagnostic||None (Open Label)|Three modes with different ventilation (nose-close) rates were studied: mode A, spontaneous breathing, with only PhO2 support, no rate; mode B, rate of 15-20 per minute with Ti 1.0 seconds; and mode C, rate of 5-10 per minute with Ti 2-4 seconds. During FB, every patient underwent all these three modes sequentially, from A to C. When the oxygen desaturation (<90%) or bradycardia (<100 beat/min) persisted more than 10 seconds, the FB was terminated. After the child was stabilized, FB was resumed, starting from the nose-close, but shifted to the next mode of NIV support. When the mode C still failed to maintain an acceptable vital status, the FB procedure was aborted with the removal of the bronchoscope to allow more aggressive NIV or even traditional resuscitation technique including endotracheal intubation and manual ventilation with high FiO2.|Upon the pharyngeal oxygen setting, this classic NIV operation was performed as per our protocol illustrated in the following steps. Firmly closed the mouth, then intermittently applied: a) assisted inspiration by nose-closure accompanied with cricoid depression; and b) assisted expiration by the release of above nose and cricoid maneuver, and simultaneous doing abdomen-compression. The above assisted ventilation cycle was performed at a rate of 0-20 cycles per minute. The bronchoscopist optionally executed both the FB and the nose- closure and release, whereas an assistant delivered the abdomen-compression.||||
1294609|NCT03666390|Randomized|Parallel Assignment||Treatment||Quadruple||0.5mg/kg vs. active placebo (0.045mg/kg Midazolam)|t|t|t|t
1294610|NCT03666377|Randomized|Parallel Assignment||Treatment||Single||This study is a prospective randomized, controlled trial.||||t
1294611|NCT03666364|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1294612|NCT03666351|Randomized|Parallel Assignment||Treatment||Single||A prospective, multicentre, randomized, open label, evaluator-blind study||||t
1294613|NCT03666338|Randomized|Parallel Assignment||Treatment||Single||||||t
1294614|NCT03666325||Single Group Assignment||Treatment||None (Open Label)||||||
1294615|NCT03666312|||Cohort||Prospective|||||||
1294616|NCT03666299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294617|NCT03666286|||Cohort||Prospective|||||||
1294623|NCT03666208||Single Group Assignment||Treatment||None (Open Label)||"This is a phase 2, pilot clinical trial to investigate the effect of SCB on thrombosed AVG. Specifically, we are focusing on AVG as they have a higher thrombosis rate than AVF and the patency rate even after successful thrombolysis is much lower than AVF. As neointimal hyperplasia is the predominant cause for stenosis at the graft vein junction, treatment with Sirolimus will intuitively delay the recurrence of neo-intimal hyperplasia and result in better patency of the AVG after successful thrombolysis.~Patients with ESRD presenting with a thrombosed AVG between June 2018 and December 2018 will be screened for suitability. Eligible patients of at least 21 years of age will be offered participation. The potential benefits and risks of SCB will be explained and informed consent obtained from participants. A total of 20 patients will be recruited for the trial and they will be followed up for 6 months after the interventions."||||
1294624|NCT03666195|Randomized|Parallel Assignment||Prevention||Double|"The outcome assessor will be blinded as well as the statistician and the participant.~The outcome assessor will count the bacterial colony forming units without knowing the type of the denture material used (Conventional acrylic resin or acrylic resin modified by titanium dioxide nanoparticles)"|Randomized controlled trial|t|||t
1294625|NCT03666182|||Cohort||Cross-Sectional|||||||
1294626|NCT03666169|||Cohort||Cross-Sectional|||||||
1294627|NCT03666156|||Cohort||Cross-Sectional|||||||
1294628|NCT03666143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294629|NCT03666130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294630|NCT03666117|||Cohort||Prospective|||||||
1294631|NCT03666104|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294632|NCT03666091|||Cohort||Prospective|||||||
1294633|NCT03666078|||Case-Only||Cross-Sectional|||||||
1294634|NCT03666065|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1294635|NCT03666052|||Case-Only||Other|||||||
1294636|NCT03666039|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1294637|NCT03666026|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1294638|NCT03666013|||Other||Cross-Sectional|||||||
1294639|NCT03666000||Single Group Assignment||Treatment||None (Open Label)||||||
1294640|NCT03665987|||Cohort||Prospective|||||||
1294641|NCT03665974|||Case-Control||Cross-Sectional|||||||
1294642|NCT03665961|||Case-Control||Cross-Sectional|||||||
1294643|NCT03665948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294644|NCT03665935|||Case-Only||Cross-Sectional|||||||
1294645|NCT03665922|Randomized|Parallel Assignment||Basic Science||Triple||Double-blind randomized placebo controlled design|t||t|t
1294646|NCT03665909|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1294647|NCT03665896|Randomized|Parallel Assignment||Treatment||Single|||t|||
1294648|NCT03665883|Randomized|Parallel Assignment||Treatment||Triple|Patients, assessors and investigators will be blinded on patient group.|the effect on seroma formation and output of pre-peritoneal drain after TEP by monoploar diathermy or blunt dissection approach will be studied|t||t|t
1294649|NCT03665870||Single Group Assignment||Prevention||None (Open Label)||Single arm pre-post study.||||
1294650|NCT03665857|Randomized|Parallel Assignment||Prevention||Single|The assessors measuring childrens' weight and height will be blinded at follow-up phases.|||||t
1294651|NCT03665844|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||1 week baseline, 3 weeks active condition||||
1294652|NCT03665831|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294653|NCT03665818|Randomized|Parallel Assignment||Treatment||Single||||||t
1294654|NCT03665805|||Cohort||Prospective|||||||
1294655|NCT03665792|||Other||Cross-Sectional|||||||
1294656|NCT03665779|Randomized|Parallel Assignment||Supportive Care||Double|A double-blind study is one in which neither the participants nor the experimenters know who is receiving a particular treatment. This procedure is utilized to prevent bias in research results. Double-blind studies are particularly useful for preventing bias due to demand characteristics or the placebo effect. In a double-blind study, the investigators who interact with the participants would not know who was receiving the actual drug and who was receiving a placebo.|"The patients will be divided into 2 groups:~Group 1:~70 pregnant females, induction of labor will be done by Intra vaginal isosorbide mono nitrate (Effox 40 mg MINAPHARM)~Group 2:~70 pregnant females, induction will be done by placebo (pyridoxine) administered in the posterior vaginal fornix."|t||t|
1294657|NCT03665766|||Cohort||Prospective|||||||
1294658|NCT03665753|Randomized|Sequential Assignment||Treatment||Quadruple||Dose escalation study.|t|t|t|t
1294659|NCT03665740|Randomized|Parallel Assignment||Treatment||Quadruple|double blind|Randomized Double-blind Placebo controlled, intent-to-treat|t|t|t|t
1294660|NCT03665727|Randomized|Parallel Assignment||Treatment||Double|Clinical assessors will be masked at postoperative follow-up||t|||t
1294661|NCT03665714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294662|NCT03665701||Single Group Assignment||Basic Science||None (Open Label)||||||
1294663|NCT03665688|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1294664|NCT03665675||Single Group Assignment||Treatment||None (Open Label)||||||
1294665|NCT03665662|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1294666|NCT03665649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294667|NCT03665636||Single Group Assignment||Treatment||None (Open Label)||This study is an interventional, open-label, feasibility pilot project to study the safety, efficacy, and tolerability of triheptanoin in patients with GSD I.||||
1294668|NCT03665623|||Cohort||Prospective|||||||
1294669|NCT03665610|||Other||Prospective|||||||
1294670|NCT03665597|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1294671|NCT03665584|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1294672|NCT03665571|||Case-Control||Prospective|||||||
1294673|NCT03665558|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1294674|NCT03665545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294675|NCT03665532|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1573308|NCT00001672||||||||||||
1294678|NCT03665493|Non-Randomized|Factorial Assignment||Basic Science||Triple||"Both groups of patients will perform the stop-signal task and the go-only task under two conditions: a) ON Levodopa medication state calculated after the first-morning dose which normally allowed the patient to attain the best control of symptoms (4) b) OFF Levodopa medication state. i.e patients did not take medications overnight prior to the study (19). Experimental conditions will be counterbalanced across patients and administered in two different experimental sessions occurring on different days.~Healthy controls will perform the stop signal task and the go-only task in the same day. The order of administration will be counterbalanced."|t|t||t
1294679|NCT03665480|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1294680|NCT03665467|||Cohort||Prospective|||||||
1294681|NCT03665454|Randomized|Crossover Assignment||Treatment||Quadruple|Investigational Drug Services, which is the investigational drug pharmacy at Hershey Medical Center, will be preparing and dispensing the drug. They will be the only party that is unblinded. Pfizer will provide placebo pills that are identical in appearance to the PF-06412562 study drug. The standard of care treatment, carbidopa/levodopa, is different in appearance to PF-06412562 and its corresponding matching placebo. In order to blind for this, Investigational Drug Services will encapsulate the carbidopa/levodopa pills. Thus, subjects may receive either an encapsulated carbidopa/levodopa pill or an empty non-active capsule, depending on the treatment arm and dosing they are scheduled to receive.|Subjects will participate in study for 2 consecutive weeks. Days 2-3 of Week 1, they will be blindly and randomly assigned to one of two treatment arms (study drug PF-06412562 or standard of care carbidopa/levodopa). Whichever treatment arm they did not receive during Week 1, they will receive during Days 2-3 of Week 2.|t|t|t|t
1294682|NCT03665441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294683|NCT03665428|Randomized|Parallel Assignment||Treatment||None (Open Label)||PAMB group (modified quadruple therapy) vs. PBMT group (bismuth-containing quadruple therapy)||||
1294684|NCT03665415|Randomized|Parallel Assignment||Prevention||Double|Participants cannot be blinded to assignment. Objective outcomes (physical activity, height, weight, blood pressure) will be collected by masked assessors. The primary investigator and all data analysts will be blinded to participant assignment.|The project will be carried out in three phases: 1) Formative research to implement the intervention with n=6 youth in order to make any modifications necessary before embarking on the full pilot in both sites in the next phase; 2) The pilot intervention comprised of a randomized wait-list controlled pilot intervention at two sites (school and clinic) during the school year; 3) an unsupported follow up period where participants in the school-based intervention will be offered the intervention during the summer months without school staff support. Wait-listed school site participants will also receive the unsupported intervention in this phase.|||t|t
1294685|NCT03665402|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294686|NCT03665389||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294687|NCT03665376|Randomized|Parallel Assignment||Supportive Care||Single||Participants were randomly allocated into two arms: intervention arm (ERAS) and control arm||||t
1294688|NCT03665363|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1294689|NCT03665350|Randomized|Parallel Assignment||Treatment||Single|"Insulin-HF is a randomized, open-label, controlled, multicenter (PROBE design, prospective Randomized Open Trial with Blinded Evaluation of Outcomes), and central adjudication of adverse events.~All study events, clinical and laboratory, will be independently validated by an Event Committee"|"The primary endpoint, glucose variability, will be computed from 3 daily glucose profiles performed before the baseline, 1, 6, 12 mo follow-up and at end study visit and calculated as the average of the three daily standard deviations. Blood glucose values will be reported by the patient in an ad hoc form and the responsible physician will input this data in the e-CRF.~An intensive ambulatory self-monitoring of weekly body weight and possible changes in diuretic treatment is required.~At 1, 6, 12 mo of follow up and/or at end of study visit:~patients will be examined,~the information about clinical events will be collected.~natriuretic peptide plasma concentration, HbA1c and urinary albumin excretion will be measured Echocardiographic evaluation will be done at baseline, 1 and 12 mo after randomization.~Central randomization in a 1:1 ratio will be performed by a web-based system."||||t
1294690|NCT03665337|Randomized|Parallel Assignment||Treatment||Triple|Participants are asked to refrain from mentioning any information about the treatment they receive when interacting with the investigator or outcomes assessors||t||t|t
1294691|NCT03665324|||Case-Control||Retrospective|||||||
1294692|NCT03665311|Randomized|Parallel Assignment||Treatment||Quadruple|The packaging for normal saline and 25% albumin will be identical (glass bottles) and be covered. The intravenous tubing will have an opaque sleeve to mask any colour discrepancy in the 2 products|A randomized controlled trial with two parallel arms 1:1|t|t|t|t
1294693|NCT03665298||Single Group Assignment||Treatment||None (Open Label)||||||
1294694|NCT03665285||Single Group Assignment||Treatment||None (Open Label)||||||
1294695|NCT03665272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294696|NCT03665259|Randomized|Parallel Assignment||Prevention||Double|"The anesthetist who in-charge of the induction of anesthesia is aware of the treatment oxygen concentration.~The patient is unaware of oxygen concentration during the induction of anesthesia.~The outcomes assessors is unaware of the concentration of oxygen treatment."|Group 1: pre-oxygenation with 100% oxygen during induction of anesthesia Group 2: pre-oxygenation with 60% oxygen during induction of anesthesia|t|||t
1294697|NCT03665246|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The present study is a cluster randomized trial (CRT) of 32 program groups with 16 groups randomly assigned to receive the intervention program (iMBC/ECD + C-PrES) and 16 groups randomly assigned to receive the control program (C-PrES only).The main reason for including randomization is to reduce the risk of selection bias. The unit of inference for this CRT is at the individual level but the unit of randomization is the C-PrES group (cluster) level due to issues of program feasibility.||||
1294698|NCT03665233|Randomized|Parallel Assignment||Treatment||Single|||||t|
1294699|NCT03665220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294700|NCT03665207|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294743|NCT03664648|||Case-Only||Prospective|||||||
1294744|NCT03664635|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1296213|NCT03645538|||Other||Cross-Sectional|||||||
1294701|NCT03665194|Randomized|Parallel Assignment||Other||Double||Thirty-two volunteers will be enrolled and evaluated (i.e. complete the study). Subjects will be dosed in four groups of eight (purely for logistical reasons relating to the procedure times expected with dosing and ECG). Volunteers will receive either the active drug or matching placebo in a 3:1 ratio. Therefore within each cohort, six volunteers will receive the active drug and two will receive matching placebo.|t||t|
1294702|NCT03665181|||Case-Control||Prospective|||||||
1294703|NCT03665168|||Case-Only||Cross-Sectional|||||||
1294704|NCT03665155||Single Group Assignment||Diagnostic||None (Open Label)||This is a phase I/II study with the goal to assess the feasibility of using the anti-CD38 monoclonal antibody daratumumab, labeled with Zirconium-89 (89Zr ) through deferoxamine (DFO), known as 89Zr-DFO-daratumumab, for PET imaging of multiple myeloma.||||
1294705|NCT03665142|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients were randomly divided into 2 groups. A randomized list is prepared in a computer environment by a statistician for randomization. In this list, the odd numbers for the control group and the KT group were given double numbers. The group identification is printed on sequentially numbered cards placed in sealed envelopes. After enrollment, the numbered envelope was opened by the patient and the blind investigator.||||
1294706|NCT03665129|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1294707|NCT03665116|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1294708|NCT03665103|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1294709|NCT03665090|||Cohort||Prospective|||||||
1294710|NCT03665077|||Cohort||Prospective|||||||
1294711|NCT03665064|||Cohort||Retrospective|||||||
1294712|NCT03665051|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1294713|NCT03665038|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294714|NCT03665025|Randomized|Parallel Assignment||Treatment||None (Open Label)||jumping gap area in aesthetic area||||
1294715|NCT03665012|||Cohort||Prospective|||||||
1294716|NCT03664999|||Cohort||Prospective|||||||
1294717|NCT03664986|Randomized|Parallel Assignment||Treatment||Single|The group you get randomized to will be chosen by chance, like flipping a coin. Neither you nor the study doctor will choose what group you will be in. You will have an equal chance of being in either group. Neither you nor the nurses nor anesthesiologist will know which group you will be in. However, your study doctor will know.||t|||
1294718|NCT03664973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294719|NCT03664960||Single Group Assignment||Treatment||None (Open Label)||||||
1294720|NCT03664947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294721|NCT03664934|Non-Randomized|Parallel Assignment||Diagnostic||Single|Outcome assessor blinded if a patient or a healthy control|||||t
1294722|NCT03664921|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1294723|NCT03664908|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1294724|NCT03664895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294725|NCT03664882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294726|NCT03664869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294727|NCT03664856||Single Group Assignment||Other||None (Open Label)||||||
1294728|NCT03664843|||Case-Only||Prospective|||||||
1294729|NCT03664830||Single Group Assignment||Treatment||None (Open Label)||Each SCD research participant will receive up to two subcutaneous injections of plerixafor (starting dose level: 240 µg/kg/dose)||||
1294730|NCT03664817|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Prospective, Randomized, Controlled||||
1294731|NCT03664804||Single Group Assignment||Other||None (Open Label)||||||
1294732|NCT03664791|||Cohort||Prospective|||||||
1294733|NCT03664778|||Other||Prospective|||||||
1294734|NCT03664765|Randomized|Parallel Assignment||Treatment||Double|Participants will be randomized and blinded to the intervention arm (upper airway and respiratory muscle training arm) versus sham arm|Randomized controlled pilot trial to assess the feasibility of using combined oropharyngeal and respiratory muscle training versus sham training on OSA in patients with chronic SCI/D|t|||t
1294735|NCT03664752|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) As a double-blinded study, the investigators, the site staff, the sponsor, and the clinical monitors will not be aware of the treatment assigned to the individual study subjects|Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study|t|t|t|t
1294736|NCT03664739|Randomized|Parallel Assignment||Treatment||Quadruple|As a double-blinded study, the investigators, the site staff, the sponsor, and the clinical monitors will not be aware of the treatment assigned to the individual study subjects|Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study|t|t|t|t
1294737|NCT03664726|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants will be assigned to complete an episodic future or recent thinking task and asked to describe positive events for different time periods.||||
1294738|NCT03664713|Randomized|Parallel Assignment||Treatment||Single|Evaluators will be blind to treatment. Participants cannot be blind to treatment due to the impossibility of creating a sham alternative to EMDR therapy, due to its use of bilateral stimulation.|The project will be carried out in the sub-acute and long-stay inpatient wards of Parc de Salut Mar, Institute of Neuropsychiatry and Addiction (INAD), located in the Centre Forum. It consists of a single-blind RCT with two parallel branches, 1) individual therapy with EMDR and TAU, and 2) TAU only, with patients matched by age, sex, psychiatric diagnosis and premorbid IQ. Once the patient has been stabilized with psychotropic medication and has begun taking part in the psychosocial activities proposed by the unit, they will be offered the chance to receive 25 individual EMDR therapy sessions, each lasting 60 minutes. The patients will be evaluated at the beginning of their hospital stay, again when discharged from the unit and then at 6 and 12 month follow up.||||t
1294739|NCT03664700|||Cohort||Prospective|||||||
1294740|NCT03664687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294741|NCT03664674|Randomized|Parallel Assignment||Treatment||Triple||Randomized, Double-blind, Placebo-controlled, Multicenter|t||t|t
1294742|NCT03664661||Sequential Assignment||Treatment||None (Open Label)||||||
1294745|NCT03664622|Randomized|Parallel Assignment||Treatment||Double||ketamine versus morphine|t|||t
1294746|NCT03664609|||Other||Retrospective|||||||
1294747|NCT03664596|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294748|NCT03664583|Randomized|Parallel Assignment||Health Services Research||Triple||A cross-jurisdictional, multi-site implementation-effectiveness type II hybrid randomized controlled trial|t||t|t
1294749|NCT03664570|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Three-way crossover||||
1294750|NCT03664557||Single Group Assignment||Other||None (Open Label)||Open label feasibility study||||
1294751|NCT03664544||Sequential Assignment||Other||None (Open Label)||||||
1294752|NCT03664531|Randomized|Crossover Assignment||Other||Quadruple|The statistician will also be masked from the treatments.|Participants will be required to be on a gluten-free diet for a period of 3 weeks before starting the study. Participants will then be randomized to take muesli bars containing either purified gluten, non-purified gluten with amylase trypsin inhibitors, or nocebo for 1 week followed by 2 weeks of washout, and then repeated for the two remaining dietary challenges so that at the end all participants have been on all dietary challenges. At the beginning and end of each challenge period, participants will visit the clinic to be evaluated for changes in IBS symptoms.|t|t|t|t
1294753|NCT03664518||Single Group Assignment||Treatment||None (Open Label)||||||
1294754|NCT03664505|Randomized|Parallel Assignment||Treatment||Single|The patient receives two different burn garments and does not know which one was produced based on the scan data and which one on the manual measuring.||t|||
1294755|NCT03664492||Single Group Assignment||Other||None (Open Label)||The recruited group of parent will answer a pre-questionnaire, then watch an educational video, then answer a post-questionnaire. If they agree, these parent will be asked to complete a third questionnaire (retention questionnaire) 4 to 6 months later.||||
1294756|NCT03664479|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1294757|NCT03664466|Randomized|Crossover Assignment||Treatment||Triple|double-blind||t|t|t|
1294758|NCT03664453|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1294759|NCT03664440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294760|NCT03664427|||Case-Control||Retrospective|||||||
1294761|NCT03664414|Randomized|Parallel Assignment||Treatment||Double|Plaebo controlled|blinded,multicenter, randomized, pentoxifylline vs placebo controlled clinical trial. Time: two years after the enrollment of the last patient.|t||t|
1294762|NCT03664401|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||Prospective, randomized controlled, split mouth (within subject) non-inferiority, single-center trial.||||
1294763|NCT03664388|||Cohort||Retrospective|||||||
1294764|NCT03664375|Randomized|Parallel Assignment||Treatment||None (Open Label)||A total of 46 patients were recruited in the study using non-probability purposive sampling and were divided randomly into two equal groups; control and experimental group, by sealed envelope method. The experimental group received botulinum toxin A followed by task specific training, while the control group received only task-specific training for 12 weeks. Data was collected at baseline, after 4 weeks, 8 weeks and 12 weeks by using upper extremity items of Motor Assessment Scale and Fugl Meyer Assessment scale of upper limb, Stroke specific quality of Life, Arm dystonia Disability scale and WOLF Motor function test.||||
1294765|NCT03664362|Randomized|Parallel Assignment||Other||Double|||t||t|
1294766|NCT03664349|||Cohort||Prospective|||||||
1294767|NCT03664336|||Cohort||Retrospective|||||||
1294768|NCT03664323|||Cohort||Retrospective|||||||
1294769|NCT03664310|Randomized|Parallel Assignment||Treatment||Single|||t|||
1294770|NCT03664297||Single Group Assignment||Treatment||None (Open Label)||||||
1294771|NCT03664284|Randomized|Parallel Assignment||Treatment||Single||The investigators will randomize 105 patient on two arms. The control group receiving no disinfection of the subcutaneous tissue (A) and intervention group, receiving disinfection of the subcutaneous tissue (B).|t|||
1294772|NCT03664271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294773|NCT03664258|||Cohort||Prospective|||||||
1294774|NCT03664245|||Cohort||Prospective|||||||
1294775|NCT03664232|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294776|NCT03664219|Randomized|Single Group Assignment||Treatment||None (Open Label)||Atrophied posterior mandible||||
1294777|NCT03664206|||Case-Control||Cross-Sectional|||||||
1294778|NCT03664193||Single Group Assignment||Treatment||None (Open Label)||Male patients with a histologically confirmed diagnosis of non-metastatic prostate adenocarcinoma, meeting the inclusion and exclusion criteria below, and electing to undergo definitive radiation treatment with SBRT, will be eligible for participation in this study. Patients will receive 35 Gy in five fractions, in addition, patients will receive a simultaneous integrated boost from 0.5-2 Gy per fx for total dose 37.5, 40, 42.5 or 45 Gy. Patients will also have an option to have a rectal balloon or a rectal spacer prior to receiving radiation therapy. Gastrointestinal/genitourinary toxicities will be assessed at every visit, including quality of life questionnaires and EPIC scores will be assessed at the one month follow up visits.||||
1294779|NCT03664180|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294780|NCT03664167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294781|NCT03664154||Single Group Assignment||Prevention||None (Open Label)||A one-group longitudinal repeated measures design. Data will be be collected at baseline, 8-weeks, Newborn Intensive Care Unit discharge, 2- and 4-months corrected age.||||
1294782|NCT03664141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294783|NCT03664128|||Cohort||Prospective|||||||
1294784|NCT03664115|Randomized|Parallel Assignment||Treatment||None (Open Label)||Interventional, Randomized, Controlled, Prospective, Open label, Phase II study.||||
1294785|NCT03664102|||Cohort||Retrospective|||||||
1294786|NCT03664089|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294787|NCT03664076|||Case-Only||Cross-Sectional|||||||
1294788|NCT03664063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294789|NCT03664050|Randomized|Parallel Assignment||Treatment||Single||||||t
1294790|NCT03664037|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1573309|NCT00001669||||Treatment||||||||
1294791|NCT03664024||Single Group Assignment||Treatment||None (Open Label)||||||
1294792|NCT03664011|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1294793|NCT03663998|Randomized|Sequential Assignment||Prevention||None (Open Label)|There will be no blinding|Groups A-F will be recruited sequentially, groups G and H once the optimal dose for IM has been determined, and group I selecting the optimal doses for IM and ID form groups A-F for combined administration. This will represent a divided dose group across two different anatomical sites. Each group will receive four vaccinations (at 0, 4, 8 and 12 weeks). The choice of four vaccinations is based on the observation that antibody responses to DNA vaccination in mice plateau after the fourth vaccination, while in rabbits after the third. Hence it is unclear where they may plateau in humans.||||
1294794|NCT03663985|||Ecologic or Community||Prospective|||||||
1294795|NCT03663972|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Young children (age 4-5) and Old children (age 7-8) will be enrolled in either a Motoric behavioral treatment arm or phonological treatment arm.||||
1294796|NCT03663959|||Cohort||Retrospective|||||||
1294797|NCT03663946|||Cohort||Prospective|||||||
1294798|NCT03663933|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294799|NCT03663920|||Cohort||Prospective|||||||
1294800|NCT03663907|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1294801|NCT03663894|||Cohort||Retrospective|||||||
1294802|NCT03663881||Single Group Assignment||Treatment||None (Open Label)||Open-label, single arm, Phase 1 study. 24 participants are anticipated, assuming that 6 participants are recruited in each of the levels of dose titration based on the 3 +3 design.||||
1294803|NCT03663868|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1294804|NCT03663855||Crossover Assignment||Treatment||None (Open Label)||||||
1294805|NCT03663842||Single Group Assignment||Treatment||None (Open Label)||||||
1294806|NCT03663829|||Cohort||Retrospective|||||||
1294807|NCT03663816||Single Group Assignment||Other||None (Open Label)||||||
1294808|NCT03663803|Randomized|Parallel Assignment||Prevention||Single||||||t
1294809|NCT03663790|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1294810|NCT03663777|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294811|NCT03663764||Single Group Assignment||Treatment||None (Open Label)||||||
1294812|NCT03663751||Single Group Assignment||Treatment||None (Open Label)||||||
1294813|NCT03663738|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1294814|NCT03663725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294815|NCT03663712||Single Group Assignment||Treatment||None (Open Label)||||||
1294816|NCT03663699|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294817|NCT03663686|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1294818|NCT03663673||Single Group Assignment||Treatment||None (Open Label)||Prospective, single center, clinical pilot study to test the hypothesis that lipid rich EpiCeram® is superior in improving skin barrier function compared to Aveeno Daily Moisturising Sheer Hydration Lotion®.||||
1294819|NCT03663660|||Cohort||Retrospective|||||||
1294820|NCT03663647|||Cohort||Retrospective|||||||
1294821|NCT03663634|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1294822|NCT03663621|||Cohort||Prospective|||||||
1294823|NCT03663608|||Cohort||Prospective|||||||
1294824|NCT03663595|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294825|NCT03663582||Single Group Assignment||Treatment||None (Open Label)||||||
1294826|NCT03663569|||Other||Prospective|||||||
1294827|NCT03663556|||Case-Only||Prospective|||||||
1294828|NCT03663543|Randomized|Parallel Assignment||Treatment||Triple||Parallel: Participants are assigned to one of two or more groups in parallel for the duration of the study|t|t|t|
1294829|NCT03663530|Randomized|Crossover Assignment||Prevention||None (Open Label)|Participants will be masked to the true outcomes of the study.|This is a 2-period crossover study in which sleep is identical in duration and timing but meals/food intake is varied relative to the sleep episode.||||
1294830|NCT03663517|||Ecologic or Community||Prospective|||||||
1294831|NCT03663504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294832|NCT03663491|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1294833|NCT03663478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294834|NCT03663465|Non-Randomized|Parallel Assignment||Prevention||Double|two groups of participants and investigator|case control study|t||t|
1294835|NCT03663452|Randomized|Sequential Assignment||Health Services Research||Single||This project will use a cluster-randomized stepped wedge design in nine MHS behavioral health outpatient clinics. All sites first receive PE training, and are randomly allocated to receive the TACTICS intervention either 5, 10, or 15 months later.||||t
1294836|NCT03663439|Randomized|Parallel Assignment||Treatment||Single|control group (modified shell technique) study group (onlay bone graft)|control group (modified shell technique) study group (onlay bone graft)||||t
1294837|NCT03663426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294838|NCT03663413|||Cohort||Prospective|||||||
1294839|NCT03663400|||Cohort||Prospective|||||||
1294840|NCT03663387|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1294841|NCT03663374|Randomized|Parallel Assignment||Treatment||Double||All eligible patients were randomized into two groups to receive investigational drug or placebo at ratio 1:1|t||t|
1294842|NCT03663361|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294843|NCT03663348|||Cohort||Prospective|||||||
1294844|NCT03663335|Randomized|Parallel Assignment||Treatment||Triple||Study CCFZ533A2201 is a randomized, 12-month, active-controlled, partially-blinded, multicenter, dose range finding study to evaluate the efficacy, safety, tolerability, PK and PD of CFZ533 in 2 different cohorts, as compared to standard of care comprised of tacrolimus, MMF and corticosteroids.|t|t|t|
1294845|NCT03663322|Randomized|Parallel Assignment||Treatment||Double|Participants and outcomes assessor will be blinded to the arm the participants have been randomly assigned||t|||t
1294846|NCT03663309|||Other||Prospective|||||||
1294848|NCT03663283|Randomized|Parallel Assignment||Treatment||Quadruple|The pharmacist will prepare, and dispense the medication sequentially. Medication syringes will be blinded utilizing black tape. Patients, care team in recovery, study team members collecting and recording data, and statisticians will be blinded to randomization assignment. All patients will be documented in EMR as receiving liposomal bupivacaine to ensure the blind is maintained and to ensure that safety features in the EMR for all patients receiving liposomal bupivacaine are activated. Further, all additional standard precautionary measures (e.g. wrist band) will be similarly implemented for both patient groups.||t|t|t|t
1294849|NCT03663270|Randomized|Parallel Assignment||Treatment||Triple|Computer generated random list|Randomized two arm study with two groups|t|t||t
1294850|NCT03663257|||Cohort||Prospective|||||||
1294851|NCT03663244|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1294852|NCT03663231|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1294853|NCT03663218||Single Group Assignment||Treatment||None (Open Label)||This is a modified dose escalation study. The first 3 patients will be given 5 Gy for five days. If all 3 patients do not have an unacceptable dose limiting toxicity, another 3 patients will be given 6 Gy for 5 days. If all 3 do not have an unacceptable dose limiting toxicity, another 3 will be given 7 Gy, and finally 8 Gy. If all 3 patients given 8 Gy do not have an unacceptable dose limiting toxicity, an additional 7 patients will be recruited at this dose. If at any point a patient develops an unacceptable dose limiting toxicity, recruitment at the current dose will immediately stop and an additional 7 patients will be recruited at a dose 1 Gy lower. If any of these additional patients develop an unacceptable dose limiting toxicity, an additional 7 will be recruited at an even lower dose.||||
1294854|NCT03663205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294855|NCT03663192|||Cohort||Prospective|||||||
1294856|NCT03663179|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1294857|NCT03663166|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1294858|NCT03663153|||Other||Prospective|||||||
1294859|NCT03663140|||Case-Control||Cross-Sectional|||||||
1294860|NCT03663127|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1294861|NCT03663114|||Other||Prospective|||||||
1294862|NCT03663101|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294863|NCT03663088|Randomized|Parallel Assignment||Treatment||Single||||||t
1294864|NCT03663075|Randomized|Factorial Assignment||Treatment||None (Open Label)|This study evaluated the effect of groups sessions or individual support. This is not a pill so it is impossible to mask participants.|Two factor design evaluating two separate treatment modalities||||
1294865|NCT03663062|||Cohort||Prospective|||||||
1294866|NCT03663049|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Two arms in the study. Patients will be randomized to either continue medication in the statin group or discontinue.||||
1294867|NCT03663036||Single Group Assignment||Treatment||None (Open Label)||||||
1294868|NCT03663023|||Cohort||Retrospective|||||||
1294869|NCT03663010||||||||||||
1294870|NCT03662997|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a prospective RCT using a crossover design to evaluate safety and efficacy. The study will be conducted in an outpatient setting of an academic clinical center. There will be two participant groups: those with VLU and those with DFU. Approximately 50% of the participants will be in the VLU group and 50% of the participants in the DFU group. Treatment sequence will be randomized so that a fair distribution is achieved. Each participant will receive a 2-week treatment with one of the three dressings followed by a 2-week treatment period with a second dressing (i.e. each participant will receive treatment with two different dressings, either the Bordered Five-Layer Foam Dressing and the Hydropolymer Foam Dressing, or the Bordered Five-Layer Foam Dressing and the Hydrocellular Multi-Layer Foam Dressing) using a cross-over (repeated measures) design, with a total of four study arms.||||
1294871|NCT03662984|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1294872|NCT03662971|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1294873|NCT03662958|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294874|NCT03662945|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||1 intervention group and 1 control group||||
1294875|NCT03662932||Single Group Assignment||Treatment||None (Open Label)||All the included participants receive the intervention||||
1294876|NCT03662919|||Cohort||Prospective|||||||
1294877|NCT03662906|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1294878|NCT03662893|Randomized|Parallel Assignment||Treatment||Single|Analysis of treatment response was performed by a single independent urologist blinded to the study groups.|Group I were instructed to apply only written guideline forms of behavioural therapy which were the same as those in the checklist, Group II were instructed to apply behavioural therapy with a written checklist for patients to fully complete and Group III received medical treatment plus behavioural therapy without checklist. Group IV received medical treatment with a written checklist to fully complete||||t
1294879|NCT03662880||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294880|NCT03662867|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1294881|NCT03662854|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinding|Placebo-controlled study|t|t|t|t
1294882|NCT03662841||Single Group Assignment||Treatment||None (Open Label)||Use of ACE for HCC of size > 10cm||||
1294883|NCT03662828|||Cohort||Retrospective|||||||
1294884|NCT03662815||Single Group Assignment||Treatment||None (Open Label)||||||
1294885|NCT03662802|||Cohort||Other|||||||
1294886|NCT03662789|Randomized|Parallel Assignment||Treatment||Quadruple|Opaque envelopes, infusion administered by third party, concealed infusion|Randomized, placebo controlled, parallel group, double blind design|t|t|t|t
1294887|NCT03662776|||Case-Crossover||Prospective|||||||
1294888|NCT03662763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294889|NCT03662750||Single Group Assignment||Basic Science||None (Open Label)||Exploratory, prospective, natural history, imaging cohort study||||
1294890|NCT03662737|||Case-Control||Prospective|||||||
1294891|NCT03662724|||Cohort||Other|||||||
1294892|NCT03662711|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1294893|NCT03662698|Randomized|Parallel Assignment||Supportive Care||Single|Due to study design, it is not possible to blind either participants or investigators to study condition. However, the biostatistician will be blinded to participant group to minimize bias in analyzing the data.|Participants will be randomized to the guided imagery intervention or to treatment as usual.||||t
1294894|NCT03662685|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1294895|NCT03662672|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1294896|NCT03662659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294897|NCT03662646|||Case-Control||Cross-Sectional|||||||
1294898|NCT03662633|||Case-Control||Prospective|||||||
1294899|NCT03662620|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized, open-label, single-dose, 2-treatment, 2-sequence, 4-period replicate crossover design||||
1294900|NCT03662607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294901|NCT03662594||Single Group Assignment||Supportive Care||None (Open Label)||||||
1294902|NCT03662581||Single Group Assignment||Treatment||None (Open Label)||This study evaluates the effect of the intervention using a single group, before-after study model. The subjects will be evaluated at baseline and followed longitudinally, until study completion and a long-term followup.||||
1294903|NCT03662568|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1294904|NCT03662555|Randomized|Parallel Assignment||Treatment||None (Open Label)||"In a multi-arm parallel randomised controlled trial design. The randomisation scheme will be generated via online software (http://www.randomization.com). Participants will be recruited to 6 weeks of training, 3 sessions a week and randomised to one of three groups.~Group 1, participants will undergo NMES and BFR (80% pressure) applied to the quadriceps for 25 min.~Group 2, participants will undergo NMES and BFR (40% pressure) applied to the quadriceps for 25 min.~Group 3, participants will undergo NMES alone (Control) applied to the quadriceps for 25 min."||||
1294905|NCT03662542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294906|NCT03662529|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants were effectively block-randomized either into individual treatment as usual (TAU)(practitioners who administered TAU) OR individual therapy with the study intervention (Mind Freedom Plan), where data from both arms was collected in parallel.||||
1294907|NCT03662516|Randomized|Crossover Assignment||Other||None (Open Label)||"Natural log transformed AUCinf, AUClast, and Cmax of EE and LN will be analyzed separately using a mixed effect model with sequence, period and treatment as fixed effects and subject within sequence as a random effect. Estimates of the adjusted mean differences (Test Reference) and corresponding 90% CIs will be obtained from the model. The adjusted mean differences and 90% CIs for the differences will be exponentiated to provide estimates of the ratio of adjusted geometric means (Test/Reference) and 90% CIs for the ratios. OC (EE and LN) alone will be the Reference treatment, while the OC (EE and LN) coadministered with PF 04965842 will be the Test treatment.~The absent of an effect of PF 04965842 on OC (EE and LN) will be concluded if the lower bound of 90% confidence interval for the ratio of adjusted geometric mean for AUCinf is ≥80%."||||
1294908|NCT03662503|||Cohort||Retrospective|||||||
1294909|NCT03662490|||Cohort||Retrospective|||||||
1294910|NCT03662477|Randomized|Single Group Assignment||Treatment||Single|||t|||
1294911|NCT03662464|||Cohort||Prospective|||||||
1294912|NCT03662451|Randomized|Parallel Assignment||Treatment||None (Open Label)||Women are randomized to either robotic single site or multi site hysterectomy||||
1294913|NCT03662438||Single Group Assignment||Treatment||None (Open Label)||This is a self-controlled study where participants will serve as their own controls. Physical activity levels and quality of life will be measured before and after a 10 week home-based exercise program.||||
1294914|NCT03662425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294915|NCT03662412||Single Group Assignment||Treatment||None (Open Label)||||||
1294916|NCT03662399|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1294917|NCT03662386|||Cohort||Prospective|||||||
1294918|NCT03662373|||Cohort||Prospective|||||||
1294919|NCT03662360|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The enrolled patients will be randomized following the 4 blocks random schema (AABB, ABAB, BBAA, BABA, ABBA, BAAB).~A repetition of the first 4 blocks will be perform up to 32 patients:~AABB, ABAB, BBAA, BABA AABB, ABAB, BBAA, BABA"||||
1294920|NCT03662347|||Cohort||Prospective|||||||
1294921|NCT03662334|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1294922|NCT03662321|||Case-Control||Other|||||||
1294923|NCT03662308|Randomized|Crossover Assignment||Other||None (Open Label)||"After the heated vest has 1) been fully bench-tested and 2) satisfied safety and tolerability testing in able-bodied subjects, it will be tested in persons with tetraplegia using a crossover design with the order of the two visits randomized.~Thermal Challenge with heated vest (subjects with tetraplegia only): Subjects with tetraplegia, while seated and wearing only a standard T-shirt and shorts, will be fitted with an appropriately sized heated vest. Subjects will be transferred to a pre-cooled thermal chamber and data will be collected for up to 2 hours with the self-regulating heated vest.~Thermal Challenge with non-heated vest (subjects with tetraplegia only): The same subjects with tetraplegia (from Visit 2), while seated and wearing only a standard T-shirt and shorts, will be fitted with an appropriately sized, similar, but non-heated vest. Subjects will be transferred to a pre-cooled thermal chamber and data will be collected for up to 2 hours."||||
1294924|NCT03662295|||Case-Only||Prospective|||||||
1294925|NCT03662282||Single Group Assignment||Treatment||None (Open Label)||||||
1294926|NCT03662269|Randomized|Parallel Assignment||Treatment||Double||a randomized, double-blind, placebo-controlled trial|t||t|
1294974|NCT03661645|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, Randomized Controlled study||||
1294975|NCT03661632|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294976|NCT03661619|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294977|NCT03661606||Single Group Assignment||Basic Science||None (Open Label)||||||
1294978|NCT03661593|Randomized|Parallel Assignment||Other||Double|Masking done by a third person following computer randomization||||t|t
1295024|NCT03660995|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1294927|NCT03662256|Randomized|Parallel Assignment||Health Services Research||Single|The randomization assignments will be kept confidential within the study team until hearing screening day, when masking the referral process assignment to participants will no longer be possible. All outcome assessors, including audiologists and ear, nose, and throat (ENT) surgeons reading telemedicine consults within the Alaska Native healthcare system and study team members performing medical record abstraction, will be masked to intervention allocation throughout the trial. Study team members who read telemedicine consults as a part of their clinical responsibilities will abstain from reading any study-related consults. The results of the preschool screen, mHealth screen, and audiometric assessments will also be masked, such that study team members performing the mHealth screen or audiometric assessment will be masked to the other results.|||||t
1294928|NCT03662243|||Case-Only||Prospective|||||||
1294929|NCT03662230|||Cohort||Retrospective|||||||
1294930|NCT03662217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294931|NCT03662204|||Cohort||Cross-Sectional|||||||
1294932|NCT03662191|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1294933|NCT03662178|||Cohort||Other|||||||
1294934|NCT03662165|Randomized|Parallel Assignment||Screening||Single|Participants were not informed about the specific research question or the fact that they would be randomized to different HIV testing options in order to avoid bias.|We selected a sample of eligible truckers and randomized them on a 1:1:1 ratio to the three study arms. After completing the 2 month follow-up, we followed the same procedure with a sample of eligible female sex workers.|t|||
1294935|NCT03662152|Randomized|Parallel Assignment||Treatment||Single|Assessor of data was blinded to statistics investigator|||||t
1294936|NCT03662139|||Case-Control||Prospective|||||||
1294937|NCT03662126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294938|NCT03662113|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1294939|NCT03662100|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1294940|NCT03662087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294941|NCT03662074||Single Group Assignment||Treatment||None (Open Label)||||||
1294942|NCT03662061|||Cohort||Prospective|||||||
1294943|NCT03662048|Randomized|Parallel Assignment||Prevention||Single|2 month photographs will be evaluated by study team members blinded to the study group.|||t||
1294944|NCT03662035||Single Group Assignment||Treatment||None (Open Label)||||||
1294945|NCT03662022|Randomized|Parallel Assignment||Prevention||None (Open Label)||A cluster randomized trial in which villages are assigned to one of four intervention groups||||
1294946|NCT03662009|||Case-Control||Cross-Sectional|||||||
1294947|NCT03661996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294948|NCT03661983|Randomized|Parallel Assignment||Treatment||Quadruple||Subject randomized 1:1:1 to 1 of 3 double-blind treatment arms to evaluate safety and efficacy|t|t|t|t
1294949|NCT03661970|||Cohort||Prospective|||||||
1294950|NCT03661957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294951|NCT03661944|||Cohort||Prospective|||||||
1294952|NCT03661931||Single Group Assignment||Diagnostic||None (Open Label)||||||
1294953|NCT03661918|Randomized|Factorial Assignment||Other||Single||This study is a 2 x 2 x 2 randomized clinical trial. In addition to the 10 core coaching sessions, there will be three additional components available to participants, depending on the experimental condition to which they are randomized. These potential additional components include 1) the first session being conducted in person, 2) involving a second adult caregiver, and 3) a weekly weighing of child via WiFi-enabled scales.|t|||
1294954|NCT03661905|Randomized|Parallel Assignment||Treatment||Single|Intervention assessors will not know which participants have been assigned to the different interventions.|A two-arm parallel assignment where one group will receive Cognitive therapy, and the other group will receive ERP.||||t
1294955|NCT03661892||Single Group Assignment||Treatment||None (Open Label)||This a prospective single arm study enrolling patients (n=20) with bone metastases form breast cancer who have been on opioid therapy for bone pain for at least 4 weeks.||||
1294956|NCT03661879|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.|Five (5) cohorts are planned. In each cohort, subjects will be randomised in a 3:1 manner to receive either: 1) NNC9204-1706: 9 subjects or 2) Placebo (NNC9204-1706): 3 subjects|t|t|t|t
1294957|NCT03661866|||Cohort||Other|||||||
1294958|NCT03661853|Randomized|Parallel Assignment||Treatment||None (Open Label)||4 arms: 3 CBT microinterventions + control condition||||
1294959|NCT03661840|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants will be randomized to the acceptance and commitment therapy intervention or to treatment as usual.||||
1294960|NCT03661827||Single Group Assignment||Diagnostic||None (Open Label)|yES|||||
1294961|NCT03661814|Randomized|Parallel Assignment||Prevention||None (Open Label)||wo cohorts. Experimental group receives the study device and the control group receives the standard of care (No device). Patients are randomized to either group.||||
1294962|NCT03661801|||Other||Prospective|||||||
1294963|NCT03661788|Randomized|Crossover Assignment||Health Services Research||Triple|||t|t|t|
1294964|NCT03661775|Randomized|Factorial Assignment||Prevention||None (Open Label)||Factorial 2-by-2 open labeled randomised controlled trial||||
1294965|NCT03661762|||Cohort||Other|||||||
1294966|NCT03661749|Randomized|Parallel Assignment||Other||None (Open Label)||PR/CR urine collected by clean catch or non -clean catch technique will be compared in term pregnancy||||
1294967|NCT03661736|||Cohort||Prospective|||||||
1294968|NCT03661723|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294969|NCT03661710|||Cohort||Prospective|||||||
1294970|NCT03661697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1294971|NCT03661684|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Two groups. Condition group and Control group, both receiving the investigated medication using the same protocol||||
1294972|NCT03661671|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Parallel assignment||||
1294973|NCT03661658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1294979|NCT03661580|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a pragmatic, parallel group, randomised controlled trial assessing the efficacy of BA compared to treatment as usual (TAU) for patients with depression who are accessing Community Drugs and Alcohol Treatment.||||
1294980|NCT03661567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294981|NCT03661554||Single Group Assignment||Treatment||None (Open Label)|Clinical study of BCMA nano-antibody CAR-T cells in the treatment of refractory recurrent multiple myeloma (single center, single arm, open clinical study)|In this study, a 3 + 3 dose gradient climbing design was used. Three dosage groups, 5 x 106 / kg, 1 x 107 / kg and 1.5 x 107 / kg, were divided into three groups.||||
1294982|NCT03661541|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||"Subjects will be recruited in three groups, all of whom are infected with HSV-1, as shown by having IgG against HSV-1:~x Group A: 12 subjects with 6 or more herpes labialis outbreaks in the past 12 months x Group B: 12 subjects with 1 to 2 outbreaks in the past 12 months x Group C: 12 subjects with zero outbreaks in the past 12 months Subjects in group A will receive 2% SADBE dose on the arm after their initial blood samples are obtained. Group A subjects will have blood collected and tests repeated 2 and 8 weeks later.~Subjects in Groups B and C will be matched to the subjects in Group A so that demographic characteristics (i.e., gender distribution, age and weight) are within broadly similar ranges."||||
1294983|NCT03661528|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1294984|NCT03661515||Sequential Assignment||Treatment||None (Open Label)||||||
1294985|NCT03661502|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1294986|NCT03661489|Randomized|Parallel Assignment||Treatment||Single|||t|||
1294987|NCT03661476||Single Group Assignment||Treatment||None (Open Label)||||||
1294988|NCT03661463|Randomized|Parallel Assignment||Treatment||Single|The assessor of radiological outcomes will be blinded to which arm of the trial patients were randomised to.|2 Parallel Arms - one with the intervention (Aspirin 300mg OD), and one with no treatment. 29 patients each arm.||||t
1294989|NCT03661450|||Cohort||Prospective|||||||
1294990|NCT03661437|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1294991|NCT03661424||Single Group Assignment||Treatment||None (Open Label)||||||
1294992|NCT03661411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1294993|NCT03661398||Single Group Assignment||Treatment||None (Open Label)||||||
1294994|NCT03661385|Randomized|Parallel Assignment||Prevention||Quadruple|Perfusionist (operating bypass) is unblinded to randomisation. They will randomize patient in a computer base (REDcap).Randomization is blinded to all other staff and the nitric oxide container is draped. Nitric oxide container will be attached in all cases.|Double blinded, randomised controlled, parallel study comparing an intervention with a control.|t|t|t|t
1294995|NCT03661372|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized||||
1294996|NCT03661359||Single Group Assignment||Other||None (Open Label)||Each patient who consents will be given the community resource interventions which apply to them based on the results of the Social Determinants of Health Screening Tool.||||
1294997|NCT03661346|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1294998|NCT03661333||Single Group Assignment||Treatment||None (Open Label)||||||
1294999|NCT03661320|Randomized|Parallel Assignment||Treatment||Quadruple|partially blinded||t|t|t|t
1295000|NCT03661307||Single Group Assignment||Treatment||None (Open Label)||||||
1295001|NCT03661294||Single Group Assignment||Other||None (Open Label)||||||
1295002|NCT03661281||Single Group Assignment||Treatment||None (Open Label)||||||
1295003|NCT03661268||Single Group Assignment||Treatment||None (Open Label)||A bag of 500ml of normal saline is infused within 15 minutes using a bag pressurized to 300 mmHg. All other treatments, including maintenance fluids, dose of vasoactive agents and ventilator settings, remain unchanged during the study period.||||
1295004|NCT03661255|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The study will have a stepped wedge design with 3 cohorts (in successive years) of 3 villages each. In each village, we will collect baseline data and follow-up data on knowledge, attitudes, and behavior related to suicide prevention from participants and non-participants. Participants will also provide data on these topics after each learning circle they attend. Intervention participants will be self-selecting.||||
1295005|NCT03661242|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||The design is a quasi-experimental prospective double- cohort study in which a lead-in group will be enrolled and receive standard of care and an intervention group will be enrolled one year after the last lead-in patient is accrued. The intervention group will receive shared care with an oncologist and an exercise physiologist trained in providing activity and exercise guidelines to the cancer patient population.||||
1295006|NCT03661229|||Case-Only||Prospective|||||||
1295007|NCT03661216|Randomized|Crossover Assignment||Other||Quadruple|Double (participant and investigator) and outcomes assessor|Double-blind, randomized, placebo-controlled, cross-over study.|t|t|t|t
1295008|NCT03661203|||Cohort||Prospective|||||||
1295009|NCT03661190|Randomized|Parallel Assignment||Prevention||Single|||t|||
1295010|NCT03661177|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1295011|NCT03661164|||Cohort||Retrospective|||||||
1295012|NCT03661151|||Other||Prospective|||||||
1295013|NCT03661138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295014|NCT03661125|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1295015|NCT03661112|||Other||Prospective|||||||
1295016|NCT03661099|||Case-Only||Prospective|||||||
1295017|NCT03661086|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label randomized controlled parallel study||||
1295018|NCT03661073|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1295019|NCT03661060|||Cohort||Prospective|||||||
1295020|NCT03661047|Randomized|Parallel Assignment||Treatment||Quadruple||Double-blind, placebo-controlled, stratified, randomized clinical trial|t|t|t|t
1295021|NCT03661034|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multi-center, four-arm prospective dose-adjusting study (2 cohorts sequentially enrolled, each with 2 randomly assigned dose levels)||||
1295022|NCT03661021|||Case-Control||Prospective|||||||
1295027|NCT03660956|Randomized|Parallel Assignment||Prevention||Single||A Quasi-Experimental design is used in this study. Participants are randomly assigned to exercise and back counselling group or back counselling only group.||||t
1295028|NCT03660943|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295029|NCT03660930||Single Group Assignment||Treatment||None (Open Label)||||||
1295030|NCT03660917|Randomized|Parallel Assignment||Treatment||Double||We opted for a randomized, double-blind, placebo-controlled pilot trial with a lead-in phase. Moreover, the patients to be included in the placebo arm will receive riluzole during the last 6 months of study, so that all patients will undergo the active drug in the last phase of the study.|t|||t
1295031|NCT03660904|Randomized|Parallel Assignment||Basic Science||Double|only the investigator knew the procedure and the media provided for each case|"Group 1 blastocysts were vitrified with the Vit (home made) HM according to shady grove protocol using open system on cryotop vit. device and thawed with gradual thawing technique using HM thawing media according to Kuwayama protocol.~Group 2 blastocysts were cryopreserved with the Global Fast Freeze Kit using open system on cryotop vit. device and thawed using Global fast thaw kit. Blastocysts were assessed immediately for survival, subsequently cultured for 6-8 h, assessed for survival and expansion, then transferred and the percentages of Positive hCG, clinical pregnancy, implantation, multiple pregnancy and abortion were recorded."||t|t|
1295032|NCT03660891|||Case-Only||Prospective|||||||
1295033|NCT03660878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295034|NCT03660865|Randomized|Single Group Assignment||Treatment||None (Open Label)|Select post operative assessments will be performed on both the experimental and control eye by an examiner who will be masked to the eye assignments.|All subjects will receive the same treatment; however, each subject will have their eyes randomized to receive the experimental treatment in either the left/right eye. The control will then be assigned to the other.||||
1295035|NCT03660852|||Case-Control||Prospective|||||||
1295036|NCT03660839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295037|NCT03660826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295038|NCT03660813|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1295039|NCT03660800|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1295040|NCT03660787|Randomized|Parallel Assignment||Prevention||Double|"The present study was conducted as a double blind trial. Neither a medical investigator, nor patients had access to the treatment assignment code in order to ensure the maximum objective evaluation of the primary endpoint.~Blinding was performed in such a way that disclosing a randomization code of a certain subject excluded a disclosure of the code in general (i.e. the randomization code had no indication to the treatment group). However, there were no cases of the randomization code disclosure in the study"||t||t|
1295041|NCT03660774|||Ecologic or Community||Cross-Sectional|||||||
1295042|NCT03660761||Single Group Assignment||Treatment||None (Open Label)|Open Label (Subject)|single arm||||
1295043|NCT03660748|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study design is open label, single center, uncontrolled pilot study of 20 participants divided into 2 groups of 10; each group will receive a different dose of MET-3. Each group will have 4-6 females, 4-6 participants with BMI 30.0-34.9 kg/m² and the remainder with BMI 35-39.9 kg/m.||||
1295044|NCT03660735|||Other||Prospective|||||||
1295045|NCT03660722||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295046|NCT03660709|Randomized|Parallel Assignment||Prevention||Single||||||t
1295047|NCT03660696|||Family-Based||Cross-Sectional|||||||
1295048|NCT03660683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295049|NCT03660670|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295050|NCT03660657|Randomized|Parallel Assignment||Treatment||Quadruple|Masking of: patients, cardiologist and cardiac surgeons (clinical assessment), investigators obtaining other parameters (quality of life, biochemical and clinical parameters), investigators for statistical analysis|Standard treatment + ozone therapy (O3/O2) versus Standard treatment + oxygen (O2) as placebo|t|t|t|t
1295051|NCT03660644|Randomized|Parallel Assignment||Other||Single|Physiotherapists will be aware of the allocation of the programmes (not possible to blind) as they will be involved with delivering information/training of the intervention components. However, a researcher blinded to group allocation will perform the quantitative analysis.|||||t
1295052|NCT03660631|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patient subjects will participate in their office's randomization group (intervention or control) for the 1st 12 months of their participation. After 12 months, each patient subject in the control group will receive the study intervention for months 13-24. Patient subjects in the intervention will be followed by study pharmacists during months 13-24.||||
1295053|NCT03660618||Single Group Assignment||Treatment||None (Open Label)||||||
1295054|NCT03660605||Single Group Assignment||Treatment||None (Open Label)||||||
1295055|NCT03660592|||Case-Control||Prospective|||||||
1295056|NCT03660579|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1295057|NCT03660566|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1295058|NCT03660553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295059|NCT03660540|Randomized|Parallel Assignment||Prevention||Single|||||t|
1295060|NCT03660527|||Other||Cross-Sectional|||||||
1295061|NCT03660514|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The Jovenes Sanos study will take place in two urban clinics in Tijuana, Mexico for all clients receiving voluntary FP counseling. The intervention study will involve a matched cluster control trial. Two clinics will serve as the intervention sites.||||
1295062|NCT03660501|||Cohort||Prospective|||||||
1295063|NCT03660488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295064|NCT03660475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295065|NCT03660462|Randomized|Crossover Assignment||Treatment||Single|||t|||
1295066|NCT03660449||Single Group Assignment||Treatment||None (Open Label)||||||
1295067|NCT03660436||Single Group Assignment||Treatment||None (Open Label)||||||
1295068|NCT03660423|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295069|NCT03660410|||Cohort||Retrospective|||||||
1295070|NCT03660397|Randomized|Parallel Assignment||Treatment||Single||||||t
1295071|NCT03660384|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1295072|NCT03660371|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1295073|NCT03660358|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1295074|NCT03660345|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1295075|NCT03660332|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1295076|NCT03660319|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants randomized into two groups: Music Therapy Intervention (Environmental Music Therapy) and Control arm with no Music Therapy.||||
1295077|NCT03660306|||Cohort||Prospective|||||||
1295078|NCT03660293|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1295079|NCT03660280|Randomized|Parallel Assignment||Treatment||Quadruple||Intervention will be add-on specific probiotic to ongoing treatment with antidepressant medication or Cognitive Behavioral Therapy (CBT). Subjects will be randomized to placebo or probiotic. To assure a balanced subject recruitment, block randomization within strata (ongoing treatment with CBT, antidepressant or both) will be performed. Blood sampling and symptom rating scales will be completed at baseline, at weeks 4 and 8 (end of study). Feces will be collected at baseline and end of study. Biomarkers (from baseline, week 4 and week 8) will be analyzed after the study. Subjects will be recruited from outpatient or inpatient settings, Psychiatry Skåne or primary care clinics in Skåne, Sweden. Subjects will be recruited via clinical referrals, but also via ads.|t|t|t|t
1295080|NCT03660267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295081|NCT03660254|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1295082|NCT03660241||Parallel Assignment||Basic Science||None (Open Label)||Part 1 will be conducted. The 8 subjects from the renal impaired group will be recruited before recruiting the 8 subjects without renal impairment function in Part 1. After statistical evaluation of results from Part 1, Part 2 may be conducted.||||
1295083|NCT03660228||Single Group Assignment||Health Services Research||None (Open Label)||||||
1295084|NCT03660215|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295085|NCT03660202||Single Group Assignment||Treatment||None (Open Label)||||||
1295086|NCT03660189|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1295087|NCT03660176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295088|NCT03660163|||Cohort||Prospective|||||||
1295089|NCT03660150|||Cohort||Retrospective|||||||
1295090|NCT03660137||Single Group Assignment||Treatment||None (Open Label)||All patients will receive both RSL and MOLLI-guided lumpectomy surgery||||
1295091|NCT03660124||Single Group Assignment||Treatment||None (Open Label)||||||
1295092|NCT03660111||Single Group Assignment||Diagnostic||None (Open Label)|subjects will be assigned to their inclusion number|||||
1295093|NCT03660098|||Case-Only||Prospective|||||||
1295094|NCT03660085||Single Group Assignment||Supportive Care||None (Open Label)||||||
1295095|NCT03660072|||Cohort||Other|||||||
1295096|NCT03660059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295097|NCT03660046|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Prospective Open Label, Non Randomized cohort study||||
1295098|NCT03660033|Randomized|Single Group Assignment||Other||None (Open Label)||Participants will be invited to the mother-child simulation centre at CHU Sainte-Justine for a 60 minute simulation session during which they will complete two neonatal resuscitation scenarios (one of pulseless VT and the other of PEA). They will be randomized to either having access or not to ECG monitoring during the resuscitations.||||
1295099|NCT03660020|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1295100|NCT03660007|||Cohort||Other|||||||
1295101|NCT03659994|Randomized|Parallel Assignment||Other||Double|||t||t|
1295102|NCT03659981||Single Group Assignment||Other||None (Open Label)||||||
1295103|NCT03659968||Single Group Assignment||Other||None (Open Label)||||||
1295104|NCT03659955||Single Group Assignment||Treatment||None (Open Label)||Cross sectional study||||
1295105|NCT03659942|||Cohort||Prospective|||||||
1295106|NCT03659929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295107|NCT03659916||Single Group Assignment||Treatment||None (Open Label)||||||
1295108|NCT03659903|||Cohort||Retrospective|||||||
1295109|NCT03659890|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1295110|NCT03659877||Single Group Assignment||Other||None (Open Label)||||||
1295111|NCT03659864|Randomized|Crossover Assignment||Basic Science||Double|Participant and lead clinical fellow will be blinded. All staff involved in initial data generation will be blinded.|Cohort study with double blind randomised cross over design|t||t|
1295112|NCT03659851|||Case-Crossover||Cross-Sectional|||||||
1295113|NCT03659838|||Other||Cross-Sectional|||||||
1295114|NCT03659825|Randomized|Crossover Assignment||Basic Science||Double|Study drinks will be matched for taste and appearance. Investigator preparing and administering the drink will not carry out the testing.|Young healthy adults.|t||t|
1295115|NCT03659812|Randomized|Parallel Assignment||Other||Double|||t|t||
1295116|NCT03659799|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1295117|NCT03659786|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1295118|NCT03659773||Single Group Assignment||Prevention||None (Open Label)||||||
1295119|NCT03659760|Randomized|Parallel Assignment||Other||Single||prospective randomize|t|||
1295120|NCT03659747|Randomized|Crossover Assignment||Prevention||Quadruple||Crossover Assignment Randomized, double-blind, placebo-controlled, parallel-group study|t|t|t|t
1295121|NCT03659734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295122|NCT03659721|Randomized|Parallel Assignment||Prevention||Double|As the participants are offered extra support as the intervention neither participants nor care providers can be blinded. Outcome assessor and data analyst will be blinded.|The study is a prospective randomized controlled trial with two study arms: intervention (FACAM) and care as usual (CAU). Pregnant women are randomized to receive either FACAM or CAU.|||t|t
1295123|NCT03659708|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1295124|NCT03659695|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1295125|NCT03659682|Randomized|Crossover Assignment||Treatment||Quadruple||delayed start design|t|t|t|t
1295126|NCT03659669|||Cohort||Prospective|||||||
1295127|NCT03659656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295128|NCT03659643|||Case-Control||Prospective|||||||
1295129|NCT03659630|Randomized|Parallel Assignment||Treatment||Single|||t|||
1295130|NCT03659617|Randomized|Parallel Assignment||Treatment||Single|Assessors collecting the data and conducting the appropriate statistical analyses for all outcomes in the study will be blinded.|||||t
1295131|NCT03659604|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Clustered randomized controlled trial/parallel assignment~Different school classes will be allocated to one of the three groups: 1) intervention group with a game based on tailored feedback, 2) active control group with a game not using tailored feedback, 3) passive control group (waiting list group)."||||
1295132|NCT03659591|Randomized|Parallel Assignment||Treatment||Single||||||t
1295133|NCT03659578||Single Group Assignment||Treatment||None (Open Label)||||||
1295134|NCT03659565|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1295135|NCT03659552||Single Group Assignment||Device Feasibility||None (Open Label)||Single group assignment||||
1295136|NCT03659539|Randomized|Parallel Assignment||Other||Double|The attending anaesthesiologist will not be blinded to the technique utilized to administer GA and also to the in-OR recovery profile immediately after tracheal extubation. However, they will be blinded to postoperative recovery parameters, which will be noted by an independent assessor unaware of the technique utilized for administering GA.|"120-patients aged 18-65 years, ASA physical status I/II, of either sex, and undergoing elective major robotic surgery will be randomly allocated to one of the following two groups:~Group-1 [CLADS Group, n=60]: Anaesthesia will be induced and maintained with propofol administered using the BIS feedback-based automated CLADS.~Group-2 [Desflurane Group, n=60]: Anaesthesia will be induced with propofol CLADS and will be maintained intraoperatively by Desflurane titrated to BIS monitoring."|t|||t
1295137|NCT03659526|||Cohort||Prospective|||||||
1295138|NCT03659513|||Case-Only||Prospective|||||||
1295139|NCT03659500|||Cohort||Retrospective|||||||
1295140|NCT03659487|Randomized|Parallel Assignment||Treatment||Double||Laparoscopic total (Nissen) vs posterior 270 degrees (Toupét) partial fundoplication for the treatment of gastroesophageal reflux disease.|t|||t
1295141|NCT03659474|Randomized|Parallel Assignment||Treatment||Single|||t|||
1295142|NCT03659461|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1295143|NCT03659448|Randomized|Parallel Assignment||Other||None (Open Label)||"Two parallel arms consisting of a treatment arm of patients who will receive the study drug and subsequently undergo surgical resections under both standard white light conditions and then NIR, and a no treatment arm to whom the study drug will not be administered and who will undergo surgical resections under standard white light conditions only."||||
1295144|NCT03659435|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1295145|NCT03659422||Single Group Assignment||Treatment||None (Open Label)||||||
1295146|NCT03659409|Randomized|Crossover Assignment||Treatment||None (Open Label)||Participants are randomized to receive either the intervention or treatment as usual. The intervention is for 4 weeks, and 3 months from the start of the intervention, participants who were assigned to the treatment as usual group will receive the same intervention.||||
1295147|NCT03659396|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1295148|NCT03659383||Single Group Assignment||Treatment||None (Open Label)||||||
1295149|NCT03659370|Randomized|Parallel Assignment||Treatment||Single||||||t
1295150|NCT03659357|||Case-Crossover||Prospective|||||||
1295151|NCT03659344|Randomized|Parallel Assignment||Prevention||Single|Patients were blind about kind of sutures which were used to close flaps.|In group1, vicryl plus suture was used to close flaps. In group2,vicryl was used to close flaps|t|||
1295152|NCT03659331||Single Group Assignment||Treatment||None (Open Label)||A model based on the assumption that at least 50 subjects will be recruited, and assuming that 50% of the patients will have a significant reduction of liver enzymes||||
1295153|NCT03659318|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1295154|NCT03659305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295155|NCT03659292|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295156|NCT03659279||Single Group Assignment||Treatment||None (Open Label)||Pre-post intervention study||||
1295157|NCT03659266|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1295158|NCT03659253|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1295159|NCT03659240|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1295160|NCT03659227|||Cohort||Prospective|||||||
1295161|NCT03659214|||Cohort||Retrospective|||||||
1295162|NCT03659201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295163|NCT03659188|Randomized|Parallel Assignment||Treatment||Single||||||t
1295164|NCT03659175|||Cohort||Prospective|||||||
1295165|NCT03659162|||Other||Cross-Sectional|||||||
1295166|NCT03659149|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1295167|NCT03659136|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295168|NCT03659123||Single Group Assignment||Health Services Research||None (Open Label)||||||
1295169|NCT03659110|||Case-Only||Prospective|||||||
1295170|NCT03659097|Randomized|Parallel Assignment||Treatment||Single||||||t
1295171|NCT03659084|||Cohort||Prospective|||||||
1295172|NCT03659071|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295173|NCT03659058|Randomized|Parallel Assignment||Treatment||None (Open Label)||200 patients will receive silymarin 420 mg + antioxidants + colchicine||||
1295174|NCT03659045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295175|NCT03659032|Randomized|Parallel Assignment||Treatment||Double|The assessors who receive participants and do the measurement are masked|Parallel assignment|||t|t
1295176|NCT03659019|||Cohort||Prospective|||||||
1297697|NCT03626207|||Case-Only||Prospective|||||||
1295177|NCT03659006||Single Group Assignment||Prevention||None (Open Label)||||||
1295178|NCT03658993|Randomized|Parallel Assignment||Treatment||Quadruple|Randomisation and labelling follow guidelines defined by the Danish Medicines Agency and will be performed by the Hospital Pharmacy Region Midtjylland Clinical Trial Unit, Aarhus University Hospital and Norgine. For equal allocation to the two treatment arms computer generated block randomisation (blocks of 8) will be performed|A prospective, randomised, double-blind, placebo-controlled trial|t|t|t|t
1295179|NCT03658980|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1295180|NCT03658967|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Double-blind, placebo-controlled, randomized|t|t|t|t
1295181|NCT03658954|Randomized|Parallel Assignment||Treatment||None (Open Label)||Random assignment to one of three groups in 2:1:1 ratio, each group receiving some variation on 2-week intervention. Measurements taken at baseline, 4 weeks, 8 weeks, 12 weeks.||||
1295182|NCT03658941|Randomized|Parallel Assignment||Prevention||Triple|"Due to the nature of the surgical procedures, the surgeon and the rest of the OR medical team will be aware of the current subject's allocation. However, in each case, the specific OR team aware of the subject's allocation will be different from the investigators performing further evaluation of the given subject. The following study procedures will be in place to ensure double-blind administration of the study.~Access to the randomization code will be strictly controlled.~The surgeon will receive information on subject's allocation after commencing the surgery.~The study blind will be broken:~During interim monitoring, after recruiting the first 100 patients.~On completion of the clinical study and after the study database has been locked.~When patients' safety requires access to allocation data."|"We plan to include 2000 subjects in this study. Each subject will undergo a craniotomy for unrelated pathology. Each of the subjects will be assigned in random order to an intervention or control group. The intervention group will not have dural tenting sutures during closure of their craniotomy while the control group will have at least three.~Both groups will be followed radiologically and clinically, in the exact same manner."|t||t|t
1295183|NCT03658928|||Cohort||Retrospective|||||||
1295184|NCT03658915|||Case-Control||Cross-Sectional|||||||
1295185|NCT03658902|||Cohort||Retrospective|||||||
1295186|NCT03658889|||Case-Only||Cross-Sectional|||||||
1295187|NCT03658876|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1295188|NCT03658863|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1295189|NCT03658850|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1295190|NCT03658837|||Cohort||Prospective|||||||
1295191|NCT03658824|Randomized|Parallel Assignment||Treatment||None (Open Label)|It is not possible to blind the assessor to phase or baseline duration of participants in the case-series, as the length of time between assessments will reveal this. Nevertheless, the assessor and clients will be asked not to disclose which therapist is treating them. Use of self-report measures as the primary outcome measure is intended to minimise potential biases on the side of the researcher.|This is a case series using a multiple baseline design whereby participants are randomly allocated to one of 6 durations of wait at baseline before commencing treatment.||||
1295192|NCT03658811||Single Group Assignment||Treatment||None (Open Label)||Patient were enrolled in the study if they had visible signs of upper lid meibomian gland dysfunction and persistent dry eye symptoms and pain despite treatment with conservative dry eye therapies.||||
1295193|NCT03658798||Single Group Assignment||Treatment||None (Open Label)|No masking of the intervention to participant or assessor because there is only 1 arm.|"Participant will be compared to themselves in a pre-post analysis"||||
1295194|NCT03658785||Single Group Assignment||Treatment||None (Open Label)||||||
1295195|NCT03658772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Cohort 1 to be enrolled before Cohort 2||||
1295196|NCT03658759|||Cohort||Prospective|||||||
1295197|NCT03658746|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1295198|NCT03658733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295199|NCT03658720|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1295200|NCT03658707|||Case-Only||Prospective|||||||
1295201|NCT03658694|Randomized|Parallel Assignment||Treatment||Double||This is an adaptive sequential trial of FM patients. In stage 1 patients were randomly allocated into two parallel arms (rTMS high dose, sham) using adaptive methodology. In stage 2, after the end of the first trial, patients will be allocated to two arms (low dose rTMS, high dose rTMS). Both stages will be conducted in a sequential methodology where an interim analysis will take place and indicate when the second trial should start and the approximate sample size based in Bayesian analyzed from the first trial and data imputations derived form it will be used to more accurately estimate the sample size of stage 2 trial.|t||t|
1295202|NCT03658681|Randomized|Crossover Assignment||Basic Science||Triple||Intervention with cross-over design. Two test meals will be tested.|t||t|t
1295203|NCT03658668|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295204|NCT03658655||Single Group Assignment||Treatment||None (Open Label)||||||
1295205|NCT03658642|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel cluster randomized||||
1295206|NCT03658629|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1295207|NCT03658616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295208|NCT03658603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295209|NCT03658590|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1295210|NCT03658577|||Cohort||Prospective|||||||
1295211|NCT03658564|Randomized|Parallel Assignment||Prevention||Single|||||t|
1295212|NCT03658551|||Case-Control||Prospective|||||||
1295213|NCT03658538|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1295214|NCT03658525||Single Group Assignment||Treatment||None (Open Label)||To assess delivery of prostate IMRT on the MR linac||||
1295215|NCT03658512|||Cohort||Other|||||||
1295216|NCT03658499|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be divided by strata (court mandated vs. voluntary) and randomly assigned to either the experimental or control condition, after completing the two-day skills group, via a research randomizer (Urbaniak & Plous, 2013), which randomly generates numbers that designate the assignment condition of each participant.||||
1295217|NCT03658486||Single Group Assignment||Other||None (Open Label)||||||
1295218|NCT03658473|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1295219|NCT03658460|||Cohort||Prospective|||||||
1295220|NCT03658447||Single Group Assignment||Treatment||None (Open Label)||||||
1295221|NCT03658434||Single Group Assignment||Treatment||None (Open Label)||Feasibility study||||
1295222|NCT03658421|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1295223|NCT03658408|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1295224|NCT03658395|Randomized|Parallel Assignment||Treatment||Single|||t|||
1295225|NCT03658382|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295226|NCT03658369|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1295227|NCT03658356|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1295228|NCT03658343||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295229|NCT03658330||Single Group Assignment||Treatment||None (Open Label)||||||
1295230|NCT03658317|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1295231|NCT03658304||Single Group Assignment||Treatment||None (Open Label)||||||
1295232|NCT03658291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295233|NCT03658278|Randomized|Parallel Assignment||Prevention||Single|||||t|
1295234|NCT03658265|Randomized|Parallel Assignment||Treatment||Single||||||t
1295235|NCT03658252|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1295236|NCT03658239||Single Group Assignment||Basic Science||None (Open Label)||||||
1295237|NCT03658226||Single Group Assignment||Treatment||None (Open Label)|The PI/therapist will be blind to the outcome measures. All measures will be marked with a participant ID by an alternative researcher so that the therapist/PI will be unaware of individual participants' scores when analysing the data.|"A series of experimental single case studies comparing individual CLBP participants' clinical outcomes during a baseline phase (receive no treatment) with those during a treatment phase (receive 8 sessions of PIT). Clinical outcomes will be the impact of treatment on pain distress/intensity, self-efficacy, mood and interpersonal functioning. There will be repeated measurement (daily/weekly) of the outcomes during baseline and intervention phases, to assess real-time change in these variables on a case-by-case basis. We will vary the length of the baseline phase randomly across participants, who will commence treatment following 3, 4, 5 or 6 weeks. This multiple baselines design will allow us to establish whether any improvement in clinical outcomes is caused by the intervention rather than natural change over time. We will assess feasibility/acceptability of the intervention by recording adverse reactions, side effects, adherence and participants' views about the intervention."||||
1295238|NCT03658213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295239|NCT03658200|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1295240|NCT03658187|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1295241|NCT03658174|Randomized|Crossover Assignment||Treatment||Quadruple||Double blind placebo controlled crossover study|t|t|t|t
1295242|NCT03658161||Single Group Assignment||Other||None (Open Label)||||||
1295243|NCT03658148|||Cohort||Retrospective|||||||
1295244|NCT03658135|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind - only investigational pharmacist is unblinded|"This is a phase 1b, randomized, double-blind, placebo-controlled, parallel cohort study of the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of BIIB092 in patients with 4 different primary tauopathy syndromes: CBS, nfvPPA, sMAPT, and TES.~A basket trial design will be used for a parallel evaluation of BIIB092 in four heterogeneous clinicopathological syndromes that share a common molecular target (tau). There will be four cohorts of approximately 8 participants each, one for each specific primary tauopathy syndrome listed above (for a total of approximately 32 participants). For each diagnostic cohort, eligible participants will be randomized 3:1 to active or placebo (i.e., 6 participants receiving BIIB092 and 2 participants receiving placebo). All eligible participants will be administered study drug (BIIB092 or placebo) as an 1-hour intravenous (IV) infusion q4w for 20 weeks (for a total of 6 infusions)."|t|t|t|t
1295245|NCT03658122|Randomized|Parallel Assignment||Treatment||Single||This is a randomized controlled trial with waitlist control. The waitlist control group will receive the study treatment after a two-month wait.||||t
1295246|NCT03658109|Randomized|Parallel Assignment||Treatment||Double|Eligible patients will undergo current standard enhanced recovery protocol (ERP) gyn-oncology protocol. All patients will receive intrathecal morphine as part of the existing ERP. They will then be randomized to receive; either lidocaine infusion, regional anesthesia truncal block (quadratus lumborum block), or intrathecal morphine alone. Patients will be randomized into either lidocaine (group 1), QL block (group 2), or intrathecal opioid alone (group 3) groups. There will be blinding of the patient and personnel involved in data collection, and patients will undergo either a posterior QL block with local anesthetic (group 2) or simulated QL block (groups 1 and 3; subcutaneous local anesthetic only) pre-operatively. All patients will also undergo a loading dose of lidocaine (groups 1) or saline (group 2 and 3) followed by continuous lidocaine infusion in the lidocaine group (group 1). Primary and secondary endpoints will be measured post-operatively.||t|||t
1295247|NCT03658096|Non-Randomized|Parallel Assignment||Diagnostic||Single||patients and healthy controls|t|||
1295248|NCT03658083|||Case-Control||Prospective|||||||
1295249|NCT03658070|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1295250|NCT03658057|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1295251|NCT03658044|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized parallel group study||||
1295252|NCT03658031|Randomized|Parallel Assignment||Treatment||None (Open Label)||After completing baseline measurements, subjects will be randomized to receive in a double blind fashion dapaglfilozin (10 mg/day) or placebo. The drug will be administered each morning before breakfast.||||
1295253|NCT03658018||Single Group Assignment||Treatment||None (Open Label)||||||
1295254|NCT03658005|||Cohort||Prospective|||||||
1295255|NCT03657992|||Cohort||Retrospective|||||||
1295256|NCT03657979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295257|NCT03657966||Single Group Assignment||Treatment||None (Open Label)||open-label DCVAC/OvCa after treatment with carboplatin in combination with either gemcitabine or paclitaxel||||
1573310|NCT00001668||||||||||||
1295258|NCT03657953|Randomized|Parallel Assignment||Treatment||None (Open Label)||single-center prospective randomized study design||||
1295259|NCT03657940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295260|NCT03657927|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1295261|NCT03657914||Single Group Assignment||Treatment||None (Open Label)||||||
1295262|NCT03657901|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Randomized control trial with a cross-over design.||||
1295263|NCT03657888|Non-Randomized|Parallel Assignment||Prevention||Single|Participants and volunteers cannot be blinded but data analyst will be blinded.|The study is a prospective controlled trial with two conditions: (1) intervention group participating in Family Club Denmark and (2) wait-list control group.||||t
1295264|NCT03657875|||Other||Retrospective|||||||
1295265|NCT03657862|Randomized|Parallel Assignment||Treatment||Triple|"The participants (children) did not know their group allocation because a placebo was applied if SDF was not applied.~The care providers (operator) and the examiners (outcome assessor) were not informed of the children's group allocation."|"There are 2 groups of study participants in this study.~Children with decayed teeth were randomly allocated into either Group 1 (receive topical application of a SDF solution) or Group 2 (placebo) using random numbers, around 10 weeks before receiving dental restoration."|t|t||t
1295266|NCT03657849||Single Group Assignment||Diagnostic||None (Open Label)||Prospective diagnostic accuracy study||||
1295267|NCT03657836|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295268|NCT03657823|||Cohort||Prospective|||||||
1295269|NCT03657810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295270|NCT03657797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295271|NCT03657784|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Successive cohorts design and single dose administration||||
1295272|NCT03657771|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, prospective, parallel||||
1295273|NCT03657758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295274|NCT03657745|||Cohort||Prospective|||||||
1295275|NCT03657732|||Cohort||Prospective|||||||
1295276|NCT03657719|Randomized|Parallel Assignment||Prevention||Double|Part 1 : Open label, Part 2 : Double blind|Part 1 : Single group, Part2 : Parallel group|t||t|
1295277|NCT03657706|Randomized|Parallel Assignment||Treatment||Single||||||t
1295278|NCT03657693|||Cohort||Prospective|||||||
1295279|NCT03657680|||Case-Control||Cross-Sectional|||||||
1295280|NCT03657667||Single Group Assignment||Treatment||None (Open Label)||||||
1295281|NCT03657654|||Cohort||Prospective|||||||
1295282|NCT03657641||Single Group Assignment||Treatment||None (Open Label)||||||
1295283|NCT03657628||Single Group Assignment||Prevention||None (Open Label)||||||
1295284|NCT03657615|Non-Randomized|Parallel Assignment||Treatment||Single||within subject||||t
1295285|NCT03657602|Randomized|Parallel Assignment||Other||Single|Participant will be blinded to group assignment|Participants will be randomly allocated one to one to the Skyla or Mirena group and assessment will occur in parallel|t|||
1295286|NCT03657589|||Cohort||Cross-Sectional|||||||
1295287|NCT03657576||Sequential Assignment||Treatment||None (Open Label)||Modified continuous reassessment model (mCRM). Using this statistical method, dose changes occur based upon toxicities (or lack thereof) observed after a 24 day observation period for the initial dose level. If toxicities occurring at any dose were acceptable, doses for subsequent cohorts can be increased by up to 1 log until a maximum tolerated dose is reached. If toxicities are unacceptable then dose de-escalation occurs until a safe acceptable maximum tolerated dosage is defined. However, it should be noted that the dose alterations are not predictable and cannot be predefined, they are statistically determined after each patient using mCRM software.||||
1295288|NCT03657563|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1295289|NCT03657550|Randomized|Sequential Assignment||Treatment||None (Open Label)||This study consists of 2 parts. Part 1 will be a randomized, open-label, single-dose, two-way crossover study to assess the relative BA of levamlodipine maleate tablets from CSPC versus Amlodipine Besylate Tablet NORVASC® from Pfizer Inc. after a single oral administration under fasted conditions in male and female healthy subjects. Part 2 will be a single-arm, open-label, single-dose phase to assess food effect on the PK profile of levamlodipine maleate tablets from CSPC. Subjects who have completed Part 1 will be rolled over to Part 2 after a wash-out period for at least 14-days since the last dosing. Subjects will receive a single oral administration of study drug under a high-fat / high-calorie meal that should derive approximately 150, 250 and 500-600 calories from protein, carbohydrate and fat, respectively.||||
1295290|NCT03657537|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1295291|NCT03657524|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295292|NCT03657511||Single Group Assignment||Health Services Research||None (Open Label)||||||
1295293|NCT03657498|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||The trial includes a study group of patients receiving orthognathic surgery. It is divided into two subgroups. Subgroup I including bimaxillary surgical patients with Le-Fort I osteotomy for the upper jaw and sagittal split ramus osteotomy for the lower jaw. Subgroup II including patients receiving mandibular surgery only. Finally, two control groups were applied. Control group I including no treatment subjects and Control group II including standard orthodontic treatment subjects||||
1295294|NCT03657485|Randomized|Parallel Assignment||Prevention||None (Open Label)||The patients we recruited were randomized into 2 groups- interventional or control group. For comparison we examined the stool samples of 32 healthy newborns delivered vaginally||||
1295295|NCT03657472|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1295296|NCT03657459|Randomized|Parallel Assignment||Treatment||Double|Documentation of enrollment will not include group assignment Investigator will be blinded from group assignment via a separate excel file with that detail|Randomized, controlled prospective trial||t|t|
1295297|NCT03657446|Randomized|Crossover Assignment||Other||Triple||3-way cross-over Phase 1 study|t|t|t|
1295298|NCT03657433|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Trial||||
1295299|NCT03657420||Single Group Assignment||Treatment||None (Open Label)||||||
1295300|NCT03657407|Randomized|Parallel Assignment||Treatment||Quadruple|"Opaque sealed envelopes generated by biostatistician used to determine intervention A or B. Drug dictionary entries created within the Pyxis system by the Mercy Medical Center Department of Pharmacy, as Protocol Drug A and Protocol Drug B, recorded in medical record in this way. Identity of Protocol Drug A and Protocol Drug B revealed by pharmacist at conclusion of data analysis."|Randomization to one-time intervention A (medicated suppository) or intervention B (placebo), allocation was sealed in consecutively numbered opaque envelopes generated by biostatistician using blocked randomized technique.|t|t|t|t
1295301|NCT03657394|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1295302|NCT03657381|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1295303|NCT03657368|Non-Randomized|Factorial Assignment||Prevention||Single||||||t
1295304|NCT03657355|Randomized|Crossover Assignment||Treatment||Quadruple|For blinding purposes, suvorexant and zolpidem will be over-encapsulated, whereas a matching-placebo will be used for ACT-541468.|Single-center, randomized, double-blind, double-dummy, placebo- and active-controlled, 6-way cross-over study|t|t|t|t
1295305|NCT03657342|Randomized|Parallel Assignment||Treatment||Single||||||t
1295306|NCT03657329||Single Group Assignment||Diagnostic||None (Open Label)||Dreem||||
1295307|NCT03657316|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1295308|NCT03657303|||Case-Control||Prospective|||||||
1295309|NCT03657290|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a randomized, open-label, single-dose, three-period, six- sequence crossover study in healthy adults. A total of 54 eligible subjects will be randomized to one of six treatment sequences (ABC, ACB, BAC, BCA, CAB, or CBA). Refer to Treatment Sequences below. Each sequence is comprised of 3 treatments||||
1295310|NCT03657277||Single Group Assignment||Basic Science||None (Open Label)||||||
1295311|NCT03657264|Randomized|Crossover Assignment||Diagnostic||Triple||Williams design for a 4*4 cross over|t||t|t
1295312|NCT03657251|||Other||Prospective|||||||
1295313|NCT03657238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295314|NCT03657225|Randomized|Parallel Assignment||Treatment||Single|||t|||
1295315|NCT03657212|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1295316|NCT03657199|||Other||Retrospective|||||||
1295317|NCT03657186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295318|NCT03657173|||Cohort||Prospective|||||||
1295319|NCT03657160|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1295320|NCT03657147|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1295321|NCT03657134||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295322|NCT03657121|||Cohort||Prospective|||||||
1295323|NCT03657108|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||3+3 dose escalation study to determine MTD||||
1295324|NCT03657095||Single Group Assignment||Treatment||None (Open Label)|Treatment during the first 4 weeks of this study is double-blind. The investigator and study staff, the subjects, the monitors, and the sponsor will remain blinded to the treatment group allocation from BPS-314d-MR-PAH-302 study and to study drug during the first 4 weeks of the OLE study. After the 4 weeks, the study will continue as unblinded and open label.|||||
1295325|NCT03657082|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1295326|NCT03657069||Single Group Assignment||Supportive Care||None (Open Label)||||||
1295327|NCT03657056||Single Group Assignment||Device Feasibility||None (Open Label)||"Participants will be recruited from the normal population of patients being treated for temporal lobe epilepsy Massachusetts General Hospital.~Patients identified as candidates for temporal lobe surgery by the clinical team will be notified via a letter that has been signed by a physician representative of the practice of their eligibility for the study. An administrator will follow-up on the letter with a phone call. The physician of potential participants will be notified of their eligibility for the study, and be provided with a copy of the consent form. A total of 3 participants will be enrolled in the project."||||
1295328|NCT03657043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295329|NCT03657030|Randomized|Sequential Assignment||Other||Quadruple||Single ascending dose and multiple ascending dose study|t|t|t|t
1295330|NCT03657017||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295331|NCT03657004|||Case-Control||Retrospective|||||||
1295332|NCT03656991|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a stepped-wedge, randomized controlled trial. Possible subjects will be randomized to 1 of 4 groups. Each patient will serve as his or her own control. Within each stratum of four, patients will be randomly assigned to intervention initiation times (~130 per initiation time). Intervention initiation times will occur every other month up to a maximum of six months.||||
1295333|NCT03656978|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1295334|NCT03656965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295335|NCT03656952|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1295336|NCT03656939|||Cohort||Other|||||||
1295337|NCT03656926|Randomized|Parallel Assignment||Treatment||Single||||||t
1295338|NCT03656913||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295339|NCT03656900|Randomized|Crossover Assignment||Treatment||Single|||t|||
1295340|NCT03656887|||Cohort||Prospective|||||||
1295341|NCT03656874|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1295342|NCT03656861|||Ecologic or Community||Retrospective|||||||
1295398|NCT03656133|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295399|NCT03656120|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1295400|NCT03656107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295401|NCT03656094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295402|NCT03656081|Randomized|Parallel Assignment||Treatment||Single|||t|||
1295403|NCT03656068||Single Group Assignment||Treatment||None (Open Label)||||||
1295404|NCT03656055|||Cohort||Prospective|||||||
1295405|NCT03656042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573311|NCT00001667||||||||||||
1295343|NCT03656848|Randomized|Parallel Assignment||Diagnostic||Double|This is a blinded clinical trial. Subjects and clinical assessor will be blinded to the assignment results. All the study site personnel will receive training for the blinding measures before the trial initiating. In addition to standard procedural sedation, music-playing headphones will be worn by the patient during the whole procedure, and patients in both groups will be preset a 5-10 minutes delay for QFR calculation before the PCI procedure, a lesion/device evaluation form (Appendix) is required to fill in during the period in both groups, to reduce the possibility of unblinding. All the study site personnel will be trained not to disclose the treatment assignment to the subject in any unplanned time. Subject blinding should be maintained until the one-year follow-up visit for all registered subjects is completed.||t|||t
1295344|NCT03656835||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295345|NCT03656822|||Cohort||Prospective|||||||
1295346|NCT03656809|||Case-Control||Prospective|||||||
1295347|NCT03656796|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1295348|NCT03656783||Single Group Assignment||Treatment||None (Open Label)||||||
1295349|NCT03656770|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1295350|NCT03656757|||Cohort||Prospective|||||||
1295351|NCT03656744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295352|NCT03656731|Randomized|Parallel Assignment||Supportive Care||Single|All physical tests will be conducted by masked health care professionals.|Participants will be randomized 1:1 to the intervention group and control group||||t
1295353|NCT03656718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295354|NCT03656705||Single Group Assignment||Treatment||None (Open Label)||||||
1295355|NCT03656692||Single Group Assignment||Treatment||None (Open Label)||||||
1295356|NCT03656679|Randomized|Parallel Assignment||Treatment||Single|Assessor will be provided with de-identified data for analysis|Parallel Assignment||||t
1295357|NCT03656666|Randomized|Parallel Assignment||Treatment||Triple||Double-blinded, randomized, placebo-controlled trial|t|t|t|
1295358|NCT03656653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295359|NCT03656640|||Case-Only||Prospective|||||||
1295360|NCT03656627|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295361|NCT03656614|||Cohort||Prospective|||||||
1295362|NCT03656601|||Cohort||Cross-Sectional|||||||
1295363|NCT03656588|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1295364|NCT03656575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295365|NCT03656562|Randomized|Parallel Assignment||Treatment||Triple|Patients, investigator staff, persons performing the assessments, and the clinical trial team (CTT) will remain blind to the identity of the treatment within each cohort from the time of randomization until end of the Week 29 visit|Patient will be randomization into one of two treatment cohorts (VAY736 or CFZ533) and to either active or placebo|t||t|t
1295366|NCT03656549||Single Group Assignment||Treatment||None (Open Label)||||||
1295367|NCT03656536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295368|NCT03656523|||Cohort||Prospective|||||||
1295369|NCT03656510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295370|NCT03656497|||Cohort||Other|||||||
1295371|NCT03656484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295372|NCT03656471|||Case-Control||Prospective|||||||
1295373|NCT03656458|Randomized|Parallel Assignment||Prevention||Single|The outcomes assessor was not aware regarding the allocation of participants to study groups.|||||t
1295374|NCT03656445|Randomized|Parallel Assignment||Treatment||Single||||||t
1295375|NCT03656432|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1295376|NCT03656419|Randomized|Parallel Assignment||Treatment||None (Open Label)||A controlled, quantitative cross-sectional clinical study.||||
1295377|NCT03656406|||Cohort||Prospective|||||||
1295378|NCT03656393|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1295379|NCT03656380|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1295380|NCT03656367|Randomized|Crossover Assignment||Prevention||Single|Due to the characteristics of the study design, blinding of project personnel and participants is not possible. However, statistical analyses of the results will be performed in a blinded fashion.|||||t
1295381|NCT03656354|||Cohort||Prospective|||||||
1295382|NCT03656341|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1295383|NCT03656328|Randomized|Parallel Assignment||Treatment||Double||double blind|t||t|
1295384|NCT03656315||Single Group Assignment||Screening||None (Open Label)||All recruited participants will be included in the study||||
1295385|NCT03656302|||Case-Control||Cross-Sectional|||||||
1295386|NCT03656289||Single Group Assignment||Prevention||None (Open Label)||||||
1295387|NCT03656276|||Cohort||Prospective|||||||
1295388|NCT03656263|||Cohort||Prospective|||||||
1295389|NCT03656250|||Case-Only||Prospective|||||||
1295390|NCT03656237|Randomized|Parallel Assignment||Prevention||Double||Cluster Randomized Trial (Clusters are the community health units - CSCOMs)|||t|t
1295391|NCT03656224|||Cohort||Prospective|||||||
1295392|NCT03656211|||Cohort||Prospective|||||||
1295393|NCT03656198|Randomized|Parallel Assignment||Prevention||Single|Participants will be blinded to their study arm allocation. The intervention procedure will be identical for both arms (intramuscular injections at Student Health Services on days 0, 7 and 21). Participants allocated to the control group will receive an intramuscular injection of sterile water for injection using identical syringes and needles as for the vaccine group. The injection will be prepared in a separate room to maintain participant blinding.|The trial design is a single-site, two-arm, parallel-group, participant-blinded, randomized, placebo-controlled, two-sided comparative study, with an internal pilot study for blinded sample size re-estimation. Allocation to study arm will be by block randomization stratified by sex within cohort (semester) with a 1:1 allocation ratio.|t|||
1295394|NCT03656185|||Cohort||Retrospective|||||||
1295395|NCT03656172|||Cohort||Prospective|||||||
1295396|NCT03656159|Randomized|Parallel Assignment||Treatment||Single||||||t
1295397|NCT03656146|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1295406|NCT03656029|Randomized|Crossover Assignment||Basic Science||Double||This will be a within-subjects, counterbalanced, placebo-controlled study of placebo or 3 doses of cannabis|t||t|
1295407|NCT03656016|||Case-Control||Prospective|||||||
1295408|NCT03656003|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1295409|NCT03655990|||Other||Prospective|||||||
1295410|NCT03655977||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295411|NCT03655964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1295412|NCT03655951|Randomized|Parallel Assignment||Prevention||Triple|Outcomes Assessor and Care Provider - NA This is a web-based study.||t|t||t
1295413|NCT03655938||Single Group Assignment||Prevention||None (Open Label)||||||
1295414|NCT03655925|||Cohort||Prospective|||||||
1295415|NCT03655912|Randomized|Parallel Assignment||Treatment||Double|Neither the patient or the care provider will be aware of the treatment modality group the patient is in. In order to achieve that, patients in different modality groups will be evaluated in different days preventing information of group modality gossip between the patients parents.||t|t||
1295416|NCT03655899|||Other||Prospective|||||||
1295417|NCT03655886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295418|NCT03655873|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1295419|NCT03655860||Single Group Assignment||Treatment||None (Open Label)||||||
1295420|NCT03655847||Single Group Assignment||Prevention||None (Open Label)||||||
1295421|NCT03655834||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295422|NCT03655821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295423|NCT03655808||Single Group Assignment||Treatment||None (Open Label)||self-control||||
1295424|NCT03655795||Single Group Assignment||Treatment||None (Open Label)||||||
1295425|NCT03655782|Randomized|Parallel Assignment||Treatment||Triple|Staff will not be told whether the subject was in the treatment or control group. The statistician will not know which group was the treatment group and which was the control group.|During Phase I and Phase II of this study, we will show that working memory and attention improve more in TBI patients after neurotraining that improves sensory and processing speed functions, improving the motion working range (PATH), more than after no training to show its feasibility and efficacy. MEG brain imaging will be used to show that PATH neurotraining improves the function of the dorsal, attention, and working memory networks (e.g., PPC, DLPFC and ACC/PCC areas), reducing over recruitment, more than found after no training.|t|t||t
1295426|NCT03655769|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1295427|NCT03655756||Single Group Assignment||Treatment||None (Open Label)||||||
1295428|NCT03655743|||Cohort||Prospective|||||||
1295429|NCT03655730|Randomized|Parallel Assignment||Prevention||Double||"This study is a comparative, randomised controlled trial that aims at demonstrating the superiority of weekly psychotherapeutic intervention during one year in lowering depression symptoms compared to usual care.~The ratio between intervention and usual care arms will be 1:1."|t||t|
1295430|NCT03655717|Randomized|Crossover Assignment||Diagnostic||Quadruple|Subjects will be randomly assigned to one of the possible orders according to a randomization schedule generated by the study staff using a random number generator and computer program. The MGH research pharmacy will generate a blinded randomization code for order of dosing and will dispense blinded drug in the dose ordered and identical placebo for use on separate study days. Ethanol or placebo drink will be prepared by a member of the research unit staff not otherwise associated with study visits.|This is a double blind, placebo controlled, 2 by 2, crossover study of the effect of intoxication with THC, ethanol, and combined THC and ethanol on brain activity as assessed with fNIRS.|t|t|t|t
1295431|NCT03655704||Single Group Assignment||Screening||None (Open Label)||Pilot study to assess the feasibility of a Phase 2 clinical trial assessing apabetalone in 10 PAH patients||||
1295432|NCT03655691|Randomized|Parallel Assignment||Treatment||Quadruple|different doses are packaged in identical containers|parallel dose groups|t|t|t|t
1295433|NCT03655678||Single Group Assignment||Treatment||None (Open Label)||||||
1295434|NCT03655665|Randomized|Parallel Assignment||Other||None (Open Label)||Clinical effectiveness model. Each subject will serve as their own control. Subject's ears will be randomized.||||
1295435|NCT03655652|||Cohort||Prospective|||||||
1295436|NCT03655639|||Cohort||Prospective|||||||
1295437|NCT03655626||Single Group Assignment||Treatment||None (Open Label)||||||
1295438|NCT03655613|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||(Phase 1) 3+3 dose escalation (Phase 2) Simon two-stage Minimax design||||
1295439|NCT03655600|Randomized|Parallel Assignment||Other||Double||Randomized two arm (intervention and usual care) clinical trial|||t|t
1295440|NCT03655587|Randomized|Parallel Assignment||Supportive Care||Single|Assessor blinded to the intervention type|Each group gets one of the 2 types of orthotics.||||t
1295441|NCT03655574|Randomized|Parallel Assignment||Treatment||Double|Participants will not be informed about which intervention arm they receive. Assessors will have the condition of the participant masked.|Two-arm randomized controlled trial|t|||t
1295442|NCT03655561|||Cohort||Prospective|||||||
1295443|NCT03655548|||Cohort||Prospective|||||||
1295444|NCT03655535|Randomized|Parallel Assignment||Treatment||Triple|randomized, placebo-controlled, double-blind||t|t|t|
1295445|NCT03655522|Randomized|Sequential Assignment||Other||Double||This was a double-blind, placebo-controlled, randomized, single ascending dose, sequential group study. Each subject participated in only 1 treatment period.|t||t|
1295446|NCT03655509||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295447|NCT03655496|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized controlled parallel trial||||
1295448|NCT03655483||Single Group Assignment||Treatment||None (Open Label)||||||
1295449|NCT03655470|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blind; participants will not be told to what condition they are assigned|2 group randomized controlled trial||||t
1295450|NCT03655457|Randomized|Parallel Assignment||Other||Single||||||t
1295451|NCT03655444|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1295569|NCT03653910|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1573312|NCT00001665||||||||||||
1295452|NCT03655431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||An experimental and control group will be utilized. The experimental group will perform the telerehabilitation intervention and the control group will receive standard care.||||
1295453|NCT03655418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1295454|NCT03655405|Randomized|Parallel Assignment||Treatment||Single||||||t
1295455|NCT03655392|Randomized|Parallel Assignment||Prevention||None (Open Label)||64 adult asthmatic patients (18-70 years old) were randomized into two groups: intervention group (IG) (n=38) or control group (CG) (n=26). IG patients were submitted to three 30-minutes intervention of a shortterm educational program delivered by a nurse at 3 mensal intervals. CG group did not receive educational intervention. All patients were submitted to a spirometry, induced sputum collection, nitric oxide measure, collecting exhaled condensed (cytokine analysis) air and it's ph measure, Asthma Control Test (ACT), Asthma Control Questionnaire (ACQ), Asthma Quality Life Questionnaire (AQLQ), Beck Depression Inventory (BDI), and answered a symptoms diary, Statistical analysis: repeated measures (Sigma Plot Software 3.0).||||
1295456|NCT03655379||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295457|NCT03655366|||Other||Cross-Sectional|||||||
1295458|NCT03655353||Single Group Assignment||Diagnostic||None (Open Label)|Investigators will determine HER2 expression by ABY-PET without knowledge of the results from the biopsies (in Phase III part).|||||
1295459|NCT03655340|||Cohort||Prospective|||||||
1295460|NCT03655327|||Case-Control||Cross-Sectional|||||||
1295461|NCT03655314|Randomized|Parallel Assignment||Prevention||Single||||||t
1295462|NCT03655301||Single Group Assignment||Treatment||None (Open Label)||||||
1295463|NCT03655288|||Other||Prospective|||||||
1295464|NCT03655275|Randomized|Parallel Assignment||Treatment||None (Open Label)|This study is randomized, placebo controlled trial.|This study is randomized, placebo controlled trial.||||
1295465|NCT03655262|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1295466|NCT03655249|Randomized|Crossover Assignment||Treatment||None (Open Label)||"Participants receive one of two interventions during the first day, and receive the alternative intervention the following day.~Interventions are : aerosoltherapy + autogenic drainage or aerosoltherapy alone"||||
1295467|NCT03655236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295468|NCT03655223|||Cohort||Prospective|||||||
1295469|NCT03655210|Randomized|Parallel Assignment||Treatment||Triple|Double-blinded||t||t|t
1295470|NCT03655197|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Healthy Subjects-No Intervention Ocular Rosacea Subjects-Mandatory Doxycycline Intervention Cutaneous Rosacea Subjects-Optional Doxycycline Intervention||||
1295471|NCT03655184|||Case-Control||Cross-Sectional|||||||
1295472|NCT03655171|||Case-Control||Cross-Sectional|||||||
1295473|NCT03655158|Randomized|Parallel Assignment||Treatment||Triple|"placebo applications were performed to mask participant~investigator who applied ozone, did not evaluate the healing~Investigator who evaluate the healing, did not know the control and test sides."|Split- mouth placebo controlled design (right quadrants of the surgical areas were assigned to receive ozone therapy in all patients. As placebo application, left quadrants received regular air from the ozone generator)|t||t|t
1295474|NCT03655145|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized prospective Phase III clinical trial comparing HLA 10/10 matched unrelated donor (standard arm) and haploidentical allogeneic hematopoietic stem cell transplantation (experimental arm) after myeloablative conditioning regimen||||
1295475|NCT03655132|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants in Phase 3 will be randomly assigned to either a wait-list control condition, or to receive the intervention of VACT-CP, including the 8 online-module based weekly sessions of treatment.||||
1295476|NCT03655119|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1295477|NCT03655106|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized control parallel assignment||||
1295478|NCT03655093|||Cohort||Prospective|||||||
1295479|NCT03655080||Single Group Assignment||Supportive Care||None (Open Label)||||||
1295480|NCT03655067|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized at the baseline visit to the CATCH-IT Intervention or Control group||||
1295481|NCT03655054||||||||||||
1295482|NCT03655041|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1295483|NCT03655028|Randomized|Parallel Assignment||Treatment||Double|Both investigator and outcome assessor will be blinded to patient allocation|Randomized controlled trial in which patients with COPD in the intervention group will undergo a home-based, exercise program augmented with RAS-enhanced music while patients with COPD in the control group will undergo a home-based, exercise program without music|||t|t
1295484|NCT03655015|||Other||Prospective|||||||
1295485|NCT03655002||Single Group Assignment||Treatment||None (Open Label)||||||
1295514|NCT03654625|Randomized|Parallel Assignment||Treatment||Single||Baseline (pre-intervention) outcome measures will be completed at the first visit to the lab at Ryerson University. Participants will then be randomly assigned to one of the following conditions: (1) standard written exposure, (2) enhanced written exposure or (3) neutral writing. All participants will write at the lab for 30 minutes on each of 4 days. The 4 writing sessions will be spaced and take place within a 2-week period. During the 2-week intervention period and the three days following the intervention period, participants will track their worry and mood twice per day. With the exception of the Modified Behavioural Avoidance Test, which will only be assessed at pre-intervention and 1 month follow-up , all other outcomes will be reassessed at post-intervention, 1-week and 1-month follow-up. An additional assessment of excessive worry will occur at mid-intervention, and additional assessments of Perceived Probability, Cost and Coping Questions will occur at each writing session.|t|||
1295515|NCT03654612||Single Group Assignment||Treatment||None (Open Label)||||||
1295516|NCT03654599|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1295570|NCT03653897||Single Group Assignment||Other||None (Open Label)||This study is a prospective, open label, clinical study evaluating the safety and effectiveness of the ID-Cap System under direct observation in the clinical setting.||||
1295571|NCT03653884|||Cohort||Prospective|||||||
1295572|NCT03653871|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295486|NCT03654989|Randomized|Parallel Assignment||Treatment||Triple|"Double blind (for the two groups treated with iontophoresis of treprostinil or placebo); open for the standard of care group.~The preparation of syringes of gel containing treprostinil or placebo will be centralized. Both gels will be physically identical, and investigators will not have access to the randomization list or to preparation records. This ensures proper blinding at treatment initiation. Treatment kits will subsequently be given to research nurses to continue the treatment at home. Nurses will not have access to the randomization list or preparation records either, which guarantees proper blinding throughout the 10-day treatment.~Unblinding will be done in case of any suspicion of an unexpected serious adverse reaction, prior to the declaration of the event to the competent authorities. Unblinding may be done 24/24h by the Pharmacy department."|"2 sub-studies:~Preliminary safety study, Phase I: single ascending dose study that aims at establishing the safety, tolerability, and PK of the procedure in patients with active ulcers; we propose an accelerated titration design with 7 doses of gel. The accelerated phase (first four doses) uses single-patient cohorts per dose. After these doses, a standard 3+3 design will be performed. Any occurrence of dose-limiting toxicity (DLT) during the accelerated phase halts the accelerated titration and the cohort is expended to the standard 3+3 design. Two instances of DLT at a dose level halt escalation, and D-1 is the maximum tolerated dose.~Proof-of-concept study, Phase II: Thirty-six patients with DFU associated with microvascular dysfunction will be randomized into three groups: Treprostinil iontophoresis; Placebo iontophoresis; Standard care. Drug administration, but not standard care, will be double-blind. After a 10-day treatment, follow-up includes 6 visits over 10 weeks."|t|t||t
1295487|NCT03654976|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Parallel-group|t|t|t|t
1295488|NCT03654963|Randomized|Parallel Assignment||Prevention||Double|Only pharmacy assistants and clinical pharmacists, who will obtain the best possible medication history and perform medication reconciliation, will know the assignment to either the intervention or the control group. Participants and outcomes assessor will be masked.|Allocation: centralized randomization; a unique list of randomization will be generated by the clinical trial unit (CTU) of the EOC with an ad hoc software, and patients will be allocated 1:1 in either the intervention or the control group.|t|||t
1295489|NCT03654950|||Cohort||Cross-Sectional|||||||
1295490|NCT03654937|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1295491|NCT03654924||Single Group Assignment||Diagnostic||None (Open Label)||Observational study||||
1295492|NCT03654911|||Case-Only||Prospective|||||||
1295493|NCT03654898|Randomized|Parallel Assignment||Other||Single|Investigators, Data analysis|||||t
1295494|NCT03654885|||Cohort||Prospective|||||||
1295495|NCT03654872|||Case-Only||Prospective|||||||
1295496|NCT03654859|||Cohort||Prospective|||||||
1295497|NCT03654846|Randomized|Parallel Assignment||Other||Single||Test of EmergencyEye functionality in real environment, comparison with conventional emergency call.||t||
1295498|NCT03654833|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295499|NCT03654820|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1295500|NCT03654807|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1295501|NCT03654794|||Cohort||Prospective|||||||
1295502|NCT03654781|Non-Randomized|Parallel Assignment||Treatment||Single||Participants with positive for both for H. pylori in gastric biopsy specimens and dental plaque samples by histologic examination with immunostaining and the rapid urease test (RUT), on gastric biopsy specimens obtained during gastrointestinal endoscopy were divided into 2 groups. Patients were allocated to one of the eradication regimens: triple therapy only or triple therapy combined with periodontal treatment. Each participant in both group received of a 10-day course of a proton pump inhibitor (Lansoprazole ) combined with amoxicillin (2 × 1 g daily) and clarithromycin (2 × 500 mg daily). Meanwhile, combined treatment group further received periodontal treatment consisted of scaling or combined with root planing and oral hygiene instructions.||||t
1295503|NCT03654768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295504|NCT03654755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295505|NCT03654742|Randomized|Parallel Assignment||Treatment||Double|Patients are masked with numbers and patient records not shown to the outcomes assessor|prospective, single-blinded, randomised|t|||t
1295506|NCT03654729|Randomized|Parallel Assignment||Treatment||Double|This is a double-blind, placebo-controlled study. Blinding is critical to the integrity of this clinical study.|"This is a Phase 3, multicenter, double-blind, placebo-controlled study to establish the efficacious dose of PledOx in prevention of chronic chemotherapy induced peripheral neuropathy (CIPN) induced by oxaliplatin.~Patients with metastatic colorectal cancer (mCRC), who are indicated for first-line modified FOLFOX6 (mFOLFOX6) chemotherapy for at least 3 months, without any pre-planned treatment breaks, will be randomized in a 1:1:1 ratio, stratified by prior oxaliplatin exposure (yes/no), to one of three treatment arms:~Arm A: PledOx (2 µmol/kg) + mFOLFOX6 chemotherapy~Arm B: PledOx (5 µmol/kg) + mFOLFOX6 chemotherapy~Arm C: Placebo + mFOLFOX6 chemotherapy~The Investigational Medicinal Product, IMP (i.e. PledOx or placebo) will be administered by an intravenous infusion on the first day of each chemotherapy (mFOLFOX6) cycle. IMP will not be administered if mFOLFOX6 is not given to the patient.~If a patient discontinues mFOLFOX6, the IMP should also be discontinued."|t|t||
1295507|NCT03654716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295508|NCT03654703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295509|NCT03654690|Randomized|Parallel Assignment||Prevention||Triple|Participants are not informed of their condition assignment, but may infer it via the procedures they are provided. Both investigators and staff assessing outcomes are blinded to participants' group assignments.||t||t|t
1295510|NCT03654677|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1295511|NCT03654664|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1295512|NCT03654651|Randomized|Crossover Assignment||Prevention||Single|||||t|
1295513|NCT03654638|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295566|NCT03653949|Randomized|Parallel Assignment||Treatment||Double|Simple blind (investigador/outcomes aseessor)||||t|t
1295567|NCT03653936|||Cohort||Prospective|||||||
1295568|NCT03653923|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Psychotherapeutic Investigation - No masking possible|Waiting-List RCT with crossover after Treatment (Waiting-List will be treated, treated subjects will rest)||||
1295517|NCT03654586|Randomized|Factorial Assignment||Prevention||None (Open Label)||"There was no answer option for our study design, but factorial is most similar. Participants will be randomly assigned to one of four conditions described below.~Calorie label (control) will display a Calories per Bottle label on all beverages, not just sugary drinks. This is modeled after the American Beverage Association's current Clear on Calories labels.~Text warning labels will display the following text on sugary beverages: WARNING: drinking beverages with added sugars contributes to obesity, diabetes, and tooth decay~Sugar graphic warning labels will display the same text as text warning labels along with graphics depicting the amount of sugar in the beverage~Health graphic warning label will display the same text as text warning labels along with graphics depicting the potential negative health consequences of over-consuming sugary drinks."||||
1295518|NCT03654573||Single Group Assignment||Other||None (Open Label)||N= 20 Diagnostic and N= 20 Therapeutic||||
1295519|NCT03654560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295520|NCT03654547|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose Escalation arm followed by Dose Expansion arm||||
1295521|NCT03654534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295522|NCT03654521|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1295523|NCT03654508|Randomized|Parallel Assignment||Treatment||Double||multicentre, double-blind, precision medicine, randomized trial|t|t||
1295524|NCT03654495|Randomized|Parallel Assignment||Treatment||None (Open Label)|The aim is to focus on recruitment, attrition and adherence to the rehabilitation intervention. This trial is composed of a comparative cross-sectional part and a randomized conventional rehabilitation-controlled trial part with 1:1 allocation ratio.|This trial is a two-arm, parallel-group, randomized-controlled pilot trial with a cross-sectional comparison at baseline.||||
1295525|NCT03654482||Single Group Assignment||Treatment||None (Open Label)||||||
1295526|NCT03654469|||Cohort||Prospective|||||||
1295527|NCT03654456|||Case-Control||Retrospective|||||||
1295528|NCT03654443|Randomized|Crossover Assignment||Other||Triple|Only the two observers are aware of the study group and none of the rest of the study team||t||t|t
1295529|NCT03654430||Single Group Assignment||Basic Science||None (Open Label)||||||
1295530|NCT03654417|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295531|NCT03654404||Single Group Assignment||Supportive Care||None (Open Label)||||||
1295532|NCT03654391|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1295533|NCT03654378|||Cohort||Prospective|||||||
1295534|NCT03654365|Randomized|Parallel Assignment||Screening||Double||||t|t|
1295535|NCT03654352|||Case-Control||Prospective|||||||
1295536|NCT03654339||Single Group Assignment||Treatment||None (Open Label)||The patients will be equally divided into two test groups. Group A and Group B after phase I therapy. the group A patients will be treated with laterally repositioned flap to obtain root coverage using microsurgical approach. The group B patients will be treated with laterally repositioned flap to obtain root coverage using macrosurgical approach||||
1295537|NCT03654326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295538|NCT03654313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295539|NCT03654300|||Cohort||Prospective|||||||
1295540|NCT03654287|||Case-Control||Prospective|||||||
1295541|NCT03654274||Single Group Assignment||Treatment||None (Open Label)||Open label extension||||
1295542|NCT03654261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295543|NCT03654248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295544|NCT03654235|Randomized|Parallel Assignment||Treatment||Single|Patients Evaluator and Outcomes Assessor are masked|||||t
1295545|NCT03654222|||Cohort||Retrospective|||||||
1295546|NCT03654209|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized to Argon Plasma Coagulation vs Snare Tip Soft Coagulation vs no treatment||||
1295547|NCT03654196|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1295548|NCT03654183|||Cohort||Prospective|||||||
1295549|NCT03654170|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1295550|NCT03654157|||Other||Prospective|||||||
1295551|NCT03654144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295552|NCT03654131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295553|NCT03654118|||Cohort||Prospective|||||||
1295554|NCT03654105|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1295555|NCT03654092|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295556|NCT03654079|Non-Randomized|Parallel Assignment||Other||Single|Group assignment will be removed from the data set prior to analysis.|Women in Centering Pregnancy groups at Wake Forest School of Medicine's Obstetrics (OB) and Gynecology (GYN) department will be recruited and sequentially assigned to participate in simulations or serve as controls.||||t
1295557|NCT03654066|Randomized|Parallel Assignment||Treatment||Single|||t|||
1295558|NCT03654053|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1295559|NCT03654040||Single Group Assignment||Treatment||None (Open Label)||||||
1295560|NCT03654027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295561|NCT03654014|Randomized|Parallel Assignment||Treatment||Quadruple|Honest broker will determine and record PEMF+ and PEMF- treated patients keeping investigator team blinded as to treatment until data analysis has been completed.|Double blinded treatment with PEMF+ and PEMF- groups with CSF and serum biomarkers compared to values from patients with normal pressure hydrocephalus.|t|t|t|t
1295562|NCT03654001|Randomized|Factorial Assignment||Treatment||None (Open Label)|N.A.|2-by-2 factorial design, open-label, multicenter, randomized, controlled trial, in patients with septic shock, as defined according to clinical criteria. Patients will be randomized in a 1:1:1:1 ratio to one of the 4 groups (Albumin + BAL, Albumin + NS, BAL, NS).||||
1295563|NCT03653988|Randomized|Parallel Assignment||Health Services Research||Double||RANDOMIZED CONTROLLED DOUBLE BLIND STUDY|t|||t
1295564|NCT03653975|||Cohort||Prospective|||||||
1295565|NCT03653962|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573313|NCT00001658||||Treatment||||||||
1295573|NCT03653858|Randomized|Parallel Assignment||Treatment||Double||multicenter, randomized, sham-controlled, double blind (patient and observer blinded)|t|||t
1295574|NCT03653845|Randomized|Parallel Assignment||Treatment||Single||||||t
1295575|NCT03653832|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomised, parallel-group, allocation concealed, controlled, open, phase 3 pragmatic clinical and cost- effectiveness trial with internal pilot||||
1295576|NCT03653819|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||All participants complete a baseline assessment followed by the randomisation to HIIT + compression or HIIT - compression.||||
1295577|NCT03653806|||Other||Prospective|||||||
1295578|NCT03653793||Single Group Assignment||Treatment||None (Open Label)||"This was a single arm pilot study to determine the feasibility of conducting an appropriately sized RCT within the same population using the same clinical outcome measures.~Eligible adult patients of the clinic with varicose veins were asked to use the cream as directed on the packaging for 6-weeks and the post-treatment measures were compared to baseline data. This study also provided SDs of the sample for comparison to the study population."||||
1295579|NCT03653780||Single Group Assignment||Basic Science||None (Open Label)||||||
1295580|NCT03653767|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomised Control Trial||||
1295581|NCT03653754|||Ecologic or Community||Cross-Sectional|||||||
1295582|NCT03653741||Single Group Assignment||Treatment||None (Open Label)||12 healthy males will undergo testing, then receive the drug intervention, followed by blood draw and testing again||||
1295583|NCT03653728|||Cohort||Prospective|||||||
1295584|NCT03653715|Randomized|Crossover Assignment||Treatment||Double|The Principal Investigator and Clinical Research Technicians, because they handle the contact lenses both in and out of their packaging, are not masked.|This single center study is a device feasibility, two-arm, single-masked, repeated measures, cross-sectional design. Each participant is tested with the four (4) study devices (i.e., contact lenses), one (1) test lens and three (3) control lenses, in randomized order. Participants are masked to each lens they wear.|t|||t
1295585|NCT03653702||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295586|NCT03653689|Randomized|Crossover Assignment||Diagnostic||Triple|The study will be double-blinded. Neither the participant nor the care providers or the outcome assessor will know which treatment is which.|The study will be a double-blinded, randomized, placebo-controlled cross-over study.|t|t||t
1295587|NCT03653676|||Cohort||Cross-Sectional|||||||
1295588|NCT03653663|Randomized|Crossover Assignment||Diagnostic||Quadruple|All members of the investigative team as well as the patients are blinded to treatment until all subjects have completed the study.|Double-blind, randomized crossover study of placebo vs. 20 mg simvastatin for 8 weeks with a 4 week washout in between|t|t|t|t
1295589|NCT03653650|Randomized|Parallel Assignment||Treatment||None (Open Label)|Not blinded study.|Subjects will be randomly assigned to three groups. Demographic characteristics and underlying etiologies will be identified. Subjects will undergo a general ophthalmologic evaluation (baseline) and PED size will be measured. Treatments will be administered until complete defect healing is achieved and visits will be scheduled weekly or as needed for continued ophthalmologic evaluation. After complete closure, subjects will be followed for three months with visits every 2 to 4 weeks to evaluate progress and identify recurrences.||||
1295590|NCT03653637|Randomized|Parallel Assignment||Treatment||Single|The individual who evaluates the outcomes of interest will not know the assigned condition of the participants.|Participants are assigned to one of two groups in parallel for the duration of the study.||||t
1295591|NCT03653624|||Case-Only||Prospective|||||||
1295592|NCT03653611|||Other||Prospective|||||||
1295593|NCT03653598|||Cohort||Prospective|||||||
1295594|NCT03653585|||Case-Control||Cross-Sectional|||||||
1295595|NCT03653572||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1295596|NCT03653559|Randomized|Parallel Assignment||Treatment||Single|Participants are only aware of the study condition in which they are allocated.|"Randomised controlled trial. The model tests a new dietary recommendation (home meals condition) against a standard dietary recommendation (healthy meals condition)"|t|||
1295597|NCT03653546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295598|NCT03653533|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1295599|NCT03653520|Randomized|Parallel Assignment||Treatment||Single|The surgeon was not aware which medication the patient received|||t||
1295600|NCT03653507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295601|NCT03653494|Randomized|Parallel Assignment||Treatment||Triple|Volunteers and data collectors was masked|"Put 80 patients divided into group S（non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia and Vagus block） and group D（non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia、Vagus block and Phrenic block）randomly.~Compare the volume of anesthetic drugs between the two groups.~If the date of group S greater than group D，it shows that the effect of anesthetic effect of group D is better than group S."|t||t|t
1295602|NCT03653481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295603|NCT03653468|Randomized|Parallel Assignment||Prevention||Single||Behavioral|||t|
1295604|NCT03653455|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1295605|NCT03653442|||Case-Only||Prospective|||||||
1295606|NCT03653429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295607|NCT03653416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295608|NCT03653403|Randomized|Parallel Assignment||Treatment||None (Open Label)||Approximately 48 subjects who meet the study criteria will be enrolled and will receive treatment with one of the 2 study drugs. Approximately 20 subjects will be enrolled in the Control Gel treatment arm and approximately 28 subjects in the IDP-126 Gel treatment arm will be enrolled||||
1295609|NCT03653390|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1295610|NCT03653377|||Cohort||Cross-Sectional|||||||
1295611|NCT03653364||Single Group Assignment||Treatment||None (Open Label)||||||
1295612|NCT03653351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295613|NCT03653338||Single Group Assignment||Treatment||None (Open Label)||||||
1295680|NCT03652467|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1295614|NCT03653325|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective randomized controlled study||||
1295615|NCT03653312|Randomized|Parallel Assignment||Treatment||Single|One blinded outcome assessor (physiotherapists) will perform measurements of functional capacity, patient reported outcome, and cognition. The Transcranial Magnetic Stimulation will be performed by un-blinded physiotherapist. Statistical analysis will be performed by a blinded statistician and a blinded interpretation of the results will be performed before breaking the randomization code.|Parallel group, assessor blinded, randomized controlled trial||||t
1295616|NCT03653299|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1295617|NCT03653286|Randomized|Parallel Assignment||Prevention||Double|Investigations of the peak muscle torque, analysis of ventilatory anaerobic thresholds, running economy and maximal oxygen consumption will be performed by a blind investigator. Data analysis will be performed by a blind investigator in the control and intervention groups.|The runners will be randomized into two groups, being: control group (CG) - will perform only run and intervention group (GI) - using the medium-frequency alternating current and run.|||t|t
1295618|NCT03653273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295619|NCT03653260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295620|NCT03653247||Single Group Assignment||Treatment||None (Open Label)||||||
1295621|NCT03653234|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295622|NCT03653221|Randomized|Single Group Assignment||Other||Double|investigator, outcome assessors will be blinded for group allocation.|"standardized patients with VRNET~standardized patients"|||t|t
1295623|NCT03653208|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1295624|NCT03653195|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||Prospective cohort study||||
1295625|NCT03653182|||Case-Only||Cross-Sectional|||||||
1295626|NCT03653169||Single Group Assignment||Treatment||None (Open Label)||||||
1295627|NCT03653156|||Cohort||Prospective|||||||
1295628|NCT03653143|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Participants will initially undergo brief telephone screen to assess eligibility. Inclusion in this study will be limited to children who are currently able to: walk across a room independently, use at least 5 words/signs. Participants will complete a series of survey and ERP/EEG assessments during the Baseline visit. After completion of the Baseline visit, participants will be randomly assigned to either the treatment group or the control/waitlist group. Group assignment will be random. The treatment group will start with 3 months of JASPER intervention and then have 3 months of their usual clinical care. The control/waitlist group will start with 3 months of their usual clinical care and then undergo 3 months of JASPER intervention. The 3-month treatment phase will involve weekly sessions with the JASPER interventionist, each 60 minutes long. Survey and ERP/EEG assessments will be repeated at the 3 month and at 6 month research visits for all participants.||||
1295629|NCT03653130|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|Parallel Interventional Study Model: Intervention participants (N=40) and usual care controls (N=40) will be eligible if they are residents of the Indianapolis VA Domiciliary who are eligible to participate in elective activities at the time of recruitment. Intervention participants will include eligible Veterans who agree to participate in the intervention. Usual Care Controls will include eligible Veterans who agree to complete the interviews and measures, but do not agree to participate in the participatory music program. Records for retrospective chart review (N=160) will be selected from past Domiciliary residents based on case-matching for gender and biological sex factors with intervention participants.||||
1295630|NCT03653117||Single Group Assignment||Treatment||None (Open Label)||This study is a prospective, single centre, interventional pilot study.||||
1295631|NCT03653104|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|This is a safety and feasibility pilot with a single intervention arm, an education control arm, a usual care control arm, and an interview only arm. The intervention arm includes participation in the melodica training program and education about pulmonary health. The education control arm includes pulmonary health education only. The interview only arm includes participation in a semi-structured interview about facilitators and barriers to participation.||||
1295632|NCT03653091|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1295633|NCT03653078|Randomized|Parallel Assignment||Treatment||Double|during the insertion procedure the principle investigator and the co supervisor couldn't be blinded, as the two insertion techniques are completely different.|adult orthodontic participants|t|||t
1295634|NCT03653065|||Case-Crossover||Retrospective|||||||
1295635|NCT03653052||Single Group Assignment||Treatment||None (Open Label)||||||
1295636|NCT03653039|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomised controlled||||
1295637|NCT03653026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295638|NCT03653013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295639|NCT03653000||Single Group Assignment||Treatment||None (Open Label)||Descriptive study||||
1295640|NCT03652987|||Cohort||Prospective|||||||
1295641|NCT03652974|Randomized|Parallel Assignment||Treatment||Double||Drug: sodium valproate with Clozapine sodium valproate may be used as a synergistic agent of clozapine in the treatment of treatment-resistant schizophrenia Other Name: Valproate Device: modified electroconvulsive therapy(MECT) with Clozapine modified electroconvulsive therapy(MECT) may be used as a synergistic agent of clozapine in the treatment of treatment-resistant schizophrenia Device: Magnetic seizure therapy(MST) with Clozapine|t||t|
1295642|NCT03652961||Single Group Assignment||Treatment||None (Open Label)||||||
1295643|NCT03652948||Single Group Assignment||Treatment||None (Open Label)||||||
1295644|NCT03652935|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1295645|NCT03652922|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1295646|NCT03652909|||Cohort||Prospective|||||||
1295647|NCT03652896|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1295681|NCT03652454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295682|NCT03652441||Single Group Assignment||Treatment||None (Open Label)||||||
1295683|NCT03652428||Single Group Assignment||Treatment||None (Open Label)||||||
1295684|NCT03652415|||Cohort||Prospective|||||||
1295685|NCT03652402|||Cohort||Prospective|||||||
1295648|NCT03652883|Randomized|Crossover Assignment||Health Services Research||Triple||Stepped wedge trial design by which the time points at which implementation sites receive the ItFits-toolkit is randomised. By the end of the trial, all implementation sites have received the ItFits-toolkit sequentially acting as control and intervention condition. There are 6 groups and 2 implementation sites per group. Sites will be informed about the group they are allocated to three months before cross-over. Every three months, a new group crosses over from IAU to using the ItFits-toolkit.|t|t||t
1295649|NCT03652870|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1295650|NCT03652857||Single Group Assignment||Treatment||None (Open Label)||||||
1295651|NCT03652844|Randomized|Parallel Assignment||Treatment||Single||Randomized cohorts|t|||
1295652|NCT03652831|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be assigned randomly into two groups: Soft tissue mobilization with neural mobilization and Soft tissue mobilization without Neural mobilization.A coin will be flipped at start of data collection for the first patient to be assigned odd number and included in Soft tissue mobilization with Neural mobilization group. Later on odd and even numbered subjects will be included in specific group.||||
1295653|NCT03652818|Randomized|Parallel Assignment||Treatment||Double|The sponsor, patients, investigators and study staff involved in the protocol procedures or those involved in data collection, data entry, data analysis will be blinded.||t||t|
1295654|NCT03652805||Single Group Assignment||Treatment||None (Open Label)||||||
1295655|NCT03652792|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1295656|NCT03652779|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1295657|NCT03652766||Single Group Assignment||Other||None (Open Label)||Single group feasibility and acceptability trial||||
1295658|NCT03652753|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1295659|NCT03652740|Randomized|Parallel Assignment||Basic Science||Triple|"As part of instructions during the informed consent process, volunteers will be given a list of drugs they may receive rather than informing them only of the specific drugs being administered. More drugs are listed than will be administered to increase the degree to which volunteers are blind to the drugs being studied. Researchers will be blind to the drug conditions on any given session because a pharmacy member with no participant interaction will assign the randomized dose sequence and prepare the study drugs."|Participants are not assigned to different groups/arms [Note: we indicated 2 arms below because the form does not allow masking in a single arm study - this study involves administration of drug conditions in different dose sequence orders]. All participants will receive the same drug conditions, but the order in which the participants receive the drug conditions will be different across participants. Participants will be randomly assigned to one of several different dose sequences.|t||t|t
1295660|NCT03652727|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295661|NCT03652714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295662|NCT03652701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295663|NCT03652688|Randomized|Parallel Assignment||Prevention||Single|Groups assigned to experimental and control conditions were given a tablet on which either the experimental or control program was provided. Both groups were told that they would be viewing a program on safety while at the club. Both groups had to respond to some questions on the tablet about the program. Both groups were asked to interact as a group to answer these questions. Without a view of the tablet, it appeared as if both experimental and controls had the same condition.|Randomized Controlled Trial|t|||
1295664|NCT03652675|Randomized|Parallel Assignment||Treatment||Single|After participants complete the screening assessment, the research coordinator will be able to determine alcohol use disorder status from the responses. The research coordinator will provide the counselor or PI with subject identification number (ID; assigned consecutively) and alcohol use disorder status. The counselor or PI will then randomize participants using pre-determined blocked lists created by a biostatistician, in order to balance treatment groups across alcohol use disorder status (the research coordinator will not randomize in order to remain blind to condition).|||||t
1295665|NCT03652662|Randomized|Parallel Assignment||Other||None (Open Label)||This is a randomized longitudinal controlled observational study. The study will recruit 30 participants and utilize a control group experimental design with dependent pretest and posttest to derive data regarding (1) feasibility and (2) within-participant effect size of the RESP-FIT intervention in terms of satisfaction, use and adherence, technical issues and acceptability, and self-reported symptom severity (dyspnea and fatigue). When completed, 30 adults (15 in each group) will have used SAMS for 6 weeks.||||
1295666|NCT03652649||Single Group Assignment||Treatment||None (Open Label)||||||
1295667|NCT03652636||Single Group Assignment||Treatment||None (Open Label)||||||
1295668|NCT03652623||Single Group Assignment||Prevention||None (Open Label)||||||
1295669|NCT03652610|Randomized|Parallel Assignment||Prevention||Quadruple|Data will be collected in an observer-blind manner. By observer-blind, it is meant that during the course of the study, the vaccine recipient and those responsible for the evaluation of any study endpoint (e.g. safety, reactogenicity and immunogenicity) will all be unaware of which vaccine was administered. To do so, vaccine preparation and administration will be done by authorized medical personnel who will not participate in any of the study clinical evaluations.||t|t|t|t
1295670|NCT03652597|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1295671|NCT03652584|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1295672|NCT03652571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295673|NCT03652558|Randomized|Parallel Assignment||Treatment||Double|"Investigators who evaluate the clinical and biochemical parameters did no know the groups.~And participants did not know ozone device work or not when holding the probe."|In this study the investigators select the split mouth study design to eleminate host effects on healing.|t||t|
1295674|NCT03652545||Single Group Assignment||Treatment||None (Open Label)||||||
1295675|NCT03652532|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1295676|NCT03652519|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1295677|NCT03652506|Randomized|Parallel Assignment||Diagnostic||Single|Participant, Outcomes Assessor|prospective,randomized|t|||
1295678|NCT03652493||Single Group Assignment||Treatment||None (Open Label)||||||
1295679|NCT03652480|||Cohort||Prospective|||||||
1295686|NCT03652389|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1295687|NCT03652376||Single Group Assignment||Basic Science||None (Open Label)||Patients with severe eosinophilic asthma (n=20) will be treated with benralizumab 3 times every 4 weeks, and the effect of this treatment on dendritic cell concentrations and dendritic cell characteristics will be investigated 4 weeks after the last benralizumab dose and after a follow-up of 3 months. There will be a separate control group of subjects (not a treatment or placebo arm) without asthma not treated with benralizumab (to study dendritic cell concentrations and dendritic cell characteristics in patients without asthma and without benralizumab treatment).||||
1295688|NCT03652363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295689|NCT03652350||Single Group Assignment||Treatment||None (Open Label)||||||
1295690|NCT03652337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295691|NCT03652324||Single Group Assignment||Treatment||None (Open Label)||||||
1295692|NCT03652311|Non-Randomized|Parallel Assignment||Treatment||Double|"Participants will not know if they are receiving therapeutic CVS or sham stimulation.~Participant survey responses will be blinded during analysis and only the use of non-informative catalogue will be used. This will eliminate bias in the analysis of the survey data."|This study is designed as a nonrandomized, single-blind, sham-controlled trail in which willing participants will receive a 5 day course of twice daily caloric vestibular stimulation (CVS) or sham treatment|t|||t
1295693|NCT03652298|Randomized|Parallel Assignment||Prevention||Single|The research assistant blind to group assignments is responsible to conduct the three follows-ups|prospective randomized|||t|
1295694|NCT03652285||Single Group Assignment||Treatment||None (Open Label)||As a proof of concept, feasibility study - First In Man Study (FIM). The study will enroll 10 patients and an additional 10% of patients to compensate for potential attrition during follow-up, resulting in a sample size of 11 patients.||||
1295695|NCT03652272|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||2-arm, multi-site, physician-randomized pragmatic trial to evaluate the impact and scalability of the Phase I EMC2 strategy to promote safe medication use and adherence.||||
1295696|NCT03652259|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1295697|NCT03652246|||Cohort||Other|||||||
1295698|NCT03652233||Single Group Assignment||Treatment||None (Open Label)||||||
1295699|NCT03652220|Randomized|Parallel Assignment||Treatment||Single||This is a three-arm, randomized, active-controlled, unblinded, parallel, exploratory study to compare the outcome in depression between standard specific treatment, multimodal specific treatment and standard treatment plus MBLM. After being screened for eligibility and signing the informed consent patients will be randomized 1:1:1 to either one of the groups. After being enrolled, patients in MBLM group receive an introductory education of the MBLM course and then join group sessions weekly for 8 weeks. They also see a consultant psychiatrist as needed for drug continuation therapy. Patients should practice MBLM related content at home for a proposed duration of 30-45 minutes per day. Patients in the control groups receive standard (control group I) or multimodal (control group II) treatment as administered by their consultant psychiatrist.||||t
1295700|NCT03652207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295701|NCT03652194|||Cohort||Other|||||||
1295702|NCT03652181|||Cohort||Prospective|||||||
1295703|NCT03652168|Randomized|Parallel Assignment||Treatment||Double|The party or parties involved in the clinical trial who are prevented from having knowledge of the interventions assigned to individual participants.||||t|t
1295704|NCT03652155|||Other||Prospective|||||||
1295705|NCT03652142|||Cohort||Prospective|||||||
1295706|NCT03652129|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1295707|NCT03652116|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to local infiltration of cesarean section wound with either bupivacaine or pethidine; with follow up of postoperative pain relief.||||
1295708|NCT03652103|Randomized|Parallel Assignment||Treatment||Single||Two groups involved. First group will receive total intravenous anesthesia and erector spinae plane block catheter Second group will receive total intravenous anesthesia and routine analgesia protocol for percutaneous Nephrolithotomy procedures.||t||
1295709|NCT03652090|||Cohort||Cross-Sectional|||||||
1295710|NCT03652077||Single Group Assignment||Treatment||None (Open Label)||||||
1295711|NCT03652064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295712|NCT03652051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295713|NCT03652038|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1295714|NCT03652025||Single Group Assignment||Treatment||None (Open Label)||premenopausal women with dull aching pain with ovarian point tenderness and post coital pain.||||
1295715|NCT03652012|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1295716|NCT03651999|||Cohort||Prospective|||||||
1295717|NCT03651986|||Cohort||Prospective|||||||
1295718|NCT03651973|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1295719|NCT03651960||Single Group Assignment||Screening||None (Open Label)||||||
1295720|NCT03651947|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1295721|NCT03651934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295722|NCT03651921|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1295723|NCT03651908|Randomized|Single Group Assignment||Treatment||Single||"In this study the patients are divided into two test groups-group A, group B. Each patient will be given careful instructions on proper oral hygiene measures. Under local anesthesia full-mouth supragingival and subgingival scaling and root planning procedure will be performed. After therapy, a periodontal evaluation will be done and the selected sites will be divided into group A and group B.~The Group A subjects will be treated with conventional flap surgery using Bioactive silica graft with PRF as a graft.~Group B will be treated with conventional flap surgery +bioactive silica graft alone in intrabony defects."|t|||
1295724|NCT03651895|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1295725|NCT03651882|Randomized|Parallel Assignment||Prevention||None (Open Label)||Before c-section the patients will be randomized to the oxytocin or the carbetocin group.||||
1295726|NCT03651869|Randomized|Crossover Assignment||Health Services Research||Single||Within-subject|||t|
1295727|NCT03651856||Single Group Assignment||Treatment||None (Open Label)||||||
1295728|NCT03651843|||Other||Prospective|||||||
1295729|NCT03651830|Randomized|Crossover Assignment||Treatment||Single|||t|||
1295730|NCT03651817|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1295731|NCT03651804|Randomized|Crossover Assignment||Treatment||Single||||||t
1295732|NCT03651791||Single Group Assignment||Treatment||None (Open Label)||||||
1295733|NCT03651778|||Case-Only||Prospective|||||||
1295734|NCT03651765||Single Group Assignment||Treatment||None (Open Label)||Open label treatment||||
1295735|NCT03651752||Single Group Assignment||Treatment||None (Open Label)||||||
1295736|NCT03651739|||Case-Only||Prospective|||||||
1295737|NCT03651726|Randomized|Parallel Assignment||Treatment||Triple||Randomized, double-blind, placebo controlled, proof of concept study, followed by an open uncontrolled treatment phase|t||t|t
1295738|NCT03651713|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Randomized||||
1295739|NCT03651700|Randomized|Parallel Assignment||Treatment||Quadruple|The individual administering TMS will keep the master file of subject assignments, but all other individuals in contact with the subject or their data will be unaware of group assignment. Participants will not be informed of their assignment to active or sham status.|Participants will be randomized to either TMS or sham TMS in a 2:1 allocation ratio.|t|t|t|t
1295740|NCT03651687|||Cohort||Prospective|||||||
1295741|NCT03651674|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1295742|NCT03651661|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1295743|NCT03651648|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1295744|NCT03651635|||Cohort||Prospective|||||||
1295745|NCT03651622|Randomized|Sequential Assignment||Treatment||None (Open Label)||This initial pilot and feasibility study uses a Sequential, Multiple Assignment, Randomized Trial (SMART) design to identify acceptable and effective dietary strategies to optimize both glycemic control and weight management. The study will be done at UNC and Stanford. Sequential randomization will occur at 0, 3.5, and 7 months. Following the baseline measurement visit and two week run-in period, participants will be randomized to one of three diets (stratified by site with block size of 4). Using a priori decision rules at 3.5 and 7 months post-initial randomization, those for whom the assigned diet is not acceptable or effective will be re-randomized (or re-assigned if only one diet remains untried). 10.5 months of follow-up time allows for evaluation of the effect of diets on initial weight loss and on early maintenance of initial weight loss. Decision criteria for re-randomization will incorporate clinical outcomes (glycemic control and weight change) and acceptability of the diet.||||
1295746|NCT03651609|Randomized|Parallel Assignment||Treatment||Single|Three examiners will perform one part of diagnostic evaluation that will include: (1) patients' history and focused neurological examination, (2) (EDx) and (3) US studies. They will be blinded to the findings of the other parts of the evaluation.|Patients with suspected UNE will be prospectively recruited in a single secondary referral center. First of three blinded examiners will obtain patients' history and perform focused neurological examination. The second examiner will perform electrodiagnostic (EDx) and the third ultrasonographic (US) studies. Patients with UNE under the HUA and in the RTC groove will be randomly distributed in two groups for surgical HUA release and conservative treatment. During surgical intervention the surgeon will cut the HUA with minimal incision technique. All patients (including surgically treated) will be given pictured recommendations with descriptions, which limb positions should be avoided. In order to prevent deterioration in conservatively treated group of patients with UNE at HUA, control neurological examination will be performed every 3 months. At 1 year follow-up we will use identical protocol as at the time of initial diagnostic evaluation.|||t|
1295747|NCT03651596|Randomized|Parallel Assignment||Treatment||Single|||t|||
1295748|NCT03651583||Single Group Assignment||Prevention||None (Open Label)||||||
1295749|NCT03651570|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1295750|NCT03651557|Randomized|Parallel Assignment||Treatment||Triple|Double Blind (Subject, Caregiver, Investigator)||t|t|t|
1295751|NCT03651544|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||"Taking into account the fact that the drug is being studied for the first time with the participation of people, initially 5 volunteers will be hospitalized, who will receive the study drug at a dose of 1. If the safety of the drug is confirmed by the results of observation on the 7th day of the study, the study will continue with the participation of 7 more volunteers in this dosing group.~Further, according to a similar scheme (each time after an interim safety assessment on day 7), volunteers receiving the drug at a dose 2 and dose 3 will be included in the study."||||
1295752|NCT03651531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295753|NCT03651518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295754|NCT03651505|||Cohort||Prospective|||||||
1295755|NCT03651492|||Cohort||Cross-Sectional|||||||
1295756|NCT03651479|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled study||||
1295757|NCT03651466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295758|NCT03651453|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|A controlled un-blinded pilot study.|A controlled un-blinded pilot study.||||
1295759|NCT03651440|Randomized|Crossover Assignment||Treatment||Single|||t|||
1295760|NCT03651427||Single Group Assignment||Treatment||None (Open Label)||Sel-controlled case series||||
1295761|NCT03651414|||Case-Control||Prospective|||||||
1295762|NCT03651401|||Case-Control||Prospective|||||||
1295763|NCT03651388|||Family-Based||Other|||||||
1295764|NCT03651375||Single Group Assignment||Treatment||None (Open Label)||||||
1295765|NCT03651362|||Cohort||Prospective|||||||
1295766|NCT03651349|Randomized|Parallel Assignment||Other||Double|||t||t|
1295767|NCT03651336||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295768|NCT03651323|||Cohort||Retrospective|||||||
1295769|NCT03651310|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295913|NCT03649438||Single Group Assignment||Treatment||None (Open Label)||||||
1295914|NCT03649425|||Cohort||Prospective|||||||
1296214|NCT03645525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295770|NCT03651297|Randomized|Crossover Assignment||Other||None (Open Label)||The first group will complete two sessions of harnessed video gaming balance training. The second group will include older adults over the age of 50 with self-reported falls or the fear of falling. The second group of older adults will complete two sessions of a reactive (slip) training protocol. For both groups, the first session participants will be assigned randomly to use a standard fall-arrest harness or the new BWS harness system. At the second session, they will switch the harness used.||||
1295771|NCT03651284|Randomized|Parallel Assignment||Treatment||Single||||||t
1295772|NCT03651271|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295773|NCT03651258|||Cohort||Prospective|||||||
1295774|NCT03651245|||Case-Control||Prospective|||||||
1295775|NCT03651232|Randomized|Parallel Assignment||Treatment||Single||||||t
1295776|NCT03651219|Randomized|Parallel Assignment||Treatment||None (Open Label)||experimental group: Irinotecan 80mg/m2 d1,d8 vi, apatinib mesylate tablets(250mg/d) po, 4-6 cycle（21d per cycle）; controlled group: Irinotecan 80mg/m2 d1,d8 vi, 4-6 cycle（21d per cycle）;||||
1295777|NCT03651206|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Phase 2 :~Arm A - Niraparib~Arm B - Niraparib plus TSR-042~Arm C - Chemotherapy drugs~Peak the winner between the Arm A or the arm B~Phase 3:~Arm A: The best arm of the phase 2~Arm B: Chemotherapy drugs"||||
1295778|NCT03651193|||Cohort||Cross-Sectional|||||||
1295779|NCT03651180|||Other||Prospective|||||||
1295780|NCT03651167|||Case-Only||Cross-Sectional|||||||
1295781|NCT03651154|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1295782|NCT03651141|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1295783|NCT03651128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295784|NCT03651115|||Other||Prospective|||||||
1295785|NCT03651102||Single Group Assignment||Treatment||None (Open Label)||||||
1295786|NCT03651089|Randomized|Sequential Assignment||Treatment||Triple||This study is set up as 3 sequential parallel studies, each testing a different drug dosage against placebo. In each dosing cohort, three patients (2 active and 1 placebo) will be randomized to receive a single study drug infusion on separate days, at least 24 hours apart. The remaining subjects in each dosing cohort (1 placebo and 4 active) will receive study drug after at least 24 hours from the 3rd subject.|t|t|t|
1295787|NCT03651076|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295788|NCT03651063|Randomized|Parallel Assignment||Treatment||Double||3 groups, each group will have a different intervention program|t|||t
1295789|NCT03651050|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1295790|NCT03651037|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295791|NCT03651024||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1295792|NCT03651011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295793|NCT03650998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295794|NCT03650985||Single Group Assignment||Treatment||None (Open Label)||Pregnancy women with complicated twin diseases, who are able to withstand risks of intrauterine treatments and informed consent.||||
1295795|NCT03650972|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295796|NCT03650959|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295797|NCT03650946|||Cohort||Prospective|||||||
1295798|NCT03650933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295799|NCT03650920||Single Group Assignment||Treatment||None (Open Label)||||||
1295800|NCT03650907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295801|NCT03650894||Single Group Assignment||Treatment||None (Open Label)||This is a phase II open-label study of nivolumab combined with ipilimumab and bicalutamide for HER2-negative metastatic or unresectable breast cancer.||||
1295802|NCT03650881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295803|NCT03650868|Randomized|Crossover Assignment||Prevention||Single||||||t
1295804|NCT03650855|||Cohort||Prospective|||||||
1295805|NCT03650842||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295806|NCT03650829|||Cohort||Prospective|||||||
1295807|NCT03650816|||Case-Control||Cross-Sectional|||||||
1295808|NCT03650803||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295809|NCT03650790|Randomized|Parallel Assignment||Prevention||Single||40 obese preeclamptic pregnant women 40 non-obese preeclamptic pregnant women 40 normal pregnant women|||t|
1295810|NCT03650777||Single Group Assignment||Other||None (Open Label)||Educational Intervention||||
1295811|NCT03650764|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1295812|NCT03650751|||Case-Only||Cross-Sectional|||||||
1295813|NCT03650738||Single Group Assignment||Treatment||None (Open Label)||||||
1295814|NCT03650725|||Cohort||Prospective|||||||
1295815|NCT03650712|Non-Randomized|Single Group Assignment||Diagnostic||Double|||t|t||
1295816|NCT03650699|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1295817|NCT03650686|||Other||Prospective|||||||
1295818|NCT03650673||Single Group Assignment||Health Services Research||None (Open Label)||||||
1295819|NCT03650660|||Case-Only||Prospective|||||||
1295820|NCT03650647|Randomized|Factorial Assignment||Treatment||Triple||Tooth receive one of the two test treatments: Stepwise Excavation (conservative treatment 1), Selective caries removal (conservative treatment 2) and are evaluated in parallel against a control group (indirect pulp capping treatment).|t||t|t
1295821|NCT03650634|||Case-Only||Cross-Sectional|||||||
1295822|NCT03650621|Randomized|Parallel Assignment||Treatment||Triple|patients are preterm infants and therefore mask, care provider will balsa masked as well as outcome assessor.|this is a two arm parallel design randomized controlled trial|t|t||t
1295823|NCT03650608|Randomized|Sequential Assignment||Basic Science||Triple|||t||t|t
1295824|NCT03650595||Single Group Assignment||Treatment||None (Open Label)||Prospective, open-label single-arm effectiveness study||||
1295957|NCT03648866|||Other||Prospective|||||||
1295958|NCT03648853|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1295825|NCT03650582|Randomized|Crossover Assignment||Basic Science||Single|Single-blinded study with participant blinded to treatment|Participants receive either glucagon or placebo as intranasal spray, in random order on 2 separate study visits, with indirect calorimetry, appetite and food intake assessment|t|||
1295826|NCT03650569|||Family-Based||Other|||||||
1295827|NCT03650556||Single Group Assignment||Treatment||None (Open Label)||||||
1295828|NCT03650543|Randomized|Parallel Assignment||Treatment||Single|The mean masking was the treating Gastroenterologist doctor.|A randomized single - blinded Clinical Trial conducted from 2012 to 2015 in Bogotá, Colombia. The aim was studying the effectiveness of triple therapy for H. pylori with amoxicillin, clarithromycin and standard dose of omeprazole versus amoxicillin, clarithromycin with dose of omeprazole according to CYP2C19 polymorphisms was studied, the subjects were allocated to a treatment regimen according to a randomized crossover sequence, provided by a computer-generated randomization list. Patients were contacted by telephone for assigned an appointment for treatment delivery according to the assigned group.||t||
1295829|NCT03650530||Single Group Assignment||Supportive Care||None (Open Label)||An intervention study with a single group design.||||
1295830|NCT03650517|||Cohort||Prospective|||||||
1295831|NCT03650504|Randomized|Parallel Assignment||Treatment||Single|||t|||
1295832|NCT03650491|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Following completion of the dose escalation phase of the study and determination of a recommended phase 2 dose, patients will be enrolled into a dose expansion cohort.||||
1295833|NCT03650478|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Prospective single center crossover study with two different arms, one conducted in the Neonatal Intensive Care Unit and the other in the Pediatric Intensive Care Unit.||||
1295834|NCT03650465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295835|NCT03650452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295836|NCT03650439|||Cohort||Prospective|||||||
1295837|NCT03650426|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1295838|NCT03650413||Single Group Assignment||Treatment||None (Open Label)||||||
1295839|NCT03650400||Sequential Assignment||Treatment||None (Open Label)||There will be 2 treatment dose cohorts studied (fevipiprant dose A once daily and one higher dose selected based on PK obtained at dose A mg/day, fevipiprant dose B once daily). Within each dose cohort, subjects will be stratified approximately 1:1 ratio into 2 age groups: ages 6 to < 9 years and ages 9 to < 12 years.||||
1295840|NCT03650387||Single Group Assignment||Treatment||None (Open Label)|Rater-blinded live evaluation of scale scores (the blinded rater does not know which indications were treated)|||||
1295841|NCT03650374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295842|NCT03650361|Randomized|Parallel Assignment||Treatment||Quadruple||Double (Participant, Investigator)|t|t|t|t
1295843|NCT03650348||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment Drug PRS-343 Combination Therapy||||
1295844|NCT03650335|||Other||Prospective|||||||
1295845|NCT03650322|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1295846|NCT03650309||Single Group Assignment||Treatment||None (Open Label)||||||
1295847|NCT03650296|||Other||Prospective|||||||
1295848|NCT03650283||Single Group Assignment||Other||Single|||t|||
1295849|NCT03650270|Randomized|Parallel Assignment||Treatment||Single|The specific treatment protocol was blinded to the data analyser|random allocation to 2 study protocols||||t
1295850|NCT03650257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295851|NCT03650244|||Case-Only||Prospective|||||||
1295852|NCT03650231|||Case-Only||Retrospective|||||||
1295853|NCT03650218||Single Group Assignment||Other||None (Open Label)||||||
1295854|NCT03650205|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1295855|NCT03650192||||||||||||
1295856|NCT03650179|||Cohort||Prospective|||||||
1295857|NCT03650166|Randomized|Parallel Assignment||Health Services Research||Single|Outcome assessor will be blinded to group assignment|||||t
1295858|NCT03650153|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1295859|NCT03650140|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1295860|NCT03650127|||Cohort||Prospective|||||||
1295861|NCT03650114||Single Group Assignment||Treatment||None (Open Label)||||||
1295862|NCT03650101|||Cohort||Prospective|||||||
1295863|NCT03650088||Single Group Assignment||Treatment||None (Open Label)||||||
1295864|NCT03650075|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1295865|NCT03650062|||Cohort||Prospective|||||||
1295866|NCT03650049|||Case-Only||Retrospective|||||||
1295867|NCT03650036|Randomized|Parallel Assignment||Treatment||Double|The clinical evaluations will be performed by two Paediatric Dentists who will not participate in the clinical part and will not know which group the teeth belong to. Participants also will not know in which group they will be allocated.|The patients will be allocated into two groups and will remain in the group until the end of the experiment.|t|||t
1295868|NCT03650023|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295869|NCT03650010|||Case-Control||Other|||||||
1295870|NCT03649997|Randomized|Sequential Assignment||Other||Double|||t||t|
1295871|NCT03649984|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||cluster-randomized waitlist design||||
1295872|NCT03649971|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295873|NCT03649958|Randomized|Parallel Assignment||Treatment||Double|Single-blind (participants and outcomes assessors blinded, but technologists are not)|randomized controlled trial|t|||t
1295874|NCT03649945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295910|NCT03649477|Randomized|Parallel Assignment||Treatment||Quadruple||Three parallel groups (two different doses of carbetocin and placebo) for the first 8 weeks; two parallel groups (two different doses of carbetocin) during 56 weeks of follow-up period|t|t|t|t
1295911|NCT03649464||Sequential Assignment||Treatment||None (Open Label)||"Dose escalation cohort: 1000mg twice daily (BID), 1000mg thrice daily (TID), 1500mg thrice daily (TID).~Expansion cohort: MTD defined in the dose escalation study."||||
1295912|NCT03649451|||Other||Prospective|||||||
1295875|NCT03649932|Randomized|Parallel Assignment||Prevention||None (Open Label)||Previous studies in patients undergoing cardiac surgery have shown that post-operative pulmonary hypertension did not develop in patients with citrulline level > 37 micromol/L. A cross-sectional study reported that citrulline levels < 29 micromol/L was associated with BPD_PH (100% sensitivity and 75% specificity) hence this may be used as a screening tool for BPD_PH2. The investigators will use the higher levels of citrulline of the reported levels as our goal (>37µmol/L). The investigators will supplement infants with 3 different dosages and check serum levels to see what dose is required to achieve the optimal plasma level of citrulline (>37µmol/L).||||
1295876|NCT03649919|||Case-Only||Prospective|||||||
1295877|NCT03649906||Single Group Assignment||Treatment||None (Open Label)||This study intends to use a single set of target values for non-randomized controlled trials, and enrolled 120 subjects who met the inclusion criteria. The small pulmonary nodules were located using an optimized pre-loaded microcoil puncture positioning method. Observe the clinical indicators such as pneumothorax incidence rate, positioning success rate, other complication rate, operation time, and number of operators, and evaluate the safety and effectiveness of the optimized CT-guided pulmonary nodule microcoil localization technique.||||
1295878|NCT03649893|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||Randomised Controlled Trial||||
1295879|NCT03649880||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295880|NCT03649867||Single Group Assignment||Other||None (Open Label)||Qualitative Study - semi-structured interviews||||
1295881|NCT03649854|||Case-Control||Prospective|||||||
1295882|NCT03649841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295883|NCT03649828|Randomized|Parallel Assignment||Treatment||Quadruple|Both Kefir and curd had been prepared to have the same consistency, color and flavor. Therefore, participants did not know if they were actually receiving kefir or curd. The care provider was a nutritionist that did not from each group the participants came from. There was two major investigators. The investigator responsible for the analysis of the data was also blind to the experimental groups, and he was also the outcome assessor.|There were two experimental groups. The kefir group (KG), that received orally probiotic milk fermented with the kefir grains, and the control group (CG), that received curd|t|t|t|t
1295884|NCT03649815||Single Group Assignment||Other||None (Open Label)||||||
1295885|NCT03649802|Randomized|Parallel Assignment||Treatment||Double|The study coordinators will be aware of the allocation into the low and high dose vitamin D groups but the patient and the investigators will be blinded from this information.|Subjects will be randomized in a double blind manner. Arterial stiffness and oxidative stress markers will be evaluated in the low dose Vitamin D (800 IU) versus a high dose vitamin D (5000 IU) over a period of a year|t||t|
1295886|NCT03649789|||Cohort||Retrospective|||||||
1295887|NCT03649776|||Ecologic or Community||Prospective|||||||
1295888|NCT03649763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295889|NCT03649750|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1295890|NCT03649737||Single Group Assignment||Supportive Care||None (Open Label)||||||
1295891|NCT03649724|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1295892|NCT03649711|Randomized|Parallel Assignment||Treatment||Triple|"CKD participants will be randomly assigned into one of the 2 study groups: ticagrelor (90 mg) one pill in the morning and one pill in the evening, or, clopidogrel (75 mg) one pill in the morning + placebo one pill in the evening. Placebo looks like the study drug but has no medicine in it. Neither participant nor the study personnel will know about allocation. The study drugs will look the same, except aspirin pill which will be dispensed to everyone in an open label manner.~There is no masking for control with normal kidney function. Participants will be asked to take open label ticagrelor, 90 mg twice daily (one pill in the morning and one pill in the evening) and aspirin 81 mg/day."|"CKD participants will be double-blind randomized in these two arms:~Arm 1 - Ticagrelor, 90 mg twice daily (one pill in the morning and one pill in the evening) + Aspirin 81 mg/day. Ticagrelor is the test treatment.~Arm 2 - Clopidogrel, 75 mg/day in the morning and a matching placebo in the evening + Aspirin 81 mg/day. Clopidogrel is the reference treatment.~Arm 3: Control with normal kidney function will be recruited after matching for age and diabetes status to the Arm 1 participants. Participants will be asked to take Ticagrelor, 90 mg twice daily (one pill in the morning and one pill in the evening) and aspirin 81 mg/day. Open label treatment.~All participants are required to take the oral treatment for a total of two weeks."|t||t|t
1295893|NCT03649698|Randomized|Parallel Assignment||Treatment||Triple|"Participant: Yes blinded for protein and omega-3~Investigator: Yes blinded for protein and omega-3~Outcomes Assessor: Yes blinded for protein and omega-3~No blinding for exercise intervention.~Statisticus is blinded for protein, omega-3 and exercise intervention."||t||t|t
1295894|NCT03649685|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1295895|NCT03649672|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Neuromuscular monitoring by TOF Watch SX on the dominant and on the non dominant arm||||
1295896|NCT03649659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1295897|NCT03649646|||Case-Only||Prospective|||||||
1295898|NCT03649633|Randomized|Parallel Assignment||Treatment||Quadruple|Participant, Care Provider, Investigator, Outcomes Assessor|Single-center, prospective, randomized, doubleblind, placebo-controlled, parallel-group clinical trial.|t|t|t|t
1295899|NCT03649620|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1295900|NCT03649607||Single Group Assignment||Treatment||None (Open Label)||||||
1295901|NCT03649594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295902|NCT03649581|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295903|NCT03649568|Randomized|Crossover Assignment||Diagnostic||Double|||||t|t
1295904|NCT03649555||Single Group Assignment||Other||None (Open Label)||||||
1295905|NCT03649542|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pre/Post||||
1295906|NCT03649529||Single Group Assignment||Treatment||None (Open Label)||Patients' autologous T cells will be isolated and transduced by GPA-TriMAR lentivirus to generate the GPA-TriMAR-T cells,and then infused back into the patient.||||
1295907|NCT03649516|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295908|NCT03649503|||Cohort||Prospective|||||||
1295909|NCT03649490|||Cohort||Prospective|||||||
1573314|NCT00001657||||||||||||
1295915|NCT03649412|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|There will be no masking as this is an open-label study.|This will be a 2 part, non-randomized, open label study which will assess the pharmacokinetic profile of GSK2982772, when administered orally as MR prototype coated tablet formulations relative to an immediate release (IR) reference tablet formulation at a fixed strength (Part A) and the pharmacokinetic profile of alternative tablet strengths of the selected modified release prototype coated tablet formulation (Part B, optional) in healthy subjects. Part A is a 6-period, 6-way fix sequence design, in which up to 4 MR tablet prototype may be evaluated, following single dose administration (240 mg) in fasted or fed state. There will be a minimum 7-day washout between doses. Part B of the study is optional. Following the final period of Part A, there will be an interim review to determine whether to proceed with optional Part B, and if so, the formulations and tablet strengths to be investigated in Part B.||||
1295916|NCT03649399||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295917|NCT03649386|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1295918|NCT03649373|||Other||Retrospective|||||||
1295919|NCT03649360|||Other||Cross-Sectional|||||||
1295920|NCT03649347|Randomized|Parallel Assignment||Treatment||None (Open Label)||Intervention vs non intervention control group; future phases will include conventional exposure therapy||||
1295921|NCT03649334|Randomized|Parallel Assignment||Other||Double|||t|t||
1295922|NCT03649321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295923|NCT03649308|Randomized|Parallel Assignment||Treatment||None (Open Label)||After split-thickness skin graft procedure, the participants are assigned to either conventional treatment or negative pressure wound therapy group in parallel for the duration of the study.||||
1295924|NCT03649295|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1295925|NCT03649282|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1295926|NCT03649269|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Voluntary subjects were assigned sequentially into two treatment groups: 1) fibrate (bezafibrate) 200 mg/day, and 2) PC-300 tea, one cup half an hour before eating.||||
1295927|NCT03649256|||Case-Control||Prospective|||||||
1295928|NCT03649243|||Case-Control||Cross-Sectional|||||||
1295929|NCT03649230|||Cohort||Prospective|||||||
1295930|NCT03649217||Single Group Assignment||Treatment||None (Open Label)||||||
1295931|NCT03649204|Randomized|Parallel Assignment||Treatment||Single||||||t
1295932|NCT03649191|Randomized|Parallel Assignment||Supportive Care||Single|Once the data is collected from all participating nursing homes, anonymized and and electronically encoded, the study arm will also be encoded and the person analyzing the data will be blinded to which group is which.|Cluster-randomized study||||t
1295933|NCT03649178|Randomized|Crossover Assignment||Other||Double|Participants and nutrition staff will know when participants are on a high salt or low salt diet. Outcomes Assessor will be kept blinded. Participants will be told not to inform outcomes assessor what diet they are on.|This will be a random-order, 2 period crossover study with washout|||t|t
1295934|NCT03649165|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1295935|NCT03649152|Randomized|Crossover Assignment||Treatment||Quadruple||Double-blind, Randomised, Placebo-Controlled, Crossover Study|t|t|t|t
1295936|NCT03649139|Randomized|Parallel Assignment||Treatment||Double||experiment:placebo=2:1|t||t|
1295937|NCT03649126|||Other||Prospective|||||||
1295938|NCT03649113||Single Group Assignment||Treatment||None (Open Label)||Clinical trials with a single arm investigating the safety and efficacy of percutaneous sclerotherapy of hepatic hemangiomas with the mixture of Bleomycin and Lipiodol||||
1295939|NCT03649100|Randomized|Parallel Assignment||Treatment||Triple|A blinded collaborator opened the opaque envelope after implant site development, giving the implant to the investigator that remain blinded. Both the test and control implants are perfectly the same.|To randomly compare implant stability quotient (ISQ) of Hiossen ET III implants with its new hydrophilic surface (NH) and Hiossen ET III implants with the conventional SA surface, in a split-mouth randomized study.|t||t|t
1295940|NCT03649087|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Vitrification of ovarian tissue||||
1295941|NCT03649074||Single Group Assignment||Treatment||None (Open Label)||The study will enroll participants into one of two cohorts according to stimulant status. Both cohorts will be assigned to AKL-T01 (with AKL-X01 symptom tracking).||||
1295942|NCT03649061|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Insufficient responders to a COBRA-Slim strategy, defined as not reaching low disease activity based on DAS28 CRP from week 8 until week 32 or not reaching remission based on DAS28 CRP at week 32, will be randomly assigned to one of the two arms.~Randomization will be balanced according to time-point of randomization, baseline (BL) disease activity and Anti-Citrullinated Protein Antibody (ACPA) and Rheumatoid Factor (RF) status to ensure comparability of the treatment groups with respect to these prognostic variables."||||
1295943|NCT03649048|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1295944|NCT03649035||Single Group Assignment||Treatment||None (Open Label)||||||
1295945|NCT03649022|||Cohort||Other|||||||
1295946|NCT03649009|Randomized|Parallel Assignment||Prevention||Single|This study is a single-blinded trial, with the participants from both intervention and placebo group will be masked|This study is a prospective, randomized controlled trial|t|||
1295947|NCT03648996|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1295948|NCT03648983|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1295949|NCT03648970|Randomized|Parallel Assignment||Prevention||Single|The diagnosis is made by resident unaware of the medication patients received|Multicenter Randomized Non Blinded Trial comparing low dose aspirin versus low dose aspirin and pravastatin in patients with high risk developing preeclampsia||||t
1295950|NCT03648957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295951|NCT03648944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295952|NCT03648931|||Cohort||Cross-Sectional|||||||
1295953|NCT03648918|||Family-Based||Prospective|||||||
1295954|NCT03648905|||Case-Control||Prospective|||||||
1295955|NCT03648892|||Case-Crossover||Prospective|||||||
1295956|NCT03648879||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295959|NCT03648840|Non-Randomized|Crossover Assignment||Basic Science||Single|Subjects are not informed which session will include aversive cues.|2 session crossover, random order, single blind|t|||
1295960|NCT03648827||Single Group Assignment||Treatment||None (Open Label)||||||
1295961|NCT03648814|Randomized|Parallel Assignment||Treatment||Single||||||t
1295962|NCT03648801|||Other||Prospective|||||||
1295963|NCT03648788|||Other||Prospective|||||||
1295964|NCT03648775|||Cohort||Prospective|||||||
1295965|NCT03648762|Randomized|Single Group Assignment||Treatment||None (Open Label)||Participants with heart failure will complete 1 of 3 exercise training interventions (aerobic vs. aerobic and strength vs. inspiratory) for 12 weeks and will be assessed pre and post to determine if any differences occur in their skeletal muscle and functional capacity as part of the exercise intervention.||||
1295966|NCT03648749||Single Group Assignment||Treatment||None (Open Label)||A single group will be studied during no intervention (no feedback about speech) and intervention (feedback about speech) phases.||||
1295967|NCT03648736|||Case-Only||Prospective|||||||
1295968|NCT03648723|||Case-Control||Prospective|||||||
1295969|NCT03648710|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1295970|NCT03648697||Single Group Assignment||Treatment||None (Open Label)||Single arm, open label, single dose phase I/II study of safety and efficacy.||||
1295971|NCT03648684|Randomized|Parallel Assignment||Prevention||Single|||t|||
1295972|NCT03648671|||Cohort||Prospective|||||||
1295973|NCT03648658||Single Group Assignment||Basic Science||None (Open Label)||||||
1295974|NCT03648645|Randomized|Parallel Assignment||Prevention||None (Open Label)||Multicenter, controlled, randomized clinical trial||||
1295975|NCT03648632||Single Group Assignment||Treatment||None (Open Label)||||||
1295976|NCT03648619||Single Group Assignment||Diagnostic||None (Open Label)||Clinically-indicated PET/CT and additional study-related MRI as a single Intervention.||||
1295977|NCT03648606|||Case-Only||Retrospective|||||||
1295978|NCT03648593|Randomized|Sequential Assignment||Prevention||None (Open Label)||randomized intervention trial with waiting list control||||
1295979|NCT03648580|Randomized|Parallel Assignment||Treatment||None (Open Label)|It's an open study. The number of protocol evaluable subjects for each group that complete the study and comply well with study protocol is planned to be 30.|the subjects will be randomized into intervention group and control group.||||
1295980|NCT03648567|||Case-Only||Retrospective|||||||
1295981|NCT03648554|Randomized|Parallel Assignment||Treatment||Single|Only centralized reading by the pathologist of the hepatic histology of the liver puncture biopsy (LPB) will be carried out in blinded procedure.|open, prospective, randomized, controlled study||||t
1295982|NCT03648541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1295983|NCT03648528|Randomized|Parallel Assignment||Treatment||Quadruple|Bottles filled with cholecalciferol or placebo pills by the drug company (Celsius) and named after randomization by the pharmacist and delivered to the dialysis unit to be administrated by the nurses|Randomized, double blind clinical trial in two arms|t|t|t|t
1295984|NCT03648515|||Other||Cross-Sectional|||||||
1295985|NCT03648502|Non-Randomized|Parallel Assignment||Diagnostic||Single||3 participants arms Diagnostic tools validation||||t
1295986|NCT03648489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1295987|NCT03648476|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1295988|NCT03648463|Randomized|Parallel Assignment||Treatment||Double|Patients will not know if they received the surgical intervention that entails removing of the calcified cartilage or not.||t|||t
1295989|NCT03648450|||Case-Only||Prospective|||||||
1295990|NCT03648437|Randomized|Parallel Assignment||Treatment||Triple|Placebo, 0.45 % saline, is similar to paracetamol, both being clear liquids, so the staff will remain unaware which drug the patient receives. The study drug will be kept and prepared away from the neonatal intensive care unit, at the separate ward 55 office, in a locked cabinet. The study drug will be prepared by the research nurse, the pharmacist of the ward, or during nighttime, by a nurse who does not participate in the study patients' treatment in any way.|one center, randomized, placebo-controlled, double-blind, clinical trial with an additional open arm|t|t|t|
1295991|NCT03648424|||Cohort||Retrospective|||||||
1295992|NCT03648411|||Ecologic or Community||Cross-Sectional|||||||
1295993|NCT03648398||Single Group Assignment||Supportive Care||None (Open Label)||||||
1295994|NCT03648385|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1295995|NCT03648372||Single Group Assignment||Treatment||None (Open Label)||||||
1295996|NCT03648359||Single Group Assignment||Diagnostic||None (Open Label)||||||
1295997|NCT03648346|Randomized|Sequential Assignment||Basic Science||Triple|||t||t|t
1295998|NCT03648333|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1295999|NCT03648320||Single Group Assignment||Treatment||None (Open Label)||||||
1296000|NCT03648307|||Cohort||Retrospective|||||||
1296001|NCT03648294|||Case-Only||Retrospective|||||||
1296002|NCT03648281|||Cohort||Prospective|||||||
1296003|NCT03648268|Randomized|Parallel Assignment||Basic Science||Quadruple|The subjects, care providers, investigators and outcome assessors will all be blinded as to the randomization sequence, and thus will be blinded as to sham vs active TMS status. Blinding codes are used to determine which side of an active/passive Magpro coil (cool B65 A/P, Magventure A/S, Denmark) is used for stimulation.|There will be four groups: an active DLPFC TMS group, an active TMS cerebellum group, a sham DLPFC group, and a sham cerebellum group. Participants will be randomized to one of these group groups, and they will receive that type of stimulation for the entire study.|t|t|t|t
1296004|NCT03648255|||Cohort||Prospective|||||||
1296005|NCT03648242|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1296006|NCT03648229|Randomized|Parallel Assignment||Treatment||Single|Study personnel assessing IOP will be masked to treatment assignment during the first 12-month period and to all prior IOP measurements at every visit. IOP will be obtained using the iCare tonometer which provides an objective, digital reading.|Prospective, randomized, active-controlled parallel-group design||||t
1296082|NCT03647241|Randomized|Parallel Assignment||Treatment||Single||||||t
1573315|NCT00001646||||Treatment||||||||
1296007|NCT03648216|Randomized|Parallel Assignment||Other||Single|Study advertisements and information provided to participants will focus on non-specific behaviour change, in order to mask participants to the purpose of the study.|Upon obtaining consent, eligible participants will complete a week-long baseline period and then will be randomly assigned to either a 1-week intervention or control group, followed by a 1-week follow-up period.|t|||
1296008|NCT03648203||Single Group Assignment||Supportive Care||None (Open Label)||This study is using a single arm, single site, pre-post assessment interventional design, with no control group. Because this is a pilot study, all subjects will receive the intervention.||||
1296009|NCT03648190|||Case-Control||Cross-Sectional|||||||
1296010|NCT03648177|Randomized|Parallel Assignment||Treatment||Single|||t|||
1296011|NCT03648164|||Other||Prospective|||||||
1296012|NCT03648151|||Cohort||Retrospective|||||||
1296013|NCT03648138|Randomized|Factorial Assignment||Prevention||None (Open Label)|Although participants are not blinded to the study arm to which they are randomized, they are not told the true purpose of the study until after completing the study.|||||
1296014|NCT03648125|Randomized|Sequential Assignment||Basic Science||None (Open Label)||"Prospective, monocentric, randomized, open-label, cross-over study. Randomization applies on the order of the training sessions with or without occlusal disturbance."||||
1296015|NCT03648112|Randomized|Crossover Assignment||Treatment||None (Open Label)||crossover design||||
1296016|NCT03648099|Randomized|Parallel Assignment||Supportive Care||Single|In order to avoid bias in assessing pain and fear, three midwives who were not involved in the study team, who worked in the hospital where the study was carried out and who did not know the groups of the participants administered the scales. The midwives who were involved in data collection during the study were trained by the researchers on the use of data collection tools.|a single-blind randomized controlled intervention trial||t||
1296017|NCT03648086|Randomized|Parallel Assignment||Treatment||None (Open Label)||an open label, parallel study||||
1296018|NCT03648073|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1296019|NCT03648060||Single Group Assignment||Treatment||None (Open Label)||||||
1296020|NCT03648047|Randomized|Parallel Assignment||Treatment||Single|All patients will be assessed by an independent outcomes assessor|||||t
1296021|NCT03648034|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1296022|NCT03648021|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1296023|NCT03648008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296024|NCT03647995|Randomized|Parallel Assignment||Prevention||Quadruple|"The randomization will be taken care of by the hospital pharmacy which will not be in contact with the patient.~The intern/resident who will recruit a patient in the study will not be in direct contact with the pharmacy.~The order will be sent to the pharmacy which, following a randomization sheet, will then send a neutral box containing a probiotic or a placebo product.~Only once the trial comes to an end, the investigator will receive from the pharmacy the randomization sheet and will then know which patient was given a probiotic and which was given a placebo regimen."||t|t|t|t
1296025|NCT03647982|Non-Randomized|Parallel Assignment||Treatment||Double|||t|t||
1296026|NCT03647969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296027|NCT03647956||Single Group Assignment||Treatment||None (Open Label)||||||
1296028|NCT03647943|Randomized|Parallel Assignment||Treatment||Triple|One arm of this study is a sham condition; both tDCS and sham tDCS conditions are blinded to participants and study assessor/s.||t||t|t
1296029|NCT03647930|Randomized|Parallel Assignment||Prevention||None (Open Label)||Prospective randomized trial||||
1296030|NCT03647917|Randomized|Single Group Assignment||Treatment||Single|||t|||
1296031|NCT03647904|Randomized|Crossover Assignment||Treatment||Single|Outcomes assessor will not know if individual were in the treatment group or waitlist control group|Wait list control||||t
1296032|NCT03647891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296033|NCT03647878|||Cohort||Prospective|||||||
1296034|NCT03647865||Single Group Assignment||Treatment||None (Open Label)||||||
1296035|NCT03647852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296036|NCT03647839|Randomized|Parallel Assignment||Treatment||None (Open Label)|This is an open‐label, multicentre, parallel phase II study designed to assess the efficacy of the combination of nivolumab and BNC105 and the combination of nivolumab and BBI‐608. Patients with microsatellite stable adenocarcinoma of colorectal origin that is not resectable are eligible and will be randomised in the ratio of 1:1 using permuted block randomisation with stratification by screening ECOG performance status (0 or 1) to receive either nivolumab and BNC105 or nivolumab and BBI‐608.|This is an open‐label, multicentre, parallel phase II study designed to assess the efficacy of the combination of nivolumab and BNC105 and the combination of nivolumab and BBI‐608. Patients with microsatellite stable adenocarcinoma of colorectal origin that is not resectable are eligible and will be randomised in the ratio of 1:1 using permuted block randomisation with stratification by screening ECOG performance status (0 or 1) to receive either nivolumab and BNC105 or nivolumab and BBI‐608.||||
1296037|NCT03647826|Randomized|Sequential Assignment||Prevention||None (Open Label)||Mind Power Intervention Group 1 starts in the beginning of the school semester, and Mind Power Intervention Group 2 functions as a Control Group until it starts six months after Group 1.||||
1296038|NCT03647813|Randomized|Parallel Assignment||Treatment||Double|Only one researcher knew in which group the patients were allocated and performed all the treatments. A blinded researcher performed all the evaluations after the procedures. The patient was also blinded to the treatment as the laser was turned off, simulating the treatment.||t||t|
1296039|NCT03647800|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The study is composed of two parts. The first part is a Phase 1 open-label, dose-escalation study to determine the recommended dose for Phase 1b. The second part is a Phase 1b open label expansion study to assess the clinical activity and safety of the dose established in the first part of the study in additional patients with AML or MDS. Patients will receive APVO436 intravenously (IV) weekly for up to six 28-day cycles, unless disease progression, intolerable toxicity, or withdrawal of consent occurs earlier.||||
1296040|NCT03647787|||Case-Only||Retrospective|||||||
1296083|NCT03647228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296084|NCT03647215|||Cohort||Prospective|||||||
1296041|NCT03647774|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"A multicenter, open-label treatment study. Extended-release naltrexone hydrochloride injectable suspension (Vivitrol®) (later referred to as XR-NTX) 380 mg/4 weeks One control group enrolled in the national ART program receives treatment as usual; flexible dose of daily oral buprenorphine or buprenorphine-naloxone in line with the clinical guidelines in Norway"||||
1296042|NCT03647761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296043|NCT03647748|Randomized|Parallel Assignment||Treatment||Double||Patients randomly assigned to either the active 532nm treatment group, or the sham device (placebo) group using a modified device rigged to not treat patients.|t|t||
1296044|NCT03647735|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1296045|NCT03647722|||Cohort||Cross-Sectional|||||||
1296046|NCT03647709|||Cohort||Prospective|||||||
1296047|NCT03647696|||Cohort||Prospective|||||||
1296048|NCT03647683|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are randomly assigned to one of three experimental groups in parallel for the duration of the study||||
1296049|NCT03647670|Randomized|Crossover Assignment||Other||None (Open Label)||Natural log transformed area under the curve from zero to infinity, area under the plasma concentration-time curve from 0 to the time of last measurement and max plasma concentration of midazolam will be analyzed using a mixed effect model with sequence, period and treatment as fixed effects and subject within sequence as a random effect. Estimates of the adj mean differences (Test-Reference) and corresponding 90% CIs will be obtained from the model. The adjusted mean differences and 90% CIs for the differences will be exponentiated to provide estimates of the ratio of adjusted geometric means (Test/Reference) and 90% confidence intervals for the ratios. Midazolam alone will be the Reference treatment, while the midazolam co-administered with PF-04965842 will be the Test treatment. The lack of an effect of PF-04965842 on midazolam PK will be concluded if the 90% CI for the ratio of adjusted geometric mean for AUCinf falls wholly within acceptance region (80%, 125%).||||
1296050|NCT03647657|Randomized|Crossover Assignment||Basic Science||None (Open Label)|No masking|Group 1 patients will receive first 177Lu-PP-F11N alone, second 177Lu-PP-F11N in combination with Sacuitril. Group 2 patients will first receive 177Lu-PP-F11N in combination with Sacuitril, second 177Lu-PP-F11N alone. Affiliation of patients to Groups 1 and 2 will be randomised.||||
1296051|NCT03647644|||Case-Control||Prospective|||||||
1296052|NCT03647631|||Case-Only||Retrospective|||||||
1296053|NCT03647618|||Cohort||Prospective|||||||
1296054|NCT03647605||Single Group Assignment||Other||None (Open Label)||||||
1296055|NCT03647592|||Cohort||Retrospective|||||||
1296056|NCT03647579|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1296057|NCT03647566|||Cohort||Prospective|||||||
1296058|NCT03647553|||Cohort||Cross-Sectional|||||||
1296059|NCT03647540|Randomized|Parallel Assignment||Treatment||Single||||||t
1296060|NCT03647527|||Case-Only||Prospective|||||||
1296061|NCT03647514||Single Group Assignment||Treatment||None (Open Label)||||||
1296062|NCT03647501|Randomized|Parallel Assignment||Treatment||Single|Subjects will be blinded to their group status for the duration of the study assessments and procedures (24 months post-operatively).|All subjects will be randomized in the trial to receive either the Nexxt Spine Nexxt MatrixxTM 3D-printed titanium cage or the HonourTM PEEK cage supplemented with a pedicle screw system and milled local autograft bone. Subject randomization will be stratified according to smoking status.|t|||
1296063|NCT03647488|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1296064|NCT03647475||Single Group Assignment||Treatment||None (Open Label)||Prospective, multi-center, single arm study enrolling eligible subjects in the United States and Japan. Subjects will remain in the study with follow-up clinical assessments through 2 years, study exit, or death, whichever comes first.||||
1296065|NCT03647462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296066|NCT03647449|Randomized|Parallel Assignment||Basic Science||Single||||||t
1296067|NCT03647436|||Cohort||Prospective|||||||
1296068|NCT03647423|Randomized|Parallel Assignment||Treatment||None (Open Label)||Chordoma Vaccine: A randomized phase 1b/2 trial of the NANT chordoma vaccine vs. radiation in subjects with unresectable chordoma.||||
1296069|NCT03647410|||Cohort||Retrospective|||||||
1296070|NCT03647397||Single Group Assignment||Prevention||None (Open Label)||||||
1296071|NCT03647384|Randomized|Parallel Assignment||Other||Quadruple|"Participants are randomly and evenly assigned to 2 groups using block randomization.Random numbers are generated by the stratified random method using the SAS statistical software and assigned by an independent statistician at the Good Clinical Practice Institute of Xiyuan Hospital. Drugs are numerically labeled and sequenced according to the random numbers. The drug randomization is conducted by drug supplier. The patients are assigned to the intervention according to the sequence.~The clinicians, patients and statistician are blind to the patients' grouping assignment and intervention. Database is locked after all data is inputted. The grouping information will be revealed when statistical analyses are conducted. The researchers reveal the second blinding and write the study report finally. Unblinding is allowed only in emergency situation for the patients"||t|t|t|t
1296072|NCT03647371|||Cohort||Prospective|||||||
1296073|NCT03647358||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296074|NCT03647345|Randomized|Parallel Assignment||Treatment||Single|||t|||
1296075|NCT03647332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296076|NCT03647319|Randomized|Parallel Assignment||Treatment||Single|||t|||
1296077|NCT03647306|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1296078|NCT03647293|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296079|NCT03647280||Single Group Assignment||Treatment||None (Open Label)||||||
1296080|NCT03647267|Randomized|Parallel Assignment||Treatment||Triple|Visual acuity and optical coherence tomography technicians will be masked to treatment group at all visits. The goal is for study participants to remain masked to their treatment group assignment, although it is likely that the gas bubble will be visible to participants in the pneumatic vitreolysis group. Investigators and study coordinators are not masked to treatment group.||t|t||t
1296081|NCT03647254|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1296085|NCT03647202|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Participants will be assigned to 1 of 6 treatment sequences (Sequences ABC, ACB, BAC, BCA, CAB, or CBA), according to a pre-generated randomization scheme.||||
1296086|NCT03647189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296087|NCT03647176|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296088|NCT03647163|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1296089|NCT03647150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296090|NCT03647137|||Case-Control||Cross-Sectional|||||||
1296091|NCT03647124|||Cohort||Retrospective|||||||
1296092|NCT03647111|||Cohort||Retrospective|||||||
1296093|NCT03647098|||Cohort||Retrospective|||||||
1296094|NCT03647085|||Cohort||Prospective|||||||
1296095|NCT03647072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296096|NCT03647059|||Case-Only||Cross-Sectional|||||||
1296097|NCT03647046||Single Group Assignment||Basic Science||None (Open Label)||||||
1296098|NCT03647033|Randomized|Parallel Assignment||Treatment||Double|"Shuffled envelope system. Patient will be blinded to the procedure. The intraocular pressure (IOP) measure and reader will be blinded to the procedure.~There will be no planned breaking of randomization. Unplanned breaking will happen if any envelopes are damaged or lost. Unmasking will take place after 1 year post operation by the study team to inform the patient of the procedure."|"Single centre, randomised prospective trial, the patient and the intraocular pressure (IOP)checking staff will be blinded. Randomised by random envelope shuffle technique.~1:1 ratio allocation 2 arms: phacoemulsification alone and phacoemulsification and iStent. 16 patients in each arm, 32 patients in total. The post-operative management is the same for both arms After operation the patient will be followed up at day 1, week 1, week 2, months 1, 3, 6 and 12.~At each visit the patient will have the following tests: Tonometry (IOP check) - Not to be taken by the operating surgeon, to be taken by 2 people, one IOP checker and one reader."|t|||t
1296099|NCT03647020|||Case-Only||Retrospective|||||||
1296100|NCT03647007|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1296101|NCT03646994|||Cohort||Retrospective|||||||
1296102|NCT03646981|||Cohort||Prospective|||||||
1296103|NCT03646968||Single Group Assignment||Treatment||None (Open Label)||||||
1296104|NCT03646955|Randomized|Parallel Assignment||Treatment||None (Open Label)||Clinically controlled randomized trial||||
1296105|NCT03646942|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296106|NCT03646929|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1296107|NCT03646916|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296108|NCT03646903|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1296109|NCT03646890|||Cohort||Retrospective|||||||
1296110|NCT03646877|Randomized|Crossover Assignment||Other||Single|||t|||
1296111|NCT03646864|Randomized|Crossover Assignment||Treatment||Quadruple||2-way crossover study|t|t|t|t
1296112|NCT03646851||Single Group Assignment||Health Services Research||None (Open Label)||||||
1296113|NCT03646838|||Cohort||Prospective|||||||
1296114|NCT03646825|||Cohort||Prospective|||||||
1296115|NCT03646812|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1296116|NCT03646799|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1296117|NCT03646786||Single Group Assignment||Other||None (Open Label)||||||
1296118|NCT03646773|||Cohort||Prospective|||||||
1296119|NCT03646760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296120|NCT03646747||Single Group Assignment||Basic Science||None (Open Label)||Single site, non-randomised basic science study||||
1296121|NCT03646734|||Case-Control||Prospective|||||||
1296122|NCT03646721|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1296123|NCT03646708|||Cohort||Prospective|||||||
1296124|NCT03646695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296125|NCT03646682|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1296126|NCT03646669|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1296127|NCT03646656|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||single group assignment||||
1296128|NCT03646643|Randomized|Parallel Assignment||Treatment||Double|Once patients are enrolled in the study, they will be randomized to arm A: PVI + triggers ablation, or arm B: PVI + triggers ablation + coronary sinus-left atrium connection ablation. Patients will be blinded to the randomization scheme.|The PRECAF study is designed as a randomized, single-blind, small scale pilot study. Enrolled subjects who satisfy all eligibility criteria will then undergo the ablation procedure. Study randomization will be performed in a 1:1 fashion using the Urn Randomization program (https://health.uconn.edu/community-medicine/programs/health-services-research-unit/project-match/urn-randomization/) while balancing sex and AF type (paroxysmal and non-paroxysmal). The master list of study assignments will be kept by the study coordinator in a password protected and encrypted computer. After the ablation procedure, participants will remain in the study for 6 months. A 30-day event monitor will be used for the first month after ablation. Then, regular clinic visits at 6 weeks and 6 months will be arranged after ablation with 12 lead electrocardiogram check-up. In the last month, a 30-day event monitor will again be utilized to detect atrial arrhythmia recurrence.|t|||t
1296129|NCT03646630|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1296130|NCT03646617|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1296131|NCT03646604|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1296132|NCT03646591|||Cohort||Prospective|||||||
1296133|NCT03646578|||Case-Only||Retrospective|||||||
1296134|NCT03646565|||Case-Only||Other|||||||
1296135|NCT03646552||Single Group Assignment||Treatment||None (Open Label)||||||
1296136|NCT03646539|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296137|NCT03646526|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1296138|NCT03646513|||Cohort||Prospective|||||||
1296181|NCT03645954|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1573316|NCT00001642||||||||||||
1296139|NCT03646500|Randomized|Parallel Assignment||Treatment||Quadruple||Prospective randomized controlled non-inferiority trial, with retrobulbar block being the gold standard. Patients will be randomized to receive conscious sedation or retrobulbar injection prior to trans-scleral diode laser (TSD).|t|t|t|t
1296140|NCT03646487|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1296141|NCT03646474|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1296142|NCT03646461|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, multi-center, randomized, controlled, clinical trial. Enrollment will be stratified by HPV status and randomized in a 1:1 ratio to either ibrutinib + cetuximab or ibrutinib + nivolumab||||
1296143|NCT03646448|Randomized|Parallel Assignment||Treatment||Single||||||t
1296144|NCT03646435||Single Group Assignment||Screening||None (Open Label)|After all the study participants are recruited, they will be assigned a study ID which investigators will use to anonymize data and track patient health data that is collected via the Fitbit.|This study model will involve a single cohort of about 50 GIM patients. All patients will be asked to wear the Fitbit Charge 2 for the duration of their stay in the hospital and the health information (heart rate, sleep, physical activity) collected from the wearable will be compared to the nurses' vital sign assessment for accuracy. There will be no other comparison group in this study.||||
1296145|NCT03646422|||Cohort||Prospective|||||||
1296146|NCT03646409|||Cohort||Retrospective|||||||
1296147|NCT03646396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"Drug sof-Dakla"||||
1296148|NCT03646383||Single Group Assignment||Treatment||None (Open Label)||||||
1296149|NCT03646370|||Cohort||Retrospective|||||||
1296150|NCT03646357|Randomized|Parallel Assignment||Treatment||None (Open Label)||PROBE - prospective, randomized, open blinded end-point||||
1296151|NCT03646344|Randomized|Parallel Assignment||Treatment||Quadruple|There will be an unblinded member of the research team (the individual administering the intervention) but otherwise the participant, the other members of the research team, the clinical team and blinded assessors will be blinded to the intervention.|Multi-centre, parallel group 1:1 randomised placebo controlled trial|t|t|t|t
1296152|NCT03646331|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1296153|NCT03646318|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo medication|Randomised controlled trial (blinded)|t|t|t|t
1296154|NCT03646305|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This will be a single-center, parallel-group study with balanced randomization of participants into four conditions; two experimental and two control [1:1:1:1]. This is a non-inferiority study to examine whether singing is as effective as verbal repetition as a cognitive defusion strategy for body image distress.||||
1296155|NCT03646292|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|This study will conduct to evaluate the efficacy of liver fat lowering and safety of empagliflozin 10mg, pioglitazone 15mg alone or in combination with empagliflozin 10mg/pioglitazone 15mg for 6 months.||||
1296156|NCT03646279||Single Group Assignment||Device Feasibility||None (Open Label)||Single-subject A-B design||||
1296157|NCT03646266|Randomized|Parallel Assignment||Treatment||None (Open Label)||pilot randomized controlled trial (RCT)||||
1296158|NCT03646253|||Case-Only||Retrospective|||||||
1296159|NCT03646240||Single Group Assignment||Treatment||None (Open Label)||"Participation includes a 4-week baseline period, a 3-week dosing period and a 12-week follow-up period. After baseline participants will receive ABI-009 given weekly IV for 3 weeks. ABI-009 will be tested in cohorts of 3 participants using the standard 3+3 dose-finding design.~Escalation to the next dose level with a new cohort of 3 participants will occur after no DLT was observed. There will be no intra-participant dose escalation allowed. If DLT occurs in a cohort, an additional 3 participants will be recruited to the cohort. If no further DLTs occur, a new cohort of 3 participants at the next higher dose level can be enrolled. If 2/6 participants at dose level 1 experience a DLT, then that cohort will be closed to further enrollment and 3 participants will be enrolled at the next lower dose level, and so on. The MTD is the highest dose level in which ≤1 participant has a DLT.~Once MTD has been determined, MTD cohort will be opened for up to 6 additional participants."||||
1296160|NCT03646227|||Case-Only||Prospective|||||||
1296161|NCT03646214|Non-Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor reading the sleep studies will have the treatment arm masked.|Controlled clinical trial||||t
1296162|NCT03646201|Randomized|Parallel Assignment||Prevention||Single||||||t
1296163|NCT03646188|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|Color-matched placebo|3+3 Design||||
1296164|NCT03646175|Randomized|Crossover Assignment||Prevention||Single|||t|||
1296165|NCT03646162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296166|NCT03646149|||Case-Control||Prospective|||||||
1296167|NCT03646136|Randomized|Sequential Assignment||Other||Single|PACU nurses and patients will not be aware of which arm patient was randomized to.|||t||
1296168|NCT03646123||Single Group Assignment||Treatment||None (Open Label)||||||
1296169|NCT03646110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296170|NCT03646097|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296171|NCT03646084|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296172|NCT03646071|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1296173|NCT03646058|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296174|NCT03646045|||Case-Control||Prospective|||||||
1296175|NCT03646032|Randomized|Parallel Assignment||Prevention||Single|A total of 400 AAA males and females will be recruited from Washington, DC (n=200) and Birmingham, Alabama (n=200). At both data collection sites, participants will be randomly assigned to one of two groups i.e., intervention and control during the pilot.||t|||
1296176|NCT03646019|||Case-Control||Prospective|||||||
1296177|NCT03646006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296178|NCT03645993|||Cohort||Prospective|||||||
1296179|NCT03645980|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1296180|NCT03645967||Single Group Assignment||Prevention||None (Open Label)||Intervention in the standard of care for indwelling urinary catheter care and maintenance.||||
1296212|NCT03645551|||Cohort||Prospective|||||||
1296182|NCT03645941|Randomized|Parallel Assignment||Treatment||None (Open Label)||Our approach follows the three-stage model of behavioral therapies development and the proposed aims correspond to the two sub-stages characterizing Stage I work. In Stage Ia formative work, we will develop the Facebook intervention. In Stage Ib, we will use rigorous design and methodology to evaluate the intervention's feasibility and potential efficacy. Stage Ib results will inform a future R01, Stage II, randomized efficacy trial||||
1296183|NCT03645928|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296184|NCT03645915|||Case-Only||Retrospective|||||||
1296185|NCT03645902|||Case-Only||Prospective|||||||
1296186|NCT03645889|Randomized|Parallel Assignment||Treatment||Quadruple||Randomised Controlled Trial|t|t|t|t
1296187|NCT03645876||Single Group Assignment||Treatment||None (Open Label)||||||
1296188|NCT03645863|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1296189|NCT03645850|Randomized|Parallel Assignment||Treatment||Single||"Parallel Assignment Because the comparator will be in commercial packaging, the blinding of the subject is not possible.~However, the study will be blinded for the investigator: evaluations will be done by an independent investigator, different than the person who will distribute the product. Subjects will be identified by a patient number. Each patient number will be associated to a treatment number, according to a randomization list provided before the beginning of the clinical investigation, and randomized either in one of both treatment groups (Vismed Gel Multi 3% or Vismed Multi 0.18%)."|||t|
1296190|NCT03645837|Randomized|Parallel Assignment||Treatment||Single||||||t
1296191|NCT03645824||Single Group Assignment||Treatment||None (Open Label)||||||
1296192|NCT03645811|Randomized|Crossover Assignment||Supportive Care||Single|Students who arrived on the day of the exam were assigned to the breathing technique (B1 and B2), music therapy (M1 and M2), and EFT (E1 and E2) groups, and the control group (K1 and K2).||t|||
1296193|NCT03645798|Randomized|Parallel Assignment||Prevention||Single||"A randomized, controlled trial was conducted for 73 nurses from The Second Xiangya Hospitcal of Central South University (33 in the experimental group, 40 in the control group). The experimental group received a Wechat-based six-month three good things positive psychotherapy from August 2015 to January 2016, while the control group only received normal psychological instruction from the hospital."|||t|
1296194|NCT03645785|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||All subjects will collect 4 urine samples on Day1 and Day 4. On day 2, 3 and 4 all subjects will drink a bottle of water with True Lemon and collect another 4 urine samples on day 4||||
1296195|NCT03645772|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1296196|NCT03645759|Randomized|Parallel Assignment||Treatment||Double|No other parties will be masked|Behavioral treatment intervention that focuses on enhancing stroke self-management, psychological distress and social functioning that will be provided to two groups (treatment and education plus usual care).|t||t|
1296197|NCT03645746|Randomized|Sequential Assignment||Basic Science||Quadruple|||t|t|t|t
1296198|NCT03645733|Randomized|Parallel Assignment||Prevention||Single|One nurse, that gives the patients their cognitive questionnaire battery, is masked from knowing which dialysis fluid temperature the patient is receiving.|The control group will be at the standard dialysate temperature of 36.5 °C (which is the standard of care in the sites), 3 times a week for 12 months. In the intervention group, patients will receive haemodialysis with a dialysate temperature of 35 degree centigrade. The intervention group will start off using a dialysate temperature that is 36 °C. Thereafter the dialysate temperature will be reduced every two week by 0.5 °C until 35 °C or the lowest tolerated temperature reached. Patients who would fail to tolerate the temperature of 35 °C, the lowest tolerated temperature will be carried over to the end of the study. The intervention group is split into 3 brackets, stratified by age group (patients under 55 years of age, 55-75 and above 75). A third group will also be recruited, but not randomised, consisting of the primary carers (family, friends, etc) of the patients in the other two group to measure the burden they feel in caring for a patient with renal problems.||||t
1296199|NCT03645720|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1296200|NCT03645707||Single Group Assignment||Treatment||None (Open Label)||"This is a secondary study to the primary study titled A Randomized Controlled Trial of a Resilience Intervention for Critical Care Nurses (Florida Hospital IRBNet #1234568). In the primary study, participants will be randomized into the intervention group or wait-list control group. However, in this secondary study, all participants will attend the 1-day CAR Training Program and the follow-up psychoeducational group sessions."||||
1296201|NCT03645694|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Individual with memory concerns and their family caregivers were randomly assigned to receive the facial recognition technology or usual care.||||
1296202|NCT03645681||Single Group Assignment||Treatment||None (Open Label)||"Patients will be implanted with an InnAVasc AVG in the forearm or upper arm using standard vascular surgical techniques. There are two model versions of the InnAVasc Graft. The looped model and the straight model. The graft will be placed in a straight (soft C) configuration in the upper arm, or looped configuration in the forearm (forearm loop) or upper arm (axillary loop)."||||
1296203|NCT03645668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296204|NCT03645655|||Cohort||Prospective|||||||
1296205|NCT03645642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296206|NCT03645629|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple||"Perform skin prick test and atopy patch test of lyophilized foods (cow milk, egg white, egg yolk, wheat, soy and shrimp) stored at different time; 0, 3 and 6 months after preparation.~Then compare the results."|t|t|t|t
1296207|NCT03645616||Single Group Assignment||Screening||None (Open Label)|All data were color coded to guarantee that the investigator who processed the data was blinded to the conditions.|||||
1296208|NCT03645603|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1296209|NCT03645590||Sequential Assignment||Health Services Research||None (Open Label)||Stroke Ready is a stepped wedge design to be delivered to each of the four Flint community quadrants over the course of 2 years.||||
1296210|NCT03645577|||Case-Only||Retrospective|||||||
1296211|NCT03645564|Randomized|Parallel Assignment||Other||None (Open Label)||It is an open, prospective, randomized, 2 arms study that will compare 2 groups of patients care for Atrial Fibrillation in the Cardiology-Electrophysiology and Cardiac Stimulation Department with direct oral anticoagulants prescription.||||
1296215|NCT03645512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296216|NCT03645499|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296217|NCT03645486||Single Group Assignment||Treatment||None (Open Label)||||||
1296218|NCT03645473||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1296219|NCT03645460||Single Group Assignment||Treatment||None (Open Label)||||||
1296220|NCT03645447||Single Group Assignment||Other||None (Open Label)||Taste tests will be undertaken, in order to establish taste thresholds. Observation of changes in taste thresholds with change in mood following antidepressant treatment may help develop a diagnostic test for depression. The taste test will not assist diagnosis of depression for the group of participants in this study, so the primary purpose is not described as diagnostic.||||
1296221|NCT03645434|Randomized|Crossover Assignment||Treatment||Double|This study will be performed in a double-blind manner. Each investigational product (IP) and its placebo will be supplied in identical packaging to enable double-blind conditions.||t||t|
1296222|NCT03645421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296223|NCT03645408|Randomized|Crossover Assignment||Treatment||Quadruple|Nursing staff at the general Clinical Research unit will not be blinded to the study medication. These nurses' only role in the study will be providing injections of the study drug. All other staff will be blinded to medication assignments. The sham injection will be a needlestick using the exenatide multi-dose syringe with no drug injected. Note that the volume of fluid injected for a 5mcg dose is only .08ml. It is not expected that subjects will sense this volume of fluid (or lack thereof) during the injection. Subjects will be shielded from seeing the injection to maintain the blind. The individual who administers medication will not participate in subject evaluation to maintain the study blind.|This is a double-blind, randomized, placebo-controlled, crossover design trial that will test the effect of exenatide on alcohol self-administration and craving following a priming dose of alcohol.|t|t|t|t
1296224|NCT03645395|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1296225|NCT03645382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296226|NCT03645369|Non-Randomized|Parallel Assignment||Supportive Care||Single|This study was conducted on receiving treatment patients in the Orthopedics and Traumatology wards of a university hospital.||t|||
1296227|NCT03645356|Randomized|Parallel Assignment||Treatment||Single||||||t
1296228|NCT03645343|Randomized|Parallel Assignment||Treatment||Single||||||t
1296229|NCT03645330|||Cohort||Prospective|||||||
1296230|NCT03645317||Single Group Assignment||Basic Science||None (Open Label)||||||
1296231|NCT03645304|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1296232|NCT03645291|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|None of the patients and participants know the type of insect allergen extracts used in skin prick and intradermal test|Comparison of skin prick testing and Intradermal skin test result of local and imported insect allergen extracts in patients with severe insect sting allergy|t|t|t|t
1296233|NCT03645278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296234|NCT03645265|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Single case experimental design||||
1296235|NCT03645252|Randomized|Parallel Assignment||Other||Double|||t|||t
1296236|NCT03645239|||Case-Control||Prospective|||||||
1296237|NCT03645226|||Case-Control||Cross-Sectional|||||||
1296238|NCT03645213|Randomized|Parallel Assignment||Prevention||None (Open Label)||This randomized controlled trial study was conducted on 120 school-age children (7 -12 years of age) with pain and fear of venipuncture. The children were randomized according to their arrival in the biochemistry laboratory; the first, second, and third children were assigned VR distraction group with a headset (n=40), non-VR distraction group on a tablet computer screen (n=40) and no distraction group (n=40), respectively. The data collection was carried out using the children identification form, Wong-Baker FACES Pain Rating Scale evaluating the pain and Childrens' Fear Scale evaluating the fear. The outcomes reported by the children, parent, and observer.||||
1296239|NCT03645200||Single Group Assignment||Treatment||None (Open Label)||||||
1296240|NCT03645187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296241|NCT03645174|Randomized|Crossover Assignment||Treatment||None (Open Label)||Manikin model Intubators are residents of Anesthesiology||||
1296242|NCT03645161|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1296243|NCT03645148||Single Group Assignment||Treatment||None (Open Label)||||||
1296244|NCT03645135|Randomized|Parallel Assignment||Health Services Research||Single|The care provider will not be informed as to which group their patient is in.|"Patients will be randomized into 1 of 2 study arms arm 1: control arm 2: intervention.~We will use a random block generator to assign participants to their study arm."||t||
1296245|NCT03645122|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||The purpose of the study is to induce plasticity in corticospinal-motoneuronal synapses serving an intrinsic hand muscle of the hemiparetic limb in humans with stroke. Neurologically-intact controls are included to verify that an effect was present in absence of stroke||||
1296246|NCT03645109|Randomized|Parallel Assignment||Treatment||Double|The capsules with vitamin D or placebo have the same organoleptic characteristics. The jars and envelopes that contain them are identical. The envelopes are identified by a code that only knows who will analyze the data|Parallel design, two arms|t|t||
1296247|NCT03645096|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1296248|NCT03645083|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized controlled trial||||
1296249|NCT03645070|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296250|NCT03645057|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is an open-label, randomized, cross-sectional study to monitor the effects of crisaborole and tacrolimus 0.03% on patient-reported outcomes and caregiver burden in children (ages 5 to 12 years, inclusive) with ≤ moderate atopic dermatitis over a 12 week period of time.||||
1296251|NCT03645044|||Cohort||Prospective|||||||
1296289|NCT03644550||Single Group Assignment||Treatment||None (Open Label)||||||
1296290|NCT03644537|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1296429|NCT03642730|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|Masking is not applicable, since software study|||||
1296252|NCT03645031|Randomized|Crossover Assignment||Treatment||Single|Participants will be blind to the order of the AIH/sham AIH visits, but this information will be provided to the participant after completion of last visit.|Participants will complete both the AIH and the sham AIH visits. The order of these visits will be randomized, but all subjects will complete both visits in the course of the study.|t|||
1296253|NCT03645018||Single Group Assignment||Diagnostic||None (Open Label)||Monocenter prospective no-profit single group interventional study.||||
1296254|NCT03645005|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1296255|NCT03644992|||Case-Crossover||Retrospective|||||||
1296256|NCT03644979|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||1) Skydiving visit, 2) Negative control visit||||
1296257|NCT03644966|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296258|NCT03644953||Single Group Assignment||Treatment||None (Open Label)||Prospective, single arm, open label study of combination hydroxyurea and simple chronic transfusion.||||
1296259|NCT03644940|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1296260|NCT03644927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296261|NCT03644914|Randomized|Parallel Assignment||Treatment||None (Open Label)||Intervention will take place in a New York City (NYC) elementary school. 24 first graders, identified by their teachers as reading below grade level, will be randomized to an intervention or control group. The 12 participants randomized to the intervention group will receive the 10-week reading program, twice weekly in 1-hour sessions. The Co-I and child will work together in individual sessions on sight recognition and phonetic decoding of words established as meeting 1st grade essential literacy standards. Intervention will incorporate word recognition and phonetic decoding within the context of games and play in which the child is able to move about and associate words with color, video, and music. Intervention will also use each child's personal interests as a context around which sight words will be learned. Control group participants will not receive intervention. Both the intervention and control group participants will continue to receive typical classroom reading instruction.||||
1296262|NCT03644901|||Cohort||Prospective|||||||
1296263|NCT03644888|Randomized|Parallel Assignment||Treatment||Single||||||t
1296264|NCT03644875|||Cohort||Prospective|||||||
1296265|NCT03644862|||Cohort||Prospective|||||||
1296266|NCT03644849|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296267|NCT03644836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296268|NCT03644823||Single Group Assignment||Treatment||None (Open Label)||||||
1296269|NCT03644810|Non-Randomized|Parallel Assignment||Diagnostic||Single|The participants are blind to the study hypothesis and therefore the expected outcome of the tests performed|The study has a cross-sectional design and includes individuals (males and females) with and without chronic low back pain into two, equally large groups|t|||
1296270|NCT03644797|||Cohort||Retrospective|||||||
1296271|NCT03644784|||Other||Prospective|||||||
1296272|NCT03644771|||Case-Control||Prospective|||||||
1296273|NCT03644758|||Other||Prospective|||||||
1296274|NCT03644745||Single Group Assignment||Other||None (Open Label)||The first 5 volunteers will be assigned for the preliminary in-home deployment to test the usability and provide feedback to potentially refine the system. Researchers will provide each participant with an activity tracker and download the required software on the participant's computer and smart phone. After 1 week, two researchers will conduct a home visit to provide the participant with a brief introduction to the system. Participants will interact with the system for 30 days while researchers use protocol analysis to record usability issues. All interactions with the system will be recorded. After 30 days, we will conduct an interview with the participant designed to uncover issues. The outcome measures described below will also be recorded. After necessary changes to the engagement and coaching system are made, we will deploy the system in an additional 15 homes for 3 months.||||
1296275|NCT03644732|||Cohort||Prospective|||||||
1296276|NCT03644719|Non-Randomized|Single Group Assignment||Treatment||Single|Participants signed up for a time slot for cognitive behavioral skills training (CBST) or a time slot for education as usual (EAU), without being informed which was which.|Two arms were used to examine the relative effect of the cognitive behavioral skills training (CBSR) and a time slot for education as usual (EAU). The CBST consists of six sessions. The first session is intended to establish rapport, build therapeutic cohesion through ice-breaking activities, and educate participants about the drug regulations stated in the Statute for Drug Hazard Prevention and Control. The following four sessions are devoted to interactively practicing refusal skills, communication skills, decision-making skills, and positive conflict resolution skills. The final session is to review what has been learned and reminds participants about the association of drug use with HIV/HCV.|t|||
1296277|NCT03644706|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1296278|NCT03644693|Randomized|Crossover Assignment||Other||Quadruple||The study design for this nutritional intervention protocol is a randomized, double blind, placebo controlled crossover study. Each patient will receive both nutritional formulation and placebo formulation, with a washout period between each arm. The dietary backgrounds will differ among patients. Acceptable diets include three basic diets: ketogenic diet (i.e. conventional 4:1 or 3:1, modified Atkins), low glycemic index diet (LGIT), and standard American diet (regular diet).|t|t|t|t
1296279|NCT03644680|Randomized|Parallel Assignment||Basic Science||Triple||In this single-center, randomized, placebo-controlled, double-blind study a total of 36 patients will be recruited into this study on a voluntary basis and will be randomised to receive a nasal challenge with either birch pollen extract or placebo.|t|t|t|
1296280|NCT03644667|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1296281|NCT03644654|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1296282|NCT03644641|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1296283|NCT03644628|Randomized|Parallel Assignment||Treatment||Single|||||t|
1296284|NCT03644615|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1296285|NCT03644602|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296286|NCT03644589||Single Group Assignment||Treatment||None (Open Label)||||||
1296287|NCT03644576|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1296288|NCT03644563|||Cohort||Prospective|||||||
1296291|NCT03644524|Non-Randomized|Parallel Assignment||Prevention||Single|It was not possible to blind the subject or PI to treatment group, but all measures that were collected were analyzed offline by a blinded investigator.|Subjects were matched for age and BMI, then assigned to either a heat therapy intervention or time control (no intervention, just outcomes assessment at matched timepoints).||||t
1296292|NCT03644511|||Cohort||Prospective|||||||
1296293|NCT03644498|||Cohort||Retrospective|||||||
1296294|NCT03644485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296295|NCT03644472|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1296296|NCT03644459||Single Group Assignment||Treatment||None (Open Label)||||||
1296297|NCT03644446|||Cohort||Prospective|||||||
1296298|NCT03644433|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296299|NCT03644420|||Case-Only||Prospective|||||||
1296300|NCT03644407|||Other||Prospective|||||||
1296301|NCT03644394||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1296302|NCT03644381|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1296303|NCT03644368|||Other||Retrospective|||||||
1296304|NCT03644355|Randomized|Parallel Assignment||Treatment||None (Open Label)||Cross-sectional, randomized controlled trial||||
1296305|NCT03644342||Single Group Assignment||Treatment||None (Open Label)||||||
1296306|NCT03644329|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296307|NCT03644316||Single Group Assignment||Treatment||None (Open Label)||||||
1296308|NCT03644303||Single Group Assignment||Treatment||None (Open Label)|Interpretation of the two paired WB DW MRI scans (baseline and 6 months) will be conducted by one assessor will be blinded to the identity of the baseline scan to ensure minimisation of any potential bias.|Single arm, prospective interventional cohort study||||
1296309|NCT03644290|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1296310|NCT03644277|Randomized|Parallel Assignment||Treatment||Double|Upon enrollment in the study, participants will be randomly assigned to one of five groups, including: massed practice training with dAIH, massed practice training with Sham dAIH, Rapael glove with dAIH, Rapael glove with Sham dAIH, and no training with dAIH.||t|||t
1296311|NCT03644264|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, Randomised, Active-controlled, Parallel Group, Multicentre,||||
1296312|NCT03644251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296313|NCT03644238|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1296314|NCT03644225|Non-Randomized|Parallel Assignment||Other||None (Open Label)|No randomisation|"Primary outcome:~Mechanical characterization of healthy and diseased skin using novel aspiration device and comparing it to the already validated Cutometer® MPA 580. Comparison of mechanical skin properties of healthy to patients' skin tissue (control vs. examined group).~Secondary outcome:~Defining predictors of the skin worsening."||||
1296315|NCT03644212|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296316|NCT03644199|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1296317|NCT03644186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296318|NCT03644173||Single Group Assignment||Supportive Care||None (Open Label)||||||
1296319|NCT03644160|Randomized|Parallel Assignment||Treatment||Double||Single-centre randomised pilot study|||t|t
1296320|NCT03644147|Randomized|Parallel Assignment||Treatment||Quadruple||Double-blind randomized controlled trial|t|t|t|t
1296321|NCT03644134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296322|NCT03644121|||Cohort||Retrospective|||||||
1296323|NCT03644108||Single Group Assignment||Basic Science||None (Open Label)||||||
1296324|NCT03644095|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1296325|NCT03644082||Single Group Assignment||Treatment||None (Open Label)||||||
1296326|NCT03644069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296327|NCT03644056||Single Group Assignment||Other||None (Open Label)||||||
1296328|NCT03644043|||Cohort||Prospective|||||||
1296329|NCT03644030|||Case-Only||Prospective|||||||
1296330|NCT03644017||Single Group Assignment||Treatment||None (Open Label)||Single arm treated with investigational device WRAPSODY Stent Graft||||
1296331|NCT03644004|||Cohort||Retrospective|||||||
1296332|NCT03643991|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||First 15 subjects enrolled in the study will be given the weighted blanket treatment and the second 15 subjects will be a control cohort.||||
1296333|NCT03643978|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized in an intervention group that reviews a decision aid and a control group that does not.||||
1296334|NCT03643965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296335|NCT03643952||Single Group Assignment||Treatment||None (Open Label)||||||
1296336|NCT03643939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296337|NCT03643926|Randomized|Parallel Assignment||Treatment||Single||||||t
1296338|NCT03643913|Randomized|Parallel Assignment||Treatment||Double|The patient and the surgeon are blinded for the intervention. The anesthesist knows the allocation.||t||t|
1296339|NCT03643900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296340|NCT03643887|Randomized|Parallel Assignment||Prevention||Triple||Double-blind, randomized, placebo controlled trial|t|t|t|
1296341|NCT03643874|Randomized|Crossover Assignment||Treatment||None (Open Label)||2-way cumulative dose crossover||||
1296342|NCT03643861||Single Group Assignment||Treatment||None (Open Label)||||||
1296343|NCT03643848|Randomized|Parallel Assignment||Basic Science||Double|Double blind (participant, outcome assessor) for Aim 3 (sham versus target sounds)|"Per NIMH policy at the time of funding, the current trial is considered a clinical trial due to prospective, randomized assignment to an intervention to observe effects on behavioral or health related outcomes. The intervention for Aim 3 (n=60) includes randomized assignment to sham sounds (sounds unrelated to the memory task) or target sounds (sounds that were played during the time of the memory task) that are played during sleep to cue memory processing."|t|||t
1296426|NCT03642769|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296344|NCT03643835|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||Participants will complete three trials under three different body cooling conditions/interventions; passive cooling using the body's natural body cooling mechanisms, body cooling using forearm ice towels, and cooling using the investigational thermal rehab machine.||||
1296345|NCT03643822|Randomized|Factorial Assignment||Other||Double|Patients who give written informed consent will be randomly assigned on the day of surgery to either of the four study groups using a computer-generated block randomization schedule in blocks of varying sizes. Group allocation will not be disclosed to the anesthesiologist performing the ACB. An anesthesia assistant will receive an opaque envelope containing the result of randomization, and will prepare the block study solution in identical syringes. The patient receiving ACB will also be blinded to the study solution injected. Furthermore, outcome assessment will be performed by a blinded research assistant.|There will be prospective,randomized,controlled,parallel group,factorial,1:1:1:1 allocation,operator,patient and assessor blinded clinical trial.|t|||t
1296346|NCT03643809|||Cohort||Retrospective|||||||
1296347|NCT03643796|Randomized|Parallel Assignment||Treatment||Single|||t|||
1296348|NCT03643783|||Case-Only||Cross-Sectional|||||||
1296349|NCT03643770|Randomized|Single Group Assignment||Diagnostic||Double||4 randomized groups: Acute Intermittent Hypoxia (AIH) treatment, AIH in combination with upper extremity training, Sham AIH therapy in combination with upper extremity training and Sham AIH therapy|t|||t
1296350|NCT03643757|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296351|NCT03643744|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1296352|NCT03643731|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296353|NCT03643718|||Cohort||Prospective|||||||
1296354|NCT03643705|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1296355|NCT03643692||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1296356|NCT03643679||Single Group Assignment||Basic Science||None (Open Label)||||||
1296357|NCT03643666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296358|NCT03643653|||Cohort||Prospective|||||||
1296359|NCT03643640|Randomized|Parallel Assignment||Treatment||Single||||||t
1296360|NCT03643627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296361|NCT03643614||Single Group Assignment||Treatment||None (Open Label)||||||
1296362|NCT03643601|||Cohort||Retrospective|||||||
1296363|NCT03643588|Randomized|Parallel Assignment||Treatment||Single||||||t
1296364|NCT03643575|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1296365|NCT03643562||||||||||||
1296366|NCT03643549||Sequential Assignment||Treatment||None (Open Label)||Botezomib 1.3mg/m2 administered IV on days 1, 4, 7, during each 4-week chemotherapy cycle with per oral Temozolomide at three dose levels: 150 mg/m2, 175 mg/m2 and 200mg/m2 5 days/week every 4 weeks starting on day 3 until disease progression and/or unacceptable toxicity. Study group will be compared to historical controls on conventional management||||
1296367|NCT03643536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||A prospective controlled before-after study||||
1296368|NCT03643523|||Cohort||Prospective|||||||
1296369|NCT03643510||Single Group Assignment||Treatment||None (Open Label)||This is a prospective, single arm study of combination CDK4 and CDK6 dual inhibitor Abemaciclib and selective estrogen receptor degrader Fulvestrant in hormone receptor positive recurrent endometrial carcinomas.||||
1296370|NCT03643497|||Cohort||Prospective|||||||
1296371|NCT03643484|||Cohort||Prospective|||||||
1296372|NCT03643471|||Case-Control||Prospective|||||||
1296373|NCT03643458|||Case-Only||Prospective|||||||
1296374|NCT03643445|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eating disorder participants will be randomly assigned either the motivation-oriented treatment condition or the psychoeducation-oriented treatment condition. Patients in both groups will receive the same care in terms of their hospital treatment and opportunities for interaction with the staff. The only difference will be that for ½ of participants, their treatment will be infused with motivation-oriented interventions. For the others, their interactions will be infused with psychoeducation-oriented interventions. All patients have interactions with an individual therapist at various time points in their hospital treatment. The points at which a patient meets with his or her individual therapist are as follows: at the orientation to the program, a 6-week check-in, and a 10-12 week check-in. As well, patients typically meet with their individual therapist whenever the treatment team determines that a patient may be struggling in the program and is at risk of premature drop-out.||||
1296375|NCT03643432|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomised between usual care or the intervention arm which will consist of a brief behavioural assessment and recommended adherence strategies based on the outcome of the assessment. A sub sample of the population will undergo a qualitative study to assess acceptability of the intervention.||||
1296376|NCT03643419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296377|NCT03643406|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1296378|NCT03643393||Single Group Assignment||Treatment||None (Open Label)||||||
1296379|NCT03643380||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1296380|NCT03643367|Randomized|Parallel Assignment||Treatment||Double|Patients will not be informed about their group assignments, technicians, processing the samples, will not have any access to ICU or patient charts (= double blind trial)|Patients with septic shock are intubated and ventilated and therefore need sedation. So far, most ICU centers use intravenously applied sedatives in these patients. In the proposed study, we will switch sedation from an intravenous to a volatile anesthetic for a short period of time (4 hours) to explore if sepsis markers improve within the following 120 hours upon sevoflurane conditioning.|t|||t
1296381|NCT03643354||Single Group Assignment||Screening||None (Open Label)||||||
1296382|NCT03643341|Randomized|Parallel Assignment||Prevention||Single|||||t|
1296383|NCT03643328||Single Group Assignment||Basic Science||None (Open Label)||||||
1296427|NCT03642756|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1296428|NCT03642743|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1296430|NCT03642717|||Case-Only||Prospective|||||||
1296384|NCT03643315|Randomized|Crossover Assignment||Other||Single|"Participants are blind to the true aim of the study. In addition, assignment of the experimental sessions are administered at random."|The present study will be of a randomised counterbalanced repeated-measures (crossover) design. Each participant (n = 30) will complete four sessions; one initial screening session (remotely administered), one baseline/familiarisation session (first lab visit) and two subsequent experimental sessions (second and third lab visits). The two experimental sessions will follow a similar protocol, except that one condition will involve an exercise protocol before an ad-libitum meal (Exercise and Meal (EX) condition), and the other, a no-exercise period (rest) before an ad-libitum (NEX) control condition.|t|||
1296385|NCT03643302|||Cohort||Prospective|||||||
1296386|NCT03643289|||Cohort||Prospective|||||||
1296387|NCT03643276|Randomized|Factorial Assignment||Treatment||None (Open Label)||"pB-ALL/MR: 2 parallel groups (R-MR) or 2x2 factorial design (R-eHR, R-MR) depending on early risk group assignment.~pB-ALL/HR: 2 parallel groups (R-HR) or 2x2 factorial design (R-eHR, R-HR) depending on early risk group assignment.~T-ALL/early non-SR: 2 parallel groups (R-T).~pB-ALL/SR: Single group.~T-ALL/early SR: Single group."||||
1296388|NCT03643263|||Case-Control||Prospective|||||||
1296389|NCT03643250|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1296390|NCT03643237|Randomized|Parallel Assignment||Prevention||Single||||||t
1296391|NCT03643224||Single Group Assignment||Treatment||None (Open Label)||||||
1296392|NCT03643211|||Case-Only||Prospective|||||||
1296393|NCT03643198|Randomized|Parallel Assignment||Treatment||Triple||2 arms|t||t|t
1296394|NCT03643185|||Cohort||Prospective|||||||
1296395|NCT03643172|||Cohort||Prospective|||||||
1296396|NCT03643159|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"Main Study patients receive treatment with Abilify MyCite during Month 1 through Month 3. During Months 4 through 6, use of Abilify MyCite will be prohibited (and the patient continues with oral aripiprazole or other appropriate treatment, per routine clinical care). Thereafter, at Day 180, a second, optional interventional period (up to 6 months of Abilify MyCite) may be initiated per the joint decision of the patients with their study physician.~In the exploratory study, each patient will receive Abilify MyCite per 1 one of the 2 sequences over a 360-day period: Sequence 1: Only in Months 1, 2, 5, and 10; Sequence 2: Only in Months 1, 4, 7, and 10."||||
1296397|NCT03643146|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1296398|NCT03643133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296399|NCT03643120||Single Group Assignment||Other||None (Open Label)||Qualitative interviews, 15 - 20 participants.||||
1296400|NCT03643107||Single Group Assignment||Treatment||None (Open Label)||"Irofulven will be administered as an intravenous dose of 0.45 mg/kg, over a 30-minute infusion period by venous access at day 1 and 8 of a three week cycle.~Irofulven will be administered in combination with a daily dose of 10 mg orally administered prednisolone."||||
1296401|NCT03643094||Single Group Assignment||Basic Science||None (Open Label)||Open-labeled 8-week study design with evaluation at baseline, 4, and 8 weeks.||||
1296402|NCT03643081|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1296403|NCT03643068|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296404|NCT03643055|||Case-Only||Prospective|||||||
1296405|NCT03643042|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Two modalities of threshold for transfusion:~Restrictive group: Hb < 80g/L and Hb maintain between 80 and 100g/L~Liberal group: Hb < 100g/L and Hb maintain between 100 and 120g/L"||||
1296406|NCT03643029||Single Group Assignment||Other||None (Open Label)||||||
1296407|NCT03643016|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296408|NCT03643003|Randomized|Crossover Assignment||Treatment||None (Open Label)||Participants will engage in a music therapy condition of interest, and a non-music, verbal discussion comparison condition. The order is randomly assigned and counterbalanced across nursing homes, and all participants complete both conditions.||||
1296409|NCT03642990||Single Group Assignment||Treatment||None (Open Label)||All subjects with stage IV breast cancer will receive 300 mg NIAGEN®) daily for one week followed by dose escalation to 1000 mg daily for 11 weeks upon reporting the development of grade 1 sensory neuropathy. Those presenting with a residual sensory neuropathy of ≤ 2 as a result of prior chemotherapy will also be enrolled.||||
1296410|NCT03642977|||Cohort||Prospective|||||||
1296411|NCT03642964|Randomized|Parallel Assignment||Treatment||Double|placebo||t|||t
1296412|NCT03642951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296413|NCT03642938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296414|NCT03642925||Single Group Assignment||Treatment||None (Open Label)|it's a Open-label clinical trial|To evaluate the impact of a nutritionally balanced conventional meal replacement diet (rich in soy/pea protein and soluble fibers) with caloric restriction in Taiwanese obese subjects.||||
1296415|NCT03642912|||Cohort||Prospective|||||||
1296416|NCT03642899|||Case-Control||Prospective|||||||
1296417|NCT03642886|Randomized|Parallel Assignment||Treatment||Double|In adjudication of arrhythmia events the adjudicators would not know if the participants have been randomized to the detraining or control group||||t|t
1296418|NCT03642873|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1296419|NCT03642860|Randomized|Crossover Assignment||Treatment||Quadruple||The study will be conducted as a randomized, placebo-controlled, double blind, crossover study consisting of two 14 days treatment periods set apart by minimum a 7-days wash-out period where no treatment is taken. In one treatment period, the subjects receive UX007 treatment and placebo treatment in the other. The study will consist of three separate groups; one group consisting of GSD III, one group of GSD VII, and one group of GSD XV subjects. Each of these groups will be blinded and randomized separately|t|t|t|t
1296420|NCT03642847|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1296421|NCT03642834||Sequential Assignment||Treatment||None (Open Label)||||||
1296422|NCT03642821|||Cohort||Prospective|||||||
1296423|NCT03642808||Single Group Assignment||Prevention||None (Open Label)||||||
1296424|NCT03642795|||Case-Only||Prospective|||||||
1296425|NCT03642782||Single Group Assignment||Diagnostic||None (Open Label)||||||
1573317|NCT00001639||||||||||||
1296431|NCT03642704||Single Group Assignment||Treatment||None (Open Label)||Prospective non-comparative study of mother-child pairs whose mother is HIV-infected and received less than 4 weeks of antiretroviral therapy before birth or whose HIV infection has been diagnosed at birth. Assess the operational efficacy of a strategy combining early diagnosis and preventive antiretroviral treatment systematically reinforced from the birth among infants at high risk of infection with HIV.||||
1296432|NCT03642691||||||||||||
1296433|NCT03642678|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1296434|NCT03642665|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter prospective randomized clinical trial||||
1296435|NCT03642652|Randomized|Parallel Assignment||Screening||Double|Participants were not aware of the trial. Only Intervention arm participants received text reminders|Randomisation into Intervention and control groups. Text message sent to Intervention group. No intervention in control group|t|t||
1296436|NCT03642639||Single Group Assignment||Treatment||None (Open Label)||||||
1296437|NCT03642626|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296438|NCT03642613|||Cohort||Cross-Sectional|||||||
1296439|NCT03642600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296440|NCT03642587|||Cohort||Prospective|||||||
1296441|NCT03642574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296442|NCT03642561|Randomized|Parallel Assignment||Treatment||Single||group 1 RFA alone group 2 TACE alone||||t
1296443|NCT03642548|Randomized|Parallel Assignment||Treatment||Quadruple|A placebo-controlled double-blind randomized study||t|t|t|t
1296444|NCT03642535|Randomized|Sequential Assignment||Prevention||Single||||||t
1296445|NCT03642522||Single Group Assignment||Treatment||None (Open Label)||||||
1296446|NCT03642509|Randomized|Parallel Assignment||Prevention||Single|Open-label study with blinded outcome assessment by an independent clinical event committee|||||t
1296447|NCT03642496|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1296448|NCT03642483|||Cohort||Prospective|||||||
1296449|NCT03642470|||Cohort||Cross-Sectional|||||||
1296450|NCT03642457|Randomized|Parallel Assignment||Treatment||Quadruple|The patient, surgeon, and anesthesiologist in the case will be blinded.||t|t|t|t
1296451|NCT03642444|Randomized|Sequential Assignment||Treatment||None (Open Label)||N-of-1 series||||
1296452|NCT03642431||||||||||||
1296453|NCT03642418|||Cohort||Prospective|||||||
1296454|NCT03642405|||Cohort||Prospective|||||||
1296455|NCT03642392|||Cohort||Prospective|||||||
1296456|NCT03642379||Single Group Assignment||Supportive Care||None (Open Label)||This is a single center/single unit (7-3600) exploratory study to examine the efficacy of three interventions on a subject's SOCRATES 8D score at time of discharge, at three months, and at six months. A convenience sample of all patients admitted to 7-3600 who meet the inclusion criteria for this study will be approached and provided information related to this study. Once entered into the study, the subjects will continue in the study through their hospitalizations and up to 90 days post hospitalization.||||
1296457|NCT03642366|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1296458|NCT03642353|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1296459|NCT03642340|||Other||Prospective|||||||
1296460|NCT03642327|Randomized|Parallel Assignment||Prevention||Single|||t|||
1296461|NCT03642314|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1296462|NCT03642301|||Cohort||Prospective|||||||
1296463|NCT03642288|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1296464|NCT03642275|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to patients' randomization assignment|||||t
1296465|NCT03642262|Randomized|Crossover Assignment||Basic Science||None (Open Label)||2-Way Crossover||||
1296466|NCT03642249|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1296467|NCT03642236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296468|NCT03642223|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296469|NCT03642210||Single Group Assignment||Treatment||None (Open Label)||||||
1296470|NCT03642197|Randomized|Parallel Assignment||Treatment||None (Open Label)||"A four-arm randomized controlled trial (RCT) using simple randomization will randomize female patients in romantic relationships into partner attended (PA) groups and treatment as usual (PA-TU) groups; patients (female or male) not in romantic relationships will be randomized into support figure attended (SFA) and SFA-TU groups.~Patients in all arms will receive routine care. Support figures/partners of patients in the SFA and PA arms will be requested to attend the four pre-surgery classes with the patient and the three clinical visits; patients in the SFA-TU and PA-TU arms will attend individually.~Assessments will be completed by patients and support figures/partners (all four arms) at the first pre-surgery class (T1) and routine clinical visits: the pre-surgery appointment (T2), two-weeks post-surgery appointment (T3), and at the two-months post-surgery appointment (T4). The study will follow all groups for roughly six months."||||
1296471|NCT03642184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296472|NCT03642171|||Cohort||Prospective|||||||
1296473|NCT03642158|Randomized|Crossover Assignment||Health Services Research||Triple|double blinded||t||t|t
1296474|NCT03642145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296475|NCT03642132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296476|NCT03642119|||Cohort||Cross-Sectional|||||||
1296477|NCT03642106|Randomized|Parallel Assignment||Prevention||None (Open Label)||Two cohorts of Latino youth and their parents (n=200 dyads each (n=100 treatment and n=100 control); N=400 dyad) with staggered start dates will be recruited from a random sample of Latino 7th graders and screened for inclusion/exclusion criteria. Those meeting the criteria and agreeing to participate will provide baseline data before being randomly assigned to either the treatment or control condition. Participants will be followed for 30 months (beginning of 7th grade (baseline), end of 7th, 8th, and 9th grades). The study will collect psychosocial measures and biomarker data, used to create an objective measure of stress and ATOD use.||||
1296478|NCT03642093|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296479|NCT03642080|||Case-Only||Prospective|||||||
1296480|NCT03642067||Single Group Assignment||Treatment||None (Open Label)||||||
1296481|NCT03642054|||Other||Prospective|||||||
1296482|NCT03642041|||Cohort||Prospective|||||||
1296483|NCT03642028|Randomized|Parallel Assignment||Treatment||Quadruple|The blind will be maintained through completion of the entire study at both sites and will only be broken once data are cleaned to an acceptable level of quality, except for medical necessity.|The investigators propose a two-site parallel group, randomized, double-blind, placebo-controlled Phase IV clinical trial to test the efficacy and safety of suvorexant on trauma-related sleep disturbance and PTSD symptoms in Veterans. The investigators will use a flexible dose design of suvorexant with a 2-week titration followed by a 10-week steady-dose phase.|t|t|t|t
1296484|NCT03642015|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1296485|NCT03642002|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Outcomes Assessor will be unfamiliar with desired outcomes||||
1296486|NCT03641989|Randomized|Parallel Assignment||Prevention||Single|Participants will not be told which toothpaste they have been given.|Participants will be randomized to brush twice daily for 30 days with the plaque disclosing agent toothpaste or a reference, non-plaque disclosing toothpaste. Toothpastes are comparable based on equivalent content of the active ingredient: fluoride.|t|||
1296487|NCT03641976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296488|NCT03641963||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296489|NCT03641950||Single Group Assignment||Treatment||None (Open Label)||||||
1296490|NCT03641937||||||||||||
1296491|NCT03641924|||Case-Only||Prospective|||||||
1296492|NCT03641911|||Cohort||Prospective|||||||
1296493|NCT03641898|||Case-Only||Prospective|||||||
1296494|NCT03641885|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1296495|NCT03641872|||Cohort||Prospective|||||||
1296496|NCT03641859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296497|NCT03641846|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1296498|NCT03641833|||Case-Control||Prospective|||||||
1296499|NCT03641820|||Other||Cross-Sectional|||||||
1296500|NCT03641807|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1296501|NCT03641794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296502|NCT03641781|Randomized|Parallel Assignment||Treatment||None (Open Label)||Athletes were randomly assigned into two groups: Isometric (ISOM) and Isokinetic (ISOK). A coin was flipped at start of data collection for the first patient to be assigned odd number and included in isometric group. Later on odd and even numbered patients were included in specific group. Additionally, data was collected from healthy athletes doing their training at Pakistan Sports Board, called healthy control group. Due to ethical constraints knee pain athletes were not included as control subjects||||
1296503|NCT03641768|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1296504|NCT03641755||Single Group Assignment||Treatment||None (Open Label)||||||
1296505|NCT03641742|||Cohort||Prospective|||||||
1296506|NCT03641729||Single Group Assignment||Treatment||None (Open Label)||The exercise training program was performed once daily during the hospital stay. The program included 2- to 5-minute warm-up session which consisted of stretching, coordination and balance exercises, followed by 10 to 20 minutes of moderate-intensity aerobic exercise using a lower limb cycle ergometer (Live up Sports, 1023, Araucária, Paraná, LS9055). Participants also performed three sets of five to ten repetitions of sit-to-stand exercises with a 1-minute rest interval between each set. A cool-down period of 2- to 5-minutes of stretching and breathing exercises was delivered at the end of the exercise session. All exercises were performed within the participant's room. The aerobic training target zone was set at 50% to 70% of heart rate (HR) reserve. The HR reserve was estimated using the following equation: [(220-age in years) - resting HR] x [50 to 70%] + resting HR.||||
1296507|NCT03641716||Single Group Assignment||Prevention||None (Open Label)||Repeated Measures||||
1296508|NCT03641703||Single Group Assignment||Treatment||None (Open Label)||||||
1296509|NCT03641690|||Case-Only||Retrospective|||||||
1296510|NCT03641677|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296511|NCT03641664|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1296512|NCT03641651||Single Group Assignment||Health Services Research||None (Open Label)||||||
1296513|NCT03641638|||Case-Control||Prospective|||||||
1296514|NCT03641625|Randomized|Parallel Assignment||Prevention||Double|Both patients and outcomes assessor are blinded to group assignment.|Randomized controlled trial|t|||t
1296515|NCT03641612|Randomized|Parallel Assignment||Other||Triple||The trial design of this study will be a prospective, parallel, Randomized clinical trial (RCT).|t||t|t
1296516|NCT03641599|||Cohort||Cross-Sectional|||||||
1296517|NCT03641586|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296518|NCT03641573||Single Group Assignment||Other||None (Open Label)||||||
1296519|NCT03641560||Single Group Assignment||Treatment||None (Open Label)||||||
1296520|NCT03641547||Single Group Assignment||Treatment||None (Open Label)||CHARIOT will use a single arm, open-label, dose escalation, Time-To-Event Continual Reassessment Method (TiTE-CRM) to find the optimal treatment schedule.||||
1296521|NCT03641534|||Case-Control||Prospective|||||||
1296522|NCT03641521|Non-Randomized|Parallel Assignment||Prevention||Single||controlled, non-randomized community nutrition intervention|t|||
1296523|NCT03641508|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296524|NCT03641495|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296525|NCT03641482|Randomized|Crossover Assignment||Prevention||Double||split mouth design|t|t||
1296526|NCT03641469||Single Group Assignment||Treatment||Single|The outcomes assessor will be blinded to brace type when measuring the out-of-brace x-ray.|Current TLSO users will crossover to use of the GSM brace.||||t
1296527|NCT03641456||Single Group Assignment||Treatment||None (Open Label)||||||
1296528|NCT03641443||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296529|NCT03641430||Single Group Assignment||Supportive Care||None (Open Label)||||||
1296574|NCT03640845|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1573318|NCT00001633||||Treatment||||||||
1296530|NCT03641417|Randomized|Crossover Assignment||Basic Science||Double||Double blind, placebo-controlled, within-subject, crossover mechanistic study|t||t|
1296531|NCT03641404|Randomized|Parallel Assignment||Prevention||Quadruple|Investigational compound and placebo coded by manufacturer. Codes provided in envelope will only be unsealed at the end of the study (data assessment) or in case of emergency.|Randomized, double-blinded, placebo-controlled study|t|t|t|t
1296532|NCT03641391||Single Group Assignment||Prevention||None (Open Label)||||||
1296533|NCT03641378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296534|NCT03641365|Randomized|Parallel Assignment||Other||Single|An expert blinded mechanical engineer (FC) performed all the measurements. Post-operative STL files were sent with a code, without indicating patient's group.|Randomized controlled trial of parallel group design conducted at one centre.||||t
1296535|NCT03641352|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1296536|NCT03641339|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296537|NCT03641326|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296538|NCT03641313||Single Group Assignment||Treatment||None (Open Label)||||||
1296539|NCT03641300|Randomized|Parallel Assignment||Treatment||Triple|Participants will be randomized into the study using a permuted block method with a random number generator. The study statistician will prepare the randomization scheme. The block size will be fixed and study personnel will be blinded to the randomization block size|The study is a randomized, double blind, parallel-group clinical trial with two treatment arms conducted at three academic institutions: the Temerty Centre for Therapeutic Brain Intervention based at CAMH in Toronto, ON; Parkwood Institute based at University of Western Ontario in London, ON; and UBC Hospital based at the University of British Columbia in Vancouver, BC. CAMH aims to recruit 40 participants. Parkwood Institute and UBC Hospital aim to recruit 30 participants each.|t|t||t
1296540|NCT03641287|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1296541|NCT03641274|||Cohort||Prospective|||||||
1296542|NCT03641261||Single Group Assignment||Supportive Care||None (Open Label)||||||
1296543|NCT03641248|Randomized|Parallel Assignment||Basic Science||Double||Pharmacokinetic|t||t|
1296544|NCT03641235|||Cohort||Prospective|||||||
1296545|NCT03641222|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296546|NCT03641209|Randomized|Parallel Assignment||Prevention||Triple|Placebo, 0.45 % saline, is similar to paracetamol, both being clear liquids, so the staff will remain unaware which drug the patient receives. The study drug will be kept and prepared away from the NICU, at the separate ward 55 office, in a locked cabinet. The study drug will be prepared by the research nurse, the pharmacist of the ward, or during nighttime, by a nurse who does not participate in the study patients' treatment in any way.|Randomized, controlled, one center trial|t|t|t|
1296547|NCT03641196|Randomized|Parallel Assignment||Treatment||Single|The analyses will be blinded regarding treatment received and time.|This study will be a stratified, parallel randomized controlled, single-blinded, with an allocation ratio of 1:1.||||t
1296548|NCT03641183|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296549|NCT03641170|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1296550|NCT03641157|||Case-Control||Prospective|||||||
1296551|NCT03641144|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296552|NCT03641131|||Case-Only||Retrospective|||||||
1296553|NCT03641118|||Cohort||Prospective|||||||
1296554|NCT03641105|||Cohort||Prospective|||||||
1296555|NCT03641092|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296556|NCT03641079||Single Group Assignment||Treatment||None (Open Label)||||||
1296557|NCT03641066||Single Group Assignment||Basic Science||None (Open Label)||||||
1296558|NCT03641053|Randomized|Parallel Assignment||Treatment||Single|Participants do not know which intervention substance they have been assigned to|A three-arm parallel assignment where one group receives honey, the second group receives povidone-iodine, and the third group receives paraffin gauze as wound dressing.|t|||
1296559|NCT03641040|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1296560|NCT03641027|Randomized|Parallel Assignment||Treatment||Single|Assessor will not be aware of which group the patients are included in.|Parallel Assignment A single blind, randomized, controlled, intervention study. Evaluation of the addition of increased physical activity for patients undergoing obesity surgery compared to standard care.||||t
1296561|NCT03641014|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1296562|NCT03641001|Randomized|Parallel Assignment||Prevention||None (Open Label)||Community based Randomized Controlled Trial||||
1296563|NCT03640988||Single Group Assignment||Treatment||None (Open Label)||Pulsed acoustic wave application on acute and chronic defects of the skin and subcutaneous soft tissues||||
1296564|NCT03640975|||Case-Control||Prospective|||||||
1296565|NCT03640962|||Case-Only||Cross-Sectional|||||||
1296566|NCT03640949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296567|NCT03640936|||Case-Control||Prospective|||||||
1296568|NCT03640923||Single Group Assignment||Other||None (Open Label)||||||
1296569|NCT03640910|Randomized|Parallel Assignment||Treatment||Single||||||t
1296570|NCT03640897|Randomized|Parallel Assignment||Prevention||None (Open Label)||A monocentric, prospective, randomized, comparator controlled, parallel groups study conducted under paediatric control.||||
1296571|NCT03640884|||Cohort||Prospective|||||||
1296572|NCT03640871||Single Group Assignment||Treatment||None (Open Label)||||||
1296573|NCT03640858||Single Group Assignment||Treatment||None (Open Label)||Study visits will take place within the patients' usual hemodialysis unit consistent with their routinely scheduled dialysis sessions. Patients will undergo their usual hemodialysis regime; however, beginning week 3 and ending at the beginning of the dialysis week on week 14, participants will use the Theranova dialyzer with no other changes to their usual dialysis prescription. At these visits, participants will answer 7 questions with each hemodialysis session regarding symptoms experienced since their last hemodialysis session using the LEVIL application. An iPad for patient use will be lent to each participating site for the duration of the study. Pre and post dialysis bloodwork will be drawn at 3 intervals (weeks 1, 3, and 14) throughout the study for laboratory evaluation.||||
1296575|NCT03640832|Randomized|Parallel Assignment||Other||Single|Evaluator blinded (dermatologist and ophthalmologist).|||||t
1296576|NCT03640819||Single Group Assignment||Treatment||None (Open Label)||||||
1296577|NCT03640806|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296578|NCT03640793||Single Group Assignment||Treatment||None (Open Label)||Single center, prospective, non-randomized, and non-blinded study||||
1296579|NCT03640780|||Other||Cross-Sectional|||||||
1296580|NCT03640767|Randomized|Parallel Assignment||Prevention||None (Open Label)||This pilot randomised controlled trial aimed at examining the effectiveness of message-based lifestyle intervention. Peripheral artery disease patients who have received revascularization in the past 6 months, are randomized into 2 groups. The total sample size will be 160.||||
1296581|NCT03640754|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1296582|NCT03640741|||Case-Only||Retrospective|||||||
1296583|NCT03640728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296584|NCT03640715|Randomized|Parallel Assignment||Other||Single||||t||
1296585|NCT03640702|||Cohort||Retrospective|||||||
1296586|NCT03640689|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1296587|NCT03640676|Randomized|Parallel Assignment||Treatment||Triple||Double-blinded randomized sham-controlled trial|t|t|t|
1296588|NCT03640663|||Cohort||Prospective|||||||
1296589|NCT03640650|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1296590|NCT03640637|||Cohort||Prospective|||||||
1296591|NCT03640624|Randomized|Parallel Assignment||Treatment||Single||||||t
1296592|NCT03640611|||Cohort||Prospective|||||||
1296593|NCT03640598|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296594|NCT03640585|Randomized|Parallel Assignment||Treatment||None (Open Label)||The patients were randomized and divided into 2 groups of 20 people. A randomized list is prepared in a computer environment by a statistician for randomization. In this list, the odd numbers for the control group and the MT group were given double numbers. The group identification is printed on sequentially numbered cards placed in sealed envelopes. After enrollment, the numbered envelope was opened by the patient and the blind investigator.||||
1296595|NCT03640572|||Cohort||Prospective|||||||
1296596|NCT03640559|Randomized|Parallel Assignment||Prevention||Double|"The present study was planned as double-blind, placebo-controlled study. With the aim of maximum objectification of end point, neither Medical Investigator, nor patients had access to the code of healthcare institution.~The test drug or the placebo were received by the sites as ready for use and blinded vials, 200 mL each. Each vial had individual number and identification of contents (Drug A or Drug B). Conformity of identification of Seroguard or the placebo was not disclosed to the sites.~Before surgery, the Medical Investigator prepared required number of vials according to identification of the drug on the vial and identification of the group in randomization envelope of patient. Individual number of each vial administered to a patient was recorded in documentation of site."|laparoscopic cholecystectomy|t||t|
1296597|NCT03640546|||Case-Only||Prospective|||||||
1296598|NCT03640533|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1296599|NCT03640520|Randomized|Parallel Assignment||Health Services Research||Double|All participants on each team at each site will be blinded as to treatment condition and to the study goal of evaluating family centered care. Study staff who rate team performance of FCC from videotaped simulated pediatric resuscitations will also be blinded as to treatment condition.|Investigators will conduct an RCT of the FACETS online skills training module (intervention) vs. an online training module reviewing pediatric readiness standards for all EDs (control).|t|||t
1296600|NCT03640507|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1296601|NCT03640494|||Case-Only||Prospective|||||||
1296602|NCT03640481|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 2, open label, randomized, multicenter study in subjects with cGVHD who have previously been treated with at least 2 prior lines of systemic therapy||||
1296603|NCT03640468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296604|NCT03640455|Randomized|Parallel Assignment||Treatment||Single|||t|||
1296605|NCT03640442|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1296606|NCT03640429|||Cohort||Prospective|||||||
1296607|NCT03640416||Single Group Assignment||Device Feasibility||None (Open Label)|No masking needed.|||||
1296608|NCT03640403|Randomized|Parallel Assignment||Prevention||None (Open Label)||"A superiority, randomized, open label, controlled trial, using a balanced block design with the standard of care arm as reference."||||
1296609|NCT03640390|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1296610|NCT03640377|Randomized|Parallel Assignment||Treatment||Triple|Tablets will be crushed and given with orange juice|Children ages 12-48 months who are infected with S. japonicum (Philippines) or S. mansoni (Uganda) will be randomized to receive either 40 or 60 mg/kg of praziquantel at baseline. Six months later, half of each group will receive second treatment at same dose or placebo.|t||t|t
1296611|NCT03640364|||Case-Only||Prospective|||||||
1296612|NCT03640351|Randomized|Parallel Assignment||Treatment||None (Open Label)||Methods: The subjects are randomly divided into three groups. Group 1 uses preservative diquafosol ophthalmic solution, Group 2 uses preservative containing diquafosol ophthalmic solution, and Group 3 uses preservative free sodium hyaluronate after cataract surgery. Before surgery, all patients underwent a detailed ophthalmological examination that included slit-lamp examination (Haag-Streit, Köniz, Switzerland), and dry eye parameters including tear breakup time (TBUT), schirmer test, ocular surface disease index (OSDI), and MGD staging. Corneal wavefront aberrations were measured using i-Trace (Tracey Technologies Corp. Houston, TX). All examinations were repeated at 1, and 3 months after surgery.||||
1296613|NCT03640338|Randomized|Parallel Assignment||Prevention||Single|||t|||
1296614|NCT03640325|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1296615|NCT03640312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296616|NCT03640299|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296617|NCT03640286|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1296780|NCT03638154|Randomized|Parallel Assignment||Treatment||Double||||t||t
1296781|NCT03638141|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296618|NCT03640273|Randomized|Parallel Assignment||Treatment||Double||"this study is a double blind randomized controlled trial study. the volunteers will be divided into 2 groups. One is received Prapchompoothaweep crude drug capsule at 1,000 mg 3 times a day before meals and the other is received Loratadine 10 mg per day before meals. it takes 6 weeks to complete the project for each volunteers.~Before enrolling, volunteers will stop using any anti-histamine drug for 1 week (wash-out period). All volunteers will be followed up in the 3rd and 6th week to evaluate the efficacy and adverse effect after received drugs.~The researcher will record characteristic data such as gender, age, BMI, vital signs and symptoms . The adverse effect will be monitored by hematology test e.g. liver function test, renal function test, lipid profile and blood sugar test."|t||t|
1296619|NCT03640260|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296620|NCT03640247|Randomized|Parallel Assignment||Treatment||None (Open Label)|All party or parties involved have knowledge of the interventions assigned to individual participants|||||
1296621|NCT03640234|||Other||Prospective|||||||
1296622|NCT03640221|Randomized|Parallel Assignment||Treatment||Triple|"Cedars-Sinai Medical Center pharmacy will be responsible for filling individual patient containers, labeling the containers and performing the blinding of the supplies.~subjects will receive two bottles of either:~Ertugliflozin 15mg tablets (active drug) and a placebo for hydrochlorothiazide; or~Placebo for ertugliflozin and hydrochlorthiazide 12.5mg capsules (active drug)"|A double-blind, randomized, parallel 2- arm study, therapy will be randomly allocated 2:1 to Ertugliflozin oral tablet daily (n=20) or hydrochlorothiazide 12.5mg oral tablet (n=10) and followed for three months.|t|t|t|
1296623|NCT03640208||Single Group Assignment||Prevention||None (Open Label)||||||
1296624|NCT03640195|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Intervention is divided into two parts: part of The Experimental group received Transcutaneous acupoint electrical stimulation 20 minutes/weeks, the acupoints are unilateral Hegu (LI4) and LU7; This study used Transcutaneous nerve electrical stimulation , 20 minutes each time, once a week for six consecutive weeks.~The second part of The Experimental group received Auricular acupressure applied to four acupoints, including shenmen (TF2), mouth (IC6), subcortex (CW2), Occiput (AT3).A seeds embedding method with seeds attached to the four sides of the unilateral ear, using the thumb and forefinger to apply pressure, the participants will feel sour, each point is 1min, 5days/week, 3 times/day.~Control group: without intervention"||||
1296625|NCT03640182||Single Group Assignment||Other||None (Open Label)||||||
1296626|NCT03640169||Single Group Assignment||Other||None (Open Label)||||||
1296627|NCT03640156|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1296628|NCT03640143|||Cohort||Retrospective|||||||
1296629|NCT03640130||Single Group Assignment||Other||None (Open Label)||||||
1296630|NCT03640117|||Cohort||Prospective|||||||
1296631|NCT03640104|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1296632|NCT03640091||Single Group Assignment||Treatment||None (Open Label)||||||
1296633|NCT03640078||Single Group Assignment||Other||None (Open Label)||||||
1296634|NCT03640065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296635|NCT03640052|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1296636|NCT03640039|Randomized|Parallel Assignment||Treatment||Single||"A Radomized clinical trial.~Parallel group study.~A trial will be carried out in hospital of oral and maxillofacial surgery department - faculty of dentistry cairo university.~Equal randomization: participants with equal probabilities for intervention.~Positive controlled: both groups receiving treatment."||||t
1296637|NCT03640026||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296638|NCT03640013|Randomized|Parallel Assignment||Treatment||None (Open Label)||Controlled randomized clinical trial||||
1296639|NCT03640000||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296640|NCT03639987|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296641|NCT03639974|Randomized|Parallel Assignment||Treatment||Single|Double blind: allocation concealment and outcome assessor|This is a randomized clinical trial that will be performed according to the CONSORT Statement (Consolidated Standards of ReportingTrials).||||t
1296642|NCT03639961|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The integrated health system leading, managing and governing for results model is constructed from: leading practices, managing practice, and governing practices; moderating factors ; health services performance, and sustainable health outcomes and impact aligned with national health goals and Sustainable Development Goals (SDGs).||||
1296643|NCT03639948||Single Group Assignment||Treatment||None (Open Label)||||||
1296644|NCT03639935||Single Group Assignment||Treatment||None (Open Label)||||||
1296645|NCT03639922|Randomized|Parallel Assignment||Treatment||Triple|The study is double-blind, only after the study is completed or terminated the treatments will be made available, or if requested by the data safety board, or if requested by treating clinician in association with possible SAE/SUSAR|randomized, double-blind, placebo-controlled, parallel-arm|t|t|t|
1296646|NCT03639909|||Cohort||Retrospective|||||||
1296647|NCT03639896|||Cohort||Prospective|||||||
1296648|NCT03639883|Randomized|Sequential Assignment||Treatment||Triple|Treating investigator will administer the study medication. Evaluating Investigator will perform the safety and efficacy evaluations.|Randomized, double-blind, vehicle-controlled, dose-escalation|t||t|t
1296649|NCT03639870||Single Group Assignment||Treatment||None (Open Label)||The iStent infinite Trabecular Micro-Bypass System Model iS3 is a sterile, single-use injector system that is pre-loaded with three G2-W stents, and is designed to deliver the stents into Schlemm's canal. The three G2-W stents are heparin-coated and manufactured from implant grade titanium.||||
1296650|NCT03639857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296651|NCT03639844||||||||||||
1296652|NCT03639831|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1296653|NCT03639818||Single Group Assignment||Other||None (Open Label)||||||
1296654|NCT03639805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296655|NCT03639792|||Cohort||Prospective|||||||
1296656|NCT03639779|Randomized|Parallel Assignment||Treatment||Double||This is a parallel two-arm study comparing sodium thiosulfate and saline control.|t||t|
1296782|NCT03638128||Single Group Assignment||Treatment||None (Open Label)||||||
1573319|NCT00001629||||Treatment||||||||
1296657|NCT03639766|Randomized|Parallel Assignment||Treatment||Double|This is a double-blind placebo-controlled trial.|This is a two-arm parallel assignment involves two groups of participants. One group/hand receives the abobotulinum toxin A, and the other group/hand receives a saline solution (control).|t||t|
1296658|NCT03639753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1296659|NCT03639740||Sequential Assignment||Treatment||None (Open Label)||Dose will be increased or maintained after predetermined intervals depending on remission||||
1296660|NCT03639727|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||This study compares citric acid and mannitol bronchial challenges in their ability to separate chronic cough subjects from healthy subjects. There are no therapeutic interventions.||||
1296661|NCT03639714|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1296662|NCT03639701||Single Group Assignment||Treatment||None (Open Label)||Open label treatment with thymidine and deoxycytidine||||
1296663|NCT03639688|Randomized|Parallel Assignment||Screening||Single|||t|||
1296664|NCT03639675||Single Group Assignment||Treatment||None (Open Label)||||||
1296665|NCT03639662|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296666|NCT03639649|Non-Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1296667|NCT03639636||Sequential Assignment||Screening||None (Open Label)||interventional prospective study||||
1296668|NCT03639623||Single Group Assignment||Treatment||None (Open Label)||||||
1296669|NCT03639610||Single Group Assignment||Treatment||None (Open Label)||||||
1296670|NCT03639597||Single Group Assignment||Treatment||None (Open Label)||||||
1296671|NCT03639584|||Cohort||Prospective|||||||
1296672|NCT03639571|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1296673|NCT03639558|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296674|NCT03639545|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1296675|NCT03639532|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1296676|NCT03639519|Randomized|Parallel Assignment||Treatment||Single|||t|||
1296677|NCT03639506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296678|NCT03639493|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1296679|NCT03639480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296680|NCT03639467||Single Group Assignment||Treatment||None (Open Label)||||||
1296681|NCT03639454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296682|NCT03639441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296683|NCT03639428|||Case-Only||Retrospective|||||||
1296684|NCT03639415||Single Group Assignment||Treatment||None (Open Label)||||||
1296685|NCT03639402|Randomized|Parallel Assignment||Prevention||None (Open Label)||one community is randomized as intervention arm, another community as control arm||||
1296686|NCT03639389|Randomized|Parallel Assignment||Treatment||Single|Outcome observer blinded to method of analgesia (spinal/no-spinal)|Prospective, randomized, observer-blinded||||t
1296687|NCT03639376|||Case-Control||Cross-Sectional|||||||
1296688|NCT03639363|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1296689|NCT03639350|Randomized|Parallel Assignment||Prevention||Triple|Participants will be provided with healthful dietary information but will not be told what diets their diet plans are based on. Participants in the IER+MED diet group will be told they are on diet plan 1 and participants in the DASH diet group will be told they are on diet plan A. The research dietitians will know which diet plan each participant is on, however; all other clinic staff who assess outcomes measures will be blinded to each participant's diet group.|Randomized controlled trial. Participants will be randomized to either the IER+Med diet or the DASH diet for 12 weeks.|t||t|t
1296690|NCT03639337|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1296691|NCT03639324||Single Group Assignment||Treatment||None (Open Label)||Patients will start on dose level 1 of venetoclax in combination with rituximab and idelalisib, then escalate or de-escalate (if lower dose is available) based upon the estimated probabilities of toxicity from an extension of the continual reassessment method for 2 agents.||||
1296692|NCT03639311|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|This is an open-label study, thus no masking.|This is an Intervention Model, with parallel assignment, where the primary purpose of the study is, treatment, with 2 arms and no masking.||||
1296693|NCT03639298|Randomized|Parallel Assignment||Treatment||Single||||||t
1296694|NCT03639285|||Cohort||Other|||||||
1296695|NCT03639272|||Case-Only||Retrospective|||||||
1296696|NCT03639259|||Cohort||Prospective|||||||
1296697|NCT03639246|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296698|NCT03639233||Single Group Assignment||Treatment||None (Open Label)||||||
1296699|NCT03639220|Randomized|Crossover Assignment||Treatment||Double|A participating researcher who programmed the PBMT device (Multi Radiance Medical™, Solon, OH) based on the randomization results performed the randomization. He will be instructed not to inform the participants or other researchers of the PBMT dose (active or placebo). Thus, the researcher who performed the PBMT will be blinded to the dose administered to the participants. To further maintain blinding, participants used opaque goggles to prevent them from seeing whether a light will be irradiated.|Randomization will be held by drawing lots, which we use to determine whether the active combination of superpulsed lasers, LEDs, comprising the PBMT or the placebo will be given during the first session. During the second session, participants will receive the opposite treatment compared to their first session. Randomization labels will be created using a randomization table at a central office where a series of sealed, opaque, and numbered envelopes ensured confidentiality.|t||t|
1296700|NCT03639207|||Other||Retrospective|||||||
1296701|NCT03639194|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1296702|NCT03639181||Single Group Assignment||Treatment||None (Open Label)||||||
1296703|NCT03639168||Single Group Assignment||Treatment||None (Open Label)||||||
1296704|NCT03639155|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1296705|NCT03639142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296706|NCT03639129||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296707|NCT03639116|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||The purpose of the study is to induce plasticity in corticospinal-motoneuronal synapses serving an intrinsic hand muscle of the hemiparetic limb in humans with stroke. Neurologically-intact controls are included to verify that an effect was present in absence of stroke. Outcome measures in controls also provide a reference point that help us to understand the size of the effect and mechanisms mediating the effect in the neurologically-intact system.||||
1296708|NCT03639103|||Case-Only||Prospective|||||||
1296709|NCT03639090|||Cohort||Prospective|||||||
1296710|NCT03639077|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1296711|NCT03639064|Randomized|Parallel Assignment||Treatment||Triple|This will be a double-blind study. The different cannabis oil formulations have the same colour, taste and smell. Study investigators will be blind to the dose/formulation of cannabis oil. Unblinding will only be performed in the event of a Serious AE. The site PI will maintain a randomization list kept in a locked secure 24h a day accessible location for emergency unblinding.|"This is an interventional, phase II, randomized, open-label, double-blind, two-centre study to evaluate the safety, tolerability, and dose-finding of Cannabis oil preparation for pain in Parkinson's disease.~Mixed oil cannabis preparation consisting of 3 differing formulations of ∆-9THC and CBD is clinically available in Canada as CanniMed®. The 3 differing formulations of CanniMed® oils contain varying proportions of ∆-9THC and CBD in the following ratios: 18:0; 10:10; 1:20. A total of 15 patients will be block randomized to one of the three groups. Each patient will receive one formulation of CanniMed® Oil only, with 5 patients per group."|t||t|t
1296712|NCT03639051|Randomized|Parallel Assignment||Treatment||Double|Subject and assessor double-blinding will be maintained through 1 year post-procedure.|Subjects will be randomized with equal allocation (1:1) into two arms: TLD therapy plus optimal medical care (Active Treatment) and optimal medical care (Sham Control). Randomization of patients on an inhaled corticosteroid will be stratified.|t|||t
1296713|NCT03639038|||Other||Prospective|||||||
1296714|NCT03639025|||Cohort||Prospective|||||||
1296715|NCT03639012|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomised control trial into 1 of 2 groups||||
1296716|NCT03638999|Randomized|Parallel Assignment||Supportive Care||Triple|Prior to initiation of study enrollment, envelopes containing study randomization assignments will be created, sequentially numbered, sealed and given to the study pharmacist. Once a patient provides consent and meets study inclusion and exclusion criteria, study pharmacist will be notified of enrollment and will randomize the patient by opening the next subsequent randomization envelope.|Participants will be randomized in 1:1 ratio to either intervention or control group. Subjects in the intervention group will receive intravenous injection of 1 ml of Ketorlac 30 mg/ml, whereas subjects in the control group will receive 1 ml of 0.9% injectable normal saline, prior to the start of the procedure. Study team, with the exception of the pharmacist, will be blinded to randomization results.|t|t|t|
1296717|NCT03638986|||Cohort||Prospective|||||||
1296718|NCT03638973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296719|NCT03638960|Randomized|Parallel Assignment||Treatment||Double|The participants and data collectors are unaware of which group the patient belongs to. The anesthesiologist performing the nerve block will not be blinded.|The investigators plan to perform a double blinded randomized control study. Patients will be randomly assigned to either group A or group B. Patients in group A will receive a bolus injection with 20 mL of 0.5% bupivacaine. Group B will receive 10 mL of 133 mg of liposomal bupivacaine mixed with 10 mL 0.5% bupivacaine.|t|||t
1296720|NCT03638947|Randomized|Parallel Assignment||Health Services Research||Single|After the patient has signed consent, they will receive a pre-surgical kit that will include swabs to be used in the nares, arm pit and groin area (standard of care). In a 1:1 randomization scheme, one half of the patients will receive povidone-iodine swab in addition to the kit (treatment).||t|||
1296721|NCT03638934|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Parallel Assignment||||
1296722|NCT03638921||Single Group Assignment||Treatment||None (Open Label)||MEOPA||||
1296723|NCT03638908||Single Group Assignment||Treatment||None (Open Label)||||||
1296724|NCT03638895|Randomized|Parallel Assignment||Treatment||Double|Double (Participant, Practitioner) Energy expenditure information (resting energy expenditure & respiratory quotient) is withheld from participant and practitioner providing care to participants in the control group.|Parallel assignment|t|t||
1296725|NCT03638882|Randomized|Parallel Assignment||Prevention||Single||||||t
1296726|NCT03638869|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1296727|NCT03638856|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296728|NCT03638843||Single Group Assignment||Treatment||None (Open Label)||||||
1296729|NCT03638830|Randomized|Parallel Assignment||Treatment||Double|"In order to minimize subjectivity, block randomization will be carried out in treatment groups without stratification in the center. Randomization will be carried out by the method of envelopes.~To minimize the subjectivity of clinical study of the efficacy and safety of the drug Ftortiazinon will be conducted with the use of a placebo, which will not differ in appearance, shape, color, and will fully simulate the investigated product.~To distribute the drug to patients, taking into account the need to observe the blinding, a special authorized person (an unblided research pharmacist) will be appointed in each medical organization."|randomized, blind, placebo-controlled study|t||t|
1296730|NCT03638817||Single Group Assignment||Treatment||None (Open Label)||||||
1296731|NCT03638804||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296732|NCT03638791|||Cohort||Prospective|||||||
1296733|NCT03638778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296734|NCT03638765||Single Group Assignment||Treatment||None (Open Label)||||||
1296735|NCT03638752|Randomized|Parallel Assignment||Diagnostic||Double|The endoscopist and endoscopy nurse will not know to which treatment arm the patient belongs as only the research assistant will has taken down this information. This information does not travel with the patient to the endoscopy room. The patient is also instructed to not reveal to the endoscopist or endoscopy nurse if he or she has taken or not taken the comprehensive education.|||t|t|
1296736|NCT03638739|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1296737|NCT03638726|Randomized|Parallel Assignment||Other||Single|Preoperative and postoperative assessment will be done by a masked observer.|Randomized clinical study||||t
1296738|NCT03638713|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||A total of 120 patients were allocated into one of two groups by computerized randomization. Patients in the group A (colonoscopy first group) received colonoscopy followed by EGD and those in the group B (EGD first group) received EGD followed by colonoscopy.||||
1296739|NCT03638700|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1296740|NCT03638687|||Cohort||Prospective|||||||
1296741|NCT03638674|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296742|NCT03638661|Randomized|Parallel Assignment||Treatment||Single|The ready-to-use soybean used formula and n3EN formula had identical packaging with no differences in appearance, texture, or smell.||t|||
1296743|NCT03638648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296744|NCT03638635|Randomized|Parallel Assignment||Supportive Care||Double|The participant and the floor nursing staff recording pain scores will be blinded to the assigned intervention.|Participants are randomized to receive either standard bupivacaine or liposomal bupivacaine.|t|||t
1296745|NCT03638622||Single Group Assignment||Treatment||None (Open Label)||Trial with single arm||||
1296746|NCT03638609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296747|NCT03638596|Randomized|Parallel Assignment||Treatment||None (Open Label)||random assignment to treatment and control arms||||
1296748|NCT03638583|||Other||Other|||||||
1296749|NCT03638557||Single Group Assignment||Prevention||None (Open Label)||pre-post quasi experimental design||||
1296750|NCT03638544|Randomized|Crossover Assignment||Treatment||Triple||Double blind placebo controlled Gluten Sensitivity|t|t|t|
1296751|NCT03638531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296752|NCT03638518|Randomized|Parallel Assignment||Treatment||Single|Neither the participants nor their therapists were blind to the treatment allocation. However, the assessor was independent to the study and was not aware of the treatments applied or the objective of the therapy.|Participants were randomized to a core stability training physiotherapy programme group, an acupuncture treatment group and control group for a 13 week study.||||t
1296753|NCT03638505|||Cohort||Prospective|||||||
1296754|NCT03638492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296755|NCT03638479|||Case-Control||Prospective|||||||
1296756|NCT03638466|Randomized|Parallel Assignment||Treatment||Quadruple||A multi-center, double-blind, randomized (1:1), placebo-controlled, parallel-group, 2-arm study|t|t|t|t
1296757|NCT03638453|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296758|NCT03638440|||Other||Prospective|||||||
1296759|NCT03638427|||Cohort||Prospective|||||||
1296760|NCT03638414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296761|NCT03638401|Non-Randomized|Single Group Assignment||Other||||||||
1296762|NCT03638388|Randomized|Parallel Assignment||Treatment||None (Open Label)||Experimental There will be two groups in this study, DN alone and DN/IES. Each group will have approximately 22 subjects, resulting in approximately 44 subjects total. Subjects will be randomized into one of the two groups via block randomization method based on order of entry into the study.||||
1296763|NCT03638375|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"The ACTME trial consists of both a phase I part to determine safety and feasibility and a phase II part to evaluate first clinical activity of IFN-alpha, nivolumab and TIL. The treatment with IFN-alpha will be added after the combination of TIL and nivolumab has proven to be safe.~Phase 1, Cohort 1: Adding TIL therapy to anti-PD1 immunotherapy. Phase 1, Cohort 2: Adding IFN-alpha to the treatment with TIL and anti-PD1 immunotherapy.~Phase 2: Patients will be treated with TIL, IFN-alpha and anti-PD1 according to the same schedule as used in phase 1 cohort 2."||||
1296764|NCT03638362|Randomized|Crossover Assignment||Treatment||Single|Placebo beverage was selected from commercially available, artificially flavored and colored fruit punches (Great Value fruit punch, Bentonville, AR) to match a closely as possible the color (red) of the TCJ.|Crossover Assignment In this study, the investigators recruited at-risk individuals who were overweight (25.0-29.9 kg/m2) and obese (> 30.0 kg/m2) and likely to exhibit one or more conditions associated with MetS. In this 10-week placebo-controlled 2 x 2 crossover dietary intervention, the investigators randomized participants to consume 240 mL (8 ounces) daily of either placebo (artificial cherry-flavored, anthocyanin-free beverage) or authentic TCJ for 4 weeks, followed by a 2-week washout period, then consumption of the alternate beverage for 4 weeks. Subsequently, the investigators determined the effect of TCJ in at-risk participants on markers of inflammation, glycemia, and lipidemia.|t|||
1296765|NCT03638349|||Other||Cross-Sectional|||||||
1296766|NCT03638336||Single Group Assignment||Treatment||None (Open Label)||||||
1296767|NCT03638323|||Case-Only||Prospective|||||||
1296768|NCT03638310|Randomized|Parallel Assignment||Treatment||None (Open Label)||two groups of patients, one group prehabituated by chemical labyrintectomy, the second control group without prehabituation before the surgery||||
1296769|NCT03638297||Single Group Assignment||Treatment||None (Open Label)||||||
1296770|NCT03638284||Single Group Assignment||Treatment||None (Open Label)|N/a-open label study|All enrolled study participants will receive 10 sessions (5 per week X 2 weeks) of tDCS in an open label study. Participants will have neurocognitive assessments at baseline and at study completion (i.e. the last day of receiving tDCS).||||
1296771|NCT03638271||Single Group Assignment||Diagnostic||None (Open Label)||prospective manner study will include 50 patients of both sex and different age with any type of cardiomyopathy diagnosed clinically or by Doppler echocardiography, will undergo cardiac magnetic resonance.||||
1296772|NCT03638258|Randomized|Parallel Assignment||Treatment||Double|ARQ-151 drug product will be supplied as a 0.3% and 0.15% cream. The matching vehicle cream will contain only excipients of ARQ-151 cream.|Parallel group, double blind, vehicle-controlled study|t||t|
1296773|NCT03638245|||Cohort||Prospective|||||||
1296774|NCT03638232|||Cohort||Prospective|||||||
1296775|NCT03638219|||Cohort||Prospective|||||||
1296776|NCT03638206||Single Group Assignment||Treatment||None (Open Label)||||||
1296777|NCT03638193||Single Group Assignment||Treatment||None (Open Label)||||||
1296778|NCT03638180|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1296779|NCT03638167|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296783|NCT03638115||Single Group Assignment||Treatment||None (Open Label)||||||
1296784|NCT03638102|Randomized|Parallel Assignment||Prevention||Single||||||t
1296785|NCT03638089||Single Group Assignment||Treatment||None (Open Label)||||||
1296786|NCT03638076|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296787|NCT03638063|||Case-Control||Cross-Sectional|||||||
1296788|NCT03638050|||Other||Cross-Sectional|||||||
1296789|NCT03638037|||Case-Control||Cross-Sectional|||||||
1296790|NCT03638024|||Case-Control||Cross-Sectional|||||||
1296791|NCT03638011|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a prospective, randomized study evaluating the effectiveness of abdominal analgesia when using 266 mg EXPAREL delivered into the bilateral TAP blocks. TAP blocks are an excellent method for providing adequate analgesia following lower abdominal surgery.~Those patients who wish to participate will be asked to sign a study consent form. Patients that decide to participate in this study will be randomized to either group 1 or group 2 (like the flip of a coin). Both groups will receive standard neuraxial anesthesia for their Cesarean Section and post-operative standard of care breakthrough medications for post-operative pain control."||||
1296792|NCT03637998||Single Group Assignment||Supportive Care||None (Open Label)||||||
1296793|NCT03637985|Randomized|Parallel Assignment||Treatment||Double|The allocation was concealed in sequentially numbered opaque envelopes by a blinded and an independent research assistant and selected 69 individuals randomly into the study.||||t|t
1296794|NCT03637972|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1296795|NCT03637959||Single Group Assignment||Other||None (Open Label)||||||
1296796|NCT03637946||Single Group Assignment||Treatment||None (Open Label)||This is a single-center, non-blinded, clinical trial 6 months in duration.||||
1296797|NCT03637933|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1296798|NCT03637920|||Cohort||Prospective|||||||
1296799|NCT03637907|||Case-Only||Prospective|||||||
1296800|NCT03637894|Randomized|Parallel Assignment||Prevention||Triple||RCT double blind study|t|t|t|
1296801|NCT03637881|||Other||Cross-Sectional|||||||
1296802|NCT03637868||Single Group Assignment||Treatment||None (Open Label)||Prospective, national, multicenter, open-label, uncontrolled, multi-cohort phase II trial||||
1296803|NCT03637855|||Cohort||Prospective|||||||
1296804|NCT03637842|Randomized|Parallel Assignment||Treatment||Quadruple|Encapsulated medication|Double Blind Randomized Controlled Trial|t|t|t|t
1296805|NCT03637829|Randomized|Crossover Assignment||Other||Double|"treatments are in individual packages labelled A, B and C. Study participants and investigators are blinded to the composition of the test treatments."|A random and within subject, repeated measures experiment to study the effect of chocolate on cognitive performance, subjective appetite, food intake, and glycemic response in normal weight adults.|t||t|
1296806|NCT03637816|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1296807|NCT03637803||Single Group Assignment||Treatment||None (Open Label)||||||
1296808|NCT03637790|Randomized|Sequential Assignment||Other||Triple|||t|t|t|
1296809|NCT03637777|||Cohort||Prospective|||||||
1296810|NCT03637764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296811|NCT03637751|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1296812|NCT03637738|Randomized|Parallel Assignment||Treatment||None (Open Label)||Medico-economic, National Multicentric, Prospective, Randomized, Comparative, Open study of a medical device||||
1296813|NCT03637725|||Cohort||Prospective|||||||
1296814|NCT03637712||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296815|NCT03637699|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1296816|NCT03637686|||Cohort||Prospective|||||||
1296817|NCT03637673|||Other||Prospective|||||||
1296818|NCT03637660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296819|NCT03637647|||Cohort||Prospective|||||||
1296820|NCT03637634|||Cohort||Other|||||||
1296821|NCT03637621|||Cohort||Retrospective|||||||
1296822|NCT03637608|||Cohort||Retrospective|||||||
1296823|NCT03637595|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1296824|NCT03637582|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1296825|NCT03637569|||Cohort||Prospective|||||||
1296826|NCT03637556|Randomized|Crossover Assignment||Treatment||None (Open Label)||open-label, two-period cross-over||||
1296827|NCT03637543|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296828|NCT03637530|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1296829|NCT03637517|Randomized|Parallel Assignment||Other||None (Open Label)||Phase 1, single-dose, open-label, randomized, parallel group design in healthy adults (males, females of non child bearing potential) in 3 groups of 14 subjects each.||||
1296830|NCT03637504|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296831|NCT03637491|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1296832|NCT03637478||Single Group Assignment||Health Services Research||None (Open Label)||"The E-SOC Model consists of the delivery of intensively integrated clinical care within pediatrics, combined with community-based parent support from family support specialists. Innovations include child mental health specialists joining the pediatrics team for huddles, psychiatry notes shared with pediatricians via the Electronic Medical Records and active inclusion of pediatricians in pre-evaluation discussions with the E-SOC Team and post-evaluation recommendations for the families. In addition, the E-SOC model includes active communication with school personnel, child welfare, and community-based resources, when needed."||||
1296833|NCT03637465|Randomized|Parallel Assignment||Prevention||None (Open Label)||This cluster RCT involves 14 matched pairs; study recruitment and randomization occurs at the recreation center-level. Participating sites are matched based on center size, summer program enrollment, presence of indoor gym, neighborhood income & race/ethnicity. Then, an intervention site and control site are randomly determined by a coin flip within each pair.||||
1296834|NCT03637452|||Case-Control||Cross-Sectional|||||||
1296835|NCT03637439|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296870|NCT03636984|||Cohort||Prospective|||||||
1296836|NCT03637426|Randomized|Parallel Assignment||Treatment||Double|For this double-blind study, the evaluator and the patient were blinded. Only one evaluator assessed pain sensitivity, who did not participate in the randomization process, and also did not know in which group the patient was. The volunteers evaluated in the experiment also were not aware of the treatment to which they were submitted. Both the Nano-P desensitizer and the placebo toothpaste have the same coloration and similar visual appearance. The desensitizers were placed in equal containers so that patients were not identified as to the application of the product.|Volunteers 18 to 50 years old with hypersensitive teeth were randomly assigned to 4 groups: GPLACEBO - positioning of the laser tip without light emission + placeo substance; GnHAP - positioning of the laser tip without light emission + nano-hydroxyapatite; GLASER - positioning of the laser tip with light emission + plcebo substance; GLASERnHAP - positioning by laser beam with light emission + nano-hydroxyapatite.|t||t|
1296837|NCT03637413||Single Group Assignment||Treatment||None (Open Label)||||||
1296838|NCT03637400|Randomized|Parallel Assignment||Treatment||Quadruple|This is a double blind trial in which both subjects and study personnel will be masked to the specific treatment arm to which the subject has been assigned and to the results of cultures obtained from the site of infection. The pharmacist will only be unblinded to the liquid formulation, in order to prepare the formulation based upon the subject's weight.||t|t|t|t
1296839|NCT03637387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296840|NCT03637374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296841|NCT03637361|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1296842|NCT03637348||Single Group Assignment||Other||None (Open Label)||||||
1296843|NCT03637335|Randomized|Parallel Assignment||Treatment||Triple||Phase-3 study, randomized, controlled, multi-center, double blind|t||t|t
1296844|NCT03637322|||Cohort||Prospective|||||||
1296845|NCT03637309||Single Group Assignment||Prevention||None (Open Label)||||||
1296846|NCT03637296|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective cohort with comparison group||||
1296847|NCT03637283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296848|NCT03637270|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1296849|NCT03637257|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Prospective, randomized, single-blinded cross-over study||||
1296850|NCT03637244||Single Group Assignment||Prevention||None (Open Label)||H1: PrEP decision support increases decision quality in both LDQ and HDQ groups, H2: HDQ + decision-support group more likely to initiate PrEP than HDQ control, H3: HDQ PrEP initiators are more likely than LDQ initiators to have serum levels consistent with adherence at 60-days. Investigators supply one smartphone/ participant,each registered to St. Mike's Hospital to protect participant privacy. The decision support aid will be a pre-programmed bookmark, an RA will give participants a brief tutorial on its use. Patients assigned to the experimental condition (LDQ + DS and HDQ + DS) will use the bookmarked link to the decision-aid within the first 7-14 days (and thereafter as needed) during the study period. The routine care group will be asked to use a bookmarked link to frequently asked questions on tenofovir + emtricitabine for PrEP. All groups will be compared on decision-quality at 14-days, self-reported PrEP initiation at 30-days, and PrEP adherence at 60-days post enrollment.||||
1296851|NCT03637231||Sequential Assignment||Diagnostic||None (Open Label)||||||
1296852|NCT03637218|Randomized|Crossover Assignment||Prevention||None (Open Label)||Including a baseline assessment and assessments at Low altitude and High altitude||||
1296853|NCT03637205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296854|NCT03637192|Randomized|Crossover Assignment||Prevention||None (Open Label)||Including a baseline assessment and assessments at Low altitude and High altitude||||
1296855|NCT03637179|Randomized|Crossover Assignment||Prevention||None (Open Label)||Crossover Assignment Including a baseline assessment and assessments at Low altitude and High altitude||||
1296856|NCT03637166|Randomized|Crossover Assignment||Prevention||None (Open Label)||Including a baseline assessment and assessments at Low altitude and High altitude||||
1296857|NCT03637153|Randomized|Crossover Assignment||Prevention||None (Open Label)||Including a baseline assessment and assessments at Low altitude and High altitude||||
1296858|NCT03637140|Randomized|Crossover Assignment||Prevention||Single|The allocated gas mixture will not be disclosed to the patient since he will breath through a facemask during both interventions.|Including a baseline assessment and assessments under simulated altitude and normoxia.|t|||
1296859|NCT03637127|Randomized|Crossover Assignment||Prevention||Single|The allocated gas mixture will not be disclosed to the patient since he will breath through a facemask during both interventions.|Including a baseline assessment and assessments under simulated altitude and normoxia.|t|||
1296860|NCT03637114|Randomized|Crossover Assignment||Prevention||Single|The allocated gas mixture will not be disclosed to the patient since he will breath through a facemask during both interventions.|Including a baseline assessment and assessments under simulated altitude and normoxia.|t|||
1296861|NCT03637101|||Cohort||Prospective|||||||
1296862|NCT03637088|Randomized|Crossover Assignment||Prevention||Single|The allocated gas mixture will not be disclosed to the patient since he will breath through a facemask during both interventions.|Including a baseline assessment and assessments under simulated altitude and normoxia.|t|||
1296863|NCT03637075|Randomized|Crossover Assignment||Other||Single||single-blinded, monocentric, prospective crossover study|t|||
1296864|NCT03637062|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open Multicentre Randomized Controlled Trial, in parallel groups, based on treatment with progesterone comparing the placement of a prophylactic cervical pessary with usual management in singleton pregnancies at high-risk of PTB due to a history of at least one previous preterm delivery and/or a history of late abortion||||
1296865|NCT03637049||Single Group Assignment||Basic Science||None (Open Label)||||||
1296866|NCT03637036|Randomized|Parallel Assignment||Health Services Research||Single|Participants receive one of four types of communications inviting them to take up the influenza vaccination in a randomized fashion. Participants will not be explicitly told that alternative versions of the communications are being sent.||t|||
1296867|NCT03637023|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1296868|NCT03637010||Single Group Assignment||Other||None (Open Label)||||||
1296869|NCT03636997|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296871|NCT03636971|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1296872|NCT03636958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296873|NCT03636945||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296874|NCT03636932|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1296875|NCT03636919|||Cohort||Prospective|||||||
1296876|NCT03636906|Randomized|Parallel Assignment||Prevention||Quadruple|Observer blind||t|t|t|t
1296877|NCT03636893|Randomized|Parallel Assignment||Treatment||None (Open Label)||DOUBLE ARM||||
1296878|NCT03636880|Randomized|Parallel Assignment||Treatment||Single|Baseline assessment is completed prior to randomization. Assessments conducted at 2 weeks and 6 months post-intervention are completed by an assessor blinded to participants' assigned condition.|||||t
1296879|NCT03636867|||Cohort||Prospective|||||||
1296880|NCT03636854|Randomized|Parallel Assignment||Treatment||Single||||||t
1296881|NCT03636841|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296882|NCT03636828|||Cohort||Prospective|||||||
1296883|NCT03636815|||Cohort||Retrospective|||||||
1296884|NCT03636802|||Cohort||Prospective|||||||
1296885|NCT03636789||Single Group Assignment||Other||None (Open Label)||||||
1296886|NCT03636776||Single Group Assignment||Supportive Care||None (Open Label)||||||
1296887|NCT03636763|||Case-Control||Retrospective|||||||
1296888|NCT03636750|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296889|NCT03636737|||Cohort||Retrospective|||||||
1296890|NCT03636724|Randomized|Parallel Assignment||Treatment||Single|||t|||
1296891|NCT03636711|||Cohort||Prospective|||||||
1296892|NCT03636698|||Other||Prospective|||||||
1296893|NCT03636685|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1296894|NCT03636672|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1296895|NCT03636659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296896|NCT03636646|||Cohort||Retrospective|||||||
1296897|NCT03636633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296898|NCT03636620|Randomized|Parallel Assignment||Treatment||Single||TACE vs.TACE+RFA||||t
1296899|NCT03636607|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1296900|NCT03636594||Single Group Assignment||Treatment||None (Open Label)||||||
1296901|NCT03636581|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1296902|NCT03636568|Randomized|Parallel Assignment||Prevention||Single|||t|||
1296903|NCT03636555|Randomized|Parallel Assignment||Treatment||Triple|UNC Hospitals Investigational Drug Service blind labels intranasal spray bottles containing oxytocin or placebo spray and dispenses bottles based on a randomization scheme provided by the study Biostatistician|Double blind, placebo-controlled trial|t|t|t|
1296904|NCT03636542|Randomized|Parallel Assignment||Screening||Triple|||t|t||t
1296905|NCT03636529|Randomized|Crossover Assignment||Treatment||Single|Placebo beverage was prepared in the ASU metabolic kitchen and matched for fructose and total carbohydrate concentrations as well as being artificially colored to match tart cherry juice.|In this study, the investigators recruited at-risk individuals who were overweight (25.0-29.9 kg/m2) and obese (> 30.0 kg/m2) and likely to exhibit one or more conditions associated with MetS. In this 12-week placebo-controlled 2 x 2 crossover dietary intervention, the investigators randomized participants to consume 240 mL (8 ounces) daily of either placebo (artificial cherry-flavored, anthocyanin-free beverage) or TCJ for 4 weeks, followed by a 4-week washout period, then consumption of the alternate beverage for 4 weeks. Subsequently, the investigators determined the effect of TCJ in at-risk participants on markers of uricemia, lipidemia, glycemia, and inflammation.|t|||
1296906|NCT03636516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296907|NCT03636503|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296908|NCT03636490||Single Group Assignment||Other||None (Open Label)|All participants will receive the same intervention. All associated groups will be aware of the intervention protocol and the single-arm study model.|All participants will be receive the same intervention.||||
1296909|NCT03636477||Single Group Assignment||Treatment||None (Open Label)||||||
1296910|NCT03636464|||Case-Only||Prospective|||||||
1296911|NCT03636451|Randomized|Parallel Assignment||Treatment||Double|The study coordinator, who will be blinded to the intervention, will pick the designated sealed, opaque envelope containing the type of paracervical block and hand it to the physician performing the procedure. The physician will then open the envelope and prepare the designated paracervical block, as it is standard practice for physicians to prepare their own paracervical blocks prior to performing any D&C in-clinic. The paracervical block will contain 2U Vasopressin, 2cc of 8.4% sodium bicarbonate, and either 1% lidocaine or 0.5% lidocaine, depending on the study group. The physician will bring the paracervical block into the clinic room where the procedure will be performed on a covered tray. The physician will perform the standardized procedure for the D&C, and the study coordinator will assess pain control during the procedure.|This is a double center, randomized, 2 arm (1:1), single blinded clinical trial comparing pain control at the time of cervical dilation with two different paracervical blocks in women undergoing D&C in the first trimester for either surgical abortion or miscarriage management.|t|||t
1296912|NCT03636438|||Other||Prospective|||||||
1296913|NCT03636425|||Other||Cross-Sectional|||||||
1296914|NCT03636412|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients will be recruited pre-transplant but on re-evaluation post-transplant based on mobility post-transplant will be enrolled in the ambulatory intervention.||||
1296915|NCT03636399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296916|NCT03636386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296917|NCT03636373|Randomized|Parallel Assignment||Treatment||Triple|Triple|Subjects will be administered a single dose of etanercept 50 mg subcutaneously (SC), at the onset of an acute gout attack, or a single dose of triamcinolone acetonide 40 mg intramuscularly (IM)|t|t|t|
1296918|NCT03636360|Randomized|Crossover Assignment||Basic Science||Single|Participants will be aware that the lighting conditions will vary during their visits, but will not be aware of the nature of the difference in the lights.||t|||
1573320|NCT00001628||||Treatment||||||||
1296919|NCT03636347|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|placebo-controlled, dose ascending, sequential group|t|t|t|t
1296920|NCT03636334|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1296921|NCT03636321|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296922|NCT03636308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296923|NCT03636295|Randomized|Parallel Assignment||Treatment||None (Open Label)||A vanguard prospective, randomized, open-label, blinded end-point (PROBE) clinical trial.||||
1296924|NCT03636282|Randomized|Parallel Assignment||Prevention||Single|Independent nurses not associated with the study team will conduct all physical measurements|Pragmatic cluster randomized controlled trial with 2 arms: intervention (immediate delivery of Hockey FIT program) and comparator (wait-list control/delayed delivery of Hockey FIT program)||||t
1296925|NCT03636269|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1296926|NCT03636256|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-label, dose rising trial consisting of a dose escalation phase and a dose confirmation phase. Doses will escalate for the direct injection dose only; the intravesical instillation dose will stay consistent for the duration of the study. In the dose escalation phase, subjects will be enrolled in sequential cohorts of three subjects starting at the lowest concentration. The dose determined to be most suitable for further evaluation, defined as the highest dose with an acceptable safety and tolerability profile (as determined by the Data Safety Monitoring Board), will enroll additional subjects to total up to 6 subjects at that dose level.||||
1296927|NCT03636243|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1296928|NCT03636230|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label, 1:1 randomized trial, stratified by site and pacemaker dependence||||
1296929|NCT03636217|Randomized|Crossover Assignment||Screening||Single|||t|||
1296930|NCT03636204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296931|NCT03636191|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1296932|NCT03636178|Randomized|Parallel Assignment||Prevention||Double|Double blind clinical trial||t|||t
1296933|NCT03636165|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1296934|NCT03636152|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized Double Blind Placebo Controlled Study|t|t|t|t
1296935|NCT03636139|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1296936|NCT03636126|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||The total study time will be 4 weeks. Participants will be asked to use the VR and tACS for two of these four weeks. Participants will be randomly assigned to one of two groups: A) a group that uses the tACS+VR for weeks 1 & 2 or B) a group that uses the tACS+VR for weeks 3 & 4.||||
1296937|NCT03636113|||Cohort||Prospective|||||||
1296938|NCT03636100|||Case-Only||Prospective|||||||
1296939|NCT03636087|Randomized|Parallel Assignment||Treatment||Single||The study is single blind since the patient will not be aware of what technique is being used. The study cannot be double blind because the dentist will need to identify the protocol to follow. Randomization by blocks (block size 4) will be performed by a statistician at Kings College Dental Institute.||||t
1296940|NCT03636074|||Case-Control||Prospective|||||||
1296941|NCT03636061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296942|NCT03636048|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296943|NCT03636035||Single Group Assignment||Supportive Care||None (Open Label)||||||
1296944|NCT03636022|Randomized|Parallel Assignment||Treatment||None (Open Label)||Virtual Reality exposure therapy system||||
1296945|NCT03636009|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two groups receiving interventions||||
1296946|NCT03635996||Single Group Assignment||Treatment||None (Open Label)||||||
1296947|NCT03635983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296948|NCT03635970|Randomized|Parallel Assignment||Treatment||Single|the evaluator of the treatment goals does not know the treatment that each patient received|Treatment for peripheral arterial disease plus diabetes with 2 arms of study.||||t
1296949|NCT03635957||Single Group Assignment||Treatment||None (Open Label)||||||
1296950|NCT03635944|||Cohort||Retrospective|||||||
1296951|NCT03635931|Randomized|Parallel Assignment||Treatment||Single||The test and control group was formed of patients with adjacent papillary defects In test group, elective minimally invasive surgery for papillary regeneration with CGF was performed. A control group was formed of patients with adjacent papillary defects who were not included to have surgical treatment.||||t
1296952|NCT03635918||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296953|NCT03635905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296954|NCT03635892||Single Group Assignment||Treatment||None (Open Label)||This is a single institution open-label phase II trial of cabozantinib and nivolumab in patients with advanced or metastatic non-clear cell Renal Cell Carcinoma (nccRCC), who have not received prior PD-1/PD-L1 directed therapy.||||
1296955|NCT03635879|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1296956|NCT03635866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1296957|NCT03635853||Single Group Assignment||Treatment||None (Open Label)||a single group of patients with palmar arsenical keratosis are given the drug, under study||||
1296958|NCT03635840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296959|NCT03635827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296960|NCT03635814|Randomized|Parallel Assignment||Treatment||Triple||Subjects who finally meet inclusion/exclusion criteria will be randomized into lower dose group (YD312 Tablet 50 mg), middle dose group (YD312 Tablet 150 mg), higher dose group (YD312 Tablet 350 mg), and placebo group as a ratio of 1:1:1:1 and the relevant investigational product will be administered for 12 weeks.|t|t|t|
1296961|NCT03635801|||Cohort||Prospective|||||||
1296962|NCT03635788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296963|NCT03635775|Randomized|Parallel Assignment||Basic Science||Double|Participants and families will be masked to intervention group. The research team members performing assessments will be masked to intervention group.||t|||t
1296964|NCT03635762||Single Group Assignment||Prevention||None (Open Label)||||||
1296965|NCT03635749|Randomized|Factorial Assignment||Treatment||Quadruple|"Two nearly identical tablet forms of Clopidogrel (75mg Clopidogrel and matching placebo) with almost the same size, color and smell will be used in this research.~Two nearly identical tablet forms of Aspirin (100mg Aspirin and matching placebo) with almost the same size, color and smell will be used in this research.~Two nearly identical tablet forms of Atorvastatin (20mg Atorvastatin and matching placebo) with almost the same size, color and smell will be used in this research.~Centers are not able to apply unblinding with biological experiment in this study. Researchers shall never unblind the code unless special situations occur such as Serious Adverse Events (SAE), which is essential for treatment. Clinical outcomes of efficacy and safety are submitted to Adjudication Committee, who should be blinded to randomization, for final determination."|"The subjects are randomly assigned to the following four groups:~Intensive antiplatelet therapy + early intensive statin therapy (80mg atorvastatin)~Intensive antiplatelet therapy + delayed intensive statin therapy (40mg atorvastatin)~Standard antiplatelet therapy + early intensive statin therapy (80mg atorvastatin)~Standard antiplatelet therapy + delayed intensive statin therapy (40mg atorvastatin)"|t|t|t|t
1296966|NCT03635736|||Case-Control||Prospective|||||||
1296967|NCT03635723|||Cohort||Prospective|||||||
1296968|NCT03635710|||Cohort||Prospective|||||||
1296969|NCT03635697|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1296970|NCT03635684||Single Group Assignment||Other||None (Open Label)||||||
1296971|NCT03635671|||Cohort||Prospective|||||||
1296972|NCT03635658|Randomized|Parallel Assignment||Treatment||None (Open Label)|because the two interventions used in this trial are clearly different and easily recognized by the investigator and the participants. neither the participant nor the investigator could be blinded|the participants are divided into two groups one control and the other is the intervention||||
1296973|NCT03635645||Single Group Assignment||Other||None (Open Label)||||||
1296974|NCT03635632||Single Group Assignment||Treatment||None (Open Label)||||||
1296975|NCT03635619|||Case-Control||Prospective|||||||
1296976|NCT03635606|||Cohort||Prospective|||||||
1296977|NCT03635593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1296978|NCT03635580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296979|NCT03635567|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1296980|NCT03635554|||Case-Only||Prospective|||||||
1296981|NCT03635541|||Cohort||Other|||||||
1296982|NCT03635528||||||||||||
1296983|NCT03635515|Randomized|Parallel Assignment||Treatment||Single|Participants will not know which study arm/intervention group they will be assigned to.|Patients will be asked to indicate their peak pain level in the twenty-four hours prior to the appointment using a visual analog scale (VAS). The VAS scale will consist of a 100mm line where 0 equals 'no pain' and 100 equals the 'worst pain imaginable'. Patients will be divided into one of two treatment groups, either standard cleaning protocol or Gentlewave irrigation. Patient demographics, anesthesia, cleaning and shaping instruments, irrigation technique, and obturation method and material will be recorded, along with the number of appointments, extent of treatment rendered, and the occurrence of over-instrumentation or overfill of obturation material. Once obturation is completed, patients will be given the same VAS scale to take home and asked to record their level of pain at 6, 24, 72, and 168 hours post-treatment.|t|||
1296984|NCT03635502|||Cohort||Prospective|||||||
1296985|NCT03635489|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1296986|NCT03635476|||Other||Other|||||||
1296987|NCT03635463|Randomized|Parallel Assignment||Treatment||Single|double blinded( participant and outcome assessor)||t|||
1296988|NCT03635450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The first cohort of three patients will receive a single dose in the first 48 postnatal hours. If there are no safety concerns, the second cohort of three patients will receive two doses, with the first dose given in the first 48 postnatal hours and the second dose given approximately two months after the first dose.||||
1296989|NCT03635437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296990|NCT03635424||Single Group Assignment||Treatment||None (Open Label)||||||
1296991|NCT03635411|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1296992|NCT03635398|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1296993|NCT03635385|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1296994|NCT03635372|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1296995|NCT03635359|||Case-Control||Prospective|||||||
1296996|NCT03635346|||Cohort||Prospective|||||||
1296997|NCT03635333|Randomized|Parallel Assignment||Other||Double|||t|t||
1296998|NCT03635320|Randomized|Parallel Assignment||Treatment||Single|Only patient is masked during the study. He/she will be notified during inform consent that either treatment will be used but they will not be informed exactly which group.|"The study population will include 188 patients with proximal femur fracture undergoing internal fixation using an intramedullary nail.~Subjects will be randomized in a 1:1 ratio to receive either the investigational TFNA devices (n=94) or to the control PFNA-II devices (n=94)."|t|||
1296999|NCT03635307|||Case-Only||Prospective|||||||
1297000|NCT03635294||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297001|NCT03635281|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297002|NCT03635268|||Cohort||Retrospective|||||||
1297003|NCT03635255|||Case-Only||Prospective|||||||
1297004|NCT03635242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297005|NCT03635229|||Cohort||Prospective|||||||
1297006|NCT03635216|||Cohort||Retrospective|||||||
1297007|NCT03635203|||Other||Retrospective|||||||
1297008|NCT03635190||Single Group Assignment||Treatment||None (Open Label)||prospective, multi-center, non-randomized single-arm study||||
1297009|NCT03635177|Randomized|Crossover Assignment||Basic Science||None (Open Label)||The patients will undergo four weeks of the intervention and four weeks of sham, separated by two weeks. The intervention consists of inflating a cuff on the upperarm to 200 mmHg for 4 x 5 minutes, performed every day. Sham consists of the same procedure but the cuff is inflated to 30 mm Hg.||||
1297010|NCT03635164||Single Group Assignment||Treatment||None (Open Label)||||||
1297011|NCT03635151|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1297012|NCT03635138|Randomized|Parallel Assignment||Treatment||Quadruple|Bottles with a label remarked with 2 letters A and B , same aspect|Split mouth, 2 premolars restored with 2 dental adhesives , 1 experimental and 1 control|t|t|t|t
1297013|NCT03635125|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||12-week Amlodipine background treatment phase followed by a 4-week Low dose Nebivolol/Metoprolol treatment phase and a 4-week high dose Nebivolol/Metoprolol treatment phase||||
1297014|NCT03635112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297015|NCT03635099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297016|NCT03635086|Randomized|Parallel Assignment||Treatment||Quadruple|Site personnel responsible for study medication preparation and administration will be unblinded.||t|t|t|t
1297017|NCT03635073||Single Group Assignment||Treatment||None (Open Label)||||||
1297018|NCT03635060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297019|NCT03635047|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1297020|NCT03635034|Randomized|Parallel Assignment||Other||None (Open Label)||We will compare the two groups for complications related to catheter or not having a catheter placed.||||
1297021|NCT03635021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297022|NCT03635008|Randomized|Parallel Assignment||Treatment||Quadruple|An investigator who applies the tDCS to the participants will not be masked. However, other investigators including outcome assessors and participants will be masked. The other care providers in our department (e.g. other physio- or occupational therapists) will be masked.|Randomized, double-blind, sham-controlled, parallel group design|t|t|t|t
1297023|NCT03634995|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297024|NCT03634982||Single Group Assignment||Treatment||None (Open Label)||||||
1297025|NCT03634969|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297026|NCT03634956||Single Group Assignment||Prevention||None (Open Label)||Group A. Sugammadex sodium-IONM in thyroid surgery Group B.Standart technique-IONM in thyroid surgery||||
1297027|NCT03634943|||Cohort||Prospective|||||||
1297028|NCT03634930|||Cohort||Prospective|||||||
1297029|NCT03634917|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1297030|NCT03634904||Single Group Assignment||Treatment||None (Open Label)||Single group assignment||||
1297031|NCT03634891|||Other||Prospective|||||||
1297032|NCT03634878||Single Group Assignment||Other||None (Open Label)||||||
1297033|NCT03634865|||Cohort||Retrospective|||||||
1297034|NCT03634852|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297035|NCT03634839|Randomized|Crossover Assignment||Other||Double|||t|t||
1297036|NCT03634826|||Case-Only||Prospective|||||||
1297037|NCT03634813|Randomized|Parallel Assignment||Diagnostic||Single||2 cohort parallel|t|||
1297038|NCT03634800||Single Group Assignment||Treatment||None (Open Label)||Patients with multiple myeloma will receive Nivolumab intravenously at 240 mg every two weeks. Infusions will be given over 60 minutes (not bolus or IV push). Patients will continue to receive infusions every two weeks until disease progression or dose limiting toxicity is reached. Patients will receive radiation for 5 consecutive days. A dose of 6 Gy x 5 days will be administered. Patients may receive radiotherapy to an additional site at 12 weeks if they have stable disease.||||
1297039|NCT03634787|||Case-Control||Prospective|||||||
1297040|NCT03634774|Randomized|Parallel Assignment||Supportive Care||Double|Mealtime observations are completed by assessors who are blinded to the order in which sites receive the intervention|Step-wedge design; all three groups receive the intervention but two are wait list control for varied amounts of time|||t|t
1297041|NCT03634761|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1297042|NCT03634748|||Case-Control||Retrospective|||||||
1297043|NCT03634735|Randomized|Crossover Assignment||Treatment||Triple|Double blinded|RCT and crossover|t|t|t|
1297044|NCT03634722|Randomized|Parallel Assignment||Prevention||Double||the transcutaneous electrical nerve stimulation by PHENIX4-8-8 PLUS|t||t|
1297045|NCT03634709|Randomized|Parallel Assignment||Treatment||Single|Assessors will be blind to allocated condition|Single blind, randomized controlled trial comparing active intervention to waitlist control||||t
1297046|NCT03634696|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1297047|NCT03634683||Single Group Assignment||Treatment||None (Open Label)||||||
1297048|NCT03634670|||Cohort||Prospective|||||||
1297049|NCT03634657|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1297050|NCT03634644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297051|NCT03634631||Single Group Assignment||Basic Science||Single|||t|||
1297052|NCT03634618|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Study||||
1297053|NCT03634605|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1297054|NCT03634592|||Cohort||Prospective|||||||
1297055|NCT03634579||Single Group Assignment||Treatment||None (Open Label)||Prospective, Interventional, Single-Arm, Unblinded trial||||
1297056|NCT03634566|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1297057|NCT03634553|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1297058|NCT03634540|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||PT2977 in combination with cabozantinib administered orally once daily||||
1297059|NCT03634527|Non-Randomized|Factorial Assignment||Treatment||Double|Participants and outcome assessor will be masked for the treatment that participants received (actual treatment vs sham treatment).||t|||t
1297060|NCT03634514|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1297061|NCT03634501||Single Group Assignment||Treatment||None (Open Label)||||||
1297062|NCT03634488|||Cohort||Prospective|||||||
1297063|NCT03634475||Single Group Assignment||Treatment||None (Open Label)||||||
1297064|NCT03634462|Randomized|Crossover Assignment||Treatment||None (Open Label)||Subjects will receive both standard manual lymphatic drainage therapy (without negative pressure) or decongestive therapy with negative pressure. Patients will be randomized into which therapy they receive first and a cross-over study will be performed (approximate washout duration = 6 months).||||
1573321|NCT00001624||||Treatment||||||||
1297065|NCT03634449|Randomized|Parallel Assignment||Other||Double||one group using the endotracheal tube one group using the i-gel|t|t||
1297066|NCT03634436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297067|NCT03634423|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1297068|NCT03634410|||Cohort||Prospective|||||||
1297069|NCT03634397|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will assess all participants and be unaware of the participants' group assignment.|Participants are randomly assigned to one of two groups. One group (treatment group) receives remediation therapy of the non-paretic arm while the control group receives paretic arm therapy.||||t
1297070|NCT03634384|||Cohort||Prospective|||||||
1297071|NCT03634371|Randomized|Crossover Assignment||Treatment||Single|||t|||
1297072|NCT03634358|Randomized|Parallel Assignment||Treatment||Single||Comparing Outcomes of two different surgical techniques between two groups|t|||
1297073|NCT03634345||Parallel Assignment||Basic Science||None (Open Label)||||||
1297074|NCT03634332||Single Group Assignment||Treatment||None (Open Label)||Single Treatment Arm for Second-Line treatment of Specific sub-set (HA high) of advanced pancreatic cancer patients||||
1297075|NCT03634319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"The Brown Glaucoma Implant (BGI) is an implantable device designed to lower intraocular pressure (IOP) in glaucoma patients by shunting aqueous humor from the anterior chamber of the eye to the surface of the eye.~Because there are no physiologic sources of outflow resistance, the device can be engineered to target an IOP that is low enough to halt the progression to blindness in a patient suffering from glaucoma."||||
1297076|NCT03634306|Randomized|Parallel Assignment||Diagnostic||Single|Patients will be randomized using a paper envelope system, just prior to surgery. Investigator will not be informed of the randomization assignment until after the patient is discharged (end of follow-up period). A simple envelope system is used. Pre-made study arm assignment envelopes will be created. Envelopes will be opened just prior to the procedure. For patients randomized & withdrawn prior to the procedure or converted to open procedure, replacement envelopes will be added to the envelope pool. To preserve blinding during the procedure, the Ultravision System consumable will be introduced into the patient, generator will appear operational during all procedures. The display will be covered during use so the investigator is not aware the system is on/off. If for any reason un blinding occurs, the reason will be recorded. Study assessments will be collected per protocol, but the data will not be pooled with blinded data for analysis.|"STUDY DESIGN This is a prospective blinded, randomized controlled study. Arms 1 and 2: Patients enrolling in study arms 1 and 2 who are undergoing hysterectomy will be randomized to either the Ultravision™ System (Arm 1) or Standard of Care/no Ultravision (Arm 2) study arms.~Arm 3: Patients enrolling in study arm 3 who are undergoing a myomectomy will have their procedure conducted with the Ultravision™ System. The procedure is purported to generate the greatest smoke and therefore constitutes a worst-case challenge for the system.~All prescribed evaluations will be performed for all study arms.~STUDY SIZE Arms 1 and 2 (randomized) will enroll 15 patients each. Arm 3 will enroll an additional 5 patients.~DURATION The total duration of the study is expected to be approximately 6 months."|||t|
1297077|NCT03634293|Randomized|Parallel Assignment||Treatment||Triple|the study drug and placebo will be identical arriving from the manufacturing company as a clear fluid for subcutaneous injection of 2 ml'. both arms, the control and intervention, will receive identical subcutaneous injections. the randomization will be prior to recruitment in the pharmacy. At the end of the study the outcomes assessor will be exposed to the data unblended.|the study is a randomized placebo controlled double blinded study. the control group will be receiving placebo and the treatment group will be receiving the study drug.|t|t|t|
1297078|NCT03634280|Randomized|Parallel Assignment||Treatment||None (Open Label)||The patients were randomised using randomisation software and divided into two groups each comprising 20 patients. Tape and splint were kept on the patients for 5 days.||||
1297079|NCT03634267||Single Group Assignment||Treatment||None (Open Label)||||||
1297080|NCT03634254|||Ecologic or Community||Retrospective|||||||
1297081|NCT03634241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297082|NCT03634228||Single Group Assignment||Treatment||None (Open Label)||||||
1297083|NCT03634215|||Cohort||Prospective|||||||
1297084|NCT03634202||Single Group Assignment||Treatment||None (Open Label)||Phase-1 study of escalade dose of radiation||||
1297085|NCT03634189||Single Group Assignment||Treatment||None (Open Label)||||||
1297086|NCT03634176|||Case-Only||Prospective|||||||
1297087|NCT03634163|Randomized|Parallel Assignment||Other||None (Open Label)||Cluster randomization with stepped wedge||||
1297088|NCT03634150||Single Group Assignment||Treatment||None (Open Label)||Experimental: IV Nerofe 96 mg\m2 followed by IV Doxorubicin 10mg\m2, once weekly||||
1297089|NCT03634137|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants were assigned to receive either a 16 mg bioresorbable afamelanotide implant from the previous manufacturing process or a 16 mg bioresorbable afamelanotide implant from the optimized final manufacturing process.||||
1297090|NCT03634124||Single Group Assignment||Other||None (Open Label)||||||
1297091|NCT03634111|Randomized|Parallel Assignment||Other||None (Open Label)|Participants were cesarean section with general anesthesia|Transversus abdominis plane block under the ultrasound guidance||||
1297092|NCT03634098|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1297093|NCT03634085|Randomized|Parallel Assignment||Treatment||Double|double-blind, placebo-controlled|In Sessions I to VI, 6 single, orally administered ascending doses of BDM-2 or placebo will be investigated, alternately dosed in 2 cohorts of 8 healthy male subjects each (Cohorts A and B). For each dose, 6 subjects will receive active treatment and 2 subjects will receive placebo. Subjects will be randomized in such a way that for each dose different subjects receive placebo. In Sessions I to VI, doses are planned to be administered under fasted conditions.|t||t|
1297094|NCT03634072|Randomized|Parallel Assignment||Treatment||Single|Subjects will be randomly assigned to one of two groups. One will undergo PVR with catheter or surgery (whichever is most appropriate ). The other group will continue with medical management.|Subjects will be randomized to PVR or no PVR|||t|
1297095|NCT03634059||Single Group Assignment||Treatment||None (Open Label)||||||
1297187|NCT03632863|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1297188|NCT03632850|||Cohort||Cross-Sectional|||||||
1297096|NCT03634046|Non-Randomized|Parallel Assignment||Treatment||Single|The outcome assessor do not know all the information about the data origin and the group.|Subjects were recruited comparatively into two groups (percutaneous transforaminal endoscopic discectomy (PTED) group and Radiofrequency Ablation (RA) group). The follow-up time points are 7 days, 1 month, 6 months and 12 months post-operation in both groups, respectively.||||t
1297097|NCT03634033|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1297098|NCT03634020||Single Group Assignment||Treatment||None (Open Label)||prospective, consecutive enrollment, single-arm study||||
1297099|NCT03634007|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1297100|NCT03633994|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1297101|NCT03633981|||Cohort||Prospective|||||||
1297102|NCT03633968|Randomized|Parallel Assignment||Health Services Research||Single|assessment of the effect of the antrostomy size in graftless lateral maxillary sinus floor elevation using AMBE (antral membrane balloon elevation) with simultaneous implant placement|assessment of the effect of the antrostomy size in graftless lateral maxillary sinus floor elevation using AMBE (antral membrane balloon elevation) with simultaneous implant placement|t|||
1297103|NCT03633955|||Cohort||Prospective|||||||
1297104|NCT03633942|||Cohort||Prospective|||||||
1297105|NCT03633929|||Cohort||Prospective|||||||
1297106|NCT03633916|Randomized|Crossover Assignment||Other||None (Open Label)||Stepped Wedge Cluster Randomised Controlled Trial (SW-CRCT), complete design.||||
1297107|NCT03633903|Randomized|Parallel Assignment||Prevention||None (Open Label)||Adolescents are randomly assigned to either a mindfulness intervention or no intervention.||||
1297108|NCT03633890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297109|NCT03633877|Randomized|Parallel Assignment||Prevention||Double||Every patient will have each tape on each side of the mouth Hy-Tape® on one side and the DuraporeTM on the other side according to the randomization schema.|t|||t
1297110|NCT03633864||Single Group Assignment||Treatment||None (Open Label)||||||
1297111|NCT03633851|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297112|NCT03633838|||Other||Retrospective|||||||
1297113|NCT03633825|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1297114|NCT03633812|||Cohort||Prospective|||||||
1297115|NCT03633799||Single Group Assignment||Treatment||None (Open Label)||VeraCept Intrauterine Device (IUD)||||
1297116|NCT03633786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297117|NCT03633773||Single Group Assignment||Treatment||None (Open Label)||||||
1297118|NCT03633760|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1297119|NCT03633747||Single Group Assignment||Treatment||None (Open Label)||||||
1297120|NCT03633734||Single Group Assignment||Treatment||None (Open Label)||||||
1297121|NCT03633721|Randomized|Crossover Assignment||Other||Double|Neither participant nor care provider will be informed when cannabis/placebo are administered.|Participants will receive either cannabis or placebo on 1st visit and the opposite on the 2nd visit.|t|t||
1297122|NCT03633708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297123|NCT03633695|Non-Randomized|Parallel Assignment||Treatment||Single|Examiner masked|||||t
1297124|NCT03633682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297125|NCT03633669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297126|NCT03633656|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1297127|NCT03633643|Randomized|Parallel Assignment||Treatment||Triple||single-dose application of Cotrimoxazole compared to a 3-day application of Cotrimoxazole|t||t|t
1297128|NCT03633630|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1297129|NCT03633617|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297130|NCT03633604||||||||||||
1297131|NCT03633591||Single Group Assignment||Other||None (Open Label)||||||
1297132|NCT03633578||Single Group Assignment||Other||None (Open Label)||||||
1297133|NCT03633565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297134|NCT03633552|Randomized|Parallel Assignment||Treatment||None (Open Label)||The patients will be randomized to 6-cycle and 12-cycle adjuvant Temozolomide groups using block randomization method (1:1).||||
1297135|NCT03633539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297136|NCT03633526|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1297137|NCT03633513|||Case-Control||Prospective|||||||
1297138|NCT03633500|Randomized|Parallel Assignment||Prevention||Triple|"Block size and number of blocks: the sample size estimated for the study was 48 the size of the blocks is fixed in nature. Hence there are 6 blocks with a block size of 8 preterm babies each in every block.~Allocation ratio: one to one allocation ratio will be used for the study. Since the block size is 8 and one to one allocation was used, each block consist of 4 babies in each group (experimental:4, control =4) Sequence generation: 6 sets of random sequence will be generated with the help of research randomizer, an online random number generator. The sequence will be generated by an external member, who was not directly involved in the study.~Allocation concealment: Concealed allocation was achieved using sequentially Numbered, Opaque, Sealed Envelopes (SNOSESs). SNOSESs were prepared by an external member, who was not a part of study and kept in an opaque envelope.~Blinding: is done by covering the syringe with adhesive silk tape."|the intervention is carried out among preterm babies below 33 weeks of gestation or weight less than 1500gm||t|t|t
1297139|NCT03633487||Single Group Assignment||Basic Science||None (Open Label)||||||
1297189|NCT03632837|Randomized|Parallel Assignment||Treatment||None (Open Label)|Participants are regularily going to be unconsciuos during the differential treatment phase due to the nature and severity of their condition, yet exceptions to this are not going to be suppressed for obvious ethical reasons.|||||
1297190|NCT03632824||Single Group Assignment||Treatment||None (Open Label)||Tranexamic acid was prescribed for women with abnormal vaginal bleeding in the first trimester less than 20 weeks gestation (threatened and recurrent miscarriage) and Antepartum hemorrhage (abruption , placenta previa, and unknown causes for vaginal bleeding)||||
1297191|NCT03632811|||Cohort||Prospective|||||||
1297698|NCT03626194|||Other||Prospective|||||||
1297140|NCT03633474|Randomized|Parallel Assignment||Prevention||Single|Non-Neisseria spp. carriers will randomised in a ratio of 2:1 to receive either 10-5 cfu N. lactamica or PBS control using randomisation software, e.g. Sealed envelope (TM) available online.|Volunteers will be blinded to the inoculum type received (i.e. N. lactamica or PBS control) throughout the study duration. Nasal secretion and throat swabs will be taken to enable mucosal immune profiling and microbiome analyses to be performed. Subjects will be screened for nasopharyngeal N. meningitidis carriage -28 to -7 days (visit 1) and non-Neisseria spp. carriers will be challenged with either 105 cfu N. lactamica suspended in PBS or PBS only control (day 0, visit 2). Volunteers identified as carriers of N. meningitidis at visit 1 will be excluded from the study and will not progress to experimental human challenge. Biological samples (nasal secretion, microbiome swab and blood) will be collected from volunteers who progress to the challenge (visit 2, Day 0) and on days +7 (+/-3), +14 (+/-3) and +28 (+/-5) post-challenge. Nasal wash sampling will not be taken at the challenge visit (Day 0) but will be taken on days +7(+/-3), +14 (+/-3) and +28 (+/-5) post-challenge.|t|||
1297141|NCT03633461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297142|NCT03633448|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1297143|NCT03633435||Single Group Assignment||Treatment||None (Open Label)||All incident and prevalent dialysis patients of our unit will get information on that assisted HHD program and will be able to choose this technique||||
1297144|NCT03633422|||Cohort||Other|||||||
1297145|NCT03633409|||Cohort||Cross-Sectional|||||||
1297146|NCT03633396|Randomized|Parallel Assignment||Treatment||Double|Double-blind||t||t|
1297147|NCT03633383|||Cohort||Retrospective|||||||
1297148|NCT03633370|Randomized|Sequential Assignment||Treatment||Single||A Stepped Wedge Cluster Randomized Controlled Trial||||t
1297149|NCT03633357|Randomized|Crossover Assignment||Basic Science||Double||Crossover, Mechanistic Pharmacological Neuroimaging Study|t||t|
1297150|NCT03633344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297151|NCT03633331||Single Group Assignment||Treatment||None (Open Label)||||||
1297152|NCT03633318|Non-Randomized|Parallel Assignment||Diagnostic||Single||Participants with IBM will be compared with a group matched on sex and age.||||t
1297153|NCT03633305|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The study involves two treatment phases of six to eight weeks. In the first phase, participants choose medication (treatment as usual), online cognitive behavior therapy, or online cognitive behavior therapy combined with medication. Participants enter a second treatment phase if they still experience insomnia after the first treatment. The treatment arms for the second phase are medication, in-person cognitive-behavior therapy, or no additional treatment.||||
1297154|NCT03633292|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1297155|NCT03633279|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1297156|NCT03633266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297157|NCT03633253|||Cohort||Retrospective|||||||
1297158|NCT03633240|||Cohort||Prospective|||||||
1297159|NCT03633227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297160|NCT03633214|Randomized|Parallel Assignment||Other||Single|||||t|
1297161|NCT03633201|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1297162|NCT03633188||Single Group Assignment||Basic Science||None (Open Label)||||||
1297163|NCT03633175|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297164|NCT03633162|||Cohort||Retrospective|||||||
1297165|NCT03633149|Randomized|Parallel Assignment||Prevention||Single||||||t
1297166|NCT03633136|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1297167|NCT03633123|Randomized|Parallel Assignment||Prevention||Single|"Subject will be blinded to the treatment arm assignment. Physicians which were not part of the team in the surgery room, or from the hospital's infectious diseases dept. will remain blinded to the study arm, and will be those assessing the incisional wound for the study primary endpoint at each follow-up visit post the index surgery.~On top, for each suspicion of infection, an external, independent and blinded adjudication committee will be the one making the final decision whether an infection occured or not."|"Males and females, >18 years old, undergoing scheduled abdominal colon surgery involving resection and anastomosis or a stoma, who meet the inclusion criteria and none of the exclusion criteria and provide signed informed consent will be enrolled in the study.~Subjects will be randomized to either the investigational arm (SOC + D-PLEX) or to the control arm (SOC only) in a 1:1 ratio.~Subjects will be blinded to the study arm."|t|||
1297168|NCT03633110|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1297169|NCT03633097|Randomized|Parallel Assignment||Treatment||Single|single blinded, outcome assessor blinded|||||t
1297170|NCT03633084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is an open label, non-controlled, sequential, dose-escalating study||||
1297171|NCT03633071|||Cohort||Prospective|||||||
1297172|NCT03633058|Randomized|Crossover Assignment||Treatment||Triple||Patients will receive either placebo or ketamine for 5 days BID and will be assessed for 2 weeks after each treatment.|t|t|t|
1297173|NCT03633045|||Cohort||Prospective|||||||
1297174|NCT03633032||Single Group Assignment||Diagnostic||None (Open Label)||Bone anatomy will be compared between different imaging modalities||||
1297175|NCT03633019||Single Group Assignment||Treatment||None (Open Label)||||||
1297176|NCT03633006|||Cohort||Prospective|||||||
1297177|NCT03632993|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1297178|NCT03632980||Single Group Assignment||Treatment||None (Open Label)||||||
1297179|NCT03632967||Single Group Assignment||Treatment||None (Open Label)||||||
1297180|NCT03632954|||Cohort||Prospective|||||||
1297181|NCT03632941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297182|NCT03632928|||Cohort||Prospective|||||||
1297183|NCT03632915|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297184|NCT03632902|||Other||Retrospective|||||||
1297185|NCT03632889|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1297186|NCT03632876|Randomized|Parallel Assignment||Treatment||Quadruple||Subjects in parallel groups will be randomized to one of two doses of vitamin A supplementation.|t|t|t|t
1297192|NCT03632798|Randomized|Parallel Assignment||Diagnostic||Quadruple|Study investigators will be kept blind to the schedule. All participants will be screened by the ChemoID drug response assay; however, the treating physician will receive the ChemoID results only for those participants who are randomized to receive ChemoID-guided treatment arm.|parallel group randomized controlled clinical trial|t|t|t|t
1297193|NCT03632785|||Case-Control||Prospective|||||||
1297194|NCT03632772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297195|NCT03632759|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||two independent open label, proof of concept studies||||
1297196|NCT03632746|||Case-Only||Prospective|||||||
1297197|NCT03632733|Randomized|Parallel Assignment||Treatment||Single|Participants are not aware of the drug they are given|Three antimicrobials ( two single and one in combination form) and a placebo will be provided in patients randomly|t|||
1297198|NCT03632720|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297199|NCT03632707||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297200|NCT03632694|Randomized|Parallel Assignment||Supportive Care||Single||3-arm randomized controlled trial; participants were block randomized with equal allocation to 3 arms within 2 strata defined by body mass index (BMI; <30 vs. >=30 kg/m2)|||t|
1297201|NCT03632681|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1297202|NCT03632668||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1297203|NCT03632655|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Men will be randomized to receiving either TPM or TRUS targeted biopsy.||||
1297204|NCT03632642|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study will be a pilot open-label multicentre randomised trial that is investigator-initiated comparing two drug regimens: benzylpenicillin vs. flucloxacillin for penicillin susceptible S. aureus bloodstream infections. We will aim to enrol 60 patients (30 in each arm) over a 12-month period. The participation duration for each enrolled patient is 90 days. Data will be collected for the participants from the date of when the first positive blood culture was obtained, which will be within 72 hours of enrollment. Consented patients will be randomised on day 1 (the day of randomisation) to either benzylpenicillin or flucloxacillin.||||
1297205|NCT03632629|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1297206|NCT03632616|||Cohort||Prospective|||||||
1297207|NCT03632603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297208|NCT03632590|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1297209|NCT03632577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297210|NCT03632564||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1297211|NCT03632551|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1297212|NCT03632538|||Case-Only||Prospective|||||||
1297213|NCT03632525||Single Group Assignment||Treatment||None (Open Label)||||||
1297214|NCT03632512|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1297215|NCT03632499|||Cohort||Prospective|||||||
1297216|NCT03632486|||Cohort||Prospective|||||||
1297217|NCT03632473|||Cohort||Prospective|||||||
1297218|NCT03632460|Randomized|Parallel Assignment||Treatment||Single|||||t|
1297219|NCT03632447|Randomized|Parallel Assignment||Treatment||Single|Assessments of pelvic floor muscle function accomplished by testing at baseline, 4-weeks (mid-study) and 8-weeks will be performed by blinded assessor|||||t
1297220|NCT03632434||Single Group Assignment||Treatment||None (Open Label)||||||
1297221|NCT03632421|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statisticians and laboratory personnel will be blinded to group allocation.|||||
1297222|NCT03632408|Randomized|Crossover Assignment||Basic Science||Triple|Alcohol not masked Zopiclone and placebo capsulated, identical in weight and appearance Third party generated code only available to pharmacy and in case of emergency||t||t|t
1297223|NCT03632395|||Cohort||Prospective|||||||
1297224|NCT03632382||Single Group Assignment||Diagnostic||None (Open Label)||Prospective||||
1297225|NCT03632369|||Other||Other|||||||
1297226|NCT03632356|Randomized|Parallel Assignment||Treatment||Single||2 stage parallel group multi-site RCT design||||t
1297227|NCT03632343|Randomized|Parallel Assignment||Health Services Research||Double||This will be a multi-centre, waitlist group controlled, data analyst blinded, 3-arm parallel-group superiority randomized controlled trial (RCT) with 1:1:1 allocation. Randomization will be stratified by recruitment site to account for differences in care across sites49 with block sizes of 6 and 9 within each stratum. This trial has been designed along the pragmatic end of the pragmatic-explanatory continuum. Our approach to study eligibility criteria, intervention intensity, and participant adherence will determine intervention effect under real-world conditions.|t|t||
1297228|NCT03632330|||Other||Other|||||||
1297229|NCT03632317||Single Group Assignment||Treatment||None (Open Label)||Patients will be divided into two stratums; newly diagnosed high-grade glioma or DIPG after radiation (stratum A) and recurrent/progressive glioma (grade II-IV, including DIPG) (stratum B).||||
1297230|NCT03632304|Randomized|Parallel Assignment||Supportive Care||Single||Randomized controlled trial||||t
1297231|NCT03632291|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1297232|NCT03632278|Randomized|Parallel Assignment||Treatment||Single||"Participants referred to the study will be assessed at a screening examination to ensure eligibility and obtain written consent from a research assistant.~Eligible participants will be randomly assigned to receive Mindfulness psychoeducation programme (MBPP) plus TAU or TAU."||||t
1297233|NCT03632252||Single Group Assignment||Basic Science||None (Open Label)||||||
1297234|NCT03632239|||Cohort||Other|||||||
1297235|NCT03632226|||Cohort||Prospective|||||||
1297236|NCT03632213|Randomized|Parallel Assignment||Treatment||Triple||"Experimental group: 15 patients, both sexes, will receive Losartan 25 mg orally for 12 months.~Control group: 15 patients, both sexes, will receive oral placebo for 12 months.~Eligible research participants for treatment will be randomly assigned to a treatment group or a control group in a ratio of 1: 1. The groups will be stratified by age and type of MPS in the following strata:~A) Diagnosis of MPS IVA: 20 patients expected B) Diagnosis of MPS VI: 10 patients expected"|t|t|t|
1297362|NCT03630575||Single Group Assignment||Other||None (Open Label)||||||
1297237|NCT03632200|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||a pilot study to compare experimental group (improved coverage) and control group (classic coverage)||||
1297238|NCT03632187|Randomized|Parallel Assignment||Treatment||Double||This is a multicenter double blinded randomized placebo controlled trial|t||t|
1297239|NCT03632174|Randomized|Parallel Assignment||Other||Single||Comparison of two cosmetic products|t|||
1297240|NCT03632161|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1297241|NCT03632148|||Cohort||Cross-Sectional|||||||
1297242|NCT03632135|Randomized|Parallel Assignment||Diagnostic||Quadruple|Study investigators will be kept blind to the schedule. All participants will be screened by the ChemoID drug response assay; however, the treating physician will receive the ChemoID results only for those participants who are randomized to ChemoID-guided treatment arm.|parallel group randomized controlled clinical trial|t|t|t|t
1297243|NCT03632122|||Cohort||Retrospective|||||||
1297244|NCT03632109||Single Group Assignment||Treatment||None (Open Label)||||||
1297245|NCT03632096|Randomized|Parallel Assignment||Treatment||Single|The sham group will have a simulation of application of the laser, with the device turned off. Because it is an infrared light, it is invisible and this will not induce the patient to notice that the device is turned off. In the group that receives the photobiomodulation the device will have its timer turned off, to avoid the perception of sound difference.||t|||
1297246|NCT03632083|Randomized|Crossover Assignment||Basic Science||Double|The first solution, the randomisation determines that the right lens will wear the fanfilcon A lens and the left eye will wear the comfilcon A lens for two hours of wear, with a two-day 'wash-out' period and the laterality of the lenses will be swapped for the second solution for two hours of wear. Lenses will be provided in lens cases which do not detail lens or care system information.|This is a double-masked, randomized, contralateral, crossover study design. Lenses are worn as an unmatched pair.|t||t|
1297247|NCT03632070|||Case-Only||Retrospective|||||||
1297248|NCT03632057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297249|NCT03632044|Randomized|Parallel Assignment||Treatment||Triple|"During the block placement the surgical team will be asked to leave the operating room briefly to remain blinded to the group assignment of all patients as the surgical team will manage the subjects post-operative care and determine discharge readiness.~ICU nursing staff and parents will be informed of participation in the study but will not be informed as to group assignment to remain blinded."|This randomized, double-blinded study. Subjects will be randomly assigned to one of two different protocols by a designated study team member based on a computer generated randomization table. Randomization will occur following consent. Randomization will be 1:1.|t|t||t
1297250|NCT03632031||Single Group Assignment||Treatment||None (Open Label)||"A patient is suitable for inclusion in the study if the patient meets the following criteria, based on known information at the time of enrolment:~1. Non-healing ulcer (any etiology) present for at least 1 month and treated in the ambulatory clinic or home healthcare setting"||||
1297251|NCT03632018|Randomized|Parallel Assignment||Treatment||Double|Because we are intentionally changing the clinic environment, study participants and care providers will not be masked to the study condition. However, the investigator and the outcome assessors will be unaware which study arm a given participant is in to reduce bias.|Cluster randomized controlled trial|||t|t
1297252|NCT03632005|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297253|NCT03631992|Randomized|Parallel Assignment||Basic Science||Triple|Participants and outcome assessors will be blind to hypotheses and group assignment. Investigators will be blind to the group assignment during statistical analyses.|The intervention group will receive snacks lower in added sugar and sweetness (children) and educational lessons on dental care, food labels, added sugar, and portion size (mothers) whereas the control group will receive typical snacks (children) and educational lessons on portion size, sleep, screen time, and physical activity (mothers). Control group will receive the educational lessons of the intervention group at the end of the trial.|t||t|t
1297254|NCT03631979|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297255|NCT03631966||Single Group Assignment||Treatment||None (Open Label)||All patient's recruited to this study will have failed prior conservative treatment, and therefore any improvements seen in symptoms from the BTX-A injection will be considered above and beyond what was provided by conservative care. As such, each patient in this study design acts as their own case control (i.e. there is no appropriate intervention and/or placebo control group for these patients).||||
1297256|NCT03631953||Single Group Assignment||Treatment||None (Open Label)||||||
1297257|NCT03631940|Randomized|Crossover Assignment||Prevention||None (Open Label)||Cluster Randomized Crossover||||
1297258|NCT03631927|||Other||Cross-Sectional|||||||
1297259|NCT03631914|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1297260|NCT03631901|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1297261|NCT03631888|||Case-Control||Prospective|||||||
1297262|NCT03631875|Randomized|Parallel Assignment||Diagnostic||Single|A nurse not involved in the study prepared two syringes with ketamine or normal saline, and administrated it according randomization (by computer generated random numbers) one minute before induction with propofol|After inhalatory induction with sevoflurane7%until abolition of the eye lash reflex, an intravenous canula was inserted in the dorsum of the hand. The sevoflurane concentration was then decreased to 2% in 100% O2.A nurse not involved in the study prepared two syringes with ketamine or normal saline, and administrated it according randomization , one minute before induction with propofol. The administration of propofol was realized on 60 seconds. An experimented anesthesiologist evaluated the LMA conditions insertion. When the jaw was relaxed, and deglutition and cough reflex and member movement were absent, the conditions were considered acceptable. The LMA was then inserted. For analgesia,we proceeded by a locoregional bloc adapted to the surgery. We recorded systolic and diastolic blood pressure, HR and SpO2 at the induction time at LMA insertion and at the 3rd,5th and10th min.||||t
1297263|NCT03631862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297264|NCT03631849|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297265|NCT03631836||Single Group Assignment||Treatment||None (Open Label)||||||
1297266|NCT03631823|||Case-Control||Prospective|||||||
1297267|NCT03631810|||Cohort||Prospective|||||||
1297268|NCT03631797||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297269|NCT03631784|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297270|NCT03631771||Single Group Assignment||Other||None (Open Label)||||||
1297271|NCT03631758|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1297272|NCT03631745|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The National Alliance on Mental Illness (NAMI) of California has developed Mental Health 101, a suite of contact-based education programs tailored for culturally diverse populations including Latino populations. Another NAMI program, FaithNet, provides resources and training on how churches can shape norms and overcome shame and stigma related to mental illness and treatment. NAMI FaithNet also assists with facilitating linkages to mental health services from providing referrals to partner mental health agencies to forming multi-sector collaboratives of social service organizations, clergy, and mental health providers to create a more holistic, coordinated system of care. The multi-component, church-based, intervention will build on NAMI's existing resources, with tailoring for Latino church-based settings.||||
1297273|NCT03631732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297274|NCT03631719|||Case-Control||Prospective|||||||
1297275|NCT03631706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297276|NCT03631693|Randomized|Parallel Assignment||Other||Single|"The calibrated examiners will be blinded to the study treatment. Samples will be labelled anonymously with subject ID and without codes relating to treatment group; therefore, all sample analyses will be blinded.~Blinding of the statistician will also take place. Data will be coded during data entry according to treatment group with a number disallowing group identification during analyses. Code details of which each treatment group will be revealed only once analyses are complete."|Single centre, randomised, single-blind, parallel-group clinical trial.||||t
1297277|NCT03631680|||Cohort||Cross-Sectional|||||||
1297278|NCT03631667|Non-Randomized|Crossover Assignment||Basic Science||Single|Deidentified samples will be analyzed by AMS at Lawrence Livermore National Laboratory and the pharmacokinetics determine at Pacific Northwest National Laboratory.|||||t
1297279|NCT03631654|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1297280|NCT03631641||Single Group Assignment||Prevention||None (Open Label)||||||
1297281|NCT03631628|Randomized|Parallel Assignment||Treatment||Single||||||t
1297282|NCT03631615||Single Group Assignment||Treatment||None (Open Label)||||||
1297283|NCT03631602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297284|NCT03631589||Single Group Assignment||Treatment||None (Open Label)||||||
1297285|NCT03631576||Single Group Assignment||Treatment||None (Open Label)||||||
1297286|NCT03631563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297287|NCT03631550||||||||||||
1297288|NCT03631537|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Study group: receive nutritional intervention from the nutritional support team; Control group: receive routine nutritional support from clinicians||||
1297289|NCT03631524|Randomized|Parallel Assignment||Treatment||Single|Block Randomisation, Initial and final outcome assessors blinded to treatment arm|Two arm single blinded RCT||||t
1297290|NCT03631511||Single Group Assignment||Treatment||None (Open Label)||||||
1297291|NCT03631498|||Case-Control||Cross-Sectional|||||||
1297292|NCT03631485|||Other||Cross-Sectional|||||||
1297293|NCT03631472||Single Group Assignment||Treatment||None (Open Label)||Treatment with Gala Airway Treatment System||||
1297294|NCT03631459|||Cohort||Prospective|||||||
1297295|NCT03631446|||Case-Only||Prospective|||||||
1297296|NCT03631433|Randomized|Parallel Assignment||Treatment||Triple|identical appearing tablets and random allocation||t|t|t|
1297297|NCT03631420||Single Group Assignment||Treatment||None (Open Label)||||||
1297298|NCT03631407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297299|NCT03631394|Randomized|Crossover Assignment||Other||Double|||t|||t
1297300|NCT03631381|||Cohort||Retrospective|||||||
1297301|NCT03631368||Single Group Assignment||Treatment||None (Open Label)||||||
1297302|NCT03631355|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1297303|NCT03631342|Randomized|Crossover Assignment||Other||None (Open Label)||"In order to perform both interventions, the patients were placed in dorsal decubitus with a head elevated at 45 ° and submitted to closed tracheal aspiration, according to the recommendations of the American Association for Respiratory Care. In addition, the bacteriological filter was changed, the cuff pressure was increased and the presence of leaks in the mechanical fan circuits was verified.~All patients underwent five hyperinflation maneuvers, the order being determined by randomization. Controlled volume ventilation (VCV) at a constant flow rate of 20 Lpm (VCV-20) and 40 Lpm (VCV-40), controlled pressure ventilation (VCV-40) was performed for 2 minutes at 10 minute intervals. PCV), pressure-controlled ventilation associated with inspiratory time adjustment (PCV + Tins) and pressure-supported ventilation (PSV). PEEP and FiO2 were maintained throughout the study."||||
1297304|NCT03631329|||Cohort||Prospective|||||||
1297305|NCT03631316|Randomized|Crossover Assignment||Prevention||Quadruple|Each participant will take both formulations. Groups will be formed regarding the order in which the different formulations of valganciclovir will be analyzed. Both formulations will be given in two identical container numbered in the specific order assigned. The order of administration of the drug will be randomized, neither the researcher nor the patient will know the order of the randomization.|Pharmacovigilance study, prospective, observational, analytical, single center, cross over design, with random assignment to the sequence of both formulations in the same patient. Our aim will be compare the pharmacokinetic parameters of the innovative versus generic formulation of valGCV in renal transplant recipients under valGCV prophylaxis in the early posttransplant stage.|t|t|t|t
1297306|NCT03631303|||Case-Control||Cross-Sectional|||||||
1297307|NCT03631290||Single Group Assignment||Health Services Research||None (Open Label)||||||
1297308|NCT03631277|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1297309|NCT03631264|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1297310|NCT03631251||Single Group Assignment||Treatment||None (Open Label)||||||
1297311|NCT03631238|||Case-Control||Prospective|||||||
1297312|NCT03631225|||Cohort||Prospective|||||||
1297363|NCT03630562||Single Group Assignment||Other||None (Open Label)||||||
1297313|NCT03631212|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking was carried out|Comparison between flexiquit and a wait-list control group||||
1297314|NCT03631199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297315|NCT03631186|||Cohort||Prospective|||||||
1297316|NCT03631173|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||2-armed, multicenter, randomized, open label, parallel-group controlled trial (RCT)||||
1297317|NCT03631160|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1297318|NCT03631147|Randomized|Parallel Assignment||Treatment||Single||||||t
1297319|NCT03631134||Single Group Assignment||Treatment||None (Open Label)||||||
1297320|NCT03631121||Single Group Assignment||Treatment||None (Open Label)||||||
1297321|NCT03631108|||Case-Control||Cross-Sectional|||||||
1297322|NCT03631095|||Cohort||Prospective|||||||
1297323|NCT03631082|Randomized|Parallel Assignment||Treatment||Single||"The two groups will be Slump stretching group and Lumbar mobilization group. All physical therapy techniques in both groups will be applied 3 times in a week up to 2 weeks with each session consisting of 25-40 minutes.~Group 1 will receive slump stretching along with standardized exercises while group 2 will recieve lumbar mobilization along with standardized exercises.~Demographic details of the patients will be collected at baseline (1st Visit) while Modified Oswestry Low Back Pain Disability Questionnaire,Numeric pain rating scale,Fear-Avoidance Beliefs Questionnaire,Active range of motion (AROM) of lumbar spine and Short-Form Health Survey (SF-36) will be measured at baseline, 1st week, and final week."|t|||
1297324|NCT03631069|||Cohort||Retrospective|||||||
1297325|NCT03631056||||||||||||
1297326|NCT03631043||Single Group Assignment||Treatment||None (Open Label)||||||
1297327|NCT03631030||Single Group Assignment||Treatment||None (Open Label)||Prospective, singe group cohort study||||
1297328|NCT03631017||Single Group Assignment||Diagnostic||None (Open Label)||This is an open label, investigator initiated single arm, first in human study of a PARP1/2 imaging agent in patients with head and neck squamous cell carcinomas scheduled to undergo surgery.||||
1297329|NCT03631004|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1297330|NCT03630991|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297331|NCT03630978|||Cohort||Prospective|||||||
1297332|NCT03630965|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1297333|NCT03630952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297334|NCT03630939|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1297335|NCT03630926|||Cohort||Prospective|||||||
1297336|NCT03630913||Single Group Assignment||Treatment||None (Open Label)||||||
1297337|NCT03630900|Randomized|Parallel Assignment||Other||Double|||t|||t
1297338|NCT03630887|Randomized|Parallel Assignment||Prevention||Double|Randomization will be carried out by a collaborator investigator using a computer program (Excel 2016) when a new patient is included into the clinical trial. This collaborator investigator will call by phone the nurse in charge of receiving the patient in the preanesthetic room, telling this nurse how long prewarming has to be given to the patient: 0 minutes (no prewarming), 15 minutes, 30 minutes or 45 minutes, according to the group given by the computer program. This collaborator investigator will not provide clinical care to the patient. Thus, principal investigator will not be able to know how long prewarming will be given by the nurse to the patient (chosen by the computer program and organized by a collaborator investigator)|We will compare different time periods: 0 minutes (control group), 15 minutes, 30 minutes and 45 minutes.||t|t|
1297339|NCT03630874|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297340|NCT03630861|||Cohort||Prospective|||||||
1297341|NCT03630848|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1297342|NCT03630835||Single Group Assignment||Screening||None (Open Label)||||||
1297343|NCT03630822|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1297344|NCT03630809||Single Group Assignment||Treatment||None (Open Label)||||||
1297345|NCT03630796|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297346|NCT03630783|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1297347|NCT03630770|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297348|NCT03630757|Randomized|Parallel Assignment||Treatment||Single||Patients were randomly divided into 2 groups of 20 people. A randomized list is prepared in a computer environment by a statistician for randomization. In this list, the odd numbers for the control group and the MT group were given double numbers. The group identification is printed on sequentially numbered cards placed in sealed envelopes. After enrollment, the numbered envelope was opened by the patient and the blind investigator. For the study group, manual therapy (MT) was given and the home exercise program was given and for the control group only home exercise program was given. In the study group, a total of 15 sessions of a manual therapy program including myofascial release and mobilization techniques were applied for 60-minute session for 3 weeks(5/wk). The treatment program has been implemented by a physiotherapist who specializes in this area.|||t|
1297349|NCT03630744|||Other||Prospective|||||||
1297350|NCT03630731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1297351|NCT03630718|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1297352|NCT03630705|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297353|NCT03630692|||Cohort||Prospective|||||||
1297354|NCT03630679|||Cohort||Prospective|||||||
1297355|NCT03630666|Randomized|Parallel Assignment||Treatment||None (Open Label)||phase 3 study, randomised, open||||
1297356|NCT03630653||Single Group Assignment||Treatment||None (Open Label)||||||
1297357|NCT03630640||Single Group Assignment||Treatment||None (Open Label)||Clinical study phase II||||
1297358|NCT03630627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297359|NCT03630614|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind|Randomized, placebo and reference treatment controlled, multicenter, double blind, double dummy, parallel group, pivotal, phase III trial.|t|t|t|t
1297360|NCT03630601||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297361|NCT03630588|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1573322|NCT00001622||||Treatment||||||||
1297364|NCT03630549|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Parallel cluster-randomized||||
1297365|NCT03630536|||Other||Other|||||||
1297366|NCT03630523||Single Group Assignment||Other||None (Open Label)||||||
1297367|NCT03630510|Randomized|Crossover Assignment||Treatment||None (Open Label)||The VHI maneuver with inspiratory time adjustment was performed in the pressure controlled ventilation mode (PCV). The inspiratory pressure was increased gradually every 5 cmH2O until reaching a maximum pressure of 35 cmH2O, according to the tolerance of the patient determined by the absence of cough. PEEP remained unchanged throughout the study. The maneuver was performed for 5 min, followed by tracheal aspiration. To perform the control (CTRL), the patients were only positioned and aspirated, without alteration in ventilatory parameters.||||
1297368|NCT03630497|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297369|NCT03630484|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1297370|NCT03630471|Randomized|Parallel Assignment||Treatment||Double|"The randomization list will be generated by an independent statistician. The randomization code will be concealed using sequentially numbered opaque sealed envelopes to maximize allocation concealment.~Baseline assessments will be carried out by field researchers prior to randomization. The six- and 12-week outcome assessments will be carried out by a team of field researchers who will be blind to allocation status."|A two-arm, individually randomized controlled trial with equal allocation of participants between arms.|||t|t
1297371|NCT03630458|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1297372|NCT03630445|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1297373|NCT03630432|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised, parallel, controlled study of 8 weeks pulmonary rehabilitation versus usual care||||
1297374|NCT03630419||Single Group Assignment||Treatment||None (Open Label)||Mito Food Plan and Cellular Repair Therapy||||
1297375|NCT03630406|||Cohort||Prospective|||||||
1297376|NCT03630393|Randomized|Single Group Assignment||Treatment||Single|||t|||
1297377|NCT03630380|||Other||Prospective|||||||
1297378|NCT03630367|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1297379|NCT03630354|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1297380|NCT03630341|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297381|NCT03630328|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1297382|NCT03630315|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1297383|NCT03630302|||Case-Only||Prospective|||||||
1297384|NCT03630289||Single Group Assignment||Treatment||None (Open Label)||||||
1297385|NCT03630276|Randomized|Single Group Assignment||Diagnostic||Single||||t||
1297386|NCT03630263|Randomized|Sequential Assignment||Basic Science||Single|Participants will be provided with a sample that doesn't contain starch.|Repeated measures ANOVA, within factors.|t|||
1297387|NCT03630250|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Cohort||||
1297388|NCT03630237|||Cohort||Prospective|||||||
1297389|NCT03630224|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297390|NCT03630211||Single Group Assignment||Treatment||None (Open Label)||||||
1297391|NCT03630198|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1297392|NCT03630185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297393|NCT03630172|Randomized|Parallel Assignment||Treatment||Quadruple|Random assignment will occur using opaque envelopes. The primary investigator (who is also the care provider) will select an envelope when a subject arrives. The research assistant, who will be blinded to group allocation, will take the pre and post intervention measurements. The primary investigator will be blinded to the pre and post intervention measurements.|Subjects will be randomly assigned to one of two dry needling conditions: dry needling or placebo.|t|t|t|t
1297394|NCT03630159||Single Group Assignment||Treatment||None (Open Label)|None (Open label)|||||
1297395|NCT03630146|Randomized|Parallel Assignment||Treatment||Single|||||t|
1297396|NCT03630133||Single Group Assignment||Treatment||None (Open Label)||||||
1297397|NCT03630120|Randomized|Parallel Assignment||Treatment||Single|Researchers consenting the patients will become unblinded upon treatment assignment.||||t|
1297398|NCT03630107||Single Group Assignment||Treatment||None (Open Label)||||||
1297399|NCT03630094||Single Group Assignment||Other||None (Open Label)||||||
1297400|NCT03630081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297401|NCT03630068|||Cohort||Retrospective|||||||
1297402|NCT03630055|Randomized|Parallel Assignment||Prevention||Single||Eligible patients will undergo a 1:1 randomization using a computer-generated randomization sequence to either receive a direct oral anticoagulant (i.e. rivaroxaban 15mg oral daily) for 7 days or to the standard of care arm (i.e. no rivaroxaban)||||t
1297403|NCT03630042||Single Group Assignment||Treatment||None (Open Label)||A single arm, non randomised phase II trial||||
1297404|NCT03630029|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1297405|NCT03630016|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1297406|NCT03630003||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1297407|NCT03629990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297408|NCT03629977|||Cohort||Prospective|||||||
1297409|NCT03629964||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1297410|NCT03629951|||Cohort||Prospective|||||||
1297411|NCT03629938|||Case-Control||Prospective|||||||
1297412|NCT03629925|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1297413|NCT03629912|Randomized|Parallel Assignment||Prevention||None (Open Label)|Staff collecting pre- and post-intervention data are masked to participant condition.|In each wave of the study (14 weeks per wave), participant groups are randomly assigned to one of four conditions (A,B,C,D). Condition A receives exercise + health education. Condition B receives exercise only. Condition C receives health education only. Condition D receives nothing.||||
1297414|NCT03629899||Single Group Assignment||Treatment||None (Open Label)||||||
1297415|NCT03629886|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297416|NCT03629873||Single Group Assignment||Treatment||None (Open Label)||||||
1297417|NCT03629860|Randomized|Crossover Assignment||Health Services Research||Single|Assessment of ascending ramus cortical plate for reconstruction of atrophic maxillary ridges versus chin cortical plates (Randomized clinical trial)|Assessment of ascending ramus cortical plate for reconstruction of atrophic maxillary ridges versus chin cortical plates (Randomized clinical trial)|t|||
1297418|NCT03629847||Single Group Assignment||Treatment||None (Open Label)||||||
1297419|NCT03629834|||Cohort||Prospective|||||||
1297420|NCT03629821|Randomized|Parallel Assignment||Treatment||Double||Two groups design where one group receives treatment and the other not in the same period of time.|||t|t
1297421|NCT03629808|||Cohort||Prospective|||||||
1297422|NCT03629795|||Cohort||Prospective|||||||
1297423|NCT03629782|||Cohort||Retrospective|||||||
1297424|NCT03629769||Single Group Assignment||Treatment||None (Open Label)||||||
1297425|NCT03629756||Sequential Assignment||Treatment||None (Open Label)||3+3 Dose escalation design.||||
1297426|NCT03629743|||Cohort||Prospective|||||||
1297427|NCT03629730|Randomized|Parallel Assignment||Treatment||Double|The Principal Investigator and Research Coordinators conducting participant assessments will be masked as to participant group assignment.|Three intervention dose groups and one active control group will be compared.|||t|t
1297428|NCT03629717||Single Group Assignment||Prevention||None (Open Label)||||||
1297429|NCT03629704|||Cohort||Prospective|||||||
1297430|NCT03629691|||Case-Only||Retrospective|||||||
1297431|NCT03629678|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized controlled trial||||
1297432|NCT03629665|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1297433|NCT03629652|Randomized|Parallel Assignment||Treatment||Single||||||t
1297434|NCT03629639|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)||t|t|t|t
1297435|NCT03629626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297436|NCT03629613|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Cardiovascular disease condition; healthy, age-matched control||||
1297437|NCT03629600|Randomized|Parallel Assignment||Prevention||None (Open Label)||Prospective randomized open-label parallel-group non-inferiority controlled clinical trial||||
1297438|NCT03629587|||Cohort||Prospective|||||||
1297439|NCT03629574|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297440|NCT03629561|||Cohort||Prospective|||||||
1297441|NCT03629548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297442|NCT03629535||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297443|NCT03629522|Randomized|Parallel Assignment||Prevention||Triple|an anesthesia nurse ; not included in the analysis, verified the allocation and prepared the syringe fulled with ondansetron or saline solution|Ondansetron group (group O): 8mg(10 ml) of Ondansetron administrated 5 minutes before spinal anesthesia control group (group C): saline solution 0,9%(10ml)|t|t||t
1297444|NCT03629509|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Stepped Wedge Cluster Randomized Trial||||
1297445|NCT03629496|Randomized|Parallel Assignment||Other||None (Open Label)||Feasibility randomised controlled trial||||
1297446|NCT03629483|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1297447|NCT03629470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297448|NCT03629457|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297449|NCT03629444|||Case-Crossover||Cross-Sectional|||||||
1297450|NCT03629431|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a study phase III, multicentre, comparative, randomized, controlled, superiority and open||||
1297451|NCT03629418|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1297452|NCT03629405|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1297453|NCT03629392|Randomized|Parallel Assignment||Basic Science||Double|"Participant: The diets are similar except for methionine and cysteine, and it is thought that the participants will not be able to identify their treatment allocation by taste.~Investigator: Randomization will be carried out by an investigator that is not related to the study. All foods will be pre-packaged and delivered to the participants by an unrelated company."||t||t|
1297454|NCT03629379|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||prospective, interventional study||||
1297455|NCT03629366|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1297456|NCT03629353|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1297457|NCT03629340|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1297458|NCT03629327|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Three arms will be followed simultaneously||||
1297459|NCT03629314||Single Group Assignment||Other||None (Open Label)||Educational-Interventional Pilot study||||
1297460|NCT03629301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297461|NCT03629288|Randomized|Parallel Assignment||Treatment||Triple||A double-blind, randomized controlled trial, where patients with a history of Moderate Periodontitis with moderate rate of progression (Stage II grade B) and Severe Periodontitis with potencial for additional tooth loss and moderate rate of progression (Stage III grade B). The intervention group received non-surgical periodontal therapy (SRP) plus azithromycin, and the control group received SRP plus placebo. The clinical variables were measured before the treatment, and in the first, third and sixth month of the end of the SRP, while the microbiological variables were measured before the treatment and in the third and sixth month after treatment.|t|t||t
1297462|NCT03629275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297463|NCT03629262|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1297464|NCT03629249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297465|NCT03629236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297466|NCT03629223|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1297515|NCT03628586|||Cohort||Prospective|||||||
1297516|NCT03628573||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297517|NCT03628560|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1297518|NCT03628547|||Cohort||Prospective|||||||
1297467|NCT03629210|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Eligible participants will be randomized in a 1:1 manner to one of the following groups:~Combination treatment (Group A): 50 participants will receive an intravitreal AFL (2.0 mg) injection and DEX implant (0.7 mg) injection within 0 to 8 days of each other.~Monotherapy treatment (Group B): 50 participants will receive DEX implant (0.7 mg) injection."||||
1297468|NCT03629197|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Physicians will be randomized after physician recruitment is complete. This ensures that arm assignment does not impact physicians' decision to participate. Arm assignment will be done using a random number generator. Due to the nature of the intervention, blinding participants (physicians) is not feasible. However, patients will not be aware of their physician's arm assignment.|Physicians will be randomized to receive the intervention versus control; patients will be recruited to see study physicians; patients will not be randomized.||||
1297469|NCT03629184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297470|NCT03629171||Single Group Assignment||Treatment||None (Open Label)||||||
1297471|NCT03629158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297472|NCT03629145|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1297473|NCT03629132|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1297474|NCT03629119||Single Group Assignment||Prevention||None (Open Label)||||||
1297475|NCT03629106|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized open-label trial to compare two arms: 1) contingent reinforcement and 2) non-contingent reinforcement.||||
1297476|NCT03629093|||Cohort||Prospective|||||||
1297477|NCT03629080|Randomized|Parallel Assignment||Prevention||Triple|The participants, investigators and care providers (study site personnel) will be blinded.|This phase 2, randomized, placebo controlled study will be conducted in two arms stratified by treatment intent. In arm 1, patients will be randomized to receive HB-101 (1a) or placebo (1b) and followed preemptively post-transplant. Approximately 50 patients will be randomized in arm 1. In arm 2, patients will be randomized to receive HB-101 (2a) or placebo (2b) before transplant. Post-transplant patients will receive 3-6 months anti-viral prophylaxis following institutional standard. Approximately 100 patients will be randomized in arm 2.|t|t|t|
1297478|NCT03629067|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1297479|NCT03629054|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1297480|NCT03629041|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1297481|NCT03629028|Randomized|Parallel Assignment||Prevention||None (Open Label)||Prospective Randomised Trial||||
1297482|NCT03629015||Sequential Assignment||Treatment||None (Open Label)||||||
1297483|NCT03629002|||Case-Control||Prospective|||||||
1297484|NCT03628989||Single Group Assignment||Treatment||None (Open Label)||||||
1297485|NCT03628976|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1297486|NCT03628963|Randomized|Parallel Assignment||Supportive Care||Single||Two Family Medicine Groups (FMG) from the same health region but covering distinct areas have been selected as the clusters. The FMGs will be randomily selected for the experimental (CONCERTO+) or control (usual care) group.||||t
1297487|NCT03628950|Randomized|Parallel Assignment||Prevention||Single||||||t
1297488|NCT03628937|Randomized|Parallel Assignment||Prevention||Single|||t|||
1297489|NCT03628924|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297490|NCT03628911||Single Group Assignment||Treatment||None (Open Label)||||||
1297491|NCT03628898||||||||||||
1297492|NCT03628885|Randomized|Factorial Assignment||Prevention||Double|Intervention videos delivered via anonymous online surveys through Survey Sampling International. Randomization to condition is built into the online survey. Participants will not know to which condition they will be randomized. Investigators are blinded by virtue of the built in randomization and anonymity of the survey.|Factorial Assignment|t||t|
1297493|NCT03628872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297494|NCT03628859|||Cohort||Prospective|||||||
1297495|NCT03628846|||Cohort||Prospective|||||||
1297496|NCT03628833||Single Group Assignment||Treatment||None (Open Label)||||||
1297497|NCT03628820|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1297498|NCT03628807|||Cohort||Other|||||||
1297499|NCT03628794|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1297500|NCT03628781|Randomized|Parallel Assignment||Treatment||Single||||||t
1297501|NCT03628768|||Cohort||Cross-Sectional|||||||
1297502|NCT03628755|Randomized|Parallel Assignment||Prevention||None (Open Label)||The three group were digital manipulation of thyroid cartilage(DMT) group,fluency shaping therapy (FST) group,combination of DMT,FST. the intervention period for each subject was three month and data was collected on day one and at the end of every 2 weeks. 4th week , 8th week, and 12th week which were aimed to reduce severity of stuttering and improve fluency||||
1297503|NCT03628742|||Other||Cross-Sectional|||||||
1297504|NCT03628729|Randomized|Parallel Assignment||Prevention||Triple||A total of 40 volunteer patients with at least 2 non-cavitated molar teeth will be assigned in this study. Patients will be randomly divided into two groups according to type of sealant (S) where in group S1, pits and fissures will be sealed with bioactive pits-and-fissure sealant; while group S2, pits and fissures will be sealed with fluoride releasing resin based pits and fissures sealant. Each restoration will be assessed after three, six months.|t||t|t
1297505|NCT03628716||Single Group Assignment||Treatment||None (Open Label)||||||
1297506|NCT03628703||Single Group Assignment||Other||None (Open Label)||||||
1297507|NCT03628690|Randomized|Parallel Assignment||Treatment||None (Open Label)||2:1 randomization||||
1297508|NCT03628677|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||3+3 Dose Escalation Design||||
1297509|NCT03628664|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1297510|NCT03628651|||Cohort||Prospective|||||||
1297511|NCT03628638|||Cohort||Prospective|||||||
1297512|NCT03628625|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized|t|t|t|t
1297513|NCT03628612||Single Group Assignment||Other||None (Open Label)||||||
1297514|NCT03628599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297519|NCT03628534||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1297520|NCT03628521|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297521|NCT03628508||Single Group Assignment||Treatment||None (Open Label)||||||
1297522|NCT03628495|Randomized|Parallel Assignment||Treatment||Double|The ultrasound data will be processed and the data will be analysed by analysts who are blinded.||t|||t
1297523|NCT03628482|Randomized|Parallel Assignment||Supportive Care||Double|Participants were randomly assigned using a computer-generated randomization schedule to receive either continuous or pulsed radiofrequency treatment of genicular nerves. The allocation sequence was concealed from the researcher enrolling and assessing participants in sequentially numbered, opaque, sealed and stapled envelopes. The corresponding envelopes were opened only at the time of intervention.|Participants were randomly assigned using a computer-generated randomization schedule to receive percutaneous radiofrequency treatment of the genicular nerves that was administered in either the continuous or in the pulsed mode.|t|||t
1297524|NCT03628469|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized controlled trial with 1:1 randomization stratified for risk of hospital admission and region||||
1297525|NCT03628456||Single Group Assignment||Treatment||None (Open Label)||||||
1297526|NCT03628443|||Cohort||Prospective|||||||
1297527|NCT03628430|Randomized|Parallel Assignment||Treatment||Triple||participants were assigned to one of two groups in parallel for the duration of the study|t|t||t
1297528|NCT03628417|Randomized|Parallel Assignment||Supportive Care||Quadruple||This randomized double blinded phase II study is comparing the effect of calcium electroporation with ECT with bleomycin on patients with cutaneous metastases of any histology where the metastases are randomized by block randomization and are done separately in each patient.|t|t|t|t
1297529|NCT03628404|||Other||Other|||||||
1297530|NCT03628391|Randomized|Parallel Assignment||Treatment||Quadruple|placebo and haloperidol (verum) will have the same appearance|Randomised controlled double-blind placebo controlled clinical trial|t|t|t|t
1297531|NCT03628378|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297532|NCT03628365|Randomized|Parallel Assignment||Prevention||Quadruple|Randomisation controlled by the Hospital Pharmacy Intervention product masked by the Hospital Pharmacy|Randomised, double blind, controlled trial|t|t|t|t
1297533|NCT03628352||Single Group Assignment||Other||None (Open Label)||||||
1297534|NCT03628339||Sequential Assignment||Other||None (Open Label)||This is a single sequence cross-over trial.||||
1297535|NCT03628326|||Case-Only||Retrospective|||||||
1297536|NCT03628313|||Case-Only||Retrospective|||||||
1297537|NCT03628300|||Case-Only||Retrospective|||||||
1297538|NCT03628287|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Stepped-wedge design: To compare effects of the original and revised CCP contemporaneously for timely viral suppression, we will randomize (within matched pairs and one trio) 17 veteran CCP-implementing agencies to immediate or delayed implementation of the revised model, with delayed implementers providing services under the original model until their assigned start date 9 months later.||||
1297539|NCT03628274||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297540|NCT03628261|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1297541|NCT03628248|Randomized|Parallel Assignment||Other||Single||||||t
1297542|NCT03628235|||Other||Prospective|||||||
1297543|NCT03628222|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1297544|NCT03628209||Single Group Assignment||Treatment||None (Open Label)||Phase Ib lead-in with extension to Phase II||||
1297545|NCT03628196|||Cohort||Prospective|||||||
1297546|NCT03628183|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1297547|NCT03628170|Randomized|Parallel Assignment||Treatment||Single||||||t
1297548|NCT03628157|Randomized|Parallel Assignment||Other||Double|||t||t|
1297549|NCT03628144|Randomized|Parallel Assignment||Supportive Care||Single|Randomized open-label, medical and radiation oncologist-blinded.||||t|
1297550|NCT03628131||Single Group Assignment||Treatment||None (Open Label)||||||
1297551|NCT03628118|||Case-Crossover||Retrospective|||||||
1297552|NCT03628105|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will complete baseline pretreatment outcome measures at the first visit to the lab. All participants will watch the same psychoeducation video explaining the nature of anxiety and rationale for exposure therapy. Participants will then be randomly assigned to either the CR Before condition or the CR After condition. CR Before will complete 15 minutes of CR (Preparation) before engaging in six 5-minute exposure trials in a claustrophobic chamber, and complete the 15-minute filler task after exposure. CR After will complete the 15-minute filler task before exposure, engage in six 5-minute exposure trials in a claustrophobic chamber, and engage in 15 minutes of CR (Consolidation) after exposure. Participants will complete posttreatment outcome measures immediately following the intervention. Participants will return one month later to complete followup outcome measures.||||
1297553|NCT03628092|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1297554|NCT03628079||Single Group Assignment||Treatment||None (Open Label)||||||
1297555|NCT03628066||Single Group Assignment||Treatment||None (Open Label)||||||
1297556|NCT03628053|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a phase III, open label, multinational, randomized trial. Eligible patients will be randomized 1:1 to Tisagenlecleucel treatment strategy (tisagenlecleucel after optional bridging chemotherapy and lymphodepleting chemotherapy) or control arm treatment strategy (blinatumomab or inotuzumab per investigator's discretion after optional bridging chemotherapy).~The randomization will be performed stratifying for the number of prior salvage therapies (0 vs. 1) and prior allogenic stem cell transplant (yes vs. no)."||||
1297644|NCT03626896||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1297645|NCT03626883|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1297646|NCT03626870|||Cohort||Prospective|||||||
1297647|NCT03626857|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1297648|NCT03626844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297649|NCT03626831|Randomized|Parallel Assignment||Treatment||Triple|double blind|randomized (1:1), prospective, double-blind, placebo controlled, parallel-group|t|t|t|
1573323|NCT00001617||||||||||||
1297557|NCT03628040|Randomized|Parallel Assignment||Treatment||Quadruple|"The randomization sequence will be computer-generated. Allocation concealment will be carried out via concealed assignments in opaque, sealed, and consecutively numbered envelopes. Blinding will be achieved by sham blocks. After patient allocation, a research assistant not participating in the clinical care and outcome assessment will prepare a syringe of 30 mL 0.5% ropivacaine or normal saline labeled study drug which will then be passed on to one of the investigators (CL or KK) who are blinded to patient allocation. Patients who are allocated to the block group (group B) will receive 0.5 ropivacaine with the ESPB while the control group (group C) will receive normal saline. In addition to ESPB, both group will receive multimodal systemic analgesia including acetaminophen, non-steroidal anti-inflammatory medication and an intravenous (IV) opioid patient-controlled analgesia (PCA) that provides IV opioids on patient-demand."|The study will be a single center (Victoria Hospital), prospective randomized, patient and assessor blinded randomized controlled trial.|t|t|t|t
1297558|NCT03628027|Randomized|Parallel Assignment||Other||Double|GPs will need to be made aware of their treatment arm in order to implement the correct treatment. However, this should not be disclosed to patients, either by the GP or Trial Co-ordinator who will also be blinded.|Cluster-randomised controlled clinical trial. GPs are randomised in blocks of N = 2 to a treatment arm. All patients under the care of a GP receive the treatment to which the GP was randomised.|t|||t
1297559|NCT03628014||Single Group Assignment||Other||None (Open Label)||||||
1297560|NCT03628001|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1297561|NCT03627988||Single Group Assignment||Other||None (Open Label)||||||
1297562|NCT03627975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297563|NCT03627962|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1297564|NCT03627949|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297565|NCT03627936|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1297566|NCT03627923|||Cohort||Prospective|||||||
1297567|NCT03627910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297568|NCT03627897|Randomized|Parallel Assignment||Treatment||Triple|Medication administration and data collection will be performed in a doubleblinded manner such that the patient, the anesthesiologist administering the block, the anesthesiologist providing anesthesia, and the intensive care unit staff giving postoperative care, including the intensivist will not aware of medication assignment.||t|t|t|
1297569|NCT03627884|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297570|NCT03627871|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1297571|NCT03627858|||Cohort||Prospective|||||||
1297572|NCT03627845|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1297573|NCT03627832|Randomized|Parallel Assignment||Treatment||Double|PI Miller will not be blinded to block size or participant assignment because she will inform study therapists of participant assignment to conditions. However, PI Miller and study therapists will be blinded to assessment outcomes, and the assessment RA will be blinded to participant condition. All participants will be told that they will be assigned to one of two insomnia treatment conditions in order to blind them to condition assignment.|Participants will be assigned to receive either Cognitive Behavioral Therapy for Insomnia (CBT-I) or Sleep Hygiene.|t|||t
1297574|NCT03627819|Randomized|Parallel Assignment||Treatment||Triple|The margarine is provided in white but colour-coded tubs and it is not known to the participant and the researcher which colour coded margarine is placebo, plant sterol or stanol ester margarine.|This study is a randomized, placebo-controlled, double blinded pilot study with a run-period of 2 weeks, an intervention period of 12 months and a wash-out period of 1 month.|t||t|t
1297575|NCT03627806|||Cohort||Prospective|||||||
1297576|NCT03627793|Randomized|Parallel Assignment||Treatment||None (Open Label)||RCT||||
1297577|NCT03627780|||Case-Control||Prospective|||||||
1297578|NCT03627767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297579|NCT03627754|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1297580|NCT03627741||Single Group Assignment||Treatment||None (Open Label)||||||
1297581|NCT03627728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297582|NCT03627715|Randomized|Crossover Assignment||Treatment||Quadruple||Double-blind, Randomised, Placebo-Controlled, Crossover Study|t|t|t|t
1297583|NCT03627702|||Cohort||Prospective|||||||
1297584|NCT03627689|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1297585|NCT03627676||Single Group Assignment||Treatment||None (Open Label)||||||
1297586|NCT03627663||Single Group Assignment||Treatment||None (Open Label)||||||
1297587|NCT03627650|Randomized|Parallel Assignment||Treatment||Double|2 skin zones per participant, A and B, 1 is treated, 1 is placebo coin toss determines which zone will be treated, this information is kept in sealed envelope|randomised controlled trial|t|||t
1297588|NCT03627637|Randomized|Crossover Assignment||Prevention||Double||Participants will receive, in random order, daily 70 g of soy nuts (soy treatment) or no food products (control treatment) for sixteen weeks, separated by a wash-out period of at least 8 weeks.|||t|t
1297589|NCT03627624|||Cohort||Retrospective|||||||
1297590|NCT03627611|Randomized|Crossover Assignment||Treatment||Double||||t||t
1297591|NCT03627598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297592|NCT03627585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297593|NCT03627572|||Cohort||Prospective|||||||
1297594|NCT03627559|||Cohort||Prospective|||||||
1297595|NCT03627546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297596|NCT03627533|Randomized|Parallel Assignment||Treatment||Triple||electroacupuncture versus sham electroacupuncture|t||t|t
1297597|NCT03627520||Single Group Assignment||Other||None (Open Label)|open label|This is single centre, open label, single dose study||||
1297650|NCT03626818|||Cohort||Prospective|||||||
1297651|NCT03626805|||Case-Control||Cross-Sectional|||||||
1297693|NCT03626259|Randomized|Parallel Assignment||Treatment||Double|double blind (subject, investigator)|assignment|t||t|
1297694|NCT03626246|||Cohort||Cross-Sectional|||||||
1297695|NCT03626233|||Cohort||Prospective|||||||
1297696|NCT03626220|||Case-Control||Prospective|||||||
1297598|NCT03627507|Randomized|Parallel Assignment||Prevention||Double|. Since the test and comparator drugs used in this clinical study have different package of vial, a double blind design is not appropriate. Study investigators along with study staffs involved in safety evaluation and laboratory analysis will be blinded regarding the assigned treatment of the participant. The vaccine administration team will be unblinded to the treatment assignment list. The vaccine administrator team members will not be involved in the evaluation of vaccine safety and laboratory analysis.|Eligible participants will be assigned to receive the Hepa-B Vaccine and Engerix-B Vaccine, in a 1:1 ratio across the target population according to the randomization schedule. The study agents (Hepa B Vaccine or Engerix B Vaccine) will be labelled as per the randomization list.79 participant will receive locally produced Hepa-B Vaccine and 79 participant of comparator group will receive Engerix B Vaccine.|||t|t
1297599|NCT03627494|Randomized|Crossover Assignment||Treatment||Double||"Part A is a Crossover group single ascending dose study with 2 arms per cohort that is subject and investigator blinded. Part B is a Parallel group repeat dose study with 2 arms per cohort that is subject and investigator blinded. Part C is a Crossover group food effect study with 2 arms per cohort that is not-masked."|t||t|
1297600|NCT03627481||Single Group Assignment||Treatment||None (Open Label)||||||
1297601|NCT03627468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297602|NCT03627455|||Cohort||Prospective|||||||
1297603|NCT03627442|Randomized|Parallel Assignment||Other||None (Open Label)|Initially, only breast surgeons knows which of the two devices was used for each breast, not plastic surgeon|Single blinded, randomized controlled pilot study (n=15) Only breast surgeon knows which device was used for each breast at initiation of surgery||||
1297604|NCT03627429|||Other||Prospective|||||||
1297605|NCT03627416|Randomized|Crossover Assignment||Treatment||Double|Sham stimulation will be provided by holding the stimulating coil perpendicularly to the scalp, which assures similar impression as during active stimulation but prevents significant magnetic field to reach the brain tissue.|16 patients with HSP or AMN will receive either active and sham stimulation in random order|t|||t
1297606|NCT03627403||Single Group Assignment||Treatment||None (Open Label)||Open label, non-randomized, prospective, single-arm study||||
1297607|NCT03627390|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label, single center, two arm||||
1297608|NCT03627377|Randomized|Sequential Assignment||Prevention||None (Open Label)||The investigators will employ a modified cluster-randomized stepped wedge and adaptive trial design involving 210 residents with SMI and 120 staff members from 12 RCFs. The RCFs will be divided randomly into four cohorts of three RCFs each. Each cohort will be tested over a 15-month period that includes three phases: a three-month initial control phase (no intervention, from baseline month 0 to end of month 3), a six-month intervention phase (months 4 through 9), and a six-month follow-up phase (no intervention, months 10 through 15). All the study participants will be assessed quarterly during the 15-month period.||||
1297609|NCT03627364|||Other||Cross-Sectional|||||||
1297610|NCT03627351|||Case-Only||Prospective|||||||
1297611|NCT03627338|||Cohort||Prospective|||||||
1297612|NCT03627325|||Other||Prospective|||||||
1297613|NCT03627312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297614|NCT03627299||Single Group Assignment||Treatment||None (Open Label)||||||
1297615|NCT03627273|Randomized|Crossover Assignment||Other||Single|||||t|
1297616|NCT03627260||Single Group Assignment||Prevention||None (Open Label)||||||
1297617|NCT03627247|Randomized|Parallel Assignment||Prevention||Single|Staff completing assessments were blind to participants' study condition|prospective, pre-test post-test, experimental control group design||||t
1297618|NCT03627234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297619|NCT03627221|Randomized|Parallel Assignment||Supportive Care||Single|A licensed sleep technician, blinded to group assignment, visually analyzed sleep polygraphs by applying standard procedures.|The intervention is social networking and music listening. The outcome variables are sleep quality, sleep knowledge, and sleep hygiene. The control variables are participants' demographic data.||||t
1297620|NCT03627208|||Cohort||Retrospective|||||||
1297621|NCT03627195|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1297622|NCT03627182|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1297623|NCT03627169|||Cohort||Prospective|||||||
1297624|NCT03627156|Randomized|Parallel Assignment||Treatment||Single|outcome assessors are not informed about the intervention and the group to which the intervention is assigned to avoid social desirability bias|A two-arm parallel cluster randomized community trial||||t
1297625|NCT03627143||Single Group Assignment||Other||None (Open Label)||Multicentre Behaviour Intervention Trial using a Stepped Wedge Cluster Randomized Design||||
1297626|NCT03627130|Randomized|Parallel Assignment||Treatment||Quadruple|IMP and placebo will be identical||t|t|t|t
1297627|NCT03627117|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1297628|NCT03627104|Randomized|Parallel Assignment||Treatment||Single|the person who will perform the statistical analysis will be blinded from the intervention group by assigning each patient|The groups will receive the treatment simultaneously||||t
1297629|NCT03627091|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297630|NCT03627078|Randomized|Parallel Assignment||Treatment||Single||||||t
1297631|NCT03627065||Single Group Assignment||Treatment||None (Open Label)||||||
1297632|NCT03627052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297633|NCT03627039|||Cohort||Retrospective|||||||
1297634|NCT03627026||Single Group Assignment||Other||None (Open Label)||||||
1297635|NCT03627013|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297636|NCT03627000|||Cohort||Retrospective|||||||
1297637|NCT03626987|||Cohort||Retrospective|||||||
1297638|NCT03626974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297639|NCT03626961|||Cohort||Prospective|||||||
1297640|NCT03626948||Single Group Assignment||Treatment||None (Open Label)||||||
1297641|NCT03626935||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1297642|NCT03626922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297643|NCT03626909|||Cohort||Prospective|||||||
1297652|NCT03626792|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Group 1 - Hypertensive: Composed of hypertensive women who participated in a training program with Pilates exercises in the soil associated to the daily antihypertensive of each one.~Group 2 - Normotensives: Composed of normotensive women who participated in a training program with solo Pilates exercises without antihypertensive presence.~Both groups underwent 12 weeks of Pilates training."||||
1297653|NCT03626779|Randomized|Parallel Assignment||Treatment||Single|||||t|
1297654|NCT03626766|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1297655|NCT03626753|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297656|NCT03626740|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1297657|NCT03626727||Single Group Assignment||Treatment||None (Open Label)||||||
1297658|NCT03626714||Single Group Assignment||Treatment||None (Open Label)||||||
1297659|NCT03626701|Randomized|Parallel Assignment||Treatment||Single|"Blinded Evaluator/Observer - local burn specialist~Independent Reviewer"|||||t
1297660|NCT03626688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297661|NCT03626675||Single Group Assignment||Other||None (Open Label)||||||
1297662|NCT03626662|Randomized|Parallel Assignment||Other||Triple|The subjects and the investigative site staff, except for the unblinded pharmacist, will be blinded to treatment assignment.||t|t|t|
1297663|NCT03626649||Single Group Assignment||Treatment||None (Open Label)||The DIAMOND FASTR-AF study is a prospective, single-arm trial being performed at multiple centers in Europe.||||
1297664|NCT03626636|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1297665|NCT03626623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297666|NCT03626610|Non-Randomized|Parallel Assignment||Health Services Research||Single||Cohort-controlled||t||
1297667|NCT03626597|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Parallel, non-blinded, patient preference model.||||
1297668|NCT03626584|||Cohort||Prospective|||||||
1297669|NCT03626571|||Cohort||Prospective|||||||
1297670|NCT03626558||Single Group Assignment||Treatment||None (Open Label)||||||
1297671|NCT03626545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297672|NCT03626532|Randomized|Parallel Assignment||Treatment||Single|Single-blind. Any investigators administering assessments will be blind to participants' group allocation.|||||t
1297673|NCT03626519|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1297674|NCT03626506|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized, controlled, open-label trial||||
1297675|NCT03626493|||Case-Crossover||Cross-Sectional|||||||
1297676|NCT03626480|||Cohort||Prospective|||||||
1297677|NCT03626467||Single Group Assignment||Treatment||None (Open Label)||A phase IV, open-label and single-arm clinical trial||||
1297678|NCT03626454|Randomized|Parallel Assignment||Prevention||Triple|"An anesthesia resident who will not be involved with the conduct of the study will prepare and label the drug in the syringes according to the randomization codes.~An investigator who will not be involved in subsequent patient care or assessment will open the topmost of 300 opaque sequentially numbered envelopes. One 50 ml and one 10 ml will be labeled as study drug and the 50 ml syringe will be connected to a syringe infusion pump. These two study drug syringes will be a part of double dummy technique to facilitate blindness. In group B, 50 ml syringe will contain saline, and 10 ml syringe will contain norepinephrine (.6 µg/ml). In group I, 50 ml syringe will contain norepinephrine (6 µg/ml) with, and 10 ml syringe will contain saline. Participant in both groups will receive bolus from 10 ml syringe over 30 seconds and infusion dose of 1 ml/kg/h simultaneously to expedite blinding."||t|t|t|
1297679|NCT03626441|Randomized|Parallel Assignment||Prevention||Quadruple|Sequentially numbered, sealed, opaque envelopes prepared and opened the evening before the surgery. Tablets containing either placebo or ginger allocated by a person not involved in any other aspect of the study and administered on the morning of surgery.|Quadruple, blind randomized, controlled trial|t|t|t|t
1297680|NCT03626428|||Case-Only||Retrospective|||||||
1297681|NCT03626415||Parallel Assignment||Basic Science||None (Open Label)||Recruitment for subjects with moderate and mild hepatic impairment (Cohorts 1 and 2) will initiate first and these subjects will be enrolled in parallel.||||
1297682|NCT03626402|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized controlled trial comparing an intervention group to usual care||||
1297683|NCT03626389|||Cohort||Prospective|||||||
1297684|NCT03626376|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297685|NCT03626363|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1297686|NCT03626350|||Other||Prospective|||||||
1297687|NCT03626337|||Case-Control||Prospective|||||||
1297688|NCT03626324||Single Group Assignment||Supportive Care||None (Open Label)||||||
1297689|NCT03626311|Randomized|Parallel Assignment||Supportive Care||Quadruple||Eligible patients will be randomized (1:1) to receive either AKBM-3031 or placebo during the randomized period.The randomized subjects will take (4)1 gram capsules of product or placebo every day, (2) 1 gram capsules in the morning and (2) 1 gram capsules in the evening, for a total of 4 grams per day for the first 24 weeks (randomized period). All subjects may continue to a 24-week extension (Open Label Extension) of open-label AKBM-3031, 4 grams/day. The total study duration per subject is 48 weeks. With about 4 months for site activation and 12 months for enrollment, the entire study is expected to complete in approximately 116 weeks.|t|t|t|t
1297690|NCT03626298|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1297691|NCT03626285||Single Group Assignment||Other||None (Open Label)||||||
1297692|NCT03626272|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"This is a randomized, non-blind controlled trial that will compare three periodicities of an educational intervention to be performed through in situ simulation. Group A will be submitted to intervention at 8-month intervals, group B every four months and group C every two months; each group will be divided into two subgroups, totaling six subgroups consisting of one nurse and three nursing technicians.~The research was approved by the Research Ethics Committees of the Federal University of Health Sciences of Porto Alegre, under approval certificate no. 56516216.9.0000.5345, and of the Universidade Católica do Rio Grande do Sul/PUCRS, under approval certificate no. 56516216.9.3001.5336."||||
1573324|NCT00001615||||Treatment||||||||
1297699|NCT03626181||Single Group Assignment||Treatment||None (Open Label)||Open label study||||
1297700|NCT03626168|Non-Randomized|Crossover Assignment||Prevention||Triple|In this crossover design, the participants principal investigators, and outcomes assessors were blinded as to which treatment (100% watermelon juice or placebo) was consumed at each time.|In a double-blind crossover design, women ages 55-69 years were randomized to two 12-ounce servings of 100% watermelon juice per day or an isocaloric placebo for four weeks each with a 2-week washout period in between.|t||t|t
1297701|NCT03626155|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1297702|NCT03626142|||Case-Only||Cross-Sectional|||||||
1297703|NCT03626129|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1297704|NCT03626116|||Case-Only||Retrospective|||||||
1297705|NCT03626103|Randomized|Factorial Assignment||Prevention||Single||||||t
1297706|NCT03626090||Single Group Assignment||Treatment||None (Open Label)|N.A.|As the primary objective of the study is to assess safety of MSC infusion, a single arm non-blinded study design has been adopted.||||
1297707|NCT03626077|Randomized|Parallel Assignment||Treatment||Single||||||t
1297708|NCT03626064||Single Group Assignment||Treatment||None (Open Label)||||||
1297709|NCT03626051|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1297710|NCT03626038||Single Group Assignment||Treatment||None (Open Label)||||||
1297711|NCT03626025|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1297712|NCT03626012|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1297713|NCT03625999|Randomized|Parallel Assignment||Basic Science||Single||||||t
1297714|NCT03625986|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1297715|NCT03625973|Randomized|Parallel Assignment||Treatment||Single|A social work graduate assistant from Dr. Berg-Weger's program and Dr. Anderson's program will administer the various behavioral tests that will produce the outcome measures. This will be a different individual than the graduate assistants who conduct the RT sessions with participants. Also the assistant administering the tests will be blind as to the treatment assignment of the participants.|||||t
1297716|NCT03625960|Randomized|Parallel Assignment||Treatment||Single|Patients will be randomized to receive treatment with trichloroacetic acid or cantharidine.|Patients will be randomized to receive either trichloroacetic acid or cantharidine treatment.|||t|
1297717|NCT03625947|||Cohort||Prospective|||||||
1297718|NCT03625934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297719|NCT03625921|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1297720|NCT03625908|Randomized|Factorial Assignment||Treatment||None (Open Label)||Patients will be assigned by use of OCT-guidance or angiography-guidance for stent implantation.||||
1297721|NCT03625895|||Cohort||Prospective|||||||
1297722|NCT03625882|||Cohort||Prospective|||||||
1297723|NCT03625869|Randomized|Parallel Assignment||Treatment||Single|Analysis of the primary endpoint, infarct size 5-days post MI assessed by CMR, will be analyzed by an independent Corelab, blinded to the allocated treatment arm.|A prospective, multicenter, randomized (1:1), controlled, study||||t
1297724|NCT03625856|Randomized|Parallel Assignment||Treatment||Triple|This study is a double-blind, randomized controlled trial. Subjects will be randomly allocated into two groups and each one will receive the supplement (Chlorella Vulgaris) or placebo for 8 weeks. To prevent selection bias, the study participants, investigators and the laboratory staff will be all blinded to treatment assignment.|Subjects will be randomly allocated into two groups; Chlorella and placebo groups.|t|t|t|
1297725|NCT03625843|Randomized|Parallel Assignment||Treatment||Single|||||t|
1297726|NCT03625830|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1297727|NCT03625817|Randomized|Crossover Assignment||Prevention||Double|There will be the necessary blinding during the conduct of the all laboratory and statistical analyses. At the start of the study, participants will be given a 2-digit code (10-60) - once the researchers have names of eligible participants, each name will be given a code. This will be participant's study ID that will accompany participant's answered questionnaires, diaries, urine vials and temperature measurement's files.|A 2 x 2 cross-over pilot study of healthy adults is proposed to prospectively describe the effect of ambient temperature gradient on metabolic hormonal secretion patterns. A total of 50-60 subjects will be followed for a period of 7 days firstly in an urban environment or in a village of the mountainous rural environment and later, for the same period, in the alternate setting, during the summer period in Cyprus. The two settings will allow for the comparison of the circadian patterns of hormones secreted by the adipose tissue among different gradient temperature changes. Continuous quantification of skin temperatures on one day in each setting will allow for characterization of how skin temperature is affected by ambient temperature. Collection of all urine voids in one day in each setting will allow for quantification of the hormone secretion by the adipose tissue.|||t|t
1297728|NCT03625804|Randomized|Crossover Assignment||Treatment||Single||Single-blind randomized cross-over study|t|||
1297729|NCT03625791|||Cohort||Prospective|||||||
1297730|NCT03625778|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297731|NCT03625765||Single Group Assignment||Supportive Care||None (Open Label)||||||
1297732|NCT03625752|Randomized|Parallel Assignment||Treatment||Triple||single-center, double-blinded, placebo controlled, randomized study.|t||t|t
1297733|NCT03625739|||Cohort||Prospective|||||||
1297734|NCT03625726|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||Exploratory, cross-sectional, case-control pathophysiology study, based on ex vivo treatment of blood samples.||||
1297735|NCT03625713|||Cohort||Prospective|||||||
1297736|NCT03625700|||Cohort||Retrospective|||||||
1297737|NCT03625687||Single Group Assignment||Prevention||None (Open Label)||||||
1297738|NCT03625674|Randomized|Parallel Assignment||Treatment||Single||||||t
1297739|NCT03625661||Single Group Assignment||Supportive Care||None (Open Label)||cohort study||||
1297740|NCT03625648|Randomized|Parallel Assignment||Treatment||Quadruple||Double blind placebo controlled|t|t|t|t
1297741|NCT03625635||Single Group Assignment||Supportive Care||None (Open Label)|Masking during data analysis. Technicians and investigators will not be aware of the participants personal data and particularities.|||||
1297830|NCT03624465||Single Group Assignment||Other||None (Open Label)||||||
1297742|NCT03625622|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind for study site and participants||t|t|t|t
1297743|NCT03625609|||Ecologic or Community||Cross-Sectional|||||||
1297744|NCT03625596|Randomized|Crossover Assignment||Prevention||Triple||Crossover assignment|t||t|t
1297745|NCT03625583|||Case-Only||Cross-Sectional|||||||
1297746|NCT03625570|Randomized|Parallel Assignment||Treatment||Single||||||t
1297747|NCT03625557|||Cohort||Prospective|||||||
1297748|NCT03625544|Randomized|Parallel Assignment||Treatment||Single||Intra-patient model, so each patient receives both conditions and serves as its own control||||t
1297749|NCT03625531|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297750|NCT03625518|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1297751|NCT03625505||Single Group Assignment||Treatment||None (Open Label)||||||
1297752|NCT03625492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297753|NCT03625466|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded in Part one, and Open label in Part 2||t|t|t|t
1297754|NCT03625453|Randomized|Parallel Assignment||Treatment||Double||Randomized, placebo-controlled|t||t|
1297755|NCT03625440|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297756|NCT03625427|Randomized|Parallel Assignment||Treatment||Quadruple|Administration of the POA supplements and placebo (olive oil capsules) will be via a simple randomized double-blinded allocation. The study sponsor will provide the Principal Investigator with bags, or boxes, of single serve packets containing two capsules for each daily dose per participant in accordance with the proper dosage for each of the three arms of the study. The study sponsor will hold the code for the subjects and will randomize the capsules. No site personnel will have access to the randomization allocation; only the study sponsor will have the code. The identity of the capsules will be revealed once all analyses are complete.|12-week randomized, double blinded study in volunteers consuming either the test agent, 500 mg or 1,000 mg POA per day, or an olive oil containing fatty acid (placebo). There are three arms to study and 36 individuals per arm, thus, a total of 108 subjects.|t|t|t|t
1297757|NCT03625414|||Case-Control||Prospective|||||||
1297758|NCT03625401|Randomized|Parallel Assignment||Treatment||Double|During the double-blind period, all of the study personnel, including Investigators, site personnel,the Sponsor's staff (eg, clinical research associate [CRA]/monitor), and study subjects will be blinded to treatment assignment. Placebo and AD-35 will be identical in appearance and packaging to preserve blinding.|AD-35 60 mg group: 2 AD-35 30 mg tablets and 1 placebo tablet;AD-35 90 mg group: 3 AD-35 tablets; Placebo group: 3 placebo tablets.|t||t|
1297759|NCT03625388|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients will be randomized to receive either dasatinib 50 mg or dasatinib 100 mg orally once daily for the duration of the study which is 18 months.||||
1297760|NCT03625375|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297761|NCT03625362|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1297762|NCT03625349|||Other||Prospective|||||||
1297763|NCT03625336|||Case-Only||Prospective|||||||
1297764|NCT03625323|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297765|NCT03625310|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1297766|NCT03625297|Randomized|Crossover Assignment||Other||None (Open Label)||This study uses a two-group randomized, repeated measures design with a delayed treatment control group.||||
1297767|NCT03625284|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1297768|NCT03625271|Randomized|Parallel Assignment||Treatment||Double|The Subject will be blinded as to study arm assignment and will provide the primary outcome measure.|Blinded participants will be randomized into a control or experimental group and receive a quantitative electroencephalogram (QEEG). Experimental group clinicians will use the PEER Interactive Report in the medication prescription process. Control group clinicians will not receive an Outcome Report. For the experimental group the clinician is expected to incorporate the guidance of the subject's PEER Outcome Report. Study staff will note the basis for all medication decisions in the subject's treatment/study file. Two evaluations are being made in this study. 1. Clinical utility of PEER Interactive where the health outcome of the experimental group will be compared to the outcomes of the control group. 2. Validation of the PEER Interactive outcomes database which is intended to measure post-hoc the health outcomes of participants where the research staff's pharmacotherapy decisions agreed with the output of PEER Interactive.|t|||t
1297769|NCT03625258|||Case-Only||Retrospective|||||||
1297770|NCT03625245|Randomized|Crossover Assignment||Other||Double|Double Blind (Participant and Investigator)||t||t|
1297771|NCT03625232|||Case-Only||Prospective|||||||
1297772|NCT03625219|Randomized|Parallel Assignment||Other||Quadruple||Cohort A Open label: 4 groups of 10 subjects Cohort B Double-Blind: 1 group of 20 subjects|t|t|t|t
1297773|NCT03625206|Randomized|Parallel Assignment||Basic Science||Double|Participants are told that they will be allocated to one of two intervention conditions, one which may be more effective than the other in challenging negative thought patterns. Outcome assessors are blind to the status of the participant.||t|||t
1297774|NCT03625193|||Cohort||Prospective|||||||
1297775|NCT03625180|||Case-Only||Prospective|||||||
1297776|NCT03625167|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297777|NCT03625154|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297778|NCT03625141|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297779|NCT03625128||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297780|NCT03625115|Randomized|Parallel Assignment||Health Services Research||Single|Research staff collecting study data will be unaware of study arm of participants.|The intervention will be a modified Patient Navigator model, that we will refer to as a Family Navigator (FN) model, that will engage, inform, and assist participating parents to follow-through with the process of EI referrals and services. Eligible children randomized to the intervention arm will be provided with services from a FN. The FN will maintain contact with the family, the child's primary care provider, and Early Intervention staff, if applicable, throughout the duration of the study.||||t
1297828|NCT03624491|Randomized|Parallel Assignment||Treatment||None (Open Label)|This is a prospective, open label, randomized study|Randomization to two different groups.||||
1297781|NCT03625102|Randomized|Parallel Assignment||Treatment||Quadruple||"This is a single-center, phase IIa, double blind, and randomized, placebo-controlled trial of Antroquinonol in patients with hepatitis B infection. Subjects with diagnosis of hepatitis B meet inclusion/exclusion criteria will be randomized into 3 groups:~Antroquinonol 100 mg PO BID~Antroquinonol 50 mg PO BID~Placebo"|t|t|t|t
1297782|NCT03625089|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297783|NCT03625076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297784|NCT03625063|Randomized|Parallel Assignment||Screening||Double|||t||t|
1297785|NCT03625050|Randomized|Parallel Assignment||Treatment||Single||||||t
1297786|NCT03625037||Sequential Assignment||Treatment||None (Open Label)||A Minimum Anticipated Biologic Effect Level (MABEL) -derived starting (priming) dose of 4.0 μg (microgram) is administered as a flat dose. The priming dose for the first patient will be followed with a subsequent dose that will be as a maximum 12.8 μg (microgram) flat dose. Dose escalation steps are based on all available data with increments not exceeding a half-log10 (3.2-fold) increase in the accelerated titration part and not exceeding 100% (2-fold) increase in the standard titration part.||||
1297787|NCT03625024|||Ecologic or Community||Cross-Sectional|||||||
1297788|NCT03625011|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1297789|NCT03624998||Single Group Assignment||Screening||None (Open Label)||||||
1297790|NCT03624985|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, controlled, double-blind study|t|t|t|t
1297791|NCT03624972|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1297792|NCT03624959|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1297793|NCT03624946|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1297794|NCT03624933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is an open label intervention of contingent reinforcement and behavioral support to try to enhance cannabis abstinence for 28 days with people with Major Depressive Disorder. We will analyze data post hoc from this study as a function of subjects who attain abstinence versus those who do not.||||
1297795|NCT03624920|Randomized|Crossover Assignment||Treatment||Triple||Complete 3 way-Crossover|t|t|t|
1297796|NCT03624907|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to either daily or non-daily stereotactic body radiotherapy (SBRT).||||
1297797|NCT03624894|||Other||Prospective|||||||
1297798|NCT03624881||Single Group Assignment||Treatment||None (Open Label)||||||
1297799|NCT03624868|Randomized|Parallel Assignment||Treatment||Single|Pre- and Post-intervention assessments will be conducted by an assessor who is blind to study condition.|Participants will be randomly assigned to Tai Chi or Wellness Education||||t
1297800|NCT03624855|||Cohort||Retrospective|||||||
1297801|NCT03624842||||||||||||
1297802|NCT03624829|||Other||Other|||||||
1297803|NCT03624816|Randomized|Parallel Assignment||Treatment||Single||||||t
1297804|NCT03624803|||Other||Other|||||||
1297805|NCT03624790||Single Group Assignment||Prevention||None (Open Label)||||||
1297806|NCT03624777|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297807|NCT03624764|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1297808|NCT03624751|||Cohort||Prospective|||||||
1297809|NCT03624738|Randomized|Parallel Assignment||Treatment||None (Open Label)||Femorofemoral bypass in redo cardiac surgery||||
1297810|NCT03624725|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297811|NCT03624712|||Case-Only||Prospective|||||||
1297812|NCT03624699||Single Group Assignment||Treatment||None (Open Label)||Historic control (before vs. after intervention).||||
1297813|NCT03624686|||Other||Prospective|||||||
1297814|NCT03624673|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1297815|NCT03624660|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients will be assigned to treatment group according to their lymph node risk.~3 treatment groups:~HR-A: Patients with <25% risk of positive pelvic nodes, without posterior extracapsular extension and negative for seminal vesicle invasion on exam pretreatment diagnostic MRI.~HR-B: Patient with ≥ 25% risk of positive pelvic nodes, without posterior extracapsular extension and negative for seminal vesicle invasion.~HR-C: Patients with seminal vesicle invasion."||||
1297816|NCT03624647|Randomized|Parallel Assignment||Treatment||Single|||||t|
1297817|NCT03624634|||Cohort||Prospective|||||||
1297818|NCT03624621|Randomized|Parallel Assignment||Treatment||Single|Codification of participants, assessor will never know what treatment arm participant was allocated|Randomized single-blind and controlled clinical trial||||t
1297819|NCT03624608||Single Group Assignment||Treatment||None (Open Label)||||||
1297820|NCT03624595|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1297821|NCT03624582|||Cohort||Cross-Sectional|||||||
1297822|NCT03624569|Randomized|Crossover Assignment||Prevention||Single||||||t
1297823|NCT03624556|Randomized|Parallel Assignment||Treatment||Quadruple|The treatment consists in FontUp (EGCG on a dietary supplement with chocolate like shake flavor) taken dissolved in 100mL of water two times a day (breakfast and afternoon snack). The placebo treatment is the same product but without the EGCG in it, taken with the same posology.|"Cohort I (Down Syndrome children): Phase II Randomized, double-blind, placebo-controlled, parallel groups to evaluate safety and tolerability of EGCG in children. The experimental group will take 10mg/kg/day of FontUp (EGCG on a dietary supplement with chocolate like shake flavor, two times a day) while the placebo group will take the same product but without the EGCG in it, taken with the same posology.~Cohort II (Fragile X syndrome children): exploratory open label study (pilot study) to assess safety and tolerability of EGCG. These patients will receive 10mg/kg/day of FontUp.~This cohort will only be recruited in Spanish sites."|t|t|t|t
1297824|NCT03624543|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297825|NCT03624530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297826|NCT03624517|Randomized|Parallel Assignment||Treatment||Single||||||t
1297827|NCT03624504||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1297829|NCT03624478||Single Group Assignment||Treatment||None (Open Label)||||||
1573325|NCT00001614||||Treatment||||||||
1297831|NCT03624452|Randomized|Parallel Assignment||Other||Single||||||t
1297832|NCT03624439|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1297833|NCT03624426|Randomized|Parallel Assignment||Prevention||Double|The patient and the outcome assessor will be blinded. The physicians and operating room nurses, anesthesiologists could not be blinded due to the nature of the intervention|1:1 parallel, superiority study|t|||t
1297834|NCT03624413|Randomized|Parallel Assignment||Other||None (Open Label)||A pilot randomized controlled trial with 40 adolescents receiving a social media intervention and 40 adolescents receiving standard of care.||||
1297835|NCT03624400|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1297836|NCT03624387|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Parallel Assignment||||
1297837|NCT03624374|||Cohort||Prospective|||||||
1297838|NCT03624361||Single Group Assignment||Treatment||None (Open Label)||MINIject glaucoma implant CS600 with Dual Operator Delivery Tool||||
1297839|NCT03624348|Randomized|Parallel Assignment||Treatment||Single|Investigator will be blind to condition throughout data accrual.|Randomization to either digital meditation condition or wait-list control.|||t|
1297840|NCT03624335|Randomized|Parallel Assignment||Other||None (Open Label)||Randomised controlled trials comparing early and late cord clamping||||
1297841|NCT03624322|Randomized|Crossover Assignment||Treatment||Quadruple|Double-blind, placebo-controlled|Period 1 (n=36) assignment to 1 of 2 reference therapy treatment groups over 3 cohorts Period 2 (n=36) assignment to 1 of 3 IP treatment groups over 3 cohorts|t|t|t|t
1297842|NCT03624309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297843|NCT03624296||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297844|NCT03624283|Randomized|Parallel Assignment||Treatment||Double||||t||t
1297845|NCT03624270||Single Group Assignment||Treatment||None (Open Label)||||||
1297846|NCT03624257|Randomized|Parallel Assignment||Treatment||Single|Masking for the assessors of microbial, immunological and radiographic analyses.|||||t
1297847|NCT03624244|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase II comparative multicentre prospective randomised (1:1 ratio) open-label study||||
1297848|NCT03624231|Randomized|Parallel Assignment||Treatment||None (Open Label)||"2-arm, randomized, multicenter, phase II. Step 1 is Registration. All patients need to sign the informed consent form for registration. Tumor tissue then be send to the central lab for defining the HPV status. If the patient is HPV negative the site will be notified if they can further proceed to patient randomization.~Step 2 is Randomization of all eligible patients with a centrally diagnosed, HPV negative tumor one of the two arms Durvalumab plus Tremelimumab + radiotherapy; Durvalumab + radiotherapy) after signing the informed consent form for step 2."||||
1297849|NCT03624218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297850|NCT03624205|||Case-Only||Prospective|||||||
1297851|NCT03624192|Randomized|Parallel Assignment||Treatment||Double||Each subject serves as their own control.|t|||t
1297852|NCT03624179|||Cohort||Prospective|||||||
1297853|NCT03624166|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1297854|NCT03624153|Randomized|Crossover Assignment||Treatment||Single||||||t
1297855|NCT03624140||Single Group Assignment||Diagnostic||None (Open Label)||Blood measurement||||
1297856|NCT03624127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297857|NCT03624114|||Cohort||Prospective|||||||
1297858|NCT03624101||Single Group Assignment||Treatment||None (Open Label)||||||
1297859|NCT03624088||Single Group Assignment||Prevention||None (Open Label)||||||
1297860|NCT03624075|Randomized|Parallel Assignment||Treatment||Double||The volunteers will be recruited from the waiting list of the Clinic School of Physiotherapy of the Faculty of Health Sciences of Rio Grande do Norte, as well as the community in general. Initially, a signature will be requested from the TCLE and the next series of personal data. When we are already included, how should participants assess muscular strength, edema, physical function, quality of life and functional capacity (T0). Then all of them must be allocated to one of the three groups, where due intervention is required for each group. After one session, muscle strength and pain were again assessed (T1) and 72 hours later (T2), all outcomes assessed at time T0 were retested.|t||t|
1297861|NCT03624062|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1297862|NCT03624049||Single Group Assignment||Treatment||None (Open Label)||Pre-post study||||
1297863|NCT03624036||Sequential Assignment||Treatment||None (Open Label)||||||
1297864|NCT03624023||Single Group Assignment||Treatment||None (Open Label)||||||
1297865|NCT03624010||Single Group Assignment||Treatment||None (Open Label)||Open-label||||
1297866|NCT03623997|||Case-Only||Prospective|||||||
1297867|NCT03623984||Single Group Assignment||Treatment||None (Open Label)||||||
1297868|NCT03623971||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297869|NCT03623958|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297870|NCT03623945|||Cohort||Prospective|||||||
1297871|NCT03623932|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Prospective study, monocentric, controlled, randomized, open-label||||
1297872|NCT03623919||Single Group Assignment||Prevention||None (Open Label)||||||
1297873|NCT03623906|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1297874|NCT03623893|Randomized|Parallel Assignment||Treatment||Double|Participants and care providers are aware of allocation; masking is impossible because of the nature of the intervention.|Multicenter randomized controlled trial.|||t|t
1297875|NCT03623880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297876|NCT03623867|Randomized|Parallel Assignment||Treatment||Quadruple||Subject will be randomised into secukinumab or placebo group in 1:1 ratio|t|t|t|t
1297877|NCT03623854||Single Group Assignment||Treatment||None (Open Label)||||||
1297878|NCT03623841|Randomized|Parallel Assignment||Treatment||Single||||||t
1297879|NCT03623828||Single Group Assignment||Treatment||None (Open Label)||This is an open-label single-arm prospective pilot study. Included patients all undergo the same study protocol.||||
1297925|NCT03623230|Randomized|Parallel Assignment||Treatment||Triple||Three groups involved. One control group and two nerve block groups with different drug concentration|t|t|t|
1297880|NCT03623815|Randomized|Crossover Assignment||Other||Single|Double blinding was carried out using a blinding code randomly assigned to each participant by a separate party. This code was entered into the transcranial direct current stimulation device by the investigator to deliver the stimulation. The investigator was not unblinded until initial analysis was complete.|Placebo controlled crossover design||||t
1297881|NCT03623802|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study design is a randomized clinical trial with parallel-group design including two intervention groups: integral movement therapy and conventional local movement therapy.||||
1297882|NCT03623789|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1297883|NCT03623776||Single Group Assignment||Treatment||None (Open Label)||||||
1297884|NCT03623763|||Cohort||Prospective|||||||
1297885|NCT03623750||Single Group Assignment||Treatment||None (Open Label)||Open-label, uncontrolled, Phase Ib clinical study||||
1297886|NCT03623737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297887|NCT03623724|Randomized|Parallel Assignment||Treatment||Single||The RCT is composed by an experimental condition and a control condition. In the experimental condition, patients will receive a treatment that integrates face-to-face cognitive-behavioral sessions with online sessions delivered through Moodbuster system (bCBT). In the control condition, patients will receive TAU that consists in routine care that they usually receive in primary care. We will not interfere with treatments delivered in TAU, but the intervention will be tracked, as well as medicine intake. One-hundred patients will be recruited and randomized in two conditions: 50 for bCBT condition and 50 for TAU condition. New cases of Major Depression signaled by GPs or other healthprofessionals will be invited to participate in the RCT. Once obtained the signed informed consent, the patients will be randomized at an individual level. The allocation will be performed by an independent researcher not involved in data collection using an automated computer-based random intergenerator.||||t
1297888|NCT03623711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297889|NCT03623698|||Case-Only||Retrospective|||||||
1297890|NCT03623685||Single Group Assignment||Screening||None (Open Label)||||||
1297891|NCT03623672|||Cohort||Prospective|||||||
1297892|NCT03623659|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1297893|NCT03623646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297894|NCT03623633|Randomized|Parallel Assignment||Treatment||Single||||||t
1297895|NCT03623620|Randomized|Parallel Assignment||Prevention||Single||||||t
1297896|NCT03623607|||Other||Prospective|||||||
1297897|NCT03623594||Single Group Assignment||Treatment||None (Open Label)||Repair of the abdominal rectus diastasis with a double row plication using absorbable Quill||||
1297898|NCT03623581||Single Group Assignment||Treatment||None (Open Label)||||||
1297899|NCT03623568||Single Group Assignment||Prevention||None (Open Label)||||||
1297900|NCT03623555|||Case-Control||Retrospective|||||||
1297901|NCT03623542|||Cohort||Prospective|||||||
1297902|NCT03623529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297903|NCT03623516|||Cohort||Retrospective|||||||
1297904|NCT03623503|||Case-Only||Retrospective|||||||
1297905|NCT03623490|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1297906|NCT03623477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297907|NCT03623464|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297908|NCT03623451||Single Group Assignment||Treatment||None (Open Label)||||||
1297909|NCT03623438|Randomized|Parallel Assignment||Treatment||Single||||||t
1297910|NCT03623425|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Phase III, open, single center, prospective, controlled and randomized crossover study comparing diagnostic performance of 68GA-PSMA-11 and 18F-Fluorocholine. 68GA-PSMA-11 PET and 18F-Fluorocholine PET interpretation will be done by different nuclear physicians.||||
1297911|NCT03623412|Non-Randomized|Parallel Assignment||Diagnostic||Single||||t||
1297912|NCT03623399|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1297913|NCT03623386|Randomized|Parallel Assignment||Supportive Care||Double|double blinded|2 cohort|t|||t
1297914|NCT03623373||Single Group Assignment||Treatment||None (Open Label)||||||
1297915|NCT03623360|||Cohort||Cross-Sectional|||||||
1297916|NCT03623347|||Case-Only||Retrospective|||||||
1297917|NCT03623334||Single Group Assignment||Treatment||None (Open Label)||||||
1297918|NCT03623321||Single Group Assignment||Treatment||None (Open Label)||||||
1297919|NCT03623308|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1297920|NCT03623295|||Cohort||Other|||||||
1297921|NCT03623282||Single Group Assignment||Treatment||None (Open Label)||"Experimental(Single arm):~The enrolled patients will be prescribed Synatura® following measurement of pre-dose pulmonary functions, quality of life and systemic inflammatory state. Pulmonary functions, quality of life and systemic inflammatory state will be repeatedly measured after taking Synatura® for 3 months, and the changes from pre-dose measurements will be observed."||||
1297922|NCT03623269|||Cohort||Retrospective|||||||
1297923|NCT03623256|Randomized|Parallel Assignment||Prevention||Single|Participant will be blinded. The investigators will not be blinded because they are the same care providers. In addition, the volume of intrathecal anesthetic is different when bupivacaine plus fentanyl is used in comparison with only one medication used.|"Patients will be randomly assigned to one of four groups:~Group A: Spinal dose of preservative-free fentanyl 25 mcg. Group B: Spinal preservative-free 0.25% bupivacaine. Group C: Spinal combination of preservative-free 0.25% bupivacaine and fentanyl 25 mcg.~Group D: Spinal preservative-free 0.25% bupivacaine and epidural fentanyl 100 mcg.~After the procedure, we will monitor the fetal heart rate and tocometry tracings for 30 min. Thereafter, an epidural infusion with a solution containing 0.125% bupivacaine and 2mcg/mL of fentanyl will be started. We will record demographic variables (age, and BMI), obstetric variables (parity, gestational age, cervical dilation, oxytocin infusion) and anesthetic variables (level of insertion of epidural catheter). We will also record level of insertion, blood pressure every 5 minutes, dermatomal level, pain level, patient satisfaction level and pruritus."|t|||
1297924|NCT03623243||Single Group Assignment||Treatment||None (Open Label)||Open-label single arm study||||
1297926|NCT03623217|||Cohort||Prospective|||||||
1297927|NCT03623204|||Case-Only||Prospective|||||||
1297928|NCT03623191|||Case-Only||Prospective|||||||
1297929|NCT03623178|||Case-Control||Prospective|||||||
1297930|NCT03623165|||Case-Only||Prospective|||||||
1297931|NCT03623152|||Case-Only||Cross-Sectional|||||||
1297932|NCT03623139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297933|NCT03623126|||Cohort||Retrospective|||||||
1297934|NCT03623113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297935|NCT03623100|Randomized|Parallel Assignment||Treatment||None (Open Label)||A single-subject staggered multiple baseline design will be used in the speech treatment program. Following procedures for this design, the children with SSD will be randomly assigned to one of two treatment conditions. These groups will be evaluated independently and in combination. Every subject will be evaluated in a baseline period in which no treatment is provided. Every subject will first complete a full baseline assessment. Subsequent baselines will consist only of a shorter baseline probe that specifically targets the phonemes each child did not produce during the initial baseline session. Thus, the first subject in each condition will have 2 baselines and then begin treatment. Each subsequent subject within each condition will have 1 additional baseline before beginning treatment.||||
1297936|NCT03623087||Single Group Assignment||Treatment||None (Open Label)||||||
1297937|NCT03623074|Randomized|Parallel Assignment||Treatment||Double|Participants and parents of participants will be masked. Investigational site staff tasked with measuring key primary variables (i.e., axial length and SER) will be masked.||t|||t
1297938|NCT03623061|||Cohort||Prospective|||||||
1297939|NCT03623048|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1297940|NCT03623035|||Cohort||Prospective|||||||
1297941|NCT03623022|Randomized|Crossover Assignment||Other||Quadruple|The pharmacy will in charge of the randomization key, all others are blinded.|Subjects will undergo an exposure to inhaled endotoxin in a crossover fashion with normal saline inhalation.|t|t|t|t
1297942|NCT03623009|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1297943|NCT03622996|||Case-Only||Prospective|||||||
1297944|NCT03622983|||Cohort||Prospective|||||||
1297945|NCT03622970|Randomized|Parallel Assignment||Treatment||Single|||t|||
1297946|NCT03622957|||Case-Only||Cross-Sectional|||||||
1297947|NCT03622944|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1297948|NCT03622931|Randomized|Parallel Assignment||Treatment||Double||74 patients (about 37 in the experimental and 37 in the placebo arm), evaluable for the principal efficacy endpoint, are required. These will be recruited from an expected number of 15 sites.|t||t|
1297949|NCT03622918|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1297950|NCT03622905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297951|NCT03622892|||Cohort||Prospective|||||||
1297952|NCT03622879|Randomized|Parallel Assignment||Treatment||Single||||||t
1297953|NCT03622866|Randomized|Crossover Assignment||Treatment||Triple|Subjects who receive a permanent implant will be randomly assigned in a 1:1 ratio to one of the two sequences of treatment. Randomization schedules for each site will be prepared by the contract research organization (CRO) statistician and uploaded into a role-limited module of the study database. In order to avoid any potential bias, each site will designate an unblinded coordinator (UC). The UC, Nuvectra field personnel (FP) and the CRO will be unblinded to the treatment group. The participant and other site staff will be blinded to the treatment group.|During the Treatment Phase of the study, all subjects will receive both treatments under a crossover design. Subjects will undergo 12 weeks of treatment in each group with a 1-week washout between groups.|t|t|t|
1297954|NCT03622853||Single Group Assignment||Treatment||None (Open Label)||To investigate the factors associated with improvement after intraarticular steroid injection for patients with Frozen shoulder||||
1297955|NCT03622840||Single Group Assignment||Supportive Care||None (Open Label)||||||
1297956|NCT03622827||Single Group Assignment||Treatment||None (Open Label)||||||
1297957|NCT03622814|Randomized|Parallel Assignment||Supportive Care||Single|Participants will not know if they are in a site that is receiving the treatment or in the usual condition site. Randomization is by site, not by individuals.|A randomized cluster-design trial will be conducted in two large respite care centers (RCCs) with five sites that serve primarily white and African American persons with dementia. RCCs will be randomized to the intervention condition (Partners at Meals; 3 sites) or ['enhanced usual care' (EUC)] (2 sites). The primary unit of analysis is the person with dementia (PWD) and caregiver (CG): 60 PWDs, 60 CGs will be enrolled; it is estimated that up to 60 volunteers/staff/managers may be enrolled. The caregivers and RCC volunteer is another dyad for analysis, as is the RCC volunteer and the PWD. Additionally, RCC Managers at both PaM and EUC sites will be interviewed regarding barriers to implementation, ways to enhance the project, and possible causes of discharge of PWD from the study related to nutritional problems.|t|||
1297958|NCT03622801|||Case-Control||Retrospective|||||||
1297959|NCT03622788||Single Group Assignment||Treatment||None (Open Label)||||||
1297960|NCT03622775||Single Group Assignment||Treatment||None (Open Label)||||||
1297961|NCT03622762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297962|NCT03622749|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1297963|NCT03622736|||Other||Prospective|||||||
1297964|NCT03622723|||Other||Prospective|||||||
1297965|NCT03622710|Randomized|Parallel Assignment||Treatment||Single||||||t
1297966|NCT03622697|Randomized|Parallel Assignment||Treatment||Double||||t||t
1297967|NCT03622684||Single Group Assignment||Treatment||None (Open Label)||||||
1297968|NCT03622671|Randomized|Parallel Assignment||Basic Science||Double|The patient will be blinded to LIMA harvesting technique. The laboratory technicians will be blinded to LIMA harvesting technique.|Randomized clinical trial with parallel group design. Equal allocation.|t|||t
1297969|NCT03622658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1297970|NCT03622645||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297971|NCT03622632|||Cohort||Prospective|||||||
1297972|NCT03622619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1297973|NCT03622606||Single Group Assignment||Diagnostic||None (Open Label)||||||
1297974|NCT03622593|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1297975|NCT03622580|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1297976|NCT03622567||Single Group Assignment||Other||None (Open Label)||||||
1297977|NCT03622554|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1297978|NCT03622541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1297979|NCT03622528|||Cohort||Cross-Sectional|||||||
1297980|NCT03622515|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1297981|NCT03622502|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1297982|NCT03622489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1297983|NCT03622476||Single Group Assignment||Treatment||None (Open Label)||||||
1297984|NCT03622463|Randomized|Parallel Assignment||Treatment||Quadruple||"This is a multi-centers, phase IIa, double blind, randomized, placebo-controlled trial of Antroquinonol in patients with atopic dermatitis. Subjects with diagnosis of atopic dermatitis, using the Hanifin and Rajka Diagnostic Criteria, who meet inclusion/exclusion criteria will be randomized into 3 groups:~Antroquinonol 100 mg PO QD~Antroquinonol 50 mg PO QD~Placebo"|t|t|t|t
1297985|NCT03622450|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1297986|NCT03622437|Randomized|Parallel Assignment||Supportive Care||Single||Participants are randomized (1:1) into either intervention or control group. This is done by block randomization, stratifying by center, sex and treatment type (± postoperative oncological treatment and ± temporary ileal stoma).||||t
1297987|NCT03622424|Randomized|Parallel Assignment||Treatment||Triple|Subjects, investigators, and sponsor will be blinded|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Assessing the Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UP|t|t|t|
1297988|NCT03622411|Randomized|Parallel Assignment||Treatment||Single||||||t
1297989|NCT03622398|Randomized|Parallel Assignment||Treatment||Double||Total knee arthroplasty is performed on patients with knee osteoarthritis. One group will receive a highly cross-linked polyethylene liner and one group will receive a conventional polyethylene liner. Other parts of procedures will be the same.|t|||t
1297990|NCT03622385|||Cohort||Other|||||||
1297991|NCT03622372|Randomized|Parallel Assignment||Treatment||Double|Participants and the Occupational Therapist performing the majority of the outcome assessments will be masked to the treatment until the 12 week post-operative visit.|Participants will be assigned using a 1:1 randomization scheme to receive either the investigational device or a suture repair for the surgical treatment of their tendon lacerations.|t|||t
1297992|NCT03622359|||Case-Control||Prospective|||||||
1297993|NCT03622346||Single Group Assignment||Treatment||None (Open Label)||Just one patient, subject to two surgeries: curettage and external fixation; subsequently the patient underwent total knee arthroplasty||||
1297994|NCT03622333||Single Group Assignment||Basic Science||None (Open Label)||||||
1297995|NCT03622320|||Case-Control||Cross-Sectional|||||||
1297996|NCT03622307||Single Group Assignment||Treatment||None (Open Label)||||||
1297997|NCT03622294||Single Group Assignment||Supportive Care||None (Open Label)||Participants will be female, asymptomatic patients randomly scheduled for a screening mammogram.||||
1297998|NCT03622281|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1297999|NCT03622268|||Cohort||Prospective|||||||
1298000|NCT03622255|Randomized|Parallel Assignment||Treatment||Double||A software (www.randomizer.org) will be used by one of the investigators who will not participate in the clinical and radiographic measurements nor the therapeutic intervention, to generate a block randomization. Thus, participants will be randomized in one of the two groups in a way that there is no difference between the two groups regarding the initial depth of the intrabony defect. In patients with more than one intrabony defects meeting the inclusion criteria, a second randomization scheme with the same software will take place, to determine which will be included. The randomization results will be placed in sealed envelopes accessible only to the principal investigator and opened for each patient after the end of MINST to determine if EMD will be applied or not.|t|||t
1298001|NCT03622242|Randomized|Parallel Assignment||Other||Double|||t||t|
1298002|NCT03622229|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1298003|NCT03622216|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1298004|NCT03622203|||Cohort||Prospective|||||||
1298005|NCT03622190|||Cohort||Prospective|||||||
1298006|NCT03622177|||Case-Control||Prospective|||||||
1298007|NCT03622164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298008|NCT03622151|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Intervention group (housing first model program) and control group (treatment as usual).||||
1298009|NCT03622138|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1298010|NCT03622125|||Case-Control||Cross-Sectional|||||||
1298011|NCT03622112|Randomized|Parallel Assignment||Treatment||Double|"All double-blind medication kits will have similar appearance regardless of the IP (AZD7594 or placebo) contained in a DPI device and will be labelled using a unique medication identification number (Kit ID) that is linked to a treatment arm. IVRS/IWRS will assign the study medication to be dispensed to each subjects at Visit 3.~Supplies of budesonide, FF and SABA (salbutamol/albuterol) will be open-label."||t|t||
1298012|NCT03622099|||Case-Only||Prospective|||||||
1298013|NCT03622086|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298014|NCT03622073|Randomized|Parallel Assignment||Treatment||Single|||||t|
1298015|NCT03622060|Randomized|Parallel Assignment||Prevention||Double|Double blind|nitroglycerin and nicardipine|||t|t
1298016|NCT03622047|Randomized|Parallel Assignment||Treatment||Single|||||t|
1298017|NCT03622034|||Ecologic or Community||Retrospective|||||||
1298018|NCT03622021|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1298019|NCT03622008|Randomized|Parallel Assignment||Basic Science||Quadruple|double-blind study|"Subjects will receive one of the following IV treatments as a q8h infusion (90 min) regimen for 10 days:~FEP-TAZ 4 g (2 g cefepime + 2 g tazobactam) (n=16)~Placebo (n=4)"|t|t|t|t
1298020|NCT03621995|||Case-Only||Retrospective|||||||
1573326|NCT00001612||||||||||||
1298021|NCT03621982||Single Group Assignment||Treatment||None (Open Label)||||||
1298022|NCT03621969|Randomized|Crossover Assignment||Other||None (Open Label)||"Group 1 will receive:~two weeks of RePlay device therapy twice per week at REACT (weeks 1-2), followed by re-assessment,~then will rest for 2 weeks (weeks 3-4),~then will take the RePlay devices and tablet computer home for two weeks (weeks 5-6) for daily device therapy, followed by re-assessment.~Group 2 will receive:~two weeks of RePlay device therapy daily at home (they will take the devices and tablet home) (weeks 1-2), followed by re-assessment,~then will rest for 2 weeks (weeks 3-4),~then will receive two weeks of RePlay device therapy twice per week at REACT (weeks 5-6), and then will undergo re-assessment."||||
1298023|NCT03621956|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298024|NCT03621943|Randomized|Parallel Assignment||Diagnostic||Single|Neurodevelopmental providers will be blinded to the randomization of the toddler during the examination.|Neurodevelopmental assessments will be done at 2 years of corrected age (22-26 months) for subjects who were randomized to receive either early cord clamping or umbilical cord milking as part of the MINVI trial.||||t
1298025|NCT03621930|||Cohort||Prospective|||||||
1298026|NCT03621917|||Case-Only||Prospective|||||||
1298027|NCT03621904|||Cohort||Prospective|||||||
1298028|NCT03621891|||Case-Control||Cross-Sectional|||||||
1298029|NCT03621878|Non-Randomized|Factorial Assignment||Treatment||Double|both the examiner and the outcomes assessor where blinded to the participants groups. the primary investigator was also blind to the outcomes of each participant during the study period.|||t||t
1298030|NCT03621865|Randomized|Crossover Assignment||Basic Science||None (Open Label)||This pharmacokinectic study is designed as a monocentric, randomized, cross-over, pilot and open clinical trial||||
1298031|NCT03621852|||Cohort||Prospective|||||||
1298032|NCT03621839|||Cohort||Prospective|||||||
1298033|NCT03621826|||Case-Control||Other|||||||
1298034|NCT03621813||Sequential Assignment||Treatment||Single||Cancer survivors will be enrolled in a 6-week delayed entry control period followed by 6-week exercise rehabilitation program.|t|||
1298035|NCT03621800|Randomized|Parallel Assignment||Other||None (Open Label)||This is a study with an experimental research design. Randomized clinical trial, parallel, prospective and monocentric.||||
1298036|NCT03621787||Single Group Assignment||Basic Science||None (Open Label)||Participants in trial will be within a single study arm. All participants will have a placebo subcutaneous implant inserted with the device being studied. The implant accuracy will be assess through palpation and ultrasound depth measurements. The implant will then be removed. Safety will be assessed by measuring bruising, bleeding, and pain to participant. A follow-up questionnaire will assess pain, bruising, and infection risk. A final visit will assess pain, bruising, and infection risk by a physician.||||
1298037|NCT03621774|Randomized|Parallel Assignment||Treatment||Single||||||t
1298038|NCT03621761|Randomized|Parallel Assignment||Treatment||Single|Rater blinded|||||t
1298039|NCT03621748|Randomized|Parallel Assignment||Treatment||Single||||||t
1298040|NCT03621735|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1298041|NCT03621722|Randomized|Parallel Assignment||Treatment||None (Open Label)|The patient will be randomly assigned to a group based on their primary symptoms. The RN will be communicating with the patient for assessments, administering medications, and submitting results collected into the EPIC system.|Patients receiving Elequil Aromatabs(treatment cohort) and patients receiving Standard of care (control cohort). In addition, patients will be receiving PRN antiemetic or PRN anxiolytics||||
1298042|NCT03621709|||Cohort||Prospective|||||||
1298043|NCT03621696|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298044|NCT03621683|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective comparative study||||
1298045|NCT03621670|Randomized|Parallel Assignment||Prevention||Quadruple|"Observer-blind study Data will be collected in an observer-blind manner. By observer blind, it is meant that during the course of the study, the subject/parent/caregiver, site and sponsor personnel involved in the clinical evaluation of the subjects are blinded while other study personnel are aware of the treatment assignment. To do so, vaccine preparation and administration will be done by authorized medical personnel who will not participate in any of the study clinical evaluation assays or procedures.~The serological data, which would lead to the unblinding of the study groups, will not be available during the course of the study to any investigator or any person involved in the clinical conduct of the study. The laboratory in charge of the laboratory testing will be blinded to the treatment, subject and visit number, and codes will be used to link the subject, visit and study to each sample."||t|t|t|t
1298046|NCT03621657|Randomized|Parallel Assignment||Treatment||Triple||This is a phase 2, double-blind, randomized, placebo-controlled trial assessing the effects of either one-time (group 1) or daily (group 2) oral FMT on the composition and function of gut microbiome compared to placebo (group 3) in a population of patients with a history of Clostridium difficile infection (CDI).|t||t|t
1298047|NCT03621644||Single Group Assignment||Treatment||None (Open Label)||||||
1298048|NCT03621631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298049|NCT03621618|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1298050|NCT03621605|Randomized|Sequential Assignment||Basic Science||Triple|Investigator and subject are blinded, sponsor and site pharmacist are unblinded.|A minimum of 56 subjects will be enrolled in 7 planned SAD cohorts (8 subjects per cohort). Subjects enrolled in SAD cohorts will be admitted to a Phase 1 unit and randomized to receive a single dose of VIB9600 or placebo administered by slow IV infusion or SC injection. A minimum of 16 subjects will be enrolled in 2 planned MAD cohorts (8 subjects per cohort). Subjects enrolled in the MAD cohorts will receive VIB9600 or placebo Q2W for 4 weeks (3 doses in total: one each on Days 1, 15 and 29).|t|t|t|
1298051|NCT03621592|Randomized|Parallel Assignment||Treatment||Single|Due to the nature of the study and products, investigator blinding is unrealistic and subject blinding is unlikely. Research staff will avoid naming the dressing or suggesting the assignment to the subjects. However, an independent monitor with experience in treating wounds will be blinded to the treatment assignment and will confirm healing outcomes based on images.|||||t
1298052|NCT03621579||Single Group Assignment||Treatment||None (Open Label)||||||
1298053|NCT03621566|||Cohort||Prospective|||||||
1298365|NCT03617510|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1298054|NCT03621553|Randomized|Parallel Assignment||Treatment||Triple|Groups separated by a) use / non-use of oral prednisone, and b) status of serum 25-hydroxy-vitamin-D level (sufficient or insufficient). Those who are vitamin-D insufficient will be randomized to receive either vitamin D2 or placebo.|Vitamin-D insufficient subjects will receive either vitamin D2 repletion or placebo Vitamin-D sufficient subjects will be observed without treatment.|t|t|t|
1298055|NCT03621540|Randomized|Parallel Assignment||Basic Science||Triple|Use of NeuroConn Stimulator study mode||t|t|t|
1298056|NCT03621527|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1298057|NCT03621514|Non-Randomized|Parallel Assignment||Treatment||Single|This study is a prospective cohort study.Participants,Care Provider, and Investigator all know the grouping situation. The Investigator collect the information and observation indicators of the two groups of participants and send to the Outcomes Assessor . The Outcomes Assessor does not know the grouping situation of each participant.|This study is a prospective cohort study.The main study content is the feasibility and advantages of painless indwelling catheter in perioperative period of uniportal video-assisted thoracoscopic surgery in lobectomy of lung cancer,divided into exposed and non-exposed groups.The exposed group was painless indwelled urethral catheter, the non-exposed group was indwelled urethral catheter routinely.||||t
1298058|NCT03621501|Randomized|Parallel Assignment||Treatment||Single|The clinical event adjudication committee, consisting of cardiologists who are not participating in the study, will be blinded for the treatment arm of the patients to avoid a potential bias in the adjudication process of events|This study is a prospective, multicenter, randomized, two-arm, international, open-label, non-inferiority study. Due to the design characteristics of the study, the study investigators and operators cannot be blinded.||||t
1298059|NCT03621488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298060|NCT03621475|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1298061|NCT03621462||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298062|NCT03621449|||Cohort||Prospective|||||||
1298063|NCT03621436||Single Group Assignment||Treatment||None (Open Label)||||||
1298064|NCT03621423||Single Group Assignment||Treatment||None (Open Label)||Patient will be positioned lying on side with the hemiplegic side up. The shoulder will be placed in a flexion and external rotation/abduction position, as possible by the patient, to give the ultrasound probe access to the posterior axillary fold.||||
1298065|NCT03621410|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298066|NCT03621397|Randomized|Parallel Assignment||Treatment||None (Open Label)||40 Spanish-speaking research participants who have sustained a subarachnoid hemorrhage in the last 6 months will participate in the research study. Participants will be randomly assigned to one of two groups: 1) Cognitive intervention group (n = 20) or 2) Control group (n = 20). The Cognitive Intervention group will receive the cognitive intervention, while the Control group will not receive any intervention.||||
1298067|NCT03621384|||Other||Cross-Sectional|||||||
1298068|NCT03621371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298069|NCT03621358|Randomized|Crossover Assignment||Other||Double|Double Blind (Participant and Investigator)||t||t|
1298070|NCT03621345|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1298071|NCT03621332|||Cohort||Prospective|||||||
1298072|NCT03621319|Randomized|Parallel Assignment||Treatment||Single|||t|||
1298073|NCT03621306|||Cohort||Cross-Sectional|||||||
1298074|NCT03621293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298075|NCT03621280||Single Group Assignment||Treatment||None (Open Label)||Open-Label Extension Study||||
1298076|NCT03621267|Randomized|Parallel Assignment||Prevention||Single||||||t
1298077|NCT03621254|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised Controlled Design||||
1298078|NCT03621241|||Other||Prospective|||||||
1298079|NCT03621228|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1298080|NCT03621215|Randomized|Parallel Assignment||Treatment||Quadruple||Participants will be randomly allocated to consume either tart cherry juice or a fruit-flavoured placebo drink (matched as closely as possible for energy and sensory characteristics) daily for 12 months.|t|t|t|t
1298081|NCT03621202||||||||||||
1298082|NCT03621189|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1298083|NCT03621176||Single Group Assignment||Treatment||None (Open Label)||All participants will undertake the exercise intervention. We will compare effects of the intervention between different cohorts included (advanced chronic kidney disease, end-stage renal disease hemodialysis o peritoneal dialysis)||||
1298084|NCT03621163|Randomized|Parallel Assignment||Treatment||Single|"Single blinded (outcome assessor). Assessors supervisor and co-supervisor will be blinded to the assigned material. However the operator and patient can't be blinded due to the difference in preparation and shade of the ceramic materials and bleaching agent.~The assessors will assess all outcomes blinded to the material assigned for each patient.~Three spectrophotometer measurements will be recorded each time, with the active point of the instrument focused on the cervical third of each tooth, then mean color from three measurements will be calculated.~Digital photograph measures the color of teeth based on the Adobe Photoshop software. (Version 5.5)."|split mouth randomized control, co-supervisor will write number for each member in each group (left side treatment A, right side treatment B or left side treatment B, right side treatment A) by indispensible pen on large white paper sheet. The sheet will be folded eight times and saved inside opaque well sealed envelope in which the inner content cannot be seen by naked eyes.||||t
1298085|NCT03621150|||Case-Only||Prospective|||||||
1298086|NCT03621137|||Cohort||Prospective|||||||
1298087|NCT03621124|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Temperature Modulation||||
1298088|NCT03621111|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298089|NCT03621098|||Case-Control||Prospective|||||||
1298090|NCT03621085|Non-Randomized|Single Group Assignment||Supportive Care||Single||single blinded placebo controlled study|t|||
1298216|NCT03619447|Randomized|Parallel Assignment||Treatment||Double|Both participants and anaesthesia provider will not know which intervention applied. Another anaesthesia provider who did not perform any block will follow and record to the study data.||t|t||
1298438|NCT03616548||Sequential Assignment||Diagnostic||None (Open Label)||||||
1573327|NCT00001605||||Treatment||||||||
1298091|NCT03621072|Randomized|Crossover Assignment||Basic Science||None (Open Label)||This is an open-label, randomized, single-dose, 2-way crossover bioequivalence study under fasted and fed conditions in healthy Chinese subjects. Under each condition, subjects will be randomized to one of the 2 treatment sequences. Each treatment sequence will consist of 2 periods, separated by a washout period of at least 14 days between each period. For sequence 1, first localized originator and then originator will be administered. The order for sequence 2 is originator and localized originator.||||
1298092|NCT03621059|Randomized|Parallel Assignment||Treatment||Single|Eligible children were randomly assigned by sealed envelope to either intervention or control group. Several methods were used to maintain the treatment blindly, including segregation of assessment and treatment staff and instructions to children and parents to avoid discussions of treatment assignment with the independent evaluators.|A collection of behavioral skills named as Comprehensive Behavioral Intervention (CBIT) for Tics had been found to be effective (Piacentini et al., 2010).The major components of CBIT includes psychoeducation of tics, habit reversal training (HRT), function-based interventions, and relaxation training (Piacentini et al., 2010).The HRT consists of several therapeutic activities, including awareness training (i.e., observing the premonitory urge or other signs preceding the occurrence of a tic), competing response training (i.e., engaging in a voluntary behavior that is physically incompatible with the tic to manage the premonitory urge), self-monitoring of tics and relaxation training (Himle et al., 2006).|t|||
1298093|NCT03621046|Randomized|Parallel Assignment||Treatment||Quadruple||A placebo controlled double-blinded proof-of-concept study|t|t|t|t
1298094|NCT03621033|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1298095|NCT03621020|||Cohort||Prospective|||||||
1298096|NCT03621007|||Cohort||Prospective|||||||
1298097|NCT03620994|||Case-Crossover||Cross-Sectional|||||||
1298098|NCT03620981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298099|NCT03620968|Randomized|Parallel Assignment||Prevention||Single|||t|||
1298100|NCT03620955|||Case-Control||Prospective|||||||
1298101|NCT03620942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298102|NCT03620929|Randomized|Parallel Assignment||Prevention||Single||||||t
1298103|NCT03620916|Randomized|Parallel Assignment||Treatment||Double||Patients will be randomized in a 1:1 ratio into experimental and control group|||t|t
1298104|NCT03620903||Single Group Assignment||Treatment||None (Open Label)||||||
1298105|NCT03620890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298106|NCT03620877||Single Group Assignment||Prevention||None (Open Label)||||||
1298107|NCT03620864|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1298108|NCT03620851|||Cohort||Retrospective|||||||
1298109|NCT03620838|||Cohort||Prospective|||||||
1298110|NCT03620825|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1298111|NCT03620812|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1298112|NCT03620799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298113|NCT03620786|||Cohort||Prospective|||||||
1298114|NCT03620773||Single Group Assignment||Diagnostic||None (Open Label)||All participants in this study will receive the same intervention.||||
1298115|NCT03620760|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients were randomly assigned in a 1:1 ratio to receive ticagrelor 90 mg twice daily plus aspirin 100mg once daily or ticagrelor 45 mg twice daily plus aspirin 100mg once daily.||||
1298116|NCT03620747||Single Group Assignment||Treatment||None (Open Label)||||||
1298117|NCT03620734|||Cohort||Prospective|||||||
1298118|NCT03620721|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1298119|NCT03620708|Randomized|Parallel Assignment||Treatment||Single|The individual conducting the outcomes assessment is blind to study condition.|Randomized clinical trial in which participants are randomized to one of three groups.||||t
1298120|NCT03620695|||Cohort||Prospective|||||||
1298121|NCT03620682||Single Group Assignment||Treatment||None (Open Label)||||||
1298122|NCT03620669||Single Group Assignment||Treatment||None (Open Label)||Prospective single-arm open-label multicenter phase II trial||||
1298123|NCT03620656|||Cohort||Prospective|||||||
1298124|NCT03620643|Non-Randomized|Parallel Assignment||Other||Single||This multi-centre study design will aim to complete recruitment over 18 months from six high volume centres including the Royal Marsden. Parallel recruitment to breast and gastric cancer cohorts will take place for this study.|t|||
1298125|NCT03620630|Randomized|Parallel Assignment||Health Services Research||Single|End of study visit to be completed by a blinded team|Randomised controlled Feasibility study||||t
1298126|NCT03620617|Randomized|Parallel Assignment||Prevention||Single|||t|||
1298127|NCT03620604|||Cohort||Prospective|||||||
1298128|NCT03620591|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1298129|NCT03620578||Single Group Assignment||Treatment||None (Open Label)||The trial is designed as a prospective, multicenter, non-randomized phase II trial. All eligible patients will be registered during or after first R-CHOP, but before start of DA-EPOCH-R treatment and before start of nivolumab treatment.||||
1298130|NCT03620565|||Cohort||Prospective|||||||
1298131|NCT03620552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298132|NCT03620539|Randomized|Parallel Assignment||Prevention||Single||||||t
1298133|NCT03620526|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1298134|NCT03620513|Randomized|Parallel Assignment||Prevention||Triple||Five arms of study group with equal number of subjects in each group|t|t||t
1298135|NCT03620500|||Cohort||Prospective|||||||
1298136|NCT03620487|||Case-Only||Prospective|||||||
1298137|NCT03620474||Single Group Assignment||Treatment||None (Open Label)||||||
1298138|NCT03620461|||Case-Only||Retrospective|||||||
1298139|NCT03620448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298140|NCT03620435||Single Group Assignment||Treatment||None (Open Label)||||||
1298268|NCT03618771|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1298269|NCT03618758||Single Group Assignment||Treatment||None (Open Label)||||||
1298270|NCT03618745|||Cohort||Prospective|||||||
1298141|NCT03620422|Randomized|Crossover Assignment||Other||Quadruple||This is a mechanistic study. The first part of the study (mild allergic asthmatics and healthy controls) is to determine reproducibility of dose responses to mannitol-induced coughs. The second part of the study (mild asthmatics only) is to determine the effect of salbutamol on mannitol-induced coughs. Salbutamol or placebo will be delivered following a mannitol cough challenge in a randomized, double-blind crossover design.|t|t|t|t
1298142|NCT03620409|||Cohort||Prospective|||||||
1298143|NCT03620396|Randomized|Parallel Assignment||Treatment||Single||Patients will be equally divided into two test groups.Group A consists of Gingivitis patients and Group B consists of Periodontitis patients. Both the group patients have been evaluated for Serum Trefoil factor 3 at baseline and treated with non surgical periodontal therapy. After three months both the group patients were again assessed for serum trefoil factor 3.||||t
1298144|NCT03620383|Randomized|Parallel Assignment||Treatment||Single|||||t|
1298145|NCT03620370|Randomized|Parallel Assignment||Treatment||Single||||||t
1298146|NCT03620357|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, randomized, multicenter, two-arm confirmatory study.||||
1298147|NCT03620344|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1298148|NCT03620331|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1298149|NCT03620318||||||||||||
1298150|NCT03620305|||Cohort||Retrospective|||||||
1298151|NCT03620292||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298152|NCT03620279||Single Group Assignment||Treatment||None (Open Label)||||||
1298153|NCT03620266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298154|NCT03620253|Randomized|Parallel Assignment||Treatment||Quadruple|25 participants will be randomly assigned to the modafinil treatment group, and 25 to the placebo group. The drug/placebo will be randomized and dispensed by the research pharmacy at St. Michael's Hospital. A research technician who is blind to the study will prepare the capsules and break the blind at the end of the study.|50 Participants (aged 18-55) who are experiencing cognitive deficits (measured as Neurocognitive Index >1 standard deviation below the mean) despite remission from depression (Montgomery-Asberg Rating Scale for Depression (MADRAS) score <7) will be eligible to receive modafinil (100-200mg daily) or two identical placebo capsules each morning for a period of 8 weeks.|t|t|t|t
1298155|NCT03620240|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1298156|NCT03620227|Randomized|Crossover Assignment||Prevention||Double|The preparation and coding of the liquids will be performed by a third party so that the researchers and participants will not know which liquid is being consumed.|The volunteers will do 2 days of intervention in random order with 7 days of wash out. In one of the days will consume 350ml of concentrated beet juice and in the other 350ml of placebo made with the juice itself denitratized by an anionic resin that does not alter taste, smell or color.|t||t|
1298157|NCT03620214|||Case-Crossover||Cross-Sectional|||||||
1298158|NCT03620201||Single Group Assignment||Treatment||None (Open Label)||||||
1298159|NCT03620188|||Cohort||Prospective|||||||
1298160|NCT03620175|Randomized|Single Group Assignment||Treatment||Single|Outcomes Assessor is blinded to treatment groups and vehicle control.|Each patient receives each of the 4 treatment arms. It is closest to a single-subject design where each participant serves as their own control. The placement of treatments on each of the 4 wounds is randomized and assessed by a blinded outcomes assessor.||||t
1298161|NCT03620162|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1298162|NCT03620149||Single Group Assignment||Treatment||None (Open Label)||||||
1298163|NCT03620136|Randomized|Parallel Assignment||Treatment||Single|||t|||
1298164|NCT03620123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298165|NCT03620110|||Case-Only||Prospective|||||||
1298166|NCT03620097|Randomized|Parallel Assignment||Treatment||Double|The nutritional supplement used will be a product marketed according to the European Union regulation. This supplement (EUPOLY-3® DHA Infant) will be provided by Biosearch SA (Granada, Spain), as well as the placebo, in identical containers labeled with a numeric code. Product code: EUP007. The composition of both will differ only in that the formula with DHA will be fish oil refined and stabilized by the addition of soy lecithin, tocopherols of natural origin and ascorbic palmitate. In addition, its level of toxic in the raw material is controlled. This product, and the placebo, will keep the rest of the fatty acid profile similar (eg content of linoleic and linolenic fatty acids). It will be designed in a formulation suitable for preschool children with ASD; in liquid form and in a concentrated dose to ingest orally in the least amount possible (approximately 1.5cc in each dose).|The nutritional supplement used will be a product marketed according to the European Union regulation. This supplement (EUPOLY-3® DHA Infant) will be provided by Biosearch SA (Granada, Spain), as well as the placebo, in identical containers labeled with a numeric code. Product code: EUP007. The composition of both will differ only in that the formula with DHA will be fish oil refined and stabilized by the addition of soy lecithin, tocopherols of natural origin and ascorbic palmitate. In addition, its level of toxic in the raw material is controlled. This product, and the placebo, will keep the rest of the fatty acid profile similar (eg content of linoleic and linolenic fatty acids). It will be designed in a formulation suitable for preschool children with ASD; in liquid form and in a concentrated dose to ingest orally in the least amount possible (approximately 1.5cc in each dose).|t||t|
1298167|NCT03620084||Single Group Assignment||Treatment||None (Open Label)||||||
1298168|NCT03620071|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1298169|NCT03620058|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1298170|NCT03620045|Randomized|Crossover Assignment||Prevention||None (Open Label)||Randomized crossover design||||
1298171|NCT03620032|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, non-blinded, randomised two cohorts study||||
1298172|NCT03620019||Single Group Assignment||Treatment||None (Open Label)||||||
1298173|NCT03620006|||Cohort||Other|||||||
1298174|NCT03619993|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1298175|NCT03619980|||Cohort||Other|||||||
1298271|NCT03618732|Randomized|Parallel Assignment||Treatment||Single||stratified, single-blinded, intervention and controlled study||||t
1298272|NCT03618719|||Case-Control||Prospective|||||||
1298633|NCT03614013|||Cohort||Retrospective|||||||
1298176|NCT03619967||Single Group Assignment||Diagnostic||None (Open Label)||Experimental: Arm 1: Multispectral Imaging Per current standard of care for patients with breast cancer, three different tracers will be injected in the patient: technetium radiocolloid, indocyanine green and methylene blue. The surgeon will identify the location of the sentinel lymph node per standard of care by using a handheld gamma-probe and by visual inspection of the wound site. During this same time period, fluorescent signals from the underarm surgical wound site will be recorded with the bio-inspired multispectral camera.||||
1298177|NCT03619954||Single Group Assignment||Treatment||None (Open Label)||||||
1298178|NCT03619941|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1298179|NCT03619928|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1298180|NCT03619915|||Other||Retrospective|||||||
1298181|NCT03619902||Single Group Assignment||Treatment||None (Open Label)||||||
1298182|NCT03619889|Randomized|Parallel Assignment||Treatment||Double|Participants don´t know to which group are assigned The statistical assessor don´t know the aim of the study|clinical trial, prospective, randomized and experimental with masking of the statistician and the participants|t|||t
1298183|NCT03619876|Randomized|Parallel Assignment||Treatment||None (Open Label)|Unblinded- open label|RA patients will be randomized in an unblinded, 1:1 ratio to treatment with abatacept vs adalimumab. A cardiac FDG PET/CT will be performed at baseline and 16(±2) weeks post-biologic treatment. T cell subpopulations associated with myocardial FDG uptake will be evaluated at both points in time with their transcriptional phenotype outlined by RNAseq.||||
1298184|NCT03619863|||Cohort||Prospective|||||||
1298185|NCT03619850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298186|NCT03619837||Single Group Assignment||Other||None (Open Label)||||||
1298187|NCT03619824||Single Group Assignment||Treatment||None (Open Label)||||||
1298188|NCT03619811|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1298189|NCT03619798|||Cohort||Prospective|||||||
1298190|NCT03619785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298191|NCT03619772|Randomized|Parallel Assignment||Treatment||Single||||||t
1298192|NCT03619759|||Cohort||Retrospective|||||||
1298193|NCT03619746|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)|All participants in the study (i.e., patients and physicians) will be aware of what arm of the study they are in.|"Pre-Post Study Design with Non-Pharmacologic Intervention~Patient in first arm of study will be treated by physicians who have not yet received educational training. Patients in the second arm of the study will be treated by physicians who went through the educational training."||||
1298194|NCT03619733|||Cohort||Prospective|||||||
1298195|NCT03619720||Single Group Assignment||Screening||None (Open Label)||||||
1298196|NCT03619707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298197|NCT03619694|||Cohort||Prospective|||||||
1298198|NCT03619681||Single Group Assignment||Treatment||None (Open Label)||||||
1298199|NCT03619668|||Cohort||Prospective|||||||
1298200|NCT03619655|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1298201|NCT03619642|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1298202|NCT03619629|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1298203|NCT03619616|Randomized|Parallel Assignment||Treatment||Quadruple|Triple(Participant, Investigator, Clinical Research Associate)||t|t|t|t
1298204|NCT03619603|||Case-Only||Prospective|||||||
1298205|NCT03619590|||Cohort||Prospective|||||||
1298206|NCT03619577|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1298207|NCT03619564|||Cohort||Prospective|||||||
1298208|NCT03619551|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomization will be performed after eligibility is confirmed. Randomization between the two busulfan dose levels will be done separately in each genotype stratum, using permuted blocks. Randomization will be stratified further by donor type (Haploidentical related vs. Matched Unrelated Donor).||||
1298209|NCT03619538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298210|NCT03619525|Randomized|Parallel Assignment||Prevention||Single|numbered, sealed opaque envelope.|sixty patients aged from 18-60 years old, scheduled for elective cardiac surgery with CPB will be included in the study. Patients will be randomly allocated into one of two groups: Group A (n=30): will receive intermittent lung recruitment during CPB.Group B (n=30): control group.|||t|
1298211|NCT03619512|||Cohort||Retrospective|||||||
1298212|NCT03619499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298213|NCT03619486|Randomized|Parallel Assignment||Treatment||Double||Double blind, placebo control study. Eligible participants will be assigned a randomization number in sequential order and each of the randomization will determine the allocation of one of the two treatment groups (LESW and Placebo) in 1: 1 ratio as shown below. The LESW and placebo will be controlled by a research assistance who will not evaluate the therapeutic outcome to ensure the double blind method.|t||t|
1298214|NCT03619473|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1298215|NCT03619460|Randomized|Parallel Assignment||Treatment||Quadruple|Sequentially sealed opaque envelopes will be opened by a nurse not involved in the treatment of the patient and a number will be assigned to the patients included in the study. The randomization code will be disclosed at the end of the statistical analysis. The doctor who will evaluate the complications, the duration of the procedure and the healing will be not aware of the type of treatment provided to the patients, nor will be the patients.|"All patients will take amoxicillin + clavulanic acid and Ibuprofen 600mg . Mepivacain with 1:100.000 adrenalin will be used for anesthesia. Local infiltration of Desamethasone 4mg and intraoral disinfection of the surgical area with povidone iodine will be done.~A full thickness flap will be raised after a sulcular incision from the mesial buccal aspect of the second molar to the distal aspect of the third one where a releasing incision begins describing an open V shape.~In the Piezoelectric group Piezoelectric tools will be used. In the conventional group manual tools and burs with a straight handpiece will be used. The flap will be sutured using a 3/0 suture. Levobupivacaine hydrochloride 5mg will be injected at the end of the procedure in the site of the operation"|t|t|t|t
1298273|NCT03618706||Single Group Assignment||Treatment||None (Open Label)||||||
1298439|NCT03616535|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1298217|NCT03619434|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking as the investigators are assessing differences in surgical technique|"This is a prospective cohort study where a maximum of 30 patients attending the cornea firm at the eye unit in University Hospitals Southampton who are indicated for penetrating keratoplasty as a result of corneal disease or pathology will be recruited.~All patients will receive a complete ophthalmological examination preoperatively.~Subjects will then be divided randomly into 2 groups of 15, should we get 30 patients;"||||
1298218|NCT03619421|Randomized|Parallel Assignment||Basic Science||Single|Random number used to label samples|||||t
1298219|NCT03619408|||Cohort||Prospective|||||||
1298220|NCT03619395|||Cohort||Prospective|||||||
1298221|NCT03619382|||Other||Cross-Sectional|||||||
1298222|NCT03619369|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1298223|NCT03619356|||Other||Prospective|||||||
1298224|NCT03619343|Randomized|Parallel Assignment||Treatment||Double||Control Intervention : ETOIMS apply group|||t|t
1298225|NCT03619330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298226|NCT03619317|||Cohort||Prospective|||||||
1298227|NCT03619304|Non-Randomized|Parallel Assignment||Treatment||Single||oral squamous cell carcinoma cell lines||||t
1298228|NCT03619291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298229|NCT03619278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298230|NCT03619265|Randomized|Parallel Assignment||Basic Science||Triple||A double-blinded, randomized, placebo-controlled, parallel-arm clinical study design will be used.|t|t||t
1298231|NCT03619252|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1298232|NCT03619239|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1298233|NCT03619226||Single Group Assignment||Basic Science||None (Open Label)||||||
1298234|NCT03619213|Randomized|Parallel Assignment||Treatment||Quadruple||International, Double-blind, Randomised, Placebo-Controlled|t|t|t|t
1298235|NCT03619200|||Cohort||Prospective|||||||
1298236|NCT03619187||Single Group Assignment||Supportive Care||None (Open Label)||This is an open-label, single-arm, multicenter study||||
1298237|NCT03619174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298238|NCT03619161|Randomized|Parallel Assignment||Treatment||Single|||||t|
1298239|NCT03619148|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"2 sub group will be recruited:~patient undergoing TOE~Staff volunteers"||||
1298240|NCT03619135|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1298241|NCT03619122|Randomized|Parallel Assignment||Screening||Single|||t|||
1298242|NCT03619109|||Other||Cross-Sectional|||||||
1298243|NCT03619096|Randomized|Single Group Assignment||Treatment||Triple|The participants and the outcomes Assessor are masked about the surgical technique that was performed. The surgical technique ir randomized in accordance with the arch side of each patient, so the investigator will open a envelope just before starting the incisions to know which technique will be performed.|Split Mouth clinical trial, comparing two different techniques. One side, the tunnel technique will be performed and on the other side, extended flap will be performed. Both surgical techniques will use Porcine Collagen Matrix.|t||t|t
1298244|NCT03619083|||Cohort||Prospective|||||||
1298245|NCT03619070|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298246|NCT03619057|||Cohort||Prospective|||||||
1298247|NCT03619044||Single Group Assignment||Other||None (Open Label)||||||
1298248|NCT03619031|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1298249|NCT03619018|||Cohort||Prospective|||||||
1298250|NCT03619005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298251|NCT03618992|Non-Randomized|Single Group Assignment||Treatment||Single||Randomized control split body study|t|||
1298252|NCT03618979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298253|NCT03618966|Randomized|Parallel Assignment||Treatment||Triple|All the electrophysiological experiments will be performed in double-blind fashion.|Patients will be randomized in two groups by receiving a sequential number according to a from a computer-generated random list. A first group will receive a real stimulation (rNMMS) of the right arm and a sham stimulation (sNMMS) of the left arm; a second group received a rNMMS of the left arm and a sNMMS of the right arm. Every cycle of stimulation will last two weeks. All patients will undergo a medial nerve conduction study (NCS) and a clinical evaluation before and at the end of the treatment and another evaluation after two weeks after the end of treatment. Clinical examination will include i) handgrip strength test for the measure of maximal isometric strength of hand and flexor forearm muscles; ii) MRC Muscle Scale for manual muscular testing of the upper limbs. At the end of the stimulation procedure, a needle muscle biopsy under a local anesthetic will be performed bilaterally from flexor carpi radialis muscle for histological, physiological and molecular studies.|t|t|t|
1298254|NCT03618953|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298255|NCT03618940||Single Group Assignment||Prevention||None (Open Label)||||||
1298256|NCT03618927|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298257|NCT03618914|||Case-Only||Prospective|||||||
1298258|NCT03618901|Randomized|Parallel Assignment||Other||Triple||"The early start group: 12-weeks (intervention) followed by 12-weeks of no exercise.~The delayed start group: 12-weeks (no exercise) followed by 12-weeks (intervention).~This model will be used for both RSB and PD SAFEx."|t||t|t
1298259|NCT03618888|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Parallel Assignments||||
1298260|NCT03618875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298261|NCT03618862|||Cohort||Prospective|||||||
1298262|NCT03618849|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dosage-escalation study||||
1298263|NCT03618836|||Case-Control||Prospective|||||||
1298264|NCT03618823|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|Experimental, open-label randomized control trial.||||
1298265|NCT03618810|||Cohort||Prospective|||||||
1298266|NCT03618797|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1298267|NCT03618784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298274|NCT03618693|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, parallel group, single centre, interventional, active controlled trial||||
1298275|NCT03618680|||Cohort||Prospective|||||||
1298276|NCT03618667||Single Group Assignment||Treatment||None (Open Label)||||||
1298277|NCT03618654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298278|NCT03618641||Sequential Assignment||Treatment||None (Open Label)||||||
1298279|NCT03618628||Single Group Assignment||Other||None (Open Label)||||||
1298280|NCT03618615|||Cohort||Prospective|||||||
1298281|NCT03618602|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1298282|NCT03618589|Randomized|Parallel Assignment||Treatment||Single|||||t|
1298283|NCT03618576||Single Group Assignment||Treatment||None (Open Label)||||||
1298284|NCT03618563|Randomized|Crossover Assignment||Treatment||Single|After the baseline evaluation, participants were randomly assigned to Intervention Group A or B by block randomization. For example, the first participant was allocated to Group A, the second to Group B, third to Group A, and so forth (Jadad 1998). Participants did not know to which group they belonged and had not contact with other participants during all study phases. Further, the OT who performed the participant evaluations was blinded to their treatment allocations.|The study was designed as a randomized controlled and crossover trial to evaluate the efficacy of the treatment among adolescents with EF deficits in their daily performance. The first Intervention Group (A) received the FITTED intervention. After a crossover switching trial, the second Intervention Group (B) received the FITTED intervention in order (Fig 1). An OT performed all four evaluations (Phases 1, 1a, 2, and 3) in similar environmental conditions. Another OT performed the intervention process according to the protocol. The Ethics Committee of the University of Haifa approved the study.|t|||
1298285|NCT03618550||Single Group Assignment||Treatment||None (Open Label)||This is a phase II study evaluating pembrolizumab plus gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in transplant eligible patients with relapsed or refractory Hodgkin lymphoma following failure of 1-line of multi-agent chemotherapy.||||
1298286|NCT03618537||Single Group Assignment||Treatment||None (Open Label)||This is a Phase II open-label study.||||
1298287|NCT03618524||Single Group Assignment||Basic Science||None (Open Label)||||||
1298288|NCT03618511|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1298289|NCT03618498||Sequential Assignment||Treatment||None (Open Label)||A 25-gauged blunt-tipped needle connected with Viscoat® (Alcon laboratories, Fort Worth, TX, USA) containing syringe was placed within the macular hole just below the level of the macular hole. A small amount of Viscoat® was injected into and around the hole. An ICG solution (25 mg ICG in 15 ml 5% glucose-water solution, final concentration = 1.7 mg/ml) was then carefully applied around the macular hole within the arcade.Excessive ICG was immediately removed by suction. ILM at the parafoveal area was peeled in a circular fashion. Care was taken not to peel the ILM flap across the hole edge. If possible, at least 1.5 to 2 disc area of partially detached ILM around the hole was left in place with central part remained attached to the edge of the hole.||||
1298290|NCT03618485|||Case-Only||Prospective|||||||
1298291|NCT03618472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298292|NCT03618459|||Cohort||Prospective|||||||
1298293|NCT03618446|||Cohort||Retrospective|||||||
1298294|NCT03618433|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1298295|NCT03618420||Single Group Assignment||Diagnostic||None (Open Label)||All study participants will receive the same intervention.||||
1298296|NCT03618407|||Case-Only||Retrospective|||||||
1298297|NCT03618394|||Case-Control||Prospective|||||||
1298298|NCT03618381|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298299|NCT03618368|Randomized|Parallel Assignment||Other||Single|blinded group: as dialyzers are almost identical except for their labels, blinding is achieved by masking dialyzer labels.|"1 blinded group on THERANOVA-500 dialyzer~1 blinded group on REVACLEAR-400 dialyzer~1 non-blinded group on THERANOVA-500 dialyzer~1 non-blinded group on REVACLEAR-400 dialyzer"|t|||
1298300|NCT03618355|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Oral administration with consecutive enrollment of overlapping dose-escalation cohorts, total treatment period 3 months. Patients will conclude treatment with previously scheduled standard of care prostate biopsy. With a single site screening patients into the cohorts at a rate of 3 patients every 6 weeks (4 weeks dosing and 2 weeks safety assessment), a new cohort will start approximately every 6 weeks. Therefore, if each cohort of 3 patients are pre-screened and there are no dose limiting toxicities (DLT), the 4th and final dose cohort will be enrolled at approximately 18 weeks. Each patient will be on study for 6 months; therefore, 10-11 months will be the shortest time for trial completion. Given unforeseen delays, we anticipate the trial to take approximately one year to complete.||||
1298301|NCT03618342|||Case-Control||Prospective|||||||
1298302|NCT03618329|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1298303|NCT03618316||Single Group Assignment||Other||None (Open Label)||||||
1298304|NCT03618303||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298305|NCT03618290|||Cohort||Prospective|||||||
1298306|NCT03618277||Single Group Assignment||Basic Science||None (Open Label)||||||
1298307|NCT03618264|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1298308|NCT03618251|||Other||Prospective|||||||
1298309|NCT03618238||Single Group Assignment||Treatment||None (Open Label)||drug||||
1298310|NCT03618225|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298311|NCT03618212|||Case-Only||Prospective|||||||
1298361|NCT03617562|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1298362|NCT03617549|||Cohort||Prospective|||||||
1298363|NCT03617536|Randomized|Parallel Assignment||Treatment||Double|"CR845 will be provided as enteric-coated tablets. All tablets are white in color with no markings and are identical in appearance, regardless of dose.~CR845 tablets will be provided at doses of 0.25, 0.5, and 1 mg."|Randomized, double-blind, placebo controlled study|t||t|
1298364|NCT03617523|Randomized|Parallel Assignment||Prevention||None (Open Label)||The study is partially randomized. Subjects are assigned a vaccine group based on age. Groups 1, 2 and 5 are not randomized, while Groups 3 and 4 are randomized.||||
1298440|NCT03616522|||Cohort||Prospective|||||||
1298312|NCT03618199|Non-Randomized|Sequential Assignment||Prevention||Single|"Subject in both phases will immediately know whether the transcranial vibrating system is on.~Analysis of outcomes (1-dizziness, 2-nausea, 3-clinical measures from vestibular nystagmography resulting from the caloric testing) will be blinded."|"First phase: test 20 subjects. They will undergo the caloric testing part of the standard vestibular testing, with and without our transcranial vibration system (10 with device on then off, 10 with device off then on) and will describe their state on a visual analog scale (both dizziness and nausea) at the end.~Success is 1) substantially reduced dizziness ad nausea, 2) statistically unchanged clinical measures.~If (and only if) the first phase is successful, we proceed to the second phase. Second phase: identical to first phase, but is conducted with patients coming in the clinic for vestibular testing.~The order (device on first, or second) will be randomly assigned."||||t
1298313|NCT03618186|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1298314|NCT03618173|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1298315|NCT03618160|Randomized|Sequential Assignment||Other||Double|||t||t|
1298316|NCT03618147|||Cohort||Other|||||||
1298317|NCT03618134|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298318|NCT03618121|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298319|NCT03618108|Randomized|Parallel Assignment||Treatment||Quadruple|Identical placebo capsule dosing||t|t|t|t
1298320|NCT03618095||||||||||||
1298321|NCT03618082|Randomized|Parallel Assignment||Prevention||Single||Randomization in 2 groups 1- control group : patients receiving a general anesthesia with propofol, ketamine and remifentanil with or without curare for the induction, desflurane, remifentanil (curare or not) for the maintenance, the dosage of the anesthetic agents will be decided by the anesthesiologist responsible for the patient based on the usual practice. 2- experimental group : patients receiving a general anesthesia with propofol, ketamine and remifentanil with or without curare for the induction, desflurane, remifentanil (curare or not) for the maintenance, administered according to a specific algorithm. In this group, the remifentanil administration will be piloted by the ANI (50 to 80), as well as the prophylactic administration of morphine at the end of the intervention. Administration of 2mg of morphine immediately before the extubating if ANI<50. And, desflurane will be administered with a targeted purpose of 0.8 to 1.2 MAC.|t|||
1298322|NCT03618069|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1298323|NCT03618056||Single Group Assignment||Prevention||None (Open Label)||||||
1298324|NCT03618043||Single Group Assignment||Treatment||None (Open Label)||||||
1298325|NCT03618030|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1298326|NCT03618017|Randomized|Parallel Assignment||Supportive Care||Triple|Participants will be randomized to the intervention (website) or control (informational template) after completing an online questionnaire; they will not be informed of which arm of the study they are participating. The allocation of participants will be masked for the investigator and outcomes assessor.|A randomized control pilot trial of a web-based, personalized navigation tool to support the continuing and team-based care of early-stage breast cancer patients who have completed their primary cancer treatment. Patients will be randomized to either the intervention (n=30), a personalized website that guides team-based, survivorship care or to the control (n=30), an static online survivorship care plan.|t||t|t
1298327|NCT03618004|Randomized|Parallel Assignment||Treatment||Single||||||t
1298328|NCT03617991|Randomized|Parallel Assignment||Treatment||Single||||||t
1298329|NCT03617978|Randomized|Crossover Assignment||Treatment||Single|participants will not be able to see the device measuring the hemodynamic parameters||t|||
1298330|NCT03617965|||Cohort||Prospective|||||||
1298331|NCT03617952|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298332|NCT03617939|||Case-Control||Prospective|||||||
1298333|NCT03617926|Randomized|Sequential Assignment||Treatment||Double|||||t|t
1298334|NCT03617913||Single Group Assignment||Treatment||None (Open Label)||||||
1298335|NCT03617900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298336|NCT03617887|Randomized|Parallel Assignment||Treatment||Single||25 subjects will be randomized into both groups: experimental and control||||t
1298337|NCT03617874|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1298338|NCT03617861|Randomized|Crossover Assignment||Diagnostic||Double|Blinded||t||t|
1298339|NCT03617848|||Cohort||Prospective|||||||
1298340|NCT03617835||Single Group Assignment||Treatment||None (Open Label)||||||
1298341|NCT03617822||||||||||||
1298342|NCT03617809|||Cohort||Prospective|||||||
1298343|NCT03617796|||Cohort||Prospective|||||||
1298344|NCT03617783|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1298345|NCT03617770|Randomized|Parallel Assignment||Treatment||None (Open Label)||Sleep optimization intervention will be compared to a healthy living attention control||||
1298346|NCT03617757||Single Group Assignment||Health Services Research||None (Open Label)||Prospective and Cohort study (Compare different cohorts)||||
1298347|NCT03617744|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 randomization to group a or group b||||
1298348|NCT03617731|Randomized|Parallel Assignment||Treatment||None (Open Label)||2 x 2 arms, 1. randomization before induction therapy (arm IA and IB), 2. randomization before maintenance therapy (arm IIA and IIB)||||
1298349|NCT03617718||Single Group Assignment||Diagnostic||None (Open Label)||All participants will go through the same study procedures.||||
1298350|NCT03617705|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1298351|NCT03617692|||Cohort||Prospective|||||||
1298352|NCT03617679|Randomized|Parallel Assignment||Treatment||Double||Active ingredient vs placebo|t||t|
1298353|NCT03617666||Single Group Assignment||Treatment||None (Open Label)||||||
1298354|NCT03617653|Randomized|Parallel Assignment||Other||Single||||||t
1298355|NCT03617640|||Cohort||Prospective|||||||
1298356|NCT03617627|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1298357|NCT03617614|||Cohort||Prospective|||||||
1298358|NCT03617601|||Cohort||Retrospective|||||||
1298359|NCT03617588||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298360|NCT03617575|Randomized|Crossover Assignment||Treatment||Single|||t|||
1298366|NCT03617497|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||The investigators will perform 48-hour ambulatory scalp-EEG and polysomnography in 100 participants with Alzheimer disease and 30 age-and gender-matched healthy participants. The investigators will determine the prevalence of 1.) epileptic discharges and epileptic seizures, 2.) sleep wake disorders and 3.) the interaction of epilepsy and sleep wake disorders in these two groups. A subgroup of 15 of these 100 participants with Alzheimer disease, with interictal epileptic spikes or sleep wake disorders (e.g., frequent nocturnal awakenings) will be invited to undergo an invasive EEG study with foramen ovale electrodes to determine the prevalence of hippocampal seizures, which are usually clinically silent and not detected with scalp EEG.||||
1298367|NCT03617484||Single Group Assignment||Treatment||None (Open Label)||||||
1298368|NCT03617471|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1298369|NCT03617458|Randomized|Factorial Assignment||Treatment||Triple|The investigators propose a phase II, 2x2 factorial randomized, blinded trial testing metformin versus placebo and a mobile health intervention (mHealth) versus usual care of 12 weeks.|This is a phase II, 2x2 factorial randomized, blinded trial testing metformin versus placebo and a mHealth intervention (mHealth) versus usual care of 12 weeks.||t|t|t
1298370|NCT03617445|Randomized|Parallel Assignment||Treatment||Quadruple||This is a phase 2, double blind, double dummy, randomized, placebo controlled trial assessing the treatment effects of FMT compared to oral Vancomycin for recurrent CDI in solid organ transplant recipients.|t|t|t|t
1298371|NCT03617432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298372|NCT03617419||Sequential Assignment||Device Feasibility||None (Open Label)||This study is being done to evaluate and gather feasibility data and user feedback on the use of the Vscan Access R2 device in vivo on pregnant volunteers in their 2nd and 3rd Trimester. The study will be conducted in two parts, including an initial pilot for determination of parameters (Part 1) and continued testing (Part 2).||||
1298373|NCT03617406||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298374|NCT03617393|||Cohort||Prospective|||||||
1298375|NCT03617380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298376|NCT03617367||Single Group Assignment||Treatment||None (Open Label)|not applicable (open label)|This is a Phase 3, open-label, multi-center trial to evaluate the long-term safety, efficacy, and immunogenicity of up to four continuous treatment cycles of daxibotulinumtoxinA (DAXI) for injection with up to four different doses in adults with isolated cervical dystonia (CD).||||
1298377|NCT03617354|||Cohort||Prospective|||||||
1298378|NCT03617341|||Cohort||Prospective|||||||
1298379|NCT03617328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298380|NCT03617315|Randomized|Parallel Assignment||Treatment||Double|The patients did not know the artificial tear that should be applied. The researcher in charge of processing the results and drawing the conclusions did not know the name of the artificial tears|Contralateral Eye Study|t|||t
1298381|NCT03617302|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298382|NCT03617289|Randomized|Single Group Assignment||Treatment||Single|||t|||
1298383|NCT03617276|||Cohort||Prospective|||||||
1298384|NCT03617263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298385|NCT03617250|||Case-Control||Prospective|||||||
1298386|NCT03617237|||Case-Only||Retrospective|||||||
1298387|NCT03617224||Single Group Assignment||Treatment||None (Open Label)||||||
1298388|NCT03617211|||Other||Cross-Sectional|||||||
1298389|NCT03617198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298390|NCT03617185|Randomized|Parallel Assignment||Treatment||Single|The neuropathy outcomes assessors will be blinded to the exercise protocol that the patients are randomized to and the surgical status for the duration of the study.|Patients will be assigned to one of 4 arms, bariatric surgery/HIIT, bariatric surgery/routine exercise, no bariatric surgery/HIIT, no bariatric surgery/routine exercise.||||t
1298391|NCT03617172|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1298392|NCT03617159|||Case-Crossover||Prospective|||||||
1298393|NCT03617146|Randomized|Parallel Assignment||Supportive Care||Single|Due to the nature of the behavioral intervention, neither participants nor clinic staff can be blinded to allocation. However, to avoid bias in assessing outcomes, the analyst who will abstract the outcomes data from the electronic health record will not have access to information about the allocation. Hence retrieval of data on baseline and follow up diabetes distress scores, HbA1c, and diabetes self-management behaviors, and the creation of the analysis dataset will be done without knowledge or consideration of allocation status.|Two-arm parallel randomized controlled trial||||t
1298394|NCT03617133||Single Group Assignment||Treatment||None (Open Label)||Interventional, observational, validation study to EMBRACE I||||
1298395|NCT03617120||Single Group Assignment||Treatment||None (Open Label)||||||
1298396|NCT03617107|||Cohort||Retrospective|||||||
1298397|NCT03617094|Randomized|Parallel Assignment||Other||Single||||||t
1298398|NCT03617081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298399|NCT03617068|Randomized|Crossover Assignment||Prevention||Double|blinding had to be done by Clinical Research Supporting Unit Faculty of Medicine, Universitas Indonesia|Batik traditional workers with occupational hand dermatitis using emolient for prevention|t||t|
1298400|NCT03617055|||Cohort||Prospective|||||||
1298401|NCT03617029|Randomized|Parallel Assignment||Treatment||Single|||t|||
1298402|NCT03617016|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1298403|NCT03617003||Single Group Assignment||Treatment||None (Open Label)||This a prospective, single institution, non-randomized open label phase 1 study.||||
1298404|NCT03616990|Randomized|Parallel Assignment||Other||None (Open Label)||Individually-randomized, two-group parallel study||||
1298405|NCT03616977|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1298406|NCT03616964|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298407|NCT03616951|||Case-Only||Prospective|||||||
1298408|NCT03616938|Randomized|Crossover Assignment||Treatment||Single|study participant had no insight on the simulator or a cardio-monitor display||t|||
1298441|NCT03616509||Single Group Assignment||Treatment||None (Open Label)||First phase: 2m with placebo Second phase: 12 m with growth hormone||||
1298409|NCT03616925|Randomized|Parallel Assignment||Treatment||None (Open Label)||The patients for this study were selected from the outpatient section of the Department of Periodontics, KLE Society's institute of Dental Sciences, Bangalore, Karnataka. Fifteen patients, aged between 30-55 years (10 males and 5 females) diagnosed with chronic periodontitis, contributing to 30 sites were enrolled for the study by convenience sampling method. It was made clear to the potential subjects that participation was voluntary. Written informed consent was obtained from patients, and ethical clearance for the study was received from the Institutional Ethics Committee (IEC), KLE Society's institute of Dental Sciences, Bangalore. This Randomized controlled trial was carried out from November 2013 to October 2014.||||
1298410|NCT03616912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298411|NCT03616899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298412|NCT03616886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298413|NCT03616873|||Cohort||Prospective|||||||
1298414|NCT03616860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1298415|NCT03616847|Randomized|Parallel Assignment||Treatment||Double|Those collecting and analysis the data will be masked to the treatment groups. It is not possible to mask the participant or the care provider in this study|Two randomised study groups with one having standard care and the other the intervention.|||t|t
1298416|NCT03616834||Single Group Assignment||Treatment||None (Open Label)||Subjects will continue their anti-PD-1/anti-PD-L1 therapy, which they had already initiated per standard of care according to the package insert, and then initiate Tomivosertib (eFT-508) at 200 mg twice daily (bid) 7 days prior to their next scheduled anti-PD-1/anti-PD-L1 therapy.||||
1298417|NCT03616821|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1298418|NCT03616808|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"A case-control study. Conventional management patients are considered as controls whereas goal-directed management patients will be considered cases."||||
1298419|NCT03616795||Single Group Assignment||Basic Science||None (Open Label)||||||
1298420|NCT03616782||Single Group Assignment||Treatment||None (Open Label)||Ixazomib 3mg on day 1, 8, 15 q 4 weeks for 24months or untile to progression||||
1298421|NCT03616769|||Cohort||Prospective|||||||
1298422|NCT03616756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298423|NCT03616743|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial.||||
1298424|NCT03616730|||Case-Control||Prospective|||||||
1298425|NCT03616717|Randomized|Crossover Assignment||Other||Triple|UCSD Experimental Pharmacy randomizes dose order and provides masked pills|Experimental medicine model; not an intervention. Within-subject double-blind placebo-controlled dose-response study.|t||t|t
1298426|NCT03616704|||Other||Prospective|||||||
1298427|NCT03616691|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298428|NCT03616678||Single Group Assignment||Treatment||None (Open Label)||||||
1298429|NCT03616665|Randomized|Parallel Assignment||Treatment||Single|Due to the nature of interventions, masking or blinding of patients/therapists is impossible, but all assessments and data analysis will be blinded to treatment allocation. Measures to insure blinding will include locating the raters separately from the study wards, instructing patients not to mention information that could reveal their allocation, and providing back-up raters in case of unintentional unblinding. All blinded observers will be trained in all instruments. The trial statistician will be blinded to the allocated treatments during the analysis of the primary outcome. Strict concealment of randomization will be guaranteed to exclude selection bias. Since randomization of therapists is impossible, demographic and professional characteristics of therapists will be assessed.|In the proposed prospective, mono-site, evaluator-blinded, randomized-controlled study, 192 PDD patients will be included. The study addresses the primary research question: Is the six-week inpatient CBASPersonalized-treatment more effective than a six-week WLC in PDD? It is hypothesized that six weeks after randomization, CBASPersonalized will significantly outperform WLC concerning reduction in depressive symptomatology. In addition, CBASPersonalized will be compared with CBIntegrative investigating differential indication by moderator, mediator, and process analyses. A follow-up survey six months after end of treatment will provide important results on long-term treatment outcome.||||t
1298430|NCT03616652|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1298431|NCT03616639|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1298432|NCT03616626|Randomized|Parallel Assignment||Treatment||Single||||||t
1298433|NCT03616613|||Cohort||Prospective|||||||
1298434|NCT03616600|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized control trial||||
1298435|NCT03616587|Randomized|Sequential Assignment||Treatment||None (Open Label)||"This is a first-in-human study of AZD9833 monotherapy (Parts A and B) and AZD9833 in combination with palbociclib (Parts C and D) in women with ER Positive HER2 Negative advanced breast cancer that is not amenable to treatment with curative intent. Parts A and C of the study allow for an escalation of AZD9833 dose alone (Part A) or in combination with palbociclib (Part C). In Parts B and D of the study, eligible subjects will be randomised to receive selected doses of AZD9833 alone (Part B) or in combination with palbociclib (Part D).~This study will include up to 240 evaluable subjects, divided among the four study parts as follows:~Part A: Up to 96 subjects (up to eight cohorts of up to 12 subjects)~Part B: Up to 48 subjects (four cohorts with up to 12 subjects)~Part C: Up to 48 subjects (up to four cohorts of up to 12 subjects)~Part D: Up to 48 subjects (depending on the results observed in Part B)"||||
1298436|NCT03616574|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Part 1 (dose escalation) of the study will use a conventional 3+3 design (3 subjects per dose cohort, with the potential to add an additional 3 subjects if dose limiting toxicity [DLT] is observed at the same dose level at which the toxicity occurred). Enrollment will occur in 2 groups, CA102N monotherapy (Group A) and CA102N combination therapy (Group B).~Subjects will be enrolled in Group A first. Once enrollment in Group A has been completed, subsequent subjects will be enrolled in Group B.~In Part 2 of the study, the safety and tolerability of the preliminary RP2D of CA102N combined with trifluridine/tipiracil (LONSURF) will be further evaluated in up to 12 additional subjects with relapsed or refractory locally advanced or metastatic colorectal cancer who have previously received oxaliplatin and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy."||||
1298437|NCT03616561|||Cohort||Prospective|||||||
1298442|NCT03616496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298443|NCT03616483|||Cohort||Prospective|||||||
1298444|NCT03616470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298445|NCT03616457|||Cohort||Prospective|||||||
1298446|NCT03616444|Randomized|Parallel Assignment||Prevention||None (Open Label)||colorectal adenomatous polyp patients after colonoscopy under colonoscopy||||
1298447|NCT03616431|||Cohort||Prospective|||||||
1298448|NCT03616418|||Cohort||Prospective|||||||
1298449|NCT03616405||Single Group Assignment||Treatment||None (Open Label)||||||
1298450|NCT03616392|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1298451|NCT03616379|Randomized|Parallel Assignment||Other||Single|The study PI and data analyst will be blind to study condition. The experimenter will and participant will be aware of the study condition because this is a behavioral intervention.||||t|
1298452|NCT03616366|||Cohort||Prospective|||||||
1298453|NCT03616353|Randomized|Single Group Assignment||Treatment||Triple|Care provider is performing a specific type of injection and therefore cannot be blinded. Those investigators responsible for collecting, managing, and analyzing data will be blinded to treatment randomization.||t||t|t
1298454|NCT03616340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298455|NCT03616327||Single Group Assignment||Other||None (Open Label)||||||
1298456|NCT03616314|||Cohort||Retrospective|||||||
1298457|NCT03616301|Randomized|Crossover Assignment||Other||Single|This study is an open-label study; the subjects and the investigator will not be blinded towards the identity of the study products. However, analysts will be blinded towards identity of the study products administered.|||||t
1298458|NCT03616288|Randomized|Parallel Assignment||Prevention||Double|double-blinded|Randomized placebo controlled, double-blinded, four-parallel arm, multicentre trial|t||t|
1298459|NCT03616275|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1298460|NCT03616262|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1298461|NCT03616249|Randomized|Parallel Assignment||Treatment||Quadruple||The elderly are initially divided into two groups. Non-Sarcophicos Group and Sarcopenico Group. 1) Training group - who will carry out the resistance training for 12 weeks or; 20 control group - who did not participate in the training in the same period.|t|t|t|t
1298462|NCT03616236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298463|NCT03616223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298464|NCT03616210|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1298465|NCT03616197|Non-Randomized|Parallel Assignment||Treatment||Single|Determination of graft area measurements and shrinkage ratio of all photographs was performed by a periodontologist , an independent specialist who had not performed any surgical procedures.|||||t
1298466|NCT03616184||Single Group Assignment||Treatment||None (Open Label)||||||
1298467|NCT03616171|Randomized|Parallel Assignment||Prevention||None (Open Label)||Prospective, randomized and unblinded||||
1298468|NCT03616158|||Other||Other|||||||
1298469|NCT03616145|Randomized|Parallel Assignment||Treatment||Triple|Blinding. The PI, statistician, recruitment personnel, research assistants conducting the assessment sessions, and data entry/verification clerks will be blind to participant's group assignment until data is unlocked at the end of the study. Only the Project Manager who will develop and oversee the randomization procedure, prepare progress reports, and inform participants of their treatment condition will be unblinded.|The overall design proposed in this study is a randomized, placebo controlled, single-blind controlled trial. Data will be collected in this developmental study to assess potential differences in gait, balance, and quality of life of patients in the intervention arm (6-week OMT intervention coupled with standard of care (SOC) versus the light touch comparator arm (6-week light touch coupled with SOC) versus the non-intervention control arm (SOC alone).|t||t|t
1298470|NCT03616132||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1298471|NCT03616119|||Cohort||Prospective|||||||
1298472|NCT03616106||Single Group Assignment||Health Services Research||None (Open Label)||This study will use a single group pretest-posttest design to evaluate if using infographics during clinic visits can lead to improved patient outcomes.||||
1298473|NCT03616093|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1298474|NCT03616080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||all were ambulatory children with CP age 5-12 years old.||||
1298475|NCT03616067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298476|NCT03616054|||Cohort||Prospective|||||||
1298477|NCT03616041|||Cohort||Prospective|||||||
1298478|NCT03616028||Single Group Assignment||Device Feasibility||None (Open Label)||This is a prospective, multicenter, open-label single arm first in human study aimed at examining the performance of the CLAAS device for LAA closure.||||
1298479|NCT03616015||Single Group Assignment||Basic Science||None (Open Label)||||||
1298480|NCT03616002||Single Group Assignment||Other||None (Open Label)||||||
1298481|NCT03615989|Randomized|Crossover Assignment||Prevention||Single|Those completing the analyses will be masked to the treatments.|Randomized acute Crossover Trial||||t
1298482|NCT03615976||Single Group Assignment||Treatment||None (Open Label)||It is prospective case series study Patients with isolated patellofemoral pain will be treated with arthroscopy and then Compare between pre and post-operative results in pain reduction, improving knee joint function, quality of life, and deferring arthritic progression.||||
1298483|NCT03615963|||Cohort||Prospective|||||||
1298484|NCT03615950|||Case-Control||Prospective|||||||
1298485|NCT03615937|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1298486|NCT03615924|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1298487|NCT03615911|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298488|NCT03615898|||Other||Retrospective|||||||
1298489|NCT03615885|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1298490|NCT03615872|||Cohort||Prospective|||||||
1298491|NCT03615859|||Cohort||Cross-Sectional|||||||
1298492|NCT03615846|||Cohort||Prospective|||||||
1298493|NCT03615833||Single Group Assignment||Treatment||None (Open Label)||||||
1298494|NCT03615820|Randomized|Parallel Assignment||Treatment||None (Open Label)||Volunteers will be divided into two groups; each group contained 12 volunteers who will receive one formula of the selected formulae||||
1298495|NCT03615807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298496|NCT03615794|||Case-Control||Prospective|||||||
1298497|NCT03615781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298498|NCT03615768|Randomized|Parallel Assignment||Treatment||Single||||||t
1298499|NCT03615755|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1298500|NCT03615742|Randomized|Crossover Assignment||Prevention||Triple|Blinding of exposures will be performed by the air pollution exposure laboratory (APEL) engineer, who will not interact with volunteers. Visually indistinguishable placebo and budesonide inhalers will be coded by research pharmacy staff. All assays will be performed by personnel who do not know the exposure conditions of individual samples.|Volunteers will visit our lab four different times to be exposed to: 1) placebo & filtered air, 2) placebo & diesel exhaust, 3) budesonide and filtered air, and 4) budesonide and diesel exhaust|t||t|t
1298501|NCT03615729|||Case-Control||Retrospective|||||||
1298502|NCT03615716|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The study has 2 groups of participants. Only one group, middle school boys (N=20), will receive the intervention. But, pre- and post-assessments will be conducted with 2 groups: (1) boys, (2) caregivers. Caregivers (N=20) will give their perspectives of boys' behavior pre- and post- intervention.||||
1298503|NCT03615703|||Other||Other|||||||
1298504|NCT03615690||Single Group Assignment||Treatment||None (Open Label)|Patients will be assigned a unique code that will be associated with their data to maintain masking|Single group assignment||||
1298505|NCT03615677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298506|NCT03615664||Single Group Assignment||Treatment||None (Open Label)||||||
1298507|NCT03615651|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1298508|NCT03615638|Randomized|Parallel Assignment||Treatment||Triple|The orthopedic surgeons, outcomes assessor and statistician will be blinded.|Single-blinded 3-arm randomized controlled trial||t|t|t
1298509|NCT03615625|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1298510|NCT03615612|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1298511|NCT03615599|||Cohort||Prospective|||||||
1298512|NCT03615586|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1298513|NCT03615573|||Cohort||Prospective|||||||
1298514|NCT03615560|||Cohort||Cross-Sectional|||||||
1298515|NCT03615547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298516|NCT03615534|Randomized|Factorial Assignment||Treatment||Single|||t|||
1298517|NCT03615521|Randomized|Crossover Assignment||Treatment||Single|||t|||
1298518|NCT03615508||Single Group Assignment||Other||None (Open Label)||Single arm, intervention trial.||||
1298519|NCT03615495|||Case-Only||Prospective|||||||
1298520|NCT03615482|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1298521|NCT03615469|Randomized|Parallel Assignment||Treatment||Quadruple|The PI will collect baseline data before the participant is randomized. The intervention/sham will be set-up by the RA and will be collected after the PI leaves the department so those collecting data will not know which group the participant has been/will be participating in. The RA who is trained in both NMES and Sham intervention will then look at the randomization schedule, and set up and train the participants on equipment use. Once trained, participants will be contacted via phone weekly by the RA who initially trained them (in order to maintain blinding). The RA applying the intervention will not have any part in the data collection of the rest of the measurements (other than adherence, tolerance and problems with equipment).|This is a double blinded, randomized controlled longitudinal study design to determine if NMES will increase muscle mass and strength, decrease sitting and lying time, and improve HF symptoms and exercise capacity thus improving likelihood of engagement with a structured exercise program. Patients will be randomized to either intervention that includes NMES or to a sham(TENS)/wait list control group. In order to ensure that the two groups are comparable between treatment and sham interventions, the participants will be randomized according to gender. Randomization via minimization will be used in order to avoid an unbalanced number of women in the two comparison groups due to chance. A file of the computer-generated random assignments will be kept by the research assistant so the PI/data collector remains blinded in a protected Box Health account.|t|t|t|t
1298522|NCT03615456|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298523|NCT03615443||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298524|NCT03615430|Randomized|Parallel Assignment||Treatment||Single|||t|||
1298525|NCT03615417|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298526|NCT03615404||Single Group Assignment||Treatment||None (Open Label)||||||
1298527|NCT03615391|||Cohort||Retrospective|||||||
1298528|NCT03615378|Randomized|Parallel Assignment||Treatment||Double||Prospective, randomized controlled trial|t|||t
1298529|NCT03615365|||Case-Only||Prospective|||||||
1298530|NCT03615352|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1298531|NCT03615339||Single Group Assignment||Basic Science||None (Open Label)|Unlabelled bottles of treatment|||||
1298532|NCT03615326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298533|NCT03615313||Single Group Assignment||Treatment||None (Open Label)||||||
1298534|NCT03615300|||Cohort||Prospective|||||||
1298535|NCT03615287|||Other||Prospective|||||||
1298536|NCT03615274|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1298537|NCT03615261||Single Group Assignment||Treatment||None (Open Label)||||||
1298538|NCT03615248||Single Group Assignment||Other||None (Open Label)||||||
1298539|NCT03615235|||Cohort||Prospective|||||||
1298631|NCT03614039|Randomized|Parallel Assignment||Treatment||Triple|Randomization was done by the study statistician based on a computer-generated list. The groups were homogeneous according to age, sex and diagnostic criteria. The assignment of groups was blind to participants, research staff and outcome assessors moreover, to maintain blind parallel study the statistician was not aware of the allocation of participants to intervention.||t||t|t
1573328|NCT00001587||||Treatment||||||||
1298540|NCT03615222|Randomized|Parallel Assignment||Treatment||Single|Assessors blind to treatment condition will complete the final assessment that includes clinical interviews.|Procedures for Successive Cohort Design (SCD) study: Stage 1: Adaptation. Two cohorts (n = 5) of functionally impaired Veterans will be treated during the adaptation and refinement stages. Clinician and Veteran qualitative feedback will guide modifications to the treatment. Veteran qualitative interviews will be conducted post-treatment and then coded and analyzed. Qualitative findings will be used to guide modifications. Stage 2: Treatment refinement. Using the revised manual, the investigators will treat a second cohort and follow the same methods described in Stage 1 to guide additional modifications. Stage 3: Pilot RCT. The investigators will conduct a pilot RCT of the modified ACT-FX protocol compared to mental health treatment as usual (TAU) with 30 treatment completers per group. The goals are to evaluate feasibility and acceptability.||||t
1298541|NCT03615209|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1298542|NCT03615196|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1298543|NCT03615183|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1298544|NCT03615170|||Cohort||Prospective|||||||
1298545|NCT03615157|Randomized|Parallel Assignment||Treatment||None (Open Label)||The participants will be randomized in two groups: Home-based and Supervised exercise groups||||
1298546|NCT03615144|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||For this trial, patients will be assigned to receive one of two conditioning regimens, based on their disease, disease severity, organ status and history of red blood cell alloimmunization.||||
1298547|NCT03615131|||Cohort||Prospective|||||||
1298548|NCT03615118|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1298549|NCT03615105|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will receive one of three myeloablative conditioning regimens followed by a Alpha/beta+ T-cell depleted peripheral blood stem cell product and short course tacrolimus. Donors are HLA mismatched unrelated adults or haploidentical family members.||||
1298550|NCT03615092|Non-Randomized|Parallel Assignment||Treatment||Double|The clinical parameters were screened by one single examiner that was not aware of the procedures|Controlled Split-mouth clinical trial|||t|t
1298551|NCT03615079||Single Group Assignment||Supportive Care||None (Open Label)||||||
1298552|NCT03615066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298553|NCT03615053||Single Group Assignment||Other||None (Open Label)||The PMCH study is a Canadian multicentre, open-label, historically-controlled clinical trial to evaluate the effects of implementing WAPPS-Hemo PopPK-based tailoring of hemophilia prophylaxis regimens using the tailoring dosing function of the WAPPS-Hemo system (WAPPS-Hemo clinical calculator). The study has a non-inferiority design for the primary efficacy and safety outcomes.||||
1298554|NCT03615040|Randomized|Parallel Assignment||Treatment||Quadruple|A or B|Single- centre, double-blinded, placebo- controlled, parallel group, randomised controlled trial|t|t|t|t
1298555|NCT03615027||Single Group Assignment||Supportive Care||None (Open Label)||This clinical trial has a sigle arm: all the dyads will go through the four visits.||||
1298556|NCT03615014||Single Group Assignment||Other||None (Open Label)||||||
1298557|NCT03615001||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298558|NCT03614988|Randomized|Crossover Assignment||Treatment||Single||||||t
1298559|NCT03614975|Randomized|Parallel Assignment||Prevention||None (Open Label)||1:1 RCT allocation to one of two influenza vaccines: Flucelvax or Fluzone.||||
1298560|NCT03614962|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1298561|NCT03614949||Single Group Assignment||Treatment||None (Open Label)||||||
1298562|NCT03614936|||Cohort||Prospective|||||||
1298563|NCT03614923|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1298564|NCT03614910|||Cohort||Prospective|||||||
1298565|NCT03614897||Single Group Assignment||Prevention||None (Open Label)||||||
1298566|NCT03614884|Randomized|Parallel Assignment||Treatment||None (Open Label)||A two-arm randomized controlled trial (RCT) will be conducted to evaluate the proposed online intervention. Eligible participants will be randomized to either the online integrated gambling and smoking treatment condition, or the gambling only (i.e., control) condition.||||
1298567|NCT03614871|||Cohort||Retrospective|||||||
1298568|NCT03614858||Single Group Assignment||Treatment||None (Open Label)||||||
1298569|NCT03614845|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298570|NCT03614832|Randomized|Parallel Assignment||Treatment||Single|||||t|
1298571|NCT03614819|Randomized|Parallel Assignment||Prevention||None (Open Label)|No masking|"Diode laser group Prophylaxis of the selected region for the study and application of diode laser (Sirolaser, Sirona Dental Systems GmbH, Bensheim, Germany) with wavelength of 970 nm +/- 10 nm, maximum power of 7 W CW, 1mW guide beam and 320μm optical fiber. Irradiation will be performed on the entire occlusal surface in contact mode, with power of 0.7 W and frequency of 10 Hz for 30 seconds, having an energy density of 222.82 J / cm2.~Glass Ionomer Sealing Group Prophylaxis of the selected region for the study, followed by relative insulation with cotton rollers of the tooth in question, application of acid polyacrylic for 15 seconds throughout the surface, light drying with cotton ball, insertion of the high viscosity glass ionomer (Equia Forte in capsule - GC) through a specific applicator, after loss of the gloss of the digital pressure material with Vaseline for due drainage and surface protection of the material."||||
1298572|NCT03614806||Single Group Assignment||Diagnostic||None (Open Label)||open label study prospective||||
1298573|NCT03614793|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1298574|NCT03614780||Single Group Assignment||Basic Science||None (Open Label)||||||
1298575|NCT03614767|||Cohort||Prospective|||||||
1298576|NCT03614754|||Cohort||Prospective|||||||
1298577|NCT03614741|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1298578|NCT03614728|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1298579|NCT03614715|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1298580|NCT03614702|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1298581|NCT03614689|||Cohort||Prospective|||||||
1298632|NCT03614026|Randomized|Parallel Assignment||Treatment||None (Open Label)||Intervention condition and business-as-usual control condition||||
1298582|NCT03614676|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||Single Group Assignment is selected because this is a low-interventional, epidemiological study. As such, the study does not have multiple groups/treatment arms that will be compared against one another statistically in the way two study arms would be compared against each other in a clinical trial. Instead, the study will longitudinally follow pregnant women through a 42-day post-delivery period and will also follow the infants born to these women. It should be noted that these are the two populations listed in the protocol, but these are not two groups that will compared against one another. Statistical analyses will be conducted within each group and some analyses will be done across the two groups. However, these two groups should not be considered equivalent to two study arms. This explains why a single group assignment is appropriate while two study groups (mothers and infants) will be examined.||||
1298583|NCT03614663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298584|NCT03614650||Single Group Assignment||Treatment||None (Open Label)||||||
1298585|NCT03614637|||Other||Prospective|||||||
1298586|NCT03614624||Single Group Assignment||Prevention||None (Open Label)|No masking description|All the healthy volunteers who consent to participate in the study, and who are eligible according to the protocol will have an clinical examination, an electrocardiogram and an echocardiography with two devices.||||
1298587|NCT03614611||Single Group Assignment||Treatment||None (Open Label)||"Participants who accept to take part in this study will be assigned to the intervention group. There will be no randomisation or controlled group.~This study will be taking place in Canada, with the intervention device being approved by Health Canada (Licence No.: 98950, Company ID: 134089, Device identifier: SKU 184)"||||
1298588|NCT03614598|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1298589|NCT03614585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298590|NCT03614572|Randomized|Parallel Assignment||Other||Single|The assessor will be blinded to the condition of the subjects|||||t
1298591|NCT03614559|||Cohort||Retrospective|||||||
1298592|NCT03614546|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298593|NCT03614533|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1298594|NCT03614520|Randomized|Crossover Assignment||Health Services Research||None (Open Label)|The subjects, because of the wine taste that cannot be hidden, will know what they drink, except from the three beers (the three types will not be distinguishable).|A 40 people group of healthy men and women. Two Cohorts group of 20 healthy volunteers of both genders.||||
1298595|NCT03614507|Randomized|Parallel Assignment||Treatment||None (Open Label)|The technology used does not allow blinding.|"This is a multicenter, prospective, randomized, open-label study. Patients will then be randomized to either the FreeO2 Arm or the Manual Arm for Oxygen Therapy with Manual Flow Adaptation."||||
1298596|NCT03614494|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1298597|NCT03614481|||Cohort||Prospective|||||||
1298598|NCT03614468|Randomized|Parallel Assignment||Treatment||Quadruple|This study is a randomized, controlled, double-blind, study of healthy term formula fed (FF) infants.|Formula feed infants will be randomized to receive either a new infant formula formulated for healthy term infants (Formula A) or a commercially available infant formula for healthy term infants (Formula B). Infants will consume the formula for a total of 26-weeks.|t|t|t|t
1298599|NCT03614455|Randomized|Sequential Assignment||Basic Science||None (Open Label)||Prior to dosing on Day 1 of Treatment Period 1, subjects will be assigned to 1 of 2 sequences (sequences AB or AC), according to a pre-generated randomization scheme.||||
1298600|NCT03614442|Randomized|Parallel Assignment||Treatment||Quadruple|the design of the dental implant||t|t|t|t
1298601|NCT03614429|Randomized|Parallel Assignment||Prevention||None (Open Label)||Comparative experimental (interventional) controlled study||||
1298602|NCT03614416||Single Group Assignment||Other||None (Open Label)||No randomisation. All subjects will test simultaneously the gold standard and the EOXY device||||
1298603|NCT03614403|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1298604|NCT03614390||Single Group Assignment||Treatment||None (Open Label)||||||
1298605|NCT03614377|||Cohort||Prospective|||||||
1298606|NCT03614364||Single Group Assignment||Treatment||None (Open Label)||||||
1298607|NCT03614351|Randomized|Parallel Assignment||Supportive Care||Single|Physical therapy staff will be blinded.|||t||
1298608|NCT03614338||Single Group Assignment||Treatment||None (Open Label)||||||
1298609|NCT03614325|Randomized|Parallel Assignment||Treatment||Single||||||t
1298610|NCT03614312|||Cohort||Prospective|||||||
1298611|NCT03614299|||Cohort||Prospective|||||||
1298612|NCT03614286|||Other||Other|||||||
1298613|NCT03614273|Randomized|Parallel Assignment||Treatment||Single|||t|||
1298614|NCT03614260|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1298615|NCT03614247|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients who had a lower calyceal stone between 1cm and 2cm in size||||
1298616|NCT03614234||Single Group Assignment||Treatment||None (Open Label)||Open-label extension study||||
1298617|NCT03614221|Randomized|Crossover Assignment||Treatment||Single||||||t
1298618|NCT03614208|Randomized|Parallel Assignment||Treatment||Single||Single blind RCT with two parallel group|||t|
1298619|NCT03614195|Randomized|Parallel Assignment||Treatment||Single||||||t
1298620|NCT03614182|Randomized|Parallel Assignment||Treatment||Single||||||t
1298621|NCT03614169|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1298622|NCT03614156|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298623|NCT03614143|||Cohort||Prospective|||||||
1298624|NCT03614130||||||||||||
1298625|NCT03614117|Randomized|Parallel Assignment||Prevention||Quadruple||This is an interventional, randomized, double-blind, placebo-controlled, parallel-group study.|t|t|t|t
1298626|NCT03614104|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1298627|NCT03614091|Randomized|Parallel Assignment||Prevention||Double|Double Blind (caregiver,outcome Assessor)|||t||t
1298628|NCT03614078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298629|NCT03614065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298630|NCT03614052|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1298634|NCT03614000||Single Group Assignment||Screening||None (Open Label)||||||
1298635|NCT03613987|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298636|NCT03613974||Single Group Assignment||Treatment||None (Open Label)|the patients and the assessment staff will not be aware with the given lidocaine concentration|||||
1298637|NCT03613961|||Cohort||Prospective|||||||
1298638|NCT03613948|||Family-Based||Cross-Sectional|||||||
1298639|NCT03613935|Randomized|Crossover Assignment||Other||None (Open Label)||This is a monocentric, controlled, randomized, open, complete crossover study design||||
1298640|NCT03613922|Randomized|Parallel Assignment||Treatment||Single||||||t
1298641|NCT03613909|Randomized|Sequential Assignment||Treatment||None (Open Label)||Repeated measures, single-subject experiment. Each subject received the same treatment.||||
1298642|NCT03613896|Non-Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1298643|NCT03613883|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1298644|NCT03613870|Randomized|Parallel Assignment||Treatment||Single||||||t
1298645|NCT03613857|||Cohort||Prospective|||||||
1298646|NCT03613844|Randomized|Parallel Assignment||Other||Quadruple||double blind and randomized placebo controlled|t|t|t|t
1298647|NCT03613831|||Case-Only||Prospective|||||||
1298648|NCT03613818|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298649|NCT03613805|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1298650|NCT03613792|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1298651|NCT03613779|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1298652|NCT03613766|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Two groups (experimental and control). Chronological order of recruitment||||
1298653|NCT03613753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298654|NCT03613740|Randomized|Parallel Assignment||Treatment||Double||Parallel Assignment|t||t|
1298655|NCT03613727||Single Group Assignment||Treatment||None (Open Label)||||||
1298656|NCT03613714|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1298657|NCT03613701|||Case-Control||Prospective|||||||
1298658|NCT03613688|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1298659|NCT03613675||Single Group Assignment||Device Feasibility||None (Open Label)||Participants will be asked to play 4 video games on asthma.||||
1298660|NCT03613662||Single Group Assignment||Treatment||None (Open Label)||||||
1298661|NCT03613649|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1298662|NCT03613636|||Cohort||Prospective|||||||
1298663|NCT03613623|||Cohort||Cross-Sectional|||||||
1298664|NCT03613610|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1298665|NCT03613597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298666|NCT03613584|Randomized|Parallel Assignment||Treatment||Double|The vWFC or placebo will be prepared by the local hospital pharmacy or independent nurses from another ward (on holidays and weekends). To keep the blinding for the treating physicians and the study team syringes and lines with light protection (orange color) will be used. So the color of the medication (colorless to slightly yellowish) cannot be distinguished.||t||t|
1298667|NCT03613571||Single Group Assignment||Treatment||None (Open Label)||||||
1298668|NCT03613558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298669|NCT03613545|Randomized|Parallel Assignment||Treatment||Single|Masking only Participant|Parallel Assignment|t|||
1298670|NCT03613532||Single Group Assignment||Treatment||None (Open Label)||||||
1298671|NCT03613519|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects who are eligible once they complete the screening questionnaire will be randomly assigned to one of the 3 intervention groups; usual care, SHUTi, or SHUTi-BW.||||
1298672|NCT03613506||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298673|NCT03613493|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1298674|NCT03613480|Randomized|Parallel Assignment||Treatment||None (Open Label)||All eligible patients will be randomized to receive either counseling sessions or care as usual||||
1298675|NCT03613467|||Case-Control||Retrospective|||||||
1298676|NCT03613454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298677|NCT03613441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298678|NCT03613428||Single Group Assignment||Treatment||None (Open Label)||Open label dosing cohorts will evaluate oral ruxolinitib (doses ranging from 10 - 80 mg) in combination with vincristine (1.4 mg/m2) and oral prednisone (1 mg/kg, 5 days a week for 4 weeks).||||
1298679|NCT03613415|Randomized|Parallel Assignment||Treatment||Double|"Each patient will be given a code by the researcher (T.A.) and the observers will be blind to which group this case belong.~Patients, evaluators and statistician will be blinded."||t|||t
1298680|NCT03613402|||Case-Control||Prospective|||||||
1298681|NCT03613389|Randomized|Parallel Assignment||Prevention||Single||||||t
1298682|NCT03613376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298683|NCT03613363||||||||||||
1298684|NCT03613350|||Case-Only||Retrospective|||||||
1298685|NCT03613337|||Case-Control||Retrospective|||||||
1298686|NCT03613324|||Case-Only||Retrospective|||||||
1298687|NCT03613311|||Case-Only||Retrospective|||||||
1298688|NCT03613298||Single Group Assignment||Treatment||None (Open Label)||||||
1298689|NCT03613285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298690|NCT03613272|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a prospective multicentre cohort study.The main study content is comparative study of the curative effect of extended thymectomy performed through the subxiphoid-right video-thoracoscopic approach with double elevation of the sternum versus intercostal video-thoracoscopic approach, divided into subxiphoid and intercostal groups. Communicating with the surgeon and patients who meet the inclusion criteria, decide whether to enter the subxiphoid or intercostal group. Subxiphoid group with subxiphoid-right video-thoracoscopic approach under double elevation of the sternum in extended thymectomy , intercostal group with traditional intercostal video-assisted thoracoscopic surgery in extended thymectomy.||||
1298691|NCT03613259||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298692|NCT03613246|||Other||Prospective|||||||
1298693|NCT03613233|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1298694|NCT03613220|Non-Randomized|Single Group Assignment||Other||None (Open Label)||This sub-protocol allows for the collection of tumor and blood samples for proteomic and ctDNA analysis respectively to better understand mechanisms of response and resistance to ribociclib therapy.||||
1298695|NCT03613207||Single Group Assignment||Treatment||None (Open Label)||||||
1298696|NCT03613194||Single Group Assignment||Other||None (Open Label)||||||
1298697|NCT03613181|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 randomization to experimental arm and comparator arm||||
1298698|NCT03613168||Single Group Assignment||Treatment||None (Open Label)||||||
1298699|NCT03613155|||Cohort||Prospective|||||||
1298700|NCT03613142|Randomized|Sequential Assignment||Treatment||Single||||||t
1298701|NCT03613129|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The study consists of a 2-week lead-in period, a first cardio-pulmonary exercise test (CPET1), a 4-week recovery period (following CPET1), a 2-week treatment period (during which drug will be administered by subcutaneous infusion on 2 separate days), a second CPET (CPET2), and a 4-week recovery period (following CPET2), followed by study exit. The study will test 3 dose-levels of the experimental drug CT38 (i.e., Low, Intermediate and High)||||
1298702|NCT03613116|Randomized|Parallel Assignment||Treatment||Quadruple|Participants receive identically appearing capsules which contain either 4,000 IU (high-dose) or 600 IU (standard-dose) of vitamin D3.|Parallel Randomized Double-Blind Intervention of high-dose versus standard-dose vitamin D3.|t|t|t|t
1298703|NCT03613103|Randomized|Parallel Assignment||Treatment||Triple|"Participants will be assigned at the time of anesthetic induction in the surgery room. The allocation to the direct laryngoscopy group and the video laryngoscopy will be 1: 1 randomly using permuted blocks, generated by a computer operated by an external assistant to the investigation. The size of the blocks will be between 4, 6, and 8.~A person external to the research group will be responsible for concealment of allocation through opaque and sealed envelopes, listed sequentially."|A single-center randomized study is performed including non-cardiac surgical patients without predictable risk of difficult mask ventilation or of difficult tracheal intubation. For direct laryngoscopy group, we use a Macintosh blade and for videolaryngoscopy group we use videolaryngoscopy highly curved blade. Induction of anesthesia is performed using myorelaxation with rocuronium. We record each five minute the vital signs in the anesthesia record. The primary outcome is observed injuries in the mucosa of the airway: Erythema, edema, ecchymosis, laceration, excoriation and / or hematoma. Injuries to dental pieces: Partial and / or total loss of tooth integrity, loosening of dental piece, damage to dental and / or aesthetic prosthetic material. Laryngeal lesions: Edema, laceration, excoriation, erythema, ecchymosis and / or bleeding pharyngeal laryngeal mucosa, arytenoid luxation. Post-intubation symptoms: Sore throat, dysphonia and / or aphonia.|t||t|t
1298704|NCT03613090|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Investigators will screen routine root canal treatment-seeking patients who present normally to clinic as potential study participants. The patients selected will be those who will require root canal therapy as a part of their routine dental care.~Participant will be randomly assigned to one or two groups:"||||
1298705|NCT03613077|||Case-Only||Prospective|||||||
1298706|NCT03613064|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1298707|NCT03613051|||Cohort||Prospective|||||||
1298708|NCT03613038||Single Group Assignment||Basic Science||None (Open Label)||Two groups of participants i.e., participants with ALS or PD and healthy controls will be asked to repeat sentences that have target words with varying phonetic complexity.||||
1298709|NCT03613025|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1298710|NCT03613012|||Case-Control||Cross-Sectional|||||||
1298711|NCT03612999||Single Group Assignment||Basic Science||None (Open Label)||||||
1298712|NCT03612986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298713|NCT03612973|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||both study groups will be investigated at same time||||
1298714|NCT03612960|Randomized|Parallel Assignment||Health Services Research||Double|Double-blind|Randomized|t||t|
1298715|NCT03612947|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1298716|NCT03612934|||Cohort||Prospective|||||||
1298717|NCT03612921|Randomized|Parallel Assignment||Prevention||Quadruple|Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)||t|t|t|t
1298718|NCT03612908|||Case-Control||Prospective|||||||
1298719|NCT03612895|Randomized|Parallel Assignment||Treatment||Single|||t|||
1298720|NCT03612882|||Cohort||Cross-Sectional|||||||
1298721|NCT03612869||Single Group Assignment||Treatment||None (Open Label)||||||
1298722|NCT03612856|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1298723|NCT03612843|||Cohort||Prospective|||||||
1298724|NCT03612830|Randomized|Parallel Assignment||Treatment||Double||Laparoscopic and Endoscopic cooperative sugery,Robotic and Endoscopic cooperative sugery|t|||t
1298725|NCT03612817|Randomized|Crossover Assignment||Treatment||Single|Only the dosing coordinator is aware of the treatment used.|Patients first undergo a baseline, habitual 24-hour pressure assessment with branded, or generic latanoprost. Suitably qualified open-angle glaucoma patients (latanoprost-treated, mean 24-hour pressure greater than 20 mm Hg) are randomized for Period 1 to receive either tafluprost/timolol fixed combination drops once in the evening (20:00) and placebo drops in the morning (08:00), or tafluporst/timolol drops once in the morning (08:00) and placebo in the evening (20:00). After 3 months of chronic therapy (± 2 weeks) study patients undergo a treated, habitual 24-hour pressure assessment. Study subjects are then switched to the opposite treatment regimen for Period 2 (tafluprost/timolol in the evening instead of morning etc) and after another 3 months they undergo the third and final evaluation of their 24-hour pressure.|||t|
1298726|NCT03612804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298727|NCT03612791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298728|NCT03612778|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized controlled trial with two parallel groups.||||
1298729|NCT03612765|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1298730|NCT03612752|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1298731|NCT03612739|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"This open-label Phase I study aims to define the recommended dose for further clinical development the NKR-2 treatment administered concurrently with AZA in treatment-naïve AML/MDS patients not candidates for intensive chemotherapy or hematopoietic stem cell transplantation.~This Phase I study is divided into three sequential cohorts evaluating three different dose-levels of NKR-2 (1x108, 3x108 and 1x109 NKR-2 per injection) using a 3+3 design evaluate. Further patients will be enrolled at the RecD to reach 9 evaluable patients in total at the RecD."||||
1298732|NCT03612726|||Cohort||Other|||||||
1298733|NCT03612713|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1298734|NCT03612700||Single Group Assignment||Basic Science||None (Open Label)||||||
1298735|NCT03612687|||Cohort||Prospective|||||||
1298736|NCT03612674|Randomized|Parallel Assignment||Screening||Single|Participants will not be informed about diagnostic procedure in order to evaluate the acceptability of the exam with or without the studied device (in fact at the end of the examination care provider will ask participant about perceived pain during the procedure through the VAS score).|Subjects will be randomized in two arms: a control-arm and an experimental-arm. Then arms data will be compared.|t|||
1298737|NCT03612661|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to either a group or guided self-help condition, of the same intervention, intuitive eating, of the same duration (8 weeks).||||
1298738|NCT03612648||Single Group Assignment||Treatment||None (Open Label)||||||
1298739|NCT03612635|||Cohort||Prospective|||||||
1298740|NCT03612622|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1298741|NCT03612609||Single Group Assignment||Basic Science||None (Open Label)||||||
1298742|NCT03612596|Randomized|Parallel Assignment||Other||Single||||||t
1298743|NCT03612583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298744|NCT03612570||Single Group Assignment||Treatment||None (Open Label)||||||
1298745|NCT03612557||Single Group Assignment||Basic Science||None (Open Label)||||||
1298746|NCT03612544|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statisticians and laboratory personnel will be blinded to group allocation.|||||
1298747|NCT03612531||Single Group Assignment||Supportive Care||None (Open Label)||||||
1298748|NCT03612518|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1298749|NCT03612505|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1298750|NCT03612492|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1298751|NCT03612479|Randomized|Parallel Assignment||Prevention||Single||||||t
1298752|NCT03612466||Single Group Assignment||Treatment||None (Open Label)||||||
1298753|NCT03612453|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statisticians and laboratory personnel will be blinded to group allocation|||||
1298754|NCT03612440|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1298755|NCT03612427|||Case-Control||Prospective|||||||
1298756|NCT03612414|Randomized|Parallel Assignment||Supportive Care||Triple|Randomization code|randomized, double-blind, placebo-controlled clinical study|t|t|t|
1298757|NCT03612401||Single Group Assignment||Treatment||None (Open Label)||Open label, pilot study comparing baseline measurement anticholinergic agent vs. study intervention mirabegron (MYRBETRIC ®) to evaluate cognitive impact and efficacy (SCIMYR)||||
1298758|NCT03612388|||Cohort||Prospective|||||||
1298759|NCT03612375|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statisticians and laboratory personnel will be blinded to group allocation|||||
1298760|NCT03612362|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster randomized control trial||||
1298761|NCT03612349|Randomized|Crossover Assignment||Other||None (Open Label)|There is no masking since participants experience both marketplace conditions.|Participants will complete the Experimental Tobacco Marketplace Task under two marketplace conditions. One condition has all tobacco products available in menthol and non-menthol flavors. The other condition does not include alternative flavored combusted products.||||
1298762|NCT03612336|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statisticians and laboratory personnel will be blinded to group allocation.|||||
1298763|NCT03612323|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1298764|NCT03612310|||Cohort||Other|||||||
1298765|NCT03612297|||Case-Only||Prospective|||||||
1298766|NCT03612284||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1298767|NCT03612271|Randomized|Parallel Assignment||Treatment||Single|||||t|
1298768|NCT03612258||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298769|NCT03612245|||Case-Control||Prospective|||||||
1298770|NCT03612232||Single Group Assignment||Treatment||None (Open Label)||||||
1298771|NCT03612219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298772|NCT03612206|||Cohort||Prospective|||||||
1298773|NCT03612193|||Cohort||Prospective|||||||
1298774|NCT03612180|||Cohort||Prospective|||||||
1298775|NCT03612167|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A quasi-experimental design with nonequivalent control was adopted in a senior center. Experimental variable was a 12 consecutive 90-minute weekly cognitive groups that included cognitive training and rehabilitation, with activity-based cognitive exercises and discussions with a focus on applications of cognitive strategies in daily lives. Participants were allocated into intervention group (cognitive intervention group) and control group (nutrition education group). The group assignment depended on what group they signed up for participate.||||
1298776|NCT03612154||Single Group Assignment||Treatment||None (Open Label)||||||
1298777|NCT03612141|||Cohort||Prospective|||||||
1298778|NCT03612128|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||In this type of controlled clinical trials, the same subjects are used as experimental and control groups, ie both the new treatment method and the classical method or the placebo method are applied to the same subjects. The efficacy is applied to the new treatment method and on the other hand the classical method is applied on the same subjects at different times and the results are compared.||||
1298779|NCT03612115|Randomized|Parallel Assignment||Treatment||Single||||||t
1298780|NCT03612102|Randomized|Parallel Assignment||Treatment||Single|"Independent evaluators assigned to assess outcomes will be masked to whether or not families participated in IGBT or were at the end of their waitlist period."|Families of children with selective mutism will be randomly assigned to receive either immediate intensive group behavioral treatment (IGBT) or to a waitlist with psychoeducational materials, and then IGBT.||||t
1298781|NCT03612089|||Case-Control||Cross-Sectional|||||||
1298782|NCT03612076|||Cohort||Retrospective|||||||
1298783|NCT03612063|Randomized|Parallel Assignment||Other||None (Open Label)||"The five heart rate monitors that will be assessed in this study include the Apple Watch Nike III, Fitbit Iconic, Garmin Vivosmart HR, TomTom Spark 3, and Polar H7 heart rate sensor. During testing, participants will wear two different wrist-worn heart rate monitors, the Polar H7 heart rate sensor, and will be connected to an ECG machine. Participants will be assigned, by chance to one of six groups:~Fitbit Iconic HR and Garmin Vivosmart HR~Fitbit Iconic HR and TomTom Spark 3~Fitbit Iconic HR and Apple Watch III~Apple Watch III and Garmin Vivosmart HR~Apple Watch III and TomTom Spark 3~Garmin Vivosmart HR and TomTom Spark 3"||||
1298784|NCT03612050|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial||||t
1298785|NCT03612037|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1298786|NCT03612024|||Cohort||Prospective|||||||
1298787|NCT03612011|Randomized|Parallel Assignment||Treatment||Double|"Cosmetic product Onco-Repair and placebo will be filled in the tubes with same appearance and smell. The tubes will be marked anonymusioly"|"Phase III multicenter, double blind, superiority, prospective, randomised controlled study Subjects will be randomized to receive either cosmetic product Onco-Repair or placebo in a 1:1 ratio"|t||t|
1298788|NCT03611998||Single Group Assignment||Treatment||None (Open Label)||One group, pretest-posttest design||||
1298789|NCT03611985||Sequential Assignment||Treatment||None (Open Label)||||||
1298790|NCT03611972||Single Group Assignment||Basic Science||None (Open Label)|All outcomes measures are analyzed using only the participant's study ID number.|Dietary intervention||||
1298791|NCT03611959|||Cohort||Retrospective|||||||
1298792|NCT03611946|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1298793|NCT03611933|Randomized|Parallel Assignment||Supportive Care||Single||Randomized-controlled quasi experimental study|t|||
1298794|NCT03611920|||Case-Control||Retrospective|||||||
1298795|NCT03611907|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective randomized controlled clinical trial is designed to highlight differences between Double Lumen Aspiration Needle and Single Lumen Needle among 2 double lumen and 2 single lumen needles commonly used in clinical practice in terms of: Number of oocytes retrieved, oocyte recovery percentage per aspirated follicles, recovery time for single oocyte, percentage of MII oocytes retrieved||||
1298796|NCT03611894|||Case-Only||Retrospective|||||||
1298797|NCT03611881|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1298798|NCT03611868||Sequential Assignment||Treatment||None (Open Label)||phase Ib portion of the study is to establish an MTD/RP2D of APG-115 in combination with pembrolizumab. Dose levels/schedule of APG115 will be tested: 50mg, 100mg, 150mg, and 200mg, QOD with 2 weeks on 1 week off as a cycle of 21 days (3 weeks), pembrolizumab will administrated with label dose. phase II portion of the study will evaluate the clinical efficacy and safety of the RP2D of APG-115 in combination with label dose of pembrolizumab in patient with unresectable or metastatic melanoma who is refractory or relapse of PD1 therapy.||||
1298799|NCT03611855|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||"Study Population in 2 groups: Group 1 participates in MRI before treatment, at crossover, and at study completion. Group 1 participants either receive rehabilitation via BCI device then cross over to a standard range-of-motion program, or start with a range-of-motion program then crossover to receive BCI rehabilitation. A balanced number of participants will be assigned to the different orders within Group 1.~Group 2 receives no MRI, and is not assigned a range-of-motion program. Thus, Group 2 only receives BCI rehabilitation and does not cross over."||||
1298800|NCT03611842|||Case-Control||Prospective|||||||
1298801|NCT03611829|Randomized|Parallel Assignment||Treatment||Single|Participants were blind to their condition, but physicians and administrative staff were not blind to participant condition. Physicians were not blind to participant condition because they were responsible for delivering the ACT intervention or standard care. They were thus required to know the participant's condition in order to deliver the adequate treatment. Administrative staff was responsible for providing physicians with this information and organizing study paperwork and thus needed to be aware of participant condition as well.|The present study was a two-arm pilot randomized controlled trial.|t|||
1298802|NCT03611816|||Cohort||Prospective|||||||
1298803|NCT03611803|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1298804|NCT03611790||Single Group Assignment||Treatment||None (Open Label)||||||
1298805|NCT03611777|||Cohort||Cross-Sectional|||||||
1298806|NCT03611764||Single Group Assignment||Supportive Care||None (Open Label)||||||
1298807|NCT03611751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298808|NCT03611738|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1298809|NCT03611725|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized either distal radial approach or radial approach.||||
1298810|NCT03611712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298811|NCT03611699|Randomized|Crossover Assignment||Basic Science||Double|Double-blind masking. Participant and Investigators will not know if the participants has received a long-acting bronchodilator or a placebo inhaler.||t||t|
1298812|NCT03611686|||Cohort||Prospective|||||||
1298813|NCT03611673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298814|NCT03611660|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Control Trial||||
1298815|NCT03611647|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1298816|NCT03611634|||Cohort||Prospective|||||||
1298817|NCT03611621|||Cohort||Prospective|||||||
1298818|NCT03611608|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1298819|NCT03611595||Single Group Assignment||Treatment||None (Open Label)||||||
1298820|NCT03611582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573329|NCT00001584||||||||||||
1298821|NCT03611569|Randomized|Sequential Assignment||Treatment||Double||Cohort|t||t|
1298822|NCT03611556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298823|NCT03611543|||Case-Only||Prospective|||||||
1298824|NCT03611530|Randomized|Parallel Assignment||Other||Double|Double blind study||t||t|
1298825|NCT03611517|Randomized|Parallel Assignment||Treatment||None (Open Label)||After signed informed consent, women complete the baseline questionnaire. After completion of the baseline questionnaire and before the end of RT, patients will be randomized to either the intervention group or the control group. The control group receives care as usual. The intervention group receives the nurse-led sexual rehabilitation intervention. All patients have follow-up appointments with their radiation-oncologist (or gynecologic oncologist) at 1, 3, 6 and 12 months post RT. For the intervention group, the sexual rehabilitation intervention sessions with the nurse will be planned immediately following the appointment with the radiation-oncologist. Women in the intervention group who are treated with RTBT receive an extra session 2 months after the end of radiotherapy. All patients are asked to complete questionnaires at baseline, and 1, 3, 6, and 12 months after completion of RT.||||
1298826|NCT03611504|||Cohort||Retrospective|||||||
1298827|NCT03611491||Single Group Assignment||Other||None (Open Label)||||||
1298828|NCT03611478|Randomized|Parallel Assignment||Other||Triple|This will be a double-blind trial, with randomisation being conducted by a disinterested third party. Unblinding will not occur until data analysis is complete.|Half the participants will receive the probiotic formulation while the other half will receive placebo.|t||t|t
1298829|NCT03611465|Non-Randomized|Parallel Assignment||Other||None (Open Label)||There is no randomization. Patients are provided into 3 groups according to their pathology.||||
1298830|NCT03611452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298831|NCT03611439|Randomized|Parallel Assignment||Treatment||Quadruple|randomized, double blind|randomized, placebo-controlled, double blind study|t|t|t|t
1298832|NCT03611426|Randomized|Sequential Assignment||Treatment||Single||The first part is ascending dose study: 3 subjects take rhThromb and 1 subjects take the same volume of saline; The second part is dose extension study:2 cohorts and 1 blank control group( the same volume of saline) used with absorbable collagen sponge;every group need 12 subject; The second part is dose extension study: 2 cohorts and 1 blank control group( the same volume of saline);every group need 12 subject;|t|||
1298833|NCT03611413|||Cohort||Prospective|||||||
1298834|NCT03611400|Randomized|Crossover Assignment||Basic Science||Triple|The participants, investigators, and anyone else involved with the study will remain blinded for its entirety.|A randomized, double-blind, placebo-controlled crossover in which participants receive one of the study supplements (probiotic or placebo) for a 3-week intervention period each will be used.|t||t|t
1298835|NCT03611387|||Cohort||Prospective|||||||
1298836|NCT03611374||Single Group Assignment||Treatment||None (Open Label)||||||
1298837|NCT03611361|||Case-Only||Prospective|||||||
1298838|NCT03611348|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1298839|NCT03611335|||Other||Prospective|||||||
1298840|NCT03611322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298841|NCT03611309|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1298842|NCT03611296|||Cohort||Prospective|||||||
1298843|NCT03611283|Randomized|Parallel Assignment||Treatment||Double|The study and placebo products had an identical appearance and were packaged identically. The sacs were numbered consecutively from 1 to 28. The company prepared and numbered the bag and all the participants were blinded to the treatment. Blinding was revealed after all participants finished the trial and all the data were collected.|Randomized double-blind placebo controlled study|t|t||
1298844|NCT03611270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1298845|NCT03611257|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single center prospective randomised clinical trial||||
1298846|NCT03611244|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1298847|NCT03611231||Single Group Assignment||Treatment||None (Open Label)||||||
1298848|NCT03611218||Sequential Assignment||Treatment||None (Open Label)||Prospective, open, controlled, cross-over (with randomized treatment sequences), interventional, multi-center||||
1298849|NCT03611205||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298850|NCT03611192|Randomized|Parallel Assignment||Prevention||Single||||||t
1298851|NCT03611179||Single Group Assignment||Treatment||None (Open Label)||40 patients diagnosed with advanced epithelial ovarian cancer presenting to Assiut university hospitals ,,the aim of the study is evaluation of response, survival and toxicity of upfront chemotherapy with Bevacizumab in those patients.||||
1298852|NCT03611166|||Cohort||Prospective|||||||
1298853|NCT03611153|Randomized|Parallel Assignment||Treatment||Double|Only research pharmacy staff will be aware of randomization scheme and all study personnel and subjects will remain blinded.|Single Administration of study drug|t||t|
1298854|NCT03611140|Randomized|Parallel Assignment||Treatment||Double|PD and placebo interventions were packaged identically in appearance, both the researcher and the participant did not know what type of maneuver was assigned. The packages were distributed by a person outside the study who was the same person who performed the randomization|In the first stage, the participants with metabolic syndrome consumed a reduced-energy diet tailored to provide a 500 kcal/d deficit as recommended by NIH with respect to their habitual diet for 15 days. In the second stage, the participants continued to consume the reduced energy diet with the addition of a combination of functional foods (dietary portfolio; DP). The DP provided 200 kcal that were subtracted from the diet. The kcal, appearance, and flavor were similar in DP and P. The DP and P were given in a package in a dehydrated form ready to be dissolved in water. The DP was divided into two packages, the first package contained 30 g of DP o P given in the breakfast and dissolved in 250ml and the second package was given at the dinner time and contained 30 g of P and DP dissolved in 250 mL of water.|t||t|
1298855|NCT03611127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298856|NCT03611114|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1298857|NCT03611101||||||||||||
1298858|NCT03611088|Randomized|Parallel Assignment||Basic Science||Single||||||t
1298859|NCT03611075|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1298860|NCT03611062|Randomized|Parallel Assignment||Other||Double|||t|t||
1298861|NCT03611049|Randomized|Parallel Assignment||Treatment||Double||Two parallel interventions in subjects with vitamin D insufficiency. A low dose vitamin D replacement arm and a high dose vitamin D replacement arm|t||t|
1298862|NCT03611036|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a multicenter, prospective, randomized, open-label study.||||
1298863|NCT03611023|||Cohort||Prospective|||||||
1298864|NCT03611010|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1298865|NCT03610997||Single Group Assignment||Treatment||None (Open Label)||Photorefractive Keratectomy||||
1298866|NCT03610984|||Case-Only||Prospective|||||||
1298867|NCT03610971||Single Group Assignment||Treatment||None (Open Label)||||||
1298868|NCT03610958||Single Group Assignment||Treatment||None (Open Label)||Prospective, single center, open-labeled single arm study.||||
1298869|NCT03610945|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||2-Part Single Group study||||
1298870|NCT03610932|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1298871|NCT03610919|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1298872|NCT03610906|||Cohort||Prospective|||||||
1298873|NCT03610893|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1298874|NCT03610880|Randomized|Parallel Assignment||Basic Science||None (Open Label)||randomized, open-label, two-arm, parallel design||||
1298875|NCT03610867|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1298876|NCT03610854||Single Group Assignment||Supportive Care||None (Open Label)||||||
1298877|NCT03610841|||Case-Control||Prospective|||||||
1298878|NCT03610828|||Other||Prospective|||||||
1298879|NCT03610815|Randomized|Parallel Assignment||Health Services Research||Single||Effectiveness-Implementation Hybrid 2 Trial|||t|
1298880|NCT03610802|||Cohort||Prospective|||||||
1298881|NCT03610789|||Cohort||Other|||||||
1298882|NCT03610776|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Masking is not possible due to the nature of the intervention (portion control vs. conventional plate).|Randomised, cross-over (within-subjects) design.||||
1298883|NCT03610763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298884|NCT03610750|Randomized|Parallel Assignment||Health Services Research||Single|De-identified aggregate clinic will be collected|Effectiveness-Implementation Hybrid 1 Trial|||t|
1298885|NCT03610737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298886|NCT03610724||Single Group Assignment||Treatment||None (Open Label)||||||
1298887|NCT03610711|Randomized|Parallel Assignment||Treatment||Single|||t|||
1298888|NCT03610698|Randomized|Crossover Assignment||Treatment||Single|||||t|
1298889|NCT03610685|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1298890|NCT03610672|Randomized|Factorial Assignment||Treatment||None (Open Label)||The current study is a two-armed, open randomized clinical trial design.||||
1298891|NCT03610659|||Other||Prospective|||||||
1298892|NCT03610646|Randomized|Parallel Assignment||Treatment||Triple|Masked study drug kits will be supplied to sites as necessary during the study. The outside label of the box will not reveal the identity of the product inside (whether it is Eylea or MYL-1701P) and will be assigned in a masked fashion through the IRT system. An un-masked team will identified at site, to be responsible for preparation and administration of the study drug.|Participants are assigned to either MYL-1701P or Eylea groups in parallel for the duration of the study|t||t|t
1298893|NCT03610633|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1298894|NCT03610620||Single Group Assignment||Diagnostic||None (Open Label)||Compare accuracy and speed of the Vivascope 2500 to frozen sections.||||
1298895|NCT03610607|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1298896|NCT03610594|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1298897|NCT03610581|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1298898|NCT03610568|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||1,400 adolescents were enrolled in the intervention group - 1,000 in-school and 400 out-of-school 1,400 adolescents were enrolled in the control group - 1,000 in-school and 400 out-of-school||||
1298899|NCT03610555|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1298900|NCT03610542|Randomized|Parallel Assignment||Treatment||Single|Sequentially numbered opaque sealed envelopes will be used to conceal allocation. Envelopes will be prepared by a member of the research team and opened by participants.|Participants will be randomly allocated to one of three conditions: Face-to-face cognitive behavioural therapy, computerised cognitive behavioural therapy or a no treatment control arm.|t|||
1298901|NCT03610529||Single Group Assignment||Prevention||None (Open Label)||The study participants will be using both the experimental device and the control device simultaneously throughout the study participation. The participant will thereby act as its own control.||||
1298902|NCT03610516|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298903|NCT03610503|Randomized|Parallel Assignment||Prevention||Triple|Anonymous data collection to be reviewed|Randomized, intervention-control, trial|t||t|t
1298904|NCT03610490||Single Group Assignment||Treatment||None (Open Label)||||||
1298905|NCT03610477|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1298906|NCT03610464||Single Group Assignment||Treatment||None (Open Label)||This was an open-label, single-site, single-dose one-period, one-treatment study in 5 pediatric subjects diagnosed with ADHD, otherwise healthy. Subjects received a single, 1 mL dose of AMPH EROS 2.5 mg/mL, from which PK was assessed over a 28 hour period.||||
1298907|NCT03610451|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pragmatic randomized controlled trial||||
1298908|NCT03610438|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The study is divided in two cohorts; cohort 1 will enroll 38 Ph+ patients, cohort 2 will enroll 38 Ph- patients, as defined with statistical analysis. The two cohorts will have the same treatment, with the exception of short term and long term maintenance.||||
1298909|NCT03610425|||Cohort||Cross-Sectional|||||||
1298944|NCT03609970|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1573330|NCT00001579||||Treatment||||||||
1298910|NCT03610412|Randomized|Parallel Assignment||Treatment||Double|"Random assignment of groups and blinding:~All participants will be submitted to the selection of a sealed envelope which will have a numerical code previously defined by a third party for each intervention group.~The total number of envelopes required to complete the minimum number of participants (28) will be divided according to sex in two boxes, there will be 14 envelopes for men and 14 envelopes for women, with numerical codes that identify the bottle of intervention treatment that should receive the participant during the intervention period. They will be divided into 7 blinded codes for cinnamomum cassia group and 7 for placebo to complete the size of each subsample. Chance guarantees blinding, neither the participant nor the researcher will know the type of treatment. The database for the blinded statistical analysis will be completed. The blind man will be removed once the statistical analysis has been completed."|"Controlled clinical trial, of two parallel groups, double blind, with random assignment and control group.~Process:~Visit 1 / Day -7: Period of scrutiny, study information, consent signature, clinical history, anthropometry, baseline laboratory tests.~Visit 2 / Day 0: Start the intervention period, simple random assignment for study groups, delivery of medication, general recommendations of diet and exercise.~Visit 3 / Day 30 - Visit 4 / Day 60: Adherence to treatment, taking laboratory tests, evaluation of adverse events, general recommendations of diet and exercise, general recommendations of diet and exercise will be evaluated.~Final Visit / Day 90 ± 7: Anthropometric measurements will be taken, laboratory tests will be taken, treatment adherence and adverse events will be evaluated, end of the intervention period."|t||t|
1298911|NCT03610399|Randomized|Parallel Assignment||Treatment||None (Open Label)||We plan to compare 3 different regimens of primaquine for P. vivax treatment.||||
1298912|NCT03610386|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298913|NCT03610373|Randomized|Parallel Assignment||Health Services Research||Single|The outcomes assessors do not have access to data regarding which arm each participant is in.|Participants are randomly assigned to receive a treatment planned primarily by the clinician (clinician guided) or planned collaboratively by the clinician, parent, and child (shared decision-making).||||t
1298914|NCT03610360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298915|NCT03610347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298916|NCT03610334|Randomized|Parallel Assignment||Other||Quadruple|Capsules used for verum or placebo (Size 5 white opaque HPMC capsule) are identical and equally-weighted|double-blind, randomized, placebo-controlled, combined single and multiple ascending dose of IFB-088 by successive cohorts study|t|t|t|t
1298917|NCT03610321|Randomized|Parallel Assignment||Treatment||Single||||||t
1298918|NCT03610308|||Cohort||Prospective|||||||
1298919|NCT03610295|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Retrospective,consecutive,nonrandomized comparative trial with historical control||||
1298920|NCT03610282|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1298921|NCT03610269||||||||||||
1298922|NCT03610256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298923|NCT03610243|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1298924|NCT03610230|Randomized|Crossover Assignment||Treatment||None (Open Label)||prospective randomized cross-over open-label trial||||
1298925|NCT03610217|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1298926|NCT03610204|Randomized|Parallel Assignment||Treatment||Double|"Since the patient are prone during the low back massage, the patient will not know what treatment they receive, as the two treatments are similar and only different in the pressure force.~The primary outcome is assessed by a self-reported questionnaire. The assessor who performs the clinical assessments will be blinded to the treatment assignment."|The patients are randomly assigned into two treatment arms.|t|||t
1298927|NCT03610191|||Case-Control||Prospective|||||||
1298928|NCT03610178|Randomized|Parallel Assignment||Basic Science||Single||Women with GDM are randomised to 2 treatment groups: group 1 - treatment group with very tight glycemic targets (<5.1 mmol / L fasting glucose and <7.0 mmol / l hour after a meal) and group 2 - treatment group with tight-moderate glycemic targets (<5.3 mmol / L fasting glucose and <7.8 mmol / l in an hour after a meal).|||t|
1298929|NCT03610165|Randomized|Parallel Assignment||Prevention||Double||Single-center randomized comparison of invasive arterial pressure monitoring vs. arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software guidance on intraoperative hypotension duration and severity.|t||t|
1298930|NCT03610152|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1298931|NCT03610139|Randomized|Parallel Assignment||Other||Single|"One of the co-investigators who will perform the MRI segmentation and analysis will be blind to the participants' treatment allocation.~Research assistants who will administer the cognitive tests to all participants will be blind to the participants' treatment allocation."|||||t
1298932|NCT03610126|||Cohort||Prospective|||||||
1298933|NCT03610113|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1298934|NCT03610100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298935|NCT03610087|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1298936|NCT03610074||Single Group Assignment||Basic Science||None (Open Label)||Adult patient displaying an hypernatremia upper than 150mmol/L or an hypernatremia upper than 145mmol/L associated with a water deficiency upper than 3L||||
1298937|NCT03610061||Sequential Assignment||Treatment||None (Open Label)||Dose Escalation||||
1298938|NCT03610048||Single Group Assignment||Treatment||None (Open Label)||Open-label||||
1298939|NCT03610035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1298940|NCT03610022||Single Group Assignment||Treatment||None (Open Label)||||||
1298941|NCT03610009|Randomized|Parallel Assignment||Other||Triple|Women (patients), clinician performing oocyte retrieval and clinical embryologist will be blinded to the method used for monitoring follicle development|Follicle development in women undergoing IVF will be monitored either by conventional 2D ultrasound or SonoAVC.|t|t||t
1298942|NCT03609996|||Other||Retrospective|||||||
1298943|NCT03609983|Randomized|Factorial Assignment||Screening||None (Open Label)||A 3x2 mixed factorial design will be used, with a between-subject factor will of self-weighing group (daily weighing; weekly weighing; and no weighing control group) and within-subject factor will of time (prior to self-weighing and feedback and during self-weighing and feedback).||||
1298945|NCT03609957|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1298946|NCT03609944|Randomized|Parallel Assignment||Treatment||Double|In addition to the participant and the investigator assessing outcomes, study coordinators involved in collecting outcomes data will be masked to the treatment assignment.|Subjects will be randomized 1:1 to either EUS+sham or EUS+ERCP with miES.|t|||t
1298947|NCT03609931|||Case-Only||Prospective|||||||
1298948|NCT03609918|||Case-Only||Retrospective|||||||
1298949|NCT03609905|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1298950|NCT03609892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298951|NCT03609879|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1298952|NCT03609866|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1298953|NCT03609853|Randomized|Crossover Assignment||Basic Science||Double|placebo controlled, double-blind||t|||t
1298954|NCT03609840|||Other||Prospective|||||||
1298955|NCT03609827|||Other||Prospective|||||||
1298956|NCT03609814|||Other||Prospective|||||||
1298957|NCT03609801|Randomized|Parallel Assignment||Treatment||Single||||||t
1298958|NCT03609788|||Other||Prospective|||||||
1298959|NCT03609775|Randomized|Crossover Assignment||Other||Quadruple||Double-dummy, four-way crossover study design|t|t|t|t
1298960|NCT03609762|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1298961|NCT03609749||Single Group Assignment||Basic Science||None (Open Label)||||||
1298962|NCT03609736|||Cohort||Prospective|||||||
1298963|NCT03609723|||Cohort||Prospective|||||||
1298964|NCT03609710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298965|NCT03609697|Randomized|Parallel Assignment||Prevention||Single|All outcome assessors will be blinded to group allocation|"It is a 12-month 2-arm randomised controlled trial, RCT (the lifestyle intervention group and the SMS intervention group). The programme will proceed in two phases: the intensive intervention phase (0-6 months) and the maintenance phase (7-12 months). During the intensive intervention phase, participants in the lifestyle intervention group will attend 7 group-based interventions plus two sessions of individual face-to-face dietician consultation. During the maintenance phase, participants will receive monthly phone call from the research team.~The SMS intervention group will receive regular SMS during both the intensive intervention and the maintenance phases."||||t
1298966|NCT03609684|Non-Randomized|Sequential Assignment||Treatment||Single|||t|||
1298967|NCT03609671|Randomized|Parallel Assignment||Supportive Care||Single||Patients will be randomized to two groups.|t|||
1298968|NCT03609658|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||There are two groups. All participants are randomized prior to informed consent, and then only patients randomized to the interventional arm are approached for consent and subsequently enrolled in the intervention group. Note that patients that do not consent to the intervention are still counted as part of control group under an intent-to-treat paradigm, which necessitates passive ascertainment mechanisms for outcomes (i.e. administrative claims or the EHR).||||
1298969|NCT03609645|Randomized|Parallel Assignment||Other||Quadruple|An unblinded study personnel not directly involved in patient care will prepare all study drugs. The anesthesiologist, patient, surgeon and the investigator collecting outcome data will be unaware of study group allocation.|This is a double-blinded randomized prospective study involving patients with hip fracture who are undergoing surgical fixation.|t|t|t|t
1298970|NCT03609632||Single Group Assignment||Other||None (Open Label)||||||
1298971|NCT03609619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298972|NCT03609606|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1298973|NCT03609593||Single Group Assignment||Treatment||None (Open Label)||||||
1298974|NCT03609580||Single Group Assignment||Treatment||None (Open Label)||||||
1298975|NCT03609567|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1298976|NCT03609554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298977|NCT03609541|||Cohort||Prospective|||||||
1298978|NCT03609528||Single Group Assignment||Diagnostic||None (Open Label)||||||
1298979|NCT03609515||Single Group Assignment||Health Services Research||None (Open Label)||A prospective study of service use during a period by a cohort of patients compared to service use by the same cohort during av similar period before inclusion.||||
1298980|NCT03609502|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||This is a 2x2 mixed (Group by Time) design||||
1298981|NCT03609489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298982|NCT03609476|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1298983|NCT03609463|Randomized|Parallel Assignment||Treatment||Single|A researcher adequately trained in the administration of questionnaires and interviews, and blinded to the experimental allocation of patients, will carry out all the evaluations.|||||t
1298984|NCT03609450|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two arms, intervention and low-dose comparator, which are randomly assigned at the same time and are implemented in parallel.||||
1298985|NCT03609437|||Case-Control||Prospective|||||||
1298986|NCT03609424||Single Group Assignment||Treatment||None (Open Label)||||||
1298987|NCT03609411|||Case-Control||Retrospective|||||||
1298988|NCT03609398||Single Group Assignment||Prevention||None (Open Label)||vaccine to be administered in 1.0mL doses SQ in the upper outer aspect of the arm||||
1298989|NCT03609385|||Cohort||Prospective|||||||
1298990|NCT03609372||Single Group Assignment||Health Services Research||None (Open Label)||||||
1298991|NCT03609359||Single Group Assignment||Treatment||None (Open Label)||||||
1298992|NCT03609346|||Cohort||Prospective|||||||
1298993|NCT03609333|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1298994|NCT03609320||Single Group Assignment||Health Services Research||None (Open Label)||This single-arm study embedded within a 2-arm cluster RCT will test the difference in the rate of missed opportunities pre- and post-implementation of a 3-component intervention including communication skills, performance feedback, and prompts. These three interventions will be implemented together in practices that previously received standard of care.||||
1298995|NCT03609307|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1298996|NCT03609294|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1298997|NCT03609281|||Cohort||Cross-Sectional|||||||
1298998|NCT03609268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1298999|NCT03609255|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1299000|NCT03609242|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Cluster RCT study design will test the impact of the bundle (communication still training, performance feedback and prompts) to reduce missed opportunities and raise HPV vaccine rates.||||
1299001|NCT03609229|Randomized|Parallel Assignment||Prevention||Single|||t|||
1299002|NCT03609216|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299003|NCT03609203|||Case-Control||Prospective|||||||
1299004|NCT03609190|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1299005|NCT03609177|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1299006|NCT03609164|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1299007|NCT03609151|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1299008|NCT03609138|||Cohort||Prospective|||||||
1299009|NCT03609125||Single Group Assignment||Treatment||None (Open Label)||||||
1299010|NCT03609112|||Cohort||Prospective|||||||
1299011|NCT03609099|Randomized|Parallel Assignment||Treatment||Triple|Double blind treatment||t|t|t|
1299012|NCT03609086|||Case-Only||Prospective|||||||
1299013|NCT03609073||Single Group Assignment||Treatment||None (Open Label)||||||
1299014|NCT03609060||Single Group Assignment||Treatment||None (Open Label)||||||
1299015|NCT03609047|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized 2:1||||
1299016|NCT03609034|||Other||Cross-Sectional|||||||
1299017|NCT03609021|||Cohort||Prospective|||||||
1299018|NCT03609008|Randomized|Parallel Assignment||Other||Quadruple||Randomized, double-blind placebo-controlled design in healthy volunteers.|t|t|t|t
1299019|NCT03608995|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1299020|NCT03608982|Randomized|Parallel Assignment||Other||Double|"Participants will be informed about participating in a study, evaluating the performance of basic first aid courses taught by the Belgian Red Cross, but will be blinded from the actual goal of the research, i.e. testing the added value of simulated patients.~The outcome assessors will not be aware of the allocation status of participants whose practical skills they judge."|This is a cluster-randomized trial, in which allocation is done at the level of the companies that request a first aid course for their employees.|t|||t
1299021|NCT03608969|||Case-Only||Cross-Sectional|||||||
1299022|NCT03608956|||Cohort||Prospective|||||||
1299023|NCT03608943|||Case-Crossover||Retrospective|||||||
1299024|NCT03608930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299025|NCT03608917|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299026|NCT03608904|Randomized|Parallel Assignment||Supportive Care||Double||Participants will be exposed to music or no music (spoken words only) during their fMRI scans.|||t|t
1299027|NCT03608891|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1299028|NCT03608878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299029|NCT03608865||Single Group Assignment||Treatment||None (Open Label)||Drug:Durvalumab + tremelimumab Dose/Potency: Durvalumab 1500mg(up to 4cycle) / tremelimumab 75mg(up to 13 cycle) Dose Frequency:Q4W Route of Administration:IV infusion Regimen/Treatment Period:Day 1 of each 4 week cycle Use:Experimental||||
1299030|NCT03608852|||Other||Prospective|||||||
1299031|NCT03608839|Randomized|Parallel Assignment||Treatment||Quadruple|"All the patients were masked. They didn't have acess to the group they belonged.~The care provider didn't know the quantity of the drug injected. The outcome assessor was masked as well."|At the baseline study visit, patients were randomized with a 1:1:1 allocation to receive dexamethasone solution 4 mg/ml: 0,01 ml; or 0,03 ml; or 0,05 ml. In follow up visits (1, 3, 7, 14, 21, 28 days after) were performed BCVA, slit-lamp biomicroscopy, applanation tonometry, fundus biomicroscopy, SD- OCT (Spectralis; Heidelberg Engineering, Heidelberg, Germany). The randomization schedule was computer generated and stored in a locked cabinet until the study ended. Both patients and the study personnel who collected BCVA, OCT data were masked to the patient study assignment.|t|t|t|t
1299032|NCT03608826||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299033|NCT03608813|||Case-Control||Prospective|||||||
1299034|NCT03608800||Sequential Assignment||Prevention||None (Open Label)||||||
1299035|NCT03608787|Randomized|Crossover Assignment||Prevention||None (Open Label)||We will: (a) identify ten pairs of matched college/university communities for a total of 20 communities; (b) recruit a minimum of 12 on-premises serving establishments in each community for participation in the project; (c) conduct 3 Pseudo-Intoxicated Mystery Shop (P-I/MS) baseline inspections in all participating outlets in all 20 communities to observe pre-intervention over-service conduct; (d) randomly assign one community from each pair to receive S-STOP immediately (Cohort 1) and the other (Cohort 2) to serve as a control group and then to receive S-STOP later; (e) implement S-STOP in Cohort 1 communities for 3 months and conduct P-I MS in Cohort 2 control communities with no feedback to the licensees or community; (f) at the end of the 3 months, end S-STOP in Cohort 1 communities, but continue unreported P-I/MS and begin S-STOP in Cohort 2 communities for 3 months.||||
1299036|NCT03608774|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299037|NCT03608761|Randomized|Crossover Assignment||Treatment||Single||||||t
1299038|NCT03608748|||Cohort||Prospective|||||||
1299039|NCT03608735|||Other||Retrospective|||||||
1299040|NCT03608722|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1299041|NCT03608709|||Cohort||Prospective|||||||
1299042|NCT03608696||Single Group Assignment||Treatment||None (Open Label)||||||
1299043|NCT03608683|||Cohort||Prospective|||||||
1299044|NCT03608670||Single Group Assignment||Other||None (Open Label)||||||
1299045|NCT03608657|||Cohort||Prospective|||||||
1299046|NCT03608644|||Cohort||Prospective|||||||
1299047|NCT03608631||Single Group Assignment||Treatment||None (Open Label)||||||
1299048|NCT03608618|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299049|NCT03608605|||Case-Control||Prospective|||||||
1299050|NCT03608592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299051|NCT03608579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299052|NCT03608566|||Cohort||Prospective|||||||
1299053|NCT03608553||Single Group Assignment||Treatment||None (Open Label)||||||
1299054|NCT03608540||Single Group Assignment||Treatment||None (Open Label)||||||
1299055|NCT03608527|Randomized|Parallel Assignment||Treatment||Single||||||t
1299056|NCT03608514|Randomized|Parallel Assignment||Treatment||Single|patients will be randomly assigned in 1:1 manner|Fifty patients will be enrolled in each arm of the study & randomly assigned in a 1:1 manner to receive either terlipressin alone versus the standard therapy (norepinephrine +/- epinephrine).|t|||
1299057|NCT03608501||Single Group Assignment||Treatment||None (Open Label)||||||
1299058|NCT03608488|Randomized|Parallel Assignment||Prevention||Single|||||t|
1299059|NCT03608475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299060|NCT03608462|Randomized|Parallel Assignment||Treatment||Double||In this research,we combine a cross-sectional case control study and a randomized controlled study.|t|||t
1299061|NCT03608449|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|not relevant|Parallel, randomized by order, open study, assignment (matching/rematching) supported by monitoring data.||||
1299062|NCT03608436|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1299063|NCT03608423|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1299064|NCT03608410|Randomized|Parallel Assignment||Other||None (Open Label)||"The randomization will be done by the AmbuFlex-system (a generic on-line system for self-recorded patient reported outcomes) as a part of the inclusion process.~A text message reminder is sent weekly for patients in the intervention group by the system.~Quality of Life questionnaires will automatically be sent via a safe internet connection to participants in both groups every 2 months."||||
1299065|NCT03608397|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blinded|Approximately 300 subjects, recruited from study centers in the United States (US), Canada, and Europe will be randomized to DAXI high dose, DAXI low dose or placebo group.|t|t|t|t
1299066|NCT03608384|||Cohort||Retrospective|||||||
1299067|NCT03608371|Randomized|Sequential Assignment||Treatment||Quadruple|double-blind study|The study will consist of 4 sequential, single ascending dose cohorts of 8 subjects each with a 6:2 randomization to BTRX-246040 or placebo|t|t|t|t
1299068|NCT03608358|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299069|NCT03608345|||Case-Control||Prospective|||||||
1299070|NCT03608332|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1299071|NCT03608319|Randomized|Crossover Assignment||Treatment||None (Open Label)||3-Way Crossover Design||||
1299072|NCT03608306|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1299073|NCT03608293|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1299074|NCT03608280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299075|NCT03608267||Single Group Assignment||Treatment||None (Open Label)||||||
1299076|NCT03608254|||Other||Cross-Sectional|||||||
1299077|NCT03608241|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Open label|||||
1299078|NCT03608228|||Other||Prospective|||||||
1299079|NCT03608215|Randomized|Parallel Assignment||Treatment||Triple||active, sham|t||t|t
1299080|NCT03608202|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Controlled clinical trial. Prospective, randomized controlled clinical trial. The type of design is with posttest only and control group. Two groups will be compared, a study group (experimental) undergoing a focal ultrasound protocol, versus a control group with conventional conventional management."||||
1299081|NCT03608189|||Case-Control||Prospective|||||||
1299082|NCT03608176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299083|NCT03608163|Randomized|Crossover Assignment||Prevention||Double|The subject and investigator will be blinded as to which study drug(s) participant is receiving first (Drug, Drug and Placebo combination, or Placebo).|This study is a combination of model types. In phase 1 of the study, non-diabetic participants who are susceptible to hypoglycemia-associated autonomic failure (HAAF) are identified. Only participants who are susceptible to HAAF are studied in the second and third phases. Thus, continuation of subjects identified in phase one into phase two and/or three studies follows a sequential model. The second phase follows a crossover design in which subjects receive naloxone or placebo nasal sprays in a randomized, double blinded fashion. In the third phase, subjects will receive either oral diazoxide or oral placebo (for diazoxide), in combination with naloxone nasal spray or placebo (for naloxone) nasal spray in a randomized, double blinded crossover design.|t||t|
1299084|NCT03608150||||||||||||
1299085|NCT03608137|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1299086|NCT03608124|||Other||Cross-Sectional|||||||
1299087|NCT03608111|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299088|NCT03608098|Randomized|Parallel Assignment||Treatment||None (Open Label)||All subjects enrolled in the study will be randomized to either short pulse or long pulse for treatment of their stones. The date of treatment will be decided between the subject and the treating surgeon. All treatments will be performed using the standard of care and will be performed in the same fashion as procedures for patients not enrolled in the study. There is no modification of the techniques used to remove the stones. Post operatively, we plan to discharge all subjects home from the recovery unit. All subjects will be seen one week to one month after surgery for stent removal and a low dose CT of the abdomen and pelvis to assess stone free rates which is standard for all stone patients.||||
1299089|NCT03608085|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1299090|NCT03608072|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1299091|NCT03608059|Randomized|Single Group Assignment||Treatment||Single||ATG+PTCy|t|||
1299092|NCT03608046||Single Group Assignment||Treatment||None (Open Label)||||||
1299093|NCT03608033|Randomized|Parallel Assignment||Treatment||Quadruple||Eligible patients will be randomized 1:1 to receive OMS721 or placebo|t|t|t|t
1299094|NCT03608020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299095|NCT03608007||Single Group Assignment||Treatment||None (Open Label)||||||
1299096|NCT03607994|Randomized|Crossover Assignment||Supportive Care||Triple||This study will compare acoustic stimulation linked to brainwave activity (HIRREM-SOP, along with continued current care, BCC) with acoustic stimulation not linked to brainwave activity (NCC, along with continued current care). The participants in the NCC group with will offered the opportunity to crossover and receive a course of BCC at the end of their original participation.|t||t|t
1299097|NCT03607981|||Case-Only||Prospective|||||||
1299098|NCT03607968|||Case-Only||Retrospective|||||||
1299099|NCT03607955||Single Group Assignment||Treatment||None (Open Label)||||||
1299100|NCT03607942|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1299101|NCT03607929|Randomized|Parallel Assignment||Treatment||Double|"The methodology for carrying out the clinical trial followed the directives proposed in the CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials (Schulz et al. 2010).~Randomization and masking Women who fulfill the inclusion criteria will assigned in a masked manner into one of two groups according to a randomization list generated in the hospital's Care Research Unit using Epidat software version 3.1. Allocations will be disclosed through opaque, sealed, consecutively numbered envelopes at the moment the woman is recruited into the study . Given the difficulty of masking allocations from the persons carrying out the intervention and collecting the information, in addition to using objective variable measurement systems, collaborators will be blinded to the results during their analysis."|"INTERVENTION GROUP  OPTIMAL HYDRATION LABOR: they will be initiated the administration of crystalloid solutions in continuous perfusion at a rate of 200ml/h, until delivery, alternating each of them: (1)Physiological Serum (2)Physiological Serum (3)Ringer Lactate. The oral intake of mineral water will be promoted, at a rate of 100ml/h. To avoid bias, the mineral water will be administered by the research team.~IMMEDIATE PUERPERIUM: Women who have had a low-risk delivery will drink mineral water at a rate of 100ml / h during the two hours of the immediate puerperium. Suspending Hydration i.v.~CONTROL GROUP  VARIABILITY IN HYDRATION The women will be hydrated in accordance with the midwives' experience, training and clinical criteria, either independently or jointly with the attending clinicians (obstetricians, gynecologists and anesthetists)."|t|||t
1299102|NCT03607916|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1299103|NCT03607903|Randomized|Parallel Assignment||Other||Triple|This study is double blind. Investigator, study staff, and subjects, are blinded until study closure. Investigational drug and matching placebo are indistinguishable and will be packaged similarly. Injection site assessments will be performed by (a) study-independent physician(s). The study physician will administer the injection, thus unblinded to type of injection. This physician will not reveal the route of administration to others. The investigator receives sealed emergency codes to be broken in case of emergency situations. If the identity of study drug administered needs to be known to manage the subject's condition i.e., in case of a medical emergency or in the case a SUSAR occurs, the treatment emergency code for that subject may be broken and the study drug identified. All such occurrences should be documented in the study file. Just prior to database lock unused emergency code labels will be checked and a statement that all are intact (or not) is made on database lock form.|This is a double blind, placebo controlled, double-dummy study.|t||t|t
1299104|NCT03607890||Single Group Assignment||Treatment||None (Open Label)||||||
1299105|NCT03607877|Randomized|Parallel Assignment||Supportive Care||Single|Randomization was conducted using opaque envelops and a randomly generated number sequence by an independent research assistant who had no prior knowledge of the recruited elders. Researchers allocated participants to their treatment condition based on the randomization code in the sealed envelope (opened in order of sequence). Investigator was blind to participants, but researchers were not blind to the patients' treatment allocation.|Three arms of experimental design were used: Pedometer walking training (PWT), positive education and pedometer walking training (PEPWT), and pedometer walking (PW). Trained walking exercise was provided by a physical education expert three times per week, 45 minutes per session. Positive education was designed and led by a licensed psychologist. Six sessions of activities targeted participants' self-strength, competence and self-efficacy in walking exercise; positive relations with others; and positive emotions about life and healthy lifestyle. Of 150 participants, 60, 60 and 30 were randomly assigned to PWT, PEPWT, and PW, respectively. Demographic information, Chinese Happiness Inventory (CHI), regular walking exercise and six-minute walking distance were assessed before and after the intervention.|||t|
1299106|NCT03607864||Single Group Assignment||Treatment||None (Open Label)||||||
1299107|NCT03607851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299108|NCT03607838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299109|NCT03607825||Single Group Assignment||Treatment||None (Open Label)||||||
1299110|NCT03607812|||Cohort||Prospective|||||||
1299111|NCT03607799|Randomized|Parallel Assignment||Prevention||Single|Those assessing the primary and secondary clinical outcomes are masked to treatment assignment.|Human||||t
1299112|NCT03607786|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1299113|NCT03607773|Randomized|Parallel Assignment||Treatment||Double|"The PI will not know which group each participant has been randomized to, nor will the study coordinator.~One study team member, who is leading the Mindfulness sessions, will be unblinded."||||t|t
1299114|NCT03607760|||Case-Control||Retrospective|||||||
1299115|NCT03607747|||Case-Only||Prospective|||||||
1299116|NCT03607734||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299117|NCT03607721|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants were divided in two groups: Parkinson's Disease patients that underwent deep brain stimulation and a control group with healthy subjects matched by age and gender.||||
1299118|NCT03607708|Randomized|Parallel Assignment||Treatment||Single||RCT||||t
1299119|NCT03607695||Single Group Assignment||Basic Science||None (Open Label)||the intervention is a 10-week gait treadmill-training program. the sessions are 1 hour long, twice a week.||||
1299120|NCT03607682||Single Group Assignment||Treatment||None (Open Label)||||||
1299121|NCT03607669|||Cohort||Prospective|||||||
1299122|NCT03607656|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299180|NCT03606902|Randomized|Parallel Assignment||Supportive Care||Quadruple|• double blinded randomized controlled study.|double blinded randomized controlled study|t|t|t|t
1573331|NCT00001577||||Treatment||||||||
1299123|NCT03607643|Randomized|Crossover Assignment||Treatment||Quadruple|Participant, care provider, investigator, and outcomes assessor will be blinded to standard of care (SOC) alone vs treatment arm|Study length for randomized patients in the treatment group(s) will be 180 days. For those subjects randomized into the control group(s), after 90 days of the control group study treatment, will be given the choice to rollover into the treatment group. Crossover is also permitted if there is progression of disease before 90 days.|t|t|t|t
1299124|NCT03607630|Randomized|Crossover Assignment||Treatment||None (Open Label)||Multiple Baseline Case Series - randomization for how long participants wait pre-intervention||||
1299125|NCT03607617|||Ecologic or Community||Prospective|||||||
1299126|NCT03607604|||Cohort||Cross-Sectional|||||||
1299127|NCT03607591|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1299128|NCT03607578|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1299129|NCT03607565|||Cohort||Retrospective|||||||
1299130|NCT03607552|||Cohort||Prospective|||||||
1299131|NCT03607539|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1299132|NCT03607526|||Other||Other|||||||
1299133|NCT03607513|Randomized|Sequential Assignment||Other||Double|||t||t|
1299134|NCT03607500|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299135|NCT03607487|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1299136|NCT03607474|||Cohort||Prospective|||||||
1299137|NCT03607461|Randomized|Parallel Assignment||Treatment||None (Open Label)||Control group will consist of those who meet the inclusion criteria and have received traditional home health services following total knee arthroplasty (TKA). Intervention group participants who meet the inclusion criteria will receive a smartphone app instead of traditional home health services to aid in knee mobility recovery following TKA||||
1299138|NCT03607448|||Cohort||Prospective|||||||
1299139|NCT03607435||Single Group Assignment||Supportive Care||None (Open Label)||||||
1299140|NCT03607422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299141|NCT03607409|||Case-Only||Prospective|||||||
1299142|NCT03607396|||Cohort||Retrospective|||||||
1299143|NCT03607383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299144|NCT03607370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299145|NCT03607357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1299146|NCT03607344|||Cohort||Prospective|||||||
1299147|NCT03607331|Randomized|Parallel Assignment||Treatment||Single||||||t
1299148|NCT03607318|Randomized|Parallel Assignment||Treatment||Single||||||t
1299149|NCT03607305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299150|NCT03607292|Randomized|Parallel Assignment||Treatment||None (Open Label)|A single blinded anesthesiologist performed posterior or anterior sciatic nerve block and femoral block and left the operating room 'after the nerve block was completed.|Randomize, single blind, prospective||||
1299151|NCT03607279|||Case-Control||Prospective|||||||
1299152|NCT03607266|||Other||Prospective|||||||
1299153|NCT03607253|Non-Randomized|Parallel Assignment||Other||Single|||||t|
1299154|NCT03607240|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1299155|NCT03607227|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299156|NCT03607214|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1299157|NCT03607201|||Other||Retrospective|||||||
1299158|NCT03607188|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299159|NCT03607175|Randomized|Parallel Assignment||Treatment||Double|Participants and outcomes assessor will be blinded to the side that the steroid eluting implant and the triamcinolone-impregnated foam in on.|Study is an intrapatient control design, each subject will receive both interventions, one in each nostril|t|||t
1299160|NCT03607162|Randomized|Parallel Assignment||Diagnostic||Single||"This is an open cluster randomized before-after clinical trial with 2 parallel groups. Clusters are defined as EDs.~2 periods will be considered, one when all children will receive usual care, whatever the cluster, and a second one when, in half of the clusters, the DIAFEVER algorithm will be applied, and in the remaining clusters, children will still receive usual care."|t|||
1299161|NCT03607149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299162|NCT03607136|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1299163|NCT03607123|||Case-Crossover||Prospective|||||||
1299164|NCT03607110|||Cohort||Prospective|||||||
1299165|NCT03607097|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1299166|NCT03607084|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299167|NCT03607071||Single Group Assignment||Treatment||None (Open Label)||Moderate dose steroid therapy||||
1299168|NCT03607058|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1299169|NCT03607045|Randomized|Parallel Assignment||Treatment||Double||two groups homogeneous|t||t|
1299170|NCT03607032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299171|NCT03607019|||Cohort||Prospective|||||||
1299172|NCT03607006|Randomized|Parallel Assignment||Treatment||None (Open Label)|None because the two interventions requires different preoperative preparations , both the participants and the investigator can't be blinded .|"A randomized clinical trial.~Parallel group study.~A trial will be carried out in hospital of Oral and Maxillofacial surgery department - Faculty of Oral and Dental Medicine - Cairo University .~Equal randomization : participants with equal probabilities for intervention.~Positive controlled : Both groups receiving treatment."||||
1299173|NCT03606993|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1299174|NCT03606980|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299175|NCT03606967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299176|NCT03606954|Non-Randomized|Parallel Assignment||Other||Triple|double-blind controlled comparative study||t||t|t
1299177|NCT03606941|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1299178|NCT03606928||Single Group Assignment||Treatment||None (Open Label)||||||
1299179|NCT03606915|||Ecologic or Community||Cross-Sectional|||||||
1299181|NCT03606889|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)||t|t|t|t
1299182|NCT03606876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299183|NCT03606863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299184|NCT03606850||Single Group Assignment||Treatment||None (Open Label)||The patients will assess for markers of cortical excitability (cortical silent period CSP, resting motor threshold RMT, motor evoked potential MEP, intra-cortical inhibition ICI and intra-cortical facilitation ICF) before treatment, at day 3, day 7, day 14, day28 and day 60 with an assessment of depression (HAMD-21).||||
1299185|NCT03606837||Single Group Assignment||Treatment||None (Open Label)||||||
1299186|NCT03606824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299187|NCT03606811|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1299188|NCT03606798|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1299189|NCT03606785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299190|NCT03606772|||Cohort||Cross-Sectional|||||||
1299191|NCT03606759|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1299192|NCT03606746||Single Group Assignment||Treatment||None (Open Label)||||||
1299193|NCT03606733||Single Group Assignment||Treatment||None (Open Label)||Injection of triamcinilone or/ and VEGF blockade agents in the Supra Choroidal Space||||
1299194|NCT03606720|Randomized|Parallel Assignment||Treatment||Quadruple|If LLLT and pelvic stabilization exercises can reduce pain and improve function there will be a new treatment option for this condition|Effect of low-level laser therapy and pelvic stablisation exercises on postpartum pelvic girdle pain.|t|t|t|t
1299195|NCT03606707|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1299196|NCT03606694|Randomized|Parallel Assignment||Treatment||Double||Assignment|t||t|
1299197|NCT03606681|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299198|NCT03606668||Single Group Assignment||Treatment||None (Open Label)||||||
1299199|NCT03606655||Single Group Assignment||Supportive Care||None (Open Label)||Single-Arm Pre- and Post- Trial||||
1299200|NCT03606642||Single Group Assignment||Treatment||None (Open Label)||DAPT or Dual Antiplatelet Therapy is a combination of two medications given after a percutaneous coronary intervention (PCI) with a drug eluting stent. The medications used for DAPT are low dose Aspirin (81mg) and one of three (3) antiplatelet medications: ticagrelor (Brilinta), clopidogrel (Plavix) or prasugrel (Effient). Because the patients are considered to be at a high risk for bleeding due to one or a combination of reasons this study is trying to determine if a shorter use of DAPT in combination with the Synergy® stent and an imaging tool called IVUS used during your PCI procedure is safe and effective to reduce the potential for serious bleeding events and early stent thrombosis. The Synergy® stent was chosen because of its enhanced method of healing and reduced inflammation of the artery after placement. The Synergy stent may be a better choice for patients who are at high risk for bleeding and could benefit from a shortened period of DAPT.||||
1299201|NCT03606629|||Cohort||Prospective|||||||
1299202|NCT03606616|||Cohort||Prospective|||||||
1299203|NCT03606603|||Other||Retrospective|||||||
1299204|NCT03606590||Single Group Assignment||Treatment||None (Open Label)||||||
1299205|NCT03606577||Single Group Assignment||Treatment||None (Open Label)||One group of subjects who must have documented Multiple Myeloma High Risk satisfying the CRAB and measurable disease.||||
1299206|NCT03606564|||Case-Only||Cross-Sectional|||||||
1299207|NCT03606551|||Case-Only||Prospective|||||||
1299208|NCT03606538|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|No masking; open-label|Matched group comparison of pharmacokinetics and metabolism of single dose of 80 mg MDMA in participants with moderate hepatic impairment and participants with normal hepatic function and matched on age, weight and gender.||||
1299209|NCT03606525|||Cohort||Prospective|||||||
1299210|NCT03606512|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1299211|NCT03606499|||Cohort||Prospective|||||||
1299212|NCT03606486||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299213|NCT03606473|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||[C-11]NPA d-amphetamine||||
1299214|NCT03606460|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1299215|NCT03606447||Single Group Assignment||Basic Science||None (Open Label)||||||
1299216|NCT03606434||Single Group Assignment||Basic Science||None (Open Label)||All participants will undergo same 30 minute intermittent hypoxia protocol.||||
1299217|NCT03606421|||Cohort||Prospective|||||||
1299218|NCT03606408||Single Group Assignment||Treatment||None (Open Label)||||||
1299219|NCT03606395|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind|Randomized, placebo-controlled, single dose|t|t|t|t
1299220|NCT03606382|||Case-Only||Prospective|||||||
1299221|NCT03606369|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299222|NCT03606356|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Open-label, single-arm, prospective multicentre, clinical study||||
1299223|NCT03606343||Single Group Assignment||Treatment||None (Open Label)||Open trial||||
1299224|NCT03606330|||Cohort||Prospective|||||||
1299225|NCT03606317|||Case-Only||Retrospective|||||||
1299226|NCT03606304||Single Group Assignment||Treatment||None (Open Label)||This is a single group, pre-/post-test design with a 6 month follow-up period. There are 8 weekly intervention sessions, each approximately 30-45 minutes long. The 3 telephone booster sessions occurring every two months during the followup phase are estimated to last 20 minutes.||||
1299227|NCT03606291||Single Group Assignment||Treatment||None (Open Label)||||||
1299277|NCT03605628||Single Group Assignment||Treatment||None (Open Label)|Assessment of the quality of operation conditions by the obstretic surgeon without information with regard to the actual depth of the neuromuscular block or the drugs administrated for improvement of the block.|||||
1299337|NCT03604848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299338|NCT03604835|||Other||Prospective|||||||
1299339|NCT03604822||Single Group Assignment||Health Services Research||None (Open Label)||Single-subject design (Repeated measures)||||
1299228|NCT03606278|Randomized|Parallel Assignment||Other||Single|For the performance and evaluation score of the adherence of the teams to the resuscitation protocols, a review of the literature was performed, and the modified version of the validated Neonatal Resuscitation Performance Evaluation (NRPE) tool was considered (1). Given that this instrument did not consider behavioral and leadership aspects, a checklist of individual performance and performance by profession was constructed in each of the scenarios that included cognitive/technical and behavioral aspects. This checklist was applied by a reviewer blinded to the assignment of the type of debriefing by reviewing the video of the participation of the groups in the scenarios.|The study participants were randomly assigned to the type of debriefing (oral or video), stratified by the type of health professional. For this randomization, the random function of Excel was used, sorting the participants in a random number order and assigning the first half to the oral group and the other half to the video-assisted group. For the conformation of the teams, a second randomization was performed, in which the professionals within an assigned group (oral or video-assisted) were randomized to form a resuscitation team. In this randomization, Excel's random function was also used, sorting the patients in a random number order and assigning the one that was ordered first to team 1, the second to team 2, and so on, each team had three professions: pediatrician, professional nurse, and respiratory therapist. The same team was maintained during the participation of each scenario.||||t
1299229|NCT03606265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299230|NCT03606252|Non-Randomized|Parallel Assignment||Other||Single||||||t
1299231|NCT03606239||Single Group Assignment||Treatment||None (Open Label)||||||
1299232|NCT03606226|||Cohort||Cross-Sectional|||||||
1299233|NCT03606213|Randomized|Parallel Assignment||Treatment||Single|||t|||
1299234|NCT03606200|||Cohort||Other|||||||
1299235|NCT03606187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299236|NCT03606174||Single Group Assignment||Treatment||None (Open Label)||||||
1299237|NCT03606161||Single Group Assignment||Supportive Care||None (Open Label)||||||
1299238|NCT03606148|||Case-Control||Prospective|||||||
1299239|NCT03606135|||Case-Control||Prospective|||||||
1299240|NCT03606122||Single Group Assignment||Treatment||None (Open Label)||||||
1299241|NCT03606109|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1299242|NCT03606096|Randomized|Parallel Assignment||Prevention||Quadruple|Neither the expectant mothers themselves nor members of the clinical trial team assessing the safety or laboratory-based endpoints (immunogenicity and exploratory immunology) will be aware which of these groups the expectant mother has been randomized into.|Eligible pregnant women will be randomized in parallel into one of four groups: two groups will receive maternal Boostrix ® Polio (GSK) the other two groups Tetanus toxoid as per EPI schedule.|t|t|t|t
1299243|NCT03606083|||Cohort||Prospective|||||||
1299244|NCT03606070||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299245|NCT03606057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299246|NCT03606044|||Cohort||Prospective|||||||
1299247|NCT03606031|||Cohort||Prospective|||||||
1299248|NCT03606018|Randomized|Crossover Assignment||Basic Science||Single|This study was blinded for Sponsor, investigators and analytical laboratory|two-way crossover||||t
1299249|NCT03606005|||Case-Control||Prospective|||||||
1299250|NCT03605992|Randomized|Parallel Assignment||Treatment||Single||||||t
1299251|NCT03605979|||Cohort||Prospective|||||||
1299252|NCT03605966|||Cohort||Prospective|||||||
1299253|NCT03605953|||Cohort||Prospective|||||||
1299254|NCT03605940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299255|NCT03605927||Single Group Assignment||Prevention||None (Open Label)||||||
1299256|NCT03605914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299257|NCT03605901|Randomized|Parallel Assignment||Supportive Care||Single|Post-operative data will be collected by blinded staff. Patient daily pain based on the analog scale of 0-10 post-operative for the first 72 hours, total opioid usage, length of stay, time to get out of bed.|Subjects will be randomly assigned to one of two different protocols by a designated study team member based on a computer generated randomization table. Randomization will occur on the day of surgery. Randomization will be 1:1.||||t
1299258|NCT03605888|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299259|NCT03605875|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||1:1 allocation||||
1299260|NCT03605862|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299261|NCT03605849||Single Group Assignment||Treatment||None (Open Label)||||||
1299262|NCT03605836|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1299263|NCT03605823||Single Group Assignment||Treatment||Single||||||t
1299264|NCT03605810|||Cohort||Retrospective|||||||
1299265|NCT03605797|||Cohort||Retrospective|||||||
1299266|NCT03605771|||Cohort||Prospective|||||||
1299267|NCT03605758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299268|NCT03605745||Single Group Assignment||Treatment||None (Open Label)||This study is a prospective, non-randomized clinical trial of subjects with benign prostatic hypertrophy (BPH).||||
1299269|NCT03605732|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1299270|NCT03605719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299271|NCT03605706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299272|NCT03605693|Randomized|Parallel Assignment||Prevention||Single|Outcomes assessors that assess PTSD symptoms 1 month after discharge (primary outcome) will be blinded to treatment assignment.|||||t
1299273|NCT03605680|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1299274|NCT03605667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299275|NCT03605654|Randomized|Parallel Assignment||Prevention||None (Open Label)||A low-dose Total Lymphoid Irradiation and anti- thymocyte globulin combined with a single infusion of MDR-102||||
1299276|NCT03605641|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1299335|NCT03604874|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1299336|NCT03604861|||Cohort||Prospective|||||||
1299278|NCT03605615|Randomized|Parallel Assignment||Prevention||None (Open Label)||This will be a randomized open-label trial with the objective of evaluating the effect of vocalization as a perineal protection maneuver during the second stage of labor. Paerturients will be randomized to receive standard care, which in the ward is already a humanized approach, with freedom of position, and to push, ou to, toguether with all this standard prodedure, receive orientation about vocalization techniques.||||
1299279|NCT03605602|||Cohort||Prospective|||||||
1299280|NCT03605589||Single Group Assignment||Treatment||None (Open Label)||This is a pilot study to assess the safety, tolerability, and preliminary anti-tumor activity of the combination of pembrolizumab and blinatumomab in children and young adult patients with relapsed and/or refractory CD19 positive B-cell hematologic malignancies.||||
1299281|NCT03605576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299282|NCT03605563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299283|NCT03605550||Single Group Assignment||Treatment||None (Open Label)||||||
1299284|NCT03605537|Randomized|Parallel Assignment||Treatment||Single||||||t
1299285|NCT03605524||Single Group Assignment||Other||None (Open Label)||||||
1299286|NCT03605511|||Cohort||Prospective|||||||
1299287|NCT03605498|||Cohort||Prospective|||||||
1299288|NCT03605485||Single Group Assignment||Treatment||None (Open Label)||||||
1299289|NCT03605472||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299290|NCT03605459||Single Group Assignment||Treatment||None (Open Label)||||||
1299291|NCT03605446|Randomized|Single Group Assignment||Basic Science||Single|Single blind white label||t|||
1299292|NCT03605433|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299293|NCT03605420|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1299294|NCT03605407|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1299295|NCT03605394|||Other||Retrospective|||||||
1299296|NCT03605381|||Cohort||Prospective|||||||
1299297|NCT03605368|Randomized|Parallel Assignment||Treatment||Single||||||t
1299298|NCT03605355|||Cohort||Prospective|||||||
1299299|NCT03605342|Randomized|Parallel Assignment||Treatment||Single|To fully assess and appreciate complex symptomatology in this patient population, assessments were selected to have both relevance to the investigators' study of PTSD and comorbid OUD. Assessments will be done by an Independent Evaluator (IE) blind to treatment group.|This study is a 14-week, open-label randomization: 1) buprenorphine (BUP) + CPT-C vs (2) BUP + IDC. Phase I: buprenorphine induction and stabilization for all participants. Participants starting dose 2mg/0.5 mg BUP/NLX this will increased as needed up to 24 mg per day. Phase II: randomization to CPT vs. IDC (x12 weeks). CPT-C will be provided by one of the investigators' licensed therapists trained. IDC will be provided by research staff. Phase III: Subjects will be referred to one of the buprenorphine clinics (West Haven or Newington) and will be referred for ongoing treatment for PTSD if they choose, including the option for CPT-C for those who did not receive this during the study. Participants will be seen on a daily basis (excluding weekends) for the initial 5-7 day induction. Once subjects are on maintenance dose of BUP/NLX, they will be seen weekly by study RN for the first 4 weeks, biweekly for a month then monthly for symptom evaluation, and medication refill.||||t
1299300|NCT03605329||Single Group Assignment||Other||None (Open Label)||||||
1299301|NCT03605316|||Cohort||Retrospective|||||||
1299302|NCT03605303||||||||||||
1299303|NCT03605290|Non-Randomized|Parallel Assignment||Diagnostic||Triple|The operative technique (Kinematic Vs. Mechanically aligned) is not revealed to the patient, investigator and outcomes assessor.||t||t|t
1299304|NCT03605277||Parallel Assignment||Basic Science||None (Open Label)||||||
1299305|NCT03605264|||Case-Only||Prospective|||||||
1299306|NCT03605251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299307|NCT03605238||Single Group Assignment||Treatment||None (Open Label)||||||
1299308|NCT03605225|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1299309|NCT03605212|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299310|NCT03605199||Single Group Assignment||Treatment||None (Open Label)||||||
1299311|NCT03605186|Randomized|Parallel Assignment||Prevention||Single||||||t
1299312|NCT03605173|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1299313|NCT03605160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299314|NCT03605147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299315|NCT03605134|||Cohort||Prospective|||||||
1299316|NCT03605121|||Cohort||Retrospective|||||||
1299317|NCT03605108|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1299318|NCT03605095|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1299319|NCT03605082|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1299320|NCT03605069|Randomized|Parallel Assignment||Treatment||Quadruple||intra-subject, placebo-controlled|t|t|t|t
1299321|NCT03605056||Single Group Assignment||Treatment||None (Open Label)||All the patients involved in this study will receive a 3-drug regimen (chindamide, lenalidomide and dexamethasone)||||
1299322|NCT03605043|||Cohort||Retrospective|||||||
1299323|NCT03605030|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299324|NCT03605017|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1299325|NCT03605004|||Other||Retrospective|||||||
1299326|NCT03604991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299327|NCT03604978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299328|NCT03604965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299329|NCT03604952|||Cohort||Prospective|||||||
1299330|NCT03604939||Single Group Assignment||Screening||None (Open Label)||35,000 households in 228 villages, among which women between 30 to 60 years residing in the villages of the block are eligible to participate||||
1299331|NCT03604926|||Case-Control||Prospective|||||||
1299332|NCT03604913|Randomized|Parallel Assignment||Treatment||Single|||||t|
1299333|NCT03604900||||||||||||
1299334|NCT03604887|||Other||Cross-Sectional|||||||
1299399|NCT03604042|Randomized|Parallel Assignment||Other||Single|||t|||
1299340|NCT03604809|Randomized|Parallel Assignment||Treatment||Double||||t||t
1299341|NCT03604796|Randomized|Parallel Assignment||Treatment||Single||||||t
1299342|NCT03604783||Single Group Assignment||Treatment||None (Open Label)||||||
1299343|NCT03604770|||Cohort||Prospective|||||||
1299344|NCT03604757||Single Group Assignment||Treatment||None (Open Label)||||||
1299345|NCT03604744|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1299346|NCT03604731|||Cohort||Prospective|||||||
1299347|NCT03604718|||Cohort||Prospective|||||||
1299348|NCT03604705||Single Group Assignment||Treatment||None (Open Label)||||||
1299349|NCT03604692||Sequential Assignment||Treatment||None (Open Label)||A dose escalation study based on the use of a modified 3 + 3 design of up to 6 subjects in each of 5 SNDX-6352 dose levels to determine the optimal biologic dose (OBD) and recommended Phase 2 dose (RP2D).||||
1299350|NCT03604679||Single Group Assignment||Treatment||None (Open Label)||||||
1299351|NCT03604666|||Cohort||Other|||||||
1299352|NCT03604653|||Cohort||Prospective|||||||
1299353|NCT03604640|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299354|NCT03604627||Single Group Assignment||Prevention||None (Open Label)||||||
1299355|NCT03604614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299356|NCT03604601|||Case-Only||Retrospective|||||||
1299357|NCT03604588||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299358|NCT03604575|Randomized|Crossover Assignment||Basic Science||Quadruple|This study was blinded for Sponsor, investigators and analytical laboratory|two-way crossover|t|t|t|t
1299359|NCT03604562||||||||||||
1299360|NCT03604549|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299361|NCT03604536|||Cohort||Prospective|||||||
1299362|NCT03604523|Randomized|Crossover Assignment||Treatment||Single||Participants are randomized to procedure, but if participant fails the first procedure they are given the opportunity to crossover to the other arm for a follow up procedure.|t|||
1299363|NCT03604510||Single Group Assignment||Health Services Research||None (Open Label)||||||
1299364|NCT03604497|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1299365|NCT03604484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299366|NCT03604471||Single Group Assignment||Other||None (Open Label)||||||
1299367|NCT03604458|||Ecologic or Community||Cross-Sectional|||||||
1299368|NCT03604445|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299369|NCT03604432||||||||||||
1299370|NCT03604419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299371|NCT03604406|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1299372|NCT03604393|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Aims II and III are interventional, using a randomized stepped-wedge design with the practice as the unit of randomization.||||
1299373|NCT03604380|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299374|NCT03604367||Single Group Assignment||Device Feasibility||None (Open Label)||The investigators will enroll healthy volunteers to determine that with active bipedal movement there will be no difference in head movement, but greater motor cortex BOLD signal, smoother force exchange between the feet, higher participant satisfaction than unipedal movement or motor imagery alone.||||
1299375|NCT03604354|Randomized|Parallel Assignment||Prevention||Quadruple|This study will be participant and investigator blinded. Allocation concealment will be done by sequentially numbered sealed drug pouches.||t|t|t|t
1299376|NCT03604341|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1299377|NCT03604328||Single Group Assignment||Treatment||None (Open Label)||||||
1299378|NCT03604315||Single Group Assignment||Treatment||None (Open Label)||||||
1299379|NCT03604302||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299380|NCT03604289|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1299381|NCT03604276|||Cohort||Prospective|||||||
1299382|NCT03604263||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1299383|NCT03604250||Single Group Assignment||Prevention||None (Open Label)||This is a pilot trial with a single group of 14 participants: 10 with prediabetes or at least 2 of the metabolic syndrome criteria (half males, half females) 4 healthy people (do not have prediabetes nor any of the metabolic syndrome criteria) of 11 weeks (77 days) duration.||||
1299384|NCT03604237|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1299385|NCT03604224|||Case-Only||Retrospective|||||||
1299386|NCT03604211|||Cohort||Retrospective|||||||
1299387|NCT03604198||Single Group Assignment||Treatment||None (Open Label)||||||
1299388|NCT03604185|Randomized|Parallel Assignment||Treatment||None (Open Label)||Sixty hearing aided older adults will be randomly assigned to one of three conditions: a choir singing class (n=20), a music appreciation class (n=20), and a do-nothing control group (n=20). Choir participants will take part in a singing class for 14 weeks, during which they will take part in group singing (2 hours/week) supported by individual online musical training (1 hour/week). Participants will undergo pre- and post-training assessments, conducted during the first week of the choir class and again after the last week. The music appreciation group will consist of hearing aided older adults attending 14 weeks of music listening classes, and the do-nothing control group will not be engaged in an active intervention. All participants will undergo the same battery of assessments, measured before and after the 14-week time frame.||||
1299389|NCT03604172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299390|NCT03604159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299391|NCT03604146|||Case-Control||Prospective|||||||
1299392|NCT03604133|||Case-Only||Prospective|||||||
1299393|NCT03604120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299394|NCT03604107|||Cohort||Prospective|||||||
1299395|NCT03604094|||Cohort||Prospective|||||||
1299396|NCT03604081|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1299397|NCT03604068|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299398|NCT03604055||Single Group Assignment||Treatment||None (Open Label)||||||
1299400|NCT03604029|||Cohort||Prospective|||||||
1299401|NCT03604016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299402|NCT03604003|Randomized|Parallel Assignment||Treatment||Single|||t|||
1299403|NCT03603990|Randomized|Parallel Assignment||Treatment||Single|Although both the patient and the investigating physician will be aware of group assignment, the evaluation of the primary endpoint (visual acuity) will be performed by independent evaluators, unaware of the randomization group for each eye. The evaluation of the CSF thickness will be automatically recorded by the OCT and therefore will not be influenced by the eye's group.|Prospective randomized open blinded end-point (PROBE) pragmatic study, in which patients act as their own control.||||t
1299404|NCT03603977|||Case-Only||Prospective|||||||
1299405|NCT03603964||Single Group Assignment||Treatment||None (Open Label)||||||
1299406|NCT03603951||Single Group Assignment||Treatment||None (Open Label)||||||
1299407|NCT03603938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299408|NCT03603925|||Case-Crossover||Prospective|||||||
1299409|NCT03603912|Randomized|Factorial Assignment||Treatment||Single||||||t
1299410|NCT03603899||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299411|NCT03603886|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Waitlist control group receives intervention following waitlist period.||||
1299412|NCT03603873|||Cohort||Prospective|||||||
1299413|NCT03603860|||Case-Only||Prospective|||||||
1299414|NCT03603847|||Case-Only||Prospective|||||||
1299415|NCT03603834||Single Group Assignment||Treatment||None (Open Label)||||||
1299416|NCT03603821|||Cohort||Prospective|||||||
1299417|NCT03603808||Single Group Assignment||Treatment||None (Open Label)||||||
1299418|NCT03603795|Randomized|Parallel Assignment||Treatment||Triple||Randomization between 2 arms|t|t|t|
1299419|NCT03603782|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1299420|NCT03603769|Randomized|Sequential Assignment||Prevention||Double|A placebo capsule (glycerine only, with no SPL)|"Each subject will participate in five daily trials on 5 separate days, at least 2 weeks apart.~Within each appointment each participant will come (after fasting overnight, 10-12 h), to our metabolic unit early in the morning (07:30 - 08.30 am) and will initially give a fasting baseline blood sample. Afterwards, in specific time he/she will be provided to consume a standardized breakfast and then he/she will be administered randomly either placebo or several versions of the food supplement containing Salmon Polar Lipids (Low Dose stomach release or High Dose stomach release or Low Dose intestine release or High Dose Intestine Release). Thus, the sequence of the trials will be randomly selected for each subject."|t||t|
1299421|NCT03603756|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299422|NCT03603743|Randomized|Parallel Assignment||Supportive Care||Double|heart rate variability analyses and echocardiography were performed by investigators blind to randomization|"subjects were randomly assigned to one of the two groups:~high intensity interval training~moderate intensity and continuous training Block size = 4, allocation ratio 1:1"|||t|t
1299423|NCT03603730||Sequential Assignment||Basic Science||None (Open Label)||There will be multiple study visits consisting of a screening, baseline testing, consumption of a liquid meal, and fMRI brain and gut imaging sessions. Visits will include active and inactive taVNS delivered to the outer ear at a moderate, non-painful level.||||
1299424|NCT03603717|Randomized|Parallel Assignment||Treatment||Double|Participants will be informed that they are receiving one of two non-medication sleep interventions. Assessors are blinded to study condition. Study staff entering data will be blinded to condition. It is not possible to blind staff delivering the interventions. The PI's are providing some supervision of the interventionists, so they will be unblinded for those participants they supervise interventionists on.|Two parallel study arms: (1) cognitive behavioral therapy for insomnia (the experimental condition) and (2) sleep hygiene (the control condition).|t|||t
1299425|NCT03603704|Randomized|Parallel Assignment||Basic Science||Double|Cohort 3 is open-label.||t||t|
1299426|NCT03603691|Randomized|Crossover Assignment||Diagnostic||Single|the outcome assessors will be blinded for the results of other assessors.|Prospective, cross-sectional and test-retest||||t
1299427|NCT03603678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299428|NCT03603665|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1299429|NCT03603652||Single Group Assignment||Treatment||None (Open Label)||||||
1299430|NCT03603639|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1299431|NCT03603626|Randomized|Parallel Assignment||Treatment||Single|||t|||
1299432|NCT03603613|Randomized|Parallel Assignment||Treatment||Single|Under the supervision of Innovations for Poverty Action (IPA) Sierra Leone, local research assistants (blind to site and youth condition assignments) will conduct all screening, baseline, and follow up quantitative assessments. Ongoing data collection at all sites will include youth attendance and satisfaction with YRI content, counselor satisfaction with content and delivery via scales and qualitative exit interviews, as well as monitored audio-recording of all sessions for fidelity by an independent expert rater hired by CARITAS. The expert fidelity monitor will be a skilled YRI trainer and supervisor from our prior RCT and will not be a part of the standard CTS training condition nor the ICT Seed Team, thus allowing them to provide impartial and blinded fidelity ratings of all audio-transcripts.|A cluster randomized three-arm trial will be employed in the pilot phase in the same districts as the scale-up study. Youth (N=180, 18-26 years old, 50% female), stratified by gender, will be randomized into the three study arms. Once youth are enrolled into the study, they will be assigned to community level sites based on geographical location. Each of these community level sites will make up one cluster. The clusters will then be randomly assigned into the three study arms so that sixty youth will be randomized into the youth employment promotion program (EPP) arm, sixty youth will be randomized into the YRI+EPP arm, and sixty youth will be randomized into the control arm . The pilot study will last approximately 12 weeks and data will be collected at baseline and post-intervention. Further, we will survey 120 third-party reporters for a total pilot study sample size of 300 participants.||||t
1299484|NCT03602937||Single Group Assignment||Supportive Care||None (Open Label)||Open label prospective acceptability study.||||
1299485|NCT03602924|||Cohort||Prospective|||||||
1299486|NCT03602911||Single Group Assignment||Diagnostic||None (Open Label)||Proof of Concept||||
1573332|NCT00001573||||Treatment||||||||
1299433|NCT03603600|Randomized|Single Group Assignment||Treatment||Double|The Investigator implanting the IOL and designated site personnel will be unmasked to the assignment of IOLs. Subjects and designated postoperative evaluator(s) will be masked to the IOLs assigned.|Approximately 334 subjects will be implanted bilaterally with the enVista MX60EF trifocal MIOL, and approximately 167 control subjects will be implanted bilaterally with the enVista MX60E monofocal IOL|t|||t
1299434|NCT03603587||Single Group Assignment||Other||None (Open Label)||This is a prospective mono-centric study of the physiopathology of cutaneous aging.||||
1299435|NCT03603574|Randomized|Parallel Assignment||Other||Single|The outcome assessment will not be present during the performance of the epidural block and waveform analysis.|Randomized trial||||t
1299436|NCT03603561|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1299437|NCT03603548|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1299438|NCT03603535|||Cohort||Prospective|||||||
1299439|NCT03603522|Randomized|Crossover Assignment||Treatment||Quadruple||Participants will have a screening period followed by 28 days treatment with BioGaia DSM17938 or placebo, followed by a washout period and will then crossover to the opposite treatment received in the first part of the study.|t|t|t|t
1299440|NCT03603509|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Eligible subjects who consent and enroll will be randomly assigned to receive either the Fluad Vaccine or Fluzone High-Dose vaccine.||||
1299441|NCT03603496|Randomized|Parallel Assignment||Treatment||Single||||||t
1299442|NCT03603483|Randomized|Parallel Assignment||Treatment||None (Open Label)||Aortic Root Enlargement in Patients with aortic stenosis with Small Aortic Annulus||||
1299443|NCT03603470|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1299444|NCT03603457|||Cohort||Prospective|||||||
1299445|NCT03603444|||Case-Control||Retrospective|||||||
1299446|NCT03603431|Randomized|Sequential Assignment||Treatment||Triple|||t||t|t
1299447|NCT03603418|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299448|NCT03603405||Single Group Assignment||Treatment||None (Open Label)||||||
1299449|NCT03603392||Sequential Assignment||Treatment||None (Open Label)||two groups (experimental and control) randomly assigned||||
1299450|NCT03603379||Single Group Assignment||Basic Science||None (Open Label)||||||
1299451|NCT03603366|||Cohort||Cross-Sectional|||||||
1299452|NCT03603353|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statisticians and laboratory personnel will be blinded to group allocation|||||
1299453|NCT03603340|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statisticians and laboratory personnel will be blinded to group allocation|||||
1299454|NCT03603327||Single Group Assignment||Treatment||None (Open Label)||||||
1299455|NCT03603314|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299456|NCT03603301|||Cohort||Prospective|||||||
1299457|NCT03603288||Single Group Assignment||Treatment||None (Open Label)||Open-Label Extension Study||||
1299458|NCT03603275|||Cohort||Cross-Sectional|||||||
1299459|NCT03603262||Single Group Assignment||Treatment||None (Open Label)||||||
1299460|NCT03603249||Single Group Assignment||Basic Science||None (Open Label)|The Outcomes Assessor will be independent of the Clinical Research Associates, i.e. he/she will be analyzing the VerifyNow samples without knowledge of the intervention the patient has received.|The study will be of a prospective, randomized, controlled, sequential trial design.||||
1299461|NCT03603236|||Case-Control||Prospective|||||||
1299462|NCT03603223||Single Group Assignment||Treatment||None (Open Label)||||||
1299463|NCT03603210|||Cohort||Retrospective|||||||
1299464|NCT03603197|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1299465|NCT03603184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299466|NCT03603171|||Case-Control||Prospective|||||||
1299467|NCT03603158|||Other||Cross-Sectional|||||||
1299468|NCT03603145|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled open label||||
1299469|NCT03603132|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1299470|NCT03603119|Randomized|Single Group Assignment||Prevention||Single|concealed envelopes|||t||
1299471|NCT03603106|Randomized|Sequential Assignment||Diagnostic||Triple||"Part I: Sequential administration within each group of healthy subjects was established.~Part II: The administration to patients within the same day was sequential to ensure the well-being of the patients. At least a 1-hour interval between the 2 administrations had to be respected."|t|t|t|
1299472|NCT03603093|||Cohort||Cross-Sectional|||||||
1299473|NCT03603080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299474|NCT03603067|||Cohort||Prospective|||||||
1299475|NCT03603054|Randomized|Parallel Assignment||Treatment||Single||The study sample will be randomly divide into 2 groups, a control group subject to a placebo technique and an intervention group subject to an active mobilization of the sciatic nerve.|t|||
1299476|NCT03603041|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1299477|NCT03603028||Single Group Assignment||Treatment||None (Open Label)||||||
1299478|NCT03603015||Single Group Assignment||Diagnostic||None (Open Label)||Single pilot group all receiving the same tests||||
1299479|NCT03603002||Single Group Assignment||Diagnostic||None (Open Label)||Compare pre- and post-SABR core biopsies of stage I NSCLC tumors to identify SABR-induced immune-mediated tumor recognition based on a significant and specific expansion of T-cell clones using a novel T-cell receptor (TCR) sequencing assay.||||
1299480|NCT03602989|||Case-Only||Cross-Sectional|||||||
1299481|NCT03602976|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)|All subjects will receive appropriately dosed UDCA after six months of observation|Subjects will act as their own controls by undergoing a six-month initial observational period prior to initiating the six-month UDCA intervention||||
1299482|NCT03602963|||Cohort||Prospective|||||||
1299483|NCT03602950|Randomized|Parallel Assignment||Prevention||None (Open Label)||The intervention group will receive PRP at surgery, whereas the control group will receive the usual care. All patients will be evaluated at baseline, one week, four weeks and eight week after the cesarean section.||||
1299487|NCT03602898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299488|NCT03602885|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1299489|NCT03602872|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299490|NCT03602859|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299491|NCT03602846|||Other||Retrospective|||||||
1299492|NCT03602833||Single Group Assignment||Treatment||None (Open Label)||||||
1299493|NCT03602820|||Cohort||Prospective|||||||
1299494|NCT03602807||Single Group Assignment||Treatment||None (Open Label)||||||
1299495|NCT03602794|Randomized|Parallel Assignment||Supportive Care||Double||Randomised Controlled|t|||t
1299496|NCT03602781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299497|NCT03602768|Randomized|Parallel Assignment||Prevention||Triple|"The study personnel who conduct screening and send pre/post-test surveys to participants are all blinded.~Randomizer is blinded to all participant pre-test outcomes. Care providers know what their participants are doing, but not aware of the full study design, including details of the other conditions or outcome test characteristics."|Participants are screened, undergo a battery of cognitive testing for the pre-test, and then are randomly assigned to one of four intervention groups: MAP, GMT, BrainHQ (active control), or waitlist. After intervention, the participants take the same test battery and complete it once more at 6 week followup.|t||t|t
1299498|NCT03602755|||Case-Only||Retrospective|||||||
1299499|NCT03602742||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299500|NCT03602729|Randomized|Parallel Assignment||Other||Single||||||t
1299501|NCT03602716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299502|NCT03602703|||Case-Control||Cross-Sectional|||||||
1299503|NCT03602690||Single Group Assignment||Treatment||None (Open Label)||||||
1299504|NCT03602677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299505|NCT03602664|||Cohort||Prospective|||||||
1299506|NCT03602651|||Cohort||Prospective|||||||
1299507|NCT03602638|Randomized|Parallel Assignment||Treatment||Single||||||t
1299508|NCT03602625|||Case-Control||Prospective|||||||
1299509|NCT03602612|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299510|NCT03602599|||Cohort||Prospective|||||||
1299511|NCT03602586||Single Group Assignment||Treatment||None (Open Label)||||||
1299512|NCT03602573|||Cohort||Prospective|||||||
1299513|NCT03602560|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299514|NCT03602547||Single Group Assignment||Treatment||None (Open Label)||||||
1299515|NCT03602534|||Case-Control||Cross-Sectional|||||||
1299516|NCT03602521|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1299517|NCT03602508|||Cohort||Retrospective|||||||
1299518|NCT03602495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299519|NCT03602482|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1299520|NCT03602469|Randomized|Parallel Assignment||Prevention||Double|Double-blind study||t|||t
1299521|NCT03602456|||Cohort||Prospective|||||||
1299522|NCT03602443|Randomized|Crossover Assignment||Treatment||Single||The study is a randomized, wait-list, cross-over design pilot feasibility trial.||||t
1299523|NCT03602430|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1299524|NCT03602417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299525|NCT03602404|||Ecologic or Community||Cross-Sectional|||||||
1299526|NCT03602391|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1299527|NCT03602378|||Other||Cross-Sectional|||||||
1299528|NCT03602365||Single Group Assignment||Other||None (Open Label)||Non randomized, single group study comparing the effects of GJ on resting oxygen consumption (VO2) measurements in seated and supine postures||||
1299529|NCT03602352|||Cohort||Retrospective|||||||
1299530|NCT03602339|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1299531|NCT03602326|Randomized|Parallel Assignment||Treatment||Triple||Patients admitted to Gazi University Hospital with stroke findings diagnosed with ischemic stroke by a Neurologist will be included in the study. Patients older than 18 years of age with a systolic blood pressure between 120 and 220 mmHg, whose oxygen saturation is >92% (with or without O2 support), with a heart rate of 40 to 100 beats/min, a body temperature of <38.5°C, a disability level of ≤4 according to the Modified Rankin Scale and those who could respond to verbal commands will be included in the study. Patients with; a history of previous stroke or any other disorder that would prevent mobilization will not be included in the study. The patients will be randomly divided into two groups: NDT-B Group and the Standard Rehabilitation Group.|t|t|t|
1299532|NCT03602313|Randomized|Parallel Assignment||Treatment||Single|Investigators were blinded to the study intervention. Data collection was performed at a separate location than the primary intervention.|Participants were randomly assigned to 1 of 2 groups for the duration of the study.|||t|
1299533|NCT03602300|Randomized|Crossover Assignment||Treatment||None (Open Label)||A Phase 1, Open-Label, Four-Period, Two-Sequence, Two-Treatment, Single Dose, Randomized, Crossover Bioequivalence Study||||
1299534|NCT03602287|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1299535|NCT03602274|||Cohort||Prospective|||||||
1299536|NCT03602261|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299537|NCT03602248|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1299538|NCT03602235||Single Group Assignment||Treatment||None (Open Label)||||||
1299539|NCT03602222|Randomized|Parallel Assignment||Other||None (Open Label)||120 MHPs will be randomized to receive the training either in-person or mobile on the web, concomitantly.||||
1299540|NCT03602209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299541|NCT03602196||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299542|NCT03602183|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1299543|NCT03602170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299544|NCT03602157||Single Group Assignment||Treatment||None (Open Label)||||||
1299545|NCT03602144|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1573333|NCT00001571||||||||||||
1299546|NCT03602131||Single Group Assignment||Treatment||None (Open Label)||||||
1299547|NCT03602118|Randomized|Parallel Assignment||Treatment||Double|All efforts will be made to blind the investigator and other key personnel of which dosage the participant was randomized to. Study drug will be dispensed by the pharmacy via a syringe to the investigator or their designee. The study medication label should only contain the protocol number, subject number and any other pertinent information. If after 1 hour following the completion of the study drug infusion, the seizure is not controlled with the initial loading dose, the patient will be considered a treatment failure in the primary efficacy analysis of this protocol/study. At this point, the blinding for the treating provider/investigator will be lifted.|This is a 1:1 randomized, double-blind, parallel-group, Phase 3 study.||t|t|
1299548|NCT03602105|Randomized|Parallel Assignment||Treatment||Single||||||t
1299549|NCT03602092|||Cohort||Prospective|||||||
1299550|NCT03602079|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299551|NCT03602066|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1299552|NCT03602053|Randomized|Parallel Assignment||Prevention||None (Open Label)||Phase IIb, single center, randomized, controlled, open label study||||
1299553|NCT03602040||Single Group Assignment||Supportive Care||None (Open Label)||This feasibility study will be using mixed methods and will be conducted in 2 phases.Phase 1 of the study is an uncontrolled clinical trial of the psychoeducational education. Phase 2 is a nested qualitative component of the feasibility study and will be comprise of at least 7 semi-structured interviews lasting up to 30 minutes with patients who participated in the trial.||||
1299554|NCT03602027||Single Group Assignment||Treatment||None (Open Label)||||||
1299555|NCT03602014|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299556|NCT03602001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299557|NCT03601988|Randomized|Parallel Assignment||Treatment||None (Open Label)||All patients randomized to receive chemotherapy or chemo-radiotherapy after D2 surgery||||
1299558|NCT03601975|Randomized|Parallel Assignment||Treatment||Single|||||t|
1299559|NCT03601962|Randomized|Crossover Assignment||Treatment||Quadruple||randomized, double blind, placebo controlled, cross over study|t|t|t|t
1299560|NCT03601949|Randomized|Parallel Assignment||Treatment||Single|The study is an assessor blinded trial and deliberate action will be needed to ensure the blind remains. This begins with randomization procedures and carries through the follow up visits. It is suggested that all follow up visit documentation not contain the visit number, but instead utilize visit dates to track progress.|||||t
1299561|NCT03601936||Single Group Assignment||Screening||None (Open Label)||||||
1299562|NCT03601923||Single Group Assignment||Treatment||None (Open Label)||||||
1299563|NCT03601910|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1299564|NCT03601897|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299565|NCT03601884|Randomized|Parallel Assignment||Treatment||Single|To reduce performance bias after the randomization process, blinding is adopted. However, due to the conflicting requirements of ethical and methodological aspects in designing a randomized controlled trial with a psychosocial intervention, double blinding and randomizing each individual participant posits a huge challenge. Patients, the attending doctors and the co-author involved in randomly assigning the group will be blinded in a way that none of them will know which group is considered the experimental group and the control group.|"This study is a Randomised Controlled Trial. The sampling frame will be patients with diabetes registered in all the government health clinics located in Putrajaya. Patients are screened at the beginning and later interviewed using a structured questionnaire and intake interview. All four Health Clinics in Putrajaya will participate in the study, randomization will be conducted at the facility level.~This study is a two arm - experimental vs. control group RCT. Participants are randomly allocated at facility level. All four health clinics will be randomly assigned to the OHP and TAU (experimental group) or TAU (control group), with two health clinics randomly allocated in the experimental group and another two the control group."|t|||
1299566|NCT03601871|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299567|NCT03601858|||Cohort||Retrospective|||||||
1299568|NCT03601845|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Additional sequences during magnetic resonance elastography by intrinsic activation with or without stimuli||||
1299569|NCT03601832||Single Group Assignment||Treatment||None (Open Label)|No masking in this study.|All patients enroled in the study are allocated to one group with 4-D navigated stereotactic radiosurgical ablation.||||
1299570|NCT03601819||Single Group Assignment||Treatment||None (Open Label)||||||
1299571|NCT03601806||Single Group Assignment||Treatment||None (Open Label)||||||
1299572|NCT03601793|Randomized|Parallel Assignment||Treatment||Single|||t|||
1299573|NCT03601780|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1299574|NCT03601767|||Cohort||Prospective|||||||
1299575|NCT03601754||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299576|NCT03601741|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1299577|NCT03601728|Randomized|Parallel Assignment||Prevention||None (Open Label)||Matched case-control study design||||
1299578|NCT03601715|Randomized|Crossover Assignment||Other||Single||A randomized single blind, crossover experimental study.||||t
1299579|NCT03601702|||Case-Only||Prospective|||||||
1299580|NCT03601689|||Cohort||Retrospective|||||||
1299581|NCT03601676|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Pragmatic clinical trial of a multidimensional technology and educational intervention undertaken over 16 months with an 8-month pre-intervention and an 8-month post-intervention period, conducted across 21 emergency departments with 10 serving as intervention and 11 as control sites.||||
1299582|NCT03601663|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1299583|NCT03601650|Randomized|Parallel Assignment||Prevention||Single|||t|||
1299584|NCT03601637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1299585|NCT03601624||Single Group Assignment||Treatment||None (Open Label)||Interventional phase 2, multicentric, open label||||
1299688|NCT03600285||Single Group Assignment||Other||None (Open Label)||||||
1299803|NCT03598790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299586|NCT03601611||Single Group Assignment||Treatment||None (Open Label)||"- Patients will receive tocilizumab 8 mg/kg given as an IV infusion over 60 minutes every 4 weeks (Q4W) for at least 2 cycles or until worsening or lack of improvement of diarrhea and/or colitis and/arthritis, in case of unacceptable toxicity, withdrawal of consent or clear clinical deterioration, according to investigator's judgment.~At the initial stage, 7 patients will be enrolled and evaluated for symptom improvement. In case of ≤ 4 patients with at least one grade improvement, accrual will be terminated. If ≥ 5 patients with at least one grade improvement will be observed at the first stage, 13 additional patients will be entered at the second stage to achieve a target sample size of 20 evaluable patients. Further exploration of the treatment strategy is warranted, if at least one grade improvement is observed for ≥14 patients."||||
1299587|NCT03601598||Single Group Assignment||Treatment||None (Open Label)||||||
1299588|NCT03601585|Randomized|Crossover Assignment||Device Feasibility||Double|||||t|t
1299589|NCT03601572|||Case-Only||Prospective|||||||
1299590|NCT03601559|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1299591|NCT03601546|||Cohort||Prospective|||||||
1299592|NCT03601533||Single Group Assignment||Treatment||None (Open Label)||||||
1299593|NCT03601520|||Cohort||Retrospective|||||||
1299594|NCT03601507||Single Group Assignment||Treatment||None (Open Label)||||||
1299595|NCT03601494|Randomized|Parallel Assignment||Treatment||Single||||||t
1299596|NCT03601481|||Other||Retrospective|||||||
1299597|NCT03601468|||Other||Cross-Sectional|||||||
1299598|NCT03601455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299599|NCT03601442||||||||||||
1299600|NCT03601429|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1299601|NCT03601416|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299602|NCT03601403|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1299603|NCT03601390|||Cohort||Prospective|||||||
1299604|NCT03601377|Randomized|Parallel Assignment||Treatment||Double|Participants and investigators were blind with regards to which group participants were allocated.|Experiment 1: 2 groups (1 intervention and 1 placebo) receive treatment in parallel Experiment 2: 3 groups (2 types of intervention and 1 placebo) receive treatment in parallel|t||t|
1299605|NCT03601364|||Case-Control||Prospective|||||||
1299606|NCT03601351|||Cohort||Retrospective|||||||
1299607|NCT03601338|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||pregnant women with history of unexplained fetal death||||
1299608|NCT03601325|||Case-Control||Prospective|||||||
1299609|NCT03601312|Randomized|Crossover Assignment||Treatment||Single|The outcomes assessor will not have information about the participant's treatment condition, so they will not know whether or not they are receiving treatment as usual (Standard ERP) or OC-Go augmented ERP.|"All participants will receive 12 weeks of exposure/response/prevention (ERP). Sessions 1 (psychoeducation/hierarchy creation) and 12 (relapse prevention & generalization training) will be identical across both randomization groups.~Treatment sequences for the randomization groups will be as follows:~OC-GO-FIRST - Sessions 2-6: ERP+OC-Go, Sessions 7-11: Standard ERP~STANDARD ERP-FIRST - Sessions 2-6: Standard ERP, Sessions 7-11: ERP+OC-Go"||||t
1299610|NCT03601299|Randomized|Parallel Assignment||Prevention||Single|||t|||
1299611|NCT03601286||Single Group Assignment||Treatment||None (Open Label)||||||
1299612|NCT03601273||Single Group Assignment||Treatment||None (Open Label)||||||
1299613|NCT03601260||Single Group Assignment||Treatment||None (Open Label)||||||
1299614|NCT03601247||Single Group Assignment||Prevention||None (Open Label)||||||
1299615|NCT03601234|Randomized|Parallel Assignment||Treatment||Single||||||t
1299616|NCT03601221|||Other||Prospective|||||||
1299617|NCT03601208||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299618|NCT03601195|||Cohort||Prospective|||||||
1299619|NCT03601182||||||||||||
1299620|NCT03601169|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1299621|NCT03601156|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299622|NCT03601143|||Cohort||Prospective|||||||
1299623|NCT03601130|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1299624|NCT03601117|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will receive stimulation to one of two brain areas. Patients will be randomized to either stimulation site.||||
1299625|NCT03601104|Randomized|Parallel Assignment||Other||Single|||||t|
1299626|NCT03601091|Randomized|Parallel Assignment||Treatment||Double|DOUBLE BLINDED|RANDOMISED- DOUBLE BLINDED|t||t|
1299627|NCT03601078||Single Group Assignment||Treatment||None (Open Label)||||||
1299628|NCT03601065|||Cohort||Prospective|||||||
1299629|NCT03601052|Randomized|Parallel Assignment||Treatment||Triple|The treatment administered to each of two wound sites will be randomized (left versus right), such that all subjects will receive both MRG-201 and placebo in a double-blinded fashion.|Up to 6 cohorts of 12-16 subjects each may be enrolled to study various dose levels and dosing regimens.|t||t|t
1299630|NCT03601039||Single Group Assignment||Treatment||None (Open Label)||||||
1299631|NCT03601026|Randomized|Parallel Assignment||Prevention||Single|Eligible participants who are randomized to not be offered the intervention will not be aware of the presence of a potential intervention. Study staff who are assessing outcomes (i.e., psychopathology, cannabis use) will not know who did and did not receive the intervention.|Trial-within-cohort||||t
1299632|NCT03601013|||Cohort||Prospective|||||||
1299633|NCT03601000|Randomized|Parallel Assignment||Treatment||Triple||A randomized, double-blind, placebo-controlled study.|t|t|t|
1299634|NCT03600987||Single Group Assignment||Treatment||None (Open Label)||Single-subject adapted alternating treatment design.||||
1299635|NCT03600974|||Other||Prospective|||||||
1299636|NCT03600961|||Cohort||Prospective|||||||
1299637|NCT03600948|||Cohort||Prospective|||||||
1299638|NCT03600935||Single Group Assignment||Treatment||None (Open Label)||||||
1299639|NCT03600922||Single Group Assignment||Treatment||None (Open Label)||||||
1299752|NCT03599453||Single Group Assignment||Treatment||None (Open Label)||||||
1299753|NCT03599440|||Other||Prospective|||||||
1299640|NCT03600909|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A three-arm phase II treatment protocol designed to examine engraftment, toxicity, graft-versus-host disease, and disease-free survival following a novel cytoreductive regimen including busulfan, cyclophosphamide and fludarabine and ATG||||
1299641|NCT03600896|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299642|NCT03600883|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299643|NCT03600870||Single Group Assignment||Treatment||None (Open Label)||||||
1299644|NCT03600857|Randomized|Parallel Assignment||Other||None (Open Label)||Open label, multicentre, RCT||||
1299645|NCT03600844|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Districts in high malaria transmission zones were assigned to intervention and comparison areas.||||
1299646|NCT03600831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299647|NCT03600818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299648|NCT03600805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299649|NCT03600792|||Family-Based||Prospective|||||||
1299650|NCT03600779|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1299651|NCT03600766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299652|NCT03600753|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1299653|NCT03600740||Single Group Assignment||Treatment||None (Open Label)||||||
1299654|NCT03600727|Randomized|Parallel Assignment||Supportive Care||Single|Outcomes Assessor will be blinded to this study.|Patients receiving total hip and knee arthroplasty will be intraoperative sedated by propofol or dexmedetomidine.||||t
1299655|NCT03600714||Single Group Assignment||Treatment||None (Open Label)||||||
1299656|NCT03600701||Single Group Assignment||Treatment||None (Open Label)||||||
1299657|NCT03600688|||Cohort||Prospective|||||||
1299658|NCT03600675|||Other||Cross-Sectional|||||||
1299659|NCT03600662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299660|NCT03600649||Single Group Assignment||Treatment||None (Open Label)||This single arm study will utilize an accelerated dose escalation, followed by a conventional 3+3 dose escalation phase to achieve maximum tolerated dose (MTD).||||
1299661|NCT03600636|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1299662|NCT03600623|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be assigned to one of two treatment arms: Arm 1 is Folfirinox (5FU/Leucovorin/Irinotecan/Oxaliplatin) and Arm 2 is Gemcitabine-nab-Paclitaxel (Abraxane). Either arm will be followed with SBRT for eligible patients.||||
1299663|NCT03600610|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1299664|NCT03600597|||Cohort||Prospective|||||||
1299665|NCT03600584|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1299666|NCT03600571|Randomized|Parallel Assignment||Treatment||Double||"64 osteoarthritic knees of cadavers were randomly assigned to two groups: the anteromedial (AM) group (n=32) and the medial midpatellar (MMP) group (n=32).~100 patients with unilateral mKOA were enrolled and randomly divided into two groups according to the injection portal of HA: the AM group (n=50) and the MMP group (n=50)."|t|||t
1299667|NCT03600558|||Cohort||Retrospective|||||||
1299668|NCT03600545|Randomized|Parallel Assignment||Treatment||Single||||||t
1299669|NCT03600532|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be assigned in even numbers to TMBI & TAU or recruited as part of a CCG||||
1299670|NCT03600519||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299671|NCT03600506|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1299672|NCT03600493|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1299673|NCT03600480|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures||t|t|t|t
1299674|NCT03600467||Single Group Assignment||Treatment||None (Open Label)||START is an open-label, single-arm, multicentre Phase IIa signal-seeking trial.||||
1299675|NCT03600454|Randomized|Parallel Assignment||Basic Science||Single|Patients will be randomized using a computer-generated permuted block randomization sequence (variable block-size, 1:1 allocation). The randomization will be determined on the preoperative anesthesia assessment. After the randomisation, the investigator will inform the patient which anesthesia he/she will get during the operation|"Two independent, but complimentary, studies will be performed to evaluate the primary objective and the secondary objectives in this prospective trail.~Group 1: The effect of spinal anesthesia as compared to general anesthesia for total hip arthroplasty~Group 2: The effect of epidural analgesia compared to general anesthesia alone for major abdominal surgery"|||t|
1299676|NCT03600441||Single Group Assignment||Treatment||None (Open Label)||open label||||
1299677|NCT03600428|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299678|NCT03600415|Randomized|Crossover Assignment||Prevention||None (Open Label)||Including a baseline assessment and assessments at Low altitude and High altitude||||
1299679|NCT03600402|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1299680|NCT03600389|Non-Randomized|Parallel Assignment||Treatment||Single|Interviewer and chart abstractor is blinded to the nature of the intervention and to the group assignment.|||||t
1299681|NCT03600376|Randomized|Parallel Assignment||Treatment||Double||Ryanodex (dantrolene sodium) for injectable suspension plus Standard of Care|t|t||
1299682|NCT03600363|Randomized|Parallel Assignment||Treatment||Single|||||t|
1299683|NCT03600350||Single Group Assignment||Treatment||None (Open Label)||Single-arm, single-institution, two-stage phase II trial||||
1299684|NCT03600337|Randomized|Crossover Assignment||Prevention||Double||||t||t
1299685|NCT03600324|Randomized|Factorial Assignment||Treatment||Double||A prospective, single-blind, four-group multi-center randomized controlled trial|t|t||
1299686|NCT03600311|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1299687|NCT03600298||Single Group Assignment||Treatment||None (Open Label)||Open interventional before and after study on the effect of on-site full-scale simulation with a subsequent course follow-up and a three month follow-up observation pertaining to behavioural changes in communication of the paediatric intensive care unit staff that is participating in the on-site simulation training||||
1299689|NCT03600272|Randomized|Parallel Assignment||Treatment||Quadruple|One anesthetist who were not involved with clinical care or data collection performed the randomization procedure and the neuraxial block according to the group allocation. The other anesthetist blinds to the procedure preform the analgesia management after neuraxial block. This anesthetist and the obstetrician, the midwives, the patients , the outcomes collector and assessor are all blind to group allocation throughout.|Participants who request neuraxial labor analgesia are randomly assigned into two groups by a computer-generated random number table using Excel. One group received combined spinal-epidural analgesia during labor, the other group received epidural analgesia during labor.|t|t|t|t
1299690|NCT03600259|||Cohort||Other|||||||
1299691|NCT03600246|||Cohort||Prospective|||||||
1299692|NCT03600233||Single Group Assignment||Treatment||None (Open Label)||||||
1299693|NCT03600220|Randomized|Parallel Assignment||Treatment||Single||||||t
1299694|NCT03600207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299695|NCT03600194||||||||||||
1299696|NCT03600181|||Other||Prospective|||||||
1299697|NCT03600168|||Cohort||Prospective|||||||
1299698|NCT03600155|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299699|NCT03600142|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299700|NCT03600129|Randomized|Parallel Assignment||Supportive Care||Quadruple|Solution used for block (local anesthetic or placebo) is known to anesthetist not involved in patient's care.|Double blind, placebo-controlled, randomised|t|t|t|t
1299701|NCT03600116||Single Group Assignment||Treatment||None (Open Label)||||||
1299702|NCT03600103|Randomized|Parallel Assignment||Treatment||Single|||||t|
1299703|NCT03600090||Single Group Assignment||Treatment||None (Open Label)||||||
1299704|NCT03600077|||Other||Other|||||||
1299705|NCT03600064|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299706|NCT03600051|||Cohort||Cross-Sectional|||||||
1299707|NCT03600038|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1299708|NCT03600025||Single Group Assignment||Basic Science||None (Open Label)||Apparently healthy volunteers will receive typhoid vaccine one time point.||||
1299709|NCT03600012|Randomized|Parallel Assignment||Treatment||Single|Single (Outcomes Assessor)|||||t
1299710|NCT03599999|||Cohort||Prospective|||||||
1299711|NCT03599986|||Other||Prospective|||||||
1299712|NCT03599973||Single Group Assignment||Other||None (Open Label)||||||
1299713|NCT03599960||Single Group Assignment||Treatment||None (Open Label)||All patients will receive 3 cycles of a combination of chemotherapy (Met/Ida/L-Asp/Dex)||||
1299714|NCT03599947|||Other||Prospective|||||||
1299715|NCT03599934|Randomized|Parallel Assignment||Prevention||Single||||||t
1299716|NCT03599921|||Cohort||Prospective|||||||
1299717|NCT03599908|||Cohort||Retrospective|||||||
1299718|NCT03599895|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1299719|NCT03599882|||Cohort||Prospective|||||||
1299720|NCT03599869|||Case-Only||Retrospective|||||||
1299721|NCT03599856|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||A prospective single center (Catharina Hospital Eindhoven) controlled before-and-after study.||||
1299722|NCT03599843||Single Group Assignment||Other||None (Open Label)||Type 2, hybrid implementation-effectiveness study||||
1299723|NCT03599830||Single Group Assignment||Other||None (Open Label)||||||
1299724|NCT03599817||Single Group Assignment||Prevention||None (Open Label)||||||
1299725|NCT03599804|||Cohort||Prospective|||||||
1299726|NCT03599791|Randomized|Parallel Assignment||Treatment||Quadruple|Blinding device|Multicentre, randomized, double-blind, active controlled, parallel group study|t|t|t|t
1299727|NCT03599778|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299728|NCT03599765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299729|NCT03599752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299730|NCT03599739|||Cohort||Retrospective|||||||
1299731|NCT03599726|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1299732|NCT03599713||Single Group Assignment||Treatment||None (Open Label)||||||
1299733|NCT03599700|||Cohort||Prospective|||||||
1299734|NCT03599687|||Case-Crossover||Prospective|||||||
1299735|NCT03599674||Single Group Assignment||Health Services Research||None (Open Label)||||||
1299736|NCT03599661||Single Group Assignment||Supportive Care||None (Open Label)||||||
1299737|NCT03599648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299738|NCT03599635|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1299739|NCT03599622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299740|NCT03599609||Single Group Assignment||Prevention||None (Open Label)||||||
1299741|NCT03599596|Randomized|Parallel Assignment||Prevention||Single||||||t
1299742|NCT03599583|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||RCT study design will test the impact of the prompts intervention to reduce missed opportunities and raise HPV vaccine rates.||||
1299743|NCT03599570|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||A cluster RCT study design will test the impact of performance feedback to reduce missed opportunities (MOs) and raise HPV vaccine rates||||
1299744|NCT03599557|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This study will use a cluster RCT study design to test the impact of the communication intervention to reduce missed opportunities (MOs) and raise HPV vaccine rates||||
1299745|NCT03599544|Randomized|Parallel Assignment||Treatment||Single|Evaluator(s) will be blinded to assigned study group and intervention.|||||t
1299746|NCT03599531|||Cohort||Prospective|||||||
1299747|NCT03599518||Single Group Assignment||Treatment||None (Open Label)||||||
1299748|NCT03599505|||Other||Prospective|||||||
1299749|NCT03599492|||Cohort||Prospective|||||||
1299750|NCT03599479|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1299751|NCT03599466|Randomized|Crossover Assignment||Other||None (Open Label)|Open label|||||
1573334|NCT00001570||||Treatment||||||||
1299754|NCT03599427|Randomized|Parallel Assignment||Supportive Care||Quadruple|The medicine used for each individual patient will be prepared by the nurse not otherwise involved in patient data collection.|Group A receives linisol 2%, group B receives placebo.|t|t|t|t
1299755|NCT03599414|||Cohort||Prospective|||||||
1299756|NCT03599401|Randomized|Parallel Assignment||Treatment||Double|Sealed Envelopes|A total of 42 subjects participated in the study. All the subjects underwent scaling and root planning and were divided into 3 groups Group 1 - low dose aspirin ( 75 mg) once daily Group 2 - omega 3 fatty acids (500 mg) twice daily Group 3 - placebo once daily|t|||t
1299757|NCT03599388||Single Group Assignment||Other||None (Open Label)||||||
1299758|NCT03599375||Single Group Assignment||Treatment||None (Open Label)||Patients with recurrent or refractory CD19+ ALL receive CD19 CAR T-cell immunotherapy.||||
1299759|NCT03599362||Single Group Assignment||Treatment||None (Open Label)||||||
1299760|NCT03599349||Single Group Assignment||Treatment||None (Open Label)||||||
1299761|NCT03599336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299762|NCT03599323|||Cohort||Prospective|||||||
1299763|NCT03599310|Non-Randomized|Crossover Assignment||Health Services Research||Single||||||t
1299764|NCT03599297||Single Group Assignment||Treatment||None (Open Label)||||||
1299765|NCT03599284|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299766|NCT03599271||||||||||||
1299767|NCT03599258|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1299768|NCT03599245||Single Group Assignment||Treatment||None (Open Label)||||||
1299769|NCT03599232|Randomized|Parallel Assignment||Other||Single|The staff who participated in the summative-OSCE(outcome assessor) were unaware of the group assignment and the two-teaching staff who participated in the intervention (Formative-OSCE) did not participate in the summative exam.|"Students in the intervention group (first-arm) attended a formative-OSCE on the first day of their pediatric module to assess the competencies they gained from previous modules. The formative-OSCE design involved a blueprint development which served as a guideline for the development and face-validation of the 8 stations, which were both interactive and static.~The formative-OSCE examiners consisted of 2 teaching staff and 11 postgraduate pediatric board trainees, who were trained by the researcher using role model and audiovisual aids. The formative-OSCE was carried out following the exact same process of the summative-OSCE. It composed of stations assessing same competencies with standardized mark sheets and feedback. Students received feedback on their performance in the formative-OSCE on the day the results were released on a one-to-one basis.~at the end of pediatric module both groups undergo summative OSCEassessment"||||t
1299770|NCT03599219|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||prospective case control||||
1299771|NCT03599206|Randomized|Crossover Assignment||Other||Single|||t|||
1299772|NCT03599193|Randomized|Parallel Assignment||Treatment||Single|Tazarotene and tazarotenic acid plasma concentrations will be determined at a designated laboratory from the blinded samples using a validated bioanalytical method.|||||t
1299773|NCT03599180|||Case-Control||Prospective|||||||
1299774|NCT03599167|||Cohort||Retrospective|||||||
1299775|NCT03599154|||Cohort||Prospective|||||||
1299776|NCT03599141|Randomized|Parallel Assignment||Treatment||Single||||||t
1299777|NCT03599128|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1299778|NCT03599115|Randomized|Parallel Assignment||Treatment||Double|Participants are told there is only one intervention for the study and are not aware if they have been assigned to the intervention group or the active control. Research assistants collecting data are blind to what arm the participant was assigned to. During data preprocessing steps, individuals will be blind to what group a participant belongs too (and all data will be preprocessed together). Only when conducting statistical analyses will the principle investigator be aware of what participant belongs to what group, in order to conduct group analyses.|There are two arms of this study: food-specific inhibitory control training (condition of interest) and a generic inhibitory control training (active control). Given baseline levels of inhibitory control (assessed at baseline visit), participants are randomly assigned to the generic or food-specific month long inhibitory control training. All other protocols, including baseline and follow-up visits and assessment of food intake and weight, are identical and follow the same time line across the two arms.|t|||t
1299779|NCT03599102|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1299780|NCT03599089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299781|NCT03599076|||Case-Control||Prospective|||||||
1299782|NCT03599063|Randomized|Sequential Assignment||Basic Science||Triple|||t|t|t|
1299783|NCT03599050||Single Group Assignment||Health Services Research||None (Open Label)||||||
1299784|NCT03599037|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299785|NCT03599024|Randomized|Parallel Assignment||Treatment||None (Open Label)|Neither the investigators nor the patients were blinded in the study.|The patients were randomized into two groups with two distinct interventions - patient-controlled analgesia vs. conventional analgesia prescribed by the attending physician.||||
1299786|NCT03599011|||Cohort||Retrospective|||||||
1299787|NCT03598998||Single Group Assignment||Treatment||None (Open Label)||||||
1299788|NCT03598985|||Case-Control||Cross-Sectional|||||||
1299789|NCT03598972|||Cohort||Retrospective|||||||
1299790|NCT03598959||Single Group Assignment||Treatment||None (Open Label)||||||
1299791|NCT03598946||Single Group Assignment||Prevention||None (Open Label)||||||
1299792|NCT03598933|||Case-Only||Retrospective|||||||
1299793|NCT03598920|||Cohort||Prospective|||||||
1299794|NCT03598907|||Other||Prospective|||||||
1299795|NCT03598894|||Case-Control||Prospective|||||||
1299796|NCT03598881|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1299797|NCT03598868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299798|NCT03598855|Randomized|Parallel Assignment||Other||Single||||||t
1299799|NCT03598842|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1299800|NCT03598829|||Cohort||Prospective|||||||
1299801|NCT03598816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299802|NCT03598803|||Cohort||Prospective|||||||
1299804|NCT03598777|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1299805|NCT03598764|Randomized|Parallel Assignment||Prevention||Single|||t|||
1299806|NCT03598751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299807|NCT03598738|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299808|NCT03598725||Single Group Assignment||Treatment||None (Open Label)||||||
1299809|NCT03598712|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 3 prospective, randomized, monocentric controlled study||||
1299810|NCT03598699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299811|NCT03598686|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"The HOSENG study is linked to a follow-up trial, the VIBRA study. Together they are called the GET ON (GETing tOwards Ninety) research project. The HOSENG study with its home-based HIV testing campaign provides the platform for the VIBRA study. The reasons for this interlinked design are: a) potential study participants for VIBRA trial (HIV-positive individuals not on ART) are recruited during the HOSENG study, b) this design allows us to assess the entire HIV/AIDS care cascade in one larger project, and c) both trials rely on interventions involving VHWs, who need to be randomized and specifically trained. Therefore, it is more efficient and feasible to run both trials parallel and randomize at one time point.~The HOSENG study is a cluster randomized, parallel-group (1:1:1:1 allocation), open-label, superiority, prospective clinical trial. Clusters are stratified by district, size of village, and village access to the nearest health facility."||||
1299812|NCT03598673|||Other||Prospective|||||||
1299813|NCT03598660|||Case-Control||Cross-Sectional|||||||
1299814|NCT03598647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299815|NCT03598634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299816|NCT03598621|Randomized|Crossover Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.||t|t|t|t
1299817|NCT03598608|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299818|NCT03598595||Single Group Assignment||Treatment||None (Open Label)||||||
1299819|NCT03598582||Single Group Assignment||Treatment||None (Open Label)||||||
1299820|NCT03598569|||Other||Prospective|||||||
1299821|NCT03598556|Randomized|Parallel Assignment||Prevention||Quadruple|Double-blind||t|t|t|t
1299822|NCT03598543|||Case-Only||Prospective|||||||
1299823|NCT03598530|||Case-Control||Prospective|||||||
1299824|NCT03598517||Single Group Assignment||Treatment||None (Open Label)||||||
1299825|NCT03598504|Non-Randomized|Crossover Assignment||Treatment||Single|Clinical measures of spasticity before, during, and after the intervention will be implemented by an evaluator blind to the treatment effects|||||t
1299826|NCT03598491|||Cohort||Prospective|||||||
1299827|NCT03598478|Randomized|Parallel Assignment||Treatment||Single||||||t
1299828|NCT03598465|||Cohort||Prospective|||||||
1299829|NCT03598452||Single Group Assignment||Treatment||None (Open Label)||||||
1299830|NCT03598439|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1299831|NCT03598426|Randomized|Parallel Assignment||Prevention||None (Open Label)||Single center, prospective, randomized, open-label study||||
1299832|NCT03598413|Randomized|Single Group Assignment||Prevention||Single|Single blind trial, analysis of all samples blinded to investigation team.|Prospective Randomised controlled trial|||t|
1299833|NCT03598400|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1299834|NCT03598387|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects eligible for this study will be randomized into APD group and IHD group. In APD group, subjects will receive PD catheter placement and subsequent APD treatment. In IHD group, subjects will receive un-tunneled hemodialysis catheter placement and subsequent hemodialysis.||||
1299835|NCT03598374|Randomized|Parallel Assignment||Treatment||Quadruple|The patients, care provides, investigators and outcome assessors are blinded for the treatment: Inositol + Folic acid versus Folic acid alone. The treatment allocation is identified by code number before the study start, and will be revealed only after data analysis.|Randomized multi centre double-blind controlled trial|t|t|t|t
1299836|NCT03598361|||Cohort||Prospective|||||||
1299837|NCT03598348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299838|NCT03598335|||Case-Control||Prospective|||||||
1299839|NCT03598322|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1299840|NCT03598309|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1299841|NCT03598296|Randomized|Parallel Assignment||Treatment||Single||Dividing 60 patients accepted Video-Assisted Thoracoscopic Lobectomy into two groups(Group A and Group B) equally and implanted two different bore size chest tube.|t|||
1299842|NCT03598283|||Cohort||Prospective|||||||
1299843|NCT03598270|Randomized|Parallel Assignment||Treatment||Triple|"Atezolizumab and placebo treatment will be double blinded, unknown to both the subject and the study staff, including the treating physician. In order to maintain the blind, atezolizumab and placebo will be identical in appearance and packaging.~The study medication will be labeled using a unique kit id number, which is linked to the randomization scheme. The active and placebo kits will be presented in the same packaging to ensure blinding of the study medication Individual treatment codes, indicating the treatment randomization for each randomized patient, will be available to the investigator(s) or pharmacists from the IVRS/IWRS. Routines for this will be described in the Interactive Voice Response System/Interactive Web Response System (IVRS/IWRS) user manual that will be provided to each centre."|Randomized, double-blinded, multi-center study|t|t|t|
1299844|NCT03598257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299845|NCT03598244||Single Group Assignment||Treatment||None (Open Label)||||||
1299846|NCT03598231|Randomized|Crossover Assignment||Treatment||Double||Cross-over of two sequences (2x2: AB / BA)|t||t|
1299847|NCT03598218|Randomized|Parallel Assignment||Treatment||Single|||t|||
1299848|NCT03598205|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1299886|NCT03597711|Randomized|Parallel Assignment||Treatment||None (Open Label)||Once consent is obtained, patients will be randomized to either 24G non-safety cannula, 24G safety or 26G safety cannula. Each patient can enter the study a maximum of three times providing 90 episodes of cannulation.||||
1299849|NCT03598192|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The TAP group will be performed the four points TAP block under the ultrasound guidance with the ultrasound machine of Logiq E, and linear 12S probe. The participants will be performed TAP block at subcostal and lateral abdominal wall at right and left side with stimuplex needle (sized 18G, length 100 mm). The investigators will approach position between aponeurosis internal oblique and transversus abdominal muscle with in-plane real-time ultrasound technique. The investigators will inject 10 ml of ropivacaine 0.375% at each one. Then, the investigators will access one catheter at TAP at right side to continuously infuse ropivacaine 0.375% during 48 hours after surgery.~PVB group: the investigators will access one catheter into the right thoracic paravertebral space at T7 before beginning general anesthesia. At the end of surgery, the investigators will inject 20 ml of ropivacaine 0.5% through catheter, and continuously infuse ropivacaine 0.25% during 48 hours after surgery."||||
1299850|NCT03598179||Single Group Assignment||Treatment||None (Open Label)||||||
1299851|NCT03598166|Randomized|Parallel Assignment||Screening||None (Open Label)||Eligible patients will be randomized 1:1 to the intervention or control group||||
1299852|NCT03598153|||Cohort||Prospective|||||||
1299853|NCT03598140|Randomized|Parallel Assignment||Treatment||Double|Investigators associated with this study will not have access to the randomization schedule. The principal investigator, study team, and study subjects will be blinded in this study.|This study is a placebo-controlled, double-blinded clinical trial. Randomization will be 1:1 sildenafil:placebo, and will be in blocks of 10. In this study, 100 boxers and 80 controls will be enrolled and randomized.|t||t|
1299854|NCT03598127|||Cohort||Prospective|||||||
1299855|NCT03598114|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299856|NCT03598101||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1299857|NCT03598088||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1299858|NCT03598075|Randomized|Crossover Assignment||Other||Triple||In a Randomized, double blind, cross over experiment. Migraine without aura patients will received amylin or CGRP in two separate days apart by a week.|t|t|t|
1299859|NCT03598062|||Other||Other|||||||
1299860|NCT03598049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299861|NCT03598036||Single Group Assignment||Treatment||None (Open Label)||||||
1299862|NCT03598023|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single-site, randomized, prospective study||||
1299863|NCT03598010|Randomized|Parallel Assignment||Treatment||Single||||||t
1299864|NCT03597997|Randomized|Parallel Assignment||Treatment||Double|Patients will not be aware of the type of anaesthesia they will receive. A separate blinded investigator will assess the patients after the operation. The anaesthetist providing general anaesthesia will be aware of the allocation, but s/he will not be involved in data collection.|Patients in one group (S) will be anaesthetized by inhalational anaesthesia using sevoflurane. The patients in the second group (P) will be anaesthetized using total intravenous propofol.|t||t|
1299865|NCT03597984|Randomized|Parallel Assignment||Treatment||Single|For each patient the following variables for balancing the study arms will be considered: Gender, age, performance status, histology, site and primary tumor and presence of visceral metastases; Randomization will be performed at the Gemelli ART of the Gemelli Polyclinic Foundation and will be done by e-mail. Patients will be randomized after verification of inclusion and exclusion criteria. Randomization will be performed according to a random list generated by the computer.|"The study is a randomized, controlled superiority trial. The study will appear as an interventionist without medicinal, multicentric, spontaneous. Randomization will take place in a 1: 1 ratio. The study involves the enrollment of 330 patients divided into two groups of 165 patients for each of the two study arms (arm A (gold standard): 4 Gy x 5 fractions (fr); arm B: 5 Gy x 3 fr (Whole Vertebra) + SIB 10 Gy x 3 fr on the Gross Tumor Volume - GTV). The expected difference between the two treatments in terms of three-month pain control rates is 15% more in the experimental arm compared to the standard arm.~The calculation of the sample size took into account a 95% CI with a coefficient α of 0.05 and a drop-out rate of 10%."|t|||
1299866|NCT03597971|Randomized|Parallel Assignment||Treatment||Triple||Double blind, randomized, placebo-controlled, dose-escalating, single dose study in healthy volunteers followed by a double blind, randomized, placebo-controlled, dose-escalating, multiple dose study in healthy volunteers.|t|t|t|
1299867|NCT03597958|||Cohort||Cross-Sectional|||||||
1299868|NCT03597945|Randomized|Parallel Assignment||Treatment||Quadruple||Participants were assigned to one of two groups in parallel for the duration of the study|t|t|t|t
1299869|NCT03597932|||Cohort||Prospective|||||||
1299870|NCT03597919|Randomized|Parallel Assignment||Prevention||None (Open Label)||a multi-center, randomized, open-label, seroconversion/immunogenicity study.||||
1299871|NCT03597906|Randomized|Parallel Assignment||Treatment||Double||A prospective, randomized and comparative interventional study|t||t|
1299872|NCT03597893|Randomized|Crossover Assignment||Basic Science||Double||The study utilized a randomized, double-blind, PBO controlled, between-subject design.|t||t|
1299873|NCT03597880||Sequential Assignment||Screening||None (Open Label)||retrospective clinical trial||||
1299874|NCT03597867|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299875|NCT03597854|||Cohort||Prospective|||||||
1299876|NCT03597841|||Cohort||Prospective|||||||
1299877|NCT03597828|||Cohort||Prospective|||||||
1299878|NCT03597815|||Case-Control||Prospective|||||||
1299879|NCT03597802|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1299880|NCT03597789||Single Group Assignment||Treatment||None (Open Label)||All families get the evidence-based treatment, Helping the Noncompliant Child (HNC)||||
1299881|NCT03597776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299882|NCT03597763|||Cohort||Prospective|||||||
1299883|NCT03597750|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1299884|NCT03597737|Randomized|Parallel Assignment||Treatment||None (Open Label)|Patients will be informed of the condition they have been assigned to.|Two conditions. Patients will be randomly assigned to one of the two conditions.||||
1299885|NCT03597724|||Other||Prospective|||||||
1299887|NCT03597698|||Cohort||Retrospective|||||||
1299888|NCT03597685|||Cohort||Retrospective|||||||
1299889|NCT03597672|||Cohort||Prospective|||||||
1299890|NCT03597659|||Cohort||Retrospective|||||||
1299891|NCT03597646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299892|NCT03597633|||Cohort||Prospective|||||||
1299893|NCT03597620|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||15 eligible patients will be enrolled. Patient will be treated for 12 weeks. There will be a total of five visits: screening, baseline, w4, w8 and w12. Metaderm cream will be applied topically twice a day to all active lesions. The metaderm scalp spray will be applied daily to the affected areas on the scalp. Patients will be provided with metaderm cleanser, can be use daily. For the subgroup for scalp psoriasis, patient will use the shampoo Head & Shoulders formula with 1% Pyrithione Zinc as the active ingredient||||
1299894|NCT03597607|Randomized|Parallel Assignment||Supportive Care||Single|Participants will be informed of their group allocation. Health care providers of the intervention will be aware of which program to deliver, therefore knowing group allocation. The investigator will be aware of group allocation. Outcomes will be assessed by a blind data analyst.|Participants randomly assigned to one of three groups: intensive smoking cessation program, abbreviated smoking cessation program or usual care.||||t
1299895|NCT03597594|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with SCID will receive TCRα/β-CD19 -depleted graft followed by CD45RA-depleted DLI.||||
1299896|NCT03597581|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299897|NCT03597568|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1299898|NCT03597555|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1299899|NCT03597542|Randomized|Crossover Assignment||Basic Science||Double|Both the participants and researchers involved with data analysis will be blinded to which condition given.|Double blind randomized cross-over design|t||t|
1299900|NCT03597529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299901|NCT03597516|Randomized|Parallel Assignment||Treatment||Quadruple||This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study conducted in the United States (US). The study is comprised of 6 study periods divided into Part A and Part B.|t|t|t|t
1299902|NCT03597503|Randomized|Parallel Assignment||Treatment||Triple||Double-blind, randomized, parallel group, two-arm, placebo-controlled study with flexible dosing|t|t|t|
1299903|NCT03597490|||Cohort||Prospective|||||||
1299904|NCT03597477|||Cohort||Prospective|||||||
1299905|NCT03597464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299906|NCT03597451|||Case-Control||Prospective|||||||
1299907|NCT03597438|||Cohort||Prospective|||||||
1299908|NCT03597425|||Cohort||Retrospective|||||||
1299909|NCT03597412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299910|NCT03597399|||Cohort||Other|||||||
1299911|NCT03597386|||Cohort||Prospective|||||||
1299912|NCT03597373|||Cohort||Retrospective|||||||
1299913|NCT03597360||Single Group Assignment||Treatment||None (Open Label)||||||
1299914|NCT03597347||Single Group Assignment||Treatment||None (Open Label)||||||
1299915|NCT03597334|||Cohort||Prospective|||||||
1299916|NCT03597321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299917|NCT03597308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299918|NCT03597295||Single Group Assignment||Treatment||None (Open Label)||||||
1299919|NCT03597282|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299920|NCT03597269|||Cohort||Prospective|||||||
1299921|NCT03597256|Randomized|Parallel Assignment||Treatment||Single||||||t
1299922|NCT03597243|Randomized|Parallel Assignment||Prevention||Single||Two arms parallel cluster randomized trial||||t
1299923|NCT03597230||Single Group Assignment||Basic Science||None (Open Label)||||||
1299924|NCT03597217|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1299925|NCT03597204||Single Group Assignment||Other||None (Open Label)||selected high risk group of individuals for CRC screening by using FIT||||
1299926|NCT03597191|Randomized|Parallel Assignment||Treatment||Triple|"The primary investigator (PI) of this study, the outcomes assessor, will be blinded to participants' group assignment and will perform the eligibility screening and standard physical therapy examination for all participants. In addition, the PI will perform the pre- and post-intervention measurements of dynamic balance using the Y- balance test, functional performance using Functional Movement Screen, pain scores using the Numeric Pain Rating Scale, and disability levels using the Modified Oswestry Low Back Pain Disability Questionnaire.~Investigator #2, the care provider, will be blinded to the outcomes measurements and will be responsible for group allocation and administering the intervention, either a spinal stabilization exercises program or a general exercises program, to participants in both groups.~Participants will be randomly assigned to one of the two study groups and will be blinded to the other group exercise program."|"This study will be a randomized clinical trial (RCT) using a prospective two-way (2 × 4) mixed-design to examine the effectiveness of spinal stabilization exercises (SSEs) on dynamic balance, functional performance, pain intensity, and disability level in adults with sub-acute and chronic low back pain (LBP).~The two independent variables are group, which is a between-subject factor, and time which is a within-subject factor. The independent variable of group has two levels: (1) the treatment group which will receive SSEs, and (2) the placebo group which will receive general range of motion and flexibility exercises.~The independent variable of time has four levels: pre-intervention at baseline, and two weeks, four weeks, and eight weeks after intervention.~The four dependent variables are (1) dynamic balance, (2) functional performance, (3) pain intensity, and (4) disability level."|t|t||t
1299927|NCT03597178||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1299928|NCT03597165|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1299929|NCT03597152|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1299930|NCT03597139|Randomized|Parallel Assignment||Treatment||Single||This is a Phase 2, multi-center, Investigator-masked, randomized, parallel-group study to evaluate the tolerability, efficacy and safety of VOS versus Restasis® over a 28-day treatment period in subjects with mild to moderate DED. Approximately 90 subjects will be randomized to either VOS or Restasis® at approximately 7 centers located in the US.|||t|
1299931|NCT03597126|Randomized|Parallel Assignment||Treatment||Single||||||t
1299932|NCT03597113|||Cohort||Prospective|||||||
1299933|NCT03597100||Single Group Assignment||Treatment||None (Open Label)||||||
1299934|NCT03597087|Randomized|Parallel Assignment||Treatment||None (Open Label)|Using a web site, and creating a randomized list at Sealedenvalop.com. Patients are randomly assigned to receive an anesthetic consent, and no masking is performed.|After randomization, they were divided into two parallel groups 289 patients were randomly assigned to a spinal anesthesia group and a general anesthesia group 1: 1.||||
1299935|NCT03597074|||Cohort||Prospective|||||||
1299936|NCT03597061|Randomized|Parallel Assignment||Prevention||None (Open Label)||Infants will be assigned to either the treatment or control condition.||||
1299937|NCT03597048|Randomized|Factorial Assignment||Health Services Research||Single|Outcomes were self-reported and completed on lap top computers without interaction with assessors. Research staff conducting home visits were not aware of which arm participants received.|A two by two by two cluster randomized fully -crossed factorial design||||t
1299938|NCT03597035||Single Group Assignment||Treatment||None (Open Label)||An open label proof-of-concept clinical trial in 50 patients with Type II diabetes evaluating the effects of MRA + Patiromer on LV mass and plaque regression over 12 months of treatment by magnetic resonance imaging (MRI).||||
1299939|NCT03597022|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299940|NCT03597009||Single Group Assignment||Treatment||None (Open Label)||We will conduct a Phase Ib/II trial that includes a safety run-in period using 3 +3 dose escalation rules to evaluate the feasibility of administering talimogene laherparepvec into the intrapleural space of subjects with malignant pleural effusion (MPE) via a pleurX catheter.||||
1299941|NCT03596996|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299942|NCT03596983||Single Group Assignment||Other||None (Open Label)||||||
1299943|NCT03596970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299944|NCT03596957|Randomized|Parallel Assignment||Treatment||Single|The endpoint blinding will be assured since all the MRI scans will be forwarded to the Comparative Medicine Laboratory in Aarhus for evaluation|Patients will be randomised in a 1:1 ration either to treatment with tolvaptan for six weeks followed by six weeks observation without trial medicaion or to the Control group receiving no tolvaptan treatment for 12 weeks||||t
1299945|NCT03596944|||Other||Retrospective|||||||
1299946|NCT03596931|||Other||Retrospective|||||||
1299947|NCT03596918||Single Group Assignment||Supportive Care||None (Open Label)||||||
1299948|NCT03596905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299949|NCT03596892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299950|NCT03596879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299951|NCT03596866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299952|NCT03596853|Randomized|Parallel Assignment||Treatment||Double|Masking: Triple (Participant, Outcomes Assessor)||t|||t
1299953|NCT03596840|||Cohort||Prospective|||||||
1299954|NCT03596827|Randomized|Parallel Assignment||Basic Science||Quadruple||The MIRRE pilot study is a randomized, double-blind dose-response, parallel human infection study in 30 healthy adults|t|t|t|t
1299955|NCT03596814|||Cohort||Retrospective|||||||
1299956|NCT03596801|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1299957|NCT03596788|Randomized|Parallel Assignment||Other||Single|||t|||
1299958|NCT03596775|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1299959|NCT03596762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1299960|NCT03596749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299961|NCT03596736|Randomized|Parallel Assignment||Treatment||||||||
1299962|NCT03596723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1299963|NCT03596710||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299964|NCT03596697|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299965|NCT03596684|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1299966|NCT03596671||Single Group Assignment||Treatment||None (Open Label)||||||
1299967|NCT03596658||Single Group Assignment||Treatment||None (Open Label)||||||
1299968|NCT03596645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299969|NCT03596632||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299970|NCT03596619|Randomized|Single Group Assignment||Treatment||Single||||||t
1299971|NCT03596606|Randomized|Parallel Assignment||Treatment||Single|The principal evaluator will be blinded in relation to the study groups. The person responsible for taking the variables (baseline data, reassessments and data analysis) will be a therapist and a medical doctor unrelated to the recruitment and treatment. Due to the nature of the interventions, it is not possible to mask the therapist responsible for the interventions.|Both groups will be treated with Osteopathic Treatment and in one of them it will be added the intervention with cognition targeted myofunctional motor control exercises.|||t|
1299972|NCT03596593||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299973|NCT03596580|||Other||Cross-Sectional|||||||
1299974|NCT03596567|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1299975|NCT03596554|||Cohort||Cross-Sectional|||||||
1299976|NCT03596541|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1299977|NCT03596528||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299978|NCT03596515|Randomized|Parallel Assignment||Treatment||Single|||t|||
1299979|NCT03596502|||Cohort||Retrospective|||||||
1299980|NCT03596489|||Cohort||Prospective|||||||
1299981|NCT03596476||Single Group Assignment||Diagnostic||None (Open Label)||||||
1299982|NCT03596463|||Other||Prospective|||||||
1299983|NCT03596450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1299984|NCT03596437|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1299985|NCT03596424|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1299986|NCT03596411|||Other||Retrospective|||||||
1299987|NCT03596398|||Cohort||Cross-Sectional|||||||
1299988|NCT03596385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300282|NCT03592563|||Case-Control||Prospective|||||||
1299989|NCT03596372|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1299990|NCT03596359|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1299991|NCT03596346|Randomized|Parallel Assignment||Other||Quadruple|double-blind|parallel-group|t|t|t|t
1299992|NCT03596333|||Case-Only||Retrospective|||||||
1299993|NCT03596320|||Other||Cross-Sectional|||||||
1299994|NCT03596307|Randomized|Crossover Assignment||Other||Double|Double blinded|Randomization 1:1. Acute phase study - Session 1 (2 days) ; Crossover; Session 2 ( 2 Days) Short Term Phase - Session 2 (Pretest), 16 day supplementation, Session 3 (Post test), Crossover; Session 4 (Pretest),16 day supplementation, Session 5 (Post test).|t||t|
1299995|NCT03596294|Randomized|Crossover Assignment||Other||None (Open Label)||Randomized, double-blind, two-period, cross-over Phase 1 study||||
1299996|NCT03596281|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Cohort A and B will be opened for inclusions at the same time. Once safety of the dual combinations confirmed in cohorts A and B, cohort C will be opened for inclusions.||||
1299997|NCT03596268|||Case-Control||Cross-Sectional|||||||
1299998|NCT03596255|||Cohort||Cross-Sectional|||||||
1299999|NCT03596242||Single Group Assignment||Supportive Care||None (Open Label)||||||
1300000|NCT03596229|||Cohort||Retrospective|||||||
1300001|NCT03596216|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1300002|NCT03596203||Single Group Assignment||Treatment||None (Open Label)||||||
1300003|NCT03596190||Single Group Assignment||Treatment||None (Open Label)||||||
1300004|NCT03596177|Randomized|Parallel Assignment||Treatment||Double||Randomised, Double-Blind, Placebo-Controlled|t||t|
1300005|NCT03596164||Single Group Assignment||Treatment||None (Open Label)||||||
1300006|NCT03596151||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300007|NCT03596138|||Other||Prospective|||||||
1300008|NCT03596125|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300009|NCT03596112|Randomized|Parallel Assignment||Treatment||Single|||||t|
1300010|NCT03596099|Randomized|Parallel Assignment||Prevention||Quadruple|A unique randomization ID number will be assigned by ClaimIt to each enrolled subject and associated with the correct study product kit number; this number will be used throughout the study (includes study execution, safety reporting, compliance with the study product, and efficacy). Both the Mizkan rice vinegar active product (acetic acid) and placebo (no acetic acid) will be labeled identically and will be distinguishable only by the individual subject ID printed on the label.|Randomized, two-arm, parallel-group, double-blind, placebo-controlled|t|t|t|t
1300011|NCT03596086||Single Group Assignment||Treatment||None (Open Label)||||||
1300012|NCT03596073|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300013|NCT03596060|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1300014|NCT03596047|Randomized|Parallel Assignment||Treatment||Double|"The Shockwave therapy machine has a device to prevent the patient from receiving the radial wave. This device will be changed for the clinic administrator.~Change device placebo wave therapy, using the respective device t"|Randomized, double-blind clinical trial.|t|||t
1300015|NCT03596034||Single Group Assignment||Other||None (Open Label)||||||
1300016|NCT03596021|||Cohort||Prospective|||||||
1300017|NCT03596008|Randomized|Crossover Assignment||Other||Single|Single blinded|Randomized, single-blind, 2-arm, placebo-controlled, within subject cross-over trial, featuring a repeated postprandial sampling paradigm|t|||
1300018|NCT03595995|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300019|NCT03595982|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Depending on the group the person gets randomized into they will receive 60 mg of nifedipine at 0h vs 30 mg of nifedipine at 0h followed by 30 mg extra at 12h, These medications will be administered by a nurse or physician on the floor.~After 12h and at the end of the 24h (plus or minus 30 min) a blood sample (2cc) with be obtained and sent to Mount Sinai Hospital to determine serum Procardia levels. This blood samples will be stored until this research study is finished and will be disposed after. A total of 20cc of blood will be obtained from each patient.~Also the patient will take a survey of side effects of the BP medication. BPs will be measured Q 4h and documented at 0h, 4h, 8h, 12h, 16h, 20h and 24h (plus or minus 30 min)"||||
1300020|NCT03595969|||Case-Control||Cross-Sectional|||||||
1300021|NCT03595956|||Cohort||Prospective|||||||
1300022|NCT03595943|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1300023|NCT03595930|||Cohort||Prospective|||||||
1300024|NCT03595917||Single Group Assignment||Treatment||None (Open Label)||||||
1300025|NCT03595904|Randomized|Parallel Assignment||Prevention||Single|The outcome assessor will be blinded to the participants' assigned study group.|Participants are randomly assigned to one of two groups (1:1).||||t
1300026|NCT03595891|||Cohort||Retrospective|||||||
1300027|NCT03595878|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300028|NCT03595865|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300029|NCT03595852|Randomized|Parallel Assignment||Health Services Research||Double|patients and investigator will be blinded for intervention|antibiotic prophylaxis versus placebo in clean non prosthetic surgery. impact on surgical site infection and patient cost.|t||t|
1300030|NCT03595839|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300031|NCT03595826|Non-Randomized|Factorial Assignment||Treatment||Single|The Pi will not be involved in post intervention testing of the children/participants.|3 phase quasi experimental design. Diagnosis and intervention.|||t|
1300032|NCT03595813||Single Group Assignment||Basic Science||None (Open Label)||||||
1300033|NCT03595800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300034|NCT03595787||Single Group Assignment||Supportive Care||None (Open Label)||||||
1300035|NCT03595774|Randomized|Crossover Assignment||Treatment||Triple||Double-blind, placebo-controlled, crossover|t||t|t
1300036|NCT03595761|||Cohort||Retrospective|||||||
1300037|NCT03595748|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1300038|NCT03595735||Single Group Assignment||Treatment||None (Open Label)||Multi-center, prospective, single-arm.||||
1300039|NCT03595722|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300040|NCT03595709||Single Group Assignment||Treatment||None (Open Label)||Single-arm, open label||||
1300041|NCT03595696|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300042|NCT03595683|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300043|NCT03595670|||Cohort||Prospective|||||||
1300044|NCT03595657||Single Group Assignment||Treatment||None (Open Label)||||||
1300045|NCT03595644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300046|NCT03595631|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1300047|NCT03595618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300048|NCT03595605|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1300049|NCT03595592|Randomized|Parallel Assignment||Other||None (Open Label)||Parallel randomization to the study arms||||
1300050|NCT03595579|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300051|NCT03595566|Randomized|Parallel Assignment||Treatment||Quadruple|In both arms patients receive the same number of doses per day. Placebo tablets are included to maintain the same number and appearance of IP in both arms.||t|t|t|t
1300052|NCT03595553|Randomized|Parallel Assignment||Treatment||Quadruple|In both arms patients receive the same number of doses per day. Placebo tablets are included to maintain same number and appearance of IP in both arms.||t|t|t|t
1300053|NCT03595540||Single Group Assignment||Other||None (Open Label)||This is a pilot, single arm prospective trial assessing feasibility and safety of a 5-day fasting-mimicking diet in patients with different cancer types and concomitant anticancer treatments.||||
1300054|NCT03595527||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300055|NCT03595514|Randomized|Parallel Assignment||Other||Double|Participants will not be allowed to see the ultrasound screen. Outcome assessors will not be present during the performance of the block.|Randomized|t|||t
1300056|NCT03595501|||Cohort||Prospective|||||||
1300057|NCT03595488||Single Group Assignment||Treatment||None (Open Label)||||||
1300058|NCT03595475|||Family-Based||Cross-Sectional|||||||
1300059|NCT03595462|Randomized|Crossover Assignment||Prevention||Single||tightly-controlled, randomized cross-over design|||t|
1300060|NCT03595449|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1300061|NCT03595436|Randomized|Crossover Assignment||Prevention||Triple|Double-blind, placebo-controlled|tightly-controlled, randomized crossover design|t||t|t
1300062|NCT03595423|||Cohort||Retrospective|||||||
1300063|NCT03595410|||Cohort||Retrospective|||||||
1300064|NCT03595397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300065|NCT03595384||Single Group Assignment||Prevention||None (Open Label)||This is a longitudinal pre-post pilot intervention study evaluating feasibility of implementation of a soccer-based Diabetes Prevention Program and preliminary changes in physical activity and diet-related measures.||||
1300066|NCT03595371||Single Group Assignment||Treatment||None (Open Label)||||||
1300067|NCT03595358||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300068|NCT03595345|||Cohort||Retrospective|||||||
1300069|NCT03595332|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1300070|NCT03595319|Non-Randomized|Sequential Assignment||Basic Science||Single|Participant will not know allocation (sevoflurane concentration) and will be under general anesthesia|"Adaptive up and down methodology. Anesthesia will be induced using etomidate, rocuronium and remifentanil. After intubation and mechanical ventilation, a high fresh gas flow and variable vaporizer target concentration will be used to stabilize the patient's target end tidal sevoflurane in less than two minutes.~Each patient's target end tidal sevoflurane is determined by the concentration used in the previous patient of the same group and by the incidence of hypotension. If the previous patient suffered hypotension, next patient's target concentration will drop. If there was no hypotension, next patient's target concentration will rise. The first patient on each group will be 2%. Target end tidal will vary 0.4% until the first crossover, then drop to 0.2% until the second crossover and will vary 0.1% thereafter."|t|||
1300071|NCT03595306|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1300072|NCT03595293|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300073|NCT03595280|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a randomized trial with 3 groups: 1) Control group that receives no study messages; 2) Untailored message group that receives general messages about the risks of hookah tobacco; 3) Tailored message group that receives messages about the risks of hookah tobacco that are personalized to their hookah tobacco use behavior and beliefs.||||
1300074|NCT03595267|||Other||Prospective|||||||
1300075|NCT03595254|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized waitlist controlled trial (first 450 participants) Open trial (following 550 participants)||||
1300076|NCT03595241|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1300077|NCT03595228||Single Group Assignment||Treatment||None (Open Label)||||||
1300078|NCT03595215||Single Group Assignment||Treatment||None (Open Label)||||||
1300079|NCT03595202|Randomized|Sequential Assignment||Basic Science||Quadruple|||t|t|t|t
1300080|NCT03595189|Randomized|Sequential Assignment||Other||Double|||t|||t
1300081|NCT03595176||Single Group Assignment||Treatment||None (Open Label)||The Coronary IVL System is a proprietary balloon catheter system designed to enhance stent outcomes by enabling delivery of the calcium disrupting capability of lithotripsy prior to balloon dilatation at low pressures. The Coronary IVL System consists of an IVL Balloon Catheter with two integrated pairs of lithotripsy emitters, a Lithotripsy Generator, and Connector Cable.||||
1300082|NCT03595163|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1300083|NCT03595150|Randomized|Parallel Assignment||Prevention||None (Open Label)||Open label randomised controlled trial of Diclofenac as prophylaxis versus no prophylaxis for prevention of post-ERCP pancreatitis||||
1300084|NCT03595137|Randomized|Parallel Assignment||Supportive Care||Triple||"sono with simple needle guide device group~sono only group"|t||t|t
1300085|NCT03595124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300086|NCT03595111||Single Group Assignment||Screening||None (Open Label)||Myocardial cell edema either focal or diffuse was detected in histopathological examination in pediatric patients undergoing total repair of Tetrology of Fallout||||
1300087|NCT03595098|Randomized|Parallel Assignment||Treatment||Single|Due to the nature of the interventions, it is not possible to blind the participants, the investigators administrating the interventions (therapists, i.e. medical doctors and clinical psychologists, and other caregivers), or parents. Blinding will be applied in all possible aspects of the trial such as: outcome assessment and MRI-scanning and neuropsychological testing. Additionally data managers, statisticians, and investigators drawing conclusions, will be fully blinded.|single-centre, parallel group superiority randomised clinical trial with blinded outcome assessment||||t
1300088|NCT03595085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300089|NCT03595072|||Cohort||Prospective|||||||
1300090|NCT03595059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300091|NCT03595046|Randomized|Parallel Assignment||Supportive Care||Double|"The subjects were randomly assigned to erector spinae plane block group (group E) and thoracic paravertebral block group (group P), and the assigned results are unknown.~The Outcomes Assessor is not related to the study, and does not know its contents."|erector spinae plane block group (group E) thoracic paravertebral block group (group P)|t||t|
1300092|NCT03595033||Single Group Assignment||Treatment||None (Open Label)||||||
1300093|NCT03595020|||Case-Control||Prospective|||||||
1300094|NCT03595007|||Cohort||Prospective|||||||
1300095|NCT03594994|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1300096|NCT03594981||Single Group Assignment||Treatment||None (Open Label)||||||
1300097|NCT03594968|||Case-Control||Cross-Sectional|||||||
1300098|NCT03594955||Single Group Assignment||Treatment||None (Open Label)||||||
1300099|NCT03594942|||Cohort||Cross-Sectional|||||||
1300100|NCT03594929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300101|NCT03594916|Randomized|Parallel Assignment||Treatment||Triple||active, sham|t||t|t
1300102|NCT03594903|Randomized|Parallel Assignment||Other||Double||participants are assigned to one of two groups in parallel for the duration of the study|t||t|
1300103|NCT03594890|Randomized|Sequential Assignment||Prevention||Double|This study will be an observer-blind study with the subject-blind and the investigator-blind.|Phase I, single center, randomized, observer-blind, placebo-controlled study.|t||t|
1300104|NCT03594877|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300105|NCT03594864|||Case-Only||Retrospective|||||||
1300106|NCT03594851||Single Group Assignment||Supportive Care||None (Open Label)||Administration of individualized advice to older people living at home complaining of sleep disorders||||
1300107|NCT03594838|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"A non-randomized 3 arm-interventional study at eight HRSs to evaluate two novel approaches of HCV viremia testing and compare them to the current standard of care. The HRS will be assigned to one of three study arms.~Six HRSs will provide HCV viremia testing on-site using one of two approaches as follows and two HRS will refer patients off-site for testing (current standard of care).~The three arms will be compared to determine differences in the proportion of anti-HCV-positive patients that receive HCV viremia test results."||||
1300108|NCT03594825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300109|NCT03594812|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1300110|NCT03594799|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1300111|NCT03594786||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300112|NCT03594773|Randomized|Parallel Assignment||Treatment||Single||||||t
1300113|NCT03594760||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300114|NCT03594747|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1300115|NCT03594734|Randomized|Parallel Assignment||Other||Single||"Randomized Controlled Trial (RCT).~Participants will be randomized into two group: (1) the GLB Intervention Group and (2) the Attention Control Group."||||t
1300116|NCT03594721|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300117|NCT03594708|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1300118|NCT03594695|||Other||Prospective|||||||
1300119|NCT03594682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300120|NCT03594669||Single Group Assignment||Prevention||None (Open Label)|No masking will be used|This study will be conducted as pilot of a one-arm intervention using,1) pre- and post-participation measures of sensorimotor control and 2) injury incidence rate over the sports-season directly after completion of the intervention compared to injury incidence rate of a historical control (the 2017 soccer season at Mississippi College). Participants will include men and women athletes on soccer teams from one Division II institution.||||
1300121|NCT03594656|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300122|NCT03594643|||Cohort||Prospective|||||||
1300123|NCT03594630|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300124|NCT03594617|Randomized|Factorial Assignment||Prevention||Single||||||t
1300125|NCT03594604|Randomized|Parallel Assignment||Prevention||Single|Patients will be randomized to receive oral contraceptive pills or norethindrone|Patients will be randomized to receive oral contraceptive pills or norethindrone|||t|
1300126|NCT03594591|||Cohort||Prospective|||||||
1300127|NCT03594578|Randomized|Parallel Assignment||Basic Science||Single|Participants assigned to both groups will be masked to experimental hypotheses.|Participants will be randomly assigned to either an episodic future thinking group or a control group (episodic recent thinking), stratified by menopausal status and baseline level of delay discounting.|t|||
1300128|NCT03594565||Single Group Assignment||Prevention||None (Open Label)||||||
1300129|NCT03594552|Randomized|Crossover Assignment||Basic Science||Double|Participants and investigators were blinded to the drug condition|Repeated-measures cross-over study, where each subject received each one of the three pharmacological probes in separate visits (i.e., placebo, arbaclofen low dose and arbaclofen high dose), with the order of tablet administration being pseudorandomized.|t||t|
1300206|NCT03593551||Sequential Assignment||Treatment||None (Open Label)|The order for five treatments and one control are randomly allocated to participants. Each participant will attend all six sessions (five treatments and one control)|within study design||||
1300207|NCT03593538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573335|NCT00001565||||Treatment||||||||
1300130|NCT03594539|Randomized|Crossover Assignment||Diagnostic||Quadruple|The pharmacy dispensing the drug will be responsible for generating placebo and distributing drug. The investigators, care providers and patient will not have access to this data. Study outcomes will be comparing arms but not with knowledge of which arm occurred when.|Participants will be randomized to either lanthanum carbonate or placebo for 2 weeks. They will then be assigned to the other arm of the study. They will be in the alternate arm for 2 weeks and then complete the study,|t|t|t|t
1300131|NCT03594526|Randomized|Parallel Assignment||Supportive Care||Triple|Masking will be done to participant, care provider of the intervention and outcomes assessor|The assigment of the mothers to each group will be like that: The allocation will be generated in the Epidat 4.1 program. This will be done by blocks in groups of equal size, randomized 1: 1, control and intervention group. The generation will be given by an statistician who will not perform the intervention, nor the initial or final evaluations.|t|t||t
1300132|NCT03594513|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1300133|NCT03594500|Randomized|Parallel Assignment||Treatment||None (Open Label)||Consenting participants will be randomly assigned to the control or intervention arm of the study. Participants in the intervention arm will receive PockeTalkers (hearing assistance devices) for the duration of their time in the emergency department. Participants in the control group will not receive hearing assistance devices during their time in the emergency department.||||
1300134|NCT03594487|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300135|NCT03594474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300136|NCT03594461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300137|NCT03594448|||Case-Only||Prospective|||||||
1300138|NCT03594435|Randomized|Parallel Assignment||Treatment||Triple||Two-Arm, Randomized, Double-Blind, Placebo-Controlled|t|t|t|
1300139|NCT03594422||Sequential Assignment||Treatment||None (Open Label)||The starting dose was 20 mg，the sequence dose would be 30mg, 40mg, 50mg and 60mg.||||
1300140|NCT03594409|||Cohort||Cross-Sectional|||||||
1300141|NCT03594396||Single Group Assignment||Treatment||None (Open Label)||||||
1300142|NCT03594383|||Case-Only||Prospective|||||||
1300143|NCT03594370|||Case-Only||Cross-Sectional|||||||
1300144|NCT03594357|||Case-Control||Prospective|||||||
1300145|NCT03594344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300146|NCT03594331|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1300147|NCT03594318|||Cohort||Prospective|||||||
1300148|NCT03594305|Randomized|Parallel Assignment||Health Services Research||Single||Cluster randomized trial in which villages are randomized to receive or not to receive the intervention.|t|||
1300149|NCT03594292|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300150|NCT03594279|Randomized|Parallel Assignment||Prevention||None (Open Label)||The intervention is based on the Behavior Change Theory.||||
1300151|NCT03594266|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300152|NCT03594253|Randomized|Parallel Assignment||Treatment||None (Open Label)||Regulation Focused Psychotherapy for Children (RFP-C; Hoffman & Rice with Prout, 2015) is a novel, manualized, time-limited psychodynamic treatment approach for children who manifest disruptive behaviors and emotional dysregulation. RFP-C conceptualizes children's externalizing behaviors as expressions of maladaptive defenses or impaired emotion regulation (ER). The child's behaviors are understood as products of developmental delays in implicit ER (Rice & Hoffman, 2014). Externalizing behaviors are conceptualized both as biologically-driven products and as functional attempts to defend against painful emotions by protecting the child from disturbing feelings such as sadness, shame, and guilt. This 16-session (plus four parent sessions) psychotherapy method iteratively addressing a child's disruptive behaviors as strategies to avoid painful affect. RFP-C is hypothesized to address developmental immaturity of the implicit ER system.||||
1300153|NCT03594240|Randomized|Parallel Assignment||Treatment||Triple||Patients were randomly assigned into two groups; intervention group who received vitamin B complex once daily orally and control group who did not receive B complex|t|t|t|
1300154|NCT03594227|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1300155|NCT03594214|||Case-Only||Cross-Sectional|||||||
1300156|NCT03594201|||Cohort||Retrospective|||||||
1300157|NCT03594188|Randomized|Parallel Assignment||Treatment||Single||||||t
1300158|NCT03594175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300159|NCT03594162||||||||||||
1300160|NCT03594149|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1300161|NCT03594136||Single Group Assignment||Basic Science||None (Open Label)||||||
1300162|NCT03594123|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1300163|NCT03594110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300164|NCT03594097|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1300165|NCT03594084|||Case-Only||Retrospective|||||||
1300166|NCT03594071|||Case-Only||Retrospective|||||||
1300167|NCT03594058|Randomized|Parallel Assignment||Treatment||Double|Sponsor representatives Site monitors Data managers Statistician|This is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Eligible female subjects (N=1200) with symptoms of overactive bladder for at least 6 months will enter a 14-day single-blind Run-in Period. Subjects (N=375) who meet prespecified criteria based on data entered into an electronic diary over 3 days will be randomized 1:1:1 (125 subjects per arm) to receive solabegron modified release tablets, low dose or high dose, or matching placebo.|t||t|
1300168|NCT03594045||Single Group Assignment||Treatment||None (Open Label)||||||
1300169|NCT03594032|||Cohort||Prospective|||||||
1300170|NCT03594019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300171|NCT03594006||Single Group Assignment||Supportive Care||None (Open Label)||||||
1300172|NCT03593993|||Case-Only||Prospective|||||||
1300173|NCT03593980||Single Group Assignment||Treatment||None (Open Label)||||||
1300208|NCT03593525|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1300209|NCT03593512||Single Group Assignment||Treatment||None (Open Label)||"Evaluation of symptomatology before and after implantation of DBS electrodes; followed by cross-over of on and off stimulation"||||
1300174|NCT03593967|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||Based on availability of schedule, participants will sign up for one of the 4 groups available (ie. 2 intervention groups and 2 wait-list control group). Wellbeing and self-concept assessments will be conducted for all groups at baseline (T1), thereafter the intervention groups will undergo a 5-weeks 15-hour ARTISAN intergenerational arts programme that integrates curated museum visits, facilitated storytelling, creative art-making, and reflective writing for exploring and sharing life narratives on heritage, adversity, strengths and unity, with the aim to foster aspirations, resilience, wellbeing and social cohesion. Upon completion of programme among the intervention group, all 4 groups will be assessed again (T2), and thereafter, the wait-listed controlled group will received the same 5-week 15-hour programme. At the end of all intervention components, a final exit assessment will be conducted on all groups (T3).||||
1300175|NCT03593954||Single Group Assignment||Other||None (Open Label)||||||
1300176|NCT03593941|||Case-Control||Prospective|||||||
1300177|NCT03593928|||Cohort||Prospective|||||||
1300178|NCT03593915||Single Group Assignment||Treatment||None (Open Label)||||||
1300179|NCT03593902||Single Group Assignment||Treatment||None (Open Label)||||||
1300180|NCT03593889|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"The intervention group will receive a collaborative stepped care programme provided by registered social workers and trained peer supporters from elderly or mental health service units (NGOs) according to level of risks, symptom severity, and intervention response. Home visits or other format of contact will be delivered by trained peer supporters employed by NGOs to detect and engage hidden cases.~The control group will receive treatment as usual, which will be determined by the responsible worker from NGO units."||||
1300181|NCT03593876||Single Group Assignment||Treatment||None (Open Label)||||||
1300182|NCT03593863|Randomized|Parallel Assignment||Basic Science||Single||The Fit to Study brain imaging study is embedded in the Fit to Study trial, which is a parallel group, superiority cluster-randomised efficacy trial of a 10-month (one academic year) vigorous physical activity (VPA) intervention versus control.||||t
1300183|NCT03593850|Randomized|Parallel Assignment||Treatment||Triple|Computer block randomization was used to generate allocation sequence of codes. Allocation was done on the same day of the intervention, patients were given opaque envelope according to the randomization codes. The envelop contained instructions to access the allocated intervention. After baseline data collection patients entered the intervention room and opened the envelop inside while investigator waited outside. Both patients had headphones on and used the same device to access the intervention assuring blinding of the investigator. After the intervention ended, patient closed the intervention file and account to the intervention. All patients were instructed to nor reveal or comment anything about the intervention at any time after the intervention was completed.|Single blinded, two parallel group, randomized clinical trial. The experimental group received listen to a son composed exclusively for this trial while control group rested for the same amount of time in silence.||t|t|t
1300184|NCT03593837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300185|NCT03593824|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1300186|NCT03593811|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1300187|NCT03593798|||Cohort||Retrospective|||||||
1300188|NCT03593785|Randomized|Parallel Assignment||Treatment||Single|"This study is single-blind with regard to treatment (AZD8233 or placebo) at each dose level.~AZD8233 and placebo will be matched for formulation, appearance and amount. Subjects randomized to placebo will receive the same volume of injection as subjects on active drug."||t|||
1300189|NCT03593772|Randomized|Single Group Assignment||Other||None (Open Label)|There are no masked roles|This research study will evaluate a CIH intervention to manage pain and PTSD related outcomes within a bio-psychosocial framework. The proposed intervention, Mission Reconnect (MR), a user-driven, dyadic, self-care management program delivered online and by mobile app that has previously shown to be effective in a non-clinically defined community-based Veteran/military population.||||
1300190|NCT03593759|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, open-label, non-inferiority, randomized controlled with blinded end-point analysis.||||
1300191|NCT03593746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300192|NCT03593733|Randomized|Parallel Assignment||Treatment||Single||||||t
1300193|NCT03593720|||Case-Control||Prospective|||||||
1300194|NCT03593707|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1300195|NCT03593694|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1300196|NCT03593681|||Case-Only||Prospective|||||||
1300197|NCT03593668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300198|NCT03593655|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1300199|NCT03593642|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded|Randomized controlled|t|t|t|t
1300200|NCT03593629|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1300201|NCT03593616|||Cohort||Prospective|||||||
1300202|NCT03593603|||Cohort||Prospective|||||||
1300203|NCT03593590|||Cohort||Prospective|||||||
1300204|NCT03593577|||Cohort||Retrospective|||||||
1300205|NCT03593564|Randomized|Crossover Assignment||Prevention||Double|"Randomization will be revealed to the principal investigator and outcomes assessor once all planned analyses are preliminarily run on a coded, dichotomous variable indicating whether the participant was in the intervention or control group. Until then, randomization codes will be kept confidential by the course manager, who will be notified by the computer programming team how to decipher the coded variable (e.g., 0= received intervention), and will store this information in a sealed envelop."|The investigators will evaluate the KINDER program using two arms, an intervention group and waitlist control. Eligible and consented subjects will be randomized into either an intervention or waitlist control group on a rolling basis using a simple (i.e., non-clustered, individual-based), computerized randomization approach. After consenting, all caregivers will complete a baseline assessment. Caregivers in the intervention group will receive the intervention and complete a reassessment after 12 weeks. If selected for the waitlist control, participants will be offered another online program for caregivers, CareJourney, and will be reassessed 12 weeks after the reassessment. Both groups will also complete a 3-month reassessment. KINDER will be provided to the control group after the caregiver has completed a 3-month reassessment.|||t|t
1300211|NCT03593486|Randomized|Parallel Assignment||Treatment||Quadruple|Participants will be randomly assigned to either the active or sham stimulation group. Because the parameters are programmed into the stimulator by the manufacturer and given generic names (Stim 1 and Stim 2), the investigators and physicians performing the procedure will not know which protocol is active or sham.||t|t|t|t
1300212|NCT03593473|Randomized|Parallel Assignment||Basic Science||Quadruple|Participants will receive a nasal insufflation bottle of oxytocin intranasal spray or placebo intranasal spray manufactured to mimic oxytocin nasal spray.|Non-pregnant women will be randomized to either 24 IU of nasal OT or placebo. The Investigational Drug Service will use a random number generator to prepare a randomization table.|t|t|t|t
1300213|NCT03593460|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Adaptive Design||||
1300214|NCT03593447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300215|NCT03593434|||Cohort||Prospective|||||||
1300216|NCT03593421|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||open label, adaptive design, dose finding study||||
1300217|NCT03593408|||Cohort||Prospective|||||||
1300218|NCT03593395|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Cluster Randomized Parallel group study||||
1300219|NCT03593382|||Cohort||Cross-Sectional|||||||
1300220|NCT03593369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300221|NCT03593356|Randomized|Single Group Assignment||Basic Science||Single|Researchers know about amount of cash payment subjects receive at the point of enrollment because they assist subjects with credit card activation and instructions. For follow-up assessments at age 1, 2, 3 interviewers will be blind to the extent possible. Subjects will be asked not to tell interviewer of monthly cash amount.|Intervention and Control Group|t|||
1300222|NCT03593343|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1300223|NCT03593330|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|All eligible patients will be consented to participate in the study. If they consent, a non-clinician study team member will randomise the patient into the control or intervention arm. Thereafter, all members of the care team will be notified of the patient's allocation in order to deliver the TCP.|Patients will be randomised into two groups: standard of care or Transitional Care Programme (TCP)||||
1300224|NCT03593317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300225|NCT03593304|Randomized|Parallel Assignment||Prevention||Double||Experimental group: Medicine- Injection Mecobalamin (500mcg), Tablet Pyridoxine hydrochloride (25 mg) Placebo group: Injection normal saline (1ml), oral placebo pill|t||t|
1300226|NCT03593291|||Cohort||Prospective|||||||
1300227|NCT03593278||Single Group Assignment||Other||None (Open Label)||||||
1300228|NCT03593265||Single Group Assignment||Other||None (Open Label)||||||
1300229|NCT03593252|Randomized|Parallel Assignment||Prevention||Double|While it is not infeasible to have all the study personnel blinded to which treatment arm the participants are in, nurses caring for participants while they are admitted to the hospital after surgery will not be aware which treatment the participant received. Also, outcome assessors (nurse practitioner or physician) will be masked to intervention.|"Patients will be stratified into small bowel surgery and large bowel surgery, then randomized to the following study arms. Note: small bowel surgery do not require mechanical bowel preparation since the content is already fluid. So this subgroup will be randomized to groups 2 and 3 only.~Combination bowel prep: Mechanical preparation and oral non-absorbable antibiotics + standard care.~Oral antibiotics + standard care.~No preparation, with standard care.~Standard care (all groups):~Standard nil per os (NPO) prior to general anesthesia~Solids until 8 hours prior to surgery, formula until 6 hours, breast milk until 4 hours, clear fluids until 2 hours~Prophylactic IV antibiotics~Cefazolin (30mg/kg) and metronidazole (15mg/kg) within 60 minutes of incision~Re-dosing if procedure exceeds 4 hours~In case of beta-lactam allergy allergy, clindamycin 5mg/kg and gentamicin 7mg/kg will be used."||t||t
1300230|NCT03593239|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1300231|NCT03593226|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Part 1- Accelerated escalation This is an accelerated escalation dose study designed to assess the safety and tolerability of escalating doses of AGI-134, as well as the Maximum Tolerated Dose (MTD) and the part 2 dose (RP2D).~Part 2 - Will comprise of two cohorts aiming to assess the safety, tolerability and anti-tumour activity of AGI-134 as a monotherapy and in combination with pembrolizumab at the RP2D."||||
1300232|NCT03593213|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1300233|NCT03593200||Single Group Assignment||Treatment||None (Open Label)||||||
1300234|NCT03593187||Single Group Assignment||Treatment||None (Open Label)||||||
1300235|NCT03593174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300236|NCT03593161|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1300237|NCT03593148||Single Group Assignment||Treatment||None (Open Label)||||||
1300238|NCT03593135|Randomized|Parallel Assignment||Treatment||Single|Single-blinded trial, Intervention and placebo given|Randomized controlled trial|t|||
1300239|NCT03593122||Single Group Assignment||Treatment||None (Open Label)||||||
1300240|NCT03593109||Single Group Assignment||Treatment||None (Open Label)||||||
1300241|NCT03593096|Randomized|Crossover Assignment||Prevention||None (Open Label)||Including a baseline assessment and assessments at Low alitude and High altitude||||
1300242|NCT03593083|Randomized|Crossover Assignment||Prevention||None (Open Label)||Including a baseline assessment and assessments at Low alitude and High altitude||||
1300283|NCT03592550|||Cohort||Prospective|||||||
1300284|NCT03592537|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple (Participant, Care provider, Investigator, Outcomes Assessor) The trial will be planned that neither the doctors nor the patients will be aware of the group allocations. The study drugs will be prepared by an anesthesiologist not involved in performing the aneshesia, patient care or in data collection.|comparison of the effect of intrathecal fentanyl with the effect of intrathecal midazolam as postoperative analgesia in children undergoing infraumbilical surgery|t|t|t|t
1300285|NCT03592524|||Case-Only||Prospective|||||||
1300286|NCT03592511|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1300287|NCT03592498|Randomized|Parallel Assignment||Treatment||None (Open Label)||Clinical study Phase II, pilot, open, monocentric and randomized.||||
1300243|NCT03593070|Randomized|Parallel Assignment||Prevention||Single|Data Collectors will be blinded to the intervention. Study participants will be asked to not disclose their treatment condition.|Study Design The study is a Stage I longitudinal randomized clinical trial. Alzheimer's disease or a related dementia (ADRD) caregivers whose family members are in long-term care facilities will be recruited, screened for inclusion criteria, and will be randomly assigned to either Chronic Grief Management Intervention-Video (CGMI-V) or a Minimal Treatment (MT) condition. Caregivers in the CGMI-V condition will participate in eight weekly professionally led, real-time, live-streaming video online group sessions. Those caregivers in the MT condition will receive written information materials about late-stage ADRD at baseline. For both conditions, data will be collected at baseline (pre-intervention), 8 weeks (immediately post-intervention) for intervention effects, and 24 week post baseline for maintenance effects. The design for this study was chosen to avoid the type of group clustering or contamination that would be engendered by the use of a randomized cluster design.||||t
1300244|NCT03593057|Randomized|Parallel Assignment||Other||Double|||t||t|
1300245|NCT03593044||Single Group Assignment||Treatment||None (Open Label)||Subjects will take drops for one week and measurements will be taken before and after treatment period.||||
1300246|NCT03593031|Randomized|Parallel Assignment||Treatment||Quadruple|Clinician did not know which treatment group. Subjects did not know which treatment group||t|t|t|t
1300247|NCT03593018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300248|NCT03593005|Randomized|Crossover Assignment||Prevention||None (Open Label)||Including a baseline assessment and assessments at Low altitude and High altitude||||
1300249|NCT03592992|Randomized|Parallel Assignment||Treatment||Triple|Allocation packages will be prepared by a member of the research team not involved in recruitment. Allocation concealment will be achieved through the use of opaque envelopes containing the pre-specified intervention for each subject prior to initiation of recruitment.|Institutional Research Ethics Board Approval was obtained (Western Research Ethics Board 111264). Term pregnant women presenting to the Obstetric Care Unit at Victoria Hospital for an elective cesarean delivery will be approached for recruitment. Consenting participants will be randomly assigned to receive either 75 mcg of hydromorphone or 150 mcg of morphine at the time of their spinal anesthetic. Randomization will be achieved through a simple computerized randomization technique (use of random numbers list for allocation).|t|t||t
1300250|NCT03592979|Randomized|Crossover Assignment||Treatment||Single|The allocated gas mixture will not be disclosed to the patient since he will breath trough a facemask during both interventions.|Including a baseline assessment and assessments under simulated altitude and normoxia|t|||
1300251|NCT03592966|Randomized|Crossover Assignment||Basic Science||Double||Randomized, cross-over, double-blind, placebo-controlled study.|t||t|
1300252|NCT03592953|Randomized|Parallel Assignment||Other||Single|the primary endpoint is the scoring of non-technical skills on the video recording of the high fidelity simulation session. The raters are blinded of the allocation group of the participant.|Randomized trial with 3 groups: classical teaching, serious game with classical scenarios, serious game with specific scenarios||||t
1300253|NCT03592940|||Cohort||Cross-Sectional|||||||
1300254|NCT03592927|Randomized|Crossover Assignment||Prevention||Single|The allocated gas mixture will not be disclosed to the patient since he will breath through a facemask during both interventions.|Including a baseline assessment and assessments under simulated altitude and normoxia.|t|||
1300255|NCT03592914|||Cohort||Prospective|||||||
1300256|NCT03592901|||Case-Only||Prospective|||||||
1300257|NCT03592888||Single Group Assignment||Treatment||None (Open Label)||||||
1300258|NCT03592875|||Case-Only||Cross-Sectional|||||||
1300259|NCT03592862|Randomized|Parallel Assignment||Treatment||Double|Double blind|Placebo controlled|t||t|
1300260|NCT03592849||Single Group Assignment||Treatment||None (Open Label)||||||
1300261|NCT03592836|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1300262|NCT03592823|Randomized|Parallel Assignment||Prevention||Double||||t||t
1300263|NCT03592810|||Cohort||Prospective|||||||
1300264|NCT03592797|Randomized|Parallel Assignment||Treatment||Triple|Sham laser acupuncture group|Randomized, sham control, double blind pilot study|t||t|t
1300265|NCT03592784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300266|NCT03592771|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1300267|NCT03592758|||Cohort||Prospective|||||||
1300268|NCT03592745|Randomized|Parallel Assignment||Treatment||Triple|Both the participants and investigators performing and analyzing clinical and objective outcome measures will remain blind to condition. Participants will be told that they have a 50-50 chance of receiving either active or sham stimulation, but they will not be told which condition they receive.|This is a double-blind, sham controlled treatment study in which patients will have a 50/50 chance of receiving robotic arm therapy with either active transcutaneous vagus nerve stimulation (tVNS) or sham tVNS (placebo).|t||t|t
1300269|NCT03592732|||Other||Cross-Sectional|||||||
1300270|NCT03592719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300271|NCT03592706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300272|NCT03592693|Randomized|Parallel Assignment||Treatment||Quadruple|Participants, Investigators performing the follow-up, and care providers will be blinded|Randomized, multicenter, parallel group, placebo-controlled [Vitamin c plus hydrocortisone or placebo plus placebo|t|t|t|t
1300273|NCT03592680|Randomized|Parallel Assignment||Prevention||Triple||One group receives Vitamin C, the other group received placebo.|t|t|t|
1300274|NCT03592667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300275|NCT03592654||Sequential Assignment||Treatment||None (Open Label)||single subject multiple baseline design||||
1300276|NCT03592641||Single Group Assignment||Treatment||None (Open Label)||||||
1300277|NCT03592628|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1300278|NCT03592615|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Cataract group: participants undergo cataract surgery for vision correction Refractive error group: participants undergo corneal refractive surgery for vision correction||||
1300279|NCT03592602||Single Group Assignment||Supportive Care||None (Open Label)||||||
1300280|NCT03592589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300281|NCT03592576||||||||||||
1300288|NCT03592485|Randomized|Parallel Assignment||Treatment||Single|Single (Participant)|Parallel Assignment|t|||
1300289|NCT03592472|Randomized|Crossover Assignment||Treatment||Double|This is a double-blind study. The sponsor, investigators, study coordinators, and the patients will be blinded to the study drug (abexinostat/placebo).||t||t|
1300290|NCT03592459||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300291|NCT03592446|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1300292|NCT03592433|Randomized|Parallel Assignment||Other||Single|||t|||
1300293|NCT03592420|Randomized|Parallel Assignment||Prevention||Single||||||t
1300294|NCT03592407||Single Group Assignment||Treatment||None (Open Label)||||||
1300295|NCT03592394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300296|NCT03592381|Randomized|Parallel Assignment||Treatment||Double||Double Blinded, Parallel group, Randomized controlled trial.|t|||t
1300297|NCT03592368|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1300298|NCT03592355|Randomized|Parallel Assignment||Other||None (Open Label)||Clinicians slated for virtual visit rollout will be randomized (stratified by department) to either receive immediate virtual visit on-boarding (intervention arm) or delayed (3-months later) virtual visit on-boarding (control arm).||||
1300299|NCT03592342|Randomized|Parallel Assignment||Treatment||Quadruple|All 4 interventions will be similar in appearance and be allocated by use of a blinded kit number (each kit contains drug for 1 week).|Randomization will be 1:1:1:1 to 1 of the 4 parallel arms (3 active and 1 placebo) and patients will be stratified according to number of patches needed (1-3 and 4-6).|t|t|t|t
1300300|NCT03592329|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1300301|NCT03592316||Single Group Assignment||Treatment||None (Open Label)||||||
1300302|NCT03592303|||Cohort||Prospective|||||||
1300303|NCT03592290|||Case-Only||Cross-Sectional|||||||
1300304|NCT03592277|Randomized|Parallel Assignment||Treatment||Quadruple|All parties involved, except for pharmacy personnel will be blinded.||t|t|t|t
1300305|NCT03592264|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1300306|NCT03592251|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1300307|NCT03592238|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1300308|NCT03592225|Randomized|Parallel Assignment||Other||Double||2 groups of General practitioners are randomized to be allocated either in the intervention group or the control group|t|t||
1300309|NCT03592212|||Case-Only||Other|||||||
1300310|NCT03592199||Single Group Assignment||Treatment||None (Open Label)||||||
1300311|NCT03592186|Randomized|Parallel Assignment||Treatment||Single||||||t
1300312|NCT03592173|Randomized|Crossover Assignment||Treatment||None (Open Label)||Thirty chronic SCI participants will given the SAS intervention and a control intervention in a randomized cross-over study, with at least one week between interventions. Each patient will be required to attend the Burke Medical Research Institute on three occasions. We will use a within-subjects design, to test changes in neurophysiologic and voluntary measures after intervention with respect to baseline.||||
1300313|NCT03592160|Randomized|Parallel Assignment||Treatment||Single|||||t|
1300314|NCT03592147||Single Group Assignment||Treatment||None (Open Label)||"Within-subject pilot study, where each participant will undergo five different relaxation therapies (guided imagery meditation, music listening, relaxation lighting, combination of light and meditation, and a combination of light and music) and one silence/control state."||||
1300315|NCT03592134|||Case-Control||Prospective|||||||
1300316|NCT03592121|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300317|NCT03592108||Single Group Assignment||Screening||None (Open Label)||||||
1300318|NCT03592095|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300319|NCT03592082|Randomized|Parallel Assignment||Treatment||None (Open Label)|none - open label study|||||
1300320|NCT03592069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300321|NCT03592056|||Case-Only||Prospective|||||||
1300322|NCT03592043|||Cohort||Retrospective|||||||
1300323|NCT03592030|||Cohort||Prospective|||||||
1300324|NCT03592017|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1300325|NCT03592004|||Cohort||Prospective|||||||
1300326|NCT03591991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300327|NCT03591978|||Cohort||Prospective|||||||
1300328|NCT03591965||Single Group Assignment||Treatment||None (Open Label)||||||
1300329|NCT03591952|Randomized|Parallel Assignment||Treatment||Single|Subjects will be randomly allocated into intervention (gravity-driven) and control (suction-driven) groups by opening an opaque study envelope just prior to starting the procedure containing group assignment. Participants will be blinded to the use of gravity VS. suction drainage to prevent knowledge of their group assignment from biasing their pain assessments.||t|||
1300330|NCT03591939|||Case-Control||Prospective|||||||
1300331|NCT03591926|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300332|NCT03591913|Randomized|Parallel Assignment||Prevention||Single|||t|||
1300333|NCT03591900|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1300334|NCT03591887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300335|NCT03591874|Randomized|Parallel Assignment||Treatment||Triple|"All subjects, investigators, and study personnel involved in the conduct of the study, including data management and statistics, will be masked to treatment assignment except for a specified staff member from the designated packaging vendor who will do the package labeling.~Unmasking will be permitted in a medical emergency that requires immediate knowledge of the subject's treatment assignment."|This will be a randomized, placebo-controlled, double-masked, multicenter phase 3 study.|t|t|t|
1300336|NCT03591861||Single Group Assignment||Treatment||None (Open Label)||||||
1300337|NCT03591848|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1300338|NCT03591835|Randomized|Parallel Assignment||Supportive Care||Single|The radiologist who will determine endotracheal tube placement in the X-ray||||t|
1300339|NCT03591822|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1300523|NCT03589430|||Case-Only||Prospective|||||||
1300340|NCT03591809|Randomized|Parallel Assignment||Treatment||Single|To ensure blinding, the assessor physiotherapist will not be aware of the arm to which the subjects belong|Randomized, controlled, single-blind trial||||t
1300341|NCT03591796|Randomized|Parallel Assignment||Treatment||Triple||When the neonate had fulfilled the included criteria, selective HFOV or CMV were started immediately on the basis of the group assignment.|t||t|t
1300342|NCT03591783|||Cohort||Prospective|||||||
1300343|NCT03591770|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1300344|NCT03591757||Single Group Assignment||Treatment||None (Open Label)||Patients with hATTR mutations conferring leptomeningeal amyloidosis.||||
1300345|NCT03591744||Single Group Assignment||Treatment||None (Open Label)||||||
1300346|NCT03591731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300347|NCT03591718|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300348|NCT03591705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300349|NCT03591692|Randomized|Parallel Assignment||Treatment||Single|The statistical analysist do not know the group assignment.|||||t
1300350|NCT03591679|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300351|NCT03591666||Single Group Assignment||Treatment||None (Open Label)||||||
1300352|NCT03591653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300353|NCT03591640|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1300354|NCT03591627|||Cohort||Prospective|||||||
1300355|NCT03591614||Single Group Assignment||Treatment||None (Open Label)||||||
1300356|NCT03591601|Randomized|Factorial Assignment||Other||Double|||t||t|
1300357|NCT03591588|Randomized|Crossover Assignment||Basic Science||Single||The study includes 2 phases, each of which includes 2 arms: phase 1 includes high-saturated fat diet and low-fat diet; phase 2 includes high-saturated fat diet and high monounsaturated fat Mediterranean type diet.||||t
1300358|NCT03591575|Randomized|Parallel Assignment||Treatment||Quadruple|The placebo solution will have the same appearance and flavor as deferiprone oral solution, and will be administered at a volume matching that required for the dose of active product.||t|t|t|t
1300359|NCT03591562|||Cohort||Prospective|||||||
1300360|NCT03591549||Single Group Assignment||Treatment||None (Open Label)||||||
1300361|NCT03591536|Randomized|Parallel Assignment||Prevention||Triple|only principle investigator knew the drug from placebo|double blind randomized clinical trial|t|t||t
1300362|NCT03591523|||Cohort||Prospective|||||||
1300363|NCT03591510||Single Group Assignment||Treatment||None (Open Label)||||||
1300364|NCT03591497|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective Cohort study involving cases with use of intervention. Matched control cohort subjects were selected using pre-specified matching criteria (for matching with interventional cohort) as comparison group.||||
1300365|NCT03591484|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1300366|NCT03591471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300367|NCT03591458|Randomized|Parallel Assignment||Treatment||Quadruple||Double-blind, randomized, placebo control|t|t|t|t
1300368|NCT03591445||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300369|NCT03591432|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1300370|NCT03591419|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1300371|NCT03591406|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, parallel design, randomised controlled multi-centre trial in Chinese subjects||||
1300372|NCT03591393||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300373|NCT03591380||Single Group Assignment||Treatment||None (Open Label)||This study is proposed to be an open-label, single-arm, pilot study to test whether the addition of belimumab, to inhibit the B cell survival factor BLyS at the time of kidney transplantation, to standard or care therapy (alemtuzumab and steroid induction with mycophenolic acid and tacrolimus maintenance immunosuppression) will prevent the prevent the generation of de novo DSA||||
1300374|NCT03591367||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300375|NCT03591354|Randomized|Parallel Assignment||Other||None (Open Label)||A randomized controlled trial of 3 months at home closed loop system vs. sensor-augmented pump.||||
1300376|NCT03591341|||Other||Prospective|||||||
1300377|NCT03591328|||Case-Control||Other|||||||
1300378|NCT03591315|||Cohort||Prospective|||||||
1300379|NCT03591302||Single Group Assignment||Treatment||None (Open Label)||Total Lymphoid Irradiation, Anti-Thymocyte Globulin and Purified Donor CD34+ and T Cell Transfusion in previous HLA Matched Living Donor Kidney Transplantation||||
1300380|NCT03591289|Randomized|Parallel Assignment||Treatment||Triple|Subjects will not be informed to which NMB depth they were randomized to.|two different regimens (doses) of two drugs (Rocuronium, Sugammadex)|t||t|t
1300381|NCT03591276||Single Group Assignment||Treatment||None (Open Label)||||||
1300382|NCT03591263|||Other||Retrospective|||||||
1300383|NCT03591250|||Cohort||Prospective|||||||
1300384|NCT03591237||Single Group Assignment||Treatment||None (Open Label)||||||
1300385|NCT03591224|Randomized|Parallel Assignment||Treatment||Double|Patients are not told of their group assignment until the end of the study, at which point they would receive a copy of their pharmacogenetic report. The consulting pharmacist also does not have knowledge of the patient's group assignment in the first encounter for baseline data collection. Group assignment is only revealed to the pharmacist after two weeks when the pharmacogenetic report is available on the Pillcheck online portal. Patients assigned to the control group will have their report appear blank to the pharmacist, whereas the intervention patient group will have their full pharmacogenetic report accessible by the consulting pharmacist. Prescribers are also informed via fax briefly of the study protocol and asked to maintain blinding of their patient's group assignment.|Enrolled subjects will be randomly assigned to either the control arm (pharmacist standard of care) or intervention arm (pharmacogenetic guided decision making by the pharmacist) in optimizing antidepressant drug therapy. Randomization is done by the primary investigator who isn't directly involved with patient consultations.|t|t||
1300386|NCT03591211|Randomized|Parallel Assignment||Treatment||Single||||||t
1573336|NCT00001554||||Treatment||||||||
1300387|NCT03591198|Randomized|Parallel Assignment||Treatment||Single||||||t
1300388|NCT03591185||Single Group Assignment||Treatment||None (Open Label)||||||
1300389|NCT03591172|Randomized|Parallel Assignment||Other||Double|||t|||t
1300390|NCT03591159|Randomized|Parallel Assignment||Prevention||Single|||t|||
1300391|NCT03591146|Randomized|Sequential Assignment||Supportive Care||Quadruple|To maintain objectiveness, the study drug will be managed and administered by an independent unblinded team, including injectors, pharmacists, and clinical research associates. Subjects, investigators, and all other site staff who directly interact with subjects, evaluate safety and efficacy, and collect subject data, will remain blinded and must not communicate or discuss any study information with the unblinded team.|Subjects will be enrolled to each cohort in a 3:1 ratio. Each cohort will comprise subjects receiving a dose of TLC590 and active comparator drug (Naropin® 150 mg; [0.5%, 5 mg/mL]) in accordance with the randomization schedule and dose-escalation scheme.|t|t|t|t
1300392|NCT03591133|Randomized|Sequential Assignment||Basic Science||Quadruple|||t|t|t|t
1300393|NCT03591120|Randomized|Parallel Assignment||Prevention||Single|||t|||
1300394|NCT03591107|Randomized|Parallel Assignment||Health Services Research||Single|"Recruitment Coordinators/Data Collectors will only recruit at one of the two sites. The baseline assessment will be conducted prior to random assignment. After the assessment, they will be aware of study assignment which is necessary for connecting patients assigned to the PCM arm to connect patients to the Care Manager. However, they will only conduct 6-month assessments with patients from the other site and therefore will not be aware of the assignments for those patients."|||||t
1300395|NCT03591094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300396|NCT03591081||Single Group Assignment||Prevention||None (Open Label)||||||
1300397|NCT03591068||Single Group Assignment||Treatment||None (Open Label)||||||
1300398|NCT03591055|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1300399|NCT03591042|Randomized|Parallel Assignment||Prevention||Single|||||t|
1300400|NCT03591029|||Case-Only||Prospective|||||||
1300401|NCT03591016|||Cohort||Prospective|||||||
1300402|NCT03591003|||Cohort||Other|||||||
1300403|NCT03590990|||Cohort||Cross-Sectional|||||||
1300404|NCT03590977|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1300405|NCT03590964|Randomized|Parallel Assignment||Treatment||None (Open Label)|Because the two interventions used in this trial are clearly different and easily recognized by the participants and investigators, neither the investigators nor participants can be blinded.|"A Randomized controlled trial.~Parallel group study.~A trial will be carried out in hospital of Oral and Maxillofacial surgery department- Faculty of Oral and Dental Medicine Cairo University~Equal randomization: participants with equal probabilities for intervention.~Positive controlled: Both groups receiving treatment."||||
1300406|NCT03590951|||Case-Only||Retrospective|||||||
1300407|NCT03590938|||Cohort||Prospective|||||||
1300408|NCT03590925|||Other||Other|||||||
1300409|NCT03590912|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300410|NCT03590899|||Cohort||Cross-Sectional|||||||
1300411|NCT03590886|||Other||Cross-Sectional|||||||
1300412|NCT03590873|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1300413|NCT03590860|Randomized|Parallel Assignment||Basic Science||Double|Part C will be open label||t||t|
1300414|NCT03590847||Single Group Assignment||Treatment||None (Open Label)||||||
1300415|NCT03590834|Randomized|Parallel Assignment||Prevention||None (Open Label)|The parents of the children were informed that their Head Start center will be randomly assigned to one of the three study groups.|||||
1300416|NCT03590821|Randomized|Crossover Assignment||Prevention||Triple|Administration of acetylsalicylic acid versus placebo will be masked|"Prospective study design, double-blinded and randomized by order for acetylsalicylic acid versus placebo, open for celecoxib.~In a prospective study each individual will undergo two treatment periods randomized by order (separated by 3 weeks of washout). In one period, placebo (matching aspirin for double-blinding) will be administered in the evening for 14 days. In the other period, aspirin (81 mg QD) will be administered in the evening for 14 days. Drug intake will be timed to occur within 1-2 hours prior to falling asleep. Celecoxib (200 mg BID) will be added openly for the final 7 days during each treatment period."|t||t|t
1300417|NCT03590808|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Double center prospective case-control clinical trial||||
1300418|NCT03590795|||Other||Prospective|||||||
1300419|NCT03590782|||Cohort||Prospective|||||||
1300420|NCT03590769||Single Group Assignment||Health Services Research||None (Open Label)||Patient undergoing percutaneous angioplasty of SFA or popliteal artery or stenting of iliac artery will have 18F-FDG-PET scan at the region of interest before intervention, then post-operatively 1 day and 1 week from treatment.||||
1300421|NCT03590756|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1300422|NCT03590743|Randomized|Single Group Assignment||Treatment||Quadruple|Double blind, placebo controlled|Multicenter, randomized, double blind, placebo-controlled, superiority clinical trial.|t|t|t|t
1300423|NCT03590730|||Cohort||Prospective|||||||
1300424|NCT03590717|Randomized|Factorial Assignment||Prevention||Single||Cluster randomized controlled trial clustered at the village level, 2 treatment arms and one control group.||||t
1300425|NCT03590704||Single Group Assignment||Treatment||None (Open Label)||||||
1300426|NCT03590691|Randomized|Parallel Assignment||Health Services Research||Single||A cluster-randomized trial design|t|||
1300427|NCT03590678|||Cohort||Prospective|||||||
1300428|NCT03590665|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||The acute response to exercise in blood flow is non-invasively assessed in group of individuals with Down syndrome and a control group of age- and sex-matched individuals without Down syndrome.||||
1300429|NCT03590652||Single Group Assignment||Treatment||None (Open Label)||||||
1300430|NCT03590639|||Other||Prospective|||||||
1300431|NCT03590626|Randomized|Parallel Assignment||Treatment||Single||will randomize the patients into either dulaglutide group or control group in a 1:1 ratio using computer-generated numbers||||t
1300518|NCT03589495|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1300519|NCT03589482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300432|NCT03590613|Randomized|Crossover Assignment||Treatment||Triple|It is a double-blinded study, where the subjects, investigators and the site-staff will be blinded.|Study will comprise of four TPs, each of at least 7 days in duration with subjects in-house for 4 nights (through 72 hours after the first dose). During each TP, subjects will be admitted to the unit, day before dosing and will be discharged after completion of 72 hours post-dose assessments. dose will be administered TID, in an ascending manner. Every individual subject will receive placebo and GSK2982772 (60, 120,240 mg TID) as per assigned sequence. For TID dosing, GSK2982772 or placebo will be administered at 0 hour (the first dosing), 7 hour (the second dosing) and 14 hour (the third dosing) on Day 1 in each period. On Day 1, subjects will fast 8hour overnight prior to first dose. breakfast will be served approximately 2hour after first dose. Lunch and dinner will be served between 2 to 3hour prior to second and third doses, respectively. A washout of atleast 7-days between the TP doses for each individual subject.|t|t|t|
1300433|NCT03590600|Randomized|Sequential Assignment||Treatment||Quadruple|Subjects, investigators and investigators' staff, persons performing the assessments or being responsible for determining dosing regimen/adjustments, and staff of the sponsor or data analysts, will remain blinded from the time of randomization until database lock, using the following methods: randomization data, including any documentation identifying the treatment allocation, are kept strictly confidential until the time of unblinding with the following exceptions: staff responsible for study drug management (i.e. the staff in the CRO CTS department preparing the IMP).||t|t|t|t
1300434|NCT03590587|||Cohort||Retrospective|||||||
1300435|NCT03590574||Single Group Assignment||Treatment||None (Open Label)||||||
1300436|NCT03590561||Sequential Assignment||Basic Science||None (Open Label)||||||
1300437|NCT03590548|||Case-Only||Other|||||||
1300438|NCT03590535|||Cohort||Prospective|||||||
1300439|NCT03590522|||Case-Control||Cross-Sectional|||||||
1300440|NCT03590509|Randomized|Parallel Assignment||Health Services Research||Single|While the families and HRCC staff cannot be blinded, the healthcare economist and the statistician will remain blinded to treatment group when performing the analyses.|Randomized Quality-Improvement Trial|||t|
1300441|NCT03590496|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1300442|NCT03590483|||Case-Only||Cross-Sectional|||||||
1300443|NCT03590470|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Non-randomized stepped-wedge design||||
1300444|NCT03590457||Single Group Assignment||Other||None (Open Label)||||||
1300445|NCT03590444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300446|NCT03590431|Randomized|Crossover Assignment||Basic Science||Single|"Two of the three test drinks will consist of milk delivering extrinsic iodine or intrinsic iodine and will appear the same. These two milks will be labelled with A and B and masking will be applied to the participant only (single-blinded). The code will be held by the Study coordinator. However, for the water iodine-solution, blinding will not be possible."||t|||
1300447|NCT03590418|||Case-Control||Prospective|||||||
1300448|NCT03590405||Single Group Assignment||Treatment||None (Open Label)||||||
1300449|NCT03590392|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300450|NCT03590379|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1300451|NCT03590366|Randomized|Parallel Assignment||Treatment||Quadruple|"This is a double blind study. Participants will be assigned to study treatment in accordance with the randomization schedule generated for the allocation of vehicle or B244 prior to the initiation of the trial. Randomization will be centrally-based and performed using an appropriate IWRS (an automated randomization system).~Each participant scheduled to receive investigational product (IP) will receive a randomization number at the time of randomization. The randomization number will be used to identify the study medication kit assigned to the participant and indicate the treatment to be administered to that participant."|Randomization will be 1:1 so that equal numbers of patients will be treated in each arm of the study.|t|t|t|t
1300452|NCT03590353|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300453|NCT03590340|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1300454|NCT03590327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300455|NCT03590314|Randomized|Parallel Assignment||Treatment||Single||Single-blind RCT with two parallel group|||t|
1300456|NCT03590301|Randomized|Factorial Assignment||Prevention||Single|Participants will not know whether they are in the control or experimental group.||t|||
1300457|NCT03590288|||Cohort||Prospective|||||||
1300458|NCT03590275|||Cohort||Retrospective|||||||
1300459|NCT03590262||Single Group Assignment||Treatment||None (Open Label)||||||
1300460|NCT03590249|Randomized|Parallel Assignment||Treatment||Triple|The practitioner providing the OMT or No Treatment will not be involved in collecting data for each subject. The practitioner(s) and technicians collecting the data will not be involved in any aspect of the procedure performed (OMT or No Treatment) on the subjects.|The design of this preliminary pilot trial is a double-masked (blind), randomized, No Treatment-controlled, parallel group design.|t||t|t
1300461|NCT03590236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300462|NCT03590223|||Cohort||Retrospective|||||||
1300463|NCT03590210|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two group, non-randomized||||
1300464|NCT03590197|Randomized|Parallel Assignment||Treatment||Triple|The recruited patients will be randomized by simple randomization into two treatment groups using computer-generated random codes. The random allocation code of the participants will be generated by PI who will not be involved in the patient recruitment. The codes will be assigned to a sequence of numbers and the numbered stickers will be pasted on the similar looking drug containers. The drug containers will be given to another investigator who will be responsible for patient recruitment. This process ensured allocation concealment.||t|t|t|
1300465|NCT03590184|||Case-Only||Retrospective|||||||
1300466|NCT03590171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300467|NCT03590158||Single Group Assignment||Prevention||None (Open Label)||||||
1300468|NCT03590145|||Case-Only||Cross-Sectional|||||||
1300520|NCT03589469||Single Group Assignment||Treatment||None (Open Label)||||||
1300521|NCT03589456|||Case-Only||Other|||||||
1300522|NCT03589443||Single Group Assignment||Diagnostic||None (Open Label)||||||
1573337|NCT00001553||||||||||||
1300469|NCT03590132|Randomized|Factorial Assignment||Prevention||Double|Neither the interventionists or the assessors were given information on participants' treatment group; however there is only partial masking for providers given that attendance in the program suggests some information on experimental group.|A 4 arm trial, participants receive either a preadolescent intervention only, a mid-adolescent intervention only, both preadolescent and mid-adolescent intervention, or no intervention||t||t
1300470|NCT03590119|Randomized|Parallel Assignment||Treatment||Single||This study uses a with-in subject randomization between intra-arterial treatment via the left or right hepatic artery.||||t
1300471|NCT03590106||Single Group Assignment||Prevention||None (Open Label)||All patients meeting the eligibility criteria will be approached about participation in the Peer Recovery Support Program. Those who agree will receive the intervention as designed. Those who receive will continue to receive standard of care.||||
1300472|NCT03590093|Randomized|Parallel Assignment||Treatment||Double|The examiner were not aware of group allocation||||t|t
1300473|NCT03590080|||Cohort||Prospective|||||||
1300474|NCT03590067|||Ecologic or Community||Cross-Sectional|||||||
1300475|NCT03590054||Single Group Assignment||Treatment||None (Open Label)||||||
1300476|NCT03590041|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Blinding is not possible with the study design. Patients will not know that there is a difference in SMAs|"The two interventions are based in the Chronic Care Model, which emphasizes whole person care, addressing physical, mental health and psychosocial needs. The conceptual model underlying patient-driven diabetes Shared Medical Appointments is based on self-determination theory (SDT) and principles of whole person care. According to SDT, human motivation and behavior are a function of the social environment and the extent to which that environment supports basic psychological needs shown to enhance self-determined motivation."||||
1300477|NCT03590028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300478|NCT03590015|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1300479|NCT03590002|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||All study ICUs will begin as control sites (i.e., no electronic medical transfer tool available). ICUs will be randomly allocated to cross over to the intervention (i.e., electronic medical transfer tool available) at regular intervals (approximately every eight weeks) until all ICUs receive the intervention.||||
1300480|NCT03589989|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statisticians and laboratory personnel will be blinded to group allocation.|||||
1300481|NCT03589976|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1300482|NCT03589963|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1300483|NCT03589950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300484|NCT03589937|||Other||Prospective|||||||
1300485|NCT03589924|Randomized|Parallel Assignment||Treatment||None (Open Label)||All patients will undergo Skin Sparing Mastectomy(SSM)/Nipple Sparing Mastectomy(NSM) with one-stage or two stage IBBR with TiLoop® Bra.||||
1300486|NCT03589911||||||||||||
1300487|NCT03589898||Single Group Assignment||Other||None (Open Label)||||||
1300488|NCT03589885|Randomized|Parallel Assignment||Treatment||Quadruple||A Phase IIIb 52-week multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in approximately 120 subjects with moderate to severe plaque-type psoriasis|t|t|t|t
1300489|NCT03589872|||Case-Crossover||Prospective|||||||
1300490|NCT03589859|||Cohort||Cross-Sectional|||||||
1300491|NCT03589846||Single Group Assignment||Device Feasibility||None (Open Label)||All patients who meet eligiblity will undergo muscle stimulation at the same time as the operative DISE procedure.||||
1300492|NCT03589833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300493|NCT03589820|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300494|NCT03589807|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1300495|NCT03589794|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1300496|NCT03589781|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1300497|NCT03589768|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1300498|NCT03589755|Randomized|Parallel Assignment||Treatment||Single|Clinical providers in the epilepsy clinic are blinded||||t|
1300499|NCT03589742||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1300500|NCT03589729||Single Group Assignment||Supportive Care||None (Open Label)||||||
1300501|NCT03589716|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1300502|NCT03589703|Randomized|Factorial Assignment||Treatment||Single|||t|||
1300503|NCT03589690|Randomized|Parallel Assignment||Treatment||Triple|This study will be conducted as a parallel randomized double-blind clinical trial. patient will randomly be divided into two groups, each will receive supplement or placebo for 12 weeks .Before the study, containers will be coded as A and B by a person other than the study researchers according the concealment rules .|In this study, samples will be randomly divided into two groups receiving the supplement or placebo.|t|t|t|
1300504|NCT03589677|||Cohort||Prospective|||||||
1300505|NCT03589664|||Cohort||Cross-Sectional|||||||
1300506|NCT03589651|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300507|NCT03589638|Randomized|Parallel Assignment||Treatment||Single||Prospective, Randomized, double blind Clinical Trial|t|||
1300508|NCT03589625|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Stepped-wedge cluster-randomized trial||||
1300509|NCT03589612|||Other||Other|||||||
1300510|NCT03589599|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1300511|NCT03589586|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, randomized, controlled, open-label trial comparing DermACELL AWM to conventional care||||
1300512|NCT03589573|||Other||Other|||||||
1300513|NCT03589560|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300514|NCT03589547||Single Group Assignment||Treatment||None (Open Label)||||||
1300515|NCT03589534||Single Group Assignment||Other||None (Open Label)||||||
1300516|NCT03589521||Single Group Assignment||Treatment||None (Open Label)||||||
1300517|NCT03589508|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573338|NCT00001546||||||||||||
1300524|NCT03589417|||Other||Prospective|||||||
1300525|NCT03589404||Single Group Assignment||Diagnostic||None (Open Label)|investigator|prospective, cohort,double blind||||
1300526|NCT03589391|Randomized|Parallel Assignment||Device Feasibility||Double|||t|t||
1300527|NCT03589378|Randomized|Parallel Assignment||Treatment||None (Open Label)||a Multicenter,Randomized and Controlled Clinical Trial||||
1300528|NCT03589365|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1300529|NCT03589352|||Cohort||Other|||||||
1300530|NCT03589339||Sequential Assignment||Treatment||None (Open Label)||||||
1300531|NCT03589326|Randomized|Parallel Assignment||Treatment||None (Open Label)|It is an open-label trial, therefore investigators and participants are unblinded.|||||
1300532|NCT03589313||Single Group Assignment||Treatment||None (Open Label)||||||
1300533|NCT03589300||Single Group Assignment||Treatment||None (Open Label)||||||
1300534|NCT03589287|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The treatment protocol consists of two stages: the first stage is a traditional 3+3 dose-escalation open study design with three cohorts. At the second stage, a total of 6 patients with knee OA will be treated by the cell products of the maximum tolerance dose (MTD) as determined by the results of the first stage.||||
1300535|NCT03589274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300536|NCT03589261||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300537|NCT03589248|||Other||Prospective|||||||
1300538|NCT03589235|Randomized|Parallel Assignment||Treatment||Single||||||t
1300539|NCT03589222||Single Group Assignment||Treatment||None (Open Label)||This is an investigator-sponsored, open-label, non-randomized Phase 2 study to evaluate the efficacy and safety of this combination for a total of 62 patients with refractory or relapsed/refractory MM patients. The treatment will be given until progression of the disease or inacceptable toxicity. This trial will be conducted in approximately 15-centers in Spain||||
1300540|NCT03589209|||Cohort||Retrospective|||||||
1300541|NCT03589196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300542|NCT03589183|||Cohort||Cross-Sectional|||||||
1300543|NCT03589170|||Ecologic or Community||Cross-Sectional|||||||
1300544|NCT03589157|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1300545|NCT03589144|||Case-Only||Prospective|||||||
1300546|NCT03589131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300547|NCT03589118|Randomized|Parallel Assignment||Treatment||Single|Primary outcome (VAS scale) will be presented to the patient and reported by a study nurse blinded of the randomization arm of the patient.|"Patients are randomized in two groups :~usual medical and psychological support in the control group~qi gong sessions added in the experimental group~Allocation between groups qi and control is 1 : 1"||||t
1300548|NCT03589105||Single Group Assignment||Treatment||None (Open Label)||||||
1300549|NCT03589092|||Cohort||Cross-Sectional|||||||
1300550|NCT03589079|||Cohort||Cross-Sectional|||||||
1300551|NCT03589066|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two different formulations of LY03003, i.e. Formulation A and Formulation B||||
1300552|NCT03589053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300553|NCT03589040|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A prospective, non-randomized, open-label, parallel, two-group, sparse-sampling pharmacokinetic study to describe etonogestrel (ENG) pharmacokinetic parameters in two treatment groups (rilpivirine or darunavir- based antiretroviral therapy) in 60 HIV-1 infected women. The primary endpoint is the comparison of the mean ENG concentrations at month 6 between the rilpivirine or darunavir treatment groups versus historical controls.||||
1300554|NCT03589027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A prospective, non-randomized, open-label, parallel, two-group, sparse-sampling pharmacokinetic (PK) study to describe levonorgestrel (LNG) PK parameters in two treatment groups (Rilpivirine or Darunavir- based ART) in 60 HIV-1 infected women.||||
1300555|NCT03589014|Randomized|Parallel Assignment||Treatment||Single|"Treat_CCM is a Prospective Randomized Open Trial with Blinded Evaluation of outcomes (PROBE).~Clinical events CCM-related (i.e. intra-cerebral hemorrhage and focal neurological deficits including seizures) will be blindly adjudicated by an independent Event Committee.All MRI exams will be read in a Central Laboratory by experienced neuroradiologists, unaware of patient identification and study treatment."|||||t
1300556|NCT03589001|||Cohort||Prospective|||||||
1300557|NCT03588988|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1300558|NCT03588975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300559|NCT03588962|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1300560|NCT03588949|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1300561|NCT03588936||Single Group Assignment||Treatment||None (Open Label)||||||
1300562|NCT03588923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300563|NCT03588910|Randomized|Parallel Assignment||Treatment||Single|The treating provider and the patient know their prescription. The outcomes assessor will be blinded when administering the postoperative surveys.|Patients are randomized to receive one of two prescription regimens.||||t
1300564|NCT03588897|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Normal diet versus normal diet + nutritional support in elderly patients||||
1300565|NCT03588884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300566|NCT03588871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300567|NCT03588858|||Case-Only||Other|||||||
1300568|NCT03588845|Randomized|Parallel Assignment||Diagnostic||Single||The primary objective of this randomized trial is to determine if a structured, treat-to-target algorithm based on treatment response and relapse performs better than standard care for the treatment of symptoms SSc-SIBO.|||t|
1300569|NCT03588832|||Ecologic or Community||Prospective|||||||
1300570|NCT03588819||Single Group Assignment||Treatment||None (Open Label)||||||
1300571|NCT03588806||Single Group Assignment||Supportive Care||None (Open Label)||||||
1300572|NCT03588793|||Cohort||Prospective|||||||
1300573|NCT03588780|||Cohort||Retrospective|||||||
1300618|NCT03588195|Randomized|Parallel Assignment||Treatment||Single||||||t
1300574|NCT03588767|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with polytrauma will be administered vitamin D3 + anabolic substance. Group of an identical size of patients who were treated in the past without administration of vitamin D3 and anabolic substance will be analyzed retrospectively.||||
1300575|NCT03588754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300576|NCT03588741||Single Group Assignment||Treatment||None (Open Label)||||||
1300577|NCT03588728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300578|NCT03588715|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study will evaluate the impact of the combination of 3BNC117 and 10-1074 with or without antiretroviral therapy in virological rebound during an ATI and effects on the HIV reservoir.~This will be a pilot phase I randomized study to evaluate the safety, tolerability, pharmacokinetics (PK), and antiviral activity of a combination of Pegylated Interferon alpha 2b with the two broadly neutralizing antibodies (3BNC117 and 10-1074) in 14 individuals or the combination the broadly neutralizing antibodies alone in 7 HIV-1 infected individuals, undergoing a brief analytical treatment interruption (ATI)."||||
1300579|NCT03588702||Single Group Assignment||Treatment||None (Open Label)|Independent blinded reviewers to view photographs to assess improvement of skin appearance of the treated side at 1 month post-treatment using the General Aesthetic Improvement Scale (GAIS) compared to the non-treated side|Subjects act as their own control.||||
1300580|NCT03588689|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a prospective randomized controlled non-blinded pilot study.||||
1300581|NCT03588676|Randomized|Crossover Assignment||Treatment||Triple||randomized, placebo controlled, double blind, cross-over trial|t||t|t
1300582|NCT03588663|Randomized|Crossover Assignment||Basic Science||Single|A blinded outcomes assessor will analyse all data. Participants will not be blinded from the study as they will know whether they are using the Bionic Leg in a given testing session or not.|||||t
1300583|NCT03588650||Sequential Assignment||Treatment||None (Open Label)||||||
1300584|NCT03588637|||Other||Other|||||||
1300585|NCT03588624||Single Group Assignment||Treatment||None (Open Label)||||||
1300586|NCT03588611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300587|NCT03588598||Single Group Assignment||Treatment||None (Open Label)||||||
1300588|NCT03588585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300589|NCT03588572|Randomized|Factorial Assignment||Treatment||Single|The investigator learned about the experimental grouping and medication situation, but the subjects did not know until the end of the experiment.|On the basis of conventional clinical treatment in both groups, the experimental group was given drug intervention, and the control group was not given drug treatment.|t|||
1300590|NCT03588559||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300591|NCT03588546|||Cohort||Prospective|||||||
1300592|NCT03588533||Single Group Assignment||Treatment||None (Open Label)||"Herzuma 8mg/kg loading over 90min (1st cycle)~Herzuma 6mg/kg maintenance over 30min (2nd cycle~ ) every 3 weeks~Capecitabine 1000mg/m2 p.o. bid D1-D14 every 3 weeks~Cisplatin 60~100mg/m2 i.v. D1 every 3 weeks"||||
1300593|NCT03588520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300594|NCT03588507|Randomized|Parallel Assignment||Treatment||Single|the records of the study participants will be assigned code numbers and the results will be assessed by a third party . coding will not be broken until all assessment and statistics will be completed|||||t
1300595|NCT03588494|Randomized|Parallel Assignment||Treatment||Triple||Patients were randomly assigned to a regimen of W1-CCRT(one treatment cycle of intravenous pump of recombinant human endostatin before chemoradiotherapy), or W2-CCRT(two treatment cycle of intravenous pump of recombinant human endostatin before chemoradiotherapy), or CCRT.|t|t|t|
1300596|NCT03588481|||Cohort||Prospective|||||||
1300597|NCT03588468|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1300598|NCT03588455|||Cohort||Retrospective|||||||
1300599|NCT03588442|||Cohort||Prospective|||||||
1300600|NCT03588429|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1300601|NCT03588416|||Cohort||Other|||||||
1300602|NCT03588403|||Case-Control||Prospective|||||||
1300603|NCT03588390|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300604|NCT03588377|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1300605|NCT03588364|Randomized|Crossover Assignment||Treatment||Triple|Only the study coordinator and the participants are privy to the assigned treatment arm (immediate vs. delayed) until the study is complete and the database is locked.|This is a 30-week prospective, randomized delayed treatment control group design in which 20 participants from the community will be randomized 1:1 into (a) an immediate treatment group that will receive 12 weeks of osteopathic manipulation (OMT) treatment plus standard of care right away or (b) delayed treatment group that will receive 12 weeks of OMT plus standard of care after a 6-week waiting period. The delayed treatment group initially serves as a control condition but then receives the experimental treatment.||t|t|t
1300606|NCT03588351|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300607|NCT03588338|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1300608|NCT03588325|||Cohort||Prospective|||||||
1300609|NCT03588312|||Case-Only||Retrospective|||||||
1300610|NCT03588299||Single Group Assignment||Treatment||None (Open Label)||||||
1300611|NCT03588286|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1300612|NCT03588273||Single Group Assignment||Basic Science||None (Open Label)||Monocentric, open-label, single-dose study with two treatment periods - before the surgery (Time 0 - T0) and 2 months after the bariatric surgery (Time 2 - T2).||||
1300613|NCT03588260|||Case-Crossover||Prospective|||||||
1300614|NCT03588247|||Cohort||Prospective|||||||
1300615|NCT03588234|||Case-Control||Cross-Sectional|||||||
1300616|NCT03588221|Randomized|Crossover Assignment||Screening||None (Open Label)||"Randomized crossover trial, comparing the following four sets of hand hygiene measurements per participant:~Six-step hand hygiene technique with an application time of 30 seconds~Six-step hand hygiene technique with an application time of 15 seconds~Three-step hand hygiene technique with an application time of 30 seconds~Three-step hand hygiene technique with an application time of 15 seconds"||||
1300617|NCT03588208|Randomized|Parallel Assignment||Treatment||Single||||||t
1300619|NCT03588182|Randomized|Parallel Assignment||Other||None (Open Label)||Parallel design, nonblinded, randomized controlled superiority trial||||
1300620|NCT03588169|||Other||Prospective|||||||
1300621|NCT03588156|Randomized|Parallel Assignment||Treatment||Triple||11 dose groups within 62.5 mg ~ 4000 mg for single-dose tolerability study to carried out from low-dose group to high-dose group|t|t|t|
1300622|NCT03588143|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1300623|NCT03588130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300624|NCT03588117|||Cohort||Prospective|||||||
1300625|NCT03588104|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pragmatic randomised trial||||
1300626|NCT03588091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300627|NCT03588078||Single Group Assignment||Treatment||None (Open Label)||Participants will receive one dose of protocol therapy||||
1300628|NCT03588065|Randomized|Parallel Assignment||Prevention||Double|The FMS as a diagnostic evaluation test was applied in two moments with three blind physiotherapeutic evaluators with specialization in therapeutic physical activity and master in Physical Activity and Sports, with an experience of more than 5 years in the field of assessment of sport condition and clinical experience. in sport over 6 years in sports clubs in the region.|For the process of imparting health education strategies in face-to-face (conference) and ICT-mediated mode, a 4-week time was estimated where 4 educational sessions were held at a rate of one each week, lasting about 40 minutes, for part of two physiotherapists experts in the theme of injury prevention around the conceptual elements of human body movement, warm-up phases, postural hygiene, sports hygiene, nutrition and clothing. Interventions were carried out simultaneously in both groups of the study, so that one researcher taught the lecture modality in person (conference group), and the other supervised the participants while using the computers of the sports training institution.|t||t|
1300629|NCT03588052|Randomized|Parallel Assignment||Treatment||Single||||||t
1300630|NCT03588039|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300631|NCT03588026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300632|NCT03588013|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"Moderately or severely malnourished (weight for height Z score (WHZ) < -2) children~Well-nourished (WHZ > 0) children~Control group of children in the US with celiac disease~Control group of children in the US with Crohn's disease~Control group of healthy age-matched children in the US"||||
1300633|NCT03588000|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1300634|NCT03587987|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1300635|NCT03587974|Randomized|Parallel Assignment||Supportive Care||Single||Cluster randomized controlled trial||||t
1300636|NCT03587961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300637|NCT03587948|||Cohort||Prospective|||||||
1300638|NCT03587935|||Cohort||Prospective|||||||
1300639|NCT03587922||Single Group Assignment||Treatment||None (Open Label)||||||
1300640|NCT03587909|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300641|NCT03587896|Randomized|Parallel Assignment||Prevention||Single|Participants, facilitators, and research staff involved in the screening and baseline assessment will not be blind to the interventions provided during the trial. Outcomes assessors will be kept blind to the study conditions.|RE-DEFINE is a prospective, randomized, parallel-group trial that will follow study participants over a period of 12-months. Syrian refugees with psychological distress, but without a mental disorder according to the MINI International Neuropsychiatric Interview (M.I.N.I.) for DSM-V and ICD-10, will be randomly assigned to the Self Help Plus intervention or to enhanced treatment as usual (ETAU).||||t
1300642|NCT03587883|Randomized|Crossover Assignment||Basic Science||Quadruple||Randomized, double-masked and cross-over dietary intervention study in healthy adults.|t|t|t|t
1300643|NCT03587870|Randomized|Parallel Assignment||Prevention||None (Open Label)||A prospective, randomised controlled pilot study in critical ill patients with a protein-rich formula||||
1300644|NCT03587857|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1300645|NCT03587844|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Following identification of a promising dose after the completion of the full Cohort 1 Simon two stage design, enrollment will initiate onto cohort 2 at the dose found to be promising in cohort 1. If neither dose is found promising, cohort 2 will not start.||||
1300646|NCT03587831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300647|NCT03587818|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||A before and after design was performed; the control group were included from November 2012 to January 2014. This was followed by introducing the intervention to the clinicians, and the intervention group were included from March 2014 to June 2015. Patients were assigned consecutively at the three hospitals. No blinding was applied.||||
1300648|NCT03587805||Single Group Assignment||Treatment||None (Open Label)||||||
1300649|NCT03587792|||Cohort||Prospective|||||||
1300650|NCT03587779|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1300651|NCT03587766|Randomized|Parallel Assignment||Treatment||Double|As the study is double-blinded, the patient, investigators, pharmacist(s) and DNDi study team members involved with the clinical trial implementation will remain blinded to treatment allocation for the duration of the clinical trial.|This study is designed as a double-blind, randomized, prospective, comparative, pharmacokinetic-pharmacodynamic, and proof-of-concept trial design, with three-parallel groups and historical placebo control in patients with chronic indeterminate Chagas Disease.|t||t|
1300652|NCT03587753|Randomized|Crossover Assignment||Basic Science||Double||Randomised cross-over|t||t|
1300653|NCT03587740||Single Group Assignment||Treatment||None (Open Label)||||||
1300654|NCT03587727|||Cohort||Prospective|||||||
1300655|NCT03587714|||Cohort||Cross-Sectional|||||||
1300656|NCT03587701|Randomized|Parallel Assignment||Treatment||Triple|The subject, investigator and study coordinator will all be blinded to the randomization assignment. Only the study pharmacist will be unblended when dispensing the study medication|This study is a randomized, placebo-controlled design with a 2:1 allocation of anakinra or placebo for the first 42 continuous days. After day 42, a second placebo-controlled period will begin for an additional 42 days.|t|t|t|
1300657|NCT03587688|||Cohort||Other|||||||
1300658|NCT03587675||Single Group Assignment||Diagnostic||None (Open Label)||adolescents from different athletic disciplines and recreational adolescents will be tested for atopy, exercise-induced bronchospasm measured by EVH and biomarkers for EIB will be studied in blood and induced sputum||||
1300659|NCT03587662||Single Group Assignment||Treatment||None (Open Label)||||||
1300660|NCT03587649||Single Group Assignment||Other||None (Open Label)||||||
1300661|NCT03587636|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300662|NCT03587623|||Case-Only||Prospective|||||||
1300663|NCT03587610|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single center, prospective, cluster randomized trial.||||
1300664|NCT03587597|Randomized|Parallel Assignment||Prevention||Single|||t|||
1300665|NCT03587584|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1300666|NCT03587571|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Comparison of two established treatment options. Prospective, randomised (central block randomisation) multi-center clinical trial.~The two treatment options (operative versus conservative) are split in two study arms and compared to each other. Patients are randomly allocated to one of the two study arms."||||
1300667|NCT03587558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300668|NCT03587545|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1300669|NCT03587532||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300670|NCT03587519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300671|NCT03587506|||Cohort||Prospective|||||||
1300672|NCT03587493||Single Group Assignment||Other||None (Open Label)||||||
1300673|NCT03587480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300674|NCT03587467|||Cohort||Retrospective|||||||
1300675|NCT03587454||Sequential Assignment||Diagnostic||Double|Investigators in teleglaucoma and conventional glaucoma clinics are masked to one another|Prospective sequential enrolment in teleglaucoma then conventional glaucoma clinical care|||t|t
1300676|NCT03587441|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1300677|NCT03587428|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1300678|NCT03587415|||Case-Control||Prospective|||||||
1300679|NCT03587402|Randomized|Parallel Assignment||Treatment||Single|Single Blind|||||t
1300680|NCT03587389||Single Group Assignment||Prevention||None (Open Label)||||||
1300681|NCT03587376|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1300682|NCT03587363|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1300683|NCT03587350|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1300684|NCT03587337|||Other||Prospective|||||||
1300685|NCT03587324||Single Group Assignment||Prevention||None (Open Label)||||||
1300686|NCT03587311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300687|NCT03587298|||Case-Control||Prospective|||||||
1300688|NCT03587285|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1300689|NCT03587272||Single Group Assignment||Treatment||None (Open Label)||||||
1300690|NCT03587259|Randomized|Parallel Assignment||Screening||Single|||||t|
1300691|NCT03587246|||Cohort||Prospective|||||||
1300692|NCT03587233|Randomized|Parallel Assignment||Prevention||Single|||t|||
1300693|NCT03587220|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1300694|NCT03587207|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1300695|NCT03587194||Single Group Assignment||Treatment||None (Open Label)||||||
1300696|NCT03587181|||Cohort||Prospective|||||||
1300697|NCT03587168|||Case-Control||Prospective|||||||
1300698|NCT03587155|||Case-Control||Prospective|||||||
1300699|NCT03587142|Randomized|Parallel Assignment||Treatment||Triple|"Participants, all clinic staff and the investigators will be masked as to whether the participant is receiving buspirone or the placebo.~The study drug will be over encapsulated in a size 0 gelatin capsule with partial filler to be identical to the placebo capsule, which contains only filler.~The random treatment assignment will consist of a numbered study drug bottle; each bottle number will be unique and each participant will be assigned a specific bottle number, which is labelled: Buspirone or placebo 10 mg. with directions.~The randomization scheme will assign participants in randomly permuted blocks of assignments stratified by clinical center. The randomization plan will be prepared and administered centrally via a secure web application by the Scientific Data Research Center."|BESST is a multi-center, randomized, placebo-controlled, double-masked, parallel treatment groups phase 2 trial with half the participants receiving the study drug, buspirone, and half receiving the placebo.|t|t|t|
1300700|NCT03587129||Single Group Assignment||Treatment||None (Open Label)||||||
1300701|NCT03587116||Single Group Assignment||Other||None (Open Label)||The data obtained from this 6 month lead-in study will serve as the control group for the subsequent Phase 3 gene therapy study.||||
1300702|NCT03587103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300703|NCT03587090|||Cohort||Prospective|||||||
1300704|NCT03587077|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300705|NCT03587064|Randomized|Parallel Assignment||Treatment||Single||||||t
1300706|NCT03587051|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1300707|NCT03587038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300708|NCT03587025|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1300709|NCT03587012||Single Group Assignment||Treatment||None (Open Label)||||||
1300710|NCT03586999||Single Group Assignment||Treatment||None (Open Label)||||||
1300711|NCT03586986|||Case-Control||Prospective|||||||
1300712|NCT03586973|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300713|NCT03586960||Single Group Assignment||Basic Science||None (Open Label)||||||
1300714|NCT03586947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300715|NCT03586934|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1301017|NCT03583008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301018|NCT03582995|Randomized|Parallel Assignment||Treatment||Single||||||t
1300716|NCT03586921|Randomized|Parallel Assignment||Treatment||None (Open Label)||All patients received enhanced primary care, which included: (1) The nurses and doctors from the Family Health Teams were trained by Matrix team mental health professionals on clinical aspects of depression and anxiety, including diagnosis, appropriate medication interventions, psycho-education, and cognitive and problem solving therapy. (2) Given the high co-occurrence of anxiety and depression, the intervention was modified from the depression-only Chile model to emphasize co-occurring anxiety and depression in diagnoses, appropriate prescription of anxiolytics and antidepressants.||||
1300717|NCT03586908||Single Group Assignment||Basic Science||None (Open Label)||||||
1300718|NCT03586895|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1300719|NCT03586882|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1300720|NCT03586869||Single Group Assignment||Treatment||None (Open Label)||||||
1300721|NCT03586856|Randomized|Crossover Assignment||Treatment||None (Open Label)||Main study design: Two armed randomized cross-over comparison of leakage for two interfaces. The trial also investigates simple measures to reduce leakage (observational)||||
1300722|NCT03586843|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1300723|NCT03586830|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300724|NCT03586817|Randomized|Parallel Assignment||Prevention||Single||||||t
1300725|NCT03586804|||Other||Prospective|||||||
1300726|NCT03586791|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1300727|NCT03586778|Randomized|Parallel Assignment||Treatment||Single|Outcome assessment will be performed by an individual blind to group assignment.|||||t
1300728|NCT03586765|||Case-Crossover||Prospective|||||||
1300729|NCT03586752|Randomized|Parallel Assignment||Prevention||Single||||||t
1300730|NCT03586739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300731|NCT03586726|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1300732|NCT03586713||Single Group Assignment||Diagnostic||None (Open Label)||Screening of patients that come to the conservative dentistry department seeking dental care will continue until the target population is achieved. The patients' teeth will be subjected to visual examination and diagnosis using dental charts. Once the patients that are potentially eligible for this study are identified, they will be contacted by the research investigator who will explain the study and ascertains the patient's interest. If interested, more detailed evaluations and preparations are made||||
1300733|NCT03586700|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1300734|NCT03586687|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1300735|NCT03586674|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300736|NCT03586661||Single Group Assignment||Treatment||None (Open Label)||||||
1300737|NCT03586648||||||||||||
1300738|NCT03586635|||Other||Prospective|||||||
1300739|NCT03586622|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1300740|NCT03586609||Single Group Assignment||Treatment||None (Open Label)||||||
1300741|NCT03586596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300742|NCT03586583|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1300743|NCT03586570|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1300744|NCT03586557|Randomized|Parallel Assignment||Treatment||Single|Outcome Assessor was masked to avoid measured bias|a open-labeled randomized comparison study||||t
1300745|NCT03586544||Single Group Assignment||Prevention||None (Open Label)||2x3 mixed ANOVA. 2 between groups: children with and without obesity. 3 within groups: control, interval warm-up, pretreatment with bronchodilator||||
1300746|NCT03586531|||Case-Only||Cross-Sectional|||||||
1300747|NCT03586518|||Cohort||Prospective|||||||
1300748|NCT03586505||Single Group Assignment||Basic Science||None (Open Label)||Each patient is its own control||||
1300749|NCT03586492||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300750|NCT03586479|Randomized|Parallel Assignment||Treatment||Single|Pre- and post-outcome assessments will be performed by an individual blind to arm assignment.|Children will be randomly assigned to one of three treatment arms||||t
1300751|NCT03586466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300752|NCT03586453||Single Group Assignment||Treatment||None (Open Label)||||||
1300753|NCT03586440|||Other||Cross-Sectional|||||||
1300754|NCT03586427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300755|NCT03586414|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1300756|NCT03586401|||Cohort||Prospective|||||||
1300757|NCT03586388||Single Group Assignment||Treatment||None (Open Label)||||||
1300758|NCT03586375|||Ecologic or Community||Prospective|||||||
1300759|NCT03586362|||Cohort||Prospective|||||||
1300760|NCT03586349|||Other||Prospective|||||||
1300761|NCT03586336|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300762|NCT03586323|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1300763|NCT03586310|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1300764|NCT03586297|||Cohort||Prospective|||||||
1300765|NCT03586284|Randomized|Parallel Assignment||Treatment||Quadruple||Multicenter, double-masked, randomized, placebo-controlled clinical trial|t|t|t|t
1300766|NCT03586271|||Cohort||Prospective|||||||
1300767|NCT03586258|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1300768|NCT03586245|Randomized|Crossover Assignment||Treatment||Single|All stable isotopes (FePP, ASP, FeSO4) were all individually added to test meal and mixed thoroughly by investigators. Participants were brought the meal to consume, unknowingly of which respective treatment they were receiving.|Subjects consumed two stable isotopes (57Fe and 58Fe). Study I, three consecutive days of meal A followed by crossover of three days meal B were consumed. Study II was a crossover between meal B and meal C.|t|||
1300769|NCT03586232|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1300901|NCT03584516|Randomized|Crossover Assignment||Treatment||Double||In Part 2 of the study, participants in the placebo group will be allowed to cross over to the experimental group after completion of the primary analysis.|t||t|
1300770|NCT03586219|Randomized|Parallel Assignment||Other||None (Open Label)||This is a randomized, non-blinded, controlled trial that will be performed at two sites. Study subjects will be randomized to either the control arm (standard perioperative instructions) or intervention arm (standard perioperative instructions with additional perioperative opioid-specific education) using a randomization program in a 1:1 ratio.||||
1300771|NCT03586206|||Cohort||Prospective|||||||
1300772|NCT03586193|||Cohort||Prospective|||||||
1300773|NCT03586180|||Case-Only||Cross-Sectional|||||||
1300774|NCT03586167||||||||||||
1300775|NCT03586154|Randomized|Parallel Assignment||Treatment||Triple|Investigators were not allowed to know randomization codes and block size until all calculations and measurements had been entered into the database for all patients. All medical caregivers, investigators and patients were blinded to group allocation. One hour before the injection procedure of an enrolled patient, a nurse (not otherwise participating in the study) opened a sealed opaque envelope containing group allocation, and then filled the assigned drug injection for each patient according to the protocol of randomization.||t|t|t|
1300776|NCT03586141||Single Group Assignment||Diagnostic||None (Open Label)||measurement of hemoglobin by a noninvasive sensor clip||||
1300777|NCT03586128|||Cohort||Prospective|||||||
1300778|NCT03586115|||Other||Cross-Sectional|||||||
1300779|NCT03586102|Randomized|Parallel Assignment||Prevention||Quadruple|Clinicians and technicians responsible for the assessment of infant body composition will be masked.||t|t|t|t
1300780|NCT03586089|Randomized|Parallel Assignment||Treatment||Double|To conceal allocation, central randomization will be conducted by the Pharmacy Department of St. Michael's Hospital using a list of random treatment assignments created on www.randomize.net.|As soon as possible after randomization, patients will receive either a single IV dose of phenobarbital (7.5 mg per kg of ideal body weight (IBW) 18, prepared in 250 ml D5W; n=25) or placebo (250 ml D5W; n=25).|t|t||
1300781|NCT03586076|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1300782|NCT03586063|||Cohort||Prospective|||||||
1300783|NCT03586050||Single Group Assignment||Treatment||None (Open Label)||||||
1300784|NCT03586037|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1300785|NCT03586024|Randomized|Parallel Assignment||Treatment||None (Open Label)||2 parallel cohort||||
1300786|NCT03586011|||Cohort||Prospective|||||||
1300787|NCT03585998||Single Group Assignment||Treatment||None (Open Label)||||||
1300788|NCT03585985|||Case-Control||Prospective|||||||
1300789|NCT03585972|Randomized|Parallel Assignment||Prevention||Single|Outcome assessors do not know which arm participants were assigned to.|||||t
1300790|NCT03585959||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300791|NCT03585946|||Cohort||Prospective|||||||
1300792|NCT03585933|||Cohort||Prospective|||||||
1300793|NCT03585920|Randomized|Crossover Assignment||Prevention||Single|All samples provided to the participant are labelled with 3 digit random codes.|This is a 3 way crossover design using a pre-load study protocol that is standard for behavioural appetite studies. The study will be conducted single-blind, as it is not feasible to blind the researcher to the pre-load food products. Each participant will attend 3 visits, the pre-load study foods will be presented to them with random blinding codes.|t|||
1300794|NCT03585907|Randomized|Parallel Assignment||Treatment||Single||||||t
1300795|NCT03585894|Randomized|Crossover Assignment||Other||Triple||Each participant will receive PACAP28 intravenous infusion over 20 min in both experiment days but treated in randomized order with sumatriptan or ketorolac.|t|t|t|
1300796|NCT03585881|Randomized|Parallel Assignment||Other||Single||||||t
1300797|NCT03585868|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1300798|NCT03585855|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||comparison with historic control||||
1300799|NCT03585842|||Ecologic or Community||Prospective|||||||
1300800|NCT03585829|Randomized|Crossover Assignment||Treatment||Double|the treatment has been put in capsules with the same size and color|crossover clinical trial|t|t||
1300801|NCT03585816|||Cohort||Prospective|||||||
1300802|NCT03585803|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300803|NCT03585790|Randomized|Crossover Assignment||Treatment||Single|||t|||
1300804|NCT03585777|||Case-Control||Prospective|||||||
1300805|NCT03585764|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1300806|NCT03585751|Randomized|Parallel Assignment||Treatment||Double|Every participant will grasp an opaque sealed envelop from a box after diagnosis of the case. Being opaque and sealed ensures allocation concealment. Envelopes have been assigned to RN who is not involved in neither the diagnosis nor the treatment phases of the cases.||t|||t
1300807|NCT03585738|Randomized|Parallel Assignment||Treatment||Quadruple|The patients, care provides, investigators and outcome assessors are blinded for the treatment: Inositol + Folic acid versus Folic acid alone. The treatment allocation is identified by code number before the study start, and will be revealed only after data analysis.|Randomized multi centre double-blind controlled trial|t|t|t|t
1300808|NCT03585725||Single Group Assignment||Treatment||None (Open Label)||||||
1300809|NCT03585712|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1300810|NCT03585699|Randomized|Parallel Assignment||Diagnostic||Single|Separate individuals completed the random allocation sequence, patient enrollment and outcome assessment. Outcome assessors were blinded to group assignment.|||||t
1300811|NCT03585686||Single Group Assignment||Treatment||None (Open Label)||||||
1300812|NCT03585673||Single Group Assignment||Treatment||None (Open Label)||Docetaxel-PM + Oxaliplatin D1,8 every 3weeks until progression||||
1300813|NCT03585660||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300814|NCT03585647|||Cohort||Prospective|||||||
1300815|NCT03585634||Single Group Assignment||Other||None (Open Label)||Prospective, non-comparative design||||
1300816|NCT03585621||Sequential Assignment||Treatment||None (Open Label)||Sequential dose escalation design||||
1300817|NCT03585608|||Cohort||Prospective|||||||
1300902|NCT03584503|Randomized|Parallel Assignment||Other||Single||A randomized prospective controlled study|t|||
1301019|NCT03582982||Single Group Assignment||Other||None (Open Label)||||||
1300818|NCT03585595|Randomized|Parallel Assignment||Prevention||Single|The participants and study physicians/nurses will not be masked to patient randomization assignments due to different BP targets between the two randomization groups. However, study personnel who collect clinical outcome data at the baseline and follow-up examinations will be masked to patient assignments. The members of the Outcome Adjudication Committee will also be masked to patient randomization.|Patients with a recent ischemic stroke will be randomized to an intensive treatment strategy (a systolic BP target of <120 mmHg) or a standard treatment strategy (a systolic BP target of <140 mmHg) for up to four years.||||t
1300819|NCT03585582|||Cohort||Prospective|||||||
1300820|NCT03585569||Single Group Assignment||Treatment||None (Open Label)||||||
1300821|NCT03585556||Single Group Assignment||Treatment||None (Open Label)||All patients with treatment naive, new onset wet AMD will be treated with an intravitreal anti-VEGF at Day 0 followed by intravitreal AAVCAGsCD59 at Day 7. Patients will be followed for 12 months and treated with additional anti-VEGF monthly as needed if recurrent disease is identified.||||
1300822|NCT03585543||Single Group Assignment||Supportive Care||None (Open Label)||||||
1300823|NCT03585530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1300824|NCT03585517||Single Group Assignment||Treatment||None (Open Label)||||||
1300825|NCT03585504|Randomized|Parallel Assignment||Prevention||None (Open Label)||participants were randomized to receive a contraceptive implant before hospital discharge or at their six week postpartum visit||||
1300826|NCT03585491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300827|NCT03585478|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1300828|NCT03585465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300829|NCT03585452|||Other||Prospective|||||||
1300830|NCT03585439|||Cohort||Retrospective|||||||
1300831|NCT03585426|Randomized|Parallel Assignment||Treatment||Single|||||t|
1300832|NCT03585413|Randomized|Parallel Assignment||Treatment||Quadruple||prospective, randomized, placebo-controlled, double-blind interventional study|t|t|t|t
1300833|NCT03585400|||Other||Retrospective|||||||
1300834|NCT03585387|||Cohort||Prospective|||||||
1300835|NCT03585374|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients will be randomly assigned to Penthrox (test group) or standard analgesic treatment (comparison group). As per local clinical practice, the standard analgesic will vary according to pain intensity score measured by Numerical Rating Scale (NRS): morphine, in case of score ≥ 7 or paracetamol/ketoprofen in case of score 4-6. Penthrox treatment will be performed by inhalatory route and will last maximum 25 minutes. the standard of care will be administered by an intravenous drip lasting at maximum 10 minutes.||||
1300836|NCT03585361|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1300837|NCT03585348|||Cohort||Retrospective|||||||
1300838|NCT03585335|||Other||Prospective|||||||
1300839|NCT03585322||Single Group Assignment||Treatment||None (Open Label)||dose escalation study||||
1300840|NCT03585309||Sequential Assignment||Treatment||None (Open Label)||||||
1300841|NCT03585296||Single Group Assignment||Treatment||None (Open Label)||||||
1300842|NCT03585283|Randomized|Parallel Assignment||Treatment||Double|"Intervention group will receive myofascial release and control group will receive a sham therapy by using same treatment and handling position without applying myofascial release techniques.~Participant will be evaluated at baseline, 4 weeks later and 12 week later by an another investigator who does not aware of groups."|Patients' information and contact will be obtained from physiatrist and willing participant's gender, age and pain onset data will be processed with a random number generator in order to form groups. Patients will divide randomly into two groups as intervention and control with a normal distribution of gender, age and pain onset.|t|||t
1300843|NCT03585270|Randomized|Parallel Assignment||Prevention||Quadruple|This study will be performed in a double-blind fashion. The investigator, study personnel, subjects, clinical research associates (CRAs), sponsor personnel, and vendor / Contract Research Organization (CRO) personnel involved in the conduct of the study will remain blinded to the study treatment received by the subjects during the double-blind treatment period until study closure||t|t|t|t
1300844|NCT03585257|Randomized|Parallel Assignment||Treatment||Quadruple||Patients will be randomized into receiving IV albumin vs placebo|t|t|t|t
1300845|NCT03585244|||Cohort||Prospective|||||||
1300846|NCT03585231|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1300847|NCT03585218|Randomized|Parallel Assignment||Prevention||Single|When a participant is eligible, according to the inclusion criteria, it is allocated to one of the groups, according to the order of entry in the study and with alternation by groups, in a ratio of 1:1.|On each moment of data collection, the researcher will apply the evaluation protocol to the participant regardless of the group. Regarding the psychophysiological variable, each participant's saliva will be collected using salivettes®, while cortisol concentrations will be analyzed through ELISA kits. At baseline, each participant will be provided with three salivettes and an explanatory leaflet so that, on the day before the 2nd Cycle (T1), they can collect their own saliva, around 23 hours before (lowest peak of the cortisol circle), and on the day of the fasting QT, on waking up and thirty minutes after waking up (highest peak of the cortisol circle and assessing reactivity). This process will be replicated throughout the remaining evaluation moments. Subsequently, it is also our goal to evaluate the cortisol levels due to QT by performing one collection of saliva before QT and another thirty minutes after QT.|t|||
1300848|NCT03585205||Single Group Assignment||Basic Science||None (Open Label)||||||
1300849|NCT03585192|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1300850|NCT03585179|Randomized|Parallel Assignment||Treatment||Triple|Participants will receive both topical and oral interventions. Group 1: pills of tranexamic acid 250 mg bid plus placebo gel bid, Group 2: pills of placebo bid plus 5% tranexamic acid gel bid and Group 3: pills of placebo bid plus 4% hydroquinone cream at night and a placebo cream at morning. Containers will be of identical appearance.|Three-arm clinical trial|t||t|t
1300851|NCT03585166|||Case-Control||Prospective|||||||
1300852|NCT03585153|||Cohort||Prospective|||||||
1300972|NCT03583593|Randomized|Parallel Assignment||Supportive Care||Double|It is a double blind study, that is, neither the researcher nor the patient knows if he takes placebo or the active tablet.||t||t|
1300853|NCT03585140|Randomized|Parallel Assignment||Treatment||Double|Diet intervention was made by the nutrition specialist. Neither the principal investigator nor the outcome assessor were aware about the group of diet intervention.|Randomized clinical trial, two-arm|||t|t
1300854|NCT03585127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300855|NCT03585114||Single Group Assignment||Treatment||None (Open Label)||Fifteen men will be recruited from Columbia University Medical Center.||||
1300856|NCT03585101||Single Group Assignment||Other||None (Open Label)||||||
1300857|NCT03585088||Single Group Assignment||Treatment||None (Open Label)||||||
1300858|NCT03585075|||Case-Control||Prospective|||||||
1300859|NCT03585062||Single Group Assignment||Treatment||None (Open Label)||||||
1300860|NCT03585049|||Cohort||Prospective|||||||
1300861|NCT03585036|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1300862|NCT03585023|||Cohort||Prospective|||||||
1300863|NCT03585010|Randomized|Parallel Assignment||Treatment||Single|Assessments will conducted by independent evaluators, blind to treatment condition.|||||t
1300864|NCT03584997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300865|NCT03584984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300866|NCT03584971|||Other||Prospective|||||||
1300867|NCT03584958|||Cohort||Prospective|||||||
1300868|NCT03584945|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Children ages 7-12 with OCD, obsessive compulsive symptoms, or healthy controls||||
1300869|NCT03584932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300870|NCT03584919|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300871|NCT03584906|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300872|NCT03584893|||Cohort||Other|||||||
1300873|NCT03584880|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300874|NCT03584867|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled study. Experimental group would receive a refresher training at six months wherease the control receive not training.||||
1300875|NCT03584854|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1300876|NCT03584841|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Intervention Model: Three Group Assignment||||
1300877|NCT03584828|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1300878|NCT03584815|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial||||t
1300879|NCT03584802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300880|NCT03584789|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1300881|NCT03584776|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1300882|NCT03584763|Randomized|Parallel Assignment||Prevention||Double|Blinding of the patients or staff in this study is not generally feasible. However, the measured outcomes in this study are objective and are unlikely to be biased by lack of blinding.|Our randomized controlled study was conducted on patients with high risk pregnancies at their third trimester who attended Ain Shams University Maternity Hospital. A total of 292 high risk pregnant women fulfilling the inclusion criteria were selected by random sampling and divided between two groups with 146 patients in each group. Group I underwent Doppler every other week and Group II underwent Doppler once weekly|t|||t
1300883|NCT03584750|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300884|NCT03584737|||Cohort||Cross-Sectional|||||||
1300885|NCT03584724|Randomized|Parallel Assignment||Treatment||Quadruple|Up to 60 eligible patients will be randomly assigned to NORFLO® ORO or placebo treatment groups in a 1:1 ratio using a stratified randomization blocks scheme.||t|t|t|t
1300886|NCT03584711||Single Group Assignment||Treatment||None (Open Label)||||||
1300887|NCT03584698|Randomized|Parallel Assignment||Treatment||Single|||t|||
1300888|NCT03584685|Randomized|Sequential Assignment||Treatment||Triple|Participants are blind as to whether they are in the control or experimental groups. The investigators and outcomes assessors are blind to which patients received the intervention.|All participants will initially be treated without the surgical mask. Then, half will be treated with the mask and the other half will be treated without the mask.|t||t|t
1300889|NCT03584672|||Case-Control||Cross-Sectional|||||||
1300890|NCT03584659|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1300891|NCT03584646|Randomized|Parallel Assignment||Treatment||Single||The investigator will conduct a patient-randomized, two-arm pilot study of 38 participants with a predicted attrition rate of 20% resulting in 30 total participants; n=10 in Arm 1 and n=20 in Arm 2. Arm 1 will serve as the control arm and Arm 2 will serve as the intervention arm.|||t|
1300892|NCT03584633||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300893|NCT03584620|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants who meet the study inclusion criteria and complete the baseline assessments were randomly allocated into one of the two groups: namely Pulmonary Rehabilitation plus Inspiratory Muscle Training Group (IMT+PR) or Pulmonary Rehabilitation Group (PR).||||
1300894|NCT03584607|||Case-Control||Prospective|||||||
1300895|NCT03584594|||Case-Only||Prospective|||||||
1300896|NCT03584581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300897|NCT03584568|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1300898|NCT03584555|Randomized|Parallel Assignment||Treatment||None (Open Label)||Enrollment period : 24 months after IRB approval Methods: The subjects are randomly divided into two groups. One group underwent SMILE surgery using 120 μm cap thickness, and the other group underwent SMILE surgery using 140 μm cap thickness. Before surgery, all patients underwent a detailed ophthalmological examination that included evaluation of logarithm of the minimum angle of resolution (logMAR) uncorrected-distance visual acuity (UDVA) and CDVA, manifest refraction, slit-lamp examination (Haag-Streit, Köniz, Switzerland), keratometry, and Scheimpflug-based corneal topography (Pentacam HR, Oculus). Dynamic corneal response (DCR) parameters were examined using Corvis ST. Corneal wavefront aberrations were measured using Keratron Scout (Optikon 2000, Rome, Italy). All examinations were repeated at 1, 3, and 6 months after surgery.||||
1300899|NCT03584542|||Other||Prospective|||||||
1300900|NCT03584529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300903|NCT03584490|Randomized|Parallel Assignment||Basic Science||None (Open Label)||The study is a two-group, three time-point experimental design. The two study groups are paper-and-pencil questionnaires versus a computerized talking touchscreen interface. The three time points are baseline, 3-month follow-up, and 6-month follow-up.||||
1300904|NCT03584477|Randomized|Parallel Assignment||Treatment||Single||||||t
1300905|NCT03584464||Single Group Assignment||Other||None (Open Label)||||||
1300906|NCT03584451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300907|NCT03584438|Randomized|Crossover Assignment||Basic Science||Double||30 healthy controls will undergo four Active TMS treatment sessions (separated by at least 24 hrs), along with a Sham TMS treatment session. The theta-burst treatments will be counterbalanced across participants.|t||t|
1300908|NCT03584425|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The investigators will enroll a total of 30 chronic stroke patients and 30 neurologically healthy controls matched for age and with at least 2 cardiovascular risk factors||||
1300909|NCT03584412|Randomized|Parallel Assignment||Treatment||Single||Participants will be randomly assigned to the ACT OPEN treatment condition immediately or following a 5 month wait using a 2:1 randomisation ratio (2: immediately; 1: waiting list control).||||t
1300910|NCT03584399|||Other||Prospective|||||||
1300911|NCT03584386|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1300912|NCT03584373|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This will be an open label, prospective study of approximately 112 subjects undergoing either ureteroscopy or percutaneous nephrolithotomy. Patients who are eligible and choose to undergo ureteroscopy or percutaneous nephrolithotomy will then be asked if they would like to participate in the study and informed consent will be obtained. Patients will then be randomized to control (opioid analgesia) or non-opioid analgesia groups, and given this medication at discharge.||||
1300913|NCT03584360|Randomized|Parallel Assignment||Other||Single|The patient will not say the treatment he puts on each treatment area|patients apply different treatment to two areas with psoriasis|||t|
1300914|NCT03584347||Single Group Assignment||Other||None (Open Label)||||||
1300915|NCT03584334||Single Group Assignment||Diagnostic||None (Open Label)||Prospective non-randomized, multi-center, diagnostic performance study of 18FDG PET for identification of early tumor escape to immunotherapy in patients with unresectable melanoma or Broncho-Pulmonary Carcinoma No to Advanced or Metastatic Small Cells||||
1300916|NCT03584321|||Cohort||Retrospective|||||||
1300917|NCT03584308|Randomized|Parallel Assignment||Treatment||Double|A double blind. To achieve the masking of the research product, these have been labeled by a computerized randomized balanced list, which will be in the possession of the promoter and the study Biostatistician. The masking will be maintained until the analysis of the data. However, access to the code will be allowed if serious adverse events arise related to the research product.|Random assignment, through a list obtained by computer. Patients will be randomized in the consultation of the upper digestive tract, once the anatomopathological result with the presence of coilocytes is received, and they meet the established selection criteria.|t||t|
1300918|NCT03584295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300919|NCT03584282|Randomized|Factorial Assignment||Prevention||None (Open Label)||The investigators will randomly assign 10 participants to each arm: 1) standard of care, 2) text messaging only, 3) peer navigation only, and 4) text messaging and peer navigation.||||
1300920|NCT03584269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300921|NCT03584256|||Cohort||Cross-Sectional|||||||
1300922|NCT03584243||Single Group Assignment||Treatment||None (Open Label)||"This experimental study is a prospective, one-center city and non-comparative study.~Patient with progressive keratoconus will be included after providing their consent. The intervention of the study is to perform transepithelial crosslinking with oxygen Outcomes will be evaluated from pretreatment baseline of the patient."||||
1300923|NCT03584230|Randomized|Parallel Assignment||Basic Science||Double|"The investigator will receive a randomized list of sequence orders for each age and gender group. Within the sequence orders, one third of them are for participants in the positive condition, one third are for participants in the negative condition, and one third are for participants in the no cues condition. The experimenter will not know which sequences relate to each condition.~The nonverbal behavior coders will also be blind to the participants' condition. They will view videos where only the participant is visible but the teacher is not."|Three conditions will be tested: assignment to a group that receives positive nonverbal teacher behaviors, assignment to a group that receives negative nonverbal teacher behaviors, and assignment to a group that receives no teacher behaviors.|||t|t
1300924|NCT03584217||Single Group Assignment||Diagnostic||None (Open Label)||||||
1300925|NCT03584204|||Cohort||Retrospective|||||||
1300926|NCT03584191|||Ecologic or Community||Cross-Sectional|||||||
1300927|NCT03584178|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1300928|NCT03584165|||Other||Other|||||||
1300929|NCT03584152|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1300930|NCT03584139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300931|NCT03584126|||Cohort||Other|||||||
1300932|NCT03584113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300933|NCT03584100|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1300934|NCT03584087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300935|NCT03584074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300936|NCT03584061||Single Group Assignment||Treatment||None (Open Label)||The five patients included will all receive a fat graft in the area affected by PHN.||||
1300937|NCT03584048|||Cohort||Prospective|||||||
1300938|NCT03584035|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will do all assessments (pre and post intervention) without group allocation.|Randomized Control Trial||||t
1300973|NCT03583580||Single Group Assignment||Treatment||None (Open Label)||||||
1300974|NCT03583567|Randomized|Parallel Assignment||Prevention||Quadruple|normal saline will be used as placebo in control group||t|t|t|t
1301139|NCT03581422|||Case-Control||Retrospective|||||||
1301140|NCT03581409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300939|NCT03584022|Randomized|Parallel Assignment||Other||None (Open Label)||Patients planned for diagnostic sural nerve biopsy will be screened. Nerve conduction study of the sural nerve is part of standard of care for patients who are screened for the study. If the amplitude of sensory nerve action potential (SNAP) is equal to or greater than 2 μV and the patient meets the other inclusive criteria, the patient will be recruited to enter the study. Ultrasonography of the sural nerve will be conducted. If the diameter of the sural nerve is greater than 2.75mm, the patient will be assigned to the control group. If sural nerve diameter is equal to or smaller than 2.75mm, the patient will be randomized to either the control or study group. A study team member (clinical coordinator) will draw a number from an envelope that holds equal amount of odd and even numbers. If the number drawn is an odd number, the patient will be assigned to the control group. If the number drawn is an even number, the patient will be assigned to the intervention group.||||
1300940|NCT03584009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300941|NCT03583996||Single Group Assignment||Diagnostic||None (Open Label)||All subjects receive HepQuant SHUNT test and DSI measurement prior to a SOC EGD, to be done within 42 days of the SHUNT test. HepQuant SHUNT is a combination product where 13C Cholate 20mg is administered intravenously once for each test and d4 Cholate 40mg is administered once orally for each test||||
1300942|NCT03583983|Randomized|Parallel Assignment||Prevention||Double|Participants will be randomized to intervention or control groups using a minimization scheme which will adaptively weight probabilities of treatment assignment based on the distribution of age (> 40 vs. < 40), gender (male vs. female), and ethnicity (European/African/East Asian/South Asian/Latino/Other). This design has been adopted to minimize unintended covariate biases, which can plague smaller trials. Randomization will be implemented through a centralized database. The intervention will be delivered via automated e-mails, minimizing direct personal contact with the intervention group.||||t|t
1300943|NCT03583970|||Cohort||Retrospective|||||||
1300944|NCT03583957|||Cohort||Prospective|||||||
1300945|NCT03583944||Single Group Assignment||Treatment||None (Open Label)||||||
1300946|NCT03583931|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective Randomized Clinical Trial||||
1300947|NCT03583918||Single Group Assignment||Treatment||None (Open Label)||||||
1300948|NCT03583905|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300949|NCT03583892|||Case-Control||Prospective|||||||
1300950|NCT03583879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300951|NCT03583866|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1300952|NCT03583853|||Case-Crossover||Prospective|||||||
1300953|NCT03583840|Randomized|Parallel Assignment||Screening||None (Open Label)|"It is not possible to blind the participants as the intervention is a website. Participants in the intervention arm will need to go through the website and will know its contents while participants in the control arm will not. Participants in the intervention arm will be given a code which only allows one-time access to the website. This is done to avoid contamination to the control group.~There is no care provider in this study as the intervention is delivered via a website.~The assignment of intervention or control arm to the participants will be done automatically by the website. After signing the consent form, participants will enter a website which will randomise them to either intervention or control arm. The investigators do not play a role in this.~The outcome assessment only involves the participants answering a questionnaire themselves. No Outcome Assessor is required to assess any outcome from the participants."|||||
1300954|NCT03583827|Randomized|Parallel Assignment||Treatment||Single||Eighty unilaterally brain injured right-handed patients, with lesion time of 6 months or more, aged 70 years or younger, 40 with left-brain and 40 with right-brain injury, will take part in the study. They will be randomly divided into a control group (GC), which will undergo conventional therapy and an experimental group (EG), which will be submitted to conventional and virtual reality training using the game virtual. The study will also include 40 healthy individuals matched for age, sex, schooling and hand laterality.||||t
1300955|NCT03583814|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The overall study utilizes a stepped wedge trial design with cluster randomization at the community level. All communities will have a baseline control period, active trial phase, and post-active trial phase follow-up period. During the active trial phase of this project, the strategy used to assign interventions to participants follows a Parallel Assignment study intervention model. During the active trial phase, individuals within that community will be assigned to an asthma intervention (1. CASE or 2. CASE and HARP) based on the child's level of asthma control. The SWT also allows us to compare community-level outcomes for participants who are not in the Active Trial (Intervention) period at that time and who are receiving standard care."||||
1300956|NCT03583801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300957|NCT03583788|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study was designed as a parallel study, where two groups were compared: one receiving treatment as usual (motivational interviewing) and the intervention (hypnotherapy group).||||
1300958|NCT03583775|||Other||Prospective|||||||
1300959|NCT03583762|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1300960|NCT03583749|||Case-Only||Prospective|||||||
1300961|NCT03583736|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1300962|NCT03583723||Single Group Assignment||Treatment||None (Open Label)||||||
1300963|NCT03583710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300964|NCT03583697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300965|NCT03583684|Randomized|Parallel Assignment||Treatment||Single|||||t|
1300966|NCT03583671|||Case-Only||Cross-Sectional|||||||
1300967|NCT03583658|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300968|NCT03583645|Randomized|Parallel Assignment||Prevention||Double|Allocation was concealed to the participants, researchers -who were in class the assessment days- and teachers.|Participants were randomized in a 1:1 ratio blocked by gender to one of two groups: experimental condition (ITP intervention) versus control condition (educational intervention) in parallel for the duration of the study.|t|||t
1300969|NCT03583632|||Case-Control||Other|||||||
1300970|NCT03583619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300971|NCT03583606|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1300975|NCT03583554|Randomized|Crossover Assignment||Basic Science||Triple|The research pharmacist compiles and has unique access to the randomization key|placebo-controlled, randomized, double-blind, cross-over|t||t|t
1300976|NCT03583541|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1300977|NCT03583528|||Cohort||Prospective|||||||
1300978|NCT03583515|Randomized|Parallel Assignment||Treatment||Double|Participants will be assigned to and receive feedback via the computer. Once they have received feedback a research assistant will print this feedback for them to take home. At this time, research assistants will become unblinded to condition, but will not administer any new procedures other than answering participant questions.|Half of participants will be randomly assigned to receive personalized normative feedback about their drinking. The other half will be randomly assigned to receive control feedback about social media use.|t||t|
1300979|NCT03583502|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1300980|NCT03583489|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1300981|NCT03583476|||Cohort||Retrospective|||||||
1300982|NCT03583463|||Other||Prospective|||||||
1300983|NCT03583450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1300984|NCT03583437|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Experimental: 1 Healthy male volunteers Behavioral: Exercise Moderate Intensity Exercise (50 % af VO2max) for 90 minutes before and after PET scanning, Experimental: 2 Healthy female volunteers Moderate Intensity Exercise (50 % af VO2max) for 90 minutes before and after a PET scanning.||||
1300985|NCT03583424||Single Group Assignment||Treatment||None (Open Label)||||||
1300986|NCT03583411|||Case-Only||Retrospective|||||||
1300987|NCT03583398|||Cohort||Prospective|||||||
1300988|NCT03583385|Randomized|Crossover Assignment||Other||Single||||||t
1300989|NCT03583372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1300990|NCT03583359|Randomized|Parallel Assignment||Treatment||Single||||||t
1300991|NCT03583346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300992|NCT03583333|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1300993|NCT03583320|Randomized|Parallel Assignment||Diagnostic||Double|"As stated earlier for patients assigned to Arm B i.e. the control arm (standard of care arm) who undergo CTCA, the results will not be released to the patient and their medical care givers in hospital.~CTCA interpretation followed by reporting will not take place in the acute hospital setting and therefore will be carried out within the following three weeks. Should the CTCA be found to have significant high risk CAD e.g. >50% stenosis in the left main (LM) coronary artery, and/or >50% stenosis in the proximal left anterior descending (LAD) coronary artery, they will be un-blinded and kept in a separate registry. Their results will be discussed with the hospital care team and if they have not had any invasive coronary imaging during the preceding hospital admission, an urgent cardiology out-patient referral will be made to enable further clinical management."|Once patients consent to participate in the study, they will be randomised into the intervention group (i.e. with CTCA) or the control group (i.e. hs-cTn based standard of care) on a 1:1 ratio. For purposes of Study 2, the control group of patients will also be consented to undergo CTCA. However, CTCA will not form part of their in-patient clinical management as the clinical teams will be blinded from CTCA findings (except for cases of prognostically significant coronary disease e.g. 50% stenosis of the LM and/or proximal LAD coronary arteries).|t|t||
1300994|NCT03583307||Single Group Assignment||Treatment||None (Open Label)||||||
1300995|NCT03583294|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1300996|NCT03583281|Randomized|Crossover Assignment||Treatment||Double|Double-blinded|Obese females|t||t|
1300997|NCT03583268|Randomized|Crossover Assignment||Prevention||Single|||t|||
1300998|NCT03583255|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1300999|NCT03583242|||Case-Only||Prospective|||||||
1301000|NCT03583229|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients with antibodies receive 4 ECP-treatments if they have CAV. If patients do not want to receive ECP-treatments, they are allocated to the control group, which do not receive ECP-treatments.~All patients receive 7 days treatment with aspirin and blood samples are drawn before and after."||||
1301001|NCT03583216|||Case-Control||Prospective|||||||
1301002|NCT03583203|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301003|NCT03583190|Randomized|Parallel Assignment||Treatment||Double|The outcome assessor will be blinded the treatment group. The clinician providing treatment will be blinded to outcomes.|||t||t
1301004|NCT03583177|||Case-Control||Cross-Sectional|||||||
1301005|NCT03583164||Single Group Assignment||Treatment||None (Open Label)||||||
1301006|NCT03583151|Randomized|Parallel Assignment||Treatment||Single|||t|||
1301007|NCT03583138|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Decide to receive buprenorphine and those who elect not to receive it.||||
1301008|NCT03583125||Single Group Assignment||Treatment||None (Open Label)||||||
1301009|NCT03583112|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1301010|NCT03583099|Randomized|Parallel Assignment||Other||Double|"Practitioners at sites randomized to the COPD education only intervention will be blinded to CAPTURE scores.~Practitioners in both intervention arms will be blinded to research spirometry results.~Participants will be blinded to spirometry results."|"Participating primary practices will be randomized to one of 2 arms.~Arm 1: Practice clinicians will receive basic COPD education, and patient-level CAPTURE information with CAPTURE interpretation education (CAPTURE+ COPD education).~Arm 2: Practice clinicians will receive basic COPD education only (COPD education)."|t|t||
1301011|NCT03583086||Single Group Assignment||Treatment||None (Open Label)||||||
1301012|NCT03583073|Non-Randomized|Parallel Assignment||Other||Single||The intervention will have two phases: 1) a Standard Care (baseline control) condition, followed by, 2) an Enhanced Referral/Linkage to Care condition. Because this is a roll-out trial, the two conditions will be compared using a non-randomized open trial design.||||t
1301013|NCT03583060|Randomized|Parallel Assignment||Basic Science||Single||||||t
1301014|NCT03583047|||Cohort||Prospective|||||||
1301015|NCT03583034|||Cohort||Prospective|||||||
1301016|NCT03583021|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1573339|NCT00001540||||||||||||
1301020|NCT03582969|Randomized|Parallel Assignment||Treatment||Triple|The placebo capsules are blocked capsules containing a mixture of saline and glycerine, identical in appearance and consistency to the FMT capsules.|This is a placebo-controlled, double blinded interventional study evaluating oral, fecal microbiota transplantation, administered in patients with mild-moderate UC.|t|t|t|
1301021|NCT03582956|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1301022|NCT03582943|Randomized|Parallel Assignment||Treatment||Single|Participants are masked to their group assignment.|Single blinded, randomized, controlled trial|t|||
1301023|NCT03582930||||||||||||
1301024|NCT03582917|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301025|NCT03582904|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1301026|NCT03582891|Randomized|Crossover Assignment||Treatment||Double|The use of objective measures of motor function with the PKG monitor, to complement physician administered rating scales, is a strategy to reduce observer bias. For physician administered scales, all exams will be videotaped so that these can be reviewed by a blinded neurologist evaluator. Subjects will be blinded to the condition (open-loop or closed-loop phases), and the order will be assigned randomly.|Investigators will run a pilot clinical trial in which individualized classifier/control strategies for each hemisphere in each subject will be embedded within the RC+S for one month of feedback-controlled stimulation will be compared with one month of empirically optimized open-loop stimulation, administered in randomized order with closed-loop stimulation. During these 1-month trials, patients and neurologists will be blinded to the state of the stimulator. This will happen at 11 and 12 months post-surgery depending upon which group the subject is randomized to.|t|||t
1301027|NCT03582878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301028|NCT03582865|||Cohort||Prospective|||||||
1301029|NCT03582852|Randomized|Parallel Assignment||Treatment||Single|||t|||
1301030|NCT03582839||Single Group Assignment||Treatment||None (Open Label)||||||
1301031|NCT03582826||Sequential Assignment||Supportive Care||None (Open Label)||||||
1301032|NCT03582813|Randomized|Parallel Assignment||Treatment||Single|Research interviewers were blinded to study condition|Self-directed care is a model of service delivery in which service recipients are allocated a individual budget from which they purchase mental health and other services and material goods needed to help them recover from their mental illness and remain outside of restrictive settings such as hospitals..||||t
1301033|NCT03582800||Single Group Assignment||Treatment||None (Open Label)||||||
1301034|NCT03582787|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1301035|NCT03582774|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1301036|NCT03582761||Single Group Assignment||Prevention||None (Open Label)||||||
1301037|NCT03582748|||Cohort||Prospective|||||||
1301038|NCT03582735|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blind to participant allocation|Participants will be allocated in two groups to receive either the experimental intervention (i.e., nerve gliding exercise program) or control intervention (i.e., no treatment)||||t
1301039|NCT03582722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301040|NCT03582709|||Cohort||Prospective|||||||
1301041|NCT03582696||Single Group Assignment||Prevention||None (Open Label)||The participants who are engaged with CHWs will be assessed in terms of weight and blood pressure compared to pre-intervention levels and will also complete pre and post dietary and physical activity questionnaires.||||
1301042|NCT03582683|Randomized|Parallel Assignment||Other||None (Open Label)||After a baseline assessment, participants will be randomized to the CPSMP intervention or a 6-month, wait-list control group based on an allocation sequence based on class size, that will be stratified by site and allocated via opaque envelopes.||||
1301043|NCT03582670|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1301044|NCT03582657|||Cohort||Prospective|||||||
1301045|NCT03582644||Single Group Assignment||Treatment||None (Open Label)||||||
1301046|NCT03582631|||Cohort||Prospective|||||||
1301047|NCT03582618||Single Group Assignment||Treatment||None (Open Label)||||||
1301048|NCT03582605|Randomized|Parallel Assignment||Prevention||Triple|The Amoxicillin and the placebo (glucose) will be prepared in capsule form by a pharmacist and made to look identical.|The study will be a double-blind randomized control trial in which half the participants will be given two grams of amoxicillin in capsule form, prepared by a pharmacist, and the other half will be given a placebo in capsule form, prepared by a pharmacist, 1 hour prior to MSI placement. Sealed envelopes containing either antibiotics or placebo capsules will be given to patients, with only the research committee chair knowing which patients are in the control group (placebo) and which are in the experimental group (antibiotics). Test subjects will be followed for 1 month (T1), 3 months (T2), 6 months (T3) following placement of MSIs.|t|t|t|
1301049|NCT03582592|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1301050|NCT03582579|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301051|NCT03582566|Randomized|Factorial Assignment||Treatment||Single|Assessors are blind to treatment condition. Intervention providers are blind to assessment outcomes.|The efficacy of phonological awareness (Earobics) and working memory (Cogmed) training alone and in combination are compared to an active control (Splashmath).||||t
1301052|NCT03582553|Randomized|Crossover Assignment||Other||Quadruple|Except for the pharmacist who will prepare and dispense the capsules, all study staff and the investigators will be blinded to the randomization.|The study consists of two cohorts of nine subjects each. In the first cohort subjects will receive the 150 mg dose and proceed to the 300 mg dose only if the 150 mg dose is deemed safe. The study is a double blind randomized controlled crossover trial, therefore, subjects could receive a placebo at the first or second visit. Similarly in the second cohort, 600 mg and 900 mg doses will be evaluated.|t|t|t|t
1301053|NCT03582540|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with a difficult biliary cannulation are included in the study if the guidewire is inserted in the pancreatic duct. At that point, patients are randomized in two arms: early versus delayed DGT. The early arm attempts biliary cannulation using the DGT immediately and the delayed arm uses the DGT only if 10 more minutes of conventional cannulation technique does not allow biliary cannulation.||||
1301054|NCT03582527|||Cohort||Prospective|||||||
1301141|NCT03581396|||Cohort||Retrospective|||||||
1301055|NCT03582514||Single Group Assignment||Treatment||None (Open Label)||Cohort inclusion is based on a 3+3 design. Three patients each are assigned to the Level 1 combinations of dose and volume. Each patient triplet is considered a cohort.||||
1301056|NCT03582501||Single Group Assignment||Basic Science||None (Open Label)||||||
1301057|NCT03582488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301058|NCT03582475||Single Group Assignment||Treatment||None (Open Label)||||||
1301059|NCT03582462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301060|NCT03582449|||Cohort||Prospective|||||||
1301061|NCT03582436|||Cohort||Prospective|||||||
1301062|NCT03582423|Randomized|Parallel Assignment||Treatment||Single|Subjects of both groups will be randomly assigned to receive either electro-acupuncture or control (sham) treatment. For randomization, simple, complete non-sequential random numbers will be generated in advance by a computer program in a block of four, and kept by the principal investigator. After a patient's eligibility is confirmed, a randomization number which corresponds to the group allocation will be provided to the acupuncturist by the PI. This arrangement will ensure that the clinical assessor and participants are blinded to the allocation.|single-blinded, randomized, sham-acupuncture controlled trial|t|||
1301063|NCT03582410|Randomized|Parallel Assignment||Treatment||Single|||t|||
1301064|NCT03582397||Single Group Assignment||Device Feasibility||None (Open Label)||This is an interventional pilot study with a pre-test/post-test design. All eligible subjects will receive the intervention. We plan to enroll up to 20 subjects, with the goal of having 10-12 evaluable subjects.||||
1301065|NCT03582384||Single Group Assignment||Treatment||None (Open Label)||||||
1301066|NCT03582371|Randomized|Parallel Assignment||Other||Single|Patients will be scored Mini-Balance evaluation System Test by blinded investigators, before and after AquaSup or Physiotherapy|Proof of concept. Study of non-inferiority, prospective, monocentric, randomized, controlled (Aqua SUP vs physiotherapy), in blind treatment compared to applied treatment.||||t
1301067|NCT03582358|||Cohort||Prospective|||||||
1301068|NCT03582345||Single Group Assignment||Diagnostic||None (Open Label)||cohort prospectic, open, non randomized||||
1301069|NCT03582332|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1301070|NCT03582319|Randomized|Parallel Assignment||Treatment||Double||Randomized clinical trial, double blinded using split mouth technique.|t|||t
1301071|NCT03582306|Randomized|Crossover Assignment||Prevention||None (Open Label)||4 week intervention and control periods will be delivered and separated by a 4 week washout. The order of intervention and control periods will be randomly allocated||||
1301072|NCT03582293|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind|Double-blind, placebo-controlled, multicentre, randomized clinical trial.|t|t|t|t
1301073|NCT03582280||Single Group Assignment||Treatment||None (Open Label)||||||
1301074|NCT03582267|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1301075|NCT03582254||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301076|NCT03582241|||Cohort||Retrospective|||||||
1301077|NCT03582228||Single Group Assignment||Other||None (Open Label)||||||
1301078|NCT03582215|Randomized|Parallel Assignment||Other||None (Open Label)||Part 1 of the study has 4 parallel arms where 4 different sunscreen products will be studied. Part 2 of the study has 4 parallel arms where 4 sunscreen products (one from Part 1 and 3 new sunscreen products) will be studied.||||
1301079|NCT03582202|Randomized|Parallel Assignment||Supportive Care||Single|Results handled without knowledge of randomization group|Randomized controlled||||t
1301080|NCT03582189||||||||||||
1301081|NCT03582176|Randomized|Parallel Assignment||Prevention||Triple||randomized, controlled, double blinded multicenter trial with 3 parallel groups (Ketotifen 2 mg or 5 mg or lactose placebo twice daily orally for 6 weeks)|t||t|t
1301082|NCT03582163|||Cohort||Retrospective|||||||
1301083|NCT03582150||Single Group Assignment||Supportive Care||None (Open Label)||||||
1301084|NCT03582137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301085|NCT03582124||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301086|NCT03582111|||Cohort||Retrospective|||||||
1301087|NCT03582098|||Cohort||Retrospective|||||||
1301088|NCT03582085|Randomized|Parallel Assignment||Treatment||Triple|Double Blind|Half of the subjects will be placed in the multi-dose BCG group and half will be placed in the placebo group.|t|t|t|
1301089|NCT03582072|Randomized|Parallel Assignment||Other||None (Open Label)||"930 practices (this will be the number of datapoints), 478 in the intervention, 452 in the control; letter sent to individual GPS (4796 subjects, as below), 2340 in the intervention, 2456 in the control~practices"||||
1301090|NCT03582059|Randomized|Crossover Assignment||Other||Single||Single blind, randomized cross over study at a single centre|t|||
1301091|NCT03582046|Randomized|Parallel Assignment||Treatment||Single||||t||
1301092|NCT03582033||Single Group Assignment||Treatment||None (Open Label)||||||
1301093|NCT03582020|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel group design (4 groups), non-randomized Run in (14 d): Food frequency protocol (FFP, 7 d), questionnaires for lifestyle/nutrition/socio-economic status Screening: Fasting blood sample taking, health check Intervention: Four groups differing in their eating habits (pre-condition: stable since at least one year) Intervention - group A: Menu plans for persons who consume a traditional Western diet Intervention - group B: Menu plans for persons who rarely consume meat and meat products (predominantly high-quality products; ≤ 2 times / week) = flexitarians Intervention - group C: Menu plans for vegetarians Intervention - group D: Menu plans for vegans||||
1301094|NCT03582007|Randomized|Parallel Assignment||Treatment||Single|Sponsor blinded|||||t
1301095|NCT03581994|Randomized|Parallel Assignment||Diagnostic||Single|Single-blind masking|Two-arm parallel intervention assignment using identical educational materials but different question prompt approaches. Control arm included.||t||
1301096|NCT03581981|Randomized|Parallel Assignment||Treatment||Single|Assessors will not be aware of patient condition and patients will be instructed and reminded not to disclose information that may lead to unblinding|||||t
1301097|NCT03581968|Randomized|Crossover Assignment||Treatment||Single||This is an open-label, randomized, two-way, cross-over study.|t|||
1301202|NCT03580603|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1301098|NCT03581955|Randomized|Crossover Assignment||Other||None (Open Label)||The present project is a randomized, controlled, crossover study with 12 subjects. A cross-over design has been selected as each subject can serve as his/her own control thereby minimizing variations. The intervention order was randomized. The study design does not allow blinding as intervention is the ingestion of different foods.In this study, we assessed the metabolomic profiles of human biofluids after consumption of two different foods: banana (240g peeled fruit) and tomato (300g fresh fruit) in order to identify novel biomarkers for each food. As a control diet, a high energy high protein drink, Fresubin ® 2kcal fiber (Fresinius kabi) was used. The study comprised three dietary interventions of 4 days each and a wash-out period no shorter than 3 days.||||
1301099|NCT03581942||Single Group Assignment||Treatment||None (Open Label)||This is an open-label, phase Ib/II trial of the pan-Phosphoinositide 3-kinase (PI3K) inhibitor Copanlisib in combination with the Bruton Tyrosine Kinase (BTK) inhibitor Ibrutinib in patients with recurrent or refractory primary central nervous lymphoma (PCNSL).||||
1301100|NCT03581929|Randomized|Crossover Assignment||Supportive Care||Double|Double Blind from Day 0 to Day 180. Open Label from Day 181 to Day 360.||t||t|
1301101|NCT03581916||Single Group Assignment||Basic Science||None (Open Label)||||||
1301102|NCT03581903||Single Group Assignment||Prevention||None (Open Label)||||||
1301103|NCT03581890|||Cohort||Prospective|||||||
1301104|NCT03581877|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will be a prospective randomized interventional study. Patients referred to Southside hospital will be consented to take part in the study. After obtaining written informed consent, investigators will subsequently enroll 136 consecutive patients (aged> 18 years) randomized in a serial 1:1 allocation for either low dose PLST or ACDT for submassive pulmonary embolism.||||
1301105|NCT03581864|||Case-Only||Retrospective|||||||
1301106|NCT03581851|Randomized|Crossover Assignment||Prevention||Single|The allocated gas mixture will not be disclosed to the patient since he will breath trough a facemask during both interventions.|Including a baseline assessment and assessments under simulated altitude and normoxia|t|||
1301107|NCT03581838|||Other||Prospective|||||||
1301108|NCT03581825||||||||||||
1301109|NCT03581812|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1301110|NCT03581799||Single Group Assignment||Other||None (Open Label)||||||
1301111|NCT03581786|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1301112|NCT03581773|Randomized|Parallel Assignment||Treatment||Quadruple|"The master randomization list will be created, maintained and kept in a locked, secure location at Hospitalsapoteket Region Midtjylland, Afdeling Herning. The randomization list will not be available to any person directly involved in the study, including the study centre personnel or the project team.~Randomization will be performed via a central randomization service available in business hours on working days by fax 7843 5165. A block design randomization procedure will be used."|Randomized, double-blind, placebo-controlled phase II trial of the effectiveness of folic acid supplement for 12 weeks on mucositis. Both arms will receive best supportive care. No crossover is allowed.|t|t|t|t
1301113|NCT03581760|Randomized|Parallel Assignment||Prevention||None (Open Label)|This is an open-label study, no masking model is applied.|Patients enrolled in the study will be randomized into two groups - active intervention and control group.||||
1301114|NCT03581747|||Case-Control||Prospective|||||||
1301115|NCT03581734|Randomized|Parallel Assignment||Prevention||Single|Laboratory staff will remain blinded throughout the study|We propose to conduct an open-label, randomized controlled study in Dhaka, Bangladesh, among healthy children aged 1 - 3 years old who have received either no dose or one dose of OPV and has not received any dose of IPV or OCV at any time before enrolment based upon immunization card record or history from parents after full informed consent. Participants will be randomized to one of three groups ; (i) OPV only, (ii) OCV only, or (iii) co-administered OPV and OCV||||t
1301116|NCT03581721|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1301117|NCT03581708|||Cohort||Prospective|||||||
1301118|NCT03581695|||Cohort||Prospective|||||||
1301119|NCT03581682|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1301120|NCT03581669|||Case-Only||Retrospective|||||||
1301121|NCT03581656||Single Group Assignment||Treatment||None (Open Label)||Single arm, multi-center, prospective, non-randomized study. The study is conducted in accordance with the guidelines of the Mitral Valve Academic Research Consortium (MVARC) regarding study design and endpoint definition as well as International Standards Organization 5840-3.||||
1301122|NCT03581643|||Cohort||Retrospective|||||||
1301123|NCT03581630|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301124|NCT03581617|||Cohort||Prospective|||||||
1301125|NCT03581604|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Patient group consisting of patients labeled as penicillin allergic and a controll group of healthy volunteers||||
1301126|NCT03581591||Single Group Assignment||Treatment||None (Open Label)||||||
1301127|NCT03581578|||Cohort||Prospective|||||||
1301128|NCT03581565|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1301129|NCT03581552|||Cohort||Prospective|||||||
1301130|NCT03581539|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients randomized to four-quadrant Transverses Abdominis Plane (TAP) block, Quadratus Lumborum (QL) block or surgeon infiltration using Exparel for postoperative analgesia after laparoscopic nephrectomy||||
1301131|NCT03581526|||Cohort||Prospective|||||||
1301132|NCT03581513|Randomized|Parallel Assignment||Treatment||Single|||t|||
1301133|NCT03581500||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301134|NCT03581487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301135|NCT03581474||Single Group Assignment||Treatment||None (Open Label)||||||
1301136|NCT03581461||Single Group Assignment||Treatment||None (Open Label)||||||
1301137|NCT03581448||Single Group Assignment||Basic Science||None (Open Label)||Study falls under device feasibility: An intervention of a device product is being evaluated in a small clinical trial to determine the feasibility of the product; or a clinical trial to test a prototype device for feasibility and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial.||||
1301138|NCT03581435|||Case-Control||Prospective|||||||
1301142|NCT03581383|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||3 Arms: Two intervention models plus a control group representing standard practice||||
1301143|NCT03581370|Randomized|Parallel Assignment||Treatment||None (Open Label)||The patient will be randomized either in the 4-hours or in the 1-hour infusion group||||
1301144|NCT03581357|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to into one of two treatment conditions (OMM Standard or OMM app for Android users) or the control group. In this case, two thirds of the participants will be randomized into a treatment arm.||||
1301145|NCT03581344|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The Patients included in the study will undergo a chemoradiotherapy neoadjuvant treatment.~Patients will undergo a clinical-instrumental restaging at 7-8 weeks and will be randomized in two groups in case of major or complete response:~Surgery 9-11 weeks after the end of neoadjuvant treatment~Second clinical and instrumental re-evaluation after 11-12 weeks and then surgery 13-16 weeks after the end of chemoradiotherapy."||||
1301146|NCT03581331||Single Group Assignment||Other||None (Open Label)||||||
1301147|NCT03581318|||Cohort||Prospective|||||||
1301148|NCT03581305|||Case-Control||Cross-Sectional|||||||
1301149|NCT03581292||Single Group Assignment||Treatment||None (Open Label)||||||
1301150|NCT03581279|Non-Randomized|Parallel Assignment||Diagnostic||Triple|All patients are assigned a unique study ID number to de-identify them.||t||t|t
1301151|NCT03581266|Randomized|Crossover Assignment||Basic Science||None (Open Label)||The study was carried out using a crossover design with a three-week washout period. The participants stayed overnight at the facility and had one out of two types of breakfast in the morning.||||
1301152|NCT03581253||Single Group Assignment||Other||None (Open Label)||||||
1301153|NCT03581240||||||||||||
1301154|NCT03581227|||Case-Only||Prospective|||||||
1301155|NCT03581214|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1301156|NCT03581201|||Cohort||Prospective|||||||
1301157|NCT03581188|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301158|NCT03581175|||Cohort||Cross-Sectional|||||||
1301159|NCT03581162|||Case-Control||Prospective|||||||
1301160|NCT03581149|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1301161|NCT03581136||Single Group Assignment||Treatment||None (Open Label)||||||
1301162|NCT03581123|Randomized|Factorial Assignment||Treatment||Double||2x2 factorial design|||t|t
1301163|NCT03581110|||Cohort||Retrospective|||||||
1301164|NCT03581097|Randomized|Parallel Assignment||Treatment||Single|Surgeon and investigators involved in subsequent data analysis were blinded to group assignment|Prospective, randomized, single-blind, single centre, parallel case-control trial|||t|
1301165|NCT03581084||Single Group Assignment||Treatment||None (Open Label)||This is a single-arm study which means all study participants will receive the same treatment||||
1301166|NCT03581071|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1301167|NCT03581058|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1301168|NCT03581045|||Case-Control||Cross-Sectional|||||||
1301169|NCT03581032|||Case-Crossover||Prospective|||||||
1301170|NCT03581019||Single Group Assignment||Treatment||None (Open Label)||Observational study||||
1301171|NCT03581006|||Case-Only||Prospective|||||||
1301172|NCT03580993|||Cohort||Prospective|||||||
1301173|NCT03580980|Randomized|Parallel Assignment||Prevention||Single||||||t
1301174|NCT03580967||Single Group Assignment||Treatment||None (Open Label)||All participants will receive a 10 or 20 mg dose of vortioxetine to take daily for 8 weeks. Study PI and sub-investigator (psychiatrist Murali Rao, MD) will determine appropriate dose.||||
1301175|NCT03580954|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1301176|NCT03580941|||Cohort||Retrospective|||||||
1301177|NCT03580928||Single Group Assignment||Treatment||None (Open Label)||||||
1301178|NCT03580915|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Approximately 10 participants will be randomly assigned to an intervention group; another 10 will be randomly assigned to a control group.||||
1301179|NCT03580902|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1301180|NCT03580889|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1301181|NCT03580876|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label study|two strategies||||
1301182|NCT03580863|||Cohort||Retrospective|||||||
1301183|NCT03580850|||Cohort||Retrospective|||||||
1301184|NCT03580837|||Cohort||Retrospective|||||||
1301185|NCT03580824|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301186|NCT03580811|Randomized|Parallel Assignment||Treatment||Single||two groups of 15 patients . One with soft tissue grafting and implant placement and other with soft and hard tissue grafting with implant placement.||||t
1301187|NCT03580798|Randomized|Parallel Assignment||Treatment||Single||||||t
1301188|NCT03580785||Single Group Assignment||Diagnostic||None (Open Label)||single group||||
1301189|NCT03580772|||Cohort||Cross-Sectional|||||||
1301190|NCT03580759|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1301191|NCT03580746|||Cohort||Retrospective|||||||
1301192|NCT03580733|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301193|NCT03580720||Single Group Assignment||Other||None (Open Label)||||||
1301194|NCT03580707|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1301195|NCT03580694|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301196|NCT03580681|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1301197|NCT03580668|||Cohort||Prospective|||||||
1301198|NCT03580655||Single Group Assignment||Treatment||None (Open Label)||||||
1301199|NCT03580642|Randomized|Parallel Assignment||Prevention||None (Open Label)||We will perform a randomised, pilot, prospective, parallel group, open, and unicentric Clinical Trial (RCT) with stroke survivors and their caregivers at Cruces University Hospital.||||
1301200|NCT03580629||Single Group Assignment||Other||None (Open Label)||||||
1301201|NCT03580616||Single Group Assignment||Treatment||None (Open Label)||||||
1301203|NCT03580590|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1301204|NCT03580577|||Case-Control||Prospective|||||||
1301205|NCT03580564||Single Group Assignment||Treatment||None (Open Label)||||||
1301206|NCT03580551|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1301207|NCT03580538||Single Group Assignment||Treatment||None (Open Label)||||||
1301208|NCT03580525|Randomized|Crossover Assignment||Health Services Research||Single|Participant will not know nicotine dose or rate of infusion.|Single blind, placebo-controlled, mixed-design with nicotine delivery as a within-subjects factor.|t|||
1301209|NCT03580512|||Cohort||Prospective|||||||
1301210|NCT03580499||Single Group Assignment||Supportive Care||None (Open Label)||||||
1301211|NCT03580486|||Case-Control||Cross-Sectional|||||||
1301212|NCT03580473|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1301213|NCT03580460|Randomized|Parallel Assignment||Treatment||Single||2 arm, RCT with waitlist control|||t|
1301214|NCT03580447|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1301215|NCT03580434||Single Group Assignment||Treatment||None (Open Label)||||||
1301216|NCT03580421|Randomized|Parallel Assignment||Treatment||None (Open Label)||a multicentre, prospective and randomised study||||
1301217|NCT03580408||Single Group Assignment||Treatment||None (Open Label)||||||
1301218|NCT03580395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301219|NCT03580382|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301220|NCT03580369|Randomized|Single Group Assignment||Treatment||Triple|Patients, investigator staff and personnel performing the study assessments will remain blinded to the identity of the treatment from the time of randomization until final database lock. The study drug must be prepared by an independent unblinded pharmacist (or authorized delegate) and administered by an independent unblinded study drug administrator. Neither the unblinded pharmacist nor the unblinded study drug administrator will be involved in any assessments.|This is a Phase III multi-center, randomized, double-blind, active- and placebo-controlled, parallel-group study. There is a screening period of up to 28 days, a 52 week double-blind treatment period, and a 12 week post-treatment follow-up period.|t|t|t|
1301221|NCT03580356|Randomized|Single Group Assignment||Treatment||Triple|Patients, investigator staff and personnel performing the study assessments will remain blinded to the identity of the treatment from the time of randomization until final database lock. The study drug must be prepared by an independent unblinded pharmacist (or authorized delegate) and administered by an independent unblinded study drug administrator. Neither the unblinded pharmacist nor the unblinded study drug administrator will be involved in any assessments.|This is a Phase III multi-center, randomized, double-blind, active- and placebo-controlled, parallel-group study. There is a screening period of up to 28 days, a 52 week double-blind treatment period, and a 12 week post-treatment follow-up period.|t|t|t|
1301222|NCT03580343||Single Group Assignment||Treatment||None (Open Label)||||||
1301223|NCT03580330|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This study reports on a community trial in which PHC centers, along their respective catchment areas, were randomly allocated into control and intervention sites with the aim of assessing the change in selected NCD care quality indicators (QIs) among community individuals and patients. Patients in the intervention sites received a 1-year mHealth intervention, and their pre- and postintervention outcomes were assessed through measurement of QIs. Patients in the control sites received no intervention.||||
1301224|NCT03580317|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1301225|NCT03580304|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1301226|NCT03580291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301227|NCT03580278|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||An exploratory, clinical study with 3 open-dose cohorts is designed to analyze the safety, tolerability, PK, and efficacy of ABY-035/AFO2 in the treatment of subjects with active plaque psoriasis.||||
1301228|NCT03580265|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301229|NCT03580252|||Cohort||Prospective|||||||
1301230|NCT03580239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301231|NCT03580226|||Other||Retrospective|||||||
1301232|NCT03580213|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1301233|NCT03580200|Randomized|Single Group Assignment||Treatment||None (Open Label)||Quasi-experimental study utilizing a pretest-posttest randomized control design||||
1301234|NCT03580187||Single Group Assignment||Treatment||None (Open Label)||Were included all patients aged 18 years and over, victims of isolated chest trauma, who were admitted to the intensive care unit. We excluded patients with any of the following criteria: not consent, pregnant woman, polytrauma, hemodynamic instability with systolic blood pressure less than 100 mmHg, treatment with morphine during transport or in the emergency room, need for initial ventilatory support, bradypnea (respiratory rate less than 12 cycles per minute), allergy to opiods, initial pain Visual Analog Scale (VAS) ≤ 4. Pain level was assessed by the pain VAS. We collected demographic, epidemiological, initial clinical examination data, explorations, lesions and we monitored the evolution of the VAS and the vital signs. Informed consent was obtained from all patients||||
1301235|NCT03580174|Non-Randomized|Parallel Assignment||Treatment||Single||"There will be two groups as Routine Physiotherapy group and Goal Directed Activity Based Physical Therapy (GDPT) group.~Routine Physiotherapy (RPT) group: Ten children with CP will RPT applications will consist of unstructured stretching exercises, massage, passive range of motions, muscle strengthening, orthotics etc.) .~Goal Directed Activity Based Physical Therapy (GDPT) group: Ten children with CP will receive structural, comprehensive activity based, goal directed therapy protocol one hour in a session, 2 times in a week during 8 weeks. GDPT will be a structural protocol and consists of daily life activities as sit to stand and reach, treadmill exercises, balance exercises with bosu-ball, orthotics, home program, following with exercise-diary."||||t
1301236|NCT03580161|||Cohort||Prospective|||||||
1301237|NCT03580148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301238|NCT03580135|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1301239|NCT03580122||Single Group Assignment||Treatment||None (Open Label)||||||
1301334|NCT03578887|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1573340|NCT00001538||||Treatment||||||||
1301240|NCT03580109|Randomized|Parallel Assignment||Other||Single|The investigator doesn't know in wich group his patient is. The spa treatment is organized by the coordinating center.|"2 groups :~Immediate spa treatment : the patient realises his spa treatment with education therapeutic soon after the inclusion in study~Late spa treatment : the patient realises his spa treatment linked with education therapeutic after 6 months visit"|||t|
1301241|NCT03580096|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1301242|NCT03580083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open-Label|Sequential Assignment Dose escalation||||
1301243|NCT03580070|||Other||Retrospective|||||||
1301244|NCT03580057|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1301245|NCT03580044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301246|NCT03580031|Randomized|Parallel Assignment||Treatment||Double|Double blinded|Cohort groups with parallel allocation|t||t|
1301247|NCT03580018|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1301248|NCT03580005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301249|NCT03579992|Randomized|Parallel Assignment||Treatment||Single|Occupational Therapists were blinded to intervention group|||||t
1301250|NCT03579979||Single Group Assignment||Treatment||None (Open Label)||||||
1301251|NCT03579966||Single Group Assignment||Treatment||None (Open Label)||||||
1301252|NCT03579953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301253|NCT03579940|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1301254|NCT03579927||Single Group Assignment||Treatment||None (Open Label)||||||
1301255|NCT03579914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301256|NCT03579901|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Multicenter Single arm||||
1301257|NCT03579888||Single Group Assignment||Treatment||None (Open Label)||||||
1301258|NCT03579875|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301259|NCT03579862|||Cohort||Prospective|||||||
1301260|NCT03579849||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301261|NCT03579836|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1301262|NCT03579823|Randomized|Parallel Assignment||Treatment||Single|This study is single blind. Operators are open to treatment allocation. Subjects are blinded to the treatment allocation. In order to keep the blind, subjects are masked during the subcutaneous injection.|Single Centre, Randomised, Single-Blind, Pilot Study|t|||
1301263|NCT03579810|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301264|NCT03579797|||Cohort||Cross-Sectional|||||||
1301265|NCT03579784||Single Group Assignment||Treatment||None (Open Label)||||||
1301266|NCT03579771||Single Group Assignment||Treatment||None (Open Label)||||||
1301267|NCT03579758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301268|NCT03579745|Randomized|Parallel Assignment||Treatment||Single||||||t
1301269|NCT03579732|||Cohort||Retrospective|||||||
1301270|NCT03579719|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1301271|NCT03579706|Randomized|Parallel Assignment||Treatment||Double|Participants anonymously complete all online measures and the intervention without contact with study personnel. Participants are randomized to the active or control condition without being told which condition they are participating in.||t|||t
1301272|NCT03579693|Randomized|Crossover Assignment||Treatment||Triple||Randomized, placebo-controlled, cross-over trial|t|t|t|
1301273|NCT03579680|||Other||Other|||||||
1301274|NCT03579667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301275|NCT03579654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301276|NCT03579641|||Cohort||Prospective|||||||
1301277|NCT03579628||Single Group Assignment||Treatment||None (Open Label)||||||
1301278|NCT03579615|Randomized|Crossover Assignment||Other||None (Open Label)|FIASP vs standard of care insulin|An open-label, single-centre, randomised, two-period, cross-over study||||
1301279|NCT03579602|Randomized|Parallel Assignment||Other||Single|Pathology assessment and post-operative MRI assessment will be blinded to fluorescence data.|Subjects will be randomized 1:10 to 1 of 2 study arms. Subjects in arm 1 (~9% of subjects) will not receive tozuleristide but will undergo neurosurgery and imaging will be performed with the Canvas. Subjects in arm 2 (~91% of subjects) will receive tozuleristide and will undergo neurosurgery and imaging will be performed with the Canvas.||||t
1301280|NCT03579589|Randomized|Parallel Assignment||Treatment||None (Open Label)||Sugammadex vs Neostigmine||||
1301281|NCT03579576|||Cohort||Prospective|||||||
1301282|NCT03579563|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1301283|NCT03579550|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective randomised trial||||
1301284|NCT03579537||Single Group Assignment||Supportive Care||None (Open Label)||One group who perform 3 first month just with normal treatment of hemodialysis and the next 3 month exercise intervention. (6 months in total)||||
1301285|NCT03579524|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1301286|NCT03579511|||Other||Cross-Sectional|||||||
1301287|NCT03579498|||Cohort||Prospective|||||||
1301288|NCT03579485|||Cohort||Retrospective|||||||
1301289|NCT03579472||Single Group Assignment||Treatment||None (Open Label)||||||
1301290|NCT03579459|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1301291|NCT03579446||Single Group Assignment||Supportive Care||None (Open Label)||||||
1301292|NCT03579433||Single Group Assignment||Treatment||None (Open Label)||||||
1301293|NCT03579420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301294|NCT03579407|Randomized|Parallel Assignment||Other||Double|||t|||t
1301295|NCT03579394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301296|NCT03579381|||Cohort||Prospective|||||||
1301297|NCT03579368||Single Group Assignment||Treatment||None (Open Label)||Single group study||||
1301335|NCT03578874||Single Group Assignment||Treatment||None (Open Label)||||||
1301336|NCT03578861||Single Group Assignment||Supportive Care||None (Open Label)||||||
1301298|NCT03579355|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"A quasi-experimental, controlled trial design was utilized to evaluate the effectiveness of a school-based tobacco program, Dentists Fighting Nicotine Dependence (DFND), to prevent the initiation of tobacco use among middle school students (grades 7-9) in Jeddah, Saudi Arabia.~Eight middle schools were selected from the regional education registry; four allocated to treatment arm (n=379) and four to control arm (n=255). The treatment arm received the new tobacco prevention program (DFND) whereas the control arm received only the regular tobacco prevention program administered by the Department of Education. DFND was delivered by trained health educators over 5 weeks, two sessions per week."||||
1301299|NCT03579342|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301300|NCT03579329|||Cohort||Prospective|||||||
1301301|NCT03579316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301302|NCT03579303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301303|NCT03579290||Single Group Assignment||Treatment||None (Open Label)||||||
1301304|NCT03579277|Randomized|Parallel Assignment||Treatment||Single|To the extend possible based on the nature of the study, subjects and researchers will be masked from the treatment arms.|Subjects are assigned to one of two treatment arms|||t|
1301305|NCT03579264|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301306|NCT03579251||Single Group Assignment||Supportive Care||None (Open Label)||1) Semi-structured, qualitative interviews; 2) protocol development; 3) single-arm pilot study||||
1301307|NCT03579238|Randomized|Sequential Assignment||Basic Science||Quadruple|The clinicians, participants, researchers and statistician will not know which stage of interaction (distant, close, touching, pulling) induces entrainment, if at all. Statistician will be blinded to stage allocation of each data set, and stages of interaction will be randomized per encounter.|Intrasubject sequential intervention design|t|t|t|t
1301308|NCT03579225|||Case-Only||Prospective|||||||
1301309|NCT03579212|||Cohort||Prospective|||||||
1301310|NCT03579199||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301311|NCT03579186||Single Group Assignment||Device Feasibility||None (Open Label)||Patients undergoing a clinical gait assessment will be recruited for this study. Those that consent to participate will complete their clinical gait assessment as part of their normal evaluation. Subjects will then complete a gait assessment while wearing experiencing optokinetic stimulation. The investigators will compare baseline gait and postural control before and during OKS stimulation.||||
1301312|NCT03579173|||Cohort||Prospective|||||||
1301313|NCT03579160|Randomized|Parallel Assignment||Treatment||Single|Blinded physician will assess outcomes from pictures|"The protocol will begin post-surgery. Eligible subjects will be assigned by computer-based randomization to case (0.25% timolol gel) or control (standard of care [SOC]) group and treated as follows:~Receiving site of FTSG/case group:~During surgery: application of 0.25% timolol gel (2 drops per cm2) on wound bed before FTSG is placed~During surgery: application of 0.25% timolol gel (2 drops per cm2) over FTSG after insetting of the graft~After bolster removal (7 days): daily cleansing and daily 0.25% timolol (2 drops per cm2) application for 4 weeks~Receiving site of FTSG/control group:~FTSG surgery as per SOC~After bolster removal (7 days): daily cleansing and daily Vaseline application for 4 weeks"||||t
1301314|NCT03579147||Single Group Assignment||Treatment||None (Open Label)||||||
1301315|NCT03579134|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1301316|NCT03579121|Randomized|Parallel Assignment||Screening||Single|Participants will not be aware of which arm of the study they are enrolled.|All subjects meeting inclusion/exclusion criteria will undergo pharmacogenomic testing. A pharmacist will review the pharmacogemic report and make recommendations for patients in the interventional group. The anesthesiologist and orthopedic surgeon will use that information for preoperative clinical decisions related to anesthesia and analgesia.|t|||
1301317|NCT03579108|||Other||Retrospective|||||||
1301318|NCT03579095|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Between and within groups model|t|t|t|t
1301319|NCT03579082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301320|NCT03579069|||Cohort||Retrospective|||||||
1301321|NCT03579056|||Cohort||Retrospective|||||||
1301322|NCT03579043|Randomized|Factorial Assignment||Screening||None (Open Label)||To see if caloric compensation occurs during 3-day exposure to non-nutritive sweeteners, a 3x4 mixed factorial design will be used, with a between-subject factor of intervention group (NNS, NS, and control) and within-subject factor of time (baseline, day 1 of beverage exposure, day 2 of beverage exposure, and day 3 of beverage exposure).||||
1301323|NCT03579030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301324|NCT03579017|||Cohort||Prospective|||||||
1301325|NCT03579004||Single Group Assignment||Treatment||None (Open Label)||||||
1301326|NCT03578991|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301327|NCT03578978|||Case-Control||Cross-Sectional|||||||
1301328|NCT03578965|Randomized|Parallel Assignment||Prevention||Quadruple|The principal investigator along with all members of the study team involved in data analysis as well as the patients will be blinded to the randomization group. The research assistant will disclose the randomization group to the anesthesiologist who will screen the patient for allergies and then obtain the appropriate antibiotics from the pharmacy and administer the antibiotics as appropriate. These will be administered prior to the procedure and so the surgeon will remain blinded to the administration||t|t|t|t
1301329|NCT03578952||Single Group Assignment||Treatment||None (Open Label)||||||
1301330|NCT03578939|||Cohort||Prospective|||||||
1301331|NCT03578926|Randomized|Crossover Assignment||Treatment||Double|Double masked (participant and investigator)|Prospective, randomized, double masked, bilateral, 2‐weeks, crossover study.|t||t|
1301332|NCT03578913|Randomized|Parallel Assignment||Treatment||Double|"Double blind (Patients and outcome assessors) both patient and assessor will be blinded to the assigned material. However the operator can't be blinded due to the difference in preparation and shade of the ceramic materials. Reem Gabr will be responsible for the try-in and final delivery of the crowns.~-The assessor will assess all outcomes blinded to the material assigned for each patient."|Patient will receive a restoration with superior function, ethetic, and excellent clinical performance.|t|||t
1301333|NCT03578900|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1573341|NCT00001536||||||||||||
1301337|NCT03578848|Randomized|Parallel Assignment||Diagnostic||Double|Each patient will be randomly assigned, using a standard computer protocol at the General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan, to intervention in a 1:1:1 ratio to home BP, uAOBP, or central BP using sealed opaque envelopes (sequentially numbered). The study coordinator will oversee the enrollment and intervention assignment and keep allocation concealment. The caring physicians will remain blinded to the allocation by providing them with the measured BP values through a standardized report form without the knowledge of the used BP monitoring devices.|BP will be taken simultaneously from both upper arms by an oscillometric BP monitor. Subjects with SBP Differences between both arms more than 5 mmHg will be excluded. For the unattended automated BP (uAOBP) and central BP (CBP), the measurements will be conducted in a quiet room without the presence of clinical personnel. Simultaneously, the central BP will be measured in the other upper arm. The determination of the right or left upper arm for uAOBP or central BP will be made in a random order by computer generated random codes before the enrollment. As for the home BP measurements, a validated device will be provided for all subjects allocated to the home BP arm to measure their BP at home. Subjects are requested to take BP in the morning and afternoon before meals for 7 consecutive days before the scheduled clinical visits. BP in the first day of the measurements will be discarded and an average of home BP will be generated and provided for clinicians to guide their treatment.|t|t||
1301338|NCT03578835|||Cohort||Prospective|||||||
1301339|NCT03578822|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301340|NCT03578809|Randomized|Parallel Assignment||Treatment||Triple|In this study, the subject and sponsor staff will be blinded. Sites will be trained to keep the investigator blinded. However, due to the acute nature of the study, members of the research team and, possibly, the investigator may be unblinded.||t|t||t
1301341|NCT03578796|||Cohort||Prospective|||||||
1301342|NCT03578783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301343|NCT03578770||Sequential Assignment||Other||None (Open Label)||Feasibility device||||
1301344|NCT03578757|Randomized|Parallel Assignment||Prevention||None (Open Label)|No masking|||||
1301345|NCT03578744|Randomized|Parallel Assignment||Treatment||Single|Sealed envelopes.|Patients will be equally divided into two test groups, Group A and Group B after phase I therapy. The group A patients will be treated with conventional flap surgery and the furcation would be debrided, following which platelet-rich fibrin will be placed as a graft and a membrane. The flap will then be sutured back. The group B patients will also be treated with conventional flap surgery after furcation area is debrided, and hyaluronic acid (gengigel)will be placed as a graft over which amniotic membrane will be placed. The flap would then be sutured.|t|||
1301346|NCT03578731|||Cohort||Retrospective|||||||
1301347|NCT03578718|||Cohort||Prospective|||||||
1301348|NCT03578705|||Case-Only||Prospective|||||||
1301349|NCT03578692|||Case-Control||Prospective|||||||
1301350|NCT03578679||Single Group Assignment||Treatment||None (Open Label)|Evaluation of therapeutic efficacy of a combination of two usual drugs.|Interventional prospective study with only one arm||||
1301351|NCT03578666|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1301352|NCT03578653||Single Group Assignment||Prevention||None (Open Label)||||||
1301353|NCT03578640||Single Group Assignment||Treatment||None (Open Label)|Open-label|An interventional, single-center, single-arm study among 30 patients who are treatment naïve, have no advanced fibrosis and mono-infected with HCV-GT4.||||
1301354|NCT03578627|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1301355|NCT03578614|Randomized|Parallel Assignment||Prevention||Single|Single-blind|Single-blind, randomized controlled trial, with a six-month intervention treatment and an additional follow-up of six months. After a four-week run-in period, the participants are randomized into two parallel groups (control group and intervention group).|||t|
1301356|NCT03578601|||Cohort||Prospective|||||||
1301357|NCT03578588|Randomized|Sequential Assignment||Treatment||None (Open Label)||A single-center, randomized, open-label, three-period and three-crossover trial design is adopted in the single-dose pharmacokinetic study; A single-center, randomized, open- label, and dose escalation trial design is used in the multiple-dose tolerability and pharmacokinetic studies||||
1301358|NCT03578575|Randomized|Parallel Assignment||Treatment||Triple||120 subjects are divided into experimental group and control group (placebo).|t|t|t|
1301359|NCT03578562||Single Group Assignment||Treatment||None (Open Label)||Prospective cohort study||||
1301360|NCT03578549||Single Group Assignment||Diagnostic||None (Open Label)||Oximetry Testing of Teeth Scheduled to be Extracted and Others||||
1301361|NCT03578536|Non-Randomized|Parallel Assignment||Treatment||Single|The Outcomes Assessor will be blinded to treatment group of study participants.|Parallel: participants are assigned to one of two or more groups in parallel for the duration of the study.||||t
1301362|NCT03578523|||Cohort||Prospective|||||||
1301363|NCT03578510|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1301364|NCT03578497||Single Group Assignment||Treatment||None (Open Label)||||||
1301365|NCT03578484|||Cohort||Prospective|||||||
1301366|NCT03578471|Randomized|Crossover Assignment||Treatment||Single|||t|||
1301367|NCT03578458|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1301368|NCT03578445||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301369|NCT03578432||Single Group Assignment||Supportive Care||None (Open Label)||||||
1301370|NCT03578419|Randomized|Crossover Assignment||Prevention||None (Open Label)||A stepped wedge cluster randomized trial in which ICUs (clusters) switch from a strategy of blood collection using standard-draw tubes (control) to soft-draw tubes (intervention). In this design, the timing at which individual ICUs switch to the intervention is randomly assigned.||||
1301371|NCT03578406||Single Group Assignment||Treatment||None (Open Label)||||||
1301372|NCT03578393|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301373|NCT03578380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301374|NCT03578367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301375|NCT03578354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301455|NCT03577314|||Case-Control||Prospective|||||||
1301456|NCT03577301|Randomized|Parallel Assignment||Prevention||Single||||||t
1301376|NCT03578341|Randomized|Sequential Assignment||Prevention||Triple|Masking Description: The colostrum and placebo will be preparing by a Human Milk Bank person, who will be knowing the treatment of both 2nd and 1st group. Both colostrum and placebo, will be administrating by nursing staff in syringes in such a way that it is not detected that it contains each of them. Neither the parents of the participants nor the researchers will be involved in the care or analysis of the data, until the end of the study.|Intervention Model Description: The Participants will be randomly and assigned to Group 1, or Group 2 . using a table of random numbers, generated by a computer. The Human Milk Bank Staff, will prepares the colostrum and water (placebo) doses in syringes in such a way that it is not detected that it contains each of them, . Group 1: Will receive 0.3 mL orally colostrum every 4 h during three days, Group 2: will receive 0.3 mL orally Sterile water. Serum immunoglobulins A, G and M concentration will be determined before de start the orally doses, day 7 and 28 days of life.he nurse in charge of the patient's care, administer the dose, a doctor will take the laboratory exams and another researcher will collect and analyze the data. The syringes will be covered, to prevent the patiente´s nurse from observing the contents.|t|t|t|
1301377|NCT03578328|||Cohort||Retrospective|||||||
1301378|NCT03578315|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1301379|NCT03578302||||||||||||
1301380|NCT03578289|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1301381|NCT03578276|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants' eyes are assigned to one of two groups.||||
1301382|NCT03578263|Randomized|Parallel Assignment||Prevention||Single|the participants blinded the arms of the study|The current study was a single-blinded randomized controlled trial conducted at a tertiary University Hospital Women included in the study were divided into 2 groups: Group (A): included 100 patients who received carbetocin 100 µg diluted in 10 ml normal saline and administered slowly (over 30-60 seconds) intravenously by anesthetist after birth of the baby. Group (B): included 100 patients who received a combination of intraoperative oxytocin 5 I.U which was diluted in 10 ml normal saline and administered slowly over (30-60 seconds) intravenously by anesthetist and intramuscular ergometrine 0.2 mg.|t|||
1301383|NCT03578250|Randomized|Parallel Assignment||Treatment||Double||Randomized Controlled Trial|t|||t
1301384|NCT03578237|Randomized|Parallel Assignment||Prevention||Triple|Only the investigator/physician applying the cryoneurolysis will be aware of the treatment group assignment.||t|t||t
1301385|NCT03578224||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301386|NCT03578211|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1301387|NCT03578198||Single Group Assignment||Treatment||None (Open Label)||||||
1301388|NCT03578185|||Cohort||Retrospective|||||||
1301389|NCT03578172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301390|NCT03578159|||Cohort||Prospective|||||||
1301391|NCT03578146|Randomized|Parallel Assignment||Treatment||Quadruple||"This study has four modules with a total of 21 cohorts, each module was reported and submitted separately.~Module 1, NCT01758432 (54 subjects with 7 cohorts including placebo); Module 2, NCT03578146 (48 subjects with 6 cohorts including placebo); Module 3, NCT03551730 (27 subjects with 4 cohorts including placebo); Module 4, NCT03551743 (28 subjects with 4 cohorts including placebo)"|t|t|t|t
1301392|NCT03578133|||Other||Cross-Sectional|||||||
1301393|NCT03578120|||Cohort||Prospective|||||||
1301394|NCT03578107|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1301395|NCT03578094|||Cohort||Prospective|||||||
1301396|NCT03578081|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1301397|NCT03578068|||Cohort||Prospective|||||||
1301398|NCT03578055|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1301399|NCT03578042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301400|NCT03578029|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1301401|NCT03578016|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1301402|NCT03578003|Randomized|Parallel Assignment||Treatment||Single||||||t
1301403|NCT03577990|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study will test the effects of ITEC added to CDSMP on two study aims: 1) BP control, and 2) adherence to antihypertensive medication and lifestyle modifications. After baseline data collection, participants complete a 6-week CDSMP course and then are randomly assigned to either the treatment or control arm. All participants will continue to receive usual care for HTN.~The treatment group will receive ITEC and wireless tools to track activity, BP, weight, food intake, and self-report medication-taking after an orientation to Fitbit Plus (a cloud-based collaborative care platform designed to store and track data). All tools will be synced to the participants' smartphone. The treatment arm will receive weekly ITEC for 3 months, biweekly ITEC for 3 months, and then no ITEC for 3 months.~The control arm will receive usual care only with monthly BP measured manually for 3 months and then receive the same wireless tools with monitoring to track comparative data with the treatment arm."||||
1301404|NCT03577977|||Cohort||Retrospective|||||||
1301405|NCT03577964|||Case-Control||Prospective|||||||
1301406|NCT03577951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301407|NCT03577938|Randomized|Parallel Assignment||Treatment||Single||||||t
1301408|NCT03577925|||Other||Cross-Sectional|||||||
1301409|NCT03577912|Randomized|Parallel Assignment||Treatment||Triple|patients, and all data collectors were blinded regarding which group the patients were in. Surgeons who performed the case were aware of the method used but were not involved with the data collection|prospective, randomized, patient and observer blinded non-inferiority trial|t||t|t
1301410|NCT03577899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301411|NCT03577886|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Dose-escalating, Randomized, Double-blinded, Placebo-controlled.|t|t|t|t
1301412|NCT03577873|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301413|NCT03577860|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1301414|NCT03577847|||Case-Control||Prospective|||||||
1301457|NCT03577288||Factorial Assignment||Other||None (Open Label)||||||
1301458|NCT03577275|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1301630|NCT03575039||Single Group Assignment||Treatment||None (Open Label)||||||
1301415|NCT03577834|Randomized|Parallel Assignment||Prevention||Double|All participants will receive 'vinegar' either in liquid form (active) or pill (not active as acetic acid concentration is below threshold of effect). Investigators measuring outcome variables (visceral fat, tooth enamel, and blood indices) are blinded to treatment assignment.|Qualifying participants will be stratified by gender, age, weight, and waist circumference, then randomized into two groups: the intervention group, vinegar drinks (VIN) or the control group, vinegar pills (CON).|t||t|
1301416|NCT03577821|||Cohort||Prospective|||||||
1301417|NCT03577808|||Cohort||Prospective|||||||
1301418|NCT03577795|||Cohort||Prospective|||||||
1301419|NCT03577782||Single Group Assignment||Treatment||None (Open Label)||HIV-infected subjects with no previous ART will begin ART together with Vedolizumab infusions at week 0, 4, 8, 12, 16, 20 and 24 weeks. At this time point ART and Vedolizumab treatment will be interrupted. Patients will be followed up until week 48. ART will be resumed if CD4+ T-cell levels drop below 350 CD4+/μL and/or viral load increases above 10e5 HIV-RNA copies/mL (two consecutive measurements).||||
1301420|NCT03577769|||Cohort||Retrospective|||||||
1301421|NCT03577756|||Case-Control||Prospective|||||||
1301422|NCT03577743||Single Group Assignment||Treatment||None (Open Label)||||||
1301423|NCT03577730|Randomized|Parallel Assignment||Treatment||Quadruple|This will be a single-center, triple-blinded, pilot randomized controlled trial at the University of Michigan Health System.||t|t|t|t
1301424|NCT03577717|Randomized|Parallel Assignment||Treatment||Single||||||t
1301425|NCT03577704|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The study used the Bayes optimal interval design (BOIN) to assign the subject's dose level and determine the maximum tolerated dose (MTD) of HLX07 in combination with chemotherapy.Each cohort contains 3 subjects and the patient in the first cohort receives treatment at the lowest dose level (single dose of 400 mg). The decision to increase or decrease the dose after each train is based on the probability of a predefined safety and toxicity threshold. When the observed rate of dose limiting toxicity (DLT) is less than 0.237 (low target safety margin), the dose for the next cohort escalates; when the observed rate of DLT is higher than 0.359 (target high toxicity cutoff), the dose deescalates. Otherwise, the dose remains the same. After each cohort is finished, a safety review committee will be held to determine the escalates or deescalates in the next cohort. The enrollment continues until the maximum 30 patients are reached.||||
1301426|NCT03577691|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||Prospective, randomized,controlled, unblinded study||||
1301427|NCT03577678||Single Group Assignment||Other||None (Open Label)||Surgery was made to fix the new prosthesis||||
1301428|NCT03577665||Single Group Assignment||Treatment||None (Open Label)||||||
1301429|NCT03577652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301430|NCT03577639|||Cohort||Prospective|||||||
1301431|NCT03577626|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1301432|NCT03577613|||Case-Only||Prospective|||||||
1301433|NCT03577600||Single Group Assignment||Treatment||None (Open Label)||A case-study study. The controls will be historical and 2 controls will be taken that will be matched to the age range (preschool, school age, early adolescent, late adolescent), type of tumor and location (infra or supratentorial). This study is expected to last for approximately 12 months, comprised of 4-8 weeks of enrollment period, 28 days of treatment and 6 months of follow up. The enrollment will be completed prior to the beginning of initial treatment. The recruitment will be carried out with a sample at convenience in patients with brain tumors in terminal phase that are outside conventional treatment. The therapy with quantum magnetic resonance (Cytotron®) will be administered as a compassionate treatment with the authorization signed by the parents and with the respective informed consent (depending on age).||||
1301434|NCT03577587|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1301435|NCT03577574|Randomized|Parallel Assignment||Other||Single|||t|||
1301436|NCT03577561|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||"Control group A: 1 -year historical data (2016/2017) The blood sampling error rate in the interns receiving PBP training in 2018 will be compared to historical data on doctors who would have received whatever training they would normally undergo as a part of their existing training program. It will not differ from what they would normally receive at that institution.~Control group B (2017/2018) In a pilot project in July 2017, 46 interns received the phlebotomy PBP training at CUH. The error rates in the interns in 2017 will be compared to the newly trained interns in 2018 to determine the effectiveness of the training over time.~Interventional Group:~The blood sampling error rate in those doctors in training given the improved proficiency based progression training under investigation from March 30th 2018"||||
1301437|NCT03577548|||Case-Only||Prospective|||||||
1301438|NCT03577535|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1301439|NCT03577522|Randomized|Parallel Assignment||Other||Single|||t|||
1301440|NCT03577509||Sequential Assignment||Treatment||None (Open Label)||||||
1301441|NCT03577496||Single Group Assignment||Prevention||None (Open Label)||||||
1301442|NCT03577483|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Exploratory comparative multicentric study.||||
1301443|NCT03577470|||Cohort||Prospective|||||||
1301444|NCT03577457|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1301445|NCT03577444|||Cohort||Cross-Sectional|||||||
1301446|NCT03577431||Single Group Assignment||Treatment||None (Open Label)||||||
1301447|NCT03577418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301448|NCT03577405|||Cohort||Prospective|||||||
1301449|NCT03577392|Randomized|Parallel Assignment||Treatment||Triple||Patients were randomly assigned to receive either three treatment cycles of intravenous pump of recombinant human endostatin before chemotherapy.|t|t|t|
1301450|NCT03577379|Randomized|Single Group Assignment||Supportive Care||Triple|Patients will be randomized to either the treatment or control group using an automated randomization program using a research electronic data capture (REDCap) system prior to surgery.||t|t||t
1301451|NCT03577366|||Other||Retrospective|||||||
1301452|NCT03577353|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301453|NCT03577340|||Cohort||Retrospective|||||||
1301454|NCT03577327|||Cohort||Prospective|||||||
1573342|NCT00001533||||Treatment||||||||
1301459|NCT03577262|Non-Randomized|Single Group Assignment||Other||None (Open Label)||evaluate the kinetics and test-retest repeatability and reproducibility of the radioligand [11C]-UCB-J for imaging synaptic density in up to10 healthy subjects and then mild to moderate Alzheimer's Disease patients||||
1301460|NCT03577249||Sequential Assignment||Treatment||None (Open Label)||45 patients with end stage renal disease will be treated with dialysis solution A (standard of care: acetate-buffered) for 3 months then with solution B (acetate-free, citrate buffered, otherwise identical to solution A) for 3 months and then with solution A for the final 3 months||||
1301461|NCT03577236||Single Group Assignment||Treatment||None (Open Label)||Multi-center, prospective, single-arm.||||
1301462|NCT03577223|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1301463|NCT03577210||Single Group Assignment||Other||None (Open Label)||||||
1301464|NCT03577197|||Cohort||Prospective|||||||
1301465|NCT03577184|||Other||Prospective|||||||
1301466|NCT03577171|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1301467|NCT03577158|Randomized|Crossover Assignment||Treatment||Single||Longitudinal, prospective, interventional study.|t|||
1301468|NCT03577145|Randomized|Crossover Assignment||Basic Science||None (Open Label)||"Acute human bioavailability studies with a cross-over design. Subjects will be given a soup or drink in one of three combinations~Tomato onion and lovage soup~Inulin~Mixture of tomato onion and lovage soup with inulin"||||
1301469|NCT03577132|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective study||||
1301470|NCT03577119|Randomized|Crossover Assignment||Prevention||Triple||This study will employ a controlled, randomized, double-blinded crossover trial comparing two diets.|t||t|t
1301471|NCT03577106||Single Group Assignment||Treatment||None (Open Label)||||||
1301472|NCT03577093|||Cohort||Prospective|||||||
1301473|NCT03577080|Randomized|Parallel Assignment||Treatment||Double||Differents groups received differents training protocoles during the same duration||t|t|
1301474|NCT03577067|||Cohort||Retrospective|||||||
1301475|NCT03577054|Randomized|Parallel Assignment||Other||Single|Outcomes assessor at analysis stage will be masked to allocation of participants|Parallel Assignment||||t
1301476|NCT03577041|||Cohort||Prospective|||||||
1301477|NCT03577028||Single Group Assignment||Treatment||None (Open Label)||||||
1301478|NCT03577015|||Cohort||Prospective|||||||
1301479|NCT03577002|Randomized|Parallel Assignment||Other||Single||||||t
1301480|NCT03576989|Randomized|Parallel Assignment||Treatment||Triple|Investigators, participants and care providers blinded as to treatment|2-group randomized, double-blind, repeated measures design|t|t|t|
1301481|NCT03576976|Randomized|Parallel Assignment||Treatment||Single||||||t
1301482|NCT03576963||Single Group Assignment||Treatment||None (Open Label)||||||
1301483|NCT03576950|||Cohort||Retrospective|||||||
1301484|NCT03576937|||Cohort||Prospective|||||||
1301485|NCT03576924|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a single-centre, parallel-group randomized controlled trial.||||
1301486|NCT03576911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301487|NCT03576898|Randomized|Parallel Assignment||Treatment||Single||||||t
1301488|NCT03576885|Randomized|Parallel Assignment||Prevention||Quadruple||Masked randomized controlled trial|t|t|t|t
1301489|NCT03576872||Single Group Assignment||Supportive Care||None (Open Label)||||||
1301490|NCT03576859|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1301491|NCT03576846|Randomized|Parallel Assignment||Treatment||Triple|The subject will not know the content of the other arm. The care provider cannot be blinded, as he/she will be performing the treatment. The investigator performing the measurements will not be aware of the treatment allocation, and the analyses will be masked for group allocation|Subjects will be randomized into two arms: 1: stretching exercises only, 2: stretching exercises and Spinal Manipulative Therapy|t||t|t
1301492|NCT03576833||Single Group Assignment||Treatment||None (Open Label)||||||
1301493|NCT03576820|Randomized|Parallel Assignment||Treatment||Quadruple|The medication and placebo doses will be prepared in the pharmacy at the study site and provided to the investigators in deidentified syringes.||t|t|t|t
1301494|NCT03576807||Single Group Assignment||Treatment||None (Open Label)||||||
1301495|NCT03576794|Randomized|Parallel Assignment||Treatment||Double||Prospective, randomized, double-blind, placebo controlled treatment study during 12 months (part I) and an additional open-label follow-up of 12 months (part II).|t|t||
1301496|NCT03576781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301497|NCT03576768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301498|NCT03576755|Randomized|Parallel Assignment||Other||Quadruple|"Due to the objectives of the study, the identity of test and control treatments will not be known to investigators, research staff, or patients. The following study procedures will be in place to ensure double-blind administration of study treatments Access to the randomization code will be strictly controlled. A color and size-matched placebo capsule that looks identical to the spironolactone capsule will be used.~Packaging and labeling of test and control treatments will be identical to maintain the blind.~The study blind will be broken on completion of the clinical study, after all study endpoints have been ascertained by blinded study coordinators and after the study database has been locked.~During the study, the blind may be broken only in emergencies when knowledge of the patient's treatment group is necessary for further patient management. The UCSF investigational pharmacy would then be notified and responsible for unblinding."|"The following treatment regimens will be used:~Experimental treatment - spironolactone, 100 mg once daily~Placebo or Comparator - one capsule, once daily"|t|t|t|t
1301499|NCT03576742|||Cohort||Prospective|||||||
1301500|NCT03576729|||Other||Prospective|||||||
1301501|NCT03576716||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301502|NCT03576703|Randomized|Crossover Assignment||Prevention||None (Open Label)||randomized crossover||||
1301503|NCT03576690||||||||||||
1301626|NCT03575091|Randomized|Parallel Assignment||Treatment||Single|"Randomisation is carried out with sealed envelopes that are only opened just before intervention starts.~There are different care givers who carry out the observations and who perform the interventions."|Comparison of tree parallel groups, 1 control and 2 intervention groups.|||t|
1301504|NCT03576677|Randomized|Parallel Assignment||Treatment||Quadruple|The study is double-blinded; hence neither patients nor investigators are aware of the treatment assignment throughout the study period. 2 unblinded study nurses at each site will perform randomization and prepare study medication blinded to the rest of the research team.|"This is a prospective multi-center, double-blinded, placebo controlled, randomized study in patients with advanced chronic heart failure. Patients who meet the eligibility criteria will be randomized in a 1:1 ratio for treatment with 6 hours infusion of either (i) levosimendan 0.2 µg/kg/min or (ii) placebo (sterile 5% dextrose).~At baseline an upright ergometer maximal exercise test is performed to determine max workload and pVO2 (Test 0). Based on this test 50% of pVO2 with corresponding workload (watt) is calculated (submax).~At Day 0 patients will perform a supine ergometer maximal exercise test (Test 1) with simultaneous invasive hemodynamic measurement by Swan-Ganz catheter. Subsequently, patients will receive 6 hours infusion of study medication.~At Day 5 (4-6 days after infusion of study medication) patients will repeat the supine ergometer maximal exercise test (Test 2) with simultaneous invasive hemodynamic measurements."|t|t|t|t
1301505|NCT03576664|Randomized|Crossover Assignment||Basic Science||Double||Randomized, cross-over, placebo-controlled study|t||t|
1301506|NCT03576651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301507|NCT03576638|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1301508|NCT03576625|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1301509|NCT03576612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Newly diagnosed HGG: surgically eligible patients AdV-tk into wall of resection cavity; 1-3 days post-surgery Valacyclovir d1-14; Day 8 RT for 6 wks; day 15 TMZ 75mg/m2 daily; Nivo 240mgIV every 2 weeks||||
1301510|NCT03576599|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1301511|NCT03576586|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1301512|NCT03576573|||Cohort||Prospective|||||||
1301513|NCT03576560|||Other||Retrospective|||||||
1301514|NCT03576547||Single Group Assignment||Treatment||None (Open Label)||||||
1301515|NCT03576534|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Control Trial||||
1301516|NCT03576521|Randomized|Parallel Assignment||Supportive Care||Triple|A double blind. The masking will be maintained until the analysis of the data. However, access to the code will be allowed if serious adverse events arise related to the research product.|Phase II randomized, controlled, double blind clinical trial.|t|t|t|
1301517|NCT03576508|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1301518|NCT03576495|Randomized|Crossover Assignment||Health Services Research||None (Open Label)|Resident program directors and research staff will not be blinded to the implementation of curriculum|Sites will be assigned to an early intervention/retention assessment group or a delayed intervention group (control) for examination of the effectiveness of the intervention as well as learner retention.||||
1301519|NCT03576482|||Cohort||Prospective|||||||
1301520|NCT03576469||Single Group Assignment||Prevention||None (Open Label)||Single Group||||
1301521|NCT03576456|Randomized|Parallel Assignment||Treatment||Quadruple||placebo controlled, double blind|t|t|t|t
1301522|NCT03576443||Single Group Assignment||Treatment||None (Open Label)||||||
1301523|NCT03576430|Randomized|Parallel Assignment||Treatment||Triple||RCT, 1:1 inclusion active:control|t||t|t
1301524|NCT03576417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301525|NCT03576404||Single Group Assignment||Other||None (Open Label)||A Quasi-Experimental Interrupted Time Series Study||||
1301526|NCT03576391|Randomized|Crossover Assignment||Basic Science||Single|The researcher that will perform the EMG-analysis, i.e. onset determination of the various muscles that were measured, will be blinded for participant, condition and muscle during that process.|Each participant will perform all 3 experimental conditions spread out over 2 test days. At test day 1 the control condition is performed. Test day 2 follows at least 5 days after the 1st one in order to make sure participants are physically and mentally recovered as the protocol at test day 1 might induce some physical or mental fatigue. On test day 2 the other 2 conditions are tested in a randomised order: either first the physical fatigue condition, followed by the cognitive fatigue condition or vice versa.||||t
1301527|NCT03576378||Single Group Assignment||Treatment||None (Open Label)||||||
1301528|NCT03576365|Randomized|Parallel Assignment||Treatment||Single|Participants are not aware of which treatment arm they are assigned.||t|||
1301529|NCT03576352|Non-Randomized|Sequential Assignment||Other||None (Open Label)||"Anesthesiologist, pediatric intensivists, surgeons, and emergency physicians who are most likely to need to perform FONA in small children, shall learn to perform RST emergent pediatric tracheotomy in less than 60 seconds. The investigators seek to measure and study their learning curves for establishing an artificial airway using the RST.~Single-center interventional trial. The only inclusion criterion is informed consent. A high quality instructional video demonstrating the RST on a rabbit cadaver will teach the participants. Performance time will be defined (from touching the skin until ventilation of the trachea with a standard self-inflating bag connected to the tube)."||||
1301530|NCT03576339|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1301531|NCT03576326|Randomized|Parallel Assignment||Prevention||Double|An independent outcomes assessor and PIs will be blinded to participants' group assignment, and participants will be told that the examiner and PIs cannot answer any incentive questions and they should not mention the incentive program to them. (Due to the nature of the intervention, the staff explaining the study arms after randomization and providing the incentive gift cards at follow-up visits cannot be blinded.)|Eligible consenting parent-child participant dyads, within strata and permuted blocks, will be randomized in equal allocation to one of two arms. Strata will be based on site and smartphone operating system (iOS or Android).|||t|t
1301532|NCT03576313|Randomized|Parallel Assignment||Prevention||Single|Malaria prevalence will be determined by technicians blinded to the treatment arm|This cluster-randomized trial will involve 32 villages in the Upper River Region of The Gambia that will be randomized to MDA with IVM and DP or to standard of care in a ratio 1:1||||t
1301533|NCT03576300|||Case-Control||Prospective|||||||
1301534|NCT03576287||Single Group Assignment||Treatment||None (Open Label)||||||
1301535|NCT03576274|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1301627|NCT03575078||Single Group Assignment||Treatment||None (Open Label)||Phase 1 Dose Escalation||||
1301536|NCT03576261|Randomized|Parallel Assignment||Other||None (Open Label)||A consecutive cohort. Signed informed consent is gathered. Non-blinded randomization is conducted to fluid therapy before anesthesia induction. Preoperative diagnostics by echocardiography is conducted to all participants.Two arms, with or without preoperative fluids, are studied regarding hemodynamic stability during anesthesia induction.||||
1301537|NCT03576248|Randomized|Crossover Assignment||Treatment||Quadruple|Study will be double-blind : neither participant nor the investigator will know which stimulation type (in-phase active, anti-phase active or sham) is on.|This study is composed of two independent sub-studies, one exploring the effects of tACS and the other the effects of tDCS, with different participants assigned to the two sub-studies. There will be 2 arms in tACS group and 2 arms in tDCS group. Among each sub-study, all participants will participate in all arms (hence the cross-over design).|t|t|t|t
1301538|NCT03576235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301539|NCT03576222|Randomized|Parallel Assignment||Prevention||Single|intraoperative use of randomized dressing|PICO dressing prevents surgical site ocurrences after abdominal Wall repair|t|||
1301540|NCT03576209|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"The described trial is a controlled before-and-after study. In this study, observations are made before and after the implementation of a walking intervention during 12 weeks, both in groups participating in the program (intervention group) and in groups who are not participating in the program (control groups).~Observations are made in intervention and control groups. Participants of the intervention group are registered for participation in this health promotion program 'Lekker Actief' prior to the start of this trial. Participants are already assigned to intervention groups, therefore randomization is determined at individual level. The control groups are composed of participants who are not participating in the program (not receiving any intervention) or the controls are waitlist controls."||||
1301541|NCT03576196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301542|NCT03576183|Randomized|Parallel Assignment||Prevention||Double|Double (Participant, Investigator)||t||t|
1301543|NCT03576170|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1301544|NCT03576157|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1301545|NCT03576144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301546|NCT03576131||Single Group Assignment||Treatment||None (Open Label)||||||
1301547|NCT03576118|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1301548|NCT03576105|Randomized|Parallel Assignment||Treatment||Double|Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)|Endpoint Classification: Bio-equivalence Study Enrollment: 64 [Anticipated]|t||t|
1301549|NCT03576092|||Case-Control||Cross-Sectional|||||||
1301550|NCT03576079|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1301551|NCT03576066|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1301552|NCT03576053|Randomized|Crossover Assignment||Basic Science||Double|Only the third sub-study is conducted in a double-blind manner.||t||t|
1301553|NCT03576040|||Cohort||Prospective|||||||
1301554|NCT03576027||Single Group Assignment||Treatment||None (Open Label)||||||
1301555|NCT03576014||Single Group Assignment||Prevention||None (Open Label)||||||
1301556|NCT03576001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301557|NCT03575988|||Case-Control||Cross-Sectional|||||||
1301558|NCT03575975|||Cohort||Cross-Sectional|||||||
1301559|NCT03575962|Randomized|Crossover Assignment||Treatment||None (Open Label)|This is an open-label study.|Subjects will receive GSK3640254 bis-hydrochloride salt capsule followed by mesylate salt capsule or vice versa in two treatment periods.||||
1301560|NCT03575949||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301561|NCT03575936|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1301562|NCT03575923|||Other||Prospective|||||||
1301563|NCT03575910|||Cohort||Prospective|||||||
1301564|NCT03575897|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301565|NCT03575884|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301566|NCT03575871|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301567|NCT03575858|Randomized|Parallel Assignment||Prevention||Single|The study examiner who will be doing the clinical examination and collecting the study data will be blinded to the group allocation; however it is not possible to blind the study subjects to the group allocation. The clinician, who will be performing the treatment and providing oral hygiene instructions, will open the envelope containing the subject's group allocation after non-surgical periodontal therapy but before giving the oral hygiene instructions.|Participants will be randomly assigned into the barrel shaped (test) and tapered (control) interdental brushes groups||||t
1301568|NCT03575845||Single Group Assignment||Treatment||None (Open Label)||single arm pretest-posttest design||||
1301569|NCT03575832||Single Group Assignment||Prevention||None (Open Label)||||||
1301570|NCT03575819|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Following completion of the dose escalation phase of the study and determination of a recommended phase 2 dose, patients will be enrolled into a dose expansion cohort.||||
1301571|NCT03575806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301572|NCT03575793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301573|NCT03575780||Single Group Assignment||Treatment||None (Open Label)||This study will test KX2-391 Ointment 1%.||||
1301574|NCT03575767|||Cohort||Prospective|||||||
1301575|NCT03575754||||||||||||
1301576|NCT03575741|||Cohort||Prospective|||||||
1301577|NCT03575728|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Based on self-report answers to screening questions, participants will be divided into two groups: (i) those who screen positive for a history of mood disorders and (ii) all other participants. All outcome measures apply only to the mood disorder group.||||
1301578|NCT03575715||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301579|NCT03575702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301628|NCT03575065|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301629|NCT03575052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301746|NCT03573531|||Case-Control||Prospective|||||||
1301580|NCT03575689|Randomized|Parallel Assignment||Treatment||Single|"The PI will be the blinded assessor. The choice of which patient gets a Doyle splint will be randomized using the sealed envelope system mentioned above.~The randomization will be balanced to ensure that both arms have patients with extensive surgeries as well as isolated NSRs"|"There will be two possible scenarios resulting from randomization: All patients will undergo septoplasty using quilting technique.~A. The Doyle splint will be places in both nostrils of the patient after septoplasty. The doyle splints will be removed 6 days after surgery as per standard of care. No other procedures will be changed during the surgery.~B. No Doyle splints will be placed in the nostrils of the patient after septoplasty. All standart of care visits will remain the same."||||t
1301581|NCT03575676|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1301582|NCT03575663|||Case-Crossover||Prospective|||||||
1301583|NCT03575650|||Cohort||Prospective|||||||
1301584|NCT03575637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301585|NCT03575624||Single Group Assignment||Treatment||None (Open Label)||A single arm model.||||
1301586|NCT03575611||Single Group Assignment||Treatment||None (Open Label)||||||
1301587|NCT03575598||Single Group Assignment||Treatment||None (Open Label)||||||
1301588|NCT03575585|Randomized|Factorial Assignment||Treatment||None (Open Label)||This is a 2 x 2 nested factorial design clinical trial. Counselors were randomized to 1) Standard training [2 hours on using a BEST feedback report] or 2) Enhanced training [Standard + 8 hours on discussing sexual risk with patients + monthly coaching]. Patients of participating counselors completed the BEST assessment and were randomized to receive no feedback or a personalized BEST feedback report, and were followed up at 3-, and 6-months (patients). Counselors were assessed at baseline, post-training and 3-months.||||
1301589|NCT03575572||Single Group Assignment||Treatment||None (Open Label)||||||
1301590|NCT03575559|Randomized|Parallel Assignment||Prevention||Single|Friendship dyads are assigned to the 4 conditions without being informed that 4 conditions exist.||t|||
1301591|NCT03575546|||Cohort||Prospective|||||||
1301592|NCT03575533|||Cohort||Prospective|||||||
1301593|NCT03575520||Single Group Assignment||Treatment||None (Open Label)||||||
1301594|NCT03575507||Single Group Assignment||Treatment||None (Open Label)||||||
1301595|NCT03575494|||Case-Control||Prospective|||||||
1301596|NCT03575481|||Cohort||Prospective|||||||
1301597|NCT03575468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301598|NCT03575455|Randomized|Parallel Assignment||Treatment||Single||Randomized block design using age and sex to randomize into 3 injured groups (40%, 60%, CON) and matching for 3 healthy groups (40%, 60%, CON)||||t
1301599|NCT03575442||Single Group Assignment||Screening||None (Open Label)||||||
1301600|NCT03575429|Randomized|Sequential Assignment||Health Services Research||Single|The diagnosticians for all measures will be kept blind to group assignment to treatment arm.|This study uses a 2-stage sequential multiple assignment randomized trial (SMART) design to optimize a menu of interventions by comparing the order and dose that best meet the needs of families. In stage 1, families will be randomly assigned to one of two study arms for 3 months. Stage 2 interventions will be for another 3 months and will be adapted based on the primary tailoring variable. Early responders will continue the same intervention and slow responders will be re-randomized to an adapted intervention for the next 3 months. The adaptations in stage 2 for slow responders include continuing the treatment arm, adding the other treatment arm, or increasing the dose of the treatment arm.||||t
1301601|NCT03575416|||Cohort||Prospective|||||||
1301602|NCT03575403|Randomized|Factorial Assignment||Basic Science||Triple|||t|t||t
1301603|NCT03575390|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1301604|NCT03575377|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301605|NCT03575364|||Cohort||Prospective|||||||
1301606|NCT03575351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301607|NCT03575338|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will not know the technique|Randomized controlled trial||||t
1301608|NCT03575325||Single Group Assignment||Treatment||None (Open Label)||This is an open label, single arm, single center, phase 2 pilot study of Vyxeos induction & consolidation in relapsed and refractory ALL.||||
1301609|NCT03575312||Single Group Assignment||Basic Science||None (Open Label)||The subjects are exposed to 250 µg of enrofloxacin on three different dosing days that are separated by at least 7 days. On the first dosing day, enrofloxacin is administered via the dermal route. On the second dosing day, enrofloxacin is administered via inhalation of 5 mL solution in a concentration of 50 µg/mL by an ultrasonic nebulizer. On the third dosing day, enrofloxacin is administered orally as a 20 mL solution in a concentration of 12.5 µg/mL.||||
1301610|NCT03575299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301611|NCT03575286|||Case-Control||Cross-Sectional|||||||
1301612|NCT03575273|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||The investigators will recruit thirty individuals meeting criteria for opioid dependence of which 15 will be receiving MMT (O+MMT) and 15 will be on no opioid agonist therapy (O-MMT). The investigators will attempt to match the O-MMT group to the O+MMT group for clinical characteristics and smoking burden. Fifteen obese/overweight adults without history of opioid/substance use will be matched to the patient groups for age, gender, education, smoking and BMI.||||
1301613|NCT03575260|||Cohort||Retrospective|||||||
1301614|NCT03575247|||Cohort||Retrospective|||||||
1301615|NCT03575234|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301616|NCT03575221|||Cohort||Other|||||||
1301617|NCT03575208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301618|NCT03575195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301619|NCT03575182|Randomized|Parallel Assignment||Treatment||Single||||||t
1301620|NCT03575169|||Cohort||Prospective|||||||
1301621|NCT03575156|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1301622|NCT03575143|||Cohort||Cross-Sectional|||||||
1301623|NCT03575130|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1301624|NCT03575117|Randomized|Parallel Assignment||Prevention||Single|||t|||
1301625|NCT03575104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301631|NCT03575026|Randomized|Parallel Assignment||Treatment||Single||||||t
1301632|NCT03575013||Single Group Assignment||Treatment||None (Open Label)||||||
1301633|NCT03575000||Single Group Assignment||Treatment||None (Open Label)||||||
1301634|NCT03574987|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Randomised controlled trial with 3 arms. One arm is a typical diet (50% CHO, 20% SUG), one arm is low sugar (50% CHO, <5% SUG), one arm is low carbohydrate (<8% CHO, <5% SUG). Stratified by sex and physical activity level (PAL).||||
1301635|NCT03574974|Randomized|Parallel Assignment||Treatment||Double|Participants will be blind to group assignment (experimental feedback intervention or control feedback intervention). The outcome assessor will be blind to group assignment.|Participants will receive either an experimental feedback intervention or a control feedback intervention. Participants who receive the control feedback intervention will be offered to return to receive the experimental feedback intervention upon completion of the study.|t|||t
1301636|NCT03574961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301637|NCT03574948|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1301638|NCT03574935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301639|NCT03574922|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1301640|NCT03574909|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1301641|NCT03574896|||Cohort||Prospective|||||||
1301642|NCT03574883|Randomized|Crossover Assignment||Basic Science||Double|Study will be double-blind : neither participant nor the investigator will know which stimulation type (in-phase active, anti-phase active or sham) is on.|This study is composed of two independent sub-studies, one exploring the effects of tACS and the other the effects of tDCS, with different participants assigned to the two sub-studies. There will be 3 arms in tACS group and 2 arms in tDCS group. Among each sub-study, all participants will participate in all arms (hence the cross-over design).|t||t|
1301643|NCT03574870|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1301644|NCT03574857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301645|NCT03574844|Randomized|Parallel Assignment||Prevention||Quadruple||Randomized, double-blind, placebo-controlled, 3 parallel-arms, pilot clinical study|t|t|t|t
1301646|NCT03574831|||Cohort||Other|||||||
1301647|NCT03574818||Single Group Assignment||Treatment||None (Open Label)||Feasibility and Biomaker Study||||
1301648|NCT03574805|Randomized|Parallel Assignment||Treatment||Single|||t|||
1301649|NCT03574792|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1301650|NCT03574779||Single Group Assignment||Treatment||None (Open Label)||||||
1301651|NCT03574766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301652|NCT03574753||Single Group Assignment||Treatment||None (Open Label)||||||
1301653|NCT03574740|||Other||Retrospective|||||||
1301654|NCT03574727|||Cohort||Retrospective|||||||
1301655|NCT03574714|||Other||Other|||||||
1301656|NCT03574701|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The patients will be randomized into 3 groups using the sealed envelope method. Each patient will be his or her own control. There will be two possible scenarios resulting from randomization:~Group A: This study group will receive intranasal vitamin A at 10,000 I.U. per day and olfactory retraining using scented oils in addition to their standard of care.~Group B: This study group will receive Vitamin A in addition to their standard of care. They will not receive olfactory retraining.~Group C: This study group will receive only standard of care ."||||
1301657|NCT03574688||Single Group Assignment||Prevention||None (Open Label)||All participants of this pilot intervention study had the intervention of 1.5 Liters of increased daily water intake per day during 6 weeks.||||
1301658|NCT03574675|Randomized|Crossover Assignment||Prevention||Single|The allocated gas mixture will not be disclosed to the patient since he will breath trough a facemask during both interventions.|Including a baseline assessment and assessments under simulated altitude and normoxia|t|||
1301659|NCT03574662||Single Group Assignment||Basic Science||None (Open Label)||||||
1301660|NCT03574649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301661|NCT03574636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301662|NCT03574623|Randomized|Parallel Assignment||Treatment||Single||||||t
1301663|NCT03574610|||Cohort||Prospective|||||||
1301664|NCT03574597|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures||t|t|t|t
1301665|NCT03574584|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.|"Three (3) cohorts are planned. In each cohort subjects will be assigned to trial product. Subjects will be randomised in a 3:1 manner within cohorts to receive either:~Semaglutide and NNC0165-1562 once weekly (9 subjects per cohort)~Semaglutide and placebo once weekly (3 subjects per cohort)"|t|t|t|t
1301666|NCT03574571|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is an open-labeled, randomized, phase III study of docetaxel versus docetaxel in combination with radium-223 in subjects with mCRPC.||||
1301667|NCT03574558||Single Group Assignment||Treatment||None (Open Label)||||||
1301668|NCT03574545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301669|NCT03574532|||Cohort||Retrospective|||||||
1301670|NCT03574519|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1301671|NCT03574506|||Cohort||Retrospective|||||||
1301672|NCT03574493|||Cohort||Prospective|||||||
1301673|NCT03574480|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1301674|NCT03574467|||Case-Control||Retrospective|||||||
1301675|NCT03574454|Non-Randomized|Single Group Assignment||Diagnostic||Single|The assessors interpretation of disease status using WB-MRI scans will be fully blinded to the reference standard (i.e. the Expert Panel's interpretation of the same scan).|Cross-sectional diagnostic test accuracy design: development of a machine-based algorithm to augment expert classification of disease status and response to treatment in myeloma patients using retrospective interpretation of WB-MRI scans and disease-free (healthy volunteers) for comparison purposes.||||t
1301715|NCT03573934|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1301676|NCT03574441|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Patients were randomized using a random number table to be allocated to one of three groups with sealed envelopes, based on the type of dressing to be used to secure the epidural catheter after its insertion:~TegadermTM plus catheter support pad.~Dressing with TegadermTM plus Steri-StripTM bands~Dressing with TegadermTM only"||||
1301677|NCT03574428|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1301678|NCT03574415|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1301679|NCT03574402|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301680|NCT03574389|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301681|NCT03574376|Randomized|Parallel Assignment||Treatment||None (Open Label)|No participants are blinded to treatment arms. Patients and investigators are aware of which patients are assigned to each treatment group.|"This is a two arm, randomized trial. Patients suffering multiple traumatic rib fractures will be offered CEA or LBINB. As the current standard of care, CEA will serve as the control, and outcomes measured in patients receiving LBINB will be statistically evaluated relative to the CEA control group.~All patients will receive standardized NSAID and opioid analgesia protocol for break through pain, as well as standardized routines for pulmonary hygiene and physiotherapy."||||
1301682|NCT03574363|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1301683|NCT03574350|Randomized|Parallel Assignment||Supportive Care||Double|The nurses who did anthropometrics measures didn't know the interventions assigned to each participant of the study, because the night shift was in charge of taking the data at 7:00 am in the mornings and the interventions were delivered in the morning shifts from 8:00 am until 5:00 pm. No interventions were delivered in the night.|Two interventions groups of 33 each, participated in the study. The first group received Kinesthetic Stimulation in Kangaroo Position (KSKP) and the second group received Kinesthetic Stimulation In incubator (KSI ), both of the interventions were delivered by parents during the period of hospitalization and at home when the infant was discharged from Hospital until 40 weeks of gestational age.|||t|t
1301684|NCT03574337|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1301685|NCT03574324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301686|NCT03574311|Randomized|Parallel Assignment||Prevention||Triple|Double blinding, study drug administration by separate staff blinded from participant and investigators|Randomized controlled 1:1|t||t|t
1301687|NCT03574298|||Cohort||Prospective|||||||
1301688|NCT03574285|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1301689|NCT03574272||Single Group Assignment||Other||None (Open Label)||||||
1301690|NCT03574259||||||||||||
1301691|NCT03574246|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1301692|NCT03574233|||Cohort||Retrospective|||||||
1301693|NCT03574220||Single Group Assignment||Treatment||None (Open Label)||||||
1301694|NCT03574207|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1301695|NCT03574194||Single Group Assignment||Treatment||None (Open Label)||Six weeks methionine-restricted diet (MRD) with 3-5 fraction SBRT (Stereotactic Body Radiation Therapy) to the lung tumor||||
1301696|NCT03574181|||Other||Prospective|||||||
1301697|NCT03574168||Single Group Assignment||Treatment||None (Open Label)||||||
1301698|NCT03574155|Randomized|Crossover Assignment||Treatment||Single||"Group control Pre-operative Orientation Routine Application of the questionnaire (ESAS) and (HADS)~Experimental Group Pre-operative Counseling and Education Application of the questionnaire (ESAS) and (HADS)"|||t|
1301699|NCT03574142||Single Group Assignment||Basic Science||None (Open Label)|Open-label Study|Single group||||
1301700|NCT03574129|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||An adolescent transition package composed of a disclosure booklet and transition tool||||
1301701|NCT03574116|||Other||Retrospective|||||||
1301702|NCT03574103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301703|NCT03574090|Randomized|Parallel Assignment||Prevention||Triple|In the operating room area we will keep a notebook with the random number sheet and a box with the numbered envelopes and containing the treatment to follow: physiological saline alone or physiological saline with antibiotic. At the end of the surgery and before closing the abdominal wall, it is definitively informed to the nurse whether or not to recruit them, a case number is assigned chronologically and in the random number sheet corresponds to an envelope containing one of the two treatments. Dilution is performed with 10cc of physiological saline solution with or without antibiotic in the outside of the operating room and then it is incorporated into the 500cc bottle of physiological saline once opened in a sterile way. We used according to the usual protocol.||t|t|t|
1301704|NCT03574077|Randomized|Parallel Assignment||Other||Single|All outcome assessors will be blinded to the group allocation, this RCT will be single-blinded.|"This pilot randomized controlled trial (RCT) has 2 arms: intervention group A (Group A), and control group (Group B). The participants will be randomly assigned to one of the 2 groups. The investigators will randomly select 12 smoking hotspots (SH) from different locations in Hong Kong Island, Kowloon and New Territories for recruitment (4 in each region). A total of 24 sessions of recruitment activities will be organized to recruit 282 participants. The onsite recruitment and counselling will be conducted by trained SC ambassadors. SC ambassadors will approach smokers using a foot-in- the-door technique. Smoking status will be validated using exhaled carbon monoxide (CO) and eligibility will be checked by a short questionnaire."||||t
1301705|NCT03574064|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1301706|NCT03574051||Single Group Assignment||Treatment||None (Open Label)||||||
1301707|NCT03574038|Randomized|Sequential Assignment||Treatment||Triple||Traditional 3+3 (rule-based, modified Fibonacci) dose escalation design|t|t||t
1301708|NCT03574025|||Family-Based||Prospective|||||||
1301709|NCT03574012|Randomized|Parallel Assignment||Prevention||Double||||t||t
1301710|NCT03573999|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1301711|NCT03573986||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301712|NCT03573973|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Natural experiment with prospective matched controlled cluster design. The setting is a UK discount supermarket chain.||||
1301713|NCT03573960||Single Group Assignment||Treatment||None (Open Label)||||||
1301714|NCT03573947||Single Group Assignment||Treatment||None (Open Label)||||||
1301716|NCT03573921|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301717|NCT03573908|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301718|NCT03573895|Randomized|Parallel Assignment||Treatment||Single||||||t
1301719|NCT03573882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301720|NCT03573869|Randomized|Parallel Assignment||Treatment||Single||||||t
1301721|NCT03573856|Randomized|Parallel Assignment||Prevention||Single|||||t|
1301722|NCT03573843|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1301723|NCT03573830|Randomized|Parallel Assignment||Prevention||Triple|"PARTICIPANT MASKING: Participants will be told the purpose of the study is to evaluate parents' reactions to two different information materials about booster seats and seatbelts.~INVESTIGATOR MASKING: The study will be conducted entirely online using a online research platform, so allocation will be masked to all investigators.~OUTCOMES ASSESSOR MASKING: Outcome evaluation will be conducted online using an online survey tool, so allocation will be masked to outcome assessors.~STATISTICAL ANALYSIS: Allocation in the online survey will be coded using random numbers unknown to the person conducting statistical analysis."||t||t|t
1301724|NCT03573817|Randomized|Parallel Assignment||Treatment||Quadruple|Study team|This is a randomized, double-blind, placebo-controlled, parallel-group study. Each subject will receive treatment daily for a total of 42 days. One group will receive placebo and formoterol and one group will receive revefenacin and formoterol.|t|t|t|t
1301725|NCT03573804||Single Group Assignment||Other||None (Open Label)||||||
1301726|NCT03573791|||Case-Control||Prospective|||||||
1301727|NCT03573778|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Controlled trial comparing active treatment to usual care||||
1301728|NCT03573765|||Cohort||Retrospective|||||||
1301729|NCT03573752||Single Group Assignment||Other||None (Open Label)||||||
1301730|NCT03573739|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This multicentre randomised controlled open trial compares two parallel groups of patients receiving mechanical ventilation and vasoactive amine therapy and given early nutritional support according to one of two strategies: early calorie/protein restriction (6 kcal/kg/d/0.2-0.4 g/kg/d: Low group) or standard calorie/protein targets (25 kcal/kg/d/1.0-1.3g/kg/d: Standard group) at the acute phase of ICU management (D0-D7).||||
1301731|NCT03573726||Single Group Assignment||Other||None (Open Label)||||||
1301732|NCT03573713|Randomized|Parallel Assignment||Prevention||Single||IPT-G Promoters will screen all women for depression who are pregnant or will have a child who will be 18m old or younger by 2 May 2018 in each of the 34 Care Group Service Areas chosen for the study. If informed consent is obtained and the women's scores on the PHQ-9 indicate mild to severe depression, they will be put into groups of approx. 8 women for IPT-G. The 34 Care Group Service Areas (CGSAs) will then be randomized into 2 arms (IPT-G and control). Women in the CGSAs in the IPT-G arm who screen positive for depression will receive IPT-G for 12 weeks. Following IPT-G treatment, all women who are pregnant or that have a child born on or after 3 August 2016 in the project area will be provided with psychoeducation through the Care Group structure. For the assessments conducted after the baseline, trained external (non-staff) enumerators will be used to assess for depression and other things, and they will be blind to which group the mothers are in (treatment or control).||||t
1301733|NCT03573700||Single Group Assignment||Treatment||None (Open Label)||||||
1301734|NCT03573687|Randomized|Crossover Assignment||Basic Science||Double|The supplements will be made by a third party person and premixed, taste-matched, and provided in opaque shaker bottles.|Randomized, crossover, double-blind, acute study with two conditions: nighttime PRO consumption (NP) and daytime PRO consumption (DP).|t||t|
1301735|NCT03573674|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Cluster randomization with stratification allocated groups selected by participating organizations to treatment and control groups. Primary stratification was by the organization. Within-organization stratification took into account the size, the type of work tasks and the response rate in the first survey of cluster. Participating organizations entered all together to be defined number of clusters, each with individuals for the intervention and active control groups (N=588 individuals). The intervention (and active control) receive different types of workshops, individual tasks and team tasks. Additional information is available from non-randomized passive control group (N=289 individuals).~Participating organizations were recruited by informing about the study. Participating units included knowledge workers, whose work tasks are cognitively rather than physically demanding."||||
1301736|NCT03573661||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1301737|NCT03573648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301738|NCT03573635||Single Group Assignment||Other||None (Open Label)||||||
1301739|NCT03573622|Randomized|Crossover Assignment||Treatment||None (Open Label)||open label, single-dose, randomized, two-period, two-treatment, two-sequence, crossover, comparative bioavailability study||||
1301740|NCT03573609|Randomized|Parallel Assignment||Other||Triple||||t|t|t
1301741|NCT03573596||Single Group Assignment||Treatment||None (Open Label)||Phase 2, multicenter study, prospective, open label, uncontrolled.||||
1301742|NCT03573583|Randomized|Parallel Assignment||Basic Science||Single|"To ensure concealment of the allocation, the randomization procedures will be performed by an investigator who are not involved in the assessments.~The team assessing study outcomes will be masked to intervention assignment."|The pilot study will be single-blind, parallel group, randomized controlled trial of 24 moderate to low functioning participants randomized in a 1:1 allocation ratio to a high-intensity Resistance Training group (RT) or a Successful Aging Health Education comparator group (HE) for 14 weeks.||||t
1301743|NCT03573570|Randomized|Parallel Assignment||Treatment||None (Open Label)||This project (implementation and accompanying evaluation) will be conducted as a cluster-randomized controlled trial, with baseline and follow-up surveys conducted 12 months apart in the same individuals. In the interim, 110 Treatment Fair Price Shops (FPS) will be assigned randomly to receive rice fortified with iron and other micronutrients, and another 110 Control FPS will be assigned randomly to conventional Public Distribution System (PDS) rice. The control arm therefore represents the status quo and serves as a control group against which any improvements observed in the treatment group will be gauged.||||
1301744|NCT03573557|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1301745|NCT03573544|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1301747|NCT03573518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301748|NCT03573505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301749|NCT03573492|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1301750|NCT03573479|||Cohort||Prospective|||||||
1301751|NCT03573466||Single Group Assignment||Basic Science||None (Open Label)||||||
1301752|NCT03573453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301753|NCT03573440|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1301754|NCT03573427|||Cohort||Prospective|||||||
1301755|NCT03573414||Single Group Assignment||Basic Science||None (Open Label)||||||
1301756|NCT03573401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301757|NCT03573388|||Cohort||Retrospective|||||||
1301758|NCT03573375||Single Group Assignment||Supportive Care||None (Open Label)||||||
1301759|NCT03573362|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1301760|NCT03573349||Single Group Assignment||Treatment||None (Open Label)||||||
1301761|NCT03573336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301762|NCT03573323|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301763|NCT03573310||Sequential Assignment||Treatment||None (Open Label)||||||
1301764|NCT03573297|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301765|NCT03573284||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301766|NCT03573271||Single Group Assignment||Treatment||None (Open Label)||||||
1301767|NCT03573258|Randomized|Crossover Assignment||Supportive Care||Single|single-blinded|Randomized, single-blinded cross-over trial in 24 morbidly obese human subjects undergoing RYGB.|t|||
1301768|NCT03573245|||Cohort||Prospective|||||||
1301769|NCT03573232|||Other||Cross-Sectional|||||||
1301770|NCT03573219||Single Group Assignment||Basic Science||None (Open Label)||The SWD applicators will be placed in the desired position, around the forearm for the upper limb experiments, or below the knee for the lower limb experiments. The distance between applicators will be adjusted until the desired pain sensation is obtained according to the subjective criterion of the volunteer. This sensation should be mild or moderate pain, but tolerable for the duration of the application. Once the first application is completed, the volunteer will be allowed to rest for a period of 10 minutes, and the assessment will be repeated to test for possible after effects. After it is verified that the muscles recovered their normal temperature and the pain sensation has completely disappeared, the variables related to changes in motor responses under rest conditions will be recorded. Then SWD will be applied a second time using the same parameters as in the first application. Once the registration is complete, the experiment will be finished.||||
1301771|NCT03573206||Single Group Assignment||Treatment||None (Open Label)||All subjects will receive the study device for femoral venotomy closure.||||
1301772|NCT03573193|Randomized|Parallel Assignment||Prevention||Single|Blinded participants|"Randomized clinical trial.~• Unicenter, single blinded, with equal randomization, active controlled, parallel group study"|t|||
1301773|NCT03573180|||Case-Only||Cross-Sectional|||||||
1301774|NCT03573167|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1301775|NCT03573154|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1301776|NCT03573141|||Cohort||Prospective|||||||
1301777|NCT03573128|Randomized|Parallel Assignment||Treatment||Single||||||t
1301778|NCT03573115||Single Group Assignment||Basic Science||None (Open Label)||||||
1301779|NCT03573102|Randomized|Parallel Assignment||Treatment||Single||||||t
1301780|NCT03573089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301781|NCT03573076|Randomized|Parallel Assignment||Treatment||Single||||||t
1301782|NCT03573063||Single Group Assignment||Basic Science||None (Open Label)||Clinical study with biological sampling in healthy young women being nutrionally restricted (using encoded data)||||
1301783|NCT03573050|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1301784|NCT03573037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301785|NCT03573024||Single Group Assignment||Treatment||None (Open Label)||||||
1301786|NCT03573011|Randomized|Parallel Assignment||Diagnostic||Triple|"Original phase 2 trial (44 subjects)~The assigned [18F]PSMA-11 dosing group will be blind to the recruiting physicians, the patient the staff member(s) while planning the [18F]PSMA-11 scanday of the patient, and the nuclear medicine physicians interpreting the images.~Next to the clinical trial coordinators, also the staff members responsible for the preparation of the individual [18F]PSMA-11 dose and the IV injection of this dose are aware of the dose group (2.0 ± 0.2 or 4.0 ± 0.4 MBq/kg body weight), which means that they are NOT blinded. However, these staff members do not carry out any further study specific handlings.~Extension phase 2 trial (22 subjects):~masking is not applicable for this part of the phase 2 trial."|"Original phase 2 (44 subjects) Concerning the dose of [18F]PSMA-11, half of the patients in the phase 2 study will be injected with 2.0 ± 0.2 MBq/kg bodyweight. The other half will be injected with 4.0 ± 0.4 MBq/kg body weight. Randomization of patients to one of these two groups will be performed using a block randomization design with block sizes of two, four, and six.~Extension phase 2 (22 subjects):~For this part of the phase 2 study, all patients will be injected with 2.0 ± 0.2 MBq/kg bodyweight [18F]PSMA-11. No Randomisation or masking is applicable for this group of 22 subjects."|t||t|t
1301787|NCT03572998||Single Group Assignment||Basic Science||None (Open Label)||Case-control. Patients function as their own control since the treated arm will be compared with the non-treated arm.||||
1301788|NCT03572985|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1301789|NCT03572972|||Cohort||Retrospective|||||||
1301790|NCT03572959|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1301791|NCT03572946|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1301792|NCT03572933|Randomized|Parallel Assignment||Treatment||Quadruple||The double-blind phase will randomize subjects to adjunctive ganaxolone or placebo at a 1:1 ratio to standard of care|t|t|t|t
1301793|NCT03572920|||Case-Only||Prospective|||||||
1301794|NCT03572907|||Cohort||Prospective|||||||
1301795|NCT03572894|||Cohort||Prospective|||||||
1301796|NCT03572881|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1301797|NCT03572868|||Cohort||Prospective|||||||
1301798|NCT03572855||Single Group Assignment||Treatment||None (Open Label)||||||
1301799|NCT03572842||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301800|NCT03572829||Single Group Assignment||Treatment||None (Open Label)||||||
1301801|NCT03572816|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study design is a parallel group, randomized controlled trial with open allocation including all patients with calcaneus fractures independent of kind of initial therapy.||||
1301802|NCT03572803|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1301803|NCT03572790|Randomized|Parallel Assignment||Basic Science||Triple||Participants will be randomly allocated to one of two groups (prucalopride or placebo). Participants in the prucalopride group will receive 1mg once daily for seven days. Participants in the placebo group will receive a lactose placebo once daily for seven days. Note that the study is not assessing the safety or efficacy of prucalopride, rather it is using prucalopride to assess the behavioural and neural effects of 5-HT4 partial agonists.|t||t|t
1301804|NCT03572777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301805|NCT03572764||Single Group Assignment||Treatment||None (Open Label)||||||
1301806|NCT03572751|||Case-Control||Prospective|||||||
1301807|NCT03572738|||Case-Only||Prospective|||||||
1301808|NCT03572725|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1301809|NCT03572712|||Case-Only||Prospective|||||||
1301810|NCT03572699|||Case-Only||Cross-Sectional|||||||
1301811|NCT03572686|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1301812|NCT03572673|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1301813|NCT03572660||Single Group Assignment||Treatment||None (Open Label)||Single arm intervention study||||
1301814|NCT03572647|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1301815|NCT03572634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Adult patients with CLL/SLL who:~are intolerant to, or have had progressive disease on B-cell receptor antagonists, BCL-2 antagonists or other investigational treatments for CLL/SLL (Group 1-TP 0903 monotherapy); or have progression of disease on ibrutinib, yet the treating provider considers continuation of ibrutinib therapy to be in the best interest of the patient (Group 2-TP-0903 and ibrutinib combination therapy)"||||
1301816|NCT03572621|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1301817|NCT03572608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301818|NCT03572595|||Other||Prospective|||||||
1301819|NCT03572582||Single Group Assignment||Treatment||None (Open Label)||||||
1301820|NCT03572569|||Family-Based||Prospective|||||||
1301821|NCT03572556|||Cohort||Prospective|||||||
1301822|NCT03572543|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1301823|NCT03572530|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301824|NCT03572517|Randomized|Parallel Assignment||Diagnostic||Single||"Patients will be allocated sequentially in 2 groups. Sequential allocation will be used in order to control age as a possible confounding factor for the outcome of interest. The randomization will be performed through free software R version 3.4.~Balanced general anesthesia.~Balanced general anesthesia associated with subarachnoid block with 0.5% heavy bupivacaine (3ml).~All patients will receive morphine 50 mcg via the spinal route."|t|||
1301825|NCT03572504|||Cohort||Prospective|||||||
1301826|NCT03572491||Single Group Assignment||Prevention||None (Open Label)||"The main group - group 1 = 1000 volunteers will be vaccinated with the vaccine Allan-toxin split inactivated against seasonal influenza vaccine.~In the main group, a subgroup will be singled out - a group of 1a = 200 volunteers who will be examined for safety, immunogenicity and immunity.~The observation group is a group of 2 = 1000 people who, when confirming the diagnosis of influenza, will compare the incidence with the main group."||||
1301827|NCT03572478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301828|NCT03572465|||Case-Only||Cross-Sectional|||||||
1301829|NCT03572452|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1301830|NCT03572439|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301831|NCT03572426|||Cohort||Cross-Sectional|||||||
1301832|NCT03572413|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1301833|NCT03572400||Single Group Assignment||Treatment||None (Open Label)||||||
1301834|NCT03572387|Randomized|Crossover Assignment||Treatment||None (Open Label)||Subjects will be assigned in a 1:1 randomization to either the '5-AZA+ATRA' group or the 'no therapy' group. Patients in the '5-AZA + ATRA' group will receive treatment on a 28-day cycle, in the absence of prohibitive toxicities, for 3 cycles. Patients will initially be observed for 3 cycles under either no therapy or combination therapy, before crossing over to receive the opposite treatment for another 3 cycles in the absence of prohibitive toxicities.||||
1301835|NCT03572374|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1301836|NCT03572361||Single Group Assignment||Treatment||None (Open Label)|No masking|Single arm, open label Phase II study in volunteers with breast cancer receiving daily dose of one pill of vaccine V3-MOMMO||||
1301837|NCT03572348|Randomized|Parallel Assignment||Treatment||Single|Patients will be randomized using software in a 1:1 ratio in either the vessel-sparing group or the transecting group. Randomisation will be stratified per participating center and single blinded; double blindation is impossible as the surgeon has to know which technique to perform.|Prospective, interventional, multicentric, single-blinded, randomized, controlled, non-inferiority, phase II trial|t|||
1301838|NCT03572335|||Cohort||Prospective|||||||
1301839|NCT03572322|||Other||Other|||||||
1301840|NCT03572309|||Cohort||Prospective|||||||
1301841|NCT03572296|Randomized|Crossover Assignment||Prevention||Double||Cross-over design. Each participant receives placebo plus 2 treatments.|t||t|
1301842|NCT03572283||Single Group Assignment||Other||None (Open Label)||Phase 0 study to assess the impact of bethanechol on pancreatic cancer biomarkers||||
1301843|NCT03572270|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|No masking|||||
1301844|NCT03572257|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1301973|NCT03570580|||Cohort||Prospective|||||||
1301845|NCT03572244|Randomized|Parallel Assignment||Treatment||None (Open Label)||6 subjects will be randomized to Laser-Lok placement, and 6 subjects will be randomized to machined healing abutment placement. The assignment will be a 1:1 scheme, with the study coordinator randomly opening pre-assigned envelopes to determine implant.||||
1301846|NCT03572231|||Cohort||Prospective|||||||
1301847|NCT03572218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301848|NCT03572205|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1301849|NCT03572192|||Other||Prospective|||||||
1301850|NCT03572179|Randomized|Parallel Assignment||Other||Single|Participants Patients can detect the transfer tray so blinding is not possible Operator The main operator is responsible for the bonding so the blinding is not possible Assessor The assessor (different from main operator will carry out the measurement blindly|all patient will receive a modified indirect technique for bonding fixed mandibular retainer and the key of modification is the fabrication of 3D printed digital positioning tray for placement of retainer with holes for composite pads for its direct application using 3 shape Ortho analyser Software ® instead of conventional indirect retainer fabrication method||||t
1301851|NCT03572166|Randomized|Crossover Assignment||Diagnostic||Single||Observational randomized cross-over diagnostic international multicenter study||||t
1301852|NCT03572153|Randomized|Parallel Assignment||Supportive Care||Double||Participants will be randomized and either be assigned to the self-hypnosis group or a self-administered white noise hypnosis group.|||t|t
1301853|NCT03572140|||Cohort||Prospective|||||||
1301854|NCT03572127|Randomized|Parallel Assignment||Basic Science||None (Open Label)||One group will consume a non-animal derived high protein diet, whilst the other group will consume a more traditional animal protein based diet.||||
1301855|NCT03572114|||Case-Control||Cross-Sectional|||||||
1301856|NCT03572101|||Cohort||Prospective|||||||
1301857|NCT03572088|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301858|NCT03572075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301859|NCT03572062|Randomized|Sequential Assignment||Prevention||Quadruple|Observer blind|Parallel|t|t|t|t
1301860|NCT03572049|Randomized|Parallel Assignment||Treatment||Single|||t|||
1301861|NCT03572036|||Cohort||Retrospective|||||||
1301862|NCT03572023||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301863|NCT03572010|Randomized|Crossover Assignment||Treatment||Single|||t|||
1301864|NCT03571997|||Case-Only||Retrospective|||||||
1301865|NCT03571984|Randomized|Parallel Assignment||Treatment||Single||||||t
1301866|NCT03571971|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1301867|NCT03571958|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301868|NCT03571945|Randomized|Parallel Assignment||Prevention||Double|The attending anaesthesiologist will not be blinded to the method of administering GA (BIS or ETAG guided) and recovery immediately after extubation inside the OR. However, the postoperative evaluation of intraoperative awareness and patient recovery profile will be evaluated by an independent assessor blinded to the technique of GA.|"2000- patients aged 18-65 years scheduled for elective surgery under general anaesthesia will be randomly allocated to one of the following two groups:~Group I [BIS Guided Group, n=1000]: GA will be monitored and controlled with Bi-spectral index (BIS).~Group II [ETAG Guided Group, n=1000]: GA will be monitored and controlled with end-tidal anaesthesia gas concentration (ETAG)."|t|||t
1301869|NCT03571932|||Other||Other|||||||
1301870|NCT03571919|Randomized|Parallel Assignment||Treatment||Triple|Immediate care providers (nurses, primary teams) will be blinded; however, lidocaine levels will be monitored by the acute pain service, a consulting team providing direct care to the patient, who will not be blinded.||t|t|t|
1301871|NCT03571906|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301872|NCT03571893|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor will be blinded to participant treatment condition.|Participants will be randomly assigned to one of two conditions, with assessments occurring prior to randomization, at 3 months and 12 months. Participants will be referred to either Weight Watchers or provided DIY resources. Study staff will not deliver intervention.||||t
1301873|NCT03571880|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1301874|NCT03571867|||Other||Prospective|||||||
1301875|NCT03571854|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1301876|NCT03571841||Single Group Assignment||Supportive Care||None (Open Label)||||||
1301877|NCT03571828|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1301878|NCT03571815|Randomized|Parallel Assignment||Prevention||None (Open Label)|interventional group-fluoride varnish application. control group-water|||||
1301879|NCT03571802||Single Group Assignment||Treatment||None (Open Label)||Pharmacokinetic parameters of simvastatin before and after laparoscopic sleeve gastrectomy will be compared in 10 patients. Each patient will serve as their own control for comparison.||||
1301880|NCT03571789||Single Group Assignment||Prevention||None (Open Label)||Multicenter, prospective, non-randomized, open-label, first-in-human (FIH) study||||
1301881|NCT03571776|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, National, assignment 1: 1, stratified by age, previous oophorectomy and uni- or bilateral ovarian involvement.||||
1301882|NCT03571763|||Cohort||Prospective|||||||
1301883|NCT03571750|Randomized|Parallel Assignment||Prevention||None (Open Label)||Approximately 110 participants will be randomly assigned to one of two conditions (1) BSA or (2) HET Control.||||
1301884|NCT03571737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301885|NCT03571724|Randomized|Parallel Assignment||Other||None (Open Label)||Longitudinal ambulatory switching study||||
1301886|NCT03571711|||Cohort||Prospective|||||||
1301887|NCT03571698|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1301927|NCT03571178||Single Group Assignment||Treatment||None (Open Label)||||||
1301928|NCT03571165||Single Group Assignment||Supportive Care||None (Open Label)||||||
1301974|NCT03570567||Single Group Assignment||Treatment||None (Open Label)||||||
1301975|NCT03570554|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1301976|NCT03570541|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301888|NCT03571685|Non-Randomized|Single Group Assignment||Other||None (Open Label)||"This is an open label, quasi-experimental study of adult patients with Schizophrenia or Schizoaffective Disorder within five years of diagnosis who are receiving SEEC intervention in phases. Approximately 50 patients will be enrolled in the study. Caregivers who would like to participate will also be included. Patients will be followed prospectively over the study period up to 24months.~It is hypothesized that patients enrolled in SEEC will have fewer/lower rate of relapses than patients in usual care. The primary endpoint for this study will be the difference in high intensity resource utilization between SEEC patients and patients who receive usual care. Health insurance claims data will capture usual care."||||
1301889|NCT03571672||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301890|NCT03571659|||Other||Retrospective|||||||
1301891|NCT03571646|Randomized|Parallel Assignment||Screening||Single|During the study Phase I, the alarms of both devices will be silenced and the screen information blinded, as is the current clinical practice. During the study Phase II, the screen information will be available and the nursing staff will be instructed to respond to both devices' alarms based on a pre-defined hospital protocol.|"The occurrence of at least one of the following RC markers will be considered as primary endpoint for patients monitored by Capnostream 20p during both study Phases: (1) SpO2 ≤ 90% for ≥ 3 minutes.(2) RR ≤ 8 or ≥ 22 bpm for ≥ 3 minutes. (3) etCO2 ≤ 15 or ≥ 60 mmHg for ≥ 3 minutes. (4) Apnea episode lasting > 30 seconds.~The occurrence of at least one of the following RC markers will be considered as primary endpoint for patients monitored by PM1000N-RR during both study Phases:~(1) SpO2 ≤ 90% for ≥ 3 minutes. (2) RR ≤ 8 or ≥ 22 bpm for ≥ 3 minutes."||t||
1301892|NCT03571633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301893|NCT03571620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301894|NCT03571607||Single Group Assignment||Prevention||None (Open Label)||||||
1301895|NCT03571594|Randomized|Sequential Assignment||Treatment||Quadruple|Double-blind (Parts A, B &C). Open-label (Part D only)||t|t|t|t
1301896|NCT03571581||Single Group Assignment||Treatment||None (Open Label)||||||
1301897|NCT03571568||Single Group Assignment||Treatment||None (Open Label)||Phase 1/2a, dose escalation, consecutive-cohort, open-label study trial of BI-1206 in combination with rituximab||||
1301898|NCT03571555|||Cohort||Prospective|||||||
1301899|NCT03571542||Single Group Assignment||Other||None (Open Label)||||||
1301900|NCT03571529|Randomized|Parallel Assignment||Treatment||Single||||||t
1301901|NCT03571516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301902|NCT03571503|||Case-Only||Prospective|||||||
1301903|NCT03571490|Randomized|Single Group Assignment||Treatment||Triple|Double blind|Double blind placebo Controlled Trial|t|t|t|
1301904|NCT03571477|||Cohort||Prospective|||||||
1301905|NCT03571464|Randomized|Crossover Assignment||Treatment||None (Open Label)||All participants were requested to complete web-based assessment, with questionnaires relating to maladaptive beliefs, mood and OC symptoms at baseline (T1), 15 days following baseline (T2) and 30 days following baseline (T3). Participants in Immediate use GGRO group started using the app at baseline and continued using the app for 15 consecutive days. They were then requested to stop using the app until T3. Participants in the Delayed use GGRO group were requested to wait for 15 days and only then start using the app (cross-over) for 15 consecutive days.||||
1301906|NCT03571451|||Cohort||Prospective|||||||
1301907|NCT03571438|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301908|NCT03571425|Randomized|Parallel Assignment||Basic Science||None (Open Label)|Oral conditions are double blinded to participant and investigator, but enteral vs oral feeding is not blinded|||||
1301909|NCT03571412|Randomized|Parallel Assignment||Treatment||Single||The purpose to this study is to valuate the clinical effects of 5Hz rTMS over Left Dorsolateral Prefrontal Cortex and Dorsomedial Prefrontal Cortex|t|||
1301910|NCT03571399|||Cohort||Cross-Sectional|||||||
1301911|NCT03571386|||Cohort||Prospective|||||||
1301912|NCT03571373|||Cohort||Prospective|||||||
1301913|NCT03571360||Single Group Assignment||Treatment||None (Open Label)||||||
1301914|NCT03571347|Randomized|Parallel Assignment||Prevention||Single|Participants, facilitators, and research staff involved in the screening and baseline assessment will not be blind to the interventions provided during the trial. Outcomes assessors will be kept blind to the study conditions.|RE-DEFINE is a prospective, multicentre, randomized, parallel-group trial that will follow study participants over a period of 12-months. Asylum seekers and refugees with psychological distress, but without a mental disorder according to the MINI International Neuropsychiatric Interview (M.I.N.I.) for DSM-V and ICD-10, will be randomly assigned to the Self Help Plus intervention or to enhanced treatment as usual (ETAU).||||t
1301915|NCT03571334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301916|NCT03571321||Sequential Assignment||Treatment||None (Open Label)||||||
1301917|NCT03571308||Single Group Assignment||Treatment||None (Open Label)|"A multicentre open-label non-randomised phase Ib/II two stage trial. Stage 1 - dose escalation will proceed until a maximum tolerated dose (MTD) is defined or the maximal administered dose (MAD) is determined in order to define the recommended Phase II dose (RP2D). 6 - 24 patients. Stage 2 - expansion to gain additional information on safety and efficacy at the RP2D from a total of 15 patients recruited.~Patients will receive conventionally dosed R-CHOP chemotherapy for 6 cycles with acalabrutinib introduced on cycle 2 onwards, at a dosage according to cohort number. This will allow for both clarity in the toxicity profile of the combination and also assess the impact of acalabrutinib on ADCC.~patients who do not complete six cycles of treatment for reasons other than toxicity will be replaced."|||||
1301918|NCT03571295|Randomized|Parallel Assignment||Basic Science||Single||||t||
1301919|NCT03571282||Single Group Assignment||Treatment||None (Open Label)||||||
1301920|NCT03571269|||Cohort||Prospective|||||||
1301921|NCT03571256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301922|NCT03571243|||Case-Only||Cross-Sectional|||||||
1301923|NCT03571230|Randomized|Parallel Assignment||Treatment||Double||Parallel Assignment|||t|t
1301924|NCT03571217|||Cohort||Prospective|||||||
1301925|NCT03571204|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1301926|NCT03571191||Single Group Assignment||Treatment||None (Open Label)||||||
1573343|NCT00001531||||||||||||
1301929|NCT03571152||Single Group Assignment||Other||None (Open Label)|No masking.|Pre-experimental study design The level of practice and knowledge of the caregiver will be evaluated according to the video(s) corresponding to the session. Patient participation is expected for the evaluation of the caregiver's level of practice. After thirty minutes of use of the video, the level of practice and knowledge of the caregiver will be evaluated again for the same video. In each session this methodology will continue until the eighth video. At the end of all the videos, the level of satisfaction of the caregivers in relation to the videos will be evaluated.||||
1301930|NCT03571139|||Cohort||Prospective|||||||
1301931|NCT03571126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301932|NCT03571113|||Cohort||Prospective|||||||
1301933|NCT03571100|Randomized|Parallel Assignment||Prevention||Single|The participant will be masked to which drug they receive, the investigator performing the analysis will also be masked|Randomized prospective trial|t|||
1301934|NCT03571087|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1301935|NCT03571074|||Cohort||Retrospective|||||||
1301936|NCT03571061|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1301937|NCT03571048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301938|NCT03571035||Single Group Assignment||Diagnostic||None (Open Label)||||||
1301939|NCT03571022|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1301940|NCT03571009|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||The patients were supposed to complete three visits (baseline, one month, and three months). Patients in the PAAS group were provided with a wearable device (Painmeter, LST, Seoul, Korea) and smartphone application (DrKooB-PAAS, iKooB Inc. Seoul, South Korea), while the control group was provided conventional treatment without using the system. After screening, patients were randomly assigned to a group with an opaque envelope that contained the written randomization result. After completing the three months of the study, patients in the control group were then allocated to the PAAS group and underwent three additional months of study.||||
1301941|NCT03570996|Randomized|Sequential Assignment||Treatment||None (Open Label)||Randomization into either transversus abdominis plane catheter (TAP) or epidural for patients undergoing esophagectomy||||
1301942|NCT03570983|Randomized|Parallel Assignment||Treatment||Single|||||t|
1301943|NCT03570970|Randomized|Parallel Assignment||Treatment||None (Open Label)||250 mg group is performed firstly. After completion of observation and confirming that the drug can be safely tolerated, study on 500 mg group is then performed. After completion of observation and confirming that the drug can be safely tolerated, study on 1000 mg group is then performed||||
1301944|NCT03570957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1301945|NCT03570944|||Cohort||Prospective|||||||
1301946|NCT03570931||Single Group Assignment||Treatment||None (Open Label)|Open Label|Single arm open-label study||||
1301947|NCT03570918||Single Group Assignment||Treatment||None (Open Label)||Open-label dose-escalation study||||
1301948|NCT03570905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301949|NCT03570892|Randomized|Parallel Assignment||Treatment||Single||Randomized, Open-Label||||t
1301950|NCT03570879|||Case-Control||Retrospective|||||||
1301951|NCT03570866|||Cohort||Prospective|||||||
1301952|NCT03570853|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1301953|NCT03570840|||Cohort||Cross-Sectional|||||||
1301954|NCT03570827|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301955|NCT03570814|Randomized|Parallel Assignment||Treatment||None (Open Label)||Cluster randomised trial. Approximately 40 clusters per study arm||||
1301956|NCT03570801|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Control Trial with randomization ratio 1:1||||
1301957|NCT03570788|||Cohort||Prospective|||||||
1301958|NCT03570775|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled clinical trial with newborns over 2000 grams of birth weight and diagnosis of indirect hyperbilirubinemia, requiring phototherapy. Patients were randomized to phototherapy with the LED sleeping bag or conventional phototherapy with blue light panels.||||
1301959|NCT03570762|||Cohort||Retrospective|||||||
1301960|NCT03570749|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301961|NCT03570736|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1301962|NCT03570723|Randomized|Parallel Assignment||Prevention||Single|The participants were blinded to the procedure performed.|The study was single-blind randomized controlled trial carried out in a tertiary University Hospital between June 2018to June 2021. Investigators included patients scheduled for CS due to complete placenta previa. They were randomly allocated to the group (I) managed by stepwise uterine devascularization, group (II) managed by A glove-loaded Foley's catheter tamponade. The primary outcome was the amount of intraoperative estimated blood loss.|t|||
1301963|NCT03570710|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which will be used.|Eligible participants were allocated to one of three groups. Group (I): patients received 110 ml normal saline IV just before skin incision Group (II): patients received 1 gm TA (2 ampoules of Capron 500 mg /5 ml; Amoun, Cairo, Egypt) intravenous just before skin incision. Group (III): patients received 2 gm topical TA (4 ampoules of Capron 500 mg/5 ml) applied on the placental bed after placental delivery.|t|t|t|t
1301964|NCT03570697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301965|NCT03570684|Non-Randomized|Crossover Assignment||Treatment||Triple||comparing the recent tie used patients with the previous respective data.|t|t||t
1301966|NCT03570671|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1301967|NCT03570658|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1301968|NCT03570645|Randomized|Parallel Assignment||Treatment||Double||thoracic paravertebral blocks using a combination of ropivacaine and dexmedetomidine or dexamethasone|||t|t
1301969|NCT03570632|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1301970|NCT03570619|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301971|NCT03570606|||Case-Control||Prospective|||||||
1301972|NCT03570593|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1301977|NCT03570528|||Case-Control||Retrospective|||||||
1301978|NCT03570515|Randomized|Parallel Assignment||Other||Double|||||t|t
1301979|NCT03570502|||Cohort||Prospective|||||||
1301980|NCT03570489|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label randomized parallel design||||
1301981|NCT03570476||Single Group Assignment||Treatment||None (Open Label)||||||
1301982|NCT03570463|||Cohort||Prospective|||||||
1301983|NCT03570450|Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose escalation from 1.10^6 cells/kg to 3.10^6 cells/kg (phase 1a,non randomized) Effect-dose: 3 doses from the phase 1a + placebo (phase 1b, randomized)||||
1301984|NCT03570437|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised, three-arm open-label trial with multi-arm-multi-stage (MAMS) design.||||
1301985|NCT03570424|Randomized|Parallel Assignment||Basic Science||Double|"Participants are block randomised to one of three nutrient conditions on provision of informed consent. This information is held by the PI and members of the research team independent of the outcomes assessor (masked). All three beverages are made up by members of the research team independent of the outcomes assessor (masked) and the participants (masked). Each participant (masked) is provided with a drink in a black, non-transparent, container with no details of its contents other than that is a nutrient supplement."|A randomly assigned, parallel group, simple pre-post design has been adopted to answer this question. 3 groups of young (aged 18-35 y), healthy, recreationally active, aerobically untrained (VO2max <50 ml.kg.min-1) males will undertake 3 weeks (9 sessions) of HIIT under different nutrient conditions following >10h overnight fast: i) Fasted placebo (0.33g.kg-1 body artificially flavoured and textured placebo); ii) Fed Whey protein (0.33g.kg-1 body mass intact whey protein 45 minutes prior to exercise); iii) Fed Whey protein hydrolysate (0.33g.kg-1 body mass hydrolysed whey protein 45 minutes prior to exercise). Participants will undergo biological sampling (venous blood and muscle biopsy) and measures of performance pre and post the intervention.|t|||t
1301986|NCT03570411|||Cohort||Prospective|||||||
1301987|NCT03570398|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1301988|NCT03570385||Single Group Assignment||Other||None (Open Label)||Interventional pilot study with minimal risks and constraints, descriptive, prospective, monocentric||||
1301989|NCT03570372|Randomized|Parallel Assignment||Treatment||Single|||t|||
1301990|NCT03570359|Randomized|Parallel Assignment||Treatment||Quadruple|"All patients will be randomised to one of two treatment groups (SNG001 or placebo).~In Part 1 the ratio will be 4:1 and in Part 2 the ratio will be 1:1, both according to a pre-specified randomisation schedule. In Part 2, prior to randomisation to SNG001 or placebo, patients will be stratified into two groups; those with cold symptoms without a moderate COPD exacerbation (Group A), and those who have a moderate COPD exacerbation with or without cold symptoms (Group B).~For both parts of the study, patients will be randomised according to a pre-specified randomisation schedule."||t|t|t|t
1301991|NCT03570346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1301992|NCT03570333|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1301993|NCT03570320|Randomized|Parallel Assignment||Other||None (Open Label)||Control arm versus interventional arm||||
1301994|NCT03570307|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301995|NCT03570294||Single Group Assignment||Treatment||None (Open Label)||||||
1301996|NCT03570281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1301997|NCT03570268|Randomized|Parallel Assignment||Treatment||Single||||||t
1301998|NCT03570255||||||||||||
1301999|NCT03570242|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302000|NCT03570229|||Case-Only||Prospective|||||||
1302001|NCT03570216||Single Group Assignment||Treatment||None (Open Label)||This will be a single group prospective study.||||
1302002|NCT03570203|||Cohort||Other|||||||
1302003|NCT03570190|||Case-Only||Prospective|||||||
1302004|NCT03570177|||Cohort||Retrospective|||||||
1302005|NCT03570164|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1302006|NCT03570151|||Cohort||Retrospective|||||||
1302007|NCT03570138|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1302008|NCT03570125|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302009|NCT03570112|||Case-Control||Prospective|||||||
1302010|NCT03570099|||Case-Control||Prospective|||||||
1302011|NCT03570086|||Cohort||Prospective|||||||
1302012|NCT03570073|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1302013|NCT03570060|||Cohort||Prospective|||||||
1302014|NCT03570047|||Cohort||Retrospective|||||||
1302015|NCT03570034|||Case-Only||Prospective|||||||
1302016|NCT03570021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302017|NCT03570008|Randomized|Parallel Assignment||Prevention||None (Open Label)|No masking|||||
1302018|NCT03569995||Single Group Assignment||Treatment||None (Open Label)||"[Induction phase]~① After induction therapy (R-M) 2 times, first evaluation~Complete, partial response or stable disease-> next step~Progressive disease-> eliminated~② After Induction therapy (R-M) was added 3 times (total 5 times), 2nd evaluation~Complete response -> consolidation therapy progress~Partial response or stable disease-> R-M 2 additional administrations~Progressive disease-> eliminated~③ After Induction therapy (R-M) was added twice (7 times in total), 3rd evaluation~Complete, partial response or stable disease-> consolidation therapy~Progressive disease-> eliminated"||||
1302019|NCT03569982|Randomized|Parallel Assignment||Supportive Care||Triple|Patients will be referred by the surgeon to MOHS surgery without knowing if integrative care will be provided at the surgery day. Allocation of integrative care to specific surgery days will be determined by a 1:1 randomization.|Prospective randomized controlled|t|t||t
1302020|NCT03569969|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1302060|NCT03569449|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1302061|NCT03569436|||Cohort||Retrospective|||||||
1302062|NCT03569423|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, consecutive, nonrandomized case-control comparative study.||||
1302063|NCT03569410|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label prospective clinical trial.||||
1573344|NCT00001530||||||||||||
1302021|NCT03569956|Randomized|Parallel Assignment||Other||Single||Subjects will be divided into two groups: the Razor group of 20 subjects, and the Regimen group of 20 subjects. In the Razor group, subjects will use the 556 Razor with their regular shaving products, and shave at least 5 or more times per week. In the Regimen group, subjects will use the 556 Razor, Pre-Shave Gel, Cleansing brush and Shaving Gel, and shave at least 5 or more times per week. All subjects will be given the 556 Razors during the 12-week study. The Regimen group will also be given the Pre-Shave Gel, Cleansing Brush, and Shaving Gel.|||t|
1302022|NCT03569943||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1302023|NCT03569930|Randomized|Parallel Assignment||Treatment||Single|||t|||
1302024|NCT03569917||Single Group Assignment||Basic Science||None (Open Label)||||||
1302025|NCT03569904|||Other||Prospective|||||||
1302026|NCT03569891||Single Group Assignment||Treatment||None (Open Label)||The reference therapy is prophylactic Factor IX replacement therapy used during the lead-in phase prior to treatment with AAV5-hFIXco-Padua (AMT-061).||||
1302027|NCT03569878|Randomized|Parallel Assignment||Treatment||Single||||||t
1302028|NCT03569865|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1302029|NCT03569852|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1302030|NCT03569839|||Case-Only||Prospective|||||||
1302031|NCT03569826|||Cohort||Other|||||||
1302032|NCT03569813|Randomized|Parallel Assignment||Prevention||None (Open Label)||This trial will include 396 participants with 2:1 allocation for the intervention (264) and control (132) conditions. The sample of 396 will target inclusion of 50% Black and 50% younger (aged 18-34) participants.||||
1302033|NCT03569800|||Case-Only||Prospective|||||||
1302034|NCT03569787|||Cohort||Retrospective|||||||
1302035|NCT03569774|Randomized|Crossover Assignment||Treatment||Single||Mechanical ventilation with individualized PEEP will be compared to mechanical ventilating with low PEEP during lung isolation in each subject. Each subject will receive one PEEP level then will receive the second PEEP level. The order in which each subject receives the PEEP level will be randomized.|t|||
1302036|NCT03569761|Randomized|Parallel Assignment||Screening||Single||The investigators will use a two-group randomized controlled trial to achieve our aims. Participants (n=120) will be randomized to view the AI culturally-adapted decision aid or an attention-control (i.e., food safety) video. The study flow diagram (Figure 2) indicates the recruitment, randomization, and assessment process.Our research to develop and evaluate the decision aid is approved by the Lumbee Tribal Council and the institutional review board (IRB) at the University of North Carolina at Chapel Hill.|t|||
1302037|NCT03569748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302038|NCT03569735|||Cohort||Prospective|||||||
1302039|NCT03569722|||Case-Only||Prospective|||||||
1302040|NCT03569709|Randomized|Parallel Assignment||Treatment||Triple||Randomized Controlled Trial||t|t|t
1302041|NCT03569696||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment All the participating patients will receive 240mg nivolumab every 2 weeks for 8 doses for 4 months, and later 480 mg every 4 weeks for 2 years (cycle 9-30) for a maximum of 30 doses, starting 10±2 weeks after the last cycle of immunochemotherapy.||||
1302042|NCT03569683||Single Group Assignment||Treatment||None (Open Label)||"The patients will be equally divided into three groups. (Groups A,B&C) All the cases will be prepared preoperatively with scaling and root planing, oral hygeine instructions, occlusal equilibration and dietary evaluation. External bevel gingivectomy will be performed wherein the inflamed gingiva will be excised and shaped.~Group A- The Surgical site will be treated with diode laser following gingivectomy procedure, immediately and on the 1st,3rd and 7th day after surgery.~Group B- Hyaluronic acid will be applied topically to the surgical site immediately after gingivectomy, tin foil would be placed and periodontal dressing given, and on the 1st,3rd and 7th day postoperatively.~Group C- Herbal gel will be applied topically and tin foil placed over which a periodontal dressing would be given immediately after the surgery and on the 1st,3rd and 7th day postoperatively."||||
1302043|NCT03569670|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1302044|NCT03569657||Single Group Assignment||Treatment||None (Open Label)||Participants are assigned to the group intervention, which is not part of routine medical care, to evaluate the group's effectiveness on participants' psychological well-being and their healthcare utilization.||||
1302045|NCT03569644||Single Group Assignment||Other||None (Open Label)||The study is based on interviews that will be recorded in digital audio and then transcribed literally. The consultation for this research is 45 to 90 minutes long. This prolongs their presence in consultation with the doctor. For this reason, the study was classified as Interventional according to French regulations||||
1302046|NCT03569631|Randomized|Crossover Assignment||Treatment||Double|Double||t||t|
1302047|NCT03569618|Randomized|Parallel Assignment||Treatment||Triple|Study assessment administrator is blinded to what digital tool the subject has been assigned.||t||t|t
1302048|NCT03569605|Randomized|Parallel Assignment||Supportive Care||Double||After completing informed consent, 7-day PA assessment, weight measurement, and baseline questionnaires, participants will be randomly assigned with equal probability to 1 of 2 treatment groups: 1) self-help or 2) intervention. Future treatment assignments will be concealed from study staff who are recruiting and enrolling participants.|||t|t
1302049|NCT03569592||Single Group Assignment||Prevention||None (Open Label)||Incarcerated people living with HIV/AIDS will be given a brief training on overdose prevention and be given naloxone at discharge from jail.||||
1302050|NCT03569579|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1302051|NCT03569566|||Cohort||Cross-Sectional|||||||
1302052|NCT03569553|||Cohort||Retrospective|||||||
1302053|NCT03569540|Randomized|Parallel Assignment||Treatment||Single|||t|||
1302054|NCT03569527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302055|NCT03569514|||Cohort||Retrospective|||||||
1302056|NCT03569501|Randomized|Factorial Assignment||Treatment||Double||||t||t
1302057|NCT03569488|||Cohort||Prospective|||||||
1302058|NCT03569475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302059|NCT03569462|Randomized|Parallel Assignment||Prevention||Single||Intervention involves demonstration of HIV self-testing and access to a mobile health application to promote HIV self-testing and HIV behavioral risk reduction||||t
1573345|NCT00001528||||||||||||
1302064|NCT03569397|Randomized|Parallel Assignment||Treatment||Single|||t|||
1302065|NCT03569384|Randomized|Parallel Assignment||Treatment||Triple||The study is a prospective randomized controlled trial comparing the effects of tele-rehabilitation and conventional rehabilitation in patients with COPD.|t|t||t
1302066|NCT03569371||Single Group Assignment||Treatment||None (Open Label)||||||
1302067|NCT03569358|Randomized|Parallel Assignment||Other||Single||||||t
1302068|NCT03569345||Single Group Assignment||Treatment||None (Open Label)||||||
1302069|NCT03569332|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1302070|NCT03569319|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302071|NCT03569306|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1302072|NCT03569293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302073|NCT03569280||Sequential Assignment||Treatment||None (Open Label)||KPG-121 Plus Enzalutamide||||
1302074|NCT03569267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302075|NCT03569254|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel assignment randomized controlled clinical trial with preterm or low birth weight infants who have low risk hyperbilirubinemia requiring phototherapy||||
1302076|NCT03569241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302077|NCT03569228|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Study 1. Participants obtaining replacement in-the-ear (ITE) or behind-the ear (ITE) hearing aids will be assigned to the ITE or BTE coupler-based fitting groups.~Study 2: Participants will be fitted with open-fit hearing aids using simulated audiograms.~Study 3. Participants obtaining replacement open fit or receiver-in-the canal hearing aids will be randomly assigned to the standard of care fitting groups (open or closed) or the coupler-based fitting groups (open or closed)."||||
1302078|NCT03569215|||Cohort||Cross-Sectional|||||||
1302079|NCT03569202|Randomized|Parallel Assignment||Treatment||Quadruple||"Part 1. Piiloset Trehalose Emulsion Eye Drop is administered on the worst eye four times during office hours of one day at the study centre.~Part 2. Piiloset Trehalose Emulsion Eye Drop is self-administered on a randomised eye and the control eye drops on the contralateral eye three times a day for 10 days in a double-blinded fashion.~Part 3. Either Piiloset Trehalose Emulsion Eye Drop or the control eye drops are self-administered on both eyes three times a day for 30 days in a randomised and double-blinded fashion."|t|t|t|t
1302080|NCT03569189||Single Group Assignment||Basic Science||None (Open Label)||||||
1302081|NCT03569176|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1302082|NCT03569163|||Cohort||Retrospective|||||||
1302083|NCT03569150|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||cluster-assigned pilot, wait-list control||||
1302084|NCT03569137|||Cohort||Prospective|||||||
1302085|NCT03569124|||Cohort||Prospective|||||||
1302086|NCT03569111|||Cohort||Prospective|||||||
1302087|NCT03569098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302088|NCT03569085||Single Group Assignment||Screening||None (Open Label)||Same patients will receive two different arms/interventions and compared||||
1302089|NCT03569072||Single Group Assignment||Treatment||None (Open Label)||||||
1302090|NCT03569059|Randomized|Parallel Assignment||Treatment||Single||Participants are assigned to one of four groups in parallel for the duration of the study.||||t
1302091|NCT03569046|Randomized|Parallel Assignment||Other||Quadruple|The same surgeons performed all the operations to ensure consistency in the estimation of the surgical field. To eliminate the observer bias, the observing anesthetist did not attend the induction of block. Also, the operating surgeon was blinded to the pharmacological treatments, anesthesia and performance of the used techniques.||t|t|t|t
1302092|NCT03569033|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1302093|NCT03569020|Randomized|Crossover Assignment||Treatment||Double|Investigators will not know which assignment the participants were given. The laboratory measuring uric acid will not know which intervention the participants were assigned.|Half of participants will be randomly assigned 1 of 2 potential sequences. All participants will ultimately participate in each study period, but the order will be randomly assigned 1:1.|||t|t
1302094|NCT03569007|Randomized|Parallel Assignment||Treatment||Triple|Double-blind||t||t|t
1302095|NCT03568994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Choice of Induction I regimen is at the treating physician's discretion (will be influenced based on drug availability)||||
1302096|NCT03568981|||Cohort||Prospective|||||||
1302097|NCT03568968|Randomized|Parallel Assignment||Treatment||Double|Both patients and all investigators are blinded during the trial and during data analysis.|Randomized double-blinded study. 200 Participants randomized in 1:1 ratio to either vitamine supplementation or placebo.|t||t|
1302098|NCT03568955|||Cohort||Retrospective|||||||
1302099|NCT03568942||Single Group Assignment||Treatment||None (Open Label)||Subjects will receive 1500 mg gepotidacin tablets BID via oral route for 5 days.||||
1302100|NCT03568929|||Cohort||Other|||||||
1302101|NCT03568916|||Cohort||Retrospective|||||||
1302102|NCT03568903|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1302103|NCT03568890|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302104|NCT03568877|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1302105|NCT03568864|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1302106|NCT03568851|||Cohort||Prospective|||||||
1302107|NCT03568838|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Patients will be randomised (1:1) using an opaque sealed envelope methodology prior to coronary angiography.~Patients allocated to the experimental arm will receive a parenteral (IA/IV) bolus dose of enoxaparin (0.75 mg/kg) pre PPCI followed by an infusion of 0.75 mg/kg over a 6-hour period to be started as soon as possible when PPCI starts.~Patients randomised to the standard therapy arm will receive treatment as guided by the treating cardiologist in line with the local standard-of-care, usually consisting of UFH and a GPI."||||
1302157|NCT03568188||Single Group Assignment||Treatment||None (Open Label)||||||
1302158|NCT03568175||Single Group Assignment||Treatment||None (Open Label)||||||
1302159|NCT03568162|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1302160|NCT03568149|||Case-Control||Prospective|||||||
1302108|NCT03568825|Randomized|Single Group Assignment||Basic Science||None (Open Label)||"The study is a RSP designed multicenter study with two interventional- and one response variable. The two-interventional variable were Number of OMTs and Interval in days between each treatment. The GERD variables were degrees of Heartburn, Chest pain, Acid in mouth, Epigastric pain and Thoracic pain. The response variable were percent reduction in sum of the GERD variables from baseline in 4 categories. Each of the two RSP designs consisted of three dose levels. Three GERD patients were allocated to the first design level given six OMT with five days' interval. Based on the results obtained from the first design level, five patients were subsequently included to the second design level. The number of OMT's and interval between each treatment was separately determined. Seven patients were included to the third design level and given number of OMT's and interval between treatments calculated based on results obtained from the second design level."||||
1302109|NCT03568812|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302110|NCT03568799||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302111|NCT03568786|Randomized|Crossover Assignment||Treatment||Single|||t|||
1302112|NCT03568773|Randomized|Parallel Assignment||Treatment||None (Open Label)||Experimental, controlled and randomized study.||||
1302113|NCT03568760|Randomized|Parallel Assignment||Treatment||Single|The results are assessed by independent assessors blinded to when the data is obtained and from which group.|||||t
1302114|NCT03568747|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1302115|NCT03568734||Single Group Assignment||Prevention||None (Open Label)||12 mothers participating in the study (due for caesarean section) are screened for transmissible diseases. A transplant sample is gathered from the mother, processed, and given to the infant at delivery by caesarean section.||||
1302116|NCT03568721|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1302117|NCT03568708|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302118|NCT03568695||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302119|NCT03568682|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302120|NCT03568669|||Case-Only||Prospective|||||||
1302121|NCT03568656|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The RP2D/MTD dose will be determined in Part A. Parts B-E will run in parallel after the completion of Part A.||||
1302122|NCT03568643|Randomized|Single Group Assignment||Treatment||Single||||||t
1302123|NCT03568630|||Cohort||Prospective|||||||
1302124|NCT03568617||Single Group Assignment||Treatment||None (Open Label)||||||
1302125|NCT03568604||Single Group Assignment||Treatment||None (Open Label)||Open label study of daily administration of 6.5 mg prasterone, approved for moderate to severe dyspareunia for vaginal atrophy in menopausal women, to see if there are changes to the vulva, vestibule, urethral meatus and vagina on vulvoscopy after 20 weeks||||
1302126|NCT03568591|Non-Randomized|Parallel Assignment||Treatment||Double|Coded-analysis group allocation and database - blind to allocation.|A researcher-blind parallel-group controlled psychosomatic therapy intervention trial.|||t|t
1302127|NCT03568578|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1302128|NCT03568565|Randomized|Sequential Assignment||Other||None (Open Label)||The model is a partial/limited SMART design. Couples are initially randomly assigned to one of five groups - a waitlist control, the ePREP program (with and without a coach) and the OurRelationship program (with and without a coach). Following initial randomization, couples initially assigned to complete either program without a coach and who are not completing activities in a timely manner will be re-randomized to either continue without a coach or received a coach.||||
1302129|NCT03568552|Randomized|Sequential Assignment||Treatment||None (Open Label)||The Patient Decision Aid for Medication Assisted Therapy (PtDA-MAT) will be tested by patients and clinicians during actual visits with OUD patients to assess its acceptability and effectiveness. We will track patients receiving PtDAT-MAT using their clinical and administration data over a 24-month period to assess outcomes associated with PtDAT-MAT. Participating clinics will be randomly selected in sequence to implement the intervention.||||
1302130|NCT03568539||Single Group Assignment||Treatment||None (Open Label)||||||
1302131|NCT03568526||Single Group Assignment||Supportive Care||None (Open Label)||||||
1302132|NCT03568513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302133|NCT03568500|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1302134|NCT03568487|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1302135|NCT03568474|Randomized|Parallel Assignment||Treatment||Triple|The participant, care provider, outcomes assessor and statistician will be masked|parallel two arm groups with 1:1 allocation ratio|t|t||t
1302136|NCT03568461|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1302137|NCT03568448|||Cohort||Prospective|||||||
1302138|NCT03568435|||Cohort||Retrospective|||||||
1302139|NCT03568422||Single Group Assignment||Treatment||None (Open Label)||||||
1302140|NCT03568409|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302141|NCT03568396|||Cohort||Prospective|||||||
1302142|NCT03568383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302143|NCT03568370|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1302144|NCT03568357|||Cohort||Prospective|||||||
1302145|NCT03568344|||Other||Prospective|||||||
1302146|NCT03568331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302147|NCT03568318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302148|NCT03568305|||Cohort||Retrospective|||||||
1302149|NCT03568292|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302150|NCT03568279|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1302151|NCT03568266|||Case-Only||Prospective|||||||
1302152|NCT03568253|Randomized|Parallel Assignment||Treatment||Single||||||t
1302153|NCT03568240|||Cohort||Prospective|||||||
1302154|NCT03568227||Single Group Assignment||Basic Science||None (Open Label)||||||
1302155|NCT03568214|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1302156|NCT03568201|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||transcutaneous oximetry||||
1302926|NCT03558165|||Cohort||Prospective|||||||
1302161|NCT03568136|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302162|NCT03568123|Randomized|Parallel Assignment||Treatment||Double|Participants are unaware of which prosthesis they receive and the research coordinator handling the collected questionnaires postoperatively is also unaware of which prosthesis the participant has received. The research assistant handling both standard RSA as well as dynamic RSA analysis is also unaware of which prosthesis the participant has received|This project is carried out as a 2-arm randomized controlled single-blinded trial, in which the clinical and radiological outcomes after treatment of hip osteoarthritis with insertion of either 1) Persona Total Knee System with MC polyethylene bearing or 2) Persona Total Knee System with CR polyethylene bearing. Allocation of the participants to one of the two treatment groups is done intraoperatively. A computer-generated random allocation sequence will be used. Non-transparent envelopes are used for the randomization process.|t|||t
1302163|NCT03568110|||Cohort||Prospective|||||||
1302164|NCT03568097||Single Group Assignment||Treatment||None (Open Label)||||||
1302165|NCT03568084|Randomized|Parallel Assignment||Health Services Research||Single||Randomized parallel group multicenter clinical trial. Randomization unit: Health Center. Unit of analysis: Patient.||||t
1302166|NCT03568071|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1302167|NCT03568058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302168|NCT03568045|Randomized|Parallel Assignment||Device Feasibility||Single||a pilot randomized control trial of 3 cohort groups.||||t
1302169|NCT03568032|||Case-Control||Cross-Sectional|||||||
1302170|NCT03568019|||Case-Only||Retrospective|||||||
1302171|NCT03568006|Randomized|Parallel Assignment||Treatment||Double|It is not possible to mask physiotherapists and patients, so the only masking will be for researchers and evaluators||||t|t
1302172|NCT03567993|Randomized|Parallel Assignment||Other||Single|||t|||
1302173|NCT03567980||Single Group Assignment||Treatment||None (Open Label)||||||
1302174|NCT03567967|Randomized|Parallel Assignment||Prevention||Double|24-hour dietary recalls are conducted by blinded registered dietitians||||t|t
1302175|NCT03567954|||Other||Prospective|||||||
1302176|NCT03567941|Randomized|Crossover Assignment||Treatment||Single|||t|||
1302177|NCT03567928|Randomized|Parallel Assignment||Treatment||Single|Induction of anesthesia and subsequent use (or not) of the device (laryngeal mask)|Two groups: one receive sedation in spontaneous breathe, the other receive sedation with laryngeal mask|t|||
1302178|NCT03567915|||Case-Control||Prospective|||||||
1302179|NCT03567902|Randomized|Crossover Assignment||Other||Double|||t|||t
1302180|NCT03567889|Randomized|Parallel Assignment||Treatment||None (Open Label)||Total patients: approximately 248. Daromun plus surgery treatment group (Arm 1): 124 evaluable patients. Surgery alone (Arm 2): 124 evaluable patients. Patients enrolled will be randomized to the two different arms of the study.||||
1302181|NCT03567876||Single Group Assignment||Treatment||None (Open Label)||||||
1302182|NCT03567863|Randomized|Sequential Assignment||Diagnostic||Double|the order of use of the 2 needles is not communicated to the cytologist||t||t|
1302183|NCT03567850|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302184|NCT03567837|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1302185|NCT03567824|Randomized|Parallel Assignment||Treatment||Double|The second phase of the study where subjects are randomized to either active or placebo will be blinded to both participant and investigator.|All subjects will be treated open label for the first 3 months on study, then randomized to receive either active or placebo for an additional 3 months.|t||t|
1302186|NCT03567811|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|All control and Chronic Fatigue Syndrome subjects were treated in identical fashion.|All subjects were participated in an identical protocol. Outcomes were compared between control and Chronic Fatigue Syndrome subjects.||||
1302187|NCT03567798|Randomized|Parallel Assignment||Treatment||Single|Single Blind|Single blind, randomized, multicentric placebo controlled study|t|||
1302188|NCT03567785|||Cohort||Prospective|||||||
1302189|NCT03567772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302190|NCT03567759|||Cohort||Prospective|||||||
1302191|NCT03567746|Randomized|Parallel Assignment||Treatment||Single||||||t
1302192|NCT03567733|||Case-Only||Prospective|||||||
1302193|NCT03567720||Single Group Assignment||Treatment||None (Open Label)||||||
1302194|NCT03567707|Randomized|Parallel Assignment||Prevention||Triple|With the exception of the study nurse performing the vaginal seeding procedure, all study participants and study personnel will be masked (blinded) to the infant's randomization status.|This study will enroll pregnant women during the third trimester of pregnancy whose infants have a first-degree relative ( the mother, biological father, or full sibling) with atopic disease or food allergy.The study excludes women with a history of active atopic dermatitis within the past 5 years to avoid the potential transfer of vaginal microbiota to the infant that may predispose to atopic disease.Women undergoing elective, unlabored C-section will be randomized to have their infants undergo vaginal seeding or placebo seeding plus standard of care. Women and infants who undergo placebo seeding will serve as a control population.In addition, women and infants undergoing vaginal delivery will also be included as a second control group, in part to determine if vaginal seeding will decrease allergen sensitization rates to a level similar to vaginally delivered infants, and also to serve as a comparator group for gut microbiome development during the infant's first year of life.|t|t|t|
1302237|NCT03567148|Randomized|Parallel Assignment||Treatment||Single|||||t|
1302238|NCT03567135|||Cohort||Retrospective|||||||
1302239|NCT03567122|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1302240|NCT03567109|||Case-Control||Prospective|||||||
1302241|NCT03567096|Randomized|Parallel Assignment||Treatment||Single||Prospective, two-arm, randomized 1:1, multicenter study||||t
1302242|NCT03567083|Randomized|Parallel Assignment||Treatment||Single||||||t
1302243|NCT03567070||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302244|NCT03567057||Single Group Assignment||Treatment||None (Open Label)||||||
1302245|NCT03567044||Single Group Assignment||Treatment||None (Open Label)||||||
1302491|NCT03563833|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1302195|NCT03567694|Randomized|Sequential Assignment||Treatment||Quadruple|The participants, principal investigator, and all other study personnel involved with participant assessments will remain blinded to the actual treatment assignments of the participants. The principal investigator will be ultimately responsible for ensuring that the integrity of the blind is maintained throughout the study and will be required to notify the sponsor in the event of any breaking of the blind for any reason. An unblinded pharmacist staff will be required at the Clinical Site to comply with the study's randomization and blinding requirements. At the Clinical Site, prior to study initiation, the principal investigator will be responsible for designating a qualified pharmacy staff to serve as the unblinded pharmacy staff in the study. Unblinded pharmacy staff may not participate in any participant assessments.|The study consists of 2 parts, Part A (SAD, including fed/fasted comparison) and Part B (MAD). Part A will include an assessment of the effect of a high-fat breakfast on the absorption and PK profile of HA115, performed in 10 participants at a single dose to be selected based on SAD results and predicted to be associated with therapeutic plasma concentrations. Part B will be a randomized, double-blind, placebo controlled parallel group study of up to 3 dose levels of HA115 given once daily. The number of days of dosing will be based on the results of the PK analysis from Part A. In each cohort, 8 participants will receive active compound fasted and 2 will receive placebo in a randomized, double blind fashion. Safety observations and PK evaluations will be made. Safety data will be reviewed with the SRC prior to each dose escalation.|t|t|t|t
1302196|NCT03567681|Randomized|Parallel Assignment||Treatment||None (Open Label)|Outcome will be assessed by computer|Open randomization to parallel treatment groups||||
1302197|NCT03567668|||Cohort||Prospective|||||||
1302198|NCT03567655||Single Group Assignment||Treatment||None (Open Label)||This study is a single arm, prospective multi-institutional study.||||
1302199|NCT03567642||Single Group Assignment||Treatment||None (Open Label)||||||
1302200|NCT03567629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302201|NCT03567616|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1302202|NCT03567603|||Case-Control||Prospective|||||||
1302203|NCT03567590|Randomized|Parallel Assignment||Treatment||Single||||||t
1302204|NCT03567577|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1302205|NCT03567564|||Cohort||Prospective|||||||
1302206|NCT03567551|||Cohort||Prospective|||||||
1302207|NCT03567538|||Cohort||Retrospective|||||||
1302208|NCT03567525|Randomized|Parallel Assignment||Prevention||Triple|Neither the patient nor the surgeon (who is also the investigator) will know to which arm patients are randomized (standard surgical approach) or experimental approach||t|t|t|
1302209|NCT03567512|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1302210|NCT03567499|Randomized|Crossover Assignment||Treatment||Double|This will be a double-blinded (Sponsor unblinded) study in which the subjects and site staff (Pharmacist unblinded to prepare study drug) will be blinded for the duration of the study|This study will consist of two parts, Part A and a conditional Part B. Part A is designed as a randomized double-blinded, 3 period, placebo-controlled, repeat-dose, cross-over study. The decision to initiate Part B will be made based on an evaluation of data from Part A which will include an overall assessment of safety, PK and PD. Part B will also employ a randomized, double-blind, repeat dose, cross-over study design and will follow the same assessments and procedures as Part A.|t||t|
1302211|NCT03567486|||Cohort||Prospective|||||||
1302212|NCT03567473|Randomized|Parallel Assignment||Treatment||Quadruple|All study personnel (including study nurses, coordinators, investigators, data management staff, and statistical team), health care staff providing patient care, and patients/families will be blinded to the study group assignment.||t|t|t|t
1302213|NCT03567460||Single Group Assignment||Prevention||None (Open Label)||||||
1302214|NCT03567447|Randomized|Parallel Assignment||Treatment||Triple|Double blind masking|Phase II single center, double-blind, randomized, placebo-controlled, efficacy study|t||t|t
1302215|NCT03567434||Crossover Assignment||Basic Science||Double|||t||t|
1302216|NCT03567421|||Case-Only||Prospective|||||||
1302217|NCT03567408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302218|NCT03567395|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1302219|NCT03567382|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1302220|NCT03567369|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1302221|NCT03567356|Randomized|Parallel Assignment||Treatment||None (Open Label)||open-label Treatment as Usual vs. Intervention||||
1302222|NCT03567343|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1302223|NCT03567330|Randomized|Parallel Assignment||Treatment||Single|Assessors and analysts will be blinded to treatment condition. Participants and providers cannot be effectively blinded to treatment condition.|Group (cluster) randomized trial.||||t
1302224|NCT03567317|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1302225|NCT03567304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302226|NCT03567291|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302227|NCT03567278||Single Group Assignment||Treatment||None (Open Label)||Medical Device Study||||
1302228|NCT03567265|||Cohort||Prospective|||||||
1302229|NCT03567252|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Participants will be compared between walking and non-walking groups to assess dietary behavior.||||
1302230|NCT03567239||Single Group Assignment||Supportive Care||None (Open Label)|Participants provide feedback of adaptive device they are provided. They, their caregiver, the investigator, and research staff are aware of all phases of the study.|Participants receive adaptive device and provide feedback.||||
1302231|NCT03567226|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1302232|NCT03567213||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1302233|NCT03567200||Single Group Assignment||Prevention||None (Open Label)||||||
1302234|NCT03567187||Single Group Assignment||Treatment||None (Open Label)||||||
1302235|NCT03567174|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Cluster-randomized trial||||
1302236|NCT03567161||Single Group Assignment||Supportive Care||None (Open Label)||||||
1573346|NCT00001527||||||||||||
1302246|NCT03567031||Single Group Assignment||Basic Science||None (Open Label)|Patient is under general anesthesia|Cerebral blood flow is measured in each patient at 3 different, controlled levels of end-tidal CO2||||
1302247|NCT03567018|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two populations are being investigated in this trial; a healthy volunteer population and a patient population. Each population will receive an MRI scan.||||
1302248|NCT03567005||||||||||||
1302249|NCT03566992|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302250|NCT03566979|Randomized|Parallel Assignment||Treatment||Quadruple||Post-operative dental pain following third molar extraction.|t|t|t|t
1302251|NCT03566966|||Case-Control||Prospective|||||||
1302252|NCT03566953|||Other||Cross-Sectional|||||||
1302253|NCT03566940|Randomized|Sequential Assignment||Prevention||Double|||t||t|
1302254|NCT03566927||Single Group Assignment||Treatment||None (Open Label)||||||
1302255|NCT03566914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302256|NCT03566901|Randomized|Parallel Assignment||Treatment||Single||"A multisite single blind randomized controlled trial involving the 3 clinical sites (Verona, Bolzano, Monza) will be performed, according to the CONSORT Statement (www.consort-statement.org). The PIs will be responsible for the randomization procedures. If eligible, patients will be randomly allocated (allocation ratio 1:1) to the experimental (EG) or conventional physiotherapy (CP) using computer-generated random numbers (www.randomization.com). In each site, one examiner blinded to group assignment will be responsible for assessments.~Prior to the start of the study the EG and CP protocols will be designed. To ensure uniformity in the delivery of treatments, one therapist from each center will be taught to training protocols by the research collaborators. Participants will receive 50-min, individual treatment sessions as outpatients 2 days a week for 5 consecutive weeks, for a total of 10 sessions. For each Unit one physiotherapist will be assigned to the EG and one to the CP."||||t
1302257|NCT03566888|||Case-Only||Cross-Sectional|||||||
1302258|NCT03566875|Randomized|Parallel Assignment||Treatment||Single|||t|||
1302259|NCT03566862|||Cohort||Cross-Sectional|||||||
1302260|NCT03566849|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized controlled trial (RCT) with two treatment groups, kinetic chain management approach (KC) and conventional training of scapula dyskinesis (CT).||||
1302261|NCT03566836|||Cohort||Prospective|||||||
1302262|NCT03566823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302263|NCT03566810|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1302264|NCT03566797|||Cohort||Prospective|||||||
1302265|NCT03566784|||Case-Control||Prospective|||||||
1302266|NCT03566771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302267|NCT03566758|||Ecologic or Community||Cross-Sectional|||||||
1302268|NCT03566745|||Case-Control||Prospective|||||||
1302269|NCT03566732|||Case-Only||Prospective|||||||
1302270|NCT03566719|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302271|NCT03566706|Randomized|Factorial Assignment||Other||Single|||t|||
1302272|NCT03566693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302273|NCT03566680||Single Group Assignment||Treatment||None (Open Label)||All subjects will be fit in orthokeratology contact lenses and be monitored for three months.||||
1302274|NCT03566667|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pragmatic randomized controlled trial||||
1302275|NCT03566654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302276|NCT03566641|Randomized|Parallel Assignment||Prevention||Double|Out study is a single-blinded randomized clinical trial. The patient will be informed about the type of dressing used for their wound care, but the investigator and the outcome assessor will be blinded for which type of dressing used for each participant patient.|Comparing the rate of occurrence of surgical site infection, total hospital cost and length of stay between two groups: group 1 represents patients who receive Prevena for postoperative wound care and group 2 represents patients who receive standard care dressing for the same purpose.|||t|t
1302277|NCT03566628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302278|NCT03566615|Randomized|Parallel Assignment||Screening||Double|||t|||t
1302279|NCT03566602||Single Group Assignment||Prevention||None (Open Label)||||||
1302280|NCT03566589||Single Group Assignment||Treatment||None (Open Label)||||||
1302281|NCT03566576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302282|NCT03566563|||Cohort||Prospective|||||||
1302283|NCT03566550|||Case-Control||Cross-Sectional|||||||
1302284|NCT03566537|||Case-Control||Prospective|||||||
1302285|NCT03566524|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1302286|NCT03566511|Randomized|Crossover Assignment||Basic Science||Single|The subject will be blinded to which study drug is received first (Drug or Placebo).This protocol follows a double blinded, randomized, crossover design.||t|||
1302287|NCT03566498|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302288|NCT03566485|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1302289|NCT03566472|||Cohort||Cross-Sectional|||||||
1302290|NCT03566459|||Case-Only||Prospective|||||||
1302291|NCT03566446||Single Group Assignment||Treatment||None (Open Label)||||||
1302292|NCT03566433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302293|NCT03566420|||Other||Cross-Sectional|||||||
1302294|NCT03566407||Single Group Assignment||Other||None (Open Label)||All study subjects will undergo a protocol required 6 month colonoscopy||||
1302295|NCT03566394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302296|NCT03566381|||Other||Prospective|||||||
1302297|NCT03566368|||Cohort||Prospective|||||||
1302298|NCT03566355||Single Group Assignment||Treatment||None (Open Label)||||||
1302299|NCT03566342|||Case-Control||Prospective|||||||
1302300|NCT03566329|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1302301|NCT03566316|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302445|NCT03564444|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1573347|NCT00001523||||||||||||
1302302|NCT03566303|Randomized|Parallel Assignment||Treatment||Single||It was adopted an equal allocation of patients to each treatment (i.e., 1:1 randomization)|||t|
1302303|NCT03566290||Single Group Assignment||Treatment||None (Open Label)||||||
1302304|NCT03566277||Single Group Assignment||Treatment||None (Open Label)||||||
1302305|NCT03566264|||Cohort||Retrospective|||||||
1302306|NCT03566251|Non-Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1302307|NCT03566238|Randomized|Parallel Assignment||Treatment||Triple||Double-Blind, Randomized, Placebo-Controlled|t|t|t|
1302308|NCT03566225|Randomized|Single Group Assignment||Treatment||Single|||t|||
1302309|NCT03566212|Randomized|Parallel Assignment||Treatment||None (Open Label)||local anesthesia is administered by using either camouflaged syringe or conventional syringe and was compared for reduction in anxiety levels in both groups||||
1302310|NCT03566199||Single Group Assignment||Treatment||None (Open Label)||||||
1302311|NCT03566186|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1302312|NCT03566173|||Case-Control||Cross-Sectional|||||||
1302313|NCT03566160||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1302314|NCT03566147|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1302315|NCT03566134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302316|NCT03566121|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1302317|NCT03566108|Randomized|Parallel Assignment||Treatment||Single||||||t
1302318|NCT03566095|Non-Randomized|Parallel Assignment||Treatment||Single|Participants were not aware of their status as a treatment or comparison community.|All data were collected from both treatment an comparison communities at the same time points.|t|||
1302319|NCT03566082|||Cohort||Prospective|||||||
1302320|NCT03566069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302321|NCT03566056|||Cohort||Other|||||||
1302322|NCT03566043|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|Open Label|Dose escalation||||
1302323|NCT03566030|||Case-Control||Prospective|||||||
1302324|NCT03566017||Single Group Assignment||Treatment||None (Open Label)||Open label extension study||||
1302325|NCT03566004||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302326|NCT03565991||Single Group Assignment||Treatment||None (Open Label)|Open label|"Single arm study with two cohorts enrolled in parallel.~Cohort 1 will enroll patients with locally advanced or metastatic solid tumors with one or more defects in the BRCA1 or BRCA2 genes~Cohort 2 will enroll patients with locally advanced or metastatic solid tumors with one or more defects in the ATM gene"||||
1302327|NCT03565978|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302328|NCT03565965|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1302329|NCT03565952|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1302330|NCT03565939|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Double-blind randomised, placebo-controlled, 24 weeks, comparative, exploratory phase II proof of concept trial.|t|t|t|t
1302331|NCT03565926|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302332|NCT03565913|Randomized|Parallel Assignment||Treatment||Quadruple|To provide adequate blinding, each medication sachet will be labelled with the study name, IRB number, principal investigator's name, expiration date and identification number of the study subject. Labels will be applied to the appropriate medication sachets once the subject has been randomized and assigned to a treatment group. Labelling of the sachets will be done by non-patient care personnel.|Subjects will be randomized into two groups in a parallel design. One group will take EffCaMgCit 15 meq (300 mg) Ca, 10 meq Mg (122 mg) and 45 meq total citrate thrice daily, while the other group will take calcium acetate suspension/solution (CaAcS) 15 meq Ca thrice daily for two years.|t|t|t|t
1302333|NCT03565900|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1302334|NCT03565887|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1302335|NCT03565874||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1302336|NCT03565861|Randomized|Sequential Assignment||Treatment||Triple||Adaptive design of placebo and up to six escalating doses of NP10679|t||t|t
1302337|NCT03565848|||Cohort||Prospective|||||||
1302338|NCT03565835||Single Group Assignment||Treatment||None (Open Label)||||||
1302339|NCT03565822||Single Group Assignment||Other||None (Open Label)||||||
1302340|NCT03565809|||Case-Control||Retrospective|||||||
1302341|NCT03565796|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1302342|NCT03565783||Single Group Assignment||Treatment||None (Open Label)||||||
1302343|NCT03565770|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302344|NCT03565757||Single Group Assignment||Supportive Care||None (Open Label)||||||
1302345|NCT03565744|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The investigators will conduct a quasi-experimental trial of B'N Fit POWER in two middle schools that have both an onsite MSHP and MMCC service.||||
1302346|NCT03565731||Single Group Assignment||Treatment||None (Open Label)||||||
1302347|NCT03565718|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1302348|NCT03565705|||Case-Control||Retrospective|||||||
1302349|NCT03565692|||Cohort||Retrospective|||||||
1302350|NCT03565679|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||Subjects will recline for the study. Reference sensors will be placed on each subject to evaluate the SpO2 accuracy and performance. Shield material may be used between any adjacent finger sensors to prevent optical crosstalk. Simultaneous data collection will be set up for devices under test. The data from the test devices will be collected by the sponsor or trained Clinimark Study staff. Data will be collected for 1 second intervals data analysis. The SpO2 accuracy of the test devices will be evaluated over the oxygen saturation range between 70-100%.||||
1302351|NCT03565666|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1302352|NCT03565653|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1302446|NCT03564431|||Case-Control||Prospective|||||||
1302447|NCT03564418|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, Controlled, Open trial.||||
1302492|NCT03563820|||Cohort||Prospective|||||||
1302353|NCT03565640|Randomized|Parallel Assignment||Supportive Care||Single|Participants and research staff will be masked during the study as much as possible, however there will be a description of the type of sacrospinous ligament fixation device used within the body of the operative note for each patient that research staff could gain access to||t|||
1302354|NCT03565627|Randomized|Crossover Assignment||Prevention||None (Open Label)||Participants will complete a baseline assessment (1 week), followed by the randomisation to using 1 of the 2 apps (3 weeks' follow up), and crossover (5 weeks' follow up).||||
1302355|NCT03565614|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Older adults (65+) applying for social care and services delivered by a municipality (Eskilstuna) in the county of Södermanland, Sweden. Presumptive participants are identified by the municipality care mangers. After informed consent, the users are randomized to either the intervention or control group. Exclusion criteria: Life-threatening disease, diagnosed mental illness, or severe cognitive dysfunction that would prevent the participant from expressing wants.||||
1302356|NCT03565601|||Cohort||Retrospective|||||||
1302357|NCT03565588|Randomized|Parallel Assignment||Prevention||Single||||||t
1302358|NCT03565575|Randomized|Parallel Assignment||Prevention||Single||||||t
1302359|NCT03565562|Randomized|Parallel Assignment||Prevention||None (Open Label)||cluster randomized, open parallel groups , controlled intervention study||||
1302360|NCT03565549|Randomized|Parallel Assignment||Other||Double|Double||t|||t
1302361|NCT03565536||Single Group Assignment||Treatment||None (Open Label)||||||
1302362|NCT03565523|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1302363|NCT03565510|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1302364|NCT03565497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302365|NCT03565484|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1302366|NCT03565471|||Case-Control||Cross-Sectional|||||||
1302367|NCT03565458|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1302368|NCT03565445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302369|NCT03565432|||Cohort||Prospective|||||||
1302370|NCT03565419|Randomized|Crossover Assignment||Device Feasibility||Single|||||t|
1302371|NCT03565406||Single Group Assignment||Treatment||None (Open Label)||||||
1302372|NCT03565393|Randomized|Parallel Assignment||Supportive Care||Quadruple|A placebo-controlled, randomized; double-blind 2 arm trial to assess the efficacy of fibersol-2 in children with acute watery diarrhea.|A placebo-controlled, randomized|t|t|t|t
1302373|NCT03565380|Randomized|Parallel Assignment||Prevention||Single|The reassessments at 6-, 12-, 24-, and 52 weeks, and prospective falls evaluation will be conducted by assessors blinded to group allocation. Due to the nature of the trial, the certified Tai Chi instructor who provides treatments and participants will not be blinded to group allocation.|||||t
1302374|NCT03565367||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302375|NCT03565354|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1302376|NCT03565341||Single Group Assignment||Treatment||None (Open Label)||Face sides will be randomized to receive either 1064nm alone or 1064nm & 585nm combination treatment||||
1302377|NCT03565328||Single Group Assignment||Basic Science||None (Open Label)||||||
1302378|NCT03565315|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302379|NCT03565302|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1302380|NCT03565289|||Case-Only||Prospective|||||||
1302381|NCT03565276||Single Group Assignment||Prevention||None (Open Label)||As part of the dose-escalation design, the investigators will start with 5mg/kg, half the smallest described dose, on a sample of up to 5 women. They will continue to administer TxA doses in increments of 5mg/kg to each successive batch of 5 women. If the number of treatment successes cannot statistically rule out a value < 75% (< 4 of 5 women are successes due to values in the low range), the dose will be increased by 5mg/kg for the next set of 5 women, and so on, until a maximum dose of 30mg/kg is reached, a dose deemed safe based on earlier studies in different populations. Once treatment success is determined at a certain dose, i.e. 4/5 women have levels in the therapeutic range), a total of 20 women will be administered that dose to ensure that 75% i.e. 18/20 women are successes at that dose.||||
1302382|NCT03565263|||Case-Control||Cross-Sectional|||||||
1302383|NCT03565250|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1302384|NCT03565237||Single Group Assignment||Prevention||None (Open Label)||||||
1302385|NCT03565224|||Cohort||Prospective|||||||
1302386|NCT03565211||Single Group Assignment||Treatment||None (Open Label)|Open-label trial|||||
1302387|NCT03565198|||Cohort||Prospective|||||||
1302388|NCT03565185|Randomized|Parallel Assignment||Treatment||Single|||||t|
1302389|NCT03565172||Single Group Assignment||Basic Science||None (Open Label)||The methodology used is : Single Case Experimental Design (SCED).||||
1302390|NCT03565159|Randomized|Parallel Assignment||Prevention||Quadruple||Participants will be randomised 1:1 to receive one single 0.5ml dose of active or placebo Investigational Medicinal Product at baseline.|t|t|t|t
1302391|NCT03565146||Single Group Assignment||Treatment||None (Open Label)||||||
1302392|NCT03565133|Randomized|Crossover Assignment||Prevention||Double|Participants and investigators will be blinded for the contents of the gastric capsule. Both cannot be blinded for the oral sham feeding||t||t|
1302393|NCT03565120||Single Group Assignment||Treatment||None (Open Label)||||||
1302394|NCT03565107|||Other||Other|||||||
1302395|NCT03565094||Single Group Assignment||Treatment||None (Open Label)||||||
1302396|NCT03565081||Single Group Assignment||Treatment||None (Open Label)||||||
1302397|NCT03565068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302398|NCT03565055|Randomized|Parallel Assignment||Treatment||Single||||||t
1302399|NCT03565042|||Other||Prospective|||||||
1302448|NCT03564405||Single Group Assignment||Treatment||None (Open Label)||||||
1302449|NCT03564392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302450|NCT03564379|Randomized|Sequential Assignment||Other||Double|||t||t|
1302451|NCT03564366||||||||||||
1303294|NCT03553381|||Cohort||Prospective|||||||
1302400|NCT03565029||Single Group Assignment||Treatment||None (Open Label)||one-stage phase II trial seeking to establish whether an oxaliplatin-based chemotherapy preceding standard neo-adjuvant fluoropyrimidines-based chemo radiotherapy, can safely spare demolitive surgical intervention in patients with operable rectal cancer, without increasing the risk of distant relapse. The trial also has a translational component aimed at establishing whether selected genomic, epigenetic, and transcriptomic markers are predictive of tumor and patient outcome.||||
1302401|NCT03565016|||Cohort||Prospective|||||||
1302402|NCT03565003||Single Group Assignment||Treatment||None (Open Label)||||||
1302403|NCT03564990|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1302404|NCT03564977||Single Group Assignment||Treatment||None (Open Label)||||||
1302405|NCT03564964||||||||||||
1302406|NCT03564951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302407|NCT03564938||Single Group Assignment||Treatment||None (Open Label)||||||
1302408|NCT03564925|Randomized|Parallel Assignment||Treatment||None (Open Label)||two groups, group one is for Wide Area Circumferential Ablation With Contact Force catheter, group two is for Cryoballoon Ablation||||
1302409|NCT03564912|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302410|NCT03564899|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants are randomized, using a 1:1:1 allocation, into one of three groups: 1) the control group (no physical activity intervention), 2) the lighter intensity physical activity intervention or 3) the higher intensity physical activity intervention.||||
1302411|NCT03564886|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1302412|NCT03564873|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1302413|NCT03564860|||Case-Only||Prospective|||||||
1302414|NCT03564847|Randomized|Parallel Assignment||Treatment||Single|Researchers doing outcome assessment will be kept blind to the group allocations|||||t
1302415|NCT03564834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302416|NCT03564821|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1302417|NCT03564808|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Quasi experimental||||
1302418|NCT03564795|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, controlled within-subject trial of 30 patients, each of whom will have a minimum of one burn treated with the KeraStat Gel device and one burn treated with the standard of care dressing||||
1302419|NCT03564782||Single Group Assignment||Basic Science||None (Open Label)||All subjects will receive intratumoral injection of the study drug PVSRIPO at a dose of 1x10^8 TCID50 (tissue culture infectious dose). On Day 14 after injection, subjects will undergo standard-of-care surgical resection of PVSRIPO-treated tumor.||||
1302420|NCT03564769|Randomized|Parallel Assignment||Prevention||Single|||t|||
1302421|NCT03564756|Randomized|Parallel Assignment||Treatment||Triple|Double blinded|Randomized Parallel Group, Placebo Controlled Trial|t|t|t|
1302422|NCT03564743|||Cohort||Prospective|||||||
1302423|NCT03564730|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized to either simultaneous or staged bilateral KA procedures using randomly generated numbers permuted in blocks of 10.||||
1302424|NCT03564717|Randomized|Parallel Assignment||Other||Single||||||t
1302425|NCT03564704||Single Group Assignment||Treatment||None (Open Label)||||||
1302426|NCT03564691|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302427|NCT03564678|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302428|NCT03564665|Randomized|Parallel Assignment||Treatment||Single|Placebo|Randomized, Placebo Controlled, Single Blinded|t|||
1302429|NCT03564652|Randomized|Parallel Assignment||Treatment||Single||||||t
1302430|NCT03564639|||Cohort||Prospective|||||||
1302431|NCT03564626|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302432|NCT03564613|||Cohort||Prospective|||||||
1302433|NCT03564600|||Cohort||Prospective|||||||
1302434|NCT03564587|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302435|NCT03564574|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302436|NCT03564561|||Cohort||Prospective|||||||
1302437|NCT03564548|Randomized|Parallel Assignment||Treatment||Triple||The first part of the study will be in a crossover model and the second part in a parallel model|t|t|t|
1302438|NCT03564535|Randomized|Parallel Assignment||Treatment||Double|"Both patients and follow-up clinician will be blinded regarding the use of mesh fixation. The mesh fixation technique will only be entered in the master chart of the student but not in the Operation notes, in order to prevent accidental disclosure by a curious patient or follow up evaluator instead the phrase, TEP done by 11x15cm mesh will be written.'' For legal reasons details of the tack applicator device will be recorded on the nursing count sheet.) Follow-up will be performed by a different clinician to the operating surgeon. There would be no external clues such as differences in the location or size of skin incisions to indicate whether fixation had been performed or not."|Patients of uncomplicated inguinal hernia presenting to the outpatient department of AIIMS, Bhubaneswar will be recruited to the study. They would be put either in the conventional tacker group or self-fixating mesh group based on the sealed envelope which will be revealed once the patient is intubated. Random allocation done using random allocation software. Surgeries would be performed by single surgery team experienced in laparoscopic hernia repair.|t|||t
1302439|NCT03564522|||Case-Control||Cross-Sectional|||||||
1302440|NCT03564509|Randomized|Parallel Assignment||Treatment||Double|FE 999302 and placebo will be identical in appearance and the trial is considered double-blind as neither the subject nor the investigator will know whether the subject is receiving FE 999302 or placebo.||t||t|
1302441|NCT03564496|Non-Randomized|Single Group Assignment||Other||Single||Participants (N=60) (20 Healthy Controls and 40 participants with neurological disorders, ie. multiple sclerosis) will be recruited to complete self-report measures and a brief cognitive assessment and then undergo an hour long stand-alone MRI scan while simultaneously undergoing tDCS stimulation.|t|||
1302442|NCT03564483|||Cohort||Prospective|||||||
1302443|NCT03564470|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302444|NCT03564457|||Cohort||Retrospective|||||||
1302452|NCT03564353|Randomized|Parallel Assignment||Basic Science||Double||Participants will be randomly assigned to one of four groups: (1) tDCS targeting location 1 paired with memory task (2) tDCS targeting location 2 with memory task (3) tDCS targeting location 3 paired with memory task (4) tDCS targeting location 4 paired with memory task|t|||t
1302453|NCT03564340|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302454|NCT03564327|||Cohort||Prospective|||||||
1302455|NCT03564314|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1302456|NCT03564301|Randomized|Parallel Assignment||Treatment||Double|It will not be possible to know which patient will correspond the prescription of the antibiotic or the placebo until the end of treatment. One of the researchers will be masked and will deliver the boxes with the placebo or the antibiotic according to the result of randomization. He will be different from the researcher who perform the treatment. This means that the treatment group will be masked to patients and dentists.|PLACEBO-CONTROLLED CLINICAL TRIAL IN HUMAN|t|t||
1302457|NCT03564288||Single Group Assignment||Treatment||None (Open Label)||||||
1302458|NCT03564275|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Matched pair analysis. Each prospective patient will be matched with two historical patients based on the inclusion, exclusion and match criteria.||||
1302459|NCT03564262|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1302460|NCT03564249|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1302461|NCT03564236|Randomized|Parallel Assignment||Treatment||Single||Paralell-group randomised controlled trial||||t
1302462|NCT03564223|||Ecologic or Community||Cross-Sectional|||||||
1302463|NCT03564210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302464|NCT03564197||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302465|NCT03564184|Randomized|Factorial Assignment||Treatment||Single|Data collectors (for self-reports) and assessors (for observational measures) will be trained in assessment procedures and blinded to participant allocation. This will be ensured by using assessors from a different ward and by asking participants not to reveal their treatment assignments. Success of blinding will be verified.|2x2 factorial, multinational, single-blind trial||||t
1302466|NCT03564171|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||we have 2 arms, one interventional and one control, we choose them by closed envelop .||||
1302467|NCT03564158|Randomized|Crossover Assignment||Other||Triple|Only Moxifloxacin will be administered open-label.||t||t|t
1302468|NCT03564145||Single Group Assignment||Treatment||None (Open Label)||||||
1302469|NCT03564132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302470|NCT03564119|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1302471|NCT03564106|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1302472|NCT03564093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302473|NCT03564080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Non-randomised control trial assessing feasibilty of new treatment method - combined supervised exercise programme||||
1302474|NCT03564067||Single Group Assignment||Treatment||None (Open Label)||||||
1302475|NCT03564054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302476|NCT03564041|Randomized|Parallel Assignment||Treatment||Triple|Participant enrolment will be masked from care provider, investigator, and the outcomes assessors through the use of third party randomization. This ensures that only participants, and those necessary in coordinating their participation in the study, are aware of whether or not they are part of the experimental or control group.|This study will be a blinded (rater, investigator, and clinician), 12-week randomized controlled trial (RCT) conducted at Western University, London, ON, Canada, and McGill University, Montreal, QC, Canada.||t|t|t
1302477|NCT03564028|Randomized|Crossover Assignment||Other||None (Open Label)||"Patients will perform two stair climbing sessions (each session include 108 steps) under two different conditions on the same day with at least 30 minutes of rest between the two sessions.~the order of the two conditions will be randomly assigned"||||
1302478|NCT03564015|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel group, randomized, open-label, controlled trial||||
1302479|NCT03564002|||Case-Control||Prospective|||||||
1302480|NCT03563989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302481|NCT03563976|||Case-Only||Retrospective|||||||
1302482|NCT03563963|Randomized|Parallel Assignment||Prevention||Triple|The anesthesia provider will be blinded to the intervention group allocation as the two solutions are clear, however they will not be blinded if their patient is in the control group. All patients will be anesthetized when the medium is placed in the ETT, thus patients will be blinded. The primary investigator will be blinded. The resident researcher who will be the outcome assessor will also be blinded.|The two intervention groups will be: 1) lidocaine 2% in the ETT cuff and 2) ropivacaine 0.5%in the ETT cuff. The control group will be air in the ETT cuff.|t||t|t
1302483|NCT03563950||Single Group Assignment||Treatment||None (Open Label)||||||
1302484|NCT03563937|||Cohort||Retrospective|||||||
1302485|NCT03563924|||Cohort||Other|||||||
1302486|NCT03563911|Randomized|Parallel Assignment||Treatment||Single||||||t
1302487|NCT03563898||Single Group Assignment||Treatment||None (Open Label)||Patients will be subjected daily for 30 minutes to the Portable Sauna Care steam bath (45 degree C temperature). The patient will decide if the time and / or temperature of the Sauna Bath is reduced to Tolerance. Before being subjected to the sauna bath, blood pressure will be taken 10 minutes prior. Weigh the patient with a Scale. You will be informed of the symptoms that may occur during the bath, and if present, you will let the health staff know that you will be present at all times during the bathing period, which will have a SURVEILLANCE TABLE which It will be filled during the intervention where they are monitored and comply with the stipulated norms as well as notes for adverse effects. After the completion of the bath, there will be a space of 15 minutes for the patient to dry the skin and the bathing suit with a towel. After 15 minutes, the patient will be weighed and the blood pressure will be taken again.||||
1302488|NCT03563885|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1302489|NCT03563872|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1302490|NCT03563846|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1573348|NCT00001520||||Treatment||||||||
1302493|NCT03563807|Randomized|Parallel Assignment||Supportive Care||Single|A blinded rater will perform the Mini-BESTest of balance before and after the intervention|||||t
1302494|NCT03563794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302495|NCT03563781||Single Group Assignment||Diagnostic||None (Open Label)||All patients with early ovarian cancer will receive sentinel node procedure before full lymphadenectomy, in order to assess the accuracy of sentinel node in diagnosing the presence of nodal metastases.||||
1302496|NCT03563768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302497|NCT03563755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302498|NCT03563742||Single Group Assignment||Treatment||None (Open Label)||||||
1302499|NCT03563729|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Six patients are enrolled in each arm. If clinical benefit is observed, each arm will be expanded to enroll a total of 20 patients.||||
1302500|NCT03563716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302501|NCT03563703|Randomized|Parallel Assignment||Treatment||Double|Because of the physical nature of the interventions, it will not be possible to conceal the group allocation from the nurses or trial participants.|Once eligibility, informed consent and assent are confirmed, participants will be randomly assigned, in the appropriate age stratum, to 1 of 3 groups: peripheral intravenous catheterization with the standard approach or with the help of either ultrasound or near-infrared vascular imaging. Randomization will be achieved with the use of an online, computer-generated program.|||t|t
1302502|NCT03563690|Randomized|Parallel Assignment||Treatment||Single|||t|||
1302503|NCT03563677|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Recruitment of 682 patients into control group during first 9 months of the project and, thereafter, recruitment of 682 patients during subsequent 9 months||||
1302504|NCT03563664||Single Group Assignment||Treatment||None (Open Label)||38 ovulatory patients with unexplained recurrent implantation failure were recruited. Endometrial αvβ3 integrin expression (using immunohistochemically stained endometrial biopsy) was compared before and after treatment with danazol.||||
1302505|NCT03563651|||Case-Only||Prospective|||||||
1302506|NCT03563638|||Case-Control||Retrospective|||||||
1302507|NCT03563625|Randomized|Parallel Assignment||Treatment||Triple|Blinded to procedure done|"The patients will be classified randomly into two groups using closed envelope technique, 25 patients each:~Group L: 25 patients will receive 1mg/kg bupivacaine 0.25% (diluted as 1ml bupivacaine + 1ml normal saline) by local infiltration in the wound before closure of the skin and subcutaneous.~Group C: 25 patients will receive caudal block with 1mg/kg bupivacaine 0.25%."|t|t||t
1302508|NCT03563612|Randomized|Crossover Assignment||Treatment||Double||prospective randomized controlled crossover study|t|||t
1302509|NCT03563599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302510|NCT03563586|Randomized|Sequential Assignment||Prevention||Triple||||t|t|t
1302511|NCT03563573|Randomized|Parallel Assignment||Treatment||Quadruple|The scoring of the lidocaine test is masked, using the coded identity of the tastes. The scoring will be done during the visit by the Scoring and Randomization Specialist so that the patient can be assigned to an intervention or control group to maintain equal numbers in treatment versus control groups. To prevent bias, the Scoring and Randomization Specialist will not be involved in any of the ADHD assessment steps and the patients will not be told about their lidocaine status until after all study testing is done. The subjects and other study personnel such as those doing the ADHD testing will be told not to discuss what they could or couldn't taste. Having scored the lidocaine test, the Scoring and Randomization Specialist will assign subjects to Intervention versus Control using a 1-to-1 allocation.|"The trial will have 2 arms, lidocaine sensitive (effective) and lidocaine insensitive (ineffective). The sample will be enriched to have 50% in each arm. Within each arm, subjects will be randomized on a 1-to-1 allocation to the treatment or control groups.~The investigators will adopt an iterative approach of testing of batches of subjects because (1) the frequency of lidocaine-insensitivity is only known approximately, (2) the frequency may be unevenly distributed across ethnic groups, and (3) the exact effect size of the potassium is not known, though reported to be high in off-label use in clinical settings with more chronic administration.~At the end of testing 40 patients, the results will be analyzed for statistical significance. (1) If the results are statistically significant with a 95% confidence, the testing may stop with the first batch of 40 subjects. (2) If not, sequential, iterative batches of 20 subjects will be tested, and the results reanalyzed."|t|t|t|t
1302512|NCT03563560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open labeled|This study consists of 2 cohorts of the ACM regimen part and 1 cohort of the A+7+3 regimen part.||||
1302513|NCT03563547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302514|NCT03563534|Randomized|Parallel Assignment||Treatment||Single||||||t
1302515|NCT03563521|||Case-Control||Prospective|||||||
1302516|NCT03563508|||Other||Cross-Sectional|||||||
1302517|NCT03563495|Randomized|Parallel Assignment||Treatment||||||||
1302518|NCT03563482||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302519|NCT03563469|||Case-Only||Cross-Sectional|||||||
1302520|NCT03563456|Randomized|Parallel Assignment||Treatment||Single|"The assessors for blood measure are not aware of the group of experiment, since the blood samples will not carry any descriptions of the group.~The assessors for physical fitness are not aware of the group of experiment, since the medical record is not provided to the assessors."|randomized controlled trial||||t
1302521|NCT03563443|||Case-Control||Prospective|||||||
1302522|NCT03563430|Randomized|Parallel Assignment||Basic Science||Triple||neuromuscular electrical stimulation, low intensity aerobic exercise, self massage with foam roller methods|t||t|t
1302523|NCT03563417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302524|NCT03563404|||Cohort||Prospective|||||||
1302525|NCT03563391||Single Group Assignment||Supportive Care||None (Open Label)||A prospective, open-label, multi-site, growth, safety and tolerance study.||||
1302526|NCT03563378|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1302527|NCT03563365|Randomized|Factorial Assignment||Treatment||Single|Subject is instructed not to discuss or disclose treatment arm with PI.||||t|
1302528|NCT03563352|||Case-Only||Prospective|||||||
1302529|NCT03563339||Single Group Assignment||Prevention||None (Open Label)||||||
1302530|NCT03563326|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302531|NCT03563313|Randomized|Parallel Assignment||Other||None (Open Label)||A randomized controlled trial of 6 month at home closed loop system vs. sensor-augmented pump.||||
1302532|NCT03563300|Randomized|Parallel Assignment||Diagnostic||Quadruple||Parallel Assignment|t|t|t|t
1302533|NCT03563287|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1302534|NCT03563274|||Cohort||Prospective|||||||
1302535|NCT03563261|Randomized|Parallel Assignment||Treatment||Double|Participants and researchers will not know if participants are allocated to the control or active product group.|Double-blinded randomized control study|t||t|
1302536|NCT03563248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302537|NCT03563235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302538|NCT03563222|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1302539|NCT03563209|||Case-Only||Cross-Sectional|||||||
1302540|NCT03563196|||Cohort||Prospective|||||||
1302541|NCT03563183|||Other||Retrospective|||||||
1302542|NCT03563170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302543|NCT03563157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302544|NCT03563144|Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a randomized parallel group study comparing the NANT Pancreatic Cancer Vaccine and standard therapy with respect to efficacy and safety in treatment naïve patients with pancreatic cancer. Patients will be stratified by ECOG status and then randomized 1:1 to receive either the NANT Pancreatic Vaccine (n~532) or standard therapy with gemcitabine alone (ECOG 2; n~266) or combined with nab-paclitaxel (ECOG 0-1; n~266). Treatment may continue for up to 2 years or until documented progression (RECIST v 1.1) or unacceptable toxicity. Patients on standard therapy who progress or experience unacceptable toxicity may crossover to receive NANT Pancreatic Vaccine.||||
1302545|NCT03563131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1302546|NCT03563118|||Other||Prospective|||||||
1302547|NCT03563105||Single Group Assignment||Diagnostic||None (Open Label)||Vascular Occlusion Test||||
1302548|NCT03563092|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, randomized clinical trial||||
1302549|NCT03563079|Randomized|Parallel Assignment||Treatment||Single|Participants selected to participate in this research will be randomly drawn and randomly allocated using sealed opaque envelopes, and therefore included randomly in one of the two groups present in this study. A collaborative researcher blind to the groups will be assigned to conduct the pre- and post-intervention evaluation process of all individuals.|Randomized clinical trial||||t
1302550|NCT03563066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302551|NCT03563053||Single Group Assignment||Treatment||None (Open Label)||Open-label, Long-term, Extension Treatment||||
1302552|NCT03563040||Single Group Assignment||Treatment||None (Open Label)||||||
1302553|NCT03563027|Randomized|Parallel Assignment||Health Services Research||Double|Investigator and Outcomes assessor will be masked until the trial is completed and all analyses are finished.|Parallel 3-arm randomized, controlled trial|||t|t
1302554|NCT03563014|||Cohort||Retrospective|||||||
1302555|NCT03563001|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with diagnosis of simple chronic obstructive pulmonary disease(COPD) and asthma-chronic obstructive pulmonary disease overlap(ACO) are recruited.Small airways function of subjects in both group(chronic obstructive pulmonary disease and asthma-chronic obstructive pulmonary disease overlap) is assessed at baseline.And then budesonide(160ug) and formoterol(4.5ug) bid will be given to the subjects for 3 months.The subjects will have a follow-up visit with the same examinations after 3 months` treatment.||||
1302556|NCT03562988|Randomized|Crossover Assignment||Other||Single|||||t|
1302557|NCT03562975|||Case-Only||Prospective|||||||
1302558|NCT03562962||Single Group Assignment||Basic Science||None (Open Label)|An independent blind Research Assistant (RA) will score and record the data from questionnaires administered before and after therapeutic sessions.|A concurrent experimental multiple baseline design (MBL) across participants with a follow-up phase will be conducted (A/B/Follow-up). Concurrent MBL controls historical factors and other threats to internal validity by sequentially introducing the treatment phase. The latter requires that the length of the baselines varies between participants. Additionally, the MBL allows comparing behavioral data among individuals across different or similar conditions, showing whether extraneous variables affect the participants in the same manner or not. The between-series comparisons control for threats to external and internal validity that might affect individuals in the same study.||||
1302559|NCT03562949|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302560|NCT03562936|||Cohort||Prospective|||||||
1302561|NCT03562923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302562|NCT03562910||Single Group Assignment||Health Services Research||None (Open Label)||||||
1302563|NCT03562897||Single Group Assignment||Supportive Care||None (Open Label)||||||
1302564|NCT03562884|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1302565|NCT03562871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302566|NCT03562858|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1302567|NCT03562845|||Case-Only||Prospective|||||||
1302568|NCT03562832||Single Group Assignment||Treatment||None (Open Label)||||||
1302569|NCT03562819|||Cohort||Cross-Sectional|||||||
1302570|NCT03562806||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302571|NCT03562793|Randomized|Parallel Assignment||Treatment||Single|Assessors will be blinded to treatment assignment when administering baseline outcome assessments.|Randomized controlled trial with behavioral intervention.||||t
1302572|NCT03562780|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1302606|NCT03562325||Single Group Assignment||Treatment||None (Open Label)||Open case trial||||
1302607|NCT03562312|Randomized|Parallel Assignment||Treatment||Single|||t|||
1302608|NCT03562299||Single Group Assignment||Treatment||None (Open Label)||||||
1302609|NCT03562286||Single Group Assignment||Treatment||None (Open Label)|Open label|Intervention model: single group assignment Masking: None (Open label) Primary purpose: treatment||||
1302573|NCT03562767|Randomized|Parallel Assignment||Supportive Care||Single|Research staff conducting the psychological, physical, outcome assessments, and study analyses will be blinded to participant's group allocation. To minimize bias, participants in the intervention group will be asked to refrain from disclosing their group assignment to study staff who collect data and questionnaires. Due to the overt nature of the CT-CB approach, the investigators and participants in the intervention group will not be blinded.|Three groups of subjects with uncontrolled diabetes Type 2 will be followed longitudinally for 3 months||||t
1302574|NCT03562754|Randomized|Parallel Assignment||Treatment||Single||||||t
1302575|NCT03562741||Single Group Assignment||Treatment||None (Open Label)||||||
1302576|NCT03562728|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302577|NCT03562715|||Case-Control||Retrospective|||||||
1302578|NCT03562702|Randomized|Parallel Assignment||Treatment||Triple|The assignment of treatment will be concealed from research team members involved in recruiting patients by using sealed, sequentially numbered, opaque envelopes containing the type of rehydration treatment to be used.||t|t|t|
1302579|NCT03562689|||Cohort||Retrospective|||||||
1302580|NCT03562676||Single Group Assignment||Basic Science||None (Open Label)||||||
1302581|NCT03562663|Randomized|Parallel Assignment||Treatment||Double|Staff delivering the transcranial direct current stimulation and performing evaluations are blinded to active vs. sham stimulation.|||t||t
1302582|NCT03562650|Randomized|Parallel Assignment||Treatment||Single|All participants are assigned to a condition and given a treatment justification, but are not told whether they are in the treatment or control condition.|Active treatment and active treatment control conditions.|t|||
1302583|NCT03562637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302584|NCT03562624|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1302585|NCT03562611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302586|NCT03562585|||Case-Only||Prospective|||||||
1302587|NCT03562572|Randomized|Parallel Assignment||Treatment||None (Open Label)||It concerns an investigator initiated prospective 1:1 randomised clinical trial in non-STEMI patients with multivessel coronary artery disease amenable to treatment with PCI.||||
1302588|NCT03562559|||Case-Only||Cross-Sectional|||||||
1302589|NCT03562546|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1302590|NCT03562533|||Case-Control||Retrospective|||||||
1302591|NCT03562520||Single Group Assignment||Treatment||None (Open Label)||||||
1302592|NCT03562507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||There are 2 cohorts for accrual with Cohort A being accrued first. Cohort B will follow and will have 2 stages of accrual. Cohort A will accrue 11 patients to monotherapy treatment. Then Cohort B will begin accrual of 17 patients to the first stage and if the interim permits, the second stage will accrue an additional 19 patients.||||
1302593|NCT03562494|Randomized|Parallel Assignment||Treatment||Triple||Randomized, Placebo Surgery Controlled, Double-blinded, Multi-center|t|t||t
1302594|NCT03562481|Randomized|Crossover Assignment||Other||Triple||"Study subjects will serve as their own controls in this crossover AB/BA study design which is uniform within sequences (groups, i.e. AB/BA, of order of drug formulation administration), uniform within periods (equal time between administration of alternating drug formulations), and balanced (equal number of subjects within each study arm).~The randomization will be performed to the type of drug given first, using a balanced randomization (half subjects buffered, half unbuffered) implemented with SAS software routines. During the first session, each subject will receive an IAN block with the first randomly assigned anesthetic formulation using the Halstead technique. At least a week later, substantially longer than the elimination half-life of the drug lidocaine (1.5-2hr), local anesthetic injections will be done using the alternate local anesthetic formulation."|t|t||t
1302595|NCT03562468|Randomized|Crossover Assignment||Other||Quadruple|"The study site will be provided placebo and TRU NIAGEN capsules, each labeled with the protocol number, blinded product code, expiration date, batch number, the statement For Investigational Use Only and a space to write the subject's initials, screen and date dispensed."|Treatments will be administered daily as 4 capsules in a double-blind, randomized, crossover manner for three 8-week treatment periods. Each subject will receive one placebo and two active treatments in a crossover design.|t|t|t|t
1302596|NCT03562455|Randomized|Parallel Assignment||Other||Single|The individual assessing performance outcomes will not be aware of which intervention the participants received.|The study will contain two arms. One group will receive virtual reality power wheelchair training, and the other will receive in-person wheelchair training by a therapist.||||t
1302597|NCT03562442|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Two groups are recruited in parallel (A) Smokers who quit smoking (Visit 1 before cessation, Visit 2 six weeks after cessation) (B) Never-smokers (Visit 1 only)||||
1302598|NCT03562429|Randomized|Parallel Assignment||Treatment||Quadruple||180 subjects are divided into treatment group and control group (placebo).|t|t|t|t
1302599|NCT03562416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302600|NCT03562403||Single Group Assignment||Treatment||None (Open Label)||||||
1302601|NCT03562390||Single Group Assignment||Treatment||None (Open Label)||||||
1302602|NCT03562377|Randomized|Parallel Assignment||Treatment||Double|"Neither the subject nor any of the investigator or LEO staff who are involved in the treatment or clinical evaluation and monitoring of the subjects will be aware of the treatment received. The packaging and labelling of tralokinumab/placebo will contain no evidence of their identity.~Since tralokinumab and placebo are visually distinct and not matched for viscosity, they will be handled and administered by a qualified, unblinded healthcare professional at the trial site who will not be involved in the management of trial subjects."||t||t|
1302603|NCT03562364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302604|NCT03562351|Randomized|Parallel Assignment||Prevention||None (Open Label)||The investigators will implement an intervention jointly with our simulation program to determine the most effective training model: verbal instructions, instructional video, or use of a mannequin. Caregivers will undergo a training curriculum, and 90 caregivers (30 assigned to each educational model) will be matched into three groups and assigned to participate in one of three educational models in the SIM Center.||||
1302605|NCT03562338|Randomized|Parallel Assignment||Screening||Single||||||t
1303393|NCT03552094|||Ecologic or Community||Prospective|||||||
1302610|NCT03562273||Single Group Assignment||Treatment||None (Open Label)||||||
1302611|NCT03562260||Single Group Assignment||Treatment||None (Open Label)||only 1 group in children who received the bipolar release||||
1302612|NCT03562247|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302613|NCT03562234|||Cohort||Prospective|||||||
1302614|NCT03562221|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1302615|NCT03562208|Randomized|Crossover Assignment||Treatment||None (Open Label)||"Group 1 (50 patients): Patients treated with total bone marrow, in the protocol as a group treatment will analyze type OPEN: The patient knows the treatment, as the investigator and sponsor. All patients continue to receive the standard treatment with insulin and other medicines prescribed by your doctor.~Group 2 (50 patients): Patient no treated, as a control group. All patients continue to receive the standard treatment with insulin and other medicines prescribed by your doctor."||||
1302616|NCT03562195|Randomized|Parallel Assignment||Treatment||Double|This will be a double blind study. Subjects and investigator will be masked.|Eligible subjects will be randomized in 1:1 ratio to receive either mepolizumab or placebo along with existing standard of care therapy during the treatment period.|t||t|
1302617|NCT03562182|||Case-Control||Prospective|||||||
1302618|NCT03562169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302619|NCT03562156|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1302620|NCT03562143|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients that agree to participate will be randomized to receive either 1 tablet of 325mg ferrous sulfate (65 mg of elemental iron) on consecutive days for 6 weeks or 2 tablets together (130 mg of elemental iron ) every other day for 6 weeks. Both groups will be receiving the same total amount of iron over the study period (2730 mg of elemental iron over 6 weeks).||||
1302621|NCT03562130||Single Group Assignment||Treatment||None (Open Label)||||||
1302622|NCT03562117|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|There will be no masking, as this is an open-label study.|||||
1302623|NCT03562104||Single Group Assignment||Diagnostic||None (Open Label)||Description of swallowing||||
1302624|NCT03562091|||Cohort||Prospective|||||||
1302625|NCT03562078|Randomized|Parallel Assignment||Prevention||Single||||||t
1302626|NCT03562065||Single Group Assignment||Treatment||None (Open Label)||||||
1302627|NCT03562052|||Cohort||Prospective|||||||
1302628|NCT03562039|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1302629|NCT03562026|||Cohort||Prospective|||||||
1302630|NCT03562013|||Cohort||Prospective|||||||
1302631|NCT03562000|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302632|NCT03561987|||Cohort||Prospective|||||||
1302633|NCT03561974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302634|NCT03561961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302635|NCT03561948|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302636|NCT03561935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302637|NCT03561922||Single Group Assignment||Treatment||None (Open Label)||||||
1302638|NCT03561909||Single Group Assignment||Other||None (Open Label)||||||
1302639|NCT03561896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302640|NCT03561883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302641|NCT03561870||Single Group Assignment||Treatment||None (Open Label)||||||
1302642|NCT03561857||Single Group Assignment||Other||None (Open Label)||||||
1302643|NCT03561844|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1302644|NCT03561831|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1302645|NCT03561818|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302646|NCT03561805||Single Group Assignment||Treatment||None (Open Label)||||||
1302647|NCT03561792|Randomized|Parallel Assignment||Other||Single|The ICU team on charge takes the decision to continue spontaneous breathing trial (SBT) according to the local practice protocols which depends on the traditional RSBI (RSBI < 105 predicts successful weaning). The ICU team will not be allowed to know the results of diaphragmatic ultrasound.|||t||
1302648|NCT03561779|Randomized|Parallel Assignment||Treatment||Double||The Subjects are injected investigational Product (YYD302 or Synovian Inj.)|t||t|
1302649|NCT03561766|||Cohort||Prospective|||||||
1302650|NCT03561753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302651|NCT03561740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302652|NCT03561727|Randomized|Parallel Assignment||Prevention||Triple|Neither the patients included in the study nor the investigators assessing the presence of incisional hernia during follow-up visits will be aware of the type of surgical technique used for abdominal closure (double-blinded study). Only the professionals present in the operating room during surgical procedure, including operator, assistants, anesthesiologist, and nurses, will be aware of the type of assigned intervention.|"The technique comprising continuous suture and mass closure will be compared to the technique 2 separate layers of continuous sutures.~Patients will be randomly assigned to one of the two techniques of abdominal closure during the operative procedure and after its main part has been completed, just before the beginning of closure of the abdominal cavity. Randomization will be performed in a 1:1 ratio and in blocks of 20 patients."|t||t|t
1302653|NCT03561714|||Case-Control||Prospective|||||||
1302654|NCT03561701|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1302655|NCT03561688|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||The study design is a cross over study. Patients is instructed in using a placebo FO for one month and receive a custom-made FO, which they will be using for one month.||||
1302656|NCT03561675|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1302657|NCT03561662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302658|NCT03561649||Single Group Assignment||Screening||None (Open Label)||||||
1302659|NCT03561636|||Cohort||Retrospective|||||||
1302660|NCT03561623|||Case-Control||Prospective|||||||
1302661|NCT03561610|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1302662|NCT03561597||Single Group Assignment||Health Services Research||None (Open Label)||prospective single arm study||||
1302663|NCT03561584|Randomized|Sequential Assignment||Treatment||Double|Participants and Providers will be masked until Week 14. If a subject continues past week 14, the study becomes Open-Label and participants are given the option to continue on the active drug for an additional 8 weeks.|There are two arms in this trial: active drug and placebo.|t|t||
1302664|NCT03561571|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1302665|NCT03561558|Randomized|Crossover Assignment||Other||None (Open Label)|This study is an open label study; the subjects and the investigator will not be blinded towards the identity of the investigational products. However, analysts will be blinded towards identity of investigational products administered.|||||
1302666|NCT03561545||Single Group Assignment||Basic Science||None (Open Label)||||||
1302667|NCT03561532|Randomized|Parallel Assignment||Treatment||Quadruple|The participant and the treating personnel are blinded of the randomization result.|Participants are randomized in two groups to receive in colonoscopy either a fecal suspension made of their own feces or a fecal suspension of a healthy donor.|t|t|t|t
1302668|NCT03561519|Randomized|Parallel Assignment||Treatment||Quadruple|Randomization was done by personnel not treating the patient. The participant or FMT providing personnel did not know the result of randomization. The doctors assessing the outcome have been blinded of the result of randomization.|Placebo controlled trial. 50% of patients received autologous FMT as placebo and 50% received FMT from a healthy donor.|t|t|t|t
1302669|NCT03561506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302670|NCT03561493|Randomized|Parallel Assignment||Treatment||Single||||||t
1302671|NCT03561480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302672|NCT03561467|||Case-Only||Prospective|||||||
1302673|NCT03561454||Single Group Assignment||Treatment||None (Open Label)||||||
1302674|NCT03561441|Randomized|Sequential Assignment||Prevention||Triple|||t|t|t|
1302675|NCT03561428|||Other||Cross-Sectional|||||||
1302676|NCT03561415|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302677|NCT03561402|||Case-Control||Prospective|||||||
1302678|NCT03561389|||Cohort||Prospective|||||||
1302679|NCT03561376||Single Group Assignment||Treatment||None (Open Label)||Split scar study (petrolatum vs. zinc oxide)||||
1302680|NCT03561363|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302681|NCT03561350|||Case-Only||Prospective|||||||
1302682|NCT03561337|Randomized|Parallel Assignment||Other||Single|Single blinded|block randomized controlled intervention|t|||
1302683|NCT03561324||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302684|NCT03561311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302685|NCT03561298||Single Group Assignment||Treatment||None (Open Label)||||||
1302686|NCT03561285|||Cohort||Cross-Sectional|||||||
1302687|NCT03561272|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1302688|NCT03561259||Single Group Assignment||Treatment||None (Open Label)||Single-arm, non-randomized, open-label study.||||
1302689|NCT03561246|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1302690|NCT03561233||Single Group Assignment||Treatment||None (Open Label)||||||
1302691|NCT03561220|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302692|NCT03561207|||Cohort||Prospective|||||||
1302693|NCT03561194||||||||||||
1302694|NCT03561181|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302695|NCT03561168|||Cohort||Retrospective|||||||
1302696|NCT03561155|Randomized|Single Group Assignment||Treatment||Single||||||t
1302697|NCT03561142||Single Group Assignment||Treatment||None (Open Label)||"Patients will undergo different treatments based on response achieved after radiochemotherapy.~Clinical Complete Response: Omission of surgery and follow-up~Near clinical complete response: Reevaluation in three months~Poor / no response: Surgery"||||
1302698|NCT03561129|||Cohort||Retrospective|||||||
1302699|NCT03561116|Randomized|Parallel Assignment||Treatment||Quadruple|Triple blind||t|t|t|t
1302700|NCT03561103|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Intervention group receives client-centered representative payee services in addition to standard of care; control group receives standard of care only.||||
1302701|NCT03561090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302702|NCT03561077||Single Group Assignment||Other||None (Open Label)||||||
1302703|NCT03561064||Single Group Assignment||Treatment||None (Open Label)||||||
1302704|NCT03561051|||Cohort||Prospective|||||||
1302705|NCT03561038|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1302706|NCT03561025|Non-Randomized|Crossover Assignment||Diagnostic||Double|||t|t||
1302707|NCT03561012|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1302708|NCT03560999|||Cohort||Prospective|||||||
1302709|NCT03560986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302710|NCT03560973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302711|NCT03560960|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1302712|NCT03560947|Randomized|Parallel Assignment||Treatment||Single||||||t
1302713|NCT03560934|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants are initially categorized as non-frequent or frequent cannabis users based on their cannabis use behavior and then receive the same treatment of 20-30mg dronabinol upon participation in the study.||||
1302714|NCT03560921|||Cohort||Prospective|||||||
1302715|NCT03560908||Single Group Assignment||Treatment||None (Open Label)||||||
1302716|NCT03560895|Randomized|Parallel Assignment||Supportive Care||Double|An independent investigator not involved in the study opened the envelopes 1hour before anesthesia induction. Study data collection will be done by well-trained investigators not involved in the study. Patients' guardians and all study personnel will be blinded to treatment assignment.|The aim of this study will be to test the accuracy of Sonography in determining the endotracheal tube size in pediatric patients whether cuffed or un-cuffed.|t|||t
1302717|NCT03560882||Single Group Assignment||Treatment||None (Open Label)||||||
1302718|NCT03560869|Randomized|Crossover Assignment||Basic Science||Single||Normal Hydration and Dehydration Estimated number of subjects to complete both protocols = 20 young adults & 20 older adults|||t|
1302719|NCT03560856||Single Group Assignment||Treatment||None (Open Label)||||||
1302720|NCT03560843|Randomized|Parallel Assignment||Treatment||None (Open Label)||MBSR is an 8 week standardized protocol that includes gentle yoga, meditation, and mindfulness practices that were originally developed by Jon Kabat-Zinn from the University of Massachusetts. A trained MBSR instructor will lead group sessions weekly for approximately 150-210 minutes to teach and demonstrate the practices. Practices include walking/standing/supine meditation, body scanning (drawing attention to various areas of the body such as the right foot or left hand), and simple hatha yoga postures.||||
1302721|NCT03560830|||Case-Control||Cross-Sectional|||||||
1302722|NCT03560817|||Cohort||Prospective|||||||
1302723|NCT03560804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302724|NCT03560791|||Case-Only||Retrospective|||||||
1302725|NCT03560778|||Cohort||Retrospective|||||||
1302726|NCT03560765|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1302727|NCT03560752||Single Group Assignment||Supportive Care||None (Open Label)||||||
1302728|NCT03560739||Parallel Assignment||Treatment||None (Open Label)||To address the primary objective of testing bioequivalence at dosing interval after Week 8 between Pre-filled Syringe (PFS) and Auto-Injector (AI), the primary analysis involves the two groups (PFS (abdomen) and AI (abdomen)). Further the pharmacokinetcs of ofatumumab will be compared between using the thigh or abdomen for injections.||||
1302729|NCT03560726|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302730|NCT03560713|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1302731|NCT03560700|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1302732|NCT03560687|Randomized|Parallel Assignment||Treatment||Single|Single blinded|Randomization of 1000 consecutive patients undergoing heart surgery to either Iron supplementation or Control||||t
1302733|NCT03560674|||Other||Cross-Sectional|||||||
1302734|NCT03560661|||Other||Prospective|||||||
1302735|NCT03560648|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1302736|NCT03560635|Randomized|Parallel Assignment||Other||Single|||||t|
1302737|NCT03560622|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Ten adults with refractory ET (ET cohort) and 20 healthy controls (control cohort) will undergo multi-modality neuroimaging (structural imaging, diffusion tensor imaging (DTI), task-based functional MRI (t-fMRI), and resting state functional MRI (rs-fMRI)). In addition the ET cohort will also undergo imaging with the identical protocol immediately after and 24 hours after FUS-T.||||
1302738|NCT03560609|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302739|NCT03560596|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1302740|NCT03560583|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302741|NCT03560570|||Case-Control||Retrospective|||||||
1302742|NCT03560557|||Cohort||Prospective|||||||
1302743|NCT03560544|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302744|NCT03560531|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||In the monotherapy portion of the study, up to 4 sequential dose escalation cohorts are planned, followed by monotherapy dose expansion. After the monotherapy dose escalation and expansion cohorts are enrolled, the combination dose escalation and expansion portion of the study will begin.||||
1302745|NCT03560518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302746|NCT03560505|||Case-Control||Prospective|||||||
1302747|NCT03560492|Randomized|Crossover Assignment||Treatment||Double|Postural assessment is performed by a blinded investigator with a device for computerized measurement of surface curvature in the upright position (SpinalMouse®).|Participants are randomised to receive one intervention during the initial 3 month phase of the study and receive the other intervention during the second 3 month phase of the study, after a wash out 3 month period.|||t|t
1302748|NCT03560479|Randomized|Parallel Assignment||Treatment||Quadruple||Patients are randomized to receive intravesical instillations of either alpha1H (fixed dose) or placebo. The randomization ratio is 1:1.|t|t|t|t
1302749|NCT03560466||Single Group Assignment||Treatment||None (Open Label)||||||
1302750|NCT03560453|Randomized|Parallel Assignment||Treatment||None (Open Label)||Non-pharmacologic randomized clinical trial and followed the Non-pharmacological Consolidated Standards of Reporting Trials Statement recommendations to conduct the research (CONSORT; Boutron, Altman, Moher, Schulz, & Ravaud, 2017)||||
1302751|NCT03560440|||Other||Retrospective|||||||
1302752|NCT03560427|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1302753|NCT03560414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302754|NCT03560401|Randomized|Parallel Assignment||Treatment||Single|Patients eligible for the study were selected by an independent research assistant. The study was explained, and informed consent was obtained from patients before the surgery. Using a randomization sequence, the patients were assigned to the brace or no brace group.|Patients in the brace group were instructed to wear a rigid brace (Knight-Taylor [chairback] brace) full-time for 12 weeks, except when bathing or lying in bed. Patients in the no brace group were instructed to wear a soft corset for 2 weeks, after which it was weaned off. All patients started wearing the brace or corset during their first ambulation out of bed following drainage tube removal after the surgery.|||t|
1302755|NCT03560388|Randomized|Parallel Assignment||Supportive Care||Triple|Participant, care provider, and investigator are blind to allocation to control vs. intervention groups. Participant is also blind to the 2nd allocation to the two intervention group sub-arms.|Two main arms of control and intervention. Intervention arm include two sub-arms of integrative treatment plus acupuncture vs. integrative treatment with no acupuncture|t|t|t|
1302756|NCT03560375|Randomized|Parallel Assignment||Treatment||Single|Allocation concealment and blinding of primary outcome assessors will be implemented|This is a single center, open-label (primary outcome assessors blinded), parallel group, clinical trial of circuit resistance training for 10 weeks; V-Med diet for 10 weeks and then circuit resistance training on top of diet for 10 weeks; empagliflozin 10mg/day for 10 weeks and then circuit resistance training on top of drug therapy for 10 weeks in subjects with type 2 diabetes mellitus||||t
1302757|NCT03560362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302758|NCT03560349|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1302759|NCT03560336|||Cohort||Prospective|||||||
1302760|NCT03560323|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||36 type 2 diabetic subjects with New York Heart Association (NYHA) Class II-III heart failure and ejection fraction <50% (documented by patient's medical records with an Echocardiogram (ECHO) or any other heart imaging) will be studied. Other inclusion criteria: age = 30-70 years; BMI =23-38 kg/m2; 18 males/18 females; HbA1c = 6.0-9.0%; BP < 145/85 mmHg; Estimated glomerular filtration rate (eGFR) > 45 ml/min•1.73 m2. Subjects must have an NT-proBNP ≥ 500 pg/ml (or ≥ 300 pg/ml if ejection fraction is less than 35 %) and be on a stable dose of guideline-directed heart fail medication (i.e. ACE inhibitor (ACEI), Angiotensin II receptor blocker (ARB), Angiotensin Receptor-Neprilysin Inhibitor (ARNI), beta blocker, diuretic and/or mineralocorticoid receptor antagonist). Patients must be on stable antihypertensive therapy for at least 2 months. Only diabetic subjects treated with diet/exercise, metformin monotherapy, sulfonylurea monotherapy (SU) or combination metformin/SU therapy.||||
1302761|NCT03560310|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel treatment arms.||||
1302762|NCT03560297|Randomized|Crossover Assignment||Other||Single||||||t
1302763|NCT03560284|||Cohort||Retrospective|||||||
1302764|NCT03560271|Randomized|Parallel Assignment||Treatment||Quadruple|The investigator, sponsor, and subject will be blinded to study treatment.|Subject will be assigned to either 6 mg Cyclo-Z, 15 mg Cyclo-Z or placebo for the duration of study treatment.|t|t|t|t
1302765|NCT03560258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302766|NCT03560245|Randomized|Parallel Assignment||Treatment||Quadruple||Eligible subjects will be stratified based on Mini Mental State Exam (MMSE-2) scores 4-9 vs. 10-15 and will be randomized 1:1 to one of two treatment arms: 20µg bryostatin or placebo for twelve weeks (7 doses).|t|t|t|t
1302767|NCT03560232|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized, open-label||||
1302768|NCT03560219|||Cohort||Cross-Sectional|||||||
1302769|NCT03560206|Randomized|Parallel Assignment||Supportive Care||Single||a randomized controlled trial|t|||
1302770|NCT03560193|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302771|NCT03560180|||Cohort||Prospective|||||||
1302772|NCT03560167||Single Group Assignment||Treatment||None (Open Label)||||||
1302773|NCT03560154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302774|NCT03560141||||||||||||
1302775|NCT03560128|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1302776|NCT03560115|||Other||Prospective|||||||
1302777|NCT03560102||Single Group Assignment||Treatment||None (Open Label)||||||
1302778|NCT03560089|Randomized|Parallel Assignment||Treatment||Single|Blinded assessment of video|||||t
1302779|NCT03560076|||Cohort||Other|||||||
1302780|NCT03560063|Randomized|Parallel Assignment||Treatment||Double|"Participants: participants in both arms will undergo total hip replacement while under general anaesthetic. Participants will not be aware of the templating method used during the total hip replacement due to the general anaesthetic, therefore will remain blinded. Wounds and dressings will be the same for both study arms. Participants in the two study arms will undergo the same pre- and post-operative imaging to prevent unmasking.~Outcomes assessors examine patients from 3 months post-operatively. There is no risk they will know which arm the patient is in, as they will not have access to the study database."|"Participants will be recruited and randomised into the two parallel study arms. Interventional arm: total hip replacement with use of the Corin Optimised Positioning System to guide templating.~Comparator arm: total hip replacement, guided by standard templating techniques"|t|||t
1302781|NCT03560050|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized trial where family child care home providers (the participant) are randomized to either nutrition or environmental health technical assistance intervention. Interventions are matched for time and contact||||
1302782|NCT03560037|Randomized|Parallel Assignment||Diagnostic||Single||Participants will be enrolled to receive either conventional colonoscopy or colonoscopy with addition of Endocuff Vision device.|t|||
1302783|NCT03560024|Randomized|Parallel Assignment||Other||Double|Randomized, double-blind placebo-controlled design in healthy volunteers.|18 healthy volunteers will receive PACAP27 or placebo. All Data will also be analyses blinded.|t||t|
1302784|NCT03560011|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|"2 Arms :~Rituximab (375 mg/m2)~Rituximab (375 mg/m2) followed by 5 injections of immunoglobulin IV once a month during 5 months (2g/kg at M1, 1.5g/kg at M2 to M5, maximal dise 100g)"||||
1302785|NCT03559998|||Cohort||Prospective|||||||
1302786|NCT03559985|Randomized|Crossover Assignment||Treatment||Quadruple|"Paracetamol 500 mg capsules (Doliprane® 500 mg) will remain packaged in their blister packs of origin. The necessary quantity of capsules will be packaged in a box labelled at the corresponding period (period 1 or 2).~Lactose capsules (placebo) of the same size and colour as the Paracetamol capsules (Doliprane® 500 mg) will be bought by the CHU Pharmacy from Clermont-Ferrand. The capsules will then be blistered; the necessary quantity of capsules placebo will be packaged in the same box used for paracetamol, labelled at the time of the treatment (period 1 or 2)."|After a week of pre-selection (D-6 to D0), each patient will receive successively in random order each of the 2 products (paracetamol and placebo) with one wash-out period of 7 days between each administration.|t|t|t|t
1302787|NCT03559972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302788|NCT03559959|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1302789|NCT03559946|Randomized|Parallel Assignment||Treatment||Double|"Patients in both CP and SP groups will come to the clinic twice per week, and will not know their group assignment until the end of the study.~All the interventions will be performed by the sub-investigator. The care providing physician will not know the group assignment of the patients."|We will be recruiting 66 patients, who will be randomized (1:1) to either the Standard Protocol (SP) group or the Condensed Protocol (CP) group.|t|t||
1302790|NCT03559933||||||||||||
1302791|NCT03559920|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302850|NCT03559153|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1302927|NCT03558152|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1302792|NCT03559907|Randomized|Parallel Assignment||Prevention||Single|Outcomes assessors who are rating intervention fidelity will be blinded to intervention assignment.|"Quasi-Experimental: Three community sites will be randomized to receive on of three prevention interventions:~Cooking Matters for Parents~Promoting Routines of Exploration and Play during Mealtime (Mealtime PREP)~Combined (Cooking Matters + Mealtime PREP)"||||t
1302793|NCT03559894|||Cohort||Prospective|||||||
1302794|NCT03559881|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1302795|NCT03559868|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1302796|NCT03559855|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302797|NCT03559842|||Case-Only||Prospective|||||||
1302798|NCT03559829||Single Group Assignment||Treatment||None (Open Label)||||||
1302799|NCT03559816|||Cohort||Prospective|||||||
1302800|NCT03559803||Single Group Assignment||Treatment||None (Open Label)||||||
1302801|NCT03559790|||Cohort||Prospective|||||||
1302802|NCT03559777|Randomized|Parallel Assignment||Other||Single|Each patient will be given a code by the researcher and the observers will be blind to which group this case belong.|The patients will be randomly divided into 2 equal groups|||t|
1302803|NCT03559764||Sequential Assignment||Treatment||None (Open Label)||||||
1302804|NCT03559751|Randomized|Crossover Assignment||Other||None (Open Label)||In part A each subject will have the opportunity to use either their own brand cigarette, nicotine gum or VLN cigarettes ad libitum for 4 hours after which they will answer a questionnaire on using the product again. In Part B the subjects will have a controlled use session with each product followed by and uncontrolled session.||||
1302805|NCT03559738|||Case-Only||Prospective|||||||
1302806|NCT03559725|Randomized|Crossover Assignment||Other||None (Open Label)||In part A each subject will have the opportunity to use either their own brand cigarette, nicotine gum or VLN menthol cigarettes ad libitum for 4 hours after which they will answer a questionnaire on using the product again. In Part B the subjects will have a controlled use session with each product followed by and uncontrolled session.||||
1302807|NCT03559712|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Using a collaborative care approach with the aid of telemedicine to treat children with ADHD||||
1302808|NCT03559699||Single Group Assignment||Treatment||None (Open Label)||||||
1302809|NCT03559686||||||||||||
1302810|NCT03559673||||||||||||
1302811|NCT03559660||||||||||||
1302812|NCT03559647|||Cohort||Prospective|||||||
1302813|NCT03559634|Randomized|Parallel Assignment||Other||None (Open Label)||Feasibility trial||||
1302814|NCT03559621|Randomized|Single Group Assignment||Prevention||None (Open Label)||RCT with a mobile based lifestyle intervention||||
1302815|NCT03559608|||Cohort||Prospective|||||||
1302816|NCT03559595||Single Group Assignment||Prevention||None (Open Label)||||||
1302817|NCT03559582|||Cohort||Prospective|||||||
1302818|NCT03559569|||Cohort||Prospective|||||||
1302819|NCT03559556||Single Group Assignment||Other||None (Open Label)|Neurosurgeon who contoured AVM nidus using interventional cerebral arteriography.|||||
1302820|NCT03559543||Single Group Assignment||Supportive Care||None (Open Label)||||||
1302821|NCT03559530|||Case-Only||Retrospective|||||||
1302822|NCT03559517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302823|NCT03559504|||Case-Only||Prospective|||||||
1302824|NCT03559491|||Cohort||Prospective|||||||
1302825|NCT03559478|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded to the intervention as they will be under anaesthetic whilst the procedure is being carried out.|A total of 70 participants will be randomized in a 1:1 ratio to either Treatment Group 1 (sharp dissection with scalpel plus electrocautery to obvious vessels) or Treatment Group 2 (electrocautery for all dissection) using the sealed opaque envelope randomization technique.|t|||
1302826|NCT03559465|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1302827|NCT03559452||Single Group Assignment||Basic Science||None (Open Label)||||||
1302828|NCT03559439||Single Group Assignment||Treatment||None (Open Label)||||||
1302829|NCT03559426|Randomized|Parallel Assignment||Treatment||Single|"Participants and treating clinicians will not be blinded because participants will start on different antipsychotic regimes, and those within the antipsychotic reduction intervention will follow an individualised reduction protocol.~Members of the research team conducting outcome assessments will be blinded to treatment allocation."|Open, parallel group, multi-centre randomised controlled trial.||||t
1302830|NCT03559413||Single Group Assignment||Treatment||None (Open Label)||||||
1302831|NCT03559400|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1302832|NCT03559387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302833|NCT03559374|||Cohort||Prospective|||||||
1302834|NCT03559361|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1302835|NCT03559348||Single Group Assignment||Treatment||None (Open Label)||||||
1302836|NCT03559335|||Cohort||Prospective|||||||
1302837|NCT03559322|||Case-Only||Prospective|||||||
1302838|NCT03559309||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302839|NCT03559296|||Other||Prospective|||||||
1302840|NCT03559283||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302841|NCT03559270||Single Group Assignment||Treatment||None (Open Label)||||||
1302842|NCT03559257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302843|NCT03559244|Randomized|Parallel Assignment||Treatment||Single|outcome assessor blinded to participants' allocated group|Parallel group randomized controlled study||||t
1302844|NCT03559231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302845|NCT03559218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302846|NCT03559205|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Before and after comparative study||||
1302847|NCT03559192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302848|NCT03559179|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1302849|NCT03559166|Randomized|Sequential Assignment||Treatment||Quadruple|Randomized, double-blind, placebo controlled||t|t|t|t
1302851|NCT03559140|Randomized|Factorial Assignment||Treatment||Double|Certified endodontists trained in the procedures, devices, and systems investigated took part in the research. All experts tracked a pre-established procedure for Reciproc instrument systems and cryotherapy.|Random Selection of instrumentation groups. Of the sample of 216 teeth, 72 were randomly assigned to the one of the 3 irrigating methods. Treatment was performed by 3 experienced endodontists; each prepared 72 teeth, 24 per technique.|t||t|
1302852|NCT03559127|Randomized|Factorial Assignment||Treatment||Double|Certified endodontist (3) trained in the procedures, devices, and irrigating systems investigated took part in the research. All experts tracked a pre-established procedure for Reciproc instrument systems and cryotherapy.|Random Selection of different temperature of irrigating solution groups. Of the sample of 240 teeth, 80 were randomly assigned to the one of the 3 irrigating protocols. Treatment was performed by 3 experienced endodontists; each prepared and irrigated 80 teeth.|t||t|
1302853|NCT03559114|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1302854|NCT03559101|Randomized|Crossover Assignment||Basic Science||Double|The ingredients-list is masked on the bottles of beverage. Test beverages are coded. The research nurse logs the code, administers the test beverage, and discards the empty bottle prior to the experiment and in the absence of the investigator and outcomes assessor. The investigator and outcomes assessor do not have access to the log. Subjects do not discuss the beverages with the investigator and outcomes assessor.|Two groups of subjects (young, older) participate in five experiments, one for each of five beverage pretreatments. Pretreatments are consumed immediately prior to the experiment. The experiments are conducted in randomized order. The trials are identical and separated by at least five days.|||t|t
1302855|NCT03559088|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1302856|NCT03559075|||Case-Only||Cross-Sectional|||||||
1302857|NCT03559062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302858|NCT03559049||Single Group Assignment||Treatment||None (Open Label)||||||
1302859|NCT03559036|||Case-Control||Prospective|||||||
1302860|NCT03559023|Randomized|Factorial Assignment||Diagnostic||Single|||t|||
1302861|NCT03559010||Single Group Assignment||Other||None (Open Label)||||||
1302862|NCT03558997|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1302863|NCT03558984|Randomized|Parallel Assignment||Prevention||Single|Subjects will be blinded to the treatment arm assignment. The study site personnel present at the baseline procedure as well as the physician performing the procedure will be trained not to disclose the treatment arm to the subject, his/her family, to health care providers outside of the surgery department and to the study sponsor.|"Eligible subjects will be randomized to either the treatment arm (D-PLEX + SOC prophylactic antibiotic treatment) or to control arm (SOC prophylactic antibiotic treatment only), in a 1:1 ratio.~Subjects will be blinded to the study arm."|t|||
1302864|NCT03558971||Single Group Assignment||Treatment||None (Open Label)||All participants follow the same treatment protocol: First, the participants ingest a defined dosage, 3-week treatment of cortisol tablets to achieve a minimum symptom state. Second, after the first is complete, participants are trained to self-administer small-dosage, 5-day regimens of cortisol tablets to quench disease exacerbations to maintain the minimum symptom state.||||
1302865|NCT03558958||Single Group Assignment||Treatment||None (Open Label)||||||
1302866|NCT03558945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302867|NCT03558932|||Cohort||Prospective|||||||
1302868|NCT03558919|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controled clinical trial||||
1302869|NCT03558906|||Case-Control||Cross-Sectional|||||||
1302870|NCT03558893||Single Group Assignment||Other||None (Open Label)||||||
1302871|NCT03558880|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1302872|NCT03558867|Randomized|Parallel Assignment||Prevention||Single|||t|||
1302873|NCT03558854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1302874|NCT03558841|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized, active-controlled||||
1302875|NCT03558828|Randomized|Sequential Assignment||Prevention||Single||A Sequential Multiple Assignment Randomized Trial (SMART) design is used for this study.||||t
1302876|NCT03558815|||Case-Control||Cross-Sectional|||||||
1302877|NCT03558802|||Cohort||Prospective|||||||
1302878|NCT03558789|||Case-Control||Prospective|||||||
1302879|NCT03558776|Randomized|Parallel Assignment||Treatment||None (Open Label)||Blood samples will be taken at the beginning and regularly every four weeks during the 12-weeks intervention period. For all groups, the consumption of additional n-3 PUFA sources is not permitted during the entire intervention period. The study intervention will consist of a daily dose of linseed oil (LO, 10 En%) and prepared daily menu plans determining the background diet, except for the control group D. The fat composition of the developed daily menu plans (fat content 20 En%) will differ between the groups A to C. For groups A to C, the daily menu plans will ensure an adequate intake of energy and nutrients according to the guidelines of the German Society of Nutrition. Group D serves as control because in this group the background diet is not fixed by menu plans. Participants of group D must follow their normal dietary habits, i.e. a typical Western diet (LA intake is about 15 g/d (5-7 En%) / SFA intake ranges from 10 to 15 En%).||||
1302880|NCT03558763|Randomized|Crossover Assignment||Prevention||None (Open Label)||This clinical trial is an open, randomized, controlled cross-over study. Eligible subjects to include will be given the possibility to participate in the study. They will at their first visit be randomized to start either telemonitoring, using the tablet system arm or to normal standard of care period for 26 weeks. After 26 weeks the subject will have a second visit and after that, four weeks (wash out) of standard of care or telemonitoring treatment. After that there will be a third visit and the subject will start the second treatment period with the alternative management. At the end of this period (56 weeks) there will be a fourth (last) visit at the center for the subject.||||
1302881|NCT03558750||Single Group Assignment||Treatment||None (Open Label)||||||
1302882|NCT03558737|Randomized|Parallel Assignment||Treatment||None (Open Label)||Infants will be stratified by GA (24 0/7 to 25 6/7, 26 0/7 to 28 6/7) and randomized to either nHFJV or NIPPV||||
1302883|NCT03558724||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302884|NCT03558711||Single Group Assignment||Diagnostic||None (Open Label)||||||
1573349|NCT00001519||||||||||||
1302885|NCT03558698|Randomized|Crossover Assignment||Prevention||Quadruple|The study is double-blinded but a few people in the research team are not blinded because of security reasons (they need to be able to control the concentrations of CO2).|The 36 children are divided into 6 groups of 6 children. Every group is exposed to all possible conditions (3) in a randomized order.|t|t|t|t
1302886|NCT03558685||Single Group Assignment||Treatment||None (Open Label)||||||
1302887|NCT03558672|||Cohort||Prospective|||||||
1302888|NCT03558659|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1302889|NCT03558646|||Cohort||Retrospective|||||||
1302890|NCT03558633|||Cohort||Retrospective|||||||
1302891|NCT03558620|Randomized|Crossover Assignment||Supportive Care||Double|We have a plan to make a screen between investigator and ventilator (outcomes assessor). The investigator will stand back on ventilator and another investigator(outcomes assessor) could see only the ventilator not a patient. So investigator cannot see the results of his intervention, and an outcomes assessor would blind what the investigator is doing.||||t|t
1302892|NCT03558607||Single Group Assignment||Treatment||None (Open Label)||||||
1302893|NCT03558594|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Behavioral: Self-Hypnosis Training~Behavioral: Mindfulness Meditation"||||
1302894|NCT03558581|Randomized|Parallel Assignment||Treatment||Single|||t|||
1302895|NCT03558568|Non-Randomized|Parallel Assignment||Other||Single||"The study initially recruited 18 patients with idiopathic PD who underwent DBS surgery for movement disorders caused by PD at Mustafa Kemal University Medical Faculty Neurosurgery Department.~Inclusion criteria:~Idiopathic PD responsive to L-Dopa treatment,~Between 40-75 years of age,~Having received bilateral STN DBS surgery at least six months prior to the investigation to ensure stable stimulation parameters,~Mentally normal patients that could understand and respond to a directives."||||t
1302896|NCT03558555|Randomized|Parallel Assignment||Treatment||Quadruple||Participants presenting for inguinal hernia surgery are assigned to either the oral or intravenous acetaminophen group|t|t|t|t
1302897|NCT03558542||Single Group Assignment||Supportive Care||None (Open Label)||||||
1302898|NCT03558529|||Cohort||Prospective|||||||
1302899|NCT03558516|Randomized|Parallel Assignment||Other||Triple|The study drug will prepared by the investigator in the same character and amount. So the patient and care provider will not know the study drug is magnesium or 0.9% sodium chloride.|We compare intraoperative blood loss in two group between the magnesium (study group) and 0.9% sodium chloride group (control group)|t|t||t
1302900|NCT03558503||Single Group Assignment||Treatment||None (Open Label)||||||
1302901|NCT03558490||Single Group Assignment||Supportive Care||None (Open Label)||||||
1302902|NCT03558477|Randomized|Parallel Assignment||Treatment||None (Open Label)||Each arm is assignted 10 persons[the percent of each arm is (treatmnet: comparator=4:1)]||||
1302903|NCT03558464|Randomized|Parallel Assignment||Prevention||Single|The nature of the intervention package compared to the control package prevents a double-blind study design and thus, only the outcome assessors (data collectors) and the study statistician can be blinded to the group assignment.|Cluster Randomized, Parallel-group, Prospective, Follow-up Effectiveness Study||||t
1302904|NCT03558451|Randomized|Parallel Assignment||Treatment||Double|Only primary care midwives know and apply the intervention|Multicentre randomized clinical trial with groups in parallel, controlled single-blind, with blind evaluation of the response variable, held in the Community of Madrid|t|||t
1302905|NCT03558438|||Cohort||Prospective|||||||
1302906|NCT03558425|Randomized|Crossover Assignment||Treatment||Single|||t|||
1302907|NCT03558412||Single Group Assignment||Treatment||None (Open Label)||||||
1302908|NCT03558399|Randomized|Parallel Assignment||Diagnostic||Triple|Results of the ERA analysis will not be disclosed to the patient or the physician or the outcome assessor, nor will the study arm to which the patient was assigned, though the patient/physician may be able to intuit assignment to the ERA arm based on the frozen embryo transfer time that she is assigned. The date and time of embryo transfer will be provided by the investigator/research team.||t|t||t
1302909|NCT03558386|||Case-Control||Prospective|||||||
1302910|NCT03558373|||Cohort||Prospective|||||||
1302911|NCT03558360|||Cohort||Cross-Sectional|||||||
1302912|NCT03558347|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study consists of 20 patients (15 female, 5 male, mean age 59) who, after implant placement and second stage surgery, are randomly divided into two groups: group A was treated with two splinted crowns, group B with non-splinted single crowns. Four patients with bilateral free-end situation received both splinted and non-splinted restorations.||||
1302913|NCT03558334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302914|NCT03558321||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302915|NCT03558308|Randomized|Parallel Assignment||Treatment||Double|Patients know that one of the conditions is a control-condition not expected to have significant clinical effects (required by the danish scientific committee), but they don't know which treatment condition they are randomised to. The outcome assessor is blind to the group allocation of patients.||t|||t
1302916|NCT03558295|||Cohort||Prospective|||||||
1302917|NCT03558282|||Cohort||Cross-Sectional|||||||
1302918|NCT03558269|Non-Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will not be exposed to the participant group|||||t
1302919|NCT03558256|Randomized|Parallel Assignment||Treatment||Single||||||t
1302920|NCT03558243|Randomized|Parallel Assignment||Prevention||Single|The investigator who will evaluate the primary end point will be blinded to which hemostatic technique the patient received.|Randomized clinical trial||||t
1302921|NCT03558230|Randomized|Parallel Assignment||Treatment||Quadruple|A double-blinded stratified randomized controlled trial||t|t|t|t
1302922|NCT03558217|Randomized|Parallel Assignment||Treatment||Single|Participants will be blinded to which group they have been assigned to until the final study visit at which point study personnel will reveal the group allocation.|Participants will be randomized to have either the collared or collarless Corail femoral implant used during surgery and randomization will be stratified by surgical approach (determined by surgeon expertise).|t|||
1302923|NCT03558204|||Cohort||Prospective|||||||
1302924|NCT03558191||Single Group Assignment||Treatment||None (Open Label)||||||
1302925|NCT03558178|Randomized|Parallel Assignment||Treatment||Single||||||t
1302928|NCT03558139||Single Group Assignment||Treatment||None (Open Label)||||||
1302929|NCT03558126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1302930|NCT03558113||Single Group Assignment||Diagnostic||None (Open Label)||Screening of patients that come to the conservative dentistry department seeking dental care will continue until the target population is achieved. The patients' restorations will be subjected to visual examination and diagnosis using dental charts. Once the patients that are potentially eligible for this study are identified, they will be contacted by the research investigator who will explain the study and ascertains the patient's interest. If interested, more detailed evaluations and preparations are made.||||
1302931|NCT03558100||Single Group Assignment||Treatment||None (Open Label)||||||
1302932|NCT03558087||Single Group Assignment||Treatment||None (Open Label)||||||
1302933|NCT03558074||Single Group Assignment||Treatment||None (Open Label)||||||
1302934|NCT03558061||Single Group Assignment||Treatment||None (Open Label)||||||
1302935|NCT03558048|||Cohort||Prospective|||||||
1302936|NCT03558035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302937|NCT03558022|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1302938|NCT03558009|||Case-Control||Prospective|||||||
1302939|NCT03557996|Randomized|Parallel Assignment||Treatment||Double|double (participant-outcome assessor)|patient will receive either silver diamine fluoride or sodium fluoride varnish|t|||t
1302940|NCT03557983|Randomized|Parallel Assignment||Treatment||Single|||t|||
1302941|NCT03557970||Single Group Assignment||Treatment||None (Open Label)||||||
1302942|NCT03557957|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to allocated treatment group|Randomized, controlled, parallel-group trial||||t
1302943|NCT03557944|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1302944|NCT03557931|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1302945|NCT03557918||Single Group Assignment||Treatment||None (Open Label)||Single group assignment||||
1302946|NCT03557905|Randomized|Parallel Assignment||Treatment||Double|Ventilator adjustments, lung recruitment, PEEP titration and ultrasonographic assessments will be done by well-trained investigators not involved in data collection. The surgeon, the parents or legal guardians and the data collection personell will be blinded to the patients' group assignment.|To explore the clinical value of ultrasonic monitoring in the diagnosis of anesthesia-induced atelectasis, the assessment of the effects of lung recruitment, the best positive end-expiratory pressure (PEEP) after RM and in the detection of the point of lung re-collapse after RM in pediatric patients undergoing lengthy microsurgery operations|t|||t
1302947|NCT03557892|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1302948|NCT03557879|||Family-Based||Retrospective|||||||
1302949|NCT03557866|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||two groups. Individuals with and without pronated foot.||||
1302950|NCT03557853|||Cohort||Prospective|||||||
1302951|NCT03557840||Single Group Assignment||Other||None (Open Label)||All patients will be simultaneously studied (disregarding the nature of their infection or the dose/schedule of temocillin)||||
1302952|NCT03557827|Randomized|Single Group Assignment||Treatment||Double|The investigator and outcome assessor were blinded from the arrangement of the treatment|Split-mouth design. Each quadrant receives different treatment|||t|t
1302953|NCT03557814|Randomized|Single Group Assignment||Treatment||Double|The investigator and outcome assessor are blinded to the study design|Split-mouth design in the same volunteer. Different quadrant receives different treatment.|||t|t
1302954|NCT03557801|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1302955|NCT03557788||Single Group Assignment||Basic Science||None (Open Label)||||||
1302956|NCT03557775|Randomized|Parallel Assignment||Treatment||Single|Perceptual ratings of voice quality and of videostroboscopic images of the larynx will be rater by external judges, who will be blinded to the group assignment and to the assessment time (pre or post treatment).|||||t
1302957|NCT03557762|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302958|NCT03557749|||Cohort||Prospective|||||||
1302959|NCT03557736|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1302960|NCT03557723|||Cohort||Prospective|||||||
1302961|NCT03557710|Randomized|Factorial Assignment||Treatment||None (Open Label)||Quantify the degree to which cognitive and behavioral interventions alter the valuation of cancer-risk foods relative to an active control. We will recruit 300 overweight/obese adults who are at risk for eating- and obesity-related cancers and randomize them to a (a) behavioral response training toward low cancer-risk foods and away from high cancer-risk foods, (b) cognitive reappraisal intervention focused on cancer-risk foods (experimental arms), or (c) non-food inhibitory control training (active control arm). Valuation, our primary mediating process as implicated in the incentive sensitization model, will be measured using behavioral economics tasks and functional magnetic resonance imaging (fMRI) of the vmPFC at pre- and posttraining. Proximal, intervention-specific mediators will also be indexed with fMRI. A final analysis will compare the potency of the intervention-specific neural systems to alter valuation via connectivity to vmPFC.||||
1302962|NCT03557697|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1302963|NCT03557684|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1302964|NCT03557671|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1302965|NCT03557658|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302966|NCT03557645|Randomized|Crossover Assignment||Treatment||Double||Crossover Assignment|||t|t
1302967|NCT03557632|Randomized|Parallel Assignment||Treatment||None (Open Label)||The proposed study will use a between-groups, randomized controlled experimental design to test the effects of Virtual Reality Cue Exposure Therapy (VRCET) compared to Relapse Prevention Drug Education (RPDE) on self-reported drug craving, physiological reactivity (i.e., Galvanic Skin Conductance [GSC] and heart rate [HR]), craving coping skills, and drug use among Mexican American IDUs and NIDUs with heroin as their primary drug of choice (see design below). All participants who are former IDU will not be randomized and will complete the VRCET protocol.||||
1302968|NCT03557619||Single Group Assignment||Basic Science||None (Open Label)||||||
1302969|NCT03557606|||Case-Only||Prospective|||||||
1302970|NCT03557593|Randomized|Sequential Assignment||Treatment||None (Open Label)||Randomized, stepped-wedge cluster trial.||||
1302971|NCT03557580|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1302972|NCT03557567|||Cohort||Other|||||||
1302973|NCT03557554||Single Group Assignment||Supportive Care||None (Open Label)||||||
1302974|NCT03557541|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1302975|NCT03557528|||Case-Control||Retrospective|||||||
1302976|NCT03557515|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1302977|NCT03557502|Randomized|Parallel Assignment||Prevention||Single||Randomized parallel study design||||t
1302978|NCT03557489|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1302979|NCT03557476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1302980|NCT03557463|Randomized|Parallel Assignment||Treatment||Triple|Supplements were coded based on protein type and both participants and researchers were blinded to the underlying code|Controlled, randomized, double blind pilot study|t|t|t|
1302981|NCT03557450||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1302982|NCT03557437|Randomized|Parallel Assignment||Treatment||Single||||||t
1302983|NCT03557424|Randomized|Parallel Assignment||Treatment||Triple|double-blind, randomized|Three armed, parallel, double blind, Placebo-controlled, interventional study|t|t|t|
1302984|NCT03557411||Single Group Assignment||Treatment||None (Open Label)||SHR-1210 Simultaneously Combined with Hypofraction Radiotherapy||||
1302985|NCT03557398||Single Group Assignment||Treatment||None (Open Label)||||||
1302986|NCT03557385||Single Group Assignment||Diagnostic||None (Open Label)||||||
1302987|NCT03557372||Single Group Assignment||Treatment||None (Open Label)||||||
1302988|NCT03557359||Single Group Assignment||Treatment||None (Open Label)||||||
1302989|NCT03557346|||Case-Crossover||Prospective|||||||
1302990|NCT03557333||Single Group Assignment||Treatment||None (Open Label)||||||
1302991|NCT03557320|||Case-Crossover||Retrospective|||||||
1302992|NCT03557307||Single Group Assignment||Treatment||None (Open Label)||Open label||||
1302993|NCT03557294|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1302994|NCT03557281|Randomized|Sequential Assignment||Treatment||None (Open Label)|This will be an open label study. Hence, there will be no masking.|Eligible subjects in each cohort will be randomized to receive sequential doses of either GSK3036656 or standard-of-care (RIFAFOUR) regimen. This study will employ dose escalation, where the decision to proceed to each subsequent dose level will be made based on safety, tolerability and preliminary pharmacokinetic data from the prior cohort.||||
1302995|NCT03557268|||Cohort||Prospective|||||||
1302996|NCT03557255|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1302997|NCT03557242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1302998|NCT03557229|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1302999|NCT03557216|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||Diagnostic clinical trial||||
1303000|NCT03557203|||Case-Only||Retrospective|||||||
1303001|NCT03557190||||||||||||
1303002|NCT03557177|||Cohort||Prospective|||||||
1303003|NCT03557164|||Cohort||Prospective|||||||
1303004|NCT03557151|Randomized|Parallel Assignment||Treatment||Single|Persons completing data scoring and entry tasks will be kept blinded to a given participant's treatment assignment.|The study design consists of a 3 Treatments (Usual Care; TC-In Person; TC-Telehealth) X 5 Time Points (0, 3, 6, 9 and 12 months) randomized treatments design.||||t
1303005|NCT03557138||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303006|NCT03557125|Randomized|Parallel Assignment||Treatment||Single|Following informed consent, all patients will be positioned, prepped and sedated for a quadratus lumborum block in the preoperative holding area to blind the patient, surgeon, intraoperative anesthesia team and data collectors. The patient will be positioned in the lateral decubitus position with the operative side up and pulse oximetry and blood pressure cuff placed for monitoring.|"The patient will be positioned in the lateral decubitus position with the operative side up and pulse oximetry and blood pressure cuff placed for monitoring. The skin will be cleaned with chlorhexidine. If the subject has been randomized to the no block group, a subcutaneous saline skin wheel will be placed and the procedure would end at this point. If the subject has been randomized to the block group, a subcutaneous lidocaine skin wheel placed will be placed followed by a quadratus lumborum regional block with 40 ml, 0.25% ropivacaine deposited deep to the transversus abdominus apnoneurosis and superficial to the fascia transversalis with direct ultrasound guidance. Local anesthetic will be injected in 5 ml aliquots with aspiration for blood performed before and after the injection of each aliquot. Local anesthetic injection will also be observed with real time ultrasound guidance."|t|||
1303007|NCT03557112|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303008|NCT03557099||Single Group Assignment||Treatment||None (Open Label)||||||
1303009|NCT03557086|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1303010|NCT03557073|Randomized|Parallel Assignment||Other||Double|Both the provider and the outcomes assessor are blinded to participant's study arm.|Participants are randomized to receiving a postoperative phone call or not receiving a postoperative phone call by a physician.||t||t
1303011|NCT03557060|||Case-Only||Prospective|||||||
1303012|NCT03557047|||Other||Prospective|||||||
1303013|NCT03557034|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1303014|NCT03557021|Randomized|Parallel Assignment||Treatment||None (Open Label)||Case control study||||
1303015|NCT03557008|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Longitudinal and Randomized||||
1303016|NCT03556995|||Cohort||Retrospective|||||||
1303017|NCT03556982||Single Group Assignment||Treatment||None (Open Label)||||||
1303018|NCT03556969|||Cohort||Cross-Sectional|||||||
1303019|NCT03556956|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, multicentre, open-label, randomized, parallel groups, seamless phase 2-3 study to compare the efficacy and safety of masitinib in combination with FOLFIRI (irinotecan, 5-fluorouracil and folinic acid), versus Best Supportive Care in third or fourth line of treatment of patients with metastatic colorectal cancer.||||
1303020|NCT03556943|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1303021|NCT03556930||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1303022|NCT03556917|Randomized|Factorial Assignment||Treatment||None (Open Label)||It is a longitudinal and randomized||||
1303023|NCT03556904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303024|NCT03556891||Single Group Assignment||Treatment||None (Open Label)||||||
1303025|NCT03556878||Single Group Assignment||Treatment||None (Open Label)||This is a 'treatment development' pilot study in which we intended to continue to develop and adapted 'Fitted TranS-C' as we gain experience. At the outset of the study, it involves 4 x 20-30 minute sessions. It utilizes four cross-cutting, 3 core and 1 optional modules from Standard TranS-C. All participants will get the same Fitted Trans-C.||||
1303026|NCT03556865|||Other||Cross-Sectional|||||||
1303027|NCT03556852|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1303028|NCT03556839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303029|NCT03556826||Single Group Assignment||Treatment||None (Open Label)||||||
1303030|NCT03556813|||Cohort||Prospective|||||||
1303031|NCT03556800|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1303032|NCT03556787||Single Group Assignment||Treatment||None (Open Label)||||||
1303033|NCT03556774|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1303034|NCT03556761|Randomized|Parallel Assignment||Prevention||Quadruple|Study medication (furosemide) and placebo will be stored at room temperature at the University of Pennsylvania research pharmacy. Pharmacy will be responsible for labeling and randomizing the medications.|Double blind, randomized, placebo control design|t|t|t|t
1303035|NCT03556748|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||WB-EMS training is performed 2x/week for 12 weeks; Stimulation protocol: Frequency of 85 Hz, pulse duration of 0.35 ms, stimulation period of 6 sec, resting period of 4 sec; supervised by certified training instructors/physiotherapists participants perform simple exercises during the stimulation period following a video tutorial||||
1303036|NCT03556735||Single Group Assignment||Treatment||None (Open Label)||||||
1303037|NCT03556722|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded|Two-arm parallel assignment involves two groups of participants. One group receives rTMS, and the other group receives sham placebo rTMS.|t|t|t|t
1303038|NCT03556709||Single Group Assignment||Treatment||None (Open Label)||||||
1303039|NCT03556696|Randomized|Parallel Assignment||Treatment||Single||"Monocentric prospective randomized controlled clinical trial~arm 1: medical device automatically administering remifentanil, guided by expert rules and continuous reading of heart rate, blood pressure and Analgesia Nociception Index (MDMS, Loos, France)~arm 2 : standard practice : remifentanil is administered using a target controlled device using a pK/pD model of Minto"|t|||
1303040|NCT03556683||Single Group Assignment||Treatment||None (Open Label)||||||
1303041|NCT03556670|Randomized|Parallel Assignment||Prevention||Single|Participants will be aware that they're part of a study, but will be masked as to whether their worksite is an intervention or control site.|There are two study conditions: intervention and control. Organizations will be randomized to conditions.|t|||
1303042|NCT03556657|Randomized|Parallel Assignment||Treatment||Single||||||t
1303043|NCT03556644||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303044|NCT03556631|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303045|NCT03556618|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1303046|NCT03556605|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1303047|NCT03556592||Single Group Assignment||Treatment||None (Open Label)||||||
1303048|NCT03556579|Randomized|Crossover Assignment||Treatment||Single|||t|||
1303049|NCT03556566||Single Group Assignment||Treatment||None (Open Label)|no masking|Single arm, open label Phase II study in volunteers with ovarian cancer receiving daily dose of one pill of vaccine V3-OVA||||
1303050|NCT03556553|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303051|NCT03556540|Randomized|Parallel Assignment||Other||Double|Volunteers will not know that there are two groups. Evaluators will not know which groups the volunteers belong to when evaluating the variables.|"Each participant will perform 30 minutes of aerobic on cycle ergometer. The exercise will begin 30 minutes after the start of hemodialysis performed three times a week for three months.~The sessions will be divided into heating, conditioning and cooling. In the warm-up phase 5 minutes of exercise will be performed between 60-70% of maximal heart rate, with Borg between 1 and 2. In the conditioning phase, 20 minutes of moderate exercise will be performed, with HR between 70-80% And Borg (modified) between 3 and 4. And the quench phase will be 5 min, with FC between 60-70% of the maximum and Borg (modified) between 1 and 2.~Exercise will be discontinued if the participant has a systolic pressure above 180mmHg, a diastolic pressure above 95mmHg, a 20% change in heart rate, a saturation of less than 88%, physical exhaustion, chest pain, dyspnoea, dizziness and fatigue of the exercised limbs ."|t||t|
1303052|NCT03556527|||Cohort||Retrospective|||||||
1303053|NCT03556514|||Case-Only||Retrospective|||||||
1303054|NCT03556501|||Cohort||Prospective|||||||
1303055|NCT03556488|||Cohort||Prospective|||||||
1303056|NCT03556475|||Cohort||Prospective|||||||
1303057|NCT03556462|Randomized|Crossover Assignment||Prevention||None (Open Label)||Stepped wedge cluster RCT Participating agencies (n=7) were randomly assigned to 'wedge 1' or 'wedge 2': Wedge 1 agencies will begin the intervention in Fall 2018 and Wedge 2 agencies will begin the intervention in Spring 2019.||||
1303058|NCT03556449|||Case-Control||Prospective|||||||
1303059|NCT03556436|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1303060|NCT03556423|||Cohort||Prospective|||||||
1303061|NCT03556410|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1303062|NCT03556397|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|No roles in the study will be marked.|The patients will be divided into four groups, according to the stage of the disease prior to neoadjuvant therapy.||||
1303063|NCT03556384||Single Group Assignment||Treatment||None (Open Label)||||||
1303147|NCT03555292|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1303148|NCT03555279|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303064|NCT03556371|Randomized|Parallel Assignment||Treatment||Triple|Patients admitted will be randomly assigned to one of the two treatment groups, according to the table previously generated by the pharmaceutical chemist (PhCh) of the research team, according to a block randomization system, every 10 patients. This will be done with an Excel spreadsheet of Random Assignment by Blocks delivered by the statistical engineer of the research team to the PhCh to generate a table with patients belonging to both groups and number the bottles with the different treatments to administer according to this. Later, the PhCh will deliver them already numbered to the clinical team, being this clinical team blind to the treatment that each patient will receive (they will only handle the bottles with the number of each patient, without knowing which group each of them will belong to). In addition, both the NAC and the placebo bottles will have the same pharmaceutical presentation, so, the patients will also be blind to the pharmacotherapy they will receive.|Randomized, double-blind, controlled, phase II-b clinical trial, with a parallel group design with CBP dependent patients in different outpatient care units in the province of Concepción, Chile. Patients who meet the cocaine (CBP) consumption disorder criteria, who have used CBP within the last month and who have started use one year at least prior to admission to the study, will be selected from among the consulting population. Patients who agree to participate in the study must sign an informed consent form before being clinically evaluated. During the evaluations, semi-structured interviews and standardized questionnaires will be used to investigate both consumption habits and symptoms of withdrawal and intensity of CBP craving, among others. All patients in the study will be attended twice weekly to treatment centers for four weeks, reporting craving, possible use of for CBP (as well as urine tests), adverse reactions to the indicated medication, among others.|t|t|t|
1303065|NCT03556358|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303066|NCT03556345||Single Group Assignment||Treatment||None (Open Label)||||||
1303067|NCT03556332||Single Group Assignment||Treatment||None (Open Label)||Single arm, Simon two-stage phase II trial of combination therapy||||
1303068|NCT03556319|Randomized|Parallel Assignment||Basic Science||Triple|The dietary supplement will be delivered to the Clinical Research Center by the Investigational Pharmacy at Vanderbilt University Medical Center. Staff nurses and participants will be blinded to the capsule content.|Participants will be randomly assigned in a blinded fashion to 2-HOBA or placebo. A computer-generated randomization sequence with a block of size 3 will be used to assign participants at the ratio of 1:2 (placebo:2-HOBA) at each dose level of the treatment. All participants receiving the lower dose regimen will be completed before enrolling participants in the higher dose group.|t|t|t|
1303069|NCT03556306|||Cohort||Retrospective|||||||
1303070|NCT03556293|Randomized|Factorial Assignment||Prevention||None (Open Label)||2x2 factorial cluster randomized trial||||
1303071|NCT03556280|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1303072|NCT03556267|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1303073|NCT03556254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303074|NCT03556241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303075|NCT03556228||Sequential Assignment||Treatment||None (Open Label)||"Cohort 1 will receive 300 mg qdd PO, 21/7 Schedule, every 28 days, for 6 cycles;~Cohort 2 will receive 600 mg qd PO, 21/7 Schedule, every 28 days, for 6 cycles;~Cohort 3 will receive 1200 mg qd PO, 21/7 Schedule, every 28 days, for 6 cycles;~Cohort C will receive the RP2D qd PO for 28 days and continue for 6 cycles.~Cohort L (optional) will receive 1200 mg qd PO for 2 days, followed by the RP2D for 26 days and continue for 6 cycles."||||
1303076|NCT03556215|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking was used in the study|Interventional parallel randomized controlled prospective trial||||
1303077|NCT03556202|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Initially double-blind (until original, pivotal studies AMAK [NCT03482011] and AMAJ [NCT03535194] are locked and unblinded), then open-label.|||||
1303078|NCT03556189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303079|NCT03556176|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1303080|NCT03556163|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303081|NCT03556150|Randomized|Parallel Assignment||Treatment||Single||||||t
1303082|NCT03556137|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1303083|NCT03556124|Randomized|Parallel Assignment||Treatment||Double|Double blind|Active and Sham controlled|t|||t
1303084|NCT03556111|Randomized|Parallel Assignment||Treatment||Single||||||t
1303085|NCT03556098|Randomized|Crossover Assignment||Basic Science||Double|The peptides/placebo is prepared, in a randomized fashion, by a laboratory assistant..|Double blinded, randomized, cross-over study|t||t|
1303086|NCT03556085||Single Group Assignment||Treatment||None (Open Label)||Prospective, multicenter, single arm, open label clinical study||||
1303087|NCT03556072|||Cohort||Retrospective|||||||
1303088|NCT03556059|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||A cohort of all patients who underwent obesity and metabolic surgery in Germany will be analyzed in relation to preoperative complications||||
1303089|NCT03556046||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303090|NCT03556033|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1303091|NCT03556020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303092|NCT03556007|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1303093|NCT03555994|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303094|NCT03555981|Randomized|Parallel Assignment||Treatment||None (Open Label)||Individually randomised controlled superiority trial||||
1303095|NCT03555968|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1303096|NCT03555955|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303097|NCT03555942|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Overall, 44 oocyte donors women will be asked to participate in a trial in which they will undergo 2 consecutive ovarian stimulation protocols within a period of 6 months with 150μg corifollitropin alfa followed by 200 IU rFSH in a fixed GnRH antagonist protocol starting in the early follicular, and luteal menstrual cycle phase||||
1303098|NCT03555929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303099|NCT03555916|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t||t|
1303100|NCT03555903|||Cohort||Prospective|||||||
1303149|NCT03555266|Randomized|Parallel Assignment||Treatment||Triple|The only person unblinded to treatment allocation will be the individual applying the device to the patient.||t|t||t
1303394|NCT03552081||Single Group Assignment||Other||None (Open Label)||||||
1303101|NCT03555890|Randomized|Crossover Assignment||Treatment||None (Open Label)||This study is 2-way crossover 2 part study. In Part 1, comparison of bioavailability of levocetirizine ODT and levocetirizine IRT taken with water in the fasted state will be done and In Part 2, comparison of bioavailability of levocetirizine ODT without water and levocetirizine IRT with water in the fasted state will be done.||||
1303102|NCT03555877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303103|NCT03555864|||Case-Crossover||Prospective|||||||
1303104|NCT03555851|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303105|NCT03555838|Randomized|Parallel Assignment||Treatment||Double|All participants, raters, and experimenters will be blinded to treatment allocation.|Within-subjects repeated measures design up to 40 SCI participants will be randomized to receive 6-week hand robotic training preceded by 20 min anodal 2mA tDCS or sham (3 sessions/week, 18 sessions total). Randomization will be done using a randomized block design with a block size of 2.|t|||t
1303106|NCT03555825|Randomized|Parallel Assignment||Other||None (Open Label)||Group 1: 60 minutes of Armeo treatment, 3 times per week for 6 weeks. (Half the patients will be assigned to 1:1 therapy and the other half to 2:1 therapy) Group 2: 30 minutes of Armeo treatment, 3 times per week for 6 weeks. (Half the patients will be assigned to 1:1 therapy and the other half to 2:1 therapy)||||
1303107|NCT03555812|Non-Randomized|Parallel Assignment||Other||None (Open Label)||measurements of pelvic inclination||||
1303108|NCT03555799|||Other||Cross-Sectional|||||||
1303109|NCT03555786|||Case-Only||Prospective|||||||
1303110|NCT03555773||Single Group Assignment||Treatment||None (Open Label)||15 patients with complex fistulizing perianal Crohn's disease refractory to biological therapy||||
1303111|NCT03555760|||Cohort||Prospective|||||||
1303112|NCT03555747|Randomized|Sequential Assignment||Treatment||Single|||||t|
1303113|NCT03555734|||Other||Prospective|||||||
1303114|NCT03555721|||Other||Prospective|||||||
1303115|NCT03555708|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1303116|NCT03555695||Single Group Assignment||Prevention||None (Open Label)||This is a non-randomized, open-label, non-blinded, 10-week pilot study of a novel intervention, namely, non-contact karate, for early to middle stage PD.||||
1303117|NCT03555682|Randomized|Parallel Assignment||Basic Science||Triple|The dietary supplement will be delivered to the Clinical Research Center by the Investigational Pharmacy at Vanderbilt University Medical Center. Staff nurses and participants will be blinded to the capsule content.|Participants will be randomly assigned in a blinded fashion to 2-HOBA or placebo. A computer-generated randomization sequence with a block of size 3 will be used to assign participants at the ratio of 1:2 (placebo:2-HOBA) at each dose level of the treatment. All participants receiving the lower dose regimen will be completed before enrolling participants in the higher dose group.|t|t|t|
1303118|NCT03555669|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||"The investigators will employ a multiple baseline evaluation design in two clinics to evaluate the impact of depression treatment on HIV outcomes. Patients who screen positive for depression using PHQ-9 during the pre period will comprise the comparison group, while patients who screen positive during the post period will comprise the active group."||||
1303119|NCT03555656|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303120|NCT03555643|||Cohort||Prospective|||||||
1303121|NCT03555630|||Other||Cross-Sectional|||||||
1303122|NCT03555617|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1303123|NCT03555604|||Other||Cross-Sectional|||||||
1303124|NCT03555591|||Cohort||Prospective|||||||
1303125|NCT03555578|||Cohort||Prospective|||||||
1303126|NCT03555565|||Cohort||Prospective|||||||
1303127|NCT03555552|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1303128|NCT03555539|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"This study will be conducted sequentially in two parts~Part 1: Subjects with moderate HI (based on Child-Pugh scores) will be compared to demographically matched subjects with normal renal function~Following review of PK and safety data from Part 1, a decision will be made on which hepatically impaired group (Mild or Severe, based on Child-Pugh scores) will be enrolled in Part 2. If a significant clinical effect is not observed in the moderately impaired group, only Severe HI will be enrolled, otherwise Mild and Severe HI will be enrolled."||||
1303129|NCT03555526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303130|NCT03555513|||Cohort||Cross-Sectional|||||||
1303131|NCT03555500|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1303132|NCT03555487||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303133|NCT03555474|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor was blinded to the type of intervention.|Single blind randomized controlled trial||||t
1303134|NCT03555461|||Cohort||Prospective|||||||
1303135|NCT03555448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303136|NCT03555435|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized controlled trial with three groups: 1) Use of online problem-solving program on one's own. 2) Use of online problem-solving program with peer support. 3) Wait control group.||||
1303137|NCT03555422|Randomized|Parallel Assignment||Treatment||Quadruple|double blind placebo controlled study||t|t|t|t
1303138|NCT03555409|||Case-Only||Retrospective|||||||
1303139|NCT03555396|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303140|NCT03555383|||Cohort||Prospective|||||||
1303141|NCT03555370|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1303142|NCT03555357|Randomized|Parallel Assignment||Treatment||Double|The subject will not be aware of which side is treated with PRP vs. PRF. The blind observer will also not be informed which side was treated with PRP vs. PRF.|Subjects will receive both PRP and PRF injections to the scar. One side will be assigned to PRP and the other PRF (randomly assigned by Clinical Research Coordinator).|t|||t
1303143|NCT03555344|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1303144|NCT03555331|||Cohort||Prospective|||||||
1303145|NCT03555318|Randomized|Parallel Assignment||Other||Single||||||t
1303146|NCT03555305|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1573350|NCT00001518||||||||||||
1303150|NCT03555253||Single Group Assignment||Supportive Care||None (Open Label)||||||
1303151|NCT03555240|||Cohort||Prospective|||||||
1303152|NCT03555227|Randomized|Parallel Assignment||Treatment||Quadruple|"All patients will be receiving both interventions i.e. USG PECS blocks and wound infiltration anesthesia, with local anesthetic 0.25% levobupivacaine (active) and 0.9% Saline depending on the randomized group allocations. As such patients will be blinded.The anaesthetist and surgeon doing the interventions will both be blinded as to the pharmacological contents of the drug. This will be done as mentioned with pharmacy labelling the drugs as PRE used for USG pecs block and POST for wound infiltration. Also the observer, in this case the recovery nurse who will be titrating analgesia in the immediate postoperative period shall be blinded as to what group the patient belongs to."|"This is a single-centre, prospective; double blinded randomised case control interventional study.Patients will be randomly allocated to group X or Y. Following anesthesia induction, all patients will receive USG modified Pecs2 blocks as described by Blanco et al with 30 mls of pharmacy prepared Drug A (active drug 0.25% levobupivacaine) or Drug P (placebo 0.9% NaCl), labelled PRE respectively based on the group allocation. After surgery, the surgeon shall infiltrate the wound with 30 mls of Drug P or Drug A respectively, labelled POST. Drug P has no active role in terms of outcomes being assessed in this study. Intraoperative analgesia will be provided by TCI Remifentanil. Following surgery, patients will be recovered by dedicated recovery nurses who will titrate intravenous morphine in the immediate postoperative period aiming to keep the NRS pain scores below 1."|t|t|t|t
1303153|NCT03555214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303154|NCT03555201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303155|NCT03555188|Randomized|Parallel Assignment||Treatment||Double|This is a double-blinded study.|TRITON is a parallel group, randomised, double-blinded, placebo controlled trial, to determine the superiority of Ondansetron.|t||t|
1303156|NCT03555175|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1303157|NCT03555162|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1303158|NCT03555149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303159|NCT03555136|||Cohort||Prospective|||||||
1303160|NCT03555123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303161|NCT03555110|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1303162|NCT03555097||Single Group Assignment||Treatment||None (Open Label)||||||
1303163|NCT03555084|Randomized|Crossover Assignment||Treatment||Single|||t|||
1303164|NCT03555071|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1303165|NCT03555058|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1303166|NCT03555045|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1303167|NCT03555032||Single Group Assignment||Treatment||None (Open Label)||"Four Cohorts of patients staggered. Cohort 1: The first patient will need to be 30 days from the end of study treatment before patients can be consented to Cohort 2.~Cohort 2: Assuming no Dose Limiting Toxicities in Cohort 1, two further patients will be recruited. Once these patients have passed 30 days from the end of study treatment Cohort 3 will open.~Cohort 3: Three further patients will be recruited and be 30 days post before Cohort 4 opens.~Cohort 4: Open recruitment for the remaining 9 patients."||||
1303168|NCT03555019|Randomized|Parallel Assignment||Supportive Care||Quadruple||Double-blind, randomized-controlled. Parallel group, single center trial|t|t|t|t
1303169|NCT03555006|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1303170|NCT03554993|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1303171|NCT03554980|Randomized|Parallel Assignment||Treatment||Double|Double (participant, Outcomes Assessor)|patient will receive either Silver Diamine Fluoride or Sodium Fluoride varnish according to the allocation ratio|t|||t
1303172|NCT03554967|||Other||Other|||||||
1303173|NCT03554954|||Cohort||Cross-Sectional|||||||
1303174|NCT03554941||Single Group Assignment||Treatment||None (Open Label)||||||
1303175|NCT03554928|||Cohort||Prospective|||||||
1303176|NCT03554915|||Cohort||Prospective|||||||
1303177|NCT03554902|||Cohort||Prospective|||||||
1303178|NCT03554889||Single Group Assignment||Treatment||None (Open Label)||||||
1303179|NCT03554876|Randomized|Parallel Assignment||Treatment||Single||||||t
1303180|NCT03554863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303181|NCT03554850|||Case-Only||Prospective|||||||
1303182|NCT03554837|||Cohort||Prospective|||||||
1303183|NCT03554824|||Cohort||Cross-Sectional|||||||
1303184|NCT03554811|Randomized|Parallel Assignment||Prevention||Single||||||t
1303185|NCT03554798|Randomized|Parallel Assignment||Prevention||Double|Allocation of each subject to a given group will be described in a computer-generated randomization schedule. Based on this randomization code, the study vaccine will be packaged and labeled. Medication code numbers will be preprinted on the study vaccine labels and assigned as subjects qualify for the study and are randomly assigned to dosing schedule.||t||t|
1303186|NCT03554785|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1303187|NCT03554772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303188|NCT03554759|||Cohort||Prospective|||||||
1303189|NCT03554746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303190|NCT03554733|Randomized|Parallel Assignment||Treatment||Single||Single-blind, waitlist-control||||t
1303191|NCT03554720|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303192|NCT03554707||Single Group Assignment||Treatment||None (Open Label)||||||
1303193|NCT03554694|Randomized|Crossover Assignment||Basic Science||Double|Both intervention and placebo products are similar in colour, texture, and taste. A third party, independent of the daya-to-day research coordinator, will randomise treatments.|Crossover Assignment Randomised Double-blind Cross-over design with 4-6 weeks of prebiotics intervention and 4-6 weeks of placebo intervention. The first intervention phase will be followed by a 3 week wash-out period prior to the second intervention phase.d.|t||t|
1303194|NCT03554681|||Cohort||Prospective|||||||
1303195|NCT03554668|||Cohort||Prospective|||||||
1303240|NCT03554083|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573351|NCT00001509||||Treatment||||||||
1303196|NCT03554655|Randomized|Parallel Assignment||Supportive Care||Double|Given the nature of the intervention, patients and healthcare providers cannot be kept blinded. Investigators responsible for data collection and data entry will be blinded as to patient allocation until all outcomes have been collected.|A two-arm, observer-blinded, parallel group randomised controlled superiority trial will be used for this intervention. Participants will be placed in one of two groups: Intervention group: treatment as usual (TAU) together with the Momentum app or (2) Control group: TAU without the Momentum app.|||t|t
1303197|NCT03554642|Randomized|Parallel Assignment||Treatment||Single||Sequential randomization into one of two groups within first week after admission.||||t
1303198|NCT03554629||Single Group Assignment||Other||None (Open Label)||||||
1303199|NCT03554616|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1303200|NCT03554603|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1303201|NCT03554590|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303202|NCT03554577|Randomized|Crossover Assignment||Treatment||Single||Each participant will be treated with each sound changing principle (Noise Reduction principle (NR)) in a randomized order.|t|||
1303203|NCT03554564|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Randomized, non-blinded crossover study||||
1303204|NCT03554551|||Case-Control||Cross-Sectional|||||||
1303205|NCT03554538|Randomized|Parallel Assignment||Treatment||Single|The trial will be simple blinded because of the impossibility to blind patients nor physiotherapists to treatment.|There will be two randomized groups in a controlled clinical trial. The two groups will receive the same treatment based on an evidence-based exercise program taught by a physiotherapist, and one group will use the app multimedia to improve the performance and adherence. The other group won't use the app but a pamphlet, to follow exercises at home.||||t
1303206|NCT03554525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303207|NCT03554512|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1303208|NCT03554499|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1303209|NCT03554486|Randomized|Crossover Assignment||Treatment||Double|Double-blinded|Subjects will be randomly assigned to start with either Fiasp insulin or Novolog insulin. After 2 weeks, they will start the previously unassigned insulin and continue using it for another 2 weeks.|t||t|
1303210|NCT03554473|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1303211|NCT03554460||Single Group Assignment||Treatment||None (Open Label)||||||
1303212|NCT03554447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303213|NCT03554434||||||||||||
1303214|NCT03554421||Single Group Assignment||Treatment||None (Open Label)|Treatment known to both investigator and patient|Only patients with chronic anal fissures treated||||
1303215|NCT03554408|Randomized|Parallel Assignment||Prevention||Double|Groups 1A, 1B, 4A, and 4B are double-blinded; All other arms are open label.||t||t|
1303216|NCT03554395|Randomized|Parallel Assignment||Treatment||Quadruple|With the method of minimum randomized dynamic random by the interactive network response system (IWRS),Participants were assigned to three groups,receive cryotherapy,conventional therapy, and activated CIK armed with anti-CD3-MUC1 bispecific antibody together with cryotherapy .every participant has a unique identification number and emergency letter which have the information of group.|This is a phase II clinical trial of single-center, and it will divide into three groups.|t|t|t|t
1303217|NCT03554382|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomization to study groups occurs after completion of informed consent, baseline assessments and questionnaires. Patients are randomly assigned in a 1:1 ratio to either the intervention group or the control group. The CONSORT‐EHEALTH checklist will be followed.||||
1303218|NCT03554369||Single Group Assignment||Treatment||None (Open Label)||||||
1303219|NCT03554356||Single Group Assignment||Treatment||None (Open Label)||||||
1303220|NCT03554343|||Ecologic or Community||Prospective|||||||
1303221|NCT03554330|Randomized|Parallel Assignment||Treatment||Double||||t||t
1303222|NCT03554317||Single Group Assignment||Treatment||None (Open Label)||||||
1303223|NCT03554304|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1303224|NCT03554291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303225|NCT03554278|||Cohort||Prospective|||||||
1303226|NCT03554265|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||mTBI patients will be in the growth hormone arm Household control subjects will be in the control arm||||
1303227|NCT03554252|Randomized|Parallel Assignment||Other||Double|||t||t|
1303228|NCT03554239||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303229|NCT03554226||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303230|NCT03554213|||Cohort||Prospective|||||||
1303231|NCT03554200|Randomized|Parallel Assignment||Treatment||Double|This trial is double-blinded. After randomization neither the patients nor the investigator will be aware of the treatment allocation. Patients assigned to one of the double-blinded treatment will take one tablet Empagliflozin or matching placebo. The tablets will be identical in appearance.|Single center, prospective, placebo-controlled, double blind, randomized, 2-arm parallel, interventional, exploratory pilot study|t||t|
1303232|NCT03554187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303233|NCT03554174|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1303234|NCT03554161||Single Group Assignment||Treatment||None (Open Label)||Tocilizumab is approved for the treatment of several inflammatory disease, this study tends to evaluate the response to TCZ in refractory BDU, thus it is a self-control study.||||
1303235|NCT03554148|||Cohort||Prospective|||||||
1303236|NCT03554135|||Cohort||Prospective|||||||
1303237|NCT03554122|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1303238|NCT03554109|Randomized|Parallel Assignment||Treatment||None (Open Label)||Treatment will be administered in 2 phases, a neoadjuvant phase and a postoperative phase. For the experimental arm, subjects will receive treatment in the neoadjuvant phase for six 3-week cycles (ie, 18 weeks total). For the control arm, subjects will receive neoadjuvant treatment for a total of 16 weeks.||||
1303239|NCT03554096||Single Group Assignment||Basic Science||None (Open Label)|The dietary supplement will be delivered to the Clinical Research Center by the Investigational Pharmacy at Vanderbilt University Medical Center.|||||
1303241|NCT03554070||Single Group Assignment||Treatment||None (Open Label)||||||
1303242|NCT03554057|||Case-Control||Prospective|||||||
1303243|NCT03554044|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303244|NCT03554031||Single Group Assignment||Treatment||None (Open Label)||||||
1303245|NCT03554018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303246|NCT03554005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303247|NCT03553992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303248|NCT03553979|Randomized|Sequential Assignment||Prevention||None (Open Label)||Stress management program (SM) Stress management and Buddy program (SM-B)||||
1303249|NCT03553966|Randomized|Parallel Assignment||Prevention||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Multicenter, double-blind, randomized, active-controlled parallel-group study.|t|t|t|t
1303250|NCT03553953|||Case-Only||Prospective|||||||
1303251|NCT03553940|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1303252|NCT03553927|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303253|NCT03553914|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1303254|NCT03553901|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1303255|NCT03553888|||Other||Cross-Sectional|||||||
1303256|NCT03553875|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303257|NCT03553862|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1303258|NCT03553849|Randomized|Parallel Assignment||Prevention||Double|The operative surgeons will be blinded to the randomization. The patient, by nature of the study, will not be blinded.|The patient will be randomized into the treatment or control arm by the research team. If they are randomized into the treatment arm, they will be prescribed with a 2-week VLCD that will begin 2 weeks prior to the scheduled elective surgery.||t||t
1303259|NCT03553836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303260|NCT03553823|Randomized|Parallel Assignment||Treatment||Single|Blinded outcome assessor will assess subjects on each visit for target plaque TCS, PASI, IGA, BSA, ppIGA, PSSI, NAPS.|This is a 16-week, randomized, open-label, parallel-group, active-control study comparing secukinumab 300 mg s.c. versus guselkumab 100 mg s.c. in subjects with plaque psoriasis who had an inadequate response to ustekinumab.||||t
1303261|NCT03553810|Randomized|Parallel Assignment||Treatment||Single||||||t
1303262|NCT03553797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303263|NCT03553784|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||A pragmatic non-randomized controlled design.||||
1303264|NCT03553771|||Cohort||Prospective|||||||
1303265|NCT03553758||Single Group Assignment||Basic Science||None (Open Label)||||||
1303266|NCT03553745|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1303267|NCT03553732|||Cohort||Prospective|||||||
1303268|NCT03553719|||Cohort||Prospective|||||||
1303269|NCT03553706|||Cohort||Retrospective|||||||
1303270|NCT03553693|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Comparative effectiveness cluster-randomized trial||||
1303271|NCT03553680|Randomized|Parallel Assignment||Treatment||Single||Emotion-Focused CBT|t|||
1303272|NCT03553667|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1303273|NCT03553654||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303274|NCT03553641|||Cohort||Cross-Sectional|||||||
1303275|NCT03553628|Randomized|Parallel Assignment||Prevention||Quadruple|Allocation of mouthwash and times of applications to groups will be done through sealed opaque sequentially numbered containers to ensure absolute concealment.|A total of 64 patients will be assigned in this study. Patients will be randomly divided into two groups according to type of mouthwash (A) where group A1 patients will use chlorhexidine mouthwash as control group while group A2 patients will use chlorhexidine with propolis and clove oil mouthwash as intervention group with 32 patients in each group. Each group will be further divided into two groups according to times of application (T) where T1 represents patients using the mouthwash once daily for one week every month for 6 months and T2 where patients will use the mouthwash twice daily for one week every month for 6 months with 16 patients in each subgroup.|t|t|t|t
1303276|NCT03553615||Single Group Assignment||Treatment||None (Open Label)||Oral Ivermectin||||
1303277|NCT03553602||Single Group Assignment||Treatment||None (Open Label)||||||
1303278|NCT03553589|||Case-Control||Cross-Sectional|||||||
1303279|NCT03553576|Randomized|Parallel Assignment||Treatment||Double|The participant and outcomes assessor will be blinded to the assigned randomization.|Two group randomized controlled trial|t|||t
1303280|NCT03553563|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||An open label, parallel four group, multi-centre, phase III study||||
1303281|NCT03553550|||Other||Prospective|||||||
1303282|NCT03553537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303283|NCT03553524|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1303284|NCT03553511|Randomized|Parallel Assignment||Prevention||None (Open Label)||Prospective Randomized Clinical trial||||
1303285|NCT03553498|Randomized|Parallel Assignment||Treatment||Quadruple|The pharmacist working in an area inaccessible to ED staff will ensure blinding by creating identical vials containing either 1000 mg acetaminophen in 100 ml normal saline or 100 ml normal saline placebo and numbering them sequentially for use in this study.|Randomized Clinical Trial|t|t|t|t
1303286|NCT03553485|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1303287|NCT03553472|||Cohort||Cross-Sectional|||||||
1303288|NCT03553459||Single Group Assignment||Treatment||None (Open Label)||||||
1303289|NCT03553446||Single Group Assignment||Treatment||None (Open Label)||||||
1303290|NCT03553433|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1303291|NCT03553420|||Case-Only||Prospective|||||||
1303292|NCT03553407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303293|NCT03553394|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized to either receive a fluid bolus immediately when urinary output is decreased for two consecutive hours or to await fluid bolus therapy for two more hours.||||
1303295|NCT03553368|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1303296|NCT03553355|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1303297|NCT03553342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303298|NCT03553329|||Case-Only||Retrospective|||||||
1303299|NCT03553316|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1303300|NCT03553303||Single Group Assignment||Treatment||None (Open Label)||||||
1303301|NCT03553290|Randomized|Single Group Assignment||Treatment||Double|The investigator and outcome assessor were blinded from the arrangement of the treatment|Split-mouth design in the same individual|||t|t
1303302|NCT03553277|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1303303|NCT03553264|Randomized|Parallel Assignment||Treatment||Single|||||t|
1303304|NCT03553251|||Case-Only||Prospective|||||||
1303305|NCT03553238||Single Group Assignment||Treatment||None (Open Label)||||||
1303306|NCT03553225|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1303307|NCT03553212||Single Group Assignment||Treatment||None (Open Label)||Feasibility trial||||
1303308|NCT03553199||Single Group Assignment||Treatment||None (Open Label)||||||
1303309|NCT03553186|Randomized|Parallel Assignment||Treatment||Quadruple|Simple blinded randomization will occur by the pharmacy prior to distribution of the intervention drug.||t|t|t|t
1303310|NCT03553173|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized open-label parallel-group trial.||||
1303311|NCT03553160||Single Group Assignment||Prevention||None (Open Label)||||||
1303312|NCT03553147||Single Group Assignment||Screening||None (Open Label)|No masking|||||
1303313|NCT03553134|||Cohort||Prospective|||||||
1303314|NCT03553121|Randomized|Parallel Assignment||Prevention||Triple|Doctor who evaluate bowel function will not know whether patients walked or not|walking preoperatively not walking preoperatively|t||t|t
1303315|NCT03553108|Randomized|Crossover Assignment||Treatment||None (Open Label)||Protocol designed to evaluate one or more interventions for treating a disease, syndrome or condition||||
1303316|NCT03553095|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1303317|NCT03553082|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1303318|NCT03553069|||Cohort||Prospective|||||||
1303319|NCT03553056|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1303320|NCT03553043|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Due to the nature of the intervention, it will not be possible ot blind participants or research staff to the different conditions.|||||
1303321|NCT03553030|||Case-Control||Retrospective|||||||
1303322|NCT03553017|||Case-Only||Cross-Sectional|||||||
1303323|NCT03553004||Single Group Assignment||Treatment||None (Open Label)||||||
1303324|NCT03552991||Single Group Assignment||Treatment||None (Open Label)||||||
1303325|NCT03552978|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1303326|NCT03552965|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1303327|NCT03552952|||Cohort||Prospective|||||||
1303328|NCT03552939|||Cohort||Prospective|||||||
1303329|NCT03552926|||Cohort||Prospective|||||||
1303330|NCT03552913|||Cohort||Retrospective|||||||
1303331|NCT03552900|Randomized|Parallel Assignment||Treatment||Single|Participants will not be masked to their mobile app however investigators conducting data analysis will be blinded to which participants were assigned to which app|Participants will be randomly assigned to one of two study groups and assigned to one of two different mobile apps|||t|
1303332|NCT03552887|||Cohort||Prospective|||||||
1303333|NCT03552874|||Cohort||Prospective|||||||
1303334|NCT03552861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303335|NCT03552848||Single Group Assignment||Treatment||None (Open Label)||15 patients will be given MSC.||||
1303336|NCT03552835|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||occlusal dentinal caries are managed by either partial caries removal upto soft dentin or partial caries removal upto firm dentine or no caries removal and will be compared||||
1303337|NCT03552822|||Cohort||Prospective|||||||
1303338|NCT03552809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303339|NCT03552796||Single Group Assignment||Treatment||None (Open Label)||||||
1303340|NCT03552783|Randomized|Parallel Assignment||Diagnostic||Single|The program coordinator is intimately involved with program participants as his role includes completing the intakes with each participant, implementing the program, and for the purpose of the study, the screening process. To eliminate the bias, the program coordinator will continue to collect intake data and screen the participants. However, we will include a Licensed Mental Health Professional (LIMHP) who will utilize the screening information to complete the comprehensive assessment, randomize, and enroll the participants in the study. In addition, the LIMHP will also complete the follow-up data collection. This will prevent researcher bias during program delivery.|The intervention will be a quasi-experimental study. The participants will be randomized into one of two study arms: Father For a Lifetime (FFL) + Cognitive Behavioral Therapy (CBT) (intervention arm) or FFL only (comparison arm).|t|||
1303341|NCT03552770|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The enrolled patients are randomized to the following therapeutic regimens: i. group A, a single intra-vitreous injection of bevacizumab pro-re-nata repeated after monthly periodic monitoring of the patient (IVIBx1 regimen); ii. group B, two combined intra-vitreous injections of bevacizumab, spaced 30 ± 10 days apart and pro-re-nata repeated after periodic monitoring of the patient (IVIBx2 regimen).||||
1303342|NCT03552757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303343|NCT03552744|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1303344|NCT03552731|||Cohort||Prospective|||||||
1303345|NCT03552718||Single Group Assignment||Treatment||None (Open Label)||||||
1303346|NCT03552705|Randomized|Parallel Assignment||Treatment||Quadruple|double blinded RCT||t|t|t|t
1303390|NCT03552133|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||One control study night vs. two intervention study nights (subject serves as own control).||||
1303391|NCT03552120|Randomized|Parallel Assignment||Treatment||Single||||||t
1303347|NCT03552692||Single Group Assignment||Treatment||None (Open Label)||"Study design This is an open-label, multi-center, single arm phase II trial, with a two-stage design, to evaluate the activity and safety of ABT-199 single agent in patients with BCL-2 pos R/R PTCL-NOS, AITL, TFH.~A pre-screening evaluation of immunohistochemical positivity of BCL-2 will be performed in the relapse biopsy, if available, or otherwise in the initial biopsy. BCL-2 evaluation will be centralized (FIL Laboratories). Only patients with a percentage of BCL-2 positive tumor cells ≥ 25% will be included onto the study. Patients will receive ABT-199 until disease progression, unacceptable toxicity, withdrawal of consent and/or the investigator determines that further therapy is not in the patient's best interest. The primary objective of the study is ORR which will be evaluated after 3 cycles of treatment."||||
1303348|NCT03552679|||Case-Only||Prospective|||||||
1303349|NCT03552666|Randomized|Crossover Assignment||Other||Single||Randomized, examiner-blind, comparator-controlled crossover study|||t|
1303350|NCT03552653|Randomized|Crossover Assignment||Other||Single||Randomized, cross-over, comparator-controlled|||t|
1303351|NCT03552640|||Other||Prospective|||||||
1303352|NCT03552627|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1303353|NCT03552614|||Cohort||Retrospective|||||||
1303354|NCT03552601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303355|NCT03552588|||Cohort||Prospective|||||||
1303356|NCT03552575|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind|Prospective, randomised, active-comparator, double-blinded study.|t|t|t|t
1303357|NCT03552562|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1303358|NCT03552549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303359|NCT03552536|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1303360|NCT03552523|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1303361|NCT03552510|Randomized|Crossover Assignment||Supportive Care||Single|Laboratory assessment of GIT hormonal level will be masked|Oropharyngeal Administration of mother's milk (OPAMM)||||t
1303362|NCT03552497|||Cohort||Retrospective|||||||
1303363|NCT03552484|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1303364|NCT03552471||Single Group Assignment||Treatment||None (Open Label)||||||
1303365|NCT03552458|Randomized|Parallel Assignment||Prevention||Triple||randomized double blind prospective placebo controlled clinical study|t||t|t
1303366|NCT03552445|Randomized|Parallel Assignment||Prevention||Single||||||t
1303367|NCT03552432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303368|NCT03552419|||Cohort||Retrospective|||||||
1303369|NCT03552406|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1303370|NCT03552393||Single Group Assignment||Treatment||None (Open Label)||||||
1303371|NCT03552380||Single Group Assignment||Treatment||None (Open Label)||||||
1303372|NCT03552367|Randomized|Parallel Assignment||Treatment||None (Open Label)|This is an open-label trial|Randomized open clinical trial||||
1303373|NCT03552354||Single Group Assignment||Treatment||None (Open Label)||||||
1303374|NCT03552341|||Cohort||Prospective|||||||
1303375|NCT03552328|Randomized|Parallel Assignment||Treatment||Double|"The randomization sequence will be implemented centrally with one of the co-investigator (Ambuj Kumar) who is off site will retain the list. Once a participant is identified the primary investigator will call the off-site co-investigator for assignment. Given that the co-investigator is not on site will ensure adequate allocation concealment.~Also, since the outcome data will be collected using a questionnaire, the possibility of interpretation does not exist. Data analysts will not be informed of the subject assignment and the coding for participant will be as group 1 or 2."|Eligible and consenting participants are randomized to one of the two study groups in a 1:1 allocation ratio. A block-stratified method using the computer will be used for generation of randomization sequence. The block size will be random.|||t|t
1303376|NCT03552315|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1303377|NCT03552302|||Case-Only||Prospective|||||||
1303378|NCT03552289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303379|NCT03552276|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|This long-term extension study will remain double-blind or partially blinded for subjects from the parent studies reach at a stage of either database lock or a certain pre-specified time period, and then the study will be open-blind for the subjects.|||||
1303380|NCT03552263|Randomized|Parallel Assignment||Treatment||Quadruple||This study is a prospective, double-blind, randomized, placebo-controlled phase 2 clinical trial having three arms including T89 low-dose, T89 high-dose and a placebo controlled group. People will be screened against the inclusion/exclusion criteria after informed consent. Eligible subjects will be randomly assigned into one of three arms and instructed to use T89 orally twice daily for 14 days (Days 1-14) before ascending, and 5 days after ascending during the observation period (Days 15-19). Specifically, for subjects in the T89 high-dose group, they will take placebo instead of T89 from Day 1 to Day 12, and take T89 on Days 13-14. The primary efficacy parameter is Lake Louise Scoring System (LLSS) which will be evaluated by subject-self and principal investigator in clinic. Other efficacy parameters include Visual Analog Scales (VAS), exercise tolerance, blood lactate, and blood oxygen saturation that will be performed at altitude.|t|t|t|t
1303381|NCT03552250||Single Group Assignment||Prevention||None (Open Label)||||||
1303382|NCT03552237||Single Group Assignment||Supportive Care||None (Open Label)||||||
1303383|NCT03552224|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1303384|NCT03552211|||Case-Control||Cross-Sectional|||||||
1303385|NCT03552198|Randomized|Factorial Assignment||Prevention||Single|To avoid bias participants were not told how the wording of the health advice had been changed.|This was a randomised control trail using a 2-way factorial design, with target population (2 levels: general population vs. individuals with a pre-existing health condition) and message format (2 levels: usual message format vs. alternative format) as between-factors.|t|||
1303386|NCT03552185|||Other||Cross-Sectional|||||||
1303387|NCT03552172|||Cohort||Retrospective|||||||
1303388|NCT03552159|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1303389|NCT03552146|||Cohort||Prospective|||||||
1303392|NCT03552107|||Case-Only||Retrospective|||||||
1303395|NCT03552068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303396|NCT03552055|||Other||Other|||||||
1303397|NCT03552042|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1303398|NCT03552029|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Part 1 Single Group 1 Arm, Part 2 Parallel, 2 Cohorts||||
1303399|NCT03552016|Randomized|Single Group Assignment||Treatment||Triple|"The researchers involved, the project investigator, and the patients will be blinded from knowing which patient will get which treatment by assigning a number to each patient and having that patient take that number to the pharmacy where they will pick up their riboflavin. The dosage of riboflavin given to the patient will be chosen by the number that the patient gives to the pharmacy. There will be no labels revealing the dose of riboflavin that the patient receives. There will be placebo dose which contains a small dose of riboflavin that has been shown to not reach therapeutic levels."|This is a 1:1:1 double-blinded randomized study for children ages 6-12 year old with axial myopia who will be treated with one of three different doses of oral riboflavin. Expected number of participants is 100.|t|t|t|
1303400|NCT03552003|||Cohort||Prospective|||||||
1303401|NCT03551990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1303402|NCT03551977|Randomized|Parallel Assignment||Treatment||None (Open Label)||A single-centre, RCT study design with two arms, one control group (N=56) and one intervention group (N=56).||||
1303403|NCT03551964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303404|NCT03551951|||Cohort||Prospective|||||||
1303405|NCT03551938|Randomized|Single Group Assignment||Prevention||Single|||t|||
1303406|NCT03551925|Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a randomized controlled trial using a pretest-posttest control group design to allow for comparison between a treatment as usual (TAU) group supporting medication adherence and a TAU group that receives an additional occupational therapy intervention.||||
1303407|NCT03551912|||Cohort||Prospective|||||||
1303408|NCT03551899|||Other||Prospective|||||||
1303409|NCT03551886|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1303410|NCT03551873|||Cohort||Prospective|||||||
1303411|NCT03551860|Randomized|Parallel Assignment||Treatment||Double|Due to nature of intervention (one single injection vs a second single injection in different anatomical location) the participant and the care provider cannot be blinded.The investigator will use an already filled data collection sheet and enter randomised data into a master file. The data will be analysed by an individual blinded to the which group the participant was in.||||t|t
1303412|NCT03551847|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1303413|NCT03551834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303414|NCT03551821||Single Group Assignment||Treatment||None (Open Label)||||||
1303415|NCT03551808|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1303416|NCT03551795||Single Group Assignment||Treatment||None (Open Label)||||||
1303417|NCT03551782|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303418|NCT03551769|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1303419|NCT03551756|||Other||Cross-Sectional|||||||
1303420|NCT03551743|Randomized|Parallel Assignment||Treatment||Quadruple||"This study has four modules with a total of 21 cohorts, each module was reported and submitted separately.~Module 1, NCT01758432 (54 subjects with 7 cohorts including placebo); Module 2, NCT03578146 (48 subjects with 6 cohorts including placebo); Module 3, NCT03551730 (27 subjects with 4 cohorts including placebo); Module 4, NCT03551743 (28 subjects with 4 cohorts including placebo)"|t|t|t|t
1303421|NCT03551730|Randomized|Parallel Assignment||Treatment||Quadruple||"This study has four modules with a total of 21 cohorts, each module was reported and submitted separately.~Module 1, NCT01758432 (54 subjects with 7 cohorts including placebo); Module 2, NCT03578146 (48 subjects with 6 cohorts including placebo); Module 3, NCT03551730 (27 subjects with 4 cohorts including placebo); Module 4, NCT03551743 (28 subjects with 4 cohorts including placebo)"|t|t|t|t
1303422|NCT03551717|||Cohort||Prospective|||||||
1303423|NCT03551704|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are randomly assigned to each of the two treatment conditions in accordance with a computer-generated randomization list. The treatment conditions will be actively running in parallel.||||
1303424|NCT03551691|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1303425|NCT03551678||Single Group Assignment||Treatment||None (Open Label)||||||
1303426|NCT03551665||Single Group Assignment||Treatment||None (Open Label)|Primary outcomes are objective (i.e. assessed via computer algorithms), thus reducing the need for masking.|Multiple-baseline, within-subject design||||
1303427|NCT03551652|||Case-Control||Prospective|||||||
1303428|NCT03551639|||Case-Only||Prospective|||||||
1303429|NCT03551626||Single Group Assignment||Treatment||None (Open Label)||||||
1303430|NCT03551613|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1303431|NCT03551600|||Cohort||Prospective|||||||
1303432|NCT03551587|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1303433|NCT03551574|||Other||Prospective|||||||
1303434|NCT03551561|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303435|NCT03551548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303436|NCT03551535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303437|NCT03551522|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind Placebo Controlled|Randomization: 1:2:2:2 (placebo: seladelpar 10 mg: 20 mg: 50 mg)|t|t|t|t
1303438|NCT03551509|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303439|NCT03551496|Randomized|Parallel Assignment||Treatment||Single|A review of the wound assessment data will be completed by an independent reviewer who will be blinded to the randomized therapy.|Approximately 201 subjects will be randomized in a 2:1 fashion for phase A RCT. Randomizations will be stratified by investigational center and lesion length with 2 subjects receiving the DES BTK for every 1 subject receiving treatment with standard PTA.||||t
1303440|NCT03551483|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303441|NCT03551470|||Cohort||Prospective|||||||
1303442|NCT03551457|||Cohort||Prospective|||||||
1573352|NCT00001502||||Treatment||||||||
1303443|NCT03551444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303444|NCT03551431|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Open labeled, randomized controlled Non-inferiority study with three parallel arms: video EEG with verbal suggestion only, cotton swab with verbal suggestion and tuning fork along with verbal suggestion||||
1303445|NCT03551418||Single Group Assignment||Health Services Research||None (Open Label)||||||
1303446|NCT03551405|||Case-Only||Retrospective|||||||
1303447|NCT03551392|Randomized|Parallel Assignment||Treatment||Triple|Research assistants who administer pre and post measures will be masked, as well as participants who receive the intervention.|This is a blinded parallel group sham controlled pilot trial, with half the participants in each group randomized to the real NIR treatment and half to the sham treatment condition.|t|t||t
1303448|NCT03551379|||Cohort||Prospective|||||||
1303449|NCT03551366|Randomized|Parallel Assignment||Other||None (Open Label)||Schools are randomly assigned to either a control (usual practice), linear PE pedagogy or nonlinear PE pedagogy arm. Both linear and nonlinear arms will receive 15 weeks of physical education lessons from trained coaches, whereas the control group will carry on with PE lessons as usual.||||
1303450|NCT03551353|||Other||Other|||||||
1303451|NCT03551340|||Case-Only||Retrospective|||||||
1303452|NCT03551327|Randomized|Parallel Assignment||Treatment||None (Open Label)|The patient and the person delivering the intervention will not be blind to treatment allocation.|||||
1303453|NCT03551314|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1303454|NCT03551301|||Cohort||Prospective|||||||
1303455|NCT03551288|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be enrolled in 1 of 3 cohorts; Cohort 1 (Food Effect Cohort), Cohort 2 (Gender Effect Cohort), and Cohort 3 (Age Effect Cohort). Subjects in Cohort 1 will receive a single oral dose of SUVN-911 on Day 1 under fasted or fed conditions and again on Day 8 under fasted or fed conditions (crossover design). Subjects in Cohort 2 and Cohort 3 will receive a single oral dose of SUVN-911 on Day 1.||||
1303456|NCT03551275|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1303457|NCT03551262|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, prospective, randomized, controlled||||
1303458|NCT03551249||Single Group Assignment||Treatment||None (Open Label)||||||
1303459|NCT03551236|||Cohort||Prospective|||||||
1303460|NCT03551223|||Cohort||Prospective|||||||
1303461|NCT03551210|Randomized|Parallel Assignment||Treatment||Double||All eligible patients will be randomized to receive either treatment with Nemonoxacin or Tavanic® in a ratio of 1:1.|t||t|
1303462|NCT03551197||Single Group Assignment||Treatment||None (Open Label)||There is only one group.Patients with diagnosis of Chronic Obstructive Pulmonary Disease are recruited.Subjects will be examined at baseline and after 3 months` treatment of budesonide and formoterol.||||
1303463|NCT03551184|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1303464|NCT03551171||Single Group Assignment||Treatment||None (Open Label)||||||
1303465|NCT03551158||Single Group Assignment||Other||None (Open Label)||||||
1303466|NCT03551145|Randomized|Parallel Assignment||Treatment||Double|The examiners will be blinded. Envelopes will be prepared by a research assistant not involved as clinician or examiner. The clinicians involved will have no access to the data collection sheets or the group allocation, whilst the examiners will have no access to the patients' treatment notes or group allocation. The examiners will be blinded with regards to the participant treatment assignments. The measures will include no access to the dental records as to which treatment has been assigned. The patients are not to reveal their treatment assignment to the examiners. Unblinding is expected when patients present with adverse outcomes during the course of the study, e.g., emphysema.|Multi-centre randomized clinical trial (2 centres) with the duration of 102 weeks for the evaluation of efficiency on the new collagen xenograft (Muco-Graft®) in comparison to the autologous connective tissue graft for the augmentation of keratinized mucosa and gaining hygienic access to the implants diagnosed with peri-implantitis|||t|t
1303467|NCT03551132|Randomized|Parallel Assignment||Basic Science||Single||A randomized controlled trial|||t|
1303468|NCT03551119|Randomized|Parallel Assignment||Treatment||Single|Due to the nature of the intervention, participants cannot be blinded to group assignment; however, the primary outcome is objectively measured (24-hour ambulatory blood pressure measurement). For main trial secondary outcomes, assessors will be blinded to allocation status.|In this parallel arm control trial, participants recruited from outpatient CKD clinics in Alberta Kidney Care North, Edmonton, Alberta, Canada will be randomized (1:1) to enhanced usual care (measurement of physical activity levels) or an exercise intervention.||||t
1303469|NCT03551106|||Other||Prospective|||||||
1303470|NCT03551093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"This will be a multi-center, adjunctive to Standard of Care, single arm study, which includes the following steps:~Screening (day 1)~Implantation (day 1)~Treatment and symptom assessment (days 1-5)~Device Positioning and Removal (day 5)~Discharge/Final Visit (day 7-10)"||||
1303471|NCT03551080|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1303472|NCT03551067|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1303473|NCT03551054|Randomized|Parallel Assignment||Prevention||None (Open Label)||Parallel randomized controlled trial||||
1303474|NCT03551041|||Cohort||Cross-Sectional|||||||
1303475|NCT03551028||Single Group Assignment||Screening||None (Open Label)||||||
1303476|NCT03551015|Randomized|Parallel Assignment||Treatment||Single||||||t
1303477|NCT03551002|||Cohort||Other|||||||
1303478|NCT03550989|||Other||Other|||||||
1303479|NCT03550976|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303480|NCT03550963|Randomized|Parallel Assignment||Treatment||Single||All participants included in the study will be randomized assigned into one of two groups in parallel. Group one will be provided with rice-richen meal, while group two will be provided with wheaten-richen meal. All other factors, i.e. nutrition education, following-up, and physical activity will be the same between two groups.||||t
1303481|NCT03550950|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1303482|NCT03550937|||Case-Only||Prospective|||||||
1303527|NCT03550352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303799|NCT03546803|||Cohort||Prospective|||||||
1303483|NCT03550924|Randomized|Parallel Assignment||Treatment||Single|The monitor measuring the main outcome parameter will be in a separate room|Prospective, single center, randomized, observer blinded, controlled|||t|
1303484|NCT03550911|||Cohort||Prospective|||||||
1303485|NCT03550898||Single Group Assignment||Diagnostic|||Dynamic ultrasonography was performed during the filling phase of the urodynamic study. The radiologist and the urodynamicist had no verbal or visual contact during the examinations, with use of a siding.|Dynamic ultrasonography was performed in all patients during the urodynamic study.||||
1303486|NCT03550885|Randomized|Crossover Assignment||Other||Single|All study personnel, excluding those directly involved with meal preparation, will be blinded to the subjects' diet sequence.|"The proposed study will utilize a randomized, crossover, controlled feeding trial design composed of two experimental diets: (1) animal-based, high in taurine and saturated fat (HT-HSAT) and (2) plant-based, low in both taurine and saturated fat (LT-LSAT) (each consumed for 21 days with a minimum 3-week washout between diets).~At baseline and post-diet (day 22) for each of the two 3-week diets, subjects will undergo a flexible sigmoidoscopy, fasting and non-fasting blood draw, and provide a stool sample."|||t|
1303487|NCT03550872|Randomized|Parallel Assignment||Other||None (Open Label)|Open Label|To evaluate the physical effect of physical training in patients with heart failure and permanent atrial fibrillation||||
1303488|NCT03550859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303489|NCT03550846|||Cohort||Prospective|||||||
1303490|NCT03550833|||Case-Only||Prospective|||||||
1303491|NCT03550820|||Case-Only||Prospective|||||||
1303492|NCT03550807||||||||||||
1303493|NCT03550794|Randomized|Parallel Assignment||Treatment||Quadruple|A randomization list will be prepared by an independent statistician using 1:1 randomization in blocks of two and four. This list will be provided to the research pharmacy, and the research pharmacy will be the only unblinded people involved with the study, and will have no patient contact or role in the analysis or other aspects of the study. Thiamine is colorless and odorless, and the 200mg dose is mixed in 5mL of normal saline. Placebo will be 50mL of normal saline and is indistinguishable in appearance from thiamine. Study team, clinical team and patient and family will all be blind to the allocation.||t|t|t|t
1303494|NCT03550781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303495|NCT03550768|||Cohort||Prospective|||||||
1303496|NCT03550755||Single Group Assignment||Treatment||None (Open Label)|no masking|Single group assignment to receive one pill of vaccine once per day for 3 months||||
1303497|NCT03550742||Single Group Assignment||Other||None (Open Label)||||||
1303498|NCT03550729||Single Group Assignment||Basic Science||None (Open Label)||||||
1303499|NCT03550716|Randomized|Parallel Assignment||Treatment||Single|The randomization will be performed when the patient is asleep.|"Trial type:~Clinical randomized multi-center controlled trial~Randomization:~Block randomization is performed with the use of a computer generated block randomization list~Participants:~Patients with NOA undergoing fertility treatment"|t|||
1303500|NCT03550703||Single Group Assignment||Treatment||None (Open Label)|no masking|open label, single arm study||||
1303501|NCT03550690|||Cohort||Prospective|||||||
1303502|NCT03550677|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1303503|NCT03550664||Single Group Assignment||Supportive Care||None (Open Label)||||||
1303504|NCT03550651|Randomized|Crossover Assignment||Prevention||Triple||5x5 latin cross over study|t||t|t
1303505|NCT03550638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303506|NCT03550625|||Cohort||Retrospective|||||||
1303507|NCT03550612|||Cohort||Retrospective|||||||
1303508|NCT03550599|||Cohort||Prospective|||||||
1303509|NCT03550586|||Case-Control||Prospective|||||||
1303510|NCT03550573|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1303511|NCT03550560|||Case-Only||Prospective|||||||
1303512|NCT03550547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303513|NCT03550534|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1303514|NCT03550521|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303515|NCT03550508||Single Group Assignment||Treatment||None (Open Label)|Open|"The accelerated titration and traditional 3+3 dose-escalation designs are applied in this study."||||
1303516|NCT03550495|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a prospective, single institution, controlled, pilot study of patients admitted to the 7W ICU which will compare the incidence and delirium rates among patients undergoing routine care before intervention (no routine psychiatric involvement) (control group) and patients after the intervention (psychiatry team rounding with the ICU team daily) (intervention group) . Randomization is not possible for this study; although block randomization was considered, it will result in sub-optimal data subject to bias.||||
1303517|NCT03550482|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The doubled minimal clinically important difference (-8) of Edmonton Symptom Assessment Scale (ESAS) total score is considered relevant for the purposes of this study. Taking into account: ESAS total score difference of -8, ESAS total score mean of 30, ESAS total score standard deviation of 17, power close to 80% and alpha 5%, branches ratio 2/1 data of 150 patients should be analyzed (exact power 77%). With the dropout of 10% 170 patients should be included in the study (110 ONCOXIN/55CTRL)||||
1303518|NCT03550469|Randomized|Parallel Assignment||Treatment||None (Open Label)||The intervention group will have oxygen therapy adjustment by computer-assistance. The control group will have adjustments by staff.||||
1303519|NCT03550456|||Other||Prospective|||||||
1303520|NCT03550443|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303521|NCT03550430|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1303522|NCT03550417|||Case-Control||Retrospective|||||||
1303523|NCT03550404|||Case-Only||Prospective|||||||
1303524|NCT03550391|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is an international multi-centre, open-label, randomized phase III trial comparing stereotactic radiosurgery (SRS) to whole brain radiotherapy (WBRT) in patients with 5 to 15 brain metastases.||||
1303525|NCT03550378|Randomized|Parallel Assignment||Treatment||Double||Randomised, Double-Blind, Placebo-Controlled|t||t|
1303526|NCT03550365|Randomized|Crossover Assignment||Other||Single|||||t|
1573353|NCT00001499||||Treatment||||||||
1303528|NCT03550339|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1303529|NCT03550326|||Cohort||Prospective|||||||
1303530|NCT03550313|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303531|NCT03550300|||Cohort||Prospective|||||||
1303532|NCT03550287|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1303533|NCT03550274||Single Group Assignment||Treatment||None (Open Label)||Mixed method pilot cohort study||||
1303534|NCT03550261|||Cohort||Prospective|||||||
1303535|NCT03550248||Single Group Assignment||Prevention||None (Open Label)||Participating organizations will deliver the Healthy Together (HT) program to children/youth and their parents/caregivers. Participants in the program will be invited to complete questionnaires to evaluate the program at mid point (after 15 sessions) and post program (after 30 sessions).||||
1303536|NCT03550235|||Case-Only||Prospective|||||||
1303537|NCT03550222|||Cohort||Prospective|||||||
1303538|NCT03550209|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple||t|t|t|t
1303539|NCT03550196|||Cohort||Prospective|||||||
1303540|NCT03550183||Single Group Assignment||Treatment||None (Open Label)||||||
1303541|NCT03550170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303542|NCT03550157|||Cohort||Prospective|||||||
1303543|NCT03550144|Randomized|Parallel Assignment||Prevention||Single|||t|||
1303544|NCT03550131|Randomized|Parallel Assignment||Treatment||Single|Participants receiving intervention will not be informed whether it is the standard or personalized treatment.|This study will utilize a 2-group randomized controlled trial design including 2 pre-intervention and 4 post-intervention assessments. The comparator group (standard intervention) will have 112 caregiver-care receiver dyads, and the experimental group (personalized intervention) will have 113 caregiver-care receiver dyads.|t|||
1303545|NCT03550118|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1303546|NCT03550105|Non-Randomized|Parallel Assignment||Other||None (Open Label)||A) Study Subjects with Baseline Glucose of > 150mg/dl, will have Gentle Jogger Only for 7 days B) Study Subjects with Baseline Glucose of < 150 mg/dl will have basal oral glucose tolerance test (OGTT) and repeat OGTT after 7 days of Gentle Jogger||||
1303547|NCT03550092||Single Group Assignment||Other||None (Open Label)||||||
1303548|NCT03550079|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303549|NCT03550066|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1303550|NCT03550053|Randomized|Parallel Assignment||Diagnostic||Single|Patient will not know which group they are randomized to.|Patients with head and neck cancer, specifically requiring surgery to their mandible.|t|||
1303551|NCT03550040|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomized study||||
1303552|NCT03550027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303553|NCT03550014|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to have receive physical therapy targeting the low back only or low back plus hip(s). Neither the participants or investigators can be blinded during this trial.||||
1303554|NCT03550001|Randomized|Parallel Assignment||Other||None (Open Label)|Open label|Parallel||||
1303555|NCT03549988|||Other||Prospective|||||||
1303556|NCT03549975||Single Group Assignment||Treatment||None (Open Label)||||||
1303557|NCT03549962|||Case-Only||Retrospective|||||||
1303558|NCT03549949|||Cohort||Prospective|||||||
1303559|NCT03549936|Randomized|Parallel Assignment||Prevention||Quadruple|Infants who develop NAS will continue to receive blinded formula as part of non-pharmacological treatment and will also receive pharmacological treatment (morphine/methadone) as per hospital guidelines directed by their medical care providers. Pharmacological treatment will be optimized and weaned as per standard hospital guidelines. Use of blinded formula A or B will be continued until 2 weeks of age at which point its use as study intervention will be completed. After this point, parents/home care providers and medical care providers may use formula of their preference. However we will offer them a choice of continuing the blinded formula until the infant is discharged at which point standard formula will have to be initiated. General clinical data will be collected at discharge including length of stay and weight.|Randomized Double Blind Clinical trial on Role of Low Lactose Formula In the Management of Neonatal Abstinence Syndrome|t|t|t|t
1303560|NCT03549923|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1303561|NCT03549910|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1303562|NCT03549897|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1303563|NCT03549884|Randomized|Parallel Assignment||Treatment||Triple|The health care giver who will perform hematocrit measurement (primary outcome) and the statistician who will perform data analysis will be blind for treatment allocation.||t|t||t
1303564|NCT03549871||Single Group Assignment||Treatment||None (Open Label)||||||
1303565|NCT03549858|||Cohort||Prospective|||||||
1303566|NCT03549845|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Pragmatic cluster randomized controlled trial with parallel intervention and control groups.~Randomization will occur at the building level (clusters) and the intervention is open to all building residents."||||
1303567|NCT03549832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303568|NCT03549819|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1303569|NCT03549806|||Cohort||Prospective|||||||
1303570|NCT03549793|Randomized|Parallel Assignment||Treatment||Single|The investigator are neurologists, blinded to the treatment received by the patient|Participants are randomly assigned to experimental group or control group. Both of the groups undergo a rehabilitation treatment. The experimental group undergoes 4-week MIRT (Multidisciplinary Intensive Rehabilitation Treatment) + dance therapy. The control group undergoes 4-week MIRT (Multidisciplinary Intensive Rehabilitation Treatment) + exercises|||t|
1303571|NCT03549780||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1303572|NCT03549767|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study is testing the acceptability of the device (springfusor) in the administration of magnesium suphate||||
1303573|NCT03549754|||Other||Prospective|||||||
1303574|NCT03549741|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1303575|NCT03549728|Randomized|Parallel Assignment||Supportive Care||Triple|: Eighty eight envelopes will be numbered serially and in each envelope the corresponding letter which denotes the allocated group will be put according to randomization table. When the first patient arrives, the first envelope will be opened and the patient will be allocated according to the letter inside into group A or B|The aim of this study is to evaluate the effect of granulocyte colony-stimulating factor on clinical pregnancy rate in patients with endometriosis undergoing in-vitro fertilization after recurrent implantation failure.|t|t|t|
1303576|NCT03549715|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|The sample size will be balanced between 2 arms. Initially, 12 patients (6 in each arm) will be included and randomized between durvalumab + ddMVAC (ARM A) or durvalumab + tremelimumab + ddMVAC (ARM B)||||
1303577|NCT03549702|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303578|NCT03549689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303579|NCT03549676||Single Group Assignment||Treatment||None (Open Label)||||||
1303580|NCT03549663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303581|NCT03549650|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1303582|NCT03549637||Single Group Assignment||Other||None (Open Label)||||||
1303583|NCT03549624|||Cohort||Prospective|||||||
1303584|NCT03549611|Randomized|Parallel Assignment||Treatment||Single|The patient will not be made aware which treatment regimen they are receiving and neither will the attending urologist.||t|||
1303585|NCT03549598||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303586|NCT03549585|||Cohort||Prospective|||||||
1303587|NCT03549572|||Case-Only||Prospective|||||||
1303588|NCT03549559|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1303589|NCT03549546||Single Group Assignment||Basic Science||None (Open Label)||||||
1303590|NCT03549533|||Other||Prospective|||||||
1303591|NCT03549520||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303592|NCT03549507||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303593|NCT03549494||Single Group Assignment||Supportive Care||None (Open Label)||||||
1303594|NCT03549481|||Cohort||Prospective|||||||
1303595|NCT03549468||Single Group Assignment||Treatment||None (Open Label)||||||
1303596|NCT03549455||Single Group Assignment||Treatment||None (Open Label)||||||
1303597|NCT03549442|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Three separate phases. Phases A and C are non-randomized, Phase B is randomized||||
1303598|NCT03549429|Randomized|Parallel Assignment||Prevention||Triple||Every patient will have each tape on each eye -EyeGard® on one eye and the TegadermTM on the other eye according to the randomization schema.|t||t|t
1303599|NCT03549416|||Other||Prospective|||||||
1303600|NCT03549403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303601|NCT03549390|Randomized|Crossover Assignment||Prevention||None (Open Label)||This study is a three period crossover design. There are three experimental conditions (yoga, continuous exercise and control) and participants will be randomised to one of six sequences requiring them to complete all three conditions.||||
1303602|NCT03549377|||Ecologic or Community||Cross-Sectional|||||||
1303603|NCT03549364||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303604|NCT03549351|||Cohort||Prospective|||||||
1303605|NCT03549338|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1303606|NCT03549325|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Group 1: Nasal inoculation with Neisseria lactamica with eradication on day 4 - up to 22 volunteers or until 11 colonised on day 4 Group 2: Nasal inoculation with Neisseria lactamica with eradication on day 14 - up to 22 volunteers or until 11 colonised on day 4||||
1303607|NCT03549312||Single Group Assignment||Treatment||None (Open Label)||||||
1303608|NCT03549299|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be treated in up to four ascending dose groups. After the last treated patient of the first dose group (Group A) was followed for 6 weeks, a safety and tolerability assessment of the applied IMP dose will be conducted by an internal committee. Dose escalation and recruitment of additional patients into the second dose group (Group B) will depend on the safety and tolerability of the IMP in Group A. The same approach applies to Group C and D.||||
1303609|NCT03549286|||Case-Only||Prospective|||||||
1303610|NCT03549273||Single Group Assignment||Treatment||None (Open Label)||||||
1303611|NCT03549260|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind and Placebo-Controlled - Study drug administered by unmasked nurse who is not involved in any other aspects of the trial|Randomized, Double-Blind, Placebo-Controlled trial to evaluate LDL-C reduction with 3 different doses of LIB003 compared to placebo|t|t|t|t
1303612|NCT03549247|||Case-Control||Cross-Sectional|||||||
1303613|NCT03549234|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303614|NCT03549221|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1303615|NCT03549208|Randomized|Parallel Assignment||Prevention||Single|||t|||
1303616|NCT03549195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303617|NCT03549182|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1303618|NCT03549169|Randomized|Parallel Assignment||Supportive Care||Single|A research assistant (nurse trained in the measurement instruments) applies the instruments that allow the evaluation of the outcomes of interest: self-care, quality of life regarding health and follow up of clinical events: emergency attention, hospitalization, death by HF.|The participants are assigned to two groups during the duration of the study. A group receives the standard attention and the intervention protocol and the other group only the standard attention.||||t
1303619|NCT03549156|Randomized|Parallel Assignment||Treatment||Quadruple|Each food will be randomized to two colors with the study coordinator, nurse, caregivers blinded to the which color is which food.||t|t|t|t
1303620|NCT03549143|||Cohort||Prospective|||||||
1303621|NCT03549130|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303622|NCT03549117|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303623|NCT03549104|Randomized|Parallel Assignment||Treatment||Single||randomized controlled trial||||t
1573354|NCT00001498||||Treatment||||||||
1303624|NCT03549091||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303625|NCT03549078||Single Group Assignment||Prevention||None (Open Label)||||||
1303626|NCT03549065|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1303627|NCT03549052|||Cohort||Prospective|||||||
1303628|NCT03549039|||Cohort||Retrospective|||||||
1303629|NCT03549026|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1303630|NCT03549013|||Cohort||Retrospective|||||||
1303631|NCT03549000|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303632|NCT03548987|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.||t|t|t|t
1303633|NCT03548974|Randomized|Parallel Assignment||Treatment||Single||||||t
1303634|NCT03548961||Single Group Assignment||Treatment||None (Open Label)||||||
1303635|NCT03548948|Non-Randomized|Crossover Assignment||Other||None (Open Label)||"Typical American Diet with high heme/non-heme iron (16 mg)~Typical American Diet with low iron (8 mg)~Plant-based Diet with high non-heme iron (16 mg)"||||
1303636|NCT03548935|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.||t|t|t|t
1303637|NCT03548922|||Cohort||Prospective|||||||
1303638|NCT03548909|||Cohort||Prospective|||||||
1303639|NCT03548896|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1303640|NCT03548883|||Case-Control||Prospective|||||||
1303641|NCT03548870|Randomized|Crossover Assignment||Treatment||Triple|sham transcutaneous electrical nerve stimulation||t||t|t
1303642|NCT03548857|||Cohort||Prospective|||||||
1303643|NCT03548844|Randomized|Parallel Assignment||Treatment||None (Open Label)||This trial is a a two-arm, open labelled, prospective, randomized phase III studies. Eligible patients with ypT0-1cN0 rectal cancer patients will be randomly assigned, in a 1:1 ratio, to receive either observation (local excision group) or complementary rectal excision (total mesorectal excision group).||||
1303644|NCT03548831|||Case-Only||Prospective|||||||
1303645|NCT03548818|||Cohort||Prospective|||||||
1303646|NCT03548805|Randomized|Parallel Assignment||Treatment||None (Open Label)||ologen® Collagen Matrix, Model 830601, shape Round cylindrical, Size 6mm (diameter) x 2mm (thickness),Manufacturer Aeon Astron Europe B. V.||||
1303647|NCT03548792|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1303648|NCT03548779|Randomized|Parallel Assignment||Diagnostic||Double|"The study coordinator will assign the first randomization to pre-visit preparation arm and care providers will not be told of the patient's pre-visit preparatory randomization arm prior to the first usual care visit. Randomization to exome sequencing will be performed after the first usual care visit by the study coordinator.~Investigators will receive de-identified coded data and thus will not be able to link a patient name to an intervention arm. Some analyses will require individual-level randomization arm status to allow for comparison of parent questionnaire responses or health outcomes by arm - a major focus of this study.~All interviewers and medical records staff conducting telephone surveys and/or medical records abstraction for clinical data will be blinded to the participants randomization status. Access to this information will be blocked in the electronic patient tracking status by study role."|||t||t
1303649|NCT03548766|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1303650|NCT03548753|||Cohort||Prospective|||||||
1303651|NCT03548740|||Case-Control||Prospective|||||||
1303652|NCT03548727|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"The study includes two arms:~Arm1: FLT PET/CT on Day1 and Day2 Arm2: Combined FMISO/FLT PET/CT on Day1 and FLT PET/CT on Day2"||||
1303653|NCT03548714|Randomized|Parallel Assignment||Other||Quadruple||Apart from the Research Pharmacists, all others engaged with this study (participants and study team) will be masked to alcohol challenge order.|t|t|t|t
1303654|NCT03548701|||Case-Control||Prospective|||||||
1303655|NCT03548688|||Cohort||Prospective|||||||
1303656|NCT03548675|Randomized|Parallel Assignment||Treatment||Single|Prescribing physicians will be unblinded for the genotype and the resulting metabolization phenotype. Outcome assessments will be performed by blinded researchers and the patients themselves (self-assessments).|This study is a randomized controlled clinical trial.||||t
1303657|NCT03548662|Non-Randomized|Parallel Assignment||Treatment||Double||||t||t
1303658|NCT03548649||Single Group Assignment||Treatment||None (Open Label)||AIS A-D SCI patients with injury level C7-L5||||
1303659|NCT03548636||Single Group Assignment||Prevention||None (Open Label)||||||
1303660|NCT03548623|||Ecologic or Community||Prospective|||||||
1303661|NCT03548610|Randomized|Parallel Assignment||Treatment||Single|Blinded physician will evaluate standardized photographs.|Nanofat is obtained via lipoaspiration of 10cc of fat from abdomen under moderate local tumescent anesthesia w/ saline. Cannula access point is anesthetized by local lidocaine infiltration. Lipoaspirate is processed into the nanofat using the Tonnard method, after 3-minute decantation. Aspiration is performed using a multihole 3mm cannula. Wound margin + bed is treated w/ topical & local injections of nanofat, then covered w/ a biological scaffold, the inferior surface of which is soaked in nanofat; scaffold is fixed w/ external dressings or resorbable sutures; external covering includes polyurethane film & 3 layers of dressings. Topical application creates a fine <1mm nanofat layer. Scaffold (Puracol Plus) is left in place to integrate w/ surrounding skin, while external dressings changed at 7 & 15 days. Lipoaspirate donor site needs mild to moderate compression for 24 hours & suture removal (if not absorbed) at 7 days.||||t
1303662|NCT03548597|||Cohort||Prospective|||||||
1303663|NCT03548584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303664|NCT03548571|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label, randomized||||
1303699|NCT03548116|Randomized|Parallel Assignment||Basic Science||Double|The study participants will be blinded to their group assignment for the entire duration of the study. The study investigators will also be blinded to participant assignments on this study, except for the investigators performing the ultrasound procedure, co-investigators randomizing the participants, and co-investigators involved in the study's monitoring.|After a screened individual is deemed eligible for continued participation, a study investigator will enter the participant's information into a randomization portal in order to receive the group assignment.|t||t|
1303665|NCT03548558|Randomized|Factorial Assignment||Health Services Research||Single|The study will have separate teams for collection of surveys and program implementation. Due to the nature of the intervention, the participants and delivery agents will not be blinded to their study allocation as part of the program implementation team. Data collectors of surveys for the research team will, however, be blinded to the intervention allocation status of participants and villages. (Baseline surveys will be collected prior to randomization.) Likewise, data analysis will be blinded to the intervention status of participants and villages.|The evaluation design consists of a clustered Randomized Control Trial (cRCT) in which 60 CHVs and their associated villages will be randomly assigned to one of three equally-sized treatment arms: group meetings only (Arm 1), group meetings with a limited number of individual home visits and booster sessions (Arm 2), and a control group (Arm 3). Within half of the villages assigned to Arms 1 and 2 (the intervention arms), fathers will also be invited to the group sessions (a 2x2 factorial design among the 40 villages assigned to receive the intervention). All households, including the control group (Arm 3), will receive basic information about child feeding during a baseline survey.||||t
1303666|NCT03548545|Randomized|Parallel Assignment||Treatment||Triple|Both the Participant, the outcome assessor and the Psychologist providing the CBT will be blinded to the type of the stimulation that the subject is receiving. Unblinding will occur at the end of the participation in the study and subjects that received sham tDCS will have the chance to receive the active tDCS.|This is a parallel randomized, double blinded, sham controlled clinical trial in which a total of 72 MDD subjects(36 per arm) will be randomized to one of two groups: CBT combined with either active or sham tDCS.|t|t||t
1303667|NCT03548532|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Based on the randomisation list, patients fulfilling the inclusion criteria will be assigned to one of each arm. A total of 119 patients are needed in every arm in this superiority trial.||||
1303668|NCT03548519|Randomized|Parallel Assignment||Prevention||Single|||t|||
1303669|NCT03548506|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1303670|NCT03548493|Randomized|Parallel Assignment||Treatment||Quadruple||"34 patients are randomly divided by computer designed lists and then concealed in closed envelopes into 2 equal groups:~Group A (n=17) will receive magnesium sulphate adjuvant to propofol for sedation.~Group B (n=17) will receive fentanyl adjuvant to propofol for sedation"|t|t|t|t
1303671|NCT03548480|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1303672|NCT03548467||Single Group Assignment||Treatment||None (Open Label)||Open Label||||
1303673|NCT03548454|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1303674|NCT03548441|||Cohort||Prospective|||||||
1303675|NCT03548428|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label, Phase II, prospective, multicentric, randomized study 2:1, 2 arm study||||
1303676|NCT03548415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303677|NCT03548402||Single Group Assignment||Treatment||None (Open Label)||||||
1303678|NCT03548389|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Quasi-experimental study||||
1303679|NCT03548376||Single Group Assignment||Treatment||None (Open Label)|the scoring of repeated evaluations was blinded regarding order. To do so, the scores of all of the instruments were calculated without the knowledge of which was the evaluation (T1, T2 or T3) or access to the previous scores of the same child. The GMFM-88 score was made by an examiner who did not participate in the data collection (evaluations and intervention). This examiner watched the videos and was blinded to the child's descriptive information and the order of the evaluation. The ECAB test score was calculated by two other external examiners who watched the videos and were also blinded regarding the same information.|Before-after trial (6 months of follow-up; one group with three repeated measurements)||||
1303680|NCT03548363|Randomized|Parallel Assignment||Treatment||Double|Both the investigators with any involvement in the study or data analysis prior to database locking and subjects are blinded to what treatment they receive.|Double-blind, placebo-controlled, 4-week parallel intervention in subjects with mild to moderate Dyspepsia (as defined by the Leeds Dyspepsia Questionnaire) in 3-treatment arms: 1.) 100 mg/d Gingest; 2.) 200 mg/d Gingest; 3.) Placebo (maltodextrin)|t||t|
1303681|NCT03548350|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303682|NCT03548337|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303683|NCT03548324|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two arms multicenter randomized controlled trial designed according to the intention-to-treat model. The assignement to one of the two arms (NCPAP or HHHFNC) is by block randomization. The randomization program is designed to obtain, in each research unit, a balance between the two arms according to gestation age (GA <28 weeks and GA ≥ 28 weeks).||||
1303684|NCT03548311|Randomized|Parallel Assignment||Treatment||Quadruple||double-blinded randomized controlled|t|t|t|t
1303685|NCT03548298||Single Group Assignment||Treatment||None (Open Label)||Men and women with diagnosis of GERD confirmed by endoscopy or pHmetry, GERD questionnaire and that accept this new treatment.||||
1303686|NCT03548285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303687|NCT03548272|Randomized|Parallel Assignment||Treatment||Single||||||t
1303688|NCT03548259|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind|Randomized Controlled Trial (Parallel Assignment)|t|t|t|t
1303689|NCT03548246|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1303690|NCT03548233||Single Group Assignment||Prevention||None (Open Label)||bcg vaccine||||
1303691|NCT03548220|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1303692|NCT03548207||Single Group Assignment||Treatment||None (Open Label)||||||
1303693|NCT03548194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303694|NCT03548181|Randomized|Parallel Assignment||Treatment||Double|The study is a randomized controlled trial|The study is a prospective, randomized controlled trial comparing the effects of tele-rehabilitation and standard treatment in patients with IPF|t|||t
1303695|NCT03548168|||Case-Control||Cross-Sectional|||||||
1303696|NCT03548155|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303697|NCT03548142||Single Group Assignment||Supportive Care||None (Open Label)||||||
1303698|NCT03548129|Randomized|Parallel Assignment||Treatment||Single|||||t|
1303797|NCT03546829|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1303700|NCT03548103|Randomized|Parallel Assignment||Treatment||Triple|Placebo|double blind placebo-controlled trial|t|t|t|
1303701|NCT03548090|Randomized|Crossover Assignment||Treatment||Single||||||t
1303702|NCT03548077||Single Group Assignment||Prevention||None (Open Label)||Quasi-experimental, pre-post study design||||
1303703|NCT03548064|Randomized|Sequential Assignment||Prevention||Double|||t||t|
1303704|NCT03548051|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1303705|NCT03548038|||Cohort||Prospective|||||||
1303706|NCT03548025||Single Group Assignment||Treatment||None (Open Label)||||||
1303707|NCT03548012|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||A stepped wedge cluster randomized controlled trial. All clusters (i.e., municipalities) will start as controls and will change to intervention at various times determined by randomization. In this way, all municipalities will contribute to control and intervention groups, thus accounting for variation between municipalities.||||
1303708|NCT03547999|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-Label|||||
1303709|NCT03547986|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The existing and new diagnostic method are performed on the same patients (paired data)||||
1303710|NCT03547973||Single Group Assignment||Treatment||None (Open Label)||||||
1303711|NCT03547960|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1303712|NCT03547947|||Cohort||Prospective|||||||
1303713|NCT03547934||Single Group Assignment||Treatment||None (Open Label)||||||
1303714|NCT03547921|||Cohort||Prospective|||||||
1303715|NCT03547908|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303716|NCT03547895|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||patients with decompensated cirrhosis with frequent hepatic encephalopathy (HE) or difficult to treat ascites were included if they had chronic active HCV||||
1303717|NCT03547882|||Other||Other|||||||
1303718|NCT03547869|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1303719|NCT03547856|||Cohort||Prospective|||||||
1303720|NCT03547843|Randomized|Crossover Assignment||Other||None (Open Label)||Pilot randomized clinical trial||||
1303721|NCT03547830||Single Group Assignment||Treatment||None (Open Label)||||||
1303722|NCT03547817||Single Group Assignment||Basic Science||None (Open Label)||||||
1303723|NCT03547804||Single Group Assignment||Treatment||None (Open Label)||||||
1303724|NCT03547791|Randomized|Parallel Assignment||Treatment||Double|Enrolled women will be randomly assigned in a 1:1 ratio to ACS (Group 1) or placebo (Group 2). The randomization will be done by web-based randomization system which is operated by medical research collaborating center of Seoul National University Hospital. The ACS or placebo will be prepared by unblended researchers [clinical trial pharmacy]. Unblinded researchers will be designated at the beginning of this trial, and they will not participate in the subsequent process of data management and data analysis. Neither the enrolled pregnant women nor the other investigators (except predeterminate unblinded researchers) will be aware of the result of random assignment.|In this multi-center, double-blind, randomized, placebo-controlled trial, women who are at risk for late preterm birth (34+0wks-36+5wks) will be enrolled and randomly assigned to two groups receiving betamethasone(ACS) or placebo.|t|t||
1303725|NCT03547778|Randomized|Parallel Assignment||Prevention||Double|The participants and the care providers (performing the procedure) will not know about the randomization. The research coordinator will perform the randomization and the medicine dispensed by the pharmacy. The study drug and placebo are similar looking, hence the participants and providers would not be able to identify them.|A Double Blind Randomized Controlled Trial|t|t||
1303726|NCT03547765|||Case-Only||Prospective|||||||
1303727|NCT03547752|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303728|NCT03547739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303729|NCT03547726|Randomized|Parallel Assignment||Treatment||Double|The physician will not know if the patient is receiving at home physical therapy or seeing a physical therapist in clinic.|There will be two groups of patients randomized either to receive formal physical therapy in clinic or a self-led at home rehabilitation regimen.||t|t|
1303730|NCT03547713||Single Group Assignment||Basic Science||None (Open Label)||||||
1303731|NCT03547700||Single Group Assignment||Treatment||None (Open Label)||||||
1303732|NCT03547687||Single Group Assignment||Treatment||None (Open Label)||||||
1303733|NCT03547674|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|Gait analysis under 4 conditions (barefoot, shoes only, untuned AFO with shoes, tuned AFO with shoes) will be performed in a random order: To determine the order, the 4 conditions will be noted on a piece of paper and randomly picked from an envelope.|Prospective, cross-sectional within-subjects comparison||||
1303734|NCT03547661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303735|NCT03547648|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1303736|NCT03547635|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a multicenter, randomized, parallel-group study comparing the outcomes associated with the use of AMNIOEXCEL Plus Placental Allograft Membrane, a marketed comparator and SOC alone in the management of diabetic foot ulcers (DFUs).||||
1303737|NCT03547622|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1303738|NCT03547609||Single Group Assignment||Other||None (Open Label)||||||
1303739|NCT03547596|||Cohort||Prospective|||||||
1303740|NCT03547583|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303741|NCT03547570||Single Group Assignment||Treatment||None (Open Label)||Intervention group only.||||
1303742|NCT03547557||Single Group Assignment||Supportive Care||None (Open Label)||||||
1303743|NCT03547544|||Case-Only||Cross-Sectional|||||||
1303744|NCT03547531|Randomized|Parallel Assignment||Treatment||Single|Examiner was blind to the allocation of the group|the data were gathered from two groups of participants (control and intervention groups)||||t
1303745|NCT03547518|Randomized|Parallel Assignment||Treatment||Single|Participant blinded to interventional or sham treatment|Randomized, single blind parallel assignment|t|||
1303746|NCT03547505|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled clinical trial|||t|
1303798|NCT03546816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303747|NCT03547492|Randomized|Single Group Assignment||Prevention||None (Open Label)||Random assignment to language (intervention) or motor (control) focused curriculums||||
1303748|NCT03547479|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The study design consists of (a) 4 qualitative focus groups (b) a pretest of 10 patient (c) a pilot randomised study of 60 patients and (d) interviews of stakeholders including healthcare professionals and policymakers||||
1303749|NCT03547453|||Case-Control||Cross-Sectional|||||||
1303750|NCT03547440|||Case-Control||Prospective|||||||
1303751|NCT03547427|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1303752|NCT03547414|||Case-Only||Retrospective|||||||
1303753|NCT03547401|||Cohort||Prospective|||||||
1303754|NCT03547388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Phase I feasibility study||||
1303755|NCT03547375||Single Group Assignment||Treatment||None (Open Label)||||||
1303756|NCT03547362|Randomized|Crossover Assignment||Basic Science||Double||The study is designed as a randomized, single-blinded within-subject (cross-over) trial in which a group of 12 subjects receive 6 different dairy products.|||t|t
1303757|NCT03547349|Randomized|Parallel Assignment||Prevention||Single|Incidence and severity of atelectasis will be radiographically assessed on a 5 point scale (no apparent disease, subsegmental atelectasis, segmental atelectasis, lobar atelectasis, or pneumonia) by a chest radiologist and two pulmonary physicians blinded to study group assignment.|Patients will be enrolled sequentially in Group 1 until the desired group enrollment number is met (N=25) at which point participants will be randomized into groups 2 and 3, stratified by surgery type (open or laproscopic)||||t
1303758|NCT03547336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303759|NCT03547323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303760|NCT03547310||Single Group Assignment||Treatment||None (Open Label)||||||
1303761|NCT03547297|||Cohort||Prospective|||||||
1303762|NCT03547284|Randomized|Parallel Assignment||Screening||Single|||||t|
1303763|NCT03547271|Randomized|Parallel Assignment||Prevention||Triple|"Modified double blind for Groups 1 and 2 and open label for Groups 3 and 4 for meningococcal vaccines. Open-label for all concomitant routine vaccines.~Modified double-blind: the participants parent / legally acceptable representative, the Investigator, and other study personnel remain unaware of the treatment assignments throughout the trial. An unblinded vaccine administrator will administer the appropriate vaccines but will not be involved in safety data collection."||t||t|t
1303764|NCT03547258|||Cohort||Other|||||||
1303765|NCT03547245|Randomized|Sequential Assignment||Prevention||Double|||t|t||
1303766|NCT03547232|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1303767|NCT03547219||Single Group Assignment||Basic Science||None (Open Label)||||||
1303768|NCT03547206|Randomized|Parallel Assignment||Treatment||Quadruple|All clinic staff and participants will be masked to group assignments. Only the Data and Safety Monitoring Board (DSMB) and designated unmasked staff at the Coordinating Center will have access to the group assignments.||t|t|t|t
1303769|NCT03547193|||Cohort||Prospective|||||||
1303770|NCT03547180|Randomized|Parallel Assignment||Treatment||Single||||||t
1303771|NCT03547167|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1303772|NCT03547154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303773|NCT03547141|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1303774|NCT03547128|||Cohort||Prospective|||||||
1303775|NCT03547115||Single Group Assignment||Treatment||None (Open Label)||This is a Phase 1, open-label, 3 + 3 dose escalation study to determine the safety and preliminary efficacy of voruciclib.||||
1303776|NCT03547102|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1303777|NCT03547089||Single Group Assignment||Treatment||None (Open Label)||||||
1303778|NCT03547076||Sequential Assignment||Diagnostic||None (Open Label)|All study personnel will be masked for findings by other study personnel. Patients will first be examined by nurses or GP in a random order, then subsequently, reference examination will be performed by cardiologist experienced in heart failure diagnostics and echocardiography.|The focused Pocket ultrasound examination and evaluation will be performed by a general practitioner. A similar focused ultrasound examination will be performed by a nurse without evaluation by the nurse. The complete echocardiographic examination by a cardiologist, using a state of the art ultrasound machine is considered the gold standard method.||||
1303779|NCT03547063|||Cohort||Prospective|||||||
1303780|NCT03547050|||Case-Control||Other|||||||
1303781|NCT03547037|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303782|NCT03547024|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1303783|NCT03547011|Randomized|Parallel Assignment||Treatment||Triple|The patients, outcome assessors and care providers are not informed with the block type done.|Double blinded randomized study.|t|t||t
1303784|NCT03546998|||Cohort||Prospective|||||||
1303785|NCT03546985|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1303786|NCT03546972|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303787|NCT03546959|Randomized|Parallel Assignment||Treatment||Double|outcome assessor blinded to participants' allocated group|Paralel group randomized controlled study|||t|t
1303788|NCT03546946|Randomized|Factorial Assignment||Basic Science||Double|||t|||t
1303789|NCT03546933|||Cohort||Prospective|||||||
1303790|NCT03546920|Randomized|Sequential Assignment||Supportive Care||None (Open Label)|This is a feasibility trial.|Step wedge design. Randomization occurred at the facility level. Facilities are randomized to the order of starting accrual in control phase and then transitioning to intervention phase once control sample has accrued.||||
1303791|NCT03546907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303792|NCT03546894|||Cohort||Prospective|||||||
1303793|NCT03546881|Randomized|Parallel Assignment||Prevention||Single|||t|||
1303794|NCT03546868|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1303795|NCT03546855||Single Group Assignment||Treatment||None (Open Label)||||||
1303796|NCT03546842||Single Group Assignment||Prevention||None (Open Label)||||||
1573355|NCT00001497||||||||||||
1303800|NCT03546790|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1303801|NCT03546777|||Case-Crossover||Prospective|||||||
1303802|NCT03546764|Randomized|Parallel Assignment||Treatment||Single|Patient does not know the details of the treatment assignment|Two arms - Percutaneous catheter arm vs Chest tube arm|t|||
1303803|NCT03546751|Randomized|Parallel Assignment||Treatment||Single|Investigators will randomize two groups of patients with OSA to receive either CPAP or intensive exercise. The study biostatistician will ensure that matching results in equal distributions of patients based on sex, age, race, severity of OSA, and obesity status.|Comparative Effectiveness Trial||||t
1303804|NCT03546738|Randomized|Crossover Assignment||Treatment||Quadruple|During the 12 months following implantation of a spinal cord stimulation (SCS) system, the patients will undergo four three-month long periods with either burst SCS or no stimulation (sham) in a randomized order. All patients will undergo two periods of SCS and sham stimulation.||t|t|t|t
1303805|NCT03546725|Randomized|Parallel Assignment||Prevention||Single|Outcomes will be self-reported, and the author that assesses the outcomes and performs data analyses will be blinded.|Participants will be randomised to wear a compression stocking on either the left or the right leg during a 3 - 3.5 hour flight. All participants will act as their own control, and as a result all data will be paired.||||t
1303806|NCT03546712|||Other||Cross-Sectional|||||||
1303807|NCT03546699|||Cohort||Prospective|||||||
1303808|NCT03546686|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 randomization||||
1303809|NCT03546673|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1303810|NCT03546660||Single Group Assignment||Screening||None (Open Label)||||||
1303811|NCT03546647|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1303812|NCT03546634|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303813|NCT03546621|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, Open-label, Randomized||||
1303814|NCT03546608|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1303815|NCT03546595|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1303816|NCT03546582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303817|NCT03546569|||Cohort||Prospective|||||||
1303818|NCT03546556|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1303819|NCT03546543|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1303820|NCT03546530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303821|NCT03546517|Randomized|Parallel Assignment||Treatment||Triple|Patients and assessor are blinded but the physiotherapist giving the treatment is not blinded||t||t|t
1303822|NCT03546504||Single Group Assignment||Treatment||None (Open Label)||Single group pre-post-follow-up||||
1303823|NCT03546491|Randomized|Crossover Assignment||Prevention||Single||||||t
1303824|NCT03546478||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303825|NCT03546465|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303826|NCT03546452|||Case-Only||Prospective|||||||
1303827|NCT03546439|||Case-Only||Prospective|||||||
1303828|NCT03546426||Single Group Assignment||Treatment||None (Open Label)||||||
1303829|NCT03546413|||Cohort||Cross-Sectional|||||||
1303830|NCT03546400||Single Group Assignment||Treatment||None (Open Label)||||||
1303831|NCT03546387|||Cohort||Prospective|||||||
1303832|NCT03546374||Single Group Assignment||Treatment||None (Open Label)||||||
1303833|NCT03546361|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1303834|NCT03546348|||Case-Only||Cross-Sectional|||||||
1303835|NCT03546335|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The first 2 patients will receive 1 mCi of 89Zr-DFO-CZP. Subsequent groups of two patients will receive 0.5 mCi decrease or increase dose (up to 2 mCi) to determine the acceptable optimal imaging dose.||||
1303836|NCT03546322|||Cohort||Prospective|||||||
1303837|NCT03546309|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1303838|NCT03546296|||Case-Control||Prospective|||||||
1303839|NCT03546283|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303840|NCT03546270|Randomized|Parallel Assignment||Treatment||Single||||||t
1303841|NCT03546257|||Other||Prospective|||||||
1303842|NCT03546244|Randomized|Parallel Assignment||Treatment||Single|||||t|
1303843|NCT03546231|||Cohort||Retrospective|||||||
1303844|NCT03546218|Randomized|Parallel Assignment||Treatment||Single||||||t
1303845|NCT03546205|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1303846|NCT03546192|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants were enrolled in two age groups: participants aged 18 to 60 years and participants aged 61 years or older.||||
1303847|NCT03546179|||Cohort||Prospective|||||||
1303848|NCT03546166||Single Group Assignment||Treatment||None (Open Label)||||||
1303849|NCT03546153||Single Group Assignment||Treatment||None (Open Label)||||||
1303850|NCT03546140|||Cohort||Prospective|||||||
1303851|NCT03546127|||Cohort||Prospective|||||||
1303852|NCT03546114|||Cohort||Cross-Sectional|||||||
1303853|NCT03546101|||Cohort||Prospective|||||||
1303854|NCT03546088||Single Group Assignment||Treatment||None (Open Label)||||||
1303855|NCT03546075|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1303856|NCT03546062|||Cohort||Other|||||||
1303857|NCT03546049|Non-Randomized|Parallel Assignment||Treatment||Double||prospective, non-randomized multicenter study (each center performs the intervention which can do best)|||t|t
1303858|NCT03546036|Randomized|Parallel Assignment||Treatment||Triple|Study participants were kept blind to treatment allocation by the information that they would be assigned to one of two types of chain blanket, without any information of the difference in weight. The outcome assessor and investigator did not participate in randomization and treatment and were blind to treatment allocation.|Randomization to intervention or control parallell groups on a 50/50 basis.|t||t|t
1303859|NCT03546023|||Cohort||Prospective|||||||
1303860|NCT03546010||Single Group Assignment||Supportive Care||None (Open Label)||||||
1303861|NCT03545997|Randomized|Crossover Assignment||Treatment||Quadruple|Montelukast will be crushed and coated in a capsule, Mannitol is into a capsule too.|It's a prospective, randomized, comparative vs placebo, double blind, multicenter, national study.|t|t|t|t
1303862|NCT03545984|Randomized|Parallel Assignment||Other||Single|The staff anesthesiologist evaluating a resident on spinal drain placement would NOT be aware of the resident's group allocation.|Prospective randomized educational trial||||t
1303863|NCT03545971|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1303864|NCT03545958|Randomized|Parallel Assignment||Prevention||Double|The Research Coordinator will manage recruitment and enrolment of study participants, and will not be involved in either measurement or the intervention. Research personnel performing the outcome assessments and data analysis will be blinded to group allocation but it is not possible to blind participants and personnel delivering the interventions.||||t|t
1303865|NCT03545945|Randomized|Single Group Assignment||Treatment||None (Open Label)||Randomized control trial||||
1303866|NCT03545932||Single Group Assignment||Prevention||None (Open Label)||||||
1303867|NCT03545919|||Case-Only||Prospective|||||||
1303868|NCT03545906|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1303869|NCT03545893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303870|NCT03545880|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1303871|NCT03545867|Randomized|Factorial Assignment||Prevention||None (Open Label)||Static first arm with randomized remaining three arms.||||
1303872|NCT03545854|Randomized|Parallel Assignment||Treatment||None (Open Label)||The cadavers will be randomized to receive the intervention (Erector Spinae Plane Block) on different levels (Vertebral level - T3, T12 and L4) and different volumes (10, 20 and 30ml)||||
1303873|NCT03545841|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1303874|NCT03545828|||Cohort||Prospective|||||||
1303875|NCT03545815||Single Group Assignment||Treatment||None (Open Label)||||||
1303876|NCT03545802||Single Group Assignment||Basic Science||None (Open Label)||||||
1303877|NCT03545789||Single Group Assignment||Other||None (Open Label)||||||
1303878|NCT03545776|||Other||Prospective|||||||
1303879|NCT03545763|||Case-Control||Prospective|||||||
1303880|NCT03545750|||Case-Control||Retrospective|||||||
1303881|NCT03545737|||Other||Prospective|||||||
1303882|NCT03545724||Single Group Assignment||Treatment||None (Open Label)||Assignment||||
1303883|NCT03545711||Single Group Assignment||Treatment||None (Open Label)||||||
1303884|NCT03545698|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1303885|NCT03545685|Randomized|Parallel Assignment||Other||Single|||t|||
1303886|NCT03545672|||Cohort||Prospective|||||||
1303887|NCT03545659|||Cohort||Retrospective|||||||
1303888|NCT03545646||Single Group Assignment||Treatment||None (Open Label)||||||
1303889|NCT03545633||Single Group Assignment||Treatment||None (Open Label)||||||
1303890|NCT03545620|||Case-Only||Prospective|||||||
1303891|NCT03545607|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303892|NCT03545594|Randomized|Parallel Assignment||Supportive Care||Single|Independent Outcome Assessor(s) blinded to the intervention arm by masking the ID and randomization arm on the assessment and outcome forms.|Randomized controlled trial||||t
1303893|NCT03545581|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1303894|NCT03545568||Single Group Assignment||Treatment||None (Open Label)||Open label individual patient clinical trial study of small sample size||||
1303895|NCT03545555|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1303896|NCT03545542|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||"Neuroblastoma group: Children with neuroblastoma enrolled after verification of diagnosis. Sampling before initiation of chemotherapy and under chemotherapy.~Control group: healthy children without gastro-intestinal or pulmonary disease recruited from paediatric surgery."||||
1303897|NCT03545529|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1303898|NCT03545516|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1303899|NCT03545503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303900|NCT03545490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303901|NCT03545477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303902|NCT03545464|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1303903|NCT03545451||Single Group Assignment||Other||None (Open Label)||||||
1303904|NCT03545438|Randomized|Sequential Assignment||Treatment||Triple|Within each dosing cohort randomization is performed according to a computer-generated randomization scheme. Other than the study drug prepared by an unblinded pharmacist and administered by unblinded nurses who will be instructed not to discuss randomized treatment assignments and have no other role in the study, all study staff and PI, along with the subjects are blinded as to treatment.|single ascending dose with placebo controll|t|t|t|
1303905|NCT03545425|||Cohort||Cross-Sectional|||||||
1303906|NCT03545412||Single Group Assignment||Treatment||None (Open Label)||||||
1303907|NCT03545399|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single-centre double-blind randomized placebo-controlled clinical trial on parallel arms of two groups of 45 subjects||||
1303908|NCT03545386|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1303909|NCT03545373|Randomized|Parallel Assignment||Diagnostic||Single|All laboratory forms for mycobacteriology and nasopharyngeal pneumococcal work will have no reference to participant treatment allocation. On Day-8, assessment of improvement from baseline symptoms will utilize audio computer-assisted self-interview (ACASI) to minimise potential for social-mediated reporting and ascertainment biases. On Day-29, clinical outcome assessment forms will bear no reference to treatment arm. Participants, research coordinators, and routine care staff will not be masked to ensure safety of the participants and allow appropriate patient management decision-making which may be related to the trial interventions.|Three treatment arms allocated using computer generated block randomization in a 1:1:1 ratio.||||t
1303910|NCT03545360||Single Group Assignment||Treatment||None (Open Label)||||||
1303911|NCT03545347|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1303912|NCT03545334||Single Group Assignment||Diagnostic||None (Open Label)|The surgeons performing SLNB will be the blinded persons. The results of the lymphoscintigraphy will not be marked on the patient's skin as usual and no preoperative access to the images will be granted to the surgeons.|A diagnostic sensitivity study to analyse the ability of intradermally administered indocyanine green (ICG) and near infrared fluorescence imaging (NIRFI) to transcutaneously identify sentinel lymph nodes (SLNs) in malignant melanoma and Merkel cell carcinoma - after intradermally administered injection of technetium 99m and traditional lymphoscintigraphy (LS)||||
1303913|NCT03545321||Single Group Assignment||Health Services Research||None (Open Label)||Stepped-wedge cluster randomized design||||
1303914|NCT03545308|||Case-Only||Prospective|||||||
1303915|NCT03545295|Randomized|Parallel Assignment||Treatment||None (Open Label)||the cadavers will be randomized to receive the intervention (Quadratus Lumborum Block) by different techniques (QLB 2/ QLB3) and different volumes (10, 20, 30 ml)||||
1303916|NCT03545282|Randomized|Parallel Assignment||Prevention||Double|The investigators and outcomes assessor will not have knowledge of the interventions assigned to individual participants.||||t|t
1303917|NCT03545269|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Biological: CartiLife® Procedure: CartiLife® is beads (1.0 to 1.5 mm in diameter) in suspension, developed from autologous chondrocytes. The beads are implanted in a volume of 1 cm3 per the capacity of the syringe to the affected area through injection along with a fibrin adhesive through minimal arthrotomy.~Active comparator: Microfracture The surgery is performed by arthroscopy, after the joint is cleaned of calcified cartilage. Through use of an awl, the surgeon creates tiny fractures in the subchondral bone plate."||||
1303918|NCT03545256||Single Group Assignment||Treatment||None (Open Label)||"The surgical procedure associated with the sentinel lymph node technique is carried out in two stages:~- Lymphoscintigraphy at Day-1 : This is the identification of the lymphatic network of the patient by a prior injection of radioactive tracer, nanocolloide labeled with technetium99, around the primary tumor.~- Surgery on D0: The patient is admitted to the hospital at 7:00 am in outpatient unit. He is reviewed by the anesthetist before the intervention and is transferred to the operating room for the intervention under AG."||||
1303919|NCT03545243||Single Group Assignment||Treatment||None (Open Label)||Prospective interventional study with study procedures at inclusion, after a baseline period of 4 weeks and Pantoprazole therapy for 4 weeks||||
1303920|NCT03545230||Single Group Assignment||Treatment||None (Open Label)||"all childre with delayed union and nonunion lateral humeral condyle will be included.~After informed consent and full explanation.The Four Not Techniqueswill be done"||||
1303921|NCT03545217|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1303922|NCT03545204|Randomized|Parallel Assignment||Supportive Care||Triple|Participant, Care provider and outcome assessor will be masked about the intervention provided in the other arm.|"A Cluster Randomized Control Trial Group 1: Facility KMC and cKMC will be provided to low birth weight babies of randomly selected union councils.~Group 2: Only facility KMC and routine standard care is provided to low birth weight babies of randomly selected union councils."|t|t||t
1303923|NCT03545191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303924|NCT03545178|||Cohort||Retrospective|||||||
1303925|NCT03545165||Single Group Assignment||Treatment||None (Open Label)||||||
1303926|NCT03545152|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1303927|NCT03545139|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1303928|NCT03545126|||Case-Control||Prospective|||||||
1303929|NCT03545113|Randomized|Parallel Assignment||Other||Single||||||t
1303930|NCT03545100|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303931|NCT03545087|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1303932|NCT03545074|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pretest and immediate postest design with an active control condition.||||
1303933|NCT03545061|||Cohort||Prospective|||||||
1303934|NCT03545048|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1303935|NCT03545035|||Cohort||Retrospective|||||||
1303936|NCT03545022|Randomized|Parallel Assignment||Treatment||Triple|"Patients who met the study criteria were randomized to the type of acupuncture (active acupuncture or placebo acupuncture) and to the side of the first surgery (right or left). The randomization was performed by a researcher not involved in the study by lottery. Four papers in two opaque envelopes were used, one with the side of the teeth and another with the protocol of acupuncture treatment to be received, protocol 1 or 2.~The patients, the surgeon, the acupuncturist and the investigator were unaware of which acupuncture treatment was used at each surgery (active or placebo). In order to conceal the randomization, the needles for the active and placebo protocol were identical and were delivered to the acupuncturist in two boxes labeled protocol 1 and 2 and the codes were revealed only after completion of the study."||t||t|t
1303937|NCT03545009|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1303938|NCT03544996|||Case-Only||Prospective|||||||
1303939|NCT03544983|Randomized|Parallel Assignment||Health Services Research||Single|Outcomes will be assessed via electronic survey and review of medical records. In cases where surveys need to be completed by telephone, the outcomes assessor will be blind to the participant's randomization.|Two group parallel design comparing Web-based education + streamlined telephone genetic counseling to usual care.||||t
1303940|NCT03544970|||Cohort||Retrospective|||||||
1303941|NCT03544957|||Cohort||Prospective|||||||
1303942|NCT03544944|Randomized|Parallel Assignment||Treatment||Single||||||t
1303943|NCT03544931|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1303944|NCT03544918|||Cohort||Cross-Sectional|||||||
1303945|NCT03544905||Single Group Assignment||Treatment||None (Open Label)||||||
1303946|NCT03544892|Randomized|Crossover Assignment||Treatment||None (Open Label)||This study uses 33 week randomized, powered study design to measure glycemic control with a low carbohydrate dietary pattern versus standard of care diabetes medical nutrition therapy. Each arm is 12 weeks with an 8 week washout between arms.||||
1303947|NCT03544879|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1303948|NCT03544866|||Cohort||Prospective|||||||
1303949|NCT03544853||Single Group Assignment||Basic Science||None (Open Label)||||||
1303950|NCT03544840||Single Group Assignment||Treatment||None (Open Label)||||||
1303951|NCT03544827|Randomized|Crossover Assignment||Prevention||Double|Participants and main investigator will be blinded to the allocation concealment||t||t|
1303952|NCT03544814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1303953|NCT03544801|||Case-Control||Prospective|||||||
1303954|NCT03544788||Single Group Assignment||Treatment||None (Open Label)||Cirvo™ Therapy||||
1303955|NCT03544775|||Cohort||Retrospective|||||||
1303956|NCT03544762||Single Group Assignment||Diagnostic||None (Open Label)||||||
1303957|NCT03544749|Randomized|Parallel Assignment||Other||Double||Randomized controlled trial|t|||t
1303958|NCT03544736|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, non-randomized, Parallell Groups, Study of Nivolumab and Radiotherapy in Patients With Esophageal Cancer||||
1303959|NCT03544723||Single Group Assignment||Treatment||None (Open Label)||intratumoral Ad-p53 combined with monthly IV Opdivo (nivolumab) infusions||||
1303960|NCT03544710|Randomized|Parallel Assignment||Prevention||Single|Mothers scheduled to deliver by emergency Caesarean section were randomly assigned to either bathing or routine care arms in a ratio of 1:1. We did simple randomization to either bathing or routine care arm without any blocks. We generated patient group assignments using the computer algorithm (computer-generated list of random numbers). The research assistant who enrolled mothers into the study assigned the study arm by checking from the list of random numbers. The research assistant and the PI, who were on the outcomes assessment arm was not allowed to ask the study participant concerning the allocation arm. Single blinding of PI and one of the research assistants assessing outcomes was done to minimize bias.|"The participants in the bathing arm were each given warm water and a tablet of soap containing chloroxylenol antiseptic and they were asked to bathe using it within at most two hours prior to the surgery. After bathing, the participants were given a clean theatre gown to put on, after which they were taken through the routine pre-operative preparation procedures according to the existing ward protocol.~The participants in the control arm were only taken through the routine preoperative preparation procedures according to the existing ward protocol"||||t
1303961|NCT03544697|||Cohort||Retrospective|||||||
1303962|NCT03544684|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1303963|NCT03544671|Randomized|Parallel Assignment||Prevention||Quadruple|The Moses Oakford method was used by an independent researcher to randomly assign each child to 1 of 3 groups to receive the administration of the three supplments. A computer was used to generate the random numbers (STATA v.13). Groups were stratified by age from 12- 18 months, from 19- 24 months and form 25- 30 months of age. Each block group was assigned 73 children.|"Double blind, randomized, parallel, controlled trial was conducted in children from 12 to 30 months of age who received four supplements. Four treatments groups were assign randomly to children: One group received 400 IU/d, the second group received 800IU/d of vitamin D2 and the third one 1,000IU/d of colecalciferol D3. The fourth group-control-group- received a multy vitamin supplementation containing: iron, vitamin A, C, and E, folic acid, niacin and vitamins B1, B2, B6 y B12.Children were enrolled from 14-day-care centers which are part of a national government program Secretaria de Desarrollo Social SEDESOL , which main objective is to support working mothers and those who intend to work and do not have access to a health service."|t|t|t|t
1303964|NCT03544658||Single Group Assignment||Diagnostic||None (Open Label)|Neither the patient, the investigator that made the color acquisition or the spectrophotometer had knowledge of tooth color assessed by the other person/method|||||
1303965|NCT03544645|Randomized|Parallel Assignment||Treatment||Single|||||t|
1303966|NCT03544632||Single Group Assignment||Treatment||None (Open Label)||||||
1303967|NCT03544619|||Case-Only||Prospective|||||||
1303968|NCT03544606|Randomized|Parallel Assignment||Supportive Care||Single|To insure that everyone has the chance of participation, Randomization will be done using computer generated randomization sheet using statsdirect version 3. Double blinding will be done by one of the supervisors who will be the only one to know the key, thus the care provider and the patient will not know is it the drug or the placebo.|The patients will be divided into 2 groups Group 1: 70 women: patients were induced by Intra vaginal isosorbide mono nitrate (Effox 40 mg MINAPHARM) Group 2: 70 patients induced by placebo (pyridoxine) administered in the posterior vaginal fornix.|t|||
1303969|NCT03544593||Single Group Assignment||Other||None (Open Label)||||||
1303970|NCT03544580|Randomized|Parallel Assignment||Treatment||Single|||t|||
1303971|NCT03544567||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1303972|NCT03544554||Single Group Assignment||Treatment||None (Open Label)|Investigator|"The study sample included 100women (50 for the intervention and 50 for the control group) diagnosed with OAB syndrome. The control group was not provided with training. In addition to the pharmacological treatment, the intervention group was provided with a counseling and training program that consisted of a 45minute presentation based on Pender's Health Promotion Model. They were also given A Manual for Training on HealthyLifestyleBehaviors among women with OAB. The intervention group was requested to follow a weekly-scheduled bladder training program, keep records on the Urinary Diary form for six weeks. In the first interview and in the third month, the women in the intervention and control groups were administered the Introductory Information Form, Urinary Diary (4day), 24hour Standard Pad Test, OAB-V8, King'sHealthQuestionnaire, Healthy LifestyleBehaviorScaleII, and BriefSymptomInventory. In addition, an Inspection Form was administered in the third month."||||
1303973|NCT03544541|||Cohort||Prospective|||||||
1303974|NCT03544528|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1303975|NCT03544515|Randomized|Parallel Assignment||Treatment||Triple||Double blind randomized clinical trial|t||t|t
1303976|NCT03544502|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1303977|NCT03544489|Randomized|Parallel Assignment||Treatment||Single||home walking exercise||||t
1303978|NCT03544476|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1303979|NCT03544463|Randomized|Crossover Assignment||Treatment||Single||||||t
1303980|NCT03544450|Randomized|Parallel Assignment||Treatment||Single||||||t
1303981|NCT03544437|||Cohort||Prospective|||||||
1303982|NCT03544424|||Cohort||Retrospective|||||||
1304177|NCT03541876|||Cohort||Prospective|||||||
1304178|NCT03541863|||Cohort||Retrospective|||||||
1304179|NCT03541850||Single Group Assignment||Treatment||None (Open Label)||||||
1303983|NCT03544411|Randomized|Crossover Assignment||Treatment||Quadruple||This study was a clinical trial with cross over study design, random allocation, and double blindness to compare changes in antioxidant, glucose, cholesterol and triglyceride levels supplemented with 15 ml / day of olive oil (KZ) with supplementation of 15 ml / day of bran oil (KB). Provision of oil for 4 weeks in a row. During the 2-week interval not being treated (wash out). After the wash out period cross-over by exchanging olive oil supplementation to rice bran and vice versa for 4 consecutive weeks.|t|t|t|t
1303984|NCT03544398|||Case-Control||Prospective|||||||
1303985|NCT03544385|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1303986|NCT03544372|||Cohort||Cross-Sectional|||||||
1303987|NCT03544359|Randomized|Crossover Assignment||Basic Science||Single||"Eligible volunteers will be randomly assigned to receive either 5 consecutive days of active tES followed by 5 consecutive days of sham/placebo tES, or vice versa (sham followed by active tES). A two-week wash-out period will separate active and sham conditions."|t|||
1303988|NCT03544346|||Case-Control||Cross-Sectional|||||||
1303989|NCT03544333|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1303990|NCT03544320|Randomized|Parallel Assignment||Health Services Research||Double|The participants will be aware of the two different study arms and the wearable devices used in both. The study investigator will not have not have knowledge of the participants assigned to each arm.|Participants are randomized to one of two wearable devices and will wear that device for the duration of the study.|||t|t
1303991|NCT03544307|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel design with treatment group and control||||
1303992|NCT03544294|||Cohort||Prospective|||||||
1303993|NCT03544281|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|This is an open-label study; therefore, no blinding of treatment identity will be done for both treatments.|This is a 2-Part study. Part 1 is dose escalation phase and Part 2 is dose expansion phase. In each part subjects will receive 2 treatments, A and B. In Part 1, subjects will receive GSK2857916, at dose of 2.5 mg/kg with either Len/Dex or Bor/Dex (Arm A and B), if well tolerated escalated to 3.4 mg/kg in next cohort of subjects to determine RP2D dose. If not tolerated, lower dose, 1.9 mg/kg, will be administered. In Part 2 (Dose Expansion Phase) additional subjects will be treated at the RP2D of GSK2857916 with either Len/Dex or Bor/Dex (Arm A and B) to assess the clinical activity of those combinations.||||
1303994|NCT03544268|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Experimental: Acoustic Angiography||||
1303995|NCT03544255|||Cohort||Prospective|||||||
1303996|NCT03544242|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1303997|NCT03544229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1303998|NCT03544216|Randomized|Crossover Assignment||Treatment||Single|||t|||
1303999|NCT03544203|||Cohort||Prospective|||||||
1304000|NCT03544190|||Cohort||Cross-Sectional|||||||
1304001|NCT03544177|Randomized|Parallel Assignment||Treatment||Single|Outcome measures assessors, blinded to group allocation, will not have access to the randomization list and unblinding will not be possible for these researchers.|Single-center pilot randomized parallel group clinical trial||||t
1304002|NCT03544164|||Cohort||Prospective|||||||
1304003|NCT03544151|||Cohort||Prospective|||||||
1304004|NCT03544138||Single Group Assignment||Treatment||None (Open Label)||||||
1304005|NCT03544125||Single Group Assignment||Treatment||None (Open Label)||||||
1304006|NCT03544112|||Cohort||Prospective|||||||
1304007|NCT03544099||Single Group Assignment||Treatment||None (Open Label)||Interventional||||
1304008|NCT03544086|||Cohort||Prospective|||||||
1304009|NCT03544073|Randomized|Parallel Assignment||Treatment||Double|Patient and provider will both be blinded to the medication that the patient receives.||t|t||
1304010|NCT03544060||||||||||||
1304011|NCT03544047||Single Group Assignment||Treatment||None (Open Label)||||||
1304012|NCT03544034|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)|No masking|A pre-post study in two hospitals. Implementation will be done at the organization level (for all 65 and older patients admitted to hospitalist service in these two hospitals.||||
1304013|NCT03544021||Single Group Assignment||Treatment||None (Open Label)||||||
1304014|NCT03544008|||Other||Other|||||||
1304015|NCT03543995|||Case-Control||Prospective|||||||
1304016|NCT03543982||Single Group Assignment||Treatment||None (Open Label)||||||
1304017|NCT03543969||Single Group Assignment||Treatment||None (Open Label)||||||
1304018|NCT03543956|||Case-Only||Prospective|||||||
1304019|NCT03543943|Randomized|Parallel Assignment||Treatment||Single|The posterior site of the achilles tendon region is covered by dark tape during the functional assesments.|||||t
1304020|NCT03543930|||Case-Crossover||Prospective|||||||
1304021|NCT03543917||Single Group Assignment||Treatment||None (Open Label)||The new combination treatment is given to all consecutive patients and compared to literature and between groups (based on the time lapsed between CVA and treatment)||||
1304022|NCT03543904|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Participants were blinded towards which group they were allocated. If participants know that they were belonging to the experimental group 1 then they will be performing better than the participants in allocated in the experimental group 2.|Parallel||||
1304023|NCT03543891|||Case-Control||Cross-Sectional|||||||
1304024|NCT03543878|Randomized|Parallel Assignment||Supportive Care||Double||Participants will be randomly assigned to one of two study arms. One group will receive the Flicker exposure for 8 weeks while the other group will receive the active exposure for 4 weeks.|t|||t
1304025|NCT03543865|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1304026|NCT03543852|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||20 pediatric cancer survivor clinics will be pair matched based on patient population size, level of current suvivorship care, and location (urban/rural). The pairs will be randomized to receive the intervention immediately or after 12 months. Selection and randomization of clinics will occur in 2019. Participants (survivors aged 18-22, or caretakers of survivors under age 18) will be recruited from the participating centers.||||
1304180|NCT03541837||Single Group Assignment||Supportive Care||None (Open Label)||Prospective series case compared to a before group of consecutive patients||||
1304027|NCT03543839|Randomized|Crossover Assignment||Treatment||Quadruple|Study drug or placebo look identical.|This is not a true cross-over study. Subjects are randomized to receive true drug or placebo in the initial phase and then those patients who were randomized to receive belimumab will be rerandomized to receive either study drug or placebo. Subjects randomized at baseline to receive placebo continue to receive placebo through the study.|t|t|t|t
1304028|NCT03543826||Single Group Assignment||Prevention||None (Open Label)||||||
1304029|NCT03543813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304030|NCT03543800|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1304031|NCT03543787|Randomized|Parallel Assignment||Other||None (Open Label)||PRECEDE-PROCEED implementation research framework; 2-arm cluster randomized controlled trial||||
1304032|NCT03543774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304033|NCT03543761|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1304034|NCT03543748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304035|NCT03543735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304036|NCT03543722|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1304037|NCT03543709|||Cohort||Prospective|||||||
1304038|NCT03543696||Single Group Assignment||Treatment||None (Open Label)||||||
1304039|NCT03543683||Single Group Assignment||Treatment||None (Open Label)||||||
1304040|NCT03543670||Single Group Assignment||Supportive Care||None (Open Label)||||||
1304041|NCT03543657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304042|NCT03543644|Randomized|Crossover Assignment||Prevention||Single||||||t
1304043|NCT03543631|||Other||Cross-Sectional|||||||
1304044|NCT03543618|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1304045|NCT03543605|Randomized|Parallel Assignment||Prevention||Single|The study will be masked in the first year (pre-intervention) and open in the year of intervention||||t|
1304046|NCT03543592||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304047|NCT03543579|||Case-Only||Prospective|||||||
1304048|NCT03543566|||Cohort||Prospective|||||||
1304049|NCT03543553|||Case-Control||Cross-Sectional|||||||
1304050|NCT03543540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304051|NCT03543527|||Cohort||Prospective|||||||
1304052|NCT03543514|||Case-Only||Prospective|||||||
1304053|NCT03543501|Randomized|Parallel Assignment||Treatment||Single|A single-blind study where the assessor will be taking measurement before and after the intervention, albeit without knowing which intervention was given.|||||t
1304054|NCT03543488|||Cohort||Retrospective|||||||
1304055|NCT03543475|Randomized|Parallel Assignment||Prevention||Single|||||t|
1304056|NCT03543462|Randomized|Parallel Assignment||Treatment||Single|The investigator check the random list only when the patients is enrolled.|Patients affected by advanced stage ovarian cancer with diaphragmatic involvement. When diaphragmatic resection is performed the patients are randomized to proceed with chest drain positioning or not|||t|
1304057|NCT03543449|||Case-Control||Retrospective|||||||
1304058|NCT03543436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304059|NCT03543423|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||"12 healthy male individuals will each be studied on two occasions in random order.~oral glucose tolerance test~liquid mixed meal test"||||
1304060|NCT03543410|Randomized|Parallel Assignment||Treatment||Quadruple|double blind||t|t|t|t
1304061|NCT03543397|||Cohort||Retrospective|||||||
1304062|NCT03543384|||Cohort||Retrospective|||||||
1304063|NCT03543371|||Cohort||Prospective|||||||
1304064|NCT03543358|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304065|NCT03543345|||Cohort||Prospective|||||||
1304066|NCT03543332|||Cohort||Prospective|||||||
1304067|NCT03543319|||Cohort||Prospective|||||||
1304068|NCT03543306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1304069|NCT03543293|||Cohort||Retrospective|||||||
1304070|NCT03543280|||Cohort||Retrospective|||||||
1304071|NCT03543267||Single Group Assignment||Basic Science||None (Open Label)||||||
1304072|NCT03543254||Single Group Assignment||Treatment||None (Open Label)||||||
1304073|NCT03543241|||Case-Only||Prospective|||||||
1304074|NCT03543228|||Case-Only||Prospective|||||||
1304075|NCT03543215|||Cohort||Prospective|||||||
1304076|NCT03543202|Randomized|Parallel Assignment||Other||Double|patients and outcome assesors will be blinded for the analgesia method|prospective randomised|t|||t
1304077|NCT03543189||Single Group Assignment||Treatment||None (Open Label)||||||
1304078|NCT03543176|||Cohort||Cross-Sectional|||||||
1304079|NCT03543163|Randomized|Parallel Assignment||Treatment||Single|"Blinding of the participants is not applicable.~Blinding of the operator is not applicable.~Outcome assessor (primary and secondary outcomes) & biostatistician will be blinded."|||||t
1304080|NCT03543150|||Case-Only||Prospective|||||||
1304081|NCT03543137|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304082|NCT03543124|Randomized|Parallel Assignment||Other||Double|"1) The patients will not be informed of the technique, and what the cap at the tip looks like; 2) The colonoscope will be set up in the absence of the patient; 3) Before the start, a small towel will cover the eye of the patients, and care will be taken not to uncover the eyes when the patient is moved.~There will be a preliminary statistical analysis of the coded data, followed by a complete review by the assessor, who will conduct the final analysis."||t|||t
1304083|NCT03543111|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1304166|NCT03542019|Randomized|Parallel Assignment||Treatment||Triple|All ceramic materials will be assigned randomly by research assistant who has randomised tables generated by a statistician|Three different ceramic types for restoration of endodontically treated teeth|t|t||t
1304167|NCT03542006||Single Group Assignment||Treatment||None (Open Label)||||||
1304168|NCT03541993|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1304169|NCT03541980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573356|NCT00001495||||Treatment||||||||
1304084|NCT03543098|Randomized|Parallel Assignment||Treatment||None (Open Label)|These are unblinded trials as the participants will know when they are receiving surgery and when they are receiving rehabilitation. The data that are collected as part of the standard of care clinical follow-up will be recorded by the clinicians that know the participant's surgery assignment. The primary outcome and most of the secondary outcomes are patient self-report. Given that our interventions are either early or delayed surgery and/or rehabilitation, it is difficult for us to estimate the direction of potential bias (if any) that could come from the unblinded nature of this study.|Two parallel prospective randomized multi-center clinical trials. Trial 1 will evaluate the effects of both the timing of surgery and post-operative rehabilitation. Trial 2 will evaluate only the effects of timing of post-operative rehabilitation.||||
1304085|NCT03543085||Single Group Assignment||Treatment||None (Open Label)||||||
1304086|NCT03543072|||Cohort||Prospective|||||||
1304087|NCT03543059|||Cohort||Prospective|||||||
1304088|NCT03543046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304089|NCT03543033|Randomized|Parallel Assignment||Prevention||Single||Randomized Control Trial with randomization ratio 1:1|t|||
1304090|NCT03543020|||Cohort||Prospective|||||||
1304091|NCT03542994|Randomized|Sequential Assignment||Treatment||Double||The study is a double-blind dose escalation cohort study in healthy volunteers and participants with either mild to moderate psoriasis or mild to moderate atopic dermatitis. The study consists of 6 cohorts and will test doses of EDP1066 versus placebo. The safety and tolerability of EDP1066 will be tested in participants with psoriasis and atopic dermatitis alongside pharmacodynamic effects on the systemic immune system and observation of any clinical effects.|t||t|
1304092|NCT03542981|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1304093|NCT03542968||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304094|NCT03542955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304095|NCT03542942||Single Group Assignment||Treatment||None (Open Label)||||||
1304096|NCT03542929|Non-Randomized|Parallel Assignment||Health Services Research||Single|A researcher was performed the interventional protocol and a different researcher was made the evaluations|||||t
1304097|NCT03542916|Randomized|Crossover Assignment||Treatment||Single|||t|||
1304098|NCT03542903|Randomized|Parallel Assignment||Treatment||Single|non-blinded treatment and blinded assessment|A multicentric, prospective, random-assignment study incorporating both non-blinded treatment and blinded assessment||||t
1304099|NCT03542890|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1304100|NCT03542877|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304101|NCT03542864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Duodenal-Enteral medical supervised feeding response||||
1304102|NCT03542851|Randomized|Crossover Assignment||Treatment||Single|||||t|
1304103|NCT03542838|Randomized|Parallel Assignment||Treatment||Double|Except for the sentinel subject, the treatment assigned to each subject is blinded to the subject, investigators, and sponsor study team. The sentinel subject, the first subject in each cohort, is dosed with resiniferatoxin in an open-label fashion.||t||t|
1304104|NCT03542825|Randomized|Parallel Assignment||Prevention||Double|Double blinded (participant and care giver)|3 groups of pregnant women will be assigned for each intervention|t|t||
1304105|NCT03542812|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Single dose pharmacokinetic studies using population PKs Steady-state pharmacokinetic studies using population PKs||||
1304106|NCT03542799||Single Group Assignment||Treatment||None (Open Label)||||||
1304107|NCT03542786|Randomized|Parallel Assignment||Treatment||Double||100 patients will be included in this trial. Patients will be randomized 2: 2: 1 to one of the following 3 branches according to the use of integrase inhibitors (INI), protease inhibitors (PI) or non-nucleoside analogue reverse transcriptase inhibitors ( ITINAN) and according to the CD4 count nadir is greater or less or equal to 200 cells / mm3: Branch A: add probiotic i3.1 to the antiretroviral therapy Branch B: add probiotic i3.1 and ProSeed prebiotic to the antiretroviral therapy Branch C: add placebo to ART The treatment periods will be of 6 months and follow-up will be carried out at month, at 3 months and at 6 after the start of the study treatment, and a last visit will be made at 3 months after discontinuing it (wash-out period).|t||t|
1304108|NCT03542773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304109|NCT03542760|||Case-Only||Prospective|||||||
1304110|NCT03542747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304111|NCT03542734|||Cohort||Prospective|||||||
1304112|NCT03542721|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304113|NCT03542708|Randomized|Parallel Assignment||Treatment||Triple|The care provider will be aware of which ovary is being treated. A different physician will serve as the outcomes assessor.|One ovary will be randomly selected for treatment with PRP. The other ovary will serve as a control.|t||t|t
1304114|NCT03542695||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304115|NCT03542682|Non-Randomized|Crossover Assignment||Basic Science||Single|single blinded|This study will be a cross-over, randomized order, single blinded clinical study in subjects with Type 1 Diabetes.|t|||
1304116|NCT03542669||Single Group Assignment||Treatment||None (Open Label)||||||
1304117|NCT03542656||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304118|NCT03542643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304119|NCT03542630|||Cohort||Prospective|||||||
1304120|NCT03542617|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304170|NCT03541967|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1304171|NCT03541954|Non-Randomized|Parallel Assignment||Basic Science||Triple||"2 types of patients will be included:~30 patients with chronic pelvic or perineal pain with sensitization (Convergences PP criteria > 5)~30 patients with chronic pelvic or perineal pain without sensitization (Convergences PP criteria < 5)"||t|t|t
1304172|NCT03541941|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1304173|NCT03541928||Single Group Assignment||Treatment||None (Open Label)||||||
1304174|NCT03541915|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304175|NCT03541902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304176|NCT03541889|||Cohort||Prospective|||||||
1304121|NCT03542604|Randomized|Parallel Assignment||Other||Double|Participants will not be blinded to the intervention assignment. However, data collection of anthropometric measurements (including height, weight, hip and waist circumference) will be done by a study member blinded to the randomization. Since participants will be aware of their intervention assignment, there are no anticipated circumstances for breaking the blinding or planned procedures for breaking the blinding.|A total of 30 participants will be randomized to either cognitive-behavioral treatment for insomnia with behavioral weight loss (CBT-I+BWL) or a sleep education control condition with behavioral weight loss (EDU+BWL). The EDU group will have study sessions spread out in a similar fashion to the CBT-I group, and clinical outcomes will be compared between groups at baseline, 8 weeks (after the CBT-I or EDU program) and at 3 and 6 months after starting BWL. The primary outcome will be % total weight loss. Additionally, eating behaviors, physical activity, and sleep parameters will be carefully assessed.||t||t
1304122|NCT03542591|||Other||Cross-Sectional|||||||
1304123|NCT03542578|||Cohort||Prospective|||||||
1304124|NCT03542565|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1304125|NCT03542552|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304126|NCT03542539|||Cohort||Prospective|||||||
1304127|NCT03542526|||Case-Control||Cross-Sectional|||||||
1304128|NCT03542513|||Cohort||Prospective|||||||
1304129|NCT03542500|Randomized|Parallel Assignment||Treatment||Single|Under the supervision of Innovations for Poverty Action (IPA) Sierra Leone, local research assistants (blind to site and youth condition assignments) will conduct all screening, baseline, and follow up quantitative assessments. Ongoing data collection at all sites will include youth attendance and satisfaction with YRI content, counselor satisfaction with content and delivery via scales and qualitative exit interviews, as well as monitored audio-recording of all sessions for fidelity by an independent expert rater hired by CARITAS. The expert fidelity monitor will be a skilled YRI trainer and supervisor from our prior RCT and will not be a part of the CTA Seed Team, thus allowing them to provide impartial and blinded fidelity ratings of all audio-transcripts.|Hybrid Type 2 Effectiveness-Implementation Cluster Randomized three-arm trial||||t
1304130|NCT03542487|Randomized|Factorial Assignment||Prevention||None (Open Label)||Primary care practices will be assigned to a provider-side treatment (physician orientation) or to control. Within treatment assigned practices, individual patients will be assigned to one of four reminder messaging groups (one of which is no messaging).||||
1304131|NCT03542474||Single Group Assignment||Treatment||None (Open Label)||||||
1304132|NCT03542461|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, randomized in a 1:1 ratio to 2 treatment arms and stratified by centre and response to first-line induction therapy (minimization method)||||
1304133|NCT03542448|||Cohort||Prospective|||||||
1304134|NCT03542435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304135|NCT03542422||Single Group Assignment||Treatment||None (Open Label)||||||
1304136|NCT03542409|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304137|NCT03542396|Randomized|Parallel Assignment||Treatment||Single||||||t
1304138|NCT03542383|Randomized|Parallel Assignment||Treatment||Triple|The assessors, tDCS administrators, and participants are masked to group assignment. Active and sham tDCS parameters are set up at each session by an experimenter who does not have contact with the participants.|Participants with Gulf War Illness and word finding difficulty will be randomly assigned to either receive active tDCS or sham.|t|t||t
1304139|NCT03542370|||Other||Prospective|||||||
1304140|NCT03542357|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1304141|NCT03542344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304142|NCT03542331|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1304143|NCT03542318|||Cohort||Prospective|||||||
1304144|NCT03542305|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1304145|NCT03542292|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1304146|NCT03542279|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1304147|NCT03542266||Single Group Assignment||Treatment||None (Open Label)||This is a phase II, multi-center study to determine the efficacy and safety of first-line CC-486 plus CHOP in patients with PTCL who have received no prior systemic therapy. The study has a sample size of 20, and follows two-stage minimax design for primary efficacy analysis.||||
1304148|NCT03542253|||Other||Other|||||||
1304149|NCT03542240||Single Group Assignment||Prevention||None (Open Label)||||||
1304150|NCT03542227|||Cohort||Prospective|||||||
1304151|NCT03542214||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1304152|NCT03542201|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1304153|NCT03542188|Randomized|Parallel Assignment||Treatment||Single|Single-blinded||||t|
1304154|NCT03542175||Single Group Assignment||Treatment||None (Open Label)||This is a single-arm Phase I study.||||
1304155|NCT03542162||Single Group Assignment||Treatment||None (Open Label)||All patients who meet the criteria and agree to paticipate in the clinical study, will be enrolled to this study after signing informed consent.||||
1304156|NCT03542149|Randomized|Parallel Assignment||Other||None (Open Label)||Based on safety and tolerability data up to Day 35 post-dose, and pharmacokinetic/pharmacodynamic (PK/PD) analysis outcomes (based on PD data up to Day 35 and PK data up to Day 28 post-dose) of the drugs given in combination, the dose(s) for the subsequent cohort will be determined. A similar analysis will be done at the end of cohort 2 combining cohorts 1 and 2 data to decide the dose(s) to be tested in cohort 3.||||
1304157|NCT03542136||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304158|NCT03542123||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1304159|NCT03542110|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304160|NCT03542097|||Cohort||Prospective|||||||
1304161|NCT03542084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304162|NCT03542071|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1304163|NCT03542058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304164|NCT03542045|||Cohort||Prospective|||||||
1304165|NCT03542032|Randomized|Parallel Assignment||Other||Single|||t|||
1573357|NCT00001493||||Treatment||||||||
1304181|NCT03541824|Randomized|Parallel Assignment||Treatment||Single|||t|||
1304182|NCT03541811|||Cohort||Cross-Sectional|||||||
1304183|NCT03541798|Randomized|Parallel Assignment||Screening||None (Open Label)||randomized controlled study||||
1304184|NCT03541785|||Cohort||Prospective|||||||
1304185|NCT03541772|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1304186|NCT03541759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304187|NCT03541746|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1304188|NCT03541733|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304189|NCT03541720||Single Group Assignment||Diagnostic||None (Open Label)||"18F-DA scans will be performed within 4 weeks of standard imaging evaluations, such as CT (computed tomography) and I-123mIBG scanning.~18F-DA will be injected into a vein in the arm or leg, or via central venous access line."||||
1304190|NCT03541707|Randomized|Parallel Assignment||Treatment||Quadruple|"Patients will be allocated, based on chance, to receive active therapy or a as if stimulation, with no knowledge of patient or therapist who receives the active therapy"|Fifty-two adolescent patients suffering from major depression that are still severely ill after at least one psychological treatment and at least 2 adequate treatments knowledge of patient or doctor who receives the active therapy. Patients will be evaluated for efficacy, side effects, and cognitive performance. Brain waves (using EEG) will be monitored to see if they can predict who will respond to deep TMS.with medications, will be recruited. After the informed consent of guardians and patients, a systematic clinical evaluation with the aid of appropriate questionnaires will be performed. Patients will be allocated in a randomized double blind placebo controlled manner to dTMS or Sham treatments for about half an hour per day over 20 consecutive working days.|t|t|t|t
1304191|NCT03541694|||Other||Prospective|||||||
1304192|NCT03541681|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1304193|NCT03541668|Randomized|Parallel Assignment||Treatment||Single||||||t
1304194|NCT03541655|Randomized|Parallel Assignment||Treatment||Single|||t|||
1304195|NCT03541642|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Women participants will be randomized to condition upon consent based on a random numbers table. Intervention arm will get enhanced intervention with customized messages and counseling/text messaging; control arm will get basic intervention with medical counseling and text message reminders."||||
1304196|NCT03541629|||Cohort||Retrospective|||||||
1304197|NCT03541616|||Cohort||Prospective|||||||
1304198|NCT03541603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304199|NCT03541590|||Cohort||Retrospective|||||||
1304200|NCT03541577|||Cohort||Prospective|||||||
1304201|NCT03541564|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1304202|NCT03541551|Randomized|Parallel Assignment||Treatment||Double|Eligible patient after screening will be assigned consecutive randomization numbers in ascending order upon enrollment. The patient will be randomized in 1:1ratio to one of two study groups, namely combined trabeculotomy with trabeculectomy with ologen® Collagen Matrix as adjunctive wound modulator(Group A) or combined trabeculotomy with trabeculectomy alone without any adjunctive (Group B). The assigned randomization number will be recorded in each subject's DCF. The randomization scheme will be generated using random function in excel before patient enrollment in order to avoid investigator's patient selection bias.|Product:ologen® Collagen Matrix, Model: 830601, Shape:Round cylindrical, Size:6mm (diameter) x 2mm (thickness, Manufacturer: Aeon Astron Europe B. V.|t||t|
1304203|NCT03541538|Randomized|Crossover Assignment||Basic Science||Double|"Examiner 1 will receive the blinding outcome will be asked: Which intervention does the patienth as received: global manipulation or especific manipulation Their responses to these questions will be recorded and used to measure the adequacy of participants and examiners."|Participants received two interventions randomly at two times: global manipulation (GM) and specific manipulation (MS)|t|||t
1304204|NCT03541525|||Cohort||Prospective|||||||
1304205|NCT03541512|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304206|NCT03541499|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1304207|NCT03541486||Single Group Assignment||Treatment||None (Open Label)||||||
1304208|NCT03541473|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1304209|NCT03541460|||Case-Control||Cross-Sectional|||||||
1304210|NCT03541447|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1304211|NCT03541434|||Cohort||Prospective|||||||
1304212|NCT03541421|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1304213|NCT03541408|Randomized|Parallel Assignment||Prevention||Single|||t|||
1304214|NCT03541395||Single Group Assignment||Basic Science||None (Open Label)||||||
1304215|NCT03541382|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1304216|NCT03541369|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1304217|NCT03541356|Randomized|Sequential Assignment||Treatment||Quadruple|Double blind|Twenty-four (24) subjects will be randomized to treatment or placebo. All subjects will receive oral benserazide hydrochloride 25 mg 60±5 minutes before study drug. Treatment assignment will be randomized 3:1 in each of 3 ascending dose cohorts of eight subjects total per cohort: INP103 (n=6) or Placebo (n=2)|t|t|t|t
1304218|NCT03541343||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1304219|NCT03541330||Single Group Assignment||Other||None (Open Label)||||||
1304220|NCT03541317|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1304221|NCT03541304|||Case-Only||Retrospective|||||||
1304222|NCT03541291||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1304223|NCT03541278||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304270|NCT03540667|||Cohort||Prospective|||||||
1304271|NCT03540654|||Cohort||Retrospective|||||||
1304272|NCT03540641|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1304393|NCT03539068|Randomized|Single Group Assignment||Other||None (Open Label)||RCT- Screening, Shared-decision making intervention with Veteran and Providers using Dartmouth Model||||
1304529|NCT03537300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304530|NCT03537287|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304224|NCT03541265|Randomized|Parallel Assignment||Treatment||Triple||This is a a randomized prospective study. Patients were assigned into two cohorts on the day of surgery using a randomization software by an independent observer. Randomization was based on age, gender, BMI and type of surgery. The investigators hypothesized that there would be no difference in the pain scores or morphine consumption. Sample size analysis for a randomized prospective trial was performed to achieve an 80% power to detect 20% difference in pain scores (2-point score difference on VAS 0-10 was deemed clinically relevant). A sealed envelope was given to the anesthesiologist and the surgeon on the day of surgery, stating the group that the patient was assigned to participate. All descriptive statistics (Mean, SD) and analysis were performed with SPSS version 21 (IBM) at a 0.05 level of significance.|t||t|t
1304225|NCT03541252||Single Group Assignment||Treatment||None (Open Label)||A prospective clinical, uncontrolled, open-label, explorative phase IIa trial||||
1304226|NCT03541239|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1304227|NCT03541226|||Cohort||Prospective|||||||
1304228|NCT03541213|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||3 groups will be performed depending on the presence or absence of a pre-operative iron deficiency and whether they had an iron treatment preoperatively (before their inclusion in the study). However, patient management will not be different in the different groups from their inclusion in the study. Therefore we can consider that there is a single interventional group.||||
1304229|NCT03541200||Single Group Assignment||Treatment||None (Open Label)||||||
1304230|NCT03541187|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1304231|NCT03541174|Randomized|Parallel Assignment||Treatment||Triple||"SB placebo run-in/randomized with 3 parts:~Part 1: double-blind (DB), randomized to aprocitentan 12.5 mg, aprocitentan 25 mg or placebo; Part 2: single blind (SB) aprocitentan 25 mg; Part 3: double-blind re-randomized (DB-WD) to aprocitentan 25 mg or placebo."|t|t|t|
1304232|NCT03541161|||Case-Control||Retrospective|||||||
1304233|NCT03541148||Single Group Assignment||Supportive Care||None (Open Label)||||||
1304234|NCT03541135|||Cohort||Prospective|||||||
1304235|NCT03541122|||Other||Prospective|||||||
1304236|NCT03541109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304237|NCT03541096|Randomized|Parallel Assignment||Basic Science||Single||||||t
1304238|NCT03541083||Single Group Assignment||Treatment||None (Open Label)||||||
1304239|NCT03541070||Single Group Assignment||Supportive Care||None (Open Label)||||||
1304240|NCT03541057|||Cohort||Prospective|||||||
1304241|NCT03541044|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304242|NCT03541031|Randomized|Parallel Assignment||Supportive Care||Quadruple|Only one individual (unblind coordinator) will know which patients are receiving placebo and which are receiving active micronutrients. She will have no contact with the subjects. All research and clinical staff and all patients will be blinded to what they are actually receiving. The unblind coordinator has verified that the placebos appear identical in appearance to the active micronutrients. The placebos have been manufactured by the same companies that make the actual micronutrients.|This is a double-blind, randomized clinical trial that will assign 120 stable adult outpatients with bipolar disorder, type I or II (DSM-V criteria) to supplementation with a 36-ingredient vitamin/mineral mix (Micronutrient) and an omega-3 fatty acid supplement (Fish oil) (N=72) or to matched double placebo (N=48) in a 3:2 ratio for a year.|t|t|t|t
1304243|NCT03541018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304244|NCT03541005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304245|NCT03540992|||Cohort||Prospective|||||||
1304246|NCT03540979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304247|NCT03540966|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304248|NCT03540953||Single Group Assignment||Treatment||None (Open Label)||||||
1304249|NCT03540940|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304250|NCT03540927|Randomized|Parallel Assignment||Prevention||Single|Only outcome assessors will be blind to allocation status of the participants.|||||t
1304251|NCT03540914|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304252|NCT03540901|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304253|NCT03540888|Randomized|Parallel Assignment||Prevention||Double||In order to compare the effects of DTFM to static and dynamic stretching techniques, participants were randomly assigned to one of three groups (a) DTFM group, (b) Dynamic stretching group, and (c) Static stretching group, and were followed- up over four weeks period.|||t|t
1304254|NCT03540875|Randomized|Parallel Assignment||Treatment||Single|||t|||
1304255|NCT03540862|||Cohort||Prospective|||||||
1304256|NCT03540849||Single Group Assignment||Treatment||None (Open Label)||||||
1304257|NCT03540836|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1304258|NCT03540823|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304259|NCT03540810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304260|NCT03540797|||Cohort||Prospective|||||||
1304261|NCT03540784|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304262|NCT03540771|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Model 1: Consultative Palliative Care (i.e. direct access to Palliative Care provider), versus Model 2: Trained Hepatologist- led PC intervention (i.e. a hepatologist will receive formal training to deliver Palliative Care services)||||
1304263|NCT03540758|Randomized|Single Group Assignment||Basic Science||Single|The subject will be blinded as to which study drug he/she is receiving first (Drug or Placebo).||t|||
1304264|NCT03540745|Randomized|Parallel Assignment||Treatment||Quadruple|All participants and investigators are blind to condition|Randomized Controlled Trial with block randomization|t|t|t|t
1304265|NCT03540732|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor (in our study, person measuring participants' quadriceps muscle thickness) is blinded.|Randomized Controlled Trial||||t
1304266|NCT03540719|||Cohort||Prospective|||||||
1304267|NCT03540706|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Stepped Wedge||||
1304268|NCT03540693|||Other||Other|||||||
1304269|NCT03540680|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1304273|NCT03540628|Randomized|Parallel Assignment||Supportive Care||Triple|Eligible patients will be randomized in equal blinded proportions by the pharmacy department to receive thiamine, vitamin C and hydrocortisone in the experimental arm or continue with hydrocortisone plus placebo and usual standard of care treatment as discussed previously.|"Enrollment for this study will be initiated in patients with septic shock that require addition of a second pressor agent.~The control arm of our randomized trial will receive a second pressor agent, hydrocortisone and standard of care. If the patient needs additional pressor support or therapy, that will be recorded in the results.~The experimental arm will receive a second pressor agent and hydrocortisone, plus thiamine and vitamin C along with the standard of care. If the patient needs additional pressor support or therapy that will be recorded in the results."|t|t|t|
1304274|NCT03540615|Randomized|Sequential Assignment||Basic Science||Quadruple||Dose escalation with safety assessment following each dose step.|t|t|t|t
1304275|NCT03540602|Randomized|Crossover Assignment||Basic Science||Double|To ensure that all subjects and researchers are unaware of the treatment assignments we will have one outside individual that will possess the knowledge of which subjects are given which supplement and which were given a placebo. This information will remain confidential until the study has been concluded. At the conclusion of the study, participants will be informed of which condition they were assigned. in an event of an emergency or the participant decides not to participate his condition will be revealed.|"20 male participants will start with a familiarization visit where they will receive either the placebo supplement or the polyphenol rich supplement that they will take for 7 days. After taking the supplement, the participants will come back and run through the acute resistance exercise protocol as well as return the next day for a post test. Next, the participants will undergo a wash out phase where they will not take any supplementation. At the end of these 2 weeks, the participants will then take the other supplement (i.e. if they took the polyphenol rich supplement in the first phase they will take the placebo supplement in the second phase). After a week of taking their assigned supplement, participants will complete the acute resistance exercise protocol and the post test."|t||t|
1304276|NCT03540589|Randomized|Parallel Assignment||Prevention||Single||||||t
1304277|NCT03540576||||||||||||
1304278|NCT03540563||Single Group Assignment||Diagnostic||None (Open Label)||Prospective observational study||||
1304279|NCT03540550||Single Group Assignment||Other||None (Open Label)||||||
1304280|NCT03540537|Randomized|Parallel Assignment||Other||Double|||t|t||
1304281|NCT03540524|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1304282|NCT03540511|||Cohort||Retrospective|||||||
1304283|NCT03540498|Randomized|Parallel Assignment||Treatment||Double|"Once the patients have been selected according to the inclusion / exclusion criteria detailed below, they will be included in one of the treatment groups (control / study) in a random and random manner. The list of randomization and the labeling of the products will be carried out by independent personnel to the research team to ensure double blindness of the trial. The production of the probiotic products and control will be carried out in both cases in white boxes without any type of identification or difference between them.~The randomization will be made from an online software available at www.randomization.com. From the list of randomization generated by this software, the different products will be labeled with the patient number and the test code. The team of researchers will not have access to the randomization list. In this way, a correct randomization and double-blind trial is guaranteed."|The study will follow a randomized, double-blind, split-mouth, placebo-controlled design with two parallel prospective follow-up groups for the evaluation of two different posology models (with or without previous professional oral cleaning).|t||t|
1304284|NCT03540485|Randomized|Parallel Assignment||Treatment||Single|||t|||
1304285|NCT03540472||Single Group Assignment||Treatment||None (Open Label)||||||
1304286|NCT03540459|||Cohort||Prospective|||||||
1304287|NCT03540446|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1304288|NCT03540433|||Cohort||Prospective|||||||
1304289|NCT03540420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304290|NCT03540407|Randomized|Parallel Assignment||Supportive Care||Double|A double blind||t||t|
1304291|NCT03540394|||Cohort||Prospective|||||||
1304292|NCT03540381|||Cohort||Prospective|||||||
1304293|NCT03540368|Randomized|Parallel Assignment||Treatment||Single|All patients will receive standard treatment equally||t|||
1304294|NCT03540355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304295|NCT03540342|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304296|NCT03540329|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Cohort prospective study model comparing two different techniques for distraction osteogenesis in 4 different subgroups||||
1304297|NCT03540316|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1304298|NCT03540303||Sequential Assignment||Treatment||None (Open Label)||CAR19 T cell therapy improves the clinical efficacy of refractory/relapsed B-cell lymphoma, and the combined PDL1 inhibitors may further improve the efficacy of CD19 CART in the treatment of lymphomas. The clinical efficacy of KITE's CAR19 T cells and PD-L1 inhibition was reported. This phase 1 study was conducted in 9 patients with DLBCL, 8 patients got remission and during which 5 got complete remission. However, this type of treatment requires more data and observation in a larger sample of patients. In addition, Kite Pharmaceuticals' CD19 CART is priced at 370,000 US dollars. The cost of immune checkpoint inhibitors is also very expensive. Only very small proportion of patients could afford for that expenses. In this study, genetically engineered CAR T cells, which carry cytoplasmic activated PD1, are not inhibited by PDL1 molecules, will avoid the simultaneous application of immune checkpoint antibodies and the according adverse events.||||
1304299|NCT03540290|Randomized|Parallel Assignment||Treatment||Single||||||t
1304300|NCT03540277|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304301|NCT03540264|Randomized|Parallel Assignment||Treatment||Single|The statistician will be blind to the treatment assigned to indivivual patients.|||||t
1304302|NCT03540251|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1304303|NCT03540238|||Other||Prospective|||||||
1304304|NCT03540225|Randomized|Factorial Assignment||Prevention||Triple||2 x 2 factorial designed trial with two factors of 200mg vs. 400mg vaginal progesterone daily from 11-14 weeks' gestation vs. 20-24 weeks'|t|t|t|
1304305|NCT03540212||Single Group Assignment||Treatment||None (Open Label)||||||
1304306|NCT03540199|Randomized|Parallel Assignment||Treatment||Quadruple|With the method of minimum randomized dynamic random by the interactive network response system (IWRS),Participants were assigned to three groups,receive cryotherapy,conventional therapy, and activated CIK armed with anti-CD3-MUC1 bispecific antibody together with cryotherapy .every participant has a unique identification number and emergency letter which have the information of group.|This is a phase II clinical trial of single-center, and it will divide into three groups.|t|t|t|t
1304307|NCT03540186||Single Group Assignment||Treatment||None (Open Label)||||||
1304308|NCT03540173|||Other||Prospective|||||||
1304309|NCT03540160||Single Group Assignment||Treatment||None (Open Label)||||||
1304310|NCT03540147|Randomized|Crossover Assignment||Basic Science||Single|The participants will not know which condition they will receive on the day of testing.|Each participant will undergo five visits to the laboratory for repeated testing under five different conditions. The sessions will be randomized and will take 2.5 hours to complete.|t|||
1304311|NCT03540134||Single Group Assignment||Treatment||None (Open Label)||||||
1304312|NCT03540121|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1304313|NCT03540108|Randomized|Parallel Assignment||Treatment||Quadruple||Single-centre, prospective, randomised, placebo-controlled, parallel-group design to determine the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in hypercholesterolaemic adults (>6mmol).|t|t|t|t
1304314|NCT03540095|Randomized|Parallel Assignment||Treatment||None (Open Label)|We are unable to mask the patient or provider for this study. The interventions are inherently similar, but different, thus making it impossible to blind.|There are two arms. Our 60 patients will be randomized to either of the two arms and studied in parallel.||||
1304315|NCT03540082|Randomized|Parallel Assignment||Prevention||Single|||t|||
1304316|NCT03540069|Randomized|Sequential Assignment||Screening||None (Open Label)||a cluster-randomized stepped wedge study across three representative clusters (each containing a district center and two rural sites) in the Kedougou region. For each aim we will collect data at baseline and at 6-month intervals in each cluster (data collection intervals coincide with the initiation of the intervention in a new cluster).||||
1304317|NCT03540056|||Cohort||Cross-Sectional|||||||
1304318|NCT03540043|Randomized|Parallel Assignment||Treatment||Quadruple|TReatment were packaged in identical jars. Eligible patients will be randomized in a 1:1:1:1 ratio to receive either one of 3 concentrations of PUR 0110 cream (0.05%, 0.1% and 0.25%) or vehicle (placebo).|Randomized, Double-Blind, Parallel-Group, Placebo-controlled|t|t|t|t
1304319|NCT03540030|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304320|NCT03540017||Single Group Assignment||Treatment||None (Open Label)||||||
1304321|NCT03540004|||Cohort||Prospective|||||||
1304322|NCT03539991||Single Group Assignment||Other||None (Open Label)||||||
1304323|NCT03539978|||Other||Prospective|||||||
1304324|NCT03539965|||Cohort||Retrospective|||||||
1304325|NCT03539952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304326|NCT03539939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304327|NCT03539926|Randomized|Parallel Assignment||Other||None (Open Label)|The process of randomization, either device use or use of strips, will be masked until the moment it is delivered to the patient. The random assignment to each product will be made through lists created by an ad hoc computer program.|"Patients will receive the product for home pH monitoring, but they will keep following the doctor's recommendations indicated in the usual clinical practice.~The proportion of patients will be 1: 1 between the study group (Lit-control®pH Meter) and the control group (test strips)."||||
1304328|NCT03539913|Randomized|Parallel Assignment||Treatment||Single|Allocation-blinded study||||t|
1304329|NCT03539900|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1304330|NCT03539887|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, Double-Blind, Placebo-Controlled|t|t|t|t
1304331|NCT03539874|||Cohort||Prospective|||||||
1304332|NCT03539861||Single Group Assignment||Prevention||None (Open Label)||||||
1304333|NCT03539848|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1304334|NCT03539835|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304335|NCT03539822||Single Group Assignment||Treatment||None (Open Label)||||||
1304336|NCT03539809||Single Group Assignment||Basic Science||None (Open Label)||||||
1304337|NCT03539796|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1304338|NCT03539783|||Case-Control||Prospective|||||||
1304339|NCT03539770|||Case-Control||Prospective|||||||
1304340|NCT03539757|||Case-Control||Prospective|||||||
1304341|NCT03539744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304342|NCT03539731|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1304343|NCT03539718|Randomized|Parallel Assignment||Prevention||Single||comparative||||t
1304344|NCT03539705|||Other||Other|||||||
1304345|NCT03539692|||Other||Other|||||||
1304346|NCT03539679|Randomized|Parallel Assignment||Other||Single|Exclusion criteria is that a volunteer must be health enough to have permission to take part in the military fitness tests.|Intervention group and control group.|t|||
1304347|NCT03539666|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1304348|NCT03539653|||Other||Prospective|||||||
1304349|NCT03539640|Randomized|Parallel Assignment||Basic Science||Single|The assessor of the MRI measurements will analyze the MRI data in a blinded fashion. The rest of the outcomes will not be analyzed in a blinded fashion.|All participants will receive the same protocol with different levels of PEEP ventilation during the first part of the study (physiological part), so the interventional study model for this part is single group. During the second part (MRI), participants are randomized for one of the three available PEEP levels (5, 10 or 15 cmH2O), so the study model for this part is parallel.||||t
1304350|NCT03539627|||Cohort||Prospective|||||||
1304392|NCT03539081|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Subjects are assigned to one of two groups based on whether they have Restless Leg Syndrome to undergo experimental measurements that are made at each of the five measurement time points.||||
1304488|NCT03537833|||Cohort||Prospective|||||||
1304489|NCT03537820|||Case-Only||Prospective|||||||
1304351|NCT03539614|Randomized|Crossover Assignment||Treatment||Triple|During the portion of the study where participants are receiving either placebo or blinded prazosin, the participants, care providers, and outcomes assessors will all be blinded as to whether the participant is at that time receiving prazosin or placebo.|This study is a modified cross-over study, also called an aggregated N-of-1 study. Each participant who meets criteria for participation in and completes the treatment portion of the study will spend time on open-label prazosin, blinded prazosin, and placebo.|t|t||t
1304352|NCT03539601|Randomized|Parallel Assignment||Treatment||Quadruple|"The investigational products above are masked for appearance, and will be placed into identical cartons. Once removed from the product cartons, the investigational products could be discerned from each other based on commercial product tube shape/size and should only be handled by unblinded site personnel.~Safety and efficacy assessments will be conducted at the investigator site by a clinical assessor blinded to treatment assignment."||t|t|t|t
1304353|NCT03539588|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304354|NCT03539575||Single Group Assignment||Other||None (Open Label)||||||
1304355|NCT03539562|||Case-Control||Prospective|||||||
1304356|NCT03539549||Single Group Assignment||Treatment||None (Open Label)||||||
1304357|NCT03539536||Single Group Assignment||Treatment||None (Open Label)||||||
1304358|NCT03539523|||Other||Other|||||||
1304359|NCT03539510|Randomized|Parallel Assignment||Supportive Care||Double||will be conducted using a single center, double-blind randomized controlled trial with 2 groups; an intervention group using the HF-ACP website and control group receiving usual care.|t||t|
1304360|NCT03539497|||Cohort||Prospective|||||||
1304361|NCT03539484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1304362|NCT03539471|||Case-Only||Prospective|||||||
1304363|NCT03539458||Single Group Assignment||Treatment||None (Open Label)||||||
1304364|NCT03539445|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304365|NCT03539432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304366|NCT03539419|||Cohort||Prospective|||||||
1304367|NCT03539406|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a phase I safety and feasibility study in a series of 12 patients who are suffering from recurrent ovarian, fallopian tube or primary peritoneal cancer. The first cohort of three patients will receive an intraperitoneal infusion of allogeneic UCB-NK cells generated ex vivo from CD34+ hematopoietic progenitor cells obtained from an allogeneic UCB unit without a preparative regimen. In the second group of three patients the same UCB-NK cell dosage will be given with a preparative regimen of four days non-myeloablative immunosuppressive conditioning regimen with cyclophosphamide and fludarabine (CyFlu). If no severe toxicity is seen in these 6 patients, an extension cohort of 6 patients will be included to answer the secondary objective.||||
1304368|NCT03539393||||||||||||
1304369|NCT03539380||||||||||||
1304370|NCT03539367|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304371|NCT03539354|Randomized|Parallel Assignment||Treatment||Single||||||t
1304372|NCT03539341|Randomized|Parallel Assignment||Prevention||Double||This study will use a randomised controlled trial design to test the effects of the Parenting for Lifelong Health 2-9 Thailand programme in comparison to participants allocated to receiving care as usual in the control group (N = 120 parents and primary caregivers of children ages 2 to 9 years; 1:1 intervention to control group ratio).|||t|t
1304373|NCT03539328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304374|NCT03539315|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304375|NCT03539302|Randomized|Parallel Assignment||Treatment||Quadruple|"Part A is open-label however subjects will be randomized to either a single dose or a double dose.~Part B is randomized with a parallel group, placebo-controlled. Subjects are randomly assigned, in a 1:1 ratio, to a single dose or to a repeat dose regimen. Within each dose regimen, subjects are randomized in a 2:1 rate to ether inhaled flecainide or matched placebo."||t|t|t|t
1304376|NCT03539289|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304377|NCT03539276|Non-Randomized|Sequential Assignment||Health Services Research||Single|It was unlikely that participants could foresee whether or when their medications have been reviewed or modified.|Pre-post study|t|||
1304378|NCT03539263|Randomized|Parallel Assignment||Treatment||Double||The trial design is parallel, with two groups (experimental group and control group) and four evaluation sessions at intervals of three weeks (T0wk = baseline, T3wk = intermediate, T6wk=final and T9wk = follow-up).|t||t|
1304379|NCT03539250||Single Group Assignment||Treatment||None (Open Label)||||||
1304380|NCT03539237|Randomized|Parallel Assignment||Screening||Single|||t|||
1304381|NCT03539224||Single Group Assignment||Treatment||None (Open Label)||Single arm opened with Intervention Type of Drug: Dolutegravir (DTG) and Lamivudina (3TC)||||
1304382|NCT03539211|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1304383|NCT03539198|||Case-Only||Prospective|||||||
1304384|NCT03539185|Randomized|Parallel Assignment||Other||None (Open Label)||Non-inferiority trial. Alpha risk de 2,5%, Power 90 %||||
1304385|NCT03539172||Single Group Assignment||Treatment||None (Open Label)||||||
1304386|NCT03539159|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1304387|NCT03539146|Randomized|Crossover Assignment||Basic Science||Single||"Forty volunteers will be randomly distributed in 4 groups that will follow a sequence of treatments according to a balanced latin square design. Treatment days involve the ingestion in acute conditions of a yogurt formulation with a different dietary fiber dose:~Cascara control yogurt with 0% dietary fiber.~Cascara yogurt with 3% dietary fiber.~Cascara yogurt with 7% dietary fiber.~Cascara yogurt with 13% dietary fiber.~Subjects will have a 48h washout period between treatment days to avoid carry-over effects."|t|||
1304388|NCT03539133|||Cohort||Prospective|||||||
1304389|NCT03539120|||Cohort||Retrospective|||||||
1304390|NCT03539107|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304391|NCT03539094|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to the intervention because they will not know the group assignment.|Randomized controlled clinical trial||||t
1304490|NCT03537807||||||||||||
1304491|NCT03537794|||Case-Control||Cross-Sectional|||||||
1573358|NCT00001489||||||||||||
1304394|NCT03539055||Single Group Assignment||Prevention||None (Open Label)||Prospective single arm intervention of dabigatran etexilate with aspirin for 90 days following Watchman LAA device closure to prevent device related thrombus (DRT)||||
1304395|NCT03539042|||Cohort||Prospective|||||||
1304396|NCT03539029|||Cohort||Retrospective|||||||
1304397|NCT03539016|||Cohort||Prospective|||||||
1304398|NCT03539003|Randomized|Parallel Assignment||Prevention||None (Open Label)||"sevoflurane group~desflurane group~total intravenous anesthesia group"||||
1304399|NCT03538990||Single Group Assignment||Treatment||None (Open Label)||||||
1304400|NCT03538977|Randomized|Parallel Assignment||Treatment||Single|For the evaluation of pain, respiratory effort and state of sleep and wakefulness, specific scales previously validated for this population will be used: NIPS (Neonatal Infant Pain Scale) scale, Silverman Andersen respiratory severity score, and the Brazelton Neonatal Behavioral Assessment Scale, respectively. Patients will be filmed during the five moments of assessment, and two physiotherapists blinded to the groups will watch the filming and perform the evaluation using the scales previously mentioned.|PTNB with a diagnosis of BPD will be randomized into two groups: conventional physiotherapy (GP) and conventional physiotherapy plus hydrotherapy (GH). The PTNB randomized to GH will be submitted to 11 hydrotherapy sessions. The PTNB from both groups will be submitted to evaluation of heart rate (HR), peripheral oxygen saturation (SpO2), respiratory rate (RR), pain, respiratory distress, sleep state, and wakefulness. The level of salivary cortisol and muscular activity (EMG) will also be evaluated.||||t
1304401|NCT03538964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304402|NCT03538951|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||3-part, open-label, multi-center study||||
1304403|NCT03538938|Randomized|Factorial Assignment||Treatment||Single|Research staff who conduct follow-up interviews and verification will be blind to study condition and will not have access to other participant data (e.g., smoking history) prior to the end of data collection.|Four-factor fully-crossed factorial design||||t
1304404|NCT03538925|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1304405|NCT03538912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304406|NCT03538899||Single Group Assignment||Treatment||None (Open Label)||Longitudinal study of autologous stem cell transplant of cells transduced with corrected DCLRE1C gene using a self-inactivating lentiviral vector (AProArt). The CliniMACS® CD34 Reagent System cell sorter device will be used to select CD 34 cells. Sub-ablative busulfan will be used for pre-transplant conditioning.||||
1304407|NCT03538886|Randomized|Parallel Assignment||Treatment||Single|The clinical outcomes will be assessed by an independent event committee with no knowledge of treatment allocation.|1:1 randomized clinical trial||||t
1304408|NCT03538873|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304409|NCT03538860|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1304410|NCT03538847|||Other||Retrospective|||||||
1304411|NCT03538834|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1304412|NCT03538821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304413|NCT03538808|Randomized|Factorial Assignment||Treatment||Double|double-blind|Balanced placebo design|t||t|
1304414|NCT03538795||Single Group Assignment||Treatment||None (Open Label)||Case series, with a no-treatment control period before the intervention||||
1304415|NCT03538782|||Cohort||Retrospective|||||||
1304416|NCT03538769|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1304417|NCT03538756|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304418|NCT03538743|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1304419|NCT03538730|Randomized|Parallel Assignment||Prevention||Double|Group allocation will be revealed to one investigator at the outset of the lab visit. Other investigators and participants will remain masked until the end of the memory interview. Outcome assessors will remain masked for the duration of the study.|At 2-weeks post-surgery, parent-child dyads will participate in a lab visit during which time they will be randomized into an intervention or control group. Randomization will be conducted by an external statistician using a computer random number generator. Allocation concealment will be achieved using sequentially numbered, opaque, and sealed envelopes.|t|||t
1304420|NCT03538717|||Cohort||Retrospective|||||||
1304421|NCT03538704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304422|NCT03538691|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1304423|NCT03538678|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1304424|NCT03538665|||Case-Control||Cross-Sectional|||||||
1304425|NCT03538652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304426|NCT03538639|||Case-Control||Prospective|||||||
1304427|NCT03538626|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1304428|NCT03538613|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1304429|NCT03538600|||Cohort||Prospective|||||||
1304430|NCT03538587|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304431|NCT03538574|Randomized|Parallel Assignment||Treatment||Double|Outcome assessor is blind to treatment condition|Randomized, non-inferiority design||t||t
1304432|NCT03538561||||||||||||
1304433|NCT03538548||Single Group Assignment||Treatment||None (Open Label)||||||
1304434|NCT03538535||Single Group Assignment||Treatment||None (Open Label)||Adapted version of Behavioral Activation psychotherapy.||||
1304435|NCT03538522|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1304436|NCT03538509|||Case-Only||Other|||||||
1304437|NCT03538496|Randomized|Parallel Assignment||Treatment||Single||||||t
1304438|NCT03538483|Randomized|Parallel Assignment||Treatment||Single||||||t
1304439|NCT03538470||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1304440|NCT03538457|||Case-Only||Prospective|||||||
1304441|NCT03538444|Randomized|Parallel Assignment||Treatment||Quadruple|Neither participants nor investigators will know whether the participant is assigned to the active or sham condition.|40 individuals (20 per group) will be randomly assigned to either active or sham rTMS.|t|t|t|t
1304442|NCT03538431|Randomized|Crossover Assignment||Other||Single|||||t|
1304443|NCT03538418|Randomized|Parallel Assignment||Other||Single|An independent assessor who is blinded to the group allocations will assess the participants' outcomes.|"A two-arm parallel (single-blinded) cluster randomized controlled trial involves two groups of participants (the WAT group and the control group). Six community centres, which provide similar types of community care and social support services for community-dwelling older people, will be invited by a convenience method to work as collaborators in this study. Using computer-generated random numbers, a biostatistician not affiliated with this study will randomize the centres into either: the control or the experimental groups. Therefore, duing the trial, participants in one group receive intervention in parallel to participants in the other group (control group)."||||t
1304444|NCT03538405||Single Group Assignment||Treatment||None (Open Label)||||||
1304445|NCT03538392|||Case-Only||Prospective|||||||
1304446|NCT03538379|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Individuals will complete the bleeding control basic (B-Con) course followed by evaluation of individuals ability to apply each of 5 different types of tourniquets. Each individual is evaluated for all 5 types of tourniquets. The order of testing for tourniquets for each individual is randomized.||||
1304447|NCT03538366||Single Group Assignment||Treatment||None (Open Label)||||||
1304448|NCT03538353||Single Group Assignment||Treatment||None (Open Label)||||||
1304449|NCT03538340|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1304450|NCT03538327||Single Group Assignment||Prevention||None (Open Label)||Pilot, single arm, interventional, longitudinal study||||
1304451|NCT03538314||Single Group Assignment||Treatment||None (Open Label)||UV1/GM-CSF||||
1304452|NCT03538301|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304453|NCT03538288||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1304454|NCT03538275|||Cohort||Prospective|||||||
1304455|NCT03538262|||Cohort||Prospective|||||||
1304456|NCT03538249|Randomized|Parallel Assignment||Prevention||Double|All evaluations were performed by investigators who were unaware of the allocation of patients to different interventions.|"Interventions Aerobic exercise training Patients follow an alternating aerobic training using a treadmill at an intensity of 60% of maximum heart rate, 3 mn and 3 mn working off an alternative way.To ensure progressive overload appropriate, we adjust moderate intensity aerobic exercise every two weeks with an overall 5% increase in heart rate.~Inspiratory muscle training The inspiratory muscle training involves a high intensity endurance training to 60% of PI, max. We recalculate the individual SPImax and PImax in each training session. Patients use the driving tool inspiratory muscle.~Resistance training The resistance should be measured on 1 RM (Repetition Maximum) for each muscle group. The exercises are performed in three sets of ten repetitions of exercises at 60% of 1RM intensity recalculated every two weeks training."|t|||t
1304457|NCT03538236|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1304458|NCT03538223|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1304459|NCT03538210|||Cohort||Prospective|||||||
1304460|NCT03538197||Single Group Assignment||Prevention||None (Open Label)||Cohort study||||
1304461|NCT03538184|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1304462|NCT03538171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304463|NCT03538158|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1304464|NCT03538145|||Cohort||Cross-Sectional|||||||
1304465|NCT03538132|||Case-Only||Cross-Sectional|||||||
1304466|NCT03538119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304467|NCT03538106|||Cohort||Retrospective|||||||
1304468|NCT03538093|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1304469|NCT03538080|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1304470|NCT03538067|||Other||Prospective|||||||
1304471|NCT03538054|Non-Randomized|Crossover Assignment||Other||Single|The participant will not know when they are taking placebo or the study medication.||t|||
1304472|NCT03538041|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304473|NCT03538028||Single Group Assignment||Treatment||None (Open Label)||||||
1304474|NCT03538015|Randomized|Parallel Assignment||Treatment||Double||Double-blinded, randomized, placebo-controlled study in patients with Type 1 diabetes mellitus and hypoglycemia unawareness|t||t|
1304475|NCT03538002|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1304476|NCT03537989|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1304477|NCT03537976||Single Group Assignment||Treatment||None (Open Label)||||||
1304478|NCT03537963|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||After the first part of the study (Qualitative Interviews), the hematopoietic cell transplant (HCT) survivors will be randomized to 2 different study arms for the intervention portion of the study.||||
1304479|NCT03537950|Randomized|Crossover Assignment||Basic Science||Double|Participants and investigators were blinded to the drug condition.|Repeated-measures cross-over study, where each subject received each of three pharmacological probes once (order of drug administration was pseudorandomised)|t||t|
1304480|NCT03537937|Randomized|Crossover Assignment||Treatment||Single|Observer bias will be minimized by use of objective endpoints collected in duplicate by [1] study personnel blinded to group assignment and [2] automated data extraction from the electronic health record.|In the PILOT trial, the entire study ICU will be assigned to a single SpO2 target (cluster-randomized) and the ICU will switch between lower, intermediate, and higher SpO2 targets every two months in a randomly generated sequence (cluster-crossover).||||t
1304481|NCT03537924|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304482|NCT03537911||Single Group Assignment||Supportive Care||None (Open Label)||||||
1304483|NCT03537898|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304484|NCT03537885||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304485|NCT03537872|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1304486|NCT03537859|Randomized|Crossover Assignment||Other||None (Open Label)||After enrollment, patients will be allocated in either the AR group or the NoAR group. The order of the intervention will be randomly selected before recruitment. A 48 hour wash-out will take place before the second intervention.||||
1304487|NCT03537846|||Cohort||Cross-Sectional|||||||
1304492|NCT03537781|Randomized|Parallel Assignment||Other||Single||Participants will be randomly allocated to a food labelling or no food labelling condition. Participants in each condition will be tested when hungry and when satiated|t|||
1304493|NCT03537768|Randomized|Parallel Assignment||Prevention||Single|||t|||
1304494|NCT03537755|||Case-Only||Cross-Sectional|||||||
1304495|NCT03537742|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1304496|NCT03537729|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304497|NCT03537716||Single Group Assignment||Treatment||None (Open Label)||||||
1304498|NCT03537703|Randomized|Parallel Assignment||Basic Science||Single|Sham tDCS|Parallel Assignment|t|||
1304499|NCT03537690||Single Group Assignment||Treatment||None (Open Label)||||||
1304500|NCT03537677||Single Group Assignment||Treatment||None (Open Label)||||||
1304501|NCT03537664||Single Group Assignment||Treatment||None (Open Label)||||||
1304502|NCT03537651||Single Group Assignment||Treatment||None (Open Label)||||||
1304503|NCT03537638|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1304504|NCT03537625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304505|NCT03537612|Randomized|Parallel Assignment||Treatment||Quadruple||Double-blind, randomized|t|t|t|t
1304506|NCT03537599||Single Group Assignment||Treatment||None (Open Label)||||||
1304507|NCT03537586||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304508|NCT03537573|Randomized|Factorial Assignment||Treatment||Double||48 primary care clinics (N=10,936 patients anticipated) randomized to 4 arms in 2x2 factorial design|t|||t
1304509|NCT03537560|||Case-Only||Prospective|||||||
1304510|NCT03537547|Randomized|Parallel Assignment||Treatment||Double|Coordinators at site are blinded, Sponsor and associates are unblinded.|Participants will be randomized to have their study clinician have access to their pharmacogenetic report (provide through the GeneSight Psychotropic tool) in order to make treatment decisions, or to not have access to their report for the first 12 weeks. At Visit 5, Week 12, all participants will receive a copy of their pharmacogenetics report and all clinicians will be unblinded for 'open label' to be able to use the results to guide treatment options for an additional 12 weeks.|t|||t
1304511|NCT03537534|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1304512|NCT03537521|||Other||Prospective|||||||
1304513|NCT03537508|Randomized|Parallel Assignment||Prevention||Triple|Modified double blind for the infant part of the study, with everyone involved in the study (participants/parents, investigators, safety outcome assessor, Sponsor) blinded to the meningococcal vaccine received, except the personnel administering the vaccine. During the toddler part of the study, individuals blinded during the infant part of the study might be potentially unblinded due to the different timing of and age of the participants at the vaccination visits and the number of vaccines received during these visits.||t||t|t
1304514|NCT03537495|Randomized|Parallel Assignment||Treatment||None (Open Label)||TB meningitis patients will be randomised into three treatment groups to either receive no linezolid (control group); or 600 mg QD or 1200 mg QD linezolid next to high dose rifampicin (~35 mg/kg, based on weight), isoniazid (H) 300 mg, pyrazinamide (Z) 1500 mg and ethambutol (E) 750 mg once daily administered orally for 14 days. All patients will receive dexamethasone according to standard dosing in TBM.||||
1304515|NCT03537482||Single Group Assignment||Treatment||None (Open Label)||dose escalation and dose expansion after MTD||||
1304516|NCT03537469|Randomized|Crossover Assignment||Basic Science||Quadruple|The subjects and operators who performed TMS were blinded to the type of stimulation applied, we then employed a randomized double-blind sham-controlled crossover design.||t|t|t|t
1304517|NCT03537456||Single Group Assignment||Treatment||None (Open Label)||"mRDX-02-17 is recommended for correction and treatment of wrinkles and dermal depressions, when administered by intradermal injection.~This is a multi-center, open-label, non-randomized, single-group clinical investigation in subjects aged 35-65 years old seeking facial rejuvenation.~Because it is a medical device with an innovative composition and that it is a first-in-human investigation, we preferred an exploratory approach for the investigation design. The main objectives and clinical endpoints are the performance and the safety profile of the investigational device.~The total study duration will be approximately 3 months or 90 days."||||
1304518|NCT03537443|||Cohort||Prospective|||||||
1304519|NCT03537430|Non-Randomized|Parallel Assignment||Treatment||Single|This study is a prospective cohort study.Participants,Care Provider, and Investigator all know the grouping situation. The Investigator collect the information and observation indicators of the two groups of participants and send to the Outcomes Assessor . The Outcomes Assessor does not know the grouping situation of each participant.|This study is a prospective cohort study.The main study content is the feasibility and advantages of tubeless uniportal video-assisted thoracoscopic surgery in total thymectomy,divided into exposed and non-exposed groups.Tubeless uniportal video-assisted thoracoscopic surgery in total thymectomy in the exposed group, uniportal video-assisted thoracoscopic surgery in total thymectomy in the non-exposed group.||||t
1304520|NCT03537417|||Case-Only||Prospective|||||||
1304521|NCT03537404|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304522|NCT03537391||Single Group Assignment||Diagnostic||None (Open Label)|Imaging modalities will be read blindly without the knowledge of results of the other imaging modalities. Readers will only know that a patient has prostate cancer with high risk for metastases. All imaging data will be analyzed visually with classifying lesions as normal, equivocal or metastatic.|This is a prospective single-institutional study comparing the diagnostic accuracy of novel imaging modalities to traditional imaging modalities among high risk prostate cancer patients at initial diagnosis||||
1304523|NCT03537378||Single Group Assignment||Treatment||None (Open Label)||||||
1304524|NCT03537365|Randomized|Parallel Assignment||Supportive Care||Single||A multicentre, non-blinded, pilot randomized controlled trial||||t
1304525|NCT03537352|||Case-Only||Cross-Sectional|||||||
1304526|NCT03537339|||Cohort||Prospective|||||||
1304527|NCT03537326||Single Group Assignment||Health Services Research||None (Open Label)||Healthy women, aged between 18 and 45 years old, weighing between 50 and 75 kg and with BMI included between 19 and 27 kg/m².||||
1304528|NCT03537313|Randomized|Factorial Assignment||Prevention||Single||Factorial 2-by-2 open labeled randomised controlled trial||||t
1573359|NCT00001485||||||||||||
1304531|NCT03537274|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304532|NCT03537261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304533|NCT03537248|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1304534|NCT03537235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304535|NCT03537222|||Other||Cross-Sectional|||||||
1304536|NCT03537209|||Other||Retrospective|||||||
1304537|NCT03537196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||All patients with detectable HCV RNA, eligible for treatment, will receive Direct Acting Antivral drugs.||||
1304538|NCT03537183|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1304539|NCT03537170|||Cohort||Prospective|||||||
1304540|NCT03537157|Randomized|Parallel Assignment||Prevention||Quadruple|Active drug will be masked with a placebo identical to the active drug. Patients will be identified by a code and central readers will not have access to the administered treatments|The study is a multicentre, randomised, double-blind, placebo controlled trial to assess the efficacy and safety of Rifaximin delayed release 400 mg tablet (800 mg BID daily) administered for 26 weeks in the prevention of endoscopic Crohn's disease recurrence following ileocolonic resection, in patients who had undergone curative ileocolonic resection, with ileocolonic anastomosis for Crohn's disease.|t|t|t|t
1304541|NCT03537144|Randomized|Parallel Assignment||Treatment||Single||||||t
1304542|NCT03537131|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304543|NCT03537118|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1304544|NCT03537105||Single Group Assignment||Basic Science||None (Open Label)||Sclerodermic patients||||
1304545|NCT03537092||Single Group Assignment||Device Feasibility||None (Open Label)||All participants will insert a placebo extended release vaginal film at Day 0. They are randomized to the timing of their first follow up visit (Day 3, 7, 10 or 14) to assess how long the film can be detected visually and/or one of its components remains detectable by biochemical assay in the lower genital tract.||||
1304546|NCT03537079|Randomized|Parallel Assignment||Treatment||Single|this is a single blind study patients don't know if they are breathing normal air (normoxia) or hypoxic air (hypoxia).||t|||
1304547|NCT03537066||Single Group Assignment||Treatment||None (Open Label)||||||
1304548|NCT03537053||Single Group Assignment||Other||None (Open Label)||a single group feasibility study||||
1304549|NCT03537040||Single Group Assignment||Other||None (Open Label)||||||
1304550|NCT03537027||Single Group Assignment||Basic Science||None (Open Label)||||||
1304551|NCT03537014|Randomized|Parallel Assignment||Treatment||Triple|Use of separate databases for outcome measures and safety data. Assessment made by pool of independent raters. Randomization will be managed via an Interactive Web Randomization System (IWRS) based on a centralized randomization schedule developed by an independent third-party vendor to maintain blinding.|Randomized, double-blind between group comparison of change in PTSD symptoms|t||t|t
1304552|NCT03537001|||Cohort||Prospective|||||||
1304553|NCT03536988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304554|NCT03536975|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Intervention group using the CAREGIVERSPRO-MMD platform versus control group"||||
1304555|NCT03536962|||Cohort||Prospective|||||||
1304556|NCT03536949|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1304557|NCT03536936|||Cohort||Retrospective|||||||
1304558|NCT03536923||Single Group Assignment||Treatment||None (Open Label)||||||
1304559|NCT03536910|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1304560|NCT03536897|||Cohort||Prospective|||||||
1304561|NCT03536884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304562|NCT03536871|Randomized|Parallel Assignment||Treatment||Quadruple|The nutritional supplement will be delivered to a 3rd party contract research organization and the allocation will only be un-blinded after data lock.||t|t|t|t
1304563|NCT03536858|Non-Randomized|Parallel Assignment||Other||Double|Hemodialysis staff will be unaware as to whether the patient was targeted based on their network centrality or clustering. Survey administrators will be unaware of which patient received the living donor intervention.|The investigators will assign every HD clinic shift to one of the two targeting strategies. They will measure the spread of information, attitudes, and behaviors by comparing the patients targeted to participate in the living donor intervention to the other patients on their shift.||t||t
1304564|NCT03536845|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304565|NCT03536832|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1304566|NCT03536819||Single Group Assignment||Treatment||None (Open Label)||Subjects will receive the treatment||||
1304567|NCT03536806|Randomized|Parallel Assignment||Treatment||Double|Double (Participant, Investigator)|Parallel Assignment|t|t||
1304568|NCT03536793|||Cohort||Prospective|||||||
1304569|NCT03536780||Single Group Assignment||Treatment||None (Open Label)||||||
1304570|NCT03536767||Single Group Assignment||Treatment||None (Open Label)||||||
1304571|NCT03536754|Randomized|Sequential Assignment||Treatment||Triple|Double-blind|Randomized, placebo-controlled, Phase 2|t|t|t|
1304572|NCT03536741|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304573|NCT03536728|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1304574|NCT03536715|||Other||Prospective|||||||
1304575|NCT03536702|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Participants will be randomized within strata formed by cancer type in order to assure that these potentially important confounding variables are balanced across groups. Patients will be enrolled on a rolling basis over a three-month period, allowing patients in intervention arm to participate in 3 months workshops (workshops would be held once every 2 weeks). Patients in control arm will be provided a book (Writing Down Bones by Natalie Goldberg) about creative writing and will be asked to do activities for 1.5 hours every 2 weeks. After three months, control group participants can join creative writing workshops at their discretion for the remaining period for writing workshops. Both group members will receive follow up surveys twice a month for two months at the completion of the participant's three-month study period.||||
1304576|NCT03536689|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||Factorial 2-by-2 open labeled randomised controlled trial||||
1304577|NCT03536676|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1304578|NCT03536663||Single Group Assignment||Treatment||None (Open Label)||||||
1304579|NCT03536650||Single Group Assignment||Treatment||None (Open Label)||||||
1304580|NCT03536637|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1304581|NCT03536624||Single Group Assignment||Prevention||None (Open Label)|no masking|||||
1304582|NCT03536611|Randomized|Parallel Assignment||Treatment||Single||||||t
1304583|NCT03536598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304584|NCT03536585|Non-Randomized|Single Group Assignment||Treatment||Single|Independent reviewer to identify the one-month and four-month post-treatment photograph of the mons pubis and labia.|||||t
1304585|NCT03536572|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1304586|NCT03536559|Randomized|Parallel Assignment||Treatment||Quadruple|The drug formulations will be identical in appearance (size, shape, volume, color) and smell. The packaging and labeling will be designed to maintain blinding to the Investigator's team and to patients. There are no visible differences between the active drug, and placebo dosing units|randomized, double-blind, parallel group, placebo controlled study|t|t|t|t
1304587|NCT03536546|Randomized|Parallel Assignment||Treatment||None (Open Label)||Veteran peer research assistants will deliver alcohol brief advice in the ED and will initiate conversations with the participant for at least 6-sessions over 2 months post-ED visit. Strengths-based discussions will include a combination of scripted and open-ended content to best facilitate reductions in drinking and engagement across severity.||||
1304588|NCT03536533||Single Group Assignment||Treatment||None (Open Label)||||||
1304589|NCT03536520|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304590|NCT03536507|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304591|NCT03536494|Non-Randomized|Parallel Assignment||Health Services Research||Single||"Intervention group: Patients with mirabegron prescription from 1st January 2017 to 31st December 2017 assigned to any of the 17 urban primary health care centers located in the northern area of Barcelona belong to the Catalan Institute of Health (CIH).~Control group (CG): All the other patients with mirabegron prescription assigned to any of the other 34 PHC located in Barcelona belonging to the CIH."|||t|
1304592|NCT03536481|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304593|NCT03536468|||Cohort||Prospective|||||||
1304594|NCT03536455|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304595|NCT03536442|||Case-Only||Retrospective|||||||
1304596|NCT03536429|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304597|NCT03536416|Randomized|Parallel Assignment||Other||Single|The schools will be randomised, and will not be told which group they have been randomised to.|The study will include three treatment arms. The first arm will receive the theatre workshop only; the second arm will receive the theatre workshop and the self-management workshops; the control group will receive usual care. Schools will be randomised to one of the groups.|t|||
1304598|NCT03536403||Single Group Assignment||Other||None (Open Label)||||||
1304599|NCT03536390|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Double-blind, placebo-controlled, parallel group study.|t|t|t|t
1304600|NCT03536377||Single Group Assignment||Treatment||None (Open Label)||||||
1304601|NCT03536364||Single Group Assignment||Treatment||None (Open Label)||||||
1304602|NCT03536351||Single Group Assignment||Treatment||None (Open Label)||One group design||||
1304603|NCT03536338|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Purposefully sampled trial||||
1304604|NCT03536325|Randomized|Parallel Assignment||Other||Double|||t||t|
1304605|NCT03536312|Randomized|Parallel Assignment||Other||Single|Information will be encrypted for assessors|Patients between the age of 18 and 79 with an asymptomatic ascending aortic aneurysm between 5.0 cm and 5.4 cm in maximal diameter are entered into the randomization study. Patients with ascending aortic aneurysm with a diameter of 4.5 cm - 4.9 cm will be observed with serial CT, and will be considered for enrolment into the trial once the aneurysm reaches 5.0 cm.||||t
1304606|NCT03536299|Randomized|Parallel Assignment||Treatment||Single|||t|||
1304607|NCT03536286|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"As part of the encouragement intervention, participants (households) will be randomly assigned to the opportunity or encouragement arm, where they will be incentivized to participate in the Asili intervention, but are allowed to choose whether or not they actually participate.~Families will be randomly sampled based on location, and a team of 2 local community champions/data collectors (hired from within the community) will visit each of the encouragement arm homes, supervised by a community outreach liaison. Control households will not receive an individualized home visit."||||
1304608|NCT03536273|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1304609|NCT03536260|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1304610|NCT03536247|Randomized|Parallel Assignment||Treatment||Single|Participants in the study will be blinded to treatment arm. Care providers and Investigators will be unblinded to treated arm.|Patients will be randomized using a pre-generated randomization schedule with concealed allocation in a 1:1 assignment to initial cholangioscopy guided laser or papillary dilation. Randomization will be blocked in groups of 12.|t|||
1304611|NCT03536234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304612|NCT03536221|||Case-Only||Other|||||||
1304613|NCT03536208||Single Group Assignment||Treatment||None (Open Label)||patients will be assigned to warfarin by mouth daily on an outpatient basis. The first 5 patients enrolled will be assigned to the 1 mg QD dose level, the next 5 patients enrolled will be assigned to the 2 mg QD dose level, and so forth until all dose levels enrolled 5 patients.||||
1304614|NCT03536195|||Cohort||Prospective|||||||
1304615|NCT03536182|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized in a 2:1 ratio (Carbon Ion Radiation Therapy : Conventional Photon Radiation Therapy)||||
1304616|NCT03536169|||Cohort||Retrospective|||||||
1304617|NCT03536156|||Other||Prospective|||||||
1304618|NCT03536143||Single Group Assignment||Treatment||None (Open Label)||||||
1304791|NCT03533881|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Group 1: following minimal nutritional changes Group 2: following minimal nutritional changes and taking Arom Digest Slim||||
1304619|NCT03536130|Randomized|Parallel Assignment||Other||None (Open Label)||Allocation: randomization 1 to 1 Endpoint classification: efficacy study Masking: Open label Intervention model: parallel assignment Primary purpose: supportive care||||
1304620|NCT03536117|Randomized|Sequential Assignment||Prevention||Quadruple|||t|t|t|t
1304621|NCT03536104|||Case-Control||Prospective|||||||
1304622|NCT03536091|||Cohort||Prospective|||||||
1304623|NCT03536078|Randomized|Parallel Assignment||Treatment||Single|Group allocation blinded to the investigator.||||t|
1304624|NCT03536065|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||Pre-Post Study Design with Non-Pharmacologic Intervention||||
1304625|NCT03536052||Single Group Assignment||Treatment||None (Open Label)||||||
1304626|NCT03536039||Single Group Assignment||Treatment||None (Open Label)||Patients will receive NGR-hTNF at dose of 0.8 mcg/sqm 1 hour before standard R-CHOP (cyclophosphamide-doxorubicin-vincristine-prednisone-rituximab) regimen every 3 weeks for six courses (except for course #1 in which only standard R-CHOP regimen will be administered)||||
1304627|NCT03536026||Single Group Assignment||Treatment||None (Open Label)||||||
1304628|NCT03536013|Randomized|Parallel Assignment||Treatment||Single||Blind study|t|||
1304629|NCT03536000|||Cohort||Prospective|||||||
1304630|NCT03535987||||||||||||
1304631|NCT03535974|Non-Randomized|Crossover Assignment||Treatment||Double|||t|t||
1304632|NCT03535961||Single Group Assignment||Treatment||None (Open Label)||||||
1304633|NCT03535948|||Cohort||Retrospective|||||||
1304634|NCT03535935|Randomized|Parallel Assignment||Treatment||Single|Assessment of primary outcomes is performed by an independent laboratory|||||t
1304635|NCT03535922|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304636|NCT03535909|||Cohort||Cross-Sectional|||||||
1304637|NCT03535896||Single Group Assignment||Other||None (Open Label)||||||
1304638|NCT03535883|||Cohort||Cross-Sectional|||||||
1304639|NCT03535870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304640|NCT03535857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304641|NCT03535844|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1304642|NCT03535831||Single Group Assignment||Diagnostic||None (Open Label)||This is a single arm study to assess the contribution of 18F-DCFPyL PET imaging (PET/MR or PET/CT) to the management of patients with prostate cancer (PCa).||||
1304643|NCT03535818|Randomized|Parallel Assignment||Treatment||Double||Randomised, controlled, prospective study|t|t||
1304644|NCT03535805|Randomized|Parallel Assignment||Treatment||Single|"The statistical evaluation of the effects of MMM versus TAU will be carried out by researchers who will be masked for the treatment allocation.~The central research-organization DEFACTUM is responsible for holding separate key files documenting the random allocation to treatment group and linking the ID numbers to the personal civil registration numbers. The analysts will be masked for treatment allocation until they have tested the primary and secondary hypotheses and confirmed or rejected the study hypotheses.~It is not possible to mask the participants and the therapists in this study design."|"The RCT is a parallel, two-arm, superiority trial comparing MMM with TAU for children aged 6-16 years with emotional and behavioural difficulties.~This primary outcome is the parent-reported SDQ-impact of problems (range 0-10). The sample size calculation was based on the parameters from the feasibility RCT. Given an estimated standard variation (SD)=2.7, significance level=0.05, and power=0.90, the sample required to detect (or reject) a difference of at least 1.0 point is N=308. This sample size is also sufficient to detect clinically meaningful group differences in secondary outcome (e.g. 7.5% versus 16% reporting harm).~The expected rate of attrition is 0.25. Hence, the investigators need to include 308/0.75=412 children to be randomly allocated (1:1). The central randomization uses concealed allocation sequences with variable block size, and stratification by region, age (6-10 or 11-16 years) and Top-problem (anxiety, depression, behavioural problems)."||||t
1304645|NCT03535792|Randomized|Parallel Assignment||Treatment||Triple|Participant, care provider and outcome assessor will not be informed with the medication used.|"Group F:~25 Patients will receive intrathecal injection of 2 ml of 0.5% hyperbaric bupivacaine plus 1 ml fentanyl (50μg).~Group N:~25 Patients will receive intrathecal injection of 2 ml of 0.5% hyperbaric bupivacaine plus 1ml nalbuphine hydrochloride (1.6 mg); (nalufin 20 mg in 1 ml ampoule, Amoun Pharmaceutical Co. Cairo, Egypt)."|t|t||t
1304646|NCT03535779|||Cohort||Prospective|||||||
1304647|NCT03535766|||Cohort||Retrospective|||||||
1304648|NCT03535753||Single Group Assignment||Treatment||None (Open Label)||||||
1304649|NCT03535740||Single Group Assignment||Treatment||None (Open Label)||||||
1304650|NCT03535727|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1304651|NCT03535714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304652|NCT03535701|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304653|NCT03535688|Randomized|Parallel Assignment||Treatment||Triple|Triple||t||t|t
1304654|NCT03535675|Randomized|Parallel Assignment||Treatment||Quadruple||This is a multicenter, double-blind, randomized study to evaluate the benefit of MPX supplementation in the subset of men who display the Alanine/Alanine SOD2 genotype of MnSOD. Based on a previous randomized phase II trial of MPX at Hopkins, PSA doubling time (PSA-DT) was prolonged in this subgroup of men.|t|t|t|t
1304655|NCT03535662|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1304656|NCT03535649|||Cohort||Other|||||||
1304657|NCT03535636|||Case-Control||Cross-Sectional|||||||
1304658|NCT03535623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304659|NCT03535610||Single Group Assignment||Treatment||None (Open Label)||Prospective, single-arm, open label study||||
1304660|NCT03535597|Randomized|Sequential Assignment||Treatment||None (Open Label)||Randomized Controlled prospective study||||
1304661|NCT03535584||Single Group Assignment||Prevention||None (Open Label)||||||
1304662|NCT03535571||Single Group Assignment||Other||None (Open Label)||||||
1304663|NCT03535558|||Cohort||Retrospective|||||||
1304664|NCT03535545|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Healthy control subjects will be enrolled first and then subjects with lung cancer and idiopathic pulmonary fibrosis meeting inclusion criteria.||||
1304967|NCT03531593|||Cohort||Prospective|||||||
1304665|NCT03535532|Randomized|Parallel Assignment||Treatment||None (Open Label)|Since one of the intervention is invasive surgical operation, the other is conservative medical treatment, the difference between these two intervention is too obvious to mask, no masking are designed in this study.|resistant hypertensive patients diagnosed with adrenal diseases based on imaging tools will be randomly allocated into unilateral laparoscopic adrenalectomy group and standard medical treatment group.||||
1304666|NCT03535519|||Cohort||Prospective|||||||
1304667|NCT03535506|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304668|NCT03535493|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1304669|NCT03535480|Randomized|Parallel Assignment||Treatment||Single|||||t|
1304670|NCT03535467|||Case-Crossover||Cross-Sectional|||||||
1304671|NCT03535454|||Case-Crossover||Cross-Sectional|||||||
1304672|NCT03535441|||Case-Control||Prospective|||||||
1304673|NCT03535428|||Cohort||Prospective|||||||
1304674|NCT03535415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304675|NCT03535402||Single Group Assignment||Treatment||None (Open Label)||||||
1304676|NCT03535389|Non-Randomized|Parallel Assignment||Diagnostic||Single||Case-control study, cross-sectional, monocentric, with prospective recruitment.|||t|
1304677|NCT03535376|||Case-Only||Prospective|||||||
1304678|NCT03535363||Single Group Assignment||Treatment||None (Open Label)||||||
1304679|NCT03535350|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A standard phase 1 design will be used with 3 patients treated at each dose level and monitored for treatment-related toxicities. Escalation to the next dose will proceed in the absence of dose-limiting toxicities (DLTs).||||
1304680|NCT03535337|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||Multiple Assignment Randomized Trial||||
1304681|NCT03535324|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1304682|NCT03535311|||Cohort||Prospective|||||||
1304683|NCT03535298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304684|NCT03535285|Randomized|Parallel Assignment||Treatment||Single||Split-mouth||||t
1304685|NCT03535272|Randomized|Parallel Assignment||Prevention||Quadruple||This study will be conducted as a double-blinded, placebo-controlled randomized clinical trial.|t|t|t|t
1304686|NCT03535259||Single Group Assignment||Treatment||None (Open Label)||||||
1304687|NCT03535246||Single Group Assignment||Treatment||None (Open Label)||||||
1304688|NCT03535233|Randomized|Parallel Assignment||Treatment||Single||||||t
1304689|NCT03535220|||Cohort||Prospective|||||||
1304690|NCT03535207||Single Group Assignment||Treatment||None (Open Label)||||||
1304691|NCT03535194|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304692|NCT03535181|||Cohort||Retrospective|||||||
1304693|NCT03535168|Randomized|Parallel Assignment||Treatment||Quadruple||Part 1: Sequential parallel-group Part 2: Two-arm crossover|t|t|t|t
1304694|NCT03535155|||Cohort||Prospective|||||||
1304695|NCT03535142|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1304696|NCT03535129|||Case-Control||Prospective|||||||
1304697|NCT03535116|Randomized|Parallel Assignment||Supportive Care||Double|drug vs placebo(saline). Identification is in a sealed envelope. The anesthetist gives the medication without telling the surgeon or the patient what medication is given(patient will be under a general anesthetic). Neither patient or surgeon will know what the patient gets until the follow up period(6 weeks) is completed.|Double Blind Randomized Control Trial of breast reduction patients and their postoperative hematoma rates with the use of ketorolac|t|t||
1304698|NCT03535103|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1304699|NCT03535090|||Cohort||Prospective|||||||
1304700|NCT03535077|||Cohort||Prospective|||||||
1304701|NCT03535064|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304702|NCT03535051|Randomized|Factorial Assignment||Treatment||Single||A total of 152 lesions in different areas of the body were evaluated in the study. Seventy six lesions received the combination treatment and 76 received topical tacrolimus alone. Forty six lesions were in the head and neck region, 40 were acral in location, 36 were in the upper and lower limbs, 22 lesions were over bony prominences and 8 lesions were present on the trunk.|t|||
1304703|NCT03535038|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1304704|NCT03535025|||Cohort||Prospective|||||||
1304705|NCT03535012|||Cohort||Prospective|||||||
1304706|NCT03534999|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with Hip Arthroplasty, one group was on TENS other group was a control||||
1304707|NCT03534986|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304708|NCT03534973|Randomized|Parallel Assignment||Prevention||Single||||||t
1304709|NCT03534960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304710|NCT03534947|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a pilot study which will evaluate the efficacy and safety of short term neoadjuvant sonidegib followed by surgery or imiquimod in the management of basal cell carcinomas in cosmetically challenging locations, assessed by optical coherence tomography and histopathology. The data from this pilot study may lead to the design of larger scale trials of neoadjuvant targeted therapy with the aim to decrease the morbidity of surgical treatment and increase the probability of a curative resection in larger patient populations.||||
1304711|NCT03534934|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||All subjects will participate in both baseline and three year follow-up visits and undergo identical interventions.||||
1304712|NCT03534921|||Case-Control||Retrospective|||||||
1304713|NCT03534908|||Cohort||Retrospective|||||||
1304714|NCT03534895|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1304792|NCT03533868|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients will be randomized to have their viral load monitored by either the standard of care or point-of-care method at their follow-up clinical visits up to 12 months.||||
1304793|NCT03533855||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304794|NCT03533842|||Case-Crossover||Prospective|||||||
1304795|NCT03533829|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1304715|NCT03534882|Randomized|Parallel Assignment||Treatment||Triple||This randomized-controlled trial studies patients with primary open angle glaucoma or ocular hypertension currently treated with topical IOP-lowering prostaglandin analogue (PGA) medications. Patients meeting inclusion criteria and having none of the exclusion criteria are contacted. If interested, patients meet research staff to discuss the study protocol and informed consent is obtained. Participants are randomized to one of two groups (A or B). Allocation to group is concealed to physicians. Participants have their IOP measured at Day 0. Group A patients are asked to discontinue their PGA for 42 days. Group B patients continue their medications as prescribed by their physician. Patients are closely followed, where IOP is measured on day 7, 21, and 42 in all participants. Once the assessment is complete, participants are debriefed on the nature of the study and potential findings. At the end of trial, participants resume standard therapy according to CJO 2009 Glaucoma Guidelines.||t|t|t
1304716|NCT03534869|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study was designed as a prospective interventional randomized parallel longitudinal single-center study to evaluate the effects of auricular acupuncture on pain relief after episiotomy conducted in the Department of Gynecology and Obstetrics, University Hospital Center Sestre milosrdnice, Zagreb, Croatia. Prospective data were collected from November 2016 to April 2017. The study included healthy pregnant women over 18 years of age, a minimum of 36 weeks gestation that underwent mediolateral episiotomy during vaginal delivery. Sixty patients were included in the study. The patients were allocated either of the groups by using a heads-tails binary result coin toss method. Twenty-nine patients were treated with auricular acupuncture for episiotomy pain relief combined with oral analgesic therapy per request, while 31 patients were treated with oral analgesics per request only. In both groups, administration of oral analgesics was recorded.||||
1304717|NCT03534856||Single Group Assignment||Treatment||None (Open Label)||||||
1304718|NCT03534843|||Cohort||Retrospective|||||||
1304719|NCT03534830|||Cohort||Prospective|||||||
1304720|NCT03534817|Randomized|Parallel Assignment||Basic Science||Single||||||t
1304721|NCT03534804||Single Group Assignment||Treatment||None (Open Label)||This is an open label, non-randomized phase 2 study||||
1304722|NCT03534791|Randomized|Parallel Assignment||Treatment||Double|Study participants will be blinded to allocation. The author who will communicate with the participants will not be blinded. Other authors and outcome assessors who will analyze data will be blinded to allocation of study participants; anonymized data will be analyzed.|"All study participants who accept participation in the study will be initially assigned 3 PLSs, and subsequently they will be assigned more PLSs when they translated the previous ones. Intervention group will receive one customized e-mail reminder two weeks after the PLS assignment if they do not translate it within two weeks.~Control group will receive no intervention, i.e. standard procedure. Participants in the control group will receive PLSs for translation, in the frequency they indicated, and they will not receive any reminders. They will be assigned new PLSs once they translate the ones that were previously assigned."|t|||t
1304723|NCT03534778||Single Group Assignment||Diagnostic||None (Open Label)||Prospective Observational||||
1304724|NCT03534765|||Cohort||Prospective|||||||
1304725|NCT03534752|||Cohort||Retrospective|||||||
1304726|NCT03534739|Randomized|Parallel Assignment||Supportive Care||Single||Participants with neck pain will be randomly assigned to receive a pain inducing massage, pain free massage, or a coldpressor task.|||t|
1304727|NCT03534726|||Cohort||Prospective|||||||
1304728|NCT03534713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304729|NCT03534700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304730|NCT03534687|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304731|NCT03534674|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304732|NCT03534661|Randomized|Crossover Assignment||Basic Science||Single|Single-blinded for participants|Each participant receives 3 randomized treatments.|t|||
1304733|NCT03534648|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1304734|NCT03534635||Single Group Assignment||Treatment||None (Open Label)||||||
1304735|NCT03534622||Single Group Assignment||Basic Science||None (Open Label)||||||
1304736|NCT03534609||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-randomized, open label||||
1304737|NCT03534596|||Cohort||Retrospective|||||||
1304738|NCT03534583|Randomized|Parallel Assignment||Treatment||Triple|Raters, investigators and physicians will not be aware of participant treatment allocation.|||t|t|t
1304739|NCT03534570|||Cohort||Prospective|||||||
1304740|NCT03534557|||Cohort||Prospective|||||||
1304741|NCT03534544|||Case-Only||Cross-Sectional|||||||
1304742|NCT03534531|||Cohort||Prospective|||||||
1304743|NCT03534518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304744|NCT03534505|Randomized|Parallel Assignment||Treatment||Single||Once given general anesthesia in the operating room, the patient will be randomly selected into one of the two arms of this report's diagram (1:1 ratio) through the drawing of a sealed, opaque envelope by one of the surgical residents in charge or by the attending surgeon. All patients will undergo herniorrhaphy with Lichtenstein Tension-Free Repair technique. After abdominal sheath will be closed by Vicryl No.0, Patients who are the Ketorolac group will receive local infiltration in abdominal sheath layer with Ketorolac 30 mg in normal saline 10ml. and patients who are the control group will receive local infiltration with 0.5% bupivacaine 10 ml. And then skin closure will be done by nylon 3-0.|t|||
1304745|NCT03534492||Single Group Assignment||Treatment||None (Open Label)||||||
1304746|NCT03534479||Single Group Assignment||Basic Science||None (Open Label)||||||
1304747|NCT03534466|Randomized|Parallel Assignment||Prevention||Triple||Parallel Assignment All subjects were divided into two groups: intervention group A (treadmill intervention + routine physical rehabilitation therapy) and positive control group (receiving routine physical rehabilitation therapy only).||t|t|t
1304748|NCT03534453||Single Group Assignment||Treatment||None (Open Label)||||||
1304749|NCT03534440|||Cohort||Prospective|||||||
1304750|NCT03534427|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||exercise intervention group, control group||||
1304751|NCT03534414|||Other||Prospective|||||||
1304968|NCT03531580||Single Group Assignment||Other||None (Open Label)||||||
1573360|NCT00001482||||Treatment||||||||
1304752|NCT03534401|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The ARCHES Kenya study will take place in six IPPF-affiliated Family Health Options Kenya (FHOK) clinics in Nairobi, Kenya or surrounding smaller cities for all clients receiving voluntary FP counseling. The intervention study will involve a matched cluster control trial. Three clinics will serve as the intervention sites and three other clinics matched on client volume and demographics, clinic structure and staffing will serve as matched comparison sites and will not receive the intervention.||||
1304753|NCT03534388||Single Group Assignment||Supportive Care||None (Open Label)||Feasibility comparing to retrospective data.||||
1304754|NCT03534375|||Cohort||Cross-Sectional|||||||
1304755|NCT03534362|Randomized|Parallel Assignment||Treatment||Single|Patients eligible for the study and consenting to participate will be randomly assigned to one of two treatment groups: 1) Nasopore group will receive frontal drill out procedure as indicated with Kenalog-soaked Nasopore stent applied to the post-operative outflow tract and 2) Propel stent group will receive frontal drill out procedure as indicated followed by Propel stent placement applied to the post-operative outflow tract.|Single-blind (Subject) randomized, active control study. Subjects will be randomized 1:1 using the rand function in Microsoft Excel program.|t|||
1304756|NCT03534349|||Other||Other|||||||
1304757|NCT03534336|Randomized|Factorial Assignment||Treatment||Single|A participant knows only the information that is specific to his/her arm.|3-arm RCT (Control, Incentive for Weight Loss, Incentive for Education) stratified by Gender.|t|||
1304758|NCT03534323||Single Group Assignment||Treatment||None (Open Label)||||||
1304759|NCT03534310|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||lifestyle modification alone, lifestyle modification and Liraglutide 3 mg daily, sleeve gastrectomy||||
1304760|NCT03534297|Randomized|Parallel Assignment||Treatment||Triple|This is a randomized, blinded, placebo-controlled study. Treatment allocation (to active or placebo treatment groups) will be blinded to all study participants, personnel, and investigators. Only the randomization statistician, drug labeling personnel and the medical monitor will be unblinded to the treatment assignment (in the event of an emergency, a scratch off label can be removed unmasking the treatment assignment to the PI and Medical Monitor).|Subjects will be assigned to receive either dapansutrile capsules or placebo capsules in a 4:1 ratio within each Cohort.|t|t|t|
1304761|NCT03534284|Randomized|Parallel Assignment||Treatment||Triple|The investigator, the participant, and the care provider will be blinded to the drug assignment (trazodone vs. placebo) for those subjects randomized into the medication intervention arm.|SLEEP-HD is a parallel group randomized controlled trial wherein 125 HD patients with chronic insomnia, treated in community-based dialysis facilities in Seattle and Albuquerque, will be randomized 1:1:1 over 31 months to 6-week treatment with telehealth CBT-I, trazodone, or medication placebo.|t|t|t|
1304762|NCT03534271|||Cohort||Prospective|||||||
1304763|NCT03534258|||Cohort||Prospective|||||||
1304764|NCT03534245|||Cohort||Prospective|||||||
1304765|NCT03534219|Randomized|Parallel Assignment||Prevention||Double|Since there will be no dummy devices in this trial, we will be unable to blind the patients and physicians to whom is using the EP device. The assessors/data collectors will be blinded for patient follow-up, and the statistician will be blinded. Therefore this will be a double blinded study.|All subjects will be randomized in a 1:1 ratio using permuted blocks. Subjects will be stratified by site (Lenox Hill) prior to randomization.|||t|t
1304766|NCT03534206|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1304767|NCT03534193|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Participants will be randomized to one of 2 arms:~Group 1 - standard Diabetic education-consisting of one on one education with a Registered Nurse in addition to the Molly Center Diabetes Care Guide (paper based) Group 2 - standard Diabetic education plus Bedside tablet with interactive Diabetic modules"||||
1304768|NCT03534180||Single Group Assignment||Treatment||None (Open Label)||||||
1304769|NCT03534167|Randomized|Parallel Assignment||Treatment||Single||||||t
1304770|NCT03534154|||Cohort||Prospective|||||||
1304771|NCT03534141|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1304772|NCT03534128||Single Group Assignment||Supportive Care||None (Open Label)||||||
1304773|NCT03534115|Randomized|Parallel Assignment||Prevention||Triple|the investigators, clinical staff and patients were blinded. The main solution containing NAC or the placebo was marked by A and B.||t|t|t|
1304774|NCT03534102|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Testing 3 sequential standards of care; each of 3 arms lasts 4 months, and all patients recruited within an arm are assigned to the same treatment.||||
1304775|NCT03534089|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1304776|NCT03534076|||Cohort||Prospective|||||||
1304777|NCT03534063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304778|NCT03534050||Single Group Assignment||Treatment||None (Open Label)||||||
1304779|NCT03534037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304780|NCT03534024|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1304781|NCT03534011||Single Group Assignment||Treatment||None (Open Label)||||||
1304782|NCT03533998|||Cohort||Retrospective|||||||
1304783|NCT03533985|Randomized|Crossover Assignment||Treatment||Double|Parents of infants will be unaware of the interventions' effects. Outcomes Assessor will be unfamiliar with desired outcomes.|Counterbalancing will be achieved by assigning a different order of presentation of conditions for each group. Participants will remain in the study for two weeks, but continue to receive music therapy for the duration of their stay in the NICU.|t|||t
1304784|NCT03533972|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304785|NCT03533959|||Cohort||Prospective|||||||
1304786|NCT03533946||Single Group Assignment||Treatment||None (Open Label)||This is a single arm, open label, phase II trial to assess efficacy of rucaparib||||
1304787|NCT03533933|Randomized|Parallel Assignment||Treatment||Single|Analyst and Histometry: The statistician and the pathologist does not know which treatment corresponds to each variable.|Split mouth||||t
1304788|NCT03533920||Single Group Assignment||Treatment||None (Open Label)||||||
1304789|NCT03533907|||Cohort||Retrospective|||||||
1304790|NCT03533894|||Cohort||Prospective|||||||
1304969|NCT03531567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304796|NCT03533816|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This dose escalation study will be conducted in two phases. The first phase will have three cohorts with three recipient/donor pairs at different dose levels for each cohort. The second phase is an expansion cohort at the maximum tolerated dose determined in the first phase.||||
1304797|NCT03533803|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304798|NCT03533790||Single Group Assignment||Treatment||None (Open Label)||||||
1304799|NCT03533777|Randomized|Parallel Assignment||Supportive Care||Triple|Placement of the IV catheter will occur after the subject is placed under general anesthesia and will be removed immediately upon arrival in the post-anesthesia care unit (PACU). Thus, the study participant will be unaware of which study arm they were in. An anesthesiologist member of the research team will place the IV immediately after randomization in the operating room. They will have a drape obscuring the view from the clinical anesthesia provider and will cover the IV with an opaque towel after insertion. Thus, the care provider will not have knowledge of which treatment arm their patient is randomized to. Intraoperative data will be gathered by the anesthesia care provider and postoperative questionnaire data will be gathered by a research coordinator member of the study team. The anesthesiologist who placed the study IV will not gather or have access to any of the subsequent data gathered on the study subject.|Study participants will be randomized to either antegrade or retrograde IV catheter placement|t|t||t
1304800|NCT03533764|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1304801|NCT03533751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304802|NCT03533738|Randomized|Crossover Assignment||Other||None (Open Label)||randomized crossover design||||
1304803|NCT03533725|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Intervention group having peer counseling and education and a comparative (control) group having standard of care||||
1304804|NCT03533712|Randomized|Crossover Assignment||Prevention||None (Open Label)||The intervention study will be an individually randomized efficacy trial. Pregnant women will be individually and randomly allocated to an intervention and a control group using a pre-defined randomization schedule. The intervention group will receive daily a fortified BEP supplement to be consumed under supervision for the duration of pregnancy. Both control and intervention group will receive the standard iron and folic acid tablet through the regular ante natal care program. After birth, mothers will be re-randomized individually to either a lactation supplement group or a control. The participants of the intervention and the control group will be assigned to intervention and control to have a balanced allocation.||||
1304805|NCT03533699|Randomized|Parallel Assignment||Treatment||Double|Then Patients will be randomly assigned to two groups using sealed, sequentially distributed envelopes to which the letters A and B will be allocated. The letter A will be assigned to the propranolol group and the letters B to the oxytocin group. The envelopes, will be opened by the investigator, and according to the letters, the group of patients will be determined. The first vaginal examination will be performed by the investigator, and then the induction will be initiated by the same researcher. Continuation of induction and the control of patients will be monitored by a coworker who knew nothing about the method of initiation of induction, neither did the patients (double blind)|"In the first group (Propranolol plus Oxytocin), a capsule consisting of 20 mg Propranolol will be administered and in the second group (Oxytocin plus placebo), a similar capsule as a placebo will be administrated orally by researcher before beginning of induction of labour.~Induction will be initiated at a dose of 2 mIu/min and it will be increased 2 mIu / minute every 15 minutes until good contractions are obtained (3 forceful contractions within 10 minutes) or to a maximum dose of 30 mIu/min; then, it will be continued at this rate for 8 hours. If patients enter the active phase of labour (cervical dilatation = 3-4 cm), induction will be continued until delivery. If no response to induction of labour, a caesarean section will be performed."|t||t|
1304806|NCT03533686|Randomized|Parallel Assignment||Treatment||None (Open Label)||Individuals who are part of Arm 3 are part of a cross-over design. Where subjects will be randomly assigned to either standard of care followed by new device, or new device followed by standard of care.||||
1304807|NCT03533673|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1304808|NCT03533660|Randomized|Parallel Assignment||Prevention||Single||RCT feedback vs. enhanced usual care||||t
1304809|NCT03533647|||Other||Prospective|||||||
1304810|NCT03533634|Randomized|Parallel Assignment||Treatment||Double|the patient and the outcomes analyzer were masked|randomized clinical trial|t|||t
1304811|NCT03533621|Randomized|Parallel Assignment||Other||Triple|Double-blind, placebo-control trial. Investigators, subjects, and assessors were unaware of which group they were randomized to. Subjects received pills in a paper bad that looked identical to each other.|Subjects were randomized to probiotic or placebo group, and remained in that group for the 12 week study period.|t||t|t
1304812|NCT03533608||Single Group Assignment||Treatment||None (Open Label)||Participants will engage in 12, 90-minute sessions of Group PE over the course of 6 weeks. Treatment consists of psychoeducation, rationale for treatment, and in vivo exposure to reduce trauma-related avoidance and thereby improve PTSD symptoms.||||
1304813|NCT03533595|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1304814|NCT03533582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304815|NCT03533569|||Case-Control||Prospective|||||||
1304816|NCT03533556|Randomized|Crossover Assignment||Treatment||Single||2.5 mg/kg body weight of L-theanine, 2.0 mg/kg body weight of caffeine and their combination each dissolved in 100 ml of water (solvent) or the solvent alone (i.e. placebo) will be administered on 4 separate days (at least 5 days apart) in a random counter-balanced order.|t|||
1304817|NCT03533543|||Cohort||Retrospective|||||||
1304818|NCT03533530|Non-Randomized|Crossover Assignment||Diagnostic||Single|The Epilepsy Surgery Group make their decision about the surgical approach only with knowledge of the LD-EEG without ESI (and knowledge of non EEG investigations). Thereafter the LD ESI results are revealed and the clinical decision is revised. Finally the HD ESI results are revealed and the clinical decision is revised.|Evaluation of low-density (LD, 25 channels) and high-density (HD, 256 channels) electrical source imaging (ESI) in epilepsy surgery||||t
1304819|NCT03533517||Single Group Assignment||Treatment||None (Open Label)||||||
1304820|NCT03533504|||Case-Only||Retrospective|||||||
1304966|NCT03531606|Randomized|Parallel Assignment||Treatment||Single||This study has been designed for randomized, double Blinded, placebo clinical trial.||t||
1304821|NCT03533491||Single Group Assignment||Treatment||None (Open Label)||All 60 teens in The Rewire Study will complete the first 4 modules of the Rewire app. Prior to using the app, they will complete a baseline assessment. Follow up surveys will be completed at 2 weeks and 8 weeks post-baseline. Survey topics include drug and alcohol use, emotion regulation, mindfulness and stress, app usability and participant satisfaction.||||
1304822|NCT03533478|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1304823|NCT03533465||Single Group Assignment||Treatment||None (Open Label)||The first aim of this study will involve a comparison of baseline psychiatric symptoms and subjective and objective measures of sleep, with specific attention to REM, in adults with CG compared to 25 healthy controls. 10 of these adults with CG who complete AIM 1 will participate in Complicated Grief Treatment (CGT).||||
1304824|NCT03533452|Randomized|Crossover Assignment||Treatment||Triple||Double-blinded, randomized controlled, prospective|t|t|t|
1304825|NCT03533439|||Cohort||Prospective|||||||
1304826|NCT03533426|Randomized|Parallel Assignment||Prevention||Single|the data collector will be blinded to the study groups|||||t
1304827|NCT03533413|Randomized|Parallel Assignment||Treatment||Single||||||t
1304828|NCT03533400|Randomized|Parallel Assignment||Treatment||None (Open Label)||Study participants will be randomized into 2 groups via random number generator. Group 1 (control group) will be given the standard Jamboxx musical device, while Group 2 (treatment group) will be given the Jamboxx respiratory therapy device, which combines musical gameplay with incentive spirometry exercises.||||
1304829|NCT03533387|Randomized|Crossover Assignment||Other||None (Open Label)||"Subjects will receive the following three treatments in a crossover fashion, administered one week apart:~ER1: Single dose (50mg) of ER Prototype 1 (one 50mg ER1 tablet),~ER2: Single dose (50mg) of ER Prototype 2 (one 50mg ER2 tablet), and~IR: Two doses of intermediate-release capsules (50mg Pinatos® capsules in two divided doses 12 hours apart, i.e., 25mg for each dose)."||||
1304830|NCT03533374|||Case-Control||Retrospective|||||||
1304831|NCT03533361||||||||||||
1304832|NCT03533348|||Case-Control||Prospective|||||||
1304833|NCT03533335|Randomized|Parallel Assignment||Treatment||Quadruple||Group 1: Oral spray (chlorhexidine) Group 2: Oral spray (chlorine dioxide) Group 3: Oral spray (water)|t|t|t|t
1304834|NCT03533322|||Cohort||Cross-Sectional|||||||
1304835|NCT03533309|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1304836|NCT03533296||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304837|NCT03533283||Single Group Assignment||Treatment||None (Open Label)||||||
1304838|NCT03533270|||Case-Only||Retrospective|||||||
1304839|NCT03533257|Randomized|Parallel Assignment||Treatment||Quadruple||Placebo-Controlled, Double-Blind, Parallel-Group|t|t|t|t
1304840|NCT03533244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304841|NCT03533231|Randomized|Parallel Assignment||Treatment||Single|||t|||
1304842|NCT03533218|||Other||Cross-Sectional|||||||
1304843|NCT03533205|||Cohort||Prospective|||||||
1304844|NCT03533192|Randomized|Parallel Assignment||Prevention||Single|Data collectors were blind to condition.|||||t
1304845|NCT03533179|Randomized|Crossover Assignment||Basic Science||Double|Interventions will be administered behind a curtain covering half the participant and thus the arm in which intervensions are administered. A list allocating participants to interventions are kept in an opaque envelope in a locked cabinet at the trial site. Outcome assessor will not have access to this list.|5-arm, participant and outcome-assessor blinded, randomized, placebo-controlled study.|t|||t
1304846|NCT03533166|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1304847|NCT03533153|Randomized|Parallel Assignment||Treatment||Single|||t|||
1304848|NCT03533140|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1304849|NCT03533127|Randomized|Parallel Assignment||Treatment||Double||The subjects will receive the treatment with LY01008 or bevacizumab combined with paclitaxel and carboplatin for 4-6 cycles, and then both groups of subjects will receive the maintenance monotherapy with LY01008|t||t|
1304850|NCT03533114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304851|NCT03533101|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Adaptive design using two different doses of tocilizumab prophylaxis||||
1304852|NCT03533088||Single Group Assignment||Treatment||None (Open Label)||A single group clinical trial||||
1304853|NCT03533075|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will remain blinded to the treatment condition for all participants.|Participants will be assigned in even numbers to TMBI + follow-up consultation or care as usual.||||t
1304854|NCT03533062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304855|NCT03533049|Randomized|Single Group Assignment||Prevention||Single|||t|||
1304856|NCT03533036|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Time series study with 15 controls and 15 experimental group. Investigators plan to enroll 30 patients in order to obtain an effect size for future studies. The mean and standard deviation of anxiety scores for each group will be used to calculate power for future studies.||||
1304857|NCT03533023|Randomized|Parallel Assignment||Treatment||Single|||||t|
1304858|NCT03533010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304859|NCT03532997||Single Group Assignment||Supportive Care||None (Open Label)||||||
1304860|NCT03532984|||Cohort||Prospective|||||||
1304861|NCT03532971|||Cohort||Other|||||||
1304862|NCT03532958|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind||t|t|t|t
1304863|NCT03532945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304864|NCT03532932|||Cohort||Other|||||||
1304865|NCT03532919|||Case-Control||Prospective|||||||
1304866|NCT03532906|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1304867|NCT03532893|||Cohort||Prospective|||||||
1304868|NCT03532880||Single Group Assignment||Treatment||None (Open Label)||||||
1304961|NCT03531671||Single Group Assignment||Device Feasibility||None (Open Label)||Assessing age related cataract, all 200 subjects will have whole eye OCT scan performed during their pre-operative cataract assessment and 50 subjects (all subjects requested to participate until 50 subject criteria met) will have these assessments reassessed during their post-operative assessment.||||
1573361|NCT00001479||||||||||||
1304869|NCT03532867||Single Group Assignment||Other||None (Open Label)||To study the changes in choroidal thickness of the macular region during aerobic exercise inducing an increase in systolic and diastolic blood pressure in healthy subjects measured by Optical Coherence Tomography (OCT) provides cross-sectional imaging of the choroid and in vivo measurement of its thickness Patients are treated in the usual way but the study is an interventional study, with minimal risks and constraints, because of the imaging (OCT image in EDI mode)||||
1304870|NCT03532854|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304871|NCT03532841|Randomized|Parallel Assignment||Prevention||Quadruple||A randomised double-blind placebo-controlled trial.|t|t|t|t
1304872|NCT03532828|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1304873|NCT03532815|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1304874|NCT03532802|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1304875|NCT03532789|Randomized|Parallel Assignment||Treatment||Quadruple||overactive bladder patients|t|t|t|t
1304876|NCT03532776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304877|NCT03532763|Randomized|Parallel Assignment||Prevention||Double||Randomized, double blind, placebo-controlled, parallel|t||t|
1304878|NCT03532750|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1:1 randomization of participants in sequential order to either the control group (best medical management), particle embolization, and coil embolization.||||
1304879|NCT03532737||Single Group Assignment||Treatment||None (Open Label)||||||
1304880|NCT03532724|||Cohort||Retrospective|||||||
1304881|NCT03532711|||Case-Only||Retrospective|||||||
1304882|NCT03532698||Single Group Assignment||Treatment||None (Open Label)||||||
1304883|NCT03532685|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1304884|NCT03532672||Single Group Assignment||Other||None (Open Label)||||||
1304885|NCT03532659|Randomized|Parallel Assignment||Other||None (Open Label)||"Intervention with two comparison groups. The control or experimental group will be randomly defined by school~Experimental group: will perform physical activity through the use of the active videogame associated with a gamification strategy three times a week for 50 minutes for a period of 8 weeks.~Control group: there will be no intervention proposal, only used for data comparison."||||
1304886|NCT03532646|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||All patients who underwent RYGB and MGB/OAGB readmitted for complications in our centre of excellence are getting observed||||
1304887|NCT03532633|||Cohort||Prospective|||||||
1304888|NCT03532620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304889|NCT03532607|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1304890|NCT03532594|Randomized|Parallel Assignment||Treatment||Single||The randomisation ratio will be 1:1 in the first instance but the trial uses an adaptive design and an interim analysis will be conducted after 100 patients have been randomised.|t|||
1304891|NCT03532581||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304892|NCT03532568|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1304893|NCT03532555|Randomized|Parallel Assignment||Treatment||None (Open Label)||Infants will be stratified by gestational age (23-24 wks, 25-26 wks, 27-29 wks) and then are randomized to receive supplemental oral zinc acetate or no zinc acetate.||||
1304894|NCT03532542|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304895|NCT03532529|||Cohort||Prospective|||||||
1304896|NCT03532516||||||||||||
1304897|NCT03532503|Randomized|Parallel Assignment||Other||Single|||t|||
1304898|NCT03532490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304899|NCT03532477|||Case-Only||Prospective|||||||
1304900|NCT03532464|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, open-label, multicenter||||
1304901|NCT03532451|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Cohort 1: Nivolumab alone. In the absence of the occurrence of high rate of treatment related adverse events, the study will proceed with enrollment into Cohort 2: Nivolumab/Lirilumab.||||
1304902|NCT03532438|||Case-Only||Cross-Sectional|||||||
1304903|NCT03532425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304904|NCT03532412|||Cohort||Retrospective|||||||
1304905|NCT03532399|||Case-Only||Prospective|||||||
1304906|NCT03532386|||Case-Control||Prospective|||||||
1304907|NCT03532373|Randomized|Parallel Assignment||Other||None (Open Label)|No masking will occur|Participants are randomly assigned to either the intervention or control group||||
1304908|NCT03532360|Randomized|Parallel Assignment||Treatment||Single|Participants will be randomized to one of three groups: a control group that will receive no treatment, a low-dose group and a high dose group. Participants in the latter two groups will be blinded as to what group they have been assigned|Randomized controlled trial|t|||
1304909|NCT03532347||Single Group Assignment||Diagnostic||None (Open Label)||All participants will receive both interventions the order i.e. FNB first or FNA first will be randomised. The pathologists reporting the samples will be blinded to the results with the alternative device||||
1304910|NCT03532334||Single Group Assignment||Other||None (Open Label)||||||
1304911|NCT03532321|||Cohort||Prospective|||||||
1304912|NCT03532308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304913|NCT03532295|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1304914|NCT03532282|Randomized|Parallel Assignment||Treatment||Double|Participants are asked to refrain from mentioning any information about the treatment they receive when interacting with the investigator or outcomes assessors||||t|t
1304915|NCT03532269|Randomized|Parallel Assignment||Other||Double|||t||t|
1304916|NCT03532256|||Cohort||Prospective|||||||
1304917|NCT03532243|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304918|NCT03532230|||Cohort||Prospective|||||||
1304919|NCT03532217||Single Group Assignment||Treatment||None (Open Label)||||||
1304920|NCT03532204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304962|NCT03531658|||Cohort||Prospective|||||||
1304963|NCT03531645||Single Group Assignment||Treatment||None (Open Label)||||||
1573362|NCT00001478||||||||||||
1304921|NCT03532191|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||The proposed intervention study will be implemented using a stepped-wedge design, which is a type of one-way crossover design in which all clinics will begin the study without the PrEP-OI intervention. Each clinic will cross over to receive the intervention one-by-one every month, with the order of clinic crossover determined at random to maximize internal validity.||||
1304922|NCT03532178|Randomized|Crossover Assignment||Treatment||Triple|The randomization of treatment groups will be blinded to the patients themselves, the psychiatrists and outcome assessors, except the anesthesiologists who will administer the drugs.|The participants will be randomized to one of the two drug groups to start with, and will switch to the other group for the next treatment period. For the study, each participant will take two treatments in a random order: (1) rocuronium to be reversed by sugammadex, and (2) succinylcholine plus normal saline placebo.|t||t|t
1304923|NCT03532165|Randomized|Sequential Assignment||Diagnostic||None (Open Label)||In all enrolled patients with concern for pulmonary embolism, a lower extremity ultrasound will be performed at the patient's bedside by the emergency room provider. If it is positive for a deep vein thrombosis, then a confimatory ultrasound will be performed by the vascular lab, and the patient started on anticoagulation to treat both the DVT and presumed PE. No CTA will be obtained in this group. Everyone else who had a negative bedside ultrasound performed by the ER provider will not receive a second ultrasound, but will rather go on to get the CT angiogram of the chest they would have likely received if not in the study.||||
1304924|NCT03532152|Randomized|Crossover Assignment||Other||Single|||||t|
1304925|NCT03532139|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients will be randomized to Arm Enoxaparin and Arm Enoxaparin + Rosuvastatin, and those requesting no randomization willl be directly assigned to Arm Standard-of-care Thromboprophylaxis||||
1304926|NCT03532126|||Cohort||Prospective|||||||
1304927|NCT03532113|Randomized|Parallel Assignment||Supportive Care||Double|The experimenters are blind in the clinical trials. Participants know that there are different training programs but they ignore the purpose of each one.|"Older participants are randomly assigned to one of three intervention conditions (Inhibition ; Updating ; General knowledge).~Young participants only complete the initial assessment."|t|||t
1304928|NCT03532100|Randomized|Factorial Assignment||Treatment||None (Open Label)||This study will use a within-subject factorial design (3x5) to identify the optimal coupling ratio between transverse- and sagittal-plane motions using a torsionally adaptive prosthesis. Participants will all walk in a straight line, in a circle with their prosthesis on the inside, and in a circle with their prosthesis on the outside (i.e., 3 activity levels). The torsionally adaptive prosthesis can be set to 5 different coupling ratios (transverse:sagittal) including 0:0, 1:6, 1:4, 1:3, and 1:2. Each participant will walk with the torsionally adaptive prosthesis set to the 5 different coupling ratios (random order). Participants will not be blinded to the activity but will be blinded to the coupling ratio.||||
1304929|NCT03532087|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1304930|NCT03532074|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|OPEN|||||
1304931|NCT03532061|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1304932|NCT03532048|Randomized|Parallel Assignment||Other||None (Open Label)|In this feasibility study there will be no masking.|Feasibility study with a randomized wait-list control group design||||
1304933|NCT03532035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304934|NCT03532022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304935|NCT03532009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304936|NCT03531996|||Cohort||Prospective|||||||
1304937|NCT03531983|||Case-Only||Prospective|||||||
1304938|NCT03531970|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1304939|NCT03531957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304940|NCT03531944|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1304941|NCT03531931|||Case-Only||Prospective|||||||
1304942|NCT03531918||Single Group Assignment||Treatment||None (Open Label)||||||
1304943|NCT03531905|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1304944|NCT03531892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304945|NCT03531879|||Case-Control||Cross-Sectional|||||||
1304946|NCT03531866|Randomized|Parallel Assignment||Treatment||Single|||t|||
1304947|NCT03531853||Single Group Assignment||Diagnostic||None (Open Label)||||||
1304948|NCT03531840||Single Group Assignment||Treatment||None (Open Label)||||||
1304949|NCT03531827|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304950|NCT03531814||Parallel Assignment||Supportive Care||None (Open Label)||||||
1304951|NCT03531801|||Case-Control||Cross-Sectional|||||||
1304952|NCT03531788|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomly assigned to trial a dynamic arm support (Armon Ayura (Kinova) or JAECO WREX)||||
1304953|NCT03531775||Single Group Assignment||Other||None (Open Label)||Clinical trial to study a novel intervention (upright MRI) to compare interventions in clinical practice||||
1304954|NCT03531762|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1304955|NCT03531749|Randomized|Parallel Assignment||Treatment||Double|A prospective double-blind, randomized clinical trial of microencapsulated of red pomegranate to treat HIV-infected patients|A prospective double-blind randomized clinical trial|t||t|
1304956|NCT03531736||Single Group Assignment||Treatment||None (Open Label)||This is a pilot study to assess engraftment of a T cell depleted (TCD) graft following a reduced intensity conditioning regimen (RIC). The conditioning regimen will include total body irradiation (TBI), Fludarabine, anti-thymocyte globulin (ATG) and post transplant cyclophosphamide (PT-Cy). The graft will be TCD and will be composed of a TCR-α/β+ lymphocyte depletion stem cells and CD34+ selected stem cells.||||
1304957|NCT03531723|||Other||Prospective|||||||
1304958|NCT03531710|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1304959|NCT03531697|Randomized|Crossover Assignment||Other||Single|||t|||
1304960|NCT03531684|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1304964|NCT03531632||Single Group Assignment||Treatment||None (Open Label)||||||
1304965|NCT03531619|||Cohort||Prospective|||||||
1304970|NCT03531554|Randomized|Crossover Assignment||Other||Double|Double (Participant, Outcomes Assessor)|randomized, blinded, placebo controlled, 2-way cross-over trial|t|||t
1304971|NCT03531541|Randomized|Factorial Assignment||Basic Science||Triple|"The blinding will be assessed by examiner 2 (responsible for administering TENS) asking the participants which TENS intervention they think they received, with 3 options for the answer: active, placebo or don't know. The same questions will be asked by examiner 2 for CJM. Next, examiner 3 (responsible for administering CJM) will receive the blinding outcome and have 3 options for the answer: active, placebo or don't know. Examiner 1 will receive the blinding outcome will be asked: Which group does the patient belong to: active TENS and CJM, active TENS and placebo CJM, placebo TENS and active CJM or placebo TENS and CJM Their responses to these questions will be recorded and used to measure the adequacy of participants and examiners"|The participants will be randomly allocated into 4 groups: (G1) active TENS and CJM, (G2) placebo TENS and CJM, (G3) placebo TENS and active CJM, (G4) active TENS and placebo CJM.|t||t|t
1304972|NCT03531528||Single Group Assignment||Treatment||None (Open Label)||||||
1304973|NCT03531515|||Cohort||Prospective|||||||
1304974|NCT03531502|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective, randomized, controlled||||
1304975|NCT03531489|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304976|NCT03531476||Single Group Assignment||Supportive Care||None (Open Label)||||||
1304977|NCT03531463|Randomized|Parallel Assignment||Treatment||Single|Physiotheraphists specialized in shoulder injuries collect all data and perform all tests / interviews of patients during FU at 3 months, 1-2-5 years. Blinded for the allocation / treatment.|Randomized controlled semiblinded trial||||t
1304978|NCT03531450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304979|NCT03531437|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1304980|NCT03531424|Randomized|Parallel Assignment||Treatment||Single||||||t
1304981|NCT03531398|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1304982|NCT03531385|||Cohort||Prospective|||||||
1304983|NCT03531372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1304984|NCT03531359|Randomized|Parallel Assignment||Treatment||Single|Anxiety will be determined by using a video recording of the child, which will be assessed by psychiatric|"Tablet Group: They'll receive a tablet with content adapted to every group. It will be divided into 4 groups (2-4 years, 4-6 years, 6-8 years and 9-10 years). The first one will receive cartoons, the second will also have games; for the other two groups will be assigned appropriate video games depending on the age.~Midazolam group: They'll receive 0,5mg/kg oral or it's equivalent in rectal administration 30 minutes to one hour prior to transfer to the theater. This patients will not be able to have contact with audiovisual devices."||||t
1304985|NCT03531346|Non-Randomized|Parallel Assignment||Other||Single|Subjects were masked with respect to the lens type.||t|||
1304986|NCT03531333|Randomized|Parallel Assignment||Treatment||Single|Gross total resection (yes/no) on post-operative T1 postcontrast MRI scans will be evaluated by a neuroradiologist who is blinded for the treatment arm.|"The US-GLIOMA study is a randomized controlled trial with blinded primary outcome measure.~The study consists of two treatment arms: non-ultrasound guided glioma resection (conventional treatment) versus ultrasound guided glioma resection (intervention) ."||||t
1304987|NCT03531320|Randomized|Sequential Assignment||Treatment||None (Open Label)||"Part 1 of the study comprises a sequential dose escalation to identify dose-limiting toxicity (DLT) and establish the maximum tolerated dose (MTD), if any, of D07001-softgel in patients with unresectable locally advanced or metastatic GI cancer. Part 1 will follow a 3+3 dose escalation scheme at predefined dose levels. There will be sequential cohorts of 3 to 6 patients each with increasing doses of 40 mg, 60 mg, 80 mg, 120 mg, and 160 mg per cohort.~In Part 2 of the study, D07001-softgel will be administered at the 2 dose levels selected for expansion from Part 1 of the study."||||
1304988|NCT03531307|||Case-Only||Retrospective|||||||
1304989|NCT03531294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304990|NCT03531281|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1304991|NCT03531268|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||All subjects meeting inclusion/exclusion criteria will undergo pharmacogenomic testing. The group for which testing is thought to have clinical utility will be compared to the group for which testing is thought to have no clinical utility.||||
1304992|NCT03531255|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1304993|NCT03531242|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Subjects who successfully complete screening will be enrolled in the study to receive either (1) a series of booster(s) or (2) one booster vaccination(s). Each vaccination will be administered as 0.5 mL subcutaneous doses in the upper outer aspect of the arm (triceps areas)||||
1304994|NCT03531229|Randomized|Sequential Assignment||Treatment||Double||36 Subjects are planned for enrolment, with 6 subjects per cohort. The subjects will be randomized to Lu AF76432 or placebo in a 4:2 ratio per cohort. A maximum of 2 additional cohorts of young healthy men will be permitted thereby allowing investigation of a maximum of 48 subjects|t||t|
1304995|NCT03531216|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1304996|NCT03531203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1304997|NCT03531190|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized to intervention. Control is the present treatment in the department + protein supplementation||||
1304998|NCT03531177|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised model, two arms. Intervention assessed against control.||||
1304999|NCT03531164|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1305000|NCT03531151|||Cohort||Prospective|||||||
1305001|NCT03531138||Single Group Assignment||Other||None (Open Label)||||||
1305002|NCT03531125|||Cohort||Prospective|||||||
1305054|NCT03530449|||Cohort||Prospective|||||||
1305055|NCT03530436|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1305056|NCT03530423|||Case-Only||Prospective|||||||
1305057|NCT03530410|||Case-Crossover||Prospective|||||||
1305058|NCT03530397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305059|NCT03530384|Randomized|Parallel Assignment||Other||Single|||t|||
1573363|NCT00001477||||||||||||
1305003|NCT03531112|Randomized|Parallel Assignment||Treatment||None (Open Label)||The proposed study will use a randomized clinical trial design. A sample of 40 black women who report at least weekly binge eating episodes will be randomized to 2 arms of a 6-month AAT intervention: AAT or a wait-list control group (delayed intervention group). AAT participants will receive an 8-week AAT program using a group format, and will be provided a smart scale (with bluetooth-connection for automatic data reporting) and instructions to weigh themselves daily. Participants will also be provided with weekly tailored feedback on self-weighing frequency and weight change. Assessments will be conducted at 0, 2, and 6 months.||||
1305004|NCT03531099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305005|NCT03531086|||Cohort||Prospective|||||||
1305006|NCT03531073|||Cohort||Prospective|||||||
1305007|NCT03531060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305008|NCT03531047||Single Group Assignment||Treatment||None (Open Label)||||||
1305009|NCT03531034|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305010|NCT03531021|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized, attention-matched trial with 1:1 randomization at a single center. Subjects will be randomized in two strata, by age (14-16 years and 17-19 years).||||
1305011|NCT03531008|||Cohort||Prospective|||||||
1305012|NCT03530995|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||Two-Part, Non-Randomised||||
1305013|NCT03530982||Single Group Assignment||Treatment||None (Open Label)|The assessor will not know the aims and content of the intervention procedures.|Individualized intensive training of functional priorities presented by adolescents with CP. The intervention will happen during 2 weeks, 5 days/week, during 3 hours in a local rehabilitation center. Trained occupational and physical therapists will conduct the intervention procedures||||
1305014|NCT03530969|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305015|NCT03530956|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1305016|NCT03530943|Randomized|Parallel Assignment||Prevention||Single|Participants remained unaware of their treatment allocation until after completing the baseline (pretest) assessments and the onset of their intervention||t|||
1305017|NCT03530930||Single Group Assignment||Treatment||None (Open Label)||||||
1305018|NCT03530917|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1305019|NCT03530904|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1305020|NCT03530891|Randomized|Parallel Assignment||Treatment||None (Open Label)|Because the two interventions requires different pre operative preparation, both the participants and investigators can't be blinded.|"A Randomized clinical trial.~Parallel group study.~A trial will be carried out in hospital of Oral and Maxillofacial surgery department- Faculty of Oral and Dental Medicine Cairo University~Equal randomization: participants with equal probabilities for intervention.~Positive controlled: Both groups receiving treatment."||||
1305021|NCT03530878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305022|NCT03530865|||Other||Retrospective|||||||
1305023|NCT03530852||Single Group Assignment||Treatment||None (Open Label)||||||
1305024|NCT03530839|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1305025|NCT03530826|||Other||Prospective|||||||
1305026|NCT03530813|Randomized|Parallel Assignment||Other||None (Open Label)||Prospective Randomised Parallel Study||||
1305027|NCT03530800|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1305028|NCT03530787|Randomized|Parallel Assignment||Treatment||Triple|Double blind|"Subjects will be randomized to two groups:~AZ Group (n= 17) Control Group (n=17)"|t||t|t
1305029|NCT03530774|Randomized|Parallel Assignment||Supportive Care||Triple|Participants will be blinded to control (carbohydrate) or egg white protein supplement||t||t|t
1305030|NCT03530761|||Cohort||Prospective|||||||
1305031|NCT03530748|||Cohort||Prospective|||||||
1305032|NCT03530735||Single Group Assignment||Treatment||None (Open Label)||||||
1305033|NCT03530722|||Case-Only||Prospective|||||||
1305034|NCT03530709|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1305035|NCT03530696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305036|NCT03530683|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1305037|NCT03530670|Randomized|Crossover Assignment||Other||Single|single (participant)|Crossover assignment Effect of pharmacological and nonpharmacological premedication on anxiety|t|||
1305038|NCT03530657|||Cohort||Prospective|||||||
1305039|NCT03530644||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1305040|NCT03530631|Randomized|Factorial Assignment||Health Services Research||Double|This will be a double-blind study. Research assistants will administer capsules, and based on package labeling, tell the participant if they are being administered Adderall or placebo. However, researchers and participants will be blind to which medication is actually being administered.|2 X 2, within-subjects, balanced placebo design|t||t|
1305041|NCT03530618|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1305042|NCT03530605|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective group (non-randomized) compared to historical matched controls||||
1305043|NCT03530592||Single Group Assignment||Treatment||None (Open Label)||Seated Ankle Robot Taining||||
1305044|NCT03530579|Non-Randomized|Parallel Assignment||Prevention||||||||
1305045|NCT03530566|||Cohort||Prospective|||||||
1305046|NCT03530553|Randomized|Single Group Assignment||Treatment||None (Open Label)||There are two arms in this study. One group will receive the HMS and the other will not and will receive standard of care.||||
1305047|NCT03530540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305048|NCT03530527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305049|NCT03530514|Randomized|Sequential Assignment||Basic Science||Triple|||t||t|t
1305050|NCT03530501|Randomized|Parallel Assignment||Treatment||Single||||t||
1305051|NCT03530488|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1305052|NCT03530475|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1305053|NCT03530462|||Case-Control||Retrospective|||||||
1573364|NCT00001468||||||||||||
1305060|NCT03530371||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305061|NCT03530358|Randomized|Parallel Assignment||Treatment||Double|A simple random number sequence will be generated by a computer and the allocation concealment will be guaranteed using sequentially numbered, opaque sealed envelopes. The therapists responsible for randomization and allocation procedures will be independent of the blind therapists and medical doctors involved in patients' screening and treatment.|Randomized Clinical Trial|||t|t
1305062|NCT03530345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305063|NCT03530332|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305064|NCT03530319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305065|NCT03530306|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1305066|NCT03530293|Randomized|Parallel Assignment||Treatment||Triple|open-label study drug treatment period followed by blinded randomization into treatment arm or placebo arm||t|t|t|
1305067|NCT03530280|Randomized|Parallel Assignment||Other||Single|||t|||
1305068|NCT03530267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305069|NCT03530254|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1305070|NCT03530241|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1305071|NCT03530228|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Cohort 1: crossover Cohort 2: parallel Cohort 3: single group||||
1305072|NCT03530215|||Case-Only||Cross-Sectional|||||||
1305073|NCT03530202|Randomized|Parallel Assignment||Prevention||Double|A research assistant who is not involved in the study in any other way will be responsible for randomization.|The study will be a double-blind, repeated measures design. Participants will be randomized on a 1:1 basis to one of two groups: high-velocity resistance training and creatine or high-velocity resistance training and placebo.|t||t|
1305074|NCT03530189|||Cohort||Prospective|||||||
1305075|NCT03530176||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305076|NCT03530163|Randomized|Parallel Assignment||Prevention||Single|Participants will be masked from knowing whether they are performing the Respiratory Muscle Training or sham training.||t|||
1305077|NCT03530150|Randomized|Parallel Assignment||Treatment||Double|The principal investigator, the person in charge of gathering the data, and the person analyzing the data will be blinded|Burn patients will be divided to receive either 600 mg of pirfenidone or usual care|||t|t
1305078|NCT03530137||Single Group Assignment||Other||None (Open Label)||||||
1305079|NCT03530124|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305080|NCT03530111|||Cohort||Cross-Sectional|||||||
1305081|NCT03530098|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||A hand radiograph will be randomly assigned to one of two groups - control and experiment. In the control group, participating radiologists will diagnose the case using the current standard of care (no intervention). In the experiment group, the radiologists will factor in the output of the Artificial Intelligence algorithm in their diagnosis. In all cases, the decision of the radiologist will be considered final.||||
1305082|NCT03530085||Single Group Assignment||Treatment||None (Open Label)||||||
1305083|NCT03530072|||Cohort||Prospective|||||||
1305084|NCT03530059|||Cohort||Prospective|||||||
1305085|NCT03530046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1305086|NCT03530033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305087|NCT03530020|Randomized|Parallel Assignment||Treatment||Double||Patient will receive a restoration with superior function, esthetics, and excellent clinical performance.|t|||t
1305088|NCT03530007|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1305089|NCT03529994|||Cohort||Prospective|||||||
1305090|NCT03529981|Randomized|Factorial Assignment||Basic Science||None (Open Label)||randomized, controlled factorial within subject design||||
1305091|NCT03529968|||Cohort||Retrospective|||||||
1305092|NCT03529955||Single Group Assignment||Treatment||None (Open Label)||||||
1305093|NCT03529942||Single Group Assignment||Treatment||None (Open Label)||||||
1305094|NCT03529929||Single Group Assignment||Treatment||None (Open Label)||||||
1305095|NCT03529916|||Case-Control||Cross-Sectional|||||||
1305096|NCT03529903|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305097|NCT03529890||Single Group Assignment||Treatment||None (Open Label)||||||
1305098|NCT03529877||Single Group Assignment||Treatment||None (Open Label)||||||
1305099|NCT03529864|Randomized|Parallel Assignment||Prevention|||This study was single-blind, parallel-group, and participants were randomly assigned to either the experimental (EG) or the control group (CG). Randomization was designed after initially evaluating the participants. The EG participated in the progressive exercise therapy program. In contrast, the CG did not receive any type of information or instructions apart from the general information sheet on the progress of the study, attached to the informed consent form.|"Why: The design of the intervention took into account the available evidence for the prevention and treatment of neck and low back pain.~What: Materials: mats, fit-balls, TheraBands, towels, Dyn-Air cushions, chairs, stretchers.~Procedures: 3 levels of exercises of increasing difficulty. Standing warm-up exercises. Exercises involving: body scanner and breathing pattern re-education (4 minutes), neutral lumbar-pelvic position control in all directions (6 minutes); transverse abdominis activation (4 minutes); neutral cervical position control (2 minutes); global stabilizer activation exercises for the lumbar-pelvic and cervical-scapular regions (4 minutes); low back flexibility (2 minutes); and muscular strengthening and stretching (12 minutes).~Who provided: Physiotherapist. How: Face to face, group with 8-9 participants."||||
1305100|NCT03529851||Single Group Assignment||Other||None (Open Label)||Feasibility pilot study||||
1305101|NCT03529838|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||45 women taking different antihypertensives (15 no medications, 15 angiotensin receptor blockers and 15 beta blockers) for at least 6 months will be assessed at baseline and after 12 weeks of combined exercise training.||||
1305102|NCT03529825|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Pilot, single arm prospective study with retrospective control arm||||
1305156|NCT03529123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305157|NCT03529110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305103|NCT03529812|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This study aims to enroll 30 hospital chaplain residents, 15 will have the CBCT intervention early and the other 15 will learn about CBCT later. Additionally, 500 patients who have spiritual services provided by the chaplains participating in the study will be enrolled in order to examine patient outcomes.||||
1305104|NCT03529799|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1305105|NCT03529786|||Other||Other|||||||
1305106|NCT03529773|Randomized|Parallel Assignment||Prevention||Quadruple|Observer blind|Parallel|t|t|t|t
1305107|NCT03529760|||Case-Only||Prospective|||||||
1305108|NCT03529747|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1305109|NCT03529734|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305110|NCT03529721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305111|NCT03529708||Single Group Assignment||Treatment||None (Open Label)||Single arm pilot study of standard of care 3D conformal radiotherapy plus Stereotactic body radiotherapy (SBRT) boost||||
1305112|NCT03529695|Randomized|Parallel Assignment||Prevention||Single||Parallel Assignment Randomization occurs at the level of home visitors who deliver the home visitation program curriculum. Home visitors will be randomized to deliver the home visitation program curriculum with (Experimental comparator) or without (Active Comparator) the obesity prevention enhancement module. Mother-child dyads enrolled in home visitation programs, and who agree to participate in the study, will receive the intervention arm delivered by their home visitor.||||t
1305113|NCT03529682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305114|NCT03529669||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1305115|NCT03529656|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305116|NCT03529643|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1305117|NCT03529630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305118|NCT03529617|||Case-Control||Prospective|||||||
1305119|NCT03529604|||Case-Control||Cross-Sectional|||||||
1305120|NCT03529591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305121|NCT03529578||Single Group Assignment||Treatment||None (Open Label)||||||
1305122|NCT03529565|||Cohort||Prospective|||||||
1305123|NCT03529552||Single Group Assignment||Treatment||None (Open Label)||||||
1305124|NCT03529539||||||||||||
1305125|NCT03529526||Sequential Assignment||Treatment||None (Open Label)||"This is a dose-escalation trial, all participants will receive treatment with KN046. Participants enrolled in this trial may receive one of the following doses dependent upon time of enrolment into the study.~Cohort 1: 0.3 mg/kg Cohort 2: 1 mg/kg Cohort 3: 3 mg/kg Cohort 4: 5 mg/kg Cohort 5: 10 mg/kg"||||
1305126|NCT03529513|||Cohort||Cross-Sectional|||||||
1305127|NCT03529500|||Cohort||Cross-Sectional|||||||
1305128|NCT03529487||Sequential Assignment||Treatment||None (Open Label)||||||
1305129|NCT03529474|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1305130|NCT03529461|Randomized|Sequential Assignment||Supportive Care||Double||Randomized controlled trial|t|||t
1305131|NCT03529448||Sequential Assignment||Treatment||None (Open Label)||Phase Ib, intra-patient dose escalation trial.||||
1305132|NCT03529435|Randomized|Parallel Assignment||Treatment||Single|Independent evaluators, who are blind to treatment condition, conduct semi-structured interviews to assess PTSD diagnosis at the posttreatment, three-month, and six-month follow-up assessments.|||||t
1305133|NCT03529422||Single Group Assignment||Treatment||None (Open Label)||||||
1305134|NCT03529409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305135|NCT03529396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305136|NCT03529383|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||"Two interventions, each alone and in combination, are evaluated in parallel against a control group. Women assigned to the connected device arm will follow a 6-month exercise program using a connected device. Women assigned to the therapeutic education arm will follow a 6-month program of therapeutic patient education in physical activity. Women assigned to the combined arm will follow both programs. Women assigned to the control arm will receive international recommendations on physical activity."||||
1305137|NCT03529370|||Cohort||Prospective|||||||
1305138|NCT03529357|||Cohort||Prospective|||||||
1305139|NCT03529344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305140|NCT03529331|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1305141|NCT03529318|||Case-Only||Prospective|||||||
1305142|NCT03529305|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1305143|NCT03529292||Single Group Assignment||Treatment||None (Open Label)||||||
1305144|NCT03529279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305145|NCT03529266||Single Group Assignment||Treatment||None (Open Label)||||||
1305146|NCT03529253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305147|NCT03529240||Single Group Assignment||Supportive Care||None (Open Label)||||||
1305148|NCT03529227|||Cohort||Prospective|||||||
1305149|NCT03529214||Single Group Assignment||Health Services Research||None (Open Label)||||||
1305150|NCT03529201|Randomized|Parallel Assignment||Treatment||Single|A regional block will be performed under general anesthesia. Patients will not be aware of this procedure.|Patients will be randomly allocated to one of the study arms: QLB or control group.|t|||
1305151|NCT03529188|||Cohort||Prospective|||||||
1305152|NCT03529175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305153|NCT03529162|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective Randomized Controlled Trial||||
1305154|NCT03529149|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1305155|NCT03529136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with decompensated liver cirrhosis are going to be assigned to receive standard medical care plus UC-MSC treatment with two different protocol (group 1 and group 2) or standard medical care (control). Four times of MSC infusion (1.5x10E6 cells/kg body weight) via peripheral vein will be given to the group 1（once every 4 days), and two times of MSC infusion once every 7 days to group 2.||||
1305158|NCT03529097|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305159|NCT03529084|Randomized|Parallel Assignment||Treatment||Single|blinded independent review committee for primary endpoint of PFS|||||t
1305160|NCT03529071|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Participants will be provided with a Question Prompt Sheet to use at their nephrology clinic visit.||||
1305161|NCT03529058|||Cohort||Retrospective|||||||
1305162|NCT03529045|||Cohort||Prospective|||||||
1305163|NCT03529032|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1305164|NCT03529019||Single Group Assignment||Supportive Care||None (Open Label)||Potential subjects with potential malnutrition and critical limb ischemia.||||
1305165|NCT03529006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305166|NCT03528993|Randomized|Parallel Assignment||Treatment||Single||randomized controlled trial|t|||
1305167|NCT03528980|||Case-Control||Prospective|||||||
1305168|NCT03528967|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305169|NCT03528954|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1305170|NCT03528941|||Other||Retrospective|||||||
1305171|NCT03528928||Sequential Assignment||Other||None (Open Label)|The patient was not allowed to see the ultrasound screen|Surface electrical stimulation, Elitone by Elidah, Inc.||||
1305172|NCT03528915|||Case-Control||Prospective|||||||
1305173|NCT03528902|Randomized|Parallel Assignment||Treatment||Quadruple||Single-center, randomized, double-blind, placebo-controlled Phase II study of 24 subjects with PAH. Eligible subjects will be randomized to treatment with a 1:1 ratio using a permuted-block randomization algorithm.|t|t|t|t
1305174|NCT03528889|Randomized|Parallel Assignment||Treatment||Single|Patients are masked about which group they are randomized in|"Randomization into two study arms:~Classic control of extension and derotation using a Moeltgen goniometer intraoperatively~Control of extension and derotation using an electromagnetic tracking device intraoperatively"|t|||
1305175|NCT03528876||Single Group Assignment||Treatment||None (Open Label)||||||
1305176|NCT03528863||Single Group Assignment||Supportive Care||None (Open Label)||||||
1305177|NCT03528850|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305178|NCT03528837|||Case-Only||Prospective|||||||
1305179|NCT03528824|Randomized|Parallel Assignment||Treatment||Single||||||t
1305180|NCT03528811|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1305181|NCT03528798|||Cohort||Retrospective|||||||
1305182|NCT03528785||Single Group Assignment||Treatment||None (Open Label)||||||
1305183|NCT03528772|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1305184|NCT03528759|||Other||Cross-Sectional|||||||
1305185|NCT03528746|Randomized|Crossover Assignment||Other||Single|Participants will be blinded to the study hypothesis|The proposed study is a participant blinded, randomised crossover superiority trial, to examine acute effect of isometric versus isotonic resistance exercise on pain in patients with patellar tendinopathy.|t|||
1305186|NCT03528733||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305187|NCT03528720|||Other||Other|||||||
1305188|NCT03528707|Randomized|Parallel Assignment||Treatment||Triple|Randomization was done by the study statistician based on a computer-generated list. The groups were homogeneous according to age, sex and diagnostic criteria. The assignment of groups was blind to participants, research staff and outcome assessors moreover, to maintain blind parallel study the statistician was not aware of the allocation of participants to intervention.||t||t|t
1305189|NCT03528694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305190|NCT03528681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305191|NCT03528668|||Other||Prospective|||||||
1305192|NCT03528655|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1305193|NCT03528642||Single Group Assignment||Treatment||None (Open Label)||||||
1305194|NCT03528629|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1305195|NCT03528616|||Case-Crossover||Prospective|||||||
1305196|NCT03528603|Randomized|Crossover Assignment||Basic Science||Double|Extra Virgin Olive Oils will be stored and provided to the study investigators in coded single serving bottles|controlled, randomized, double-blind, with 2 interventions|t||t|
1305197|NCT03528590|Randomized|Parallel Assignment||Other||Single|||t|||
1305198|NCT03528577|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1305199|NCT03528564|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305200|NCT03528551|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305201|NCT03528538|Randomized|Parallel Assignment||Treatment||Double|The investigators and the participants remained blind until after the total completion of the experiment.|Subjects will complete 3 assessments during the study at Day 0, Week 4, and Week 8. At each assessment, they complete the following: self-report inventories (e.g., Aging Male Symptoms Questionnaire, Trait Anxiety Inventory, Health-related Quality of Life), body composition via BOD POD, heart rate, blood pressure, and blood draws. The subjects will be randomized to one of the following three conditions: (1) AlphaFenTM fenugreek (400 mg/d), (2) AlphaFenTM fenugreek (500 mg/d), or (2) placebo control. The subjects will be asked to take one capsule of the fenugreek supplement or placebo daily for eight weeks.|t||t|
1305202|NCT03528525|||Case-Only||Prospective|||||||
1305203|NCT03528512|Randomized|Parallel Assignment||Treatment||Quadruple|A randomization list created by an online randomization tool will be used to assign participants to a treatment arm (in random blocks of 4, 6, and 8). As participants are enrolled in the study, they will be assigned to the next available sequential treatment arm.|Randomized double blinded control trial|t|t|t|t
1305204|NCT03528499|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305205|NCT03528486|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1305206|NCT03528473|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a randomized, controlled, double-group assignment, open label study with intermediate crossover||||
1305207|NCT03528460|||Cohort||Retrospective|||||||
1305208|NCT03528447||Single Group Assignment||Treatment||None (Open Label)||||||
1305311|NCT03527108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305209|NCT03528434|Randomized|Parallel Assignment||Prevention||Triple||A randomized, placebo-controlled, double blind clinical trial|t|t|t|
1305210|NCT03528421||Single Group Assignment||Treatment||None (Open Label)||||||
1305211|NCT03528408||Single Group Assignment||Treatment||None (Open Label)||||||
1305212|NCT03528395|Randomized|Parallel Assignment||Treatment||Single|All assessments will be made by blind evaluators with respect to the established study groups|"Patients will be randomly distributed to a control group or experimental group using the QuickCalcs application of GraphPad Software.~The following considerations will be taken into account:~Control group: 8 weeks of conventional rehabilitation based on a task-oriented approach. Consisting of five weekly sessions of physical therapy and of occupational therapy, lasting 45 minutes each.~Experimental group: 8 weeks of conventional rehabilitation provided identically as in the control group, plus virtual reality semi-immersive sessions. VR sessions will be applied following a protocol using commercial video games, three days a week (Monday, Wednesday and Friday) after the conventional rehabilitation sessions."|||t|
1305213|NCT03528382|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305214|NCT03528369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305215|NCT03528356|Randomized|Parallel Assignment||Treatment||Single||||||t
1305216|NCT03528343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305217|NCT03528330|Randomized|Crossover Assignment||Treatment||Single|||t|||
1305218|NCT03528317||Single Group Assignment||Prevention||None (Open Label)||||||
1305219|NCT03528304|Randomized|Factorial Assignment||Prevention||None (Open Label)||We used a 2x2 factorial design to evaluate contingency management (CM) for weight loss and smoking abstinence among women who were both overweight/obese and current smokers. Participants were accordingly randomized in equal numbers into one of four groups: 1) women receiving CM for weight loss, 2) women receiving CM for smoking abstinence, 3) women receiving CM for both weight loss and smoking abstinence, or 4) a non-contingent control group.||||
1305220|NCT03528291|||Cohort||Prospective|||||||
1305221|NCT03528278|||Ecologic or Community||Prospective|||||||
1305222|NCT03528265|||Cohort||Cross-Sectional|||||||
1305223|NCT03528252|Randomized|Parallel Assignment||Prevention||Triple|Randomization by sealed envelopes, opened in private. Allocation sequence and envelopes provided by external agent. Participants are instructed not to discuss intervention outside household. No more than one (randomly selected) participant per household allowed.|Two identical parallel groups|t|t|t|
1305224|NCT03528239|||Cohort||Retrospective|||||||
1305225|NCT03528226|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1305226|NCT03528213|Randomized|Parallel Assignment||Treatment||None (Open Label)||bolus then continuous infusion of molar sodium lactate (2 doses) or normal saline||||
1305227|NCT03528200||Single Group Assignment||Treatment||None (Open Label)||||||
1305228|NCT03528187|||Case-Control||Prospective|||||||
1305229|NCT03528174||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1305230|NCT03528161|||Other||Prospective|||||||
1305231|NCT03528148|Randomized|Parallel Assignment||Treatment||Single||randomize control trials|t|||
1305232|NCT03528135|Randomized|Parallel Assignment||Prevention||None (Open Label)||"The study includes a randomized controlled trial with one intervention condition and one wait-list control condition. All participants will complete the pre-test and be randomized to receive Project PRIDE immediately or to wait approximately 5 months before receiving it. Randomization will occur as follows: for each recruitment wave (n = 41 per wave), 41 sealed envelopes, each containing a card with the condition (14 cards labeled wait-list for the wait-list control group; 27 labeled group to start shortly for the intervention group), will be pinned to a foam board. Each participant will choose one card and open it. Those in the intervention group will be assigned to one of two groups of 13-14 participants. After completing the 8 sessions, those in the intervention and those in the matched control will complete the post-test. Approximately 3 months later, these participants will complete the follow-up; those in the control will then receive Project PRIDE."||||
1305233|NCT03528122||Single Group Assignment||Treatment||None (Open Label)||Individuals with recurrent macular hole associated retinal detachment||||
1305234|NCT03528109|Randomized|Parallel Assignment||Treatment||Single||||||t
1305235|NCT03528096|Randomized|Single Group Assignment||Treatment||Single|Blinding of the participants is impossible, as the stimulation is easy to perceive and cannot be confused with a baseline night. Therefore, participants are informed about the character of the night (max. 5 minutes) before the moment of lights off. For safety reasons the experimenter that is present is also aware of the condition.|Crossover Assignment|t|||
1305236|NCT03528083|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||The investigators will conduct a quality improvement process for all children diagnosed with bronchiolitis at our hospital who meet inclusion criteria. Outcomes for these patients will be compared with retrospective controls.||||
1305237|NCT03528070||Single Group Assignment||Treatment||None (Open Label)||||||
1305238|NCT03528057|Randomized|Parallel Assignment||Treatment||Triple|The surgical team and the patient will be blinded as to which arm the patient will be assigned both at the time of recruitment in the clinic and at the start of surgery. The patient and surgeon will both be blinded at the start of the surgery (RALPN). The surgeon will be informed intra-operatively during the renorrhaphy portion of the procedure as to which arm the patient will be assigned, at which point he will be un-blinded. Following completion of the entire surgery, the patient will also be informed as to which arm he/she was randomized upon request.||t|t|t|
1305239|NCT03528044|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||In this study, patients undergoing bariatric surgery will be assessed at baseline and after bariatric surgery. We intend to analyze the changes in this repeated and dependent measurements. The other group will be undisturbed during the follow up except for clinical assessments and MRI imaging.||||
1305312|NCT03527095|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1305313|NCT03527082|||Other||Prospective|||||||
1305314|NCT03527069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305315|NCT03527056|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305316|NCT03527043|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305317|NCT03527030|||Other||Cross-Sectional|||||||
1305240|NCT03528031|Randomized|Parallel Assignment||Prevention||None (Open Label)||This clinical trial aims to assess the effect of providing one avocado per day on established parameters of health in comparison with a control group maintaining their habitual diets. Participants are pre-screened over the telephone initially to assess eligibility and likelihood of compliance. For those that remain eligible, additional screening is conducted at a study visit. Participants' eligibility is confirmed by the data entry system on the trial website when the Inclusion/Exclusion form is complete and entered. Randomization is performed automatically by the data entry system using a block design and stratified by site. Participants are randomly assigned to one of two equally sized groups. Neither participants nor staff will be blinded to intervention assignment. Both groups are instructed to continue to follow their habitual diet but the intervention group will receive one avocado per day. Participants are followed for outcomes for a six-month period.||||
1305241|NCT03528018|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1305242|NCT03528005|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305243|NCT03527992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305244|NCT03527979|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1305245|NCT03527966|Randomized|Parallel Assignment||Basic Science||Double|The surgical team, including the surgeons, will be blinded to the treatment options until decompression/instrumentation have been completed. The patients and all staff, including hospital nursing staff, case management, and physical therapists, will be blinded as to which bone graft treatment the patient received.||t|t||
1305246|NCT03527953|Randomized|Parallel Assignment||Treatment||Single|single||t|||
1305247|NCT03527940|||Cohort||Retrospective|||||||
1305248|NCT03527927||Single Group Assignment||Treatment||None (Open Label)||||||
1305249|NCT03527914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305250|NCT03527901|||Cohort||Cross-Sectional|||||||
1305251|NCT03527888||Single Group Assignment||Treatment||None (Open Label)||||||
1305252|NCT03527875|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305253|NCT03527862|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1305254|NCT03527849|Non-Randomized|Parallel Assignment||Basic Science||Single|The study will be structured as a parallel-group controlled trial. The Principal Investigator will assign participants into the three groups. This will allow for equalization of distribution of participants across the three groups. It will not be possible to blind the participants to which arm of the trial they are participating in, as the content or lack thereof of their activities will be obvious to them. For results analysis, collaborators at the UCD West Coast Metabolomics Center will be blinded to the treatment of the respective samples, thus eliminating potential bias during analysis.|||||t
1305255|NCT03527836|Randomized|Parallel Assignment||Basic Science||Triple|"Patients, the operating team, nurses, and observers involved in the assessment of the follow-up data collection were unaware of group allocation. The labor analyst is unaware of group allocation.~The list of cases will be provided in spreadsheet program by an observer-blinded assistant and was statistically evaluated by an independent analyst."|Study participants n=10 in the L group, n=10 in the B group and n=10 in the mixture group|t||t|t
1305256|NCT03527823|||Cohort||Prospective|||||||
1305257|NCT03527810|Randomized|Parallel Assignment||Prevention||Single|||t|||
1305258|NCT03527797|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305259|NCT03527784|Randomized|Parallel Assignment||Prevention||Single|Subject is blinded of the mesh used. Outcome at 12 month follow-up is assessed by surgeon who was not involved in the operation.|Prestoma is a prospective randomized controlled multicenter trial.|t|||
1305260|NCT03527771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305261|NCT03527758|Randomized|Parallel Assignment||Prevention||Single|||t|||
1305262|NCT03527745|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1305263|NCT03527732|Randomized|Parallel Assignment||Treatment||Quadruple|The parallel group trial will be double blinded (i.e. study participants and the trial team/researchers conducting the treatment and assessing the outcomes will be blinded) using repacked tablets including appearance-matched placebos while the dose-finding study will be single blinded (i.e. all outcome assessors except the investigators who provide the treatment and the study participants who get either active or placebo tablets matching in appearance will be blinded) due to the nature of this study (i.e. including ascending doses).||t|t|t|t
1305264|NCT03527719|Randomized|Parallel Assignment||Treatment||Single|Outcome Assessment Committee members will be blinded to intervention assignment.|||||t
1305265|NCT03527706|||Cohort||Prospective|||||||
1305266|NCT03527693|||Cohort||Retrospective|||||||
1305267|NCT03527680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305268|NCT03527667|Randomized|Parallel Assignment||Treatment||None (Open Label)||3-arm randomized controlled trial||||
1305269|NCT03527654|||Cohort||Prospective|||||||
1305270|NCT03527641|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants are assigned to one of two or more group conditions in parallel for the duration of the study - (1) Salud sin Barreras or (2) La Vida Saludable. Both of these programs meet for 6 weeks, twice per week for 12 total 2-hour sessions. Youth are assessed at baseline, post-treatment, and 6-month follow-up.||||
1305271|NCT03527628|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305272|NCT03527615|||Cohort||Retrospective|||||||
1305273|NCT03527602|Randomized|Parallel Assignment||Treatment||Single|Single-blind. (Participants)||t|||
1305274|NCT03527589||Single Group Assignment||Treatment||None (Open Label)||||||
1305275|NCT03527576|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1305276|NCT03527563|Randomized|Parallel Assignment||Other||None (Open Label)||The study is a multi-center, randomized, open, and parallel study. Approximately 958 subjects will be enrolled in 16 sites. The random number table will be adopted to conduct cluster randomization per township hospital/community health service center. Patients will be randomized 1:1 to receive blood pressure management in Internet medical model or Conventional medical model. After follow-ups of 3 months and 6 months, the blood pressure in each group will be observed and compared||||
1305277|NCT03527550|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1305318|NCT03527017|||Other||Cross-Sectional|||||||
1305319|NCT03527004|||Other||Cross-Sectional|||||||
1305278|NCT03527537|Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a randomized, controlled trial of 284 women with a diagnosis of GDM. Women will be consented and randomized at the time of their diagnosis. All women with GDM will receive counseling regarding diet and exercise and instructions on self-monitoring blood glucose values. The investigators will apply cutoffs of 95 mg/dL for fasting and 120 mg/dL for 2-hour post-prandial levels. Once randomized, the first treatment arm will be assigned to a limit of 20% abnormal values before we start treatment and to titrate up dosages as needed, while using the 20% threshold of abnormal CBG values at each subsequent review of glucose log. To specify, if more than 20% of values for the week are elevated, treatment would be initiated. Once treatment is initiated, the dosage of medication will be adjusted with cutoff of 20% of abnormal values per week. The second treatment arm will utilize the same protocol, however, the limit to start medications or adjust dosages will be 40% abnormal values.||||
1305279|NCT03527524|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1305280|NCT03527511|||Other||Cross-Sectional|||||||
1305281|NCT03527498|Randomized|Parallel Assignment||Prevention||Triple||All subjects were divided into two groups: intervention group A (treadmill intervention + routine physical rehabilitation therapy) and positive control group (receiving routine physical rehabilitation therapy only).||t|t|t
1305282|NCT03527485|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1305283|NCT03527472|Randomized|Parallel Assignment||Treatment||Quadruple||Double-blind, randomized, placebo-controlled|t|t|t|t
1305284|NCT03527459|Non-Randomized|Parallel Assignment||Treatment||Double|Participants are masked as to the treatment arm to which they are assigned. Care providers in the control arm are masked to the interventions being tested in the experimental arm, so as to not inadvertently deliver aspects of SPARC B intervention to the SPARC A group. The outcomes assessor is not collecting primary outcome data, which is self-reported via online survey.|Half of the clients in the SPARC clinical program are enrolled into either the original program or SPARC B (which will overlap significantly with SPARC A but targets in some sessions specific negative cognitions of perceived burdensomeness). The program is already structured so that each patient consistently attends either a morning or an afternoon track, with different therapists running each track. This allows for separate programs in each track. Clinically justifiable innovations are routinely introduced into the program usually in a stepwise fashion in one or another part by one set of therapists at a time. We will assess relative impact of SPARC A and SPARC B on depressive symptoms and suicide ideation. Our investigation will allow us to assess whether this innovation is effective. Patients will not be randomized at the individual level, but rather their time slot (usually decided based on opening within the program) will place them into either SPARC A or SPARC B.|t|t||
1305285|NCT03527446|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Individuals living with obesity (BMI ≥ 30 km/m2; n=15) as well as normal weight (BMI ≥ 18.5 < 25.0 km/m2; n=15) adults (aged between 19 to 60 years) will be recruited to participate in the study. All participants will be asked to come in for a total of two visits and participate in a 4-week intervention.||||
1305286|NCT03527433|Randomized|Parallel Assignment||Treatment||Triple||1:1 ratio|t||t|t
1305287|NCT03527420|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305288|NCT03527407|||Case-Only||Prospective|||||||
1305289|NCT03527394|||Cohort||Prospective|||||||
1305290|NCT03527381|Randomized|Parallel Assignment||Prevention||Triple|Trial participants, data analysts, and report writers are blinded.|Single-center prospective, randomized, placebo-controlled study|t|t||t
1305291|NCT03527368|Randomized|Parallel Assignment||Prevention||Single||||||t
1305292|NCT03527355|Randomized|Parallel Assignment||Prevention||Quadruple|Observer Blinded|Participants age 6-23 months|t|t|t|t
1305293|NCT03527342|||Cohort||Prospective|||||||
1305294|NCT03527329|||Case-Control||Prospective|||||||
1305295|NCT03527316|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1305296|NCT03527303|Randomized|Parallel Assignment||Treatment||Single|Investigator will be blind to condition throughout data accrual.|Randomization to either digital meditation condition or wait-list control.|||t|
1305297|NCT03527290|Randomized|Parallel Assignment||Prevention||Triple|Participants are blinded to the nature of the other intervention so as not to contaminate the intervention. The clinical research staff taking the measurements is also blinded to the respective intervention the participant has been randomized to.||t|t||t
1305298|NCT03527277|Randomized|Parallel Assignment||Basic Science||Single|All outcomes will be analyzed/assessed by subject identity number, which are assigned prior to randomization to experimental arm.|Randomized controlled trial||||t
1305299|NCT03527264|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305300|NCT03527251||Sequential Assignment||Treatment||None (Open Label)||Patients received two doses of intravenous ipilimumab (at a dose of 1 mg per kilogram of body weight) every 3 weeks, following by intravenous SHR-1210 (at a fixed dose of 200mg) every 2 weeks.||||
1305301|NCT03527238|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1305302|NCT03527225|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Consented, eligible female subjects to be randomized to Music or No Music to evaluate pre and post treatment anxiety level via STAI and SDT anxiety questionnaire at their first radiotherapy treatment for cancer."||||
1305303|NCT03527212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305304|NCT03527199|||Case-Only||Prospective|||||||
1305305|NCT03527186||Sequential Assignment||Treatment||None (Open Label)||This is an open-label, 1-sequence study to evaluate the PK, safety, and tolerability of risperidone ISM® in subjects with schizophrenia who are on stable oral risperidone treatment. The study consists of a screening visit, 1 treatment period with inpatient and outpatient visits, and a follow-up visit.||||
1305306|NCT03527173|Randomized|Parallel Assignment||Prevention||Quadruple|Observer-blind The subject, the site and sponsor personnel involved in the clinical evaluation of the subjects are blinded while other study personnel may be aware of the treatment assignment.||t|t|t|t
1305307|NCT03527160|||Cohort||Prospective|||||||
1305308|NCT03527147|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305309|NCT03527134|Randomized|Parallel Assignment||Treatment||Triple||Two groups: one with amantadine treatment and the other with amantadine treatment.|t|t||t
1305310|NCT03527121|Randomized|Parallel Assignment||Treatment||Single||||||t
1305320|NCT03526991||Single Group Assignment||Device Feasibility||None (Open Label)||A total of 10 patients with a diagnosis of Parkinson's disease and treatment refractory freezing of gait will be recruited in this study.||||
1305321|NCT03526978|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1305322|NCT03526965|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305323|NCT03526952|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1305324|NCT03526939|||Cohort||Prospective|||||||
1305325|NCT03526926|||Cohort||Prospective|||||||
1305326|NCT03526913|Randomized|Factorial Assignment||Treatment||Single||Comparison of combined autologous PRP and skin grafting to skin grafting alone in chronic leg ulcers (comparing one ulcer to another in bilateral cases, or one half of ulcer to the other in big ulcers)|t|||
1305327|NCT03526900||Single Group Assignment||Treatment||None (Open Label)||||||
1305328|NCT03526887|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||2 groups depending on when the progression disease is diagnosed but the treatment after progression will be the same: Pembrolizumab||||
1305329|NCT03526874|Randomized|Parallel Assignment||Treatment||Double||Randomized, double-blind greater occipital nerve injection of lidocaine versus saline after open-label lidocaine cream run-in|t||t|
1305330|NCT03526861|Randomized|Parallel Assignment||Treatment||Double|Neither the subject nor any of the investigator or LEO staff who are involved in the treatment or clinical evaluation and monitoring of the subjects will be aware of the treatment received. The packaging and labelling of the investigational medicinal products (IMPs) will contain no evidence of their identity. Since tralokinumab and placebo are visually distinct and not matched for viscosity, IMP will be handled and administered by a qualified, unblinded healthcare professional at the site who will not be involved in the management of trial subjects and who will not perform any of the assessments.||t||t|
1305331|NCT03526848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305332|NCT03526835||Single Group Assignment||Treatment||None (Open Label)||||||
1305333|NCT03526822||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305334|NCT03526809|||Case-Only||Prospective|||||||
1305335|NCT03526796||Single Group Assignment||Treatment||None (Open Label)||||||
1305336|NCT03526783|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305337|NCT03526770|Randomized|Crossover Assignment||Prevention||Single|only primary investigator will know the intervention done by the subject. The outcome investigator(assessor) will be unaware (blinded) to which intervention the subject is undertaken.|||||t
1305338|NCT03526757|Randomized|Parallel Assignment||Screening||Single|Outcomes assessors are masked for subject allocation.|The subjects will be allocated to one of two groups: intervention protocol (high volume of standing Pilates exercises) or control protocol (standard sequence of Pilates exercises).||||t
1305339|NCT03526744|Randomized|Sequential Assignment||Basic Science||Double||A simple open step-up design will be employed with no placebo control, but the sequence will be randomized. Both participant and investigator are blinded for the dose.|t||t|
1305340|NCT03526731|Randomized|Parallel Assignment||Treatment||Double||||t||t
1305341|NCT03526718|||Cohort||Cross-Sectional|||||||
1305342|NCT03526705|||Case-Only||Prospective|||||||
1305343|NCT03526692|Randomized|Parallel Assignment||Prevention||Double||Comparison between three groups : two experimental groups and a control group|t|||t
1305344|NCT03526679||Single Group Assignment||Treatment||None (Open Label)||||||
1305345|NCT03526666|||Case-Only||Prospective|||||||
1305346|NCT03526653|Non-Randomized|Crossover Assignment||Screening||Single||||||t
1305347|NCT03526640|Randomized|Parallel Assignment||Prevention||None (Open Label)||Block randomized design||||
1305348|NCT03526627|||Cohort||Prospective|||||||
1305349|NCT03526614|||Cohort||Prospective|||||||
1305350|NCT03526601|||Cohort||Cross-Sectional|||||||
1305351|NCT03526588||Single Group Assignment||Treatment||None (Open Label)||||||
1305352|NCT03526575|Randomized|Crossover Assignment||Supportive Care||Triple||Experiment 1 will involve N=14 subjects randomized to placebo , 10 mg Zolpidem (Ambien) and 10 mg Zaleplon (Sonata) in counterbalanced order and will be awakened 90 min. post-placebo administration (half at 60 min and half at 90 min). The latter will be done to maintain some degree of blinding relative to the participants knowledge of conditions and the staff working on the protocol. Females and those subjects who have had a previous adverse experience with 10 mg zolpidem will be placed into Experiment 2, which will involve N=20 subjects randomized to placebo , 5 mg zolpidem and 10 mg zaleplon. Experiment 1 and 2 will provide data on zaleplon 10 mg compared to placebo on a total of 34 subjects consisting of astronauts and other subjects considered analogous to the astronaut population, which will provide the larger sample needed to identify those subjects who have cognitive performance deficits on abrupt awakening to the less sedating 10 mg zaleplon.|t||t|t
1305353|NCT03526562||Single Group Assignment||Treatment||None (Open Label)||phase I study with an exercise prescription as intervention||||
1305354|NCT03526549||Single Group Assignment||Treatment||None (Open Label)||||||
1305355|NCT03526536|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305356|NCT03526523|Randomized|Parallel Assignment||Prevention||Single|The staff member who will be assessing for the presence of major depressive disorder in the follow-up period (in cases where a participant's CES-D score is 16 or greater) will be unaware of the participant's treatment assignment.|A stratified randomization method will be used to balance the number of baseline stressful life events in each treatment group (<3 vs. 3+ in the last 6 months). Randomization will be performed once baseline stressful life events are determined.||||t
1305357|NCT03526510|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Trial||||
1305358|NCT03526497|||Cohort||Prospective|||||||
1305359|NCT03526484|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1305360|NCT03526471||Single Group Assignment||Prevention||None (Open Label)||||||
1305361|NCT03526458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305362|NCT03526445|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1305363|NCT03526432||Single Group Assignment||Treatment||None (Open Label)||||||
1305364|NCT03526419|||Cohort||Prospective|||||||
1305415|NCT03525756|||Cohort||Prospective|||||||
1305365|NCT03526406|Randomized|Parallel Assignment||Basic Science||Triple||Acute on chronic|t||t|t
1305366|NCT03526393||Single Group Assignment||Other||None (Open Label)||||||
1305367|NCT03526380|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1305368|NCT03526367|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305369|NCT03526354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305370|NCT03526341|||Other||Retrospective|||||||
1305371|NCT03526328|||Other||Prospective|||||||
1305372|NCT03526315|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a randomized controlled trial involving 127 children ages between 4 and 5 years. They will be examined and chosen randomly for the study. One hundred and twenty seven children will be divided equally into three groups: Group 1 will use CPP-ACP twice daily, Group 2 will apply fluoride toothpaste twice daily, Group 3 will apply fluoridated toothpaste and CPP-ACP twice daily. Oral swabs will be collected from children to measure MS levels in terms of (CFU) using Saliva Check Mutans kits ( GC, Asia) for this purpose. Samples will be analyzed for MS colonization before antibacterial agent application (baseline) and at 3, and 6 month intervals.||||
1305373|NCT03526302|||Cohort||Prospective|||||||
1305374|NCT03526289|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1305375|NCT03526276|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a randomized controlled trial involving 118 children ages between 4 and 5 years. They will be examined and chosen randomly for the study. Children will be divided equally into three groups: Group 1 will use CPP-ACP twice daily, Group 2 will apply fluoridated toothpaste twice daily, Group 3 will apply fluoridated toothpaste and CPP-ACP twice daily. Quantitative assessment of white spot lesions will be carried out using QLF before remineralizing agent application (baseline) and at 3, and 6 month intervals.||||
1305376|NCT03526263||Single Group Assignment||Treatment||None (Open Label)||||||
1305377|NCT03526250||Single Group Assignment||Treatment||None (Open Label)||||||
1305378|NCT03526237|Randomized|Crossover Assignment||Prevention||Double||||t||t
1305379|NCT03526224|||Case-Control||Retrospective|||||||
1305380|NCT03526211||Single Group Assignment||Other||None (Open Label)||||||
1305381|NCT03526198|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1305382|NCT03526185||Single Group Assignment||Treatment||None (Open Label)||||||
1305383|NCT03526172|||Cohort||Prospective|||||||
1305384|NCT03526159||Single Group Assignment||Treatment||None (Open Label)||||||
1305385|NCT03526146|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Study participants will be randomly assigned to receive the PLIE intervention program (1 hour, 2 days/week, 4 months) or Usual Care (UC) control (standard senior center activities, 1 hour, 2 days/week, 4 months) (N=40, 20/group) using a wait-list design. After 4 months, the groups will cross-over. The UC group will receive the PLIE intervention while the first PLIE group will participate in standard senior center activities for 4 months.||||
1305386|NCT03526133|||Cohort||Prospective|||||||
1305387|NCT03526120|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Two parallel groups according a block randomization stratified on habitual energy intake and initial body weight (as in http://www.consort-statement.org/checklists/view/32--consort-2010/87-randomisation-type, § 8B). Randomisation: type).||||
1305388|NCT03526107|Randomized|Crossover Assignment||Basic Science||Quadruple||Dietary intervention study in healthy young adult males|t|t|t|t
1305389|NCT03526094|Randomized|Crossover Assignment||Basic Science||Single|Investigator processing samples and performing statistical analyses|Cross-over dietary intervention study in healthy young adult males|||t|
1305390|NCT03526081|Non-Randomized|Crossover Assignment||Basic Science||Single|Investigator doing data analysis and statistical analyses|Cross-over dietary intervention study in healthy young adult males|||t|
1305391|NCT03526068||Single Group Assignment||Treatment||None (Open Label)||||||
1305392|NCT03526055|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1305393|NCT03526042|Randomized|Parallel Assignment||Prevention||None (Open Label)||Open randomized clinical trial with parallel group comparing AT1R-ab blockade with losartan and enalapril as a control group.||||
1305394|NCT03526029|||Cohort||Other|||||||
1305395|NCT03526016|||Cohort||Prospective|||||||
1305396|NCT03526003|||Cohort||Prospective|||||||
1305397|NCT03525990|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305398|NCT03525977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305399|NCT03525964|Randomized|Parallel Assignment||Treatment||Single|The posterior site of the achilles tendon region is covered by dark tape during the functional assesments.|Prospective||||t
1305400|NCT03525951|Non-Randomized|Parallel Assignment||Treatment||Single|The research team members doing the language sample analysis and behavioral coding will be blind to group membership and whether the session was recorded pre-test vs. posttest.|Participants in three groups (caregivers and typically developing children, children with developmental language disorder, and children with autism) will all receive the same parent training intervention.||||t
1305401|NCT03525938|Randomized|Parallel Assignment||Treatment||Single||||||t
1305402|NCT03525925||Single Group Assignment||Treatment||None (Open Label)||||||
1305403|NCT03525912||Single Group Assignment||Treatment||None (Open Label)||single group assignment interventional||||
1305404|NCT03525899|||Case-Only||Retrospective|||||||
1305405|NCT03525886|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1305406|NCT03525873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305407|NCT03525860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305408|NCT03525847|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1305409|NCT03525834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Single arm, open label||||
1305410|NCT03525821||Single Group Assignment||Treatment||None (Open Label)||||||
1305411|NCT03525808||Single Group Assignment||Treatment||None (Open Label)||||||
1305412|NCT03525795||Single Group Assignment||Treatment||None (Open Label)||||||
1305413|NCT03525782|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305414|NCT03525769|||Cohort||Prospective|||||||
1305416|NCT03525743|||Cohort||Prospective|||||||
1305417|NCT03525730|Randomized|Parallel Assignment||Treatment||None (Open Label)||6 week study, including 2 week intervention and 4 week post-treatment period.||||
1305418|NCT03525717|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1305419|NCT03525704||||||||||||
1305420|NCT03525691|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1305421|NCT03525678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305422|NCT03525665|||Cohort||Retrospective|||||||
1305423|NCT03525652|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305424|NCT03525639||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305425|NCT03525626||Single Group Assignment||Other||None (Open Label)||||||
1305426|NCT03525613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305427|NCT03525600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305428|NCT03525587|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||"Patients with a previous documented AGHD fitting the inclusion/exclusion criteria will be enrolled and grouped as follows:~Group 1: patients on long-term r-hGH therapy;~Group 2: patients previously treated with r-hGH, who had stopped the treatment for any reason (age, concomitant adverse reactions, contraindications or personal will);~Group 3: patients never treated for any reason (according to age, contraindications or lack of patient's consent).~The whole cohort of AGHD patients (n=100) will undergo 2 consecutive phases: in the first phase (12 months) patients will be evaluated as usual every six months according to our standard clinical practice without using the App and the wearable device (baseline visit, visit 1 and visit 2), while in the second phase (following 12 months) they will be evaluated every six months during the use of the App (visit 3 and visit 4)."||||
1305429|NCT03525574||Single Group Assignment||Treatment||None (Open Label)||||||
1305430|NCT03525561|Randomized|Crossover Assignment||Basic Science||Single|Single-blind use of acetazolamide where participant is not informed. Goal is to evaluate effect (or lack thereof) on exercise performance.|Subjects will serve as their own controls. Will exercise during simulated altitude exposure twice, once with acetazolamide and once with placebo.|t|||
1305431|NCT03525548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305432|NCT03525535|||Cohort||Prospective|||||||
1305433|NCT03525522|Randomized|Parallel Assignment||Treatment||Single|Hystology and photographic assessment performed by independant investigators unaware of the assignement.|Patients assigned randomly to two groups: laser-treatment group and topical-corticosteroid group.||||t
1305434|NCT03525509|Randomized|Crossover Assignment||Treatment||Triple|At enrollment, each participant will be assigned a study number, which will match a previously prepared computer-generated list of randomization numbers to determine the interventions. Pharmacy staff who prepares blinded syringes of medications for administration will not be involved in medication administration, outcomes assessment, or statistical analysis. The participants and all other study personnel will be blinded to the treatment allocation.|Randomized, double-blinded, crossover design in healthy volunteers|t||t|t
1305435|NCT03525496|||Cohort||Retrospective|||||||
1305436|NCT03525483||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305437|NCT03525470|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Cross-over design where on one occasion subjects lost 0.5% body weight,and drank 300ml water and on another occasion nothing was consumed||||
1305438|NCT03525457||Single Group Assignment||Treatment||None (Open Label)||||||
1305439|NCT03525444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305440|NCT03525431||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305441|NCT03525418|Randomized|Parallel Assignment||Treatment||Double|Phase 1: no masking. Phase 2: HLHS patients which will be randomized to the treatment and control arms in a 1:1 ratio|"Phase 1: 10 patient safety run-in: all patients treated with LMSCs during Stage II surgery.~Phase 2: 20 patients randomized 1:1 to receive either LMSCs or no cells (controls) during Stage II surgery."|t||t|
1305442|NCT03525405||Single Group Assignment||Treatment||None (Open Label)||||||
1305443|NCT03525392||Single Group Assignment||Treatment||None (Open Label)||||||
1305444|NCT03525379|Randomized|Sequential Assignment||Diagnostic||Double|The randomization codes will be maintained in REDCap. The principal investigator will have authority to unblind patients if safety concerns arise.|"After providing written informed consent, patients who qualify will be randomized via the web-based system coordinated by Research Electronic Data Capture (REDCap) at the University of Alberta. A patient's eligibility will be confirmed and a unique identifier will be assigned.~Blinding of the patients and study personnel is preserved by using matching placebo capsules. Clinical outcomes will be adjudicated by a Clinical Events Committee, and core laboratories will assess the CMR measures and biomarkers independently and blinded to treatment assignment."|t|t||
1305445|NCT03525366|||Case-Only||Cross-Sectional|||||||
1305446|NCT03525353|||Case-Only||Retrospective|||||||
1305447|NCT03525340|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Participants will be randomly assigned 2:1 to intervention group with peer navigation or standard of care||||
1305448|NCT03525327|||Cohort||Retrospective|||||||
1305449|NCT03525314|||Cohort||Prospective|||||||
1305450|NCT03525301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305451|NCT03525288|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients are randomly selected from a standard-care cohort.||||
1305452|NCT03525275|Randomized|Parallel Assignment||Treatment||None (Open Label)||2 x 5 Mixed model ANOVA||||
1305453|NCT03525262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305454|NCT03525249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305455|NCT03525236||Single Group Assignment||Supportive Care||None (Open Label)||||||
1305456|NCT03525223|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1305457|NCT03525210|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305458|NCT03525197|Randomized|Parallel Assignment||Other||Double|Each subject's supplement is coded with a different number, and neither the researchers nor the subjects are aware of the condition the subject is placed in.|Parallel group design (with repeated measurements within each group)|t||t|
1306207|NCT03515447|||Case-Only||Retrospective|||||||
1305459|NCT03525184|Non-Randomized|Crossover Assignment||Basic Science||Single||Participants will undergo the study during normal sleep, sleep restriction without the multi-nutrient beverage and sleep restriction with the multi-nutrient beverage|t|||
1305460|NCT03525171|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||We prospectively studied 23 prepubertal children with GH deficiency treated with GH for at least 12 months and 12 healthy subjects with short stature, matched for age and pubertal status||||
1305461|NCT03525158|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Single case experimental AB design with or without optional replication (ABAB)||||
1305462|NCT03525145|||Cohort||Prospective|||||||
1305463|NCT03525132|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305464|NCT03525119|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1305465|NCT03525106|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305466|NCT03525093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305467|NCT03525080||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305468|NCT03525067|||Cohort||Prospective|||||||
1305469|NCT03525054|||Cohort||Prospective|||||||
1305470|NCT03525041|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305471|NCT03525028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305472|NCT03525015|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1305473|NCT03525002|Randomized|Parallel Assignment||Treatment||Triple|double-blind||t|t|t|
1305474|NCT03524989|Randomized|Crossover Assignment||Treatment||Quadruple||Randomized blinded controlled 2 groups with SHAM treatment|t|t|t|t
1305475|NCT03524976|||Cohort||Prospective|||||||
1305476|NCT03524963|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1305477|NCT03524950|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1305478|NCT03524937|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1305479|NCT03524924|||Cohort||Prospective|||||||
1305480|NCT03524911||Single Group Assignment||Prevention||None (Open Label)||Delayed intervention||||
1305481|NCT03524898||Single Group Assignment||Treatment||None (Open Label)||This is a single-arm phase Ib/IIa multi-center study in patients with locally advanced or metastatic soft tissue sarcoma who have received first line or second line chemotherapy with no response or with evidence of disease progression.||||
1305482|NCT03524885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305483|NCT03524872|Randomized|Parallel Assignment||Treatment||Quadruple|The devices will have the same shape and will be delivered to the surgeon unlabeled in an identical sterile envelope.||t|t|t|t
1305484|NCT03524859|||Case-Control||Cross-Sectional|||||||
1305485|NCT03524846|Randomized|Parallel Assignment||Treatment||None (Open Label)||This was a prospective randomized, single-blind, placebo-controlled study||||
1305486|NCT03524833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||20 participants receive intraluminal eradication of H. pylori. Patients fail to achieve intraluminal eradication of H. pylori will be assigned to the oral antibiotic rescue therapies with triple therapy which contains a proton pump inhibitor and two antibiotics (amoxicillin, and metronidazole) for 14 days.||||
1305487|NCT03524820||Single Group Assignment||Treatment||None (Open Label)||||||
1305488|NCT03524807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305489|NCT03524794|||Cohort||Prospective|||||||
1305490|NCT03524781|||Cohort||Prospective|||||||
1305491|NCT03524768|||Cohort||Prospective|||||||
1305492|NCT03524755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305493|NCT03524742|Randomized|Parallel Assignment||Other||Single|open-label, blinded outcome assessment|Academic, open-label, blinded outcome assessment (PROBE design), clinical trial.||||t
1305494|NCT03524729|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)|No masking|"The osteoarthritis participants will wear the control shoe, rocker bottom shoe, and AFO for multiple weeks each. The order of the treatments (control shoe, rocker bottom shoe, and AFO) will be randomize.~The control group will only wear the control shoe."||||
1305495|NCT03524716|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305496|NCT03524703|Randomized|Parallel Assignment||Treatment||Single||||||t
1305497|NCT03524690|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Randomized, cross-over controlled trial||||
1305498|NCT03524677|||Cohort||Prospective|||||||
1305499|NCT03524664|Randomized|Parallel Assignment||Treatment||Single||||||t
1305500|NCT03524651|Randomized|Parallel Assignment||Treatment||Double|Double blind|Double-dummy, blind, randomized, phase IV clinical trial|t||t|
1305501|NCT03524638|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305502|NCT03524625|||Other||Other|||||||
1305503|NCT03524612||Single Group Assignment||Treatment||None (Open Label)||||||
1305504|NCT03524599|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305505|NCT03524586|Randomized|Parallel Assignment||Screening||Single||||||t
1305506|NCT03524573|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to the intervention.|Randomized Controlled Trial||||t
1305507|NCT03524560|||Other||Cross-Sectional|||||||
1305508|NCT03524547|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1305509|NCT03524534|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305510|NCT03524521|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305511|NCT03524508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305512|NCT03524482|Randomized|Parallel Assignment||Prevention||None (Open Label)||We will conduct a 2-arm semi-pragmatic randomized design among current tobacco users (N=100). CMHA residents will be randomly assigned to receive (1) the newly translated Path2Quit or (2) SmokeFreeText (NCI's publicly available, standard text messaging program) combined with brief behavioral counseling session plus 2 weeks of nicotine replacement therapy (NRT).||||
1305513|NCT03524469|||Cohort||Prospective|||||||
1305514|NCT03524456|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305515|NCT03524443|||Cohort||Prospective|||||||
1305516|NCT03524430||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305517|NCT03524417||Single Group Assignment||Treatment||None (Open Label)||||||
1305518|NCT03524404||Single Group Assignment||Prevention||None (Open Label)||||||
1305519|NCT03524391|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305520|NCT03524378||Single Group Assignment||Treatment||None (Open Label)||||||
1305521|NCT03524365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305522|NCT03524352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305523|NCT03524339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305524|NCT03524326||Single Group Assignment||Treatment||None (Open Label)||||||
1305525|NCT03524313|||Cohort||Prospective|||||||
1305526|NCT03524300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305527|NCT03524287||Single Group Assignment||Treatment||None (Open Label)||||||
1305528|NCT03524274|Randomized|Parallel Assignment||Treatment||Quadruple|With the method of minimum randomized dynamic random by the interactive network response system (IWRS),Participants were assigned to three groups,receive cryotherapy,conventional therapy, and activated CIK armed with anti-CD3-MUC1 bispecific antibody together with cryotherapy .every participant has a unique identification number and emergency letter which have the information of group.|This is a phase II clinical trial of single-center, and it will divide into three groups.|t|t|t|t
1305529|NCT03524261|Randomized|Parallel Assignment||Treatment||Quadruple|With the method of minimum randomized dynamic random by the interactive network response system (IWRS),Participants were assigned to three groups,receive cryotherapy,conventional therapy, and activated CIK armed with anti-CD3-MUC1 bispecific antibody together with cryotherapy .every participant has a unique identification number and emergency letter which have the information of group.|This is a phase II clinical trial of single-center, and it will divide into three groups.|t|t|t|t
1305530|NCT03524248||Single Group Assignment||Treatment||None (Open Label)||||||
1305531|NCT03524235|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305532|NCT03524222||Single Group Assignment||Treatment||None (Open Label)||||||
1305533|NCT03524209|Randomized|Parallel Assignment||Other||None (Open Label)||"A prospective selection of patients with pyogenic spondylitis fulfilling above mentioned inclusion criteria is performed with subsequent randomization into treatment group 1 versus treatment group 2 after informed consent. Group1 are patients treated by minimally invasive surgery and group 2 are patients treated by thoracolumbar brace.~Radiologic deformity assessment is performed on lateral thoracolumbar radiographs in standing position. A modified sagittal index measuring the angulation between cranial endplate of cranial vertebra and caudal endplate of the caudal vertebra as this parameter is normalized to 0°.~Assessment of osteolysis at vertebral bodies on CT expressed as a ratio of vertebral body height in the mid-sagittal plane in comparison to non-infected vertebral bodies adjacent to the index level. Assessment of complete fusion, partial fusion, pseudarthrosis is performed on CT at 1-year FU.~Type and length of antibiotic treatment"||||
1305534|NCT03524196||Single Group Assignment||Other||None (Open Label)||||||
1305535|NCT03524183|Randomized|Parallel Assignment||Prevention||Single|The unit of randomization (control vs. treatment) is at the school level. Participants at each school will be masked of the other schools' assigned condition.|The efficacy of the VFB Ecosystem will be tested using a cluster randomized trial with repeated measures at baseline, posttest (immediately after 3-month intervention), mid-term follow up (6 months post intervention), and a long-term follow up (12 months post intervention). A 3-month intervention period was selected to observe variance in engagement over the course of an academic semester in the afterschool programs. A cluster randomized design is indicated when outcomes are tracked at a group level (afterschool programs) instead of at the individual level (children) and is the preferred method to reduce the impact of dependency in the data. From a pool of 24 demographically matched afterschool programs, we will randomly assign pairs to either receive the Ecosystem or physical activity as usual. Outcomes will be modeled and expressed as changes occurring at the afterschool program level--the unit of randomization.|t|||
1305536|NCT03524170||Single Group Assignment||Treatment||None (Open Label)||||||
1305537|NCT03524157|Randomized|Parallel Assignment||Treatment||Triple|"Blinding It will consist in the elimination of the primary label (commercial) in the case of Xyel Ofteno® and Systane Ultra® and the placement of a label identical to the other interventions. Because the bottle in which Systane Ultra® is packaged differs in the color and shape of the lid used by Xyel Ofteno® and PRO-087, a masking will be carried out on the primary packaging which will be identical for the three interventions.The allocation sequence will be generated by personnel assigned. The research center will receive a set of envelopes which will contain the intervention number individually. The envelopes will be identical on the outside. Each of these envelopes will be shown to the participants for their election by the principal investigator or by a designated member of their team.~The blinding will correspond to the research subject and the principal investigator. In addition, the statistical analysis will be carried out in a blinded manner for the all analysis."|Phase I clinical trial, controlled, of parallel groups, double blind, randomized, exploratory.|t||t|t
1305538|NCT03524144||Sequential Assignment||Other||None (Open Label)||||||
1305539|NCT03524131|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305540|NCT03524118|Randomized|Sequential Assignment||Prevention||Triple||Single ascending dose|t|t|t|
1305541|NCT03524105|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1305542|NCT03524092|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305543|NCT03524079|||Cohort||Prospective|||||||
1305544|NCT03524066|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1305545|NCT03524053|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Patients will undertake 3 separate conditions in a randomised order.||||
1305546|NCT03524040|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1305547|NCT03524027||Single Group Assignment||Treatment||None (Open Label)||||||
1305548|NCT03524014|||Case-Control||Prospective|||||||
1305549|NCT03524001|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1305593|NCT03523429||Single Group Assignment||Treatment||None (Open Label)||||||
1305594|NCT03523416||||||||||||
1306809|NCT03507621|||Case-Control||Prospective|||||||
1305550|NCT03523988|Randomized|Parallel Assignment||Treatment||Triple|"The medications were prepared by the Kelley-Ross Compounding Group (Seattle, WA) and were identical in appearance. The bottles were labeled as A, B, or C and the identity of the medications were not revealed until after the data analysis was completed."|Patients of the University of Washington Graduate Orthodontics Clinic|t|t|t|
1305551|NCT03523975||Single Group Assignment||Treatment||None (Open Label)||||||
1305552|NCT03523962|Randomized|Crossover Assignment||Treatment||Single|The orthopaedic team (including the study coordinators) cannot be blinded to the treatment allocation as the antiseptic solutions are visually distinguishable and these individuals need to lead the implementation of the cluster-crossover protocol at their clinical site. The Adjudication Committee Members and data analysts will be blinded to the study treatment. All interpretation of study results will initially be done in a blinded manner by developing two interpretations of the results. One interpretation will assume treatment A is iodine povacrylex, the other interpretation will assume it is CHG. Once the data interpretations for each assumption are finalized, the data will be unblinded and the correct interpretation will be accepted.|Treatment allocation will be determined using a cluster-randomized crossover trial design. The open and closed fracture populations will be treated with the same allocated solution at all times during the trial. The order of treatment allocation for each orthopaedic practice will be randomly assigned using a computer-generated randomization table. Each site will start with the initially allocated study solution and eventually crossover to the other solution for their second recruitment period. This process of alternating treatments will repeat approximately every 2 months as dictated by the initial randomization.||||t
1305553|NCT03523949||Single Group Assignment||Other||None (Open Label)||||||
1305554|NCT03523936|Randomized|Parallel Assignment||Prevention||Single||Double blind placebo controlled trial|||t|
1305555|NCT03523923|Randomized|Parallel Assignment||Treatment||Single|This study uses masked outcome assessments; research staff members who collect outcome data from participants at 4 and 8 months must be unaware of participants' treatment group allocation.|Randomized, 1:1 controlled trial effectiveness study comparing Collaborative Care (CC) to usual care (UC) to reduce pain interference among outpatients in our UW Medicine TBI clinics who have chronic pain, including headache, and meet other eligibility criteria.||||t
1305556|NCT03523910||Single Group Assignment||Diagnostic||None (Open Label)||Single center, open label, single-arm||||
1305557|NCT03523897|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1305558|NCT03523884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305559|NCT03523871||Single Group Assignment||Treatment||None (Open Label)||||||
1305560|NCT03523858|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1305561|NCT03523845|||Case-Control||Other|||||||
1305562|NCT03523832|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1305563|NCT03523819||Single Group Assignment||Treatment||None (Open Label)||||||
1305564|NCT03523806|Randomized|Parallel Assignment||Other||Double|||||t|t
1305565|NCT03523793|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||cross-sectional stepped wedge design||||
1305566|NCT03523780|||Other||Retrospective|||||||
1305567|NCT03523767|Randomized|Crossover Assignment||Basic Science||Double|The study clinician/ nurse will be aware of the nature of the injection. The study subjects and researcher collecting/analyzing the data will remain blinded to the intervention due to the possible confounding effects of the participant expectations and researcher analyzing the data.|In this double blind crossover design, each participant will receive saline injection or typhoid vaccine injection at the first study visit, and will then receive the other injection at the second study visit.|t|||t
1305568|NCT03523754|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Primigravida.~From 20 to 30 years old.~Singleton term (between 40 to 42 weeks of gestation).~Good general condition with straightforward enthusiasm for the trial."||||
1305569|NCT03523741|||Case-Only||Prospective|||||||
1305570|NCT03523728|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1305571|NCT03523715|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305572|NCT03523702|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305573|NCT03523689|||Cohort||Prospective|||||||
1305574|NCT03523676|||Cohort||Retrospective|||||||
1305575|NCT03523663|||Cohort||Cross-Sectional|||||||
1305576|NCT03523650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305577|NCT03523637||Single Group Assignment||Treatment||None (Open Label)||Replicated experimental case series, also called replicated single-subject design or replicated single-case research design.||||
1305578|NCT03523624|||Cohort||Prospective|||||||
1305579|NCT03523611|||Cohort||Prospective|||||||
1305580|NCT03523598|Randomized|Parallel Assignment||Treatment||None (Open Label)|Triple (Participant, Investigator, Outcomes Assessor)|||||
1305581|NCT03523585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305582|NCT03523572|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Part 1 will be a sequential dose-finding (dose escalation) study, Part 2 will consist of a single group of four cohorts who receive the recommended dose (determined during Part 1)||||
1305583|NCT03523559|||Case-Control||Prospective|||||||
1305584|NCT03523546|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1305585|NCT03523533||Single Group Assignment||Other||None (Open Label)||This is an observational study.||||
1305586|NCT03523520|Randomized|Parallel Assignment||Treatment||Triple|Each participant will be receiving one injection and tablets which have been randomly assigned.|Participants will be assigned to one of three groups i. Methylnaltrexone oral tablets (total 450 mg) + subcutaneous water injection ii. Methylnaltrexone 12mg subcutaneous injection + placebo sugar tablets iii. Naloxegol oral tablets (total 25 mg) + subcutaneous water injection|t|t|t|
1305587|NCT03523507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305588|NCT03523494|||Cohort||Retrospective|||||||
1305589|NCT03523481|||Cohort||Retrospective|||||||
1305590|NCT03523468|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1305591|NCT03523455|Randomized|Parallel Assignment||Other||Double||Two groups: placebo, 30mg dose|t||t|
1305592|NCT03523442||Single Group Assignment||Treatment||None (Open Label)||||||
1305595|NCT03523403|Randomized|Parallel Assignment||Basic Science||Single||All 60 participants will participate in the Chronic phase of the study, which will follow a randomized, controlled, parallel-arm design to investigate the effects of consuming 3 apples per day for 6 weeks. 30 of those 60 participants will also participate in the Acute phase of the study, which will follow a randomized, crossover design to investigate the effects of eating 3 apples in addition to a high-fat meal in one sitting.||||t
1305596|NCT03523390||Sequential Assignment||Treatment||None (Open Label)||Subsequent cohorts of subjects treated at different dose levels in this study.||||
1305597|NCT03523377||Single Group Assignment||Prevention||None (Open Label)||The OnFACT study is a single-arm trial of prolonged overnight fasting among 50 overweight or obese adult survivors of childhood cancer followed in the Memorial Sloan Kettering Adult Long Term Follow Up Program.||||
1305598|NCT03523364|||Cohort||Retrospective|||||||
1305599|NCT03523351|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||In this trial patients will be divided into 2 cohorts. Patients in Cohort 1 will undergo standard of care therapy for bone metastases. Patients in Cohort 2 will undergo upfront RT to ≤5 highest risk bone metastases first followed by standard of care therapy.||||
1305600|NCT03523338||Single Group Assignment||Treatment||None (Open Label)||||||
1305601|NCT03523325||Single Group Assignment||Treatment||None (Open Label)||One intervention with comparison between males and females||||
1305602|NCT03523312||Single Group Assignment||Treatment||None (Open Label)||This phase II trial.||||
1305603|NCT03523299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305604|NCT03523286||Single Group Assignment||Treatment||None (Open Label)||||||
1305605|NCT03523273|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1305606|NCT03523260|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1305607|NCT03523247||Single Group Assignment||Treatment||None (Open Label)||||||
1305608|NCT03523234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305609|NCT03523221|Randomized|Parallel Assignment||Treatment||Single|||||t|
1305610|NCT03523208||||||||||||
1305611|NCT03523195|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1305612|NCT03523182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305613|NCT03523169|||Cohort||Prospective|||||||
1305614|NCT03523156|Randomized|Parallel Assignment||Treatment||None (Open Label)||Sixty-four kebeles (sub-districts) of Amhara will be randomized to receive annual mass treatment or annual mass treatment plus targeted treatment. One gott (village) per kebele will be selected and 50 children from each gott will be randomly selected.||||
1305615|NCT03523143|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305616|NCT03523130|||Cohort||Prospective|||||||
1305617|NCT03523117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305618|NCT03523104|||Cohort||Prospective|||||||
1305619|NCT03523091|Randomized|Parallel Assignment||Treatment||Single||2 arm parallel study with 1 to 1 randomization|t|||
1305620|NCT03523078|||Cohort||Prospective|||||||
1305621|NCT03523065|||Cohort||Prospective|||||||
1305622|NCT03523052|||Cohort||Prospective|||||||
1305623|NCT03523039|Randomized|Parallel Assignment||Treatment||Single||||||t
1305624|NCT03523026|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305625|NCT03523013|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1305626|NCT03523000|Randomized|Crossover Assignment||Treatment||Triple|The drugs will be delivered by the pharmacy to a blinded physician and labeled as Intrathecal solution 1 and Intrathecal solution 2 to be administered sequentially, separated by a 4-6-hr infusion of preservative-free saline. The content of Intrathecal solution 1 and 2 will be unknown to all investigators and participants in the study with the exception of the investigational pharmacy. The order of the Intrathecal solution (1 or 2) will be determined by pharmacy using a computer generated random sequence allocation.|"Patients who are considered candidates for intrathecal pump implant fulfilling the inclusion/exclusion criteria and who elect to participate in the study will be randomly assigned to two groups:~Group A tested with continuous infusion of intrathecal bupivacaine 0.625 mg/ml and fentanyl 1 mcg/ml for 14-18 hours followed by a trial with normal saline for another 14-18 hours; separated by a 4-6-hr infusion of preservative-free saline.~Group B tested with intrathecal normal saline for 14-18 hours followed by intrathecal Bupivacaine 0.625 mg/ml and fentanyl 1 mcg/ml for another 14-18 hours; separated by a 4-6-hr infusion of preservative-free saline."|t|t|t|
1305627|NCT03522987||Single Group Assignment||Treatment||None (Open Label)||Epileptologist-driven medication treatment intervention for anxiety and depression, carried out directly in the epilepsy clinic during a regularly scheduled visit and supported by advanced practice provider (APP).||||
1305628|NCT03522974|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1305629|NCT03522961|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1305630|NCT03522948||Single Group Assignment||Prevention||None (Open Label)||Open pilot study to test feasibility of intervention||||
1305631|NCT03522935|Randomized|Sequential Assignment||Treatment||Double|||t|t||
1305632|NCT03522922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305633|NCT03522909|||Cohort||Retrospective|||||||
1305634|NCT03522896|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1305635|NCT03522883|Randomized|Parallel Assignment||Screening||Double|||t|||t
1305636|NCT03522870|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305637|NCT03522857|||Cohort||Cross-Sectional|||||||
1305638|NCT03522844|Randomized|Parallel Assignment||Treatment||Single||Participants will be randomized to receive one of two treatments over the course of 8-weeks. One group will participate in an 8-week Mindfulness-Based Stress Reduction Course and the other group will receive a daily medication treatment (escitalopram).||||t
1305639|NCT03522831|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1305640|NCT03522818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305641|NCT03522805||Single Group Assignment||Treatment||None (Open Label)||||||
1305684|NCT03522246|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind||t|t|t|t
1305685|NCT03522233|||Cohort||Prospective|||||||
1305642|NCT03522792|Randomized|Crossover Assignment||Basic Science||Triple|Participants will not be informed of the nature of the infusion they are administered on any of the study days. The investigator will be provided with an infusion (either isotonic saline with HSA or isotonic salin with HSA + neurotensin) prepared by a designated colleague|Participants will be studied on multiple occasions (5 days) in a randomised and double blinded fashion. One day will serve as an acclimatization day.|t||t|t
1305643|NCT03522779|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1305644|NCT03522766|||Cohort||Prospective|||||||
1305645|NCT03522753|Randomized|Parallel Assignment||Other||Quadruple|"The resident/fellow performing closure will know what has been done for their patient, but blinded to other participants. Splints or other dressings will cover the closure. Patients will be physically blinded (i.e. eye cover) during the removal procedure. Patients and observers will assess scar appearance. Observers are the blinded surgeon or other blinded medical personnel (nurse, research assistant, CRNP, or resident/fellow who was not involved)."||t|t|t|t
1305646|NCT03522740|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305647|NCT03522727|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1305648|NCT03522714|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 allocation ratio||||
1305649|NCT03522701|Randomized|Parallel Assignment||Treatment||Single||A randomised, assessor-blind, parallel group controlled trial||||t
1305650|NCT03522688|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1305651|NCT03522675||||||||||||
1305652|NCT03522662||Single Group Assignment||Treatment||None (Open Label)||||||
1305653|NCT03522649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305654|NCT03522636|||Case-Control||Prospective|||||||
1305655|NCT03522623|||Cohort||Cross-Sectional|||||||
1305656|NCT03522610|Randomized|Parallel Assignment||Prevention||Double||This study is a two-group randomized controlled effectiveness trial with baseline and three follow-up assessment points|||t|t
1305657|NCT03522597|||Cohort||Prospective|||||||
1305658|NCT03522584||Single Group Assignment||Treatment||None (Open Label)||||||
1305659|NCT03522571|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1305660|NCT03522558|Randomized|Parallel Assignment||Treatment||Single||||||t
1305661|NCT03522545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305662|NCT03522532|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"According to Black's Classification Criteria, patients were classified into four groups (K2 - K5). The number of patients within those groups were as follows: K2 (n=58), K3 (n=10), K4 (n=6) and K5 (n=14).~Six different DMs were used in this study. The type of DM to be used for each patient was determined in relation to the dental lesion degree. DM placement was performed in one session and only one type was used per patient. Accordingly, 6 groups (arms) of dental patients (Amg, ZnPhC, ZnPoC, GIC, TEC and BF) were formed.~Parameters of OS (MDA, GSH and tSOD) were measured in the GCF of the patients both before (day 0) and after treatment (on the 7th and 30th day)."||||
1305663|NCT03522519|||Cohort||Prospective|||||||
1305664|NCT03522506|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1305665|NCT03522493|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1305666|NCT03522480|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomly assigned to one of two study groups: A or B. Participants assigned to study group A will be taught by a respiratory therapist how to perform the autogenic drainage technique in week 0, and will be asked to perform the technique regularly on their own for secretion clearance for the first 8 weeks of the study. Beginning in week 8, they will be taught to use autogenic draining technique guided by a videogame through the Jamboxx respiratory therapy device and will be advised to perform the technique regularly using the game for guidance through week 16 Participants in group B will be taught to perform the autogenic draining technique using the Jamboxx respiratory therapy guided by a videogame in week 0, and will be instructed to perform the technique regularly for the next 16 weeks using the game for guidance||||
1305667|NCT03522467||Single Group Assignment||Treatment||None (Open Label)||Prospective, single-arm cohort||||
1305668|NCT03522454|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor who will perform the 3 and 6 month visits will be blinded to the participant's assigned intervention.|||||t
1305669|NCT03522441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305670|NCT03522428|Randomized|Parallel Assignment||Prevention||Single||randomized clinical trial||t||
1305671|NCT03522415|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305672|NCT03522402|Randomized|Parallel Assignment||Other||Double|||t|t||
1305673|NCT03522389|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305674|NCT03522376|||Other||Cross-Sectional|||||||
1305675|NCT03522363|Randomized|Parallel Assignment||Other||None (Open Label)||Phase I, exploratory, prospective, mechanistic pilot clinical trial with two parallel follow-up groups that differ in the number of treament applications.||||
1305676|NCT03522350|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1305677|NCT03522337|Randomized|Parallel Assignment||Prevention||Double|The randomised sequence will be generated by an investigator who does not participate in the outreach service. The allocation sequence will be sealed in an envelope, and opened at the Special Child Care Centres by an assistant. The assistant will be responsible for delivering the materials to children and their parents.|This study is designed as a 24-month randomised, controlled, blind, parallel clinical trial conducted in Special Child Care Centres, aiming to promote oral health among preschool children with special needs.|t|||t
1305678|NCT03522324|||Cohort||Prospective|||||||
1305679|NCT03522311|||Case-Control||Retrospective|||||||
1305680|NCT03522298||Single Group Assignment||Treatment||None (Open Label)||The phase 2a study comprises an open-label, multicenter, phase 2a dose-escalation and expansion study to assess the safety, tolerability, RP2D, PK and clinical activity of GDC 0084 in patients with newly-diagnosed GBM with unmethylated MGMT promoter status as adjuvant therapy following surgical resection and initial chemoradiation with TMZ.||||
1305681|NCT03522285|||Case-Only||Prospective|||||||
1305682|NCT03522272|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1305683|NCT03522259|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305686|NCT03522220|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1305687|NCT03522207|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1305688|NCT03522194|||Cohort||Prospective|||||||
1305689|NCT03522181|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1305690|NCT03522168|||Cohort||Prospective|||||||
1305691|NCT03522155|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This randomized controlled trial will involve two arms: (1) an intervention arm consisting of a patient-centered communication strategy for life expectancy and (2) standard of care treatment counseling. The intervention will be randomized at the level of the patient to balance study arms in terms of measured and unmeasured patient characteristics.||||
1305692|NCT03522142|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305693|NCT03522129|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind for study site and participants|Phase 1b, randomized, double‐blind, placebo‐controlled parallel‐group trial in adults with mild to moderate AD.|t|t|t|t
1305694|NCT03522116|||Cohort||Prospective|||||||
1305695|NCT03522103|||Cohort||Prospective|||||||
1305696|NCT03522090|||Cohort||Retrospective|||||||
1305697|NCT03522077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305698|NCT03522064||Single Group Assignment||Treatment||None (Open Label)||||||
1305699|NCT03522051||Single Group Assignment||Treatment||None (Open Label)||Patients with symptomatic deep caries in a permanent molar tooth will receive pulpotomy treatment and placement of a calcium silicate based material (Neo MTA plus) over the pulp and followed by restoration.||||
1305700|NCT03522038|||Cohort||Prospective|||||||
1305701|NCT03522025|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305702|NCT03522012|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1305703|NCT03521999|Randomized|Parallel Assignment||Health Services Research||Single|Post-treatment assessors and a co-investigator in charge of randomization will be blind to condition assignment|376 Veterans who are referred for a PTSD evaluation through the Charleston VAMC PTSD Clinic Team (PCT) and Telehealth Programs and are recommended for PTSD specialty care will be randomized to receive an online peer-to-peer digital storytelling resource [AboutFace] or an educational brochure for PTSD [enhanced Usual Care; eUC]||||t
1305704|NCT03521986|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1305705|NCT03521973|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1305706|NCT03521960|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind placebo controlled study. Patients are randomized to receive either active buspirone or placebo, each of which is over-encapsulated to support blinding.|Patient completing a residential stay on the Pain Treatment Unit in which this study is being conducted will be enrolled and randomly assigned to receive either buspirone or placebo.|t|t|t|t
1305707|NCT03521947|||Case-Only||Cross-Sectional|||||||
1305708|NCT03521934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305709|NCT03521921|||Cohort||Prospective|||||||
1305710|NCT03521908|||Cohort||Retrospective|||||||
1305711|NCT03521895|||Cohort||Retrospective|||||||
1305712|NCT03521882|||Other||Prospective|||||||
1305713|NCT03521869|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Only bilateral knee replacements will be utilized so each patient can serve as their internal control||||
1305714|NCT03521856|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1305715|NCT03521843|Randomized|Parallel Assignment||Treatment||Single|only the doctors know the group the patient goes into||t|||
1305716|NCT03521830|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Patients from Arm A can crossover to Arm B||||
1305717|NCT03521817|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a between-subjects parallel study design. All women will undergo a 30% energy restriction for 8-weeks and will be randomized to an ethanol-consuming group or a non-ethanol control group at the start of the study.||||
1305718|NCT03521804||Single Group Assignment||Treatment||None (Open Label)||||||
1305719|NCT03521791|Randomized|Parallel Assignment||Treatment||Triple|The double-blind study is a procedure in which the subject and the principal investigator do not know which of the intervention groups was assigned to the subject of the study. To achieve the blinding of the drug, both the investigational drug and the placebo, will be packed in the same bottle, containing the same legends on the label. The blinding codes are protected by a person outside the study designated by the sponsor. The codes are also available in the research center (fully sealed), so that they can be consulted by the Investigator in the event that the subject presents a serious adverse event, prior authorization of the study sponsor, as well as strict continuous blindness during the analysis of data.|A controlled, randomized, double-blind, masked clinical trial comparing the safety and efficacy of PRO-155 in the treatment of conjunctival hyperemia in pterygium I to III compared to placebo.|t||t|t
1305720|NCT03521778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305721|NCT03521765|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1305722|NCT03521752|Randomized|Crossover Assignment||Other||Single|||t|||
1305723|NCT03521739|||Cohort||Prospective|||||||
1305724|NCT03521726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||20 participants receive intraluminal eradication of H. pylori. Patients fail to achieve intraluminal eradication of H. pylori will be assigned to the oral antibiotic rescue therapies with High-dose PPI-amoxicillin dual therapy (rabeprazole 20 mg and amoxicillin 750 mg 4 times/day) for 14 days.||||
1305725|NCT03521713|Randomized|Parallel Assignment||Treatment||Single|Only investigators will be blinded||||t|
1305726|NCT03521700|Randomized|Parallel Assignment||Treatment||None (Open Label)||Intensive lipid lowering gourp:10 mg/d rosuvastatin was initially prescribed and target LDL-C was < 1.8mmol/L; Conventional lipid lowering: 5 mg/d rosuvastatin was initially prescribed and target LDL-C was ≥1.8mmol/L, <3.3mmol/L||||
1305727|NCT03521687||Single Group Assignment||Treatment||None (Open Label)||This is an open-label study that will enroll 20 subjects with central centrifugal cicatricial alopecia. All subjects will receive apremilast.||||
1305728|NCT03521674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305729|NCT03521661|||Cohort||Prospective|||||||
1305730|NCT03521648|||Case-Control||Prospective|||||||
1305731|NCT03521635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305732|NCT03521622|Randomized|Parallel Assignment||Screening||Double|||t|||t
1305733|NCT03521609||Single Group Assignment||Treatment||None (Open Label)||||||
1305734|NCT03521596|||Cohort||Other|||||||
1305735|NCT03521583|||Cohort||Prospective|||||||
1305736|NCT03521570||Single Group Assignment||Treatment||None (Open Label)||||||
1305737|NCT03521557|Randomized|Factorial Assignment||Treatment||Single|Participants will be assessed at baseline prior to randomization. Once baseline assessments are completed, participants will be randomized to one of 2 study groups. Interventions will occur at a different site than assessments to avoid unmasking. At the post test and follow-up assessment time points, participants will be instructed not to divulge their group assignment to their assessor (the same individual that assessed them at baseline).|2 group x 3 time interval||||t
1305738|NCT03521544|Randomized|Parallel Assignment||Treatment||Single||||||t
1305739|NCT03521531|||Cohort||Prospective|||||||
1305740|NCT03521518|||Cohort||Prospective|||||||
1305741|NCT03521505|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305742|NCT03521492|Randomized|Parallel Assignment||Prevention||Single|||t|||
1305743|NCT03521479|Randomized|Parallel Assignment||Prevention||Quadruple|The double-blinding only applies between groups A and B. Subjects for groups C and D will be recruited on an open label basis.|"Subjects will receive on a double blind basis one of two treatment regimens:~Group A: 15 subjects, treated with 2% SADBE on day 0 and with 2% SADBE on the visits at week 3, week 6, week 9, and month 8.~Group B: 15 subjects, treated with 2% SADBE on day 0 and with 0.5% SADBE on the visits at week 3, week 6, week 9, and month 8.~And subjects will be recruited on an open label basis to two other treatment regimens:~Group C: 15 subjects, treated with 2% SADBE on day 0, month 3, and month 6.~Group D: 15 subjects, treated with 2% SADBE on day 0 and month 6."|t|t|t|t
1305744|NCT03521466|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305745|NCT03521453|||Case-Control||Prospective|||||||
1305746|NCT03521440|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305747|NCT03521427|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305748|NCT03521414|Randomized|Crossover Assignment||Other||Single|||||t|
1305749|NCT03521401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305750|NCT03521388|Randomized|Parallel Assignment||Prevention||Single||||||t
1305751|NCT03521375|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305752|NCT03521362|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305753|NCT03521349|Randomized|Parallel Assignment||Other||Single|||t|||
1305754|NCT03521336|Randomized|Parallel Assignment||Treatment||Single||A 2:1 ratio of randomization (intervention group:control group) was used.|t|||
1305755|NCT03521323|Randomized|Parallel Assignment||Treatment||Single||A 2:1 ratio of randomization (intervention group:control group) was used.|t|||
1305756|NCT03521310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305757|NCT03521297|Randomized|Parallel Assignment||Treatment||Single|single(Investigator)|Randomized parallel control|||t|
1305758|NCT03521284|||Other||Prospective|||||||
1305759|NCT03521271|||Case-Only||Prospective|||||||
1305760|NCT03521258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305761|NCT03521245|||Case-Only||Retrospective|||||||
1305762|NCT03521232|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305763|NCT03521219||Single Group Assignment||Treatment||None (Open Label)||||||
1305764|NCT03521206|Randomized|Parallel Assignment||Health Services Research||Single|During the data collection the investigators cannot be blinded, due to the nature of the intervention. However, during data analysis the researchers will be blinded for the unit of randomization of each nursing home, making use of encrypted data.|Seven of the 14 nursing homes will be randomized to the intervention group. The other seven nursing homes will be randomized to the control group.|||t|
1305765|NCT03521193||Single Group Assignment||Treatment||None (Open Label)||||||
1305766|NCT03521180|||Cohort||Prospective|||||||
1305767|NCT03521167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305768|NCT03521154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305769|NCT03521141|Randomized|Parallel Assignment||Treatment||Single|Assessors will be blind to participant arm assignment until delivery of lab results at month 6.|Assessing parallel precision care interventions (groups 1, 2) and control group.||||t
1305770|NCT03521128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305771|NCT03521115|Randomized|Parallel Assignment||Prevention||Single|Parents and Teens were either assigned to the full intervention or provided with didactic materials available on the internet.|Randomized Controlled Trial|t|||
1305772|NCT03521102|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1305773|NCT03521089|Randomized|Parallel Assignment||Treatment||Double|Double-blind|Randomized 1:1 to active or sham transcranial direct current stimulation (tDCS) intervention|t||t|
1305774|NCT03521076|Randomized|Crossover Assignment||Supportive Care||Single|Researcher #1 will break the blind and know which condition the participant is in. Researcher #1 will then be the one to video record the treatment session. Researcher #1 will leave the room immediately following the treatment intervention. Researcher #2 will enter the room and will support the patient, parent/caregiver, and provider in completing outcomes assessments.|Participants who are having botulinum toxin injections will be enrolled in the study. We will use a crossover study design, such that participants will access VR in addition to standard of care in one session and then experience only standard of care in the other condition. Participants will be randomized following the consent process. The participants will experience the opposite condition at their 2nd visit.||||t
1305775|NCT03521063|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1305776|NCT03521050|||Cohort||Other|||||||
1305777|NCT03521037||Single Group Assignment||Other||None (Open Label)||||||
1305778|NCT03521024|Randomized|Parallel Assignment||Treatment||Double||Patient will receive a restoration with superior function, esthetics, and quality.|t|||t
1305779|NCT03521011|||Cohort||Prospective|||||||
1573365|NCT00001466||||||||||||
1305780|NCT03520998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305781|NCT03520985||Single Group Assignment||Treatment||None (Open Label)||||||
1305782|NCT03520972|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1305783|NCT03520959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305784|NCT03520946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305785|NCT03520933|||Other||Prospective|||||||
1305786|NCT03520920||Single Group Assignment||Treatment||None (Open Label)||||||
1305787|NCT03520907|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1305788|NCT03520894||Single Group Assignment||Treatment||None (Open Label)||||||
1305789|NCT03520881||Single Group Assignment||Supportive Care||None (Open Label)||There is one group (intervention arm only) in this proof of concept study.||||
1305790|NCT03520868|||Case-Only||Prospective|||||||
1305791|NCT03520855|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305792|NCT03520842||Single Group Assignment||Treatment||None (Open Label)||||||
1305793|NCT03520829|||Other||Prospective|||||||
1305794|NCT03520816|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305795|NCT03520803|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1305796|NCT03520790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305797|NCT03520777||Single Group Assignment||Other||None (Open Label)||||||
1305798|NCT03520764|Randomized|Parallel Assignment||Other||Double||Intervention group: New infant formula with synbiotics; Control group: Standard infant formula with prebiotics|t||t|
1305799|NCT03520751|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305800|NCT03520738|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1305801|NCT03520725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305802|NCT03520712||Single Group Assignment||Treatment||None (Open Label)||||||
1305803|NCT03520699|||Case-Only||Prospective|||||||
1305804|NCT03520686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305805|NCT03520673||Single Group Assignment||Diagnostic||None (Open Label)||Diagnostic Accuracy Study||||
1305806|NCT03520660|||Cohort||Prospective|||||||
1305807|NCT03520647|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1305808|NCT03520634||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305809|NCT03520621|||Other||Cross-Sectional|||||||
1305810|NCT03520608|||Case-Only||Cross-Sectional|||||||
1305811|NCT03520595|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305812|NCT03520582|||Cohort||Other|||||||
1305813|NCT03520569|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Each subject is studied 4 times in a randomized sequential order||||
1305814|NCT03520556|||Other||Prospective|||||||
1305815|NCT03520543|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1305816|NCT03520530|Randomized|Parallel Assignment||Prevention||None (Open Label)||This will be a randomized controlled trial in which patients who make it to the second stage of labor will be randomized to wear a mouth guard while pushing during the second stage of labor or continue through the second stage of labor without a mouth guard. They will be randomized in a 1:1 fashion using RedCap.||||
1305817|NCT03520517||Single Group Assignment||Treatment||None (Open Label)||||||
1305818|NCT03520504||Single Group Assignment||Treatment||None (Open Label)||Single-arm, prospective trial with 3+3 dose de-escalation and dose expansion cohort.||||
1305819|NCT03520491|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This is a pilot study designed to evaluate neoadjuvant nivolumab and nivolumab in combination with ipilimumab in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for treatment with cisplatin-based chemotherapy. The study is designed with three sequential 15-patient cohorts.||||
1305820|NCT03520478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305821|NCT03520465|Randomized|Parallel Assignment||Prevention||Double|Double blind, for the patient and the radiologist who analyses the results of the imaging tests.||t|||t
1305822|NCT03520452|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1305823|NCT03520439|Randomized|Parallel Assignment||Treatment||Quadruple|The appearance of Mifepristone Tablets and placebo tablets is the same (size, shape and color). In different treatment groups, the packaging of research drugs is the same, so that researchers or subjects or applicants can not know the assigned treatment.||t|t|t|t
1305824|NCT03520426|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305825|NCT03520413|Randomized|Parallel Assignment||Health Services Research||Single|Because participants will receive information on both study arms during the consent process, we will not attempt to blind participants to randomization assignment. However, in order to assure blinding of the staff that manage outcome data collection, randomization (including participant notification of group assignment by phone) will be managed by the project coordinator.|VA Home Telehealth (HT) nurses will deliver the 5 intervention components during telephone encounters. The standard encounter frequency will be every two weeks, but may be extended to every 4 weeks for participants achieving their HbA1c goal. Should Veterans relapse while receiving the lower encounter frequency, HT will return to every-two-week encounters until the next HbA1c assessment. The 5 intervention components are: Telemonitoring, Self-management support, Diet/activity support, Medication management, & Depression support||||t
1305826|NCT03520400|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized controlled trial||||
1305827|NCT03520387|Randomized|Factorial Assignment||Treatment||Triple|Some investigators are not masked, for safety monitoring purposes.|"The proposed research will use a 2 x 2 factorial randomized controlled trial (RCT) design to examine the individual and combined effects of 1) lumbar medial branch nerve radiofrequency ablation (LRFA) (vs. simulated LRFA control), and 2) a novel video telehealth tablet- and personal computer (PC)-based Activity Tracker-Informed Video-Enabled Cognitive Behavioral Therapy program (AcTIVE-CBT) (vs. a telephone-based supportive contact and education control). This pilot RCT will involve 30 Veterans with chronic low back pain (CLBP) who will be followed to evaluate functional recovery for 3 months."|t|t||t
1305828|NCT03520374|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1573366|NCT00001462||||||||||||
1305829|NCT03520361|Randomized|Parallel Assignment||Diagnostic||Single|Single Blind (Investigator)||||t|
1305830|NCT03520348|Randomized|Parallel Assignment||Treatment||Triple|"The blinding will correspond to the research subject and the principal investigator. In addition, the statistical analysis will be carried out in a blinded manner for the partial and final analysis.~The masking will be done using boxes in the primary packaging identical in the two groups. Blinding for the research subject and the researcher will be done by replacing the commercial labels in the case of the comparator in the bottles and the use of identical labels that contain the allocation number.~Blinding may be opened in the following cases:~Presence of a serious adverse event.~Safety alarm due to the use of the drugs under study.~In case the sponsor determines it for any reason of security or other reason that considers pertinent."|Phase I clinical trial, controlled, of parallel groups, double blind, randomized, exploratory.|t||t|t
1305831|NCT03520335|||Case-Only||Prospective|||||||
1305832|NCT03520322|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1305833|NCT03520309|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1305834|NCT03520296|||Other||Prospective|||||||
1305835|NCT03520283||Single Group Assignment||Supportive Care||None (Open Label)||||||
1305836|NCT03520270|||Cohort||Prospective|||||||
1305837|NCT03520257|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1305838|NCT03520244|Randomized|Parallel Assignment||Supportive Care||Single|Outcomes assessors are masked to participant group.|Participants will be assigned to one of two groups in parallel for the duration of the study. One group is interventional (exercise + education sessions). This group will be evaluated in parallel against a wait-list control group.||||t
1305839|NCT03520231|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305840|NCT03520218||Single Group Assignment||Diagnostic||None (Open Label)||||||
1305841|NCT03520205|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1305842|NCT03520192|||Cohort||Prospective|||||||
1305843|NCT03520179|||Cohort||Cross-Sectional|||||||
1305844|NCT03520166|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Type inclusion was consecutively type|Quasi-experimental, longitudinal, pre-/post-. Level of evidence II/III.||||
1305845|NCT03520153|||Cohort||Prospective|||||||
1305846|NCT03520140|||Cohort||Prospective|||||||
1305847|NCT03520127|||Cohort||Prospective|||||||
1305848|NCT03520114|Randomized|Parallel Assignment||Treatment||Double|Participants and research staff will be masked during the one-year follow-up period.Precautions will be taken to minimize unmasking the study groups: Since RP slings require two suprapubic stab incisions, identical sham incision will also be performed in the SIS group.||t|||t
1305849|NCT03520101|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, multicenter, randomized trial including patients with surgical aortic bioprosthetic dysfunction in the presence of a small stented surgical valve. Patients will be randomized to either receive an Edwards (SAPIEN XT or SAPIEN 3) valve or a Core Valve Evolut R or Evolut PRO system.||||
1305850|NCT03520088|Randomized|Parallel Assignment||Prevention||Single|The analysis of the results will be blind for the investigator|||||t
1305851|NCT03520075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305852|NCT03520062||Single Group Assignment||Basic Science||None (Open Label)||||||
1305853|NCT03520049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305854|NCT03520036|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1305855|NCT03520023|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305856|NCT03520010|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305857|NCT03519997||Single Group Assignment||Treatment||None (Open Label)||Locally advanced or metastatic HCC not amenable to locoregional therapy||||
1305858|NCT03519984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305859|NCT03519971|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1305860|NCT03519958|||Cohort||Prospective|||||||
1305861|NCT03519945||Single Group Assignment||Treatment||None (Open Label)||||||
1305862|NCT03519932|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1305863|NCT03519919||Single Group Assignment||Treatment||None (Open Label)||||||
1305864|NCT03519906|||Case-Only||Prospective|||||||
1305865|NCT03519893|||Case-Only||Prospective|||||||
1305866|NCT03519880||Single Group Assignment||Device Feasibility||None (Open Label)|There is no masking.|All trial enrollees will receive the custom-designed 3D printed non-invasive ventilation mask interface.||||
1305867|NCT03519867|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305868|NCT03519854|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305869|NCT03519841|Non-Randomized|Parallel Assignment||Device Feasibility||Single||Non-randomized interventional study comparing device and blood reference measurements in diabetic patients||||t
1305870|NCT03519828|||Case-Control||Retrospective|||||||
1305871|NCT03519815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1305872|NCT03519802|||Cohort||Prospective|||||||
1305873|NCT03519789|||Case-Control||Prospective|||||||
1305874|NCT03519776|||Case-Only||Prospective|||||||
1305875|NCT03519763|||Case-Control||Prospective|||||||
1305876|NCT03519750|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||Each volunteer will have melatonin administered through all five routes of administration, and will have a wash-out of a minimum of 7 days between each administration.||||
1305877|NCT03519737|Randomized|Parallel Assignment||Treatment||Quadruple|Blinding is achieved through operator entry of a randomization variable obtained from IWRS at the time of enrollment and randomization. This randomization variable (A or B), the meaning of which is blinded to the operator, is entered into the control box and determines the mode of the device as either active insonation or sham insonation.|Sham control and active insonation. During lead-in phase for the first 40 subjects, only active insonation will be programmed.|t|t|t|t
1305878|NCT03519724|Randomized|Parallel Assignment||Prevention||Single|||t|||
1305927|NCT03519087|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1305928|NCT03519074||Single Group Assignment||Basic Science||None (Open Label)||||||
1573367|NCT00001461||||||||||||
1305879|NCT03519711|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients will receive treatment with CNSA-001 for a total of 14 days (i.e., two 7-day treatment periods separated by a 3- to 4-day washout). Patients will be randomized into one of 2 cohorts, with each cohort assessing 2 dose levels of CNSA-001 via intra-patient titration.~Cohort 1, patients will receive 2.5 mg/kg/day for 7 days in Period 1, undergo a 3- to 4-day washout period, then escalate to 10 mg/kg/day for 7 days in Period 2 (14 days total treatment)~Cohort 2, patients will receive 5 mg/kg/day for 7 days in Period 1, undergo a 3- to 4-day washout period, then escalate to 20 mg/kg/day for 7 days in Period 2 (14 days total treatment)."||||
1305880|NCT03519698|Randomized|Crossover Assignment||Treatment||Single|||t|||
1305881|NCT03519685|Randomized|Parallel Assignment||Prevention||Single||||||t
1305882|NCT03519672|||Cohort||Prospective|||||||
1305883|NCT03519659|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1305884|NCT03519646||Single Group Assignment||Treatment||None (Open Label)||||||
1305885|NCT03519633|Randomized|Parallel Assignment||Prevention||Single|||t|||
1305886|NCT03519620||Single Group Assignment||Prevention||None (Open Label)||||||
1305887|NCT03519607|Randomized|Factorial Assignment||Supportive Care||Single|Participant assignment will be masked for data analysis|Comparison of distress scores between the intervention group and the control group||||t
1305888|NCT03519594|||Cohort||Retrospective|||||||
1305889|NCT03519581|Randomized|Parallel Assignment||Treatment||Double|Subjects will be masked to their treatment assignment. The research coordinator that performs the measurement of best corrected visual acuity will be masked to the treatment assignment. The reading center analyst responsible for reviewing and analyzing OCT and microperimetry reports will be masked to treatment assignment.||t|||t
1305890|NCT03519568|Randomized|Parallel Assignment||Prevention||Single|||t|||
1305891|NCT03519555|||Cohort||Prospective|||||||
1305892|NCT03519542|||Cohort||Prospective|||||||
1305893|NCT03519529|||Cohort||Retrospective|||||||
1305894|NCT03519516|Randomized|Parallel Assignment||Treatment||Triple|"The blinding will correspond to the research subject and the principal investigator. In addition, the statistical analysis will be carried out in a blinded manner for the partial and final analysis.~The masking will be done using boxes in the primary packaging identical in the two groups. Blinding for the research subject and the researcher will be done by replacing the commercial labels in the case of the comparator in the bottles and the use of identical labels that contain the allocation number.~Blinding may be opened in the following cases:~Presence of a serious adverse event.~Safety alarm due to the use of the drugs under study.~In case the sponsor determines it for any reason of security or other reason that considers pertinent."|Phase I clinical trial, controlled, of parallel groups, double blind, randomized, exploratory.|t||t|t
1305895|NCT03519503|||Case-Only||Cross-Sectional|||||||
1305896|NCT03519490|Randomized|Parallel Assignment||Treatment||Quadruple|All lenses are identical in size, color and fitting characteristics. Lenses are supplied from the manufacturer with labels with full parameter information. This information will be removed or masked on the vials prior to being delivered to the office by the study coordinator.|Using a covariate adaptive randomization strategy, participants will be assigned to wear either multifocal or single vision Duette hybrid contact lenses for a period of two years. Additionally, subjects wearing the MFCLs will wear distance center in one eye and near center in the other eye, switching every six months.|t|t|t|t
1305897|NCT03519477|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1305898|NCT03519464||Single Group Assignment||Prevention||None (Open Label)||||||
1305899|NCT03519451|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305900|NCT03519438|||Cohort||Prospective|||||||
1305901|NCT03519425|Randomized|Parallel Assignment||Health Services Research||Double||A pragmatic open, three-arm individually-randomised controlled trial and economic evaluation|||t|t
1305902|NCT03519412|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305903|NCT03519399|||Case-Control||Prospective|||||||
1305904|NCT03519386|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305905|NCT03519373|||Case-Control||Prospective|||||||
1305906|NCT03519360|Randomized|Crossover Assignment||Treatment||Single|||||t|
1305907|NCT03519347|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1305908|NCT03519334|||Other||Cross-Sectional|||||||
1305909|NCT03519321||Single Group Assignment||Treatment||None (Open Label)||||||
1305910|NCT03519308|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1305911|NCT03519295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305912|NCT03519282||||||||||||
1305913|NCT03519269|Randomized|Parallel Assignment||Treatment||Single|||t|||
1305914|NCT03519256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305915|NCT03519243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305916|NCT03519230|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1305917|NCT03519217|||Cohort||Retrospective|||||||
1305918|NCT03519204|Randomized|Parallel Assignment||Treatment||Single||||||t
1305919|NCT03519191|Randomized|Crossover Assignment||Other||None (Open Label)||This socio-behavioral intervention project will randomly assign participants to the HRE-only or the HRE+Technology bootcamp arms, with a waitlist for accommodation of additionally interested youth, and a cross-over option||||
1305920|NCT03519178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1305921|NCT03519165|Randomized|Parallel Assignment||Treatment||Double||Flotrac System 4.0 Edwards Lifesciences, Irvine, CA, USA|t|||t
1305922|NCT03519152|Randomized|Crossover Assignment||Treatment||Single|patient were masked for which tablet they were reciving during the study.||t|||
1305923|NCT03519139|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305924|NCT03519126|Randomized|Parallel Assignment||Treatment||Single||It is a randomized, controlled, simple blind trial with comparative analysis between study groups and a control, performed in three moments: pre and post clinical intervention and one month after the end of treatment (follow up).||||t
1305925|NCT03519113|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305926|NCT03519100|||Cohort||Prospective|||||||
1305929|NCT03519061||Single Group Assignment||Treatment||None (Open Label)||Non randomized, single arm, prospective||||
1305930|NCT03519048|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305931|NCT03519035|||Other||Prospective|||||||
1305932|NCT03519022|Randomized|Factorial Assignment||Basic Science||Triple|||t|t||t
1305933|NCT03519009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305934|NCT03518996|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1305935|NCT03518983|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1305936|NCT03518970|Randomized|Parallel Assignment||Supportive Care||Single|the participants in this study won't know if they are in the intervention group or in the control group|This study proposes phase II in the development of randomized clinical trials for complex interventions, which refers to the development of an exploratory trial. This approach will be developed with participants randomly assigned to two groups (intervention and control) and pre-test and post-test measurements will be taken. The nursing intervention of this study is designed to be evaluated in terms of its viability, acceptability and preliminary effects in a health care institution with family caregivers of people with cancer in palliative care.|t|||
1305937|NCT03518957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305938|NCT03518944|||Cohort||Prospective|||||||
1305939|NCT03518931|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1305940|NCT03518918|||Cohort||Prospective|||||||
1305941|NCT03518905|Randomized|Parallel Assignment||Treatment||Single|Patients are blinded either to sham or treatment and unblinded after 24 weeks after final examination|randomized sham-controlled|t|||
1305942|NCT03518892|||Case-Control||Prospective|||||||
1305943|NCT03518879||Single Group Assignment||Health Services Research||None (Open Label)||This is a single-arm proof of concept study to evaluate the impact of the ASTHMA-Educator on process and clinical outcomes||||
1305944|NCT03518866|||Other||Prospective|||||||
1305945|NCT03518853||Single Group Assignment||Treatment||None (Open Label)||Phase I/II study of radiotherapy fractionation||||
1305946|NCT03518840||Single Group Assignment||Treatment||None (Open Label)||All patients will receive and be fitted by the PI with an SIJ belt.||||
1305947|NCT03518827|||Cohort||Prospective|||||||
1305948|NCT03518814|||Case-Only||Prospective|||||||
1305949|NCT03518801|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind study. Only pharmacist will have access to randomization table.|Participants randomly assigned to one of two treatment conditions.|t|t|t|t
1305950|NCT03518788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305951|NCT03518775|||Cohort||Prospective|||||||
1305952|NCT03518762|Randomized|Parallel Assignment||Treatment||Single||||t||
1305953|NCT03518749|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1305954|NCT03518736|Randomized|Parallel Assignment||Treatment||Single||||||t
1305955|NCT03518723|Randomized|Parallel Assignment||Treatment||Single|The outcome assessors will be masked to group allocation. The participants will be given repeated instructions not to reveal their group allocation to the outcome assessors. In case of failure in keeping the outcome assessor masked (i.e, a patient reveals his/her group allocation), a second trained outcome assessor will be available.|Prospective, assessor-blind, parallel-group randomized controlled multicenter trial with a pre- and post-intervention design||||t
1305956|NCT03518710||Single Group Assignment||Other||None (Open Label)||||||
1305957|NCT03518697|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305958|NCT03518684|Randomized|Parallel Assignment||Prevention||None (Open Label)||In this randomized controlled study, the patients will be randomly assigned to either Group 1 in which they will receive the standard care during labor and delivery without the use of the obstetrical gel or Group 2 in which they will have the standard care during labor and delivery with the vaginal application of the obstetrical gel according to the study protocol. Those 2 groups will be further divided into 4 subgroups where the parity will be accounted for (nulliparous [never delivered beyond 20 weeks of gestation in a previous pregnancy] or primiparous or more). Based on our departmental statistics, ~90% of laboring patients receive epidural. Hence receiving an epidural will not have a major impact on the duration of the second stage of labor; yet, whether the patient received epidural or not will be adjusted for.||||
1305959|NCT03518671||Single Group Assignment||Supportive Care||None (Open Label)||||||
1305960|NCT03518658|||Cohort||Prospective|||||||
1305961|NCT03518645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305962|NCT03518632|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1305963|NCT03518619||Single Group Assignment||Treatment||None (Open Label)||||||
1305964|NCT03518606|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a phase I/II national, multicentre, multiple cohort, prospective open-label, non-randomised and non-comparative study divided in two parts:~Phase I part: dose escalation study of metronomic oral vinorelbine associated with durvalumab + tremelimumab combination immunotherapy,~Phase II part: activity study of metronomic oral vinorelbine associated with durvalumab + tremelimumab combination immunotherapy."||||
1305965|NCT03518593|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305966|NCT03518580|||Ecologic or Community||Other|||||||
1305967|NCT03518567||Single Group Assignment||Basic Science||None (Open Label)||||||
1305968|NCT03518554||Single Group Assignment||Treatment||None (Open Label)||||||
1305969|NCT03518541|Randomized|Parallel Assignment||Treatment||Single|Patients are masked about which group they are randomized in|"Randomization into two study arms:~Classic control of derotation using a Moeltgen goniometer intraoperatively~Control of derotation using an electromagnetic tracking device intraoperatively"|t|||
1305970|NCT03518528|||Cohort||Prospective|||||||
1305971|NCT03518515|Randomized|Parallel Assignment||Basic Science||Single||||||t
1305972|NCT03518502|Randomized|Parallel Assignment||Treatment||None (Open Label)||Sorafenib monotherapy vs. transarterial chemoembolization-sorafenib sequential therapy||||
1305973|NCT03518489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1305974|NCT03518476|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1306056|NCT03517410|||Case-Only||Cross-Sectional|||||||
1305975|NCT03518463|Randomized|Parallel Assignment||Treatment||Double|Mothers delivering by emergency CS were randomly assigned to either ERAS or routine care arms in a ratio of 1:1. We did simple randomization to either ERAS or routine care arm without any blocks. We generated patient group assignments using the computer algorithm (computer-generated list of random numbers) and placed in identical sealed opaque envelopes. A statistician not involved in the research generated the random number list. The envelopes were opened sequentially by the anesthetist when an eligible patient was encountered. Mothers were recruited into the study by the two research assistants implementing ERAS elements. Single blinding of PI and the two research assistants assessing outcomes was done to minimize bias.|The ERAS arm was exposed to modified ERAS elements including preoperative counseling and education, prophylaxis against nausea and vomiting (PONV), individualized goal directed fluid therapy, early mobilization at 6-8 hours postoperative, early feeding within 1 hour postoperative,urethral catheter removal at 6 hours, oral fixed combination non opioid analgesia, oral antibiotics and anti-emetics. PONV included intravenous metoclopromide and dexametasone, no ondansetron given. Patients in the control arm recovered with routine care.|||t|t
1305976|NCT03518450|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305977|NCT03518437|||Cohort||Prospective|||||||
1305978|NCT03518424|||Cohort||Prospective|||||||
1305979|NCT03518411||Single Group Assignment||Prevention||None (Open Label)||||||
1305980|NCT03518398|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1305981|NCT03518385|||Case-Control||Prospective|||||||
1305982|NCT03518372|||Cohort||Prospective|||||||
1305983|NCT03518359|Randomized|Parallel Assignment||Prevention||Double|Participants do not know that the investigator is testing mindfulness. Participants only will be told that they will be learning stress-reduction skills for physicians.|Randomized, partially-blinded.|t|||t
1305984|NCT03518346|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1305985|NCT03518333|Randomized|Parallel Assignment||Treatment||Single|Sham treatment|Prospective, multi-center, two-arm, blinded, randomized treatment. Covariate adaptive randomization will be used. Covariates included in the adaptive randomization process will be investigational center, history of diabetes, and radical prostatectomy.|t|||
1305986|NCT03518320||Single Group Assignment||Treatment||None (Open Label)||||||
1305987|NCT03518307|||Other||Retrospective|||||||
1305988|NCT03518294|Randomized|Parallel Assignment||Treatment||None (Open Label)||Standard of care Aerobic exercise||||
1305989|NCT03518281|Randomized|Parallel Assignment||Prevention||Quadruple|All parties, except an outside person not involved in the study, will be blinded to the treatment conditions|Randomized, Double-Blind, Placebo Controlled|t|t|t|t
1305990|NCT03518268|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1305991|NCT03518255|Randomized|Crossover Assignment||Supportive Care||None (Open Label)|This study has no masking.|||||
1305992|NCT03518242||Single Group Assignment||Treatment||None (Open Label)||||||
1305993|NCT03518229|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1305994|NCT03518216|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1305995|NCT03518203||Single Group Assignment||Treatment||None (Open Label)||||||
1305996|NCT03518190||Single Group Assignment||Prevention||None (Open Label)||||||
1305997|NCT03518177|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two parallel groups will be formed from patients with hospital-based pulmonary rehabilitation (Group 1) and those with home-based pulmonary rehabilitation(Group 2).||||
1305998|NCT03518164|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1305999|NCT03518151|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||WRAPPED1 is a natural experiment with a prospective matched controlled cluster design||||
1306000|NCT03518138|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1306001|NCT03518125|Randomized|Parallel Assignment||Prevention||Triple||Subjects will be randomized to receive either BioThrax or AV7909. Randomization will be stratified by sex and age (18-50, 66-74, and ≥75 years). Subjects ≥66 years of age will be randomized 1:1:1:1 within stratum across 4 treatment arms (approximately 50 subjects per group), and subjects 18 through 50 years of age will be randomized 1:1 within stratum across 2 treatment arms (approximately 50 subjects per group). Once randomized, subjects will receive 3 vaccinations, each separated by approximately 14 days, on Day 1, Day 15, and Day 29, based on their assigned treatment arm.|t||t|t
1306002|NCT03518112||Single Group Assignment||Treatment||None (Open Label)||||||
1306003|NCT03518099|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1306004|NCT03518086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1306005|NCT03518073|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1306006|NCT03518060|||Cohort||Prospective|||||||
1306007|NCT03518047|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1306008|NCT03518034|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306009|NCT03518021|Randomized|Parallel Assignment||Treatment||Quadruple|"The whole study team, including the statistician, will be blinded until after database lock and the primary analysis are done. The allocation list will be stored by by the Hospital Pharmacy Trondheim. There will not be automatic unblinding of SAEs. Study personnel do not have any access to the allocation list. An emergency option for individual unblinding is available to medical monitor in case of SAE/ SUSAR Study workers are blinded to the different preparations. This is carefully performed by covering the vials with neutral and opaque labels for study drug. The risk of for unintentional unblinding is very small. The procedure for securing credible blinding is described in the study protocol and approved by the Norwegian Medicines Agency."|Double blinded, double dummy, randomized controlled trial|t|t|t|t
1306010|NCT03518008||||||||||||
1306011|NCT03517995|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1306012|NCT03517982|||Cohort||Prospective|||||||
1306013|NCT03517969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306014|NCT03517956||Single Group Assignment||Treatment||None (Open Label)||||||
1306015|NCT03517943|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1306016|NCT03517930|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1306017|NCT03517917|||Case-Only||Prospective|||||||
1306018|NCT03517904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306019|NCT03517891|Randomized|Parallel Assignment||Prevention||Triple|We will use a random allocation process for each clinic with the exception of the 2 satellite clinics which will be randomly assigned separately to ensure assignment of 1 satellite clinic per treatment arm. Additional attention to the distribution of the satellite clinics is deemed necessary as the flow of participants at these sites differs from other clinics due to extended working hours and location of facilities (shopping malls). Randomization will take into account the number of pregnant participants per clinic as well as breastfeeding statistics as an important determinant of future infant obesity.|Cluster-randomized controlled trial in 20 WIC clinics. We will randomly assign 10 clinics to the intervention arm and 10 to control (usual care) arm. The intervention will combine key messages and activities designed to promote sound parenting skills that support and sustain healthy lifestyles beginning at birth until the infant is 12 months of age. Participants will be recruited at the WIC clinics during in the last trimester of pregnancy. The primary, intention-to-treat, analysis will evaluate the effect of the intervention on excessive weight gain and rate of weight gain from birth until 12 months. The intention-to-treat approach will allow us to evaluate the expected effect of adding the proposed intervention to the current WIC curriculum. Secondary analyses will include effects of the intervention on objective measures of infant activation, sedentary behaviors and sleep, diet quality, and feeding practices.||t|t|t
1306020|NCT03517878|||Case-Control||Prospective|||||||
1306021|NCT03517865|||Cohort||Other|||||||
1306022|NCT03517852||Single Group Assignment||Diagnostic||None (Open Label)|This is an open-label, non-randomized, single center, study of IVM observation in conjunction with fluorescein and ICG in subjects with peritoneal carcinomatosis undergoing CRS-HIPEC.|||||
1306023|NCT03517839|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1306024|NCT03517826|||Other||Prospective|||||||
1306025|NCT03517813|||Case-Crossover||Prospective|||||||
1306026|NCT03517800|||Other||Retrospective|||||||
1306027|NCT03517787|Randomized|Crossover Assignment||Treatment||Single|||t|||
1306028|NCT03517774||Single Group Assignment||Other||None (Open Label)||||||
1306029|NCT03517761|Randomized|Crossover Assignment||Treatment||Single|Participants are blind to treatment condition until 6 months post-procedure. Participants in sham control group can crossover to treatment group at that time.|Single-center, prospective, single-blinded, randomized, controlled study to include 80 subjects total, 40 treated with Bone Marrow Concentrate and 40 subjects treated with a Sham Procedure with cross-over from the sham to active group at 6 months|t|||
1306030|NCT03517748|Randomized|Parallel Assignment||Treatment||Single||"Because the comparator will be in commercial packaging, the blinding of the subject is not possible.~However, the study will be blinded for the investigator: evaluations will be done by an independent investigator, different than the person who will distribute the product. Subjects will be identified by a patient number. Each patient number will be associated to a treatment number, according to a randomization list provided before the beginning of the clinical investigation, and randomized either in one of both treatment groups (DM05 or Optive®)."|||t|
1306031|NCT03517735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1306032|NCT03517722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1306033|NCT03517709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306034|NCT03517696|Randomized|Parallel Assignment||Treatment||None (Open Label)|Intervention is not able to be blinded|Non-blinded Randomized Controlled Trial||||
1306035|NCT03517683|Randomized|Parallel Assignment||Other||Single||||||t
1306036|NCT03517670|||Other||Prospective|||||||
1306037|NCT03517657|Randomized|Parallel Assignment||Treatment||Double||Patients are stratified by Fugl Meyer score. After stratification, patients will be randomized to one of two groups|||t|t
1306038|NCT03517644|Randomized|Parallel Assignment||Treatment||Single|Using a cover story, participants are instructed to think that there are three experimental groups: a treatment condition, a placebo condition, and a control condition. Therefore, participants from the open-label groups do know that they receive a placebo, but do not know which specific mechanism is being addressed in their condition.|Participants are assigned to one of four experimental groups in parallel for the duration of the study|t|||
1306039|NCT03517631|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Infusion of autologous CD34+ cells transduced with shRNAs targeting CCR5 and HIV genome||||
1306040|NCT03517618||Single Group Assignment||Treatment||None (Open Label)||||||
1306041|NCT03517605||Single Group Assignment||Treatment||None (Open Label)||An exercise program was performed by the Specialist Nurses in Rehabilitation Nursing, comprising the combination of the various components of the exercise: aerobic and recovery/stretching. The program will start in the intensive care unit after the 24 hours post-surgery, and later, during hospitalization. The evaluations will be performed during hospitalization, in phase I of cardiac rehabilitation, and one-month post-discharge, in the Nursing visits of follow-up (phase II of cardiac rehabilitation). Clinical data (Blood Pressure, Heart Rate, Peripheral Oxygen Saturation) and Borg scale will be recorded in the initial, intermediate and final periods of each session. Capillary glycemia will be evaluated at the beginning of each session. Three sessions of exercises will be performed weekly with duration of 30 min to 60 min, divided in heating (10-25 min), aerobic exercise (10 min) and recovery (10-25min).||||
1306042|NCT03517592|Randomized|Parallel Assignment||Treatment||Single||||||t
1306043|NCT03517579||Single Group Assignment||Diagnostic||None (Open Label)||This is a pilot experimental study||||
1306044|NCT03517566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306045|NCT03517553||Single Group Assignment||Treatment||None (Open Label)||||||
1306046|NCT03517540|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1306047|NCT03517527|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1306048|NCT03517514|||Cohort||Prospective|||||||
1306049|NCT03517501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306050|NCT03517488||Sequential Assignment||Treatment||None (Open Label)||||||
1306051|NCT03517475|Randomized|Parallel Assignment||Prevention||Single||||||t
1306052|NCT03517462||Single Group Assignment||Treatment||None (Open Label)||||||
1306053|NCT03517449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306054|NCT03517436||Single Group Assignment||Treatment||None (Open Label)||||||
1306055|NCT03517423|||Case-Only||Prospective|||||||
1306057|NCT03517397||Single Group Assignment||Treatment||None (Open Label)||||||
1306058|NCT03517384||Single Group Assignment||Treatment||None (Open Label)||||||
1306059|NCT03517371|Randomized|Parallel Assignment||Treatment||Single|Blinded assessors will administer standardizes outcome measures across sites (BU & WU)|This study will take place at Boston University (BU) and Washington University in St. Louis (WU). This is a two-arm, single-blinded, 1-year randomized controlled trial. Persons with mild to moderate PD are randomly assigned to one of two treatment arms. In the mHealth arm, individuals participate in a cognitive-behavioral community-based walking program plus home-based walking enhancing progressive resistance exercises delivered using a mobile health platform. The active control condition receives the same components and dose of walking and exercise but without a cognitive-behavioral approach or the use of mobile health technology.||||t
1306060|NCT03517358|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1306061|NCT03517345|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306062|NCT03517332|||Cohort||Prospective|||||||
1306063|NCT03517319|Randomized|Single Group Assignment||Treatment||Single||||||t
1306064|NCT03517306|||Cohort||Retrospective|||||||
1306065|NCT03517293|Randomized|Parallel Assignment||Prevention||Single|Due to the nature of an exercise study, the participant cannot be blinded to the group. However, those assessing outcomes are blinded to group assignment.|women were randomly assigned to either aerobic exercise intervention or no exercise.||||t
1306066|NCT03517280|||Cohort||Prospective|||||||
1306067|NCT03517267|||Case-Only||Prospective|||||||
1306068|NCT03517254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306069|NCT03517241|||Case-Control||Prospective|||||||
1306070|NCT03517228||Single Group Assignment||Treatment||None (Open Label)||||||
1306071|NCT03517215|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306072|NCT03517202|||Cohort||Retrospective|||||||
1306073|NCT03517189||Single Group Assignment||Treatment||None (Open Label)||||||
1306074|NCT03517176|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1306075|NCT03517163|||Case-Only||Prospective|||||||
1306076|NCT03517150|Randomized|Parallel Assignment||Other||Single||||||t
1306077|NCT03517137||Single Group Assignment||Treatment||None (Open Label)||||||
1306078|NCT03517124|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled clinical study|t|||t
1306079|NCT03517111|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomization to treatment conditions (FPNG+, FPNG, or comparison [RAD]) will occur at the school level. From the 18 participating schools, 6 each will be randomized into one of the three conditions.||||
1306080|NCT03517098|Randomized|Parallel Assignment||Treatment||Single||||||t
1306081|NCT03517085|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306082|NCT03517072|||Cohort||Prospective|||||||
1306083|NCT03517059|||Cohort||Prospective|||||||
1306084|NCT03517046|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306085|NCT03517033|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306086|NCT03517020|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306087|NCT03517007|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306088|NCT03516994|Randomized|Parallel Assignment||Other||None (Open Label)||Mixed-methods, longitudinal, multi-site study, cluster randomized trial||||
1306089|NCT03516981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306090|NCT03516968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306091|NCT03516955|||Cohort||Prospective|||||||
1306092|NCT03516942|||Cohort||Prospective|||||||
1306093|NCT03516929|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1306094|NCT03516916|||Cohort||Cross-Sectional|||||||
1306095|NCT03516903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306096|NCT03516890|||Cohort||Retrospective|||||||
1306097|NCT03516877||Single Group Assignment||Treatment||None (Open Label)||||||
1306098|NCT03516864|||Case-Crossover||Prospective|||||||
1306099|NCT03516851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306100|NCT03516838|Randomized|Crossover Assignment||Treatment||Double|During treatment, the type of filling material was concealed from the patient, and the patient had no information which material was used in each side of the mouth. The type of material was not mentioned in the patient's file. Instead, it was replaced by a combination which the outcomes assessors were not familiar with. The operator was also blinded for the type of restoration during tooth preparation and was informed only at the time of restoration placement. The purpose of this discretion was to ensure double blinding both at the patient, as well as the outcomes assessor level.|"Experimental prospective double blinded split-mouth randomized controlled trial .~Each patient receive both types of treatment in the oral cavity, one type of the treatment on each side.~The patients act as their control"|t|||t
1306101|NCT03516825||Single Group Assignment||Treatment||None (Open Label)|All participants were given no information about this intervention. Participants only followed the direction by student music therapist.|The same intervention has been used for all participants (two) for this study.||||
1306102|NCT03516812||Single Group Assignment||Treatment||None (Open Label)||||||
1306103|NCT03516799|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Non-randomized trial across four time points at one study site||||
1306104|NCT03516786|||Cohort||Prospective|||||||
1306105|NCT03516773|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized, active comparator, two-part, within-part, partial crossover design.||||
1306106|NCT03516760||Sequential Assignment||Treatment||None (Open Label)||Dose escalation scheme; Single patient cohorts on the first three dose levels, 3+3 afterwards.||||
1306107|NCT03516747||Single Group Assignment||Diagnostic||None (Open Label)||open label, non- randomised, prospective||||
1306201|NCT03515525|||Cohort||Retrospective|||||||
1306202|NCT03515512||Single Group Assignment||Treatment||None (Open Label)||||||
1306203|NCT03515499|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1573368|NCT00001459||||||||||||
1306108|NCT03516734|Randomized|Parallel Assignment||Other||Triple|Participants, care provider, and investigators will be masked on the distribution of iron-fortified lentil among 3 different adolescent group.|Thick preparation of cooked Iron-fortified lentils (37.5gm raw lentil) will be provided. There will be three lentils based dietary intervention arm in this efficacy trial. Arm 1 will be intervened with iron-fortified lentils, Arm 2 will be non-iron fortified lentils, and Arm 3 arm will be the usual intake of lentil (no additional lentil). Arm 2 will be served as a comparison group and arm 3 will be served as control group.|t|t|t|
1306109|NCT03516721|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1306110|NCT03516708|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1306111|NCT03516695|||Other||Prospective|||||||
1306112|NCT03516682|Randomized|Parallel Assignment||Prevention||Double|The Investigator and Analyst will stay blinded to the randomization arm throughout the trial.||||t|t
1306113|NCT03516669|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||20 participants receive intraluminal eradication of H. pylori. Patients fail to achieve intraluminal eradication of H. pylori will be assigned to the oral antibiotic rescue therapies with triple therapy which contains a proton pump inhibitor and two antibiotics ( amoxicillin, and clarithromycin) for 14 days.||||
1306114|NCT03516656|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306115|NCT03516643||Single Group Assignment||Treatment||None (Open Label)||||||
1306116|NCT03516630|Randomized|Crossover Assignment||Other||Double|Subjects and the investigator administering the study products and collecting the data are blinded with respect to Trazodone and placebo treatments, and open with respect to moxifloxacin treatment. Trazodone and placebo final solutions for administration is prepared by an independent Pharmacist under open conditions.||t||t|
1306117|NCT03516617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306118|NCT03516604|Randomized|Parallel Assignment||Basic Science||Quadruple||Participants will be randomly allocated to one of three groups (PF-04995264, citalopram or placebo) and receive their allocated study medication for 7 days.|t|t|t|t
1306119|NCT03516591|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1306120|NCT03516578|||Cohort||Prospective|||||||
1306121|NCT03516565|||Case-Control||Prospective|||||||
1306122|NCT03516552|||Cohort||Prospective|||||||
1306123|NCT03516539|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306124|NCT03516526||Single Group Assignment||Treatment||None (Open Label)||||||
1306125|NCT03516513|Randomized|Parallel Assignment||Health Services Research||Single|Research Assistants and expert raters will not be informed of condition therapists are assigned to.|Phase 1 will consist of qualitative interviews; Phase 2 will consist of rapid iterative design that includes qualitative interviews; Phase three will be a pilot randomized trial||||t
1306126|NCT03516500||Single Group Assignment||Treatment||None (Open Label)||After the investigators cut the pulmonary vessels and ligate the segmental bronchus. The investigators inject Iron Sucrose (100 mg dissolved in 50 mL saline) through a butterfly needle into the bronchus of the targeting segment.||||
1306127|NCT03516487|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Dose-escalating, Randomized, Double-blinded, Placebo-controlled|t|t|t|t
1306128|NCT03516474|||Case-Control||Prospective|||||||
1306129|NCT03516461||Single Group Assignment||Treatment||None (Open Label)||||||
1306130|NCT03516448|Randomized|Parallel Assignment||Treatment||Single|||||t|
1306131|NCT03516435|Randomized|Parallel Assignment||Treatment||Single|||t|||
1306132|NCT03516422|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1306133|NCT03516409|Randomized|Parallel Assignment||Treatment||None (Open Label)|A multicenter, double blind, parallel group, placebo controlled, randomized study.|"Treatment groups: 6 - 35 months old.~Bio-Kult Infantis~Placebo (maltodextrine DE19)"||||
1306134|NCT03516396|Randomized|Sequential Assignment||Other||None (Open Label)||Randomized cluster design of households in rural Nepal. Groups will be randomized to receive either: (a) Training Only (livestock management and child nutrition), (b) Training plus enhanced community development activities, or (c) no inputs (Control). After 24 months, groups A and C will receive community development inputs||||
1306135|NCT03516383|||Case-Control||Prospective|||||||
1306136|NCT03516370|Randomized|Crossover Assignment||Treatment||Single|patients were masked they didnt know which mixture they recived during treatment ensuring single blind study||t|||
1306137|NCT03516357|||Case-Only||Retrospective|||||||
1306138|NCT03516344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306139|NCT03516331|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1306140|NCT03516318|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306141|NCT03516305||Single Group Assignment||Basic Science||None (Open Label)||All subjects receive a single dose of Staccato Alprazolam 1 mg||||
1306142|NCT03516292|||Case-Control||Prospective|||||||
1306143|NCT03516279||Single Group Assignment||Treatment||None (Open Label)||||||
1306144|NCT03516266|||Cohort||Cross-Sectional|||||||
1306145|NCT03516253|Randomized|Parallel Assignment||Basic Science||Triple|Double blind|"This study is a parallel, randomized, double blind, controlled, 3-months supplementation, investigating health effects of dietary intake of fish oil and EPO, in patients with breast cancer undergoing chemotherapy.~At the beginning of the study, all patients received nutritional counseling, where half of the study subjects are randomly assigned to a treatment arm with fish oil and EPO, or control arm with olive oil as placebo. Treatment arm is provided with 2 gel capsules of fish oil and 3 gel capsules of EPO (400 mg eicosapentaenoic acid, 600 mg docosahexaenoic acid and 351 mg gamma-linolenic acid). Control arm will consume 5 gel capsules of 1g of olive oil."|t||t|t
1306146|NCT03516240|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1306147|NCT03516227|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1306148|NCT03516214||Single Group Assignment||Treatment||None (Open Label)||||||
1306149|NCT03516201|||Cohort||Other|||||||
1306204|NCT03515486||Single Group Assignment||Health Services Research||None (Open Label)||||||
1306205|NCT03515473|||Case-Control||Retrospective|||||||
1306206|NCT03515460|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1306150|NCT03516188|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|Asymptomatic obese patients will be randomised into either groups according to alginate antacid group [Gaviscon Advance (GA), Reckitt Benckiser, UK] and non antacid alginate group [simple antacid]. Both groups will be studied for 48 hours using the ambulatory wireless capsule and pH impedance. Participants according to their group will take either alginate antcid [Gaviscon Advance (GA), Reckitt Benckiser, UK] or non alginate antacid [simple antacid] which has equivalent strength of antacid after taking late night standardised meals.||||
1306151|NCT03516175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306152|NCT03516162|||Cohort||Prospective|||||||
1306153|NCT03516149|Randomized|Parallel Assignment||Treatment||Single|All of participants must be healthy.|There are 2 groups. Study group will receive foam rolling exercise. Control group will receive no foam rolling exercise. They will be handed a brochure about the proprioception and its role in injury prevention and foam rolling . Study group will be evaluated before foam rolling exercise . Afterwards, second evaluation will be performed after exercise at the same day. Control group will be evaluated for the first time. Afterwards, second evaluation will be performed after resting period (2 minutes) at the same day.|t|||
1306154|NCT03516136|||Cohort||Retrospective|||||||
1306155|NCT03516123||Single Group Assignment||Treatment||None (Open Label)||||||
1306156|NCT03516110|||Cohort||Prospective|||||||
1306157|NCT03516097|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1306158|NCT03516084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306159|NCT03516071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306160|NCT03516058||Single Group Assignment||Other||None (Open Label)||||||
1306161|NCT03516045||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306162|NCT03516032|Randomized|Parallel Assignment||Health Services Research||Single|The specific purpose of the clinical staff study not directly involved in the study is not specified in terms of not affecting the participants.|||t||
1306163|NCT03516019|Randomized|Factorial Assignment||Prevention||Single|eFHS researchers, statistician, research assistant, and clinic staff are masked to intervention assignment.|The research design includes a cohort eFHS Study and an embedded randomized factorial trial on a subset of the cohort.|||t|
1306164|NCT03516006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306165|NCT03515993|||Cohort||Prospective|||||||
1306166|NCT03515980|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306167|NCT03515967|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1306168|NCT03515954|||Cohort||Retrospective|||||||
1306169|NCT03515941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306170|NCT03515928|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1306171|NCT03515915|||Cohort||Prospective|||||||
1306172|NCT03515902|Randomized|Parallel Assignment||Treatment||Single|||||t|
1306173|NCT03515889|Randomized|Parallel Assignment||Other||Single|Throughout the study every effort will be made to ensure objective and blinded assessments of outcomes. Although participants will be told of their treatment assignment they will not be provided details about the intervention techniques of the other treatment groups. Focus will instead be maintained on the group to which they are assigned. Staff who obtain and record participant assessments at the clinical assessments will not be informed of the participant's treatment assignment and will not participate in the delivery of the study interventions.|Participants (n=192) with BMI ≥30 and ≤49 will be randomized to one of two parallel study arms: Group A: Ideal Protein Weight Loss Intervention; Group B: Standard Low-Fat, Low-Calorie, Guideline-based Weight Loss Intervention. Participants will undergo baseline testing, and if eligible, will be randomly assigned to study group, undergo three months of their assigned study intervention, and clinical testing at baseline, 6, and 12 weeks.||||t
1306174|NCT03515876|||Case-Control||Prospective|||||||
1306175|NCT03515863|||Case-Control||Prospective|||||||
1306176|NCT03515850|||Case-Only||Prospective|||||||
1306177|NCT03515837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306178|NCT03515824|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306179|NCT03515811|||Other||Prospective|||||||
1306180|NCT03515798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306181|NCT03515785|||Case-Only||Other|||||||
1306182|NCT03515772|||Case-Control||Prospective|||||||
1306183|NCT03515759|||Cohort||Cross-Sectional|||||||
1306184|NCT03515746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306185|NCT03515733|Randomized|Parallel Assignment||Basic Science||Quadruple||Participants will be randomly allocated to one of two groups (PF-04995264 or placebo) and receive their allocated study medication for 7 days.|t|t|t|t
1306186|NCT03515720|Randomized|Sequential Assignment||Treatment||Triple|||t||t|t
1306187|NCT03515707||Single Group Assignment||Treatment||None (Open Label)||||||
1306188|NCT03515694|Randomized|Parallel Assignment||Treatment||Double||Parallel, Double blind Monocentric Prospective Vs placebo|t|t||
1306189|NCT03515681|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1306190|NCT03515668|Randomized|Single Group Assignment||Basic Science||Single|Double-blinding of participant and investigator, with independent investigator in charge of placebo and drug.|Healthy males 18-30 years of age|||t|
1306191|NCT03515655|||Cohort||Retrospective|||||||
1306192|NCT03515642|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1306193|NCT03515629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306194|NCT03515616|||Cohort||Prospective|||||||
1306195|NCT03515603|Randomized|Parallel Assignment||Treatment||Double|only surgeon knows the used technique, endocrinologist, patient and all involved medical staff is blinded|prospective randomized|t|t||
1306196|NCT03515590|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1306197|NCT03515577||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306198|NCT03515564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306199|NCT03515551|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1306200|NCT03515538|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306208|NCT03515434|Randomized|Crossover Assignment||Treatment||Double||||t||t
1306209|NCT03515421||Single Group Assignment||Other||None (Open Label)||||||
1306210|NCT03515408|Randomized|Parallel Assignment||Treatment||Single|||||t|
1306211|NCT03515395|||Cohort||Prospective|||||||
1306212|NCT03515382|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1306213|NCT03515369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306214|NCT03515356|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306215|NCT03515343|||Cohort||Prospective|||||||
1306216|NCT03515330|Randomized|Parallel Assignment||Supportive Care||Single|Patients will be aware of which arm they are randomized to; thus, the study will not be blinded to practitioners or patients. However, study personnel performing data analysis will receive de-identified data that does not explicitly describe which group is intervention and which is control, but simply the code without a key. Only the PI and necessary personnel performing data extraction will have the key for the code to minimize bias in data analysis.|This is a single center, prospective, randomized control trial with two arms. Participants in the intervention arm will use the mHealth app to manage and track their immunosuppression medical regimen post-transplant, and participants in the control arm will receive the current standard of follow-up care post-transplant.||||t
1306217|NCT03515317|Randomized|Parallel Assignment||Treatment||Single||||||t
1306218|NCT03515304|Randomized|Parallel Assignment||Treatment||Quadruple|Persons performing the PET imaging, laboratory technicians are all masked.|Double-blind, placebo controlled trial|t|t|t|t
1306219|NCT03515291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306220|NCT03515278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306221|NCT03515265|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306222|NCT03515252||Single Group Assignment||Treatment||None (Open Label)||||||
1306223|NCT03515239|||Cohort||Prospective|||||||
1306224|NCT03515226|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized clinical trial||||
1306225|NCT03515213|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1306226|NCT03515200||Single Group Assignment||Treatment||None (Open Label)||"Palbociclib will be administered orally on Days 1-5, and 11-15 concurrently with dexamethasone of each 30 day cycle for one cycle (dose escalation) or up to 3 cycles for responders (dose expansion). Bortezomib will be given on Days 7, 10, 17 and 20. Doxorubicin will be given on Days 7 and 17.~Patients with Ph-like or Ph+ ALL will receive the tyrosine kinase inhibitor (TKI), dasatinib, beginning on Day 7.~Triple intrathecal chemotherapy (MHA) will be given on Day 1 of the course. The frequency and total number of IT MHA is based on the patient's level of CNS disease."||||
1306227|NCT03515187|Randomized|Parallel Assignment||Treatment||Single|||t|||
1306228|NCT03515174|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1306229|NCT03515161||Single Group Assignment||Treatment||None (Open Label)||SINGLE GROUP ASSIGNMENT||||
1306230|NCT03515148|Randomized|Parallel Assignment||Treatment||Single|||||t|
1306231|NCT03515135|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1306232|NCT03515122|||Case-Control||Cross-Sectional|||||||
1306233|NCT03515109|Randomized|Parallel Assignment||Treatment||Double|they will not be aware of the procedure they are going to perform or have.|prospective randomised|t||t|
1306234|NCT03515096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306235|NCT03515083|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized, prospective||||
1306236|NCT03515070|||Family-Based||Cross-Sectional|||||||
1306237|NCT03515057|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1306238|NCT03515044|Randomized|Parallel Assignment||Treatment||Triple|Blinding will be maintained in the QD SSD cohorts by administering placebo as the second daily dose.|Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study|t|t|t|
1306239|NCT03515031|Randomized|Parallel Assignment||Treatment||Single|Assessor will be blind to the treatment allocation|open randomized controlled trial||||t
1306240|NCT03515018|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306241|NCT03515005|Randomized|Parallel Assignment||Treatment||Single||||||t
1306242|NCT03514992|Randomized|Parallel Assignment||Health Services Research||Double|In this study, since the Principal Investigator was the intervener to both study groups, and also the data collector, an effort was made to ensure that both the pre- and posttest were administered in the presence of one other OTR and/or a Physical Therapist, who shared the use of the room with Mrs. Teng, test booklets were encrypted, and, that the participants, parents, test graders (one different OTR to each test instrument), and statisticians were kept blind to the group assignment of each participant.||t|||t
1306243|NCT03514979|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a phase IIb, open label study to evaluate the responses of patients with ANCA associated vasculitis (AAV) to pneumococcal vaccination. It has been designed primarily to assess the immunogenicity of pneumococcal vaccines in patients with AAV treated with rituximab compared to disease controls, but also to provide mechanistic information on vaccine response by comparing AAV patients and healthy controls.||||
1306244|NCT03514966|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1306245|NCT03514953||Single Group Assignment||Basic Science||None (Open Label)||||||
1306246|NCT03514940|||Cohort||Prospective|||||||
1306247|NCT03514927||Single Group Assignment||Treatment||None (Open Label)||||||
1306248|NCT03514914|Randomized|Parallel Assignment||Other||None (Open Label)||To evaluate the impact of CHARM2 on reversible contraceptive use (including LARC), unintended pregnancy, and MSV via a two armed cluster RCT with N=1000-1200 married couples from 20 geographic clusters (n=50-60 couples per cluster) in rural India. The control arm will receive standard of care in the form of community health workers offering pills/condoms and linking women to public health clinics.||||
1306249|NCT03514901|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-label|A randomized, open-label study||||
1306250|NCT03514888||Single Group Assignment||Treatment||None (Open Label)||HIPEC with Mitomycin-C||||
1306251|NCT03514875|Randomized|Crossover Assignment||Treatment||Double||1:1 Randomized, cross-over design|t||t|
1306252|NCT03514862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306253|NCT03514849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306254|NCT03514836||Single Group Assignment||Treatment||None (Open Label)||Open label combination treatment||||
1306255|NCT03514823|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1306256|NCT03514810|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1306257|NCT03514797|Randomized|Parallel Assignment||Treatment||Single||||||t
1306258|NCT03514784|Randomized|Parallel Assignment||Treatment||Triple|The head statistician and study pharmacist will be aware of randomization scheme. The investigators will use an adaptive minimization program for randomization that balances the 3 study arms with respect to distributions of sex and age (4-10 vs. 11-15 y.o.). Patients will be randomized to placebo, 1 billion CFU, and 10 billion CFU study arms at a ratio of 1:2:2. (Currently marketed over-the-counter probiotics typically contain 0.1-50 billion CFUs per dose.) The performance of our covariate adaptive randomization algorithm will be verified through simulation studies before implementation.|After psychological screening, the subjects will be randomize children to one of 3 groups. The total number of subject to be enrolled will be 70 healthy children with confirmed ASD status, randomizing each child to placebo (maltodextrin), low daily dose (1 billion cfu's), and higher daily dose (10 billion cfu's) of BB-12+LGG once daily at 1:2:2 ratio. Data will be combined with 30 patients obtained from two funding sources: Texas (THECB) and U.T. pilot project. The data will be combined and an identical design of the placebo and 1 billion cfu dose arms.|t|t|t|
1306259|NCT03514771||Single Group Assignment||Treatment||Single|Efficacy evaluations of photographs will be performed by two trained and experienced evaluators who are blinded to which side of the face has been treated, and which side of the face has not been treated.|All subjects will have one side of the face (Right-Left) treated with the laser and the other side will be untreated to act as a control.||||t
1306260|NCT03514758||Single Group Assignment||Other||None (Open Label)||a group of normal-hearing volunteers||||
1306261|NCT03514745|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1306262|NCT03514732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1306263|NCT03514719||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306264|NCT03514706|Randomized|Parallel Assignment||Screening||Single|Lung ultrasound will be done by an investigator blinded to group allocation|"Adult patients scheduled for elective thoracic surgery with one lung ventilation will be included in the study. Patients will be randomly allocated into one of two groups:~Group V: will receive volume controlled mechanical ventilation. Group P: will receive pressure controlled mechanical ventilation."|||t|
1306265|NCT03514693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306266|NCT03514680|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"The study expect to enroll 142 patients, 50 clinicians, and 30 healthy controls for a total of 222.~71 patients will be recruited in Period 1 (usual care) and a separate 71 will be recruited in Period 2 (algorithm use). The 50 clinicians will be recruited prior to Period I and will participate in Periods I and II. We will use purposive sampling to recruit 30 health controls to match the age and demographic characteristics of the recruited patients. The healthy controls will receive no intervention."||||
1306267|NCT03514667|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1306268|NCT03514654|Randomized|Parallel Assignment||Treatment||None (Open Label)|Neither the patients nor the clinical team will be blinded to the trial arms of this study|To evaluate whether a sufficient number of eligible patients can be identified and are willing to accept randomisation of the interventions in question. Recruitment and compliance rates of which will inform the feasibility and design of a larger trial||||
1306269|NCT03514641|Randomized|Parallel Assignment||Treatment||Quadruple|"Study 603A: bexagliflozin tablets, 20 mg or placebo~Study 603B week 1 to week 12: bexagliflozin tablets, 20 mg~Study 603B week 13 to week 24: bexagliflozin tablets, 20 mg or placebo"|"The primary endpoint of study 603A is the change from baseline (Day 1) to week 12 in the 24-hour average SBP of the bexagliflozin group compared to the placebo group using a superiority testing at an overall two-sided 0.05 level of significance.~The primary endpoint of study 603B is the change from week 12 (cumulative week 24) to week 24 (cumulative week 36) in the 24-hour average SBP in the bexagliflozin group compared to the placebo group using a superiority testing at an overall two-sided 0.05 level of significance."|t|t|t|t
1306270|NCT03514628|Randomized|Parallel Assignment||Treatment||Double|Data analysis and determination of primary outcome will be done blind to allocation|1:1 randomisation to VAD or standard care|||t|t
1306271|NCT03514615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1306272|NCT03514602|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Multicomponent behavioral intervention||||
1306273|NCT03514589|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1306274|NCT03514576|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306275|NCT03514563|||Cohort||Prospective|||||||
1306276|NCT03514550|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1306277|NCT03514537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306278|NCT03514524|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1306279|NCT03514511|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1306280|NCT03514498|||Case-Control||Prospective|||||||
1306281|NCT03514485|Randomized|Factorial Assignment||Other||Single|The Principal Investigator (PI) will be masked to the participant-level intervention group. Unmasking will occur if there is an adverse event that warrants investigation or if the DSMB instructs the PI to become unmasked.|A factorial design has enhanced statistical power and can handle cluster randomization of schools. Statistical methods will be used to estimate variation in the effect across schools over time. Linear mixed effects models with random intercepts and slopes for school, and fixed effects for the school-level intervention, time, and time-by-intervention interaction will be applied. Second, marginal models using generalized estimating equations will produce robust estimates that adjust for clustering at the school level. Third, assumption-free, randomization-test-based methods do not rely on assumptions of parametric models. Investigators will use conventional levels of statistical significance (p=0.05) for all pre-specified comparisons for our objectives. Variability of the intervention effect across schools will reflect consistency of intervention effects and thus generalizability in new settings. Both mixed effects models and permutation-test methods will estimate variance components.|||t|
1573369|NCT00001455||||||||||||
1306282|NCT03514472|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||"In the study 34 of ages between 13-30 years divided into 2 age groups (below and above 18) were selected (excluding pregnant and lactating women) and were intervened with value added supplement  Moringa oleifera for a period of three months."||||
1306283|NCT03514459|Randomized|Parallel Assignment||Screening||None (Open Label)||Cluster randomized trial of family planning clinics||||
1306284|NCT03514446|Randomized|Parallel Assignment||Treatment||Single||||||t
1306285|NCT03514433|Non-Randomized|Parallel Assignment||Health Services Research||Single||"A randomized cluster stepped wedge design will be conducted. This pragmatic design involves a sequential, randomized roll-out of the intervention across 6 participating clinical sites or clusters over 3 month intervals or steps. Consistent with a stepped wedge design with one cluster per step, prior to the collection of data in the pre-intervention period, the investigators will generate a set of uniform random numbers for each of the six clusters to assign a starting period for the study intervention. There will be no crossover of patients from usual care to the intervention. That is, patients at each site during the pre-intervention period will experience only usual care and will act as historical controls and those enrolled after the initiation of intervention will experience the intervention."||||t
1306286|NCT03514420||Single Group Assignment||Treatment||None (Open Label)||||||
1306287|NCT03514407||Single Group Assignment||Treatment||None (Open Label)||||||
1306288|NCT03514394|Randomized|Parallel Assignment||Health Services Research||Single|Research Assistants and expert reviewers of therapy sessions will not be made aware of which condition the therapist is assigned to.|Phase 1 will consist of observation and qualitative interviews; Phase two will consist of iterative design methods; phase three is a pilot randomized clinical trial||||t
1306289|NCT03514381||Single Group Assignment||Treatment||None (Open Label)||||||
1306290|NCT03514368||Single Group Assignment||Other||None (Open Label)||||||
1306291|NCT03514355|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomization of consenting eligible patients in intervention and control groups using separate permutated random blocks of 4||||
1306292|NCT03514342|||Cohort||Prospective|||||||
1306293|NCT03514329||Single Group Assignment||Treatment||None (Open Label)||||||
1306294|NCT03514316|Randomized|Parallel Assignment||Treatment||Single|The observer who performed all the measurements was blinded to the group assignment. The study was blinded in regard to the statistical analysis: blinding was obtained by eliminating from the elaboration file every reference to patient group assignment.|a prospective three-arm parallel group randomized clinical trial with 1:1:1 allocation ratio||||t
1306295|NCT03514303|||Cohort||Prospective|||||||
1306296|NCT03514290|Randomized|Crossover Assignment||Treatment||Double|Only principal investigator performed the clinical research steps. A single evaluator performed the assessment of the dental sensitivity without knowing which treatment was applied. The volunteers evaluated in this study also did not know which hemi-arch received the LLL.|Twenty-one volunteers were evaluated through the split-mouth model, so that the right and left maxillary/mandibular quadrants were randomized and allocated to one of two groups: GPLACEBO - the laser tip was positioned without the emission of light (placebo effect) + tooth bleaching with 35% hydrogen peroxide (HP); GLASER - treated with LLL + tooth bleaching with 35% HP.|t||t|
1306297|NCT03514277|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1306298|NCT03514264|Randomized|Parallel Assignment||Treatment||Single|After 6 months the results will be evaluated by two independent professionals, who did not participate in the interventions and are not aware of the allocation. The evaluation will be performed by means of tomography and clinical examination|A randomized, interventional, prospective, unicentric, double blind clinical trial.||||t
1306299|NCT03514251|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1306300|NCT03514238|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1306301|NCT03514225||Single Group Assignment||Other||None (Open Label)||||||
1306302|NCT03514212||Single Group Assignment||Other||None (Open Label)||Feasibility study||||
1306303|NCT03514199|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized clinical trial will be conducted and the sample will consist of 50 participants who performed portable respiratory polysomnography. Cases with AHI between 15 and 50 events per hour will be sent for medical evaluation to identify inclusion/exclusion criteria. Eligible individuals who agree to participate in the study, after signing the Informed Consent Term, will perform physical, biochemical, questionnaire and randomized to receive guidelines on the Mediterranean-type diet or low-fat diet.||||
1306304|NCT03514186|Randomized|Parallel Assignment||Treatment||Single|Because of the nature of the intervention, neither the treating SLPs nor the subjects can be masked regarding the scheduling of treatment. To minimize outcome ascertainment bias, an evaluator (testing speech-language pathologist) who is not directly associated with the daily activities of the trial and, therefore, blind to the treatment arm will administer and score all the assessments. Subjects will be introduced to the treatment arm to which they have been assigned with a script that emphasizes similar expectations from the intervention, regardless of the treatment group. This will reduce subject bias resulting from such beliefs that one of the therapies is less effective.|Both treatment arms will provide 60 hours of comprehensive aphasia therapy. In the ICAP arm, the 60 hours of treatment will be applied intensively, 4 hours per day, 5 days a week for three weeks. In the Distributed Treatment arm, the 60 hours of comprehensive treatment will be distributed over 15 weeks (i.e. two 2-hour visits per week).||||t
1306305|NCT03514173|||Other||Other|||||||
1306306|NCT03514160|Randomized|Parallel Assignment||Other||None (Open Label)||Randomization to group exercise or an attention-control group for 12 weeks (2:1 ratio). Group exercise sessions took place once per week at a community center.||||
1306307|NCT03514147|Randomized|Parallel Assignment||Treatment||Single|||||t|
1306308|NCT03514134|Randomized|Parallel Assignment||Treatment||Single||||||t
1306309|NCT03514121||Single Group Assignment||Treatment||None (Open Label)||Single arm trial with multiple cohorts||||
1306354|NCT03513536|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1306355|NCT03513523|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1306356|NCT03513510||Single Group Assignment||Treatment||None (Open Label)||||||
1306357|NCT03513497|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1573370|NCT00001450||||Treatment||||||||
1306310|NCT03514108|Randomized|Factorial Assignment||Treatment||Quadruple||"Patients can be allocated to either~both Hydralazine Isosorbide Dinitrate / Placebo and Metformin hydrochloride / Placebo~to only Hydralazine Isosorbide Dinitrate / Placebo.~to only Metformin hydrochloride / Placebo.~Patient characteristics are entered in an electronic CRF. According to in- and exclusion criteria they are randomized in three blocks:~Patients receiving both Hydralazine Isosorbide Dinitrate / Placebo and Metformin hydrochloride / Placebo~Patients receiving only Hydralazine Isosorbide Dinitrate / Placebo and~Patients receiving only Metformin hydrochloride / Placebo~Analysis will be performed in:~all patients who have received Hydralazine Isosorbide Dinitrate / Placebo (H-HeFT) and~all patients who have received Metformin hydrochloride / Placebo (Met-HeFT)~The study is event driven. Anticipated: both H-HeFT and Met-HeFT 900, only H-HeFT 400, only Met-HeFT 200 patients."|t|t|t|t
1306311|NCT03514095|Randomized|Parallel Assignment||Other||Quadruple|The randomization process it will be done in https://www.random.org/ by an independent person.|Participants will be assigned in two groups, a control group who will usual care by their caregivers and an experimental group who will receive the MD3 program.|t|t|t|t
1306312|NCT03514082|||Case-Control||Prospective|||||||
1306313|NCT03514069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306314|NCT03514056|||Cohort||Prospective|||||||
1306315|NCT03514043|||Other||Prospective|||||||
1306316|NCT03514030|||Other||Retrospective|||||||
1306317|NCT03514017||Single Group Assignment||Treatment||None (Open Label)||||||
1306318|NCT03514004|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1306319|NCT03513991|Randomized|Parallel Assignment||Other||Single|The participant did not know which formula was assigned. Infant formulas were packed in the same presentation and identified by a number.|"The exclusively formula-fed infants were randomized to one of three study formulas with different protein profile.~A control group was selected with women that voluntarily chose to exclusively breast feed for at least 4 months."|t|||
1306320|NCT03513978|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1306321|NCT03513965|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1306322|NCT03513952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306323|NCT03513939||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-randomized, single arm||||
1306324|NCT03513926|||Cohort||Cross-Sectional|||||||
1306325|NCT03513913|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1306326|NCT03513900|||Case-Crossover||Cross-Sectional|||||||
1306327|NCT03513887|||Case-Crossover||Cross-Sectional|||||||
1306328|NCT03513874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306329|NCT03513861|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1306330|NCT03513848|Randomized|Parallel Assignment||Treatment||Single|||t|||
1306331|NCT03513835||||||||||||
1306332|NCT03513822|Randomized|Parallel Assignment||Treatment||Triple|"The randomisation is done with R software. Each randomisation card is put in a sealed opaque envelope. The two products being transparent, it's impossible to differentiate the two products with identical packaging is a syringe of 50 cc Luer Lock Plastipack BD with a standard extension for syringe Luer Lock.~Both products will be prepared by an SSPI nurse who opens the envelope, the nurse does not participate in the study, the patient assessment investigator as well as the patient will remain blind about the administration of the product. Each syringe will be labeled for each patient with a special label without indication of the product The outcomes assessor, investigator and participant are blinded."|Interventional randomized placebo-controlled clinical trial. Adult, medullary injured (BM), with chronic neuropathic pain (DN). 4 groups: BM with DN with bedsore Ketamine Group versus Placebo Group BM with DN without bedsore group Ketamine versus Placebo Group Ketamine infusion 1 mg / kg IVSE over two hours versus Nacl perfusion 0.9%|t||t|t
1306333|NCT03513809|||Cohort||Prospective|||||||
1306334|NCT03513796|||Case-Only||Retrospective|||||||
1306335|NCT03513783||Single Group Assignment||Other||None (Open Label)||||||
1306336|NCT03513770|Randomized|Crossover Assignment||Basic Science||Double|These two trials (A and B) will be performed in random order and in a double-blind fashion for subjects and the data analyzing team. The medical staff who prepare and administrate the drugs and monitor the subject's safety, will not be blinded.|The investigators will examine (using a prospective observational design) if a COX blockade will inhibit the Muscle Sympathetic Nerve Activity response to venous distension, and if a COX blockade will alter vein sizes during venous distension using MRI. Each subject will serve as their own control.|t|||t
1306337|NCT03513757|Randomized|Parallel Assignment||Treatment||Triple|The patients and their parents/guardians as well as the blinded observer or investigator who participates in outcomes assessment will be blinded to the drug or drugs administered.|observer blinded comparison of propofol with low-dose propofol and dexmedetomidine for pediatric MRI sedation|t||t|t
1306338|NCT03513744|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1306339|NCT03513731|Randomized|Parallel Assignment||Treatment||None (Open Label)|It is a single-blinded trial in which the radiologists are blinded. Subjects and the Investigator are unblinded.|||||
1306340|NCT03513718|||Other||Retrospective|||||||
1306341|NCT03513705|Randomized|Crossover Assignment||Treatment||None (Open Label)||Stepped-wedge cluster randomized trial||||
1306342|NCT03513692|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306343|NCT03513679|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1306344|NCT03513666||Single Group Assignment||Treatment||None (Open Label)||||||
1306345|NCT03513653|||Cohort||Retrospective|||||||
1306346|NCT03513640|||Cohort||Prospective|||||||
1306347|NCT03513627|||Cohort||Prospective|||||||
1306348|NCT03513614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306349|NCT03513601|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306350|NCT03513588|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1306351|NCT03513575|Randomized|Crossover Assignment||Prevention||Single|only primary investigator will know the intervention done by the subject. The outcome investigator(assessor) will be unaware (blinded) to which intervention the subject is undertaken.|||||t
1306352|NCT03513562||Single Group Assignment||Treatment||None (Open Label)||||||
1306353|NCT03513549|||Cohort||Prospective|||||||
1306358|NCT03513484||Single Group Assignment||Treatment||None (Open Label)||||||
1306359|NCT03513471|Randomized|Crossover Assignment||Treatment||Double|The randomization will be done by the department biostatistician and communicated with Investigational Drug Services so the experiment will remain blinded.|Study subjects will be randomized to one of two arms, either receiving Anakinra or placebo, then having a washout period and receiving the opposite treatment.|t||t|
1306360|NCT03513458|Randomized|Crossover Assignment||Treatment||Double|The randomization to study arms will be done by the department biostatistician and communicated to Investigational Drug Services to maintain the double-blind nature of the study.|Subjects are randomized to one of two arms, either taking Anakinra or placeo. After a washout period, the subjects will be moved to the opposite arm.|t||t|
1306361|NCT03513445|Randomized|Parallel Assignment||Treatment||Single|This is a single blind study in which participants are unaware of whether or not they received a peri-incisional injection of pain medication during their surgery.||t|||
1306362|NCT03513432|Randomized|Parallel Assignment||Supportive Care||Quadruple||"This is a three-arm parallel-group, randomized controlled study to evaluate the effect of consumption of beer with or without alcohol (5.20 %, 0.45 % and 0.00 %), during 4 weeks, on healthy individuals.~The study will focus on the effects of beer on microbiota and biochemical biomarkers in healthy human volunteers."|t|t|t|t
1306363|NCT03513419|Randomized|Parallel Assignment||Treatment||Single||||||t
1306364|NCT03513406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306365|NCT03513393|Randomized|Crossover Assignment||Other||None (Open Label)||An open-label, 3-period, single-centre, phase-I, multi PPI dose, single velpatasvir dose trial in 12 healthy volunteers.||||
1306366|NCT03513380|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306367|NCT03513367|||Other||Prospective|||||||
1306368|NCT03513354|Randomized|Parallel Assignment||Treatment||Single|blinded assessment|3 groups (swimming pool, soil, control group)|||t|
1306369|NCT03513341|||Cohort||Cross-Sectional|||||||
1306370|NCT03513328|Randomized|Sequential Assignment||Treatment||None (Open Label)||"The study builds in rules for escalation of thiotepa dose based on graft failure by day 42. Patients are stratified in two groups A (lower risk of graft failure) and B (higher risk of graft failure). Patients undergoing 10/10 HLA matched bone marrow and peripheral blood transplants are assigned to Group A, and patients receiving <10/10 matched bone marrow or peripheral blood, or receiving cord blood, even if fully matched, are assigned to Group B.~If criteria for thiotepa dose escalation are met first in Group A, which has a lower risk of graft failure, thiotepa dose will be escalated for all subjects (Groups A and B). If criteria for thiotepa dose escalation are met first in Group B, dose will be escalated only in Group B and Group A will continue enrolling patients at a lower dose level."||||
1306371|NCT03513315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306372|NCT03513302|Randomized|Crossover Assignment||Treatment||Triple||Double-blind, placebo-controlled, crossover|t||t|t
1306373|NCT03513289|||Cohort||Retrospective|||||||
1306374|NCT03513276|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1306375|NCT03513263|Randomized|Parallel Assignment||Treatment||Single|the participants will not know the arm of the study they are in.|scaling and polishing plus oral hygiene instructions will be provided for the intervention arm while only oral hygiene instruction will be provided for the control arm. At the end of the six month follow up the control arm will also be provided with scaling and polishing.|t|||
1306376|NCT03513250|Randomized|Parallel Assignment||Prevention||Quadruple||A prospective randomized clinical trial|t|t|t|t
1306377|NCT03513237|Randomized|Parallel Assignment||Prevention||Double|The women will be blinded to the intervention, but the investigator will not be blinded to the procedure allocation (due to the nature of the intervention).||t|||t
1306378|NCT03513224||Single Group Assignment||Health Services Research||None (Open Label)||||||
1306379|NCT03513211|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Phase I intra-patient dose escalation study Phase II Simon 2-stage cohort expansion||||
1306380|NCT03513198|||Cohort||Prospective|||||||
1306381|NCT03513185|||Cohort||Prospective|||||||
1306382|NCT03513172|Randomized|Crossover Assignment||Prevention||Triple||||t|t|t
1306383|NCT03513159|Randomized|Parallel Assignment||Supportive Care||Single|The patients data will be anonymized and entered into an electronic Case Report form. The Outcomes Assessor will only see the anonymized data.|The Intervention Group will be supported by the activities of the pathfinder, the Control Group will not. Both Groups will be tested for functional and nutritional Status and for Quality of life and stress scores.||||t
1306384|NCT03513146|Randomized|Parallel Assignment||Prevention||Single|Microbiological assessment of bacterial colonization of the oropharyngeal cavity and the GIT will be masked|Oropharyngeal Administration of mother's milk (OPAMM)||||t
1306385|NCT03513133||Single Group Assignment||Treatment||None (Open Label)||a group of 10 patients with severe TBI will receive 3-month rehabilitation of working memory and will be compared to a group of 10 healthy controls||||
1306386|NCT03513120|||Cohort||Prospective|||||||
1306387|NCT03513107|||Case-Only||Cross-Sectional|||||||
1306388|NCT03513094||Single Group Assignment||Treatment||None (Open Label)||Single group, repeated measures.||||
1306389|NCT03513081|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1306390|NCT03513068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306391|NCT03513055||Single Group Assignment||Treatment||None (Open Label)||||||
1306392|NCT03513042|||Cohort||Prospective|||||||
1306393|NCT03513029||Single Group Assignment||Treatment||None (Open Label)||||||
1306394|NCT03513016|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1306395|NCT03513003|Randomized|Parallel Assignment||Treatment||Single||||||t
1306437|NCT03512457|Randomized|Parallel Assignment||Prevention||Single|study arm not disclosed||||t|
1306438|NCT03512444|Randomized|Parallel Assignment||Other||Single||"2 groups: intervention and control (both are in each arm of the same participant).~Intervention will be applied at one arm (chosen randomly) with using the contralateral arm as a control."|t|||
1306439|NCT03512431|||Cohort||Prospective|||||||
1306440|NCT03512418|Randomized|Parallel Assignment||Prevention||None (Open Label)||Pilot randomized controlled trial||||
1306396|NCT03512990||Single Group Assignment||Basic Science||None (Open Label)||"We suggest an injection more distally, where superior trunk is in costoclavicular space below omohyoid muscle, proximal to the suprascapular outlet. The needle is advanced below the prevertebral layer of deep cervical fascia, avoiding that the tip of the needle lies in the fascial plane between investing layer of deep vertebral fascia and prevertebral layer.~Patients scheduled for rotator cuff surgery will receive 6 mL of 0,5% bupivacaine. Successful block is defined as motor score of ≤ 2 on modified Bromage scale in the deltoid and bíceps; absent sensation to cold and pinprick sensation in C5 and C6 dermatomes within 30 minutes of injection.~To evaluate phrenic nerve, diaphragmatic excursion will be assessed by ultrasonography of ipsilateral hemidiaphragm and with impedance tomography.~Moreover, 6 mL of methylene blue will be injected into cadavers to evaluate if dispersion was restricted to fibers of the superior trunk and don`t reach phrenic nerve."||||
1306397|NCT03512977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306398|NCT03512964||Single Group Assignment||Treatment||None (Open Label)||||||
1306399|NCT03512951|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306400|NCT03512938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306401|NCT03512925|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Eligible participants are randomly assigned either to the intervention arm (standardized debriefing session) or to the Treatment-as-usual (TAU) arm (non-standardized debriefing).||||
1306402|NCT03512912|||Cohort||Prospective|||||||
1306403|NCT03512899|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparison between internal jugular vein versus via axilar vein with single-incision for placement of implantable ports in cancer patients. Investigators are recruiting 240 patients and randomizing 120 for each arm. Primary outcome is early complications, until 30 days and secondary outcome late complications, between 30 days and 6 months. The follow-up is 6 months.||||
1306404|NCT03512886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306405|NCT03512873||Single Group Assignment||Treatment||None (Open Label)||||||
1306406|NCT03512860|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1306407|NCT03512847|||Cohort||Prospective|||||||
1306408|NCT03512834||Single Group Assignment||Treatment||None (Open Label)||Paclitaxel + Avelumab||||
1306409|NCT03512821|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306410|NCT03512808|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306411|NCT03512795|||Other||Prospective|||||||
1306412|NCT03512782|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1306413|NCT03512769|||Other||Cross-Sectional|||||||
1306414|NCT03512756|Randomized|Sequential Assignment||Treatment||Single|Blinded independent centralized radiologic review and un-masked investigator determined outcomes are used in this trial.|||||t
1306415|NCT03512743|||Cohort||Prospective|||||||
1306416|NCT03512730|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1306417|NCT03512717|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306418|NCT03512704|||Cohort||Prospective|||||||
1306419|NCT03512691|Randomized|Parallel Assignment||Health Services Research||Single||The study is a randomized parallel experiment with two treatment groups and one control group. Randomized assignment of treatment will be done at the level of the barangay, which is the smallest administrative unit in the Philippines roughly equivalent to an electoral ward. The 847 barangays in the Nueva Ecija province will be stratified by urban/rural classification.|t|||
1306420|NCT03512678|||Case-Only||Prospective|||||||
1306421|NCT03512665|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306422|NCT03512652||Single Group Assignment||Device Feasibility||None (Open Label)||One randomly selected knee is treated by the intervention device Patello||||
1306423|NCT03512639|Randomized|Parallel Assignment||Prevention||Triple|"The medications were packed in bottles, each containing 5 grams of the preparation, and consecutively numbered. The prefix 'A' indicated Arnica montana, and 'B' Bellis perennis .~Participants were randomly allocated into groups given either homeopathic medication (Arnica montana C30 and Bellis perennis C30) or placebo (alcohol 40% and alcohol 40%) in a 1:1 ratio. . The randomization code was held in confidence and the code was not broken until the data analysis. The same randomization list was used to blind the Arnica montana and the Bellis perennis, creating similar pairs. The placebos and the active medication were indistinguishable in appearance, taste and smell."|RCT|t|t|t|
1306424|NCT03512626|Randomized|Parallel Assignment||Treatment||Double||"Consecutive patients with bilateral cataract were included after meeting all the inclusion and none of exclusion criteria and when written informed consent was obtained from all patients.~Patients were randomly assigned to have bilateral implantation with either a monofocal IOL (AR40e, AMO-Abbot 30 Laboratories Inc. Abbot Park, Illinois, USA) or multifocal IOL (OptiVis™, Aaren Scientific, Inc, Ontario, CA, USA)."|t||t|
1306425|NCT03512613|||Other||Prospective|||||||
1306426|NCT03512600||Sequential Assignment||Other||None (Open Label)||||||
1306427|NCT03512587|Randomized|Parallel Assignment||Treatment||Single||||||t
1306428|NCT03512574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306429|NCT03512561|||Cohort||Prospective|||||||
1306430|NCT03512548|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1306431|NCT03512535|||Other||Prospective|||||||
1306432|NCT03512522|Randomized|Parallel Assignment||Treatment||None (Open Label)||A patient preference randomized controlled trial (RCT) will be used for this study. Participants will be randomly assigned to be enrolled in the online group or workbook group, or be placed on a twelve-week wait list control, which will serve as a control group to control for the influence of time on symptom change between groups.||||
1306433|NCT03512509|Randomized|Crossover Assignment||Prevention||Single|Subjets will not be aware of which test meal they will recieve first, and are not able to distinguish between the two potatoes.|Single-blind randomized crossover|t|||
1306434|NCT03512496|Randomized|Crossover Assignment||Basic Science||Triple|Randomized, double blind, crossover design|Randomized, double blind, crossover design|t||t|t
1306435|NCT03512483|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1306436|NCT03512470|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573371|NCT00001449||||Treatment||||||||
1306441|NCT03512405||Single Group Assignment||Treatment||None (Open Label)||||||
1306442|NCT03512392|Randomized|Parallel Assignment||Treatment||None (Open Label)|Group assignment and early (up to 28 day) data will be locked and unavailable to investigators undertaking 6-month follow up.|Randomised, open-label, allocation concealed, pilot trial||||
1306443|NCT03512379|Randomized|Parallel Assignment||Treatment||Single||Robot-assisted surgery group Free-hand surgery group Navigation-assisted surgery group||||t
1306444|NCT03512366|Randomized|Parallel Assignment||Treatment||Double|This will be a double blind trial .The patient will not be revealed about the technique being performed. The investigator who will follow up the patients post operatively in the out-patient clinic will also be blinded about the procedure performed on the patient.|"DESARDA'S NO MESH REPAIR:~It will be performed according to the surgical technique described by Dr. Desarda. A strip will be separated from the upper leaf of the external oblique aponeurosis keeping its insertion and continuity with the muscle intact. This strip will be sutured with the inguinal ligament below and the newly formed upper leaf of EOA above behind the spermatic cord to form the new inguinal floor. Continuous non absorbable prolene 2-0 suture will be used to secure the aponeurotic strip to the inguinal ligament inferiorly , and the strip will be secured superiorly to the internal oblique muscle using interrupted absorbable vicryl sutures. This strip will be put under tension by muscular contraction and works as a shield to prevent recurrence as it gives additional strength to the weakened internal oblique and transverses abdominis muscles."|t||t|
1306445|NCT03512353||Single Group Assignment||Treatment||None (Open Label)||||||
1306446|NCT03512340|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"This Phase 1/1b, open-label, first-in-human, monotherapy study will be conducted in 2 parts. Part A will consist of the SRF231 monotherapy dose-escalation portion of the study, and will enroll up to 48 patients with advanced solid tumors and lymphoma/CLL.~Part B will include 5 monotherapy expansion cohorts: in advance solid and hematologic cancers (100 patients total)."||||
1306447|NCT03512327||Single Group Assignment||Treatment||None (Open Label)||||||
1306448|NCT03512314||Single Group Assignment||Treatment||None (Open Label)||||||
1306449|NCT03512301|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1306450|NCT03512288|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1306451|NCT03512275|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1306452|NCT03512262|Randomized|Parallel Assignment||Treatment||Quadruple|Treatment will be blinded to participants, investigators, outcome Assessor and care provider throughout the study except in a medical emergency where the identity of study medication is necessary to appropriately treat the patient.|Randomized patients will received a 2:1 ratio of abaloparatide:placebo injections.|t|t|t|t
1306453|NCT03512249|Randomized|Parallel Assignment||Prevention||Triple|"The unblinded persons in the study are the study vaccine manager (and designee) who manages the subject inventory log(s) at the trial site, the unblinded site staff, and the unblinded clinical trial site monitor(s) responsible for monitoring the investigational product at the trial site. All unblinded persons must take care to not reveal individual subject treatment assignments to any blinded member of the study team. There will be an unblinded contact person at the sponsor's site in order to manage queries from the unblinded site staff or the unblinded monitors in the trial.~The study vaccine manager (and designee) should be a designated site team member, such as the study pharmacist. Unblinded site staff must not participate in the evaluation of adverse events.~The randomization list will be provided by the unblinded statistician and will be implemented as a module in the eCRF."|2 Cohorts - H56:IC31 and Placebo. First 100 participants will be in a safety group with additional scheduled evaluations.|t|t|t|
1306454|NCT03512236|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1306455|NCT03512223|Randomized|Parallel Assignment||Prevention||Single|||t|||
1306456|NCT03512210||Single Group Assignment||Treatment||None (Open Label)||||||
1306457|NCT03512197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306458|NCT03512184||Single Group Assignment||Health Services Research||None (Open Label)||||||
1306459|NCT03512171|Randomized|Crossover Assignment||Basic Science||Double|The participant and the research analyst running their session are both blind, however a PET tech is unmasked who monitors the participant for any adverse reactions.|All subjects receive the same diagnositc intervention, with counterbalanced order|t||t|
1306460|NCT03512158|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will be an open-label, parallel arm, randomized controlled trial with a 1:1 allocation ratio of individual patients in randomly varying blocks of 4, 6, or 8. Neither investigators, nor bedside clinicians will be blinded due to the nature of the investigation, but allocation will be concealed by way of using sealed opaque envelopes that will be opened after consent. Given the pilot nature of this trial, and relatively small sample size, no particular stratification strategy for randomization will be employed. This study will be conducted in the McMaster Children's Hospital NICU.||||
1306461|NCT03512145||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306462|NCT03512132|||Cohort||Prospective|||||||
1306463|NCT03512119|||Cohort||Other|||||||
1306464|NCT03512106|Randomized|Parallel Assignment||Treatment||Single|Acupuncture sham will be applied (placebo).|Chinese traditional acupuncture will be applied.||||t
1306465|NCT03512093|||Cohort||Other|||||||
1306466|NCT03512080|||Cohort||Cross-Sectional|||||||
1306467|NCT03512067||Single Group Assignment||Treatment||None (Open Label)||This study is a device trial to examine the efficacy of the new mode of mechanical ventilation. It will be single-armed and open label.||||
1306468|NCT03512054||Single Group Assignment||Supportive Care||None (Open Label)||||||
1306469|NCT03512041|Randomized|Parallel Assignment||Treatment||Single|Participants will be masked to their group assignment (RLIC or Sham conditioning) throughout the study. Participants will intuitively know the dose (number of cycles) of their assignment.|Single blinded, randomized controlled trial|t|||
1306470|NCT03512028|Randomized|Parallel Assignment||Treatment||Single|Participants are masked to group assignment (RLIC vs. Sham conditioning).|Single blinded, randomized controlled trial|t|||
1306471|NCT03512015|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Consenting patients will be assigned in a 1:1 randomized way to receiving either standard care or LuCApp in addition to standard care. During the treatment period, LuCApp allows daily monitoring and grading of a list of symptoms which trigger alerts to the physicians in case predefined severity thresholds are met.||||
1306472|NCT03512002|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||This study will compare acoustic stimulation linked to brainwave activity (HIRREM, along with continued current care, HCC), with continued current clinical care alone (CCC). Both groups will continue their other current care throughout, including non-pharmacological, and lifestyle modification therapies. The participants in the CCC group will be offered the opportunity to crossover and receive a course of HCC.||||
1306473|NCT03511989|Randomized|Parallel Assignment||Treatment||Single||||||t
1306474|NCT03511976|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1306475|NCT03511963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306476|NCT03511950|||Cohort||Prospective|||||||
1306477|NCT03511937|Randomized|Parallel Assignment||Prevention||Single|This trial uses incomplete disclosure to mask the purpose of the trial from participants.||t|||
1306478|NCT03511924|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1306479|NCT03511911|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1306480|NCT03511898|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1306481|NCT03511885|||Cohort||Cross-Sectional|||||||
1306482|NCT03511872|Randomized|Parallel Assignment||Other||Single|Two blinded 10-year experienced professionals in emergency training (trainers in the Syrian resuscitation council) are asked to evaluate students' skills independently A third assessor who is also professional in emergency training is asked to resolve conflict judgments between live and camera assessment when existed.|A randomized controlled trial with blinded assessors on medical students from the pre-clinical years (1st to 3rd years in Syria) at Syrian Private University. Students are randomly assigned to peer-led or to professional-led training group for one-day-course of basic life support skills.||||t
1306483|NCT03511859|||Cohort||Prospective|||||||
1306484|NCT03511846|Non-Randomized|Parallel Assignment||Basic Science||Double|In the oxygen portion of the study, subjects and the outcomes assessors will be told that they will be receiving either medical air or oxygen.||t|||t
1306485|NCT03511833|Randomized|Parallel Assignment||Other||Quadruple||"Eligible patients will be randomized according to a blocked randomization scheme using www.sealedenvelope.com (site accessed Sep 10, 2017), which permits assignment of the participant to either group A or group B (the IN ketamine or IV morphine group). Only the pharmacy will have knowledge of which group is Ketamine and which group is Morphine. Eligible patients will be divided in equal proportions (58 in group A and 58 in group B). Both medications will be prepared by the pharmacy as coded kits, and will be stored in the ER safe with clear signage: For ketamine/morphine clinical trial only. Shelf life of the kits is 6 months. Each vial in a kit will be marked by the group name either A or B and by either IN or IV. The IV vials will either contain: morphine (10 mg of morphine in 10 ml saline) or 10 ml saline for IV administration, and the IN vials will either contain ketamine (100 mg in 2ml saline) or 2 ml saline for nasal administration."|t|t|t|t
1306486|NCT03511820|||Case-Only||Prospective|||||||
1306487|NCT03511807||Single Group Assignment||Treatment||None (Open Label)||||||
1306488|NCT03511794|||Cohort||Retrospective|||||||
1306489|NCT03511781||Single Group Assignment||Treatment||None (Open Label)||||||
1306490|NCT03511768||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306491|NCT03511755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306492|NCT03511742|||Cohort||Prospective|||||||
1306493|NCT03511729|||Cohort||Prospective|||||||
1306494|NCT03511716|||Cohort||Prospective|||||||
1306495|NCT03511703|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1306496|NCT03511690|Randomized|Parallel Assignment||Screening||Single|Randomization schedules will be developed by the biostatistician and administered by an individual (staff) not involved in the study analyses so that the statistician will be blinded to the allocation. This method will ensure unbiased results. After the baseline interview, the RA will be informed of the allocation by the staff member|Participants are randomized to two arms||||t
1306497|NCT03511677|Randomized|Parallel Assignment||Treatment||Double|Placebo insole||t|||t
1306498|NCT03511664|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study population includes patients with progressive PSMA-positive mCRPC who received at least one novel androgen axis drug [NAAD] (such as enzalutamide or abiraterone) and were previously treated with 1 to 2 taxane regimens. Patients treated with only 1 prior taxane regimen are eligible if the patient is unwilling or the patient's physician deems the patient unsuitable to receive a second regimen.||||
1306499|NCT03511651|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1306500|NCT03511638|Randomized|Parallel Assignment||Treatment||Quadruple||a multicenter, controlled, randomized, monocular trial of Bausch & Lomb DVisc40 (test) OVD compared to the currently marketed Alcon VISCOAT® (control) OVD|t|t|t|t
1306501|NCT03511625|Randomized|Parallel Assignment||Treatment||Single||||||t
1306502|NCT03511612|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1306503|NCT03511599|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1306504|NCT03511586|||Family-Based||Prospective|||||||
1306505|NCT03511573|||Cohort||Prospective|||||||
1306506|NCT03511560|Randomized|Parallel Assignment||Prevention||None (Open Label)||this is a prospective, randomized, open-label trial examining once versus twice daily tacrolimus dosing regimen using two preparations, Envarsus vs Prograf||||
1306507|NCT03511547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306508|NCT03511534|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Participants will choose to enter the psychotherapy or pharmacotherapy arm.||||
1306509|NCT03511521|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients receiving single dose steroids who become hyperglycemic will be randomized to two treatment arms in a parallel design: (1) NPH added to basal/bolus insulin; (2) increase in doses of basal and bolus insulin||||
1306510|NCT03511508|Randomized|Parallel Assignment||Prevention||Single||Intervention Group and Control group||||t
1306511|NCT03511495|||Case-Only||Cross-Sectional|||||||
1306512|NCT03511482|Randomized|Single Group Assignment||Supportive Care||Single|The study will have a blinded team to perform final assesments|Open Feasibility||||t
1306602|NCT03510312|||Cohort||Prospective|||||||
1306603|NCT03510299|Randomized|Parallel Assignment||Other||Double|||t||t|
1306513|NCT03511469|Randomized|Parallel Assignment||Treatment||Single|All assesment will be conducted with another therapist who is not aware of patient's treatment groups|Randomized Control, Parallel Group Study||||t
1306514|NCT03511456|||Case-Only||Retrospective|||||||
1306515|NCT03511443||Single Group Assignment||Diagnostic||None (Open Label)||If P.f malaria case were detected, the responsible malaria worker or basic health staff will inform to survey team and blood samples for cRDT, hsRDT, Dried Blood Spot for PCR will be collected from index case and contacts (nearby 10-household members and peers). Then the results of cRDT and hsRDT will be confirmed by PCR for evaluating their performance. Then the applicability of hsRDT to detect low parasitaemia for enhancing malaria elimination activities will be evaluated.||||
1306516|NCT03511430|||Cohort||Prospective|||||||
1306517|NCT03511417||Single Group Assignment||Treatment||None (Open Label)||||||
1306518|NCT03511404||Sequential Assignment||Diagnostic||None (Open Label)||A correlation study between clinical examination by Numeric Pain Rating Scale (NPRS) and electrophysiology assessment by surface EMG will be conducted at enrollment and 6 weeks physiotherapy.||||
1306519|NCT03511391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306520|NCT03511378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306521|NCT03511365||Single Group Assignment||Basic Science||None (Open Label)||Single group interventional pilot study with each subject serving as his or her own control||||
1306522|NCT03511352|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1306523|NCT03511339||||||||||||
1306524|NCT03511326||Single Group Assignment||Other||None (Open Label)||||||
1306525|NCT03511313|Randomized|Parallel Assignment||Treatment||Single|||t|||
1306526|NCT03511300|Randomized|Crossover Assignment||Other||Single|Participants will not be told which group they are assigned to.|The study is a single-blind randomized controlled trial. It employs a mixed design, with a between-subjects (instruction type: goal-setting or standard instructions) and a within subjects (pre- and post-instruction manipulation) variable. Seventy-two stroke patients will undergo baseline cognitive testing to assess their verbal ability, learning, memory, attention, visuospatial ability, and exective functioning, with standardized instructions. After completing baseline testing and ratings of apathy (AES), depression (CES-D), anxiety, motivation, and fatigue, participants (N = 72) will either be assigned to the standardized instruction condition (n = 30) or the goal-setting instruction condition (n = 30).|t|||
1306527|NCT03511287||Single Group Assignment||Treatment||None (Open Label)||All patients from the advanced lung disease and pre lung transplantation ambulatory||||
1306528|NCT03511274|Randomized|Parallel Assignment||Prevention||None (Open Label)||CMV seronegative pregnant women will be randomised to one of two study arms: treatment as usual or the education intervention||||
1306529|NCT03511261|Randomized|Factorial Assignment||Treatment||Single|single blinded|four groups, each group with different formulations.|t|||
1306530|NCT03511248|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind study, with randomisation undertaken by Barts Cardiovascular Clinical Trials Unit|Randomised double-blind placebo-controlled parallel two-limb study|t|t|t|t
1306531|NCT03511235|||Cohort||Retrospective|||||||
1306532|NCT03511222|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306533|NCT03511209|Randomized|Parallel Assignment||Treatment||Double|Only the participants and the outcome assessors will be masked.||t|||t
1306534|NCT03511196||Single Group Assignment||Treatment||None (Open Label)||||||
1306535|NCT03511183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306536|NCT03511170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306537|NCT03511157|Randomized|Single Group Assignment||Treatment||Single|||t|||
1306538|NCT03511144|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306539|NCT03511131|Randomized|Sequential Assignment||Prevention||Single|||t|||
1306540|NCT03511118|||Other||Prospective|||||||
1306541|NCT03511105|Randomized|Parallel Assignment||Treatment||Triple|This will be a double blind study where investigator, sub-investigators, other site staff and the subject will be blinded. Selected sponsor study team members will be unblinded to perform the interim analysis. This may include the medical monitor, study statistician, study programmer (and delegates) and study pharmacokineticist.|This is a randomised, placebo-controlled, parallel-group study wherein, subjects will be randomised in a ratio of 1:1 to receive 2 single doses of either 4.8 milligrams GSK2798745, then 2.4 milligrams GSK2798745 12 hours later; or a dose of placebo, then another dose of placebo 12 hours later.|t|t|t|
1306542|NCT03511092|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1306543|NCT03511079|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|There will be no blinding in this study.|There will be two groups. The intervention group will listen to music each night several days before and after surgery. The control group will not listen to music each night around the time of surgery.||||
1306544|NCT03511066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306545|NCT03511053||Single Group Assignment||Treatment||None (Open Label)||Each participant receives a saline lavage followed by the lumbar epidural steroid injection||||
1306546|NCT03511040||Single Group Assignment||Treatment||None (Open Label)||Prospective, multi-center, open-label, single-arm trial||||
1306547|NCT03511027|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This study will utilize a multi-site randomized controlled trial design. One week prior to discharge from inpatient rehab, consenting patients will be randomly assigned to receive medication self-management education only (SME) or medication self-management education + Karie (SME+K).||||
1306548|NCT03511014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306549|NCT03511001|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1306550|NCT03510988||Single Group Assignment||Treatment||None (Open Label)||||||
1306551|NCT03510975|Randomized|Parallel Assignment||Treatment||Single||All participants were divided into three groups. Twenty-five children and their parents were instructed only a verbal behavioral therapy, 25 were instructed a behavioral therapy with a written check-list form and 25 children received desmopressin treatment plus verbal behavioral therapy were randomly included in the study.|t|||
1306604|NCT03510286|||Cohort||Cross-Sectional|||||||
1306605|NCT03510273||Single Group Assignment||Treatment||None (Open Label)||Thermal coagulator ablation treatment||||
1306552|NCT03510962|Randomized|Crossover Assignment||Prevention||Single|only primary investigator will know the intervention done by the subject. The outcome investigator(assessor) will be unaware (blinded) to which intervention the subject is undertaken.|||||t
1306553|NCT03510949|Randomized|Parallel Assignment||Prevention||Triple||"Group N: Patients' nasal mucosa will be anaesthetized and vasoconstricted. The NPA will then be advanced into the dominant nostril along the septum horizontally.~Group L: K-Y gel will be applied to the tip of the laryngeal mask (LMA) of appropriate size. The LMA will be introduced along the hard palate towards the hypopharynx until resistance is felt."|t|t||t
1306554|NCT03510936|Randomized|Parallel Assignment||Treatment||Single|||t|||
1306555|NCT03510923|||Cohort||Prospective|||||||
1306556|NCT03510910|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1306557|NCT03510897|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1306558|NCT03510884|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1306559|NCT03510871||Single Group Assignment||Treatment||None (Open Label)||||||
1306560|NCT03510858|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1306561|NCT03510845|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1306562|NCT03510832|||Cohort||Prospective|||||||
1306563|NCT03510819|||Other||Cross-Sectional|||||||
1306564|NCT03510806|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1306565|NCT03510793|||Case-Control||Prospective|||||||
1306566|NCT03510780|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1306567|NCT03510767||Single Group Assignment||Treatment||None (Open Label)||||||
1306568|NCT03510754|||Cohort||Retrospective|||||||
1306569|NCT03510741|Randomized|Factorial Assignment||Other||Quadruple|Double-blind placebo controlled trial|This will be a 2x2 factorial design trial|t|t|t|t
1306570|NCT03510728|Randomized|Factorial Assignment||Treatment||Single||There are three conditions at the start of the study regarding assignment to a single-session intervention: none (control), standard BMI (CDCU), and the standard BMI plus a PBS-component. These are crossed with the type of application for their phone: an ecological momentary assessment-only or an ecological momentary intervention.|t|||
1306571|NCT03510715||Single Group Assignment||Treatment||None (Open Label)||||||
1306572|NCT03510702|||Case-Control||Cross-Sectional|||||||
1306573|NCT03510689|||Cohort||Prospective|||||||
1306574|NCT03510676||Single Group Assignment||Treatment||None (Open Label)||||||
1306575|NCT03510663|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1306576|NCT03510650|||Cohort||Prospective|||||||
1306577|NCT03510637|||Cohort||Prospective|||||||
1306578|NCT03510624||Single Group Assignment||Treatment||None (Open Label)||||||
1306579|NCT03510611|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306580|NCT03510598|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Kybella and CoolMini||||
1306581|NCT03510585|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1306582|NCT03510572|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1306583|NCT03510559|Randomized|Parallel Assignment||Supportive Care||Single|The research assistants who will be performing the follow-up assessments of the patient will be blinded as to block group allocation. No other members of the team will be blinded for this study due to methodological constraints as the end result of these blocks is very different due to upper arm weakness expected with brachial plexus blocks, but not with forearm blocks.|"Patients scheduled for ambulatory hand surgery will be assessed in the pre-operative assessment clinic at the time of surgical booking for recruitment into the study by their surgeon. A research assistant will then speak with the patient regarding the study in order to obtain informed consent for their participation.~If the patient consents to participate in the study, they will be randomized into either the brachial plexus or forearm nerve block groups. The research assistants will be blinded as to the patient's allocation and during block performance to minimize bias."||||t
1306584|NCT03510546|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1306585|NCT03510533|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Eating disorders compared to healthy volonteers||||
1306586|NCT03510520|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a single-centre, pilot, open-label, interventional, randomised controlled study.||||
1306587|NCT03510507|||Cohort||Retrospective|||||||
1306588|NCT03510494|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Intervention group receiving 270 minutes of weekly physical education Control group receiving 90 minutes of weekly physical education Intervention group physical education teachers receiving physical education courses (ATK-concept)||||
1306589|NCT03510481|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1306590|NCT03510468||Single Group Assignment||Other||None (Open Label)||||||
1306591|NCT03510455||Single Group Assignment||Treatment||None (Open Label)||||||
1306592|NCT03510442|||Cohort||Prospective|||||||
1306593|NCT03510429|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1306594|NCT03510416||Single Group Assignment||Treatment||None (Open Label)||||||
1306595|NCT03510403||Single Group Assignment||Treatment||None (Open Label)||||||
1306596|NCT03510390||Single Group Assignment||Other||None (Open Label)||Window-of-opportunity||||
1306597|NCT03510377|Randomized|Parallel Assignment||Prevention||None (Open Label)||Volunteers that will meet the inclusion criteria will be randomly divided to three intervention groups.||||
1306598|NCT03510364||Single Group Assignment||Other||Single|Participants were blinded to the actual study aim. They were told that the aim of the study is to study the relationship between consumption of dietary macronutrient ratios and metabolic rate.|A prospective feeding study with convenience sampling|t|||
1306599|NCT03510351|||Case-Only||Retrospective|||||||
1306600|NCT03510338|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1306601|NCT03510325|Randomized|Sequential Assignment||Treatment||Double||"Real-World Study Based on SMART Design: Subjects were arranged according to patient's wishes and randomized allocation. Next phase of treatment was determined based on the patient's response (efficacy and adverse reactions). We could not achieve double blind designed protocol; however, assessor's blindness could be achieved in the design."|||t|t
1306606|NCT03510260|Randomized|Parallel Assignment||Other||None (Open Label)||Unblinded randomized clinical trial.||||
1306607|NCT03510247|||Cohort||Retrospective|||||||
1306608|NCT03510234|||Cohort||Prospective|||||||
1306609|NCT03510221|Non-Randomized|Parallel Assignment||Treatment||Single||A group of hypertensive patients and a group of normotensive individuals|t|||
1306610|NCT03510208|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1306611|NCT03510195||Single Group Assignment||Other||None (Open Label)||||||
1306612|NCT03510182||Single Group Assignment||Treatment||None (Open Label)||All eligible participants with aphasia will receive the tDCS||||
1306613|NCT03510169||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1306614|NCT03510156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306615|NCT03510143|Randomized|Parallel Assignment||Treatment||Single|Participants cannot know the Neoveil apply in their surgery|Neoveil applied // Neoveil non-applied|t|||
1306616|NCT03510130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306617|NCT03510117||Single Group Assignment||Other||None (Open Label)||To evaluate different forms of validity (e.g., construct, criterion), responsiveness to change over time, and estimation of minimally important differences, we will administer new mindfulness short forms, legacy measures, and an experiential measure of focused attention to ~250 mindfulness students at baseline, 8-weeks, and 16 weeks in multiple, on-going 8-week Mindfulness-Based Stress Reduction (MBSR) courses and similar MBI programs at Pittsburgh and Chicago sites, as well as at member sites from the Academic Consortium for Integrative Medicine and Health and the BraveNet Practice-Based Research Network.||||
1306618|NCT03510104||Single Group Assignment||Treatment||None (Open Label)||||||
1306619|NCT03510091||Single Group Assignment||Health Services Research||None (Open Label)||||||
1306620|NCT03510078|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306621|NCT03510065|||Cohort||Prospective|||||||
1306622|NCT03510052||Single Group Assignment||Treatment||None (Open Label)||||||
1306623|NCT03510039|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"Mono-centric pilot comparative study like  Before /After . It will be necessary to recruit at first 35 thirds benefiting from the in current load, Before phase, then to set up our intervention, and recruit another 35 different thirds for the After."||||
1306624|NCT03510026||Single Group Assignment||Treatment||None (Open Label)||||||
1306625|NCT03510013||Single Group Assignment||Treatment||None (Open Label)||All participants will receive sevoflurane 8% with O2:N2O or O2:air 1:1 L/min under controlled ventilation. Time to achieve alveolar concentration of sevoflurane of 1%, 1.5%, 2%, 2.5%, 3% and 3.5% will be recorded.||||
1306626|NCT03510000||Single Group Assignment||Treatment||None (Open Label)||||||
1306627|NCT03509987||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306628|NCT03509974||Single Group Assignment||Treatment||None (Open Label)||||||
1306629|NCT03509961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306630|NCT03509948|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306631|NCT03509935|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306632|NCT03509922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306633|NCT03509909|Randomized|Parallel Assignment||Treatment||Single|The outcome evaluator is blind to experimental condition|Experimental condition: Manualized hatha yoga, a 12-session group-based yoga class led by a trained teacher Control condition: Manualized supportive physical activity, a 12-session group-based stretching and strengthening class led by a trained instructor||||t
1306634|NCT03509896|||Cohort||Retrospective|||||||
1306635|NCT03509883|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306636|NCT03509870||Single Group Assignment||Treatment||None (Open Label)|open|unblinded single arm intervention||||
1306637|NCT03509857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306638|NCT03509844|Randomized|Parallel Assignment||Treatment||Single|Outcome is assessed with CAPS-V by research assistants blind to the patients allocation to treatment arms|||||t
1306639|NCT03509831|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306640|NCT03509818|Randomized|Single Group Assignment||Other||Single||Description of the sample|t|||
1306641|NCT03509805|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306642|NCT03509792|Randomized|Parallel Assignment||Prevention||Single|||t|||
1306643|NCT03509779|||Cohort||Other|||||||
1306644|NCT03509766||Single Group Assignment||Diagnostic||Single|Neither the subject nor the technician are masked as to which device is being placed. However, the investigator who reads the skin prick test results is blinded as to which device is which.||||t|
1306645|NCT03509753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306646|NCT03509740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306647|NCT03509727|||Cohort||Prospective|||||||
1306648|NCT03509714|Randomized|Crossover Assignment||Treatment||Triple|Oxaloacetate/Vitamin C capsules were bottled in 30 count HDPE bottles. Placebo capsules (rice flour) were manufactured to similar size capsules and bottles. Bottles were labeled either Group A or Group 1. Code was broken at the end of Phase 1 of the study.|Baseline measurement of all participants. Randomized double-blinded placebo controlled crossover study for Phase 1. Due to carry-over effects, Phase 2 of the study started each participant with placebo.|t|t|t|
1306649|NCT03509701|||Case-Control||Prospective|||||||
1306650|NCT03509688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306651|NCT03509675|Randomized|Crossover Assignment||Treatment||Triple|Double-blinded crossover study|Non Steroidal anti-inflammatory topical rinse|t|t|t|
1306693|NCT03509129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306694|NCT03509116|||Other||Other|||||||
1306695|NCT03509103|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1306696|NCT03509090|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1306697|NCT03509077|||Other||Prospective|||||||
1306698|NCT03509064|||Other||Prospective|||||||
1306699|NCT03509051||Single Group Assignment||Prevention||None (Open Label)||||||
1306652|NCT03509662|Randomized|Parallel Assignment||Treatment||Quadruple||"In this multicentre, placebo controlled double-blind randomized clinical trial patients will be recruited from the Intensive Care Units of 8 hospitals.~270 comatose patients suffering an out-of-hospital cardiac arrest with ventricular fibrillation/tachycardia as first registered cardiac rhythm and EMV-score ≤8 will be included.~As soon as possible patients will be randomly allocated to one of 3 treatment groups of 90 patients each and vitamin C or placebo will be started for 96 hours. Group 1 will be treated with placebo, group 2 with 2 times a day a bolus of 1.5 gr vitamin C and group 3 with 2 times a day a bolus of 5 gr vitamin C.~All patients will receive thiamine 200 mg q 12 hourly for 4 days to limit the conversion of vitamin C to oxalate."|t|t|t|t
1306653|NCT03509649|Randomized|Parallel Assignment||Treatment||Triple|Participants randomly assigned to one of 2 instructional sets (positive/ negative) and randomly assigned to one of 2 practitioner experience levels (experienced/ novice)||t||t|t
1306654|NCT03509636||Single Group Assignment||Treatment||None (Open Label)||||||
1306655|NCT03509623||Single Group Assignment||Screening||None (Open Label)||||||
1306656|NCT03509610|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1306657|NCT03509597|Randomized|Parallel Assignment||Treatment||Double|Patients are trained to not comment about the type os treatment they have been assigned to with the investigator who performs the assessments.|Randomized parallel assignment: Cognitive Training, Aerobic Exercise & Treatment as usual.|||t|t
1306658|NCT03509584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306659|NCT03509571|Randomized|Parallel Assignment||Other||Single||||||t
1306660|NCT03509558|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306661|NCT03509545|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1306662|NCT03509532|||Cohort||Prospective|||||||
1306663|NCT03509519|Randomized|Parallel Assignment||Treatment||Single||This clinical trial will use a pre-test - post-test randomized experimental design. Subject will be randomly assigned to the treatment group or the sham group. Study outcomes will be measured pre- and post-intervention.|t|||
1306664|NCT03509506|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306665|NCT03509493|||Cohort||Prospective|||||||
1306666|NCT03509480|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparison of ultraporous beta-tricalcium phosphate (Vitoss) with autologous bone marrow aspirate vs ultraporous beta-tricalcium phosphate with calcium sulfate (Prodense)||||
1306667|NCT03509467|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306668|NCT03509454|||Cohort||Cross-Sectional|||||||
1306669|NCT03509441|||Case-Control||Cross-Sectional|||||||
1306670|NCT03509428|Randomized|Factorial Assignment||Treatment||Double|Masking of CPET assessors and dual reporting, masking of personnel involved in outcome data collection, masking of sarcopenia assessors|2x2 factorial design randomised controlled interventional trial|||t|t
1306671|NCT03509415|||Cohort||Prospective|||||||
1306672|NCT03509402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306673|NCT03509389|||Cohort||Prospective|||||||
1306674|NCT03509376|Randomized|Parallel Assignment||Treatment||Single|The physiotherapist doing the clinical examinations at different phases of the study|Patients are randomised to a suture repair or suture with mesh repair||||t
1306675|NCT03509363|Randomized|Parallel Assignment||Treatment||Single|All research study personnel, including those who collect data and assess outcomes will be blinded to the group assignment. The envelopes and the randomization list will not be revealed to any of the study personnel until completion of recruitment and data collection.|randomized, controlled||||t
1306676|NCT03509350|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1306677|NCT03509337|||Cohort||Prospective|||||||
1306678|NCT03509324||Single Group Assignment||Treatment||None (Open Label)||||||
1306679|NCT03509311|||Case-Control||Cross-Sectional|||||||
1306680|NCT03509298|Randomized|Parallel Assignment||Treatment||Quadruple|With the method of minimum randomized dynamic random by the interactive network response system (IWRS),Participants were assigned to three groups,receive cryotherapy,conventional therapy, and activated CIK armed with anti-CD3-MUC1 bispecific antibody together with cryotherapy .every participant has a unique identification number and emergency letter which have the information of group.|This is a phase II clinical trial of single-center, and it will divide into three groups.|t|t|t|t
1306681|NCT03509285|Randomized|Crossover Assignment||Basic Science||Double|Double-blind||t||t|
1306682|NCT03509272|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306683|NCT03509259|||Cohort||Prospective|||||||
1306684|NCT03509246||Single Group Assignment||Treatment||None (Open Label)||||||
1306685|NCT03509233|Randomized|Parallel Assignment||Treatment||Single|The examiner performing the measurement of all clinical periodontal parameters is not aware of the type of treatment provided to the patient.|multicenter randomized controlled intervention trial|||t|
1306686|NCT03509220|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1306687|NCT03509207||Single Group Assignment||Treatment||None (Open Label)||||||
1306688|NCT03509194|||Cohort||Prospective|||||||
1306689|NCT03509181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1306690|NCT03509168|Randomized|Parallel Assignment||Treatment||Double||multicenter-randomized single blind controlled trial with a (1:1) allocation ratio.|t|t||
1306691|NCT03509155|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"The intervention is running parallel in three arms.~The first arm as a control group obtaining only routine IYCF counseling by the cadre and without the provision of biscuits. If there are respondents at the first three months data collection who experience a decrease in nutritional status, then the respondent will be given biscuits immediately~The second arm as the first intervention group to get biscuit with portion as recommended by Ministry of Health and also given the IYCF counseling by the cadres and nutritionist~The third arm as the second intervention group receiving biscuit with adjustment in portion and IYCF Counseling that emphasize the optimization of local food In the 2nd and 3rd arm, treatment was administered for 3 months according to the recommended duration of biscuit delivery by the Ministry of Health, but all respondents from three arms will continue to be followed in third, sixth, and ninth months from the beginning of treatment."||||
1306692|NCT03509142||Single Group Assignment||Treatment||None (Open Label)||||||
1306700|NCT03509038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306701|NCT03509025||Single Group Assignment||Treatment||None (Open Label)||||||
1306702|NCT03509012|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306703|NCT03508999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306704|NCT03508986|||Cohort||Prospective|||||||
1306705|NCT03508973||Single Group Assignment||Treatment||None (Open Label)||||||
1306706|NCT03508960|||Cohort||Prospective|||||||
1306707|NCT03508947|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1306708|NCT03508934|Randomized|Parallel Assignment||Prevention||None (Open Label)||Glucose Telemetry System (Continuous Glucose Monitoring Devices)||||
1306709|NCT03508921|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306710|NCT03508908|Randomized|Crossover Assignment||Prevention||None (Open Label)||This trial will use a modified stepped wedge design to evaluate the yield of the HIV-1 RNA testing intervention at 6 public or private health facilities in Kenya, before (1,375 patients) and after (1,500 patients) intervention delivery. This study will be conducted in two phases (observation phase and intervention phase) at each site.||||
1306711|NCT03508895|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1306712|NCT03508882|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1306713|NCT03508869|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306714|NCT03508856||Single Group Assignment||Treatment||None (Open Label)||||||
1306715|NCT03508843||Single Group Assignment||Prevention||None (Open Label)||||||
1306716|NCT03508830|Randomized|Parallel Assignment||Treatment||Triple|Syringe with Obscuring Over-Wrap||t|t|t|
1306717|NCT03508817|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Intervention group: Optimal myopia correction with single vision glasses and topical atropine 0.01%, one drop at night time.~Control group: Optimal myopia correction with single vision glasses"||||
1306718|NCT03508804|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1306719|NCT03508791|Non-Randomized|Parallel Assignment||Other||Double|||t|||t
1306720|NCT03508778||||||||||||
1306721|NCT03508765||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306722|NCT03508752||Single Group Assignment||Treatment||None (Open Label)||||||
1306723|NCT03508739|Randomized|Crossover Assignment||Other||Quadruple|Double-blind|prospective randomized, double-blind, crossover study, mechanistic/ translational study (not to change labeling or marketing, not classic phase 3 or 4 study), IND exempt|t|t|t|t
1306724|NCT03508726||Single Group Assignment||Treatment||None (Open Label)||||||
1306725|NCT03508713|||Cohort||Prospective|||||||
1306726|NCT03508700||Single Group Assignment||Treatment||None (Open Label)||Open-label Study||||
1306727|NCT03508687|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1306728|NCT03508674||Single Group Assignment||Other||None (Open Label)||||||
1306729|NCT03508661||Single Group Assignment||Supportive Care||None (Open Label)||||||
1306730|NCT03508648|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1306731|NCT03508635|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1306732|NCT03508622|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial.||||
1306733|NCT03508609||Single Group Assignment||Treatment||None (Open Label)||||||
1306734|NCT03508596|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1306735|NCT03508583|||Case-Only||Prospective|||||||
1306736|NCT03508570|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306737|NCT03508557||Single Group Assignment||Other||None (Open Label)||Single group before-after||||
1306738|NCT03508544|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1306739|NCT03508531|Randomized|Crossover Assignment||Treatment||Triple||Controlled randomized study|t|t||t
1306740|NCT03508518|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1306741|NCT03508505|||Cohort||Retrospective|||||||
1306742|NCT03508492|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1306743|NCT03508479||Single Group Assignment||Basic Science||None (Open Label)||||||
1306744|NCT03508466|||Case-Only||Cross-Sectional|||||||
1306745|NCT03508453|Randomized|Parallel Assignment||Treatment||Quadruple|Pharmacy preparation of identical-appearing placebo|Randomized, Double-Blind, Placebo-Controlled|t|t|t|t
1306746|NCT03508440|Randomized|Parallel Assignment||Treatment||None (Open Label)|There is no masking available as subject will know if they are receiving an intratympanic injection.|One arm will receive standard of care (SOC) in the form of high dose oral steroids for 10 days. The second arm will receive SOC plus 3 intratympanic steroid injections (space 7 days apart). Arm 3 is for patients who can not, for medical reasons, receive SOC; these patients will receive 3 intratympanic steroid injections (space 7 days apart).||||
1306747|NCT03508427||Single Group Assignment||Supportive Care||None (Open Label)||One-arm study||||
1306748|NCT03508414|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1306749|NCT03508401||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306750|NCT03508388|||Cohort||Prospective|||||||
1306751|NCT03508375|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1306752|NCT03508362|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1306753|NCT03508349|Randomized|Parallel Assignment||Prevention||Single||Health facilities in high malaria transmission zones were pair matched and then randomized to be an intervention or a control facility.|t|||
1306754|NCT03508336|||Cohort||Prospective|||||||
1306755|NCT03508323|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1306756|NCT03508310|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Quasi-experimental design, in which the intervention condition (i.e., video and posters) was implemented for 10 months and the historical comparison condition (i.e., standard waiting room environment) was the prior 10-month period.||||
1306757|NCT03508297|||Cohort||Prospective|||||||
1306758|NCT03508284|||Case-Control||Cross-Sectional|||||||
1306759|NCT03508271|||Cohort||Retrospective|||||||
1306760|NCT03508258|||Cohort||Retrospective|||||||
1306761|NCT03508245||Single Group Assignment||Treatment||None (Open Label)||||||
1306762|NCT03508232|Randomized|Parallel Assignment||Prevention||Quadruple|Double-blinding. Randomization will be done prior to the study and with binary encoding, for further blinding. Drug randomization (placebo or doxycycline) will be done by the Drug Development and Innovation Centre in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, with 50% allocated in the Placebo Control Group and 50% in the Doxycycline Group. The coding list will be generated and kept sealed by the PI. Patients will be randomized during recruitment, following a previously generated list with 50% of patients allocated to each group.|Randomized, double-blinded, placebo-controlled study|t|t|t|t
1306763|NCT03508219||Single Group Assignment||Treatment||None (Open Label)||||||
1306764|NCT03508206|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1306765|NCT03508193||Single Group Assignment||Treatment||None (Open Label)||||||
1306766|NCT03508180|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306767|NCT03508167|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1306768|NCT03508154|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1306769|NCT03508141|Randomized|Parallel Assignment||Treatment||Single||||||t
1306770|NCT03508128|||Cohort||Retrospective|||||||
1306771|NCT03508115|||Case-Only||Prospective|||||||
1306772|NCT03508102|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1306773|NCT03508089|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1306774|NCT03508076|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1306775|NCT03508063|||Other||Retrospective|||||||
1306776|NCT03508050|Randomized|Parallel Assignment||Basic Science||Triple||"Just before induction of anesthesia and according to the computerized randomization list generated by the statistical department, each of the 30 patients is allocated to one of the following groups:~Control group : OLV with the specific lumen of the NVL opened to ambient air. Experimental group : OLV with a clamp on the specific lumen of the NVL"|t|t||t
1306777|NCT03508037|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1306778|NCT03508024|||Cohort||Retrospective|||||||
1306779|NCT03508011||Single Group Assignment||Treatment||None (Open Label)||||||
1306780|NCT03507998||Single Group Assignment||Treatment||None (Open Label)||||||
1306781|NCT03507985|||Cohort||Prospective|||||||
1306782|NCT03507972||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306783|NCT03507959|Randomized|Parallel Assignment||Treatment||Single|With regard to the four treatment groups, the investigator is not aware which experimental condition participants were allocated to. Regarding the control group, masking is not feasible.|Participants are assigned to one of five experimental groups in parallel for the duration of the study|||t|
1306784|NCT03507946||Single Group Assignment||Treatment||None (Open Label)|"Randomization will be conducted by the study coordinator and will take place in a separate room away from the PI.~The Study coordinator will number the 2 plaques 1 and 2. The Study coordinator will draw a sequential envelope containing the randomization code for the control and test. The code will inform the study coordinator which plaque is control and which test.~The Study coordinator will complete the randomization coding worksheet which identifies the test and control plaque and location.~The randomization coding worksheet will be kept separate from the subjects' case report form."|Randomized, Blinded, Controlled Trial||||
1306785|NCT03507933|||Case-Only||Retrospective|||||||
1306786|NCT03507920|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306787|NCT03507907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1306788|NCT03507894|||Other||Prospective|||||||
1306789|NCT03507881|||Cohort||Prospective|||||||
1306790|NCT03507868|||Cohort||Prospective|||||||
1306791|NCT03507855|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1306792|NCT03507842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306793|NCT03507829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306794|NCT03507816|||Cohort||Retrospective|||||||
1306795|NCT03507803|Randomized|Parallel Assignment||Treatment||Single|Clinician involved in rehabilitation will not know if participant has been enrolled in the gait biofeedback arm or the control (no biofeedback) arm.|Participants will be randomized at the baseline visit to either the intervention or control group. The intervention group will receive gait biofeedback. Participants will remain within their designated allocation for the entire study.||t||
1306796|NCT03507790|Randomized|Parallel Assignment||Treatment||Quadruple||This is a multi-center Phase 2, randomized, double-blind, placebo-controlled, parallel-group study.|t|t|t|t
1306797|NCT03507777|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306798|NCT03507764|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306799|NCT03507751|||Case-Control||Prospective|||||||
1306800|NCT03507738|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306801|NCT03507725|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306802|NCT03507712|Randomized|Parallel Assignment||Treatment||Double|Both participants and outcome assessor (the orthoptist) will be blinded regarding the type of surgery|"Group I: Symmetrical IO weakening surgery - Bilateral IO Myectomy / Bilateral equal graded IO Recession (Same surgery in both eyes).~Group II: Asymmetrical IO weakening surgery - IO Myectomy in one eye - IO Recession in the fellow eye / Bilateral IO Recession (different amounts) in each eye."|t|||t
1306803|NCT03507699|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||a phase I inter-patient dose-escalation study.||||
1306804|NCT03507686||Single Group Assignment||Treatment||None (Open Label)||||||
1306805|NCT03507673|||Cohort||Prospective|||||||
1306806|NCT03507660||Single Group Assignment||Treatment||None (Open Label)||all participants will receive the same six verbal instruction given in a random order.||||
1306807|NCT03507647|Randomized|Parallel Assignment||Treatment||Single|Outcomes will be assessed by independent research assistants blind to condition. Participants will be instructed to avoid unblinding as much as possible.|Randomized, multicenter, prospective, evaluator-blinded clinical trial of MBCT added to treatment as usual (TAU) versus TAU alone||||t
1306808|NCT03507634|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1306810|NCT03507608|Randomized|Parallel Assignment||Treatment||None (Open Label)||The initial phase is a 6-patient single-arm run-in phase to test feasibility and rule out futility of the intervention. All patients within the run-in phase will receive 50mg flutamide prior to brachytherapy and prostatic biopsy. If futility is ruled out (>1 patients with DSBs on biopsy), then accrual will continue in the randomized in a 2:1 ratio (12:6 patients), for an all-trial total of 18 patients receiving flutamide vs 6 patients receiving placebo.||||
1306811|NCT03507595|||Cohort||Prospective|||||||
1306812|NCT03507582|Randomized|Parallel Assignment||Other||Single||||||t
1306813|NCT03507569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1306814|NCT03507556||Single Group Assignment||Treatment||None (Open Label)||Revascularization for immature necrotic permanent teeth with apical periodontitis.||||
1306815|NCT03507543||Single Group Assignment||Treatment||None (Open Label)||||||
1306816|NCT03507530|||Cohort||Prospective|||||||
1306817|NCT03507517|||Cohort||Prospective|||||||
1306818|NCT03507504|||Cohort||Prospective|||||||
1306819|NCT03507491||Single Group Assignment||Treatment||None (Open Label)||||||
1306820|NCT03507478||Single Group Assignment||Treatment||None (Open Label)||||||
1306821|NCT03507465|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306822|NCT03507452|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1306823|NCT03507439|||Cohort||Prospective|||||||
1306824|NCT03507426|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1306825|NCT03507413|Randomized|Parallel Assignment||Treatment||Quadruple||prospective, randomized, double blind, placebo-controlled, safety and efficacy study|t|t|t|t
1306826|NCT03507400|Randomized|Sequential Assignment||Prevention||None (Open Label)||waiting list control study||||
1306827|NCT03507387|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1306828|NCT03507374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306829|NCT03507361|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1306830|NCT03507348|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1306831|NCT03507335|||Case-Control||Prospective|||||||
1306832|NCT03507322|||Cohort||Prospective|||||||
1306833|NCT03507309|||Cohort||Prospective|||||||
1306834|NCT03507296|||Case-Control||Prospective|||||||
1306835|NCT03507283|||Cohort||Retrospective|||||||
1306836|NCT03507270||Single Group Assignment||Diagnostic||None (Open Label)||Single-center study||||
1306837|NCT03507257|||Cohort||Prospective|||||||
1306838|NCT03507244||Single Group Assignment||Treatment||None (Open Label)||||||
1306839|NCT03507231|Randomized|Parallel Assignment||Prevention||Single|||t|||
1306840|NCT03507218|||Case-Control||Prospective|||||||
1306841|NCT03507205|||Cohort||Prospective|||||||
1306842|NCT03507192|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306843|NCT03507179|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1306844|NCT03507166||Single Group Assignment||Treatment||None (Open Label)||Drug: RC48-ADC||||
1306845|NCT03507153|Randomized|Parallel Assignment||Other||Double|"Only statistician will be blinded as the 2 materials have different colors The patients: they won't be aware of the lab procedures till finishing and delivery of the dentures.~The outcome assessor: the assessor who will assess the muscular activity will be blinded."||t|||t
1306846|NCT03507140|||Cohort||Prospective|||||||
1306847|NCT03507127|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1306848|NCT03507114|Randomized|Parallel Assignment||Treatment||Single|Folow-up interviews will be carried out by a different team of assessors (blinded to the treatment condition)|||||t
1306849|NCT03507101|||Case-Only||Prospective|||||||
1306850|NCT03507088||Single Group Assignment||Treatment||None (Open Label)||All patients will undergo FES-PET/CT at baseline and FES-PET after 28 days of fulvestrant treatment. Whenever possible, tumor biopsies will be performed to correlate to FES-PET results.||||
1306851|NCT03507075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306852|NCT03507062|Non-Randomized|Parallel Assignment||Other||Single||||||t
1306853|NCT03507049|Randomized|Parallel Assignment||Treatment||Quadruple|double blinded|Randomized controlled trial comparing sacroiliac joint fusion and sham surgery. A prospective double blinded randomized controlled multicenter trial.|t|t|t|t
1306854|NCT03507036||Single Group Assignment||Treatment||None (Open Label)||||||
1306855|NCT03507023|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1306856|NCT03507010|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1306857|NCT03506997||Single Group Assignment||Treatment||None (Open Label)||Two stage Simon Minimax design phase II trial, with 90% power and 5% type I error to discard treatment if <20% responses are observed and detect activity >40%||||
1306858|NCT03506984|Randomized|Parallel Assignment||Prevention||Single|the participant|Participants will randomely divided into two equal groups. Group (A) will receive a programe of high intensity interval training 30-40 minutes three times per week for one month.the participant will start cycling slowly for five minute without resistance at the beginning of the exercise as warming up, then the active phase will last 20-30 minutes, then decrease the speed with no resistance at the end of the exercise as cooling down. The participant will be closely monitored by the handheld telemetry. Group (B) will receive a program of inspiratory muscle training by using the threshold based inspiratory muscle trainer for 10-15 minutesonce daily with frequency three times per week for four weeks.|t|||
1306859|NCT03506971|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306860|NCT03506958|||Cohort||Prospective|||||||
1306861|NCT03506945|Randomized|Parallel Assignment||Treatment||Single||||||t
1306862|NCT03506932|Randomized|Crossover Assignment||Prevention||None (Open Label)||Randomized, controlled, cross-over study||||
1306863|NCT03506919|Randomized|Parallel Assignment||Treatment||Single|||t|||
1306864|NCT03506906|||Cohort||Prospective|||||||
1306865|NCT03506893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306910|NCT03506308||Single Group Assignment||Treatment||None (Open Label)||||||
1573372|NCT00001448||||||||||||
1306866|NCT03506880|Randomized|Parallel Assignment||Prevention||Single||1 group receives the MADD parent intervention; the second group receives active control parent materials from the Surgeon General; and the third group is TAU|t|||
1306867|NCT03506867|Randomized|Crossover Assignment||Other||Double|The research staff analyzing the data and members of the Data and Safety Monitoring Committee will be blinded to the allotment and reported outcomes.|Randomized Controlled Cross-Over Trial comparing access to improvement in 'social capital' vs. usual care in low income People Who Use Drugs at-risk for or living with HIV/AIDS and/or HCV. The usual care group will be offered the intervention after six months.|||t|t
1306868|NCT03506854|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1306869|NCT03506841|Randomized|Parallel Assignment||Treatment||Single||||||t
1306870|NCT03506828|Randomized|Parallel Assignment||Treatment||Single|Single blind (Investigator) study||||t|
1306871|NCT03506815|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Pilot Trial comparing two groups - Rivaroxaban 10mg po daily x90 days vs standard of care(usual treatment)||||
1306872|NCT03506802||Single Group Assignment||Treatment||None (Open Label)||||||
1306873|NCT03506789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1306874|NCT03506776|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306875|NCT03506763|Randomized|Sequential Assignment||Treatment||Triple|RCT, blind|RCT|t|t|t|
1306876|NCT03506750|Randomized|Parallel Assignment||Treatment||Single|||||t|
1306877|NCT03506737|Randomized|Sequential Assignment||Treatment||Double|||||t|t
1306878|NCT03506724|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients who present to the hospitals in this study will be randomized to receive IV labetalol or oral nifedipine when presenting with persistent severe range blood pressures (2 readings or more within 15 minutes) of either 160mmHg systolic or 110mmHg diastolic. These anti-hypertensives are first line therapy for management of severe range blood pressures by the American Congress of Obstetricians and Gynecologists.||||
1306879|NCT03506711|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1306880|NCT03506698|||Case-Only||Prospective|||||||
1306881|NCT03506685|Randomized|Factorial Assignment||Treatment||Single||2x5 mixed model anova||||t
1306882|NCT03506672|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1306883|NCT03506659|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Parallel group open label Monocentric||||
1306884|NCT03506646|Randomized|Crossover Assignment||Treatment||Double||1:1 randomized, cross-over, double-blinded|t||t|
1306885|NCT03506633|Randomized|Crossover Assignment||Treatment||Double||1:1 Randomized, cross-over, double-blinded design|t||t|
1306886|NCT03506620|Randomized|Parallel Assignment||Treatment||Double|The anesthesiologist, surgeon, and patient will all be blinded to the intervention. After patients consent to join the study, a member of the study team who is not involved in patient care will randomly allocate patients to 1 of 2 groups, the intervention or the controls. A statistician not involved with the study will creat a randomization table and coordinate with the Research Pharmacy to keep the study team blinded. Naropin (Ropivacaine) will be dispensed by the research pharmacy. The nurse will prepare the study injection accordingly for the blind anesthesiologist to administer. The QL block will be administered by a trained musculoskeletal regional anesthesia specialist before the standard induction of general anesthesia. The injection will occur under sedation to minimize discomfort for the patient. The QL block group's injection will consist of 20 cc of 0.25% Ropivacaine, whereas the control group will receive 20 cc of saline.|This study is a randomized, controlled, double-blind trial. Patients undergoing hip arthroscopy who agree to participate will be randomly selected to receive an ultrasound-guided QL block with either local anesthetic (QL block group) or normal saline (control group) preoperatively.|t|t||
1306887|NCT03506607|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1306888|NCT03506594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1306889|NCT03506581|||Cohort||Cross-Sectional|||||||
1306890|NCT03506568|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1306891|NCT03506555|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1306892|NCT03506542|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients are randomized and have phacotrabeculectomy augmented with either OLO (Ologen) or MMC (Mitomycin C).||||
1306893|NCT03506529|||Case-Control||Prospective|||||||
1306894|NCT03506516|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1306895|NCT03506503||Single Group Assignment||Treatment||None (Open Label)||||||
1306896|NCT03506490||Single Group Assignment||Prevention||None (Open Label)||||||
1306897|NCT03506477|Randomized|Crossover Assignment||Treatment||Quadruple|Double-blind, vehicle-controlled from week 0 to 4|4:1 Enstilar(R): placebo from baseline to week 4, then open-label Enstilar from weeks 4 to 8.|t|t|t|t
1306898|NCT03506464|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306899|NCT03506451||Single Group Assignment||Other||None (Open Label)||||||
1306900|NCT03506438|Randomized|Parallel Assignment||Supportive Care||Double|"The electronic study data system login/password arrangement will not allow any investigator to ascertain treatment group.~The study data system will automatically send links to study surveys for participant self-completion, and therefore outcomes assessors will be blinded to the majority of post-randomization data collection."|Unit of randomization is the ICU clinician. We anticipate 15 clinicians for intervention and 15 for control. Therefore each clinician will likely have 6-12 family members each.|||t|t
1306901|NCT03506425|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1306902|NCT03506412||Single Group Assignment||Treatment||None (Open Label)||Entresto™ will be administered to subjects with high and low circulating neprilysin (NEP) levels.||||
1306903|NCT03506399|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1306904|NCT03506386|||Cohort||Retrospective|||||||
1306905|NCT03506373||Single Group Assignment||Treatment||None (Open Label)||||||
1306906|NCT03506360||Single Group Assignment||Treatment||None (Open Label)||||||
1306907|NCT03506347|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306908|NCT03506334||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1306909|NCT03506321||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306911|NCT03506295|Randomized|Parallel Assignment||Supportive Care||Double|Primary bronchoscopist will perform localization of biopsy spot, after biopsy is determined to be in the control or intervention group. He/she will then perform the cryobiopsy per protocol. A bedside assistant will assist in managing the endobronchial blocker at all times. Secondary bronchoscopist will be stationed outside the operating room during initial part of the procedure. He will be prompted to enter the room by research coordinator to take control of the bronchoscope and assess post cryobiopsy bleeding. He will hence be blinded to the use or non-use of radial probe ultrasound. Research coordinator will be present at all times and will coordinate the switching process between proceduralists. Reference image of the radial USG determining the biopsy location on fluoroscopy monitor will be erased before secondary bronchoscopist enters the room. Patient will be blinded as he/she will be sedated. Four biopsies will be planned per procedure, two each from control & intervention arm.||t|t||
1306912|NCT03506282|Randomized|Crossover Assignment||Prevention||Double|The participants and the research assistant operator who will deliver the experimental conditions will not be masked to the condition whilst the outcome assessor, the statistician and the principal investigator will be blinded.|"The experimental conditions to be tested in each subject will be: 0, running with no music; 1, running and listening to audio track resembling normal outdoor noise (70 dB); 2, running with music at moderate volume (80 dB); 3, running with music at moderate to high volume (85 dB). The experimental conditions will be carried out in random order, with a wash-out period of 10 minutes, to ensure the return to the auditory and vestibular baseline.~Depending on the random sequence generated, the subject will undergo the four conditions in the specified order. Each condition will be completed with the three steps lasting 2 mins each (A, running at 6 km/h; B, running at 8 km/h; C, running at 10 km/h) and carried out at 1-min time interval in between, before proceeding to the next one. A complete rest of 10 minutes will be allowed among the conditions to restore the physiological state of the auditory and vestibular systems and to recover from the submaximal running effort."|||t|t
1306913|NCT03506269|||Ecologic or Community||Cross-Sectional|||||||
1306914|NCT03506256||Single Group Assignment||Treatment||None (Open Label)||||||
1306915|NCT03506243|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1306916|NCT03506230|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized to the intervention group and the control group. The randomization will be in blocks of 6. In addition, the randomization will be in strata according to the level of HbA1c: 8.5% <HbA1c> 9.5%, 9.6%> HbA1c> 11%.||||
1306917|NCT03506217|||Other||Retrospective|||||||
1306918|NCT03506204|||Cohort||Prospective|||||||
1306919|NCT03506191|||Cohort||Retrospective|||||||
1306920|NCT03506178|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1306921|NCT03506165|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1306922|NCT03506152|||Cohort||Cross-Sectional|||||||
1306923|NCT03506139||Single Group Assignment||Treatment||None (Open Label)||Group treated to 75 Gray of radiation to at-risk target||||
1306924|NCT03506126||Single Group Assignment||Other||None (Open Label)||||||
1306925|NCT03506113|Randomized|Parallel Assignment||Treatment||Single||||||t
1306926|NCT03506100||Single Group Assignment||Other||None (Open Label)||||||
1306927|NCT03506087|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants will be randomized 1:1 to an intervention arm or an enhanced control arm. Participants in the intervention group will receive printed educational materials plus one or more ACP coaching sessions. Participants in the enhanced control arm will receive printed materials only.||||
1306928|NCT03506074|||Cohort||Cross-Sectional|||||||
1306929|NCT03506061||Single Group Assignment||Treatment||None (Open Label)||||||
1306930|NCT03506048||Single Group Assignment||Treatment||None (Open Label)||||||
1306931|NCT03506035|||Case-Control||Prospective|||||||
1306932|NCT03506022||Single Group Assignment||Other||None (Open Label)||All patients over 18 years with type 1 mellitus diabetes will be included. The exclusion criteria are type-free diabetes (type 1 slow), age <18 years, a poor compliance with the follow-up (meetings unfulfilled without justification). All patients with known sleep disorders (OSA, narcolepsy, idiopathic hypersomnia).||||
1306933|NCT03506009|Randomized|Parallel Assignment||Treatment||Single|||t|||
1306934|NCT03505996||Single Group Assignment||Treatment||None (Open Label)||||||
1306935|NCT03505983|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1306936|NCT03505970|Randomized|Crossover Assignment||Other||Triple||Double-blind crossover|t||t|t
1306937|NCT03505957||Single Group Assignment||Supportive Care||None (Open Label)||SafeBreak Vascular works with all IVs. The study participants will have SafeBreak Vasculars installed in all of their existing IV lines or new IV lines that are installed during their enrollment in the study.||||
1306938|NCT03505944||Single Group Assignment||Treatment||None (Open Label)||||||
1306939|NCT03505931|||Case-Only||Prospective|||||||
1306940|NCT03505918|Randomized|Parallel Assignment||Treatment||Single||Randomised controlled trial with two parallel groups|||t|
1306941|NCT03505905|Randomized|Sequential Assignment||Treatment||Quadruple||A double-blind, placebo-controlled, Sequential Parallel Comparison Design (SPCD) trial of pregnenolone. SPCD is a clinical trial design that may reduce the effect of placebo response on signal detection and maximize the ability to assess efficacy by dividing the trial into two phases, and then re-randomizing placebo non-responders.|t|t|t|t
1306942|NCT03505892|||Cohort||Prospective|||||||
1306943|NCT03505879|||Case-Control||Prospective|||||||
1306944|NCT03505866||Single Group Assignment||Supportive Care||None (Open Label)||The intervention was started in February and March, 2015 and was completed six month later. The program comprises of psychosocial support/peer counseling, ART adherence support and counseling, basic health care, and referral for further care. The support team comprises of a community health worker, a trained HIV-positive person, and a social worker.||||
1306945|NCT03505853||Single Group Assignment||Treatment||None (Open Label)||||||
1306946|NCT03505840|||Cohort||Prospective|||||||
1306947|NCT03505827|||Cohort||Prospective|||||||
1306948|NCT03505814|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1306949|NCT03505801|||Cohort||Prospective|||||||
1306950|NCT03505788|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1306994|NCT03505216|||Cohort||Prospective|||||||
1306951|NCT03505775||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306952|NCT03505762|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306953|NCT03505749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306954|NCT03505736|||Case-Only||Prospective|||||||
1306955|NCT03505723|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1306956|NCT03505710|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1306957|NCT03505697|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1306958|NCT03505684|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1306959|NCT03505671|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1306960|NCT03505658|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306961|NCT03505645|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306962|NCT03505632|Randomized|Parallel Assignment||Supportive Care||Double|This study is double blind study|Mechanical ventilation with either recruitment maneuver and low PEEP versus conventional mechanical ventilation and high PEEP|t|||t
1306963|NCT03505619|Non-Randomized|Parallel Assignment||Treatment||Double|"The older adults will be included if they fulfil the following inclusion criteria a) ≥65 years or older and live at home, b) home care has been granted and the user is deemed not to need home rehabilitation performed by rehabilitation staff, c) two or more identified challenges in everyday activities that can benefit from everyday rehabilitation, d) are able to understand and express themselves in Swedish. One or more of the reasons will result in exclusion from the study: have cognitive limitations that make reablement unappropriate, in need of care in institutional dwelling or are terminally ill ,the older adults have had home help services more than three years.~When the older person in either the intervention or control group agrees to be involved in the study, they will be asked if they could consider involving a significant other.~The home care providers delivering ASSIST 1.0 or the ordinary home care will be included consisting of 8-10 staff from each group."|A feasibility study with a pre-post-test design.|t|t||
1306964|NCT03505606|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1306965|NCT03505593||||||||||||
1306966|NCT03505580|||Cohort||Prospective|||||||
1306967|NCT03505567||Single Group Assignment||Diagnostic||None (Open Label)||Eligible participants assigned two interventions under random sequence assignments.||||
1306968|NCT03505554||Single Group Assignment||Treatment||None (Open Label)||||||
1306969|NCT03505541|||Cohort||Prospective|||||||
1306970|NCT03505528||Sequential Assignment||Treatment||None (Open Label)||"An open, non-randomised, cumulative cohort group design (across 5 groups) with a target toxicity fraction of 30% and a margin of 10%. This means that a dose will be escalated between groups when the observed toxicity rate is < 20%, de-escalated when > 40% and maintained otherwise.~The toxicity fraction is the number of participants receiving that dose who experience a DLT."||||
1306971|NCT03505515|||Cohort||Retrospective|||||||
1306972|NCT03505502|Randomized|Parallel Assignment||Prevention||Quadruple|Patients were randomized to three groups, each compromised of thirty-five patients according to a three-blocked randomization list which was coded (1 or 2 or 3) at 1:1:1 ratio. The three parallel groups were prepared using a Computer-generated randomization system. The allocated groups will be concealed in serially numbered sealed opaque envelopes that will only be opened after recruitment. The patient allocation will be performed prior to the induction of anesthesia by an independent person, who will not otherwise be involved in this study. The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which will be used.|a double-blinded randomized placebo-controlled trial|t|t|t|t
1306973|NCT03505489|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1306974|NCT03505476||Single Group Assignment||Diagnostic||None (Open Label)||All subjects consented and enrolled will receive the same intervention. There is no control group.||||
1306975|NCT03505463|||Cohort||Prospective|||||||
1306976|NCT03505450|||Other||Prospective|||||||
1306977|NCT03505437|Randomized|Parallel Assignment||Other||Single|||||t|
1306978|NCT03505424|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1306979|NCT03505411||Single Group Assignment||Prevention||None (Open Label)||||||
1306980|NCT03505398|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1306981|NCT03505385|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1306982|NCT03505372||Single Group Assignment||Diagnostic||None (Open Label)||||||
1306983|NCT03505359|Randomized|Parallel Assignment||Treatment||Single||A blinded randomized clinical trial will be conducted to evaluate the effects of two protocols for the rehabilitation of patients undergoing combined re-construction of ACL and ALL.|||t|
1306984|NCT03505346|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1306985|NCT03505333|Randomized|Parallel Assignment||Treatment||Single|Patients were randomized to two groups according to a two-blocked randomization list which was coded (a) or (b) at 1:1 ratio. The two parallel groups were prepared using a Computer-generated randomization system. The allocated groups were concealed in serially numbered sealed opaque envelopes that were opened only after recruitment. Patient allocation was performed prior to the induction of anesthesia by an independent researcher, who was not otherwise being involved in this study. The trial was appropriately single-blinded. The participants were blinded to the procedure performed.|single-blinded randomized trials|t|||
1306986|NCT03505320|Non-Randomized|Parallel Assignment||Treatment||Double|Participants will be enrolled to receive zolbetuximab as monotherapy or in combination with mFOLFOX6 in an unblinded fashion.||t||t|
1306987|NCT03505307|||Case-Only||Prospective|||||||
1306988|NCT03505294|Randomized|Parallel Assignment||Treatment||Single|To ensure blinding, the assessor physiotherapist will not be aware of the arm to which the subjects belong.|Randomized, controlled, single-blind trial||||t
1306989|NCT03505281|||Cohort||Prospective|||||||
1306990|NCT03505268|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1306991|NCT03505255|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1306992|NCT03505242|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1306993|NCT03505229||Single Group Assignment||Treatment||None (Open Label)|no masking|non randomised-single arm phase II||||
1573373|NCT00001446||||Treatment||||||||
1306995|NCT03505203|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be assigned to one of two conditions: (1) Sleep Soothe, where parents are given information on how to respond to their baby's cues related to sleeping and fussiness, and (2) Sleep Safe, where parents are given information on a safe sleep environment, as well as other strategies they can use to keep their baby safe.||||
1306996|NCT03505190|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1306997|NCT03505177||Single Group Assignment||Basic Science||None (Open Label)||Supplementation during 3 weeks with 4.5g of chitin-glucan||||
1306998|NCT03505164|||Cohort||Prospective|||||||
1306999|NCT03505151||Single Group Assignment||Treatment||None (Open Label)||||||
1307000|NCT03505138|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307001|NCT03505125|||Other||Retrospective|||||||
1307002|NCT03505112|Randomized|Parallel Assignment||Prevention||Quadruple||Prospective, single-center, double-blind, parallel-group, randomized, controlled trial|t|t|t|t
1307003|NCT03505099||Single Group Assignment||Treatment||None (Open Label)||Open-label, single arm||||
1307004|NCT03505086|||Case-Control||Prospective|||||||
1307005|NCT03505073|||Cohort||Prospective|||||||
1307006|NCT03505060|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1307007|NCT03505047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307008|NCT03505034||Single Group Assignment||Treatment||None (Open Label)||||||
1307009|NCT03505021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307010|NCT03505008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307011|NCT03504995||Single Group Assignment||Treatment||None (Open Label)||||||
1307012|NCT03504982|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1307013|NCT03504969|||Cohort||Prospective|||||||
1307014|NCT03504956|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1307015|NCT03504943|Randomized|Crossover Assignment||Treatment||Single||||||t
1307016|NCT03504930|||Cohort||Prospective|||||||
1307017|NCT03504917|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307018|NCT03504904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307019|NCT03504891|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will have cardiac MRI prior to CRT.||||
1307020|NCT03504878|||Cohort||Cross-Sectional|||||||
1307021|NCT03504865|Randomized|Parallel Assignment||Treatment||Single||||||t
1307022|NCT03504852|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1307023|NCT03504839||Single Group Assignment||Treatment||None (Open Label)||Consecutive patients consented for SICD as per standard indications for device implantation||||
1307024|NCT03504826||Single Group Assignment||Treatment||None (Open Label)||||||
1307025|NCT03504813|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307026|NCT03504800|||Case-Control||Prospective|||||||
1307027|NCT03504787|||Other||Cross-Sectional|||||||
1307028|NCT03504774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Food allergy OIT in a parallel group design||||
1307029|NCT03504761||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307030|NCT03504748|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307031|NCT03504735|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1307032|NCT03504722|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1307033|NCT03504709|||Cohort||Prospective|||||||
1307034|NCT03504696|||Cohort||Retrospective|||||||
1307035|NCT03504683|Randomized|Parallel Assignment||Treatment||Single||||||t
1307036|NCT03504670|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to early amniotomy (<4cm cervical dilation) or late amniotomy (≥4cm dilated). Participants may crossover due due to clinical conditions that are not preventable. These conditions include: unengaged vertex at time of attempted amniotomy or cervical dilation that does not reach 4cm.||||
1307037|NCT03504657|Randomized|Parallel Assignment||Treatment||Double||||t||t
1307038|NCT03504644||Single Group Assignment||Treatment||None (Open Label)||||||
1307039|NCT03504631|||Case-Only||Cross-Sectional|||||||
1307040|NCT03504618|||Case-Only||Cross-Sectional|||||||
1307041|NCT03504605|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1307042|NCT03504592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307043|NCT03504579|Randomized|Parallel Assignment||Other||Double||In the R61 phase of the study,changes in a target brain region(s) will be demonstrated after the rt-fMRI based neurofeedback session.|t|t||
1307044|NCT03504566|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1307045|NCT03504553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307046|NCT03504540|||Case-Control||Prospective|||||||
1307047|NCT03504527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307048|NCT03504514|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||monocentric, open, randomized, crossover study||||
1307049|NCT03504501|Randomized|Crossover Assignment||Treatment||Triple||Monocenter, randomized, double-blind, parallel-group, placebo controlled, cross-over design with a series of three experiments (Noonan Syndrome: 2 experiments; Neurofibromatosis type 1 1 experiment) and n=14 participants per experiments|t||t|t
1307050|NCT03504488||Single Group Assignment||Treatment||None (Open Label)||||||
1307051|NCT03504475|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1307052|NCT03504462||Single Group Assignment||Other||None (Open Label)||||||
1307053|NCT03504449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307054|NCT03504436|||Cohort||Prospective|||||||
1307055|NCT03504423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307056|NCT03504410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307057|NCT03504397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307058|NCT03504384|||Other||Prospective|||||||
1307059|NCT03504371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307060|NCT03504358|||Cohort||Retrospective|||||||
1307061|NCT03504345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307062|NCT03504332|Randomized|Parallel Assignment||Treatment||Single||||||t
1307063|NCT03504319|||Case-Control||Prospective|||||||
1307064|NCT03504306|||Cohort||Cross-Sectional|||||||
1307065|NCT03504293|||Cohort||Prospective|||||||
1307066|NCT03504280|Randomized|Parallel Assignment||Treatment||None (Open Label)||single center, interventional, open labelled study||||
1307067|NCT03504267|Randomized|Parallel Assignment||Other||Single|||t|||
1307068|NCT03504254|||Cohort||Prospective|||||||
1307069|NCT03504241|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307070|NCT03504228|||Case-Only||Prospective|||||||
1307071|NCT03504215||Single Group Assignment||Prevention||None (Open Label)||Group assignments. Both groups are evaluated before and after a 14 week supervised exercise (aerobic and resistance training) intervention.||||
1307072|NCT03504202||Single Group Assignment||Treatment||None (Open Label)||||||
1307073|NCT03504189||Single Group Assignment||Other||None (Open Label)||Open Label||||
1307074|NCT03504176|||Other||Prospective|||||||
1307075|NCT03504163||Single Group Assignment||Treatment||None (Open Label)||This is a phase II trial of Pembrolizumab (MK-3475) as first-line therapy.||||
1307076|NCT03504150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307077|NCT03504137||Single Group Assignment||Supportive Care||None (Open Label)||This is a single center prospective control trial. Participants in this study will use the mHealth application to manage and track their immunosuppression medical regimen post-transplant.||||
1307078|NCT03504124|Randomized|Parallel Assignment||Treatment||None (Open Label)||A cluster randomized trial including 32 rural health districts managed by the Ministry of Health (MOH) of Guatemala. Sixteen health districts will be assigned to a multicomponent intervention and 16 to usual care. Each health district will recruit 55 patients aged ≥40 years with uncontrolled hypertension.||||
1307079|NCT03504111|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307080|NCT03504098|||Case-Only||Prospective|||||||
1307081|NCT03504085|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||We will be conducting a pilot RCT with two types of yoga interventions. A total of 50 participants will be randomized to attend either active Hatha yoga or restorative yoga. Enrollment will be conducted on a rolling basis.||||
1307082|NCT03504072|Randomized|Parallel Assignment||Prevention||None (Open Label)||Follow up period will be 9 months (visits 0, 1, 3, 6 and 9). Study subjects (87) will receive toficitinib (5 mg 12 hourly). Control patients will get eternacept (50 mg subcutaneously every 7 days interval for 1st month then 50 mg in 15 days interval for 2nd month then 50 mg every 21 days interval till final visit.||||
1307083|NCT03504059|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307084|NCT03504046||Single Group Assignment||Treatment||None (Open Label)||||||
1307085|NCT03504033|Randomized|Parallel Assignment||Treatment||Triple|This trial will be performed double-blinded. After randomization neither the patients nor the investigator of the baseline assessment and the postoperative assessment will be aware of the treatment allocation. The intraoperative anesthesiologist will not be blinded, due to feasibility and safety reasons.|Single-center, controlled, double-blinded, randomized, two-arm parallel, interventional clinical trial|t||t|t
1307086|NCT03504020|Randomized|Parallel Assignment||Treatment||Single||||||t
1307087|NCT03504007|||Cohort||Prospective|||||||
1307088|NCT03503994||Single Group Assignment||Treatment||None (Open Label)||||||
1307089|NCT03503981|||Cohort||Prospective|||||||
1307090|NCT03503968|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307091|NCT03503955|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307092|NCT03503942|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307093|NCT03503929||Single Group Assignment||Device Feasibility||None (Open Label)||Open label, prospective, single site, multi-investigator||||
1307094|NCT03503916|||Cohort||Prospective|||||||
1307095|NCT03503903||Single Group Assignment||Treatment||None (Open Label)||||||
1307096|NCT03503890||||||||||||
1307097|NCT03503877|Non-Randomized|Parallel Assignment||Treatment||Triple||sibling embryo study|t|t||t
1307098|NCT03503864|Randomized|Parallel Assignment||Treatment||None (Open Label)||Experimental group：combined induction chemotherapy with arsenic trioxide Control group：conventional induction chemotherapy without arsenic trioxide||||
1307099|NCT03503851|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, multi-center, randomized, parallel-arm trial||||
1307100|NCT03503838|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Intervention group with a wait-list control group||||
1307101|NCT03503825|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"This is a Phase 1, non-randomized, open-label, single-centre clinical trial. A total of 12 to 24 subjects will be enrolled:~6 Healthy volunteers (HV) (3 males and 3 females)~6 - 18 subjects with osteoarthritis of the knee (KOA) Once 6 HVs and 6 KOA subjects (to be enrolled concurrently) have completed the study, image data will be assessed to determine whether any more KOA subjects should be imaged."||||
1307102|NCT03503812|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Following the eligibility assessment, we will randomize each group of participants (group with asthmatic children and group with AF patients) with a 1:1:1 ratio to three parallel groups to receive: a) no intervention for DDS, b) intervention for outdoor exposure reduction, by reducing the time spend outdoors and by avoiding physical activity, c) interventions for outdoor (as above) and indoor exposure reduction (by minimizing home ventilation and filtering indoor air). In the indoor intervention arm of the study, exposure reduction measures will be applied in the asthmatic child's classroom/school and bedroom/household settings and in the AF patient's household/bedroom settings. The study design offers also the opportunity to assess: 1.outdoor exposures to PM, and 2.indoor exposures to PM and related health outcomes in three parallel groups during the same DDS events with and without intervention measures.||||
1307103|NCT03503799|||Case-Only||Prospective|||||||
1307104|NCT03503786|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 2 randomized with a safety run-in cohort for the experimental arm||||
1307157|NCT03503097|||Case-Only||Cross-Sectional|||||||
1307105|NCT03503773|Randomized|Parallel Assignment||Treatment||Double|Blinded (The subject, sponsor, and hypertensionist/nephrologist performing the screening and follow-up assessments are blinded. The interventionalist and cath lab staff are unblinded.)|"Subjects who continue to be eligible at the end of the run-in period will be randomized in a 1:1 ratio to one of the following 2 groups via central randomization (stratified by study site):~Treatment Arm: renal denervation (using the Peregrine Kit) performed with alcohol infused through the Peregrine Catheter~Sham Control Arm: only renal angiography performed"|t|||t
1307106|NCT03503760|Randomized|Crossover Assignment||Supportive Care||Double|Participant and care provider were unaware of the treatment as the machine does not make any sound or heat during the session. Only the nurse that physically connect the cable to the generator knows if the patient recieve or not the therapy but she was not involved in clinical evaluation.|"Patients have been randomized in two groups using Research randomizer avaliable at www.randomizer.org.~The first group of patients true-sham received 6 twice a week sessions of true ELF therapy of one hour with LIMFA Therapy®, following the antinflammatory, analgesic and biorhythm settings of the device. Then, after a wash-out period (three weeks), it received the sham therapy (no therapy) twice a week for three weeks.~The second group sham-true received 6 twice a week sessions of sham therapy (no therapy) and then, after the wash-out period (three weeks), it received 6 session of true ELF therapy twice a week for three weeks.~A set of questionnaires were administrated: before first session, after first session, after the wash-out period, after second session and after three week follow-up in both groups."|t|t||
1307107|NCT03503747|||Cohort||Cross-Sectional|||||||
1307108|NCT03503734|||Cohort||Prospective|||||||
1307109|NCT03503721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307110|NCT03503708||Single Group Assignment||Supportive Care||None (Open Label)||||||
1307111|NCT03503695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307112|NCT03503682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307113|NCT03503669|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307114|NCT03503656|||Case-Only||Retrospective|||||||
1307115|NCT03503643|||Cohort||Prospective|||||||
1307116|NCT03503630||Single Group Assignment||Treatment||None (Open Label)||||||
1307117|NCT03503617|Randomized|Parallel Assignment||Treatment||Single||||||t
1307118|NCT03503604|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307119|NCT03503591|||Case-Only||Prospective|||||||
1307120|NCT03503578||Single Group Assignment||Basic Science||None (Open Label)||||||
1307121|NCT03503565|||Cohort||Prospective|||||||
1307122|NCT03503552|||Other||Other|||||||
1307123|NCT03503539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307124|NCT03503526|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized wait list control study with a mixed methods design||||
1307125|NCT03503513|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1307126|NCT03503500|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Open label, randomized parallel controlled trial||||
1307127|NCT03503487|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307128|NCT03503474|||Case-Control||Other|||||||
1307129|NCT03503461|||Case-Control||Prospective|||||||
1307130|NCT03503448|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307131|NCT03503435||Single Group Assignment||Supportive Care||None (Open Label)||This is a pre and post design quasi-experimental study looking at changes before and after a supportive care art therapy intervention.||||
1307132|NCT03503422|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307133|NCT03503409||Single Group Assignment||Treatment||None (Open Label)||Subjects enrolled will receive continuous 28-day cycles of AG-120. AG-120 will be dispensed on Day 1 of each treatment cycle||||
1307134|NCT03503396|Randomized|Parallel Assignment||Prevention||Single||Participants will be assigned to either receive feedback from a breathalyzer device or to receive no information.||||t
1307135|NCT03503383|||Case-Control||Cross-Sectional|||||||
1307136|NCT03503370|Randomized|Parallel Assignment||Prevention||Quadruple||This is a single center, randomized, double blind (participant, outcome assessor), parallel group clinical trial comparing daily foot care with cloths containing 2% chlorhexidine compared to daily foot care with cloths not containing chlorhexidine.|t|t|t|t
1307137|NCT03503357|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1307138|NCT03503344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307139|NCT03503331||Single Group Assignment||Diagnostic||None (Open Label)||Brain amyloid PET levels will be measured with the PET tracer [C-11]PiB in all study participants.||||
1307140|NCT03503318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307141|NCT03503305|Randomized|Parallel Assignment||Treatment||Double|It is a double-blinded trial in which the subjects, investigator and radiologists are blinded to treatment assignment.||t||t|
1307142|NCT03503292|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307143|NCT03503279|Randomized|Parallel Assignment||Prevention||Single|||t|||
1307144|NCT03503266||Single Group Assignment||Other||None (Open Label)||Open Label||||
1307145|NCT03503253||Single Group Assignment||Treatment||None (Open Label)||Prospective, single arm study with consecutive, eligible subject enrollment. All subjects will undergo percutaneous LAA leak closure procedure with detachable coils.||||
1307146|NCT03503240|||Case-Crossover||Prospective|||||||
1307147|NCT03503227|Randomized|Parallel Assignment||Other||Single||||||t
1307148|NCT03503214|||Case-Control||Prospective|||||||
1307149|NCT03503201|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307150|NCT03503188||Single Group Assignment||Treatment||None (Open Label)||||||
1307151|NCT03503175|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307152|NCT03503162||Single Group Assignment||Screening||None (Open Label)||||||
1307153|NCT03503149|||Cohort||Prospective|||||||
1307154|NCT03503136|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1307155|NCT03503123|||Case-Control||Cross-Sectional|||||||
1307156|NCT03503110||Single Group Assignment||Other||None (Open Label)||||||
1307158|NCT03503084||Single Group Assignment||Health Services Research||None (Open Label)||Twenty-one TCC practitioners and nineteen normal controls were included in this study. The hemodynamics, serum insulin, indices of insulin resistance/sensitivity, serum endothelin-1 (ET-1), blood lipids and aldosterone before and 30 min after a rest or a session of classical Yang's TCC exercise were compared.||||
1307159|NCT03503071|||Cohort||Prospective|||||||
1307160|NCT03503058|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1307161|NCT03503045|||Cohort||Cross-Sectional|||||||
1307162|NCT03503032|||Cohort||Prospective|||||||
1307163|NCT03503019|||Cohort||Prospective|||||||
1307164|NCT03503006|||Cohort||Prospective|||||||
1307165|NCT03502993|||Case-Control||Prospective|||||||
1307166|NCT03502980|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307167|NCT03502967|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||TBI patients and healthy control subjects||||
1307168|NCT03502954|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1307169|NCT03502941|Randomized|Crossover Assignment||Basic Science||Double||"Arm 1 and 2: Crossover design for two different doses of the product (~6.3 and 12.6 g of active components).~Arm 3: Parallel comparison equal to the double dose of whey protein isolate (12.6 g)"|t|||t
1307170|NCT03502928|Randomized|Parallel Assignment||Treatment||Single||||||t
1307171|NCT03502915|Randomized|Parallel Assignment||Treatment||Quadruple|The Nitronox device will be covered. The person setting up the device with either 100% oxygen or 50% nitrous/50% oxygen, will not be participating in the study. The patient, investigator and labor and delivery personnel (obstetrician and nursing staff) will be blinded as to the medication being administered during the procedure.||t|t|t|t
1307172|NCT03502902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307173|NCT03502889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307174|NCT03502876|||Cohort||Prospective|||||||
1307175|NCT03502863|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1307176|NCT03502850||Single Group Assignment||Treatment||None (Open Label)||||||
1307177|NCT03502837|||Other||Prospective|||||||
1307178|NCT03502824|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307179|NCT03502811|||Cohort||Prospective|||||||
1307180|NCT03502798||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307181|NCT03502785|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307182|NCT03502772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307183|NCT03502759|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1307184|NCT03502746||Single Group Assignment||Treatment||None (Open Label)||||||
1307185|NCT03502733||Single Group Assignment||Treatment||None (Open Label)||||||
1307186|NCT03502720|||Case-Control||Prospective|||||||
1307187|NCT03502707|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1307188|NCT03502694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307189|NCT03502681||Single Group Assignment||Treatment||None (Open Label)||||||
1307190|NCT03502668|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, open label||||
1307191|NCT03502655|Randomized|Parallel Assignment||Other||Quadruple|Patient allocation to each arm will be based on the sequential opening of an opaque envelope containing an non-consecutive number indicating a track number of the recorded message (control or intervention). Randomization will be based on randomly mixed block of size 2 to 6 patients.|Each eligible patient will be randomized in a 1: 1 ratio between the two arms of the study, double-blind (patient, caregiver, investigator) in the first study and single-blind (patient) in the second study.|t|t|t|t
1307192|NCT03502642|Randomized|Parallel Assignment||Treatment||Triple|healthy, term women scheduled for cesarean delievry|randomized controlled trial|t|t||t
1307193|NCT03502629||Single Group Assignment||Treatment||None (Open Label)||||||
1307194|NCT03502616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307195|NCT03502603|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1307196|NCT03502590||Single Group Assignment||Supportive Care||None (Open Label)||||||
1307197|NCT03502577||Single Group Assignment||Treatment||None (Open Label)||||||
1307198|NCT03502564|Randomized|Parallel Assignment||Treatment||Single||||||t
1307199|NCT03502551||Single Group Assignment||Treatment||None (Open Label)||||||
1307200|NCT03502538|Randomized|Crossover Assignment||Prevention||Double||This is a study designed where all the participants will have to try the two devices that were being tested.|t||t|
1307201|NCT03502525||Single Group Assignment||Other||None (Open Label)||||||
1307202|NCT03502512|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307203|NCT03502499|Randomized|Parallel Assignment||Other||Double|||t||t|
1307204|NCT03502486|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1307205|NCT03502473|Randomized|Parallel Assignment||Treatment||None (Open Label)||Flanks will be randomized in accordance with randomization list. One flank will receive a single treatment pass or no treatment. The other side will receive multiple passes (up to 5 passes) during the same treatment session.||||
1307206|NCT03502460||Single Group Assignment||Other||None (Open Label)||||||
1307207|NCT03502447|Randomized|Crossover Assignment||Treatment||Single||||||t
1307208|NCT03502434|Randomized|Parallel Assignment||Treatment||Double|The Principal Investigator, subjects, and the site personnel who will be performing Reaction Grade assessments will be blinded to the Test Material identity, with the exception of the Positive Control.||t||t|
1307209|NCT03502421|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Prospective Clinical Trial||||
1307210|NCT03502408||Single Group Assignment||Prevention||None (Open Label)||||||
1307211|NCT03502395|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1307212|NCT03502382||Single Group Assignment||Treatment||None (Open Label)||Cases of osteoarthritis of the knee with varus deformity undergoing unilateral TKA.||||
1307333|NCT03500809||Single Group Assignment||Treatment||None (Open Label)||||||
1307334|NCT03500796||Single Group Assignment||Treatment||None (Open Label)||||||
1307213|NCT03502369|Randomized|Parallel Assignment||Treatment||Single||"Adult 90 orthopaedic patient ASA physical status |-||| will be randomly allocated in two groups each one 45 patients, one group will receive the anterior quadratus lumborum block and the other group will not receive the block."||||t
1307214|NCT03502356|Randomized|Parallel Assignment||Prevention||Single||"Control Group:~This group will include 200women undergoing elective cs. In this group, patients will receive standard antibiotic prophylaxis CEFAZOLIN (at a dose of 1 g) and azithromycin (at a dose of 1g) 2 hours preoperative.~Study Group:~This group will include 200women undergoing elective cs. In this group, patients will receive only standard prophylaxis antibiotic(CEFAZOLIN)"|t|||
1307215|NCT03502343||Single Group Assignment||Treatment||None (Open Label)||||||
1307216|NCT03502330|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1307217|NCT03502317|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1307218|NCT03502304|Randomized|Parallel Assignment||Prevention||Single||Behavioral|||t|
1307219|NCT03502291|Randomized|Parallel Assignment||Health Services Research||Double|Physical blind folds worn by participant. Unblinded research nurses to deliver the vaccines|DBRCT performed as two studies over two flu seasons. 2 arms to each study.|t||t|
1307220|NCT03502278|Randomized|Parallel Assignment||Treatment||None (Open Label)||A small RCT (N = 60) will be conducted comparing Islamic Trauma Healing in an U.S. Somali refugee sample to a waitlist control||||
1307221|NCT03502265||Single Group Assignment||Treatment||None (Open Label)||single subject research design case series||||
1307222|NCT03502252|Randomized|Parallel Assignment||Treatment||Single||||||t
1307223|NCT03502239|Randomized|Parallel Assignment||Treatment||Single||||||t
1307224|NCT03502226|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1307225|NCT03502213|||Case-Only||Prospective|||||||
1307226|NCT03502200||||||||||||
1307227|NCT03502187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307228|NCT03502174|||Cohort||Prospective|||||||
1307229|NCT03502161|||Cohort||Prospective|||||||
1307230|NCT03502148||Single Group Assignment||Treatment||None (Open Label)||Phase 1/2, Open-Label, Single-Arm||||
1307231|NCT03502135||Single Group Assignment||Treatment||None (Open Label)||Single-Arm, unblinded trial.||||
1307232|NCT03502122|Randomized|Parallel Assignment||Treatment||Single||||||t
1307233|NCT03502109|Randomized|Parallel Assignment||Health Services Research||Single|Each participant will sign an informed consent, without knowing that there are other group of intervention.||t|||
1307234|NCT03502096|Randomized|Factorial Assignment||Treatment||Single||The two factors were meal portion size and provision of a to-go container. The portion size factor was within-subjects (crossover). All subjects received each of the 4 portions served (the order in which portions were served was counterbalanced). The container factor was between-subjects. Subjects were randomly assigned to 1 of 2 groups: one group had uneaten food packaged to take home, the other group (control) did not.|t|||
1307235|NCT03502083|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1307236|NCT03502070||Single Group Assignment||Other||None (Open Label)||||||
1307237|NCT03502057|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307238|NCT03502044|Randomized|Parallel Assignment||Treatment||Double|"Both the participants and investigator are blinded with regarding the administration of KOS or placebo treatments during the first 8 treatments.~During the following 8 treatments only the patients, not the investigator, are blinded."|Double blinded placebo controlled trial design during the first 8 treatments. Single blinded (patient is blinded) controlled trial design during the last 8 treatments.|t||t|
1307239|NCT03502031|Randomized|Parallel Assignment||Treatment||None (Open Label)||Combination of RAAS blockers and Spironolactone therapy will exert a selective benefit to African American or Hispanic subpopulations. Randomization of African Americans and other ethic cohorts in a 2:1 ratio to Caucasian patients.||||
1307240|NCT03502018|Randomized|Parallel Assignment||Treatment||Triple|Participants, Investigator(s), outcome assessors will all be blinded throughout the duration of the trial. Care providers pre- and post- op will be blinded as well, the operative team will not be blinded.|There will be a total of 50 patients enrolled in this randomized blinded prospective two arm study. The participants will be randomized into either the control or the EXPAREL treatment group, with 25 patients in each cohort.|t||t|t
1307241|NCT03502005||Single Group Assignment||Treatment||None (Open Label)||Prospective 48 week single cohort study to evaluate the efficacy and safety of switching from ATRIPLA to BIKTARVY® in HIV-1 infected adult subjects who are virologically suppressed (HIV-1 RNA < 50 copies/mL).||||
1307242|NCT03501992|Randomized|Factorial Assignment||Prevention||Single|The data analyst will conduct the measurement of the patients eligible and vaccinated and the calculations of the outcomes. The investigators will blind the data analyst to which intervention(s) each practice was assigned to receive. However that only masks the practices' interventions for Step 2 and Step 3 as all practices receive the same interventions in Step 1 (current care) and Step 4 (combined reminder-audit).|A factorial, stepped-wedge cluster randomized trial with process evaluation||||t
1307243|NCT03501979||Single Group Assignment||Treatment||None (Open Label)||Subjects will receive combination treatment with tucatinib + trastuzumab + capecitabine every 21 days, which is one cycle. Evaluation will be done every two cycles with an MRI of the brain and spine. Cycles 3 and beyond will be at the discretion of the physician. A scan will be done every four cycles.||||
1307244|NCT03501966|Randomized|Parallel Assignment||Treatment||Single|Partially-masked technicians for perimetry, fundus photos, OCT, and refraction/ visual acuity|Subjects will be randomly assigned with equal allocation to one of the three treatment groups. Using a permuted block design, randomization will be stratified by PMD (average of 2 size V stimulus tests) in the eligible eye(s) (-6 dB to >-12 dB; -12 dB to >-20 dB; -20 dB to -27 dB). If a subject has two eligible eyes, the average PMD of the two eyes will be used for stratification.||||t
1307245|NCT03501953|Randomized|Parallel Assignment||Basic Science||Triple||Participants are randomly assigned to one of two intervention classes that either take place outdoors or indoors. Intervention conditions are identical in protocol and measurements taken, and differ only in location of intervention.|t|t||t
1307246|NCT03501940||||||||||||
1307335|NCT03500783|Randomized|Parallel Assignment||Prevention||Triple|Trial participants, data analysts, and report writers are blinded.|Single-center prospective, randomized, placebo-controlled study|t|t||t
1307247|NCT03501927|Randomized|Parallel Assignment||Prevention||None (Open Label)||Preoperative point-of-care focused cardiopulmonary ultrasound (FOCUS) Patients are to be randomised in a 1:1 ratio to either 1) FOCUS prior to anaesthesia or 2) no FOCUS performed (standard treatment).||||
1307248|NCT03501914||Single Group Assignment||Other||None (Open Label)||||||
1307249|NCT03501901|||Cohort||Prospective|||||||
1307250|NCT03501888|Randomized|Parallel Assignment||Treatment||Single||||||t
1307251|NCT03501875||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307252|NCT03501862|Randomized|Parallel Assignment||Treatment||Single|Assignment to the study groups will be made independently of staff involved in the recruitment and management of participants in the study.|"Participants referred to the study will be assessed at a screening examination to ensure eligibility and obtain written consent by a research assistant. Eligible participants will undertake a further interview on outcome measures prior to randomization within 3 weeks the commencement of intervention.~Eligible participants will be randomly assigned to receive Mindfulness-based Cognitive Therapy for Psychosis (MBCTp) plus TAU or TAU plus Psychoeducation for Psychosis (PEp).~Simple randomization will be used to ensure that participants will have equal opportunity to be included into the study (Altaman and Bland, 1999)."||||t
1307253|NCT03501849||Single Group Assignment||Prevention||None (Open Label)||||||
1307254|NCT03501836||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307255|NCT03501823|||Cohort||Cross-Sectional|||||||
1307256|NCT03501810|||Cohort||Prospective|||||||
1307257|NCT03501797|Randomized|Crossover Assignment||Treatment||Single||||||t
1307258|NCT03501784|Non-Randomized|Parallel Assignment||Prevention||Single||This is an exploratory, comparative, self-controlled, single blind study|t|||
1307259|NCT03501771||Single Group Assignment||Treatment||None (Open Label)||A single group, pre-post intervention study||||
1307260|NCT03501758|||Cohort||Prospective|||||||
1307261|NCT03501745|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307262|NCT03501732|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1307263|NCT03501719|||Cohort||Retrospective|||||||
1307264|NCT03501706|Randomized|Factorial Assignment||Treatment||Single|||t|||
1307265|NCT03501693|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1307266|NCT03501680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307267|NCT03501667|Randomized|Parallel Assignment||Diagnostic||Double|Data collected by an RA, PI and outcome assessment (I.e., data analyst) are blinded to which arm the participant was assigned to. Given use of software, the participant cannot be blinded to the arm he/she was assigned|Comparing use of deision support group (intervention group) to use of common literature (control group) among pediatric trainees treating patients with possible rheumatologic disorder|||t|t
1307268|NCT03501654||Single Group Assignment||Treatment||None (Open Label)||||||
1307269|NCT03501641|Randomized|Parallel Assignment||Health Services Research||Double|Blinding to the purpose of the study during recruitment is maintained to minimize preparation bias. After randomization, the participants are unblinded and use image-based virtual reality model or conventional video-based model on a virtual reality eyeglass in an ordinary office environment for 10 minutes. Heart rate variation will be monitored during learning and cognitive load will be assessed by the participants. Subsequently, each participant will perform history taking and physical examination for a real patient in a teaching clinic. The competence will be evaluated using the mini-clinical evaluation exercise, direct observation of procedural skills (DOPS), and milestone assessments. Investigators and outcome assessors are blinded to their randomization and learning models.|This randomized controlled trial will recruit 64 subjects who are novices in otolaryngology at an academic teaching hospital. The cognitive style of the participants is assessed using the Group Embedded Figures Test. The subjects are randomly assigned (1:1) to a novel image-based virtual reality group and conventional video-based group matched by age, sex, and cognitive style.|||t|t
1307270|NCT03501628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307271|NCT03501615||||||||||||
1307272|NCT03501602|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1307273|NCT03501589|||Case-Only||Prospective|||||||
1307274|NCT03501576||Single Group Assignment||Prevention||None (Open Label)||||||
1307275|NCT03501563|||Other||Prospective|||||||
1307276|NCT03501550||Single Group Assignment||Treatment||None (Open Label)||||||
1307277|NCT03501537||Single Group Assignment||Treatment||None (Open Label)||Single-prospective one-arm study||||
1307278|NCT03501524|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307279|NCT03501511|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307280|NCT03501498|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Randomised cross-over study. Volunteers will be assessed at baseline, then after either taking loperamide or senna at the maximally tolerated dose for 2 days prior to the 'assessment period' then during the assessment period (5-7 days). After a washout period of at least 21 days, volunteers will then repeat the same assessments but cross over to take the second drug either loperamide or senna.||||
1307281|NCT03501485|||Case-Control||Cross-Sectional|||||||
1307282|NCT03501472|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1307283|NCT03501459||Single Group Assignment||Treatment||None (Open Label)||||||
1307284|NCT03501446|||Other||Prospective|||||||
1307285|NCT03501433|Randomized|Crossover Assignment||Basic Science||Double|I single investigator will be responsible for blinding. All researchers involved in collection and evaluation of data will remain blinded to treatments.|Randomized, cross-over|t|||t
1307286|NCT03501420|||Cohort||Cross-Sectional|||||||
1307287|NCT03501407|||Cohort||Prospective|||||||
1307288|NCT03501394||Single Group Assignment||Basic Science||None (Open Label)|Single group with one arm and no masking.|Single group longitudinal study.||||
1307289|NCT03501381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307290|NCT03501368||Single Group Assignment||Treatment||None (Open Label)||||||
1307291|NCT03501355|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1307292|NCT03501342|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective randomize controlled study||||
1307293|NCT03501329|||Cohort||Prospective|||||||
1307294|NCT03501316|Randomized|Parallel Assignment||Treatment||Double|Both the patients and clinicians will remain blinded to the intervention until the intervention is carried out. Research personnel will remain blinded to specific patient allocation throughout the process through the means of patient barcodes. The key linking the barcodes to the patients will be available to the Chief Investigator. The intervention codes will only be available once the key analyses have taken place.|"Analysis: the effect of treatment group (Manual vs ultrasonic) on changes in CRP levels (and other secondary outcomes):~Appropriate generalised linear models~Binary logistic models (for dichotomous outcomes)"|||t|t
1307295|NCT03501303|Randomized|Parallel Assignment||Treatment||None (Open Label)||In an online randomization module the randomization will be performed with permuted block randomization to 1:1 ratio.||||
1307296|NCT03501290||Single Group Assignment||Other||None (Open Label)||All patients will be in one group, receiving the product.||||
1307297|NCT03501277|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1307298|NCT03501264|Randomized|Parallel Assignment||Prevention||Single|||t|||
1307299|NCT03501251|Randomized|Parallel Assignment||Treatment||Triple|Participants will receive placebos. Outcome assessors and caregivers will not have access to the list of children allocated to each treatment arm.||t|t||t
1307300|NCT03501238|Randomized|Crossover Assignment||Basic Science||Single|Participants will not know the specifics of each beverage they are taking home.||t|||
1307301|NCT03501225|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1307302|NCT03501212|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1307303|NCT03501199|Randomized|Parallel Assignment||Treatment||Single||||||t
1307304|NCT03501186|Randomized|Parallel Assignment||Treatment||Quadruple|The treatment given by investigator unaware of allocation of patients and outcome variables measured by different investigator||t|t|t|t
1307305|NCT03501173|||Cohort||Prospective|||||||
1307306|NCT03501160|||Family-Based||Prospective|||||||
1307307|NCT03501147|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1307308|NCT03501134|||Cohort||Prospective|||||||
1307309|NCT03501121|||Cohort||Prospective|||||||
1307310|NCT03501108|Randomized|Parallel Assignment||Prevention||Single|The researcher obtaining outcome measurements will be blinded to the group allocation of patient participants.|Comparison of application of explicit deprescribing criteria (STOPPFrail) with standard pharmaceutical care versus standard pharmaceutical care alone. The intervention is applied randomly at a single time point in hospitalized older people who will undergo a transition of care from the community to nursing home. The primary outcome measure is total number of daily prescription drugs.||||t
1307311|NCT03501095|||Cohort||Prospective|||||||
1307312|NCT03501082|Randomized|Crossover Assignment||Other||Double||Randomized three arm cross over placebo controlled trial|t||t|
1307313|NCT03501069|Randomized|Sequential Assignment||Other||Triple|||t||t|t
1307314|NCT03501056|Randomized|Parallel Assignment||Treatment||Quadruple|With the method of minimum randomized dynamic random by the interactive network response system (IWRS),Participants were assigned to three groups,receive cryotherapy,conventional therapy, and activated CIK armed with anti-CD3-MUC1 bispecific antibody together with cryotherapy .every participant has a unique identification number and emergency letter which have the information of group.|This is a phase II clinical trial of single-center, and it will divide into three groups.|t|t|t|t
1307315|NCT03501043||Single Group Assignment||Treatment||None (Open Label)||||||
1307316|NCT03501030|Randomized|Parallel Assignment||Prevention||Single||Single center, parallel group non-blinded, prospective, interventional non-pharmacologic, no profit, randomized and controlled trial||||t
1307317|NCT03501017|Randomized|Parallel Assignment||Prevention||Single|||t|||
1307318|NCT03501004|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1307319|NCT03500991|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307320|NCT03500978|Randomized|Parallel Assignment||Prevention||Single|Randomization occurs after the baseline assessment, so the assessor is blinded to study condition. Follow-up assessments of outcome are completed by study personnel who are blinded to intervention (i.e., they had no part in the intervention and no access to the randomization schedule). An electronic research management system (RedCAP) is used to deliver the random assignments to the interventionist digitally after baseline is completed. None of the data collection or intervention staff have access to the database underlying the random assignment in RedCAP. The randomization schedule was established by the biostatistician, who has no role in the data collection or intervention delivery.|Two group (behavioral intervention vs. no treatment) randomized trial with a pre-intervention and 10- and 14-week post-intervention assessment phases.||||t
1307321|NCT03500965|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1307322|NCT03500952|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307323|NCT03500939|Randomized|Parallel Assignment||Treatment||Single||||||t
1307324|NCT03500926|Randomized|Parallel Assignment||Treatment||Single|implant|randomized 1/1 comparison|t|||
1307325|NCT03500913|||Cohort||Prospective|||||||
1307326|NCT03500900|Randomized|Crossover Assignment||Other||Single|||t|||
1307327|NCT03500887|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1307328|NCT03500874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307329|NCT03500861|Randomized|Sequential Assignment||Treatment||Double|||t|||t
1307330|NCT03500848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307331|NCT03500835|Randomized|Parallel Assignment||Supportive Care||Single|Blocked randomization will be utilized, to ensure the groups are balanced in terms of number of subjects and the distribution of potential confounding variables. Blocked randomization will be used to ensure the number of eligible subjects assigned to each group is equally distributed. Block size will be blinded from the primary investigator performing the study.|The proposed multi-site randomized control trial (RCT) will test the effectiveness of an addiction-based weight loss intervention, embodied as a smartphone app with telephone coaching compared 1) an addiction-based weight loss intervention alone and 2) an in-clinic weight management intervention based on a traffic-light based approach in a larger sample of economically, racially and ethnically diverse adolescents (ages 14-18).||||t
1307332|NCT03500822|Randomized|Crossover Assignment||Basic Science||Single||||||t
1573374|NCT00001445||||Treatment||||||||
1307336|NCT03500770||Single Group Assignment||Other||None (Open Label)||||||
1307337|NCT03500757||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307338|NCT03500744|Randomized|Parallel Assignment||Treatment||Triple|Sham block will be performed||t|t||t
1307339|NCT03500731||Single Group Assignment||Treatment||None (Open Label)||||||
1307340|NCT03500718||Single Group Assignment||Treatment||None (Open Label)||||||
1307341|NCT03500705|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor only was masked.|Pilot Randomised Controlled Trial||||t
1307342|NCT03500692|||Cohort||Prospective|||||||
1307343|NCT03500679|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1307344|NCT03500666|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307345|NCT03500653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307346|NCT03500640|Randomized|Parallel Assignment||Prevention||Single||An initial 16-session Diabetes Prevention Program (DPP), called Group Lifestyle Balance (GLB) and aligned with current Medicare guidelines, will be administered to all enrolled participants primarily through group telephone contact, videos, and workbooks. Subsequently one-half of those enrolled will be randomly assigned to either (1) 30-minute DPP behavior intervention group telephone contact, or (2) 15-minute support group telephone contact for a toal of 18 additional months.|||t|
1307347|NCT03500627|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1307348|NCT03500614|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1307349|NCT03500601|Randomized|Crossover Assignment||Other||Triple||2 x 4 week intervention with 4 week washout|t||t|t
1307350|NCT03500588|||Case-Control||Prospective|||||||
1307351|NCT03500575|Randomized|Parallel Assignment||Prevention||Double||Pilot study, single center, randomized controlled trial, single blind, 2 parallel arms|||t|t
1307352|NCT03500562|||Cohort||Prospective|||||||
1307353|NCT03500549|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1307354|NCT03500536|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1307355|NCT03500523|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1307356|NCT03500497|||Cohort||Prospective|||||||
1307357|NCT03500484|Randomized|Parallel Assignment||Treatment||Single||15 control and 30 obese subjects|t|||
1307358|NCT03500471|||Cohort||Prospective|||||||
1307359|NCT03500458|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1307360|NCT03500445||Single Group Assignment||Treatment||None (Open Label)||||||
1307361|NCT03500432|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1307362|NCT03500419|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1307363|NCT03500406|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1307364|NCT03500393|Randomized|Parallel Assignment||Other||Double|Participants will be blind to study hypotheses, data collector will be blind to treatment assignment|Participants will be randomized to the remotely supervised exercise (REM) or the unsupervised exercise (UNSUP) arm upon completion of the baseline assessment battery.|t|||t
1307365|NCT03500380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307366|NCT03500367||Single Group Assignment||Treatment||None (Open Label)||||||
1307367|NCT03500354||Single Group Assignment||Treatment||None (Open Label)||Pilot feasibility open-label study||||
1307368|NCT03500341||||||||||||
1307369|NCT03500328|Randomized|Parallel Assignment||Treatment||Single||||||t
1307370|NCT03500315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307371|NCT03500302||Single Group Assignment||Treatment||None (Open Label)||Pilot clinical trial to study HIV+ patients with baseline coronary endothelial dysfunction and assess changes in that function from the baseline measure to 1 and 6 weeks following initiation of therapy with evolocumab so as to test the hypotheses that PCSK9 inhibition with evolocumab improves coronary endothelial function (CEF) measured directly and non-invasively with MRI at 1 week and 6 weeks after initiation of evolocumab.||||
1307372|NCT03500289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307373|NCT03500276|Randomized|Parallel Assignment||Supportive Care||Single|Blinded rater will be used to assess disease activity by DAS28CRP score.|Randomized controlled clinical trial||||t
1307374|NCT03500263|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1307375|NCT03500250|||Cohort||Prospective|||||||
1307376|NCT03500237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307377|NCT03500224||Single Group Assignment||Other||None (Open Label)||||||
1307378|NCT03500211|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307379|NCT03500198||||||||||||
1307380|NCT03500185|Randomized|Parallel Assignment||Treatment||Single||||||t
1307381|NCT03500172|Randomized|Sequential Assignment||Treatment||None (Open Label)||This sequential multistage adaptive randomized trial (SMART) assesses two interventions to address treatment barriers: (1) nurse-led mobile decentralized treatment programs (DTP) and (2) peer-led, individualized case management (ICM).||||
1307382|NCT03500159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307383|NCT03500146|||Cohort||Prospective|||||||
1307384|NCT03500133|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Initial disease risk assignment defines three arms: low, intermediate and high risk. After early disease response assessment 7 Arms are defined, treated with more intense chemotherapy according to initial risk and therapy response. Finally radiotherapy is delivered only to patients who do not achieve complete remission after chemotherapy at late disease response assessment.||||
1307385|NCT03500120|||Case-Control||Prospective|||||||
1307386|NCT03500107||Single Group Assignment||Treatment||None (Open Label)||||||
1307387|NCT03500094||Single Group Assignment||Treatment||None (Open Label)||||||
1307388|NCT03500081|||Case-Only||Prospective|||||||
1307389|NCT03500068||Single Group Assignment||Basic Science||None (Open Label)||||||
1307390|NCT03500055|Randomized|Parallel Assignment||Prevention||Double|Only the primary investigators will be able to be blinded for this study. The surgeon is unable to be blinded and since the patient is awake during c-sections, blinding will be impossible.|Single center, randomized controlled trial|||t|t
1573375|NCT00001443||||Treatment||||||||
1307391|NCT03500042|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1307392|NCT03500029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307393|NCT03500016||Single Group Assignment||Basic Science||None (Open Label)||||||
1307394|NCT03500003|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1307395|NCT03499990|||Cohort||Prospective|||||||
1307396|NCT03499977|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1307397|NCT03499964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307398|NCT03499951|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307399|NCT03499938|||Cohort||Prospective|||||||
1307400|NCT03499925|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1307401|NCT03499912|||Case-Only||Prospective|||||||
1307402|NCT03499899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307403|NCT03499886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307404|NCT03499873|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1307405|NCT03499860||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307406|NCT03499847|Randomized|Parallel Assignment||Health Services Research||Single|subjects will be interviewed over the telephone 6 weeks after initial intervention by a blinded assessor to assess outcomes|"3-arm, randomised control trial~Active Intervention group (n=65) Counselling provided Pamphlet given~Passive Intervention group (n=65) Pamphlet given~Control group (n=65) Neither counselling nor pamphlet given"||||t
1307407|NCT03499834||Single Group Assignment||Treatment||None (Open Label)||||||
1307408|NCT03499821||Single Group Assignment||Treatment||None (Open Label)||Device: Open label, all subjects receive same treatment||||
1307409|NCT03499808||Single Group Assignment||Treatment||None (Open Label)||||||
1307410|NCT03499795||Single Group Assignment||Treatment||None (Open Label)||||||
1307411|NCT03499782|||Cohort||Retrospective|||||||
1307412|NCT03499769|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1307413|NCT03499756|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1307414|NCT03499743|Randomized|Parallel Assignment||Prevention||Quadruple|The investigators who will insert the IUDs and will collect important data, the patients and the statistician who will perform the final data analysis will be blinded to the group allocations||t|t|t|t
1307415|NCT03499730|||Cohort||Prospective|||||||
1307416|NCT03499717|||Other||Retrospective|||||||
1307417|NCT03499704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307418|NCT03499691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307419|NCT03499678|||Case-Control||Retrospective|||||||
1307420|NCT03499665|Randomized|Parallel Assignment||Treatment||Single|Participants didn't know taking which exercise treatment methods|Experimental, Randomized Controlled Study|t|||
1307421|NCT03499652|||Cohort||Other|||||||
1307422|NCT03499639||Single Group Assignment||Treatment||None (Open Label)||||||
1307423|NCT03499626||Single Group Assignment||Treatment||None (Open Label)||||||
1307424|NCT03499613|||Cohort||Prospective|||||||
1307425|NCT03499600|Randomized|Parallel Assignment||Other||Double|Coders assessing therapist fidelity to the CFI are kept unaware of the condition to which each participant is assigned. Participants will also be unaware of the condition to which they have been assigned.|Randomized control trial in which participants are randomly assigned to either receive a diagnostic and clinical assessment plus the cultural formulation interview (CA+CFI) or the diagnostic and clinical assessment (CA).|t|||t
1307426|NCT03499587|||Cohort||Prospective|||||||
1307427|NCT03499574|Randomized|Parallel Assignment||Treatment||Single||Randomised Controlled Trial||||t
1307428|NCT03499561|||Cohort||Prospective|||||||
1307429|NCT03499548||Single Group Assignment||Treatment||None (Open Label)||||||
1307430|NCT03499535|Randomized|Factorial Assignment||Prevention||Single|Participants blinded to condition.|Study 1: Participants randomly assigned to one of two conditions. Study 2: Participants randomly assigned to one of three conditions.|t|||
1307431|NCT03499522|||Cohort||Prospective|||||||
1307432|NCT03499509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307433|NCT03499496|||Case-Only||Retrospective|||||||
1307434|NCT03499483||Single Group Assignment||Prevention||None (Open Label)||Open Label single arm study||||
1307435|NCT03499470|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307436|NCT03499457||Single Group Assignment||Other||None (Open Label)||||||
1307437|NCT03499444||Sequential Assignment||Treatment||None (Open Label)||||||
1307438|NCT03499431|||Cohort||Prospective|||||||
1307439|NCT03499418|||Cohort||Prospective|||||||
1307440|NCT03499405|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Intervention group will have access to a culturally matched family navigator, control group will not have access to a culturally matched family navigator.||||
1307441|NCT03499392||Single Group Assignment||Health Services Research||None (Open Label)||||||
1307442|NCT03499379|||Cohort||Prospective|||||||
1307443|NCT03499366||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307444|NCT03499353|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||THIS IS AN OPEN LABEL SINGLE ARM STUDY||||
1307445|NCT03499340|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1307446|NCT03499327|Randomized|Parallel Assignment||Treatment||Single|The wheat germ oil is dispensed in dark glass bottles without label. The distinction between the groups is based on the expiration date (08.05.2018 vs. 09.05.2018).|"The randomized, single-blind human intervention study will be conducted in parallel design.~Half of the participants (n = 17) will consume wheat germ oil UV-treated (intervention) and half of the participants (n = 17) will consume wheat germ oil untreated (placebo). The daily dosage of wheat germ oil is 10 ml and the study products will be consumed over an entire period of 6 weeks (no follow-up).~The third group (n = 16) do not receive any study products (control)."|t|||
1307447|NCT03499314|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1307448|NCT03499301|||Cohort||Prospective|||||||
1307449|NCT03499288|||Cohort||Cross-Sectional|||||||
1307450|NCT03499275|Randomized|Parallel Assignment||Treatment||Double||"This is a study that comprises:~A parallel group, randomised placebo-controlled, assessor-blinded trial with participants randomised (1:1) to usual care (home based exercise programme) with either placebo or active NMES for six weeks, with a 12 week follow-up.~Qualitative interviews with participants and staff."|t|||t
1307451|NCT03499262||Single Group Assignment||Treatment||None (Open Label)||||||
1307452|NCT03499249||Single Group Assignment||Treatment||None (Open Label)||"This is a Phase 2 clinical trial using the two-stage minimax design described by Simon (Simon, 1989). As a Phase 2 trial, the trial's objective is to determine whether NAC has sufficient biological activity as adjunctive therapy for BA to warrant further study. By choosing the two-stage minimax design, we gain two advantages: (i) early termination if the drug is not efficacious, and (ii) using historical controls and therefore an overall smaller sample size to test the hypothesis, i.e., no randomization or control arm. This study design only identifies large effects (response >20%). For BA this is appropriate, because the field is in need of a robust therapy that can substantially limit liver damage and delay/prevent need for liver transplantation."||||
1307453|NCT03499236|Randomized|Parallel Assignment||Treatment||Quadruple|In the randomized cohort, participants and the heart failure clinical team will be blinded to study assignment.|Randomized treatment versus control (1:1). Control patients will be allowed to cross-over at the completion of the blinded phase. A parallel roll-in arm will enroll up to 3 patients per site in an open-label study.|t|t|t|t
1307454|NCT03499223|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307455|NCT03499210||Single Group Assignment||Other||None (Open Label)||||||
1307456|NCT03499197|||Cohort||Prospective|||||||
1307457|NCT03499184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307458|NCT03499171|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1307459|NCT03499158|||Other||Retrospective|||||||
1307460|NCT03499145||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307461|NCT03499132|||Cohort||Prospective|||||||
1307462|NCT03499119|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1307463|NCT03499106||Single Group Assignment||Other||None (Open Label)||||||
1307464|NCT03499093|||Other||Prospective|||||||
1307465|NCT03499080|||Other||Prospective|||||||
1307466|NCT03499067||||||||||||
1307467|NCT03499054|Randomized|Parallel Assignment||Supportive Care||Single||Randomized hemodialysis patients in hospital|||t|
1307468|NCT03499041|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1307469|NCT03499028|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307470|NCT03499015|Randomized|Parallel Assignment||Treatment||Triple|only surgeon knows treated side, documentation of side only visible to surgeon and investigator|single-sided treatment, contralateral side with same pathology works as control|t|t||t
1307471|NCT03499002|Randomized|Parallel Assignment||Other||Single|Research assistant will be present when student randomly chooses which environment they will learn how to suture in. The principal investigator will be unaware of this randomization.||||t|
1307472|NCT03498989|Randomized|Parallel Assignment||Prevention||Single|||t|||
1307473|NCT03498976|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1307474|NCT03498963||Single Group Assignment||Basic Science||None (Open Label)||||||
1307475|NCT03498950|Randomized|Single Group Assignment||Treatment||Single|The patients will be randomized and distributed into two groups: Placebo Group (n=40) - submitted to the routine laser therapy protocol in addition to simulated laser irradiation on the taste papillae; Test Group (n= 40) - submitted to the same laser therapy protocol as that of the Placebo Group, however, laser irradiation on the taste papillae will be effective.|"The study sample will be composed of 80 patients selected at the Hematopoietic Stem Cell Transplantation Center of the Hospital Israelita Albert Einstein. The patients will be randomized and distributed into two groups."|t|||
1307476|NCT03498937|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1307477|NCT03498924|||Case-Control||Prospective|||||||
1307478|NCT03498911|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307479|NCT03498898|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307480|NCT03498885|Randomized|Parallel Assignment||Treatment||Double||"Procedure： Low ligation with apical lymph node dissection~Procedure： High ligation with apical lymph node dissection"|t|t||
1307481|NCT03498872|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1307482|NCT03498859|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1307483|NCT03498846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307484|NCT03498833||Single Group Assignment||Other||None (Open Label)||All the domains and items in CKOAI will undergo reliability testing. Minimum 60 IKOA will be evaluated with the scale on two occasions within two weeks to establish test retest reliability. Cronbach's alpha for internal consistency and Intra class correlation coefficient for test retest reliability will be used to determine the degree of consistency of items in the scale. MDC will be calculated using the formulae, SEM = SD x √ (1-reliability) and MDC95 = √2 x (1.9) x (SEM). Significant level will be set at p value less than 0.05 (p < 0.05) to minimize the type-I error.||||
1307485|NCT03498820|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1307486|NCT03498807|Non-Randomized|Parallel Assignment||Treatment||Single|During this period, all patients were total sedation using continuous infusion, to prevent any spontaneous breathing .All patients were ventilated using a ventilator|Moderate to severe ARDS patient on mechanical ventilation from ER or word transfer ICU.(P/F<200+PEEP ≥ 5cmH20)|t|||
1307487|NCT03498794|Randomized|Factorial Assignment||Treatment||None (Open Label)||Comparison Between Ureteral Stent versus Percutaneous Nephrostomy in Obstructed infected kidney due to Ureteric calculi||||
1307488|NCT03498781|Randomized|Factorial Assignment||Other||None (Open Label)||This study will be a between group factorial design. The between subjects variable will be group assignment. The within subjects variable will be time.||||
1307489|NCT03498768|||Cohort||Prospective|||||||
1307543|NCT03498053||Single Group Assignment||Other||None (Open Label)||Not-randomized crossover study with a single group||||
1307544|NCT03498040|||Cohort||Prospective|||||||
1307545|NCT03498027|||Case-Only||Prospective|||||||
1307996|NCT03492151|||Cohort||Prospective|||||||
1307490|NCT03498755|Randomized|Parallel Assignment||Prevention||None (Open Label)||Two communities in each of two study regions will be assigned to one of the three treatments (i.e., six communities in total per region). Assigning two communities to the same treatment in each region will allow us to assess differential intervention design and implementation needs for communities in similar geographic areas. Ten women in each community will be purposefully selected for participation to ensure intra-community variation on participant age, socioeconomic status, years of experience with fish smoking, and the scale of fish smoking enterprises. Across both regions, 120 women will be recruited from a total of 12 communities. While the interventions will be delivered to individual women, treatment assignment will be carried out at the community-level given the risk of sharing information and inputs within communities that could contaminate intervention exposure and bias observed treatment effects.||||
1307491|NCT03498742|||Case-Control||Prospective|||||||
1307492|NCT03498729|||Case-Control||Prospective|||||||
1307493|NCT03498716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307494|NCT03498703|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1307495|NCT03498690|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized 1:1:1 to feedback that is integrative or role specific or presented consecutively||||
1307496|NCT03498677|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307497|NCT03498664|Randomized|Parallel Assignment||Treatment||Single||||||t
1307498|NCT03498651|Randomized|Sequential Assignment||Treatment||Single|Participants will be aware whether they are completing the intervention by phone or computer, and will know if they are receiving coaching or not.||||t|
1307499|NCT03498638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307500|NCT03498625||Single Group Assignment||Other||None (Open Label)||||||
1307501|NCT03498612||Single Group Assignment||Treatment||None (Open Label)||||||
1307502|NCT03498599|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1307503|NCT03498586|Randomized|Parallel Assignment||Other||Double|||t||t|
1307504|NCT03498573||Single Group Assignment||Treatment||None (Open Label)||||||
1307505|NCT03498560|||Cohort||Prospective|||||||
1307506|NCT03498547|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307507|NCT03498534|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307508|NCT03498521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307509|NCT03498508|||Case-Only||Cross-Sectional|||||||
1307510|NCT03498495|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307511|NCT03498482||Single Group Assignment||Treatment||None (Open Label)||||||
1307512|NCT03498469|Randomized|Parallel Assignment||Prevention||Single|Randomized assignment will be done by the individuals who are evaluating the study outcomes, but will be blind to participant assignment|Participants are assigned to either of the two arms in parallel for the duration of the study||||t
1307513|NCT03498456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307514|NCT03498443|||Case-Control||Prospective|||||||
1307515|NCT03498430||Single Group Assignment||Basic Science||None (Open Label)||||||
1307516|NCT03498417|||Cohort||Cross-Sectional|||||||
1307517|NCT03498404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307518|NCT03498391|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1307519|NCT03498378||Single Group Assignment||Treatment||None (Open Label)||||||
1307520|NCT03498365|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307521|NCT03498352|||Cohort||Prospective|||||||
1307522|NCT03498326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307523|NCT03498313|Randomized|Crossover Assignment||Basic Science||Double|double-blind|Crossover 3-condition placebo-controlled trial|t||t|
1307524|NCT03498300|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307525|NCT03498287|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1307526|NCT03498274|Randomized|Crossover Assignment||Other||None (Open Label)||This is a controlled, randomized, cross-over, open label, comparative clinical investigation. A randomized cross-over design is used with half of the test subjects wearing the device fit with the traditional fitting method first and the other half using the self-directed method and then switching after approximately 10 +/-5 days.||||
1307527|NCT03498261|Randomized|Single Group Assignment||Prevention||Double|Once the randomization group has been defined, the pharmacist will prepare both medications and will place them inside a bag for further handling. Medications will be identified following institutional standard of procedures.|Adult patients scheduled to undergo rhinoplasty at the Ohio State University Wexner Medical Center|t||t|
1307528|NCT03498248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||neutropenia after cytotoxic chemotherapy||||
1307529|NCT03498235|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1307530|NCT03498222|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1307531|NCT03498209|||Ecologic or Community||Cross-Sectional|||||||
1307532|NCT03498196||Single Group Assignment||Treatment||None (Open Label)||||||
1307533|NCT03498183||Single Group Assignment||Diagnostic||None (Open Label)||All the patients will have the scintigraphie with MIBI-Tc99m/Iodine-123||||
1307534|NCT03498170||Single Group Assignment||Treatment||None (Open Label)||||||
1307535|NCT03498157|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307536|NCT03498144|||Case-Control||Prospective|||||||
1307537|NCT03498131|Randomized|Parallel Assignment||Treatment||Quadruple|The study is blinded to patients and providers.|Subjects will be randomly assigned to receive melatonin at 3 milligrams (mg) once a day or 5mg once a day. The study drug will be taken at 21:00 each day ± 2 hours.|t|t|t|t
1307538|NCT03498118|Randomized|Parallel Assignment||Prevention||Single|the participants will be blinded to the medication type, which will be used.|Randomized Controlled Trial|t|||
1307539|NCT03498105|||Cohort||Prospective|||||||
1307540|NCT03498092|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1307541|NCT03498079|||Other||Prospective|||||||
1307542|NCT03498066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307546|NCT03498014|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307547|NCT03498001||Single Group Assignment||Treatment||None (Open Label)||||||
1307548|NCT03497988|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1307549|NCT03497975|Randomized|Crossover Assignment||Treatment||Quadruple|Matching Placebo|Randomized, double-blinded, placebo-controlled, 2-arm study with an open label extension period following double-blind treatment.|t|t|t|t
1307550|NCT03497962|||Cohort||Prospective|||||||
1307551|NCT03497949|||Cohort||Retrospective|||||||
1307552|NCT03497936|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants randomly assigned to one of two arms (intervention, no intervention). Intervention participants receive Women's Stories. No intervention participants receive treatment as usual. All participants are administered a pretest and two post tests, and clinical records are examined for vaccination outcomes.||||
1307553|NCT03497923|Randomized|Parallel Assignment||Treatment||Quadruple|quadruple|2 arms, randomized, double blind trial|t|t|t|t
1307554|NCT03497910||||||||||||
1307555|NCT03497897|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307556|NCT03497884|Randomized|Parallel Assignment||Treatment||Single|||||t|
1307557|NCT03497871|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307558|NCT03497858|Randomized|Parallel Assignment||Treatment||Single|||||t|
1307559|NCT03497845|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1307560|NCT03497832||Single Group Assignment||Basic Science||None (Open Label)||||||
1307561|NCT03497819||Single Group Assignment||Treatment||None (Open Label)||||||
1307562|NCT03497806||Single Group Assignment||Treatment||None (Open Label)||||||
1307563|NCT03497793||Single Group Assignment||Treatment||None (Open Label)||||||
1307564|NCT03497780|||Cohort||Prospective|||||||
1307565|NCT03497767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307566|NCT03497754||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307567|NCT03497741|||Cohort||Retrospective|||||||
1307568|NCT03497728|||Family-Based||Prospective|||||||
1307569|NCT03497715|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1307570|NCT03497702||Single Group Assignment||Treatment||None (Open Label)||||||
1307571|NCT03497689||Single Group Assignment||Treatment||None (Open Label)||||||
1307572|NCT03497676|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1307573|NCT03497663|Randomized|Parallel Assignment||Treatment||Single|Baseline Assessor|The families randomly assigned to the VIA Family Group will be offered regular contact with a case manager. A multidisciplinary team of specialists from adult mental health services/psychiatry , child and adolescent mental health services and social services will be responsible for providing the basic treatment elements that are: case management, psychoeducation for the whole family, parental training (Triple P) and early intervention for mental problems of the child.||||t
1307574|NCT03497650|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor only was masked.|Pilot Randomised Controlled Trial||||t
1307575|NCT03497637|Randomized|Parallel Assignment||Treatment||Single||||||t
1307576|NCT03497624|||Other||Prospective|||||||
1307577|NCT03497611|||Case-Only||Retrospective|||||||
1307578|NCT03497598|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1307579|NCT03497585|||Cohort||Prospective|||||||
1307580|NCT03497572|||Case-Control||Cross-Sectional|||||||
1307581|NCT03497559|Randomized|Parallel Assignment||Treatment||Quadruple|iPods with music and no music, same headphones. Patients and parents are blinded to the intervention the same as bedside nurses, data collectors and principal investigators.|Double blind randomized controlled trial|t|t|t|t
1307582|NCT03497546|Randomized|Parallel Assignment||Treatment||Double|"Investigators, study coordinators, outcome assessors, and clinical staff will be blinded to the group allocation.~Participants and providers of the exercise delivery will not be blinded to the group allocation."|"Eligible participants will be randomly assigned (1:1) sequentially, as they will be submitted to bariatric surgery, to one of the two following groups:~CON - Usual care (following international guidelines) after bariatric surgery. EX - Usual care plus supervised exercise program."|||t|t
1307583|NCT03497533||Single Group Assignment||Treatment||None (Open Label)||||||
1307584|NCT03497520||Single Group Assignment||Treatment||None (Open Label)||||||
1307585|NCT03497507|Randomized|Parallel Assignment||Treatment||Double||Once an obstetrician determines that a patient laboring with an epidural catheter should have a non-emergent cesarean section instead of continuing labor, the clinical anesthesiologist will contact the research team. A member of the research team will contact the patient while she is still in the labor and delivery room, at which time informed consent would be obtained.|t|||t
1307586|NCT03497494|Randomized|Parallel Assignment||Prevention||Triple||"All patients enrolled in this study underwent laparoscopic sleeve gastrectomy. According to the starting point of resection to pylorus distance and whether to the strengthen suture of esophageal hole, the cases were randomly divided into 6 groups:~G1: 2 cm away from the pylorus edge, without hiatal suture; G2: 4 cm away from the pylorus edge, without hiatal suture; G3: 6 cm away from the pylorus edge, without hiatal suture; G4: 2 cm away from the pylorus edge, with hiatal suture G5: 4 cm away from the pylorus edge, with hiatal suture; G6: 6 cm away from the pylorus edge, with hiatal suture;"|t|t|t|
1307587|NCT03497481|||Cohort||Prospective|||||||
1307588|NCT03497468|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307589|NCT03497455|||Other||Prospective|||||||
1307590|NCT03497442|Randomized|Parallel Assignment||Treatment||Quadruple|This is a split face study. All participants will follow an identical protocol with active medication applied to half of their face and placebo applied to the other half. Treatment and placebo side will be randomized.||t|t|t|t
1307591|NCT03497429|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1307592|NCT03497416|||Case-Control||Prospective|||||||
1307593|NCT03497403|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants were assigned to one of two groups in parallel for the duration of the study.||||
1307594|NCT03497390|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Open label|||||
1573376|NCT00001439||||Treatment||||||||
1307595|NCT03497377||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307596|NCT03497364|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1307597|NCT03497351|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1307598|NCT03497338|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307599|NCT03497325|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1307600|NCT03497312|||Other||Other|||||||
1307601|NCT03497299|Randomized|Parallel Assignment||Treatment||Quadruple|The investigators will have a sham rTMS coil to provide full blinding for the active rTMS condition.|The study is a randomized controlled trial of active versus sham high frequency rTMS to the dorsolateral prefrontal cortex (DLPFC) in patients with schizophrenia who have co-occurring tobacco use disorder. The duration of treatment is 4 weeks and all subjects would receive open label Varenicline 2mg/day. The primary outcome measure is time to lapse to smoking.|t|t|t|t
1307602|NCT03497286|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a randomized control trial design that will compare the outcomes of randomly assigned treatment and control groups after participation in the NurturePA program.||||
1307603|NCT03497273||Single Group Assignment||Treatment||None (Open Label)||||||
1307604|NCT03497260|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1307605|NCT03497247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307606|NCT03497234||Single Group Assignment||Diagnostic||None (Open Label)|Investigator is blinded to results of the analyzer but all patients have samples run on analyzer|This is a multi-centered, prospective study, involving pregnant women presenting to the labor and delivery unit||||
1307607|NCT03497221|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307608|NCT03497208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307609|NCT03497195|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1307610|NCT03497182||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307611|NCT03497169|||Case-Only||Prospective|||||||
1307612|NCT03497156|||Case-Only||Prospective|||||||
1307613|NCT03497143|||Case-Only||Prospective|||||||
1307614|NCT03497130|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1307615|NCT03497117||Single Group Assignment||Other||None (Open Label)||Participants undergoing treatment for a pulmonary exacerbation will perform multiple breath washout and undergo an MRI with inhalation of a gas contrast agent (79% perfluorppropane (PFP) mixed with 21% oxygen) at the beginning and end of treatment.||||
1307616|NCT03497104|||Cohort||Prospective|||||||
1307617|NCT03497091|||Cohort||Retrospective|||||||
1307618|NCT03497078||Single Group Assignment||Other||None (Open Label)||||||
1307619|NCT03497065|||Cohort||Cross-Sectional|||||||
1307620|NCT03497052|||Other||Prospective|||||||
1307621|NCT03497039|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1307622|NCT03497026||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307623|NCT03497013|Randomized|Parallel Assignment||Treatment||Double|This study is a randomized, double-blind, sham-controlled clinical trial.All patients received 2-mA anodal left/cathodal right prefrontal tDCS treatment (fifteen 30-minutes sessions: Monday to Friday once daily, every other week to do a group of treatment). All evaluations were performed at baseline, the end of 3rd weeks, 5th weeks, and 7th weeks by 2 psychiatrists blinded to the treatment assigned. Inter-rater reliability was satisfactory(ka=0.86).|The aim of the study was to evaluate the efficacy, safety, and cognitive function of transcranial direct current stimulation (tDCS) in chronic schizophrenia patients with tardive dyskinesia (TD).|t|||t
1307624|NCT03497000|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1307625|NCT03496987|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients are randomly assigned immediately before performing the procedure to either of the two investigational arms: manual drainage or vacuum bottle drainage.||||
1307626|NCT03496974|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1307627|NCT03496961|Randomized|Parallel Assignment||Treatment||Double|This will use simple randomization ways. Sofware20.0 will used to generate a random unique number for each integral number from 1 to 90 and divide the 90 numbers (1 to 90) into three groups with a ratio of 1:1:1 based on the random numbers group. The number grouping is unknown. This will be a double blind trial.|"Clinically evaluated, medically unexplained fatigue of at least 6 months duration:~Of new onset. Not a result of ongoing exertion. Not substantially alleviated rest and associated with a substantial reduction in previous levels of activity"|t|||t
1307628|NCT03496948|Randomized|Parallel Assignment||Treatment||Double||Study arms: TeGeCoach (Intervention); Treatment-as-Usual (TAU)|||t|t
1307629|NCT03496935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307630|NCT03496922||Single Group Assignment||Basic Science||None (Open Label)|Participants will not be told which cigarettes (ventilated or unventilated) are which.|||||
1307631|NCT03496909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307632|NCT03496896|Randomized|Parallel Assignment||Health Services Research||Single|Given the nature of the intervention, it will be not possible to blind patients and nurses providing the TARGET intevention. However, treatment allocation in the database will be coded and the study nurses collecting the outcomes or working on data cleaning and the statistician performing the analysis will be blinded to the group allocation.|||||t
1307633|NCT03496883|Randomized|Parallel Assignment||Treatment||Quadruple|Blinded study medication||t|t|t|t
1307634|NCT03496870||Single Group Assignment||Treatment||None (Open Label)||||||
1307635|NCT03496857|Randomized|Parallel Assignment||Treatment||Single|Statistic evaluation|RANDOMIZED CLINICAL TRIAL||||t
1307636|NCT03496844|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1307637|NCT03496831|||Cohort||Retrospective|||||||
1307638|NCT03496818|||Case-Control||Prospective|||||||
1307639|NCT03496805|Randomized|Parallel Assignment||Treatment||Triple|This is a double-blind study. Only the lead-site investigational pharmacy team and the statistician will unblinded. The blind will be maintained until the study is complete.||t|t|t|
1307719|NCT03495752||Single Group Assignment||Other||None (Open Label)||||||
1307720|NCT03495739|Randomized|Crossover Assignment||Treatment||Single||||||t
1307640|NCT03496792|Non-Randomized|Parallel Assignment||Basic Science||Single|Outcomes assessor will not know trial intervention prior to data analysis.|"The investigators will examine if individuals with elevated standing blood pressure have a heightened VDR. Two groups of subjects, BP elevated with standing group and BP maintained with standing group will be examined for this experiment. The tilt + external pressure and tilt + no external pressure, or the limb occlusion + negative pressure and limb occlusion + no negative pressure trials will be performed in random order using a Latin Square design. Because the nature of the interventions, neither the subjects nor the investigators can be blinded to the interventions"||||t
1307641|NCT03496779||Single Group Assignment||Treatment||None (Open Label)||This study is an open label, multicenter phase 2 study. Patients treated with gemcitabine will receive brentuximab vedotin (GBv) for 4 cycles of induction.||||
1307642|NCT03496766||Single Group Assignment||Treatment||None (Open Label)||||||
1307643|NCT03496753|Randomized|Parallel Assignment||Treatment||Single|Statistic analysis|Randomized clinical trial||||t
1307644|NCT03496740|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1307645|NCT03496727|||Case-Control||Retrospective|||||||
1307646|NCT03496714|Randomized|Parallel Assignment||Prevention||Single|Participants will be told of the specifications only of the condition to which they are assigned.|Immediately after baseline assessment, each participant will be automatically randomized into one of three study conditions. Randomization will be stratified based on number and severity of safety behaviors used and level of Acute Stress Disorder symptoms reported at baseline. Once randomized, participants in the two psychoeducation conditions will immediately receive psychoeducation materials, and all participants will receive rationale for their study condition, as specified above. All three conditions will complete the same schedule of assessments.|t|||
1307647|NCT03496701||||||||||||
1307648|NCT03496688|Randomized|Parallel Assignment||Treatment||Triple|Participant, Investigator, Outcome Assessor|A randomized,controlled, double-blind clinical trial|t||t|t
1307649|NCT03496675|Randomized|Factorial Assignment||Treatment||Single|Blinding of assessors will be ensured by using assessors who do not participate in the daily care of each unit. Assessors will also remind participants not to reveal the unit's allocation to them. At the time of the last assessment, success of blinding will be verified by asking assessors whether they inadvertently discovered the unit's allocation. Intervention providers and study participants (PLWD and staff) cannot be blinded due to the nature of the interventions. However, efforts will be made to ensure that no differential expectations are created and equipoise is maintained (e.g., by careful wording of the patient information and consent form).|||||t
1307650|NCT03496662|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1307651|NCT03496649||Single Group Assignment||Treatment||None (Open Label)||||||
1307652|NCT03496636||Single Group Assignment||Treatment||None (Open Label)||||||
1307653|NCT03496623|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1307654|NCT03496610|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307655|NCT03496597|||Cohort||Prospective|||||||
1307656|NCT03496584|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1307657|NCT03496571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307658|NCT03496558|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1307659|NCT03496545|Randomized|Parallel Assignment||Treatment||Single|The data analyst who will analyze the data from each patient will be masked to what medication(s) the patients received.|open label, blinded endpoint, randomized (1:1) controlled trial with two arms: control - acetaminophen and intervention - acetaminophen and bromocriptine.||||t
1307660|NCT03496532|Non-Randomized|Sequential Assignment||Treatment||Single||Different stimulation paradigm tested sequentially in every patient of the group|t|||
1307661|NCT03496519|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1307662|NCT03496506||Single Group Assignment||Other||None (Open Label)||Open-label, two-treatment, one-sequence, cross-over study||||
1307663|NCT03496493|||Cohort||Prospective|||||||
1307664|NCT03496480|||Cohort||Retrospective|||||||
1307665|NCT03496467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307666|NCT03496454||Single Group Assignment||Basic Science||None (Open Label)||||||
1307667|NCT03496441|||Case-Control||Prospective|||||||
1307668|NCT03496428||Single Group Assignment||Screening||None (Open Label)|Altough it is a single arm two different techniques will be used and obtained STL files will be identified as A and B and the outcomes assessor will not be informed which group corresponds to intra-oral scanner and extra-oral scanner|"To describe the soft tissues dimensional changes (based on STL files) occurred between an intra-oral scanner and standartized scan-body and a extra-oral scanner of stone cast poured from silicone impression with a customized impression coping~12 months after implant placement and simultaneous regeneration with L-PRF and bovine bone graft in the aesthetic zone of atrophic maxillae in full arch implant supported rehabilitations"||||
1307669|NCT03496415|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1307670|NCT03496402|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307671|NCT03496389|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1307672|NCT03496376|Randomized|Parallel Assignment||Treatment||Single|An assessor who was blinded to treatment groups assessed clinical outcomes before the treatment process. The same assessor was also repeated assessments at 6th week (at the end of treatment process)|||||t
1307673|NCT03496363|||Case-Control||Prospective|||||||
1307674|NCT03496350|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants get randomly assigned to either treatment or wait-list control.||||
1307675|NCT03496337|||Cohort||Prospective|||||||
1307676|NCT03496324|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1307677|NCT03496311|||Case-Control||Prospective|||||||
1307678|NCT03496298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307679|NCT03496285||Parallel Assignment||Other||None (Open Label)||||||
1307680|NCT03496272|||Case-Only||Other|||||||
1307721|NCT03495726|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307722|NCT03495713||Single Group Assignment||Treatment||None (Open Label)||||||
1308214|NCT03489317|||Cohort||Prospective|||||||
1307681|NCT03496259|Randomized|Parallel Assignment||Treatment||Triple|The patient, family and clinical care team (nurses, residents, physician assistants) will be blinded, as well as the research team collecting outcomes. The surgeons (including primary investigator) will not be blinded as will be placing the device.|Randomized, controlled study|t|t||t
1307682|NCT03496246|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||It is a Clinical trial with three arms||||
1307683|NCT03496233||Single Group Assignment||Treatment||None (Open Label)||||||
1307684|NCT03496220|Randomized|Crossover Assignment||Prevention||None (Open Label)||Clustered randomized cross over trial||||
1307685|NCT03496207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307686|NCT03496194|||Other||Prospective|||||||
1307687|NCT03496181|||Cohort||Prospective|||||||
1307688|NCT03496168||Single Group Assignment||Treatment||None (Open Label)||||||
1307689|NCT03496155|Randomized|Parallel Assignment||Other||None (Open Label)||Treatment groups receive intervention and control groups receive usual care.||||
1307690|NCT03496142|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients who will have prostate biopsy will be randomized 1:1 among transperineal or transrecal approach||||
1307691|NCT03496129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307692|NCT03496116|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1307693|NCT03496103|Non-Randomized|Parallel Assignment||Health Services Research|||Investigator received de-identified biological material for further studies.|Healthy non allergic and ragweed allergic subjects were exposed to ragweed pollen in a pollen exposure chamber for 3 hrs and symptom score was recorded||||
1307694|NCT03496090|Randomized|Parallel Assignment||Treatment||Double|"The patient data will be delivered to the investigator/s of the study of each hospital, who will fill out the Data Collection Notebook (DCN) of each patient and program their controls without information of the group to which the patient has been assigned, as such In this way, the consultations are carried out with blinding of the evaluator (the investigator who will do the controls will not know to which group the patient has been assigned).~The person in charge of carrying out the statistical analysis will not be able to know to which group the patient has been assigned due to the coding done in the DCN."|The study is a randomized, multicentric, controlled with active comparator, parallel group, blind to the evaluator, to demonstrate the non-inferiority in the efficacy and therapeutic and safety of the free diet (group 1) compared to the progressive diet (group 2) in the treatment of uncomplicated acute diverticulitis. This study will be carried out on 134 patients with uncomlpicated acute diverticulitis. The subjects will be randomized in a 1: 1 ratio to receive treatment with progressive diet or diet at free demand. The main analysis will take place two months after the start of treatment.|||t|t
1307695|NCT03496077|Randomized|Crossover Assignment||Other||None (Open Label)||Randomized cross-over study||||
1307696|NCT03496064|||Cohort||Retrospective|||||||
1307697|NCT03496038|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1307698|NCT03496025||Single Group Assignment||Treatment||None (Open Label)||||||
1307699|NCT03496012|Randomized|Parallel Assignment||Treatment||Single|"Outcomes-assessors will be masked to whether the subjects is in the treated or the control group.~Subjects and trial centres will be masked to whether high or low dose has been administered in the treated group."|A Randomised, Open Label, Outcomes-Assessor Masked, Prospective, Parallel Controlled Group Study.||||t
1307700|NCT03495999|||Cohort||Prospective|||||||
1307701|NCT03495986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307702|NCT03495973|||Cohort||Prospective|||||||
1307703|NCT03495960|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Multicenter open label phase II trial. The patients will be stratified according to their suitability to tolerate an induction chemo-immunotherapy regimen containing high-dose methotrexate.~Patients eligible for high-dose methotrexate-based induction chemotherapy will enter the run-in phase of Part A of the study and after the induction phase will be randomly assigned to procarbazine or lenalidomide maintenance monotherapy. Forty assessable patients per treatment arm are required.~Patients ineligible for high-dose methotrexate-based induction chemotherapy will be treated în Part B with concomitant whole-brain radiotherapy, temozolomide and rituximab and will receive temozolomide as maintenance.According to the Simon's two-stage minimax design, 46 patients will be treated in the first stage. If ≤ 16 patients will be progression-free at 2 years from maintenance treatment start, the study will be stopped. Otherwise, 19 additional patients will be treated for a total of 65"||||
1307704|NCT03495947|||Cohort||Prospective|||||||
1307705|NCT03495934||Single Group Assignment||Other||None (Open Label)||||||
1307706|NCT03495921|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Group A (i) oral temozolomide 100 mg/m2 daily (Days 1 - 5, total dose 500 mg/m2/cycle), (ii) oral irinotecan 50 mg/m2 daily (Days 1 - 5, total dose 250mg/m2/cycle), and (iii) Vigil 1.0 x 10e6 cells/injection cells/injection, intradermally on Day 15.~or~Group B (i) (oral temozolomide 100 mg/m2 daily (Days 1 - 5, total dose 500 mg/m2/cycle), and (ii) oral irinotecan 50 mg/m2 daily (Days 1 - 5, total dose 250mg/m2/cycle)."||||
1307707|NCT03495908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307708|NCT03495895|Randomized|Sequential Assignment||Treatment||Single|As the intervention is a home visiting intervention participants and care providers cannot be blinded. Outcome assessor and data analyst will be blinded.|||||t
1307709|NCT03495882||Single Group Assignment||Treatment||None (Open Label)||||||
1307710|NCT03495869|||Cohort||Prospective|||||||
1307711|NCT03495856||Single Group Assignment||Treatment||None (Open Label)||Single-group, mixed methods repeated measures design (pre and post assessments)||||
1307712|NCT03495843|||Cohort||Cross-Sectional|||||||
1307713|NCT03495830|||Cohort||Prospective|||||||
1307714|NCT03495817||Single Group Assignment||Treatment||None (Open Label)||||||
1307715|NCT03495804|Randomized|Parallel Assignment||Diagnostic||Double||Participants are randomly assigned to group A or B. Participants of group A are given isotonic mannitol as oral contrast agent, while participants of group B are given isotonic polyethylene glycol as oral contrast agent.||t||t
1307716|NCT03495791|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1307717|NCT03495778|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1307718|NCT03495765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307723|NCT03495700|Randomized|Parallel Assignment||Treatment||Double||This study is designed as a randomized controlled clinical trial.|||t|t
1307724|NCT03495687|||Case-Control||Cross-Sectional|||||||
1307725|NCT03495674||Single Group Assignment||Prevention||None (Open Label)||||||
1307726|NCT03495661|Randomized|Parallel Assignment||Treatment||Double||prospective clinical randomised clinical trial|t|t||
1307727|NCT03495648|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307728|NCT03495635|Randomized|Parallel Assignment||Prevention||Single|An independent survey research center will collect the 18-month follow-up surveys from participating youth and parents; those collecting these data will be kept blind to intervention vs. control group status until all outcome measures have been administered on each survey; juvenile justice authorities providing arrest record information will be masked to study arm of participants as will all those on the research team who are involved in coding this information.|Enrolled participants will be assigned randomly to participate in the Big Brothers Big Sisters Community-Based Mentoring Program (treatment group) or to a wait-list control group that is not eligible to participate in the program for a period of 4 years.||||t
1307729|NCT03495622|Randomized|Parallel Assignment||Treatment||None (Open Label)||Cluster Randomized Controlled Trial||||
1307730|NCT03495609||Single Group Assignment||Prevention||None (Open Label)||||||
1307731|NCT03495596|||Cohort||Cross-Sectional|||||||
1307732|NCT03495583|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomised controlled trial in which breastfed infants were randomised (equal groups) either to introduce 6 allergenic foods (cow's milk, egg, wheat, peanut, sesame, fish) from 3 months of age or to continue exclusive breastfeeding until about 6 months of age.||||
1307733|NCT03495570|||Cohort||Prospective|||||||
1307734|NCT03495557|Randomized|Parallel Assignment||Prevention||Double||Control will have simple closure while experimental group will have simple closure+mesh|t||t|
1307735|NCT03495544|||Case-Control||Prospective|||||||
1307736|NCT03495531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307737|NCT03495518|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307738|NCT03495505||Single Group Assignment||Treatment||None (Open Label)||20 patients will be recruited into this feasibility study with a 6 month follow-up. There will be no blinding nor randomisation.||||
1307739|NCT03495492||Single Group Assignment||Treatment||None (Open Label)||Clinical trials with a single arm||||
1307740|NCT03495479|||Cohort||Prospective|||||||
1307741|NCT03495466|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1307742|NCT03495453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307743|NCT03495440|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307744|NCT03495427||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307745|NCT03495414|||Case-Control||Cross-Sectional|||||||
1307746|NCT03495401|Randomized|Parallel Assignment||Treatment||Quadruple||Intervention group given fortified synbiotic milk, control group given non-fortified synbiotic milk|t|t|t|t
1307747|NCT03495388|||Other||Prospective|||||||
1307748|NCT03495375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307749|NCT03495362|Randomized|Parallel Assignment||Prevention||Double|The all details of groups assignment are arranged and controlled by the research designers. The color, shape, and external packaging of the yeast beta-glucan and placebo are consistent. Each bottle of capsules will be marked with the name (or identify number) of the participants by research designers. Thus, the grouping of participants is blind to the rest of the researchers (like outcomes assessors).||t|||t
1307750|NCT03495349|||Cohort||Prospective|||||||
1307751|NCT03495336|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1307752|NCT03495323||Single Group Assignment||Treatment||None (Open Label)||||||
1307753|NCT03495310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307754|NCT03495297|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1307755|NCT03495284|Randomized|Crossover Assignment||Prevention||Single|||||t|
1307756|NCT03495271|||Case-Control||Prospective|||||||
1307757|NCT03495258|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307758|NCT03495245|||Case-Control||Cross-Sectional|||||||
1307759|NCT03495232|||Cohort||Prospective|||||||
1307760|NCT03495219|||Other||Prospective|||||||
1307761|NCT03495206||Sequential Assignment||Treatment||None (Open Label)||||||
1307762|NCT03495193|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The proposed study is a randomized, controlled, interventional study to investigate the impact of a novel exercise intervention on executive dysfunction (Aim 1) and objective sleep outcomes (Aim 2) in patients with PD. Thirty participants with idiopathic PD will be recruited from the University of Alabama at Birmingham (UAB) Movement Disorders Center and randomized (1:1) to one of two groups (15 per group): exercise intervention (Ex) group or no-exercise (no-Ex) control group.||||
1307763|NCT03495180||Single Group Assignment||Treatment||None (Open Label)||||||
1307764|NCT03495167||Single Group Assignment||Treatment||None (Open Label)||||||
1307765|NCT03495154||Single Group Assignment||Treatment||None (Open Label)|All subjects enrolled will receive the Parietene DS Composite Mesh|||||
1307766|NCT03495141|Randomized|Parallel Assignment||Other||Single|Outcomes assessor will not know who was randomized to supervised versus unsupervised simulator training.|||||t
1307767|NCT03495128|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||longitudinal assessment||||
1307768|NCT03495115|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1307769|NCT03495102|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307817|NCT03494478||Single Group Assignment||Other||None (Open Label)||||||
1307818|NCT03494465|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1307819|NCT03494452|||Cohort||Cross-Sectional|||||||
1307820|NCT03494439|||Other||Cross-Sectional|||||||
1307821|NCT03494426|Randomized|Parallel Assignment||Treatment||Single||||||t
1307822|NCT03494413|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1307823|NCT03494400|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1307770|NCT03495089|Non-Randomized|Parallel Assignment||Screening||Single|A neurologist will be blinded to previous test results and will perform neurographyc test including sensory conduction study of the median, ulnar and sural nerves, and motor conduction study of the deep peroneal nerve.|consecutively there will be included patients with type 2 DM over 40 years of age, with or without symptoms of neuropathy, attended in Primary Care. We will also include the following two groups of patients matched by age and gender: one including patients with prediabetes (intermediate alterations of glucose metabolism defined as impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) determined by OGTT after 2-hour 75 g oral glucose administration and another including patients without glucose alterations (normal glucose tolerance) (control group)|||t|
1307771|NCT03495076|Randomized|Sequential Assignment||Basic Science||Double|"Participants will not be informed about the hypotheses tested and will not be informed about the sham-injection condition. The fact that they received only one injection during the study period will be uncovered at the end of the project.~Examiner will be blinded towards conditions sequence. Between pre-test and post-test examiner will not be present in the research room to provide blinding towards the manipulation provided (control, saline injection, sham injection)."|Within-group designed study. All participants will be assessed in three different experimental conditions (control, saline injection, sham injection). The order of conditions will be counterbalanced across participants and randomly chosen.|t|||t
1307772|NCT03495063|Randomized|Crossover Assignment||Other||Double||This protocol uses a crossover design. The subject sample is randomized. Subjects will serve as their own controls as they will be asked to intake both the natural and synthetic caffeine at two different occasions.|t||t|
1307773|NCT03495050|||Cohort||Prospective|||||||
1307774|NCT03495037|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1307775|NCT03495024||Single Group Assignment||Treatment||None (Open Label)||A 12 week exploratory, open-label, proof-of-concept, pilot study of smoking cessation treatment with varenicline in 10 schizophrenia or schizoaffective disorder patients who are actively smoking and have pre-existing TD while receiving stable doses of antipsychotics.||||
1307776|NCT03495011|||Cohort||Prospective|||||||
1307777|NCT03494998|||Cohort||Prospective|||||||
1307778|NCT03494985|Randomized|Parallel Assignment||Treatment||Single|The examiner and site staff reviewing the efficacy assessments were blinded to the treatment allocation of participants. All other study personnel (study statistician, data management staff and other employees of the Sponsor who may influence study outcomes) were blinded to the study treatments.|||||t
1307779|NCT03494972|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1307780|NCT03494959||Single Group Assignment||Treatment||None (Open Label)||||||
1307781|NCT03494946|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized study were half of the subjects will be given standard chemo therapy and the other half will undergo liver transplantation.||||
1307782|NCT03494933|Randomized|Parallel Assignment||Treatment||Single||||||t
1307783|NCT03494920|Randomized|Parallel Assignment||Treatment||Single|Blinded core laboratory adjudications of the primary outcome. NIHSS and mRS (secondary outcomes) performed by blinded assessor.|Patients will be randomised to either direct endovascular clot retrieval or to bridging intravenous thrombolysis with endovascular clot retrieval.||||t
1307784|NCT03494907|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1307785|NCT03494894|||Cohort||Prospective|||||||
1307786|NCT03494881||Single Group Assignment||Treatment||None (Open Label)||Mepolizumab for the treatment of chronic spontaneous urticaria||||
1307787|NCT03494868|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307788|NCT03494855|||Cohort||Prospective|||||||
1307789|NCT03494842|Randomized|Parallel Assignment||Treatment||Quadruple|After the written informed consent is obtained, subjects will be randomly allocated into one of the two groups: (a) the active TENS group and (b) the placebo TENS group.||t|t|t|t
1307790|NCT03494829|||Cohort||Prospective|||||||
1307791|NCT03494816||Single Group Assignment||Treatment||None (Open Label)||||||
1307792|NCT03494803|||Case-Control||Retrospective|||||||
1307793|NCT03494790|||Cohort||Prospective|||||||
1307794|NCT03494777|Randomized|Sequential Assignment||Treatment||Double|The investigator and outcomes assessor will be blinded to treatment assignment of study participants.|"Randomized controlled trial with two intervention arms and a control group will receive an intervention for twelve months; those not showing viral suppression at month 12 will be randomized to either continue receiving the year 1 intervention for another twelve months, or receive an additional intervention component for twelve months.~The main analysis will be based on the sample of 330 treatment mature clients, from which the 70 treatment initiating clients will be excluded."|||t|t
1307795|NCT03494764|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1307796|NCT03494751|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307797|NCT03494738|||Cohort||Prospective|||||||
1307798|NCT03494725|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1307799|NCT03494712|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1307800|NCT03494699|Randomized|Parallel Assignment||Prevention||Single||||||t
1307801|NCT03494686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307802|NCT03494673|||Case-Control||Prospective|||||||
1307803|NCT03494660|||Cohort||Other|||||||
1307804|NCT03494647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307805|NCT03494634||Single Group Assignment||Treatment||None (Open Label)||||||
1307806|NCT03494621|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307807|NCT03494608|||Cohort||Prospective|||||||
1307808|NCT03494595|||Cohort||Prospective|||||||
1307809|NCT03494582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307810|NCT03494569||Single Group Assignment||Treatment||None (Open Label)||||||
1307811|NCT03494556|||Cohort||Prospective|||||||
1307812|NCT03494543|||Cohort||Retrospective|||||||
1307813|NCT03494530|||Cohort||Prospective|||||||
1307814|NCT03494517|||Case-Control||Prospective|||||||
1307815|NCT03494504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307816|NCT03494491|Non-Randomized|Crossover Assignment||Other||Single|||t|||
1307824|NCT03494387|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1307825|NCT03494374||Single Group Assignment||Treatment||None (Open Label)||Annual evaluation after applying UCBL and exercise treatment. Cohort study.||||
1307826|NCT03494361|||Other||Prospective|||||||
1307827|NCT03494348|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307828|NCT03494335||Single Group Assignment||Health Services Research||None (Open Label)||||||
1307829|NCT03494322|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised phase II study with safety run in||||
1307830|NCT03494309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307831|NCT03494296|||Case-Control||Prospective|||||||
1307832|NCT03494283|||Cohort||Prospective|||||||
1307833|NCT03494270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307834|NCT03494257|Randomized|Parallel Assignment||Treatment||Double|Patients will be unaware of their groupe assignment. The investigator who will measure the IOP will also be masked to group assignment.|Prospective randomized double-masked comparative study|t||t|
1307835|NCT03494244|||Cohort||Prospective|||||||
1307836|NCT03494231||Single Group Assignment||Treatment||None (Open Label)||||||
1307837|NCT03494218|Randomized|Parallel Assignment||Diagnostic||Double||The order of the administration was randomly selected. All patients' total scores assessed by rater A were recorded to test the internal consistency of NCS-R (A1). Meanwhile, to assess the concurrent validity, the scores of the FLACC were recorded together with NCS-R by rater A on day 1. In order to analyze the test-retest reliability, rater A complete the second evaluation of NCS-R on day 2 (A2)|t||t|
1307838|NCT03494205|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized parallel design||||
1307839|NCT03494192|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307840|NCT03494179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307841|NCT03494166|Randomized|Sequential Assignment||Supportive Care||Single|Data collectors will be blinded to the arm of the study.|Following baseline, symptom management need (high versus low need) will be determined. The low need group will not receive interventions, but will be followed at week 4 for a brief symptom assessment and at week 13. The high need group will be randomly assigned to either: 1) SMSH alone or 2) TIP-C+SMSH for 8 weeks followed by continued 4 weeks of SMSH alone. We will mail the SMSG, printed in the survivor's preferred language, following randomization. All high need participants will receive weekly telephone contacts during weeks 1-12 to assess symptoms, deliver the assigned intervention, and assess intervention enactment and fidelity. After the initial 4 weeks, responders on depression will continue with the SMSH only. Non-responders will re-randomized to either continue with the SMSH alone or add TIP-C. Those initially randomized to TIP-C+SMSH will not be re-randomized. Total duration of each of the three intervention sequences is 12 weeks.||||t
1307842|NCT03494153|||Cohort||Prospective|||||||
1307843|NCT03494140|||Other||Prospective|||||||
1307844|NCT03494127|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||Repeated measures crossover clinical study design||||
1307845|NCT03494114|Non-Randomized|Parallel Assignment||Diagnostic||Single|The radiologist who evaluates the PET scan will be blinded to the to patient groups (COPD versus control)|Testing whether folate-based imaging using 68 Ga-EC2115 can be used to identify macrophages expressing the high affinity folate receptor (folate receptor beta).||||t
1307846|NCT03494101|||Cohort||Prospective|||||||
1307847|NCT03494088|||Cohort||Prospective|||||||
1307848|NCT03494075|||Other||Prospective|||||||
1307849|NCT03494062|Randomized|Parallel Assignment||Treatment||Single||||t||
1307850|NCT03494049|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307851|NCT03494036|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1307852|NCT03494023|||Cohort||Prospective|||||||
1307853|NCT03494010|||Cohort||Prospective|||||||
1307854|NCT03493997|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307855|NCT03493984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307856|NCT03493971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307857|NCT03493958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307858|NCT03493945|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1307859|NCT03493932||Single Group Assignment||Other||None (Open Label)||||||
1307860|NCT03493919|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1307861|NCT03493906||Single Group Assignment||Supportive Care||None (Open Label)||||||
1307862|NCT03493893|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1307863|NCT03493880|||Cohort||Prospective|||||||
1307864|NCT03493867||Single Group Assignment||Other||None (Open Label)||Vitaliti Continuous Vital Sign Monitoring Device - Version 2.0||||
1307865|NCT03493854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307866|NCT03493841|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1307867|NCT03493828|Randomized|Parallel Assignment||Treatment||Quadruple|The randomization sheet was given to someone who is not involved in the study, also the person who prepare the medicine is not involved in the study.|Arm 1: Bupivacaine 05%, arm 2: Bupivacaine 0.25%, and arm 3: placebo (Normal saline)|t|t|t|t
1307868|NCT03493815|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1307869|NCT03493802|||Case-Control||Prospective|||||||
1307870|NCT03493789||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307871|NCT03493776|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1307872|NCT03493763|||Case-Only||Retrospective|||||||
1307873|NCT03493750|Randomized|Parallel Assignment||Prevention||Single|Dentists are masked of the patient group|Impact of an oral evaluation realized by a nurse combined with a questionnaire (the healthplan guide)||t||
1307874|NCT03493737|||Case-Control||Prospective|||||||
1307875|NCT03493724|||Other||Prospective|||||||
1307876|NCT03493711|||Cohort||Prospective|||||||
1307877|NCT03493698|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1307878|NCT03493685|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1307879|NCT03493672|||Cohort||Prospective|||||||
1307880|NCT03493659|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants are assigned to either a sitting or a standing tutorial, where their learning will be measured.||||
1307881|NCT03493646|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Phase II open label multicentre study. All participants will commence with Vidaza for 6 cycles, followed by 6 cycles of CC 486 regardless of response to Vidaza||||
1307882|NCT03493633|||Other||Prospective|||||||
1307883|NCT03493620|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307884|NCT03493607||Single Group Assignment||Treatment||None (Open Label)||Single Group, open label||||
1307885|NCT03493594|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1307886|NCT03493581||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307887|NCT03493568|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Treatments~Genvoya 150Mg-150Mg-200Mg-10Mg Tablet ( 1 pill every 24 hours)~Dolutegravir 50 mg (1 pill every 24 hours) plus one Reverse Trascriptase Inhibitor (at label dose)"||||
1307888|NCT03493555||Single Group Assignment||Prevention||None (Open Label)||||||
1307889|NCT03493542|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307890|NCT03493529|||Case-Control||Prospective|||||||
1307891|NCT03493516|||Cohort||Prospective|||||||
1307892|NCT03493503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307893|NCT03493490|Randomized|Parallel Assignment||Treatment||Triple||Randomization of the study patient takes place pre-surgery. Successfully randomized patients will receive two infusions over 30 minutes after fixation of the graft replacement and with a time interval of 8 hours each during the first 24 hours postoperatively. All patients will be provided with a PCA device as postoperative rescue medication. Consequently the possibility of an inadequate postoperative pain treatment in the study patients is very low, also in the placebo group.|t|t|t|
1307894|NCT03493477|||Other||Prospective|||||||
1307895|NCT03493464||Sequential Assignment||Diagnostic||None (Open Label)||A total of sixty (60) subjects will be evaluated in the study. The first 10 subjects enrolled in the study will receive BR55 at a dose of 0.03 mL/kg. Assuming these first 10 subjects will show technically adequate images, subsequent subjects enrolled in the study will continue to receive 0.03 mL/kg dose of BR55; otherwise, subjects will be switched to a 0.05 mL/kg dose of BR55.||||
1307896|NCT03493451||Single Group Assignment||Treatment||None (Open Label)||||||
1307897|NCT03493438|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controled clinical trial||||
1307898|NCT03493425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307899|NCT03493412|Randomized|Crossover Assignment||Treatment||Double|Double-blinded study|1:1 Randomized, cross-over, double-blinded design|t||t|
1307900|NCT03493399||Sequential Assignment||Treatment||None (Open Label)||||||
1307901|NCT03493386|Randomized|Crossover Assignment||Treatment||None (Open Label)||This study will be conducted in two parts. Part 1 is the bioequivalence part in which subjects will receive single dose of 2 tablets of 2 mg daprodustat and single dose of 1 tablet of 4 mg daprodustat in crossover manner. Part 2 is Food effect part. In this part, subjects will receive single dose of 4 mg daprodustat tablet in fasting and fed state in a crossover manner.||||
1307902|NCT03493373|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307903|NCT03493360|Randomized|Crossover Assignment||Treatment||Single|||t|||
1307904|NCT03493347||Single Group Assignment||Treatment||None (Open Label)||multiple baseline single case experimental design||||
1307905|NCT03493334|Randomized|Parallel Assignment||Treatment||Single|||t|||
1307906|NCT03493321||Single Group Assignment||Treatment||None (Open Label)||||||
1307907|NCT03493308||Single Group Assignment||Other||None (Open Label)||||||
1307908|NCT03493295|||Cohort||Prospective|||||||
1307909|NCT03493282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307910|NCT03493269|Randomized|Parallel Assignment||Treatment||Quadruple||Double blind|t|t|t|t
1307911|NCT03493256|||Cohort||Prospective|||||||
1307912|NCT03493243|||Cohort||Prospective|||||||
1307913|NCT03493230||Single Group Assignment||Other||None (Open Label)||||||
1307914|NCT03493217||Single Group Assignment||Treatment||None (Open Label)||||||
1307915|NCT03493204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307916|NCT03493191|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1307917|NCT03493178|||Case-Control||Prospective|||||||
1307918|NCT03493165||||||||||||
1307919|NCT03493152||||||||||||
1307920|NCT03493139|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1307921|NCT03493126|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1307922|NCT03493113|||Cohort||Retrospective|||||||
1307923|NCT03493100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307924|NCT03493087|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1307925|NCT03493074|||Case-Only||Prospective|||||||
1307926|NCT03493061||Single Group Assignment||Treatment||None (Open Label)||||||
1307927|NCT03493048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307928|NCT03493035|||Case-Control||Other|||||||
1307929|NCT03493022|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1307930|NCT03493009|Randomized|Parallel Assignment||Screening||None (Open Label)|No blinding is applicable in this study .|"Randomization in blocks will be applied for each site to allocate patients to one of two different bowel preparation regimens (Prep A- split doae of 10mg of Magnesium citrate versus Prep B- split doae of 15mg of Magnesium citrate). The study will utilize randomization in blocks using the standard envelope procedure, which will be applied in order to allocate patients into two arms:~Group 1 - Will go through the Prep A procedure~Group 2 - Will go through the Prep B procedure The site randomization plan will be provided to the study coordinator prior the study start."||||
1307931|NCT03492996||Single Group Assignment||Treatment||None (Open Label)||||||
1307932|NCT03492983|Randomized|Parallel Assignment||Other||Double||||t|t|
1307933|NCT03492970||Single Group Assignment||Screening||None (Open Label)||To specify the evolution of the nycthéméral cycle of the secretion of melatonin in 10 adult subjects carrying a SMS||||
1307934|NCT03492957||Single Group Assignment||Treatment||None (Open Label)|Blinding: outcomes are assessed by independent assessors, otherwise not involved in the study.|Participants can select either individual treatment at home, or group treatment in a community setting, but the intervention content and dose are the same.||||
1307935|NCT03492944|||Cohort||Prospective|||||||
1307936|NCT03492931||Single Group Assignment||Other||None (Open Label)|Study has an Open-Label design.|||||
1307937|NCT03492918||Single Group Assignment||Treatment||None (Open Label)||||||
1307938|NCT03492905||Single Group Assignment||Health Services Research||None (Open Label)|Outcome assessment is automatic, pre-programmed, on-line|||||
1307939|NCT03492892|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1307940|NCT03492879|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1307941|NCT03492866|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Assessing in 8 patients the efficacy of topical gentamycin treatment on 1 side of the scalp by determining the amount of hair loss on the treated versus the untreated side of the scalp||||
1307942|NCT03492853|||Case-Control||Prospective|||||||
1307943|NCT03492840||Single Group Assignment||Treatment||None (Open Label)||An open label clinical trial - subjects will receive the investigational drug only||||
1307944|NCT03492827|Randomized|Sequential Assignment||Prevention||Single|||t|||
1307945|NCT03492814|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1307946|NCT03492801|||Case-Only||Prospective|||||||
1307947|NCT03492788|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1307948|NCT03492775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307949|NCT03492762|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1307950|NCT03492749|||Case-Only||Prospective|||||||
1307951|NCT03492736|Randomized|Parallel Assignment||Basic Science||Triple||Randomized, double-blind, placebo-controlled, parallel|t|t|t|
1307952|NCT03492723|Randomized|Parallel Assignment||Prevention||Double|both, the participants and the investigators will be blind 2 groups will be assigned randomally|This is a randomized, controlled, examiner-blind, 2-treatment parallel group study.|t||t|
1307953|NCT03492710||Single Group Assignment||Treatment||None (Open Label)||Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter||||
1307954|NCT03492697|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1307955|NCT03492684|||Case-Only||Prospective|||||||
1307956|NCT03492671||Single Group Assignment||Treatment||None (Open Label)||||||
1307957|NCT03492658|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, randomized, single center, two-arm, investigator-initiated, interventional clinical study||||
1307958|NCT03492645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307959|NCT03492632|||Case-Control||Prospective|||||||
1307960|NCT03492619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307961|NCT03492606|||Cohort||Retrospective|||||||
1307962|NCT03492593|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1307963|NCT03492580|||Cohort||Retrospective|||||||
1307964|NCT03492567||Single Group Assignment||Basic Science||None (Open Label)||||||
1307965|NCT03492554|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1307966|NCT03492541||Single Group Assignment||Treatment||None (Open Label)||||||
1307967|NCT03492528||Single Group Assignment||Diagnostic||None (Open Label)||||||
1307968|NCT03492515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307969|NCT03492502||Single Group Assignment||Treatment||None (Open Label)||||||
1307970|NCT03492489||||||||||||
1307971|NCT03492476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307972|NCT03492463|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1307973|NCT03492450|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307974|NCT03492437||Single Group Assignment||Other||None (Open Label)||||||
1307975|NCT03492424|||Other||Prospective|||||||
1307976|NCT03492411|Randomized|Parallel Assignment||Prevention||Single|Outcome assessor will be blinded to group allocation. Follow up data will be collected via online survey or telephone interview with survey questions. Mode of data collection will depend on participant preference|150 couples will be randomized to group allocation, intervention group or control group with use sequentially numbered opaque envelopes||||t
1307977|NCT03492398|Randomized|Parallel Assignment||Treatment||Quadruple||A randomized, double blind, placebo-controlled, single and multiple dosing, dose escalation study|t|t|t|t
1307978|NCT03492385|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1307979|NCT03492372|||Case-Only||Prospective|||||||
1307980|NCT03492359|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1307981|NCT03492346|||Cohort||Other|||||||
1307982|NCT03492333||Single Group Assignment||Diagnostic||None (Open Label)||Intervention GFD in IBS and HV(controls)||||
1307983|NCT03492320|||Case-Only||Prospective|||||||
1307984|NCT03492307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307985|NCT03492294|||Cohort||Prospective|||||||
1307986|NCT03492281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1307987|NCT03492268||Single Group Assignment||Treatment||None (Open Label)||Patients undergo leukapheresis to separate their lymphocytes, from which CART cells are produced. Patients will receive a conditioning therapy with cyclophosphamide and fludarabine before CART therapy. BCMA-CART cells will be injected intravenously (IV) into patients on day 0.||||
1307988|NCT03492255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1307989|NCT03492242|||Case-Only||Cross-Sectional|||||||
1307990|NCT03492229|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1307991|NCT03492216|Randomized|Factorial Assignment||Prevention||Single||||t||
1307992|NCT03492203|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1307993|NCT03492190|||Case-Only||Cross-Sectional|||||||
1307994|NCT03492177||Single Group Assignment||Treatment||None (Open Label)||||||
1307995|NCT03492164||Single Group Assignment||Treatment||None (Open Label)||||||
1307997|NCT03492138||Single Group Assignment||Treatment||None (Open Label)||Single arm, open-label, standard 3+3 phase 1 with a Simon 2-stage design followed by stage 2||||
1307998|NCT03492125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||a limited 3+3 phase 1 dose escalation study with expansion cohorts||||
1307999|NCT03492112||Single Group Assignment||Screening||None (Open Label)||||||
1308000|NCT03492099||Single Group Assignment||Treatment||None (Open Label)||||||
1308001|NCT03492086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308002|NCT03492073|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1308003|NCT03492060|||Cohort||Prospective|||||||
1308004|NCT03492047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308005|NCT03492034|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1308006|NCT03492021|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1308007|NCT03492008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308008|NCT03491995|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1308009|NCT03491982|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1308010|NCT03491969|Randomized|Sequential Assignment||Other||Double|||t|t||
1308011|NCT03491956||Single Group Assignment||Treatment||None (Open Label)||||||
1308012|NCT03491943|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1308013|NCT03491930|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||A single group of participants will undergo study participation of listed interventions, over a 3 month outpatient period, to assess the effects on weight loss. A control group will receive all of the interactions and testing as the intervention group, except they will not use the weight loss app or receive weekly phone coaching.||||
1308014|NCT03491917|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1308015|NCT03491904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308016|NCT03491891|||Ecologic or Community||Cross-Sectional|||||||
1308017|NCT03491878|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1308018|NCT03491865|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308019|NCT03491852|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308020|NCT03491839|||Case-Only||Retrospective|||||||
1308021|NCT03491826|||Cohort||Retrospective|||||||
1308022|NCT03491813|||Case-Control||Cross-Sectional|||||||
1308023|NCT03491800||Single Group Assignment||Health Services Research||None (Open Label)|Given the nature of the intervention and it's intended purpose (i.e., to enhance communication with participants and health care providers), it is not possible to blind participants, care providers, or the investigators.|Individual patients and dyads (i.e., a HF patient and family member) will receive the question/topic prompt list immediately before their clinic visit||||
1308024|NCT03491787|||Case-Control||Retrospective|||||||
1308025|NCT03491774||Single Group Assignment||Other||None (Open Label)||It's a single arm study||||
1308026|NCT03491761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308027|NCT03491748|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1308028|NCT03491735|||Case-Only||Prospective|||||||
1308029|NCT03491722|||Cohort||Cross-Sectional|||||||
1308030|NCT03491709|Randomized|Parallel Assignment||Treatment||Single|||||t|
1308031|NCT03491696||Single Group Assignment||Treatment||None (Open Label)||It is an exploratory open label study with a single group, considered as a population of interest. Datas will be reported to existing knowledges and could not be a evidence of an effect but a suggestion for eventual future studies which have to be controlled versus placebo.||||
1308032|NCT03491683|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308033|NCT03491670|||Cohort||Prospective|||||||
1308034|NCT03491657|Randomized|Crossover Assignment||Treatment||None (Open Label)|"Blinding can be challenging in behavioral studies. To help control for demand characteristics, the current study uses an active comparator music distraction vs. the experimental treatment condition immersive virtual reality."|Within-subject design with repeated measures, with random assignment to initial treatment.||||
1308035|NCT03491644|Randomized|Parallel Assignment||Prevention||Single|"The study will be an open-label randomized clinical trial with regards to treatment: treating staff will be aware of the patient's randomization group.~Outcome assessors (attending anesthesiologist for pneumonia and research assistant for long term outcomes (GOSE after 30 days, ARDS* within 30 days, pneumonia diagnosed after discharge within 30 days)) will be blinded to the patients' randomization.~To ensure blinding, prior to assessing the outcomes, all information indicative of the allocation will be censured by the PI.~To validate the blinding, the attending anesthesiologist and research assistant assessing outcome variables will be asked to guess which group of randomization the patient is in.~ARDS: PaO2/FiO2 will be calculated for the assessor in order to maintain blinding."|"Intervention: restrictive oxygen treatment for the first 24 hours. This implies administration of the lowest dosage of oxygen possible in order to achieve a saturation of 94%, using mechanical ventilation (intubated patients), a nasal cannula, a non-rebreather or nothing. A saturation above 94% shall not be aimed for using supplemental oxygen, and thus only patients without oxygen requirement shall have saturations above 94%.~Control: liberal oxygen treatment for the first 24 hours. In the trauma bay and during intrahospital transportation this implies an FiO2 of 1.0 for intubated patients and an oxygen flow on a non-rebreather with reservoir of 15 l/min for non-intubated patients. In the OR, patients will receive a FiO2 of ≥ 0.8 to obtain a saturation of ≥ 98%. Patients admitted to the ICU/PACU/floor will receive and FiO2 of ≥ 0.8 or more to obtain a saturation of ≥ 98% when intubated and for non-intubated patients a non-rebreather with reservoir will be set to 15 l/min."||||t
1308036|NCT03491631|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1308037|NCT03491618|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective comparative study.||||
1308038|NCT03491605|||Cohort||Prospective|||||||
1308039|NCT03491592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308040|NCT03491579||Single Group Assignment||Treatment||None (Open Label)||||||
1308041|NCT03491566|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1308224|NCT03489187|||Case-Only||Retrospective|||||||
1308042|NCT03491553|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308043|NCT03491540|Randomized|Parallel Assignment||Prevention||Double|Both participants and investigators are unaware of the intervention assignment||t||t|
1308044|NCT03491527|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308045|NCT03491514|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1308046|NCT03491501|||Case-Only||Prospective|||||||
1308047|NCT03491488|Randomized|Parallel Assignment||Other||None (Open Label)||randomized controlled trial at 60 public crèches in São Paulo, Brazil||||
1308048|NCT03491475|||Cohort||Cross-Sectional|||||||
1308049|NCT03491462|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|placebo-controlled, parallel group|t|t|t|t
1308050|NCT03491449|Randomized|Parallel Assignment||Treatment||None (Open Label)||National, multicenter, open, two-parallel groups, randomized 1: 1||||
1308051|NCT03491436||Single Group Assignment||Prevention||None (Open Label)||Women (at risk of) GDM will be included in this study. They receive a iHealth Align (a glucose monitor) and associated glycemiestrips.||||
1308052|NCT03491423||Single Group Assignment||Other||None (Open Label)||||||
1308053|NCT03491410|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1308054|NCT03491397||Single Group Assignment||Treatment||None (Open Label)||The stratification will not be randomized, but each category will be limited to 20 patients.||||
1308055|NCT03491384|||Cohort||Prospective|||||||
1308056|NCT03491371|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1308057|NCT03491358|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1308058|NCT03491345||Single Group Assignment||Treatment||None (Open Label)||||||
1308059|NCT03491332|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1308060|NCT03491319|Randomized|Parallel Assignment||Supportive Care||Triple|First anaesthesiologist performed the spinal anaesthesia, gave table tilt using clinometer according to group allocation and assessed spinal blockade till 10 min after intrathecal injection. Thereafter it was done by the second anaesthesiologist who was blinded to the patient grouping|Patients were randomly allocated to one of the 3 groups by closed envelope method||t|t|t
1308061|NCT03491306|Randomized|Parallel Assignment||Other||Triple||2 parallel groups one group will receive RPD with PEEK denture base and the other will get Bre Flex denture base material|t|t||t
1308062|NCT03491293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308063|NCT03491280|||Cohort||Other|||||||
1308064|NCT03491267|Randomized|Parallel Assignment||Basic Science||Single|assesors will be blinded|Areas on a single scalp will be treated or untreated and monitored||||t
1308065|NCT03491254|||Cohort||Prospective|||||||
1308066|NCT03491241|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1308067|NCT03491228|||Other||Prospective|||||||
1308068|NCT03491215||Single Group Assignment||Treatment||None (Open Label)||||||
1308069|NCT03491202|||Case-Control||Prospective|||||||
1308070|NCT03491189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308071|NCT03491176||Single Group Assignment||Other||None (Open Label)||||||
1308072|NCT03491163|||Case-Only||Prospective|||||||
1308073|NCT03491150||Single Group Assignment||Treatment||None (Open Label)||Open Label Extention (OLE)||||
1308074|NCT03491137|||Cohort||Prospective|||||||
1308075|NCT03491124|Randomized|Parallel Assignment||Treatment||Single|||||t|
1308076|NCT03491111|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1308077|NCT03491098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308078|NCT03491085|Randomized|Crossover Assignment||Treatment||Single|||t|||
1308079|NCT03491072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308080|NCT03491059|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1308081|NCT03491046|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308082|NCT03491033|||Cohort||Retrospective|||||||
1308083|NCT03491020|||Cohort||Prospective|||||||
1308084|NCT03491007|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind, placebo (PBO)-controlled, randomized Phase 2 pilot study|This is a parallel-group, double-blind, placebo (PBO)-controlled, randomized Phase 2 pilot study using adjunctive dehydroxyepiandrosterone [DHEA (400 mg)] will be evaluated to establish Proof of Concept (POC) for this agent in Veterans with PTSD.|t|t|t|t
1308085|NCT03490994|Randomized|Parallel Assignment||Treatment||None (Open Label)||warfarin vs. rivaroxaban||||
1308086|NCT03490981|Randomized|Parallel Assignment||Treatment||Single|Only the outcomes assessor will be masked|Two arm parallel design: 1) primary care treatment as usual, or 2) primary care treatment as usual and Brief Cognitive Behavioral Therapy for Chronic Pain||||t
1308087|NCT03490968|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308088|NCT03490955|Randomized|Crossover Assignment||Treatment||Single|||||t|
1308089|NCT03490942|Randomized|Parallel Assignment||Treatment||Double|double-blind, placebo-controlled|This is a prospective, randomized, controlled, double-blind, parallel 4-group trial with the primary analysis after 4 weeks treatment with CSGI or placebo.|t||t|
1308090|NCT03490929||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308091|NCT03490916|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1308092|NCT03490903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308093|NCT03490890||Single Group Assignment||Treatment||None (Open Label)|All patient with GGO were treated with microwave ablation|All patient with GGO were treated with microwave ablation||||
1308094|NCT03490877|||Case-Only||Prospective|||||||
1308095|NCT03490864|Randomized|Parallel Assignment||Basic Science||Quadruple||The study is designed as a randomized controlled trial where each participant will receive one of four intervention types. Subjects will be randomized at baseline visit to one of four arms using a randomized block design to achieve balanced groups. Randomization will be stratified by sex. The allocation will be created using an online randomization tool. This study will include a 6 week four arm field intervention to evaluate the independent effect of meal of timing or melatonin as well as their combined effects.|t|t|t|t
1308096|NCT03490851|Randomized|Crossover Assignment||Basic Science||Single||||||t
1308097|NCT03490838|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Phase 1 dose escalation: patients enrolled in parallel to one of three dose groups Phase 2 dose expansion: single group, enrolled after Phase 1 dose escalation completed||||
1308098|NCT03490825|Randomized|Parallel Assignment||Basic Science||Quadruple||The study is designed as a randomized controlled trial where each participant will receive one of four intervention types. Subjects will be randomized at baseline visit to one of four arms using a randomized block design to achieve balanced groups. Randomization will be stratified by sex. The allocation will be created using an online randomization tool. This study will include a 6 week four arm field intervention to evaluate the independent effect of meal timing or melatonin as well as their combined effects|t|t|t|t
1308099|NCT03490812|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1308100|NCT03490799|||Case-Only||Prospective|||||||
1308101|NCT03490786||Single Group Assignment||Treatment||None (Open Label)||dose escalation||||
1308102|NCT03490773|||Case-Control||Cross-Sectional|||||||
1308103|NCT03490760||Single Group Assignment||Treatment||None (Open Label)||Single-arm Phase II||||
1308104|NCT03490747|Non-Randomized|Factorial Assignment||Prevention||Single|Post hoc data analysis will be blinded via an independent coding method for condition and time frame (i.e. pre-post measures).|"3 arm quasi-experimental trial~1. Co-developed scheme 2. Usual care 3. No treatment control"||||t
1308105|NCT03490734|Randomized|Parallel Assignment||Diagnostic||Single|Experimental and flavor conditions will be blinded to those performing analyses.|Stratified randomization techniques will be used to distribute: 1) male & females, 2) those with a BMI > 26.1 & those with a BMI < 26.1, and 3) regular SSB consumers (> 1/day; 12 fl oz) & low or non-SSB consumers equally across the 2 experimental conditions (SSB vs. unsweetened beverage) and then to the two flavors within each experimental condition. BMI of 26.0 was selected as it is the midpoint of inclusion criteria 18 < BMI < 34.|t|||
1308106|NCT03490721|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1308107|NCT03490708||Single Group Assignment||Treatment||None (Open Label)||||||
1308108|NCT03490695|Randomized|Parallel Assignment||Prevention||None (Open Label)||"For the first 12-month of the study, the intervention will not be implemented as this is a stepped-wedged design. During this time period, primary outcome (adoption ratings) and secondary outcome (Systolic BP) data will be collected at the CHPS Zones following TASSH training and the PFOs will provide support to their assigned CHPS zones to prepare to implement the TASSH protocol.~Each CHPS zones will then be randomly assigned to one of the two intervention arms: Group A will receive the Practice Facilitation Strategy at 12 months and Group B will initially serve as a Usual Care comparison group. Group B will then receive Practice Facilitation beginning 24 months into the trial, as this is a stepped wedge design. Sustainability for groups A and B will be assessed one year after the end of the intervention."||||
1308109|NCT03490682|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1308110|NCT03490669|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-Label||||
1308111|NCT03490656|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1308112|NCT03490643|Non-Randomized|Parallel Assignment||Screening||Single|||t|||
1308113|NCT03490630|||Cohort||Prospective|||||||
1308114|NCT03490617|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1308115|NCT03490604|||Cohort||Prospective|||||||
1308116|NCT03490591||Single Group Assignment||Treatment||None (Open Label)||||||
1308117|NCT03490578|Randomized|Parallel Assignment||Treatment||Single||A randomized controlled trial||||t
1308118|NCT03490565|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1308119|NCT03490552|Randomized|Parallel Assignment||Diagnostic||Triple||A double blind, randomized, controlled investigational study|t|t|t|
1308120|NCT03490539|||Cohort||Prospective|||||||
1308121|NCT03490526|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308122|NCT03490513|Randomized|Parallel Assignment||Treatment||Quadruple|One of the investigators will be unblinded for safety purposes and to adjust the dose of medication|"Intervention: Subjects will be randomized to 2 groups: 1) placebo+weight loss, and 2) anastrozole+weight loss. Intervention will be conducted for 12 months.~Weight loss + placebo: Subjects will participate in a supervised dietary and exercise program plus a placebo.~Anastrozole + weight loss: Subjects will participate in a supervised dietary and exercise program plus the aromatase inhibitor, anastrozole at 1 mg daily.~All subjects will be provided supplements to ensure an intake of ~1500 mg of calcium/day and ~1000 IU vitamin D/day. We will maintain a serum 25-hydroxyvitamin D level of at least 30 ng/dl. Additional vitamin D supplements will be provided for those with level <30 ng/dl.~Dosage adjustments and monitoring will be done by an unblinded investigator."|t|t|t|t
1308123|NCT03490500|||Cohort||Prospective|||||||
1308124|NCT03490487|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1308125|NCT03490474|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1308126|NCT03490461|||Cohort||Retrospective|||||||
1308127|NCT03490448||Single Group Assignment||Health Services Research||None (Open Label)||||||
1308128|NCT03490435|||Cohort||Prospective|||||||
1308129|NCT03490422||Single Group Assignment||Treatment||None (Open Label)||||||
1308130|NCT03490409|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308131|NCT03490396|Randomized|Parallel Assignment||Other||Single|OM grading via the WHO oral toxicity grading scale will be performed by the trained blinded evaluator at least 3X/week (e.g., M, W and F), with ≤ 48h (±24h) in between each assessment.|The initial design is a prospective, randomized, single-blind (evaluator), parallel, three arm, controlled clinical study.||||t
1308132|NCT03490383|||Case-Control||Prospective|||||||
1308133|NCT03490370||Single Group Assignment||Treatment||None (Open Label)||Proof of concept study.||||
1308215|NCT03489304||Single Group Assignment||Treatment||None (Open Label)||6-week open-label study evaluating zaleplon for insomnia in HIV positive patients with comorbid depression||||
1308216|NCT03489291||Single Group Assignment||Treatment||None (Open Label)||open-label, single-dose, single-arm, multi-center trial||||
1308217|NCT03489278|||Cohort||Prospective|||||||
1308222|NCT03489213|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308223|NCT03489200|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1308134|NCT03490357|Randomized|Parallel Assignment||Treatment||Double|Outcome assessor and patient blinded to type of block that the patient receives. Outcome assessor will check dermatomal levels after surgery.|"The expected cephalad dermatomal distribution of the TAP block is T10. A positive outcome is a QL block with patient anesthesia at 2 or more dermatomes higher than the TAP block. The investigators will assume that there is a 30% difference between the two blocks, which leads to between 24 and 33 patients in each arm (ideally aiming for 30 patients in each group).~The investigators have included other sample sizes should they find that there is a higher or lower percentage difference between the QL and TAP blocks.~Outcome: A positive block is considered anesthesia at T8 or above and a negative block is considered analgesia below T8"|t|||t
1308135|NCT03490344||Single Group Assignment||Treatment||None (Open Label)||||||
1308136|NCT03490331||Single Group Assignment||Treatment||None (Open Label)||||||
1308137|NCT03490318|||Cohort||Prospective|||||||
1308138|NCT03490305|||Cohort||Prospective|||||||
1308139|NCT03490292|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is a two-part phase 1/2 clinical trial conducted in one center.~Part 1. Run-in phase to assess the safety and tolerability of avelumab in combination with chemoradiation. Will enroll 6 patients, after which accrual will be stopped temporarily while safety data is being obtained.~Part 2. An open-label phase 2 study. Part 2 will obtain further safety data of the proposed drug combination and will evaluate the anti-tumor efficacy of perioperative avelumab and chemoradiation in this patient population. Will enroll 18 additional patients.~Each phase of the study will have a 21-day screening period, treatment procedures (neoadjuvant therapy, resection and adjuvant therapy), and active surveillance for a year after the completion of adjuvant therapy.~After active surveillance visit at 12 months post treatment completion, survival data and disease status will be collected via phone calls or medical record review every 6 months during the following 3 years."||||
1308140|NCT03490279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308141|NCT03490266|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308142|NCT03490253|Randomized|Sequential Assignment||Supportive Care||Double|Participants in the static and adaptive messaging arms receive different total number of messages per week and therefore might be aware of their assignment. The investigators and those completing the statistical analyses will not be aware of the true study assignments|First randomization into adaptive vs. static text messaging support for physical activity; Second randomization will re-randomize those who have dropped out into receiving vs. not receiving phone outreach|||t|t
1308143|NCT03490240|Randomized|Parallel Assignment||Other||Single|The investigators will advertise the study as comparing two approaches delivered through the Internet for managing consequences of MS and improving health indicators. On randomization, the investigators will again reaffirm this position with the participant. The participant will not be informed about which condition is the control or the intervention.||t|||
1308144|NCT03490227|||Cohort||Cross-Sectional|||||||
1308145|NCT03490214|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1308146|NCT03490201|Randomized|Parallel Assignment||Treatment||Single|Subjects are blinded to the randomization assignment.|Pivotal medical device study|t|||
1308147|NCT03490188|Randomized|Single Group Assignment||Prevention||None (Open Label)||A single institution randomized control trial assigning patients getting discharged after a kidney transplant to treatment and control group||||
1308148|NCT03490175|||Cohort||Prospective|||||||
1308149|NCT03490162|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1308150|NCT03490149|||Case-Control||Prospective|||||||
1308151|NCT03490136|||Ecologic or Community||Cross-Sectional|||||||
1308152|NCT03490123|Randomized|Parallel Assignment||Treatment||Single|Data collection teams separate from the teams responsible for MDA and screening.|Community intervention study||||t
1308153|NCT03490110|Randomized|Parallel Assignment||Diagnostic||Double||training in brain state regulation compared to treatment-as-usual|||t|t
1308154|NCT03490097|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308155|NCT03490084|||Cohort||Prospective|||||||
1308156|NCT03490071|||Cohort||Prospective|||||||
1308157|NCT03490058|||Cohort||Prospective|||||||
1308158|NCT03490045|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308159|NCT03490032|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||"Phase I: characterize PK and dosimetry Phase II: diagnostic potential in 2 groups~Prostate Cancer in biochemical relapse, and~Metastatic Prostate Cancer"||||
1308160|NCT03490019||Single Group Assignment||Treatment||None (Open Label)||Prospective pilot study without control group||||
1308161|NCT03490006|Randomized|Parallel Assignment||Treatment||Single|The practitioner must know which block to perform, and the patient will be able to deduce which block was performed because paravertebral requires two injections, and erector spinae requires only one injection. The outcomes assessor will not know which group each patient is in.|Two parallel arms. One group will receive erector spinae plane block, and the other will receive paravertebral block.||||t
1308162|NCT03489993|||Cohort||Prospective|||||||
1308163|NCT03489980|||Cohort||Prospective|||||||
1308164|NCT03489967|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1308165|NCT03489954|||Case-Crossover||Cross-Sectional|||||||
1308166|NCT03489941|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308218|NCT03489265|Randomized|Crossover Assignment||Treatment||Triple|Patients will not be aware when Eluxadoline or Placebo are administered. Investigators will be masked to whether Eluxadoline is given in Treatment Period 1 or Treatment Period 2 unless there is an adverse event that requires unmasking the treatment for this patient to ascertain whether the adverse event is drug-related.|Patients will be randomized to 1 of 2 sequences. Each sequence includes 4 periods: Run-in, Treatment Period 1, Treatment Period 2, and Follow-Up. In Sequence A, Eluxadoline will be given 100 mg BID in Treatment Period 1 and Placebo will be given in Treatment Period 2. In Sequence B, Placebo will be given in Treatment Period 1 and Eluxadoline will be given in Treatment Period 2. Placebo will be given during Baseline and Follow-Up of both arms.|t|t|t|
1308219|NCT03489252||Single Group Assignment||Supportive Care||None (Open Label)||||||
1308220|NCT03489239||Single Group Assignment||Other||None (Open Label)||||||
1308221|NCT03489226|Randomized|Crossover Assignment||Treatment||Double|Supplement and placebo capsules with identical appearance|4 arm crossover trial|t||t|
1308167|NCT03489928|Randomized|Parallel Assignment||Treatment||None (Open Label)|Group assignment will be concealed until time induction is to begin, when randomization will occur. No attempt will be made at formal blinding of caregivers following concealed randomization, although neonatal assessment will be carried out by a team unaware of study group assignment.|Patients will be randomly assigned to one of three approaches to initiation of labour induction. Study group allocation will be stratified based on membrane status (ruptured/intact). Sequentially numbered opaque envelopes contain group assignment prepared using computer generated random number tables, in blocks of 4 and 6. Group 1 will receive misoprostol 50µgs, repeated at 4hr intervals until one of the following occurs: progressive labour, contraction frequency of 3 per 10 minutes, non-reassuring fetal heart rate tracing, or delivery. Group 2 will receive misoprostol 25µg initial dose and then 25-50µg placed in the vagina at 6hr intervals to the same effect. Group 3 will have induction of labour managed by the usual method here at the IWK (intravaginal or intracervical prostaglandin gel and IV oxytocin drip). All care decisions will be made by the attending physician. The patient will be reassessed before each administration of misoprostol.||||
1308168|NCT03489915|||Case-Only||Prospective|||||||
1308169|NCT03489902|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308170|NCT03489889|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1308171|NCT03489876|Randomized|Parallel Assignment||Treatment||None (Open Label)|The computer-based randomization sequence will be concealed from investigators using REDCap.|Upon eligibility verification and informed consent, computer-based randomization will allot patients into one of the two treatment groups, either synthetic cartilage implant or osteochondral autograft transfer.||||
1308172|NCT03489863|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomized||||
1308173|NCT03489850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308174|NCT03489837|Randomized|Parallel Assignment||Treatment||Single||||t||
1308175|NCT03489824|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308176|NCT03489811|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1308177|NCT03489798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308178|NCT03489785|||Other||Retrospective|||||||
1308179|NCT03489772|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1308180|NCT03489759|Randomized|Parallel Assignment||Health Services Research||Quadruple|"The randomization list will be kept in a special lockable closet, not accessible to the other investigators involved in the study. The one who will create the list will not be involved in any other role in the present study.~The filter label, and hence the name, will be covered by a white covering label. Each kit of filters needed to perform a single treatment will be prepared in a closed box and the patient number will be written on it, so that the user who performs the treatment will not be able to understand which filter it is.~All the other investigators involved in the present study (nurses in the Nephrology department who will follow the treatment, the researchers who will collect the clinical data, the biologists who will analyze the samples and the statisticians who will analyze the data) will not know which filter has been applied in each treatment."||t|t|t|t
1308181|NCT03489746|Randomized|Parallel Assignment||Treatment||Double|All data will be analysed anonymously|Cluster randomized controlled trial at practice level|||t|t
1308182|NCT03489733|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1308183|NCT03489720|Randomized|Crossover Assignment||Prevention||None (Open Label)||balanced order-randomized, 16-week within-subject crossover study||||
1308184|NCT03489707|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1308185|NCT03489694|||Cohort||Prospective|||||||
1308186|NCT03489681|Randomized|Parallel Assignment||Treatment||None (Open Label)||The investigators performed prospective, randomized controlled study with three arms, the high-dose acupuncture, low-dose acupuncture and herb-medicine controlled groups.||||
1308187|NCT03489668|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1308188|NCT03489655|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308189|NCT03489642||Single Group Assignment||Health Services Research||None (Open Label)||||||
1308190|NCT03489629||Single Group Assignment||Treatment||None (Open Label)||||||
1308191|NCT03489616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308192|NCT03489603|||Other||Prospective|||||||
1308193|NCT03489590||Single Group Assignment||Other||None (Open Label)||This study enrolls both healthy volunteers and volunteers with cystic fibrosis. Both healthy and CF participants will receive the same treatment throughout the entirety of the study.||||
1308194|NCT03489577|||Cohort||Prospective|||||||
1308195|NCT03489564|||Cohort||Prospective|||||||
1308196|NCT03489551||Single Group Assignment||Supportive Care||None (Open Label)||||||
1308197|NCT03489538|||Case-Only||Retrospective|||||||
1308198|NCT03489525|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|Open-label|||||
1308199|NCT03489512|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients will receive one or the other treatment depending on where and when they are treated and will continue the treatment until the end.||||
1308200|NCT03489499|||Cohort||Prospective|||||||
1308201|NCT03489486|||Cohort||Prospective|||||||
1308202|NCT03489473|||Case-Only||Prospective|||||||
1308203|NCT03489460|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308204|NCT03489447|||Cohort||Retrospective|||||||
1308205|NCT03489434|Randomized|Single Group Assignment||Other||Single|||t|||
1308206|NCT03489421|||Case-Control||Other|||||||
1308207|NCT03489408|||Case-Only||Prospective|||||||
1308208|NCT03489395||Single Group Assignment||Treatment||None (Open Label)||Non-controlled, open-label pilot study.||||
1308209|NCT03489382|Randomized|Parallel Assignment||Treatment||Single|All data linkage and analyses will be conducted by statisticians who are blind to the study site allocations.|Multi-Centre Cluster Randomized Controlled Trial||||t
1308210|NCT03489369||Single Group Assignment||Treatment||None (Open Label)||||||
1308211|NCT03489356|Randomized|Parallel Assignment||Prevention||Single|||t|||
1308212|NCT03489343||Single Group Assignment||Treatment||None (Open Label)||||||
1308213|NCT03489330|||Cohort||Retrospective|||||||
1308225|NCT03489174|Randomized|Parallel Assignment||Screening||Double|Participants will not know if they are assigned to the intervention or control group. Their weekly urine test that is collected by the opioid substitution therapy clinic will be tested monthly for pregnancy. Pregnancy will then be reported to the patient's attending physician on the day of testing, who would then communicate the result to the patient. The physician will continue with standard pregnancy care. The investigators will remain blind throughout data analysis and will not know if the pregnancy was discovered via monthly testing or standard practice.|Participants will be randomly assigned to either standard practice or monthly pregnancy screening.|t||t|
1308226|NCT03489161||Single Group Assignment||Treatment||None (Open Label)||||||
1308227|NCT03489148|Non-Randomized|Parallel Assignment||Prevention||Single|The Tamarkoz® class instructor was not informed about which of her students from the class was participating in the study.|Participants were recruited from the University of California, Berkeley for an 18-week quasi-experimental study with pretest-posttest and follow-up in three groups. Assessments were conducted with blood pressure, heart rate, the 10-item perceived stress scale, the 38-item dispositional positive emotions scale, and the 16-item daily spiritual experiences scale in a Tamarkoz® group, a wait-list control, and a third group utilizing the campus health center's stress management resources. Blood pressure and heart rate measurements were taken by the researcher using a validated home monitoring device. Additionally, all participants provided 3 diurnal saliva samples to determine changes in salivary immunoglobulin A and salivary cortisol. All data were collection was through non-evasive procedures and were assessed at baseline, end of the school semester (12 weeks) and 18 weeks.||t||
1308228|NCT03489135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1308229|NCT03489122|Randomized|Parallel Assignment||Treatment||Single|This is a behavioral intervention such that participants cannot be blinded. Participant questionnaires are fill out by participants without staff involvement. Outcome assessors: Clinicians completing the depression scales will be blinded to group assignment. Individuals analyzing magnetic resonance spectroscopy (MRS) and electrocardiogram (ECG) data will receive blinded data for analysis|Participants will be randomized to a Iyengar yoga and coherent breathing or walking intervention. Two interventions a week for 12 weeks are prescribed||||t
1308230|NCT03489109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308231|NCT03489096||Single Group Assignment||Treatment||None (Open Label)||Single-center, open-label pilot study||||
1308232|NCT03489083|Randomized|Parallel Assignment||Basic Science||None (Open Label)||The aim of this study was to compare the heat shock response (HSR) between healthy middle-aged adults (45-59 years old), healthy elderly adults (> 60 y.o.) and type 2 diabetic elderly people (> 60 y.o.). In addition, considering the effects of strength exercise in promoting health, we aimed to test the effects of strength training over the HSR in diabetic elderly people.||||
1308233|NCT03489070|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1308234|NCT03489057|Randomized|Parallel Assignment||Supportive Care||Triple|The investigator and data collectors will be masked to intervention.|||t|t|t
1308235|NCT03489044|Randomized|Crossover Assignment||Treatment||Quadruple|Double blind, block randomised,|Placebo controlled|t|t|t|t
1308236|NCT03489031|||Case-Only||Cross-Sectional|||||||
1308237|NCT03489018|Randomized|Parallel Assignment||Prevention||Triple|Participants, parents of participants and all of the study team apart from the vaccinator will be masked with respect to the infant's allocation to a trial arm between A-F. If randomly allocated to trial arm G, parents and study personnel will be unmasked due to the necessity for trial arm G to receive a different vaccine schedule compared to trial arms A-F. It is thought that this unmasking will have minimal impact on retention, follow up and outcome assessment across the trial arms for primary and secondary outcomes.|"Participants will be randomised to one of seven groups for the duration of the study:~A. Full dose PCV13 vaccination in a 2p+1 schedule; B. 40% fractional dose PCV13 vaccination in a 2p+1 schedule; C. 20% fractional dose PCV13 vaccination in a 2p+1 schedule; D. Full dose PCV10 vaccination in a 2p+1 schedule; E. 40% fractional dose PCV10 vaccination in a 2p+1 schedule; F. 20% fractional dose PCV10 vaccination in a 2p+1 schedule; G. Full dose PCV10 vaccination in a 3p+0 schedule."|t||t|t
1308238|NCT03489005|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1308239|NCT03488992|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1308240|NCT03488979|||Cohort||Prospective|||||||
1308241|NCT03488966|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1308242|NCT03488953||Single Group Assignment||Treatment||None (Open Label)||||||
1308243|NCT03488940|Randomized|Parallel Assignment||Treatment||Single||||||t
1308244|NCT03488927|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized control intervention trial with a wait-list control condition, randomized at the individual level||||
1308245|NCT03488914|Randomized|Parallel Assignment||Prevention||Single|Randomization to YMHP or enhanced Treatment as Usual (eTAU)||t|||
1308246|NCT03488901|||Cohort||Retrospective|||||||
1308247|NCT03488888|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308248|NCT03488875|Randomized|Parallel Assignment||Prevention||None (Open Label)|"Participants cannot be made blind to study assignment due to the nature of the intervention.~Baseline (T1) measures will be collected prior to treatment assignment. Every effort will be taken to minimize knowledge of group assignment by the study team, in particular the PI and other individuals involved in data analysis; however, the small size of the study team and overlapping roles of team members may preclude masking of group assignment for all members of the study team."|Participants are randomized to an active treatment group and a waitlist control group.||||
1308249|NCT03488862|||Cohort||Prospective|||||||
1308250|NCT03488849||||||||||||
1308251|NCT03488836|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308252|NCT03488823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308253|NCT03488810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308254|NCT03488797|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1308255|NCT03488784|||Cohort||Prospective|||||||
1308256|NCT03488771|||Cohort||Prospective|||||||
1308257|NCT03488758|Randomized|Parallel Assignment||Other||Double|||t||t|
1308258|NCT03488745||Single Group Assignment||Supportive Care||None (Open Label)||||||
1308259|NCT03488732|||Cohort||Prospective|||||||
1308260|NCT03488719|Randomized|Crossover Assignment||Treatment||Triple|"Tesofensine dosing will be performed open-label. Metoprolol dosing will be performed single-blind."|Each subject will participate in a Screening Period (Day 28 to Day 3), a Baseline Period (Day -2 to Day -1) and a Treatment Period (Day 1 to Day 24) and will have two Follow-up phone calls (Day 30 and Day 50).|t|t|t|
1308261|NCT03488706|||Cohort||Prospective|||||||
1308262|NCT03488693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308263|NCT03488680|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308264|NCT03488667||Single Group Assignment||Treatment||None (Open Label)||||||
1308265|NCT03488654|||Other||Prospective|||||||
1308266|NCT03488641|||Cohort||Prospective|||||||
1308267|NCT03488628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308268|NCT03488615|||Cohort||Retrospective|||||||
1308269|NCT03488602|Randomized|Parallel Assignment||Treatment||Single|The research staff responsible for measuring outcomes will be blinded to participants' randomization.|||||t
1308270|NCT03488589|||Case-Only||Other|||||||
1308271|NCT03488576|Randomized|Parallel Assignment||Treatment||None (Open Label)||This was a prospective study including ninety-one eyes of 190 phakic patients scheduled to undergo vitrectomy for idiopathic macular pucker or macular hole, from July 2014 to December 2016. Patients were randomized in a 1:1 ratio to complete peeling of the ILM (CP group) or foveal sparing (FS group).||||
1308272|NCT03488563|Randomized|Parallel Assignment||Prevention||Quadruple|Each participant scheduled to receive investigational product (IP) will receive a randomization number at the time of randomization. The randomization number will be used to identify the study medication kit assigned to the participant and indicate the treatment to be administered to that participant.|Randomization will be 1:1:1 so that equal number of subjects will be treated in each arm of the study.|t|t|t|t
1308273|NCT03488550||Sequential Assignment||Treatment||None (Open Label)||||||
1308274|NCT03488537||Single Group Assignment||Diagnostic||None (Open Label)||This is a Multi center prospective cohort study in subjects eligible for colonoscopy with suspicion for malignant or premalignant lesions of the colon.||||
1308275|NCT03488524||Single Group Assignment||Treatment||None (Open Label)||This an open-label extension study to CENTAUR (AMX-3500)||||
1308276|NCT03488511|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308277|NCT03488498|||Case-Control||Prospective|||||||
1308278|NCT03488485||Single Group Assignment||Health Services Research||None (Open Label)||Real Life Efficacy Study||||
1308279|NCT03488472||Single Group Assignment||Treatment||None (Open Label)||||||
1308280|NCT03488459|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1308281|NCT03488446|||Cohort||Prospective|||||||
1308282|NCT03488433|Randomized|Parallel Assignment||Treatment||None (Open Label)|Patients will be randomly assigned to either neutral rotation brace, or antirotation sling following reverse total shoulder arthroplasty. The patients, PI and co-investigators all will be blinded to patient assignments until the day of surgery when an envelope with their assignments are given to surgeon at day of surgery.|Patients undergoing reverse total shoulder arthroplasty or rotator cuff repair will be randomly assigned to two groups of immobilization method groups, namely abduction brace group and antirotation sling group.||||
1308283|NCT03488420|||Cohort||Prospective|||||||
1308284|NCT03488407|||Cohort||Prospective|||||||
1308285|NCT03488394||Single Group Assignment||Treatment||None (Open Label)||||||
1308286|NCT03488381|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1308287|NCT03488368|||Other||Retrospective|||||||
1308288|NCT03488355|Randomized|Parallel Assignment||Treatment||Single||||t||
1308289|NCT03488342|Randomized|Single Group Assignment||Treatment||Double|Double (Participant, Investigator)|randomized,controlled and double-blind study|t||t|
1308290|NCT03488329|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308291|NCT03488316|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308292|NCT03488303|||Cohort||Prospective|||||||
1308293|NCT03488290|Randomized|Parallel Assignment||Treatment||Single|Researchers doing outcome assessment will be kept blind to the group allocations|This will be a two arm study: 1) LTP Plus TF-CBT added to TAU 2) Treatment as usual (TAU)||||t
1308294|NCT03488277|Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1308295|NCT03488264|||Cohort||Cross-Sectional|||||||
1308296|NCT03488251|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1308297|NCT03488238||||||||||||
1308298|NCT03488225||Single Group Assignment||Treatment||None (Open Label)||||||
1308299|NCT03488212|Randomized|Parallel Assignment||Treatment||Single|||||t|
1308300|NCT03488199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308301|NCT03488186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308302|NCT03488173|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1308303|NCT03488160||Single Group Assignment||Treatment||None (Open Label)||||||
1308304|NCT03488147|Randomized|Parallel Assignment||Treatment||Triple|"Subjects assigned to the treatment group 'A' will receive one 20 mg esomeprazole tablet daily starting 1 week prior to the cervical operation and will continue to receive the esomeprazole until the end of the study (12 week follow-up).~Subjects belonging to the treatment group 'B' will receive one placebo tablet (physically resembling a 20 mg esomeprazole tablet) daily starting one week prior to the cervical operation. Subjects will then receive one 20 mg esomeprazole daily starting immediately after the operation and will continue to receive the esomeprazole until the end of the study.~Subjects belonging to the treatment group 'C' will receive one placebo tablet (physically resembling a 20 mg esomeprazole tablet) daily starting one week prior to the cervical operation and will continue to receive the placebo tablet until the end of the study (12 week follow-up)."|After consent has been obtained, eligible subjects will be randomized into 1 of 3 different treatment groups designated A, B, and C, using a random number generator.|t|t|t|
1308305|NCT03488134|||Cohort||Prospective|||||||
1308306|NCT03488121|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1308307|NCT03488108|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1573377|NCT00001438||||Treatment||||||||
1308308|NCT03488095|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1308309|NCT03488082||Single Group Assignment||Basic Science||None (Open Label)||||||
1308310|NCT03488069|||Other||Prospective|||||||
1308311|NCT03488056|Randomized|Parallel Assignment||Prevention||Double|"The division of the control and experimental groups was done by center and for neither group are revealed to the patient nor responsible for the type of intervention they are undergoing.~After a certain time of the study, a blind investor will examine the children's centers and evaluate the outcome of the study. This researcher will not know which center is a control or experimental group."|The randomization was made by centers of the SESC (Social Service of the Commerce) of São Paulo state. Four centers will follow the ICCMS criteria and four other centers will follow criteria for diagnosis and treatment of SESC. The randomization will be stratified by sociodemographical conditions. The minimization will be used to equate preexisting oral health-related activities. According to allocated strategy, dentists in the center will guide their conduct with children attended to the CURUMIM project.|t|||t
1308312|NCT03488043|||Cohort||Other|||||||
1308313|NCT03488030|||Cohort||Retrospective|||||||
1308314|NCT03488017|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1308315|NCT03487991|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308316|NCT03487978|||Case-Control||Prospective|||||||
1308317|NCT03487965|Randomized|Parallel Assignment||Prevention||Triple|Interventions coded, blinded code kept in sealed envelope until study closed|individuals are assigned prospectively to two different interventions according to a protocol, to evaluate the effect of the interventions|t|t|t|
1308318|NCT03487952|||Cohort||Prospective|||||||
1308319|NCT03487939||Single Group Assignment||Treatment||None (Open Label)||||||
1308320|NCT03487926|||Other||Prospective|||||||
1308321|NCT03487913|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308322|NCT03487900||Single Group Assignment||Other||None (Open Label)||||||
1308323|NCT03487887|||Cohort||Prospective|||||||
1308324|NCT03487874|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1308325|NCT03487861|||Cohort||Prospective|||||||
1308326|NCT03487848||Single Group Assignment||Treatment||None (Open Label)||||||
1308327|NCT03487835|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308328|NCT03487822|Randomized|Parallel Assignment||Supportive Care||Single|The co-investigators performing assessments will be blind to the participant's arm.||||t|
1308329|NCT03487809|||Cohort||Prospective|||||||
1308330|NCT03487796|Randomized|Parallel Assignment||Prevention||Single|||t|||
1308331|NCT03487783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308332|NCT03487770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308333|NCT03487757|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308334|NCT03487744|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308335|NCT03487731|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308336|NCT03487718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308337|NCT03487705||Single Group Assignment||Other||None (Open Label)||||||
1308338|NCT03487692|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1308339|NCT03487679||Single Group Assignment||Basic Science||None (Open Label)||||||
1308340|NCT03487666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308341|NCT03487653|||Other||Prospective|||||||
1308342|NCT03487640|||Cohort||Prospective|||||||
1308343|NCT03487627|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308344|NCT03487614|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||We Are for Children, LLC (WAFC), is a collaboration of non-profit pediatric practices in West Michigan formed to help members respond to healthcare needs. Four primary care pediatric offices from WAFC were selected to participate in the current study based on site interest and capacity. Participating pediatric offices were then matched into pairs based on similarities in office size (i.e. physician FTEs and patient load) and patient demographics characteristics, after which one of each matched pair was assigned as a treatment or control site.||||
1308345|NCT03487601|Randomized|Parallel Assignment||Supportive Care||Single|Participants will be randomized to either active or sham tDCS and will undergo 5 consecutive treatments of daily tDCS beginning the Monday following the first day of their on-study chemotherapy cycle. Active treatment will consist of a mild electrical current (2mA) administered via saline-soaked sponge electrodes placed along the intact scalp for 30 minutes a day for five days. Sham stimulation will involve brief delivery of current in a manner that does not result in changes in neuronal firing patterns, but that is perceived as active treatment by participants.|The proposed feasibility trial is a randomized, sham-controlled, double-blind experiment.|t|||
1308346|NCT03487588||Single Group Assignment||Treatment||None (Open Label)||||||
1308347|NCT03487575||Single Group Assignment||Supportive Care||None (Open Label)||||||
1308348|NCT03487562|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1308349|NCT03487549||Sequential Assignment||Treatment||None (Open Label)||This study has 2 cohorts. Cohort 1 of the study enrolled 21 subjects and has completed all subject related study activities. Analysis is to be conducted at Day 84. Cohort 2 will utilize 4 sites with an enrollment of approximately 35 subjects. The primary analysis will be conducted at Day 84 with an additional period of follow up out to Day 147.||||
1308350|NCT03487536|||Case-Only||Prospective|||||||
1308351|NCT03487523|Randomized|Crossover Assignment||Prevention||Single||The study will be a cross sectional randomised controlled trial|t|||
1308352|NCT03487510|||Ecologic or Community||Other|||||||
1308353|NCT03487497|||Cohort||Retrospective|||||||
1308354|NCT03487484|||Case-Control||Prospective|||||||
1308355|NCT03487471|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1308356|NCT03487458|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308357|NCT03487445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308358|NCT03487432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308359|NCT03487419|||Cohort||Cross-Sectional|||||||
1308360|NCT03487406|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1308361|NCT03487393||Single Group Assignment||Treatment||None (Open Label)||Prospective||||
1308362|NCT03487380|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The study will compare three groups of 100 patients, corresponding to 200 patients with Alzheimer disease (whom 100 patients in the rapid cognitive decline group and 100 patients without rapid cognitive decline) and 100 patients in the control group.||||
1308363|NCT03487367|||Cohort||Prospective|||||||
1308364|NCT03487354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308365|NCT03487341|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308366|NCT03487328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308367|NCT03487315||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308368|NCT03487302|||Case-Control||Cross-Sectional|||||||
1308369|NCT03487289|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1308370|NCT03487276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308371|NCT03487263|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-label, dose-escalation, safety and pharmacokinetic||||
1308372|NCT03487250|||Cohort||Prospective|||||||
1308373|NCT03487237||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308374|NCT03487224|||Cohort||Cross-Sectional|||||||
1308375|NCT03487211|Randomized|Parallel Assignment||Treatment||Single|Patients shall be provided medication with numeric labels|Randomized Control Trial|t|||
1308376|NCT03487198|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1308377|NCT03487185|Randomized|Parallel Assignment||Treatment||None (Open Label)|This study is an unmasked randomized controlled multi-center clinical trial.|"Nulliparous women with a singleton gestation and obstructive sleep apnea (OSA) will be randomized to one of two arms at participating MFMU Network clinical center:~Autotitrating CPAP with weekly contact, incentives for compliance and initial sleep hygiene counseling~Initial sleep hygiene counseling alone"||||
1308378|NCT03487172|Randomized|Parallel Assignment||Treatment||Double||"Enrolled subjects will be randomized to 2 treatment groups: Right side treated and Left side treated. All subjects will receive three, single-sided injections of PLLA, performed 1 month apart. Treatments will be provided to one randomly assigned knee. The non-treatment knee will receive bacteriostatic water, injected in the same manner as PLLA. Up to one (1) syringe of PLLA, diluted at 16 mL, will be used per session"|t|||t
1308379|NCT03487159|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"The study model includes 2 study arms:~Patients with chronic liver diseases who will undergo a routine liver biopsy, Shear Wave elastography and the MRE in order to evaluate the liver fibrosis stage.~Patients with chronic liver diseases who will undergo a routine Shear Wave elastography and the MRE in order to evaluate the liver fibrosis stage.~Demographic and clinical information will be collected from the patient's medical files."||||
1308380|NCT03487146|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308381|NCT03487133||Single Group Assignment||Treatment||None (Open Label)||||||
1308382|NCT03487120|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308383|NCT03487107||Single Group Assignment||Treatment||None (Open Label)||||||
1308384|NCT03487094|Randomized|Parallel Assignment||Other||Triple||Multi-Investigator, Prospective, Randomized Clinical Trial|t|t||t
1308385|NCT03487081|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1308386|NCT03487068||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308387|NCT03487055||Single Group Assignment||Treatment||None (Open Label)||||||
1308388|NCT03487042||Sequential Assignment||Treatment||None (Open Label)||||||
1308389|NCT03487029|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308390|NCT03487016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308391|NCT03487003|Randomized|Parallel Assignment||Supportive Care||Quadruple||Randomized parallel prospective non-inferiority study|t|t|t|t
1308392|NCT03486990|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Single ascending dose followed by repeat dose||||
1308393|NCT03486977|||Cohort||Prospective|||||||
1308394|NCT03486964|||Cohort||Retrospective|||||||
1308395|NCT03486951|||Cohort||Prospective|||||||
1308396|NCT03486938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308397|NCT03486925|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1308398|NCT03486912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308399|NCT03486899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308400|NCT03486886||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308401|NCT03486873|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308402|NCT03486860|Randomized|Parallel Assignment||Treatment||Single||||||t
1308403|NCT03486847|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308404|NCT03486834|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1308405|NCT03486821||Single Group Assignment||Treatment||None (Open Label)||||||
1308406|NCT03486808|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1308407|NCT03486795|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1308408|NCT03486782|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308409|NCT03486769|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308410|NCT03486756||Single Group Assignment||Treatment||None (Open Label)||This is an uncontrolled feasibility study with one arm.||||
1308411|NCT03486743|Randomized|Parallel Assignment||Other||None (Open Label)||different sites of participant recruitment will be randomized between the use of an informational video during the survey process and no video. The primary focus of the study is the survey that is designed to collect information about cultural perspectives on LARC in the participants.||||
1308412|NCT03486730|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1308413|NCT03486717||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1308414|NCT03486704|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1308415|NCT03486691|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308416|NCT03486678||Single Group Assignment||Treatment||None (Open Label)||||||
1308417|NCT03486665|||Case-Only||Prospective|||||||
1308418|NCT03486652|||Cohort||Prospective|||||||
1308419|NCT03486639|||Cohort||Prospective|||||||
1308420|NCT03486626||Single Group Assignment||Treatment||None (Open Label)||||||
1308421|NCT03486613|Randomized|Crossover Assignment||Other||None (Open Label)||A randomised, within-participants, open, cross-over design trial||||
1308422|NCT03486600||Single Group Assignment||Supportive Care||None (Open Label)||Trauma patients of both sexes and diagnosed to be in hemorrhagic shock and there is an expected delay in blood and blood products transfusion for more than 40 minutes||||
1308423|NCT03486587||Single Group Assignment||Prevention||None (Open Label)||a single-arm, single-institutional, phase II study||||
1308424|NCT03486574|||Family-Based||Prospective|||||||
1308425|NCT03486561||Single Group Assignment||Treatment||None (Open Label)||Open Labelled Phase IV clinical trial||||
1308426|NCT03486548|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1308427|NCT03486535|||Cohort||Prospective|||||||
1308428|NCT03486522|||Cohort||Prospective|||||||
1308429|NCT03486509||Single Group Assignment||Treatment||None (Open Label)||||||
1308430|NCT03486496||Single Group Assignment||Treatment||None (Open Label)||||||
1308431|NCT03486483|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1308432|NCT03486470|||Case-Only||Cross-Sectional|||||||
1308433|NCT03486457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308434|NCT03486444|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1308435|NCT03486431|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||3+3 phase I trial design||||
1308436|NCT03486418|||Cohort||Retrospective|||||||
1308437|NCT03486405|Randomized|Crossover Assignment||Treatment||Single||This study will be a randomized control trial crossover design.|t|||
1308438|NCT03486392|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308439|NCT03486379|||Cohort||Prospective|||||||
1308440|NCT03486366|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"With EPIMARKER we aim to develop clinically useful tools enabling accurate and early detection of risk of drug resistant or recurrent seizures and stablish the new therapeutic and preventative possibilities for epilepsy.~The Epimarker algorithms will include selected data obtained in 3 unique models of epilepsy in developing brain.~EEG recordings and clinical data from a prospective study of drug-resistant epilepsy development in young children with TSC,~EEG recording and clinical data from a prospective study of epilepsy after antiepileptic drug withdrawal in children with TSC~Molecular biomarkers in both above clinical setting, established by means of a broad range of molecular analyses, including a diverse set of cutting edge analyses of blood samples, that will be obtained at study entry, at the onset of drug- resistance or recurrent epilepsy, and after 12-month follow-up and the verified in a Epimarker cellular model."||||
1308441|NCT03486353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"open-label, Simon 2-stage clinical study of the combination of FF-10501-01 and azacitidine in MDS patients. The Phase 2 portion of the trial will be preceded by a Phase 1 run-in to evaluate the safety of the combination of FF-10501-01 plus azacitidine."||||
1308442|NCT03486340|Randomized|Parallel Assignment||Prevention||Single||||||t
1308443|NCT03486327|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Up to 24 subjects will be enrolled into 3 dose groups starting with the lowest dose group as follows: Dose group 0.03mL/kg, dose group 0.05mL/kg and dose group 0.08mL/kg/, with a maximum of 8 patients in each dose group.||||
1308444|NCT03486314|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1308445|NCT03486301|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1308446|NCT03486288|||Case-Control||Prospective|||||||
1308447|NCT03486275|Randomized|Parallel Assignment||Other||Quadruple|double-blinded randomized trial : Participants do not know their assignment group. The questionnaires, identical in both groups, were completed by the participants and blinded from their assignment group.|randomized trial comparing the learning provided by a week of access to the game Hygie or source articles|t|t|t|t
1308448|NCT03486262|||Cohort||Retrospective|||||||
1308449|NCT03486249||Single Group Assignment||Diagnostic||None (Open Label)||All patients will have a cardiac echo examination and diaphragm function assessment.||||
1308450|NCT03486236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308451|NCT03486223|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1308452|NCT03486210|||Case-Control||Cross-Sectional|||||||
1308453|NCT03486197||Single Group Assignment||Treatment||None (Open Label)||||||
1308454|NCT03486184|||Cohort||Prospective|||||||
1308455|NCT03486171|||Cohort||Prospective|||||||
1308456|NCT03486158|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1308457|NCT03486145|Randomized|Parallel Assignment||Prevention||Triple|"Both the study investigators and the participants were blinded regarding supplement assignments, and the identity of the A and B supplements were not revealed to study investigators until all data analyses were complete."|Participants were stratified by age, height, weight, BMI, blood pressure and athletic status and randomly assigned to consume daily either the fruit and vegetable rich juice supplement (B) or prune juice (A; control treatment).|t||t|t
1308458|NCT03486132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308459|NCT03486119|||Other||Prospective|||||||
1308460|NCT03486106|Randomized|Parallel Assignment||Treatment||Double||||t||t
1308461|NCT03486093|Randomized|Parallel Assignment||Prevention||Single||"Patients have been randomized into two groups:~patients with CVC managed by healthcare workers trained/retrained to GAVECELT recommendations.~Patients with CVC managed by healthcare workers trained/retrained to GAVECELT recommendations with the aid of port protector devices."|t|||
1308462|NCT03486080|Randomized|Parallel Assignment||Treatment||Quadruple|Blinded placebo controlled||t|t|t|t
1308463|NCT03486067||Single Group Assignment||Treatment||None (Open Label)||||||
1308464|NCT03486054|Randomized|Sequential Assignment||Treatment||Quadruple|Randomized, double-blind Stage 1; single arm open label in Stage 2|Stage 1: parallel assignement to experimental or control group Stage 2: Dose escalation group|t|t|t|t
1308465|NCT03486041|Randomized|Parallel Assignment||Treatment||Single|The project coordinator at each site will conduct baseline assessments. All later assessments will be conducted by different research assistants, masked to experimental condition of the participant.|Immediate ComB and MAC participants will each be assessed at baseline (week 0). ComB will begin weekly therapy sessions, and MAC will receive weekly phone check-ins. All will be assessed at week 6 [mid-treatment] and week 12 [end of controlled phase]. After week 12, ComB enters maintenance and MAC participants start to receive delayed ComB. There is another assessment at week 25 (3-month followup for immediate ComB, post-ComB for MAC) and a final assessment at week 38 (6-month followup for immediate ComB, 3-month followup for MAC).||||t
1308466|NCT03486028|||Case-Control||Other|||||||
1308467|NCT03486015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308468|NCT03486002|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1308469|NCT03485989||Single Group Assignment||Basic Science||None (Open Label)||||||
1308470|NCT03485976||Single Group Assignment||Treatment||None (Open Label)||||||
1308471|NCT03485963||Single Group Assignment||Treatment||None (Open Label)||||||
1308472|NCT03485950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308473|NCT03485937|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308474|NCT03485924|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1308475|NCT03485911|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1308476|NCT03485898|||Cohort||Prospective|||||||
1308477|NCT03485885|||Cohort||Prospective|||||||
1308478|NCT03485872|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1308479|NCT03485859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308480|NCT03485846||Single Group Assignment||Treatment||None (Open Label)||||||
1308481|NCT03485833||Single Group Assignment||Treatment||None (Open Label)||||||
1308482|NCT03485820|Randomized|Parallel Assignment||Treatment||Single||Single-blind, parallel-group, randomized controlled trial||||t
1308483|NCT03485807|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1308484|NCT03485794|||Case-Only||Prospective|||||||
1308485|NCT03485781|||Case-Only||Prospective|||||||
1308486|NCT03485768|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective, one-center, controlled clinical study with random assignment to PDCN or manual therapy group to explore their effectiveness and safety for the treatment of cervicogenic dizziness. Participants will be randomized and allocated to either PDCN group or manual therapy group with 1:1 ratio and with 35 patients in each group.||||
1308487|NCT03485755|||Cohort||Prospective|||||||
1308488|NCT03485742|||Cohort||Cross-Sectional|||||||
1308489|NCT03485729|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308490|NCT03485716|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1308491|NCT03485703|Randomized|Parallel Assignment||Prevention||None (Open Label)||for a period of 5 days, a group of infants will receive azithromycin EV at a dose of 10 mg / kg / day and another group will receive placebo (SF 0.9%) in the same volume, every 24 hours.||||
1308492|NCT03485690|||Cohort||Prospective|||||||
1308493|NCT03485677|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1308494|NCT03485664|||Case-Control||Prospective|||||||
1308495|NCT03485651|||Cohort||Prospective|||||||
1308496|NCT03485638|||Cohort||Prospective|||||||
1308497|NCT03485625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308498|NCT03485612|||Cohort||Prospective|||||||
1308499|NCT03485599|||Ecologic or Community||Cross-Sectional|||||||
1308500|NCT03485586|||Case-Control||Prospective|||||||
1308501|NCT03485573|||Cohort||Prospective|||||||
1308502|NCT03485560||Single Group Assignment||Treatment||None (Open Label)||||||
1308503|NCT03485547||Single Group Assignment||Treatment||None (Open Label)||||||
1308504|NCT03485534|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, randomized, Parallel||||
1308505|NCT03485521|Randomized|Parallel Assignment||Supportive Care||Single|"The randomization list is established by the researcher before the search begins.~A document describing the randomization procedure is kept confidential."|It is a pilot study, monocentric with randomization of para-medical personnel The randomization list is established by the researcher before the search begins. The strengths of the 3 treatment groups are balanced (15 per group). A document describing the randomization procedure is kept confidential.||t||
1308506|NCT03485508|||Cohort||Retrospective|||||||
1308507|NCT03485495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308508|NCT03485482|Randomized|Crossover Assignment||Other||None (Open Label)||open label, randomized, single-dose, three-period, crossover design||||
1308509|NCT03485469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308510|NCT03485456||Single Group Assignment||Treatment||None (Open Label)||||||
1308511|NCT03485443|Randomized|Crossover Assignment||Prevention||Single|The postoperative assessment following the anesthesiologist, nurse and parents were blind during the entire study group||||t|
1308512|NCT03485430|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308513|NCT03485417|Randomized|Parallel Assignment||Treatment||Single|treatment group randomised to each participant is masked to the outcome assessors|prospective randomised single-blinded||||t
1308514|NCT03485404|Randomized|Parallel Assignment||Prevention||Double|Central randomization. Groups are marked as A and B with no participants, care provider, investigator and outcome assessors know which group is the drug and which is the placebo. Placebo are made as tablets that mimics the color, shape and size of the drugs.||t|t||
1308515|NCT03485391|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1308516|NCT03485378||Single Group Assignment||Treatment||None (Open Label)||||||
1308517|NCT03485365|Randomized|Sequential Assignment||Treatment||Double|This will be a double blind study. Subjects and investigator will be masked.|Subjects will be randomized in 3:1 ratio to receive GSK3858279 and placebo in sequential manner in Part A. In Part B, subjects will be randomized in parallel groups to receive either GSK3858279 or placebo.|t||t|
1308518|NCT03485352|||Other||Prospective|||||||
1308519|NCT03485339|||Case-Control||Other|||||||
1308520|NCT03485326|||Cohort||Prospective|||||||
1308521|NCT03485313|||Cohort||Prospective|||||||
1308522|NCT03485300|||Cohort||Cross-Sectional|||||||
1308523|NCT03485287||Single Group Assignment||Treatment||None (Open Label)||Open-label multi-site study axamining safety and effects of three sessions of MDMA-assisted psychotherapy, with Clinician-Administered PTSD Scale for DSM 5 (CAPS-5) severity after treatment compared with baseline||||
1308524|NCT03485274|Randomized|Parallel Assignment||Treatment||Single|treatment in each intervention arms is masked to the outcome assessor|prospective randomised single-blinded||||t
1308525|NCT03485261|||Other||Cross-Sectional|||||||
1308526|NCT03485248|Randomized|Crossover Assignment||Prevention||Double|Double- Blind||t||t|
1308527|NCT03485235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308528|NCT03485222|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308529|NCT03485209||Single Group Assignment||Treatment||None (Open Label)||||||
1308530|NCT03485196|||Cohort||Prospective|||||||
1308531|NCT03485183|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients will be recruited for the intervention group and receive the intervention. Their data will be compared to baseline data--data without personal identifiers retrieved from chart review. These data will serve as the control group.||||
1308532|NCT03485170||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308533|NCT03485157|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308534|NCT03485144|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1308535|NCT03485131|Randomized|Parallel Assignment||Treatment||Triple|Raters were blind as was PI.|Two group randomized, parallel design|t||t|t
1308536|NCT03485118|Randomized|Parallel Assignment||Treatment||Single||Randomized, single-blind, controlled, multicenter phase II study.|t|||
1308537|NCT03485105|||Cohort||Retrospective|||||||
1308538|NCT03485092|Randomized|Parallel Assignment||Treatment||Quadruple|placebo controlled trial|Randomised, placebo controlled trial|t|t|t|t
1308539|NCT03485079|||Cohort||Prospective|||||||
1308540|NCT03485066|Randomized|Parallel Assignment||Basic Science||Single||||||t
1308541|NCT03485053||Single Group Assignment||Treatment||None (Open Label)||||||
1308542|NCT03485040|||Cohort||Prospective|||||||
1308543|NCT03485027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||investigator chose the optimal reintroduction regimen for chemotherapy according to criteria||||
1308544|NCT03485014||Single Group Assignment||Treatment||None (Open Label)||||||
1308545|NCT03485001|Randomized|Factorial Assignment||Treatment||Single|||||t|
1308546|NCT03484988|Randomized|Parallel Assignment||Prevention||Double|The all details of groups assignment are arranged and controlled by the research designers. The color, shape, and external packaging of the n-3 polyunsaturated fatty acid and placebo are consistent (faint yellow to yellow oil in transparent soft capsules). Each bottle of capsules will be marked with the name (or identify number) of the participants by research designers. Thus, the grouping of participants is blind to the rest of the researchers (like outcomes assessors).||t|||t
1308547|NCT03484975||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308548|NCT03484962|Randomized|Parallel Assignment||Treatment||Quadruple|With the method of minimum randomized dynamic random by the interactive network response system (IWRS),Participants were assigned to three groups,receive cryotherapy,non-intervention therapy, and activated CIK armed with anti-CD3-MUC1 bispecific antibody together with cryotherapy .every participant has a unique identification number and emergency letter which have the information of group.|This is a phase II clinical trial of single-center, and it will divide into three groups.|t|t|t|t
1308549|NCT03484949|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1308550|NCT03484936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308551|NCT03484923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308552|NCT03484910|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1308553|NCT03484897||Single Group Assignment||Treatment||None (Open Label)||||||
1308554|NCT03484884|||Cohort||Prospective|||||||
1308555|NCT03484871|||Cohort||Prospective|||||||
1308556|NCT03484858|Randomized|Crossover Assignment||Other||None (Open Label)||Randomized cross over design||||
1308557|NCT03484845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308558|NCT03484832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308559|NCT03484819||Single Group Assignment||Treatment||None (Open Label)||||||
1308560|NCT03484806|||Cohort||Prospective|||||||
1308561|NCT03484793|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1308562|NCT03484780||Single Group Assignment||Treatment||None (Open Label)|Independent data review and analysis by the University of Glasgow Department of Biostatistics|Patients implanted with the VisONE implantable system for delivering chronic Asymptomatic Diaphragmatic Stimulation (ADS).||||
1308563|NCT03484767|||Cohort||Prospective|||||||
1308564|NCT03484754|Randomized|Parallel Assignment||Treatment||None (Open Label)|blinding impossible|"The main pitfall of these studies is indeed the difficulty in ensuring a double-blind when the TB is injected into the corrugator and the procerus with placebo as physiological saline, since the patient as the examiner can guess which product was administered.~The main objective of our study is therefore to evaluate the efficacy of OnaA injections in the glabellar zone , using lateral muscle injection orbicularis oculi (involved in crow's feet wrinkles) as another injection zone in comparison."||||
1308565|NCT03484741||Single Group Assignment||Treatment||None (Open Label)||||||
1308566|NCT03484728|||Cohort||Prospective|||||||
1308567|NCT03484715|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|As the primary aim of this study is to establish feasibility of the intervention and study processes, there will be no outcome assessor or participant blinding.|Randomised controlled pilot feasibility study||||
1308568|NCT03484702||Single Group Assignment||Treatment||None (Open Label)||||||
1308569|NCT03484689||Single Group Assignment||Treatment||None (Open Label)||||||
1308570|NCT03484676||Single Group Assignment||Treatment||None (Open Label)||||||
1308898|NCT03480412|||Cohort||Prospective|||||||
1308571|NCT03484663|Randomized|Parallel Assignment||Treatment||Single|patient who will do vats procedure|case of small catheter drainage with chest tube versus chest tube alone after uniport vats|t|||
1308572|NCT03484650|Randomized|Parallel Assignment||Prevention||Triple|The patient, physician, and data abstractors will be blinded to the arm.|Prospective randomized controlled trial|t|t||t
1308573|NCT03484637|||Cohort||Prospective|||||||
1308574|NCT03484624||Single Group Assignment||Other||None (Open Label)||||||
1308575|NCT03484611|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1308576|NCT03484598||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308577|NCT03484585||Single Group Assignment||Treatment||None (Open Label)||||||
1308578|NCT03484572|||Case-Only||Cross-Sectional|||||||
1308579|NCT03484559|||Cohort||Retrospective|||||||
1308580|NCT03484546|||Cohort||Prospective|||||||
1308581|NCT03484533|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1308582|NCT03484520||Single Group Assignment||Treatment||None (Open Label)||||||
1308583|NCT03484507|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1308584|NCT03484494|Randomized|Crossover Assignment||Basic Science||Triple|The device is operated using subject-specific links on a laptop. The active or sham identity of the links is prepared automatically and not known to study staff or participants.|This is a sham controlled, randomized, double blinded crossover design study of immediate change to brain activity caused by Low Field Magnetic Stimulation.|t|t|t|
1308585|NCT03484481|||Cohort||Cross-Sectional|||||||
1308586|NCT03484468|||Cohort||Retrospective|||||||
1308587|NCT03484455||||||||||||
1308588|NCT03484442|||Case-Only||Prospective|||||||
1308589|NCT03484429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308590|NCT03484416|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1308591|NCT03484403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308592|NCT03484390|Randomized|Parallel Assignment||Treatment||||||||
1308593|NCT03484377|Randomized|Parallel Assignment||Treatment||Single|Participants will be randomly allocated, using a computer generated code, to receive either anodal tDCS or sham. For sham stimulation, the current will be delivered only in the first 10 seconds, after which the stimulation will cease but with the electrodes still in place throughout the session|Concurrent tDCS-MEG parallel arms single-blinded experimental design (right anodal v sham tDCS).|t|||
1308594|NCT03484364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308595|NCT03484351||Single Group Assignment||Health Services Research||None (Open Label)||||||
1308596|NCT03484338|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1308597|NCT03484325|||Other||Prospective|||||||
1308598|NCT03484312|||Cohort||Other|||||||
1308599|NCT03484299||Single Group Assignment||Treatment||None (Open Label)||All subjects undergoing IRE will receive treatment with either FOLFIRINOX or gemcitabine (based on which regimen was received prior to IRE)||||
1308600|NCT03484286|Randomized|Parallel Assignment||Supportive Care||Single|"Cardiovascular events will be adjudicated as heart failure related or not, by a blinded expert.~Data analysis will be performed by staff blinded to the patients IDs."|Parallell randomized clinical trial with continuous sampling and a 1:1 randomization.||||t
1308601|NCT03484273|Randomized|Crossover Assignment||Treatment||None (Open Label)||There will be 4 compression conditions based on strap configuration of the Lifewrap garment: full abdominal and lower extremity compression, abdominal only compression, lower extremity only compression and no compression. The order of these interventions will be randomized.||||
1308602|NCT03484260|||Case-Control||Retrospective|||||||
1308603|NCT03484247|Randomized|Parallel Assignment||Prevention||Single|||||t|
1308604|NCT03484234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308605|NCT03484221||Single Group Assignment||Treatment||None (Open Label)||||||
1308606|NCT03484208|||Cohort||Prospective|||||||
1308607|NCT03484195||Single Group Assignment||Treatment||None (Open Label)||||||
1308608|NCT03484182|Randomized|Parallel Assignment||Treatment||Single||||||t
1308609|NCT03484169|Randomized|Parallel Assignment||Prevention||Double|The result of the randomization will be placed in sealed and opaque envelopes and the information will be revealed to the member in charge of the training only at the moment the intervention is performed, guaranteeing the secrecy of the allocation. The study will be triple blind, since the randomization and allocation of participants will be performed by researcher A, electromyographic evaluations, data tabulation and statistical analysis (researcher B) and intervention (researcher C).|Will be part of the study 30 healthy women at menacme, eutrophic, nulliparous and aged between 18 and 35 years, recruited among students of the Department of Physical Therapy of the Federal University of Pernambuco. The initial sample will be divided into two groups: intervention group n=15 (GI) and one control group n=15 (CG), randomized through www.randomization.com by a researcher who will be blind regarding outcomes.|||t|t
1308610|NCT03484156||Single Group Assignment||Prevention||None (Open Label)||||||
1308611|NCT03484143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308612|NCT03484130|||Cohort||Prospective|||||||
1308613|NCT03484117|Randomized|Parallel Assignment||Treatment||Single||||||t
1308614|NCT03484104|||Cohort||Prospective|||||||
1308615|NCT03484091|Randomized|Parallel Assignment||Treatment||Quadruple||A double-blind, placebo controlled RCT|t|t|t|t
1308616|NCT03484078|Randomized|Parallel Assignment||Treatment||Triple||Children with CP will be randomly assigned to a vibration or a placebo group.|t|t|t|
1308617|NCT03484065|||Cohort||Cross-Sectional|||||||
1308618|NCT03484052||Single Group Assignment||Other||None (Open Label)||||||
1308619|NCT03484039|Randomized|Parallel Assignment||Supportive Care||Quadruple||Patients will be enrolled in one module of own choice. Except for Module 3 Submodule 2, every module will consist of a particular intervention, as well as, its accompanying set of assessments. Prior to being given the intervention, subjects assigned to a given module will be randomly assigned to either an Immediate Intervention (II) or a Delayed Intervention (DI) group. Although every subject will receive the intervention, the timing of the intervention and assessments will distinguish the II and DI group.|t|t|t|t
1308620|NCT03484026||Single Group Assignment||Supportive Care||None (Open Label)||Consumption of BioFe in a single cohort of up to 8 subjects with iron deficiency.||||
1308621|NCT03484013|||Other||Other|||||||
1308622|NCT03484000|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1308623|NCT03483987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants who relapsed to prior treatment with one or two DAA will be retreated with second course of DAA regimen and ribavirin with or without pegylated interferon. The duration of treatment will be 24 weeks. The drugs will be chosen based upon their prior exposure to DAA, liver disease severity and virus genotype.||||
1308624|NCT03483974|||Ecologic or Community||Prospective|||||||
1308625|NCT03483961|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1308626|NCT03483948||Single Group Assignment||Treatment||None (Open Label)||||||
1308627|NCT03483935|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised, internally controlled trial||||
1308628|NCT03483922|||Cohort||Prospective|||||||
1308629|NCT03483909|Randomized|Crossover Assignment||Treatment||Triple|participants, outcome assessors and raters are blinded. rTMS application is performed by an unblinded investigator|randomized, double-blind, cross-over trial of 3 rTMS protocols|t|t||t
1308630|NCT03483896|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1308631|NCT03483883||Single Group Assignment||Treatment||None (Open Label)||||||
1308632|NCT03483870|Randomized|Parallel Assignment||Prevention||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) The trial will be planned that neither the doctors (investigator) nor the parturients will be aware of the group allocation. The study drugs will be prepared by an anesthesiologist not involved in performing the intrathecal anesthesia, patient care or in data collection.|comparison of the effect of intravenous granisetron with the effect of using placebo on morphine induced pruritus in parturients undergoing elective cesarean section under spinal anesthesia.|t|t|t|t
1308633|NCT03483857|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Two arm study assessing to determine feasibility and acceptability of a pilot PN intervention among 100 HIV-positive MSM. We will explore associations between PN participation and continuum of care outcomes in a cohort of 55 HIV-positive MSM receiving PN, as compared to a cohort of 48 HIV-positive MSM receiving standard-of-care clinical referral, in preparation for a full-scale multi-site behavioral efficacy trial.||||
1308634|NCT03483844|||Other||Prospective|||||||
1308635|NCT03483831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308636|NCT03483818|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a feasibility study comparing delivery of care pathways rather than evaluating medication||||
1308637|NCT03483805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308638|NCT03483792|||Case-Control||Prospective|||||||
1308639|NCT03483779|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1308640|NCT03483766|Non-Randomized|Single Group Assignment||Health Services Research||Single|Patients with tetraplegia under the care of our department will be recruited. Spinal cord resting-state fMRI and DTI, surface EMG tests from different muscles from arm will be detected to define 5 most possible suitable candidates for this project.|This study will apply spinal cord resting-state fMRI and DTI to patients with cervical spinal cord injury. Findings with fMRI/DTI will compare to clinical hand function evaluation by using American Spinal Injury Association (ASIA) with full ASIA sensory and motor examinations (International standards for neurological classification of spinal cord injury (ISNCSCI)). After baseline spinal cord MRI scan, those patients will receive 3 months muscle strength enhancement as pre-rehabilitation. Then, we will design robotic hand rehabilitation programme for each individuals. All participants will receive robotic rehabilitation for 1 year. After then, a follow-up spinal cord MRI scan and clinical assessment will evaluate the results of this project.|||t|
1308641|NCT03483753|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1308642|NCT03483740|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a pilot, parallel design, randomized, controlled trial (RCT) that will allocate a sample (n=16) of people (≥ 40 yrs old) aging with HIV who have been diagnosed with MND from St. Michael's Hospital (SMH) in Toronto to either arm 1: 8 weekly 3-hour sessions of CRGT; or arm 2: 8 weekly 3-hour sessions of HIV group therapy.||||
1308643|NCT03483727|Randomized|Parallel Assignment||Treatment||Single|single|with or without the cognitive aid|t|||
1308644|NCT03483714|||Cohort||Cross-Sectional|||||||
1308645|NCT03483701|Randomized|Parallel Assignment||Treatment||Single|This randomized controlled trial will use a single-blind study design with two treatment arms. The research team that assesses participants at baseline and follow-up will have no knowledge of their assigned treatment arm. The participants, however, will know which treatment arm they have been assigned.|||||t
1308646|NCT03483688||Single Group Assignment||Treatment||None (Open Label)||||||
1308647|NCT03483675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308648|NCT03483662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308649|NCT03483649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308650|NCT03483636|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1308651|NCT03483623|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||This protocol is a Quasi Experimental Cross Factor study. The subject sample is nonrandomized. Subjects will be their own control and have repeated measurements to compare baseline and supine transcutaneous oxygenation levels and laser Doppler pressures units on four different surface combinations.||||
1308652|NCT03483610|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308653|NCT03483597|||Cohort||Cross-Sectional|||||||
1308654|NCT03483584|||Cohort||Prospective|||||||
1308655|NCT03483571|||Cohort||Prospective|||||||
1308656|NCT03483558|Non-Randomized|Crossover Assignment||Basic Science||Single||||||t
1308657|NCT03483545||Single Group Assignment||Other||None (Open Label)||||||
1308658|NCT03483532|||Cohort||Prospective|||||||
1308659|NCT03483519|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1308660|NCT03483506||Single Group Assignment||Treatment||None (Open Label)||||||
1308661|NCT03483493|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1573378|NCT00001437||||Treatment||||||||
1308662|NCT03483480|Randomized|Parallel Assignment||Treatment||Single||||||t
1308663|NCT03483467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308664|NCT03483454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308665|NCT03483441|Randomized|Crossover Assignment||Treatment||Triple||Each patient serves as his/her own control. Two PDT sessions are given, constituting Arm 1 and Arm 2. Arm 1 is placebo pill, then PDT. Arm 2 is Vit D pill, then PDT. In any given patient, the order of Arm 1 vs. Arm 2 will be randomized.|t|t|t|
1308666|NCT03483428|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308667|NCT03483415|Randomized|Parallel Assignment||Treatment||Single||Prospective, randomized, controlled, single-blind|t|||
1308668|NCT03483402||Single Group Assignment||Treatment||None (Open Label)||Single-center, one-arm, prospective clinical trial.||||
1308669|NCT03483389|Randomized|Crossover Assignment||Other||Double|||t|||t
1308670|NCT03483376|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two parallel arms of the study will be used. One arm will receive dental plaque removal using standard protocol. The other arm will receive the standard plaque removal, followed by antimicrobial photodynamic therapy.||||
1308671|NCT03483363|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1308672|NCT03483350|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308673|NCT03483337|||Cohort||Prospective|||||||
1308674|NCT03483324||Single Group Assignment||Treatment||None (Open Label)||||||
1308675|NCT03483311|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1308676|NCT03483298|||Cohort||Prospective|||||||
1308677|NCT03483285|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1308678|NCT03483272|||Cohort||Prospective|||||||
1308679|NCT03483259|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible subjects who did not meet the exclusion criteria were randomly assigned to one of the three groups: group A, B, and C (administration TRR, RTR and RRT, 9 subjects in each group, where T is the test formulation and R is the reference formulation) .||||
1308680|NCT03483246|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308681|NCT03483233||Single Group Assignment||Basic Science||None (Open Label)||||||
1308682|NCT03483220|||Cohort||Cross-Sectional|||||||
1308683|NCT03483207|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Diagnosis of acute MVT will be based on clinical presentation &positive CT scan.(9) .patients with confirmed diagnosis of acute MVT on CT scan but having no signs of peritonitis or established CT signs of gangrene will be treated conservatively .(11)In addition to usual care ,intravenous heparin will be started and the dose is adjusted to maintain APTT levels at 2-2.5 times the normal. (12) followed by oral anticoagulation (warfarin) for 6 months or for life in the presence of coagulation abnormality. All patients will be critically monitored for the progress of response of therapy , failure to improve or worsening in condition,will be an urgent indication for surgical intervention with resection of the infarcted bowel segment .If there is suspicion about the viability of remaining bowel intraoperative or later on based on clinical evidences,then second look laparotomy will be perfomed .The mortality and all complications associated with surgery will be recorded."||||
1308684|NCT03483194|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1308685|NCT03483181|||Cohort||Prospective|||||||
1308686|NCT03483168|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308687|NCT03483155|||Other||Prospective|||||||
1308688|NCT03483142|Randomized|Parallel Assignment||Supportive Care||Single||"Intervention~All women will be randomly assigned to either:~Group A ( study group ) ( 25 patient): who will receive placebo . two rectal placebo tablet of the same size and shape as the misoprostol.~Group B (control group ) ( 25 patient): who will receive 400 microgram (tablet 200mcg X 2) misoprostol rectally one hour before operation"|t|||
1308689|NCT03483129|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomised into either the intervention or the control group. Participants in INT will receive a 15 minute one to one consultation with a nurse at their general practice. The consultation will provide the participant with information regarding the benefits of physical activity and healthy eating. Emphasis will placed on the importance of achieving at least 150 minutes of moderate physical activity each week as well as adhering to healthy dietary habits, based on the NHS Eatwell Guide. Participants will have the opportunity to discuss pre-diabetes with a nurse and ask any questions they may have. Participants placed in CON will not receive the consultation and will only attend visits to the WARU. A subgroup of participants will also be randomised for additional physical activity monitoring.||||
1308690|NCT03483116|Randomized|Parallel Assignment||Prevention||Quadruple||This is a Phase II, randomised, double-blind, placebo-controlled, four-arm parallel group study of two different dosing schedules of oral RV3-BB|t|t|t|t
1308691|NCT03483103||Single Group Assignment||Treatment||None (Open Label)||||||
1308692|NCT03483090|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Treatment arm and Placebo arm|t|t|t|t
1308693|NCT03483077|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308694|NCT03483064|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308695|NCT03483051|Randomized|Crossover Assignment||Treatment||Quadruple||In this phase IIb, double-blind, cross-over trial, we will assign 22 subjects who are post-TAVR for severe AS to: (A) Potassium nitrate administered by mouth at a dose of 6 mEq three times daily for 4 weeks, or (B) Potassium chloride (KCl) at identical doses. The order of the interventions (AB-BA design) will be randomized, with a 1-week washout period separating each intervention. A crossover design will enable each subject to receive both treatments.|t|t|t|t
1308696|NCT03483038||Single Group Assignment||Treatment||None (Open Label)||||||
1308697|NCT03483025|Randomized|Single Group Assignment||Other||Triple|The six hair cleansing products will be packaged in identical 1 ml capped tuberculin syringes (with no needles) and provided to participants. Each syringe will be labeled with the forearm location for application. Identical syringes containing the six hair cleansing products will be dispensed. Treatment site allocation will be determined by a computer-generated randomization log.|randomized, double-blind, controlled|t||t|t
1308698|NCT03483012||Single Group Assignment||Treatment||None (Open Label)||||||
1308699|NCT03482999|||Case-Control||Retrospective|||||||
1308700|NCT03482986|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1573379|NCT00001436||||Treatment||||||||
1308701|NCT03482973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308702|NCT03482960|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1308703|NCT03482947|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1308704|NCT03482934|||Cohort||Cross-Sectional|||||||
1308705|NCT03482921|||Case-Control||Cross-Sectional|||||||
1308706|NCT03482908|Randomized|Single Group Assignment||Prevention||None (Open Label)||A multi-site, randomized controlled trial (RCT) to test that hypothesis that an individually tailored responsive parenting obesity prevention intervention that coordinates care provided by WIC nutritionists and primary care providers will be effective to ultimately reduce/prevent obesity in infants.||||
1308707|NCT03482895|||Cohort||Cross-Sectional|||||||
1308708|NCT03482882||Single Group Assignment||Treatment||None (Open Label)||||||
1308709|NCT03482869||Single Group Assignment||Other||None (Open Label)||Prospective cohort||||
1308710|NCT03482856|Randomized|Parallel Assignment||Treatment||Triple||The trial will randomize 120 patients with CSP and comorbid insomnia, aged between 18 and 65 years, to the experimental intervention (i.e. 18 sessions of the modern neuroscience approach combined with CBT-I, including 3 sessions of therapeutic pain neuroscience education, 6 sessions of CBT-I and 9 sessions of cognition-targeted exercise therapy, n=60) or the control intervention (i.e. 18 sessions of the modern neuroscience approach alone, including 3 sessions of therapeutic pain neuroscience education, and 15 sessions of cognition-targeted exercise therapy, n=60).|t||t|t
1308711|NCT03482843|||Cohort||Prospective|||||||
1308712|NCT03482830|||Cohort||Prospective|||||||
1308713|NCT03482817||Single Group Assignment||Treatment||None (Open Label)||open-label, non-randomized, single-sequence study||||
1308714|NCT03482804|||Other||Prospective|||||||
1308715|NCT03482791|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308716|NCT03482778|||Cohort||Retrospective|||||||
1308717|NCT03482765|Randomized|Parallel Assignment||Supportive Care||Double|Apart from the participant and Investigator, the study team is also blinded.||t||t|
1308718|NCT03482752|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Open Label, Non-controlled||||
1308719|NCT03482739||Single Group Assignment||Prevention||None (Open Label)||||||
1308720|NCT03482726||Single Group Assignment||Other||None (Open Label)||||||
1308721|NCT03482713|Randomized|Parallel Assignment||Treatment||Double||Japanese adult participants with refractory or unexplained chronic cough will be randomized to 1 of 2 treatment groups: gefapixant 45 mg twice daily (BID), or placebo BID.|t||t|
1308722|NCT03482700|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||There are two groups: An intervention group and a control group. The intervention group will have their usual annual COPD review performed by a specialist respiratory doctor at baseline and 12 months. The patients will receive care using our local COPD guidance which has been accepted by all local commissioning groups and secondary care organisations. The control group will receive the usual standard of care.||||
1308723|NCT03482687|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308724|NCT03482674|Randomized|Parallel Assignment||Prevention||Single|||t|||
1308725|NCT03482661|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1308726|NCT03482648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308727|NCT03482635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308728|NCT03482622|||Other||Retrospective|||||||
1308729|NCT03482609|||Cohort||Prospective|||||||
1308730|NCT03482596||Single Group Assignment||Prevention||None (Open Label)||||||
1308731|NCT03482583|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308732|NCT03482570|||Cohort||Prospective|||||||
1308733|NCT03482557||Single Group Assignment||Screening||None (Open Label)||||||
1308734|NCT03482544|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308735|NCT03482531|||Other||Prospective|||||||
1308736|NCT03482518|Randomized|Parallel Assignment||Treatment||Double|Participants will be informed that they will be drawn to participate in one of the two groups (intervention group or control group). Allocation in the groups will be done randomly, by lot, following the order of randomization, keeping the confidentiality, ie, one should not know to which group the participant will be sent before he / she agrees to be evaluated and sign the TCLE.|A randomized controlled trial|t||t|
1308737|NCT03482505||Single Group Assignment||Other||None (Open Label)||||||
1308738|NCT03482492|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1308739|NCT03482479|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1308740|NCT03482466||Single Group Assignment||Treatment||None (Open Label)||"12 PTSD patients will be exposed to the real time functional MRI neurofeedback training. The investigators will assess PTSD symptoms both clinically and with a take home wearable device that will collect data on physical activity, heart rate, and sleep patterns."||||
1308741|NCT03482453|Randomized|Sequential Assignment||Other||Triple|||t|t|t|
1308742|NCT03482440|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1308743|NCT03482427|Randomized|Parallel Assignment||Prevention||None (Open Label)||We will test our intervention compared to usual care (control)||||
1308744|NCT03482414|Randomized|Parallel Assignment||Treatment||Single||3-arm randomized controlled trial|t|||
1308745|NCT03482401|Randomized|Parallel Assignment||Screening||None (Open Label)||Randomised, parallel-controlled dietary intervention||||
1308746|NCT03482388|Randomized|Parallel Assignment||Screening||None (Open Label)||Participants will be randomly assigned in a 1:1 ratio to the study intervention or control||||
1308747|NCT03482375|||Cohort||Prospective|||||||
1308748|NCT03482362|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a two-stage, single-arm, multi-center, open-label, two-cohort, clinical, phase II, proof of principal study.||||
1308749|NCT03482349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308803|NCT03481647|Randomized|Parallel Assignment||Prevention||Single|The participants will not be aware of the care/treatment given to the other group|Intervention group: intensified oral care programme Control group: conventional oral care|t|||
1308804|NCT03481634||Parallel Assignment||Treatment||Double|||t||t|
1308899|NCT03480399|||Cohort||Prospective|||||||
1308750|NCT03482336|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|Participants were handled differently in the methods. For the first block of participants, the FOP was not pointed out. For the second block, researchers merely pointed to the FOP and indicated that it might be helpful in decision making.|Two blocks of participants were recruited. One block received no information regarding the FOP; for the second block, researchers pointed to an FOP and suggested that the information might be helpful in deciding which product was healthier.||||
1308751|NCT03482323|Randomized|Parallel Assignment||Supportive Care||Single|All baseline and follow-up assessments will be carried out by research staff who are blinded to allocation. The statistician and laboratory staff for the measurement of biomarkers remains still blinded until the end of the whole study.|The participants will be randomised into equally sized arms; tai-chi classes, exercise classes, or control.||||t
1308752|NCT03482310||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1308753|NCT03482297||||||||||||
1308754|NCT03482284|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||All participants receive all interventional diets.||||
1308755|NCT03482271|||Other||Retrospective|||||||
1308756|NCT03482258|Randomized|Parallel Assignment||Prevention||Double|Blinding of supplements will be conducted by Frieslandcampina who are providing both prebiotic and maltodextrin||t||t|
1308757|NCT03482245|Randomized|Parallel Assignment||Basic Science||None (Open Label)||randomized pilot clinical trial||||
1308758|NCT03482232|||Cohort||Retrospective|||||||
1308759|NCT03482219|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled clinical trial|t|||
1308760|NCT03482206||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308761|NCT03482193|||Cohort||Cross-Sectional|||||||
1308762|NCT03482180|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308763|NCT03482167|Randomized|Parallel Assignment||Treatment||Double|Double-blind||t||t|
1308764|NCT03482154|||Cohort||Retrospective|||||||
1308765|NCT03482141||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308766|NCT03482128|||Cohort||Retrospective|||||||
1308767|NCT03482115|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1308768|NCT03482102||Single Group Assignment||Treatment||None (Open Label)||||||
1308769|NCT03482089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308770|NCT03482076||Single Group Assignment||Diagnostic||None (Open Label)||||||
1308771|NCT03482063|Randomized|Parallel Assignment||Supportive Care||Quadruple||Randomised, placebo-controlled, double-blind, parallel groups design|t|t|t|t
1308772|NCT03482050||Sequential Assignment||Treatment||None (Open Label)||Dose-escalating, four subject-groups clinical study; a single treatment administration of AstroRx, administered in an escalating low, medium and high dose or two consecutive administrations of the medium dose separated by an interval. AstroRx will be administered by intrathecal (spinal) injection to subjects with ALS at the early disease stage.||||
1308773|NCT03482037|Randomized|Sequential Assignment||Treatment||Triple||two sequential cohorts, each corresponding to a dose level.|t|t|t|
1308774|NCT03482024|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1308775|NCT03482011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308776|NCT03481998|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1308777|NCT03481985|||Cohort||Prospective|||||||
1308778|NCT03481972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308779|NCT03481959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308780|NCT03481946||Single Group Assignment||Basic Science||None (Open Label)||||||
1308781|NCT03481933|Randomized|Parallel Assignment||Treatment||Triple||left-excitatory tDCS ; right-inhibitory tDCS; sham tDCS (placebo)|t||t|t
1308782|NCT03481920||Single Group Assignment||Treatment||None (Open Label)||||||
1308783|NCT03481907||Single Group Assignment||Treatment||None (Open Label)||This is a self-controlled trial in which subjects will receive punch biopsies at sites on each leg, and will receive a different treatment on each of the 2 sites.||||
1308784|NCT03481894|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308785|NCT03481881|||Cohort||Prospective|||||||
1308786|NCT03481868|||Cohort||Prospective|||||||
1308787|NCT03481855|||Cohort||Prospective|||||||
1308788|NCT03481842||Single Group Assignment||Prevention||None (Open Label)||"Single application in the morning of a vaginal suppository ELTA:~Five days per week (with a treatment-free interval of two days in a row.) e.g. Monday and Tuesday - treatment-free days."||||
1308789|NCT03481829|||Cohort||Prospective|||||||
1308790|NCT03481816|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1308791|NCT03481803|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Sequential Assignment Eligible patients will be receiving increased doses from lower, middle to upper range of study medication MS1819-SD||||
1308792|NCT03481790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308793|NCT03481777|Randomized|Parallel Assignment||Treatment||Double|Participant. Outcome assessor.|Prospective, randomized, patient-assessor blinded, sham-controlled trial|t|||t
1308794|NCT03481764|||Case-Control||Retrospective|||||||
1308795|NCT03481751|||Cohort||Prospective|||||||
1308796|NCT03481738|||Cohort||Prospective|||||||
1308797|NCT03481725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308798|NCT03481712|||Cohort||Prospective|||||||
1308799|NCT03481699|Randomized|Parallel Assignment||Prevention||Double|Allocation was concealed to the participants, researchers -who were in class the assessment days- and teachers.|Participants were randomized in a 1:1 ratio blocked by gender to one of two groups: experimental condition (ITP intervention) versus control condition (educational intervention) in parallel for the duration of the study.|t|||t
1308800|NCT03481686||Single Group Assignment||Supportive Care||None (Open Label)||||||
1308801|NCT03481673||Single Group Assignment||Basic Science||None (Open Label)||Single group, pre-experimental, intervention pilot study.||||
1308802|NCT03481660|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308849|NCT03481049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308805|NCT03481621|Randomized|Parallel Assignment||Treatment||Double|All participants will get real treatments, the first group patients will get acupuncture treatments focus on the points within pudendal nerve distribution area; the second group patients will get acupuncture treatments focus on the points from traditional meridian theory. And the third group will get the standard care (no acupuncture). Participants and outcomes assessor will be blinded for the study aims.|Acupuncture 1: focus on the points within pudendal nerve distribution arae; Acupuncture 2: focus on the points from traditional meridian theory; Standard care: no acupuncture, but use physical therapy, pain medications, nerve blocking, etc.|t|||t
1308806|NCT03481608|Randomized|Crossover Assignment||Basic Science||Single|Participants will be blinded to the intervention oil (single-blind).|Acute feeding study. Participants will arrive at our Human Metabolic Research Unit on 2 separate occasions. Participants will be randomized to consume 1 of 2 shake on each occasion. Shakes will be prepared with 2 tablespoons of either control (olive) or intervention (coconut) oils.|t|||
1308807|NCT03481595|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1308808|NCT03481582|Randomized|Parallel Assignment||Treatment||Double|"After enrollment, participants would be given the next available number in a computer generated randomization plan .~Allocation concealment (among unexplained infertile groups):~Opaque, serially-numbered, sealed envelopes will enclose the letter corresponding to the group the patient will follow. Envelopes will be opened when the patient is enrolled and she will receive the intervention accordingly.~-Blinding The study design precludes neither participant nor the doctor will be blinded."|"90 female patients will be divided into 3 equal groups:~Group I: 30 female patients with unexplained infertility.~Group II: 30 female patients with unexplained infertility will receive nitroglycerin trans-dermal patch."|t|t||
1308809|NCT03481569||Single Group Assignment||Other||None (Open Label)||Pharmacokinetic study||||
1308810|NCT03481556|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308811|NCT03481543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308812|NCT03481530|Randomized|Parallel Assignment||Diagnostic||Triple|One arm is blinded, one isn't.||t||t|t
1308813|NCT03481517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308814|NCT03481504|Randomized|Crossover Assignment||Treatment||Triple|The particpant is kept naieve about the fact that the moment of starting the intervention is randomized but coiuld not be blinded for the intervention. The outcome assessor and investigator are blinded for randomization|Single case methodology with a multple baseline design in a mixed methods approach in which a quantitative approach will be followed by a qualitative approach. The star of the experiemental intervention will be randomized|t||t|t
1308815|NCT03481491|Non-Randomized|Parallel Assignment||Basic Science||Single|Participants will be blinded to the TMS procedure (SHAM or real stimulation).||t|||
1308816|NCT03481478|||Case-Only||Prospective|||||||
1308817|NCT03481465|||Cohort||Cross-Sectional|||||||
1308818|NCT03481452|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308819|NCT03481439|||Cohort||Prospective|||||||
1308820|NCT03481426|Randomized|Parallel Assignment||Prevention||Single|||t|||
1308821|NCT03481413|||Cohort||Prospective|||||||
1308822|NCT03481400|Randomized|Crossover Assignment||Other||Double|Double-blind study.|Placebo-controlled, crossover design.|t||t|
1308823|NCT03481387||Single Group Assignment||Treatment||None (Open Label)||||||
1308824|NCT03481374|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1308825|NCT03481361|||Cohort||Cross-Sectional|||||||
1308826|NCT03481348|Randomized|Parallel Assignment||Treatment||Single||||||t
1308827|NCT03481335|Randomized|Parallel Assignment||Prevention||None (Open Label)||This study is a parallel 26-community cluster randomized controlled trial. A community cluster design was chosen as CHAP-P is intended as a community-level intervention. Thirteen communities (barangays) will receive the CHAP-P sessions and will be considered intervention, while the other 13 communities will receive care as usual and will be considered control. Measures of individual participants will be taken as a repeated cross-sectional sample at baseline and at six months. A community process evaluation and cost-effectiveness evaluation will also be undertaken.||||
1308828|NCT03481322|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1308829|NCT03481309|Randomized|Crossover Assignment||Basic Science||Quadruple|This is a double-blind and cross-over study.|Each participant will be assigned to 2 active and sham conditions on a different day.|t|t|t|t
1308830|NCT03481296|Randomized|Parallel Assignment||Prevention||Single|||t|||
1308831|NCT03481283|||Cohort||Cross-Sectional|||||||
1308832|NCT03481270|Randomized|Parallel Assignment||Other||Double||RCT|t|t||
1308833|NCT03481257|||Cohort||Prospective|||||||
1308834|NCT03481244|||Cohort||Prospective|||||||
1308835|NCT03481231|||Case-Only||Prospective|||||||
1308836|NCT03481218|||Case-Only||Retrospective|||||||
1308837|NCT03481205||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1308838|NCT03481192|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"To groups of patients :~A group of patients admitted for IMV exclusively using amnesic substances.~A control group admitted for IMV and ingested exclusively non-amnesic~Two visits, the first one for the first evaluation of cognitive functions directly following the psychiatric interview (E1), and the second one at 24h-48h after the psychiatric evaluation (E2)"||||
1308839|NCT03481179|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308840|NCT03481166|Randomized|Parallel Assignment||Prevention||Single||||||t
1308841|NCT03481153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308842|NCT03481140|||Case-Control||Retrospective|||||||
1308843|NCT03481127|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1308844|NCT03481114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308845|NCT03481101||Single Group Assignment||Diagnostic||None (Open Label)||response evaluation with FDG-PET and free circulating DNA in patients with inoperable lung cancer of non small cell type during first treatment with chemotherapy or immunotherapy.||||
1308846|NCT03481088||Single Group Assignment||Treatment||None (Open Label)||||||
1308847|NCT03481075||Single Group Assignment||Supportive Care||None (Open Label)||||||
1308848|NCT03481062|||Case-Crossover||Cross-Sectional|||||||
1573380|NCT00001435||||||||||||
1308850|NCT03481036||Single Group Assignment||Treatment||None (Open Label)||||||
1308851|NCT03481023|Randomized|Parallel Assignment||Treatment||Double|Participants will be blinded to which condition they were assigned; the Outcomes Assessor will be blinded to the hypotheses of the study as well as the condition to which the participant was assigned.||t|||t
1308852|NCT03481010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308853|NCT03480997|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1308854|NCT03480984|Randomized|Parallel Assignment||Other||Single|Investigators will not have direct access to settings on the pump||||t|
1308855|NCT03480971|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1308856|NCT03480958|Randomized|Crossover Assignment||Prevention||Single||||||t
1308857|NCT03480945||Single Group Assignment||Diagnostic||Single||||||t
1308858|NCT03480932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308859|NCT03480919|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308860|NCT03480906|Non-Randomized|Crossover Assignment||Other||Single||||||t
1308861|NCT03480893|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1308862|NCT03480880|Randomized|Parallel Assignment||Treatment||Double|"Anaesthetic care provider in one arm of first part of study was blinded to intraoperative changes in Bispectral index.~Anaesthetic care provider was blinded to Bispectral Index changes in second part of study."|"Inj. Thiopentone dose requirement for induction of anaesthesia with and without the use of Bispectral Index guidance.~Observation of Bispectral Index change in intraoperative period."|t|t||
1308863|NCT03480867||Single Group Assignment||Treatment||None (Open Label)||RT 28Gy in 7 fractions with a concomitant boost of 42Gy in 7 fractions+ Temozolomide (75mg/m2) followed by surgery then Temozolomide (150-200mg/m2) q 5 days every 28 days.||||
1308864|NCT03480854|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This is a two-part prospective study to be conducted over 3 years with option to extend to 5 years. In Year 1, we will gather baseline performance data from participating MS clinics (microsystems), create a combined MSCQI systems-level database, and conduct analyses of performance variation and benchmarking. In the second part of the study (Years 2-3), we will investigate the effect of Continuous Quality Improvement interventions on primary endpoints and selected secondary measures.||||
1308865|NCT03480841||Single Group Assignment||Treatment||None (Open Label)||||||
1308866|NCT03480828|||Cohort||Prospective|||||||
1308867|NCT03480815|Randomized|Parallel Assignment||Treatment||None (Open Label)||a randomized, controlled study||||
1308868|NCT03480802|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1308869|NCT03480789|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308870|NCT03480776|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1308871|NCT03480763|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1308872|NCT03480750||Single Group Assignment||Treatment||None (Open Label)||||||
1308873|NCT03480737|Randomized|Crossover Assignment||Treatment||Single|||t|||
1308874|NCT03480724|Randomized|Parallel Assignment||Treatment||Single|The outcome accessor will have no patient contact and will not have access to the information on the type of intervention study patients were given.|3 groups of patients One group with no VR One group with Oculus rift VR One group with google cardboard box VR||||t
1308875|NCT03480711|Randomized|Parallel Assignment||Treatment||Double|"participants are going to be randomly assigned into two groups outcomes assessor will asses~visual acuity and BCVA~IOP using Goldmann applanation tonometry~slit-lamp and fundus examination of cup-disc ratio,~Ultrasound Biomicroscopy (UBM) to assese ostium patency and extent of bleb area will be done once after 6 weeks post-operatively.~Colored photography of the filtering blebs will be performed for grading. Bleb grading will be classified according moorfields grading scale~Perimetry will be performed at the end of follow up."|Randomized non-controlled comparative prospective interventional study|t|||t
1308876|NCT03480698|||Other||Prospective|||||||
1308877|NCT03480685|Non-Randomized|Single Group Assignment||Diagnostic||Single|Images will be identified by number not associated with case, patient, or institution.|||||t
1308878|NCT03480672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308879|NCT03480659|||Case-Control||Retrospective|||||||
1308880|NCT03480646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308881|NCT03480633|||Case-Control||Prospective|||||||
1308882|NCT03480620|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||A stratified random sampling approach will be used for this study whereby graduates from the BPRP will first be identified as having weaned off opioid medications (weaners) or did not wean off opioid medication (non-weaners). Once stratified into these two groups, participants will then be randomly assigned to either the standard care group (control group) or the telerehabilitation group (intervention group) based on sequential enrollment into each study group. Participants will continue with there post-discharge exercise and self-management program for one year, completing follow up assessment using the online platform at 1, 3, 6, 9, and 12 months post discharge.||||
1308883|NCT03480607|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1308884|NCT03480594|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Non-randomized prospective, non-blinded, single center, translational research||||
1308885|NCT03480581|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1308886|NCT03480568||Single Group Assignment||Treatment||None (Open Label)||Open-label, nonrandomized study||||
1308887|NCT03480555|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1308888|NCT03480542|||Other||Retrospective|||||||
1308889|NCT03480529|||Case-Only||Cross-Sectional|||||||
1308890|NCT03480516|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308891|NCT03480503|||Case-Control||Retrospective|||||||
1308892|NCT03480490|||Case-Only||Cross-Sectional|||||||
1308893|NCT03480477|||Cohort||Retrospective|||||||
1308894|NCT03480464|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308895|NCT03480451||Single Group Assignment||Supportive Care||None (Open Label)||||||
1308896|NCT03480438||Single Group Assignment||Treatment||None (Open Label)||||||
1308897|NCT03480425||Single Group Assignment||Prevention||None (Open Label)||||||
1308900|NCT03480386|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomization will be stratified by whether the participant has poor lung function (forced expiratory volume [FEV1] <50% predicted) and whether the participant has severe dyspnea (recorded modified Medical Research Council Dyspnea Scale [mMRC] score, 3-4; scale, 0-4); critical factors that can make the study arms unbalanced regarding risk factors.||||
1308901|NCT03480373|||Cohort||Prospective|||||||
1308902|NCT03480360||Single Group Assignment||Treatment||None (Open Label)||||||
1308903|NCT03480347|||Cohort||Prospective|||||||
1308904|NCT03480334||Single Group Assignment||Treatment||None (Open Label)||||||
1308905|NCT03480321|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1308906|NCT03480308|Randomized|Parallel Assignment||Treatment||Single|Randomization Will be Done Using Computer Generated Tables|"Patients will receive ultrasound guided paravertebral block and stratified into 3 groups according to medication used :~Group 1 : bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg Group 2 : bupivacaine (0.5%) 20 ml , dexamethasone 4 mg Group 2 : bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg , dexamethasone 4 mg"|||t|
1308907|NCT03480295|Randomized|Parallel Assignment||Treatment||Single|||||t|
1308908|NCT03480282||Single Group Assignment||Health Services Research||None (Open Label)||||||
1308909|NCT03480269|||Case-Only||Prospective|||||||
1308910|NCT03480256||Sequential Assignment||Treatment||None (Open Label)||||||
1308911|NCT03480243||Sequential Assignment||Basic Science||None (Open Label)||||||
1308912|NCT03480230||Single Group Assignment||Treatment||None (Open Label)||||||
1308913|NCT03480217|Randomized|Parallel Assignment||Health Services Research||Single|Outcomes assessors will be blinded to group assignment when coding medical records to determine whether providers ordered out-of-office BP testing for eligible patients.|||||t
1308914|NCT03480204|||Cohort||Prospective|||||||
1308915|NCT03480191||Single Group Assignment||Treatment||None (Open Label)||||||
1308916|NCT03480178|||Cohort||Prospective|||||||
1308917|NCT03480165|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308918|NCT03480152|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308919|NCT03480139|||Cohort||Prospective|||||||
1308920|NCT03480126|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1308921|NCT03480113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308922|NCT03480100|||Other||Prospective|||||||
1308923|NCT03480087|||Cohort||Prospective|||||||
1308924|NCT03480074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308925|NCT03480061|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1308926|NCT03480048|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308927|NCT03480035|||Other||Prospective|||||||
1308928|NCT03480022|Randomized|Parallel Assignment||Treatment||Quadruple|Double- Blind 2:1 Drug: Placebo||t|t|t|t
1308929|NCT03480009|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized Controlled Trial|t|t|t|t
1308930|NCT03479996|Randomized|Parallel Assignment||Treatment||Single|||t|||
1308931|NCT03479983|Randomized|Parallel Assignment||Treatment||Double||Parallel assignment|t||t|
1308932|NCT03479970|Non-Randomized|Crossover Assignment||Treatment||Single|||||t|
1308933|NCT03479957|Randomized|Parallel Assignment||Treatment||Single||||||t
1308934|NCT03479944|Randomized|Parallel Assignment||Treatment||Single||||||t
1308935|NCT03479931|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308936|NCT03479918|Randomized|Parallel Assignment||Treatment||None (Open Label)||Factorial Assignment||||
1308937|NCT03479905|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1308938|NCT03479892|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures||t|t|t|t
1308939|NCT03479879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308940|NCT03479866||Single Group Assignment||Basic Science||None (Open Label)||||||
1308941|NCT03479853|||Case-Control||Prospective|||||||
1308942|NCT03479840|||Cohort||Retrospective|||||||
1308943|NCT03479827||Single Group Assignment||Basic Science||None (Open Label)||||||
1308944|NCT03479814||Single Group Assignment||Treatment||None (Open Label)||||||
1308945|NCT03479801|||Case-Control||Prospective|||||||
1308946|NCT03479788|||Cohort||Prospective|||||||
1308947|NCT03479775|||Cohort||Prospective|||||||
1308948|NCT03479762|||Cohort||Retrospective|||||||
1308949|NCT03479749|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1308950|NCT03479736|||Other||Retrospective|||||||
1308951|NCT03479723|||Case-Only||Other|||||||
1308952|NCT03479710|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1308953|NCT03479697|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||This study will compare acoustic stimulation linked to brainwave activity (HIRREM, along with continued current care, HCC), with continued current clinical care alone (CCC). Both groups will continue their other current care throughout, including non-pharmacological, and lifestyle modification therapies. The participants in the CCC group will be offered the opportunity to crossover and receive a course of HCC.||||
1308954|NCT03479684|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308955|NCT03479671|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||Baseline insulin sensitivity will be measured in healthy volunteers, and then 1-3 weeks later insulin sensitivity will be measured in response to a low-dose fatty acid infusion. If there is no response to this low-dose infusion, then 1-3 weeks later insulin sensitivity will be measured in response to a medium-dose fatty acid infusion.||||
1308956|NCT03479658|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308957|NCT03479645|Randomized|Parallel Assignment||Screening||Single|||t|||
1308958|NCT03479632|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1308959|NCT03479619|Randomized|Parallel Assignment||Other||Single|||t|||
1308960|NCT03479606|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1308961|NCT03479593|||Case-Only||Prospective|||||||
1308962|NCT03479580|||Cohort||Prospective|||||||
1308963|NCT03479567|Non-Randomized|Parallel Assignment||Other||None (Open Label)||cross-sectional||||
1308964|NCT03479554|Randomized|Parallel Assignment||Treatment||Double|The study physicians and nurses will not be masked to patients' randomization assignments because of the different time points for initiating BP treatment between the two randomization groups. The data on BP will also be unmasked because they are management tools for attaining the specific treatment targets. However, the study neurologists and nurses who conduct the neurological and functional assessments and collect clinical outcome data at the baseline and follow-up examinations will be masked to patients' assignments. The members of the Outcome Adjudication Committee will also be masked to patients' randomization.|"Randomization will be conducted centrally at the SDCC. The randomization will be stratified by participating hospitals and use of antihypertensive medication. In each stratum, patients will be randomly assigned to the early antihypertensive treatment group or the delayed antihypertensive treatment group within each block. The block size will be random among 4, 6, and 8. The early BP lowering group will receive antihypertensive treatment immediately according to the study protocol, and the delayed BP lowering group will discontinue antihypertensive treatment for the first seven days after randomization.~The randomization schedules will be generated using SAS PROC PLAN in SAS and will be concealed at the SDCC. When an eligible participant is ready for randomization, the site investigator/study coordinator will log-in to a password-protected website to obtain the randomization assignment."|t|||t
1308965|NCT03479541|Randomized|Parallel Assignment||Treatment||Double|Single-blinded design.||||t|t
1308966|NCT03479528|||Case-Crossover||Cross-Sectional|||||||
1308967|NCT03479515|||Cohort||Prospective|||||||
1308968|NCT03479502|Randomized|Parallel Assignment||Treatment||Triple|Double Blind Masking|Patients meeting the inclusion criteria will be randomized into either the control group of intra-articular injection of 40mg Methylprednisolone once every 2 two weeks for 4 weeks (day 1, week 2, week 4) or the experimental group of intraarticular injection of 50 mg doxycycline once every 2 two weeks for 4 weeks (day 1, week 2, week 4), with 20 patients in each group. Injections will be administered by the treating physician. The Vanderbilt Investigational Pharmacy will provide the doxycycline and the steroid solutions and will be in charge of patient randomization.|t||t|t
1308969|NCT03479489||Single Group Assignment||Treatment||None (Open Label)||||||
1308970|NCT03479476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308971|NCT03479463|||Case-Control||Other|||||||
1308972|NCT03479450|||Cohort||Prospective|||||||
1308973|NCT03479437|||Other||Prospective|||||||
1308974|NCT03479424|||Cohort||Prospective|||||||
1308975|NCT03479411|Randomized|Sequential Assignment||Treatment||None (Open Label)||The study has 3 parts: 1) Single Ascending Dose Escalation and 2) Multiple Ascending Dose Escalation to be conducted in Normal Healthy Volunteers and 3) A two-period crossover study of single doses of PUR1900 and Sporanox in Adults with Asthma||||
1308976|NCT03479398|||Ecologic or Community||Prospective|||||||
1308977|NCT03479385|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1308978|NCT03479372|Randomized|Parallel Assignment||Treatment||Quadruple|Masking will be maintained by using a coded drug supply.||t|t|t|t
1308979|NCT03479359|||Cohort||Prospective|||||||
1308980|NCT03479346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308981|NCT03479333|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1308982|NCT03479320|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308983|NCT03479307|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1308984|NCT03479294|||Cohort||Prospective|||||||
1308985|NCT03479268||Single Group Assignment||Treatment||None (Open Label)||||||
1308986|NCT03479255|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective clinical trial that will randomize patients in 1:1 ratio to smartphone-enabled structured exercise therapy (SE-SET) vs. standard exercise therapy (usual care)||||
1308987|NCT03479242|||Cohort||Prospective|||||||
1308988|NCT03479229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1308989|NCT03479216|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1308990|NCT03479203||Single Group Assignment||Basic Science||None (Open Label)||||||
1308991|NCT03479190|Randomized|Parallel Assignment||Treatment||Quadruple||The trial will be a two arm single centre double blind randomised control trial. The study will include a two-way comparison between PRP and placebo normal saline injections for treating GTPS. Participants will be reviewed at baseline, 3, 6 and 12 with patient reported outcome measures (PROM) completed at each of these reviews.|t|t|t|t
1308992|NCT03479177|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1308993|NCT03479164||Single Group Assignment||Other||None (Open Label)||||||
1308994|NCT03479151||Single Group Assignment||Treatment||None (Open Label)||||||
1308995|NCT03479138|||Cohort||Prospective|||||||
1308996|NCT03479125|||Case-Only||Prospective|||||||
1308997|NCT03479112|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1308998|NCT03479099|||Cohort||Prospective|||||||
1308999|NCT03479086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309000|NCT03479073|||Cohort||Retrospective|||||||
1309001|NCT03479060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309002|NCT03479047||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309003|NCT03479034|||Cohort||Prospective|||||||
1309004|NCT03479021|||Cohort||Prospective|||||||
1309005|NCT03479008|||Case-Control||Prospective|||||||
1309006|NCT03478995||Sequential Assignment||Treatment||None (Open Label)||||||
1309007|NCT03478982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309008|NCT03478969|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1309009|NCT03478956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309010|NCT03478943|||Other||Prospective|||||||
1309134|NCT03477331|||Cohort||Prospective|||||||
1309135|NCT03477318|||Other||Prospective|||||||
1309136|NCT03477305||Single Group Assignment||Other||None (Open Label)||||||
1309137|NCT03477292|Randomized|Parallel Assignment||Treatment||Triple||Randomized trial|t||t|t
1309011|NCT03478930|Non-Randomized|Parallel Assignment||Treatment||Triple|Although this is an open-label study and all participants will be receiving omalizumab, in order to minimize bias in this study participants and the evaluating physicians will be blinded to treatment assignment of the previous studies (GA39688/GA39855) until all participants have either completed the study through the follow-up period (Week 76) or discontinued early from the study, the database is locked, and the study analyses are final.||t||t|t
1309012|NCT03478917|||Cohort||Retrospective|||||||
1309013|NCT03478904|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1309014|NCT03478891|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1309015|NCT03478878||Single Group Assignment||Other||None (Open Label)||||||
1309016|NCT03478865||Single Group Assignment||Other||None (Open Label)||||||
1309017|NCT03478852|||Case-Control||Prospective|||||||
1309018|NCT03478839|||Cohort||Prospective|||||||
1309019|NCT03478826|||Other||Retrospective|||||||
1309020|NCT03478813|Randomized|Parallel Assignment||Treatment||None (Open Label)||A parallel randomized trial conducted in 9 Child welfare clinics in one City in southern Finland. The study subjects are randomly allocated into intervention and control groups.||||
1309021|NCT03478800||Single Group Assignment||Treatment||None (Open Label)||||||
1309022|NCT03478787|Randomized|Parallel Assignment||Treatment||Single||||||t
1309023|NCT03478774|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded as they receive general anesthesia. Care providers cannot be blinded, due to obvious differences in set-up of the different interventions.|single centre, prospective, randomized-controlled trial|t|||
1309024|NCT03478761|||Cohort||Other|||||||
1309025|NCT03478748|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|Both investigators and participants knew about the intervention and who were involved.|The model is an oral health education package that covers the following aspects: (i) cognitive component (for example, the provision of basic oral health knowledge using an anticipatory guidance technique); (ii) psychomotor component (for example, the demonstration of basic oral health skills such as toothbrushing skills with a hands-on practical); and (iii) attitude component (activities that help to improve the children's attitude towards oral health). Children (along with their older siblings and mothers) in the study group were required to make six-monthly visits to the dental clinic in the three-year study period. Those in the control group received the conventional Ministry of Health programme.||||
1309026|NCT03478735|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309027|NCT03478722|||Cohort||Cross-Sectional|||||||
1309028|NCT03478709|||Case-Control||Prospective|||||||
1309029|NCT03478696|Randomized|Parallel Assignment||Treatment||Double|This is a phase 4 double blind study, which will use a triple dummy design for dosing.|This is a parallel group study. Eligible subjects will be randomized in a ratio of 1:1 to receive either FF/UMEC /VI single inhaler triple therapy or multiple inhaler triple combination therapy (budesonide/formoterol plus tiotropium) during the treatment period.|t||t|
1309030|NCT03478683|Randomized|Parallel Assignment||Treatment||Double|This is a phase 4 double blind study, which will use a triple dummy design for dosing.|This is a parallel group study. Eligible subjects will be randomized in a ratio of 1:1 to receive either FF/UMEC/VI single inhaler triple therapy or multiple inhaler triple combination therapy (budesonide/formoterol plus tiotropium) during the treatment period.|t||t|
1309031|NCT03478670|||Cohort||Prospective|||||||
1309032|NCT03478657||Single Group Assignment||Treatment||None (Open Label)||Subjects from the age group of 5 to 11 years with documented history of symptoms of asthma or diagnosis of asthma for at least 6 months prior to Visit 1 will be assessed for the ease of use of ELLIPTA DPI.||||
1309033|NCT03478644|Randomized|Parallel Assignment||Device Feasibility||Double|The dental examiner and dermatologist blinded for both treatment arms.||||t|t
1309034|NCT03478631|Randomized|Parallel Assignment||Treatment||Quadruple|Participants and study coordinators will be blinded to the nature of the treatment allocation. Stratified randomization lists by baseline sex and age will be created.|The study will be a randomized, double-blind, controlled parallel study. There will be two experimental arms of 16-week duration, in which participants are assigned to test or control arms under free living conditions in an outpatient setting.|t|t|t|t
1309035|NCT03478618|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1309036|NCT03478605|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase II randomized trial||||
1309037|NCT03478592|Randomized|Parallel Assignment||Treatment||Single|||||t|
1309038|NCT03478579|||Cohort||Prospective|||||||
1309039|NCT03478566||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309040|NCT03478553|||Family-Based||Prospective|||||||
1309041|NCT03478540|||Cohort||Prospective|||||||
1309042|NCT03478527|Randomized|Parallel Assignment||Basic Science||Double|double blind|"1 Verum group, receiving the probiotic Vivomixx® powder~1 Placebo group, receiving a placebo powder (similar taste and consistency as Vivomixx® powder)"|t||t|
1309043|NCT03478514||Single Group Assignment||Treatment||None (Open Label)||The proposed study is a single-arm, multi-center, open-label phase II study of the combination of palbociclib and ibrutinib in patients with previously treated mantle cell lymphoma.||||
1309044|NCT03478501|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1309045|NCT03478488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309046|NCT03478475|Randomized|Parallel Assignment||Prevention||Quadruple|Neither the investigator nor the subjects were aware of the group allocation; the pharmacist (in charge of the placebo tablets as well as the packing and coding of the supplements) was the only person to know to which group each participant belonged.|This was a randomized, controlled, double blind study. Participants were randomized into 2 groups; the vitamin D group received three times per week a supplement of 10,000 IU cholecalciferol (Euro-Pharm International, Canada) and the placebo group who also received three times per week a tablet containing microcrystalline cellulose (66.3%), starch (33.2%), and magnesium stearate (0.5%), per serving. The treatment was led for a period of 6 months.|t|t|t|t
1309047|NCT03478462||Single Group Assignment||Treatment||None (Open Label)||||||
1309048|NCT03478449|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1309049|NCT03478436|Randomized|Parallel Assignment||Other||None (Open Label)||parallel groups to compare outcomes between fed and fasting conditions||||
1309050|NCT03478423|Randomized|Parallel Assignment||Treatment||Quadruple|Pharmacy will prepare study drugs in opaque vials with identical labels based on a randomization scheme provided by the trial methodologist. The opaque vials will be included in sealed, sequentially numbered study packets that will be replaced as they are used. To avoid potential patient selection and allocation bias, all physicians, nurses, RAs and patients will be blinded to the randomization schedule. Study investigators will be permitted to un-blind the study medication in the event of allergic reaction, consisting of rash and/or airway compromise.||t|t|t|t
1309051|NCT03478410|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Comparative study between patients with and without atrial fibrillation||||
1309052|NCT03478397|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309053|NCT03478384|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Parallel Assignment of patients to two groups (group A: patients receive self-efficacy coaching, group B: patients do not receive additional coaching)||||
1309054|NCT03478371|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1309055|NCT03478358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309056|NCT03478345||Single Group Assignment||Treatment||None (Open Label)||||||
1309057|NCT03478332|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309058|NCT03478319|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1309059|NCT03478306|Randomized|Crossover Assignment||Treatment||Quadruple|Melatonin and placebo tablets are identicle in terms of taste, colour, tablet-size etc. The tablets are packed and masked by external manufacturer.|A Double-blind, randomized, placebo-controlled trial|t|t|t|t
1309060|NCT03478293||Single Group Assignment||Treatment||None (Open Label)|Single (Outcomes Assessor)|||||
1309061|NCT03478280|Randomized|Parallel Assignment||Treatment||Triple||A randomised, double-blind, placebo-controlled, trial|t||t|t
1309062|NCT03478267|||Cohort||Prospective|||||||
1309063|NCT03478254|||Cohort||Cross-Sectional|||||||
1309064|NCT03478241|Randomized|Parallel Assignment||Screening||Single|the patient did not know which shaping system was used on them|after each group has been treated with their respective Ni-Ti root canal shaping system, post operative pain was assessed at 6, 12, 18, 24, 48, and 72 h; 7 days; and 1 month.|t|||
1309065|NCT03478228|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1309066|NCT03478215|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1309067|NCT03478202||Single Group Assignment||Basic Science||None (Open Label)||||||
1309068|NCT03478189|||Cohort||Prospective|||||||
1309069|NCT03478176|||Cohort||Prospective|||||||
1309070|NCT03478163|Randomized|Parallel Assignment||Prevention||None (Open Label)||Open label, randomized controlled trial||||
1309071|NCT03478150|Randomized|Parallel Assignment||Prevention||Single|"the examiner who will carry the microbiological analysis of dentin samples will be blinded to the type of agent applied during treatment. Finally, the treatment results will be assessed blindly by a statistician.~Blinding:~Blinding of the operator is not possible, because the natures of both interventions are obviously different. The operator is blinded until randomization into groups, to avoid biases with regard to the application of antibacterial agent. Also, the examiner who will carry the microbiological analysis of dentin samples will be blinded to the type of agent applied during treatment. Finally, the treatment results will be assessed blindly by a statistician also to avoid the risk of bias of results in favor of one intervention over the other."|||||t
1309072|NCT03478137|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309073|NCT03478124|||Cohort||Other|||||||
1309074|NCT03478111|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1309075|NCT03478098|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1309076|NCT03478085|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309077|NCT03478072|||Case-Only||Prospective|||||||
1309078|NCT03478059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309079|NCT03478046||Single Group Assignment||Basic Science||None (Open Label)||||||
1309080|NCT03478033|Randomized|Parallel Assignment||Treatment||Single||Participates are assigned to one of two groups in parallel for the duration of the study.||||t
1309081|NCT03478020||Sequential Assignment||Treatment||None (Open Label)||||||
1309082|NCT03478007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309083|NCT03477994|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1309084|NCT03477981||Sequential Assignment||Other||None (Open Label)||Participants will consume their habitual diet with standard white bread for two week, then will be given the alginate bread for two weeks.||||
1309085|NCT03477968|||Cohort||Prospective|||||||
1309086|NCT03477955|Randomized|Parallel Assignment||Prevention||Single|||||t|
1309087|NCT03477942|Non-Randomized|Parallel Assignment||Treatment||Single||Prospective, single-center phase I pilot study to evaluate the safety and tolerability of a single intra-articular injection of autologous bone marrow-derived MSCs in 16 subjects, 8 who have knee osteoarthritis and 8 who have a focal chondral defect in the knee.|t|||
1309088|NCT03477929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309089|NCT03477916|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1309090|NCT03477903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309091|NCT03477890|Randomized|Parallel Assignment||Diagnostic||Single|Participants are randomised to a 'Disclosed group' (Intervention group) or a 'Not disclosed group' (Standard Care). In the standard care group, coronary function parameters are measured but the results are not disclosed to the attending clinician or the participant. Coronary function is measured in all participants.|Randomized, double-blind, parallel group, prospective|t|||
1309138|NCT03477279|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1309139|NCT03477266|Randomized|Parallel Assignment||Prevention||Triple|Color coded active tablets backed in red while identical dummy tablets coded in blue,both tablets are physically identical and usually no anticipated noticed side effects from mosapride||t|t||t
1309140|NCT03477253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309141|NCT03477240|||Case-Only||Cross-Sectional|||||||
1309142|NCT03477227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309092|NCT03477877|Randomized|Parallel Assignment||Prevention||None (Open Label)||"This is a community randomised controlled trial, randomized at the level of sector (Rwandan geographic administrative units are: Province > District > Sector > Cell > Village). 28 sectors spread across 7 districts are participating; randomisation as intervention or control was stratified across districts to ensure adequate geographical spread of program delivery. Within each randomised sector are two separate assessments of impact: (1) A Couple Cohort comprised of heterosexual couples who enrol together in a couples training program or similarly situated couples in control communities, surveyed at enrolment, 12 months post-baseline, and 24 months post-baseline. (2) A Community Survey designed to measure community diffusion which comprises a repeat cross-sectional population-based household survey of married/cohabiting adults in intervention/control communities who are NOT direct participants in the couples cohort, surveyed at baseline and 24 months."||||
1309093|NCT03477864|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1309094|NCT03477851|Randomized|Parallel Assignment||Treatment||Single|Trained care provider (nurse) prepares the active drug or placebo directly before the procedure according to randomisation list (secured).|Randomized, double blinded two-arm parallel assignment||t||
1309095|NCT03477838||Single Group Assignment||Treatment||None (Open Label)||||||
1309096|NCT03477825|Randomized|Parallel Assignment||Other||Quadruple|Double blinded|Thirty (30) subjects meeting the inclusion criteria without any of the exclusion criteria will be enrolled in this study. This study will be a double blinded study. Each subject will be randomized a priori to receive either placebo, Rubia cordifolia, or Triphala tablets.|t|t|t|t
1309097|NCT03477812|||Case-Control||Prospective|||||||
1309098|NCT03477799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309099|NCT03477786|Randomized|Parallel Assignment||Prevention||Single|||t|||
1309100|NCT03477773|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Pilot, exploratory, randomized controlled trial||||
1309101|NCT03477760|||Ecologic or Community||Prospective|||||||
1309102|NCT03477747|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind (Subject, Investigator)|Double-blind randomise controlled trial|t|t|t|t
1309103|NCT03477734|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||Males and females, 50 of them diagnosed with atrial fibrillation (AF), and 50 healthy participants, at least 30% of each gender in each group.||||
1309104|NCT03477721|||Case-Control||Prospective|||||||
1309105|NCT03477708|||Case-Control||Prospective|||||||
1309106|NCT03477695||Single Group Assignment||Treatment||None (Open Label)||||||
1309107|NCT03477682|Randomized|Parallel Assignment||Treatment||Single|The plastic surgeon who performs the sartorius flap does not know which group the patient will be randomized to (early ambulation versus standard 5 days bedrest) until after the surgery is completed.|||t||
1309108|NCT03477669|Randomized|Parallel Assignment||Treatment||Triple|Double-blinded|The study will be performed as a 4 week, placebo controlled, pilot trial with a one week run in period. Thirty subjects will be randomly assigned to each group for a total enrollment of 60 infants.|t|t|t|
1309109|NCT03477656|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309110|NCT03477643|||Case-Only||Retrospective|||||||
1309111|NCT03477630|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open, cohort, prospective study with a comparison group, randomized and one year follow-up.||||
1309112|NCT03477617|Randomized|Parallel Assignment||Treatment||Double||"Parallel Assignment Participants are randomized to two groups; both groups will have an intraoperative minimally invasive cardiac output monitor connected.~In the intervention arm, the anesthesiologist will treat episodes of hypotension using a hemodynamic algorithm based on the information for the cardiac output monitor.~In the control arm, the anesthesiologist will treat episodes of hypotension using standard of care management and will be blinded to the information from the cardiac output monitor. Data from the monitor will be stored for comparison between the arms.~This is a pilot study; therefore, the main objective is to assess feasibility of a future multicenter RCT, based on the following domains: (i) participation rate among eligible patients; (ii) practicality of implementing the study intervention in a clinical setting; (iii) collect descriptive data for differences between the 2 arms; (iv) collect safety data to ensure no harm has resulted from the study protocol"|t|||t
1309113|NCT03477604||Single Group Assignment||Treatment||None (Open Label)||||||
1309114|NCT03477591|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1309115|NCT03477578|||Case-Control||Other|||||||
1309116|NCT03477565|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1309117|NCT03477552|Randomized|Parallel Assignment||Other||None (Open Label)||Adult sickle cell patients who need of a new peripheral intravenous catheter placement (for fluid or porphine therapy) will be randomized between two arms : usual technique or use of the AccuveinV400® device). The randomization list (ratio 1: 1) will be made by the statistician of the study using the SAS software and balanced by random blocks of small size (2, 4, 6) to make it unpredictable. The randomization will be stratified on the center and the number of hospitalizations in the previous year (>3, <3).||||
1309118|NCT03477539||Single Group Assignment||Treatment||None (Open Label)||||||
1309119|NCT03477526|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1309120|NCT03477513||Single Group Assignment||Treatment||None (Open Label)||||||
1309121|NCT03477500|Randomized|Parallel Assignment||Treatment||Single||||||t
1309122|NCT03477487|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Ascending dose-ranging study||||
1309123|NCT03477474|||Cohort||Prospective|||||||
1309124|NCT03477461|||Other||Retrospective|||||||
1309125|NCT03477448|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1309126|NCT03477435|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Type 1 hybrid effectiveness/implementation study to evaluate two population-based approaches||||
1309127|NCT03477422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309128|NCT03477409|||Cohort||Cross-Sectional|||||||
1309129|NCT03477396||Single Group Assignment||Treatment||None (Open Label)||||||
1309130|NCT03477383|||Cohort||Prospective|||||||
1309131|NCT03477370||||||||||||
1309132|NCT03477357|||Other||Cross-Sectional|||||||
1309133|NCT03477344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309143|NCT03477214|||Cohort||Cross-Sectional|||||||
1309144|NCT03477201|Randomized|Parallel Assignment||Prevention||Single|Patients will be randomized into two groups either laparoscopic or robotic assisted arm.|The investigators plan to conduct a prospective, randomized controlled trial of patients undergoing elective laparoscopic or robotic unilateral inguinal hernia repair. Patients will be randomized into two groups, with one group undergoing laparoscopic transabdominal preperitoneal (TAPP) technique and a second group undergoing robotic inguinal hernia repair (TAPP technique) with the Xi DaVinci System (Intuitive, Sunnyvale, CA). The monopolar instrument will deliver via standard instruments on 30W coagulation mode (ForceTriad electrosurgical generator, Covidien, Boulder, CO). At the completion of the procedure, skin biopsies will be taken at each of the three port incisions. These samples will be examined for visual and histologic evidence of thermal injury by a blinded pathologist.|t|||
1309145|NCT03477188|Randomized|Parallel Assignment||Treatment||Single|Participants didn't know taking which exercise treatment methods.|Experimental, Randomized Controlled Study|t|||
1309146|NCT03477175|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309147|NCT03477162||Single Group Assignment||Basic Science||None (Open Label)||||||
1309148|NCT03477149||Single Group Assignment||Treatment||None (Open Label)||French multicenter, phase 2b (device), prospective study||||
1309149|NCT03477136|||Cohort||Prospective|||||||
1309150|NCT03477123|Randomized|Parallel Assignment||Treatment||Single|The evaluator does not have information on the group the patient was enrolled.|||||t
1309151|NCT03477110||Single Group Assignment||Treatment||None (Open Label)||||||
1309152|NCT03477097|Randomized|Factorial Assignment||Prevention||Single|||t|||
1309153|NCT03477084|||Cohort||Prospective|||||||
1309154|NCT03477071|||Cohort||Retrospective|||||||
1309155|NCT03477058||Single Group Assignment||Treatment||None (Open Label)||||||
1309156|NCT03477045|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1309157|NCT03477032|||Cohort||Prospective|||||||
1309158|NCT03477019|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two liver metastases in every patient are preselected on baseline computer tomography. These will be randomized to either 1) target lesion to be treated or 2) control lesion. Difference in response (pre- and post-treatment measure) between treated lesions and control lesions will be the primary outcome of the trial.||||
1309159|NCT03477006|Randomized|Parallel Assignment||Treatment||Single||||||t
1309160|NCT03476993||Single Group Assignment||Treatment||None (Open Label)||||||
1309161|NCT03476980|Randomized|Parallel Assignment||Diagnostic||Quadruple|Neurodevelopmental providers will be blinded to the randomization of the toddler during the examination.|Neurodevelopmental assessments will be done at 2 years of corrected age (22-26 months) for subjects who were randomized at birth to receive either delayed cord clamping or umbilical cord milking as part of the PREMOD2 trial.|t|t|t|t
1309162|NCT03476967|||Cohort||Prospective|||||||
1309163|NCT03476954||Single Group Assignment||Other||None (Open Label)||||||
1309164|NCT03476941|Randomized|Parallel Assignment||Treatment||Single|Written consent will be obtained from all participants. Then, each participant will be randomized into two arms. Nurse will administer the drain flush either with normal saline or antibiotic irrigation.|There will be two group, study and control group. In control group, patient will receive standard intra-abdominal drain care with daily flushing of the drain with normal saline. In study group, patient will receive daily flush with antibiotic for 7 days.|t|||
1309165|NCT03476928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309166|NCT03476915|||Cohort||Cross-Sectional|||||||
1309167|NCT03476902||Single Group Assignment||Treatment||None (Open Label)||||||
1309168|NCT03476889|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1309169|NCT03476876|Randomized|Parallel Assignment||Treatment||Single|Both of acellular dermal matrices are considered as a standard of care for deep wound. The subject will be unaware of type of matrices.|The investigators will randomize using 1-1 ratio and based on wound cases. In the case that a subject had two eligible wound cases, the randomization will be done to have similar probably for the wound location (e.g. forefoot, mid-foot, hind-foot, etc). If an eligible subject had more than two wounds, only one of them will be considered as an intervention and only one of them as a control case.|t|||
1309170|NCT03476863|Randomized|Parallel Assignment||Treatment||Single|||||t|
1309171|NCT03476850|Randomized|Parallel Assignment||Treatment||Triple|Prospective randomized double-blinded trial to compare TAP block versus QL block for pain management in living donor nephrectomy patients. Participants will be blinded to the type of block received and physicians will be blinded both intra- and post-op regarding which block patients received. The team who performs the block will know which block the patient received. No one else involved in the care of the patient will know. The surgery team will not know, and the primary (in the OR) anesthesia team will not know. None of the providers involved in post-operative care of the patient will know.||t|t||t
1309172|NCT03476837|Randomized|Parallel Assignment||Prevention||Single|The recruiter will not know the client allocation. The CHW will not know who the women are in the control group.|Participants will be randomized into two groups based on the baseline assessment of CS policy (no policy/partial policy). WCGs in the treatment group will receive a three-session dose at 1, 3, and 6 months. During each treatment group session, the CHW will provide the tobacco biofeedback, motivational interviewing and educational materials at the end of the session. WCGs in the control group will receive by mail the same series of educational materials received by the treatment group at 1, 3 and 6 months. Survey and other assessments will be collected at baseline, 1, 3, 6, and 12 months.||t||
1309173|NCT03476824|||Cohort||Retrospective|||||||
1309174|NCT03476811|Randomized|Parallel Assignment||Treatment||Triple||This trial is a comparative trial investigating outcomes in 3 parallel groups. The control group will receive standard of care pain control following surgery, the Marcaine group will receive infusion of FDA approved Marcaine around the operative site following surgery through an FDA approved surgical device. The Placebo group will have the drug delivery device implanted with delivery of saline.|t||t|t
1309175|NCT03476798||Single Group Assignment||Treatment||None (Open Label)||||||
1309176|NCT03476785|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor will be blinded to subject randomization.|Parallel Assignment||||t
1309177|NCT03476772|||Case-Control||Prospective|||||||
1573381|NCT00001431||||Treatment||||||||
1309178|NCT03476759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309179|NCT03476746|Randomized|Single Group Assignment||Other||None (Open Label)||A single application of LEO 90100 foam and Dovobet® ointment will be applied to multiple test sites on the innerside of both arms of trial subjects. The trial consists of 2 parts. The first part, (pilot part) will evaluate the pharmacokinetic profile of LEO 90100 foam and Dovobet® ointment by measuring the amount of each of the active ingredients in the stratum corneum and determine conditions for the second part of the trial. The second part (pivotal part) will compare the amount of each of the active ingredients at steady state or close-to-steady state between LEO 90100 foam and Dovobet® ointment. The sample size and the number of application sites in the pivotal part will be determined based on the results of the pilot part.||||
1309180|NCT03476733|||Cohort||Prospective|||||||
1309181|NCT03476720|||Cohort||Prospective|||||||
1309182|NCT03476707|||Cohort||Prospective|||||||
1309183|NCT03476694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309184|NCT03476681||Single Group Assignment||Treatment||None (Open Label)||NEO-201 will be given in four increasing doses, it will start at a low dose (1 mg/kg) and be increased 3 times (2, 4, 6 mg/kg) over the period of the study in 4 different groups of patients. Each group will enroll 3-6 patients to a maximum of 24 patients.||||
1309185|NCT03476668|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309186|NCT03476655|||Cohort||Retrospective|||||||
1309187|NCT03476642|Randomized|Parallel Assignment||Basic Science||Quadruple||This will be a randomized,double blinded, controlled study.|t|t|t|t
1309188|NCT03476629|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1309189|NCT03476616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309190|NCT03476603|||Case-Only||Prospective|||||||
1309191|NCT03476590|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective, randomized (1:1), open-label and controlled, parallel group study||||
1309192|NCT03476577|||Case-Only||Prospective|||||||
1309193|NCT03476564|Randomized|Parallel Assignment||Supportive Care||Single|Computer generated random number table will be used for randomization. Group assignments will be placed in sealed opaque sequentially numbered envelopes|Endometrial thickness will be measured on the day of the HCG prescription in both groups by one of the two attending physicians. Chemical pregnancy will be detected by serum beta-hCG analysis 14 days after embryo transfer and transvaginal ultrasound scan will be scheduled 2 weeks later to confirm the diagnosis of clinical pregnancy. The intervention group will receive pentoxifylline (Trental S.R.) 400 mg/BD plus vit E (PHARCO) 400 mg/BD 2 cycles before starting ICSI cycle and the medication will be continued until the beta-hCG becomes positive or the cycle is cancelled. The comparison group will not receive the above drugs. The main outcome measure will be clinical pregnancy rate.|t|||
1309194|NCT03476551|||Case-Only||Prospective|||||||
1309195|NCT03476538|||Case-Only||Prospective|||||||
1309196|NCT03476525|||Case-Only||Prospective|||||||
1309197|NCT03476512|||Other||Cross-Sectional|||||||
1309198|NCT03476499||Single Group Assignment||Other||None (Open Label)|The physician taking the images will be blinded to the images until the end of the study.|"KENT CAMERA MULTISPECTRAL IMAGING DEVICE Health Canada Medical device Licence: 99281 First Issue Date: 2017/06/07 Device class 2 Handheld near infrared multispectral imaging device with custom software. A new commercially available imaging technology uses NIR spectroscopy to measure regional tissue hemoglobin oxygenation, StO2. These images are processed to produce a colour coded StO2 image of a large tissue area (~6 by 4). Since the image device doesn't contact the skin the depth of measurement is ~2mm instead of ~10mm with a point system. Compared to dye based angiography methods, StO2 NIR imaging does not require the injection of a dye. The advantage of the NIR imaging device over point NIR systems is a lack of patient contact. Thus StO2 NIR imaging is completely non-invasive, non-contact. Images can be captured and displayed in less than 5 seconds therefore imaging can be repeated as needed with no risk to the patient and no cost for disposables."||||
1309199|NCT03476486|Non-Randomized|Parallel Assignment||Treatment||Single|single blind masking (assessor)|controlled interventional clinical trial||||t
1309200|NCT03476473|||Cohort||Cross-Sectional|||||||
1309201|NCT03476460|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309202|NCT03476447|Randomized|Parallel Assignment||Basic Science||Triple|Participants, investigators and data evaluators will be blinded to the treatment assignments.|Subjects will be enrolled and randomized 1:1:1:1 to the following treatment arms (daily dose of B. infantis EVC001): high dose, medium dose, low dose, and placebo.|t||t|t
1309203|NCT03476434|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Patients are randomized into two groups with tandem explorations: in the group A or white light group (HR-WLE) where inspection is performed with white light in both colonoscopies, and in the group B or chromoendoscopy group (HR-CE) where a first inspection is performed with white light and the second with panchromoendoscopy with indigo carmine.||||
1309204|NCT03476421|||Cohort||Prospective|||||||
1309205|NCT03476408||Single Group Assignment||Health Services Research||None (Open Label)||||||
1309206|NCT03476395|||Other||Cross-Sectional|||||||
1309207|NCT03476382||Single Group Assignment||Treatment||None (Open Label)||||||
1309208|NCT03476369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309251|NCT03475810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309252|NCT03475797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309253|NCT03475784|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1309254|NCT03475771|||Cohort||Retrospective|||||||
1309255|NCT03475758|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309256|NCT03475745|||Cohort||Prospective|||||||
1309257|NCT03475732||Single Group Assignment||Treatment||None (Open Label)||100mL XueBiJing injection (dissolved with 100 mL of 0.9% normal saline),intravenous infusion for 1.25 h, q12h for 5 days||||
1309258|NCT03475719|Randomized|Crossover Assignment||Treatment||None (Open Label)||A randomized, open-label, single-dose, two-treatment, two-sequence, two-way crossover study||||
1309309|NCT03475056|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||Dose escalation||||
1309310|NCT03475043|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Experimental group Active control group||||
1309209|NCT03476356|Randomized|Parallel Assignment||Treatment||Double|One hundred and six opaque envelopes will be numbered serially and, in each envelope, there will be the corresponding letter which denotes the allocated group according to the randomization table. Then all of the envelopes will be closed and they will be placed in one box. When the first woman arrives, the first envelope will be opened and she will be allocated according to the letter inside, and this step will be repeated until the 106 envelopes are finished.|"A total of 106 women with the diagnosis of PCOS based on the European Society of Human Reproduction and Embryology/ American Society for Reproductive Medicine (ESHRE/ASRM) guidelines criteria (Rotterdam Criteria, 2003) will be randomly assigned using a computer-generated randomization sheet and they will be distributed into two groups:~Group L (53 patients):~This group will receive oral clomiphene citrate (Clomid, Global Napi Pharmaceuticals (GNP), Egypt) (50 mg tablet, two times per day) from the third day of the cycle until the seventh day of the cycle plus oral carnitine supplementation (Carnivita Forte, Eva Pharma, Egypt) (1g tablet, three times per day) from the third day of the cycle until the day of the pregnancy test.~Group C (53 patients):~This group will receive oral clomiphene citrate only (Clomid, Global Napi Pharmaceuticals (GNP), Egypt) (50 mg tablet, two times per day) from the third day of the cycle until the seventh day of the cycle."|t|t||
1309210|NCT03476343||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309211|NCT03476330||Single Group Assignment||Prevention||None (Open Label)||||||
1309212|NCT03476317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309213|NCT03476304|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309214|NCT03476291|||Other||Cross-Sectional|||||||
1309215|NCT03476278|||Cohort||Prospective|||||||
1309216|NCT03476265||Single Group Assignment||Treatment||None (Open Label)||||||
1309217|NCT03476252||Single Group Assignment||Diagnostic||None (Open Label)||Stemi group undergoing primary pci||||
1309218|NCT03476239||Single Group Assignment||Treatment||None (Open Label)||"Evaluate the efficacy and safety of blinatumomab in Chinese subjects with relapsed/refractory B-precursor ALL, The study will consist of a screening period, a treatment period, and a follow-up period.~Treatment will consist of up to 5 cycles of blinatumomab"||||
1309219|NCT03476226|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309220|NCT03476213|Randomized|Parallel Assignment||Prevention||Triple||Group A will be anesthetized using TIVA, group B using TCI|t|t||t
1309221|NCT03476200|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1309222|NCT03476187||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309223|NCT03476174||Single Group Assignment||Treatment||None (Open Label)||||||
1309224|NCT03476161|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1309225|NCT03476148|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1309226|NCT03476135||Single Group Assignment||Prevention||None (Open Label)||||||
1309227|NCT03476122|||Cohort||Prospective|||||||
1309228|NCT03476109|Randomized|Factorial Assignment||Treatment||Single|The analysis of the response rate and magnitude, as well as of biomakers predicting the response, will be performed by an independent assessor and a biostatistician.|Severe asthma patients who are eligible to both anti-IgE (omalizumab) and anti-IL-5 (mepolizumab) therapies, will be randomized to decide the first treatment to start. Patients will then be prolonged or switched to the other according to the clinical response. There will be 5 possibilities: oma(lizumab) group, mepo(lizumab) group, oma-mepo switch, mepo-oma switch, and oma/mepo failure.||||t
1309229|NCT03476096|||Case-Only||Prospective|||||||
1309230|NCT03476083|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309231|NCT03476070|||Cohort||Prospective|||||||
1309232|NCT03476057|||Cohort||Prospective|||||||
1309233|NCT03476044|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1309234|NCT03476031|||Case-Crossover||Cross-Sectional|||||||
1309235|NCT03476018|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1309236|NCT03476005|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||Incidence of wrong blood in tube in interns provided with proficiency based progression training supported by technology enhanced learning in 2017 will be compared with historical controls from the same period in 2016||||
1309237|NCT03475992|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"The study is performed on 3 groups of patients:~Group 1: 15 patients with pre-diagnosed breast cancer (core needle biopsy performed at least 2 weeks before the microwave breast investigation).~Group 2: 10 patients with breast cyst. No prior biopsy~Group 3: 5 patients with pre-diagnosed benign lesion (core needle biopsy performed at least 2 weeks before the microwave breast investigation)."||||
1309238|NCT03475979|||Cohort||Prospective|||||||
1309239|NCT03475966|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1309240|NCT03475953|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a multicenter, prospective open-labeled phase Ib trial based on a dose escalation study design (3+3 traditional design) assessing three dose levels of Regorafenib given in combination with Avelumab (no dose escalation for Avelumab) in patients with advanced digestive solid tumors followed by a phase II trial to evaluate the association of Regorafenib at the RP2D with Avelumab in 4 cohorts of advanced or metastatic tumors.||||
1309241|NCT03475940|||Cohort||Retrospective|||||||
1309242|NCT03475927|||Ecologic or Community||Cross-Sectional|||||||
1309243|NCT03475914|||Cohort||Other|||||||
1309244|NCT03475901||Single Group Assignment||Treatment||None (Open Label)||||||
1309245|NCT03475888|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Single center three-arm pilot study of patients with CTO.||||
1309246|NCT03475875|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1309247|NCT03475862|Randomized|Crossover Assignment||Other||Quadruple|Double-blind, double-dummy|4-way single-dose crossover with an exploratory 5th treatment arm|t|t|t|t
1309248|NCT03475849|||Case-Control||Cross-Sectional|||||||
1309249|NCT03475836|Randomized|Crossover Assignment||Other||Triple|Double blind. Treatments were prepared and coded by a third party researcher who had no further involvement with the study.|Randomised, placebo controlled, crossover|t||t|t
1309250|NCT03475823|Randomized|Parallel Assignment||Other||Triple|All treatment was prepared and randmised by a third-party researcher who had no further involvement in the study.||t||t|t
1573382|NCT00001428||||Treatment||||||||
1309259|NCT03475706|Randomized|Parallel Assignment||Treatment||Double|Sponsor representatives Site monitors Data managers Statisticians|This is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Eligible female subjects (N=406) with symptoms of overactive bladder for at least 6 months will enter a 14-day single-blind Run-in Period. Subjects (N=375) who meet prespecified criteria based on data entered into an electronic diary over 3 days will be randomized 1:1:1 (125 subjects per arm) to receive solabegron immediate release tablets, low dose or high dose, or matching placebo.|t||t|
1309260|NCT03475693|Randomized|Parallel Assignment||Treatment||Single|Patients will be assigned a 3 digit number given at random and treatment arm will be randomized to day of presentation with treatment determined by even or odd day of the month|Randomized, prospective, cohort study comparing two non-invasive treatments for Mild traumatic brain injury in patients ages 12-18 that present to the Lakeland Health Emergency departments in either St. Joseph, MI or Niles, MI.|t|||
1309261|NCT03475680|Randomized|Parallel Assignment||Prevention||Double|Double Blind : both participants and investigators are unaware of the intervention assignment||t||t|
1309262|NCT03475667|||Cohort||Prospective|||||||
1309263|NCT03475654|Randomized|Parallel Assignment||Prevention||None (Open Label)||prospective randomized controlled trial||||
1309264|NCT03475641|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1309265|NCT03475628||Single Group Assignment||Treatment||None (Open Label)||Single arm: Daratumumab||||
1309266|NCT03475615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309267|NCT03475602|||Cohort||Prospective|||||||
1309268|NCT03475589||Single Group Assignment||Other||None (Open Label)||||||
1309269|NCT03475576||Single Group Assignment||Supportive Care||None (Open Label)||before and after study||||
1309270|NCT03475563|||Case-Only||Prospective|||||||
1309271|NCT03475550|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1309272|NCT03475537||Single Group Assignment||Treatment||None (Open Label)||||||
1309273|NCT03475524|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309274|NCT03475511|||Case-Control||Prospective|||||||
1309275|NCT03475498|||Cohort||Prospective|||||||
1309276|NCT03475485|Randomized|Crossover Assignment||Device Feasibility||Triple|Capsules are identical in appearance. Only unblinded pharmacy personnel at the study site will be aware of the ingestion allocation of active ID-Capsules or placebo capsules.|This study is a prospective, blinded, clinical study evaluating the safety and effectiveness of the ID-Cap System under direct observation in the clinical setting. Subjects will ingest a series of active ID capsules containing ingestible sensors and a series of empty placebo capsules that will be randomly administered. The ID-Capsule System's feasibility/ability to properly record actual ingestions (Positive Detection Accuracy) and to not record blank ingestions (Negative Detection Accuracy) will be evaluated.|t||t|t
1309277|NCT03475472|||Cohort||Prospective|||||||
1309278|NCT03475459||Single Group Assignment||Treatment||None (Open Label)|This study is a single-arm, open label, dose escalation study. QT interval will be evaluated by blinding outcome assessor in this study.|||||
1309279|NCT03475446|Randomized|Parallel Assignment||Basic Science||Double|Double blind design|Participants are allocated to one of 3 groups: real tACS, real tDCS or sham. Each participant belongs also to a subpopulation with or without memory impairment (Healthy elderly, MCI, AD)|t||t|
1309280|NCT03475433|||Cohort||Prospective|||||||
1309281|NCT03475420|||Cohort||Retrospective|||||||
1309282|NCT03475407||Single Group Assignment||Treatment||None (Open Label)||||||
1309283|NCT03475394|Randomized|Parallel Assignment||Treatment||Single||||||t
1309284|NCT03475381|||Cohort||Retrospective|||||||
1309285|NCT03475368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309286|NCT03475355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309287|NCT03475342|Randomized|Parallel Assignment||Prevention||Quadruple|Masking was done by an independent clinical trials supply company. It will involve the removal of the original manufacturer's label and replacement with the clinical trial label bearing the randomisation number, which will be used as the pack identification. Apart from the randomisation number, all pack label texts will be identical for tranexamic acid and placebo.|A randomised, double blind, placebo controlled trial among 10,000 women with moderate or severe anaemia having given birth vaginally.|t|t|t|t
1309288|NCT03475329|||Case-Only||Prospective|||||||
1309289|NCT03475316|Randomized|Parallel Assignment||Prevention||Single|||t|||
1309290|NCT03475303||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309291|NCT03475290|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309292|NCT03475277|||Other||Other|||||||
1309293|NCT03475264|||Case-Control||Prospective|||||||
1309294|NCT03475251||Single Group Assignment||Treatment||None (Open Label)||||||
1309295|NCT03475238|||Cohort||Prospective|||||||
1309296|NCT03475225|Randomized|Parallel Assignment||Treatment||Triple|Double blind|Double blind|t|t|t|
1309297|NCT03475212||Single Group Assignment||Treatment||None (Open Label)||||||
1309298|NCT03475199|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Prospective, multicentric, controlled, national study||||
1309299|NCT03475186||Single Group Assignment||Supportive Care||None (Open Label)||||||
1309300|NCT03475173||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309301|NCT03475160|Randomized|Parallel Assignment||Treatment||Double||Sildenafil Citrate (SC) vaginal suppositories compared to Placebo vaginal suppositories.|t||t|
1309302|NCT03475147|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1309303|NCT03475134||Single Group Assignment||Treatment||None (Open Label)||||||
1309304|NCT03475121|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309305|NCT03475108|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized Controlled Trial||||
1309306|NCT03475095||Single Group Assignment||Basic Science||None (Open Label)||||||
1309307|NCT03475082|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled trial -double blind|t|||t
1309308|NCT03475069|Randomized|Parallel Assignment||Treatment||Single||||||t
1573383|NCT00001427||||Treatment||||||||
1309311|NCT03475030|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1309312|NCT03475017|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1309313|NCT03475004|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1309314|NCT03474991|Randomized|Parallel Assignment||Treatment||Quadruple||KIDS-STEP is a phase III strategic investigator-initiated, randomised, placebo-controlled, fully blinded multicentre superiority trial with two parallel groups|t|t|t|t
1309315|NCT03474978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309316|NCT03474965||Single Group Assignment||Treatment||None (Open Label)||||||
1309317|NCT03474952|Randomized|Parallel Assignment||Treatment||Quadruple||RIPC group and control (sham-RIPC) group|t|t|t|t
1309318|NCT03474939|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1309319|NCT03474926|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1309320|NCT03474913|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Patients will have both a standard MRI and an Upright MRI to image potential prostate lesions. The order of the MRIs will be random, and the second will be done within two weeks of the first.||||
1309321|NCT03474900|Randomized|Parallel Assignment||Treatment||None (Open Label)|The patient was informed about the treatment method that he or she was randomised. The operating surgeon knew the group and treatment that the patient belonged to.|The patients were randomised to 2 groups, titanium nailing or biodegradable nailing.||||
1309322|NCT03474887|||Cohort||Prospective|||||||
1309323|NCT03474874||||||||||||
1309324|NCT03474861||Single Group Assignment||Treatment||None (Open Label)||||||
1309325|NCT03474848|Randomized|Parallel Assignment||Treatment||Single||||||t
1309326|NCT03474835|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1309327|NCT03474822||Single Group Assignment||Treatment||None (Open Label)||||||
1309328|NCT03474809|||Cohort||Retrospective|||||||
1309329|NCT03474796|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309330|NCT03474783||Single Group Assignment||Health Services Research||None (Open Label)||||||
1309331|NCT03474770||Single Group Assignment||Treatment||None (Open Label)||||||
1309332|NCT03474757|||Cohort||Retrospective|||||||
1309333|NCT03474744||Single Group Assignment||Treatment||None (Open Label)||||||
1309334|NCT03474731|Randomized|Crossover Assignment||Treatment||None (Open Label)||Background and justification: Nearly 29 million Americans (9.3% of the population) have type 2 Diabetes Mellitus (T2DM) and another 86 million are considered prediabetic, 20-30% of whom will develop diabetes within five years.4,5 T2DM disproportionately affects those from lower socioeconomic status (SES) and rural backgrounds. Appalachian residents represent an extreme version of this already vulnerable population, with rates of diabetes 46% higher than national averages.6,7 We have developed, pilot tested (N=41) and refined (N=48 in-depth interviews, 4 focus groups with 31 participants, and 2 CAB meetings with 16 members), a culturally appropriate, feasible, and promising intervention that combines diabetes self-management education and tailored patient navigation intervention.||||
1309335|NCT03474718|Randomized|Parallel Assignment||Treatment||Double|Second offsite investigator will assess the patient for clinical improvement and will be unaware of the patient's randomization assignment.||t||t|
1309336|NCT03474705||Single Group Assignment||Treatment||None (Open Label)||||||
1309337|NCT03474692|||Case-Only||Other|||||||
1309338|NCT03474679||Single Group Assignment||Treatment||None (Open Label)||||||
1309339|NCT03474666|Randomized|Parallel Assignment||Treatment||None (Open Label)||Insulin initially as continuous infusion/subcutaneous for first 24-48 hours followed by subcutaneous administration once subjects eating until hospital discharge.||||
1309340|NCT03474653|||Cohort||Prospective|||||||
1309341|NCT03474640|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1309342|NCT03474627|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309343|NCT03474614|Randomized|Parallel Assignment||Other||None (Open Label)||Two groups, intervention and control||||
1309344|NCT03474601|||Cohort||Prospective|||||||
1309345|NCT03474588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309346|NCT03474575||Single Group Assignment||Prevention||None (Open Label)||Prospective and Biomedical Research excluding Health Product||||
1309347|NCT03474562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309348|NCT03474549||Single Group Assignment||Treatment||None (Open Label)||||||
1309349|NCT03474536|||Cohort||Retrospective|||||||
1309350|NCT03474523|Randomized|Parallel Assignment||Treatment||Double|external evaluator|Randomized controlled longitudinal experimental study|t|||t
1309351|NCT03474510|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1309352|NCT03474497||Single Group Assignment||Treatment||None (Open Label)||All patients will receive pembrolizumab and intralesional IL-2 in combination with hypofractionated radiotherapy.||||
1309353|NCT03474484|||Case-Only||Retrospective|||||||
1309354|NCT03474471|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1309355|NCT03474458|Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be an open-label parallel-group randomized (1:1) trial. Control patients receive standard supportive therapy.||||
1309356|NCT03474445|Randomized|Parallel Assignment||Treatment||Single|||t|||
1309357|NCT03474432||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309358|NCT03474419|||Cohort||Prospective|||||||
1309359|NCT03474406|||Cohort||Prospective|||||||
1309360|NCT03474393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309361|NCT03474380|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Stepped Wedge Cluster Randomized Trial (where clusters are VAMC sites) - a form of crossover design with unidirectional crossover (from control to experimental) but with randomization of when each VAMC site undertakes the transition. In the stepped wedge design, there is a staggered roll-out of the intervention, where the time and sequence of VAMC sites that will start the intervention at each period are determined by random allocation.||||
1309362|NCT03474367|||Cohort||Prospective|||||||
1309363|NCT03474354|||Cohort||Prospective|||||||
1309364|NCT03474341|||Cohort||Prospective|||||||
1309365|NCT03474328||Single Group Assignment||Supportive Care||None (Open Label)||||||
1309366|NCT03474315|||Cohort||Prospective|||||||
1309367|NCT03474302|Randomized|Parallel Assignment||Prevention||Single|Assessors will not know the group randomization of the participants.|The randomized controlled trial will assign insufficiently active African American adults aged 65-85 to an intervention or successful aging control group||||t
1309368|NCT03474289|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309369|NCT03474276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309370|NCT03474263||Single Group Assignment||Treatment||None (Open Label)||Open-label Biomarkers-Driven Study Historical controls||||
1309371|NCT03474250|||Case-Only||Prospective|||||||
1309372|NCT03474237|||Cohort||Prospective|||||||
1309373|NCT03474224|||Case-Only||Prospective|||||||
1309374|NCT03474211|||Cohort||Prospective|||||||
1309375|NCT03474198|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study uses a multi-arm, multi-stage (MAMS) parallel study design||||
1309376|NCT03474185|||Cohort||Prospective|||||||
1309377|NCT03474172|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1309378|NCT03474159||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309379|NCT03474146|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1309380|NCT03474133||Single Group Assignment||Treatment||None (Open Label)||||||
1309381|NCT03474120|||Cohort||Prospective|||||||
1309382|NCT03474107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309383|NCT03474094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309384|NCT03474081|Randomized|Parallel Assignment||Treatment||Double|This will be a double blind study. Subjects and investigator will be masked.|Subjects will be randomized 1:1 to receive either FF/UMEC/VI via ELLIPTA DPI along with placebo to match tiotropium or tiotropium via HANDIHALER along with placebo to match FF/UMEC/VI in the morning for 84 days.|t||t|
1309385|NCT03474068|||Cohort||Retrospective|||||||
1309386|NCT03474055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309387|NCT03474042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309388|NCT03474029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309389|NCT03474016|||Other||Other|||||||
1309390|NCT03474003|||Cohort||Prospective|||||||
1309391|NCT03473990|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1309392|NCT03473977|Randomized|Parallel Assignment||Treatment||Triple|The study is double blind. Randomization will be performed by external investigational pharmacy staff, which the dispenser of the drug/placebo at CCHMC.|Participants will receive 3 doses of drug or placebo. An optional OLE will also be available following the double blind period.|t|t|t|
1309393|NCT03473964|||Case-Only||Retrospective|||||||
1309394|NCT03473951|||Cohort||Retrospective|||||||
1309395|NCT03473938|||Case-Only||Retrospective|||||||
1309396|NCT03473925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309397|NCT03473912|||Cohort||Prospective|||||||
1309398|NCT03473899|Randomized|Parallel Assignment||Treatment||Double|"A medical assistant at the clinic of the Principal Investigator will allocate interventions by means of opaque sealed envelopes that will be marked according to the allocation schedule. The medical assistant will be unaware of the size of the blocks.~The randomized intervention assignment as outlined above will be concealed from both patients and health care staff until recruitment will be complete and irrevocable.~Patients will be blinded in this study. The assessor will be blinded in this study. The assessor is the person who will assess the outcome of treatment during follow up. In this study, the assessor will be a medical assistant at the clinic of the Principal Investigator.~The therapist will not be blinded in this study. The therapist is the person who will administer either rESWT or sham-rESWT to the patient. In this study, the therapist will be the Principal Investigator."||t|||t
1309399|NCT03473886||Single Group Assignment||Treatment||None (Open Label)||||||
1309400|NCT03473873|||Cohort||Prospective|||||||
1309401|NCT03473860|||Cohort||Prospective|||||||
1309402|NCT03473847|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Scans from 4 devices obtained on the same patient population for comparison||||
1309403|NCT03473834|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Only patients with PD who meet the inclusion and exclusion criteria will be invited to participate in the study. All participants will be assessed for daily activity and motor skill using the Unified Parkinson's Disease Rating Scale (UPDRS). At pre- and post- assessments, eye movement and turning characteristics will be assessed using xIMU sensors and EOG.||||
1309404|NCT03473821|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will be blinded, but due to the nature of the study, neither the primary investigator, participant, nor the care providers can be blinded|1:1 single assessor-blinded adaptive randomized controlled trial, which will conform to the CONSORT statement||||t
1309405|NCT03473808||Single Group Assignment||Treatment||None (Open Label)||||||
1309406|NCT03473795|||Ecologic or Community||Prospective|||||||
1309407|NCT03473782|||Cohort||Prospective|||||||
1309408|NCT03473769|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1309409|NCT03473756|Randomized|Parallel Assignment||Treatment||Quadruple|There is masking only in the Part B. Part A is open-label.||t|t|t|t
1309410|NCT03473743|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1309411|NCT03473730|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309412|NCT03473717|Randomized|Parallel Assignment||Other||Single|||t|||
1309413|NCT03473704|Randomized|Parallel Assignment||Treatment||Single||The treatment group (TG) will receive the web treatment, which consists of 9 weekly sessions, while the control group (CG) will be evaluated in the same phases as the TG. For ethical reasons, the CG will receive the web treatment once the TG intervention has been completed. There will be a follow-up at 3, 6 and 12 months.||t||
1309414|NCT03473691||Single Group Assignment||Treatment||None (Open Label)||||||
1309415|NCT03473678|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1309416|NCT03473665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573384|NCT00001424||||||||||||
1309417|NCT03473652||Single Group Assignment||Other||None (Open Label)||||||
1309418|NCT03473639||Single Group Assignment||Treatment||None (Open Label)||||||
1309419|NCT03473626|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1309420|NCT03473613|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309421|NCT03473600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309422|NCT03473587|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1309423|NCT03473574|Randomized|Parallel Assignment||Treatment||None (Open Label)||Treatment Arm A: Combination of Durvalumab, Tremelimumab and Gemcitabine Treatment Arm B: Combination of Durvalumab, Tremelimumab, Gemcitabine and Cisplatin Treatment Arm C: Gemcitabine and Cisplatin||||
1309424|NCT03473561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309425|NCT03473548||Single Group Assignment||Other||None (Open Label)||Single-center, un-blinded, feasibility, methods comparison, and non-inferiority study||||
1309426|NCT03473535||Single Group Assignment||Treatment||None (Open Label)||Cohort Study||||
1309427|NCT03473522|Randomized|Parallel Assignment||Treatment||Double|double-blind|A randomized, double-blind, sham-controlled, clinical trial involving two types of intervention: (1) Physical therapy + active tDCS; (2) Physical therapy + sham tDCS.|t|||t
1309428|NCT03473509|Randomized|Parallel Assignment||Treatment||Single||||||t
1309429|NCT03473496||Single Group Assignment||Treatment||None (Open Label)||||||
1309430|NCT03473483|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1309431|NCT03473470|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1309432|NCT03473457||Single Group Assignment||Treatment||None (Open Label)||||||
1309433|NCT03473444|||Ecologic or Community||Cross-Sectional|||||||
1309434|NCT03473431|Randomized|Parallel Assignment||Other||Quadruple||randomized, double-blind, dose-controlled follow-up study|t|t|t|t
1309435|NCT03473418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309436|NCT03473405|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1309437|NCT03473392|||Cohort||Retrospective|||||||
1309438|NCT03473379|||Other||Cross-Sectional|||||||
1309439|NCT03473366|Randomized|Crossover Assignment||Other||None (Open Label)||The sequence of standard vs Tao mask will be determined by random number generator. Mask ventilation will be scored with both masks before and after the standard administration of paralytic medication. The duration of the study procedures is variable but would last approximately 30-60 seconds, seldom exceeding 5 minutes additional time to the study patient from what is necessary in a non-study patient. The number of ventilations to achieve adequate ventilation is variable with both the standard mask and the Tao mask. After grading mask ventilation the study intervention is complete and the remainder of surgical and anesthesia care will be based on the clinical needs and decisions of the care team.||||
1309440|NCT03473353||Single Group Assignment||Other||None (Open Label)||||||
1309441|NCT03473340|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309442|NCT03473327|||Cohort||Prospective|||||||
1309443|NCT03473314||Single Group Assignment||Treatment||None (Open Label)||Open label study||||
1309444|NCT03473301|Randomized|Parallel Assignment||Treatment||Single|Every attempt will be made to blind the outcomes assessor.|||||t
1309445|NCT03473288|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1309446|NCT03473275|||Case-Control||Prospective|||||||
1309447|NCT03473262|||Case-Control||Prospective|||||||
1309448|NCT03473249|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1309449|NCT03473236|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1309450|NCT03473223|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1309451|NCT03473210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309452|NCT03473197||Single Group Assignment||Treatment||None (Open Label)||||||
1309453|NCT03473184||Single Group Assignment||Treatment||None (Open Label)||||||
1309454|NCT03473171||Single Group Assignment||Other||None (Open Label)||||||
1309455|NCT03473158|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1309456|NCT03473145|Randomized|Parallel Assignment||Prevention||Single||||||t
1309457|NCT03473132||Single Group Assignment||Treatment||None (Open Label)||Pilot study of consecutive patients.||||
1309458|NCT03473119|||Case-Control||Prospective|||||||
1309459|NCT03473106|Non-Randomized|Parallel Assignment||Diagnostic||Single|Surgical side can not be randomized. Only data assessor will be blinded.|||||t
1309460|NCT03473093|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1309461|NCT03473080||Single Group Assignment||Treatment||None (Open Label)||||||
1309462|NCT03473067|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1309463|NCT03473054|||Case-Only||Prospective|||||||
1309464|NCT03473041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309465|NCT03473028|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized controlled trial||||
1309466|NCT03473015|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309467|NCT03473002|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1309468|NCT03472989|Randomized|Parallel Assignment||Treatment||Double|The patients who receive rESWT or sham-rESWT will be blinded.|Participants will be randomly assigned to one of the four intervention groups in parallell for the duration of the study.|||t|t
1309469|NCT03472976|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1309470|NCT03472963|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1309471|NCT03472950|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1309472|NCT03472937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309473|NCT03472924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309474|NCT03472911|||Case-Only||Prospective|||||||
1309475|NCT03472898|||Other||Other|||||||
1309476|NCT03472885|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Four groups will be studied and enrolled sequentially.||||
1573385|NCT00001422||||Treatment||||||||
1309477|NCT03472872|Randomized|Parallel Assignment||Treatment||Double|"The provider will place orders in the electronic medical record for Headache study order set. This order set includes Compazine® 10 mg IV, Benadryl® 25 mg IV, and study drug. Pharmacy will receive the order for the study drug. The research pharmacist will randomly assign participants to group A (1000 mg Ofirmev®) or group B (15 mg ketorolac)."|Randomized, double-blind trial comparing two parenteral adjuvant treatments for headache among patients presenting to the Lakeland Health Emergency Department in St. Joseph, MI.|t|t||
1309478|NCT03472859|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309479|NCT03472846|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1309480|NCT03472833|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1309481|NCT03472820|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1309482|NCT03472807|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||prospective multicenter study, not therapeutic,||||
1309483|NCT03472794|||Case-Only||Prospective|||||||
1309484|NCT03472781|||Other||Retrospective|||||||
1309485|NCT03472768|||Cohort||Prospective|||||||
1309486|NCT03472755|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients provided written informed consent to participate in this study, as approved by the local ethics committee. Prior to surgery, patients were informed about the benefits and risk of the conventional posterolateral and direct anterior approaches. Then they performed postural test and a Performance-Oriented Mobility Assessment Walking test with and without step. After randomization, patients were operated according the conventional posterolateral or direct anterior techniques.||||
1309487|NCT03472742|||Cohort||Prospective|||||||
1309488|NCT03472729|Randomized|Parallel Assignment||Other||Double|||||t|t
1309489|NCT03472716|||Cohort||Prospective|||||||
1309490|NCT03472703|Randomized|Crossover Assignment||Basic Science||None (Open Label)||We will use a counter-balanced, crossover, within-subject design||||
1309491|NCT03472690|Randomized|Parallel Assignment||Treatment||Quadruple|Stage one is Open Label||t|t|t|t
1309492|NCT03472677|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309493|NCT03472664|Randomized|Parallel Assignment||Treatment||Double|"It is not possible for participants and the dietitian to be blinded to the study diet.~Study personnel involved in performing cognitive testing or other outcome procedures or data analysis will be blinded."|Adults with amnestic mild cognitive impairment will be randomized on a 1:1 schedule to receive either a 4-month Modified Mediterranean Ketogenic Diet or American Heart Association Diet intervention. Diet interventions will be equicaloric with participants' normal diets. Personalized nutritional guidance and menus will be provided, and compliance will be assessed by a registered dietitian. Amyloid positron emission tomography (PET) will be conducted at baseline. Blood collection and cognitive assessment will be conducted at baseline and after 2 and 4 months of diet. Lumbar puncture (LP) and MRI will be conducted at baseline and following the intervention for all participants.|||t|t
1309494|NCT03472651|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1309495|NCT03472638|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1309496|NCT03472625|||Cohort||Prospective|||||||
1309497|NCT03472612||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309498|NCT03472599||Single Group Assignment||Treatment||None (Open Label)||All subjects will take home skin surface electrodes and a simple one-channel electrical stimulators appropriate for extended use set to the stimulus parameters found effective during an initial urodynamics test. Genital nerve stimulation will be applied either continuously or on-demand when individuals turn stimulation on when they feel the onset of bladder leaking.||||
1309499|NCT03472586||Single Group Assignment||Treatment||None (Open Label)||||||
1309500|NCT03472573||Single Group Assignment||Treatment||None (Open Label)||||||
1309501|NCT03472560||Single Group Assignment||Treatment||None (Open Label)||||||
1309502|NCT03472547||Single Group Assignment||Screening||None (Open Label)||||||
1309503|NCT03472534||Single Group Assignment||Screening||None (Open Label)||||||
1309504|NCT03472521|Randomized|Parallel Assignment||Treatment||Quadruple|A randomization table will be used by the research pharmacy and study drug will be prepared in numbered bottles.|Double blind randomized|t|t|t|t
1309505|NCT03472508|Randomized|Parallel Assignment||Treatment||Double||Multicenter, randomized, double-blind, controlled clinical trial|t||t|
1309506|NCT03472495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309507|NCT03472482|||Case-Control||Cross-Sectional|||||||
1309508|NCT03472469|Randomized|Parallel Assignment||Treatment||Single|||t|||
1309509|NCT03472456|||Case-Control||Prospective|||||||
1309510|NCT03472443|Randomized|Crossover Assignment||Treatment||Single|||t|||
1309511|NCT03472430|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1309512|NCT03472417|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1309513|NCT03472404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309514|NCT03472391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309515|NCT03472378|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309516|NCT03472365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309517|NCT03472352||Single Group Assignment||Treatment||None (Open Label)||||||
1309518|NCT03472339|Randomized|Parallel Assignment||Treatment||Double|A computer generated block randomization sequence will be generated and stored with sequential coding known to the clinical pharmacist only. Within the randomization another stratified randomized sequence will be generated, for the patients to be enrolled for the PK study. Among the 300 trial packets prepared for the study, 20 packets will contain one additional code that will indicate the subject to be enrolled in the PK study.|Double blind randomized trial|t|||t
1309519|NCT03472326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309520|NCT03472313||Single Group Assignment||Other||None (Open Label)||||||
1309521|NCT03472300|||Cohort||Prospective|||||||
1309522|NCT03472287|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309523|NCT03472274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309524|NCT03472261|Randomized|Parallel Assignment||Treatment||Single|||||t|
1309525|NCT03472248||Single Group Assignment||Treatment||None (Open Label)||||||
1309526|NCT03472235|Randomized|Parallel Assignment||Treatment||None (Open Label)||"TCA peeling session: Facial skin will be cleansed with tap water and degreased by rubbing with an alcohol sponge .~Then TCA 25% will be applied to the whole face by cotton tipped applicator or gauze pad. The entire face will be treated until complete frosting occur.~The patients will be instructed to wash their faces to decrease the burning sensation.~Combined session: starts with microneedling using microneedling device (Dermapen) The skin of each patient is cleaned with anti septic solution and anesthetic cream may be applied to lessen discomfort.~(Dermapen) will be applied on the lesional skin in four direction, vertical, horizontal and in the two diagonal until pin point bleeding occur which will be gently massaged .~After 10 minutes TCA peeling will be applied TCA peeling will be done for 8 session with 2 weeks interval between each session.~Microneedling will be done for 4session with 4 weeks interval between each session."||||
1309527|NCT03472222||Single Group Assignment||Prevention||None (Open Label)||Quasi experimental design||||
1309528|NCT03472209|||Case-Control||Prospective|||||||
1309529|NCT03472196||Single Group Assignment||Device Feasibility||None (Open Label)||Open label, single arm, open label study||||
1309530|NCT03472183|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||"3 types of patients will be included:~10 patients with Alzheimer's disease and as controls:~10 patients with Parkinson's disease~10 patients without neurodegenerative disease.~During the course of the colonoscopy that these 30 patients should have in the context of their medical usual care, additionnal biopsies of colon will be removed to perform in vitro analysis for this study."||||
1309531|NCT03472170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309532|NCT03472157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309533|NCT03472144|Randomized|Parallel Assignment||Supportive Care||Quadruple|Principle investigator will be non blinded and all others will be blinded|This is a single-blinded Randomized Control Trial study, in which every patient receives active gel on one side and placebo on the other (L or R to be randomly selected).|t|t|t|t
1309534|NCT03472131||Single Group Assignment||Treatment||None (Open Label)||||||
1309535|NCT03472118||Single Group Assignment||Treatment||None (Open Label)||||||
1309536|NCT03472105|Randomized|Crossover Assignment||Prevention||None (Open Label)||The aim of this study was to investigate if 7 days of dietary intake of New Nordic Renal Diet reduces the 24-hour urinary phosphorus excretion and other components of the phosphorus homeostasis in 18 moderate CKD patients compared to 7 days of habitual diet.||||
1309537|NCT03472092|Randomized|Parallel Assignment||Basic Science||Triple|Cognitive behavioral therapy assignment is known to the treating therapist/care provider. Placebo and amitriptyline are double blinded.|Mechanistic trial examining brain changes and conditioned pain modulation changes in youth with migraine treated with either cognitive behavioral therapy, placebo, or amitriptyline.|t||t|t
1309538|NCT03472079|||Cohort||Retrospective|||||||
1309539|NCT03472066|||Case-Control||Prospective|||||||
1309540|NCT03472053|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized in 1:1 ratio to either BIO-11006 plus Standard of Care (intervention) or Standard of Care (Pemetrexed plus Carboplatin) (intervention).||||
1309541|NCT03472040|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309542|NCT03472027||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1309543|NCT03472014||Single Group Assignment||Prevention||None (Open Label)||||||
1309544|NCT03472001|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309545|NCT03471988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309546|NCT03471975|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309547|NCT03471962|||Case-Only||Prospective|||||||
1309548|NCT03471949||Single Group Assignment||Health Services Research||None (Open Label)||||||
1309549|NCT03471936||Single Group Assignment||Treatment||None (Open Label)||||||
1309550|NCT03471923|||Cohort||Cross-Sectional|||||||
1309551|NCT03471910|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1309552|NCT03471897|||Cohort||Retrospective|||||||
1309553|NCT03471884|Randomized|Parallel Assignment||Treatment||Single|||t|||
1309554|NCT03471871|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1309555|NCT03471858|Randomized|Parallel Assignment||Treatment||Single||||||t
1309556|NCT03471845||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1309557|NCT03471832||||||||||||
1309558|NCT03471819|||Case-Control||Prospective|||||||
1309559|NCT03471806|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1309560|NCT03471793|||Cohort||Prospective|||||||
1309561|NCT03471780|||Cohort||Prospective|||||||
1309562|NCT03471767|Randomized|Parallel Assignment||Treatment||Double||Participants are randomized to either take AXS-05 or BUP SR in parallel for the duration of the study.|t|t||
1309563|NCT03471754||Single Group Assignment||Treatment||None (Open Label)||Pilot, Open Label, single center trial||||
1309564|NCT03471741|||Other||Retrospective|||||||
1309565|NCT03471728|||Cohort||Prospective|||||||
1309566|NCT03471715|||Other||Retrospective|||||||
1309567|NCT03471702||Single Group Assignment||Treatment||None (Open Label)||||||
1309568|NCT03471689|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1309569|NCT03471676|||Cohort||Prospective|||||||
1309570|NCT03471663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309571|NCT03471650||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309572|NCT03471637||Single Group Assignment||Health Services Research||None (Open Label)||||||
1309573|NCT03471624||Single Group Assignment||Treatment||None (Open Label)||||||
1309574|NCT03471611||Single Group Assignment||Treatment||None (Open Label)||||||
1309575|NCT03471598|||Cohort||Prospective|||||||
1309628|NCT03470909|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309680|NCT03470220|||Cohort||Prospective|||||||
1309681|NCT03470207|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1310211|NCT03463291|||Case-Control||Prospective|||||||
1309576|NCT03471585|Randomized|Crossover Assignment||Basic Science||Double|"A lab member that knew the design of the study but was not running participants sorted placebo and THC capsules into bags labeled first capsule and second capsule for each participant."|Half of the participants will receive placebo during the retrieval session in the first experimental arm and THC during the retrieval session in the second experimental arm. The other half of participants will receive THC during the retrieval session in the first experimental arm and placebo during the retrieval session in the second experimental arm.|t||t|
1309577|NCT03471572|||Cohort||Cross-Sectional|||||||
1309578|NCT03471559|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1309579|NCT03471546||Single Group Assignment||Supportive Care||None (Open Label)||Patients newly diagnosed with World Health Organization (WHO) Grade IV malignant glioma will be referred to a Palliative Care provider in the clinic, in order to assess the impact of early palliative care intervention.||||
1309580|NCT03471533|Randomized|Parallel Assignment||Prevention||Double||Randomized, controlled clinical trial, with two parallel branches, (experimental product and placebo), double blind and unicentric.|t||t|
1309581|NCT03471520||Single Group Assignment||Prevention||None (Open Label)||||||
1309582|NCT03471507|Randomized|Parallel Assignment||Treatment||Quadruple|"The bottles will be labelled by pharmacy either Drug A or Drug B according to their designation with a label affixed to cover any drug manufacturing labeling. Only the dispensing pharmacy will not be blinded."|Subjects will be randomized to one of two study groups (Bonipar or diclofenac gel 1%), utilizing a predetermined randomization schedule in a 1:1 ratio.|t|t|t|t
1309583|NCT03471494|||Cohort||Prospective|||||||
1309584|NCT03471481|||Case-Only||Cross-Sectional|||||||
1309585|NCT03471468||Single Group Assignment||Basic Science||None (Open Label)||||||
1309586|NCT03471455|Randomized|Parallel Assignment||Treatment||Single|||||t|
1309587|NCT03471442|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1309588|NCT03471429|||Cohort||Prospective|||||||
1309589|NCT03471416|||Cohort||Prospective|||||||
1309590|NCT03471403|||Cohort||Prospective|||||||
1309591|NCT03471390||Sequential Assignment||Health Services Research||None (Open Label)||non- randomized incomplete stepped-wedge design||||
1309592|NCT03471377|||Case-Control||Prospective|||||||
1309593|NCT03471364|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309594|NCT03471351||Single Group Assignment||Treatment||None (Open Label)||||||
1309595|NCT03471338|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1309596|NCT03471325|Randomized|Crossover Assignment||Treatment||Double|The examiner, who chart the plaque score is blinded to the treatment assignment.|In each subject, his/her right and left dentition will be randomized into Plaque Disclosed (PD) and Non Plaque Disclosed (NPD) groups. Subsequently, the upper and lower jaws will be randomized into Air Flow (AF) and Rubber Cup (RC).|t|||t
1309597|NCT03471312|||Case-Only||Prospective|||||||
1309598|NCT03471299|||Case-Only||Retrospective|||||||
1309599|NCT03471286||Single Group Assignment||Treatment||None (Open Label)||||||
1309600|NCT03471273|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309601|NCT03471260||Single Group Assignment||Treatment||None (Open Label)||||||
1309602|NCT03471247|Randomized|Parallel Assignment||Treatment||Single||||||t
1309603|NCT03471234|||Cohort||Prospective|||||||
1309604|NCT03471221|Randomized|Parallel Assignment||Supportive Care||Double|Outcomes Assessors include clinical research assistants and laboratory personnel. Laboratory personnel will be blinded. Clinical research assistants collecting surveys and specimens will not be blinded.||||t|t
1309605|NCT03471208|Randomized|Parallel Assignment||Treatment||Single|Investigation of the post-op images included anonymized patient names providing unbiased analysis.|Dental implant surgery assisted by a stereotaxic surgical instrument|||t|
1309606|NCT03471195|||Case-Control||Cross-Sectional|||||||
1309607|NCT03471182|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309608|NCT03471169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309609|NCT03471156|||Cohort||Prospective|||||||
1309610|NCT03471143||Single Group Assignment||Treatment||None (Open Label)||Phase 1/2a, open-label, dose escalation, multi-center study of VTS-270 in subjects with NPC dosed twice a week with IV VTS-270 for six weeks for a total of 12 administrations, followed by a six month open-label extension phase in which the subjects are dosed monthly with IV VTS-270 for six months for a total of six administrations||||
1309611|NCT03471130|Randomized|Parallel Assignment||Other||Triple||Double blind, placebo controlled|t||t|t
1309612|NCT03471117|Randomized|Crossover Assignment||Basic Science||Single|Subjects will either receive placebo or pioglitazone pills in a randomized order. Placebo pills will be sugar pills of same shape and size as the pioglitazone pills. The randomization for study drugs will be carried out by research personnel. All treatments will be encapsulated so that pills are identical and patients cannot identify the treatment arm.|This will be a randomized, placebo-controlled crossover design study|t|||
1309613|NCT03471104|Randomized|Sequential Assignment||Other||None (Open Label)||||||
1309614|NCT03471091|Randomized|Parallel Assignment||Treatment||Single||||||t
1309615|NCT03471078|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1309616|NCT03471065||Single Group Assignment||Treatment||None (Open Label)||SAPIEN 3 Ultra Delivery System with the SAPIEN 3 Ultra THV||||
1309617|NCT03471052|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1309618|NCT03471039|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1309619|NCT03471026|||Case-Control||Prospective|||||||
1309620|NCT03471013|||Other||Cross-Sectional|||||||
1309621|NCT03471000|Randomized|Parallel Assignment||Treatment||Single|||t|||
1309622|NCT03470987|||Case-Control||Prospective|||||||
1309623|NCT03470974|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1309624|NCT03470961|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309625|NCT03470948|||Cohort||Prospective|||||||
1309626|NCT03470935|||Cohort||Retrospective|||||||
1309627|NCT03470922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573386|NCT00001421||||Treatment||||||||
1309629|NCT03470896|Randomized|Parallel Assignment||Other||Single|"Participant and care provider know the allocation group teleconsultation or traditional consultation."|One group : preanesthesia teleconsultation / One group : preanesthesia traditional teleconsultation / One sub-group : bis preanesthesia traditional teleconsultation||||t
1309630|NCT03470883|||Cohort||Retrospective|||||||
1309631|NCT03470870|||Cohort||Retrospective|||||||
1309632|NCT03470857|||Cohort||Prospective|||||||
1309633|NCT03470844|||Cohort||Prospective|||||||
1309634|NCT03470818|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1309635|NCT03470805||Single Group Assignment||Treatment||None (Open Label)||Olaparib as maintenance therapy||||
1309636|NCT03470792|Randomized|Parallel Assignment||Other||Double|||t|||t
1309637|NCT03470779|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study design is a randomized, wait-list controlled pilot study. A parallel group study design will be used to compare a treatment group and a wait-list control group. This study design will be effective for addressing the gap in literature by examining both the initial treatment estimates related to health and functioning and the feasibility of performing a similar study on a larger scale.||||
1309638|NCT03470766|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind. Implanter is blinded, research staff are blinded, subject is blinded. One unblinded research personnel at each recruiting site programming the patients at device activation.|Multicentre, randomised, double-blinded, sham-controlled trial with parallel economic evaluation. Patients will be allocated 1:1 to activated 10kHz SCS plus usual care (intervention) or sham 10kHz SCS plus usual care (control) and followed up to 6 months.|t|t|t|t
1309639|NCT03470753|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309640|NCT03470740|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1309641|NCT03470727||Single Group Assignment||Treatment||None (Open Label)||prospective comparison study||||
1309642|NCT03470714|Randomized|Parallel Assignment||Treatment||Single||||||t
1309643|NCT03470701|Randomized|Parallel Assignment||Screening||Single||||||t
1309644|NCT03470688|||Cohort||Prospective|||||||
1309645|NCT03470675|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1309646|NCT03470662|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309647|NCT03470649|Randomized|Parallel Assignment||Prevention||Double||Randomized controlled trial|t|||t
1309648|NCT03470636||Single Group Assignment||Treatment||None (Open Label)||||||
1309649|NCT03470623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309650|NCT03470610|||Cohort||Prospective|||||||
1309651|NCT03470597|||Case-Only||Prospective|||||||
1309652|NCT03470584|||Cohort||Prospective|||||||
1309653|NCT03470571|||Cohort||Retrospective|||||||
1309654|NCT03470558|||Cohort||Prospective|||||||
1309655|NCT03470545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309656|NCT03470532|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1309657|NCT03470519|||Cohort||Prospective|||||||
1309658|NCT03470506|||Cohort||Prospective|||||||
1309659|NCT03470493||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309660|NCT03470480|Randomized|Parallel Assignment||Treatment||Triple||This preliminary study aims to consent and enroll 20 individuals with Methamphetamine Use Disorder. Participants will be randomized into two rTMS conditions (real versus sham) and two picture cues conditions (METH versus neutral). Randomization provides the following four groups: real METH (RM), real neutral (RN), sham METH (SM) and sham neutral (SN). The randomizations can be performed with a web-based randomization generator (www.randomization.com) (47). Subjects and rTMS administrators will be blinded to the treatment.|t||t|t
1309661|NCT03470467|||Cohort||Prospective|||||||
1309662|NCT03470454|||Case-Control||Cross-Sectional|||||||
1309663|NCT03470441|Randomized|Parallel Assignment||Other||Triple|This is a double-blind study where all study staff and participants are blinded to whether the patient receives active drug or placebo.|All subjects who fulfill all study eligibility criteria will be randomized to receive one of the 4 treatments.|t|t|t|
1309664|NCT03470428|||Cohort||Prospective|||||||
1309665|NCT03470415|||Other||Cross-Sectional|||||||
1309666|NCT03470402|Randomized|Parallel Assignment||Prevention||None (Open Label)||A cluster randomization in which both a provider and his/her enrolled patients will be enrolled in either the intervention or control arm.||||
1309667|NCT03470389||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309668|NCT03470376|Randomized|Crossover Assignment||Treatment||Single|Patients names and allocation to arms was masked for outcomes assessors|NC vs noNC||||t
1309669|NCT03470363|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1309670|NCT03470350||Single Group Assignment||Treatment||None (Open Label)||||||
1309671|NCT03470337|Randomized|Parallel Assignment||Supportive Care||Quadruple|Double-Blinded||t|t|t|t
1309672|NCT03470324|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1309673|NCT03470311|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1309674|NCT03470298|Randomized|Parallel Assignment||Other||Quadruple||The patients in study undergo endometrial scratch technique after being randomly assigned in to one of two groups . First group undergo ES just after finishing oocyte pick up and the other group undergo ES one week before starting COH. Manual Vacuum Aspiration (MVA) size 5 moved from below upwards with suction ,scratching anterior uterine wall then posterior then left lateral uterine wall then right lateral uterine wall and lastly funds.|t|t|t|t
1309675|NCT03470285||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309676|NCT03470272||Single Group Assignment||Treatment||None (Open Label)||||||
1309677|NCT03470259|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1309678|NCT03470246|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The PACO trial is based on randomized clinical trial. Besides the standard post-operative care, the cardiac operation patients of the intervention groups will receive activity guidance during a 90-day intervention after elective coronary artery bypass grafting, aortic valve replacement or mitral valve repair. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.||||
1309679|NCT03470233|||Case-Only||Other|||||||
1309682|NCT03470194|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1309683|NCT03470181|||Cohort||Prospective|||||||
1309684|NCT03470168|Randomized|Parallel Assignment||Health Services Research||Double||30 alcohol dependent patients were divided into A: Treatment group and B: Placebo group using simple randomization technique.|t|||t
1309685|NCT03470155|||Case-Only||Prospective|||||||
1309686|NCT03470142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309687|NCT03470129|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1309688|NCT03470116|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309689|NCT03470103|||Cohort||Prospective|||||||
1309690|NCT03470090|Randomized|Parallel Assignment||Treatment||Single|Participants didn't know taking which exercise treatment methods.|Experimental, Randomized Controlled Study|t|||
1309691|NCT03470077|Randomized|Parallel Assignment||Prevention||Double|The trial will be planned that neither the doctors (investigators) nor the patients' guardians or even children themselves will be aware of the group allocation and timing of drug received|"Patients will be randomly allocated into two groups of 40 patients each:~Group A: will receive IV nalbuphine 0.1 mg/kg with induction of anesthesia. Group B: will receive IV nalbuphine 0.1 mg/kg at the end of surgery just before discontinuation of anesthesia."|t||t|
1309692|NCT03470064|||Cohort||Prospective|||||||
1309693|NCT03470051|||Other||Prospective|||||||
1309694|NCT03470038|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1309695|NCT03470025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309696|NCT03470012||Single Group Assignment||Treatment||None (Open Label)||||||
1309697|NCT03469999||Single Group Assignment||Treatment||None (Open Label)||||||
1309698|NCT03469986|||Case-Control||Cross-Sectional|||||||
1309699|NCT03469973|||Case-Only||Cross-Sectional|||||||
1309700|NCT03469960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309701|NCT03469947|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective observational cohort administered TXA prehospital and a retrospective cohort for matched controls.||||
1309702|NCT03469934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309703|NCT03469921|||Cohort||Retrospective|||||||
1309704|NCT03469895|||Cohort||Retrospective|||||||
1309705|NCT03469882|Randomized|Crossover Assignment||Treatment||Single|Blinded outcomes assessment|Randomized controlled phase 2 study||||t
1309706|NCT03469869|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1309707|NCT03469856||Single Group Assignment||Treatment||None (Open Label)||The ASET Pilot study is a multicenter, single arm, open-label trial of single antiplatelet therapy with prasugrel for patients undergoing successful and optimal PCI for chronic stable angina with normal cardiac biomarkers values.||||
1309708|NCT03469843|||Case-Only||Prospective|||||||
1309709|NCT03469830|Randomized|Parallel Assignment||Treatment||Single|The subjects and the analyser of the data were blinded.||t|||
1309710|NCT03469817|Non-Randomized|Parallel Assignment||Other||None (Open Label)||1 control group who have had been implanted with a Trident cup and have already had MRIs taken at their one year post-operative visit. This group's MRI's will be compared with MRI's from Tridend II patients who have had MRI's at 1 year post-operative visit.||||
1309711|NCT03469804||Single Group Assignment||Treatment||None (Open Label)||2-stage phase II Simon's Optimal Design||||
1309712|NCT03469791|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Non-inferiority cohort study||||
1309713|NCT03469778||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1309714|NCT03469765|||Cohort||Prospective|||||||
1309715|NCT03469752|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized-controlled trial||||
1309716|NCT03469739|||Other||Cross-Sectional|||||||
1309717|NCT03469726||Single Group Assignment||Diagnostic||None (Open Label)||International multicenter prospective cohort study||||
1309718|NCT03469713||Single Group Assignment||Treatment||None (Open Label)||||||
1309719|NCT03469700|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1309720|NCT03469687||Single Group Assignment||Treatment||None (Open Label)||||||
1309721|NCT03469674|Randomized|Parallel Assignment||Treatment||None (Open Label)||2:1 randomisation to adjuvant treatment assignment based on the integrated molecular risk profile or standard adjuvant vaginal brachytherapy||||
1309722|NCT03469661|||Cohort||Prospective|||||||
1309723|NCT03469648|||Cohort||Prospective|||||||
1309724|NCT03469635|||Cohort||Retrospective|||||||
1309725|NCT03469622|Randomized|Factorial Assignment||Diagnostic||Single|||t|||
1309726|NCT03469609|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, open-label, randomized, parallel group, controlled trial||||
1309727|NCT03469596|||Cohort||Retrospective|||||||
1309728|NCT03469583|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1309729|NCT03469570||Single Group Assignment||Treatment||None (Open Label)||||||
1309730|NCT03469557|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309731|NCT03469544|||Case-Control||Retrospective|||||||
1309732|NCT03469531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309733|NCT03469518|Randomized|Crossover Assignment||Basic Science||Double||Crossover Assigment|t|||t
1309734|NCT03469505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309735|NCT03469492|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309736|NCT03469479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309737|NCT03469466|||Other||Prospective|||||||
1309738|NCT03469453||Single Group Assignment||Treatment||None (Open Label)||||||
1309739|NCT03469440|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309740|NCT03469427|||Case-Only||Prospective|||||||
1309741|NCT03469414|||Case-Only||Cross-Sectional|||||||
1309742|NCT03469401|||Cohort||Prospective|||||||
1309743|NCT03469388||Single Group Assignment||Diagnostic||None (Open Label)||prospective,multidisciplinary single center study||||
1309744|NCT03469375|||Case-Control||Prospective|||||||
1309745|NCT03469362|Randomized|Parallel Assignment||Other||None (Open Label)||1:1 randomization||||
1309746|NCT03469349|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309747|NCT03469336|Randomized|Single Group Assignment||Treatment||None (Open Label)|This study is a single arm multi-intervention study. The interventions are masked to participant, investigator, providers and assessors.|||||
1309748|NCT03469323|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1309749|NCT03469310|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||option 1: Tylenol (also known as acetaminophen) with tramadol if needed, or option 2: Tylenol #3 as needed||||
1309750|NCT03469297||Single Group Assignment||Treatment||None (Open Label)||||||
1309751|NCT03469284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309752|NCT03469271|Randomized|Factorial Assignment||Supportive Care||Triple|||t|t|t|
1309753|NCT03469258||Single Group Assignment||Supportive Care||None (Open Label)||||||
1309754|NCT03469245|||Cohort||Prospective|||||||
1309755|NCT03469232|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309756|NCT03469219|||Case-Control||Retrospective|||||||
1309757|NCT03469206|Randomized|Parallel Assignment||Treatment||Single||||||t
1309758|NCT03469193|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309759|NCT03469180|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309760|NCT03469167|Randomized|Parallel Assignment||Treatment||Single|||t|||
1309761|NCT03469154|Randomized|Parallel Assignment||Other||Single|After training participants demonstrate skills in a standardised scenario test with children resuscitation manikins. All tests are video recorded. Participants in videos identified by a unique id number. Training method is not mentioned in videos. Assessors have no knowledge on the relation between group and unique id (are blinded for the interventions). Assessors assess videos of all participants in a randomised order .|"Two parallel groups. Participants randomised to either dyad training or instructor led training.~Dyad training in pairs guided by instructional videos Instructor led training with maximum 6 participants per instructor."||||t
1309762|NCT03469141|Randomized|Parallel Assignment||Prevention||Single|Following the training/goal setting session, participants will be randomly assigned into either the intervention group that will receive biofeedback via the smartphone app for 4 weeks, or the control group that will continue to have the WC sensor system for measurement only and will not receive biofeedback.|All participants will complete two weeks of recording PR behavior by the monitoring system without feedback. Following baseline assessment, participants will be randomized into one of two groups: an intervention group that will receive an education session on PU prevention with goal setting for PR frequency and duration followed by four weeks of biofeedback via the smartphone app component of the monitoring system, or a control group that will receive only the education and goal setting session, but will not receive biofeedback and will have the WC sensor system for measurement only. After four weeks, the biofeedback feature in the intervention group will be turned off. The system will continue to monitor activities for another two weeks. We will assess whether improvements in PR adherence are retained after the 4-week bout of biofeedback (washout). Participants will return one year following the 8-week intervention to assess whether they have developed a PU.|t|||
1309763|NCT03469128|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||participants were grouped into the following groups: first: Cognitive Processing Therapy (CPT) in which participants completed 12 sessions of CPT. Second: Medication group in which patients with co-occurrence PTSD & SUD disorders were treated by medicine (Disulfiram, Naltrexone and Buprenorphine). Third: control group that consists of patients with co-occurrence PTSD & SUD disorders who were not treated yet (waiting lists in the hospital).||||
1309764|NCT03469115|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||Adolescents aged 13-17 will be divided into two groups according to BMI (body mass index)||||
1309765|NCT03469102|||Cohort||Retrospective|||||||
1309766|NCT03469089|Randomized|Crossover Assignment||Basic Science||Double|Double blinded|All subjects will get each treatment according to balanced latin square design for four treatments with 12 days intervals|t||t|
1309767|NCT03469076||Single Group Assignment||Treatment||None (Open Label)||||||
1309768|NCT03469063|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1309769|NCT03469050|Randomized|Parallel Assignment||Prevention||Quadruple||This study is a phase II, multicenter, double-blind, placebo-controlled, randomized clinical trial.|t|t|t|t
1309770|NCT03469037|Randomized|Crossover Assignment||Treatment||Single|||t|||
1309771|NCT03469024|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1309772|NCT03469011||Sequential Assignment||Treatment||None (Open Label)||||||
1309773|NCT03468998|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1309774|NCT03468985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309775|NCT03468972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309776|NCT03468959|||Cohort||Prospective|||||||
1309777|NCT03468946|Non-Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1309778|NCT03468933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309779|NCT03468920|Randomized|Parallel Assignment||Treatment||Quadruple|Only pharmacy staff will have randomization scheme and be aware of whether patient received oral Acetaminophen with IV placebo OR if the patient received IV Acetaminophen with oral placebo|This study will use a randomized, double-blind, placebo controlled design with two arms.|t|t|t|t
1309780|NCT03468907|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|The care provider, participant, investigator and outcomes assessor all konw the process.|Pregnant mothers who opt for antiviral therapy will start on oral LDT 600 mg or TDF 300 mg (as per patients' wishes) daily between gestational weeks 24 and 28. Antiviral therapy will be discontinued in intrapartum or at postpartum 6 weeks.||||
1309781|NCT03468894|Randomized|Parallel Assignment||Prevention||None (Open Label)||Pilot RCT||||
1309782|NCT03468881|||Cohort||Prospective|||||||
1309783|NCT03468868|Randomized|Parallel Assignment||Supportive Care||Single|Evaluators who assess clinical reported outcomes will be blinded to arm assignment.|Two-stage randomized choice design aimed at noninferiority.||||t
1309784|NCT03468855||Single Group Assignment||Treatment||None (Open Label)||||||
1309983|NCT03466255|||Cohort||Prospective|||||||
1309785|NCT03468842|Randomized|Parallel Assignment||Treatment||Double||The study will follow a randomized, double-blind, placebo-controlled design with 2 parallel prospective follow-up groups.|t||t|
1309786|NCT03468829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309787|NCT03468816|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1309788|NCT03468803||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309789|NCT03468790|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind|placebo parallel-controlled|t|t|t|t
1309790|NCT03468777|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1309791|NCT03468764|||Case-Only||Prospective|||||||
1309792|NCT03468751||Single Group Assignment||Treatment||None (Open Label)||||||
1309793|NCT03468738|||Other||Prospective|||||||
1309794|NCT03468725|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1309795|NCT03468712||Single Group Assignment||Treatment||None (Open Label)||Laparoscopic D2 distal gastrectomy after 3-Cycle XELOX neo-adjuvant chemotherapy||||
1309796|NCT03468699||Single Group Assignment||Treatment||None (Open Label)||||||
1309797|NCT03468686|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309798|NCT03468673|||Other||Prospective|||||||
1309799|NCT03468660|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Experimental group Active control group||||
1309800|NCT03468647||Single Group Assignment||Prevention||None (Open Label)||||||
1309801|NCT03468634|||Case-Only||Cross-Sectional|||||||
1309802|NCT03468621|Randomized|Parallel Assignment||Prevention||Single||Patients are randomised to intradermal and transdermal wound closure techniques. Randomisation is 1:1 and block randomisation is used|||t|
1309803|NCT03468608|||Other||Prospective|||||||
1309804|NCT03468595|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1309805|NCT03468582||Single Group Assignment||Basic Science||None (Open Label)||Monocentric, open-label and uncontrolled study||||
1309806|NCT03468569|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309807|NCT03468556|Randomized|Parallel Assignment||Treatment||Quadruple|placebo|test drug|t|t|t|t
1309808|NCT03468543|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1309809|NCT03468530|||Cohort||Prospective|||||||
1309810|NCT03468517|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1309811|NCT03468504|Randomized|Parallel Assignment||Treatment||Double|"Experimental Group saw mirror image of non-affected limb in mirror while walking on treadmill.~Placebo Group saw no refection of the non-affected limb due to positioning of mirror while walking on treadmill.~Outcome assessor was blinded to treatment allocation. They evaluated participants in separate lab and was asked not to discuss the treatment given to patients. Even if the patient mentioned the trials they would discuss the fact that they were using Mirrors and Treadmill."|Pilot Randomised Placebo Controlled Trial|t|||t
1309812|NCT03468491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309813|NCT03468478|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309814|NCT03468465|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309815|NCT03468452|||Cohort||Retrospective|||||||
1309816|NCT03468439||Single Group Assignment||Treatment||None (Open Label)||||||
1309817|NCT03468426||Single Group Assignment||Treatment||None (Open Label)||||||
1309818|NCT03468413|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1309819|NCT03468400|||Ecologic or Community||Prospective|||||||
1309820|NCT03468387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309821|NCT03468374|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1309822|NCT03468361|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1309823|NCT03468348|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309824|NCT03468335||Single Group Assignment||Treatment||None (Open Label)||Open label, single arm, multicenter phase IIIb trial||||
1309825|NCT03468322|Randomized|Parallel Assignment||Treatment||Quadruple||Intra-individual comparison|t|t|t|t
1309826|NCT03468309|||Case-Only||Prospective|||||||
1309827|NCT03468296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309828|NCT03468283|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1309829|NCT03468270|||Case-Only||Prospective|||||||
1309830|NCT03468257|Randomized|Parallel Assignment||Prevention||Single||||||t
1309831|NCT03468244||Single Group Assignment||Treatment||None (Open Label)||||||
1309832|NCT03468231|Randomized|Parallel Assignment||Treatment||Triple|In the OXA group, saline replace the fluorouracil and leucovorin solution and patients are treated the same time as the FOLFOX group.||t|t||t
1309833|NCT03468218||Single Group Assignment||Treatment||None (Open Label)||||||
1309834|NCT03468205|||Cohort||Prospective|||||||
1309835|NCT03468192|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster-randomized study of 394 patients operated with direct anterolateral approach.||||
1309836|NCT03468179||Single Group Assignment||Basic Science||None (Open Label)||All subjects will have baseline blood drawn, fed controlled serving of oatmeal, and blood drawn sequentially over subsequent 2 hours.||||
1309837|NCT03468166|||Case-Only||Cross-Sectional|||||||
1309838|NCT03468153||Single Group Assignment||Treatment||None (Open Label)||||||
1309839|NCT03468140|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Five end-stage liver disease (ESLD) patients will be matched to 5 historical controls.||||
1309840|NCT03468127|||Other||Prospective|||||||
1309841|NCT03468114|Randomized|Parallel Assignment||Prevention||None (Open Label)|Outcome assessors are not informed of allocation but would likely infer this from the presence of highly visible domestic products that are part of the intervention. Lab technicians and data analysts are masked to allocation status.|||||
1309842|NCT03468101|||Case-Only||Prospective|||||||
1309843|NCT03468088|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309844|NCT03468075||Single Group Assignment||Treatment||None (Open Label)||||||
1309845|NCT03468062|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1309846|NCT03468049|Randomized|Parallel Assignment||Treatment||Single|the outcome assessor will be blinded from knowing the nature of treatment that participants will be recieving either in the intervention groups or control group|participant will be randomly allocated into 4 groups Topical Application of Allum Cepa Extract, Phonophoresis of Allium Cepa Etract, Raw Mashed Allium Cepa Application and Standard Physiotherapy group ) the first 3 groups will be recieving standard physiotherapy management of shoulder pain post stroke just like those in the standard physiotherapy group in addition to specific treatment assigned to each of the groups||||t
1309847|NCT03468036|||Case-Control||Prospective|||||||
1309848|NCT03468023|Randomized|Parallel Assignment||Treatment||Double||"Non-inferiority trial aimed at comparing the non inferiority of a short arm cast (below elbow cast) as opposed to a long arm cast (below elbow cast) in terms of fracture reduction maintenance ratio.~The sample size was selected as the highest required to test all non-inferiority thresholds and considering a drop-out percentage of 15%. Continuous values of all radiological parameters were used in order to keep results objective and reproducible."|||t|t
1309849|NCT03468010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309850|NCT03467997|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1309851|NCT03467984|Randomized|Parallel Assignment||Prevention||Single|||t|||
1309852|NCT03467971|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1309853|NCT03467958||Single Group Assignment||Treatment||None (Open Label)||||||
1309854|NCT03467945|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1309855|NCT03467932|Randomized|Parallel Assignment||Treatment||Quadruple|"Single-Blind Placebo Run-in (Masking will be with Participant):~During the placebo run-in period subjects will self- administer blinded placebo study medication at night prior to bedtime (@10 PM ± 90 minutes each night, no sooner than 2 hours after dinner). Outpatient glycemic levels and adverse events will be measured using self-monitored blood glucose (SMBG) and recorded in a diary.~Treatment Period (Masking will be Participant, Care Provider, Investigator, Outcomes Assessor) Part 1 In the first two weeks of active treatment (Part 1) subjects will receive double-blind therapy according to their randomized regimen (placebo or ORMD-0801) to be taken QHS, BID or TID.~Part 2:~During Part 2, subjects will remain on fixed doses of ORMD-0801 or matched placebo for 10 weeks. Doses will not be adjusted unless clinically indicated for adverse events or hypoglycemia. Treatment arms will consist of subjects receiving ORMD-0801 QHS, ORMD-0801 BID and ORMD-0801 TID versus placebo."||t|t|t|t
1309856|NCT03467919|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309857|NCT03467906|||Cohort||Cross-Sectional|||||||
1309858|NCT03467893|||Cohort||Prospective|||||||
1309859|NCT03467880|||Cohort||Cross-Sectional|||||||
1309860|NCT03467867||Single Group Assignment||Treatment||None (Open Label)||||||
1309861|NCT03467854|||Cohort||Prospective|||||||
1309862|NCT03467841|||Cohort||Prospective|||||||
1309863|NCT03467828|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1309864|NCT03467815|||Cohort||Prospective|||||||
1309865|NCT03467802|||Other||Prospective|||||||
1309866|NCT03467789|Randomized|Parallel Assignment||Treatment||Double|"The study will be double-blinded. Neither the patient nor the treating physicians will know which patients receive the Vitamin D3 or placebo pills. Using a coin toss approach, the Research Pharmacist will assign each patient to a study group"||t|t||
1309867|NCT03467776|||Cohort||Other|||||||
1309868|NCT03467763|Randomized|Crossover Assignment||Treatment||Triple|Patients, care providers, and investigators will be masked to the identity of the trial medication until the conclusion of the trial, and unblinding.|This study is an N-of-1 trial design that will recruit 20 previously metformin-intolerant patients for re-challenge with metformin in a double-blind scenario. Patients will be assigned to take their baseline medication regimen plus 2 weeks of 250 mg per day of metformin extended release, followed by 500 mg metformin XR, 750 mg, and 1,000 mg metformin XR with each treatment period separated by a 2-week course of placebo. Initial treatment, placebo or metformin XR, will be decided randomly.|t|t|t|
1309869|NCT03467750|Randomized|Parallel Assignment||Supportive Care||Single|The PACU nurses will be blinded to ketorolac administration, but will be informed of all other medications given. The PACU nurses will evaluate the patients using FLACC scores at 10 minutes post-op, 20 minutes post-op and at time of PACU discharge. Morphine will be administered to obtain a FLACC score of less than 3.|||t||
1309870|NCT03467737|Randomized|Crossover Assignment||Other||Single|||t|||
1309871|NCT03467724|Non-Randomized|Single Group Assignment||Treatment||Single|The blinded reviewer will review the baseline photographs of the surgical scar(s) and compare them to the photographs taken at follow-up month 3, 4, 5 and 12.|The subject will act as their own control. Each surgical scar is split into two areas with one side of the scar receiving the study treatment while the other side of the scar remains as the control.||||t
1309872|NCT03467711|||Case-Only||Prospective|||||||
1309873|NCT03467698|Randomized|Parallel Assignment||Basic Science||Double||Participants will be randomly assigned to one of two groups: (1) active tDCS (2) Sham tDCS.|t|||t
1309874|NCT03467685|Randomized|Single Group Assignment||Prevention||Single|Subjects will be asked to close their eyes prior to the vibration anesthetic device (VAD) being applied to their skin. Only the user will know whether the VAD will be on or off based on the result of a random number generator. This will prevent anticipatory changes on the subjects side. The subject will be aware of the intervention after the device is turned on or left in the off position.|"Subjects will be randomly assigned into one of two groups:~Group 1: Vibratory anesthetic device (VAD) is in the OFF mode Group 2: VAD is in the ON mode~We will use a random number generator to place patients into one of the two groups."|t|||
1309875|NCT03467672|||Case-Control||Prospective|||||||
1309876|NCT03467659|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1309877|NCT03467646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309878|NCT03467633|Randomized|Parallel Assignment||Other||Double|||||t|t
1309879|NCT03467620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309880|NCT03467607|Randomized|Parallel Assignment||Prevention||None (Open Label)|open label, randomisation blinded|parallel assignment||||
1309881|NCT03467594|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309882|NCT03467581|||Cohort||Prospective|||||||
1310212|NCT03463278|||Cohort||Prospective|||||||
1309883|NCT03467568|Randomized|Parallel Assignment||Basic Science||Double|Salt / placebo will be consumed by capsule under a double blind procedure|The study has four arms. Salt alone; salt plus water; placebo alone, placebo plus water|t||t|
1309884|NCT03467555||Single Group Assignment||Treatment||None (Open Label)||||||
1309885|NCT03467542||Single Group Assignment||Treatment||None (Open Label)||||||
1309886|NCT03467529|||Cohort||Prospective|||||||
1309887|NCT03467516||Single Group Assignment||Treatment||None (Open Label)||The Phase 2 study will follow the Simon's optimal two-stage design. Fifteen patients will be included in the first stage; if there are 1 or fewer patients responding to therapy the trial will be terminated. If at least 2 responses are observed, expansion into Stage 2 to a total of 47 patients will occur. If at least 6 patients respond to therapy, the study therapy would be considered to have met its primary study goal.||||
1309888|NCT03467503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309889|NCT03467490|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1309890|NCT03467477||Single Group Assignment||Diagnostic||None (Open Label)||||||
1309891|NCT03467464||Single Group Assignment||Treatment||None (Open Label)||||||
1309892|NCT03467451|||Other||Retrospective|||||||
1309893|NCT03467438|Randomized|Parallel Assignment||Treatment||Double|The manufacturer will provide packages of the investigational medical product/placebo that are indistinguishable. Every package have a code written on it; only the manufacturer knows whether that code refers to the IMD or placebo.||t||t|
1309894|NCT03467425|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be randomized in a ratio of 1:1 to receive one of the following study treatment regimens: TRELEGY ELLIPTA once daily in the morning or Non-ELLIPTA MITT twice-daily treatment.||||
1309895|NCT03467412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309896|NCT03467399||Single Group Assignment||Treatment||None (Open Label)||||||
1309897|NCT03467386||Single Group Assignment||Treatment||None (Open Label)||||||
1309898|NCT03467373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309899|NCT03467360||Single Group Assignment||Treatment||None (Open Label)||Phase I study with a prospective, multicenter, non randomized, open-label extension cohort, evaluating the safety of acetazolamide in combination with platinum and etoposide-based radiochemotherapy in patients with Localized Small cell lung cancer||||
1309900|NCT03467347|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309901|NCT03467334|Randomized|Parallel Assignment||Treatment||Double|The control group is the usual treatment that is administered differently (oral drops, 4 times a day) to the 2 research treatments (powder, 1 time a day).||||t|t
1309902|NCT03467321|||Case-Control||Cross-Sectional|||||||
1309903|NCT03467308|||Case-Control||Prospective|||||||
1309904|NCT03467295|||Cohort||Prospective|||||||
1309905|NCT03467282|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309906|NCT03467269|||Cohort||Retrospective|||||||
1309907|NCT03467256||Single Group Assignment||Treatment||None (Open Label)||||||
1309908|NCT03467243|Randomized|Parallel Assignment||Health Services Research||Single|Research assistants administering the outcomes measures will be blinded to the Veteran's treatment condition.|"Cognitive Behavioral Social Skills Training for Peer Specialists (CBSST-Peer). At each site, two PSs will co-lead a series of 20 weekly, 60-minute CBSST-Peer classes, grouped into two 10-class modules: the Cognitive Skills Module and the Social Skills Module. The treatment manual includes a patient workbook and includes homework assignments.~Social Skills Training-Peer. These groups will run according to the Bellack et al. model used in VA's SST rollout. Groups will use behavioral rehearsal role play to improve communication and interaction skills GFSC-Peer group. GFSC is a manualized, semi-structured intervention consisting of check-in about symptoms and potential crisis management and work on individual goals."||||t
1309909|NCT03467230|||Case-Only||Prospective|||||||
1309910|NCT03467217|Randomized|Parallel Assignment||Treatment||Triple|Participants, investigators, clinical staff, and data monitoring committee will not have knowledge of the interventions assigned to individual participants.||t|t|t|
1309911|NCT03467204||||||||||||
1309912|NCT03467191|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1309913|NCT03467178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309914|NCT03467165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Pilot study||||
1309915|NCT03467152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309916|NCT03467139|Randomized|Parallel Assignment||Treatment||Single||||||t
1309917|NCT03467113||Single Group Assignment||Treatment||None (Open Label)||Single group assignment||||
1309918|NCT03467100|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1309919|NCT03467087||Single Group Assignment||Supportive Care||None (Open Label)||||||
1309920|NCT03467074|||Cohort||Prospective|||||||
1309921|NCT03467061|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1309922|NCT03467048|Randomized|Parallel Assignment||Treatment||Single|||t|||
1309923|NCT03467035|||Cohort||Prospective|||||||
1309924|NCT03467022|||Other||Prospective|||||||
1309925|NCT03467009|Randomized|Parallel Assignment||Prevention||Single||||||t
1309926|NCT03466996|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1309927|NCT03466983|Randomized|Parallel Assignment||Treatment||Quadruple|double-blinded||t|t|t|t
1309928|NCT03466970|||Other||Prospective|||||||
1309929|NCT03466957||Single Group Assignment||Treatment||None (Open Label)||||||
1309930|NCT03466944|||Cohort||Prospective|||||||
1309931|NCT03466931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1309932|NCT03466918||Single Group Assignment||Treatment||None (Open Label)||||||
1309933|NCT03466905|Non-Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1309934|NCT03466892|||Cohort||Prospective|||||||
1309935|NCT03466879|||Case-Control||Prospective|||||||
1309936|NCT03466866|Randomized|Parallel Assignment||Health Services Research||Double||Single blind, randomized controlled trial|||t|t
1309937|NCT03466853|||Cohort||Cross-Sectional|||||||
1573387|NCT00001416||||Treatment||||||||
1309938|NCT03466840|Randomized|Parallel Assignment||Treatment||Single|According to the allocation sequence obtained from the computer software the numbers will be written in small folded opaque papers and put in opaque sealed envelopes. All those papers will be ready before conducting any procedure. The patients will be allowed to pick his/her number from the pile of envelopes and will be assigned accordingly. The number of papers will decrease as each patient picks his number and so on.||t|||
1309939|NCT03466827||Single Group Assignment||Treatment||None (Open Label)||||||
1309940|NCT03466814|||Cohort||Prospective|||||||
1309941|NCT03466801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309942|NCT03466788|Non-Randomized|Parallel Assignment||Other||Single|open label||t|||
1309943|NCT03466775|||Cohort||Retrospective|||||||
1309944|NCT03466762|||Other||Cross-Sectional|||||||
1309945|NCT03466749||Single Group Assignment||Treatment||None (Open Label)||||||
1309946|NCT03466736|||Cohort||Prospective|||||||
1309947|NCT03466723|||Case-Control||Prospective|||||||
1309948|NCT03466710|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1309949|NCT03466697||Single Group Assignment||Other||None (Open Label)||||||
1309950|NCT03466684|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1309951|NCT03466671|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1309952|NCT03466658|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309953|NCT03466645|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1309954|NCT03466632|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1309955|NCT03466619||Single Group Assignment||Treatment||None (Open Label)||inflatable penile prosthesis (IPP)||||
1309956|NCT03466606|Randomized|Parallel Assignment||Prevention||Single||||||t
1309957|NCT03466593|Randomized|Parallel Assignment||Prevention||None (Open Label)||"A prospective cohort compared to historical controls~A randomized, controlled, intervention study."||||
1309958|NCT03466580|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||A stepped wedge cluster randomized controlled trial. All clusters (i.e., specialized palliative care (SPC) units) will start as controls and will change to intervention at various times determined by randomization. In this way, all SPC units will contribute to control and intervention groups, thus accounting for variation between SPC units.||||
1309959|NCT03466567|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a 3-period cross-over study. The participants will be randomised to three treatment sequences each consisting of three treatment periods. One treatment period with a single dose of 3 mg oral semaglutide alone, one treatment period with a single dose of 600 mg ciclosporin 1 hour prior to administration of a single dose of 3 mg oral semaglutide and one treatment period with 500 mg probenecid administered twice daily for 3½ days with the last dose 2 hours prior to administration of a single dose of 3 mg oral semaglutide. Pharmacokinetics of sodium N-(8-(2-hydroxybenzoyl) amino) caprylate (SNAC) and SNAC metabolites will be assessed after each single dose of 3 mg oral semaglutide.||||
1309960|NCT03466554|Randomized|Crossover Assignment||Treatment||Single||||||t
1309961|NCT03466541|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309962|NCT03466528|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a 3- arm randomised, open label, controlled study in a cohort of alcoholic patients admitted through A&E. Patients will be randomised to concurrent infusion of one of the following:~Arm 1: IV thiamine~Arm 2: IV magnesium sulphate followed by delayed IV thiamine~Arm 3: IV thiamine and IV magnesium sulphate Thiamine will be administered as IV Pabrinex, a compound preparation which also contains B vitamins and vitamin C. Administration of IV Pabrinex is standard care in this patient group and magnesium sulphate is routinely co-administered at Glasgow Royal Infirmary."||||
1309963|NCT03466515||Single Group Assignment||Treatment||None (Open Label)||pilot study with a maximum of 20 patients||||
1309964|NCT03466502|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1309965|NCT03466489|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized||||
1309966|NCT03466476|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients who meet enrollment criteria will be randomized to either the treatment group where they will receive their consensus tracpatch or be assigned to the control group where no wearable technology will be employed.||||
1309967|NCT03466463||Sequential Assignment||Treatment||None (Open Label)||||||
1309968|NCT03466450||Sequential Assignment||Treatment||None (Open Label)||Phase Ib/II, multicentric, non-randomized, open label||||
1309969|NCT03466437|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1309970|NCT03466424|||Cohort||Prospective|||||||
1309971|NCT03466411|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1309972|NCT03466398|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1309973|NCT03466385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1309974|NCT03466372|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1309975|NCT03466359|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1309976|NCT03466346|Randomized|Parallel Assignment||Health Services Research||Single|participants will be evaluated by an outcomes assessor that is not aware of which treatment the participant is receiving. This will be achieved by keeping the randomization key locked and accessible only to the study coordinator and investigators. Participants who are scheduled for assessments will be reminded not to spontaneously disclose their treatment modality to the outcomes assessor.|fluoxetine versus interpersonal psychotherapy (IPT) for treatment of Major Depressive Disorder (MDD)||||t
1309977|NCT03466333|Randomized|Parallel Assignment||Treatment||Quadruple||Double blind randomised controlled trial (40 participants) Eligible women who decline to take art in the interventional arm, can consent to the observational arm of the study (up to 40 participants)|t|t|t|t
1309978|NCT03466320|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1309979|NCT03466307|||Case-Control||Prospective|||||||
1309980|NCT03466294||Single Group Assignment||Treatment||None (Open Label)||||||
1309981|NCT03466281|Randomized|Parallel Assignment||Treatment||Single||Active Comparator: 1 Structured patients group intervention - IBS School Active Comparator: 2 Structured Patient education via Internet||||t
1309982|NCT03466268||Single Group Assignment||Treatment||None (Open Label)||||||
1309984|NCT03466242|Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a feasibility pilot study, and as such, will be non-blinded, and utilize a convenience sample of children aged 2-18 years old requiring closed reduction under conscious sedation for distal forearm fractures. 20 children recruited in IN Dex arm and 20 children in Ketamine arm||||
1309985|NCT03466229|Randomized|Parallel Assignment||Treatment||Single|The active compound and placebo are given a number and the list linking this number to the type of preparation (placebo or active compound) is stored by one of the sponsors (Octean)|Double blind randomised placebo controlled study|||t|
1309986|NCT03466216||Single Group Assignment||Treatment||None (Open Label)||||||
1309987|NCT03466203|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1309988|NCT03466190|Randomized|Parallel Assignment||Treatment||None (Open Label)|Because the two interventions used in this trial are clearly different and easily recognized by the participants and investigators, neither the investigator nor participants can be blinded|"A Randomized clinical trial.~A trial will be carried out in hospital of Oral and Maxillofacial surgery department- Faculty of Oral and Dental Medicine Cairo University~Equal randomization: participants with equal probabilities for intervention.~Positive controlled: Both groups receiving treatment.~Parallel group study: Each group of patients receives a single treatment simultaneously."||||
1309989|NCT03466177|||Cohort||Cross-Sectional|||||||
1309990|NCT03466164|Randomized|Parallel Assignment||Basic Science||None (Open Label)||discordant twin design||||
1309991|NCT03466151|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 Randomization||||
1309992|NCT03466138|||Case-Only||Retrospective|||||||
1309993|NCT03466125|||Cohort||Retrospective|||||||
1309994|NCT03466112|Randomized|Parallel Assignment||Other||Double|||||t|t
1309995|NCT03466099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1309996|NCT03466086|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1309997|NCT03466073|Randomized|Sequential Assignment||Treatment||Quadruple|visibly indistinguishable therapy|sequential dose escalation|t|t|t|t
1309998|NCT03466060|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1309999|NCT03466047|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1310000|NCT03466034|||Cohort||Prospective|||||||
1310001|NCT03466021|Randomized|Parallel Assignment||Treatment||Double||A prospective, randomized, placebo-controlled, double-blinded, parallel group and two-center trial.|t||t|
1310002|NCT03466008|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||between (two groups: WBC and control), and within subjects (two repeated measures: pre and post intervention)||||
1310003|NCT03465995|||Case-Only||Prospective|||||||
1310004|NCT03465982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310005|NCT03465969||Single Group Assignment||Other||None (Open Label)||||||
1310006|NCT03465956||Single Group Assignment||Treatment||None (Open Label)||All patients,males and females with age (20-50 years old) with morbid obesity (BMI ≥ 40 kg/m2 or > 35 kg/m2 associated with co-morbidity).||||
1310007|NCT03465943|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1310008|NCT03465930|||Case-Only||Cross-Sectional|||||||
1310009|NCT03465917||Single Group Assignment||Basic Science||None (Open Label)||||||
1310010|NCT03465904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310011|NCT03465891|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a two-arm, parallel, open-label, phase II clinical trial.||||
1310012|NCT03465878|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1310013|NCT03465865|||Case-Control||Retrospective|||||||
1310014|NCT03465852|Randomized|Parallel Assignment||Prevention||Single|Study participants will be randomly assigned to the intervention or the wait list comparison arm|The intervention study uses an intervention arm and a wait list comparison (control) arm||||t
1310015|NCT03465839|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1310016|NCT03465826|Randomized|Parallel Assignment||Other||Double|||||t|t
1310017|NCT03465813|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1310018|NCT03465800|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1310019|NCT03465787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1310020|NCT03465774|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310021|NCT03465761||Single Group Assignment||Treatment||None (Open Label)||||||
1310022|NCT03465748|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310023|NCT03465735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310024|NCT03465722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310025|NCT03465709||Single Group Assignment||Treatment||None (Open Label)||||||
1310026|NCT03465696|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1310027|NCT03465683|||Cohort||Other|||||||
1310028|NCT03465670|Randomized|Parallel Assignment||Supportive Care||Triple|The patient, the clinical operators as well as the clinical examiner were kept blinded with respect to treatment allocation until the termination of the study. To ensure blindness, CHX and CHX+HA+ADS mouthrinses were provided in identical, masked containers numbered according to the randomization sequence.|Single-center, parallel-arm, triple-blind, randomized controlled clinical trial|t||t|t
1310029|NCT03465657|||Ecologic or Community||Cross-Sectional|||||||
1310030|NCT03465644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310031|NCT03465631|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310032|NCT03465618|Non-Randomized|Parallel Assignment||Diagnostic||Single|Two expert PET scan readers, who are board-certified in Nuclear Medicine, will be designated to read and evaluate PET-CT scans. Volumetric region-of-interest analysis and extraction of the mean and maximum standard uptake values (SUVs) will be provided. Both readers will initially be blinded to the patient's clinical information for scan interpretation. A second interpretation will then be performed after both readers are provided with clinical information about the primary tumor site.|This is a two-year microdosing study that will enroll 19 malignant or metastatic brain tumor patients, including surgical (n=14) and non-surgical candidates (n=5).||||t
1310033|NCT03465605|||Cohort||Prospective|||||||
1310034|NCT03465592||Single Group Assignment||Treatment||None (Open Label)||"Nivolumab will be infused intravenously (IV, in a vein) over 60 minutes every 14 days for a maximum of 24 doses (12 cycles). A cycle is considered 28 days. Participants may continue to receive Nivolumab unless they develop serious side effects or the tumor worsens.~There are two parts to this study. The first part, Part A, is for patients who have relapsed or have progressive disease after their BMT. Part A will enroll approximately 3-9 patients. The second part, Part B, is for patients who have not yet relapsed or progressed after BMT. Part A will be completed to prove that administering the experimental drug after BMT is safe and part B will begin once part A is completed"||||
1310035|NCT03465579|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310036|NCT03465566|||Case-Control||Cross-Sectional|||||||
1310037|NCT03465553||Single Group Assignment||Treatment||None (Open Label)||||||
1310038|NCT03465540||Sequential Assignment||Treatment||None (Open Label)||||||
1310039|NCT03465527||Single Group Assignment||Supportive Care||None (Open Label)||||||
1310040|NCT03465514||||||||||||
1310041|NCT03465501|||Case-Control||Retrospective|||||||
1310042|NCT03465488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310043|NCT03465475|||Case-Control||Prospective|||||||
1310044|NCT03465462|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Three stages of the study:~stage 1- diagnosis of primary hypertension~stage 2 (lasting 3 months) - antihypertensive monotherapy in all subjects~stage 3 (lasting 30 days) - 3 groups (3 arms): group/arm C (control group), group/arm D (diet group) and group/arm S (supplementation group)."||||
1310045|NCT03465449|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1310046|NCT03465436|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1310047|NCT03465423|||Case-Control||Prospective|||||||
1310048|NCT03465410|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized, prospective, multicenter study||||
1310049|NCT03465397|Randomized|Parallel Assignment||Prevention||None (Open Label)||Multicenter open clinical trial, randomized, stratified by age, parallel groups||||
1310050|NCT03465384|Randomized|Parallel Assignment||Treatment||Single|Independent clinicians will perform diagnostic assessments at pre and post measurements. The clinicians will be blind to the experimental condition the participants they assess.|Participants are randomized to the standard intervention (Parent training in group format) or the experimental condition (Internet-based parent training).||||t
1310051|NCT03465371|Randomized|Parallel Assignment||Treatment||None (Open Label)||A cluster randomized non-inferiority trial||||
1310052|NCT03465358|||Other||Prospective|||||||
1310053|NCT03465345||Single Group Assignment||Treatment||None (Open Label)||||||
1310054|NCT03465332|||Cohort||Cross-Sectional|||||||
1310055|NCT03465319|||Case-Only||Prospective|||||||
1310056|NCT03465306|Randomized|Sequential Assignment||Treatment||Single||This study is been designed to have pre, post, and follow-up phases.|t|||
1310057|NCT03465293|||Cohort||Prospective|||||||
1310058|NCT03465280|||Cohort||Prospective|||||||
1310059|NCT03465267|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor does not know the allocation of participants.|||||t
1310060|NCT03465254|||Cohort||Prospective|||||||
1310061|NCT03465241|||Cohort||Prospective|||||||
1310062|NCT03465228|Randomized|Factorial Assignment||Supportive Care||Double|The participants will be not informed if the LED appliance will be on or off, and the outcomes will be numbers for identification.|The first day, will be explanation of the project and signing of the Informed Consent Term. The participants will go to collect blood samples for analysis creatine kinase and cortisol levels. They will be submitted an anthropometric evaluation, psychometric questionnaires and perform functional tests, and perform of a continuous submaximal exertion test. All these procedures will be performed again at the end of the intervention, and the pain intensity scale will be applied in all meetings with participants (beginning and end of each session). After the evaluations, the participants will be randomized into three experimental groups with 15 participants in each: the first group will be the training group that will perform interval training sessions in addition to continuous training sessions. The second group will perform the same training model, and before the training sessions the LED will be applied. And the third group will only receive the LED application.|t|||t
1310063|NCT03465215||Single Group Assignment||Diagnostic||None (Open Label)||The investigators will include 29 CD patients with a symptomatic intestinal stricture requiring surgery. From these patients, the investigators will collect fullthickness surgical specimen from the non-stenotic and stenotic intestinal wall and will perform analysis using digital holographic microscopy and in histopathological analysis.||||
1310064|NCT03465202||Single Group Assignment||Basic Science||None (Open Label)||||||
1310065|NCT03465189|||Cohort||Prospective|||||||
1310066|NCT03465176|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310067|NCT03465163|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1310068|NCT03465150|||Cohort||Prospective|||||||
1310069|NCT03465137|Randomized|Parallel Assignment||Treatment||None (Open Label)||Immediate therapy versus waitlist arms||||
1310070|NCT03465124|Randomized|Parallel Assignment||Diagnostic||Quadruple|Groups will be randomized. Randomization information will be put in a sealed envelope on screening date and opened in operating theatre right before procedure start.|Bilateral cataract surgery will be performed in individuals with age-related cataract. Eyes will be randomized into two groups receiving either Femtosecond Laser assisted Cataract Surgery (LCS) or conventional Manual Cataract Surgery (MCS).|t|t|t|t
1310071|NCT03465111|Randomized|Parallel Assignment||Treatment||None (Open Label)||"ATLAS is an Investigator-initiated, open-labelled, multi-center, randomized, phase II clinical trial, to evaluate the effect of two dose regimens of subcutaneous ACTH gel in subjects with non-infectious anterior scleritis. Thirty (30) subjects with non-infectious anterior scleritis will be enrolled and randomized (1:1) at their first visit to one of the two treatment arms:~Mandatory 80 U twice weekly treatment with SC ACTH gel, starting at the Baseline visit (Day 0) until end of week 16. Starting at week 17, the treatment will be administered on as needed basis, based on the retreatment criteria.~Mandatory 80 U thrice weekly treatment with SC ACTH gel, starting at the Baseline visit (Day 0) until end of week 16. Starting at week 17, the treatment will be administered on as needed basis, based on the retreatment criteria."||||
1310072|NCT03465098||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310073|NCT03465085|Randomized|Factorial Assignment||Treatment||Triple|Investigators prepared and administered the study medication. participants, ICU physician and nurses, and the outcomes assessor were blinded to the two randomized groups|"Group (I): Heparin group (n=20) received nebulized Heparin 10000 IU/4h. Group (II): Streptokinase group (n=20) received nebulized Streptokinase 250,000 IU/4h.~Group (III): Control group (n=20) received conservative management"|t|t||t
1310074|NCT03465072||Single Group Assignment||Basic Science||None (Open Label)||||||
1310075|NCT03465059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310076|NCT03465046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310077|NCT03465033|Randomized|Parallel Assignment||Treatment||Triple|All patients will be told that two interventions are compared but they will not know which one is the usual care or the early physiotherapy. Professionals that will evaluate the measurements and the investigators that will make the statistical analysis, all will be blinded to treatment allocation.|Patients undergoing OS will be studied. All patients will be told that two interventions are compared but they will not know which one is the usual care or the early physiotherapy. All of them will receive instructions of basic care after surgery: use of intermaxillary elastics, soft diet during the first month and semi-soft during the second month. Patients will be asked to remove the intermaxillary elastics 30min before the measurements.|t||t|t
1310078|NCT03465020|||Cohort||Prospective|||||||
1310079|NCT03465007|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1310080|NCT03464994|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310081|NCT03464981|||Cohort||Prospective|||||||
1310082|NCT03464968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310083|NCT03464955|Randomized|Parallel Assignment||Prevention||Single||||||t
1310084|NCT03464942|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants with triple negative breast cancer will be randomised to receive either SABR 20Gy in one fraction or 24 Gy in 3 fractions , they will then go onto receive atezolizumab for up to 24 months||||
1310085|NCT03464929|||Other||Prospective|||||||
1310086|NCT03464916||Sequential Assignment||Treatment||None (Open Label)||To determine DLT and MTD, the design uses a 3+3 rule-based design. Dose escalation is permitted between successive cohorts based upon a specified algorithm, using discrete dosage steps.||||
1310087|NCT03464903|||Case-Control||Other|||||||
1310088|NCT03464890||Single Group Assignment||Treatment||None (Open Label)||||||
1310089|NCT03464877||Single Group Assignment||Other||None (Open Label)||Prospective cohort study||||
1310090|NCT03464864|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1310091|NCT03464851|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310092|NCT03464838|Randomized|Parallel Assignment||Treatment||Double|Participants will be allocated either to a tDCS Stimulation condition or to a tDCS Sham condition. Neither the investigator nor the participant will know to which condition the participant has been allocated.|Investigation of the effects of transcranial direct current stimulation (tDCS) in combination with cognitive behavioural therapy (CBT) against the effects of CBT alone.|t||t|
1310093|NCT03464825|Randomized|Parallel Assignment||Prevention||Single||One intervention group receiving Specific and progressive balance training One control group|||t|
1310094|NCT03464812||Single Group Assignment||Supportive Care||None (Open Label)||||||
1310095|NCT03464799|||Case-Only||Prospective|||||||
1310096|NCT03464786|Randomized|Parallel Assignment||Treatment||Single||||||t
1310097|NCT03464773|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1310098|NCT03464760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310099|NCT03464747|||Cohort||Prospective|||||||
1310100|NCT03464734||Single Group Assignment||Treatment||None (Open Label)||||||
1310101|NCT03464721|||Cohort||Prospective|||||||
1310102|NCT03464708|Randomized|Parallel Assignment||Prevention||Quadruple|Double blind.|Double blind, placebo controlled, randomised controlled trial|t|t|t|t
1310103|NCT03464695|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1310104|NCT03464682|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1310105|NCT03464669|||Cohort||Prospective|||||||
1310106|NCT03464656||Single Group Assignment||Treatment||None (Open Label)||Single-center, prospective, comparative study||||
1310107|NCT03464643|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310108|NCT03464630|Randomized|Parallel Assignment||Treatment||Double|Assessors and participants are naive to treatment condition|Two arm, randomized controlled intent to treat trial|t|||t
1310109|NCT03464617|||Cohort||Prospective|||||||
1310110|NCT03464604|||Case-Control||Prospective|||||||
1310111|NCT03464591|||Case-Only||Prospective|||||||
1310112|NCT03464578|||Cohort||Prospective|||||||
1310113|NCT03464565|||Cohort||Prospective|||||||
1310114|NCT03464552|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1310115|NCT03464539||Single Group Assignment||Prevention||None (Open Label)||||||
1310116|NCT03464526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310117|NCT03464513||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310118|NCT03464500|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1310119|NCT03464487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310120|NCT03464474||Single Group Assignment||Diagnostic||None (Open Label)||Colonic biopsies from 28 patients with ulcerative colitis will be endoscopically acquired. These biopsies will be examined by digital holographic microscopic and by analysis due to an experienced histopathologists using an established scoring system (Goldstandard).||||
1310121|NCT03464461|Randomized|Parallel Assignment||Treatment||Double|blinded drug|4 groups with 3 different treatments|t|t||
1310122|NCT03464448|||Cohort||Prospective|||||||
1310123|NCT03464435||Single Group Assignment||Treatment||None (Open Label)||||||
1310124|NCT03464422|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||HIV positive MSM and HIV negative MSM will receive the same intervention in separate group settings.||||
1310125|NCT03464409|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310126|NCT03464396|||Cohort||Prospective|||||||
1310127|NCT03464383|Randomized|Parallel Assignment||Treatment||Single|Outcome assessment phone calls for gathering scaled instrument scores will be carried out by a second study coordinator, blinded to treatment assignment.|Participants will be randomized to one of two groups. Those randomized to the intervention group will receive an epileptologist-driven medication treatment for anxiety and depression, carried out directly in the epilepsy clinic during a regularly scheduled visit and supported by advanced practice provider (APP). Those randomized to the control group will receive an referral order to psychiatry placed by their epileptologist.||||t
1310128|NCT03464370|Non-Randomized|Parallel Assignment||Other||None (Open Label)||This pilot study is prospective, monocentric, epidemiologic, case control||||
1310129|NCT03464357|Non-Randomized|Parallel Assignment||Other||None (Open Label)||The study will compare the extent of neuronal activation at the visual cerebral cortex between a group with photophobia related to dry eye syndrome and a group of asymptomatic patients (without dry eye and no photophobia) with an MRIf.||||
1310130|NCT03464344|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310131|NCT03464331|Randomized|Parallel Assignment||Supportive Care||Single||Simple individual randomization method by sequentially numbered, opaque sealed envelopes (SNOSE) will be used to ensure the research staff / interventionists and participants will be concealed from the allocation sequence. The statistician will prepare about 150 identical, opaque, sealed, A5-sized envelops, with a unique 3-digit serial number on the cover of each envelope as an identifier. Half of them will each contain a card indicating EXP and the other half, CON. For EXP, the card will further indicate activity tracker or no tracker, in 1:1 ratio. After consent, the RS will open an envelope according to the sequence of the serial number and assign participant to either EXP or CON group. The envelop must be opened according to the serial number. All others will not know the group allocation before the envelope is opened. Frequent checks (at least weekly) of these numbers will be done to ensure no deviation.|t|||
1310132|NCT03464318|||Other||Prospective|||||||
1310133|NCT03464305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310134|NCT03464292|Randomized|Parallel Assignment||Basic Science||Single|Identically looking placebo will be used. The outcome assessor will not be aware which study drug was applied to the subjects|This parallel study will be age & sex matched, randomized and placebo controlled . Only the outcome assessor but not the subjects will be blinded to the study intervention||||t
1310135|NCT03464279|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1310136|NCT03464266|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1310137|NCT03464253|||Cohort||Prospective|||||||
1310138|NCT03464240|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1310139|NCT03464227|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1310140|NCT03464214|Randomized|Parallel Assignment||Treatment||Single||||||t
1310141|NCT03464201||Single Group Assignment||Treatment||None (Open Label)||||||
1310142|NCT03464188|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1310143|NCT03464175|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1310144|NCT03464162|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will choose if they want to receive Social Network Meetings or be in a group that does not receive Social Network Meetings. Entrance of clients into the study will be staggered with no more than approximately 5 individuals in the Social Network group and no more than 5 individuals not in the Social Network group enrolled each month. There will be a maximum of 15 participants (clients) in each group.||||
1310145|NCT03464149||Sequential Assignment||Diagnostic||None (Open Label)||For every patient, blood samples from four consecutive quarterly routine controls are analyzed using the four assays, respectively. This cross-sequential study design allows to study both, the agreement between two PTH assays at a given time point (i.e., cross sectionally) as well as to analyse the longitudinal variance of the analytical results of the four PTH assays (i.e., sequentially).||||
1310146|NCT03464136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310147|NCT03464123|||Cohort||Prospective|||||||
1310148|NCT03464110|Randomized|Parallel Assignment||Other||None (Open Label)||Interventional: To determine the effect of a clinician communication coaching intervention versus control on an objective measure of the quality of communication (primary outcome) and patients' perceptions of the quality of patient-centered care (secondary outcome), both overall and within Black and White patients.||||
1310149|NCT03464097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310150|NCT03464084|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1310151|NCT03464071|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1310152|NCT03464058|Randomized|Crossover Assignment||Basic Science||Triple|Part 1 and 2 of the study are open-label and therefore blinding is not required. Part 3 of the study is double-blind.||t||t|t
1310153|NCT03464045|||Cohort||Prospective|||||||
1310154|NCT03464032||Single Group Assignment||Treatment||None (Open Label)||||||
1310155|NCT03464019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1310156|NCT03464006|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a single centre, randomized controlled trial.||||
1310157|NCT03463993|Randomized|Parallel Assignment||Prevention||None (Open Label)|Trial is an open label randomized control trial|Randomized control trial with two arms. Participants receive either 10mg/kg of TXA 10 minutes prior to elective caesarean section with prophylactic oxytocin administration after delivery of the baby, versus prophylactic oxytocin alone after delivery of the baby.||||
1310158|NCT03463980|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310159|NCT03463967|Randomized|Crossover Assignment||Treatment||Single||||||t
1310160|NCT03463954||Single Group Assignment||Treatment||None (Open Label)||||||
1310161|NCT03463941||Single Group Assignment||Prevention||None (Open Label)||||||
1310162|NCT03463928|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1310163|NCT03463915|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1310209|NCT03463317|Randomized|Parallel Assignment||Prevention||None (Open Label)||Event-driven group-sequential design, non-inferiority test, if significant followed by superiority test||||
1310164|NCT03463902|Randomized|Crossover Assignment||Treatment||Triple|participants, outcome assessors and raters are blinded. tDCS application is performed by an unblinded investigator|randomized, double-blind, cross-over trial of 5 tDCS protocols|t|t||t
1310165|NCT03463889||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310166|NCT03463876||Single Group Assignment||Treatment||None (Open Label)||||||
1310167|NCT03463863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1310168|NCT03463850|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310169|NCT03463837|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310170|NCT03463824|Randomized|Parallel Assignment||Treatment||Quadruple|The principal investigators, the statistician, and members of the data collection team will remain blinded to intervention assignment throughout the duration of the study. They will be given the identifying codes only at the end of the study when it is necessary to interpret the results. The un-blinded study coordinator, who is responsible for scheduling testing and treatment sessions, will serve to receive the study patients and escort them to the various testing and treatments sites to minimize the interaction between patients; however, the study coordinator will not participate in the assessments.|Participants will be randomly assigned to one of two intervention arms. Both intervention arms involve immersive video games that encourage participants to produce progressively larger lumbar flexion excursions at each game level and across treatment sessions. The two groups are distinguished by the amount of lumbar flexion needed to achieve game objectives.|t|t|t|t
1310171|NCT03463811|||Cohort||Prospective|||||||
1310172|NCT03463798|||Cohort||Prospective|||||||
1310173|NCT03463785|||Cohort||Prospective|||||||
1310174|NCT03463772|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients that have provided informed consent will be randomized to either IVM or standard IVF. Randomization and allocation of patients to study groups will be performed on the day 2 or 3 of the menstrual cycle. Randomization will be centrally controlled by administrative staff in the trial center, who are not involved in the treatment procedure. When there is an eligible participant to be enrolled into the study, nurses from the specific site will log in the trial center to get allocation of patients according to a computer-generated randomization list in a 1:1 ratio, with a variable block size of 2, 4 or 8 and stratified by center.||||
1310175|NCT03463759|||Case-Control||Prospective|||||||
1310176|NCT03463746|Randomized|Single Group Assignment||Treatment||Single|Only assessors of the primary outcomes will be blinded to group assignment|Monocentric, randomised-controlled, single-blind trial.||||t
1310177|NCT03463733||Single Group Assignment||Treatment||None (Open Label)||||||
1310178|NCT03463720|||Cohort||Retrospective|||||||
1310179|NCT03463707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310180|NCT03463694|Randomized|Parallel Assignment||Treatment||Single|The team in the virology lab carrying out the analysis of the nasal swabs will be blinded to the allocation of the participant.|ELVIS Kids is a parallel, open label, randomised controlled trial (RCT) of HS nose drops (~2.6% NaCl) vs. standard care in children <7 years of age with symptoms of an URTI.||||t
1310181|NCT03463681||Single Group Assignment||Treatment||None (Open Label)||||||
1310182|NCT03463668|||Cohort||Retrospective|||||||
1310183|NCT03463655|||Cohort||Prospective|||||||
1310184|NCT03463642|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1310185|NCT03463629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310186|NCT03463616|||Cohort||Retrospective|||||||
1310187|NCT03463603|||Cohort||Cross-Sectional|||||||
1310188|NCT03463590||Single Group Assignment||Treatment||None (Open Label)||All subjects will receive bilateral surgical implantation of DBS system||||
1310189|NCT03463577|||Cohort||Retrospective|||||||
1310190|NCT03463564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310191|NCT03463551|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310192|NCT03463538|Randomized|Parallel Assignment||Treatment||Single|independent clinical reviewer of patients ROM and collection of outcome scores|randomised control trial between interventions||||t
1310193|NCT03463525||Single Group Assignment||Other||None (Open Label)||||||
1310194|NCT03463512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310195|NCT03463499||Single Group Assignment||Treatment||None (Open Label)||||||
1310196|NCT03463486|||Cohort||Prospective|||||||
1310197|NCT03463473||Single Group Assignment||Treatment||None (Open Label)||Dose escalation||||
1310198|NCT03463460||Single Group Assignment||Treatment||None (Open Label)||||||
1310199|NCT03463447||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310200|NCT03463434|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This multi-center, randomized, open-label, two treatment, parallel group study is designed to obtain comparative data on the healing rates of type 3 & 4 pressure injuries.~The randomization schedule will be set up in blocks, and within a block, the randomization numbers will be assigned equally to the two treatment groups (Envella AFT, FIS bed surface types). A separate randomization schedule will be set up for each stage (3, 4 PI). The anticipated number of investigative sites is 3."||||
1310201|NCT03463421|||Cohort||Other|||||||
1310202|NCT03463408|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||two cohort, open label, non-randomized study||||
1310203|NCT03463395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Sixty patients ≥ 18 years of age presenting to the investigator's laryngology outpatient clinic with LPR, with an RFS ≥ 7 and an RSI ≥ 13, not on anticoagulants, able to tolerate an endoscopy and consent to participate in this research study will be included. One cohort (Group A) will receive standard care (n =30), the other (Group B) will receive standard care plus the Reza band (to be worn as recommended by the manufacturer; n = 30).||||
1310204|NCT03463382|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1310205|NCT03463369|Randomized|Sequential Assignment||Other||Triple|||t||t|t
1310206|NCT03463356||Single Group Assignment||Treatment||None (Open Label)||non-concurrent multiple baseline design||||
1310207|NCT03463343|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1310208|NCT03463330|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310210|NCT03463304|||Ecologic or Community||Prospective|||||||
1310213|NCT03463265|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1310214|NCT03463252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310215|NCT03463239||Single Group Assignment||Treatment||None (Open Label)||||||
1310216|NCT03463226|||Cohort||Prospective|||||||
1310217|NCT03463213||Single Group Assignment||Prevention||None (Open Label)||This is a feasibility study with a single group pre/post outcome design.||||
1310218|NCT03463200|Randomized|Parallel Assignment||Treatment||Single||||||t
1310219|NCT03463187|Randomized|Sequential Assignment||Treatment||Quadruple||This is a multiple dose escalating design in 3 sequential cohorts at 3 dose levels (80mg, 160mg, and 240mg) with potential two lower dose levels (20mg and 40mg) in plaque psoriasis subjects.|t|t|t|t
1310220|NCT03463174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310221|NCT03463161|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be assigned to one of 2 study groups based on response to prior therapy.||||
1310222|NCT03463148|||Cohort||Retrospective|||||||
1310223|NCT03463135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310224|NCT03463122|Randomized|Crossover Assignment||Treatment||Single||||||t
1310225|NCT03463109|Non-Randomized|Parallel Assignment||Basic Science||Single|Every participant will recive stimulation on his back in a pre-defined random order.|The same procedure will be used for people with chronic low back pain and for healthy volunteers.|t|||
1310226|NCT03463096||Single Group Assignment||Basic Science||None (Open Label)||||||
1310227|NCT03463083|Randomized|Parallel Assignment||Supportive Care||Double|An online randomization program (http://www.randomizer.org) will be used to generate random list and to allocate patients into the study groups. Random allocation numbers will be concealed in opaque closed envelops. The patient and investigator assessing study outcomes will all be blinded to the study groups allocation. The study drugs will be prepared by a separate investigator not involved in outcome assessment|"This double-blind, prospective, randomised clinically controlled study is designed to study the efficacy of epidural analgesia of dexmedetomidine and compare the analgesic effect of its epidural injection with bupivacaine versus fentanyl with bupivacaine in the post operative period of elective spine surgeries.~To determine if the epidural route provide an acceptable analgesia in spine surgeries and avoided the need for excessive IV analgesics. Also to determine whatever dexmedetomidine or fentanyl is more better neuroaxial adjuvant regarding providing early onset and prolonged analgesia and stable cardiorespiratory parameters."|t|t||
1310228|NCT03463070|Randomized|Parallel Assignment||Prevention||Single|||t|||
1310229|NCT03463057||Single Group Assignment||Treatment||None (Open Label)||||||
1310230|NCT03463044|Randomized|Parallel Assignment||Other||Double|||t||t|
1310231|NCT03463031|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310232|NCT03463018|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1310233|NCT03463005|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||The study subjects were voluntarily assigned to royal gel and IUI groups. In royal gel group, 5 grams of royal gel was used after menstruation and every other night before and after intercourse. IUI group received 75 units of FSH from the second day of the cycle.||||
1310234|NCT03462992|||Cohort||Prospective|||||||
1310235|NCT03462979|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1310236|NCT03462966||Single Group Assignment||Treatment||None (Open Label)||||||
1310237|NCT03462953|Randomized|Parallel Assignment||Basic Science||Single||||||t
1310238|NCT03462940||Single Group Assignment||Basic Science||None (Open Label)||||||
1310239|NCT03462927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310240|NCT03462914|||Cohort||Prospective|||||||
1310241|NCT03462901||Single Group Assignment||Treatment||None (Open Label)||Fracture clavicle in adults||||
1310242|NCT03462888|||Cohort||Retrospective|||||||
1310243|NCT03462875|||Cohort||Cross-Sectional|||||||
1310244|NCT03462862|Randomized|Parallel Assignment||Other||Triple||2 parallel groups one group will receive RPD with PEEK denture base and the other will get Bre Flex denture base material|t|t||t
1310245|NCT03462849|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310246|NCT03462836|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1310247|NCT03462823|Randomized|Parallel Assignment||Treatment||Single||Randomized patient-blinded two-group parallel comparison trial using an active comparator.|t|||
1310248|NCT03462810||||||||||||
1310249|NCT03462797|||Other||Prospective|||||||
1310250|NCT03462784|||Other||Cross-Sectional|||||||
1310251|NCT03462771|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1310252|NCT03462758|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1310253|NCT03462745|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1310254|NCT03462732|Randomized|Parallel Assignment||Prevention||Quadruple||assignment|t|t|t|t
1310255|NCT03462719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310256|NCT03462706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310257|NCT03462693|||Cohort||Prospective|||||||
1310258|NCT03462680|Randomized|Parallel Assignment||Health Services Research||Quadruple|Only Pharmacists keep the log of the drug dispensed. Everyone else is blinded.|There are two arms, niacin and placebo. They are double blind and randomized.|t|t|t|t
1310259|NCT03462667|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310260|NCT03462654|Randomized|Parallel Assignment||Prevention||Single||Participants will be randomized into either the iLiFE or gLiFE arm of the study.||||t
1310261|NCT03462641|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1310262|NCT03462628|Randomized|Parallel Assignment||Treatment||Single|Single (Participant)|Parallel Assignment|t|||
1310263|NCT03462615|||Case-Only||Cross-Sectional|||||||
1310264|NCT03462602|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1310265|NCT03462589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310266|NCT03462576||||||||||||
1310267|NCT03462563|Randomized|Parallel Assignment||Prevention||Single|||||t|
1310268|NCT03462550|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310269|NCT03462537|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1310270|NCT03462524|||Cohort||Retrospective|||||||
1310271|NCT03462511|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1310272|NCT03462498|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310273|NCT03462485|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||The project will be a randomised controlled trial with a partial crossover. Each condition will be followed for eight weeks, with the crossover occurring after eight weeks for the control group. The intervention group will continue for the full sixteen weeks.||||
1310274|NCT03462472|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1310275|NCT03462459|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1310276|NCT03462446|||Cohort||Retrospective|||||||
1310277|NCT03462433|||Cohort||Prospective|||||||
1310278|NCT03462420|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1310279|NCT03462407|Randomized|Parallel Assignment||Other||None (Open Label)||Participants will be randomized prospectively into one of three possible groups following initial assessments and screening (e.g., eligibility), 1) 10 participants in an experimental (DAID intervention), 2) 10 control participants (dog walking), 3) 10 waitlisted control participants (true control, waitlisted for DAID during summer 2 of the project).||||
1310280|NCT03462394|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1310281|NCT03462381|Randomized|Parallel Assignment||Basic Science||Double||Participants will perform three endurance training sessions weekly for 12 weeks. All participants will be randomly assigned to the protein supplementation group or the placebo (iso-caloric carbohydrate) group. During the 12 weeks endurance training program participants allocated to the protein group (30 g protein per beverage) will receive a protein drink after exercise and prior to sleep at night on training days. On non-training days participants will only receive a protein drink before sleep. Participants allocated to the carbohydrate group (30 g carbohydrates) will receive a carbohydrate drink instead of a protein drink.|t||t|
1310282|NCT03462368|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1310283|NCT03462355|||Cohort||Prospective|||||||
1310284|NCT03462342||Single Group Assignment||Treatment||None (Open Label)||Each cycle is 28 days. Patient will take Olaparib daily for all 28 days of the cycle and patient will take the investigational AZD6738 from days 1-7 of the cycle. Patient will visit the care provider to assess the treatment effects.||||
1310285|NCT03462329|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||"Patients will evaluate their pre-treatment expectations about treatment outcome of erythema migrans.~Nonspecific symptoms will be assessed in patients and control subjects."||||
1310286|NCT03462316||Single Group Assignment||Treatment||None (Open Label)||||||
1310287|NCT03462303|Randomized|Factorial Assignment||Basic Science||Double|||t|||t
1310288|NCT03462290|Randomized|Parallel Assignment||Treatment||Double||a randomized, double-blind, cross-over, placebo-controlled pilot study|t||t|
1310289|NCT03462277|||Cohort||Prospective|||||||
1310290|NCT03462264|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomised control trial||||
1310291|NCT03462251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310292|NCT03462238|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310293|NCT03462212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310294|NCT03462199|Randomized|Parallel Assignment||Prevention||Quadruple||randomized, double-blind, placebo controlled, parallel study|t|t|t|t
1310295|NCT03462186|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1310296|NCT03462173|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1310297|NCT03462160|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1310298|NCT03462147|Randomized|Single Group Assignment||Device Feasibility||Single|||t|||
1310299|NCT03462134|||Other||Cross-Sectional|||||||
1310300|NCT03462121|Randomized|Parallel Assignment||Treatment||Quadruple|1:2||t|t|t|t
1310301|NCT03462108|Randomized|Parallel Assignment||Prevention||Double|The study for the neonates is double-blind, randomized study. While, the study for the adults and childrens is open-labeled study|"Adults and Children Group: Experimental, open labeled, prospective intervention study~Neonates Group: Experimental, randomized, double blind, prospective intervention study"|t||t|
1310302|NCT03462095|Randomized|Factorial Assignment||Treatment||Single|||||t|
1310303|NCT03462082|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1310304|NCT03462069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310305|NCT03462056||Single Group Assignment||Treatment||None (Open Label)||||||
1310306|NCT03462043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1310307|NCT03462030|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo controlled||t|t|t|t
1310308|NCT03462017|Randomized|Sequential Assignment||Basic Science||Triple|||t||t|t
1310309|NCT03462004|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1310310|NCT03461991||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310311|NCT03461978|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310312|NCT03461965|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients will be recruited from University Hospitals Department of Dermatology Mohs Micrographic Surgery Clinics at the Cleveland Medical Center, Chagrin Highlands and Westlake Locations. These patients will be randomly assigned to a control (50%) or experimental group (50%) prior to the onset of the study protocol.||||
1310313|NCT03461952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310314|NCT03461939|||Cohort||Prospective|||||||
1310370|NCT03461198||Single Group Assignment||Treatment||None (Open Label)||||||
1310371|NCT03461185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310372|NCT03461172|||Cohort||Retrospective|||||||
1310373|NCT03461159|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1310374|NCT03461146||Single Group Assignment||Treatment||None (Open Label)||||||
1310375|NCT03461133|||Cohort||Retrospective|||||||
1310425|NCT03460483||Single Group Assignment||Screening||None (Open Label)||||||
1310315|NCT03461926|Randomized|Factorial Assignment||Prevention||None (Open Label)||This study will employ a prospective, 2-group, repeated measure (2x5), randomized controlled trial design. All participants will be randomized into either a 6-week HAPA-treatment (SB-related planning + text messages intervention) or waitlisted control (no treatment) condition. All primary outcomes will be assessed at four time points (baseline, 2, 4, and 6 weeks), and again at a two-week follow-up (8 weeks). Action and coping planning and action control towards reducing workplace sitting time will be assessed at the same time points. Secondary outcome assessments (i.e., work- and health-related outcomes) will occur pre- (baseline) and post-intervention (6 weeks).||||
1310316|NCT03461913|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310317|NCT03461900|Randomized|Parallel Assignment||Treatment||Double||stepped wedge cluster randomized trial|t|||t
1310318|NCT03461887|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310319|NCT03461874|Randomized|Parallel Assignment||Treatment||Single||||||t
1310320|NCT03461861|Randomized|Crossover Assignment||Prevention||Quadruple||This is a randomized, double-blind, placebo-controlled crossover study in which a low dose of LEV (125 mg, BID) or placebo will be administered to 50 healthy 55-75-year-old subjects (comprising 25 APOE 4 carriers and 25 noncarriers), with the order of treatments counterbalanced in a within-subject crossover design.|t|t|t|t
1310321|NCT03461848|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1310322|NCT03461835|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1310323|NCT03461822|||Case-Control||Prospective|||||||
1310324|NCT03461809|||Cohort||Retrospective|||||||
1310325|NCT03461783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310326|NCT03461770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1310327|NCT03461757|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1310328|NCT03461744|||Cohort||Prospective|||||||
1310329|NCT03461731|Randomized|Parallel Assignment||Basic Science||Single|The participant cannot tell if the laser is turned on because the fan runs for the placebo as well|Each participant receives placebo and two different light treatments in random order|t|||
1310330|NCT03461718|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310331|NCT03461705||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310332|NCT03461692|||Cohort||Prospective|||||||
1310333|NCT03461679|Randomized|Parallel Assignment||Treatment||Triple||RCT|t|t||t
1310334|NCT03461666|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||parallel group||||
1310335|NCT03461653|Randomized|Parallel Assignment||Other||None (Open Label)||Randomised trial||||
1310336|NCT03461640|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1310337|NCT03461627|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind|Drug：Salmeterol Xinafoate and Fluticasone Propinate Powder for inhalation (50ug/250ug) Drug：Seretide (50ug/250ug)|t|t|t|t
1310338|NCT03461614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310339|NCT03461601|Randomized|Parallel Assignment||Treatment||Single|Vaginal flushing with 10 ml saline was performed in the control group|intrauterine injection of human chorionic gonadotropin before intrauterine insemination (IUI) compared to IUI alone|t|||
1310340|NCT03461588|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310341|NCT03461575|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1310342|NCT03461562|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1310343|NCT03461549|||Cohort||Prospective|||||||
1310344|NCT03461536|Randomized|Parallel Assignment||Diagnostic||Triple|Patients, investigators, and outcome assessors will be blinded to study arm.||t||t|t
1310345|NCT03461523|||Cohort||Prospective|||||||
1310346|NCT03461510|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310347|NCT03461497|||Cohort||Prospective|||||||
1310348|NCT03461484|||Cohort||Prospective|||||||
1310349|NCT03461471||Single Group Assignment||Supportive Care||None (Open Label)||||||
1310350|NCT03461458|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1310351|NCT03461445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310352|NCT03461432||Single Group Assignment||Treatment||None (Open Label)||A case-control study design with pre- and post-therapy assessment.||||
1310353|NCT03461419|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310354|NCT03461406|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310355|NCT03461393|||Cohort||Retrospective|||||||
1310356|NCT03461380|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1310357|NCT03461367|||Cohort||Prospective|||||||
1310358|NCT03461354|Randomized|Crossover Assignment||Treatment||Single|||t|||
1310359|NCT03461341|||Cohort||Retrospective|||||||
1310360|NCT03461328|Randomized|Parallel Assignment||Supportive Care||Double||Intra-operative intravenous infusion of magnesium sulphate in patients with chronic obstructive pulmonary diseases undergoing total laryngectomy and assess the influence on arterial oxygenation and pulmonary Mechanics in|t|||t
1310361|NCT03461315|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Quasi-experimental study .||||
1310362|NCT03461302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310363|NCT03461289||Single Group Assignment||Treatment||None (Open Label)||Open-label, single-arm, single-dose, trial of AVXS-101||||
1310364|NCT03461276|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1310365|NCT03461263|Randomized|Parallel Assignment||Treatment||Double|Group A, wherein patients received phonophoresis treatment using pumpkin seeds oil; Group B, where members of the group received trans-perineal continuous low-intensity ultrasound; and Group C, in which the participant received placebo low- intensity ultrasound. All of The three groups of the organized trail received their corresponding treatment daily up-to 3 weeks.||t|||t
1310366|NCT03461250|||Case-Control||Cross-Sectional|||||||
1310367|NCT03461237|||Cohort||Prospective|||||||
1310368|NCT03461224|||Other||Retrospective|||||||
1310369|NCT03461211||Single Group Assignment||Treatment||None (Open Label)||||||
1573388|NCT00001415||||||||||||
1310376|NCT03461120|Randomized|Parallel Assignment||Prevention||Quadruple|The only individuals aware of treatment assignment will be the Investigational Drug Service pharmacists who prepare the treatment infusate||t|t|t|t
1310377|NCT03461107|||Cohort||Prospective|||||||
1310378|NCT03461094||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310379|NCT03461081|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1310380|NCT03461068|Randomized|Crossover Assignment||Basic Science||Double|Placebo masked with flavouring and participants consume in opaque containers||t|||t
1310381|NCT03461055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310382|NCT03461042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1310383|NCT03461029|||Case-Only||Cross-Sectional|||||||
1310384|NCT03461016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310385|NCT03461003|Randomized|Parallel Assignment||Treatment||Single||||||t
1310386|NCT03460990|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1310387|NCT03460977|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310388|NCT03460964||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310389|NCT03460951|||Case-Control||Prospective|||||||
1310390|NCT03460938|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1310391|NCT03460925||Sequential Assignment||Treatment||None (Open Label)||||||
1310392|NCT03460912|||Cohort||Prospective|||||||
1310393|NCT03460899||Single Group Assignment||Basic Science||None (Open Label)||||||
1310394|NCT03460886|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1310395|NCT03460873|||Cohort||Prospective|||||||
1310396|NCT03460860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310397|NCT03460847|||Cohort||Prospective|||||||
1310398|NCT03460834|||Cohort||Prospective|||||||
1310399|NCT03460821|||Cohort||Prospective|||||||
1310400|NCT03460808||Single Group Assignment||Treatment||None (Open Label)||||||
1310401|NCT03460795||Single Group Assignment||Treatment||None (Open Label)||||||
1310402|NCT03460782||||||||||||
1310403|NCT03460769|||Case-Control||Prospective|||||||
1310404|NCT03460756|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310405|NCT03460743|Randomized|Parallel Assignment||Other||Double|Participant- and observer-blind, the vaccine will be administered by a non-blinded vaccinator that will not participate in the clinical evaluation.|"Visit 1: screening visit, baseline blood sampling and administration of the study vaccine that can be performed on Day 0.~Visit 1A and 2: Remote follow up contacts on day 2 and 7 post-vaccination. Visit 3: i. Follow up and blood sampling (for the 1-dose group); ii. Visit 3A, follow-up and application of the second dose of the vaccine (for the corresponding group); iii. Visit 3B, follow-up and blood sampling for the 2-dose group. The visits occur on Day 28.~Months 3, 4, 5: Remote Contacts for safety tracking Visit 4: Remote contact for study closure and safety tracking at Month 6"|t||t|
1310406|NCT03460730||Single Group Assignment||Basic Science||None (Open Label)||||||
1310407|NCT03460717|Non-Randomized|Single Group Assignment||Treatment||Double|the person performing the intervention and the assessment are different|intervention offered and those who decline are followed as a waiting list control|||t|t
1310408|NCT03460704|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1310409|NCT03460691|||Cohort||Prospective|||||||
1310410|NCT03460678|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients will be randomized into either the arm of Erlotinib 150 mg once daily, or the arm of Pemetrexed 500 mg/m2 administered as an intravenous infusion over 10 minutes on the first day of each 21‐day cycle, until disease progression or unacceptable toxic effects.||||
1310411|NCT03460665|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1310412|NCT03460652||Single Group Assignment||Treatment||None (Open Label)||||||
1310413|NCT03460639|Randomized|Parallel Assignment||Treatment||Single|In the sham group, the laser will be switched off and a recording of the emission sounds will be used to give the volunteer the auditory sensation of laser therapy.|Tiredness will be induced by isometric contraction occlusion time. Patients will be evaluated in two stages. The first moment will be maximum occlusion in all patients in order to be able to measure the individual time for fatigue of the masseter muscle (evaluation by electromyography). The second will have the application of the laser in a group (at the wavelength of 780nm, 134 J / cm2, power of 50 mW irradiance of 1.675 W / cm2, for 80 seconds per point in 3 points in the masseter muscle and one in the temporal muscle on each side); simulation of the application (placebo-psychic factor), control (without application); after this first moment, we will have maximum occlusion in all the patients in order to be able to measure the individual time for fatigue (evaluation by electromyography).|t|||
1310414|NCT03460626|Randomized|Parallel Assignment||Supportive Care||Single|Group-I and Group-II will be blinded to the intervention while Group-III would not be administered an intervention.|The students will be divided into three groups randomly as Group-I (Control group: treated with a placebo that is an odorless oil without any therapeutic effect), Group-II (Treated group: administered with lavender oil) and Group-III (Untreated group)|t|||
1310415|NCT03460613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310416|NCT03460600|||Case-Only||Retrospective|||||||
1310417|NCT03460587||Single Group Assignment||Treatment||None (Open Label)||||||
1310418|NCT03460574|Randomized|Parallel Assignment||Treatment||Single|The investigator randomly assigns participants to one of the experimental conditions. Participants are not aware which experimental condition they are allocated to.|Parallel Assignment Participants are assigned to one of four experimental groups in parallel for the duration of the study|||t|
1310419|NCT03460561|Randomized|Parallel Assignment||Prevention||Single||||||t
1310420|NCT03460548|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1310421|NCT03460535|||Case-Only||Prospective|||||||
1310422|NCT03460522||Single Group Assignment||Treatment||None (Open Label)||||||
1310423|NCT03460509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310424|NCT03460496|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||An advanced practice nurse (APN)-led Intervention which focuses on improving parental mental health and well-being, on infant growth and development and on lowering overall costs.||||
1310426|NCT03460470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310427|NCT03460457||Single Group Assignment||Treatment||None (Open Label)||||||
1310428|NCT03460444||Single Group Assignment||Other||None (Open Label)||All participants complete the supplementation condition.||||
1310429|NCT03460431|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1310430|NCT03460418|||Cohort||Prospective|||||||
1310431|NCT03460405|Randomized|Parallel Assignment||Treatment||Double|"Subject aged 2 - 40 years old:~Randomized, observer-blind, superiority design compared to Vi polysaccharide vaccine.~Subject 6-23 months old:~Randomized, observer-blind, superiority design compared to Inactivated Poliomyelitis Vaccine (IPV)."|"Subject aged 2 - 40 years old:~Randomized, observer-blind, superiority design compared to Vi polysaccharide vaccine.~Subject aged 6-23 months old:~Randomized, observer-blind, superiority design compared to Inactivated Poliomyelitis Vaccine (IPV)."|t||t|
1310432|NCT03460392|||Other||Prospective|||||||
1310433|NCT03460379|||Case-Only||Prospective|||||||
1310434|NCT03460366|||Case-Only||Prospective|||||||
1310435|NCT03460353|||Case-Only||Prospective|||||||
1310436|NCT03460340|Randomized|Parallel Assignment||Treatment||Single|participants do not know if they are getting the DTMS treatment or sham.|randomized control trial (RCT)|t|||
1310437|NCT03460327|||Case-Only||Prospective|||||||
1310438|NCT03460314|||Case-Only||Prospective|||||||
1310439|NCT03460301|||Cohort||Prospective|||||||
1310440|NCT03460288|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is a randomly controlled study with 2 conditions: Condition 1: Computer-based training program (retraining), condition 2: Wait-list control group (access to the training after the post-assessment).~Two assessments-points, the intervention period (pre-post) is eight weeks. Sociodemographic and pathological data are obtained with an internet survey on Unipark®."||||
1310441|NCT03460275||Single Group Assignment||Treatment||None (Open Label)||||||
1310442|NCT03460262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310443|NCT03460249|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1310444|NCT03460236|||Cohort||Prospective|||||||
1310445|NCT03460223||Single Group Assignment||Treatment||None (Open Label)||||||
1310446|NCT03460210|||Case-Only||Prospective|||||||
1310447|NCT03460197|||Other||Prospective|||||||
1310448|NCT03460184|||Cohort||Prospective|||||||
1310449|NCT03460171|||Cohort||Prospective|||||||
1310450|NCT03460158||Single Group Assignment||Treatment||None (Open Label)||||||
1310451|NCT03460145|Randomized|Parallel Assignment||Prevention||Single|||t|||
1310452|NCT03460132||Single Group Assignment||Treatment||None (Open Label)||||||
1310453|NCT03460119|||Cohort||Retrospective|||||||
1310454|NCT03460106|||Case-Only||Cross-Sectional|||||||
1310455|NCT03460093|||Case-Control||Prospective|||||||
1310456|NCT03460080|||Case-Crossover||Other|||||||
1310457|NCT03460067|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310458|NCT03460054|||Cohort||Prospective|||||||
1310459|NCT03460041|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1310460|NCT03460028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310461|NCT03460015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310462|NCT03460002|Randomized|Parallel Assignment||Prevention||Single||"The RECAMP trials test two separate hypotheses relating to the potential beneficial non-specific effects of providing live vaccines in general vaccination campaigns.~The RECAMP-MV trial tests the effect of a Measles Vaccination campaign among children aged 9-59 months The RECAMP-OPV trial tests the effect of an Oral Polio Vaccination campaign in children aged 0-8 months"||t||
1310463|NCT03459989|||Cohort||Prospective|||||||
1310464|NCT03459976|||Case-Control||Retrospective|||||||
1310465|NCT03459963|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310466|NCT03459950|||Cohort||Prospective|||||||
1310467|NCT03459937|Randomized|Parallel Assignment||Treatment||Double|Outcomes assessors will be masked to intervention condition. Selected investigators who are overseeing the intervention will also be masked to study outcomes.|Participants will be randomly assigned to one of two intervention conditions, with assessments occurring at pre-intervention and post-intervention.|||t|t
1310468|NCT03459924|||Cohort||Retrospective|||||||
1310469|NCT03459911|Randomized|Crossover Assignment||Other||None (Open Label)|This study is an open label study; the subjects and the investigator will not be blinded towards the identity of the investigational products. However, analysts will be blinded towards identity of investigational product administered.|||||
1310470|NCT03459898|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310471|NCT03459885||Single Group Assignment||Treatment||None (Open Label)||||||
1310472|NCT03459872|||Other||Prospective|||||||
1310473|NCT03459859|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Dose escalation, traditional 3:3 design||||
1310474|NCT03459846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310475|NCT03459833|Randomized|Crossover Assignment||Treatment||Single||Patients with premature ejaculation according to the definition of Fourth International Consultation on Sexual Medicine 2015|t|||
1310476|NCT03459820||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310477|NCT03459807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310478|NCT03459794|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1310479|NCT03459781|Randomized|Parallel Assignment||Supportive Care||Single|All investigators will remain blinded, except for the study interventionists who will administ the CBCT® and CHE programs to participants and research coordinator who will inform participants about group assignment. Study interventionists and the study coordinator will not conduct data collection procedures or analyses of data that is collected.|Over the course of the study we will randomize 20 survivor-caregiver dyads to CBCT®, and 20 dyads to the CHE. We will conduct the study in several cohorts, with 4-10 dyads randomized to CBCT® and 4-10 dyads randomized with CHE in each cohort.|||t|
1310480|NCT03459768|||Cohort||Prospective|||||||
1310481|NCT03459755|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310482|NCT03459742|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster randomized controlled trial. The randomization unit will be the schools. The primary outcome will be measured individually, but the effect size will also be calculated at the school level.||||
1310483|NCT03459729||Single Group Assignment||Other||None (Open Label)||||||
1310484|NCT03459716|||Cohort||Prospective|||||||
1310485|NCT03459703|Randomized|Parallel Assignment||Treatment||None (Open Label)|Statistical analyses will be performed blinded.|||||
1310486|NCT03459690|Non-Randomized|Parallel Assignment||Other||None (Open Label)||This is a prospective trial enrolling healthy volunteers, including novice meditators and experienced meditators. Subjects will undergo an EEG at baseline and again after 6 weeks. During the 6 weeks, subjects will be asked to meditate twice a day, 12 minutes each time.||||
1310487|NCT03459677|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study is a randomized controlled superiority trial (RCT) that compares a modular trans-diagnostic CBT intervention (Back2School), treating school absenteeism in youths aged 7-17 years with treatment as usual (TAU). The design will follow a two (Back2School and TAU) by four (Time: pre, post, 3-month, and 1-year assessment) mixed between-within design.||||
1310488|NCT03459664|Randomized|Parallel Assignment||Health Services Research||Single|Individuals who evaluate the outcomes of interest will remain blinded regarding a participant's condition (RECOVER/TAU) over the course of the study. Randomization will be conducted after baseline assessment and communicated to the participant by a person that is not the outcome assessor. During follow-up assessments after 6 and 12 month the outcome assessor will remain blinded regarding a participant's condition.|Randomized controlled study with two arms (RECOVER or treatment as usual)||||t
1310489|NCT03459651||Single Group Assignment||Treatment||None (Open Label)||||||
1310490|NCT03459638|||Other||Cross-Sectional|||||||
1310491|NCT03459625|Randomized|Parallel Assignment||Treatment||Single|Participants will participate in laboratory assessments at baseline and immediately post-treatment, as well as at 6 months and 12 months post-treatment. Measures include standardized and validated parent and teacher questionnaires, gold-standard psychological assessments, and observational and interview ratings. All assessors for laboratory assessments will remain blind to treatment group assignment for the duration of the project. Teachers will also be blind to treatment group assignment. Research assistants involved in observational coding will be blind to both treatment condition and visit time point.|The proposed study is a randomized controlled trial of 138 families that will be conducted in three cohorts. Each cohort will involve a recruitment phase of 46 participants. Within each cohort parents will be randomly assigned to the MBSR (N=23) or PE group (N=23), and the groups will run concurrently.||||t
1310492|NCT03459612|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1310493|NCT03459599|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310494|NCT03459586||Single Group Assignment||Other||None (Open Label)||The purpose of this study is to determine if the 9zest app for Parkinson's disease is feasible, safe, and efficacious when used independently by individuals with Parkinson's disease.||||
1310495|NCT03459573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310496|NCT03459560|Randomized|Parallel Assignment||Prevention||Single||||||t
1310497|NCT03459547|Randomized|Parallel Assignment||Diagnostic||Double|double-blind|Patients of more than 18 years old without systemic disease/ disorders, smokers of less 5 cigarettes per day, periodontally healthy or treated with full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) ≤ 15% at baseline with edentulous space needing an all on four or all on six treatment with overdenture width of the keratinized gingiva ≥ 2 at the level of the crest|t||t|
1310498|NCT03459534||Single Group Assignment||Treatment||None (Open Label)||||||
1310499|NCT03459521||Single Group Assignment||Other||None (Open Label)||||||
1310500|NCT03459508|||Case-Only||Cross-Sectional|||||||
1310501|NCT03459495|Randomized|Parallel Assignment||Treatment||Double||prospective,randomized,placebo- controlled, double blind|t|||t
1310502|NCT03459482|Randomized|Parallel Assignment||Treatment||Triple||Parallel Design|t|t|t|
1310503|NCT03459469||Single Group Assignment||Treatment||None (Open Label)||||||
1310504|NCT03459456|||Case-Control||Cross-Sectional|||||||
1310505|NCT03459443|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1310506|NCT03459430|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1310507|NCT03459417|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1310508|NCT03459404|||Case-Only||Retrospective|||||||
1310509|NCT03459391|Randomized|Sequential Assignment||Treatment||Double|Blinding was carried out by using Placebo equivalent to XC221 tablets without active substance and the corresponding labeling of the study drug.|The dose cohorts were included into the study subsequently based on preliminary safety results evaluation performed by the Data Safety Monitoring Committee. 2 doses of XC221/placebo (60 mg and 200 mg) were used in the study.The duration of exposure to the study drug was 6 days in each cohort: Day 1, once, at the step of single administration, and then in 6 days, daily, 1 time a day for 5 days at the step of multiple administration.|t||t|
1310510|NCT03459378|||Case-Only||Retrospective|||||||
1310511|NCT03459365||Single Group Assignment||Treatment||None (Open Label)||||||
1310512|NCT03459352||Single Group Assignment||Health Services Research||None (Open Label)||||||
1310513|NCT03459339||Single Group Assignment||Diagnostic||None (Open Label)||A hundred patients are enrolled in year 1 in each of five participating centers.||||
1310514|NCT03459326|||Cohort||Prospective|||||||
1310515|NCT03459313|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310516|NCT03459300|||Cohort||Prospective|||||||
1310517|NCT03459287|Randomized|Parallel Assignment||Treatment||Quadruple||Parallel group|t|t|t|t
1310518|NCT03459274|||Cohort||Prospective|||||||
1310519|NCT03459261|||Cohort||Prospective|||||||
1310520|NCT03459248|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1310521|NCT03459235||Single Group Assignment||Screening||None (Open Label)||||||
1310522|NCT03459222|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310523|NCT03459209|||Cohort||Prospective|||||||
1310524|NCT03459196||Single Group Assignment||Treatment||None (Open Label)||||||
1310714|NCT03456726|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310525|NCT03459183|Randomized|Parallel Assignment||Basic Science||Single|Participants will not know their group assignment (ultrasound - verum, ultrasound - placebo; infrasound - verum, infrasound - placebo).||t|||
1310526|NCT03459170||Single Group Assignment||Treatment||None (Open Label)||||||
1310527|NCT03459157||Single Group Assignment||Prevention||None (Open Label)||||||
1310528|NCT03459144|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1310529|NCT03459131|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1310530|NCT03459118|Randomized|Single Group Assignment||Other||Single||This is an intervention study testing Function Focused Care. The supplement, however, addresses a subsample of the population with dementia and explore the impact of pain on function and behavior and explores if this is a differential impact of the intervention between those with and without dementia. It is a descriptive study.||||t
1310531|NCT03459105|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1310532|NCT03459092|Randomized|Parallel Assignment||Treatment||Single||||||t
1310533|NCT03459079|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind, placebo-controlled trial.|A two arm randomized (1:1), double-blind, placebo-controlled, trial.|t|t|t|t
1310534|NCT03459066|||Other||Cross-Sectional|||||||
1310535|NCT03459053|Randomized|Parallel Assignment||Supportive Care||Double|Research coordinator will conduct the randomization and all information will be deidentified. Investigator will not know who is in which group.||||t|t
1310536|NCT03459040||Single Group Assignment||Prevention||None (Open Label)||Open label single arm||||
1310537|NCT03459027|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1310538|NCT03459014|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1310539|NCT03459001|||Cohort||Prospective|||||||
1310540|NCT03458988||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310541|NCT03458975|Randomized|Parallel Assignment||Treatment||Single||||||t
1310542|NCT03458962|||Family-Based||Prospective|||||||
1310543|NCT03458949||Single Group Assignment||Screening||None (Open Label)||||||
1310544|NCT03458936|||Cohort||Prospective|||||||
1310545|NCT03458923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310546|NCT03458910|Randomized|Parallel Assignment||Basic Science||Single||Participants will be randomly assigned to either the HRV-increase group or the HRV-decrease group.|t|||
1310547|NCT03458897||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310548|NCT03458884|Randomized|Parallel Assignment||Treatment||Single||1:1 prospective randomized open-label trial with blinded evaluators (PROBE-design)||||t
1310549|NCT03458871||Single Group Assignment||Treatment||None (Open Label)||||||
1310550|NCT03458858|Randomized|Crossover Assignment||Other||Double|||||t|t
1310551|NCT03458845|||Case-Control||Prospective|||||||
1310552|NCT03458832|||Cohort||Prospective|||||||
1310553|NCT03458819|||Cohort||Prospective|||||||
1310554|NCT03458806|||Case-Control||Cross-Sectional|||||||
1310555|NCT03458793|Randomized|Parallel Assignment||Treatment||Single|Computerised randomisation will be performed by an external researcher not involved in the delivery of the intervention or outcome assessment. Participants who will be assessors of their psychosocial outcomes using self-report questionnaires will be blind to the allocation concealment at the time of completing the initial questionnaires. Intervention providers who will be responsible for outcome assessments will not be blind to the intervention assignment as this would not be possible given the study and walks will be conducted by the PhD student.|This will be a two-arm randomised controlled trial (RCT) with a wait-list control group|t|||
1310556|NCT03458780|||Case-Only||Prospective|||||||
1310557|NCT03458767|Randomized|Parallel Assignment||Supportive Care||Single|A trained research assistant, blinded to the participant's group assignment, will collect the NIH Toolbox measures using an iPad at baseline and 8-weeks (post-intervention).|"This pilot feasibility study employs a mixed methods design conducted in a community setting. Phase 1 uses a single-group qualitative design involving a convenience sample of 5 adults with MS; Phase 2 uses a randomized controlled trial (RCT) design conducted with a sample of 20 adults with MS (10 intervention/10 control). Phase 2 data will be collected at baseline (before the intervention) and at 8-weeks (post-intervention). Data includes self-report measures, an objective measure of physical activity, and neurocognitive tests. An enhanced usual care control group is selected as most appropriate for this pilot feasibility study of a non-pharmacologic, behavioral intervention."||||t
1310558|NCT03458754|||Case-Control||Cross-Sectional|||||||
1310559|NCT03458741||Sequential Assignment||Basic Science||None (Open Label)||||||
1310560|NCT03458728|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310561|NCT03458715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310562|NCT03458702|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1310563|NCT03458689|Randomized|Crossover Assignment||Treatment||Single|Information connecting the patients to the data are kept locked and will be destroyed after the end of the investigation||t|||
1310564|NCT03458676||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310565|NCT03458663|Randomized|Parallel Assignment||Supportive Care||Single|Patients will be seen and the primary outcome assesed by a nurse in the out patient department who is blinded to the postoperative care the patient has recieved.|Single blinded, randomized controlled trial .||||t
1310566|NCT03458650|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1310567|NCT03458637|Randomized|Parallel Assignment||Treatment||Single|Staff involved in anthropometric measurements will be masked to group allocation.|One arm will be randomised to usual care The experimental arm group will be randomised to usual care and LITE program||||t
1310568|NCT03458624|||Case-Only||Prospective|||||||
1310630|NCT03457818|Randomized|Parallel Assignment||Prevention||Double|Clinical Research Coordinators|The study is a 12 month randomized (2:1 assignment) double-blind placebo-controlled trial of T2D postmenopausal women assigned to either Denosumab 60 mg subcutaneously (SC) at baseline and 6 months (n=44) or placebo (n=22); total study n=66.|t||t|
1310631|NCT03457805||Single Group Assignment||Treatment||None (Open Label)||||||
1310632|NCT03457792|||Cohort||Prospective|||||||
1310715|NCT03456713|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1310569|NCT03458611|Randomized|Crossover Assignment||Treatment||Double|Patients are not explicitly explained that a placebo and active version of the intervention will be compared, which makes it more likely for patients not to be aware of the treatment conditions. However they may notice a difference between the two interventions when they switch over from the first to the second intervention condition. In addition, the clinician who will administer the intervention to the patient on a daily basis cannot be blinded to the specific intervention that is administered to the patient, because the clinician will remain present during the intervention to guide the patient through the intervention. However, the clinicians that will perform the evaluation of symptoms using the tasks that are most sensitive to observer bias will be blinded to the treatment condition that is currently applied to the patient to avoid that the measurement of outcome is affected by observer bias.|The study design is a mix of a within-subject manipulation of the placebo and active intervention conditions and a between-subject manipulation of the order of these two within-subject conditions. To clarify, a placebo and active version of the VR game based attention training will be administered to each patient. The order of these two within-subject conditions is counterbalanced between-subjects to account for differences in order between the two treatment conditions.|t|||t
1310570|NCT03458598|Randomized|Parallel Assignment||Treatment||Triple|The intra-operative anesthesiologist, surgeon and outcomes assessor are blinded to group allocation||t|t||t
1310571|NCT03458585|||Other||Cross-Sectional|||||||
1310572|NCT03458572|Randomized|Parallel Assignment||Prevention||Single|||t|||
1310573|NCT03458559|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients will be randomized between~radium-223-chloride intravenously, for a total of 6 administrations (every 4weeks)~rhenium-188-HEDP intravenously for a total of 3 administratrions (every 8 weeks)"||||
1310574|NCT03458546||Single Group Assignment||Treatment||None (Open Label)||||||
1310575|NCT03458533|||Cohort||Prospective|||||||
1310576|NCT03458520|||Cohort||Prospective|||||||
1310577|NCT03458507|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||The patients will be randomized for two periods of one week to use NIV either with nasal or oronasal mask. The randomization will be stratified according to the type of interface previously used at home by the patient (nasal and oronasal). Such stratification will allow a balance between the number of patients that will begin with their usual interface versus with an alternative interface. In these patients, NIV withdrawal is not acceptable in terms of patient's security and ethics. Therefore, it is not possible to include a wash out period between both arms. The potential carry-over effect will be taken into account in the statistical analysis.||||
1310578|NCT03458494|Randomized|Crossover Assignment||Prevention||Single||randomized crossover dietary intervention|||t|
1310579|NCT03458481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310580|NCT03458468|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinded randomized||t|t|t|t
1310581|NCT03458455|||Cohort||Prospective|||||||
1310582|NCT03458442|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1310583|NCT03458429||Single Group Assignment||Treatment||None (Open Label)||To determine the safety and tolerability of 12 once monthly transfusions of GMFFP (Granulocyte - Colony Stimulating Factor (G-CSF) Mobilized Fresh Frozen Plasma harvested from young, healthy donors), given to older, frail individuals who are at risk due to unhealthy aging and who will then have a subsequent 12-month follow-up period.||||
1310584|NCT03458416||Single Group Assignment||Treatment||None (Open Label)||||||
1310585|NCT03458403||Single Group Assignment||Other||None (Open Label)||||||
1310586|NCT03458390||Single Group Assignment||Device Feasibility||None (Open Label)||HyGIeaCare colon irrigation procedure and PillCam COLON procedure||||
1310587|NCT03458377|Randomized|Parallel Assignment||Supportive Care||Single|The endoscope that performs the colonoscopy and the person in charge of collecting the data of colonoscopy complications and the overall satisfaction of the procedure will be blind to the patient group.|"Reference population: all outpatient referred for the realization of a colonoscopy, regardless of the requesting Service.~Two groups. One of them will receive an complete educational telephone call 7 days before de procedure in addition to the information received from the primary care center on the day of the request for the test. The inclusion in each one of the groups will be done through a randomization sheet.~The intervention includes educational aspects:~Explanation of the importance of making the test. Guidelines for the usual medication of the patient. Definition of fasting, explanation of colon cleansing adjusted to the presence of predictors of poor basic preparation. Explanation of the endoscopic procedure with the elimination of erroneous concepts of the patient with respect to the procedure. Explanation of norms of action subsequent to the endoscopy. Management of scheduling, destined to improve the adherence of the patient for the test."|||t|
1310588|NCT03458364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310589|NCT03458351|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1310590|NCT03458338|||Cohort||Cross-Sectional|||||||
1310591|NCT03458325|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||A prospective treatment arm (i.e., Furoscix administered via the Furoscix Infusor) administered outside the hospital that will be compared to a propensity-matched historical control arm of patients admitted to the hospital for ≤ 72 hours (i.e., Treatment As Usual (TAU)) that will be derived from administrative claims data.||||
1310592|NCT03458312|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)|a sample of patients with HGG (n=30) and their caregivers (n=30) recruited for intervention group (IG) with 'Nurse-led Family and Network Consultations' using pretest and posttest measures.|"To explore the feasibility of a 'Nurse-led Family and Network Consultation' (FNC) that seek to identify and address patients' symptoms/concerns and caregiver burden on one side and identify the resources and opportunities to ease their burdens on the other side.~To explore the impact of these nurse consultations on the nurses' perception of autonomy, self-esteem, and confidence, representing their professional identity"||||
1310593|NCT03458299|Randomized|Parallel Assignment||Prevention||None (Open Label)|No masking|Allocation: Randomized Intervention Model: Parallel Assignment||||
1310633|NCT03457779|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Patients with TNBC will receive [1,2-13C]-glucose IV to prior to undergoing a biopsy of their breast cancer and blood collection to allow for in depth evaluation.||||
1310634|NCT03457766||Single Group Assignment||Supportive Care||None (Open Label)||Using high frequency ultrasound in identification of safety margins of skin cancers||||
1310594|NCT03458286|Randomized|Parallel Assignment||Treatment||Single|Analysis of data will be blinded and carried out by a statistician. Patient data will be coded and not identifiable directly. The key to the code book information will be secured separately from the dataset in an encrypted file, which will only be accessible by the researcher and the supervisors of the study. Therefore the each arm will be coded and none identifiable to the outcome assessor.|"Participants will be randomly allocated into an experimental arm and a control arm of the study. The experimental group will receive the adjunctive CUSECS treatment along their usual treatment for their diabetic ulcer twice weekly for 8 weeks using the BRH-A2 wound healing device. They will also have a follow up appointment 4 weeks after completion of treatment.~The control group will be required to attend the diabetic foot clinic for their usual care for their diabetic foot ulcer with weekly review for a maximum of eight weeks. They will also have a follow up appointment 4 weeks after completion of treatment."||||t
1310595|NCT03458273|||Case-Control||Retrospective|||||||
1310596|NCT03458260||Single Group Assignment||Treatment||None (Open Label)||||||
1310597|NCT03458247|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1310598|NCT03458234||Single Group Assignment||Treatment||None (Open Label)||||||
1310599|NCT03458221||Single Group Assignment||Treatment||None (Open Label)||on the basis of primary Signalling Transduction Pathway Activation 'targeted therapy' will be administered to ovarian carcinoma patients||||
1310600|NCT03458208|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Open Label|four-way crossover||||
1310601|NCT03458195||Single Group Assignment||Basic Science||None (Open Label)||Patients aged 18 or more, for whom Crohn's disease diagnosis is confirmed and ileum or ileocecal Crohn's disease require surgical resection. in addition to usual practice, a bio-banking (blood samples, biopsies and surgical specimens) is collected.||||
1310602|NCT03458182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310603|NCT03458169||Single Group Assignment||Other||None (Open Label)||||||
1310604|NCT03458156|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1310605|NCT03458143|||Other||Prospective|||||||
1310606|NCT03458130|Randomized|Parallel Assignment||Treatment||Quadruple||A randomized, doubleblind, placebo-controlled, dose-ranging design is considered to be the most appropriate study design for meeting this objective. On the basis of information gained from previous clinical experience with AG10, the doses used in this study will be selected to determine the dose with the better safety and tolerability profile.|t|t|t|t
1310607|NCT03458117||Single Group Assignment||Treatment||None (Open Label)||||||
1310608|NCT03458104|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310609|NCT03458091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310610|NCT03458078|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1310611|NCT03458065|||Case-Control||Prospective|||||||
1310612|NCT03458052|||Other||Prospective|||||||
1310613|NCT03458039|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||8 counselors who are experienced delivering a cognitive behavioral therapy approach called Common Elements Transdiagnostic Approach (CETA) will be randomized 1:1 to either the Live or Technology train-the-trainer program. These trainers will then train 100 counselors in CETA. After being trained in CETA, the counselors will treat 500 patients with mental health and/or substance use problems.||||
1310614|NCT03458026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310615|NCT03458013|Non-Randomized|Parallel Assignment||Other||None (Open Label)||We are using a 2-cohort, nonrandomized comparative design focused on assessing feasibility and acceptability.||||
1310616|NCT03458000|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1310617|NCT03457987|||Cohort||Prospective|||||||
1310618|NCT03457974|Non-Randomized|Parallel Assignment||Diagnostic||Single||cross sectional study was carried out with 42 CHD and 42 healthy children|t|||
1310619|NCT03457961|||Cohort||Prospective|||||||
1310620|NCT03457948|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310621|NCT03457935|||Cohort||Prospective|||||||
1310622|NCT03457922|||Case-Only||Prospective|||||||
1310623|NCT03457909||Single Group Assignment||Other||None (Open Label)||||||
1310624|NCT03457896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310625|NCT03457883|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1310626|NCT03457870|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310627|NCT03457857|Randomized|Parallel Assignment||Other||Single|"This study will be evaluator-blinded, so the PI/expert graders will not know which group (Group 1 or Group 2) each subject is in. Personnel dispensing the IPs or supervising IP use will not participate in the evaluation of subjects in order to minimize potential bias. IPs will be kept separate from the site personnel involved in assessing or evaluating the subjects, and subjects will be instructed not to discuss their assigned IPs with the PI/expert graders or other subjects.~To keep the evaluator blinded, the study staff will keep the grading forms separate from the bulk of the source documents so the evaluator will not have access to the sheets that indicate randomization and the study staff will instruct the subjects/LAR to not say anything about what product they are using."|"The duration of this trial will be approximately 5 weeks and will consist of a screening visit followed by an approximately 1-week (7-day) washout period; a 4-week (28 day) treatment period with visits conducted at baseline (Day 0, ± 2 days), week 2 (Day 14, ± 2 days), and week 4 (Day 28, ± 2 days); and a regression period with a visit 3-5 days after the week 4 visit.~During the one week washout period, subjects will use a commercial available Baby Wash at least 3x per week.~For the next 4 weeks, subjects will be randomly assigned to use one of two IP regiments. Subjects in Group 1 will use the Baby Wash & Shampoo at least 3x per week, but no more than once daily. Subjects in Group 2 will use the Baby Wash & Shampoo at least 3x per week, but no more than once daily, plus the Baby Lotion at least once daily. The lotion should be applied after bathing (as applicable).~At Visit 4, subjects will begin a 3-5 day regression period."|||t|
1310628|NCT03457844||Single Group Assignment||Treatment||None (Open Label)||||||
1310629|NCT03457831|||Cohort||Prospective|||||||
1310635|NCT03457753||Single Group Assignment||Other||None (Open Label)||This is a multi-center, open label safety and tolerability trial. Approximately twenty-five (25) individuals with amyotrophic lateral sclerosis (ALS) will be enrolled.||||
1310636|NCT03457740|Randomized|Parallel Assignment||Prevention||Double|Double blind masking|Randomized, parallel group, placebo controlled, double blind|t||t|
1310637|NCT03457727|Randomized|Crossover Assignment||Treatment||None (Open Label)|This will be an open-label study and blinding will not be performed.|Subjects will receive danirixin reference and test formulations in a cross-over manner.||||
1310638|NCT03457714|||Cohort||Prospective|||||||
1310639|NCT03457701|Randomized|Crossover Assignment||Treatment||None (Open Label)|This is an Open-label study.|Subjects will be randomly assigned either to remain on their current therapy (either epoetin alfa or darbepoetin alfa) or be switched to daprodustat in either of the treatment period.||||
1310640|NCT03457688|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1310641|NCT03457675|Non-Randomized|Parallel Assignment||Treatment||Double|"In all cases, the sequence will be as follows in one-week segments: 100% Active, 50% Active, Sham and Sham. Subjects will be seen weekly. Amplitude will be reduced by 50% at start of week 2 and turned off at start of week 3. Subjects will be told that DBS will be discontinued at some point during the 4 weeks. The purpose of the 50% initial reduction is to minimize rebound effects. The programmer (not the PI in this case) will be open to the design and perform sham activation. Relapse is defined as a 25% increase of the Y-BOCS over two consecutive visits compared to discontinuation baseline."|At the end of month 8 after DBS implant, all subjects will enter a one-month delayed onset withdrawal period in which the subject and Independent Evaluators are blinded to timing of discontinuation. See description below.|t|||t
1310642|NCT03457662|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1310643|NCT03457649|Randomized|Sequential Assignment||Other||Quadruple||SAD MAD|t|t|t|t
1310644|NCT03457636||Single Group Assignment||Treatment||None (Open Label)||||||
1310645|NCT03457623|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1310646|NCT03457610||Single Group Assignment||Treatment||None (Open Label)||prospective, single arm, single center study||||
1310647|NCT03457597|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1310648|NCT03457584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310649|NCT03457571|||Cohort||Prospective|||||||
1310650|NCT03457558|||Other||Cross-Sectional|||||||
1310651|NCT03457545|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Testing a home-based intervention to treat frailty in adult lung transplant candidates using a mobile health technology||||
1310652|NCT03457532|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1310653|NCT03457519|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Intervention Group A - Community Health Workers (CHWs) (Basic training in CHW curriculum, ChARM training and 8-month application of the ChARM device, self-monitoring, direct observation and review of CHW routine monthly reports and drug supply sheets): 8 months, March- November 2018.~Intervention Group B - Community Health Workers (Basic training in CHW curriculum, ChARM training and 4-month application of the ChARM device, self-monitoring, direct observation and review of CHW routine monthly reports and drug supply sheets): March- November 2018.~Control Group C - Community Health Workers (Basic training in CHW curriculum, direct observation and CHW routine monthly reports and drug supply sheets): 8 months, March- November 2018."||||
1310654|NCT03457506||Single Group Assignment||Diagnostic||None (Open Label)||All included patients will have two PET scans, one on the conventional PET (Ingenuity TF, Philips Healthcare) and one on the digital PET (Vereos, Philips Healthcare). The order of the two PET scans will differ per patient.||||
1310655|NCT03457493|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1310656|NCT03457480|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310657|NCT03457467||Single Group Assignment||Treatment||None (Open Label)||||||
1310658|NCT03457454||Single Group Assignment||Prevention||None (Open Label)||||||
1310659|NCT03457441|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310660|NCT03457428|||Case-Only||Prospective|||||||
1310661|NCT03457415|||Cohort||Other|||||||
1310662|NCT03457402|Randomized|Parallel Assignment||Basic Science||Single|"Care Providers are told about the two possible groups during the Consent and will be aware of their child's assignment in terms of whether the child begins treatment immediately after baseline or has to wait 6 weeks prior to treatment.~Members of the research team who are designated as video coders for the Effortful Control tasks will be blind to the group assignment of the participants in the video recordings."|"Participants are randomly assigned to one of two possible groups.~Group 1: Treatment; this group begins 6-week training with the self-control shaping application immediately after baseline.~Group 2: Wait-list Control; After baseline, this group waits for 6-weeks before completing another pre-training assessment and then starts the 6-week training with the self-control application."||||t
1310663|NCT03457389|Randomized|Parallel Assignment||Treatment||None (Open Label)||One experimental group and one control group||||
1310664|NCT03457376|||Case-Control||Retrospective|||||||
1310665|NCT03457363|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Comparison of level oxygenation between classical oxygenation with nasal canulae with or without adjunctive of a double trunk mask||||
1310666|NCT03457350|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1310667|NCT03457337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310668|NCT03457324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310669|NCT03457311||Single Group Assignment||Screening||None (Open Label)||||||
1310670|NCT03457298|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310671|NCT03457285||Single Group Assignment||Treatment||None (Open Label)|No masking will take place|All participants will receive the same intervention||||
1310672|NCT03457272|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The study consists of two intervention and two control departments. The intervention consists of a risk assesment to ensure systematic and standardized identification of patients in risk of clinical deterioration and a decision support algorithm. Actions are undertaken on the basis of the standardized decision support and when a patient is determined to be at risk escalation plans are activated. As part of the intervention, huddles are conducted and patients at risk are interdisciplinarily discussed.||||
1310673|NCT03457259|Randomized|Parallel Assignment||Other||None (Open Label)||60 patients in each group, with a total of 2 groups||||
1310674|NCT03457246|Randomized|Parallel Assignment||Treatment||None (Open Label)||intra-individual hand controlled trial (left/ right comparison)||||
1310675|NCT03457233|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310676|NCT03457220|||Other||Prospective|||||||
1310677|NCT03457207||Single Group Assignment||Treatment||None (Open Label)||||||
1310678|NCT03457194|||Cohort||Prospective|||||||
1310679|NCT03457181|Randomized|Parallel Assignment||Other||Single||||||t
1310680|NCT03457168|Randomized|Parallel Assignment||Prevention||Double|Participants unaware of their assigned randomized group. Outcomes evaluated by an independent Events Committee.|Prospective, randomized, open-label (for medication treatment), two-arms, blinded-endpoint clinical trial.|t|||t
1310681|NCT03457155||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310682|NCT03457142||Single Group Assignment||Treatment||None (Open Label)||||||
1310683|NCT03457129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310684|NCT03457116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310685|NCT03457103|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310686|NCT03457090||Single Group Assignment||Prevention||None (Open Label)||Patient treated with Venoarterial Extracorporeal membrane oxygenation (ECMO) Realization of transcranial doppler (TCD) of the right and left middle cerebral artery in the first 48 hours of the setting up of the ECMO with joint realization of an Trans-thoracic echocardiography (TTE) then every 24 hours until the end of the using of the ECMO and the realization of TCD and TTE during the 24 hours after removal of the ECMO.||||
1310687|NCT03457077|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized controlled trial||||
1310688|NCT03457064|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310689|NCT03457051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310690|NCT03457038||Single Group Assignment||Diagnostic||None (Open Label)||Major patients admitted to the Resuscitation Department of the CHU Toulouse-Rangueil for severe sepsis, or development of sepsis during the stay resuscitation; sepsis defined by a SOFA score ≥ 2||||
1310691|NCT03457025|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310692|NCT03457012|||Cohort||Prospective|||||||
1310693|NCT03456999|Randomized|Parallel Assignment||Prevention||Triple|This is a patient, investigator and sponsor-blinded study. Patients and investigators will remain blinded to study treatment throughout the study,|This is a non-confirmatory, randomized, placebo-controlled, blinded, proof-of-concept study in kidney transplant recipients. Approximately 96 eligible patients are planned to be randomized 2:1 to receive MAU868 or placebo.|t||t|t
1310694|NCT03456986|Randomized|Parallel Assignment||Prevention||Triple|All data will be encrypted so participant's ID does not identify person. Two interventions, both improving motion discrimination will be investigated. Both have the potential of improving cognitive skills, so staff will not think one works better than the other. All data will be input by the senior research assistants who will not know what group a participant belonged to.|The feasibility of PATH neurotraining will be evaluated by comparing it with another cognitive training program, Brain HQ's Target Tracker, and ascertaining the relative advantage(s) of PATH neurotraining for enhancing cognition in older adults between 55 and 75 years of age whose cognition is either in the age-normative range or in the mild cognitive impairment (MCI) range of standardized psychometric measures.|t|t||t
1310695|NCT03456973||Single Group Assignment||Supportive Care||None (Open Label)||||||
1310696|NCT03456960|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1310697|NCT03456947|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1310698|NCT03456934|Randomized|Parallel Assignment||Other||Quadruple||Prospective, randomized, double-blind with nonrandomized breast-fed reference group|t|t|t|t
1310699|NCT03456921||Single Group Assignment||Other||None (Open Label)||"This project uses an evidence-based and effective intervention--an end-of-life conversation game called Hello--to engage and activate participants to perform advance care planning. Quantitative data will be collected before and after immediately playing the game. Focus groups also will be held immediately after the game. Three months after playing the game, participants will complete surveys and also engage in semi-structured interviews about the game and about their ACP activities."||||
1310700|NCT03456908|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310701|NCT03456895|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Three populations are being investigated in this trial; a healthy volunteer population, a patient population, and a staff population. Each population has the potential to participate in survey tools and/or physical environmental experiences.||||
1310702|NCT03456882|Randomized|Parallel Assignment||Other||||Multicenter, randomized, double-blind, placebo-controlled, parallel group, add-on phase II trial. ALS Patients who meet the study's inclusion/exclusion criteria and sign the Informed Consent Form will be enrolled. A total of 142 subjects will be randomly assigned to receive treatment with either RNS60 or placebo while concomitantly taking riluzole (50 mg tablet t.i.d.). RNS60 or placebo will be administered intravenously once a week as well as inhaled via nebulization every morning in the remaining six days of each week for 24 weeks. Blood samples for biomarker analysis will be collected on day 1, week 4, w12, and w24. Safety and preliminary efficacy will be assessed by way of physical exam, vital signs and AEs. Changes in disability and quality of life will be assessed using the ALSFRS-R scale, FVC and ALSAQ-40 scale. Each patient will be followed up for a maximum period of 48 weeks (24-week treatment + 24-week follow up) or until death or tracheostomy, whichever occurs first.||||
1310703|NCT03456869||Single Group Assignment||Treatment||None (Open Label)||||||
1310704|NCT03456856||Single Group Assignment||Treatment||None (Open Label)||||||
1310705|NCT03456843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310706|NCT03456830|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1310707|NCT03456817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310708|NCT03456804||Single Group Assignment||Treatment||None (Open Label)||||||
1310709|NCT03456791|||Case-Control||Prospective|||||||
1310710|NCT03456778||Single Group Assignment||Treatment||None (Open Label)||||||
1310711|NCT03456765|||Cohort||Prospective|||||||
1310712|NCT03456752|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1310713|NCT03456739|||Ecologic or Community||Prospective|||||||
1310716|NCT03456700||Single Group Assignment||Treatment||None (Open Label)||||||
1310717|NCT03456687||Single Group Assignment||Treatment||None (Open Label)||||||
1310718|NCT03456674||Single Group Assignment||Treatment||None (Open Label)||A single cohort of study subjects will receive study treatment.||||
1310719|NCT03456661|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1310720|NCT03456648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Single dose pharmacokinetics study||||
1310721|NCT03456635|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)|unblinded|quasi-experimental study Time-series analysis, with a non-equivalent variable prospective Quality Improvement project||||
1310722|NCT03456622|||Cohort||Prospective|||||||
1310723|NCT03456609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310724|NCT03456596|||Other||Prospective|||||||
1310725|NCT03456583|||Case-Only||Prospective|||||||
1310726|NCT03456570|Randomized|Parallel Assignment||Treatment||Single|||||t|
1310727|NCT03456557||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310728|NCT03456544|||Case-Crossover||Retrospective|||||||
1310729|NCT03456531|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective randomized clinically controlled study .||||
1310730|NCT03456518|||Cohort||Prospective|||||||
1310731|NCT03456505|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1310732|NCT03456492|||Case-Control||Retrospective|||||||
1310733|NCT03456479||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310734|NCT03456466|Randomized|Parallel Assignment||Treatment||Triple|Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)|TQB2303 and Rituximab|t||t|t
1310735|NCT03456453|Randomized|Parallel Assignment||Prevention||Single|||t|||
1310736|NCT03456440|||Case-Control||Prospective|||||||
1310737|NCT03456427||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1310738|NCT03456414|Randomized|Crossover Assignment||Treatment||Double|A team of assessors, different to the researchers implementing the exercise, will record all dependent variables|All participants will receive during hemodialysis the conditions 'virtual reality exercise' for 12 weeks and 'control period-no exercise' for 12 more weeks|||t|t
1310739|NCT03456401||Single Group Assignment||Treatment||None (Open Label)||||||
1310740|NCT03456388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310741|NCT03456375|||Other||Prospective|||||||
1310742|NCT03456362|Randomized|Parallel Assignment||Treatment||Single|||||t|
1310743|NCT03456349|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1310744|NCT03456336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310745|NCT03456323|Randomized|Parallel Assignment||Supportive Care||Single|The research coordinator who makes the baseline assessment and outcome assessments will be blinded to treatment allocation.|Older survivors of acute respiratory failure and their surrogates (i.e., patient-surrogate pairs, n = 80 participants total) will be randomized to an inpatient palliative care consultation versus usual care in a 1:1 ratio (i.e. 20 patient-surrogate pairs (40 participants total) in each study arm) once enrolled patients are registered to be transferred from the ICU to the general ward.||||t
1310746|NCT03456310||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310747|NCT03456297|Randomized|Parallel Assignment||Health Services Research||Single|"The 10 clinical departments will be randomised into two clusters, experimental and controlled clusters. The participants will be randomised based on the department that they work in. The advantage of the cluster randomised controlled trial is the ability to control for contamination across individuals, for example, one individual's use of WCP may influence another individual in the same department (Kellar & Kelvin, 2013)."|A prospective cluster randomisation trial will be used for this study. The Web-based Clinical Pedagogy Program will be provided to the participants in the experimental cluster, while the participants in the control cluster will receive the current preceptorship course.|t|||
1310748|NCT03456284||Single Group Assignment||Treatment||None (Open Label)||||||
1310749|NCT03456271|||Cohort||Prospective|||||||
1310750|NCT03456258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310751|NCT03456245||Single Group Assignment||Diagnostic||None (Open Label)||Group members had their vision tested with the following devices/methods: D-EYE Portable Retinal Imaging System, Eyenetra NETRA, PlenOptika Quicksee, Right Manufacturing Retinomax K Plus 3, and standard eyesight tests using eye charts, phoropters, and slit lens lamp imaging.||||
1310752|NCT03456232|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310753|NCT03456219|Randomized|Crossover Assignment||Prevention||Single|||t|||
1310754|NCT03456206|||Cohort||Prospective|||||||
1310755|NCT03456193||Single Group Assignment||Treatment||None (Open Label)||||||
1310756|NCT03456180|||Case-Only||Prospective|||||||
1310757|NCT03456167|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1310758|NCT03456154|Randomized|Parallel Assignment||Treatment||Single||||||t
1310759|NCT03456141|||Case-Only||Prospective|||||||
1310760|NCT03456128|Randomized|Single Group Assignment||Other||Single|1: 1. The outcome assessor will be unaware of which groups the older adults are assigned to.|The study is a single-masked, two-group, randomized trial to test the effectiveness of CAPABLE in reducing ADL difficulties compared to those randomized to usual care.||||t
1310761|NCT03456115||Single Group Assignment||Treatment||None (Open Label)|Participants will be unaware of which nasal dilator they are trialing.|All participants will undergo the same intervention, which is a trial of various internal nasal dilators.||||
1310762|NCT03456102|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1310763|NCT03456089|||Cohort||Cross-Sectional|||||||
1310764|NCT03456076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310765|NCT03456063|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1310766|NCT03456050|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1310767|NCT03456037|||Other||Retrospective|||||||
1310768|NCT03456024|||Cohort||Prospective|||||||
1310769|NCT03456011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310770|NCT03455998|||Cohort||Prospective|||||||
1310771|NCT03455985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310772|NCT03455972||Single Group Assignment||Treatment||None (Open Label)||||||
1310773|NCT03455959||Single Group Assignment||Basic Science||None (Open Label)||A single time point study with all information obtained at the time of bronchoscopy||||
1310774|NCT03455946||Single Group Assignment||Other||None (Open Label)||||||
1310775|NCT03455933|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1310776|NCT03455920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310777|NCT03455907|||Cohort||Prospective|||||||
1310778|NCT03455894||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310779|NCT03455881|||Cohort||Prospective|||||||
1310780|NCT03455868|||Cohort||Prospective|||||||
1310781|NCT03455855||Single Group Assignment||Treatment||None (Open Label)||||||
1310782|NCT03455842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310783|NCT03455829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310784|NCT03455816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310785|NCT03455803|||Case-Only||Prospective|||||||
1310786|NCT03455790|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1310787|NCT03455777||Single Group Assignment||Treatment||None (Open Label)||||||
1310788|NCT03455764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310789|NCT03455751|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1310790|NCT03455738|||Cohort||Prospective|||||||
1310791|NCT03455725|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple-blinded, placebo-controlled study. Patients, investigators, the CRO, core labs and the sponsor will be blinded for individual treatment adjudication.|Prospective, multi-center, 2:1 randomized (Treatment vs Sham Control), blinded trial comparing 2 paralel groups of patients with CMI treated with CardiAMP cell therapy system vs sham treatment.|t|t|t|t
1310792|NCT03455712|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Subjects to be enrolled into the intervention and standard-of-care groups depending on their gestational age at the time of consent during the expected 2 month period of enrollment. Any subject who is between 6 weeks 0 days and 14 weeks 6 days of pregnancy at the time of consent and who has had no prior prenatal visits will be enrolled in the intervention group. Any subject who is between 15 weeks 0 days to 22 weeks 6 days of pregnancy at the time of consent and who has had at least one prior prenatal visit will be enrolled in the control group.||||
1310793|NCT03455699|||Cohort||Prospective|||||||
1310794|NCT03455686||Single Group Assignment||Basic Science||None (Open Label)||||||
1310795|NCT03455673|||Cohort||Cross-Sectional|||||||
1310796|NCT03455660|||Cohort||Retrospective|||||||
1310797|NCT03455647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310798|NCT03455634|Randomized|Parallel Assignment||Treatment||Single||||||t
1310799|NCT03455621|Randomized|Crossover Assignment||Prevention||Single||||||t
1310800|NCT03455608|Randomized|Parallel Assignment||Treatment||Single||||||t
1310801|NCT03455595|||Other||Prospective|||||||
1310802|NCT03455582|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1310803|NCT03455569|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1310804|NCT03455556||Single Group Assignment||Treatment||None (Open Label)||||||
1310805|NCT03455543|Randomized|Parallel Assignment||Treatment||Quadruple|Active and sham devices will look identical. Participants and site staff will be blind to the randomization.|Two parallel groups, active device group versus sham device group. Subjects will be randomized 1:1 at baseline and treat with active PEMF or sham for 4 months.|t|t|t|t
1310806|NCT03455530|Randomized|Parallel Assignment||Other||Quadruple|Data collection will be conducted by research staff blinded to the intervention condition. CHWs will only be present at the first baseline-assessment prior to data collection.|Both groups will receive a baseline exposure assessment, health screenings from El Rio Community Health Center, and Sonora Environmental Research Institute's existing packets on pollution prevention to ensure that all businesses have the same pollution prevention information at baseline. Then, the intervention group will receive the industrial hygiene (IH)-enhanced community health worker (CHW) intervention. After the second exposure assessment, the delayed group will receive the intervention. A third exposure assessment will be obtained to determine if exposure levels and controls are maintained in the intervention group, and to assess the intervention in the delayed group. This will help us assess sustainability of the intervention. CHWs will accompany evaluators during the first assessment but leave before data collection begins. We anticipate that the CHW intervention will be completed over a 60-day time period (range: 30-90 days).|t|t|t|t
1310807|NCT03455517||Single Group Assignment||Treatment||None (Open Label)||Multicenter, prospective, interventional, single arm study||||
1310808|NCT03455504|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Study run-in and phase II||||
1310809|NCT03455491|Randomized|Parallel Assignment||Treatment||Double|Blinding will carried out by using Placebo equivalent to XC221 tablets without active substance and the corresponding labeling of the study drug.||t||t|
1310810|NCT03455478|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310811|NCT03455465|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1310812|NCT03455452|||Cohort||Prospective|||||||
1310813|NCT03455439|||Cohort||Prospective|||||||
1310814|NCT03455426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310815|NCT03455413|||Cohort||Prospective|||||||
1310816|NCT03455400|||Cohort||Prospective|||||||
1310817|NCT03455387|||Cohort||Prospective|||||||
1310818|NCT03455374||Single Group Assignment||Treatment||None (Open Label)||Prospective||||
1310819|NCT03455361|||Cohort||Retrospective|||||||
1310820|NCT03455348|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310821|NCT03455335|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Advanced Therapeutic Medicinal Product ( ATMP) Bone Marrow Derived Mesenchymal Stem Cells||||
1310822|NCT03455322|Randomized|Parallel Assignment||Treatment||Single|||t|||
1310823|NCT03455309|Randomized|Parallel Assignment||Prevention||Quadruple|Sponsor, principal investigator and study site are all blinded but can access key if safety issues require unblinding|double-blind, placebo-controlled, randomized study|t|t|t|t
1310824|NCT03455296|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1310825|NCT03455283|||Cohort||Prospective|||||||
1310826|NCT03455270|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1310827|NCT03455257|Randomized|Parallel Assignment||Other||None (Open Label)|Clarify randomization and masking|Participating families are randomized into one of two groups, an assessment-only controls group or a cash transfer group.||||
1310828|NCT03455244|||Cohort||Prospective|||||||
1310829|NCT03455231||Single Group Assignment||Treatment||None (Open Label)||||||
1310830|NCT03455218|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, Double Blinded, Placebo Controlled|t|t|t|t
1310831|NCT03455205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310832|NCT03455192|Randomized|Sequential Assignment||Treatment||Double||double-blind randomized placebo-controlled clinical trial|t||t|
1310833|NCT03455179|Randomized|Parallel Assignment||Prevention||Double|For masking the participants, the investigators will not inform participants of what group they will be in. For outcome assessor, data collectors and data analysts independent people will be use, and if this is not possible, a random code will be created for each participant so that it is not possible to identify which group belongs to.|This is a randomized, duoble-blind (participant-outcome assessor), 4 arms prospective parrallel desing clinical trial. The older adults will be recruited from the Municipal Activity Centers for Older People located in Valencia and will be randomized in a prospective clinical trial study with a 4 parallel arms study design to a slow-speed traditional resistance training, high-speed resistance training, multicomponent training or control over a 20 weeks period.|t|||t
1310834|NCT03455166|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310835|NCT03455153|||Cohort||Prospective|||||||
1310836|NCT03455140|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310837|NCT03455127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310838|NCT03455114||Single Group Assignment||Treatment||None (Open Label)||||||
1310839|NCT03455101|||Cohort||Cross-Sectional|||||||
1310840|NCT03455088|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1310841|NCT03455075|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1310842|NCT03455062|||Cohort||Prospective|||||||
1310843|NCT03455049|Randomized|Crossover Assignment||Treatment||Double|Double Blind|Clinical Trials with Randomization, Double Blind, Crossover|t||t|
1310844|NCT03455036||Single Group Assignment||Basic Science||None (Open Label)||The design of the study is a single-centre cross-sectional single-arm intervention study.||||
1310845|NCT03455023|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1310846|NCT03455010|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Masking is not possible because the experimental condition is obvious. Participants and testers cannot influence outcome parameters.|Controlled multimodal data collection (biological, biomechanical) with block randomization.||||
1310847|NCT03454997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310848|NCT03454984||Single Group Assignment||Prevention||None (Open Label)||all patients eligible to receive SGI-110 at day 40 to day130 after transplantation, will be treated||||
1310849|NCT03454971||Single Group Assignment||Health Services Research||None (Open Label)||||||
1310850|NCT03454958||Single Group Assignment||Other||None (Open Label)||||||
1310851|NCT03454945|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1310852|NCT03454932|||Cohort||Prospective|||||||
1310853|NCT03454919||Single Group Assignment||Treatment||None (Open Label)||||||
1310854|NCT03454906|||Case-Only||Prospective|||||||
1310855|NCT03454893||Single Group Assignment||Treatment||None (Open Label)||||||
1310856|NCT03454880|||Cohort||Prospective|||||||
1310857|NCT03454867|Randomized|Parallel Assignment||Treatment||None (Open Label)||Hemofiltration protocol. Hemofiltration was started after all enrollment criteria (informed consent, inclusion/exclusion criteria checklists, registration and assignment to treatment arm) had been met . Vascular access was secured by inserting an 11F double lumen catheter (GamCath, Gambro, Germany) into the jugular, femoral or subclavian vein. CVVH (continuous veno-venous hemofiltration) was carried out using a hemofiltration machine (Fresenius Multifiltrate, Germany). In all patients a 1.9 m2 highly permeable cellulose triacetate hemofilter was used (NIPRO UF205, Nissho corporation, Japan). All patients were treated by CVVH with the predilution mode; the blood flow was set at 180 ml/min.||||
1310858|NCT03454854||Single Group Assignment||Treatment||None (Open Label)||||||
1310859|NCT03454841|Randomized|Parallel Assignment||Treatment||Single||||||t
1310860|NCT03454828|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310861|NCT03454815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310862|NCT03454802|Non-Randomized|Sequential Assignment||Basic Science||Single|||t|||
1310863|NCT03454789|Randomized|Parallel Assignment||Basic Science||Triple|Patients, the operating team, nurses, and observers involved in the quality assessment of blocks and the follow-up data collection were unaware of group allocation. The research coordinator after the BPB was not present in the operating theatre at the time of tourniquet inflation and the beginning of the surgery. The intra- and postoperative parameters, drug consumptions and VNR values were collected and matched retrospectively, the list of cases was provided in the form of a spreadsheet program by an observer-blinded assistant and was statistically evaluated by an independent analyst.|LB= 15 ml lidocaine 1% + 15 ml bupivacaine 0.5%; BS= 20 ml bupivacaine 0.5% + 10 ml normal saline; LS=20 ml lidocaine 1% + 10 ml normal saline; and BL=20 ml bupivacaine 0.5% + 10 ml lidocaine 1%.|t||t|t
1310864|NCT03454776|Randomized|Parallel Assignment||Treatment||Single||Two groups with same problem of osteoarthritis in knee|||t|
1310865|NCT03454763|Randomized|Parallel Assignment||Treatment||None (Open Label)||comparative||||
1310866|NCT03454750||Single Group Assignment||Treatment||None (Open Label)||||||
1310867|NCT03454737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1310920|NCT03454048|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310868|NCT03454724|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 Randomization of Study Device and Control||||
1310869|NCT03454711|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310870|NCT03454698||Single Group Assignment||Prevention||None (Open Label)||||||
1310871|NCT03454685|||Case-Only||Other|||||||
1310872|NCT03454672||||||||||||
1310873|NCT03454659|||Case-Control||Prospective|||||||
1310874|NCT03454646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310875|NCT03454633|Randomized|Parallel Assignment||Treatment||Single||A randomised controlled study|t|||
1310876|NCT03454620|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310877|NCT03454607||Single Group Assignment||Other||None (Open Label)||||||
1310878|NCT03454594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310879|NCT03454581|Randomized|Parallel Assignment||Treatment||Single||||||t
1310880|NCT03454568|||Cohort||Prospective|||||||
1310881|NCT03454555|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomly assigned to one of two intervention arms for the duration of the study. The study will use real-time randomization to limit participant loss prior to treatment. Eligible patients will be randomized using a stratified, permuted-block design, as this constrained randomization approach ensures balance between treatment groups within each of the 3 clinical institutions (our only stratification factor) at the completion of each block. Consequently, throughout the trial, the treatment arms will have approximately equal sample sizes both within a site and across the study.||||
1310882|NCT03454542|Randomized|Crossover Assignment||Treatment||Double|This will be a double-masked study, with both the study participants and study investigators being masked to the order of lens wear for the initial and modified DD lens design. Study lenses will be dispensed to the participants at V2 and V4 by unmasked research assistants from paper cups. Lenses and blister-pack solution will be directly transferred into the paper cups, and only the paper cups will be taken to the examination room where lenses are being dispensed.|This will be a double-masked, cross-over, bilateral wear study design with five (5) study visits across three (3) study visit days. Participants will be dispensed and wear both the initial and modified lens design for a total of six (6) hours each on two (2) separate visit days, with the order of lens wear being randomized; participants will be allowed to leave the CCLR on their lens wearing days between dispense and follow-up visit.|t||t|
1310883|NCT03454529||Single Group Assignment||Treatment||None (Open Label)||||||
1310884|NCT03454516|Randomized|Parallel Assignment||Other||Single|the Data analysis will be performed by an independent team with masking the patients groups|two randomized parallel groups. one group with standard care and one group with telemonitoring of blood pressure and hypertension.||||t
1310885|NCT03454503|||Cohort||Prospective|||||||
1310886|NCT03454490|||Case-Only||Retrospective|||||||
1310887|NCT03454477|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310888|NCT03454464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310889|NCT03454451|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1310890|NCT03454438|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1310891|NCT03454425|Randomized|Crossover Assignment||Treatment||Single||||||t
1310892|NCT03454412|||Case-Only||Prospective|||||||
1310893|NCT03454399|Non-Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1310894|NCT03454386|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310895|NCT03454373|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1310896|NCT03454360|||Cohort||Prospective|||||||
1310897|NCT03454347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310898|NCT03454334|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1310899|NCT03454321|||Other||Prospective|||||||
1310900|NCT03454308|Randomized|Parallel Assignment||Other||Single||||||t
1310901|NCT03454295|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1310902|NCT03454282||Single Group Assignment||Treatment||None (Open Label)||Clinical trials with a single arm and three cohorts of patients||||
1310903|NCT03454269|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1310904|NCT03454256|Randomized|Parallel Assignment||Treatment||Single||||||t
1310905|NCT03454243||Single Group Assignment||Treatment||None (Open Label)||Dose escalation, conventional 3+3 scheme||||
1310906|NCT03454230|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||To assess efficacy of a positioning schedule whose frequency of positioning is adapted every day to pressure ulcer risk assessed by Braden scale on occurrence of pressure ulcer in adult ICU in comparison with the routine patient management (without positioning schedule adapted on PU risk) at the 28th day, or when leaving ICU wall, or at death if it occurs before.||||
1310907|NCT03454217|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1310908|NCT03454204|||Other||Prospective|||||||
1310909|NCT03454191|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1310910|NCT03454178|||Other||Prospective|||||||
1310911|NCT03454165||Sequential Assignment||Treatment||None (Open Label)||Open label dose escalation study, with a Storer D ; 3-3 cohort design||||
1310912|NCT03454152|||Cohort||Cross-Sectional|||||||
1310913|NCT03454139|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1310914|NCT03454126|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310915|NCT03454113|||Cohort||Prospective|||||||
1310916|NCT03454100|Randomized|Parallel Assignment||Prevention||None (Open Label)||Panel cluster randomized intervention trial||||
1310917|NCT03454087|Randomized|Parallel Assignment||Treatment||Quadruple|Infusion solutions will be prepared by pharmacy services at the local institution but participants, investigators, care providers, and outcomes assessors will be blinded to group allocation until the end of the study.|Participants will be randomized in a blinded 1:1 fashion to receive either a low level enteral infusion of dextrose solution (intervention group) or an enteral infusion of free water (placebo group)|t|t|t|t
1310918|NCT03454074|Randomized|Parallel Assignment||Prevention||Single||||||t
1310919|NCT03454061|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310921|NCT03454035||Single Group Assignment||Treatment||None (Open Label)||This is a standard 3+3 dose escalation design.||||
1310922|NCT03454022|Randomized|Parallel Assignment||Supportive Care||Single||"Participants (patient-caregiver dyads) will be randomized to receive either usual care education (a pamphlet published by the National Kidney Foundation, Choosing a Treatment for Kidney Failure, or usual care education plus DART."||||t
1310923|NCT03454009|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310924|NCT03453996|Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1310925|NCT03453983|Randomized|Parallel Assignment||Treatment||Double|"Participants will not be informed of the stimulation group to which they are randomized. Both stimulation groups produce similar transient scalp sensations in participants and the sham protocol that will be used has been shown to be valid and ensures that participants are naïve to their assigned treatment group [9]. Participants will be asked which stimulation group they felt they took part in to ensure adequate blinding.~Outcomes assessors will be blinded. Offline video analysis will be used to score motor assessment performance. These videos will exclude all identifying information including the participant's face and their stimulation group."|The currently proposed study is a randomized, sham controlled clinical trial that includes 30 adolescents diagnosed with DCD. Participants will be randomized to one of two tDCS treatment groups.|t|||t
1310926|NCT03453970|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1310927|NCT03453957|Randomized|Parallel Assignment||Health Services Research||Single|Participating therapists will be aware of their group (Professional development training vs no training control); however, their participating patient/clients will not know which experimental group their therapists belongs to.|This will be a 2-arm, parallel, prospective, single-blind cluster RCT with 1-1 allocation comparing: (a) therapists who receive the professional development intervention to identify and repair alliance tensions at the study outset versus (b) therapists who receive the intervention after participation is complete (no training control). Therapists will be randomized to study condition and patients will be clustered within therapists. Randomization will control for: (a) the effect of therapist variables (age, gender, theoretical orientation, experience, differing initial skill level) on competence, therapeutic alliance, or patient outcomes; (b) potential biases caused by pre-treatment patient variables (symptom severity, co-morbidity, chronicity, psychoactive medications); and (c) treatment or study factors (e.g. frequency of sessions, time to complete the study sessions, treatment received after the study sessions). Patients will be blind to therapist study arm allocation.|t|||
1310928|NCT03453944|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1310929|NCT03453931|||Case-Only||Prospective|||||||
1310930|NCT03453918|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1310931|NCT03453905|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients will be randomized to two arms and followed prospectively||||
1310932|NCT03453892|||Case-Only||Prospective|||||||
1310933|NCT03453879|||Case-Only||Prospective|||||||
1310934|NCT03453866|Randomized|Parallel Assignment||Treatment||Double|Sealed Opaque Envelope|Prospective Randomized Controlled Trial|t|||t
1310935|NCT03453853||Single Group Assignment||Treatment||None (Open Label)||||||
1310936|NCT03453840|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective multi-site study accomplished through a randomized design where children will be randomized to either 3-day or 5-day AL regimen and then for subsequent episodes of malaria, should they occur..||||
1310937|NCT03453827|||Case-Control||Retrospective|||||||
1310938|NCT03453814|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1310939|NCT03453801|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1310940|NCT03453788|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Prospective cohort study with reference group.||||
1310941|NCT03453775|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, randomized, controlled, open trial||||
1310942|NCT03453762|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1310943|NCT03453749||Single Group Assignment||Treatment||None (Open Label)||5 consecutive adult patients with severe head trauma will receive treatment||||
1310944|NCT03453736|||Other||Prospective|||||||
1310945|NCT03453723|Randomized|Parallel Assignment||Treatment||Single||||||t
1310946|NCT03453710|Randomized|Parallel Assignment||Treatment||Single|Patients will be evaluated by a blinded study nurse, unaware of treatment allocation, for administration of baseline questionnaires, as well as subsequent post-operative questionnaires.|Prospective, randomized controlled trial||||t
1310947|NCT03453697||Single Group Assignment||Other||None (Open Label)||||||
1310948|NCT03453684||Single Group Assignment||Treatment||None (Open Label)||||||
1310949|NCT03453671|Randomized|Parallel Assignment||Prevention||Triple|Participants will know their own condition (strategy) but not what the other conditions are. The primary investigator will be blind to participants' assignment to condition.||t||t|t
1310950|NCT03453658|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will be a different examiner who will be unaware of the allocated group.|Randomized, single-blind, controlled clinical trial with two parallel arms.||||t
1310951|NCT03453645|||Case-Only||Prospective|||||||
1310952|NCT03453632|Randomized|Crossover Assignment||Treatment||Triple||Each subject is his own witness, receiving the 2 treatments : left foot vs. right foot|t|t|t|
1310953|NCT03453619||Single Group Assignment||Treatment||None (Open Label)||||||
1310954|NCT03453606|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1310955|NCT03453593|||Cohort||Prospective|||||||
1310956|NCT03453580|||Case-Control||Cross-Sectional|||||||
1310957|NCT03453567|||Cohort||Prospective|||||||
1310958|NCT03453554|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1310959|NCT03453541|Randomized|Parallel Assignment||Treatment||Double|CRNAs, PACU nurses, and participants are all blinded||t|t||
1310960|NCT03453528||Single Group Assignment||Diagnostic||None (Open Label)||||||
1310961|NCT03453515|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310962|NCT03453502|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1310963|NCT03453489||Single Group Assignment||Treatment||None (Open Label)||||||
1573389|NCT00001402||||Treatment||||||||
1310964|NCT03453476|Randomized|Parallel Assignment||Treatment||Triple|"Allocation of test and control quadrants were done randomly by asking each study participant to choose either numbers 1 or 2. Number 1 defined quadrants 1 and 3 as the test quadrants while number 2 referred to quadrants 2 and 4 as the test quadrants. The remaining quadrants served as the control quadrants."|Split-mouth design|t|t|t|
1310965|NCT03453463|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor are not aware of participant status and are nor allowed to ask correspondingly|||||t
1310966|NCT03453450|||Cohort||Other|||||||
1310967|NCT03453437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310968|NCT03453424|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1310969|NCT03453411|||Cohort||Prospective|||||||
1310970|NCT03453398|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Participants are divided in three different groups on the bases of their actual shift work modalities. Thus no allocation process is possible within this project.||||
1310971|NCT03453385|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1310972|NCT03453372|Randomized|Parallel Assignment||Treatment||Double|Participating patients will be blinded to treatment assignment and to the ongoing results of the study; they will remain blinded to their assignment throughout the study period. All the staff involved in the pre- and post-treatment evaluation of patients will be also blinded. The evaluation of patients will be performed by physicians not involved in the treatment to ensure double blinding.|Double-blind placebo-controlled randomized clinical trial|t||t|
1310973|NCT03453359|Randomized|Parallel Assignment||Supportive Care||Single|Patients will be randomly assigned to one of the two study groups. The anesthesiologist who records the information knows which group they belong to, according to a randomization table provided in collaboration with the Research Unit, but the patients do not know it.|We compared the results of two groups of patients. Experimental group, in which sedation is adjusted using as main parameters the information obtained by the bispectral index monitor. Control Group, with sedation based on subjective monitoring using the Ramsay scale as a reference.|t|||
1310974|NCT03453346||Single Group Assignment||Treatment||None (Open Label)||Open label, single arm, historical control||||
1310975|NCT03453333|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1310976|NCT03453320|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1310977|NCT03453307|||Cohort||Cross-Sectional|||||||
1310978|NCT03453294|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1310979|NCT03453281||Single Group Assignment||Treatment||None (Open Label)||Every subject was given the same treatment (intravitreal Aflibercept injection).||||
1310980|NCT03453268|Randomized|Parallel Assignment||Other||None (Open Label)||Therapeutic strategies: reduction of the antihypertensive treatment (intervention arm) vs. usual treatment (control arm)||||
1310981|NCT03453255||Single Group Assignment||Treatment||None (Open Label)||||||
1310982|NCT03453242|||Cohort||Prospective|||||||
1310983|NCT03453229|||Cohort||Prospective|||||||
1310984|NCT03453216||Single Group Assignment||Basic Science||None (Open Label)||||||
1310985|NCT03453203|Randomized|Parallel Assignment||Treatment||Single|The follow-up physician will be blinded to treatment vs control arm. Patient will be selected randomly depending on the time of recruitment.|Blinded control trial||t||
1310986|NCT03453190||Single Group Assignment||Treatment||None (Open Label)||||||
1310987|NCT03453177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1310988|NCT03453164||Single Group Assignment||Treatment||None (Open Label)||||||
1310989|NCT03453151||Single Group Assignment||Treatment||None (Open Label)||||||
1310990|NCT03453138|Randomized|Parallel Assignment||Treatment||Single||||||t
1310991|NCT03453125|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1310992|NCT03453112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310993|NCT03453099|||Cohort||Prospective|||||||
1310994|NCT03453086|Randomized|Parallel Assignment||Supportive Care||Double|•Patients will be randomly allocated to one of the two groups by sealed closed envelop technique|"Although thoracic epidural analgesia is the gold standard technique after breast surgery paravertebral block (PVB) has become a potential alternative approach. However, both techniques may be associated with serious complications such as pneumothorax, total spinal anaesthesia and inadvertent intravascular injection. Recently since the advent of ultrasound (US) in anaesthetic practice several interfascial plane blocks have been described. Serratus plane block is a novel interfascial plane block which can provide analgesia after breast surgery.~The serratus anterior plane block is an interfascial plane block where the local anaesthetics are injected superficial to serratus anterior at the 5th rib level in the mid axillary line. The serratus plane block is a progression from Blanco's et al work with the Pecs I and II blocks by making the technique easier in its application using single injection and to lower the potential side-effects"|t|t||
1310995|NCT03453073|||Ecologic or Community||Prospective|||||||
1310996|NCT03453060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1310997|NCT03453047|||Other||Prospective|||||||
1310998|NCT03453034||Single Group Assignment||Other||None (Open Label)||||||
1310999|NCT03453021|||Cohort||Prospective|||||||
1311000|NCT03453008|||Case-Only||Prospective|||||||
1311001|NCT03452995|Randomized|Parallel Assignment||Treatment||Single||||||t
1311002|NCT03452982||Single Group Assignment||Diagnostic||None (Open Label)||Controlled, prospective, descriptive and not randomized||||
1311003|NCT03452969|||Case-Only||Prospective|||||||
1311004|NCT03452956|||Cohort||Retrospective|||||||
1311005|NCT03452943|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311006|NCT03452930|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311007|NCT03452917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311008|NCT03452904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311009|NCT03452891|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311010|NCT03452878|||Case-Only||Prospective|||||||
1311011|NCT03452865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311012|NCT03452852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311013|NCT03452839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311014|NCT03452826|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1311015|NCT03452813|||Cohort||Prospective|||||||
1311016|NCT03452800|||Cohort||Other|||||||
1311017|NCT03452787|||Cohort||Retrospective|||||||
1311018|NCT03452774|||Cohort||Prospective|||||||
1311019|NCT03452761|Randomized|Parallel Assignment||Screening||Double|Supplemental packets were not labeled except with the code A or B - placed by the supplement laboratory. PI notified of groups after completion.|Randomized, double-blinded, 2-groups (condition and placebo)|t||t|
1311020|NCT03452748||Single Group Assignment||Diagnostic||None (Open Label)|no masking|all excised membranes will be examined with FTIR spectroscopy, there will be no control group||||
1311021|NCT03452735|||Case-Control||Prospective|||||||
1311022|NCT03452722|||Cohort||Prospective|||||||
1311023|NCT03452709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311024|NCT03452696|Randomized|Parallel Assignment||Treatment||Single|Women||t|||
1311025|NCT03452683|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311026|NCT03452670|Randomized|Parallel Assignment||Prevention||Double|Participants will be blinded by study ID# during data collection and management.|The waitlist group will be maintained as a control group throughout all assessments and will be provided enrollment in the mindfulness app at the end of the study.|||t|t
1311027|NCT03452657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311028|NCT03452644|||Other||Retrospective|||||||
1311029|NCT03452631|||Cohort||Retrospective|||||||
1311030|NCT03452618|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The study compare the diagnostic's variables in patients who received NIV one year after diagnosis and those who did not.||||
1311031|NCT03452605|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1311032|NCT03452592||Single Group Assignment||Treatment||None (Open Label)||||||
1311033|NCT03452579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311034|NCT03452566||Single Group Assignment||Treatment||None (Open Label)||To determine the toxicity profile and the maximum tolerated dose (MTD) of ingenol mebutate for treatment of actinic cheilitis and to determine the therapeutic response with a dose below the maximum tolerated dose (MTD). The MTD will be tested in the phase 2 stage of this study.||||
1311035|NCT03452553||Single Group Assignment||Treatment||None (Open Label)||Open Label||||
1311036|NCT03452540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311037|NCT03452527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311038|NCT03452514|||Cohort||Prospective|||||||
1311039|NCT03452501|||Cohort||Prospective|||||||
1311040|NCT03452488|Randomized|Parallel Assignment||Treatment||Double|Each treatment kit will show a preprinted kit number affixed on the primary, secondary and tertiary container. The kit number will be assigned via the eCRF after a patient is qualified and is randomised. Nor the Investigator and his staff, either the Sponsor will be aware of the treatment that corresponds to the kit number. The assigned treatment cannot be retrieved from the system, unless a specific unblinding procedure is engaged by the investigator when this is judged necessary by the responsible physician of the investigator center in the context of a severe or serious adverse event.|Parallel assignment|t||t|
1311041|NCT03452475|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomised 1:1:1 to one of the three treatment arms||||
1311042|NCT03452462|Randomized|Crossover Assignment||Treatment||Single||||||t
1311043|NCT03452449|||Cohort||Prospective|||||||
1311044|NCT03452436|||Case-Control||Prospective|||||||
1311045|NCT03452423||Single Group Assignment||Treatment||None (Open Label)||||||
1311046|NCT03452410|||Cohort||Retrospective|||||||
1311047|NCT03452397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311048|NCT03452384|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311049|NCT03452371|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1311050|NCT03452358|||Cohort||Retrospective|||||||
1311051|NCT03452345|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311052|NCT03452332||Single Group Assignment||Treatment||None (Open Label)||||||
1311053|NCT03452319|Randomized|Parallel Assignment||Prevention||Single|Assessor will not be aware of which group the patients are included in.|A single blind, randomized, controlled, intervention study. Evaluation of the addition of increased physical activity and respiratory muscle training for patients undergoing thoracoabdominal esofagus resection compared to standard care|||t|
1311054|NCT03452306|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Open Label|four-way crossover||||
1311055|NCT03452293|||Cohort||Prospective|||||||
1311056|NCT03452280|||Case-Only||Other|||||||
1311057|NCT03452267|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1311058|NCT03452254|Randomized|Parallel Assignment||Treatment||Quadruple|Patients will be assigned to the active tDCS plus mCIMT group or to the sham tDCS plus mCIMT group using randomized blocking to ensure the balance between the treatments. Once the person in charge of recruiting receives the patient's informed consent, he will notify this to the person in charge of randomization who will not have any relationship with the patient, will not know the patient's clinical record, and will not be influenced by the head researchers, the evaluators, or the therapist. This person will send a text message to the person responsible for programming and installing the tDCS, who will proceed to set the tDCS either active or simulated. Patients, treating occupational therapists, and the results evaluator will be kept masked to the assignment process.|Sham randomized multicenter double clinical trial.|t|t|t|t
1311059|NCT03452241|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1311060|NCT03452228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311061|NCT03452215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311062|NCT03452202|Non-Randomized|Crossover Assignment||Treatment||Double|||t|t||
1311063|NCT03452189|Randomized|Crossover Assignment||Treatment||Double||randomized double-blinded placebo-controlled crossover study|t|t||
1311064|NCT03452176|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311065|NCT03452163||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1573390|NCT00001395||||||||||||
1311066|NCT03452150||Single Group Assignment||Treatment||None (Open Label)||||||
1311067|NCT03452137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311068|NCT03452124|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1311069|NCT03452111||Single Group Assignment||Other||None (Open Label)||||||
1311070|NCT03452098|||Case-Only||Retrospective|||||||
1311071|NCT03452085|Randomized|Crossover Assignment||Prevention||None (Open Label)|The two types of pump-spray had a different bottle design but the bottles were blank with no identification|"Patients were randomized to two groups, whereas one group starts treatment with AS and the other group starts treatment with TT (control).~After a wash out phase of 3 days, the patients have to take the other product for also 3 days.~(e. g. randomized patient takes AS for 3 days, after a wash out period of 3 days he takes TT also for three days.)"||||
1311072|NCT03452072|Randomized|Parallel Assignment||Treatment||Single|Blinded physician will assess outcomes from pictures|"The protocol will begin post-surgery. Eligible subjects will be assigned by computer-based randomization to case (0.25% timolol gel) or control (standard of care [SOC]) group and treated as follows:~Case group:~Timolol 0.25% gel will be applied to wound bed immediately after surgery before dressing is applied~Starting the day after surgery: each day, the patient will cleanse the surgical site, apply 0.25% topical timolol gel (1 drop = 0.1ml for each cm2 of wound area), and re-cover wound with clean dressing~Daily routine continues for 12 weeks' post-surgery (even if the surgical defect has completely healed)~SOC group:~Vaseline will be applied to wound bed immediately after surgery before dressing is applied~Starting the day after surgery: each day, the patient will cleanse the surgical site, apply Vaseline, and re-cover wound with clean dressing~This daily routine continues for 12 weeks' post-surgery (even if the surgical defect has completely healed)"||||t
1311073|NCT03452059|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1311074|NCT03452046|||Cohort||Prospective|||||||
1311075|NCT03452033|Randomized|Parallel Assignment||Treatment||Double|Double-masked containers|Double-maksed, parallel|t||t|
1311076|NCT03452020||Single Group Assignment||Diagnostic||None (Open Label)||||||
1311077|NCT03452007||Single Group Assignment||Treatment||None (Open Label)||||||
1311078|NCT03451994|||Cohort||Retrospective|||||||
1311079|NCT03451981|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311080|NCT03451968|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1311081|NCT03451955|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1311082|NCT03451942|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311083|NCT03451929|||Cohort||Prospective|||||||
1311084|NCT03451916|Randomized|Sequential Assignment||Treatment||Triple||, subjects will be randomized using a 1:1 allocation scheme to either 150×106 PLX-PAD cells or to placebo treatment, respectively|t||t|t
1311085|NCT03451903|||Cohort||Retrospective|||||||
1311086|NCT03451890|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311087|NCT03451877|Randomized|Crossover Assignment||Screening||Double|||t||t|
1311088|NCT03451864|||Cohort||Prospective|||||||
1311089|NCT03451851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311090|NCT03451838|||Cohort||Prospective|||||||
1311091|NCT03451825|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1311092|NCT03451812|||Case-Only||Prospective|||||||
1311093|NCT03451799||Single Group Assignment||Treatment||None (Open Label)||Single arm, prospective cohort||||
1311094|NCT03451786||||||||||||
1311095|NCT03451773|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1311096|NCT03451760|Randomized|Parallel Assignment||Treatment||Quadruple|This is a double-blind, placebo-controlled study. The placebos will be matched to the active supplement in both sensory and physical characteristics. The participants, study investigators, research associates, and study coordinators will have no knowledge of study assignment. Data analysis will be performed blinded to treatment status. The OHSU Research Pharmacy will be responsible for establishing a randomization scheme for newly enrolled participants. Additionally, the Research Pharmacy will ensure blinding of all study medications. The investigators will also evaluate the effectiveness of our blinding by giving study evaluators, participants, study partners, and investigators a short questionnaire asking about knowledge of group assignment. The randomization code will be broken only after data analysis or if there are numerous serious adverse events before the end of the study.|Randomized, double-blind, placebo-controlled clinical trial with a 12 week intervention period.|t|t|t|t
1311097|NCT03451747|||Case-Control||Retrospective|||||||
1311098|NCT03451734|||Cohort||Prospective|||||||
1311099|NCT03451721|||Case-Only||Prospective|||||||
1311100|NCT03451708|Randomized|Crossover Assignment||Treatment||Single|Patient blinded||t|||
1311101|NCT03451695|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1311102|NCT03451682|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1311103|NCT03451669|||Cohort||Prospective|||||||
1311104|NCT03451656|||Cohort||Prospective|||||||
1311105|NCT03451643|Randomized|Parallel Assignment||Treatment||None (Open Label)||RANDOMIZED CONTROLLED TRIAL||||
1311106|NCT03451630|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||We chose an individual, stratified randomized trial design to randomly assign each enrollee to one of the three interventions arms, minimizing and balancing confounding variables. We will utilize an unequal randomization ratio of 2:2:1 for High-Touch, High-Tech, and Usual Care, respectively. While the less resource intensive Usual Care may, in fact, improve meaningful outcomes for certain patient subgroups, our health care system has invested heavily in High-Touch and High-Tech as evidence-based solutions for chronic disease care. We will use a mixed-methods approach that incorporates both qualitative and quantitative data.||||
1311107|NCT03451617|Randomized|Parallel Assignment||Other||Single|||t|||
1311108|NCT03451604|||Cohort||Prospective|||||||
1311109|NCT03451591|Randomized|Factorial Assignment||Prevention||Single||Patients will be randomised to start one of four treatments; isosorbide mononitrate only; cilostazol only; both isosorbide mononitrate and cilostazol or neither isosorbide mononitrate nor cilostazol.||||t
1311110|NCT03451578||Single Group Assignment||Diagnostic||None (Open Label)||||||
1311111|NCT03451565|||Cohort||Prospective|||||||
1311112|NCT03451552|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|There is no masking in the study.The participant, their primary care provider, and the study team will know which arm the patient is in.|"This is a prospective, mixed method (patient) randomized controlled trial of navigation services provided by Ontario 211 vs. navigation services provided by a lay Patient Navigator. Randomization is 1:1 control:intervention.~The mixed method design is a sequential, explanatory design. Patients having consented to participate in the study will complete a survey, after which their random assignment to one of two arms (intervention or control) will be revealed.~The randomization schedule will be blocked at the practice level to ensure a balance of control and intervention patients for each practice, including all providers.~Patients randomized to the intervention arm will have access to services provided by the ARC Patient Navigator, whereas patients randomized to the control arm will be directed to the Ontario 211 navigation service."||||
1311113|NCT03451539|||Other||Other|||||||
1311114|NCT03451526|||Case-Control||Retrospective|||||||
1311115|NCT03451513|Randomized|Parallel Assignment||Prevention||Double|The investigator will not be told which condition individual participants are in. Outcome assessors at follow-up will not be told which condition the participant was in; any assessments regarding the content of intervention will be done by a separate, unblind assessor. The research assistants who enter the data from the clinician-based assessments administered by the outcome assessors will also be blind to participant condition assignment.|On a phone screen, participants will be orally consented, and assessed briefly for eligibility. Participants who seem eligible will come in for an assessment made up of self- and clinician-report assessments, where they will be consented and assessed for eligibility. Eligible participants will be randomized. All participants completed intervention as determined by randomized assignment (i.e., MA or PBP). Each subject ID is pre-assigned to a study condition, determined by an online randomization program, prior to recruitment. Each eligible participant had a 1/2 chance to be assigned to either of the two study conditions. Participants will take part in two intervention sessions spaced a week apart. 1 to 2 weeks after the last session, participants will complete a follow-up, where they will do self- and clinician-report assessments. Further follow-up assessments, also comprised of both self- and clinician report assessments will be completed 6, 12, 18, and 24 months after treatment.|||t|t
1311116|NCT03451500|Randomized|Parallel Assignment||Treatment||Triple|All tablets will be identical in appearance. The Director of Research will be aware of treatment assignment. Patients, their Care Providers and all other study staff will be blinded to treatment.|Randomized, prospective, placebo controlled|t|t||t
1311117|NCT03451487|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1311118|NCT03451474||Single Group Assignment||Treatment||None (Open Label)||||||
1311119|NCT03451461|||Cohort||Prospective|||||||
1311120|NCT03451448|||Cohort||Prospective|||||||
1311121|NCT03451435|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311122|NCT03451422|Randomized|Parallel Assignment||Treatment||Triple|The phase 1b and phase 2a parts of the study are double-blind. In the phase 1b part of the study, treatment assignment will be blinded to all subjects and site personnel as described below. In the phase 2a part of the study treatment assignment will be blinded to all subjects, site personnel, and Amgen as described below.|"Phase 1b The phase 1b part of the study is a double-blind, placebo-controlled, multicenter, multiple ascending dose (MAD) study to evaluate the safety, tolerability, PK, and PD of AMG 592 in subjects with SLE. Subjects will be treated for a total of 12 weeks after which they will be followed for an additional 6 weeks for safety and additional PK/PD data collection. Three dosing cohorts are planned for the phase 1b part of the study.~Phase 2a The phase 2a part of the study is a 52-week multicenter, double-blind, placebo controlled study in subjects with moderate to severe SLE or cutaneous lupus with inadequate response to standard of care therapy. The phase 2a part of the study will commence after a RP2D is identified. Subjects will be randomly assigned in a 2:1 ratio to either AMG 592 or placebo."|t|t|t|
1311123|NCT03451409|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1311124|NCT03451396|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311125|NCT03451383|||Case-Control||Prospective|||||||
1311126|NCT03451370|||Cohort||Prospective|||||||
1311127|NCT03451357|||Case-Only||Prospective|||||||
1311128|NCT03451344|Randomized|Parallel Assignment||Supportive Care||Single|To minimize the risk of biased results as much as possible, the persons who conduct the urine tests and complete the evaluation of the ASI will be different from those who provides the intervention. But subjects may talk about the CAREs intervention during the assessment so it is not possible to completely 'blind' the evaluators to the intervention group of the subjects.|||||t
1311129|NCT03451331|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-label|||||
1311130|NCT03451318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311131|NCT03451305|Randomized|Single Group Assignment||Treatment||Single|Patients eligible for the study were selected by an independent research assistant. The study was explained, and informed consent was obtained from patients before the surgery. Using a randomization sequence, the patients were assigned to the international or control group. The attending surgeons and patients were blinded before the surgery.|Patients with single level osteoporotic compression fracture|||t|
1311132|NCT03451292|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311133|NCT03451266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311134|NCT03451253|Randomized|Parallel Assignment||Other||Triple|Single (physician) blinded.|4 week randomized into 2 arms, followed by 4 weeks of open label non-randomized follow-up.||t|t|t
1311135|NCT03451240||Single Group Assignment||Other||None (Open Label)||To determine the impact of the Corporate Athlete® Resilience product through recalibrating mindset and changing resilience supportive behavior.||||
1311136|NCT03451227|Randomized|Parallel Assignment||Basic Science||Double|"Patients will be randomly allocated (computer generated) to receive either a dexmedetomidine infusion or a remifentanil infusion.~The patient, interventional cardiologist and data analyser will be blinded to the drugs given. The anaesthesia care provider will not be blinded"|This is a prospective, single blind, randomised controlled study looking at the feasibility of dexmedetomidine for sedation during ablation procedures at Toronto General Hospital.|t|t||
1311137|NCT03451214||Single Group Assignment||Basic Science||None (Open Label)||||||
1311179|NCT03450655|Randomized|Parallel Assignment||Treatment||Single|The Data Analyst will also be masked.|||||t
1311138|NCT03451201|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomised Clinical Trial, 3 parallel groups: HIIT ( High-Intensity Interval Training) MCT (moderate intensity continuous training) and Sedentary Control Group.||||
1311139|NCT03451188|||Cohort||Prospective|||||||
1311140|NCT03451175|||Cohort||Prospective|||||||
1311141|NCT03451162|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1311142|NCT03451149||Single Group Assignment||Device Feasibility||None (Open Label)||A single group of up to 10 participants will be enrolled to evaluate a radiofrequency wire for cutting through liver parenchyma instead of the standard trocar needle during transjugular intrahepatic portosystemic shunt creation. This will be to test this device for feasibility and not health outcomes.||||
1311143|NCT03451136|||Cohort||Prospective|||||||
1311144|NCT03451123||Single Group Assignment||Diagnostic||None (Open Label)||Single group assignment||||
1311145|NCT03451110|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1311146|NCT03451097|||Case-Only||Cross-Sectional|||||||
1311147|NCT03451084|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1311148|NCT03451071|||Other||Prospective|||||||
1311149|NCT03451058|||Cohort||Cross-Sectional|||||||
1311150|NCT03451045|Randomized|Parallel Assignment||Treatment||Double||Multicenter, double-blind, randomized, placebo-controlled, parallel group study.|t||t|
1311151|NCT03451032|||Cohort||Prospective|||||||
1311152|NCT03451019|Randomized|Crossover Assignment||Treatment||None (Open Label)||Prospective randomized open-label study included 34 patients with CKD. Single oral dose of one of phosphate binders (sevelamer or lanthanum) were administered in random order 15 minutes after 5 g calcium carbonate with standardized meal. Serum calcium, phosphate and parathormone were measured at 0, 3, 6, 12, 24 hours after each medication. Bone alkaline phosphatase (BAP), sclerostin, calcitriol and FGF-23 were measured at 0, 12 and 24 hours after dose. Calcium and phosphate were measured in 24h urine collections after each drug.||||
1311153|NCT03451006|Randomized|Parallel Assignment||Treatment||Double||"Arms Assigned interventions Placebo Comparator: Metformin Chronic metformin administration through augmentation of cellular regeneration and reduction of senescence will improve frailty and physical functioning as studied by the short physical performance battery (SPPB) test. Drug: Metformin versus placebo This will be a pilot, feasibility study. Twelve subjects ≥60 years with stable CAD and prediabetes, who score <9 on SPPB test will be randomized to receive up to 2gm of oral metformin or placebo for 12 months.~Placebo comparator: Placebo Placebo will be compared to chronic metformin administration Drug: Metformin versus placebo This will be a pilot, feasibility study. Twelve subjects ≥60 years with stable CAD and prediabetes, who score <9 on SPPB test will be randomized to receive up to 2gm of oral metformin or placebo for 12 months."|t||t|
1311154|NCT03450993|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1311155|NCT03450980||Single Group Assignment||Screening||None (Open Label)|"Aim 1) In the comparison of the app against the ground truth the study staff will be masked to the ground truth value.~Aim 2) In comparison of the app against the clinical gold standards, the study staff making the clinical gold standard measures (prism alternating cover test and Modified Thorington test) will be masked to the app measurement.~Analyses: Study staff and statistician performing the analysis will be masked to which group data is from the app and which is from the ground truth and gold standard tests."|||||
1311156|NCT03450967||Single Group Assignment||Treatment||None (Open Label)||||||
1311157|NCT03450954|||Case-Control||Retrospective|||||||
1311158|NCT03450928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311159|NCT03450915|Randomized|Parallel Assignment||Treatment||Quadruple|All parties are blinded except for the person who prepares the syringe for injection. The M-001 is cloudy white and its appearance is different from the transparent saline that is used for placebo. The person prepares the syringe with an opaque sticker that fully covers the syringe contents. People administering the syringe are not involved or present during syringe preparation, and are thus fully blinded.|Experimental group: 2 immunizations with M-001 Control group: 2 injection of saline (placebo)|t|t|t|t
1311160|NCT03450902|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1311161|NCT03450889|||Cohort||Prospective|||||||
1311162|NCT03450876|||Cohort||Prospective|||||||
1311163|NCT03450863|||Cohort||Prospective|||||||
1311164|NCT03450850||Single Group Assignment||Treatment||None (Open Label)||||||
1311165|NCT03450837|||Case-Control||Cross-Sectional|||||||
1311166|NCT03450824|||Case-Control||Retrospective|||||||
1311167|NCT03450811|Non-Randomized|Parallel Assignment||Diagnostic||Single|The control group consisted of volunteer participitants who were admitted to the outpatient clinics with various reasons or healthy persons|The patients who underwent elective open or laparoscopic inguinal hernia repair were treated by a single general surgeon.|t|||
1311168|NCT03450798|Randomized|Parallel Assignment||Treatment||Single||||||t
1311169|NCT03450785|||Cohort||Prospective|||||||
1311170|NCT03450772|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1311171|NCT03450759|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1311172|NCT03450746|||Cohort||Prospective|||||||
1311173|NCT03450733|||Cohort||Cross-Sectional|||||||
1311174|NCT03450720||Single Group Assignment||Treatment||None (Open Label)||||||
1311175|NCT03450707|Randomized|Parallel Assignment||Treatment||Quadruple|A randomization list was prepared by an independent statistician using 1:1 randomization in blocks of four. This list will be provided to the research pharmacy, and the research pharmacy will be the only unblinded people involved with the study, and will have no patient contact or role in the analysis or other aspects of the study. Thiamine is colorless and odorless, and the 500mg dose is mixed in 100mL of normal saline. Placebo will be 100mL of normal saline and is indistinguishable in appearance from thiamine. Study team, clinical team and patient and family will all be blind to the allocation.||t|t|t|t
1311176|NCT03450694|||Cohort||Prospective|||||||
1311177|NCT03450681|Randomized|Parallel Assignment||Treatment||Single||||||t
1311178|NCT03450668|Randomized|Crossover Assignment||Supportive Care||Triple|Choice of incubator used is randomized and blinded until the subject has been recruited and incubator arm assigned. After which it will be known to all concerned.|a randomized two-arm crossover study|t|t|t|
1311180|NCT03450642|||Cohort||Prospective|||||||
1311181|NCT03450629|Randomized|Parallel Assignment||Treatment||Single|||||t|
1311182|NCT03450616|Randomized|Parallel Assignment||Treatment||Double|Subjects and treating physician will be blinded to treatment.|All subjects will receive both treatment arms at the same time.|t|t||
1311183|NCT03450603|||Cohort||Prospective|||||||
1311184|NCT03450590|||Case-Control||Prospective|||||||
1311185|NCT03450577|||Cohort||Prospective|||||||
1311186|NCT03450564|Randomized|Parallel Assignment||Health Services Research||Single|The study will be masked to the participants in which they don't disclose the type of intervention.|This cluster randomized controlled trail will be designed to enhance family planning utilization in pastoralist community. It has three arm and these are two community based intervention and one control group. The community interventions are women education about family planning and male involvement towards family planning use. The intervention study will stay for a total of 9 month and data will be collected three times with a four and half month gap. Every month there will be a provision of health education message to the interventions arm by experts on family planning, clan/religious leader and model women who are using family planning. The message will be tailored to the intervention based.|t|||
1311187|NCT03450551|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311188|NCT03450538|||Cohort||Prospective|||||||
1311189|NCT03450525|||Cohort||Prospective|||||||
1311190|NCT03450512|||Case-Only||Prospective|||||||
1311191|NCT03450499|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311192|NCT03450486|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||This study will include one intervention arm and one control arm. The intervention arm will include balance measurements from the affected side of individuals with unilateral knee osteoarthritis. The control arm will will include balance measurements from the unaffected side of individuals with unilateral knee osteoarthritis.||||
1311193|NCT03450473||Single Group Assignment||Other||None (Open Label)||||||
1311194|NCT03450460|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311195|NCT03450447|||Cohort||Prospective|||||||
1311196|NCT03450434|Randomized|Parallel Assignment||Treatment||Double|"Single-blinding was conducted during the run-in period of the study (each patient received simultaneously 3 tablets of Placebo matching 2, 10, and 100 mg XC8), the form of the package (a blister with three lines of tablets of each dosage), corresponding package labeling of the study drug (IP kit numbers).~Double-blinding in the treatment period was provided by Placebo masking (each patient received simultaneously 3 tablets corresponding to 2 mg or Placebo, 10 mg or Placebo, 100 mg or Placebo), the form of the package (a blister with three lines of tablets of each dosage), corresponding package labeling of the study drug (IP kit numbers) and distribution of the drug by IWRS."|At Visit 2, Week -1 the patients who meet all inclusion/exclusion criteria were included in the single-blind placebo run-in period. At Visit 3, Week 0 all patients were randomized to 4 treatment groups in 1:1:1:1 ratio (30 patients per each group of XC8 2 mg, 10 mg or 100 mg; and 30 patients to Placebo group).|t||t|
1311197|NCT03450421|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311198|NCT03450408|Randomized|Parallel Assignment||Prevention||Single|The individual or individuals responsible for assessing outcome data will be blinded to group assignment.|||||t
1311199|NCT03450395|Randomized|Crossover Assignment||Basic Science||Double||For each of the two periods, a hot breakfast cereal will be consumed once daily for a duration of 6 weeks each. There will be a 4 week washout period in between each test substance.|t||t|
1311200|NCT03450382|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Open label, quasi-experimental clinical trial comparative study.||||
1311201|NCT03450369||Single Group Assignment||Treatment||None (Open Label)||Open label.||||
1311202|NCT03450356|||Other||Prospective|||||||
1311203|NCT03450343||Single Group Assignment||Treatment||None (Open Label)||||||
1311204|NCT03450330||Single Group Assignment||Treatment||None (Open Label)||dose escalation||||
1311205|NCT03450317|Randomized|Parallel Assignment||Prevention||Single||||||t
1311206|NCT03450304|||Case-Crossover||Prospective|||||||
1311207|NCT03450291|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Three parallel groups: those who have recovered from anorexia nervosa; those who worry a lot about eating, shape and weight; and healthy control participants will be included, and all will complete some questionnaires and two tasks.||||
1311208|NCT03450278|Randomized|Parallel Assignment||Treatment||Single||||||t
1311209|NCT03450265|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311210|NCT03450252|Randomized|Crossover Assignment||Treatment||Triple||"Taking part in this study will involve recording the information at a pre-implant visit, a visit for cardiac pacemaker implantation and follow-up visits six and twelve months later.~At the pre-implant visit, participants will undergo assessment of symptoms, physical performance and blood test for a protein, Brain natriuretic peptide (BNP).~During the pacemaker implantation, the investigators will record the pressures within the heart using a catheter during both active pacing and back-up pacing settings.~The day after the pacemaker implant participants will undergo double-blind randomisation into either the treatment or non-treatment arm (active or back-up pacing respectively). At six months, cross-over takes place with assessment as above, before device reprogramming into either the treatment or non-treatment arm depending on which was completed first.~At the end of the second six month period, participants will undergo repeat assessment as above. That will conclude the study."|t|t|t|
1311211|NCT03450239|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||All participants undero go an MRI scan, complete some questionnaires and two computer tasks. Participants are in two groups: those who have recovered from anorexia nervosa, and healthy control participants.||||
1311212|NCT03450226|Randomized|Parallel Assignment||Prevention||Quadruple||randomized controlled trial|t|t|t|t
1311213|NCT03450213|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1311214|NCT03450200|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311287|NCT03449251|Randomized|Parallel Assignment||Other||Triple|Identical, colourless solution||t||t|t
1311295|NCT03449147|Randomized|Parallel Assignment||Treatment||Double||Participants with refractory or unexplained chronic cough will be randomized to 1 of 3 treatment groups: gefapixant 45 mg twice daily (BID), gefapixant 15 mg BID, or placebo.|t||t|
1311215|NCT03450187|Randomized|Parallel Assignment||Other||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|"Up to 5 cohorts of 8 subjects each will be enrolled. Subjects in each cohort will be randomized 6:2 to receive multiple oral doses of TP 271 at 1 of 5 ascending doses of TP-271 or placebo once or twice daily for 7 days, as shown in the table below. Every effort will be made to dose all subjects in a cohort on the same day.~Proposed Oral Doses of Study Drug by Dose Cohort Cohort Dose Regimen Proposed Oral Dose A Once daily 50 mg TP-271 q24 (n = 6) or matching placebo (n = 2) B Once daily 100 mg TP-271 q24 (n = 6) or matching placebo (n = 2) C Once daily 200 mg TP-271 q24 (n = 6) or matching placebo (n = 2) D Once daily 300 mg TP-271 q24 (n = 6) or matching placebo (n = 2) E Once daily 400 mg TP-271 q24 (n = 6) or matching placebo (n = 2) Abbreviations: q24 = every 24 hours."|t|t|t|t
1311216|NCT03450174|Randomized|Factorial Assignment||Prevention||Double|||t|t||
1311217|NCT03450161|Randomized|Single Group Assignment||Prevention||Quadruple|Only an otherwise uninvolved anesthesiologist will know dosing schemes.|randomized, double-blinded, three arm study|t|t|t|t
1311218|NCT03450148|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1311219|NCT03450135||Single Group Assignment||Basic Science||None (Open Label)||All participants will receive same protocol.||||
1311220|NCT03450122|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311221|NCT03450109|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1311222|NCT03450096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311223|NCT03450083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311224|NCT03450070||||||||||||
1311225|NCT03450057||Single Group Assignment||Treatment||None (Open Label)||Single arm: Daratumumab + Dexamethasone||||
1311226|NCT03450044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311227|NCT03450031|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1311228|NCT03450018||Single Group Assignment||Treatment||None (Open Label)||"This is a traditional Phase I 3+3 study designed to identify the MTD by assessment of DLT of SLC-0111. Sample size estimates are not statistically based, but are based on acquisition of appropriate numbers of subjects to adequately describe the safety, tolerability, PK, and PD of SLC-0111 in combination with gemcitabine.~Up to 18 subjects are anticipated to be enrolled in the dose escalation part; however, the actual number recruited will be dependent upon the number of dose escalations. Dose expansion (Part 2) may enroll up to 12 subjects."||||
1311229|NCT03450005|||Case-Only||Prospective|||||||
1311230|NCT03449992|Randomized|Parallel Assignment||Other||Triple|"Twelve participants were randomly assigned to either an intervention group or a placebo group, and a 4 digits code based on their Spanish ID card were used to code their names.~Then, an independent researcher prepared individual bags with either a 15-days worth of placebo drinks or beetroot drinks, and gave it to the athletes. Then, this person was withdrawn for the research procedures.~Finally, another group of researchers, without knowing what athlete was on each group (intervention or placebo), conducted the performance tests pre and post 15 days of supplementation, and another group analyzed the data once collected."|Twelve elite distance runners were randomly assigned to either an intervention group or a placebo group. Participants in each group consumed beetroot juice or a placebo drink for 15 consecutive days.|t||t|t
1311231|NCT03449979|Randomized|Parallel Assignment||Basic Science||Double|This is a double-blind study, meaning that neither the participant nor the experimenter knows what kind of stimulation the participant is receiving. An unblinded monitor (separate from the staff that interacts with the participant) is responsible for creating the stimulation codes that run each session and for ensuring that these codes worked correctly.|This study recruits both patients currently experiencing a depressive episode (regardless of diagnosis) and those with no history of neurological or psychiatric illness. Randomization will occur in a 1:1 ratio for both of these groups, with half of each group receiving transcranial alternating current stimulation (tACS) at 10Hz and the other half receiving placebo (or sham) stimulation.|t||t|
1311232|NCT03449966|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||All procedures were performed with both WLE and pCLE. One patient underwent both WLE and pCLE. Target biopsy under pCLE and random biopsy at cancer lesion under WLE will be done for one patient. The proportion of remnant cancer cells in biopsy samples will be compared.||||
1311233|NCT03449953|||Cohort||Prospective|||||||
1311234|NCT03449940|Randomized|Parallel Assignment||Treatment||None (Open Label)||A block randomization sequence was created and cases were allocated 1:1 to either immediate repair (group 1) or delayed repair (group 2). Allocation sequence numbers were kept concealed in sequentially numbered folders and access was only granted to the principal investigator.||||
1311235|NCT03449927|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1311236|NCT03449914|||Cohort||Prospective|||||||
1311237|NCT03449901||Single Group Assignment||Treatment||None (Open Label)||||||
1311238|NCT03449888|||Cohort||Prospective|||||||
1311239|NCT03449875|||Cohort||Prospective|||||||
1311240|NCT03449862|Randomized|Parallel Assignment||Health Services Research||Triple|Electronic web-based simulation study with built-in randomization tool|Multi-center, double-blinded simulation-based randomized controlled trial|t||t|t
1311241|NCT03449849|Randomized|Crossover Assignment||Other||Double|||||t|t
1311242|NCT03449836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311243|NCT03449823|||Case-Control||Prospective|||||||
1311288|NCT03449238||Single Group Assignment||Treatment||None (Open Label)||"Patients with metastatic breast cancer with at least 2 brain metastases, eligible to receive SRS. Patients will complete radiation therapy within 1 week and Pembrolizumab may be continued every 3 weeks until evidence of brain progression or serious adverse toxicity. Patients will be followed until death.~Pembrolizumab will be infused the day before SRS, at the standard dose of 200mg IV over 30 minutes and repeated every 3 weeks until disease progression or unacceptable toxicity."||||
1311289|NCT03449225|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1311290|NCT03449212|||Case-Control||Prospective|||||||
1311291|NCT03449199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311292|NCT03449186|||Case-Control||Prospective|||||||
1311293|NCT03449173||Single Group Assignment||Treatment||None (Open Label)||||||
1311294|NCT03449160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311244|NCT03449810|Randomized|Factorial Assignment||Treatment||Quadruple|The participants would randomly be allocated to four groups as follows. All outcome measures at baseline will be measured by examiner 1 who will be blinded to group allocation. Participants will randomly be assigned by another Examiner 2(which is unknown to Examiner 1), using a random number generator, to group (A= MET), (B=CSE), (C=MET +CSE) and (D=CONTROL), all the groups will receive their intervention from Examiner 3, Examiner 2 then take the readings at 6 weeks and 12 weeks. Group indication would be placed in a sealed envelope that will be opened after Examiner 1 had performed the initial assessment. Group indication will only be known by Examiner 2. Participants will also be unaware of their group procedure. However, the reading on outcomes taken initially by examiner 1 will be written on the outside of the sealed envelope used for allocating the groups and it will serve as baseline data.|The Intervention Models Includes; Muscles Energy Technique which would be administered to participants group A, Core Stability Exercise to be administered to group B, a combination of Muscles Energy Technique and Core Stability Exercises would be administered to group C participants and Group D would be the control group and would receive patient Education and Counselling.|t|t|t|t
1311245|NCT03449797|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1311246|NCT03449784|||Cohort||Prospective|||||||
1311247|NCT03449771||Single Group Assignment||Other||None (Open Label)||||||
1311248|NCT03449758||Single Group Assignment||Treatment||None (Open Label)||||||
1311249|NCT03449745|||Cohort||Prospective|||||||
1311250|NCT03449732|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1311251|NCT03449719|Randomized|Parallel Assignment||Treatment||None (Open Label)||A Phase II study is suitable to investigate the interaction of systemic therapy (ADT and abiraterone) with locoregional therapy (SBRT). The duration of the study equal to 40 months was defined taking into account both the expected time of occurrence of investigated endpoints and feasibility considerations related to patient availability.||||
1311252|NCT03449706|||Cohort||Prospective|||||||
1311253|NCT03449693|Randomized|Parallel Assignment||Prevention||None (Open Label)||Two groups: Intervention group and control group. The intervention group will receive institutional care protocol plus oral supplementation with magnesium. The control group will receive institutional care protocol only.||||
1311254|NCT03449680|Randomized|Parallel Assignment||Treatment||Triple|The anesthesiologist performing the nerve block will be aware of group allocation; but a separate anesthesiologist providing intra-operative care will remain blinded. The patient and the research staff collecting outcome data will remain blinded until all data are collected.|Patients will be randomized between one of two treatment groups. The intervention of femoral articular branch block or the control group (non-invasive placebo).|t|t||t
1311255|NCT03449667|Randomized|Crossover Assignment||Treatment||Triple|All individuals will be masked to treatment with the exception of the anesthesiologist administering the procedure who will choose which probe to use: the functional or sham. Of note, this individual could not be masked to treatment since the cryoneurolysis ice ball is visualized on ultrasound; and, the practitioner would see a lack of ice ball formation for the sham probes.|The primary endpoint at 4 months following the initial treatment will utilize a parallel group study design; however, an optional crossover is offered to subjects following this time point.|t||t|t
1311256|NCT03449654|Randomized|Parallel Assignment||Prevention||Double|Dobbelt-blinded|Randomized, Placebo-controlled, Parallel|t||t|
1311257|NCT03449641||Single Group Assignment||Treatment||None (Open Label)||||||
1311258|NCT03449628|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311259|NCT03449615|||Case-Only||Prospective|||||||
1311260|NCT03449602|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1311261|NCT03449589|||Cohort||Prospective|||||||
1311262|NCT03449576|Randomized|Parallel Assignment||Prevention||Single||||||t
1311263|NCT03449563|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311264|NCT03449550|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1311265|NCT03449537|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311266|NCT03449524|Randomized|Parallel Assignment||Treatment||Quadruple||CXA-10|t|t|t|t
1311267|NCT03449511|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1311268|NCT03449498|Randomized|Parallel Assignment||Treatment||Double||RCT|t|||t
1311269|NCT03449485|||Case-Only||Prospective|||||||
1311270|NCT03449472|||Case-Only||Prospective|||||||
1311271|NCT03449459|Randomized|Parallel Assignment||Prevention||None (Open Label)|Although this study is unblinded, we will adopt method of allocation concealment to reduce selection bias.|Participants are equally assigned to four groups in parallel to accept oral probiotics, aerosol inhaled amikacin, combined vaccination or blank control for the duration of the study.||||
1311272|NCT03449446|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311273|NCT03449433|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1311274|NCT03449420|||Cohort||Retrospective|||||||
1311275|NCT03449407|||Case-Only||Other|||||||
1311276|NCT03449394|Randomized|Parallel Assignment||Treatment||Single||||||t
1311277|NCT03449381|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1311278|NCT03449368|||Cohort||Retrospective|||||||
1311279|NCT03449355|||Other||Cross-Sectional|||||||
1311280|NCT03449342||Single Group Assignment||Treatment||None (Open Label)||||||
1311281|NCT03449329|Randomized|Parallel Assignment||Treatment||Quadruple||double blinded randomized two study group|t|t|t|t
1311282|NCT03449316|Randomized|Parallel Assignment||Treatment||Single|Blinding for the investigator that acess outcomes, that will not be involved in the intervention process.|Two arms single blinded randomised controlled trial with a 1 year follow up||||t
1311283|NCT03449303|Randomized|Parallel Assignment||Supportive Care||Single|Participants will be seen in two separate clinic rooms. Intervention and placebo will have identical packaging and labeling with the addition of an A or B.|The study design uses a randomized, single-blind, placebo-controlled quantitative (QUAN) strand paralleled by a photovoice methodology qualitative (QUAL) strand.|t|||
1311284|NCT03449290|Randomized|Parallel Assignment||Treatment||Single||||||t
1311285|NCT03449277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311286|NCT03449264||Single Group Assignment||Other||None (Open Label)||||||
1311296|NCT03449134|Randomized|Parallel Assignment||Treatment||Double||Participants with refractory or unexplained chronic cough will be randomized to 1 of 3 treatment groups: gefapixant 45 mg twice daily (BID), gefapixant 15 mg BID, or placebo. Participants will remain on their assigned treatment at randomization throughout the study. A safety follow-up phone call will be conducted at a minimum of 14 days after last dose of study treatment.|t||t|
1311297|NCT03449121||Single Group Assignment||Treatment||None (Open Label)||||||
1311298|NCT03449108|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311299|NCT03449095|Randomized|Factorial Assignment||Basic Science||Single||||||t
1311300|NCT03449082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311301|NCT03449069||Single Group Assignment||Treatment||None (Open Label)||||||
1311302|NCT03449056||Single Group Assignment||Treatment||None (Open Label)||||||
1311303|NCT03449043|||Cohort||Retrospective|||||||
1311304|NCT03449030|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1311305|NCT03449017||Single Group Assignment||Basic Science||None (Open Label)||2 session x 2 condition within participant||||
1311306|NCT03449004|||Other||Cross-Sectional|||||||
1311307|NCT03448991|||Cohort||Prospective|||||||
1311308|NCT03448978||Single Group Assignment||Treatment||None (Open Label)||||||
1311309|NCT03448965|||Other||Cross-Sectional|||||||
1311310|NCT03448952|||Cohort||Cross-Sectional|||||||
1311311|NCT03448939|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311312|NCT03448926|||Cohort||Prospective|||||||
1311313|NCT03448913|||Cohort||Prospective|||||||
1311314|NCT03448900|Randomized|Parallel Assignment||Treatment||Single|Randomization was performed by one member of the research team who generated a blocked random number sequence, using EpiInfo version 7.0.9.7, and prepared the sealed opaque sequentially numbered envelopes (1-255) with the corresponding condition written inside. After each student agreed to participate in the study, the enve- lope was opened, determining the group to which he or she would be assigned. Students were unaware of the group assignments and randomization scheme.||t|||
1311315|NCT03448887|Randomized|Parallel Assignment||Treatment||None (Open Label)||Exploratory, Multicenter, Randomized||||
1311316|NCT03448874|Randomized|Parallel Assignment||Treatment||Single|This study is single blinded. The subject will be blinded to the treatment arm; however, by nature of the type of the proposed study, blinding of the investigator/ surgeon is not feasible. In order to minimize bias, subjects will be randomized during the surgery upon confirmation of the intra-operative exclusion criteria. This will ensure that the surgeon will not know prior to surgery and until completion of anastomosis creation, whether or not Seal-G MIST will be used.|Controlled, Randomized, single blind study|t|||
1311317|NCT03448861||Single Group Assignment||Diagnostic||None (Open Label)||||||
1311318|NCT03448848|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1311319|NCT03448835||Single Group Assignment||Treatment||None (Open Label)||single group, open label||||
1311320|NCT03448822|||Cohort||Prospective|||||||
1311321|NCT03448809|Randomized|Parallel Assignment||Treatment||None (Open Label)||No sample size calculation was performed for this parallel, two-arm feasibility RCT. Because the study population was heterogeneous and included children with a broad spectrum of emotional and behavioral mental health problems, 100-120 children were needed in the new experimental MMM arm to answer the research questions related to implementation and acceptability of the MMM manual. Therefore the goal was to include 150 children to be randomly allocated (3:1) to MMM versus TAU. The central, computerized randomization was performed by DEFACTUM using concealed computer-generated allocation sequences with variable block size, and stratification by region (Zealand or Central Denmark), and by age (6-10 years or 11-16 years).||||
1311322|NCT03448796|Randomized|Parallel Assignment||Treatment||Single|The clinical assessors are blinded when applicable.|Prospective randomized controlled trial.||||t
1311323|NCT03448783|||Case-Only||Prospective|||||||
1311324|NCT03448770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311325|NCT03448757||Single Group Assignment||Treatment||None (Open Label)||measuring hemodynamic parameters heart beat to heart beat during single-frequency exposure||||
1311326|NCT03448744|Randomized|Parallel Assignment||Treatment||Single|||||t|
1311327|NCT03448731||Single Group Assignment||Treatment||None (Open Label)||||||
1311328|NCT03448718||Single Group Assignment||Treatment||None (Open Label)||||||
1311329|NCT03448705|Randomized|Parallel Assignment||Prevention||Single|The study is single-blind (blinded for the participant).|According to the objective, as well as the primary endpoints of the study, this is a Phase I study, open-label to the route of administration, single-blind to the ID doses, randomised, active-controlled that will be conducted in three parallel groups. Three visits will be performed in the study: on Day 0, Day 7-9 and Day 21-28. Pre-vaccination and post-vaccination serum samples are to be taken on Day 0 and Day 21-28. Adverse events will be documented between the enrollment and Day 21-28.|t|||
1311330|NCT03448692|Non-Randomized|Sequential Assignment||Treatment||Triple|Open label||t|t|t|
1311331|NCT03448679|||Cohort||Retrospective|||||||
1311332|NCT03448666||Single Group Assignment||Treatment||None (Open Label)||This is a single arm trial with a single group assignment||||
1311333|NCT03448653||Single Group Assignment||Prevention||None (Open Label)||||||
1311334|NCT03448640|||Case-Control||Prospective|||||||
1311335|NCT03448627|||Case-Control||Prospective|||||||
1311336|NCT03448614|||Cohort||Prospective|||||||
1311337|NCT03448601|Randomized|Parallel Assignment||Health Services Research||Single|Content of each arm will not be described to the participant.|Participants will be randomized in equal proportions either to receive a standard, non-tailored educational brochure on Alzheimer's Disease (AD), the value of precision medicine (PM), and the importance of research (control); or to receive a culturally tailored brochure with graphics and identical information and to view a digital story featuring personal narratives of AI/ANs (intervention).|t|||
1311338|NCT03448588|||Case-Control||Retrospective|||||||
1311376|NCT03448094|Randomized|Parallel Assignment||Other||Double||Participants will recieve either Resveratrol or Placebo for a period of 3 months.|t||t|
1311377|NCT03448081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311378|NCT03448068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311339|NCT03448575|Randomized|Parallel Assignment||Other||Quadruple|Waivers of consent have been obtained for providers and for patients/parents/guardians. None are informed of the study design or study activities by arm. The investigator is blind to study arm assignment of providers and patients. Only automated data collection is utilized for this practical trial. Study arm is masked for the programmer/analyst pulling outcomes data from health system records. Study arm will also be masked for study staff verifying study eligibility prior to the official study enrollment. Arm is not masked for study intervention staff (consulting psychiatrists, behavioral health navigators, bridging therapists) since these staff only interact with intervention arm subjects.|Providers are preassigned to one of two study arms: usual care control or intervention arm. Patients are assigned to the same arm as the provider triggering the best practice alert and study algorithm.|t|t|t|t
1311340|NCT03448562|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311341|NCT03448549|Randomized|Parallel Assignment||Treatment||Triple||Patients enrolled are randomized into SOX group and XELOX group||t|t|t
1311342|NCT03448536|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1311343|NCT03448523|Randomized|Parallel Assignment||Prevention||None (Open Label)||open label, randomised, efficacy study||||
1311344|NCT03448510|Randomized|Parallel Assignment||Treatment||Single|The data will be analyzed in a blinded manner.|Irreversible electroporation (IRE) is a novel ablation modality using electric pulses to create nanoscale defects in the cell membrane.||||t
1311345|NCT03448497|||Cohort||Retrospective|||||||
1311346|NCT03448484|Randomized|Parallel Assignment||Prevention||Single|The nature of the intervention package compared to the control package prevents a double-blind study design and thus, only the outcome assessors (data collectors) and the study statistician can be blinded to the group assignment|Cluster Randomized, Parallel-group, Prospective, Follow-up Effectiveness Study||||t
1311347|NCT03448471|||Case-Control||Prospective|||||||
1311348|NCT03448458||Single Group Assignment||Diagnostic||None (Open Label)||||||
1311349|NCT03448445|||Case-Control||Prospective|||||||
1311350|NCT03448432|||Cohort||Prospective|||||||
1311351|NCT03448419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311352|NCT03448406|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311353|NCT03448393||Single Group Assignment||Treatment||None (Open Label)||||||
1311354|NCT03448380|||Cohort||Prospective|||||||
1311355|NCT03448367|||Cohort||Prospective|||||||
1311356|NCT03448354|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparative effectiveness of HIPEC following interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy: Multicenter, prospective, cohort study||||
1311357|NCT03448341|||Cohort||Prospective|||||||
1311358|NCT03448328|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized, parallel group||||
1311359|NCT03448315|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311360|NCT03448302|||Other||Prospective|||||||
1311361|NCT03448289|Non-Randomized|Parallel Assignment||Health Services Research||Single|Because we are studying health behaviors, we cannot share the specific aims of the study with control group participants as this could bias behavior. The control group participants will be told that this is a study monitoring women's general health care experiences at UIH.|The control group will be enrolled during phase 1 (first 4 months) prior to the introduction of the intervention. After enrollment of the control group, a 6-week washout period prior to phase 2 (intervention) will ensure women are not enrolled into both arms of the study.|t|||
1311362|NCT03448276|Randomized|Parallel Assignment||Treatment||Triple|Triple: a researcher shall be exclusively responsible for the evaluations and reevaluations not having knowledge of what intervention group the patient will enter. The patient will be allocated among three groups. After the final evaluations, all data will be analyzed by another researcher directed solely to that purpose. Therefore, there will be a triple blinding (researcher, patient and statistician).|Two groups: The experimental group (GI) that will hold the training in the vibrating platform and the control group (GC) that will perform the walk, settling 1 treatment session.|t|t|t|
1311363|NCT03448263|Randomized|Factorial Assignment||Treatment||Double|Certified endodontists trained in the procedures, devices, and systems investigated took part in the research. All experts tracked a pre-established procedure for the Balanced Force technique, WaveOne, and Reciproc instrument systems.|Random Selection of instrumentation groups. Of the sample of 216 teeth, 72 were randomly assigned to the one of the 3 instrumentation methods. Treatment was performed by 3 experienced endodontists; each prepared 72 teeth, 24 per technique.|t||t|
1311364|NCT03448250|Randomized|Parallel Assignment||Treatment||Single||||||t
1311365|NCT03448237|Randomized|Parallel Assignment||Treatment||None (Open Label)||Interventional comparative study over 9 months, of three modes of care: Speech-language, or proprioceptive, or combined (speech therapy or proprioceptive)||||
1311366|NCT03448224|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311367|NCT03448211||Sequential Assignment||Treatment||None (Open Label)||||||
1311368|NCT03448198||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1311369|NCT03448185|Randomized|Factorial Assignment||Treatment||Triple|Subjects and investigative team (except for statistician) are blinded to omega-3 vs olive oil placebo. Subjects and investigators are aware of exercise modality. Outcomes assessors are blinded to all aspects of subject randomization.|2x2 factorial design. Subjects are randomized to aerobic exercise or yoga as well as high dose omega-3 fatty acids or olive oil placebo.|t||t|t
1311370|NCT03448172|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1311371|NCT03448159|Randomized|Parallel Assignment||Treatment||Quadruple||Arm 1: Intervention group (will receive the trial drug, fluoxetine, as well as an exercise intervention) Arm 2: Placebo group (will receive a placebo as well as an exercise intervention|t|t|t|t
1311372|NCT03448146||Single Group Assignment||Treatment||None (Open Label)||||||
1311373|NCT03448133|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1311374|NCT03448120|Randomized|Factorial Assignment||Treatment||Single||||t||
1311375|NCT03448107|Randomized|Parallel Assignment||Prevention||Single|The investigators responsible for analyzing the data for primary outcomes will be masked.|Two-arm, parallel, non-inferiority cluster randomized trial||||t
1573391|NCT00001387||||Treatment||||||||
1311379|NCT03448055||Single Group Assignment||Health Services Research||None (Open Label)||Nutritional supplemetation with Immunocal 20gm daily for 6 months (180 days)||||
1311380|NCT03448042|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1311381|NCT03448029|||Cohort||Prospective|||||||
1311382|NCT03448016|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||[C-11]NOP-1A||||
1311383|NCT03448003|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311384|NCT03447990|Randomized|Parallel Assignment||Treatment||Quadruple||"This is a a two part study. The first part is a randomized, crossover, double-blind, placebo-controlled, two cohort, sequential ascending single dose study. All patients will receive placebo and active doses of MYK-491.~The second part is a randomized, parallel, double-blind, placebo-controlled, sequential ascending multiple dose study. All patients will receive placebo and/or active doses of MYK-491."|t|t|t|t
1311385|NCT03447977|Randomized|Parallel Assignment||Treatment||Single||||||t
1311386|NCT03447964|||Cohort||Cross-Sectional|||||||
1311387|NCT03447951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311388|NCT03447938|Randomized|Parallel Assignment||Treatment||Single||||||t
1311389|NCT03447925|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311390|NCT03447912|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This is a matched-pairs community randomized controlled trial. 14 communities will receive the behavioral intervention and 14 will serve as control communities. Enrollment is on the community level rather than individual level.||||
1311391|NCT03447899|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1311392|NCT03447886|||Other||Other|||||||
1311393|NCT03447873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311394|NCT03447860|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1311395|NCT03447847|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1311396|NCT03447834|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients will be randomized in a 1:1 fashion to either routine PPCI (control arm) or intracoronary hypothermia in addition to PPCI (hypothermia arm). For the patients randomized to intracoronary hypothermia will follow the steps below.~For the routine PPCI a regular guidewire will be advanced across the occlusion followed by pre-dilatation and/or (direct) stenting according to the operator's preference."||||
1311397|NCT03447821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311398|NCT03447808||Single Group Assignment||Treatment||None (Open Label)||||||
1311399|NCT03447795|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled clinical trial (RCT) with parallel group, two arm, with 1:1 allocation ratio.|t|||t
1311400|NCT03447782||Single Group Assignment||Diagnostic||None (Open Label)||This group includes patients reviewed after 3 months of observational study with NDPH who have not improved clinically-they will take naltrexone, 4.5 mg, for 3 months||||
1311401|NCT03447769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311402|NCT03447756|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311403|NCT03447743|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311404|NCT03447730|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind||t|t|t|t
1311405|NCT03447717||Single Group Assignment||Treatment||None (Open Label)||patients meeting the inclusion criteria are included||||
1311406|NCT03447704|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1311407|NCT03447691|Randomized|Parallel Assignment||Other||Triple|"The investigator who research the QoR-40 questionnaire before and after the surgery will not know which group the patient is assigned to.~Because of the difference in anesthesia method, it is impossible to apply blindness to an anesthesiologist practicing anesthesia. Thus, the anesthesiologist will maintain anesthesia with the same target in both groups. (anesthesia depth, hemodynamic status and pain control)~Blind is released to investigator and outcomes assessor after completion of QoR-40 questionnaire."||t||t|t
1311408|NCT03447678||Single Group Assignment||Treatment||None (Open Label)||||||
1311409|NCT03447665|Randomized|Parallel Assignment||Treatment||Single|The individuals coding videosomnography are blinded to the participant's condition.|Families are randomly assigned to one of three groups: control, bedtime only (intervention), or all night (intervention).||||t
1311410|NCT03447652|Randomized|Parallel Assignment||Prevention||Single|Outcomes assessor is blinded to which group the subjects were in.|4 independent groups||||t
1311411|NCT03447639|Randomized|Parallel Assignment||Prevention||None (Open Label)||2 arm parallel study with 1 to 1 randomization||||
1311412|NCT03447626|||Case-Control||Prospective|||||||
1311413|NCT03447613|||Cohort||Cross-Sectional|||||||
1311414|NCT03447600|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1311415|NCT03447587|Randomized|Parallel Assignment||Treatment||Double||Randomized to two groups in 1:1 ratio.|t|||t
1311416|NCT03447574|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1311417|NCT03447561|Randomized|Crossover Assignment||Basic Science||None (Open Label)||All participants will receive one PETMR scan session with the combination of anticipatory (viewing high-calorie food images) and consummatory reward (drinking sips of chocolate milkshake), and one PETMR scan session with purely consummatory reward, in a randomized and counterbalanced order.||||
1311418|NCT03447548|Randomized|Parallel Assignment||Treatment||Double|Double blind|Randomized controlled trial with intervention versus active control|t|||t
1311419|NCT03447535|||Case-Control||Retrospective|||||||
1311420|NCT03447509|Randomized|Crossover Assignment||Treatment||Single|participants will not know if they receive real or sham stimulation|Magnetic Stimulation|t|||
1311421|NCT03447496|||Case-Control||Prospective|||||||
1311422|NCT03447483||Single Group Assignment||Other||None (Open Label)||||||
1311423|NCT03447470||Single Group Assignment||Treatment||None (Open Label)|Open label design|Dose escalation||||
1311424|NCT03447457|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||FLORAL-ER is a before/after study||||
1311425|NCT03447444||Single Group Assignment||Supportive Care||None (Open Label)||case studies||||
1311426|NCT03447431|||Cohort||Retrospective|||||||
1311427|NCT03447418||Single Group Assignment||Basic Science||None (Open Label)||||||
1311428|NCT03447405|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Test the usability of the device (safety for the NICU was confirmed), not the effectiveness of the parents' voice delivery for the infant. Parent and nursing questionnaires about the importance of the device availability and its usability will be collected from parents and RN staff that choose to provide the feedback.||||
1311429|NCT03447392|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311430|NCT03447379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311431|NCT03447366||Single Group Assignment||Diagnostic||None (Open Label)||||||
1311432|NCT03447353|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1311433|NCT03447340|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311434|NCT03447327||Single Group Assignment||Treatment||None (Open Label)||||||
1311435|NCT03447314|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||In Part 1, one dose level of GSK3174998, GSK3359609, or pembrolizumab with up to 5 dose levels of GSK1795091 are planned for evaluation. Sequential cohorts will be enrolled and dose escalation (or de-escalation) will proceed according to Neuenschwander-Continual Reassessment Method (N-CRM design). In Part 2, subjects will be administered GSK1795091 in combination with either 24 mg GSK3174998, 80 mg GSK3359609, or 200 mg pembrolizumab at a dose identified in Part 1.||||
1311436|NCT03447301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311437|NCT03447288|||Cohort||Prospective|||||||
1311438|NCT03447275|||Case-Control||Cross-Sectional|||||||
1311439|NCT03447262||Single Group Assignment||Treatment||None (Open Label)||||||
1311440|NCT03447249|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1311441|NCT03447236||Single Group Assignment||Prevention||None (Open Label)||||||
1311442|NCT03447223|||Cohort||Retrospective|||||||
1311443|NCT03447210||Single Group Assignment||Diagnostic||None (Open Label)||Prospective cohort study with nested cross-sectional studies||||
1311444|NCT03447197|Randomized|Parallel Assignment||Treatment||Single||||||t
1311445|NCT03447184|||Case-Only||Prospective|||||||
1311446|NCT03447171|||Cohort||Prospective|||||||
1311447|NCT03447158|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311448|NCT03447145||Single Group Assignment||Treatment||None (Open Label)||||||
1311449|NCT03447132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311450|NCT03447119||Single Group Assignment||Prevention||None (Open Label)||||||
1311451|NCT03447106|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311452|NCT03447093|||Case-Control||Cross-Sectional|||||||
1311453|NCT03447080|Randomized|Crossover Assignment||Other||None (Open Label)||Randomized crossover study||||
1311454|NCT03447067|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1311455|NCT03447054|Randomized|Parallel Assignment||Treatment||Triple||2 (active, sham tDCS) x 2 (active, inactive response inhibition training) factorial design|t|t||t
1311456|NCT03447041|||Other||Prospective|||||||
1311457|NCT03447028|||Cohort||Cross-Sectional|||||||
1311458|NCT03447015|Randomized|Parallel Assignment||Supportive Care||Single|The principal researcher will be kept blind for those participants who are in the intervention and control groups. Completing the second part of the study tool, which is related to maternal and infant health outcomes, will be in maternal ward and by the primary investigators 24 to 48 hours after birth.|A randomised controlled study will be conducted with primiparous women. In the intervention group women will be encouraged to ambulate and women in the control group will receive usual maternity care|||t|
1311459|NCT03447002|||Case-Control||Prospective|||||||
1311460|NCT03446989||Single Group Assignment||Health Services Research||None (Open Label)||||||
1311461|NCT03446976|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1311462|NCT03446963||Single Group Assignment||Health Services Research||None (Open Label)||||||
1311463|NCT03446950|Randomized|Parallel Assignment||Supportive Care||Double|Participants will be blinded to their intervention group. Investigators following up with participants at 6 weeks will be blinded to the group allocation of the participants|To compare patient positioning during vaginal surgery we plan to conduct a single site single blinded randomized controlled trial where patients planning elective vaginal surgery will be randomized to be positioned in Candy cane or Boot stirrups|t|||t
1311464|NCT03446937|Randomized|Parallel Assignment||Prevention||Triple|double blind|Randomised controlled trial|t|t|t|
1311465|NCT03446924|Randomized|Parallel Assignment||Basic Science||Double|An individual with no direct study involvement will administer treatments in a double-blind manner. Investigators will be un-blinded to treatment arms upon completion of data analysis.|Parallel-designed study in which participants will be randomized to receive phosphatidic acid or placebo treatment. A parallel design was chosen due to the number of invasive muscle biopsies performed during each experimental trial.|t||t|
1311466|NCT03446911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311467|NCT03446898|||Cohort||Other|||||||
1311468|NCT03446885|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1311469|NCT03446872|||Cohort||Prospective|||||||
1311470|NCT03446859|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects were randomly allocated to two groups, experimental and control||||
1311471|NCT03446846|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311472|NCT03446833||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1311473|NCT03446820||Sequential Assignment||Other||None (Open Label)||Participants will be randomly assigned to sleep in the residential module of the Well Living Lab. One week will be with standard sheets, followed by one week of hygro cotton sheets.||||
1311474|NCT03446807|Randomized|Parallel Assignment||Treatment||Double|The first phase is double-blind and the second phase is open label.||t||t|
1311475|NCT03446794|||Case-Only||Prospective|||||||
1311476|NCT03446781|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1311477|NCT03446768|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1311478|NCT03446755||Single Group Assignment||Device Feasibility||None (Open Label)||The aim of this pilot study study is to test if the device is feasible in preventing adhesions to develop again after adhesiolsysis.||||
1573392|NCT00001385||||||||||||
1311479|NCT03446742|||Cohort||Prospective|||||||
1311480|NCT03446729|Randomized|Parallel Assignment||Treatment||Single||||||t
1311481|NCT03446716|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to the ADHD or Typically Developing group based on diagnosis history. Each then completes the intervention (EXTENSION) either preceded or followed by a week of baseline sleep (CONTROL). The order is pseudo-randomized.||||
1311482|NCT03446703|Randomized|Parallel Assignment||Treatment||Single|Trained raters who were blind to treatment condition assessed participants on the following variables at baseline, post-treatment and 3-month follow-up|A randomized three group pre-post design will be used to investigate effects of the Training of Affect Recognition (TAR), compared to the Social Cognition and Interaction Training (SCIT). Performance in social cognition measures, basic cognitive functioning symptomatology and functional capacity will be assessed before (T0), after (T1) treatment and (T2) 3 months later.||||t
1311483|NCT03446690|Non-Randomized|Parallel Assignment||Prevention||Single||33 subjects were prospectively recruited for the project in the MI Varnish group. These subjects were studied against a control group of 29 orthodontically treated subjects who received routine treatment and oral hygiene regimes. All subjects will be patients seeking orthodontic treatment at the Department of Orthodontics, School of Dentistry, University of Alabama at Birmingham.||||t
1311484|NCT03446677||Single Group Assignment||Screening||None (Open Label)||||||
1311485|NCT03446664||Single Group Assignment||Treatment||None (Open Label)||Two cohorts of subjects with refractory epilepsy; (1) subjects with primary generalized tonic-clonic seizures and (2) subjects with partial onset seizures including complex partial seizures with or without secondary generalization.||||
1311486|NCT03446651|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1311487|NCT03446638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311488|NCT03446625|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1311489|NCT03446612|Randomized|Parallel Assignment||Treatment||None (Open Label)|This is an open-label study. However, a central FBF reader, who will read and evaluate the FBF data, will be blinded to the treatment assignment.|Subjects will be randomized to either daprodustat or darbepoetin alfa. A central randomization approach will be used with stratification by center.||||
1311490|NCT03446599|Randomized|Parallel Assignment||Treatment||None (Open Label)|Masking is unfortunately not feasible due to characteristic side effects from each medication that alert most healthcare providers to its presence: methylene blue - transient interference with pulse oximetry, blue chromaturia; hydroxocobalamin - red chromaturia.|||||
1311491|NCT03446586|||Cohort||Other|||||||
1311492|NCT03446573|Randomized|Parallel Assignment||Treatment||None (Open Label)|This will be an open-label study and therefore no blinding is required. The Sponsor team aims to remain blinded to subject assignment, and will instruct sites to refrain from mentioning assignment when sending in queries (as the sites/subjects will not be blinded). No summaries of the study data according to actual randomized treatment groups will be available to sponsor staff prior to the planned Week 24 preliminary analysis.|This is a randomized study with parallel group assignment where subjects will be randomized into one of the two treatment groups. Subjects randomized to DTG + 3TC will receive DTG + 3TC up to Week 200. Subjects randomized to TBR will continue to take their current regimen up to Week 148, at which time and if HIV-1 RNA <50 c/mL at Week 144, these subjects will switch to DTG + 3TC up to Week 200. Randomization will be stratified by Baseline third agent class (protease inhibitor [PI], integrase inhibitor [INI], or non-nucleoside reverse transcriptase inhibitor [NNRTI]).||||
1311493|NCT03446560|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, open-label, multicenter, parallell group design||||
1311494|NCT03446547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311495|NCT03446534|Randomized|Parallel Assignment||Treatment||Quadruple||The study is a phase IV double-blind, placebo-controlled, multicenter, nationwide, randomized superiority trial of amoxicillin versus placebo in children aged 1-5 years of age with a lower respiratory infection.|t|t|t|t
1311496|NCT03446521|||Cohort||Prospective|||||||
1311497|NCT03446508|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1311498|NCT03446495|||Other||Prospective|||||||
1311499|NCT03446482|||Cohort||Prospective|||||||
1311500|NCT03446469||Single Group Assignment||Treatment||None (Open Label)||||||
1311501|NCT03446456|Randomized|Parallel Assignment||Basic Science||Double|Randomization will be performed/maintained by the University of Maryland Medical Center Pharmacy. Blind will only be broken in case of a potential medical emergency during the experiment.|This experiment has a between-subjects design. Participants will be randomized into two groups: AVP and control. Both the experimenter and participant will be blinded to the group allocation. Participants have 50%/50% chance of being placed in either group. Participants in the AVP group will receive intranasal AVP and the participants in the control group will receive intranasal saline before the fMRI experiment. The experiment in the fMRI scanner is divided into two phases: an observational phase in which participants will observe a video of a demonstrator experiencing analgesia and a testing phase in which study participants will receive heat pain to investigate how their pain perception. During both phases there will be a placebo condition (pain with the expectation of having received a treatment) and a control condition (pain without the expectation of having received a treatment). All participants will complete both phases, including the observational and testing phase.|t||t|
1311502|NCT03446443|Randomized|Parallel Assignment||Treatment||Single||||||t
1311503|NCT03446430||Single Group Assignment||Other||None (Open Label)||||||
1311504|NCT03446417|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1311505|NCT03446404|||Cohort||Prospective|||||||
1311506|NCT03446391|||Case-Control||Other|||||||
1311507|NCT03446378|Randomized|Parallel Assignment||Treatment||Double||randomized controlled double-blind clinical trial|t|||t
1311508|NCT03446365|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||6th to 8th grade middle schoolers will be enrolled then randomly assigned to one of three conditions: 1) ASMAS, 6th to 8th grade middle schoolers will be enrolled then randomly assigned to 1) ASMAS, or 2) Asthma Education plus Child Health control condition, or 3) a no treatment control condition||||
1311509|NCT03446352|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311510|NCT03446339|||Case-Only||Prospective|||||||
1573393|NCT00001384||||Treatment||||||||
1311511|NCT03446326||Single Group Assignment||Treatment||None (Open Label)||||||
1311512|NCT03446313|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311513|NCT03446300|||Cohort||Prospective|||||||
1311514|NCT03446287|||Case-Control||Prospective|||||||
1311515|NCT03446274||Single Group Assignment||Basic Science||None (Open Label)||||||
1311516|NCT03446261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311517|NCT03446248|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1311518|NCT03446235|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311519|NCT03446222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311520|NCT03446209|Randomized|Parallel Assignment||Treatment||Double|Investigator and patient will be masked. There' ll be one qualified person in each center who s not going to be masked to prepare study treatment|Multi-center, phase II, randomized, placebo-controlled, double blind proof of concept trial|t||t|
1311521|NCT03446196|Randomized|Parallel Assignment||Other||None (Open Label)||Adult patients with end stage kidney disease undergoing single kidney transplantation from deceased donor. Two arms. One arm will undergo fluid replacement based on mostcare UP information, other arm will undergo fluid replacement based on clinician experience.||||
1311522|NCT03446183|||Case-Control||Other|||||||
1311523|NCT03446170|Randomized|Factorial Assignment||Prevention||None (Open Label)|The study tests the effects of graphic cigarette warning labels and packaging regulations, therefore it is unmasked.|The experimental design is a 2 (graphic warning message framing: gain versus loss) by 2 (cigarette packaging: standardized, plain or branded) factorial design. An unexposed control group is also included.||||
1311524|NCT03446157||Single Group Assignment||Treatment||None (Open Label)||This is a multicenter, single-arm, phase II clinical trial of combination therapy with cetuximab and palbociclib in refractory KRAS, NRAS, and BRAF wild-type metastatic colorectal cancer (CRC) patients||||
1311525|NCT03446144|Randomized|Parallel Assignment||Treatment||Triple|Double Masked||t|t|t|
1311526|NCT03446131|||Cohort||Prospective|||||||
1311527|NCT03446118||Single Group Assignment||Other||None (Open Label)||Twenty patients with eosinophilic esophagitis will be studied. Ten of these patients will have mild to moderate stricture formation (narrowed segment <8 cm in length and lumen diameter > 12mm) and 10 will have small caliber esophagus (a narrowed segment >8 cm in length with minimum diameter < 10mm). These groups will be delineated by routine barium esophagography performed in all Mayo patients with eosinophilic esophagitis during their initial clinical evaluation. Patients will then undergo an 8 week treatment with 3 mg budesonide twice daily as per routine clinical treatment with clinically indicated follow up endoscopy with esophageal biopsies to assess mucosal response. All patients will complete the EESAI dysphagia score per routine practice at Mayo. MRI of the esophagus will be performed in these patients initially and upon completion of the 8 week course of steroid therapy.||||
1311528|NCT03446105|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants will be randomly assigned (stratified by age and sex) to one of the treatment conditions in a 2:1 ratio (2 to intervention: 1 to attention control).||||
1311529|NCT03446092||Single Group Assignment||Supportive Care||None (Open Label)||||||
1311530|NCT03446079||Single Group Assignment||Prevention||None (Open Label)|Investigators and participants will be blinded to the results genetic testing results during the trial duration. Only participants will be blinded to the identity of the study product.|Cross sectional will utilize gene-specific candidate and genome wide association analysis to identify SNP's that may be associated with response to a topical product.||||
1311531|NCT03446066|||Case-Control||Prospective|||||||
1311532|NCT03446053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311533|NCT03446040|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311534|NCT03446027|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311535|NCT03446014|||Cohort||Prospective|||||||
1311536|NCT03446001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311537|NCT03445988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311538|NCT03445975|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||This study had a cluster-crossover design, where each of the two involved ICUs was the cluster. The genaral aim was to test the effectiveness of a 3-in-1 perineal care washcloth versus standard of care (e.g., water and pH neutral soap) to prevent and treat pressure ulcers in ICUs. The study has been articulated in two phases, lasted three months each. In the first phase, from the 1st of February to the 2nd of May, the 3-in-1 perineal care washcloth procedure has been adopted by the ICU of San Donato Hospital (Milan, Italy), while the Cardiovascular Intensive Care Unit (CVICU) continued to adopt the standard procedure (water and pH neutral soap). In the second phase, from the 2nd of May to 31st of July, the two procedures have been switched between the two wards.||||
1311539|NCT03445962|||Case-Control||Prospective|||||||
1311540|NCT03445949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311541|NCT03445936|Randomized|Parallel Assignment||Prevention||Double|Subject is blinded of the mesh used. Outcome at 10 month follow-up is assessed by surgeon who was not involved in the operation.|This is a prospective randomized controlled multicenter trial|t|||t
1311542|NCT03445923|Randomized|Parallel Assignment||Treatment||Triple||Randomized controlled trial|t|t||t
1311543|NCT03445910|Randomized|Parallel Assignment||Treatment||Single|one hundred opaque envelopes will be numbered serially and in each envelope the corresponding letter which denotes the allocated group will be put according to randomization table. Then all envelopes will be closed and put in one box. When the first patient arrives, the first envelope will be opened and the patient will be allocated according to the letter inside.||||t|
1311544|NCT03445897||Single Group Assignment||Treatment||None (Open Label)||Bolivian cutaneous leishmaniasis due to Leishmania braziliensis was treated with the combination of miltefosine (150 mg/day for 28 days) plus intralesional pentamidine (120 ug/mm2 lesion area on days 1, 3, and 5).||||
1311545|NCT03445884|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311546|NCT03445871|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311547|NCT03445858||Single Group Assignment||Treatment||None (Open Label)||||||
1311548|NCT03445845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311549|NCT03445832|||Case-Only||Retrospective|||||||
1311550|NCT03445819|Randomized|Parallel Assignment||Treatment||Single|Data analysts will be blinded to the study treatment.Wherever possible, outcome assessors will be blinded to the study treatment.|||||t
1311551|NCT03445806|||Cohort||Prospective|||||||
1311552|NCT03445793|||Cohort||Prospective|||||||
1311553|NCT03445780|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1311554|NCT03445767|Randomized|Parallel Assignment||Other||Double|||t|||t
1311555|NCT03445754|Randomized|Crossover Assignment||Treatment||Triple|Blinding will be done so the investigator performing the FMD, LSCI and PWA testing will be blinded to the allocation of TVS||t|t||t
1311556|NCT03445741|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to three groups in parallel for the duration of the study.||||
1311557|NCT03445728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311558|NCT03445715|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311559|NCT03445702|Randomized|Crossover Assignment||Screening||Quadruple|Investigators, participants, research coordinator will be blinded to intervention provided to subject|Randomized, double blinded, placebo controlled crossover trial|t|t|t|t
1311560|NCT03445689|||Other||Prospective|||||||
1311561|NCT03445676|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311562|NCT03445663||Single Group Assignment||Treatment||None (Open Label)||||||
1311563|NCT03445650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311564|NCT03445637|||Ecologic or Community||Prospective|||||||
1311565|NCT03445624|||Case-Control||Prospective|||||||
1311566|NCT03445611|Randomized|Parallel Assignment||Prevention||None (Open Label)|randomized into either Group1 or Group 2 medication with or without presevatives.|||||
1311567|NCT03445598|Randomized|Parallel Assignment||Supportive Care||Double|The participant is masked to the intervention assigned to them. All outcome measures are self-reported by the participants through a computer program without any involvement of the experimenters.||t|||t
1311568|NCT03445585|||Other||Prospective|||||||
1311569|NCT03445572|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1311570|NCT03445559|Randomized|Crossover Assignment||Health Services Research||Single||The proposed behavioral intervention will be implemented according to a stepped wedge cluster-randomized design. This is a single direction cross-over randomized trial where every site serves, at some point, as both a control and an intervention site. The first time point will be a baseline measurement, where none of the study sites have yet received the intervention. At subsequent time points, study sites initiate the intervention. The time at which each site initiates implementation of the intervention is randomized.||||t
1311571|NCT03445546|||Case-Control||Prospective|||||||
1311572|NCT03445533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311573|NCT03445520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311574|NCT03445507|Randomized|Parallel Assignment||Treatment||None (Open Label)|Intervention can´t be masked. We will objectify primary outcome by biochemistry validation, and statistician conducting the analysis will not know to which study arm a given patient has been assigned.|N = 460 smokers (230 in each arm), who will be recruited before randomization. Interventions: Intervention group: Use of an evidence-based chat bot for smoking cessation. Control group: Usual care (Madrid Health System Portfolio).||||
1311575|NCT03445494|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized 1:1||||
1311576|NCT03445481||Single Group Assignment||Treatment||None (Open Label)||||||
1311577|NCT03445468|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1311578|NCT03445455|||Case-Only||Prospective|||||||
1311579|NCT03445442|||Cohort||Retrospective|||||||
1311580|NCT03445429|Randomized|Crossover Assignment||Other||Single|||t|||
1311581|NCT03445416|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||We will employ an experimental design with pre/posttest measures to determine changes in vaccination awareness, intention and status, as well as engagement in health care. A total of 20 POLs will be identified and randomized to either the intervention or comparison arm. Regardless of assignment, POLs will be asked to diffuse information to at least 5 YBMSM network recruits; either the intervention (comprised of vaccination messaging developed in partnership with YBMSM) or comparison group health messaging. The comparison group content will be developed by the investigative team and consist of general, non-tailored health-related messaging (e.g., no vaccination messaging, will not address stigma or medical mistrust). Outcome analysis will compare the 50 intervention recruits to the 50 SOC recruits at 3 months post intervention.||||
1311582|NCT03445403|Non-Randomized|Parallel Assignment||Screening||Double|During offset analgesia testing, participants will be exposed to 3 heat pain paradigms: a constant heat stimulus, the offset analgesia paradigm, and a control paradigm. The participants will not be aware of the direction/pattern of temperature changes or which paradigm is being applied. Participants will not be allowed to view the computer screen so that it would not influence their response. The statistician will be unaware of the participants allocation of children with chronic pain vs. control|Response to a moderate heat pain [defined as a heat stimulus producing pain rated at 50mm on a scale of 0-100 mm] applied the the skin of the forearm using a paradigm known as offset analgesia will be compared in children with chronic pain disorders and healthy, age and sex matched controls.|t|||t
1311583|NCT03445390|Randomized|Crossover Assignment||Treatment||Double||Patients selected for this study were being treated for Moyamoya disease and required two operations, scheduled 1-2 weeks apart. With random assignment, patients were administered 1 gram of intravenous acetaminophen at the beginning and end of surgery, and placebo during the other operation.|t|t||
1311584|NCT03445377|Randomized|Crossover Assignment||Other||None (Open Label)|This is an open-label, multi-centre, randomised, crossover design study, involving a 2-week run-in period with blinded CGM, followed by two 8 weeks study periods during which subjects will monitor daily glucose levels either with real-time CGM or SMBG in random order.|This is an open-label, multi-centre, randomised, crossover design study, involving a 2-week run-in period with blinded CGM, followed by two 8 weeks study periods during which subjects will monitor daily glucose levels either with real-time CGM or SMBG in random order.||||
1311585|NCT03445364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573394|NCT00001383||||Treatment||||||||
1311586|NCT03445351||Single Group Assignment||Prevention||None (Open Label)||Intervention study, prospective, a cohort with 17 PLHA participants of the exercise program||||
1311587|NCT03445338||Single Group Assignment||Treatment||None (Open Label)||||||
1311588|NCT03445325||Single Group Assignment||Prevention||None (Open Label)||||||
1311589|NCT03445312|||Cohort||Prospective|||||||
1311590|NCT03445299||Single Group Assignment||Treatment||None (Open Label)||Within-subject design||||
1311591|NCT03445286|Randomized|Parallel Assignment||Treatment||Triple|The participants, care provider and outcome Assessor will be blinded The participants will be blinded about which interventions they will receive and the Outcomes Assessor who will evaluate the gingival condition will be blinded about the interventions, and also the care provider who will apply the intervention will be blinded|The participants with gingivitis are randomly allocated to two groups: group 1(case group) who will receive SDF application once every week within three weeks period and group 2 (control group) who will receive normal saline application once a week within three-week period|t|t||t
1311592|NCT03445273|||Other||Prospective|||||||
1311593|NCT03445260|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1311594|NCT03445247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311595|NCT03445234|Randomized|Parallel Assignment||Treatment||Double|Blueberry freeze dried powder or placebo powder|Randomized parallel group|t||t|
1311596|NCT03445221|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1311597|NCT03445208|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1311598|NCT03445195|Randomized|Parallel Assignment||Treatment||Quadruple||This study is a double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of IV ETX2514SUL in patients with cUTIs.|t|t|t|t
1311599|NCT03445182|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized Intervention Model: Split-mouth assignment||||
1311600|NCT03445169|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1311601|NCT03445156|Randomized|Factorial Assignment||Basic Science||None (Open Label)||Two studies (i.e., pilot study, experiment proper).||||
1311602|NCT03445130|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1311603|NCT03445117|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||two-arm cluster randomised crossover trial||||
1311604|NCT03445104|Randomized|Crossover Assignment||Other||Triple|Randomization allocation will be performed by personnel not involved in data collection to maintain participant and investigator blinding.|The participants will be randomized to receive huperzine A or placebo during the first session. They will then receive the other treatment during the second session.|t||t|t
1311605|NCT03445091||Single Group Assignment||Supportive Care||None (Open Label)||||||
1311606|NCT03445078|Randomized|Crossover Assignment||Diagnostic||Single|All participants will be blinded. Both the selenium-rich corn powder and the ordinary corn powder (placebo) have the same smell, color and taste.|20 participants with selenium deficiency (confirmed in previous phase (ID: Liuyanping3)) will be recruited to receive selenium-rich corn powder (20g/d, offering selenium 100μg/d) and ordinary corn powder (20g/d, offering selenium ＜ 0.5μg/d ) in two different sequences (10 subjects each) with a four-week washout period.Plasma samples were obtained at different time points before and after administration of the selenium-rich corn powder and ordinary corn powder.|t|||
1311607|NCT03445065|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1311608|NCT03445052|Randomized|Parallel Assignment||Prevention||Single|"Group Allocation will be concealed from the statisticians conducting the analysis until the analysis relevant to the primary study objective has been completed.~Care providers: Group allocation will be concealed from the XP clinical team who are not part of the research team. This is to avoid change in the standard care of these participants during the trial (i.e., greater/less discussion of adherence to photoprotection during the routine clinical appointment). Randomisation will be broken if the intervention facilitator is concerned about the participant's emotional wellbeing at any point during delivering the intervention. In this case the clinical team will be alerted and the participant will be referred to the clinical psychologist at the XP service for assessment."|"The study will test the efficacy of the intervention using a randomised controlled trial design. It is a delayed RCT, one group will receive the intervention in year 1 and be compared to the other control group in year 2. The control group will receive the intervention in year 2. The UVR dose to the face will be measured at baseline (21 days in March -April 2018) and will then be assessed at two follow-up periods in 2018 (June to July; August to September); two periods in 2019 (delayed intervention group). Psychosocial constructs will be measured by self report questionnaires at baseline and at the start of each UVR measurement period, as well as daily during these episodes. 9 months after baseline self-report questionnaires will be completed. A qualitative process evaluation will be conducted after the intervention is complete. A health economic evaluation of the intervention will be assessed by completion of HRQOL and service use questionnaires in December 2018, 2019."||||t
1311609|NCT03445039|Randomized|Parallel Assignment||Treatment||Double|All of the patients will be divided into four groups by using randomization tables. The assignment will be concealed from the clinical operators until the beginning of implant surgery. The outcome examiners will be kept blinded to the assignment.||||t|t
1311610|NCT03445026|||Other||Cross-Sectional|||||||
1311611|NCT03445013|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311612|NCT03445000||Single Group Assignment||Treatment||None (Open Label)||||||
1311613|NCT03444987|||Case-Control||Prospective|||||||
1311614|NCT03444974|Randomized|Parallel Assignment||Treatment||None (Open Label)||Symptom reduction in the treatment group (adolescent patients with substance abuse and dependency) in comparison to age and gender matched waiting-list and healthy controls. Changes in stress levels, problem solving and communication skills of parents in the treatment group in comparison to waiting-list parents.||||
1311615|NCT03444961||Single Group Assignment||Treatment||None (Open Label)||||||
1311616|NCT03444948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311663|NCT03444337|||Case-Only||Prospective|||||||
1311826|NCT03442218|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1311827|NCT03442205|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311828|NCT03442192|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311617|NCT03444935|Randomized|Parallel Assignment||Prevention||Single|Crisis Clinicians who consent individuals for participation will be masked from randomization. The randomization process will be completed by a different staff member separate from the Crisis Clinician to prevent allocation bias.|Participants are randomized to one of two groups: intervention or control. Participants will receive a set number of follow-up phone calls based on the group to which they are randomized.|t|||
1311618|NCT03444922|Randomized|Crossover Assignment||Treatment||Single|Double-blinded study; Study statistician computer generated randomization|||||t
1311619|NCT03444909|Randomized|Parallel Assignment||Other||None (Open Label)||"35 women will be divided into 3 test groups. results will be analyse in fonction of the repartition of the gestationnal age~10 women between 24-29 Week of amenorrhea (WA); 15 women between 30-35 WA; 10 women between 36-41 WA will be included."||||
1311620|NCT03444896|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311621|NCT03444883|Randomized|Parallel Assignment||Treatment||Triple||A mulicenter, randomized, parallel, double blind, placebo-controlled|t|t|t|
1311622|NCT03444870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311623|NCT03444857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311624|NCT03444844||Single Group Assignment||Diagnostic||None (Open Label)||||||
1311625|NCT03444831|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1311626|NCT03444818||Single Group Assignment||Basic Science||None (Open Label)||||||
1311627|NCT03444805|||Cohort||Prospective|||||||
1311628|NCT03444792|Randomized|Parallel Assignment||Prevention||Double|The included patients will be randomized using sealed opaque envelope method into two groups|Prospective randomized controlled trial|||t|t
1311629|NCT03444779|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311630|NCT03444766||Single Group Assignment||Treatment||None (Open Label)||||||
1311631|NCT03444753|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311632|NCT03444740|||Cohort||Cross-Sectional|||||||
1311633|NCT03444727|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomly assigned to either pre-treatment with ice inside a sterile glove or with room-temperature water inside an exam glove.||||
1311634|NCT03444714||Single Group Assignment||Treatment||None (Open Label)||3 + 3 dose escalation study design||||
1311635|NCT03444701|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a Phase 1 study of E7130 in participants with advanced solid tumors. This study will be conducted in 2 parts (Part 1 and Part 2). Part 1 will be the dose escalation portion of this study, conducted to assess dose-limiting toxicity (DLT) and to determine the maximum tolerated dose (MTD) in participants with solid tumors. The dosage and the duration of the treatment cycle in Part 2 will be determined based on the data from Part 1. Part 2 will be comprised of cohort expansions to further characterize the safety and tolerability of E7130.||||
1311636|NCT03444688|Randomized|Parallel Assignment||Treatment||Single||"The recruited subjects will be divided into 2 groups through a simple randomization scheme using Microsoft Excel (rand function); 1) Conventional gait training (CT, control group) and 2) Gait rehabilitation with the new walker modified after 1st stage (WT, experimental group). Each subject will undergo training programs consisting of 45 minutes training session (excluding rest periods), 3 days (alternate) a week for 6 consecutive weeks."||||t
1311637|NCT03444675|||Cohort||Prospective|||||||
1311638|NCT03444662|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1311639|NCT03444649||Single Group Assignment||Treatment||None (Open Label)||||||
1311640|NCT03444636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311641|NCT03444623|||Cohort||Prospective|||||||
1311642|NCT03444610||Single Group Assignment||Other||None (Open Label)||||||
1311643|NCT03444597|||Cohort||Prospective|||||||
1311644|NCT03444584|Randomized|Parallel Assignment||Treatment||Quadruple|Randomized, Placebo-controlled, Double-blind Study|Efficacy and Safety of MEDI0382 versus Placebo in Overweight/Obese Subjects with Type 2 Diabetes Mellitus Treated with Dapagliflozin and Metformin|t|t|t|t
1311645|NCT03444571|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1311646|NCT03444558|Randomized|Parallel Assignment||Supportive Care||Double|double-blind study|placebo-controlled study|t||t|
1311647|NCT03444545|||Case-Only||Prospective|||||||
1311648|NCT03444532|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1311649|NCT03444519|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311650|NCT03444506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311651|NCT03444493|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Stabilizastion (exercise group) and control group||||
1311652|NCT03444480|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1311653|NCT03444467|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures||t|t|t|t
1311654|NCT03444454|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1311655|NCT03444441|||Cohort||Prospective|||||||
1311656|NCT03444428|||Cohort||Prospective|||||||
1311657|NCT03444415|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311658|NCT03444402|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1311659|NCT03444389|||Case-Control||Prospective|||||||
1311660|NCT03444376||Single Group Assignment||Treatment||None (Open Label)||||||
1311661|NCT03444363|Randomized|Parallel Assignment||Treatment||Double|The results of the study were evaluated in a blinded manner|This study was designed as a randomized, controlled.|t||t|
1311662|NCT03444350|Randomized|Parallel Assignment||Treatment||Double|"The clinician who performed the therapy (S.D.) was not informed about the modality of the treatment till the first session of each patient (right at this moment, a sealed envelope was opened and the clinician was then able to see the treatment modality). The results of the study were evaluated in a blinded manner (both before treatment and after treatment).~The ozone was applied in the gingival sulcus of all teeth with a fine-tipped tool placed in the periodontal pocket. It was moved in the apical-coronal direction in a sweeping motion. Within 30 seconds, this application was applied in mesial, distal, buccal, and lingual manner. No ozone application was used in the Control Group, and they received only placebo."|RANDOMIZED CONTROLLED TRIAL|t||t|
1311664|NCT03444324|Randomized|Parallel Assignment||Treatment||Triple|Study 995 will be partially blinded; surgeon, surgical staff and subjects will be blinded to treatment allocation throughout the entire surgery. The IMP (BT524 or FFP) will be administered by an unblinded anaesthesiologist.|Patients are randomly assigned to treatment with BT524 or FFP.|t|t|t|
1311665|NCT03444311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311666|NCT03444298|Randomized|Crossover Assignment||Treatment||Triple|"The randomization schedule will be generated by the biostatistician and provided to the investigational pharmacy. Only the biostatistician and the pharmacist will have access to the randomization schedule.~Participants will consume 1400 mg of γT-enriched supplement or matching placebo every 12 hours for 4 doses, with the final dose occurring on the morning of the WSP exposure."|Subjects will be allocated to begin the first period of the crossover study with placebo or gamma tocopherol treatment using permuted block randomization with a block size of 4 (2 placebo, 2 gamma tocopherol for the first treatment period of the protocol).|t|t|t|
1311667|NCT03444285|Randomized|Parallel Assignment||Prevention||None (Open Label)||Two groups. One realize an static warm-up and the other a dynamic warm-up.||||
1311668|NCT03444272||Single Group Assignment||Treatment||None (Open Label)||||||
1311669|NCT03444259|||Cohort||Prospective|||||||
1311670|NCT03444246|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1311671|NCT03444233|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1311672|NCT03444220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311673|NCT03444207|Randomized|Parallel Assignment||Basic Science||None (Open Label)||The study was designed as a prospective randomized trial.||||
1311674|NCT03444194||Single Group Assignment||Basic Science||None (Open Label)||||||
1311675|NCT03444181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311676|NCT03444168|||Cohort||Prospective|||||||
1311677|NCT03444155|Randomized|Crossover Assignment||Basic Science||Double|Masking was organized and supervised by the randomization person in charge. Group assignment was 1:1 (control vs. verum group) with identical packages for both Vitamin supplements with 126 capsules for each subject per phase. Randomization was done with sealed envelopes.|Vitamin B complex (natural vs. synthetic) administered in capsules each day for 6 weeks - 2 weeks wash-out phase I (2 weeks) - cross-over 6 weeks - wash-out phase II (6 weeks)|t||t|
1311678|NCT03444142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311679|NCT03444129|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311680|NCT03444116|||Case-Control||Other|||||||
1311681|NCT03444103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311682|NCT03444090|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311683|NCT03444077|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1311684|NCT03444064|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311685|NCT03444051|||Cohort||Retrospective|||||||
1311686|NCT03444038||Single Group Assignment||Treatment||None (Open Label)||||||
1311687|NCT03444025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311688|NCT03444012|||Other||Cross-Sectional|||||||
1311689|NCT03443999|||Other||Prospective|||||||
1311690|NCT03443986|Randomized|Parallel Assignment||Treatment||Triple|"Triple: a researcher shall be exclusively responsible for the evaluations and reevaluations not having knowledge of what intervention~group the patient will enter. The patient will be allocated among three groups. After the final evaluations, all data will be analyzed by another researcher directed solely to that purpose. Therefore, there will be a triple blinding (researcher, patient and statistician)."|Three groups: resistance training associated with whole body vibration (G1), resistance training associated with vibration sham; (G2) and control group-guidelines about foot care (GC)|t|t|t|
1311691|NCT03443973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311692|NCT03443960|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1311693|NCT03443947||Single Group Assignment||Diagnostic||None (Open Label)||||||
1311694|NCT03443934|||Cohort||Prospective|||||||
1311695|NCT03443921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311696|NCT03443908|||Case-Only||Prospective|||||||
1311697|NCT03443895|Randomized|Sequential Assignment||Treatment||Double|This will be a double-blind study. Subjects and investigator will be masked.||t||t|
1311698|NCT03443882|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1311699|NCT03443869|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1311700|NCT03443856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311701|NCT03443843|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1311702|NCT03443830|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Time Lagged, Parallel-Group, Single Ascending Dose Study||||
1311703|NCT03443817|Randomized|Parallel Assignment||Treatment||Triple||prospective randomized controlled trial comparing the effects of a follow-up tele-rehabilitation program and conventional follow-up rehabilitation in patients with severe COPD. 54 patients fulfilling the inclusion criteria will be randomized in two groups to either an 8 week follow-up tele-rehabilitation program or to standard follow up after rehabilitation. Participants will be tested at baseline, after 8 weeks and 6 months after cessation of the training programs. In the intervention group, a real- and a virtual physiotherapist agent will facilitate the rehabilitation.|t|t||t
1311704|NCT03443804|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1311705|NCT03443791|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1311706|NCT03443778|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1311707|NCT03443765|||Cohort||Prospective|||||||
1311774|NCT03442894|Randomized|Parallel Assignment||Treatment||Single|Subjects in the dry needling and sham dry needling groups will be masked (blinded) to whether or not they are receiving the sham or actual dry needling.|3 groups: Standard physical therapy treatment (SPT), SPT plus dry needling and SPT plus sham dry needling|t|||
1311775|NCT03442881|||Cohort||Prospective|||||||
1311776|NCT03442868||Single Group Assignment||Treatment||None (Open Label)||||||
1311777|NCT03442855|||Cohort||Prospective|||||||
1311778|NCT03442842||||||||||||
1573395|NCT00001382||||Treatment||||||||
1311708|NCT03443752|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will complete the experimental procedures of the present study during a 12-week training period. All participants will be asked to participate in a Shotokan-karate or Tai Chi training group. The Shotokan-karate training will involve one hour training sessions broken down into 3 components; warm-up exercises, Katas, and cool-down exercises. The protocol for Tai Chi will involve a one-hour training session which will be conducted by an instructor at the Sun Life Financial Movement Disorders and Rehabilitation Centre. All exercises will be administered by trained instructors throughout the 12-week training period. The 30-minute UPDRS assessment will be administered by Dr. Quincy Almeida,a movement disorder specialist.||||
1311709|NCT03443739|||Cohort||Prospective|||||||
1311710|NCT03443726|Randomized|Parallel Assignment||Treatment||Triple|"The participant is not told which technique will be used on him/her.~Surgeon does not know the anesthetic technique used to numb the third molar.~When the statistician and primary investigator receive the collected data to be analyzed, the techniques are labeled 1 and 2."|"Control group: inferior alveolar nerve block with 1.8 cc of 4% articaine 1:100.000 epinephrine and 1.8 cc of the same anesthetic for the buccal nerve block.~Test group: infiltration anesthesia buccaly between first and second mandibular molar with 3.6 cc of 4% articaine 1:100.000 epinephrine and 0.6 cc ligually to the third molar using the same anesthetic."|t|t||t
1311711|NCT03443713|Randomized|Parallel Assignment||Other||None (Open Label)||Subjects randomly assigned to one of three types of exercise.||||
1311712|NCT03443700|Randomized|Parallel Assignment||Treatment||Single|Because of the use of an evident Medical Device (exoskeleton), enrolled subjects cannot be blind about their assignment group, however objective and standardized clinical measure scales will be employed; moreover, assessments (also neurophysiological and neuroimaging ones) will be conducted by blind experts.|Randomized controlled trial||||t
1311713|NCT03443687|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to either Pelvic Floor Physical Therapy (PFPT) or home biofeedback. The therapy allocation will then be carried out with each arm completing 3 months of therapy.||||
1311714|NCT03443674||Sequential Assignment||Treatment||None (Open Label)||||||
1311715|NCT03443661||Single Group Assignment||Treatment||None (Open Label)||||||
1311716|NCT03443648||Single Group Assignment||Treatment||Single|||t|||
1311717|NCT03443635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311718|NCT03443622|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1311719|NCT03443609||Single Group Assignment||Diagnostic||None (Open Label)||"All the imaging sequences will be done in an outpatient setting. There will be no premedication or other treatment before and after 68Ga-HBED-CC-PSMA PET scans. PET / CT will be performed at participating centers on a hybrid PET camera.~68Ga-HBED-CC-PSMA will be administered to the patient by single intravenous injection (Y-infused with isotonic saline infusion) within 60 min of reconstitution of the radiopharmaceutical.~The first TEP 68Ga-HBED-CC-PSMA whole body acquisition starts 60 min after the injection of 150 MBq of 68Ga-HBED-CC-PSMA and continues for 20-30 minutes, the second full-body acquisition of the same duration takes place 120 minutes after the injection is a total duration of 1 hour of imaging and 2:30 to 3:00 in the service."||||
1311720|NCT03443596|Randomized|Parallel Assignment||Treatment||Single|Allocation of the BP control arm was not disclosed to the study participants|Randomized controlled study|t|||
1311721|NCT03443583|Randomized|Single Group Assignment||Treatment||Single|Only the participant does not know which treatment is used on which teeth. The care provider and investigator have to know because different treatment protocol steps that have to be taken.|A split mouth clinical trial comparing ceramic restorations cemented with either IDS or DDS after one year of three years of clinical service.|t|||
1311722|NCT03443570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311723|NCT03443557|||Cohort||Cross-Sectional|||||||
1311724|NCT03443544|||Cohort||Retrospective|||||||
1311725|NCT03443531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311726|NCT03443518|Randomized|Parallel Assignment||Supportive Care||Triple|Physicians giving intraoperative care and recording data were blind to group type. Meanwhile, the anesthesiologist caring for the patient was aware to group type||t|t||t
1311727|NCT03443505|||Cohort||Prospective|||||||
1311728|NCT03443492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311729|NCT03443479|||Cohort||Retrospective|||||||
1311730|NCT03443466|Randomized|Parallel Assignment||Treatment||None (Open Label)|No Masking|Parallel Assignment||||
1311731|NCT03443453|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1311732|NCT03443440|||Cohort||Prospective|||||||
1311733|NCT03443427|Randomized|Parallel Assignment||Prevention||Quadruple|"By observer-blind, it is meant that during the course of the study, the vaccine recipient and those responsible for the evaluation of any study endpoint (e.g. safety, reactogenicity) will all be unaware of whether vaccine or placebo was administered. Each study site is responsible for having a blinding plan. To work in an observer-blind manner, vaccine preparation and administration will be done by authorised medical personnel (e.g. study nurse) who will not participate in any of the study clinical evaluation assays. Two teams of study personnel will hence be set up:~A team of unblinded personnel (responsible for the preparation and the administration of the vaccines)~A team of blinded personnel (responsible for the clinical evaluation of the subjects).~The laboratory in charge of the laboratory testing will be blinded to the treatment, and codes will be used to link the subject and study (without any link to the treatment attributed to the subject) to each sample."||t|t|t|t
1311734|NCT03443414|Randomized|Parallel Assignment||Treatment||Double|The nebuliser cup will be obscured to prevent the Investigator or outcomes assessor so the contents are not visible to the Investigator our outcomes assessor. The visual appearance of the study medication will not be discussed with the subject||||t|t
1311735|NCT03443401|||Cohort||Prospective|||||||
1311779|NCT03442829|Randomized|Parallel Assignment||Basic Science||Double|Intervention allocation will be undertaken by a researcher not directly involved with participants following randomization by drawing lots.||||t|t
1311780|NCT03442816||Single Group Assignment||Other||None (Open Label)||Subjects will undergo 1) an ophthalmic evaluation and 2) an evaluation with the device (camera)||||
1311781|NCT03442803||Single Group Assignment||Other||None (Open Label)||||||
1311829|NCT03442179|Randomized|Parallel Assignment||Prevention||Single||||||t
1311736|NCT03443388|Randomized|Sequential Assignment||Prevention||None (Open Label)||This is an open-label, randomized, 2-way crossover pilot safety study of the Hövding helmet device in patients with drug resistant epilepsy. Reference therapy is no head-protective device. Part 1 will test helmets on 4 normal controls falling from standing. If the helmet deploys in at least 3 out of 4 falls, we will proceed to Part 2. Part 2 will enroll up to 20 patients with Drug Resistant Epilepsy. Patients will be block randomized to first wear the helmet in their daily lives until helmet deployment or for up to 3 months, or to first not wear a helmet for up to 3 months. Patients in each group will complete self-administered questionnaires. We will compare circumstances, injuries, and post concussive scales in seizures resulting in falls occurring while the helmet was worn versus seizures resulting in falls occurring while the helmet was not being worn using daily seizure calendar, medical records review, the Rivermead Post Concussive Scale and other qualitative questionnaires.||||
1311737|NCT03443375|Randomized|Parallel Assignment||Other||Single||||||t
1311738|NCT03443362|||Cohort||Prospective|||||||
1311739|NCT03443349||Single Group Assignment||Other||None (Open Label)||"The medical device will be used according to its market authorization, i.e. CE-Certification. Because it will be used for the first time in pregnant women, a vulnerable population, the following three step application procedure has been determined:~First five pregnant women use the device for 10 minutes. Each of them in a position and module proposed by the midwife with the agreement of the woman.~Next 10 pregnant women use the device for 20 minutes. Again, position and module according to the decision of the midwife in agreement with the woman.~All the remaining pregnant women (35) use the device for 30 minutes. Position and module proposed by the midwife with the agreement of the woman.~During the intervention period, position and module might be changed once if required.~There will be a safety review board meeting after each group of the pregnant women having used the device, checking the safety criteria according to predefined Adverse Device Effects and Adverse Events."||||
1311740|NCT03443336|||Other||Prospective|||||||
1311741|NCT03443323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311742|NCT03443310||Single Group Assignment||Prevention||None (Open Label)||Patients who have symptomatic DVT undergo diagnostic venous duplex examination.||||
1311743|NCT03443297|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311744|NCT03443284|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311745|NCT03443271|Randomized|Parallel Assignment||Prevention||Triple|Patients will be randomly allocated in equal groups of 25 each to undergo TAP block (T group) with 20ml of 0.25% bupivacaine per side or TAP block with 20 ml of normal saline on both sides, which will be the control group (C group). The allocation sequence will be generated by a random number table, and group allocation will be concealed in sealed, opaque envelopes, which will not be opened until patient consent will be obtained. The process of randomization and blinding will be done by the clinical trial unit and according to the group allocation; pre-formed sterile syringes will be dispensed by the clinical trial unit to anesthesiologist performing the TAP block. The anesthesiologist performing the TAP block, patients and staff providing postoperative care will be blinded to group assignment.|Prospective double blind randomized control trial|t||t|t
1311746|NCT03443258|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients are assigned to either intervention or control group. The intervention group receives a nursing consultation using a need assessment and decision making tool. The control group receives usual care.||||
1311747|NCT03443245|||Case-Control||Prospective|||||||
1311748|NCT03443232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311749|NCT03443219|Randomized|Parallel Assignment||Health Services Research||Triple|opening a sealed envelope, provided by an independent physician blinded to patient's allocation In addition, outcome assessor were blinded||t|t||t
1311750|NCT03443206|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1311751|NCT03443193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311752|NCT03443180||Single Group Assignment||Other||None (Open Label)||All subjects will receive a dietary intervention. They will be instructed and asked to follow a diet free of gluten and the protein amylase trypsin inhibitors (ATI), which is frequently found in gluten-containing foods, for four weeks. They will then be asked to resume their normal diet.||||
1311753|NCT03443167|Randomized|Parallel Assignment||Supportive Care||Single|Only the phase of data analysis will be masked|multicentric clinical trial based on an ad hoc questionnaire||||t
1311754|NCT03443154|||Cohort||Prospective|||||||
1311755|NCT03443141|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1311756|NCT03443128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1311757|NCT03443115|||Cohort||Retrospective|||||||
1311758|NCT03443102|||Case-Control||Prospective|||||||
1311759|NCT03443089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311760|NCT03443076|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1311761|NCT03443063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311762|NCT03443050|Randomized|Parallel Assignment||Other||Single||||||t
1311763|NCT03443037|||Cohort||Prospective|||||||
1311764|NCT03443024|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311765|NCT03443011||Single Group Assignment||Diagnostic||None (Open Label)||||||
1311766|NCT03442998|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1311767|NCT03442985|Randomized|Parallel Assignment||Treatment||Quadruple||Multicenter, randomized, double-blind, placebo-controlled|t|t|t|t
1311768|NCT03442972|Randomized|Parallel Assignment||Basic Science||Single|Single-blinded study with participant blinded to treatment|Participants will be randomly assigned to receive either teduglutide or placebo as a single subcutaneous injection, 1 hour prior to duodenal biopsy|t|||
1311769|NCT03442959|||Cohort||Prospective|||||||
1311770|NCT03442946|||Other||Retrospective|||||||
1311771|NCT03442933|Randomized|Crossover Assignment||Basic Science||Quadruple||There are two groups and each participant participate in both groups.|t|t|t|t
1311772|NCT03442920|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1311773|NCT03442907|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311824|NCT03442244|Randomized|Single Group Assignment||Other||Double|||t||t|
1311825|NCT03442231|||Cohort||Other|||||||
1311782|NCT03442790|Non-Randomized|Parallel Assignment||Diagnostic||Double|The participants will not have any knowledge of the intervention and the investigator who is doing the ultrasound confirmation will not have access to the results of the chest x-ray confirmation until the end of the study period when all the data is analyzed.||t|t||
1311783|NCT03442777|Randomized|Parallel Assignment||Prevention||None (Open Label)||patients will be allocated to 1 of the 3 study arms based on a 1:1:1 allocation||||
1311784|NCT03442764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311785|NCT03442751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311786|NCT03442738|||Case-Only||Prospective|||||||
1311787|NCT03442725|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1311788|NCT03442712|Randomized|Parallel Assignment||Treatment||Single|The effects of the treatment will be evaluated by another researcher (second RA) who is blinded to the type of treatment modality received by the participants.|This study is a three-arm randomised waitlist-controlled feasibility trial.||||t
1311789|NCT03442699||Single Group Assignment||Treatment||None (Open Label)||Participants will receive up to 10 daily sessions of CBT (depending on length of stay), for about an hour each day. During this time the therapist will work with participants to develop a crisis response plan and build coping skills to prevent future suicidal thoughts and behaviors.||||
1311790|NCT03442686|Non-Randomized|Crossover Assignment||Other||None (Open Label)||This study uses a wait list control design. One group of participants will be evaluated before receiving the intervention (in Spring 2018) and compared to those who receive the intervention in Spring 2018. The first group will go on to receive the intervention in Fall 2018.||||
1311791|NCT03442673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311792|NCT03442660||Single Group Assignment||Other||None (Open Label)||||||
1311793|NCT03442647|Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1311794|NCT03442634|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311795|NCT03442621|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1311796|NCT03442608|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1311797|NCT03442595|||Case-Control||Retrospective|||||||
1311798|NCT03442582|||Cohort||Prospective|||||||
1311799|NCT03442569||Single Group Assignment||Treatment||None (Open Label)||This will be a single-arm, open-label, multicenter Phase II clinical trial investigating the clinical efficacy of nivolumab, ipilimumab, and panitumumab in subjects with unresectable refractory KRAS/NRAS/BRAF wild-type microsatellite stable metastatic colorectal cancer after an initial safety lead-in cohort to ensure the three drug combination is well-tolerated.||||
1311800|NCT03442556||Single Group Assignment||Treatment||None (Open Label)||||||
1311801|NCT03442543|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1311802|NCT03442530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311803|NCT03442517|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311804|NCT03442504||Single Group Assignment||Other||None (Open Label)||||||
1311805|NCT03442491|||Case-Only||Retrospective|||||||
1311806|NCT03442478||Single Group Assignment||Diagnostic||None (Open Label)||||||
1311807|NCT03442465|||Cohort||Prospective|||||||
1311808|NCT03442452||Single Group Assignment||Supportive Care||None (Open Label)||For this study, we will test the feasibility and preliminary efficacy of utilizing a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment options.||||
1311809|NCT03442439|Randomized|Parallel Assignment||Other||Double|||t||t|
1311810|NCT03442426||Single Group Assignment||Health Services Research||None (Open Label)||We have proposed a strong quasi-experimental alternative with inclusion of a usual care group of patients prior to initiation of the intervention. Specifically, our study will use a quasi-experimental control group design with pre-test and post-test. Our control group will receive usual care, and the intervention group will receive the proposed intervention (screening, care coordination and individual care plans, engagement in decision making, and technology support). The usual care group will be followed for 6 months after study entry (baseline period). Once completed, the intervention will be implemented and recruitment for the intervention group will begin. The intervention group will also be followed for 6 months after study entry (intervention period). We will be able to compare the intervention group with the usual care group.||||
1311811|NCT03442413||Single Group Assignment||Other||None (Open Label)||||||
1311812|NCT03442400||Single Group Assignment||Diagnostic||None (Open Label)||A single group of patients with severe aortic stenosis and intermediate coronary stenoses will undergo coronary physiology assessment with iFR/FFR before and after transcatheter aortic valve replacement.||||
1311813|NCT03442387|Randomized|Parallel Assignment||Other||Single|||t|||
1311814|NCT03442374|Non-Randomized|Parallel Assignment||Basic Science||Single||Stratified by fatty infiltration severity (n=20/group x 2 groups + non exercise controls n=20)||||t
1311815|NCT03442361|||Other||Retrospective|||||||
1311816|NCT03442348|Randomized|Parallel Assignment||Basic Science||Single||The study will be a randomised controlled parallel intervention study in which participants will be grouped into 2 different study arms.|t|||
1311817|NCT03442335|||Cohort||Prospective|||||||
1311818|NCT03442322|Randomized|Parallel Assignment||Health Services Research||Single|Outcome assessors will be blinded to the treatment arm the facility is randomly assigned to.|The nursing facilities are randomized and assigned prospectively to one of the two interventions according to the predetermined protocol to evaluate the effect of the facility-based intervention(s) on medication dispensing in the facility.||||t
1311819|NCT03442309|Randomized|Parallel Assignment||Prevention||Single|The investigators responsible for analyzing the data for primary outcomes will be masked.|Two-arm, parallel, non-inferiority cluster randomized trial||||t
1311820|NCT03442296|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1311821|NCT03442283|||Other||Prospective|||||||
1311822|NCT03442270|||Other||Prospective|||||||
1311823|NCT03442257|Randomized|Parallel Assignment||Treatment||Triple|The research assistant, the patients' GPs, as well as all researchers except one (MS) will be blinded to group allocation. If the patients have questions regarding the SMS function they will be able to contact MS for help.|Randomized controlled trial||t|t|t
1573396|NCT00001381||||Treatment||||||||
1311830|NCT03442166|Randomized|Parallel Assignment||Treatment||Double|After the suture is completed, the researcher responsible for applying the LED will remove and open the envelope containing the information from the experimental group in which the patient will be inserted and proceed to the experiment. A single examiner will run the daily application of the LED and will not perform any type of evaluation. Surgical procedures will be performed by the same surgeon. The preoperative and postoperative evaluations (1, 2, 5 and 7 days postoperatively) will be done by an examiner who will not be aware of the group in which each patient is allocated. Patients will not be aware of whether or not they received LED irradiation, because the person in charge of the LED application will position the plate in place for intra and extraoral irradiation in all patients and only trigger the light when and where predicted in the specific experimental group. The characteristic sound of the device will be triggered by recording in the sham group.||t||t|
1311831|NCT03442153|Randomized|Parallel Assignment||Supportive Care||Double||The product in not drug or medical device (but a dietary supplement). There are 76 participants divided inti 2 groups : experimental group (38) and Placebo group (38). The period of the intervention: 90 days|t||t|
1311832|NCT03442140||Single Group Assignment||Health Services Research||None (Open Label)||||||
1311833|NCT03442127||Single Group Assignment||Other||None (Open Label)||||||
1311834|NCT03442114|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Stepped Wedge Randomized Clinical Trial||||
1311835|NCT03442101|||Cohort||Prospective|||||||
1311836|NCT03442088|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is an open label pilot study of the impact of treatment with standard dosing of APM for 16 weeks on AM-endotype psoriasis patients, identified by elevated (>150% of normal): 1.) Intermediate (CD14++CD16+) monocytes % of cells in circulation, or 2.) circulating monocyte doublets % of adherent monocyte-monocyte pairs, or 3.) circulating monocyte-platelet aggregates (MPA) % monocytes adherent to platelets.||||
1311837|NCT03442075|||Cohort||Retrospective|||||||
1311838|NCT03442062|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1311839|NCT03442049|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Trial||||
1311840|NCT03442036|Randomized|Parallel Assignment||Treatment||Double||Subjects will be randomized using a computer-generated list and opaque, sealed envelopes to one of two treatment groups (blocks of 4, no stratification): perineural catheter insert using (1) through-the-needle technique or (2) suture technique.|t|||t
1311841|NCT03442023|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1311842|NCT03442010|||Cohort||Prospective|||||||
1311843|NCT03441997|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311844|NCT03441984|Randomized|Crossover Assignment||Treatment||None (Open Label)|This is an open-label study in healthy volunteers.|2-part study with 3-TPs each. Part 1, compares relative BA of TRIUMEQ dispersible tablets for pediatric populations (DTG, 5 milligram [mg]/abacavir [ABC] 60 mg/3TC 30 mg), when administered as direct-to-mouth and when dispersed into purified water, with adult TRIUMEQ conventional tablet (DTG 50 mg/ABC 600 mg/3TC 300 mg), administered as direct-to-mouth (reference). Additionally, part 2 will compare relative BA of DTG/3TC (DTG 5 mg/3TC 30 mg), dispersible tablets for pediatric populations, when administered as direct-to mouth and when dispersed into purified water, with adult DTG (50 mg) and 3TC (300 mg) conventional tablets, when administered as direct-to-mouth (reference). Each TP, in Part 1 and 2 will have, wash-out period of 7-days (with minus 4 hours) between each single dose, for flexible dosing. During TPs, subjects will be admitted, to clinic on Day-1, following completion of last study procedure on Day 4, post which follow-up visit conducted, 7 to 10 days after last dose.||||
1311845|NCT03441971||||||||||||
1311846|NCT03441958||Single Group Assignment||Treatment||None (Open Label)||||||
1311847|NCT03441945|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1311848|NCT03441932|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"Dysphagia screening in the Emergency department for any patient admitted to Hotêl-Dieu de France university hospital for Stroke based on the  Emergency department dysphagia-screening tool.~Subjets will be then sorted in two groups:~1-Screening passed~2-Screening failed~Subjets within the two groups will after than have FEES with videotaping of pharyngeal phase after giving subjects a standardised food consisting of thin Puree. An ENT resident blinded to the result of the screening test will do this intervention."||||
1311849|NCT03441919|||Other||Prospective|||||||
1311850|NCT03441906|||Cohort||Prospective|||||||
1311851|NCT03441893|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311852|NCT03441880||||||||||||
1311853|NCT03441867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|The neuroimaging analysis will be masked.|||||
1311854|NCT03441854|||Case-Control||Prospective|||||||
1311855|NCT03441841|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1311856|NCT03441828|Randomized|Parallel Assignment||Supportive Care||Single|in the assessment of the surgical field quality surgeons are blind respect the level of neuromuscular block received by patients|"After enrollment, patients will be randomized in the two study groups:~Deep Neuromuscular Block group (group DNMB) Moderate Neuromuscular Block group (group MNMB)"||t||
1311857|NCT03441815|Randomized|Sequential Assignment||Treatment||Double|Blinding was carried out by using Placebo equivalent to XC8 tablets without active substance and the corresponding labeling of the study drug.|The dose cohorts were included into the study subsequently based on preliminary safety results evaluation performed by the Data Safety Monitoring Committee. 4 doses of XC8/placebo (2 mg, 10 mg, 50 mg and 200 mg) were used in the study.The duration of exposure to the study drug was 15 days in each cohort: Day 1, once, at the step of single administration, and then in 6 days, daily, 1 time a day for 14 days at the step of multiple administration.|t||t|
1311858|NCT03441802|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311859|NCT03441789|Randomized|Parallel Assignment||Treatment||Single|||||t|
1311860|NCT03441776|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a single site, randomized, open label, pilot study to test the environment, resources and tools required to perform a comparative effectiveness trial assessing two different standard of care vestibular rehabilitation approaches.||||
1311861|NCT03441763|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311862|NCT03441750|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573397|NCT00001378||||Treatment||||||||
1311863|NCT03441737|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1311864|NCT03441724|||Case-Only||Prospective|||||||
1311865|NCT03441711|||Case-Control||Prospective|||||||
1311866|NCT03441698|Randomized|Factorial Assignment||Supportive Care||Triple|||t||t|t
1311867|NCT03441685||Single Group Assignment||Treatment||None (Open Label)|Participants' completion of study tasks requires knowledge of intervention condition. Participants are blinded to study hypotheses.|All participants complete the three intervention conditions within a single session. Order of conditions is counterbalanced across participants.||||
1311868|NCT03441672|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1311869|NCT03441659|||Cohort||Prospective|||||||
1311870|NCT03441633|||Cohort||Retrospective|||||||
1311871|NCT03441620|Randomized|Crossover Assignment||Treatment||Single|||t|||
1311872|NCT03441607|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311873|NCT03441594|||Other||Cross-Sectional|||||||
1311874|NCT03441581|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311875|NCT03441568||Single Group Assignment||Treatment||None (Open Label)||||||
1311876|NCT03441555||Single Group Assignment||Treatment||None (Open Label)||||||
1311877|NCT03441542|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311878|NCT03441529|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1311879|NCT03441516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311880|NCT03441503|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This study is a rapid cycle randomized control trial. Participating units will alternate between the intervention arm (day of discharge survey via inpatient television) and control arm (post-discharge mailed survey). Patients will be assigned to the intervention or control arm depending on the status of their discharging unit. Units will alternate arms throughout the study period.||||
1311881|NCT03441490|Randomized|Factorial Assignment||Treatment||None (Open Label)||Design is a two‐by‐two factorial randomized trial with four intervention groups: 1, ICBT with therapeutic guidance through mail. 2, ICBT with therapeutic guidance through chat. 3, ICBT with learning support and terapeutic guidance through mail. 4. ICBT with learning support and terapeutic guidance through chat.||||
1311882|NCT03441477||||||||||||
1311883|NCT03441464|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Dose escalation||||
1311884|NCT03441451|||Other||Prospective|||||||
1311885|NCT03441438|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1311886|NCT03441425|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1311887|NCT03441412||Single Group Assignment||Supportive Care||None (Open Label)||The study is an experimental observational study in ten healthy volunteers. Volunteers fulfilling all of the inclusion and none of the exclusion criteria will be included. Enrollment will be continued until the required sample size is achieved (10 subjects).||||
1311888|NCT03441399|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1311889|NCT03441386||Single Group Assignment||Treatment||||Three counterbalanced experimental sessions for the same group||||
1311890|NCT03441373|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1311891|NCT03441360|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311892|NCT03441347|Randomized|Crossover Assignment||Treatment||None (Open Label)||Patients in the experimental arm start the 17 week experimental intervention right after they enter the study. Patients in the second arm first continue to receive their usual care for 17 weeks, after which they also receive the experimental intervention. Both groups are assessed at baseline and after the initial 17 weeks. The second group is assessed a third time, after they have completed the 17-week experimental treatment program.||||
1311893|NCT03441334|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311894|NCT03441321|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1311895|NCT03441308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311896|NCT03441295|Randomized|Parallel Assignment||Treatment||Single||Study 1 comparing Ligamys (DIS) and Internal Bracing. Study 2 comparing Internal Bracing and ACL Reconstruction.|t|||
1311897|NCT03441282|||Cohort||Prospective|||||||
1311898|NCT03441269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311899|NCT03441256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311900|NCT03441243|||Case-Control||Prospective|||||||
1311901|NCT03441230|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1311902|NCT03441217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311903|NCT03441204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311904|NCT03441191|Randomized|Parallel Assignment||Treatment||Single|||t|||
1311905|NCT03441178||Single Group Assignment||Treatment||None (Open Label)||||||
1311906|NCT03441165|||Cohort||Prospective|||||||
1311907|NCT03441152|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1311908|NCT03441139|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1311909|NCT03441126|||Cohort||Prospective|||||||
1311910|NCT03441113|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311911|NCT03441100||Single Group Assignment||Treatment||None (Open Label)||||||
1311912|NCT03441087|Non-Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1311913|NCT03441074|Randomized|Parallel Assignment||Prevention||Single||||||t
1311914|NCT03441061||Single Group Assignment||Treatment||None (Open Label)||||||
1311915|NCT03441048||Single Group Assignment||Treatment||None (Open Label)||||||
1311916|NCT03441035|||Cohort||Prospective|||||||
1311917|NCT03441022||Single Group Assignment||Prevention||None (Open Label)||||||
1311918|NCT03441009|||Cohort||Prospective|||||||
1311959|NCT03440476|Randomized|Parallel Assignment||Treatment||Single|The intervention is an online program, not an individual, so masking is not necessary. Similarly, the same online survey is deployed in all follow-up assessments regardless of condition, and data are not collected by individuals, so masking is not necessary.||t|||
1573398|NCT00001377||||||||||||
1311919|NCT03440996|Randomized|Parallel Assignment||Prevention||Double||Three groups of 30 subjects (one group with Clinpro™ 5000, one group with MI-Paste Plus, and one group with Clinpro™ Tooth Crème) each will be evaluated as a protocol for the reduction of white spot lesions at the start of orthodontic treatment. Subjects will be recruited through the Orthodontic Postgraduate Clinic at the University of Alabama at Birmingham School of Dentistry.|t|||t
1311920|NCT03440983||Single Group Assignment||Other||None (Open Label)||||||
1311921|NCT03440970|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1311922|NCT03440957||Single Group Assignment||Supportive Care||None (Open Label)||||||
1311923|NCT03440944|Randomized|Parallel Assignment||Treatment||None (Open Label)|Given the devices are different we will not be able to mask.|randomized to one of two therapies, peripheral ultrasound IV or midline||||
1311924|NCT03440931|||Cohort||Prospective|||||||
1311925|NCT03440918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311926|NCT03440905|||Cohort||Other|||||||
1311927|NCT03440892|||Cohort||Prospective|||||||
1311928|NCT03440879|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1311929|NCT03440866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311930|NCT03440853|Randomized|Parallel Assignment||Treatment||Single|Patient reported outcomes will be administered centrally by blinded interviewers using computer-assisted telephone interviewing (CATI).|Patients will be randomized 1:1 to TASCCI or technology-delivered health education and undergo a 12-week intervention. Psychological and clinical outcomes will be collected at baseline, post intervention, 6 and 12 months.||||t
1311931|NCT03440840|Randomized|Parallel Assignment||Treatment||Double|Individuals will receive either active or sham tDCS. The outcomes assessor will be blind to treatment group assignment.|Randomized parallel group|t|||t
1311932|NCT03440827||Single Group Assignment||Other||None (Open Label)||||||
1311933|NCT03440814|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1311934|NCT03440801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311935|NCT03440788|||Cohort||Prospective|||||||
1311936|NCT03440775|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1311937|NCT03440762||Single Group Assignment||Screening||None (Open Label)||Single group pre-post educational intervention||||
1311938|NCT03440749|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Comparative monocentric physiopathological study with 2 groups of children : children with cerebral palsy and children age-matched for the control group||||
1311939|NCT03440736|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a randomized, multi-center, open label, parallel group, active comparator-controlled study with a duration of 28 weeks and a 28 week extension phase.||||
1311940|NCT03440723|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)|Masking is not possible since physicians and participants will know whether they are using the device or not.|Randomized controlled trial in which participants are randomly assigned to one of two arms, control or treatment||||
1311941|NCT03440710|Randomized|Parallel Assignment||Treatment||Single||||||t
1311942|NCT03440697|||Cohort||Prospective|||||||
1311943|NCT03440684||Single Group Assignment||Treatment||None (Open Label)||Participants were included group exercise programme. The programme had been performed for 6 weeks. And participants were evaluated after exercise training programme.||||
1311944|NCT03440671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311945|NCT03440658|||Case-Control||Retrospective|||||||
1311946|NCT03440645||Single Group Assignment||Prevention||None (Open Label)||||||
1311947|NCT03440632|Randomized|Crossover Assignment||Treatment||Single|The physical examination and the advanced analysis of the 3D gait analysis will be done be a blinded examiner.|randomisation for the order of treatments and thereby for the total length of the 'conventional therapy phase'.||||t
1311948|NCT03440619||||||||||||
1311949|NCT03440606|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||participants will be randomly assigned to either the intervention or waitlist control group. Those assigned to in the intervention group will attend 6 weekly Mindful-Compassion Art Therapy supervision led by a credentialed art therapist and an experienced mindfulness practitioner at the training facilities of HCA. Each session will last for 3 hours and each group will consists of 15 participants. Outcome assessments will be conducted at two-time-points: immediately after intervention [T2] and four weeks post intervention [T3]. Those assigned to the waitlist control group will receive no intervention until approximately three month later; equivalent intervention and assessment procedures will be administered.||||
1311950|NCT03440593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311951|NCT03440580|Randomized|Parallel Assignment||Prevention||None (Open Label)|Schools will be randomized into intervention or control schools. Randomization will be done by an independent researcher. After the randomization, the intervention school receives the BOOSTH intervention. The control school receives BOOSTH after the study is finished.|The study design will be a randomized controlled trial regarding a physical activity intervention. A 1:1 randomization will be applied with intervention schools and matched control schools. The intervention school will recieve the BOOSTH intervention||||
1311952|NCT03440567|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311953|NCT03440554||Single Group Assignment||Diagnostic||None (Open Label)||Prostate cancer patients will have a research whole body MRI scan within 90 days of their standard of care imaging. Patients receiving additional standard of care imaging within 12 months of the research scan will be asked to have an additional research scan within 90 days of their follow-up imaging.||||
1311954|NCT03440541||Single Group Assignment||Treatment||None (Open Label)||||||
1311955|NCT03440528|||Case-Only||Prospective|||||||
1311956|NCT03440515||Single Group Assignment||Treatment||None (Open Label)||||||
1311957|NCT03440502|||Case-Control||Prospective|||||||
1311958|NCT03440489||Single Group Assignment||Screening||None (Open Label)||skeletal muscle dysfunction in patient with idiopathic pulmonary fibrosis six minute walking test||||
1312063|NCT03439124|Randomized|Parallel Assignment||Treatment||Single||||||t
1312200|NCT03437343|||Case-Only||Retrospective|||||||
1312201|NCT03437330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311960|NCT03440463|Randomized|Parallel Assignment||Treatment||Single|The intervention is an online program, not an individual, so masking is not necessary. Similarly, the same online survey is deployed in all follow-up assessments regardless of condition, and data are not collected by individuals, so masking is not necessary.||t|||
1311961|NCT03440450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|None, open label|Open label, dose escalation||||
1311962|NCT03440437||Single Group Assignment||Treatment||None (Open Label)||||||
1311963|NCT03440424|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311964|NCT03440411|Randomized|Factorial Assignment||Treatment||None (Open Label)||This is a 2x2 factorial randomized study.||||
1311965|NCT03440398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311966|NCT03440385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311967|NCT03440372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1311968|NCT03440359|Randomized|Parallel Assignment||Other||Single|Data analysis was completed by blinded observer who had access only to participant ID number, cycle number and treatment, and pregnancy outcome|Participants who met criteria were randomized to either Crinone vaginal therapy versus no therapy in the luteal phase of an ovulation induction cycle. Participants who did not achieve a pregnancy were able to participate in up to 3 cycles, and were re-randomized with each cycle.||||t
1311969|NCT03440346||Single Group Assignment||Basic Science||None (Open Label)||||||
1311970|NCT03440333|||Case-Only||Retrospective|||||||
1311971|NCT03440320|Randomized|Parallel Assignment||Treatment||Double|"Demographic data and measures will be collected by a blinded and trained research assistant.~The assessor and participants will be blinded to the randomization. We will maintain assessor and participant blinding through established mechanisms (e.g., not discussing information or intervention)."||t|||t
1311972|NCT03440307|Randomized|Parallel Assignment||Prevention||Single|Single-blinded study|Participants randomized to intervention or control.||||t
1311973|NCT03440294|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1311974|NCT03440281|||Cohort||Prospective|||||||
1311975|NCT03440268|Randomized|Parallel Assignment||Prevention||Double|The participant of the study won't know what is he receiving (placebo or NAC) and the assessor will not have any contact with the participants|There will be one group placebo/control and one group intervention. The group intervention will receive the medication N AcetylCysteyn (NAC), while the control will receive a placebo|t|||t
1311976|NCT03440255||Single Group Assignment||Treatment||None (Open Label)||||||
1311977|NCT03440242|||Cohort||Prospective|||||||
1311978|NCT03440229|Randomized|Parallel Assignment||Other||Quadruple|This is a randomized double-blind controlled feeding experiment.||t|t|t|t
1311979|NCT03440216|Non-Randomized|Parallel Assignment||Other||None (Open Label)||2 groups of patients studied in parallel||||
1311980|NCT03440203|||Other||Cross-Sectional|||||||
1311981|NCT03440190|||Case-Only||Prospective|||||||
1311982|NCT03440177|||Case-Only||Prospective|||||||
1311983|NCT03440164|||Other||Cross-Sectional|||||||
1311984|NCT03440151|Randomized|Parallel Assignment||Treatment||None (Open Label)|"Because the two interventions used in this trial are clearly different and easly recognized by the participants and investigators, neither investigators nor Participants can be blinded.~The statistician will be blinded."|||||
1311985|NCT03440138|||Case-Only||Retrospective|||||||
1311986|NCT03440125|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1311987|NCT03440112|Randomized|Parallel Assignment||Other||Triple|Participant, Investigator||t|t|t|
1311988|NCT03440099||Single Group Assignment||Basic Science||None (Open Label)||||||
1311989|NCT03440086|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized controlled trial (no blinded)||||
1311990|NCT03440073|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1311991|NCT03440060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1311992|NCT03440047||Single Group Assignment||Diagnostic||None (Open Label)||Registry of endoscopic image and pathology correlation of different pathological condition such as: inflammatory bowel disease, colon polyps||||
1311993|NCT03440034||Single Group Assignment||Basic Science||None (Open Label)||Open-label, non-randomized trial in 15 patients with sIBM||||
1311994|NCT03440021|Randomized|Parallel Assignment||Basic Science||Double||High-dosage (60mg), Low-dosage (10mg), Placebo|t||t|
1311995|NCT03440008|||Cohort||Other|||||||
1311996|NCT03439995|Randomized|Parallel Assignment||Treatment||Single|Outcomes in donors and lung transplant recipients will be done by assessors who are blinded to ventilator treatment assignment|Enrolled donors will be randomly assigned to two different modes of mechanical ventilation for the duration of donor management||||t
1311997|NCT03439982||Single Group Assignment||Treatment||None (Open Label)||||||
1311998|NCT03439969|Randomized|Parallel Assignment||Prevention||Single|The researcher was blind to the patients||||t|
1311999|NCT03439956|||Case-Control||Prospective|||||||
1312000|NCT03439943|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312001|NCT03439930|Randomized|Parallel Assignment||Treatment||Single||||||t
1312002|NCT03439917|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1312003|NCT03439904|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312004|NCT03439891|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1312005|NCT03439878|Randomized|Crossover Assignment||Basic Science||Double|Participants and the researchers performing biochemical analyses will be blinded to the intervention.|Randomized, blinded crossover design.|t|||t
1312006|NCT03439865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312007|NCT03439852|Randomized|Parallel Assignment||Prevention||Single|data management / data entry blinded to study condition|cluster randomized controlled trial comparing intervention to delayed treatment condition||||t
1312008|NCT03439839||Single Group Assignment||Treatment||None (Open Label)|No masking used in the study|Single group, open label, non-randomized study||||
1312009|NCT03439826|||Case-Only||Prospective|||||||
1312254|NCT03436641|||Cohort||Prospective|||||||
1312255|NCT03436628||Single Group Assignment||Health Services Research||None (Open Label)||||||
1312010|NCT03439813|Randomized|Parallel Assignment||Treatment||Single|"Participant receives one of the two TASK interventions. Both are considered active interventions for anxiety.~Once started on the intervention participant may realise the type of intervention he has received, thus unblinding treatment allocation. Participants remain unaware of the contents of intervention given to the other group. Outcomes are self-completed by participants electronically to achieve assessor blinding."|||||t
1312011|NCT03439800|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1312012|NCT03439787|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, placebo-controlled, double-blinded design|t|t|t|t
1312013|NCT03439774||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312014|NCT03439761||Single Group Assignment||Treatment||None (Open Label)||PT-112 injection alone-chemotherapy||||
1312015|NCT03439748|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312016|NCT03439735||Single Group Assignment||Treatment||None (Open Label)||||||
1312017|NCT03439722|||Case-Control||Prospective|||||||
1312018|NCT03439709|Randomized|Parallel Assignment||Treatment||None (Open Label)|Technically, the procedure of gamma knife radiosurgery includes fixating stereotactic frame on the head of patients. Therefore, It is not possible to keep masking for participants and other investigators.|The patients with acromegaly due to growth hormone secreting pituitary adenoma who receive primary surgical resection and fail to achieve endocrinologic remission at 3 months after surgical resection are enrolled. They are devided into two groups; One consists of patients underwent upfront stereotactic radiosurgery combinated with standard drug therapy, and another group consists of patients receiving only standard drug therapy.||||
1312019|NCT03439696|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312020|NCT03439683|||Other||Cross-Sectional|||||||
1312021|NCT03439670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312022|NCT03439657|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312023|NCT03439644|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1312024|NCT03439631|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Tiered OR set up design will be compared to standard OR set up design as related to patient satisfaction with surgical experience||||
1312025|NCT03439618|Randomized|Parallel Assignment||Treatment||Single||||||t
1312026|NCT03439605|||Cohort||Cross-Sectional|||||||
1312027|NCT03439592|||Cohort||Prospective|||||||
1312028|NCT03439579||Single Group Assignment||Treatment||None (Open Label)||Single group pilot study||||
1312029|NCT03439566|||Cohort||Prospective|||||||
1312030|NCT03439553|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1312031|NCT03439540|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1312032|NCT03439527|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Open-label, monocentric, first-in-man trial to assess safety and tolerability of a new therapeutic strategy for stress urinary incontinence based on the implantation of muscle precursor cells (MPCs) 40 female patients suffering from urinary incontinence since at least 6 months (predominant clinical diagnosis of SUI) and who are candidate for a surgical treatment will be included .~All patients are treated by the same product: Autologous MPCs. After treatment, the patients will be randomized 1:1 in the MPC-group or NMES+MPC-group to investigate the benefits of an additional physiotherapy."||||
1312033|NCT03439514|Randomized|Parallel Assignment||Treatment||Double|During the randomized, double-blind period, patients, Investigators, site personnel and the sponsor personnel directly involved with the conduct of the study will remain blinded to assigned treatment, except for regulatory reporting requirements.|The study will be conducted in 2 parts: a randomized, double-blind treatment period for at least 24 weeks, followed by an ARRY-371797 open-label treatment period.|t||t|
1312034|NCT03439501||Single Group Assignment||Treatment||None (Open Label)||||||
1312035|NCT03439488|Randomized|Sequential Assignment||Other||Triple|||t||t|t
1312036|NCT03439475||||||||||||
1312037|NCT03439462|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1312038|NCT03439449|||Cohort||Prospective|||||||
1312039|NCT03439436|Randomized|Parallel Assignment||Treatment||Triple|Bottles kept in neutral outer boxes. Staff performing assessments kept unaware of treatment.||t||t|t
1312040|NCT03439423|||Case-Only||Prospective|||||||
1312041|NCT03439410|||Cohort||Prospective|||||||
1312042|NCT03439397|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312043|NCT03439384|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1312044|NCT03439371||Single Group Assignment||Treatment||None (Open Label)||||||
1312045|NCT03439358|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1312046|NCT03439345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312047|NCT03439332|||Case-Only||Retrospective|||||||
1312048|NCT03439319|Randomized|Parallel Assignment||Treatment||Single||A two-arm, parallel group, multicentre, single-blind, randomized controlled trial||||t
1312049|NCT03439306|||Case-Only||Prospective|||||||
1312050|NCT03439293||Single Group Assignment||Treatment||None (Open Label)||||||
1312051|NCT03439280|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1312052|NCT03439267|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312053|NCT03439254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312054|NCT03439241|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The trial starts with a baseline period. After 4 baseplate changes the subjects is randomised into two arms.||||
1312055|NCT03439228|Randomized|Parallel Assignment||Treatment||Single||||||t
1312056|NCT03439215||Single Group Assignment||Treatment||None (Open Label)||||||
1312057|NCT03439202||Single Group Assignment||Other||None (Open Label)|No drug and no arm are used for this study. This is a clinical study, because subjects are exposed to hypoxic conditions.|Crossover randomized study||||
1312058|NCT03439189||||||||||||
1312059|NCT03439176||Single Group Assignment||Basic Science||None (Open Label)||||||
1312060|NCT03439163|||Cohort||Cross-Sectional|||||||
1312061|NCT03439150||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312062|NCT03439137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312064|NCT03439111|Randomized|Crossover Assignment||Treatment||Triple||Participants receive one of two (or more) alternative interventions during the initial phase of the study and receive the other intervention during the second phase of the study|t|t|t|
1312065|NCT03439098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312066|NCT03439085||Single Group Assignment||Treatment||None (Open Label)||||||
1312067|NCT03439072|Randomized|Crossover Assignment||Treatment||Single|||t|||
1312068|NCT03439059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312069|NCT03439046||Single Group Assignment||Treatment||None (Open Label)||||||
1312070|NCT03439033|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||Subjects may be assigned to one of three groups, each with a different intervention in terms of either mode or frequency||||
1312071|NCT03439020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312072|NCT03439007|||Cohort||Prospective|||||||
1312073|NCT03438994|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple||"This study will follow the Standard for Reporting Diagnostic accuracy studies (STARD) guidelines"|t|t|t|t
1312074|NCT03438981|||Cohort||Prospective|||||||
1312075|NCT03438968|Randomized|Parallel Assignment||Treatment||Single|At stress testing, cardiologist will not know group assignment|Randomized controlled trial||||t
1312076|NCT03438955|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1312077|NCT03438942|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1312078|NCT03438929||Single Group Assignment||Treatment||None (Open Label)||||||
1312079|NCT03438916|||Cohort||Prospective|||||||
1312080|NCT03438903|||Case-Control||Prospective|||||||
1312081|NCT03438890|Randomized|Parallel Assignment||Treatment||Double|Allocation information was hidden from the participants and outcome assessor.||t|||t
1312082|NCT03438877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312083|NCT03438864|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312084|NCT03438851|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Participants will self-select into one of two treatment conditions: a full-time intensive program or a part-time program. Participants in the full-time program will be asked to complete 4 experimental sessions with the NeuroCatch PlatformTM over the course of 3 months (i.e. one session/ month); whereas, participants in the part-time program will be asked to complete 3 scans over 3 months (i.e. one session/1.5 months).||||
1312085|NCT03438838|Randomized|Parallel Assignment||Treatment||Single|Patients will be randomized using computer generated table of random numbers contained in a sealed opaque envelope to be opened in operation theatre after induction anesthesia.||t|||
1312086|NCT03438825|||Cohort||Prospective|||||||
1312087|NCT03438812|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312088|NCT03438799|||Cohort||Prospective|||||||
1312089|NCT03438786|Randomized|Parallel Assignment||Treatment||Single||"patients will be randomized into two groups according to the surgical technique performed as follows :-~Group A: Patients undergoing TIPP hernioplasty~Group B: Patients undergoing lichtnestein's technique hernioplasty"|t|||
1312090|NCT03438773|Randomized|Parallel Assignment||Other||None (Open Label)||"Patients randomized into the study group will be prescribed Envarsus, mycophenolate and prednisone as a regimen vs. standard therapy with twice a day tacrolimus, mycophenolate and prednisone.~Patients randomized to the control group will be prescribed standard immunosuppression with tacrolimus twice a day, anti-proliferative twice a day, and prednisone once a day at doses that are standard at our institution."||||
1312091|NCT03438760|Randomized|Parallel Assignment||Treatment||None (Open Label)|Although it is impossible to mask the assessors of the proximal outcome measures, those assessing some of the distal outcomes can be masked. Specifically, the people scoring the results of the Lens on Science Assessment (a distal measure of generalized scientific content and process) will be masked to the treatment arm assignments. Also, the people transcribing, coding, and analyzing the words and gestures used in the science story retell task (a distal measure of generalized scientific practice outcomes) will be masked to the treatment arm assignments.|Participants will assigned to one of three groups in parallel for the duration of the study.||||
1312092|NCT03438747|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1312093|NCT03438734|Randomized|Crossover Assignment||Screening||Single||Prospective Randomized Clinical Study|||t|
1312094|NCT03438721|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1312095|NCT03438708||Single Group Assignment||Treatment||None (Open Label)||||||
1312096|NCT03438695||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312097|NCT03438682|||Cohort||Retrospective|||||||
1312098|NCT03438669|||Cohort||Cross-Sectional|||||||
1312099|NCT03438656||Single Group Assignment||Treatment||None (Open Label)||||||
1312100|NCT03438643|||Cohort||Prospective|||||||
1312101|NCT03438630|||Case-Control||Other|||||||
1312102|NCT03438617|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study uses a stepped wedge design in three successive cohorts. Ten community health centers (CHC) will be randomized to one of three cohorts. All ten CHCs will recruit study participants and collect baseline participant data the start of the study. The first cohort of 3 CHCs will implement the intervention while the second and third cohorts wait. After 3 months, the second cohort of 3 CHCs will implement the intervention, the third cohort waits, and the first cohort continues the intervention. After another 3 months, all 10 CHCs will conduct a second round of data collection. At this point, the third cohort of 4 CHCs will implement the intervention and the first and second cohort continue the intervention. After another 6 months, all 10 CHCs will conduct a third round of data collection.||||
1312103|NCT03438604|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312104|NCT03438591||Single Group Assignment||Treatment||None (Open Label)||patients who meet the criteria of current CRT treatment||||
1312105|NCT03438578|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312106|NCT03438565|||Case-Only||Other|||||||
1312107|NCT03438552|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1312256|NCT03436615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312257|NCT03436602|||Cohort||Retrospective|||||||
1312443|NCT03434184|||Case-Only||Prospective|||||||
1312108|NCT03438539|Randomized|Parallel Assignment||Treatment||None (Open Label)||An Internet survey hosted by Amazon.com's Mechanical Turk and Qualtrics: Online Survey Software will be used in this protocol. Cognitive tasks will be coded using PsyToolKit, an open-source tool for programming and running cognitive-psychological experiments and surveys online (Stoet, 2017). A mixed-model design will be used such that subjects are randomly assigned to one of three cognitive training conditions and two information feedback conditions (i.e., between-subjects variables). The same subjects will be sampled at each time point in the study (i.e., repeated/longitudinal variables).||||
1312109|NCT03438526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312110|NCT03438513|||Cohort||Prospective|||||||
1312111|NCT03438500||Single Group Assignment||Treatment||None (Open Label)||||||
1312112|NCT03438487|||Cohort||Prospective|||||||
1312113|NCT03438474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312114|NCT03438461|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1312115|NCT03438448|||Cohort||Prospective|||||||
1312116|NCT03438435||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312117|NCT03438422|Randomized|Parallel Assignment||Other||Single|||t|||
1312118|NCT03438409||Single Group Assignment||Treatment||None (Open Label)||||||
1312119|NCT03438396||Single Group Assignment||Treatment||None (Open Label)||||||
1312120|NCT03438383|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients were assigned into the following two study groups postoperatively:~Sham Bi-PAP (control group) group in which sham Bi-PAP was applied through nasal mask for 3 days postoperatively.~Bi-PAP group in which Bi-PAP through nasal mask, at individualized IPAP/EPAP pressures, was applied for 3 days postoperatively."||||
1312121|NCT03438370|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Cluster Randomized Trial comparing three different antiretroviral therapy (ART) dispensing strategies.||||
1312122|NCT03438357|||Case-Only||Retrospective|||||||
1312123|NCT03438344|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1312124|NCT03438331|Randomized|Parallel Assignment||Treatment||Single||||||t
1312125|NCT03438318|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1312126|NCT03438305|||Other||Prospective|||||||
1312127|NCT03438292|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1312128|NCT03438279|||Cohort||Retrospective|||||||
1312129|NCT03438266|Randomized|Parallel Assignment||Treatment||Single||||||t
1312130|NCT03438253|||Cohort||Prospective|||||||
1312131|NCT03438240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312132|NCT03438227|Randomized|Parallel Assignment||Treatment||Double|The research team will be blinded to the patients' treatment arm. A team of resident physicians who are unfamiliar with the study aims will provide standard obstetric care to all participants.|All participants at less than 28 weeks gestation will have an anemia evaluation and work up per standard prenatal care. Those who meet a clinical diagnosis of iron-deficiency anemia will initiate oral iron and have their CBC rechecked between 24 and 28 weeks gestation. If their hemoglobin is less than 10 mg/dL, they will be randomized to either continue their oral iron supplementation or receive a single intravenous dextran iron transfusion. If the patient is enrolled after 28 weeks and receives a diagnosis of iron deficiency anemia, she will be randomized at that time.|||t|t
1312133|NCT03438214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312134|NCT03438201|Randomized|Parallel Assignment||Treatment||Single||||||t
1312135|NCT03438188|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|"Smoking participants will be studding under both smoking as usual and abstinent conditions (crossover) and non-smokers only under abstinence."|This is a within-subject cross-over neuroimaging investigation of 3 potential neural mechanisms of increased caloric intake during initial smoking cessation. Eighty smokers will be scanned on 2 occasions: (1) after 4 days of monitored abstinence (biochemically verified), and (2) after 4 days of smoking as usual (order counterbalanced). In addition, 30 healthy non-smokers (matched for sex, age, and education) will complete one period of the study to serve as a baseline comparison group.||||
1312136|NCT03438175|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312137|NCT03438162|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312138|NCT03438149|||Case-Only||Prospective|||||||
1312139|NCT03438136|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Half of the participants will participate in the intervention, and the other half will be assigned to a no contact control group.||||
1312140|NCT03438123||Single Group Assignment||Other||None (Open Label)||All subjects undergo baseline clinically referred routine nuclear scintigraphy imaging and sequential imaging on the CZT SPECT investigational device following a single dose of radiopharmaceutical.||||
1312141|NCT03438110|||Cohort||Prospective|||||||
1312142|NCT03438097|||Cohort||Other|||||||
1312143|NCT03438084|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1312144|NCT03438071|||Other||Prospective|||||||
1312145|NCT03438058|||Other||Retrospective|||||||
1312146|NCT03438045||Single Group Assignment||Health Services Research||None (Open Label)||Feasibility and acceptability study.||||
1312147|NCT03438032|||Cohort||Cross-Sectional|||||||
1312148|NCT03438019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312149|NCT03438006|||Cohort||Prospective|||||||
1312150|NCT03437993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312151|NCT03437980||Single Group Assignment||Supportive Care||None (Open Label)||||||
1312196|NCT03437395||Single Group Assignment||Treatment||None (Open Label)||Patients will be offered either balloon brachytherapy or 3D conformal radiation therapy to treat the tumor bed alone. Data will be collected so that our results can be compared to the results of the randomized trial. Specifically, we will be comparing our local control rates and cosmetic results to those of favorable risk patients from the NSABP B-39 trial.||||
1312197|NCT03437382||Single Group Assignment||Treatment||None (Open Label)||single-arm, interventional, dose escalation study||||
1312198|NCT03437369|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1312199|NCT03437356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312152|NCT03437967|Randomized|Crossover Assignment||Treatment||Double|Sham therapy will consist of treatment using an identically appearing device that delivers low level LASER POWER to simulate LASER treatment.|This is a prospective interventional study using a double-blind 4-period crossover design to assess the efficacy of LASER Photobiomodulation therapy compared to sham (LOW POWER LASER) therapy in reducing pain and improving compliance with OPM weaning. LASER photobiomodulation treatments or sham treatments will be provided three times a week using standardized protocols. Crossover will occur every 3 weeks with weekly data collection occurring at the end of each week allowing for washout and to minimize the carryover effects of active treatment. Data collection will consist of LASER and sham treatments, prescribed pain medication dosage and quantity, subjective pain questionnaires, and urine samples. Cognitive and memory screening will occur every 3 weeks at the end of each period prior to crossover.|t|||t
1312153|NCT03437954|Randomized|Parallel Assignment||Other||Double||||t||t
1312154|NCT03437941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312155|NCT03437928||Single Group Assignment||Treatment||None (Open Label)||||||
1312156|NCT03437915||Single Group Assignment||Treatment||None (Open Label)||||||
1312157|NCT03437902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312158|NCT03437889||Single Group Assignment||Supportive Care||None (Open Label)||||||
1312159|NCT03437876||Single Group Assignment||Treatment||None (Open Label)||a open-label, self-control study||||
1312160|NCT03437863||Single Group Assignment||Device Feasibility||None (Open Label)||Participants will be recruited to a pre-post design study.||||
1312161|NCT03437850|||Cohort||Prospective|||||||
1312162|NCT03437837|||Case-Only||Retrospective|||||||
1312163|NCT03437824|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1312164|NCT03437811||Single Group Assignment||Treatment||None (Open Label)|Data interpretation, statistical analysis performed by third party|Active Active arm, Electro Flo Percussor, Model 5000 airway clearance system for daily basis as needed (pro re nata).||||
1312165|NCT03437798|||Cohort||Retrospective|||||||
1312166|NCT03437785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312167|NCT03437772|||Cohort||Prospective|||||||
1312168|NCT03437759|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312169|NCT03437746||Single Group Assignment||Treatment||None (Open Label)||||||
1312170|NCT03437733||Single Group Assignment||Treatment||None (Open Label)||||||
1312171|NCT03437720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312172|NCT03437707|Randomized|Parallel Assignment||Treatment||Single||Prospective, Randomized, Placebo-Controlled Clinical Trial|t|||
1312173|NCT03437694|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Participants will be randomized in a 1:1 ratio to either the intervention or control group.||||
1312174|NCT03437681||Single Group Assignment||Basic Science||None (Open Label)||The project is a within-subject consecutive design examining 18 healthy individuals after baseline and after 4 nights of insufficient sleep.||||
1312175|NCT03437668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312176|NCT03437655|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1312177|NCT03437642|||Case-Control||Other|||||||
1312178|NCT03437629|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1312179|NCT03437616|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Longitudinal controlled study: The intervention group (n=150) participates in Tulppa rehabilitation program and the control group (n=150) do not participate in Tulppa rehabilitation.||||
1312180|NCT03437603||Single Group Assignment||Treatment||None (Open Label)||||||
1312181|NCT03437590|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1312182|NCT03437577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312183|NCT03437564|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1312184|NCT03437551|||Case-Crossover||Prospective|||||||
1312185|NCT03437538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312186|NCT03437525|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study uses a cluster randomized controlled trial design with one experimental condition and one control condition. Ten community health centers (CHC) will be randomized to either the experimental or control condition. The five CHCs in the experimental group will deliver the peer support intervention for 12 months and the five CHCs in the control group will deliver usual care.||||
1312187|NCT03437512|Randomized|Parallel Assignment||Treatment||Quadruple|A researcher who is not involved in any aspect of the study will randomize participants into the sham and active study arms using a minimization procedure. Allocation concealment will be achieved by assigning a unique 6-digit random code per participant, which will be provided to the researcher. The code is used to deliver stimulation. The participants and the researchers who deliver stimulation, assess outcomes, and analyze data will be masked to trial arm.||t|t|t|t
1312188|NCT03437499|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1312189|NCT03437486|||Family-Based||Prospective|||||||
1312190|NCT03437473|Randomized|Parallel Assignment||Device Feasibility||Quadruple|||t|t|t|t
1312191|NCT03437460|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312192|NCT03437447|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1312193|NCT03437434|||Cohort||Retrospective|||||||
1312194|NCT03437421|Non-Randomized|Parallel Assignment||Supportive Care||Single|Single-masked study. Clinicians and researchers in charge of main outcomes (eg cardiac remodelling and global function, regional myocardial function) measurements will not be aware of group allocation (eg vitamin D deficient and non-deficient sub-groups) and time study (eg baseline or post vitamin D supplementation).|Type I and II diabetic patients will be investigated. Within each diabetic population, vitamin D deficient and non-deficient individuals will be compared at baseline. Then, within each diabetic population, those with vitamin D deficiency at baseline will be compared before and after a 3 month vitamin D supplementation.||||t
1312195|NCT03437408||Single Group Assignment||Diagnostic||None (Open Label)||Ventricular Substrate maps in patients undergoing ablation for VT - maps collected with automated tagging in different pacing modalities. Validation of collected substrate. Collection of impedance and ablation index data during ablation||||
1573399|NCT00001376||||||||||||
1312202|NCT03437317|Randomized|Parallel Assignment||Treatment||Single|Participants were blind to their assigned condition.|"Participants were randomly assigned to either an active training group or a control group. The active participants completed 8 blocks of a perceptual training task, while the control group performed 8 blocks of a gender discrimination task~that received the perceptual retraining protocol"|t|||
1312203|NCT03437304|Randomized|Parallel Assignment||Prevention||Single||||||t
1312204|NCT03437291|||Cohort||Prospective|||||||
1312205|NCT03437278|Randomized|Parallel Assignment||Treatment||Quadruple|Patients, investigator staff and personnel performing the study assessments will remain blinded to the identity of the treatment from the time of randomization until final database lock. Data managers, programmers, statisticians, pharmacometricians and clinical experts of the Novartis trial team will also remain blinded until final database lock. The study drug must be prepared by an independent unblinded pharmacist (or authorized delegate) and administered by an independent unblinded administrator.|This is a Phase 2b dose-finding, randomized, double-blind, parallel group, placebo controlled multicenter study in adolescent patients|t|t|t|t
1312206|NCT03437265||Single Group Assignment||Treatment||None (Open Label)||||||
1312207|NCT03437252|||Case-Crossover||Prospective|||||||
1312208|NCT03437239|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312209|NCT03437226|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1312210|NCT03437213|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1312211|NCT03437200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312212|NCT03437187|Randomized|Crossover Assignment||Treatment||Single|Information connecting the patients to the data are kept locked and will be destroyed after the end of the investigation||t|||
1312213|NCT03437174|||Cohort||Cross-Sectional|||||||
1312214|NCT03437161||Single Group Assignment||Supportive Care||None (Open Label)||||||
1312215|NCT03437148||Single Group Assignment||Other||None (Open Label)|NO MASKING|||||
1312216|NCT03437135|||Cohort||Cross-Sectional|||||||
1312217|NCT03437122||Single Group Assignment||Basic Science||None (Open Label)||||||
1312218|NCT03437109|||Cohort||Prospective|||||||
1312219|NCT03437096||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312220|NCT03437083|||Cohort||Retrospective|||||||
1312221|NCT03437070||Single Group Assignment||Treatment||None (Open Label)||Dose escalation||||
1312222|NCT03437057||Single Group Assignment||Health Services Research||None (Open Label)||||||
1312223|NCT03437044|Randomized|Parallel Assignment||Treatment||None (Open Label)|Staff performing PK/PD assessments will remain blinded to treatment assignment.|Prospective randomized||||
1312224|NCT03437031|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel randomized controlled trials||||
1312225|NCT03437018|||Case-Crossover||Prospective|||||||
1312226|NCT03437005|Randomized|Parallel Assignment||Basic Science||Double|Investigator and subject will be blinded.|The patient will be randomized to one of two groups, with one group receiving ketoconazole cream and the other receiving desonide ointment.|t||t|
1312227|NCT03436992|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312228|NCT03436979|||Cohort||Prospective|||||||
1312229|NCT03436966|||Cohort||Prospective|||||||
1312230|NCT03436953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312231|NCT03436940|Randomized|Crossover Assignment||Other||None (Open Label)||cluster randomized cross-over trial||||
1312232|NCT03436927|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1312233|NCT03436914||Single Group Assignment||Treatment||None (Open Label)||There is only one arm in this study. Patients diagnosed as NERD will take PPI (Esomezol) for 8 weeks.||||
1312234|NCT03436901||Single Group Assignment||Diagnostic||None (Open Label)||Non-inferiority study||||
1312235|NCT03436888|||Other||Cross-Sectional|||||||
1312236|NCT03436875|||Cohort||Prospective|||||||
1312237|NCT03436862||Single Group Assignment||Treatment||None (Open Label)||||||
1312238|NCT03436849|Randomized|Sequential Assignment||Basic Science||Triple|||t|t|t|
1312239|NCT03436836|Randomized|Parallel Assignment||Supportive Care||Double|"The enrolled patients were randomized according to computer‑generated random number into two equal groups of twenty two patients each and concealed using sequentially numbered sealed opaque envelopes.~Patients of Group N received local anesthetics received 6 ml of 0.5% bupivacaine 1 ml hyaluronidase (75 IU) , and 4mg of Nalbuphine in 1 ml of saline (total 8 ml) and patients of Group C received 6 ml of 0.5% bupivacaine, 1 ml hyaluronidase (75 IU) and1 ml saline (total 8 ml)"|Forty-four patients were enrolled in the current study and randomly allocated into two equal groups [Group N (n=22) and Group C (n=22)]. Two patients in Group N and three patients in Group C were excluded from the study due to failure of the block to achieve satisfactory surgical condition (inadequate akinesia OMS>2) so, received additional supplementations 2-3 ml of LA mixture and were excluded from the study|t|t||
1312240|NCT03436823|Randomized|Parallel Assignment||Treatment||Single||||||t
1312241|NCT03436810|Randomized|Parallel Assignment||Treatment||Double||Parallel Assignment|t|||t
1312242|NCT03436797||Single Group Assignment||Treatment||None (Open Label)||||||
1312243|NCT03436784|Randomized|Parallel Assignment||Treatment||Single|Participants who were recruited at the same time and location were assigned to the same treatment group to prevent knowledge of different treatment groups in the study.|Parallel-arm intervention with inactive control group and intervention group|t|||
1312244|NCT03436771|||Cohort||Prospective|||||||
1312245|NCT03436758|||Case-Only||Prospective|||||||
1312246|NCT03436745|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1312247|NCT03436732|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1312248|NCT03436719|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312249|NCT03436706|||Cohort||Prospective|||||||
1312250|NCT03436693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312251|NCT03436680|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312252|NCT03436667|||Cohort||Prospective|||||||
1312253|NCT03436654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573400|NCT00001375||||||||||||
1312258|NCT03436589|Randomized|Parallel Assignment||Treatment||Single|Participants who were recruited at the same time and location were assigned to the same treatment group to prevent knowledge of different treatment groups in the study.|Parallel-arm intervention with inactive control group and intervention group|t|||
1312259|NCT03436576|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1312260|NCT03436563|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312261|NCT03436550|||Cohort||Prospective|||||||
1312262|NCT03436537|||Case-Control||Cross-Sectional|||||||
1312263|NCT03436524|||Cohort||Retrospective|||||||
1312264|NCT03436511|||Cohort||Retrospective|||||||
1312265|NCT03436498|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312266|NCT03436485|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312267|NCT03436472|Randomized|Parallel Assignment||Prevention||Quadruple||Parallel Assignment|t|t|t|t
1312268|NCT03436459|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1312269|NCT03436446|||Cohort||Prospective|||||||
1312270|NCT03436433|Randomized|Parallel Assignment||Treatment||None (Open Label)||Upon consent, patients will be randomized in REDCap™ to receive either LCM, LEV, or no AED. Randomization will be stratified by suspected histologic grade (LGG vs HGG) based on MRI review by the treating neurosurgeon and/or neuro-oncologist. A stratified permuted block randomization algorithm will be used assign patients to treatment arms.||||
1312271|NCT03436420||Single Group Assignment||Treatment||None (Open Label)||||||
1312272|NCT03436407|||Case-Control||Prospective|||||||
1312273|NCT03436394|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1312274|NCT03436381|||Cohort||Prospective|||||||
1312275|NCT03436368|Randomized|Parallel Assignment||Supportive Care||Single||Using computer & sealed envelope randomization, patients are assigned to receive either continuous spinal anesthesia [CSA group: n =30] or general anesthesia [GA group: n=30]||||t
1312276|NCT03436355||Single Group Assignment||Prevention||None (Open Label)||||||
1312277|NCT03436342||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312278|NCT03436329|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312279|NCT03436316|Randomized|Sequential Assignment||Treatment||Double|Part 1 of this study will be single-blind. Part 2 of this study will be open-label.||t||t|
1312280|NCT03436303|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomly assigned to three groups: CEE 0.3 mg/micronized progesterone (MP) 100 mg group, CEE 0.625 mg/MP 100 mg group,CEE 0.625 mg/dydrogesterone 10 mg group.||||
1312281|NCT03436290|Randomized|Parallel Assignment||Treatment||Single||||||t
1312282|NCT03436277|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312283|NCT03436264|||Cohort||Cross-Sectional|||||||
1312284|NCT03436251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312285|NCT03436238|||Cohort||Prospective|||||||
1312286|NCT03436225|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312287|NCT03436212||Single Group Assignment||Other||None (Open Label)||||||
1312288|NCT03436199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312289|NCT03436186|||Cohort||Prospective|||||||
1312290|NCT03436173|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1312291|NCT03436160|Randomized|Parallel Assignment||Diagnostic||None (Open Label)|Blinding is not necessary in this study|Subjects will be randomized to one of three groups to receive 100 mcg Carbon-14 radio labeled WR826647, WR909388, or WR909390||||
1312292|NCT03436147|||Other||Prospective|||||||
1312293|NCT03436134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312294|NCT03436121|Randomized|Parallel Assignment||Treatment||Quadruple||Participants will be randomly assigned to either the experimental condition (ketamine + midazolam) or the active control condition (placebo + midazolam)|t|t|t|t
1312295|NCT03436108|||Case-Control||Prospective|||||||
1312296|NCT03436095|||Cohort||Prospective|||||||
1312297|NCT03436082|||Cohort||Prospective|||||||
1312298|NCT03436069|||Cohort||Other|||||||
1312299|NCT03436056|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose Escalation phase with 2 dose levels followed by an Expansion phase||||
1312300|NCT03436043|Randomized|Parallel Assignment||Treatment||Single|single blind||t|||
1312301|NCT03436030||Single Group Assignment||Diagnostic||None (Open Label)||Healthy reclining adult volunteers, with Valsalva manoeuver, Muller manoeuver, light continuous positive airway pressure by mask, passive leg raising, and maximal hand-grip. Ultrasound heart images captured before and during.||||
1312302|NCT03436017|||Other||Prospective|||||||
1312303|NCT03436004|Randomized|Parallel Assignment||Diagnostic||None (Open Label)|Concealed assignation|Randomized Multicenter prospective trial with medical device||||
1312304|NCT03435991|||Cohort||Prospective|||||||
1312305|NCT03435978|||Cohort||Prospective|||||||
1312306|NCT03435965|||Case-Control||Prospective|||||||
1312307|NCT03435952||Single Group Assignment||Treatment||None (Open Label)||||||
1312308|NCT03435939||Single Group Assignment||Other||None (Open Label)||||||
1312309|NCT03435926|||Cohort||Prospective|||||||
1312310|NCT03435913|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1312311|NCT03435900|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Quasi-randomised controlled trial||||
1312312|NCT03435887|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312313|NCT03435874|Randomized|Sequential Assignment||Prevention||Quadruple|Double-blind.|A Phase Ib age de-escalation dose-escalation randomised, double-blind, controlled study of the safety and immunogenicity of heterologous prime-boost with the candidate malaria vaccines ChAd63 RH5 and MVA RH5|t|t|t|t
1312314|NCT03435861|Randomized|Parallel Assignment||Treatment||Quadruple||Our mono-centric project will consist in a double-blinded randomized placebo-controlled study, assessing the effect of neflamapimod on brain inflammation in patients suffering of AD by using [18F]-DPA714|t|t|t|t
1312315|NCT03435848||Single Group Assignment||Treatment||None (Open Label)||||||
1312390|NCT03434873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312316|NCT03435835|Randomized|Crossover Assignment||Treatment||Double|Subjects will not be told outright which therapy there are receiving (thermoneutral or HT) and the Cardiologist supervising the exercise test will not be told which therapy was given.||t|||t
1312317|NCT03435822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312318|NCT03435809|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312319|NCT03435796||Single Group Assignment||Treatment||None (Open Label)||||||
1312320|NCT03435783|Randomized|Single Group Assignment||Prevention||Single||Randomized controlled trial where participants are assigned to either a treatment or control group.|||t|
1312321|NCT03435770||Single Group Assignment||Treatment||None (Open Label)||prospective, open label||||
1312322|NCT03435757|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1312323|NCT03435744|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind plcaebo controlled trial|1-Simvastatin plus TAU, 2- Placebo plus TAU|t|t|t|t
1312324|NCT03435731||Single Group Assignment||Supportive Care||None (Open Label)||||||
1312325|NCT03435718|Randomized|Parallel Assignment||Treatment||Quadruple|Each patient's treatment condition will be masked by a code assigned at randomization. The study pharmacist will know this assignment. A person other than the investigator will administer the drug as directed by the pharmacists.|This study will be conducted as a field trial. Patients will be randomly assigned to one of five treatment groups: 6 mg/kg, 15 mg/kg or 30 mg/kg oxfendazole as a single dose; 15 mg/kg oxfendazole on three consecutive days; or 400 mg albendazole as a single dose (50 patients per group). The main objective of this study is to assess the efficacy (Cure Rate) of oral oxfendazole. Secondary objectives are to assess the Egg Reduction Rate for Trichuris in those subjects not cured of infection, to assess the efficacy (Cure Rate and Egg Reduction Rate) of oxfendazole against other common intestinal helminth infections, and to assess the safety and tolerability of oxfendazole treatment in adult patients.|t|t|t|t
1312326|NCT03435705|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1312327|NCT03435692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312328|NCT03435679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312329|NCT03435666|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312330|NCT03435653|Randomized|Parallel Assignment||Treatment||Single||||||t
1312331|NCT03435640|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312332|NCT03435627|||Cohort||Prospective|||||||
1312333|NCT03435614|||Cohort||Prospective|||||||
1312334|NCT03435601|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312335|NCT03435588|Randomized|Parallel Assignment||Diagnostic||Single||"Procedures are performed with a linear echoendoscope under conscious sedation. EUS-FNB is performed with a 22 gauge Core-needle. Tissue sampling technique is standardized between the endoscopists. Two passes are performed using the core needle. A third pass is allowed if, on macroscopic inspection of the acquired sample, the specimen is deemed insufficient by the endoscopist. EUS-FNA with ROSE is performed with a 22 gauge FNA needle.~This is a multi-center, randomized, single blinded, non-inferiority, trial comparing EUS-FNB alone to EUS-FNA with ROSE in the diagnosis of solid pancreatic masses. Following consent, patients are randomized, at the time of the procedure, to undergo either EUS-FNB alone or EUS-FNA with ROSE. The randomization sequence will be generated by a computerized randomization scheme using a block size of 10 stratified according to the endoscopist."|t|||
1312336|NCT03435575|Randomized|Parallel Assignment||Treatment||None (Open Label)|Randomization into intervention or control group. Children in the intervention group will receive Boosth at the start of the study. Children in the control group will receive Boosth after the study is finished|Intervention and control group parallel||||
1312337|NCT03435562|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1312338|NCT03435549|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1312339|NCT03435536||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312340|NCT03435523||Single Group Assignment||Treatment||None (Open Label)||||||
1312341|NCT03435510||Single Group Assignment||Other||None (Open Label)||||||
1312342|NCT03435497|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312343|NCT03435484|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1312344|NCT03435471|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312345|NCT03435458|Randomized|Parallel Assignment||Other||Single||The study is a randomized, multicentre, open-label, controlled trial comparing association of balloon catheter plus oral prostaglandin E1 versus oral prostaglandin E1 alone to induce labor in a 1:1 randomization of nulliparous obese women.||||t
1312346|NCT03435445|Randomized|Parallel Assignment||Treatment||Single||3 arms: Experimental group 1 receives diet, physical change and behavior change recommendations via an online platform for 24 weeks; Experimental Group 2 receives recommendations via an online platform plus a dietitian coaching via the online platform for 24 weeks; Control groups receives a minimal intervention with access to diet and physical change recommendations videos. After 24 weeks, the control group will gain access to the online platform.||||t
1312347|NCT03435432|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1312348|NCT03435419|||Case-Control||Prospective|||||||
1312349|NCT03435406|||Cohort||Cross-Sectional|||||||
1312350|NCT03435393|||Cohort||Other|||||||
1312351|NCT03435380|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomly assigned, in a ratio of 1:1:1, to one of the three groups: control, patient activation (PA), or patient activation + primary care provider activation (PA+PCP). Participants will remain in the group they are randomized to with no crossover throughout the study.||||
1312352|NCT03435367|Randomized|Parallel Assignment||Treatment||Single||||||t
1312353|NCT03435354|Randomized|Parallel Assignment||Prevention||Single|Those conducting the post-intervention assessments will be blind to study group allocation.|Cluster-randomized trial, with randomization by within each site by week (i.e., site-week)||||t
1312354|NCT03435341|||Cohort||Prospective|||||||
1312355|NCT03435328||Single Group Assignment||Treatment||None (Open Label)||||||
1312356|NCT03435315|Randomized|Parallel Assignment||Other||Single|||t|||
1312357|NCT03435302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312358|NCT03435289||Single Group Assignment||Treatment||None (Open Label)||This is a single arm, open-label study of CPI-613 in combination with gemcitabine and nab-paclitaxel for patients with locally advanced or metastatic pancreatic cancer||||
1312359|NCT03435276|Randomized|Parallel Assignment||Treatment||Single|This study is single-blind (in which the study center staff have to remain blinded during the clinical conduct of a given cohort) with regard to treatment (AZD9977 or placebo) at each dose level. In the event of a medical emergency when management of a subject's condition requires knowledge of the trial medication, the treatment received may be revealed by personnel authorized by the PI. Reasons for breaking a code will be clearly explained and justified in ClinBase. The date on which the code was broken together with the identity of the person responsible will also be documented.||t|||
1312360|NCT03435263|||Cohort||Prospective|||||||
1312361|NCT03435250||Single Group Assignment||Treatment||None (Open Label)||||||
1312362|NCT03435237|||Case-Only||Prospective|||||||
1312363|NCT03435224||||||||||||
1312364|NCT03435211||||||||||||
1312365|NCT03435198||Single Group Assignment||Basic Science||None (Open Label)||||||
1312366|NCT03435185|||Case-Control||Prospective|||||||
1312367|NCT03435172|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Subjects will have at least one deep partial or full thickness burn wound of ≥ 250 cm2 that is to be autografted with a split thickness skin graft (STSG) meshed at either (2:1 or 3:1). The Subjects will be randomized to treatment or usual care group at 2:1 ratio. Harvested tissue will be processed in the Celution® System to isolate and concentrate ADRCs. Then the subject will be followed by peripheral intravenous delivery of ADRCs within 4 hours of completion of Celution® processing.~Up to 30 subjects will be enrolled. Each subject will contribute up to three qualified wound areas for the analysis. Randomization will be stratified to ensure that the numbers of wounds treated with 2:1 and 3:1 STSG are balanced across the treatment groups."||||
1312368|NCT03435159|Randomized|Parallel Assignment||Screening||Single||30 participants were divided into 2 groups. In the first group, participants were applied manual chiropractic manipulation, and in the second group, participants were applied instrumental chiropractic manipulation.||||t
1312369|NCT03435146||Sequential Assignment||Treatment||None (Open Label)||"Group 1: The first 12 participants (Group 1a) will take dolutegravir 50mg once daily (with tenofovir/emtricitabine) plus once weekly rifapentine/ isoniazid for the study period. Semi-intensive PK measurements of dolutegravir,rifapentine,isoniazid will be collected at protocol-defined intervals.~An interim pharmacokinetic, safety,and HIV viral load assessment will be performed to ensure that dolutegravir 50mg once daily is safe and meets PK targets.~The next 18 participants (Group 1B) will receive either dolutegravir 50mg or a higher or more frequent dose of dolutegravir, if adjustment is required, plus once weekly rifapentine/isoniazid. Semi-intensive PK measurements of dolutegravir,rifapentine,isoniazid will be collected at protocol-defined intervals.~Group 2: The next 30 participants will receive dolutegravir at the same dose and frequency as Group 1B. Sparse PK samples of dolutegravir, safety labs and HIV viral load will be measured at protocol-defined intervals."||||
1312370|NCT03435133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312371|NCT03435120|||Cohort||Prospective|||||||
1312372|NCT03435107||Single Group Assignment||Treatment||None (Open Label)||||||
1312373|NCT03435094|||Case-Only||Prospective|||||||
1312374|NCT03435081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312375|NCT03435068|Randomized|Parallel Assignment||Treatment||None (Open Label)||The trial is parallel-designed, controlled, prospective clinical study.||||
1312376|NCT03435055||Single Group Assignment||Basic Science||None (Open Label)||||||
1312377|NCT03435042|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312378|NCT03435029|Randomized|Parallel Assignment||Prevention||Single|||t|||
1312379|NCT03435016||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312380|NCT03435003|Randomized|Parallel Assignment||Prevention||Single|||t|||
1312381|NCT03434990|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor won't have any knowledge about the study purposes and will be unaware of the group allocation. The statistical analysis will also be performed blinded for group allocation.|This is a randomized controlled trial, characterized by the application of manual therapy, in which subjects will be randomly allocated into two groups: spinal manipulation plus myofascial release and spinal manipulation. The participants will be individuals with non-specific chronic low back pain. The study will be reported following the recommendations of the CONSORT Statement. For the present study, non-specific chronic low back pain was defined as uninterrupted low back pain for more than 12 weeks, with unknown causes.||||t
1312382|NCT03434977|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312383|NCT03434964|||Cohort||Prospective|||||||
1312384|NCT03434951|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1312385|NCT03434938|Randomized|Parallel Assignment||Prevention||Triple|After inclusion in the study and obtaining informed consent, participants will be randomized to intervention or control group in a concealed allocation manner. Centralized randomization will be conducted through a block randomization procedure, with random-varying block size, stratified by participating centre. Participants will be randomized after the baseline assessment, guaranteeing the blinded assessment. The 30 days and 3 months assessments will be conducted by an assessor blinded to participants' group allocation, who will ask the participants not to disclose their group allocation. Afterwards, the assessor will record whether he/she was made aware of the participant allocation.|"MI intervention will be associated to standard geriatric rehabilitation. MI will be structured in 4 sessions (within 72 hours from admission, within next 6 days after first MI session, at 1 week from the second session and pre-discharge), with the goals of reducing disability obtaining patients' collaboration, creating a shared tailored plan which would complement the individual approach established by the multidisciplinary team as part of routine geriatric rehabilitation unit, and reinforcing engagement and adherence at 3 months.~Standard rehabilitation and control includes a multidisciplinary and individualized treatment plan based on comprehensive geriatric and specific rehabilitation assessments."|t||t|t
1312386|NCT03434925||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312387|NCT03434912|||Cohort||Prospective|||||||
1312388|NCT03434899|Randomized|Parallel Assignment||Treatment||Single||||||t
1312389|NCT03434886|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312391|NCT03434860|Randomized|Parallel Assignment||Treatment||Triple|Randomization was done by the study statistician based on a computer-generated list. The groups were homogeneous according to age, sex and diagnostic criteria. The assignment of groups was blind to participants, research staff and outcome assessors moreover, to maintain blind parallel study the statistician was not aware of the allocation of participants to intervention||t||t|t
1312392|NCT03434847|Randomized|Parallel Assignment||Supportive Care||Single|"At enrollment, each patient will be assigned a study number, which will match a previously prepared computer-generated list of randomization numbers to determine whether they will be in the intervention or control arm. Pre-operatively, all patients will complete an initial questionnaire. The patients in the intervention group (n=50) will, in addition to the standard pre-operative assessment, also receive pre-operative educational instruction of what to expect from a post-operative pain perspective including education material to take home.~For this study, we will be using deception, with the reasoning that the patients' knowledge of the different education materials will affect their rating of the impact of the intervention on satisfaction scores."|Prospective, randomized, single-blind study|t|||
1312393|NCT03434834||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312394|NCT03434821|||Other||Prospective|||||||
1312395|NCT03434808||Single Group Assignment||Other||None (Open Label)||||||
1312396|NCT03434795|||Cohort||Prospective|||||||
1312397|NCT03434782|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1312398|NCT03434769||Single Group Assignment||Treatment||None (Open Label)||||||
1312399|NCT03434756||Single Group Assignment||Screening||None (Open Label)||||||
1312400|NCT03434743|Randomized|Parallel Assignment||Treatment||Single|The assessor, responsible for data collection and follow up interview post hospitalization, is blind to group assignment.|||||t
1312401|NCT03434730||Single Group Assignment||Treatment||None (Open Label)||||||
1312402|NCT03434717|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||RCT||||
1312403|NCT03434704||Single Group Assignment||Treatment||None (Open Label)||||||
1312404|NCT03434691|Randomized|Parallel Assignment||Screening||Double|||||t|t
1312405|NCT03434678|Randomized|Parallel Assignment||Treatment||Single|(surgical staff) blinded|Prospective randomized controlled single institution trial.|||t|
1312406|NCT03434665||Single Group Assignment||Other||None (Open Label)||Feasibility pilot study||||
1312407|NCT03434652|Randomized|Crossover Assignment||Treatment||Quadruple||Each subject randomized to active vs sham therapy, then cross over to the other during next illness cycle|t|t|t|t
1312408|NCT03434639|||Case-Control||Cross-Sectional|||||||
1312409|NCT03434626|Randomized|Parallel Assignment||Other||Single|Outcome assessor conducting interviews does not have information on group assignment|||||t
1312410|NCT03434613|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|This study will conduct to evaluate the efficacy of liver fat lowering and safety of rosuvastatin 5mg alone or in combination with rosuvastatin 5mg / ezetimibe 10mg for 6 months.||||
1312411|NCT03434600|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312412|NCT03434587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312413|NCT03434574|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1312414|NCT03434561|||Cohort||Prospective|||||||
1312415|NCT03434548|||Case-Control||Other|||||||
1312416|NCT03434535|Randomized|Parallel Assignment||Other||Single|||t|||
1312417|NCT03434522|||Case-Only||Prospective|||||||
1312418|NCT03434509||Single Group Assignment||Treatment||None (Open Label)||||||
1312419|NCT03434496|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1312420|NCT03434483|||Case-Control||Prospective|||||||
1312421|NCT03434470|||Cohort||Prospective|||||||
1312422|NCT03434457|||Cohort||Prospective|||||||
1312423|NCT03434444|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312424|NCT03434431|||Cohort||Cross-Sectional|||||||
1312425|NCT03434418||Single Group Assignment||Treatment||None (Open Label)||||||
1312426|NCT03434405|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Multi-center, rater-blinded, prospective (48 weeks follow-up), non-randomized, controlled (versus treatment as usual [TAU]), clinical trial. The experimental arm will receive TAU (both drug and psychosocial therapy) and mindfulness-based social cognition group training (SocialMind), specifically designed for patients with first episode psychosis by the research team. The control arm will receive TAU (both drug and psychosocial therapy). Participants will be assigned to either experimental arm or control arm according to their preferences.||||
1312427|NCT03434392|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Participants are assigned to one of four groups in parallel for the duration of the study based on prior clinical history.||||
1312428|NCT03434379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312429|NCT03434366|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312430|NCT03434353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312431|NCT03434340|Randomized|Parallel Assignment||Prevention||Single|||t|||
1312432|NCT03434327|Randomized|Parallel Assignment||Treatment||Single||||||t
1312433|NCT03434314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312434|NCT03434301|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1312435|NCT03434288|||Case-Only||Prospective|||||||
1312436|NCT03434275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312437|NCT03434262|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a phase 1 limited dose escalation to define RP2D of the doublets with an early expansion cohort to evaluate preliminary efficacy.||||
1312438|NCT03434249|Randomized|Parallel Assignment||Treatment||Quadruple||This is a prospective randomized double blind placebo controlled clinical trial|t|t|t|t
1312439|NCT03434236|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1312440|NCT03434223|||Cohort||Prospective|||||||
1312441|NCT03434210|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor would not known the arm, and forbiden to ask and comminicate with patients about the intervention.|||||t
1312442|NCT03434197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312444|NCT03434171|Randomized|Parallel Assignment||Treatment||None (Open Label)||What is the effect of aerobic exercises with diet modification on hot flushes, lutenizing hormone (L.H) and follicle stimulating hormone (F.S.H) in post-menopausal women||||
1312445|NCT03434158||Single Group Assignment||Treatment||None (Open Label)||||||
1312446|NCT03434145|||Case-Only||Prospective|||||||
1312447|NCT03434132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312448|NCT03434119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312449|NCT03434106|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312450|NCT03434093|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1312451|NCT03434080|||Cohort||Other|||||||
1312452|NCT03434067|||Cohort||Prospective|||||||
1312453|NCT03434054|Randomized|Parallel Assignment||Basic Science||Double|Study medication and placebo are over-encapsulated to look identical, and both the participants and investigators in direct contact with partiicpants are blind to group allocation.|This is a double-blind, placebo-controlled experimental medicine study, where healthy volunteers are randomised to receiving either a single dose of losartan (50mg) or matching placebo.|t||t|
1312454|NCT03434041|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312455|NCT03434028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312456|NCT03434015|||Cohort||Prospective|||||||
1312457|NCT03434002|Randomized|Sequential Assignment||Other||None (Open Label)||"building the technical components for interaction within the virtual reality environment (phase 1);~application of this virtual reality in medical training (phase 2) and~measurement of training effectiveness with this Virtual Reality simulator against mannequin based training (phase 3)."||||
1312458|NCT03433989||Single Group Assignment||Diagnostic||None (Open Label)||Monocentric, prospective, epidemiological, descriptive and analytical study.||||
1312459|NCT03433976|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312460|NCT03433963|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1312461|NCT03433950|||Cohort||Prospective|||||||
1312462|NCT03433937|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312463|NCT03433924|||Cohort||Prospective|||||||
1312464|NCT03433911|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312465|NCT03433898|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1312466|NCT03433885|||Cohort||Prospective|||||||
1312467|NCT03433872||Single Group Assignment||Treatment||None (Open Label)||The goal of the field test is to evaluate use of the We Grow Together system by typical early childhood professionals working in a variety of care settings serving infants and toddlers. The field test will take place in 8 to 12 geographic areas across the country. This study will include only centers and FCC settings that already have local PD providers—the investigators will exclude ECE settings without established PD providers. The field test will include a purposive sample of 175 center-based classrooms (approximately half will be affiliated with Early Head Start [EHS], and half will be community-based child care programs). The field test sample will also include 125 FCCs, including those operating under EHS and in community-based settings.||||
1312468|NCT03433859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312469|NCT03433846|||Cohort||Prospective|||||||
1312470|NCT03433833||Single Group Assignment||Treatment||None (Open Label)||||||
1312471|NCT03433820|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||A single-arm, observational study||||
1312472|NCT03433807||||||||||||
1312473|NCT03433794|Randomized|Parallel Assignment||Treatment||Single|The intervention is an online program, not an individual, so masking is not necessary. Similarly, the same online survey is deployed in all follow-up assessments regardless of condition, and data are not collected by individuals, so making is not necessary.||t|||
1312474|NCT03433781||Single Group Assignment||Treatment||None (Open Label)||||||
1312475|NCT03433768|||Case-Control||Prospective|||||||
1312476|NCT03433755|Randomized|Parallel Assignment||Treatment||Quadruple|"The dose frequencies of Q2W and QM will not be blinded but the identity of investigational product (evolocumab or matching SC placebo) will be blinded. In order to protect the blinding of the double-blind treatment period the following labs will be blinded post-investigational product treatment until unblinding of the clinical database and not reported to sites as noted below:~• Blinded to the Amgen study team and site staff: lipid panel, ApoA1,ApoB, lipoprotein(a), hsCRP, and PCSK9."|"Participants will be screened for this study and if found eligible as described by the study protocol may be randomized into 1 of 4 groups. Randomized means that you are put into a group by chance. It is like drawing numbers out of a hat. Randomization will be done using a 2:2:1:1 ratio. This means for every 6 participants randomized:~2 participants will be randomized to evolocumab 140 mg every 2 weeks~2 participants will be randomized to evolocumab 420 mg once a month~1 participant will be randomized to placebo every 2 weeks~1 participant will be randomized to placebo once a month."|t|t|t|t
1312477|NCT03433742|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1312478|NCT03433729|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1312479|NCT03433716|Randomized|Parallel Assignment||Treatment||Single||||||t
1312480|NCT03433703||Single Group Assignment||Treatment||None (Open Label)||||||
1312481|NCT03433690|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled trial||||
1312482|NCT03433677|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1312483|NCT03433664|Randomized|Parallel Assignment||Treatment||Double|Patient and treating clinician were aware of which scar half had been treated, however investigator and assessor were blinded|Scar area (10x10cm square) randomly assigned a square vector 'map' which split the scar into a control and treatment half along one of 4 vectors: vertical, horizontal, and along both diagonals. The envelope revealing the vector map and treatment zones was opened by the treating laser clinician immediately prior to the first treatment. The same treating clinician performed all laser treatments to minimise inter-user variability.|||t|t
1312484|NCT03433651|Randomized|Parallel Assignment||Treatment||Double|Subjects will be randomized using a random number generator to receive either creatine monohydrate or a placebo for 90 days. Both subjects and investigators will be blinded to the study group assignments||t||t|
1312485|NCT03433638|||Cohort||Retrospective|||||||
1312486|NCT03433625|Randomized|Parallel Assignment||Treatment||Single||||||t
1312487|NCT03433612||Single Group Assignment||Other||None (Open Label)|The estimation marks from each technique (two total) will be on the back of the patient (one on the left flank, one on the right flank), therefore the patient does not know where the marks are. Additionally, each mark will be covered with a taped on gauze pad to conceal it so that the two investigators are blinded to each others assessment. The ultrasound clinician will be masked to the two estimations. The marks will still remain covered while the interspace is determined by the third assessor using lumbar ultrasound.|All patients will undergo estimation of the L4-L5 interspace using the classic and novel technique, followed by identification of the interspace using lumbar ultrasound.||||
1312488|NCT03433599|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1312489|NCT03433586|Randomized|Crossover Assignment||Basic Science||Double|Double-blind||t||t|
1312490|NCT03433573||Single Group Assignment||Other||None (Open Label)||||||
1312491|NCT03433560|||Cohort||Prospective|||||||
1312492|NCT03433547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312493|NCT03433534|||Cohort||Prospective|||||||
1312494|NCT03433521|||Ecologic or Community||Retrospective|||||||
1312495|NCT03433508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312496|NCT03433495|Randomized|Crossover Assignment||Treatment||Single|A neuropsychologist blinded to the patients' clinical characteristics and the group to whom the patient was allocated evaluated outcome variables.|||||t
1312497|NCT03433482|Randomized|Parallel Assignment||Prevention||Quadruple|Data will be collected in an observer-blind manner. By observer-blind, it is meant that during the course of the study, the vaccine recipient and those responsible for the evaluation of any study endpoint (e.g. safety, reactogenicity and immunogenicity) will all be unaware of which vaccine was administered. To do so, vaccine preparation and administration will be done by authorized medical personnel who will not participate in any of the study clinical evaluations.||t|t|t|t
1312498|NCT03433469||Single Group Assignment||Treatment||None (Open Label)||||||
1312499|NCT03433456|Randomized|Parallel Assignment||Prevention||Single||Caregiver-child dyads will be randomized to either the intervention group (receiving home intervention + HABITS program) or the a control group to receive their standard of care (home intervention without HABITS)||||t
1312500|NCT03433443|Randomized|Parallel Assignment||Treatment||None (Open Label)|Due to the nature of this study it was not possible to mask the participants, care providers or the investigator. We did not use any objective outcome measures assessed by outcome assessors.|||||
1312501|NCT03433430||Single Group Assignment||Treatment||None (Open Label)||||||
1312502|NCT03433417||Single Group Assignment||Treatment||None (Open Label)||||||
1312503|NCT03433404|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1312504|NCT03433391|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1312505|NCT03433378|Randomized|Parallel Assignment||Treatment||Triple||Bioequivalence|t|t|t|
1312506|NCT03433365|||Other||Prospective|||||||
1312507|NCT03433352|||Case-Control||Cross-Sectional|||||||
1312508|NCT03433339|Randomized|Parallel Assignment||Treatment||Quadruple|An independent operator (trained personnel from the research team) will prepare the tsDCS device parameters for each session, but will not participate in the rest of the assessments. Patients and raters will remain blinded to spinal stimulaion protocol assigned to each participant throughout the study.|8-week, double blinded, randomized, sham controlled, parallel group, pilot clinical trial study design.|t|t|t|t
1312509|NCT03433326|||Case-Only||Prospective|||||||
1312510|NCT03433313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312511|NCT03433300|Randomized|Parallel Assignment||Treatment||Single|Investigators who will conduct performance-based assessments will be blinded to the intervention.|Pilot randomized controlled trial||||t
1312512|NCT03433287||Single Group Assignment||Diagnostic||None (Open Label)||Open cohort study||||
1312513|NCT03433274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312514|NCT03433261|Randomized|Crossover Assignment||Prevention||Double|Neither the investigator nor the outcomes assessor will no the ketone level of the participant during either arm of the study|Each subject will randomize to one of two arms and will crossover to the other arm at least one week later.|||t|t
1312515|NCT03433248|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312516|NCT03433235|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312517|NCT03433222|Randomized|Parallel Assignment||Other||Single||Single-blind, dose escalation, randomized controlled Phase 1 study|t|||
1312518|NCT03433209|Randomized|Parallel Assignment||Other||Single|||t|||
1312519|NCT03433196|Randomized|Parallel Assignment||Treatment||Double|Double blind, Double dummy||t||t|
1312520|NCT03433183||Single Group Assignment||Treatment||None (Open Label)||A Simon's two-stage phase 2 trial of MEK inhibitor selumetinib in combination with the mTOR inhibitor sirolimus to determine the safety and clinical benefit in patients with unresectable or metastatic MPNST||||
1312521|NCT03433170|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1312522|NCT03433157|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312523|NCT03433144|Randomized|Parallel Assignment||Treatment||Single|The patient will be unaware of which group they have been randomized into|In this study, patients will be randomized into two groups: and intervention group and placebo. The intervention group will receive a single pre-operative dose of TXA IV (10mg/kg) and the placebo group will receive the same volume of fluid intravenously.|t|||
1312524|NCT03433131||||||||||||
1312525|NCT03433118|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial (RCT) comparing standard care against standard care with additional acupuncture||||
1312526|NCT03433105|||Cohort||Prospective|||||||
1312527|NCT03433092|||Other||Retrospective|||||||
1312528|NCT03433079|||Case-Only||Prospective|||||||
1312564|NCT03432611|Randomized|Parallel Assignment||Prevention||None (Open Label)||randomized, three-armed pragmatic study||||
1312565|NCT03432598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312566|NCT03432585|||Cohort||Prospective|||||||
1312617|NCT03431922||Single Group Assignment||Treatment||None (Open Label)||||||
1573401|NCT00001371||||||||||||
1312529|NCT03433066|Randomized|Parallel Assignment||Treatment||Triple||"This clinical study will be conducted on twenty-two (22) interproximal intrabony defects in patients with moderate to severe chronic periodontitis.These patients will be divided randomly into two groups:~Group I: (test) will include eleven interproximal intrabony defects that will be treated with (Advanced platelet rich fibrin & biphasic alloplast)~Group II: (control) will include eleven interproximal intrabony defects that will be treated with (biphasic alloplast mixed with saline.)"|t||t|t
1312530|NCT03433053|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312531|NCT03433040|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312532|NCT03433027||Single Group Assignment||Treatment||None (Open Label)||||||
1312533|NCT03433014|Randomized|Parallel Assignment||Other||Single||The infiltration group will receive local infiltration with 0.5% Levobupivacaine. The trocar insertion sites are infiltrated before the skin incision is made. Using the Lap-Assist Transversus Abdominis Plane Block Technique, the total volume of infiltrated 0.5% Levobupivacaine is 20 ml, divided proportionally according to the length of the skin incision (2 ml for the 5-mm trocar and 3 ml for the 10-mm trocars, and 10 mL for specimen retrieval incision). The control group will not receive any local infiltrative agent.|||t|
1312534|NCT03433001|||Cohort||Prospective|||||||
1312535|NCT03432988||Sequential Assignment||Supportive Care||None (Open Label)||||||
1312536|NCT03432975|Randomized|Parallel Assignment||Treatment||Single||20 patients (=40 half-mouth); 20 half-mouth per group|t|||
1312537|NCT03432962|||Other||Cross-Sectional|||||||
1312538|NCT03432949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312539|NCT03432936||Single Group Assignment||Treatment||None (Open Label)||||||
1312540|NCT03432923|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind design. Placebo indistinguishable to active in appearance and dosing schedule.||t|t|t|t
1312541|NCT03432910||Single Group Assignment||Treatment||None (Open Label)||Assignment||||
1312542|NCT03432897||Single Group Assignment||Treatment||None (Open Label)||||||
1312543|NCT03432884|Randomized|Crossover Assignment||Basic Science||Double|Part A: zanubrutinib and placebo will be double-blind Part B: zanubrutinib and placebo will be double-blind; Moxifloxacin will be open-label|Part A: Single Group Part B: Crossover|t||t|
1312544|NCT03432871||Single Group Assignment||Treatment||None (Open Label)|Experimental medicine study (open label)|Experimental medicine study (open label)||||
1312545|NCT03432858|Randomized|Parallel Assignment||Prevention||Double|Principal investigator, co-investigators, and participants are blinded to study intervention||t||t|
1312546|NCT03432845|||Cohort||Prospective|||||||
1312547|NCT03432832|Randomized|Parallel Assignment||Treatment||Single||||||t
1312548|NCT03432819|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312549|NCT03432806|||Cohort||Prospective|||||||
1312550|NCT03432793|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312551|NCT03432780|Randomized|Parallel Assignment||Prevention||None (Open Label)||A prospective, multicenter, multidisciplinary, parallel-group, open-label study with randomized group assignment||||
1312552|NCT03432767|||Cohort||Prospective|||||||
1312553|NCT03432754|Randomized|Parallel Assignment||Treatment||Double|Randomization was conducted by the principle investigator (PI) and study coordinator using a computerized random number generator program (randomization.com). All experimenters (except the PI and study coordinator) were blinded to group assignments until study conclusion. To further reduce demand characteristics, participants were unaware of which group was considered the experimental intervention until debriefed by an experimenter after completing the study. Study binders were created to blind group assignment, and participants in each group were asked not to discuss the sessions with members of the other group or with the experimenter at their post-intervention assessment.|This randomized control trial compared a mindfulness-based attention training (MBAT) group with an active control lifestyle education group. A total of 147 individuals underwent eligibility screening over the phone and in-person at an initial assessment session. Of those eligible, 75 participants volunteered to participate and were randomly assigned to groups. However, one of these participants did not complete the first assessment session and was randomized in error. Thus, 74 participants who completed the first assessment session and met all eligibility criteria were randomly assigned to either the MBAT group or the active control group (lifestyle education). Randomization was conducted by a study author using a computerized random number generator program (randomization.com), applying a varying block size of two and four and stratifying participants by gender. A total of 37 participants were allocated to the each of the two groups.|t|||t
1312554|NCT03432741||Single Group Assignment||Treatment||None (Open Label)||||||
1312555|NCT03432728|||Case-Control||Prospective|||||||
1312556|NCT03432715|Randomized|Factorial Assignment||Prevention||Single|All data collectors are masked.|A portion of participating schools will receive a Student Wellness Champion curriculum, training for their wellness team, as well as technical assistance provided by a Wellness Specialist (WCC-S Group). Other participating schools will only receive the training and technical assistance (WCC Group) and some will solely receive resources (Control Group). The process to determine which school receives which intervention is completely random, and will not be decided until after baseline data collection.||||t
1312557|NCT03432702|Randomized|Parallel Assignment||Treatment||Double|Outcome measurements will be recorded by an examiner, who will not participate in any study procedure, and will be blind to the allocated treatment. This blinded examiner will be trained and calibrated to perform measurements. A dentist who is blinded to the treatment protocol will performe all radiographic measurements.|Single center, prospective, controlled, parallel-armed, randomized clinical trial.|t|||t
1312558|NCT03432689|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1312559|NCT03432676||Single Group Assignment||Treatment||None (Open Label)||||||
1312560|NCT03432663|Randomized|Parallel Assignment||Treatment||Single||60 emergency adult patients who were candidates for drug cardioversion after first symptomatic episodes of Atrial fibrillation to either (1)24 hour continuous infusion or (2)72 hours continuous intravenous Amiodarone or until sinus rhythms was reached.|t|||
1312561|NCT03432650|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312562|NCT03432637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312563|NCT03432624|||Case-Control||Prospective|||||||
1312567|NCT03432572|Randomized|Parallel Assignment||Diagnostic||Triple|The interventions will be blinded to the investigator, the care providers (surgeons), and will be blinded to the patients in the study|This will be a 3 arm randomized controlled double blinded study. The arms will all be studied in parallel to each other and compared in their effectiveness for evaluation for urine jets on cystoscopy.|t|t|t|
1312568|NCT03432559||Single Group Assignment||Diagnostic||None (Open Label)|the investigator doing the transesophageal examination will not be informed about the results of the endoscopy|endoscopy of pharynx, upper esophagus, mid esophagus, cardia, gastric fundus, and gastric body||||
1312569|NCT03432546|||Cohort||Prospective|||||||
1312570|NCT03432533|Randomized|Parallel Assignment||Treatment||None (Open Label)|This is an open-label study; blinding procedures are not applicable.|"After signing the informed consent form (ICF), subjects will undergo the following periods:~Screening period (35 days) to complete eligibility assessments~Open-label treatment period (6 months)~Follow-up period (3 months) During the open-label treatment period, subjects will be randomized to receive romosozumab either via HCP administration with PFS or via self-administration withAI/Pen.~During the follow-up period, subjects will be followed for an additional 3 months to ensure appropriate follow-up for anti-romosozumab antibody formation and adverse events.~The primary analysis will be performed after all subjects have had the opportunity to complete the Month 6 visit. The final analysis will be performed after all subjects have had the opportunity to complete the Month 9 visit."||||
1312571|NCT03432520|||Cohort||Prospective|||||||
1312572|NCT03432507|||Cohort||Cross-Sectional|||||||
1312573|NCT03432494||Single Group Assignment||Treatment||None (Open Label)||||||
1312574|NCT03432481||Single Group Assignment||Treatment||None (Open Label)||Single group||||
1312575|NCT03432468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312576|NCT03432455|||Cohort||Other|||||||
1312577|NCT03432442|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1312578|NCT03432429|||Case-Only||Prospective|||||||
1312579|NCT03432416|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1312580|NCT03432403|||Case-Control||Prospective|||||||
1312581|NCT03432390|Randomized|Parallel Assignment||Prevention||Single|||t|||
1312582|NCT03432377|||Cohort||Prospective|||||||
1312583|NCT03432364||Single Group Assignment||Treatment||None (Open Label)||||||
1312584|NCT03432351|||Cohort||Prospective|||||||
1312585|NCT03432338|||Case-Control||Cross-Sectional|||||||
1312586|NCT03432325||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1312587|NCT03432312|Randomized|Crossover Assignment||Other||Single||||||t
1312588|NCT03432299||Single Group Assignment||Treatment||None (Open Label)||||||
1312589|NCT03432286|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312590|NCT03432273|Randomized|Crossover Assignment||Other||Single||||||t
1312591|NCT03432260||Sequential Assignment||Treatment||None (Open Label)||||||
1312592|NCT03432247|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312593|NCT03432234|||Cohort||Prospective|||||||
1312594|NCT03432221|||Case-Only||Prospective|||||||
1312595|NCT03432208|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1312596|NCT03432195|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312597|NCT03432182||Single Group Assignment||Other||None (Open Label)||||||
1312598|NCT03432169|Randomized|Parallel Assignment||Other||Single|Will code data entered into database.|Group A receives Yoga (stretching with mindfulness) and Group B receives stretching (stretching without mindfulness)||||t
1312599|NCT03432156|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Experimental group: immunotherapy. subjects who are treated with autologous Tcm cells immunotherapy.~No intervention group: subjects who are treated without autologous Tcm cells immunotherapy."||||
1312600|NCT03432143|Randomized|Parallel Assignment||Other||None (Open Label)||24 community members will receive training and mentoring in reviewing manuscripts. The trial will involve 568 manuscripts that will be randomly assigned to two groups using a random number generator.||||
1312601|NCT03432130|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1312602|NCT03432117|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The subjets were randomized(1:1:1) to 3 group(A: Fixed respiratory rehabilitation program group, B: Mixed respiratory rehabilitation program group( Fixed respiratory rehabilitation for 6 weeks, and then responsive respiratory rehabilitation for 6 weeks) and C: Control group(Ordinary rehabilitation service of the site).||||
1312603|NCT03432104|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1312604|NCT03432091|||Other||Prospective|||||||
1312605|NCT03432078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312606|NCT03432065||Single Group Assignment||Treatment||None (Open Label)||||||
1312607|NCT03432052|||Case-Only||Retrospective|||||||
1312608|NCT03432039|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1312609|NCT03432026|||Case-Only||Prospective|||||||
1312610|NCT03432013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312611|NCT03432000|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"This study consists in:~evaluate the links (correlation) between perception of temporal sequencing and perception of causality using an adapted experimental paradigm (Michotte paradigm) and to compare performance between healthy subjects and controls~investigate the existence of a correlation between these alterations and the peculiarities of the subjective experience of time (EAWE scale) in the group of subjects with schizophrenia~The measures that will be realized are:~Performances of patients and controls on temporal task~Subjective alterations of time perception in patients with an adapted scale (EAWE)~Global symptomatology with PANSS (positive and negative symptom scale)"||||
1312612|NCT03431987|||Other||Other|||||||
1312613|NCT03431974|Randomized|Parallel Assignment||Treatment||Quadruple|Over-encapsulated||t|t|t|t
1312614|NCT03431961|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1312615|NCT03431948|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be enrolled in parallel based on physician preference and slot availability.||||
1312616|NCT03431935|||Cohort||Prospective|||||||
1312618|NCT03431909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312619|NCT03431896|||Cohort||Prospective|||||||
1312620|NCT03431883||||||||||||
1312621|NCT03431870||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312622|NCT03431857|||Cohort||Other|||||||
1312623|NCT03431844|||Cohort||Prospective|||||||
1312624|NCT03431831|Randomized|Parallel Assignment||Treatment||Double|Statistician will make random assignment envelopes, clerical staff will collect intake forms and make envelope assignments according to randomization schedule. Participants will see different providers based on trial arm assigned to.|||t|t|
1312625|NCT03431818|||Case-Crossover||Prospective|||||||
1312626|NCT03431805|Randomized|Parallel Assignment||Prevention||Double|Double blind||t||t|
1312627|NCT03431792||Single Group Assignment||Treatment||None (Open Label)||Treatment of fetuses with severe CDH with an observed / expected total fetal lung volume ratio (o/e TFLV) ratio < 25% or with o/e TFLV ratio < 35% combined with herniation of the liver in thorax using the intrauterine fetoscopic tracheal occlusion (FETO) with the long tail latex balloon of 2.5 ml.||||
1312628|NCT03431779|Randomized|Parallel Assignment||Treatment||None (Open Label)||However, subjects in the lipofilling group will be able to undergo surgery (excision) 3 months after the lipofilling of this intervention did not have the requested effect.||||
1312629|NCT03431766|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1312630|NCT03431753||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312631|NCT03431740|||Other||Prospective|||||||
1312632|NCT03431727|||Cohort||Prospective|||||||
1312633|NCT03431714||Single Group Assignment||Treatment||None (Open Label)||The first group of 88 children were recruited first and given dihydroartemisinin- piperaquine, once the sample size was attained, the second group for artesunate amodiaquine followed and the follow-up for the two groups were running concurrently||||
1312634|NCT03431701|Randomized|Parallel Assignment||Other||Single|||t|||
1312635|NCT03431688|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312636|NCT03431675|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312637|NCT03431662|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1312638|NCT03431649|Randomized|Parallel Assignment||Treatment||Double|the researchers don't know which drug taken by the patient and don't know the previous PA pressure||t|||t
1312639|NCT03431636|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312640|NCT03431623|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, double-blind, multi-center, phase 3 clinical trial|t|t|t|t
1312641|NCT03431610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312642|NCT03431597|Randomized|Parallel Assignment||Treatment||None (Open Label)||3-arm randomized controlled trial, unblinded, with 125 women per arm.||||
1312643|NCT03431584|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312644|NCT03431571||Single Group Assignment||Treatment||None (Open Label)||||||
1312645|NCT03431558|Randomized|Parallel Assignment||Prevention||Quadruple|"Randomization will be carried out by Data management unit and all investigators /dispensers and participants will be masked to the randomization.~Clinical Trial Unit (CTU) of the Aga khan university will dispense the randomized supplemnt/placebo"|"Group 1: bLF (150 mg) will be administered after 48 hours of age with a single daily dose mixed with milk (preferentially breast milk otherwise premature formula milk).~Group 2: bLF will be administered (300mg) after 48 hours of life with a single daily dose mixed with milk (preferentially breast milk otherwise premature formula milk).~Group 3: Placebo will be administered after 48 hours of life (Placebo will be physically identical to the bLF mixed with breast milk or premature formula milk)."|t|t|t|t
1312646|NCT03431545|Randomized|Parallel Assignment||Prevention||Single||||||t
1312647|NCT03431532|||Cohort||Other|||||||
1312648|NCT03431519|||Other||Retrospective|||||||
1312649|NCT03431506|Randomized|Single Group Assignment||Treatment||Double||||t||t
1312650|NCT03431493|Randomized|Parallel Assignment||Treatment||Single||||||t
1312651|NCT03431480||Single Group Assignment||Treatment||None (Open Label)||Safety||||
1312652|NCT03431467|Randomized|Parallel Assignment||Treatment||Single|All data will be masked as far as possible. For example, Echo data will be masked|Randomised controlled trial at three U Penn Sites||||t
1312653|NCT03431454|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1312654|NCT03431441||Single Group Assignment||Treatment||None (Open Label)|Due to visible print differences, subjects and investigators will be aware of the patterns/variants of the investigational product. However, subjects will be masked to the lens brand to prevent bias during the lens discussions.|||||
1312655|NCT03431428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312656|NCT03431415|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312657|NCT03431402|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1312658|NCT03431389|Randomized|Parallel Assignment||Treatment||None (Open Label)||Tracheostomy done to all patients by open surgical technique and was done in ICUs without need to transfer to theatre. The patients were followed up daily until discharge from ICU. The following items were recorded: Duration of application of tracheostomy tube before decannulation (cannulation time), complications of tracheostomy, mortality due to tracheostomy.||||
1312659|NCT03431376|||Cohort||Prospective|||||||
1312660|NCT03431363|||Cohort||Prospective|||||||
1312661|NCT03431350|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1312698|NCT03430869|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1312699|NCT03430856|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label Trial|Study is conducted in two parts. Part I has 3 arms and Part 2 has 2 arms.||||
1312700|NCT03430843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312701|NCT03430830|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312702|NCT03430817|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1312703|NCT03430804|||Cohort||Prospective|||||||
1312788|NCT03429699|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1312830|NCT03429153|||Cohort||Retrospective|||||||
1313429|NCT03421327|||Cohort||Retrospective|||||||
1312662|NCT03431337|Randomized|Parallel Assignment||Treatment||Quadruple|Unlabeled bottles of study medications, identified only by participant #, prepared by the pharmacist member of research team. The placebo will be similar in appearance to plain amoxicillin. The pills inside the bottle will be difficult to see until the bottle is opened by the patient.|"Ill adult patients coming to a primary care office will be diagnosed by the treating physicians with acute bacterial sinusitis in accordance with the guidelines of the Infectious Disease Society of America.~If they do not meet exclusion criteria, they will be offered enrollment in the study.~If they agree, they will be provided unlabeled study medication, either amoxicillin/clavulante 875/125 + placebo pills bid x 7 days (standard dose) or amoxicillin/clavulanate 875/125 + amoxicillin immediate-release 875 (high dose).~Outcomes will be assessed, by telephone or over the web (through Qualtrics), at 3 and 10 days after enrollment."|t|t|t|t
1312663|NCT03431324|Randomized|Factorial Assignment||Basic Science||Single|Participants will be blind to the hypothesis of the study and to the condition to which they are assigned. They will be informed of both of these details during a debriefing provided by the researcher upon the conclusion of data collection.|"Stage 1 will employ a between-subjects experimental design to establish the effectiveness of the mating-EFT intervention and compare its effectiveness to that of the established general-EFT intervention (Chiou & Wu, 2017) and a yoked control condition. This study will determine whether the effectiveness of these interventions is moderated by individual differences in relationship status, fundamental social motives (including mate-seeking motivation), self-efficacy, and nicotine dependence.~Stage 2 will employ a quasi-experimental design in which participants who are either currently involved in a committed romantic relationship or single will be randomly assigned to complete either a mating-centric EFT intervention, a general-EFT intervention, or a control activity that involves no intervention."|t|||
1312664|NCT03431311||Single Group Assignment||Treatment||None (Open Label)||||||
1312665|NCT03431298|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312666|NCT03431285|Randomized|Parallel Assignment||Treatment||Triple|Triple-blind study. The study solution will be prepared in identical 100-ml Normal Saline bags by the research nurse||t|t||t
1312667|NCT03431272||Single Group Assignment||Treatment||None (Open Label)||||||
1312668|NCT03431259|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1312669|NCT03431246||Single Group Assignment||Prevention||None (Open Label)||Single group exploratory study||||
1312670|NCT03431233|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1312671|NCT03431220||Single Group Assignment||Treatment||None (Open Label)||||||
1312672|NCT03431207|||Case-Control||Prospective|||||||
1312673|NCT03431194|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1312674|NCT03431181|Randomized|Parallel Assignment||Other||Single|||t|||
1312675|NCT03431168|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1312676|NCT03431155|Randomized|Parallel Assignment||Other||Single|"Masking will be done by data collectors and statisticians.~Data will be collected by the assistant investigator who does not know anything about participants of experiment and control group.~Data will be recorded on the computer by the assistant investigator without specifying the experiment and control group.~The experimental and control groups will be codified by the co-investigator.~The analysis of the data encoded by the groups will be done by a statistical expert. Data collectors, statistical analyzes and report writing will be blinded."|||||t
1312677|NCT03431142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312678|NCT03431129|||Case-Control||Prospective|||||||
1312679|NCT03431116|||Cohort||Prospective|||||||
1312680|NCT03431103||Single Group Assignment||Treatment||None (Open Label)||||||
1312681|NCT03431090||Single Group Assignment||Treatment||None (Open Label)||The mobilized peripheral blood cell collection (apheresis product) will be processed using a Miltenyi CliniMACS device according to the manufacturing instructions. The processing will deplete the αβTCR+ cells and CD19+ cells from the apheresis product to formulate the graft.||||
1312682|NCT03431077||Single Group Assignment||Treatment||None (Open Label)||||||
1312683|NCT03431064|||Cohort||Prospective|||||||
1312684|NCT03431051|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312685|NCT03431038|||Case-Only||Prospective|||||||
1312686|NCT03431025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312687|NCT03431012|Randomized|Factorial Assignment||Prevention||Single|Participants were blinded to group assignment.|This study was a vignette-based randomised controlled trial, with a 2 (human vs virus agency assignment) x 2 (negative vs positive frame of antivirals side effects) between-participants factorial design. All participants were presented with a hypothetical pandemic flu scenario describing moderate health consequences (i.e. about 1 in 1000 infected people dying). The scenario: 1) in the initial scenario participants were told to imagine that their GP (although not confirming whether it was a pandemic case) had advised them to take antivirals as a precaution; 2) after measuring baseline intentions, participants were introduced to the second part of the scenario where they were asked to imagine being at their local pharmacy where a pharmacist provided them with some health messages and information about the antivirals. Participants were randomised to one of the four health messages described below. After reading the health messages their intentions to use antivirals were re-measured.|t|||
1312688|NCT03430999|Randomized|Sequential Assignment||Treatment||Double|Double-blind||t||t|
1312689|NCT03430986|Randomized|Parallel Assignment||Treatment||Single||||||t
1312690|NCT03430973|Randomized|Factorial Assignment||Basic Science||None (Open Label)||Seven driving simulation experiments on aggressive driving and road rage (see descriptions above).||||
1312691|NCT03430960|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1312692|NCT03430947||Single Group Assignment||Treatment||None (Open Label)||||||
1312693|NCT03430934||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1312694|NCT03430921||Single Group Assignment||Treatment||None (Open Label)||||||
1312695|NCT03430908|||Cohort||Prospective|||||||
1312696|NCT03430895||Single Group Assignment||Treatment||None (Open Label)||This is a single-arm, phase II study with a Simon minimax design testing the combination of durvalumab and tremelimumab in patients with non-TCC of the urothelial tract.||||
1312697|NCT03430882||Single Group Assignment||Treatment||None (Open Label)||||||
1573402|NCT00001365||||Treatment||||||||
1312704|NCT03430791|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is an open-label, phase II trial with two parallel arms, two-stage design and appropriate stopping rules for poor efficacy. Arm A will enroll participants without prior PD1/PDL1 checkpoint inhibitor, while Arm B will enroll participants with prior PD1/PDL1 checkpoint inhibitor. The investigator expect to enroll at least 30 (15 in each Arm) and a maximum of 60 (30 in each Arm) evaluable subjects. All subjects will receive TTFields therapy plus nivolumab infusions for a maximum of 24 months, plus/minus concurrent ipilimumab for a maximum of 4 doses.||||
1312705|NCT03430778|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1312706|NCT03430765|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Controlled Trial||||
1312707|NCT03430752|||Cohort||Cross-Sectional|||||||
1312708|NCT03430739|||Cohort||Prospective|||||||
1312709|NCT03430726||Single Group Assignment||Other||None (Open Label)||All eligible participants will be assigned to receive the commercially available yogurt drink containing a multi-strain probiotic, Bio-Kidz® (12.5 billion CFU/98g; Lactobacillus acidophilus CL1285®, Lactobacillus casei LBC80R® and Lactobacillus rhamnosus CLR2®), daily for 14 days.||||
1312710|NCT03430713||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312711|NCT03430700||Single Group Assignment||Treatment||None (Open Label)||All patients will receive treatment||||
1312712|NCT03430687||Single Group Assignment||Treatment||None (Open Label)||||||
1312713|NCT03430674||Single Group Assignment||Treatment||None (Open Label)||||||
1312714|NCT03430661|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1312715|NCT03430648|||Cohort||Prospective|||||||
1312716|NCT03430635|||Cohort||Retrospective|||||||
1312717|NCT03430622|Randomized|Parallel Assignment||Treatment||Single|Researchers doing outcome assessment will be kept blind to the group allocations|||||t
1312718|NCT03430609|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label randomized clinical trial to be conducted at Lauro Wanderley University Hospital, at Federal University of Paraiba, from September 2017 to August 2020. Eighty-four patients will be randomly allocated to three groups according to the hemostatic technique used during laparoscopic surgery for ovarian endometrioma: bipolar coagulation, laparoscopic suture and hemostatic matrix. Ovarian function will be assessed by measuring serum anti-Mullerian hormone and follicle-stimulating hormone levels and by ultrasound antral follicle counts before surgery and 1, 3 and 6 months after surgery.||||
1312719|NCT03430596|Randomized|Parallel Assignment||Treatment||Single||||||t
1312720|NCT03430583|||Cohort||Prospective|||||||
1312721|NCT03430570|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomized to complete a computerized intervention or a wait list control.||||
1312722|NCT03430557|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312723|NCT03430544|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312724|NCT03430531||Single Group Assignment||Treatment||None (Open Label)||Open-label, single arm, pilot study||||
1312725|NCT03430518||Single Group Assignment||Treatment||None (Open Label)||||||
1312726|NCT03430505|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1312727|NCT03430492|||Case-Only||Prospective|||||||
1312728|NCT03430479|Non-Randomized|Single Group Assignment||Treatment||Double|||t|t||
1312729|NCT03430466|Non-Randomized|Single Group Assignment||Treatment||Double|||t|t||
1312730|NCT03430453||Single Group Assignment||Supportive Care||None (Open Label)||||||
1312731|NCT03430440|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1312732|NCT03430427|||Cohort||Prospective|||||||
1312733|NCT03430414|||Other||Retrospective|||||||
1312734|NCT03430401|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1312735|NCT03430388|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312736|NCT03430375|Randomized|Crossover Assignment||Supportive Care||None (Open Label)|Participants, care providers if present, and investigators who are the outcomes assessors will all be aware of which cushion that the participant is sitting on, the participants' diagnoses or if healthy, the static and active conditions described above, and outcome measures results; therefore, no masking is taking place.|Each of 3 populations or groups (healthy adults, participants post-stroke, participants with spinal cord injury) will sit on two wheelchair cushions (alternating air cushion, static air cushion) under two conditions including static sitting (#1 static condition) and while performing upper extremity reaching (#2 active condition) while monitoring interface pressure between the cushion and buttock/posterior thighs.||||
1312737|NCT03430362|Randomized|Parallel Assignment||Treatment||Quadruple||Group A will receive injection Hyoscine butyl bromide 20 mg first dose at the time of amniotomy, and second dose 2 hours after. Group B, will receive normal saline same volume first dose at the time of amniotomy, and second dose 2 hours after|t|t|t|t
1312738|NCT03430349|Randomized|Sequential Assignment||Prevention||Triple|"the study will be conducted with each candidate vaccine sequentially. After randomization of the first subject of Group 1 the next 14 subjects will all be enrolled in the same Group and receive the same nOPV2 candidate and the next 15 subjects will be enrolled in the other Group and receive the corresponding nOPV2 candidate. Prior to the start of the study the CRO will provide the site with 2 randomization envelopes for the first subject. By randomly choosing 1 of the envelopes first subject will be dedicated to a certain nOPV2 candidate and this will determine the allocation of the next 14 subjects to the same Group.~Study staff will be blinded in the same way and will be blinded for individual shedding results of the participants of a Group until end of containment of this Group."||t|t|t|
1312739|NCT03430336|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Due to the character of the intervention, a blinding is not possible.|||||
1312740|NCT03430323|||Case-Only||Cross-Sectional|||||||
1312741|NCT03430310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312742|NCT03430297|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312743|NCT03430284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312785|NCT03429738|Randomized|Crossover Assignment||Treatment||None (Open Label)||open-label, single-dose, randomized, two-period, two-treatment, twosequence, crossover, comparative bioavailability study.||||
1312786|NCT03429725|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1573403|NCT00001363||||||||||||
1312744|NCT03430271|Randomized|Parallel Assignment||Treatment||Single|The study assessor will be blinded to the treatment assignment. The study investigators and interventionists will not be blinded.|The ENGAGE Somerville Study is designed as a single blind, randomized-controlled, parallel-group pilot study. This study plans to enroll up to 50 participants to be randomized into the PA or health aging intervention.||||t
1312745|NCT03430258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312746|NCT03430245||Single Group Assignment||Treatment||None (Open Label)||||||
1312747|NCT03430232|Randomized|Parallel Assignment||Treatment||Quadruple||For part I: crossover model For part II: parallel model|t|t|t|t
1312748|NCT03430219|||Case-Only||Prospective|||||||
1312749|NCT03430206|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients are randomized at time of enrollment to either the control or intervention arms.||||
1312750|NCT03430193|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312751|NCT03430180|Randomized|Parallel Assignment||Treatment||Triple|Double Blind|"Treatment Group A: Naloxone hydrochloride 40mg/ml nasal spray Naloxone hydrochloride will be dosed at 4mg / dose (one spray of 0.1ml of the 40mg/ml formulation into one nostril) up to four times daily as needed in response to gambling urges with at least 2 hours between each dose (within 24 hours from 6am each day) for 12 weeks.~One spray of naloxone hydrochloride 40mg/ml nasal spray contains 4 mg naloxone hydrochloride in a formulation of benzalkonium chloride, sodium edetate, sodium chloride, hydrochloric acid and purified water.~Treatment Group B: Placebo nasal spray One spray of 0.1ml of the placebo formulation in one nostril up to four times daily as needed in response to gambling urges with at least 2 hours between each dose (within 24 hours from 6am each day) for 12 weeks.~One spray of placebo nasal spray contains benzalkonium chloride, sodium edetate, sodium chloride, hydrochloric acid and purified water"|t||t|t
1312752|NCT03430167|Randomized|Parallel Assignment||Treatment||Single|post operative assessor obtaining range of motion and performing physical exam will be blinded to participant's group.|||||t
1312753|NCT03430154|||Ecologic or Community||Cross-Sectional|||||||
1312754|NCT03430141||Single Group Assignment||Prevention||None (Open Label)||Hybrid effectiveness-implementation||||
1312755|NCT03430128|Randomized|Parallel Assignment||Supportive Care||Quadruple|The investigators and the clinical team which manages the patient, will be blinded.||t|t|t|t
1312756|NCT03430115|||Cohort||Retrospective|||||||
1312757|NCT03430102|||Cohort||Prospective|||||||
1312758|NCT03430089|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Phase I-like, open-label, descriptive, monocenter study, which includes 5 groups of participants of varying ages and doses||||
1312759|NCT03430076|Randomized|Parallel Assignment||Other||Single|||t|||
1312760|NCT03430063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312761|NCT03430050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312762|NCT03430037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312763|NCT03430024|||Other||Prospective|||||||
1312764|NCT03430011||Single Group Assignment||Treatment||None (Open Label)||||||
1312765|NCT03429998|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Non-controlled intervention study to evaluate the different therapies in the treatment of hypercholesterolemia, in which each patient will be self-controlled. The variables will be analyzed during different phases~Phase LDL apheresis:~evolocumab phase~Combined phase"||||
1312766|NCT03429985|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1312767|NCT03429972|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312768|NCT03429959|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1312769|NCT03429946|Randomized|Crossover Assignment||Basic Science||Triple|Investigator performing the clamp studies is only aware of the type of clamp - euglycemic versus hypoglycemic - but not aware of placebo versus spironolactone.|Participants complete all 3 arms of the study in random order.|t||t|t
1312770|NCT03429933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312771|NCT03429920|Randomized|Crossover Assignment||Prevention||Double|Both the participants and the investigators will not be aware of which powder is the active powder and which one is the placebo. Only the Principle Investigator will be made aware.|This dietary intervention trial is a randomized, 2x2 crossover design with 24 subjects in free-living conditions.There will be a two week run-in (acclimation period), after which subjects will be randomized to receive either Q CAN powder or placebo powder for 12 weeks. Following a two week wash out period, subjects will be switched over to the alternate treatment.|t||t|
1312772|NCT03429907|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312773|NCT03429894|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"All patients will have the baseline stent implantation with intravascular ultrasound.~Two imaging sub studies will be conducted:~Sub-set 1- angiographic and IVUS follow up at 6 months. Sub-set 2-angiographic, IVUS and clinical follow up at 9 months"||||
1312774|NCT03429881|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1312775|NCT03429868||Single Group Assignment||Other||None (Open Label)||||||
1312776|NCT03429855|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized controlled||||
1312777|NCT03429842|||Cohort||Prospective|||||||
1312778|NCT03429829|Non-Randomized|Parallel Assignment||Prevention||Single||Class A and B of the reception grade and grade 1 of two schools will be selected for the treatment group and class C and D into the control group.||||t
1312779|NCT03429816||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312780|NCT03429803|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312781|NCT03429790|Randomized|Parallel Assignment||Treatment||Single||||||t
1312782|NCT03429777|Non-Randomized|Parallel Assignment||Screening||Single||For this study the investigators will test at least 50 subjects with some form or hearing loss and 50 control subjects between the ages of 18-80. The subjects will be invited to take the app. The approach for this study is to characterize hearing-in-noise thresholds (also referred to as a speech-reception threshold) as measured by the app in both subject groups.||||t
1312783|NCT03429764|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1312784|NCT03429751|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1312787|NCT03429712||Single Group Assignment||Other||None (Open Label)||||||
1312789|NCT03429686||Single Group Assignment||Treatment||None (Open Label)||A single group pre-post intervention feasibility study with process evaluation. Data will be collected from residents and staff in Jordanian care homes through questionnaires, from care home records, and qualitative interviews.||||
1312790|NCT03429673|||Cohort||Retrospective|||||||
1312791|NCT03429660|||Cohort||Prospective|||||||
1312792|NCT03429647||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312793|NCT03429634|Randomized|Sequential Assignment||Treatment||Double|||t|||t
1312794|NCT03429621|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1312795|NCT03429608|||Case-Only||Prospective|||||||
1312796|NCT03429595|Randomized|Parallel Assignment||Treatment||Double||Subjects will be randomly assigned (stratified by age) by using an Interactive Web Response System (IWRS) to one of five treatment groups|t||t|
1312797|NCT03429582|Randomized|Parallel Assignment||Treatment||Single||||||t
1312798|NCT03429569|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|||||
1312799|NCT03429556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312800|NCT03429543|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312801|NCT03429530|||Case-Control||Cross-Sectional|||||||
1312802|NCT03429517|||Case-Control||Prospective|||||||
1312803|NCT03429504|||Case-Control||Retrospective|||||||
1312804|NCT03429491|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1312805|NCT03429478|Randomized|Parallel Assignment||Basic Science||Triple|The Participants will be randomized to be part of the study groups. The Care providers will not be aware of the grouping of the participants as the intervention is done in the pre-operative holding area. All patients will undergo Laparoscopic Cholecystectomy under standard operative and anesthesia protocol. The Investigator (Nurse and the doctor staff) will also be unaware of the grouping of the patients. The recorded data will be analyzed by an individual outcome asser unaware of the grouping or identity of the patient.|50 patients meeting the inclusion criteria will be included in the study after written and informed consent. They will be randomized and divided into 2 groups. Group 1 will be labelled as intervention group (recieving pre-operative music intervention), The group 2 will be labelled as controlled group (Not receiving pre-operative music intervention). Clinico-biochemical, Bio-cellular & Neurohumoral data evaluation will be done in both the groups.The results will be analyzed using standard SPSS software.||t|t|t
1312806|NCT03429465||Single Group Assignment||Prevention||None (Open Label)||||||
1312807|NCT03429452|||Ecologic or Community||Prospective|||||||
1312808|NCT03429439|Randomized|Parallel Assignment||Treatment||None (Open Label)||an open label, parallel study||||
1312809|NCT03429426|||Cohort||Prospective|||||||
1312810|NCT03429413|Randomized|Parallel Assignment||Health Services Research||Single|The statistical team is blinded to the clinic assignment.|Clinics are randomly assigned to use the intervention app or not. A 5th clinic, will use the app, but has not been involved in the app development.||||t
1312811|NCT03429400||Single Group Assignment||Treatment||None (Open Label)||||||
1312812|NCT03429387|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Participants will be randomized to either the PET/CT arm or the conventional CT arm||||
1312813|NCT03429374|Randomized|Parallel Assignment||Treatment||Single||"Patients are randomly allocated to group 1 or group 2:~Group 1: Mesh fixation with tacks.~Group 2: Mesh fixation with glue."|t|||
1312814|NCT03429361|||Cohort||Prospective|||||||
1312815|NCT03429348|Randomized|Parallel Assignment||Other||None (Open Label)||Working with Scottsdale Fire Department firefighers during training fire exercises, Dr. Jeff Burgess and his study team will compare a chemical commonly excreted in firefighter urine samples after firefighting to assess the value of adding sauna to rehab post-fire. Firefighter heart rate and temperature will be monitored using a core body temperature/heart rate monitor data recorder. Urine will be collected for 12 hours immediately before the scheduled training fire and for 12 hours afterwards. After the fire, the firefighter will perform the standard rehab. During this time, the UA study team will randomly select half of the firefighters to an additional sauna rehab and the other half of the firefighters to no additional rehab. Dermal (skin) wipe samples will be taken off the calf, arm, and neck before the fire, before standard rehab, and after sauna/no additional treatment. A post-fire survey will be administered.||||
1312816|NCT03429335|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients will be randomized individually in permuted blocks with randomly varying sizes of 2 and 4, and allocation ratio 1:1 for intervention and control groups.||||
1312817|NCT03429322|Randomized|Parallel Assignment||Treatment||None (Open Label)||Community-based randomized pragmatic clinical trial of a complex behavioral intervention delivered remotely||||
1312818|NCT03429309||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312819|NCT03429296|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Zelen : patients will be randomized according to the Zelen randomization design (as described in Zelen M. Randomized consent designs for clinical trials: An update. Stats in Med. 1990;9:645-656)"||||
1312820|NCT03429283|||Other||Retrospective|||||||
1312821|NCT03429270||Single Group Assignment||Diagnostic||None (Open Label)||||||
1312822|NCT03429257|||Cohort||Prospective|||||||
1312823|NCT03429244||Single Group Assignment||Diagnostic||None (Open Label)|Two separate Radiologists (one from Nuclear Medicine and one from MRI) will do the imaging reads in a blinded fashion.|68Ga-PSMA-11 PET will be performed and we will study how the knowledge of the results helps inform treatment decisions.||||
1312824|NCT03429231|||Cohort||Prospective|||||||
1312825|NCT03429218||Single Group Assignment||Treatment||None (Open Label)||||||
1312826|NCT03429205|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312827|NCT03429192|||Cohort||Retrospective|||||||
1312828|NCT03429179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312829|NCT03429166|Randomized|Parallel Assignment||Health Services Research||Single||The current study proposes a blending of design components of clinical effectiveness and implementation research for the purposes increasing translational gains and providing useful information to inform future implementation that would otherwise not be available or take much longer to obtain. This Hybrid Type 1 design combines a randomized clinical effectiveness trial with a mixed-method, multi-stakeholder process evaluation of the delivery of the intervention.||||t
1312831|NCT03429140|Randomized|Parallel Assignment||Treatment||Double|Once it has been determined that a subject meets the entry requirements of the study they will be randomized, like the flipping of coin into one of two treatment groups. Neither the subject nor the investigator will be told which of the two treatments that the subject is assigned to. However, the investigator can find out in the case of emergency. Treatment assignment will be released to the subject after they have completed all study visits.||t||t|
1312832|NCT03429127|||Case-Control||Prospective|||||||
1312833|NCT03429114|||Case-Control||Cross-Sectional|||||||
1312834|NCT03429101||Single Group Assignment||Treatment||None (Open Label)||"Part 1: Dose Finding To determine the MTD/MAD of poziotinib in combination with the standard dose of T-DM1 by using a 3+3 design. At least 3 patients may be enrolled in each cohort before a decision is made to proceed to the next cohort.~Part 2: MTD/MAD Expansion An additional 10 patients will be treated at the dose identified during Part 1 of the study to further evaluate the safety and efficacy."||||
1312835|NCT03429088|Randomized|Parallel Assignment||Other||Single||||||t
1312836|NCT03429075|Randomized|Parallel Assignment||Treatment||Single|||||t|
1312837|NCT03429062|||Cohort||Prospective|||||||
1312838|NCT03429049|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312839|NCT03429036|||Other||Other|||||||
1312840|NCT03429023|||Cohort||Prospective|||||||
1312841|NCT03429010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312842|NCT03428997||||||||||||
1312843|NCT03428984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312844|NCT03428971|||Cohort||Retrospective|||||||
1312845|NCT03428958|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"This is a 2-part study of NUC-3373 administered every 2 weeks as an IV infusion, in separate combinations with folinic acid (leucovorin, LV), oxaliplatin, oxaliplatin + bevacizumab, oxaliplatin + panitumumab and irinotecan, and irinotecan + cetuximab.~A minimum of 12 patients will be enrolled in Part 1 (LV cohorts only) and a minimum of 6 patients per cohort will be enrolled in Part 2. Additional patients may be enrolled in Part 1 or 2 to replace patients who withdraw prior to completing the 28-day safety evaluation in cycle 1 in order to complete a minimum of 12 patients in Part 1 and 6 patients per cohort in Part 2. If the DSMC determines that an increased number of patients are required to evaluate alternate doses within a cohort, enrolment in a cohort may be expanded. The maximum enrolment in Part 1 is estimated to be 18 patients. The maximum enrolment in each cohort in Part 2 is estimated to be approximately 12 patients."||||
1312846|NCT03428945|Randomized|Parallel Assignment||Prevention||Double|Active drug and placebo will be identical in appearance and packaging|Treatment assignment (active drug: placebo) will be assigned in a parallel, randomized, 2:1 model. Assignment will be stratified based on prior treatment for T1D prevention and age.|t||t|
1312847|NCT03428932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312848|NCT03428919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312849|NCT03428906|Randomized|Crossover Assignment||Basic Science||Double||The study utilized a randomized, double-blind, PBO controlled, within-subject design, in which each participant was tested under two acute treatment conditions separated by at least 1 wk wash-out period.|t||t|
1312850|NCT03428893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312851|NCT03428880|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1312852|NCT03428867|||Cohort||Prospective|||||||
1312853|NCT03428854|||Cohort||Prospective|||||||
1312854|NCT03428841|||Case-Control||Prospective|||||||
1312855|NCT03428828|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312856|NCT03428815|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1312857|NCT03428802||Single Group Assignment||Treatment||None (Open Label)||||||
1312858|NCT03428789|||Cohort||Prospective|||||||
1312859|NCT03428776|Randomized|Parallel Assignment||Health Services Research||Double||Single blinded prospective study|||t|t
1312860|NCT03428763|Randomized|Parallel Assignment||Supportive Care||Single||The current trial is designed to assess whether the effectiveness of home-based disease activity monitoring via a home-based (eHealth) intervention is superior to standard clinical disease activity assessment in obtaining and maintaining a low(er) disease activity in patients with RA.||||t
1312861|NCT03428750|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1312862|NCT03428737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312863|NCT03428724|Randomized|Parallel Assignment||Treatment||Double|single-blind||||t|t
1312864|NCT03428711|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1312865|NCT03428698|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312866|NCT03428685|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1312867|NCT03428672|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1312868|NCT03428659|||Case-Only||Prospective|||||||
1312869|NCT03428646|||Case-Only||Prospective|||||||
1312870|NCT03428633|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1312871|NCT03428620|Randomized|Parallel Assignment||Treatment||Single||||||t
1312872|NCT03428607||Single Group Assignment||Treatment||None (Open Label)||||||
1312873|NCT03428594|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, double-blind, multi-center, phase 3 clinical trial|t|t|t|t
1312874|NCT03428581|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312875|NCT03428568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312876|NCT03428555|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Participants are not blinded.|Intervention Arm (n=30 over 17 months at, CAMH): The intervention is an integrated care pathway and Comparison Arm- Treatment As Usual (n=30 over 17 months at SHSC):||||
1312877|NCT03428542|Randomized|Parallel Assignment||Prevention||None (Open Label)||Parallel-group RCT with three arms during 5 weeks. Subjects were randomized to a control group, the Yin Yoga intervention group or the YOMI intervention group. YOMI intervention combines Yin yoga with psychoeducation and mindfulness practice.||||
1312878|NCT03428529|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 randomization||||
1312879|NCT03428516|Randomized|Parallel Assignment||Other||Double|||t||t|
1312880|NCT03428503|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1312881|NCT03428490|Randomized|Parallel Assignment||Treatment||Single||Eligible participants will be randomized to the Fully Integrated Treatment (FIT; N =30) or usual care in the Matrix Institute IOP (UC; N = 30).||||t
1312882|NCT03428477|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1312883|NCT03428464|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1312884|NCT03428451|Randomized|Parallel Assignment||Prevention||Single|||t|||
1312885|NCT03428438|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Subjects recruited will be randomized into two groups: one group of subjects (the study group) A physical reminder by a physiotherapist, and a daily reminder of physical exercise by SMS on weekdays A through E. The second group (the control group) will be given a routine training in the ward by a nurse and you will receive a weekly SMS message||||
1312886|NCT03428425||Single Group Assignment||Treatment||None (Open Label)||||||
1312887|NCT03428412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1312888|NCT03428399|||Cohort||Prospective|||||||
1312889|NCT03428386||Single Group Assignment||Treatment||None (Open Label)||||||
1312890|NCT03428373|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1312891|NCT03428360||Single Group Assignment||Treatment||None (Open Label)||The study population will be male or female pediatric, adolescent and adult subjects with a clinical diagnosis of epilepsy and with bouts of increased seizure activity, Acute Repetitive Seizures (ARS), frequent breakthrough seizures, seizure clusters or cluster seizures.Subjects self-administer the study drug doses or with the caregiver's assistance if applicable to treat seizures, in response to the occurrence of the same characteristic events as they previously would with their usual rescue medication, e.g. Diastat® AcuDial™ or usual rescue therapy.||||
1312892|NCT03428347|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312893|NCT03428334||Single Group Assignment||Treatment||None (Open Label)||||||
1312894|NCT03428321|||Cohort||Retrospective|||||||
1312895|NCT03428308||Single Group Assignment||Screening||None (Open Label)||Patients who meet the inclusion criteria will be identified and invited to participate by their general practitioner. Patients who agree to partcipate will be invited to a screening consultation focusing on selected somatic diseases. Patients who are diagnosed with one or more of the selected somatic diseases will be included in the intervention, which consists of individualized courses of treatment focusing on initiation and maintenance of medical treatment and complying with current clinical guidelines and course programmes. The intervention is planned to run for one year.||||
1312896|NCT03428295||Single Group Assignment||Treatment||None (Open Label)||Experimental: Single Cohort in CRC This study is a single-arm, multi-center, observational clinical trial being conducted in a Clinical Research Center (CRC) setting. Intervention: Device: Dose Safety Artificial Pancreas (AP) System||||
1312897|NCT03428282|Randomized|Parallel Assignment||Treatment||Single|||t|||
1312898|NCT03428269|Randomized|Parallel Assignment||Other||None (Open Label)||Parallel assignment, not blinded, randomized study||||
1312899|NCT03428256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312900|NCT03428243|||Case-Only||Retrospective|||||||
1312901|NCT03428230|Randomized|Parallel Assignment||Supportive Care||Triple|The study will be double-blind. Neither the Investigator/co-investigators/study nurses involved in the clinical study procedures, nor will the patients be aware of the administered treatment. At the site, syringes for injection will then be prepared by a person not involved in any other study-related activities where a bias is possible.|Eligible patients will be randomised into four treatment groups (15 patients/group) to receive either one of the three single doses of Paracetamol 3% (30 mg, 60 mg, 90 mg) or placebo solution (1 mL, 2 mL, 3 mL) according to the randomised, parallel-group design.|t||t|t
1312902|NCT03428217|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind in place with blinded Independent Radiology Committee reviewing adjudicated progression free survival of patients|This is a double blinded placebo-controlled study where patients will be randomized 1:1 to either CB-839 plus cabozantinib or placebo plus cabozantinib|t|t|t|t
1312903|NCT03428204|Randomized|Parallel Assignment||Treatment||None (Open Label)||The effect of two balloon inflation times will be evaluated in peripheral balloon angioplasty||||
1312904|NCT03428191|||Case-Only||Prospective|||||||
1312905|NCT03428178||Single Group Assignment||Treatment||None (Open Label)||10 patients of Leber Hereditary Optic Neuropathy (LHON) onset within 3 months,10 between 3 to 6 months,10 between 6 to 12 months,10 between 12 to 24 months,and 10 over 24 months.||||
1312906|NCT03428165|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1312907|NCT03428152|||Cohort||Prospective|||||||
1312908|NCT03428139|Randomized|Parallel Assignment||Treatment||Single||||||t
1312909|NCT03428126||Single Group Assignment||Treatment||None (Open Label)||||||
1312910|NCT03428113|||Case-Only||Other|||||||
1312911|NCT03428100|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312912|NCT03428087|||Cohort||Cross-Sectional|||||||
1312913|NCT03428074|||Case-Control||Retrospective|||||||
1312914|NCT03428061|||Cohort||Prospective|||||||
1312915|NCT03428048|||Cohort||Prospective|||||||
1312916|NCT03428035|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1312917|NCT03428022||Single Group Assignment||Treatment||None (Open Label)||||||
1312918|NCT03428009|||Cohort||Prospective|||||||
1312919|NCT03427996|||Cohort||Prospective|||||||
1312920|NCT03427983|Randomized|Parallel Assignment||Treatment||Triple||Randomized blinded study looking at two different ways of drug administration rather than the drug itself. We will compare ultrasound guided injection with hydrodissection to ultrasound guided injection without hydrodissection. In both groups, the active drug is the same in type and amount.|t||t|t
1312921|NCT03427970|Randomized|Parallel Assignment||Treatment||Single||||||t
1312922|NCT03427957|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded to the type of grasper used to perform hysteroscopic endometrial biopsy.|Randomized controlled trial|t|||
1312923|NCT03427944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312924|NCT03427931||Single Group Assignment||Other||None (Open Label)||||||
1573404|NCT00001346||||||||||||
1312925|NCT03427918|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1312926|NCT03427905|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1312927|NCT03427892||Single Group Assignment||Treatment||None (Open Label)||||||
1312928|NCT03427879|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1312929|NCT03427866|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312930|NCT03427853|Randomized|Parallel Assignment||Treatment||Double|double-blind,|randomized, double-blind, parallel-group, placebo-controlled, single-dose escalation|t||t|
1312931|NCT03427840|||Cohort||Prospective|||||||
1312932|NCT03427827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312933|NCT03427814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1312934|NCT03427801|||Case-Control||Retrospective|||||||
1312935|NCT03427788|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1312936|NCT03427775|||Cohort||Prospective|||||||
1312937|NCT03427762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312938|NCT03427749|||Cohort||Prospective|||||||
1312939|NCT03427736|||Other||Prospective|||||||
1312940|NCT03427723|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||accuvein versus standard||||
1312941|NCT03427710|Randomized|Parallel Assignment||Treatment||Single||Adaptive design allowing modifications in single and multidose arms|t|||
1312942|NCT03427697|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1312943|NCT03427684||Single Group Assignment||Treatment||None (Open Label)||||||
1312944|NCT03427671||Single Group Assignment||Treatment||None (Open Label)||||||
1312945|NCT03427658|Randomized|Parallel Assignment||Basic Science||Double|Intervention allocation will be undertaken by a researcher not in direct contact with any one participant, following randomization by drawing lots.||||t|t
1312946|NCT03427645|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1312947|NCT03427632|||Cohort||Prospective|||||||
1312948|NCT03427619||Single Group Assignment||Treatment||None (Open Label)||All eligible participants receive the actual drug.||||
1312949|NCT03427606|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1312950|NCT03427593|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1312951|NCT03427580|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1312952|NCT03427567|||Cohort||Retrospective|||||||
1312953|NCT03427554|Randomized|Parallel Assignment||Treatment||Single|||||t|
1312954|NCT03427541|||Cohort||Retrospective|||||||
1312955|NCT03427528|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||We will conduct an uncontrolled pilot study examining acceptability and feasibility of the Fathers and Babies (FAB) curriculum.||||
1312956|NCT03427515|Randomized|Parallel Assignment||Prevention||Triple||Healthy medical students were assigned|t||t|t
1312957|NCT03427502|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1312958|NCT03427489|||Case-Control||Prospective|||||||
1312959|NCT03427476|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1312960|NCT03427463|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded|This study will be conducted as a randomized controlled single-blinded clinical trial with patients being randomized to receive either 0.1 or 0.05 mg of IT morphine.|t|||
1312961|NCT03427450|||Cohort||Prospective|||||||
1312962|NCT03427437|Randomized|Parallel Assignment||Treatment||Single|Double Participant, Outcomes Assessor||t|||
1312963|NCT03427424|||Cohort||Other|||||||
1312964|NCT03427411||Single Group Assignment||Treatment||None (Open Label)||||||
1312965|NCT03427385||Single Group Assignment||Other||None (Open Label)||||||
1312966|NCT03427372|||Cohort||Prospective|||||||
1312967|NCT03427359||Single Group Assignment||Treatment||None (Open Label)||All patients received 3 cycles of induction chemotherapy (cisplatin 80mg/m2, day 1; oral capecitabine 1000mg/m2 twice daily from day1-14, repeated every 3 weeks) followed by concomitant cisplatin (100mg/m2,day1,every 3 weeks) for a total of 2 cycles with radiotherapy.||||
1312968|NCT03427346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312969|NCT03427333||Single Group Assignment||Supportive Care||None (Open Label)||Intervention Model: Single Group Assignment||||
1312970|NCT03427320||Single Group Assignment||Other||None (Open Label)||||||
1312971|NCT03427307|||Case-Crossover||Cross-Sectional|||||||
1312972|NCT03427294|||Cohort||Prospective|||||||
1312973|NCT03427281||Single Group Assignment||Treatment||None (Open Label)|the investigator is blinded for the identity of the participating surgeons in the questionnaire|||||
1312974|NCT03427268||Single Group Assignment||Treatment||None (Open Label)||||||
1312975|NCT03427255|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Trial with a waiting list condition||||
1312976|NCT03427242||Single Group Assignment||Treatment||None (Open Label)||apatinib||||
1312977|NCT03427229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312978|NCT03427216|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1312979|NCT03427203|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1312980|NCT03427190|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1312981|NCT03427177|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1312982|NCT03427164||Single Group Assignment||Prevention||None (Open Label)||||||
1312983|NCT03427151||Single Group Assignment||Treatment||None (Open Label)||open label||||
1312984|NCT03427138|Randomized|Parallel Assignment||Treatment||Single||||||t
1312985|NCT03427125|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1312986|NCT03427112|||Case-Only||Cross-Sectional|||||||
1312987|NCT03427099|Randomized|Sequential Assignment||Treatment||Single|||t|||
1313029|NCT03426553|Non-Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1313030|NCT03426540|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313031|NCT03426527|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1312988|NCT03427086|Randomized|Parallel Assignment||Treatment||Quadruple|The subjects, care givers, investigator, and coordinator will be blinded. The pharmacist, who will be responsible for the drug supply, will be unblinded. The investigational drug and the placebo will have identical pill shape and color. They will be supplied in identical boxes.|Prospective, double blind, placebo control, randomized 2:1 study|t|t|t|t
1312989|NCT03427073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1312990|NCT03427060||Single Group Assignment||Treatment||None (Open Label)||||||
1312991|NCT03427047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312992|NCT03427034|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||all eligible patients will be recruited||||
1312993|NCT03427021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1312994|NCT03427008|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a single center, prospective, randomized control trial with two arms. Participants in the intervention arm will use the mHealth app to manage and track their immunosuppression medical regimen post-transplant, and participants in the control arm will receive the current standard of follow-up care post-transplant.||||
1312995|NCT03426995|Randomized|Crossover Assignment||Treatment||Double|This will be a double blind (sponsor open) study with respect to allocation of GSK3358699 or placebo to subjects. All site staff will be blinded with the exception of un-blinded pharmacists. Investigators will be un-blinded with respect to the LPS and GM-CSF allocation. The food effect part of the study (Part B) will be open-label|Study will be conducted as Part A, B and C. Part A will consist of 2-interlocking cohorts, where each subject will receive maximum 2-single ascending oral doses of GSK3358699 and 1 dose of placebo, in Treatment Periods (TP) 1 to 3. In TP 4 subjects will receive GSK3358699, dose evaluated in TP (1 to 3) or placebo, with cantharidin induced blisters and either LPS or GM-CSF in vivo challenge. Part B will comprise of single cohort taking part in two-way cross over, with open label phase where each subject will receive single oral dose of GSK3358699 (based on Part A), under fed and fasted conditions in each TP. Part C will consist of 3 cohorts with multiple ascending doses, with every cohort having one repeat dose TP with 14 days of daily dosing of either GSK3358699 or placebo. Subjects on Day 14 will receive cantharidin induced blisters with either LPS or GM-CSF in vivo challenge. An optional, cohort 7 may be included for further dose evaluation of GSK3358699 or alternate dosing schedule.|t||t|
1312996|NCT03426982|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"After randomization, the patients must be monitored using either anti-Xa activity or aPTT.~Only that specific test should be prescribed by the ward, and only that the corresponding test result be given by the laboratory."||||
1312997|NCT03426969||Single Group Assignment||Treatment||None (Open Label)||||||
1312998|NCT03426956|Randomized|Crossover Assignment||Basic Science||Single||10 gastric bypass patients|t|||
1312999|NCT03426943|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313000|NCT03426930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313001|NCT03426917|||Other||Retrospective|||||||
1313002|NCT03426904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313003|NCT03426891||Single Group Assignment||Treatment||None (Open Label)||||||
1313004|NCT03426878|Randomized|Parallel Assignment||Screening||Single|The participant will not know if they are receiving traditional or modified genetic counseling.|All participants will receive exome sequencing. The randomization will be into one of two types of genetic counseling - traditional and modified.|t|||
1313005|NCT03426865||Single Group Assignment||Diagnostic||None (Open Label)||FDA approved tracer being assessed in a non-FDA approved disease.||||
1313006|NCT03426852|||Cohort||Prospective|||||||
1313007|NCT03426839|Randomized|Sequential Assignment||Treatment||None (Open Label)||"Patients will be randomly assigned to each of two treatment groups using sealed envelopes:~Patient group 1: haemostasis strategy guided by conventional coagulation tests.~Patient group 2: transfusion algorithm guided by viscoelastic POC tests and algorithms."||||
1313008|NCT03426826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313009|NCT03426813||Single Group Assignment||Treatment||None (Open Label)||||||
1313010|NCT03426800|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1313011|NCT03426787||Single Group Assignment||Supportive Care||None (Open Label)||pre-post within subjects design||||
1313012|NCT03426774|Randomized|Crossover Assignment||Other||None (Open Label)||Evaluation of the effects of GentleJogger and Gentle Jumper on noninvasive biometric data in various postures in two specify age groups a) Younger 25-59 yrs b) Older > 60 yrs Each Subject will serve as his or her own Sham Control||||
1313013|NCT03426761|Randomized|Sequential Assignment||Treatment||None (Open Label)||"Since it's a pilot study, the sample size is fixed (n = 50). The sample size were not selected based on statistical criteria. However, we would need to know what would be the detectable effect size.~∆^2=((z_(α/2)+z_β )^2 (σ_1^2+σ_2^2 ))/n"||||
1313014|NCT03426748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313015|NCT03426735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313016|NCT03426722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313017|NCT03426709|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313018|NCT03426696|||Case-Only||Prospective|||||||
1313019|NCT03426683|Randomized|Parallel Assignment||Treatment||None (Open Label)||an open label, parallel study||||
1313020|NCT03426670|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomization in a 1:1 ratio to either monthly HIVST with quarterly in-clinic testing (intervention) or quarterly in-clinic HIV testing (standard of care).||||
1313021|NCT03426657||Single Group Assignment||Treatment||None (Open Label)|Open Label|Prospective, Open-Label, Non-Randomized||||
1313022|NCT03426644|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313023|NCT03426631|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1313024|NCT03426618|||Case-Only||Prospective|||||||
1313025|NCT03426605||Single Group Assignment||Treatment||None (Open Label)||Open Label, Dose-Escalation||||
1313026|NCT03426592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313027|NCT03426579|||Cohort||Prospective|||||||
1313028|NCT03426566|||Other||Retrospective|||||||
1313587|NCT03419260|||Cohort||Prospective|||||||
1313032|NCT03426514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313033|NCT03426501|||Cohort||Prospective|||||||
1313034|NCT03426488|||Cohort||Prospective|||||||
1313035|NCT03426475|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Blinded study nurses with respect of primary outcome.|||||
1313036|NCT03426462|Non-Randomized|Parallel Assignment||Other||Single|The analysis of the electroencephalogram will be blinded to the age of the participant.|Age groups 1-6 years will be compared with 8-13 years whilst undergoing propofol anesthesia to detect whether there is indeed a difference in the speed of onset of the hypnotic effect of the drug.||||t
1313037|NCT03426449|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313038|NCT03426436||Single Group Assignment||Diagnostic||None (Open Label)|The cardiologist will be blinded to the type of waveform they are analyzing (synthesized versus actual).|||||
1313039|NCT03426423|Randomized|Parallel Assignment||Prevention||Double|"According to the article 18 of the LRH, participants will not be given the full information regarding the main purpose of the study (assess the efficacy of a smoking cessation trial) in order not to influence participants regarding the intervention and also to decrease selection bias (only smokers motivated to quit would take part and thus induce a selection bias). Methodologically, such a blinding to procedure would allow a better assessment of its efficacy. Furthermore, risks associated to the intervention are considered as very low. Participants will be informed a posteriori once they have completed the study or before in case they remove their consent or quit the study.~The outcome assessor will be a research collaborator independent of the study nurse who performed the intervention and blinded to the intervention."||t|||t
1313040|NCT03426410|||Ecologic or Community||Cross-Sectional|||||||
1313041|NCT03426397|||Cohort||Prospective|||||||
1313042|NCT03426384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313043|NCT03426371|Randomized|Parallel Assignment||Treatment||Triple||multicenter, double-blind, randomized, controlled phase III trial|t|t|t|
1313044|NCT03426358||Single Group Assignment||Diagnostic||None (Open Label)||All the patients with onco-hematological disease and an indication for transplantation of hematopoietic stem cells will be consecutively studied.||||
1313045|NCT03426345|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313046|NCT03426332|||Cohort||Prospective|||||||
1313047|NCT03426319|||Cohort||Cross-Sectional|||||||
1313048|NCT03426306||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313049|NCT03426293|||Cohort||Prospective|||||||
1313050|NCT03426280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313051|NCT03426267|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1313052|NCT03426254|Randomized|Parallel Assignment||Treatment||None (Open Label)||The intent of this study was to assess the safety and efficacy of two forms of Talazoparib therapy for the treatment of advanced solid tumors . After an enrollment period, patients will randomized to receive oral Talazoparib (1 mg, one times a day ) or subcutaneously Talazoparib (1 mg subcutaneous injection by pen-syringe / mechanical dispenser) .||||
1313053|NCT03426241|||Case-Control||Cross-Sectional|||||||
1313054|NCT03426228|||Cohort||Prospective|||||||
1313055|NCT03426215|||Case-Only||Prospective|||||||
1313056|NCT03426202|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1313057|NCT03426189|||Cohort||Prospective|||||||
1313058|NCT03426176|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1313059|NCT03426163|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1313060|NCT03426150|Randomized|Crossover Assignment||Prevention||Single|||t|||
1313061|NCT03426137|Randomized|Parallel Assignment||Treatment||Triple|Oxycodone and Placebo will be identical in terms of appearance, taste, and smell so as to keep the investigators, care providers, and participants blind to their treatment allocation. Oxycodone and placebo oral suspensions will be manufactured and dispensed by the pharmacy at University of Maryland Medical Center. All research personnel, aside from the pharmacists and team members responsible for final review and write-up of the study, will be blinded to participants' treatment groups. For participants in the Partial Reduction group (Arm 2), the pharmacy will dispense the study drug such that participants in Arm 2 will receive four doses of Oxycodone (10 mg) followed by one of four repeating schedules of administration alternating between Oxycodone (10 mg) and placebo.|Patients will be randomized to three arms. Arm 1 will be a Full Dose (FD) group, which will receive all NSAIDs will be dosed in accordance with the STC Guidelines for NSAID use and Oxycodone (10mg). Arm 2 will be a Partial Reinforcement (PR) group, which will receive NSAIDs, Oxycodone (10mg), and placebo pills to reach a 50% reduction of the total intake of opioids. Finally, Arm 3 will be a Control (C) group receiving NSAIDs and placebos.|t|t|t|
1313062|NCT03426124|||Cohort||Other|||||||
1313063|NCT03426111|Randomized|Parallel Assignment||Treatment||Double||Multicenter, randomized,controlled and double-blind study with two parallel arms, placebo (normal endoscopy and lifestyle modification) or endoscopic gastric tubulization with OverStitch® system (Apollo Endosurgery, Austin, TX, USA) and lifestyle modification.|t||t|
1313064|NCT03426098||Single Group Assignment||Treatment||None (Open Label)|Blinded-investigator assessments will be performed at Baseline and Days 28, 56, 146, and 180 to evaluate treatment efficacy for facial wrinkling. Of note, the blinded-investigators will be blinded to treatment settings and technique, and number of treatments.|All subjects will receive up to three treatments at four week intervals to their full faces with the Secret RF device.||||
1313065|NCT03426085|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1313066|NCT03426072|Randomized|Parallel Assignment||Health Services Research||Triple|control sites are propensity matched to intervention sites. All sites have comprehensive dataset. Trial status of each home is unknown to assessor and statistician|cluster randomised controlled trail with nursing home unit as the cluster, care aides and residents as the unit of analysis||t|t|t
1313067|NCT03426059|||Cohort||Prospective|||||||
1313068|NCT03426046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313069|NCT03426033|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1313070|NCT03426020|Randomized|Crossover Assignment||Other||Single||Effect of pharmacologic or nonpharmacologic premedication on emergency agitation|t|||
1313071|NCT03426007||Single Group Assignment||Basic Science||None (Open Label)||||||
1313072|NCT03425994|||Cohort||Prospective|||||||
1313073|NCT03425981|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313074|NCT03425968|||Case-Control||Prospective|||||||
1313075|NCT03425955|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313076|NCT03425942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313077|NCT03425929|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1313078|NCT03425916|||Case-Control||Prospective|||||||
1313079|NCT03425903|Randomized|Crossover Assignment||Treatment||None (Open Label)||All participants received WBC sessions and after that become controls||||
1313080|NCT03425890|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will be blinded to which group the participants are in|Randomised Blinded Controlled Pilot Trial||||t
1313081|NCT03425877|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1313082|NCT03425864|Randomized|Parallel Assignment||Treatment||Double|"Double blinded Blinding will be done to the clinical, radiographic assessors, without involving them in sequence generation or allocation concealment or surgery performing.~Blinding of the biostatistian."|Eligible patients will be randomized using sequence generation program (Random.org in equal proportions between control group (immediate implant alone) and study group (immediate implant covered with sub-epithelial connective tissue graft with full coverage technique).|||t|t
1313083|NCT03425851|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313084|NCT03425838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313085|NCT03425825|||Cohort||Retrospective|||||||
1313086|NCT03425812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313087|NCT03425799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313088|NCT03425786|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313089|NCT03425773||Single Group Assignment||Treatment||None (Open Label)||Accelerated titration||||
1313090|NCT03425760|||Cohort||Prospective|||||||
1313091|NCT03425747|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1313092|NCT03425734|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1313093|NCT03425721|||Cohort||Prospective|||||||
1313094|NCT03425708|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313095|NCT03425695|Randomized|Parallel Assignment||Treatment||Triple||Randomized placebo-controlled parallel design|t||t|t
1313096|NCT03425682|||Case-Only||Prospective|||||||
1313097|NCT03425669|Randomized|Crossover Assignment||Treatment||Triple|Participants will be randomized to placebo or stimulant medication during assessments. Participants will be unaware if they will get sham stimulation or SVS (but not the test administrator).|"Patients will be recruited from Child and Adolescent Psychiatry in Lund and Malmö. Typically developing children (TDC) and inattentive children without diagnosis will be recruited from schools.~All participants will perform a double-blind placebo cross over control study. ADHD participants will perform the entire test battery at three occasions with 2-3 weeks intermission in between tests. One occasion with placebo medication and sham SVS stimulation; one occasion with active SVS stimulation; and one occasion with active medication. TD children will only be tested twice and just perform under SVS vs. sham conditions.~Test battery: 1) Episodic memory will be tested trough Auditory Verbal Learning Test (AVLT) (e.g. Dige et al., 2008). 2) Visuo-spatial working memory will be tested through the Spanboard task (Westerberg et al., 2004). 3) Motor-neurological investigation. 4) A finger tapping task. 5) Evaluation of an iPhone auditory noise application in a normal school setting."|t|t||t
1313098|NCT03425656|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313099|NCT03425643|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313100|NCT03425630|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313101|NCT03425617|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1313102|NCT03425604|||Case-Control||Retrospective|||||||
1313103|NCT03425591|||Cohort||Prospective|||||||
1313104|NCT03425578|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1313105|NCT03425565||Single Group Assignment||Treatment||None (Open Label)||||||
1313106|NCT03425552|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1313107|NCT03425539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313108|NCT03425526||Single Group Assignment||Treatment||None (Open Label)||||||
1313109|NCT03425513|||Case-Only||Prospective|||||||
1313110|NCT03425500|Randomized|Parallel Assignment||Treatment||Double||Randomized Control Trial|t|||t
1313111|NCT03425487|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1313112|NCT03425474|Randomized|Parallel Assignment||Other||Single|||t|||
1313113|NCT03425461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313114|NCT03425448|Randomized|Sequential Assignment||Treatment||None (Open Label)||Multi-center, double-blind, randomized controlled trial||||
1313115|NCT03425435|||Cohort||Prospective|||||||
1313116|NCT03425422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313117|NCT03425409|Non-Randomized|Sequential Assignment||Device Feasibility||None (Open Label)||||||
1313118|NCT03425396|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1313119|NCT03425383|||Other||Cross-Sectional|||||||
1313161|NCT03424837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313162|NCT03424824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313163|NCT03424811|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1313164|NCT03424798|||Case-Only||Prospective|||||||
1313165|NCT03424785|||Cohort||Retrospective|||||||
1313166|NCT03424772|||Family-Based||Prospective|||||||
1313167|NCT03424759||Single Group Assignment||Treatment||None (Open Label)||||||
1313168|NCT03424746||Single Group Assignment||Prevention||None (Open Label)||||||
1313169|NCT03424733|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||Patients in both arms first take Tylenol and then take Tylenol in combination with Prednisone.||||
1313170|NCT03424720||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313171|NCT03424707|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1573405|NCT00001344||||Treatment||||||||
1313120|NCT03425370|Randomized|Parallel Assignment||Other||Single|The efficacy of intervention methods will be assessed at the 3 month and 6 month follow-ups by having the patient and two blinded observers rate the healing progression of the wound using the POSAS. The observers will be either dermatology faculty or dermatology. The POSAS is a standard metric in measuring wound healing in cutaneous surgery studies since it does not require training but takes into account the scar assessment of the patient and observers. Subsequently, the height and width of the scar will be measured and compared to the surrounding unaffected skin. The assessments of the two blind observers will be averaged.|"Wounds halves will be labeled as A (left/superior) or B (right/inferior), the halves will be randomized to receive either tissue glue or deep sutures. The nurse will refer to the randomization list and inform the surgeon which side of the wound will receive tissue glue and which side will receive deep sutures. Following common practice of wound labeling, side A will always be left or superior from the surgeon's perspective, whereas side B will always be right or inferior from the surgeon's perspective.~Per randomization, half of the wound will be closed with deep absorbable sutures followed by superficial non-absorbable sutures. The other half of the wound will be closed with superficial non-absorbable sutures followed by tissue glue (Dermabond). Tissue glue will be spread to cover an area extending one cm from the wound margin on both sides."||||t
1313121|NCT03425357||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313122|NCT03425344||Single Group Assignment||Diagnostic||None (Open Label)||A case-control study without intervention||||
1313123|NCT03425331||Single Group Assignment||Treatment||None (Open Label)||||||
1313124|NCT03425318||Single Group Assignment||Supportive Care||None (Open Label)||||||
1313125|NCT03425305|||Cohort||Prospective|||||||
1313126|NCT03425292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313127|NCT03425279||Single Group Assignment||Treatment||None (Open Label)||||||
1313128|NCT03425266|Randomized|Parallel Assignment||Health Services Research||Double|Participants are not aware of whether they are in the treatment or control group. Providers are not informed which group a patient is in, however, because the intervention generates a summary page that the patient may choose to send to their provider, the provider would be aware of a patients' group assignment if they shared the summary with the provider.|Participants are randomly assigned to either the new intervention (PainApp) or a website designed for people with chronic pain before an upcoming appointment with their provider.|t|t||
1313129|NCT03425253||Single Group Assignment||Treatment||None (Open Label)||||||
1313130|NCT03425240||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1313131|NCT03425227||Single Group Assignment||Treatment||None (Open Label)||"Screening was arranged for 65 subjects in total in accordance with the following criteria.~Of the 65 individuals who showed interest in taking part in the study, 46 met the inclusion criteria, and these subjects were again asked to carry out some specific tests in order to evidence their degree of frailty.~Frailty screening was undertaken using the short physical performance battery (SPPB).~Of the 46 subjects, 40 obtained scores below 10, i.e. 40 subjects may be considered frail.~In addition to the Barthel scale, the 40 subjects filled in the following questionnaire: EuroQol 5D-5L™. Medical records related to risk of heart failure were also gathered.~To undertake randomisation, these 40 subjects were classified according to range of age, gender and Barthel score, obtaining a study group and a control group of subjects respectively."||||
1313132|NCT03425214|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1313133|NCT03425201||Single Group Assignment||Other||None (Open Label)||Open-label, multicenter, phase I/II dose-escalation study||||
1313134|NCT03425188|||Cohort||Prospective|||||||
1313135|NCT03425175|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Open label|Non-randomised intervenion||||
1313136|NCT03425162|Randomized|Parallel Assignment||Treatment||Double||prospective,randomized,single blind|t|||t
1313137|NCT03425149|Randomized|Parallel Assignment||Prevention||Triple|only dedicated site staff responsible for handling including preparation and administration of the vaccine will be unblinded||t||t|t
1313138|NCT03425136|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||A three-wave stepped-wedge (phased-in) cluster randomized trial, with districts as the unit of randomization (and outcomes assessed at the clinic/individual level within each district)||||
1313139|NCT03425123||Single Group Assignment||Treatment||None (Open Label)||||||
1313140|NCT03425110|||Cohort||Prospective|||||||
1313141|NCT03425097|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1313142|NCT03425084||Single Group Assignment||Other||None (Open Label)||||||
1313143|NCT03425071|||Case-Only||Cross-Sectional|||||||
1313144|NCT03425058|||Cohort||Prospective|||||||
1313145|NCT03425045|Randomized|Parallel Assignment||Treatment||Double|The study subjects and outcomes assessors will be masked, the investigator will know which treatment is being provided for which patient.|The study is designed as interventional, blinded, randomized, controlled trial with three parallel arms|t|||t
1313146|NCT03425032|||Cohort||Prospective|||||||
1313147|NCT03425019||Single Group Assignment||Treatment||None (Open Label)||||||
1313148|NCT03425006||Single Group Assignment||Treatment||None (Open Label)||||||
1313149|NCT03424993|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1313150|NCT03424980|||Cohort||Retrospective|||||||
1313151|NCT03424967||Single Group Assignment||Treatment||None (Open Label)||||||
1313152|NCT03424954||Single Group Assignment||Prevention||None (Open Label)||All patients undergoing ileostomy surgery will receive the study intervention. We will compare to a historical control.||||
1313153|NCT03424941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313154|NCT03424928|Randomized|Crossover Assignment||Treatment||None (Open Label)||two-way crossover||||
1313155|NCT03424915|||Cohort||Prospective|||||||
1313156|NCT03424902|||Case-Only||Cross-Sectional|||||||
1313157|NCT03424889|Randomized|Parallel Assignment||Health Services Research||Quadruple|Concealed envelopes|Randomized, double blind, placebo controlled|t|t|t|t
1313158|NCT03424876|||Cohort||Retrospective|||||||
1313159|NCT03424863|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1313160|NCT03424850||Single Group Assignment||Treatment||None (Open Label)||||||
1314312|NCT03409809|Randomized|Parallel Assignment||Other||Double|||t|t||
1313172|NCT03424694|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Radiation: HDR brachytherapy monotherapy (1 vs 2 fractions on single implant)~Brachytherapy in this study consists of treatment with a single interstitial HDR brachytherapy procedures with temporary interstitial catheters. The number of temporary interstitial catheters will be based on the size and shape of the prostate (at least 16 catheters will be implanted).~In one arm patient will received a single fraction of 19.5 Gray (Gy), in the other arm patient will received 29 Gy/ 2 fractions of 14.5 Gy separated by 6 hours on a single implant.~Implant will be done with transperineal insertion of interstitial catheters under sterile conditions guided by transrectal ultrasounds.~Optimization of treatment plan will be done with Oncentra (Elekta) based on MRI imaging done post-implant."||||
1313173|NCT03424681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313174|NCT03424668|||Cohort||Prospective|||||||
1313175|NCT03424655|Randomized|Factorial Assignment||Treatment||Double|Certified endodontists trained in the procedures, devices, and systems investigated took part in the research. All experts tracked a pre-established procedure for the Balanced Force technique, Twisted File Adaptive, WaveOne, and Reciproc instrument systems.|teeth selected for conventional RCT for prosthetic reasons detected with only vital pulps. Of the sample of 224 teeth, 56 were selected to the 4 instrumentation methods. For hand instrumentation, Balanced Force were used. All canals were clean and shaped with hand Flex-R files (fMoyco/Union Broach, York PA, USA). For mechanical shaping, all instruments were used with a micro motor (VDW, Munich Germany). Twisted files adaptive, WaveOne and Reciproc instruments. Final irrigation with cold (6oC) 17% EDTA served as a lubricant.|t||t|
1313176|NCT03424642|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1313177|NCT03424629|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313178|NCT03424616|Randomized|Parallel Assignment||Treatment||Quadruple||Stagger-on design|t|t|t|t
1313179|NCT03424603||Single Group Assignment||Treatment||None (Open Label)||||||
1313180|NCT03424590|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1313181|NCT03424577||Single Group Assignment||Basic Science||None (Open Label)||||||
1313182|NCT03424564|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1313183|NCT03424551||Single Group Assignment||Basic Science||None (Open Label)||Effects of vibration on presynaptic inhibition in patients wiht spastic spinal cord injury and healthy controls||||
1313184|NCT03424538|Randomized|Parallel Assignment||Treatment||Single||The single-arm, 5-week intervention is monitor every day on the effect of postural control on walking performance, balance and quality of life. The intervention team (n = 15) takes 25 training sessions for 5 weeks. Every move takes 60 minutes to continuously increase the load intensity of the X-box program. Before each intervention started, the patients perform a 10 minute warm-up and the drainage exercises are 15 minutes stretching exercises. The MStp group (n=14) participated in a 5-week physiotherapy course. The general treatment consisted of strengthening, stretching and walking correction. During the 5-week period, 25 patients attended training. One treatment takes 60 minutes. The control group (n = 14) did not receive physiotherapeutic treatment outside the medication.|||t|
1313185|NCT03424525|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1313186|NCT03424512||Single Group Assignment||Treatment||None (Open Label)||||||
1313187|NCT03424499|Randomized|Parallel Assignment||Treatment||Single|Blinding process to participants and care providers was impossible due to the nature of intervention therapy. Data were analyzed by an impartial statistician (outcomes assessor), referring to each arm with an encoded name: Group A (sterile single-use catheter) and Group B (Reused catheter).|Subjects will be randomized into 2 parallel groups: Group 1 will be assigned to use a single-use polyvinylchloride (PVC) catheter for Intermittent bladder catheterization for neurogenic bladder. Group 2 will use a reused PVC catheter. Both groups will have a follow-up of 8 weeks. Subjects will be randomized into block sizes of 6 using a computer generated list. Both groups will be instructed to use sterile water-soluble lubricant in each catheterization. In the reused catheter group, PVC catheter is washed with water and soap, and stored in a container with 0.5% benzalkonium chloride. Each catheter is programmed to last a week. Patients and parents are going to be instructed to use clean technique by hand washing with water and soup, and penis/vulva cleansing with antiseptic wipes. Urine cultures will be taken on day 0, 7, 14, 28, 42 and 56, collecting urine samples from a fresh midstream catheter specimen, and evaluation of symptoms related to urinary tract infections.||||t
1313188|NCT03424486|||Other||Cross-Sectional|||||||
1313189|NCT03424473||||||||||||
1313190|NCT03424460|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"Two populations:~Population n°1: prospective, with 3 arms~Population n°2: retrospective, with 2 arms"||||
1313191|NCT03424447|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||Ambispective cohort study||||
1313192|NCT03424434|||Other||Cross-Sectional|||||||
1313193|NCT03424421||Single Group Assignment||Treatment||None (Open Label)||pilot study||||
1313194|NCT03424408||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313195|NCT03424395||Single Group Assignment||Other||None (Open Label)||Single arm (open-label) containing three periods: (1) run-in (control), (2) personalized advice/counseling and meals, (3) personalized advice/counseling only.||||
1313196|NCT03424382|||Cohort||Prospective|||||||
1313197|NCT03424369|||Cohort||Prospective|||||||
1313198|NCT03424356|Randomized|Crossover Assignment||Screening||Double|||t|||t
1313199|NCT03424343|||Cohort||Prospective|||||||
1313200|NCT03424330|Randomized|Crossover Assignment||Other||None (Open Label)||"The study will employ a randomized, controlled crossover study design.~The study comprises two stages:~Stage 1: ReX-C Intervention in which subjects will use ReX-C to receive medication.~Stage 2: Control, in which Treatment as Usual (TAU). All subjects enrolled for the study will participate in both stages in a randomized crossover mode."||||
1313201|NCT03424317|Randomized|Parallel Assignment||Treatment||Single||single blind, randomized|t|||
1313202|NCT03424304||Single Group Assignment||Other||None (Open Label)||||||
1313203|NCT03424291||Single Group Assignment||Treatment||None (Open Label)||||||
1313204|NCT03424278|Randomized|Parallel Assignment||Treatment||Single|An assessor who don't now in which groups the participants has been allocated.|Parallel randomized controlled trial.||||t
1313205|NCT03424265|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1573406|NCT00001342||||||||||||
1313206|NCT03424252|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313207|NCT03424239||Single Group Assignment||Prevention||None (Open Label)||All of the participants will receive zoledronic acid, as well as supplementation with calcium and vitamin D.||||
1313208|NCT03424226|Randomized|Parallel Assignment||Prevention||Quadruple|Visually identical pills|Double blind randomized controlled trial|t|t|t|t
1313209|NCT03424213|||Cohort||Retrospective|||||||
1313210|NCT03424200|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1313211|NCT03424187|Randomized|Crossover Assignment||Prevention||Single|||t|||
1313212|NCT03424174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313213|NCT03424161||Single Group Assignment||Other||None (Open Label)||||||
1313214|NCT03424148||Single Group Assignment||Other||None (Open Label)||||||
1313215|NCT03424135|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313216|NCT03424122|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313217|NCT03424109|||Cohort||Retrospective|||||||
1313218|NCT03424083|||Cohort||Prospective|||||||
1313219|NCT03424070|Randomized|Crossover Assignment||Other||Single|The evaluator who measures the height between the lateral canthus of the eye of the anesthesiologist to the table top will be blinded to the presence of a shoulder roll. The evaluator who will review the final photos of the laryngeal inlet will be blinded to the order of the positioning.|All children will undergo laryngoscopy with and without a shoulder roll (randomly assigned) during which photos will be taken of the larynx. The views will be compared using the POGO scale. Contemporaneously, the anesthesiologist's height from the table top to the lateral canthus of left eye.||||t
1313220|NCT03424057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313221|NCT03424044|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313222|NCT03424031|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1313223|NCT03424018||Single Group Assignment||Treatment||None (Open Label)||||||
1313224|NCT03424005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313225|NCT03423992||Single Group Assignment||Treatment||None (Open Label)||||||
1313226|NCT03423979||Single Group Assignment||Treatment||None (Open Label)||treatment group - treated with Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter||||
1313227|NCT03423966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313228|NCT03423953|||Cohort||Prospective|||||||
1313229|NCT03423940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313230|NCT03423927|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants who agree to participate in the intervention are assigned in the experimental group, whereas participants who do not agree to participate in the intervention, but agree to answer the questionnaires, are assigned in the control group||||
1313231|NCT03423914|Randomized|Parallel Assignment||Supportive Care||Double|random allocation of the mother to the control or intervention group|Mixed study, where the quantitative and qualitative. From the quantitative is an experimental study type controlled clinical trial. From the qualitative it will be interpretive phenomenological|t|t||
1313232|NCT03423901|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1313233|NCT03423888||Single Group Assignment||Supportive Care||None (Open Label)||||||
1313234|NCT03423875|Randomized|Parallel Assignment||Diagnostic||Double|"To prevent outcome assessment bias, research staff will be masked as to the randomization status of participants until after they have completed and recorded gold-standard delirium assessments of delirium using the Confusion Assessment Method .~Similarly, ED physicians will be blinded to the gold standard assessments of delirium made by research assistants as well as the results of the PrEDICT test scores when they make their baseline clinical assessments of delirium. ED Physicians will also remain masked until they have recorded their discharge plan. The intervention focuses on the impact of revealing the result of the PrEDICT game scores on ED physicians' recognition of delirium, so randomization status must be revealed to them."||t|||t
1313235|NCT03423862|||Cohort||Prospective|||||||
1313236|NCT03423849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313237|NCT03423836|||Cohort||Prospective|||||||
1313238|NCT03423823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313239|NCT03423810||Single Group Assignment||Basic Science||None (Open Label)||||||
1313240|NCT03423797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313241|NCT03423784|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313242|NCT03423771|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1313243|NCT03423758|||Cohort||Prospective|||||||
1313244|NCT03423745|||Cohort||Prospective|||||||
1313245|NCT03423732|Randomized|Parallel Assignment||Treatment||Quadruple|"The Data and Safety Monitoring Board (DSMB) will be blinded at project start, but may request unblinding if necessary to accommodate effective review of data.~Other than the DSMB (if necessary), the only other un-blinded parties, meaning that they will have knowledge as to the patient's treatment assignment, will be the PBTiK UJ CM employee who participates in randomization utilizing randomization lists and investigational medication preparation."|"The N-O CLI trial will enroll 105 patients with randomization into active and sham therapy with 2:1 ratio.~Additional 5-10 subjects meeting inclusion/exclusion criteria will receive, in a non-blinded fashion, labelled CardioCell to determine the early uptake and retention of IMP in the target ischemic tissues."|t|t|t|t
1313246|NCT03423719|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1313247|NCT03423706||Single Group Assignment||Treatment||None (Open Label)||||||
1313248|NCT03423693|||Cohort||Retrospective|||||||
1313249|NCT03423680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313250|NCT03423667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313251|NCT03423654|Randomized|Parallel Assignment||Other||None (Open Label)||Spatial Training group and Control group||||
1313252|NCT03423641|||Cohort||Retrospective|||||||
1313301|NCT03423004|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1313302|NCT03422991||Single Group Assignment||Basic Science||None (Open Label)||||||
1573407|NCT00001341||||Treatment||||||||
1313253|NCT03423628||Single Group Assignment||Treatment||None (Open Label)||AZD1390 will be administered to patients in three different Arms (A, B and C), with each arm receiving standard of care radiation therapy (RT) for their disease setting. In each arm, AZD1390 will be administered in three cycles; Cycle 0 (before RT), Cycle 1 (during RT) and Cycle 2 (after RT). Within each arm, AZD1390 will be administered in dose escalating cohorts, first in an intermittent and then in a consecutive fashion, to achieve daily administration prior to RT.||||
1313254|NCT03423615|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||We will use a stepped-wedge cluster controlled model to reflect the pragmatic enrollment and crossover of schools between intervention arms.||||
1313255|NCT03423602||Single Group Assignment||Treatment||None (Open Label)||prospective, multi-centred, non-randomized study||||
1313256|NCT03423589||Single Group Assignment||Other||None (Open Label)||||||
1313257|NCT03423576|Non-Randomized|Parallel Assignment||Health Services Research|||there was no masking of patients or outcome assessors|||||
1313258|NCT03423563|Randomized|Parallel Assignment||Basic Science||None (Open Label)|In this prospective randomized controlled study 60 patients with ASA physical status Ӏ-ӀӀ, aging 20-50 years will be randomly allocated into two groups, 30 patients in each group|In this prospective randomized controlled study 60 patients with ASA physical status Ӏ-ӀӀ, aging 20-50 years will be randomly allocated into two groups, 30 patients in each group||||
1313259|NCT03423550|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1313260|NCT03423537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313261|NCT03423524||Single Group Assignment||Treatment||None (Open Label)||||||
1313262|NCT03423511|Randomized|Parallel Assignment||Treatment||Single|This is a single-blind trial, such that the patient or patient's family will NOT be told which stent they have received.|MiStent group vs. the Xience/Promus group.|t|||
1313263|NCT03423498|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1313264|NCT03423485||Single Group Assignment||Other||None (Open Label)||||||
1313265|NCT03423472|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313266|NCT03423459|||Cohort||Prospective|||||||
1313267|NCT03423446|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313268|NCT03423433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313269|NCT03423420|||Cohort||Retrospective|||||||
1313270|NCT03423407|||Cohort||Prospective|||||||
1313271|NCT03423394|Randomized|Parallel Assignment||Treatment||Single||||||t
1313272|NCT03423381|Randomized|Crossover Assignment||Prevention||Single||Crossover randomised|t|||
1313273|NCT03423368|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313274|NCT03423355|Randomized|Parallel Assignment||Treatment||Triple||Single center, prospective, randomized, double-blind, controlled, parallel group, exploratory study|t||t|t
1313275|NCT03423342|Randomized|Single Group Assignment||Other||Triple|Randomization and dispensing of matching placebo will be performed by Investigational Drug Services at the University of Washington|2:1 randomization to nicotinamide riboside vs. matching placebo|t|t|t|
1313276|NCT03423329|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1313277|NCT03423316|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1313278|NCT03423303|Randomized|Parallel Assignment||Screening||None (Open Label)||Of the approximately 67,000 men aged 50-63 years resident in Helsinki and Tampere, a fourth will be randomised to screening and the rest to control arm (after exclusion of prevalent cases).||||
1313279|NCT03423290|||Cohort||Prospective|||||||
1313280|NCT03423277||Single Group Assignment||Treatment||None (Open Label)||||||
1313281|NCT03423264|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants receiving radiation therapy as part of the OPTIMA II trial (NCT03107182) will be randomized to receive prophylactic gabapentin plus best supportive care versus best supportive care alone.||||
1313282|NCT03423251||||||||||||
1313283|NCT03423238|Randomized|Parallel Assignment||Supportive Care||Double|All assessments will take place by study staff blinded to the participant's treatment assignment. To ensure that staff remain blinded, participants will be asked not to discuss their intervention with the assessor||||t|t
1313284|NCT03423225||Single Group Assignment||Screening||None (Open Label)||||||
1313285|NCT03423212|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313286|NCT03423199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313287|NCT03423186|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313288|NCT03423173|Randomized|Parallel Assignment||Prevention||Quadruple|A double-blind study.||t|t|t|t
1313289|NCT03423160|||Case-Control||Prospective|||||||
1313290|NCT03423147|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313291|NCT03423134||Single Group Assignment||Basic Science||None (Open Label)||||||
1313292|NCT03423121|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1313293|NCT03423108|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1313294|NCT03423095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313295|NCT03423082||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313296|NCT03423069|Randomized|Parallel Assignment||Treatment||Single||Randomized, single blind clinical trial|t|||
1313297|NCT03423056||Single Group Assignment||Supportive Care||None (Open Label)||"The individualized aerobic training program will be developed according to Karvonem's equation . It will programmed in 3 sessions/week (not in row) during 4 weeks~Each 50-minutes session will be organized in three phases: warm up, central and back to calm. The heart rate target will be prescribed as follows:~Week 1: heart rate target: 50% of maximum heart rate~Week 2: heart rate target: 60% of maximum heart rate~Week 3: heart rate target: 70% of maximum heart rate~Week 4: heart rate target: 60% of maximum heart rate~The aerobic exercise will be carried on a treadmill or in a stationary bicycle, according to the patient's preferences and will be supervised by a physical therapist.~The post intervention aerobic capacity will be measured at week 3 and 4 with the 6-minute walk test."||||
1313298|NCT03423043|||Cohort||Prospective|||||||
1313299|NCT03423030|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1313300|NCT03423017|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313303|NCT03422978|Randomized|Factorial Assignment||Basic Science||Single|Assessor of sedation scores post-procedure will be blinded to group allocation.|||||t
1313304|NCT03422965|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1313305|NCT03422952|||Cohort||Prospective|||||||
1313306|NCT03422939|||Case-Only||Other|||||||
1313307|NCT03422926|Randomized|Parallel Assignment||Prevention||Single|||t|||
1313308|NCT03422913|Randomized|Parallel Assignment||Prevention||Double|Both patients and surgeons are blinded, and anesthesiologist opened the envelope during the operation||t||t|
1313309|NCT03422900|Randomized|Parallel Assignment||Treatment||Double|cover label|Comparison of two formulas of enteral nutrition (diabetes-specific enteral formula (lower glycemic index and presence of soluble and insoluble fiber) compared to an standard formula (isocaloric and isonitrogenated formula without fiber)) in patients without diabetes mellitus admitted due to stroke and with indication of nutritional support by nasogastric tube|t|t||
1313310|NCT03422887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313311|NCT03422874||Single Group Assignment||Treatment||None (Open Label)||||||
1313312|NCT03422861|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1313313|NCT03422848|Randomized|Parallel Assignment||Prevention||None (Open Label)||Parallel-group RCT with two arms during 12 months. Subjects will be randomized to the water-intervention (in total 1.5 L increment daily on the top of habitual intake) and control groups (1:1) by computer-generated block randomization. Both groups will receive general life style advice (general oral and written advice on diet and physical activity).||||
1313314|NCT03422835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313315|NCT03422822|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313316|NCT03422809|||Cohort||Prospective|||||||
1313317|NCT03422796|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1313318|NCT03422783||Single Group Assignment||Diagnostic||None (Open Label)||Prospective Pilot study||||
1313319|NCT03422770|Non-Randomized|Parallel Assignment||Diagnostic||Single|Analysis will be blinded|All participants will undergo 'echo', bloodtests and MRI. Participating patients will in addition undergo electrocardiogram (ECG/Holter ECG) and 6 min walking test.||||t
1313320|NCT03422757|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1313321|NCT03422744||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313322|NCT03422731|||Other||Prospective|||||||
1313323|NCT03422718|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1313324|NCT03422705|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1313325|NCT03422692|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313326|NCT03422679||Single Group Assignment||Treatment||None (Open Label)||||||
1313327|NCT03422666|Randomized|Crossover Assignment||Basic Science||Single|Single-blinded study with participant blinded to treatment|On visits 3 & 4, participants will receive either teduglutide or placebo, in random order, 5 hours after a high-fat drink|t|||
1313328|NCT03422653|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313329|NCT03422640||Single Group Assignment||Treatment||None (Open Label)||This is open label single side study involvement 20 patient treated with Apremilast. Each enrolled patient may be evaluated at by a dermatologist using the Lichen Planopilaris Activity Index and Frontal Fibrosing Alopecia Index. Other measures include physician global assessment, dermatology quality of life and patients analogue score for pruritus. Pt will have visits at Week 0,2,4,8,12,16,20,24||||
1313330|NCT03422627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1313331|NCT03422614|||Case-Control||Prospective|||||||
1313332|NCT03422601|||Cohort||Retrospective|||||||
1313333|NCT03422588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313334|NCT03422575|Randomized|Crossover Assignment||Other||None (Open Label)||This was a bioequivalence study.||||
1313335|NCT03422562|Randomized|Parallel Assignment||Basic Science||Single||Blinded, placebo controlled, randomized clinical trial||||t
1313336|NCT03422549|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313337|NCT03422536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313338|NCT03422523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313339|NCT03422510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313340|NCT03422497|||Cohort||Cross-Sectional|||||||
1313341|NCT03422484|||Other||Prospective|||||||
1313342|NCT03422471||Single Group Assignment||Treatment||None (Open Label)||||||
1313343|NCT03422458|Randomized|Parallel Assignment||Treatment||Single||||||t
1313344|NCT03422445||Single Group Assignment||Treatment||None (Open Label)||||||
1313345|NCT03422432|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313346|NCT03422419|Randomized|Parallel Assignment||Treatment||Single||||||t
1313347|NCT03422406|||Case-Only||Prospective|||||||
1313348|NCT03422393||Single Group Assignment||Treatment||None (Open Label)||||||
1313349|NCT03422380|||Case-Control||Cross-Sectional|||||||
1313350|NCT03422367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313351|NCT03422354|Randomized|Parallel Assignment||Supportive Care||Double|The patients were randomized to two groups using a computer-generated list and kept in a sealed envelope into two groups:|"after approval of the ethical committee (N-73-2017)Which approval date was 12/2/2018 74 patients scheduled for elective hip surgery were included in the study after detailed description and signing a detailed informative consent (figure1). The patients were randomized to two groups using a computer-generated list and kept in a sealed envelope into two groups:~Group P: 37 patients were received single shot L1-L2 paravertebral block before undergoing general anesthesia (GA).~Group G: 37 patients were received GA. The target of the mean blood pressure was to be more than 50mm Hg while the systolic pressure to be between 80 and 100 mm Hg and the diastolic blood pressure targeted to be 50 to 70 mmHg."||t|t|
1313352|NCT03422341|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1313425|NCT03421379|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313426|NCT03421366|||Cohort||Prospective|||||||
1314362|NCT03409159|||Cohort||Retrospective|||||||
1313353|NCT03422328||Single Group Assignment||Treatment||None (Open Label)||"The study is designed as an open-label, single-arm, multicenter trial in which all subjects roll over from a parent study in order to continue their dose of macitentan 10 mg once every day as already received in the parent studies."||||
1313354|NCT03422315||Single Group Assignment||Basic Science||None (Open Label)||||||
1313355|NCT03422302||Single Group Assignment||Treatment||None (Open Label)||||||
1313356|NCT03422289|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||All the patients were given orally Inofolic® (Lo.Li. Pharma, Rome, Italy), containing 2 g myo-inositol and 0.2 mg folic acid twice a day for three months, in order to induce ovulation. Then, non-responder partecipants were administered orally with 2 g myo-inositol plus 50 mg α-lactalbumin, twice a day for three months||||
1313357|NCT03422276|Randomized|Parallel Assignment||Supportive Care||Single|This study uses masked outcome assessment, which means study researchers will make every effort to ensure that staff members who collect outcomes data from both patient and caregiver participants at 3-, 6-, 9- and 12 months are unaware of patient participants' treatment group allocation.|||||t
1313358|NCT03422263|||Case-Control||Prospective|||||||
1313359|NCT03422250|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1313360|NCT03422237|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1313361|NCT03422224|||Case-Control||Prospective|||||||
1313362|NCT03422211|||Cohort||Prospective|||||||
1313363|NCT03422198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313364|NCT03422185|||Other||Cross-Sectional|||||||
1313365|NCT03422172||Single Group Assignment||Treatment||None (Open Label)|This will be an open-label study; hence, there will be no masking.|Eligible subjects will receive oral doses of CAB for 4 weeks followed by IM dosing with CAB LA at Week 5, Week 9, Week 17, Week 25 and Week 33.||||
1313366|NCT03422159|Randomized|Parallel Assignment||Treatment||Triple|Patients will be randomized to receive either vitamin C/hydrocortisone/thiamine or triple placebo using a random number table provided to the dispensing pharmacists. Each patient will be allocated a unique subject ID which will be linked to the randomization sequence. Only the dispensing pharmacists will have a record of the subject ID and randomization sequence.|This is a double-blind placebo controlled study. Only the dispensing pharmacist will be aware of the treatment allocation. Patients will be randomized to receive either vitamin C/hydrocortisone/thiamine or triple placebo using a random number table provided to the dispensing pharmacists. Each patient will be allocated a unique subject ID which will be linked to the randomization sequence. Only the dispensing pharmacists will have a record of the subject ID and randomization sequence.|t|t|t|
1313367|NCT03422146|Randomized|Parallel Assignment||Treatment||Double|"Information concerning the group the patient was randomized into will not be available to the physicians that will see the participants at future appointments and grade their outcomes (masked assessor).~All microbiology readers will be masked to treatment group allocation."|"This study is a single-centre, randomized, outcomes-assessor masked trial with two groups. Patients with chronic blepharitis will be randomized into either the Cliradex® eyelid hygiene or I-Lid 'n Lash® Hygiene group.~There will be 20 participants enrolled in each group. Although both eyes will receive treatment, only the worse eye will be enrolled in the study. In addition to randomizing the participants into treatment group they will also be placed by chance into either the 3 visit or 4 visit group (n=10 per group)."|||t|t
1313368|NCT03422133|||Case-Control||Prospective|||||||
1313369|NCT03422120|||Cohort||Prospective|||||||
1313370|NCT03422107|||Cohort||Prospective|||||||
1313371|NCT03422094|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1313372|NCT03422081|||Cohort||Prospective|||||||
1313373|NCT03422068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313374|NCT03422055||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313375|NCT03422042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313376|NCT03422029||Single Group Assignment||Treatment||None (Open Label)||||||
1313377|NCT03422016|||Case-Control||Cross-Sectional|||||||
1313378|NCT03422003|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313379|NCT03421990|||Cohort||Prospective|||||||
1313380|NCT03421977|||Other||Prospective|||||||
1313381|NCT03421964|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1313382|NCT03421951|||Cohort||Prospective|||||||
1313383|NCT03421938|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313384|NCT03421925|Randomized|Parallel Assignment||Treatment||Single||||||t
1313385|NCT03421912|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Arm A : Use of Cicaplast balm B5 since de first day of iEGFR initiation treatment for 30 days Arm B : Use of Dexeryl cream since de first day of iEGFR initiation treatment for 30 days||||
1313386|NCT03421899|||Other||Prospective|||||||
1313387|NCT03421886|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313388|NCT03421873|||Cohort||Prospective|||||||
1313389|NCT03421860|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1313390|NCT03421847|||Case-Control||Other|||||||
1313391|NCT03421834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313392|NCT03421821|Randomized|Parallel Assignment||Treatment||Triple||"The investigators random divided subjects into two groups, the subfascial injection groupand the extrafascial injection group. Two groups were injected 0.33% ropivacaine 30 ml to the target location."|t|t||t
1313393|NCT03421808|Randomized|Parallel Assignment||Treatment||Quadruple|All subjects will get EEGS and TMS, but in one group the TMS pulses are synchronized to the EEG, and in the other not. There is no way for the subject or treater or anyone to detect who is in which arm.|In a double blind, randomized (1:1) trial enrolling only at MUSC over three years in 60 treatment resistant depressed patients, we hypothesize that daily prefrontal rTMS over 4-6 weeks with the initial TMS pulse of each train synchronized to the subject's alpha phase (SYNC TMS), will result in improvement in depression, and that these improvements will be greater than the improvements seen using the same form of treatment but not with the initial pulse synchronized (NON-SYNC TMS).|t|t|t|t
1313427|NCT03421353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313428|NCT03421340|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313394|NCT03421795|Randomized|Parallel Assignment||Other||None (Open Label)|"Organizations will not be made explicitly aware of whether they have been allocated as part of the control or experimental conditions. Organizations will be told, however, that if they are not assigned to the experimental group, they will be given the option to also have an additional training about pain in children with DD at the end of the study. They will also know about the topics of both training programs and the purpose of the study. Participants will only be told that the purpose of the study is to learn about the impact that training programs can have on respite workers' knowledge about caring for children with DD. However, given some of the information in the consent form (e.g., study title is Let's Talk about Pain), it is likely that the treatment condition is clear to participants."|This is a multi-centre clustered parallel RCT with an intervention group (pain training) and control group (control training about family centered care, with an option to receive pain training after follow-up).||||
1313395|NCT03421782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313396|NCT03421769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313397|NCT03421756||Single Group Assignment||Treatment||None (Open Label)||||||
1313398|NCT03421743|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, non-controlled, multicenter, pilot clinical trial||||
1313399|NCT03421730|Randomized|Sequential Assignment||Treatment||None (Open Label)|This is an open label trial.|"This is an open label, randomized, balanced, incomplete block design trial. Eligible subjects will be randomized to 1 of 12 treatment sequences (A,B), (A,C), (A,D), (B,A), (B,C), (B,D), (C,A), (C,B), (C,D), (D,A), (D,B) or (D,C), corresponding to the following treatment regimens:~(A) 5 four-second inhalations of VR647 Inhalation Suspension delivered by the VR647 Inhalation System~(B) 10 four-second inhalations of VR647 Inhalation Suspension delivered by the VR647 Inhalation System~(C) 20 four-second inhalations of VR647 Inhalation Suspension delivered by the VR647 Inhalation System~(D) 1 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer nebulized to empty~The treatment period comprises 2 dosing visits. Each subject will receive their first treatment regimen during Visit 2 and their second treatment regimen during Visit 3."||||
1313400|NCT03421717|Randomized|Parallel Assignment||Treatment||Double|Maintenance treatment (test/control) was performed after the investigator left the room. Investigator did not have access to the registration forms where information regarding assignment (test/control) was noted|6 month after surgical intervention, the population is randomly assigned to two parallel groups, receiving one of two maintenance programs - use of titanium curettes or chitosan brushes. Randomization was performed by pulling notes test/control.|||t|t
1313401|NCT03421704|||Cohort||Prospective|||||||
1313402|NCT03421691||Single Group Assignment||Other||None (Open Label)||||||
1313403|NCT03421678|||Case-Control||Cross-Sectional|||||||
1313404|NCT03421665|||Case-Only||Prospective|||||||
1313405|NCT03421652||Single Group Assignment||Treatment||None (Open Label)||||||
1313406|NCT03421639|Randomized|Parallel Assignment||Treatment||Quadruple|Patients will take similar kind medications by an indipendent person|Randomized controlled trial in two arms study (75 each one)|t|t|t|t
1313407|NCT03421626|||Case-Only||Cross-Sectional|||||||
1313408|NCT03421613|Randomized|Crossover Assignment||Treatment||Double|Subjects will be randomized to receive either treatment wih 3VM1001 cream or the comparator daily for 10 days followed by 5 day wash out period before 10 days of treatment with the comparator or investigational treatment, .|Double-blind, Placebo-controlled, Crossover study to evaluate treatment and tolerability of the experimental product for treatment of post herpetic pain.|t|t||
1313409|NCT03421600|Randomized|Parallel Assignment||Screening||Single|||t|||
1313410|NCT03421587|||Case-Control||Cross-Sectional|||||||
1313411|NCT03421574||Single Group Assignment||Treatment||None (Open Label)||||||
1313412|NCT03421561|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313413|NCT03421548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313414|NCT03421535|Randomized|Single Group Assignment||Treatment||Triple|Each player was randomly assigned to either a sleeper stretch group or an opposite SI joint stretch group. The investigators were blinded to the treatment groups.|All 23 players of a minor league baseball team voluntarily participated in the study.|t||t|t
1313415|NCT03421522|Randomized|Parallel Assignment||Prevention||Single|Eligible participants will be randomized to one of two treatment groups: 1) ICBN preservation, or 2) usual surgical technique (ICBN sacrifice). Due to the nature of the intervention, it will not be feasible to blind the treating surgeons or the study personnel. The patients, data analysts, and those interpreting the study results will be blinded to treatment allocation.To ensure concealed allocation, eligible patients will be randomized using the randomization function within the REDCap Cloud electronic data capture system. Treatment allocation will be stratified by clinical site to account for systematic differences in surgeons and peri-operative care. To avoid crossover between treatment allocation, randomization will take place in the operating room after the surgeon has confirmed that the participant is a candidate for ICBN preservation.|For participants randomized to the ICBN preserving technique, surgeons will perform axillary dissection in which the second ICBN, just inferior to the axillary vein, will be preserved|t|||
1313416|NCT03421509|||Case-Only||Cross-Sectional|||||||
1313417|NCT03421496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313418|NCT03421483|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1313419|NCT03421457|Randomized|Parallel Assignment||Treatment||Double|Care provider will be blind to the operation type. Outcomes will be assessed by a gynecologist who will be blind to the operation type, indications and complications. Assessor has wide experience in urogynecological sonography.|||t||t
1313420|NCT03421444|||Cohort||Prospective|||||||
1313421|NCT03421431|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1313422|NCT03421418|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313423|NCT03421405||Single Group Assignment||Device Feasibility||None (Open Label)||All participants will be asked to attend 4 separate experimental sessions over the course of approximately 4 weeks (i.e. one session/week). During each session, participants will listen to three different auditory stimulus sequences including sounds and words while EEG activity is recorded. There will be 5-minute break between each audio sequence. Each experimental session will take approximately 30-45 minutes to complete.||||
1313424|NCT03421392|||Cohort||Prospective|||||||
1573408|NCT00001338||||Treatment||||||||
1313430|NCT03421314|Randomized|Parallel Assignment||Supportive Care||Triple|Triple||t|t|t|
1313431|NCT03421301|Randomized|Parallel Assignment||Treatment||Double|"PD and placebo interventions were packaged identically in appearance, both the researcher and the participant did not know what type of maneuver was assigned. The envelopes were distributed by a person outside the study who was the same who performed the randomization.~Study staff and participants were blinded during the assignment and execution of interventions in the study. The packages given to the participants were 2 per day, the placebo packages were matched in grams, calories, color, appearance, flavor to the PD."|In the first stage, the participants with type 2 diabetes consumed a reduced-energy diet tailored to provide a 500-kcal/d deficit as recommended by NIH (8) the with respect to their habitual diet for 15 days. In the second stage the participants continued to consume the reduced energy diet with the addition of a combination of functional foods (dietary portfolio; DP). The DP provided 200 kcal that were subtracted from the diet. The DP consisted of a mi The kcal, appearance and flavor were similar in DP and P. The DP and P was given in a package in dehydrated form ready to be dissolved in water. The DP was divided into two packages, the first package contained 17.3 g of DP or P given in the breakfast and dissolved in 250 ml and the second package was given at the dinner time (15:00-16:00 h) and contained 34.7g of P and DP dissolved in 300 mL of water.|t||t|
1313432|NCT03421288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313433|NCT03421275|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1313434|NCT03421262|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1313435|NCT03421249|Randomized|Parallel Assignment||Treatment||Single|||||t|
1313436|NCT03421236||Single Group Assignment||Treatment||None (Open Label)||||||
1313437|NCT03421223|||Case-Control||Prospective|||||||
1313438|NCT03421210||Single Group Assignment||Basic Science||None (Open Label)||||||
1313439|NCT03421197|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized|t|t|t|t
1313440|NCT03421184|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313441|NCT03421171|||Other||Other|||||||
1313442|NCT03421158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313443|NCT03421145||||||||||||
1313444|NCT03421132|||Cohort||Prospective|||||||
1313445|NCT03421119|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1313446|NCT03421106|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313447|NCT03421093|||Cohort||Retrospective|||||||
1313448|NCT03421080|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1313449|NCT03421067|||Cohort||Retrospective|||||||
1313450|NCT03421054||Single Group Assignment||Treatment||None (Open Label)||||||
1313451|NCT03421041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313452|NCT03421028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1313453|NCT03421015|||Cohort||Retrospective|||||||
1313454|NCT03421002||Single Group Assignment||Treatment||None (Open Label)||||||
1313455|NCT03420989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313456|NCT03420976||Single Group Assignment||Treatment||None (Open Label)||||||
1313457|NCT03420963||Single Group Assignment||Treatment||None (Open Label)||||||
1313458|NCT03420950|Randomized|Parallel Assignment||Other||Quadruple|The nurse administering the drug is not blinded, but the outcome assessor and physician performing the intubation are blinded to drug order.||t|t|t|t
1313459|NCT03420937|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313460|NCT03420924|Randomized|Parallel Assignment||Prevention||Single|||t|||
1313461|NCT03420911|Randomized|Parallel Assignment||Treatment||Triple|Sequenced study medications were prepared by a nurse, and another nurse administered the medications.|Participants were randomly assigned into two groups with a 1:1 allocation following simple randomization procedures by a program generating an online random number|t||t|t
1313462|NCT03420898|||Cohort||Prospective|||||||
1313463|NCT03420885|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313464|NCT03420872|||Cohort||Prospective|||||||
1313465|NCT03420859|||Cohort||Other|||||||
1313466|NCT03420846|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Participants are randomly assigned to two arms. Participants in the first arm receive Mohs surgery using OCT mapping to delineate tumor margins.~Participants in the Control Arm receive Mohs surgery using clinical estimation of tumor margins (ie. standard care) The average number of Mohs surgery cycles will be compared for the two arms."||||
1313467|NCT03420833|Randomized|Crossover Assignment||Basic Science||Double|Participants randomly assigned to have CRT-ON or OFF. At 6 months, participant CRT function will be crossed over.|Single-center, randomized cross-over study|t||t|
1313468|NCT03420820|Randomized|Parallel Assignment||Prevention||Single|||t|||
1313469|NCT03420807||Single Group Assignment||Diagnostic||None (Open Label)||Subjects will undergo 1) clinical characterization, 2) ophthalmic evaluation, 3) evaluation with the device (camera) and 4) brain imaging session (MRI + amyloid PET).||||
1313470|NCT03420794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313471|NCT03420781|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1313472|NCT03420768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313473|NCT03420755|Randomized|Factorial Assignment||Prevention||None (Open Label)||The investigators will use a stepped wedge design—a form of RCT that involves sequential, but random, rollout of the intervention over multiple time periods. The investigaotrs have created two HV program clusters. Both clusters will initially implement MB 1-on-1 and will recruit MB participants for one quarter (i.e., three months) before crossing over to recruit MB-TXT participants for one quarter. MB-TXT's core curriculum is identical to MB 1-on-1 and adds a series of text messages throughout the curriculum.||||
1313474|NCT03420742||Sequential Assignment||Other||None (Open Label)||||||
1313475|NCT03420729|Non-Randomized|Parallel Assignment||Device Feasibility||Single||||t||
1313476|NCT03420716|Randomized|Crossover Assignment||Prevention||Quadruple|Type of yogurt fed is blind for participants and investigators|3 weeks on symbiotic yogurt or control yogurt, with a 3 week wash out period in between. Type of yougurt consumed first is randomized.|t|t|t|t
1573409|NCT00001333||||Treatment||||||||
1313477|NCT03420703|Randomized|Crossover Assignment||Treatment||Single||||||t
1313478|NCT03420690|||Cohort||Retrospective|||||||
1313479|NCT03420677|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1313480|NCT03420664|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Research subjects receive lower limb immobilisation with cast and with orthosis alternatively, randomised so as subsequent persons begin with different modality.||||
1313481|NCT03420651|Randomized|Parallel Assignment||Treatment||Single|When patients are randomized to the non-peak flow guided therapy, physicians are blinded to the peak flow values|||t||
1313482|NCT03420638|Randomized|Parallel Assignment||Treatment||Double|Using sealed envelope assignment, the participant will be placed in study Arm 1 or 2. The PI will not be masked because the PI will administer the adjunct treatment or the standard of care only. The outcome assessor will be masked to study group assignment for gathering data from trial participants.|Randomized clinical trial|t|||t
1313483|NCT03420625|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1313484|NCT03420612|||Cohort||Prospective|||||||
1313485|NCT03420599|||Case-Control||Cross-Sectional|||||||
1313486|NCT03420586|Randomized|Parallel Assignment||Treatment||Double|Subjects will be randomized into two groups by computer-generated random numbers. Each allocation number will be concealed in an opaque envelope before the start of the surgery and will be revealed 30 min before the end of the operation. Early recovery (eye opening, following verbal commands, time to extubation, orientation to time and place) will be recorded by an anesthesiologist blinded to the anesthesia technique. The same anesthesiologist blinded to the anesthesia technique will collect all postoperative data.|Intervention Model: Parallel Assignment|t|||t
1313487|NCT03420573|||Cohort||Prospective|||||||
1313488|NCT03420560|Randomized|Parallel Assignment||Prevention||Double|Patients will not knowing the exact temperature of the room,thought they will have their own feeling about it. Data was collecting with a anesthesia nurse who do not know what will do with these data. data were assessed to an anesthesiologist who did not know the Group allocation.|patients for observation will sent to a warmer operating room,while Patients in controled Group will send to normal setting operating room at about 23 centigrade.|t|||t
1313489|NCT03420547|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1313490|NCT03420534|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1313491|NCT03420521||Single Group Assignment||Treatment||None (Open Label)||||||
1313492|NCT03420508||Single Group Assignment||Treatment||None (Open Label)||This single arm, single center, open label Phase 2 trial will utilize a Simon 2 stage design.||||
1313493|NCT03420495|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The current study has two diagnostic arms (the OCD group and the Non-Psychiatric Control group) all receiving a single interventional protocol.||||
1313494|NCT03420482|Randomized|Parallel Assignment||Treatment||Quadruple|Randomization will be performed by the lab producing the FMT and placebo capsules. Participants, providers, investigators and research assistants will be blinded.|This is a two part study. The first part is a 10-patient pilot study, used to find 2 stool donors who precipitate the largest improvement in recipient neurological function and microbiome composition. The second part is a 20-patient RCT, where patients will be randomized to FMT or placebo.|t|t|t|t
1313495|NCT03420469||Sequential Assignment||Basic Science||None (Open Label)||This is an open-label, four-phases, fixed sequence healthy volunteers study investigating: the steady state stereoselective disposition of bupropion and metabolites; and effect of multiple doses of bupropion on CYP2D6 activity, as measured by the metabolism and pharmacokinetics of a single dose of dextromethorphan||||
1313496|NCT03420456|Randomized|Crossover Assignment||Treatment||Double|All subjects and investigators (except the study statistician) will be blind to treatment sequence assignment.|2-phase sequential parallel design|t||t|
1313497|NCT03420443|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1313498|NCT03420430||||||||||||
1313499|NCT03420417||Single Group Assignment||Other||None (Open Label)||||||
1313500|NCT03420404|Randomized|Parallel Assignment||Treatment||Double|The rheumatologist will be blinded for the first 6 weeks.|||t|t|
1313501|NCT03420391|Randomized|Parallel Assignment||Prevention||Triple||"Fifty participants were enrolled in the study. Participants were randomized in five groups according to PBMT application:~Placebo: Participants received placebo PBMT; 5 minutes: Participants performed the eccentric exercise protocol 5 minutes after PBMT.~3 hours: Participants performed the eccentric exercise protocol 3 hours after PBMT.~6 hours: Participants performed the eccentric exercise protocol 6 hours after PBMT.~24 hours: Participants performed the eccentric exercise protocol 24 hours after PBMT.~Assessments were performed before exercise protocols, after 1 minute, and 1, 24 and 48 hours after the end of exercise protocol."|t|t||t
1313502|NCT03420378||Single Group Assignment||Screening||None (Open Label)||||||
1313503|NCT03420365||Single Group Assignment||Prevention||None (Open Label)||||||
1313504|NCT03420352|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313505|NCT03420339||Single Group Assignment||Treatment||None (Open Label)||In this study all participants will participate in behavioral assessments (i.e., preference assessments, functional analysis, choice assessments) while taking a stimulant medication and without taking a stimulant medication. All participants will experience the same protocol.||||
1313506|NCT03420326|||Ecologic or Community||Cross-Sectional|||||||
1313507|NCT03420313|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized parallel two-group trial||||
1313508|NCT03420300||Single Group Assignment||Treatment||None (Open Label)||||||
1313509|NCT03420287|Randomized|Parallel Assignment||Treatment||Single||||||t
1313510|NCT03420274|Randomized|Parallel Assignment||Health Services Research||Single||This will be a cluster randomized trial examining a shared decision-making intervention.||||t
1313511|NCT03420261|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1313512|NCT03420248|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1313588|NCT03419247||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313589|NCT03419234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313590|NCT03419221|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1313591|NCT03419208|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1313513|NCT03420235|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective randomized clinical multi-center study to evaluate the effect of home monitoring on disease-specific HRQOL, (appropriate) medication use and other patient-relevant outcomes in patients with IPF treated with anti-fibrotic drugs. Patients with IPF about to start on anti-fibrotic medication will be randomly assigned to receive either the home monitoring program integrated with standard care or standard care alone after informed consent. Patient will be stratified for study center and medication.||||
1313514|NCT03420222|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1313515|NCT03420209|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313516|NCT03420196|Randomized|Parallel Assignment||Treatment||Single|Single-Blind|||||t
1313517|NCT03420183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313518|NCT03420170|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313519|NCT03420157|||Other||Prospective|||||||
1313520|NCT03420144|Randomized|Parallel Assignment||Treatment||Single||||||t
1313521|NCT03420131|||Cohort||Prospective|||||||
1313522|NCT03420118||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313523|NCT03420105|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"50 patients including:~25 patients being treated with adjuvant hormone therapy (Group A)~25 patients not receiving adjuvant hormone therapy (Group B)~25 healthy volunteers"||||
1313524|NCT03420092|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313525|NCT03420079|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313526|NCT03420066|||Case-Only||Retrospective|||||||
1313527|NCT03420053|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1313528|NCT03420040|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1313529|NCT03420027|||Cohort||Prospective|||||||
1313530|NCT03420014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313531|NCT03420001|||Case-Control||Prospective|||||||
1313532|NCT03419988|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized control trial: exercise intervention versus non-exercise control||||
1313533|NCT03419975|Randomized|Parallel Assignment||Treatment||Single||||||t
1313534|NCT03419962|||Cohort||Prospective|||||||
1313535|NCT03419949||||||||||||
1313536|NCT03419936|||Case-Only||Prospective|||||||
1313537|NCT03419923|Randomized|Parallel Assignment||Treatment||Single|||||t|
1313538|NCT03419910||Single Group Assignment||Treatment||None (Open Label)||||||
1313539|NCT03419897||Single Group Assignment||Treatment||None (Open Label)||||||
1313540|NCT03419871|||Cohort||Prospective|||||||
1313541|NCT03419858|Randomized|Crossover Assignment||Basic Science||Triple|Only the study physician, research coordinator, and research pharmacist were aware of drug assignments. Research staff (nurses; research technicians) and the PI were not blinded to drug assignment.|The study employed a double blind 3x2x2 crossover factorial design. Baseline pain intensity and pain unpleasantness ratings were assessed using visual analog scales (11 point) obtained before and after four, 5-minute noxious heat stimulation series (49°C). Study volunteers (20/group; 60 total) were randomized and subsequently participated in a four session (20min/session) mindfulness meditation, placebo-meditation, or slow-breathing training regimen. After training completion, subjects reported to the Wake Forest Clinical Research Unit to test the study hypotheses across two separate experimental sessions. Half of the study volunteers (n=10) from each group were administered naloxone (opioid antagonist; 0.15 mg/kg bolus+ 0.1mg/kg/hour infusion) and in the subsequent session were administered IV placebo-saline and vice versa.|t||t|t
1313542|NCT03419845||Single Group Assignment||Device Feasibility||None (Open Label)||Single arm, open trial to qualitatively explore the user's experience of the Step Right Buddy after a one week pilot trial and to assess the introduction of new risks to the patient as a result of the adaptation.||||
1313543|NCT03419832|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1313544|NCT03419819||Single Group Assignment||Treatment||None (Open Label)||Two phase study consisting of a 1 week taste introduction period followed by a 4 week period assessing acceptability and metabolic control.||||
1313545|NCT03419806|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1313546|NCT03419793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313547|NCT03419780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313548|NCT03419767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313549|NCT03419754|Randomized|Crossover Assignment||Prevention||None (Open Label)||The subject will complete one intervention with consumption of 75 g of glucose with fidgeting and one intervention with no glucose consumption with fidgeting.||||
1313550|NCT03419741|Randomized|Parallel Assignment||Treatment||Triple|Sham TMS|This is a randomized, double-blinded design of active rTMS and sham rTMS. The pilot will include a total of 20 nicotine-dependent patients with cancer. Subjects will be randomized to either sham rTMS or real rTMS over the left DLPFC. At the end of 7-day study, everyone can be referred to the Hollings Cancer Center (HCC) Tobacco Treatment Program for active treatment.|t||t|t
1313551|NCT03419728|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313552|NCT03419715|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1313553|NCT03419702|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1313554|NCT03419689||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313592|NCT03419195||Single Group Assignment||Treatment||None (Open Label)||||||
1313593|NCT03419182|Randomized|Parallel Assignment||Treatment||Single|The individual administering the WOMAC or SF-36 will be blinded to the patient's treatment arm.|Patients will be randomized t wo treatment groups : 1. Open reduction internal fixation (ORIF) 2. Acute primary total hip athroplasty (THA) +ORIF. These are both two standard accepted treatments for this injury. Participants who do not consent to being randomized will be asked if they would consent to participating in an observational arm. In this case, type of surgery would be planned and chosen by clinical decision making from the surgeon and patient. As these procedures are both standard of care, partipants could end up in either group as well. All follow up will be the same.||||t
1313682|NCT03418025|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1313555|NCT03419676|Randomized|Parallel Assignment||Prevention||Double||"All patient data are anonymous. Each patient who meets the selection criteria and has signed the informed consent will be entered into a database and identified by a number (from 1 to 64). The list of patient identification numbers will be in the hands of the principal investigator. After carrying out the surgery, the patient number is entered into an online computerized randomization tool (Randomizer for clinical trials), https://www.meduniwien.ac.at/randomizer. It is a tool of the University of Vienna in Austria, where it is registered in a study, which allows, once the patient number is entered, the randomization of the same, obtaining one of the two methods to compare (32 patients in each study group):~Basic treatment: duct-to-mucosa pancreaticojejunostomy WITHOUT Hemopatch reinforcement.~The same, but reinforced WITH Hemopatch.~Once the treatment to be performed is obtained, surgery will be carried out according to the treatment obtained in the randomization."|t|||t
1313556|NCT03419663|||Other||Retrospective|||||||
1313557|NCT03419650||Single Group Assignment||Treatment||None (Open Label)||treatment arm will then be observed.||||
1313558|NCT03419637|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1313559|NCT03419624|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313560|NCT03419611|Randomized|Sequential Assignment||Treatment||Single|Coders will be blind to condition.|"Following the selection of target words based on sounds in the child's speech repertoire as described below, participants will be randomly assigned with equal probability to either the multimodal or TAU treatment in phase one. If data indicates a positive slope in the number of words correct in speech production probes and at least 2 words produced with > 80% accuracy, the participant will meet responder criterion, and continue in their originally assigned intervention. Participants who do not meet this criterion will be re-assigned to one of the stage 2 treatment conditions as depicted in figure 1. Participants who do not respond to the TAU will be randomly reassigned with equal probability to receive either the multimodal intervention or the high intensity multimodal intervention. Participants will continue in this second stage of intervention until 40 words have been learned or 12 weeks elapse (whichever occurs first)."||||t
1313561|NCT03419598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|This virtual trial allows all participants to receive both treatments, i.e. HTO using existing generic technique and HTO using novel subject specific technique|This is a virtual clinical trial, virtual cohort generated from anonymised imaging data from patients with osteoarthritis of the knee||||
1313562|NCT03419585|Randomized|Parallel Assignment||Prevention||Double|Participants will be randomized to one of two arms: an intervention light group or a comparison light group. Both the participant and the investigator will be blind to the light assignment.||t||t|
1313563|NCT03419572|||Cohort||Prospective|||||||
1313564|NCT03419559||Single Group Assignment||Treatment||None (Open Label)||||||
1313565|NCT03419546|||Cohort||Cross-Sectional|||||||
1313566|NCT03419533|||Cohort||Cross-Sectional|||||||
1313567|NCT03419520|Randomized|Parallel Assignment||Prevention||None (Open Label)||The present study is an observational and long-term intervention study. There is an initial evaluation carried out on all children involved in the study at 1st and 2nd grades and it is going to be followed by 3 monitoring actions in the following years where the progression of anthropometric measurements and dietary habits are going to be studied. Besides, the intervention group is going to receive nutritional education aimed to reduce the risk of developing obesity.||||
1313568|NCT03419507|Randomized|Crossover Assignment||Other||Single|The doctors will be informed about the research, but they will be blind to the specific purposes of the study|Equal numbers 1 and 2 will be written on the same sized papers. After separating participants into two groups, doctors that drawed envelop number 1 will be asked to intubate with No. 3 Macintosh laryngoscopy and doctors that drawed envelop number 2 will be asked to intubate with endotracheal tube introducer. Than groups will be changed.|t|||
1313569|NCT03419494|||Case-Control||Prospective|||||||
1313570|NCT03419481||Single Group Assignment||Treatment||None (Open Label)||||||
1313571|NCT03419468|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313572|NCT03419455|||Cohort||Prospective|||||||
1313573|NCT03419442|||Cohort||Retrospective|||||||
1313574|NCT03419429|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1313575|NCT03419416|||Case-Only||Prospective|||||||
1313576|NCT03419403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313577|NCT03419390|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||Proof of concept study, medical device investigation||||
1313578|NCT03419377|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1313579|NCT03419364||Single Group Assignment||Treatment||None (Open Label)||All participants will receive study agent. 2.5 gm nicotinamide given orally in 3 divided doses (1000 in morning, 500 in afternoon, 1000 at bedtime).||||
1313580|NCT03419351||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313581|NCT03419338|Randomized|Parallel Assignment||Treatment||Single||||||t
1313582|NCT03419325|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||After being consented, patients will undergo rapid ex vivo platelet functional testing (i.e., residual platelet reactivity units, PRU, measured using the VerifyNow P2R12 assay for Clopidogrel response) and CYP2C19 genotyping. Patients will then be categorized into 4 groups based on tests results: 1) high on-treatment platelet reactivity (HTPR)/ CYP2C19 loss-of-function (LOF) alleles (i.e., presence of both HTPR and CYP2C19 LOF alleles); 2) HTPR/No-LOF (presence of HTPR, but no CYP2C19 LOF allele); 3) No-HTPR/LOF (presence of a CYP2C19 LOF allele, but no HTPR); 4) No-HTPR/No-LOF (absence of both HTPR and CYP2C19 LOF alleles).||||
1313583|NCT03419312|Randomized|Crossover Assignment||Basic Science||Triple|"The stimulation periods with sham stimulation and burst are blinded to all included in the study except SCS nurse 1 who program and reset IPG during study phase 2.~Sham stimulation is achieved by switching of the stimulation equipment in connection with programming prior to the start of the current stimulation period. The programming procedure is identical before burst and sham stimulation periods."|"Patients are randomized to 1 of 2 different treatment sequences:~Sequence A: Active burst stimulation followed by sham stimulation. Sequence B: Sham stimulation followed by burst stimulation. Sham and burst stimulation are separated by 7 days washout."|t||t|t
1313584|NCT03419299|||Other||Retrospective|||||||
1313585|NCT03419286|||Case-Only||Retrospective|||||||
1313586|NCT03419273|||Cohort||Prospective|||||||
1313594|NCT03419169|Randomized|Parallel Assignment||Treatment||Single|The assessor of all outcome measures will be masked as to which group patients have been assigned. Patient information will be coded using a numerical system by and independent member of the research team during the course of the study and data analysis.|Patients will be assigned to one of two groups: 1) Light load BFR resistance training; or 2) Heavy load resistance training. An independent member of the research team will carry out block randomisation using opaque envelopes containing slips of paper. Each envelope will contain four slips (Two x BFR group and two x heavy load group), thus patients will be randomised in groups of four.||||t
1313595|NCT03419156||Single Group Assignment||Screening||None (Open Label)||All patients with SBS on TPN at Cardinal Glennon will receive text messages inquiring about their symptoms instead of weekly phone calls from a nurse. There will be no randomization. All patients will be sent text-messages from the automated system for 6 months to assess response rates and the amount of time saved by the nurse staff. If the patient does not respond to the text messages or the text message responses suggest that the patient may be presenting with potentially harmful symptoms, the nurse will call the patient to inquire about more information.The text messages are designed to help target calls made by the nursing staff.||||
1313596|NCT03419143|||Cohort||Prospective|||||||
1313597|NCT03419130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313598|NCT03419117|Randomized|Parallel Assignment||Treatment||Double|Recruited patients will be allocated to an experimental or placebo-control arm. Patients in the experimental arm will receive an ESP block prior to induction of general anesthetic for their thoracoscopic wedge resection, while patients allocated to the placebo-control arm will receive a placebo injection of normal saline in a fashion almost identical to that of the ESP block.||t|t||
1313599|NCT03419104||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313600|NCT03419091|Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a prospective, randomized clinical trial. Patients will be randomized 1:1 in randomization blocks of 4 to undergo the procedure with either the LithoVue single use flexible ureteroscope or the digital reusable flexible ureteroscope. Ureteroscopy will be performed using a standardized technique.||||
1313601|NCT03419078|||Cohort||Retrospective|||||||
1313602|NCT03419065||Single Group Assignment||Supportive Care||None (Open Label)||||||
1313603|NCT03419052|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1313604|NCT03419039|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1313605|NCT03419026|||Cohort||Prospective|||||||
1313606|NCT03419013||Single Group Assignment||Basic Science||None (Open Label)||||||
1313607|NCT03419000|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1313608|NCT03418987|||Cohort||Retrospective|||||||
1313609|NCT03418974|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to one of two or more groups in parallel for the duration of the study.||||
1313610|NCT03418961|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1313611|NCT03418948|Randomized|Crossover Assignment||Diagnostic||Double|Participants will be blinded for the allocation. Physicians can not be blinded for the use of Endocuff, but during the first procedure they will be blinded for the second procedure method to limit observer related bias.||t||t|
1313612|NCT03418935|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1313613|NCT03418922|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1313614|NCT03418909|||Case-Control||Prospective|||||||
1313615|NCT03418896||Single Group Assignment||Basic Science||None (Open Label)||simple one arm intervention study||||
1313616|NCT03418883|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313617|NCT03418870|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||"Phase 1 is usual care and Phase 2 is the intervention phase."||||
1313618|NCT03418857|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1313619|NCT03418844|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Patients and healthy volunteers will complete several self-questionnaires on living conditions and quality of life. Patients will also perform a cardiac, pulmonary, auditory and biological assessment||||
1313620|NCT03418831|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313621|NCT03418818||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313622|NCT03418805|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1313623|NCT03418792||Single Group Assignment||Treatment||None (Open Label)||||||
1313624|NCT03418779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313625|NCT03418766|||Cohort||Prospective|||||||
1313626|NCT03418753|||Cohort||Prospective|||||||
1313627|NCT03418740|||Cohort||Prospective|||||||
1313628|NCT03418727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313629|NCT03418714||Single Group Assignment||Other||None (Open Label)|Participants will not be aware of exact doses salvinorin A (i.e. they will be told they may receive placebo or up to a moderately high dose of of salvinorin A).|||||
1313630|NCT03418701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313631|NCT03418688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313632|NCT03418675|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)||t|t|t|t
1313633|NCT03418662|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1313634|NCT03418649|Randomized|Parallel Assignment||Treatment||Triple|Drug or look-alike placebo dispensed according to a randomization schedule.|Double blind placebo controlled. Equal numbers of subjects receive 10 day course of eplerenone or placebo following their clinically indicated epidural steroid injection|t|t|t|
1313635|NCT03418636|Randomized|Parallel Assignment||Prevention||Single||||||t
1313676|NCT03418103|||Cohort||Prospective|||||||
1313677|NCT03418090|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Open label crossover study||||
1313678|NCT03418077|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1313679|NCT03418064|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1313680|NCT03418051|Randomized|Parallel Assignment||Basic Science||Single||||||t
1313681|NCT03418038|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313636|NCT03418623|Randomized|Crossover Assignment||Basic Science||Quadruple|"The study will be double-blinded. At initiation visit the Investigator will be instructed on the method for blind breaking. The CRO will provide the Investigator with a prime set of sealed envelopes, each containing the unblinding information for a patient kit; the envelopes will be kept in the Pharmacy until the end of the study. A second set of sealed envelopes will be kept by the Sponsor pharmacovigilance officer.~Unblinding codes should only be used in emergency situations for reasons of subject safety. The Investigator should contact the Sponsor before breaking the blind, or, when this is not possible, the Sponsor should be informed immediately afterwards. When the blinding code is broken, the reason must be fully documented and entered on the case report form.~The un-blinding envelopes will be checked for integrity by the CRA and will be returned to the Sponsor at the end of the study.~The subjects for whom the blind will be broken will be withdrawn from the study."|After the eligibility of a subject has been determined in an initial screening period, the study will be conducted in 2 consecutive phases: in the first phase (phase A) the participant will be administered GET73 or placebo in a randomized order, in the other phase (phase B), the participant will be administered the treatment not received during phase A.|t|t|t|t
1313637|NCT03418610||Single Group Assignment||Treatment||None (Open Label)||Single Site, Single Arm Open Label Study||||
1313638|NCT03418597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313639|NCT03418584||Single Group Assignment||Treatment||None (Open Label)||||||
1313640|NCT03418571|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1313641|NCT03418558||Single Group Assignment||Treatment||None (Open Label)||||||
1313642|NCT03418545||||||||||||
1313643|NCT03418532||Single Group Assignment||Treatment||None (Open Label)||||||
1313644|NCT03418519|Randomized|Parallel Assignment||Treatment||Single||||||t
1313645|NCT03418506|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313646|NCT03418493|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1313647|NCT03418480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1313648|NCT03418467|||Case-Control||Prospective|||||||
1313649|NCT03418454|||Case-Control||Prospective|||||||
1313650|NCT03418441|||Cohort||Prospective|||||||
1313651|NCT03418428|||Case-Control||Cross-Sectional|||||||
1313652|NCT03418415||Single Group Assignment||Treatment||None (Open Label)||||||
1313653|NCT03418402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313654|NCT03418389|||Cohort||Other|||||||
1313655|NCT03418376|Randomized|Parallel Assignment||Other||Quadruple|All parties are blinded regarding the dietary supplement (beta-alanine) or placebo.|Twenty multiple sclerosis (MS) patients and twenty healthy controls (HC), aged >18y will be included following written informed consent. Subjects will be excluded if they experience contraindications to participate in moderate to high intensity exercise or have an EDSS score >3. First, exercise capacity (maximal graded exercise test) will be evaluated. Heart function will be assessed by an experienced medical doctor, followed by measurement of body composition (DEXA). Maximal strength of the back- and abdominal muscles will be assessed to evaluate core stability. MS patients and HC will be randomly allocated to one of four intervention groups following 6 months of moderate-to-high-intensity cardiovascular exercise therapy with (MSβ, n=10; HCβ, n=10) or without (MSpla, n=10; HCplac, n=10) β-alanine supplementation. Groups not receiving β-alanine supplements, will receive placebo tablets. Following 6 months of exercise training (POST) measurements will be performed similar to baseline.|t|t|t|t
1313656|NCT03418363|Randomized|Parallel Assignment||Basic Science||Triple|Double blind||t||t|t
1313657|NCT03418350|||Cohort||Prospective|||||||
1313658|NCT03418337|Randomized|Parallel Assignment||Treatment||None (Open Label)||a prospective, randomized, open-level clinical study to evaluate 8 weeks PPI response rate for atypical GERD||||
1313659|NCT03418324|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Bayesian design||||
1313660|NCT03418311|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313661|NCT03418298||Single Group Assignment||Treatment||None (Open Label)||||||
1313662|NCT03418285|||Case-Only||Prospective|||||||
1313663|NCT03418272|||Case-Control||Prospective|||||||
1313664|NCT03418259|Randomized|Parallel Assignment||Treatment||Double|Placebo device|Double blinded randomised clinical trial|t||t|
1313665|NCT03418246|Randomized|Parallel Assignment||Treatment||Double|Investigator and participants are blinded to restoration used.|One group will be treated with a tooth colored filling that will be placed near the gum line (Glass Ionomer). The second group will be treated with Biodentine that will be placed near the gum line.|t||t|
1313666|NCT03418233|Randomized|Parallel Assignment||Treatment||Quadruple|"The Data and Safety Monitoring Board (DSMB) will be blinded at project start, but may request unblinding if necessary to accommodate effective review of data.~Other than the DSMB (if necessary), the only other un-blinded parties, meaning that they will have knowledge as to the patient's treatment assignment, will be the PBTiK UJ CM employee who participates in randomization utilizing randomization lists and investigational medication preparation."|"The CIHF trial will enroll 105 patients with randomization into active and placebo therapy with 2:1 ratio.~Additional 5-10 subjects meeting inclusion/exclusion criteria will receive, in a non-blinded fashion, labelled CardioCell to determine the early myocardial uptake and retention of IMP."|t|t|t|t
1313667|NCT03418220|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1313668|NCT03418207||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313669|NCT03418194|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313670|NCT03418181|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The participants will be randomly allocated to 2 groups:~Thrice weekly dialysis (control arm)~Incremental dialysis - Twice weekly dialysis to start with and slowly increasing the duration and frequency of dialysis to thrice weekly depending on their native kidney function."||||
1313671|NCT03418168||Single Group Assignment||Treatment||None (Open Label)||||||
1313672|NCT03418155|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313673|NCT03418142|Randomized|Parallel Assignment||Treatment||Single||||||t
1313674|NCT03418129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313675|NCT03418116||Single Group Assignment||Treatment||None (Open Label)||||||
1313683|NCT03418012|Randomized|Parallel Assignment||Prevention||None (Open Label)|due to the nature of the intervention (placement of a cervical pessary) a masking is not possible|"parallel groups:~Controll group with management as usual~Pessary group with insertion of cervical pessary at 12+0-16+0 weeks of gestation"||||
1313684|NCT03417999|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1313685|NCT03417986|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1313686|NCT03417973|||Cohort||Prospective|||||||
1313687|NCT03417960||Single Group Assignment||Treatment||None (Open Label)||Open label pilot||||
1313688|NCT03417947|Randomized|Parallel Assignment||Other||Quadruple|"The Applied Clinical Research Unit of Sainte-Justine UHC will generate the randomisation scheme. Group allocation codes will be held in a secure location with a restricted access by the Central pharmacy (Sainte-Justine UHC). All participants and research personnel, including the nurse, research trainee and research team will be blinded to group assignment.~The supplier Euro-Pharm will provide the placebo and vitamin D3 preparations in coded bottles. Pharmacy will prepare the 6-mL bolus in coded syringes following the randomisation scheme."|This is a randomised, quadruble-blind, placebo-controlled, parallel-group trial of vitamin D3 bolus supplementation.|t|t|t|t
1313689|NCT03417934|||Case-Only||Prospective|||||||
1313690|NCT03417921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313691|NCT03417908|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313692|NCT03417895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313693|NCT03417882|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The study will follow a Simon two-stage design [1] with up to 90 subjects enrolled if both Cohort 1 and Cohort 2 are selected for expansion in Stage 2. All subjects will receive GRN-1201 at a dose of 3.0 mg per peptide in combination with 75 µg sargramostim (Leukine®) and 200 mg pembrolizumab.||||
1313694|NCT03417869|||Other||Prospective|||||||
1313695|NCT03417856|||Case-Control||Cross-Sectional|||||||
1313696|NCT03417843||Single Group Assignment||Treatment||None (Open Label)||A Prospective, open- label study||||
1313697|NCT03417830|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Part A of the study will include 3 subjects with ATTR-CM who will participate in two dosing sessions and Part B of the study will include 3 subjects with ATTR-CM who will participate in one dosing session. A single dosing session will constitute treatment with carboxy pyrrolidine hexanoyl pyrrolidine carboxylate (CPHPC), total mass dose (TMD) administration of anti-serum amyloid P (SAP) monoclonal antibody (mAb) consisting of in vivo mixing of a single infusion of unlabeled anti-SAP mAb and a separate infusion of 89Zr-GSK2398852 via a different peripheral venous line, and up to 3 serial PET scanning procedures after administration of 89Zr-GSK2398852.||||
1313698|NCT03417817||Single Group Assignment||Other||None (Open Label)||healthy subjects and subjects referred for gastroscopy in context of other conditions||||
1313699|NCT03417804|||Cohort||Prospective|||||||
1313700|NCT03417791|||Cohort||Retrospective|||||||
1313701|NCT03417778|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313702|NCT03417765|Randomized|Sequential Assignment||Supportive Care||Quadruple|Double-blind|Placebo-control, ascending dose|t|t|t|t
1313703|NCT03417752|Randomized|Parallel Assignment||Other||Double|||t||t|
1313704|NCT03417739||Single Group Assignment||Treatment||None (Open Label)||||||
1313705|NCT03417726|||Case-Control||Prospective|||||||
1313706|NCT03417713|||Cohort||Prospective|||||||
1313707|NCT03417700|Randomized|Sequential Assignment||Prevention||Single|Participants will receive vitamin D supplementation, but the dose will be known only to one investigator, who will be not be participating in any other assessment.|"Model I~Women and men over 65 years old will participate in the training programme. All subjects will undergo a medical check-up before being subject to exercise. All procedures will be performed with the approval from the Bioethical Committee of the Regional Medical Society in Gdansk. One week prior to the beginning of the experiment, a battery of physiological and psychological tests will be performed. The same procedure will be repeated after the training period.~In addtition to training, supplementation of vitamin D (800IU and 4000IU) will be administered.~Model II~Young women will participate in the training programme. They will perform a high-intensity circuit training according to the ACSM. They will perform a single session of HICT and 12 units of HICT regularly. One week prior to the beginning of the experiment, a battery of physiological and psychological test will be performed. The same procedure will be repeated after the training period."|||t|
1313708|NCT03417687|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Open label crossover study||||
1313709|NCT03417674|Randomized|Sequential Assignment||Prevention||Single||||||t
1313710|NCT03417661|Randomized|Parallel Assignment||Other||Double|||t||t|
1313711|NCT03417648|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1313712|NCT03417635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313713|NCT03417622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313714|NCT03417609|||Cohort||Prospective|||||||
1313715|NCT03417596|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1313716|NCT03417583|Non-Randomized|Parallel Assignment||Other||Single||||||t
1313717|NCT03417570|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1313718|NCT03417557||||||||||||
1313719|NCT03417544||Single Group Assignment||Treatment||None (Open Label)||||||
1313720|NCT03417531|Randomized|Factorial Assignment||Prevention||Triple||2x2 factorial design|t||t|t
1313721|NCT03417518|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1313722|NCT03417505|Randomized|Crossover Assignment||Supportive Care||Double||Randomized, double-masked crossover study|t|t||
1313723|NCT03417492||Single Group Assignment||Treatment||None (Open Label)||Open-label, non-placebo controlled||||
1313724|NCT03417479|||Cohort||Prospective|||||||
1313725|NCT03417466||Single Group Assignment||Treatment||None (Open Label)||||||
1313726|NCT03417453||Parallel Assignment||Supportive Care||None (Open Label)||||||
1313782|NCT03416725|||Case-Only||Prospective|||||||
1313863|NCT03415672|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1313864|NCT03415659||Single Group Assignment||Treatment||None (Open Label)||||||
1313727|NCT03417440|Randomized|Factorial Assignment||Other||Single|Study measures (apart from accelerometry, Health-ITUES, and usage data-see below) will be administered by a condition-blind tester at a study site at baseline and post-intervention.|Multiphase Optimization Strategy (MOST) is a recent methodology for optimizing multi-component interventions prior to performing more comprehensive testing in large RCTs. The Most Framework includes 5 steps: (1) Establish theoretical model; (2) Identify individual intervention components; (3) Conduct experiment to examine individual components; (4) Assemble beta intervention package; and (5) Confirm efficacy of optimized intervention. To our knowledge, only two prior studies have used MOST to refine a complex app with physical activity elements and disentangle the relative efficacy of specific features within a larger suite.||||t
1313728|NCT03417427|Randomized|Parallel Assignment||Treatment||Single|||||t|
1313729|NCT03417414|||Cohort||Prospective|||||||
1313730|NCT03417401||Single Group Assignment||Treatment||None (Open Label)||||||
1313731|NCT03417388|Randomized|Parallel Assignment||Treatment||Single|The Clinical Events Committee (CEC) will be masked to all treatment assignment.|This will be a PROBE design, that will evaluate an intensive statin/ACE-I (or ARB) treatment strategy (IMT) vs. primary prevention risk factor therapy treatment strategy (UC) in symptomatic (chronic angina or equivalent) women with non-obstructive CAD.||||t
1313732|NCT03417375|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313733|NCT03417362|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1313734|NCT03417349|||Cohort||Prospective|||||||
1313735|NCT03417336|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313736|NCT03417323|Randomized|Crossover Assignment||Treatment||Double||||t||t
1313737|NCT03417310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313738|NCT03417297||Single Group Assignment||Device Feasibility||None (Open Label)||This is a pilot study. There are no statistical testing. Ten (10) adults with refractory, partial-onset epilepsy with secondary generalization and able to provide informed consent will be enrolled. Initially, 3 participants will be enrolled and followed for 3 months to assess the safety of study intervention. Pending review by the Data and Safety Monitoring Committee (DSMC) and the US Food and Drug Administration (FDA), an additional 7 participants will be enrolled.||||
1313739|NCT03417284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313740|NCT03417271|Randomized|Crossover Assignment||Treatment||Double|Neither participants nor outcomes assessors will be aware whether the patient is receiving stimulation at 30us or 60us pulse widths.||t|||t
1313741|NCT03417258|||Other||Cross-Sectional|||||||
1313742|NCT03417245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313743|NCT03417232|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313744|NCT03417219|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1313745|NCT03417206|Randomized|Parallel Assignment||Prevention||Single|||t|||
1313746|NCT03417193|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1313747|NCT03417180|Randomized|Parallel Assignment||Prevention||Single|||t|||
1313748|NCT03417167|||Other||Prospective|||||||
1313749|NCT03417154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313750|NCT03417141||Single Group Assignment||Treatment||None (Open Label)||Adults patient with active Lichen Planopilaris or Frontal Fibrosing Alopecia||||
1313751|NCT03417128|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313752|NCT03417115|||Cohort||Prospective|||||||
1313753|NCT03417102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313754|NCT03417089|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313755|NCT03417076||Single Group Assignment||Treatment||None (Open Label)||||||
1313756|NCT03417063|||Case-Only||Prospective|||||||
1313757|NCT03417050|||Cohort||Retrospective|||||||
1313758|NCT03417037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313759|NCT03417024|||Cohort||Prospective|||||||
1313760|NCT03417011|||Cohort||Prospective|||||||
1313761|NCT03416998|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1313762|NCT03416985|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1313763|NCT03416972|||Cohort||Prospective|||||||
1313764|NCT03416959|||Case-Only||Prospective|||||||
1313765|NCT03416946|Randomized|Parallel Assignment||Treatment||Single|Randomization will occur after enrolment and subjects will be blinded to assignment group. All subjects will be scheduled for and receive the same MRI experience. It is not possible to blind the surgeon to the surgical technique.|The block randomization process will be stratified by surgeon to ensure equal distribution between the two surgical techniques.|t|||
1313766|NCT03416933||Single Group Assignment||Other||None (Open Label)||||||
1313767|NCT03416920||Single Group Assignment||Supportive Care||None (Open Label)||Enroll and onboard 150 patients with the Wellframe application||||
1313768|NCT03416907|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1313769|NCT03416894||Single Group Assignment||Treatment||None (Open Label)||||||
1313770|NCT03416881|||Case-Only||Cross-Sectional|||||||
1313771|NCT03416868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313772|NCT03416855|||Cohort||Prospective|||||||
1313773|NCT03416842||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1313774|NCT03416829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313775|NCT03416816||Single Group Assignment||Treatment||None (Open Label)||||||
1313776|NCT03416803|Randomized|Parallel Assignment||Prevention||Single|||||t|
1313777|NCT03416790|||Case-Only||Cross-Sectional|||||||
1313778|NCT03416777|Randomized|Parallel Assignment||Prevention||None (Open Label)|In this trial blinding of participants and investigators will not be possible because of obvious differences between the intervention diets|Randomized parallel open dietary intervention study with 3 arms of intervention||||
1313779|NCT03416764|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313780|NCT03416751|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313781|NCT03416738|Randomized|Crossover Assignment||Treatment||Single||||||t
1313783|NCT03416712|Randomized|Single Group Assignment||Screening||None (Open Label)||Quantify unmet socioeconomic determinants of health (SDH) needs using a screening tool in the inpatient settings at Texas Children's Hospital (TCH). Screen will assess educational attainment, employment, literacy, language skills, substance dependence, childcare and child behavior, mental health, domestic violence, housing insecurity and conditions, medical insurance, access to primary care, transportation to medical appointments, ability to pay for prescriptions, legal issues and immigration services. 2. Increase vulnerable family enrollment in community resources to decrease unmet psychosocial and economic needs in the study population 3. Evaluate impact of this intervention on health outcome indicators and hospital resource utilization (body mass index (BMI), return visit to ED, hospital readmission, and parent's perception of child's health).||||
1313784|NCT03416699|||Case-Only||Prospective|||||||
1313785|NCT03416686||Single Group Assignment||Treatment||None (Open Label)||Radiofrequency with local anesthesia: 1 episode of treatment||||
1313786|NCT03416673|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313787|NCT03416660|Randomized|Parallel Assignment||Treatment||Single|masked to the parameters of laser treatment in each lesion|"The study included 25 Egyptian patients with burn scars recruited from the Out Patient Clinic, Dermatology Department, Cairo University. Each has three post burn scars, assigned to monthly fractional carbon dioxide laser sessions with a total of 3 sessions. parameters are :~Lesion A or part A parameters: 20 W, 800-1000μs dwell time, 2 to 3 stacks according to scar thickness, 900µm spacing (7.4% density).~Lesion B or part B parameters: 20 W, 800-1000μs dwell time, 2 to 3 stacks according to scar thickness, 600µm spacing (12.6% density).~Lesion C or part C parameters: 20 W, 800-1000μs dwell time, 2 to 3 stacks according to scar thickness, 300 µm spacing (25.6% density).~3 mm punch biopsy is taken before and one month after last session for assessment of collagen via (Masson's trichrome strain). In addition clinical evaluation is done via Vancouver & Patient and Observer Scar Assessment Scale"||||t
1313788|NCT03416647||Single Group Assignment||Treatment||None (Open Label)||||||
1313789|NCT03416634|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||90 participants will use a wearable device and 90 will use a smartphone app to track activity. These groups will be further randomized to receive an automated motivational intervention, or a personalized motivational intervention or no additional intervention; each study arm will have 30 participants.||||
1313790|NCT03416621|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1313791|NCT03416608|||Cohort||Cross-Sectional|||||||
1313792|NCT03416595|Randomized|Parallel Assignment||Prevention||Quadruple||The model is a randomized, double-blinded, parallel, placebo-controlled intervention study to assess effect of N1115 Probiotic Supplement (containing Junlebao Lp. N1115) on gut development in young children. Up to 60 healthy children, between the ages of 6 months and 3 years who were born by caesarean section will be recruited into this study. Participants will be randomly assigned to one of two treatment groups, one group is N1115 Probiotic Supplement intervention which contains Lp. N1115 and maltodextrin, the other group is placebo intervention which contains maltodextrin only.|t|t|t|t
1313793|NCT03416582||Single Group Assignment||Supportive Care||None (Open Label)||||||
1313794|NCT03416569||Single Group Assignment||Basic Science||None (Open Label)|The study will be double-blind. Only the statistician performing randomization and the dispensing pharmacist will know the sequence of test conditions.|Each participant is tested with each of four test conditions, in counterbalanced sequence.||||
1313795|NCT03416556|Randomized|Crossover Assignment||Treatment||Double|"The participant were assigned to the treatment group with a computer program.~Outcomes assessor did´t know the treatment applied to the participants"||t|||t
1313796|NCT03416543|||Cohort||Prospective|||||||
1313797|NCT03416530|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313798|NCT03416517||Single Group Assignment||Treatment||None (Open Label)||||||
1313799|NCT03416504|Randomized|Parallel Assignment||Treatment||Single|Independent evaluators were blind to the exposure condition participants were assigned to.|Participants were randomly assigned to either gradual or variable exposure||||t
1313800|NCT03416491|Randomized|Parallel Assignment||Treatment||None (Open Label)|The centralized laboratory was blinded to treatment assignment.|parallel, stratified assignment||||
1313801|NCT03416478|||Case-Only||Prospective|||||||
1313802|NCT03416465|||Cohort||Prospective|||||||
1313803|NCT03416452||Parallel Assignment||Supportive Care||None (Open Label)||||||
1313804|NCT03416439|Randomized|Parallel Assignment||Treatment||Single||Lifestyle intervention program carried out by trained professionals versus standard, unstructured information given by the family physicians||||t
1313805|NCT03416426|||Cohort||Retrospective|||||||
1313806|NCT03416413|Randomized|Parallel Assignment||Treatment||Single||||||t
1313807|NCT03416400|||Case-Control||Prospective|||||||
1313808|NCT03416387||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313809|NCT03416374||Single Group Assignment||Treatment||None (Open Label)||||||
1313810|NCT03416361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313811|NCT03416348|Randomized|Crossover Assignment||Treatment||Double|For Aim 1 there will be no masking. Aim 2, recruitment methods will be by convenience sampling. Subjects in Aim 1 reporting an HDSS of 2 or greater and additional subjects as needed from the U of U or VA clinics with HDSS of 2 or greater will be invited to participate in this crossover study. Subjects will be randomized equally to two sequence arms by a random number generator. The first arm will receive in sequential order every 3 weeks: Aluminum Chloride, a placebo of ethyl alcohol base, Aluminum Chloride, and placebo. The second arm will receive in sequential order every 3 weeks: placebo, Aluminum Chloride, placebo, and Aluminum Chloride. Each condition will last for 3 weeks, which will allow enough time for the Aluminum Chloride and placebo to demonstrate their respective effects. The first week of each period will also serve as a sufficient washout for the previous period. The total trial length, then, will be 12 weeks.|For the two aims of the study, subjects will be recruited from the amputee clinics held at the Salt Lake VA Medical Center or the University of Utah. Combined, these clinics serve approximately 500 patients and see approximately 75 new patients each year. Based on the investigators work, which showed 66% of patients with HDSS scores of 2 or greater, we will have a potential pool of up to 330 eligible patients for the studies that follow. We expect to enroll approximate equal numbers from both sites for each of the aims of this study.|t||t|
1313812|NCT03416335||Single Group Assignment||Treatment||None (Open Label)||||||
1313813|NCT03416322|Randomized|Parallel Assignment||Prevention||Single|Randomization of participants will be done in a 1:1 ratio, with the random sequence in blocks 2, 4 and 6. The sequence of treatments within the blocks and the block sequence will be randomized. For this randomization, the REDCap platform will be used.|"Clinical, prospective and comparative, randomized study. Patients referred to the Endoscopy Department of the Barretos Cancer Hospital from August 2017 to August 2018 will be invited to participate in the study, with an indication of performing a diagnostic colonoscopy for high-risk CCR screening (Lynch and Li Fraumeni Syndrome) or who are in post-polypectomy follow-up.~After agreeing and signing the Informed Consent Term (ICF), the included patients will be divided into two groups. The first group will be submitted to the technique of second right frontal view of the right colon (SEVF), which consists in reexamining the right colon after reaching the hepatic angle on colonoscope withdrawal. The second group will be submitted to the Underwater technique, which consists in evaluating the right colon after this segment has been cleaned with water, injected water and aspirated after. During aspiration of water, the colon will be examined."|t|||
1313814|NCT03416309|||Cohort||Prospective|||||||
1313815|NCT03416296|||Case-Control||Prospective|||||||
1313816|NCT03416283|Randomized|Parallel Assignment||Supportive Care||Single|Single (Investigator)||||t|
1313817|NCT03416270|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind study|Patients will be randomized to 15 mg (10mg + 5mg tablets) PO ertugliflozin daily or a matched placebo.|t|t|t|t
1313818|NCT03416257|||Cohort||Prospective|||||||
1313819|NCT03416244|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313820|NCT03416231||Single Group Assignment||Treatment||None (Open Label)||||||
1313821|NCT03416218||Single Group Assignment||Other||None (Open Label)|There is only one condition to this study, so no masking will be used.|Participants enrolled in the study will play Prognosis, a game-based intervention designed to improve STEM skills.||||
1313822|NCT03416205|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313823|NCT03416192|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313824|NCT03416179|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind study.|Randomized, double-blind, multi-center, placebo controlled study.|t|t|t|t
1313825|NCT03416166|||Case-Only||Prospective|||||||
1313826|NCT03416153|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313827|NCT03416140|Randomized|Parallel Assignment||Treatment||Single||||||t
1313828|NCT03416127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313829|NCT03416114|||Cohort||Other|||||||
1313830|NCT03416101|||Cohort||Retrospective|||||||
1313831|NCT03416088||Sequential Assignment||Basic Science||None (Open Label)||50 participants will be enrolled. Each subject undergoes three period which include water deprivation,drinking pure water,and drinking coffee or wine.Each period lasts 1.5 hours.OCTA images are taken every 30 minutes.OCTA examination are taken 16 times in total.||||
1313832|NCT03416075|||Cohort||Retrospective|||||||
1313833|NCT03416062|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1313834|NCT03416049|||Case-Control||Prospective|||||||
1313835|NCT03416036|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1313836|NCT03416023||Single Group Assignment||Treatment||None (Open Label)||Prospective single-arm multicentre open clinical study||||
1313837|NCT03416010|Randomized|Parallel Assignment||Basic Science||None (Open Label)||longitudinal, randomized block RCT with repeated measures||||
1313838|NCT03415997|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1313839|NCT03415984|||Cohort||Prospective|||||||
1313840|NCT03415971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313841|NCT03415958|||Cohort||Prospective|||||||
1313842|NCT03415945||Single Group Assignment||Treatment||None (Open Label)||||||
1313843|NCT03415932||Single Group Assignment||Supportive Care||None (Open Label)||baseline and follow up in one population||||
1313844|NCT03415919|||Case-Only||Cross-Sectional|||||||
1313845|NCT03415906|Randomized|Crossover Assignment||Basic Science||Double|double|Prospective, monocentric, active-controlled, double-blind, cross-over with randomized sequence of treatments|t||t|
1313846|NCT03415893|||Cohort||Retrospective|||||||
1313847|NCT03415880|Randomized|Parallel Assignment||Prevention||Single|The investigator measuring the outcome measures will be blinded to patient allocation. Patients are asked not to mention their allocated group or the programme they follow and not to wear or mention the wrist-worn activity tracker during measurements.|The study consists of an intervention group and a control group. Both arms run parallel and both groups are measured at the same time points.|||t|
1313848|NCT03415867||Sequential Assignment||Treatment||None (Open Label)||||||
1313849|NCT03415854||Single Group Assignment||Treatment||None (Open Label)||||||
1313850|NCT03415841|Randomized|Parallel Assignment||Other||None (Open Label)||"50 patients who are randomized to the intervention group (mHealth) will be enabled with remote monitoring devices (Blood Pressure and wearable vital signs monitor, Biovotion) and Kardia mobile application, for home-based rehabilitation program followed by review in the outpatient Cardiology clinics. The control group (50 patients) will just be monitored at fixed intervals in the outpatient Cardiology clinics"||||
1313851|NCT03415828|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313852|NCT03415815|||Cohort||Retrospective|||||||
1313853|NCT03415802||Single Group Assignment||Treatment||None (Open Label)||||||
1313854|NCT03415789|||Case-Only||Cross-Sectional|||||||
1313855|NCT03415776|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313856|NCT03415763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313857|NCT03415750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313858|NCT03415737|||Case-Only||Prospective|||||||
1313859|NCT03415724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313860|NCT03415711|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1313861|NCT03415698|Randomized|Parallel Assignment||Treatment||Single||||||t
1313862|NCT03415685|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be assigned to one of two treatments group depending on the dermatologic condition to be treated.||||
1313865|NCT03415646|Randomized|Crossover Assignment||Prevention||Single||||||t
1313866|NCT03415633|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1313867|NCT03415620||Single Group Assignment||Treatment||None (Open Label)||||||
1313868|NCT03415607|||Cohort||Prospective|||||||
1313869|NCT03415594|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t||t
1313870|NCT03415581|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313871|NCT03415568|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1313872|NCT03415555|Randomized|Parallel Assignment||Treatment||Single|Single (Participant)|Parallel Assignment|t|||
1313873|NCT03415542||Single Group Assignment||Basic Science||None (Open Label)||||||
1313874|NCT03415529|||Cohort||Retrospective|||||||
1313875|NCT03415516|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313876|NCT03415503|Randomized|Parallel Assignment||Prevention||Single|||t|||
1313877|NCT03415490|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1313878|NCT03415477||Single Group Assignment||Treatment||None (Open Label)|Open Label|Patients with recurrent and/or refractory aneurysmal bone cysts treated with denosumab perioperatively.||||
1313879|NCT03415464|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313880|NCT03415451||Single Group Assignment||Supportive Care||None (Open Label)||||||
1313881|NCT03415438|||Cohort||Prospective|||||||
1313882|NCT03415425|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1313883|NCT03415412|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313884|NCT03415399||Sequential Assignment||Treatment||None (Open Label)||||||
1313885|NCT03415386|Randomized|Sequential Assignment||Treatment||Single||||||t
1313886|NCT03415373||Single Group Assignment||Other||None (Open Label)||"Subjects will be first randomized to receive each of the injection (A, B, C, and D) in each of the 3 visits of the study, according to the block randomization scheme produced by inVentiv. The following sequences will be used: 1st (upper right location), 2nd (lower right location), 3rd (upper left location) and 4th lower left location) where:~A. Investigational device with 50 μL saline B. Control device with 50 μL saline C. Investigational device with 100 μL saline D. Control device with 100 μL saline"||||
1313887|NCT03415360||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1313888|NCT03415347|Randomized|Parallel Assignment||Treatment||Single||Participants will be randomised to one of two groups, intervention 1 (abscess de-roofing and curettage) or intervention 2 (abscess wide local excision), then followed up for 1 year to detect recurrence rate of pilonidal abscess|t|||
1313889|NCT03415334||Single Group Assignment||Prevention||None (Open Label)|care providers were not the same persons who did the assessment and the evaluation .|The study passed through three phases; first phase pre-interventional assessment of level of the recommended behavior development towards eradication of HCV, dominance of current risky behaviors and the wrong believes regarding HCV . The second phase included: community based interventions and the setting of the educational activation plan for HCV elimination in the village and the third was post-intervention evaluation of the change of level of community behaviors adoption according to a preset indicators.||||
1313890|NCT03415321|Randomized|Parallel Assignment||Prevention||Double||A randomized controlled trial with a two-group pre-test and post-test design.|||t|t
1313891|NCT03415308|||Other||Other|||||||
1313892|NCT03415295|||Case-Control||Retrospective|||||||
1313893|NCT03415282||Single Group Assignment||Treatment||None (Open Label)||||||
1313894|NCT03415269||Single Group Assignment||Basic Science||None (Open Label)||||||
1313895|NCT03415256|Randomized|Parallel Assignment||Other||None (Open Label)||"After completing the tests, you will be randomly assigned by the computer to either the treatment group or control group.~The treatment group will receive a passive vibration treatment for 15 minutes twice a week for 4 weeks.~The control group will not receive any treatment and they will continue their usual lifestyle."||||
1313896|NCT03415243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313897|NCT03415230|Randomized|Parallel Assignment||Treatment||Double|therapeutic massage vs sham massage||t|t||
1313898|NCT03415217||Single Group Assignment||Other||None (Open Label)||||||
1313899|NCT03415204|Randomized|Parallel Assignment||Treatment||Double||||t||t
1313900|NCT03415191|Randomized|Parallel Assignment||Treatment||Quadruple||This was a single center, double-blind, placebo controlled, parallel-group, prospective study. Patients were randomly assigned to Ketamine or Placebo group in 1:1 ratio and no changes to methods after trial commencement as type of randomization or eligibility criteria were attended.|t|t|t|t
1313901|NCT03415178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313902|NCT03415165|Randomized|Parallel Assignment||Treatment||Single||||||t
1313903|NCT03415152|||Cohort||Prospective|||||||
1313904|NCT03415139|||Cohort||Prospective|||||||
1313905|NCT03415126|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313906|NCT03415113|||Other||Prospective|||||||
1313907|NCT03415100||Single Group Assignment||Treatment||None (Open Label)||||||
1313908|NCT03415087|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1313909|NCT03415074|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Eligible patients will enter a run-in phase (3 mo), when mild protein diet (0.8g/kg dry ideal bw) will be initiated and compliance will be evaluated twice monthly.~Those who will prove compliant during the run-in phase and still fulfill the selection criteria will be randomized 1:1 (computer-generated numbers) to receive the low protein diet (0.6 g/kg-day, mainly vegetarian) supplemented with ketoanalogues of essential amino-acids (Ketosteril 1 tb/10 kg dry bw) or to continue the mild protein restriction (0.8 g/kg-day)."||||
1313910|NCT03415061|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1313911|NCT03415048|||Case-Only||Prospective|||||||
1313912|NCT03415035|||Cohort||Prospective|||||||
1313913|NCT03415022|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor will not be informed as to whether a participant is randomized to 4 or 8 weeks of treatment.|Computer-based task involving free viewing of faces and listening to music||||t
1313914|NCT03415009|||Case-Only||Prospective|||||||
1573410|NCT00001332||||Treatment||||||||
1313915|NCT03414996|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313916|NCT03414983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313917|NCT03414970|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1313918|NCT03414957|||Cohort||Prospective|||||||
1313919|NCT03414944||Single Group Assignment||Treatment||None (Open Label)||||||
1313920|NCT03414931|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313921|NCT03414918||Single Group Assignment||Diagnostic||None (Open Label)||"Study 1: We will enroll consecutive hypertensive patients with PA, who need to undergo adrenal vein sampling (AVS) before being referred for adrenalectomy, according to current guidelines12.~Study 2: Regardless of the results of study 1, we will recruit consecutive referred hypertensive patients undergoing screening for secondary hypertension. This is because to prove unambiguously the role of macrolides in the screening of mutated APA we must enroll a population of patients with and without PA and with/without the different gene mutations so far identified in APA."||||
1313922|NCT03414905||Single Group Assignment||Health Services Research||None (Open Label)||||||
1313923|NCT03414892|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313924|NCT03414879|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1313925|NCT03414866|||Cohort||Prospective|||||||
1313926|NCT03414853|||Cohort||Prospective|||||||
1313927|NCT03414840|||Cohort||Prospective|||||||
1313928|NCT03414827|||Cohort||Prospective|||||||
1313929|NCT03414814||Single Group Assignment||Treatment||None (Open Label)||||||
1313930|NCT03414801|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1313931|NCT03414788||Single Group Assignment||Other||None (Open Label)||||||
1313932|NCT03414775|Randomized|Parallel Assignment||Other||None (Open Label)||Critically-ill children who are medically stable and ready for enteral tube feeds will be randomized to receive either Pediasure or Nourish. Nutritional needs will be calculated per previously established standards at our institution and performed in conjunction with trained dieticians and nutritionists.||||
1313933|NCT03414762|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1313934|NCT03414749|Randomized|Crossover Assignment||Treatment||Double|Treatment was unknown to outcome assessors. Participant were unaware of what the treatment would be and how it may / may not impact the outcome.|This study used a randomized, crossover experimental design over three days of testing.|t|||t
1313935|NCT03414736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313936|NCT03414723||Single Group Assignment||Basic Science||None (Open Label)||||||
1313937|NCT03414710|Randomized|Parallel Assignment||Prevention||Single||||||t
1313938|NCT03414697|Randomized|Parallel Assignment||Treatment||Single||||||t
1313939|NCT03414684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313940|NCT03414671|||Cohort||Other|||||||
1313941|NCT03414658|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313942|NCT03414645|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313943|NCT03414632||Single Group Assignment||Diagnostic||None (Open Label)||||||
1313944|NCT03414619|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The current study has two diagnostic arms (the Intrusive Thoughts group and the Non-Psychiatric Control group) all receiving a single interventional protocol.||||
1313945|NCT03414606|||Case-Control||Cross-Sectional|||||||
1313946|NCT03414593|Randomized|Parallel Assignment||Prevention||Double||Patients who underwent surgery on both feet at the same time. One foot is performed before surgery and the other is performed after surgery.|t|||t
1313947|NCT03414580|||Cohort||Prospective|||||||
1313948|NCT03414567|||Other||Other|||||||
1313949|NCT03414554|||Cohort||Prospective|||||||
1313950|NCT03414541|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1313951|NCT03414528|||Family-Based||Prospective|||||||
1313952|NCT03414515|||Case-Only||Prospective|||||||
1313953|NCT03414502||Single Group Assignment||Treatment||None (Open Label)||||||
1313954|NCT03414489||||||||||||
1313955|NCT03414476|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|Monocentric, Exploratory study, open, comparative, in parallel groups|"1 group of women with effluvium télogène~1 group of women without effluvium télogène"||||
1313956|NCT03414463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1313957|NCT03414450|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||In Phase 1A, an adaptive design using the ordinal Continual Reassessment Method (oCRM) will be used to determine the MTD and RD of ETC-1907206 in combination with dasatinib.||||
1313958|NCT03414437|||Case-Only||Other|||||||
1313959|NCT03414424||Single Group Assignment||Basic Science||None (Open Label)||||||
1313960|NCT03414411|||Cohort||Prospective|||||||
1313961|NCT03414398|||Cohort||Prospective|||||||
1313962|NCT03414385||Single Group Assignment||Prevention||None (Open Label)||||||
1313963|NCT03414372|Randomized|Parallel Assignment||Supportive Care||Single||"This study includes 3 phases: 1) formative research to refine and enhance Tough Talks with input from YMSM and their social/sexual networks; 2) a technical pilot to optimize functionality and technical performance; and 3) a three-arm RCT to evaluate efficacy and effectiveness of Tough Talks among HIV-infected YMSM.~In the RCT, the investigators will conduct a combined efficacy/effectiveness trial to compare the intervention delivered online, in the clinic or standard of care clinic messaging. Primary outcomes will be assessed at intervention completion (1 month) and at 6 months and include HIV viral load and CAI."|t|||
1313964|NCT03414359|Randomized|Parallel Assignment||Treatment||Single|||||t|
1313965|NCT03414346|Randomized|Crossover Assignment||Other||Single||A randomized single blind, crossover experimental study.||||t
1313966|NCT03414333|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313967|NCT03414320||Single Group Assignment||Other||None (Open Label)||proof-of-concept, open label, single arm||||
1313968|NCT03414307||Single Group Assignment||Other||None (Open Label)||Subject enrolled serve as their own control to evaluate the effect of ROSA robotic-assisted intracerebral catheter placement.||||
1314011|NCT03413748|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1313969|NCT03414294|Randomized|Sequential Assignment||Other||Double|Masking for Part A (SAD) and Part B (MAD), open for Part C (FE)|Sequential Assignment/Crossover (for food effect)|t||t|
1313970|NCT03414281|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1313971|NCT03414268|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313972|NCT03414255|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1313973|NCT03414242||Single Group Assignment||Screening||None (Open Label)||||||
1313974|NCT03414229|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a single-center, phase II study to evaluate the efficacy of the IDO1 inhibitor, epacadostat, given in combination with the anti-PD1 monoclonal antibody, pembrolizumab, for patients with metastatic and/or locally advanced grade sarcomas.||||
1313975|NCT03414216|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1313976|NCT03414203|Randomized|Parallel Assignment||Treatment||Quadruple||"The patients will be randomized into 1 of 3 groups:~group A: active tDCS for 15 minutes, group B: active tDCS for 15 minutes, with an interval of 20 minutes and group C: more 15 minutes os stimulation, sham tDCS for 15 minutes."|t|t|t|t
1313977|NCT03414190|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1313978|NCT03414177|Randomized|Parallel Assignment||Treatment||None (Open Label)||One group will receive asthma follow up care via telemedicine at a remote clinical sites. The second group will receive in-person asthma follow-up care at a specialty clinic.||||
1313979|NCT03414164|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1313980|NCT03414151|||Case-Only||Prospective|||||||
1313981|NCT03414138|Randomized|Parallel Assignment||Basic Science||Triple|Subjects will be randomly assigned to two groups by the research coordinator. Investigators, study staff and MRI technicians will be blind as to the participant's group assignment.|Healthy research participants, trained to psychophysically rate their experience in response to a range of thermal stimuli, will be randomly assigned to one of two experimental groups (mindfulness meditation n=20 or deep-breathing meditation n=20). After receiving four twenty-minute meditation training sessions, participants will return for a final session of thermal testing while lying in the MRI scanner. Participants will be exposed to 4 blocks of testing, using thermal stimuli cycled between painful (49°C) and non-painful (35°C) temperatures for 6 minutes. Blood oxygen-level dependent imaging will be used to map the functional connectivity of brain regions in response to the thermal fluctuations. In the first two blocks participants will lie quietly with eyes closed. After a 10 minute rest, subjects will begin meditating and the thermal testing will resume.|t||t|t
1313982|NCT03414125|Randomized|Parallel Assignment||Screening||Single|Single Blind|Evaluate effect of offering choice of FIT or colonoscopy (n=2,000) compared to FIT alone (n=8,000) on one-time CRC screening completion, repeat screening, and follow-up of abnormal FIT results.||||t
1313983|NCT03414112|Randomized|Parallel Assignment||Other||Triple|The study will be double blind; participants and study staff will not know if the participant is receiving intranasal oxytocin or placebo.|Participants with anorexia nervosa and age-matched control participants will complete two separate fMRI and test meal assessments: one following administration of intranasal oxytocin and one following placebo. The study will be double blind.|t||t|t
1313984|NCT03414099|Randomized|Crossover Assignment||Other||Quadruple|Ketum and placebo drinks will be matched for taste and appearence. Each study participant will receive a sequence of ketum and placebo drinks in random order.|Within-subject, repeated measures|t|t|t|t
1313985|NCT03414086|||Cohort||Prospective|||||||
1313986|NCT03414073|Randomized|Crossover Assignment||Prevention||Single|Only the Principal investigator will know the intervention being done by subject. The outcome investigator(assessor) will be unaware (blinded) to which intervention the subject is undertaken|Subjects will be randomly allotted to three groups. each group will undergo three treatment phases with an in-between washout phase.In each treatment phase the group subjects will test a different intervention||||t
1313987|NCT03414060||Single Group Assignment||Treatment||None (Open Label)||repeated measures||||
1313988|NCT03414047|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313989|NCT03414034||Single Group Assignment||Treatment||None (Open Label)||||||
1313990|NCT03414021|||Cohort||Prospective|||||||
1313991|NCT03414008|Randomized|Parallel Assignment||Treatment||Single|||t|||
1313992|NCT03413995||Single Group Assignment||Treatment||None (Open Label)||||||
1313993|NCT03413982|||Cohort||Prospective|||||||
1313994|NCT03413969||Single Group Assignment||Other||None (Open Label)||||||
1313995|NCT03413956|||Cohort||Retrospective|||||||
1313996|NCT03413943|Randomized|Parallel Assignment||Other||Single|The gaze training subjects will be blinded to their cohort assignment, but investigators will know in order to carry out the proper training pending randomization.|After identification of the expert gaze, subjects will be randomized into explicit or implicit gaze training techniques.|t|||
1313997|NCT03413930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1313998|NCT03413917|||Other||Other|||||||
1313999|NCT03413904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314000|NCT03413891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314001|NCT03413878|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1314002|NCT03413865|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1314003|NCT03413852|||Cohort||Prospective|||||||
1314004|NCT03413839|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1314005|NCT03413826|Randomized|Factorial Assignment||Treatment||None (Open Label)||Baseline demographic and physical characteristics will be reported as means and standard errors. Baseline group (6 days/week, 2 days per week exercise, sedentary control) differences will be tested with one-way ANOVA. Alterations in accumulated negative energy balance, body composition, RRVfood, RRVexercise, dietary intake, energy expenditure, exercise discomfort, hunger/satiety hormones, and fitness will be tested with two-way repeated measures analysis of variance (RMANOVA) with group treated as a between-subjects variable and time treated as a within subjects variable.||||
1314006|NCT03413813|||Other||Prospective|||||||
1314007|NCT03413800||Single Group Assignment||Treatment||None (Open Label)||||||
1314008|NCT03413787|||Case-Only||Prospective|||||||
1314009|NCT03413774|||Case-Control||Prospective|||||||
1314010|NCT03413761|||Cohort||Prospective|||||||
1314012|NCT03413735|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1314013|NCT03413722|||Cohort||Prospective|||||||
1314014|NCT03413709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314015|NCT03413696|||Cohort||Cross-Sectional|||||||
1314016|NCT03413683|||Cohort||Prospective|||||||
1314017|NCT03413670|||Case-Control||Cross-Sectional|||||||
1314018|NCT03413657|Randomized|Crossover Assignment||Diagnostic||Quadruple||"Subjects will be randomized to either undergo the PEEP challenge or tidal volume challenge first. After the initial challenge, subjects will cross over to whichever challenge has not yet been performed.~Subjects will be separated into the following categories: fluid responders and non-responders and analyzed in those categories."|t|t|t|t
1314019|NCT03413644|||Cohort||Prospective|||||||
1314020|NCT03413631|Randomized|Parallel Assignment||Treatment||None (Open Label)||The participants were randomized into the intervention and control groups using a computer-generated block-randomization with block size of four. A separate randomisation assignment was used for women medication-assisted treatment for opioid addiction.||||
1314021|NCT03413618|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor does not involve in randomisation and treatment process, has no information about the patient's belonging to one of the study groups|Randomized open-labeled clinical trial with a masked outcomes assessor||||t
1314022|NCT03413605|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1314023|NCT03413592||Single Group Assignment||Other||None (Open Label)||||||
1314024|NCT03413579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1314025|NCT03413566|||Cohort||Cross-Sectional|||||||
1314026|NCT03413553|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1314027|NCT03413540|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314028|NCT03413527||Single Group Assignment||Treatment||None (Open Label)||||||
1314029|NCT03413514||Sequential Assignment||Treatment||None (Open Label)||||||
1314030|NCT03413501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314031|NCT03413488|Randomized|Parallel Assignment||Treatment||Single|||||t|
1314032|NCT03413475|||Other||Prospective|||||||
1314033|NCT03413462|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1314034|NCT03413449|||Cohort||Prospective|||||||
1314035|NCT03413436|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1314036|NCT03413423|Randomized|Parallel Assignment||Treatment||Single||||||t
1314037|NCT03413410||Single Group Assignment||Treatment||None (Open Label)||||||
1314038|NCT03413384|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1314039|NCT03413371|Randomized|Parallel Assignment||Prevention||Single|Single (Participant)|Crossover Assignment|t|||
1314040|NCT03413358|Randomized|Parallel Assignment||Treatment||None (Open Label)||These subjects will be randomized (1:1) to treatment group or control group.||||
1314041|NCT03413345|||Case-Control||Prospective|||||||
1314042|NCT03413332|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1314043|NCT03413319||Single Group Assignment||Treatment||None (Open Label)||||||
1314044|NCT03413306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314045|NCT03413293|||Case-Only||Prospective|||||||
1314046|NCT03413280|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1314047|NCT03413267|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Because the food matrices ingested by the volunteers have different aspects, no masking is really possible. However, blood samples will be analyzed by partners without knowledge of the matrix that has been ingested.|"Bioavailability protocol : each volunteer participates in 4 interventions (4 food matrices), during 4 different days (one food matrix per day). At least 3 weeks between each intervention day. An intervention consists in food matrix ingestion (t=0) and blood sampling for 8 h postprandial (10 sampling times).~Mastication protocol : each volunteer participates in 1 session during which 2 solid matrices will be studied. For each matrix, 13 samples are proposed to the volunteer; food bolus are collected just before the volunteer feels the need of swallowing."||||
1314048|NCT03413254|Randomized|Parallel Assignment||Diagnostic||None (Open Label)|In order to prevent caretakers from being influenced by the assigned follow-up strategy, the randomization outcome will remain unknown to everyone involved in the patient's care until the 18 months CT-scan is reported by the radiologist.|||||
1314049|NCT03413241|||Cohort||Prospective|||||||
1314050|NCT03413228|||Other||Prospective|||||||
1314051|NCT03413215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314052|NCT03413202|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1314053|NCT03413189|||Cohort||Prospective|||||||
1314054|NCT03413176|||Case-Only||Cross-Sectional|||||||
1314055|NCT03413163|Randomized|Parallel Assignment||Treatment||Single||||t||
1314056|NCT03413150|||Cohort||Retrospective|||||||
1314057|NCT03413137|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Using the NaviGo™ system each patient will undergo a biopsy using the transperineal followed by transrectal approach.||||
1314058|NCT03413124|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1314059|NCT03413111|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1314060|NCT03413098||Single Group Assignment||Treatment||None (Open Label)||||||
1314061|NCT03413085|Randomized|Parallel Assignment||Treatment||Quadruple||Paired-eye comparison|t|t|t|t
1314062|NCT03413072|||Other||Cross-Sectional|||||||
1314063|NCT03413059|Randomized|Parallel Assignment||Treatment||Double||"Group (m): which will receive morphine dose 0.1mg /kg with 9 ml of 0.125 % bupivacaine with through epidural catheter in T 7-T10 .on admission. Then continuous epidural infusion of bupivacaine (0.1 mg.kg-1.h)~Group (s) : will receive mixture consisting of 9 ml of 0.125 % bupivacaine with 80mg of triamcinolone ( 10 ml total volume) .through epidural catheter in-T7- T10 .on admission"|t|t||
1314064|NCT03413046|||Case-Control||Prospective|||||||
1314065|NCT03413033|||Case-Only||Prospective|||||||
1314066|NCT03413020||Single Group Assignment||Treatment||None (Open Label)||||||
1314067|NCT03413007|||Cohort||Prospective|||||||
1573411|NCT00001330||||||||||||
1314068|NCT03412994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314069|NCT03412981|||Cohort||Prospective|||||||
1314070|NCT03412968|Randomized|Parallel Assignment||Treatment||Single||The perfusionist's role is essential during the procedure involving Cardiopulmonary Bypass (CPB). This study purpose to know the impact of using polysulfone membranes on continuous ultrafiltration with volume replacement in patients undergoing cardiac surgery. In this type of surgery, techniques such as conventional ultrafiltration (CUF) and modified ultrafiltration (MUF) are known for controlling the patient's fluid balance and blood lactate levels during the procedure.|t|||
1314071|NCT03412955||Single Group Assignment||Treatment||None (Open Label)||||||
1314072|NCT03412942||Single Group Assignment||Other||None (Open Label)||||||
1314073|NCT03412929||Single Group Assignment||Treatment||None (Open Label)||||||
1314074|NCT03412916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314075|NCT03412903|||Cohort||Prospective|||||||
1314076|NCT03412890||Single Group Assignment||Treatment||None (Open Label)||Open-Label Extension||||
1314077|NCT03412877||Parallel Assignment||Treatment||None (Open Label)||||||
1314078|NCT03412864|||Case-Only||Prospective|||||||
1314079|NCT03412851|||Cohort||Prospective|||||||
1314080|NCT03412838|Randomized|Parallel Assignment||Treatment||Double|Patients included in the clinical trial were randomly allocated by a blinded assistant in two groups: in the cortico-cancellous group (CC), and cancellous group (C). Allocation of participants to intervention groups in a truly unpredictable, randomized sequence was performed using a computerized random number generated by the GraphPadQuickCalc software (GraphPad Software Inc., La Jolla, CA). Blocked randomization was performed to maintain equal group size. As a result 14 patients were randomly assigned to de CC group and other 14 to the C group. All bone augmentation surgeries were performed by the same oral surgeon, with expertise on block surgeries (JT).|Twenty-eight patients referred for implant placement and with insufficient bucco-lingual (BL) alveolar bone width (<4 mm) were included in the study. Patients received freeze dried bone allograft (FDBA) blocks of either allogeneic cancellous or cortico-cancellous bone obtained from the iliac crest. Patients included in the clinical trial were randomly allocated by a blinded assistant in two groups: in the cortico-cancellous group (CC), and cancellous group (C).|t||t|
1314081|NCT03412825|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1314082|NCT03412812||Single Group Assignment||Treatment||None (Open Label)||||||
1314083|NCT03412799||Single Group Assignment||Treatment||None (Open Label)||||||
1314084|NCT03412786|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|Not a randomized study. The first 10 patients included will be treated in arm A - the last 10 will be treated in arm B.|||||
1314085|NCT03412773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314086|NCT03412760||Single Group Assignment||Diagnostic||None (Open Label)||All cases of non-immune hydrops fetalis (NIHF) or other birth defects enrolled in the study will be offered whole exome sequencing (WES). This will be trio WES ideally, meaning that WES will be offered for the affected fetus as well as for both of the biologic parents. If one or both of the parents are unavailable, then duo or proband-only WES could be done, respectively.||||
1314087|NCT03412747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314088|NCT03412734|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314089|NCT03412721|Randomized|Crossover Assignment||Treatment||Double||Allocation: Randomized Intervention Model: Split-mouth assignment with two-way repeated measures design Masking: Double (Participant, Outcomes Assessor)|t|||t
1314090|NCT03412708|Randomized|Parallel Assignment||Treatment||Single|Single blind|Prospective||||t
1314091|NCT03412695|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314092|NCT03412682|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1314093|NCT03412669|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1314094|NCT03412656||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1314095|NCT03412643||||||||||||
1314096|NCT03412630||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314097|NCT03412617|||Ecologic or Community||Cross-Sectional|||||||
1314098|NCT03412604||Single Group Assignment||Treatment||None (Open Label)||||||
1314099|NCT03412591||Single Group Assignment||Treatment||None (Open Label)||We intend to evaluate the efficacy of suvorexant in a group of opioid dependent (n=14) and a group of alcohol dependent subjects (n=14) in a residential treatment facility. It is an open label trial on subjects with opioid or alcohol dependence who are 5to 10 days post withdrawal.||||
1314100|NCT03412578|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1314101|NCT03412565|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314102|NCT03412552|||Cohort||Prospective|||||||
1314103|NCT03412539||||||||||||
1314104|NCT03412526||Single Group Assignment||Treatment||None (Open Label)||||||
1314105|NCT03412513|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1314106|NCT03412500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314107|NCT03412487|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1314108|NCT03412474|Randomized|Parallel Assignment||Prevention||Quadruple|The trial will be planned that neither the doctors (investigators) nor the patients' guardians or even children themselves will be aware of the group allocation and drug received. The study drugs will be prepared by an anesthesiologist not involved in performing the block, patient care or in data collection.|comparison of the analgesic effect of adding dexmedetomidine to bupivacaine with the analgesic effect of using bupivacaine alone in bilateral SMB for children undergoing CP repair under general anesthesia.|t|t|t|t
1314150|NCT03411928||Single Group Assignment||Treatment||None (Open Label)|Unblinded|Prospective interventional study||||
1314151|NCT03411915||Sequential Assignment||Treatment||None (Open Label)||||||
1314152|NCT03411902|Randomized|Parallel Assignment||Supportive Care||Double|Both participant and research associate charged with administering medication or placebo capsules will be blinded.|This pilot study is a RCT, involving 24 sleeve gastrectomy patients randomized to Risedronate or placebo capsules for 24 weeks|t|t||
1314153|NCT03411889||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314363|NCT03409146|||Cohort||Prospective|||||||
1314109|NCT03412461|Randomized|Parallel Assignment||Other||Double|To maintain partial blindness, researchers administering surveys will not be aware of the group allocation of participants. A researcher who will not be in contact with participants will conduct the randomization. Recruitment materials do not include any reference to the intervention (Thought Spot) and therefore, mitigates any potential demand characteristics among participants|Students will be recruited and randomized to the intervention arm or the control arm. The intervention group participants will have access to the Thought Spot platform. The control group participants will receive a pamphlet that outlines mental health services and wellness services across the GTA. Both groups will also have access to usual care.|t||t|
1314110|NCT03412448|||Cohort||Prospective|||||||
1314111|NCT03412435|||Cohort||Prospective|||||||
1314112|NCT03412422|||Case-Only||Prospective|||||||
1314113|NCT03412409||Single Group Assignment||Treatment||None (Open Label)||||||
1314114|NCT03412396||Single Group Assignment||Treatment||None (Open Label)||||||
1314115|NCT03412383||Single Group Assignment||Treatment||None (Open Label)||||||
1314116|NCT03412370|||Cohort||Prospective|||||||
1314117|NCT03412357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314118|NCT03412344|||Other||Cross-Sectional|||||||
1314119|NCT03412331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314120|NCT03412318|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314121|NCT03412305|Randomized|Parallel Assignment||Prevention||Quadruple|The tablets corresponding to each patient is packed in a container by the manufacturer of the trial drug. Each drug container is labeled by a code number (1-1000) and the contents of the containers are distributed according to a randomization list with block size 6. Randomization is thus carried out by the manufacturer, independent of investigator and participating clinicians.|Randomized, placebo-controlled trial|t|t|t|t
1314122|NCT03412292||Single Group Assignment||Treatment||None (Open Label)||||||
1314123|NCT03412279|||Cohort||Cross-Sectional|||||||
1314124|NCT03412266||Single Group Assignment||Treatment||None (Open Label)||||||
1314125|NCT03412253||Single Group Assignment||Treatment||None (Open Label)||||||
1314126|NCT03412240||Single Group Assignment||Prevention||None (Open Label)||||||
1314127|NCT03412227|Randomized|Parallel Assignment||Treatment||Single|Independent evaluators will be masked to the treatment conditions.|Randomized Clinical Trial, stratified by principal youth diagnosis (anxiety or depression).||||t
1314128|NCT03412214|||Cohort||Prospective|||||||
1314129|NCT03412201|Randomized|Parallel Assignment||Treatment||None (Open Label)||multicenter, randomized, parallel group study||||
1314130|NCT03412188|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients will be divided into 2 groups:~Group 1 (eltrombopag arm n=20 patients): Patients who showed no response (platelet count ≤ 20x109/L) initially for 3 months or relapse after 6 months after at least one prior ITP therapy. patients will receive a total daily dose of eltrombopag of (25-50mg/d). Dose adjustments may be made based on platelets count.~Group 2 (n=20 patients) Patients who are currently receiving other lines of treatment (steroids, IVIG, azathioprine, and rituximab)."||||
1314131|NCT03412175|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1314132|NCT03412162|Randomized|Parallel Assignment||Basic Science||Single|Post-doctoral scholar conducting the statistical data analyses will be provided with de-identified data and will not be informed of which condition is which. Rather, they will be provided with a neutral and randomly assigned set of names identifying each condition: Condition 1 and Condition 2.|Two conditions will be tested: an ethnic-racial identity promotion intervention, and academic skills promotion control condition.||||t
1314133|NCT03412149|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1314134|NCT03412136|Randomized|Crossover Assignment||Basic Science||Single|The experimental beverages contained either 1g of glucose monohydrate (BioShop Canada Inc., Burlington, Ontario, Canada) or 1g of protein (plain whey-protein isolate; BiPro USA., Eden Prairie, Minnesota, U.S.A) per kg of bodyweight. A non-calorie drink was used as control. All beverages were flavoured with 1.5ml of chocolate extract (Vanilla Food Company, Markham, Ontario, Canada) to account for the flavor differences and mixed with 500ml of water. The whey protein and control beverages were sweetened with 0.2g sucralose (Tate & Lyle, Stoney Creek, Ontario, Canada) in order to match sweetness with the glucose beverage.|In a randomized, crossover study, sixteen 9-18 y old males were given beverages containing either: 1) whey protein (1g/kg bodyweight), 2) glucose (1g/kg bodyweight) or a calorie-free control (C). Serum testosterone, appetite biomarkers and subjective appetite were measured prior (0) and at 20, 35 and 65 minutes after the consumption of the beverage. Food intake at an ad libitum pizza meal was assessed 20 min later (65-85min).|t|||
1314135|NCT03412123||Single Group Assignment||Prevention||None (Open Label)||||||
1314136|NCT03412110|||Other||Prospective|||||||
1314137|NCT03412097|||Case-Only||Prospective|||||||
1314138|NCT03412084|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314139|NCT03412071|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized, open label with 5 arms||||
1314140|NCT03412058|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1314141|NCT03412045||Single Group Assignment||Treatment||None (Open Label)||a convenience sample of patients admitted to hospital for vaso-occlusive sickle cell crisis to be treated with hyperbaric oxygen in an effort to ameliorate pain and shorten the length of stay. In this sense, hyperbaric oxygen will be the intervention and used as a treatment drug.||||
1314142|NCT03412032|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1314143|NCT03412019|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"There will be two arms of this randomized controlled trial as follows:~Control group: baseline hemodynamics and anxiety screen; no music~Intervention group - Mozart: A study investigator will turn on a playlist of pre-selected Mozart music."||||
1314144|NCT03412006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314145|NCT03411993|||Cohort||Cross-Sectional|||||||
1314146|NCT03411980|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1314147|NCT03411967||Single Group Assignment||Treatment||None (Open Label)||||||
1314148|NCT03411954|||Cohort||Prospective|||||||
1314149|NCT03411941|||Cohort||Retrospective|||||||
1314154|NCT03411876|Randomized|Crossover Assignment||Treatment||Single||||||t
1314155|NCT03411863||Single Group Assignment||Basic Science||None (Open Label)||||||
1314156|NCT03411850|Randomized|Crossover Assignment||Other||Single|||t|||
1314157|NCT03411837|||Cohort||Prospective|||||||
1314158|NCT03411824|||Cohort||Prospective|||||||
1314159|NCT03411811|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to one of two or more groups in parallel for the first 9 weeks. after that the study becomes one arm as both groups are offered dextrose.||||
1314160|NCT03411798||Sequential Assignment||Treatment||None (Open Label)||Yisaipu® was introduced only during the active state and was switched to DMARDs, methotrexate(MTX), sulfasalazine(SSZ) and hydroxychloroquine(HCQ), after disease remission (ESR & CRP reduce to normal and BASDAI＜4) maintenance.||||
1314161|NCT03411785|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1314162|NCT03411772|Randomized|Parallel Assignment||Treatment||Double|Patients will sign an informed consent entailing their knowledge and acceptance of being included in the trial, however patients will not be aware to the group they will be included to. In addition, the operating surgeon will not be aware to the nature of the study.||t|t||
1314163|NCT03411759|||Case-Only||Cross-Sectional|||||||
1314164|NCT03411746|||Case-Only||Prospective|||||||
1314165|NCT03411733|||Cohort||Prospective|||||||
1314166|NCT03411720|Randomized|Parallel Assignment||Prevention||Single||||||t
1314167|NCT03411707|||Case-Only||Prospective|||||||
1314168|NCT03411694|||Cohort||Cross-Sectional|||||||
1314169|NCT03411681|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1314170|NCT03411668|Randomized|Parallel Assignment||Other||Single|The assignment to the arms will be made by an independent researcher using random.org.|||||t
1314171|NCT03411655|Randomized|Parallel Assignment||Treatment||Single|||||t|
1314172|NCT03411642|||Cohort||Cross-Sectional|||||||
1314173|NCT03411629|||Cohort||Prospective|||||||
1314174|NCT03411616|||Other||Cross-Sectional|||||||
1314175|NCT03411603|||Ecologic or Community||Cross-Sectional|||||||
1314176|NCT03411590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314177|NCT03411577|Randomized|Parallel Assignment||Prevention||Single|Data collectors were unaware of group assignment of participants.|Mother-daughter dyads were randomly assigned to either HIV risk-reduction intervention group or control group||||t
1314178|NCT03411564|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Longitudinal quasi-experimental educational intervention study. The evaluation will be carried out using an on-line questionnaire distributed to an intervention and a control groups at three time periods: before starting the program (Baseline, time 0 or T0), after finishing the study - including the dissemination phase - (time 1 or T1) and six months after implementation (time 2 or T2). In addition, a process evaluation will be carried out with the intervention group.||||
1314179|NCT03411551|Randomized|Parallel Assignment||Treatment||Single||||||t
1314180|NCT03411538|||Cohort||Prospective|||||||
1314181|NCT03411525|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Stepped wedge cluster randomized trial||||
1314182|NCT03411512|||Case-Control||Prospective|||||||
1314183|NCT03411499|Randomized|Parallel Assignment||Treatment||None (Open Label)||Partially Randomized Preference Trial||||
1314184|NCT03411473||Single Group Assignment||Treatment||None (Open Label)||||||
1314185|NCT03411460|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1314186|NCT03411447|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314187|NCT03411434||Single Group Assignment||Other||None (Open Label)||Interventional study designed to evaluate routine care. The patients are their own controls. Oculomotor and neurocognitive performances are assessed at baseline (V0), during the methylphenidate test (V1), and after 6 months of methylphenidate treatment||||
1314188|NCT03411421|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1314189|NCT03411408||Single Group Assignment||Treatment||None (Open Label)||||||
1314190|NCT03411395|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1314191|NCT03411382|Randomized|Parallel Assignment||Other||Single||||||t
1314192|NCT03411369|Randomized|Parallel Assignment||Other||Double|Double blind study design. The dietary supplement of Creatine, D-Ribose, B1 Vitamin, and B6 vitamin will come in the form of water-soluble powder in sachets of 4 grams. Each sachet contains 1 gram of Creatine, 2.5 grams of D-Ribose, 0.33 mg of B1 vitamin and 0.42 mg of B6 vitamin. The same administration will come for placebo group with the inert product sachets consisting of starch powder.|Two groups, one receiving treatment (Creatine, D-Ribose, B1 Vitamin, and B6 vitamin), and one receiving placebo.|t||t|
1314193|NCT03411356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314194|NCT03411343|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1314195|NCT03411330|Randomized|Parallel Assignment||Supportive Care||Double|Prospective randomized double blinded clinical study on humans|"The investigators hypothesize that, the addition of hyaluronidase may affect the quality of the block by enhancing the spread of the local anaesthetics through the facial planes and thus, reaching the target nerves more easily, rapid and effective that may provide better effective block in short duration and lasting for longer duration. This effect will be measured in terms of stress response and  analgesic quality Total sample size of 64 patients randomly allocated into two equal groups. According to study Hyaluronidase in sub-Tenon's anesthesia for phacoemulsification that was done and published in International Journal of Ophthalmology (2012) to detect difference in post-operative pain between those patients receiving Lidocaine only versus Lidocaine and hyaluronidase, sample size of 29 patients per group is needed with confidence level 95% power of the study 80% & type I error 0.05. Sample size calculation was done using Medcalc Software version 15.4."|t||t|
1314196|NCT03411317|||Cohort||Prospective|||||||
1314197|NCT03411304|||Cohort||Prospective|||||||
1314198|NCT03411291|||Other||Prospective|||||||
1314255|NCT03410550||Single Group Assignment||Treatment||None (Open Label)||Twenty subjects will participate in a powered exoskeleton (EKSO) for one or twice a week for 12 weeks. The program will involve walking with the robotic suits for 1 hour for persons with complete (n=10) and persons with incomplete (n=10) SCI.||||
1314256|NCT03410537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314199|NCT03411278|Randomized|Crossover Assignment||Other||Single||A randomized, cross-over, repeated measures design is used to evaluate the effects of DO on recovery. At random in study phase I the half of the group performs a DO self-treatment twice daily (4 applications) for 15 minutes each, whereas the other half gets no intervention. After a washing out period in study phase II a crossover will be performed. The same protocol is performed again, whereas the other half of the participants carries out the DO intervention .||||t
1314200|NCT03411265||Single Group Assignment||Prevention||None (Open Label)||||||
1314201|NCT03411252|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1314202|NCT03411239||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314203|NCT03411226|||Case-Only||Retrospective|||||||
1314204|NCT03411213|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1314205|NCT03411200|Randomized|Parallel Assignment||Supportive Care||Single|All physical tests will be conducted by masked health care professionals.|Participants will be randomized 1:1 to the intervention group and control group.||||t
1314206|NCT03411187|Randomized|Parallel Assignment||Treatment||Quadruple||This study is a prospective randomized controlled study to select a continuous case of thyroid surgery in the fujian medical university union hospital from January 2017 to June 2017.|t|t|t|t
1314207|NCT03411174||Single Group Assignment||Treatment||None (Open Label)||||||
1314208|NCT03411161|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"This study will be conducted in two successive parts:~a dose escalation phase I part, which is a single arm, non-randomised and non-comparative study in patient with mBC~a randomised phase II part, which is a two-arm, randomised study at RP2D (recommended phase II dose), to evaluate the efficacy and the safety of S 81694 in combination with paclitaxel (experimental arm) versus paclitaxel alone (comparator arm) in untreated mTNBC"||||
1314209|NCT03411148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314210|NCT03411135|||Other||Prospective|||||||
1314211|NCT03411122||Single Group Assignment||Treatment||None (Open Label)||||||
1314212|NCT03411109|||Cohort||Retrospective|||||||
1314213|NCT03411096|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1314214|NCT03411083|||Cohort||Prospective|||||||
1314215|NCT03411070||Single Group Assignment||Treatment||None (Open Label)||||||
1314216|NCT03411057|||Cohort||Prospective|||||||
1314217|NCT03411044|||Cohort||Prospective|||||||
1314218|NCT03411031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314219|NCT03411018|||Cohort||Prospective|||||||
1314220|NCT03411005||Single Group Assignment||Other||None (Open Label)||Each subject will randomly receive 3 levels of lysine provided as free amino acids, sorghum, or sorghum combined with lentils for a total of 8 studies x 3 days per study.||||
1314221|NCT03410992|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314222|NCT03410979|Randomized|Sequential Assignment||Basic Science||Quadruple|||t|t|t|t
1314223|NCT03410966||Single Group Assignment||Basic Science||None (Open Label)||||||
1314224|NCT03410953||Single Group Assignment||Prevention||None (Open Label)||non-responders to conventional treatment of hepatitis B vaccination and consent to participate||||
1314225|NCT03410940|||Cohort||Prospective|||||||
1314226|NCT03410927||Sequential Assignment||Treatment||None (Open Label)||In Phase 1, TAS0728 will be evaluated for safety and tolerability, and in phase 2a will be evaluated preliminary efficacy.||||
1314227|NCT03410914||Single Group Assignment||Prevention||None (Open Label)||||||
1314228|NCT03410901||Single Group Assignment||Treatment||None (Open Label)||||||
1314229|NCT03410888|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1314230|NCT03410875||Single Group Assignment||Treatment||None (Open Label)||||||
1314231|NCT03410862|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1314232|NCT03410849|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1314233|NCT03410836|Randomized|Parallel Assignment||Treatment||Quadruple|The drug administered intraoperatively (intravenous lidocaine or intravenous placebo) will be blinded to patient, anesthesiologist, research nurse for the entire duration of the study.|Two groups of patients. Randomization into the treatment group or placebo group according to a randomization list for a total number of patients of 60.|t|t|t|t
1314234|NCT03410823||Single Group Assignment||Supportive Care||None (Open Label)||||||
1314235|NCT03410810|||Cohort||Cross-Sectional|||||||
1314236|NCT03410797||Single Group Assignment||Treatment||None (Open Label)||||||
1314237|NCT03410784||Single Group Assignment||Treatment||None (Open Label)||||||
1314238|NCT03410771|||Cohort||Prospective|||||||
1314239|NCT03410758|||Cohort||Retrospective|||||||
1314240|NCT03410745|Randomized|Parallel Assignment||Basic Science||Single||||||t
1314241|NCT03410732|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314242|NCT03410719|Randomized|Parallel Assignment||Other||Single||block randomized, parallel, controlled,||||t
1314243|NCT03410706|||Cohort||Prospective|||||||
1314244|NCT03410693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314245|NCT03410680|Randomized|Parallel Assignment||Treatment||None (Open Label)|The recruiting staff will not have access to the results of randomization prior to recruiting the participant.|||||
1314246|NCT03410667|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314247|NCT03410654||Single Group Assignment||Treatment||None (Open Label)||||||
1314248|NCT03410641|||Other||Prospective|||||||
1314249|NCT03410628||Single Group Assignment||Treatment||None (Open Label)||||||
1314250|NCT03410615|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a non-comparative, randomized, phase II study of cisplatin plus radiotherapy or durvalumab plus radiotherapy followed by adjuvant durvalumab or durvalumab plus radiotherapy followed by adjuvant tremelimumab and durvalumab in intermediate risk, HPV-positive, locoregionally advanced oropharyngeal squamous cell cancer (LA-OSCC) of the head and neck.||||
1314251|NCT03410602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1314252|NCT03410589|||Other||Cross-Sectional|||||||
1314253|NCT03410576|||Cohort||Prospective|||||||
1314254|NCT03410563|||Cohort||Prospective|||||||
1314257|NCT03410524|Randomized|Parallel Assignment||Diagnostic||Triple|Endoscopist and patient blinded study.||t|t|t|
1314258|NCT03410511|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1314259|NCT03410498||Single Group Assignment||Basic Science||None (Open Label)||||||
1314260|NCT03410485|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314261|NCT03410472|Randomized|Parallel Assignment||Treatment||Single|Only the individual performing the outcome measures will me masked to the assignment of the subjects.|This is a randomized parallel design study||||t
1314262|NCT03410459|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1314263|NCT03410446||Single Group Assignment||Treatment||None (Open Label)||||||
1314264|NCT03410433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314265|NCT03410420|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||This is a prospective study designed to determine the safety and value of pimonidazole hydrochloride to detect levels of tissue hypoxia in patients presenting with ascending aortic aneurysm||||
1314266|NCT03410407|||Case-Only||Retrospective|||||||
1314267|NCT03410394|||Cohort||Prospective|||||||
1314268|NCT03410381||Single Group Assignment||Other||None (Open Label)||||||
1314269|NCT03410368|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with small-cell lung cancer receive autologous NK cells adoptive cancer immunotherapy as a maintenance therapy in the presence of stable disease (SD), partial remission (PR) or complete remission (CR) after the first-line chemotherapy.||||
1314270|NCT03410355|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will be blinded to the intervention|randomized control trial||||t
1314271|NCT03410342|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1314272|NCT03410329|Randomized|Parallel Assignment||Other||Single||||||t
1314273|NCT03410316|||Cohort||Prospective|||||||
1314274|NCT03410303||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314275|NCT03410290|||Cohort||Prospective|||||||
1314276|NCT03410277||Single Group Assignment||Basic Science||None (Open Label)||||||
1314277|NCT03410264|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors are prevented from having knowledge of the interventions assigned to individual participants.|Randomized controlled trial with three treatment conditions.||||t
1314278|NCT03410251|||Other||Cross-Sectional|||||||
1314279|NCT03410238|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1314280|NCT03410225|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomized through a permuted random blocks assignment procedure with block stratification (by age group). Strings of varying length (2, 4, 6, 8, for example), with equal allocations T and C (randomly ordered) within a string, are combined to produce a single, long string of T and C combinations (e.g. TTCCTCTTCCC, etc.). Because the long string is made up of blocks of T and C strings with equal allocations of Ts and Cs, the observed percentage of the sample in the treatment condition will always be very close to 0.5, and the true P(T) for all observations will be 0.5. Randomization will be conducted via an algorithm on the online portal at the time of enrollment in order for the project coordinator to assign the participant to an intervention arm.||||
1314281|NCT03410212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314282|NCT03410199|||Case-Control||Prospective|||||||
1314283|NCT03410186|||Case-Only||Prospective|||||||
1314284|NCT03410173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314285|NCT03410160|||Case-Control||Prospective|||||||
1314286|NCT03410147|Randomized|Crossover Assignment||Basic Science||Single||A single blind, randomized, crossover monocentric study in a cohort of adult healthy volunteers|t|||
1314287|NCT03410134||Single Group Assignment||Treatment||None (Open Label)||||||
1314288|NCT03410121|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1314289|NCT03410108||Single Group Assignment||Treatment||None (Open Label)||||||
1314290|NCT03410095|||Cohort||Prospective|||||||
1314291|NCT03410082|Randomized|Parallel Assignment||Supportive Care||Single|The person who surveys the patient's satisfaction in the post anesthesia care unit does not know which group the patient was assigned to.|Randomized controlled trial||||t
1314292|NCT03410069||Single Group Assignment||Prevention||None (Open Label)||||||
1314293|NCT03410056|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1314294|NCT03410043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314295|NCT03410030||Single Group Assignment||Treatment||None (Open Label)||||||
1314296|NCT03410017|||Case-Only||Prospective|||||||
1314297|NCT03410004||Single Group Assignment||Treatment||None (Open Label)||||||
1314298|NCT03409991|Randomized|Parallel Assignment||Other||Single||||t||
1314299|NCT03409978|||Case-Only||Prospective|||||||
1314300|NCT03409965||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-randomized study||||
1314301|NCT03409952|Non-Randomized|Sequential Assignment||Treatment||Single|"Group A: Three blinded physician evaluators will assess an identical set of split side post-treatment photos, comparing the left and right photo for improvement in benign pigmented lesions.~Group B: Three blinded physician evaluators will assess an identical set of pre-treatment and post-treatment photos, comparing the left and right photo for improvement in benign pigmented lesions."|Subjects will be enrolled first into Group A, then Group B will be enrolled. Subjects may not be enrolled in both groups.||||t
1314302|NCT03409939||Single Group Assignment||Basic Science||None (Open Label)||||||
1314303|NCT03409926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314304|NCT03409913|||Case-Control||Retrospective|||||||
1314305|NCT03409900|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1314306|NCT03409887|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1314307|NCT03409874|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1314308|NCT03409861|||Other||Other|||||||
1314309|NCT03409848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314310|NCT03409835|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1314311|NCT03409822||Single Group Assignment||Diagnostic||None (Open Label)||||||
1573412|NCT00001324||||||||||||
1314313|NCT03409796|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1314314|NCT03409783|Randomized|Parallel Assignment||Treatment||Single|Devices are assigned per the randomization schedule, with the sham device identical to the active device in every way except that no neuromodulation is delivered. The neuromodulation that the active device delivers can be done in a way that causes no sensation, so subjects are not unmasked.|Single blind, randomized, sham controlled study|t|||
1314315|NCT03409770|Randomized|Parallel Assignment||Treatment||Single|MR spectroscopy analysis will be masked to the allocation|Therapeutic hypothermia (33 to 34 C) for 3 different durations (24, 48, or 72 h) and usual care (normothermia)||||t
1314316|NCT03409757|||Case-Control||Prospective|||||||
1314317|NCT03409744||Single Group Assignment||Treatment||None (Open Label)||||||
1314318|NCT03409731||Single Group Assignment||Prevention||None (Open Label)||||||
1314319|NCT03409718|||Cohort||Prospective|||||||
1314320|NCT03409705|Randomized|Parallel Assignment||Treatment||Single||||||t
1314321|NCT03409692|||Case-Only||Retrospective|||||||
1314322|NCT03409679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314323|NCT03409666|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 assignment of treatment||||
1314324|NCT03409653|||Cohort||Prospective|||||||
1314325|NCT03409640|||Cohort||Prospective|||||||
1314326|NCT03409627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1314327|NCT03409614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314328|NCT03409601|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1314329|NCT03409588||Single Group Assignment||Treatment||None (Open Label)||||||
1314330|NCT03409575|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1314331|NCT03409562|Randomized|Parallel Assignment||Treatment||Single||||||t
1314332|NCT03409549|||Cohort||Prospective|||||||
1314333|NCT03409536|||Cohort||Prospective|||||||
1314334|NCT03409523|||Other||Prospective|||||||
1314335|NCT03409510||Single Group Assignment||Basic Science||None (Open Label)||This is single-centre, open and non-blinded clinical trial. Enrolled participants were allocated into two groups, light-skinned group and darker-skinned group, based on their Fitzpatrick Skin Type and ethnic origin. As both groups received identical intervention no masking was used. The main purpose was to include participants representing a broad variation in skin pigmentation for common analysis. To ensure this, participants were allocated into two groups and firstly analysed as such to determine if a common analysis was possible.||||
1314336|NCT03409497|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1314337|NCT03409484|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1314338|NCT03409471|||Other||Cross-Sectional|||||||
1314339|NCT03409458||Single Group Assignment||Treatment||None (Open Label)||||||
1314340|NCT03409445|||Cohort||Retrospective|||||||
1314341|NCT03409432||Single Group Assignment||Treatment||None (Open Label)||||||
1314342|NCT03409419|||Cohort||Prospective|||||||
1314343|NCT03409406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314344|NCT03409393|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||The participants will be randomly assigned (1:1) to either an Intervention Group that in the initial study phase (week 0-8) receives the COPUS intervention plus usual care (i.e. OPUS treatment) or to a Control Group that only receives usual care in the initial phase. In the second phase of the study (week 8-16), participants allocated to the control group are offered the COPUS intervention.||||
1314345|NCT03409380|Randomized|Crossover Assignment||Basic Science||Quadruple||double - blind randomized, crossover design trial|t|t|t|t
1314346|NCT03409367|Randomized|Single Group Assignment||Prevention||Triple|"Due to the nature of the intervention, it is not possible blind dyads to the intervention. Administering a placebo emollient is impossible as there are no active ingredients in the emollient and using an emollient that has no barrier improvement properties may irritate the skin. The clinician completing the final assessment will be a blinded assessor.~Clinic staff will not be informed of participant enrollment or study arm. Parents will be instructed not to disclose their treatment group to clinic staff. Clinicians and clinic staff will direct participants to follow skin care recommendations as described by the study materials.~Blinded researchers will be responsible for health record review to collect the primary outcome. At completion of health record review, researchers will complete a form measuring whether the assessor became unblinded while reviewing the record."|"This is a pragmatic, multi-site, randomized community-based trial in which dyads of a parent or legal guardian (parent) and an infant age 0 to 2 months are enrolled. Participating dyads are randomly assigned to receive lipid-rich emollient with web-based instructions for daily use to infants plus routine skin care instructions (every day moisturizer group) or routine skin care instructions alone (natural skin group). Both groups will receive e-mail and text message reminders to follow protocol instructions based on their group allocation until the infant reaches 24 months old."||t|t|t
1314347|NCT03409354|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1314348|NCT03409341|||Case-Only||Prospective|||||||
1314349|NCT03409328|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314350|NCT03409315|||Cohort||Prospective|||||||
1314351|NCT03409302|Randomized|Parallel Assignment||Treatment||Double|Double blind (subject, outcome assessor)||t||t|
1314352|NCT03409289|||Cohort||Prospective|||||||
1314353|NCT03409276|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1314354|NCT03409263|||Case-Only||Prospective|||||||
1314355|NCT03409250||Single Group Assignment||Treatment||None (Open Label)||||||
1314356|NCT03409237|||Case-Control||Prospective|||||||
1314357|NCT03409224|||Cohort||Prospective|||||||
1314358|NCT03409211|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314359|NCT03409198|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, open-label||||
1314360|NCT03409185|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314361|NCT03409172|Randomized|Parallel Assignment||Treatment||Single|Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking)|Three-arm parallel, Randomized-controlled study||||t
1314364|NCT03409133||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1314365|NCT03409120||Single Group Assignment||Basic Science||None (Open Label)|"This study will run in conjunction with Biomarkers to Guide Directional DBS for Parkinson's Disease (ClinicalTrials.gov Identifier: NCT03353688). It is a double blinded study investigating the effectiveness of directional DBS leads in which participants and some investigators will have no knowledge of the DBS settings participants experience."|To measure the effects of directional DBS on dystonia, we will measure the change in the Burke-Fahn-Marsden Dystonia Rating Scale at 2, 4, 6, and 12 months after surgery versus preoperative baseline||||
1314366|NCT03409107|Randomized|Parallel Assignment||Treatment||Double|This will be a double-blind study. The subject, investigator, site staff, and study team will be blinded to the assigned study treatment.|Subjects will be randomized to receive Daprodustat or placebo in a randomized manner.|t||t|
1314367|NCT03409094|||Cohort||Prospective|||||||
1314368|NCT03409081||||||||||||
1314369|NCT03409068|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1314370|NCT03409055|||Cohort||Retrospective|||||||
1314371|NCT03409042|||Cohort||Prospective|||||||
1314372|NCT03409029||Single Group Assignment||Basic Science||None (Open Label)||Single site, non-randomised basic science study||||
1314373|NCT03409016|||Case-Control||Cross-Sectional|||||||
1314374|NCT03409003|||Cohort||Prospective|||||||
1314375|NCT03408990|||Cohort||Cross-Sectional|||||||
1314376|NCT03408977|Randomized|Parallel Assignment||Other||Single|||t|||
1314377|NCT03408964|||Cohort||Prospective|||||||
1314378|NCT03408951|||Cohort||Prospective|||||||
1314379|NCT03408938|||Cohort||Cross-Sectional|||||||
1314380|NCT03408925|Randomized|Parallel Assignment||Prevention||Double|Test assessors and data collectors will be blinded to treatment allocation. The randomized phase will be unblinded after 14 weeks of data collection and the long-term follow-up (4 months) will be conducted by test assessors blinded to treatment allocation.|RCT, two groups (intervention/control)|||t|t
1314381|NCT03408912||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314382|NCT03408899||Single Group Assignment||Prevention||None (Open Label)||||||
1314383|NCT03408886|Randomized|Parallel Assignment||Treatment||Quadruple|In Part 1, everyone is blinded except for the research pharmacist. In Part 2, the participants and study coordinator are unblinded, but the professional evaluators are blinded.|There are two groups. In Part 1, group A receives treatment and group B receives placebo. In Part 2, group A continues to receive treatment, and group B is switched to treatment.|t|t|t|t
1314384|NCT03408873||Single Group Assignment||Treatment||None (Open Label)||||||
1314385|NCT03408860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314386|NCT03408847|Randomized|Parallel Assignment||Supportive Care||Double|Patients will receive a bottle with experiental oil or placebo, consisting of commercial refined olive oil. No diffencences between the two bottles.|Pilot study|t||t|
1314387|NCT03408834|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1314388|NCT03408821||Single Group Assignment||Treatment||None (Open Label)||Participants will attend 8 weekly sessions of Case Manager delivered Problem Solving Therapy.||||
1314389|NCT03408808|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will be blinded to the treatment received.|Randomisaed controlled trial with two arms. Control - Aspiration alone. Intervention - aspiration plus injection of platelet righ plasma.||||t
1314390|NCT03408795||Single Group Assignment||Other||None (Open Label)||||||
1314391|NCT03408782|||Cohort||Prospective|||||||
1314392|NCT03408769|||Cohort||Prospective|||||||
1314393|NCT03408756|Randomized|Parallel Assignment||Treatment||Single|||||t|
1314394|NCT03408743|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1314395|NCT03408730|Randomized|Parallel Assignment||Prevention||Triple||Double-blind Randomized Controlled Trial|t||t|t
1314396|NCT03408717|||Cohort||Prospective|||||||
1314397|NCT03408704|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Parallel group randomized controlled trial||||
1314398|NCT03408691|Randomized|Parallel Assignment||Treatment||Double|double blind only in Test and Control arm open label in arm without intervention|Single-site exploratory randomized, controlled interventional trial with a parallel group design: double blind with Test and Control arm + open label arm without intervention.|t||t|
1314399|NCT03408678|||Cohort||Retrospective|||||||
1314400|NCT03408665||Single Group Assignment||Treatment||None (Open Label)||||||
1314401|NCT03408652|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1314402|NCT03408639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314403|NCT03408626|Randomized|Parallel Assignment||Treatment||Single||||||t
1314404|NCT03408613|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314405|NCT03408600|||Cohort||Prospective|||||||
1314406|NCT03408587||Single Group Assignment||Treatment||None (Open Label)||||||
1314407|NCT03408574|Randomized|Parallel Assignment||Basic Science||Triple|This is a double blind study. The PI and all study personnel are blinded. Only the pharmacist dispensing the medication and the biostatistician who created the counterbalancing order are unblended.|Healthy older adults aged 65-75 and healthy younger adults aged 18-30 will be recruited. Each participant will take part in 3 nicotinic drug challenge days. The three drugs are counterbalanced across study days within each group and balanced by sex.|t||t|t
1314408|NCT03408561||Single Group Assignment||Health Services Research||None (Open Label)||||||
1314447|NCT03408054|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314448|NCT03408041|||Cohort||Retrospective|||||||
1314449|NCT03408028|||Cohort||Retrospective|||||||
1314450|NCT03408015|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Three groups of individuals will be recruited: asymptomatic non-contact lens wearers; symptomatic non-contact lens wearers, with dry eye disease; symptomatic contact lens wearers, with contact lens discomfort. All three groups will receive the same Xiidra treatment for the complete study duration.||||
1314451|NCT03408002|Randomized|Parallel Assignment||Prevention||Single|||t|||
1314452|NCT03407989|||Cohort||Prospective|||||||
1573413|NCT00001318||||Treatment||||||||
1314409|NCT03408548|Randomized|Parallel Assignment||Other||Quadruple|"Periodontal clinical examination (pre- and post-intervention) will be conducted by a single trained and calibrated examiner, who will be blinded to the experimental groups of the study. The examiner will also be blinded to the microbiological and immunological evaluations. SRP procedures will be performed by specialist in Periodontics, trained for these purposes, who will also be blinded to the experimental groups of the study.~The coded lozenge will be given to the examiner, who will distribute them to the patients and will not have any access to information regarding the content of the lozenge. In addition, the patients will be blinded to the content of the lozenge and the treatment assignment during the study. The meaning of each code number will be revealed by the study coordinator only after conducting the statistical analysis of the experimental data."|According to a random numeric table generated by a computer software, the study coordinator will allocate each patient into one of the following groups: Control (Scaling and Root Planing - SRP) or Test (SRP + probiotic therapy). The subjects (Control group) will receive placebo lozenge. In the Test group, the lozenge will contain Bifidobacterium lactis HN019. Individuals will be instructed (immediately after the first session of mechanical instrumentation) to consume twice a day for 4 weeks by dissolving the lozenge before bedtime and when wake up. They will also be instructed not to consume other probiotic product during the study. Clinical, immunological and microbiological parameters will be assessed at baseline (pre-intervention) and after completion of non-surgical periodontal therapy 30 and 90 days.|t|t|t|t
1314410|NCT03408535||Single Group Assignment||Supportive Care||None (Open Label)||A single-centre feasibility study of a clinical study with one arm (intervention-only). A before and after intervention design will be used. A sub-group of participants will take part in a qualitative follow-up session.||||
1314411|NCT03408522|||Cohort||Prospective|||||||
1314412|NCT03408509||Single Group Assignment||Prevention||None (Open Label)||||||
1314413|NCT03408496|Randomized|Parallel Assignment||Treatment||Single||Participants will be allocated in 3 groups. The myofascial release group, muscle stretching group and control group.||||t
1314414|NCT03408483|Randomized|Parallel Assignment||Treatment||Double||In this randomized controlled study we aim to compare QLB (intervention) with control (no intervention) group in patients undergoing THA with regard to the VAS pain scores (at PACU arrival & dischage,12, 24 & 36 hours), duration of analgesia, time to first opioid medication, physical therapy evaluations, time to discharge, and surgeon and patient satisfaction scores.|t||t|
1314415|NCT03408470|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1314416|NCT03408457|||Case-Only||Prospective|||||||
1314417|NCT03408444||||||||||||
1314418|NCT03408431|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled trial|t|||t
1314419|NCT03408418|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1314420|NCT03408405||Sequential Assignment||Diagnostic||None (Open Label)||"Inclusion Criteria:~Patients between the ages of 2-21 years who fail a minimum of 12 weeks of cumulative therapy with prednisone OR one other alternate immunosuppressive agent for treatment of nephrotic syndrome, will be eligible for inclusion. Nephrotic syndrome is defined as: Presence of edema, Edema, UP/C ≥2, ≥300mg/dl or 3+ protein on Albustix, and hypoalbuminemia ≤2.5 g/dL~Calculated GFR (eGFR) using modified Schwartz formula of > 50 mls/min/m2. (Modified Schwartz formula = 0.413 x height (cms) ÷ serum creatinine mg/dL)~A clinical or biopsy diagnosis of nephrotic syndrome within the last 3 years prior to enrollment in the study.~Renal biopsy (if available) consistent with a diagnosis of Minimal Change Disease, IgM nephropathy, Mesangioproliferative Glomerulonephritis, Primary Focal Segmental Glomerulosclerosis or C1q Nephropathy"||||
1314421|NCT03408392|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1314422|NCT03408379|||Case-Only||Prospective|||||||
1314423|NCT03408366||Single Group Assignment||Treatment||None (Open Label)||Twenty consecutive patients will be enrolled: the first 10 will have skin closure with staples, and the second 10 will have skin closure with a running subcuticular suture.||||
1314424|NCT03408353|||Case-Only||Prospective|||||||
1314425|NCT03408340|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants in the study will be randomized to the control arm or experimental arm using computer-generated random assignment, which will be prepared at the start of the study and the assignments held in sealed envelopes. Once the participant is enrolled in the study and consent has been obtained the investigator will open the next consecutive sealed envelope which contains the patient's group assignment (experimental or control).||||
1314426|NCT03408327|Randomized|Parallel Assignment||Other||Single||We will conduct a single-blinded, randomized controlled study. Ninety participants will be randomly assigned to experimental group or control group. The intervention for both groups will last for 12 weeks, with a 12-week of follow-up.|t|||
1314427|NCT03408314|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1314428|NCT03408301|||Cohort||Prospective|||||||
1314429|NCT03408288|||Other||Prospective|||||||
1314430|NCT03408275|||Cohort||Prospective|||||||
1314431|NCT03408262|Randomized|Parallel Assignment||Prevention||Single|||t|||
1314432|NCT03408249||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314433|NCT03408236|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1314434|NCT03408223|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314435|NCT03408210|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314436|NCT03408197|Randomized|Parallel Assignment||Prevention||Single|||t|||
1314437|NCT03408184|Randomized|Parallel Assignment||Supportive Care||Single||Parallel Assignment||||t
1314438|NCT03408171|Randomized|Parallel Assignment||Other||None (Open Label)||Participants are assigned to one of two groups for the duration of the study.||||
1314439|NCT03408158|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314440|NCT03408145|Randomized|Sequential Assignment||Treatment||Single|||t|||
1314441|NCT03408132||Single Group Assignment||Supportive Care||None (Open Label)||||||
1314442|NCT03408119|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314443|NCT03408106|||Cohort||Prospective|||||||
1314444|NCT03408093|||Cohort||Cross-Sectional|||||||
1314445|NCT03408080||Single Group Assignment||Treatment||None (Open Label)|This is an open trial. There is no masking.|||||
1314446|NCT03408067|||Case-Only||Cross-Sectional|||||||
1573414|NCT00001317||||Treatment||||||||
1314453|NCT03407976||Single Group Assignment||Treatment||None (Open Label)||open label nonrandomized Phase I/ IIA trial designed to assess the safety, tolerability, and efficacy of apatinib in combination with pembrolizumab||||
1314454|NCT03407963||Single Group Assignment||Treatment||None (Open Label)||||||
1314455|NCT03407950|Randomized|Parallel Assignment||Treatment||Single||||||t
1314456|NCT03407937||Single Group Assignment||Basic Science||None (Open Label)||Repeated measures on a single group of participants||||
1314457|NCT03407924|Randomized|Parallel Assignment||Treatment||None (Open Label)||Intervention will consist of aerobic exercise sessions at predetermined heart rate range.||||
1314458|NCT03407911|||Ecologic or Community||Other|||||||
1314459|NCT03407898|||Case-Crossover||Prospective|||||||
1314460|NCT03407885|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1314461|NCT03407872|Randomized|Sequential Assignment||Treatment||Double|Only PART C will be double-blind.||t||t|
1314462|NCT03407859||Sequential Assignment||Treatment||None (Open Label)||||||
1314463|NCT03407846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314464|NCT03407833|||Case-Control||Prospective|||||||
1314465|NCT03407820|Randomized|Parallel Assignment||Treatment||Double|Both patient and surgeon will be blinded until just before the start of the procedure.||t|t||
1314466|NCT03407807|||Cohort||Prospective|||||||
1314467|NCT03407794|Randomized|Parallel Assignment||Prevention||Double|The study investigators will be blinded to the treatment conditions and the outcome assessors will only have access to study ID numbers when conducting the lab analyses.|This is a randomized parallel-arm trial|||t|t
1314468|NCT03407781||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314469|NCT03407768||Single Group Assignment||Treatment||None (Open Label)||||||
1314470|NCT03407755|Randomized|Parallel Assignment||Treatment||Double|Surgeon and patient masked to choice of intraocular gas. Study coordinator not masked.|Patients randomized to either air or sulfur hexafluoride (SF6)|t||t|
1314471|NCT03407742|Randomized|Parallel Assignment||Prevention||Single|Data manager was in charge of conducting randomization and allocating parents to treatment conditions.|Participants were randomized to one of two conditions: (a) intervention consisting of parenting program, or (b) wait-list control group|t|||
1314472|NCT03407729|||Cohort||Prospective|||||||
1314473|NCT03407716|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1314474|NCT03407703|||Cohort||Prospective|||||||
1314475|NCT03407690|||Family-Based||Prospective|||||||
1314476|NCT03407677||Single Group Assignment||Supportive Care||None (Open Label)|During the baseline period patients will be blinded to the feature of the ROTO track®, which registers site of insulin injection and the features (vibration and light) that can assist the patient in rotation of injections. Patients will in the first week of the study be informed, that the ROTO track® is being developed as a new automatic device to register data on insulin injections including day, time and dose of insulin.|||||
1314477|NCT03407664|||Cohort||Retrospective|||||||
1314478|NCT03407651|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1314479|NCT03407638|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|"Statistical analysts (biostatisticians) who analyze trial results will be masked for objectives 1 and 2.~Main analyses of the primary outcome will be conducted by the National Drug Abuse Treatment Clinical Trials Network (NDAT CTN) Data and Statistics Center (DSC). The de-identified dataset provided to the DSC by the data management team at Kaiser Permanente Washington Health Research Institute will have the identity of the intervention and Usual Primary Care clinic at each site masked."|Pragmatic Trial: Six health systems are participating in a pragmatic, cluster-randomized, quality improvement trial (hybrid Type III implementation trial). Each of the 6 health systems provided 2 PC clinics willing to be in the randomized controlled trial. Each health system will implement collaborative care for OUD treatment in one randomly selected PC clinic. All data used to evaluate primary and secondary outcomes are secondary data from the EHR or insurance claims.||||
1314480|NCT03407625|Randomized|Parallel Assignment||Treatment||None (Open Label)||Cluster randomized trial||||
1314481|NCT03407612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314482|NCT03407599|Randomized|Crossover Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.||t|t|t|t
1314483|NCT03407586||Single Group Assignment||Prevention||None (Open Label)|All participants provided written informed consent to join the intervention of diagnostic rather than syndromic management.|Prospective cohort study||||
1314484|NCT03407573|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1314485|NCT03407560||Single Group Assignment||Treatment||None (Open Label)||Pilot study||||
1314486|NCT03407547||Single Group Assignment||Basic Science||None (Open Label)||||||
1314487|NCT03407534|||Cohort||Prospective|||||||
1314488|NCT03407521|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314489|NCT03407508|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1314490|NCT03407495||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314491|NCT03407482||Single Group Assignment||Treatment||None (Open Label)||||||
1314492|NCT03407469|||Cohort||Prospective|||||||
1314493|NCT03407456|||Cohort||Prospective|||||||
1314494|NCT03407443|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1314495|NCT03407430|Randomized|Crossover Assignment||Prevention||Quadruple|Double-blind|placebo-controlled, double blind, randomized crossover trial|t|t|t|t
1314496|NCT03407417|Randomized|Parallel Assignment||Screening||Single|Study Team will recruit an ethnically diverse sample of eligible patients (N = 3,000, 1,500 men, 1,500 women, evenly distributed across White, African-American, Hispanic/Latino) to complete the intervention||t|||
1314535|NCT03406884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314536|NCT03406871||Single Group Assignment||Treatment||None (Open Label)||||||
1314537|NCT03406858||Single Group Assignment||Treatment||None (Open Label)||||||
1314538|NCT03406845|Randomized|Parallel Assignment||Treatment||Single|As described above.|RCT||||t
1314539|NCT03406832|Randomized|Parallel Assignment||Prevention||Single||||||t
1314497|NCT03407404|Randomized|Parallel Assignment||Treatment||Double|"Drugs will be premixed and coded for ketamine-midazolam or morphine-midazolam. The colorless drug mixture shall be provided to the attending physician to start the infusion at 2ml/hour and to be titrated to the desired level of sedation.~The investigator and participant will be unaware of which group a certain patient is under."|Patients will be randomized to either receive ketamine-midazolam or morphine-midazolam for continous sedation at enrollment, then followed up for outcomes.|t||t|
1314498|NCT03407391|||Cohort||Prospective|||||||
1314499|NCT03407378|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1314500|NCT03407365|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1314501|NCT03407352|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1314502|NCT03407339|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1314503|NCT03407326|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1314504|NCT03407313||Single Group Assignment||Treatment||None (Open Label)||||||
1314505|NCT03407300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314506|NCT03407287|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1314507|NCT03407261|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1314508|NCT03407248|||Ecologic or Community||Cross-Sectional|||||||
1314509|NCT03407235||Single Group Assignment||Health Services Research||None (Open Label)||||||
1314510|NCT03407222|Randomized|Parallel Assignment||Treatment||None (Open Label)||Send text messages which encourage step-by-step increment of daily step count||||
1314511|NCT03407209|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314512|NCT03407196|||Cohort||Retrospective|||||||
1314513|NCT03407183|||Cohort||Prospective|||||||
1314514|NCT03407170||Single Group Assignment||Treatment||None (Open Label)||||||
1314515|NCT03407157|Randomized|Parallel Assignment||Treatment||Quadruple|The randomisation process will assign each participant with a unique study ID number. This study ID number will be required when allocating study drug bottles and lozenge packages and for recording data on the case report form (CRF). The drug bottle number and lozenge packs will be dispensed by a study team member directly to the participant. Probiotics and placebos will look and taste identical and drug bottles and lozenge packs and labels will look identical.|Randomisation will be centrally controlled using a web-based computerised randomisation platform at the BC Children's Hospital Research Institute, run by the PRE-EMPT (Pre-eclampsia Eclampsia Monitoring Prevention and Treatment) research group, UBC. PRE-EMPT will provide the randomisation platform, and web-linked drug supply management system. Randomisation will occur in random blocks of 2 and 4. Women will be randomised on a 1:1 ratio to probiotic:placebo.|t|t|t|t
1314516|NCT03407144|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314517|NCT03407131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314518|NCT03407118|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1314519|NCT03407105||Single Group Assignment||Treatment||None (Open Label)||||||
1314520|NCT03407092|||Cohort||Prospective|||||||
1314521|NCT03407079|Randomized|Crossover Assignment||Other||Double|||t||t|
1314522|NCT03407066|||Cohort||Cross-Sectional|||||||
1314523|NCT03407053|||Cohort||Cross-Sectional|||||||
1314524|NCT03407040|||Cohort||Retrospective|||||||
1314525|NCT03407027|Randomized|Parallel Assignment||Treatment||Quadruple||In this randomized, double-blind trial, patients will be randomized into one of three groups. First group, infiltration of the quadratus lumborum muscle and fascia (with 40mg of triamcinolone and 10ml of levobupivacaine 0,25%). Second group, gluteus maximus and fascia infiltration with 40mg of triamcinolone and 10ml of levobupivacaine 0,25%. The last group, namely the control group, infiltration of the quadratus lumborum muscle and fascia with 10ml of levobupivacaine 0,25%.|t|t|t|t
1314526|NCT03407001||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314527|NCT03406988|Randomized|Parallel Assignment||Treatment||Double|"Each enrolled patient will be blind regarding the administered therapy (active and sham procedure).~Evaluation of primary and secondary outcomes will be performed by assessors blind regarding the administered therapy."|"Candidate SSc patients will have only one active DU of at least 6 mm in diameter, lasting for at least 6 weeks, despite conventional vascular therapy. Patients with severe visceral manifestations, diabetes and treated with immune-suppressors and endothelin inhibitors will be excluded. Active therapy: implantation of 0.5-1 ml of autologous AT at the base of the finger with DU. Autologous AT will be obtained by liposuction from abdominal fat.~SP will be blindly performed in the control group to simulate the AT-G. A false liposuction will be performed followed by the injection of 0.5-1 ml of 0.9% saline solution at the base of the affected finger. Basal therapy: weekly iloprost infusion (0.5-2 ng/Kg/min), and calcium-channel blockers (oral nifedipine 20 mg daily) will be continued during the entire observation time in all of the patients recruited in both arms of the study. The administration of analgesics to alleviate the DU-related pain will be also allowed for each patient."|t|||t
1314528|NCT03406975|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1314529|NCT03406962||Single Group Assignment||Treatment||None (Open Label)||||||
1314530|NCT03406949||Single Group Assignment||Treatment||None (Open Label)||3+3+3 dose escalation design followed by Cohort Expansion Phase.||||
1314531|NCT03406936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314532|NCT03406923|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1314533|NCT03406910|||Cohort||Prospective|||||||
1314534|NCT03406897|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is a two-arm, open label, randomized trial. All four groups will receive standard intensive diabetes treatment with insulin and dietary management.~Group I: Fourteen (14) adults (18-65 years) of established T1D > 6 months (>180 days) and up to 10 years of T1D duration Group II: Fourteen (14) adults (18-65 years) of new-onset T1D diagnosed within last 6 months (≤ 180 days) Group III: Fourteen (14) children (6-17 years) of established T1D > 6 months (>180 days) and up to 10 years of T1D duration Group IV: Fourteen (14) children (6-17 years) of new-onset T1D diagnosed within last 6 months (≤ 180 days)~Participants in each group will be randomly assigned in a 1:1 ratio to receive either one year of high dose Omega-3 fatty acids and Vitamin D combination (Arm A) or Vitamin D alone (Arm B). Both arms will receive Vitamin D supplementation."||||
1573415|NCT00001314||||||||||||
1314540|NCT03406819|Randomized|Parallel Assignment||Prevention||Single||||||t
1314541|NCT03406806|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1314542|NCT03406793|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1314543|NCT03406780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314544|NCT03406767|Non-Randomized|Parallel Assignment||Treatment||Single|"As both intervention arms are exercise-based it is impossible to mask the participants or individuals delivering the programs.~All outcome measurements will be performed by a research assistant who is blinded to participant group assignment."|"This study involves evaluation of knee osteoarthritis patients who are participating in one of two existing community-based exercise programs (i.e., the GLA:D® or the JointEffort program). Given the pre-experimental design participants will be enrolled after they have registered for one of the two programs (i.e., participants will not be allocated to group assignment) and there is no control group.~The GLA:D® program consists of 1) pre and post program self-reported and functional outcome measures; 2) 2, 1.5 hour education sessions; and 3) neuromuscular exercise training program administered in 1 hour, small (up to 10 persons) group-based, supervised sessions twice weekly for 6 weeks.~The Joint Effort program consists of: 1) one visit aimed at individualized program design; 2) registered dietician led nutrition seminar; and 3) individualized exercise training program administered in 1 hour, small (up to 10 persons) group-based, supervised sessions twice weekly for 6 weeks."||||t
1314545|NCT03406754|||Cohort||Prospective|||||||
1314546|NCT03406741||Single Group Assignment||Supportive Care||None (Open Label)||||||
1314547|NCT03406728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314548|NCT03406715||Single Group Assignment||Treatment||None (Open Label)||||||
1314549|NCT03406702||Single Group Assignment||Treatment||None (Open Label)||||||
1314550|NCT03406689|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1314551|NCT03406676|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1314552|NCT03406663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314553|NCT03406650||Single Group Assignment||Treatment||None (Open Label)||||||
1314554|NCT03406637|||Case-Only||Other|||||||
1314555|NCT03406624|||Case-Control||Prospective|||||||
1314556|NCT03406611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314557|NCT03406598|||Other||Prospective|||||||
1314558|NCT03406585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314559|NCT03406572|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1314560|NCT03406559||Single Group Assignment||Treatment||None (Open Label)||study on 14 male adolescent patients having skeletal class II, Angle's class II division 2 malocclusion.||||
1314561|NCT03406546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314562|NCT03406533|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1314563|NCT03406520||Single Group Assignment||Prevention||None (Open Label)||Prospective cohort study||||
1314564|NCT03406507||Single Group Assignment||Treatment||None (Open Label)||||||
1314565|NCT03406494|Randomized|Parallel Assignment||Prevention||Single|Outcomes assessor will be independent from the study and blinded from patient allocations.|prospective, multicenter, assessor-blinded, randomized controlled trial||||t
1314566|NCT03406481|||Case-Only||Prospective|||||||
1314567|NCT03406468||Single Group Assignment||Treatment||None (Open Label)||Given the objective of this phase II trial and the limited number of patients, no formal statistical analyses are planned. Analysis will be limited to presentation of frequencies and proportions and the report of descriptive statistics (e.g. mean, median and/or range) in tabulated form.||||
1314568|NCT03406455|||Cohort||Prospective|||||||
1314569|NCT03406442||Single Group Assignment||Treatment||None (Open Label)||||||
1314570|NCT03406429||Single Group Assignment||Other||None (Open Label)|Through use of SHAM rTMS stimulation|Within-subject crossover design||||
1314571|NCT03406416||Single Group Assignment||Treatment||None (Open Label)||||||
1314572|NCT03406403|Randomized|Parallel Assignment||Supportive Care||Double|The patients will be randomized into three equal groups. 60 slips of papers will be taken and labeled as group L (LMA), group M (Magnesium sulphate) and group C (Control). These slips will be placed in an envelope and one slip will be raised for each patient.|We hypothesize that the LMA is more effective than Magnesium sulphate in attenuating systemic stress response during emergence of patients undergoing supratentorial tumours|t|t||
1314573|NCT03406390|||Case-Control||Prospective|||||||
1314574|NCT03406377|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1314575|NCT03406364||Sequential Assignment||Treatment||None (Open Label)||"Phase I:~Eligible subjects will receive 1 of 3 different dosages of the combination therapy of GW5074 and sorafenib. The dose cohorts include:~Monotherapy with 750 mg QD GW5074, followed by 750 mg QD GW5074 + 200 mg QD Sorafenib~1500 mg QD GW5074 + 200 mg QD Sorafenib~750 mg BID GW5074 + 200 mg QD Sorafenib~Phase IIa:~Eligible patients will receive the chosen doing regimen of the combination therapy of GW5074 and sorafenib (within the safe dosing range defined at Phase I) for ≥168 days (24 weeks)."||||
1314576|NCT03406351|||Case-Control||Prospective|||||||
1314577|NCT03406338|Randomized|Parallel Assignment||Treatment||Single|Before examination the patients will wear thin gloves in the treated hands to conceal possible surgical scars so the examiner will be blinded to the group allocation.|Randomized parallel Group, ratio 1:1.||||t
1314578|NCT03406325|||Cohort||Cross-Sectional|||||||
1314579|NCT03406312|||Case-Control||Cross-Sectional|||||||
1314580|NCT03406299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314581|NCT03406286|||Case-Only||Prospective|||||||
1314582|NCT03406273|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314583|NCT03406260|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1314584|NCT03406247|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1314585|NCT03406234|||Cohort||Cross-Sectional|||||||
1314586|NCT03406221|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1314587|NCT03406208|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314588|NCT03406195||Single Group Assignment||Treatment||None (Open Label)||We will perform episodic memory task before and after the TMS session||||
1314589|NCT03406182|||Ecologic or Community||Prospective|||||||
1314590|NCT03406169|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1314591|NCT03406156||Single Group Assignment||Treatment||None (Open Label)||||||
1314592|NCT03406143|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1314593|NCT03406130|Randomized|Parallel Assignment||Treatment||||||||
1314594|NCT03406117|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1314595|NCT03406104|||Cohort||Prospective|||||||
1314596|NCT03406091|||Case-Only||Prospective|||||||
1314597|NCT03406078|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind|Subjects will be randomized in a 1:1 ratio to either tezepelumab or matching placebo both administered subcutaneously|t|t|t|
1314598|NCT03406065|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1314599|NCT03406052|Randomized|Parallel Assignment||Supportive Care||Triple|Psychiatrists providing psychiatric care will be blinded to the group allocation of subjects under their treatment. One outcome assessor (who will conduct the 24-item Hamilton Rating Scale for Depression (HRSD-24) will be blinded. Investigators will be blinded.|||t|t|t
1314600|NCT03406039|Randomized|Parallel Assignment||Treatment||None (Open Label)||A two-arm RCT will be conducted to evaluate the proposed online intervention. Eligible participants will be randomized to either the online integrated treatment condition, or the psycho-educaton (i.e., control) condition.||||
1314601|NCT03406026|Randomized|Parallel Assignment||Treatment||Single||||||t
1314602|NCT03406013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314603|NCT03406000||Single Group Assignment||Treatment||None (Open Label)||||||
1314604|NCT03405987|||Cohort||Prospective|||||||
1314605|NCT03405974|Randomized|Parallel Assignment||Treatment||Quadruple|"Due to the objectives of the study, the identity of ASA and Placebo treatments will not be known to investigators, research staff, or patients. Access to the randomization code will be strictly controlled in order to ensure double-blind administration of study treatments. Packaging and labeling of ASA and Placebo treatments will be identical to maintain the blind.~All of the study drug profiles will be prepared in order to be identical in appearance to preserve the study blinding. The investigator and the subject, as well as all staff involved in the conduct or management of the study will be blinded to which treatment is assigned."|This study is a multicenter, prospective, randomized, double-blind, placebo-controlled trial that aims to test the efficacy of the proposed medical intervention (ASA). The design is intended to be parallel group where a total of 114 patients will be randomized in a 1:1 ratio to the treatment (ASA) and the control (Placebo) arms.|t|t|t|t
1314606|NCT03405961|||Case-Control||Prospective|||||||
1314607|NCT03405948|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1314608|NCT03405935||Single Group Assignment||Treatment||None (Open Label)||||||
1314609|NCT03405922|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1314610|NCT03405909|||Cohort||Prospective|||||||
1314611|NCT03405896||Single Group Assignment||Basic Science||None (Open Label)||||||
1314612|NCT03405883|||Cohort||Prospective|||||||
1314613|NCT03405870|Randomized|Parallel Assignment||Treatment||Single|Because this is a pilot study, and because the lipid emulsion appears white and will be visible to the treatment team, the study will not be blinded. Data abstractors will, however, be blinded to the treatment effect. As the treatment effects are objective measurements (lipid levels, SOFA score, etc.) the likelihood of bias is low.|The study has a Phase I/II design, with the first 16 patients enrolled in the study to evaluate for dose limiting toxicity (DLT). For the first 16 patients enrolled in the Phase I dose-escalation study, there will be no control group, with doses starting at 1.0g/kg and increasing incrementally by 0.2g/kg to a maximum dose of 1.8g/kg. Dose escalation or de-escalation will occur based on whether DLTs are observed at a specific dose, with the threshold for toxicity set at 10%. After evaluating for DLT, the two highest and safest doses will be used to randomize the remaining 48 patients into the Phase II study to either Smoflipid or control (no active treatment) using a Bayesian Optimal Interval Design. Thus, the Phase II arm will include 24 patients randomized to one of the two most efficacious doses of the study drug, while the control group will receive no drug.||||t
1314614|NCT03405857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314615|NCT03405844|||Cohort||Prospective|||||||
1314616|NCT03405831|Randomized|Parallel Assignment||Treatment||Quadruple||"This is a prospective single-center, double-blinded, placebo controlled, randomized study in long-term heart transplant recipients.~Patients who meet the eligibility criteria will be randomized 1:1 at inclusion for one of two treatment groups: (i) treatment with ivabradine 5 mg bid or (ii) treatment with placebo bid for a period of 12 weeks. 35 participants will be enrolled."|t|t|t|t
1314617|NCT03405818||Single Group Assignment||Treatment||None (Open Label)||This was a single group study.||||
1314618|NCT03405805|||Cohort||Prospective|||||||
1314619|NCT03405792|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314620|NCT03405779|||Cohort||Prospective|||||||
1314621|NCT03405766|||Cohort||Retrospective|||||||
1314622|NCT03405753|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1314623|NCT03405740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314624|NCT03405727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314625|NCT03405714||Single Group Assignment||Treatment||None (Open Label)||||||
1314626|NCT03405701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314627|NCT03405688|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1314628|NCT03405675|||Cohort||Prospective|||||||
1314672|NCT03405103|Randomized|Parallel Assignment||Prevention||None (Open Label)||Repeated measures randomized clinical trial||||
1314673|NCT03405090|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1314674|NCT03405077||Single Group Assignment||Treatment||None (Open Label)||||||
1314675|NCT03405064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314676|NCT03405051|||Cohort||Prospective|||||||
1314677|NCT03405038|||Other||Retrospective|||||||
1315156|NCT03398785|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315157|NCT03398772|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1314629|NCT03405662|Randomized|Parallel Assignment||Treatment||Quadruple|Blind assignment determined by a computer-generated random allocation schedule|"Participants randomized to the Active PBM group will use an active Vielight Neuro device, for 16 weeks, once every other day (e.g., Mon, Wed, Fri) for 20 minutes.~Participants randomized to the Sham PBM group will use a a sham Vielight Neuro device, for 16 weeks, once every other day (e.g., Mon, Wed, Fri) for 20 minutes.~All study participants will undergo cognitive and behavioral assessments, blood draw, and lumbar puncture at baseline (before using Vielight Neuro Gamma device) and after 16 weeks of using the Vielight Neuro Gamma device.~Upon completion of the post-16 week assessments, blood draw, and lumbar puncture, patients randomized to the Sham PBM group will be offered an opportunity to use an active Vielight Neuro Gamma device for 16 weeks. We will assess cognition and behavioral symptoms in Sham patients who opt to undergo active PBM 16 weeks after they start active PBM treatments."|t|t|t|t
1314630|NCT03405649|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Women contacting the lab will be divided into those women who have babies less than 20 weeks of age (Group A) and those whose babies are greater than 20 weeks of age (Group B). Each of these groups will be given a separate postpartum exercise program that will run concurrently. These groups were divided by baby age because we felt early postpartum women and babies are a different group than those women with babies 6 months and older.||||
1314631|NCT03405636||Single Group Assignment||Treatment||None (Open Label)||||||
1314632|NCT03405623|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1314633|NCT03405610|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314634|NCT03405597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314635|NCT03405584|Randomized|Parallel Assignment||Treatment||Single||||||t
1314636|NCT03405571|||Case-Only||Prospective|||||||
1314637|NCT03405558|||Cohort||Prospective|||||||
1314638|NCT03405545|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two parallel training groups||||
1314639|NCT03405532|||Case-Control||Prospective|||||||
1314640|NCT03405519||Single Group Assignment||Treatment||None (Open Label)||||||
1314641|NCT03405506|||Cohort||Prospective|||||||
1314642|NCT03405493|Randomized|Parallel Assignment||Treatment||Single||"Both groups will receive treatment as usual.~Triple Chronotherapy. This consists of (a) Total Sleep Deprivation with group support on days one and two; (b) Phase Advance of Sleep over 5 days and daily Light Therapy. (c) Bright Light Therapy is given on Day 2 onwards daily.~Comparator Intervention: Participants will be given information on sleep hygiene and getting a good night's sleep in a written leaflet and given the opportunity to ask questions. They are then given Dim Amber Light Therapy daily for 1 week."||||t
1314643|NCT03405480|Randomized|Parallel Assignment||Treatment||Single||||||t
1314644|NCT03405467|||Case-Only||Retrospective|||||||
1314645|NCT03405454|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized 2:1 to receive either durvalumab at a dose of 1500mg every four weeks for a maximum of 24 months or physician's choice of chemotherapy||||
1314646|NCT03405441|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1314647|NCT03405428||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314648|NCT03405415||Single Group Assignment||Basic Science||None (Open Label)||||||
1314649|NCT03405402|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1314650|NCT03405389|||Case-Only||Prospective|||||||
1314651|NCT03405376||Single Group Assignment||Treatment||None (Open Label)||||||
1314652|NCT03405363|||Cohort||Other|||||||
1314653|NCT03405350|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314654|NCT03405337|||Cohort||Other|||||||
1314655|NCT03405324|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1314656|NCT03405311|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1314657|NCT03405298|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1314658|NCT03405285||Single Group Assignment||Supportive Care||None (Open Label)||||||
1314659|NCT03405272||Single Group Assignment||Treatment||None (Open Label)|Single Arm, Open-label|Treated with recombinant anti-EGFR Monoclonal antibody（SCT200）until disease progression||||
1314660|NCT03405259|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314661|NCT03405246|Randomized|Parallel Assignment||Prevention||Single||||||t
1314662|NCT03405233|Randomized|Parallel Assignment||Treatment||Double|the patients do not know which group will they belong the duplex operator will not know the details of operative data||t|||t
1314663|NCT03405220|Randomized|Factorial Assignment||Prevention||None (Open Label)||"Study 1 will use a 2 (self-affirmation: self-affirmation, control) X 3 (Mode of example: none, write, imagine) experimental design. In the self-affirmation condition, participants will complete the self-affirmation kindness quiz (10 questions) and in the control condition they will complete a personal opinion survey (10 questions). Depending on the mode of example condition, participants will not be asked to provide examples, asked to write examples for each of the 10 questions, or asked to imagine examples for each of the 10 questions.~Based on examination of data from Study 1 (i.e., which items receive more yes responses and for which items examples are provided), in Study 2 we will test whether using fewer self-affirmation items influences dependent variables. Study 2 will use a 3 (Number of questions: 10, 5, 3) X 3 (Mode of example: none, write, imagine) experimental design."||||
1314664|NCT03405207|Randomized|Parallel Assignment||Treatment||Triple||we have 2 groups entitled active drug receiver and placebo receiver and patients will randomly allocated between these two groups at first and continue until finishing the study.|t|t|t|
1314665|NCT03405194|Randomized|Parallel Assignment||Treatment||None (Open Label)||Same-Day ART with Genvoya vs. EFV/TDF/3TC||||
1314666|NCT03405181|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor won't have any knowledge about the study purposes and will be unaware of the group allocation.|||||t
1314667|NCT03405168||Single Group Assignment||Treatment||None (Open Label)||||||
1314668|NCT03405155||Single Group Assignment||Treatment||None (Open Label)||||||
1314669|NCT03405142||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314670|NCT03405129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314671|NCT03405116|||Cohort||Prospective|||||||
1315541|NCT03393780|||Cohort||Prospective|||||||
1314678|NCT03405025||Single Group Assignment||Other||None (Open Label)||All participants will undergo the intervention: endoscopic ultra-sound guided radiofrequency ablation of their left adrenal aldosterone producing adenoma. The primary outcome is safety and feasibility||||
1314679|NCT03405012|||Case-Control||Prospective|||||||
1314680|NCT03404999|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Four-month time series trial||||
1314681|NCT03404986|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314682|NCT03404960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314683|NCT03404947|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1314684|NCT03404934||Single Group Assignment||Treatment||None (Open Label)||||||
1314685|NCT03404921|Randomized|Parallel Assignment||Treatment||None (Open Label)|The operator only understands the operation method required by the patient and is unaware of the observation indicators|||||
1314686|NCT03404908|Randomized|Parallel Assignment||Treatment||Single|Single (Participant)|Parallel Assignment|t|||
1314687|NCT03404895|Randomized|Parallel Assignment||Treatment||Single||Subjects are randomized in the OR to one of two study arms: conventional therapy vs. conventional therapy + venous stent(s).|t|||
1314688|NCT03404882|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to treatment group allocation by not involving them in discussions about study participants and not granting them access to the database which contains the randomization code. In addition, study participants will be asked not to reveal their treatment allocation to their assessor. Moreover, these assessors will not be involved in data analysis. To test the success of blinding we will ask the assessor to guess the treatment group for each participant at six and 12-month follow-up. After data collection is complete all data will undergo a blind review for the purposes of finalizing the planned analysis.|This will be a longitudinal, prospective, parallel design, three arm, rater-blinded randomized clinical trial with a recruitment period of six months and an observation period of 12 months for each participant.||||t
1314689|NCT03404869||Single Group Assignment||Treatment||None (Open Label)||||||
1314690|NCT03404856||Single Group Assignment||Treatment||None (Open Label)||||||
1314691|NCT03404843|Randomized|Crossover Assignment||Basic Science||Triple|A person not associated with any data collection or data analysis is randomizing the treatment and preparing it in a separate room. All data is collected as visit 1 or visit 2.|This is a randomized, double-blind, placebo-controlled, crossover study. Approximately 20 young and 20 older adults will be recruited for participation and randomly assigned to either a placebo (saline) infusion or a fasudil hydrochloride infusion. The dose of fasudil hydrochloride is 60 mg/ 60 min.|t||t|t
1314692|NCT03404830|Randomized|Parallel Assignment||Treatment||Triple|Groups were assigned during the months of July and August through the sports centers where these elderly people performed some kind of physical activity.|Randomized controlled trial||t|t|t
1314693|NCT03404817|Randomized|Crossover Assignment||Other||None (Open Label)||"3-period, 3-sequence crossover evaluating 3 treatments~Treatment-1: new formulation under fed conditions~Treatment-2: new formulation under fasted conditions~Treatment-3: original formulation under fed conditions"||||
1314694|NCT03404804|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1314695|NCT03404791||Single Group Assignment||Treatment||None (Open Label)||||||
1314696|NCT03404778|||Cohort||Prospective|||||||
1314697|NCT03404765|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|All personals involved the study (participants, community center supporting staff, investigators and outcome assessors) had not masked for treatment assignment.|"This interventional study involved two groups of participants, the experimental and usual-care control groups, with no randomization taking place. The participants were recruited from four community health centers and allocated to the experimental or control groups according to the centers to which they belonged.This arrangement avoided possible contamination of the experiment by diffusing the Tai Chi learning.~The intervention group received a 16-week Tai Chi program, of 32 sessions (2 sessions per week), each being one hour long. The control group had no treatment regime and joined different recreational activity groups in the respective community centers as usual within the study period."||||
1314698|NCT03404752|Randomized|Parallel Assignment||Prevention||Single||||||t
1314699|NCT03404739|Randomized|Parallel Assignment||Prevention||Triple|Sequentially numbered, opaque sealed envelopes(SNOSE) will be the method to conceal allocation from the study team.|single- versus multiple-dose antimicrobial prophylaxis|t|t|t|
1314700|NCT03404726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1314701|NCT03404713|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Each eligible participant receives the same standard group treatment for the first four weeks. Early responders continue in that treatment for an additional 12 weeks. Early weak responders are assigned to a higher intensity individualized treatment for the next 12 weeks.||||
1314702|NCT03404700|Randomized|Crossover Assignment||Other||None (Open Label)||"The proposed study will comprise of two parts: Part I: an observational study based on ecological momentary assessment, and Part II: a randomized partial crossover clinical trial. Same subjects will participate in both parts of the study.~In the observational study, the dietary intake of the subjects will be evaluated using an ecological momentary assessment approach for 7 days. In the randomized partial crossover clinical trial, four test breakfasts will be administered so that each subject will get exposed to only two out of the four diets (thus, partial crossover). Therefore, there will be six possible combinations of diets (i.e. 4! / 2! [4-2]!) and 12 possible ordered combinations (i.e. permutations; 4! / [4-2]!) of diets. Four subjects will be randomly assigned to each of these 12 possible ordered combinations of diets. Thus, the total sample size will be 48 (i.e. n = 4x12)."||||
1314703|NCT03404687|||Case-Crossover||Prospective|||||||
1314704|NCT03404674|Randomized|Sequential Assignment||Other||None (Open Label)||||||
1314705|NCT03404661|||Case-Control||Prospective|||||||
1314706|NCT03404648||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314707|NCT03404635|||Cohort||Prospective|||||||
1314818|NCT03403192|Randomized|Parallel Assignment||Supportive Care||Single|The surgeon will be blinded to technique and queried as to the quality of isolation upon entry into the chest and this will be recorded.|The objective of this study is to evaluate the positional stability and quality of lung isolation provided by the EZ-blocker compared to a DLT for both right and left sided thoracic surgery||t||
1573416|NCT00001311||||Treatment||||||||
1314708|NCT03404622|Randomized|Parallel Assignment||Health Services Research||Double|Randomization will be based on the sequence generation created by computer and randomization tablets. Consenting patients fulfilling inclusion criteria will be randomizes into one of the following 2 groups. Randomized allocation will be kept in opaque sealed envelopes, with enrollment numbers written on the envelopes. the envelopes will contain a card on with the designated study group will be written. after enrollment of the patients in the study , the envelopes marked with study number will be unsealed and the patients allocated to either groups|200 pregnant women will be included in this study, will be divided into two groups Group 1 IUCD will be inserted immediate post-placental removal and include 100 pregnant women Group2 IUCD will be inserted 6 weeks postpartum and include 100 pregnant women.|t|t||
1314709|NCT03404609||Single Group Assignment||Treatment||None (Open Label)||||||
1314710|NCT03404596||Single Group Assignment||Prevention||None (Open Label)||||||
1314711|NCT03404583|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1314712|NCT03404570|Randomized|Parallel Assignment||Treatment||Quadruple|The study drug will be provided as oral tablets with active and placebo indistinguishable in product and packing characteristics.|Subjects will be randomized (1:1:1) to one of three Treatment Arms|t|t|t|t
1314713|NCT03404557|||Cohort||Prospective|||||||
1314714|NCT03404544|Randomized|Parallel Assignment||Prevention||Triple|Only the clinical nurse won't be blinded|"Prevention of hemodynamic carbetocin-induced side effects when the study drug carbetocin 100 mcg intravenous is given as an infusion over 10 minutes versus a single shot rapid bolus (same dose). Two syringes per subject will be prepared by the research nurse :~one 3 ml syringe containing 1 ml of either carbetocin 100 mcg or normal saline (according to the patient's study group);~one 10 ml syringe containing carbetocin 100 mcg (1 ml) diluted with 9 ml of normal saline for a total volume of 10 ml, or 10 ml of normal saline (according to the patient's study group).~The volume in the 3 ml syringe will be injected as an IV push bolus after cord clamping and the volume in the 10 ml syringe will be infused over 10 minutes at cord clamping. The study subject, the attending anesthesiologist and the anesthesiologist collecting intraoperative data will be blinded to patient group allocation. The research nurse will not be blinded to patient group allocation."|t|t|t|
1314715|NCT03404531|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314716|NCT03404518|Randomized|Parallel Assignment||Treatment||Double||Patients will be randomized to one of two groups prior to surgery. All patients will be prescribed both Hydrocodone/acetaminophen and Ibuprofen. Group 1 will take the narcotic medication for initial pain control followed by Ibuprofen if pain is not adequately controlled. Group 2 will take Ibuprofen for initial pain control followed by the narcotic medication if pain is not adequately controlled.|||t|t
1314717|NCT03404505|Randomized|Parallel Assignment||Treatment||Single||||||t
1314718|NCT03404492||Single Group Assignment||Other||None (Open Label)||||||
1314719|NCT03404479|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1314720|NCT03404466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314721|NCT03404453|||Cohort||Prospective|||||||
1314722|NCT03404440|Randomized|Parallel Assignment||Treatment||Double|Placebo capsules were identical in shape, colour and taste to Gastrus capsules but without L. reuteri|double-blind randomized, parallel-group, placebo-controlled study.|t||t|
1314723|NCT03404427|Randomized|Crossover Assignment||Basic Science||Single|When analyzing the results (endurance, magnitude of the premotor potential), the outcomes assessor will not know if it is a normal night or a sleepless night|To compare the motor endurance of healthy subjects after a normal sleep night and after a sleepless night.||||t
1314724|NCT03404414||Single Group Assignment||Diagnostic||None (Open Label)|None (Open Label)|Single Group Assignment||||
1314725|NCT03404401|Randomized|Parallel Assignment||Treatment||Single||||||t
1314726|NCT03404388||Single Group Assignment||Treatment||None (Open Label)||||||
1314727|NCT03404375||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314728|NCT03404362|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1314729|NCT03404349||Single Group Assignment||Health Services Research||None (Open Label)||||||
1314730|NCT03404336|Randomized|Parallel Assignment||Treatment||Single|Participants will not be informed if they will receive the WBT or the control condition. Of course, after the end of the study they will receive this information and they will be told why they were blind.|This is a pilot study, designed as a randomized (1:1) controlled trial, comparing WBT vs a control condition. The patients will receive a baseline assessment to confirm the diagnosis of chronic migraine, then socio-demographic information, information on pharmacological/non-pharmacological treatments, on the history of medical diseases and on the psychological status will be collected as well as the number of migraine attacks per month, the duration of migraine attacks, the occurrence of migraine exclusively with menses, and the level of disability related to migraine. Thereafter, the subjects will be randomly assigned to WBT or to a control condition. The subjects will be re-assessed at the end of session 4, 8 of treatment, at 3-month and 6-month follow-ups.|t|||
1314731|NCT03404323|||Cohort||Prospective|||||||
1314732|NCT03404310|Randomized|Parallel Assignment||Treatment||Single|Single-blinded placebo controlled||t|||
1314733|NCT03404297|Randomized|Parallel Assignment||Treatment||None (Open Label)|The trial is open label but the randomization scheme will be determined by an automatic randomization algorithm performed independently of the investigators|"The study will include two different types of evaluation based on the disease process that the patient has. For patients with chronic leg ulcers, a retrospective, observational approach will be used to track the efficacy of locally sourced compression in improving wound healing.~For patients with Kaposi Sarcoma associated leg lymphedema, they will be randomized to to receive immediate compression therapy or delayed compression therapy."||||
1314734|NCT03404284|||Other||Other|||||||
1314735|NCT03404271|Randomized|Factorial Assignment||Other||Triple|Investigators and participants will be blinded to dietary supplement (i.e. HMB or placebo). However, neither the investigators nor participants will be blinded to dietary intervention (TRF or ND) due to the nature of these dietary programs. When possible, outcome assessors will be blinded to group assignment.||t||t|t
1314736|NCT03404258|||Cohort||Prospective|||||||
1314737|NCT03404245|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1314905|NCT03402061|||Other||Prospective|||||||
1314906|NCT03402048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314738|NCT03404232|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||All patients requiring lumbar spinal surgery by the use of a hybrid spinal implant (DTO): (1) patients with their first surgical intervention at the lumbar spine, (2) patients with a previous surgical decompression but non-fusion procedure after LSS and (3) patients with medical history of PLIF-/TLIF-technique and later onset of symptomatic ASD within the superior adjacent segment.||||
1314739|NCT03404219||Single Group Assignment||Health Services Research||None (Open Label)||||||
1314740|NCT03404206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314741|NCT03404193||Single Group Assignment||Treatment||None (Open Label)||||||
1314742|NCT03404180||Single Group Assignment||Basic Science||None (Open Label)||Pilot clinical trial with a single arm||||
1314743|NCT03404167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1314744|NCT03404154|||Cohort||Prospective|||||||
1314745|NCT03404141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1314746|NCT03404128||Single Group Assignment||Other||None (Open Label)||||||
1314747|NCT03404115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314748|NCT03404102|||Cohort||Prospective|||||||
1314749|NCT03404089||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314750|NCT03404076|||Case-Only||Prospective|||||||
1314751|NCT03404063|Randomized|Parallel Assignment||Treatment||Quadruple|"The Data and Safety Monitoring Board (DSMB) will be blinded at project start, but may request unblinding if necessary to accommodate effective review of data.~Other than the DSMB (if necessary), the only other un-blinded parties, meaning that they will have knowledge as to the patient's treatment assignment, will be the PBTiK UJ CM employee who participates in randomization utilizing randomization lists and investigational medication preparation."|"The AMI trial will enroll 105 patients with randomization into active vs. sham therapy with 2:1 ratio.~Additional 5-10 subjects meeting inclusion/exclusion criteria will receive, in a non-blinded fashion, labelled CardioCell to determine the early uptake and retention of IMP in the target ischemic tissues."|t|t|t|t
1314752|NCT03404050||Single Group Assignment||Treatment||None (Open Label)||Assessments taken at three different time periods: week zero, week five and week eleven.||||
1314753|NCT03404037|||Cohort||Prospective|||||||
1314754|NCT03404024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314755|NCT03404011|Randomized|Parallel Assignment||Basic Science||Single||||||t
1314756|NCT03403998|Randomized|Parallel Assignment||Treatment||Triple|Patients (reporting one of the main outcome for this study - pain) will be unaware of the hypothesis of this study and performance biases will be avoided by telling them that both treatment options have similar effectiveness. Assessors (measuring clinician assessed tests) and Statistician will be blinded to hypothesis and group allocation following established guidelines.|A randomization sequence will be computer-generated by a research assistant (RA) not involved in the study. To ensure concealment, the RA will distribute the results of the sequence to the therapist in consecutively numbered, opaque, and sealed envelopes. Participants will be unaware of the study hypothesis. Assessors (who will measure clinician-assessed tests and analyze imaging outcomes) and the statistician will be blinded to the hypothesis and group allocation, following established guidelines. Participants randomized to the treatment group will receive MCTF as described in the Intervention section. Participants randomized to the placebo group will receive placebo transcutaneous electrical nerve stimulation (TENS) as described in the Intervention section|t||t|t
1314757|NCT03403985|Randomized|Parallel Assignment||Treatment||Single|patients are not aware about type of capping material used|Randomized Controlled Retrospective clinical trial|t|||
1314758|NCT03403972||Single Group Assignment||Basic Science||None (Open Label)||||||
1314759|NCT03403959|Non-Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor and the participant is unaware of ipRGC function prior to and during treatment|The study combines two models: a case/control study with observational outcomes where all cases are consequently included in a non-randomized interventional study||||t
1314760|NCT03403946||Single Group Assignment||Treatment||||||||
1314761|NCT03403933||Single Group Assignment||Treatment||None (Open Label)||||||
1314762|NCT03403920|||Case-Only||Prospective|||||||
1314763|NCT03403907||Single Group Assignment||Treatment||None (Open Label)||||||
1314764|NCT03403894|||Cohort||Retrospective|||||||
1314765|NCT03403881|Randomized|Parallel Assignment||Treatment||Single||||||t
1314766|NCT03403868||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314767|NCT03403855|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||"All patients will have a regular full length Rocket catheter inserted at baseline, with an external length of 16cm. All patients will have their catheter length modified at 2 weeks in clinic and shortened to an external length of 5cm. Patient satisfaction will be collected at 2 weeks prior to the modification, and 4 weeks when the patient has a shorter catheter.~The modification is easily done without any use of anesthesia as it is external to the patient. It is done with the tool kit that comes along with the catheter.~All patients will be referred to palliative home care services for assistance with drainage. Drainage catheters are usually provided by Ontario Medical Supplies. However, the drainage catheters to be used in this study will be those supplied by Rocket Medical Inc., as they will be providing Dr. Amjadi with some samples to evaluate their product."||||
1314768|NCT03403842|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1314769|NCT03403829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314770|NCT03403816|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314771|NCT03403803|||Case-Control||Prospective|||||||
1314772|NCT03403790|||Cohort||Prospective|||||||
1314773|NCT03403777||Single Group Assignment||Treatment||None (Open Label)||Non-randomized, open-label, multi-centre trial to assess efficacy (as measured by 12-week progression-free survival) of AVELUMAB in patients with refractory germ cell tumors (GCTs). The Simon optimal 2-stage design (see statistical section) will be used. See section 6 (Statistical Considerations) for specific details.||||
1314907|NCT03402035|||Cohort||Prospective|||||||
1314908|NCT03402022|||Cohort||Retrospective|||||||
1314909|NCT03402009|Randomized|Parallel Assignment||Prevention||Single||||||t
1314910|NCT03401996|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1573417|NCT00001301||||||||||||
1314774|NCT03403764|Randomized|Crossover Assignment||Supportive Care||Triple|The investigator and participants involved in this clinical trial are prevented from having knowledge which intervention is assigned to individual participants. A second control group has no knowledge of the parallel conducted Consciousness Field Project.|Participants receive one of two alternative interventions during the initial phase of the study and receive the other intervention during the second phase of the study and are evaluated in parallel against a control group|t||t|t
1314775|NCT03403751|Randomized|Parallel Assignment||Treatment||Triple|Sponsor personnel and CRAs will also be blinded to study treatment.|1:1 randomization of study drug (Reltecimod) and placebo (normal saline)|t|t|t|
1314776|NCT03403738|Randomized|Parallel Assignment||Treatment||Single|single (outcomes assessor)|Parallel Assignment||||t
1314777|NCT03403725||Single Group Assignment||Treatment||None (Open Label)||||||
1314778|NCT03403712|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1314779|NCT03403699|||Cohort||Other|||||||
1314780|NCT03403686|||Cohort||Other|||||||
1314781|NCT03403673|||Cohort||Prospective|||||||
1314782|NCT03403660|Randomized|Parallel Assignment||Other||None (Open Label)||Women are randomly assigned to having their postpartum physician team wear a white coat (WC) or not (no-WC) during rounds.||||
1314783|NCT03403647|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314784|NCT03403634||Single Group Assignment||Treatment||None (Open Label)||||||
1314785|NCT03403621|Randomized|Parallel Assignment||Prevention||Triple|Randomization will done by the Research Pharmacy|"All participants will receive two treatments: drug and vehicle. Drug will be applied to one of two treatment sites. Vehicle will be applied to the other site. Treatment sites are distal and proximal end of the incision. Drug will be randomized to treatment site distal or proximal and masking will be as indicated. A 1-2 cm border zone will remain untreated in the middle of the scar."|t|t|t|
1314786|NCT03403608|||Cohort||Prospective|||||||
1314787|NCT03403595||Single Group Assignment||Treatment||None (Open Label)||||||
1314788|NCT03403582|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1314789|NCT03403569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314790|NCT03403556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314791|NCT03403543|||Cohort||Prospective|||||||
1314792|NCT03403530|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314793|NCT03403517|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1314794|NCT03403504|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1314795|NCT03403491|Randomized|Crossover Assignment||Other||None (Open Label)||Prospective, open-label, sham-controlled, observational study. Usual care run-in period (2 weeks) followed by random order 2 x 4-week crossover periods. Comparison is active pMp app [+ digital weighing scales + BP monitor] for 4 weeks vs. sham application for 4 weeks.||||
1314796|NCT03403478|Randomized|Crossover Assignment||Treatment||Single|To acute session, the participant will not be informed about what aquatic exercise session (light-, moderate-, high-intensity or control) intensity will be performed.||t|||
1314797|NCT03403465||Single Group Assignment||Other||None (Open Label)||||||
1314798|NCT03403452||Single Group Assignment||Treatment||None (Open Label)||||||
1314799|NCT03403439||Single Group Assignment||Treatment||None (Open Label)||||||
1314800|NCT03403426||Single Group Assignment||Treatment||None (Open Label)||||||
1314801|NCT03403413||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1314802|NCT03403400|Randomized|Parallel Assignment||Treatment||None (Open Label)||Experimental Design. To answer the study objective, a pragmatic, randomized, prospective, clinical study on 54 older adults with dizziness will be utilized. This will be conducted at Florida Hospital Sports Medicine and Rehabilitation locations that offer vestibular therapy. These are in East Orlando and Winter Park.||||
1314803|NCT03403387|Randomized|Parallel Assignment||Basic Science||Double||Half of the participants will be randomized to receive the supplement and the other half will receive the placebo.|t|t||
1314804|NCT03403374||Single Group Assignment||Treatment||None (Open Label)||||||
1314805|NCT03403361|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1314806|NCT03403348|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1314807|NCT03403335|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1314808|NCT03403322|Non-Randomized|Crossover Assignment||Treatment||Single|The person that performed data analysis was blind to all conditions.|||||t
1314809|NCT03403309|Randomized|Parallel Assignment||Treatment||Quadruple|Triple-blinded||t|t|t|t
1314810|NCT03403296|||Cohort||Retrospective|||||||
1314811|NCT03403283|||Case-Control||Prospective|||||||
1314812|NCT03403270||Single Group Assignment||Prevention||None (Open Label)|Outcome Assessors will not be aware of previous research data collected. As this is a single group study, all participants will receive the intervention as described.|Time Series Quasi-Experiment||||
1314813|NCT03403257|||Cohort||Prospective|||||||
1314814|NCT03403244|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314815|NCT03403231|Randomized|Factorial Assignment||Prevention||Single||The investigators will use a factorial design to test the main effects and a limited number of interaction effects of 5 messaging strategies.|||t|
1314816|NCT03403218||Single Group Assignment||Basic Science||None (Open Label)||single group assignment. cross-sectional survey.||||
1314817|NCT03403205|Randomized|Parallel Assignment||Treatment||Single|This study is rater-blinded for the Unified Wilson Disease Rating Scale (UWDRS) assessment only. The rater will be blinded and will have no knowledge of the subject's treatment assignment and no access to systems that could result in potential unblinding of treatment assignment. Both raters and subjects will be instructed to avoid lines of inquiry, questions, and responses that could potentially lead to unblinding of the subject's treatment. The blinding will be documented by the rater after each UWDRS assessment. The rater assessments will be strictly limited to administration of the protocol specified instruments and assessments.|||||t
1314911|NCT03401983|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1314912|NCT03401970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314913|NCT03401957|||Cohort||Prospective|||||||
1314819|NCT03403179||Single Group Assignment||Other||None (Open Label)||This study is a single center, open-label, outpatient clinical trial with no randomization or blinding. The Barcelona Functional Remediation for Bipolar Disorder (FR) Program will be tested over a 21-week period using 30 participants split into two equal cohorts. The study will evaluate the feasibility and preliminary efficacy of the intervention.||||
1314820|NCT03403166|||Cohort||Prospective|||||||
1314821|NCT03403153||Single Group Assignment||Other||None (Open Label)||This study is examining the feasibility and acceptability of an intervention to improve parent-child functioning. It will also conduct a preliminary test for movement in target outcomes.||||
1314822|NCT03403140||Single Group Assignment||Treatment||None (Open Label)||||||
1314823|NCT03403127||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314824|NCT03403114|||Other||Cross-Sectional|||||||
1314825|NCT03403101||Single Group Assignment||Treatment||None (Open Label)||||||
1314826|NCT03403088|Randomized|Parallel Assignment||Treatment||None (Open Label)||60 participants with NCCLs and positive for DH are enrolled in the study to receive randomly the followed treatments: LA= 780 nm and 70mW GaAlAs Laser/ 4 sessions; LAP= placebo laser/ four sessions; CP= ClinproTM XT Varnish/ in-office single session; RX= adhesive RelyXTM Arc/ in-office single session; DE= stannous fluoride dentifrice/30-days-home-use; DE-P= placebo dentifrice/30-days-home-use||||
1314827|NCT03403075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314828|NCT03403062|||Case-Only||Prospective|||||||
1314829|NCT03403049||Single Group Assignment||Treatment||None (Open Label)||||||
1314830|NCT03403036||Single Group Assignment||Treatment||None (Open Label)||||||
1314831|NCT03403023||Single Group Assignment||Diagnostic||None (Open Label)||A single group of patients with DES is imaged before and after treatment with Restasis, a medication which is already FDA approved for this indication.||||
1314832|NCT03403010|Randomized|Crossover Assignment||Treatment||None (Open Label)||Children are randomized into the intervention group (conventional, usual therapy including the use of rehabilitation-specific gaming) or the control group (PT, usual physiotherapy not including gaming), followed by a cross-over. After the intervention period of 3 months, wash-out period will be organized to evaluate follow-up effects.||||
1314833|NCT03402997|||Case-Only||Prospective|||||||
1314834|NCT03402984|Randomized|Crossover Assignment||Other||Single|||t|||
1314835|NCT03402971|||Case-Control||Prospective|||||||
1314836|NCT03402958|||Case-Only||Retrospective|||||||
1314837|NCT03402945|Randomized|Crossover Assignment||Prevention||Single|Blinded adjudication of the s-SSIs will be performed by a committee consisting of three members.|1) cefazolin prophylaxis plus Prevena*(*diabetic and/or obese patients (BMI >30kg/m2)) 2) cefazolin and vancomycin prophylaxis plus Prevena*(*diabetic and/or obese patients (BMI >30kg/m2)), 3) cefazolin prophylaxis plus standard wound dressing, 4) cefazolin and vancomycin prophylaxis plus standard wound dressing.||||t
1314838|NCT03402932|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1314839|NCT03402919|||Cohort||Prospective|||||||
1314840|NCT03402906|Randomized|Parallel Assignment||Treatment||Single||||||t
1314841|NCT03402893||Single Group Assignment||Treatment||None (Open Label)||||||
1314842|NCT03402880||Single Group Assignment||Treatment||None (Open Label)||||||
1314843|NCT03402867||Single Group Assignment||Treatment||None (Open Label)||Deep dry needling||||
1314844|NCT03402854|Randomized|Parallel Assignment||Treatment||Triple|Participants and care providers will not be told of their group allocation. Participants in the sham group will receive a brief stimulation of the scalp, which will give them a feeling of being stimulated. This sham stimulation has been shown to effectively blind participants to group. Assessors will not be told the type of study being conducted.|Children will be randomly allocated to one of two parallel arms of the study.|t|t||t
1314845|NCT03402841||Single Group Assignment||Treatment||None (Open Label)|Open|Single arm study||||
1314846|NCT03402828|||Cohort||Prospective|||||||
1314847|NCT03402815|Randomized|Crossover Assignment||Treatment||Single||||||t
1314848|NCT03402802|||Cohort||Prospective|||||||
1314849|NCT03402789|Randomized|Parallel Assignment||Treatment||Single|The participants will not be informed of whether they are taking the treatment drug or the placebo. Technicians measuring participants' visual outcomes are also masked. The principal investigator and co-investigators will know how the patient's are randomized.|single blinded randomized controlled pilot study with 2/3 of participants randomized into the treatment arm and 1/3 of participants randomized into the placebo arm.|t|||
1314850|NCT03402776|Randomized|Parallel Assignment||Prevention||None (Open Label)||randomized, open-label, prospective, multicenter study||||
1314851|NCT03402763|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|All patients and researchers are aware if the patient receives a handout or watches the ACP video.|Participants will (1) be given either a short informational handout on the process and choices involved in advanced care planning or (2) be shown a less 6 minute video describing CPR, breathing tube placement and mechanical breathing support in addition to the general process of advanced care planning.||||
1314852|NCT03402750|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1314853|NCT03402737||Sequential Assignment||Treatment||None (Open Label)||"The range of dose-painting will be escalated in following levels:~2x 6-8Gy~3x 6-8Gy~The standard 3+3 design will be used for the this trial. To obtain more precise toxicity rate of the MTD we will double the number of patients at the first dose prescription that gives totally 6 patients. The 3 remaining dose levels will include 3 patients each. Thus, fifteen (6+3+3+3) patients will be included in this radiotherapy dose finding study investigating the MTD.~The number of patients will be doubled in case of 2 DLTs at the dose prescription I and 1 DLT at dose prescriptions II-IV with DLT in a maximum of 10 out of 30 patients.~3x 6-10Gy~3x 6-12Gy"||||
1314854|NCT03402724|||Cohort||Prospective|||||||
1314855|NCT03402711|||Case-Only||Prospective|||||||
1314856|NCT03402698||Single Group Assignment||Prevention||None (Open Label)||||||
1314914|NCT03401944|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1314915|NCT03401931|||Cohort||Prospective|||||||
1314916|NCT03401918|Non-Randomized|Sequential Assignment||Treatment||Single||||||t
1315158|NCT03398759|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1314857|NCT03402685|Randomized|Parallel Assignment||Treatment||Double|The statistician is not informed about the group names, the APGAR scores are awarded by independent neonatologists/pediatricians and gynaecologists.|Randomisation of patients using a randomisation list drawn up by an independent statistician in either NIBP or ClearSight group. In both groups, the above-mentioned standard procedure according to SOP and also the non-invasive continuous blood pressure measurement to improve blood pressure monitoring with the ClearSight system, so that all patients are monitored by both monitoring systems. In the NIBP Group, anaesthetists are blinded against the ClearSight measurement. In the ClearSight group, anaesthetists are blinded against the NIBP measurement. Blinding is achieved by completely covering the measured values of the other method.|t|||t
1314858|NCT03402672||Single Group Assignment||Prevention||None (Open Label)||||||
1314859|NCT03402659|Randomized|Parallel Assignment||Treatment||Quadruple||Double-blind, placebo-controlled|t|t|t|t
1314860|NCT03402646|Randomized|Parallel Assignment||Health Services Research||Double||This will be a single-blind three-arm cluster randomized controlled trial involving post-partum mothers and/or caregivers of infants (age 0-12months) attending immunization clinics in 12 randomly selected Primary Health Care Centres (clusters) across Sokoto, Jigawa, Kano, Ogun, Oyo and Lagos States of Nigeria. Additionally, the investigators will be implementing a photovoice methodology in 6 community clusters (one in each State) involving group discussions between community members (pregnant women in their third trimester, parents/caregivers of infants age 0-12 months), community leaders, service providers and policy makers on benefits of timely immunization and consequences of non-vaccination.|||t|t
1314861|NCT03402633|||Case-Only||Cross-Sectional|||||||
1314862|NCT03402620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314863|NCT03402607|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1314864|NCT03402594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314865|NCT03402581|||Case-Control||Prospective|||||||
1314866|NCT03402568|||Cohort||Cross-Sectional|||||||
1314867|NCT03402555|||Cohort||Prospective|||||||
1314868|NCT03402542|||Cohort||Retrospective|||||||
1314869|NCT03402529||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314870|NCT03402516|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized trial||||
1314871|NCT03402503|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1314872|NCT03402490|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||One group of participants received motivational counseling to enhance physical activity; the other group received usual care||||
1314873|NCT03402477|||Cohort||Prospective|||||||
1314874|NCT03402464||Single Group Assignment||Treatment||None (Open Label)||||||
1314875|NCT03402451|||Cohort||Prospective|||||||
1314876|NCT03402438|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1314877|NCT03402425||Single Group Assignment||Diagnostic||None (Open Label)|The result of the PET scan is masked until a treatment plan for the patient has been decided by the treatment responsible clinicians based on the MRI findings.|We aim to include all patients that fullfil the inclusion criteria.||||
1314878|NCT03402412||Single Group Assignment||Basic Science||None (Open Label)||||||
1314879|NCT03402399|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1314880|NCT03402386||Single Group Assignment||Treatment||None (Open Label)||||||
1314881|NCT03402373|Randomized|Parallel Assignment||Supportive Care||Quadruple|Double Blind, Randomized|Double Blind, Randomized, Placebo-Controlled|t|t|t|t
1314882|NCT03402360|Randomized|Parallel Assignment||Treatment||Single||||||t
1314883|NCT03402347||Single Group Assignment||Basic Science||None (Open Label)||Excess skin from corrective surgery will be evaluated ex vivo.||||
1314884|NCT03402334|Randomized|Parallel Assignment||Treatment||Single|Single-blinded study. Participants are blinded to their designation in the study arms. Investigators cannot be blinded since the intervention they are providing is patient counseling.|This is a two-arm study. Group A will receive the intervention in addition to standard of care counseling while Group B will receive only standard of care counseling.|t|||
1314885|NCT03402321|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1314886|NCT03402308|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1314887|NCT03402295|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Retrospectively compared two different groups of treatments||||
1314888|NCT03402282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314889|NCT03402269|||Cohort||Prospective|||||||
1314890|NCT03402256|Randomized|Parallel Assignment||Treatment||Single|All clinical members of the liver transplantation service will be blind to the results of self-report data collected during the study and to urine toxicology results. The PI and Co-I, who also serves as the Project Manager, will not be blind to participant condition. The Research Assistant will not be blind to the participant condition after delivery of the study-provided cell phone to participants randomized to the Text Message condition.|Participants will be randomized to either the Text Message intervention or to Standard Care based on a preset randomization schedule generated via computer by a statistician.||t||
1314891|NCT03402243|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1314892|NCT03402230|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1314893|NCT03402217|||Case-Only||Cross-Sectional|||||||
1314894|NCT03402204|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1314895|NCT03402191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314896|NCT03402178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1314897|NCT03402165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314898|NCT03402152|Randomized|Parallel Assignment||Treatment||Triple|Participants and Care Providers will be masked with regard to medication administered.||t|t||t
1314899|NCT03402139|||Cohort||Prospective|||||||
1314900|NCT03402126|||Cohort||Prospective|||||||
1314901|NCT03402113|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314902|NCT03402100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314903|NCT03402087||Single Group Assignment||Treatment||None (Open Label)||||||
1314904|NCT03402074||Single Group Assignment||Treatment||None (Open Label)||||||
1314917|NCT03401905|Randomized|Parallel Assignment||Treatment||Double|Randomized list that was only known by the therapist. Subjects do not know about the treatment they were receiving.|Double blind randomized control trial.|t|||t
1314918|NCT03401892|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1314919|NCT03401879|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1314920|NCT03401866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1314921|NCT03401853||Single Group Assignment||Treatment||None (Open Label)||||||
1314922|NCT03401840||Single Group Assignment||Treatment||None (Open Label)||||||
1314923|NCT03401827||Single Group Assignment||Treatment||None (Open Label)||||||
1314924|NCT03401814|||Cohort||Prospective|||||||
1314925|NCT03401801|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314926|NCT03401788||Single Group Assignment||Treatment||None (Open Label)||Phase 2 Open Label||||
1314927|NCT03401775|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1314928|NCT03401762|Randomized|Parallel Assignment||Treatment||Double|Participants will be blinded as to sham vs. intervention, but not as to which interventional arm.||t|||t
1314929|NCT03401749|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1314930|NCT03401736|Randomized|Parallel Assignment||Other||Single|||t|||
1314931|NCT03401723|Non-Randomized|Parallel Assignment||Other||None (Open Label)|This is a vialidation study of a computerized analysis of the colonoscope movements during a simulated procedure.|||||
1314932|NCT03401710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314933|NCT03401697|||Case-Control||Other|||||||
1314934|NCT03401684||Single Group Assignment||Prevention||None (Open Label)||||||
1314935|NCT03401671|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314936|NCT03401658|||Case-Only||Prospective|||||||
1314937|NCT03401645|Randomized|Parallel Assignment||Treatment||Single||||||t
1314938|NCT03401632|||Case-Only||Prospective|||||||
1314939|NCT03401619|||Cohort||Other|||||||
1314940|NCT03401606|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1314941|NCT03401593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314942|NCT03401580|Randomized|Parallel Assignment||Treatment||Double|Double-blind||t||t|
1314943|NCT03401567|Randomized|Parallel Assignment||Other||Single|All of the participants must have no neck and upper extremity pain, any fracture and surgical history for the upper extremity, cervical and thoracic area.|There are 2 groups of 30 people each. Elbow bending exercises with blood flow restriction will be performed to the exercise group during 6 weeks for 3 times a week. Control group will continue daily activities and a brochure on strengthening exercises and protection from injuries.|t|||
1314944|NCT03401554|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314945|NCT03401541|Randomized|Crossover Assignment||Treatment||Double||Each arm will first receive 25(OH)D and then vitamin D or vitamin D and then 25(OH)D|t||t|
1314946|NCT03401528|Randomized|Sequential Assignment||Treatment||Single||This study has two portions: a single ascending dose (SAD) portion consisting of 4 sequential dose escalation cohorts, and a repeat dose (RD) portion. In both study portions, subjects are randomized to receive either a study intervention (AVB-S6-500) or a placebo.|t|||
1314947|NCT03401515|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1314948|NCT03401502|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind|"Treatment group:Ranolazine 1000 mg:~Control group: Placebo"|t|t|t|t
1314949|NCT03401489|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1314950|NCT03401476|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1314951|NCT03401463|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The study will include patients staying in the intensive care unit, requiring ventilation of the artificial airways in the form of endotracheal or tracheostomy tube. Patients will be over 18 years of age.||||
1314952|NCT03401450|Randomized|Parallel Assignment||Treatment||Single|||t|||
1314953|NCT03401437|||Cohort||Prospective|||||||
1314954|NCT03401424|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1314955|NCT03401411|Randomized|Parallel Assignment||Other||Double|||t||t|
1314956|NCT03401398|Randomized|Parallel Assignment||Treatment||Quadruple|Subjects, families, critical care providers and investigators will be blinded to study drug administration. Only the local performance site research pharmacist will be un-blinded.|Patients randomized to the hydrocortisone treatment arm will receive an initial bolus of 2 mg/kg IV hydrocortisone, followed by 1 mg/kg (maximum 50 mg) of hydrocortisone dosed every six hours for a maximum of seven days or until all vasoactive infusions have been discontinued for at least 12 hours, whichever comes first. When the hydrocortisone course is completed, the medication will be discontinued. Patients randomized to the placebo treatment arm will receive an equivalent volume of normal saline, with the identical dosing schedule outlined above.|t|t|t|t
1314957|NCT03401385|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Single group, but in two study parts, therefore two sequential arms are identified||||
1314958|NCT03401372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314959|NCT03401359||Sequential Assignment||Basic Science||None (Open Label)||||||
1314960|NCT03401346|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1314961|NCT03401333||Single Group Assignment||Prevention||None (Open Label)||A brief motivational interview and four weeks of text messaging.||||
1314962|NCT03401320|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Phase I, open label, sequential, single ascending dose||||
1314963|NCT03401307|||Cohort||Prospective|||||||
1314964|NCT03401294||Single Group Assignment||Treatment||None (Open Label)||||||
1314965|NCT03401281|Randomized|Parallel Assignment||Basic Science||Triple|Fats will be embedded in processed cheese - extend of masking will be assessed in sensory study||t||t|t
1314966|NCT03401268||Single Group Assignment||Treatment||None (Open Label)||||||
1314967|NCT03401255|||Case-Only||Prospective|||||||
1314968|NCT03401242|||Cohort||Prospective|||||||
1314969|NCT03401229|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315152|NCT03398837|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1314970|NCT03401216|Randomized|Parallel Assignment||Treatment||None (Open Label)||80 patients, that underwent PCI with Synergy 48 mm stent implantation, will be randomized into 2 groups of follow-up OCT-visualization - 3 and 6 month.||||
1314971|NCT03401203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1314972|NCT03401190|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1314973|NCT03401177|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1314974|NCT03401151|||Cohort||Prospective|||||||
1314975|NCT03401138|||Cohort||Prospective|||||||
1314976|NCT03401125|||Cohort||Retrospective|||||||
1314977|NCT03401112|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1314978|NCT03401099|Randomized|Parallel Assignment||Treatment||Single|Blinded outcome assessment|Participants will be randomised 1:1 into two groups to receive either of the two treatments.||||t
1314979|NCT03401086|Randomized|Parallel Assignment||Treatment||Double|The KT group received Kinesio taping application, while the PG group received pressure garment (40-60 mmHg) for at least 15-18 hours per day through the study.||t|||t
1314980|NCT03401073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314981|NCT03401060|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1314982|NCT03401047||Single Group Assignment||Basic Science||None (Open Label)||This is a prospective interventional cohort study. Women with PCOS and controls will receive identical treatment (transdermal estradiol) and will be monitored using the same surveillance protocol. The study does not involve randomization, and it is not blinded.||||
1314983|NCT03401034|||Cohort||Prospective|||||||
1314984|NCT03401021|||Cohort||Cross-Sectional|||||||
1314985|NCT03401008|||Cohort||Cross-Sectional|||||||
1314986|NCT03400995||Single Group Assignment||Treatment||None (Open Label)||||||
1314987|NCT03400982||Single Group Assignment||Other||None (Open Label)||||||
1314988|NCT03400969|Randomized|Crossover Assignment||Supportive Care||Quadruple|A Block randomisation is made by a person, other than the one who applies the product. Neither the patient nor the person who records the product or the person who registers data knows which product is used for the intervention. The product is not labeled with name|The different moisturizers will be compared in a double blind, cross-over design. Patient responses will be collected at baseline, immediately after exposure and after 2 hours.|t|t|t|t
1314989|NCT03400956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314990|NCT03400943|Randomized|Parallel Assignment||Treatment||Quadruple|Blinding will be applied to Treatment Groups A1, B1, and B2; Treatment Group A2 will be open-label||t|t|t|t
1314991|NCT03400930|||Cohort||Prospective|||||||
1314992|NCT03400917||Single Group Assignment||Treatment||None (Open Label)||||||
1314993|NCT03400904|||Cohort||Prospective|||||||
1314994|NCT03400891|Randomized|Parallel Assignment||Prevention||Single|||t|||
1314995|NCT03400878|Randomized|Parallel Assignment||Basic Science||Double||Randomised trial of 15,600 infants 1:1 to BCG-Japan or BCG-Russia||t||t
1314996|NCT03400865||Single Group Assignment||Treatment||None (Open Label)||||||
1314997|NCT03400852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1314998|NCT03400839|||Cohort||Prospective|||||||
1314999|NCT03400826|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315000|NCT03400813|Randomized|Parallel Assignment||Prevention||Double|Investigator / Outcomes Assessor||||t|t
1315001|NCT03400800|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1315002|NCT03400787|Randomized|Crossover Assignment||Treatment||Single|Participants will be masked to treatment assignment through the 3-month assessment period.|Sham procedure participants will be allowed to crossover to receive Latera implants after the 3-month assessment if they continue to meet eligiblity criteria. Crossover participants will be followed through 24 months post implant. Sham participants who do not crossover will be exited after the 3-month assessment.|t|||
1315003|NCT03400774|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1315004|NCT03400761|||Cohort||Retrospective|||||||
1315005|NCT03400748||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1315006|NCT03400735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315007|NCT03400722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315008|NCT03400709|Randomized|Parallel Assignment||Prevention||Single|||t|||
1315009|NCT03400696|Randomized|Parallel Assignment||Other||Double||Participants are randomized to either a RCT or 'Participant choice' block, with 3 parallel interventions within each block|||t|t
1315010|NCT03400683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315011|NCT03400670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315012|NCT03400657|||Case-Control||Prospective|||||||
1315013|NCT03400644|Randomized|Parallel Assignment||Supportive Care||Double||Prospective, parallel single-blinded randomized controlled trial||t||t
1315014|NCT03400631|Randomized|Parallel Assignment||Basic Science||Quadruple|Masking only of above.|The first two weeks of this study involve two groups with a crossover at 1 week. From two weeks on, there is a single arm.|t|t|t|t
1315015|NCT03400618|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315016|NCT03400605|||Cohort||Prospective|||||||
1315017|NCT03400592||Single Group Assignment||Treatment||None (Open Label)||||||
1315018|NCT03400579||Single Group Assignment||Other||None (Open Label)||Prospective, single center, single arm pilot study evaluating the feasibility of delivering remote ischemic conditioning by emergency medical services during ground ambulance transport of patients experiencing chest pain or anginal equivalent symptom||||
1315019|NCT03400566|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1315020|NCT03400553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315021|NCT03400540|Randomized|Parallel Assignment||Treatment||None (Open Label)||2 groups randomly divided. Both groups will be given three different verbal instructions to contract pelvic floor muscles.||||
1315022|NCT03400527||Single Group Assignment||Treatment||None (Open Label)||||||
1315023|NCT03400514|||Case-Only||Retrospective|||||||
1315024|NCT03400501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315025|NCT03400488|Randomized|Parallel Assignment||Treatment||Single|This study is single-blind (in which the study centre staff will remain blinded during the clinical conduct of a given cohort) with regard to treatment (AZD5718 or placebo) at each dose level. In the event of a medical emergency when management of a subject's condition requires knowledge of the trial medication, the treatment received may be revealed by personnel authorized by the Principal Investigator (PI).||t|||
1315026|NCT03400475|Randomized|Parallel Assignment||Treatment||Triple|Only the study coordinator will know whether the intervention is simvastatin or control.||t||t|t
1315027|NCT03400462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315028|NCT03400449|Randomized|Parallel Assignment||Prevention||None (Open Label)||Two groups randomized to counseling type.||||
1315029|NCT03400436|||Cohort||Retrospective|||||||
1315030|NCT03400423|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1315031|NCT03400410|Randomized|Parallel Assignment||Prevention||Single|The investigator assigned to follow up will be masked to which group a participant was assigned to.||||t|
1315032|NCT03400397|||Case-Only||Retrospective|||||||
1315033|NCT03400384|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1315034|NCT03400371|||Case-Control||Other|||||||
1315035|NCT03400358|||Cohort||Prospective|||||||
1315036|NCT03400345|||Cohort||Prospective|||||||
1315037|NCT03400332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315038|NCT03400319|||Cohort||Prospective|||||||
1315039|NCT03400306|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315040|NCT03400293|||Cohort||Cross-Sectional|||||||
1315041|NCT03400280|Randomized|Crossover Assignment||Treatment||None (Open Label)||Stepped-wedge cluster randomized trial||||
1315042|NCT03400267|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized controlled trial, with randomization to either paracetamol intravenously or fentanyl.||||
1315043|NCT03400254|Randomized|Single Group Assignment||Treatment||Single|||t|||
1315044|NCT03400241|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315045|NCT03400228|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1315046|NCT03400215|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1315047|NCT03400202|||Case-Control||Prospective|||||||
1315048|NCT03400189||Single Group Assignment||Other||None (Open Label)||Phase I, single centre, prospective, ascending single oral doses, open-label, 3-period clinical trial||||
1315049|NCT03400176|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1315050|NCT03400163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315051|NCT03400150|Randomized|Parallel Assignment||Supportive Care||Single|Study subjects are blinded to group assignment.|Subjects will be randomized in a 2:1 ratio (ProSpace implantation:control)|t|||
1315052|NCT03400137|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1315053|NCT03400124|Randomized|Parallel Assignment||Treatment||Single||||||t
1315054|NCT03400111|Randomized|Parallel Assignment||Treatment||Double|Patients in the first group will undergo active irradiation with low-level laser therapy but they will consume placebo tablets. Patients in the second group will consume real Panadol-extra tablets but they will be subjected to a placebo red-beam as if they are irradiated with a laser beam. Patients in the third group will be subjected to both placebo procedures (i.e. placebo red-beam and not low-level laser therapy and placebo tablets).||t|||t
1315055|NCT03400098||||||||||||
1315056|NCT03400085|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a single-center, prospective, randomized control trial with two arms. Participants in the intervention arm will use an mHealth application to complete their mandated living kidney donor follow-up at 6 months, 1 year, and 2 years, and participants in the control arm will receive the current standard of follow-up care and complete their required follow-up without the use of an mHealth application.||||
1315057|NCT03400072|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315058|NCT03400059|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1315059|NCT03400046|||Cohort||Retrospective|||||||
1315060|NCT03400033|Randomized|Parallel Assignment||Treatment||Quadruple|This is a double-blind study, in which the subject, investigator, site staff and the sponsor will remain blinded to each subjects study treatment assignment throughout the course of the study, with the exception of a limited number of unblinded site staff who are necessary to maintain the blind, as well as a limited number of sponsor staff.|Subjects will be randomized to receive either daprodustat or epoetin alfa in a parallel manner. .|t|t|t|t
1315061|NCT03400020|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1315062|NCT03400007|||Cohort||Prospective|||||||
1315063|NCT03399994|Randomized|Parallel Assignment||Treatment||Single|The members of the Event Adjudication Committee will be blinded to the patient assignment. All medical records, source documentation and event information collected for the adjudication process will be blinded to treatment assignment|Randomized multi-centre controlled clinical trial||||t
1315064|NCT03399981|||Cohort||Other|||||||
1315065|NCT03399968|Randomized|Parallel Assignment||Treatment||Triple||prospective randomized controlled double blinded clinical intervention study|t||t|t
1315066|NCT03399955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315067|NCT03399942|Randomized|Crossover Assignment||Other||Double|||t||t|
1315068|NCT03399929|||Cohort||Prospective|||||||
1315069|NCT03399916|Randomized|Factorial Assignment||Prevention||None (Open Label)||PART B: A three-factor design with two-levels yielded eight experimental conditions, half of which encouraged standing more (stand; n prompt types = 80, n total prompts =800) and the other half encouraged moving more (move; n prompt types = 80, n total prompts =800).||||
1315070|NCT03399903|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315071|NCT03399890|||Cohort||Prospective|||||||
1315153|NCT03398824||Single Group Assignment||Treatment||None (Open Label)||||||
1315154|NCT03398811|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315159|NCT03398746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315195|NCT03398278|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1315072|NCT03399877|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Children who meet the inclusion criteria and no exclusion criteria are assigned to perform one of the three test protocols in order of registration according to a computer gererated randomization list. Children who assigned group A perform uroflowmetry-electromyography for the first and subsequently perform uroflowmetry-electromyography again. Children who assigned Group B perform uroflowmetry-electromyography for the first, and subsequently perform sole uroflowmetry. Children who assigned Group C firstly perform sole uroflowmetry and subsequently perform uroflowmetry-electromyography.||||
1315073|NCT03399864|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1315074|NCT03399851|Randomized|Parallel Assignment||Treatment||Single||||||t
1315075|NCT03399838|Randomized|Parallel Assignment||Treatment||Triple||randomised trial comparing 2 drugs (midazolam, dexmedetomidine)|t||t|t
1315076|NCT03399825|||Case-Only||Prospective|||||||
1315077|NCT03399812|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1315078|NCT03399799|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1315079|NCT03399786|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315080|NCT03399773||Single Group Assignment||Treatment||None (Open Label)||||||
1315081|NCT03399760|Randomized|Parallel Assignment||Treatment||Single|One blinded|"Two Arms injectable platelet rich fibrin group: consisted of two subgroups~Experimental group : injectable platelet rich fibrin assisted upper canine retraction~Control group: conventional upper canine retraction"||||t
1315082|NCT03399747||Single Group Assignment||Treatment||None (Open Label)||||||
1315083|NCT03399734|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1315084|NCT03399721|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315085|NCT03399708|||Cohort||Prospective|||||||
1315086|NCT03399695|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315087|NCT03399682|||Cohort||Prospective|||||||
1315088|NCT03399669||Single Group Assignment||Treatment||None (Open Label)||||||
1315089|NCT03399656|Randomized|Parallel Assignment||Basic Science||Quadruple|Placebo control||t|t|t|t
1315090|NCT03399643|||Cohort||Prospective|||||||
1315091|NCT03399630|Randomized|Parallel Assignment||Treatment||Double|Patient and treating physician are both blinded, being that neither are aware of which knee received the autologous adipose tissue injection and which knee received the placebo lactated ringers injection|Double blind parallel groups assignment|t|t||
1315092|NCT03399617|Randomized|Parallel Assignment||Prevention||Single||||||t
1315093|NCT03399604||Single Group Assignment||Treatment||None (Open Label)||"The study will evaluate the long term safety and tolerability of LIQ861 in PAH patients transitioning from stable doses of inhaled treprostinil therapy, or who are taking no more than 2 approved, non-prostacylcin, oral PAH therapies.~Patients transitioning from inhaled treprostinil will be initiated at a comparable dose of LIQ861, and then titrate in 25ug incremental doses to tolerance and symptom relief. Patients adding LIQ861 to current oral therapies will start at a 25ug dose, and increase in 25ug increments on a weekly basis to tolerance and symptom relief.~A subset of the patients transitioning from inhaled treprostinil will be enrolled in a one-directional crossover to compare the bioavailability and pharmacokinetics of treprostinil as they transition to LIQ861. Serial PK sample collections will be taken on back to back days for transitioning and LIQ861 treprostinil formulations. These patients will then continue to be followed as all other patients enrolled in the study."||||
1315094|NCT03399591|||Cohort||Prospective|||||||
1315095|NCT03399578|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315096|NCT03399565|||Case-Only||Other|||||||
1315097|NCT03399552||Single Group Assignment||Treatment||None (Open Label)||This is a single-arm, two-stage study that will be conducted at Memorial Sloan Kettering Cancer Center Main Campus and regional sites.||||
1315098|NCT03399539||Single Group Assignment||Treatment||None (Open Label)||||||
1315099|NCT03399526|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315100|NCT03399513||Single Group Assignment||Treatment||None (Open Label)||||||
1315101|NCT03399500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315102|NCT03399487||Single Group Assignment||Treatment||None (Open Label)||||||
1315103|NCT03399474|Randomized|Parallel Assignment||Treatment||Single||||||t
1315104|NCT03399461|||Cohort||Cross-Sectional|||||||
1315105|NCT03399448|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1315106|NCT03399435|Randomized|Parallel Assignment||Other||Triple|Sponsor, personnel of the central research pharmacy at the site, the pharmacy CRA and the bioanalytical lab are not blinded.|"Part A: 8 cohorts (equivalent to 40 subjects) are planned to be treated with ascending doses of neosaxitoxin combined with fixed doses of bupivacaine and epinephrine.~Part B: Part B will start at the earliest after 4 cohorts of Part A have been treated. Ascending doses of neosaxitoxin combined with fixed doses of bupivacaine.~Part C: Part C will comprise 4 treatment groups in which all participants will receive the same neosaxitoxin dose alone, or neosaxitoxin combined with epinephrine, or neosaxitoxin combined with bupivacaine with or without epinephrine."|t||t|t
1315107|NCT03399422|Randomized|Crossover Assignment||Treatment||Single|One blinded|"Two Arms injectable platelet rich fibrin group: consisted of two subgroups~Experimental group : injectable platelet rich fibrin assisted upper canine retraction Control group: conventional upper canine retraction"||||t
1315108|NCT03399409|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1315155|NCT03398798|Randomized|Parallel Assignment||Treatment||Triple|"Neither subjects nor the treating orthodontists will know whether a .014 or 0.16 dimension wire is being used. The investigator will assign wire dimensions using a random number generator and distribute the wires to the treating orthodontists with the archwire dimension number removed from the package. The outcomes assessor will be blinded as to which patients were treated with which archwires while analyzing the digital models of the teeth.~Because there is a clear visual difference between twin and self-ligating brackets, there will be no blinding with regard to ligation method (bracket type)."|"There will be four different groups in this study, each consisting of 20 patients.~In the twin bracket cohort, 20 patients will be treated with .014 dimension wire, and 20 patients will be treated with .016 dimension wire.~In the self-ligating bracket cohort, 20 patients will be treated with .014 dimension wire, and 20 patients will be treated with .016 dimension wire."|t|t||t
1315109|NCT03399396|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Due to the nature of the intervention, it is not possible to blind the practices or study staff to study arm allocation. To minimize bias, allocation will be masked until after baseline data collection of outcome measures, when it is time for each practice to initiate the intervention.|"Using a two-group, cluster randomized control trial (RCT) design, with the clusters being pediatric practices, practices will be randomized to two study arms representing two delivery modalities of the intervention: In-Person Coaching Arm and Web-Based Coaching Arm.~The intervention targets the providers and staff in the pediatric practices to make changes aimed to improve their quality of care, and the study participants are the providers and staff (not patients). Individual patients will not be recruited or enrolled in the study, since the intervention is focused on QI and all patient vaccination outcome data will be collected via aggregated reports from the EHR or other clinical data systems (no individual patient-level private health information (PHI)). The study practices include approximately 190 providers (physicians, nurse practitioners, physician assistants) and 275 other staff (nurses, clinical support staff, administrative staff)."||||
1315110|NCT03399383||Single Group Assignment||Other||None (Open Label)||Within the longitudinal part of the trial, patients with chronic adrenal insufficiency will be assessed by questionnaire before and after participation in the standardized education program (=intervention).||||
1315111|NCT03399370|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1315112|NCT03399357|||Cohort||Prospective|||||||
1315113|NCT03399344||Single Group Assignment||Diagnostic||None (Open Label)||Patients will undergo an additional MRI, including a diffusion-weighted sequence, for assessing the extent of peritoneal carcinomatosis. Whether or not cytoreductive surgery is feasible will be scored using the peritoneal cancer index on diffusion-weighted magnetic resonance imaging||||
1315114|NCT03399331|Randomized|Single Group Assignment||Prevention||Double|Pain scores of the oral mucosa will be conducted twice a daily for study purposes. The patients will be assessed by their RNs for pain which is documented in the patient charts twice per day in the morign and in the evening (even in the absence of pain), the nurses will have no knowlegde of group assignment.||||t|t
1315115|NCT03399318|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1315116|NCT03399305|||Cohort||Retrospective|||||||
1315117|NCT03399292|||Cohort||Prospective|||||||
1315118|NCT03399279|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1315119|NCT03399266|Randomized|Parallel Assignment||Treatment||None (Open Label)||"200 pregnant women with one previous cesarean section and PROM along with an unfavourable cervix (Bishop Score ≤ 6) are expected to be entered into the study.~All eligible women will be presented with the study protocol by a study coordinator.The following screening medical procedures will be completed:~Medical and gynecological history, physical and vaginal speculum examination, Ultrasonography and a non-stress test (NST).~For eligible patients, and following an informed consent, group randomization will take place:~GROUP 1: Expectant management (standard protocol). GROUP 2: Insertion of a balloon cervical catheter (study group).~The randomization process will be as follows:~A. The eligible patient will sign the informed consent prior to randomization. B. The patient will receive a subject number for the study (from 1 to 200) The study coordinator will open a sealed envelope with the patient's study number to reveal the patient's assigned study group."||||
1315120|NCT03399253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315121|NCT03399240||Single Group Assignment||Other||None (Open Label)||||||
1315122|NCT03399227|||Case-Control||Prospective|||||||
1315123|NCT03399214|Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1315124|NCT03399201|Randomized|Parallel Assignment||Screening||Single||||||t
1315125|NCT03399188||Single Group Assignment||Treatment||None (Open Label)||Inflammatory bowel disease patients in active stage.||||
1315126|NCT03399175||Single Group Assignment||Other||None (Open Label)||Early systemic high-dose corticosteroid and immunosuppressive therapy||||
1315127|NCT03399162|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315128|NCT03399149|||Cohort||Prospective|||||||
1315129|NCT03399136|Randomized|Parallel Assignment||Other||Double||||t||t
1315130|NCT03399123|Randomized|Parallel Assignment||Prevention||Triple||Two different tidal volume are conducted on the participant base on the randomized choices|t|t||t
1315131|NCT03399110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315132|NCT03399097|||Other||Other|||||||
1315133|NCT03399084|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1315134|NCT03399071||Single Group Assignment||Treatment||None (Open Label)||All patients will receive chemo-immunotherapy consisting of FLOT chemotherapy and the PD-L1 inhibiting monoclonal antibody Avelumab. Four cycles of two-weekly chemo-immunotherapy will be administered before surgery and four further cycles post-operatively in patients who are fit enough to receive further chemo-immunotherapy after surgery. Resectional surgery will take place 4-8 weeks following the last dose of chemo-immunotherapy in patients who remain fit.||||
1315135|NCT03399058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315136|NCT03399045|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1315137|NCT03399032|||Cohort||Prospective|||||||
1315138|NCT03399019|Randomized|Parallel Assignment||Other||Triple||This study compares to the same intervention (monitor BIS scores and OAA/S scores timely) between all of three sedative drugs.|t|t|t|
1315139|NCT03399006|||Cohort||Prospective|||||||
1315140|NCT03398993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315141|NCT03398980|||Case-Only||Retrospective|||||||
1315142|NCT03398967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1315143|NCT03398954|||Case-Only||Prospective|||||||
1315144|NCT03398941||Single Group Assignment||Treatment||None (Open Label)||||||
1315145|NCT03398928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315146|NCT03398915|||Cohort||Prospective|||||||
1315147|NCT03398902|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1315148|NCT03398889|||Cohort||Cross-Sectional|||||||
1315149|NCT03398876|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1315150|NCT03398863|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315151|NCT03398850|||Cohort||Cross-Sectional|||||||
1315160|NCT03398733||Single Group Assignment||Treatment||None (Open Label)||A total of 200 patients with rheumatic valvular heart disease waiting for heart valve replacement were screened for obstructive sleep apnea (OSA). Of them, 30 OSA patients were enrolled and randomly received CPAP treatment and non-CPAP treatment (15:15 patients).The CPAP treatment group received both baseline and CPAP treatment for 7 days preoperatively. The non-CPAP treatment group only received baseline treatment.||||
1315161|NCT03398720|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315162|NCT03398707|||Cohort||Prospective|||||||
1315163|NCT03398694||Single Group Assignment||Treatment||None (Open Label)||||||
1315164|NCT03398681|Randomized|Parallel Assignment||Treatment||Triple|Because ferric carboxymaltose is a dark-brown solution that is easily distinguishable from the saline placebo, study personnel responsible for the preparation and administration of the study drug will aware of the group assignments and therefore, not involved in any study assessments. To ensure that patients will be unaware of the study drug, materials used in drug administration will be covered with aluminum foil or other opaque material and the injection site shield from the patient view. Once treatment is allocated, the investigators team will ensure that patients are blinded to the treatment received.|After providing informed consent, patients will be randomly assigned, with a remote, web-based computer-generated block randomization procedure in an allocation 1:1 ratio, to either receive intravenous ferric carboxymaltose (FCM) or placebo. Intramyocardial iron will be evaluated at 3 time points: before administration of CMF/placebo, and at 7 and 30 days. At 30 days, patients assigned to placebo will receive intravenous CMF if iron deficiency persists.|t|t|t|
1315165|NCT03398668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315166|NCT03398655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315167|NCT03398642||Single Group Assignment||Prevention||None (Open Label)||||||
1315168|NCT03398629|||Cohort||Prospective|||||||
1315169|NCT03398616|||Cohort||Prospective|||||||
1315170|NCT03398603|||Case-Control||Prospective|||||||
1315171|NCT03398590||Single Group Assignment||Other||None (Open Label)||||||
1315172|NCT03398577|Randomized|Parallel Assignment||Treatment||Triple||The study is designed as a single-center, double-blinded, placebo controlled, 2-arm clinical trial to provide evidence on the effects of Dapagliflozin on key biomarkers of athero-thrombosis, inflammation and ventricular loading conditions (NT ProBNP).|t|t|t|
1315173|NCT03398564|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1315174|NCT03398551|||Cohort||Prospective|||||||
1315175|NCT03398538|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multi-center, Randomized Controlled Clinical Trial Evaluating the Effect of Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers||||
1315176|NCT03398525|Randomized|Parallel Assignment||Prevention||None (Open Label)||randomization with 1:1 allocation ratio||||
1315177|NCT03398512||Single Group Assignment||Treatment||None (Open Label)||||||
1315178|NCT03398499||Single Group Assignment||Treatment||None (Open Label)||Rehabilitation of patients after orthognathic procedures was performed, in which orthognathic surgery was performed - Bilateral Sagittal Split Osteotomy (BSSO). In the study it was used treatments a combination physicotherapies that combines two therapeutic physical factors - the electromagnetic field and the electromagnetic wave of red and infrared light in the form of led light therapy generated by the Viofor JPS device (Med&Life, Poland). Treatments with a slow-changing electromagnetic field were carried out using ring and elliptic applicators. Treatments with magnetoledotherapy using elliptical magnetic applicators combined with light. For physiotherapeutic purposes, led lighttherapy was used, which is a combined use of Extremely Low Frequency Magnetic Field (ELF-MF) and light coming from high energy LEDs (Light Emitting Diode) in the range of red (R) and infrared (IR). Therapies were used once a day, doing three described applications for a period of 10 days.||||
1315179|NCT03398486|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Experimental: Kinesiotaping Participants receive an application of active tapes (KT) Original kinesiotaping active tapes Duration: 2 times Application maintenance 5 days with a break for the weekend Muscle application on the masseter muscle area, using a tape (5 cm wide) dissected into 2 parts called tails, which included the treatment site without their tension.~Experimental: active inactivation of trigger points (TrP) Duration: 10-20 minutes of surgery; 2 inactivation treatments Between the treatments 5 days break"||||
1315180|NCT03398473|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1315181|NCT03398460||Single Group Assignment||Supportive Care||None (Open Label)||||||
1315182|NCT03398447|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1315183|NCT03398434|Randomized|Parallel Assignment||Basic Science||Single|blinded (with majuscule) endpoint evaluation|This is a randomized, open-label, blinded endpoint evaluation, active controlled, dose-range finding study.||||t
1315184|NCT03398421|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)|This will be an open-label study. Hence, there will be no masking.|Subjects will receive nemiralisib alone on Day 1 in Period 1 and itraconazole from Day 1 to Day 10 followed by nemiralisib on Day 5 in Period 2.||||
1315185|NCT03398408|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1315186|NCT03398395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315187|NCT03398382|Randomized|Parallel Assignment||Supportive Care||Triple|The selection of anaesthesia combination with oral placebo or magnesium for each side will be determined by random selection, which will not be known to either the patient or the examiner until the trial is completed.|The study will be a double-blind, randomized, split mouth, placebo controlled trial.|t|t|t|
1315188|NCT03398369|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315189|NCT03398356|Randomized|Crossover Assignment||Basic Science||Single|At the beginning of the study, patients are assigned a number by a nurse and are assigned to group A or B according to ID. When analyzing the results, the researchers only knows the numbers of blood samples.|The group of patients taking the drug at the target dose of 3 x 1000 after 4 weeks returns to the dose of 3 x 500 mg|||t|
1315190|NCT03398343|||Cohort||Prospective|||||||
1315191|NCT03398330|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1315192|NCT03398317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315193|NCT03398304||Single Group Assignment||Basic Science||None (Open Label)||||||
1315194|NCT03398291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315196|NCT03398265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315197|NCT03398252|Randomized|Parallel Assignment||Other||Single|||t|||
1315198|NCT03398239|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315199|NCT03398226|||Cohort||Prospective|||||||
1315200|NCT03398213|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315201|NCT03398200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315202|NCT03398187|||Case-Only||Cross-Sectional|||||||
1315203|NCT03398174|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to participants' treatment allocation|||||t
1315204|NCT03398161||Single Group Assignment||Treatment||None (Open Label)||||||
1315205|NCT03398148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315206|NCT03398135|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1315207|NCT03398122|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315208|NCT03398109||Single Group Assignment||Treatment||None (Open Label)||||||
1315209|NCT03398096|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315210|NCT03398083|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1315211|NCT03398070|||Cohort||Prospective|||||||
1315212|NCT03398057|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315213|NCT03398044|Randomized|Parallel Assignment||Treatment||Double|Masking was provided by a nurse not participating upon the research.|The study subjects were randomised into two arms, one group with active treatment using dexamethasone, and the other arm of subjects receiving placebo.|t||t|
1315214|NCT03398031|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1315215|NCT03398018||Single Group Assignment||Treatment||None (Open Label)||||||
1315216|NCT03398005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315217|NCT03397992|Randomized|Crossover Assignment||Prevention||Double|Patients, primary providers, ICU nurses and primary nephrology team are blinded. The PI and the dialysis nurses are not.||t|t||
1315218|NCT03397979|Randomized|Crossover Assignment||Treatment||Triple|A single treating physician assessed outcomes and, along with those analyzing the data, was masked to group assignment. In other words, the care provider, investigator, and outcomes assessor were blinded to which bathing arm (twice daily or twice weekly) the study participants were in.|Randomized, Single-blinded, Prospective Crossover Controlled Trial||t|t|t
1315219|NCT03397966|Randomized|Crossover Assignment||Other||Single|The participant will be blinded as to which infusion they are receiving at which visit. Also, the individuals analyzing fat gene expression will be blinded.|In this cross-over study, each subject will receive BNP infusion at one visit and control at the other visit, in random order. The sequence of the treatments will be randomized. There will be a washout period (at least 7 days) between visits. Subjects will be stratified by BMI category (lean or obese).|t|||
1315220|NCT03397953|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1315221|NCT03397940|||Cohort||Prospective|||||||
1315222|NCT03397927||Single Group Assignment||Prevention||None (Open Label)||||||
1315223|NCT03397914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315224|NCT03397901||Single Group Assignment||Treatment||None (Open Label)||||||
1315225|NCT03397888|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315226|NCT03397875|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1315227|NCT03397862|Randomized|Sequential Assignment||Other||Quadruple|Blinding will occur at package level.|Induction Phase will consist of application of the once-weekly TDS for 3 consecutive weeks to the same skin site, followed by a rest period of 2 weeks. The TDS application site will be visually scored for skin irritation approximately 30 minutes following each patch removal and prior to the next patch application. The Challenge Phase will consist of 2 days of TDS application followed by 3 days of visual scoring of TDS application site following TDS removal. Subjects meeting the guidance criteria for Re-Challenge phase will continue with a rest period of 4-8 weeks, followed by 2-day TDS application and a 3-day visual scoring of the TDS application site following TDS removal.|t|t|t|t
1315228|NCT03397849|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Patients that are randomized to usual care group will receive guideline-standardized medications and lifestyle recommendations. Cardiovascular risk management and compliance to medication and lifestyle recommendation will be assessed and controlled by three cardiologists in clinical visits performed at 6 and 12 months. For the necessary cases counseling to other specialities will be performed for smoke cessation and weight management.~Each study patients that are randomized to IMT plus usual care group will receive a group of smart devices including mobile phone (Vestel Venus e2) (Vestel, Manisa, Turkey), wristband (Xiaomi band 2) (Beijing Xiaomi Technology Co., Beijing, China), weight scale (Bluecat, Yongkang Tiansheng Electronic Co., Zhejiang, China) and blood pressure monitor (Clever Chek TD-3250) (TaiDoc Technology Co., Taipei County, Taiwan)."||||
1315229|NCT03397836|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315230|NCT03397823|||Other||Prospective|||||||
1315231|NCT03397810||Single Group Assignment||Treatment||None (Open Label)||||||
1315232|NCT03397797|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1315233|NCT03397784|||Case-Control||Prospective|||||||
1315234|NCT03397771|Randomized|Parallel Assignment||Treatment||Quadruple|double blind placebo control||t|t|t|t
1315235|NCT03397758||Single Group Assignment||Treatment||None (Open Label)||||||
1315236|NCT03397745||Single Group Assignment||Other||None (Open Label)||||||
1315237|NCT03397732|||Case-Control||Prospective|||||||
1315238|NCT03397719|Randomized|Parallel Assignment||Treatment||Single||||||t
1315239|NCT03397706|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Phase 1: dose escalation phase (3+3 design with definitions of dose limiting toxicity) to define a recommended phase 2 dose~Phase 2: dose expansion"||||
1315240|NCT03397693|||Case-Control||Cross-Sectional|||||||
1315281|NCT03397160|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||This is a site-randomized, cluster-crossover clinical trial of a decision support intervention (DSI) vs. usual care, among men with low prognostic risk prostate cancer, to assess differences in informed decision making (i.e., knowledge), anxiety, and decision quality and self-efficacy.||||
1315241|NCT03397680|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Participants with positive rapid urease test or pathologic findings were divided into 2 groups and enrolled into randomization with 1:1 block of four methods. Each participant in group1 received 7-day once daily dose regimen of 1-tablet 750-mg Levofloxacin after meal, 2-tablet 500-mg Clarithromycin MR after meal, 3-tablet 20-mg Rabeprazole before meal and 1-tablet 1,048-mg Gastro bismol after meal.~Meanwhile, each participant in group2 received 14-day once daily dose regimen of 1-tablet 750-mg Levofloxacin after meal, 2-tablet 500-mg Clarithromycin MR after meal, 3-tablet 20-mg Rabeprazole before meal and 1-tablet 1,048-mg Gastro bismol after meal."||||
1315242|NCT03397667|Randomized|Parallel Assignment||Health Services Research||Single|The outcomes assessor is blinded to which arm a dyad is enrolled.|||||t
1315243|NCT03397654||Single Group Assignment||Treatment||None (Open Label)||||||
1315244|NCT03397641|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315245|NCT03397628|Randomized|Parallel Assignment||Prevention||||||||
1315246|NCT03397615|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1315247|NCT03397602|Randomized|Parallel Assignment||Other||Double|||||t|t
1315248|NCT03397589|Randomized|Parallel Assignment||Other||Single|Because of the nature of the intervention, participants will know after randomization which arm they are in. Outcomes assessors and data analysts will be masked to study arm. Most investigators will be masked to study arm.|cluster-randomized two arm trial with wait list control||||t
1315249|NCT03397576|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor is blinded to treatment assignment|Randomized controlled trial||||t
1315250|NCT03397563|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1315251|NCT03397550|||Cohort||Prospective|||||||
1315252|NCT03397537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315253|NCT03397524|Randomized|Parallel Assignment||Treatment||Single|The patient participant will be unaware of randomization.|The interventional arm outcomes will be compared to the control.|t|||
1315254|NCT03397511||Single Group Assignment||Treatment||None (Open Label)||||||
1315255|NCT03397498|Randomized|Parallel Assignment||Prevention||Double|Participants are not told which group they are assigned to, and the investigator (PI) and coordinators completing the cognitive evaluation are not told which group the participants are assigned to.||t||t|
1315256|NCT03397485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315257|NCT03397472|||Other||Prospective|||||||
1315258|NCT03397459|||Cohort||Prospective|||||||
1315259|NCT03397446||Single Group Assignment||Treatment||None (Open Label)||Participants will be instructed to take LDX once daily for two months. The trial will begin with a 4-week titration period followed by a 4-week maintenance period for a total treatment duration of 8 weeks. The treatment phase will be followed by a 1-week follow-up.||||
1315260|NCT03397433|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a prospective, pragmatic trial of initial antibiotic prescribing review by Infectious Disease Specialists. The study involves 4 hospitals, 2 of which are intervention and 2 control for 18 months, followed by switching the intervention and control hospitals in a crossover fashion for another 18 months. Medical and economic outcomes will be assessed and reported||||
1315261|NCT03397420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315262|NCT03397407|||Cohort||Cross-Sectional|||||||
1315263|NCT03397394||Sequential Assignment||Treatment||None (Open Label)||||||
1315264|NCT03397381|||Cohort||Prospective|||||||
1315265|NCT03397368|||Other||Cross-Sectional|||||||
1315266|NCT03397355|||Cohort||Prospective|||||||
1315267|NCT03397342|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1315268|NCT03397329|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1315269|NCT03397316|Randomized|Parallel Assignment||Other||Quadruple|Each patient will be given a code by researcher (A.A) and the observers will be blind to which group this case belong.||t|t|t|t
1315270|NCT03397303|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1315271|NCT03397290||Single Group Assignment||Screening||None (Open Label)||||||
1315272|NCT03397277|Randomized|Parallel Assignment||Supportive Care||Triple|All women will be shown a video (also women not screening positive for IPV). Unless staff ask women about the content of the video or the women discloses this, care providers will not know which film participants have viewed. As we include a group of women who screened negative for IPV in the assessment three months after birth care providers will not know who who screened positive and who screened negative. In the file the variable for control og intervention video will be blinded. Women will be selected for the post-partum questionnaire based on the screening for abuse. All abused women and for each abused woman two without abuse will be selected.|Pregnant women will be screened for IPV using a modified version of the Abuse Assessment Screening. Women who screen positive are randomized into either the intervention video or a control video. Women screening negative for violence will be shown the control video. All women receive standard care and a card with high quality websites about safe pregnancy. Hidden among these is a webside that informs women about IPV (rights, safety etc..). Three months after birth all the women screening positive for violence will receive another questionnaire to fill out. In addition will a random sample of women who screened negative for IPV be asked to fill out a questionnaire at the same time. This group will be double the size of the women screening positive.||t|t|t
1315273|NCT03397264|Randomized|Parallel Assignment||Treatment||Quadruple|Ph 1b open label; Ph 2a quadruple masked|Phase 1b - sequential dose followed by Phase 2a - parallel arm|t|t|t|t
1315274|NCT03397251||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-randomized, non-blinded, single-arm study evaluating the feasibility and safety of the AMDS||||
1315275|NCT03397238|||Case-Control||Prospective|||||||
1315276|NCT03397225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315277|NCT03397212|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1315278|NCT03397199||Single Group Assignment||Treatment||None (Open Label)||||||
1315279|NCT03397186||Single Group Assignment||Basic Science||None (Open Label)||||||
1315280|NCT03397173||Single Group Assignment||Treatment||None (Open Label)||||||
1315282|NCT03397147|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized trial with 2 conditions (intervention and usual care).||||
1315283|NCT03397134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315284|NCT03397121|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1315285|NCT03397108|||Case-Control||Prospective|||||||
1315286|NCT03397095|Randomized|Parallel Assignment||Treatment||Quadruple||S-CURE study has a two-stage design. Stage 1 is an open-labled, lead-in study. 20 participants will be enrolled in this stage. It is conducted to assess the feasibility and safety of the study procedures as well as the bioactivity of the products. Stage 2 is an randomized, placebo controlled study, 100 participants will be enrolled in this stage.|t|t|t|t
1315287|NCT03397082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315288|NCT03397069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315289|NCT03397056|||Cohort||Prospective|||||||
1315290|NCT03397043||Single Group Assignment||Basic Science||None (Open Label)|Participants blinded to the protein dose consumed in a given metabolic trial|||||
1315291|NCT03397030|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking was used in this study.|This study is designed randomized controlled, 2 arm parallel group pilot study.||||
1315292|NCT03397017|||Cohort||Prospective|||||||
1315293|NCT03397004|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1315294|NCT03396991|||Other||Cross-Sectional|||||||
1315295|NCT03396978||Single Group Assignment||Basic Science||None (Open Label)||||||
1315296|NCT03396965|Randomized|Single Group Assignment||Treatment||Single||Patients randomized to fluoroscopically-aided reduction of fracture, versus no fluoroscopic guidance||||t
1315297|NCT03396952||Single Group Assignment||Treatment||None (Open Label)||||||
1315298|NCT03396939|Randomized|Parallel Assignment||Treatment||Single|"Assessments of the study population are performed at baseline, at the end of week 3, at week 12 upon completion of the intervention. A blinded therapist, not involved in the project, will perform all the testing."|"The study is a two-step trial: first with the feasibility trial in a cohort of stroke patients regardless of location and temporal evolution then followed by a pilot randomized controlled study (RCT).~The feasibility study will include 30 stroke patients with reduced arm and hand functions to explore and establish a target group for whom the intervention may be best suitable in terms of compliance and improvement of perceived use.~The pilot RCT will include 30 first-time stroke patients with reduced arm and hand functions. The experimental group (15 patients) will receive an orthotic device for use during the exercises, while the control group (15 patients) will not. Both groups will receive the same amount of a study-specific training program."||||t
1315299|NCT03396926||Single Group Assignment||Treatment||None (Open Label)||||||
1315300|NCT03396913|Randomized|Parallel Assignment||Treatment||Single|Subjects in the study arm will receive a series of IPL pulses using the M22 IPL handpiece. In subjects of the control arm, the device will be disabled. The subject will feel the lightguide on the skin, will hear clicking sounds, but no light will be actually produced by the M22 device. Since during treatment both eyes of the subject will be fully occluded, no subject will be able to see if the treatment is actual or sham. There is no way to completely mask the subjects, since the IPL generally causes slight redness of the skin, and in some patients is may also cause some discomfort|Subjects will be randomized 1:1 to a study arm and a control arm. Subjects in the study arm will be treated with IPL and meibomian gland expression. Subjects in the control arm will be treated with sham and meibomian gland expression.|t|||
1315301|NCT03396900|Randomized|Parallel Assignment||Treatment||Triple|The orthodontist (HA) who performed the relevant treatment after PAOO was different from the orthodontist (MRR) randomizing the subjects into C or C+BMP groups and hence was blinded to the treatment received by the patient. One periodontist performed the PAOO surgeries (KM) and another periodontist (RVC) blinded to the therapy received by the subjects recorded the clinical and radiographic data pertinent to the study. The blind was not broken until the end of study period.|This study is a randomized controlled clinical trial where systemically healthy individuals undergoing orthodontic therapy and willing to participate in the study were referred from the Department of Orthodontics and were followed up over a 6 month period after treatment.|t|t|t|
1315302|NCT03396887|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants will be randomised to intervention or control condition.||||
1315303|NCT03396874||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315304|NCT03396861||Single Group Assignment||Treatment||None (Open Label)||||||
1315305|NCT03396848||Single Group Assignment||Supportive Care||None (Open Label)||Patient will have access to an online clinic after their prostate cancer treatment. This is a feasibility study to determine whether it would be feasible to implement SHAReClinic as a pan-Canadian sexual health and rehabilitation intervention||||
1315306|NCT03396835||||||||||||
1315307|NCT03396822|||Cohort||Prospective|||||||
1315308|NCT03396809||Single Group Assignment||Supportive Care||None (Open Label)||Investigators will be performing a case crossover study. First patients who consent will be asked to complete an Ocular Surface Disease Index (OSDI). Those whose score indicates a diagnosis of dry eye will eligible for the study. Three to five days after their intravitreal injection, patients will be contacted over the telephone and asked to complete the OSDI. At their next visit, one month later, a punctal plug will be inserted before their second injection. Three to five days after their second injection, they will be asked to complete the OSDI over the telephone. At their third visit they will receive an intravitreal injection and three to five days after they will be asked to complete a final OSDI. If patients are receiving bilateral intravitreal injections, and the OSDI survey indicates dry eyes bilaterally, then only one of the eyes will be randomly chosen for plug insertion. The other eye will then be used as a control.||||
1315309|NCT03396796|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1315310|NCT03396783|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1315311|NCT03396770|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||open labeled randomized clinical trial||||
1315312|NCT03396757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315313|NCT03396744|Randomized|Single Group Assignment||Treatment||None (Open Label)||Dose finding study||||
1315314|NCT03396731|Randomized|Parallel Assignment||Treatment||Single|The assessors will be blinded to the study participants and what treatment they are receiving.|||||t
1315315|NCT03396718|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1315316|NCT03396705|||Cohort||Prospective|||||||
1315317|NCT03396692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315318|NCT03396679|||Cohort||Prospective|||||||
1315319|NCT03396666|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1315320|NCT03396653|Randomized|Parallel Assignment||Treatment||Single||||||t
1315321|NCT03396640|Randomized|Parallel Assignment||Treatment||Quadruple|Stratified, permuted block randomization with a 1:1 allocation ratio. Block sizes will be 4, 6, 8 and 10. Stratification will be two-dimensional, where surgeon is one dimension and patient sex the other. The randomization will be done immediately preceding surgery. Randomization is blinded to everyone (patient, staff, GP, physiotherapists etc.) except theatre staff, for the first year following surgery.|Double Blinded, randomized controlled trial.|t|t|t|t
1315322|NCT03396627|||Cohort||Prospective|||||||
1315323|NCT03396614|||Cohort||Cross-Sectional|||||||
1315324|NCT03396601|Randomized|Parallel Assignment||Treatment||Quadruple|Participants and Care Providers will be masked with regard to medication administered. Outcomes Assessors will not be present during IV infusion of medication.||t|t|t|t
1315325|NCT03396588|Randomized|Parallel Assignment||Treatment||Quadruple|The study will mask parents and child caregivers, and NICU nurses giving the drug, other personnel, residents and attending physicians, and research staff. Since initial dose is set using weight based-dosing, a physician's order can be entered in the electronic medical record to give the initial study drug with the infant's weight stated in the order. Increase in dosing will be ordered as to increase by 25% of initial dose or decrease of dose by 10% of maximum dose. During the pilot study, masking of treating personnel was maintained while the hospital pharmacist was the only person aware of which study drug the infant was receiving. The examiners for administration of the NNNS and the research nurse and research case worker will be masked to treatment received. Those seeing the infant in the clinic will also be masked to the treatment assignment. Morphine and clonidine are dispensed in identical appearance, color, smell, and volume.|The study is intended to treat NAS using a randomized and double-blind study design to compare the use of opiate (morphine) or non-opiate (clonidine). Newborns meeting the study criteria for drug withdrawal and treatment will be randomized to receive one of the drugs (morphine, clonidine). Newborns requiring a second drug to help relieve the symptoms will be treated with phenobarbital for both groups. Randomization, blinding and dispensing will occur in the Investigational Drug Services Unit. Nursing personnel in the NICU will be masked to the treatment administered to each baby.|t|t|t|t
1315326|NCT03396575|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Patients in this study will either receive concurrent TMZ during RT and dose-intensive TMZ as maintenance treatment (Group A) or radiotherapy only prior to DC vaccination and without maintenance DI TMZ (Group B). Immune responses during cycles of DC vaccination with or without DI TMZ will be evaluated in both treatment groups.~Once Group A accrual is completed and evaluated for toxicity, 6 Group B patients will be enrolled and treated at the Maximally Achievable Dose (MAD) or (Maximum Tolerated Dose) MTD determined in Group A cohort."||||
1315327|NCT03396562|||Case-Only||Prospective|||||||
1315328|NCT03396549|Randomized|Single Group Assignment||Basic Science||Double|Only the assistant delivering tDCS will not be blind to conditions.|Cross-over blind. All get sham and real tDCS.|t|||t
1315329|NCT03396536|||Case-Control||Prospective|||||||
1315330|NCT03396523|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1315331|NCT03396510|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1315332|NCT03396497||Single Group Assignment||Treatment||None (Open Label)||||||
1315333|NCT03396484|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1315334|NCT03396471||Single Group Assignment||Treatment||None (Open Label)||||||
1315335|NCT03396458|||Case-Only||Prospective|||||||
1315336|NCT03396445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315337|NCT03396432|Randomized|Parallel Assignment||Other||Single|Statistician will be blinded at the time of data analysis.|Prospective, randomized, multi-center parallel group trial||||t
1315338|NCT03396419|||Cohort||Other|||||||
1315339|NCT03396406|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1315340|NCT03396393|Randomized|Parallel Assignment||Treatment||Quadruple||Patients will be received DHA 40mg or DHA 80mg or DHA 120mg or placebo continuously for 24 weeks.|t|t|t|t
1315341|NCT03396380|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1315342|NCT03396367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315343|NCT03396354|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315344|NCT03396341|||Cohort||Prospective|||||||
1315345|NCT03396328|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1315346|NCT03396315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||open-label study in which they would choose whether to take oral alendronate 70 mg weekly for 12 months or a single intravenous dose of zoledronic acid 5 mg.||||
1315347|NCT03396302|Randomized|Parallel Assignment||Treatment||Single||||||t
1315348|NCT03396289|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1315349|NCT03396276||Single Group Assignment||Treatment||None (Open Label)||||||
1315350|NCT03396263|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315351|NCT03396250|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315352|NCT03396237|||Case-Control||Prospective|||||||
1315353|NCT03396224|||Cohort||Prospective|||||||
1315354|NCT03396211||Single Group Assignment||Treatment||None (Open Label)||This protocol contains two parts: 1) a classic 3+3 dose escalation period to evaluate the safety of apatinib (also known as rivoceranib) in combination with nivolumab, and 2) an expansion period with open-label administration of apatinib at a dose up to 700 mg qd (as 869 mg apatinib mesylate) or at the maximum tolerated dose (MTD) obtained from Part I of this study. Subjects for both Part I and Part II will be enrolled after informed consent and deemed eligible following screening procedures.||||
1315355|NCT03396198|||Cohort||Prospective|||||||
1315356|NCT03396185||Single Group Assignment||Treatment||None (Open Label)||||||
1315357|NCT03396172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315358|NCT03396159||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315359|NCT03396146|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1315360|NCT03396133|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1315361|NCT03396120|||Cohort||Retrospective|||||||
1315362|NCT03396107|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1315363|NCT03396094|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study consists of 2 arms (intervention and control) of parallel design. The intervention arm will receive high flow nasal cannula (HFNC) oxygenation at 60L/min for pre- and apnoeic oxygenation while the control arm will receive pre-oxygenation via non-rebreather mask and apnoeic oxygenation via nasal cannulae at 15L/min.||||
1315364|NCT03396081|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1315365|NCT03396068|Randomized|Parallel Assignment||Treatment||Quadruple|Participants and Care Providers will be masked with regard to medication administered. Outcomes Assessors will not be present during IV infusion of medication.||t|t|t|t
1315366|NCT03396055|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1315367|NCT03396042|||Cohort||Prospective|||||||
1315368|NCT03396029|Randomized|Parallel Assignment||Prevention||Single|A computer programme designed by the research team IT developer carried out the randomization. The recruitment and the contact between the investigators and the participants was mailed. There was no face-to-face contact.||||t|
1315369|NCT03396016|||Cohort||Prospective|||||||
1315370|NCT03396003|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1315371|NCT03395990|Randomized|Parallel Assignment||Treatment||Triple|Group allocation by sealed envelope; unblinded investigator prepared syringes of study drug (chloroprocaine vs. saline), which look identical to blinded investigator and assessor.|randomized, blinded observational study|t|t||t
1315372|NCT03395977|Randomized|Crossover Assignment||Basic Science||Double|Febuxostat and Rasburicase will be prepared by an independant pharmacist.|"This is a prospective, randomized, placebo-controlled, double-blinded and 3 ways cross-over study. Two groups : healthy subjects and subjects with hypertension (minimum 15 participants in each group).~For 5 subjects in each group, we will perform a fourth session with Placebo PO and Rasburicase IV. That session will be non-randomized and blinded only for the subject."|t||t|
1315373|NCT03395964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315374|NCT03395951|||Cohort||Prospective|||||||
1315375|NCT03395938|Randomized|Parallel Assignment||Screening||Double|||t|||t
1315376|NCT03395925||Single Group Assignment||Treatment||None (Open Label)||||||
1315377|NCT03395912|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315378|NCT03395899|Randomized|Parallel Assignment||Other||None (Open Label)|No masking - open label|||||
1315379|NCT03395886|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1315380|NCT03395873||Single Group Assignment||Treatment||None (Open Label)||||||
1315381|NCT03395860|Randomized|Parallel Assignment||Treatment||None (Open Label)||drug: rATG drug: PTCy||||
1315382|NCT03395847||Single Group Assignment||Treatment||None (Open Label)||||||
1315383|NCT03395834||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315384|NCT03395821|Randomized|Parallel Assignment||Other||None (Open Label)||Two groups will be compared according to their surgical skills.||||
1315385|NCT03395808||Single Group Assignment||Other||None (Open Label)||||||
1315386|NCT03395795||Single Group Assignment||Treatment||None (Open Label)||||||
1315387|NCT03395782|||Cohort||Prospective|||||||
1315388|NCT03395769||||||||||||
1315389|NCT03395756|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Participants in this study will be assigned to one of three groups based on leading follicle size: 12-14 mm, 15-17mm, and 18 mm or greater. Each group will receive the same medication (intramuscular depot medroxyprogesterone acetate), and be followed in the same manner for five consecutive days after administration with transvaginal ultrasound and blood draws for hormonal assays (progesterone, estradiol, and luteinizing hormone levels)||||
1315390|NCT03395743||||||||||||
1315391|NCT03395730|Randomized|Parallel Assignment||Prevention||Double|Randomization will be based on the sequence generation created by computer and the randomization tables will be kept with the study supervisor. Consenting patients fulfilling inclusion criteria will be randomized into one of the following 3 groups. Randomized allocation will be kept in opaque sealed envelopes, with enrollment numbers written on the envelopes. The envelopes will contain a card on with the designated study group will be written. After enrollment of the patients in the study, the envelopes marked with study number will be unsealed and the patients allocated to either groups|"The present study will be conducted on 150 women recruited from the delivery ward of our hospital after they had received information on the purpose and course of the study from the medical investigator and had provided the written consent during routine prenatal visits , they will be randomly divided into:~Group (A) Study Group 1: (n = 50)~Group (B) Study Group 2: (n = 50)~Group (C) Control Group: (n = 50)"|t|t||
1315392|NCT03395717|Randomized|Parallel Assignment||Treatment||Single||Single blind||||t
1315393|NCT03395704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315394|NCT03395691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315395|NCT03395678|Randomized|Parallel Assignment||Treatment||Single||||||t
1315396|NCT03395665|||Case-Crossover||Retrospective|||||||
1315397|NCT03395652|||Cohort||Prospective|||||||
1315398|NCT03395639|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315399|NCT03395626|Randomized|Parallel Assignment||Treatment||Triple||randomized, double-blind, placebo-controlled, parallel-group|t|t|t|
1315400|NCT03395613|Randomized|Parallel Assignment||Prevention||None (Open Label)||Preoperative randomization||||
1315401|NCT03395600|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1315402|NCT03395587|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective, multicenter, open-label, randomized phase 2 study with two parallel groups||||
1315403|NCT03395574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315404|NCT03395561|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315405|NCT03395548|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1315406|NCT03395535|Randomized|Single Group Assignment||Treatment||Single|All clinical tests and outcomes are by masked observers.|||||t
1315544|NCT03393741|||Cohort||Prospective|||||||
1315407|NCT03395522||Single Group Assignment||Treatment||None (Open Label)||device group only||||
1315408|NCT03395509|||Cohort||Prospective|||||||
1315409|NCT03395496|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1315410|NCT03395483|||Cohort||Prospective|||||||
1315411|NCT03395470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315412|NCT03395457|Randomized|Parallel Assignment||Treatment||Single||pragmatic randomised control trial||||t
1315413|NCT03395444|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315414|NCT03395431|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will be blinded to group assignment|A single blind parallel group randomized control trial||||t
1315415|NCT03395418|||Other||Prospective|||||||
1315416|NCT03395405|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315417|NCT03395392|Randomized|Parallel Assignment||Treatment||Quadruple|Participants and Care Providers will be masked with regard to medication administered.||t|t|t|t
1315418|NCT03395379|||Cohort||Retrospective|||||||
1315419|NCT03395366|Randomized|Parallel Assignment||Other||Double||The study will be designed as a 16-week randomized controlled trial in which 40 subjects on hemodialysis with below average HrQOL will be assigned to one of two educational interventions.|t|||t
1315420|NCT03395353||Single Group Assignment||Treatment||None (Open Label)||||||
1315421|NCT03395340||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1315422|NCT03395327|||Cohort||Prospective|||||||
1315423|NCT03395314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315424|NCT03395301||Sequential Assignment||Treatment||None (Open Label)||Platinum coils were inserted into the tubes.||||
1315425|NCT03395288|Randomized|Parallel Assignment||Prevention||Single|Participants in the RCT treatment and RCT control arm will not be told the name of the nutraceutical being studied. Participants in the observational arm will be aware of the nutraceutical being studied.|There will be a RCT portion of the study with a treatment arm and a control arm and an additional observational arm of the study.|t|||
1315426|NCT03395275||Single Group Assignment||Diagnostic||None (Open Label)||The study will be a non-randomized prospective trial. Participants will be selected for microdose intrathecal pump therapy by their pain physicians. Eligible participants will undergo an opioid taper by their physicians, and sensory tests will be carried out in the various stages of the intrathecal microdose treatment process (pre-taper, mid-taper, post-taper and post-implant phase).||||
1315427|NCT03395262|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1315428|NCT03395249|Randomized|Parallel Assignment||Treatment||Quadruple|Subjects will be randomized in a 3:1 ratio of SPR994 to placebo. Study drug tablets, both active and placebo, are the same shape, weight and size. Those blinded to study drug assignment include the sponsor, the PI, clinical study personnel participating in subjects' care or clinical evaluations, and the subjects. Those unblinded to study drug assignment include the statisticians preparing the randomisation, pharmacy personnel, the unblinded study monitor, the bioanalytical laboratory, and the pharmacokineticist performing interim PK analysis.|Randomized, double-blind, placebo-controlled, combined single and multiple ascending dose (SAD and MAD) trial|t|t|t|t
1315429|NCT03395236||Single Group Assignment||Treatment||None (Open Label)||||||
1315430|NCT03395223||Single Group Assignment||Treatment||None (Open Label)||||||
1315431|NCT03395210||Sequential Assignment||Treatment||None (Open Label)||||||
1315432|NCT03395197|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind.|To assess radiographic PFS in men with mCRPC (with no systemic treatments initiated after documentation of mCRCP) treated with talazoparib and enzalutamide vs. placebo plus enzalutamide|t|t|t|t
1315433|NCT03395184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315434|NCT03395171|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315435|NCT03395158|||Cohort||Prospective|||||||
1315436|NCT03395145|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315437|NCT03395132|Randomized|Parallel Assignment||Treatment||Single|In order to keep the trial investigator-blind, packaging and labelling of the outer box will be identical for all investigational medicinal products (IMPs). Handling of individual tubes of IMP will therefore be handled by a designated third person. Individual tubes of IMP will be inaccessible for the (sub)investigator and other trial staff involved in evaluation of subjects and conduct of the trial. Subjects will be instructed to only reveal the IMP to the drug dispenser and not to the trial staff.||||t|
1315438|NCT03395119|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1315439|NCT03395106|Randomized|Parallel Assignment||Health Services Research||Single|Statisticians completing the analysis of the primary outcome will be blinded.|Factorial design 2x2||||t
1315440|NCT03395093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315441|NCT03395080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315442|NCT03395067|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled trial including 2 arms: intervention group and control group.|||t|t
1315443|NCT03395054|Randomized|Parallel Assignment||Treatment||Single||||||t
1315444|NCT03395041|||Case-Control||Prospective|||||||
1315445|NCT03395028||Single Group Assignment||Supportive Care||None (Open Label)||Dose determination for GCSF||||
1315446|NCT03395015|||Case-Control||Prospective|||||||
1315447|NCT03395002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315448|NCT03394989|Randomized|Parallel Assignment||Treatment||Double||A multicenter, randomized, parallel-group, placebo-controlled|||t|t
1315449|NCT03394976|||Case-Control||Prospective|||||||
1315450|NCT03394963|||Other||Other|||||||
1315451|NCT03394950|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315452|NCT03394937|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1315453|NCT03394924|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315537|NCT03393832|Randomized|Parallel Assignment||Supportive Care||Double|Oral care syringes will be covered with yellow tape.|Pilot, randomized controlled trial|t|t||
1315542|NCT03393767||Single Group Assignment||Treatment||None (Open Label)||||||
1315543|NCT03393754|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1315454|NCT03394911|Randomized|Crossover Assignment||Treatment||Quadruple|Identical packaging, identical labeling, identifying random numbers in key onsite with pharmaceuticals technician on site. Identical vehicle. Pheromone is odorless, colorless, tasteless. Placebo handled exactly as Pheromone/experimental, but without application of pheromone.|Double-blind, cross-over, placebo-controlled clinical trial in hospital setting overseen by attending physician, χ2 test for categorized data|t|t|t|t
1315455|NCT03394898|||Cohort||Prospective|||||||
1315456|NCT03394885||Single Group Assignment||Treatment||None (Open Label)||||||
1315457|NCT03394872|||Cohort||Prospective|||||||
1315458|NCT03394859|||Cohort||Prospective|||||||
1315459|NCT03394846||Single Group Assignment||Treatment||None (Open Label)||||||
1315460|NCT03394833|Randomized|Single Group Assignment||Other||None (Open Label)||Non-blinded randomization. Standardized method comparison.||||
1315461|NCT03394820|Randomized|Parallel Assignment||Other||Double|The patient will be randomized prior to surgery. The pre-randomized envelope will be given to the anesthesia assistant by the blinded research associate. The anesthesia assistant will then prepare the four mini-bags labelled with the time each bag should be hung.The four bags will include 1 active drug and 3 placebo, to administer to the patient. The clinical fellow who will be administering the four doses will be blinded, as well as the research associate.|the patients will be randomized into four differently times groups. The patients will receive dexamethasone either 1 hour before the block, during the block, 1 hour after the block or 2 hours after the block||t|t|
1315462|NCT03394807|Randomized|Parallel Assignment||Treatment||Quadruple|Blinded|Prospective, randomised, placebo controlled trial|t|t|t|t
1315463|NCT03394794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315464|NCT03394781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315465|NCT03394768|||Cohort||Prospective|||||||
1315466|NCT03394755||Single Group Assignment||Treatment||None (Open Label)||||||
1315467|NCT03394742|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1315468|NCT03394729|Randomized|Crossover Assignment||Prevention||Triple|"In the study, the principal investigator will be blind to the order of the tablets consumed by adolescents. The propolis tablets and control tablets will have a similar appearance, taste, texture and sizes, will be coded as A and B by an independent investigator and will be delivered to participants in an opaque and closed bottle. Individuals will be instructed to consume each type of tablet (propolis and propolis) twice a day (10 a.m. and 5 p.m.) for 7 days, giving a 30 day interval between test and control. Volunteers will be followed at the beginning and end of each intervention."|Clinical trial of prevention, cross, blind, randomized controlled with two arms in the study phase 2-3.||t|t|t
1315469|NCT03394716|||Cohort||Prospective|||||||
1315470|NCT03394703|||Cohort||Prospective|||||||
1315471|NCT03394690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315472|NCT03394677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315473|NCT03394664|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1315474|NCT03394651|||Cohort||Prospective|||||||
1315475|NCT03394638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315476|NCT03394625|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1315477|NCT03394612||Single Group Assignment||Treatment||None (Open Label)||||||
1315478|NCT03394599|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1315479|NCT03394586|||Cohort||Other|||||||
1315480|NCT03394573|||Cohort||Prospective|||||||
1315481|NCT03394560|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1315482|NCT03394547|Randomized|Parallel Assignment||Treatment||Triple|"Participants will be randomly allocated to a treatment arm through telephone randomisation. If they are allocated to no treatment they will be aware of the management, however if allocated to use of a device the participant and care provider will be blinded to weather it is an active device or placebo device. The outcome assessor will be blinded to the treatment allocation."|Participants are allocated to 1 of 3 arms: either treatment with an active device, treatment with a placebo device, or no treatment.|t|t||t
1315483|NCT03394534|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1315484|NCT03394521|||Cohort||Retrospective|||||||
1315485|NCT03394508|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315486|NCT03394495|Randomized|Parallel Assignment||Treatment||Single|An independent assessor who is blinded to the group allocations will assess the participants' outcomes.|"A three-arm parallel (single-blinded) cluster randomized controlled trial involves three groups of participants (the COMB, the EXER and the control group). Twelve community health centres that provide similar types of community care and social support services for community-dwelling older people, have been invited by a convenience method to work as collaborators in this study. Using computer-generated random numbers, a biostatistician not affiliated with this study will randomize the centres into either: control, EXER, or COMB group. So during the trial, participants in one group receive combination intervention in parallel to participants in the other two groups (the control group and the exercise group)."||||t
1315487|NCT03394482|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315488|NCT03394469||Single Group Assignment||Screening||None (Open Label)|No masking|||||
1315489|NCT03394456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315490|NCT03394443|||Case-Only||Prospective|||||||
1315491|NCT03394430|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1315492|NCT03394417|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1315493|NCT03394404||Single Group Assignment||Treatment||None (Open Label)||||||
1315538|NCT03393819|Randomized|Parallel Assignment||Treatment||Single|Blinding of the participants and care providers after the assignment of the intervention is not possible as the two solutions are distinct, and one creates a unique discolouration of the skin. Those performing the laboratory analysis and reporting the results of the bacterial culture of will be blind to which treatment the participant was assigned (i.e. the label will not identify which group the participant belongs to).|||||t
1315539|NCT03393806|Randomized|Parallel Assignment||Treatment||Double||Participants will be randomized in a 1:1 ratio to receive either 10 mg/kg GSK3772847 or matching placebo intravenously.|t||t|
1315540|NCT03393793|||Cohort||Retrospective|||||||
1315494|NCT03394391|Randomized|Parallel Assignment||Supportive Care||Triple|The investigators, data manager, research assistants, counselors and other project staff will be blinded throughout the study. An independent medical internet technology firm will be contracted to randomize participants and to send the required SMS to the participants. After scientific review has been completed and data collection has been completed, at the point of analysis, a list of participants' unique identifiers in two groups will be sent to the data analysts without specifying which the investigation or control group is. The blinding of the clinical database will finally be removed after final data analysis has been completed.|A single-blind, parallel-design (ratio 1:1), and multi-centre RCT of 230 adolescent living with HIV who are non-adherent to medications will be conducted over a one-year period in Southwest Nigeria.||t|t|t
1315495|NCT03394378|||Other||Cross-Sectional|||||||
1315496|NCT03394365||Single Group Assignment||Treatment||None (Open Label)||||||
1315497|NCT03394352|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1315498|NCT03394339|||Other||Prospective|||||||
1315499|NCT03394326|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315500|NCT03394313|||Cohort||Prospective|||||||
1315501|NCT03394300|||Case-Crossover||Prospective|||||||
1315502|NCT03394287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315503|NCT03394274|||Other||Retrospective|||||||
1315504|NCT03394261|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The Patient Decision Aid for Medication Assisted Therapy (PtDA-MAT) will be pilot-tested by patients and clinicians during actual visits with OUD patients to assess its acceptability and feasibility. We will track patients receiving PtDAT-MAT using their clinical and administration data over a 3-month period and compare outcomes to those of treatment admissions during the 3 months prior to the pilot testing to assess preliminary outcomes associated with PtDAT-MAT.||||
1315505|NCT03394248|||Cohort||Prospective|||||||
1315506|NCT03394235||Single Group Assignment||Treatment||None (Open Label)||This is a pilot study. We plan to enroll 15 participants who requires to do hair transplantation or normal participants who are eligible for the study.||||
1315507|NCT03394222|Randomized|Parallel Assignment||Supportive Care||Double|One research assistant was tasked to give the interventional medication in indentical containers to the anesthesiologists(care provider) in charge of the participants for preoperative preparations.Both the participants and care providers were blinded.||t|t||
1315508|NCT03394209||Single Group Assignment||Treatment||None (Open Label)||"This is a adaptive study, which include two steps.~1st step: 1600mg BID on day 1, followed by 600mg BID for 9 days. Sample size: 15 PK analysis: If the proportion of patients with a minimum observed plasma trough concentration above the MEC (20μg/ml) at all measured time points after the second dose is greater than or equal to 80% then the dose is considered adequate and the study will be completed. If not, then a second patient cohort will be recruited and will receive favipiravir 1800mg BID on day 1, followed by favipiravir 800mg BID for 9 days. Sample size: 15"||||
1315509|NCT03394196|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315510|NCT03394183|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||All participants will be enrolled in the cardiac rehabilitation program which involves weekly 1.5 hour visits at the Toronto Rehabilitation Institute Rumsey Centre for 6 months. Each visit will consist of an exercise and a risk factor education lecture. Prior to the start of the program, participants will attend two assessment sessions with cardiac rehabilitation staff members to review medical history as well as complete a cardiopulmonary exercise test. During the cardiac rehabilitation program, participants will walk at 60-80% of their VO2peak heart rate based on the results of their exercise test, as per standard care procedures. Adjustments will be made to the patient's exercise prescription under the discretion of the cardiac rehabilitation supervisor, as per standard care procedures. Patients will also be asked to exercise an additional four times during the week on their own time for a total of five times per week, as per standard care procedures.||||
1315511|NCT03394170|||Other||Prospective|||||||
1315512|NCT03394157||Single Group Assignment||Treatment||None (Open Label)||||||
1315513|NCT03394144||Single Group Assignment||Treatment||None (Open Label)||||||
1315514|NCT03394131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315515|NCT03394118||Single Group Assignment||Treatment||None (Open Label)||||||
1315516|NCT03394105||Single Group Assignment||Treatment||None (Open Label)||||||
1315517|NCT03394092|||Case-Control||Prospective|||||||
1315518|NCT03394079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315519|NCT03394066||Single Group Assignment||Basic Science||None (Open Label)||||||
1315520|NCT03394053|||Family-Based||Prospective|||||||
1315521|NCT03394040|||Cohort||Cross-Sectional|||||||
1315522|NCT03394027||Single Group Assignment||Treatment||None (Open Label)||||||
1315523|NCT03394014|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1315524|NCT03394001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315525|NCT03393988|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315526|NCT03393975|Randomized|Crossover Assignment||Prevention||None (Open Label)||This is a Phase 3, prospective, randomized, controlled, open-label, multicenter, 2-period crossover study with a single arm continuation evaluating the safety and efficacy of BAX 930 in the prophylactic and on-demand treatment of subjects with severe congenital thrombotic thrombocytopenic purpura (cTTP).||||
1315527|NCT03393962||Single Group Assignment||Treatment||None (Open Label)||||||
1315528|NCT03393949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315529|NCT03393936|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||Subjects with ROR2 positive biopsy will receive CCT301-59. Subjects with AXL positive biopsy that are ROR2 negative will receive CCT301-38.||||
1315530|NCT03393923|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1315531|NCT03393910|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1315532|NCT03393897|||Cohort||Prospective|||||||
1315533|NCT03393884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315534|NCT03393871|||Cohort||Prospective|||||||
1315535|NCT03393858||Single Group Assignment||Treatment||None (Open Label)||||||
1315536|NCT03393845||Single Group Assignment||Treatment||None (Open Label)||||||
1315545|NCT03393728||Single Group Assignment||Treatment||None (Open Label)||Open label Before and After design||||
1315546|NCT03393715|Randomized|Crossover Assignment||Treatment||None (Open Label)||open label randomised controlled trial with crossover of perindopril administered in the morning versus evening on blood pressure control||||
1315547|NCT03393702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315548|NCT03393689||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315549|NCT03393676|||Case-Control||Prospective|||||||
1315550|NCT03393663|||Cohort||Prospective|||||||
1315551|NCT03393650|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1315552|NCT03393637|Randomized|Parallel Assignment||Treatment||None (Open Label)||Following consent, the participants will randomized to either the treatment or control groups using a computer-generated randomization table developed prior to study start. They will be randomized to either the MOMS intervention or prenatal care without the MOMS. Women randomized to the MOMS program will be assigned to a MOMS group in the first trimester.||||
1315553|NCT03393624|||Case-Control||Prospective|||||||
1315554|NCT03393611||Single Group Assignment||Treatment||None (Open Label)||||||
1315555|NCT03393598|Randomized|Parallel Assignment||Treatment||Single||||||t
1315556|NCT03393585|||Other||Prospective|||||||
1315557|NCT03393572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315558|NCT03393559|Randomized|Parallel Assignment||Prevention||Double||randomized controlled trial|t|||t
1315559|NCT03393546|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315560|NCT03393533|Randomized|Parallel Assignment||Treatment||Single|Surgical procedures were always performed by the same surgeon and assistant, who was unaware of the group that belonged to the patient, as well as the patient himself. This randomization was performed involving numbers and envelopes, being only the investigator's knowledge.|"The sample will consist of 32 lower third molars, semi-inclusively or included. This study will be a randomized, blind, controlled, split-mouth clinical trial, divided into two groups simultaneously, namely:~Group I (16 teeth) - without therapeutic banding on the face, after the third molar extraction.~Group II (16 teeth) - with therapeutic banding on the face, after the third molar extraction."||t||
1315561|NCT03393520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315562|NCT03393507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315563|NCT03393494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315564|NCT03393481||Parallel Assignment||Prevention||Single|Open-label, blinded endpoint assessment|||||t
1315565|NCT03393468|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315566|NCT03393455|||Other||Retrospective|||||||
1315567|NCT03393442|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Female subjects exposed to Gd-based contrast media and female subjects not exposed to Gd-based contrast media will be examined by a diagnostic test (brain MRI scan) to determine the presence or absence of Gd-deposit related signal alterations in the brain.||||
1315568|NCT03393429|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1315569|NCT03393416||Single Group Assignment||Treatment||None (Open Label)||||||
1315570|NCT03393403|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1315571|NCT03393390|||Case-Control||Prospective|||||||
1315572|NCT03393377|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1315573|NCT03393364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315574|NCT03393351|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||A stepped wedge design, a variant of the cluster randomized controlled trial feasible to evaluate interventions in routine implementation, will be used. Participating clinics will receive the multifaceted implementation program in a randomized sequence.||||
1315575|NCT03393338|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1315576|NCT03393325|||Cohort||Prospective|||||||
1315577|NCT03393312|Randomized|Crossover Assignment||Other||Triple|A study mode on the tDCS device is used, which requires the researcher to enter a code determining whether active or sham stimulation is applied. The codes have been assigned to the participants in a randomised manner by a researcher not involved in the stimulation sessions or assessment of the outcomes. All participants receive active tDCS in one session and sham tDCS in the other session in a randomised order.|Repeated-measures double-blinded research study comparing the effects of non-invasive brain stimulation to a sham condition.|t||t|t
1315578|NCT03393299|Randomized|Parallel Assignment||Prevention||Single|||t|||
1315579|NCT03393286|||Cohort||Prospective|||||||
1315580|NCT03393273||Single Group Assignment||Treatment||None (Open Label)||||||
1315581|NCT03393260|||Other||Cross-Sectional|||||||
1315582|NCT03393247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315583|NCT03393234|Randomized|Parallel Assignment||Treatment||Triple|Patients will be assigned to two different groups and receive intraoperative radiation randomly. The care provider and investigator also don't know the concrete situation of the patients.||t|t|t|
1315584|NCT03393221|Randomized|Parallel Assignment||Treatment||||||||
1315585|NCT03393208|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1315586|NCT03393195|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a randomized controlled trial. Participants will randomly assigned to one of two diet interventions for the duration of the 12-week study.||||
1315587|NCT03393182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315588|NCT03393169|||Cohort||Prospective|||||||
1315589|NCT03393156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315590|NCT03393143|||Case-Control||Other|||||||
1315591|NCT03393130|||Cohort||Prospective|||||||
1315592|NCT03393117|Randomized|Parallel Assignment||Supportive Care||Single|Medication utilized will be blinded in the chart per inpatient pharmacy.||t|||
1315593|NCT03393104|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to participants' treatment allocation.|||||t
1315594|NCT03393091|||Other||Prospective|||||||
1315595|NCT03393078|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1315627|NCT03392662|||Cohort||Prospective|||||||
1315596|NCT03393065|Randomized|Parallel Assignment||Treatment||Double|Results of the lung ultrasounds will not be made publicly available|The patients will be randomized in two groups: in the intervention group pulmonary congestion, as assessed by the BLS will guide the fluid management, with a target of below 15 BLS. In the control group the fluid management will not be LUS guided. In both groups, further complementary fluid assessment methods will be performed blindly from the investigators: body composition assessment by bioimpedance and biochemical panel consisting in cardiac biomarkers (NTproBNP, cTnT) and inflamatory markers (IL-6).|t|||t
1315597|NCT03393052|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1315598|NCT03393039||Single Group Assignment||Basic Science||None (Open Label)||||||
1315599|NCT03393026||Single Group Assignment||Treatment||None (Open Label)||Lurasidone 40-160 mg/day||||
1315600|NCT03393013|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1315601|NCT03393000|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, randomized, controlled||||
1315602|NCT03392987||Single Group Assignment||Treatment||None (Open Label)||This will be a single arm study. All subjects will receive OTL-200 gene therapy and will be followed up for 8 years post-gene therapy.||||
1315603|NCT03392974||Single Group Assignment||Treatment||None (Open Label)||||||
1315604|NCT03392961|Randomized|Crossover Assignment||Treatment||None (Open Label)||3 Cohorts Cohort 1: 5 periods, 4 treatments and 5 sequences with a partial replicate crossover design Cohort 2: 6 periods, 6 treatments and 6 sequences in a cross-over design Cohort 3: 6 periods, 6 treatments and 6 sequences in a cross over design||||
1315605|NCT03392948|||Cohort||Prospective|||||||
1315606|NCT03392935||Single Group Assignment||Treatment||None (Open Label)|Outcome assessors are masked and will not know which photos are pre-treatment or post treatment, however, they do know that all subjects received treatment at some point. They will rate the dermatofibromas to determine efficacy. However, there is only one arm of this study. All patients are receiving the same treatment. Outcomes assessors are the only masked roles.|All subjects will have their dermatofibromas treated with the laser at week 0, and week 4. Blinded outcome assessors will rate photos to determine efficacy.||||
1315607|NCT03392922|Randomized|Factorial Assignment||Other||Double|||t|||t
1315608|NCT03392909||Single Group Assignment||Treatment||None (Open Label)||||||
1315609|NCT03392896|Randomized|Parallel Assignment||Treatment||Double|SAD period in NHV is single-blind (unblinded clinical site staff member who is not a member of study team administers dose). SAD period in Group B (PH1 and PH2 patients) is open-label.|Two-arm (active and placebo), single-blind, SAD period (Group A, NHVs) followed by open-label, SAD period (Group B, PH1 and PH2 patients).|t||t|
1315610|NCT03392883||Single Group Assignment||Health Services Research||None (Open Label)||The investigators will initially pilot test this mental health service delivery model at a single primary care site and then refine the model based on pilot data. The investigators will then expand implementation across 6 Colombia-based healthcare sites in urban and rural communities (including approximately 2000 participants). Consistent with a modified stepped wedge design (multiple baseline design), the investigators will implement the model across sites on a staggered basis and expand the number of sites in which the investigators implement over time. By conducting this multi-site implementation research project, the investigators can assess the extent to which the implementation model and associated outcomes are replicable across sites and/or the extent to which the model needs to be modified for differing contexts.||||
1315611|NCT03392870|Randomized|Parallel Assignment||Treatment||Single|A researcher will be masked for group aleatorization (active, group) in order to unbiasedly evaluate outcomes which require subjective assesment of functionality.|||||t
1315612|NCT03392857|||Cohort||Prospective|||||||
1315613|NCT03392844|Randomized|Parallel Assignment||Treatment||Single|Research team members who are responsible for the assessment of study outcomes will be blinded to group condition. Blinding of the Lead Investigator is not possible due to the need to coordinate intervention with the Beds for Kids program. Blinds of the participants is not possible due to the nature of the intervention (scheduling and provision of beds).|Caregiver-child dyads will be assigned to the intervention group, in which they receive a bed through the Beds for Kids program after a 7-day period, or to the waitlist control group, in which they receive a bed after a 14-day period.||||t
1315614|NCT03392831|Randomized|Parallel Assignment||Other||None (Open Label)||Prospective Randomized Open Blinded End-Point (PROBE) study||||
1315615|NCT03392818|Randomized|Factorial Assignment||Other||Triple|||t||t|t
1315616|NCT03392805|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1315617|NCT03392792|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315618|NCT03392779|Randomized|Parallel Assignment||Treatment||Quadruple|Masking for Participant, Investigator and Clinical Research Associate||t|t|t|t
1315619|NCT03392766|Randomized|Parallel Assignment||Other||Double|||t|||t
1315620|NCT03392753|Randomized|Parallel Assignment||Treatment||Double|An internet-based randomisation service will be used Outcome assessors will be blinded as to treatment offered||t|||t
1315621|NCT03392740|Randomized|Parallel Assignment||Prevention||Double||Prospective, 1:1 randomized, double-blinded and placebo-controlled clinical trial we plan to enroll patients who are to be treated with anthracycline chemotherapy to either lisinopril or placebo group.|t|t||
1315622|NCT03392727|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315623|NCT03392714||Single Group Assignment||Treatment||None (Open Label)||||||
1315624|NCT03392701|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1315625|NCT03392688|Non-Randomized|Parallel Assignment||Screening||Single|The algorithm used to calculate the onset of the EMG was identified according to the point at which the signal deviated by more than three times standard deviations, for a minimum of 25 ms from the baseline level (computing started 200 ms prior to the start of walking). MatLab program (R2011 version) was used for design a custom made program for data analysis. Additionally to automatic calculation, all data was visually checked to ensure that there was no signal noise, deteriorating the signal analysis, possibly caused by the movement artefact. A blind assessor visualy checked the onsets of the MH and LH muscles and record the onset time.|Participants which were included in the study were divided into 2 groups as patient group who included the patients diagnosed with Patellofemoral pain and asymptomatic group which was considered as control group.||||t
1315626|NCT03392675|Randomized|Parallel Assignment||Supportive Care||Single|Using a stratified and blocked randomization scheme.||t|||
1315628|NCT03392649|Randomized|Parallel Assignment||Prevention||Single|||t|||
1315629|NCT03392636|Randomized|Parallel Assignment||Treatment||Triple||Group A will get Mitchell Banks herniotomy done and Group B will get Fergusson Gross Herniotomy done.|t|t||t
1315630|NCT03392623|Randomized|Parallel Assignment||Other||Double|double bind||t||t|
1315631|NCT03392610|||Case-Control||Prospective|||||||
1315632|NCT03392597|Randomized|Crossover Assignment||Prevention||None (Open Label)||Waitlist control design in which matched sites are randomly assigned to an intervention or waitlist control group to implement and evaluate the Brothers as Allies program. Intervention groups will participate in the Brothers as Allies program from the Council for Boys and Young Men. Waitlist control groups will participate in programming-as-usual until implementation with the intervention groups is complete, at which point they will receive the intervention. All participants will complete surveys at baseline, immediate post-intervention, and at 3 and 6 months post-intervention.||||
1315633|NCT03392584|||Cohort||Prospective|||||||
1315634|NCT03392571||Single Group Assignment||Treatment||None (Open Label)||Patients receive 3 cycles of preoperative chemotherapy. The regimen consists of gemcitabine 800 mg/m2, nab-paclitaxel 100 mg/m2 and cisplatin 25 mg/m2 given IV weekly x 2, every 3 weeks (one cycle).||||
1315635|NCT03392558|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1315636|NCT03392545||Single Group Assignment||Treatment||None (Open Label)||||||
1315637|NCT03392532|Randomized|Crossover Assignment||Other||Double|||t||t|
1315638|NCT03392519|||Case-Only||Cross-Sectional|||||||
1315639|NCT03392506||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315640|NCT03392493|Randomized|Crossover Assignment||Treatment||Single|Single Blind (Outcomes Assessor)|AB or BA||||t
1315641|NCT03392480|||Case-Control||Prospective|||||||
1315642|NCT03392467|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1315643|NCT03392454|||Case-Only||Prospective|||||||
1315644|NCT03392441||Single Group Assignment||Basic Science||None (Open Label)||||||
1315645|NCT03392428|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label, randomised, stratified, 2-arm, phase 2 trial||||
1315646|NCT03392415|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized registry with option of crossover after 6months||||
1315647|NCT03392402|||Cohort||Prospective|||||||
1315648|NCT03392389|Randomized|Sequential Assignment||Prevention||Double|||t||t|
1315649|NCT03392376|Randomized|Parallel Assignment||Treatment||Quadruple||Parallel Assignment|t|t|t|t
1315650|NCT03392363|||Cohort||Prospective|||||||
1315651|NCT03392350|Randomized|Parallel Assignment||Prevention||Single|The staff doing the end point assessment were blinded as to treatment assignment.|One Control group one Intervention arm. The intervention group are the only subjects receiving a body scan consultation and behavioral intervention.|||t|
1315652|NCT03392337||Single Group Assignment||Treatment||None (Open Label)||open label||||
1315653|NCT03392324||Single Group Assignment||Treatment||None (Open Label)||||||
1315654|NCT03392311||Single Group Assignment||Treatment||None (Open Label)||||||
1315655|NCT03392298|Randomized|Parallel Assignment||Treatment||Single||||||t
1315656|NCT03392285|||Cohort||Prospective|||||||
1315657|NCT03392272|Randomized|Parallel Assignment||Treatment||Single|The physician will randomly assign the patient into the tisseel group or the sutures group|A prospective randomized study||t||
1315658|NCT03392259|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315659|NCT03392246||Single Group Assignment||Treatment||None (Open Label)||||||
1315660|NCT03392233||Single Group Assignment||Treatment||None (Open Label)||Eligible patients will receive Stereotactic body radiation therapy (SBRT) for spinal metastatic lesion in 24Gy/3f(cervical vertebra) or 30Gy/3f (thoracic vertebra/lumbar vertebra) every other day and receive relevant system treatment at same time.||||
1315661|NCT03392220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315662|NCT03392207|||Cohort||Prospective|||||||
1315663|NCT03392194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315664|NCT03392181||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315665|NCT03392168|Randomized|Parallel Assignment||Treatment||Double|Cohort 1 is open label. Cohort 2 is double blind.||t||t|
1315666|NCT03392155||Single Group Assignment||Other||None (Open Label)||||||
1315667|NCT03392142||Single Group Assignment||Treatment||None (Open Label)||||||
1315668|NCT03392129|Randomized|Parallel Assignment||Treatment||Single||||||t
1315669|NCT03392116|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1315670|NCT03392103||Single Group Assignment||Treatment||None (Open Label)||||||
1315671|NCT03392090||Single Group Assignment||Supportive Care||None (Open Label)||||||
1315672|NCT03392077|||Other||Cross-Sectional|||||||
1315673|NCT03392064||Sequential Assignment||Treatment||None (Open Label)||||||
1315674|NCT03392051|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1315675|NCT03392038|Randomized|Parallel Assignment||Treatment||Single||||||t
1315676|NCT03392025|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1315677|NCT03392012|||Case-Only||Other|||||||
1315678|NCT03391999|||Cohort||Prospective|||||||
1315679|NCT03391986|Randomized|Parallel Assignment||Supportive Care||Triple|"Participant: only participants in the pyonex needle and placebo adhesive group will be masked during the study. Equipment is opened behind the participant and the needles and adhesives are placed outside the view of the participant.~Care Provider: A colored hat that covers the participants ears will be placed. Outcomes Assessor: Group assignment will be masked."|Participants will be randomized to either 1 - auricular acupuncture with pyonex needle, 2 - placebo adhesive, or 3 - routine care using a 1:1:1 ratio. The randomization scheme will use randomly permuted blocks with a block size of 6 or 9.|t|t||t
1315680|NCT03391973||Single Group Assignment||Treatment||None (Open Label)||This is a multi-centre, single arm phase 2 study of Pembrolizumab (Keytruda™ or MK-3475) in treatment naïve patients with poor prognosis carcinoma of unknown primary site (CUP).||||
1315681|NCT03391960|||Other||Prospective|||||||
1315732|NCT03391284|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315682|NCT03391947|Randomized|Crossover Assignment||Treatment||Single||Split-mouth design, i.e. the right side will receive the first intervention, whereas the other side (the left side) will receive the second intervention.|t|||
1315683|NCT03391934|Randomized|Parallel Assignment||Treatment||Double|Both of the drugs used in the study are indistinguishable for patients and their respective curative staff because they are similar in size and shape of the vials, caps, aluminum sealing and paints, and it is not possible to distinguish the type of brand from the appearance of the vials. Additionally, people who are evaluating the results and analyzing data are not aware of the type of patient grouping.||t||t|
1315684|NCT03391921||Single Group Assignment||Prevention||None (Open Label)||All patients will receive the ninevalent vaccine against HPV (Garadsil9)||||
1315685|NCT03391908|||Cohort||Prospective|||||||
1315686|NCT03391895|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1315687|NCT03391882|Randomized|Crossover Assignment||Treatment||None (Open Label)|"Open label: APL-130277 and Subcutaneous Apomorphine~Single-Blinded Rater for MDS-UPDRS Part III Motor Examination assessment in Part B."|||||
1315688|NCT03391869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315689|NCT03391856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315690|NCT03391843||Single Group Assignment||Treatment||None (Open Label)||||||
1315691|NCT03391830|Randomized|Parallel Assignment||Prevention||Single|||t|||
1315692|NCT03391817|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315693|NCT03391804||Single Group Assignment||Treatment||None (Open Label)||||||
1315694|NCT03391791|||Case-Only||Prospective|||||||
1315695|NCT03391778||Single Group Assignment||Other||None (Open Label)||||||
1315696|NCT03391765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315697|NCT03391752|||Other||Prospective|||||||
1315698|NCT03391739||Single Group Assignment||Treatment||None (Open Label)||||||
1315699|NCT03391726||Single Group Assignment||Treatment||None (Open Label)||||||
1315700|NCT03391713|Randomized|Sequential Assignment||Other||None (Open Label)||||||
1315701|NCT03391700|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1315702|NCT03391687|||Cohort||Prospective|||||||
1315703|NCT03391674|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315704|NCT03391661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315705|NCT03391648|||Other||Retrospective|||||||
1315706|NCT03391635|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1315707|NCT03391622|||Cohort||Prospective|||||||
1315708|NCT03391609|Randomized|Crossover Assignment||Treatment||Triple|double-blinding||t|t|t|
1315709|NCT03391596|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315710|NCT03391583|Randomized|Parallel Assignment||Treatment||Single|Subjects will be randomized via block randomization. An outcome assessor will have sealed envelopes that will assign the patients to either the intervention group versus the current standard of care. There will be three intervention time points 0, 6 and 12 weeks from the patient's initial presentation at the St. Michael's head injury clinic.|Randomized Control Feasibility trial looking at educational intervention at multiple time points during a patient's recovery from mild traumatic brain injury. The control group will be followed at these time points as well and will continue on with the current standard of care.||||t
1315711|NCT03391570|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315712|NCT03391557||Single Group Assignment||Diagnostic||None (Open Label)||Patients who underwent EBUS-TBNA examination in department of respiration,Nanjing Hospital Affiliated to Nanjing Medical University during 21June 2016 and 17 April 2017 were included in the study, All patients were evaluated by chest enhanced CT and/or 18-FDG PET-CT,those who had enlarged intrathoracic lymph nodes(≥1cm) and/or 18-FDG high uptake (SUV Max > 2.5) without bleeding tendency, abnormal coagulation function and serious cardiac dysfunction.||||
1315713|NCT03391544||Single Group Assignment||Treatment||None (Open Label)||||||
1315714|NCT03391531|Randomized|Parallel Assignment||Treatment||Quadruple|Person who prepares the study solution is involved neither in any step of the care of the patient neither in the collection of the study parameters|two groups : treatment group (TAP block with local anesthestic) compared to control group (TAP block with saline)|t|t|t|t
1315715|NCT03391518||Parallel Assignment||Basic Science||None (Open Label)||||||
1315716|NCT03391505|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1315717|NCT03391492|||Case-Control||Prospective|||||||
1315718|NCT03391479||Single Group Assignment||Treatment||None (Open Label)||||||
1315719|NCT03391466|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two arms, SOC and experimental treatment||||
1315720|NCT03391440||Single Group Assignment||Treatment||None (Open Label)||||||
1315721|NCT03391427|Randomized|Parallel Assignment||Treatment||Triple|All persons are blinded as the drug is formulated by the investigator who is not the care giver or outcomes assessor|Lidocaine, ketamine, combination and placebo are being evaluated for treating postoperative pain in major liver resection|t|t||t
1315722|NCT03391414|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1315723|NCT03391401|||Cohort||Prospective|||||||
1315724|NCT03391388|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1315725|NCT03391375||Single Group Assignment||Prevention||None (Open Label)||||||
1315726|NCT03391362||Single Group Assignment||Treatment||None (Open Label)||||||
1315727|NCT03391349|||Other||Other|||||||
1315728|NCT03391336|||Case-Only||Retrospective|||||||
1315729|NCT03391323|Randomized|Parallel Assignment||Other||Single|||t|||
1315730|NCT03391310|Randomized|Parallel Assignment||Treatment||Single||RCT||||t
1315731|NCT03391297|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prolonged exposure therapy (PE), a specific exposure therapy for PTSD, has been proved an effective treatment for PTSD. PE usually consists of 10-15 individual sessions. Treatment includes psychoeducation, in vivo exposure (i.e., confronting trauma-related situations and objects that are being avoided), imaginal exposure (i.e., revisiting and recounting traumatic memory) followed by processing (discussing the experience of revisiting the trauma memory, with a focus on new learning and changed beliefs or perspectives).||||
1315733|NCT03391271|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1315734|NCT03391258||Single Group Assignment||Treatment||None (Open Label)||To describe the dimensional changes (based on CBCT scans) occurred 12 months after implant placement and simultaneous regeneration with L-PRF and bovine bone graft in the aesthetic zone of atrophic maxillae in full arch implant supported rehabilitations||||
1315735|NCT03391245|||Cohort||Prospective|||||||
1315736|NCT03391232||Single Group Assignment||Treatment||None (Open Label)||||||
1315737|NCT03391219|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1315738|NCT03391206|||Cohort||Prospective|||||||
1315739|NCT03391193|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315740|NCT03391180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315741|NCT03391167|Randomized|Parallel Assignment||Treatment||Single||Controlled randomised blinded preospective study||t||
1315742|NCT03391154|Randomized|Parallel Assignment||Treatment||Single||||||t
1315743|NCT03391141|||Cohort||Prospective|||||||
1315744|NCT03391128|||Case-Only||Prospective|||||||
1315745|NCT03391115|||Other||Prospective|||||||
1315746|NCT03391102|||Ecologic or Community||Prospective|||||||
1315747|NCT03391089||Single Group Assignment||Treatment||None (Open Label)||||||
1315748|NCT03391076|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1315749|NCT03391063|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315750|NCT03391050||Single Group Assignment||Treatment||None (Open Label)||||||
1315751|NCT03391037|||Cohort||Prospective|||||||
1315752|NCT03391024||Single Group Assignment||Treatment||None (Open Label)||||||
1315753|NCT03391011||Single Group Assignment||Treatment||None (Open Label)||||||
1315754|NCT03390998|||Other||Cross-Sectional|||||||
1315755|NCT03390985|||Cohort||Prospective|||||||
1315756|NCT03390972|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1315757|NCT03390959|Randomized|Parallel Assignment||Treatment||Double|Double (Investigator, Outcomes Assessor) The one who assess the patients in the beginning and in the final moment (investigator) not know in what group the patient is. As the investigator that will do the statistic (outcome assessor).|Two groups: Control Group (CG) and the Trained Group (TG)|||t|t
1315758|NCT03390946||Single Group Assignment||Treatment||None (Open Label)||||||
1315759|NCT03390933||Single Group Assignment||Treatment||None (Open Label)||The cross-sectional study will involve assessments of depressive symptoms (PHQ-9) and quality of life for 1083 patients. These data will be used to address Aim A. The single arm trial will involve 96 patients with DSM5-confirmed depression.||||
1315760|NCT03390920||Single Group Assignment||Treatment||None (Open Label)||||||
1315761|NCT03390907||Single Group Assignment||Treatment||None (Open Label)|Following Standard EMR all patients will undergo adjuvant Hybrid Argon Plasma Coagulation (APC) of the base and edges of the polypectomy site to fulgurate any potential microscopic residual disease.|This is a pilot study design which patients with non-pedunculated large polyps ≥ 20mm undergoing EMR. Following standard EMR all patients will undergo adjuvant Hybrid Argon Plasma Coagulation (APC) of the base edges of the polypectomy site to fulgurate any potential microscopic residual disease.||||
1315762|NCT03390894|||Cohort||Other|||||||
1315763|NCT03390881|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1315764|NCT03390868|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Intervention arm: web-based training for staff working with people with intellectuall disabilities and challenging behaviour Other: control arm||||
1315765|NCT03390855||Single Group Assignment||Prevention||None (Open Label)||The intervention consisted on a 10-week period which included daily consumption of a portion (30 g) of raw, fresh broccoli sprouts. After the intervention period, a follow-up recovery period for all subjects continued for other 90 days with no ingestion of broccoli sprouts.||||
1315766|NCT03390842|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315767|NCT03390829|||Other||Other|||||||
1315768|NCT03390816|||Cohort||Prospective|||||||
1315769|NCT03390803|||Case-Control||Prospective|||||||
1315770|NCT03390790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315771|NCT03390777|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1315772|NCT03390764|Randomized|Parallel Assignment||Prevention||None (Open Label)||Multicenter randomized controlled trial||||
1315773|NCT03390751|||Cohort||Prospective|||||||
1315774|NCT03390738||Single Group Assignment||Treatment||None (Open Label)||||||
1315775|NCT03390725|Randomized|Parallel Assignment||Prevention||Single||||||t
1315776|NCT03390712|||Other||Retrospective|||||||
1315777|NCT03390699||Single Group Assignment||Diagnostic||None (Open Label)||Microbial profile among patients before partial maxillectomy||||
1315778|NCT03390686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315779|NCT03390673|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1315780|NCT03390660|||Cohort||Retrospective|||||||
1315781|NCT03390647|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1315782|NCT03390634|||Cohort||Retrospective|||||||
1315783|NCT03390621|||Cohort||Cross-Sectional|||||||
1315784|NCT03390608|||Cohort||Retrospective|||||||
1315785|NCT03390595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315786|NCT03390582|||Cohort||Cross-Sectional|||||||
1315787|NCT03390569||Single Group Assignment||Supportive Care||None (Open Label)||||||
1315788|NCT03390556||Single Group Assignment||Health Services Research||None (Open Label)||||||
1315789|NCT03390543|Randomized|Parallel Assignment||Supportive Care||Triple|participants, investicator, outcome assessors will be blinded for group allocation.|"sono with simple needle guide device group~sono only group"|t||t|t
1315790|NCT03390530|Randomized|Parallel Assignment||Prevention||Quadruple|Double-blinded and randomized|Double-blinded, placebo-controlled, and randomized controlled trial to compare outcomes between thyroxine and placebo treatment|t|t|t|t
1315791|NCT03390517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315792|NCT03390504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315793|NCT03390491|Randomized|Parallel Assignment||Other||Double|||||t|t
1315794|NCT03390478|Randomized|Parallel Assignment||Prevention||Double|The randomization process it will be done in https://www.random.org/ by an independent person.|Participants will be assigned in two groups, a control group who will receive institutional usual care and an experimental group who will receive the combined intervention.|||t|t
1315795|NCT03390465|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315796|NCT03390452|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1315797|NCT03390439|Randomized|Parallel Assignment||Treatment||Double|"Clinical evaluators will evaluate the photos after the treatments blindly for which type of treatment applied.~Evaluators of skin biopsies will be blinded to what type of treatment is applied and for pre-treatment and post-treatment."|Each patient will have the abdomen divided equally. Each segment of the abdomen will be randomized using the Excel 2013 program to receive laser or microneedle treatment.|||t|t
1315798|NCT03390426|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1315799|NCT03390413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315800|NCT03390400|Randomized|Single Group Assignment||Treatment||Triple|Groups will be randomized. Randomization information will be put in a sealed envelope on screening date and opened in operating theatre right before procedure start.|Bilateral femtosecond-laser assisted cataract surgery will be performed in individuals with age-related cataract. Eyes will be randomized into two groups receiving either anterior capsulotomy before lens fragmentation or vice versa in the contralateral eye. After laser procedure samples of aqueous humor will be collected and when complete all samples will be analysed by ELISA for Prostaglandin.|t|t|t|
1315801|NCT03390387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315802|NCT03390374|Randomized|Parallel Assignment||Prevention||None (Open Label)||The participants is randomly allocated into 2 study groups (nystatin group and control group) during study period||||
1315803|NCT03390361|Randomized|Single Group Assignment||Treatment||Triple|Groups will be randomized. Randomization information will be put in a sealed envelope on screening date and opened in operating theatre right before the surgery.|Patients' eyes will be randomized into two groups receiving either MCS or LCS. In the LCS group aqueous humour will be collected exactly five minutes after laser pretreatment. In the MCS group aqueous humour will be collected before manual manipulation of anterior chamber. Aqueous humour will be screened with Enzyme-linked Immunosorbent Assay (ELISA) Kits for Interleukin-1β; Interleukin-6 and PG.|t|t|t|
1315804|NCT03390348|||Case-Only||Prospective|||||||
1315805|NCT03390335||Sequential Assignment||Prevention||None (Open Label)||This design is a two factor, incomplete block design - three altitudes (8,000, 10,000, and 12,000 feet) and 2 breathing gases (air, 35% O2-N2). The investigators expect to see 0 events in the combinations tested, calculated by the Bayesian Method. If the rate of events is larger than expected, the investigators will use logistic regression to assess if the main effect Air (Air vs. 35% O2-N2) or altitude (8,000, 10,000 or 12,000 feet) or the interaction of these 2 factors imparts relative increased risk. The investigators will set a Type-I error rate of 0.05 (two-tailed).In the presence of 'zero cells', the investigators will either (1) collapse cells into reasonable groups, or (2) add a very small set of constants to the frequency and assess the impact on the effect sizes and tests of significance.1 In the absence of an interaction effect, main effects will be reported.||||
1315806|NCT03390322||Single Group Assignment||Treatment||None (Open Label)||||||
1315807|NCT03390309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315808|NCT03390296|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315809|NCT03390283|||Cohort||Prospective|||||||
1315810|NCT03390270|||Cohort||Other|||||||
1315811|NCT03390257||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315812|NCT03390244||Single Group Assignment||Treatment||None (Open Label)||||||
1315813|NCT03390231||Single Group Assignment||Treatment||None (Open Label)|Open-label study with all subjects received SCE therapy.|In this project, the optimized SCE therapy for diabetes will be tested in a prospective, single-arm, open-label, single-center study||||
1315814|NCT03390218|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized control trial||||
1315815|NCT03390205|||Case-Control||Prospective|||||||
1315816|NCT03390192|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315817|NCT03390179|||Case-Control||Prospective|||||||
1315818|NCT03390166|Randomized|Parallel Assignment||Prevention||Double|double blinded|non-inferiority double-blinded, randomized, controlled trial|t||t|
1315819|NCT03390153|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1315820|NCT03390140|Randomized|Parallel Assignment||Treatment||Single||||||t
1315821|NCT03390127|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1315822|NCT03390114|Randomized|Parallel Assignment||Treatment||Single|The primary investigator is blinded to the treatment assignment|10-week, randomized, controlled, single-blinded, two-arm, parallel group, pilot trial at a single center|||t|
1315823|NCT03390101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315824|NCT03390088|||Cohort||Prospective|||||||
1315825|NCT03390075|||Case-Only||Cross-Sectional|||||||
1315826|NCT03390062||Single Group Assignment||Treatment||None (Open Label)||||||
1315827|NCT03390049|Randomized|Parallel Assignment||Treatment||Double|"Each subject will be assigned a study identification number, and demographic and clinical data will be recorded in REDCAP on de-identified data collection forms. The lead research coordinator will maintain the key linking the identification number to each subject in a locked, password-protected site. A random number generator in REDCAP will then randomly assign each subject to either fractional CO2 laser or sham laser.~The physician administering the laser sessions will be blinded to treatment arm assignment."||t|||t
1315828|NCT03390036|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1315829|NCT03390023|||Case-Control||Retrospective|||||||
1315830|NCT03390010|Randomized|Parallel Assignment||Prevention||Single|||t|||
1315831|NCT03389997||Single Group Assignment||Prevention||None (Open Label)||Iterative nasal swabs will be performed to screen for virus shedding||||
1315832|NCT03389984||Single Group Assignment||Basic Science||None (Open Label)||||||
1315833|NCT03389971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315834|NCT03389958|||Case-Only||Prospective|||||||
1315835|NCT03389945|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1315836|NCT03389932|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1315837|NCT03389919||Single Group Assignment||Treatment||None (Open Label)||||||
1315838|NCT03389906||Single Group Assignment||Basic Science||None (Open Label)||Pilot study||||
1315839|NCT03389893|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315840|NCT03389880|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1315841|NCT03389867||Single Group Assignment||Health Services Research||None (Open Label)||||||
1315842|NCT03389854|Randomized|Factorial Assignment||Basic Science||Double|Objective outcomes including penile length and curvature will be masked for the investigator and outcome assessor by obtaining photographs of the penis in the lateral and dorsal planes. Curvatures will also be assessed by a clinician in the case where photographs are not able to be obtained or if the participant refuses photographs. These will be assessed without any knowledge as to which grouping the patient is located by two independent reviewers. If there are differences >5 degrees (curvature), or 0.5 cm (length), a 3rd individual will mediate the difference.|Men will be randomized into one of four groups: no traction therapy, penile traction 30 minutes once daily, penile traction 30 minutes twice daily, and penile traction 30 minutes three times daily. This treatment will continue for 3 months, after which men will enter an open label phase for 3 months. Primary and secondary outcomes will be evaluated at the completion of the 3 month and 6 month time points. Additional AEs will be assessed at 9 months after study initiation.|||t|t
1315843|NCT03389841|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1315844|NCT03389828|||Other||Cross-Sectional|||||||
1315845|NCT03389815||Single Group Assignment||Treatment||None (Open Label)||||||
1315846|NCT03389802|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Stratum 1: Recurrent or refractory primary malignant CNS tumor patients; Stratum 2: Newly diagnosed DIPG patients||||
1315847|NCT03389789|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1315848|NCT03389776|||Cohort||Prospective|||||||
1315849|NCT03389763|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1315850|NCT03389750|Randomized|Crossover Assignment||Basic Science||Double||Intravenous Challenge Drug|t|||t
1315851|NCT03389737|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1315852|NCT03389724|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a prospective randomized study where all patients presenting to the CCHE with de novo diagnosis of Bone tumor (ES and OS) and AML will be randomized to receive (Intervention arm) or not to receive (Control arm) prophylactic ACE-I with the start of chemotherapy.||||
1315853|NCT03389711|||Cohort||Prospective|||||||
1315854|NCT03389698|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1315855|NCT03389685|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315856|NCT03389672|||Case-Only||Prospective|||||||
1315857|NCT03389659|Randomized|Parallel Assignment||Treatment||Double|double-blined||t||t|
1315858|NCT03389646|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Prospective with retrospective matched controls.||||
1315859|NCT03389633|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315860|NCT03389620|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1315861|NCT03389607|||Cohort||Prospective|||||||
1315862|NCT03389594|Randomized|Parallel Assignment||Other||Quadruple|Each patient will be given a code by researcher (M.H) and the observers will be blind to which group this case belong||t|t|t|t
1315863|NCT03389581|||Other||Prospective|||||||
1315864|NCT03389568||Single Group Assignment||Treatment||None (Open Label)||||||
1315865|NCT03389555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315866|NCT03389542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315867|NCT03389529|||Cohort||Prospective|||||||
1315868|NCT03389516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315869|NCT03389503|Non-Randomized|Sequential Assignment||Other||None (Open Label)||1~3 months: Right radial approach 4~6 months: Left radial approach||||
1315870|NCT03389490|Randomized|Parallel Assignment||Treatment||Single||||||t
1315871|NCT03389477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315872|NCT03389464|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315873|NCT03389451||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315874|NCT03389438|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Experimental arm: autologous Tcm cells immunotherapy. participants who were treated with autologous Tcm cells immunotherapy.~No intervention arm: participants who were treated with no autologous Tcm cells immunotherapy."||||
1315875|NCT03389425||Single Group Assignment||Treatment||None (Open Label)||||||
1315876|NCT03389412|Randomized|Parallel Assignment||Treatment||Single|The children and the parents will not know, if there treatment is based on home recordings or not.|Randomized, controlled study|t|||
1315877|NCT03389399|||Cohort||Prospective|||||||
1315878|NCT03389386|||Case-Control||Prospective|||||||
1315879|NCT03389373||Single Group Assignment||Diagnostic||None (Open Label)|Provider and investigator will know if child has clinical caries or not at the time of saliva sample.|Children will have a saliva sample analyzed for amount of bacteria. Children who have higher bacteria counts are at higher risk of developing cavities.||||
1315880|NCT03389360|||Cohort||Retrospective|||||||
1315881|NCT03389347||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1315882|NCT03389334||Single Group Assignment||Other||None (Open Label)||||||
1315883|NCT03389321||Single Group Assignment||Other||None (Open Label)||All the subjects included in the study will be included in a single group and will receive the drugs according to the same sequence||||
1315921|NCT03388827|Randomized|Parallel Assignment||Treatment||Triple|double blinded||t|t||t
1315922|NCT03388814|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1315923|NCT03388801||Single Group Assignment||Treatment||None (Open Label)||||||
1315924|NCT03388788|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1315884|NCT03389308||Single Group Assignment||Treatment||None (Open Label)|Each treatment cycle will consist of 8 weeks on treatment, followed by 8 weeks off treatment with a maximum of 2 treatment cycles allowed for up to 1 year. Subjects should be assessed at minimum every 8 weeks for disease activity. Once a subject completes two cycles of treatment or reaches Week 52, the subject will be discharged from the study. Subjects may not start a new treatment cycle past Week 36 from Baseline Visit without prior sponsor approval. The duration of a subject's participation in the extension study may be as short as 32 weeks or as long as 52 weeks depending on the cycle initiation schedule for each individual subject.|This is an international, multicenter, open-label, long term extension study evaluating the safety of topical Diacerein 1% Ointment for the treatment of subjects with EBS. At Baseline Visit, EBS subjects who has completed the CCP-020-301 double-blind safety and efficacy study or participated in the CCP-020-101 PK study (feeder studies) and who meet all the inclusion/exclusion criteria will be eligible to enroll in this study.||||
1315885|NCT03389295||Single Group Assignment||Treatment||None (Open Label)||Drug: TPF regimen comprised docetaxel (60 mg/m2/day, day 1), cisplatin (25 mg/m2/day, days 1-3), and 5-fluorouracil (500 mg/m2/day with a 120-h infusion) Radiotherapy：Reduced Target Delineation||||
1315886|NCT03389282|||Cohort||Prospective|||||||
1315887|NCT03389269|||Case-Control||Prospective|||||||
1315888|NCT03389256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315889|NCT03389243|Randomized|Crossover Assignment||Prevention||Single|||t|||
1315890|NCT03389230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1315891|NCT03389217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315892|NCT03389204|||Cohort||Prospective|||||||
1315893|NCT03389191||Single Group Assignment||Treatment||None (Open Label)||||||
1315894|NCT03389178|||Case-Control||Prospective|||||||
1315895|NCT03389165||Single Group Assignment||Other||None (Open Label)||||||
1315896|NCT03389152|||Cohort||Retrospective|||||||
1315897|NCT03389139|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1315898|NCT03389126||Single Group Assignment||Treatment||None (Open Label)||||||
1315899|NCT03389113|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients were randomly assigned to one of the two groups in a 1:1 ratio using an odd or even random numbers table. Whole body vibration group performed five sessions of whole body vibration exercise via a vibrating platform (Galileo® Advanced Plus, Novotec Medical, Pforzheim, Germany) with a magnitude of 20 Hz and an amplitude of 4 mm. The control group performed the same sessions without vibration.||||
1315900|NCT03389100||Single Group Assignment||Diagnostic||None (Open Label)||Study subjects will receive a single injection of 18F-MK6240 for tau positron emission tomography (PET) imaging two times, separated by an interval between 18 and 30 months.||||
1315901|NCT03389087||Single Group Assignment||Treatment||None (Open Label)||||||
1315902|NCT03389074|||Case-Only||Prospective|||||||
1315903|NCT03389061|Randomized|Crossover Assignment||Other||None (Open Label)||Bio-equivalence Study||||
1315904|NCT03389048||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1315905|NCT03389035||Sequential Assignment||Treatment||None (Open Label)||||||
1315906|NCT03389022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315907|NCT03389009|||Other||Cross-Sectional|||||||
1315908|NCT03388996|||Case-Control||Prospective|||||||
1315909|NCT03388983|Randomized|Parallel Assignment||Treatment||Triple|The orthopedic surgeons, outcome assessor and statistician will be blinded to the group allocation of participants.|A single-blinded randomized controlled trial||t|t|t
1315910|NCT03388970|Randomized|Parallel Assignment||Treatment||None (Open Label)|patient and family members|||||
1315911|NCT03388957|Randomized|Parallel Assignment||Treatment||Triple||Four groups, with 20 children in each group|t|t||t
1315912|NCT03388944|Randomized|Parallel Assignment||Supportive Care||Double||Children with suspected or proven sepsis will be randomized to the PCT guided group or the standard practices group and will be followed up for the outcome measures that include treatment failure and mortality. We would also be comparing the duration and prescription rate of antibiotic therapy between the two groups as secondary outcome measures.|t|||t
1315913|NCT03388931||Single Group Assignment||Treatment||None (Open Label)||||||
1315914|NCT03388918|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised controlled trial||||
1315915|NCT03388905||Single Group Assignment||Prevention||None (Open Label)||||||
1315916|NCT03388892|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315917|NCT03388879|Randomized|Parallel Assignment||Treatment||Single|The researcher doing the statistical analyses will be masked for treatment Group (i.e. Group 1 or 2) in a databse blinded for treatment grioups and without variables indirectly revealing treatmnet arm. These will be analyzed later.|Prospective randomized two-group clinical trial with block randomization.||||t
1315918|NCT03388866|Randomized|Parallel Assignment||Treatment||Triple|Subjects will be randomly divided into blocks of random size 4 or 6 and stratified according to age (less than 12 years and greater / equal 12 years) and severity (SCORAD less than 50 and greater / equal 50), performed by through the RedCap platform, available at FMRPUSP. This process will be performed by laboratory staff who will provide the extracts and the researchers will not have access to the lists of patients in each group. As for blinding, the bottles with extract and placebo will be provided by the already coded laboratory, and the team will only be responsible for the delivery and storage of the same.|"A total of 94 patients, 3 years of age or older, with clinical diagnosis of AD, without distinction of gender, ethnicity or social group, will be selected at HCFMRP-USP Allergy and Dermatology outpatient clinics. These patients will undergo clinical evaluation and laboratory tests, including blood count, total IgE, inhalant panel specific IgE, and / or immediate hypersensitivity skin tests, and mite allergen specific IgG4 (Der p 1 and Der p 2), before of the study.~Patients in the treatment group will undergo sublingual allergen-specific immunotherapy with weekly and weekly doses of extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae mites (60% and 40% respectively), according to the predetermined schedule. Patients in the control group will be submitted to the same administration schedule, but with allergen extract diluent (doubly distilled water solution and glycerin)."|t|t|t|
1315919|NCT03388853|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1315920|NCT03388840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315925|NCT03388775|||Cohort||Prospective|||||||
1315926|NCT03388762|Randomized|Parallel Assignment||Treatment||Double|The study products will be delivered to the investigative sites prior to enrollment of subjects. A study code will be provided for every batch of study product shipped to the investigational site prior to the beginning of the study. The placebo utilized in this clinical trial will be formulated to be as similar as possible to the active in appearance, odor, and other key characteristics, and packaging for both intervention and placebo will be the same. The de-identified study product will be packaged and labeled according to the study code and participant identification numbers; the Study Coordinator will oversee a locked master list of these, in addition to batch numbers.|This study is a 12-week, randomized, double-blinded, placebo-controlled clinical trial of GlucoSupreme™ Herbal. Eligible participants will be recruited from within participating clinical practices. All study outcomes will be biomarkers, capturing normal structure and function of the human body, derived from blood draws ordered during two physician visits spaced 12 weeks apart. This is a typical interval between blood assessments of glycemic control in routine clinical practice. An IRB-approved research associate will call each study participant at the 6-week mid-point of the study to assess compliance and collect data on any adverse events. Serious adverse events, while not anticipated, will be reported by the participant to a study physician as soon as possible.|t|t||
1315927|NCT03388749||Sequential Assignment||Treatment||None (Open Label)||||||
1315928|NCT03388736|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1315929|NCT03388723|||Cohort||Prospective|||||||
1315930|NCT03388710|||Cohort||Prospective|||||||
1315931|NCT03388697|||Cohort||Prospective|||||||
1315932|NCT03388684|||Cohort||Retrospective|||||||
1315933|NCT03388671|Randomized|Parallel Assignment||Treatment||Double|The data collection personnel and the patients' guardians will be blinded to the group assignment.|The aim of this study will be to investigate the safety and analgesic efficacy of Transversus Abdominis Plane (TAB) Block versus psoas blocks. Both blocks will be administered surgically and guided by the laparoscopy screen in children undergoing laparoscopic surgery.|t|||t
1315934|NCT03388658|||Cohort||Retrospective|||||||
1315935|NCT03388645|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1315936|NCT03388632||Single Group Assignment||Treatment||None (Open Label)||||||
1315937|NCT03388619|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315938|NCT03388606|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315939|NCT03388593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315940|NCT03388580|||Case-Only||Retrospective|||||||
1315941|NCT03388567|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1315942|NCT03388554|Randomized|Parallel Assignment||Treatment||Double|In sham stimulation, the current was turned on for 30 sec and then ramped down to 0 mA.|Direct current (DC) generated by a DC stimulator (Eldith DC stimulator: www. neuroconn.de/dc-stimulator_plus_en/) was bilaterally delivered through a pair of saline-soaked surface sponge electrodes (35 square centimeter). The anode was placed with the middle of the electrode over a point midway between F3 and FP1 (left dorsolateral prefrontal cortex and left prefrontal cortex). The cathode was located over a point midway between T3 and P3 (left temporo-parietal junction). Stimulation was applied at an intensity of 2 mA for 20 min, twice-daily on 5 consecutive weekdays. The twice daily sessions were separated by at least 3 hours.|t|||t
1315943|NCT03388541|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1315944|NCT03388528||Single Group Assignment||Treatment||None (Open Label)||Forty patients with a genetically or biochemically proven diagnosis of mitochondrial disease will be recruited from the mitochondrial Clinics for Research and Service in Themed Assessments (CRESTA) clinic and / or Medical Research Council Mitochondrial Disease Patient Cohort Study in Newcastle||||
1315945|NCT03388515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315946|NCT03388502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315947|NCT03388489|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1315948|NCT03388476||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315949|NCT03388463|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1315950|NCT03388450|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1315951|NCT03388437|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Randomised controlled trial~A web generated a block randomisation list.~A block of 4, stratification based on GA, gender & antenatal steriods~Sequentially numbered, opaque and sealed envelopes~Restricted access to envelopes"||||
1315952|NCT03388424|||Ecologic or Community||Prospective|||||||
1315953|NCT03388411|||Cohort||Prospective|||||||
1315954|NCT03388398|||Other||Cross-Sectional|||||||
1315955|NCT03388385|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1315956|NCT03388372||Single Group Assignment||Treatment||None (Open Label)||||||
1315957|NCT03388359|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1315958|NCT03388346||Single Group Assignment||Diagnostic||None (Open Label)||||||
1315959|NCT03388333|||Cohort||Retrospective|||||||
1315960|NCT03388320||Single Group Assignment||Health Services Research||None (Open Label)||||||
1315961|NCT03388307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315962|NCT03388294|Randomized|Crossover Assignment||Treatment||Single|Assessors at all time points after randomization will be blind to the child's treatment arm allocation. Since parents are being coached as part of the intervention, it is not possible to keep them blind to their treatment arm.|The intervention phases of the study will use a randomized comparative trial design, with two phases. For Study Phase 1, dyads will participate in pretesting; then families will be randomized, stratifying by child age, to one of two treatment arms. Arm 1 families will participate in initial coaching on the PIE sensory reactivity (SR) domain, and Arm 2 families will participate in initial coaching on the PIE prelinguistic communication (PC) domain. Families will participate in 6 weekly coaching sessions in their respective treatment arms, and return for Posttest-1. For Study Phase 2, dyads in Arm 1 will receive 6 weekly coaching sessions on the PC domain, and dyads in Arm 2 will receive 6 weekly coaching sessions on the SR domain. Then families will return for Posttest-2. Follow-up assessments are planned at 3 months after Posttest-2, and at ages 30 and 36 months, to track diagnostic and developmental outcomes of this at-risk sample.||||t
1315963|NCT03388281|||Cohort||Retrospective|||||||
1315964|NCT03388268|Randomized|Parallel Assignment||Other||Quadruple|Placebo|Double-blinded randomized controlled trial of CDI treatment with oral vancomycin vs. placebo|t|t|t|t
1315965|NCT03388255||Single Group Assignment||Treatment||None (Open Label)||||||
1315966|NCT03388242|||Cohort||Prospective|||||||
1315967|NCT03388229|||Other||Retrospective|||||||
1315968|NCT03388216|Randomized|Sequential Assignment||Other||Single|||t|||
1315969|NCT03388203|||Cohort||Retrospective|||||||
1315970|NCT03388190|Randomized|Parallel Assignment||Treatment||None (Open Label)||The METIMMOX study is a multicenter open-label randomized phase 2 trial in first-line treatment of MSS mCRC using the standard-of-care Nordic FLOX regimen (control arm) or sequential therapy with the Nordic FLOX regimen and nivolumab (experimental arm), to investigate whether the experimental arm shows superiority in PFS, safety, tolerability, and QoL.||||
1315971|NCT03388177|Randomized|Parallel Assignment||Treatment||Single|The project uses a blinded rater to assess the primary outcome measure of symptoms of depression|Randomized controlled trial||||t
1315972|NCT03388164|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1315973|NCT03388151|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1315974|NCT03388138||||||||||||
1315975|NCT03388125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315976|NCT03388112|Randomized|Parallel Assignment||Treatment||Single|||t|||
1315977|NCT03388099|||Cohort||Prospective|||||||
1315978|NCT03388086|||Cohort||Retrospective|||||||
1315979|NCT03388073|Randomized|Crossover Assignment||Basic Science||Triple|Both the study participants and the research staff interacting with study participants will be blinded to the plant based extract versus placebo.|The study uses a randomized double-blinded placebo-controlled cross-over study design.|t|t||t
1315980|NCT03388060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315981|NCT03388047||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1315982|NCT03388034|||Cohort||Prospective|||||||
1315983|NCT03388021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315984|NCT03388008|Randomized|Parallel Assignment||Treatment||Single|Investigators examining lung biopsy results and blood for the development of donor-specific HLA antibodies will be blinded to study participants' treatment arm assignment.|Study participants will be randomized to 1 of 2 arms: Belatacept-based immunosuppression or standard of care immunosuppression||||t
1315985|NCT03387995|||Cohort||Prospective|||||||
1315986|NCT03387982|||Cohort||Prospective|||||||
1315987|NCT03387969|||Case-Control||Cross-Sectional|||||||
1315988|NCT03387956|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1315989|NCT03387943||Single Group Assignment||Treatment||None (Open Label)||||||
1315990|NCT03387930|||Case-Control||Prospective|||||||
1315991|NCT03387917||Single Group Assignment||Treatment||None (Open Label)||The trial uses an accelerated titration design (ATD) up to the occurrence of the first DLT, followed by a modified continual reassessment method (mCRM) for dose escalation||||
1315992|NCT03387904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1315993|NCT03387891|||Case-Only||Prospective|||||||
1315994|NCT03387878||Single Group Assignment||Other||None (Open Label)||||||
1315995|NCT03387865|||Case-Only||Prospective|||||||
1315996|NCT03387852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1315997|NCT03387839|||Cohort||Other|||||||
1315998|NCT03387826|Randomized|Crossover Assignment||Treatment||Single|Single (outcome assessor)|Crossover Assignment||||t
1315999|NCT03387813|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316000|NCT03387800|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1316001|NCT03387787||Single Group Assignment||Treatment||None (Open Label)||||||
1316002|NCT03387774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316003|NCT03387761||Single Group Assignment||Treatment||None (Open Label)||Single-arm open clinical trial||||
1316004|NCT03387748||Single Group Assignment||Basic Science||None (Open Label)||non-factorial, cross-sectional study (with control group)||||
1316005|NCT03387735|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1316006|NCT03387722|||Cohort||Prospective|||||||
1316007|NCT03387709|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316008|NCT03387696|||Cohort||Retrospective|||||||
1316009|NCT03387683|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1316010|NCT03387670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316011|NCT03387657||Single Group Assignment||Treatment||None (Open Label)||||||
1316012|NCT03387644|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1316013|NCT03387631|||Case-Only||Prospective|||||||
1316014|NCT03387618||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316015|NCT03387605|Randomized|Parallel Assignment||Treatment||Triple||Randomized, Double Blind, Placebo Controlled single center study.|t|t|t|
1316016|NCT03387592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316017|NCT03387579|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients will be randomized to one of the two treatment arms, either composite lipid (Smoflipid) or soy-based lipid reduction.||||
1316018|NCT03387566|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1316019|NCT03387553|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The trial will consist of two phases. The first lead in phase will enroll 12 participants evenly divided into two arms (alternating enrollment) with different initial priming vaccination schedules.~Following accrual of this initial group of 12 patients, HER2 ELISPOT post vaccination responses will be assessed to determine which of the two sequences provides the greater increase in anti HER2 response at week 4 over baseline. This will determine which sequence will be used in the second expansion phase of accrual. If both arms are determined equal then Arm A will be selected as the default sequence."||||
1316020|NCT03387540|||Case-Only||Cross-Sectional|||||||
1316021|NCT03387527||Single Group Assignment||Supportive Care||None (Open Label)||||||
1573418|NCT00001300||||Treatment||||||||
1316022|NCT03387514||Single Group Assignment||Diagnostic||None (Open Label)||This study is a single cohort study without randomization or stratification.||||
1316023|NCT03387501||Single Group Assignment||Treatment||None (Open Label)||||||
1316024|NCT03387488||Single Group Assignment||Treatment||None (Open Label)||||||
1316025|NCT03387475||Single Group Assignment||Treatment||None (Open Label)||||||
1316026|NCT03387462||Single Group Assignment||Other||None (Open Label)||||||
1316027|NCT03387449||Single Group Assignment||Treatment||None (Open Label)||||||
1316028|NCT03387436|Randomized|Parallel Assignment||Supportive Care||Double|"As in most psychological interventions, care providers (psychologists) can not be blinded, because they are delivering the intervention.~Patients only know if they are in one of the intervention groups or in TAU. All other study personnel will be blinded."|"Participants will be allocated randomly to three arms:~palliative treatment as usual (TAU)~sham-intervention + (TAU)~study-intervention + (TAU)~Stratification will be carried out for sex, and availability of a care giver."|||t|t
1316029|NCT03387423|||Cohort||Prospective|||||||
1316030|NCT03387410||Single Group Assignment||Other||None (Open Label)||||||
1316031|NCT03387397||Single Group Assignment||Supportive Care||None (Open Label)||quasi-experimental pretest and posttest study design.||||
1316032|NCT03387384|||Case-Only||Prospective|||||||
1316033|NCT03387371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316034|NCT03387358|||Other||Other|||||||
1316035|NCT03387345|Randomized|Crossover Assignment||Prevention||None (Open Label)||Otherwise healthy male and female adults||||
1316036|NCT03387332||Single Group Assignment||Treatment||None (Open Label)||||||
1316037|NCT03387319|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Participants will receive both interventions and will be randomized to which order the interventions are received. Of the 100 participants recruited, 80 will have a diagnosis of chronic kidney disease (CKD) and 20 will not.||||
1316038|NCT03387306|||Case-Control||Retrospective|||||||
1316039|NCT03387293|Randomized|Crossover Assignment||Screening||Single|||t|||
1316040|NCT03387280|||Case-Only||Retrospective|||||||
1316041|NCT03387267||Sequential Assignment||Screening||None (Open Label)|An operationally seamless single-arm, prospective, multicenter, single-blinded for central outcomes assessors trial to test DDS in assessing swallowing safety and efficiency in patients at risk of oropharyngeal dysphagia.|The clinical trial will initially start as a 3-look group sequential design (GSD). Alpha-spending will be calculated using Lan-DeMets spending function (with O'Brien-Fleming parameter). At the first interim analysis (IA-1) the threshold on the ROC curve may be re-computed using the ROC curve generated using the IA-1 data, in which case, the validation trial would start afresh following IA-1 using a 2-look GSD. Data included in the IA-1 would no longer be used for the validation phase.||||
1316042|NCT03387254|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1316043|NCT03387241|Randomized|Parallel Assignment||Treatment||Quadruple|A double blind, double dummy, randomised, multicentre, two arm parallel design||t|t|t|t
1316044|NCT03387228|Randomized|Parallel Assignment||Other||Single|Outcome assessor and statistician performing data analysis will be masked for the group allocation of all the participants.|Feasibility of a two group randomized clinical trial.||||t
1316045|NCT03387215|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1316046|NCT03387202|||Case-Only||Prospective|||||||
1316047|NCT03387189|||Cohort||Prospective|||||||
1316048|NCT03387176|||Cohort||Prospective|||||||
1316049|NCT03387163|||Cohort||Other|||||||
1316050|NCT03387150|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316051|NCT03387137|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1316052|NCT03387124|||Cohort||Prospective|||||||
1316053|NCT03387111||Single Group Assignment||Treatment||None (Open Label)||||||
1316054|NCT03387098||Single Group Assignment||Treatment||None (Open Label)||||||
1316055|NCT03387085||Single Group Assignment||Treatment||None (Open Label)||||||
1316056|NCT03387072|||Case-Control||Prospective|||||||
1316057|NCT03387059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316058|NCT03387046|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316059|NCT03387033||Single Group Assignment||Other||None (Open Label)||||||
1316060|NCT03387020||Single Group Assignment||Treatment||None (Open Label)||||||
1316061|NCT03387007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316062|NCT03386994|||Cohort||Prospective|||||||
1316063|NCT03386981|||Other||Prospective|||||||
1316064|NCT03386968|Randomized|Parallel Assignment||Treatment||None (Open Label)||"A Randomized Block Design will be utilized in order to attempt to match subjects according to functional level and diagnosis (cerebral palsy or acquired brain injury). Upon signing consent the subjects will be grouped based on their diagnosis. At that time gait speed for the 10 M Walk Test will be utilized to categorize all participants into a fast and slow group. (subjects performing the 10 M Walk Test at a speed less than .4 m/s will be placed in the slow group, and subjects testing at a speed greater than or equal to .4 m/s will be placed in the fast group After this determination is made, subjects will be randomized to control (usual care), and intervention one therapy session replaced with a session utilizing Active video games and the Rutger's V-step. A minimum of 2 subjects per grouping will be sought in order to analyze for differences."||||
1316065|NCT03386955||Single Group Assignment||Treatment||None (Open Label)||||||
1316066|NCT03386942||Single Group Assignment||Treatment||None (Open Label)||This is a Phase 1 study of MORAb-202 in participants with solid tumors. This study will be conducted in 2 parts (Part 1 and Part 2). Part 1 will be the dose escalation portion of this study to evaluate dose-limiting toxicity (DLT) and to determine the maximum tolerated dose (MTD) of MORAb-202 in participants with solid tumors. Considering efficacy, safety, and the pharmacokinetic (PK) profile, one dose may be selected from Part 1 for Part 2. Part 2 will comprise cohort expansions to further characterize the safety of MORAb-202 and to evaluate the preliminary efficacy of MORAb-202 in participants with folate receptor α (FRA)-positive triple negative breast cancer (TNBC) and Type 2 endometrial carcinoma. The recommended dose for future studies will be determined based on the data from Part 1 and Part 2.||||
1316067|NCT03386929||Single Group Assignment||Treatment||None (Open Label)||||||
1316068|NCT03386916|||Case-Only||Retrospective|||||||
1316069|NCT03386903|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1316070|NCT03386890|||Cohort||Prospective|||||||
1316071|NCT03386877|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316072|NCT03386864|||Case-Control||Cross-Sectional|||||||
1316073|NCT03386851|||Case-Only||Prospective|||||||
1316074|NCT03386838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316075|NCT03386825|||Other||Retrospective|||||||
1316076|NCT03386812|||Other||Prospective|||||||
1316077|NCT03386799|||Cohort||Prospective|||||||
1316078|NCT03386786|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316079|NCT03386773|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Recruited participants will be randomized to one of two arms, intervention or control. Both intervention and control groups will engage in a 16-week program where they will receive regular health promotion messaging about (a) food, nutrition, and diet; and (b) exercise and physical activity. Intervention patients will be asked to track patient generated health data elements related to weight management through a mobile health app loaded on their phones and/or through using a fitness tracker, depending on patient preference, and to share that information with the research team. Intervention patients will also be asked to provide answers to patient-reported outcomes measures on a weekly basis. If intervention patients do not have a fitness tracker, a low-cost option will be provided for them. Both iOS and Android phone options will be supported. The app will be selected from a limited set of well-established options such as LoseIt!, MyFitnessPal, Apple Health, or Google Fit.||||
1316080|NCT03386760|Randomized|Parallel Assignment||Treatment||Single||||t||
1316081|NCT03386747|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Treatment requires active participation and will be revealed immediately.|||||
1316082|NCT03386734|Randomized|Parallel Assignment||Other||Single|||t|||
1316083|NCT03386721|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316084|NCT03386708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316085|NCT03386695|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1316086|NCT03386682||Single Group Assignment||Treatment||None (Open Label)||||||
1316087|NCT03386669||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316088|NCT03386656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316089|NCT03386643|Randomized|Parallel Assignment||Treatment||Double|Both patients and investigators who will assess the outcomes have no knowledge of the interventions assigned to individual participants.|Symptomatic patients presenting OLP will be randomly assigned to either topical Bifidobacterium animalis subsp lactis HN019 or clobetasol propionate 0.05%, and they will receive capsules to be diluted in 15 ml of water containing 6 x 109 CFUs of Bifidobacterium subsp. lactis HN019 (experimental group) or 0.05% clobetasol propionate (control group) for mouth washing, twice a day for 4 weeks.|t||t|
1316090|NCT03386630|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized clinical trial, without masking techniques, is proposed in pregnant women who are to undergo elective caesarean section by subarachnoid anesthesia with hyperbaric bupivacaine associated with sufentanil or morphine||||
1316091|NCT03386617||Single Group Assignment||Treatment||None (Open Label)||||||
1316092|NCT03386604|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1316093|NCT03386591|Randomized|Crossover Assignment||Treatment||None (Open Label)||This will be an inpatient open-label, randomized, 5-period, 5-treatment, 5-sequence, crossover study involving approximately 30 healthy subjects.||||
1316094|NCT03386578|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316095|NCT03386565|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1316096|NCT03386552|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316097|NCT03386539|Randomized|Parallel Assignment||Treatment||Single|The Coronary Angiography Core Laboratory readers will be blinded to treatment assignment and time point (study visit). The Adjudication Committee members will be blinded to treatment assignment.|Multicenter open-label randomized clinical trial with randomization within 4 strata, defined by donor-specific antibody status and center annual transplant volume. There are 2 parallel groups of equal sizes for randomization: everolimus/low-dose tacrolimus and tacrolimus/mycophenolate mofetil.||||t
1316098|NCT03386526||Single Group Assignment||Treatment||None (Open Label)||||||
1316099|NCT03386513||Single Group Assignment||Treatment||None (Open Label)||||||
1316100|NCT03386500||Single Group Assignment||Treatment||None (Open Label)||||||
1316101|NCT03386487|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316102|NCT03386474|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316103|NCT03386461|Randomized|Parallel Assignment||Basic Science||Single|Two types of pills (calanus or placebo) will be prescribed to subjects, investigator will randomly assign the subjects to the arms|The exercise training intervention with or without omega-3 supplementation (Calanus oil) will be prescribed to non-trained sedentary elderly women|t|||
1316104|NCT03386448|Randomized|Parallel Assignment||Treatment||Double|The participants and physician are both blinded to medication vs. control medication|Double blinded, randomized, controlled parallel design|t|t||
1316105|NCT03386435|Randomized|Parallel Assignment||Prevention||Single|single blind masking|study group : remote ischemic preconditioning control group : none|t|||
1316106|NCT03386422|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1316107|NCT03386409|Randomized|Sequential Assignment||Prevention||Single|Participants are not informed about their group allocation.|In the first phase of the study, all participants are assigned to an observational baseline group. Once the enrollment milestone is met, the second phase of the study will open. In this phase, participants all receive the intervention of safe firearm storage device distribution. Participants are randomized to either the free device group, or the low cost ($5) device group.|t|||
1316108|NCT03386396|Randomized|Parallel Assignment||Other||Quadruple||One group will be given a high protein/low carbohydrate shake and one group will be given a high carbohydrate/low protein shake|t|t|t|t
1316109|NCT03386383|Randomized|Parallel Assignment||Supportive Care||Single|4||||t|
1316110|NCT03386370||Single Group Assignment||Treatment||None (Open Label)||||||
1573419|NCT00001298||||Treatment||||||||
1316111|NCT03386357|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|Open-label, Controlled, randomized trial||||
1316112|NCT03386344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316113|NCT03386331||Single Group Assignment||Basic Science||None (Open Label)||||||
1316114|NCT03386318|||Cohort||Prospective|||||||
1316115|NCT03386305|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316116|NCT03386292|||Cohort||Cross-Sectional|||||||
1316117|NCT03386279|Randomized|Crossover Assignment||Other||Quadruple|"PF-04965842 and placebo oral tablets will be prepared in the CRU by 2 operators, 1 of whom is an unblinded pharmacist. PF-04965842 and placebo will be administered in blinded fashion to the subject.~Moxifloxacin 400 mg tablets will be packaged in an open-label manner at the CRU in the individual dosing containers by 2 operators, 1 of whom is an appropriately qualified and experienced member of the study staff (eg, physician, nurse, physician's assistant, practitioner, or pharmacist)."||t|t|t|t
1316118|NCT03386266|||Cohort||Prospective|||||||
1316119|NCT03386253|Randomized|Parallel Assignment||Other||Double|||t||t|
1316120|NCT03386240|Randomized|Parallel Assignment||Treatment||Triple|A confidential computer-generated simple randomization scheme will be prepared and provided on an ongoing basis. A randomization log will be used to track the randomization process. Patients will be masked to the suture material. Both suture types look similar. Patient, surgeons, and staff ascertaining the outcomes will be masked for the suture type.|Double-blinded controlled clinical trial|t|t|t|
1316121|NCT03386227|Randomized|Parallel Assignment||Other||Single|The embryologists who assess embryo outcomes (as noted in the secondary outcomes) will be blinded to randomization.|This study will have patients randomized in a 1:1 fashion to antibiotic prophylaxis or withholding antibiotic prophylaxis.||||t
1316122|NCT03386214|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1316123|NCT03386201||Single Group Assignment||Other||None (Open Label)||||||
1316124|NCT03386188||Single Group Assignment||Basic Science||None (Open Label)||||||
1316125|NCT03386175|||Cohort||Prospective|||||||
1316126|NCT03386162|Randomized|Parallel Assignment||Treatment||None (Open Label)||"In the randomized treatment phase, patients will be randomized 2:1 to receive:~• Experimental arm (Arm A3): fulvestrant (500 mg intramuscular [as two 5 mL injections] every 28 days ± 3 days, with an additional injection on 15 after the first administration + Alpelisib (300 mg by mouth once daily, in a 21-day cycle). Premenopausal women will receive LH-RH analogs in addition every 28 days± 3 days.~OR~• Control arm (Arm B3): maintenance chemotherapy, meaning the same chemotherapy regimen used during the first 6-8 cycles (investigator's choice) or no antineoplastic treatment in case of toxicity after 4 full cycles.~A total of approximately 90 patients will be enrolled"||||
1316127|NCT03386149|Randomized|Parallel Assignment||Treatment||Single||||||t
1316128|NCT03386136||Single Group Assignment||Treatment||None (Open Label)||||||
1316129|NCT03386123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316130|NCT03386110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316131|NCT03386097|||Case-Control||Other|||||||
1316132|NCT03386084|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1316133|NCT03386071||||||||||||
1316134|NCT03386058||Single Group Assignment||Basic Science||None (Open Label)||Open study||||
1316135|NCT03386045|Randomized|Parallel Assignment||Treatment||None (Open Label)|no masking|||||
1316136|NCT03386032|Randomized|Parallel Assignment||Treatment||Triple|As above|Subjects will be randomized and balanced into one of the 3 treatment groups by their baseline SCORAD grade (moderate = 25-40 and severe = 41+) and ethnicity (black or non-black).|t||t|t
1316137|NCT03386019||Single Group Assignment||Treatment||None (Open Label)||There will be a total of 4 different time points where outcome measures will be assessed including: baseline, immediately after pre-conditioning, immediately after treatment and 10 minutes after treatment. Once the participant completed the assessment of one treatment, another assessment session from one of the two remaining treatments will be scheduled in the following week, and the data collections for all three treatments will be finished in three consecutive weeks. This could ensure that all participants receive similar training schedules with similar training intensity within a fixed time period.||||
1316138|NCT03386006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316139|NCT03385993||Single Group Assignment||Prevention||None (Open Label)||||||
1316140|NCT03385980|||Other||Prospective|||||||
1316141|NCT03385967|Randomized|Parallel Assignment||Treatment||Double|Double Blind|This is a prospective, randomized, double blind study of adding dexmedetomidine 0.25mcg/kg body weight to standard dose (25ml) of 0.5%ropivacaine for Brachial plexus block and assessing the analgesia with VAS pain scales (0-10), Satisfaction scale by VAS scale (0-10) and time to first analgesic consumption.|t|t||
1316142|NCT03385954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316143|NCT03385941|||Case-Control||Prospective|||||||
1316144|NCT03385928|Randomized|Parallel Assignment||Treatment||Quadruple||"The study will be prospective phase II randomised, double-blind, placebo-controlled investigator-driven trial in acute intracerebral haemorrhage patients.~The study has 2 arms with 1:1 randomisation to either intravenous Tranexamic acid or placebo."|t|t|t|t
1316145|NCT03385915|||Cohort||Retrospective|||||||
1316146|NCT03385902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316147|NCT03385889|Randomized|Parallel Assignment||Treatment||Single|Assessors of joint position sense, balance, and cervical spine range of motion via the Cervical Flexion Rotation Test will be blinded to group allocation|Pre-test, Post-test, control group design 3 groups - mobilization, manipulation, control||||t
1316148|NCT03385876||Single Group Assignment||Diagnostic||None (Open Label)||Assignment||||
1316149|NCT03385863|||Case-Only||Retrospective|||||||
1316150|NCT03385850|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316151|NCT03385837|||Cohort||Prospective|||||||
1316152|NCT03385824|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1316153|NCT03385811|||Cohort||Prospective|||||||
1316154|NCT03385798|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized clinical trial||||
1316155|NCT03385785|||Cohort||Prospective|||||||
1316240|NCT03384680|||Case-Only||Cross-Sectional|||||||
1316156|NCT03385772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a prospective interventional pilot study of the efficacy of the sphenopalatine ganglion block for treatment of post-dural puncture headache in post-partum women.||||
1316157|NCT03385759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316158|NCT03385746|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316159|NCT03385733|Randomized|Parallel Assignment||Treatment||Double||Patients will randomize into two groups as Group A: inspiratory muscle training, and Group B (control group)|t|||t
1316160|NCT03385720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316161|NCT03385707||Single Group Assignment||Treatment||None (Open Label)|Participants will be masked to sensor glucose levels during glucose monitoring data acquisition.|The proposed study is designed to evaluate individuals who are currently experiencing symptoms of hypoglycemia, in order to discern correlations between microbiome composition, dietary intake, and patterns of postprandial glycemia.||||
1316162|NCT03385694|||Cohort||Prospective|||||||
1316163|NCT03385681|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Two parallell groups- intervention and control||||
1316164|NCT03385668||Single Group Assignment||Treatment||None (Open Label)||||||
1316165|NCT03385655|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316166|NCT03385642|||Cohort||Prospective|||||||
1316167|NCT03385629|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1316168|NCT03385616||Single Group Assignment||Device Feasibility||None (Open Label)||Treatment with Gala Airway Treatment System||||
1316169|NCT03385603|Randomized|Parallel Assignment||Treatment||Single|An investigator who will not interact with study participants will perform the random intervention assignment.|Participants will be randomized to receive one of two treatments.|||t|
1316170|NCT03385590|Randomized|Parallel Assignment||Other||Double|Subjects will be blinded, on-site investigator will not be blinded due to the difficulty with blinding the foods. The off-site PI and outcome assessors will be blinded.|Children 6-36 months will be fed soy-fiber-maize or soy-maize complementary foods for 6 months.|t|||t
1316171|NCT03385577||Single Group Assignment||Supportive Care||None (Open Label)||||||
1316172|NCT03385564|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316173|NCT03385551|||Cohort||Prospective|||||||
1316174|NCT03385538||Single Group Assignment||Prevention||None (Open Label)||||||
1316175|NCT03385525||Single Group Assignment||Treatment||None (Open Label)||||||
1316176|NCT03385512|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Patient and health care team participants and the clinics in which they practice will be randomly assigned to one of three groups for the duration of their participation in the study: 1) OPEN High Tech, 2) OPEN High Touch and 3) ASK. Unit of randomization is clinic. Physicians will be clustered in clinics and patients clustered within physicians.||||
1316177|NCT03385499|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1316178|NCT03385486||Sequential Assignment||Treatment||None (Open Label)||"The study will consist of a Dose Escalation Phase and a Dose Expansion Phase. TBX-3400 will be administered on Day 1 of each treatment cycle and can be repeated.~In the Dose Escalation Phase, a 3+3 design will be employed. Each dose cohort will initially enroll 3 patients. Enrollment and treatment of the first 3 patients in the first cohort will be staggered to allow for evaluation of safety. After each cohort has been enrolled and all patients in the cohort have completed Cycle 1, a Data Safety Monitoring Committee will review cumulative safety data to determine whether to proceed with further dose escalation.~Each cohort may be expanded in groups of 3 patients to a maximum of 12 patients. Up to six TBX 3400 dose levels will be evaluated during the Dose Escalation Phase of the study."||||
1316179|NCT03385473|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1316180|NCT03385460||Single Group Assignment||Treatment||None (Open Label)||||||
1316181|NCT03385447||Single Group Assignment||Prevention||None (Open Label)||||||
1316182|NCT03385434|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1316183|NCT03385421|||Cohort||Prospective|||||||
1316184|NCT03385408|Randomized|Single Group Assignment||Treatment||Single|||t|||
1316185|NCT03385395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316186|NCT03385382|||Other||Other|||||||
1316187|NCT03385369|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1316188|NCT03385356|Randomized|Parallel Assignment||Treatment||Triple||1000 IU/day of Vitamin D vs 4000 IU of Vitamin D /day; IU (international units)|t|t|t|
1316189|NCT03385343||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316190|NCT03385330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316191|NCT03385317||Single Group Assignment||Supportive Care||None (Open Label)||||||
1316192|NCT03385304|Randomized|Crossover Assignment||Treatment||Single|The orthopaedic team (including the study coordinators) cannot be blinded to the treatment allocation as the antiseptic solutions are visually distinguishable and these individuals need to lead the implementation of the cluster-crossover protocol at their clinical site. The Adjudication Committee Members and data analysts will be blinded to the study treatment. All interpretation of study results will initially be done in a blinded manner by developing two interpretations of the results. One interpretation will assume treatment A is povidone-iodine, the other interpretation will assume it is CHG. Once the data interpretations for each assumption are finalized, the data will be unblinded and the correct interpretation will be accepted.|Treatment allocation will be determined using a cluster-randomized crossover trial design. The order of treatment allocation for each orthopaedic practice will be randomly assigned using a computer generated randomization table. Each site will start with the initially allocated study solution and eventually crossover to the other solution for their second recruitment period. This process of alternating treatments will repeat approximately every 2 months as dictated by the initial randomization.||||t
1316193|NCT03385291|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316194|NCT03385278|Randomized|Crossover Assignment||Treatment||Triple||This study was designed and performed as a randomized, controlled cross-over trial. All patients were randomly received active 20-Hz rTMS and sham stimulation for 5 consecutive days, in separate sessions spaced one week.|t|t||t
1316195|NCT03385265|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316196|NCT03385252|Randomized|Parallel Assignment||Prevention||Double|Participants will not be masked. Data collectors will not be informed of the participant's group assignments. Data analysis will be conducted on blinded datasets until the primary analysis is complete.||||t|t
1316197|NCT03385239|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316198|NCT03385226||Single Group Assignment||Treatment||None (Open Label)||||||
1316199|NCT03385213|||Case-Control||Retrospective|||||||
1316200|NCT03385200|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parellel Assignment||||
1316201|NCT03385187||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316202|NCT03385174||Single Group Assignment||Other||None (Open Label)||||||
1316203|NCT03385161|Randomized|Parallel Assignment||Treatment||Triple|Only the surgeon during injection knows the active material||t||t|t
1316204|NCT03385148||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316205|NCT03385135|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1316206|NCT03385122|||Ecologic or Community||Prospective|||||||
1316207|NCT03385109|||Cohort||Prospective|||||||
1316208|NCT03385096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316209|NCT03385083|Randomized|Parallel Assignment||Treatment||Single|||||t|
1316210|NCT03385070|||Case-Control||Cross-Sectional|||||||
1316211|NCT03385057|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1316212|NCT03385044|Randomized|Crossover Assignment||Treatment||Double|The randomization table of a treatment sequence will be managed by the third person who will not involve in this study.|Two methods of cuff sealing will be applied in a random sequence to each patient.|t|||t
1316213|NCT03385031|||Cohort||Prospective|||||||
1316214|NCT03385018|Randomized|Parallel Assignment||Treatment||None (Open Label)||2-arm randomized controlled study||||
1316215|NCT03385005|Non-Randomized|Sequential Assignment||Device Feasibility||None (Open Label)||The study will involve 3-10 eligible healthy volunteers and 2-5 eligible individuals with a traumatic spinal cord injury. The study will first enroll healthy volunteers into the study in order to determine the feasibility of evoking refined hand movements through electrical stimulation, and determine the electrical stimulation parameters and electrode spatial configurations responsible for various hand movements. After this is done, the study will proceed with the enrollment of individuals with spinal cord injuries. This enrollment process is being done to reduce the participation time required for spinal cord injury participants, and thus lower the likelihood of risks that are more prevalent among spinal cord injury participants.||||
1316216|NCT03384992|Randomized|Factorial Assignment||Supportive Care||Triple||FoRtitude includes three CSMs: (1) diaphragmatic breathing and relaxation, (2) cognitive restructuring, and (3) scheduled worry practice. The fourth intervention component is (4) telephone coaching. We assigned two levels (yes, no) to each component. Evaluating individual and combined intervention components, each with two levels, results in a classic full factorial design with 16 (2 x 2 x 2 x 2) experimental conditions|t|t|t|
1316217|NCT03384979|Randomized|Parallel Assignment||Supportive Care||Triple|Patients will be assigned to the TBW or LBW group based on a randomization generated by a computer, the progressive sequences containing the randomization code will be perform by an outside operator to the experiment group. Only CT technician and nurse that will record patient's data and results from scale analysis will know and will register in which group the patients will be assigned.|The study design is monocentric, comparative, randomized, double blinded. Patients will undergo a CT scan of abdomen (multi-phasic) with contrast agent and will be measured: TBW, height, LBW and body mass index (BMI) through formulas known in literature and with a balance for bioelectrical impedance analysis. There is no administration of drugs other than indicated in the request of the treating physician.|t|t|t|
1316218|NCT03384966|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinding will apply to treatment (ACT-246475 vs placebo). The dose (8 mg vs 16 mg) will be single blinded (subject blinded). The site for the sub-cutaneous injection (thigh vs abdomen) will not be blinded.||t|t|t|t
1316219|NCT03384953|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316220|NCT03384940|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1316221|NCT03384927|||Case-Crossover||Prospective|||||||
1316222|NCT03384914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316223|NCT03384901|||Case-Only||Retrospective|||||||
1316224|NCT03384888|Randomized|Parallel Assignment||Treatment||Triple||The parallel clinical trial simultaneously compares two groups of individuals, one of which receives the intervention of interest and the other is a control group (sham).|t|t|t|
1316225|NCT03384875|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1316226|NCT03384862|Randomized|Parallel Assignment||Other||Triple|All participants, field staff, and investigators will be blinded to the intervention status of participants.||t|t|t|
1316227|NCT03384849|||Case-Only||Prospective|||||||
1316228|NCT03384836||Single Group Assignment||Treatment||None (Open Label)||||||
1316229|NCT03384823|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1316230|NCT03384810|||Cohort||Prospective|||||||
1316231|NCT03384797|||Cohort||Cross-Sectional|||||||
1316232|NCT03384784|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1316233|NCT03384771|||Other||Prospective|||||||
1316234|NCT03384758|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316235|NCT03384745|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316236|NCT03384732|||Case-Only||Cross-Sectional|||||||
1316237|NCT03384719|Randomized|Parallel Assignment||Basic Science||Quadruple||The study is a randomized, controlled, double-blind, parallel food intervention study with 3 study arms|t|t|t|t
1316238|NCT03384706|Randomized|Crossover Assignment||Treatment||Single|The assessors will remain blind to treatment condition throughout the study.|This study will examine the effectiveness of Cognitive Processing Therapy (CPT) as compared to Accelerated Resolution Therapy (ART) and a Waitlist (WL) control using a Randomized, Cross-Over Design. 280 participants will be randomly assigned to ART, CPT or WL. Upon completion of the WL condition, participants will be re-randomized to ART or CPT.||||t
1316239|NCT03384693||Single Group Assignment||Prevention||None (Open Label)||Defibrotide 6.25mg/kg administered intravenously for 28-35 days||||
1573420|NCT00001296||||Treatment||||||||
1316241|NCT03384667|Randomized|Parallel Assignment||Treatment||Quadruple||A randomized, double-blind, placebo-controlled trial|t|t|t|t
1316242|NCT03384654|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316243|NCT03384641||Single Group Assignment||Treatment||None (Open Label)||||||
1316244|NCT03384628|Non-Randomized|Crossover Assignment||Treatment||Single|Subjects will be masked to lens type and lens codes. A sealed decoding envelope will be provided to the investigator. In the event of an emergency the investigator will break the masking and the medical monitor will be notified.|Each subject will wear the three contact lens types bilaterally in random succession|t|||
1316245|NCT03384615|Randomized|Parallel Assignment||Treatment||Single||Block randomization in REDcap (copyright by Vanderbuilt University, USA) conducted by external biostatistician||||t
1316246|NCT03384602|Randomized|Parallel Assignment||Prevention||Double||Two intervention groups: Active I = Dalcroze Eurhythmic Program Active II: simple home exercise program Control group: no change in daily activities, no intervention|||t|t
1316247|NCT03384589|Randomized|Parallel Assignment||Prevention||None (Open Label)||Group 1: 3 doses of PCV13 (2, 4, 12 months), 2+1 Group 2: 2 doses of PCV13 (2, 12 months), 1+1||||
1316248|NCT03384576|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1316249|NCT03384563|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1316250|NCT03384550|Randomized|Factorial Assignment||Prevention||Single||||||t
1316251|NCT03384537|Randomized|Parallel Assignment||Prevention||Single|A third party will perform the allocation sequence and assign the participants to rinsing agent in sequentially numbered opaque envelop.|"The participants in this study will be randomly divided into two groups according to the application of the mouth rinse agent (M); the first group M1) The participants will use Tropolone containing as a mouth rinse, the second group (M2) The participants will use chlorhexidine 0.2% as a mouth rinse.~Then each participant will be monitoring at the base line T0: before using any mouthwash, T1: immedially after using tested mouthwash, T2: after one week and finally, T3: after two weeks of using the tested mouthwash.~Each participant will be the reference/counted for self as a record."||||t
1316252|NCT03384524|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316253|NCT03384511||Single Group Assignment||Treatment||None (Open Label)||Apatinib at oral dose of 250 mg twice daily (500 mg/day) for a minimum of 30 days||||
1316254|NCT03384498|||Cohort||Prospective|||||||
1316255|NCT03384485||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316256|NCT03384472|||Cohort||Prospective|||||||
1316257|NCT03384459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316258|NCT03384446|Randomized|Parallel Assignment||Treatment||Double|Participants will not know which intervention was administered. Outcome assessor will be different than care provider and will be masked.||t|||t
1316259|NCT03384433||Single Group Assignment||Treatment||None (Open Label)||||||
1316260|NCT03384420||Single Group Assignment||Treatment||None (Open Label)||||||
1316261|NCT03384407||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1316262|NCT03384394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316263|NCT03384381||||||||||||
1316264|NCT03384368|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1316265|NCT03384355|||Cohort||Prospective|||||||
1316266|NCT03384342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316267|NCT03384329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316268|NCT03384316|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1316269|NCT03384303|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1316270|NCT03384290|Randomized|Parallel Assignment||Treatment||Single|Randomization is assigned by the pharmacist according to predetermined randomization code.|Single Group Assignment This is a phase 1, dose escalating study to assess safety, tolerability, and PK of a single dose of PRS-060 administered by oral inhalation or IV infusion to healthy male and female subjects. This study will be conducted utilizing a single-blind, randomized, dose-escalating design.|t|||
1316271|NCT03384277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316272|NCT03384264|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1316273|NCT03384251|Randomized|Parallel Assignment||Prevention||None (Open Label)|Participants are not required to write their names on the questionnaires. therefore responses provided are anonymous|A multi-stage sampling method shall be conducted. A random sampling of six (6) out 12 mixed Senior High Schools in Tamale Metropolis-Northern Ghana would be selected. We shall randomly allocate three (3) schools as the intervention and the other three (3) as control groups respectively. In each school, one class shall be selected at random from each grade in both intervention and control groups.||||
1316274|NCT03384238||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316275|NCT03384225|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment open labled randomized controlled study||||
1316276|NCT03384212|Randomized|Parallel Assignment||Treatment||None (Open Label)||open labled randomized controlled study||||
1316277|NCT03384199||Single Group Assignment||Health Services Research||None (Open Label)||||||
1316278|NCT03384186||Single Group Assignment||Other||None (Open Label)||||||
1316279|NCT03384173||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316280|NCT03384160|Randomized|Parallel Assignment||Prevention||Double|Surgical procedures were always performed by the same surgeon and assistant, who was unaware of the group that belonged to the patient, as well as the patient himself. This randomization was performed involving numbers and envelopes, being only the investigator's knowledge.|"The sample will consist of 32 lower third molars, semi-inclusively or included. This study will be a randomized, double blind, controlled, split-mouth clinical trial, divided into two groups simultaneously, namely:~Group 1 (16 teeth) - using anesthetic mepivacaine in third molar extraction. Group 2 (16 teeth) - using anesthetic articaine in third molar extraction"|t|t||
1316453|NCT03381911|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||There are 2 study arms: ECA and E-Consent. In the ECA group subjects will have the consent form reviewed with them by the Embodied Conversational Agent character. In the E-Consent group (the standard of care), subjects will review the consent form on a computer screen with the option to have it read to them verbatim.||||
1573421|NCT00001292||||||||||||
1316281|NCT03384147|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)|Intake of alcoholic drinks or abstaining cannot be masked to participants or care providers (delivering the alcoholic beverages). The outcomes included biomarkers of alcohol intake so in practice the investigator and outcomes assessor could not be blinded either.|The study was conducted in two predefined groups of volunteers, 1) daily alcohol users of maximally one (females) or two (males) drinks per day, and 2) occasional drinkers (0-2 drinks per week). Group 1 was asked to abstain from alcohol for 3 weeks, then to resume drinking 1-2 drinks daily for the next three weeks. Group 2 was asked to drink 1-2 drinks daily for 3 weeks and then to abstain for the following 3 weeks. During the alcohol intake period both groups were randomized to sequences of 4-5 days with red wine, white wine, lager beer, apple cider, or spirits. The primary endpoint was an effect of alcohol on dihydroepiandrosterone sulphate excretion in urine. Biomarkers of alcohol intake and alcohol-induced metabolic change, physical activity, or well-being were secondary outcomes.||||
1316282|NCT03384134|Randomized|Parallel Assignment||Other||None (Open Label)||Following informed consent, participants will be randomized to the intervention or control group using a blocked randomization scheme with block size equal to 4 and stratified by age group, gender and diagnosis. An online program to will be used to derive an assignment. Patients will be randomized at a 1:1 ratio with equal numbers randomized to the intervention and control groups.||||
1316283|NCT03384121||Single Group Assignment||Treatment||None (Open Label)||This is a phase 1 pilot study whereby all participants start the study at a starting dose 5mg/kg/day (at study visit 2) for two months, and those that do not respond to 5mg/kg/day, otherwise known as non-responders, will receive a higher dose of 10 mg/kg/day (at study visit 4) for another two months. Recruited patients will be followed prospectively for a total of 6-11 months. This will include 2 months of observation, 2 months of receiving the starting dose of rifampin of 5mg/kg/day with a maximum dose of 600mg/day followed by a 2 month washout phase. The efficacy of the starting dose of rifampin will be determined prior to proceeding only in non-responders to the higher dose of 10 mg/kg/day with a maximum dose of 600 mg/day.||||
1316284|NCT03384108|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||In Vivo vs. Ex Vivo assessment of 5-13C-Glutamine incorporation by plasma cells via a bone marrow aspiration.||||
1316285|NCT03384095|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1316286|NCT03384082|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316287|NCT03384069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316288|NCT03384056|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1316289|NCT03384043|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1316290|NCT03384030||Single Group Assignment||Basic Science||None (Open Label)|Subjects will be kept naïve with respect to the fact that stress responses are the primary responses of interest.|All participants receive the same intervention. 30 healthy males are subjected to the adapted STMST to induce emotional sweating.||||
1316291|NCT03384017||Single Group Assignment||Treatment||Single|All assessors will be blind to intervention|||||t
1316292|NCT03384004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316293|NCT03383991|Randomized|Parallel Assignment||Treatment||||||||
1316294|NCT03383978||Single Group Assignment||Treatment||None (Open Label)||||||
1316295|NCT03383965||Single Group Assignment||Treatment||None (Open Label)|None (Open Label)|||||
1316296|NCT03383952||Single Group Assignment||Treatment||None (Open Label)||||||
1316297|NCT03383939|Randomized|Parallel Assignment||Supportive Care||Single||2 parallel groups of patients with bronchictasis were investigated: 1 receiving inhaled prolastina and 1 receiving placebo (saline solution) all bronchiectasis patients were initially compared with 10 control patients with no bronchiectasis|||t|
1316298|NCT03383926|Randomized|Parallel Assignment||Treatment||Double|Neither the evaluator of the research and the participant do not know the lenght of the Longo's intervention that is performed.|In the surgery, Longo's intervention would be done by two ways differing in the distance of the suture from the tobacco pouch to the anal margin (4.5 cm in the first group and 6 cm in the second group).|t|||t
1316299|NCT03383913|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1316300|NCT03383900|Randomized|Parallel Assignment||Treatment||Double||Participants will be randomized into two groups: experimental (G-IMT) and sham (Gn-IMT). The two groups will perform a protocol of 12 weeks of training (4 days / week) with the PowerBreath|t|||t
1316301|NCT03383887|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1316302|NCT03383874|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1316303|NCT03383861|||Case-Control||Retrospective|||||||
1316304|NCT03383848|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1316305|NCT03383835||Single Group Assignment||Prevention||None (Open Label)||||||
1316306|NCT03383822|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1316307|NCT03383809|Randomized|Crossover Assignment||Basic Science||None (Open Label)||"Acute human bioavailability studies with a cross-over design will be given to subjects in the form of a drink in one of three combinations~Strawberry juice alone~Inulin alone~Mixture of strawberry juice and inulin"||||
1316308|NCT03383796|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1316309|NCT03383783|Randomized|Crossover Assignment||Other||Double|||||t|t
1316310|NCT03383770|Randomized|Parallel Assignment||Treatment||Single||The selection of the puncture cannula for regional anaesthesia is not up to the performing anaesthetist, as is usual in the clinical standard, but is made randomly on the basis of a random list. The blockade is carried out by two anaesthetists experienced in regional anaesthesia, who have the principle of dual control. The ultrasound image acquired during the blockade is recorded in the form of an ultrasound video for subsequent evaluation. The recorded ultrasound videos are stored pseudonymously on the server of the Klinik für Anästhesiologie m. S. operativ Intensivmedizin reported to the data protection department.|t|||
1316311|NCT03383757||Single Group Assignment||Other||None (Open Label)||||||
1316312|NCT03383744|Randomized|Single Group Assignment||Treatment||None (Open Label)||n subjects received the treatment and then randomly divided in two groups for outcome evaluation after one and three months respectively||||
1316457|NCT03381859||Single Group Assignment||Treatment||None (Open Label)||||||
1316458|NCT03381846||Single Group Assignment||Treatment||None (Open Label)||||||
1573422|NCT00001291||||||||||||
1316313|NCT03383731|Randomized|Parallel Assignment||Treatment||Single|In this study, the third party independent evaluation method is used to evaluate the results of the study. The analyzer is in the masking state, and the subjects and the surgeons are in the non-masking state..|"This is a prospective, randomized, controlled study involving multiple visits within 12 months. The patients with macular hole retinal detachment caused by high myopia are randomly divided into 2 treatment groups.~Group 1: standard 3-port 23 gauge pars plana vitrectomy + internal limiting membrane peeling + air-fluid exchange + silicone oil infusion Group 2: standard 3-port 23 gauge pars plana vitrectomy + internal limiting membrane peeling + inverted internal limiting membrane insertion + air-fluid exchange"||||t
1316314|NCT03383718|||Cohort||Prospective|||||||
1316315|NCT03383705||Single Group Assignment||Treatment||None (Open Label)||||||
1316316|NCT03383692|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1316317|NCT03383679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316318|NCT03383666|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1316319|NCT03383653|||Cohort||Prospective|||||||
1316320|NCT03383640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316321|NCT03383627||Single Group Assignment||Prevention||None (Open Label)||||||
1316322|NCT03383614|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316323|NCT03383601|||Cohort||Prospective|||||||
1316324|NCT03383588|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1316325|NCT03383575|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316326|NCT03383562|||Cohort||Prospective|||||||
1316327|NCT03383549|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1316328|NCT03383536|||Case-Control||Cross-Sectional|||||||
1316329|NCT03383523|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a single-centre, open-label, randomized, parallel-group relative bioavailability study in healthy men. The study will be done in 2 parts, as follows:~Part 1 - single oral doses of 5 mg emodepside will be tested:~Part 1a - the LSF (reference formulation) and 2 new IR-tablet formulations (test formulations) will be administered in the fasted state.~Part 1b - the 2 new IR-tablet formulations will be administered in the fed state (high-fat, high-calorie meal).~Part 2 - single oral doses of 10 mg emodepside will be tested: depending on the results from Part 1, one or both IR-tablet formulations will be administered in the fasted state."||||
1316330|NCT03383510|Randomized|Parallel Assignment||Other||Single|||t|||
1316331|NCT03383497|||Cohort||Retrospective|||||||
1316332|NCT03383484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316333|NCT03383471|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t||t|
1316334|NCT03383458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316335|NCT03383445|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized in a 1:1 fashion to either TAVR or SAVR||||
1316336|NCT03383432|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316337|NCT03383419||Single Group Assignment||Prevention||None (Open Label)||||||
1316338|NCT03383406||Single Group Assignment||Treatment||None (Open Label)||||||
1316339|NCT03383393|||Cohort||Prospective|||||||
1316340|NCT03383380||Single Group Assignment||Treatment||None (Open Label)||||||
1316341|NCT03383367||Single Group Assignment||Screening||None (Open Label)||A prospective interventional study to evaluate the impact of a reminder sent by the Adémas-69 organization to improve coloscopy surveillance and compliance with recommendations for high risk of colorectal cancer people.||||
1316342|NCT03383354|||Cohort||Prospective|||||||
1316343|NCT03383341|Randomized|Crossover Assignment||Other||Triple|Recipes containing cricket powder were matched for taste, color, and texture to creat placebo intervention foods. All foods were prepared by study personnel and then blinded by a third party individual that was not directly associated with the study.|Randomized, placebo controlled crossover dietary intervention|t||t|t
1316344|NCT03383328|Randomized|Parallel Assignment||Prevention||Single||||||t
1316345|NCT03383315|Randomized|Parallel Assignment||Prevention||Triple|The study drugs were prepared under sterile conditions by a pharmacist independent to the study and kept in packs.The patients recruited were randomized to receive one of the study packs. The study pack were numbered by the pharmacist, who used a computer-generated random number sequence to assign treatment allocations. The allocation list was kept by the pharmacist. Treatment allocations were revealed only after study completion, when all outcome measurements had been performed and recorded by the investigator in the study database.|Patients are randomized into two groups. One group receives tramadol and metoclopramide, while another group receives tramadol and placebo (normal saline).|t|t|t|
1316346|NCT03383302||Single Group Assignment||Treatment||None (Open Label)||This is a single arm, phase Ib/II open label study of nivolumab administered on completion of SBRT to patients with early stage NSCLC.||||
1316347|NCT03383289|Randomized|Parallel Assignment||Prevention||Single|Research Assistants||t|||
1316348|NCT03383276||Sequential Assignment||Treatment||None (Open Label)||||||
1316349|NCT03383263|||Cohort||Prospective|||||||
1316350|NCT03383250||Single Group Assignment||Other||None (Open Label)||||||
1316351|NCT03383237||Single Group Assignment||Treatment||None (Open Label)||||||
1316352|NCT03383224|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized to genotype-guided therapy or standard of care||||
1316353|NCT03383211|||Case-Control||Prospective|||||||
1316354|NCT03383198|Randomized|Parallel Assignment||Treatment||Triple|Only anesthesiologist performing injection will be aware of which side is injected with each drug.||t|t||t
1316355|NCT03383185|||Cohort||Retrospective|||||||
1316356|NCT03383172|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316357|NCT03383159|||Case-Control||Cross-Sectional|||||||
1316358|NCT03383146|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1316359|NCT03383133||Single Group Assignment||Basic Science||None (Open Label)||This study will involve only a single individual.||||
1316459|NCT03381833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316460|NCT03381820|Randomized|Parallel Assignment||Treatment||Single||Randomised control trial||||t
1316360|NCT03383120|Randomized|Parallel Assignment||Treatment||Single|The treatment group will be concealed at all time points from both clinical examiners (N.C., A.Z.) and the biostatistician (D.C.). Only the operator (D.H.) will be aware of the type of treatment to be performed based on the computer-generated allocation table. The un-blinded operator will perform the first follow-up visit one week post-operatively to ensure blinding of the examiners.|Prospective, single-centre, superiority, randomized, controlled clinical trial||||t
1316361|NCT03383107|||Other||Prospective|||||||
1316362|NCT03383094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316363|NCT03383081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316364|NCT03383068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316365|NCT03383055||Single Group Assignment||Treatment||None (Open Label)||||||
1316366|NCT03383042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316367|NCT03383029||Single Group Assignment||Treatment||None (Open Label)||||||
1316368|NCT03383016|||Cohort||Prospective|||||||
1316369|NCT03383003|Randomized|Parallel Assignment||Treatment||Single|||||t|
1316370|NCT03382990|||Cohort||Retrospective|||||||
1316371|NCT03382977|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|None, open-label Allocation (FDAAA)|"3+ 3 Dose Escalation~Therapeutic Vaccine: VBI-1901~The vaccine is formulated with GM-CSF and administered intradermally (ID) to patients with recurrent GBM."||||
1316372|NCT03382964|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1316373|NCT03382951|||Other||Cross-Sectional|||||||
1316374|NCT03382938|Randomized|Parallel Assignment||Prevention||Double|Double (Investigator, Outcomes Assessor)|Parallel Assignment|||t|t
1316375|NCT03382925|Randomized|Parallel Assignment||Treatment||Single|Each subject will be randomized into a group assignment in a 1:1 manner, #1 or #2, as outlined in the Methods section.||t|||
1316376|NCT03382912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316377|NCT03382899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316378|NCT03382886||Single Group Assignment||Treatment||None (Open Label)||This is an open label, phase I study to test for maximum tolerated dose (MTD) or recommended phase II dose (RP2D)||||
1316379|NCT03382873|Randomized|Parallel Assignment||Prevention||Single||The proposed translational study applies an innovative experimental approach, an adaptive design, to optimize treatment for weight loss and weight loss maintenance in individuals with prediabetes. All participants will begin a standard lifestyle intervention to promote weight loss. Those who do not achieve >2.5% weight loss during the first month of the intervention will transition to augmented care to enhance weight loss during the intensive intervention phase. Following the intensive phase, participants will be randomly assigned to either the standard intervention or the enhanced intervention for the maintenance study phase. By randomly assigning participants to either the standard maintenance phase of the intervention or the innovative maintenance phase of the intervention following the initial core phase, the impact of extended training in self-regulation for weight loss maintenance will be evaluated.||||t
1316380|NCT03382860|||Cohort||Prospective|||||||
1316381|NCT03382847||Single Group Assignment||Treatment||None (Open Label)||||||
1316382|NCT03382834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316383|NCT03382821|Randomized|Parallel Assignment||Treatment||Single|Each subject will be randomized into a group assignment in a 1:1 manner, #1 or #2, as outlined in the Methods section|Prospective, randomized, comparative trial|t|||
1316384|NCT03382808|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1316385|NCT03382795||Single Group Assignment||Treatment||None (Open Label)||||||
1316386|NCT03382782|Randomized|Parallel Assignment||Treatment||None (Open Label)||The behavioral weight loss intervention (BWLI) consists of an 8-month intervention phase followed by a 4-month maintenance phase. The initial intervention phase comprises four types of contact: 1) One-hour group weight management class led by facilitator (once per week); 2) 45-minute physical activity class led by facilitator (1-2 per week); 3) 20-minute, individual visit with facilitator (once per month); 4) Weigh-in (once each week). Persons are randomly assigned to peer navigators to begin simultaneously with BWLI and run concurrently across the eight months of the intervention. PNs may work with participants to partner on BWLI homework, meet with participant and BWLI facilitator individually, attend health care appointments, and partner on tasks that arise out of those appointments.||||
1316387|NCT03382769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316388|NCT03382756|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1316389|NCT03382743|Randomized|Parallel Assignment||Prevention||Single||Randomized controlled trial|t|||
1316390|NCT03382730|Randomized|Parallel Assignment||Prevention||Single||Multi-centered stepped wedge cluster randomized controlled trial||||t
1316391|NCT03382717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316392|NCT03382704|||Case-Only||Prospective|||||||
1316393|NCT03382691||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316394|NCT03382678|||Case-Only||Cross-Sectional|||||||
1316395|NCT03382665|||Cohort||Prospective|||||||
1316396|NCT03382652|||Cohort||Prospective|||||||
1316397|NCT03382639|Randomized|Parallel Assignment||Other||Double|||t||t|
1316398|NCT03382626|Randomized|Parallel Assignment||Treatment||Triple||Prospective, double-blind, randomized, parallel, controlled study|t||t|t
1316399|NCT03382613|||Cohort||Prospective|||||||
1316400|NCT03382600|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316401|NCT03382587|||Cohort||Other|||||||
1316402|NCT03382574|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316403|NCT03382561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316454|NCT03381898||Single Group Assignment||Treatment||None (Open Label)|The outcomes assessment and the care providers will be blind to the aims of the study.|This is a feasibility and safety trial of a single arm a telehealth intervention (pharmacy, physical therapy, and speech therapy) to people with Parkinson's disease.||||
1316455|NCT03381885|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1316456|NCT03381872|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, open label, two-arm, randomized controlled trial||||
1316404|NCT03382548|Randomized|Parallel Assignment||Treatment||Double|Patients will be blinded to the study, as they will not be informed of the treatment duration and likely to be sedated and unaware of the treatment regimens. Investigators will be blinded during the assessment of the participants for clinical stability based on the above-described criteria to minimise observer bias. Once conditions for stopping antibiotics are satisfied, the investigator will be unblinded and contact the primary physicians to stop antibiotics. The physicians will remain blinded until they are informed that the participant is suitable to stop antibiotics.|Randomisation will be done via stratified block randomisation by the study sites to ensure participants with similar characteristics such as gender and age are distributed equally in the intervention and control groups. Randomisation will be done with a computer programme with a seed to allow reproducibility. Randomisation will be done with a 1:1 ratio.|t||t|
1316405|NCT03382535|Randomized|Parallel Assignment||Treatment||Single|Participants are not told what kind of a therapy they are receiving.|"Participants are randomly divided into three groups. Group 1: Voice therapy. Group 2: Voice therapy with carryover strategies (supplementary tasks and reminders).~Group 3. Controls. No treatment during control period. After the control period participants are having Voice therapy or Voice therapy with carryover strategies."|t|||
1316406|NCT03382522|||Cohort||Retrospective|||||||
1316407|NCT03382509|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1316408|NCT03382496|||Cohort||Prospective|||||||
1316409|NCT03382483|||Other||Other|||||||
1316410|NCT03382470|||Cohort||Prospective|||||||
1316411|NCT03382457||Single Group Assignment||Treatment||None (Open Label)||||||
1316412|NCT03382444|||Other||Prospective|||||||
1316413|NCT03382431|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316414|NCT03382418|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1316415|NCT03382405|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1316416|NCT03382392|||Cohort||Retrospective|||||||
1316417|NCT03382379|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1316418|NCT03382366|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316419|NCT03382353|Randomized|Parallel Assignment||Treatment||Single||||||t
1316420|NCT03382340||Single Group Assignment||Treatment||None (Open Label)||||||
1316421|NCT03382327||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316422|NCT03382314|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1316423|NCT03382301|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1316424|NCT03382288||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316425|NCT03382275|||Cohort||Prospective|||||||
1316426|NCT03382262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316427|NCT03382249|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316428|NCT03382236|Randomized|Parallel Assignment||Treatment||Single||||||t
1316429|NCT03382223|||Cohort||Prospective|||||||
1316430|NCT03382210|||Cohort||Prospective|||||||
1316431|NCT03382197|Randomized|Crossover Assignment||Treatment||Double|Two experienced researchers will participate in the study, one being responsible for the evaluation of the outcomes (researcher 1) and the other responsible for the application of the intervention in each patient (researcher 2). The researcher 2 will receive in opaque and sealed envelopes the randomized order of the interventions of each patient, keeping them in secrecy until the end of the whole study.|"Patients will be randomized regarding the order of intervention they will receive:~Group 1 - control intervention, will only perform nebulization; Group 2 - intervention, will perform nebulization associated with positive expiratory pressure valve in the airways (EPAP); Group 3 - intervention, will perform nebulization associated with non-invasive ventilation Bi-level mode;~All patients will be evaluated BEFORE, DURING and AFTER each intervention through Electrical Impedance Tomography, Pulmonary Scintigraphy and Spirometry."|||t|t
1316432|NCT03382184|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective, dual-arm study involving the Fraxel DUAL or Halo laser for the regrowth of hair after alopecia.||||
1316433|NCT03382171|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316434|NCT03382158|||Cohort||Retrospective|||||||
1316435|NCT03382145|||Cohort||Retrospective|||||||
1316436|NCT03382132|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1316437|NCT03382119|Non-Randomized|Parallel Assignment||Diagnostic||Single|data analysts will be blinded to the subject's cohort assignment|Subjects from two patient populations will be enrolled in order to test these two technologies.||||t
1316438|NCT03382106|Randomized|Parallel Assignment||Basic Science||Double|Subject and study team are masked to which arm subject is assigned (study drug or placebo). Investigational pharmacy will not be masked.||t||t|
1316439|NCT03382093|Randomized|Parallel Assignment||Treatment||Single||If participant meets eligibility criteria, the participant will be randomly assigned to complete a computer-delivered intervention: either the (a) Personalized Feedback Intervention or (b) smoking information control.|t|||
1316440|NCT03382080|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316441|NCT03382067|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1316442|NCT03382054|||Cohort||Retrospective|||||||
1316443|NCT03382041|Randomized|Parallel Assignment||Treatment||None (Open Label)||The investigators will compare intramedullary nailing( placing a rod in the tibia) of open and closed tibia shaft fractures with carbon fiber implant (tibial nail) versus titanium implant (tibial nail) in a Level I trauma setting.||||
1316444|NCT03382028|||Case-Only||Retrospective|||||||
1316445|NCT03382015|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1316446|NCT03382002|||Cohort||Prospective|||||||
1316447|NCT03381989||Single Group Assignment||Treatment||None (Open Label)||||||
1316448|NCT03381976|Randomized|Factorial Assignment||Treatment||Single|||||t|
1316449|NCT03381963|||Cohort||Prospective|||||||
1316450|NCT03381950|||Cohort||Prospective|||||||
1316451|NCT03381937|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||monocentric, open, randomize, crossover study||||
1316452|NCT03381924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573423|NCT00001287||||Treatment||||||||
1316461|NCT03381807||Single Group Assignment||Treatment||None (Open Label)||||||
1316462|NCT03381794|||Cohort||Other|||||||
1316463|NCT03381781||Single Group Assignment||Treatment||None (Open Label)||||||
1316464|NCT03381768||Single Group Assignment||Treatment||None (Open Label)||Fixed dose safety study||||
1316465|NCT03381755|Randomized|Parallel Assignment||Prevention||Single||||||t
1316466|NCT03381742|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1316467|NCT03381729|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316468|NCT03381716|||Cohort||Retrospective|||||||
1316469|NCT03381703|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1316470|NCT03381690|||Case-Control||Retrospective|||||||
1316471|NCT03381677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316472|NCT03381664|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1316473|NCT03381651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316474|NCT03381638|||Case-Only||Prospective|||||||
1316475|NCT03381625|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1316476|NCT03381612|||Other||Cross-Sectional|||||||
1316477|NCT03381599||Single Group Assignment||Other||None (Open Label)||||||
1316478|NCT03381586|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1316479|NCT03381573|||Cohort||Retrospective|||||||
1316480|NCT03381560|||Case-Only||Cross-Sectional|||||||
1316481|NCT03381547|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1316482|NCT03381534|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1316483|NCT03381521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316484|NCT03381508|||Cohort||Retrospective|||||||
1316485|NCT03381495|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316486|NCT03381482|||Cohort||Prospective|||||||
1316487|NCT03381469|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Three groups of patients will be examined parallel to each other||||
1316488|NCT03381456|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||10 patient with dystonia and 10 healthy subject paired by sex and age.||||
1316489|NCT03381443|||Cohort||Prospective|||||||
1316490|NCT03381430||Single Group Assignment||Treatment||None (Open Label)||||||
1316491|NCT03381417|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1316492|NCT03381404||Single Group Assignment||Other||None (Open Label)||Open Label||||
1316493|NCT03381391|Randomized|Parallel Assignment||Prevention||Single|||t|||
1316494|NCT03381378|||Cohort||Other|||||||
1316495|NCT03381365||Single Group Assignment||Treatment||None (Open Label)||||||
1316496|NCT03381352||Single Group Assignment||Treatment||None (Open Label)||||||
1316497|NCT03381339|Randomized|Parallel Assignment||Treatment||Single|examiners will be unaware of which toothbrush has been assigned to each subject|3 month home use parallel-arm design to assess the efficacy of powered toothbrush use in the treatment of gingivitis in a moderate sized population, n=70.|||t|
1316498|NCT03381326|||Case-Only||Prospective|||||||
1316499|NCT03381313||Single Group Assignment||Treatment||None (Open Label)||12 patients suffering from pure anomia in the chronic stage of the disease underwent a word repetition training with a computerized telemedicine protocol. Each patient trained two word sets, one in a conditioned and the other in a non-conditioned training modality; a third non trained set served as control.||||
1316500|NCT03381300||Single Group Assignment||Treatment||None (Open Label)||||||
1316501|NCT03381287|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1316502|NCT03381274|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316503|NCT03381261||Single Group Assignment||Basic Science||None (Open Label)||||||
1316504|NCT03381248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316505|NCT03381235|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316506|NCT03381222|||Cohort||Prospective|||||||
1316507|NCT03381209|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1316508|NCT03381196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316509|NCT03381183|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1316510|NCT03381170||Single Group Assignment||Treatment||None (Open Label)||||||
1316511|NCT03381157|||Case-Control||Prospective|||||||
1316512|NCT03381144|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316513|NCT03381131|||Case-Only||Cross-Sectional|||||||
1316514|NCT03381118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316515|NCT03381105|||Ecologic or Community||Prospective|||||||
1316516|NCT03381092|||Cohort||Prospective|||||||
1316517|NCT03381079|Randomized|Parallel Assignment||Treatment||Single||||||t
1316518|NCT03381066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316519|NCT03381053|||Cohort||Prospective|||||||
1316520|NCT03381040|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1316521|NCT03381027|Randomized|Parallel Assignment||Basic Science||Single|Neurodevelopmental assessors are blinded to interventional arm.|single centre, unblinded, randomised, controlled study to evaluate whether a multi-sensory enrichment programme in the first 4 months of life will improve sleep architecture and neurodevelopment in healthy infants.||||t
1316522|NCT03381014|||Cohort||Prospective|||||||
1316523|NCT03381001|Randomized|Parallel Assignment||Treatment||Triple||prospective, randomized, triple-blinded study|t||t|t
1316524|NCT03380988|Randomized|Crossover Assignment||Treatment||Single||||||t
1316600|NCT03380000|Randomized|Crossover Assignment||Basic Science||Double|Treatment order will be randomly assigned to participants by Clinical Research Center (CRC) staff using computer-based mathematical software. The generated list that determines each participants treatment order will be kept in a secure location in the CRC which cannot be accessed directly by research team members.||t||t|
1316601|NCT03379987|Randomized|Parallel Assignment||Treatment||Single||||||t
1573424|NCT00001285||||||||||||
1316525|NCT03380975||Single Group Assignment||Treatment||None (Open Label)|Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1 receptor.Montelukast should be taken once daily in the evening|Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1 receptor. Montelukast inhibits physiologic actions of LTD4 at the CysLT1 receptor without any agonist activity. As a result, bronchoconstriction is inhibited with decreased airway and blood eosinophil's leading to improved control over asthma and allergic rhinitis||||
1316526|NCT03380962||Single Group Assignment||Treatment||None (Open Label)||Ten enrolled study patients will receive study medication (Clazakizumab, Vitaeris Inc; Vancouver Canada, BC)||||
1316527|NCT03380949|Randomized|Parallel Assignment||Treatment||Double|Participants are not informed about the group assignement (intervention takes place in general anesthesia). Outcome assessors are persons without knowledge on former treatment in intervention/control group.|Participants are assigned to intervention groups by chance|t|||t
1316528|NCT03380936|Randomized|Parallel Assignment||Treatment||None (Open Label)||Only patients meeting histologic criteria for AMR by Banff 2013 criteria will be randomized (ptc + g + c4d ≥ 2). Subjects will be randomized to either undergo optimization (conversion to Envarsus with goal trough tacrolimus level > 8 ng/ml, mycophenolic acid at 720 mg, prednisone at current dose (5mg) or continue taper to 5mg per center standard of care protocol of or treatment.); or, to treat clinical AMR (antibody mediated rejection) with plasma exchange x 5 treatments, each followed by IVIG (intravenous immunoglobulin) 200 mg/kg except last dose of 1 gm/kg. Rituximab 375 mg/m2 following final plasma exchange treatment.||||
1316529|NCT03380923|Randomized|Parallel Assignment||Basic Science||Double|"Outcomes assessors analyzing biospecimen samples are blinded to the arm to which each participant has been randomly assigned when doing analysis.~Investigators are blinded to each participant's randomized assignment."|Randomized to moderate intensity vs. high-intensity exercise training prescription.|||t|t
1316530|NCT03380910|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316531|NCT03380897|Randomized|Factorial Assignment||Health Services Research||None (Open Label)|Open Label|Factorial assignment||||
1316532|NCT03380884|Randomized|Parallel Assignment||Treatment||Single||||||t
1316533|NCT03380871||Single Group Assignment||Treatment||None (Open Label)||||||
1316534|NCT03380858|||Cohort||Prospective|||||||
1316535|NCT03380845|Randomized|Parallel Assignment||Treatment||Double||Randomized split-face clinical trial|t|||t
1316536|NCT03380832|||Case-Only||Cross-Sectional|||||||
1316537|NCT03380819||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316538|NCT03380806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316539|NCT03380793||Single Group Assignment||Treatment||None (Open Label)||||||
1316540|NCT03380780||Single Group Assignment||Treatment||None (Open Label)||||||
1316541|NCT03380767|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pragmatic randomized controlled trial||||
1316542|NCT03380754|Randomized|Parallel Assignment||Prevention||Quadruple|Research assistant who is not involved in any of the patients clinical care is responsible for randomization collection of data. All others are blinded to the groups involved.|Prospective, randomized, double blinded, placebo controlled trial|t|t|t|t
1316543|NCT03380741|||Other||Prospective|||||||
1316544|NCT03380728|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1316545|NCT03380715|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1316546|NCT03380702|Randomized|Parallel Assignment||Treatment||Triple||RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED TRIAL|t|t|t|
1316547|NCT03380689||Single Group Assignment||Treatment||None (Open Label)||||||
1316548|NCT03380676|||Case-Control||Prospective|||||||
1316549|NCT03380663|Randomized|Parallel Assignment||Prevention||None (Open Label)||A multi-center randomized control study, including single-treatment and repeated treatment trials on individuals suffering from heart failure and healthy control subjects.||||
1316550|NCT03380650|Randomized|Parallel Assignment||Treatment||Single|only the doctor know the group the patient goes into||t|||
1316551|NCT03380637|||Case-Control||Prospective|||||||
1316552|NCT03380624|Randomized|Crossover Assignment||Treatment||Single|Investigator instills eye drop masked to participant|Single masked, randomized|t|||
1316553|NCT03380611|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1316554|NCT03380598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316555|NCT03380585|Randomized|Parallel Assignment||Treatment||Single|Single-blinded (Participant)||t|||
1316556|NCT03380572|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1316557|NCT03380559|Randomized|Parallel Assignment||Treatment||Quadruple||Ratio 1:1:1|t|t|t|t
1316558|NCT03380546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316559|NCT03380533|Randomized|Parallel Assignment||Treatment||Triple||Randomized Controlled Trial|t|t|t|
1316560|NCT03380520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316561|NCT03380507|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label, prospective, randomized, two-arm parallel-group trial||||
1316562|NCT03380494|Randomized|Parallel Assignment||Treatment||Triple||Double blind, randomised controlled trial|t||t|t
1316563|NCT03380481|||Cohort||Prospective|||||||
1316564|NCT03380468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316565|NCT03380455||Sequential Assignment||Other||None (Open Label)||Fixed sequence||||
1316566|NCT03380442|Randomized|Parallel Assignment||Basic Science||Quadruple|Since the psilocybin is ingested orally in capsule form, whereas ketamine is administered intranasally, the participants will either receive a placebo capsule containing microcrystalline cellulose (if they belong to the group receiving ketamine), or intranasally administered saline solution (with added bitter flavoring which will mimic the taste of ketamine that is often detectable even when administered intranasally).|In a randomized, double-blind placebo-controlled design, 20 of the participants will receive ketamine, and 20 will receive psilocybin. 20 of the participants will be included in the study as a no-treatment group, so that natural time-dependent changes in depressive symptoms can be controlled for and thus the antidepressive effects of ketamine and psilocybin treatment can be verified. The no-treatment group will only attend the initial clinical interviews, and their depressive symptoms will be assessed remotely.|t|t|t|t
1316567|NCT03380429|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible subjects will receive RELVAR/BREO maintenance therapy via ELLIPTA DPI and salbutamol rescue medication via MDI. Clip-on sensors will be attached to both inhalers which will provide data on maintenance therapy and rescue medication use to the subjects and their HCP. Subjects will be randomized into five treatment arms in a ratio of 1:1:1:1:1 depending on whether the data, from RELVAR/BREO ELLIPTA or RELVAR/BREO ELLIPTA and salbutamol MDI, is fed back to the subject or subject and HCP, or not at all.||||
1316568|NCT03380416|Randomized|Parallel Assignment||Treatment||Double||||t||t
1316569|NCT03380403|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||non-randomized clinical trial||||
1316570|NCT03380390||Single Group Assignment||Treatment||None (Open Label)||||||
1316571|NCT03380377||Single Group Assignment||Treatment||None (Open Label)||All ten patients enrolled will receive study medication (Clazakizumab, Vitaeris, Inc, Vancouver, Canada, B.C)||||
1316572|NCT03380364||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316573|NCT03380351|||Case-Only||Prospective|||||||
1316574|NCT03380338||Single Group Assignment||Treatment||None (Open Label)||||||
1316575|NCT03380325|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1316576|NCT03380312|||Cohort||Prospective|||||||
1316577|NCT03380299|||Other||Cross-Sectional|||||||
1316578|NCT03380286|||Cohort||Prospective|||||||
1316579|NCT03380273|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)|It is that preventino measures are enforced in the hospital. This will apply to all patients and no masking is required.|During two years, patients with fractures are recorded and the occurence of surgical site infections (SSI) in these patients is monitored in different sites over the world. After two years, a bundle of known prevention measures are teached and enforced in these sites. Then the occurence of SSI in fracture patients is monitored for another two years to see whether the bundle decreased the SSI occurence.||||
1316580|NCT03380260|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1316581|NCT03380247|||Case-Only||Prospective|||||||
1316582|NCT03380234|Randomized|Parallel Assignment||Prevention||Double|All participants will be told that they will be randomly allocated to one of two interventions, and will be advised not to discuss with other parents and students about the intervention. The group status of hair samples will not be revealed to the Laboratory. Variables applicable only to the intervention arm (e.g. process evaluation items) will be kept in a separate data set, and the data analysts will be blinded to the group status of the data sets.|Cluster randomised controlled trial|t||t|
1316583|NCT03380221|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1316584|NCT03380208|||Cohort||Prospective|||||||
1316585|NCT03380195|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1316586|NCT03380182|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316587|NCT03380169|Randomized|Parallel Assignment||Prevention||Single|Patients do not know which group they belongs to, and all wounds (for both experimental and control group) will be covered by gauze dressing at the top.|This is a single-blind two-arm parallel randomized controlled trial on occlusive ionic silver-containing dressing conducted in Princess Margaret Hospital (PMH). PMH is a major acute general hospital in Kowloon West Cluster in Hong Kong, providing 1,542 beds to maintain a wide range of specialist care. There are around 150 abdominal colorectal surgery provided every year in our department. Both the subjects, data collectors and outcome assessors will be blinded to the type of dressing being used. Eligible inpatients receiving colorectal surgery from the department of surgery will be consecutively recruited in each surgical ward (namely, A4 ward, B4 ward and CD4 ward).|t|||
1316588|NCT03380156|Randomized|Crossover Assignment||Treatment||Triple|Blinding will be done so the investigator performing the FMD and PWA testing will be blinded to the allocation of TNS||t||t|t
1316589|NCT03380143|Randomized|Parallel Assignment||Prevention||None (Open Label)||This design can be described as a staggered-start, stepped-wedge, community randomized trial. The design includes two sequential intervention waves.||||
1316590|NCT03380130||Single Group Assignment||Treatment||None (Open Label)||||||
1316591|NCT03380117|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||In eBridge, students take an online screen and receive personalized feedback about their self-reported depression, alcohol/substance use, and level of functioning. Students are randomly assigned to either the eBridge or control condition. In the eBridge condition, personalized feedback is provided in a graphic format that is accompanied by motivational-interviewing-adherent statements. In this condition, students' communications with eBridge counselors will occur via online dialogues, in which students and counselors exchange messages using a secure website. In the control condition, personalized feedback will also be delivered online to students, highlighting their personal data and specify links between key screening variables and negative outcomes. However, in the control condition, this is provided in a straightforward graphic, informational format, which is consistent with standard practice in online screening programs for college students.||||
1316592|NCT03380104||Single Group Assignment||Basic Science||None (Open Label)||All subjects enrolled in this study will undergo Intradural Spinal Cord Stimulation.||||
1316593|NCT03380091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316594|NCT03380078|Randomized|Parallel Assignment||Health Services Research||Single|Coders assessing provider outcomes are masked from study condition and aims.|We will use a randomized factorial dismantling design to examine the independent and combined effectiveness of the TEAMS modules. MH programs (AIM HI study) and School districts (CPRT study) from San Diego, Sacramento, and LA Counties will be randomized to one of four conditions (STANDARD EBI-specific training only (control condition); TIPS (Motivational Module); TLI (LOCI Implementation Leadership Module).||||t
1316595|NCT03380065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316596|NCT03380052|||Case-Control||Prospective|||||||
1316597|NCT03380039||Single Group Assignment||Treatment||None (Open Label)||||||
1316598|NCT03380026|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||open-label, split-face study||||
1316599|NCT03380013||Single Group Assignment||Treatment||None (Open Label)||Infants recruited for this study are treated with OMT upon completion of hypothermia. They are compared 1:3 with matched historical controls.||||
1316789|NCT03377543|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1316602|NCT03379974|Randomized|Crossover Assignment||Treatment||None (Open Label)|The randomization of the participant to a study arm will be done prior to the study visit by the pharmacy at the hospital. The Investigator and study team will know the arm each participant is in before the patient's visit. This information will also be provided to the participant before the visit.|||||
1316603|NCT03379961|||Other||Prospective|||||||
1316604|NCT03379948|||Other||Prospective|||||||
1316605|NCT03379935|||Cohort||Retrospective|||||||
1316606|NCT03379922|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316607|NCT03379909||Single Group Assignment||Treatment||None (Open Label)||||||
1316608|NCT03379896|||Cohort||Prospective|||||||
1316609|NCT03379883|Randomized|Parallel Assignment||Supportive Care||Single|Single blind (investigator) study||||t|
1316610|NCT03379870|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316611|NCT03379857||Single Group Assignment||Prevention||None (Open Label)||Cannabis User||||
1316612|NCT03379844||Single Group Assignment||Treatment||None (Open Label)||||||
1316613|NCT03379831|||Case-Only||Prospective|||||||
1316614|NCT03379818|Randomized|Parallel Assignment||Treatment||Single|Participants will be randomly assigned to one of two posible groups. In both groups, they will receive an intervention, however participants and their parents will not know which one. At the end of the study, participants and their parents will be informed about which group they were in and a document containing a detailed description of each intervention will be provided to them.|Over a series of 9 weekly sessions, children diagnosed as Late Talkers will be assessed in different tasks that can be divided into 5 phases: Vocabulary and developmental assessments, initial cognitive assessments, training sessions, word learning test 1, and word learning test 2. Each group (shape training group and specific word training group) will receive a different training programme, however the other assessments will be identical across the groups. In the shape training group, participants will be taught to attend to shape when learning and extending novel labels. In the specific word training group, participants will be taught specific words that they do not know. Before and after the intervention, participants vocabulary will be assessed to compare which intervention enhances word learning. One year later, all participants will be assessed with a language test and a cognitive test. The same assessments will be used in both groups.|t|||
1316615|NCT03379805|||Case-Control||Cross-Sectional|||||||
1316616|NCT03379792|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1316617|NCT03379779|||Case-Only||Prospective|||||||
1316618|NCT03379766|Randomized|Crossover Assignment||Treatment||Single|||t|||
1316619|NCT03379753|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316620|NCT03379740|Randomized|Parallel Assignment||Other||None (Open Label)|This is an open-label study; however the site (except the pharmacy staff preparing the IPs for administration) will be masked to the randomization sequences until they are assigned. Subjects will not be informed of the complete sequence to which they have been assigned to receive the P4M3 products.|||||
1316621|NCT03379727||Single Group Assignment||Treatment||None (Open Label)||"Considering the limited safety impact and the significant clinical benefit of the addition of midostaurin to the standard 7+3 regimen in the RATIFY study (CPKC412A2301), this Phase IIIb study is designed as a single arm study and allows the assessment of variation of the 7+3 regimen in an extended patient population compared to RATIFY (higher dose of daunorubicin (60-90 mg/m2/day), the substitution of daunorubicin by idarubicin (12mg/m2/day), and lower dose of cytarabine (100-200 mg/m2/day) and the 5+2 reduced dose regimen). Safety is the primary endpoint. CR/CRi (see Section 7.2.1) in induction, consolidation and maintenance therapy is collected as secondary endpoint.~Patients who are newly diagnosed with AML, have a known FLT3 ITD or TKD, mutation and have recently started on 7+3 or 5+2 in induction and high dose of cytarabine in consolidation will be consented and screened for the clinical study.~Number of Arms:~1"||||
1316622|NCT03379714|||Case-Only||Prospective|||||||
1316623|NCT03379701|||Cohort||Prospective|||||||
1316624|NCT03379688|||Cohort||Retrospective|||||||
1316625|NCT03379675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316626|NCT03379662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316627|NCT03379649|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded to the treatment they received, but providers and investigators will be aware.|||t||
1316628|NCT03379636|Randomized|Crossover Assignment||Treatment||Double|The physiotherapist who applied the tape was not blinded but he did not participate in outcome assessment. The main investigator who collected the data was blind as subjects wore a long-sleeve shirt which hid the tape and the tape was administered behind a folding screen.|"All subjects were tested without tape, with kinesiotape (KT) and with a sham tape (ST). KT and ST were applied in a randomized order.~The sequence always began with the NT condition. Then the two tapes were applied in a randomized order and the subjects repeated the same procedure. Group allocation, KT vs ST group, corresponded to the last tape the subject received and had to wear for the next three days. A computer block (n=8) randomization process was performed and sealed opaque envelopes were used."|||t|t
1316629|NCT03379623|Randomized|Parallel Assignment||Supportive Care||Double|Randomization will be performed by an independent person from Kulliyyah of Nursing research unit. The researcher will not be involved in allocation to intervention or control group. The participants will be advised not to talk about the study during assessments to prevent unblinding.||t||t|
1316630|NCT03379610|||Case-Only||Prospective|||||||
1316631|NCT03379597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316632|NCT03379584||Single Group Assignment||Treatment||None (Open Label)||||||
1316633|NCT03379571|||Cohort||Prospective|||||||
1316634|NCT03379558|||Cohort||Prospective|||||||
1316635|NCT03379545||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316636|NCT03379532|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1316637|NCT03379519|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1316638|NCT03379506||Single Group Assignment||Treatment||None (Open Label)||||||
1316639|NCT03379493||Sequential Assignment||Treatment||None (Open Label)||||||
1316640|NCT03379480|Randomized|Parallel Assignment||Treatment||Single||||||t
1316790|NCT03377530|||Cohort||Retrospective|||||||
1573425|NCT00001280||||Treatment||||||||
1316641|NCT03379467|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|The allocation sequence will be concealed from the study staff responsible for screening and enrolling participants in serially numbered, opaque, sealed envelopes.|This is an individually randomized, three-arm parallel group design randomized control trial with equal allocation in the two treatment groups and control group. The parents of infants in SMS and interactive reminder groups will receive 3-5 reminders for scheduled follow-up immunization visits. The difference in between SMS and interactive reminders is that parents in SMS reminders are not asked to respond back to SMS reminders. The infants in control group will carry out routine follow-ups without any added intervention.||||
1316642|NCT03379454|||Ecologic or Community||Prospective|||||||
1316643|NCT03379441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316644|NCT03379428|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"This is a Phase I/II, open-label, unblinded, nonrandomized, standard 3+3 dose-escalation study designed to evaluate the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT) of ibrutinib (560 or 840 or 420 mg QD) given orally in combination with trastuzumab (8 mg/kg loading dose followed by 6 mg/kg q3w) administered intravenously (IV) in patients with HER2-amplified MBC.~Once the recommended phase II dose of ibrutinib plus trastuzumab has been determined (no more than 1 of 6 patients with dose-limiting toxicity) in the required 6 to 18 patients over the 3 possible dose levels, additional patients will be enrolled on the phase II part of the study at the recommended phase II dose of ibrutinib plus trastuzumab, for a maximum of 51 patients total."||||
1316645|NCT03379415|Randomized|Parallel Assignment||Treatment||Single|Only the participant is blinded to the randomization|Testing meniscus patients for several different shoes|t|||
1316646|NCT03379402|||Case-Only||Prospective|||||||
1316647|NCT03379389|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316648|NCT03379376||Single Group Assignment||Supportive Care||None (Open Label)||||||
1316649|NCT03379363|||Case-Only||Retrospective|||||||
1316650|NCT03379350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316651|NCT03379337||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316652|NCT03379324|Randomized|Parallel Assignment||Treatment||Double|Eligible patients will be randomized to FlōGraft®-augmented repair versus repair alone. Surgeons cannot be blinded to treatment; however, follow-up MRIs will be assessed by blinded radiologists.|This will be a stratified, randomized, radiograph and patient blinded, prospective trial enrolling 260 subjects undergoing rotator cuff repair|t|||t
1316653|NCT03379311||Single Group Assignment||Other||None (Open Label)||||||
1316654|NCT03379298|||Cohort||Retrospective|||||||
1316655|NCT03379285|||Cohort||Retrospective|||||||
1316656|NCT03379272|||Case-Only||Cross-Sectional|||||||
1316657|NCT03379259|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316658|NCT03379246|||Cohort||Retrospective|||||||
1316659|NCT03379233|Randomized|Parallel Assignment||Device Feasibility||Single|||t|||
1316660|NCT03379220|||Cohort||Prospective|||||||
1316661|NCT03379207|||Case-Control||Prospective|||||||
1316662|NCT03379194|Randomized|Parallel Assignment||Health Services Research||Triple|For final data analysis the biostatistician will be blinded for treatment allocation of physicians.||t||t|t
1316663|NCT03379181||Single Group Assignment||Basic Science||None (Open Label)||||||
1316664|NCT03379168|Randomized|Parallel Assignment||Treatment||Single|It is not feasible to blind patients who are randomized to receive Lipogems, as adipose tissue must be obtained from the participant. However, patients randomized to receive intra-articular corticosteroids or placebo injections will be blinded.|This study will be conducted as a randomized, placebo-controlled clinical trial. Patients will be randomized to receive either Lipogems, intra-articular corticosteroids, or a placebo injection of saline. Lipogems is cleared for use by the FDA in orthopaedics and arthroscopy and is offered as a treatment option for knee osteoarthritis. This study will be evaluating the effectiveness (not safety) of Lipogems when compared to corticosteroids and placebo. Thus, no information will be submitted to the FDA.|t|||
1316665|NCT03379155|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial design, comparing to a waitling list||||
1316666|NCT03379142||Single Group Assignment||Health Services Research||None (Open Label)||||||
1316667|NCT03379129|||Cohort||Prospective|||||||
1316668|NCT03379116|||Case-Only||Retrospective|||||||
1316669|NCT03379103|Randomized|Parallel Assignment||Treatment||Single|Statistical analysis will not open label for group allocation|"Patients will be allocated by means of a randomized table in 2 groups:~GP - patients will be anesthetized with sevoflurane associated with subarachnoid anesthesia and will be preconditioned with 1 MAC sevoflurane for 15 minutes before the installation of ischemia by tourniquete~GC - patients will be anesthetized with sevoflurane associated with subarachnoid anesthesia"||||t
1316670|NCT03379090|||Case-Only||Cross-Sectional|||||||
1316671|NCT03379077|Randomized|Parallel Assignment||Other||Single|researchers doing outcome assessment will be kept blind on both implementation groups|||||t
1316672|NCT03379064|Randomized|Parallel Assignment||Treatment||Single||||||t
1316673|NCT03379051||Single Group Assignment||Treatment||None (Open Label)||||||
1316674|NCT03379038|Randomized|Crossover Assignment||Prevention||None (Open Label)||The two groups were progressive physical therapy group and maintenance physical therapy group. For any given subject, spasticity, defecation frequency and constipation severity evaluations were completed on the same day. Each subject in PPT group completed 6 weeks of physical therapy sessions which were aimed to decrease spasticity, increase ROM, and improve strength and functional activity level. Each subject was evaluated for changes in symptoms on, 2nd week, 4th week and 6th week. In MPT group same protocol was used but the aim was to maintain current status of level of spasticity, ROM, strength and functional activity. After 6 weeks of physical therapy sessions were completed both groups underwent a 2-week washout period to eliminate the effects of 6-week physical therapy. After the washout period subjects were crossed over from PPT group to MPT group and vice versa.||||
1316675|NCT03379025|Randomized|Parallel Assignment||Other||Single|||t|||
1316676|NCT03379012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316677|NCT03378999|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1316678|NCT03378986|||Cohort||Prospective|||||||
1316971|NCT03375177|||Cohort||Prospective|||||||
1316679|NCT03378973|Randomized|Parallel Assignment||Other||Single|The anesthesiologist administering anesthetic agents will have knowledge of their doses. The technologist performing motor evoked potential testing and other participants will not.||||t|
1316680|NCT03378960||Sequential Assignment||Other||None (Open Label)||This was a single-dose, open-label, bioavailability study of surgical group and controls.||||
1316681|NCT03378947|||Other||Retrospective|||||||
1316682|NCT03378934|Randomized|Parallel Assignment||Treatment||None (Open Label)||"On the first day of the treatment period (Visit 1), eligible patients will be randomized into the Berberine Arm and the Control Arm.~In the Berberine Arm, patients will receive berberine 200 mg twice daily for 4±1 weeks (Stage 1); then, 300 mg twice daily for 4±1 weeks (Stage 2); then, 400 mg twice daily for 4±1 weeks (Stage 3) in addition to standard treatment, including aspirin 100 mg once daily and clopidogrel 75 mg once daily for 12±1 weeks.~In the Control Arm, patients will receive standard treatment, including aspirin 100 mg once daily and clopidogrel 75 mg once daily for 12±1 weeks."||||
1316683|NCT03378921|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1316684|NCT03378908|Randomized|Crossover Assignment||Supportive Care||None (Open Label)|Glycemic profile will be collected with a blind-sensor during the study.|||||
1316685|NCT03378895||Single Group Assignment||Prevention||None (Open Label)|No masking|||||
1316686|NCT03378882|||Cohort||Prospective|||||||
1316687|NCT03378869|||Case-Only||Retrospective|||||||
1316688|NCT03378856|||Cohort||Prospective|||||||
1316689|NCT03378843|||Cohort||Prospective|||||||
1316690|NCT03378830|||Cohort||Prospective|||||||
1316691|NCT03378817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Pilot study, case matched (1:2)||||
1316692|NCT03378804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316693|NCT03378791|Randomized|Parallel Assignment||Treatment||Single||||||t
1316694|NCT03378778|||Case-Control||Prospective|||||||
1316695|NCT03378765|||Cohort||Prospective|||||||
1316696|NCT03378752|||Cohort||Prospective|||||||
1316697|NCT03378739|||Other||Prospective|||||||
1316698|NCT03378726|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1316699|NCT03378713|Randomized|Parallel Assignment||Treatment||Single|||||t|
1316700|NCT03378700|Randomized|Parallel Assignment||Supportive Care||Single|The principal investigator and the nurse providing the intervention are aware of the patient group assignment. Assessment of the baseline and endpoints of the patient outcomes will be performed by an independent research assistant blinded to group allocation, who was not involved in the intervention.|This study is a single-blinded randomised controlled trial. On completion of the baseline assessment and the screening procedure, eligible participants will be randomly assigned in equal number into either a brief hope intervention (BHI) or the control group using sets of computer-generated random numbers.||||t
1316701|NCT03378687|||Cohort||Retrospective|||||||
1316702|NCT03378674|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1316703|NCT03378661|Randomized|Parallel Assignment||Treatment||Quadruple|Double Dummy|Parallel Assignment|t|t|t|t
1316704|NCT03378648|Randomized|Sequential Assignment||Treatment||Quadruple|"Part 1 double-blind~Part 2 double-blind~Part 3 placebo-controlled (double-blind), active-controlled (open labelled)"|"Part 1 alternating cross-over design~Part 2 parallel group design~Part 3 3-way cross-over design"|t|t|t|t
1316705|NCT03378635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316706|NCT03378622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316707|NCT03378609||Sequential Assignment||Health Services Research||None (Open Label)||||||
1316708|NCT03378596|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1316709|NCT03378583|||Cohort||Prospective|||||||
1316710|NCT03378570|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316711|NCT03378557|||Case-Only||Prospective|||||||
1316712|NCT03378544|Randomized|Parallel Assignment||Treatment||Single||A cluster randomized controlled trial||||t
1316713|NCT03378531||Single Group Assignment||Treatment||None (Open Label)||||||
1316714|NCT03378518|||Other||Retrospective|||||||
1316715|NCT03378505|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants will be randomly assigned to two conditions. Half of the participants will be required to use a daily check-in mobile app that promotes alignment of daily behaviors with their individualized life purpose. The other half of participants will complete brief bi-weekly reflections. Alternative assignment provided for non-participating students.||||
1316716|NCT03378492|Randomized|Parallel Assignment||Other||Single||||||t
1316717|NCT03378479|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316718|NCT03378466|Randomized|Parallel Assignment||Treatment||Single||||||t
1316719|NCT03378453|Non-Randomized|Parallel Assignment||Other||Single||||||t
1316720|NCT03378440|||Cohort||Prospective|||||||
1316721|NCT03378427||Single Group Assignment||Treatment||None (Open Label)||Pilot study||||
1316722|NCT03378414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316723|NCT03378401|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1316724|NCT03378388|||Cohort||Prospective|||||||
1316725|NCT03378375|||Cohort||Retrospective|||||||
1316726|NCT03378362||Single Group Assignment||Treatment||None (Open Label)||||||
1316727|NCT03378349|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1316728|NCT03378336|||Cohort||Prospective|||||||
1316729|NCT03378323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316730|NCT03378310|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1316731|NCT03378297|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||The first 15 patients (5 at each site) will be feasibility study cohort. Each treatment Group will be ditributed to 32 women.||||
1316732|NCT03378284|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1316733|NCT03378271||Single Group Assignment||Treatment||None (Open Label)||||||
1316734|NCT03378258|||Cohort||Prospective|||||||
1316735|NCT03378245||Single Group Assignment||Supportive Care||||||||
1316881|NCT03376347|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316736|NCT03378232|Randomized|Parallel Assignment||Treatment||Double|Participant as well as student investigators were blinded to the treatment randomization.||t||t|
1316737|NCT03378219|||Cohort||Prospective|||||||
1316738|NCT03378206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316739|NCT03378193|||Cohort||Retrospective|||||||
1316740|NCT03378180|||Cohort||Retrospective|||||||
1316741|NCT03378167|Randomized|Crossover Assignment||Treatment||Triple|"COLONOSCOPY:~Microbial enemas are drawn up in a 500cc syringe that is concealed with an opaque bag, used to infuse contents through the colonoscope. This will insure contents are blinded to non-study personnel in the room~Patients randomized to the control study arm will have identical concealment of the 500cc syringe used to infuse contents through the colonoscope. For the NS infusion, study personnel will add an additional 0.75 ml of commercially available (Club House® brand), food-grade food coloring (2 drops red, 3 drops green, 7 drops yellow) to confer a brown color to the clear normal saline solution. This step will maintain blinding for the patient and non-study personnel in the room, as the contents of the liquid will be visible endoscopically, but will still retain a similarly-colored brown appearance akin to human stool.~ORAL CAPSULAR THERAPY:~a), b) The opaque color of both the OMC and OPC will insure that blinding is preserved to the study patient."|"Patients will be randomized 2:1 to one of two groups upon consent: intervention or control. 30 patients will be randomized to receive an FMT via colonoscopy + oral microbiota capsular (OMC) therapy (INTERVENTION), and 15 patients will be randomized to receive normal saline (NS) via colonoscopy + dextrose-containing oral capsules (oral placebo capsule, OPC) (CONTROL). Randomization will occur through a computer-generated block-randomization pattern (block size = 6 participants).~Patients randomized to the control group will be given the option of receiving open-label treatment, with the intervention therapy, either: upon completion of the trial, or if they are removed from the trial due to disease exacerbation or other adverse event, at the discretion of their primary gastroenterologist."|t|t||t
1316742|NCT03378154|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1316743|NCT03378141|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316744|NCT03378128||Single Group Assignment||Treatment||None (Open Label)||||||
1316745|NCT03378115|||Other||Other|||||||
1316746|NCT03378102||Single Group Assignment||Supportive Care||None (Open Label)||||||
1316747|NCT03378089|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316748|NCT03378076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316749|NCT03378063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316750|NCT03378050|Randomized|Parallel Assignment||Supportive Care||Single||A randomized, controlled trial (RCT) will be used to compare a 12-week intervention group with a waiting-list control group.||||t
1316751|NCT03378037|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316752|NCT03378024|||Case-Only||Prospective|||||||
1316753|NCT03378011|Randomized|Parallel Assignment||Treatment||Single||||||t
1316754|NCT03377998|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1316755|NCT03377985|Randomized|Parallel Assignment||Other||||||||
1316756|NCT03377972|||Cohort||Other|||||||
1316757|NCT03377959|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1316758|NCT03377946|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316759|NCT03377933||Single Group Assignment||Treatment||None (Open Label)||Single-center exploratory study||||
1316760|NCT03377920||Single Group Assignment||Other||None (Open Label)||||||
1316761|NCT03377907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316762|NCT03377894|Randomized|Parallel Assignment||Other||Double|||t|||t
1316763|NCT03377881|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Two-step design with a first step using paired design for blood-analysis and a second step using randomisation between prostate biopsy strategy.||||
1316764|NCT03377868|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Observational study of a cohort of patients with amyotrophic lateral sclerosis compared to a parallel cohort of healthy age and sex matched subjects||||
1316765|NCT03377855||Single Group Assignment||Other||None (Open Label)||This is a interrupted time series study model with one study group.||||
1316766|NCT03377842|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316767|NCT03377829|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1316768|NCT03377816|Randomized|Parallel Assignment||Supportive Care||Double|The control group is designed to be similar to the intervention, participants will be engaged in interacting with art materials. Research assistants will be blinded to group allocation when collecting data.||t|||t
1316769|NCT03377803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316770|NCT03377790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316771|NCT03377777|||Cohort||Cross-Sectional|||||||
1316772|NCT03377764|||Case-Control||Prospective|||||||
1316773|NCT03377751|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316774|NCT03377738|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1316775|NCT03377725|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316776|NCT03377712|||Cohort||Prospective|||||||
1316777|NCT03377699|Randomized|Parallel Assignment||Treatment||None (Open Label)|Sponsor staff involved in the clinical trial is masked according to company standard procedures.|||||
1316778|NCT03377686|||Case-Control||Cross-Sectional|||||||
1316779|NCT03377673|||Case-Only||Prospective|||||||
1316780|NCT03377660|||Cohort||Prospective|||||||
1316781|NCT03377647|||Other||Prospective|||||||
1316782|NCT03377634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316783|NCT03377621||Single Group Assignment||Treatment||None (Open Label)||One group will receive intervention and will be evaluated before and after intervention.||||
1316784|NCT03377608|||Case-Control||Cross-Sectional|||||||
1316785|NCT03377595|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316786|NCT03377582|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1316787|NCT03377569|||Case-Only||Prospective|||||||
1316788|NCT03377556||Single Group Assignment||Treatment||None (Open Label)||||||
1316791|NCT03377517||Single Group Assignment||Treatment||None (Open Label)||Patients will be treated to a dose of 150 Gy in a single fraction. All patients will undergo CT simulation with 1 mm slices as well as MRI simulation including at least high resolution 1 mm slice T1 weighted MRI. They will be treated in a supine position using an aquaplast mask system for immobilization.||||
1316792|NCT03377504|Randomized|Parallel Assignment||Treatment||Single|single blind (outcomes assessor)|Prospective randomized single blind controlled study||||t
1316793|NCT03377491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316794|NCT03377478||Single Group Assignment||Treatment||None (Open Label)||||||
1316795|NCT03377465|Non-Randomized|Parallel Assignment||Prevention||Single|||||t|
1316796|NCT03377452|Randomized|Parallel Assignment||Treatment||Double|Participants and outcome assessors will be blinded to group assignment.|Individuals will be assigned to one of two educational programs simultaneously|t|||t
1316797|NCT03377439|||Cohort||Prospective|||||||
1316798|NCT03377426|Randomized|Parallel Assignment||Basic Science||Single|A blinded evaluator will perform the safety and efficacy assessments|||||t
1316799|NCT03377413|||Case-Only||Cross-Sectional|||||||
1316800|NCT03377400||Single Group Assignment||Treatment||None (Open Label)||||||
1316801|NCT03377387||Single Group Assignment||Treatment||None (Open Label)||This is a phase Ib/II study of capecitabine 7/7 with neratinib in patients with HER2-positive metastatic breast cancer.||||
1316802|NCT03377374|Randomized|Parallel Assignment||Treatment||Quadruple|Randomization list will by assembled by independient organization not related with participant, care provider, investigators or sponsors. eCRF will include randomization selection|Randomized controlled trial, double blind allocation concealment, parallel assignment|t|t|t|t
1316803|NCT03377361|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316804|NCT03377348||Single Group Assignment||Treatment||None (Open Label)||||||
1316805|NCT03377335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316806|NCT03377322|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded|Placebo Controlled|t|t|t|t
1316807|NCT03377309||Single Group Assignment||Treatment||None (Open Label)||||||
1316808|NCT03377296||Single Group Assignment||Other||None (Open Label)||||||
1316809|NCT03377283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316810|NCT03377270|Randomized|Crossover Assignment||Treatment||Single|outcomes assessor (those completed the swallow studies, those scoring)|Randomized-controlled trial with 2 arms (intervention and control)||||t
1316811|NCT03377257|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1316812|NCT03377244|||Cohort||Prospective|||||||
1316813|NCT03377231|Non-Randomized|Parallel Assignment||Other||None (Open Label)||The study involved the use of Stratamark® in prevention and treatment of stretch marks in 2 study arms.||||
1316814|NCT03377218|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1316815|NCT03377205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316816|NCT03377192|||Case-Only||Prospective|||||||
1316817|NCT03377179||Single Group Assignment||Treatment||None (Open Label)||This will be a single-arm Phase IIA study with all participants receiving ABC294640, continuously administered in 28 day cycles, until disease progression, unacceptable toxicity or voluntary withdrawal initiated by the participant or physician. A maximum of 39 participants evaluable for efficacy will be enrolled in a two-stage design. In the first stage, 12 participants will be accrued. If none of the first 12 patients respond, the registration will be halted. If one or more patients respond, an additional 27 patients will be enrolled.||||
1316818|NCT03377166|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1316819|NCT03377153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316820|NCT03377140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316821|NCT03377127|Randomized|Parallel Assignment||Treatment||Double|The patients and physicians will not be blinded to the intervention. However, the data collectors and the data analysts will be unaware of the patients allocation. The outcome assessors will also not be aware of the allocation. The biostatistician will also be blinded.|This is a randomized open-label, controlled parallel group trial of a pharmacist managed diabetes clinic in high-risk diabetes patients, with a 1:1 allocation to either standard of care (SOC) or SOC and PMDC and a 6-month and 12-month follow-up.|||t|t
1316822|NCT03377114|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1316823|NCT03377101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316824|NCT03377088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316825|NCT03377075|||Cohort||Prospective|||||||
1316826|NCT03377062|||Cohort||Prospective|||||||
1316827|NCT03377049|||Cohort||Prospective|||||||
1316828|NCT03377036|Randomized|Parallel Assignment||Screening||None (Open Label)||Participants will be randomized to either Digital Breast Tomosynthesis plus synthesized 2D mammograms (DBT+s2D) or 2D Full-Field Digital Mammography (2D-FFDM)||||
1316829|NCT03377023|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316830|NCT03377010|||Case-Control||Prospective|||||||
1316831|NCT03376997|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1316832|NCT03376984|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316833|NCT03376971||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316834|NCT03376958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316835|NCT03376945|||Cohort||Retrospective|||||||
1316836|NCT03376932|Randomized|Parallel Assignment||Treatment||None (Open Label)|This will be an open-label study. Hence, masking will not be provided.|Subjects will be randomized in a 1:1 ratio to receive either FF/UMEC/VI via the ELLIPTA DPI with the CIS or FP/SAL via the DISKUS DPI plus TIO via the RESPIMAT inhaler.||||
1316837|NCT03376919||Single Group Assignment||Treatment||None (Open Label)||||||
1316882|NCT03376334|Randomized|Parallel Assignment||Prevention||Single|The outcome assessor (using balance test) was not aware of neither the group to which the subject belonged nor to the baseline values of the subjects' balance score|One group received Mental Motor Imagery training, and the other group acted as a control with no specific intervention.||||t
1317321|NCT03370614|||Other||Prospective|||||||
1316838|NCT03376906||Single Group Assignment||Treatment||None (Open Label)||"The subjects were welcomed for a visit to the Laboratory of Studies of Physical Training Applied to Health, where they performed an evaluation of body composition, maximal ergospirometric exercise test, and three experimental sessions in a random order, which were performed with a 96 h interval between them. In order to obtain the experimental session order, the researcher asked each subject to pick out random numbers that were inside an opaque envelope generated at www.randomizer.org.~Before the experimental sessions, subjects were instructed to maintain a regular sleep pattern, and to not consume alcohol, caffeine or xanthines (coffee, chocolate, soft drinks and tea), take medication or exercise in the 24 h prior to the experimental protocol sessions. In addition, they were duly instructed to fill out the food registry (food recall)."||||
1316839|NCT03376893|||Cohort||Prospective|||||||
1316840|NCT03376880|||Cohort||Prospective|||||||
1316841|NCT03376867|||Cohort||Prospective|||||||
1316842|NCT03376854|Randomized|Parallel Assignment||Treatment||None (Open Label)|Since it will be obvious to observers of the subjects whether they are in the treatment (cooling) or control groups, the study is not masked but all treatments that determine outcome are protocolized.|Randomized (1:1) control (non-blinded) trial||||
1316843|NCT03376841|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316844|NCT03376828|Randomized|Crossover Assignment||Prevention||None (Open Label)||Prospective||||
1316845|NCT03376815|||Case-Control||Prospective|||||||
1316846|NCT03376802|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1316847|NCT03376789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316848|NCT03376776|||Case-Control||Retrospective|||||||
1316849|NCT03376763|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316850|NCT03376750|Randomized|Parallel Assignment||Treatment||Double||three-arm randomized control trail (RCT) including pre/post intervention and follow-up|||t|t
1316851|NCT03376737||Single Group Assignment||Treatment||None (Open Label)||||||
1316852|NCT03376724|Randomized|Parallel Assignment||Treatment||Single||||||t
1316853|NCT03376711|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316854|NCT03376698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316855|NCT03376685|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a 6-week exercise training study, with three possible parallel training groups: endurance (END), sprint (SIT) or combined endurance-sprint (COMB) training.||||
1316856|NCT03376672|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316857|NCT03376659|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1316858|NCT03376646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316859|NCT03376633|Randomized|Parallel Assignment||Treatment||None (Open Label)|Treatment individuals will be provided information about the trial and consented into the study as part of WOW program materials (note: program participation is not conditional on participation in the research). Control individuals will not be provided information about the study, but may be provided information if they inquire about programming. Due to the intervention type, it is not possible to mask the identity of treatment participants from the provider or from participants. However, the provider will not be informed of the identity of the control group.|||||
1316860|NCT03376620|Randomized|Parallel Assignment||Prevention||Double|Label number coded by manufacturer and released after blinding period|Double-Blind Randomized Controlled Trial; Patient as their own control|t||t|
1316861|NCT03376607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316862|NCT03376594|Randomized|Parallel Assignment||Treatment||Double|Grouping uses Randomize controlled trial (RCT) and groups by using Random allocation by means of Simple Randomization as well as using the code with BJK followed by 3 digits (BJK001, BJK002, ...) and treating in double blinding form.|RCT|t||t|
1316863|NCT03376581||Single Group Assignment||Treatment||None (Open Label)||||||
1316864|NCT03376568|||Case-Control||Cross-Sectional|||||||
1316865|NCT03376555|Randomized|Crossover Assignment||Basic Science||Double|Investigator and Outcomes Assessor are masked according to treatment.|All subjects participate in 4 diets in randomized order. The diets differ in the amount of sodium and dairy cheese content. Each diet is consumed for 8 days. Minimum washout of 1 week between diets. Baseline experiment is conducted prior to first dietary intervention, and the experiment is repeated after each dietary intervention.|||t|t
1316866|NCT03376542||Single Group Assignment||Diagnostic||None (Open Label)||All patients included in the study will perform cardiopulmonary exercise testing prior to surgery||||
1316867|NCT03376529|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1316868|NCT03376516||Single Group Assignment||Treatment||None (Open Label)||||||
1316869|NCT03376503|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1316870|NCT03376490|||Ecologic or Community||Cross-Sectional|||||||
1316871|NCT03376477|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized to receive either lenalidomide alone or in combination with vaccine. Patients assigned to vaccine therapy will receive injections on day 14 (+/-3 days) of cycles 1, 2, 3 and 6 from enrollment, and then annually thereafter. All patients will be followed for a minimum of 3 years.||||
1316872|NCT03376464|Randomized|Parallel Assignment||Treatment||Single||||||t
1316873|NCT03376451||Single Group Assignment||Diagnostic||None (Open Label)||EndoSearch recruits two groups of patients : affected by endometriosis and unaffected (controls) but both of them need a surgery for different indication (endometriosis for patients and other for controls (i.e dermoid cyst).||||
1316874|NCT03376438|||Cohort||Prospective|||||||
1316875|NCT03376425|||Cohort||Prospective|||||||
1316876|NCT03376412||Single Group Assignment||Treatment||None (Open Label)|No Masking.|The study will be a prospective, single-center, open label clinical trial where a maximum of 60 consecutive non-dominant eyes are implanted with the Raindrop Near Vision Inlay.||||
1316877|NCT03376399|||Cohort||Prospective|||||||
1316878|NCT03376386||Single Group Assignment||Treatment||None (Open Label)||Feasibility study||||
1316879|NCT03376373|Randomized|Parallel Assignment||Treatment||Single|independent evaluators are masked to condition assignment|||||t
1316880|NCT03376360|||Cohort||Retrospective|||||||
1573426|NCT00001278||||||||||||
1316883|NCT03376321|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316884|NCT03376308|||Case-Crossover||Prospective|||||||
1316885|NCT03376295|||Cohort||Retrospective|||||||
1316886|NCT03376282|Randomized|Crossover Assignment||Treatment||Single||||||t
1316887|NCT03376269|Randomized|Crossover Assignment||Treatment||Single||||||t
1316888|NCT03376256|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1316889|NCT03376243|Randomized|Parallel Assignment||Prevention||Single||||||t
1316890|NCT03376230|||Case-Control||Cross-Sectional|||||||
1316891|NCT03376217|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster randomized controlled trial||||
1316892|NCT03376204|||Other||Prospective|||||||
1316893|NCT03376191|||Cohort||Prospective|||||||
1316894|NCT03376178|Randomized|Parallel Assignment||Treatment||Triple|All investigators, patients, and other clinical staff were blinded to the treatment group. The investigator in charge of the patient was unaware of patient allocation. He did not perform the block or open the sealed and opaque envelope, but followed the patient in the ward. An opaque skin dressing was used in order to blind the type of catheter used. End-hole catheter Vygon is white and stiff whereas six-hole catheter contiplex is yellow and flexible.|Eighty adult patients (aged ≥18 years) scheduled to undergo primary total knee arthroplasty under a combination of CFNB, sciatic nerve block and general anesthesia were randomized to CFNB using either a 3-pair micro-hole (Contiplex, BRAUN®, 20G - 400 mm) or an end-hole (Silverstim VYGON®, 20G - 500 mm) catheter. Once the femoral catheter was sited, a bolus of 20 mL lidocaine 1% was injected. An electronic pump then delivered an automated 5 mL bolus of ropivacaine 0.2% hourly, with 10 mL self-administered patient controlled analgesia boluses.|t||t|t
1316895|NCT03376165|||Cohort||Prospective|||||||
1316896|NCT03376152|Randomized|Parallel Assignment||Prevention||Single||||||t
1316897|NCT03376139|Randomized|Parallel Assignment||Treatment||Quadruple|The study will be conducted in a double-masked fashion in that both the participants and the site investigators and staff interacting with participants and assessing study outcomes will be masked to treatment assignment. The only individuals at the site with assess to treatment assignment information will be the research pharmacists.||t|t|t|t
1316898|NCT03376126|||Cohort||Prospective|||||||
1316899|NCT03376113|Randomized|Parallel Assignment||Prevention||Single||||||t
1316900|NCT03376100|Randomized|Parallel Assignment||Treatment||Single||||||t
1316901|NCT03376087|||Cohort||Prospective|||||||
1316902|NCT03376074|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316903|NCT03376061|Randomized|Parallel Assignment||Prevention||Quadruple|The pharmacy will prepare 1 syringe of 50 ml of topical TA (5 g) or placebo. They will also prepare for the same patient 2 syringes of 50 ml (5 g) for intravenous (i.v.) injection or placebo. TA is similar in all aspects to normal saline. Blinding of both teams will be easy. The syringes will be prepared and randomized in pharmacy before the surgery.|Tranexamic Acid intravenous + Placebo topical versus Placebo intravenous + Tranexamic Acid topical|t|t|t|t
1316904|NCT03376048|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316905|NCT03376035|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Determine skin temperature after breast reconstruction||||
1316906|NCT03376022|||Other||Cross-Sectional|||||||
1316907|NCT03376009|||Case-Only||Prospective|||||||
1316908|NCT03375996|||Case-Only||Prospective|||||||
1316909|NCT03375983||Single Group Assignment||Treatment||None (Open Label)||||||
1316910|NCT03375970|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316911|NCT03375957|Randomized|Parallel Assignment||Treatment||Single||||||t
1316912|NCT03375944|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316913|NCT03375931|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Prospective Randomized open study||||
1316914|NCT03375918|Randomized|Sequential Assignment||Health Services Research||Single|The primary outcome is blood pressure (BP) change as recorded in the electronic medical record (EMR) of racial/ethnic minority patients and Medicaid recipients of any race/ethnicity with controlled and uncontrolled hypertension. Secondary outcomes are patient-reported quality of care and clinician communication, and patient adherence to medications, visits and diet changes. Patient participants are masked to the intervention status of their provider trainees.|Clusters of clinical trainees [stratified by specialty (internal medicine (IM), family medicine (FM), NP students) and by training block] will be randomly assigned to 1 of 5 start dates. Clinical outcomes will be assessed at the patient level.||||t
1316915|NCT03375905||Single Group Assignment||Treatment||None (Open Label)||||||
1316916|NCT03375892||Single Group Assignment||Treatment||None (Open Label)||||||
1316917|NCT03375879|Randomized|Parallel Assignment||Supportive Care||Single|The investigator will place a contact lens on both eyes and immediately take it off from one (this will be the sham lens eye). Randomization of the lens placement will be determined by a flip of a coin (heads - keep lens on right eye. Tails - keep lens on left eye). Investigator will randomly generate for each patient whether the contact lens will be kept on right or left eye, sham contact lens will be placed on other eye, placing it and immediately removing it. Therefore, the patient will not know which eye has a lens.|The investigators will place a contact lens on both eyes and immediately take it off from one (this will be the sham lens eye). Randomization of the lens placement will be determined by a flip of a coin (heads - keep lens on right eye. Tails - keep lens on left eye). Investigator will randomly generate for each patient whether the contact lens will be kept on right or left eye, sham contact lens will be placed on other eye, placing it and immediately removing it. Therefore, the patient will not know which eye has a lens.|t|||
1316918|NCT03375866|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316919|NCT03375853|Randomized|Parallel Assignment||Treatment||Single|||t|||
1316920|NCT03375840|Randomized|Factorial Assignment||Prevention||||||||
1316921|NCT03375827||Single Group Assignment||Health Services Research||None (Open Label)||||||
1316967|NCT03375229|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316968|NCT03375216|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1316969|NCT03375203|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316970|NCT03375190|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1316922|NCT03375814|Randomized|Crossover Assignment||Treatment||Single||Osteoarthritis patients who have age between 40 to 75 years old will be selected; Based on radiographic images of patients the severity of joints damage will get detailed and they will be placed in between grade 2 and grade 3 in terms of gradation; these patients will be not located underwent surgery; Patients will complete WOMAC and KOOS questionnaires to obtain some information such as following items; They will be no history of injury; they will not have diabetic disorders, rheumatism and kidney disease, osteonecrosis, gout; they will not have a long history anti-inflammatory drugs consumption; They will not have individuals with insufferable jobs carrying heavy loads; Patients will not have the Body Mass Index (BMI) of 30 or more|t|||
1316923|NCT03375801|Non-Randomized|Sequential Assignment||Other||None (Open Label)|"first 164 patients will not receive the decision aid, they will only fill out the questionnaires.~The next 164 patients will receive the decision aid and will be asked to fill out the same questionnaires."|Pre- and post intervention study.||||
1316924|NCT03375788|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, double-blind, placebo controlled phase for first 12 months, followed by open-label phase for 6 months during which all participants receive active medication (tesamorelin)|t|t|t|t
1316925|NCT03375775|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Open controlled study||||
1316926|NCT03375762|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1316927|NCT03375749|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1316928|NCT03375736||Single Group Assignment||Treatment||None (Open Label)||The study participants would receive 4 weeks of whole body vibration therapy, 4 sessions per week for 18 minutes per session.||||
1316929|NCT03375723|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized, controlled, intervention study. Evaluation of the addition of information and breathing technique for patients with respiratory associated chest pain in acute pulmonary embolism compared to standard care||||
1316930|NCT03375710||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316931|NCT03375697|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1316932|NCT03375684|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1316933|NCT03375671|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1316934|NCT03375658|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316935|NCT03375645|||Cohort||Prospective|||||||
1316936|NCT03375632|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1316937|NCT03375619|||Cohort||Retrospective|||||||
1316938|NCT03375606|Randomized|Sequential Assignment||Other||Quadruple|||t|t|t|t
1316939|NCT03375593|Randomized|Parallel Assignment||Treatment||Double|study medication will be masked to participant and investigator. Medication will be dispensed by pharmacy in identical blister packs|participants will be randomized to receive either the narcotic hydrocodone with acetaminophen or a combination of acetaminophen plus ibuprofen for post-fracture pain|t||t|
1316940|NCT03375580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316941|NCT03375567|Non-Randomized|Parallel Assignment||Treatment||Single||After patients are treated with Carfilzomib Lenalidomide Dexamethasone (CRD), lesion biopsies will be performed per usual care. Patients will have biopsies performed on lesions using a novel image guided technique.||||t
1316942|NCT03375554|||Cohort||Prospective|||||||
1316943|NCT03375541|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized control trial||||
1316944|NCT03375528||Single Group Assignment||Prevention||None (Open Label)||Patients derived from a population of patients referred to 12 months follow-up coronary angiography for ischemic heart disease who are enable to be performed IVUS will be enrolled in the present trial, between December 2017 and December 2018. The study was an all comers design involving consecutive enrollment of patients with stable angina or acute coronary syndrome who had at least 1 coronary lesion (defined as a stenosis of >50%) suitable for stent implantation 12 months before. The follow-up coronary angiography was performed according to standard techniques by experienced interventionalists only. Instent restenosis was defined as a diameter stenosis ≥50% of the vessel reference diameter by visual assessment. Detailed demographic details including anthropometric measurements, cardiovascular risk factors and medication use were recorded for the participants.||||
1316945|NCT03375515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316946|NCT03375502|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1316947|NCT03375489|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316948|NCT03375476|||Cohort||Prospective|||||||
1316949|NCT03375463|Randomized|Parallel Assignment||Basic Science||Double|Part A and Part B are not blinded. Part C is blinded to Participant and Investigator||t||t|
1316950|NCT03375450|||Cohort||Retrospective|||||||
1316951|NCT03375437||Single Group Assignment||Screening||None (Open Label)||||||
1316952|NCT03375424|||Cohort||Prospective|||||||
1316953|NCT03375411||Single Group Assignment||Treatment||None (Open Label)||||||
1316954|NCT03375398|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1316955|NCT03375385|Randomized|Parallel Assignment||Other||Single|||t|||
1316956|NCT03375372|Randomized|Parallel Assignment||Treatment||Single||||||t
1316957|NCT03375359|||Case-Only||Prospective|||||||
1316958|NCT03375346|Randomized|Parallel Assignment||Treatment||Single||Eligible patients were randomly assigned to one of the two groups in a 1:1 ratio using an odd or even random numbers table. Whole body vibration group performed a single session of whole body vibration exercise via a vibrating platform (Galileo® Advanced Plus, Novotec Medical, Pforzheim, Germany) with a magnitude of 20 Hz and an amplitude of 4 mm. The control group performed the same session without vibration.|||t|
1316959|NCT03375333|||Cohort||Prospective|||||||
1316960|NCT03375320|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1316961|NCT03375307||Single Group Assignment||Treatment||None (Open Label)||||||
1316962|NCT03375294||Single Group Assignment||Treatment||None (Open Label)||||||
1316963|NCT03375281||Single Group Assignment||Treatment||None (Open Label)||||||
1316964|NCT03375268|||Other||Retrospective|||||||
1316965|NCT03375255||Sequential Assignment||Treatment||None (Open Label)||||||
1316966|NCT03375242|||Case-Only||Prospective|||||||
1316972|NCT03375164|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316973|NCT03375151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316974|NCT03375138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1316975|NCT03375125|Randomized|Parallel Assignment||Treatment||Quadruple|Randomization list will by assembled by independient organization not related with participant, care provider, investigators or sponsors. eCRF will include randomization selection|Randomized controlled trial, double blind allocation concealment, parallel assignment|t|t|t|t
1316976|NCT03375112|Randomized|Parallel Assignment||Supportive Care||Triple|The patients will be randomized to receive fascia iliaca blocks post-operatively or to receive a touch with a blunt needle and a bandaid post-operatively by the regional anesthesia team. Neither the patient nor the investigators will have knowledge of which group the patients belong to until the completion of the data collection.||t||t|t
1316977|NCT03375099|Randomized|Factorial Assignment||Prevention||Single|Participants will not be informed of the nature of the conditions other than the one they are randomly assigned to receive|2 (Lethal Means Counseling vs Health and Stress Reduction) x 2 (Provision of free gun locks vs No gun locks)|t|||
1316978|NCT03375086||Single Group Assignment||Treatment||None (Open Label)||Open-label, multi-center, dose escalation.||||
1316979|NCT03375073|Randomized|Parallel Assignment||Basic Science||Double||Randomized controlled trial, with a 1:1 allocation ratio|||t|t
1316980|NCT03375060|||Case-Only||Retrospective|||||||
1316981|NCT03375047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1316982|NCT03375034|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1316983|NCT03375021|Randomized|Crossover Assignment||Treatment||Quadruple|200 mg of drug product or placebo in matching size 0 capsules|A Randomized, Double-Blind, Two-Period Crossover Study|t|t|t|t
1316984|NCT03375008||Single Group Assignment||Prevention||None (Open Label)||||||
1316985|NCT03374995|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1316986|NCT03374982|Randomized|Crossover Assignment||Supportive Care||Single|The person administering the FACES pain rating scale will be masked|||||t
1316987|NCT03374969|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1316988|NCT03374956|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1316989|NCT03374943||Sequential Assignment||Treatment||None (Open Label)||The study will use a 3+3 methodology for the 3 dose levels proposed. In brief, three patients will be recruited per dose level. In the absence of any Dose Limiting toxicity (DLT) in a cohort, escalation to the next dose level will occur.||||
1316990|NCT03374930||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316991|NCT03374917||Single Group Assignment||Treatment||None (Open Label)||||||
1316992|NCT03374904|Randomized|Parallel Assignment||Treatment||Single|"Interview analysis, for ascertaining the level of PRF will be done by an encoder highly trained in said techniques. Transcriptions will be anonymous in order to mask the identity of the caregiver. Whether the caregiver belongs to a control or intervened group will also be masked when working in transcriptions.~Due to the characteristics of the intervention, the main researcher will not be masked regarding who receives the intervention and who is in the control group."|Participants will be randomized to intervention or control group at a 2:1 ratio||||t
1316993|NCT03374891|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Step-wedge design. 6 groups will begin recruiting participants as control participants. Throughout the study, at 5 month intervals, 1 randomly selected site at a time will begin intervention.||||
1316994|NCT03374878|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Cross sectional study with 16 in each group.||||
1316995|NCT03374865|||Case-Control||Prospective|||||||
1316996|NCT03374852||Single Group Assignment||Treatment||None (Open Label)||||||
1316997|NCT03374839||Single Group Assignment||Treatment||None (Open Label)||||||
1316998|NCT03374826||Single Group Assignment||Diagnostic||None (Open Label)||||||
1316999|NCT03374813|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1317000|NCT03374800|Randomized|Parallel Assignment||Prevention||Quadruple|blinded study drug and placebo|Randomized stratified, parallel group blinded non-Inferiority trial|t|t|t|t
1317001|NCT03374787||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1317002|NCT03374774|||Cohort||Prospective|||||||
1317003|NCT03374761|Randomized|Parallel Assignment||Prevention||None (Open Label)|It is not possible to mask as it is a behavioral intervention and the outcomes are self-reported.|Stratified, clustered randomized pragmatic trial||||
1317004|NCT03374748|||Ecologic or Community||Cross-Sectional|||||||
1317005|NCT03374735||Single Group Assignment||Treatment||None (Open Label)||||||
1317006|NCT03374722|||Cohort||Prospective|||||||
1317007|NCT03374709||Single Group Assignment||Treatment||None (Open Label)||||||
1317008|NCT03374696|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster-randomized controlled trial with parallel assignment||||
1317009|NCT03374683|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1317010|NCT03374670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317011|NCT03374657||Single Group Assignment||Treatment||Single|"This is a partially masked study. The patients will not be masked. The treating physicians and personnel at the surgical location (surgeons, anesthesiologist, operating room personnel and others) will not be masked.~At the clinical sites, there will be an unmasked ophthalmologist. The remaining assessors at the clinical sites (ophthalmologist, study nurse, ophthalmic technician, etc) doing the ophthalmic examinations should be masked to the study (treated) eye.~The following unmasked sponsor roles are required for this study:~Sponsor clinical staff required to assist in the management and re-supply of investigational drug product.~The independent committee assessing unmasked interim results and the independent analysis team.~All other sponsor staff will stay masked to treatment assignments"|This is a non-confirmatory, open-label single ascending dose gene replacement-therapy study to assess safety, tolerability and efficacy of CPK850 in patients with RLBP1 retinitis pigmentosa due to biallelic mutations in the RLBP1 gene. The trial design uses a staggered patient enrollment.||||t
1317012|NCT03374644||Single Group Assignment||Prevention||None (Open Label)||||||
1317070|NCT03373877|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1573427|NCT00001272||||Treatment||||||||
1317013|NCT03374631|Randomized|Crossover Assignment||Basic Science||Double||Participants will complete active and sham simulation sessions in a randomized, counterbalanced order approximately one week apart.|t|||t
1317014|NCT03374618|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317015|NCT03374605|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1317016|NCT03374592|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial|t|||
1317017|NCT03374579||Single Group Assignment||Diagnostic||None (Open Label)||Fluid challenge with assessment of change of co2 gap||||
1317018|NCT03374566|||Cohort||Prospective|||||||
1317019|NCT03374553||Single Group Assignment||Treatment||None (Open Label)||||||
1317020|NCT03374540|||Cohort||Retrospective|||||||
1317021|NCT03374527|||Cohort||Cross-Sectional|||||||
1317022|NCT03374514|Randomized|Parallel Assignment||Treatment||Triple||randomized, controlled and double-blind experimental study.|t|t|t|
1317023|NCT03374501|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1317024|NCT03374488|Randomized|Parallel Assignment||Treatment||None (Open Label)|The study will be unblinded after the last participant completes Week 9 imaging assessment for efficacy analysis and after appropriate EC/IRB approvals have been received.|||||
1317025|NCT03374475|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317026|NCT03374462||Single Group Assignment||Health Services Research||None (Open Label)||||||
1317027|NCT03374449|Randomized|Parallel Assignment||Other||None (Open Label)|Endpoint validated by an adjudication commitee blinded to the arm.|The aim of this study is to evaluate the impact of Renin-Angiotensin System inhibitors management (Continuation or discontinuation 48 hours before surgery) on outcome in patients undergoing scheduled major non-cardiac surgery (surgery with an expected duration of more than 2 hours from the surgical incision and a post-operative hospital stay of least 3 days)||||
1317028|NCT03374436|Randomized|Crossover Assignment||Other||None (Open Label)|It is not possible to mask the exercise or diet interventions.|Participants complete three conditions in a repeated crossover design.||||
1317029|NCT03374423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317030|NCT03374397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317031|NCT03374384|||Other||Cross-Sectional|||||||
1317032|NCT03374371|||Case-Control||Retrospective|||||||
1317033|NCT03374358|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a randomized, open, parallel design study.||||
1317034|NCT03374345|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317035|NCT03374332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1317036|NCT03374319|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317037|NCT03374306|Randomized|Parallel Assignment||Prevention||Double|Double-blinded|Randomized clinical trial|t||t|
1317038|NCT03374293||Single Group Assignment||Treatment||None (Open Label)||||||
1317039|NCT03374280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317040|NCT03374267|||Cohort||Prospective|||||||
1317041|NCT03374254|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317042|NCT03374241|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1317043|NCT03374228||Single Group Assignment||Other||None (Open Label)||||||
1317044|NCT03374215|||Cohort||Prospective|||||||
1317045|NCT03374202||Parallel Assignment||Treatment||None (Open Label)||||||
1317046|NCT03374189|Randomized|Parallel Assignment||Prevention||Single|||t|||
1317047|NCT03374176|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1317048|NCT03374163|Randomized|Parallel Assignment||Treatment||None (Open Label)||"To evaluate the effect ofempiricintralipidinfusion therapy on pregnancy outcomes in patient withunexplained recurrentimplantation failure (RIF) undergoIntracytoplasmic sperm injection (ICSI).~A total of 142 patients with history of unexplained RIF3 or more cycles were included in the study. Patient were randomized into two groups, study group (n=71) and control group (n=71). The study groupreceivedintralipid 20%infusionon the day of embryo transfer (ET) and a second dose on the day of pregnancy test. The control group underwent ET without intralipidinfusion.Allpatientswereclosely monitored for any side effectsincluding allergic reactions."||||
1317049|NCT03374150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317050|NCT03374137|||Cohort||Prospective|||||||
1317051|NCT03374124|||Cohort||Retrospective|||||||
1317052|NCT03374111|Randomized|Parallel Assignment||Treatment||Quadruple|double blind|Parallel Assignment|t|t|t|t
1317053|NCT03374098|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1317054|NCT03374085||Sequential Assignment||Treatment||None (Open Label)||||||
1317055|NCT03374072|Randomized|Parallel Assignment||Treatment||Single||||||t
1317056|NCT03374059|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled||||
1317057|NCT03374046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317058|NCT03374033|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1317059|NCT03374020|||Other||Prospective|||||||
1317060|NCT03374007|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317061|NCT03373994|||Cohort||Prospective|||||||
1317062|NCT03373981||Single Group Assignment||Treatment||None (Open Label)||open label single arm||||
1317063|NCT03373968||Single Group Assignment||Treatment||None (Open Label)||||||
1317064|NCT03373955|||Case-Only||Prospective|||||||
1317065|NCT03373942|||Case-Control||Retrospective|||||||
1317066|NCT03373929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Non-randomized, single-center, observational study||||
1317067|NCT03373916|Randomized|Parallel Assignment||Prevention||Single||||||t
1317068|NCT03373903|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1317069|NCT03373890||Single Group Assignment||Treatment|||Muscle function assessor masked to frequency group, Muscle architecture captured via ultrasound Community walking activity collected by accelerometry, thus non-human data collection|Pre/post intervention design with participants randomized to two different frequency of intervention||||
1317071|NCT03373864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317072|NCT03373851|||Cohort||Prospective|||||||
1317073|NCT03373838|||Other||Prospective|||||||
1317074|NCT03373825|Non-Randomized|Parallel Assignment||Screening||Single|"Participants in ARM1 were only aware of the use of the Take home rapid drug test as a urine test. Participants in ARM2, while instructed to test their drug residue, were aware of the ability to use the take home rapid drug test as a urine test."|Participants will be assigned to either ARM1 or ARM2 depending on when they enrolled in the study.|t|||
1317075|NCT03373812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317076|NCT03373799|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317077|NCT03373786|Non-Randomized|Sequential Assignment||Treatment||Double|||t||t|
1317078|NCT03373773|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1317079|NCT03373760||Single Group Assignment||Treatment||None (Open Label)||||||
1317080|NCT03373747|Randomized|Parallel Assignment||Other||Double|||t|||t
1317081|NCT03373734||Single Group Assignment||Health Services Research||None (Open Label)||Enjoy Your Bump is an online life skills course based on cognitive behavioural therapy principles. It has been designed to address issues pertinent to mood in pregnancy. The course compiles five modules delivered in the form of an online slideshow with audio. It can be accessed from a range of devices. There are a series of worksheets the user can access and download which accompany the modules.||||
1317082|NCT03373721|||Cohort||Prospective|||||||
1317083|NCT03373708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317084|NCT03373695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317085|NCT03373682|||Cohort||Prospective|||||||
1317086|NCT03373669|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is an open label, randomized, phase 2 clinical trial of the immunogenicity of OCV when the vaccine is administered to participants of three age cohorts (1-4 years, 5-14 years, and >14 years) and in two dose interval groups (DIGs). The subjects in each age cohort will be randomized to a DIG of 2 weeks (DIG-1) or 6 months (DIG-2). A total of 120 subjects will be enrolled and these are equally divided between the different groups (20 per age/dose interval group).||||
1317087|NCT03373656|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317088|NCT03373643||Single Group Assignment||Screening||None (Open Label)||||||
1317089|NCT03373630||Single Group Assignment||Other||None (Open Label)||||||
1317090|NCT03373617|||Cohort||Prospective|||||||
1317091|NCT03373604|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1317092|NCT03373591|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1317093|NCT03373578|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1317094|NCT03373565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317095|NCT03373552|||Case-Only||Cross-Sectional|||||||
1317096|NCT03373539|||Cohort||Prospective|||||||
1317097|NCT03373526|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled clinical trial, with only statistical analysis blinded||||t
1317098|NCT03373513|Randomized|Parallel Assignment||Treatment||None (Open Label)||Women are randomized to either robotic single site or multi port lapsoscopic hystrectomy||||
1317099|NCT03373500|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single centre, randomised controlled parallel study.||||
1317100|NCT03373487|Randomized|Parallel Assignment||Treatment||Single|Well-trained research assistants, who are conducting neuropsychological assessments, are blinded.|||||t
1317101|NCT03373474|Randomized|Parallel Assignment||Treatment||Single||||||t
1317102|NCT03373461|Randomized|Parallel Assignment||Treatment||Double||"The primary variable is the change from baseline of log transformed UPCR derived from the 24h urine collections at baseline and day 90.~An interim analysis will be performed once the last patient has completed treatment in Part 1. The intention of this analysis is to provide preliminary evidence of dose-response relationship for proteinuria, to determine the sample size for Part 2, and to determine the treatment arms to be studied in Part 2."|t||t|
1317103|NCT03373448|Randomized|Parallel Assignment||Supportive Care||Double|Examiners blinded to treatment allocation since treatment is performed by a dental hygienist.|Patients will be allocated either to test (Labrida BioClean® or control (titanium curettes) treatment by computer-generated block randomization to ensure equal sample sizes. The examiners will be blinded to the treatment allocation.|||t|t
1317104|NCT03373435|Randomized|Crossover Assignment||Treatment||Single|||t|||
1317105|NCT03373422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317106|NCT03373409|Randomized|Crossover Assignment||Treatment||None (Open Label)||3-way single dose crossover||||
1317107|NCT03373396|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||It is a case-control study. There will be two groups. The patient will be assigned to a group according to the Metavir classification. F0 patients will be in the control group.||||
1317108|NCT03373383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317109|NCT03373370|||Cohort||Prospective|||||||
1317110|NCT03373357|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"All the patients will have sampling blood specific to the protocol:~Insulinémie~US CRP(TEACHERS' CENTRE)~Implementation of a sérothèque"||||
1317111|NCT03373344|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317112|NCT03373331|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317113|NCT03373318|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1317114|NCT03373305||Single Group Assignment||Treatment||None (Open Label)||||||
1317115|NCT03373292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317116|NCT03373279|||Case-Only||Prospective|||||||
1317117|NCT03373266|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1317118|NCT03373253|||Cohort||Prospective|||||||
1317119|NCT03373240|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to either a (1) cognitive remediation program (training tasks) specifically designed to address cognitive-affective dysregulation or (2) control tasks (verbal fluency tasks).||||
1317120|NCT03373227|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317121|NCT03373214|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1317122|NCT03373201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317123|NCT03373188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317124|NCT03373175|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1317125|NCT03373162||Single Group Assignment||Basic Science||None (Open Label)||||||
1317126|NCT03373149|Randomized|Parallel Assignment||Treatment||Single||||||t
1317127|NCT03373136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317128|NCT03373123||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317129|NCT03373110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317130|NCT03373097||Single Group Assignment||Treatment||None (Open Label)||||||
1317131|NCT03373084|||Cohort||Prospective|||||||
1317132|NCT03373071||Single Group Assignment||Treatment||None (Open Label)||||||
1317133|NCT03373058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317134|NCT03373045|||Cohort||Prospective|||||||
1317135|NCT03373032|Randomized|Sequential Assignment||Prevention||Single|Blind ramdomization and blind final evaluation|A computer program will produce a randomization list, which will generate random sequences for the three groups and will be recorded and placed in sealed, opaque, non-translucent and sequentially numbered envelopes. This intervention should be done by someone else and not by the principal investigator. These envelopes will be opened after the consent of the patient to participate in the research and only then will the researcher know as well as the patient the group that she will be allocated. 93 envelopes were available where 31 would contain code that allocates the patients in group A, 31 in group B and 31 in group C. This choice was chosen to avoid influences of the preference of the therapist or patient in relation to the intervention|||t|
1317136|NCT03373019||Single Group Assignment||Treatment||None (Open Label)||||||
1317137|NCT03373006||Single Group Assignment||Diagnostic||None (Open Label)|No masking|Cohort||||
1317138|NCT03372993|||Cohort||Prospective|||||||
1317139|NCT03372980|||Cohort||Other|||||||
1317140|NCT03372967|||Cohort||Prospective|||||||
1317141|NCT03372954|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317142|NCT03372941|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This study will be single center, randomized, non-blinded study comparing two active treatment arms to treat uncomplicated ABSSSI suspected to be due to Gram-positive bacteria:~Alternative treatment strategy comprised of a single dose of dalbavancin administered in the BJH ED or ED observation unit followed by discharge w/ close Infectious Disease outpatient clinic follow-up vs.~Usual care (i.e., hospital admission for intravenous antibiotics - typically, vancomycin) - antibiotic and doses to be determined at the discretion of the treating clinician (both in the BJH ED and on the BJH inpatient ward)"||||
1317143|NCT03372928|Randomized|Crossover Assignment||Basic Science||Double||Randomized, double-blind, cross-over controlled trial|t||t|
1317144|NCT03372915|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317145|NCT03372902|||Cohort||Prospective|||||||
1317146|NCT03372889|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Subjects are randomized into one of the following two groups:~Group 1: Print based PEM Group 2: Media based PEM All study outcomes are compared between the two groups."||||
1317147|NCT03372876|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1317148|NCT03372863|||Other||Prospective|||||||
1317149|NCT03372850|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1317150|NCT03372837||Single Group Assignment||Treatment||None (Open Label)||||||
1317151|NCT03372824|||Cohort||Prospective|||||||
1317152|NCT03372811|Randomized|Parallel Assignment||Treatment||Double|Double||t|||t
1317153|NCT03372798|||Case-Only||Prospective|||||||
1317154|NCT03372785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317155|NCT03372772|Randomized|Parallel Assignment||Treatment||Single|Single Blind|Control Group- Patients with only levothyroxine therapy Interventional Group- Patients with Levocarnitine supplementation in addition to levothyroxine therapy|t|||
1317156|NCT03372759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317157|NCT03372746|||Cohort||Prospective|||||||
1317158|NCT03372733|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1317159|NCT03372720|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1317160|NCT03372707|Randomized|Parallel Assignment||Diagnostic||Triple|Patients, Research Coordinators, study investigators, adjudicators, and data analysts will be blinded to the results of CLT in the control group.||t||t|t
1317161|NCT03372694|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317162|NCT03372681|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317163|NCT03372668||Single Group Assignment||Treatment||None (Open Label)||"Repeated measures, single-subject withdrawal design with three, 4-week study phases; also referred to as an ABA withdrawal design. Study intervention consisted of twice weekly, 20-minute treatments for four weeks (8 total treatments) and is delivered during the second 4-week study phase.~All subjects who enroll in the study will receive the intervention during the second 4-week study phase. There is no randomization."||||
1317164|NCT03372655|||Cohort||Prospective|||||||
1317165|NCT03372642|||Cohort||Cross-Sectional|||||||
1317166|NCT03372629|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1317167|NCT03372616|||Cohort||Cross-Sectional|||||||
1317168|NCT03372603|Randomized|Crossover Assignment||Treatment||Double|All study staff involved in clinical assessments (which includes the investigator, sub-investigators, other site staff), and the subject will be blinded to the treatment allocated to individual subjects.|This is a multi-center, randomized, placebo-controlled, double-blind, two-period crossover study. Each subject will be screened (screening may be conducted across more than 1 visit); each subject will have 2 treatment periods (each 7 days) with a washout period of 14 to 21 days between the treatment periods; and each subject will have a follow-up visit (within 7 to 10 days after their last dose). Each subject will be involved in the study for a maximum of 10 and a half weeks.|t||t|
1317169|NCT03372590|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1573428|NCT00001271||||Treatment||||||||
1317170|NCT03372577|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1317171|NCT03372564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317172|NCT03372551||||||||||||
1317173|NCT03372538|||Case-Control||Prospective|||||||
1317174|NCT03372525|Randomized|Parallel Assignment||Treatment||Triple||When the neonate had fulfilled the included criteria, selective HFOV or CMV were started immediately on the basis of the group assignment.|t||t|t
1317175|NCT03372512|||Cohort||Prospective|||||||
1317176|NCT03372499|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1317177|NCT03372486|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1317178|NCT03372473|Randomized|Crossover Assignment||Treatment||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Children allocated on different arms will receive montelukast + loratadine vs. montelukast + placebo. Both product are identical in appearence and flavor|Randomized clinical crossover trial, in 80 children who were allocated to receive montelukast + loratadine vs montelukast in two different periods of 4 weeks each, with a 2 weeks of wash-out between periods of treatment|t|t|t|t
1317179|NCT03372460|Randomized|Parallel Assignment||Treatment||Double|double blind tDCS|Participants are assigned to receive either active or sham stimulation during the tDCS+VR sessions in parallel for the duration of the study|t||t|
1317180|NCT03372447||Single Group Assignment||Treatment||None (Open Label)||||||
1317181|NCT03372434||||||||||||
1317182|NCT03372421|Randomized|Parallel Assignment||Supportive Care||Single|Participants will not be told whether they are in the experimental or control group.||t|||
1317183|NCT03372408|||Cohort||Retrospective|||||||
1317184|NCT03372395|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||Pilot study||||
1317185|NCT03372382|Randomized|Parallel Assignment||Treatment||None (Open Label)||two parallel groups included, randomized to control analgesic regimen versus alternative analgesic regimen and followed prospectively.||||
1317186|NCT03372369|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317187|NCT03372356|||Cohort||Prospective|||||||
1317188|NCT03372343||||||||||||
1317189|NCT03372330|||Cohort||Prospective|||||||
1317190|NCT03372317|||Cohort||Cross-Sectional|||||||
1317191|NCT03372304|Randomized|Parallel Assignment||Treatment||Quadruple|All patients and outcome assessors will be blinded to the delivery administrations. Investigators will not be present while programming of the infusion pump is taking place. The display of the infusion pump will be concealed at all times after initiation. Furthermore, throughout the trial, the infusion pump will be concealed from the patient through a non-transparent bag. Trial interventions will not be visible in electronic patient charts. The infusion pump is making a discrete noise when administering medications. To make sure that the PCA group and the continuous infusion group is blinded to interventions, a sham administration is activated every 8th hour. This sham administration will be 0.1 mL of ropivacaine 0.2%. Such a small dose of LA will not have any anesthetic effect nor pose a risk for the patient.|3 arms (API, CI and PCA only)|t|t|t|t
1317192|NCT03372291|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1317193|NCT03372278|||Cohort||Prospective|||||||
1317194|NCT03372265|Randomized|Parallel Assignment||Treatment||Quadruple|All patients and outcome assessors will be blinded to the delivery administrations. Investigators will not be present while programming of the infusion pump is taking place. The display of the infusion pump will be concealed at all times after initiation. Furthermore, throughout the trial, the infusion pump will be concealed from the patient through a non-transparent bag. Trial interventions will not be visible in electronic patient charts. The infusion pump is making a discrete noise when administering medications. To make sure that the PCA group and the continuous infusion group is blinded to interventions, a sham administration is activated every 10th hour. This sham administration will be 0.1 mL of ropivacaine 0.2%. Such a small dose of LA will not have any anesthetic effect nor pose a risk for the patient.|3 arms (API, CI and PCA only)|t|t|t|t
1317195|NCT03372252|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1317196|NCT03372239|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1317197|NCT03372226|Randomized|Parallel Assignment||Treatment||Double||"The study is a randomly controlled study with 2 conditions: Condition 1: Online Intervention Program (treatment of emotional and gambling-related symptoms), condition 2: Wait-list control group (access to the online program after the post-assessment).~Two assessments-points, the intervention period (pre-post) is eight weeks. At both measuring points sociodemographic and pathological data are obtained with an internet survey on Unipark®."|||t|t
1317198|NCT03372213|||Cohort||Cross-Sectional|||||||
1317199|NCT03372200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317200|NCT03372187||Single Group Assignment||Other||None (Open Label)||All 20 participants will be placed into the intervention group.||||
1317201|NCT03372174|Randomized|Parallel Assignment||Prevention||Single|||t|||
1317202|NCT03372161|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317203|NCT03372148||Single Group Assignment||Treatment||None (Open Label)||Pharyngeal High Resolution Manometry and Impedance (pHRMi) in the Longitudinal Evaluation of Swallow Function in Head and Neck Cancer Patients||||
1317204|NCT03372135|||Cohort||Retrospective|||||||
1317205|NCT03372122|Randomized|Parallel Assignment||Supportive Care||Double||The two study products will be assigned to opposite forearms per a computer-generated randomization schedule. Additionally, the location for baseline and post-product samples will be randomly assigned to the two longitudinally-arranged sites per forearm.|t|||t
1317206|NCT03372109|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1317207|NCT03372096||Single Group Assignment||Treatment||None (Open Label)||This will be an open label pilot study with a small population undergoing an intervention to determine initial safety and potential for efficacy as measured by improvement of LUTS and decrease in prostate size||||
1317208|NCT03372083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1317209|NCT03372070||Single Group Assignment||Treatment||None (Open Label)||||||
1317210|NCT03372057||Sequential Assignment||Treatment||None (Open Label)||||||
1317211|NCT03372044|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1317262|NCT03371381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317212|NCT03372031|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized members of dyads (formed by residential treatment facility personnel) in to therapy order conditions. Two weeks piano therapy for one while the other listened followed by two week in reversed roles. Half the participants played first and listened second and the other half did the reverse.||||
1317213|NCT03372018|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317214|NCT03372005|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317215|NCT03371992||Single Group Assignment||Basic Science||None (Open Label)||||||
1317216|NCT03371979||Single Group Assignment||Treatment||None (Open Label)||||||
1317217|NCT03371966|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1317218|NCT03371953|Randomized|Parallel Assignment||Other||Triple|The patient, the attending anaesthesiologist, and the personnel recording the assessment parameters will be blinded to the randomisation sequence and the drug inside the 5-ml solution is supplied in a 5-ml syringe. The study drug for the three group allocation will be contained in a similar 5-ml solution (drug+0.9% saline solution).|"Patients will be randomly divided into three groups in a 1:1:1 distribution undertaken by a computer-generated random number system.~Vecuronium group - 0.08mg/kg vecuronium alone~Atracurium group- 0.6mg/kg atracurium alone~Vecuronium-atracurium group- 0.04mg/kg vecuronium and 0.3 mg/kg atracurium combination"|t||t|t
1317219|NCT03371940|Randomized|Parallel Assignment||Treatment||None (Open Label)||Study subjects were randomly assigned to one of the four groups: talk therapy, exercise, talk therapy + exercise, or usual care. Separate randomization lists were generated by the study statistician for use by each of the three study sites.||||
1317220|NCT03371927|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317221|NCT03371914|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1317222|NCT03371901||Single Group Assignment||Treatment||None (Open Label)||||||
1317223|NCT03371888|Randomized|Parallel Assignment||Treatment||None (Open Label)||An intervention performed in experimental group and control group||||
1317224|NCT03371875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317225|NCT03371862||Single Group Assignment||Treatment||None (Open Label)||Pilot study||||
1317226|NCT03371849|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1317227|NCT03371836||Single Group Assignment||Treatment||None (Open Label)||All participants receive treatment and outcome is assessed; there is no control group.||||
1317228|NCT03371823|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1317229|NCT03371810|Randomized|Parallel Assignment||Prevention||Single|Observer-blinded assessment of the primary outcome measure|Prospective, randomized, observer-blinded, controlled, multi-centre, pilot phase-IIa parallel-group design with three arms (two treatment groups and one control group); three trial phases: baseline assessment, 10 weeks of treatment versus treatment as usual; 12 weeks post-treatment observation period.||||t
1317230|NCT03371797|||Other||Prospective|||||||
1317231|NCT03371784|Randomized|Parallel Assignment||Treatment||Triple||1:1 model randomization|t||t|t
1317232|NCT03371771|Randomized|Parallel Assignment||Treatment||Single||Participants will be randomized to receive either Volunteer or MSW-delivered Behavioral Activation||||t
1317233|NCT03371758|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317234|NCT03371745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317235|NCT03371732|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1317236|NCT03371719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317237|NCT03371706|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317238|NCT03371693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317239|NCT03371680||Single Group Assignment||Basic Science||None (Open Label)||||||
1317240|NCT03371667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317241|NCT03371654|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1317242|NCT03371641|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1317243|NCT03371628|Randomized|Parallel Assignment||Treatment||None (Open Label)||A parallel group study is a simple and commonly used clinical design which compares two treatments. Usually a test therapy is compared with a standard therapy. The allocation of subjects to groups is usually achieved by randomisation. The groups are typically named the treatment group and the control group. Parallel group designs do not require the same number of subjects in each group, although often similar numbers are observed. The design is commonly used in randomised controlled trials. Statistical analysis often boils down to a simple t-test of the between group difference in the outcome, which is usually a mean or a proportion.||||
1317244|NCT03371615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317245|NCT03371602|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1317246|NCT03371589||Single Group Assignment||Treatment||None (Open Label)||Patients who cannot receive the oral treatment due to a prior condition e.g. diabetes, high blood pressure, pregnancy.||||
1317247|NCT03371576|||Cohort||Prospective|||||||
1317248|NCT03371563|||Case-Control||Prospective|||||||
1317249|NCT03371550||Single Group Assignment||Treatment||None (Open Label)||This was a prospective, open-label, multicentric, phase II study.||||
1317250|NCT03371537|||Cohort||Prospective|||||||
1317251|NCT03371524|||Case-Only||Prospective|||||||
1317252|NCT03371511|||Cohort||Cross-Sectional|||||||
1317253|NCT03371498|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1317254|NCT03371485|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317255|NCT03371472|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||In a group of patients with PVL there are defined two arms: one where PVL is located in mitral position (10 patients) and the second one where PVL is located in aortic position (10 patients).||||
1317256|NCT03371459|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1317257|NCT03371446|||Case-Control||Other|||||||
1317258|NCT03371433|||Cohort||Retrospective|||||||
1317259|NCT03371420||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317260|NCT03371407|||Cohort||Prospective|||||||
1317261|NCT03371394|||Cohort||Prospective|||||||
1317263|NCT03371368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Cohort||||
1317264|NCT03371355|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317265|NCT03371342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317266|NCT03371329|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose escalation study||||
1317267|NCT03371316||Single Group Assignment||Treatment||None (Open Label)||All patients requiring a hemicraniectomy will also receive the amnion patch as an anti-adhesive barrier||||
1317268|NCT03371303|||Cohort||Prospective|||||||
1317269|NCT03371290|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1317270|NCT03371277|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317271|NCT03371264|||Cohort||Retrospective|||||||
1317272|NCT03371251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317273|NCT03371238|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317274|NCT03371225|Randomized|Factorial Assignment||Other||Triple|||t||t|t
1317275|NCT03371212|Randomized|Parallel Assignment||Treatment||Single|The patient will not have information about the treatment group they've been assigned to until after surgery.|Patients will be randomized to 1 of 2 treatment groups, which they will be in for the duration of the study. Because of the nature of the study, there will be no crossover.|t|||
1317276|NCT03371199|Randomized|Parallel Assignment||Prevention||Single|||t|||
1317277|NCT03371186||Single Group Assignment||Health Services Research||None (Open Label)||Stepped wedge, cluster-controlled implementation science trial||||
1317278|NCT03371173||Single Group Assignment||Treatment||None (Open Label)||Explorative, open-label, uncontrolled monocenter study||||
1317279|NCT03371160||||||||||||
1317280|NCT03371147|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1317281|NCT03371134|||Case-Control||Prospective|||||||
1317282|NCT03371121||Single Group Assignment||Treatment||None (Open Label)||||||
1317283|NCT03371108|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects who meet the study eligibility criteria will be centrally randomized 1:1 in an open-label fashion to receive either Gan & Lee Insulin Glargine Injection or Lantus® for 26 weeks.||||
1317284|NCT03371095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317285|NCT03371082|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects who meet the study eligibility criteria will be centrally randomized 1:1 in an open-label fashion to receive either Gan & Lee Insulin Glargine Injection or Lantus® for 26 weeks. Randomization will be stratified by country.||||
1317286|NCT03371069|||Cohort||Retrospective|||||||
1317287|NCT03371056|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||There are 4 pre-specified groups||||
1317288|NCT03371043|||Cohort||Retrospective|||||||
1317289|NCT03371030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317290|NCT03371017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317291|NCT03371004||Single Group Assignment||Treatment||None (Open Label)||||||
1317292|NCT03370991|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317293|NCT03370978|Randomized|Parallel Assignment||Other||Single|||t|||
1317294|NCT03370965||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317295|NCT03370952|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317296|NCT03370939|||Cohort||Prospective|||||||
1317297|NCT03370926|||Cohort||Prospective|||||||
1317298|NCT03370913||Single Group Assignment||Treatment||None (Open Label)||||||
1317299|NCT03370900|Randomized|Parallel Assignment||Diagnostic||Single|All analyses were blinded to group assignment|This was a four arm randomized control trial. All participants completed an 80-case deliberately practiced learning set of pediatric elbow radiographs followed by an immediate 20-case post-test. Following this, Group 1 had no testing until 12 months; Groups 2, 3, and 4 had testing (20 cases without feedback) every 2 months until 12 months, but Group 3 also had refresher education (20 cases with feedback) at six months while Group 4 had refresher education at two, six, and ten months.||||t
1317300|NCT03370887|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1317301|NCT03370874|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317302|NCT03370861|||Cohort||Prospective|||||||
1317303|NCT03370848|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1317304|NCT03370835|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1317305|NCT03370822|||Cohort||Prospective|||||||
1317306|NCT03370809||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317307|NCT03370796|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317308|NCT03370783||Single Group Assignment||Other||Single|||t|||
1317309|NCT03370770|||Cohort||Retrospective|||||||
1317310|NCT03370757|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Infants will be randomly assigned and stratified by birth weight (≤ 800 grams, >800 grams to 1150 grams, > 1150 grams) to either 3- or 6- hour bundled diaper care.||||
1317311|NCT03370744|||Case-Control||Prospective|||||||
1317312|NCT03370731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317313|NCT03370718||Single Group Assignment||Treatment||None (Open Label)||||||
1317314|NCT03370705|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Multicentric open-label controlled trial||||
1317315|NCT03370692|||Cohort||Prospective|||||||
1317316|NCT03370679|||Cohort||Prospective|||||||
1317317|NCT03370666|Randomized|Parallel Assignment||Treatment||None (Open Label)||Non-inferiority||||
1317318|NCT03370653|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo|"Preliminary safety assessment (N=2): an open-label, escalating dose (2 doses) study.~Core study: conducted on 2 populations in parallel:~A first cohort (N=18): MPS VI patients receiving ERT assigned in 3 arms:~Placebo (N=6)~Odiparcil 500 mg per day (250 mg BID) (N=6)~Odiparcil 1000 mg per day (500 mg BID) (N=6).~A second cohort (N=6): MPS VI patients not receiving ERT (odiparcil 1000 mg per day (500 mg BID))."|t|t|t|t
1317319|NCT03370640|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1317320|NCT03370627||Single Group Assignment||Basic Science||None (Open Label)||||||
1317322|NCT03370601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317323|NCT03370588|Randomized|Parallel Assignment||Supportive Care||Double|Investigator prepared the drug and participant and outcomes assessor were blind to the group allocation|Double blind randomized controlled trial|t|||t
1317324|NCT03370575|Randomized|Parallel Assignment||Treatment||Single||||||t
1317325|NCT03370562|Randomized|Parallel Assignment||Treatment||Quadruple|Study medication provided in blinded syringe labeled with study number||t|t|t|t
1317326|NCT03370549|Randomized|Parallel Assignment||Treatment||None (Open Label)||We employed a two-arm randomized clinical trial to test the preliminary feasibility, safety, and efficacy for AWARE intervention comparing the AWARE intervention group (n=48) with the wait-list group (n =48).||||
1317327|NCT03370536||Single Group Assignment||Treatment||None (Open Label)||||||
1317328|NCT03370523|||Case-Only||Prospective|||||||
1317329|NCT03370510|Randomized|Parallel Assignment||Treatment||Quadruple||Eighty children will be randomly assigned to receive PRT with either oxytocin (forty children) or a placebo (forty children).|t|t|t|t
1317330|NCT03370497|Randomized|Crossover Assignment||Basic Science||Triple||Randomised, double-blind crossover|t||t|t
1317331|NCT03370484|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1317332|NCT03370471|Randomized|Crossover Assignment||Other||None (Open Label)||2x2 crossover design comparing two learning paradigms (Study Only vs. Retrieval Practice) and two training conditions (Moderate Intensity Exercise vs. Gentle Stretching)||||
1317333|NCT03370458|Randomized|Parallel Assignment||Treatment||Triple|Masking will be subjected to Participant, Care Provider, Investigator|Placebo and DR7 will be administered via a parallel design|t|t|t|
1317334|NCT03370445|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317335|NCT03370432|||Other||Prospective|||||||
1317336|NCT03370419||Single Group Assignment||Prevention||None (Open Label)||This is a non-comparative, single group prospective design.||||
1317337|NCT03370406|Randomized|Parallel Assignment||Treatment||None (Open Label)||10 participants will serve as a control group, and will receive neither 5FU injection nor topical imiquimod. 10 participants will receive one 1ml intralesional injection of 50mg/ml 5FU aqueous injectable solution every week for 3 weeks. 10 participants will receive intralesional 5FU as in the previous group, additionally they will also receive concomitant three-times-weekly topical application of 5% imiquimod to the same lesion. At the end of week two, a 2mm punch biopsy of the lesion will be obtained for mid-point analysis, and will be stored for tissue banking. A week after the last injection (week 4), the lesion will be surgical resected in all participants including the control group, to render the participants disease free. Resection is the current standard of care. A portion of the resected tumor and skin will also be stored for tissue banking, for future study.||||
1317338|NCT03370393|Randomized|Parallel Assignment||Prevention||None (Open Label)||The families will be randomized to Pathways for African Americans' Success (PAAS) intervention program or a wait-list condition (1:1 ratio) for 6 weeks. The wait-list group has the option to participate in the PAAS program at the end of the study.||||
1317339|NCT03370380|||Other||Prospective|||||||
1317340|NCT03370367|Randomized|Parallel Assignment||Prevention||Single|||t|||
1317341|NCT03370354|||Cohort||Prospective|||||||
1317342|NCT03370341|Randomized|Crossover Assignment||Basic Science||Double||Participants will complete active and sham simulation sessions in a randomized, counterbalanced order approximately one week apart.|t|||t
1317343|NCT03370328|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317344|NCT03370315|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317345|NCT03370302|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1317346|NCT03370289||Single Group Assignment||Prevention||None (Open Label)||||||
1317347|NCT03370276|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317348|NCT03370263|||Case-Only||Prospective|||||||
1317349|NCT03370250|||Case-Only||Retrospective|||||||
1317350|NCT03370237|||Case-Only||Cross-Sectional|||||||
1317351|NCT03370224|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317352|NCT03370211|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1317353|NCT03370198|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||There will be a hepatic transarterial administration of NKR-2 every 2 weeks for a total of 3 administrations within 4 weeks (28 days). Three dose-level will be assessed (dose escalation with 3 dose-levels or 3 cohorts).||||
1317354|NCT03370185||Single Group Assignment||Treatment||None (Open Label)||||||
1317355|NCT03370172|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1317356|NCT03370159||Single Group Assignment||Treatment||None (Open Label)||||||
1317357|NCT03370146|||Cohort||Prospective|||||||
1317358|NCT03370133|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317359|NCT03370120||Single Group Assignment||Treatment||None (Open Label)||||||
1317360|NCT03370107|Randomized|Parallel Assignment||Treatment||Quadruple|The sham coil of the Hcoil procedure produces a similar acoustic artefact and scalp sensation as the active coil and mimics the facial muscle activation induced by the active coil. The sham stimulation of the conventional rTMS will be carried out with the opposite face of the coil (biface coil) of identical size, color and shape emitting a sound similar to that emitted by the active coil (B65 A/P Butterfly Coil Magventure).|Patients will be randomly assigned to one of 2 treatment groups: active rTMS and Hcoil or sham rTMS and sham Hcoil, according to a 2 : 1 ratio (2 for active, 1 for placebo).|t|t|t|t
1317361|NCT03370094|||Cohort||Prospective|||||||
1317362|NCT03370081|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1317363|NCT03370068|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1317364|NCT03370055|Randomized|Crossover Assignment||Treatment||Single|A blinded assesor will evaluate wound healing at the first woundhealing and 2 weeks after woundhealing|observer blinded, randomised, controlled study||||t
1317365|NCT03370042|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317366|NCT03370029|||Case-Control||Cross-Sectional|||||||
1317367|NCT03370016|Randomized|Parallel Assignment||Supportive Care||Triple|Double Blinded|Prospective, Randomized Trial|t|t|t|
1317368|NCT03370003|||Cohort||Other|||||||
1573429|NCT00001270||||Treatment||||||||
1317369|NCT03369990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317370|NCT03369977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317371|NCT03369964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317372|NCT03369951||Single Group Assignment||Treatment||None (Open Label)||||||
1317373|NCT03369938|Randomized|Parallel Assignment||Treatment||Single||||||t
1317374|NCT03369925|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1317375|NCT03369912||Parallel Assignment||Treatment||Triple|"This is a patient, investigator and sponsor-blinded study. Patients, investigators and sponsor will remain blinded to study treatment throughout the study.~With the exception of any unblinded site staff identified below, all site staff (including study investigator and study nurse) will be blinded to study treatment throughout the study.~Drug product will be supplied in patient specific kits, so an unblinded pharmacist who is independent of the study team will be required in order to maintain the blind. Appropriate measures must be taken by the unblinded pharmacist to ensure that the treatment assignments are concealed from the rest of the site staff."|This is a randomized, patient, investigator and sponsor blinded, placebo-controlled study in pregnant women with primary HCMV infection. This study is a non-confirmatory trial.|t||t|t
1317376|NCT03369899|||Cohort||Prospective|||||||
1317377|NCT03369886|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"3 subject groups:~Normal control:~Subjects who has normal fundus, normal visual field and normal intraocular pressure.~Early glaucoma:~: Patients who shows glaucomatous visual field abnormality but visual field mean deviation is > -6 dB~Advanced glaucoma : Patients who shows glaucomatous visual field abnormality but visual field mean deviation is < -6 dB"||||
1317378|NCT03369873|Randomized|Parallel Assignment||Other||Single|The profissional that evaluated the patients, was not informed if the patients were of the control or intervention group. The outcomes assessor was not informed if the group 1 and 2 was control or intervention group.|The patients were randomized to one of two groups (control or intervention), according to the sequence determined by the Random System||||t
1317379|NCT03369860||Single Group Assignment||Basic Science||None (Open Label)||||||
1317380|NCT03369847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317381|NCT03369834|Randomized|Parallel Assignment||Treatment||Double||Control Group (GC=24) LED red group (GLED-V = 24) Infrared LED Group (GLED-IV = 24)|||t|t
1317382|NCT03369821|||Case-Control||Cross-Sectional|||||||
1317383|NCT03369808|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1317384|NCT03369795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317385|NCT03369782|Randomized|Parallel Assignment||Treatment||Quadruple|The syringes are prepared by the research assistant who was not involved in patient management. The anesthetist and surgeon are blinded for patient allocation.|Group A receives rocuronium, followed by sugammadex. Group B receives placebo|t|t|t|t
1317386|NCT03369769|Non-Randomized|Crossover Assignment||Health Services Research||Single|Coders for the videotaped behavioral data collected via the OHAIRE-M tool were blind to specific study objective.|To investigate the effect of canine animal assisted activities (AAA) on physiological arousal levels in children and adolescents with autism spectrum disorder (ASD) (ages 4 to 17 years) in a specialized psychiatric hospital program. It is hypothesized that children with ASD will demonstrate lower physiological arousal in the presence of canines, compared to a non-animal control.||||t
1317387|NCT03369756||Single Group Assignment||Treatment||None (Open Label)||||||
1317388|NCT03369743|||Case-Control||Cross-Sectional|||||||
1317389|NCT03369730|||Case-Only||Prospective|||||||
1317390|NCT03369717|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317391|NCT03369704|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1317392|NCT03369691|||Cohort||Cross-Sectional|||||||
1317393|NCT03369678|||Case-Only||Cross-Sectional|||||||
1317394|NCT03369665||Single Group Assignment||Treatment||None (Open Label)||||||
1317395|NCT03369652|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1317396|NCT03369639|||Case-Only||Prospective|||||||
1317397|NCT03369626||Single Group Assignment||Treatment||None (Open Label)||evaluation of pre/post measures of a single group||||
1317398|NCT03369613|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1317399|NCT03369600||Single Group Assignment||Health Services Research||None (Open Label)||||||
1317400|NCT03369587|Randomized|Parallel Assignment||Treatment||Single|Assessor Blind to group allocation|A phase II exploratory randomised controlled trial of a handwriting intervention with an active comparator control group and blinded assessments||||t
1317401|NCT03369574|||Cohort||Prospective|||||||
1317402|NCT03369561|||Cohort||Prospective|||||||
1317403|NCT03369548|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317404|NCT03369535|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1317405|NCT03369522|||Cohort||Prospective|||||||
1317406|NCT03369509|||Cohort||Prospective|||||||
1317407|NCT03369496|||Cohort||Prospective|||||||
1317408|NCT03369483|||Cohort||Prospective|||||||
1317409|NCT03369470|Randomized|Parallel Assignment||Treatment||Single||||||t
1317410|NCT03369457|||Case-Control||Prospective|||||||
1317411|NCT03369444||Single Group Assignment||Treatment||None (Open Label)||||||
1317412|NCT03369431|Randomized|Crossover Assignment||Treatment||Quadruple||3-month randomised controlled cross-over design with 4-week washout. Outcomes measured at baseline and last week of each treatment phase.|t|t|t|t
1317413|NCT03369418|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317414|NCT03369405|||Other||Retrospective|||||||
1317415|NCT03369392|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1317416|NCT03369379|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind, the subject of study and researcher.|Longitudinal, prospective, interventional, randomized.|t|t|t|t
1317417|NCT03369366||Single Group Assignment||Treatment||None (Open Label)||||||
1317418|NCT03369353|||Cohort||Prospective|||||||
1317523|NCT03367988|Randomized|Parallel Assignment||Prevention||Single|Single Blinded: Study participants will not know what form of anesthesia they are being given.|Randomized Controlled Trial|t|||
1317419|NCT03369340|Randomized|Crossover Assignment||Other||None (Open Label)|Sponsor staff, Investigator, the subjects and the investigational site will be blinded to the randomization sequences until they are assigned. Subjects will not be informed of the complete sequence to which they have been assigned.|A single-center, open-label, randomized, crossover study.||||
1317420|NCT03369327||Single Group Assignment||Treatment||None (Open Label)||||||
1317421|NCT03369314|||Case-Only||Prospective|||||||
1317422|NCT03369301|||Case-Only||Prospective|||||||
1317423|NCT03369288||Single Group Assignment||Diagnostic||None (Open Label)||Prospective PET-MRI follow-up||||
1317424|NCT03369275|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind||t|t|t|t
1317425|NCT03369262|Randomized|Parallel Assignment||Treatment||Quadruple|Matching placebo.|A phase 2a, double-blind, parallel group, randomised, placebo controlled, added-on to atosiban.|t|t|t|t
1317426|NCT03369249|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317427|NCT03369236|Randomized|Parallel Assignment||Treatment||Double|Investigator and subject blinded; Sponsor Open|Randomized, Double-Blind|t||t|
1317428|NCT03369223|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317429|NCT03369210|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1317430|NCT03369197|Randomized|Parallel Assignment||Treatment||Single|||||t|
1317431|NCT03369184|Randomized|Parallel Assignment||Treatment||Triple|The patients are randomized in a double blinded fashion by a designated study nurse (simple envelope randomization) to either supplemental oxygen 6l/min delivered by an open face mask (Oxymask®) or ambient air (sham placement of Oxymask®). Neither the patient, nor the performing physician will be aware of the randomization status. Peripheral oxygen saturation will be disclosed only to the nurse responsible for randomization.||t|t||t
1317432|NCT03369171||Single Group Assignment||Other||None (Open Label)||||||
1317433|NCT03369158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317434|NCT03369145|Randomized|Crossover Assignment||Basic Science||None (Open Label)||The study design is a randomised, controlled, crossover design in which participants undertake two 7-day dietary conditions in a randomised order with a three week washout period in between.||||
1317435|NCT03369132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317436|NCT03369119|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317437|NCT03369106|||Cohort||Prospective|||||||
1317438|NCT03369093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317439|NCT03369080|||Cohort||Prospective|||||||
1317440|NCT03369067|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1317441|NCT03369054|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317442|NCT03369041|||Cohort||Prospective|||||||
1317443|NCT03369028|||Cohort||Prospective|||||||
1317444|NCT03369015|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1317445|NCT03369002|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317446|NCT03368989|||Cohort||Prospective|||||||
1317447|NCT03368976|||Cohort||Prospective|||||||
1317448|NCT03368963||Single Group Assignment||Treatment||None (Open Label)||||||
1317449|NCT03368950|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised Wait list or Intervention Arms||||
1317450|NCT03368937||Single Group Assignment||Other||None (Open Label)||||||
1317451|NCT03368924||Single Group Assignment||Basic Science||None (Open Label)||||||
1317452|NCT03368911|Randomized|Parallel Assignment||Prevention||Single|Primary outcome is assessed by other investigator who do not know which endotrachdeal tube is used.|||||t
1317453|NCT03368898|||Other||Cross-Sectional|||||||
1317454|NCT03368885|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1317455|NCT03368872|Randomized|Parallel Assignment||Treatment||Quadruple||Parallel assignment|t|t|t|t
1317456|NCT03368859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317457|NCT03368846||Single Group Assignment||Basic Science||None (Open Label)||||||
1317458|NCT03368833|||Case-Control||Prospective|||||||
1317459|NCT03368820|||Cohort||Prospective|||||||
1317460|NCT03368807|||Other||Prospective|||||||
1317461|NCT03368794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317462|NCT03368781||Single Group Assignment||Diagnostic||None (Open Label)||None randomized, single-arm, open label.||||
1317463|NCT03368768|||Case-Only||Prospective|||||||
1317464|NCT03368755|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1317465|NCT03368742|Randomized|Parallel Assignment||Treatment||None (Open Label)||Active treatment group vs untreated control group.||||
1317466|NCT03368729|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||There are two phases to this study. Phase 1 will enroll 6-12 patients and Phase 2 will enroll up to 40. Trastuzumab will be given intravenously at 6 mg/kg on Day 1 for each 21 day cycle in both phases. Niraparib will be given by mouth every day at a dosage of 300 mg for phase 1 participants and 200 mg (or 300 mg/kg) for phase 2 participants. Tumor measurement and response will be monitored by MRI or CT scans after cycles 3 and 6 and then every 12 weeks for up to 2 years or until disease progression. Blood and tissue samples will be collected for pharmacokinetics, biomarkers, and laboratory evaluations.||||
1317467|NCT03368716||Single Group Assignment||Treatment||None (Open Label)||||||
1317468|NCT03368703|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1317469|NCT03368690|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1317470|NCT03368677|||Case-Control||Prospective|||||||
1317471|NCT03368664||Single Group Assignment||Treatment||None (Open Label)||||||
1317472|NCT03368651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317473|NCT03368638||Single Group Assignment||Treatment||None (Open Label)||Case Series||||
1317474|NCT03368625||Single Group Assignment||Treatment||None (Open Label)||Patients with resectable brain mets will receive neoadjuvant stereotactic radiosurgery prior to surgical resection.||||
1317475|NCT03368612|||Cohort||Prospective|||||||
1317476|NCT03368599|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1317477|NCT03368586|||Case-Only||Prospective|||||||
1317478|NCT03368573|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Participants in the experimental arm (QbTest) protocol will also undergo standard assessment as usual plus a QbTest. If a QbTest was not conducted within 12 weeks prior to starting medication (as part of the ADHD diagnostic assessment procedure) the young person will sit a QbTest at baseline (off medication). Once on medication they will sit another QbTest 2-4 weeks after commencing medication and again 8-10 weeks later (and no later than 12 weeks).~Participants in the control arm will undergo standard treatment as usual for ADHD. This will involve the clinician reviewing the child's symptom improvement once on medication and altering the dose according to their clinical judgement which may be informed by rating scales (completed by the parent, teacher and/or young person) and interviews with the parent and young person."||||
1317479|NCT03368560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This study will recruit 30 patients with treatment-resistant late life depression, and 7 age-matched controls.||||
1317480|NCT03368547||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317481|NCT03368534||Single Group Assignment||Treatment||None (Open Label)||||||
1317482|NCT03368521|Randomized|Parallel Assignment||Screening||Single|||t|||
1317483|NCT03368508|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1317484|NCT03368495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317485|NCT03368482|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317486|NCT03368469||Single Group Assignment||Treatment||None (Open Label)||||||
1317487|NCT03368456|Randomized|Parallel Assignment||Prevention||Double||To test the preliminary efficacy of S4E, we will conduct a Stage I RCT and use a mixed between/within-subjects design with two levels of intervention (S4E and Usual Care) as the between-subjects factor and three repeated measures assessments (Baseline, 3-, and 6-months post-Baseline) as the within-subjects factor.|t||t|
1317488|NCT03368443|Randomized|Parallel Assignment||Treatment||Single||||||t
1317489|NCT03368430|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317490|NCT03368417|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317491|NCT03368404|Randomized|Parallel Assignment||Treatment||Single|||||t|
1317492|NCT03368391|Randomized|Crossover Assignment||Other||Triple|the dentist who administered the study medications will know their identity but the participant, investigator who tests the teeth, and person calling for later outcomes will not know.|triple blinded cross over randomized controlled trial|t||t|t
1317493|NCT03368378|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317494|NCT03368365||Single Group Assignment||Prevention||None (Open Label)|The occurrence of unplanned hospitalizations is independent of the spirometer used.|All transplanted subjects will be equiped with the Ventilotel (r) after their inclusion in the study.||||
1317495|NCT03368352|Randomized|Crossover Assignment||Basic Science||Quadruple||Randomized, double-blind, placebo controlled|t|t|t|t
1317496|NCT03368339|Randomized|Parallel Assignment||Treatment||Double|Double-Masked||t||t|
1317497|NCT03368326|||Case-Crossover||Prospective|||||||
1317498|NCT03368313|Randomized|Parallel Assignment||Treatment||Single||||||t
1317499|NCT03368300|Non-Randomized|Parallel Assignment||Other||None (Open Label)|Not masking, 2 groups parallel|"The primary aim of this study is to estimate the frequency and to characterize clinically atypical parkinsonism in the French West Indies and Guyana.~This study has been designed as epidemiological, multicentric transversal descriptive and longitudinal prospective study with biological collection and post-mortem neuropathological sub-study of brain tissue."||||
1317500|NCT03368287||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317501|NCT03368274||Single Group Assignment||Treatment||None (Open Label)||To compare IgG4-RD responder index, serum parameters and blood lymphocytes subpopulations at baseline and after treatment of 12 weeks and 24 weeks||||
1317502|NCT03368261||Single Group Assignment||Other||None (Open Label)||||||
1317503|NCT03368248|||Other||Prospective|||||||
1317504|NCT03368235|Randomized|Parallel Assignment||Treatment||Triple|Double dummy technique|Randomized, double blind, parallell arm study with two weeks treatment of AZD9567 or prednisolone|t|t|t|
1317505|NCT03368222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"Part A - Dose escalation cohort. DOSE LEVEL 1: 200mg pembrolizumab week 1 (then 3 weekly) + SBRT dosed at 30 Gy in 3 fractions (#) (Monday, Wednesday & Friday) in week 3.~DOSE LEVEL 2: 200mg pembrolizumab in week 1 (then 3 weekly) + SBRT dosed at 54 Gy in 3# (Monday, Wednesday & Friday) in week 3.~Part B - Expansion cohort. 12 patients 200mg of pembrolizumab week 1 (then 3 weekly) + SBRT in week 3, dosed at MTD determined in Part A (3# - Monday, Wednesday & Friday)."||||
1317506|NCT03368209|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Open, non-randomized comparison study between device and blood references with diabetic patients||||
1317507|NCT03368196||Single Group Assignment||Treatment||None (Open Label)||||||
1317508|NCT03368183|Non-Randomized|Sequential Assignment||Treatment||Single||In alternating months providers will be given the SCAMP vs. a shorter forms that does not include clinical decision support||||t
1317509|NCT03368170|Randomized|Parallel Assignment||Treatment||Quadruple||Double blind, placebo controlled|t|t|t|t
1317510|NCT03368157|||Cohort||Prospective|||||||
1317511|NCT03368144||Single Group Assignment||Treatment||None (Open Label)||||||
1317512|NCT03368131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317513|NCT03368118||Single Group Assignment||Treatment||None (Open Label)||open-label, follow-up study||||
1317514|NCT03368105|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1317515|NCT03368092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317516|NCT03368079||Single Group Assignment||Supportive Care||None (Open Label)||||||
1317517|NCT03368066||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317518|NCT03368053||Single Group Assignment||Basic Science||None (Open Label)||Descriptive mono-centric study with one single group.||||
1317519|NCT03368040|||Cohort||Prospective|||||||
1317520|NCT03368027|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1317521|NCT03368014|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317522|NCT03368001|Randomized|Parallel Assignment||Treatment||Single||||||t
1317524|NCT03367975|||Cohort||Prospective|||||||
1317525|NCT03367962|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1317526|NCT03367949|Randomized|Parallel Assignment||Other||Quadruple|"Each patient will be given a code by the researcher (A.A) and the observers will be blind to which group this case belong.~Patients, evaluators and data analyst will be blinded"||t|t|t|t
1317527|NCT03367936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317528|NCT03367923|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1317529|NCT03367910||Single Group Assignment||Prevention||None (Open Label)||Participants with eligible MDRO UTIs will receive FMT.||||
1317530|NCT03367897|||Case-Control||Prospective|||||||
1317531|NCT03367884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317532|NCT03367871||Single Group Assignment||Treatment||None (Open Label)||||||
1317533|NCT03367858|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1317534|NCT03367845|Randomized|Factorial Assignment||Other||Double|Care Providers and Assessors represent two different teams of staff. Each is blind to the other status (how families did during assessment and which group families are assigned to). They do not have access to each others' files.|2 X 2 factorial design testing two different interventions||t||t
1317535|NCT03367832|||Cohort||Prospective|||||||
1317536|NCT03367819|Randomized|Parallel Assignment||Treatment||None (Open Label)||Random assignment used only for allocation to Cohort A-1 or A-2||||
1317537|NCT03367806|||Cohort||Prospective|||||||
1317538|NCT03367793|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1317539|NCT03367780|||Cohort||Prospective|||||||
1317540|NCT03367767|||Cohort||Prospective|||||||
1317541|NCT03367754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317542|NCT03367741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317543|NCT03367728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317544|NCT03367715||Single Group Assignment||Treatment||None (Open Label)||||||
1317545|NCT03367702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317546|NCT03367689||Single Group Assignment||Treatment||None (Open Label)||This is an international, multi-centre, non-controlled, open-label, single arm, two-stage Simon Design phase II study.||||
1317547|NCT03367676||Single Group Assignment||Treatment||None (Open Label)||||||
1317548|NCT03367663|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317549|NCT03367650||Single Group Assignment||Diagnostic||None (Open Label)||Bi-centric epidemiological prospective, cross-sectional descriptive study coupled with a longitudinal study.||||
1317550|NCT03367637|Randomized|Parallel Assignment||Supportive Care||Single||"We will enroll 80 advanced cancer patients with moderate to severe pain needs (10 per month) with estimated 40% females. Following informed consent, study staff will administer baseline assessments, assess eligibility and obtain consent. Subsequently, eligible consenting patients, will be randomly assigned via computer-generated randomization, to standard palliative care (currently provided at Rwanda Palliative Care and Hospice Organization) or to the new smartphone intervention (with biweekly and SOS symptom assessment and response) plus standard care for 3 months. The probability of being assigned to either group will be equal (50%).~With 36 patients per group, we will have 85% power to detect a clinically significant difference of 1 point on the pain score [SD=1.4] between the two treatment groups at 3-months with an alpha of 0.05. Based on prior studies and assuming an attrition rate of no more than 10%, we increased our sample size to 40 patients per group."||||t
1317551|NCT03367624|||Case-Only||Retrospective|||||||
1317552|NCT03367611||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317553|NCT03367598|||Case-Control||Prospective|||||||
1317554|NCT03367585|Randomized|Parallel Assignment||Treatment||Double||Randomized prospective clinical trial, double-blind, placebo-controlled intervention|t||t|
1317555|NCT03367572|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1317556|NCT03367559||Single Group Assignment||Prevention||None (Open Label)|An open label study to evaluate immunogenicity, safety, and reactogenicity of Rotavac® (live attenuated rotavirus vaccine) as a 3-dose series in healthy infants aged between 6 weeks and 8 weeks in Vietnam|||||
1317557|NCT03367546||Single Group Assignment||Treatment||None (Open Label)||||||
1317558|NCT03367533|Randomized|Crossover Assignment||Basic Science||Double||The investigators employ a counter-balanced cross-over design in which ketamine plus perampanel is given on one day, and approximately 14 days later ketamine plus placebo is given.|t||t|
1317559|NCT03367520||Single Group Assignment||Treatment||None (Open Label)||This project has two phases. Phase 1: Develop StayQuit materials and train the study interventionist. Phase 2: Implement StayQuit with 10-20 Veterans who are hospitalized on the inpatient psychiatric unit at the Baltimore VA Medical Center.||||
1317560|NCT03367507|Randomized|Parallel Assignment||Treatment||Double|Participants will not be blinded to group assignment, as it would be impossible to make them unaware of how intense their exercise prescription should be but they will be blinded to the other treatment assignment and masked to the study hypothesis. The treating sport medicine physician will be blinded to group assignment. There will be an exercise physiologist who will be responsible for conducting the treadmill tests and, prescribing aerobic exercise programs. The study exercise physiologist will not be blinded and will not relay any information pertaining to group assignment to other members involved in the study other than the participants themselves and their parents. Those assessing adverse events will not be masked and if needed to facilitate clinical care the managing physician will be made aware of the treatment group. Compliance will be tracked through the use of Actigraph accelerometers, heart rate monitors and daily activity logs.|Research statement:This study is a multi-centre RCT. The purpose of the RCT is to evaluate the efficacy of a moderate intensity (80% symptom threshold HR, Borg RPE 12-16) sub-symptom aerobic exercise prescription compared to a lower level aerobic exercise group (60% HR, Borg RPE 7-11) on time to medical clearance to receive medical clearance to return to play in adolescents (aged 13-19) with suggested physiological Post-Concussion Disorder (P-PCD).|||t|t
1317561|NCT03367494|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1317562|NCT03367481|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1317563|NCT03367468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317564|NCT03367455|||Cohort||Retrospective|||||||
1317565|NCT03367442|||Cohort||Prospective|||||||
1317566|NCT03367429|Randomized|Parallel Assignment||Other||None (Open Label)||"Please see study design for details regarding how design for this experiment will be determined.~If the within-subject design is used, N=15 and subjects will be randomized 1:1 to receive the standard injection to either the LGM or MGM. The experimental injection will be delivered to the muscle not receiving the standard injection.~If the between-subject design must be used, N=25 and subjects will be randomized 2:3 to receive either the experimental or standard injection to the spastic LGM.~Please note the following:~Standard Injection: 25 units of onobotulinumtoxinA (Botox®) diluted in 0.25cc of saline.~Experimental Injection: 25 units of onobutilinumtoxinA (Botox®) diluted in 0.50cc of saline."||||
1317567|NCT03367416|||Cohort||Cross-Sectional|||||||
1317568|NCT03367403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317569|NCT03367390||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1317570|NCT03367377|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317571|NCT03367364|Randomized|Parallel Assignment||Prevention||Double|Within strata, a coin toss (ERH) will be used to randomize floors into either the Patient education bundle arm or the Nurse feedback arm. The VTE prophylaxis medication non-administration dataset provided to the biostatistical team (i.e. outcomes assessors) for analysis will be blinded by treatment arm and department.|"In the PEB arm, the intervention will include:~A charge nurse will intervene in real-time via an EHR-triggered alert when there is documentation that a dose of VTE prophylaxis medication is not given for any reason. The charge nurse will speak to the bedside nurse and one of them will provide the patient with the education bundle including one-on-one personalized discussion, supplemented by a 2-page paper handout and patient education video.~In the NFC arm, the intervention will include:~Nurse leadership (i.e. managers, directors) will provide data to all nurses on their personal clinical effectiveness with the proportion of doses of VTE prophylaxis administered. The data will have comparisons to their nurse peers on the same floor. Coaching for nurses will include one-on-one conversations with bedside nurses with lower performance than their peers."|t|||t
1317572|NCT03367351|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, un-blinded intervention/control design||||
1317573|NCT03367338|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1317574|NCT03367325|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1317575|NCT03367312||Single Group Assignment||Diagnostic||None (Open Label)|The outcomes assessor, the radiologist who is reading the imaging will be blinded to treatment.|This will be a single blinded open label study enrolling 10 patients with Pulmonary Hypertension who are currently on a stable dose of Inhaled Prostacyclin for treatment of PH.||||
1317576|NCT03367299||Single Group Assignment||Treatment||None (Open Label)||||||
1317577|NCT03367286|||Cohort||Prospective|||||||
1317578|NCT03367273|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1317579|NCT03367260|||Cohort||Prospective|||||||
1317580|NCT03367247||Single Group Assignment||Supportive Care||None (Open Label)||||||
1317581|NCT03367234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317582|NCT03367221||Single Group Assignment||Treatment||None (Open Label)||||||
1317583|NCT03367208|||Cohort||Retrospective|||||||
1317584|NCT03367195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317585|NCT03367182|||Cohort||Retrospective|||||||
1317586|NCT03367169|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|||||
1317587|NCT03367156|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1317588|NCT03367143||Single Group Assignment||Treatment||None (Open Label)||||||
1317589|NCT03367130|Randomized|Parallel Assignment||Health Services Research||Double|This study will be a double blinded RCT. HIV-positive individuals will be blinded to allocation group. Further, those who deliver the intervention will be blinded to the allocation. Intervention and control groups will receive similar intervention strategies. Only the content of the interventions will be different. Therefore, it is difficult for HIV-positive individuals to tell if they are receiving intervention or control. The outcome assessor will be masked to the allocation of each HIV-positive individual by using trial identity numbers. Only the principal researcher will have complete access to all the information.||t|||t
1317590|NCT03367117|||Cohort||Retrospective|||||||
1317591|NCT03367104|||Case-Control||Prospective|||||||
1317592|NCT03367091||Single Group Assignment||Basic Science||None (Open Label)||||||
1317593|NCT03367078|||Cohort||Other|||||||
1317594|NCT03367065||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317595|NCT03367052|Randomized|Parallel Assignment||Treatment||None (Open Label)||542 DDD patients (age from 20 to 70) from several hospitals matching the inclusion criteria will be randomly assigned to two groups (271 patients in each group). One group will be treated with two level ProDisc-C vivo disc replacement. The other group will be treated with hybrid construct. Clinical outcomes and radiological analysis will be compared between the two groups at 1.5, 3, 6, 12, 24, 36, 60, and 84 months after the surgical treatments.||||
1317596|NCT03367039|Randomized|Parallel Assignment||Treatment||None (Open Label)||648 DDD patients (age from 20 to 70) from several hospitals matching the inclusion criteria will be randomly assigned to two groups (324 patients in each group). One group will be treated with ProDisc-C vivo disc replacement. The other groups will be treated with ACDF.||||
1317597|NCT03367026|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1317598|NCT03367013|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1317599|NCT03367000|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, open label controlled trial||||
1317600|NCT03366987|||Other||Cross-Sectional|||||||
1317601|NCT03366974||Single Group Assignment||Basic Science||None (Open Label)||An open-label, one-sequence, three-period study||||
1317602|NCT03366961||Single Group Assignment||Treatment||None (Open Label)||||||
1317603|NCT03366948|||Other||Prospective|||||||
1317604|NCT03366935|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317645|NCT03366402|||Cohort||Prospective|||||||
1317646|NCT03366389|||Case-Control||Cross-Sectional|||||||
1317647|NCT03366376||Single Group Assignment||Treatment||None (Open Label)||||||
1317697|NCT03365726|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1317605|NCT03366922|Randomized|Parallel Assignment||Treatment||Double|"Two research assistants will be recruited and trained as observers and data collectors to increase accuracy and consistency in documenting the needed data. They will be assisted by the HIV clinic staff and these research assistants will be blinded to the hypotheses of this study to minimize observer bias and facilitate participant randomization. Senior clinician at the HIV clinic will supervise the trial and administration of treatments for HAART patients attending at the MRRH clinic.~To endure blinding, a study nurse will randomize and interview the participants and or draw blood whenever necessary. Study phlebotomist will draw blood and deliver it to the respective laboratory with codes masking the arm in which that patient is randomized. Independent laboratory technicians will run the tests at Epicenter and MUST research Labs."|Participants will be stratified according to baseline CD4 levels: 350 - 250, 249 - 150, below 149. Computer generated numbers will be used to assign selected participants into study groups using simple randomization method to either control group with HAART only, or HAART with Artemisia annua group or HAART with Artemisia annua and Moringa oleifera group of 1:1:1.|t|t||
1317606|NCT03366909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317607|NCT03366896||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317608|NCT03366883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317609|NCT03366870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317610|NCT03366857|Randomized|Parallel Assignment||Treatment||Double|Participants don´t know the randomized oxygen concentration. The postoperative follow up will be performed by a blinded research fellow.||t|||t
1317611|NCT03366844||Single Group Assignment||Treatment||None (Open Label)||"Single Arm with Two Cohorts~Cohort 1: High-risk, ER-positive and HER2-negative breast cancer patients with primary tumors measuring at least 2cm~Cohort 2: TNBC patients with primary tumors measuring at least 2cm"||||
1317612|NCT03366831|Randomized|Parallel Assignment||Other||Single|||t|||
1317613|NCT03366818||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1317614|NCT03366805|Randomized|Parallel Assignment||Supportive Care||Single|Care provider is not informed of which patient education video(s) the patient was provided, unless that patient initiates a conversation with the provider regarding the video.|prospective, randomized clinical trial||t||
1317615|NCT03366792||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317616|NCT03366779||Single Group Assignment||Prevention||None (Open Label)||Multicenter non-randomized device trial||||
1317617|NCT03366766|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317618|NCT03366753|Non-Randomized|Factorial Assignment||Supportive Care||None (Open Label)||Acute normovolemic hemodilution consists of phlebotomy and intravascular volume resuscitation by using crystalloid/colloid in a same amount of phlebotomy||||
1317619|NCT03366740|Randomized|Parallel Assignment||Treatment||None (Open Label)||Study design: This will be an open-labeled randomized controlled clinical trial with three treatment arms (3/4th strength rice suji, full strength rice suji with modification and GB mixed full strength rice suji). Investigators will prospectively screen, children > 6 to 36 months of age admitted to the Dhaka hospital of icddr,b, with PD or developed PD during their treatment period and failed to respond with milk suji and enroll them for the study. Thereafter permuted block randomization technique will be followed to select treatment arms for each child.||||
1317620|NCT03366727|Randomized|Parallel Assignment||Treatment||Single||one arm treated with drug-coated balloon catheter, the other arm treated with plain balloon catheter||||t
1317621|NCT03366714|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1317622|NCT03366701|||Cohort||Prospective|||||||
1317623|NCT03366688|Randomized|Parallel Assignment||Other||Double|||t||t|
1317624|NCT03366675||Single Group Assignment||Treatment||None (Open Label)||||||
1317625|NCT03366662|||Cohort||Prospective|||||||
1317626|NCT03366649|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317627|NCT03366636|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317628|NCT03366623|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1317629|NCT03366610|||Cohort||Prospective|||||||
1317630|NCT03366597||Single Group Assignment||Treatment||None (Open Label)||one group is treated with sevoflurane, the other is not.||||
1317631|NCT03366584|Randomized|Parallel Assignment||Prevention||Single|The neonates outcomes, hyaline membrane disease and feeding intolerance, will be assessed for maximum period of 4 weeks by doctor who in charge in NICU. They are outside the research team and blind to maternal treatment allocation.|The research will be held in Cipto Mangunkusumo General Hospital. Each participant of each group will be given dexamethasone 2x6 mg intravenous for 2 days which aims to support lung maturation followed by planned delivery within 1 week due to indication of maternal or fetal. The maternal dan cord blood sample are obtained for zinc, vitamin A and 25(OH)D levels examinations. Randomly, subjects will be divided into 2 groups which are group who is given the oral beta-carotene 25,000 IU, oral vitamin D3 50,000 IU and oral zinc 50 mg/day for 3 days, and group who is not given the intervention. After the premature neonates was born, observation will be done for maximum period of 4 weeks. The presence and severity of HMD and feeding intolerance or NEC will be recorded.||||t
1317632|NCT03366571|||Cohort||Prospective|||||||
1317633|NCT03366558|||Case-Control||Prospective|||||||
1317634|NCT03366545|||Other||Prospective|||||||
1317635|NCT03366532|||Cohort||Prospective|||||||
1317636|NCT03366519|||Cohort||Prospective|||||||
1317637|NCT03366506|||Cohort||Prospective|||||||
1317638|NCT03366493|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1317639|NCT03366480|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317640|NCT03366467|Randomized|Crossover Assignment||Other||None (Open Label)||The participants will be randomly assigned into two groups. Group 1 will initially be treated under SADE (Time 1) and receive RDE on the second encounter (Time 2). For the second group, the procedure is reversed (RDE at Time 1 and SADE at Time 2).||||
1317641|NCT03366454|||Cohort||Prospective|||||||
1317642|NCT03366441|Randomized|Parallel Assignment||Other||Single|||t|||
1317643|NCT03366428||Single Group Assignment||Treatment||None (Open Label)||||||
1317644|NCT03366415|Randomized|Parallel Assignment||Treatment||None (Open Label)||Stratified by stage and treatment center.||||
1317648|NCT03366363|Randomized|Parallel Assignment||Treatment||Double|Acupuncturist (Electro-acupuncture group and Manual acupuncture group), Participant, Outcome Assessor||||t|t
1317649|NCT03366350||Single Group Assignment||Treatment||None (Open Label)||Patients receive CAR-T therapy and HSCT.||||
1317650|NCT03366337|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317651|NCT03366324||Single Group Assignment||Treatment||None (Open Label)||The only one group of patients will receive the combination of CAR-T therapy and HSCT.||||
1317652|NCT03366311|Randomized|Crossover Assignment||Treatment||Single||Prospective randomised crossover manikin study|t|||
1317653|NCT03366298|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1317654|NCT03366285|||Cohort||Prospective|||||||
1317655|NCT03366272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317656|NCT03366259|Randomized|Parallel Assignment||Prevention||Single||||||t
1317657|NCT03366246|Randomized|Crossover Assignment||Treatment||Quadruple|1 tube containing anesthetic and 1 tube containing placebo, both with the same aspect (same vehicle) were randomized in respect of which side each formulation should be applied. Tubes were labeled with the subject number and the indication of LEFT or RIGHT side for application. Therefore, these identical tubes, no longer possible to distinguish whether a particular tube was referring to test or control formulation. Those responsible for the separation did not participate in the conduct of activities of the study.|Double-blind, crossover study where the same participant received in one side of the forehead the active drug and in the other side of the forehead placebo.|t|t|t|t
1317658|NCT03366233|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1317659|NCT03366220|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1317660|NCT03366207||Single Group Assignment||Treatment||None (Open Label)||Open label study of ciprofloxacin for uncomplicated urinary tract infection||||
1317661|NCT03366194||||||||||||
1317662|NCT03366181|||Cohort||Prospective|||||||
1317663|NCT03366168|||Cohort||Cross-Sectional|||||||
1317664|NCT03366155||Single Group Assignment||Treatment||None (Open Label)||||||
1317665|NCT03366142|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1317666|NCT03366129|||Cohort||Prospective|||||||
1317667|NCT03366116||Single Group Assignment||Treatment||None (Open Label)||||||
1317668|NCT03366103||Single Group Assignment||Treatment||None (Open Label)||||||
1317669|NCT03366090|||Case-Control||Prospective|||||||
1317670|NCT03366077|Randomized|Parallel Assignment||Prevention||Single||double-blinded, randomized, placebo-controlled, parallel-group|||t|
1317671|NCT03366064||Single Group Assignment||Treatment||None (Open Label)||||||
1317672|NCT03366051|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Non-Inferiority Trial||||
1317673|NCT03366038|||Cohort||Prospective|||||||
1317674|NCT03366025|||Cohort||Prospective|||||||
1317675|NCT03366012||Single Group Assignment||Screening||None (Open Label)||||||
1317676|NCT03365999|Randomized|Parallel Assignment||Prevention||Single|Prior to being included in the study, the patient will be mentioned the times when he will receive the medication as well as the dosage of administration (which is the same for each of the two medications). The patient will not know what medication is being administered to him / her. no time The pills will be given to you in a medicine cup without access to any information legend.|Two study groups will be generated, each consisting of 40 research subjects, randomly each recipient will receive 3 doses of one of the two study drugs (tranexamic acid or aminocaproic acid). The group to which the patient belongs will be assigned through a computer program, the patient will not know to which group he belongs or what medication he will receive. The patients will be extracted from the external traumatology clinic.|t|||
1317677|NCT03365986|||Cohort||Prospective|||||||
1317678|NCT03365973|||Cohort||Prospective|||||||
1317679|NCT03365960|Randomized|Crossover Assignment||Other||Single|||t|||
1317680|NCT03365947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317681|NCT03365934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317682|NCT03365921|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1317683|NCT03365908|Randomized|Parallel Assignment||Treatment||Double|Operating surgeon and outcome assessor will be blind to whether patient had nerve block prior to OR.||||t|t
1317684|NCT03365895||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317685|NCT03365882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317686|NCT03365869|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317687|NCT03365856|||Cohort||Cross-Sectional|||||||
1317688|NCT03365843|Randomized|Parallel Assignment||Treatment||Triple|The participants, study coordinator and care-givers are blinded to the assigned treatment arm. Participants may be able to guess which treatment group they have been assigned. This will be assessed at the end of the study by asking participants to identify the group to which they think they have been assigned.|Randomized, single centre, double-blind clinical study|t|t||t
1317689|NCT03365830|||Cohort||Prospective|||||||
1317690|NCT03365817|Randomized|Parallel Assignment||Treatment||None (Open Label)||Random assignment||||
1317691|NCT03365804|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317692|NCT03365791||Single Group Assignment||Treatment||None (Open Label)||This is a phase II, open-label, parallel-cohort study to determine the efficacy and safety of treatment with the combination of PDR001+LAG525 across multiple tumor types that are relapsed and/or refractory to available standard of care therapies. Patients will receive study treatment for a maximum of 2 years, All disease assessments will be performed locally by the investigator.||||
1317693|NCT03365778|Randomized|Parallel Assignment||Other||None (Open Label)||Selective Laser Trabeculoplasty (SLT) Educational Intervention group (n=20) or Usual Care group (n=20). Knowledge, beliefs, barriers, and attitudes about SLT vs. medication as first line treatment of glaucoma will be assessed in both groups.||||
1317694|NCT03365765|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study has one Intervention Type of Drug.||||
1317695|NCT03365752|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317696|NCT03365739|Randomized|Crossover Assignment||Other||Single|||t|||
1573430|NCT00001269||||Treatment||||||||
1317698|NCT03365713|||Cohort||Prospective|||||||
1317699|NCT03365700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317700|NCT03365687|Randomized|Parallel Assignment||Prevention||Quadruple|The manufacturer, Europharm, will provide the active vitamin D3 and placebo preparations, identical in appearance and taste, in coded latex-free bottles. A web-based randomisation system will allow Site pharmacies to login, obtain allocated treatment, prepare the 2 mL bolus in coded syringes and the coded bottles containing the daily dose, and dispense study drugs in masked kits.|This is a randomised, quadruble-blind, placebo-controlled, parallel-group multicentre trial of vitamin D3 supplementation.|t|t|t|t
1317701|NCT03365674|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317702|NCT03365661||Single Group Assignment||Treatment||None (Open Label)||||||
1317703|NCT03365648|Randomized|Parallel Assignment||Treatment||Double|Double-blinded|A randomized, double-blinded, parallel-group, placebo-controlled clinical study|t||t|
1317704|NCT03365635|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||An interventional, prospective, non-randomized, non-blinded trial to evaluate real world strategies to identify and treat hepatitis C infected hemodialysis patients with Zepatier||||
1317705|NCT03365622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317706|NCT03365609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317707|NCT03365596||Single Group Assignment||Supportive Care||None (Open Label)||||||
1317708|NCT03365583|||Cohort||Cross-Sectional|||||||
1317709|NCT03365570|||Ecologic or Community||Cross-Sectional|||||||
1317710|NCT03365557|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1317711|NCT03365544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||One group has their eating window between 6am-2pm and the other has their eating window between 2pm-10pm.||||
1317712|NCT03365531|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Trial of Caloric Restriction vs. Alternate-Day Fasting||||
1317713|NCT03365518|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1317714|NCT03365505|||Cohort||Prospective|||||||
1317715|NCT03365492||Single Group Assignment||Treatment||None (Open Label)||Commercially available BioFreedomTM (stainless steel BA9TM drug-coated stent)||||
1317716|NCT03365479||Single Group Assignment||Basic Science||None (Open Label)||||||
1317717|NCT03365466|||Cohort||Prospective|||||||
1317718|NCT03365453||Single Group Assignment||Treatment||None (Open Label)||||||
1317719|NCT03365440|||Other||Prospective|||||||
1317720|NCT03365427|Randomized|Parallel Assignment||Treatment||Single||||||t
1317721|NCT03365414|Randomized|Crossover Assignment||Treatment||Single||Phase I (albumin or normal saline): 4 weeks -> washout/crossover: 4 weeks ->Phase II(albumin or normal saline, whichever wasn't administered in phase I): 4 weeks|t|||
1317722|NCT03365401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317723|NCT03365388|Randomized|Parallel Assignment||Treatment||Single|The evaluation of the subjects will be conducted by the blind researchers. The IMP administration of the subjects will be conducted by non blind researchers or legal staff authorized by the principal investigator (PI)|The patient was diagnosed with periarthritis of shoulder||||t
1317724|NCT03365375|Randomized|Parallel Assignment||Treatment||Single||||||t
1317725|NCT03365362|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1317726|NCT03365349|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1317727|NCT03365336|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label study|Parallel follow up of two groups randomly allocated through a central randomization process.||||
1317728|NCT03365323|||Case-Control||Retrospective|||||||
1317729|NCT03365310|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label study|Parallel follow up of two treatment groups randomly allocated through a central randomization process||||
1317730|NCT03365297||Single Group Assignment||Treatment||None (Open Label)||Single centre, single arm open labelled Phase II window study||||
1317731|NCT03365284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317732|NCT03365271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317733|NCT03365258|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1317734|NCT03365245||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317735|NCT03365232|Randomized|Parallel Assignment||Other||Double|||t|||t
1317736|NCT03365219|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1317737|NCT03365206|||Case-Only||Prospective|||||||
1317738|NCT03365193|||Cohort||Prospective|||||||
1317739|NCT03365180||Single Group Assignment||Treatment||None (Open Label)||||||
1317740|NCT03365167|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317741|NCT03365154||Single Group Assignment||Treatment||None (Open Label)||||||
1317742|NCT03365141|Randomized|Parallel Assignment||Treatment||Single||||||t
1317743|NCT03365128|||Case-Only||Prospective|||||||
1317744|NCT03365115|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1317745|NCT03365102|Randomized|Parallel Assignment||Diagnostic||Double|Neither participant or outcome aware of condition|anodal tDCS over the rIFG, anodal tDCS over the lOFC, sham stimulation condition|t|||t
1317746|NCT03365089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317747|NCT03365076|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label randomized control trial. Randomization 1:1||||
1317748|NCT03365063|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1317749|NCT03365050|||Cohort||Retrospective|||||||
1317750|NCT03365037|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized, open, parallel controlled, non inferiority clinical trial design was used in this trial.Objective to evaluate the safety and effectiveness of electret static physiotherapy film in Beijing Youshilin science and Technology Development Co., Ltd.The patients were followed up after receiving the electret static physiotherapy film, and the treatment and complication rate of the patients were observed after the electret static physiotherapy film was attached to the patient.The data were compared between the experimental group and the control group.||||
1573431|NCT00001267||||Treatment||||||||
1317751|NCT03365024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317752|NCT03365011|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1317753|NCT03364998|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Each subject will receive the two treatments. Pharmacokinetic samples will be collected from pre-dose until 120 hours after the end of the injection of the single dose in each treatment arm.||||
1317754|NCT03364985|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1317755|NCT03364972|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317756|NCT03364959|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1317757|NCT03364946|||Other||Cross-Sectional|||||||
1317758|NCT03364933|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1317759|NCT03364920|||Cohort||Retrospective|||||||
1317760|NCT03364907|||Cohort||Prospective|||||||
1317761|NCT03364894|||Cohort||Prospective|||||||
1317762|NCT03364881|||Case-Only||Prospective|||||||
1317763|NCT03364868|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1317764|NCT03364855|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317765|NCT03364842|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1317766|NCT03364829||Single Group Assignment||Treatment||None (Open Label)||single group with comparisom before and after intervention||||
1317767|NCT03364816|||Cohort||Retrospective|||||||
1317768|NCT03364803|||Cohort||Prospective|||||||
1317769|NCT03364790|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1317770|NCT03364777|||Cohort||Prospective|||||||
1317771|NCT03364764||Single Group Assignment||Treatment||None (Open Label)||||||
1317772|NCT03364751|Randomized|Single Group Assignment||Other||Single|The Dentist (Investigator) or Dental Hygienist performing the periodontal assessments will be blinded to the arm allocation.||||t|
1317773|NCT03364738||Single Group Assignment||Treatment||None (Open Label)||||||
1317774|NCT03364725||Single Group Assignment||Treatment||None (Open Label)||||||
1317775|NCT03364712|||Cohort||Prospective|||||||
1317776|NCT03364699|Randomized|Parallel Assignment||Other||Double|||t||t|
1317777|NCT03364686||Single Group Assignment||Basic Science||None (Open Label)||||||
1317778|NCT03364673||Single Group Assignment||Supportive Care||None (Open Label)||||||
1317779|NCT03364660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317780|NCT03364647|Randomized|Parallel Assignment||Treatment||Triple|Participants, outcomes assessors, and the PI will be blinded as to the participant's group assignment.|Parallel assignment|t||t|t
1317781|NCT03364634|||Cohort||Prospective|||||||
1317782|NCT03364621|||Cohort||Prospective|||||||
1317783|NCT03364608|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1317784|NCT03364595|||Cohort||Retrospective|||||||
1317785|NCT03364582|||Cohort||Prospective|||||||
1317786|NCT03364569|||Cohort||Retrospective|||||||
1317787|NCT03364556|||Other||Cross-Sectional|||||||
1317788|NCT03364543|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1317789|NCT03364530||Single Group Assignment||Treatment||None (Open Label)||||||
1317790|NCT03364517|Randomized|Parallel Assignment||Supportive Care||Single||Randomized controlled cluster study.|t|||
1317791|NCT03364504||Single Group Assignment||Basic Science||None (Open Label)||||||
1317792|NCT03364491|Randomized|Parallel Assignment||Prevention||Quadruple|The patient nor the clinical staff will be aware of the treatment assignment. The TXA or placebo solutions will be prepared by the center research pharmacies.|Participants will be randomized to receive either TXA (1 gram [10cc] mixed with 40 cc of normal saline) administered intravenously or a placebo control of 50 cc of normal saline administered intravenously|t|t|t|t
1317793|NCT03364478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317794|NCT03364465|Randomized|Parallel Assignment||Prevention||Single|||t|||
1317795|NCT03364452|||Other||Cross-Sectional|||||||
1317796|NCT03364439||Single Group Assignment||Treatment||None (Open Label)||||||
1317797|NCT03364426|||Other||Cross-Sectional|||||||
1317798|NCT03364413|||Cohort||Other|||||||
1317799|NCT03364400||Sequential Assignment||Treatment||None (Open Label)||||||
1317800|NCT03364387|||Cohort||Prospective|||||||
1317801|NCT03364374|||Case-Control||Cross-Sectional|||||||
1317802|NCT03364361||Single Group Assignment||Prevention||None (Open Label)||||||
1317803|NCT03364348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317804|NCT03364335|Randomized|Parallel Assignment||Treatment||Triple|This is a double blind, placebo controlled trial||t|t|t|
1317805|NCT03364322|||Cohort||Prospective|||||||
1317806|NCT03364309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317807|NCT03364296||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317808|NCT03364283|||Cohort||Prospective|||||||
1317809|NCT03364270||Single Group Assignment||Diagnostic||None (Open Label)||Pilot study||||
1317810|NCT03364257|||Other||Prospective|||||||
1317811|NCT03364244|||Case-Only||Prospective|||||||
1317812|NCT03364231||Single Group Assignment||Treatment||None (Open Label)||||||
1317813|NCT03364218|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1317814|NCT03364205|Randomized|Crossover Assignment||Prevention||Single|There was no intervention in the control group which was in parallel.|Randomized Controlled Trials|||t|
1317815|NCT03364192|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||All participants will receive peer-delivered Whole Health Coaching but the start date will be randomized between 4 and 13 weeks from initiation of the study.||||
1317816|NCT03364179|||Case-Only||Prospective|||||||
1317817|NCT03364166|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1317818|NCT03364153|Randomized|Parallel Assignment||Treatment||Single|||||t|
1317819|NCT03364140|||Case-Only||Retrospective|||||||
1317820|NCT03364127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317873|NCT03363438|||Ecologic or Community||Cross-Sectional|||||||
1317821|NCT03364114|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1317822|NCT03364101|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1317823|NCT03364088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317824|NCT03364075|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1317825|NCT03364062|||Cohort||Prospective|||||||
1317826|NCT03364049||Single Group Assignment||Treatment||None (Open Label)||||||
1317827|NCT03364036||Single Group Assignment||Treatment||None (Open Label)||||||
1317828|NCT03364023|||Cohort||Prospective|||||||
1317829|NCT03364010||Single Group Assignment||Basic Science||None (Open Label)||||||
1317830|NCT03363997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317831|NCT03363984||Single Group Assignment||Other||None (Open Label)||||||
1317832|NCT03363971|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1317833|NCT03363958|Randomized|Parallel Assignment||Treatment||Single|||||t|
1317834|NCT03363945|Randomized|Parallel Assignment||Prevention||None (Open Label)||Total lymphoid irradiation and anti-thymocyte globulin||||
1317835|NCT03363932|||Cohort||Prospective|||||||
1317836|NCT03363919|Randomized|Parallel Assignment||Treatment||Double|In both phases of the study (phase I and phase II) participants and study team members completing clinical rating scales will be blinded to treatment assignment. The study team member completing clinical rating scales and analyzing TMS neurophysiology measures will not be allowed in the treatment suite during therapeutic rTMS sessions (10 Hz, 1 Hz, iTMS, or cTBS).||t|t||
1317837|NCT03363906|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1317838|NCT03363893||Single Group Assignment||Treatment||None (Open Label)||||||
1317839|NCT03363880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317840|NCT03363867||Single Group Assignment||Treatment||None (Open Label)||||||
1317841|NCT03363854|Randomized|Parallel Assignment||Treatment||Double|"Neither the subject nor any of the investigator or LEO staff who are involved in the treatment or clinical evaluation and monitoring of the subjects will be aware of the treatment received. The packaging and labelling of the investigational medicinal products (IMPs) will contain no evidence of their identity.~Since tralokinumab and placebo are visually distinct and not matched for viscosity, IMP will be handled and administered by a qualified, unblinded health-care professional at the site who will not be involved in the management of trial subjects and who will not perform any of the assessments."||t||t|
1317842|NCT03363841||Single Group Assignment||Treatment||None (Open Label)||non comparator, single arm||||
1317843|NCT03363828|||Cohort||Prospective|||||||
1317844|NCT03363815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317845|NCT03363802|||Other||Cross-Sectional|||||||
1317846|NCT03363789|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will analyze the data as group 1 and 2, not knowing which group received what treatment.|Randomized Control Trial||||t
1317847|NCT03363776|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317848|NCT03363763|Randomized|Parallel Assignment||Treatment||Quadruple||"Subjects will be randomly assigned in a 1:1:1 ratio to receive 1 of 2 treatments or placebo. The randomization is stratified by site.~Subjects who complete the double-blind phase of the study with an overall compliance rate >80% and <120%, as determined by weight of returned study medication, will be offered entry into an open-label period for an additional 12 weeks."|t|t|t|t
1317849|NCT03363750||Single Group Assignment||Other||None (Open Label)||||||
1317850|NCT03363737|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1317851|NCT03363724|||Cohort||Retrospective|||||||
1317852|NCT03363711|||Cohort||Prospective|||||||
1317853|NCT03363698|||Cohort||Prospective|||||||
1317854|NCT03363685|||Cohort||Prospective|||||||
1317855|NCT03363672|||Cohort||Prospective|||||||
1317856|NCT03363659||Single Group Assignment||Treatment||None (Open Label)||||||
1317857|NCT03363646|||Cohort||Prospective|||||||
1317858|NCT03363633|Randomized|Parallel Assignment||Treatment||Single|||||t|
1317859|NCT03363620|Randomized|Parallel Assignment||Treatment||Single||||||t
1317860|NCT03363607|Randomized|Parallel Assignment||Other||Single||||||t
1317861|NCT03363594|||Case-Control||Cross-Sectional|||||||
1317862|NCT03363581|||Case-Control||Prospective|||||||
1317863|NCT03363568|Randomized|Parallel Assignment||Treatment||Double||Children were randomly assigned to adaptive treatment (n=20) or non-adaptive control (n=20) with identical tasks, stimuli, and goals. Children were instructed to train for 5 days a week (25m/day) for 4-weeks. All participants had between 10-20 training sessions at study completion.|t||t|
1317864|NCT03363555||Single Group Assignment||Treatment||None (Open Label)||||||
1317865|NCT03363542|Randomized|Parallel Assignment||Other||Single||diet rich in fruits, vegetables and/or whole-grain fiber|t|||
1317866|NCT03363529|Randomized|Parallel Assignment||Treatment||Single|Hamilton depression interview is done by external assessor blinded to condition|Standard versus dynamic lighting||||t
1317867|NCT03363516|||Other||Prospective|||||||
1317868|NCT03363503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317869|NCT03363490|Randomized|Factorial Assignment||Treatment||Single|Assessor will not know which group the patients are enrolled when evaluate the baseline and follow-up situation|Patients of knee OA will be divided into A, B, C, D four parallel groups with fully informed, each group will enroll 100 patients, A for control group, B for neuromuscular exercise, C for self-management program, D for neuromuscular exercise and self-management program, respectively.||||t
1317870|NCT03363477|Randomized|Crossover Assignment||Treatment||Triple|This study will be double blinded in that the subjects and laboratories will be blinded. While the enoxaparin (manufactured by Rovi, Spain) and Clexane (manufactured by Sanofi, EU) solutions for SC injection may be identical in appearance, the prefilled syringes for both study drugs may not be identical. Therefore, the unblinded pharmacist will be responsible for dispensing the study drug in a manner consistent with maintaining the blind and a dedicated unblinded team member will perform study drug administration.|single-dose, randomized, double-blind, 2-period, 2-sequence crossover study|t|t|t|
1317871|NCT03363464|||Cohort||Retrospective|||||||
1317872|NCT03363451|||Case-Only||Retrospective|||||||
1317874|NCT03363425|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1317875|NCT03363412||Single Group Assignment||Prevention||None (Open Label)||||||
1317876|NCT03363399|||Cohort||Cross-Sectional|||||||
1317877|NCT03363386|Randomized|Parallel Assignment||Prevention||None (Open Label)||The sample of study consists of patients with Type 2 Diabetes Mellitus (DM) got diagnosed at least 6 months and who referred to Fitness Center in Pendik Arif Nihat Asya Kültür Merkezi Istanbul Turkey by a medical doctor between December 2016- March 2017. The study included in 30 patients (24F, 6M) with T2DM. The patients who met inclusion criteria are divided into two groups||||
1317878|NCT03363373||Single Group Assignment||Treatment||None (Open Label)||Participants will receive up to 15 cycles of GM-CSF and Naxitamab for a total of 93 weeks. Safety and efficacy will be investigated with short-term follow-up at 8 weeks after last treatment and with long-term follow-up for up to 3 years after end of treatment visit.||||
1317879|NCT03363360|||Other||Cross-Sectional|||||||
1317880|NCT03363347|||Case-Control||Retrospective|||||||
1317881|NCT03363334||||||||||||
1317882|NCT03363321|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1317883|NCT03363308|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a cluster-randomized trial in phase I and interrupted time series in phase II||||
1317884|NCT03363295|Randomized|Parallel Assignment||Prevention||Double|Both the patients and the investigator will be masked. The cataract surgeon won't be.||t||t|
1317885|NCT03363282|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317886|NCT03363269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317887|NCT03363256|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1317888|NCT03363243|Randomized|Parallel Assignment||Treatment||None (Open Label)||1 Treatment group with STOP therapy; 1 Treatment as usual group||||
1317889|NCT03363230|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317890|NCT03363217|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|There is no masking as part of this study. Only one study treatment will be given to all treatment groups at age and weight based dose.|This trial will include 4 parallel groups. Each group will include a particular type of peripheral nerve or central nervous system tumor or mutation.||||
1317891|NCT03363204||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317892|NCT03363191|Randomized|Parallel Assignment||Treatment||Double||Subjects will receive either fluticasone furoate/vilanterol 100/25 mcg or fluticasone furoate 100 mcg once daily in this parallel group study.|t||t|
1317893|NCT03363178||Single Group Assignment||Prevention||None (Open Label)||||||
1317894|NCT03363165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317895|NCT03363152|||Other||Prospective|||||||
1317896|NCT03363139|||Cohort||Prospective|||||||
1317897|NCT03363126|||Case-Only||Retrospective|||||||
1317898|NCT03363113|||Case-Only||Retrospective|||||||
1317899|NCT03363100|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1317900|NCT03363087||Single Group Assignment||Diagnostic||None (Open Label)||Biatrial automated scar mapping in patients undergoing ablation for atrial fibrillation. Confirmation of scar by pacing in all patients. Collection of impedance data during clinical ablation.||||
1317901|NCT03363074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317902|NCT03363061|||Cohort||Prospective|||||||
1317903|NCT03363048|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1317904|NCT03363035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317905|NCT03363022|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317906|NCT03363009|Randomized|Parallel Assignment||Other||Single|||t|||
1317907|NCT03362996|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317908|NCT03362983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317909|NCT03362970|Randomized|Parallel Assignment||Health Services Research||Double|Data extractors and Investigators will be unaware of allocation assignment.||||t|t
1317910|NCT03362957|Randomized|Crossover Assignment||Treatment||Double||This will be a single-blinded randomized-controlled study of GAE versus placebo in a small population with knee pain secondary to arthritis to determine safety and efficacy. The placebo procedure will be a diagnostic angiogram of the knee, without embolization. Appropriate measures will be taken to ensure patients and nursing staff caring for the patient are blinded to assignment. Each patient will be told at the time of recruitment that they may be randomly assigned to sham, but if after 1 month they have not had symptom improvement, their assigned procedure would be revealed and, if they had undergone a sham procedure, they will be allowed to proceed with embolization.|t|||t
1317911|NCT03362944|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1317912|NCT03362931||Single Group Assignment||Treatment||None (Open Label)||||||
1317913|NCT03362918|Randomized|Parallel Assignment||Treatment||Single|The outcome assessors will be blind to the allocation of the study participants.|||||t
1317914|NCT03362905|Randomized|Parallel Assignment||Treatment||Double||This study will include 123 patients who are candidates for IUD contraception. The aim of the study will be explained to all patients and an informed written consent will be taken. After recruitment, patients will be randomized to the 3 study arms using computer generated randomization sheet using MedCalcc version 13 to receive any of: lidocaine spray, cream and injection|t||t|
1317915|NCT03362879|||Cohort||Cross-Sectional|||||||
1317916|NCT03362866|||Cohort||Prospective|||||||
1317917|NCT03362853|Randomized|Crossover Assignment||Treatment||Quadruple|"Stage I: the administration sequences of the 4 groups were CABD, ADCB, BCDA and DBAC respectively. D represents moxifloxacin, the positive control drug, for which an open design was adopted. For the other 3 groups, i.e. 500 mg nemonoxacin, 750 mg nemonoxacin, and placebo, a double-blind design was employed.~Stage II: An open design for 12 subjects who had completed Stage I to receive a single oral dose of 500 mg nemonoxacin after taking a high-fat test meal"||t|t|t|t
1317918|NCT03362840|Non-Randomized|Factorial Assignment||Treatment||Single||||||t
1317919|NCT03362827|||Other||Cross-Sectional|||||||
1317920|NCT03362814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317921|NCT03362801|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1317922|NCT03362788|||Cohort||Prospective|||||||
1317923|NCT03362775||Single Group Assignment||Basic Science||None (Open Label)|EEG will be electronically recorded and anonymised. The outcome assessor will analyse the EEG without knowledge of the propofol concentration.|Every subject will have an EEG recording in the absence of propofol, or during light sedation with propofol at an effect-site target concentration of 0.5 µg/mL and 1.0 µg/mL. Each subject will be his own control.||||
1317924|NCT03362762|||Case-Only||Prospective|||||||
1317925|NCT03362749|||Case-Only||Prospective|||||||
1317926|NCT03362736||||||||||||
1317927|NCT03362723|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1317928|NCT03362710||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317929|NCT03362697|Randomized|Parallel Assignment||Treatment||Quadruple|Randomization list will by assembled by independient organization not related with participant, care provider, investigators or sponsors. eCRF will include randomization selection|Randomized controlled trial, double blind allocation concealment, parallel Assignment|t|t|t|t
1317930|NCT03362684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317931|NCT03362671||Single Group Assignment||Treatment||None (Open Label)||||||
1317932|NCT03362658|||Case-Control||Prospective|||||||
1317933|NCT03362645|||Case-Control||Retrospective|||||||
1317934|NCT03362632|||Case-Only||Prospective|||||||
1317935|NCT03362619||Single Group Assignment||Treatment||None (Open Label)||||||
1317936|NCT03362606||Single Group Assignment||Treatment||None (Open Label)||||||
1317937|NCT03362593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317938|NCT03362580|||Cohort||Prospective|||||||
1317939|NCT03362567|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study involved 47 patients with cervical radiculopathy which were purposively recruited from the Physiotherapy Department Outpatient Clinic of Usmanu Danfodio University Teaching Hospital, Sokoto for the study. Subjects were randomly allocated to Sustained Natural Apophyseal Glides (SNAGS)and Mechanical Cervical Traction (MCT) group. All the subjects were treated using cryotherapy for seven minutes. Subjects in SNAGS group were then treated with sustained natural apophyseal glides, twice weekly for six weeks while subjects in MCT received mechanical cervical traction, for 15 minutes each session twice in a week for six weeks. Visual analogue scale, neck disability index questionnaires and inclinometer were used to assess pain intensity, disability and cervical range of motion respectively at the beginning, 3rd and 6th week of treatment||||
1317940|NCT03362554|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317941|NCT03362541|Randomized|Parallel Assignment||Treatment||Double|Both the MS INFoRm group and the control group will receive a login and password, although participants in the groups will be directed to a different webpages (i.e. a MS INFoRm page or usual care control webpage). This will facilitate blinding of participants to their allocation. The research assistant will complete the scheduling, data collection, and data entry blinded to the group allocation.|This study will use a randomized controlled trial design to test the efficacy and effectiveness of MS INFoRm. Two hundred participants from at least three sites across Canada will be randomly assigned to one of two groups: the experimental (MS INFoRm) group or usual care control group. After completing the study, participants in the usual care control group will be given access to MS INFoRm in order to provide them with any benefits of the website, if any are uncovered. Both groups will be evaluated on primary (fatigue impact) and secondary (self-efficacy, cognitive function, participation and autonomy, depression) outcomes at baseline (week 1), after 3-month use of the MS INFoRm website (week 12), and after 6-month follow-up (week 36).|t|||t
1317942|NCT03362528|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1317943|NCT03362515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317944|NCT03362502|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1317945|NCT03362489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317946|NCT03362476|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1317947|NCT03362463|||Cohort||Prospective|||||||
1317948|NCT03362450|||Cohort||Retrospective|||||||
1317949|NCT03362437|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1317950|NCT03362424|Randomized|Parallel Assignment||Treatment||Single|Surgeon and patients not blinded|Randomized controlled trial||||t
1317951|NCT03362411|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1317952|NCT03362398|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1317953|NCT03362385|||Cohort||Prospective|||||||
1317954|NCT03362372|Randomized|Parallel Assignment||Prevention||None (Open Label)||Controlled, parallel, multicenter, cluster-randomized clinical trial.||||
1317955|NCT03362359||Single Group Assignment||Diagnostic||None (Open Label)||||||
1317956|NCT03362346|||Cohort||Retrospective|||||||
1317957|NCT03362333|Randomized|Parallel Assignment||Treatment||Single||||||t
1317958|NCT03362320|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317959|NCT03362307|Randomized|Parallel Assignment||Other||None (Open Label)||Subjects were aligned based on computer randomization in two groups: In group 1(intervention), subjects received LLL and LED after implant placement and in group 2 (control) the same device was used while device was off.||||
1317960|NCT03362294||Single Group Assignment||Treatment||None (Open Label)||||||
1317961|NCT03362281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317962|NCT03362268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317963|NCT03362255|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1317964|NCT03362242|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1317965|NCT03362229|Randomized|Parallel Assignment||Treatment||None (Open Label)|There is no blinding possible in this trial as the presence or absence of medial sided surgery is obvious to both the surgeon and the patient due to the presence or absence of a skin incision.|Randomised controlled trial with 50:50 randomisation into one of 2 groups. Randomisation will also be stratified be age of patient (>= 65 and <65 years).||||
1317966|NCT03362216|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1317967|NCT03362203|||Other||Cross-Sectional|||||||
1317968|NCT03362190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317969|NCT03362177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1317970|NCT03362164|||Cohort||Prospective|||||||
1317971|NCT03362151|Randomized|Crossover Assignment||Treatment||Double|Subjects will not be told which meal they are eating.|"Subjects will consume pre-determined meals on 6 difference occasions. There will be three categories of study meals consisting of:~Regular pasta (42 grams carbohydrate per meal)~High protein pasta (38 grams carbohydrate per meal)~White rice (43 grams carbohydrate per meal)~Each subject will consume each meal on two separate occasions in random order."|t||t|
1317972|NCT03362138|||Case-Only||Cross-Sectional|||||||
1317973|NCT03362125|||Case-Only||Prospective|||||||
1317974|NCT03362112|||Cohort||Retrospective|||||||
1317975|NCT03362099|Randomized|Parallel Assignment||Treatment||Double|"The patients will be totally blinded to know which arms will be used in the treatment.~The investigator who makes clinical visits of the protocol do not have access to randomizing list, therefore they are blinded for the use of varenicline indicated, but not for bupropion use."|The Patients will be randomized in two arms. 150 will be treated in the pharmacogenetic arm and 150 in the varenicline arm ( control ).|t||t|
1317976|NCT03362086|||Family-Based||Prospective|||||||
1317977|NCT03362073||Single Group Assignment||Treatment||None (Open Label)||Prospective, Single institution, Open-label, Phase 2||||
1317978|NCT03362060||Single Group Assignment||Treatment||None (Open Label)||||||
1317979|NCT03362047|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicentre, randomized, prospective, open pilot study||||
1317980|NCT03362034|Randomized|Parallel Assignment||Other||Double|||t|||t
1317981|NCT03362021|||Cohort||Prospective|||||||
1317982|NCT03362008|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1317983|NCT03361995|Randomized|Parallel Assignment||Treatment||Single|||t|||
1317984|NCT03361982|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1317985|NCT03361969|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1317986|NCT03361956|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1317987|NCT03361943|||Other||Other|||||||
1317988|NCT03361930||Single Group Assignment||Treatment||None (Open Label)||||||
1317989|NCT03361917|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1317990|NCT03361904|||Cohort||Prospective|||||||
1317991|NCT03361891|Randomized|Parallel Assignment||Prevention||Single||"Patients will be randomized via REDCap (Research Electronic Data Capture), a secure, centralized web-based randomization module to:~Standard of care; or~WalkMORE Ambulation program + Standard of care. Patients will ambulate with a trained WalkMORE Volunteer Coach two times per day; once in the morning (0900-1200hrs) and once in the afternoon (1300-1700hrs), Monday- Friday, until hospital discharge. Patients randomized to the WalkMORE intervention will be assessed daily by the Research Coordinator to ensure patients remain fit for independent ambulation. The duration of each walking session will be determined daily by the RC and the medical team."||||t
1317992|NCT03361878|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Two arms - metformin tolerant and metformin intolerant. All participants given single dose of metformin.||||
1317993|NCT03361865|Randomized|Parallel Assignment||Treatment||None (Open Label)|The study will be unblinded after the last participant completes Week 9 imaging assessment for efficacy analysis and after appropriate EC/IRB approvals have been received.|||||
1317994|NCT03361852||Single Group Assignment||Treatment||None (Open Label)||||||
1317995|NCT03361839|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||non randomized||||
1317996|NCT03361826|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Using a case-control design, the investigators will compare individuals receiving MST and DBT with matched patient control group receiving DBT alone.||||
1317997|NCT03361813|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1317998|NCT03361800||Single Group Assignment||Basic Science||None (Open Label)||||||
1317999|NCT03361787||Single Group Assignment||Treatment||None (Open Label)||||||
1318000|NCT03361774|Randomized|Parallel Assignment||Treatment||Single|The clinical examiner will be blinded to treatment received. The study statistician, data management staff, other employees of the Sponsor and vendors acting on behalf of the sponsor, who may influence study outcomes will also be blinded to the treatment allocation.|||||t
1318001|NCT03361761|||Case-Only||Prospective|||||||
1318002|NCT03361748||Single Group Assignment||Treatment||None (Open Label)||||||
1318003|NCT03361735||Single Group Assignment||Treatment||None (Open Label)||||||
1318004|NCT03361722|||Cohort||Retrospective|||||||
1318005|NCT03361709|Randomized|Parallel Assignment||Treatment||Single||||||t
1318006|NCT03361696|||Cohort||Prospective|||||||
1318007|NCT03361683|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318008|NCT03361670|||Case-Only||Prospective|||||||
1318009|NCT03361657|Randomized|Parallel Assignment||Treatment||Double|Randomization will be done according to a computer-generated randomized number table. Data collection will be done by well-trained investigators not involved in the study. Patients' guardians and all study personnel will be blinded to group assignment.|The surgical team performed a laparoscopy using a Hasson technique for the umbilical corkscrew port insertion (a three-port approach), 5-mm instruments. Insufflation pressures were set at 8, or 10 or 12 mmHg according to group assignment and continuously measured using the GS 1002 402 Insufflator (ConMed Linvatec, Largo, FL, USA).|t|||t
1318010|NCT03361644|Randomized|Parallel Assignment||Treatment||None (Open Label)||2x3 repeated-measures randomized control trial.||||
1318011|NCT03361631||Single Group Assignment||Treatment||None (Open Label)||||||
1318012|NCT03361618|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Semen volume after treatment.||||
1318013|NCT03361605||Single Group Assignment||Basic Science||None (Open Label)||||||
1318014|NCT03361592|Randomized|Parallel Assignment||Treatment||Single|Participants were initially instructed about the study procedures with therapeutic interventions. After collected data, the participants were asked about the therapeutic intervention, if they are capable to identify which intervention were performed, SMT or SHAM, as parte of study protocol.|randomized controlled single-blinded study.||||t
1318060|NCT03360994|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318015|NCT03361579|Randomized|Crossover Assignment||Treatment||Double|The investigator is blinded about the source of education a participant recieved prior to Placebo application. Investigator is blinded about during which Intervention the Placebo is applicated|investigator blinded, cross over design|||t|t
1318016|NCT03361566|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1318017|NCT03361553|||Case-Only||Prospective|||||||
1318018|NCT03361540|Randomized|Sequential Assignment||Basic Science||Triple|||t|t|t|
1318019|NCT03361527|||Other||Prospective|||||||
1318020|NCT03361514|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is designed as a cluster-randomized controlled trial conducted in primary care, randomizing General Practitioners over a.) Supported Protocolized Discontinuation (SPD) alone or b.) SPD with additional Mindfulness-Based Cognitive Therapy (MBCT). Both the patient, GP and the research team will be aware of the allocated condition.||||
1318021|NCT03361501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318022|NCT03361488|Randomized|Parallel Assignment||Other||Double|||t|||t
1318023|NCT03361475|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318024|NCT03361462|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318025|NCT03361449|Randomized|Parallel Assignment||Treatment||Single|||||t|
1318026|NCT03361436||Single Group Assignment||Treatment||None (Open Label)||||||
1318027|NCT03361423|Randomized|Parallel Assignment||Treatment||Double|"For sham control, electrical pulses of similar width and intensity, but much lower frequency compared to the active device will be administered. This sham program produces pulses that are perceivable by the user, thus maintaining the blinding, but on the other hand do not have therapeutic qualities.~The devices will be delivered with an identifying number, without exposing to the investigator or participant if it is an active or a pacebo/sham device"|A prospective, randomized, double blinded, sham controlled study|t||t|
1318028|NCT03361410|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318029|NCT03361397|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1318030|NCT03361384|Randomized|Parallel Assignment||Basic Science||Double|Double (Participant, Outcomes Assessor)|Participants are randomly assigned to a beverage condition: alcohol, placebo, or control (water).|t|||t
1318031|NCT03361371|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor is blinded to the intervention.|Prospective interventional.||||t
1318032|NCT03361358|||Case-Only||Retrospective|||||||
1318033|NCT03361345|Randomized|Parallel Assignment||Treatment||None (Open Label)||Split-face study in which topical tranexamic acid will be applied to one side of the face and the other side of the face will be the placebo/vehicle as a control.||||
1318034|NCT03361332|||Other||Prospective|||||||
1318035|NCT03361319|Randomized|Parallel Assignment||Treatment||Quadruple|Part 2 only of the study is double-blinded. 2 arms|Part I: A dose-escalation - standard 3+3 design. Part 2: A placebo-controlled, randomised, double-blind, 2-arms.|t|t|t|t
1318036|NCT03361306||Single Group Assignment||Treatment||None (Open Label)||||||
1318037|NCT03361293|Randomized|Parallel Assignment||Treatment||Quadruple|Participants and families will be blinded. The principal investigator will be blinded. The research staff member coordinating the visit will be blinded. The care provider is not involved in the research and is, therefore, blinded.|1:1 randomized allocation to active tDCS or placebo (sham tDCS).|t|t|t|t
1318038|NCT03361280|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1318039|NCT03361267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318040|NCT03361254||Single Group Assignment||Treatment||None (Open Label)||demonstrate the ability of this technique to follow high intensity regimen recommendations||||
1318041|NCT03361241|Randomized|Parallel Assignment||Treatment||Single|Single blinded (outcomes assessor)|Parallel Assignment||||t
1318042|NCT03361228|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318043|NCT03361215|||Cohort||Prospective|||||||
1318044|NCT03361202|||Cohort||Prospective|||||||
1318045|NCT03361189|Randomized|Crossover Assignment||Treatment||Double||"Patient Enrollment: The treating physician will identify potential subjects with a previously implanted pacemaker and present a brief overview of the study. Informed consent will be obtained by the investigator after discussing the study, including the voluntary nature of participation and notification the subject can withdraw at any time. The investigator will give the subject and his/her legal guardian the opportunity to take the consent home to think about it more, with the option to call or meet with the investigator to ask additional questions. If the subject and/or his/her parent/legal guardian agree to participate, the investigator will ask them to sign a written, informed consent and assent.~Randomization Procedure: This will be a single-blind placebo-controlled randomized crossover study with 2 treatments: CLS-on versus CLS-off (accelerometer only). Each enrolled patient will receive both treatments for 3 months. The order of treatments will be randomized 1:1."|t|||t
1318046|NCT03361176|Randomized|Parallel Assignment||Treatment||Double|Participants and Outcomes Assessors will be blinded to the treatment arms subjects are randomized to.|10 subjects will be part of a control group treated without triamcinolone and 20 subjects will be treated with triamcinolone.|t|||t
1318047|NCT03361163||Sequential Assignment||Basic Science||None (Open Label)||Observational, sequential, dose-escalation||||
1318048|NCT03361150|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1318049|NCT03361137||Single Group Assignment||Treatment||None (Open Label)||||||
1318050|NCT03361124|Randomized|Parallel Assignment||Prevention||Double|Covering of labels on IV fluids|Randomized double-blinded controlled|t||t|
1318051|NCT03361111|||Cohort||Cross-Sectional|||||||
1318052|NCT03361098|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1318053|NCT03361085||Sequential Assignment||Prevention||None (Open Label)||stepped wedged study design||||
1318054|NCT03361072|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective open label study on oral immunotherapy with either milk, or peanut or egg white food products.||||
1318055|NCT03361059|||Cohort||Prospective|||||||
1318056|NCT03361046|||Cohort||Prospective|||||||
1318057|NCT03361033|||Cohort||Prospective|||||||
1318058|NCT03361020|||Case-Control||Prospective|||||||
1318059|NCT03361007|||Cohort||Prospective|||||||
1318061|NCT03360981|Randomized|Parallel Assignment||Treatment||Single||"arm 1 , diabetics treated by coronary artery bypass grafting (CABG), receiving epicardial tissue biopsy, and than treated by incretin therapy plus standard anti ischemic therapy..~arm 2, diabetics, treated by coronary artery bypass grafting (CABG), receiving epicardial tissue biopsy, and than treated by standard hypoglycemic drug therapy plus standard anti ischemic therapy.~arm 3, non diabetics, treated by coronary artery bypass grafting (CABG), receiving epicardial tissue biopsy, and than treated by standard anti ischemic therapy."|t|||
1318062|NCT03360968|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1318063|NCT03360955|||Cohort||Cross-Sectional|||||||
1318064|NCT03360942|||Case-Only||Other|||||||
1318065|NCT03360929||Single Group Assignment||Treatment||None (Open Label)||This is a multi-center, open-label, dose escalation and phase II study, consisting of dose escalation study in Part A and phase II study in Part B.||||
1318066|NCT03360916|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1318067|NCT03360903|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1318068|NCT03360890|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318069|NCT03360877||Single Group Assignment||Prevention||None (Open Label)||The initial 8-month baseline period will be used to collect data on the evaluation criteria of interest prior to the administration of any intervention of the study and will develop appropriate pedagogical tools to support the uptake of each cleaning strategy during subsequent intervention periods. After the reference period, a one-month introductory period will allow the organization of the first intervention at each site (ie - a soap and water cleansing administered by the carers in a structure or - a cleaning HCG administered by caregivers in the other facility) followed by eight months of active follow-up of the study with the first intervention. Following the eight months of active follow-up with the first intervention, there will be a crossover with an introductory period of one month and eight months of active follow-up with the other intervention. A final period of interruption will occur during the last eight months of the study.||||
1318070|NCT03360864|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1318071|NCT03360851|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Parallel cluster-randomised trial with historical control period||||
1318072|NCT03360838|||Cohort||Prospective|||||||
1318073|NCT03360825|||Cohort||Prospective|||||||
1318074|NCT03360812|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1318075|NCT03360799|||Cohort||Prospective|||||||
1318076|NCT03360786|Randomized|Parallel Assignment||Prevention||Single|An assessor who is blinded to group allocation will perform the pre and post assessment measures.|||||t
1318077|NCT03360773|||Cohort||Other|||||||
1318078|NCT03360760|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1318079|NCT03360747||Single Group Assignment||Treatment||None (Open Label)||||||
1318080|NCT03360734||Single Group Assignment||Treatment||None (Open Label)||||||
1318081|NCT03360721||Single Group Assignment||Treatment||None (Open Label)||||||
1318082|NCT03360708||Single Group Assignment||Treatment||None (Open Label)||||||
1318083|NCT03360695|Randomized|Parallel Assignment||Supportive Care||Single|"A consensus panel of disease-specific oncologists who are blinded to intervention arm will review all patients at 24 weeks of care and evaluate for disruptions in cancer care.~The 12-week assessment of the BPRS will be completed by an independent study assessor who is blinded to intervention arm."|||||t
1318084|NCT03360682|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318085|NCT03360669|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1318086|NCT03360656||Single Group Assignment||Treatment||None (Open Label)||||||
1318087|NCT03360643|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1318088|NCT03360630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318089|NCT03360617|Randomized|Parallel Assignment||Other||Double|When the pharmacist prepares the medication he/she will refer to the randomization form to select the correct study arm. The pharmacist will place a protective cover over the syringe and over the piggyback bag before it is provided to the nurse administering the medication.|Single-center, prospective, double-blinded, double-dummy, randomized controlled trial|t|t||
1318090|NCT03360604|Randomized|Crossover Assignment||Basic Science||Single|Participants are not told which condition they are taking part in during each test day.|All participants took part in both conditions|t|||
1318091|NCT03360591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318092|NCT03360578|||Case-Only||Prospective|||||||
1318093|NCT03360565|||Cohort||Prospective|||||||
1318094|NCT03360552|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1318095|NCT03360539|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||The Nurse-Family Partnership (NFP) was launched by pediatrician David Olds in the early 1970s in response to the observation that low-income mothers are less likely to engage in positive health and parenting behaviors that are associated with better child development outcomes (Olds et al. 1986). NFP is a prenatal and infancy home visiting program for low-income, first-time mothers and their families. Registered nurses begin visiting their clients as early in the pregnancy as possible, helping the mother-to-be make informed choices. The nurses continue visiting regularly until the child is two years old.||||
1318096|NCT03360526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318097|NCT03360513|||Other||Retrospective|||||||
1318098|NCT03360500|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1318099|NCT03360487|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1318100|NCT03360474||Single Group Assignment||Diagnostic||None (Open Label)||Descriptive analysis will be conducted on demographic (e.g., age, gender) variables to report characteristics of the sample. The data to be collected are reflected in the attached measures. Days spent in the ICU and total days spent in the hospital will be analyzed using standard t-tests to assess difference in length of stay in ICU and overall hospitalization for 60 days prior to initiation of the delirium protocol and 60 days following the initiation of the protocol.||||
1318101|NCT03360461||Single Group Assignment||Treatment||None (Open Label)||Single-centre stage IIa developmental study, Open label, single arm, non-randomised feasibility study.||||
1318102|NCT03360448|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind|Randomized|t|t|t|t
1318103|NCT03360435|||Cohort||Prospective|||||||
1318104|NCT03360422|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318105|NCT03360409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318106|NCT03360396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318107|NCT03360383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318108|NCT03360370|||Cohort||Prospective|||||||
1318109|NCT03360357|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1318110|NCT03360344|Randomized|Parallel Assignment||Other||Single|Participants do not know which group they will be randomly assigned|prospective randomized controlled trial|t|||
1318111|NCT03360331|||Cohort||Retrospective|||||||
1318112|NCT03360318|Randomized|Single Group Assignment||Treatment||Single||||||t
1318113|NCT03360305|Randomized|Parallel Assignment||Prevention||Single|Data extractors will be blinded to the specific study arm each participant has been randomized to.|||||t
1318114|NCT03360292|Randomized|Crossover Assignment||Treatment||None (Open Label)|Infants will be randomised to either higher (92-97%) or lower (90-95%) oxygen saturation target range, and then cross-over to the alternative range after 6 hours of monitoring (with 12 hours in total study time). The study is randomised but not blinded.|This is a randomised cross-over study of oxygen target ranges in premature infants, with infants acting as their own controls.||||
1318115|NCT03360279|Randomized|Parallel Assignment||Treatment||Single|The IVUS interpreter and follow-up evaluators are masked.|||||t
1318116|NCT03360266|Randomized|Parallel Assignment||Prevention||Single|Investigator is masked in application of fluoride varnish and during all followup visits|The study model involves three groups|||t|
1318117|NCT03360253|Randomized|Parallel Assignment||Treatment||Quadruple|Children allocated on different arms will receive drops of probiotics or placebo. Both product are identical in appearence and flavor|Randomized controlled trial, double blind allocation concealment|t|t|t|t
1318118|NCT03360240|||Case-Control||Cross-Sectional|||||||
1318119|NCT03360227|||Other||Prospective|||||||
1318120|NCT03360214|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1318121|NCT03360201||Single Group Assignment||Treatment||None (Open Label)||The study will follow a single case (N of 1) series design. Pre-post changes will be measured, and repeated measures will be administered before, during, and following the intervention to track change over time. The timing of entry into the study and the numbers of repeated measures data points are randomized across families. Data analysis will aim to (a) identify patterns of change over the course of the intervention and (b) relate change trajectories to theorized mechanisms of action.||||
1318122|NCT03360188|||Cohort||Retrospective|||||||
1318123|NCT03360175|||Cohort||Prospective|||||||
1318124|NCT03360162|||Cohort||Retrospective|||||||
1318125|NCT03360149|||Cohort||Retrospective|||||||
1318126|NCT03360136||Single Group Assignment||Treatment||None (Open Label)||Open Clinical Trial||||
1318127|NCT03360123|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1318128|NCT03360110||||||||||||
1318129|NCT03360097|Randomized|Parallel Assignment||Treatment||None (Open Label)||All participants will be randomized by an intention to treat approach. Randomization at the blastocyst stage is chosen to avoid cycle cancellation if randomized earlier. All components of the IVF/ICSI cycle including stimulation medications, monitoring protocols, etc. will be at the discretion of the participant's primary physician; while this information will be documented it will not constitute criteria for enrolment. The group allocation will take place the day of the embryo transfer. The clinician will randomize all included patients into one of the two study groups using an open computer-generated list. An interim analysis is planned and sample size will be plan accordingly, under the Pocok method, including 2 stages, with p-value as boundary scale, calculated to have 80% power to detect a 20% difference with a reference proportion of 25% clinical pregnancy rate and a one-sided (upper) alpha of 0.025||||
1318130|NCT03360084|||Cohort||Retrospective|||||||
1318131|NCT03360071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318132|NCT03360058|Randomized|Parallel Assignment||Other||None (Open Label)||Primary care practices are either assigned to immediate or delayed access to the online training and print pieces with the delayed group acting as our controls for number of referral to weight management services per practice||||
1318133|NCT03360045|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1318134|NCT03360032|||Cohort||Prospective|||||||
1318135|NCT03360019|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Counterbalanced within-subject design. Specifically, each target patient will randomly be assigned to either have the technology or not have the technology applied for a period of three months, followed by three months of the opposite condition. Caregivers will provide caregiver ratings twice monthly during these two epochs.||||
1318136|NCT03360006||Single Group Assignment||Treatment||None (Open Label)||||||
1318137|NCT03359993|||Cohort||Retrospective|||||||
1318138|NCT03359980||Single Group Assignment||Other||None (Open Label)||||||
1318139|NCT03359967|||Cohort||Prospective|||||||
1318140|NCT03359954||Single Group Assignment||Treatment||None (Open Label)||||||
1318141|NCT03359941||Single Group Assignment||Treatment||None (Open Label)||||||
1318142|NCT03359928|Randomized|Crossover Assignment||Other||None (Open Label)||Using a randomised crossover trial design participants will be randomised computer assisted random sequence generation to sequences in which they are exposed to each experimental condition (exercise modality: stair stepping, stair climbing and non-contact boxing).||||
1318143|NCT03359915|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||RCT Phase - Parallel Groups: 240 in total Control arm - 120 participants Intervention Arm - 120 participants||||
1318144|NCT03359902|Randomized|Crossover Assignment||Basic Science||Double|The sham stimulation experience is very similar to the tVNS stimulation experience. The electrodes are placed in a proximal location. Thus, without knowledge of the anatomy, the participants will be unable to determine which stimulation session is the tVNS one.|All participants will be assigned to either transcutaneous vagal nerve stimulation or sham for the first session, then switch to the other condition for their second session after a 1 week washout period.|t||t|
1318145|NCT03359889|||Cohort||Cross-Sectional|||||||
1318146|NCT03359876|||Cohort||Retrospective|||||||
1318147|NCT03359863||Single Group Assignment||Treatment||None (Open Label)||||||
1318148|NCT03359850|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1318149|NCT03359837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318150|NCT03359824||Single Group Assignment||Basic Science||None (Open Label)||||||
1318151|NCT03359811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318152|NCT03359798|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318153|NCT03359785|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1318154|NCT03359772|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318155|NCT03359759|||Cohort||Prospective|||||||
1318156|NCT03359746||Single Group Assignment||Treatment||None (Open Label)||||||
1318157|NCT03359733|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1318158|NCT03359720|||Ecologic or Community||Cross-Sectional|||||||
1318159|NCT03359707|||Other||Cross-Sectional|||||||
1318160|NCT03359694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318161|NCT03359681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318162|NCT03359668|Randomized|Parallel Assignment||Diagnostic||Single|The investigator will read the randomized non-contrast CTs separately from the contrast-enhanced CTs|Each patient had CT imaging with and without IV contrast|||t|
1318163|NCT03359655|Randomized|Parallel Assignment||Diagnostic||Quadruple|Double blind masking|Three group parallel design|t|t|t|t
1318164|NCT03359642|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318165|NCT03359629|||Cohort||Prospective|||||||
1318166|NCT03359616|Randomized|Parallel Assignment||Treatment||Single|||t|||
1318167|NCT03359603|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1318168|NCT03359590|Randomized|Crossover Assignment||Treatment||Triple|This is a double-blind randomised trial. Except for the unblinded persons involved in the preparation of the IMP (these persons are not involved in any other trial activities), everyone involved in the trial will be blinded until completion of the trial and the final data review.|This is a postmarketing phase 2 trial. The trial is designed as single centre, randomised, double blind, two-way treatment, placebo controlled crossover trial in subjects with type 2 diabetes mellitus treated to fasting plasma glucose targets with insulin glargine and metformin.|t||t|t
1318169|NCT03359577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318170|NCT03359564|||Cohort||Prospective|||||||
1318171|NCT03359551|||Cohort||Prospective|||||||
1318172|NCT03359538|Randomized|Parallel Assignment||Treatment||Double|treatment double blinded to patients and physicians||t||t|
1318173|NCT03359525|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1318174|NCT03359512||Single Group Assignment||Other||None (Open Label)||||||
1318175|NCT03359499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318176|NCT03359486|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1318177|NCT03359473|Randomized|Parallel Assignment||Treatment||Double||Study treatment will consist of two dosing cohorts: Cohort 1 will comprise of male subjects randomized to receive either placebo or 2 milligrams (mg) of GSK2881078 and Cohort 2 will comprise of post-menopausal female subjects randomized to receive either placebo or 1 mg of GSK2881078.|t||t|
1318178|NCT03359460||Single Group Assignment||Treatment||None (Open Label)||||||
1318179|NCT03359447|Randomized|Parallel Assignment||Prevention||Double|"Outcomes assessor: the outcomes are defined by hemoglobin and ferritin (corrected by CRP), also genomic instability is defined by a laboratory result such as comet assay. The members of the laboratory will receive labeled specimens with a code unrelated to the allocated arm.~The investigators that will analyze the data will not carry out the study. All the clinical data will be obtained by the care providers."|Two main arms: weekly vs daily iron supplementation. Infants who are exclusively breast fed will be randomized into three groups: no iron supplementation, weekly iron supplementation and daily iron supplementation. Infants that are partially fed with infant formula will be randomized into two groups: weekly iron supplementation and daily iron supplementation.|||t|t
1318180|NCT03359434||Single Group Assignment||Prevention||None (Open Label)||||||
1318181|NCT03359421|||Cohort||Other|||||||
1318182|NCT03359408|Randomized|Parallel Assignment||Treatment||Single||||||t
1318183|NCT03359395|Randomized|Crossover Assignment||Treatment||Double|study med prepared by a provider not involved in the anesthesia care of the subject||t|t||
1318184|NCT03359382|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1318185|NCT03359369|||Other||Other|||||||
1318186|NCT03359356|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1318187|NCT03359343|||Cohort||Prospective|||||||
1318188|NCT03359330|||Cohort||Prospective|||||||
1318189|NCT03359317||Single Group Assignment||Treatment||None (Open Label)||||||
1318190|NCT03359304|||Family-Based||Prospective|||||||
1318191|NCT03359291||Single Group Assignment||Other||None (Open Label)||All subjects will receive rosuvastatin alone (treatment A) or with macitentan at steady state (treatment B). A fixed sequence design was selected to avoid a lengthy washout period and unnecessary prolongation of subjects' participation in the study.||||
1318192|NCT03359278|||Cohort||Prospective|||||||
1318193|NCT03359265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318194|NCT03359252|Non-Randomized|Parallel Assignment||Other||None (Open Label)||non-stent assisted coiling of unruptured intracranial aneurysms stent assisted coiling of unruptured intracranial aneurysms||||
1318195|NCT03359239||Single Group Assignment||Treatment||None (Open Label)||||||
1318196|NCT03359226||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318197|NCT03359213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318198|NCT03359200|||Other||Retrospective|||||||
1318199|NCT03359187|Randomized|Parallel Assignment||Prevention||Triple||Experimental design in 3 groups|t|t||t
1318200|NCT03359174||Single Group Assignment||Treatment||None (Open Label)||||||
1318260|NCT03358394|Randomized|Parallel Assignment||Other||Single|||t|||
1318261|NCT03358381|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318262|NCT03358368|||Cohort||Prospective|||||||
1318201|NCT03359161||Single Group Assignment||Treatment||None (Open Label)||This is a prospective, open-label, descriptive two-phase study to evaluate the clinical effectiveness of a novel formulation of furosemide delivered by subcutaneous administration. Participants with mild to moderate signs of fluid overload will be included in the study. The study involves at home treatment with a novel formulation of subcutaneous furosemide. In the Pilot Phase (20 patients) will undergo 3 days of at home treatment for fluid overload. If determined to require more, will undergo an extra 4 days of treatment. The Investigator and her team will review the results for the first cohort and depending on the results will proceed to the Evaluation phase (40 patients).||||
1318202|NCT03359148|||Other||Prospective|||||||
1318203|NCT03359135|||Case-Control||Prospective|||||||
1318204|NCT03359122|||Case-Only||Retrospective|||||||
1318205|NCT03359109|||Case-Control||Prospective|||||||
1318206|NCT03359096|Randomized|Crossover Assignment||Treatment||Triple||Washout Period 1 (Study Week 1): The patient will not use Hypoglossal Nerve Stimulation (HGNS) for 1 week. Randomization Visit (Study Week 2): The patient will be randomized to sub-therapeutic HGNS (sham) or therapeutic HGNS (treatment) for 28 days. Sympathetic and Vascular testing (Study Week 6). Washout Period 2 (Study Week 6-7): The patient will not use HGNS for 7 days. The patient will be switched to the other intervention arm (treatment to sham vs. sham to treatment) for 28 days.Sympathetic and Vascular testing (Study Week 11).|t||t|t
1318207|NCT03359083|||Other||Other|||||||
1318208|NCT03359070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318209|NCT03359057|Non-Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1318210|NCT03359044|||Cohort||Prospective|||||||
1318211|NCT03359031|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1318212|NCT03359018||Single Group Assignment||Treatment||None (Open Label)||Every patients will received apatinib 500mg or 250mg orally daily and SHR-1210 3mg/kg (no more than 200mg) iv every 2 weeks until disease progression or intolerance to side effects||||
1318213|NCT03359005||Single Group Assignment||Treatment||None (Open Label)||||||
1318214|NCT03358992|||Cohort||Prospective|||||||
1318215|NCT03358979|||Other||Prospective|||||||
1318216|NCT03358966|||Cohort||Prospective|||||||
1318217|NCT03358953|Randomized|Single Group Assignment||Basic Science||None (Open Label)||E-cigarette versus nicotine replacement patches||||
1318218|NCT03358940||Single Group Assignment||Diagnostic||None (Open Label)||Will be included in the student a patient who is maximum 24 weeks pregnant with miscarriage complications or not, or threatened miscarriage, or voluntary termination of pregnancy using misoprostol.||||
1318219|NCT03358927|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized in a 1:1 ratio||||
1318220|NCT03358914|||Cohort||Prospective|||||||
1318221|NCT03358901|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1318222|NCT03358888|Randomized|Parallel Assignment||Prevention||Single|||t|||
1318223|NCT03358875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318224|NCT03358862|||Case-Only||Other|||||||
1318225|NCT03358849||Single Group Assignment||Treatment||None (Open Label)||||||
1318226|NCT03358836|||Cohort||Prospective|||||||
1318227|NCT03358823|||Case-Only||Prospective|||||||
1318228|NCT03358810|Randomized|Parallel Assignment||Treatment||Single||||t||
1318229|NCT03358797|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||this is an interventional, Pre - Post study, with quasi-experimental comparison group||||
1318230|NCT03358784|||Other||Cross-Sectional|||||||
1318231|NCT03358771|Randomized|Crossover Assignment||Health Services Research||Triple|||t||t|t
1318232|NCT03358758|||Cohort||Retrospective|||||||
1318233|NCT03358745|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1318234|NCT03358732|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized into 2 groups 1. study group had endometrial navigation using IUI catheterone day before embryo transfer control group no intervention||||
1318235|NCT03358719||Single Group Assignment||Treatment||None (Open Label)||||||
1318236|NCT03358706|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318237|NCT03358693|||Case-Only||Prospective|||||||
1318238|NCT03358680|||Cohort||Prospective|||||||
1318239|NCT03358667|||Cohort||Prospective|||||||
1318240|NCT03358654||Single Group Assignment||Treatment||None (Open Label)||||||
1318241|NCT03358641|||Cohort||Prospective|||||||
1318242|NCT03358628|||Cohort||Prospective|||||||
1318243|NCT03358615|||Ecologic or Community||Cross-Sectional|||||||
1318244|NCT03358602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318245|NCT03358589||Single Group Assignment||Diagnostic||None (Open Label)|it is a single-arm study|Prospective cohort||||
1318246|NCT03358576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318247|NCT03358563||Single Group Assignment||Treatment||None (Open Label)||||||
1318248|NCT03358550|Randomized|Single Group Assignment||Basic Science||None (Open Label)|Sequence of tests was randomized. It is no multi-arm study.|||||
1318249|NCT03358537|Randomized|Parallel Assignment||Other||Single|This was a randomized, endoscopists' blinded comparison of bowel cleanising, tolerability and quality indicators for colonoscopy|A total of 215 subjects were randomly assigned for this study, 105 in the clear liquid diet and 100 in the low residue-diet, 5 subjects were excluded in each group||t||
1318250|NCT03358524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318251|NCT03358511||Single Group Assignment||Basic Science||None (Open Label)||||||
1318252|NCT03358498|||Cohort||Cross-Sectional|||||||
1318253|NCT03358485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318254|NCT03358472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318255|NCT03358459|||Case-Only||Cross-Sectional|||||||
1318256|NCT03358446|||Case-Only||Prospective|||||||
1318257|NCT03358433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318258|NCT03358420|||Case-Only||Retrospective|||||||
1318259|NCT03358407|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1573432|NCT00001249||||Treatment||||||||
1318263|NCT03358355||Single Group Assignment||Treatment||None (Open Label)||||||
1318264|NCT03358342|||Cohort||Prospective|||||||
1318265|NCT03358329||Single Group Assignment||Treatment||None (Open Label)||||||
1318266|NCT03358316|||Other||Cross-Sectional|||||||
1318267|NCT03358303|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1318268|NCT03358290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318269|NCT03358277||Single Group Assignment||Treatment||None (Open Label)||||||
1318270|NCT03358264|Randomized|Parallel Assignment||Prevention||Single|||t|||
1318271|NCT03358251|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318272|NCT03358238|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1318273|NCT03358225|||Cohort||Retrospective|||||||
1318274|NCT03358212|||Cohort||Prospective|||||||
1318275|NCT03358199|||Case-Control||Retrospective|||||||
1318276|NCT03358186|||Cohort||Prospective|||||||
1318277|NCT03358173|||Cohort||Retrospective|||||||
1318278|NCT03358160|||Other||Cross-Sectional|||||||
1318279|NCT03358147|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind vs Placebo, Open Label Spiriva Respimat|Linear repeated measures model|t|t|t|t
1318280|NCT03358134||Single Group Assignment||Basic Science||None (Open Label)||||||
1318281|NCT03358121|||Cohort||Cross-Sectional|||||||
1318282|NCT03358108|||Case-Control||Prospective|||||||
1318283|NCT03358095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318284|NCT03358082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318285|NCT03358069|||Cohort||Prospective|||||||
1318286|NCT03358056||Single Group Assignment||Treatment||None (Open Label)||||||
1318287|NCT03358043|||Cohort||Prospective|||||||
1318288|NCT03358030|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1318289|NCT03358017|Randomized|Parallel Assignment||Treatment||None (Open Label)||"After providing informed consent for study participation, patients fulfilling the eligibility criteria will be randomized to receive standard anthracyclines/taxanes based neoadjuvant chemotherapy (ARM A) or the combination of zoledronate and atorvastatin associated with the above mentioned neoadjuvant chemotherapy (ARM B).~Randomization will use a biased-coin minimization procedure having as stratification factor the type of neoadjuvant chemotherapy chosen by the center and the p53 level in the FFPE diagnostic core biopsy determined by IHC (<30% vs >30% vs unknown).~Randomization and e-CFR will be handled by HeavyBase , an Open Source push based peer to peer electronic data management system."||||
1318290|NCT03358004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318291|NCT03357991|||Cohort||Prospective|||||||
1318292|NCT03357978||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318293|NCT03357965|||Cohort||Prospective|||||||
1318294|NCT03357952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318295|NCT03357939|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1318296|NCT03357926|||Cohort||Prospective|||||||
1318297|NCT03357913|||Cohort||Retrospective|||||||
1318298|NCT03357900||Single Group Assignment||Treatment||None (Open Label)||||||
1318299|NCT03357887|||Cohort||Retrospective|||||||
1318300|NCT03357874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318301|NCT03357861|||Cohort||Prospective|||||||
1318302|NCT03357848|||Cohort||Prospective|||||||
1318303|NCT03357835|||Case-Control||Prospective|||||||
1318304|NCT03357822|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318305|NCT03357809||Single Group Assignment||Treatment||None (Open Label)||||||
1318306|NCT03357796|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1318307|NCT03357783|||Cohort||Prospective|||||||
1318308|NCT03357770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318309|NCT03357757||Single Group Assignment||Treatment||None (Open Label)||||||
1318310|NCT03357744|||Case-Only||Cross-Sectional|||||||
1318311|NCT03357731|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1318312|NCT03357718|Randomized|Parallel Assignment||Prevention||Single||Retrospective clinical trial|||t|
1318313|NCT03357705|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318314|NCT03357692||Single Group Assignment||Treatment||None (Open Label)||||||
1318315|NCT03357679|Randomized|Parallel Assignment||Treatment||Single|Investigator is blinded to the initial laryngeal exposure during the sniffing position, but is unblinded during assessment of laryngeal exposure in either the bed up head elevated position or glidescope assisted tracheal intubation||||t|
1318316|NCT03357666|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1318317|NCT03357653|Randomized|Parallel Assignment||Treatment||Quadruple||The investigators will test the effect of ARB to prevent the development of significant proteinuria, defined as random urine protein-to-creatinine ratio of >1g/g creatinine. In this study, the investigators choose losartan as a testing ARB. The investigators will compare the rate of significant proteinuria development between 2 arms, namely losartan group and placebo group after 144 weeks' treatment.|t|t|t|t
1318318|NCT03357640|Randomized|Parallel Assignment||Treatment||Double|Both trial participants and research coordinator will be blinded about the treatment after assignment. Oral contraceptive pills and placebo will be put in 2 packages with different colors and only the main researcher will know the type of treatment used for each group. Unbinding is only permissible, if sever morbidity or even mortality occur to any participants.||t|t||
1318319|NCT03357627|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1318320|NCT03357614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318321|NCT03357601|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Each participant will be match-paired to either HIIT or MCEET group based on their time to complete a mile run. There will be rank from 1 to 40, where number one will be assigned randomly to one group while two goes to the other group. Then, number three goes to the second group and fourth is assigned to the first group. Alternating patterns will be continued thereafter.||||
1318322|NCT03357588|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318323|NCT03357575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318324|NCT03357562||Single Group Assignment||Prevention||None (Open Label)||||||
1318325|NCT03357549|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1318326|NCT03357536|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1318327|NCT03357523|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1318328|NCT03357497|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1318329|NCT03357484|Randomized|Parallel Assignment||Treatment||Double|Participants and Independent Outcomes Assessor were blinded to study groups. Names of participants were coded and known to Principal investigator only.|Patients who met the inclusion criteria for this split-mouth study underwent bilateral IMTM surgical extractions. Following extraction, randomization was done. One socket received L-PRF, and the other socket served as a regular blood clot control.|t|||t
1318330|NCT03357471|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318331|NCT03357458|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1318332|NCT03357445|Randomized|Parallel Assignment||Other||Single|"The two subgroups will have the medical device with the following objectives:~Subgroup 1 Prospective non Controlled to Document long term performance of AVANTAGE® RELOAD.~Subgroup 2 Randomized Controlled Trial to Evaluate wear rate of E1 liner in comparison to ArCom® liner."||t|||
1318333|NCT03357432|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||A crossover design where subject are randomized to consume all 3 intervention doses.||||
1318334|NCT03357419|Randomized|Parallel Assignment||Prevention||Quadruple||"A randomized, 1:1, double-blind, placebo controlled trial designed to evaluate the effect of prophylactic antibiotic on patients presenting for skin excision from lower limbs.~Before the surgery patient's demographics, medical history, skin lesion's site, properties and size will be documented. During the surgery the size of the wound and the sutures used will be documented. Afterwards, the wound will be assed for signs of infection (criteria adapted from the Centre for Disease Control and Prevention definition for superficial SSI [42]) and other complications during the follow-up period as needed until sutures will be removed at our clinic."|t|t|t|t
1318335|NCT03357406|Randomized|Single Group Assignment||Treatment||Double|treatment method is masked till the surgical procedure, during which, both surgeon and patient are informed|Split mouth design|||t|t
1318336|NCT03357393|Randomized|Parallel Assignment||Treatment||Single|The bronchoscopist is blinded regarding given premedication for patients given PCS (two sedation arms).|||t||
1318337|NCT03357380|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures||t|t|t|t
1318338|NCT03357367||Single Group Assignment||Treatment||None (Open Label)||||||
1318339|NCT03357354||Single Group Assignment||Prevention||None (Open Label)||||||
1318340|NCT03357341|||Cohort||Prospective|||||||
1318341|NCT03357328|Randomized|Parallel Assignment||Treatment||Double|"Although the placebo effect might not be an issue in those with severe dementia, the treatment may affect staff, creating bias such as the Hawthorne effect. Potential changes in staff routines and behaviours in response to the treatment may affect outcome, making a control condition necessary. In this controlled trial, we will compare patients receiving the intervention (therapy light rooms) with control units receiving placebo light (standard light). The researchers will install the same standard light solution (100 lux at eye level, 3000K) in all control units. This represents the placebo light intervention, which at the same time ensures a constant standard light condition in all control units."|"4 nursing home units will receive the intervention (ceiling mounted LED-light in the living room) and 4 will receive the control condition (standard light). The trial lasts for 24 weeks. Data will be collected at baseline and after 8, 16 and 24 weeks."|t|t||
1318342|NCT03357315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318343|NCT03357302|||Cohort||Cross-Sectional|||||||
1318344|NCT03357289|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1318345|NCT03357276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318346|NCT03357263|Randomized|Parallel Assignment||Prevention||Single|||t|||
1318347|NCT03357250|||Cohort||Prospective|||||||
1318348|NCT03357237|Randomized|Parallel Assignment||Treatment||Triple||"Intervention or experimental group: treatment regimen with oral rehydration solution and xyloglucan~Control or reference group: treatment regimen with oral rehydration solution and placebo."|t|t|t|
1318349|NCT03357224||Single Group Assignment||Treatment||None (Open Label)||||||
1318350|NCT03357211|||Case-Only||Prospective|||||||
1318351|NCT03357198|||Cohort||Prospective|||||||
1318352|NCT03357185|||Cohort||Prospective|||||||
1318353|NCT03357172|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318354|NCT03357159||Single Group Assignment||Treatment||None (Open Label)||The patients will get conventional GVHD prophylaxis consisting of ATLG 15mg/kg total (5mg/kg day) on days -3 to -1 pre transplantation. Cyclophosphamide at 25mg/kg dose will be administrated at day +3 post infusion of the stem cell (SC) graft to the first 3 patients. If no > grade II toxicity* occurs, the next 3 patients will receive cyclophosphamide at 25mg/kg dose at day +3 and +4 post SC graft infusion. If no > grade II toxicity*occurs, the next 3 patients will receive cyclophosphamide at 37.5 mg/kg dose at day +3 and +4 post SC graft infusion. If no > grade II toxicity* occurs, the next 3 patients will receive the target dose of cyclophosphamide at 50 mg/kg dose on day +3 and +4 post SC graft infusion. The residual 18 patients will receive cyclophosphamide at the maximal tolerated dose (MTD) established in the first part of the study. Patients will also receive GVHD prophylaxis consisting of a cyclosporine and cellcept starting on day +5 after transplantation.||||
1318355|NCT03357146|||Cohort||Cross-Sectional|||||||
1318356|NCT03357133|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318357|NCT03357120||Single Group Assignment||Other||None (Open Label)||||||
1318358|NCT03357107|||Cohort||Retrospective|||||||
1318359|NCT03357094|||Case-Only||Prospective|||||||
1318360|NCT03357081|||Cohort||Prospective|||||||
1318361|NCT03357068|Randomized|Parallel Assignment||Treatment||Double||Split mouth design - one side of mouth is test group, other side is control group|t|||t
1318362|NCT03357055|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1573433|NCT00001239||||Treatment||||||||
1318363|NCT03357042|Randomized|Parallel Assignment||Treatment||Double||Three group: Aerobic retraining intervention, standard of care intervention, healthy control|||t|t
1318364|NCT03357029|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1318365|NCT03357016|Randomized|Parallel Assignment||Prevention||Single|Data collected on the volunteers will be made anonymous.||t|||
1318366|NCT03357003|||Cohort||Prospective|||||||
1318367|NCT03356990||Single Group Assignment||Other||None (Open Label)||||||
1318368|NCT03356977||Single Group Assignment||Treatment||None (Open Label)||||||
1318369|NCT03356964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318370|NCT03356951|||Case-Control||Cross-Sectional|||||||
1318371|NCT03356938|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1318372|NCT03356925|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1318373|NCT03356912|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1318374|NCT03356899|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1318375|NCT03356886|Randomized|Parallel Assignment||Treatment||Single|Once the patient has accepted the invitation to participate, the same researcher (FAGT) will gather the clinical assessment and determine eligibility. After this initial assessment, participants will be randomly assigned following simple computerized randomisation procedures to one of the two treatment groups through the use of cards previously placed in opaque sealed envelopes. The allocation sequence will be generated by a researcher (TCC) not involved in the assessment and interventions, and another research assistant will assign participants to interventions.|The recruited subjects will be randomized through the use of randomizer software in two groups of 52 individuals: SMT group which will receive PNE + SMT interventions or SMT alone. Both groups will be assessed at baseline (before the initial treatment session) by a blinded investigator. Immediately after the end of the last session and after the one-month follow-up, the primary outcomes and secondary outcomes will be re assessed. A single blinded investigator for the interventions administered will accomplish the assessment protocol. Another trained researcher (physiotherapist trained in SMT - 8 years of clinical experience) will administer the SMT maneuvers and a third researcher will be involved in the administration of the PNE. The treatment will last at least 8 sessions. The treatment will last at least 8 sessions lasting between 20 and 30 minutes each.|||t|
1318376|NCT03356873|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1318377|NCT03356860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318378|NCT03356847||Single Group Assignment||Treatment||None (Open Label)||||||
1318379|NCT03356834|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318380|NCT03356821||Single Group Assignment||Treatment||None (Open Label)||A phase I/II, open-label, single-arm, single-center intervention study in the NICU at the Wilhelmina children's Hospital / University Medical Centre in Utrecht of (near-)term newborns ≥36 weeks of gestation within the first week of onset of presenting clinical symptoms.||||
1318381|NCT03356808||Single Group Assignment||Treatment||None (Open Label)||||||
1318382|NCT03356795||Single Group Assignment||Treatment||None (Open Label)||||||
1318383|NCT03356782||Single Group Assignment||Treatment||None (Open Label)||||||
1318384|NCT03356769|Randomized|Parallel Assignment||Treatment||Quadruple|Patients, investigators, site personnel, and the sponsor's study team were masked to treatment allocation, but allocation was not concealed from personnel in charge of drug supply, and implementation of the randomisation list. The Data Safety Monitoring Board (DSMB) independent statistician and programmer were semi-blind to treatment allocation at the time of DSMB meetings.||t|t|t|t
1318385|NCT03356756|||Cohort||Prospective|||||||
1318386|NCT03356743|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1318387|NCT03356730|Randomized|Parallel Assignment||Treatment||Double|Masking for placebo or vitamin D use|This is a clinical research study, characterized by a randomized, double-blind, placebo-controlled trial.|t||t|
1318388|NCT03356717|Randomized|Parallel Assignment||Other||None (Open Label)||randomized study||||
1318389|NCT03356704|||Cohort||Retrospective|||||||
1318390|NCT03356691|Randomized|Parallel Assignment||Other||Double|The investigators did not know which group the patients were allocated.||t||t|
1318391|NCT03356678|||Case-Only||Retrospective|||||||
1318392|NCT03356665||Single Group Assignment||Diagnostic||None (Open Label)|The reference laboratory, generating the results for 4 index tests, is masked for index test and reference test results obtained at the clinical trial site|Sequential assignement||||
1318393|NCT03356652||Single Group Assignment||Treatment||None (Open Label)||||||
1318394|NCT03356639|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1318395|NCT03356626|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1318396|NCT03356613|||Other||Prospective|||||||
1318397|NCT03356600||Single Group Assignment||Treatment||None (Open Label)||||||
1318398|NCT03356587||Single Group Assignment||Prevention||None (Open Label)||"During or after palliative 1st line platinum based chemotherapy, we will perform prescreening NGS based molecular characterization.~Molecular tumor board to determine characterization will be held for every patients. Once each patients have relevant genetic pathway, the patients will be allocated each treatment arm"||||
1318399|NCT03356574|||Cohort||Retrospective|||||||
1318400|NCT03356561|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1318401|NCT03356548|||Case-Only||Prospective|||||||
1318402|NCT03356535|||Case-Control||Prospective|||||||
1318403|NCT03356522|||Case-Only||Prospective|||||||
1318404|NCT03356509|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1318405|NCT03356496|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1318406|NCT03356483|Randomized|Parallel Assignment||Treatment||Quadruple||In the study, half of the participants will be randomized to receive psilocybin (n=15) or the active-placebo-control, niacin (n=15). Following the first treatment session of either the active agent or active-placebo-control, participants who were randomized to receive active-placebo-control will be offered the option to receive open-label psilocybin. The blind will be broken at 48-hours to make this determination.|t|t|t|t
1318407|NCT03356470|||Cohort||Prospective|||||||
1318460|NCT03355781|||Cohort||Prospective|||||||
1318585|NCT03354156|||Case-Control||Prospective|||||||
1318408|NCT03356457|Randomized|Crossover Assignment||Treatment||Single|Once stable hypoglycemia is reached, a cognitive testing battery will be administered by a study co-investigator who will be blinded to the treatment assignment.|"This will be a single center, placebo-controlled, cross-over, randomized clinical pilot study.~At the screening visit informed consent will be obtained. Medical history and documents will be reviewed to screen potential subjects by inclusion and exclusion criteria. Subjects will receive a physical examination and laboratory blood work (BUN/creatinine, electrolytes, lipid profile, liver function, and HbA1c) as well as urine toxicology screens (to confirm self-report of alcohol, and drug information) to ensure good physical health."|t|||
1318409|NCT03356444|Randomized|Parallel Assignment||Treatment||None (Open Label)|The administration methods of the two groups are different, therefore, the investigators decide not to use masking.|||||
1318410|NCT03356431|Randomized|Parallel Assignment||Treatment||Single||||||t
1318411|NCT03356418|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1318412|NCT03356405|||Cohort||Prospective|||||||
1318413|NCT03356392|||Cohort||Prospective|||||||
1318414|NCT03356379|Non-Randomized|Parallel Assignment||Diagnostic||Single||transcutaneous oximetry|t|||
1318415|NCT03356366|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1318416|NCT03356353||Single Group Assignment||Prevention||None (Open Label)||This is an open label single arm trial.||||
1318417|NCT03356340|||Cohort||Prospective|||||||
1318418|NCT03356327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318419|NCT03356314|||Cohort||Retrospective|||||||
1318420|NCT03356301|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1318421|NCT03356288|||Cohort||Prospective|||||||
1318422|NCT03356275||Single Group Assignment||Supportive Care||None (Open Label)||||||
1318423|NCT03356262|||Cohort||Prospective|||||||
1318424|NCT03356249|||Cohort||Prospective|||||||
1318425|NCT03356236|||Cohort||Prospective|||||||
1318426|NCT03356223||Single Group Assignment||Treatment||None (Open Label)||||||
1318427|NCT03356210|Randomized|Parallel Assignment||Treatment||Single|RA's doing follow-up assessment will be blinded to condition assignment|||||t
1318428|NCT03356197|||Ecologic or Community||Retrospective|||||||
1318429|NCT03356184||||||||||||
1318430|NCT03356171|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1318431|NCT03356158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318432|NCT03356145|Randomized|Parallel Assignment||Treatment||Single|The provider and staff will be aware of arm allocation, but participants will remain blinded.|Participants will be randomized to one of two study arms via computer-generated block randomization using REDCap software.|t|||
1318433|NCT03356132|||Cohort||Prospective|||||||
1318434|NCT03356119||Single Group Assignment||Health Services Research||None (Open Label)||All recruited subjects will be assigned to implant removal using the RemovAid IMD. There is no formal comparator in this study. The investigators are investigating design functionality and safety.||||
1318435|NCT03356106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318436|NCT03356093|||Cohort||Prospective|||||||
1318437|NCT03356080||Single Group Assignment||Treatment||None (Open Label)||||||
1318438|NCT03356067|Randomized|Crossover Assignment||Treatment||Double||Randomized sham-procedure controlled trial with crossover after 6 months after procedure|t|||t
1318439|NCT03356054||Single Group Assignment||Treatment||None (Open Label)||||||
1318440|NCT03356041|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1318441|NCT03356028|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Interventional research involving the category 2 human person at minimal risk and constraint, excluding health product, multicentre||||
1318442|NCT03356015|Randomized|Parallel Assignment||Screening||Double|||||t|t
1318443|NCT03356002|Non-Randomized|Parallel Assignment||Diagnostic||Double|The colonoscopists will be blinded to the C-Scan system results and FIT results and the reviewers of C-Scan system results will be blinded to Fit and colonoscopy results|||t|t|
1318444|NCT03355989|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|The participant allocation sequence will be concealed from the study staff responsible for screening and enrolling participants through the use of real time phone based randomization sequence.|This is an individually randomized, twelve-arm parallel group design randomized control trial. The study has a cross-cutting design where one experiment (1) will investigate (1a) sharply increasing versus slowly increasing payouts; (1b) high incentive versus low incentive and (1c) simple SMS reminder vs no reminder. A second experiment (2), orthogonal to the first, will also test lottery payouts vs non-lottery payouts and we will cross-cut (1a), (1b) and (1c) with (2). The first experiment would enrol 1600 participants with the second distributing these participants to 900 participants each in the lottery vs non lottery payout. There will also be an SMS only arm and a control arm each enrolling 1600 participants.||||
1318445|NCT03355976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318446|NCT03355963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318447|NCT03355950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318448|NCT03355937|Randomized|Crossover Assignment||Screening||Double|||t||t|
1318449|NCT03355924|||Cohort||Retrospective|||||||
1318450|NCT03355911|||Cohort||Retrospective|||||||
1318451|NCT03355898|||Other||Retrospective|||||||
1318452|NCT03355885|||Cohort||Cross-Sectional|||||||
1318453|NCT03355872|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318454|NCT03355859||Single Group Assignment||Treatment||None (Open Label)||||||
1318455|NCT03355846|Randomized|Parallel Assignment||Treatment||Single|||||t|
1318456|NCT03355833|||Other||Retrospective|||||||
1318457|NCT03355820||Single Group Assignment||Prevention||None (Open Label)||||||
1318458|NCT03355807|Randomized|Parallel Assignment||Other||Quadruple|A Patient, investigator and anesthesiologist who was blinded to the assignment of the patients recorded levels of sedation, pain, cumulative morphine consumption, and hemodynamic variables|The patients undergoing sleeve gastrectomy.|t|t|t|t
1318459|NCT03355794|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318461|NCT03355768|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318462|NCT03355755||Single Group Assignment||Treatment||None (Open Label)||Single-arm safety and feasibility study.||||
1318463|NCT03355742||Single Group Assignment||Treatment||None (Open Label)||||||
1318464|NCT03355729|||Family-Based||Cross-Sectional|||||||
1318465|NCT03355716|Randomized|Parallel Assignment||Treatment||Triple||"At the end of the procedure, all the subjects will be randomly allocated to groups using computer‑generated random numbers. Each group of 30 subjects, that is,~Group A (placebo):~instillation of bupivacaine alone: Bupivacaine 25 ml (0.25%) after surgery completion;~Group B :~Instillation of bupivacaine and morphine: Bupivacaine 25 ml (0.25%) + Morphine (3.0 mg)~Group C :~Instillation of bupivacaine and fentanyl: Bupivacaine25 ml (0.25%) + fentanyl (30.0 Mc)~Group D :~Instillation of bupivacaine and Ketamine: Bupivacaine25 ml (0.25%) + ketamine (0.5 mg/kg)."|t|t|t|
1318466|NCT03355703|||Case-Control||Prospective|||||||
1318467|NCT03355690|||Cohort||Prospective|||||||
1318468|NCT03355677|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1318469|NCT03355664|Randomized|Parallel Assignment||Treatment||None (Open Label)||open-label randomised trial||||
1318470|NCT03355651|Randomized|Parallel Assignment||Treatment||Single|ACL parasagittal cuts were performed in T1 sequences and analyzed by a blinded musculoskeletal radiologist to improve the quality of the study|||||t
1318471|NCT03355638|Randomized|Parallel Assignment||Treatment||None (Open Label)||This was a prospective, randomized, pilot study in 60 patients with treatment-naïve choroidal neovascularization. Patients were randomized 1:1:1 into 3 groups: aflibercept monotherapy, aflibercept plus pranoprofen, or aflibercept plus nutraceutical tablets containing multivitamin antioxidant and mineral supplementation plus omega-3.||||
1318472|NCT03355625|||Cohort||Prospective|||||||
1318473|NCT03355612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318474|NCT03355599||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318475|NCT03355586|||Cohort||Prospective|||||||
1318476|NCT03355573||Single Group Assignment||Treatment||None (Open Label)||||||
1318477|NCT03355560||Single Group Assignment||Treatment||None (Open Label)||||||
1318478|NCT03355547|||Cohort||Prospective|||||||
1318479|NCT03355534|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1318480|NCT03355521|Randomized|Parallel Assignment||Treatment||Double|Outcomes Assessor|Experimental: Nordic walking Experimental: Nordic walking Training The total period of training was composed by 9-week of walking with poles, two sessions per week. The cycles were divided into four microcycles composed of three training sessions. Each training session took 60 min. Nordic walking aerobics training was used during the training period. These exercises were performed alternating volume and intensity. The training session was divided into three stages: (a) stretching, joint mobility, and heating; (b) main part (FW or NW); (c) return to the calm and ultimate stretching. The participants were trained with individualized prescription according to their maximum distance. A heart rate monitor, Model FT4 attached to the chest of the xiphoid process, was used to control the progression of intensity for the training cycles ranging from 60% to 80% of heart rate reserve. Additionally, we used the Borg RPE for training intensity control, which ranged between 13 and 17 of that scale.|||t|t
1318481|NCT03355508|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1318482|NCT03355495|Randomized|Parallel Assignment||Screening||None (Open Label)||Randomized Controlled Trial||||
1318483|NCT03355482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318484|NCT03355469|Randomized|Parallel Assignment||Prevention||Quadruple||Each subject will be randomly assigned to receive low intensity exercise training + placebo, high intensity exercise training + placebo, or these exercise programs with metformin.|t|t|t|t
1318485|NCT03355456|Randomized|Parallel Assignment||Treatment||Double|Patients will be blinded to whichever ablation arm they are randomized to. Events adjudicator will be blinded to randomization arm.|"Randomized comparison of three ablation techniques:~Pulmonary vein isolation (PVI) alone to~PVI plus total left atrial low voltage-directed ablation to~PVI plus non-voltage-directed posterior wall ablation"|t|||t
1318486|NCT03355443|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318487|NCT03355430|||Case-Only||Retrospective|||||||
1318488|NCT03355417||Single Group Assignment||Treatment||None (Open Label)||This study will use a non-concurrent multiple baseline design (MBD) where subjects will serve as their own control||||
1318489|NCT03355404|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318490|NCT03355391|||Cohort||Prospective|||||||
1318491|NCT03355378|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318492|NCT03355365|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1318493|NCT03355352|||Case-Control||Prospective|||||||
1318494|NCT03355339|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1318495|NCT03355326|Randomized|Parallel Assignment||Treatment||Single|||||t|
1318496|NCT03355313|Non-Randomized|Parallel Assignment||Treatment||Quadruple||Nutritional status of 50 children will be measured according the World Health Organization. The volume of saliva will be measured and, also, the salivary flow rate(mL/min) and buffering capacity will be determined. Concentrations of salivary IgA in all samples will be measured using a ELISA kit. Laser will be administered for 10 seconds on four intraoral points and four extraoral points in the region of the parotid glands bilaterally as well as one intraoral point and one extraoral point in the regions of the submandibular and sublingual glands. Three sessions of laser therapy will occur (after the collection of saliva, 7 and 14 days after the first session, respectively). The final saliva collection will be performed after the third laser session. The laser will be adjusted according to the following parameters: 808nm, 4 J, Continuous and contact mode,100mW, Irradiation at target (mW/cm2)=2500,Irradiated area (cm2)=0.40.|t|t|t|t
1318497|NCT03355300||Single Group Assignment||Treatment||None (Open Label)||||||
1318498|NCT03355287|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1318499|NCT03355274|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Patients with thoracic outlet syndrom (patients) Healthy asymptomatic patients (controls)||||
1318500|NCT03355261|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318586|NCT03354143|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1573434|NCT00001237||||Treatment||||||||
1318501|NCT03355248|Randomized|Factorial Assignment||Health Services Research||Single|Participants are blinded to the group assignment and are not made aware of what interventions are being assigned, only that pain management and satisfaction are being evaluated||t|||
1318502|NCT03355235|||Cohort||Prospective|||||||
1318503|NCT03355222|Randomized|Parallel Assignment||Prevention||None (Open Label)|"Chickens are how we intervene and this is not possible to blind'. Two villages will be far apart. We will not disclose nature of intervention to examiners."|Subjects to be drawn from two simlar villages: one is intervention village and other is control village.||||
1318504|NCT03355209|Randomized|Parallel Assignment||Treatment||Quadruple|Part 1: double-Blind Part 2: Open-Label|Part 1: Double-Blind ZX008 - 0.2 mg/kg/day or Placebo and Part 2: Open-Label|t|t|t|t
1318505|NCT03355196||Parallel Assignment||Treatment||Double|||t||t|
1318506|NCT03355183||Single Group Assignment||Screening||None (Open Label)||||||
1318507|NCT03355170|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1318508|NCT03355157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318509|NCT03355144||Single Group Assignment||Treatment||None (Open Label)||||||
1318510|NCT03355131|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318511|NCT03355118|||Other||Prospective|||||||
1318512|NCT03355105|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1318513|NCT03355092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318514|NCT03355079|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1318515|NCT03355066||Single Group Assignment||Treatment||None (Open Label)||||||
1318516|NCT03355053|Randomized|Parallel Assignment||Prevention||Quadruple||phase II, mechanistic, randomized, three-arm parallel group clinical trial|t|t|t|t
1318517|NCT03355040|||Cohort||Prospective|||||||
1318518|NCT03355027|Randomized|Parallel Assignment||Basic Science||None (Open Label)||"Randomisation to be performed to a 1:1 ratio.~Alirocumab treatment arm*:~Alirocumab (150mg) & Statin (either: Simvastatin 80mg od, Rosuvastatin 20mg/40mg od or Atorvastatin 40/80mg od)~*May be required to complete a 4 week washout period on a statin before entering the study: Simvastatin 80mg od, Rosuvastatin 20mg/40mg od or Atorvastatin 40/80mg od.~Comparator treatment arm*:~Ezetimibe (10mg) & Statin (either: Simvastatin 80mg od, Rosuvastatin 20mg/40mg od or Atorvastatin 40/80mg od)~*May be required to complete a 4 week washout period on a statin before entering the study: Simvastatin 80mg od, Rosuvastatin 20mg/40mg od or Atorvastatin 40/80mg od."||||
1318519|NCT03355014|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1318520|NCT03355001|||Cohort||Prospective|||||||
1318521|NCT03354988|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1318522|NCT03354975|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1318523|NCT03354962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318524|NCT03354949|||Cohort||Prospective|||||||
1318525|NCT03354936|||Cohort||Prospective|||||||
1318526|NCT03354923|Randomized|Crossover Assignment||Treatment||Single||||||t
1318527|NCT03354910|Randomized|Parallel Assignment||Health Services Research||Double||Treatment assignments will be based on a computer-generated randomization scheme, stratified by age (<60 vs. ≥60 yrs old) and household income (<250% vs. ≥250% of federal poverty guidelines), since older and low-income patients are known to have lower LDKT rates a priori. Patients will be randomized into one of three treatment arms in a 1:3:3 fashion such that 54 Usual Care, 160 HC and 160 HC+PM patients will be enrolled. The study investigators and research assistants conducting the study assessments of patients will remain blinded to the treatment assignments. KT candidates will be informed of group assignment immediately after completing the Baseline assessment.|||t|t
1318528|NCT03354897||Single Group Assignment||Treatment||None (Open Label)|prospective cohort study|This study is a multi-centre prospective cohort study to investigate whether individuals possessing the AA genotype of the single nucleotide polymorphism, rs13333226, are better responders to loop diuretics compared to those possessing the G allele.||||
1318529|NCT03354884||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1318530|NCT03354871|||Cohort||Prospective|||||||
1318531|NCT03354858|||Cohort||Prospective|||||||
1318532|NCT03354845|Randomized|Parallel Assignment||Other||Single|Group assignment was made known to the pharmacists and doctors involved in the deprescribing study intervention. However, patients were not aware of which group they had been assigned to.|The study was conducted as an open trial with two parallel groups. A total of 200 patients were randomized to an intervention (deprescribing) or control (usual care) group in a 1:1 ratio. Randomization of patients was performed after recruitment by an independent administrator using GraphPad randomization sequence software ©2017. Doctors were free to make any changes to patients' medication regimens as they wished in both groups.|t|||
1318533|NCT03354832|||Other||Prospective|||||||
1318534|NCT03354819|Randomized|Parallel Assignment||Supportive Care||Single|The eligible participants will be randomized into the 2 groups (MBCT and SIRE), following the allocation concealment mechanism by an independent assistant. The research assistants who were blinded to the group assignment performed all of the outcome measurements and data entries. The procedure and treatment allocation will be blinded to the investigator and the interventionists until the baseline measurement is completed.|A prospective, single-blind, parallel-group randomized controlled trial (RCT) will be adopted to test the hypotheses and compare the immediate effects and its effects over a 3-month follow up between the MBCT program and an active control group (social interactions and routine education on dementia care) for the family caregivers of PWD in the community. The MBCT program consists of seven sessions, including different mindfulness activities (such as mindful eating and mindful walking) and peer sharing, while the parallel active control group will have the social interactions and routine education on dementia care, including seven education sessions on dementia care, caregiver skills training and group sharing, aiming to control/balance the social interaction effects that can also be found in the MBI group. The study will also follow the guideline recommended by the latest Consolidated Standards of Reporting Trials (Schulz et al., 2010) statements.||||t
1318583|NCT03354182|Randomized|Parallel Assignment||Treatment||Single|The patients didn't know whether they were the control or test group|Randomized clinical study with 1 control group and 1 test group|t|||
1318887|NCT03350230|||Case-Control||Prospective|||||||
1318535|NCT03354806|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Comparative, monocentric study including 2 parallel groups. Patient's allocation is based on recommended criteria for catheters for continuous peripheral nerve blocks uses such as anlagesic treatment (ropivacain) tolerance and acceptance or analgesic treatment refusal||||
1318536|NCT03354793|||Cohort||Retrospective|||||||
1318537|NCT03354780|||Cohort||Retrospective|||||||
1318538|NCT03354767|||Cohort||Prospective|||||||
1318539|NCT03354754|Randomized|Parallel Assignment||Basic Science||Single|A blinded evaluator will perform the safety and efficacy assessments|||||t
1318540|NCT03354741|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1318541|NCT03354728||Single Group Assignment||Supportive Care||None (Open Label)||||||
1318542|NCT03354715|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1318543|NCT03354702|Randomized|Parallel Assignment||Treatment||Single||||||t
1318544|NCT03354689|||Cohort||Prospective|||||||
1318545|NCT03354676|||Cohort||Cross-Sectional|||||||
1318546|NCT03354663||Single Group Assignment||Treatment||None (Open Label)||||||
1318547|NCT03354650|||Case-Only||Cross-Sectional|||||||
1318548|NCT03354637|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318549|NCT03354624|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1318550|NCT03354611||Single Group Assignment||Diagnostic||None (Open Label)||Subjects in this group will be enrolled from screening assigned BIRADS 0, patient complaint, or referral for second opinion. The enrolled patient will accept CE-CBBCT scans within 4 weeks of her diagnostic mammography and before breast biopsy if biopsy is needed.||||
1318551|NCT03354598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318552|NCT03354585|Randomized|Parallel Assignment||Basic Science||Single||One group - Mindfulness Meditation training Other group - Meditation training Other group - Book Listening Control|t|||
1318553|NCT03354572|Randomized|Parallel Assignment||Treatment||Quadruple||The study will be a single centre double blinded randomized placebo controlled trial|t|t|t|t
1318554|NCT03354559|||Cohort||Retrospective|||||||
1318555|NCT03354546|||Cohort||Retrospective|||||||
1318556|NCT03354533||Single Group Assignment||Treatment||None (Open Label)||||||
1318557|NCT03354520|Randomized|Parallel Assignment||Prevention||Single|||t|||
1318558|NCT03354507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318559|NCT03354494|||Cohort||Retrospective|||||||
1318560|NCT03354481||Single Group Assignment||Other||None (Open Label)||||||
1318561|NCT03354468|||Cohort||Cross-Sectional|||||||
1318562|NCT03354455|Randomized|Crossover Assignment||Basic Science||Single|Sham stimulation||t|||
1318563|NCT03354442|Randomized|Parallel Assignment||Treatment||Single|A person who is not related to the research will paste a piece of paper over the Patient's name and the date of the photo then will give each x-ray a code and blind these codes on the researcher during the assessing process.|||||t
1318564|NCT03354429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318565|NCT03354416|||Cohort||Prospective|||||||
1318566|NCT03354403|||Cohort||Cross-Sectional|||||||
1318567|NCT03354390||Single Group Assignment||Treatment||None (Open Label)||||||
1318568|NCT03354377|Randomized|Parallel Assignment||Prevention||Single||||||t
1318569|NCT03354364|Randomized|Crossover Assignment||Other||Double|||t||t|
1318570|NCT03354351|||Ecologic or Community||Prospective|||||||
1318571|NCT03354338|Randomized|Parallel Assignment||Treatment||Quadruple|Participant, care provider, Investigator, Outcomes Assessor and Statistic. The treatment codes of the study were not accessible to the investigators and to the examiner until the data will be analyzed.|"A triple-blind randomized controlled trial with 90 participants will be conducted. Participants will be assigned using block randomization in two groups and will received intensive periodontal therapy under local anaesthesia.~Test group pre-medication with 2 gr of oral amoxicilline 1 hour before treatment.~Control group with 2 gr of placebo 1 hour before treatment. Samples of blood will be taken at baseline (before treatment), immediately finished the treatment, 30 minutes later, after 24 hours, after seven days and on the day 30th to asses bacteremia and inflammatory markers"|t|t|t|t
1318572|NCT03354325|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1318573|NCT03354312|Randomized|Crossover Assignment||Other||None (Open Label)||The randomization determines if a subject will be assigned to receive either lidocaine gel or articaine injection anesthesia as the first anesthesia during SRP Treatment of the right upper and lower jaw. The second anesthesia during SRP at visit 2 will be carried out with the remaining anesthetic on the left side of the upper and lower jaw.||||
1318574|NCT03354299|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The patients were divided into 2 groups, groups I received 25 g of sugar plus 50 cc of coconut milk (200 kkal) as late night snacks (LNS); and group II received 50 g of sugar alone (200 kkal) as LNS||||
1318575|NCT03354286|Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1318576|NCT03354273||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318577|NCT03354260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318578|NCT03354247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318579|NCT03354234|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1318580|NCT03354221||Single Group Assignment||Supportive Care||None (Open Label)||||||
1318581|NCT03354208|||Cohort||Prospective|||||||
1318582|NCT03354195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"During surgery, the ACL will be inspected, manually stressed and probed following standard techniques to assess its structure and function.(20, 21) The state of the ACL will be recorded and classified into one of four categories per these intra-operative examinations (22) and available pre-operative MRI data:~Group 1 - intact ACL ligament~Group 2 - intact but fibrillated (frayed) ligament)~Group 3 - nearly completely torn ligament (>50% and disrupted)~Assessment will be performed by the PI. Knees with ACLs classified as Group 1 and Group 2 will be accepted as functionally intact. Those classified as Group 3 will be deemed as having functionally absent ACLs"||||
1318584|NCT03354169|Randomized|Crossover Assignment||Other||None (Open Label)||Randomized within subjects, cross-over design||||
1573435|NCT00001233||||||||||||
1318587|NCT03354130|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Data analyst will know the foods consumed before samples were taken|Volunteers consume five different diets in a randomized cross-over dietary intervention.||||
1318588|NCT03354117||Single Group Assignment||Prevention||None (Open Label)||Single, open-label trial of one-time dosing of ulipristal acetate and meloxicam at a peak fertility time point.||||
1318589|NCT03354104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318590|NCT03354091|Randomized|Parallel Assignment||Treatment||Single|Masking is performed through sealed envelopes. The investigator has no knowledge of which patients who is randomized to intervention or control|Cluster-Randomized controlled trial|||t|
1318591|NCT03354078|Randomized|Parallel Assignment||Prevention||Single|||t|||
1318592|NCT03354065|Randomized|Parallel Assignment||Treatment||Triple|blinding of the evaluator to the study group blinding of patient to study hypothesis||t||t|t
1318593|NCT03354052|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1318594|NCT03354039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318595|NCT03354026|Randomized|Parallel Assignment||Treatment||Quadruple|Our randomized program was completed by the key research laboratory of clinical research from the Traditional Chinese medicine Hospital of Guangdong Province. We design 306 cases into three groups: Group A, B, C in the proportion of 1:1:1. Group A is the experimental group used RBS, which include 8 herbals. Group B is the experimental group used PBS, which include all the herbals in Group A except Leech and Tabanus, rhubarb. Group C is a placebo group. This study adopts a stratified random sampling method and intra slice randomization on the basis of using PROC PLAN progress on SAS V9.2. On the other hand, this trial measures and the control measures will be made blind doubly. The surface of the opaque random envelopes will indicate the information of the test name, hospital name and the entry sequence number of patient. The research process of incorporating patient, dispensing medicine depending on the random envelopes and ect will all be supervised by the researchers each other.||t|t|t|t
1318596|NCT03354013||Single Group Assignment||Treatment||None (Open Label)||||||
1318597|NCT03354000|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1318598|NCT03353987|Randomized|Parallel Assignment||Prevention||Double|The attending anaesthetist and assessors will be blinded|"Home based cognitive training (CogniTrain)~Intervention: Using memory logbook and newspaper cuttings for cognitive improvement"||t||t
1318599|NCT03353974|Randomized|Parallel Assignment||Treatment||Single||||||t
1318600|NCT03353961|Randomized|Parallel Assignment||Treatment||Single||||||t
1318601|NCT03353948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318602|NCT03353935|||Case-Only||Prospective|||||||
1318603|NCT03353922|Randomized|Crossover Assignment||Treatment||Triple|subjects are blindfolded to receive oral dose of treatment, matching placebo, or unblinded active control|multiple-dose 3-way cross-over study|t||t|t
1318604|NCT03353909|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1318605|NCT03353896||Single Group Assignment||Treatment||None (Open Label)||||||
1318606|NCT03353883|Randomized|Parallel Assignment||Treatment||Quadruple|sealed envelopes||t|t|t|t
1318607|NCT03353870|||Other||Prospective|||||||
1318608|NCT03353857|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318609|NCT03353844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318610|NCT03353831|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1318611|NCT03353818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318612|NCT03353805|||Cohort||Prospective|||||||
1318613|NCT03353792|Randomized|Parallel Assignment||Treatment||Single|The intervention consists of treatment with a CL/AP-enabled insulin pump/CGM combination; subjects in the control group will continue their usual diabetes care (insulin pump therapy) along with CGM recording .|The design is a single-site, parallel group, randomized clinical trail. Following enrollement and CGM documentation of hypoglycemia during the 4-week run-in period, study participants are randomized to intervention and control groups.|t|||
1318614|NCT03353779|||Cohort||Prospective|||||||
1318615|NCT03353766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318616|NCT03353753|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1318617|NCT03353740||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318618|NCT03353727||Single Group Assignment||Other||None (Open Label)||||||
1318619|NCT03353714|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1318620|NCT03353701||Single Group Assignment||Other||None (Open Label)||Participants will serve as their own controls with pre- and post-measures.||||
1318621|NCT03353688|Randomized|Crossover Assignment||Treatment||Triple|This is a triple blind study. Participants, raters, and investigator are masked to the assignment of directional versus omnidirectional unilateral subthalamic deep brain stimulation guided by behavioral programming for Parkinson's disease with motor fluctuations. For the nested exploratory arm evaluating directional DBS guided by electrophysiology biomarkers, the study is double-blind (investigator is not blinded).|This is a triple blind, randomized crossover study of directional versus omnidirectional unilateral subthalamic deep brain stimulation for Parkinson's disease with motor fluctuations.|t||t|t
1318622|NCT03353675||Single Group Assignment||Treatment||None (Open Label)||||||
1318623|NCT03353662|||Cohort||Cross-Sectional|||||||
1318624|NCT03353649|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1318625|NCT03353636|Randomized|Crossover Assignment||Other||Quadruple||Five period crossover study|t|t|t|t
1318626|NCT03353623|Randomized|Crossover Assignment||Treatment||Single|The study was masked only for the medical doctor who performed the motor assessments with clinical scales: she did not follow the rehabilitation sessions.|The investigators adopted a 2x2 crossover design (2-sequence, 2-period, 2-treatment crossover design, with sequences AB and BA): each participant received both conventional and VR-aided therapy for a period of 4 weeks per treatment (2 sessions per week of 45 minutes) assigned in a different order. A wash out period of 4 weeks was included before the second period of intervention started.||||t
1318627|NCT03353610|||Cohort||Prospective|||||||
1318628|NCT03353597||Single Group Assignment||Treatment||None (Open Label)||||||
1318629|NCT03353584|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1318630|NCT03353571||Single Group Assignment||Other||None (Open Label)||"Safety and efficacy of the Catheter Science C3 Umbrella Catheter in establishing urinary drainage and allowing the control of micturition when indwelling for up to 7 days.~The reduction in Catheter Acquired Urinary Tract Infection (CAUTI)~A single arm study design was chosen because there is no alternative treatment to serve as an appropriate control. The C3 catheterizes the bladder with engagement into the bladder neck under the control of the patient or care giver. A Foley catheter, a pre- amendment device, was considered for a control treatment. However, although a Foley catheter is used to establish urinary drainage with close to 100% efficacy, it does not restore voiding function like the C3, and severely impairs activities of daily life."||||
1318631|NCT03353558|||Case-Control||Prospective|||||||
1318632|NCT03353545|||Cohort||Other|||||||
1318633|NCT03353532|||Case-Control||Retrospective|||||||
1318634|NCT03353519|Randomized|Parallel Assignment||Supportive Care||Single||The IPCAS Trial is a two-arm cluster randomised controlled trial with general practices as the unit of randomisation.|t|||
1318635|NCT03353506|Randomized|Parallel Assignment||Treatment||Quadruple|LFMT and LSFF capsules appear identical. Randomization is performed by lab staff not involved in any aspect of treatment administration or care|double blind randomized|t|t|t|t
1318636|NCT03353493|Randomized|Parallel Assignment||Basic Science||Single|Participants are masked at baseline assessment to treatment allocation. Outcome assessors are masked to treatment allocation.|Randomised to Mindfulness-based cognitive therapy plus treatment as usual, or treatment as usual.||||t
1318637|NCT03353480|Randomized|Crossover Assignment||Basic Science||None (Open Label)||"This is an open-label, randomized, single-dose, 3-way crossover, reference scaled bioequivalence study under fasted and fed conditions in healthy Chinese subjects.~Under each condition, subjects will be randomized to one of the 3 treatment sequences. Each treatment sequence will consist of 3 periods, separated by a washout period of at least 14 days between each period. For sequence 1, first localized originator, then originator and finally originator will be administered. The order for sequence 2 is originator, localized originator and originator. The order for sequence 3 is originator, originator and localized originator."||||
1318638|NCT03353467|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318639|NCT03353454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318640|NCT03353441|Randomized|Parallel Assignment||Treatment||Double|Partly double-blind (Glycine (MSG), Placebo, control without treatment)||t||t|
1318641|NCT03353428||Single Group Assignment||Treatment||None (Open Label)||||||
1318642|NCT03353415||Sequential Assignment||Treatment||None (Open Label)|The proposed study is designed to assess the efficacy of unmasked personal CGM to reduce the frequency of hypoglycemia after gastric surgery. Participants themselves will not be masked to study design. The only masking will be of the device itself during the first 2 weeks of the study.|The proposed study is designed to assess the efficacy of unmasked personal CGM to reduce the frequency of hypoglycemia after gastric surgery. Specifically, we will analyze glycemic patterns during 2 weeks of unmasked CGM wear, in comparison to the baseline 2 weeks of masked CGM wear. Please note that we have chosen to have a consistent masked monitoring first, as providing unmasked data to participants first could alter their dietary or other patterns and reduce ability of the study to independently assess efficacy of the CGM intervention.||||
1318643|NCT03353402||Single Group Assignment||Treatment||None (Open Label)||||||
1318644|NCT03353389|||Cohort||Retrospective|||||||
1318645|NCT03353376|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1318646|NCT03353363|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind Study|Parallel Assignment|t|t|t|
1318647|NCT03353350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318648|NCT03353337|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1318649|NCT03353324|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1318650|NCT03353311|||Cohort||Prospective|||||||
1318651|NCT03353298|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1318652|NCT03353285|||Cohort||Prospective|||||||
1318653|NCT03353272|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1318654|NCT03353259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318655|NCT03353246||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318656|NCT03353233|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1318657|NCT03353220|Randomized|Crossover Assignment||Other||Double|||t||t|
1318658|NCT03353207|||Case-Control||Cross-Sectional|||||||
1318659|NCT03353194|||Other||Prospective|||||||
1318660|NCT03353181|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1318661|NCT03353168|||Cohort||Prospective|||||||
1318662|NCT03353155|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Patients are randomly assigned to one of two groups. Group 1 is usual care, in which patients are followed up after surgery by the ambulatory clinic assigned to their case. Patients in usual care have access to occupational and physical therapy, and medical social work, if they choose to use them. Group 2 is CareHub, in which patients are followed up by a dedicated care coordinator who proactively calls patients at home and schedules their clinic appointments, and consults with therapists and medical social workers.||||
1318663|NCT03353142||Single Group Assignment||Treatment||None (Open Label)||Consecutive participants meeting eligibility criteria will be enrolled||||
1318664|NCT03353129|||Cohort||Prospective|||||||
1318665|NCT03353116|Randomized|Parallel Assignment||Treatment||Single|||t|||
1318666|NCT03353103|Non-Randomized|Parallel Assignment||Diagnostic||Double||||t|t|
1318667|NCT03353090|||Cohort||Retrospective|||||||
1318668|NCT03353077||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1318669|NCT03353064|Randomized|Parallel Assignment||Health Services Research||Single|Statisticians will be receiving de-identified data|Randomized Controlled Trial||||t
1318670|NCT03353051|||Cohort||Prospective|||||||
1318671|NCT03353038||Single Group Assignment||Treatment||None (Open Label)||||||
1318672|NCT03353025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318673|NCT03353012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319124|NCT03347149|||Cohort||Prospective|||||||
1318674|NCT03352999||Single Group Assignment||Other||None (Open Label)||Prospective, monocentric, open, routine care assessment study||||
1318675|NCT03352986|||Cohort||Prospective|||||||
1318676|NCT03352973|Randomized|Crossover Assignment||Basic Science||Double|double blind: both participants and experiment won't know the stimulation condition|within-subject, sham-controlled design: all subjects will receive active and sham tDCS in a randomized order|t||t|
1318677|NCT03352960|||Cohort||Prospective|||||||
1318678|NCT03352947|Randomized|Parallel Assignment||Treatment||None (Open Label)||INTERIM is a multi-centre, open label, two arm, randomised phase II feasibility trial||||
1318679|NCT03352934||Single Group Assignment||Treatment||None (Open Label)||||||
1318680|NCT03352921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318681|NCT03352908|||Cohort||Cross-Sectional|||||||
1318682|NCT03352895|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1318683|NCT03352882||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318684|NCT03352869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318685|NCT03352856|Randomized|Crossover Assignment||Basic Science||Quadruple||Double-blind, cross-over, randomly allocated, placebo controlled|t|t|t|t
1318686|NCT03352843||Single Group Assignment||Prevention||None (Open Label)||||||
1318687|NCT03352830|Randomized|Factorial Assignment||Prevention||None (Open Label)|Masking is not feasible for this intervention.|||||
1318688|NCT03352817|||Other||Cross-Sectional|||||||
1318689|NCT03352804|||Case-Crossover||Cross-Sectional|||||||
1318690|NCT03352791|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1318691|NCT03352778|||Case-Control||Prospective|||||||
1318692|NCT03352765||Single Group Assignment||Treatment||None (Open Label)||This is a phase I/II single arm, open label trial||||
1318693|NCT03352752|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|It's a randomized controlled study, there were 218 cases, the ratio of the control group to the experimental group was one to one，109 cases per group.||||
1318694|NCT03352739|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1318695|NCT03352726||Single Group Assignment||Other||None (Open Label)||||||
1318696|NCT03352713||Single Group Assignment||Basic Science||None (Open Label)||||||
1318697|NCT03352700|Randomized|Parallel Assignment||Screening||Single|||||t|
1318698|NCT03352687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318699|NCT03352674|Randomized|Parallel Assignment||Treatment||Single|||t|||
1318700|NCT03352661|||Cohort||Prospective|||||||
1318701|NCT03352648|||Cohort||Prospective|||||||
1318702|NCT03352635|||Cohort||Cross-Sectional|||||||
1318703|NCT03352622|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||CASES AND CONTROLS||||
1318704|NCT03352609|Randomized|Parallel Assignment||Treatment||Quadruple|Randomized double blind control using a sham rTMS system|Randomized, double blind, control|t|t|t|t
1318705|NCT03352596|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1318706|NCT03352583|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1318707|NCT03352570||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1318708|NCT03352557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318709|NCT03352544|Randomized|Parallel Assignment||Treatment||Single||||||t
1318710|NCT03352531||Single Group Assignment||Treatment||None (Open Label)||||||
1318711|NCT03352518||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1318712|NCT03352505|||Case-Only||Prospective|||||||
1318713|NCT03352492|Randomized|Parallel Assignment||Supportive Care||Single|Subject is masked to which eye has the iridotomy at which location|Paired eye|t|||
1318714|NCT03352479||Single Group Assignment||Prevention||None (Open Label)||Each participant will be given on envelope to return unused opioids||||
1318715|NCT03352466|Randomized|Sequential Assignment||Prevention||Double|Double-blind||t||t|
1318716|NCT03352453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318717|NCT03352440|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318718|NCT03352427||Single Group Assignment||Treatment||None (Open Label)||||||
1318719|NCT03352414|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1318720|NCT03352401|||Other||Prospective|||||||
1318721|NCT03352388|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1318722|NCT03352375|Randomized|Parallel Assignment||Treatment||None (Open Label)||All pediatric patients, who were scheduled to undergo laparoscopic surgery||||
1318723|NCT03352362|Randomized|Parallel Assignment||Treatment||Single||Participants are divided 3 groups(caldolor, denogan, combination group) randomly. Each groups are received a medication by protocol during surgery|t|||
1318724|NCT03352349||Single Group Assignment||Treatment||None (Open Label)||||||
1318725|NCT03352336|||Cohort||Prospective|||||||
1318726|NCT03352323||Single Group Assignment||Treatment||None (Open Label)||||||
1318727|NCT03352310|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Study Group - autologous umbilcial cord blood transfusion~Control Group - standard care"||||
1318728|NCT03352297||Single Group Assignment||Treatment||None (Open Label)||||||
1318729|NCT03352284||Single Group Assignment||Treatment||None (Open Label)||||||
1318730|NCT03352271|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318731|NCT03352258|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, monocentric, prospective pilot study, pre- and post-intervention intraindividual comparison in the treated arm comparison of changes in neuropsychological performance in the treated and observational arms||||
1318732|NCT03352245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318733|NCT03352232|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||There will be two populations based on when they experienced a stroke. Subacute stroke patients will have suffered an ischemic stroke within 3 months of enrollment and have persistent neurological deficits. The second group will be patients who suffered an ischemic stroke more than 6 months (chronic) from time of enrollment and have persistent neurological deficits compromising activities of daily living.||||
1318734|NCT03352219|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318735|NCT03352206|||Case-Control||Cross-Sectional|||||||
1318736|NCT03352193|||Case-Control||Prospective|||||||
1318737|NCT03352180|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1318738|NCT03352167|||Cohort||Cross-Sectional|||||||
1318739|NCT03352154||Single Group Assignment||Diagnostic||None (Open Label)|Not Apply|Verify the alteration of the latency and amplitude of the P300 as markers of the cognitive response after Cochlear Implant Assist in prognosis after implantation cochlear implant.||||
1318740|NCT03352141||Single Group Assignment||Other||None (Open Label)||||||
1318741|NCT03352128|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1318742|NCT03352115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318743|NCT03352102|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318744|NCT03352089|||Case-Control||Prospective|||||||
1318745|NCT03352076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318746|NCT03352063|Randomized|Parallel Assignment||Prevention||None (Open Label)||Subjects will be randomly assigned to either the sitting plus exercise or walking plus exercise.||||
1318747|NCT03352050|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1318748|NCT03352037||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318749|NCT03352024|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1318750|NCT03352011|Randomized|Parallel Assignment||Treatment||Single||||||t
1318751|NCT03351998|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1318752|NCT03351985|||Case-Only||Prospective|||||||
1318753|NCT03351972|Randomized|Parallel Assignment||Other||Single|||||t|
1318754|NCT03351959|||Cohort||Other|||||||
1318755|NCT03351946|Randomized|Parallel Assignment||Prevention||Double|Sealed envelopes.||t|||t
1318756|NCT03351933||Single Group Assignment||Prevention||None (Open Label)||||||
1318757|NCT03351920|||Cohort||Prospective|||||||
1318758|NCT03351907|||Cohort||Prospective|||||||
1318759|NCT03351894|Randomized|Parallel Assignment||Treatment||Single|||t|||
1318760|NCT03351881|Randomized|Parallel Assignment||Other||Single|||t|||
1318761|NCT03351868||Single Group Assignment||Treatment||None (Open Label)||||||
1318762|NCT03351855||Single Group Assignment||Treatment||None (Open Label)||||||
1318763|NCT03351842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318764|NCT03351829||Single Group Assignment||Treatment||None (Open Label)||||||
1318765|NCT03351816|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318766|NCT03351803|||Cohort||Prospective|||||||
1318767|NCT03351790|||Cohort||Prospective|||||||
1318768|NCT03351777|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318769|NCT03351764|||Other||Cross-Sectional|||||||
1318770|NCT03351751|Randomized|Sequential Assignment||Basic Science||Double|||t||t|
1318771|NCT03351738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318772|NCT03351725|||Cohort||Prospective|||||||
1318773|NCT03351712|Randomized|Factorial Assignment||Treatment||None (Open Label)||Single subject design and group design combined||||
1318774|NCT03351699|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1318775|NCT03351686|Randomized|Parallel Assignment||Prevention||Single|||t|||
1318776|NCT03351673||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318777|NCT03351660|||Case-Only||Cross-Sectional|||||||
1318778|NCT03351647|||Cohort||Prospective|||||||
1318779|NCT03351634||Single Group Assignment||Treatment||None (Open Label)||||||
1318780|NCT03351621|||Other||Cross-Sectional|||||||
1318781|NCT03351608|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1318782|NCT03351595|||Cohort||Prospective|||||||
1318783|NCT03351582|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1318784|NCT03351569|Randomized|Crossover Assignment||Treatment||Quadruple|"Drug and placebo had the same appearance and are wrapped in foil paper before being shown to the patient.~Outcome evaluation is carried out by personnel not involved in the treatment at a distant site, one month after treatment."|sigle patient trial|t|t|t|t
1318785|NCT03351556|Randomized|Parallel Assignment||Health Services Research||Single|Participants in the cash transfer arms will be masked to the knowledge that there are two cash value arms.||t|||
1318786|NCT03351543|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1318787|NCT03351530|||Case-Control||Prospective|||||||
1318788|NCT03351517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318789|NCT03351504|Randomized|Parallel Assignment||Treatment||Single|Randomization will be performed using dummy codes to represent intervention and control groups by an independent statistician; blinding of the intervention to the participants and field team is not possible, but data analysis will take place prior to unblinding.|||||t
1318790|NCT03351491|||Other||Cross-Sectional|||||||
1318791|NCT03351478|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318792|NCT03351465|Randomized|Parallel Assignment||Treatment||Single||Participants will be recruited and randomized to the CALM intervention delivered in their homes or to treatment as usual.||||t
1318793|NCT03351452|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1318794|NCT03351439|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1318795|NCT03351426|Randomized|Parallel Assignment||Treatment||Double|The study is double blind. Neither the participants or the investigator delivering the intervention and collecting the outcomes will be aware of the group allocation. This is achieved via sham tDCS procedure and blinding of tDCS parameters with code system.||t|||t
1318796|NCT03351413|Randomized|Parallel Assignment||Treatment||Single||Single-blind, two group randomized pilot trial. Randomization is 2:1 (27 intervention, 13 control). Participants have a chance of being in the LIVE-LiFE group or the control group.|||t|
1318797|NCT03351400||Single Group Assignment||Treatment||None (Open Label)||||||
1318798|NCT03351387|||Cohort||Prospective|||||||
1318799|NCT03351374|||Ecologic or Community||Prospective|||||||
1318800|NCT03351361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318801|NCT03351348|Randomized|Parallel Assignment||Treatment||Double|Treatment assignments can be viewed only by the hospital pharmacists who are dispensing the study drugs.|A prospective, double-blind, randomized, placebo-controlled trial|t||t|
1318802|NCT03351335|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1318803|NCT03351322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318804|NCT03351309|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1318805|NCT03351296|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparative phase II trial with two randomizations||||
1318806|NCT03351283|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1318807|NCT03351270||Single Group Assignment||Other||None (Open Label)||||||
1318808|NCT03351257|||Case-Control||Prospective|||||||
1318809|NCT03351244|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318810|NCT03351231|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1318811|NCT03351218|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Two groups study : patients versus healthy controls||||
1318812|NCT03351205|Randomized|Parallel Assignment||Prevention||Single||||||t
1318813|NCT03351192||||||||||||
1318814|NCT03351179|||Case-Control||Retrospective|||||||
1318815|NCT03351166||Single Group Assignment||Treatment||None (Open Label)||||||
1318816|NCT03351153|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1318817|NCT03351140|||Cohort||Prospective|||||||
1318818|NCT03351127|||Case-Control||Prospective|||||||
1318819|NCT03351114||Single Group Assignment||Treatment||None (Open Label)||||||
1318820|NCT03351101|Randomized|Parallel Assignment||Treatment||Triple||randomized, bilateral, d o u b l e - masked, 1-month study with two parallel groups|t|t|t|
1318821|NCT03351088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318822|NCT03351075|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1318823|NCT03351062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318824|NCT03351049|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1318825|NCT03351036|||Cohort||Prospective|||||||
1318826|NCT03351023|||Cohort||Prospective|||||||
1318827|NCT03351010|Randomized|Parallel Assignment||Treatment||Single|Eligible patients will 1) have any cancer type or stage, 2) be 18-60 years of age, 3) have a worst pain score > 4 in the past 7 days, 4) be able to read and write the Thai language, 5) have a Karnofsky Performance status > 70%, and be willing to travel to the temple. Exclusion criteria will be any diagnosed psychiatric illness that would prevent the patient from giving informed consent or from participating fully in the study. Patients with comorbidities (e.g., arthritis, bone metastasis, deformity, certain neurologic conditions such as biracial plexus nerve compression) that would impair the ability to perform the hand and arm movements also are ineligible.|Using a randomized controlled trial design, the investigators will test theTBbM intervention to improve pain in Thai outpatients (N=160) with cancer who are receiving cancer care at Sawanpracharak Hospital, Thailand. The control group (n = 80) will receive usual care and participate in a one-hour video educational program about cancer pain. The intervention group (n = 80) will receive usual care, participate in a one-hour video educational program about cancer pain, and receive an 8-week TBbM intervention.|t|||
1318828|NCT03350997|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1318829|NCT03350984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318830|NCT03350971|Randomized|Parallel Assignment||Treatment||Triple||Randomized clinical trial|t|t|t|
1318831|NCT03350958|Randomized|Crossover Assignment||Basic Science||Quadruple|As it necessary in double-blind crossover studies, neither the researchers nor the participants will know which food they are receiving at each visit. All randomisation will be carried out in anonymised fashion by an independent researcher, who will code foods and participants accordingly.|Placebo, controlled double-blind crossover study will recruit participants (males and females, who have previously had ileostomy surgery, but currently have no health issues) from the Newcastle upon Tyne/Gateshead area. Subjects will be randomly allocated to one of two treatment groups. One group will receive a test meal containing the dietary fibre first, then on the second visit, the same meal without dietary fibre. The second group will receive the meal without dietary fibre first, followed by the meal containing dietary fibre on the second visit. For each group, the two visits will be at least 2 weeks apart. As the foods will look exactly the same (the fibres used are colourless and tasteless). As it necessary in double-blind crossover studies, neither the researchers nor the participants will know which food they are receiving at each visit. All randomisation will be carried out in anonymised fashion by an independent researcher, who will code foods and participants accordingly.|t|t|t|t
1318832|NCT03350945|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1318833|NCT03350932|Randomized|Parallel Assignment||Basic Science||Single|Children will not be aware about the type of comparison that will be made with the data; and they will not be aware in which group they will participate in.|"Two groups of children will be constituted: the first group, the control group, will have to perform a sensory imagination task about neutral facts. The second group, the food sensory imagination group, will have to perform a sensory imagination task foods."|t|||
1318834|NCT03350919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318835|NCT03350906|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1318836|NCT03350893|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized, Parallel, Open Label Study||||
1318837|NCT03350880|Randomized|Parallel Assignment||Treatment||Double||Randomized Clinical Trial|||t|t
1318838|NCT03350867|Randomized|Parallel Assignment||Treatment||Double|Double (Participant, Outcomes Assessor) The one who assess the patients in the beginning and in the final moment (investigator) not know what group the patient is. The participants don't know if they are using a placebo or personalized insole.|Two groups: a Personalized Insole Group and a Placebo Group.|t|||t
1318839|NCT03350854|Randomized|Parallel Assignment||Other||Single|||t|||
1318840|NCT03350841|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1318841|NCT03350828|||Cohort||Prospective|||||||
1320805|NCT03325244|||Cohort||Prospective|||||||
1318842|NCT03350815|Randomized|Parallel Assignment||Treatment||Double|Patients and Investigators will be blinded to the secukinumab dose during Treatment Period 2.||t||t|
1318843|NCT03350802|||Cohort||Prospective|||||||
1318844|NCT03350789|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1318845|NCT03350776|||Other||Cross-Sectional|||||||
1318846|NCT03350763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318847|NCT03350750|Randomized|Parallel Assignment||Treatment||Double||"The primary intervention will be the initiation of the randomized initial shunt valve opening pressure setting to create a delayed treatment group in half of the study patients.~Randomization will be to active or placebo (closed) shunt settings. At the time of the standard four-month evaluation, all subjects will be similarly non-invasively adjusted to bring all subjects in both groups to the active setting while maintaining blinding of the subjects. All settings will be verified by the adjusting neurosurgeon."|t|||t
1318848|NCT03350737|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Prospective, randomized, open-label study design. These no-option patients will be allocated (30 for each group) to 2 treatments"||||
1318849|NCT03350724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318850|NCT03350711|||Case-Only||Other|||||||
1318851|NCT03350698||Single Group Assignment||Prevention||None (Open Label)||Prospective Single-Subject Experimental Design||||
1318852|NCT03350685|||Cohort||Retrospective|||||||
1318853|NCT03350672|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"1a) Ten healthy subjects will be given seven daily doses of TAF/FTC under direct observation to ensure adherence.~1b) Ten healthy subjects will be given one daily dose of TAF/FTC under direct observation to ensure adherence. Morning (not first morning) urine and plasma samples will be collected starting the day the dose is given (1 hr post-dose) and every day thereafter for 6 days.~2) Ten HIV-positive patients who have had undetectable viral loads for greater than 12 weeks (and a recent undetectable viral load in the previous 4 weeks) on an antiretroviral regimen containing TAF/FTC (i.e. Genvoya™, Odefsey™, or Descovy™ in combination with another HIV medication or medications) will have one-time pre-dose urine (early morning) and plasma samples drawn for tenofovir (TFV) concentration, as well as a comprehensive metabolic panel for measurement of creatinine clearance."||||
1318854|NCT03350659|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, open-label clinical trial.||||
1318855|NCT03350646|Randomized|Parallel Assignment||Other||Single|||t|||
1318856|NCT03350633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318857|NCT03350620|Randomized|Crossover Assignment||Treatment||Double|"If subjects meet eligibility criteria at the Screening/Baseline visit (Day 0), subjects will be randomly assigned to masked study medication.~The study will be double masked. The study medication will be provided in identical-appearing laminated pouches with no labeling indicating the identity of the study group or the contents of the ampules. The laminated pouches will contain identical-appearing ampules. Study subjects and study management personnel will be masked to the identity of treatment until after the final database lock."|"This will be a 3-arm randomized, multicenter, double-masked, placebo-controlled study conducted in 2 stages.~Stage 1 is a safety and efficacy phase of 3 years in duration, during which subjects will be allocated to 1 of 3 study medications.~Stage 2 is a randomized cross-over phase of 1 year in duration, during which subjects will be re-randomized to receive 1 of the 3 study medications with subjects initially randomized to Vehicle only eligible for randomization to low or high dose NVK-002."|t||t|
1318858|NCT03350607|||Cohort||Prospective|||||||
1318859|NCT03350594|Randomized|Parallel Assignment||Treatment||Single||||||t
1318860|NCT03350581|Randomized|Parallel Assignment||Treatment||Single|||t|||
1318861|NCT03350568|||Cohort||Prospective|||||||
1318862|NCT03350555|Randomized|Parallel Assignment||Other||Double||One arm includes participants who will receive additioned endoscopy assisted ERCP, and the other arm includes participants who will not receive additioned endoscopy assisted ERCP.|t|||t
1318863|NCT03350542||Single Group Assignment||Treatment||None (Open Label)||Prospective, open label, single arm, multi-center||||
1318864|NCT03350529|Non-Randomized|Parallel Assignment||Other||None (Open Label)||This study is a early phase 1 non-randomized prospective single-institutional and four arm study to determine the applicability, feasibility and safety of MRI guided transurethral HIFU ablation of prostate separately in each pre-specified group/arm.||||
1318865|NCT03350516|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1318866|NCT03350503||Single Group Assignment||Treatment||None (Open Label)||||||
1318867|NCT03350490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318868|NCT03350477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318869|NCT03350464||Single Group Assignment||Treatment||None (Open Label)||||||
1318870|NCT03350451||Single Group Assignment||Treatment||None (Open Label)||||||
1318871|NCT03350438|||Cohort||Cross-Sectional|||||||
1318872|NCT03350425|||Other||Prospective|||||||
1318873|NCT03350412|||Cohort||Prospective|||||||
1318874|NCT03350399|||Case-Control||Prospective|||||||
1318875|NCT03350386|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1318876|NCT03350373|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1318877|NCT03350360|Randomized|Parallel Assignment||Treatment||Double|Random assignment and coded entry to a computer website||t|t||
1318878|NCT03350347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318879|NCT03350334|Randomized|Parallel Assignment||Treatment||Single|Participants do not know whether they take placebo or Duloxetine|Prospective randomised|t|||
1318880|NCT03350321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318881|NCT03350308|||Case-Only||Cross-Sectional|||||||
1318882|NCT03350295|Randomized|Crossover Assignment||Treatment||None (Open Label)||Group 1 ( Treatment A,B,C - 3 way cross-over), Group 2 ( Treatment D, E - 2 way cross over)||||
1318883|NCT03350282|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1318884|NCT03350269|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized controlled trial||||
1318885|NCT03350256||Single Group Assignment||Treatment||None (Open Label)||||||
1318886|NCT03350243|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1318888|NCT03350217|Randomized|Parallel Assignment||Treatment||Single|The Investigator is blinded to the randomization process but can be unblinded after the product has been dispensed if the patient has a medical issue that requires it.||||t|
1318889|NCT03350204|Randomized|Parallel Assignment||Basic Science||Single||Testing both meniscus patients and uninjured individuals for comparison|t|||
1318890|NCT03350191|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1318891|NCT03350178||Single Group Assignment||Supportive Care||None (Open Label)||||||
1318892|NCT03350165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318893|NCT03350152|||Other||Retrospective|||||||
1318894|NCT03350139|||Cohort||Prospective|||||||
1318895|NCT03350126||Single Group Assignment||Treatment||None (Open Label)||||||
1318896|NCT03350113||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318897|NCT03350100|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1318898|NCT03350087|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1318899|NCT03350074|||Cohort||Retrospective|||||||
1318900|NCT03350061||Single Group Assignment||Treatment||None (Open Label)||||||
1318901|NCT03350048|||Cohort||Prospective|||||||
1318902|NCT03350035|Randomized|Parallel Assignment||Treatment||Quadruple||Double-blind study that will randomize subjects to ganaxolone or placebo in a 1:1 ratio as adjunctive therapy to their standard of care.|t|t|t|t
1318903|NCT03350022||Single Group Assignment||Prevention||None (Open Label)||||||
1318904|NCT03350009|||Case-Control||Other|||||||
1318905|NCT03349996||Single Group Assignment||Treatment||None (Open Label)||||||
1318906|NCT03349983||Sequential Assignment||Treatment||None (Open Label)||||||
1318907|NCT03349970|||Other||Prospective|||||||
1318908|NCT03349957|||Cohort||Retrospective|||||||
1318909|NCT03349944|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1318910|NCT03349931|||Cohort||Prospective|||||||
1318911|NCT03349918||Single Group Assignment||Other||None (Open Label)||||||
1318912|NCT03349905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318913|NCT03349892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1318914|NCT03349879|||Family-Based||Retrospective|||||||
1318915|NCT03349866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318916|NCT03349853|||Other||Prospective|||||||
1318917|NCT03349840|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label randomised prospective study||||
1318918|NCT03349827||Single Group Assignment||Treatment||None (Open Label)||||||
1318919|NCT03349814|||Cohort||Prospective|||||||
1318920|NCT03349801|||Cohort||Prospective|||||||
1318921|NCT03349788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318922|NCT03349775|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1318923|NCT03349762|||Cohort||Prospective|||||||
1318924|NCT03349749|||Case-Only||Cross-Sectional|||||||
1318925|NCT03349736||Single Group Assignment||Other||None (Open Label)||A feasibility study including 50 women for the first objective. Second an implementation study of approximately 200 women to compare compliers and non-compliers. Pre and post study design will be conducted to assess the change in PFM activation||||
1318926|NCT03349723|Randomized|Parallel Assignment||Treatment||Single|||t|||
1318927|NCT03349710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318928|NCT03349697|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1318929|NCT03349684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318930|NCT03349671|||Other||Cross-Sectional|||||||
1318931|NCT03349658|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1318932|NCT03349645||Single Group Assignment||Treatment||None (Open Label)||Open Label||||
1318933|NCT03349632||||||||||||
1318934|NCT03349619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318935|NCT03349606|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||[C-11]FLB 457 d-amphetamine||||
1318936|NCT03349593|||Cohort||Prospective|||||||
1318937|NCT03349580|Randomized|Parallel Assignment||Treatment||Single||Randomized Controlled Trial|t|||
1318938|NCT03349567|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1318939|NCT03349554||Single Group Assignment||Other||None (Open Label)||||||
1318940|NCT03349541|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1318941|NCT03349528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318942|NCT03349515|Randomized|Parallel Assignment||Other||Single||Group A - povidone-iodine ophthalmic solution, or Group B - ophthalmic balanced salt solution. This randomization will be determined using a simple randomization scheme provided by the study's statistician|t|||
1318943|NCT03349502||Single Group Assignment||Treatment||None (Open Label)||Single center, single arm, open-labeled phase 2 trial||||
1318944|NCT03349489|Randomized|Crossover Assignment||Treatment||Single|||t|||
1318945|NCT03349476||Single Group Assignment||Treatment||None (Open Label)||||||
1318946|NCT03349463||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318947|NCT03349450||Single Group Assignment||Treatment||None (Open Label)||||||
1318948|NCT03349437||||||||||||
1318949|NCT03349424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318950|NCT03349411|||Cohort||Prospective|||||||
1318951|NCT03349398|Randomized|Sequential Assignment||Treatment||Double|||t|||t
1318952|NCT03349385|||Cohort||Prospective|||||||
1318953|NCT03349372|||Cohort||Retrospective|||||||
1318954|NCT03349359|||Cohort||Retrospective|||||||
1318955|NCT03349346|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318956|NCT03349333||Single Group Assignment||Treatment||None (Open Label)||||||
1318957|NCT03349320|||Other||Prospective|||||||
1318958|NCT03349307||Single Group Assignment||Other||None (Open Label)||||||
1318959|NCT03349294|||Case-Only||Prospective|||||||
1320806|NCT03325231|||Cohort||Retrospective|||||||
1318960|NCT03349281|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318961|NCT03349268|Randomized|Crossover Assignment||Prevention||Quadruple|All healthcare personnel (including device operators and environmental services staff) will be blinded to the intervention/sham status of the devices. In addition, the study personel including the PI and individuals performing data analysis, will be blinded to the intervention/sham status of the devices. The device status will be written on a piece of paper by the manufacturer with the serial numbers of each device indicated, sealed in an envelope and kept in a secure location by the study statistician for later retrieval when trial data analysis has been completed.|Two-armed crossover with an initial intervention period of 12 months, followed by a 6 month washout period and a second intervention period of 12 months. The 6 month washout period will be necessary because of the long-term survivability of eiHAIs, such as C. difficile, on environmental services.|t|t|t|t
1318962|NCT03349255|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1318963|NCT03349242|||Other||Prospective|||||||
1318964|NCT03349229|||Cohort||Prospective|||||||
1318965|NCT03349216|Randomized|Parallel Assignment||Treatment||None (Open Label)|not blinded|Bier's Block with Lidocaine versus Conscous Sedation with ketamine||||
1318966|NCT03349203||Single Group Assignment||Treatment||None (Open Label)||||||
1318967|NCT03349190|||Cohort||Retrospective|||||||
1318968|NCT03349177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318969|NCT03349164|||Other||Other|||||||
1318970|NCT03349151|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Prospective randomised||||
1318971|NCT03349138|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Conventional treatment allocated to patients in all arms. Supplemental dose matched treatment to each of the four arms (9 weeks, 3 treatments a week) as follows:~conventional treatment (27 treatments)~functional electrical stimulation (27 treatments)~robotic glove ( 27 treatments )~robotic glove and electrical stimulation ( each session uses one device, half of the sessions uses the robotic glove, half the functional electrical stimulation )"||||
1318972|NCT03349125|||Cohort||Cross-Sectional|||||||
1318973|NCT03349112|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||During both the anesthetized and non-anesthetized conditions as per standard of care, the study team member will apply 1 mL of 2% viscous lidocaine to each nares prior to the passage of the catheter. During only the anesthetized condition, subjects will receive up to .8 ml of a 4% Lidocaine spray to both nares.||||
1318974|NCT03349099|Randomized|Parallel Assignment||Treatment||Single|Videos will be analyzed by blinded urologists who will rate the extent of ureteral damage on a standardized scale of 0 to 4 according to the study published by Traxer et al. 2013. After the study, subjects will not be contacted.|||t||
1318975|NCT03349086|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants will undergo one of two study conditions immediately following a standard of care Botox injections. One condition is a 45 minute voice rest condition and the other condition is a 45 minute voice exercise condition.||||
1318976|NCT03349073||Single Group Assignment||Treatment||None (Open Label)||||||
1318977|NCT03349060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318978|NCT03349047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318979|NCT03349034|Randomized|Parallel Assignment||Supportive Care||Quadruple||The study is a double-blind prospective randomized placebo controlled trial wherein patients undergoing osseocutaneous free flap surgery are randomized to receive continuous infusion of Ropivacaine or normal saline (placebo) via local infusion catheter, which will be placed intraoperatively at the time of donor site closure. Outcomes are tracked and assessed for the first 48 hours post-operatively - median post-operative pain assessed via VAS every 8 hours, total analgesic used (all patients receive Tylenol 650 and dilaudid PCA post-operatively), physical therapy outcomes assessed on post-operative day two, and a patient satisfaction survey.|t|t|t|t
1318980|NCT03349021||Single Group Assignment||Treatment||None (Open Label)||Single Group interventional study||||
1318981|NCT03349008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1318982|NCT03348995||Single Group Assignment||Treatment||None (Open Label)||Cohort Study||||
1318983|NCT03348982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318984|NCT03348969|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Clinical Trial||||
1318985|NCT03348956||Single Group Assignment||Diagnostic||None (Open Label)||||||
1318986|NCT03348943|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1318987|NCT03348930|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1318988|NCT03348917|Randomized|Sequential Assignment||Prevention||Single|Single|Twelve healthy volunteers will be randomized into three arms with three different treatment sequences with four healthy volunteers in each arm. Up to fifteen healthy volunteers may be recruited with the consideration that up to three subjects may drop out.||||t
1318989|NCT03348904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1318990|NCT03348891|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1318991|NCT03348878||Single Group Assignment||Other||None (Open Label)||||||
1318992|NCT03348865|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1318993|NCT03348852|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1318994|NCT03348839|Randomized|Crossover Assignment||Health Services Research||None (Open Label)|no one|Multicentre study, in randomized mastered clusters, in stepped wedge||||
1318995|NCT03348826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1318996|NCT03348813|Randomized|Parallel Assignment||Prevention||Double||Enrolled participants were randomized to either the targeted intervention group or the attention control group at the diagnostic visit. The permuted-block randomization technique was used with a block size of 4 and a 1:1 allocation ratio. Dr. Alex Hanlon (biostatistics consultant) generated the randomization list using a pseudo-randomizer computer program. The Research Coordinator maintained the spreadsheet for tracking and allocation concealment. To reduce the risk of encountering a floor or ceiling effect with intervention responsiveness, participants were stratified based on their PHQ-9 total scores (none/moderate depression versus moderately severe/severe depression) and gender.|||t|t
1319115|NCT03347266|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1319116|NCT03347253|||Case-Only||Prospective|||||||
1318997|NCT03348800|Randomized|Parallel Assignment||Treatment||Double|Participants will be blindfolded during the tooth extractions and the outcome assessors will be unaware of dental procedures|"This study has a split-mouth model so participants will be anesthetized in one half of the maxilla with a conventional syringe and in the other half with the computer controlled delivery system.~The anesthetic techniques will be the same in the two haves."|t|||t
1318998|NCT03348787||Single Group Assignment||Treatment||None (Open Label)||||||
1318999|NCT03348774|||Cohort||Retrospective|||||||
1319000|NCT03348761||Single Group Assignment||Basic Science||None (Open Label)||Participants receive 20 sessions of neuronavigation rTMS to lDLPFC over a 4-week period. Individual sessions consist of 30 minutes of 10 Hz rTMS (3000 pulses; 30-second cycles, 5 seconds on, 25 seconds off). A magnetic device is used with a 70-mm double air film coil and manually centered at MNI coordinates -46, 45, 38 . Resting motor threshold (MT) is defined as the minimum TMS intensity that elicits a motor-evoked potential (MEP) of peak to peak in the contralateral abductor pollicis brevis in 5 out of 10 trials. MT is measured before the first treatment and re-checked every 10 days. The stimulation output is 120% of MT||||
1319001|NCT03348748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319002|NCT03348735|Randomized|Parallel Assignment||Treatment||Double|Stratified randomization by site and Neuropathic Pain Symptom Inventory (NPSI) will be applied, and coordinated centrally which randomizes eligible patients to one of three treatment arms, and assigns patient numbers. Medication will be dispensed by the hospital pharmacies of the individual participating multidisciplinary pain centres, after proper labelling.|A multicentre, randomized, open-label comparative trial evaluating topical treatment options (lidocaine 5% or capsaicine 8% patch) versus oral systemic treatment (pregabaline as standard of care) in adult patients suffering from localized neuropathic pain (LNP) syndromes.|||t|t
1319003|NCT03348722|||Cohort||Prospective|||||||
1319004|NCT03348709|Randomized|Crossover Assignment||Treatment||Quadruple|Randomisation by Third party; Unblinded study nurse to mix and deliver study product; masking of product to ensure comparable palatability and appearance; blinding to analyses|Double-blinded, active comparator, cross-over intervention study|t|t|t|t
1319005|NCT03348696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319006|NCT03348683|Randomized|Parallel Assignment||Treatment||Triple|Study drug and placebo will be randomized and mixed to appear identical by the Mount Sinai Investigational Drug Service (IDS). The randomization code will be kept by the lead pharmacist of the IDS until completion of the trial, at which point data will be unmasked.||t|t|t|
1319007|NCT03348670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319008|NCT03348657|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319009|NCT03348644|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized, multiple crossover study||||
1319010|NCT03348631||Single Group Assignment||Treatment||None (Open Label)||||||
1319011|NCT03348618||Single Group Assignment||Treatment||None (Open Label)||||||
1319012|NCT03348605|Randomized|Crossover Assignment||Screening||Single|"As this study is described as single blinded, the only entity of the trial not aware of the group or sequence of the participant is the participant itself.~The other personell involved in the trial needs to be aware of the position of the participant within the study so to apply the right measures.~In this case the participant is unaware of the fact whether his stimulation system is turned on or off."|"The primary outcomes are the changes in size and position over time and their timed occurrence after the amputation of these receptive fields as well as the inter-/intratester reliability in their detection.~The secondary outcomes are the change in selected gait parameters and phantom sensations through the application of the stimulating system (Phantom Stimulator (Cort X Sensorics, Spaichingen, Germany)).~The primary outcome is of mere descriptive nature. Therefore, no control group is created and the participants are not blinded or randomized.~For the secondary outcomes, every tested subject serves as its own control (cross over). The gait analysis as well as the questionnaire are performed three times. The two measurements after the first familiarization measurements are performed in a randomized order."|t|||
1319013|NCT03348592||Single Group Assignment||Basic Science||None (Open Label)||This is a 28 week study. Participants take no treatment for 8 weeks, followed by 12 weeks on the pre-biotic p-inulin, followed by no treatment for 8 weeks. The treatment arms are no treatment and the pre-biotic p-inulin. Inulin is derived from chicory root fiber.||||
1319014|NCT03348579|||Case-Only||Prospective|||||||
1319015|NCT03348566|||Cohort||Prospective|||||||
1319016|NCT03348553|Randomized|Parallel Assignment||Prevention||None (Open Label)||subjects are randomised into one of 4 intervention groups (control group (CG; consumption of 2 capsules of JP+® Omega Blend/d (Ω2); consumption of 4 capsules JP+® Omega Blend/d (Ω4); consumption of 2 capsules JP+® Omega Blend + Juice Plus+® fruit, vegetable and berry juice concentrate with 2 capsules each /d (Ω2+OGV)). Subjects allocated to Ω2 and Ω4 will receive the herbal fatty acid nutraceutical in the 4-month long study period (intervention phase), subjects allocated to Ω2+OGV will additionally receive the fruit, vegetable and berry juice concentrate. The control group will refrain from using any supplements over the course of this period and will maintain their usual eating habits.||||
1319017|NCT03348540|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1319018|NCT03348527|Randomized|Parallel Assignment||Treatment||Single|Participant is blinded to whether they are receiving a treatment dose of 35% or 45% of total prostate volume in stage I or 16mL or 20mL in stage II.|"Stage I: 20 Subjects will be enrolled into one of two groups, each receiving a single dose of Liproca®Depot. The target treatment dose will be 35% (Cohort 1) or 45% (Cohort 2) of the prostate volume (mL).~Stage II: 40 subjects will be randomized to receive either 16 mL (Cohort 3) or 20mL (Cohort 4) of Liproca®Depot."|t|||
1319019|NCT03348514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a Phase I, first-in-human, multicenter, open label, dose escalating study to evaluate the DLTs and MTD and to determine the recommended Phase 2 dose (RP2D) of CPX-POM administered IV in patients with any histologically- or cytologically-confirmed solid tumor type.||||
1319020|NCT03348501|||Cohort||Prospective|||||||
1319021|NCT03348488|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||The 2 arms applied to the same subject studied twice (case controlled)||||
1319022|NCT03348475||Single Group Assignment||Treatment||None (Open Label)||||||
1319117|NCT03347240|Randomized|Parallel Assignment||Treatment||Single||||||t
1573436|NCT00001232||||||||||||
1319023|NCT03348462|Randomized|Parallel Assignment||Treatment||Single||The aim of the present study was to develop an ethosomal delivery system anthralin and evaluate its effectiveness and safety in treatment of psoriasis and comparing it with liposomal delivery system anthralin.|t|||
1319024|NCT03348449|||Cohort||Retrospective|||||||
1319025|NCT03348436|Randomized|Parallel Assignment||Treatment||Double||A total of 100 patients with persistent，in whom successful RF ablation of slow pathway or accessory pathway was performed. Patients with atrial fibrillation, structural heart disease, ventricular arrhythmias, impaired left ventricular systolic function or on antiarrhythmics were excluded. All the patients had echocardiographic study before ablation 、1 day and 1 months after ablation.|t|||t
1319026|NCT03348423|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind, double-dummy||t|t|t|t
1319027|NCT03348410|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319028|NCT03348397|||Cohort||Retrospective|||||||
1319029|NCT03348384|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||[C-11]NOP-1A||||
1319030|NCT03348371|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1319031|NCT03348358|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319032|NCT03348345|Randomized|Crossover Assignment||Prevention||None (Open Label)|A computer system will randomly select participants to be enrolled in the program or waitlisted at both time points.|A computer system will randomly select 100 participants (from 200) to be enrolled in the Eat Breathe Thrive (EBT) intervention group (once a week for two hours) and the other 100 will be wait-listed (WL) for seven weeks. Assessments will be done at week 1 and week 7. At week 7, WL will be enrolled in the 7-week Eat Breathe Thrive program. A second post-test will be given at the end of the second round of Eat Breathe Thrive, administered to those 100 participants only. There will also be three month follow up for all 200 participants.||||
1319033|NCT03348332|Randomized|Parallel Assignment||Prevention||Single||||||t
1319034|NCT03348319|||Case-Only||Prospective|||||||
1319035|NCT03348306||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319036|NCT03348293||Single Group Assignment||Treatment||None (Open Label)||||||
1319037|NCT03348280|||Other||Cross-Sectional|||||||
1319038|NCT03348267|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1319039|NCT03348254|||Cohort||Other|||||||
1319040|NCT03348241|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is an experimental study. It was a two-arm randomized, controlled, open-label trial. The patients was categorized into two groups; study group and control group. Patients of study group was received a dose of 30 grams Gum Arabic per day as oral solution (dissolved in 250 ml purified water) for six weeks along with the chemotherapy prescribed, while patients of control group was received only chemotherapy regimen.||||
1319041|NCT03348228|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319042|NCT03348215||Sequential Assignment||Treatment||None (Open Label)|The primary gait measure (number of daily steps in teh community) will be collected by an independent assessor.|This is a singles subject design with participants acting as their own control. Control data being recorded during the week before the intervention begins||||
1319043|NCT03348202|||Other||Other|||||||
1319044|NCT03348189|||Other||Other|||||||
1319045|NCT03348176|Randomized|Factorial Assignment||Prevention||Single|Investigators coding parental outcome measures of the study from videomaterial are masked for study-arm||||t|
1319046|NCT03348163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319047|NCT03348150|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1 randomization||||
1319048|NCT03348137|||Cohort||Prospective|||||||
1319049|NCT03348124|Randomized|Crossover Assignment||Prevention||Single|The researchers are outcome assessors, independent from the intervention.|Cluster randomized intervention study with waiting list control group.||||t
1319050|NCT03348111||Single Group Assignment||Treatment||None (Open Label)||||||
1319051|NCT03348098||Single Group Assignment||Treatment||None (Open Label)||||||
1319052|NCT03348085|||Case-Control||Prospective|||||||
1319053|NCT03348072|||Case-Control||Prospective|||||||
1319054|NCT03348059|||Cohort||Retrospective|||||||
1319055|NCT03348046|||Cohort||Prospective|||||||
1319056|NCT03348033||Single Group Assignment||Treatment||None (Open Label)||||||
1319057|NCT03348020|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1319058|NCT03348007|Randomized|Parallel Assignment||Treatment||Double||"This is a multicenter, randomized (2-arm), double-blind, comparative study versus weakly mineralized water (placebo) in women with functional constipation (Rome Criteria III).~During the selection visit functional constipation will be evaluated by retrospective examination over the previous 3 months according to the diagnostic criteria for functional constipation in Rome III. During the 7 to 9 days prior to randomization, the patients selected by the investigators will observe a period of Wash out and will have to drink 1.5l of Nestlé PureLife® (low mineral water) water per day and inform them daily about their symptomatology ( stool frequency, abdominal pain aspect), their water intake and rescue laxative treatment.~Wash-out period concerned previous taking of laxatif drugs"|t||t|
1319059|NCT03347994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Dose escalation||||
1319060|NCT03347981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319061|NCT03347968|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1319062|NCT03347955|Randomized|Parallel Assignment||Treatment||Quadruple|"All of the above were masked. Only the neurosurgeon (Dr. Breeze) who did the implant and the person in charge of random assignment were aware of which participant received which treatment."|In this double-blind study, 20 participants were randomly assigned to the treatment group and 20 to the sham surgery group with the blind being maintained for 12 months.|t|t|t|t
1319118|NCT03347227|Randomized|Parallel Assignment||Treatment||Single|Single-blinded|Prospective, parallel arm randomized clinical trial|t|||
1319119|NCT03347214|||Family-Based||Retrospective|||||||
1319120|NCT03347201|Randomized|Parallel Assignment||Prevention||Single||||||t
1319121|NCT03347188|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1319122|NCT03347175|Randomized|Parallel Assignment||Treatment||Single|||t|||
1319123|NCT03347162|||Cohort||Prospective|||||||
1319063|NCT03347942|Randomized|Parallel Assignment||Treatment||Single|Participants will not be blinded, as they will be instructed to perform the intervention in the control of meal time. This is a limitation of the study design, however, it is expected to minimize the bias by not explaining to the participants what is expected by the intervention of the research. The researcher, who will measure the outcomes, will not know to which group the individual belongs.|Randomized and controlled clinical trial in adults of both sexes, overweight and obese who accepted to participate in the research at the Hospital de Clínicas in the city of Porto Alegre. Individuals will be divided into two paired groups for age, gender and waist diameter. These two groups will be randomized by lottery.||||t
1319064|NCT03347929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319065|NCT03347916|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1319066|NCT03347903|||Cohort||Prospective|||||||
1319067|NCT03347890|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, single-centre, double-blind, placebo controlled, parallel group, clinical trial.|t|t|t|t
1319068|NCT03347877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319069|NCT03347864||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319070|NCT03347851|||Case-Control||Prospective|||||||
1319071|NCT03347838||Single Group Assignment||Treatment||None (Open Label)||The goal of this clinical research study is to determine whether the Programmed cell death protein 1 (PD-1) inhibitor nivolumab improves premalignant bronchial dysplastic lesions in subjects that are at high risk for the development of lung cancer, including those with a prior smoking history, or history of lung cancer or head and neck cancer. The safety and tolerability of nivolumab will also be studied.||||
1319072|NCT03347825|||Cohort||Retrospective|||||||
1319073|NCT03347812|||Cohort||Prospective|||||||
1319074|NCT03347799|||Cohort||Retrospective|||||||
1319075|NCT03347786||Single Group Assignment||Treatment||None (Open Label)||||||
1319076|NCT03347773|Randomized|Parallel Assignment||Other||None (Open Label)||Open label randomized controlled trial||||
1319077|NCT03347760||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319078|NCT03347747|||Cohort||Prospective|||||||
1319079|NCT03347734|Randomized|Parallel Assignment||Treatment||Double|Participants do not have information about treatment content and groups. He is only aware of exercise therapy applied to him.The ophthalmologist performed evaluations without knowledge of the groups in which the participants were included and of exercise therapy administered.|Randomized Controlled Double-Blind Study|t|||t
1319080|NCT03347721|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1319081|NCT03347708|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t|||t
1319082|NCT03347695||Single Group Assignment||Treatment||None (Open Label)||||||
1319083|NCT03347682|||Other||Cross-Sectional|||||||
1319084|NCT03347669|Randomized|Single Group Assignment||Diagnostic||None (Open Label)|No masking|||||
1319085|NCT03347656|||Cohort||Prospective|||||||
1319086|NCT03347643|Randomized|Parallel Assignment||Treatment||Double||Patients with internet gaming disorder will be randomly allocated into 1) actual real stimulation with tDCS group, and 2) sham stimulation with tDCS group.|t||t|
1319087|NCT03347630||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319088|NCT03347617||Single Group Assignment||Treatment||None (Open Label)||||||
1319089|NCT03347604|||Case-Only||Cross-Sectional|||||||
1319090|NCT03347591|||Case-Only||Cross-Sectional|||||||
1319091|NCT03347578|||Cohort||Prospective|||||||
1319092|NCT03347565|||Case-Control||Prospective|||||||
1319093|NCT03347552|Non-Randomized|Parallel Assignment||Treatment||Single|The blind assessor will administer follow up measures. In order to keep the assessor blind to participant status (active vs. control), research staff will facilitate phone calls. To monitor blinding, the blind assessor will record if participants inadvertently un-blind themselves during the assessment and also record their guess to which treatment condition (active versus E-CARE)participants were allocated.|||||t
1319094|NCT03347539|||Case-Only||Prospective|||||||
1319095|NCT03347526|Randomized|Parallel Assignment||Treatment||None (Open Label)|Blinded outcome measure|||||
1319096|NCT03347513|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1319097|NCT03347500|||Other||Prospective|||||||
1319098|NCT03347487||Single Group Assignment||Treatment||None (Open Label)||All subjects will receive bilateral surgical implantation of DBS system.||||
1319099|NCT03347474||Single Group Assignment||Treatment||None (Open Label)||All subjects will receive bilateral surgical implantation of DBS system||||
1319100|NCT03347461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319101|NCT03347448|||Cohort||Cross-Sectional|||||||
1319102|NCT03347435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319103|NCT03347422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319104|NCT03347409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319105|NCT03347396||Single Group Assignment||Treatment||None (Open Label)||||||
1319106|NCT03347383||Single Group Assignment||Treatment||None (Open Label)||||||
1319107|NCT03347370|||Cohort||Prospective|||||||
1319108|NCT03347357||Single Group Assignment||Treatment||None (Open Label)||||||
1319109|NCT03347344|Randomized|Parallel Assignment||Treatment||Triple|"Treatments will be presented in numbered boxes, labeled for this study according to the Good Manufacturing Practices by the General Agency of Equipment and Health Products (AGEPS).~Each numbered box will consist of 6 months of treatment: 20 blister packs of 20 active or placebo tablets"|Multi-centric, double-blind randomized, two-arm controlled study (one group with 50 mg riluzole twice a day versus one group with placebo), during one year|t|t|t|
1319110|NCT03347331|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1319111|NCT03347318|||Cohort||Prospective|||||||
1319112|NCT03347305|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|No masking|||||
1319113|NCT03347292|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1319114|NCT03347279|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind|Subjects will be randomized in a 1:1 ratio to either tezepelumab or matching placebo both administered subcutaneously.|t|t|t|
1319125|NCT03347136|Randomized|Parallel Assignment||Treatment||None (Open Label)|Due to type of intervention masking was not possible.|The neonates with mild to moderate respiratory distress were randomly allocated to tratment with NIPPV and CPAP.||||
1319126|NCT03347123|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319127|NCT03347110||Single Group Assignment||Treatment||None (Open Label)||||||
1319128|NCT03347097||Single Group Assignment||Treatment||None (Open Label)||||||
1319129|NCT03347084|Randomized|Parallel Assignment||Device Feasibility||Single|Participants and the participants' caregivers will be blinded to arm assignment.|"Participants will be randomly assigned to one of two LIFUP pulsing paradigms: one that excites the activity of hippocampal neurons (Paradigm A), or a second that inhibits them (Paradigm B). The participants will then be administered four successive LIFUP treatments while the participants are in a functional magnetic resonance imaging (MRI)."|t|||
1319130|NCT03347071|||Case-Control||Prospective|||||||
1319131|NCT03347058||Single Group Assignment||Supportive Care||None (Open Label)||||||
1319132|NCT03347045|Randomized|Parallel Assignment||Treatment||Single|Assessor blinding; due to the nature of the study, participant, care provider & investigator cannot be blinded.|Single-center pragmatic randomized-control trial.||||t
1319133|NCT03347032|Randomized|Parallel Assignment||Prevention||Single|||t|||
1319134|NCT03347019|Randomized|Parallel Assignment||Treatment||Single|||t|||
1319135|NCT03347006|Randomized|Crossover Assignment||Basic Science||Double|Double blind placebo controlled|SPM Active is the supplement tested in this study|t||t|
1319136|NCT03346993|Randomized|Crossover Assignment||Treatment||Single|||t|||
1319137|NCT03346980|||Cohort||Prospective|||||||
1319138|NCT03346967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||30 patients with sexual hormone deficiency will be injected AD-MSCs||||
1319139|NCT03346954||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319140|NCT03346941|||Cohort||Prospective|||||||
1319141|NCT03346928|||Cohort||Retrospective|||||||
1319142|NCT03346915||Single Group Assignment||Prevention||None (Open Label)||"We are proposing a single arm proof of concept. We will recruit 30 parents/guardians and their age-eligible child for the single arm proof of concept.~For this proof of concept/pilot trial, we will assess the feasibility and impact of WOW to improve provider communication about HPV vaccination and increase the initial and complete vaccination rates for both boys and girls aged 9-17 and to enhance knowledge and awareness about risks and benefits of HPV vaccine among dyads. The power of our proposed pilot for determining intervention effects is limited. However, because we are proposing a proof of concept pilot and feasibility study, in our experience and that of others, our proposed sample size generally provides sufficient data to estimate subject retention, distribution of variables and feasibility as we plan for a larger-multi-site RCT of the proposed study. We expect our intervention to demonstrate feasibility of the intervention in a clinic setting."||||
1319143|NCT03346902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319144|NCT03346889|||Cohort||Prospective|||||||
1319145|NCT03346876|||Cohort||Prospective|||||||
1319146|NCT03346863|||Cohort||Prospective|||||||
1319147|NCT03346850|Randomized|Parallel Assignment||Other||Single||||||t
1319148|NCT03346837|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319149|NCT03346824|||Other||Retrospective|||||||
1319150|NCT03346811||Single Group Assignment||Treatment||None (Open Label)||||||
1319151|NCT03346798|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319152|NCT03346785|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319153|NCT03346772||Single Group Assignment||Basic Science||None (Open Label)||||||
1319154|NCT03346759|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Subjects were provided with 24 Tampax Pearl Regular Tampons (tampon A) to use exclusively for one of the first two menstrual cycles during the study. Subjects were provided with 24 Playtex Gentle Glide 360 Regular Tampons (tampon B) to use exclusively for the other of the first two menstrual cycle during the study. Subjects used tampons A and B in a randomly assigned order. Subjects then used tampons of their choosing for the third menstrual cycle of the study.||||
1319155|NCT03346746|Randomized|Crossover Assignment||Basic Science||Single|Participants were not told what diet they were consuming each day.|All participants took part in both conditions.|t|||
1319156|NCT03346733|||Other||Prospective|||||||
1319157|NCT03346720|||Cohort||Prospective|||||||
1319158|NCT03346707|||Case-Control||Prospective|||||||
1319159|NCT03346694|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participant randomly assigned to either a control or one of two intervention groups||||
1319160|NCT03346681|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients meeting inclusion criteria will be randomly assigned to the treatment or control group||||
1319161|NCT03346668||Single Group Assignment||Treatment||None (Open Label)||Cohort study||||
1319162|NCT03346655|||Cohort||Prospective|||||||
1319163|NCT03346642||Single Group Assignment||Treatment||None (Open Label)||||||
1319164|NCT03346629||Single Group Assignment||Treatment||None (Open Label)||||||
1319165|NCT03346616|Randomized|Parallel Assignment||Other||None (Open Label)||"Participants were randomly assigned to a Texting Group or a Non-Texting Group using a random number generator. The texting group received a daily text message containing a board style multiple choice question. If the participant wanted immediate feedback, the message contained a link to a website containing the answer to the question along with an explanation, the source material, and a more complete clinical vignette. One hour after the initial text message was sent, a follow up answer text message was delivered. Text messages were sent 6 days per week (Monday through Saturday) at 2pm and 3pm. To minimize perceived impropriety, the non-texting group received access to the journal articles from which the content was derived, but did not receive any text messages or any of the synthesized material. The primary outcome was performance on the NBME Pediatric Subject Examination."||||
1319166|NCT03346603|||Case-Only||Prospective|||||||
1319167|NCT03346590|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|No masking|||||
1319168|NCT03346577|||Case-Only||Prospective|||||||
1319169|NCT03346564|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1573437|NCT00001229||||||||||||
1319170|NCT03346551|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1319171|NCT03346538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319172|NCT03346525|Randomized|Parallel Assignment||Treatment||Single||||||t
1319173|NCT03346512|||Cohort||Retrospective|||||||
1319174|NCT03346499||Single Group Assignment||Treatment||None (Open Label)||||||
1319175|NCT03346486|Non-Randomized|Crossover Assignment||Other||None (Open Label)||Open, fixed sequence diet-switch 4-week intervention||||
1319176|NCT03346473|||Ecologic or Community||Cross-Sectional|||||||
1319177|NCT03346460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319178|NCT03346447|||Other||Prospective|||||||
1319179|NCT03346434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|"Part A: Open Label;~Part B: Masked, Randomized"|"Part A: Single-ascending-dose cohorts staggered by age;~Part B: Parallel Group"||||
1319180|NCT03346421|||Other||Prospective|||||||
1319181|NCT03346408|||Cohort||Prospective|||||||
1319182|NCT03346395|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1319183|NCT03346382|||Cohort||Retrospective|||||||
1319184|NCT03346369||Single Group Assignment||Treatment||None (Open Label)||This study investigates the efficacy and the safety of Lanthanum Carbonate for the reduction of urinary oxalate excretion in patients with secondary hyperoxaluria and nephrolithiasis. Patients will be treated during 2 consecutive 14-day treatment periods with a low and a high dose of Lanthanum Carbonate respectively.||||
1319185|NCT03346356|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319186|NCT03346343||Single Group Assignment||Diagnostic||None (Open Label)||This will be a single center prospective observational study with pre-specified Aims and Hypotheses||||
1319187|NCT03346330|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319188|NCT03346317|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1319189|NCT03346304|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319190|NCT03346291||Single Group Assignment||Treatment||None (Open Label)||||||
1319191|NCT03346278|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1319192|NCT03346265|Randomized|Crossover Assignment||Treatment||Triple||Subjects participated in a baseline assessment session (T0, before rehabilitative treatment), followed by random allocation to 8 weeks of rehabilitative treatments (A or B) (T1), followed by 1 month of inactivity wash out period. Following this wash-out period, patients who received treatment A switched to the treatment B and viceversa. A computerized randomization schedule was generated on the computer and held by an investigator not involved in subject recruitment or assessment.|t|t|t|
1319193|NCT03346252||Single Group Assignment||Treatment||None (Open Label)||Open Label.||||
1319194|NCT03346239|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1319195|NCT03346226|Randomized|Parallel Assignment||Prevention||Single|the intervention is happend in the operation，the outcome assessment is going after the operation|Dexmedetomidine group：dexmedetomidine is given to patients under spinal anesthesia until the end of surgery propofol group:Propofol is given to patients uunder spinal anesthesia until the end of surgery||||t
1319196|NCT03346213|||Cohort||Prospective|||||||
1319197|NCT03346200|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1319198|NCT03346187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1319199|NCT03346174|Non-Randomized|Parallel Assignment||Treatment||Single|Data will be analyzed by an experienced paediatric gastro-enterologist, blinded to the different treatment modalities|||||t
1319200|NCT03346161|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1319201|NCT03346148|||Other||Prospective|||||||
1319202|NCT03346135||Single Group Assignment||Treatment||None (Open Label)||||||
1319203|NCT03346122|Randomized|Parallel Assignment||Other||Double|||t||t|
1319204|NCT03346109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319205|NCT03346096||Single Group Assignment||Treatment||None (Open Label)||TEAM conditioning consisted of THIOTEPA 5mg/kg on days -7-6, etoposide 200 mg/m2 , Cytosar (ARA-C) 200 mg/m2 on days -5,-4, -3, -2 and melphalan 140 mg/m2 on day -1 followed by autologous hematopoietic stem-cell transplantation as per standard institutional protocols.||||
1319206|NCT03346083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1319207|NCT03346070|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1319208|NCT03346057|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1319209|NCT03346044|Randomized|Parallel Assignment||Treatment||None (Open Label)||A comparative single centre study of two porcine bioprostheses indicated for the surgical treatment of heart valve diseases. The study will compare two equal sized patient groups using either the Medtronic Mosaic and Carpentier-Edwards SAV bioprostheses.||||
1319210|NCT03346031|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1319211|NCT03346018|||Cohort||Prospective|||||||
1319212|NCT03346005||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319213|NCT03345992|Randomized|Parallel Assignment||Treatment||Quadruple||Patients assigned to either intravenous clarithromycin or placebo|t|t|t|t
1319214|NCT03345979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319215|NCT03345966|Non-Randomized|Parallel Assignment||Diagnostic||Single||Bmi-1 antibody using immunohistochemistry and PCR||||t
1319216|NCT03345953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319217|NCT03345940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319218|NCT03345927|||Case-Control||Retrospective|||||||
1319219|NCT03345914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319220|NCT03345901|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1319221|NCT03345888|||Cohort||Retrospective|||||||
1319271|NCT03345238|Randomized|Factorial Assignment||Treatment||Double||Randomized controlled trial with double-blind|t|||t
1319272|NCT03345225|Randomized|Parallel Assignment||Device Feasibility||Single||||||t
1319273|NCT03345212|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1319274|NCT03345199||Single Group Assignment||Treatment||None (Open Label)||||||
1573438|NCT00001218||||||||||||
1319222|NCT03345875||Single Group Assignment||Screening||None (Open Label)||"This is a prospective cohort study of women in an HPV self-collection screen-and-treat strategy for cervical cancer prevention to assess collection, triage and treatment through a service delivery model using descriptive, quantitative methods, and formative, qualitative research with providers and women.~Methods to assess feasibility of the service model are electronic medical record (EMR) documentation of women's progression from eligibility for and receipt of services through each step of the HPV self-collection screen-and-treat strategy, from self-collection through test results to treatment of precancer, including referral for suspect cancer.~Acceptability will entail: a) in-depth interviews with health providers, community mobilizers, health facility staff and managers and b) in-depth interviews and surveys with women who receive services as well as women that are eligible and decline services."||||
1319223|NCT03345862|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319224|NCT03345849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319225|NCT03345836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319226|NCT03345823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319227|NCT03345810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319228|NCT03345797|Non-Randomized|Parallel Assignment||Other||None (Open Label)||dual arm: naïve vs TRT experienced||||
1319229|NCT03345784||Single Group Assignment||Treatment||None (Open Label)||||||
1319230|NCT03345771|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1319231|NCT03345758|||Case-Only||Prospective|||||||
1319232|NCT03345745|||Case-Control||Prospective|||||||
1319233|NCT03345732|||Cohort||Prospective|||||||
1319234|NCT03345719|||Cohort||Prospective|||||||
1319235|NCT03345706|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319236|NCT03345693||Single Group Assignment||Treatment||None (Open Label)||||||
1319237|NCT03345680|Randomized|Parallel Assignment||Screening||Double|||||t|t
1319238|NCT03345667|||Ecologic or Community||Retrospective|||||||
1319239|NCT03345654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319240|NCT03345641|||Cohort||Prospective|||||||
1319241|NCT03345628|||Case-Control||Other|||||||
1319242|NCT03345615|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||2:1 enrollment into parallel groups (intensive monitoring vs. standard care).||||
1319243|NCT03345602|||Cohort||Prospective|||||||
1319244|NCT03345589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319245|NCT03345576|Randomized|Parallel Assignment||Treatment||Single|Participant will be masked to the type of electrical stimulation (LPWS vs. standard NMES)||t|||
1319246|NCT03345563|Randomized|Parallel Assignment||Supportive Care||Double|Participants will be instructed not to discuss their arm assignment with study personnel during their assessments; questionnaires will be self-administered, administered in person or by telephone based on participant need and preference. Some investigators, the data manager, biostatisticians, biometric testing and lab technicians will be blinded to intervention allocation. The technicians who analyze biospecimens will be blinded to all other data.|After obtaining informed consent and baseline assessments, 210 fatigued prostate cancer survivors age 55 years and older will be randomized to the BMT arm or intensity-matched Body Training (BT), or Usual Care (UC) arms. Patient-reported assessments (surveys) will occur at baseline (within 2-weeks pre- intervention), mid-intervention (6 weeks), 1-week post-intervention (13 weeks), and at 3 months and 12 months post-intervention. Phlebotomy is done at baseline, 1 week post intervention (13 weeks), and 3 months and 12 months post intervention. Dietary assessments are done at baseline, and week 13 (1 week post intervention), 3 months and 1 year post-intervention. Physical activity is assessed weekly throughout the intervention. Sleep diaries are collected at all time points.||t||t
1319247|NCT03345550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319248|NCT03345537|||Cohort||Prospective|||||||
1319249|NCT03345524|Randomized|Parallel Assignment||Supportive Care||Double|Will be blinded to subjects group assignment|Randomized Controlled Trial|||t|t
1319250|NCT03345511||Single Group Assignment||Treatment||None (Open Label)||interventional||||
1319251|NCT03345498|||Case-Only||Prospective|||||||
1319252|NCT03345485||Single Group Assignment||Treatment||None (Open Label)||||||
1319253|NCT03345472||Single Group Assignment||Treatment||None (Open Label)||||||
1319254|NCT03345459|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are randomized to internet-based treatment (two-thirds of sample) or usual care (one-third of sample).||||
1319255|NCT03345446|||Cohort||Prospective|||||||
1319256|NCT03345433||Single Group Assignment||Supportive Care||None (Open Label)||interactive group drumming sessions||||
1319257|NCT03345420||Single Group Assignment||Treatment||None (Open Label)||||||
1319258|NCT03345407|Randomized|Parallel Assignment||Treatment||Double|This will be a double blind, sponsor- open study.|Subjects will be randomized to receive either nemiralisib (50-750 µg) or placebo in a parallel group.|t||t|
1319259|NCT03345394|Randomized|Crossover Assignment||Treatment||None (Open Label)||Crossover randomized controlled trial||||
1319260|NCT03345381|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1319261|NCT03345368|Randomized|Parallel Assignment||Treatment||Single|Sham rTMS will be administered with the coil held in contact with the head but at 180 degrees from scalp to avoid stimulation.|Study participants will be randomly assigned to one of two groups: the experimental group receiving rTMS and a placebo group receiving sham rTMS. Both groups will be on the low-carb diet.|t|||
1319262|NCT03345355|||Case-Control||Prospective|||||||
1319263|NCT03345342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319264|NCT03345329|||Case-Control||Prospective|||||||
1319265|NCT03345316||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319266|NCT03345303|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1319267|NCT03345290||Single Group Assignment||Prevention||None (Open Label)||||||
1319268|NCT03345277|||Cohort||Retrospective|||||||
1319269|NCT03345264||Single Group Assignment||Supportive Care||None (Open Label)||||||
1319270|NCT03345251|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1319275|NCT03345186|Randomized|Parallel Assignment||Other||Double||Interventional group: structured nurse led patient management programm & sc Control group standard of care (sc) alone|||t|t
1319276|NCT03345173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319277|NCT03345160||Single Group Assignment||Treatment||None (Open Label)||Open Label crossover||||
1319278|NCT03345147|||Cohort||Prospective|||||||
1319279|NCT03345134||Single Group Assignment||Treatment||None (Open Label)||||||
1319280|NCT03345121||||||||||||
1319281|NCT03345108|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1319282|NCT03345095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319283|NCT03345082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319284|NCT03345069|||Cohort||Prospective|||||||
1319285|NCT03345056||Single Group Assignment||Treatment||None (Open Label)||||||
1319286|NCT03345043|Randomized|Parallel Assignment||Prevention||Triple|Double blind||t|t|t|
1319287|NCT03345030|||Cohort||Prospective|||||||
1319288|NCT03345017||||||||||||
1319289|NCT03345004|Randomized|Parallel Assignment||Treatment||Quadruple||The study is a 2-arm, randomized, double-blind, placebo-controlled, multicenter, clinical trial.|t|t|t|t
1319290|NCT03344991|Randomized|Parallel Assignment||Prevention||None (Open Label)||Infants will be randomized to either open crib (standard of care) or mylar-lined cardboard box following care in a radiant warmer||||
1319291|NCT03344978|Randomized|Crossover Assignment||Prevention||None (Open Label)||Randomized crossover. Participant will be randomly assigned initially to care in one of two devices for 24 hours, then crossed over to other device for 24 hours. This will be repeated once more for a total of 96 hours study time. Patterns may be A-B-A-B or B-A-B-A.||||
1319292|NCT03344965|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319293|NCT03344952|||Case-Only||Retrospective|||||||
1319294|NCT03344939|||Cohort||Prospective|||||||
1319295|NCT03344926||Single Group Assignment||Treatment||None (Open Label)||Pilot study of treatment delivery in a new format.||||
1319296|NCT03344913|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Adults with knee osteoarthritis and healthy controls will both undergo the same walking intervention. The goal is to examine basic mechanism for pain sensitivity after walking.||||
1319297|NCT03344900|||Cohort||Prospective|||||||
1319298|NCT03344887|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1319299|NCT03344874|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1319300|NCT03344861||Single Group Assignment||Other||None (Open Label)||||||
1319301|NCT03344848||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1319302|NCT03344835|||Cohort||Other|||||||
1319303|NCT03344822||Single Group Assignment||Diagnostic||None (Open Label)|Even if the study has only one arm, the results of both PET imageries will be blind assessed.|Each patient will realize a 18F-Choline PET/CT then a 68Ga-PSMA-11 PET/CT||||
1319304|NCT03344809|||Cohort||Prospective|||||||
1319305|NCT03344796|||Cohort||Prospective|||||||
1319306|NCT03344783|||Other||Other|||||||
1319307|NCT03344770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319308|NCT03344757|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1319309|NCT03344744|||Case-Control||Prospective|||||||
1319310|NCT03344731|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1319311|NCT03344718|||Cohort||Cross-Sectional|||||||
1319312|NCT03344705||Single Group Assignment||Treatment||None (Open Label)||||||
1319313|NCT03344692|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1319314|NCT03344679|Randomized|Crossover Assignment||Other||Double|||t|||t
1319315|NCT03344666|Randomized|Factorial Assignment||Treatment||Single||||||t
1319316|NCT03344653|Randomized|Parallel Assignment||Treatment||Single|Subjects will be randomized at a 1:1 ratio to treatment with Resolute Onyx stent or the BioFreedom stent (control).|Prospective, multi-center, blinded, randomized, controlled study enrolling eligible subjects at global centers. The enrollment period is anticipated to be approximately 14 months.|t|||
1319317|NCT03344640|Randomized|Parallel Assignment||Treatment||Quadruple|The patient and investigator will be blinded throughout the study, while the sponsor will be blinded until after the analysis of the primary endpoint.|Parallel Assignment|t|t|t|t
1319318|NCT03344627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319319|NCT03344614||Single Group Assignment||Treatment||None (Open Label)||||||
1319320|NCT03344601|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This is a 12 month observational study with a nested randomised controlled trial of a physical activity intervention||||
1319321|NCT03344588|Randomized|Parallel Assignment||Treatment||Single|Patients accept to participate have to sign a written informed consent and will be unaware of randomization.||t|||
1319322|NCT03344575|Randomized|Parallel Assignment||Treatment||Double|The patient undergoing surgery and the physician performing the follow-up are masked to the allocation.|Double-blind randomized controlled trial.|t|||t
1319323|NCT03344562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319324|NCT03344549|Randomized|Parallel Assignment||Treatment||None (Open Label)||In the experimental group, the nutritional intervention will be done through teleconsultation with the free technological tool chosen (the patients from home and the nutritionist from the remote clinic); and in the control group will be offered the nutritional intervention through face-to-face consultations carried out by the nutritionist of the nutrition service of the institution, both arms will be intervened monthly for four months, the duration of the sessions will be 45 minutes and will include evaluation or re-evaluation of dietary data, diagnosis, treatment and educational approach.||||
1319325|NCT03344536||Single Group Assignment||Treatment||None (Open Label)||This is an open-label, single institution, phase Ib/phase II non-randomized trial.||||
1319326|NCT03344523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319468|NCT03342677||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319508|NCT03342157|Randomized|Parallel Assignment||Treatment||Single|||t|||
1319509|NCT03342144|||Cohort||Prospective|||||||
1319510|NCT03342131|||Case-Control||Prospective|||||||
1319327|NCT03344510|Randomized|Crossover Assignment||Treatment||None (Open Label)||The study will be an open label split-body crossover trial, using healthy adult volunteers recruited from the faculty, staff and student body of the University of Pennsylvania, and from the University City area of Philadelphia. Participants will be randomized to one of three anatomic sites deemed relevant: the nasofacial sulcus, the lateral forehead, and the upper back. Participants will then be randomized to receive injection with the KAD first or second. They will receive one injection with and one injection without the interventional device, in a randomized order.||||
1319328|NCT03344497|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319329|NCT03344484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319330|NCT03344471|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1319331|NCT03344458||Single Group Assignment||Treatment||None (Open Label)||All study participants will receive TransCon hGH||||
1319332|NCT03344445|Randomized|Single Group Assignment||Other||Single||simple compare of information gain between traditional visit and video-assisted visit||||t
1319333|NCT03344432|||Other||Prospective|||||||
1319334|NCT03344419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319335|NCT03344406|||Cohort||Cross-Sectional|||||||
1319336|NCT03344393|Randomized|Parallel Assignment||Prevention||Single|||||t|
1319337|NCT03344380|||Cohort||Retrospective|||||||
1319338|NCT03344367||Single Group Assignment||Treatment||None (Open Label)||||||
1319339|NCT03344354|Randomized|Crossover Assignment||Other||None (Open Label)||This is a non-significant risk, cross-over, comparative, prospective, five-armed, open-label clinical investigation in which the failure rate of surgical gloves from four different manufacturers will be evaluated in double-gloving fashion.||||
1319340|NCT03344341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319341|NCT03344328|||Cohort||Retrospective|||||||
1319342|NCT03344315|Randomized|Parallel Assignment||Treatment||Single|"Observer: Another periodoncist outside the intervention, would be in charge of recording the clinical parameters.~Analyst: The statistician does not know which treatment corresponds to each variable."|split mouth||||t
1319343|NCT03344302|Randomized|Parallel Assignment||Prevention||Single|||t|||
1319344|NCT03344289|Randomized|Parallel Assignment||Prevention||None (Open Label)||An international, multicenter, parallel randomized controlled trial.||||
1319345|NCT03344276|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"In this pilot study 20 patients, undergoing CAS for CS, will undergo cognitive testing at 2 time points before intervention (1 months, and 2 months) and at 2 time points after invention (1 month and 2 months). The two preoperative time points will serve as the control group and the two postoperative time points will serve as the intervention group.~Patients will serve as their own controls, classifying the study as a within-subjects design. Patients will also have venous blood drawn to ascertain the change in serum markers associated with endothelial dysfunction and inflammation before and after intervention. Finally, patients will have magnetic resonance imaging (MRA) one month before intervention and 2 months after intervention in order to assess changes in global cerebral blood flow."||||
1319346|NCT03344263||Single Group Assignment||Treatment||None (Open Label)||||||
1319347|NCT03344250||Single Group Assignment||Treatment||None (Open Label)||EGFR BATs administered in combination with standard of care temozolomide and radiation||||
1319348|NCT03344237|||Other||Retrospective|||||||
1319349|NCT03344224|||Cohort||Retrospective|||||||
1319350|NCT03344211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319351|NCT03344198|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319352|NCT03344185|Randomized|Crossover Assignment||Basic Science||Single|Participants were not told which diet they were consuming each day.|All participants took part in both diet conditions|t|||
1319353|NCT03344172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319354|NCT03344159|Randomized|Parallel Assignment||Treatment||Quadruple|Patients will be blinded to study treatment for the duration of the study. Clinicians will also be blinded to study drug assignment. Evaluation of all study results will be done blinded to treatment randomization. Because of the double-blind design, safety laboratory tests, and monitoring of potential side effects will be performed for each participant for the duration of the trial, regardless of the treatment arm.|STAR-HF is a phase 4 single center, randomized, placebo controlled trial comparing spironolactone 12.5mg daily up to a maximum dose of 50 mg daily if tolerated to matching placebo.|t|t|t|t
1319355|NCT03344146|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1319356|NCT03344133|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319357|NCT03344120|Randomized|Parallel Assignment||Treatment||Single|||t|||
1319358|NCT03344107|Randomized|Parallel Assignment||Treatment||Single|||t|||
1319359|NCT03344094|||Cohort||Prospective|||||||
1319360|NCT03344081|||Cohort||Cross-Sectional|||||||
1319361|NCT03344068|Randomized|Parallel Assignment||Treatment||None (Open Label)||The patients eligible are divided randomly. All the patients will receive radical radiotherapy with or without chemotherapy. The cases in the Experimental Group will receive Nutren® Optimum of 7 scoops tid at begin of radiotherapy.||||
1319362|NCT03344055|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1319363|NCT03344042|Randomized|Parallel Assignment||Treatment||Double|Participant not aware of opioid administered||t|||t
1319364|NCT03344029|Randomized|Parallel Assignment||Prevention||Triple|An observer-blind procedure will be followed in the study such that neither the Investigator, subject, nor the Sponsor will know which vaccine has been administered.|Blind-observer, monocenter, randomized, comparative, Phase IV study|t||t|t
1319413|NCT03343392|Randomized|Parallel Assignment||Treatment||Triple|This was a triple-mask study, in which the patient, operator and evaluator were blinded to the group assignment.|This was a randomized, parallel, placebo-controlled, triple-mask clinical trial, in which the patient, operator and evaluator were masked to the group assignment. A third researcher, not involved in the evaluation process, was responsible for the randomization process, and delivery and guidance on the administration of the drugs. This study was performed from 01/2016 to 12/2017 in the city of Cascavel (Paraná, Brazil). All bleaching procedures were carried out within the Clinics of the Dental School of the State University of Oeste do Paraná (Cascavel, Paraná, Brazil).|t||t|t
1319365|NCT03344016|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"To provide evidence whether strict follow-up will result in improvement in clinical outcome parameters as compared to standard care follow-up, patients upon inclusion into the study protocol will be randomized into two groups:~Standard care follow-up group: Patients will receive an information leaflet (see appendix), which advises on recommended routine follow-up according to international guidelines.~Special care follow-up group: In addition to the information leaflet patients will be actively contacted by the clinical center to increase the likelihood that patients meet recommended follow-up schedules.~Stratification will be done for inclusion criteria (newly diagnosed PPGL, previous history of PPGL, gene carrier, presence of malignant PPGL and center)."||||
1319366|NCT03344003|||Cohort||Other|||||||
1319367|NCT03343990|||Case-Control||Prospective|||||||
1319368|NCT03343977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319369|NCT03343964|||Cohort||Prospective|||||||
1319370|NCT03343951|||Cohort||Cross-Sectional|||||||
1319371|NCT03343938|Randomized|Parallel Assignment||Other||Double|||t|t||
1319372|NCT03343925|||Cohort||Prospective|||||||
1319373|NCT03343912|Randomized|Parallel Assignment||Prevention||None (Open Label)||Single centre, open-label, randomized (assignment to treatment group), parallel-group, three-arm single-dose clinical trial with application performed over 1 treatment cycle of 21 days.||||
1319374|NCT03343899|||Cohort||Prospective|||||||
1319375|NCT03343886|||Cohort||Prospective|||||||
1319376|NCT03343873|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1319377|NCT03343860|Randomized|Parallel Assignment||Treatment||Single|||t|||
1319378|NCT03343847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319379|NCT03343834||Single Group Assignment||Basic Science||None (Open Label)|"1 population divided in 2 groups: Retrospective study (n=80): Patient who underwent HSCT, in Saint-Antoine hospital, between 2010-2015, treated by rituximab for high level EBV-DNAemia (above 3.3 log copies/mL).~Prospective study (n=58): Patients who underwent HSCT, in Saint-Antoine hospital and la Pitié-Salpêtrière, in 2016-2017, treated by rituximab for high level EBV-DNAemia (above 10 000c/mL), And/or having post-transplant lymphoproliferative diseases(PTLD) Concerned population Allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients with a high Epstein-Barr virus (EBV) viral load"|||||
1319380|NCT03343821|||Case-Only||Prospective|||||||
1319381|NCT03343808|||Case-Only||Retrospective|||||||
1319382|NCT03343795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319383|NCT03343782|Randomized|Parallel Assignment||Treatment||Double||30 patients were randomly assigned into 2 groups for injection (intravenous injection or dorsal pancreatic artery infusion).|t|t||
1319384|NCT03343769|||Case-Control||Prospective|||||||
1319385|NCT03343756|||Other||Other|||||||
1319386|NCT03343743||Single Group Assignment||Treatment||None (Open Label)||||||
1319387|NCT03343730|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1319388|NCT03343717|Randomized|Parallel Assignment||Other||Triple||randomized clinical trial|t|t|t|
1319389|NCT03343704||Single Group Assignment||Treatment||None (Open Label)||||||
1319390|NCT03343691|||Cohort||Prospective|||||||
1319391|NCT03343678||Parallel Assignment||Treatment||None (Open Label)||||||
1319392|NCT03343665||Single Group Assignment||Treatment||None (Open Label)||||||
1319393|NCT03343652||Single Group Assignment||Treatment||None (Open Label)||||||
1319394|NCT03343639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319395|NCT03343626|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1319396|NCT03343613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1319397|NCT03343600|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1319398|NCT03343587|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1319399|NCT03343574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319400|NCT03343561|Randomized|Parallel Assignment||Prevention||Single|As soon as the samples are obtained from the subjects, subjects will be coded straight-away. No samples will be stored with the subjects' name on, only codes will be used. Only the investigating team will be able to break the codes and trace the results back to the subjects. All the questionnaires will be only shown the subjects' code without subjects' name on them. No data file in hard or soft copy format will contain all the information on the subject's name, project code and experiment result.|||||t
1319401|NCT03343548|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1319402|NCT03343535||Single Group Assignment||Treatment||None (Open Label)||OCS Lung System||||
1319403|NCT03343522|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1319404|NCT03343509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319405|NCT03343496|||Case-Only||Prospective|||||||
1319406|NCT03343483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319407|NCT03343470|||Cohort||Prospective|||||||
1319408|NCT03343457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319409|NCT03343444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319410|NCT03343431||Single Group Assignment||Prevention||None (Open Label)||All participants receive the intervention||||
1319411|NCT03343418|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1319412|NCT03343405|Randomized|Parallel Assignment||Treatment||None (Open Label)||A between groups repeated measure experimental design. Participants that met inclusion criteria and were interested in continuing with the study were randomized to either the treatment or wait-list group. Participants randomized to the treatment group were provided with 10 online program modules provided weekly over 10 weeks. After 10-weeks the wait-list group had the opportunity to participate in the intervention protocol if they desire. All participants will be asked to complete pre-, mid-, post-, f/u- intervention questionnaires.||||
1319414|NCT03343379||Single Group Assignment||Screening||None (Open Label)||1 group of participants was screened at the start of the study and followed prospectively for 2 years||||
1319506|NCT03342183|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1319507|NCT03342170|||Cohort||Prospective|||||||
1320807|NCT03325218|||Other||Cross-Sectional|||||||
1319415|NCT03343366|Randomized|Parallel Assignment||Prevention||Single|A parallel group, single blind three-arm design randomized controlled trial (RCT) will be conducted. The examiners, both for periodontal examination and laboratory investigations will be blinded.|This multi-centric randomized controlled trial (RCT) will be conducted on the baseline sample derived from periodontal clinics of dental institutes of Dow University of Health Sciences. More than 1000 patients will be screened to recruit 150 calculated sample participants (with 50 in each group) with reference to 0.7%, 0.6% reduction and no reduction (0.06%) in the baseline mean HbA1c over a period of 3 months among SRP+AAT, SRP Only and no treatment groups respectively(48) the calculated sample size is 35 in each group (1:1:1) with 99% power of test and 99% confidence interval. Adding 40% dropout rate expected over 6-months follow-up, 49 participants in each group will be required that will be rounded off to 50 in each group (with a ratio of 1:1:1).|||t|
1319416|NCT03343353|Randomized|Parallel Assignment||Treatment||Double||"Volunteers will be randomized into groups:~Group Sham= 35 Group red LED= 35 Group infrared LED = 35"|||t|t
1319417|NCT03343340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319418|NCT03343327|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1319419|NCT03343314|||Cohort||Prospective|||||||
1319420|NCT03343301||Single Group Assignment||Treatment||None (Open Label)||||||
1319421|NCT03343288||Single Group Assignment||Prevention||None (Open Label)||In this study, hip joint prostheses, intramedullary nails and external fixator implants to be used in 30 patients . CE marked, domestic manufactured standard orthopedic implants will be used in patients after silver doped HA coating . Antimicrobial effectiveness of the coating will be evaluated. These patients will be tasted for the evaluation of liver and kidney functions and blood and urine silver levels in addition to routine tests such as full blood, complete biochemistry, C-reactive protein, erythrocyte sedimentation rate required in the normal diagnosis and treatment processes, and will be monitored for at least 12 months.||||
1319422|NCT03343275|Randomized|Parallel Assignment||Prevention||Double||Adults attending urology/nephrology consultation whom have been recently implanted a double J stent or have its implantation programmed and are able of taking care in urinary pH self-control.|t||t|
1319423|NCT03343262|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319424|NCT03343249||Single Group Assignment||Other||None (Open Label)||||||
1319425|NCT03343236|||Cohort||Prospective|||||||
1319426|NCT03343223|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319427|NCT03343210|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319428|NCT03343197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319429|NCT03343184|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1319430|NCT03343171|||Cohort||Prospective|||||||
1319431|NCT03343158|||Other||Cross-Sectional|||||||
1319432|NCT03343145|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319433|NCT03343132|||Case-Control||Prospective|||||||
1319434|NCT03343119|||Ecologic or Community||Other|||||||
1319435|NCT03343106|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1319436|NCT03343093|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1319437|NCT03343080|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1319438|NCT03343067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319439|NCT03343054||Sequential Assignment||Treatment||None (Open Label)||||||
1319440|NCT03343041|Randomized|Parallel Assignment||Treatment||Single||The ultimate goal is to perform a prospective, single-center, double-blinded, parallel group, randomized, controlled trial on the safety and efficacy of low-carbohydrate enteral nutrition in adult patients admitted to the MICU with bacterial septic shock.|t|||
1319441|NCT03343028||||||||||||
1319442|NCT03343015|||Cohort||Retrospective|||||||
1319443|NCT03343002|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1319444|NCT03342989|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1319445|NCT03342976|Randomized|Parallel Assignment||Prevention||Single||||t||
1319446|NCT03342963|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1319447|NCT03342950|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1319448|NCT03342937||Single Group Assignment||Treatment||None (Open Label)||||||
1319449|NCT03342924||Single Group Assignment||Other||None (Open Label)||||||
1319450|NCT03342911||Single Group Assignment||Treatment||None (Open Label)||||||
1319451|NCT03342898|Randomized|Parallel Assignment||Prevention||Single||||||t
1319452|NCT03342885|Randomized|Parallel Assignment||Treatment||Single||||||t
1319453|NCT03342872|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a cluster randomized trial testing two additive implementation strategies for installing FBS quality improvement procedures in ASU outpatient treatment. Nine ASU treatment sites will be yoked and randomized into three conditions to enhance ecological validity; 1) Core Training Only; 2) Core Training and Facilitation; and 3) Control (no intervention). The implementation strategies (i.e., Core Training Only, Core + Facilitation), are system-level strategies for translating evidence-based interventions into multi-site service settings.||||
1319454|NCT03342859|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319455|NCT03342846|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1319456|NCT03342833|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1319457|NCT03342820||Single Group Assignment||Basic Science||None (Open Label)||||||
1319458|NCT03342807|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319459|NCT03342794||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319460|NCT03342781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319461|NCT03342768|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319462|NCT03342755|||Case-Control||Other|||||||
1319463|NCT03342742|Randomized|Parallel Assignment||Other||Double|||||t|t
1319464|NCT03342729|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1319465|NCT03342716|||Cohort||Prospective|||||||
1319466|NCT03342703|||Case-Only||Prospective|||||||
1319467|NCT03342690|||Case-Only||Prospective|||||||
1319469|NCT03342664|Randomized|Parallel Assignment||Treatment||Single|180 day mRS is blinded|Subjects will be randomized to either minimally invasive hematoma evacuation with the Artemis Neuro Evacuation Device with medical management (MIS group) or best medical management alone (2:1) (MM).||||t
1319470|NCT03342651||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319471|NCT03342638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319472|NCT03342625||Single Group Assignment||Other||None (Open Label)||||||
1319473|NCT03342612||Single Group Assignment||Health Services Research||None (Open Label)||Magnetic resonance imaging (MRI) to assess cerebral blood flow using Arteria Spin Labelling (ASL), structural changes using Diffusion Tensor Imaging (DTI), susceptibility weighted imaging (SWI), and functional changes using BOLD resting-functional MRI.||||
1319474|NCT03342599|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1319475|NCT03342586|||Cohort||Prospective|||||||
1319476|NCT03342573||Single Group Assignment||Treatment||None (Open Label)||Cosentyx (Secukinumab) for the treatment of adult onset pityriasis rubra pilaris||||
1319477|NCT03342560||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319478|NCT03342547||Single Group Assignment||Basic Science||None (Open Label)||||||
1319479|NCT03342534|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1319480|NCT03342521|||Cohort||Prospective|||||||
1319481|NCT03342508|Randomized|Parallel Assignment||Prevention||Triple|Each patient will have a Fetal Pillow inserted vaginally by the obstetrician after catheterization of the bladder (if it has not been previously performed). Once the Fetal Pillow is in place, the woman's legs will be placed flat on the operating table. The anesthesiologist will then inflate the Fetal Pillow if the patient has been randomized into the Fetal Pillow Inflated (FPI) group. In the Fetal Pillow Not Inflated (FPNI) group, the device will remain, not inflated, in the vagina. The obstetrician will therefore be blinded to the intervention.||t|t|t|
1319482|NCT03342495|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Two groups of participants will be randomized by primary clinical area||||
1319483|NCT03342482|Randomized|Crossover Assignment||Treatment||Triple||Subjects will be randomized to immediately start a one-month dietary intervention restricting consumption of glutamate, or will be waitlisted as a control group for the first month, and then will begin the one-month dietary intervention period (which will be completed at home). Then subjects will return to DC, will complete all measures again, and then will participate in a double-blind, placebo-controlled, crossover challenge with MSG and placebo.|t||t|t
1319484|NCT03342469|Randomized|Crossover Assignment||Treatment||Double|The investigators and the participants will be masked as to contents of the chocolate cookies provided during the challenge periods. One research assistant will be unblinded and will not have contact with the participants.|Participants will be exposed to all challenge mixtures with adequate washout periods between exposures.|t||t|
1319485|NCT03342456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319486|NCT03342443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319487|NCT03342430|||Cohort||Prospective|||||||
1319488|NCT03342417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Open-Label, Non-Randomization Phase 2 clinical trial with Safety Run-In (3 parts): Part 1 in 20 newly diagnosed patients who have Stage II-III breast cancer, with the primary cancer in place. These patients have not received prior therapy and intend to undergo surgery after completion of investigational neoadjuvant therapy. Parts 2 and 3 in 20 PRROC and gastric cancer patients, respectively. Enrollment of patients in each of the 3 parts will begin with 3 patients. If no dose-limiting toxicities (DLTs, defined as toxicity ≥Grade 3) are observed during the first cycle, enrollment can continue for the remaining 17 patients. If 1 of the first 3 patients experiences a DLT, the enrollment will be expanded to a total of 6 subjects. If no more than 1 of 6 subjects experiences a DLT, enrollment can continue for the remaining 14 patients. If 2 or more of the first 2-6 subjects experience a DLT, enrollment may be paused and the study data will be reviewed.||||
1319489|NCT03342404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319490|NCT03342391||Single Group Assignment||Treatment||None (Open Label)||||||
1319491|NCT03342378|||Cohort||Prospective|||||||
1319492|NCT03342365|||Case-Only||Prospective|||||||
1319493|NCT03342352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319494|NCT03342339|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319495|NCT03342326|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319496|NCT03342313|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Randomized cross-over design||||
1319497|NCT03342300|Randomized|Parallel Assignment||Treatment||Single|A web-based central randomisation with block sizes of two and four was stratified by extent of disease,anthracycline administration method, and previous systemic therapy. Participants and investigators will not be masked to treatment assignment. The primary endpoint will be assessed in the intention-to-treat population. The outcome assessors will be masked to the two research groups.|Patients will be randomly assigned (1:1) to receive pegylated liposomal doxorubicin (50 mg/m² on day 1 of every 21-day cycle for up to six cycles) or pirarubicin (60 mg/m² on day 1 of every 21-day cycle for up to six cycles) plus ifosfamide (2 g/m²/d d2-4 of every 21-day cycle for up to six cycles) and dacarbazine (300 mg/m²/d d2-4 of every 21-day cycle for up to six cycles).||||t
1319498|NCT03342287|||Cohort||Prospective|||||||
1319499|NCT03342274|Randomized|Parallel Assignment||Treatment||None (Open Label)||After the end of year 1 outcomes the control arm crosses over and a year 2 follow-up is conducted on both arms.||||
1319500|NCT03342261|||Cohort||Retrospective|||||||
1319501|NCT03342248|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319502|NCT03342235|Randomized|Parallel Assignment||Treatment||Single||"Surgical Group: treatment with PRK and patching prescribed 2 hours per day with continued refractive correction (with spectacles and/or contact lenses) as able.~o Surgery will be performed within 60 days of randomization~Non-surgical Control Group: patching prescribed 2 hours per day with continued refractive correction (with spectacles and/or contact lenses) as able."||||t
1319503|NCT03342222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319504|NCT03342209||Single Group Assignment||Treatment||None (Open Label)||||||
1319505|NCT03342196||Single Group Assignment||Treatment||None (Open Label)||||||
1319511|NCT03342118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319512|NCT03342105|Randomized|Parallel Assignment||Treatment||Single||||||t
1319513|NCT03342092|||Cohort||Prospective|||||||
1319514|NCT03342079|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1319515|NCT03342066|||Cohort||Prospective|||||||
1319516|NCT03342053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319517|NCT03342040|Randomized|Parallel Assignment||Treatment||Double|Participant and assessors are masked|Prospective double blinded balanced allocation, randomized clinical trial|t|||t
1319518|NCT03342027|Randomized|Factorial Assignment||Treatment||Double||4 conditions: (1) bupropion + Positively Smoke Free (an 8 session tailored behavioral intervention for PLWH smokers); (2) bupropion + Standard of Care (brief advice to quit); (3) Placebo + Positively Smoke Free; and (4) Placebo + Standard of Care.|||t|t
1319519|NCT03342014||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319520|NCT03342001||Single Group Assignment||Treatment||None (Open Label)||||||
1319521|NCT03341988||Single Group Assignment||Treatment||None (Open Label)||||||
1319522|NCT03341975|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1319523|NCT03341962|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1319524|NCT03341949||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319525|NCT03341936||Single Group Assignment||Treatment||None (Open Label)||||||
1319526|NCT03341923|Randomized|Crossover Assignment||Treatment||Single|||t|||
1319527|NCT03341910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319528|NCT03341897||Single Group Assignment||Treatment||None (Open Label)||||||
1319529|NCT03341884|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319530|NCT03341871|||Cohort||Prospective|||||||
1319531|NCT03341858|||Family-Based||Prospective|||||||
1319532|NCT03341845||Single Group Assignment||Treatment||None (Open Label)||simon's two stage design||||
1319533|NCT03341832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319534|NCT03341819|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319535|NCT03341806||Single Group Assignment||Treatment||None (Open Label)||||||
1319536|NCT03341793||Single Group Assignment||Basic Science||None (Open Label)||||||
1319537|NCT03341780|||Cohort||Prospective|||||||
1319538|NCT03341767|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Parallel assignment, placebo-controlled with later arm for pharmacokinetics|t|t|t|t
1319539|NCT03341754|Randomized|Parallel Assignment||Prevention||Single|Trial subjects will be blinded from their treatment|The study will include 2 vaccine groups and an infectivity control (IC) group consisting of non-immunized subjects.|t|||
1319540|NCT03341741|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized, open label clinical study||||
1319541|NCT03341728|Randomized|Crossover Assignment||Treatment||None (Open Label)|No Masking|"In two 20 min sessions, on different days in a randomized cross-over design, older adults with a history of falls will walk with (treatment session) and without (control session) prolonged exposure to optical flow perturbations."||||
1319542|NCT03341715|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1319543|NCT03341702|||Cohort||Retrospective|||||||
1319544|NCT03341689|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1319545|NCT03341676|Randomized|Parallel Assignment||Treatment||Triple|The participant, Investigator supervising the visit and the Outcome Assessor will be blinded to the treatment allocation|Double-blind, randomised controlled trial|t||t|t
1319546|NCT03341663|||Case-Only||Cross-Sectional|||||||
1319547|NCT03341650|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1319548|NCT03341637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319549|NCT03341624||Single Group Assignment||Screening||None (Open Label)||||||
1319550|NCT03341611|||Case-Control||Cross-Sectional|||||||
1319551|NCT03341598|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1319552|NCT03341585||Single Group Assignment||Treatment||None (Open Label)||||||
1319553|NCT03341572|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319554|NCT03341559|||Cohort||Prospective|||||||
1319555|NCT03341546|||Case-Only||Cross-Sectional|||||||
1319556|NCT03341533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319557|NCT03341520||Single Group Assignment||Treatment||None (Open Label)||Open, non-controlled, national multi-center phase II trial||||
1319558|NCT03341507||Single Group Assignment||Treatment||None (Open Label)||A group of patients with difficult airway criteria will be intubated using the rigid tube for laryngoscopy. A classical laryngoscopy with a Mc Coy laryngoscope will be performed prior intubation and the Cormack-Lehane grade of glottis visualisation will be noted.||||
1319559|NCT03341494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319560|NCT03341481|Randomized|Parallel Assignment||Treatment||Triple|To mask intervention the placebo was used. In this case, the placebo was prepared as a blend of sucrose, apple fiber and natural aroma caramel by subcontractor of the producer, accordingly to the GMP (number of sachets prepared 1534). Placebo sachets were in the same size sachets as the product and could be hardly distinguished in term of color, taste or texture and flavor. To the end of the trial patients and medical staff were blinded which sachet contained active product. People responsible for the data clean-up and statistics were partially blinded since theyhad to know which patients were in the same treatment group.|Treatment was given to the mothers assigned to the galactogogue group, whereas a placebo was given to those assigned to the placebo group. Each patient randomized to either treatment or placebo group received 28 sachets for 14 days of the trial.|t|t|t|
1319561|NCT03341468|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319636|NCT03340493|Randomized|Parallel Assignment||Treatment||Single|Blinded core laboratory adjudication of the primary outcome. NIHSS and mRS (secondary outcomes) performed by blinded assessor.|Patients will receive either intravenous tenecteplase (0.4mg/kg, maximum 40mg, administered as a bolus over ~10 seconds) or intravenous tenecteplase (0.25mg/kg, maximum 25mg, administered as a bolus over ~10 seconds).||||t
1320895|NCT03324074|||Cohort||Cross-Sectional|||||||
1319562|NCT03341455|Randomized|Parallel Assignment||Prevention||Single|"Allocation of interventions cannot be concealed from either training staff or study participants once implementation occurs.~All data collectors will be blinded to the intervention status of preschools.~The study will be presented as a project related to family health and wellbeing, no specific study hypotheses will be presented to participants, and data collectors will not be involved in delivering the intervention. However, parents at preschools receiving the intervention will be aware of the training activities, and may still link the intervention to survey activities."|The study will be implemented using a randomised controlled trial design. Parents with children attending government-managed preschools in two study areas will be recruited to participate. Preschools will be randomly assigned to an intervention or control group. Preschool teachers in the intervention group will also be recruited to participate.|t|||
1319563|NCT03341442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319564|NCT03341429|Randomized|Parallel Assignment||Treatment||Quadruple|The investigator who will conduct the follow-up assessments and the trial subjects will be blinded to participants' allocation and will not be involved in delivering any of the intervention. The statistician conducting the data analysis will be blind to group allocation.|This study is a double-blind, randomised, placebo-controlled, two-arm, parallel group, single-site trial|t|t|t|t
1319565|NCT03341416|Randomized|Crossover Assignment||Treatment||Triple||"After surgery patients will undergo a first washout period intended to allow their ataxia return to baseline (preoperative levels), thus avoiding post surgery effects bias.~Phase 1: Participants will be randomized to either ON or OFF stimulation. The assigned stimulation will be performed for one week.~Phase 2: Open label phase. All patients are in the ON stimulation condition and will be followed for 6 months.~Duration:~Phase 1 will last from one to 2 months and phase 2 will last six months."|t|t||t
1319566|NCT03341403|Randomized|Single Group Assignment||Treatment||Quadruple|Only Phacobel which provide the pills will have the knowledge of the pills codes.|randomized double blind placebo control study|t|t|t|t
1319567|NCT03341390|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1319568|NCT03341377|||Cohort||Prospective|||||||
1319569|NCT03341364|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Recruitment of participants to the group intervention will start first. When a maximum of 10 participants have been recruited to the group intervention and/or one week before start of group intervention, recruitment to the Active Control group will start. The individual therapies will start at different times, depending on the flow of referrals.||||
1319570|NCT03341351|Randomized|Parallel Assignment||Health Services Research||Single|Outcome assessor performing the objective structured assessment of technical skills will be masked to the intervention of the participant.|||||t
1319571|NCT03341338|||Cohort||Prospective|||||||
1319572|NCT03341325|Randomized|Crossover Assignment||Treatment||Single|||t|||
1319573|NCT03341312|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1319574|NCT03341299|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1319575|NCT03341286|Randomized|Parallel Assignment||Supportive Care||Triple||Randomized, placebo-controlled|t|t|t|
1319576|NCT03341273|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1319577|NCT03341260|Randomized|Parallel Assignment||Prevention||Quadruple||"The patients will be randomly divided into 2 groups:~Experimental group:~50 mg Diclofenac Potassium to be administered one hour before treatment.~Control group:~Placebo to be administered one hour before treatment."|t|t|t|t
1319578|NCT03341247|||Other||Prospective|||||||
1319579|NCT03341234|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1319580|NCT03341221|||Case-Only||Cross-Sectional|||||||
1319581|NCT03341208|||Case-Only||Prospective|||||||
1319582|NCT03341195|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster randomized trial, four intervention arm and one control arm||||
1319583|NCT03341182|Randomized|Parallel Assignment||Supportive Care||Double|"The subjects were randomly assigned to normal method group (group A) and mirror use group (group B), and the assigned results are unknown.~The Outcomes Assessor is not related to the study, and does not know its contents."|normal method group (group A) mirror use group (group B)|t||t|
1319584|NCT03341169|Randomized|Parallel Assignment||Prevention||Quadruple||A Randomized, Double-Blinded, Placebo-Controlled Trial|t|t|t|t
1319585|NCT03341156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319586|NCT03341143||Single Group Assignment||Treatment||None (Open Label)||||||
1319587|NCT03341130|Randomized|Parallel Assignment||Supportive Care||Single|Analysis of primary outcomes will be performed by an examiner blinded to group allocation.|||||t
1319588|NCT03341117|Randomized|Single Group Assignment||Treatment||Double|"A randomized double blind, placebo controlled clinical trial was carried out in 21 drug naïve adults,regimen was prescribed to the subjects.~The allocation was 1:1 concealed and done by simple randomization using a table of random numbers. After randomization, 11 patients received of ASA 300 mg once daily and 10 patients received placebo (calcined magnesia) in the same pharmacological presentation for 90 days, the dose was based in the non-affectation of renal uric acid resorption."|A randomized double blind, placebo controlled clinical trial was carried out in 21 drug naïve adults (35-50 year of age) with DM2 with <5 years since diagnosis. They were overweight or obese (BMI 25.0 - 35.0 kg/m2), had glycosylated hemoglobin A1C (HbA1c) level between 6.5 - 9%. This protocol study was reviewed and approved by the hospital based ethics committee, and written informed consent was obtained from all volunteers. Subject was selected from the same residential area and socioeconomic status. No participants were excessively sedentary or participated in heavy physical activity. All individuals were nonsmokers. Their body weight was stable for al last 3 months before the study.|t||t|
1319589|NCT03341104|||Cohort||Retrospective|||||||
1319590|NCT03341091|Randomized|Parallel Assignment||Supportive Care||Single|An independent assessor who was blinded to group allocation assessed the participants' motor performance variables.|"A two-arm parallel (single-blinded) cluster randomised controlled trial involves two groups of participants (Tai-chi and the control group). Four community health centers that provide dementia care services were recruited through convenience sampling and each was viewed as one cluster and was randomised to either the Tai-chi or the control group, based on computer-generated random numbers. So during the trial, participants in one group receive Tai-chi group programme in parallel to participants in the other group, who took part in group recreational activities and continue their usual lifestyles and levels of physical activity."||||t
1319591|NCT03341078|Randomized|Parallel Assignment||Treatment||Double||Healthy controls will be recruited and have baseline evaluations for neuroinflammation and associated behaviors. Participants with methamphetamine-use disorder will also be recruited and enrolled in a placebo controlled portion of this study. Participants in the placebo controlled portion of this study will be dosed with either the study drug or a placebo twice daily for 6 weeks and will have pre/post evaluations for neuroinflammation and associated behaviors.|t||t|
1319592|NCT03341065|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1319593|NCT03341052|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1319594|NCT03341039|||Cohort||Prospective|||||||
1319595|NCT03341026|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319596|NCT03341013|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1319597|NCT03341000||Single Group Assignment||Device Feasibility||None (Open Label)||prospective, multi-center, open-label, feasibility study||||
1319598|NCT03340987|Randomized|Parallel Assignment||Treatment||Double||||t||t
1319599|NCT03340974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319600|NCT03340961|Randomized|Parallel Assignment||Treatment||Quadruple|"Each subject will be allocated to one of the following treatment groups, receiving 1 capsule once daily in the morning for 16 weeks:~DFD-29 Extended Release Capsules (40 mg)~DFD-29 Extended Release Capsules (20 mg)~Doxycycline Modified Release Hard Capsules (40 mg)~Placebo Capsules"|A Multi-Center, Randomized, Double-Blind, Parallel-Group, Controlled Study|t|t|t|t
1319601|NCT03340948||Single Group Assignment||Supportive Care||None (Open Label)||Pilot and feasibility study of one cohort.||||
1319602|NCT03340935||Single Group Assignment||Treatment||None (Open Label)||||||
1319603|NCT03340922|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective, randomized, controlled and international multicenter study. All patients who fulfill the inclusion criteria will be consecutively enrolled and randomized on a 1:1 basis to each of the LAT annotation systems (WF vs. M-method) before the ablation procedure. Ablation will be directed to the earliest activation site identified with the assigned annotation system. Any change of the assigned annotation system during the procedure won't be allowed, thus being a reason for justifying study exclusion.||||
1319604|NCT03340909|Randomized|Parallel Assignment||Treatment||Quadruple||Placebo-controlled randomized 1:1 comparison.|t|t|t|t
1319605|NCT03340896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319606|NCT03340883||Single Group Assignment||Treatment||None (Open Label)||Single arm study||||
1319607|NCT03340870|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319608|NCT03340857||Single Group Assignment||Other||None (Open Label)||||||
1319609|NCT03340844|Randomized|Parallel Assignment||Other||None (Open Label)||"Prospective, randomized (1:1) to 2 study groups according to duodenopancreatectomy surgical approach: No-Touch group (NT) or Artery First group (SMA) in patients with pancreatic and periampullary tumors, to evaluated circulating tumor cells (CTCs) levels during the surgery."||||
1319610|NCT03340831|||Cohort||Prospective|||||||
1319611|NCT03340818|Randomized|Parallel Assignment||Treatment||Double|Participant and PA providing follow up care and assessing data from ODI, VAS etc will be blinded. Physician performing procedure will not be blinded.|Randomized, double-blind placebo controlled|t|||t
1319612|NCT03340805|Randomized|Parallel Assignment||Other||None (Open Label)|Study participants, care provider, investigator, and outcomes assessor will not be masked to intervention allocation.|Single-center, open-label, randomized pragmatic clinical trial||||
1319613|NCT03340792||Single Group Assignment||Supportive Care||None (Open Label)||||||
1319614|NCT03340779|Randomized|Crossover Assignment||Treatment||None (Open Label)||3 first hours : strategy 1, norepinephrine alone with increased dose or norepinephrine + dobutamine 0.5 hour : wash-out (decrease of norepinephrine dose or weaning of dobutamine) 3 last hours : strategy 2, crossover, norepinephrine alone with increased dose or norepinephrine + dobutamine||||
1319615|NCT03340766|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1319616|NCT03340753|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1319617|NCT03340740|Randomized|Parallel Assignment||Treatment||Quadruple|The medication and placebo doses will be prepared in the pharmacy at the study site and provided to the investigators in deidentified bottles.||t|t|t|t
1319618|NCT03340727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319619|NCT03340714||Single Group Assignment||Supportive Care||None (Open Label)||||||
1319620|NCT03340701||Single Group Assignment||Other||None (Open Label)||Pharmacokinetic study to assess plasma concentration time profile of vaginal progesterone in pregnant women.||||
1319621|NCT03340688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319622|NCT03340675|Randomized|Parallel Assignment||Treatment||Quadruple|Each individual bottle is labelled with a unique numeric code that identifies the contents to the unblinded sponsor representative.|Randomized, placebo-controlled, double-blind, dose-ranging|t|t|t|t
1319623|NCT03340662|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1319624|NCT03340649|||Case-Only||Prospective|||||||
1319625|NCT03340636|||Cohort||Prospective|||||||
1319626|NCT03340623|||Cohort||Retrospective|||||||
1319627|NCT03340610||Single Group Assignment||Treatment||None (Open Label)||||||
1319628|NCT03340597|Randomized|Sequential Assignment||Other||None (Open Label)||||||
1319629|NCT03340584|Randomized|Parallel Assignment||Treatment||Single||||||t
1319630|NCT03340571|||Cohort||Prospective|||||||
1319631|NCT03340558|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1319632|NCT03340545|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1319633|NCT03340532|Randomized|Parallel Assignment||Other||None (Open Label)||Participants are randomized to view one of two SunSmart educational videos or a control video on sleep hygiene. In the three months following the video intervention, participants' sun protection attitudes and behaviors are assessed. An additional measure of sun protection behaviors 12-months later will be provided by participants who participate in the optional 1-year follow-up.||||
1319634|NCT03340519|||Case-Control||Prospective|||||||
1319635|NCT03340506||Single Group Assignment||Treatment||None (Open Label)||||||
1319637|NCT03340480|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1319638|NCT03340467||Single Group Assignment||Other||None (Open Label)||||||
1319639|NCT03340454|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319640|NCT03340441|||Cohort||Prospective|||||||
1319641|NCT03340428|Randomized|Parallel Assignment||Health Services Research||Double|Intervention arm will be masked to the field researchers and the investigators until unblinding during final analysis.|Individually randomized trial with 2:1 allocation to the intervention compared to care as usual|||t|t
1319642|NCT03340415|Randomized|Parallel Assignment||Treatment||Single|Surgeon blinded||||t|
1319643|NCT03340402||Single Group Assignment||Treatment||None (Open Label)||||||
1319644|NCT03340389||Single Group Assignment||Screening||None (Open Label)||||||
1319645|NCT03340376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319646|NCT03340363|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319647|NCT03340350||Single Group Assignment||Treatment||None (Open Label)||||||
1319648|NCT03340337|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1319649|NCT03340324||Single Group Assignment||Treatment||None (Open Label)|no masking|open-label, single arm study||||
1319650|NCT03340311||Sequential Assignment||Other||None (Open Label)||Quasi-experimental pre-post design||||
1319651|NCT03340298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319652|NCT03340285|Randomized|Parallel Assignment||Prevention||Single||||||t
1319653|NCT03340272|||Cohort||Prospective|||||||
1319654|NCT03340259|||Case-Only||Prospective|||||||
1319655|NCT03340246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319656|NCT03340233|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1319657|NCT03340220|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1319658|NCT03340207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319659|NCT03340194|||Case-Only||Prospective|||||||
1319660|NCT03340181|Randomized|Parallel Assignment||Other||Single|||t|||
1319661|NCT03340168|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1319662|NCT03340155||Single Group Assignment||Other||None (Open Label)||Biomarker search;||||
1319663|NCT03340142||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319664|NCT03340129|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||All patients will receive ipilimumab and nivolumab for 12 weeks, followed by nivolumab monotherapy until disease progression, toxicities or death Between 6 and 12 weeks on systemic treatment, patients with RECIST determined intracranial disease progression will receive either stereotactic radiotherapy (for 5 or few progressing brain metastases) or whole brain radiotherapy (for 6 or more progressing brain metastases)||||
1319665|NCT03340116|||Case-Control||Prospective|||||||
1319666|NCT03340103|Randomized|Parallel Assignment||Prevention||Triple|Pilot study, non-commercial, with food supplement, treated vs. control with a ratio 1: 1 double-blind. The identical vials, corresponding to placebo and active product, have an alphanumeric code without meaning for the operator, but that identifies the treaties from controls, in an anonymous document kept by the Statistical. The document will be placed in a sealed and anonymous envelope and it will be kept open by the statistician at the time of data analysis.|"Since birth, premature newborns, that are comply with the inclusion parameters, will be introduced and separated in two random groups (A and B).~All newborns, during the observation period, will be submitted to the blood collection (1 ml) from the umbilical cord and peripheral site (at the same time with the routine collections) on which there will be performed blood gas analysis and oxidative stress markers (TH and BAP)"|t|t|t|
1319667|NCT03340090|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two randomized groups of 100 patients will undergo standard CABG procedure in Cardio-Pulmonary Bypass (CPB). In first group (100 patients) two pieces of Hemopatch will be applied in one patient. Second group is the control group without above described intervention.||||
1319668|NCT03340077|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319669|NCT03340064||Single Group Assignment||Treatment||None (Open Label)||||||
1319670|NCT03340051|Randomized|Parallel Assignment||Treatment||Single|||t|||
1319671|NCT03340038|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319672|NCT03340025|Randomized|Parallel Assignment||Treatment||Single||||||t
1319673|NCT03340012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319674|NCT03339999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319675|NCT03339986|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319676|NCT03339973|Randomized|Parallel Assignment||Treatment||Double||Randomized, placebo-controlled, double-blind, interventional, multicenter, phase I/IIa clinical trial|t||t|
1319677|NCT03339960|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319678|NCT03339947|||Other||Cross-Sectional|||||||
1319679|NCT03339921|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319680|NCT03339908||Single Group Assignment||Treatment||None (Open Label)||||||
1319681|NCT03339895|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1319682|NCT03339882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319683|NCT03339869||Single Group Assignment||Other||None (Open Label)||patient hospitalized in intensive care unit||||
1319684|NCT03339856||Single Group Assignment||Treatment||None (Open Label)||||||
1319685|NCT03339843||Sequential Assignment||Treatment||None (Open Label)||This is a two step, open-label, basket trial looking at 5 different tumour types.||||
1319686|NCT03339830|||Cohort||Prospective|||||||
1319687|NCT03339817||Single Group Assignment||Other||None (Open Label)||||||
1319688|NCT03339804||Single Group Assignment||Basic Science||None (Open Label)||||||
1319689|NCT03339791|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1319690|NCT03339778|||Cohort||Prospective|||||||
1319691|NCT03339765|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319692|NCT03339752|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1573439|NCT00001217||||Treatment||||||||
1319693|NCT03339739|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1319694|NCT03339726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319695|NCT03339713|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1319696|NCT03339700||Single Group Assignment||Treatment||None (Open Label)||||||
1319697|NCT03339687|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319698|NCT03339674|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319699|NCT03339661|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1319700|NCT03339648|Randomized|Sequential Assignment||Prevention||None (Open Label)|All participants and study staff will be aware of which schools are in each arm.|During the measurement period, the experimental arm will receive the intervention while the control arm continues business as usual. After all data collection, the control arm will receive the intervention.||||
1319701|NCT03339635|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1319702|NCT03339622|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1319703|NCT03339609|||Case-Control||Cross-Sectional|||||||
1319704|NCT03339596|Randomized|Parallel Assignment||Treatment||Single||||||t
1319705|NCT03339583|Randomized|Crossover Assignment||Treatment||None (Open Label)||"Study design implied that every patient underwent two different treatment courses in random sequence: hypnotic or structured educational program (BBT-I) delivered in two sessions.~Subjects were randomly assigned to one of treatment sequences by card sorting method. Patients of the zopiclone-first group underwent the medication therapy for the first two weeks followed by educational program. Patients of the BBT-I-first group received two-week educational program followed by medication therapy.~Each treatment course was separated by 2-weeks washout period that provided the opportunity to evaluate the sustainability of treatment effect.~Before and after each treatment course and after each washout period subjects completed set of questionnaires."||||
1319706|NCT03339570|||Cohort||Prospective|||||||
1319707|NCT03339557|Randomized|Parallel Assignment||Treatment||Triple|Patients will be operated upon using the implant allocated in randomization. Participants are blinded to the implant design used for their operation. Staff at the ward is also blinded. And the physiotherapists conducting the follow-up visits (at 2-3 months, 1 year and 2 years, i.e. the outcome assessors) are also blinded to the allocation.|Patients will be recruited from Coxa outpatient clinic according to inclusion and exclusion criteria. The participating orthopedic surgeons will recruit patients along their out-patient work. The indications for the surgical treatment in the study will follow the routine clinical guidelines of the hospital. When TKR surgery is decided, the eligible patients will be informed and those willing to participate will be randomized into one of the three implant groups.|t|t||t
1319708|NCT03339544|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319709|NCT03339531||Single Group Assignment||Treatment||None (Open Label)||||||
1319710|NCT03339518|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1319711|NCT03339505|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded until the end of the trial. Unmasking will take place once all patients are included and the trial is concluded.|Randomized, double blinded and prospective.|t|t|t|t
1319712|NCT03339492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319713|NCT03339479|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||self-control method||||
1319714|NCT03339466||Single Group Assignment||Treatment||None (Open Label)||||||
1319715|NCT03339453|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1319716|NCT03339440|Randomized|Crossover Assignment||Treatment||None (Open Label)||The investigators will use a two-arm, randomized crossover controlled trial to compare routine primary care management of childhood obesity versus a novel clinic/family/community partnership program to treat childhood obesity. This design will allow for a randomized comparison of Group 1 (6-month standard control) to Group 2 (immediate 6-month intervention program) and to Group 3 (delayed crossover intervention on the standard control group). The design will also allow the investigators to observe intervention effects at 3 months in both intervention groups (Groups 2 and 3), and to track Group 2 for 6 additional months after active intervention to assess whether health benefits seen at 6 months were sustained to 12 months.||||
1319717|NCT03339427|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319718|NCT03339414|||Cohort||Prospective|||||||
1319719|NCT03339401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319720|NCT03339388||||||||||||
1319721|NCT03339375|||Case-Control||Prospective|||||||
1319722|NCT03339362|Randomized|Parallel Assignment||Other||Double||Patients with persistent low back pain, referred to a community or hospital-based pain clinic by their general practitioner, will be reviewed and assessed by a pain physiotherapist and pain physician. They will be screened and recruited based on clinical history and examination. Participants will receive diagnostic injections (medial branch nerve blocks); those with a positive response will randomly receive either steroid FJIs or a sham procedure, under x-ray guidance.|t|||t
1319723|NCT03339349||Single Group Assignment||Other||None (Open Label)||||||
1319724|NCT03339336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319725|NCT03339323|Non-Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1319726|NCT03339310||Single Group Assignment||Treatment||None (Open Label)||Optimizer Smart System||||
1319727|NCT03339297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319728|NCT03339284|Randomized|Parallel Assignment||Treatment||Quadruple|Patients are randomized and allocated in blocks of nine to either placebo or QLB with dexamethasone or QLB without dexamethasone group||t|t|t|t
1319729|NCT03339271|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319730|NCT03339258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319731|NCT03339245|Randomized|Crossover Assignment||Basic Science||Double|Double blind||t||t|
1319732|NCT03339232|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants are randomized into one of three arms||||
1319733|NCT03339219||Single Group Assignment||Treatment||None (Open Label)||||||
1319734|NCT03339206|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319735|NCT03339193|||Cohort||Prospective|||||||
1319736|NCT03339180|||Cohort||Prospective|||||||
1319737|NCT03339167||Single Group Assignment||Other||None (Open Label)||Each subject will randomly receive 3 levels of lysine provided as free amino acids, millet, or millet combined with lentils for a total of 8 studies x 3 days per study.||||
1319738|NCT03339154||Single Group Assignment||Other||None (Open Label)||Each subject will randomly receive 4 levels of methionine provided as free amino acids, chickpeas, or chickpeas combined with rice for a total of 10 studies x 3 days per study.||||
1319739|NCT03339141|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|||||
1319740|NCT03339128|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1319741|NCT03339115||Single Group Assignment||Treatment||None (Open Label)||||||
1319742|NCT03339102|||Cohort||Prospective|||||||
1319743|NCT03339089|||Cohort||Prospective|||||||
1319744|NCT03339076||Single Group Assignment||Treatment||None (Open Label)||"This single arm prospective study is designed to produce valid scientific evidence regarding safety and efficacy of the M3 in establishing urinary drainage and allowing the control of micturition when indwelling for <28 days in male patients. The total study population will initially include 50 subjects with open enrollment of additional subjects.~1. Study Timeline and Calendar~The maximum indwelling time for the DEVICE should be <28 days, at which time the DEVICE will be removed, and the patient will be offered the option of insertion of a new M3 Catheter or return to the bladder drainage technique used prior to M3 Catheter insertion. All patients will be followed until patient is off study or until end of study, whichever occurs first."||||
1319745|NCT03339063|||Cohort||Prospective|||||||
1319746|NCT03339050||Single Group Assignment||Prevention||None (Open Label)||Health for Hearts United is a longitudinal church-based intervention to reduce cardiovascular disease (CVD) risk in mid-life and older African Americans. Using community-based participatory research (CBPR) approaches and undergirded by both the Transtheoretical Model of Behavior Change and Socio-ecological theory, the 18-month intervention was developed in six North Florida churches (three treatment, three comparison).||||
1319747|NCT03339037|Randomized|Crossover Assignment||Treatment||Quadruple|randomization by computer, sham/ treatment will be known to chamber technicians and nurses but not to investigators|randomized controlled trial using a SHAM treatment compared to treatment|t|t|t|t
1319748|NCT03339024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319749|NCT03339011|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1319750|NCT03338998|Randomized|Parallel Assignment||Treatment||Triple|Subject- and investigator-blinded|This is a randomized, patient- and investigator-blinded, placebo-controlled, parallel group study of BAF312 on top of standard-of-care for ICH, consisting of 3 epochs: Screening/Baseline, Treatment (Day 1-14), and Follow-Up (to Day 90)|t||t|t
1319751|NCT03338985||Single Group Assignment||Basic Science||None (Open Label)||||||
1319752|NCT03338972||Single Group Assignment||Treatment||None (Open Label)||||||
1319753|NCT03338959||Single Group Assignment||Treatment||None (Open Label)||||||
1319754|NCT03338946|||Cohort||Prospective|||||||
1319755|NCT03338933|||Case-Control||Prospective|||||||
1319756|NCT03338920|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1319757|NCT03338907|Randomized|Crossover Assignment||Treatment||Single|The sequence whether the IMP or the comparator is applied first will be randomly assigned using the web-based randomizer.|Controlled, randomized, single blind, crossover|t|||
1319758|NCT03338894||Single Group Assignment||Supportive Care||None (Open Label)||||||
1319759|NCT03338881||Single Group Assignment||Other||None (Open Label)||||||
1319760|NCT03338868|||Case-Control||Prospective|||||||
1319761|NCT03338855|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1319762|NCT03338842||Single Group Assignment||Treatment||None (Open Label)||In the first phase (A), subjects will receive the Distraction VR treatment during 5, 6, or 7 one-hour-long sessions occurring twice weekly. After the A phase, the remaining sessions (B phase) will consist of Lower-Limb VR treatment. This number includes a mean of 6 (range 5-7) phase A sessions and mean of 11 (range 10-12) phase B sessions.||||
1319763|NCT03338829|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319764|NCT03338816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319765|NCT03338803|||Cohort||Retrospective|||||||
1319766|NCT03338790|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319767|NCT03338777||Single Group Assignment||Treatment||None (Open Label)||Suicide plus immunogene therapy||||
1319768|NCT03338764|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319769|NCT03338751|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1319770|NCT03338738||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319771|NCT03338725|Randomized|Sequential Assignment||Health Services Research||Single||Cluster Randomized Trials and The Stepped Wedge (Cluster Analysis Mesh Terms)||||t
1319772|NCT03338712|||Cohort||Prospective|||||||
1319773|NCT03338699|Randomized|Parallel Assignment||Prevention||None (Open Label)||In the pilot phase of the study, participating infants will be allocated to circumcision with either the ShangRing or Mogen clamp. Infants will be randomized in a 1:1 fashion.||||
1319774|NCT03338686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319775|NCT03338673|Randomized|Crossover Assignment||Other||None (Open Label)||Participants will be randomized to receive either dual therapy (cognitive exercises plus brain stimulation) or monotherapy (cognitive exercises alone) first; after 3 weeks participants will switch to the other condition||||
1319776|NCT03338660|Randomized|Crossover Assignment||Treatment||Double|the assesor of platelet function and the PI will be blinded to group.|crossover study of various storage infusions techniques with each subject receiving various fluids aliquots.|||t|t
1319777|NCT03338647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319778|NCT03338634|||Case-Only||Prospective|||||||
1319779|NCT03338621|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 2c multi-center, open-label, partially randomized clinical trial in DS-TB and DR-TB participants||||
1319780|NCT03338608|Randomized|Parallel Assignment||Treatment||None (Open Label)||There are two groups. One group will have the vertical platysma incision and the other group will have the transverse incision.||||
1319781|NCT03338595|||Cohort||Prospective|||||||
1319782|NCT03338582|||Cohort||Prospective|||||||
1319783|NCT03338569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319784|NCT03338556|Randomized|Parallel Assignment||Prevention||Quadruple|Double blind||t|t|t|t
1319785|NCT03338543|Randomized|Parallel Assignment||Treatment||Quadruple|Participant is allocated randomly by staff A, and grouping situation is concealed; Technician (stuff B) or chargeing docotor operates PENS or TENS, or administers oral analgesic medication; Related datas are collected according to perdetermined forms by stuff C; Outcomes are assessed by stuff D.|patients with liver cancer pain.|t|t|t|t
1319786|NCT03338530|Randomized|Parallel Assignment||Treatment||Single|Child testing and behavioral observations were completed by evaluators blinded to treatment condition; evaluators consisted of advanced graduate students with training in the specific outcome measures|The efficacy of the comprehensive school-based intervention (CSBI) was evaluated in a cluster randomized trial (pretest-posttest control group design). School buildings were randomly assigned to receive the CSBI or their typical educational programming. The CSBI was examined for its effect on the social performance/competence, ASD symptoms, and academic skills of children with HFASD compared to children with HFASD that did not receive the intervention. School staff delivered the multi-component intervention during the school year and research staff monitored intervention implementation (fidelity).||||t
1319787|NCT03338517|Randomized|Parallel Assignment||Treatment||Double|Group (I) who received medical treatment with Helium-Neon Laser therapy (HNLT), (ASA Medical laser device (manufactured by ASA Terza- Via Alessandro, Italy) and Group (II) who received medical treatment with Infrared Laser therapy (ILT), (PHYACTION 792/796 manufactured in The Netherlands by Uniphy BV). The nature of the therapy was described and explained to the patient.||t|||t
1319788|NCT03338504|||Cohort||Prospective|||||||
1319789|NCT03338491|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319790|NCT03338478|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1319791|NCT03338465|Randomized|Parallel Assignment||Treatment||Triple|The participants will be blinded to the type of ESWT treatment and the assessor, data managers, statistician and study monitors will be blinded to the allocation. All participants who receive ESWT treatment will be treated using the same device (Duolith SD1, STORZ Medical, Switzerland) regardless of what group they are included in. The participants will not be able to predict the allocated group based on the appearance of the ESWT treatment. The blinding will be maintained until the data are locked. For blinding evaluation, allocation guessing will be assessed immediately after the final treatment. Practitioners and assessors will be instructed to treat the participants according to predefined standard operating procedures during the trial to maintain blinding.||t||t|t
1319792|NCT03338452||Single Group Assignment||Treatment||None (Open Label)||"Longitudinal intervention study with repeated measurements. Participants will be subjected to a 12-week low energy ketogenic diet (LEKD) and requested not to change their physical activity levels throughout the study.~The participants will underwent a series of tests and consultations at baseline (prior to the start of the intervention), and after 1, 2, 4, 8 , and 12 weeks of LEKD intervention. At the end of each time points, body weight and composition will be measured in the fasting state, food and exercise diaries checked by a dietitian and a kinesiologist and discussed with the participants, psychological and cognitive tests will be performed by a psychologist. At the same time-points, different serum analyses will be performed."||||
1319793|NCT03338439|||Cohort||Retrospective|||||||
1319794|NCT03338426|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1319795|NCT03338413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319796|NCT03338400|Randomized|Parallel Assignment||Treatment||Single|||t|||
1319797|NCT03338387|Randomized|Parallel Assignment||Treatment||Single|||t|||
1319798|NCT03338374||Single Group Assignment||Treatment||None (Open Label)||Exploratory single-centre, open label, non-randomised, prospective cohort study||||
1319799|NCT03338361|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1319800|NCT03338348||Single Group Assignment||Treatment||None (Open Label)||||||
1319801|NCT03338335|||Other||Other|||||||
1319802|NCT03338322|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1319803|NCT03338309|||Case-Only||Prospective|||||||
1319804|NCT03338296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319805|NCT03338283|Randomized|Parallel Assignment||Treatment||Single|||||t|
1319806|NCT03338270|||Case-Control||Prospective|||||||
1319807|NCT03338257|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The evaluation follows a pre-test/post-test control group design with children nested within classrooms at center and school-based early care programs located in low-income communities or areas with high SNAP eligibility rates||||
1319808|NCT03338244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319809|NCT03338231|||Other||Retrospective|||||||
1319810|NCT03338218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319811|NCT03338205||Single Group Assignment||Treatment||None (Open Label)||Pilot study||||
1319812|NCT03338192|||Case-Control||Prospective|||||||
1319813|NCT03338179|Randomized|Parallel Assignment||Basic Science||None (Open Label)|no masking|||||
1319814|NCT03338166|||Cohort||Prospective|||||||
1319815|NCT03338153|||Cohort||Prospective|||||||
1319816|NCT03338140|||Cohort||Prospective|||||||
1319817|NCT03338127|||Case-Only||Retrospective|||||||
1319818|NCT03338114||Single Group Assignment||Treatment||None (Open Label)||||||
1319819|NCT03338101|||Ecologic or Community||Retrospective|||||||
1319820|NCT03338088|||Ecologic or Community||Other|||||||
1319821|NCT03338075|||Cohort||Retrospective|||||||
1319822|NCT03338062||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319823|NCT03338049||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319824|NCT03338036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will include two intervention arms and two control arms. The intervention arms will include 1) heart rate variability biofeedback, 2) a combination of heart rate variability biofeedback and neurofeedback. The control arms will be 1) age-matched post-concussive individuals and 2) age-matched individuals who have not been diagnosed with a concussion in the last two years.||||
1319825|NCT03338023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573440|NCT00001216||||||||||||
1319826|NCT03338010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319827|NCT03337997||Single Group Assignment||Treatment||None (Open Label)|CT scans and PET scans will be read by two radiologists and concensus obtained. The two radiologists will be unaware of prior chemo, patient age, original tumor size.|Patients with biopsy-proven adenocarcinoma of the head of the pancreas deemed to be resectable by a multi-disciplinary team will be invited to participate.||||
1319828|NCT03337984|||Case-Only||Other|||||||
1319829|NCT03337971|Randomized|Crossover Assignment||Basic Science||Single|Single blind (participant only)|A block randomised, cross-over design receiving either a milk-based protein supplement (MBPS) or isoenergetic (corn starch) placebo control (PLACEBO).|t|||
1319830|NCT03337958|Randomized|Parallel Assignment||Supportive Care||Single||A randomized clinical trial.|t|||
1319831|NCT03337945||Single Group Assignment||Other||None (Open Label)||A single center, single dose, open label, single period study to characterize CYP isoforms by the use of the Basel Phenotyping cocktail in patients at different stages of liver cirrhosis||||
1319832|NCT03337932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319833|NCT03337919||Single Group Assignment||Treatment||None (Open Label)||This is a single-arm, phase II, multi-centre study. It will use an Ahern single stage design with independent trials steering committee review to monitor for safety and efficacy.||||
1319834|NCT03337906|||Cohort||Prospective|||||||
1319835|NCT03337893|||Cohort||Prospective|||||||
1319836|NCT03337880|||Case-Control||Prospective|||||||
1319837|NCT03337867|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1319838|NCT03337854|||Case-Only||Retrospective|||||||
1319839|NCT03337841||Single Group Assignment||Prevention||None (Open Label)||||||
1319840|NCT03337828|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1319841|NCT03337815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319842|NCT03337802|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319843|NCT03337789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319844|NCT03337776|Randomized|Parallel Assignment||Other||Single|||t|||
1319845|NCT03337763|||Cohort||Prospective|||||||
1319846|NCT03337750||Single Group Assignment||Treatment||None (Open Label)||||||
1319847|NCT03337737|Randomized|Crossover Assignment||Other||Single|||t|||
1319848|NCT03337724|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1319849|NCT03337711|||Cohort||Prospective|||||||
1319850|NCT03337698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319851|NCT03337672|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1319852|NCT03337659|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1319853|NCT03337646||Single Group Assignment||Treatment||None (Open Label)||Multi-Center Open Label||||
1319854|NCT03337633|Randomized|Parallel Assignment||Other||Single|Participants were blinded to treatment allocation.|Parallel arm randomized controlled trial|t|||
1319855|NCT03337620|Randomized|Parallel Assignment||Treatment||Quadruple|The subject, investigator, study coordinator, and additional study staff will remain blinded. One member of the staff will assign subjects to a treatment group based on a computerized randomization number produced by a computer software system. The number will correspond to a kit number, of which the staff member will then use to prepare the Tx360® device for each of the subject's treatments during the 4-week treatment phase. If the clinical site has a pharmacy, it is preferred that the pharmacy receive the study medication and Tx360® devices, maintain custody of the study medication and Tx360® devices during the study, and prepared the medication in Tx360® devices for each subject's treatment, according to the computer-generated randomization. In order to maintain subject-blinding during the active phase of the study, subjects will be given a piece of lemon candy prior to each procedure as a taste distractor|multi-center, double blind, parallel, prospective, randomized; 28 days of screening; 4 weeks active treatment; 3 months of follow-up post-treatment|t|t|t|t
1319856|NCT03337607|Randomized|Parallel Assignment||Treatment||Single|"A medical assistant at the Department of Pain Medicine at the First Affiliated Hospital of Zhejiang University will allocate interventions by means of opaque sealed envelopes that will be marked according to the allocation schedule. The medical assistant will be unaware of the size of the blocks.~The randomized intervention assignment as outlined above will be concealed from both patients and health care staff until recruitment will be complete and irrevocable.~Neither patients nor therapists will be blinded in the proposed study. The therapist will be the person who will administer rEWST to the patient.~The assessor will be blinded in the proposed study. The assessor is the person who will assess treatment success during follow up."|||||t
1319857|NCT03337594|||Cohort||Prospective|||||||
1319858|NCT03337581|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1319859|NCT03337568|||Case-Only||Prospective|||||||
1319860|NCT03337555|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319861|NCT03337542||Single Group Assignment||Treatment||None (Open Label)||||||
1319862|NCT03337529|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1319863|NCT03337516||Single Group Assignment||Other||None (Open Label)||||||
1319864|NCT03337503|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1319865|NCT03337490|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319866|NCT03337477|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1319867|NCT03337464|Non-Randomized|Parallel Assignment||Treatment||Single|The assessor will be blinded to subject group and intervention.|1 PD group and 1 one age matched non-PD subjects||||t
1319868|NCT03337451||Single Group Assignment||Treatment||None (Open Label)||||||
1319869|NCT03337438|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1319870|NCT03337425|Randomized|Crossover Assignment||Treatment||None (Open Label)||a Norwegian multicenter study||||
1319871|NCT03337412|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||uncontrolled, non-randomized, open-plan, multi-centre study||||
1319872|NCT03337399|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319873|NCT03337386|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1319874|NCT03337373||Single Group Assignment||Basic Science||None (Open Label)||||||
1319875|NCT03337360|Randomized|Parallel Assignment||Treatment||Triple||Multicentre, randomised double blind placebo controlled clinical trial/superiority study.|t|t|t|
1319876|NCT03337347||Single Group Assignment||Diagnostic||None (Open Label)||||||
1319877|NCT03337334|Randomized|Parallel Assignment||Basic Science||Single||||||t
1319878|NCT03337321|||Cohort||Cross-Sectional|||||||
1319879|NCT03337308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319880|NCT03337295|||Case-Crossover||Retrospective|||||||
1319881|NCT03337282|||Cohort||Prospective|||||||
1319882|NCT03337269|Randomized|Single Group Assignment||Prevention||Single|||t|||
1319883|NCT03337256||Single Group Assignment||Diagnostic||None (Open Label)||Early endoscopy in emergency department + other clinical parameters||||
1319884|NCT03337243|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319885|NCT03337230||Single Group Assignment||Prevention||None (Open Label)||pre-post study design||||
1319886|NCT03337217|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319887|NCT03337204|Randomized|Parallel Assignment||Prevention||Single|||t|||
1319888|NCT03337191|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1319889|NCT03337178|Randomized|Parallel Assignment||Other||Single||||t||
1319890|NCT03337165||Single Group Assignment||Treatment||None (Open Label)||||||
1319891|NCT03337152|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized into one of two arms. 1a will receive primaquine for 14 days, and Arm 1b will receive chloroquine for 3 days and concomitant primaquine for 14 days.||||
1319892|NCT03337139|Randomized|Parallel Assignment||Treatment||Single||||||t
1319893|NCT03337126|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized, Open-Label, Single Dose, Two Sequence, Crossover||||
1319894|NCT03337113|Randomized|Factorial Assignment||Treatment||Single|The participant will be prevented from having knowledge of the interventions assigned.|A 2x2 factorial model will include four groups (Working Memory Training [WMT] + repetitive Transcranial Magnetic Stimulation ]rTMS], sham WMT+rTMS, WMT+sham TMS, and sham WMT+sham rTMS) capable of isolating independent and combined effects of WMT and rTMS on the primary outcome variables.|t|||
1319895|NCT03337100|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1319896|NCT03337087||Single Group Assignment||Treatment||None (Open Label)||||||
1319897|NCT03337074|||Case-Control||Prospective|||||||
1319898|NCT03337061|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319899|NCT03337048||Single Group Assignment||Basic Science||None (Open Label)||||||
1319900|NCT03337035|Randomized|Crossover Assignment||Treatment||Double|this study will be double blinded for both participants/guardians and medication administrator|Phase 1: a. oral Vitamin C as placebo, and b. oral probiotics; Phase 2: a. intranasal OXT + oral Vitamin C placebo, and b. intranasal OXT + oral probiotics|t|t||
1319901|NCT03337022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319902|NCT03337009|Randomized|Parallel Assignment||Prevention||Single|||||t|
1319903|NCT03336996|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1319904|NCT03336983|Randomized|Parallel Assignment||Treatment||None (Open Label)||prostate cancer patients with hormone sensitive metastatic bone disease||||
1319905|NCT03336970|Randomized|Parallel Assignment||Treatment||Single||||||t
1319906|NCT03336957|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1319907|NCT03336944||||||||||||
1319908|NCT03336931|||Cohort||Prospective|||||||
1319909|NCT03336918|||Other||Prospective|||||||
1319910|NCT03336905||Single Group Assignment||Prevention||None (Open Label)||||||
1319911|NCT03336892|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1319912|NCT03336879||Single Group Assignment||Treatment||None (Open Label)||non-randomized, open label study||||
1319913|NCT03336866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319914|NCT03336853|Randomized|Parallel Assignment||Treatment||Single||single center, participants and data analyst blind, two-arm, randomized, placebo controlled clinical trial study|t|||
1319915|NCT03336840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319916|NCT03336827|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||This is a two-armed, randomized, waiting-list controlled trial. Patients who agree to participate in the study will be randomly assigned to two groups: 1) the experimental group (EG) where six patients will receive one individual pre-group session and 8 sessions of group intervention combining cognitive-behavioral therapy and hypnosis; and 2) the waiting-list control group (CG) where six patients will receive the same intervention 4 months later. Patients will be assessed at three time points: 1) at baseline (T1), 2) 4 months later (T2), that means just after the intervention for the experimental group (EG) and just before the intervention for the control group (CG), and 3) 4 months later (T3), that means 4 months after the T2 for the experimental group and just after the intervention for the control group (CG).||||
1319917|NCT03336814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319918|NCT03336801|Randomized|Parallel Assignment||Prevention||Single||Patients are randomized into one of two treatment groups which during surgery receives one of two different anesthetic agents. The two groups are then compared to each other.|||t|
1319919|NCT03336788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319920|NCT03336775|Randomized|Parallel Assignment||Supportive Care||Single|Outcomes, inclduing VDS, rosenbek Penetration-Aspiration Scale scores, opening of upper esophageal sphincter(UES) and excursion of hyoid bone would be evaluated by two radiologists with blind method.|||||t
1319921|NCT03336762|||Cohort||Prospective|||||||
1319922|NCT03336749|Randomized|Parallel Assignment||Treatment||Single|The assessors are blinded to the participants' group allocation.|Participants are assigned to one of two or more groups in parallel for the duration of the study||||t
1319923|NCT03336736|||Cohort||Prospective|||||||
1319924|NCT03336723|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1319925|NCT03336710|||Cohort||Prospective|||||||
1319926|NCT03336697|||Case-Control||Cross-Sectional|||||||
1319983|NCT03335956|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1319927|NCT03336684|Randomized|Parallel Assignment||Health Services Research||Single|The investigator will be blinded from randomization and recruitment process.||||t|
1319928|NCT03336671|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective Randomized Controlled Trial||||
1319929|NCT03336658|||Cohort||Prospective|||||||
1319930|NCT03336645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1319931|NCT03336632||Single Group Assignment||Treatment||None (Open Label)||||||
1319932|NCT03336619|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319933|NCT03336606|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be stratified by tumor type and randomly assigned to a MEDI0562 administration schedule; initially 5 patients will enroll to each of two cohorts.||||
1319934|NCT03336593|Randomized|Parallel Assignment||Prevention||Double|The study for subjects 9-40 years of age is randomized, double blind study. While the study for subjects 6 months-8 years of age is open labeled study.|Subjects 9- 40 years of age: Experimental, randomized, double blind bridging study Subjects 6 months - 8 years of age: Experimental, open labeled bridging study|t||t|
1319935|NCT03336580||Single Group Assignment||Treatment||None (Open Label)||Dose Escalation Study||||
1319936|NCT03336567|||Cohort||Cross-Sectional|||||||
1319937|NCT03336554|||Cohort||Prospective|||||||
1319938|NCT03336541|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1319939|NCT03336528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319940|NCT03336515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1319941|NCT03336502||Single Group Assignment||Prevention||None (Open Label)||||||
1319942|NCT03336489|||Case-Only||Prospective|||||||
1319943|NCT03336476|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomised||||
1319944|NCT03336463|||Case-Control||Retrospective|||||||
1319945|NCT03336450|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1319946|NCT03336437|Randomized|Parallel Assignment||Basic Science||Single|Single blind||t|||
1319947|NCT03336424|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Parallel study, where group A receives non-invasive investigations and group B receives Invasive investigations.||||
1319948|NCT03336411|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1319949|NCT03336398|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1319950|NCT03336385|Randomized|Parallel Assignment||Supportive Care||Quadruple|"The randomization list was generated and provided by the Fibebiotics consortium (part of the EU framework 7 program) using unique study codes for participants.~All study product labels were coded by a third-party. All investigators and study participants remained blinded until final analysis"|The study participants were allocated through block randomization into three different intervention arms that ran in parallell throughout the study|t|t|t|t
1319951|NCT03336372||Single Group Assignment||Treatment||None (Open Label)||||||
1319952|NCT03336359|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1319953|NCT03336346|||Other||Cross-Sectional|||||||
1319954|NCT03336333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319955|NCT03336320|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319956|NCT03336307|||Case-Control||Prospective|||||||
1319957|NCT03336294|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1319958|NCT03336281|||Cohort||Prospective|||||||
1319959|NCT03336268|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1319960|NCT03336255|Randomized|Parallel Assignment||Prevention||Single||||||t
1319961|NCT03336242|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319962|NCT03336229|Randomized|Parallel Assignment||Other||Single||||||t
1319963|NCT03336216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319964|NCT03336203|Randomized|Parallel Assignment||Treatment||None (Open Label)||180 participants in parallel groups. These patients with high SUA level (>8 mg/dL; 480 µmol/L) are going to be divided into 2 arms (90+90) 1) with gout (EULAR's criteria) and 2) without gout but with presence of CKD 1-4)||||
1319965|NCT03336190|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319966|NCT03336177|||Other||Prospective|||||||
1319967|NCT03336164||Single Group Assignment||Other||None (Open Label)||After a control period with no specific front-of-pack labeling, the intervention consists in the apposition of a front-of-pack labeling (Nutri-Score) to individual foods in a campus university restaurant. All foods are individually labeled.||||
1319968|NCT03336151||Single Group Assignment||Other||None (Open Label)||After a control period with no specific front-of-pack labeling, the intervention consists in the apposition of a front-of-pack labeling (Nutri-Score) to individual foods in a campus cafeteria. All foods are individually labeled.||||
1319969|NCT03336138|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1319970|NCT03336125|Randomized|Parallel Assignment||Supportive Care||Single|Double blind|Pre and post-test design|t|||
1319971|NCT03336112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319972|NCT03336099||Single Group Assignment||Treatment||None (Open Label)||||||
1319973|NCT03336086|Non-Randomized|Parallel Assignment||Other||Single||||||t
1319974|NCT03336073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319975|NCT03336060|||Case-Control||Cross-Sectional|||||||
1319976|NCT03336047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319977|NCT03336034|||Other||Prospective|||||||
1319978|NCT03336021|Non-Randomized|Parallel Assignment||Other||Single|Enumerators will be blinded (to the extent possible) to the treatment assignment of farmers.|||||t
1319979|NCT03336008|||Cohort||Prospective|||||||
1319980|NCT03335995|||Cohort||Prospective|||||||
1319981|NCT03335982||Single Group Assignment||Supportive Care||None (Open Label)||||||
1319982|NCT03335969|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Each patient will serve as their own control by comparing their bowel habits in a diary 4 weeks prior to colon irrigation to the bowel habits in their diary 4 weeks post colon irrigation.||||
1319984|NCT03335943||Single Group Assignment||Treatment||None (Open Label)||||||
1319985|NCT03335930|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||"Participants were randomly assigned to one of three exercise times (morning/08:00-10:00, afternoon/14:00-16:00 evening/18:00-20:00).~Training protocol: Treadmills were used for the aerobic exercise training. Participants received supervised exercise training three times per week on alternate days for 12 weeks at the medical centre.~All participants followed this training protocol and maintained their usual lifestyles. The duration of each training session was 30 minutes and took place 1 to 2 hours after a meal.~The intensity of the training was set at 60% VO2max (approximately equal to 72% HRmax) obtained from the GXT.~During each session of the 30-minute aerobic exercise training, the patient's heart rate was maintained at 72% of heart rate maximal on treadmill. Appropriate speed and grade were used to achieve the target heart rate being tracked by the heart rate monitor and to accurately control the required exercise intensity."||||
1319986|NCT03335917|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Randomized,Counter Balanced, Repeated Measures, Crossover||||
1319987|NCT03335904|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1319988|NCT03335891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1319989|NCT03335878|||Cohort||Cross-Sectional|||||||
1319990|NCT03335865|||Cohort||Prospective|||||||
1319991|NCT03335852||Single Group Assignment||Treatment||None (Open Label)||||||
1319992|NCT03335839|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1319993|NCT03335826|Randomized|Parallel Assignment||Prevention||Single||||||t
1319994|NCT03335813||Single Group Assignment||Supportive Care||None (Open Label)||||||
1319995|NCT03335800||Single Group Assignment||Screening||None (Open Label)||||||
1319996|NCT03335787|Randomized|Parallel Assignment||Treatment||Double|"Both group will recevie conventional stroke rehabilitation. Intervention group will receive Kinesio taping and control group would not receive a sham taping due to the possible sensory intervention of sham taping eventhough applying it without any stretch.~Outcomes will be recorded by physical therapist using SPSS and groups would not be specified with letter. Statistical analysis will be conducted by another researcher who does not aware of groups given numbers on SPSS."|Patients' information and contact will be obtaioned from neurologist and willing participant's gender, age and stroke onset data will be processed with a random number generator in order to form groups. Patients will divide into two groups as intervention and control with a normal distrubution of gender, age and stroke onset.|t|||t
1319997|NCT03335774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1319998|NCT03335761|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1319999|NCT03335748|Randomized|Parallel Assignment||Treatment||Double|Double-blind evaluation Participant and assessor are blind|Participants were randomized into an experimental group that received the Cogmed program and an active control group that received a low-intensity comparison version of the training|t|||t
1320000|NCT03335735|Randomized|Parallel Assignment||Prevention||Single|Participant will be blinded to their random assignment into the control, loss-framed messaging, or gain-framed messaging group.||t|||
1320001|NCT03335722|Randomized|Parallel Assignment||Treatment||Quadruple|"A researcher from another research group who is not involved in any aspect of the trial will perform the randomisation of participants into the sham and tDCS study arms using a minimisation procedure within randPack package in R (Carey and Gentleman, 2016). Allocation concealment will be achieved by assigning a unique 5-digit code per participant (containing no identifying information regarding trial arm). This will be emailed to the researcher. The code is used to deliver stimulation via study mode on the stimulator (http://www.neurocaregroup.com/dc_stimulator_plus.html). The participants and the researchers who will deliver the intervention, assess the outcomes, and analyse the data will be masked to trial arm."|Double-blind, placebo-controlled (sham tDCS), randomised trial, with 20 participants with developmental stuttering recruited for each of the two arms of the trial.|t|t|t|t
1320002|NCT03335709||Single Group Assignment||Treatment||None (Open Label)||||||
1320003|NCT03335696|||Cohort||Prospective|||||||
1320004|NCT03335683|Randomized|Single Group Assignment||Treatment||Quadruple|Triple blind|Split mouth design|t|t|t|t
1320005|NCT03335670||Single Group Assignment||Diagnostic||None (Open Label)||||||
1320006|NCT03335657|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1320007|NCT03335644|||Cohort||Prospective|||||||
1320008|NCT03335631|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320009|NCT03335618|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1320010|NCT03335605|||Case-Control||Prospective|||||||
1320011|NCT03335592|||Cohort||Retrospective|||||||
1320012|NCT03335579|||Cohort||Retrospective|||||||
1320013|NCT03335566|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1320014|NCT03335553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320015|NCT03335540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320016|NCT03335527|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1320017|NCT03335514|||Case-Control||Prospective|||||||
1320018|NCT03335501|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1320019|NCT03335488|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, Controlled, Open-Label Parallel Arm study||||
1320020|NCT03335475|Randomized|Parallel Assignment||Prevention||None (Open Label)|Investigator, research assistants, coaches (interventionists), and participants do not know which condition a participant is in until the condition is revealed (opening an envelop with the condition listed) after the participant assents/consents to Phase 2. Envelopes with the conditions were prepared by the study statistician.|Study includes 2 possible conditions to which participants are randomized: (1) Fitbit only and (2) Fitbit + coaching sessions.||||
1320021|NCT03335462||Single Group Assignment||Other||None (Open Label)||||||
1320022|NCT03335449|Randomized|Crossover Assignment||Prevention||Single||||t||
1320023|NCT03335436|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1320101|NCT03334422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320102|NCT03334409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320103|NCT03334396|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320024|NCT03335423|Randomized|Crossover Assignment||Basic Science||None (Open Label)||"In part 1 a single group of healthy volunteers will ingest a single dosis of metformin and then have a blood sample drawn after 3 and 10 hours.~In part 3, 18 healthy subjects will be randomized to ingest: a) oral metformin b) intravenous metformin c) 4 pills of codeine with the 5th taken together with oral metformin and d) 4 pills of codeine with the 5th taken together with intravenous metformin."||||
1320025|NCT03335410|||Cohort||Prospective|||||||
1320026|NCT03335397|Randomized|Parallel Assignment||Treatment||Single||||||t
1320027|NCT03335384|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Cross-sectional||||
1320028|NCT03335371|Randomized|Sequential Assignment||Treatment||Triple|||t||t|t
1320029|NCT03335358|Randomized|Crossover Assignment||Treatment||Single||Waitlist control design; participants are assigned to receive intervention or be waitlisted for 4-6 weeks and then receive intervention.||||t
1320030|NCT03335345|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320031|NCT03335332|Randomized|Parallel Assignment||Treatment||Single||||||t
1320032|NCT03335319|Randomized|Parallel Assignment||Prevention||Triple||Patients will be randomized and stratified (by gender and age) into either one of the two groups exercise training groups: 1) periodization or 2) non periodization. The randomization code will be developed with a computer random-number generator to select random permuted blocks.|t|t||t
1320033|NCT03335306|||Cohort||Prospective|||||||
1320034|NCT03335293|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1320035|NCT03335280|||Cohort||Prospective|||||||
1320036|NCT03335267||Single Group Assignment||Treatment||None (Open Label)||||||
1320037|NCT03335254|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants receive identical dosing for Period 1 and Period 2. Beginning with Period 3 subjects are assigned to one of several doses based on dose adjustments. Period 3 dosing groups are run in parallel for the duration of the study.||||
1320038|NCT03335241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320039|NCT03335228||Single Group Assignment||Treatment||None (Open Label)||||||
1320040|NCT03335215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320041|NCT03335202|||Cohort||Retrospective|||||||
1320042|NCT03335189|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1320043|NCT03335176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320044|NCT03335163||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-inferiority study to evaluate the pharmacokinetic effect of topiramate on serum ENG levels in contraceptive implant users||||
1320045|NCT03335150|Randomized|Parallel Assignment||Treatment||Double|Investigator and Assessor are blinded to group assignment.||||t|t
1320046|NCT03335137|||Case-Control||Prospective|||||||
1320047|NCT03335124|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1320048|NCT03335111|Randomized|Parallel Assignment||Prevention||Single|Patients without BAIPC are admistrated by 5 cycles extremities ischemia (5-minute blood-pressure cuff inflation using pressure 0 mmHg , followed by 5-minute cuff deflation). All subjects will take BAIPC for 1 week using 'Remote Ischemic Conditioning Equipment' .|BAIPC group patients are admistrated by 5 cycles extremities ischemia (5-minute blood-pressure cuff inflation up to 50 mmHg higher than baseline, followed by 5-minute cuff deflation).|t|||
1320049|NCT03335098||Single Group Assignment||Treatment||None (Open Label)||||||
1320050|NCT03335085|Non-Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1320051|NCT03335072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320052|NCT03335059||Single Group Assignment||Treatment||None (Open Label)||||||
1320053|NCT03335046|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The study will be a randomized wait-list control trial. Participants will be randomized to the intervention or control arm for the study observation period. At the conclusion of the observation period, the control group will receive the intervention.||||
1320054|NCT03335033|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1320055|NCT03335020|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1320056|NCT03335007|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1320057|NCT03334994|Randomized|Parallel Assignment||Treatment||Double|Blinded participants: patient will be ensured by masking the instruments during the surgery. The patient will be informed of the steps of the surgery (as mentioned in the consent form) without getting into details. Blinding to the clinical, radiographic assessors is done by not involving them in sequence generation or allocation concealment or surgery performing.|"The patients was randomly classified into two groups:~Group A: Patient will be treated with immediate implant alone. Group B: Patients will be treated with connective tissue graft combined with immediate implant."|t|||t
1320058|NCT03334981|||Cohort||Prospective|||||||
1320059|NCT03334968|||Case-Control||Prospective|||||||
1320060|NCT03334955||Single Group Assignment||Treatment||None (Open Label)||Laparoscopic ovarian drilling was performed under general anesthesia with good muscle relaxation and endotracheal intubation using the three-punctures technique (one puncture 10mm at the umbilicus and the other two punctures 5mm at both iliac fossa) in the early follicular phase. A specially designed monopolar electrocautery probe was used to penetrate the ovarian capsule at 4 points (regardless of the size of the ovary), with the aid of a short burst of monopolar diathermy. The probe (which has a distal stainless steel needle measuring 10 mm in length and 2 mm in diameter) was applied to the surface of the ovary at a right angle to avoid slippage and to minimize surface damage. A monopolar coagulating current at a 40 W power setting was used. The needle was pushed through the ovarian capsule for about 4 mm depth into the ovarian tissue and electricity was activated for 4 seconds. The ovary was then cooled using 200 ml crystalloid solution before releasing the ligament.||||
1320104|NCT03334383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320105|NCT03334370|||Case-Control||Prospective|||||||
1320106|NCT03334357|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320107|NCT03334344|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1320108|NCT03334331|||Other||Cross-Sectional|||||||
1320109|NCT03334318|||Cohort||Prospective|||||||
1573441|NCT00001211||||||||||||
1320061|NCT03334942|Randomized|Parallel Assignment||Treatment||Single|Only the study coordinator and VIP staff members will be aware of a participant's randomization assignment. The study research assistants (RAs), who will be responsible for administering baseline, 4-month, and 10-month assessments will be blinded to the participant's study condition throughout the duration of the study.|Research assistants (RAs) will perform eligibility screening in the CHOP ED or Trauma Unit on potentially eligible youth and their parents who present for care following an assault-related injury. For individuals discharged before being screened, RAs will phone them within 7 days of discharge for screening. Consented youth and parents will complete baseline study assessments followed by random assignment to either the intervention [Violence Intervention Program (VIP) with Child and Family Traumatic Stress Intervention (CFTSI)] or control (VIP-only) conditions. VIP is the standard of care provided to assault injured youth treated in the CHOP ED or Trauma Unit. The study coordinator or VIP staff member will notify youth of their assigned condition. CFTSI clinicians will schedule intervention sessions with the families in community-based mental health centers. RAs will be blinded to participant condition and administer baseline and follow-up assessments to all participants.||||t
1320062|NCT03334929|Randomized|Parallel Assignment||Other||Double|||t|t||
1320063|NCT03334916|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320064|NCT03334903|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two-arm parallel design.||||
1320065|NCT03334890|||Case-Only||Prospective|||||||
1320066|NCT03334877|||Case-Control||Prospective|||||||
1320067|NCT03334864|||Cohort||Other|||||||
1320068|NCT03334851|Randomized|Sequential Assignment||Basic Science||Quadruple|||t|t|t|t
1320069|NCT03334838|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1320070|NCT03334825|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||randomized controlled trial||||
1320071|NCT03334812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320072|NCT03334799||Single Group Assignment||Screening||None (Open Label)||case control||||
1320073|NCT03334786||Single Group Assignment||Treatment||None (Open Label)||||||
1320074|NCT03334773|Randomized|Parallel Assignment||Other||Double|The health professionals (physicians, dietitians, nursing professionals) who serve the patients will only know the patient is participating in the study through a sticker on the medical records but they will not know the treatment allocation (group). Outcome assessors for biochemical parameters will not know the patient allocation as the assessments for the parameters are done alongside other routine assessments. Furthermore, they do not have the information that there are different patient groups|The intervention (nutrition education programme) will employ a randomised control design with two parallel groups (intervention & control). Randomisation will be stratified based on age and gender into four strata. Concealed opaque envelopes for each stratum will be used for randomization. The intervention will be implemented over one year. The (intervention) comprises of four components i) 7-monthly group training (curriculum), ii) 2 bi-monthly group follow-up sessions, iii) one individual counseling and goal setting session (10-15 minutes) fitted during the monthly meetings, and iv) participant's workbook for goal setting activity and education materials (fridge/wall poster, pamphlet). The intervention group will receive the intervention while the control group will only receive the education material (fridge/wall poster, pamphlet). Both groups will continue with usual care at the diabetes outpatient clinic of the hospital.||t||t
1320075|NCT03334760|||Cohort||Prospective|||||||
1320076|NCT03334747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320077|NCT03334734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320078|NCT03334721|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1320079|NCT03334708|||Case-Control||Prospective|||||||
1320080|NCT03334695|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1320081|NCT03334682|Randomized|Parallel Assignment||Treatment||Double|The products used in both arms will be over-encapsulated by the Pharmacy of Nantes University Hospital||t||t|
1320082|NCT03334669|Randomized|Crossover Assignment||Prevention||None (Open Label)||The stepped wedge design is a pragmatic design that is well suited for interventions that use a service delivery protocol and do not rely on individual recruitment of participants. The intervention is integrated into Head Start service delivery and data compiled for all enrolled children are used to evaluate the intervention.||||
1320083|NCT03334656|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1320084|NCT03334643|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be assigned to either the Non-Diabetes or Prediabetes/Diabetes group based on their diagnosis of type 2 diabetes (if any) and their fasting blood glucose concentrations.||||
1320085|NCT03334630|Randomized|Parallel Assignment||Treatment||Single||||t||
1320086|NCT03334617|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is an open-label, multi-centre, umbrella Phase II study in patients with metastatic NSCLC who have progressed on an anti-PD-1/PD-L1 containing therapy. This study is modular in design, allowing initial assessment of the efficacy, safety, and tolerability of multiple treatment arms.~Within each module, there will be treatment cohorts."||||
1320087|NCT03334604|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1320088|NCT03334591|Randomized|Parallel Assignment||Treatment||Single||||||t
1320089|NCT03334578|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320090|NCT03334565|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1320091|NCT03334552|||Cohort||Prospective|||||||
1320092|NCT03334539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320093|NCT03334526||Single Group Assignment||Other||None (Open Label)||this study is interventional because of it acts on the physical and respiratory capacities of patients||||
1320094|NCT03334513|||Case-Control||Retrospective|||||||
1320095|NCT03334500|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320096|NCT03334487||Single Group Assignment||Treatment||None (Open Label)||||||
1320097|NCT03334474|||Case-Only||Cross-Sectional|||||||
1320098|NCT03334461|Randomized|Parallel Assignment||Prevention||Quadruple|Unlabeled bottles containing testing agent|Randomized controlled trail|t|t|t|t
1320099|NCT03334448|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1320100|NCT03334435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320110|NCT03334305|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320111|NCT03334292|||Cohort||Prospective|||||||
1320112|NCT03334279|||Other||Cross-Sectional|||||||
1320113|NCT03334266|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320114|NCT03334253|Randomized|Parallel Assignment||Treatment||Single|Cycloplegic autorefraction, axial length, and additional biometry will be measured by a masked examiner at all follow-up visits using the same instrumentation on the participant throughout the study. Masking will be accomplished by having site personnel administer cyclopentolate to both eyes of each participant and wait 30 minutes before he/she sees the masked examiner. The masked examiner may be a technician or an investigator and must be certified to complete these measurements.|The current study is designed as an efficacy study, making effort to maximize adherence to treatment group assignments. After a run-in phase during which all participants are treated with daily artificial tear eyedrops for 2-4 weeks (and glasses are updated if required) to assess their ability to adhere to daily eye drops, participants are randomly assigned to daily atropine or placebo for 24 months, followed by 6 months off treatment.||||t
1320115|NCT03334240|Randomized|Parallel Assignment||Treatment||Double|Double-blind|A total of 48 subjects are planned to be enrolled within one of the following three groups: a.) Immunocompetent patients with anogenital warts, b.) Immunocompromised with anogenital warts and c.) Immunocompromised with vulvar HSIL [3:1, active/vehicle]. Eligible subjects may enroll in an (up to) 8-week open-label Part 2 of study|t||t|
1320116|NCT03334227|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with severe sepsis will be randomized to recieve conventional oxygenotherapy if needed or high flow nasal cannula.||||
1320117|NCT03334214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320118|NCT03334201|Randomized|Crossover Assignment||Basic Science||Single|Single-blind|Randomized, single-blind crossover|||t|
1320119|NCT03334188|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320120|NCT03334175|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320121|NCT03334162|Randomized|Parallel Assignment||Supportive Care||Double|All investigators dealing with the assessments (neurological and sport scientific) and data are blinded, solely the patient as well as the training staff can't be blinded due to the nature of an exercise interventional study.|This pilot study will follow a prospective, multicenter, two-armed, randomized controlled design (RCT with follow-up)|||t|t
1320122|NCT03334149|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Note Women in BUMP 1 will transfer to BUMP 2 if they develop hypertension. Women in BUMP 2 can be randomised de novo or join from BUMP 1 maintaining their original randomisation. The enrolment number below therefore includes BUMP 1 (2262) plus BUMP 2 (512) but because of the overlap, the total number of women is anticipated to be 2412.||||
1320123|NCT03334136|Randomized|Parallel Assignment||Treatment||Quadruple||Participants will be randomized to high dose vitamin D (20.000 IU/week) versus placebo for 4 months.|t|t|t|t
1320124|NCT03334123|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1320125|NCT03334110|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320126|NCT03334097||Single Group Assignment||Treatment||None (Open Label)|There will be no masking as the purpose of the study is to analyse responsiveness of a questionnaire after educational intervention|A single groupof pregant women will complete the spanish version of Delivery Expectancy/Experience Questionnaire, Version A (WDEQ-A, spanish version) before and after an educational information.||||
1320127|NCT03334084|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1320128|NCT03334071|Randomized|Parallel Assignment||Treatment||Double|Cardiopulmonary exercise testing assessor, outcome/toxicity assessor|Exercise intervention|||t|t
1320129|NCT03334058||Single Group Assignment||Treatment||None (Open Label)||||||
1320130|NCT03334045|||Case-Control||Other|||||||
1320131|NCT03334032|||Cohort||Prospective|||||||
1320132|NCT03334019|||Cohort||Prospective|||||||
1320133|NCT03334006|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The control group will receive standard-of-care treatment, i.e., the IgGAM is an add-on treatment in this study.~The active study treatment is IgGAM (Pentaglobin®). The preparation to be provided contains (per ml solution) 50 mg human plasma proteins, of which >95% are immunoglobulins: IgM 6 mg, IgA 6 mg and IgG 38 mg. The IgG subclass distribution is IgG1 ~63%, IgG2 ~26%, IgG3 ~4%, IgG4 ~7%. IgGAM is administered by continuous infusion over 5 days at a dose level of 0.4 ml per kg body weight per hour, until a total dose of 7 ml/kg on that day has been reached; administration will then be stopped and recommenced on the following day, until administration has been completed for 5 consecutive days."||||
1320134|NCT03333993|Randomized|Parallel Assignment||Treatment||Single||||||t
1320135|NCT03333980|||Other||Cross-Sectional|||||||
1320136|NCT03333967|||Cohort||Prospective|||||||
1320137|NCT03333954||Single Group Assignment||Treatment||None (Open Label)||||||
1320138|NCT03333941|||Cohort||Prospective|||||||
1320139|NCT03333928|Randomized|Parallel Assignment||Treatment||Quadruple||A primary parallel group comparison for a 6-week treatment, followed by a 6-week dose-controlled extension, and followed by a 6-week random withdrawal.|t|t|t|t
1320140|NCT03333915||Single Group Assignment||Treatment||None (Open Label)||||||
1320141|NCT03333902|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1320142|NCT03333889|Randomized|Parallel Assignment||Treatment||Double|double blind :outcome asessor,participant||t|||t
1320143|NCT03333876||||||||||||
1320144|NCT03333863|||Case-Only||Retrospective|||||||
1320145|NCT03333850|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||There will be sequential inclusion to each cohort. Each sequence includes 18 patients (corresponding to the number of beds at the department). Thus the patients hospitalised during the first period will receive feedback (exposed cohort). In the second period the patients will not receive feedback (non-exposed cohort), and so forth. A total of 108 patients will be included resulting in 6 periods of 18 patients each.||||
1320205|NCT03333044|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1320206|NCT03333031||Single Group Assignment||Other||None (Open Label)||||||
1320207|NCT03333018|||Cohort||Prospective|||||||
1320217|NCT03332888||Single Group Assignment||Treatment||None (Open Label)||||||
1321008|NCT03322605|||Case-Control||Prospective|||||||
1320146|NCT03333837|Randomized|Parallel Assignment||Supportive Care||Single|All study assessments will be conducted by experienced staff certified annually on the proper conduct of study assessments and blinded to group assignment.|Randomized controlled trial. Investigators will use a 2x2 factorial design to test the separate and combined effects of social engagement and dance movement on QoL in 120 community-dwelling older adults adjudicated as having mild cognitive impairment (MCI) or early-stage dementia of the presumed AD or mixed AD/vascular type. Participants will be randomized to one of four 12-week interventions: 1) Dance Group 2) Non-group Dance, 3) Social Group, or 4) No Contact Control.||||t
1320147|NCT03333824||Single Group Assignment||Treatment||None (Open Label)||||||
1320148|NCT03333798|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1320149|NCT03333785|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Improving Cancer Care Together through eOncoNote is a concurrent mixed-methods hybrid type I effectiveness-implementation study design. Effectiveness of eOncoNote will be assessed by a pragmatic randomized controlled trial with individual patient randomization and outcomes measured at the patient level. Implementation will be assessed using a mixed methods process evaluation involving key stakeholders to assess barriers and facilitators to implementation of the intervention.||||
1320150|NCT03333772||Single Group Assignment||Other||None (Open Label)||||||
1320151|NCT03333759||Single Group Assignment||Treatment||None (Open Label)||||||
1320152|NCT03333746||Single Group Assignment||Treatment||None (Open Label)||||||
1320153|NCT03333733|Randomized|Parallel Assignment||Prevention||Double|Treatment allocation will be withheld from research staff collecting the data. Screening forms will not indicate whether they have been recruited from active or control Centres The chief investigator, trial coordinator and statistician will not be provided details of treatment allocation.||||t|t
1320154|NCT03333720||Single Group Assignment||Supportive Care||None (Open Label)||||||
1320155|NCT03333707|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1320156|NCT03333694|Randomized|Parallel Assignment||Treatment||Double|investigator and patient blinded|A first in human,proof of concept study. The study is investigator-and patient-blinded, randomized, placebo-controlled study in patients with SCCis, to assess safety, tolerability and initial efficacy of CLL442 after up to 84 days twice daily application of CLL442 or placebo on one lesion.|t||t|
1320157|NCT03333681||Single Group Assignment||Treatment||None (Open Label)||||||
1320158|NCT03333668|Randomized|Crossover Assignment||Basic Science||Double||Each participant will complete all three experimental conditions (LISDEX, GXR, placebo) in a randomised order.|t||t|
1320159|NCT03333655||Single Group Assignment||Basic Science||None (Open Label)||||||
1320160|NCT03333642||Single Group Assignment||Treatment||None (Open Label)||||||
1320161|NCT03333629|Randomized|Parallel Assignment||Screening||Double|||t|||t
1320162|NCT03333616||Single Group Assignment||Treatment||None (Open Label)||||||
1320163|NCT03333603||Single Group Assignment||Treatment||None (Open Label)||Investigators will give 40 mg/day esomeprazole in the first two weeks and 80 mg/day from the third week to the end of the trial. Investigators will check the area under the concentration of metabolites of esomeprazoleon Day 1, Day 14 and Day 56 and the genotype of CYP2C19. The GI symptoms and related drug side effects will be evaluated.||||
1320164|NCT03333590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a dose escalation trial that will begin with the minimal efficacious dose as determined by preclinical studies and approved by the FDA. During the course of the trial, if safety is shown the dose will be escalated according to the clinical protocol.||||
1320165|NCT03333577||Single Group Assignment||Treatment||None (Open Label)||||||
1320166|NCT03333564|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1320167|NCT03333551||Single Group Assignment||Diagnostic||None (Open Label)||each participant will be subject to the intervention which is PET/CT imaging (Positron emission tomography-computed tomography) with florbetapir F-18||||
1320168|NCT03333538|Randomized|Parallel Assignment||Prevention||Double|This clinical trial is designed as a double blind randomized placebo-controlled study|Parallel Assignment|t||t|
1320169|NCT03333525|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1320170|NCT03333512|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1320171|NCT03333499|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1320172|NCT03333486||Single Group Assignment||Treatment||None (Open Label)||||||
1320173|NCT03333473|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1320174|NCT03333460|Randomized|Parallel Assignment||Treatment||Triple|With regard to the treatment, to ensure that both participants and investigators are blind to the condition (active or sham), the selection of the operation mode (15 Hz, sham) will be pre-programmed by member of the that will not be involved in data collection and analysis. Study personnel will not know which mode is being activated. Sham stimulation will use the same coil placement as that used for active stimulation. Outcomes Assessors will not be present during the rTMS sessions.|double blind, randomized, sham-controlled with a 1:1 allocation into 2 parallel arms|t||t|t
1320175|NCT03333447|||Other||Cross-Sectional|||||||
1320176|NCT03333434|Randomized|Crossover Assignment||Treatment||Single||||||t
1320177|NCT03333408|Randomized|Parallel Assignment||Treatment||Single|||||t|
1320178|NCT03333395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320179|NCT03333382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320208|NCT03333005||Sequential Assignment||Other||None (Open Label)||The first 10 patients enrolled will be administered IV APX001. The second 10 patients enrolled will be administered oral APX001||||
1320209|NCT03332992|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1320210|NCT03332979|||Cohort||Prospective|||||||
1320211|NCT03332966|||Cohort||Prospective|||||||
1320212|NCT03332953||Single Group Assignment||Basic Science||None (Open Label)||||||
1320213|NCT03332940||Sequential Assignment||Diagnostic||None (Open Label)||||||
1320214|NCT03332927|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1320215|NCT03332914|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Crossover||||
1320216|NCT03332901|||Cohort||Prospective|||||||
1573442|NCT00001210||||||||||||
1320180|NCT03333369|Randomized|Crossover Assignment||Basic Science||Triple|"For the randomization of the intervention and placebo the Research Randomizer on www.randomizer.org will be used. The randomization will be performed by the Kantonsapotheke in Zurich. The generated list of condition sequences will be stored at there. The list will not be accessible for study members who are associated with the assessment. The Boxes containing the cachets will be labelled with the subject number and A or B for the first or second session, respectively as well as with the ID of the study. The cachets will be prepared and labelled at the Kantonsapotheke in Zurich. DA and placebo will be provided in identical cachets. The blinding will be broken only after a subject has completed both experimental sessions or in case of an acute reaction during the session."|"Each subject in the group will participate in two test sessions, separated by at least one week. All sessions will start at 15:30.~In a double-blind within-design procedure, participants will be randomly assigned to receive either a cachet of a dual-release formulation of 200 mg levodopa/50 mg benserazide (a peripheral L-dihhydroxyphenylalanine-decarboxylase inhibitor) or a placebo in the first session. In the second session they will receive the other intervention."|t|t|t|
1320181|NCT03333356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320182|NCT03333343|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320183|NCT03333330||Single Group Assignment||Diagnostic||None (Open Label)||||||
1320184|NCT03333317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320185|NCT03333304|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients will be randomized at 1:1 ratio by a separate list per study site into two treatment groups. The two groups of treatment will be as follows:~Standard of care: these patients will receive antimicrobials according to standard practice of the attending physicians but PCT will not be measured and antimicrobials will be stopped according to the local standard practice.~PCT group: these patients will receive antimicrobials according to standard practice of the attending physicians and antimicrobials will be discontinued according to PCT kinetics."||||
1320186|NCT03333291||Single Group Assignment||Treatment||None (Open Label)||Open pilot study||||
1320187|NCT03333278|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multi-centre, Randomised, Open-label controlled Trial||||
1320188|NCT03333265|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1320189|NCT03333252|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1320190|NCT03333239|Randomized|Factorial Assignment||Treatment||Single||||||t
1320191|NCT03333226|Randomized|Parallel Assignment||Prevention||Double|Patients will be randomized before the SLNB procedure. Due to the type of intervention, the blinding of the treating surgeon will not be possible, thus the surgeon will be aware of both the intraoperative crossover between ARM lymph node and SLN (secondary outcome) and the allocation to ARM lymph node preservation or removal. Data about BCRL (primary outcome) will be collected by the physiatrist and the physiotherapist that will be blinded about the allocation (ARM lymph node preservation/removal) and the crossover between SLN of the breast and the arm's lymph node. The assessment of lymphoscintigraphic subclinical modification in the arm lymphatic drainage after SLNB and ALND (secondary outcomes) will be performed by a blinded nuclear medicine physician that will not be aware of the allocation (ARM lymph node preservation/removal) and the crossover between ARM lymph node and breast's SLN.|"Eligible patients for radioguided sentinel lymph node biopsy (rSLNB) will be randomly divided in two groups:~experimental group in which all patients will be sent to both rSLNB and photodynamic Axillary Reverse Mapping (ARM) to evaluate the crossover between SLN and ARM lymph node. In case of SLN metastases, an ALND with ARM lymph node preservation will be performed.~control group in which all patients will be sent to both rSLNB and photodynamic Axillary Reverse Mapping (ARM) to evaluate the crossover between SLN and ARM lymph node. In case of SLN metastases, an ALND with ARM lymph node removal will be performed."|t|||t
1320192|NCT03333213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320193|NCT03333200|||Cohort||Prospective|||||||
1320194|NCT03333187|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Treatment A (only with a suitable stem cell donor):~Allogeneic SCT after 3 months of Ruxolitinib induction therapy~Treatment B:~Ruxolitinib continuous therapy"||||
1320195|NCT03333174|Randomized|Crossover Assignment||Treatment||None (Open Label)||(b) The first 24h of the data collection will be the baseline data. Over the next 72h, we will evaluate 3 interventions in a cross-over manner: Intervention 1 (24-48h of data), Intervention 2 (48-72h), and Intervention 3 (72-96h; same as intervention 1). Initial intervention will be by random assignment (computer-generated). The intervention will be to provide oxygen either by nasal cannula or by servo-controlled oxygen environment, followed by cross-over to other intervention for 24h, and then back to original intervention.||||
1320196|NCT03333161|Randomized|Crossover Assignment||Treatment||None (Open Label)||The investigators will use the data from the 96 hours of intensive multiparametric physiologic monitoring at 2 weeks postnatal age. The first 24 hours of the data collection will be the baseline data, followed by evaluation of 3 interventions in a cross-over manner, with the initial intervention randomly assigned (computer-generated): Intervention 1 (24-48h of data), Intervention 2 (48-72h), and Intervention 3 (72-96h). The interventions will be to adjust transcutaneous carbondioxide measurements (TcCO2) up or down by 5 mm Hg, while maintaining TcCO2 within usual safe thresholds.||||
1320197|NCT03333148|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320198|NCT03333135|Non-Randomized|Parallel Assignment||Basic Science||Triple|Study team and participants will not know if they have received the PEMF device or the sham||t||t|t
1320199|NCT03333122|||Cohort||Prospective|||||||
1320200|NCT03333109|Randomized|Parallel Assignment||Prevention||Quadruple||This study uses a single-cohort, 3-treatment arm, randomized, double-blind study design in adult patients with episodic migraine. A screening period of 2 weeks will be used to assess initial eligibility, followed by a 4-week baseline period. After randomization/Day 1, visits will occur at four week intervals until Week 12, which is the End of Treatment visit, Last Patient Last Treatment (LPLT). The final visit, Last Patient Last Visit (LPLV), a Safety Follow-Up visit, will occur 12 weeks later, at Week 24.|t|t|t|t
1320201|NCT03333096||Single Group Assignment||Screening||None (Open Label)||||||
1320202|NCT03333083||Single Group Assignment||Treatment||None (Open Label)||||||
1320203|NCT03333070|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1320204|NCT03333057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321214|NCT03319914|||Cohort||Prospective|||||||
1320218|NCT03332875|Randomized|Parallel Assignment||Treatment||None (Open Label)||Couples are randomized to receive either one call with a coach or four calls with a coach.||||
1320219|NCT03332862|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320220|NCT03332849|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320221|NCT03332836|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320222|NCT03332823||Single Group Assignment||Prevention||None (Open Label)||||||
1320223|NCT03332810|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320224|NCT03332797|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320225|NCT03332784|Randomized|Sequential Assignment||Other||Double|||t||t|
1320226|NCT03332771|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320227|NCT03332758|||Cohort||Prospective|||||||
1320228|NCT03332745|||Case-Control||Prospective|||||||
1320229|NCT03332732|Randomized|Sequential Assignment||Basic Science||Double||Part 1: Cross-over Part 2: Parallel|t||t|
1320230|NCT03332719|Randomized|Parallel Assignment||Treatment||Single||||||t
1320231|NCT03332706|||Cohort||Prospective|||||||
1320232|NCT03332693|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1320233|NCT03332680|Randomized|Parallel Assignment||Treatment||Triple|In terms of blinding, the physician and/or nurses as well as the patients will be blinded and will not know what arm of the study the participant has been allocated too. The embryologists however will be unblinded (as they provide intervention and will have to be aware).|This study is a positive control study with a single site two arm parallel design|t||t|t
1320234|NCT03332667||Single Group Assignment||Treatment||None (Open Label)||||||
1320235|NCT03332654|||Cohort||Retrospective|||||||
1320236|NCT03332641|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1320237|NCT03332628||Single Group Assignment||Basic Science||None (Open Label)||||||
1320238|NCT03332615|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320239|NCT03332602|Randomized|Crossover Assignment||Prevention||Single|||t|||
1320240|NCT03332589||Single Group Assignment||Treatment||None (Open Label)||Once 6 subjects are treated in the Safety Run-in Phase and a maximum tolerated dose (MTD) is confirmed the Expansion Phase will begin. An additional cohort of up to N=18 subjects will be treated at the MTD. Subjects treated at the MTD in the Safety Run-in Phase will count towards accrual in the Expansion Phase.||||
1320241|NCT03332576|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320242|NCT03332563|Randomized|Sequential Assignment||Treatment||Triple||This study will employ a stepped wedge cluster randomized design in which clinic sites are randomized sequentially to initiate the intervention. Prior to initiating patient recruitment, each of the 8 clinics will be randomized to one of two waves in the stepped wedge design. During the non-exposure periods, patients will receive usual care from the clinic.||t|t|t
1320243|NCT03332550|||Cohort||Retrospective|||||||
1320244|NCT03332537|Randomized|Parallel Assignment||Supportive Care||Single|Using a stratified and blocked randomization scheme.||t|||
1320245|NCT03332524|Randomized|Factorial Assignment||Treatment||Quadruple||Multi-centers double-blinded clinical trial with one intervention arm with SP160412 (Ibuprofen and Chlorpheniramine combined) with one arm with Active control (Ibuprofen with placebo) and a third arm (Chlorpheniramine with Placebo)|t|t|t|t
1320246|NCT03332511||Single Group Assignment||Treatment||None (Open Label)||||||
1320247|NCT03332498||Single Group Assignment||Treatment||None (Open Label)||||||
1320248|NCT03332485|Randomized|Parallel Assignment||Other||Double|||||t|t
1320249|NCT03332472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320250|NCT03332459|Non-Randomized|Parallel Assignment||Other||Double||||t|t|
1320251|NCT03332446|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1320252|NCT03332433|Randomized|Parallel Assignment||Prevention||Single|||t|||
1320253|NCT03332420|||Cohort||Prospective|||||||
1320254|NCT03332407|||Case-Only||Prospective|||||||
1320255|NCT03332394|||Cohort||Prospective|||||||
1320256|NCT03332381|Randomized|Parallel Assignment||Treatment||None (Open Label)||RCT||||
1320257|NCT03332368|||Cohort||Prospective|||||||
1320258|NCT03332355||Single Group Assignment||Treatment||None (Open Label)||PAC-1 in combination with temozolomide (Component 2): after the MTD is established for single agent PAC-1 in Component 1, a modified-Fibonacci dose-escalation 3+3 design starts in Component 2, at a PAC-1 dose one level lower than the MTD of PAC-1 established in the single agent PAC-1 component (i.e., Component 1) and 150 mg/m2 dose of temozolomide given for the 5 days starting at day 8 of cycle 1 in cohorts of 3-6 patients. The combination cohort that reaches MTD will expanded to at least 9 patients, similar to the PAC-1 alone cohort at MTD.||||
1320259|NCT03332342|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1320260|NCT03332329||Single Group Assignment||Treatment||None (Open Label)||||||
1320261|NCT03332316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320262|NCT03332303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320263|NCT03332290|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized opened clinical trial||||
1320264|NCT03332277||Single Group Assignment||Treatment||None (Open Label)||||||
1320265|NCT03332264|Randomized|Parallel Assignment||Treatment||None (Open Label)|Corelab will be masked for the bare metal and paclitaxel coated stent arm.|Vessel patency will be compared by quantitative angiography at 12 months in patients who have been treated either with paclitaxel coated balloon catheter, paclitaxel coated stent or bare metal stent in femoropopliteal arteries||||
1320266|NCT03332251|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320267|NCT03332238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320268|NCT03332225|Randomized|Parallel Assignment||Treatment||Quadruple||Treatment with recombinant human interferon-gamma or anakinra|t|t|t|t
1320269|NCT03332212|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320270|NCT03332199|Non-Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1320271|NCT03332186|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320272|NCT03332173||Single Group Assignment||Treatment||None (Open Label)||||||
1320273|NCT03332160|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1320274|NCT03332147||||||||||||
1320275|NCT03332134|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320276|NCT03332121||Single Group Assignment||Treatment||None (Open Label)||||||
1320277|NCT03332108|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1320278|NCT03332095|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320279|NCT03332082||Single Group Assignment||Treatment||None (Open Label)||20 patients will be recruited and treated with a commercially available tooth positioner. The results will be compared with the other group from previously treated patients who were in the alignment phase of Orthodontics.||||
1320280|NCT03332069|Randomized|Parallel Assignment||Treatment||Double|Clinicians conducting follow up evaluations, radiographers and nuclear medicine physicians reporting on the PET/CT investigations are unaware of the group that the participants have been assigned to.|||t||t
1320281|NCT03332056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320282|NCT03332043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320283|NCT03332030|||Cohort||Other|||||||
1320284|NCT03332017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320285|NCT03332004||Single Group Assignment||Diagnostic||None (Open Label)||In the selected patients, after a first white light visual inspection, 0.25 mg/(kg BW) ICG were injected intravenously. After 5 to 30 minutes a second inspection of the abdomen and pelvis in Near Infrared vision was made. All the visualized lesions were carefully described pre and post the Indocyanine Green injection, removed and listed||||
1320286|NCT03331991|||Cohort||Prospective|||||||
1320287|NCT03331978|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1320288|NCT03331965|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1320289|NCT03331952|||Cohort||Prospective|||||||
1320290|NCT03331939|Randomized|Single Group Assignment||Treatment||None (Open Label)||Pilot Study||||
1320291|NCT03331926|||Cohort||Retrospective|||||||
1320292|NCT03331913|Randomized|Parallel Assignment||Treatment||Single||||||t
1320293|NCT03331900|Randomized|Sequential Assignment||Other||Double|||t||t|
1320294|NCT03331887|Randomized|Parallel Assignment||Treatment||Double|no masking||t|||t
1320295|NCT03331874|||Cohort||Prospective|||||||
1320296|NCT03331861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320297|NCT03331848|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1320298|NCT03331835|Randomized|Parallel Assignment||Treatment||Single||||||t
1320299|NCT03331822|Randomized|Crossover Assignment||Prevention||None (Open Label)||This is randomized crossover trial, in which each nursing subject will serve as his or her own control: i.e., matched. The subjects will be nurses from the 6FG Trauma Intensive Care Unit at UPMC Presbyterian hospital.||||
1320300|NCT03331809|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1320301|NCT03331796|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320302|NCT03331783||Single Group Assignment||Basic Science||None (Open Label)||||||
1320303|NCT03331770||Single Group Assignment||Treatment||None (Open Label)||A prospective, open-label, single-arm, multicenter, 12-week study||||
1320304|NCT03331757|Randomized|Crossover Assignment||Other||Double|Participants were assigned to the interventions using a sequence of random numbers extracted from computer software. A researcher not involved with the collection and the analysis of the scientific data, was responsible for the randomization of the volunteers to the intervention days examining the test foods. All test meals (glucose and honeys) were diluted in 300ml water and were served in dark paper cups covered with a lid in order to achieve double blind conditions.|Eleven healthy participants consumed in random order 50g available carbohydrates as glucose (tested three times) and 50g available carbohydrates as fir, chestnut, healther, thyme, pine, citrus, tested once, on separate occasions|t||t|
1320305|NCT03331744|||Case-Only||Prospective|||||||
1320306|NCT03331731||Single Group Assignment||Treatment||None (Open Label)||Single arm, open label, phase II, international, multicentre study||||
1320307|NCT03331718|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320308|NCT03331705|||Case-Only||Prospective|||||||
1320309|NCT03331692|Randomized|Parallel Assignment||Prevention||Double|"During the anesthesia, in all the participants an AAI-A line ARX index was continuously monitored. The electrodes were placed after the induction of anesthesia.~Intraoperatively, both auditory evoked potentials with AAI index and electroencephalogram with burst suppression analysis was recorded. Recorded data were blinded for anesthesiologists, so were not used for analysis of level of anesthesia during surgery."|Participants are assigned to intravenous or volatile anesthesia. In both groups both the clinical and instrumental monitoring of the proper level of anesthesia was analyzed.|t|t||
1320310|NCT03331679||Single Group Assignment||Treatment||None (Open Label)||||||
1320311|NCT03331666|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1320312|NCT03331653|Randomized|Parallel Assignment||Treatment||Double|Double-blind, masking the patient and the outcomes assesor. A simple randomization will be performed with Epidat software.|Randomized Clinical Trial (RCT) with two groups.|t|||t
1320313|NCT03331640|Randomized|Crossover Assignment||Treatment||Single|||t|||
1320314|NCT03331627|Randomized|Parallel Assignment||Treatment||Double|double-blind|"intratympanic gel injection followed by 12 weeks oral treatment~intratympanic gel injection followed by 12 weeks oral treatment placebo~intratympanic gel injection placebo followed by 12 weeks oral treatment placebo"|t||t|
1320315|NCT03331614|Non-Randomized|Parallel Assignment||Treatment||Single|The data collected by the investigator will be submitted to the assessor without indication of which group is active and which is control.|Subjects will be sequentially divided into a control group or an active treatment group.||||t
1320316|NCT03331601||Single Group Assignment||Diagnostic||Single||||||t
1320361|NCT03331016|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized stepped wedge design with waitlist controls||||
1320362|NCT03331003|Randomized|Parallel Assignment||Treatment||Single|||||t|
1320420|NCT03330249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320317|NCT03331588|Randomized|Parallel Assignment||Treatment||Double|In the operating room a dressing will be placed so that it covers the entire hemithorax whereby the incision is hidden. This is done identically regardless of surgical technique. This dressing is left in place until discharge. If changing of the dressing is needed, either the project-nurse or a nurse for another team will assist.|Parallel Assignment|t|t||
1320318|NCT03331575|Randomized|Parallel Assignment||Treatment||Single|||||t|
1320319|NCT03331562|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo controlled|This is a double-blind, randomized, placebo-controlled phase II trial with the identity of the treatment unknown to the patients, investigators, and the Sponsor.|t|t|t|t
1320320|NCT03331549|||Cohort||Prospective|||||||
1320321|NCT03331536|||Cohort||Prospective|||||||
1320322|NCT03331523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320323|NCT03331510|||Cohort||Prospective|||||||
1320324|NCT03331497|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320325|NCT03331484||Single Group Assignment||Prevention||None (Open Label)||||||
1320326|NCT03331471|Randomized|Parallel Assignment||Prevention||Double||ARM group-applying alveolar recruitment maneuver Conventional goup-not applying alveolar recruitment maneuver|t|||t
1320327|NCT03331458||Single Group Assignment||Supportive Care||None (Open Label)||||||
1320328|NCT03331445||Sequential Assignment||Treatment||None (Open Label)||Open label safety study||||
1320329|NCT03331432|Randomized|Crossover Assignment||Basic Science||Single|Participants are not told which are placebo or tauroursodeoxycholic acid capsules|Single-blinded randomized crossover study|t|||
1320330|NCT03331419|||Case-Only||Prospective|||||||
1320331|NCT03331406||Single Group Assignment||Supportive Care||None (Open Label)||||||
1320332|NCT03331393|||Cohort||Retrospective|||||||
1320333|NCT03331380|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1320334|NCT03331367|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||This study involves four arms consisting of patients who have undergone either total cryotherapy, focal cryotherapy, Cyberknife SBRT or radical prostatectomy.||||
1320335|NCT03331354|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessors will be blinded to conditions|Patients will be randomly assigned to either a distance learning program (COMPASS) or basic vocational services.||||t
1320336|NCT03331341||Single Group Assignment||Treatment||None (Open Label)||||||
1320337|NCT03331328|Randomized|Parallel Assignment||Treatment||Triple||All subjects will be consented for the study prior to the procedure. They will be made aware of the meaning of case control study. Subjects will be randomized to a treatment or a non-treatment group.|t||t|t
1320338|NCT03331315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320339|NCT03331302|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||COPD patients with standard vs study diagnostic methods (imaging procedures)||||
1320340|NCT03331289|Randomized|Single Group Assignment||Basic Science||None (Open Label)||Participants will be randomized to one of four groups (20 per group): i) placebo; (ii) exenatide 5 ug subcutaneously; (iii) dapagliflozin (10 mg); and (iv) dapagliflozin 10 mg plus exenatide 5 ug||||
1320341|NCT03331276|Randomized|Parallel Assignment||Other||Quadruple|This study is a randomized, controlled, double-blind, study of healthy term formula fed (FF) infants.|Formula feed infants will be randomized to receive either a new infant formula formulated for healthy term infants (Formula B) or a commercially available infant formula for healthy term infants (Formula A). Infants will consume the formula for a total of 16-weeks.|t|t|t|t
1320342|NCT03331263|Randomized|Crossover Assignment||Prevention||Single|laboratory-blinded, 3-period, 3-sequence, crossover study|||||t
1320343|NCT03331250||Single Group Assignment||Treatment||None (Open Label)||||||
1320344|NCT03331237|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1320345|NCT03331224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320346|NCT03331211|||Case-Only||Prospective|||||||
1320347|NCT03331198|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 1: subjects will be assigned to receive JCAR017, or JCAR017 + ibrutinib Phase 2: subjects will be randomized to receive JCAR017 or standard of care. Patients who receive standard of care may cross over to receive JCAR017 in the event of disease progression.||||
1320348|NCT03331185|Randomized|Parallel Assignment||Treatment||None (Open Label)||A prospective,randomized clinical trial will be conducted. The trial aims at obtaining information to determine which material would provide a superior clinical result, as well as reporting on patient related outcomes. 42 participants will be randomly assigned to two groups and a direct comparison will be made between the results obtained from the two groups.||||
1320349|NCT03331172||Single Group Assignment||Treatment||None (Open Label)||||||
1320350|NCT03331159|Randomized|Parallel Assignment||Treatment||Single||Randomized clinical trial|t|||
1320351|NCT03331146|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1320352|NCT03331133|||Cohort||Prospective|||||||
1320353|NCT03331120|Randomized|Parallel Assignment||Treatment||Double||A pilot single-blind randomized controlled trial, 24 patients will be randomized to into two groups (study and control) by block randomization. The both groups will receive conventional treatment consisting of moist hot pack, soft tissue mobilization, manual therapy, therapeutic exercise. Additionally, the study group will receive ambulatory mirror image functional re-training through wearing 3D adjustable CTPCO.|||t|t
1320354|NCT03331107|||Cohort||Prospective|||||||
1320355|NCT03331094|||Case-Control||Prospective|||||||
1320356|NCT03331081|Randomized|Parallel Assignment||Treatment||Single||||||t
1320357|NCT03331068|||Cohort||Prospective|||||||
1320358|NCT03331055|Randomized|Parallel Assignment||Treatment||Quadruple|Participant is allocated randomly by staff A, and grouping situation is concealed; Technician (stuff B) or chargeing docotor operates PENS or TENS, or administers oral analgesic medication; Related datas are collected according to perdetermined forms by stuff C; Outcomes are assessed by stuff D.|patients with pancreatic cancer pain|t|t|t|t
1320359|NCT03331042|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1320360|NCT03331029||Single Group Assignment||Basic Science||None (Open Label)||Single Center interventional study||||
1321266|NCT03319238|||Cohort||Prospective|||||||
1320363|NCT03330990||Single Group Assignment||Other||None (Open Label)||All patients entering this study will receive midazolam and entrectinib.||||
1320364|NCT03330977||Single Group Assignment||Treatment||None (Open Label)||Comparison before/after||||
1320365|NCT03330964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320366|NCT03330951|||Cohort||Prospective|||||||
1320367|NCT03330938|Randomized|Parallel Assignment||Treatment||Single|Evaluation measures|Prospective, parallel, randomized clinical trial|||t|
1320368|NCT03330925||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1320369|NCT03330912|Randomized|Single Group Assignment||Treatment||None (Open Label)||Single subject - participants will be compared to themselves. STROBE guidelines will be followed.||||
1320370|NCT03330899|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1320371|NCT03330886|||Cohort||Prospective|||||||
1320372|NCT03330873|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1320373|NCT03330860|Randomized|Crossover Assignment||Other||None (Open Label)||Crossover randomized clinical trial||||
1320374|NCT03330847|Randomized|Parallel Assignment||Treatment||None (Open Label)|Given the study treatment design (monotherapy and 2 different combination therapies will be employed) neither patients nor Investigators will be blinded to study treatment.|||||
1320375|NCT03330834||Single Group Assignment||Treatment||None (Open Label)||||||
1320376|NCT03330821||Single Group Assignment||Treatment||None (Open Label)||||||
1320377|NCT03330808|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1320378|NCT03330795||Single Group Assignment||Treatment||None (Open Label)||||||
1320379|NCT03330782|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1320380|NCT03330769|||Cohort||Prospective|||||||
1320381|NCT03330756|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single-center, open randomized controlled clinical trial||||
1320382|NCT03330743|Randomized|Parallel Assignment||Treatment||Single||||||t
1320383|NCT03330730|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320384|NCT03330717|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1320385|NCT03330704|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1320386|NCT03330691||Single Group Assignment||Treatment||None (Open Label)||||||
1320387|NCT03330678||Single Group Assignment||Basic Science||None (Open Label)||Healthy young women will be given VSL#3 for 4 weeks||||
1320388|NCT03330665|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320389|NCT03330652|||Cohort||Prospective|||||||
1320390|NCT03330639|Randomized|Parallel Assignment||Treatment||Single||Randomized parallel group|t|||
1320391|NCT03330626|Randomized|Parallel Assignment||Treatment||None (Open Label)||One is control for the patients under conventional methods (I/O based fluid monitoring). The other is case for the patients under Inbody S10 methods.||||
1320392|NCT03330613|Randomized|Parallel Assignment||Screening||Double|||t|t||
1320393|NCT03330600|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1320394|NCT03330587|||Ecologic or Community||Prospective|||||||
1320395|NCT03330574|||Cohort||Prospective|||||||
1320396|NCT03330561||Single Group Assignment||Treatment||None (Open Label)|None (Open Label)|Drug PRS-343 Monotherapy||||
1320397|NCT03330548|Randomized|Parallel Assignment||Treatment||Single|The assessor for the imaging studies will be blinded to the study arms of the subjects.|Subjects will be randomized 2:1 into Culinary Rx or TeleMOVE! prior to baseline measures. We plan to enroll a subset of the 80 participants to undergo a PET-MRI sub-study (total of 21 participants). This cohort requires participants to have a pooled cohort risk score of ≥ 7.5%, be willing and able to undergo FDG-PET-MRI. [The ACC/AHA pooled risk calculator utilizes information such as age, lipid profile, hypertension to estimate 10 year risk of ASCVD.||||t
1320398|NCT03330535|Randomized|Parallel Assignment||Prevention||Triple||Four groups of participants will be formulated. Each will will receive messages in different time interval starting from none, once a week, three times a week and daily.||t|t|t
1320399|NCT03330522|Randomized|Parallel Assignment||Prevention||Single|||t|||
1320400|NCT03330509|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||"A stepped-wedge design will be used for this study, unblinded due to practical challenges of blinding. There will be 4 teams (clusters) within the DMO inpatient service, each comprising a team of senior consultant physicians, middle level and junior doctors, and oncology nurses. This follows current team structures. During the intervention period, a palliative care physician and nurse will join the team as integrated members.~The study will be conducted over 20 months from November 2017 to June 2019, with each cluster crossing over from 'usual care' to 'spark intervention' at 4-month intervals. Each cluster will be randomly assigned a specific timing of crossing over."||||
1320401|NCT03330496|||Cohort||Prospective|||||||
1320402|NCT03330483|||Case-Control||Prospective|||||||
1320403|NCT03330470|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1320404|NCT03330457|Randomized|Parallel Assignment||Treatment||Triple|Double Blind||t|t|t|
1320405|NCT03330444|||Cohort||Prospective|||||||
1320406|NCT03330431|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320407|NCT03330418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320408|NCT03330405|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320409|NCT03330392|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1320410|NCT03330379|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320411|NCT03330366|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1320412|NCT03330353|||Cohort||Prospective|||||||
1320413|NCT03330340|||Cohort||Prospective|||||||
1320414|NCT03330327|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320415|NCT03330314|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320416|NCT03330301|||Ecologic or Community||Prospective|||||||
1320417|NCT03330288|||Cohort||Prospective|||||||
1320418|NCT03330275|Randomized|Crossover Assignment||Treatment||Single|||t|||
1320419|NCT03330262|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320421|NCT03330236|Randomized|Parallel Assignment||Prevention||Double|This is a double blinded, randomized and controlled parallel trial|The study is a prospective, double blinded, randomized 1:1 and controlled parallel trial.|t|t||
1320422|NCT03330223|||Cohort||Prospective|||||||
1320423|NCT03330210|||Other||Prospective|||||||
1320424|NCT03330197||Single Group Assignment||Treatment||None (Open Label)||There will be two groups of patients enrolled.||||
1320425|NCT03330184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320426|NCT03330171|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Participants receive measles vaccine as part of routine medical care at 6 and 12 months of age. Half of the participants will receive varicella vaccine at 18 months of age and the other half will receive hepatitis-A at 18 months of age. All vaccines are administered according to their approved dosages, formulations and indications.||||
1320427|NCT03330158||Single Group Assignment||Treatment||None (Open Label)||||||
1320428|NCT03330145|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320429|NCT03330132|Randomized|Parallel Assignment||Prevention||Triple||Annual vaccination with standard influenza vaccine or enhanced influenza vaccine, including some combination strategies (alternating each year) and some strategies with the same vaccine administered each year|t||t|t
1320430|NCT03330119|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320431|NCT03330106|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1320432|NCT03330093|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320433|NCT03330080|||Cohort||Prospective|||||||
1320434|NCT03330067|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Before surgery patients will be assigned to one of two types of CO2 gas (conventional-room temperature and dry, or conditioned-95°F and 95% humidity) by a method similar to the flip of a coin.||||
1320435|NCT03330054|||Case-Control||Retrospective|||||||
1320436|NCT03330041|Randomized|Single Group Assignment||Other||Single||At the follow-up visit, two blinded observers will record their scores independently using the physician observer scar assessment score instrument (POSAS).||||t
1320437|NCT03330028||Single Group Assignment||Treatment||None (Open Label)||||||
1320438|NCT03330015|||Cohort||Prospective|||||||
1320439|NCT03330002|||Cohort||Prospective|||||||
1320440|NCT03329989||Single Group Assignment||Treatment||None (Open Label)||||||
1320441|NCT03329976|||Cohort||Prospective|||||||
1320442|NCT03329963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320443|NCT03329950|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1320444|NCT03329937||Single Group Assignment||Treatment||None (Open Label)||||||
1320445|NCT03329924|||Cohort||Prospective|||||||
1320446|NCT03329911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320447|NCT03329898|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1320448|NCT03329885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320449|NCT03329872|||Cohort||Prospective|||||||
1320450|NCT03329859|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1320451|NCT03329846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320452|NCT03329833|Randomized|Factorial Assignment||Other||Double|Participants will be aware which group they are assigned to. Study team members who will be providing assessments will be blinded to the condition the participant is in.|This study examines how a web-based application and/or motivational interviewing impact a participant's exercise routine compared to an educational control group.||t||t
1320453|NCT03329820|||Case-Only||Cross-Sectional|||||||
1320454|NCT03329807|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1320455|NCT03329794||||||||||||
1320456|NCT03329781|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1320457|NCT03329768|||Cohort||Prospective|||||||
1320458|NCT03329755|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1320459|NCT03329742|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a longitudinal randomized parallel groups design of n=30 subjects randomized in a 1:1 ratio to either sipuleucel-T plus control diet arm (20% protein content) or sipuleucel-T plus intervention low-protein content diet (10% protein diet).||||
1320460|NCT03329729|||Other||Prospective|||||||
1320461|NCT03329716|Randomized|Parallel Assignment||Treatment||None (Open Label)||A non-blinded, randomized controlled trial for testing two brace weaning protocols, being immediate removal of brace or gradual weaning of brace, over a course of 6 months.||||
1320462|NCT03329703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320463|NCT03329690|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Two randomized investigative arms will run in parallel (DS-8201a and Physician's Choice), with participants who have disease progression after two previous regimens.~Two non-randomized exploratory arms will run with HER2 treatment-naive participants."||||
1320464|NCT03329677||Single Group Assignment||Treatment||None (Open Label)|Not applicable. Treatment is transference-focused psychotherapy for borderline personality disorder and each participant understands that she will receive it for 18 months.|Our study is a longitudinal (i.e., 18-month) treatment outcome study using a within-subjects design with repeated measures. We do not include a control group or a TAU group in our study design.||||
1320465|NCT03329664|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1320466|NCT03329651|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1320467|NCT03329638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320468|NCT03329625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320469|NCT03329612|Randomized|Parallel Assignment||Prevention||Single|||t|||
1320517|NCT03328988|Randomized|Parallel Assignment||Treatment||None (Open Label)|Patients are randomized and allocated in blocks of ten to either epidural of QLB group|Prospective randomized controlled study||||
1320518|NCT03328975|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1320749|NCT03325972|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1320803|NCT03325270|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1320470|NCT03329599|Randomized|Parallel Assignment||Treatment||Quadruple||SMAART incorporates (i) a pilot randomized controlled trial and (ii) a human capital/institutional capacity building component. We propose a randomized, open label, blinded endpoint clinical trial with the intervention arm assigned to a polypill containing 2/3 antihypertensives, a moderate/high-intensity statin and Aspirin to be taken orally, once daily in the form of a hard capsule compared with the 'usual care' arm who will continue to take separate, individual secondary preventive medications as prescribed their physicians to assess CIMT changes as a robust intermediary outcome measure for CVD events, as well as adherence, tolerability, and risk factor control rates. Furthermore, a cadre of emerging investigators from Ghana will benefit from the rich learning environment to be created through the implementation of the RCT and the interactions (2 years) with experts from the Medical University of South Carolina.|t|t|t|t
1320471|NCT03329586||Single Group Assignment||Treatment||None (Open Label)||||||
1320472|NCT03329573|Randomized|Crossover Assignment||Treatment||None (Open Label)|This study is an open-label treatment period; hence, masking will not be performed.|In this study, each subject will receive paroxetine IR 40mg A or B in a cross-over manner||||
1320473|NCT03329560||Single Group Assignment||Treatment||None (Open Label)||||||
1320474|NCT03329547|Randomized|Crossover Assignment||Treatment||None (Open Label)|This will be an open-label study. Hence, masking will not be provided.|This will be a two-period crossover study. Subjects will receive single oral dose of cefixime 400 mg test capsules and cefixime 400 mg reference capsules in treatment period 1 and 2 under fasting conditions.||||
1320475|NCT03329534|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1320476|NCT03329521|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1320477|NCT03329508|Randomized|Parallel Assignment||Treatment||Triple|double blind study|4 arms|t|t|t|
1320478|NCT03329495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320479|NCT03329482|Randomized|Parallel Assignment||Treatment||Single|One of the Physiotherapist who carried out the assessment especially when the intervention started did not aware of the study|A total number of 50 subjects were enrolled for the study: 25 subjects for the PUS group and 25 subjects for the KM group in order to give room for attrition. For the purpose of the study the following instruments were used: verbal-rating scale, Roland-Morris disability questionnaire, and an ultrasound machine||||t
1320480|NCT03329469||Single Group Assignment||Diagnostic||None (Open Label)||||||
1320481|NCT03329456||Single Group Assignment||Treatment||None (Open Label)||||||
1320482|NCT03329443|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1320483|NCT03329430||Single Group Assignment||Treatment||None (Open Label)||||||
1320484|NCT03329417|Randomized|Parallel Assignment||Treatment||Single||||||t
1320485|NCT03329404|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1320486|NCT03329391|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1320487|NCT03329378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320488|NCT03329365|||Cohort||Prospective|||||||
1320489|NCT03329352||||||||||||
1320490|NCT03329339|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1320491|NCT03329326|||Cohort||Cross-Sectional|||||||
1320492|NCT03329313|Randomized|Parallel Assignment||Treatment||Single|simple blind||t|||
1320493|NCT03329300||Single Group Assignment||Treatment||None (Open Label)||||||
1320494|NCT03329287|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1320495|NCT03329274|||Cohort||Prospective|||||||
1320496|NCT03329261|Randomized|Parallel Assignment||Treatment||None (Open Label)||A comparative, interventional, multicenter, randomized, prospective, two-arm study with monotherapy in two different doses||||
1320497|NCT03329248||Single Group Assignment||Treatment||None (Open Label)||||||
1320498|NCT03329235|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320499|NCT03329222|Randomized|Parallel Assignment||Other||Quadruple|Double-blind|Randomized, two arms|t|t|t|t
1320500|NCT03329209||Single Group Assignment||Other||None (Open Label)||||||
1320501|NCT03329196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320502|NCT03329183|Randomized|Parallel Assignment||Treatment||Single|||||t|
1320503|NCT03329170|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1320504|NCT03329157||Single Group Assignment||Supportive Care||None (Open Label)||Single group design.||||
1320505|NCT03329144||Single Group Assignment||Treatment||None (Open Label)||||||
1320506|NCT03329131||Single Group Assignment||Treatment||None (Open Label)||||||
1320507|NCT03329118||Single Group Assignment||Treatment||None (Open Label)||||||
1320508|NCT03329105|Randomized|Parallel Assignment||Prevention||Single||||||t
1320509|NCT03329092|Randomized|Parallel Assignment||Treatment||Single|"An independent adjudication committee (central blinded assessor) will be convened at regular intervals during the study. The adjudication committee will be blinded to study treatment and will review the clinical response assessments at each visit. In case of a discrepancy with the Investigator's assignment of clinical response, the adjudication committee's assessment will prevail.~In addition, for cIAI subjects classified as a clinical failure, and all cIAI subjects classified as a cure who undergo another procedure (eg, another surgical procedure) subsequent to randomization, the expert panel will review the adequacy of the surgical source control."|Prospective, Randomized, Multicenter, Open Label, Central Assessor Blinded, Parallel Group, Comparative Study||||t
1320510|NCT03329079|Randomized|Parallel Assignment||Prevention||None (Open Label)|The research nurse will know which group assignment the subject has been given as is required for him to download the appropriate app and provide training on the technology to the subject.|||||
1320511|NCT03329066|Randomized|Parallel Assignment||Treatment||Single|The research assistants who interview the teenager and their parents/caregivers will not know to which arm the participants are randomized.|||||t
1320512|NCT03329053|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320513|NCT03329040|||Case-Control||Retrospective|||||||
1320514|NCT03329027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320515|NCT03329014|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1320516|NCT03329001|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1320519|NCT03328962|Randomized|Sequential Assignment||Prevention||None (Open Label)||"The intervention group will receive structured smoking cessation counselling based on MI and adapted for the cancer setting combined with provision of smoking cessation medication (nicotine replacement therapy) while in the control group there will be standard care which may vary from hospital to hospital (intervention program and standard care will be described in details later).~The recruitment period for the control group will be from September 2017 to March 2018. Participants in the control group will be invited to answer a follow up questionnaire after 6 months. Six months after the last recruited participant to the control group, i.e. from September 2018, recruitment of participants to the intervention group will begin and last for six months, to the end of February 2019 and the participants in the intervention group will be followed for 6 months, to the end of August 2019. The figure below gives an overview of the timing of recruitment and observations."||||
1320520|NCT03328949||Single Group Assignment||Treatment||None (Open Label)||Intravascular Coronary Lithotripsy System||||
1320521|NCT03328936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320522|NCT03328923|Randomized|Parallel Assignment||Other||Triple||Participants will receive either 500mg brown seaweed powder (InSea2) or placebo|t||t|t
1320523|NCT03328910|||Cohort||Prospective|||||||
1320524|NCT03328897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320525|NCT03328884||Single Group Assignment||Treatment||None (Open Label)||This is an international, prospective, open-label, multicenter, single arm, two-stage Simon Design phase II clinical trial||||
1320526|NCT03328871|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1320527|NCT03328858||Single Group Assignment||Supportive Care||None (Open Label)||"Ketogenic Diet will be initiated as inpatient, once all necessary studies are obtained and reviewed. The classic ketogenic diet will be initiated, and once ketosis is reached and patient demonstrates tolerance to diet he/she will be discharged home. Follow-up visits will be necessary up to 1 year."||||
1320528|NCT03328845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320529|NCT03328832|Randomized|Parallel Assignment||Prevention||Single|||t|||
1320530|NCT03328819|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1320531|NCT03328806|||Case-Only||Cross-Sectional|||||||
1320532|NCT03328793|Randomized|Parallel Assignment||Other||Single|The research assistant who will be doing the Visual Analog Mood Scale (VAMS) with the patients pre and post intervention will be blinded in regards to the group attribution of the patient.|||||t
1320533|NCT03328780|||Cohort||Prospective|||||||
1320534|NCT03328767|Randomized|Parallel Assignment||Treatment||Single||A 30 patient, multicentre, randomised, trial of early individualised physical training compared to standard care.||||t
1320535|NCT03328754|Randomized|Parallel Assignment||Treatment||Double|Randomization was done with Simple Randomisation method to ensure 1:1 allocation ratio and allocation concealment was achieved with similar looking sealed opaque envelopes. The name of the groups 'Forsus' and 'PowerScope' were written on 13 pieces of paper resulting in total 26 pieces of paper which were folded and shuffled in a box, then taken out and without opening put in 26 opaque envelopes which were then sealed and kept again in the box. The envelopes were shuffled inside the box each time the patient was asked to pick one envelope from the box .The patient was assigned to the group mentioned in the envelope which was opened by the primary investigator who was not involved in data analysis..|Comparative evaluation of treatment effects of PowerScope and Forsus|t|||t
1320536|NCT03328741|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1320537|NCT03328728|Randomized|Parallel Assignment||Treatment||Single||||||t
1320538|NCT03328715|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1320539|NCT03328702||Single Group Assignment||Supportive Care||None (Open Label)||||||
1320540|NCT03328689|Randomized|Parallel Assignment||Prevention||Double|Given that this is an exercise study blinding of participants and those delivering the exercise program will not be possible. Outcome measures will be collected by an investigator not aware of treatment allocation, but most outcome measures will be self-reported and thus, true assessor blinding will no be possible. All statistical analysis will be conducted by a blinded investigator.||||t|t
1320541|NCT03328676|Randomized|Parallel Assignment||Treatment||Triple||A Phase II, Randomized, Double-blind, Placebo-controlled Trial|t|t|t|
1320542|NCT03328663|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320543|NCT03328650||Single Group Assignment||Diagnostic||None (Open Label)||Participants who have elected to participate in the optional, interventional arm of this study will undergo routine proximal humeral plate fixation for their proximal humerus fracture. Once the participant has been anesthetized prior to stabilizing the fracture with a ALPS proximal humerus plate, the participant's arm will be secured and the orthopaedic surgeon will indent the proximal humeral metaphysis, distal to the site of the fracture, at 10 to 15 locations ((~2 mm apart) using the OsteoProbe-RPI. The indent size is approximately ~300 μm in diameter and ~300 μm in depth.||||
1320544|NCT03328637|Randomized|Parallel Assignment||Treatment||Single||The study is a Randomized Controlled Trial (RCT) with single blind rating. The randomization of participants is across two groups (1) one provided with intervention of CBT and (2) the other group will be on Treatment As Usual (TAU)||||t
1320545|NCT03328624||Single Group Assignment||Other||None (Open Label)||||||
1320546|NCT03328611|||Cohort||Prospective|||||||
1320547|NCT03328598|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320548|NCT03328585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320549|NCT03328572|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1320550|NCT03328559|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1320551|NCT03328546|||Cohort||Prospective|||||||
1320552|NCT03328533|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1320553|NCT03328520||Single Group Assignment||Other||None (Open Label)||||||
1320554|NCT03328507|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320555|NCT03328494|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320556|NCT03328481|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1320557|NCT03328468||Single Group Assignment||Basic Science||None (Open Label)||||||
1320804|NCT03325257|||Cohort||Retrospective|||||||
1320558|NCT03328455|Randomized|Parallel Assignment||Basic Science||Single|40 elderly participants will be randomly assigned to one of the two training groups but will not be told whether they are in the active or passive training group.|40 elderly participants will be randomly assigned to one of the two training groups and will be asked to undergo 5 days of active or passive training.|t|||
1320559|NCT03328442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320560|NCT03328429|Randomized|Parallel Assignment||Treatment||Single|||||t|
1320561|NCT03328416||Single Group Assignment||Other||None (Open Label)||||||
1320562|NCT03328403|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized to use either the Aspiration System or one of the stent-retreivers (Trevo / Solitaire) first. Other devices would be used if the first device failed to open the occluded vessel satisfactorily, depending on clinical situation and the involved interventionists' preferences.||||
1320563|NCT03328390|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1320564|NCT03328377|||Case-Control||Prospective|||||||
1320565|NCT03328364|||Cohort||Retrospective|||||||
1320566|NCT03328351|Randomized|Parallel Assignment||Treatment||Double||triple-blind (The researcher was blinded to the outcome measures, whereas the assessor, who performed the outcome measures was blinded to the patient groups. The patient was blinded to treatment)|t|||t
1320567|NCT03328338|||Case-Only||Prospective|||||||
1320568|NCT03328325||Single Group Assignment||Prevention||None (Open Label)||||||
1320569|NCT03328312|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1320570|NCT03328299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320571|NCT03328286||Single Group Assignment||Treatment||None (Open Label)||||||
1320572|NCT03328273|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320573|NCT03328260||Single Group Assignment||Treatment||None (Open Label)||||||
1320574|NCT03328247|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1320575|NCT03328234|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1320576|NCT03328221|||Other||Prospective|||||||
1320577|NCT03328208|Randomized|Parallel Assignment||Other||Triple|"The four tablets used in the study will be labeled A,B,C,D and will be preloaded with the app or white noise by the Hypnalgesics, LLC in randomized sequence. Personnel at TUSDM will not be aware which tablet presents test or control content. The opening screen and option screen of the white noise control app will use the same color scheme and lay-out as the one of the test Comfort Talk app. The statistical team will receive the encoded data entries and will not be informed about the content of the tablets until all analyses are completed. Since they also will not have direct contact with the study patients they are also not at risk of becoming unblinded during app use by the patients.~At the end of their visit, patients will receive a sealed envelope which according to their number will either contain a download coupon for the app for home use or a thank you note. To maintain blinding, all patients who send their diaries back will receive a download coupon."|This is a single-blind placebo-controlled trial comparing a Comfort Talk® calmative app (App Group) with a white noise app (Control Group).||t|t|t
1320578|NCT03328195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320579|NCT03328182||Single Group Assignment||Other||None (Open Label)||||||
1320580|NCT03328169|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320581|NCT03328156|||Cohort||Prospective|||||||
1320582|NCT03328143||Single Group Assignment||Other||None (Open Label)||||||
1320583|NCT03328130|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Four successive cohorts separated by DSMC assessments||||
1320584|NCT03328117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320585|NCT03328104||Single Group Assignment||Treatment||None (Open Label)||||||
1320586|NCT03328091|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320587|NCT03328078||Single Group Assignment||Treatment||None (Open Label)||||||
1320588|NCT03328065|||Case-Only||Prospective|||||||
1320589|NCT03328052|Randomized|Parallel Assignment||Treatment||Single|All patients undergo EEG, but results are not released to physician or patient in the control group.||t|||
1320590|NCT03328039|||Cohort||Prospective|||||||
1320591|NCT03328026||Single Group Assignment||Treatment||None (Open Label)||||||
1320592|NCT03328013|||Cohort||Prospective|||||||
1320593|NCT03328000|||Cohort||Prospective|||||||
1320594|NCT03327987|||Case-Only||Prospective|||||||
1320595|NCT03327974||Single Group Assignment||Other||None (Open Label)||||||
1320596|NCT03327961|||Cohort||Prospective|||||||
1320597|NCT03327948||Single Group Assignment||Treatment||None (Open Label)||||||
1320598|NCT03327935|Randomized|Parallel Assignment||Treatment||None (Open Label)|Baseline data are collected prior to the randomization and thus are masked. But during and after the intervention both participants and investigators are unblinded.|3 groups of 50 patients each by randomization||||
1320599|NCT03327922|Randomized|Factorial Assignment||Other||Single||At the follow-up visit, two blinded observers will record their scores independently using the physician observer scar assessment score instrument (POSAS).||||t
1320600|NCT03327909|Randomized|Parallel Assignment||Treatment||None (Open Label)||Cluster randomized parallel group trial||||
1320601|NCT03327896|||Case-Only||Retrospective|||||||
1320602|NCT03327883|||Cohort||Retrospective|||||||
1320603|NCT03327870|||Case-Control||Cross-Sectional|||||||
1320604|NCT03327857||Single Group Assignment||Treatment||None (Open Label)||||||
1320605|NCT03327844|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1320606|NCT03327831||Single Group Assignment||Treatment||None (Open Label)||||||
1320607|NCT03327818|||Case-Only||Retrospective|||||||
1320608|NCT03327805|Randomized|Crossover Assignment||Prevention||Double||Double-blind, placebo-controlled, crossover design|t|||t
1320609|NCT03327792|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1320610|NCT03327779|||Ecologic or Community||Prospective|||||||
1320611|NCT03327766|||Case-Control||Prospective|||||||
1320702|NCT03326583|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1320703|NCT03326570|||Cohort||Prospective|||||||
1320612|NCT03327753|Randomized|Parallel Assignment||Treatment||Double|Given that this is an exercise study blinding of participants and those delivering the exercise program will not be possible. Outcome measures will be collected by an investigator not aware of treatment allocation, but most outcome measures will be self-reported and thus, true assessor blinding will no be possible. All statistical analysis will be conducted by a blinded investigator.|Participants will be randomized into one of two groups, both of which are exercises considered part of standard care.|||t|t
1320613|NCT03327740|||Cohort||Prospective|||||||
1320614|NCT03327727|Randomized|Parallel Assignment||Treatment||Single|The Sponsor, safety monitoring board, and data review committee are masked.|||||t
1320615|NCT03327714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Children in classes that perform regular mindfulness are compared to children in classes that do not.||||
1320616|NCT03327701|Randomized|Parallel Assignment||Treatment||Triple|The study will be conducted under double-blind conditions. Neither the subject nor the investigator and clinical site personnel will know which medication is administered. The medication given will be determined according to a randomization table handled by a collaborating IUCPQ-UL pharmacist. Only the pharmacist responsible for preparing the medication for the randomized patients will have access to information on treatment allocations (unblended). Benralizumab and placebo solutions for injection in an accessorized pre-filled syringe (PFS) will have the same packaging.|This study is a parallel study, double-blind, placebo controlled randomized trial, with a ratio placebo-active drug 1:2.|t|t|t|
1320617|NCT03327688|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Part 1: All referrals to hospital due to a suspected DVT before intervention in year 2014, vs all referrals due to a suspected DVT after intervention in year 2017.~Part 2: POCUS group vs radiologist group"||||
1320618|NCT03327675||Single Group Assignment||Diagnostic||None (Open Label)||||||
1320619|NCT03327662|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with CTC count >5 CTC/7.5 mL at screening will be randomised 1:1 to either the control group (standard of care) or intervention group (CTC guided treatment). All patients will commence first line chemotherapy with docetaxel 75mg/m2 three-weekly and will receive a minimum of 3 cycles of treatment before any recommendation to discontinue first-line docetaxel.||||
1320620|NCT03327649|Randomized|Parallel Assignment||Treatment||Quadruple|double blind|randomized controlled trial|t|t|t|t
1320621|NCT03327636|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be arranged into either HIFU group or AS group randomly||||
1320622|NCT03327623|||Cohort||Prospective|||||||
1320623|NCT03327610|Randomized|Crossover Assignment||Treatment||Single||||||t
1320624|NCT03327597|Randomized|Parallel Assignment||Screening||Quadruple|Investigators and participants will be blinded to what participants are in the normal group and which participants are in arm 1 in the MGUS-group.||t|t|t|t
1320625|NCT03327584|Randomized|Parallel Assignment||Treatment||Single||||t||
1320626|NCT03327571|||Cohort||Retrospective|||||||
1320627|NCT03327558|Randomized|Parallel Assignment||Treatment||Double||Single center, laboratory-blinded, randomized, two-treatment, two-sequence, four-period, full replicate, crossover bioequivalence study|t|t||
1320628|NCT03327545|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320629|NCT03327532||Single Group Assignment||Other||None (Open Label)||||||
1320630|NCT03327519|Randomized|Parallel Assignment||Treatment||None (Open Label)||experimental, longitudinal, randomized controlled trial||||
1320631|NCT03327506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320632|NCT03327493||Single Group Assignment||Diagnostic||None (Open Label)||"Refractory cardiogenic shock patients under ECLS. Assessment at ECLS start, day 3 and Day ECLS weaning for various biological variables"||||
1320633|NCT03327480|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled prospective trial||||
1320634|NCT03327467||||||||||||
1320635|NCT03327454|||Case-Only||Cross-Sectional|||||||
1320636|NCT03327441|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1320637|NCT03327428|||Cohort||Prospective|||||||
1320638|NCT03327415|||Cohort||Cross-Sectional|||||||
1320639|NCT03327402||Single Group Assignment||Treatment||None (Open Label)||||||
1320640|NCT03327389|Randomized|Parallel Assignment||Prevention||Triple|participants, investicator, outcome assessors will be blinded for group allocation.|"Dexmedetomidine group~Control group"|t||t|t
1320641|NCT03327376|||Cohort||Prospective|||||||
1320642|NCT03327363|Randomized|Parallel Assignment||Other||None (Open Label)||a prospective, randomized controlled, multicenter study||||
1320643|NCT03327350|||Cohort||Prospective|||||||
1320644|NCT03327337|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1320645|NCT03327324||Single Group Assignment||Supportive Care||None (Open Label)||||||
1320646|NCT03327311|||Case-Only||Prospective|||||||
1320647|NCT03327298||Single Group Assignment||Treatment||None (Open Label)||||||
1320648|NCT03327285||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1320649|NCT03327272|Randomized|Parallel Assignment||Prevention||Single|||t|||
1320650|NCT03327259|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320651|NCT03327246|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Matched intervention - control group study||||
1320652|NCT03327233|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Matched intervention - control group study||||
1320653|NCT03327220|Randomized|Parallel Assignment||Treatment||None (Open Label)||The active group will receive the iovera° treatment prior to a Total Knee Arthroplasty (TKA). The control group will receive a TKA and no iovera° treatment.||||
1320654|NCT03327207|||Cohort||Prospective|||||||
1320655|NCT03327194||Single Group Assignment||Treatment||None (Open Label)||Monocentric prospective interventional single-subject design||||
1320656|NCT03327181|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320657|NCT03327168|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||Each subject participates in PET/CT scans in room temperature conditions, during cold exposure and during i.v. infusion of adenosine.||||
1320748|NCT03325985|Randomized|Parallel Assignment||Supportive Care||Single|Estimated Enrollment (1350 patients, 675 caregivers)||t|||
1320658|NCT03327155||Single Group Assignment||Prevention||None (Open Label)||The study is proposed as implementation research to mimic the conditions that will occur when PrEP is rolled out at the population level. However, as the version of TDF/FTC used in this study, manufactured by Mylan, is not approved for use as PrEP in Australia, the study is conducted under the Clinical Trial Notification (CTN) scheme and within the CTN framework. After collection of consent and enrolment information, all follow-up information will be collected through electronic data capture to allow accurate and timely analyses.||||
1320659|NCT03327142|||Cohort||Retrospective|||||||
1320660|NCT03327129|||Case-Control||Cross-Sectional|||||||
1320661|NCT03327116||Single Group Assignment||Basic Science||None (Open Label)||||||
1320662|NCT03327103|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320663|NCT03327090|Randomized|Parallel Assignment||Other||Double|||t||t|
1320664|NCT03327077|Randomized|Parallel Assignment||Health Services Research||Single||Randomized|t|||
1320665|NCT03327064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320666|NCT03327051|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1320667|NCT03327038|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1320668|NCT03327025||Single Group Assignment||Supportive Care||None (Open Label)||||||
1320669|NCT03327012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320670|NCT03326999|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized controlled trial with two arms: one arm will receive adductor canal block and obturator nerve block with the local anesthetic bupivacaine; second arm will receive adductor canal block with bupivacaine and obturator nerve block with saline.|t|t|t|t
1320671|NCT03326986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320672|NCT03326973|||Cohort||Prospective|||||||
1320673|NCT03326960|||Cohort||Prospective|||||||
1320674|NCT03326947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320675|NCT03326934|Randomized|Crossover Assignment||Basic Science||Single|None of the subjects will be aware of the intent of the study to the type of chocolate consumed prior to each of two testing sessions|Randomized, single-masked crossover study to assess potential effects of dark chocolate vs. milk chocolate on multiple aspects of visual function and performance.|t|||
1320676|NCT03326921||Single Group Assignment||Treatment||None (Open Label)||||||
1320677|NCT03326908|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1320678|NCT03326895|||Cohort||Prospective|||||||
1320679|NCT03326882|Randomized|Parallel Assignment||Other||Single||||||t
1320680|NCT03326869|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|No Masking.|The study will be a prospective, multicenter, open label clinical trial where a maximum of 30 non-dominant eyes are implanted with the Raindrop Near Vision Inlay. Each surgical site will be responsible for assigning patients to either the delayed or the non-delayed groupings.||||
1320681|NCT03326856|Randomized|Factorial Assignment||Treatment||Quadruple||sequential, dose escalating study|t|t|t|t
1320682|NCT03326843||Single Group Assignment||Treatment||None (Open Label)||||||
1320683|NCT03326830|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single-center, open-label, parallel, randomized trial with 1:2 allocation ratio (2 patients assigned to standard oxygen therapy for 1 patient assigned to High Flow Nasal Oxygen therapy)||||
1320684|NCT03326817|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||Comparing the control group and intervention group||||
1320685|NCT03326804|||Case-Only||Prospective|||||||
1320686|NCT03326791|Randomized|Parallel Assignment||Prevention||Quadruple|Eligible patients will be allocated in a 1:1 ratio using a computer randomization procedure stratified by centre. The randomization will be blocked within each stratum.|Multi-centre, double-blinded, randomized, placebo-controlled clinical intervention trial.|t|t|t|t
1320687|NCT03326778|||Case-Only||Prospective|||||||
1320688|NCT03326765|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"2 groups:~30 Children(0-18y) withTSC without epilepsy~30 Adults(>18y) withTSC without epilepsy"||||
1320689|NCT03326752|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|N/A - There is no masking in this study.|"In the Dose Escalation phase of the study, 5 DV281 dose cohorts will be evaluated in combination with an approved anti-PD-1 Inhibitor.~The Dose Expansion phase of the study will establish the Recommended Phase 2 Dose of DV281 in combination with an approved anti-PD-1 inhibitor."||||
1320690|NCT03326739|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1320691|NCT03326726||Single Group Assignment||Prevention||None (Open Label)||||||
1320692|NCT03326713|Randomized|Parallel Assignment||Prevention||Double|Randomization will be single blinded. Research team members who are assessing the outcomes will be blinded to study arm assignment. Research staff who are conducting follow-up interviews will be blinded to group assignment as much as possible. At the beginning of the follow-up interviews, the interviewer will request that the participant does not reveal the study arm they were assigned to.|3-arm Randomized Controlled Trial|||t|t
1320693|NCT03326700|Randomized|Parallel Assignment||Treatment||None (Open Label)||176 men with unilateral inguinal hernia were randomized in two groups. Group T(n=88) were operated TEP and Group L(n:88) were operated by LH repair. Patients demografigs, perioperative findings were recorded. For all patients preoperative, postoperative 7th,30th and 90th day SF 36 and IIEF were filled up.||||
1320694|NCT03326687|Randomized|Parallel Assignment||Treatment||None (Open Label)||All participants will receive both the isolated and combined treatments in an ABAB or BABA order of phases.||||
1320695|NCT03326674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320696|NCT03326661|Randomized|Parallel Assignment||Treatment||None (Open Label)|masking is not possible|patients randomized to treatment by needle aspiration or tonsillectomy a chaud||||
1320697|NCT03326648|Randomized|Parallel Assignment||Basic Science||Single|Subjects and testers will not be blinded. All analyses of muscle samples will be performed blinded.|||||t
1320698|NCT03326635|||Cohort||Prospective|||||||
1320699|NCT03326622|Randomized|Parallel Assignment||Supportive Care||Single|single blinded|||||t
1320700|NCT03326609|Randomized|Sequential Assignment||Basic Science||Triple|||t||t|t
1320701|NCT03326596||Single Group Assignment||Prevention||None (Open Label)||Prospective Cohort||||
1320704|NCT03326557|Randomized|Parallel Assignment||Treatment||None (Open Label)|This is a non-blinded study in which subjects, medical staffs, and investigators are not blinded to group assignment. This is because both IOL methods are distinctly different procedure. However, both intervention arms are considered receiving equal treatment. In term of safety, both membrane sweeping and transcervical Foley catheter are non-pharmacological in nature and thus the risk of scar rupture does not differ in both methods. In term of efficacy, there is no previous study to compare effectiveness between these two methods. Individual studies revealed that membrane sweeping is likely to reduce the need for formal IOL in post-date pregnancy and transcervical Foley catheter could improve cervical favourability.|"Pregnant women with one previous Caesarean section who are indicated for induction of labour (IOL) and eligible will be recruited in the study.~Eligible subjects will be randomly assigned to one of the treatment groups below.~Group 1: IOL with membrane sweeping~Group 2: IOL with transcervical Foley catheter Blocked randomisation, in a block size of 6 and an allocation ratio of 1:1, will be performed using a computer-generated randomisation sequence by Research Randomizer (available online at https://www.randomizer.org/). The allocation assignment indicating membrane sweeping or transcervical Foley catheter will be sealed in sequentially numbered, opaque envelopes by principal investigator. Envelopes will be kept in a locked box in Labour Ward. When study consent is signed, the next sequential envelope will be taken out from the box and opened to determine allocation."||||
1320705|NCT03326544|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1320706|NCT03326531|||Case-Control||Retrospective|||||||
1320707|NCT03326518|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1320708|NCT03326505|Randomized|Parallel Assignment||Treatment||Single|||||t|
1320709|NCT03326492|||Cohort||Prospective|||||||
1320710|NCT03326479|||Cohort||Retrospective|||||||
1320711|NCT03326466|||Case-Control||Cross-Sectional|||||||
1320712|NCT03326453|Randomized|Parallel Assignment||Treatment||Single|The Principal investigator ,main supervisor and co-supervisor cannot be blinded as the implant placement technique for both groups will be different. In addition during assessment of 2ry outcome (bone height change) the x-ray will reveal the difference in the shape of both types of implants thus assessor couldn't be blind.||t|||
1320713|NCT03326440|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320714|NCT03326427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320715|NCT03326414|Randomized|Parallel Assignment||Treatment||Single||40 patients are to be investigated during the project. In phase one 20 patients are ventilated with constant PEEP of 10mbar and the tidal volume is set to 4-5ml/kg IBW or 8-10ml/kg IBW respectively. In phase two further 20 patients are ventilated with a constant tidal volume of 8ml/kg IBW and the PEEP is set to 3mbar or 12mbar respectively.|t|||
1320716|NCT03326401|||Case-Control||Retrospective|||||||
1320717|NCT03326388||Single Group Assignment||Treatment||None (Open Label)||Single Arm Study of Intermittent Schedule of Drug Dosing||||
1320718|NCT03326375|Randomized|Parallel Assignment||Treatment||None (Open Label)|open labled|||||
1320719|NCT03326362|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1320720|NCT03326349|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1320721|NCT03326336||Sequential Assignment||Treatment||None (Open Label)||3 dose-escalation cohorts with 3 subjects per each cohort plus 1 extension cohort at the highest well-tolerated dose.||||
1320722|NCT03326323|||Cohort||Prospective|||||||
1320723|NCT03326310||Single Group Assignment||Treatment||None (Open Label)||||||
1320724|NCT03326297|Randomized|Parallel Assignment||Treatment||Single||||||t
1320725|NCT03326284|Randomized|Parallel Assignment||Prevention||Single|The protein doses provided will be masked. As all participants will receive the same amount and the drinks will taste similarly.|: Forty women (~ 50 years) will be randomized to four groups. Following a five day hypocaloric diet (three groups) or an energy balanced diet (one group). The women will report to the laboratory to ingest one of three different protein doses.|t|||
1320726|NCT03326271|||Cohort||Retrospective|||||||
1320727|NCT03326258||Single Group Assignment||Treatment||None (Open Label)||||||
1320728|NCT03326245||Single Group Assignment||Basic Science||Double|||t||t|
1320729|NCT03326232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320730|NCT03326219||Single Group Assignment||Diagnostic||None (Open Label)||||||
1320731|NCT03326206|||Case-Control||Prospective|||||||
1320732|NCT03326193||Single Group Assignment||Treatment||None (Open Label)||||||
1320733|NCT03326180|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320734|NCT03326167|||Cohort||Prospective|||||||
1320735|NCT03326154|||Cohort||Prospective|||||||
1320736|NCT03326141|Randomized|Factorial Assignment||Prevention||Single|The specific content of the intervention condition/arm that is assigned to each participant will be masked from data collectors/outcome assessors.|Our research team will conduct a 2 x 2 factorial experiment testing the individual and combined effects of two empirically and theoretically relevant sets of behavior change strategies on community-dwelling older adults' physical activity.||||t
1320737|NCT03326128|Randomized|Parallel Assignment||Treatment||Triple|Participant will be unaware of which medication condition they have been assigned to, the care provider will not know which dose of medication they are distributing.|Participants will be randomly assigned to receive either 300 or 450 mg of Bupropion XL.|t|t||t
1320738|NCT03326115|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1320739|NCT03326102|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be assigned to DHP107 or IV paclitaxel in a ratio of 2:1 (n=48 to DHP107 and n=24 to IV paclitaxel)||||
1320740|NCT03326089|Randomized|Parallel Assignment||Treatment||Double|participants are blindly randomized to receive oxygen or not during rehabilitation.||t||t|
1320741|NCT03326076|||Cohort||Prospective|||||||
1320742|NCT03326063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320743|NCT03326050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320744|NCT03326037|||Cohort||Prospective|||||||
1320745|NCT03326024|||Case-Control||Retrospective|||||||
1320746|NCT03326011||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1320747|NCT03325998||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1320750|NCT03325959|Randomized|Crossover Assignment||Treatment||Double|randomization by computer, the patient and her primary care physician will know the treatment received. Any side effects during therapy will be reported to the care providers and nurses and physicians unrelated to the study. Investigators and outcome assessors will not know the patient's arm.|randomized controlled trial using conventional pharmacotherapy treatment compared to hyperbaric oxygen therapy|||t|t
1320751|NCT03325946|||Cohort||Prospective|||||||
1320752|NCT03325933|Randomized|Parallel Assignment||Prevention||Single||||||t
1320753|NCT03325920|Non-Randomized|Parallel Assignment||Diagnostic||Triple|Participants, as well as the investigating dentist are blind to the result obtained from the polysomnographic recording. The statistican is also unaware of the sleep bruxism diagnosis.|Single-center, national, double-blind, controlled clinical trial with parallel group design|t||t|t
1320754|NCT03325907||Single Group Assignment||Device Feasibility||None (Open Label)||single-armed feasibility trial||||
1320755|NCT03325894||Single Group Assignment||Treatment||None (Open Label)||||||
1320756|NCT03325881|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320757|NCT03325868||Single Group Assignment||Treatment||None (Open Label)||||||
1320758|NCT03325855|||Other||Prospective|||||||
1320759|NCT03325842|||Cohort||Cross-Sectional|||||||
1320760|NCT03325829|||Cohort||Prospective|||||||
1320761|NCT03325816|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320762|NCT03325803|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1320763|NCT03325790|Randomized|Parallel Assignment||Treatment||Quadruple|DOUBLE-BLIND|RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED|t|t|t|t
1320764|NCT03325777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320765|NCT03325764|Non-Randomized|Parallel Assignment||Other||None (Open Label)||monocentric cross-sectional study comparing two groups of obese patients||||
1320766|NCT03325751|||Case-Control||Cross-Sectional|||||||
1320767|NCT03325738|||Cohort||Retrospective|||||||
1320768|NCT03325725||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1320769|NCT03325712|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1320770|NCT03325699|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320771|NCT03325686|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1320772|NCT03325673|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1320773|NCT03325660|Randomized|Parallel Assignment||Treatment||Double|The study group included 30 patients participated in pelvic floor muscle training and whole-body vibrations, 3 times weekly for 4 consecutive weeks; the frequency and peak-to-peak displacement of vibration were 2 mm/20 Hz for the first week for 5 minutes, 3mm/25 Hz, 10 minutes for the second week and 4 mm/30 Hz, 15 minutes for the last two weeks. The control group included 31 patients received only pelvic floor training only. Pelvic floor exercises: Each patient was prepared and taught a program of pelvic floor exercises to be performed in daily sessions in lying, sitting, and standing positions consisting of 10 seconds of contractions followed by 10 seconds of relaxation and repeating the exercises 15 times each session.||t|||t
1320774|NCT03325647|Randomized|Crossover Assignment||Treatment||Double||||t|t|
1320775|NCT03325634||Single Group Assignment||Treatment||None (Open Label)||||||
1320776|NCT03325621|Randomized|Parallel Assignment||Treatment||Quadruple||Multicenter, double-blind, placebo-controlled, two dose groups|t|t|t|t
1320777|NCT03325608|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1320778|NCT03325595|Randomized|Sequential Assignment||Treatment||Double|This will be a double-blind study. Subjects and investigator will be masked.||t||t|
1320779|NCT03325582|||Cohort||Prospective|||||||
1320780|NCT03325569|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1320781|NCT03325556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320782|NCT03325543|Randomized|Parallel Assignment||Treatment||Single||||||t
1320783|NCT03325530|||Case-Only||Retrospective|||||||
1320784|NCT03325517|||Case-Only||Prospective|||||||
1320785|NCT03325504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320786|NCT03325491|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1320787|NCT03325478|||Other||Prospective|||||||
1320788|NCT03325465||Single Group Assignment||Treatment||None (Open Label)||||||
1320789|NCT03325452||Single Group Assignment||Other||None (Open Label)||The hypothesis of our study is that the evaluation of the initial lactate in the early cardiopulmonary resuscitation could be a prognostic factor of RACS||||
1320790|NCT03325439||Single Group Assignment||Treatment||None (Open Label)||||||
1320791|NCT03325426|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320792|NCT03325413|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||"The study has 3 arms with patients allocated to them in a fixed chronological order.~For six months, patients will be recruited for the control arm. In this arm, participants receive usual care without any additional intervention initiated by the study.~After finishing recruitment for the control arm, patients will be recruited for the implementation arm for six months. In this arm, stepwise implementation of the study interventions begins with the possibility of flexibly adapting them to the specific conditions.~After finishing recruitment for the implementation arm, patients will be recruited for the full-scale intervention arm for six months. In this arm, all study interventions will be utilized."||||
1320793|NCT03325400|Non-Randomized|Parallel Assignment||Screening||Single|||t|||
1320794|NCT03325387|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1320795|NCT03325374|||Case-Control||Prospective|||||||
1320796|NCT03325361|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320797|NCT03325348|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320798|NCT03325335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320799|NCT03325322|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1320800|NCT03325309|||Cohort||Retrospective|||||||
1320801|NCT03325296|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320802|NCT03325283||Single Group Assignment||Device Feasibility||None (Open Label)||Human patients indicated for transcatheter aortic valve replacement||||
1320808|NCT03325205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320809|NCT03325192|Randomized|Parallel Assignment||Treatment||Triple|"Subject assignment will be done using randomly generated assignment tables based on stratification by tumor type (Lung, Breast, Other) and assigned 1:1 using random permuted blocks of 4.~Subjects will be blinded to their group assignment to minimize bias on follow up surveys.~Physicians evaluating the patient during the initial visit and on subsequent postprocedure followup will be blinded to subject assignment. The provider responsible for placement of the catheter and delivery of the pleurodesis agent or placebo will not be involved in post procedure followup care~All treatment physicians will follow prespecified protocols in deciding on adequate pleurodesis and timing of IPC removal."|Prospective, Randomized, Controlled, Double Blinded, Parallel Design, Trial|t||t|t
1320810|NCT03325179||Single Group Assignment||Treatment||None (Open Label)||||||
1320811|NCT03325166||Single Group Assignment||Treatment||None (Open Label)||||||
1320812|NCT03325153|||Cohort||Cross-Sectional|||||||
1320813|NCT03325140|||Cohort||Prospective|||||||
1320814|NCT03325127|||Cohort||Retrospective|||||||
1320815|NCT03325114||Single Group Assignment||Treatment||None (Open Label)||||||
1320816|NCT03325101||Single Group Assignment||Treatment||None (Open Label)||||||
1320817|NCT03325088|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1320818|NCT03325075|Randomized|Parallel Assignment||Prevention||Double|Double Blind||t||t|
1320819|NCT03325062|Randomized|Parallel Assignment||Treatment||Double|Participants are only informed that they will participate in one of two post-operative rehabilitation programs (without specific details). Outcome assessors are also blinded to group assignment.||t|||t
1320820|NCT03325049|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This randomized controlled pilot study used a pre-test, post-test design with intervention and control groups||||
1320821|NCT03325036|||Cohort||Prospective|||||||
1320822|NCT03325023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320823|NCT03325010|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1320824|NCT03324997|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1320825|NCT03324984|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320826|NCT03324971||Single Group Assignment||Treatment||None (Open Label)||A prospective cohort study .The aim of this study to recruit a cohort of diabetic patients,eliminate unnecessary medications,aiming at improving adherence to anti-diabetic medications.||||
1320827|NCT03324958|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Assessment of the mean local pain during brachytherapy applicator'setting up, with and without virtual reality helmet use.||||
1320828|NCT03324945||Single Group Assignment||Supportive Care||None (Open Label)||||||
1320829|NCT03324932||Single Group Assignment||Prevention||None (Open Label)||||||
1320830|NCT03324919|||Ecologic or Community||Cross-Sectional|||||||
1320831|NCT03324906|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320832|NCT03324893||Single Group Assignment||Diagnostic||None (Open Label)||||||
1320833|NCT03324880|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320834|NCT03324867|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1320835|NCT03324854|Randomized|Parallel Assignment||Treatment||Double|"The randomisation for allocation the type of mesh for each patient was realized with numbers generated by computer with the program R version 3.0.2 with the simple function.~The participant and the outcomes assessor did not know the type of mesh."|The simple size for pilot study was been calculated in 20 patients, according with Browne for not knowing the variability of the treatment. 10 patients in the group of Polypropylene mesh (Prolene ®) and , and 10 patients in the group of mesh of PEBD (mosquito net).|t|||t
1320836|NCT03324841|||Cohort||Prospective|||||||
1320837|NCT03324828|Randomized|Parallel Assignment||Treatment||Quadruple|Clowns: outcomes assesor Hidroxicine: participant, care provider, investigator and outcomes assessor||t|t|t|t
1320838|NCT03324815|Randomized|Parallel Assignment||Treatment||Single||||||t
1320839|NCT03324802|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1320840|NCT03324789|Randomized|Parallel Assignment||Treatment||Single|Blinding will only be done for the outcome assessor for patient satisfaction and the statistician|||||t
1320841|NCT03324776||Single Group Assignment||Treatment||None (Open Label)||||||
1320842|NCT03324763|||Cohort||Prospective|||||||
1320843|NCT03324750|||Other||Prospective|||||||
1320844|NCT03324737|Randomized|Parallel Assignment||Prevention||Double|The subjects who participate in the study may be seeing the doctors or allied health professionals involved in this study at the clinic. However, recruitment will not be done by them though they will help to improve the awareness of such a study to their patients. There will be no coercion involved as the subjects have the full autonomy to decide if they wish to participate.|"A prospective Randomized Control Trial will be conducted to compare an INTERACTIVE SMARTPHONE APP versus STANDARD care to optimize post-delivery weight in women with recent GDM. The aim is to reduce diabetes and cardiometabolic risk.~During the antenatal period, subjects will be informed about the study during regular NUH nurse-led dietary counseling sessions. After delivery, women will be offered the opportunity to join the study. Informed consent will be obtained before discharge from hospital post-delivery. An appointment will be given for the first study visit at 6 weeks post-delivery."|||t|t
1320845|NCT03324724||Single Group Assignment||Treatment||None (Open Label)||||||
1320846|NCT03324711||Single Group Assignment||Other||None (Open Label)||||||
1320847|NCT03324698|||Cohort||Retrospective|||||||
1320848|NCT03324685||Single Group Assignment||Treatment||None (Open Label)||||||
1320849|NCT03324672|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1320850|NCT03324659|Randomized|Parallel Assignment||Treatment||Single||||||t
1320851|NCT03324646|||Cohort||Prospective|||||||
1320852|NCT03324633|||Cohort||Prospective|||||||
1320853|NCT03324620|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)|86 patients in experimental group. 104 patients retrospectively collected from the inclusion of the first patient of the intervention group.|Mixed study. Retrospective control group.||||
1320854|NCT03324607||Single Group Assignment||Diagnostic||None (Open Label)||||||
1573443|NCT00001209||||Treatment||||||||
1320855|NCT03324594|Randomized|Crossover Assignment||Device Feasibility||Single|Throughout the study, neither participating couples, clinic staff, research assistants or researchers are masked to condom assignment as there are observable differences on packaging and design between the test condom (WLC and WLM) and the control condom (durex-Together). However, statisticians, sponsors, and medical reviewers are masked until completion of the final report to minimize biases potentially emerge during data analyses and results reporting.|||||t
1320856|NCT03324581|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1320857|NCT03324568|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1320858|NCT03324555||Single Group Assignment||Treatment||None (Open Label)||||||
1320859|NCT03324542|||Case-Only||Retrospective|||||||
1320860|NCT03324529||Single Group Assignment||Treatment||None (Open Label)||||||
1320861|NCT03324516|Randomized|Parallel Assignment||Treatment||None (Open Label)|Patients will be given assigned a research limb the morning of the surgery|||||
1320862|NCT03324503||Single Group Assignment||Diagnostic||None (Open Label)||||||
1320863|NCT03324490|Randomized|Parallel Assignment||Supportive Care||Double||Using computer & sealed envelope randomization, patients are assigned to receive either thoracic spinal anesthesia [TSA group: n=30] or thoracic epidural anesthesia [TEA group: n=30].|t|||t
1320864|NCT03324477|Randomized|Parallel Assignment||Prevention||Single|||t|||
1320865|NCT03324464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320866|NCT03324451|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Patients with T2DM at a clinic in southern Taiwan are assigned to the intervention arm, whereas patients with T2DM at the endocrinology department of a hospital in northern Taiwan are placed in the control arm. Eligible patients that match the inclusion criteria are recommended by doctors to initiate insulin treatment. Research assistants will explain the objectives of this study to eligible participants. Subsequently, baseline data will be collected from participants by research assistants after the participants sign the consent forms. Afterwards, the participants in the intervention arm will receive the intervention. For the control arm, the participants will receive regular patient education originally administered at the hospital.||||
1320867|NCT03324438|Randomized|Factorial Assignment||Treatment||None (Open Label)||MOST methodology uses factorial designs and the hypotheses in Aim 1 will be tested through a 2x2 factorial experiment, a highly efficient experimental design despite several common misconceptions about sample size requirements and power. A 2x2 factorial experiment is NOT a 4-arm trial in which each condition is compared in turn to a control condition. In fact, factorial designs do not require a larger number of participants than other designs (e.g., RCT) and when used to address suitable research questions, they require fewer participants than other designs. Adding factors does not require a dramatic increase in sample size to maintain power. The number of arms is listed below as 4 as # of arms is required by the clinicaltrails.gov site; please refer above for a more accurate description of the study design.||||
1320868|NCT03324425||Single Group Assignment||Treatment||None (Open Label)||||||
1320869|NCT03324412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1320870|NCT03324399|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320871|NCT03324386|Non-Randomized|Single Group Assignment||Health Services Research||Triple|Individual Orientation: receiving individual orientation required by an embracement strategy characterized by 7 nursing visits at 20-day intervals, for 4 months);|VLE Group use the technology in a virtual learning environment(VLE) for distance learning (DL), HYBRID Group use the educational technology in the E-blended mode leraning, A Group he use of embracement strategy (relational strategies).|t|t|t|
1320872|NCT03324373||Single Group Assignment||Treatment||None (Open Label)||||||
1320873|NCT03324360|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320874|NCT03324347|Randomized|Crossover Assignment||Treatment||Single||||||t
1320875|NCT03324334|||Case-Control||Retrospective|||||||
1320876|NCT03324321||Single Group Assignment||Basic Science||None (Open Label)||Single-centre, prospective, before and after study||||
1320877|NCT03324308||Single Group Assignment||Diagnostic||None (Open Label)||||||
1320878|NCT03324295|||Other||Cross-Sectional|||||||
1320879|NCT03324282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320880|NCT03324269||Single Group Assignment||Diagnostic||None (Open Label)|All patients wear NOL monitoring and are aware of it. Anesthesiologist can read NOL values.|Patients undergoing cardiac surgery and thyroid surgery have NOL monitoring||||
1320881|NCT03324256|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1320882|NCT03324243||Single Group Assignment||Treatment||None (Open Label)||||||
1320883|NCT03324230|||Cohort||Prospective|||||||
1320884|NCT03324217|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1320885|NCT03324204|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1320886|NCT03324191|Randomized|Crossover Assignment||Basic Science||Double|Participants and Researchers will be blinded to the interventions.|Double-blind, single-centre randomised controlled trial using a cross-over experimental design.|t||t|
1320887|NCT03324178|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||A pilot two-armed, parallel-design, individually randomised controlled trial, using stratified randomization with blocking||||
1320888|NCT03324165|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1320889|NCT03324152|Randomized|Parallel Assignment||Treatment||Single|The physical therapist performing assessments of muscle function (primary outcome), distributes questionnaires and who is present at maximal oxygen uptake tests and who plan all other assessments logistically is blinded to group allocation. The rheumatologists performing assessment of disease activity and the personell analysing biopsy data are also blinded to group allocation. The care provider is the only one who is not masked.|Patients are dandomized to either a high-intensity interval group (HIIT) or a control group performing standard low-intensity home exercise.||||t
1320890|NCT03324139|Randomized|Parallel Assignment||Treatment||Double||A randomized, double-blind, two-parallel, placebo-controlled, phase III multicenter clinical trial.|t||t|
1320891|NCT03324126|||Cohort||Prospective|||||||
1320892|NCT03324113|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320893|NCT03324100|||Cohort||Prospective|||||||
1320894|NCT03324087|||Case-Only||Prospective|||||||
1320896|NCT03324061|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320897|NCT03324048||Single Group Assignment||Other||None (Open Label)||||||
1320898|NCT03324035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320899|NCT03324022|||Case-Control||Prospective|||||||
1320900|NCT03324009||Single Group Assignment||Prevention||None (Open Label)||Cross-sectional study||||
1320901|NCT03323996|||Other||Prospective|||||||
1320902|NCT03323983|||Cohort||Prospective|||||||
1320903|NCT03323970|||Other||Cross-Sectional|||||||
1320904|NCT03323957|||Case-Only||Cross-Sectional|||||||
1320905|NCT03323944|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1320906|NCT03323931|Randomized|Factorial Assignment||Treatment||Single|Principal investigator, the research team, and data analyst are all blind to the treatment conditions.|Random allocation to one of two intervention conditions: (1) standard therapy, derived from applied behavior analysis (ABA) and (2) a robot-enhanced intervention in which the same intervention is delivered by a semi-autonomous robotic mediator agent (the robot acts as a mediator while the therapist is supervising the session).|||t|
1320907|NCT03323918|Randomized|Parallel Assignment||Treatment||Double|The investigators who are involved in the testing sessions and data analysis are blind to group assignment. An investigator which is not directly involved in participant testing or data analysis takes care of the randomisation, and coordinates it with the home guidance centers that administer the intervention.|"Group 1 will receive the intervention specifically targeting social-communicative abilities (Project ImPACT).~Group 2 will receive a generic intervention, that will not focus on social-communicative skills."|||t|t
1320908|NCT03323905||Single Group Assignment||Treatment||None (Open Label)||Pilot single arm feasibility trial.||||
1320909|NCT03323892|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||a prospective sibling oocyte study: both study arms will be applied to the oocytes of 1 patient||||
1320910|NCT03323879||Sequential Assignment||Treatment||None (Open Label)||Sequential dose escalation design||||
1320911|NCT03323866|Randomized|Parallel Assignment||Treatment||Triple||Randomized controlled trial comparing mometasone nasal spray to budesonide irrigations for treatment of chronic rhinosinusitis with nasal polyposis||t|t|t
1320912|NCT03323853|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1320913|NCT03323840||Single Group Assignment||Health Services Research||None (Open Label)||||||
1320914|NCT03323827|||Cohort||Prospective|||||||
1320915|NCT03323814|||Cohort||Prospective|||||||
1320916|NCT03323801||Single Group Assignment||Treatment||None (Open Label)||20 mg 13-cis retinoic acid twice daily (BID) with meals for 32 weeks||||
1320917|NCT03323788|||Cohort||Prospective|||||||
1320918|NCT03323775|||Case-Only||Prospective|||||||
1320919|NCT03323762||Single Group Assignment||Treatment||None (Open Label)||||||
1320920|NCT03323749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320921|NCT03323736||||||||||||
1320922|NCT03323723||Single Group Assignment||Treatment||None (Open Label)||Efficacy and Safety Study, Single Group, Open Study, Open Label||||
1320923|NCT03323710||Single Group Assignment||Treatment||None (Open Label)||Two-stage optimal Simon design||||
1320924|NCT03323697|Randomized|Parallel Assignment||Treatment||Triple||Randomized, double-blind controlled trial|t|t|t|
1320925|NCT03323684|Randomized|Parallel Assignment||Basic Science||Single||||||t
1320926|NCT03323671|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320927|NCT03323658||Sequential Assignment||Prevention||None (Open Label)||||||
1320928|NCT03323645|||Cohort||Other|||||||
1320929|NCT03323632||Single Group Assignment||Treatment||None (Open Label)||||||
1320930|NCT03323619|||Cohort||Prospective|||||||
1320931|NCT03323606|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1320932|NCT03323593|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1320933|NCT03323580|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1320934|NCT03323567|Randomized|Crossover Assignment||Treatment||Double|Participants and care providers had no knowledge about the substance prepared for the injection. The information for the main investigator was the number of patient and the number of injection|patients were divided into the three groups and examination and therapy was performed after 7 and 14 days|t|t||
1320935|NCT03323554|Randomized|Parallel Assignment||Treatment||Single||a prospective, randomised, multicentre, comparative, open label, non-inferiority study in parallel groups of patients presenting stress urinary incontinence following prostate ablation for cancer.||||t
1320936|NCT03323541|||Cohort||Retrospective|||||||
1320937|NCT03323528|Randomized|Parallel Assignment||Treatment||Quadruple|investigation: participant, care provider and investigator blinded assessment: participant, care provider and investigator blinded outcome analysis: statistician blinded|randomized allocation of participants to verum or placebo (1:1)|t|t|t|t
1320938|NCT03323515||||||||||||
1320939|NCT03323502|Randomized|Parallel Assignment||Supportive Care||Double||Behavioral: ACP Specialist Program|||t|t
1320940|NCT03323489||Single Group Assignment||Treatment||None (Open Label)||all of the patients will be treated.||||
1320941|NCT03323476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320942|NCT03323463||Single Group Assignment||Treatment||None (Open Label)||||||
1320943|NCT03323450|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1320944|NCT03323437|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1320945|NCT03323424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320946|NCT03323411|||Cohort||Prospective|||||||
1320947|NCT03323398||Single Group Assignment||Treatment||None (Open Label)||||||
1320948|NCT03323385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1320949|NCT03323372|Randomized|Parallel Assignment||Prevention||Triple||The design of this randomized, double blind, intervention study was structured based on the CONSORT (Consolidated Standards of Reporting Trials) standards.|t||t|t
1320950|NCT03323359|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320951|NCT03323346||Single Group Assignment||Treatment||None (Open Label)||||||
1320952|NCT03323333||Single Group Assignment||Supportive Care||None (Open Label)||||||
1320953|NCT03323320|||Cohort||Retrospective|||||||
1320954|NCT03323307||Single Group Assignment||Diagnostic||None (Open Label)||||||
1320955|NCT03323294|||Other||Prospective|||||||
1320956|NCT03323281|||Other||Prospective|||||||
1320957|NCT03323268|||Cohort||Prospective|||||||
1320958|NCT03323255|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1320959|NCT03323242|Randomized|Parallel Assignment||Treatment||None (Open Label)|"Blinding the surgical staff is impossible due to the use of different methods in the three groups under investigation. Since the primary endpoint total blood loss will be precisely recorded during surgery by independent staff and secondary endpoints are objective physiological findings, blinding the subjects is not needed. Therefore, the open design is not expected to cause any avoidable bias."|||||
1320960|NCT03323229|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1320961|NCT03323216|||Cohort||Prospective|||||||
1320962|NCT03323203|||Cohort||Prospective|||||||
1320963|NCT03323190||Single Group Assignment||Other||None (Open Label)||||||
1320964|NCT03323177|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320965|NCT03323164|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1320966|NCT03323151|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Phase I: Standard 3+3 design with the primary objective of determining the maximum tolerate dose (MTD)/recommended phase 2 dose (RP2D) of this combination in MCL. Both ibrutinib-pretreated and ibrutinib-naïve patients will be enrolled.~Phase II: MTD/RP2D. Patients will be enrolled to two cohorts, based on prior ibrutinib treatment: ibrutinib-pretreated and ibrutinib-naïve."||||
1320967|NCT03323138||Single Group Assignment||Treatment||None (Open Label)||Prospective, interventional and monocentric study based in a university hospital setting||||
1320968|NCT03323125|||Other||Cross-Sectional|||||||
1320969|NCT03323112|||Cohort||Prospective|||||||
1320970|NCT03323099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320971|NCT03323086|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1320972|NCT03323073|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1320973|NCT03323060|||Family-Based||Prospective|||||||
1320974|NCT03323047|Randomized|Parallel Assignment||Supportive Care||Single|Participants will blinded to the group that they have been allocated to. Blinding will be possible as all patients will be given either acetaminophen or medication without active ingredients (placebo pilll) and dexamethasone will be administered while the participant is asleep. Participants will be debriefed on which group they were assigned to after all study material is returned (i.e., at their post-operative follow-up appointment).|A prospective, randomized, longitudinal, double-blinded trial at a single centre with 3 groups of 20 children each. Group 1 receives acetaminophen (15 mg/kg) 30 min-1 hr pre-operatively and high-dose dexamethasone (0.5 mg/kg, max. 10 mg) immediately after induction of anesthesia. Group 2 receives acetaminophen (15 mg/kg) 30 min- 1 hr pre-operatively and low-dose dexamethasone (0.15 mg/kg, max. 8 mg) immediately after induction of anesthesia. Group 3 receives placebo 1 hr pre-operatively and low dose dexamethasone (0.15 mg/kg, max. 8 mg) immediately after induction of anesthesia. We will recruit a convenience sample of 60 patients aged 3-13 scheduled for tonsillectomy with the principal investigator or co-investigators. The patients will be placed in one of the groups by a computerized randomization table.|t|||
1320975|NCT03323034||Single Group Assignment||Treatment||None (Open Label)||||||
1320976|NCT03323021|Randomized|Parallel Assignment||Treatment||Single|||t|||
1320977|NCT03323008||Single Group Assignment||Other||None (Open Label)||||||
1320978|NCT03322995|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320979|NCT03322982|Randomized|Parallel Assignment||Other||Single|Diet adherence assessments will be conducted by blinded assessors from OHSU bionutrition team.|||||t
1320980|NCT03322969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320981|NCT03322956|Randomized|Factorial Assignment||Treatment||Single||One way, mixed, Randomized Controlled Trial(RCT), intention to threat design, level 2b.|t|||
1320982|NCT03322943|||Cohort||Other|||||||
1320983|NCT03322930|||Case-Only||Prospective|||||||
1320984|NCT03322917||Single Group Assignment||Treatment||None (Open Label)||Prospective interventional non-comparative consecutive case series.||||
1320985|NCT03322904|||Case-Control||Cross-Sectional|||||||
1320986|NCT03322891||Single Group Assignment||Other||None (Open Label)||||||
1320987|NCT03322878|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1320988|NCT03322865||Single Group Assignment||Treatment||None (Open Label)||||||
1320989|NCT03322852|||Case-Crossover||Prospective|||||||
1320990|NCT03322839|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1320991|NCT03322826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1320992|NCT03322813||Single Group Assignment||Treatment||None (Open Label)||||||
1320993|NCT03322800|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1320994|NCT03322787|Randomized|Parallel Assignment||Screening||Single||||t||
1320995|NCT03322774|Randomized|Sequential Assignment||Prevention||Single|||t|||
1320996|NCT03322761|Randomized|Parallel Assignment||Treatment||Single||||||t
1320997|NCT03322748|Randomized|Parallel Assignment||Treatment||Single||||||t
1320998|NCT03322735||Single Group Assignment||Treatment||None (Open Label)||||||
1320999|NCT03322722|||Cohort||Prospective|||||||
1321000|NCT03322709|||Case-Control||Prospective|||||||
1321001|NCT03322696|||Case-Only||Prospective|||||||
1321002|NCT03322683|Randomized|Parallel Assignment||Treatment||Single|Blind researcher|RANDOMIZED CLINICAL TRIAL WITH BLIND EVALUATION BY THIRD PARTIES, LONGITUDINAL AND PROSPECTIVE.|||t|
1321003|NCT03322670|||Cohort||Prospective|||||||
1321004|NCT03322657|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1321005|NCT03322644|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1321006|NCT03322631|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1321007|NCT03322618|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1321009|NCT03322592|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321010|NCT03322579||Single Group Assignment||Treatment||None (Open Label)||Unilateral or bilateral balloon catheter dilation will be performed on patients with eustachian tube dysfunction||||
1321011|NCT03322566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321012|NCT03322553|Randomized|Parallel Assignment||Treatment||Double|Double blinded|Randomized, Double blinded, sham controlled trial|t||t|
1321013|NCT03322540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321014|NCT03322527|||Cohort||Prospective|||||||
1321015|NCT03322514|Randomized|Parallel Assignment||Prevention||Quadruple||double blind, randomised, controlled, paralleled study|t|t|t|t
1321016|NCT03322501||Single Group Assignment||Prevention||None (Open Label)||||||
1321017|NCT03322488|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||20 patients with Crohn's disease and 20 patients without Crohn's disease will be recruited||||
1321018|NCT03322475||Single Group Assignment||Treatment||None (Open Label)||||||
1321019|NCT03322462||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321020|NCT03322449|Randomized|Crossover Assignment||Prevention||Single||randomized crossover dietary intervention|||t|
1321021|NCT03322436|||Cohort||Prospective|||||||
1321022|NCT03322423|Randomized|Crossover Assignment||Treatment||Single|||t|||
1321023|NCT03322410||Single Group Assignment||Other||None (Open Label)||||||
1321024|NCT03322397|Randomized|Parallel Assignment||Basic Science||Single|Participants will be told that we are studying the daily lives of teens. They will not be informed of the other arms of the experiment.|90 participants will randomly be assigned to one of three interventions. Participants will complete a 4-week intervention. All outcomes will be measured before and after the intervention, and some psychological measures will be collected weekly throughout the intervention.|t|||
1321025|NCT03322384||Single Group Assignment||Treatment||None (Open Label)||All patients will begin epacadostat on day 1 of radiotherapy, which will consist of three threatments over one week. Epacadostat will continue until disease progression or intolerance occurs. On days 1, 8, 15, 22, 29, intralesional injectinons of SD101 will be given to patients.||||
1321026|NCT03322371|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321027|NCT03322358|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1321028|NCT03322345|||Cohort||Prospective|||||||
1321029|NCT03322332|||Cohort||Cross-Sectional|||||||
1321030|NCT03322319||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321031|NCT03322306|||Cohort||Prospective|||||||
1321032|NCT03322293|Randomized|Parallel Assignment||Treatment||Single|This is a single-blinded study, as the subject cannot be blinded to treatment. Disease assessments and aminolevulinic acid (ALA) application will be performed by the blinded investigator. History, concomitant medications, randomization, light exposure, symptom assessment, and Skindex-16 will be administered by the unblinded study coordinator.|Randomized (1:1:1), single-blind controlled trial with parallel group design|||t|
1321033|NCT03322280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321034|NCT03322267||Single Group Assignment||Treatment||None (Open Label)||Adjuvant cisplatin-chemoradiotherapy followed by pembrolizumab||||
1321035|NCT03322254|||Other||Other|||||||
1321036|NCT03322241|||Other||Other|||||||
1321037|NCT03322228||Single Group Assignment||Supportive Care||None (Open Label)||This study plans to enroll 20 subjects. All subjects will receive 1 music therapy intervention lasting approximately 1 hour.||||
1321038|NCT03322215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321039|NCT03322202|Randomized|Parallel Assignment||Other||Double|Patient participants will be blinded as will an assessor measuring participation during sessions. Therapist participants will be aware of the arm in which they will be placed.|Patients in the experimental group will be exposed to a Physical or Occupational Therapist trained in Motivational Interviewing. The control group will receive standard therapy communication.|t|||t
1321040|NCT03322189|||Other||Other|||||||
1321041|NCT03322176|||Other||Prospective|||||||
1321042|NCT03322163|||Cohort||Prospective|||||||
1321043|NCT03322150|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1321044|NCT03322137|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321045|NCT03322124|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1321046|NCT03322111||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321047|NCT03322098|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1321048|NCT03322085|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321049|NCT03322072||Single Group Assignment||Treatment||None (Open Label)||Single arm prospective cohort study||||
1321050|NCT03322059|Randomized|Parallel Assignment||Prevention||Single||||||t
1321051|NCT03322046|||Case-Control||Prospective|||||||
1321052|NCT03322033||Single Group Assignment||Treatment||None (Open Label)||||||
1321053|NCT03322020|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321054|NCT03321994|Randomized|Parallel Assignment||Other||Single||||||t
1321055|NCT03321981|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||three combination treatments will be evaluated, two in Cohort 1 and one in Cohort 2||||
1321056|NCT03321968|Randomized|Parallel Assignment||Prevention||Single||||||t
1321057|NCT03321955||Single Group Assignment||Treatment||None (Open Label)||||||
1321058|NCT03321942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321059|NCT03321929||Single Group Assignment||Other||None (Open Label)||||||
1321060|NCT03321916|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321061|NCT03321903|||Cohort||Prospective|||||||
1321062|NCT03321890||Single Group Assignment||Treatment||None (Open Label)||||||
1321063|NCT03321877||Single Group Assignment||Other||None (Open Label)||||||
1321064|NCT03321864||Single Group Assignment||Basic Science||None (Open Label)||All available patients||||
1321215|NCT03319901||Single Group Assignment||Treatment||None (Open Label)||||||
1321216|NCT03319888|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1321065|NCT03321851||Single Group Assignment||Diagnostic||None (Open Label)|Vital sign results obtained by the device under study are not displayed on phone screen.|Each participant tests two equivalent vital sign sensors (devices under test) mounted on two different smartphones, one after another to assess accuracy of the device compared to equivalent reference devices.||||
1321066|NCT03321838||Single Group Assignment||Treatment||None (Open Label)||||||
1321067|NCT03321825|Randomized|Parallel Assignment||Treatment||Single||||||t
1321068|NCT03321812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321069|NCT03321799|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321070|NCT03321786|||Case-Control||Prospective|||||||
1321071|NCT03321773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321072|NCT03321760|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This is a Phase II single-institution trial with a 3 + 3 safety run-in period. SABR will be delivered per protocol, followed by a planned 4 cycles of sequential chemotherapy within 3-8 weeks after the completion of SABR. Four cycles of chemotherapy shall be planned as typically used for adjuvant chemotherapy following surgical resection for T1-2aN1 non-small cell lung carcinoma (NSCLC) unless otherwise indicated by institutional guidelines.||||
1321073|NCT03321747|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This trial is a Phase I/II study designed to determine the maximum tolerated radiation dose and evaluate the efficacy of dose escalated SABR for early stage lung squamous cell carcinoma.||||
1321074|NCT03321734|Randomized|Parallel Assignment||Treatment||Quadruple|All clinical team personnel and all research staff (except research pharmacist) will remain blinded to study group until study completion.|Randomized, placebo-controlled, double-blinded clinical trial A site-stratified randomly-permuted blocked randomization design will be used to ensure balance at each site. Randomization will also be stratified into 2 birth gestational age categories of <28 wks and 28 wks + 0 days to 30 wks + 6 days gestation to ensure balance. The randomization scheme will be developed by the DCC using specialized software, and clinical sites will be provided appropriate enrollment logs and randomization procedures from the research pharmacy.|t|t|t|t
1321075|NCT03321721|Randomized|Parallel Assignment||Treatment||Single|patients are randomized after informed consent evaluation of cosmetic outcome at 4m is blinded to researchers|randomized, parallel group, comparative study||||t
1321076|NCT03321708|||Cohort||Prospective|||||||
1321077|NCT03321695|||Cohort||Prospective|||||||
1321078|NCT03321682|Randomized|Parallel Assignment||Treatment||Single||||||t
1321079|NCT03321669|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321080|NCT03321656|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Treatment: Envarsus® 0.07-0.14 mg/kg/day every morning~Control: Generic tacrolimus 0.1-0.2 mg/kg/day in 2 divided doses given every 12 hours"||||
1321081|NCT03321643||Single Group Assignment||Treatment||None (Open Label)||||||
1321082|NCT03321630||Single Group Assignment||Treatment||None (Open Label)||||||
1321083|NCT03321617|Randomized|Parallel Assignment||Treatment||Triple|Identity of medications will be blinded having every subject take an equal number of pills (using identical looking tables of placebo)|Double-blind, randomized, phase 1b, multiple dose trial|t||t|t
1321084|NCT03321604|||Cohort||Prospective|||||||
1321085|NCT03321591|||Case-Only||Cross-Sectional|||||||
1321086|NCT03321578|||Case-Only||Cross-Sectional|||||||
1321087|NCT03321565|||Cohort||Cross-Sectional|||||||
1321088|NCT03321552||Single Group Assignment||Treatment||None (Open Label)||||||
1321089|NCT03321539|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Cancer Center of Guangzhou Medical University~The First Affiliated Hospital/School of Clinical Medicine of Guangdong Pharmaceutical University"||||
1321090|NCT03321526|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321091|NCT03321513|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321092|NCT03321500|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321093|NCT03321487|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1321094|NCT03321474|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321095|NCT03321461|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321096|NCT03321448|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321097|NCT03321435|||Cohort||Prospective|||||||
1321098|NCT03321422|||Cohort||Prospective|||||||
1321099|NCT03321409|||Other||Prospective|||||||
1321100|NCT03321396||Single Group Assignment||Treatment||None (Open Label)||||||
1321101|NCT03321383|||Case-Only||Cross-Sectional|||||||
1321102|NCT03321370|||Case-Only||Prospective|||||||
1321103|NCT03321357|||Cohort||Prospective|||||||
1321104|NCT03321344||Single Group Assignment||Treatment||None (Open Label)||Single arm, non-randomized||||
1321105|NCT03321331|Randomized|Parallel Assignment||Prevention||Single|Assessments regarding body weight and waist circumference will be conducted by nurses at the University Health Services clinics, who are blind to treatment allocation. The assessor will go through an assessment training program and will be informed about the study, but not about the allocation or treatments. Due to the nature of the intervention neither participants nor staff can be blinded to allocation, but are strongly inculcated not to disclose the allocation status of the participant at the follow up assessments.|||||t
1321106|NCT03321318|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321107|NCT03321305|||Case-Only||Cross-Sectional|||||||
1321108|NCT03321292|Randomized|Parallel Assignment||Treatment||Single||Group(A) 130 pregnant women diagnosed with IUGR will receive L-arginine and Acetylesalicylic acid 75mg Group(B) 130 pregnant women diagnosed with IUGR will receive Acetylesalicylic acid 75mg|t|||
1321109|NCT03321279|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1321110|NCT03321266|||Cohort||Retrospective|||||||
1321111|NCT03321253||Sequential Assignment||Treatment||None (Open Label)||sequential self-controlled clinical trial||||
1321112|NCT03321240|||Cohort||Prospective|||||||
1321217|NCT03319875|||Other||Retrospective|||||||
1321218|NCT03319862|||Cohort||Retrospective|||||||
1321219|NCT03319849|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321113|NCT03321227|Randomized|Crossover Assignment||Other||None (Open Label)||A random and within subject repeated measures experiment to study the effects of egg consumption on cognitive performance in children and the underlying physiological mechanisms in this relationship.||||
1321114|NCT03321214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321115|NCT03321201|Randomized|Parallel Assignment||Treatment||Triple|Surgeons will not be blinded. All the other investigators, as well as study participants, outcome assessors and author that will analyze the data will be blinded.||t||t|t
1321116|NCT03321188||Single Group Assignment||Treatment||None (Open Label)||||||
1321117|NCT03321175|Randomized|Parallel Assignment||Prevention||Triple||Randomization will be performed by an online software. Randomized cards will be in sealed envelopes and will be open by surgeon at the time of surgery.|t|t|t|
1321118|NCT03321162|||Other||Other|||||||
1321119|NCT03321149||Single Group Assignment||Supportive Care||None (Open Label)||||||
1321120|NCT03321136|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1321121|NCT03321123||Single Group Assignment||Treatment||None (Open Label)||||||
1321122|NCT03321110|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1321123|NCT03321097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321124|NCT03321084|Randomized|Parallel Assignment||Treatment||Double|The one who assess the patients in the beginning and in the final moment (investigator) not know in what group the patient is. As the investigator that will do the statistic (outcome assessor).|Two groups: a MatPilates group (MG) and a Control group (CG).|||t|t
1321125|NCT03321071|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321126|NCT03321058|||Case-Only||Cross-Sectional|||||||
1321127|NCT03321045||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321128|NCT03321032|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1321129|NCT03321019|||Case-Control||Prospective|||||||
1321130|NCT03321006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321131|NCT03320993|Randomized|Crossover Assignment||Other||Single|Data analysis will be carried out by a person not involved in the study (she/he will be blind to the study condition)|3-period, 3-treatment crossover design||||t
1321132|NCT03320980|||Case-Control||Retrospective|||||||
1321133|NCT03320967|||Cohort||Prospective|||||||
1321134|NCT03320954||Single Group Assignment||Treatment||None (Open Label)||"Phase 1 participants will include people with and without acquired brain injuries. This phase does not involve any intervention.~Phase 2 participants will include only people with acquired brain injuries. This portion of the research involves an intervention procedure. All participants will receive the same intervention.~Phase 3 participants will be limited to those people with acquired brain injuries who completed Phases 1 and 2. Phase 3 does not involved any intervention."||||
1321135|NCT03320941|Randomized|Parallel Assignment||Treatment||Triple|Parallel Assignment||t|t|t|
1321136|NCT03320928|||Cohort||Retrospective|||||||
1321137|NCT03320915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321138|NCT03320902|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1321139|NCT03320889|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Group 1: Educational Intervention includes Pamphlets plus Review with Expert Educator Group 2: Educational Intervention includes Pamphlets only||||
1321140|NCT03320876||Single Group Assignment||Treatment||None (Open Label)||||||
1321141|NCT03320863|Randomized|Parallel Assignment||Treatment||Quadruple|Devices are assigned per the randomization schedule, with the sham device identical to the active device in every way except that no neuromodulation is delivered. The neuromodulation that the active device delivers can be done in a way that causes no sensation, so subjects are not unmasked.|Double-blind, randomized, sham controlled study|t|t|t|t
1321142|NCT03320850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321143|NCT03320837|||Cohort||Prospective|||||||
1321144|NCT03320824||||||||||||
1321145|NCT03320811|||Case-Control||Retrospective|||||||
1321146|NCT03320798|||Case-Only||Retrospective|||||||
1321147|NCT03320785|||Cohort||Prospective|||||||
1321148|NCT03320772|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321149|NCT03320759|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321150|NCT03320746|Randomized|Parallel Assignment||Treatment||Single||||||t
1321151|NCT03320733|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1321152|NCT03320720|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1321153|NCT03320707|Randomized|Sequential Assignment||Other||Double|||t||t|
1321154|NCT03320694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321155|NCT03320681|Randomized|Crossover Assignment||Other||Double||Double-blind|t||t|
1321156|NCT03320668|Randomized|Parallel Assignment||Prevention||Single|Blind analysis to prevent bias|Non-inferiority clinical trial, multicentric, simple blind||||t
1321157|NCT03320655|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321158|NCT03320642||Single Group Assignment||Prevention||None (Open Label)||||||
1321159|NCT03320629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321160|NCT03320616|Randomized|Parallel Assignment||Treatment||None (Open Label)||The subjects will be randomized to 1 of 4 treatment sequences.||||
1321161|NCT03320603|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1321162|NCT03320590|||Cohort||Prospective|||||||
1321163|NCT03320577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321164|NCT03320564||Single Group Assignment||Diagnostic||None (Open Label)|Reader will not be informed which scan was infiltrated.|All patients with a moderate or greater infiltration on a routine F-18 FDG PET will be invited to return for a repeat scan.||||
1321165|NCT03320551||Single Group Assignment||Other||None (Open Label)||||||
1321166|NCT03320538|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321167|NCT03320525||Single Group Assignment||Treatment||None (Open Label)||Open label||||
1321220|NCT03319836|||Other||Retrospective|||||||
1321267|NCT03319225|||Case-Control||Prospective|||||||
1321168|NCT03320512|Randomized|Factorial Assignment||Prevention||None (Open Label)||The trial will consist of a three-arm RCT to test intervention efficacy among YMSM and YTWSM who are starting PrEP or are non-adherent to PrEP. Study arms will include P3, P3+, and SOC. Participants will be recruited from six iTech cities. The investigators will enroll up to 240 participants and randomize them 2:2:1 to receive P3, P3+, or SOC. Assessments will be completed at months 0, 3, and 6.||||
1321169|NCT03320499|||Case-Control||Prospective|||||||
1321170|NCT03320486|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321171|NCT03320473||Single Group Assignment||Treatment||None (Open Label)||||||
1321172|NCT03320460|Randomized|Parallel Assignment||Treatment||Triple|Control group will be treated with clobetasol propionate 0.05% gel for 30 consecutive days and the laser device will be positioned over the lesion but will be switched off to mask the treatment. The experimental group will be treated with placebo gel for 30 consecutive days to mask the treatment and patients will receive laser treatment twice a week during 1 month for PBM|Control group Experimental Group|t||t|t
1321173|NCT03320447|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1321174|NCT03320434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321175|NCT03320421||Single Group Assignment||Treatment||None (Open Label)||||||
1321176|NCT03320408|||Cohort||Prospective|||||||
1321177|NCT03320395||Single Group Assignment||Treatment||None (Open Label)||||||
1321178|NCT03320382|||Cohort||Cross-Sectional|||||||
1321179|NCT03320369||Single Group Assignment||Treatment||None (Open Label)||||||
1321180|NCT03320356|||Case-Only||Prospective|||||||
1321181|NCT03320343|||Cohort||Prospective|||||||
1321182|NCT03320330||Single Group Assignment||Treatment||None (Open Label)||||||
1321183|NCT03320317|||Other||Prospective|||||||
1321184|NCT03320304|||Cohort||Prospective|||||||
1321185|NCT03320291||Single Group Assignment||Treatment||None (Open Label)||||||
1321186|NCT03320278|||Cohort||Prospective|||||||
1321187|NCT03320265|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321188|NCT03320252|||Cohort||Prospective|||||||
1321189|NCT03320239|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321190|NCT03320226||Single Group Assignment||Other||None (Open Label)||||||
1321191|NCT03320213|||Case-Control||Prospective|||||||
1321192|NCT03320200|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321193|NCT03320187|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321194|NCT03320174|Randomized|Parallel Assignment||Prevention||Quadruple|Identically matched placebo control.||t|t|t|t
1321195|NCT03320161|||Cohort||Prospective|||||||
1321196|NCT03320148|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Due to the nature of the new model of care and comparison, it is not possible to blind the patients or health care providers. Since the primary outcomes are self-reported outcome measures, the assessor is also not blind to the intervention.|This is a pilot cluster randomized controlled trial randomizing 4 sites to the PT-led primary care model for back pain or usual care model||||
1321197|NCT03320135|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1321198|NCT03320122|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The proposed program will target MTUs and patients in counties were pediatric physiatrists and other multidisciplinary team members are underrepresented. In this proposed model, the investigators will randomly select at least 350 patient encounters: approximately 175 children will receive care using tele-physiatrist medical direction; 101 children will receive care from a pediatric physiatrist who travels to the MTU to provide in-person care; and 74 children will receive care under a non-pediatric specialist's medical directorship. Once the care model has been created at each site, patients from each cohort will be selected using a clustered, clinic based randomization scheme.||||
1321199|NCT03320109|||Cohort||Prospective|||||||
1321200|NCT03320096||Single Group Assignment||Treatment||None (Open Label)||||||
1321201|NCT03320083|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1321202|NCT03320070|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321203|NCT03320057||Single Group Assignment||Health Services Research||None (Open Label)||Prospective cohort||||
1321204|NCT03320044|||Case-Only||Prospective|||||||
1321205|NCT03320031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321206|NCT03320018|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1321207|NCT03320005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321208|NCT03319992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321209|NCT03319979|||Ecologic or Community||Cross-Sectional|||||||
1321210|NCT03319966|||Case-Control||Prospective|||||||
1321211|NCT03319953|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1321212|NCT03319940||Single Group Assignment||Treatment||None (Open Label)|The patient, investigator, investigative staff, medical monitor and care provider will not be masked for the study.|This is an open-label, ascending, multiple dose, phase 1 study evaluating AMG 757 in subjects with Small Cell Lung Cancer. The dose exploration phase of the study will estimate the maximum tolerated dose (MTD) or Recommended Phase 2 Dose (RP2D) of AMG 757. This will be followed by dose expansion phase to confirm the MTD and to obtain further safety and efficacy data. Alternative dosing schedule(s) may be explored based on emerging pharmacokinetic and safety data||||
1321213|NCT03319927|Randomized|Parallel Assignment||Prevention||None (Open Label)||This randomized control study will include 88 child care centers in four CA counties and be conducted in 9-month cycles over five years. The counties will be matched and randomized to the intervention group (integrated pest management) or attention control group (physical activity). Each study cycle will include Recruitment, Baseline Assessments, Intervention, and Post-Intervention Assessments. Baseline Assessments are completed as director interviews, child care provider surveys, research assistant objective observations using standardized Checklists, review of written policies, child anthropometrics, center dust samples to measure pesticides, and silicone wristband personal samplers worn by 5 children per center for a 7-days. During the 7-month Intervention phase, CCHCs will conduct one workshop per center on the intervention topic (IPM or physical activity) and provide seven monthly consultations per center. The Post-Intervention stage will repeat all the baseline assessments.||||
1321221|NCT03319823|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Study Design and Procedures~Participants who meet the inclusion criteria will be contacted by the study team. The purpose of the study will be explained, and they will be asked to sign an informed consent form. Based on their nocturnal systolic blood pressure, the investigators will assign participants to one of two treatment groups:~Group (1): Thiazide Therapy Group: Men without diabetes, and mild hypertension - a sleeping systolic blood pressure of 125-139 mm Hg, and an awake average blood pressure of < 160 mm Hg.~Group (2): Combination Therapy Group: Men with diabetes, or with more severe hypertension - a sleeping blood pressure of ≥ 140 mm Hg, or an awake average blood pressure of ≥ 160 mm Hg."||||
1321222|NCT03319810||Single Group Assignment||Treatment||None (Open Label)||This is a single center, open label, proof of concept, out-patient study.||||
1321223|NCT03319797||Single Group Assignment||Treatment||None (Open Label)||Prospective, Multicenter, Single-arm Phase III||||
1321224|NCT03319784|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded to the kind of injection they receive, but the physicians who perform the injection will not be blinded for the medical record purposes.||t|||
1321225|NCT03319771|Randomized|Parallel Assignment||Treatment||Single||||||t
1321226|NCT03319758|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1321227|NCT03319745||Single Group Assignment||Treatment||None (Open Label)||||||
1321228|NCT03319732||Single Group Assignment||Treatment||None (Open Label)||||||
1321229|NCT03319719||||||||||||
1321230|NCT03319706|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321231|NCT03319693|||Cohort||Retrospective|||||||
1321232|NCT03319680|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321233|NCT03319667|Randomized|Parallel Assignment||Treatment||Single||Parallel and crossover||||t
1321234|NCT03319654||Single Group Assignment||Diagnostic||None (Open Label)||Single center, university setting, no commercial affiliation||||
1321235|NCT03319641||Single Group Assignment||Diagnostic||None (Open Label)||diagnostic study||||
1321236|NCT03319628||Single Group Assignment||Treatment||None (Open Label)||Open-label, dose escalation to reach MTD. The MTD will be confirmed in 3 parallel cohorts: (1) patients with platinum-resistant ovarian cancer; (2) patients with non-squamous NSCLC; and (3) patients with papillary thyroid carcinoma, endometrial carcinoma, papillary renal cell carcinoma, or salivary duct carcinoma.||||
1321237|NCT03319615|Randomized|Crossover Assignment||Basic Science||Single||The baseline non-intervention control arm only used in the present secondary data analysis|t|||
1321238|NCT03319602|Non-Randomized|Crossover Assignment||Treatment||Single|Assessor blind|Comparison of level oxygenation between classical oxygenation with nasal canulae with or without adjunctive of a double trunk mask||||t
1321239|NCT03319589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321240|NCT03319576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321241|NCT03319563|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1321242|NCT03319550|Randomized|Crossover Assignment||Basic Science||Double|"The three different protein supplements will be fabricated with the same taste, colour and weight. They will be named A, B and C and the investigator will not know which protein is which until all data has been collected and analysed."|"Interventions*:~I. LPS (1 ng/kg as bolus) + 36 h fasting + 36 h bedrest + Casein~II. LPS (1 ng/kg as bolus) + 36 h fasting + 36 h bedrest + Whey~III. LPS (1 ng/kg as bolus) + 36 h fasting + 36 h bedrest + Leucine-enriched whey~* LPS will be administered on study day 1 and measurements of metabolism will be performed on study day 2 where we see the secondary effects of acute inflammation. The patient will stay at the hospital over night to ensure continues fast and bedrest.~The beverages will be isocaloric and with the same total protein content. The basal period will be 2,5 hour with infusion of tracer. Hereafter a total amount of 0,6 g protein/kg bodyweight will be orally administered, 1/3 as a bolus and 2/3 as sipping over 3,5 hours. Muscle biopsies and blodsampels will be collected during both the basal and the sipping period."|t||t|
1321243|NCT03319537|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This study is a single institution trial with two cohorts to test the efficacy of the NEDD8 inhibitor, pevonedistat as a single agent in patients with NF2 mutant MM (Cohort 1), and also to test the safety of pevonedistat in combination with standard chemotherapy, pemetrexed/cisplatin (Cohort 2).||||
1321244|NCT03319524|||Cohort||Prospective|||||||
1321245|NCT03319511|Randomized|Parallel Assignment||Supportive Care||Double|a dorsal thoracic gauze cover.||t|||t
1321246|NCT03319498|Randomized|Parallel Assignment||Treatment||Double||Randomized Controlled Trial|t|t||
1321247|NCT03319485|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1321248|NCT03319472|||Cohort||Prospective|||||||
1321249|NCT03319459|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321250|NCT03319446|||Cohort||Prospective|||||||
1321251|NCT03319433|||Cohort||Prospective|||||||
1321252|NCT03319420|Randomized|Parallel Assignment||Treatment||Triple|Investigator staff involved in the dispensation of study treatments and treatment compliance checks will not be involved in data collection - doublemasked treatment design.|A randomized, double-Masked, comparative study|t||t|t
1321253|NCT03319407||Single Group Assignment||Supportive Care||None (Open Label)||||||
1321254|NCT03319394|Randomized|Parallel Assignment||Treatment||Single|Study statistician did not know which condition participants were assigned to.|||||t
1321255|NCT03319381|||Case-Control||Prospective|||||||
1321256|NCT03319368|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1321257|NCT03319355||Single Group Assignment||Supportive Care||Single||||||t
1321258|NCT03319342|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1321259|NCT03319329|||Cohort||Cross-Sectional|||||||
1321260|NCT03319316|Randomized|Parallel Assignment||Treatment||None (Open Label)||2-arm open-label randomized study in each of two separate cohorts (non-squamous and squamous NSCLC) according to histology.||||
1321261|NCT03319303|||Cohort||Prospective|||||||
1321262|NCT03319290|||Other||Cross-Sectional|||||||
1321263|NCT03319277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321264|NCT03319264||Single Group Assignment||Screening||None (Open Label)||||||
1321265|NCT03319251|||Case-Only||Prospective|||||||
1321268|NCT03319212||Single Group Assignment||Treatment||None (Open Label)||||||
1321269|NCT03319199|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321270|NCT03319186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321271|NCT03319173|Randomized|Parallel Assignment||Treatment||None (Open Label)||To assess differences between the control and experimental groups, a mixed model will be fit for each variable separately using both baseline (week 0) and post program (week 12) values for each subject. Models will include week, group, and their interaction as fixed effects, gender as a covariate, and subject as a random effect. To assess significant differences, we will use the difference at week 12 adjusted for the baseline difference, and will report p-values, least squares means, and 95% confidence intervals. Further analysis of treatment effects over time will be examined by comparing the within-group differences over time.||||
1321272|NCT03319160|||Cohort||Prospective|||||||
1321273|NCT03319147|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1321274|NCT03319134|Randomized|Parallel Assignment||Basic Science||Double||Participants will be randomly assigned to one of three groups: (1) active HD-tDCS with retrieval memory task, (2) sham HD-tDCS with retrieval memory task, (3) active cathodal HD-tDCS with retrieval memory task|t|||t
1321275|NCT03319121|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|Participants will be randomly allocated into either the empirical group or guided group for 8 weeks.||||
1321276|NCT03319108|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1321277|NCT03319095|Randomized|Parallel Assignment||Treatment||Double|The main investigators and assessor will be blinded in relation to the allocation of participants in the groups||||t|t
1321278|NCT03319082|||Cohort||Prospective|||||||
1321279|NCT03319069|Randomized|Parallel Assignment||Treatment||None (Open Label)|Check none|Assignment Masking: open label||||
1321280|NCT03319056|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1321281|NCT03319043|Randomized|Parallel Assignment||Treatment||Triple|Randomization sequences will be concealed in lightproof, sealed envelopes kept by a specified project manager and the sponsor, who are not involved in the recruitment, intervention, assessment, or statistical analysis. The treatment allocation will be blinded to the participants and investigators throughout the study, and the outcome assessors and statisticians will not be involved in the participants' screening and allocation. Each patient will receive a unique randomized number corresponding to the drug according to the group allocation. Furthermore, the intervention group type will be replaced by the letter A, B as blind codes of allocation. The blind codes will not be disclosed until the statistical analysis is completed.|A total of 120 eligible participants will be randomly allocated to the placebo group and treatment group in a 1:1 ratio. Randomized sequences of each center and every packed drug were generated by an independent professor at the Drug Clinical Research Center of Shanghai University of TCM, using a stratified block randomization method with 30 blocks of block size 8 based on the PROC PLAN function of the SAS 9.2 software analysis system (SAS Institute, Cary, NC, USA).|t|t|t|
1321282|NCT03319030|||Cohort||Cross-Sectional|||||||
1321283|NCT03319017|||Case-Only||Prospective|||||||
1321284|NCT03319004||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321285|NCT03318991|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321286|NCT03318978|Non-Randomized|Single Group Assignment||Basic Science||Single|Deidentified samples will be analyzed by AMS at Lawrence Livermore National Laboratory and the pharmacokinetics determine at Pacific Northwest National Laboratory.|||||t
1321287|NCT03318965|||Case-Only||Cross-Sectional|||||||
1321288|NCT03318952|Randomized|Crossover Assignment||Treatment||Single|||t|||
1321289|NCT03318939||Single Group Assignment||Treatment||None (Open Label)||"Each treatment cycle is 28 calendar days in duration. There will be four patient cohorts and eligible patients will be enrolled into each cohort in parallel based on EGFR or HER2 exon 20 mutation status and prior treatment status:~Cohort 1: Previously treated patients with EGFR exon 20 insertion mutant positive NSCLC~Cohort 2: Previously treated patients with HER2 exon 20 insertion mutant positive NSCLC~Cohort 3: Treatment naive patients with EGFR exon 20 insertion mutant positive NSCLC~Cohort 4: Treatment naive patients with HER2 exon 20 insertion mutant positive NSCLC"||||
1321290|NCT03318926|||Cohort||Retrospective|||||||
1321291|NCT03318913|Randomized|Crossover Assignment||Treatment||Double|Double blind||t||t|
1321292|NCT03318900||Single Group Assignment||Treatment||None (Open Label)||A maximum of 18 evaluable patients will be enrolled in a dose escalation study of Utomilumab.||||
1321293|NCT03318887|||Cohort||Retrospective|||||||
1321294|NCT03318874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321295|NCT03318861||Single Group Assignment||Treatment||None (Open Label)||Single Arm, Dose-Escalation||||
1321296|NCT03318848|Randomized|Parallel Assignment||Other||Double|The teacher that evaluated the students, was not informed if the student was of the control or intervention group. The outcomes assessor was not informed if the group 1 and 2 was control or intervention group.|The students were randomized to one of two groups (control or intervention), according to the sequence determined by the Random System|||t|t
1321297|NCT03318835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321298|NCT03318822|||Cohort||Prospective|||||||
1321299|NCT03318809||Sequential Assignment||Treatment||None (Open Label)|The patient, investigator, investigative staff, medical monitor and care provider will not be masked for the study.|This is a multisite (approximately 3 sites), open-label, non-randomized, single-dose study in subjects with severely impaired kidney function and healthy subjects. About 12 subjects will be assigned to two groups: Group 1: 6 with severely impaired kidney function , and Group 2: 6 subjects with normal kidney function.||||
1321300|NCT03318796||Single Group Assignment||Treatment||None (Open Label)||Prospective, single arm open label registry||||
1321301|NCT03318783|Randomized|Parallel Assignment||Treatment||Quadruple|Investigational pharmacy staff will maintain the randomization list and study/drug placebo assignment. Participants, care providers, the investigators and outcomes assessors will be blinded to the grouping.|"Subjects will be randomized to one of the two treatment arms based on an unrestricted or fair-coin randomization procedure."|t|t|t|t
1321302|NCT03318770|||Case-Control||Prospective|||||||
1321303|NCT03318757|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321304|NCT03318744|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1321305|NCT03318731|Randomized|Parallel Assignment||Other||Double||Three groups: placebo, 300mg dose (low) and 500mg dose (high)|t||t|
1321306|NCT03318718||Single Group Assignment||Treatment||None (Open Label)||||||
1321307|NCT03318705|||Case-Control||Prospective|||||||
1321308|NCT03318692|Randomized|Parallel Assignment||Treatment||Single|Patient is masked to the surgery procedure|prospective, randomized, partially blinded|t|||
1321309|NCT03318679|||Cohort||Prospective|||||||
1321310|NCT03318666|Randomized|Parallel Assignment||Health Services Research||Double||||t||t
1321311|NCT03318653|||Cohort||Cross-Sectional|||||||
1321312|NCT03318640|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Comparison between treated group or not||||
1321313|NCT03318627||Single Group Assignment||Treatment||None (Open Label)||||||
1321314|NCT03318614|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|Participants assigned to the M-63 group were given a sachet of B. infantis M63 (2.5 x 109 cfu/g per sachet) (Morinaga Milk Industry Co. Ltd., Japan) to consume daily for three months in addition to advice of good hygiene and sanitation practices. No drug intervention was given to the control group over three months other than advice of good hygiene and sanitation practices.||||
1321315|NCT03318601||Single Group Assignment||Other||None (Open Label)||cirrhotic patients with ascites requiring prolonged hospitalization in the Hepato-gastroenterology departments of the Besançon, Nancy and Reims hospitals.||||
1321316|NCT03318588|||Case-Control||Prospective|||||||
1321317|NCT03318575|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321318|NCT03318562|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321319|NCT03318549|||Cohort||Prospective|||||||
1321320|NCT03318536|||Cohort||Retrospective|||||||
1321321|NCT03318523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321322|NCT03318510||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321323|NCT03318497||Single Group Assignment||Diagnostic||None (Open Label)||"The interim 18F FLT-PET/CT will be performed after the 2nd cycle of chemotherapy regimen, but before the commencement of 3rd cycle.~Clinical Follow Up: Standard of care clinical follow-up data will be collected up to 2 years following the end of chemotherapy."||||
1321324|NCT03318484|Randomized|Parallel Assignment||Treatment||Single||||||t
1321325|NCT03318471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321326|NCT03318458|Randomized|Parallel Assignment||Treatment||Triple|"The assignment to the groups will be of simple random type and hidden. Those responsible for admitting patients to the intervention phase will not know what group has been assigned each. This assignment will be made in advance by a researcher who will not intervene in the later stages of evaluation, intervention, data recording and elaboration of database. The assignment will be communicated through sealed and totally opaque envelopes.~All measurements given above will be made both to the control group and to the experimental group just prior to the start of the intervention, and immediately after and six months after the end of this period, and the results will be recorded in a data record"|Randomized controlled trial||t|t|t
1321327|NCT03318445|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321328|NCT03318432|||Cohort||Other|||||||
1321329|NCT03318419||Single Group Assignment||Treatment||None (Open Label)||||||
1321330|NCT03318406|||Cohort||Prospective|||||||
1321331|NCT03318393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321332|NCT03318380||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321333|NCT03318367||Single Group Assignment||Supportive Care||None (Open Label)||||||
1321334|NCT03318354|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321335|NCT03318341|Randomized|Crossover Assignment||Treatment||Quadruple|Participants will be blinded to the conditions, since they will not perceive any vibration for both conditions. The researcher conducting the evaluations with participants will also be blinded with the following procedure: A person outside the university will generate a random condition assignment sequence and send a custom program to the researcher to use.|The study will use a 2×2 crossover design. Participants will be randomly assigned to either the treatment or control condition for the first month, followed by a 2-week washout period and then crossover to the other condition.|t|t|t|t
1321336|NCT03318328|||Case-Only||Other|||||||
1321337|NCT03318315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321338|NCT03318302|||Ecologic or Community||Other|||||||
1321339|NCT03318289|Randomized|Parallel Assignment||Treatment||Single||||||t
1321340|NCT03318276|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321341|NCT03318263||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321342|NCT03318250|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321343|NCT03318237|||Case-Only||Prospective|||||||
1321344|NCT03318224|||Cohort||Cross-Sectional|||||||
1321345|NCT03318211|Randomized|Parallel Assignment||Treatment||Single||||||t
1321346|NCT03318198|Randomized|Crossover Assignment||Other||None (Open Label)||We conducted a 9-month randomized, cross-over trial on an inpatient medicine teaching service where 22 faculty provided either: 1) direct supervision where attendings joined work rounds on established (previously admitted) patients or 2) standard supervision where attendings were available, but did not join work rounds. Each faculty member participated in both arms in random order. The primary safety outcome was rate of medical errors. Resident education was evaluated via a time motion study to assess resident participation on rounds and surveys to measure resident and attending educational ratings.||||
1321347|NCT03318185|Randomized|Parallel Assignment||Treatment||Single||||||t
1321383|NCT03317717|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1321384|NCT03317704|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1321385|NCT03317691|||Cohort||Retrospective|||||||
1321386|NCT03317678|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321387|NCT03317665|||Cohort||Prospective|||||||
1321388|NCT03317652||Single Group Assignment||Basic Science||None (Open Label)||||||
1321389|NCT03317639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321390|NCT03317626||Single Group Assignment||Treatment||None (Open Label)||||||
1321348|NCT03318172|Randomized|Crossover Assignment||Treatment||Triple|The day of the SCS implantation (RestoreSensor Surescan MRI Neurostimulator, Medtronic ©) the patients are randomized based on a random number assigned from www.randomization.com. The random number table is sent to the MedTronic representative in charge of the SCS mode control by the operating nurse who has no information about the study protocol. At this time, implantation practitioners and other research participants don't know which group is assigned first. Subjects with SCS implantation will be assigned 1:1 to either group C (conventional stimulation) or H (High-Density stimulation) to find an effective mode of pain relief.|"V1 SCS trial for 6 days (3d conventional + 3d HD stimulation).~V2 Enrolled if positive response (≥50% pain reduction) in one of the two modes during V1 + informed consent and randomization + blinding~Group C Conventional mode (2 weeks) + HD mode (2 weeks)~Groups H HD mode (2 weeks) + conventional mode (2 weeks)~V3 After 2 weeks (+3d allowed) from V2. Cross-over performed by the MedTronics person in charge of adjusting the SCS mode. Mode-related information will not be shared with other researchers~V4 (unblinding) 2 weeks from V3 (+3d allowed). Patients will be questioned about the more effective mode (primary endpoint). The SCS will be programmed accordingly~V5 (follow-up 1) 4 weeks after V4 (±5d). Short-term assessment of effectiveness and safety~V6 (follow-up 2) 12 weeks after V4 (±5d). Middle-term assessment of effectiveness and safety~V7 (follow-up 3) 24 weeks after V4 (±5d). Long-term assessment of effectiveness and safety"|t|t|t|
1321349|NCT03318159||Single Group Assignment||Prevention||None (Open Label)||"open label, single arm, phase 2, multicenter~*historical control will be used for comparison: historical control patients are defined as those diagnosed with AA/hMDS and underwent ATG treatment with either fluconazole or itraconazole prophylaxis."||||
1321350|NCT03318146|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is a prospective, open-label, controlled non-randomized study, comparative split body-design study comparing unilateral Latanoprost-loaded punctual plug in patients with open angle early visual field defects glaucoma or ocular hypertension with Xalatan © eye drops treatment in the second eye."||||
1321351|NCT03318133|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1321352|NCT03318120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321353|NCT03318107||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321354|NCT03318094|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1321355|NCT03318081|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321356|NCT03318068||Single Group Assignment||Supportive Care||None (Open Label)||This is a feasibility study to determine if a yoga intervention can be delivered via to outpatients receiving chemotherapy.||||
1321357|NCT03318055|||Case-Only||Prospective|||||||
1321358|NCT03318042||Single Group Assignment||Screening||None (Open Label)||||||
1321359|NCT03318029|Randomized|Parallel Assignment||Prevention||Double||Two controlled, randomized, double-blind clinical trials developed and undertaken (one in Brazil and the other in the UK) with an intervention period of 12 weeks. The women selected were randomly divided into two groups: Placebo Group and Supplemented Group, the latter will receive 600UI of vitamin D, in each country. Groups (arms): Placebo UK trial; Vitamin D UK trial; Placebo Brazuk trial; Vitamin D Brazil trial.|t||t|
1321360|NCT03318016||Single Group Assignment||Treatment||None (Open Label)||"Cohort -1 (3-6 subjects, if needed): Cyclophosphamide 500 mg/m2~Cohort 1 (3-6 subjects): Cyclophosphamide 1000 mg/m2~Cohort 2 (3-6 subjects): Cyclophosphamide 2000 mg/m2~Cohort 3 (3-6 subjects): Cyclophosphamide 3000 mg/m2~Cohort 4 (3 subjects): Cyclophosphamide 4000 mg/m2~ATO and Cyclophosphamide will be repeated every 28 days."||||
1321361|NCT03318003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321362|NCT03317990|Randomized|Parallel Assignment||Treatment||Single|Patients and the research team collecting follow up data will be blinded as to whether the person has had NeuroSAFE procedure. The surgeon and pathologist cannot be blinded to this.|Feasibility study. Parallel group, two-arm, randomised trial with 1:1 allocation ratio between nerve sparing guided by NeuroSAFE and current UK practice (guided by MRI, biopsy and clinical examination).|t|||
1321363|NCT03317977|Randomized|Parallel Assignment||Treatment||Single||||||t
1321364|NCT03317964|||Case-Control||Prospective|||||||
1321365|NCT03317951|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, controlled, open-label, randomized, bicenter study parallel-group design||||
1321366|NCT03317938||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321367|NCT03317925|||Cohort||Prospective|||||||
1321368|NCT03317912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321369|NCT03317899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321370|NCT03317886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321371|NCT03317873|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1321372|NCT03317860|Randomized|Crossover Assignment||Other||Triple|Participants will receive both conditions (active and sham transcranial direct current stimulation paired with arm rehabilitation training [repetitive task-specific practice]) in this cross-over design study. Individuals will be randomized to determine which condition they receive first and the participant and treatment therapist and assessor will be blinded to the order that the interventions are delivered. The PI will oversee randomization so that each patient is randomized and assigned a unique five digit code. When this code is entered on the tDCS device, the device will automatically assign the patient to receive either real or sham stimulation. Because the sham stimulation provides a ramp up/ramp down stimulation for 15 seconds at the start and end of the session the participant may perceive the sham stimulation as active stimulation.||t||t|t
1321373|NCT03317847|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321374|NCT03317834|||Cohort||Prospective|||||||
1321375|NCT03317821|||Cohort||Prospective|||||||
1321376|NCT03317808|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321377|NCT03317795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321378|NCT03317782|||Cohort||Prospective|||||||
1321379|NCT03317769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321380|NCT03317756|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|intervention and control arms|||||
1321381|NCT03317743||Single Group Assignment||Treatment||None (Open Label)||||||
1321382|NCT03317730||Single Group Assignment||Treatment||None (Open Label)||||||
1573444|NCT00001194||||||||||||
1321391|NCT03317613||Single Group Assignment||Treatment||None (Open Label)||Cancer patients treated with qutenza (capsaicin patch)||||
1321392|NCT03317600|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1321393|NCT03317587||Single Group Assignment||Prevention||None (Open Label)||||||
1321394|NCT03317574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321395|NCT03317561|||Case-Control||Prospective|||||||
1321396|NCT03317548|||Case-Control||Retrospective|||||||
1321397|NCT03317535|Randomized|Parallel Assignment||Other||Single||||||t
1321398|NCT03317522|||Cohort||Prospective|||||||
1321399|NCT03317509|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321400|NCT03317496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321401|NCT03317483|||Cohort||Prospective|||||||
1321402|NCT03317470|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1321403|NCT03317457|Randomized|Parallel Assignment||Treatment||None (Open Label)||Treatment Arm A: Combination of Durvalumab and Tremelimumab Treatment Arm B: Doxorubicin||||
1321404|NCT03317444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321405|NCT03317431|||Cohort||Prospective|||||||
1321406|NCT03317418|||Cohort||Prospective|||||||
1321407|NCT03317405|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321408|NCT03317392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321409|NCT03317379|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Since this is a behavioral intervention, participants, care providers, and investigators are aware of each patient's randomization. Outcomes are assessed electronically.|Randomization occurs at the beginning of each individual's participation in the study. Participants are randomized to one condition and not re-randomized during any portion of the study||||
1321410|NCT03317366||||||||||||
1321411|NCT03317353|Randomized|Parallel Assignment||Prevention||Double|"Double (Investigator, Outcomes Assessor)~After the first screening visit, the patients who grant their consent will be included in the study and randomised to one of the following study arms. Randomisation will be performed by C.H.U de Santiago Clinical Epidemiology and Biostatistics Unit. Once the informed consent form is signed, the care provider will contact the unit, which will give him the code of the arm to which the patient is assigned. A n= 20 block balanced randomisation sequence will be used. The investigator will analyse results and evolution, being blind type and duration of vestibular rehabilitation."|Experimental study, single-center, open, randomized (balanced blocks of patients) in four branches in parallel, in 139 elderly patients (over 65 years) with high risk of falls; follow-up period: twelve months.|||t|t
1321412|NCT03317340|||Cohort||Prospective|||||||
1321413|NCT03317327||Single Group Assignment||Treatment||None (Open Label)||Exploratory||||
1321414|NCT03317314|||Case-Only||Prospective|||||||
1321415|NCT03317301|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321416|NCT03317288||Single Group Assignment||Prevention||None (Open Label)|Here is no masking of the intervention.|Repeated measures design. Subject serves as his or her own control.||||
1321417|NCT03317275|Randomized|Parallel Assignment||Diagnostic||Single||Prospective randomised cohort study, partial blinded|t|||
1321418|NCT03317262|||Other||Prospective|||||||
1321419|NCT03317249|||Cohort||Prospective|||||||
1321420|NCT03317236|Randomized|Crossover Assignment||Other||None (Open Label)||Single-dose, two-way crossover.||||
1321421|NCT03317223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321422|NCT03317210|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||According to hemoglobin level at the start of the therapy, the women were either treated with intravenous iron and rhEPO or with intravenous iron only twice weekly.||||
1321423|NCT03317197|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1321424|NCT03317184|Randomized|Parallel Assignment||Treatment||Double||Expertise-based, single intuition, assessor-blinded, randomized clinical trial.|||t|t
1321425|NCT03317171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321426|NCT03317158|Randomized|Crossover Assignment||Treatment||None (Open Label)|Open-Label|||||
1321427|NCT03317145|Randomized|Sequential Assignment||Prevention||None (Open Label)||Patients who have had a total hip replacement will be randomised to wear either a foot compression (IPC) device or a neuromuscular electrostimulation (NMES) device (gekoTM) first. Blood flow will be measured using both devices on the same patient in sequence. The blood flow measurements will be done by ultrasound. Each ultrasound assessment will take approximately 30 minutes in total. Baseline blood flow measurements will be taken initially. The first device will then be fitted and allowed to operate for 10 minutes before ultrasound measurements are taken. After a rest period of 30 minutes, the second device is then fitted and allowed to operate for 10 minutes, following which blood flow measurements are repeated. Patients will then be asked to complete a questionnaire to assess the comfort of each device.||||
1321428|NCT03317132|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1321429|NCT03317119||Single Group Assignment||Treatment||None (Open Label)||||||
1321430|NCT03317106|||Cohort||Prospective|||||||
1321431|NCT03317093||Single Group Assignment||Treatment||None (Open Label)||||||
1321432|NCT03317080|||Cohort||Prospective|||||||
1321433|NCT03317067|Randomized|Parallel Assignment||Treatment||Double|double blind||t||t|
1321434|NCT03317054|||Other||Prospective|||||||
1321435|NCT03317041|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1321436|NCT03317028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321437|NCT03317015|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321438|NCT03317002|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321439|NCT03316989|||Case-Control||Prospective|||||||
1321440|NCT03316976|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321441|NCT03316963||Single Group Assignment||Treatment||None (Open Label)||||||
1321442|NCT03316950|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321495|NCT03316261|||Cohort||Cross-Sectional|||||||
1321496|NCT03316248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321497|NCT03316235|||Cohort||Retrospective|||||||
1321443|NCT03316937|Randomized|Factorial Assignment||Treatment||Single||The buccal and lingual surface of the 23 participants' crowns will be randomly assigned to receive scaling and root planing with either Teflon scalers, or non-Teflon scalers after implant crown delivery. Each patient will act as their own control.|t|||
1321444|NCT03316924|||Case-Only||Cross-Sectional|||||||
1321445|NCT03316911|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321446|NCT03316898|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321447|NCT03316885||Single Group Assignment||Treatment||None (Open Label)||||||
1321448|NCT03316872||Single Group Assignment||Treatment||None (Open Label)||||||
1321449|NCT03316859|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321450|NCT03316846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321451|NCT03316833|||Cohort||Prospective|||||||
1321452|NCT03316820|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321453|NCT03316807|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1321454|NCT03316794||Single Group Assignment||Treatment||None (Open Label)||||||
1321455|NCT03316781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321456|NCT03316768|||Case-Control||Prospective|||||||
1321457|NCT03316755|Randomized|Parallel Assignment||Prevention||Double||randomised|||t|t
1321458|NCT03316742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321459|NCT03316729|Randomized|Sequential Assignment||Treatment||Double||Ascending doses in sequential cohorts (1-3) will be evaluated against placebo|t||t|
1321460|NCT03316716|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321461|NCT03316703|Randomized|Parallel Assignment||Treatment||Single||||||t
1321462|NCT03316690|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1321463|NCT03316677||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321464|NCT03316664|Randomized|Parallel Assignment||Treatment||Double||An 8-week, randomized, controlled, assessor-blind, three-parallel-arm trial is planned with patients diagnosed with a schizophrenic psychosis.|||t|t
1321465|NCT03316651||Single Group Assignment||Treatment||None (Open Label)||||||
1321466|NCT03316638|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1321467|NCT03316625||Single Group Assignment||Other||None (Open Label)||||||
1321468|NCT03316612|Randomized|Parallel Assignment||Prevention||Double|The all details of groups assignment are arranged and controlled by the research designers. The color, shape, and external packaging of the bilberry extract and placebo are consistent (brown oval tablets). Each bottle of tablets will be marked with the name (or identify number) of the participants by research designers. Thus, the grouping of participants is blind to the rest of the researchers (like outcomes assessors).||t|||t
1321469|NCT03316599||Single Group Assignment||Treatment||None (Open Label)||||||
1321470|NCT03316586||Single Group Assignment||Treatment||None (Open Label)||||||
1321471|NCT03316573||Single Group Assignment||Treatment||None (Open Label)||||||
1321472|NCT03316560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1321473|NCT03316547|Randomized|Parallel Assignment||Treatment||Double||||t||t
1321474|NCT03316534|Randomized|Crossover Assignment||Prevention||Double||HIV subjects (all on ABC therapy) who fulfilled thee admission criteria will be randomized to either of 2 groups (A or B) with 20 subjects each that received placebo or aspirin (100 mg/daily) for two weeks. At the end of the two week period (T15), patients of group A will be switched to placebo, while group B will be switched to aspirin for another 2 weeks (T30). Adherence will be confirmed by pill count at the end of each study period.|t||t|
1321475|NCT03316521|Randomized|Sequential Assignment||Treatment||None (Open Label)||This is a prospective, single-center, open-label FIH study investigating the safety, tolerability, PK and PD after single and multiple doses of AMY-101 in healthy male volunteers. In the SAD part of the study, a single dose at ascending dose levels of AMY-101 will be administered to different cohorts, following a careful dose-escalation strategy. In the MD part of the study, multiple doses will be administered using different dosing intervals; the cohorts will include a minimum of four (4) subjects each. Additional subjects may be added in the cohorts if necessary.||||
1321476|NCT03316508|||Other||Prospective|||||||
1321477|NCT03316495|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1321478|NCT03316482||Single Group Assignment||Treatment||None (Open Label)||Leuprorelin treatment||||
1321479|NCT03316469|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1321480|NCT03316456|||Cohort||Prospective|||||||
1321481|NCT03316443|Randomized|Parallel Assignment||Other||Single||"Eligible 90 adult patients will be randomly allocated by a computer-generated randomization sequence into 2 equal groups:~Macintosh group: 45 patients will be intubated by Macintosh laryngoscope (Group M).~Glidescope group: 45 patients will be intubated by Glidescope (Group G)."|t|||
1321482|NCT03316430|||Cohort||Prospective|||||||
1321483|NCT03316417|||Cohort||Other|||||||
1321484|NCT03316404|||Cohort||Prospective|||||||
1321485|NCT03316391|||Case-Only||Prospective|||||||
1321486|NCT03316378|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||In this mechanistic study, the Achilles tendinopathy group receives an anesthetic injection. The healthy control group does not receive an injection.||||
1321487|NCT03316365|Randomized|Parallel Assignment||Treatment||Double|"Home training instructions were provided by a certified physical therapist and board-certified neurologic music therapist blinded to treatment allocation of the subjects.~The TUG and the BBS were administered by an experienced physical therapist blinded to the study design."|||t||t
1321488|NCT03316352|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321489|NCT03316339|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321490|NCT03316326||Single Group Assignment||Treatment||None (Open Label)||Simon's two-stage optimum design||||
1321491|NCT03316313|||Cohort||Retrospective|||||||
1321492|NCT03316300|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321493|NCT03316287|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1321494|NCT03316274||Sequential Assignment||Treatment||None (Open Label)||Standard 3+ 3 design during the initial safety cohort, then expansion cohort||||
1321498|NCT03316222|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1321499|NCT03316209|||Cohort||Prospective|||||||
1321500|NCT03316196|Randomized|Parallel Assignment||Treatment||Triple||Two arm randomized controlled trial|t||t|t
1321501|NCT03316183|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321502|NCT03316170|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1321503|NCT03316157|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomised (1:1) unblinded feasibility trial of a rehabilitation programme (exercise and nutrition) versus waiting list control, in patients with advanced cancer||||
1321504|NCT03316144|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321505|NCT03316131|Randomized|Crossover Assignment||Treatment||Double|The pharmacokineticist will remain blinded during the study conduct, unless otherwise required based on study findings. The pharmacokineticist will be unblinded to perform the final PK analyses after all patients have completed the study, final bioanalytical results are available and all required study data are considered clean. This may occur before database lock.||t|||t
1321506|NCT03316118|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1321507|NCT03316105|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1321508|NCT03316092|||Cohort||Retrospective|||||||
1321509|NCT03316079|Randomized|Crossover Assignment||Treatment||Single|||t|||
1321510|NCT03316066|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1321511|NCT03316053|||Case-Only||Prospective|||||||
1321512|NCT03316040|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321513|NCT03316027|||Case-Only||Cross-Sectional|||||||
1321514|NCT03316014|||Cohort||Retrospective|||||||
1321515|NCT03316001|||Case-Control||Retrospective|||||||
1321516|NCT03315988||Single Group Assignment||Prevention||None (Open Label)||||||
1321517|NCT03315975||Single Group Assignment||Basic Science||None (Open Label)||||||
1321518|NCT03315962|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321519|NCT03315949|Randomized|Parallel Assignment||Other||Double|||||t|t
1321520|NCT03315936|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321521|NCT03315923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321522|NCT03315910|Randomized|Factorial Assignment||Prevention||None (Open Label)||The investigators have chosen to conduct a full factorial experimental design.||||
1321523|NCT03315897|Randomized|Parallel Assignment||Treatment||Single||||||t
1321524|NCT03315884|Randomized|Single Group Assignment||Treatment||Single|||t|||
1321525|NCT03315871||Single Group Assignment||Treatment||None (Open Label)||||||
1321526|NCT03315858|||Cohort||Prospective|||||||
1321527|NCT03315845|||Cohort||Prospective|||||||
1321528|NCT03315832|Randomized|Parallel Assignment||Treatment||Quadruple||Patients with the diagnosis of severe AS and indication for valve intervention (i.e. SAVR or TAVR) fulfilling all inclusion/exclusion criteria will be randomized using 1:1 ratio.|t|t|t|t
1321529|NCT03315819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321530|NCT03315806|Randomized|Crossover Assignment||Prevention||Double|Double blind||t||t|
1321531|NCT03315793|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321532|NCT03315780|Randomized|Crossover Assignment||Treatment||Single|||t|||
1321533|NCT03315767||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321534|NCT03315754||Single Group Assignment||Treatment||None (Open Label)||Single center, single-arm, open-label, 60-month follow-up phase IIb clinical trial||||
1321535|NCT03315741||Single Group Assignment||Treatment||None (Open Label)||This is a phase 1, non-randomized, single arm, open label, single center clinical trial to determine the tolerability and safety of pirfenidone in patients with BOS associated with lung GVHD after hematopoietic cell transplant (HCT). Approximately 30 patients will be enrolled. All patients will follow the 'patient-centered' drug titration approach.||||
1321536|NCT03315728|||Ecologic or Community||Prospective|||||||
1321537|NCT03315715|||Other||Prospective|||||||
1321538|NCT03315702|||Cohort||Prospective|||||||
1321539|NCT03315689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321540|NCT03315676|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321541|NCT03315663|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Open Label|This Pivotal Study will be a multicenter, parallel group, open-label randomized controlled trial with a planned period of 12-month follow-up with the primary effectiveness endpoint assessed at 6 months to compare Sweetch's mHealth Personalized Intervention Program (PIP) to usual care for adults with prediabetes. We intend to enroll 155 subjects in each arm, for a total of 310 subjects in this Study. Subjects will attend a total of 3 visits during the study period with point-of-care measurement of A1C at each study visit (0, 6, and 12 months). A difference in change in A1c of 0.1 between the intervention and control arms and in favor of the intervention arm will be considered clinically meaningful.||||
1321542|NCT03315650|||Case-Only||Prospective|||||||
1321543|NCT03315637||Single Group Assignment||Treatment||None (Open Label)||||||
1321544|NCT03315624||Sequential Assignment||Treatment||None (Open Label)||Prospective, open, controlled, cross-over (with randomized treatment sequences), interventional, multi-center||||
1321545|NCT03315611|Randomized|Parallel Assignment||Treatment||Single||The working hypothesis fo this study is, that local treatment with 'Eucerin AtopiControl Lotion' and 'Eucerin AtopiControl Gesichtscreme' compared to no treatment signifixantly reduces the increase of SCORAD that is elicited during challenge in an environmental challenge chamber (ECC) with grass pollen.||||t
1321546|NCT03315598||Single Group Assignment||Treatment||None (Open Label)||||||
1321547|NCT03315585||Single Group Assignment||Treatment||None (Open Label)||||||
1321548|NCT03315572|||Cohort||Cross-Sectional|||||||
1321549|NCT03315559|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)|This will be an open-label study. Hence, masking will not be provided to the subjects.|This will be a 2-period, single-sequence crossover study. Subjects will receive IV and inhaled doses of GSK2269557 in treatment period 1 and oral dose of GSK2269557 in treatment period 2.||||
1322312|NCT03305601||Single Group Assignment||Other||None (Open Label)||||||
1321550|NCT03315546||Single Group Assignment||Treatment||None (Open Label)||non-randomised feasiblity study||||
1321551|NCT03315533|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321552|NCT03315520||Single Group Assignment||Treatment||None (Open Label)||||||
1321553|NCT03315507||Single Group Assignment||Treatment||None (Open Label)||Open Label||||
1321554|NCT03315494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321555|NCT03315481|Randomized|Parallel Assignment||Device Feasibility||Triple|"The volunteers are randomized using sealed opaque envelopes with a 1:1 ratio. The randomization defines which leg to be used for insertion of a catheter in the long-axis plane and which leg to be used for insertion in the short-axis plane of the adductor canal. Furthermore the randomization defines whether dislocation is executed in the direction of the entry or exit site. The envelopes are prepared by health personnel with no relation to the study and are based on a computer-generated randomization list.~Investigator 2, evaluating loss of sensation to cold, will be blinded to insertion technique and direction of dislocation as well as assessments of spread within the adductor canal. Investigators 3+4 are blinded with regard to direction of dislocation, each other's assessment of spread and to assessments from investigator 1+2. They will be unblinded with regard to insertion technique when they perform US scans"|This is a randomized clinical trial in healthy volunteers. 12 volunteers will have suture-method catheters placed in the adductor canal of each leg using the long-axis plane and short-axis plane technique|t||t|t
1321556|NCT03315468|||Cohort||Prospective|||||||
1321557|NCT03315455|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321558|NCT03315442|Randomized|Parallel Assignment||Screening||None (Open Label)||20 healthy adults, (11 males; 9 females) averaging 26.1 years of age, stood on a MatScan™ pressure mat, which measured center of pressure (CoP), anteroposterior (AP) and mediolateral (ML) postural sways during eight different balance tests (BALT's). BALT's were designed to alter or cancel the systems involved in postural control: visual, vestibular and somatosensory. Subjects were randomly assigned to a caffeine group and an energy drink group. MANOVA analysis was performed for all variables of interest.||||
1321559|NCT03315429||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321560|NCT03315416|||Cohort||Other|||||||
1321561|NCT03315403|||Cohort||Prospective|||||||
1321562|NCT03315390|Randomized|Parallel Assignment||Treatment||Single||multi-center, observer-blinded, randomized, controlled trial with complex psychological intervention||||t
1321563|NCT03315377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321564|NCT03315364|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Phase II clinical trial~Multicenter, Open-label, Single arm, Simon's optimal two-stage design~Phase III clinical trial~Multicenter, Prospective Randomized Open-label Blinded Endpoint (PROBE) design"||||
1321565|NCT03315351||Single Group Assignment||Other||None (Open Label)||||||
1321566|NCT03315338|Randomized|Parallel Assignment||Basic Science||Triple||The 5 study parts may not be conducted entirely sequentially provided that this is justified by PK and safety data obtained from completed cohorts. The first MAD cohort will not start until data are available from at least 2 SAD levels using the same formulation.|t|t|t|
1321567|NCT03315325|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|There was no masking. Every individual was told about injecting the kisspeptin, however, they were not informed at the time when kisspeptin was injected.|Healthy men, 15 in number were selected. These individuals were classified on the basis of their ages in three groups: adult, middle age and advanced aged. Each group comprised of five participants.||||
1321568|NCT03315312|Randomized|Parallel Assignment||Prevention||None (Open Label)||Split-mouth design||||
1321569|NCT03315299||||||||||||
1321570|NCT03315286|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1321571|NCT03315273|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparison of 2 groups: one existing of patients with traumatic brain injury and one control group of healthy volunteers matched for age, sex and educational level||||
1321572|NCT03315260|||Cohort||Prospective|||||||
1321573|NCT03315247|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Control Trial||||
1321574|NCT03315234|||Cohort||Prospective|||||||
1321575|NCT03315221|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1321576|NCT03315208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321577|NCT03315195|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321578|NCT03315182|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a dose escalation trial that will begin with the minimal efficacious dose as determined by preclinical studies and approved by the FDA. During the course of the trial, if safety is shown the dose will be escalated according to the clinical protocol.||||
1321579|NCT03315169|Randomized|Parallel Assignment||Treatment||Single|Note that only the clinician assessing healing and fistulae are masked.|||||t
1321580|NCT03315156|||Case-Only||Prospective|||||||
1321581|NCT03315143|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1321582|NCT03315130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321583|NCT03315117||||||||||||
1321584|NCT03315104|Randomized|Parallel Assignment||Treatment||Quadruple||Staggered enrollment for the first 9 subjects, then parallel low and high dose treatment with a placebo group|t|t|t|t
1321585|NCT03315091|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321586|NCT03315078||Single Group Assignment||Treatment||None (Open Label)||||||
1321587|NCT03315065|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1321588|NCT03315052|Randomized|Single Group Assignment||Treatment||None (Open Label)||Comparison of standard immunosuppression to immunosuppression incorporating budesonide in place of prednisone||||
1321589|NCT03315039||Sequential Assignment||Treatment||None (Open Label)||||||
1321590|NCT03315026||Single Group Assignment||Treatment||None (Open Label)||This is a phase II study investigating the symptomatic and cytokine response to an anti-IL-6 chimeric monoclonal antibody (siltuximab) during the acute phase of autologous stem cell transplantation (ASCT) in older individuals with multiple myeloma (MM) and systemic AL amyloidosis (AL).||||
1321591|NCT03315013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321592|NCT03315000|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1321593|NCT03314987|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1321594|NCT03314974|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321595|NCT03314961|||Cohort||Prospective|||||||
1321596|NCT03314948|||Other||Prospective|||||||
1321597|NCT03314935|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1321598|NCT03314922||Single Group Assignment||Treatment||None (Open Label)||||||
1321599|NCT03314909|Randomized|Parallel Assignment||Treatment||None (Open Label)|This study is designed as a non-blinded trial because of the apparently different equipment of the interventions|Parallel Assignment||||
1321600|NCT03314896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321601|NCT03314883||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321602|NCT03314870|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321603|NCT03314857||Single Group Assignment||Treatment||None (Open Label)||||||
1321604|NCT03314844|||Cohort||Other|||||||
1321605|NCT03314831|||Cohort||Prospective|||||||
1321606|NCT03314818|||Cohort||Prospective|||||||
1321607|NCT03314805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321608|NCT03314792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321609|NCT03314779|||Cohort||Prospective|||||||
1321610|NCT03314766|||Cohort||Prospective|||||||
1321611|NCT03314753|||Other||Retrospective|||||||
1321612|NCT03314740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321613|NCT03314727|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1321614|NCT03314714||Single Group Assignment||Basic Science||None (Open Label)||||||
1321615|NCT03314701|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321616|NCT03314688|Randomized|Parallel Assignment||Treatment||Double|The following study personnel will be masked to participant study arm: clinic medical staff performing clinic measures, study staff reviewing forms and entering data, the PI and Co-Is. Only the statistician, study manager, and interventionists (study dieticians) will be unblinded.|||t||t
1321617|NCT03314675||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321618|NCT03314662|Randomized|Parallel Assignment||Prevention||Quadruple|The trial is designed as a double-blind study||t|t|t|t
1321619|NCT03314649|||Cohort||Prospective|||||||
1321620|NCT03314636||Single Group Assignment||Treatment||None (Open Label)||||||
1321621|NCT03314623|||Cohort||Prospective|||||||
1321622|NCT03314610|||Cohort||Prospective|||||||
1321623|NCT03314597|Randomized|Parallel Assignment||Treatment||Single||||||t
1321624|NCT03314584|Randomized|Parallel Assignment||Treatment||Triple|This is a double-blinded study where only the statistician is aware of the randomization.||t|t|t|
1321625|NCT03314571|||Cohort||Prospective|||||||
1321626|NCT03314558|||Cohort||Prospective|||||||
1321627|NCT03314545|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321628|NCT03314532|Randomized|Parallel Assignment||Treatment||Quadruple|Cases will be randomized by computer into the groups|A randomized controlled experimental design method will be adopted.|t|t|t|t
1321629|NCT03314519|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1321630|NCT03314506||Single Group Assignment||Basic Science||None (Open Label)||||||
1321631|NCT03314493|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321632|NCT03314480|||Case-Only||Prospective|||||||
1321633|NCT03314467|||Case-Control||Prospective|||||||
1321634|NCT03314454|Non-Randomized|Parallel Assignment||Other||Single|Participants are aware of the interventions, but are not aware of the assigned arm.||t|||
1321635|NCT03314441||Single Group Assignment||Treatment||None (Open Label)||4 yoga lessons with and instructors on a 3 months period. Patients are asked to exercise yoga daily for 5 to 30 minutes.||||
1321636|NCT03314428||Single Group Assignment||Treatment||None (Open Label)|Data will be analyzed by an assessor blinded to date of data collection for each testing session. Following data collection, a researcher not involved with data collection or analysis will re-code data timepoints to ensure that the assessor is unaware of the timepoint each datapoint was obtained.|Single Group cohort study||||
1321637|NCT03314415|Randomized|Crossover Assignment||Treatment||None (Open Label)||Robotic-assisted weight loss||||
1321638|NCT03314402|Randomized|Parallel Assignment||Treatment||Quadruple||"SAD: 8 cohorts, 8 subjects take jaktinib and 2 subjects take placebo;~MAD: 5 cohorts, 8 subjects take jaktinib and 2 subjects take placebo;~Postprandial Phamocokinetics:12 subjects, crossover designing"|t|t|t|t
1321639|NCT03314389||Single Group Assignment||Screening||None (Open Label)||||||
1321640|NCT03314376|Randomized|Parallel Assignment||Treatment||Single|||||t|
1321641|NCT03314363||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321642|NCT03314350|||Cohort||Cross-Sectional|||||||
1321643|NCT03314337|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1321644|NCT03314324|Randomized|Crossover Assignment||Other||None (Open Label)||Prospective, randomized, open-label, multicenter, cross-over phase II trial||||
1321645|NCT03314311|Randomized|Parallel Assignment||Treatment||Single||||||t
1321646|NCT03314298||Single Group Assignment||Prevention||None (Open Label)||open labelled pharmacokinetic study||||
1321647|NCT03314285|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1321648|NCT03314272|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321649|NCT03314259|Randomized|Parallel Assignment||Prevention||Quadruple|This is a double blind, placebo- controlled trial. After establishing the eligibility of the patients and obtaining the necessary informed consent, the research assistant (third party) will provide them with pre-assigned sealed envelopes that contain information with regards to their designated arm. The patients in the intervention arm will then be provided with Tamsulosin, while the rest will be given the placebo in a similar packaging. Blinded personnel would include the study participants and doctors/nurses involved in the surgery and peri-operative care. As such, participants, care providers and outcome assessors would all be blinded in our study. There will be no unmasking in our trial.||t|t|t|t
1321650|NCT03314246|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1321651|NCT03314233||Single Group Assignment||Other||None (Open Label)||Unblinded single-arm pilot interventional trial. All enrolled infants will receive the DING intervention (Delayed cord clamping for INtubation and Gentle ventilation)||||
1321652|NCT03314220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321653|NCT03314207|||Cohort||Prospective|||||||
1321654|NCT03314194||Single Group Assignment||Basic Science||None (Open Label)||Pre Post Design||||
1321655|NCT03314181|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321656|NCT03314168|Randomized|Parallel Assignment||Other||Single|The endpoints fatigue, neuromuscular parameters, and quality of life will be masking regarding the outcomes assessors.|||||t
1321657|NCT03314155||Single Group Assignment||Diagnostic||None (Open Label)|Images' analysis will be done by an INSERM engineer without the knowledge of the group to which the subjects belong.|||||
1321658|NCT03314142|Randomized|Crossover Assignment||Other||Single|||||t|
1321659|NCT03314129|Randomized|Parallel Assignment||Treatment||Double||||t||t
1321660|NCT03314116|Randomized|Parallel Assignment||Prevention||Single||"All participants will be randomly assigned to two groups:~The video group will be guided by a 7-minute video that explains the importance of using ear plugs and correct installation.~The control group, will be instructed to use earplugs properly, including practical exercises by a medic"||||t
1321661|NCT03314103|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1321662|NCT03314090||Single Group Assignment||Treatment||None (Open Label)||Testing silicone gel in the treatment of upper lip scar||||
1321663|NCT03314077|||Cohort||Other|||||||
1321664|NCT03314064||Single Group Assignment||Treatment||None (Open Label)||This is an open label, single group study where the eligible subjects will receive DTG 50 mg once daily.||||
1321665|NCT03314051|||Cohort||Retrospective|||||||
1321666|NCT03314038|||Other||Cross-Sectional|||||||
1321667|NCT03314025|Randomized|Parallel Assignment||Prevention||Quadruple|Everyone is blinded except the pharmacy department where the randomization list is kept. This department is the one able to unblind a patient, if needed.|Randomized, double-blind, placebo-controlled clinical trial|t|t|t|t
1321668|NCT03314012||Single Group Assignment||Treatment||None (Open Label)||||||
1321669|NCT03313999||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321670|NCT03313986|||Case-Only||Prospective|||||||
1321671|NCT03313973|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1321672|NCT03313960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321673|NCT03313947|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321674|NCT03313934|Randomized|Parallel Assignment||Treatment||Double|The subject will not be aware of which tear trough has the PRF condition. Additionally, the blind observer, who is going to evaluate improvement based on before/after photos, will also be blind to to which tear trough as treated with the PRF condition.|10 subjects will receive treatment with hyaluronic acid fillers for tear trough rejuvenation. Each subject with have one tear trough treated with HA filler mixed with Platelet Rich Fibrin, and the other tear trough injected with HA filler mixed with saline. The subject with be blind as to which tear trough contains the PRF. This will be randomly assigned for each subject and documented by the CRC.|t|||t
1321675|NCT03313921||Single Group Assignment||Diagnostic||None (Open Label)||cross-sectional open-label non-inferiority assessment of a novel diagnostic entity compared to current gold-standard in two seperate groups of patients (healthy and diseased)||||
1321676|NCT03313908||Single Group Assignment||Prevention||None (Open Label)||||||
1321677|NCT03313895|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1321678|NCT03313882|||Cohort||Retrospective|||||||
1321679|NCT03313869|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1321680|NCT03313856|Randomized|Parallel Assignment||Treatment||Double|Simple random. It was done with a table of numbers using random selection program Excel 2010.|Two study groups were formed that were randomly assigned with the closed envelope technique to the corresponding group. Group Placebo vs. Guazuma ulmifolia plusTecoma stans|t||t|
1321681|NCT03313843|||Case-Only||Prospective|||||||
1321682|NCT03313830|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1321683|NCT03313817|||Case-Only||Prospective|||||||
1321684|NCT03313804||Single Group Assignment||Treatment||None (Open Label)||||||
1321685|NCT03313791|Randomized|Crossover Assignment||Basic Science||Double||2 groups of 10 subjects both receive a different set of 6 different dairy products. Each subject within a group will receive all treatments on the same day of the week with a 1 week washout period between treatments. Results of the two groups will be analyzed separately, and products will only be compared within the same group of subjects, treating the data as two independent studies.|||t|t
1321686|NCT03313778|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1321687|NCT03313765|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321688|NCT03313752|Randomized|Parallel Assignment||Treatment||Single||||t||
1321689|NCT03313739|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1321690|NCT03313726|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321691|NCT03313713|Randomized|Crossover Assignment||Treatment||Single|||t|||
1321692|NCT03313700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321693|NCT03313687|||Cohort||Retrospective|||||||
1321694|NCT03313674|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321695|NCT03313661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321696|NCT03313648|Randomized|Parallel Assignment||Treatment||Double||Two different treatments are conducted on the participant base on the randomized choices|||t|t
1321697|NCT03313635|||Cohort||Prospective|||||||
1321698|NCT03313622|||Case-Only||Prospective|||||||
1321699|NCT03313609|||Cohort||Prospective|||||||
1321700|NCT03313596|Randomized|Parallel Assignment||Treatment||Single||||||t
1321701|NCT03313583|||Case-Only||Prospective|||||||
1321702|NCT03313557||Single Group Assignment||Treatment||None (Open Label)||||||
1321703|NCT03313544||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321704|NCT03313531|||Other||Other|||||||
1321705|NCT03313518|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1321706|NCT03313505|||Cohort||Prospective|||||||
1321707|NCT03313492|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321708|NCT03313479|||Cohort||Prospective|||||||
1321709|NCT03313466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321710|NCT03313453|Randomized|Parallel Assignment||Treatment||Quadruple|Allocation of intervention arm and scoring of symptom and medication scire will be performed by a designated unblinded member of the study staff (i.e. a qualified person who is independent of the protocol-defined study assessments). Once prepared, active air-cleaner and mock device will be identical in appearance. The blinding of all those involved in the evaluation of the study treatment (e.g. physician/nurse as well as the subject) shall be maintained at all times.||t|t|t|t
1321711|NCT03313440|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1321712|NCT03313427|Randomized|Sequential Assignment||Treatment||Double|||t|||t
1321713|NCT03313414||Single Group Assignment||Prevention||None (Open Label)||||||
1321714|NCT03313401|||Case-Only||Prospective|||||||
1321715|NCT03313388|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1321716|NCT03313375|Randomized|Crossover Assignment||Treatment||Single||Subjects will have a randomized order of treatment (exercise bouts). Each subject will complete all three (control, cont. exercise, aerobic interval), but in a randomized order.|||t|
1321717|NCT03313362||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321718|NCT03313349|Randomized|Parallel Assignment||Treatment||Triple|"Participants in the study are allocated to each arm by using randomization system. After determining which of the three school Units the student will attend, the participants are distributed in to one of the two arms at each school (UP & ENP).~It is not possible to fully blind parents and students as they have to give informed consent. Teachers and social workers will be kept blind to allocation as far as possible . They are not directly involved in the treatment measured in this study, even though they play a great part in it. The blindness of the teachers and social workers is important as they will be providing the ratings used in the analyses."|"Design: A pragmatic RCT designed according to CONSORT guidance (CONSORT, 2010) to compare UP and ENB.~Students, attending the schools, were randomly allocated to either UP or ENP according to a one-to-one ratio. Outcome measures (see below) were collected at pre-intervention (T1), post-intervention (T2 - 3 months post randomization) and follow up (T3 - 6 months post randomization). If possible, the a last follow up (T4 - 12 months post randomization)."|t|t||t
1321719|NCT03313336|Randomized|Crossover Assignment||Supportive Care||Double||This study will be a double-blind, randomized, 2-period, placebo-controlled, crossover study in healthy male and female subjects, performed at a single study center. Prior to inclusion, informed consent will be obtained. A brief medical history, including limited demographic data (gender, age and ethnicity) will be recorded, and eligibility for inclusion to the study will be established through a physical inspection of hands. Subjects will be shown how to complete the visual analogue scale (VAS). At each specific study visit, each subject will undergo a left-right comparison of two patch preparations, followed by a repeated test with an alternate combination of preparations. Thus, the study will comprise: Visit 1: EMLA Test Patch plus Placebo Patch OR EMLA Test Patch plus EMLA current Reference Patch. Visit 2: EMLA Test Patch plus EMLA current Reference Patch OR EMLA Test Patch plus Placebo Patch.|t|t||
1321720|NCT03313323||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321721|NCT03313310||Single Group Assignment||Prevention||None (Open Label)||A single-arm longitudinal pre/post study||||
1321722|NCT03313297|Randomized|Parallel Assignment||Treatment||Quadruple|Treatment groups will be allocated in a double-blind manner. Participants will be blinded to the treatment they receive (placebo or drug) throughout all stages of the study. Investigators will also be blinded to the treatment until all samples have been collected and processed. Blinding will be generated by a dedicated trials pharmacy representative who is not otherwise associated with this study.|Double-blind, randomised, parallel group, placebo-controlled phase II pilot trial|t|t|t|t
1321723|NCT03313284||Single Group Assignment||Treatment||None (Open Label)||||||
1321724|NCT03313271|||Cohort||Other|||||||
1321725|NCT03313258|Randomized|Sequential Assignment||Prevention||Single|||t|||
1321726|NCT03313245|||Cohort||Cross-Sectional|||||||
1321727|NCT03313232|Non-Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1321728|NCT03313219||Single Group Assignment||Treatment||None (Open Label)||||||
1321729|NCT03313206||Single Group Assignment||Treatment||None (Open Label)||||||
1321730|NCT03313193|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Pragmatic Randomized Controlled Trial||||
1321731|NCT03313180||Single Group Assignment||Treatment||None (Open Label)||||||
1321732|NCT03313167|||Cohort||Prospective|||||||
1321733|NCT03313154|||Case-Control||Prospective|||||||
1321734|NCT03313141||Single Group Assignment||Basic Science||None (Open Label)||To compare diaphragm elastrography provided by ultrasound to diaphragm function indices provided by magnetic/electrical phrenic nerves stimulation||||
1321735|NCT03313128|||Cohort||Prospective|||||||
1321736|NCT03313115|||Cohort||Prospective|||||||
1321737|NCT03313102|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1321738|NCT03313089|||Cohort||Prospective|||||||
1321739|NCT03313076|Randomized|Factorial Assignment||Prevention||Quadruple|Double-blind|2x2 Factorial design|t|t|t|t
1321740|NCT03313063|||Case-Control||Retrospective|||||||
1321741|NCT03313050|Randomized|Parallel Assignment||Prevention||Triple|Observer-blinded||t|t|t|
1321742|NCT03313037|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1321743|NCT03313024|||Cohort||Prospective|||||||
1321744|NCT03313011|||Cohort||Prospective|||||||
1321745|NCT03312998||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321746|NCT03312985|Randomized|Parallel Assignment||Treatment||Single|The statistical analysist do not know the group assignment.|||||t
1321747|NCT03312972||Single Group Assignment||Treatment||None (Open Label)||||||
1321748|NCT03312959|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1321749|NCT03312946||Single Group Assignment||Treatment||None (Open Label)||||||
1321750|NCT03312933|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321751|NCT03312920|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1321752|NCT03312907|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321753|NCT03312894|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321754|NCT03312881|||Cohort||Prospective|||||||
1321755|NCT03312868||Single Group Assignment||Treatment||None (Open Label)||||||
1321756|NCT03312855|Randomized|Parallel Assignment||Treatment||Quadruple||with 2 doses (80 and 160 mg) of Revacept versus placebo|t|t|t|t
1321757|NCT03312842||Single Group Assignment||Treatment||None (Open Label)||||||
1321758|NCT03312829|||Cohort||Prospective|||||||
1321759|NCT03312816|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1321760|NCT03312803|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1321761|NCT03312790|Randomized|Crossover Assignment||Basic Science||Single||||||t
1321762|NCT03312777|Randomized|Crossover Assignment||Treatment||Quadruple|Overencapsulation||t|t|t|t
1321763|NCT03312764|Randomized|Parallel Assignment||Prevention||Double|All study investigators that collect data or analyze the data are prevented from knowing the interventions assigned to individual participants.|Participants are randomly allocated to one of two groups for the duration of the study.|||t|t
1321764|NCT03312751||Single Group Assignment||Treatment||None (Open Label)||||||
1321765|NCT03312738|Randomized|Parallel Assignment||Treatment||Quadruple|double blinded study|this is a double-blind, randomized, placebo-controlled study, parallel groups,|t|t|t|t
1321766|NCT03312725|||Case-Only||Prospective|||||||
1321767|NCT03312712|||Case-Control||Prospective|||||||
1321768|NCT03312699|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1321769|NCT03312686|||Cohort||Prospective|||||||
1321770|NCT03312673|||Cohort||Prospective|||||||
1321771|NCT03312660|Randomized|Parallel Assignment||Prevention||Quadruple|Both groups will receive fermented dairy products with similar color, flavor and nutritional composition, except the prebiotic components, which will only be administered to the intervention group.|Cluster randomized controlled trial|t|t|t|t
1321772|NCT03312647|||Case-Control||Prospective|||||||
1321773|NCT03312634||Single Group Assignment||Treatment||None (Open Label)|None (Open Label)|A multicenter, open-label study. Untreated subjects from the FOP NHS will serve as the control arm.||||
1321774|NCT03312621|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1321775|NCT03312608|||Case-Control||Prospective|||||||
1321776|NCT03312595||Single Group Assignment||Treatment||None (Open Label)||||||
1321777|NCT03312582|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321778|NCT03312569|||Case-Only||Prospective|||||||
1321779|NCT03312556|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321780|NCT03312543|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321781|NCT03312530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321782|NCT03312517|Randomized|Crossover Assignment||Treatment||Triple|Study is double blinded. Investigator, participant, or care provider will be blinded to watch drug the subject receives during each treatment week.|double-blind, randomized 3-way crossover design|t|t|t|
1321783|NCT03312504|Randomized|Parallel Assignment||Prevention||Double|Participants (teachers and students) are not aware of what arm they are randomized to; however, they are aware that there are two arms. The primary investigators performing the analysis and overseeing all decisions are blinded to the schools receiving the intervention vs control program.|Randomized controlled trial. Upon enrolment into the study, a school will be randomly assigned to the intervention (neuromuscular training warm-up) or control group (standard-of-practice warm-up). Schools that have been randomized to the control arm will be invited to participate in the study in the following year as an intervention school. Schools that have been randomized to the intervention arm will be invited to participate in the study in the following year as a maintenance school (will continue with the intervention).|t||t|
1321784|NCT03312491|||Cohort||Prospective|||||||
1321785|NCT03312478|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321786|NCT03312465|||Cohort||Prospective|||||||
1321787|NCT03312452|Randomized|Parallel Assignment||Prevention||Double|Participants will blinded to group allocation by concealment of the IV fluid delivery device in the operating room. Analysts will be presented with data that has been coded to conceal each participants' allocation to either the intervention or control group.||t|||t
1321788|NCT03312439|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The intervention group are tested and given advice based on the results with the general aim to increase physical activity and reduce obesity. The risk of future non-communicable disease is compared to the general Swedish population of the same age. Different models will be used. The first model will include a control group consisting of all Swedish citizens of the same age, and the results will be adjusted for differences in baseline characteristics. In a second each participant in the intervention group will be matched against 3 controls (or more) from the general population based on propensity scores.||||
1321789|NCT03312426|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1321790|NCT03312413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321791|NCT03312400|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321792|NCT03312387|Randomized|Parallel Assignment||Other||Double|||t||t|
1321793|NCT03312374|||Cohort||Prospective|||||||
1321794|NCT03312361||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321795|NCT03312348||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321796|NCT03312335||Single Group Assignment||Basic Science||None (Open Label)||||||
1321797|NCT03312322|Randomized|Crossover Assignment||Treatment||Double|Sham placebo will be used to blind patient. The outcome assessor will be invited to join the room after the experimental condition is installed.|"Three constant workload testing will be performed on three different days.~Every test will be carried out with a different condition :~Sham transcutaneous electrical nerve stimulation;~High-frequency transcutaneous electrical nerve stimulation;~Low-frequency transcutaneous electrical nerve stimulation."|t|||t
1321798|NCT03312309||Single Group Assignment||Treatment||None (Open Label)||||||
1321799|NCT03312296|||Case-Only||Prospective|||||||
1321800|NCT03312283|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321801|NCT03312270||Single Group Assignment||Supportive Care||None (Open Label)||Examination of comprehension differences when information is presented under different conditions: (a) written only, (b) auditory only or (c) combined written and auditory.||||
1321802|NCT03312257||Single Group Assignment||Treatment||None (Open Label)||||||
1321803|NCT03312244|Randomized|Crossover Assignment||Treatment||Quadruple|All participants will be blinded. The steering committee will have the authority to open the blinding in case of adverse effects|12x12 weeks of pyridostigmine or placebo followed by crossing-over to the other arm of intervention|t|t|t|t
1321804|NCT03312231|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1321805|NCT03312218|Randomized|Parallel Assignment||Other||Double|||t||t|
1321806|NCT03312205||Single Group Assignment||Treatment||None (Open Label)||||||
1321807|NCT03312192|Randomized|Parallel Assignment||Treatment||None (Open Label)||1. Stand-alone ACDF, which means the placement of an interbody device (cage) without anterior fixation or plating; 2. ACDF with and interbody cage and anterior plating for fixation.||||
1321808|NCT03312179|||Case-Control||Prospective|||||||
1321809|NCT03312166||Single Group Assignment||Prevention||None (Open Label)||||||
1321810|NCT03312153|Randomized|Parallel Assignment||Treatment||Double|"The study will be double-blinded which are the patients and the assessor.~The participants will drag the envelop and will not know which irrigant they will be treated with to not affect their behavior and their responses to the subjective outcome measures. also, not provide biased assessment of the effectiveness of the intervention .~The study will be double-blinded which are the patients and the assessor.~The participants will drag the envelop and will not know which irrigant they will be treated with .~Assessors in the microbiology laboratory in Microbiology department, Faculty of Medicine, Cairo University also will be blinded during assessment of data of endotoxins will not know the treatment group of the patients."||t|||t
1321811|NCT03312140||Single Group Assignment||Treatment||None (Open Label)||Pilot study to evolve the effect ot the treatment by comparing data before and after the treatment within the same patients||||
1321812|NCT03312127||Single Group Assignment||Treatment||None (Open Label)||||||
1321813|NCT03312114||Single Group Assignment||Treatment||None (Open Label)||||||
1321814|NCT03312101|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel asigmanet||||
1321815|NCT03312088|||Cohort||Prospective|||||||
1321816|NCT03312075|||Cohort||Prospective|||||||
1321817|NCT03312062|Randomized|Parallel Assignment||Treatment||Single|All of participants must be healthy.|There are 2 groups. Study group will receive foam rolling exercise. Control group will receive no foam rolling exercise. They will be handed a brochure about the proprioception and its role in injury prevention and foam rolling . Study group will be evaluated before foam rolling exercise . Afterwards, second evaluation will be performed after 4 weeks and follow up after 4 more weeks. Control group will be evaluated for the first time. Afterwards, second evaluation will be performed after 4 weeks and follow up after 4 more weeks.|t|||
1321818|NCT03312049|||Cohort||Prospective|||||||
1321819|NCT03312036||Single Group Assignment||Supportive Care||None (Open Label)||||||
1321820|NCT03312023||Single Group Assignment||Treatment||None (Open Label)||Open-label Study||||
1321821|NCT03312010|Randomized|Parallel Assignment||Treatment||Triple|Subjects and assessors randomized to HF blinded Subjects and assessors randomized to sham blinded|Prospective, partially double-blinded, randomized|t||t|t
1321822|NCT03311997|Randomized|Parallel Assignment||Treatment||Single|Personell assessing functional performance of patients are blinded.|||||t
1321823|NCT03311984|||Case-Only||Prospective|||||||
1321824|NCT03311971|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparison of intervention with conventional therapy. The intervention group includes use of virtual reality spectacles. The control group includes routine postoperative care||||
1321825|NCT03311958||Single Group Assignment||Treatment||None (Open Label)||Regular testing of DLBCL patients who have successfully undergone chemotherapy and are negative for ctDNA. Treatment of patients who become positive for ctDNA with Nivolumab||||
1321826|NCT03311945||Single Group Assignment||Treatment||None (Open Label)||||||
1321827|NCT03311932|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321828|NCT03311919|||Cohort||Prospective|||||||
1321829|NCT03311906|Randomized|Crossover Assignment||Treatment||Double|Double blind|A split mouth study design is used where all participants receive both interventions|t|||t
1321830|NCT03311893|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1321831|NCT03311880||Single Group Assignment||Treatment||None (Open Label)||||||
1321832|NCT03311867|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321833|NCT03311854||Single Group Assignment||Treatment||None (Open Label)||||||
1321834|NCT03311841|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321835|NCT03311828||Single Group Assignment||Diagnostic||None (Open Label)||||||
1321836|NCT03311815|||Case-Only||Prospective|||||||
1321837|NCT03311802|||Case-Only||Cross-Sectional|||||||
1321838|NCT03311789||Single Group Assignment||Treatment||None (Open Label)||Enrolled patients will be treated with PD-1 inhibitor in combination with gemcitabine/cisplatin chemotherapy.||||
1321839|NCT03311776|||Cohort||Prospective|||||||
1321840|NCT03311763|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1321841|NCT03311750||Single Group Assignment||Treatment||None (Open Label)||||||
1321842|NCT03311737|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321843|NCT03311724|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321844|NCT03311711|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"During Phase I, 20 patient and surrogate dyads (40 participants in total) will participate in the first phase of the study which will refine the intervention to address the needs of this specific population. Preliminary effects of the intervention will also be examined. The dyads will be randomized to the SPIRIT-in person or SPIRIT-remote study arms. Enrollment and data collection for Phase I was completed in October 2018.~In the randomized control trial portion of the study (Phase II), 120 dyads (240 participants in total) will be randomized to one of three different study arms: SPIRIT-in person, SPIRIT-remote study arms, or usual care."||||
1321845|NCT03311698|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321846|NCT03311685|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321847|NCT03311672|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1321848|NCT03311659|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)|The treatment allocation would be non-randomised and stratified by age into four strata [4-9 years (children), 10-17 years (adolescents), 18-64 (adults) years and ≥65 years (elderly population)].|||||
1321849|NCT03311646|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1321850|NCT03311633|Randomized|Parallel Assignment||Treatment||None (Open Label)||Three week percutaneous pinning group versus Six week percutaneous pinning group||||
1321851|NCT03311620||Single Group Assignment||Diagnostic||None (Open Label)|The needle size to be used first will be chosen by permuted block randomization scheme by the statistician|All abnormal lymph nodes able to be visualized by EBUS will be biopsied with sequential passes until a macroscopic specimen can be seen in the sample container. Each needle size will be used to take consecutive passes until the sample is complete and each pass will consist of 15-20 agitations. The needle size to be used first will be chosen by permuted block randomization scheme by the statistician. After all passes are done with the first needle, the alternate size needle will be used to biopsy the same lymph node. Samples will be placed in separate containers of formalin. Any subsequent lymph nodes in the same patient will be biopsied with the alternate sized needle first. Further, any lung nodules or masses that can be adequately visualized by EBUS where biopsy is clinically indicated will be sampled with both 22g and 19g TBNA needles in the same fashion. However, these lesions will be randomized separately from any lymph nodes biopsied during the case.||||
1321852|NCT03311607||Single Group Assignment||Treatment||None (Open Label)||Prospective cohort study||||
1321853|NCT03311594|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1321854|NCT03311581|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321855|NCT03311568|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||Prospective observational study. Validation of a new non-invasive ultrasound device in four controlled categories of study participants.||||
1321856|NCT03311555||Single Group Assignment||Treatment||None (Open Label)||||||
1321857|NCT03311542||||||||||||
1321858|NCT03311529|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1321859|NCT03311516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321860|NCT03311503||Single Group Assignment||Treatment||None (Open Label)||open labeled, multi-center, phase I/II, cohort study||||
1321861|NCT03311490|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1321862|NCT03311477||Single Group Assignment||Treatment||None (Open Label)||||||
1321863|NCT03311464||Single Group Assignment||Treatment||None (Open Label)||||||
1321864|NCT03311451||Single Group Assignment||Treatment||None (Open Label)||Patients with previously untreated (by means of ablation therapy) flat type Barrett's Esophagus (BE) (extent BE ≤C3 and ≥M1) with Low-Grade Dysplasia (LGD) or High-Grade Dysplasia (HGD), or residual BE after endoscopic resection of dysplasia or early adenocarcinoma.||||
1321865|NCT03311438||Single Group Assignment||Prevention||None (Open Label)||Longitudinal study design, promoting oral health among children with congenital heart defects. Oral examination and intervention at baseline (below three years), at first follow-up (three years) and at second follow-up (five years).||||
1321866|NCT03311425|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321867|NCT03311412||Single Group Assignment||Treatment||None (Open Label)||||||
1321868|NCT03311399|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1321869|NCT03311386||Single Group Assignment||Other||None (Open Label)||"All patients with acute ischemic stroke within 4.5 hours - legible for receiving IV r TPA. These patients will undergo: 1. A noncontrast CT scan of the brain and high-resolution CT angiography will be performed in all patients before administering IV tPA and another CTA will be performed on day 2 and Collaterals will be evaluated by a Neuroradiologist, using 3 predefined criteria: the Miteff system, the Maas system, and 20-point collateral.~2. ASPECT score and NIHSS score will be recorded 3. Functional outcome will be assessed by the modified Rankin Scale (mRS) at 3months."||||
1321870|NCT03311373|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321871|NCT03311360|||Cohort||Prospective|||||||
1321872|NCT03311347|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Two arms are studied, breathing air or 100%O2. In each arm, subjects are studied at two occasions: with and without positive pressure breathing. These occasions are randomized.||||
1321873|NCT03311334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321874|NCT03311321|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1321875|NCT03311308|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321876|NCT03311295||Single Group Assignment||Treatment||None (Open Label)||||||
1321877|NCT03311282|Randomized|Parallel Assignment||Other||None (Open Label)|This was a prospective, open-label, monocentric, interventional clinical study.|"Treatment groups: bottle-fed infants~Group 1: 10 infants aged 0-4 weeks (+/- 7 days): 0-4 m bottle~Group 2: 10 infants aged 4 months (+/- 10 days): 4-6 m bottle~Group 3: 10 infants aged 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants~Group 4: 10 infants aged 0-4 weeks (+/- 7 days)~Group 5: 10 infants aged 4 months (+/- 10 days)~Group 6: 10 infants aged 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)~Number of subjects enrolled and allocated: 61 healthy infants, both male and female as follows:~Treatment groups: bottle-fed infants~Group 1: 11 infants aged 0-4 weeks (+/- 7 days): 0-4 m bottle~Group 2: 10 infants aged 4 months (+/- 10 days): 4-6 m bottle~Group 3: 10 infants aged 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants~Group 4: 10 infants aged 0-4 weeks (+/- 7 days)~Group 5: 10 infants aged 4 months (+/- 10 days)"||||
1321878|NCT03311269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1321879|NCT03311256|||Cohort||Prospective|||||||
1321880|NCT03311243|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321881|NCT03311230|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1321882|NCT03311217|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster randomized trial with four communities assigned to intervention and four communities assigned to control||||
1321883|NCT03311204|Randomized|Crossover Assignment||Treatment||Single|The clinical signs are photographed and an outcomes accessor grades the clinical signs. This process ensures that there is no bias in recording the results. This method was specially chosen, due to the lack or inability to mask the treatment procedures, due to their nature of treatment.|Single-center, randomized, cross-over, open-label interventional study||||t
1321884|NCT03311191|||Case-Control||Cross-Sectional|||||||
1321885|NCT03311178||Single Group Assignment||Treatment||None (Open Label)||||||
1321886|NCT03311165|||Cohort||Prospective|||||||
1321887|NCT03311152|Non-Randomized|Parallel Assignment||Diagnostic||Triple|The index test (mSEPT9) will be reported at the final step of the research, at time of data analysis.|Cross-sectional biomarker Phase II design|t|t|t|
1321888|NCT03311139|||Cohort||Retrospective|||||||
1321889|NCT03311126||Single Group Assignment||Treatment||None (Open Label)||||||
1321890|NCT03311113|||Cohort||Prospective|||||||
1321891|NCT03311100|||Cohort||Retrospective|||||||
1321892|NCT03311087|||Cohort||Other|||||||
1321893|NCT03311074||Single Group Assignment||Treatment||None (Open Label)|No masking will be performed in the study and all subjects who have received GSK2696273 will be included in the analysis.|There will be no separate treatment groups in the study.||||
1321894|NCT03311061|Randomized|Parallel Assignment||Prevention||Single|Students are masked through|Two groups of participants. group A will receive the DREAMS Curriculum intervention. Group B (Control group) will receive curriculum already in place at school.|t|||
1321895|NCT03311048|Non-Randomized|Parallel Assignment||Other||Single|Participants, divided in four groups based on workplace: Hospital, University, Housekeeper and Control.|: This study included 167 participants, divided in four groups based on workplace: Hospital, University, Housekeeper and Control. Nasal swab was collect to upper airways inflammation evaluation. Clinical profile and respiratory symptoms employees' evaluation were performed using specific questionnaires (European Community Respiratory Health Survey for occupational diseases evaluation (ECRHS), (adapted by Ribeiro et al, 2007) and the International Study of Asthma and Allergies in Childhood (ISAAC) - Asthma module, previously translated and validated.|t|||
1321896|NCT03311035|Randomized|Parallel Assignment||Treatment||Single||"Patients will be classified into two groups according to the surgical procedure performed as follows:~Group A: Patients undergoing cutting Seton.~Group B: Patients undergoing LIFT technique"|t|||
1321897|NCT03311022|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1321898|NCT03311009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321899|NCT03310996|Randomized|Sequential Assignment||Basic Science||Triple|Both sham and active treatment arms will have electrodes places on the scalp. The sham arm will have the current turned off in 10 seconds.|NeuroConn DC-STIMULATOR PLUS (NeurConn, GmbH), model number: 0021; serial number: 0351|t||t|t
1321900|NCT03310983|||Cohort||Prospective|||||||
1321901|NCT03310970|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1321902|NCT03310957||Single Group Assignment||Treatment||None (Open Label)||||||
1321903|NCT03310944|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1321904|NCT03310931|||Case-Control||Prospective|||||||
1321905|NCT03310918|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1321906|NCT03310905|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321907|NCT03310892|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1321908|NCT03310879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321909|NCT03310866|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1321910|NCT03310853|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1321911|NCT03310840|||Other||Other|||||||
1321912|NCT03310827|Randomized|Parallel Assignment||Health Services Research||Single||a phase I randomized controlled trial of 42 adults (19 to 50 years) with depressive disorders using a 2:1 ratio of group selection (28 in the intervention {I} group and 14 in the control {C} group) is proposed.|t|||
1321913|NCT03310814|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321914|NCT03310801|||Cohort||Retrospective|||||||
1321915|NCT03310788|||Cohort||Prospective|||||||
1321916|NCT03310775|Randomized|Sequential Assignment||Treatment||Double|||t|t||
1321917|NCT03310762|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|The allocation sequence will be concealed from the study staff responsible for screening and enrolling participants in serially numbered, opaque, sealed envelopes.|This is an individually randomized, three-arm parallel group design randomized control trial with equal allocation in the two treatment groups and control group. Children in intervention group A will receive the simple silicon bracelets, children in intervention group B will receive the bracelets developed by Alma Sana Inc. and children in the Control group will not receive any intervention.||||
1321918|NCT03310749|Randomized|Crossover Assignment||Treatment||None (Open Label)||Open, randomized, multiple dose, three way, three period, cross over, drug-drug interaction, safety and tolerability study||||
1321919|NCT03310736|||Cohort||Prospective|||||||
1321920|NCT03310723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321921|NCT03310710||Single Group Assignment||Treatment||None (Open Label)||Treatment with Viabahn BX stents||||
1321922|NCT03310697||Single Group Assignment||Screening||None (Open Label)||Transverse prevalence study. For each child, a toxicological screening will be carried out on the blood and urine for the research of proconvulsive molecules by conventional technique on the one hand and by gas chromatography coupled with a mass spectrograph on the other hand.||||
1321923|NCT03310684|||Cohort||Prospective|||||||
1321924|NCT03310671|||Case-Control||Prospective|||||||
1321925|NCT03310658||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1321926|NCT03310645|Randomized|Parallel Assignment||Treatment||Quadruple|double blind|Part 1: Ascending multiple doses in healthy volunteers Part 2: Ascending doses within two-way crossover design in patients|t|t|t|t
1322057|NCT03308942|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322058|NCT03308929|||Cohort||Prospective|||||||
1322059|NCT03308916||Single Group Assignment||Diagnostic||None (Open Label)||Single intervention group selected for screening with a historical control group||||
1321927|NCT03310632||Single Group Assignment||Treatment||None (Open Label)||"Phase I~Run-in DDI and dose escalation:~Six patients will be enrolled in the run-in DDI cohort of the dose-escalation part of the study (ie, Cohort 1) and 3 to 6 patients may be enrolled in Cohort 2. The total number of patients to be entered in the dose-escalation part of this study will depend on the emergence of DLTs at each dose level, but will be up to 12 if no replacement occurs at the 2 predefined dose levels.~Phase II~Cohort expansion:~Up to an additional 40 patients may be enrolled at the MTD or MFD/RD. A power calculation was not employed to determine the sample size of the study, as this is aproof of concept study with a preliminary assessment of anti-tumor activity of antroquinonol in combination with nab-paclitaxel + gemcitabine in metastatic pancreatic cancer patients."||||
1321928|NCT03310619||Single Group Assignment||Treatment||None (Open Label)||||||
1321929|NCT03310606||Single Group Assignment||Other||None (Open Label)||||||
1321930|NCT03310593|Randomized|Parallel Assignment||Treatment||Quadruple||Double-blind, randomized and placebo controlled study|t|t|t|t
1321931|NCT03310580|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1321932|NCT03310567||Single Group Assignment||Treatment||None (Open Label)||Women with recurrent/ metastatic endometrial carcinoma would be treated with Epacadostat and pembroluzimab||||
1321933|NCT03310554|Randomized|Parallel Assignment||Prevention||Single|||t|||
1321934|NCT03310541|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be an open label, single institution, non-randomized, pilot study.||||
1321935|NCT03310528|||Case-Control||Prospective|||||||
1321936|NCT03310515|||Cohort||Prospective|||||||
1321937|NCT03310502|||Other||Cross-Sectional|||||||
1321938|NCT03310489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321939|NCT03310476|Randomized|Crossover Assignment||Prevention||Single||||||t
1321940|NCT03310463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321941|NCT03310450|||Cohort||Prospective|||||||
1321942|NCT03310437|||Other||Prospective|||||||
1321943|NCT03310424|||Cohort||Prospective|||||||
1321944|NCT03310411|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1321945|NCT03310398|||Cohort||Prospective|||||||
1321946|NCT03310385|Randomized|Parallel Assignment||Treatment||Triple|double-blind|multicentre, dose-finding,double-blind, randomized placebo-controlled trial|t||t|t
1321947|NCT03310372||Single Group Assignment||Treatment||None (Open Label)||||||
1321948|NCT03310359|Randomized|Parallel Assignment||Other||Quadruple||This project is a double-blind, placebo-controlled, randomized, Phase I study|t|t|t|t
1321949|NCT03310346|||Case-Only||Prospective|||||||
1321950|NCT03310333|Randomized|Parallel Assignment||Treatment||None (Open Label)|open|||||
1321951|NCT03310320|Randomized|Parallel Assignment||Treatment||Quadruple|"The study is double-blind; patients, study site personnel and AZ personnel involved in the evaluation of the data must be kept blinded.~Packaging and labelling of study drug will be performed in a way that ensures blinding."|This is a randomised, double-blind, placebo-controlled, multi-centre, parallel group Phase 1b study in patients with moderate to severe plaque psoriasis. The study is designed to evaluate the pharmacodynamic effects, clinical efficacy and safety of AZD0284 compared with placebo as measured by the relative change from baseline in Psoriasis Area and Severity Index score and biomarkers associated with the mechanism of disease and AZD0284. It comprises 8 clinic visits over approximately 10 weeks including screening visit.|t|t|t|t
1321952|NCT03310307|Randomized|Parallel Assignment||Treatment|||Double blind|||||
1321953|NCT03310294|Randomized|Parallel Assignment||Treatment||Double|"As a double blind study neither the researchers nor the participants knew which treatment each participant received. The treatment was randomly allocated to the subjects according to the procedure for treatment assignment described above.~To maintain the blind (see also paragraph 4.4.1) no differences between the active treatment and the placebo were evident on the package, and the carton boxes containing the study products were identified by a number corresponding to the randomization (the products will be labelled with a batch number, Investigator/center, subject ID number and expiry date)."|"This is a phase IV, parallel, placebo-controlled, double-blind, multicenter, randomized study to evaluate the effect of a combination of probiotics and prebiotics in subjects with recurrent Herpes labialis.~This specific design has been chosen as the most suitable to achieve the objectives of the trial, mainly the demonstration of the clinical efficacy of the combination of probiotics and prebiotics in subjects with recurrent Herpes labialis in terms of reduction of the number of HL recurrences at day 49 vs baseline."|t||t|
1321954|NCT03310281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321955|NCT03310268|Randomized|Parallel Assignment||Treatment||Single||||||t
1321956|NCT03310255|||Cohort||Prospective|||||||
1321957|NCT03310242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321958|NCT03310229|||Other||Cross-Sectional|||||||
1321959|NCT03310216|Randomized|Crossover Assignment||Diagnostic||Single||Patients are assigned to two groups: participants in group I are provided AI visual inspection system first and EDTRS later, while in Group II, the participants are provided EDTRS first and AI visual inspection system later.||||t
1321960|NCT03310203|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1321961|NCT03310190|||Cohort||Prospective|||||||
1321962|NCT03310177|||Case-Control||Prospective|||||||
1321963|NCT03310164|||Case-Control||Prospective|||||||
1321964|NCT03310151|Randomized|Parallel Assignment||Treatment||None (Open Label)|As this is a small, education, non-funded project masking has not been possible|Randomised controlled trial with one control and one interventional group||||
1321965|NCT03310138|Randomized|Parallel Assignment||Treatment||Single|||t|||
1321966|NCT03310125|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1322060|NCT03308903|||Cohort||Cross-Sectional|||||||
1322061|NCT03308890|Randomized|Parallel Assignment||Other||None (Open Label)||Arm 1：0.5mg Entecavir QD for 6 months after cessation of TDF. Arm 2：0.5mg Entecavir QD for 12 months after cessation of TDF. Arm 3：No consolidation arm and observation only. Clinical observation for up to 6 months after the end of study follow-up for all arms.||||
1322062|NCT03308877|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1322063|NCT03308864|Randomized|Parallel Assignment||Treatment||Single||||||t
1321967|NCT03310112|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||"Participants will be assigned into three groups: (i) a 4-week MT group (MT4, n = 40) that will receive MBAT in 4, 2-hour sessions over 4 weeks; (ii) a 2-week MT group (MT2, n = 40) that will receive MBAT in 4, 2-hour sessions over 2 weeks; (iii) a no-training control group that will be tested before and after a no-training interval (NTC4, n = 40). After the end of the course sessions, participants from the training groups will still be assigned homework exercises until third testing session (T3). Hence, the MBAT program consists of delivery of the MBAT course, including homework mindfulness practice, and followed by an interval of homework mindfulness practice without course meetings.~The design relies on group randomization at the level of individual military cohort units. This is due to the military requirement that organic unit structure can be maintained during testing and course session scheduling."||||
1321968|NCT03310099||Single Group Assignment||Treatment||None (Open Label)||||||
1321969|NCT03310086|Randomized|Parallel Assignment||Treatment||Single||||||t
1321970|NCT03310073||Single Group Assignment||Prevention||None (Open Label)||||||
1321971|NCT03310060|Randomized|Single Group Assignment||Prevention||Single|||t|||
1321972|NCT03310047|Randomized|Crossover Assignment||Basic Science||Triple|"The process of intervention-implementation and intervention will not be in the participant's line of sight.~Investigators will not be in the room during the intervention. Outcome assessors will not be in the room during the intervention."|"We will use a two-armed crossover design.~Day one; Right side low dose nerve block and left side high dose nerve block~Repeated after 24 hours Day three; Left side low dose nerve block and right side high dose nerve block~Repeated after 24 hours~Day one; Left side low dose nerve block and right side high dose nerve block~Repeated after 24 hours Day three; Right side low dose nerve block and left side high dose nerve block~Repeated after 24 hours"|t||t|t
1321973|NCT03310034|Randomized|Crossover Assignment||Basic Science||Double||Randomized, dubbel-blind, cross-over trial|t||t|
1321974|NCT03310021|Randomized|Parallel Assignment||Treatment||Triple|Double Blind (Participant, Care Provider, Investigator, Sponsor)||t|t|t|
1321975|NCT03310008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"Biological: NKR-2 cells The intervention will consist of an infusion of NKR-2 cells administered concurrently to a standard chemotherapy every 2 weeks (14 days) for a total of 3 infusions within 4 weeks (28 days).~Other Name: NKG2D CAR-T cells"||||
1321976|NCT03309995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1321977|NCT03309982|Randomized|Crossover Assignment||Other||Triple||A randomized placebo-controlled cross-over design study|t|t|t|
1321978|NCT03309969|||Cohort||Prospective|||||||
1321979|NCT03309956||Single Group Assignment||Diagnostic||None (Open Label)||All patients will receive the same intervention, namely both devices at the same time for 48 hours.||||
1321980|NCT03309943|Randomized|Parallel Assignment||Basic Science||Triple|Double-blind|Participants will be randomly assigned to receive propranolol (40 mg) or placebo|t||t|t
1321981|NCT03309930||Single Group Assignment||Supportive Care||None (Open Label)||During Study 1 participants will be exposed to three different conditions: (a) written text only, (b) auditory synthetic speech output only and (c) a combined condition (written and auditory output). During Study 2 participants will be provided repeated exposure to synthetic speech. Participants can participate in 1 or both studies with 1 study results not being dependent on the other study. .||||
1321982|NCT03309917||Single Group Assignment||Basic Science||None (Open Label)||||||
1321983|NCT03309904|Randomized|Parallel Assignment||Prevention||Single|Statistician performing outcome analyses are blinded to group belonging|Parallell group cluster-randomized trial||||t
1321984|NCT03309891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321985|NCT03309878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1321986|NCT03309865||Single Group Assignment||Treatment||None (Open Label)||||||
1321987|NCT03309852|||Cohort||Prospective|||||||
1321988|NCT03309839|||Cohort||Prospective|||||||
1321989|NCT03309826|Randomized|Parallel Assignment||Treatment||Single|Analysis of all outcome measures will be conducted on a blinded basis.|||||t
1321990|NCT03309813|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1321991|NCT03309800|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1321992|NCT03309787|||Cohort||Prospective|||||||
1321993|NCT03309774||Single Group Assignment||Basic Science||None (Open Label)||||||
1321994|NCT03309761|||Cohort||Prospective|||||||
1321995|NCT03309748|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1321996|NCT03309735|||Other||Prospective|||||||
1321997|NCT03309722|||Cohort||Prospective|||||||
1321998|NCT03309709|Randomized|Parallel Assignment||Treatment||Single||||||t
1321999|NCT03309696|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1322000|NCT03309683|Randomized|Parallel Assignment||Prevention||Single|||t|||
1322001|NCT03309670|||Case-Only||Retrospective|||||||
1322002|NCT03309657||Single Group Assignment||Basic Science||None (Open Label)||Open label pharmacokinetic study where enrolled critically ill patients with infection receive a single dose of ceftolozane-tazobactam (in addition to other active therapy).||||
1322003|NCT03309644|||Cohort||Retrospective|||||||
1322004|NCT03309631|||Cohort||Prospective|||||||
1322005|NCT03309618|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1322006|NCT03309605|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322007|NCT03309592||Single Group Assignment||Treatment||None (Open Label)||||||
1322008|NCT03309579|Randomized|Parallel Assignment||Treatment||Single|open-label blinded-endpoint|Multicentre pragmatic, open-label blinded-endpoint||||t
1322009|NCT03309566|Randomized|Crossover Assignment||Other||None (Open Label)||Single-dose, two-way crossover.||||
1322064|NCT03308851|Randomized|Crossover Assignment||Treatment||None (Open Label)||A split mouth design will be used where the experimental subjects will receive one procedure on one side of the upper dental arch and another procedure on the other side.||||
1322065|NCT03308838|||Case-Control||Cross-Sectional|||||||
1322066|NCT03308825|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Multicenter, Open-label, Phase IV Study||||
1322067|NCT03308812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322010|NCT03309553|Randomized|Parallel Assignment||Health Services Research||Single|The randomization assignments will be kept confidential within the study team until hearing screening day, when masking the referral process assignment will no longer be possible. All outcome assessors, including audiologists and ear, nose, and throat (ENT) surgeons reading telemedicine consults within the Alaska Native healthcare system and study team members performing medical record abstraction, will be masked to intervention allocation. Study team members who read telemedicine consults as a part of their clinical responsibilities will abstain from reading any study-related consults. The results of the school screen, mHealth screen, and audiometric assessments will also be masked, such that study team members performing the mHealth screen or audiometric assessment will be masked to the other results.|||||t
1322011|NCT03309540|Randomized|Factorial Assignment||Treatment||Single|University of Brussels Medical expertise and rehabilitation center IJsselstein|Level of evidence 1b, One way, RMANOVA, mixed, Pilot RCT, design|t|||
1322012|NCT03309527|Randomized|Parallel Assignment||Treatment||Double||A two-arm parallel design involves two groups of participants with insomnia. One group receives internet delivered sleep hygiene education, and the other group receives internet delivered cognitive behavior therapy.|t|||t
1322013|NCT03309514||Single Group Assignment||Treatment||None (Open Label)||||||
1322014|NCT03309501|Randomized|Parallel Assignment||Treatment||Quadruple||positive control|t|t|t|t
1322015|NCT03309488|||Cohort||Prospective|||||||
1322016|NCT03309475|Randomized|Parallel Assignment||Treatment||Double|The evaluators will not know the patients' asigned treatment arm until the end of the follow-up period. This information will only be delivered to investigators in charge of intervention groups, but not to those in charge of statistical analyses.|Pilot, multi-center, rater-blinded, prospective (48-weeks follow-up), randomized, controlled (versus active comparator [psychoeducation]), clinical trial. The experimental arm will receive treatment as usual (both drug and psychosocial therapy) and mindfulness-based social cognition group training, specifically designed for patients with first episode psychosis by the research team. The active comparator arm will receive treatment as usual (both drug and psychosocial therapy) and psychoeducation group training for psychosis.|||t|t
1322017|NCT03309462|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1322018|NCT03309449|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322019|NCT03309436|Randomized|Parallel Assignment||Treatment||Single||||t||
1322020|NCT03309423|||Case-Only||Prospective|||||||
1322021|NCT03309410|||Case-Only||Cross-Sectional|||||||
1322022|NCT03309397|||Cohort||Prospective|||||||
1322023|NCT03309384|||Cohort||Prospective|||||||
1322024|NCT03309371|||Cohort||Retrospective|||||||
1322025|NCT03309358|Randomized|Sequential Assignment||Treatment||Double||This is a multiple-site, randomized, double-blind, placebo-controlled, single ascending dose (SAD) study to assess the safety and tolerability of inhaled SNSP113 in healthy subjects (Part A) and subjects with stable CF (Part B).|t||t|
1322026|NCT03309345|||Case-Control||Cross-Sectional|||||||
1322027|NCT03309332||Single Group Assignment||Prevention||None (Open Label)||||||
1322028|NCT03309319||Single Group Assignment||Treatment||None (Open Label)||||||
1322029|NCT03309306|Randomized|Parallel Assignment||Other||None (Open Label)||A subset of subjects will complete Phase I, which is the lab-based portion of the study, prior to the RCT.||||
1322030|NCT03309293|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322031|NCT03309280|||Cohort||Prospective|||||||
1322032|NCT03309267|||Case-Control||Retrospective|||||||
1322033|NCT03309254|Randomized|Crossover Assignment||Other||None (Open Label)||Randomized crossover study||||
1322034|NCT03309241|Randomized|Sequential Assignment||Basic Science||Triple|Double-blind (sponsor open)||t|t|t|
1322035|NCT03309228|||Other||Cross-Sectional|||||||
1322036|NCT03309215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322037|NCT03309202|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1322038|NCT03309189|||Cohort||Cross-Sectional|||||||
1322039|NCT03309176|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Stair step group: blind start ovulation induction (no progesterone induced withdrawal bleeding and stair step protocol in case of treatment failure.~Control: standard care; a progesterone induced withdrawal bleeding in case of no spontaneous menses before starting an ovulation induction cycle and in between anovulatory cycles."||||
1322040|NCT03309163|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1322041|NCT03309150||Single Group Assignment||Treatment||None (Open Label)||||||
1322042|NCT03309137|Randomized|Parallel Assignment||Prevention||None (Open Label)||An Open Label Randomized Feasibility Pilot Study||||
1322043|NCT03309124|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1322044|NCT03309111||Single Group Assignment||Treatment||None (Open Label)||||||
1322045|NCT03309098|||Cohort||Prospective|||||||
1322046|NCT03309085||Single Group Assignment||Diagnostic||||||||
1322047|NCT03309072|Randomized|Parallel Assignment||Basic Science||Double||Participants will be randomly assigned to one of two groups: (1) active tDCS with Face Name associate memory task (2) sham tDCS with Face Name associate memory task|t|||t
1322048|NCT03309059|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1322049|NCT03309046|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1322050|NCT03309033|||Cohort||Prospective|||||||
1322051|NCT03309020|||Case-Control||Prospective|||||||
1322052|NCT03309007|Randomized|Parallel Assignment||Treatment||Quadruple|Only the study research pharmacy will have access to the randomization list.|This is a double-blind, approximate placebo-controlled trial of 12 weeks of metformin vs. CaCO3 (Placebo) among adult patients with prediabetes.|t|t|t|t
1322053|NCT03308994|||Cohort||Other|||||||
1322054|NCT03308981|Randomized|Parallel Assignment||Prevention||Double||Participants will be randomly assigned to one of three groups: 1) REThink group, 2) Rational-Emotive-Behavioral Education (REBE) group and 3) wait-list condition.|||t|t
1322055|NCT03308968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322056|NCT03308955|Randomized|Parallel Assignment||Treatment||Single|Single (Outcomes Assessor)|prospective,randomized,single blind|t|||
1573445|NCT00001193||||Treatment||||||||
1322068|NCT03308799|Randomized|Parallel Assignment||Treatment||Single|||||t|
1322069|NCT03308786||Single Group Assignment||Basic Science||None (Open Label)||||||
1322070|NCT03308773|||Cohort||Other|||||||
1322071|NCT03308760|||Cohort||Prospective|||||||
1322072|NCT03308747|Non-Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1322073|NCT03308734|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomised Control Trial||||
1322074|NCT03308721|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures||t|t|t|t
1322075|NCT03308708|Randomized|Parallel Assignment||Prevention||Single|||t|||
1322076|NCT03308682||Single Group Assignment||Treatment||None (Open Label)||||||
1322077|NCT03308669|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1322078|NCT03308656|||Cohort||Prospective|||||||
1322079|NCT03308643|Randomized|Parallel Assignment||Prevention||Double|Randomization will be performed by an online software and the list will be given to anesthesiologist so that neither the surgeon nor patient will know which intervention was performed. Randomized cards will be in sealed envelopes and will be open by anesthesiologist at the time of surgery.|The abdominal myomectomy cases will be randomized into 2 separate groups in a parallel fashion using an online software at 1:1 ratio.|t||t|
1322080|NCT03308630||Single Group Assignment||Other||None (Open Label)||||||
1322081|NCT03308617|||Cohort||Prospective|||||||
1322082|NCT03308604||Single Group Assignment||Treatment||None (Open Label)||This is a phase 1 clinical trial evaluating the safety, tolerability of escalating doses of AGuIX-NP in combination with radiation and cisplatin in patients with locally advanced cervical cancer. Dose escalation will be conducted using the modified toxicity probability interval (mTPI) method. Three dose levels of intravenous AGuIX nanoparticles will be explored: 20mg/kg (level -1), 30 mg/kg (level 1) and 50 mg/kg (level 2).||||
1322083|NCT03308591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322084|NCT03308578|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1322085|NCT03308565||Single Group Assignment||Treatment||None (Open Label)||||||
1322086|NCT03308552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322087|NCT03308539|||Case-Control||Cross-Sectional|||||||
1322088|NCT03308526|||Cohort||Prospective|||||||
1322089|NCT03308513|||Cohort||Retrospective|||||||
1322090|NCT03308500|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Experimental design is applied where HIIG is compared with MIG. The participants of the study will be divided into two groups; HIIG and MIG. Both of them will have two sessions per week during 12 weeks of intervention.~Follow up: children are contacted 3 months after finishing the intervention."||||
1322091|NCT03308487|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1322092|NCT03308474|||Cohort||Prospective|||||||
1322093|NCT03308461||Single Group Assignment||Treatment||None (Open Label)||||||
1322094|NCT03308448|Randomized|Parallel Assignment||Treatment||Double|Participants are unaware of the dose of EPO. Outcome assessors are masked to the dose of EPO|3 treatment groups of patients with TON will receive different total dose of EPO.|t|||t
1322095|NCT03308435|||Cohort||Prospective|||||||
1322096|NCT03308422|||Case-Only||Cross-Sectional|||||||
1322097|NCT03308409|Randomized|Parallel Assignment||Treatment||Single||||t||
1322098|NCT03308396||Single Group Assignment||Treatment||None (Open Label)|Open-label|Phase Ib/II||||
1322099|NCT03308383||Single Group Assignment||Health Services Research||None (Open Label)||||||
1322100|NCT03308370||Single Group Assignment||Treatment||None (Open Label)||||||
1322101|NCT03308357|||Cohort||Prospective|||||||
1322102|NCT03308344|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants will be assigned into three groups: (i) a mindfulness training with spouse trainers (MT-ST, n = 60) that will receive the training from peers who underwent an extensive training practicum; (ii) a mindfulness training with mindfulness expert trainer group (MT-ME, n = 30) that will receive the training from a mindfulness expert trainer; and (ii) a wait-list control group (WLC, n = 30) that will be tested before and after a no-training interval and may receive MT at a later time after their second testing if they are interested.||||
1322103|NCT03308331|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1322104|NCT03308318|||Case-Only||Prospective|||||||
1322105|NCT03308305|||Cohort||Prospective|||||||
1322106|NCT03308292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322107|NCT03308279|||Other||Cross-Sectional|||||||
1322108|NCT03308266|||Case-Control||Retrospective|||||||
1322109|NCT03308253|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1322110|NCT03308240|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two groups will be studied: an experimental group (patient and caregiver) receiving one magic therapy session within the hospitalization period and a control group (patient and caregiver) who will receive standard child life therapies.||||
1322111|NCT03308227|||Cohort||Prospective|||||||
1322112|NCT03308214|||Case-Only||Prospective|||||||
1322113|NCT03308201||Single Group Assignment||Treatment||None (Open Label)||||||
1322114|NCT03308188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322115|NCT03308175|Randomized|Parallel Assignment||Treatment||Single||||||t
1322116|NCT03308162||Single Group Assignment||Treatment||None (Open Label)||Within subjects repeated measures||||
1322117|NCT03308149|||Cohort||Retrospective|||||||
1322118|NCT03308136|Randomized|Parallel Assignment||Supportive Care||Double|"The subjects were randomly assigned to subcutaneous anesthesia group (group A) and muscle anesthesia group (group B), and the assigned results are unknown.~The Outcomes Assessor is not related to the study, and does not know its contents."|subcutaneous anesthesia group (group A) muscle anesthesia group (group B)|t||t|
1322119|NCT03308123|||Other||Retrospective|||||||
1322120|NCT03308110||Crossover Assignment||Other||None (Open Label)||||||
1322121|NCT03308097|Randomized|Parallel Assignment||Prevention||Single|||t|||
1322122|NCT03308084|Randomized|Parallel Assignment||Prevention||Single|||t|||
1322216|NCT03306849|||Case-Control||Cross-Sectional|||||||
1322123|NCT03308071|Randomized|Parallel Assignment||Treatment||Single|The treating team including surgeons, anesthesiologists, pain consultants, hospitalists who are in charge of administering pain medication and documenting outcomes will be blinded to the intervention.|||t||
1322124|NCT03308058|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1322125|NCT03308045||Single Group Assignment||Treatment||None (Open Label)||Clinical trial with a single arm||||
1322126|NCT03308032|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322127|NCT03308019|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1322128|NCT03308006||Single Group Assignment||Treatment||None (Open Label)||||||
1322129|NCT03307993||Single Group Assignment||Treatment||None (Open Label)||||||
1322130|NCT03307980||Single Group Assignment||Treatment||None (Open Label)||This is a long term follow up (LTFU) study designed to evaluate the overall long term safety, durability of transgene expression, and effect on clinical outcomes of SPK 9001 mediated gene transfer. While safety will be monitored in general, new onset of oncologic, hematologic, neurologic, or auto immune events will be of particular interest. This trial will last for 5 years providing a minimum of 6 years of follow up post vector administration.||||
1322131|NCT03307967|Randomized|Parallel Assignment||Screening||Single||||||t
1322132|NCT03307954|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised controlled trial||||
1322133|NCT03307941||Single Group Assignment||Treatment||None (Open Label)||||||
1322134|NCT03307928|Non-Randomized|Parallel Assignment||Screening||Double|The investigator did not have access to the exams that the volunteers realized, either they have access to what they were doing or the order of the exams.|The participants were divided into two groups: (1) hypertension without OSA (NO-OSA group; AHI < 5 events/h; n = 15) and (2) hypertension with OSA (OSA group: AHI ≥ 15 events/h; n = 13).|t||t|
1322135|NCT03307915|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1322136|NCT03307902|Randomized|Parallel Assignment||Prevention||Triple|Double blind||t||t|t
1322137|NCT03307889|||Case-Only||Prospective|||||||
1322138|NCT03307876|||Case-Control||Prospective|||||||
1322139|NCT03307863|Non-Randomized|Parallel Assignment||Other||Single||It is a non-randomized clinical trial (controlled clinical trial)||||t
1322140|NCT03307850||Single Group Assignment||Other||None (Open Label)||||||
1322141|NCT03307837|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322142|NCT03307824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322143|NCT03307811||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322144|NCT03307798|||Other||Prospective|||||||
1322145|NCT03307785|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322146|NCT03307772|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322147|NCT03307759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322148|NCT03307746|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patient will be randomised into Arm A (20 patients) or Arm B (20 Patients)||||
1322149|NCT03307733|Randomized|Parallel Assignment||Prevention||None (Open Label)|It is difficult to mask in these type of interventions.|Feasibility Randomized Control Trial||||
1322150|NCT03307720|Randomized|Parallel Assignment||Treatment||None (Open Label)||IVF patients enrolled either to HCG or agonist trigger ovulation induction||||
1322151|NCT03307707|||Cohort||Prospective|||||||
1322152|NCT03307694|||Other||Prospective|||||||
1322153|NCT03307681|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1322154|NCT03307668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322155|NCT03307655|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Semen and FF samples will be obtained from donors and patients by masturbation after 2-7 days of sexual abstinence and they will be analyzed according to WHO guidelines (2010). FF samples will be obtained during the oocyte pick up procedure. After oocyte removal, the FF will be centrifuged for 10 min at 2000g and stored at -20°C until evaluation. NO concentration will be determined in the FF samples with the help of ion selective electrodes.~Sperm will be capacitated in the presence and absence of FF. In a first set of experiments, the FF will be supplemented with L-Arginine and the NOS inhibitor L-NAME. In another set of experiments the same supplementations to the capacitation medium will be examined, but without using FF.~Changes in NOS expression, protein nitrosylation, PKA activity, tyrosine phosphorylation and tyrosine nitration in sperm will be determined. The same treatment will be performed on all semen samples regardless of whether they come from patients or donors."||||
1322156|NCT03307642|Randomized|Parallel Assignment||Health Services Research||Double||SLIV will be offered at all schools in an urban school district. Students will be randomized into either SLIV + standard communication about SLIV or SLIV + standard communication + text message reminders.|t|||t
1322157|NCT03307629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322158|NCT03307616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322159|NCT03307603||Single Group Assignment||Treatment||None (Open Label)||||||
1322160|NCT03307590|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322161|NCT03307577|Randomized|Parallel Assignment||Treatment||Quadruple|This is a double-blind study, which means that neither the patient nor the investigator will know which cream the patient is using.||t|t|t|t
1322162|NCT03307564||Single Group Assignment||Treatment||None (Open Label)||marking the interface between the pancreas and duodenum with TraceIT Tissue Marker in patients undergoing image-guided radiotherapy||||
1322217|NCT03306836|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322218|NCT03306823|||Cohort||Prospective|||||||
1322219|NCT03306810|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322220|NCT03306797|Randomized|Parallel Assignment||Treatment||Single||||||t
1322221|NCT03306784|||Other||Prospective|||||||
1322222|NCT03306771|||Case-Control||Prospective|||||||
1322223|NCT03306758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322313|NCT03305588||Single Group Assignment||Treatment||None (Open Label)||||||
1322353|NCT03305068|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1322466|NCT03303599|||Cohort||Prospective|||||||
1322163|NCT03307551|Randomized|Parallel Assignment||Basic Science||Double|The patient will be blinded to the type of anaesthesia intervention.The attending anaesthesiologist will however not be blinded to the technique utilized to administer GA and recovery immediately after extubation inside the OR. The postoperative patient recovery profile will be evaluated by an independent assessor blinded to the technique of GA.|"30-patients aged 18-65 years, ASA physical status I-III, of either sex, and undergoing unilateral open thoracic surgery or unilateral video-assisted thoracic surgery (VATS) will randomly allocated by computer generated numbers to one of the following two groups of 15 patients each:~Group-1 [CLADS Group, n=15, Study group]: Anaesthesia will be induced and maintained with propofol administered using the automated CLADS.~Group-2 [Manual Group, n=15, Control group]: Anaesthesia will be induced and maintained with propofol administered using manually controlled infusion pumps titrated to BIS scores."|t|||t
1322164|NCT03307538||Single Group Assignment||Treatment||None (Open Label)||||||
1322165|NCT03307525|||Cohort||Prospective|||||||
1322166|NCT03307512|Randomized|Crossover Assignment||Treatment||None (Open Label)||Randomized, open-label, cross-over design||||
1322167|NCT03307499||Single Group Assignment||Prevention||None (Open Label)||||||
1322168|NCT03307486|||Cohort||Prospective|||||||
1322169|NCT03307473|||Cohort||Prospective|||||||
1322170|NCT03307460||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322171|NCT03307447||Single Group Assignment||Treatment||None (Open Label)||||||
1322172|NCT03307434|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322173|NCT03307421|Randomized|Parallel Assignment||Other||Single||2 parallel groups, stratified by center, randomized by center|t|||
1322174|NCT03307408|||Cohort||Prospective|||||||
1322175|NCT03307395||Single Group Assignment||Treatment||None (Open Label)||||||
1322176|NCT03307382||Single Group Assignment||Diagnostic||None (Open Label)||Cohort study||||
1322177|NCT03307369|||Cohort||Retrospective|||||||
1322178|NCT03307356||Single Group Assignment||Treatment||None (Open Label)||||||
1322179|NCT03307343|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to the participant group assignment.|||||t
1322180|NCT03307330|||Case-Control||Prospective|||||||
1322181|NCT03307317|||Case-Control||Prospective|||||||
1322182|NCT03307304|||Cohort||Other|||||||
1322183|NCT03307278|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1322184|NCT03307265|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322185|NCT03307252|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1322186|NCT03307239|Randomized|Parallel Assignment||Treatment||Single|the researcher assigned participants to one of the two groups: cold application (experimental group) or tap water packs application (sham group) according the random allocation sequence.|subjects in the experimental group received cold application of 600 g ice packs 15 min before CTR, whereas subjects in the sham group|t|||
1322187|NCT03307226|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1322188|NCT03307213|Randomized|Parallel Assignment||Treatment||Single||Patients will be randomised to one of the treatment arms to receive either the BioFreedom™ SS or the BioFreedom™ CoCr stent.|t|||
1322189|NCT03307200|||Cohort||Prospective|||||||
1322190|NCT03307187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1322191|NCT03307174|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322192|NCT03307161|Randomized|Factorial Assignment||Treatment||Single||||||t
1322193|NCT03307148||Single Group Assignment||Treatment||None (Open Label)||||||
1322194|NCT03307135|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1322195|NCT03307122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322196|NCT03307109|||Cohort||Prospective|||||||
1322197|NCT03307096|Randomized|Crossover Assignment||Treatment||Single||A total of 200 patients, aging between 18 and 60 years are enrolled into the study, patients will be prospectively randomized into group A and group B with a 1:1 ratio. Group A will receive the microperc surgery and group B will undergo FURS.||||t
1322198|NCT03307083||Single Group Assignment||Other||None (Open Label)||||||
1322199|NCT03307070|Randomized|Crossover Assignment||Treatment||Single||Phase I of the study is an open trial with a single arm. Phase II of the study is a randomized, waitlist controlled trial||||t
1322200|NCT03307057|Randomized|Sequential Assignment||Treatment||Single|The diagnosticians for all measures will be kept blind to group assignment.|This study uses a 2-stage sequential multiple assignment randomized trial (SMART) design to develop an adaptive intervention. Participants will be randomized into one of two study arms at Stage 1 (6 months of age) and re-randomized into one of four arms for Stage 2 at 12 months of age. Certain study arms during Stage 2 will only be available for participants who are showing early signs of ASD.||||t
1322201|NCT03307044||Single Group Assignment||Treatment||None (Open Label)||||||
1322202|NCT03307031|Non-Randomized|Parallel Assignment||Treatment||Double||A CONTROLLED CLINICAL TRIAL|||t|t
1322203|NCT03307018|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1322204|NCT03307005|Randomized|Parallel Assignment||Treatment||Double||Single-site, randomized, parallel, placebo controlled, double blind study|t||t|
1322205|NCT03306992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322206|NCT03306979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322207|NCT03306966|||Case-Only||Prospective|||||||
1322208|NCT03306953|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1322209|NCT03306940|Randomized|Parallel Assignment||Treatment||Single||||||t
1322210|NCT03306927|Randomized|Crossover Assignment||Prevention||None (Open Label)||Randomized, controlled, cross-over study||||
1322211|NCT03306914|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1322212|NCT03306901|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors and data analysists will be blinded|||||t
1322213|NCT03306888||Single Group Assignment||Other||None (Open Label)||Single arm feasibility study with 14 participants||||
1322214|NCT03306875||Single Group Assignment||Other||None (Open Label)||||||
1322215|NCT03306862|Randomized|Crossover Assignment||Prevention||None (Open Label)||Randomized, controlled, cross-over study||||
1322224|NCT03306745|Randomized|Parallel Assignment||Treatment||Double|The medications are unlabeled for both groups and will be dispensed in unlabeled blisteres. However, patients could search for the actual look of the PROfertil ® female soft capsules and the pills (for example on the internet). Since they differ from the folic acid capsules, patients could identify the control medications. We are aware of the fact that this kind of blinding is not according to standards and could introduce some kind of bias.||t||t|
1322225|NCT03306732|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1322226|NCT03306719|||Case-Control||Prospective|||||||
1322227|NCT03306706|Randomized|Crossover Assignment||Prevention||None (Open Label)||randomized, controlled, cross-over||||
1322228|NCT03306693|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322229|NCT03306680||Single Group Assignment||Treatment||None (Open Label)||||||
1322230|NCT03306667|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1322231|NCT03306654|Randomized|Parallel Assignment||Other||None (Open Label)||Users are randomly assigned between arms after completing baseline assessment and stay in that arm for the duration of the study.||||
1322232|NCT03306641||||||||||||
1322233|NCT03306628|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322234|NCT03306615|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1322235|NCT03306602|Randomized|Parallel Assignment||Treatment||Triple|The cavity in an individual will be randomly assigned to either the experimental or the control restoration, according to a predetermined scheme of randomization. If the participants have two cavities, they will not know in which cavity the experimental and control restoration were placed. All the restorations will be analyzed by using Modified United States Public Health Services (USPHS) criteria. The investigators and outcome assessors evaluating the restorations will not know which tooth has been restored with the experimental or control restoration|All the participants will receive both the experimental and control restoration. In the experimental cavity, Filtek Bulk Fill Posterior Restorative (3M ESPE) will be placed in 5 mm increments, eliminating the need for additional layers or multiple steps. The control restoration will be filled with Filtek Z350 XT (3M ESPE) using the 2 mm incremental layering technique.|t||t|t
1322236|NCT03306589|Randomized|Parallel Assignment||Diagnostic||None (Open Label)|This will be an open label study and no masking will be performed.|Subjects in 2 separate groups will be randomized to receive either LPS or GM-CSF at the same time.||||
1322237|NCT03306576|Randomized|Parallel Assignment||Treatment||None (Open Label)||Each participant will receive 2 matched restorations, one of each material.||||
1322238|NCT03306563|Non-Randomized|Parallel Assignment||Diagnostic||Single|Analytical evaluation and testing laboratories will get the samples blinded (coded).|"Total of 160 patients Phase 2a, 60 patients divided in three groups with TBI, orthopedic injury, and healthy volunteers (controls).~Phase 2b: 100 patients with concussion and mild traumatic brain injury."||||t
1322239|NCT03306550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322240|NCT03306537|||Cohort||Prospective|||||||
1322241|NCT03306524|Randomized|Crossover Assignment||Treatment||Single|Neonates|Ten different interventions (with changing slope time or ventilation mode) will be compared in a crossover design. Each intervention will be given for 15 minutes. For details of the intervention see study design details.|t|||
1322242|NCT03306511|||Case-Control||Cross-Sectional|||||||
1322243|NCT03306498|||Cohort||Prospective|||||||
1322244|NCT03306485|||Other||Prospective|||||||
1322245|NCT03306472|Randomized|Parallel Assignment||Treatment||None (Open Label)|Unblinded|This is a three arm, open-label, multicentre, randomized, window of opportunity, Phase II trial which will evaluate the effects of 15 days (+ 4 days) preoperative therapy with Letrozole, or Letrozole plus low dose Megestrol acetate (40mg), or Letrozole plus high dose Megestrol acetate (160mg) in postmenopausal women with newly diagnosed, ER-positive, HER2-negative, invasive primary breast cancer of at least 1 cm size.||||
1322246|NCT03306459|||Case-Control||Prospective|||||||
1322247|NCT03306446||Single Group Assignment||Treatment||None (Open Label)||||||
1322248|NCT03306433|Randomized|Parallel Assignment||Prevention||Quadruple|The trial design is triple-blinded. The manufacturer will deliver the blinded treatments in identical bottles labelled A and B, therefore, neither the patient nor the clinician will know which treatment is rendered to each tooth. However, the no sealant control will not be blinded. Blinding will continue to be present during the histological portion of the experiment as the assessors will not be aware of which sealant was used to treat each tooth. After a blinded assessment, blinds will be lifted when between-group analysis is performed.|prospective, paired randomized control trial for which treatment (no sealant, UDMA control, UDMA-K18 sealant) will be applied clinically and evaluated on extracted teeth in laboratory conditions.|t|t|t|t
1322249|NCT03306420|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322250|NCT03306407|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322251|NCT03306394||Single Group Assignment||Treatment||None (Open Label)||||||
1322252|NCT03306381|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1322253|NCT03306368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322254|NCT03306355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322255|NCT03306342||Single Group Assignment||Treatment||None (Open Label)||||||
1322256|NCT03306329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322257|NCT03306316|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1322258|NCT03306303|||Cohort||Other|||||||
1322259|NCT03306290||Single Group Assignment||Prevention||None (Open Label)||||||
1322260|NCT03306277||Single Group Assignment||Treatment||None (Open Label)||one-time intravenous administration of AVXS-101||||
1322261|NCT03306264|Randomized|Crossover Assignment||Treatment||None (Open Label)||Multicenter, randomized, open-label, 2-period, 2-sequence crossover study||||
1322262|NCT03306251|||Cohort||Prospective|||||||
1322308|NCT03305653||Single Group Assignment||Basic Science||None (Open Label)||||||
1322309|NCT03305640|||Cohort||Retrospective|||||||
1322310|NCT03305627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322311|NCT03305614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573446|NCT00001189||||Treatment||||||||
1322263|NCT03306238|Randomized|Parallel Assignment||Treatment||Triple|The patient and the investigator will not be informed of the type of approach they had. These will be marked as A and B with only the care povide/surgeon being aware of the actual approach. The investigator of complications and assessor of the case outcomes will collect data without the knowledge of the group the patient belongs to. The surgeon or car eprovider cannot be masked in this case due to technical limitations but they will not contribute towards analysing the results.|This is a randomised single blinded prospective trial comparing two similar groups directly to check for differnces in time to approach and complication rate|t||t|t
1322264|NCT03306225|||Cohort||Retrospective|||||||
1322265|NCT03306212|Randomized|Parallel Assignment||Treatment||Single|||||t|
1322266|NCT03306199|||Cohort||Retrospective|||||||
1322267|NCT03306186||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322268|NCT03306173|Randomized|Parallel Assignment||Other||Single|Participants will be randomly assigned to either ventilated or unventilated cigarettes and will not be informed of their group assignment.|Participants will be assigned to either use a ventilated or unventilated cigarette.|t|||
1322269|NCT03306160|||Cohort||Prospective|||||||
1322270|NCT03306147||Single Group Assignment||Supportive Care||None (Open Label)||||||
1322271|NCT03306134|||Cohort||Prospective|||||||
1322272|NCT03306121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322273|NCT03306108|||Cohort||Prospective|||||||
1322274|NCT03306095|||Case-Control||Prospective|||||||
1322275|NCT03306082||Single Group Assignment||Treatment||None (Open Label)||Prospective Cohort study||||
1322276|NCT03306069|Randomized|Parallel Assignment||Treatment||Single|Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking).|Parallel Assignment parallel-group, randomized-controlled study||||t
1322277|NCT03306056|Randomized|Parallel Assignment||Treatment||Single|Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking).|parallel-group, randomized-controlled study||||t
1322278|NCT03306043||Single Group Assignment||Treatment||None (Open Label)||A single group of subjects will receive 300 mg SC mepolizumab every 4 Weeks.||||
1322279|NCT03306030|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1322280|NCT03306017||Single Group Assignment||Basic Science||None (Open Label)||||||
1322281|NCT03306004|||Other||Prospective|||||||
1322282|NCT03305991|||Cohort||Prospective|||||||
1322283|NCT03305978|Non-Randomized|Sequential Assignment||Diagnostic||Single|blinding evaluation of criteria|Major Patient Addressed for Thoracic CT without Injection of Contrast||||t
1322284|NCT03305965|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patient navigation vs. care as usual||||
1322285|NCT03305952|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322286|NCT03305939|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322287|NCT03305926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322288|NCT03305913|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||According to the standard 3+3 dose finding strategy, a safety assessment will be performed after the test of each dose level (patient cohorts of n=3) and the frequency of DLTs determined. Based on the results the dose for the consecutive patient cohort will either be escalated (0/3 DLTs), repeated (1/3 DLTs) or deescalated (>1/3 DLTs).||||
1322289|NCT03305900|||Cohort||Cross-Sectional|||||||
1322290|NCT03305887|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322291|NCT03305874|||Case-Control||Other|||||||
1322292|NCT03305861|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322293|NCT03305848||Single Group Assignment||Treatment||None (Open Label)||||||
1322294|NCT03305835|||Cohort||Retrospective|||||||
1322295|NCT03305822|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1322296|NCT03305809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322297|NCT03305796|||Case-Only||Prospective|||||||
1322298|NCT03305783|||Case-Control||Prospective|||||||
1322299|NCT03305770||||||||||||
1322300|NCT03305757|Randomized|Parallel Assignment||Treatment||Triple|Randomisation is achieved using a web based randomization programme (RANDI2). Randomization will take place on the day of surgery, after the start of the operation and 30 minutes before wound closure. Blocked randomisation will take place with randomly selected block sizes (6/9/12) with an allocation ratio of 1:1:1. Randomisation will be stratified per site. Both patients and surgeons will be blinded. Patients will be informed preoperatively that their post-operative check ups will NOT be performed by the surgeon that performed the surgery. Randomisation will take place 30 minutes before wound closure in the operating theatre. Post-operatively, patients will not be evaluated by their own surgeon. The OR report will contain the following information (in Dutch) so as to ensure that blinding of the physicians will not be compromised.|"Study design is a double-blind randomized controlled trial. All patients are > 18 years and will be enrolled after obtaining informed consent in the surgical out patient clinics of Zuyderland Medical Center (Heerlen and Sittard), Maastricht University Medical Center, St Jans Gasthuis, Weert and Albert Schweitser Hospital, Dordrecht. All patients have an indication to undergo mastectomy due to invasive breast cancer or DCIS.~Follow up will be performed until 1 year after surgery. Patients will be evaluated in the out patient clinic 2 weeks, 6 weeks, 3 months, 6 months and 12 months postoperatively."|t|t|t|
1322301|NCT03305744|||Case-Control||Cross-Sectional|||||||
1322302|NCT03305731||Single Group Assignment||Treatment||None (Open Label)||||||
1322303|NCT03305718|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1322304|NCT03305705|Randomized|Sequential Assignment||Basic Science||Double|The patients will be blinded with respect to the treatment sequence. The outcome assessor (PET scan evaluator) will be blinded with respect to the participant identity and the date of the PET scan.||t|||t
1322305|NCT03305692|Randomized|Parallel Assignment||Treatment||Single|Individual analyzing echocardiograms (primary outcome) will not know randomization of the subjecdt.|1:1 randomization||||t
1322306|NCT03305679|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1322307|NCT03305666|Randomized|Parallel Assignment||Treatment||None (Open Label)||Non-inferiority, randomized, clinical trial||||
1322314|NCT03305575|Randomized|Parallel Assignment||Treatment||Triple|"The anesthesia provider responsible for the clinical care of the patient will be given an envelope prepared during randomization and instructed to open it and prepare the medication in a separate room, such that the investigator and patient cannot see which vial is being used to prepare the medication. The anesthesia provider will also be instructed not to reveal the allocation group to the investigator or the patient.~Both bupivacaine and chloroprocaine are clear liquids, and the intended doses of both medications are the same volume, to insure complete blinding."|Prospective, randomized, double blinded clinical trial.|t||t|t
1322315|NCT03305562|||Cohort||Other|||||||
1322316|NCT03305549|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Pilot 2-arm parallel-comparison randomized clinical trial comparing TIW dialysis (control) to a conservative dialysis strategy."||||
1322317|NCT03305536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322318|NCT03305523||Single Group Assignment||Other||None (Open Label)||"Short and long-term complications of male circumcisions using thermocautery was examined during 2 years period.~Complications were classified as perioperative (bleeding during the circumcision or under observation at the hospital after circumcision that required knotting or cauterization, scrotum or penile injury), early postoperative (first 10 days after being discharged) and long-term (late postoperative = after 10 days) (skin-mucosal bridge, delayed wound healing, secondary phimosis, meatitis)."||||
1322319|NCT03305510|||Cohort||Retrospective|||||||
1322320|NCT03305497|||Ecologic or Community||Prospective|||||||
1322321|NCT03305484|||Case-Control||Prospective|||||||
1322322|NCT03305471|Randomized|Parallel Assignment||Treatment||Double|Masking description is for Part B only - Parts A and C are Open Label, so have no masking|"Part A has a 2-period, open-label, randomized, 2-way crossover design with a single dose of Treatments A1 and A2~Part B participants are randomized with a 2:3:3:3 ratio to Treatment B1, B2, B3, and B4, respectively, using a double-blind, repeated dose, parallel design~Part C is an optional, single-arm, open label, repeated dose design"|t||t|
1322323|NCT03305458|Randomized|Parallel Assignment||Treatment||Single||||||t
1322324|NCT03305445||Single Group Assignment||Treatment||None (Open Label)||This multi-center study open-label trial will enroll a single cohort of relapsed/refractory diffuse large B cell lymphoma (DLBCL) patients whom are ineligible for autologous stem cell transplant (ASCT).||||
1322325|NCT03305432|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1322326|NCT03305419|Randomized|Sequential Assignment||Treatment||Double|This will be a double-blind study. Subjects and investigator will be masked.|This study will consist of two parts; Part A and Part B. Part A will be a 3-way crossover design and Part B will be a sequential-group design.|t||t|
1322327|NCT03305406|||Cohort||Prospective|||||||
1322328|NCT03305393||Single Group Assignment||Treatment||None (Open Label)||||||
1322329|NCT03305380|||Other||Other|||||||
1322330|NCT03305367|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Subjects complete three oral glucose tolerance tests (OGTT) on different days, with a minimum of one week in between. First visit is a combined screening and baseline OGTT, with no supplementation. At the second and third visit subjects are randomly assigned to either 3 g of hydrolyzed pine nut oil or 6 g of hydrolyzed pine nut oil.||||
1322331|NCT03305354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322332|NCT03305341|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322333|NCT03305328|Randomized|Parallel Assignment||Treatment||Single|Participants were unaware of the presence of a Sham condition. Therefore, all participants believed they received the Active stimulation.|Participants were randomly assigned to either an Active or Sham Control group. The Active group received the 30 minutes of alpha-tACS for four consecutive days, whereas the Sham Control group received Sham (no) stimulation.|t|||
1322334|NCT03305315|||Other||Prospective|||||||
1322335|NCT03305302|||Case-Only||Prospective|||||||
1322336|NCT03305289|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1322337|NCT03305276|||Ecologic or Community||Retrospective|||||||
1322338|NCT03305263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322339|NCT03305250|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1322340|NCT03305237|Randomized|Crossover Assignment||Treatment||Single|||t|||
1322341|NCT03305224||Single Group Assignment||Treatment||None (Open Label)||||||
1322342|NCT03305211||Single Group Assignment||Other||None (Open Label)||patients requiring renal biopsy for medical reasons||||
1322343|NCT03305198||Single Group Assignment||Basic Science||None (Open Label)|Metabolomic analysis will be performed blinded to the exercise test results|Analysis of changes in metabolomic signature from rest to post exercise||||
1322344|NCT03305185|Randomized|Parallel Assignment||Treatment||Double|Assessor, statistician and investigator blinded|"Patients diagnosed with AIS referred for bracing through the hospital's specialist outpatient clinic are eligible to enrol the study. The Investigator will document whether each patient meets the selection criteria before enrolment into the study. The Investigator or designee will also obtain an IRB/EC approved Informed consent from each patient and/or guardian.~Recruited patients will be randomly assigned to either SSE group or control group in a ratio of 1:1. The radiographic evaluation, physical examination and PROM questionnaires will be assessed at baseline, 3 months, 6 months and 12 months post treatment."|||t|t
1322345|NCT03305172|Randomized|Parallel Assignment||Other||Double|||||t|t
1322346|NCT03305159|Randomized|Single Group Assignment||Other||Single|Patients will be randomized to the control or intervention and not be told which antiseptic they received for the surgical preparation of the vagina.|Eligible patients will be randomized to either the control (povidone iodine) or intervention (chlorhexidine gluconate).|t|||
1322347|NCT03305146||Single Group Assignment||Diagnostic||None (Open Label)||First 20 patients for pilot study to test the feasibility of the molecular analysis then 120 patients to continue the trial.||||
1322348|NCT03305133|||Cohort||Retrospective|||||||
1322349|NCT03305120|||Case-Control||Prospective|||||||
1322350|NCT03305107|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1322351|NCT03305094|Randomized|Parallel Assignment||Treatment||Single|Participant is blinded to group assignment|Randomized controlled prospective trial|t|||
1322352|NCT03305081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322354|NCT03305055|Randomized|Parallel Assignment||Treatment||Quadruple|"Pharmacy receives order from provider and then prepares the study drug in an unmarked, nondescript delivery system (bag) and the study drug information is entered from the bag into the pump so that delivery that is timed and volume controlled per study protocol. This is hung next to patient, connected and started. Masked personnel include provider (order study drug protocol), nurse (wound care), data assessor (Research Assistant), and consenting participant (patient with acute burn)."|Randomized, placebo-controlled, repeated exposure (twice daily, 7 days), safety and efficacy trial of Usual Care (fentanyl PLUS saline / placebo) versus Usual Care plus Study Drug Augmentation (fentanyl PLUS ketamine) in reducing acute pain severity assessed before, during and after wound care for acute burn injury in the Burn Center of an Academic Medical Center.|t|t|t|t
1322355|NCT03305042|||Other||Cross-Sectional|||||||
1322356|NCT03305029||Single Group Assignment||Treatment||None (Open Label)||||||
1322357|NCT03305016||Single Group Assignment||Treatment||None (Open Label)||All study participants will receive TransCon hGH||||
1322358|NCT03305003|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1322359|NCT03304990|||Cohort||Prospective|||||||
1322360|NCT03304977||Single Group Assignment||Other||None (Open Label)||||||
1322361|NCT03304964|Randomized|Sequential Assignment||Treatment||Double|MAD part (Part 1) - double-blind; FE part (Part 2) - open-label|MAD part (Part 1) - sequential multiple ascending doses; FE part (Part 2) - crossover food effect after single dose administration|t||t|
1322362|NCT03304951||Single Group Assignment||Treatment||None (Open Label)||||||
1322363|NCT03304938|Randomized|Crossover Assignment||Treatment||Quadruple|Lavender Essential oil as medication and almond oil as placebo put in similar dark buttle and the head of placebo bottle aromatized whit Lavender Essential oil and all of participants, care provider, investigator and outcomes assessor will be blind.|40 diabetic patients with sleep disorder with the inclusion criteria will enter into the crossover study and randomly assign to treatment or placebo groups.|t|t|t|t
1322364|NCT03304925||Single Group Assignment||Other||None (Open Label)||||||
1322365|NCT03304912|||Cohort||Prospective|||||||
1322366|NCT03304899|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1322367|NCT03304886|||Case-Control||Cross-Sectional|||||||
1322368|NCT03304873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322369|NCT03304860||Single Group Assignment||Screening||None (Open Label)||||||
1322370|NCT03304847||Single Group Assignment||Treatment||None (Open Label)||single group assignment||||
1322371|NCT03304834||Single Group Assignment||Treatment||None (Open Label)||Monocentric study||||
1322372|NCT03304821|Randomized|Parallel Assignment||Treatment||Double|Participants and the primary investigator will be blinded to group assignment. Blinding will be maintained by Investigational Pharmacy and blood counts will be reviewed by one of the study co-investigators who will make dose-modifications, when necessary.|"Participants will be randomized, in a 2:1 manner, to receive:~Group A: Subcutaneous GM-CSF 500µg on Monday, Wednesday, Friday (n=117)~Group B: Placebo on Monday, Wednesday, Friday (n=59)~Participants will be stratified on diabetes status ensuring that a proportionate number of diabetics (2:1) are randomized to each group."|t||t|
1322373|NCT03304808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322374|NCT03304795|||Ecologic or Community||Cross-Sectional|||||||
1322375|NCT03304782|||Cohort||Prospective|||||||
1322376|NCT03304769|Randomized|Single Group Assignment||Other||None (Open Label)||Selected from a single-site level one pediatric emergency department. Pediatric patients aged 4-17 years requiring an IV. Random number generator used to decide which patients will be using VR and which will have standard IV placement||||
1322377|NCT03304756||Single Group Assignment||Treatment||None (Open Label)||||||
1322378|NCT03304743|||Case-Control||Cross-Sectional|||||||
1322379|NCT03304730|||Cohort||Prospective|||||||
1322380|NCT03304717|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1322381|NCT03304704|||Cohort||Prospective|||||||
1322382|NCT03304691|||Cohort||Prospective|||||||
1322383|NCT03304678|||Cohort||Prospective|||||||
1322384|NCT03304665|||Cohort||Cross-Sectional|||||||
1322385|NCT03304652|||Cohort||Prospective|||||||
1322386|NCT03304639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322387|NCT03304626||Single Group Assignment||Treatment||None (Open Label)||20 subjects will receive open label Budesonide along with standard immune suppression and their outcomes will be compared to 20 matched controls receiving standard of care treatment including prednisone plus standard immune suppression||||
1322388|NCT03304613|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized 2:2:1 as follows: e-CBT (n=120), PRISM (n=120) and usual care (n = 60).||||
1322389|NCT03304600|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322390|NCT03304587|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322391|NCT03304574|Randomized|Parallel Assignment||Screening||Single|Participants will be blinded to their group assignment.|Participants will be randomly assigned to one of two groups, a control or intervention group. Those assigned to the control group will complete the electronic health assessment only and will not receive integrated personalized feedback. Those assigned to the intervention group will complete the electronic health assessment and will receive integrated personalized feedback.|t|||
1322392|NCT03304561|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322393|NCT03304548|||Cohort||Cross-Sectional|||||||
1322394|NCT03304535|||Cohort||Prospective|||||||
1322395|NCT03304522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322396|NCT03304509|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Patients will be included and assigned randomly, using an informatic program, to one of the study arms before hospital discharge.||||
1322397|NCT03304496|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1322398|NCT03304483||Single Group Assignment||Screening||None (Open Label)|Before and after the race|athletes participating in the ultra marathon running||||
1322399|NCT03304470|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1322400|NCT03304457|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized, open label, active controlled study||||
1322401|NCT03304444|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1322402|NCT03304431|Randomized|Parallel Assignment||Treatment||Single|QTc (corrected QT), QT dispersion (QTd), P wave dispersion will calculated by a blind researcher.|The induction of group L will be performed 5 minutes after administration of 10% topical lidocaine (Vemcaine pump spray 10% 50 ml) 160 mg (16 puffs).||||t
1322403|NCT03304418||Single Group Assignment||Treatment||None (Open Label)||This is a phase IIa, open label, single arm, prospective study||||
1322404|NCT03304405|||Cohort||Prospective|||||||
1322405|NCT03304392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322406|NCT03304379|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1322407|NCT03304366|||Cohort||Prospective|||||||
1322408|NCT03304353|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322409|NCT03304340|Randomized|Parallel Assignment||Treatment||Single||||||t
1322410|NCT03304327||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322411|NCT03304314|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1322412|NCT03304301|Randomized|Parallel Assignment||Treatment||Single||||||t
1322413|NCT03304288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322414|NCT03304275|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1322415|NCT03304262|Randomized|Crossover Assignment||Diagnostic||Double|Participants will be blinded to treatment group, investigator administering tDCS will be blinded to which treatment arm subject is assigned to, and the data analyst will be conducting analysis off site and is different than investigator applying stimulation.|This is a randomized, sham-controlled, double blinded crossover trial.|t||t|
1322416|NCT03304249|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322417|NCT03304236|||Cohort||Prospective|||||||
1322418|NCT03304223||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322419|NCT03304210|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1322420|NCT03304197|Randomized|Crossover Assignment||Treatment||Double|Doubly-blinded & randomised using an online randomisation website.||t||t|
1322421|NCT03304184|Randomized|Parallel Assignment||Treatment||None (Open Label)||One group will be treated with a tooth colored filling that will be placed near the gum line. The second group will be treated with a white colored filling that will be placed near the gum line.||||
1322422|NCT03304171|||Cohort||Prospective|||||||
1322423|NCT03304158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322424|NCT03304145||Single Group Assignment||Supportive Care||None (Open Label)||||||
1322425|NCT03304132|||Case-Control||Prospective|||||||
1322426|NCT03304119|||Cohort||Prospective|||||||
1322427|NCT03304106|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322428|NCT03304093||Single Group Assignment||Treatment||None (Open Label)||||||
1322429|NCT03304080||Single Group Assignment||Treatment||None (Open Label)||||||
1322430|NCT03304067|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1322431|NCT03304054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322432|NCT03304041|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1322433|NCT03304028|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Prospective, multicenter, longitudinal pilot study on cohort, in 3 phases||||
1322434|NCT03304015|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322435|NCT03304002|||Cohort||Prospective|||||||
1322436|NCT03303989|Randomized|Parallel Assignment||Treatment||Double|Double blind|Phase II, double blind, placebo controlled multisite proof-of-concept trial in subjects initiating pegloticase for treatment of chronic gout|t||t|
1322437|NCT03303976|Randomized|Parallel Assignment||Prevention||Single|||t|||
1322438|NCT03303963|||Cohort||Prospective|||||||
1322439|NCT03303950||Single Group Assignment||Treatment||None (Open Label)||||||
1322440|NCT03303937|||Cohort||Prospective|||||||
1322441|NCT03303924||Single Group Assignment||Basic Science||None (Open Label)||||||
1322442|NCT03303911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322443|NCT03303898|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1322444|NCT03303885|||Other||Cross-Sectional|||||||
1322445|NCT03303872|||Cohort||Prospective|||||||
1322446|NCT03303859|||Cohort||Prospective|||||||
1322447|NCT03303846||Single Group Assignment||Screening||None (Open Label)||||||
1322448|NCT03303833|||Cohort||Other|||||||
1322449|NCT03303820|||Cohort||Retrospective|||||||
1322450|NCT03303807||Single Group Assignment||Prevention||None (Open Label)||||||
1322451|NCT03303794|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322452|NCT03303781|||Ecologic or Community||Retrospective|||||||
1322453|NCT03303768|||Cohort||Prospective|||||||
1322454|NCT03303755|||Other||Prospective|||||||
1322455|NCT03303742|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1322456|NCT03303729|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1322457|NCT03303716|||Cohort||Prospective|||||||
1322458|NCT03303703|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1322459|NCT03303690||Single Group Assignment||Treatment||None (Open Label)||||||
1322460|NCT03303677|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomization into one of three treatment arms||||
1322461|NCT03303664|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1322462|NCT03303651|Randomized|Parallel Assignment||Treatment||Double|Participants are not informed about the group assignement (intervention takes place in general anesthesia). Outcome assessors are persons without knowledge on former treatment in intervention/control group.|Participants are assigned to intervention groups by chance|t|||t
1322463|NCT03303638||Single Group Assignment||Basic Science||None (Open Label)||||||
1322464|NCT03303625|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1322465|NCT03303612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322467|NCT03303586|Randomized|Crossover Assignment||Treatment||None (Open Label)||Participants will be randomly assigned to wearing compression stockings for next two weeks or not wearing compression stockings for next two weeks, and crossed over.||||
1322468|NCT03303573|||Cohort||Retrospective|||||||
1322469|NCT03303547||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322470|NCT03303534|Randomized|Parallel Assignment||Basic Science||None (Open Label)||3:2 randomization to short-term protein calorie restriction diet versus regular meals prior to elective carotid artery endarterectomy||||
1322471|NCT03303521|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1322472|NCT03303508||Single Group Assignment||Diagnostic||None (Open Label)||"The study will include patients with suspected diagnosis of autoimmune rheumatic diseases referred to the Laboratory of Clinical Immunology, Clinical Pathology Department, Assiut University Hospital for anti-dsDNA test. Patients will be recruited into the study within period of one year.~Also, apparently healthy subjects (at least 25 subjects; according to international method verification guidelines) will be included as a control group."||||
1322473|NCT03303495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322474|NCT03303482|Randomized|Parallel Assignment||Other||Single||The investigators will randomly assign consenting teachers by classroom (lead teacher and/or assistant teacher) to either the fall or spring course (intervention and waitlist control groups, respectively). The course will be taught to groups of 16 teachers, with four groups in the fall course (64 teachers) and four in the spring course (64 teachers). To determine the impacts of the training intervention on those assigned to the fall course (intervention groups), those assigned to the spring course (control groups) will serve as concurrent controls during the fall.||||t
1322475|NCT03303469||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322476|NCT03303456|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1322477|NCT03303443|||Other||Prospective|||||||
1322478|NCT03303430|||Case-Only||Prospective|||||||
1322479|NCT03303417|Randomized|Crossover Assignment||Basic Science||Single|MRI analysis will be performed blind to the intervention|||||t
1322480|NCT03303404||Single Group Assignment||Other||None (Open Label)||||||
1322481|NCT03303391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322482|NCT03303378|Randomized|Parallel Assignment||Treatment||Single||Patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention||||t
1322483|NCT03303365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322484|NCT03303352|Randomized|Crossover Assignment||Diagnostic||Single|"At the end of the study, all slides will be scored for cellularity and quality on a 0 to 3 discrete scale, according to the previous work done by Mukai S et al [12], by an independent pathologist, from an institution not involved in the initial histological analysis, blinded to the type of pass (fast or slow)."|A prospective, multicenter, randomized, crossover study.||||t
1322485|NCT03303339|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1322486|NCT03303326|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1322487|NCT03303313||Single Group Assignment||Treatment||None (Open Label)||||||
1322488|NCT03303300|||Cohort||Prospective|||||||
1322489|NCT03303287|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||: Three schools under the Aga Khan Education Service in Karachi will be included in a two-arm parallel cluster intervention trial. All schools belong to lower to middle income class, at different locations, all having the same school curriculum. Baseline data will be collected from all three schools during a three month period by trained research staff||||
1322490|NCT03303274|Randomized|Parallel Assignment||Prevention||Single|||t|||
1322491|NCT03303261|||Cohort||Prospective|||||||
1322492|NCT03303248|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322493|NCT03303235|Randomized|Parallel Assignment||Treatment||Triple|The patient and obstetrician will all be blinded to group assignments. The anesthesiologist will make and administer the medication, as it is important for timely administration of the methylergonovine when it is asked to be used. The anesthesiologist directly taking care of the patient will not be blinded.||t|t||t
1322494|NCT03303222|||Cohort||Prospective|||||||
1322495|NCT03303209|||Cohort||Prospective|||||||
1322496|NCT03303196|Randomized|Crossover Assignment||Treatment||None (Open Label)||This will be an open-label, pilot clinical trial to assess efficacy and safety of the bihormonal bionic pancreas in children and young adults with HI who have developed post-pancreatectomy diabetes. Subjects will be studied during two research inpatient admissions at the CHOP HI Center. The order of the interventions will be randomized.||||
1322497|NCT03303183|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1322498|NCT03303170|Randomized|Parallel Assignment||Treatment||Single||||||t
1322499|NCT03303157|||Case-Only||Prospective|||||||
1322500|NCT03303144|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1322501|NCT03303131|||Ecologic or Community||Retrospective|||||||
1322502|NCT03303118||Single Group Assignment||Other||None (Open Label)||Single-Blind study.||||
1322503|NCT03303105|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322504|NCT03303092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322505|NCT03303079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322506|NCT03303066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322507|NCT03303053|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multi-center, open label, randomised, parallel-group||||
1322508|NCT03303040|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a within subjects design. One side of each subject's diaphragm will be stimulated. The other side of the subject's diaphragm will not be stimulated and will therefore serve as the control. Biopsies will be taken from both sides and compared.||||
1322509|NCT03303027|Non-Randomized|Factorial Assignment||Other||Single||The primary endpoint will be the score of two blinded reviewers using the patient observer scar assessment score at a three-month assessment visit.||||t
1322510|NCT03303014|Randomized|Factorial Assignment||Other||Single||||||t
1322511|NCT03303001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322675|NCT03300869|||Other||Retrospective|||||||
1322512|NCT03302988|Randomized|Factorial Assignment||Other||None (Open Label)||Each wound will have 2 treatments. The type of treatment (Type of suturing) will be chosen by random assignment||||
1322513|NCT03302975||Single Group Assignment||Prevention||None (Open Label)||||||
1322514|NCT03302962|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1322515|NCT03302949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322516|NCT03302936|Randomized|Parallel Assignment||Prevention||Single|||t|||
1322517|NCT03302923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322518|NCT03302910|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1322519|NCT03302897|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322520|NCT03302884||Single Group Assignment||Basic Science||None (Open Label)||||||
1322521|NCT03302871|Randomized|Parallel Assignment||Treatment||Single|||||t|
1322522|NCT03302858||Single Group Assignment||Treatment||None (Open Label)||||||
1322523|NCT03302845|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1322524|NCT03302832|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized clinical trial||||
1322525|NCT03302819|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1322526|NCT03302806|||Other||Prospective|||||||
1322527|NCT03302793|Randomized|Crossover Assignment||Treatment||Single|||t|||
1322528|NCT03302780|Randomized|Crossover Assignment||Treatment||Single|||t|||
1322529|NCT03302767||Single Group Assignment||Supportive Care||None (Open Label)||To complete||||
1322530|NCT03302754||Single Group Assignment||Other||None (Open Label)||||||
1322531|NCT03302741|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1322532|NCT03302728||Single Group Assignment||Treatment||None (Open Label)||"This is a single arm dose escalation study. There are four dose levels for the combination of Brentuximab vedotin and Lenalidomide considered during the dose escalation.~Starting Dose Level 1: Brentuximab vedotin 1.8mg/kg q21 days & Lenalidomide 15 mg daily (D1-14)~The dose can be decreased as follows:~Level -2 Brentuximab vedotin 1.2mg/kg q21 days & Lenalidomide 5 mg daily (D1-14)~Level -1 Brentuximab vedotin 1.2mg/kg q21 days & Lenalidomide 10 mg daily (D1-14)~or the dose can be escalated as follows:~Level 2 Brentuximab vedotin 1.8mg/kg q21 days & Lenalidomide 25 mg daily (D1-14)~Patients will be assigned a starting dose by the safety committee; this will be communicated by the PI and/or their designated sub-investigator prior to planned Cycle1 Day 1 for each patient."||||
1322533|NCT03302715||Single Group Assignment||Prevention||None (Open Label)||Consecutive cohort study with mucosal samples during colonoscopy||||
1322534|NCT03302702||Single Group Assignment||Treatment||None (Open Label)||||||
1322535|NCT03302689|Randomized|Parallel Assignment||Treatment||Double|Women after the operation do not know what drug they injected with TAP-block The researcher does not know what type of drug is injected|Two groups of women after cesarean section under spinal anesthesia|t||t|
1322536|NCT03302676|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||2:1 randomization in favor of chewing gum (intervention)||||
1322537|NCT03302663|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Participants will be assigned to appropriate arm depending on outcome of routine obstetric screening||||
1322538|NCT03302650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322539|NCT03302637|||Case-Control||Prospective|||||||
1322540|NCT03302624|||Cohort||Prospective|||||||
1322541|NCT03302611|Randomized|Parallel Assignment||Treatment||Single|The assessor will be blinded to participants' intervention condition.|Consenting active duty service members with major depressive disorder will be randomized to receive 6 weeks of either surf or hike therapy. Participants will be allowed to receive the other intervention (i.e., the condition that they were not originally randomized to) if interested after the initial intervention period.||||t
1322542|NCT03302598||Single Group Assignment||Treatment||None (Open Label)||A prospective study of 40 patients admitted with the diagnosis of enterocutaneous fistula and prepared for definite surgical repair in the form of resection anastomosis of ECF. the investigators used preoperative serum C-reactive protein as predicting factor to recurrence and independent variable for timing of surgery.||||
1322543|NCT03302585|Randomized|Parallel Assignment||Treatment||Quadruple|Masked randomization and allocation, only data safety monitor will know allocation if adverse event requires unblinding|A double-blind randomized placebo/standard therapy phase II trial|t|t|t|t
1322544|NCT03302572|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322545|NCT03302559||Single Group Assignment||Treatment||None (Open Label)||||||
1322546|NCT03302546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322547|NCT03302533|||Case-Control||Retrospective|||||||
1322548|NCT03302520|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322549|NCT03302507|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322550|NCT03302494|Randomized|Parallel Assignment||Prevention||Single|If the subject is suspected of having a stroke since their most recent follow-up, a Neurologist blinded to subject's randomization and implanted device must evaluate the subject or otherwise provide rationale for why an in-person neurology visit and exam are unnecessary. Neurology or blinded trial personnel should also administer mRS & NIHSS if there is suspicion of stroke A Clinical Events Committee, also blinded to subject's randomization, will adjudicate primary safety and effectiveness.|||||t
1322551|NCT03302481||Single Group Assignment||Other||None (Open Label)||patients with obesity surgery with a laparoscopic approach scheduled in the department of digestive surgery of the CHU de Nantes||||
1322552|NCT03302468|||Cohort||Prospective|||||||
1322553|NCT03302455|Randomized|Parallel Assignment||Treatment||Single||One group receives e-aid short-term cognitive behavior therapy, and the other group does not receive any interventions during a clinical study.||||t
1322554|NCT03302442|||Cohort||Retrospective|||||||
1322555|NCT03302429|Randomized|Parallel Assignment||Treatment||Single||"Eighteen patients will be divided into two equal groups. Each group comprises nine patients.~Group A: Platelet-rich Fibrin combined with Biphasic Calcium Phosphate.(interventional group) Group B: autogenous bone graft (controlled group)"||||t
1322556|NCT03302416||Single Group Assignment||Basic Science||None (Open Label)||Baseline [C-11]NOP-1A scan Post-hydrocortisone [C-11]NOP-1A scan||||
1322557|NCT03302403||Single Group Assignment||Treatment||None (Open Label)||||||
1322558|NCT03302390|||Other||Prospective|||||||
1322559|NCT03302377||Single Group Assignment||Prevention||None (Open Label)||As this is a feasibility study, all participants will receive the intervention||||
1322560|NCT03302364|||Cohort||Prospective|||||||
1322561|NCT03302351|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1322562|NCT03302338|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1322563|NCT03302325|||Case-Only||Prospective|||||||
1322564|NCT03302312|||Other||Retrospective|||||||
1322565|NCT03302299||Single Group Assignment||Other||None (Open Label)||||||
1322566|NCT03302286|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1322567|NCT03302273||Single Group Assignment||Treatment||None (Open Label)||||||
1322568|NCT03302260|Randomized|Parallel Assignment||Other||Double|The nature of the intervention (i.e., the CardioPrevent® cognitive-behavioural lifestyle counsellor) does not lend itself to blinding of the participant. However, the research assistant responsible for the outcome assessments will be blinded to each participant's group allocation and will be instructed not to ask any questions pertaining to the study intervention. The study statistician will also be blinded to group allocation.||||t|t
1322569|NCT03302247||Single Group Assignment||Treatment||None (Open Label)||Nivolumab 240mg, IV on day 1, 15 + Gemcitabine 1000mg/m2, IV on day 1, 8, 15 of 28 days cycle||||
1322570|NCT03302234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322571|NCT03302221|Randomized|Parallel Assignment||Treatment||Single||Doppler Ultrasonography Assessed Vascular Changes||||t
1322572|NCT03302208|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1322573|NCT03302195|Randomized|Parallel Assignment||Treatment||Single|Participant is blinded to group assignment|Randomized control prospective trial|t|||
1322574|NCT03302182|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1322575|NCT03302169|Randomized|Single Group Assignment||Treatment||Triple||This is a prospective randomized controlled trial to assess early urinary continence recovery rates after robotic assisted radical prostatectomy when a posterior rhabdosphincter reconstruction is performed or not.|t|t|t|
1322576|NCT03302156|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1322577|NCT03302143|Randomized|Parallel Assignment||Treatment||Double||A comparative, randomized, prospective, clinical study|t|||t
1322578|NCT03302130||Single Group Assignment||Other||None (Open Label)||||||
1322579|NCT03302117|||Case-Crossover||Prospective|||||||
1322580|NCT03302104|||Other||Cross-Sectional|||||||
1322581|NCT03302091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1322582|NCT03302078|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1322583|NCT03302065|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1322584|NCT03302052|||Cohort||Prospective|||||||
1322585|NCT03302039|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1322586|NCT03302026|Randomized|Parallel Assignment||Treatment||Single|Treatment-seeking smokers complete an intake session and then be randomized to an active NFT group or a control group.|The proposed study will evaluate the effects of rt-fMRI neurofeedback training on the ability to resist craving for cigarettes. The study will be conducted in two phases: a technical development phase and a proof-of-concept phase focused on efficacy. The technical development phase will be completed before beginning the proof-of-concept phase. Eligible consenting treatment-seeking smokers complete an intake session and then be randomized to an active NFT group or a control group. Both groups will complete three scanning sessions, followed by a smoking resist evaluation.|t|||
1322587|NCT03302013|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322588|NCT03302000|Randomized|Parallel Assignment||Prevention||Single||||||t
1322589|NCT03301987||Single Group Assignment||Treatment||None (Open Label)||||||
1322590|NCT03301974|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322591|NCT03301961|||Case-Only||Prospective|||||||
1322592|NCT03301948|Randomized|Crossover Assignment||Prevention||Single||Single blind, counterbalanced, crossover trial|t|||
1322593|NCT03301935|||Cohort||Prospective|||||||
1322594|NCT03301922|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised Controlled Trial||||
1322595|NCT03301909||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1322596|NCT03301896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322597|NCT03301883||Single Group Assignment||Treatment||None (Open Label)||||||
1322598|NCT03301870|Randomized|Parallel Assignment||Other||Double||"the assignment of the test articles to the test sites will be randomized. Each arm is a different patch of skin on the same study participant"|t|||t
1322599|NCT03301857|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322600|NCT03301844|Randomized|Sequential Assignment||Treatment||None (Open Label)||A randomized, controlled study with a closed sequential design||||
1322601|NCT03301831|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||2-arm RCT with participants randomized to either the intervention or attention control group.||||
1322602|NCT03301818||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322603|NCT03301805||Single Group Assignment||Treatment||None (Open Label)||||||
1322604|NCT03301792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322605|NCT03301779|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1322606|NCT03301766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322607|NCT03301753|||Cohort||Prospective|||||||
1322676|NCT03300856|||Other||Retrospective|||||||
1322677|NCT03300843||Parallel Assignment||Treatment||None (Open Label)||||||
1322678|NCT03300830|||Cohort||Prospective|||||||
1322679|NCT03300817||Single Group Assignment||Prevention||None (Open Label)||||||
1322680|NCT03300804|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1322681|NCT03300791|||Other||Prospective|||||||
1322682|NCT03300778|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1322683|NCT03300765||Single Group Assignment||Treatment||None (Open Label)||||||
1322608|NCT03301740|Randomized|Crossover Assignment||Treatment||Triple|The study will be double-blinded in that participants will not be informed of the treatment paradigm. Investigators, including those performing transthoracic echocardiography (TTE) interpretation, will be blinded to treatment paradigm. Ultrasonographers performing intra-HD TTEs will be blinded to treatment paradigm.|The study is a 4-phase crossover trial in which participants are successively alternated between conventional HD and conventional HD + linear UF profiling across 4 phases with intervening wash-out periods. The study compares conventional HD (the participant's standard HD prescription with no UF profiling) to conventional HD + linear UF profiling. Participants will be randomly allocated to conventional HD or conventional HD + linear UF profiling for phase 1. Participants will undergo 9 treatments during each phase for a total of 18 conventional HD treatments and 18 UF profiled treatments. Participants will undergo 3 wash-out HD treatments between phases.|t||t|t
1322609|NCT03301727|Randomized|Parallel Assignment||Treatment||Single||||||t
1322610|NCT03301714|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322611|NCT03301701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322612|NCT03301688|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322613|NCT03301675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322614|NCT03301662|||Cohort||Prospective|||||||
1322615|NCT03301649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322616|NCT03301636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322617|NCT03301623|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"The study team will randomize the study on the provider level and use a random number generator to assign providers to study arms.~Patients within the physicians randomized to the IDM arm will not receive the PEAT materials; their physicians will receive the CDS alerts via the EHR when certain order criteria are triggered appropriately.~Patients within the physicians randomized to the SDM arm will receive the PEAT materials via REDCap two days before their PCP office visit. They will receive these materials every time they have an office visit with their PCP."||||
1322618|NCT03301610|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This prospective study has been designed as quasi-experimental study. This study seeks to explore both a treatment and control group in efforts to compare outcomes which are dependent on the type of intervention. Study participants will be assigned into one of two study arms, intervention or control, based on random assignment determined by the location they are bedded in hospital. One of two patient care units will offer standard education, the other unit will offer the mobile, iPad based education. The patient care unit to offer the mobile, iPad based education will be selected at random.||||
1322619|NCT03301597|Randomized|Parallel Assignment||Prevention||Single|This is an open-label study.|Subjects will be randomized to 1 of 3 Investigational Arms or a Control Arm in a 1:1:1:1 ratio.||||t
1322620|NCT03301584|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A prospective, controlled, intervention study. Evaluation of a modified model of in-patient rehabilitation compared to standard care, with follow-up at 1 month post-discharge.||||
1322621|NCT03301571||Single Group Assignment||Basic Science||None (Open Label)||All patients will receive the same interventions||||
1322622|NCT03301558|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Patients will be randomized in a 1:1 ratio to either receive low-dose (1500 mg/d) sodium bicarbonate followed by high-dose (3000mg/d) sodium bicarbonate (sequence A-B) or to receive high-dose sodium bicarbonate followed by low-dose sodium bicarbonate (sequence B-A) with washout-phases in between.||||
1322623|NCT03301545|Randomized|Parallel Assignment||Treatment||Single|Each study participant will be assigned a unique study identification number (study ID). All information/data regarding the participant will be collected using the Study ID. In this way, data analyses by the outcomes assessor will be blinded.|Patients consenting to participate will be randomized to one of two groups: (1) fast-track to bariatric surgery, or (2) Best diabetic care under the guidance of an endocrinologist for one year. Note: participants in the best diabetic care group will have the option to undergo bariatric surgery after one year if desired.||||t
1322624|NCT03301532||Single Group Assignment||Treatment||None (Open Label)||||||
1322625|NCT03301519|||Cohort||Prospective|||||||
1322626|NCT03301506|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322627|NCT03301493|||Other||Other|||||||
1322628|NCT03301480|||Case-Control||Cross-Sectional|||||||
1322629|NCT03301467|Randomized|Parallel Assignment||Treatment||Quadruple|Matching placebo|Placebo crossover to active|t|t|t|t
1322630|NCT03301454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322631|NCT03301441|||Cohort||Prospective|||||||
1322632|NCT03301428|Randomized|Parallel Assignment||Treatment||Single||||||t
1322633|NCT03301415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1322634|NCT03301402|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1322635|NCT03301389|||Cohort||Prospective|||||||
1322636|NCT03301376|||Cohort||Prospective|||||||
1322637|NCT03301363|||Cohort||Prospective|||||||
1322638|NCT03301350||Single Group Assignment||Treatment||None (Open Label)||||||
1322639|NCT03301337|Randomized|Crossover Assignment||Other||Double|Outcome assessor and investigator will be blindet. Participants cannot be blindet, as they will consume three different meat products, that we cannot mask.|Single-blindet randomized cross-over study|||t|t
1322640|NCT03301324|||Cohort||Prospective|||||||
1322641|NCT03301311|Randomized|Crossover Assignment||Treatment||None (Open Label)||We are using a series of N-of-1 trials where patients alternate (cross) between the two study interventions at set intervals. N-of-1 trial results will be examined at the individual and population level (through meta-analysis of individual N-of-1 trials)||||
1322642|NCT03301298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322643|NCT03301285|||Case-Crossover||Retrospective|||||||
1322684|NCT03300752|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1322685|NCT03300739|||Case-Only||Prospective|||||||
1322686|NCT03300726|||Case-Control||Prospective|||||||
1322687|NCT03300713|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322688|NCT03300700|||Cohort||Prospective|||||||
1322689|NCT03300687|Non-Randomized|Single Group Assignment||Other||Single|||t|||
1322644|NCT03301272|Randomized|Crossover Assignment||Treatment||Triple|Double-blinded study whereby the subject, the movement disorder specialist injecting neurotoxin, and the movement disorder specialist rating the patient will be unaware of the solution injected and/or planned for injection same day. To ensure that the injecting specialist is blinded to the solution, syringes will be premixed by a separate member of the research team and de-identified of any possible labels that would indicate the properties of the solution being administered to the subject.|The study will comprise of a double blinded, crossover study where the subjects will serve as their own controls. There will be no medication changes made to Parkinson's disease medications throughout the subjects' participation in the study.|t|t|t|
1322645|NCT03301259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322646|NCT03301246||Single Group Assignment||Treatment||None (Open Label)||45 patients will be treated using the 1.0mm dilatation catheter and 15 patients treated with the 1.25mm dilatation catheter for a total of 60 subjects enrolled and treated. Patients may be consented, enrolled and treated until the sample size is reached, with n=60 completing the study.||||
1322647|NCT03301233|Randomized|Parallel Assignment||Diagnostic||Single|Ninety opaque envelopes will be numbered serially and in each envelope the corresponding letter which denotes the allocated group will be put according to randomization table. Then all envelopes will be closed and put in one box. When the first patient arrives, the first envelope will be opened and the patient will be allocated according to the letter inside.||t|||
1322648|NCT03301220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322649|NCT03301207||Single Group Assignment||Other||None (Open Label)||||||
1322650|NCT03301194|||Cohort||Retrospective|||||||
1322651|NCT03301181|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1322652|NCT03301168||Single Group Assignment||Treatment||None (Open Label)||||||
1322653|NCT03301155|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1322654|NCT03301142|Randomized|Parallel Assignment||Treatment||Single||||||t
1322655|NCT03301129|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1322656|NCT03301116|Randomized|Parallel Assignment||Prevention||Single|N/A (there are no other parties who will be masked in the clinical trial)|Home care aide-client pairs will be randomly assigned to one of two groups in parallel for the duration of the study. Home care aides will not be allowed to have multiple participating clients assigned to different groups to prevent group contamination.||||t
1322657|NCT03301103|Randomized|Parallel Assignment||Treatment||Triple|All researchers of the project team will be kept blind to assignment of treatment, and so will be the study subjects.The placebo will be matched in appearance and flavour to PTM202.|The APA12/PANTER study is a randomized, double-blind, placebo-controlled, parallel intervention study of 3 weeks in 72 healthy adults. Subjects will be orally infected with a live, but attenuated, diarrheagenic E. coli (strain E1392-75-2A; collection NIZO food research; dose 1E10 CFU (at study day 14). At study day 14, 15 and 16 subjects will receive either placebo or PTM202, a dietary formula containing dried bovine colostrum and dried whole egg.|t||t|t
1322658|NCT03301090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322659|NCT03301077|||Other||Cross-Sectional|||||||
1322660|NCT03301064|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study is a phase 2 randomized controlled trial to determine the efficacy of a 3-session intervention that combines Motivational Enhancement Therapy and Strengths Based Case Management (MET/SBCM) to reduce unhealthy alcohol use. Participants (n=260) will be block randomized to either the MET/SBCM intervention or to a control condition that receives an educational brochure about alcohol and its associated risks. Both the MET/SBCM intervention and the control condition (i.e., the educational brochure) will be provided by promotores who work for the Providence Center for Community Improvement in Los Angeles, California. Participants will be Latinos served by Providence's outreach programs who exceed low-risk drinking guidelines.||||
1322661|NCT03301051|Randomized|Parallel Assignment||Prevention||Single||||||t
1322662|NCT03301038||Single Group Assignment||Treatment||None (Open Label)||||||
1322663|NCT03301025|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1322664|NCT03301012|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Participants in the control and experimental condition will have access to post treatment recovery support services as usual.~Participants in the experimental condition will receive a smartphone, a calling/texting/data plan, and the SARC-A mobile applications for the first 6 months post treatment discharge. Experimental participants will 1) complete a 2-3 minute recovery-focused ecological momentary assessment (EMA) at 5 random times a day, receive feedback on their current answers, and provided access to behavioral charting of their past answers over time; and 2) receive continuous access to a suite of self-initiated ecological momentary interventions (EMI) to support their recovery via tool box of coping tools, apps related to getting support, and apps related to maintaining a healthy lifestyle."||||
1322665|NCT03300999|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1322666|NCT03300986|||Cohort||Prospective|||||||
1322667|NCT03300973|Randomized|Parallel Assignment||Treatment||||||||
1322668|NCT03300960|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322669|NCT03300947|Randomized|Parallel Assignment||Treatment||Quadruple|Phase One: Double blind (both participant AND researchers (In room Care Provider, Investigators, Blinded Outcomes Assessor) Phase Two: Single blind (Participant and Blinded Outcomes Assessor)|All participants will be randomly assigned to administration of low dose (100 µg/kg) psilocybin, High dose (300 µg/kg) psilocybin, or Lorazepam (1 mg). Eight different sessions divided in two phases will ensure all subjects are exposed to psilocybin at some point during the study in a blinded fashion.|t|t|t|t
1322670|NCT03300934|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1322671|NCT03300921|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Arm A: 50mcg IV weekly Arm B: 12mcg PO daily||||
1322672|NCT03300908|Randomized|Parallel Assignment||Supportive Care||Single|Participants were not aware of which intervention they were assigned to. A randomization scheme was developed and participants were assigned to treatment groups accordingly.|Participants were randomly assigned to Project ADHERE, or the control condition, MACE. The randomization process was described to participants during the informed consent process.|t|||
1322673|NCT03300895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322674|NCT03300882|||Cohort||Prospective|||||||
1322690|NCT03300674|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1322691|NCT03300661||Single Group Assignment||Treatment||None (Open Label)||A single cohort of patients with NAFLD, without control group.||||
1322692|NCT03300648|Randomized|Parallel Assignment||Treatment||Single|Investigators assessing outcome will be blinded to the arm to which the participant was randomly assigned|Participants will be randomly assigned to one of three study arms.||||t
1322693|NCT03300635|Non-Randomized|Parallel Assignment||Other||Single||Patients and healthy control subjects will attend the same interventions: a) muscle function test (distressing task vs. relaxing) with e.g. psychological questionnaires, b) glucose tolerance test and other blood analyses including metabolomics, and c) bicycle ergometry with physiological measurements and blood analyses including metabolomics.||||t
1322694|NCT03300622|||Cohort||Prospective|||||||
1322695|NCT03300609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322696|NCT03300596|Randomized|Parallel Assignment||Treatment||Single||||||t
1322697|NCT03300583|||Cohort||Prospective|||||||
1322698|NCT03300570|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1322699|NCT03300557||Single Group Assignment||Treatment||None (Open Label)||||||
1322700|NCT03300544||Single Group Assignment||Treatment||None (Open Label)||||||
1322701|NCT03300531|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1322702|NCT03300518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322703|NCT03300505||Single Group Assignment||Treatment||None (Open Label)||||||
1322704|NCT03300492||Single Group Assignment||Treatment||None (Open Label)||Prospective, single center, open-label, single arm study||||
1322705|NCT03300479|Randomized|Parallel Assignment||Treatment||None (Open Label)||After admission to the ICU the patients presenting with primary intracerebral hemorrhage are evaluated for enrollment. If systolic blood pressure is higher than 160 mmHg, the patient will be randomized in one of the two study groups and intravenous therapy with Cleviprex® or Ebrantil® will start immediately. Data of systemic haemodynamics will be collected continuously by online monitoring, starting at baseline and ending after 24h. If the target values are not attained within 30 minutes, the investigators can add or switch to alternative antihypertensive drugs of their choice. 24h after initiation of Cleviprex® or Ebrantil®, all patients receive Cardene® (standard care in daily clinical routine) for another 24h followed by orally administered antihypertensive medication.||||
1322706|NCT03300466|Randomized|Parallel Assignment||Treatment||Single||||||t
1322707|NCT03300453||Single Group Assignment||Treatment||None (Open Label)||||||
1322708|NCT03300440|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1322709|NCT03300427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322710|NCT03300414|||Cohort||Prospective|||||||
1322711|NCT03300401||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322712|NCT03300388|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1322713|NCT03300375|Randomized|Parallel Assignment||Treatment||Single|Permuted block randomization with block sizes of four will made by means of a computer algorithm to ensure balanced group sizes and allocation concealment.|Two group, parallel study|t|||
1322714|NCT03300362|Randomized|Parallel Assignment||Prevention||Single|Investigators recording clinical outcomes will also be blinded||t|||
1322715|NCT03300349|||Case-Control||Retrospective|||||||
1322716|NCT03300336|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Stepped Wedge Cluster Randomized Trial - a form of crossover design with unidirectional crossover (from control to experimental) but with randomization of when each cluster undertakes the transition. In the stepped wedge design, there is a staggered roll-out of the intervention, where the time and sequence of clusters that will start the intervention at each period determined by random allocation.||||
1322717|NCT03300323|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1322718|NCT03300310|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322719|NCT03300297|Randomized|Parallel Assignment||Treatment||Double|Participants will be blinded to group allocation. Blind assessors will be utilized to measure objective change in range of motion and pain pressure threshold.|Participants will be randomly assigned to one of two intervention groups. Both will receive intervention and one group will receive cervical spine thrust joint manipulation while the other receives sham manipulation.|t|||t
1322720|NCT03300284|||Cohort||Prospective|||||||
1322721|NCT03300271|Randomized|Parallel Assignment||Prevention||Double|A designated researcher will be responsible for the random allocation and mask the results, so the investigators and the outcomes assessor do know the which group the participants are been allocated in.|Participants will be randomly assigned to either the experimental conditions (mobile application), or the usual condition (education).|||t|t
1322722|NCT03300258|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322723|NCT03300245|||Cohort||Cross-Sectional|||||||
1322724|NCT03300232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322725|NCT03300219||Single Group Assignment||Treatment||None (Open Label)||||||
1322726|NCT03300206|||Cohort||Prospective|||||||
1322727|NCT03300193|||Cohort||Prospective|||||||
1322728|NCT03300180|Randomized|Parallel Assignment||Screening||Double|||t|||t
1322729|NCT03300167||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1322730|NCT03300154|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322731|NCT03300141|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1322774|NCT03299582|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||"The first part of this study is in healthy subjects, followed by breast cancer patients receiving paclitaxel to study the effect of limb hypothermia in the prevention of chemotherapy-induced neuropathy.~The second part of this study is to study the effect of cryocompression in the prevention of chemotherapy-induced neuropathy."||||
1322775|NCT03299569|||Case-Control||Other|||||||
1322776|NCT03299556|||Cohort||Prospective|||||||
1322777|NCT03299543|||Cohort||Prospective|||||||
1322778|NCT03299530|||Case-Only||Cross-Sectional|||||||
1322779|NCT03299517|Randomized|Sequential Assignment||Treatment||Double|||||t|t
1322780|NCT03299504|||Cohort||Retrospective|||||||
1322732|NCT03300128|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Participants will be randomized 1:1 into a treatment group (IY-ASD parent training program) or comparison group (Circle of Parents parent support program). The 14-week parent groups will be offered twice per year. Once participants are enrolled in the study, they will complete a set of baseline measures (described in Section 5). The study coordinator will provide Dr. Dababnah a complete list of participants (unique identifiers only which do not contain identifiable information). Dr. Dababnah will randomize participants using a computer-generated randomization plan into either IY-ASD or Circle of Parents support group. While participants and the research team will not be blinded to group assignment, only the PI and her Research Assistant(s) at UMB will have access to the randomization plan. Dr. Dababnah and her team will review baseline measures for each period after individuals have been randomized."||||
1322733|NCT03300115||Single Group Assignment||Treatment||None (Open Label)||||||
1322734|NCT03300102|||Cohort||Prospective|||||||
1322735|NCT03300089|Randomized|Parallel Assignment||Treatment||Single|Outcomes Assessor and statistician are blinded.|||||t
1322736|NCT03300076|||Other||Prospective|||||||
1322737|NCT03300063|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1322738|NCT03300050|Randomized|Parallel Assignment||Prevention||Triple|An unblinded pharmacist will prepare Dose 1 and Dose 2. Participants and study staff will remain blinded to their exact treatment group but will be unblinded to their overall group allocation (inpatient or outpatient).|Eligible enrolled subjects will be randomized to any of the treatment arms (LAIV-IIV, Groups 1, 2, and 3; or IIV-IIV, Groups 4 and 5) under one allocation sequence, stratified by site, to allow comparability between study groups, such as LAIV-IIV vs IIV-IIV regimens (Groups 1 vs 4). Groups 1-3 will be inpatient and receive either LAIV or placebo as nasal drops at Dose 1. Groups 4-5 ill be outpatient and receive either IIV or placebo as an injection at Dose 1.|t|t|t|
1322739|NCT03300037|||Cohort||Prospective|||||||
1322740|NCT03300024|Randomized|Parallel Assignment||Treatment||Single|The study will not be blinded because patient side blinding is expected to have minimal to no effect, while physician side blinding is impractical; and difficult to achieve due to the primary surgeon being the one usually who follows up on any intervention or treatment.|Patients will undergo surgery as per standard of care and receive the randomized graft in compliance to National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines for Arteriovenous graft creation. Surgeries will be elective in nature. The grafts will be placed either in the arm (brachial artery-axillary vein) or forearm (brachial artery to cephalic or suitably sized vein) based on anatomic suitability||||t
1322741|NCT03300011|Non-Randomized|Sequential Assignment||Other||Double|masking for Ultrasonic Cardiogram investigator||||t|t
1322742|NCT03299998|||Cohort||Retrospective|||||||
1322743|NCT03299985|Randomized|Parallel Assignment||Treatment||Double||double blinded randomized clinical trial|t||t|
1322744|NCT03299972|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1322745|NCT03299959|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-Label, adaptive design with interim analyses|Open-label Randomized Controlled Trial||||
1322746|NCT03299946||Single Group Assignment||Treatment||None (Open Label)||||||
1322747|NCT03299933||||||||||||
1322748|NCT03299920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322749|NCT03299907|||Other||Cross-Sectional|||||||
1322750|NCT03299894|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||"Patients will be prospectively included at Emergency Department triage during 2 consecutive 6-month periods (1-month wash-out interlude between the 2 inclusion periods):~First inclusion period: usual procedures for patient triage at Emergency Department admission and management of suspected or proven bacterial infection.~Second inclusion period: usual procedure for patient triage at Emergency Department admission PLUS routine calculation of qSOFA in all patients admitted to the Emergency Department with a suspected or proven bacterial infection. Patients with a qSOFA value ≥2 will be directly and immediately notified to Emergency Department physicians by triage nurses."||||
1322751|NCT03299881|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, adaptive parallel arm study||||
1322752|NCT03299868|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, Single institution, Open-label, Randomized, Phase 2||||
1322753|NCT03299855||Single Group Assignment||Other||Single||Passation of MMS and MoCA tests associated to passation of neuropsychological test|t|||
1322754|NCT03299842||Single Group Assignment||Treatment||None (Open Label)||ZX008-1503 Fenfluramine, open-label||||
1322755|NCT03299829|||Cohort||Retrospective|||||||
1322756|NCT03299816|Randomized|Parallel Assignment||Treatment||Single||Single center, randomized controlled trial with two parallel arms.||||t
1322757|NCT03299803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322758|NCT03299790|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322759|NCT03299777|||Cohort||Prospective|||||||
1322760|NCT03299764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322761|NCT03299751||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322762|NCT03299738||Single Group Assignment||Treatment||None (Open Label)||||||
1322763|NCT03299725||Single Group Assignment||Treatment||None (Open Label)||||||
1322764|NCT03299712||Single Group Assignment||Other||None (Open Label)||||||
1322765|NCT03299699|||Cohort||Prospective|||||||
1322766|NCT03299686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322767|NCT03299673|||Other||Prospective|||||||
1322768|NCT03299660||Single Group Assignment||Treatment||None (Open Label)||All participants will receive standard LCCRT treatment followed by 4 cycles of Avelumab followed by surgical resection||||
1322769|NCT03299647|||Case-Control||Cross-Sectional|||||||
1322770|NCT03299634|||Other||Cross-Sectional|||||||
1322771|NCT03299621|Non-Randomized|Single Group Assignment||Other||Single||||||t
1322772|NCT03299608|||Cohort||Prospective|||||||
1322773|NCT03299595|||Other||Cross-Sectional|||||||
1322781|NCT03299491|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1322782|NCT03299478|||Cohort||Prospective|||||||
1322783|NCT03299465||Single Group Assignment||Other||None (Open Label)||||||
1322824|NCT03298932|||Case-Only||Prospective|||||||
1322784|NCT03299452||Single Group Assignment||Treatment||None (Open Label)||This single center, open-label, single arm, non-randomized study is designed to evaluate safety, progression-free survival(PFS),overall survival (OS), objective response rate (OPR), and disease control rate (DCR) of chemotherapy or target therapy or chinese medicine based on the accelerated PDX model screening in subjects with advanced malignant tumor.||||
1322785|NCT03299439|Randomized|Parallel Assignment||Treatment||Single||||||t
1322786|NCT03299426|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1322787|NCT03299413||Single Group Assignment||Treatment||None (Open Label)||||||
1322788|NCT03299400||Single Group Assignment||Diagnostic||None (Open Label)||"All eligible patients who have given informed consent will attend the ophthalmology clinic for screening.~Patient will undergo general anaesthesia for prone spinal surgery. The degree of inclination was set prior to the start of the case and independently confirmed using a goniometer. Patients will be placed in the prone position on a Jackson Spine table.~Once positioned, the head is carefully placed on the GentleTouch prone positioning pillow of the appropriate size.~Patient will continue to wear the contact lens postoperatively for a total of 24 hours or until the patient cannot tolerate the contact lens. After removal of the contact lens sensor, the recorded profiles will be collected and visualized graphically on a computer interface. The output of the sensor expressed in voltage, and can be analysed in real time points corresponding to the intraoperative events."||||
1322789|NCT03299387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322790|NCT03299374|Randomized|Parallel Assignment||Other||Double|Participants are informed, so masking is not ensured Outcomes evaluator masked Physiotherapist none masked External adviser masked (randomization and data analysis)||t|||t
1322791|NCT03299361|||Case-Only||Prospective|||||||
1322792|NCT03299348|Randomized|Parallel Assignment||Basic Science||Triple|Study participants, group leaders, and outcomes assessors will not know the study objectives or hypotheses.|The study has an active treatment group and an active control group|t|t||t
1322793|NCT03299335|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1322794|NCT03299322|Randomized|Parallel Assignment||Treatment||Triple|This is a Double-blind Trial|All treatment group received a standard anti-asthma treatment plus Jia Wei Yang He Formula on study entry, and the control group received Jia Wei Yang He Formula placebo instead.|t|t|t|
1322795|NCT03299309||Single Group Assignment||Treatment||None (Open Label)||||||
1322796|NCT03299296|Randomized|Sequential Assignment||Prevention||Single||single blind, sequentially simple randomized controlled clinical trial|t|||
1322797|NCT03299283|||Cohort||Prospective|||||||
1322798|NCT03299270|||Cohort||Prospective|||||||
1322799|NCT03299257|Randomized|Parallel Assignment||Treatment||Triple|donepezil and placebo will be dispensed to volunteers in similar pills and numbered boxes.|Randomized, parallel groups, 30-day trial|t|t|t|
1322800|NCT03299244|Randomized|Parallel Assignment||Treatment||Quadruple|Subjects will be randomized by IVR/IWR in a 1:1 ratio to either TIW IV etelcalcetide (and daily oral placebo tablets) or daily oral cinacalcet tablets (and TIW IV placebo) in a double-blind, double-dummy manner. Treatment groups will be blinded to the investigator, subjects, and the Amgen study team.||t|t|t|t
1322801|NCT03299231|Randomized|Parallel Assignment||Treatment||Triple|Randomization carried by a third party not involved in the study.|Prospective, Parallel group (1:1), Randomized, double blind, sham controlled, single center.|t|t|t|
1322802|NCT03299218|Randomized|Factorial Assignment||Prevention||None (Open Label)||"Control Group~Cash-based transfers only by BISP~Cash-based transfers and enhanced behaviour change communication (BCC)~Cash-based transfer and SNF~Cash-based transfers, SNF and BCC"||||
1322803|NCT03299205||Single Group Assignment||Prevention||None (Open Label)||||||
1322804|NCT03299192|Randomized|Parallel Assignment||Treatment||Single|Research Specialists will be unaware of study group.|Comparison of Tai Chi to Health Education and to Usual Medical Care||||t
1322805|NCT03299179|||Case-Control||Prospective|||||||
1322806|NCT03299166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322807|NCT03299153|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1322808|NCT03299140||Single Group Assignment||Prevention||None (Open Label)||||||
1322809|NCT03299127|Randomized|Parallel Assignment||Treatment||None (Open Label)|self-report serves as outcomes, patients are not masked|randomized-controlled trial, wait-list control condition||||
1322810|NCT03299114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322811|NCT03299101||Single Group Assignment||Health Services Research||None (Open Label)||A novel a novel, multifaceted, home-based prehabilitation intervention designed to improve functional capacity and postoperative outcomes for frail Veterans anticipating cardiothoracic surgery. Prehabilitation will include: (a) aerobic conditioning; (b) strength and coordination training; (c) respiratory muscle training; and (d) nutritional coaching and supplementation.||||
1322812|NCT03299088|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322813|NCT03299075|||Cohort||Prospective|||||||
1322814|NCT03299062|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1322815|NCT03299049|Randomized|Parallel Assignment||Treatment||None (Open Label)|This will be an open-label study and therefore no blinding is required|Two groups of subjects will be randomized to receive CAB LA + RPV LA Q4W, or CAB LA + RPV LA Q8W regimen||||
1322816|NCT03299036||Single Group Assignment||Treatment||None (Open Label)||||||
1322817|NCT03299023|||Cohort||Prospective|||||||
1322818|NCT03299010|||Cohort||Retrospective|||||||
1322819|NCT03298997|Randomized|Parallel Assignment||Treatment||Triple|Blinding will exist at the level of the patient and the investigator who will record the data postoperatively, regarding the surgical technique applied. There will be no blinding at the level of the surgeon and the anesthesiologist.||t||t|t
1322820|NCT03298984||Single Group Assignment||Treatment||None (Open Label)||||||
1322821|NCT03298971|||Cohort||Cross-Sectional|||||||
1322822|NCT03298958|Randomized|Parallel Assignment||Treatment||Double|Double-blinded for study staff (investigator) and patient|"When it is determined that you are eligible for the study, you will be assigned by chance (like flipping a coin) to one of 2 study groups.~Sirolimus 0.5 mg/day for 2 years or until disease recurrence~Placebo"|t||t|
1322823|NCT03298945|Randomized|Parallel Assignment||Health Services Research||Single||Parallel groups||||t
1322825|NCT03298919|Randomized|Parallel Assignment||Treatment||Single||3-group design||||t
1322826|NCT03298906||Single Group Assignment||Other||None (Open Label)||||||
1322827|NCT03298893||Single Group Assignment||Treatment||None (Open Label)||||||
1322828|NCT03298880||Sequential Assignment||Other||None (Open Label)|Participants will not be able see manometer when using VAD Analysis of ECG traces will be blind to intervention as traces will be marked with a code, interventions carried out in random order and analysed in batches|Four repeated measures in each participant in random order||||
1322829|NCT03298867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322830|NCT03298854||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322831|NCT03298841|||Cohort||Retrospective|||||||
1322832|NCT03298828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322833|NCT03298815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322834|NCT03298802|Randomized|Parallel Assignment||Prevention||Triple|Randomization will be performed by a person not involved in the clinical trial using a computer random list of numbers generated using STATA (StataCorp 14.0, Dallas, TX). This list of random number assignments will be kept secure and sent directly to the investigational drug service (IDS), who will be responsible for the allocation and dispensing of the medications|double-blind randomized placebo controlled clinical trial|t|t|t|
1322835|NCT03298789|Randomized|Crossover Assignment||Basic Science||None (Open Label)||19 subjects will be devided into two groups. The first group will conduct the control condition on Saturday and the second group will conduct the experimental condition on Sunday. One week later, the subjects will undergo the second visit, each group of subjects performing the opposite condition.||||
1322836|NCT03298776|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1322837|NCT03298763|Randomized|Sequential Assignment||Treatment||Single||"Phase I:~Single centre, accelerated dose dose de-escalation design with a modified Bayesian continual reassessment method (mCRM) to estimate the recommended Phase II dose (RP2D) of MSCTRAIL in combination with pemetrexed/cisplatin chemotherapy.~Phase II:~Multicentre, randomised single blind placebo controlled trial comparing MSCTRAIL at the RP2D and pemetrexed/cisplatin chemotherapy versus pemetrexed/cisplatin chemotherapy alone."|t|||
1322838|NCT03298750||Single Group Assignment||Treatment||None (Open Label)||||||
1322839|NCT03298737|||Cohort||Prospective|||||||
1322840|NCT03298724||Single Group Assignment||Treatment||None (Open Label)||Single case experimental design (multiple baseline across setting)||||
1322841|NCT03298711|||Case-Only||Prospective|||||||
1322842|NCT03298698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322843|NCT03298685|||Other||Prospective|||||||
1322844|NCT03298672|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1322845|NCT03298659|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||1:1 randomization to (A) an active treatment arm with complete, iFR-guided revascularization of every noninfarct coronary lesion >50% and iFR ≤0.89; or (B) a deferred treatment arm, in which patients will undergo an adenosine stress perfusion CMR scan within 6 weeks after STEMI, with revascularization of the noninfarct coronary lesions with associated perfusion defects.||||
1322846|NCT03298646|Randomized|Parallel Assignment||Prevention||Single||||t||
1322847|NCT03298633|Randomized|Parallel Assignment||Treatment||None (Open Label)|The blinding method in out study is open-label in general. However, in order to avoid psychological effect for participants and unexpected drop-off, the trial is designed to inform participants their insemination method on the day of fresh embryo transfer or the day of embryo freezing. Prior to this, randomization will be strictly performed and keep secret to participants and clinicians.|Eligible patients that have provided informed consent will be randomized to either ICSI or conventional IVF. Randomization and allocation of patients to study groups will be performed on the day of oocyte retrieval. Stratified permuted block randomization will be centrally controlled by administrative staffs in the trial center, who are not involved in the treatment procedure. When there is an eligible participant to be enrolled into the study, nurses from the specific site will login the trial system to get allocation of patients according to a computer-generated randomization list in a 1:1 ratio, with a variable block size of 2, 4 or 8 and stratified by center.||||
1322848|NCT03298620|Randomized|Parallel Assignment||Prevention||Double|A dental team (dentist and dental hygienist) assessed the outcome measure at baseline and after the two months RCT trial. A neutral dentist implements the intervention after baseline registration. Toothbrushes used in the intervention period is hidden to the dental team during assessments at the end of the RCT period.|Randomized Clinical trial|||t|t
1322849|NCT03298607|Randomized|Parallel Assignment||Prevention||Quadruple|Placebo controlled|2 months treatment with (Food Supplement - Serelys PMS)|t|t|t|t
1322850|NCT03298594|Randomized|Parallel Assignment||Diagnostic||Single|The cervicograph of all participants will be reviewed by two assessors blinded to the study group. In order to be blinded, lines will be added to the cervicographs of the control group by a third party not involved in the evaluation|||||t
1322851|NCT03298581||Single Group Assignment||Treatment||None (Open Label)||Open label, single treatment arm study||||
1322852|NCT03298568||Single Group Assignment||Treatment||None (Open Label)||||||
1322853|NCT03298555|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1322854|NCT03298542|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1322855|NCT03298529|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1322856|NCT03298516|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322857|NCT03298503|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1322858|NCT03298490|||Case-Only||Prospective|||||||
1322859|NCT03298477||Single Group Assignment||Treatment||None (Open Label)||Prospective, multicenter, single arm study with consecutive, eligible subject enrollment at each site. All subjects will undergo the Endovascular Aneurysm repair procedure with the Nellix System. Sites have been chosen with a suitable research infrastructure and physician experience in endovascular aneurysm repair to ensure adequate enrollment. Subjects will be followed procedurally to discharge, at 30 days (primary safety endpoint), six months, one year (primary effectiveness endpoint) and annually thereafter to five years (total follow-up commitment).||||
1322860|NCT03298464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322861|NCT03298451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322862|NCT03298438|||Cohort||Prospective|||||||
1322863|NCT03298425|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1322864|NCT03298412||Single Group Assignment||Treatment||None (Open Label)||||||
1322865|NCT03298399|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1322866|NCT03298386|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322867|NCT03298373|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1322868|NCT03298360|||Other||Other|||||||
1322869|NCT03298347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322870|NCT03298334|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1322871|NCT03298321|||Cohort||Prospective|||||||
1322872|NCT03298308||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322873|NCT03298295||Single Group Assignment||Basic Science||None (Open Label)|The only person blinded in this study is the pathologist analyzing the tissue sections.|Non-diabetic patients scheduled for selective plastic surgery (abdominoplasty).||||
1322874|NCT03298282|||Cohort||Prospective|||||||
1322875|NCT03298269|Randomized|Parallel Assignment||Treatment||Single||||||t
1322876|NCT03298256|||Cohort||Prospective|||||||
1322877|NCT03298243|Randomized|Crossover Assignment||Basic Science||None (Open Label)||"Aim 1: Single-group cross-over study. Each participant will experience several different methods of applying vibrotactile feedback. On another day, each participant will also experience feedback applied to different body locations.~Aim 2: Single-group longitudinal study. Participants will practice reaching to locations in front of them using vibrotactile feedback to guide the precision of the movements. The tasks will be organized to slowly become more difficult as practice continues. Subjects will be asked to perform simulated tasks of daily living at the beginning or end of practice to test transfer of the vibrotactile training/learning."||||
1322878|NCT03298230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322879|NCT03298217||Single Group Assignment||Screening||None (Open Label)||||||
1322880|NCT03298204|||Case-Control||Retrospective|||||||
1322881|NCT03298191|Randomized|Parallel Assignment||Prevention||Single|false preterm labour|complications ofthe drugs good response to drugs|t|||
1322882|NCT03298178|||Cohort||Prospective|||||||
1322883|NCT03298165|Randomized|Parallel Assignment||Prevention||Single|outcome assessor the assessor will not be blind about the type of intervention/control assessment methods. however it will not be allowed amongst the examiners to exchange any information throughout the entire study period|||||t
1322884|NCT03298152|Randomized|Parallel Assignment||Treatment||Single|||t|||
1322885|NCT03298139||Single Group Assignment||Basic Science||||||||
1322886|NCT03298126|Randomized|Parallel Assignment||Other||Single|Randomization was carried out after written informed consent through SNOSE (Sequentially Numbered Opaque Sealed Envelopes) method to ensure allocation concealment. Patients were randomized into two groups for TR band removal i.e. Group 1 received protocol A which is currently in practice at AKUH and group 2 underwent protocol B developed by Cohen and Alfonso which is supported by literature. The techniques for protocol A and protocol B. Radial artery patency was determined at 24 hours by a trained resident doctor who was blinded to the protocol administered.|The parallel group, non-inferiority trial||||t
1322887|NCT03298113|Randomized|Parallel Assignment||Treatment||Single|Central reader|||||t
1322888|NCT03298100|||Cohort||Prospective|||||||
1322889|NCT03298087||Single Group Assignment||Treatment||None (Open Label)||Single arm Phase II clinical trial||||
1322890|NCT03298074|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1322891|NCT03298061||Single Group Assignment||Treatment||None (Open Label)||Subjects who participated in clinical study MEA115921 and require a dose of prednisolone (or equivalent) of >=5 mg/day for adequate control of their EGPA will be included in this study based on the confirmation of their eligibility by GSK Medical Monitor. Eligible subjects will receive subcutaneously administered mepolizumab at a dose of 300 mg SC every 4 weeks.||||
1322892|NCT03298048|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1322893|NCT03298035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322894|NCT03298022||Single Group Assignment||Treatment||None (Open Label)||||||
1322895|NCT03298009|Randomized|Crossover Assignment||Basic Science||Double||Placebo-controlled, double-blind, randomized crossover 2-week intervention study.|t|||t
1322896|NCT03297996|||Case-Control||Prospective|||||||
1322897|NCT03297983|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1322898|NCT03297970|||Cohort||Prospective|||||||
1322899|NCT03297957||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322900|NCT03297944|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1322901|NCT03297931|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1322902|NCT03297918|Randomized|Parallel Assignment||Treatment||Single|randomised|Interventional, single-center, randomised clinical trial|t|||
1322903|NCT03297905|Randomized|Sequential Assignment||Treatment||None (Open Label)||Sequential Multiple Assignment Randomized Trial (SMART)||||
1322904|NCT03297892|||Cohort||Prospective|||||||
1322905|NCT03297879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322906|NCT03297866|||Cohort||Cross-Sectional|||||||
1322907|NCT03297853|||Other||Retrospective|||||||
1322908|NCT03297840|||Other||Other|||||||
1322909|NCT03297827|||Cohort||Prospective|||||||
1322910|NCT03297814|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1322911|NCT03297801|||Cohort||Prospective|||||||
1322912|NCT03297788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322913|NCT03297775|||Cohort||Prospective|||||||
1322914|NCT03297762|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322915|NCT03297749|||Case-Control||Cross-Sectional|||||||
1322916|NCT03297736|Randomized|Parallel Assignment||Device Feasibility||Single|||t|||
1322917|NCT03297723|||Cohort||Prospective|||||||
1322918|NCT03297710||Single Group Assignment||Treatment||None (Open Label)||||||
1322919|NCT03297697|||Cohort||Prospective|||||||
1322920|NCT03297684|||Case-Only||Prospective|||||||
1322921|NCT03297671|||Cohort||Prospective|||||||
1322922|NCT03297658|Randomized|Parallel Assignment||Supportive Care||Triple||"All subjects will have electro-acupuncture pads applied at four points bilaterally: pericardial 4 (PC 4), pericardial 6 (PC 6), large intestine 4 (LI 4) and stomach 36 (ST 36). No needles will be used. (Appendix A; 1)~Group 1: Receive electro-acupuncture (EA) (treatment) frequency will be at 2Hz and 100 Hz the amplitude will be microA.~Group 2: Receive sham (control) will not have stimulation."|t|t|t|
1322923|NCT03297645|Randomized|Parallel Assignment||Prevention||Single||||||t
1322924|NCT03297632|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1322925|NCT03297619|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomly assigned to one of two active self-help interventions for the duration of the study.||||
1322926|NCT03297606|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322927|NCT03297593||Single Group Assignment||Treatment||None (Open Label)||Prospective single-stage single-arm multicenter phase II trial.||||
1322928|NCT03297580|||Cohort||Prospective|||||||
1322929|NCT03297567|Randomized|Parallel Assignment||Prevention||Double|Investigations of the level of physical activity, functional outcome, peripheral muscle strength and clinical complications will be performed by a blind investigator. Data analysis will be performed by a blind investigator in the control and intervention groups.|The patients will be randomized into two groups: intervention and control. The intervention group will receive verbal guidance and a booklet developed by the authors on the deleterious effects of hospitalization and the importance of staying active during hospital admission on the day they are included in the study. The control group will not receive any type of intervention, nor even verbal guidance.|||t|t
1322930|NCT03297554||Single Group Assignment||Treatment||None (Open Label)||||||
1322931|NCT03297541||Single Group Assignment||Treatment||None (Open Label)||||||
1322932|NCT03297528|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1322933|NCT03297515|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1322934|NCT03297502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1322935|NCT03297489||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322936|NCT03297476|||Cohort||Prospective|||||||
1322937|NCT03297463|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1322938|NCT03297450|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1322939|NCT03297437|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1322940|NCT03297424||Single Group Assignment||Treatment||None (Open Label)||||||
1322941|NCT03297411|Randomized|Crossover Assignment||Treatment||Double|Both participants and the outcome assessor will be blinded.|Each participant will be randomly allocated to a sequence of treatments using designs for crossover studies with fewer periods (3) than treatments (4) involving two sets of ECT electrode placements and two sets of pulse width.|t|||t
1322942|NCT03297398|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1322943|NCT03297385||Single Group Assignment||Treatment||None (Open Label)||A phase II prospective single-arm analysis. With a power of 80% to detect an expected reduction in positive surgical margin rate from 34% to 17% we will have to included 55 men. For the AR/DNA interaction patients will serve as there own control since biopsies will be taken before and after enzalutamide treatment.||||
1322944|NCT03297372||Single Group Assignment||Treatment||None (Open Label)||||||
1322945|NCT03297359||Single Group Assignment||Treatment||None (Open Label)||||||
1322946|NCT03297346||Single Group Assignment||Prevention||None (Open Label)||||||
1322947|NCT03297333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322948|NCT03297320|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Healthcare teams in Internal Medicine at London Health Sciences Centre will be asked if they have any patients that need further goals of care discussions or ACP.~A random selection of Internal Medicine patients will also be selected for further indepth conversations related to goals of care discussions or ACP"||||
1322949|NCT03297307|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a prospective intervention study of female bariatric surgical patients and their children. The dyads, consisting of one female bariatric patients and one child living in the home, will be enrolled in the study. Half of the children will attend the dietary, physical activity, and psychological counseling with the mother prior to her surgery, and the other half of the children will not receive the behavioral intervention. Outcomes from each mother-child dyad will be measured at baseline, and 3 and 6 months postoperatively||||
1322950|NCT03297294|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1322951|NCT03297281|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322952|NCT03297268|||Family-Based||Cross-Sectional|||||||
1322953|NCT03297255|||Cohort||Prospective|||||||
1322954|NCT03297242|||Case-Only||Retrospective|||||||
1322955|NCT03297229|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1322956|NCT03297216|Randomized|Parallel Assignment||Prevention||Triple||Phase III, double-masked, placebo-controlled, randomized controlled trial|t|t|t|
1322957|NCT03297203|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322958|NCT03297190|Randomized|Factorial Assignment||Prevention||None (Open Label)||Four arms: (1) SMS only; (2) SMS + interpersonal; (3) interpersonal only; (4) none||||
1322959|NCT03297177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1322960|NCT03297164|||Cohort||Prospective|||||||
1322961|NCT03297151|Randomized|Factorial Assignment||Basic Science||Double|Double blind (participant and investigator)|Block randomised, between group study|t||t|
1322962|NCT03297138|||Cohort||Retrospective|||||||
1322963|NCT03297125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Device: NovoCure-TTF-200A~How TTFields works:~Adhesive bandages hold insulated ceramic discs (transducer arrays) that deliver electricity transformed into electromagnetic energy to the scalp. The battery operated-TTF device generates low intensity, intermediate frequency, alternating electrical fields to the brain. These electrical fields exert selective toxicity in proliferating cells thereby halting cell division and destroying the cancer cells."||||
1322964|NCT03297112||Single Group Assignment||Diagnostic||None (Open Label)||||||
1322965|NCT03297099|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1573447|NCT00001188||||Treatment||||||||
1322966|NCT03297086|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1322967|NCT03297073|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1322968|NCT03297060|Randomized|Crossover Assignment||Health Services Research||Single|Participants will not know which arm their institution has been assigned to.|This study utilizes a stepped wedge design.|t|||
1322969|NCT03297047|Randomized|Parallel Assignment||Treatment||None (Open Label)||one Group with upper arm cast one Group with forearm cast||||
1322970|NCT03297034|||Cohort||Prospective|||||||
1322971|NCT03297021|Randomized|Factorial Assignment||Prevention||Triple|Random allocation by opaque envelope and random number generator. Investigator will draw up study medication and give to care-providers. Outcome assessor not present for drawing up of medications.||t|t||t
1322972|NCT03297008|||Cohort||Cross-Sectional|||||||
1322973|NCT03296995||Single Group Assignment||Screening||None (Open Label)||||||
1322974|NCT03296982|||Cohort||Prospective|||||||
1322975|NCT03296969|Randomized|Parallel Assignment||Prevention||Single|||t|||
1322976|NCT03296956|Randomized|Parallel Assignment||Prevention||Quadruple|all are blinded|one arm receives Motherwell and one arm receives placebo; randomized double blind The supplement is expected to prevent depressed mood induction during postpartum blues whereas the placebo is not. The effect of depressed mood induction is strong during postpartum blues in 75% to 95% of mothers (who do not take Motherwell).|t|t|t|t
1322977|NCT03296943|Randomized|Crossover Assignment||Treatment||Quadruple|The containers for essential oil and perfume are identical dark-glass tubes with a roll-on-cap on top and double-covered with a plain cap on each tube.||t|t|t|t
1322978|NCT03296930|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1322979|NCT03296917|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1322980|NCT03296904||Single Group Assignment||Treatment||None (Open Label)||||||
1322981|NCT03296891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1322982|NCT03296878|Randomized|Factorial Assignment||Other||None (Open Label)||This study will utilize a three factor design, with one between-subject factor and two within-subject factors. The between-subject factor is participation in a federal food assistance program. The within-subject factors are price change condition and price change scenario.||||
1322983|NCT03296865|Non-Randomized|Crossover Assignment||Treatment||Triple|Children and the person that performed the evaluation were blind only to KT and placebo conditions, since they did not know if KT was tensioned were not. The person that performed data analysis was blind to all conditions.|We used a blinded and repeated-measure design, with the application of a placebo condition|t||t|t
1322984|NCT03296852||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1322985|NCT03296826|||Cohort||Retrospective|||||||
1322986|NCT03296813|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will be a randomized, unblinded, two-arm, multi-center clinical trial of patients with heart failure who are hospitalized. Patients will be randomized 1:1 to either oral torsemide OR oral furosemide prior to hospital discharge.||||
1322987|NCT03296800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1322988|NCT03296787|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322989|NCT03296774|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1322990|NCT03296761|||Cohort||Retrospective|||||||
1322991|NCT03296748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||female patients with stress urinary incontinence and asymptomatic grade II anterior vaginal wall prolapse were divided into Group A: treated only with trans-obturator tape (TOT) and group B where` TOT was associated with anterior colporrhaphy .||||
1322992|NCT03296735|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1322993|NCT03296722|Randomized|Parallel Assignment||Treatment||Single|||||t|
1322994|NCT03296709|Randomized|Parallel Assignment||Treatment||None (Open Label)||Split mouth design||||
1322995|NCT03296696|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Bayesian logistic regression model||||
1322996|NCT03296683||Single Group Assignment||Screening||None (Open Label)||||||
1322997|NCT03296670|Randomized|Parallel Assignment||Treatment||Single||||||t
1322998|NCT03296657||Single Group Assignment||Basic Science||None (Open Label)||subject will brush twice a day for 2 weeks with stannous fluoride paste for at least 1 minute||||
1322999|NCT03296644|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1323000|NCT03296631|||Cohort||Prospective|||||||
1323001|NCT03296618||Single Group Assignment||Treatment||None (Open Label)||||||
1323002|NCT03296605|||Case-Control||Prospective|||||||
1323003|NCT03296592|||Cohort||Prospective|||||||
1323004|NCT03296579|Randomized|Parallel Assignment||Treatment||None (Open Label)|It is not possible to use non-invasive face masks on the control patients so the study is unblinded.|||||
1323005|NCT03296566|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1323006|NCT03296553|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1323007|NCT03296540|Randomized|Parallel Assignment||Treatment||None (Open Label)||Crushed versus uncrushed tablets Prasugrel loading dose||||
1323008|NCT03296527|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1323009|NCT03296514|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1323010|NCT03296501||Single Group Assignment||Treatment||None (Open Label)||||||
1323011|NCT03296488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323012|NCT03296475||Single Group Assignment||Basic Science||None (Open Label)||A single arm prospective cohort study||||
1323013|NCT03296462|Randomized|Parallel Assignment||Treatment||Double|Patient and research assistant are blind to next allocation. Outcome assessors (physiotherapist and exercise physiologist) and one investigator are blinded to group of allocation. Statistician will be masked to group of allocation.||||t|t
1323014|NCT03296449|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1323015|NCT03296436||Single Group Assignment||Treatment||None (Open Label)||||||
1323016|NCT03296423|Randomized|Parallel Assignment||Prevention||Quadruple||Patients vaccinated with placebo or BCG|t|t|t|t
1323017|NCT03296410|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1323018|NCT03296397|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1323019|NCT03296384|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323020|NCT03296371||||||||||||
1323021|NCT03296358|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1323022|NCT03296345|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323023|NCT03296332|||Ecologic or Community||Prospective|||||||
1323024|NCT03296319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323025|NCT03296306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323026|NCT03296293|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323027|NCT03296280|||Cohort||Prospective|||||||
1323028|NCT03296267||Single Group Assignment||Basic Science||||||||
1323029|NCT03296254|Randomized|Crossover Assignment||Treatment||Double||It is a 2-sequence, 2-period, 2-treatment crossover design with sequences AB and BA|||t|t
1323030|NCT03296241|Randomized|Parallel Assignment||Treatment||Double|Patients are unaware of the assignment. Both groups were treated according to the IncontiLaseTM clinical treatment protocol for SUI with non-ablative thermal-only Er:YAG laser, except that there was no energy output when treating the sham group.|Patients assigned randomly to two groups: laser-treatment group and sham (control) group|t|||t
1323031|NCT03296228|||Cohort||Prospective|||||||
1323032|NCT03296215|||Cohort||Prospective|||||||
1323033|NCT03296202|||Cohort||Prospective|||||||
1323034|NCT03296189|Randomized|Parallel Assignment||Prevention||Triple|10 mls of solution will be handed to operating surgeon by the scrub nurse. The nurse will be the only person aware of the solution content and it will be documented discreetly. The operating surgeon, the investigator and the patients will not be aware of the solution used.|Three arm double-blinded prospective randomised controlled trial|t|t|t|
1323035|NCT03296176|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323036|NCT03296163|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323037|NCT03296150|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323038|NCT03296137||Single Group Assignment||Treatment||None (Open Label)||||||
1323039|NCT03296124|||Cohort||Retrospective|||||||
1323040|NCT03296111|||Case-Only||Cross-Sectional|||||||
1323041|NCT03296098||Single Group Assignment||Other||None (Open Label)||||||
1323042|NCT03296085|||Cohort||Prospective|||||||
1323043|NCT03296072|Randomized|Crossover Assignment||Treatment||Double|"Laboratory sample analyst will be blinded to treatment received. All study products will be overwrapped to conceal any labelling.~The dispensing staff will not be involved in any clinical assessments or laboratory analysis during the study. Dental examiner will also be blinded to the treatment received."||||t|t
1323044|NCT03296059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323045|NCT03296046|||Cohort||Cross-Sectional|||||||
1323046|NCT03296033|Randomized|Parallel Assignment||Basic Science||None (Open Label)||After consenting to the study, patients will be randomized to one of two groups.||||
1323047|NCT03296020|Randomized|Parallel Assignment||Other||None (Open Label)||randomized clinical trials that included 2 armes: the control group and the case group||||
1323048|NCT03296007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323049|NCT03295994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323050|NCT03295981|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial|t|||
1323051|NCT03295968|Randomized|Crossover Assignment||Basic Science||Single|Water control and ibuprofen solution contained 0.8 g of Sucralose (Heartland Food Products Group, Amsterdam, HP, Netherlands) and 1.2 g of orange flavored Kool-Aid (Kraft Foods, Northfield, IL, United States) to mask the taste of the Motrin solution. To match sweetness and calorie content of the ibuprofen Motrin drink, the water control also contained 6 mL high fructose corn syrup (ACH Food Companies, Mississauga, ON, Canada).|Fifteen normal-weight boys (aged 13-18y) were randomly assigned in a crossover design to four sessions: 1) Water + Rest; 2) Rest + ibuprofen; 3) Water + high intensity exercise; 4) high intensity exercise + ibuprofen. High intensity exercise consisted of three 10min bouts of high intensity exercise at 75% VO2peak at 60-70RPM with 1:30min active rest interposed. IBU was given in a 300mg liquid solution. EI, visual analog scale ratings and plasma biomarkers of appetite, inflammation, stress and glucose control were measured.|t|||
1323052|NCT03295955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323053|NCT03295942||Single Group Assignment||Treatment||None (Open Label)||OMP-336B11||||
1323054|NCT03295929|||Other||Retrospective|||||||
1323055|NCT03295916||Single Group Assignment||Treatment||None (Open Label)||||||
1323056|NCT03295903|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1323057|NCT03295890|Non-Randomized|Crossover Assignment||Treatment||Double|||t|||t
1323058|NCT03295877|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1323059|NCT03295864|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1323060|NCT03295851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323061|NCT03295838||Single Group Assignment||Treatment||None (Open Label)||Patients were selected using a research protocol with defined criteria, all patients that were intended to treat in the Mentalization-based Treatment program were followed over 18 months and assessed for primary and secondary outcomes.||||
1323062|NCT03295825||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323063|NCT03295812|||Cohort||Prospective|||||||
1323064|NCT03295799|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1323065|NCT03295786|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind|Randomised, Double-Blind, Placebo Controlled|t|t|t|t
1323066|NCT03295773|||Case-Only||Prospective|||||||
1323067|NCT03295760|||Case-Crossover||Retrospective|||||||
1323068|NCT03295747||Single Group Assignment||Treatment||None (Open Label)||||||
1323069|NCT03295734|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1323070|NCT03295721|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1323071|NCT03295708|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573448|NCT00001173||||||||||||
1323072|NCT03295695||Single Group Assignment||Supportive Care||None (Open Label)||||||
1323073|NCT03295682|||Other||Prospective|||||||
1323074|NCT03295669|||Other||Prospective|||||||
1323075|NCT03295656||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323076|NCT03295643||Single Group Assignment||Other||None (Open Label)||All subjects experience same program||||
1323077|NCT03295630|||Cohort||Prospective|||||||
1323078|NCT03295617|||Cohort||Retrospective|||||||
1323079|NCT03295604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323080|NCT03295591|||Cohort||Prospective|||||||
1323081|NCT03295578|Randomized|Parallel Assignment||Prevention||Double|Participants will be assigned to the personalised feedback group or generic feedback group (control) by an independent researcher that is not involved in the study. Assignment will be random and balanced for gender and age. To avoid subjects being aware of the group they are in, both groups will receive some sort of feedback, either generic or personalised. Subjects will be informed that they should not discuss their feedback with other study participants.|Randomized controlled trial with two parallel arms.|t||t|
1323082|NCT03295565|Randomized|Sequential Assignment||Treatment||None (Open Label)||randomized, open label, Phase IIB trial||||
1323083|NCT03295552||Single Group Assignment||Treatment||None (Open Label)||||||
1323084|NCT03295539||Single Group Assignment||Treatment||None (Open Label)||||||
1323085|NCT03295526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323086|NCT03295513|Randomized|Parallel Assignment||Supportive Care||Double||Patient will receive a restoration with superior function, esthetics, and quality.|t|||t
1323087|NCT03295500|||Other||Prospective|||||||
1323088|NCT03295487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323089|NCT03295474|||Cohort||Prospective|||||||
1323090|NCT03295461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323091|NCT03295448|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1323092|NCT03295435|||Cohort||Cross-Sectional|||||||
1323093|NCT03295422|Randomized|Parallel Assignment||Treatment||Single||||||t
1323094|NCT03295409|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1323095|NCT03295396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1323096|NCT03295383|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323097|NCT03295370|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1323098|NCT03295357|||Other||Retrospective|||||||
1323099|NCT03295344|||Other||Prospective|||||||
1323100|NCT03295331|||Case-Only||Retrospective|||||||
1323101|NCT03295318|Randomized|Parallel Assignment||Prevention||Quadruple|"Observer blind wherein the pharmacist and other study staff involved in vaccine administration will be aware of the treatment allocation.~The other study staff involved in safety assessments will be masked to treatment arm. The laboratory involved in immunogenicity analysis will also be blinded to the treatment allocation."||t|t|t|t
1323102|NCT03295305|Randomized|Parallel Assignment||Treatment||Single||||||t
1323103|NCT03295292|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323104|NCT03295279|||Cohort||Retrospective|||||||
1323105|NCT03295266|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323106|NCT03295253||Single Group Assignment||Treatment||None (Open Label)||||||
1323107|NCT03295240||Single Group Assignment||Treatment||None (Open Label)||||||
1323108|NCT03295227||Single Group Assignment||Treatment||None (Open Label)||||||
1323109|NCT03295214|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1323110|NCT03295201|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1323111|NCT03295188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323112|NCT03295175|||Cohort||Prospective|||||||
1323113|NCT03295162|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323114|NCT03295149|||Cohort||Prospective|||||||
1323115|NCT03295136||Single Group Assignment||Prevention||None (Open Label)||This study includes a pre/post study.||||
1323116|NCT03295123|||Case-Only||Prospective|||||||
1323117|NCT03295110|Randomized|Parallel Assignment||Prevention||Single||||||t
1323118|NCT03295097||Single Group Assignment||Supportive Care||None (Open Label)||||||
1323119|NCT03295084|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Open labelled study with enrollment in the order of confirmation of eligibility. Escalating doses of study drug in sequential patient cohorts for identification of DLT and MTD (Phase 1)||||
1323120|NCT03295071|||Cohort||Cross-Sectional|||||||
1323121|NCT03295058|Randomized|Single Group Assignment||Treatment||None (Open Label)||severe aplastic anemia patients will receive two different conditioning regimens before doing allogenic stem cell transplantation||||
1323122|NCT03295045|||Cohort||Prospective|||||||
1323123|NCT03295032|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Part 1: Randomised Controlled Trial with an intervention (ACT group) and Waiting List Control arm.~Part 2: Interviews"||||
1323124|NCT03295019|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1323125|NCT03295006|||Other||Retrospective|||||||
1323126|NCT03294993||Single Group Assignment||Screening||None (Open Label)||Doppler Ultrasonography Assessed Vascular Changes Before and After Radial Artery Puncture||||
1323127|NCT03294980|||Cohort||Prospective|||||||
1323128|NCT03294967|Randomized|Crossover Assignment||Diagnostic||Single|Participants will not see the label of the capsule.|This will be a crossover study. Each subject is required to consume 200mg caffeine capsule and 200IU vitamin E control capsule, as control, in two different visits. The two visits will be randomized, with a washout period of at least one week.|t|||
1323129|NCT03294954||Single Group Assignment||Treatment||None (Open Label)||||||
1323130|NCT03294941||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323131|NCT03294928||Single Group Assignment||Other||None (Open Label)||||||
1323132|NCT03294915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323133|NCT03294902|||Cohort||Prospective|||||||
1323134|NCT03294889||Single Group Assignment||Treatment||None (Open Label)||||||
1323135|NCT03294876|||Cohort||Prospective|||||||
1323136|NCT03294863|Randomized|Factorial Assignment||Other||Single||Each subject receives both types of interventions upon the same scar in order for comparison.||||t
1323137|NCT03294850|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1323138|NCT03294837|||Case-Only||Other|||||||
1323139|NCT03294824|||Case-Control||Prospective|||||||
1323140|NCT03294811|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1323141|NCT03294798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323142|NCT03294785|Randomized|Parallel Assignment||Treatment||Single||||||t
1323143|NCT03294772|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1323144|NCT03294759|Randomized|Parallel Assignment||Treatment||Double|Bone marrow aspirate will be collected through the surgical site from the distal femur with a trocar designed for this purpose. Therefore patients will be unable to determine if they have had stem cells harvested|"ACL harvested for autograft reconstruction of the ACL with either hamstring or patellar tendon grafts. The graft will be wrapped in a collagen wrap and injection with aspirate from the patient's bone marrow.~The control group will have standard ACL reconstruction with either hamstring or patellar tendon grafts."|t|||t
1323145|NCT03294746||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323146|NCT03294733||Single Group Assignment||Diagnostic||None (Open Label)||ultrasound carpal tunnel size on subjects||||
1323147|NCT03294720||Single Group Assignment||Treatment||None (Open Label)||Normal ACL reconstruction with either patellar or hamstring autograft will be done and prior to fixation the graft will be wrapped in a amion collagen wrap. Bone marrow aspirate will be obtained from distal femur at the time of the arthroscopy and stem cells isolated using the Arthrex Angel System. These stem cells with be under direct visualization impregnated into the ACL autograft amion wrap complex.||||
1323148|NCT03294707|Randomized|Parallel Assignment||Treatment||Quadruple|Subjects will be randomized with an overall ratio of 3:1 to AG10: placebo within each cohort||t|t|t|t
1323149|NCT03294694|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323150|NCT03294681|||Cohort||Prospective|||||||
1323151|NCT03294668|Randomized|Parallel Assignment||Treatment||Double|The Assessor is blind to the participant's allocation to the intervention and active control group.|The participants will be randomly allocated into an intervention group (KONTAKT Australia) and an active control group (Social cooking group).|||t|t
1323152|NCT03294655|Randomized|Parallel Assignment||Treatment||Single|only the post test assessor will be blinded to condition, as participants will know which condition they are assigned to|pre-post experimental design, 60 adults aged 50+ will be randomized to either a no-contact control or intervention condition||||t
1323153|NCT03294642|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1323154|NCT03294629|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1323155|NCT03294616|Non-Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1323156|NCT03294603||Single Group Assignment||Treatment||None (Open Label)||||||
1323157|NCT03294590|Randomized|Parallel Assignment||Prevention||Double|Outcome Assessors and Oral Health Examiners will be blind to treatment condition.|||t||t
1323158|NCT03294577|Randomized|Parallel Assignment||Supportive Care||Triple|During Phase 3 Only: Plinabulin and pegfilgrastim are each masked using a double-dummy design. Docetaxel/Doxorubicin/Cyclophasphamide administration is not masked.||t|t|t|
1323159|NCT03294564|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1323160|NCT03294551|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1323161|NCT03294538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323162|NCT03294525|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1323163|NCT03294512||Single Group Assignment||Other||None (Open Label)||||||
1323164|NCT03294499|||Other||Prospective|||||||
1323165|NCT03294486||Sequential Assignment||Treatment||None (Open Label)||"Phase 1 :~Dose-escalation trial using an accelerated titration 3+3 design. Eligible patients will first be consecutively enrolled in a one-patient cohort at lowest dose level and then in 3-patients cohorts up to a DLT observation. All patients within a given cohort will be treated with the same dose schedule of TG6002. Following the 1st and 2nd infusion of TG6002 patients will be given oral 5-FC for 3 days starting on Day 5 and 12 and ending on Day 7 and 14, respectively. Following the 3rd infusion of TG6002 on Day 15, patients will be given oral 5-FC for 21 days starting on Day 19 and ending on Day 39 (end of treatment).~Phase 2a Patients will be treated IV at the Recommended Phase 2 dose (RP2D)."||||
1323166|NCT03294473|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1323167|NCT03294460|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1323168|NCT03294447||Single Group Assignment||Treatment||None (Open Label)||||||
1323169|NCT03294434|||Cohort||Prospective|||||||
1323170|NCT03294421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323171|NCT03294408||Single Group Assignment||Prevention||None (Open Label)||Interventional study among patients suffering from knee osteoarthritis for at least six months. All the patients will benefit from a multimodal imaging and clinical assessment.||||
1323172|NCT03294395|Randomized|Parallel Assignment||Treatment||Quadruple|All participants receive either intramuscular treatment and oral placebo or intramuscular placebo and oral treatment. Both particpant and care provider are blind to the regimen.|A double-blind randomized clinical trial with non-inferiority design|t|t|t|t
1323173|NCT03294382|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1323174|NCT03294369|||Cohort||Prospective|||||||
1323175|NCT03294356|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323176|NCT03294343|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1323177|NCT03294330||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323178|NCT03294317|||Cohort||Prospective|||||||
1323179|NCT03294304||Single Group Assignment||Treatment||None (Open Label)||||||
1323180|NCT03294291|Randomized|Parallel Assignment||Treatment||Double||All Children will be randomly assigned to one of 2 groups of 25 patients each using a computer-generated number table.|t|||t
1323181|NCT03294278|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1573449|NCT00001169||||||||||||
1323182|NCT03294265|Randomized|Parallel Assignment||Prevention||None (Open Label)||Non-probabilistic sampling, by convenience (for the leaders). Randomization was performed by random stratified sampling, for which we considered age, sex and metabolic parameters (HbA1c, tryglycerides, blood pressure and body-mass index) of every patient in its fourth visit||||
1323183|NCT03294252||Single Group Assignment||Treatment||None (Open Label)||||||
1323184|NCT03294239|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323185|NCT03294226|Randomized|Parallel Assignment||Other||Single|||t|||
1323186|NCT03294213|||Cohort||Prospective|||||||
1323187|NCT03294200||Single Group Assignment||Treatment||None (Open Label)||||||
1323188|NCT03294187|Randomized|Parallel Assignment||Treatment||Single||||||t
1323189|NCT03294174|||Case-Control||Prospective|||||||
1323190|NCT03294161|Randomized|Parallel Assignment||Treatment||Single||||||t
1323191|NCT03294148|Randomized|Parallel Assignment||Treatment||Single|Researchers will not know which treatment the participants will be receiving (placebo or psychotherapy).|Participants will be randomized to one of two different studies: a placebo vs. waitlist study or a psychotherapy vs. waitlist study, with randomization stratified on pain intensity, age, gender, and opioid use. After an eligibility session, eligible participants will be randomized to the treatment group or the waitlist group (with a ratio of 2:1 treatment:waitlist), using a computer-generated random sequence. This scheme will result in three equally sized groups—placebo, psychotherapy, and waitlist—as the investigators will collapse data from the waitlist arms in the two studies for analyses. The investigators do not use a standard three-way randomization because the investigators do not want placebo participants to think they are in a control condition. Thus, the investigators constrain participant's expectations to either injection vs. waitlist or to psychotherapy vs. waitlist.||||t
1323192|NCT03294135|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||All subjects will come to the yearly scheduled blood draw visit for investigation of 11 to 15 year persistence of Neutralization Test (NT) titres. Subjects who have an NT titre below 10 at one of the scheduled visits will receive a second booster dose 6 months after this visit at an unscheduled visit. Subsequent data of these subjects will be analysed separately in a subgroup.||||
1323193|NCT03294122|||Cohort||Prospective|||||||
1323194|NCT03294109|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1323195|NCT03294096|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1323196|NCT03294083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323197|NCT03294070||Single Group Assignment||Treatment||None (Open Label)||||||
1323198|NCT03294057|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Parallel Assignment||||
1323199|NCT03294044|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|No masking|Parallel Assignment||||
1323200|NCT03294031|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1323201|NCT03294018|||Case-Only||Prospective|||||||
1323202|NCT03294005|||Other||Retrospective|||||||
1323203|NCT03293992|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323204|NCT03293979|||Cohort||Prospective|||||||
1323205|NCT03293966|||Cohort||Prospective|||||||
1323206|NCT03293953|||Cohort||Prospective|||||||
1323207|NCT03293940|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1323208|NCT03293927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323209|NCT03293914|Randomized|Parallel Assignment||Treatment||None (Open Label)|This is an implementation trial being conducted in a real-world clinical setting in which masking is not appropriate.|||||
1323210|NCT03293901|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1323211|NCT03293888|||Case-Only||Prospective|||||||
1323212|NCT03293875|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Quasi experimental design repeated time series analysis||||
1323213|NCT03293862|Randomized|Parallel Assignment||Prevention||Single||Group A (suture only) and Group B (prophylactic mesh).||t||
1323214|NCT03293849|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323215|NCT03293836|Randomized|Parallel Assignment||Treatment||Single||||||t
1323216|NCT03293823|Randomized|Parallel Assignment||Prevention||Single|Participants will not be informed whether it is an intervention or control group; instead they will be informed they will receive a computerized cognitive intervention.|6-week cognitive training group vs. an active control group|t|||
1323217|NCT03293810|||Other||Prospective|||||||
1323218|NCT03293797||Single Group Assignment||Treatment||None (Open Label)||||||
1323219|NCT03293784|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323220|NCT03293771|||Other||Other|||||||
1323221|NCT03293758|||Cohort||Prospective|||||||
1323222|NCT03293745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323223|NCT03293732|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1323224|NCT03293719|||Cohort||Prospective|||||||
1323225|NCT03293706|Randomized|Crossover Assignment||Other||Single|||t|||
1323226|NCT03293693|Non-Randomized|Crossover Assignment||Basic Science||Triple||Intervention With cross-over design. Three test meals will be tested.|t||t|t
1323227|NCT03293680||Single Group Assignment||Treatment||None (Open Label)||||||
1323228|NCT03293667||Single Group Assignment||Basic Science||None (Open Label)||||||
1323229|NCT03293654|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1323230|NCT03293641|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Controlled Pilot Trial in which children aged 6 months to less than 13 years were randomized on a ration of 1:1 to receive the Zinc plus Standard of Care versus Standard of Care Management for Sickle Cell Disease||||
1323270|NCT03293121|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1323271|NCT03293108|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323272|NCT03293095|||Cohort||Cross-Sectional|||||||
1323273|NCT03293082|||Cohort||Cross-Sectional|||||||
1323274|NCT03293069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323423|NCT03291132||Single Group Assignment||Health Services Research||||||||
1323231|NCT03293628|Randomized|Parallel Assignment||Treatment||Single|The allocation of patients to one group or another was only known moments before the surgical procedure was started.|Patients were allocated in two arms (50 patients each): without vaginal pack (group 1 - GP1) and with vaginal pack (group 2 - GP2).Randomization was generated through a computer program creating a random entry list in the study, separating in group 1 (local application of Monsel's solution without intra-vaginal gauze buffer) and group 2 (application of Monsel's solution with intra-vaginal gauze). In this way, all patients had an equal chance of being included in both groups.|t|||
1323232|NCT03293615|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1323233|NCT03293602||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323234|NCT03293589|||Cohort||Retrospective|||||||
1323235|NCT03293576|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1323236|NCT03293563|||Cohort||Prospective|||||||
1323237|NCT03293550|||Cohort||Prospective|||||||
1323238|NCT03293537||Single Group Assignment||Basic Science||None (Open Label)||||||
1323239|NCT03293524|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323240|NCT03293511|Randomized|Crossover Assignment||Basic Science||Triple||Randomized placebo-controlled double-blind within-subject design|t||t|t
1323241|NCT03293498|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1323242|NCT03293485||Single Group Assignment||Treatment||None (Open Label)||||||
1323243|NCT03293472|Randomized|Parallel Assignment||Treatment||Single|Patient unaware of the local anesthetic used.|Parallel study|t|||
1323244|NCT03293459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323245|NCT03293446|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1323246|NCT03293433|||Cohort||Prospective|||||||
1323247|NCT03293420|||Other||Retrospective|||||||
1323248|NCT03293407|||Cohort||Prospective|||||||
1323249|NCT03293394|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323250|NCT03293381|||Cohort||Prospective|||||||
1323251|NCT03293368|Randomized|Parallel Assignment||Treatment||Single||||||t
1323252|NCT03293355|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1323253|NCT03293342|Randomized|Parallel Assignment||Treatment||Single|"Each patient receives a project number. A codebook between project number and journal number is stored at Tannhelsetjenestens kompetansesenter sør in Arendal. All data will be registered online using Nettskjema to collect data directly into Services for sensitive data (TSD). The research data from each patient will only be identified by the project number.~All data will be stored and analysed using the TSD platform. TSD complies with the directive of privacy and electronic communication in Norway. TSD is developed and operated by USIT, the UiO centre for IT."|Randomized Clinical Trial||||t
1323254|NCT03293329|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1323255|NCT03293316|Randomized|Crossover Assignment||Basic Science||Double|Randomized Double-Blind||t||t|
1323256|NCT03293303|Randomized|Parallel Assignment||Prevention||Single|Participants (i.e., older adults will be blinded); it's not possible to blind the healthcare professionals.|A randomised controlled trial with 12 months follow-up will be conducted. In total, five homecare teams from MeanderGroep Zuid-Limburg and the local domestic support workers will be trained in 'Stay Active at Home' (intervention group). Another five homecare teams and domestic support workers will deliver usual care (control group). Both groups of professionals and their clients will be compared at baseline and after 6 and/or 12 months follow-up.|t|||
1323257|NCT03293290||Single Group Assignment||Prevention||None (Open Label)||||||
1323258|NCT03293277|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1323259|NCT03293264|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1323260|NCT03293251|||Cohort||Retrospective|||||||
1323261|NCT03293238|Randomized|Parallel Assignment||Treatment||Double|Patients will be blindfolded for the duration of their procedure. Investigator will always place ultrasound probe on patient's knee regardless of group assignment to eliminate bias. To further enhance blinding, the ultrasound screen will placed on freeze for the patients randomized into the groups without ultrasound guidance. Radiologist will be blinded to patient's group assignment.|Patients will be randomized into one of four intervention arms for the purpose of obtaining patient reported outcomes as it relates to the accuracy of injections into the knee joint with or without ultrasound guidance.|t|||t
1323262|NCT03293225|||Case-Control||Prospective|||||||
1323263|NCT03293212|||Case-Only||Cross-Sectional|||||||
1323264|NCT03293199|Randomized|Parallel Assignment||Treatment||Double|Since patients are alert and conscious, therefore we are unable to blind the participants. However, care provider will not take part in the data acquisition and outcome analysis. The investigator and outcome assessor will be blinded to patients allocated group and treatment type provided in each patients.|Patients will be randomly and equally assigned to study groups, as follows: group (a) will undergo chest tube drainage implementation and group (b) will undergo repetitive needle aspiration till pnuemothorax resolution.|||t|t
1323265|NCT03293186|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1323266|NCT03293173|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Stratification into group A (standard) or group B (experimental) based on biological risk factors||||
1323267|NCT03293160|||Cohort||Other|||||||
1323268|NCT03293147|Randomized|Parallel Assignment||Treatment||Double|"Participants and clinicians will initially be blinded to the result of the baseline (at trial entry) HPLC-MS/MS based urine test to determine the participant adherence to antihypertensive treatment.~Non-adherent patients allocated to Arm A will be un-blinded at the stage of visit 3 where the results of their HPLC-MS/MS urine test will be revealed to them as a part of HPLC-MS/MS-guided intervention. The doctor will also require un-blinding to provide the required intervention. However, during further study visits the research personnel will remain blinded as to the adherence status of these patients, the results of their HPLC-MS/MS-based analysis and the treatment allocation. The doctor who delivers the intervention will not be involved in collecting clinical information necessary to define outcomes during appointments 4 and 5.~Hypertensive patients randomised to Arms B and C will remain blinded to the results of their HPLC-MS/MS-based urine test throughout all stages of the study."|Multi-center randomised controlled trial|t||t|
1323269|NCT03293134|||Other||Other|||||||
1573450|NCT00001164||||||||||||
1323275|NCT03293056|Randomized|Parallel Assignment||Treatment||Double||Parallel Assignment: highintensity interval training water versus aerobic continuous|||t|t
1323276|NCT03293043||Single Group Assignment||Device Feasibility||None (Open Label)||"The purpose of this Phase I Early Feasibility Proof of Concept clinical trial will be to evaluate initial performance and safety of the NPV-EVLP device to assess and improve the function of marginal donor lungs. By nature, efficacy measures and outcomes of the device will also become evident from the results of this study.~This is a prospective, non-randomized, interventional trial, taking place solely at the University of Alberta Hospital/Mazankowski Alberta Heart Institute. Lungs deemed marginal, based on standard lung donor criteria that meet the study's eligibility criteria, will be assessed on our NPV-EVLP device to determine suitability for lung transplantation. Objective assessment of quality will be made while the lungs are on the device based on pre-determined functional parameters of lung physiology. Once a total of 12 sets of lungs are transplanted after using the device, safety will be determined by post-operative lung function and recipient survival."||||
1323277|NCT03293030||Single Group Assignment||Treatment||None (Open Label)||||||
1323278|NCT03293017|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1323279|NCT03293004|Randomized|Crossover Assignment||Treatment||Double|All nutritional interventions taste and look similar and are prepared for subjects in opaque bottles|A double blinded cross over design where subject are randomized to consume all 5 intervention doses.|t||t|
1323280|NCT03292991|||Case-Only||Prospective|||||||
1323281|NCT03292978|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1323282|NCT03292965|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1323283|NCT03292952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323284|NCT03292939||Single Group Assignment||Prevention||None (Open Label)||||||
1323285|NCT03292926|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1323286|NCT03292913|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323287|NCT03292900|||Cohort||Retrospective|||||||
1323288|NCT03292887|||Other||Prospective|||||||
1323289|NCT03292874||Single Group Assignment||Diagnostic||None (Open Label)||Single arm, paired imaging||||
1323290|NCT03292861|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323291|NCT03292848|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1323292|NCT03292835|||Case-Crossover||Prospective|||||||
1323293|NCT03292822|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1323294|NCT03292809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323295|NCT03292796|Randomized|Parallel Assignment||Treatment||Single|"The patient is not masked as to treatment group and are aware of whether they are to continue or stop the PGA drops~The care providers are not masked as to treatment group~Outcome assessors are masked as to the patient's treatment group for their analysis of the OCT scans over the 4 week peri-operative period.~The scans are recorded with only the randomised identifier.~This is to reduce bias in the analysis of the scans~Unmasking of each patient will occur after their analysis of their week 4 OCT scan"|Randomised Control Trial||||t
1323296|NCT03292783||Single Group Assignment||Treatment||None (Open Label)||||||
1323297|NCT03292770|Randomized|Parallel Assignment||Treatment||Double|All included patients will be blinded of the procedure.|All participants will be randomized by an intention to treat approach. All other components of the IVF/ICSI cycle including stimulation medications, monitoring protocols, etc. will be at the discretion of the participant's primary physician; while this information will be documented it will not constitute criteria for enrolment. The group allocation will take place the day of the embryo transfer. The clinician will randomize all included patients into one of the two study groups using an open computer-generated list.|t|||t
1323298|NCT03292757|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323299|NCT03292744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323300|NCT03292731|Randomized|Parallel Assignment||Treatment||None (Open Label)||open labelled rct||||
1323301|NCT03292718||Single Group Assignment||Treatment||None (Open Label)||Single group, open label, with intervention||||
1323302|NCT03292705|Randomized|Parallel Assignment||Prevention||Single|Outcome assessor will be blinded to the group assignment. The participants will be informed to avoid discussing their intervention activities at the post-training and follow up assessments.|A single-blinded, multi-site (4 SLCs) randomized controlled trial of PEP+CCI, vs. control + CCI is involved. For PEP+CCI group, PEP will be implemented for the first 4 weeks, and CCI for the following 6 weeks. For the control + CCI group, an inert control condition, consisting of nothing outside of the ordinary, will be implemented for the first 4 weeks, and CCI for 6 more weeks. Assessments will be conducted by our research team. Separate staff blind to group assignment will conduct post-training and follow-up assessments. All intervention and assessments will occur in private rooms in relevant SLCs.||||t
1323303|NCT03292692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323304|NCT03292679|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323305|NCT03292666|||Cohort||Retrospective|||||||
1323306|NCT03292653|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323307|NCT03292640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323308|NCT03292627|||Case-Control||Prospective|||||||
1323309|NCT03292614|||Cohort||Prospective|||||||
1323310|NCT03292601|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1323311|NCT03292588|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323312|NCT03292575|||Cohort||Prospective|||||||
1323313|NCT03292562|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323314|NCT03292549|||Cohort||Prospective|||||||
1323315|NCT03292536||Single Group Assignment||Treatment||None (Open Label)||a single arm, open label, pharmacodynamics, intrapatient dose escalation phase 1B study||||
1323316|NCT03292523|||Cohort||Prospective|||||||
1323362|NCT03291925|Randomized|Parallel Assignment||Other||None (Open Label)||Prospective, randomized, open-label trial.||||
1323363|NCT03291912|Randomized|Parallel Assignment||Treatment||Single||||||t
1323364|NCT03291899||Single Group Assignment||Treatment||None (Open Label)||Simon 2-stage optimum design Model||||
1573451|NCT00001158||||||||||||
1323317|NCT03292510|Randomized|Parallel Assignment||Treatment||Single|A 2-group mixed methods stratified randomized controlled trial following CONSORT55 criteria is proposed. Group allocation will be concealed and outcome evaluation blinded|"Experimental: GO-OUT program An outdoor walking workshop with stations to learn various outdoor walking skills and information, followed by a supervised, group based outdoor walking program, twice a week for 60 minutes, for 3 months.~Intervention: Other: GO-OUT program Active Comparator: Task-oriented outdoor walking workshop An outdoor walking workshop with stations to learn various outdoor walking skills and information.~Intervention: Other: Task-oriented outdoor walking workshop"||||t
1323318|NCT03292497|Randomized|Parallel Assignment||Treatment||Single|Echocardiographic outcome assessment will be blinded.|||||t
1323319|NCT03292484||Single Group Assignment||Treatment||None (Open Label)||||||
1323320|NCT03292471|Randomized|Parallel Assignment||Treatment||Single||Participants will be assigned to receive 10 sessions of inhibitory rTMS to right hemisphere pars triangularis (RH PTr), either preceded by a 6 Hz priming rTMS stimulation sequence or not.||||t
1323321|NCT03292458|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1323322|NCT03292445||Single Group Assignment||Treatment||None (Open Label)||Total Lymphoid Irradiation, Anti-Thymocyte Globulin and Purified Donor CD34+ and T Cell Transfusion in HLA Haplotype Matched Related and 3 Ag HLA Matched Unrelated Living Donor Kidney Transplantation||||
1323323|NCT03292432|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a phase II, two-arm, randomized, open-label study.||||
1323324|NCT03292419||Single Group Assignment||Treatment||None (Open Label)|N0ne|Topography guided||||
1323325|NCT03292406|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323326|NCT03292393|Randomized|Factorial Assignment||Health Services Research||Triple|||t|t|t|
1323327|NCT03292380|||Ecologic or Community||Cross-Sectional|||||||
1323328|NCT03292367|||Cohort||Prospective|||||||
1323329|NCT03292354|Randomized|Parallel Assignment||Supportive Care||Double|All investigators who assess the image quality will be blinded to the assigned contrast media protocol. Only the technicians who complete the scan and injection protocol will be unblinded for the contrast media protocol chosen.||||t|t
1323330|NCT03292341|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323331|NCT03292328|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323332|NCT03292315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323333|NCT03292302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323334|NCT03292289||Single Group Assignment||Health Services Research||None (Open Label)||||||
1323335|NCT03292276|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1323336|NCT03292263||Single Group Assignment||Treatment||None (Open Label)||||||
1323337|NCT03292250|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"During or after palliative 1st line platinum based chemotherapy, we will perform prescreening NGS based molecular characterization.~Molecular tumor board to determine characterization will be held for every patients. Once each patients have relevant genetic pathway, the patients will be allocated each treatment arm.If the patients have no relevant genetic alteration, such a patients will allocated to durvalumab+/- tremelimumab arm regardeless of PD-L1 positivity. If the patients who allocated to BYL719(Arm1),poziotinib(Arm2), nintedanib(Arm3), and abemaciclib(Arm4) experience disease progression but still meet the inclusion/ exclusion criteria for durvalumab+/- tremelimumab arm((Arm5) the cross over to durvalumab+/- tremelimumab arm will be permitted. Vice versa (cross over from durvalumab+/- tremelimumab arm to another arms) is not permitted."||||
1323338|NCT03292237|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||multicentre, prospective, parallel, randomised controlled trial||||
1323339|NCT03292224|||Case-Only||Prospective|||||||
1323340|NCT03292211|Randomized|Parallel Assignment||Treatment||Single||||||t
1323341|NCT03292198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323342|NCT03292185|Randomized|Crossover Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.|Three-period complete cross-over, six treatment sequences|t|t|t|t
1323343|NCT03292172|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1323344|NCT03292159|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1323345|NCT03292146|Randomized|Parallel Assignment||Treatment||Double|Double blind||t||t|
1323346|NCT03292133||Single Group Assignment||Treatment||None (Open Label)||||||
1323347|NCT03292120||Single Group Assignment||Prevention||None (Open Label)||||||
1323348|NCT03292107|||Cohort||Prospective|||||||
1323349|NCT03292094|||Cohort||Prospective|||||||
1323350|NCT03292081|Randomized|Parallel Assignment||Treatment||Single||||||t
1323351|NCT03292068|Randomized|Parallel Assignment||Treatment||None (Open Label)||Triangulation design will be used including both qualitative and quantitative methods. All the intervention groups will receive usual care in combination with a special intervention. The control group will only receive usual care. In the study the three interventions will be performed at one hospital each.||||
1323352|NCT03292055|||Cohort||Prospective|||||||
1323353|NCT03292042|Randomized|Parallel Assignment||Treatment||Single||||t||
1323354|NCT03292029||Single Group Assignment||Other||None (Open Label)||Exploratory, interventional, open, multi-center, prospective||||
1323355|NCT03292016|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1323356|NCT03292003|||Case-Only||Retrospective|||||||
1323357|NCT03291990||Single Group Assignment||Other||None (Open Label)||5 fraction hypofractionated stereotacic radiosurgery along with standard temozolomide||||
1323358|NCT03291977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323359|NCT03291964|||Cohort||Prospective|||||||
1323360|NCT03291951|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This randomized controlled trial of resistance training intervention in colon cancer patients receiving chemotherapy consists of two arms: an in-person and telephone-based intervention to promote home-based resistance training, and a wait-list, control group.||||
1323361|NCT03291938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323422|NCT03291145|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1323365|NCT03291886|Randomized|Parallel Assignment||Treatment||Quadruple||Double-blinded, randomized trial|t|t|t|t
1323366|NCT03291873|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323367|NCT03291860|||Cohort||Prospective|||||||
1323368|NCT03291847|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||One group of n=40 study participants will receive buprenorphine-naloxone medication assisted therapy for the treatment of opioid use disorder during pregnancy, a second group of n=40 will receive methadone as standard of care. Subjects will undergo identical study procedures.||||
1323369|NCT03291834|||Cohort||Retrospective|||||||
1323370|NCT03291821|Randomized|Parallel Assignment||Other||None (Open Label)||Unicentric, prospective, randomized, non-blind, parallel-group controlled phase IV clinical study.||||
1323371|NCT03291808||Single Group Assignment||Other||None (Open Label)||||||
1323372|NCT03291795||Single Group Assignment||Prevention||None (Open Label)||||||
1323373|NCT03291782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323374|NCT03291769|||Cohort||Prospective|||||||
1323375|NCT03291756|||Cohort||Prospective|||||||
1323376|NCT03291743|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1323377|NCT03291730||Single Group Assignment||Supportive Care||None (Open Label)||||||
1323378|NCT03291717|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323379|NCT03291704||Single Group Assignment||Treatment||None (Open Label)||||||
1323380|NCT03291691|||Cohort||Prospective|||||||
1323381|NCT03291678|Randomized|Parallel Assignment||Treatment||None (Open Label)||one group which is control group will not subjected to internal ring ligation and another group will subjected to closure of the internal ring||||
1323382|NCT03291665|||Case-Only||Cross-Sectional|||||||
1323383|NCT03291652|||Case-Control||Prospective|||||||
1323384|NCT03291639|||Case-Only||Prospective|||||||
1323385|NCT03291626|||Cohort||Prospective|||||||
1323386|NCT03291613||Single Group Assignment||Supportive Care||None (Open Label)||||||
1323387|NCT03291600|Randomized|Parallel Assignment||Treatment||None (Open Label)||Behavioral: Virtual Psychiatric Care for Perinatal Depression||||
1323388|NCT03291587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323389|NCT03291574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323390|NCT03291561|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323391|NCT03291548|Randomized|Crossover Assignment||Prevention||Double|Double Blind: researcher and particiapant unaware of the intervention assignment||t||t|
1323392|NCT03291535|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1323393|NCT03291522|||Case-Only||Prospective|||||||
1323394|NCT03291509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323395|NCT03291496|||Cohort||Prospective|||||||
1323396|NCT03291483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323397|NCT03291470|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1323398|NCT03291457|||Cohort||Prospective|||||||
1323399|NCT03291444|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323400|NCT03291431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323401|NCT03291418|Randomized|Parallel Assignment||Prevention||Quadruple|Encapsulated tablets||t|t|t|t
1323402|NCT03291405|||Other||Prospective|||||||
1323403|NCT03291392|||Other||Other|||||||
1323404|NCT03291379||Single Group Assignment||Treatment||None (Open Label)||1 mL BTG-002814 containing 100 mg vandetanib||||
1323405|NCT03291366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323406|NCT03291353||Single Group Assignment||Treatment||None (Open Label)||||||
1323407|NCT03291340|||Cohort||Prospective|||||||
1323408|NCT03291327|Randomized|Parallel Assignment||Prevention||Quadruple|"The study randomisation schedule will be provided by an independent statistician in a sealed envelope and will be kept in a Study Master File (Test Products). The study blind will only be broken in an emergency where it was essential to know which formulation a participant had received in order to give the appropriate medical care. In the event of the requirement to break the code, the investigator (or designee) will, where possible, contact the Sponsor prior to breaking the blind. The investigator will then sign and date the broken code envelope and document the reason for breaking the code.~All study products will be provided by the Sponsor, in blister packs pre-labelled with randomisation numbers according the Sponsor's randomisation schedule. Toothpaste with Fluoride (Colgate/Crest) together will also be provided."|Single Centre parallel arm (3) double blind placebo controlled study|t|t|t|t
1323409|NCT03291314|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Open label, single-center, stratified phase II clinical trial.~Patients will be stratified according to their baseline use of corticosteroids: <Stratum A> = no need for corticosteroids and <Stratum B> = baseline need for steroid treatment"||||
1323410|NCT03291301|Randomized|Parallel Assignment||Treatment||Single||||||t
1323411|NCT03291288|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-label, single sequence study with 2 parts||||
1323412|NCT03291275|||Cohort||Prospective|||||||
1323413|NCT03291262|||Cohort||Prospective|||||||
1323414|NCT03291249|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323415|NCT03291236|||Cohort||Prospective|||||||
1323416|NCT03291223|||Cohort||Prospective|||||||
1323417|NCT03291210|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1323418|NCT03291197||Single Group Assignment||Other||None (Open Label)||Open label preliminary study testing the tolerability of the procedure.||||
1323419|NCT03291184||Single Group Assignment||Diagnostic||Double|The participant will still be under sedation at the moment of measuring neuromuscular blockade. The care provider will perform measurements, while the investigator is blinded.|Patients admitted to the ICU after elective cardiac surgery and ready for weaning from the ventilator.|t||t|
1323420|NCT03291171|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial with two groups: intervention group and waiting-list control group||||
1323421|NCT03291158||Single Group Assignment||Treatment||None (Open Label)||||||
1323424|NCT03291119|||Cohort||Prospective|||||||
1323425|NCT03291106|||Cohort||Prospective|||||||
1323426|NCT03291093|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1323427|NCT03291080|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1323428|NCT03291067|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1323429|NCT03291054||Single Group Assignment||Treatment||None (Open Label)||||||
1323430|NCT03291041|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323431|NCT03291028|||Cohort||Retrospective|||||||
1323432|NCT03291015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323433|NCT03291002|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, cohort-based, dose escalation and expansion study||||
1323434|NCT03290989|||Case-Only||Prospective|||||||
1323435|NCT03290976|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patient-preference, randomized controlled study||||
1323436|NCT03290963|Randomized|Parallel Assignment||Basic Science||Triple|Triple blinded study. The staff accessible to the blind includes pharmacy staff and one assigned investigator.||t||t|t
1323437|NCT03290950||Single Group Assignment||Treatment||None (Open Label)||Phase II study and treated with 4-drug combination of daratumumab, carfilzomib, lenalidomide, and dexamethasone.||||
1323438|NCT03290937|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1323439|NCT03290924|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1323440|NCT03290911|||Cohort||Retrospective|||||||
1323441|NCT03290898|Randomized|Parallel Assignment||Treatment||Double|Single blindet, randomization and training intervention by non-investigator. Open-label after primary follow up. After unblinding, blindet 3rd party performs tests (visit 9 and 12 months, e.g. spirometry)|A randomized, controlled parallel group, outcome assessor blinded, clinical trial|||t|t
1323442|NCT03290885|Randomized|Parallel Assignment||Other||Single||||||t
1323443|NCT03290872|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323444|NCT03290859|||Case-Control||Prospective|||||||
1323445|NCT03290846|Randomized|Crossover Assignment||Basic Science||Single|Participants receive drug and placebo infusion without knowing which day is which.|Single blinded randomised study, secretin infusion is given on one day, saline infusion on an other day.|t|||
1323446|NCT03290833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323447|NCT03290820|Randomized|Parallel Assignment||Treatment||None (Open Label)||The patients eligible are divided randomly. All the patients will receive concurrent chemoradiotherapy. The cases in the Experimental Group will receive daily aspirin of 75mg.||||
1323448|NCT03290807|||Cohort||Prospective|||||||
1323449|NCT03290794|||Other||Prospective|||||||
1323450|NCT03290781|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323451|NCT03290768||Single Group Assignment||Supportive Care||None (Open Label)||||||
1323452|NCT03290755|||Other||Prospective|||||||
1323453|NCT03290742|||Cohort||Retrospective|||||||
1323454|NCT03290729||Single Group Assignment||Treatment||None (Open Label)||multicenter single cohort prospective study||||
1323455|NCT03290716|Randomized|Parallel Assignment||Prevention||Single||||||t
1323456|NCT03290703|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1323457|NCT03290690|||Cohort||Prospective|||||||
1323458|NCT03290677||Single Group Assignment||Treatment||None (Open Label)||||||
1323459|NCT03290664|Randomized|Parallel Assignment||Treatment||None (Open Label)||The first twenty-four patients enrolled in the study will be randomized to CD3-/CD19- or CD3-/CD56+ in a parallel comparison of the two products. Twelve patients will be randomized to each product. The chosen product will then be given to an additional 17 patients based on success of the primary endpoint. If one of the products achieves the necessary number of complete remissions during stage 1 (6 or more out of 12) but the other product does not, that product will continue onto stage 2. If neither product achieves the necessary number of CRs, then this approach will be deemed unworthy of further study.||||
1323460|NCT03290651|Randomized|Parallel Assignment||Basic Science||Double||Double blind randomized, placebo-controlled pilot trial.|t|t||
1323461|NCT03290638|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1323462|NCT03290625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323463|NCT03290612|Randomized|Crossover Assignment||Supportive Care||Quadruple|Vitamin C and Placebo doses will be blinded by the research pharmacy, so that participants and investigators are masked to the identity of the tablet. Data analysis will be blinded to the conditions as well until the completion of the study.||t|t|t|t
1323464|NCT03290599|||Other||Prospective|||||||
1323465|NCT03290586|||Case-Control||Cross-Sectional|||||||
1323466|NCT03290573|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323467|NCT03290560|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323468|NCT03290547||Single Group Assignment||Treatment||None (Open Label)||||||
1323469|NCT03290534||Single Group Assignment||Treatment||Single||||||t
1323470|NCT03290521|Randomized|Parallel Assignment||Treatment||Single||"Patients will therefore be divided into two groups:~A - Yes Washing (SL) B - No Washing (NL)"|t|||
1323471|NCT03290508|||Cohort||Prospective|||||||
1323528|NCT03289767|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1323529|NCT03289754||Single Group Assignment||Basic Science||None (Open Label)||||||
1323530|NCT03289741|Randomized|Crossover Assignment||Treatment||None (Open Label)||Two-arm randomized design||||
1323531|NCT03289728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323532|NCT03289715||Single Group Assignment||Supportive Care||None (Open Label)||||||
1323533|NCT03289702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323534|NCT03289689|Randomized|Parallel Assignment||Treatment||Single||||||t
1323716|NCT03287323|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||Prospective before-and after interventional study including 100 patients who receive usual intensive care followed by an interventional part with 100 patients who receive additional palliative care consultations||||
1323771|NCT03286608|||Cohort||Prospective|||||||
1323472|NCT03290495|Randomized|Parallel Assignment||Basic Science||Triple|The patients well be randomized to one of the two groups by closed envelope technique. After opening the envelope, the study drug (ketamine 100µg/kg total body weight (Isoket group)) or normal saline ((Isonly) or control group) will be prepared, made up to 10 ml and administered by an assistant in the proper timing. The patient identification will be written on a slip and put back into an envelope and sealed. The person doing the procedure and monitoring along with the patient will be blinded to the dose and nature of solution. The equal volume test solution will be given intravenously by an assistant who was not involved in the administration of anesthesia and monitoring|"An intravenous catheter was placed and normal saline (0.9%) will be infused. Spinal anesthesia will be given. The stability of spinal anesthesia will be assured before propofol injection and at the end of procedure.~Propofol will be given to facilitate isoflurane inhalation which will be varied between 0.8-1.2percent to keep (BIS) in the range 40-60. Anesthesia will be kept as so for 30 minutes. Then the test drug (either ketamine or saline) will be given slowly, to pressor response in case of ketamine. Anesthesia will be maintained for another 30 minutes then isoflurane is discontinued. Recovery from anesthesia will then be tested.. No other drugs will be routinely given. Development of complications or signs of inadequate anesthesia will cause drop of the case from study and any measures will be taken to insure patient safety and comfort.The patient will be let to recover from anesthesia then transferred to postoperative care unit."|t||t|t
1323473|NCT03290482|||Cohort||Prospective|||||||
1323474|NCT03290469|Randomized|Parallel Assignment||Other||Triple|All investigators are masked to the study arm until Day 15 to ensure SOC throughout first 15 days on study.|Multi-cohort, time delay study receiving Clinical Whole Genome Sequencing (cWGS) at either 15 days or 60 days in an acutely ill newborn population|t|t|t|
1323475|NCT03290456|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1323476|NCT03290443||Single Group Assignment||Treatment||None (Open Label)||||||
1323477|NCT03290430|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||this is a quasi-experiment, with 4 intervention arms plus options for supplemental intervention support||||
1323478|NCT03290417|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel groups, one with a control diet, the other with a modified diet||||
1323479|NCT03290404|||Cohort||Prospective|||||||
1323480|NCT03290391|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1323481|NCT03290378|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323482|NCT03290365|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1323483|NCT03290352|||Cohort||Prospective|||||||
1323484|NCT03290339|||Cohort||Prospective|||||||
1323485|NCT03290326||Single Group Assignment||Treatment||None (Open Label)||||||
1323486|NCT03290313|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323487|NCT03290300|||Cohort||Prospective|||||||
1323488|NCT03290287|||Case-Control||Prospective|||||||
1323489|NCT03290274|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323490|NCT03290261||Single Group Assignment||Treatment||None (Open Label)||non-randomised, single center, pilote study||||
1323491|NCT03290248|Randomized|Parallel Assignment||Treatment||Quadruple|This is a double blind study.|Randomization will be 1:1:1 so that equal number of subjects will be treated in each arm of the study.|t|t|t|t
1323492|NCT03290235|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323493|NCT03290222|||Case-Only||Prospective|||||||
1323494|NCT03290209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323495|NCT03290196||Single Group Assignment||Treatment||None (Open Label)||||||
1323496|NCT03290183|||Case-Only||Cross-Sectional|||||||
1323497|NCT03290170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323498|NCT03290157|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1323499|NCT03290144|||Cohort||Other|||||||
1323500|NCT03290131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323501|NCT03290118|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1323502|NCT03290105|||Cohort||Prospective|||||||
1323503|NCT03290092||Single Group Assignment||Treatment||None (Open Label)||||||
1323504|NCT03290079||Single Group Assignment||Treatment||None (Open Label)||Simon 2-stage design||||
1323505|NCT03290066|Randomized|Crossover Assignment||Treatment||Single||Each woman will be assigned to a sequence of treatments, including two treatments (kinesiotape and usual dysmenorrhea treatment). The sample will be randomized in two different sequences of treatments (kinesiotape/usual treatment or usual treatment/kinesiotape)||||t
1323506|NCT03290053|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1323507|NCT03290040|||Cohort||Prospective|||||||
1323508|NCT03290027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323509|NCT03290014|||Cohort||Prospective|||||||
1323510|NCT03290001|||Cohort||Prospective|||||||
1323511|NCT03289988|||Cohort||Cross-Sectional|||||||
1323512|NCT03289975|||Other||Prospective|||||||
1323513|NCT03289962|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1323514|NCT03289949|Non-Randomized|Sequential Assignment||Basic Science||Single|||t|||
1323515|NCT03289936|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1323516|NCT03289923|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1323517|NCT03289910|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323518|NCT03289897|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323519|NCT03289884|||Other||Cross-Sectional|||||||
1323520|NCT03289871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323521|NCT03289858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323522|NCT03289845||Single Group Assignment||Treatment||None (Open Label)||||||
1323523|NCT03289832|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1323524|NCT03289819||Single Group Assignment||Treatment||None (Open Label)||||||
1323525|NCT03289806|||Case-Control||Prospective|||||||
1323526|NCT03289793|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1323527|NCT03289780|||Cohort||Prospective|||||||
1323535|NCT03289676|Randomized|Parallel Assignment||Treatment||Single|The person who assesses follow-up assessments will be blind to treatment condition.|": The proposed study has two phases.~Phase 1. Development of Narrative Video: We will first develop narrative videos in collaboration with community organizations of WLHIV in Boston. The video will be filmed in person at the University of Massachusetts Boston.~Phase 2. A Randomized Controlled Trial (RCT) of a Story Telling Narrative Communication Intervention: We will conduct a two-arm RCT assigning participants at a ratio of 1:1 to either one of the two arms (Experimental: HIV-tailored plus SNC interventions vs. Control: HIV-tailored plus attention-control interventions). Both arms will have eight weekly sessions of a 30-minute HIV-tailored cessation intervention (cognitive behavioral therapy plus nicotine patches). All research-related procedures will be conducted remotely."||||t
1323536|NCT03289663|Randomized|Parallel Assignment||Prevention||Single|The 2 groups of villages will randomly receive either the bednets treated with conventional insecticide (Pyrethroid) or the synergistic combination of insecticides. None of the groups knows which bednets they receive.|Cluster-randomized trial|t|||
1323537|NCT03289650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323538|NCT03289637|Randomized|Parallel Assignment||Treatment||Double|Neither the participant, nor the care provider will be informed if active supplementation or placebo will be given, nor will blood sample results be open for care provider|Double blind, parallel, placebo controlled study|t|t||
1323539|NCT03289624|Randomized|Parallel Assignment||Other||Single|No other parties will be masked in the trial|Persons with chronic conditions and their family caregivers will be randomly assigned to a treatment or control group|t|||
1323540|NCT03289611|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1323541|NCT03289598|Randomized|Parallel Assignment||Health Services Research||Single|Single Blind|||||t
1323542|NCT03289585|||Cohort||Prospective|||||||
1323543|NCT03289572|||Case-Only||Prospective|||||||
1323544|NCT03289559|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1323545|NCT03289546|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1323546|NCT03289533|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323547|NCT03289520|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1323548|NCT03289507|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1323549|NCT03289494|Randomized|Crossover Assignment||Prevention||Double|"Each diet will be labelled Diet A or Diet B"|Each subject will receive two independant weeks of diet intervention, in a crossover design|t|||t
1323550|NCT03289481|Randomized|Crossover Assignment||Treatment||Quadruple|Masking will be done by the pharmacy. Active and placebo lozenges will look identical.|Double-blind, placebo controlled crossover study|t|t|t|t
1323551|NCT03289468|||Other||Cross-Sectional|||||||
1323552|NCT03289455||Single Group Assignment||Treatment||None (Open Label)||||||
1323553|NCT03289442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323554|NCT03289429|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1323555|NCT03289416|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomly assigned to either a PRP intervention group or the BMC intervention group. Knee pain and function outcomes of enrolled patients in the two groups will be compared to determine which treatment is more effective in treating knee osteoarthritis.||||
1323556|NCT03289403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323557|NCT03289390|||Cohort||Prospective|||||||
1323558|NCT03289377||Single Group Assignment||Health Services Research||None (Open Label)||||||
1323559|NCT03289364||Single Group Assignment||Prevention||None (Open Label)||Patients will use the Penguin Cold Caps during prior to, during, and after chemotherapy administration. Cold-cap therapy will commence at least 50 minutes prior to infusion, and will continue for 4 hours following completion of chemotherapy.||||
1323560|NCT03289351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323561|NCT03289338|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323562|NCT03289325|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1323563|NCT03289312|||Case-Control||Prospective|||||||
1323564|NCT03289299||Single Group Assignment||Treatment||None (Open Label)||Subjects will receive treatment in 3 phases - induction (6 cycles), consolidation (6 cycles), and maintenance (12 cycles).||||
1323565|NCT03289286||Single Group Assignment||Health Services Research||None (Open Label)||||||
1323566|NCT03289273|||Cohort||Prospective|||||||
1323567|NCT03289260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323568|NCT03289247|Randomized|Parallel Assignment||Treatment||Single|Investigator evaluating primary outcome is blinded to intervention||||t|
1323569|NCT03289234|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323570|NCT03289221||Single Group Assignment||Diagnostic||None (Open Label)||Thirty (30) consecutive patients indicated for treatment of prostate cancer with HIFU (FocalOneR, Edap TMS, France) will be selected to the manometry study before the treatment together with the application of specific questionnaires (Cleveland Clinic Incontinence Score-CCIS, Fecal Incontinence Quality of Life Score-FIQLS, and Rome IV for functional constipation. This evaluaton will be conducted again after the treatment.||||
1323571|NCT03289208|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323572|NCT03289195||Single Group Assignment||Diagnostic||None (Open Label)||This prospective single institution pilot study.||||
1323573|NCT03289182|||Cohort||Prospective|||||||
1323574|NCT03289169||Single Group Assignment||Treatment||None (Open Label)||||||
1323575|NCT03289156|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1323576|NCT03289143|Randomized|Parallel Assignment||Treatment||Triple|Additional blinded personnel will include study site personnel who will evaluate participant status, contract research organization (CRO) personnel who will review case report forms (CRFs), and other sponsor agents (with the exception of the interactive voice or web-based response system [IxRS] vendor).||t||t|t
1323577|NCT03289130|||Case-Only||Cross-Sectional|||||||
1323683|NCT03287752|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|open label|The aim of this study will be compare the safety and performance characteristics of the BASKA mask versus end tracheal tube in females undergoing laparoscopic gynecological surgery.||||
1323578|NCT03289117|Randomized|Parallel Assignment||Supportive Care||Single|Open label|"Arm 1: Experimental: Novel device: Assigned Interventions: Catheter change with novel device. Each subject will undergo catheter change with novel gel instillation device.~Arm 2: Comparator: Standard procedure: Assigned Interventions: Catheter change with standard procedure. Each subject will undergo catheter change with standard procedure."||||t
1323579|NCT03289104|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323580|NCT03289091|Randomized|Parallel Assignment||Prevention||Single||||||t
1323581|NCT03289078|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323582|NCT03289065|||Other||Prospective|||||||
1323583|NCT03289052|Randomized|Parallel Assignment||Treatment||Single||||||t
1323584|NCT03289039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323585|NCT03289026||Single Group Assignment||Treatment||None (Open Label)||||||
1323586|NCT03289013||Single Group Assignment||Other||None (Open Label)||||||
1323587|NCT03289000|||Cohort||Retrospective|||||||
1323588|NCT03288987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323589|NCT03288974|||Cohort||Prospective|||||||
1323590|NCT03288961|||Case-Only||Cross-Sectional|||||||
1323591|NCT03288948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323592|NCT03288935|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1323593|NCT03288922|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1323594|NCT03288909|||Case-Control||Prospective|||||||
1323595|NCT03288896|Randomized|Parallel Assignment||Prevention||None (Open Label)||A Cluster Randomized Controlled Trial is conducted to test the effectiveness of Alerta Alcohol in students aged 16 to 18 years. The study is performed in 16 high schools from Andalusia (southern Spain), which are randomized either to the experimental or the control condition (EC and CC). The EC receives the Alerta Alcohol intervention, which consists of four sessions at school. The adolescents are provided highly specific feedback regarding their knowledge, risk perception, self-esteem, attitude, social influence, and self-efficacy. In addition, two booster sessions are given at home to reinforce the contents of the three scenarios. The CC just completes the baseline and the evaluation questionnaires and then they are allowed to receive the intervention as well (as a waiting list control condition).||||
1323596|NCT03288883|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1323597|NCT03288870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323598|NCT03288857|Randomized|Parallel Assignment||Treatment||Single|||||t|
1323599|NCT03288844|||Case-Only||Prospective|||||||
1323600|NCT03288831|Randomized|Parallel Assignment||Other||Triple|Subjects will be block randomized to either gluten-containing or placebo challenge.|Randomized, double-blinded, placebo-controlled oral gluten challenge|t|t|t|
1323601|NCT03288818||Single Group Assignment||Treatment||None (Open Label)||||||
1323602|NCT03288805|||Cohort||Prospective|||||||
1323603|NCT03288792||Single Group Assignment||Screening||None (Open Label)||||||
1323604|NCT03288779||Single Group Assignment||Treatment||None (Open Label)||||||
1323605|NCT03288766|||Case-Only||Prospective|||||||
1323606|NCT03288753|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323607|NCT03288740|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.||t|t|t|t
1323608|NCT03288727|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1323609|NCT03288714|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind|Sham Controlled|t|t|t|t
1323610|NCT03288701||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323611|NCT03288688|Randomized|Parallel Assignment||Treatment||Single||||||t
1323612|NCT03288675|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1323613|NCT03288662||Single Group Assignment||Diagnostic||None (Open Label)||Cross-sectional descriptive study on 53 patients with diagnosed of thymoma by CT and had postoperative histopathology results as thymic epithelial tumors||||
1323614|NCT03288649|||Other||Prospective|||||||
1323615|NCT03288636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323616|NCT03288623|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1323617|NCT03288610|||Cohort||Prospective|||||||
1323618|NCT03288597|||Cohort||Prospective|||||||
1323619|NCT03288584|||Case-Control||Prospective|||||||
1323620|NCT03288571||Single Group Assignment||Treatment||None (Open Label)||||||
1323621|NCT03288558|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1323622|NCT03288545|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||multi-cohort, open-label, multicenter study||||
1323623|NCT03288532|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multi-Arm Multi-Stage Design||||
1323624|NCT03288519|||Other||Prospective|||||||
1323625|NCT03288506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323626|NCT03288493||Single Group Assignment||Treatment||None (Open Label)||3 + 3 design of dose-escalating cohorts||||
1323627|NCT03288480||Single Group Assignment||Treatment||None (Open Label)||"This is a multicenter, open-label study of PT-112 in patients with relapsed or refractory MM. The study will be conducted in two parts:~Part 1: Dose escalation Part 2: Dose expansion"||||
1323628|NCT03288467|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1323629|NCT03288454|Randomized|Sequential Assignment||Treatment||Single|||t|||
1323630|NCT03288441|||Cohort||Prospective|||||||
1323631|NCT03288428|Randomized|Parallel Assignment||Treatment||Triple|double blind||t|t|t|
1323632|NCT03288415|||Cohort||Retrospective|||||||
1323633|NCT03288402|Randomized|Crossover Assignment||Screening||None (Open Label)||double crossover (ongoing fasted; or caffeine containing beverages; of 5-item English breakfast)||||
1323684|NCT03287739|||Cohort||Prospective|||||||
1323685|NCT03287726|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323686|NCT03287713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323687|NCT03287700|||Other||Cross-Sectional|||||||
1324056|NCT03282903|||Cohort||Prospective|||||||
1323634|NCT03288389|Randomized|Crossover Assignment||Treatment||Triple|Participants will be randomized by a nurse consultant into placebo and supplement arms and will be masked from lead investigator, physician participants and research nurse coordinator. Placebo and Product will be in identical white numbered bottles and look, feel, taste and smell the same. Data will be collected independently online by a specialty company and after the trial is completed, it will be transferred to an independent statistical unit at the University of California, Irvine for analysis and at that time the code will be broken for analysis purposes.|The purpose of this study is to determine the clinical effectiveness of an all-natural, patented, Food and Drug Administration (FDA)-approved oral lipid nutritional supplement (NTFactor Lipids) on reducing pain, fatigue and other symptoms and improving quality of life in Fibromyalgia and other related conditions. The investigators will evaluate the efficacy of a dietary product called NTFactor Lipids made by Nutritional Therapeutics, Inc. of New York on pain, fatigue and gastrointestinal symptoms as well as quality of life indicators in adult male and female subjects. The addition of NTFactor Lipids to the diet is expected to improve cellular energy function, decrease fatigue and pain and lower the severity of other symptoms and improve quality of life indicators in Fibromyalgia patients. This study will be a randomized, placebo-controlled, cross-over study.|t|t|t|
1323635|NCT03288376|||Case-Only||Prospective|||||||
1323636|NCT03288363|Randomized|Parallel Assignment||Treatment||Quadruple|the operator enters in the tDCS apparatus the code number of the kind of stimulation to deliver; This code number has been randomly assigned, and the correspondence list is not accessible by the different intervenants.|sham versus stimulation|t|t|t|t
1323637|NCT03288350||Single Group Assignment||Treatment||None (Open Label)||||||
1323638|NCT03288337|||Cohort||Cross-Sectional|||||||
1323639|NCT03288324||Single Group Assignment||Treatment||None (Open Label)||||||
1323640|NCT03288311|Randomized|Crossover Assignment||Treatment||Single||||||t
1323641|NCT03288298|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323642|NCT03288285|||Case-Crossover||Cross-Sectional|||||||
1323643|NCT03288272|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomization Best Supportive Care, Two Radiotherapy Dosing Regimens||||
1323644|NCT03288259||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323645|NCT03288246|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1323646|NCT03288233|||Other||Cross-Sectional|||||||
1323647|NCT03288220|||Cohort||Other|||||||
1323648|NCT03288207|||Other||Prospective|||||||
1323649|NCT03288194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323650|NCT03288181|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1323651|NCT03288168|||Cohort||Retrospective|||||||
1323652|NCT03288155|Randomized|Parallel Assignment||Treatment||Double|Double blind randomized controlled feasibility trial with assessors and participant blinded to intervention||t|||t
1323653|NCT03288142|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized controlled trial with randomization stratified by age and baseline systolic blood pressure.||||
1323654|NCT03288129||Single Group Assignment||Treatment||None (Open Label)||||||
1323655|NCT03288116|||Case-Control||Prospective|||||||
1323656|NCT03288103||Single Group Assignment||Treatment||None (Open Label)||||||
1323657|NCT03288090|||Cohort||Prospective|||||||
1323658|NCT03288077||Single Group Assignment||Basic Science||None (Open Label)||||||
1323659|NCT03288064|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1323660|NCT03288051|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323661|NCT03288038|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1323662|NCT03288025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323663|NCT03288012|||Cohort||Prospective|||||||
1323664|NCT03287999|||Cohort||Prospective|||||||
1323665|NCT03287986|||Case-Control||Cross-Sectional|||||||
1323666|NCT03287973|Randomized|Parallel Assignment||Treatment||Single|The research assistant who scores the sleep study and the laboratory technician who does the blood test are blinded to the intervention arm.|||||t
1323667|NCT03287960||Single Group Assignment||Treatment||Quadruple||Open-label with an 8 week Double-Blind Placebo-Controlled Withdrawal Period|t|t|t|t
1323668|NCT03287947||Single Group Assignment||Treatment||None (Open Label)||Single arm phase 2 study.||||
1323669|NCT03287934|Randomized|Parallel Assignment||Treatment||Single|due to the nature of study only the participants could be blinded||t|||
1323670|NCT03287921|||Case-Crossover||Prospective|||||||
1323671|NCT03287908||Single Group Assignment||Treatment||None (Open Label)||||||
1323672|NCT03287895|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323673|NCT03287882|Randomized|Parallel Assignment||Prevention||Double|Some investigators are blinded to the allocation of the intervention, and all study data collectors are blinded.||||t|t
1323674|NCT03287869||Single Group Assignment||Treatment||None (Open Label)||Group composed of eligible rollover subjects who completed one of the double-blind, phase 3 efficacy trials (331-201-00080 or 331-201-00081). In the event the sponsor determines that the enrollment rate of rollover subjects will not be sufficient to meet the target completion, de novo subjects may be enrolled at select sites. The enrollment of de novo subjects at any site will not be permitted until initiation and notification by the sponsor.||||
1323675|NCT03287856||Single Group Assignment||Treatment||None (Open Label)||||||
1323676|NCT03287843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323677|NCT03287830|Randomized|Parallel Assignment||Health Services Research||Triple|The care provider, primary statistician and analyst will be blinded to participant status.|||t|t|t
1323678|NCT03287817||Single Group Assignment||Treatment||None (Open Label)||A dose escalation phase (Phase 1) followed by a dose expansion phase (Phase 2; to further assess the recommended Phase II dose [RP2D]).||||
1323679|NCT03287804||Single Group Assignment||Treatment||None (Open Label)||||||
1323680|NCT03287791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323681|NCT03287778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323682|NCT03287765||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324157|NCT03281590|||Other||Other|||||||
1323688|NCT03287687|Randomized|Parallel Assignment||Other||Quadruple|"Randomization will be done 1:1, double blinded. - Procedure nurse will randomly choose an envelope from a box; the envelope contains a card listing either CO2 or Air. The envelopes will be unmarked and will be prepared with an equal number of cards for each arm. The procedure nurse then turns on either CO2 or air insufflation according to the card in the envelope. The air/CO2 controls will be kept covered to preserve blinding of the endoscopist. She will also record the patient's arm allocation in a logbook, which will be kept in a locked cabinet.~These events will precede entry of the patient and endoscopist into the procedure room.~Therefore, all study participants are blinded and allocation is also blinded also."|Double blinded, placebo controlled study|t|t|t|t
1323689|NCT03287674||Single Group Assignment||Treatment||None (Open Label)||||||
1323690|NCT03287661|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Trial||||
1323691|NCT03287648|||Cohort||Cross-Sectional|||||||
1323692|NCT03287635||Single Group Assignment||Treatment||None (Open Label)||||||
1323693|NCT03287622|Randomized|Factorial Assignment||Prevention||Triple|"Group assignment will be coded for parents and data collectors. Parents will be blinded to whether the information they receive is the Intervention vs. Control.~Group assignment will coded on data entry and unblinded after analyses."|Four-armed, randomized, control, factorial design|t||t|t
1323694|NCT03287609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323695|NCT03287596|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1323696|NCT03287583|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|participants will be randomized to receive either the Gambling Specific SBIRT Intervention or enhanced control.||||
1323697|NCT03287570|Randomized|Parallel Assignment||Treatment||Single||||||t
1323698|NCT03287557|||Case-Only||Prospective|||||||
1323699|NCT03287544|Non-Randomized|Parallel Assignment||Supportive Care||Single|After the allocation in the groups, rehabilitation is not done blindly since the speech therapist knows what activities he offers to patients. However, the evaluations carried out by a speech therapist, are done without the knowledge of the rehabilitation group.|"There are two arms in the protocol: one experimental arm corresponding to the combined rehabilitation (linguistic/communication) compared with another arm corresponding to the linguistic rehabilitation.~All included patients, after allocation based on aphasia severity to the  combined  and  linguistic  groups, will have a first evaluation (E1: language, neurologic and neuropsychological exams) within 7 days after the onset. Then after a 3 months rehabilitation period they will be assessed (E2: language, neurologic and neuropsychological exams). At 6 months after the onset they will finally have the last assessment (E3: language, neurologic and neuropsychological exams)."||||t
1323700|NCT03287531|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323701|NCT03287518|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind, placebo-controlled|Randomized, double-blind, placebo-controlled, parallel-group study|t|t|t|t
1323702|NCT03287505|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323703|NCT03287492|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1323704|NCT03287479|Randomized|Parallel Assignment||Other||None (Open Label)||"Patients presenting ≥ 2 surplus regularly fertilized oocytes for cryoperservation on day 1 and patients undergoing elective cryopreservation of all available 2PN oocytes are are allocated to one of the two following procedures:~Study group: surplus or all 2PN-stage oocytes are vitrified/warmed using the semiautomated Gavi® protocol.~Control group: surplus or all 2PN-stage oocytes are vitrified/warmed using the manual Cryotop® protocol.~Randomization will be performed on day of fertilization check by lab staff by opening a numbered, opaque sealed envelopes. The random sequence will be software-generated and blocks will be used."||||
1323705|NCT03287466|Randomized|Parallel Assignment||Other||Single|Clinicians and other healthcare providers will not be blinded to treatment allocation, nor will the clinical research team. This is because knowing the patient's blood oxygen level is an essential component of the study. Those members of the research team analysing data after the recruitment phase of the study will be blinded to group allocation. Participants will not be blinded but are unlikely to be aware to their allocation due to the severity of their illness.|feasibility, multi-centre, randomised controlled trial||||t
1323706|NCT03287453||Single Group Assignment||Screening||None (Open Label)||||||
1323707|NCT03287440|Randomized|Sequential Assignment||Health Services Research||Double|The principal investigator and outcome assessor will be masked to when the participant completes the intervention and to whether or not they received the Health Advocates adherence strategy.|"A step-wedge design will allow all participants to receive the intervention. Participants not immediately enrolled into the intervention will serve as controls. At the time of the intervention, these participants will move over to the treatment arm.~The first two groups will be used to refine the COPD Wellness intervention and identify social barriers specific to individuals living with COPD. Starting with group 3, we will alternate the addition of the Health Advocates (HA) program as an adherence strategy in order to determine the HA's effect on participation in COPD Wellness."|||t|t
1323708|NCT03287427||Single Group Assignment||Treatment||None (Open Label)||||||
1323709|NCT03287414|Randomized|Parallel Assignment||Treatment||Quadruple|A subject-, investigator-, and sponsor-blinded||t|t|t|t
1323710|NCT03287401|||Cohort||Prospective|||||||
1323711|NCT03287388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"Each patient wil serve as its own control:~Each patient will start without neuromuscular blockade (phase 1), followed by moderate neuromuscular blockade (phase 2) and deep neuromuscular blockade (phase 3)."||||
1323712|NCT03287375||Single Group Assignment||Treatment||None (Open Label)||Cohorte study||||
1323713|NCT03287362|Randomized|Parallel Assignment||Treatment||None (Open Label)||Incoming patients from the clinic of Max Planck Institute of Psychiatry are continuously screened for study eligibility and - after they have given informed consent - are block wise randomly assigned to one of 3 study arms (schema therapy, cognitive behavioral therapy, individual supportive therapy)||||
1323714|NCT03287349|||Case-Only||Prospective|||||||
1323715|NCT03287336|Non-Randomized|Sequential Assignment||Prevention||Single||Three doses of Tranexamic acid (5 mg/kg, 10 mg/kg, and 15 mg/kg) will be used in a dose escalation fashion by cohort with the lowest dose first.||||t
1323769|NCT03286634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||risk stratification-directed chemotherapy||||
1573452|NCT00001153||||||||||||
1323717|NCT03287310|Randomized|Parallel Assignment||Treatment||Double||This is a multi-center, double-blind study in which subjects will be allocated to five cohorts. The subjects in each cohort will be randomized to receive GSK3511294 and placebo in a ratio of 3:1. In each cohort, dosing will be staggered: one subject will receive GSK3511294 and one subject will receive placebo at least 72 hours before the remaining subjects in that cohort are dosed. The remaining subjects will be dosed if the review of all safety data up to 72 hours after dosing of the first two subjects in each cohort is satisfactory.|t||t|
1323718|NCT03287297|||Cohort||Cross-Sectional|||||||
1323719|NCT03287284|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1323720|NCT03287271||Single Group Assignment||Treatment||None (Open Label)||||||
1323721|NCT03287258|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1323722|NCT03287245||Single Group Assignment||Treatment||None (Open Label)||||||
1323723|NCT03287232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323724|NCT03287219|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|None. Open label|Open label, staining efficacy exploratory study.||||
1323725|NCT03287206|||Cohort||Prospective|||||||
1323726|NCT03287193|||Cohort||Prospective|||||||
1323727|NCT03287180|Randomized|Parallel Assignment||Treatment||None (Open Label)||This 12-week randomized controlled pilot trial will begin by an induction on sublingual buprenorphine/naloxone for all participants who would usually receive buprenorphine based treatment in the clinic. After the two-week induction phase, participants will be randomized into two groups. While continuing buprenorphine/naloxone the experimental group will receive a 12-week course of A-CRA, while the control group will be provided medical management by the prescriber. Medical management is the standard treatment approach for prescribing buprenorphine and covers medication adherence, side effects of the medication, assessment of withdrawal/cravings and dose adjustment as indicated. After completion of the 12-week A-CRA intervention, all individuals will receive weekly medical management sessions until week 24 (6 month follow up).||||
1323728|NCT03287167|Randomized|Parallel Assignment||Treatment||Double||Parallel Assignment|t||t|
1323729|NCT03287154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323730|NCT03287141|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1323731|NCT03287128|||Cohort||Retrospective|||||||
1323732|NCT03287115||Single Group Assignment||Other||None (Open Label)||||||
1323733|NCT03287102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323734|NCT03287089|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1323735|NCT03287076|Randomized|Parallel Assignment||Treatment||Single||||||t
1323736|NCT03287063|||Cohort||Prospective|||||||
1323737|NCT03287050||Single Group Assignment||Treatment||None (Open Label)||||||
1323738|NCT03287037||Single Group Assignment||Treatment||None (Open Label)||Sixty patients with unipolar depression (major depressive disorder) and 60 with bipolar depression were treated with 10 sessions of tDCS.||||
1323739|NCT03287024||Single Group Assignment||Treatment||None (Open Label)||"Prospective, multi-centre, explorative single-arm study This open-label, non-randomized multi-centre study uses an umbrella protocol (Part A and Part B) designed to collect data for performance and safety as well as long-term safety data from pulmonary artery stenosis patients who are treated with the BeGrow stent system to treat the stenosis~Part A: Safety and Performance (Implantation and Re-dilatation) Part B: Safety on Long-Term Follow-up"||||
1323740|NCT03287011|Randomized|Parallel Assignment||Prevention||Double|Toothpaste tubes will be masked so the care provider would not know which tube he/she allocating to the participants as well the outcome assessor would be masked from both groups ( test and control) so data is assessed unbiased.|interventional preventive trial||t||t
1323741|NCT03286998|||Cohort||Prospective|||||||
1323742|NCT03286985|||Cohort||Prospective|||||||
1323743|NCT03286972|||Case-Only||Prospective|||||||
1323744|NCT03286959|Randomized|Parallel Assignment||Treatment||Double|double||t|||t
1323745|NCT03286946|Randomized|Parallel Assignment||Screening||Single||||||t
1323746|NCT03286933||Single Group Assignment||Treatment||None (Open Label)||||||
1323747|NCT03286920|||Cohort||Prospective|||||||
1323748|NCT03286907|Randomized|Parallel Assignment||Prevention||Single||||||t
1323749|NCT03286894|||Other||Cross-Sectional|||||||
1323750|NCT03286881|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1323751|NCT03286868|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled trial|t|||t
1323752|NCT03286855|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective feasibility open-label randomised controlled trial||||
1323753|NCT03286842||Single Group Assignment||Treatment||None (Open Label)||||||
1323754|NCT03286829|Randomized|Parallel Assignment||Other||Single|||t|||
1323755|NCT03286816|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1323756|NCT03286803|Randomized|Parallel Assignment||Prevention||None (Open Label)||This will be a four arms randomized controlled trial. Arms 1 and 2 will randomize children aged 14 weeks old into either full dose or fractional dose IPV and arms 3 and 4 will randomize children aged 9 months old into either full dose or fractional dose IPV||||
1323757|NCT03286790|||Cohort||Prospective|||||||
1323758|NCT03286777|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1323759|NCT03286764|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1323760|NCT03286751|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1323761|NCT03286738|||Case-Only||Prospective|||||||
1323762|NCT03286725|Randomized|Parallel Assignment||Treatment||Single|Single blind (outcome assessor)|Parallel assignment||||t
1323763|NCT03286712||Single Group Assignment||Treatment||None (Open Label)||||||
1323764|NCT03286699|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1323765|NCT03286686|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1323766|NCT03286673|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1323767|NCT03286660||Sequential Assignment||Diagnostic||None (Open Label)||||||
1323768|NCT03286647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323770|NCT03286621|||Case-Control||Cross-Sectional|||||||
1573453|NCT00001152||||||||||||
1323772|NCT03286595|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1323773|NCT03286582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323774|NCT03286569|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1323775|NCT03286556|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label randomized controlled trial.||||
1323776|NCT03286543|Randomized|Parallel Assignment||Treatment||None (Open Label)||Half of the subjects enrolled will be randomized (like flipping a coin) to the treatment group and half will be randomized to the control group. Both groups will receive the standard of care for pain management following total knee replacement surgery. Subjects in the treatment group will receive SPR's SPRINT Beta Peripheral Nerve Stimulation (PNS) System in addition to standard of care.||||
1323777|NCT03286530||Single Group Assignment||Treatment||None (Open Label)||||||
1323778|NCT03286517|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|All the participants were told for injecting the kisspeptin.|All the groups were injected with exogenous IV kisspeptin according to the body weight.||||
1323779|NCT03286504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323780|NCT03286491|||Cohort||Prospective|||||||
1323781|NCT03286478|Randomized|Parallel Assignment||Prevention||None (Open Label)|Masking not possible within design.|Parallel 4-arm cluster randomised controlled trial.||||
1323782|NCT03286465|Randomized|Parallel Assignment||Prevention||Single||||||t
1323783|NCT03286452|||Case-Only||Prospective|||||||
1323784|NCT03286439|||Cohort||Prospective|||||||
1323785|NCT03286426||Single Group Assignment||Screening||None (Open Label)||All patients will have images taken of the back of the eye with a portable fundus camera. If able, visual acuity and color vision will be checked.||||
1323786|NCT03286413|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323787|NCT03286400|||Cohort||Prospective|||||||
1323788|NCT03286387||Single Group Assignment||Basic Science||None (Open Label)||||||
1323789|NCT03286374||Single Group Assignment||Health Services Research||None (Open Label)|Due to the nature of the study intervention, it is not possible to blind the participants. Some of the participants will give a focus group interview and their identity will be known for the other participants in the group. The health care providers will not get information about who will participate or not.|The study is a Clinical cohort trial with a pseudo prospective, parallel mixed methods design. Questionnaires and register data at baseline, T1, and T2. Focus group interviews at T3, and register data at T4.||||
1323790|NCT03286361||Single Group Assignment||Treatment||None (Open Label)||||||
1323791|NCT03286348|||Ecologic or Community||Prospective|||||||
1323792|NCT03286335||Single Group Assignment||Treatment||None (Open Label)||||||
1323793|NCT03286322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323794|NCT03286309|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1323795|NCT03286296||Single Group Assignment||Treatment||None (Open Label)||||||
1323796|NCT03286283||Single Group Assignment||Treatment||None (Open Label)|This is a single-arm study in which investigators are not blinded. However, blinded Independent Photographic Reviewers (IPR) will be utilized to review all images (baseline and all follow-up time points) and assign FWS scores.|This is a multi-center, single arm, evaluator-blind prospective study of 55 study subjects who are seeking a procedure to reduce the appearance of wrinkles and rhytides. Enrolled study subjects will receive one procedure with J-Plasma at enrollment. Wrinkle severity will be assessed using the Fitzpatrick Wrinkle and Elastosis Scale (FWS) at baseline and at each follow-up time point. Scores at each follow-up time point will be compared to the scores at baseline for each enrolled subject.||||
1323797|NCT03286270|||Cohort||Retrospective|||||||
1323798|NCT03286257||Single Group Assignment||Treatment||None (Open Label)||||||
1323799|NCT03286244||Single Group Assignment||Treatment||None (Open Label)||||||
1323800|NCT03286231|||Cohort||Prospective|||||||
1323801|NCT03286218|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1323802|NCT03286205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323803|NCT03286192||Single Group Assignment||Supportive Care||None (Open Label)||Single group feasibility study of a psychosocial intervention||||
1323804|NCT03286179|||Cohort||Prospective|||||||
1323805|NCT03286166|||Case-Only||Retrospective|||||||
1323806|NCT03286153|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Subjects are randomized to receive factor based either on ideal body weight or actual body weight first followed by receiving factor based on the other category next||||
1323807|NCT03286140|Randomized|Parallel Assignment||Treatment||Single|Blinded assessment of ulcer healing photos|"The EVRA ulcer trial is a pragmatic; multicentre randomised clinical trial with participants randomised1:1 to either:~'Standard' therapy consisting of multilayer elastic compression bandaging/ stockings with deferred treatment of superficial reflux (usually once the ulcer has healed)~Early endovenous treatment of superficial venous reflux(within 2 weeks) in addition to standard therapy"||||t
1323808|NCT03286127|||Case-Only||Prospective|||||||
1323809|NCT03286114||Single Group Assignment||Treatment||None (Open Label)||||||
1323810|NCT03286101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323811|NCT03286088|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323812|NCT03286075|Randomized|Parallel Assignment||Health Services Research||Quadruple||3 arms will take part in the study: Anode tDCS Cathode tDCS Placebo tDCS These 3 types of tDCS stimulation will enable us to study the different modulations possible for the DLPFC and the impact on all the variables previously mentioned|t|t|t|t
1323813|NCT03286062||Single Group Assignment||Diagnostic||None (Open Label)||Multi dose Phase I study with injection of VM110 at 5 dose levels||||
1323814|NCT03286049|||Other||Prospective|||||||
1323815|NCT03286036|||Cohort||Prospective|||||||
1323816|NCT03286023|||Cohort||Prospective|||||||
1323817|NCT03286010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323818|NCT03285997|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1323968|NCT03284047|Randomized|Parallel Assignment||Treatment||Single||||||t
1323969|NCT03284034|Randomized|Parallel Assignment||Treatment||Single||||||t
1573454|NCT00001142||||||||||||
1323819|NCT03285984|Randomized|Crossover Assignment||Treatment||Double||The randomization schedule will indicate the treatment order sequence. Each subject will complete all four treatment regimens, one treatment regimen in each of the four treatment periods. This randomization will use a Williams Square layout and be provided by the Biostatistics Department, GSKCH.|||t|t
1323820|NCT03285971|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323821|NCT03285958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323822|NCT03285945|||Cohort||Prospective|||||||
1323823|NCT03285932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323824|NCT03285919|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1323825|NCT03285906||Single Group Assignment||Screening||None (Open Label)||||||
1323826|NCT03285893|||Cohort||Prospective|||||||
1323827|NCT03285880|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)|Within-subject; participants/experimenters are aware of conditions|Within subject comparison of nap and wake conditions||||
1323828|NCT03285867|||Cohort||Prospective|||||||
1323829|NCT03285854|||Case-Control||Prospective|||||||
1323830|NCT03285841|||Other||Other|||||||
1323831|NCT03285828|Non-Randomized|Parallel Assignment||Other||Single||A pilot pre-post study investigating the effects of a training programme, by comparing performance before and after its implementation|t|||
1323832|NCT03285815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323833|NCT03285802||Single Group Assignment||Treatment||None (Open Label)||||||
1323834|NCT03285789|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1323835|NCT03285776|||Case-Control||Cross-Sectional|||||||
1323836|NCT03285763||Single Group Assignment||Treatment||None (Open Label)||||||
1323837|NCT03285750|||Case-Control||Cross-Sectional|||||||
1323838|NCT03285737|Randomized|Parallel Assignment||Prevention||Double|Double blind|Parallel group design (with repeated measurements within each group)|t|||t
1323839|NCT03285724||||||||||||
1323840|NCT03285711|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323841|NCT03285698|Randomized|Parallel Assignment||Treatment||Single|Photographs are submitted and evaluated by a blind, independent assessor.|||||t
1323842|NCT03285685|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1323843|NCT03285672|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323844|NCT03285659|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1323845|NCT03285646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323846|NCT03285633||Single Group Assignment||Treatment||None (Open Label)||||||
1323847|NCT03285620|Randomized|Sequential Assignment||Treatment||Triple||Dose Escalation|t||t|t
1323848|NCT03285607|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1323849|NCT03285594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323850|NCT03285581||Single Group Assignment||Treatment||None (Open Label)||||||
1323851|NCT03285568|||Cohort||Retrospective|||||||
1323852|NCT03285555|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323853|NCT03285542|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323854|NCT03285529|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323855|NCT03285516||Single Group Assignment||Health Services Research||None (Open Label)||||||
1323856|NCT03285503||Single Group Assignment||Other||None (Open Label)||||||
1323857|NCT03285490|Randomized|Parallel Assignment||Treatment||Quadruple|All Central Vendors and the sponsor will be masked. The sponsor will unblind at the end of Day 57.|This study will test KX2-391 Ointment 1% against a placebo.|t|t|t|t
1323858|NCT03285477|Randomized|Parallel Assignment||Treatment||Quadruple|All Central Vendors and the sponsor will be masked. The sponsor will unblind at the end of Day 57.|This study will test KX2-391 Ointment 1% against a placebo.|t|t|t|t
1323859|NCT03285464|Randomized|Parallel Assignment||Treatment||Single|Only the subjects will not know which group they are being assigned to|One group will do current hip focused intervention published previously second group will receive a new hip intervention and then pre/post testing will take place for static and dynamic kinematics and hip strength|t|||
1323860|NCT03285451|||Other||Prospective|||||||
1323861|NCT03285438|Randomized|Parallel Assignment||Prevention||Single||The trial is designed as an academic, multicenter, open, with blind evaluation (PROBE), randomized, parallel arm, controlled.||||t
1323862|NCT03285425|||Cohort||Retrospective|||||||
1323863|NCT03285412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323864|NCT03285399|||Cohort||Prospective|||||||
1323865|NCT03285386|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||"Participants will serve as their own controls. Participants will alternate between primed (experimental condition) and non-primed (control condition) in their visits."||||
1323866|NCT03285373|||Cohort||Cross-Sectional|||||||
1323867|NCT03285360|Randomized|Parallel Assignment||Treatment||Double|double blinded|Dentin Hypersensitivity|t|||t
1323868|NCT03285347|Randomized|Parallel Assignment||Health Services Research||Single|Before and after the intervention period, the patients are tested in a neuropsychological battery to asses their executive functioning. The tester is blinded to the Group allocation of the patients.|Two intervention Groups training with each their computer-based cognitive programme, one control Group receiving no intervention except for the same amount of follow-ups as the two intervention Groups.||||t
1323869|NCT03285334|Randomized|Parallel Assignment||Treatment||Double|"The patients will drag an envelope and will not know to which group they will be assigned.~The patients who already do not know their treatment group will assess the level of their post-operative pain and will record the number of analgesic tablets used.~The laboratory technician at the microbiological department will not know the treatment group of the patients."||t|||t
1323870|NCT03285321|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1323871|NCT03285308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1323872|NCT03285295||||||||||||
1323873|NCT03285282|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1323874|NCT03285269|||Cohort||Prospective|||||||
1323875|NCT03285256|Randomized|Parallel Assignment||Treatment||Double|Both the participant and the research assistant conducting the assessments will be blinded to group assignment.|Participants will be randomly assigned to one of three treatment conditions: an experimental memory training program or one of two comparator memory training programs.|t||t|
1323876|NCT03285243|Randomized|Parallel Assignment||Prevention||Double|After enrollment and consent, each patient will be randomized to either placebo or intervention group. 110 sealed envelopes randomizing patients to the exposure group A (monochromatic light) or bulb B (placebo) white light bulb with blue outer coating. The recover room nursing staff will evaluate the patient using the PAED standard emergence delirium scale unaware of which light is monochromatic.|This is a double blinded randomized control trial. The placebo arm will serve as the control group. After enrollment and consent, each patient will be randomized to either placebo or intervention group. 110 sealed envelopes randomizing patients to the exposure group A (monochromatic light) or bulb B (placebo) white light bulb with blue outer coating.|t|t||
1323877|NCT03285230|||Cohort||Prospective|||||||
1323878|NCT03285217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323879|NCT03285204|||Case-Control||Prospective|||||||
1323880|NCT03285191|||Cohort||Cross-Sectional|||||||
1323881|NCT03285178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323882|NCT03285165|Randomized|Parallel Assignment||Treatment||Double|double-blind|this study will be accomplished to investigate the effect of dexmedetomidine sedation on the cerebral blood flow in intubated mechanically ventilated trauma patients with and without traumatic brain injury, in comparison with propofol.|t|||t
1323883|NCT03285152|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective, MSK investigator-initiated, multi-center, randomized, pilot study of KD vs SD consumption in treatment naïve endometrial cancer patients during the presurgical window period between diagnosis and surgical staging.||||
1323884|NCT03285139|Randomized|Parallel Assignment||Treatment||Single||||||t
1323885|NCT03285126|||Case-Only||Prospective|||||||
1323886|NCT03285113||Single Group Assignment||Treatment||None (Open Label)||||||
1323887|NCT03285100|||Cohort||Prospective|||||||
1323888|NCT03285087||Single Group Assignment||Treatment||None (Open Label)|Open label|The primary end point will be the occurrence of at least 1 episode of clinically significant hemodynamic instability during dexmedetomidine therapy defined as systolic blood pressure (SBP) < 80 mm Hg, diastolic blood pressure (DBP) <50 mm Hg, or heart rate <50 beats per minute (bpm) To qualify as an event, the hemodynamic variable had to remain below the specified threshold for at least 2 consecutive readings (≥30 minutes of recorded hemodynamic instability). The cumulative incidence of hemodynamic instability events during dexmedetomidine sedation will be plotted and Cox proportional hazards models will be constructed to determine hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk factors of hemodynamic instability during dexmedetomidine therapy.||||
1323889|NCT03285074|||Cohort||Prospective|||||||
1323890|NCT03285061|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1323891|NCT03285048||Single Group Assignment||Treatment||None (Open Label)||||||
1323892|NCT03285035|||Cohort||Prospective|||||||
1323893|NCT03285022|Randomized|Parallel Assignment||Treatment||Double|Outcome assessor and participant will be blinded to the type of material||t|||t
1323894|NCT03285009||Single Group Assignment||Prevention||None (Open Label)|Masking not possible as individual treatment is given|||||
1323895|NCT03284996|||Case-Control||Cross-Sectional|||||||
1323896|NCT03284983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323897|NCT03284970|||Cohort||Retrospective|||||||
1323898|NCT03284957|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323899|NCT03284944|||Cohort||Prospective|||||||
1323900|NCT03284931|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1323901|NCT03284918|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323902|NCT03284905|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1323903|NCT03284892|Randomized|Parallel Assignment||Treatment||Double||"The first stage is to test the accuracy of a two-step Post-extubation dysphagia screening tool. Every participants will receive the screening and FEES examination.~The second stage of this study will be an intervention study. All participants will randomly assigned into the intervention or control group. The control group only receive the usual care in the unit they stay while the intervention group received additional 7-day, once-daily PED Care including oral exercise, oral cleaning and intake education."|t|||t
1323904|NCT03284879|||Case-Only||Prospective|||||||
1323905|NCT03284866|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1323906|NCT03284853|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1323907|NCT03284840|||Ecologic or Community||Cross-Sectional|||||||
1323908|NCT03284827|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1323909|NCT03284814|Randomized|Crossover Assignment||Other||None (Open Label)||Three-period crossover bioavailability study will include 21 subjects who will test three CoQ10 formulations. Subjects will test 3 formulations of single dose CoQ10 within first 3 weeks to assess bioavailability, which will be followed with 2 weeks of continuous administration of one of study formulations to demonstrate and assesse multiple-dose profile of CoQ10.||||
1323910|NCT03284801|||Case-Only||Prospective|||||||
1323911|NCT03284788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323912|NCT03284775||Single Group Assignment||Treatment||None (Open Label)||||||
1323913|NCT03284762|||Cohort||Prospective|||||||
1323914|NCT03284749|Randomized|Parallel Assignment||Prevention||Quadruple|"After inclusion all patients will be randomised for a wound dressing or maternity pad with (study group) or without copper (control group). The two sets of wound dressings and pads will be marked A or B. Both the clinician and the patient will be blinded to the randomised group. Only the manufacturer will be aware of which group contains copper."|All women are randomised to either the copper or the control group. Randomisation will be done separately for the caesarean section and vaginal delivery group.|t|t|t|t
1323970|NCT03284021||Single Group Assignment||Treatment||None (Open Label)||||||
1323971|NCT03284008|Randomized|Parallel Assignment||Treatment||Single||||||t
1323972|NCT03283995|||Case-Control||Prospective|||||||
1323915|NCT03284736|Randomized|Parallel Assignment||Treatment||Double|Both the participant and primary investigator are blinded in the study until whole surgical procedure is completed and before suturing the flap.|A total number of 15 patients in each group were selected. Patients were randomly allocated by computer program into two group. Clinical and radiographic examinations were performed every 3, 6 and 12 months by assessing the same parameters as baseline except that PD, CAL, and GMP were measured until 12 months. Routine examination procedure were used to evaluate any evidence of signs and/or symptoms. Jig radiographs were taken at 3, 6 and 12th month of follow up. Inter and intra observation of data will be analyzed by distribution of data. Categorical data will be analyzed by chi square test. Regression analysis will be done to observe any association between independent and dependent variables. Interobserver/intraobserver reliability with cohen kappa analysis.|t||t|
1323916|NCT03284723||Sequential Assignment||Treatment||None (Open Label)||||||
1323917|NCT03284710|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1323918|NCT03284697|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1323919|NCT03284684|||Case-Only||Prospective|||||||
1323920|NCT03284671||Single Group Assignment||Treatment||None (Open Label)||||||
1323921|NCT03284658|||Cohort||Prospective|||||||
1323922|NCT03284645|||Cohort||Prospective|||||||
1323923|NCT03284632|||Cohort||Prospective|||||||
1323924|NCT03284619||Single Group Assignment||Treatment||None (Open Label)||Proof of concept including accuracy and safety aspects according to R-IDEAL stage 1 criteria||||
1323925|NCT03284606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323926|NCT03284593|||Cohort||Retrospective|||||||
1323927|NCT03284580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323928|NCT03284567|Randomized|Parallel Assignment||Supportive Care||Single|Personnel assessing the primary outcome is blinded for study participants group allocation.|1/3 of participants will be randomly allocated to the control group and 2/3 of participants will be randomly allocated to the Football fitness intervention group.||||t
1323929|NCT03284554|Randomized|Crossover Assignment||Prevention||Quadruple|Double-blind|A double-blind, randomized crossover design with four arms including three experimental conditions and placebo|t|t|t|t
1323930|NCT03284541|Randomized|Parallel Assignment||Prevention||Double||Couples are randomized into an experimental condition or existing public health practice.|t||t|
1323931|NCT03284528|||Cohort||Retrospective|||||||
1323932|NCT03284515|||Cohort||Prospective|||||||
1323933|NCT03284502|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1323934|NCT03284489|||Cohort||Prospective|||||||
1323935|NCT03284476|||Cohort||Prospective|||||||
1323936|NCT03284463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1323937|NCT03284450|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1323938|NCT03284437|Randomized|Parallel Assignment||Supportive Care||Single|Outcomes assessor is not participating in patient enrollment or administration of study intervention and will not be aware of study group assignment.|Randomized controlled trial||||t
1323939|NCT03284424|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323940|NCT03284411||Single Group Assignment||Treatment||None (Open Label)||||||
1323941|NCT03284398|||Other||Retrospective|||||||
1323942|NCT03284385||Single Group Assignment||Treatment||None (Open Label)||||||
1323943|NCT03284372|Randomized|Factorial Assignment||Prevention||Single||||||t
1323944|NCT03284359|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1323945|NCT03284346|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323946|NCT03284333||Single Group Assignment||Other||None (Open Label)||||||
1323947|NCT03284320|||Cohort||Retrospective|||||||
1323948|NCT03284307||Single Group Assignment||Basic Science||None (Open Label)||||||
1323949|NCT03284294|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized Controlled Trial|t|t|t|t
1323950|NCT03284281|Randomized|Parallel Assignment||Treatment||Single||||||t
1323951|NCT03284268||Single Group Assignment||Treatment||None (Open Label)||||||
1323952|NCT03284255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323953|NCT03284242||Single Group Assignment||Treatment||None (Open Label)||Single intravenous infusion of autologous, ex vivo, expanded Treg cells in renal transplant recipients who are on Everolimus-based immunosupressive therapy.||||
1323954|NCT03284229||Single Group Assignment||Treatment||None (Open Label)||As per the 25th SEC (Cardiovascular & Renal) meeting which deliberated the proposals on 30-10-2015 and recommended the firm (Spectranetics Corporation - Sponsor) shall conduct a Bridging study in Indian Population at least 25 patients with coronary artery disease. The directorate suggested that the sponsor submit a protocol for the study in India for clinical trial approval. Considering the 5 dropouts, Sponsor has set up this protocol to conduct the Excimer Laser Coronary Atherectomy (ELCA®) study in India on 30 eligible patients across 05 sites as a Stand-alone modality or in conjunction with Percutaneous Transluminal Coronary Balloon Angioplasty (PTCA) in single or multi-vessel coronary artery disease.||||
1323955|NCT03284216|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1323956|NCT03284203||Single Group Assignment||Health Services Research||None (Open Label)||||||
1323957|NCT03284190|||Cohort||Retrospective|||||||
1323958|NCT03284177||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323959|NCT03284164|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Tenofovir exalidex (TXL)||||
1323960|NCT03284151|||Cohort||Prospective|||||||
1323961|NCT03284138|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1323962|NCT03284125|||Cohort||Prospective|||||||
1323963|NCT03284112|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1323964|NCT03284099|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1323965|NCT03284086|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1323966|NCT03284073||Single Group Assignment||Treatment||None (Open Label)||Human uterus transplantation from a live donor||||
1323967|NCT03284060||Single Group Assignment||Treatment||None (Open Label)||open Label||||
1575713|NCT00000760||||Treatment||||||||
1323973|NCT03283982|Randomized|Parallel Assignment||Treatment||Single|||t|||
1323974|NCT03283969|Randomized|Crossover Assignment||Basic Science||Triple|The test powders where pre-packaged by the study sponsor and sent to the investigators coded.|Randomized, double-blind, controlled crossover dietary intervention trial|t|t|t|
1323975|NCT03283956|||Case-Control||Retrospective|||||||
1323976|NCT03283943||Single Group Assignment||Treatment||None (Open Label)||||||
1323977|NCT03283930|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1323978|NCT03283917||Single Group Assignment||Treatment||None (Open Label)||||||
1323979|NCT03283904||Single Group Assignment||Prevention||None (Open Label)||Control vs Intervention clusters of schools||||
1323980|NCT03283891|Randomized|Parallel Assignment||Other||Single||Mixed methods cluster randomised controlled trial||||t
1323981|NCT03283878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323982|NCT03283865||Single Group Assignment||Treatment||None (Open Label)|"Single blinded prospective trial in which all patients serve as their own clinical control group.~Provider doing the procedure will be blinded to intervention"|Single blinded prospective trial in which all patients serve as their own clinical control group.||||
1323983|NCT03283852|||Cohort||Cross-Sectional|||||||
1323984|NCT03283839|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1323985|NCT03283826||Sequential Assignment||Treatment||None (Open Label)||||||
1323986|NCT03283813|Randomized|Parallel Assignment||Treatment||Quadruple|The study is a triple blind study in which the treatment or intervention is unknown to the research participant, the individuals who administer the treatment or intervention, and the researchers who assess the outcomes.||t|t|t|t
1323987|NCT03283800|Randomized|Parallel Assignment||Supportive Care||Quadruple|All stockings are marked with an 'L' for the left or 'R' for the right foot. The manufacturer has randomly marked the copper stockings with an 'L' or 'R' and paired these with a non-copper stocking. A closed envelope will contain the unique numbers of all the pairs of stockings and the information on which stocking contains the copper. This envelope will remain closed for the whole recruitment period and throughout analysis of the results.|All participants will be asked to wear compression stockings. One of the pair will have copper oxide ions permanently attached to the nylon fibres and these stockings will contain 2-3% copper ions. The participants will wear a copper stocking on one leg (study leg) and a non-copper stocking on the other (control leg).|t|t|t|t
1323988|NCT03283787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1323989|NCT03283774|||Ecologic or Community||Prospective|||||||
1323990|NCT03283761||Single Group Assignment||Treatment||None (Open Label)|Open-Label|||||
1323991|NCT03283748||Single Group Assignment||Diagnostic||None (Open Label)||||||
1323992|NCT03283735|Randomized|Parallel Assignment||Prevention||Double||"This phase of the study is expected to start in September 2019 and will last for 6 months.~Two groups will be created with a minimum of 190 patients each, one of which will be composed from patients from the region of Aveiro, Coimbra and Guarda and the other from patients from the region of Castelo Branco, Leiria and Viseu. In the intervention group the investigators will give enablement tools and talks with their GPs about how to issue the problem of polypharmacy. The information given in this group will result from the knowledge obtained in phase II in the shape of small leaflets and other information materials to be made according to the best practice, to be given and remembered at scheduled times to the intervention group."|t||t|
1323993|NCT03283722|||Cohort||Prospective|||||||
1323994|NCT03283709|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|A prospective, randomized controlled trial comparing treatment outcomes for partial edentulism using two restorative materials. A convenience sample of study participants will be randomly assigned to either a treatment group or a control group.||||
1323995|NCT03283696||Single Group Assignment||Treatment||None (Open Label)||||||
1323996|NCT03283683|||Cohort||Prospective|||||||
1323997|NCT03283670|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1323998|NCT03283657|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1323999|NCT03283644|||Case-Control||Prospective|||||||
1324000|NCT03283631||Single Group Assignment||Treatment||None (Open Label)||||||
1324001|NCT03283618|Randomized|Parallel Assignment||Other||Single|Following baseline visits, participants were randomized to a video conference or control groups.|All subjects were randomized in a balanced fashion and stratified by sex into either one of the two groups video conferencing or a control group.|t|||
1324002|NCT03283605||Single Group Assignment||Treatment||None (Open Label)|Open-label|Single group assignment||||
1324003|NCT03283592|Randomized|Parallel Assignment||Health Services Research||Single|Single blind (outcome assessor)|2-arm, parallel assignment||||t
1324004|NCT03283579|||Cohort||Prospective|||||||
1324005|NCT03283566|Randomized|Parallel Assignment||Treatment||Triple|The study will be single-blinded. The PI, biostatistician who will analyze the data, consultants, and technicians running assays will be blinded to the study arm into which the subjects have been randomized. An alphanumeric identifier that refers to the study subject without any indicators of study arm allocation will be used. Only the surgeons and the research coordinator, but not the personnel conducting the metabolic studies, will be un-blinded as to the study arm randomization.|open label, randomized, two-arm, single-blinded, placebo-controlled, parallel|t||t|t
1324006|NCT03283553|Randomized|Parallel Assignment||Health Services Research||Double||||t|t|
1324007|NCT03283540|||Cohort||Prospective|||||||
1324008|NCT03283527|||Case-Only||Prospective|||||||
1324009|NCT03283514|||Other||Prospective|||||||
1324010|NCT03283501|||Cohort||Retrospective|||||||
1324011|NCT03283488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324051|NCT03282968|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1324052|NCT03282955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324053|NCT03282942|Randomized|Factorial Assignment||Treatment||Single||||||t
1324054|NCT03282929|Randomized|Crossover Assignment||Treatment||None (Open Label)||Pharmacokinetics and pharmacodynamics of epinephrine in healthy male and female subjects with different skin-to-muscle depth (STMD) of the thigh after injections with four different marketed auto-injectors||||
1324055|NCT03282916|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1324012|NCT03283475|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||"The sample will be divided into two groups:- - Control group which will include 60 adult individuals between 18 and 35 years old who have BMI between 19 and 25, not complaining of any thigh contour deformities or skin redundancy with no history of body weight fluctuations. This group will be divided into two subgroups, 30 males and 30 females.~The following measurements will be recorded :- Weight, height, thigh length, hip circumference, maximum buttocks circumference, upper thigh, middle thigh and lower thigh circumferences.~- Patient group which will include 40 patients suffering from thigh lipodystrophy and contour deformities who will undergo surgical intervention after their assessment.~After assessment, one of the following techniques will be selected:-~Liposuction only.~thigh lift.~Liposuction assisted thigh lift."||||
1324013|NCT03283462|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1324014|NCT03283449||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324015|NCT03283436|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded to the treatment arm; however, the surgeon will know if a patient has been randomized to receive the block during the hysterectomy.||t|||
1324016|NCT03283423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1324017|NCT03283410||Single Group Assignment||Supportive Care||None (Open Label)||||||
1324018|NCT03283397|Randomized|Parallel Assignment||Treatment||Single|A blinded examining neurologist/assessor will conduct neurological examinations, relapse and EDSS evaluations at each site. Treating investigators will not be blinded to the study treatment. Additionally, blinded evaluation of MRI scans will be performed at a central reading facility in which, anonymized and standardized images of patient with RRMS will be read by a treatment blinded assessor and data will be implemented in a post-hoc analysis for selected time-points.|Patients will be randomized to one of the two treatment arms and will be observed during the treatment period of 144 weeks||||t
1324019|NCT03283384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324020|NCT03283371|Randomized|Parallel Assignment||Treatment||Triple|Double-blind|This is a 6-month randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of natalizumab as adjunctive therapy in the treatment of adult subjects with drug-resistant focal epilepsy. The placebo-controlled phase is followed by a 6-month open-label phase during which all subjects receive natalizumab.|t||t|t
1324021|NCT03283358|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324022|NCT03283345|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1324023|NCT03283332|||Cohort||Prospective|||||||
1324024|NCT03283319|Randomized|Parallel Assignment||Prevention||Quadruple||Participants will be randomized to one of the six treatment groups at Day 1 and will receive the assigned dose of antigen and adjuvant on Day 1 and Day 29.|t|t|t|t
1324025|NCT03283306|||Cohort||Prospective|||||||
1324026|NCT03283293||Single Group Assignment||Treatment||None (Open Label)||||||
1324027|NCT03283280|Randomized|Parallel Assignment||Treatment||Single|The outcome assessors will be blinded to the material type|||||t
1324028|NCT03283267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324029|NCT03283254|Randomized|Parallel Assignment||Prevention||Single|The person administering the outcome measures is blind to participant group.|Two groups: One receives PREPP prevention intervention and the other group receives Enhanced Treatment as Usual (psychoeducation about Postpartum Depression, referral and monitoring)||||t
1324030|NCT03283241|Randomized|Parallel Assignment||Treatment||Triple|The devices are delivered single packed and sterile to distributor. The distributor performs blinding, randomization and distribution. The labels are, after blinding of lot number, identical for both the Active and the placebo device.|Parallel groups ration 1;1|t|t|t|
1324031|NCT03283228|||Case-Control||Cross-Sectional|||||||
1324032|NCT03283215|||Cohort||Prospective|||||||
1324033|NCT03283202||Single Group Assignment||Treatment||None (Open Label)||||||
1324034|NCT03283189|||Other||Cross-Sectional|||||||
1324035|NCT03283176|||Cohort||Prospective|||||||
1324036|NCT03283163|Non-Randomized|Parallel Assignment||Treatment||Single|The endpoint assessor will have no knowledge of which study group the participant belongs to.|This study includes two groups: Trauma-exposed healthy controls and individuals suffering from both chronic musculoskeletal pain and PTSD. Those who meet diagnostic criteria for Chronic pain and PTSD will be assigned to that group. Those who are trauma exposed and do not meet criteria for Chronic Pain and PTSD will be assigned to the trauma-exposed control group.||||t
1324037|NCT03283150|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1324038|NCT03283137||Single Group Assignment||Treatment||None (Open Label)||||||
1324039|NCT03283124|Randomized|Parallel Assignment||Treatment||Single|participant and investigator are not blinded. outcome assessor who are in charge of follow-up assement is masked.|||||t
1324040|NCT03283111||Single Group Assignment||Treatment||None (Open Label)||||||
1324041|NCT03283098|Randomized|Parallel Assignment||Treatment||Triple||This is a multiple dose, double-blind, randomized, placebo-controlled clinical study conducted in Chinese subjects residing in Mainland China with chronic kidney disease receiving hemodialysis. The treatment duration will be approximately 4 weeks with a post treatment followup of 4 weeks. A dose will be given at each scheduled hemodialysis session (Dose administered three times a week for 4 weeks, for a total of 12 doses).|t|t|t|
1324042|NCT03283085|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324043|NCT03283072|Randomized|Sequential Assignment||Other||Triple|Participants can't see the device and therefore the settings. The assessment of sensory function is done by a separate investigator who did not participate in the set up of the hypoxicator|within subjects design with randomization of presentation of the different hypoxia/normoxia intervals.|t||t|t
1324044|NCT03283059|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324045|NCT03283046||Single Group Assignment||Treatment||None (Open Label)||||||
1324046|NCT03283033|Randomized|Parallel Assignment||Prevention||Single|||t|||
1324047|NCT03283020|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1324048|NCT03283007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324049|NCT03282994||||||||||||
1324050|NCT03282981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1575714|NCT00000759|||Natural History|||||||||
1324057|NCT03282890|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324058|NCT03282877|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1324059|NCT03282864|Randomized|Crossover Assignment||Prevention||Triple|The real air filtration device and the placebo air filtration device looked identical, however the placebo air filtration device lacked the HEPA and active carbon filters which functioned to remove airborne pollutants.|Every study subject had the air in their bedroom processed by an air filtration device (with a pre-filter, a HEPA filter and an active carbon filter) for two weeks (active comparator arm), processed by a placebo air filtration device (which did not possess the HEPA filter and active carbon filters) for two weeks (placebo arm), and underwent a two-week washout period (no use of air filtration device) between the two intervention periods.|t|t||t
1324060|NCT03282851|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1324061|NCT03282838|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1324062|NCT03282825||Single Group Assignment||Treatment||None (Open Label)||||||
1324063|NCT03282812|||Case-Control||Prospective|||||||
1324064|NCT03282799|Randomized|Parallel Assignment||Treatment||Single||||||t
1324065|NCT03282786|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1324066|NCT03282773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324067|NCT03282760||Sequential Assignment||Treatment||None (Open Label)||"Fifteen to 24 patients affected by SPMS will be enrolled, according to a standard phase I design over 18 months. All patients will enter a 3 months run in phase. Thereafter they will receive one of four different doses of allogenic hNSCs (dose A=5 millions hNSCs; dose B=10 millionshNSCs; dose C=16 millions hNSCs; dose D=24 millions hNSCs)."||||
1324068|NCT03282747|||Cohort||Cross-Sectional|||||||
1324069|NCT03282734|Randomized|Parallel Assignment||Treatment||Single||||||t
1324070|NCT03282721|||Case-Control||Retrospective|||||||
1324071|NCT03282708|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||"1 group of caretakers (9 volunteers). For this group: one sample collection of spontaneously produced fresh stools (of the approximate size of 3 green beans);~1 group of caretakers (8 volunteers). For this group: no intervention (participant-observation only)"||||
1324072|NCT03282695|||Cohort||Prospective|||||||
1324073|NCT03282682|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||The study is 3 arms 12-week strength training program to assess the effect of testosterone replacement therapy (TRT) with strength training (ST) and strength training (ST) for hypogonadal patients without testosterone replacement therapy (NON-TRT) with control healthy eugonadal group, that is also engaged in strength training.||||
1324074|NCT03282669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324075|NCT03282656||Single Group Assignment||Treatment||None (Open Label)||Open-label, non-randomized, single center, pilot and feasibility, single arm cohort study||||
1324076|NCT03282643|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324077|NCT03282630|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1324078|NCT03282617|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be given CD137L-DC-EBV-VAX for about 5 - 7 times and be followed up until a maximum of 3 years from study entry.||||
1324079|NCT03282604|||Cohort||Prospective|||||||
1324080|NCT03282591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324081|NCT03282578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324082|NCT03282565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324083|NCT03282552|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1324084|NCT03282539|||Cohort||Prospective|||||||
1324085|NCT03282526|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1324086|NCT03282513|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324087|NCT03282500|Randomized|Parallel Assignment||Treatment||Triple|The participants and outcomes assessor are blind to the assigned condition.|Participants are randomly assigned to either the experimental condition or the active control condition.|t|t||t
1324088|NCT03282487|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1324089|NCT03282474||Single Group Assignment||Treatment||None (Open Label)||Prospective, open-label, single-arm multicenter, phase II pilot trial||||
1324090|NCT03282461||Single Group Assignment||Treatment||None (Open Label)|none - open label|open label||||
1324091|NCT03282448|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324092|NCT03282435|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1324093|NCT03282422|Randomized|Parallel Assignment||Treatment||Double||Randomized Controlled Trial|||t|t
1324094|NCT03282409|||Cohort||Prospective|||||||
1324095|NCT03282396||Single Group Assignment||Treatment||None (Open Label)||||||
1324096|NCT03282383|||Case-Crossover||Prospective|||||||
1324097|NCT03282370|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1324098|NCT03282357|Randomized|Single Group Assignment||Treatment||Triple||Split-face|t|t||t
1324099|NCT03282344|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is an open-label, multi-center, pilot study to evaluate the efficacy of NKTR- 214 in combination with nivolumab in patients with selected locally advanced/metastatic, high grade sarcoma.||||
1324100|NCT03282331|Randomized|Parallel Assignment||Treatment|||open|||||
1324101|NCT03282318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324102|NCT03282305|||Cohort||Prospective|||||||
1324103|NCT03282292|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized controlled trial||||
1324104|NCT03282279|||Case-Only||Retrospective|||||||
1324105|NCT03282266|Randomized|Parallel Assignment||Treatment||Single|sham operation||t|||
1324106|NCT03282253|||Cohort||Prospective|||||||
1324107|NCT03282240|Randomized|Parallel Assignment||Prevention||Double|QHD00013 will be a modified double-blind trial with an unblinded administrator used at each trial site. The administrator will not be involved in any of the blinded study assessments (e.g., safety).|QHD00013 is a phase III, randomized, modified double-blind, active-controlled, multi-center trial.|t|||t
1324108|NCT03282227||Single Group Assignment||Treatment||None (Open Label)|Open-label|Single dose, open-label treatment||||
1324109|NCT03282214|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1324110|NCT03282201|||Other||Prospective|||||||
1324111|NCT03282188|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||This is a open-label, non-randomised, single centre study.||||
1324112|NCT03282175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324113|NCT03282162|Randomized|Crossover Assignment||Basic Science||Triple||Randomized placebo-controlled double-blind within-subject design|t||t|t
1324114|NCT03282149|Randomized|Sequential Assignment||Treatment||Quadruple|Unblinded pharmacy provides injection preparation for blinded administration|Inflammation and pain due to osteoarthritis in the knee|t|t|t|t
1324115|NCT03282136|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324116|NCT03282123||Single Group Assignment||Treatment||None (Open Label)|This study will be open label|Examining safety and effects of three sessions of MDMA-assisted psychotherapy, with Clinician-Administered PTSD Scale for DSM 5 (CAPS-5) severity after treatment compared with baseline||||
1324117|NCT03282110|Randomized|Parallel Assignment||Treatment||Single||||||t
1324118|NCT03282097|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1324119|NCT03282084|||Other||Prospective|||||||
1324120|NCT03282071|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324121|NCT03282058|Randomized|Parallel Assignment||Supportive Care||Single|Histology of the healing tissues will be examined by a pathologist who is blinded to whether the patient received or did not receive stenting.|Participants will be randomly assigned in one of two groups (stent vs no stent).||||t
1324122|NCT03282045|Randomized|Parallel Assignment||Treatment||Single|||||t|
1324123|NCT03282032|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1324124|NCT03282019|Randomized|Parallel Assignment||Treatment||Single||||||t
1324125|NCT03282006||Single Group Assignment||Treatment||None (Open Label)||||||
1324126|NCT03281993|||Other||Prospective|||||||
1324127|NCT03281980|Randomized|Parallel Assignment||Other||Single|The testers of the participants will not have the information about type of intervention of the children|||||t
1324128|NCT03281967||Single Group Assignment||Treatment||None (Open Label)||||||
1324129|NCT03281954|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1324130|NCT03281941||Single Group Assignment||Other||None (Open Label)||||||
1324131|NCT03281928|Randomized|Crossover Assignment||Other||Double|||||t|t
1324132|NCT03281915|||Case-Only||Prospective|||||||
1324133|NCT03281902|||Other||Prospective|||||||
1324134|NCT03281889||Single Group Assignment||Treatment||None (Open Label)||||||
1324135|NCT03281876|Randomized|Parallel Assignment||Prevention||Quadruple|"Data will be collected in an observer-blind manner. By observer-blind, it is meant that during the course of the study, the vaccine recipient and those responsible for the evaluation of any study endpoint (e.g. safety, reactogenicity and efficacy) will all be unaware of whether vaccine or placebo was administered. Each study site is responsible for having a blinding plan. To work in an observer-blind manner, vaccine preparation and administration will be done by authorised medical personnel who will not participate in any of the study clinical evaluation assays. Two teams of study personnel will hence be set up:~A team of unblinded personnel (responsible for the preparation and the administration of the vaccines)~A team of blinded personnel (responsible for the clinical evaluation of the subjects)."|Phase IIB, randomised, observer-blind, placebo-controlled, multi-centric study with two parallel groups.|t|t|t|t
1324136|NCT03281863|||Cohort||Prospective|||||||
1324137|NCT03281850|||Cohort||Prospective|||||||
1324138|NCT03281837|Randomized|Crossover Assignment||Treatment||Double|This is a single-blind study. There will be a blinded evaluator who will not be informed about the intervention (Hymovis + PEP or PEP alone) to which study subjects will be randomized|"This post-market, single blind, multicenter, randomized, controlled clinical study is designed to enroll a relatively young, active population of subjects with patellofemoral osteoarthritis (PFOA) and/or tibiofemoral osteoarthritis (TFOA), and to compare responses to treatment with HYMOVIS injections combined with a physical exercise program (PEP) to PEP alone. The study provides for subjects randomized to the PEP alone study group to cross over to HYMOVIS+PEP if improvement has not been achieved by the 3 month follow up visit.~Subjects will be recruited over a 18 month period. The duration of the trial per center will be approximately 27 months. This includes the enrollment period of 6 months, the follow-up period at 3 and 6 months and the additional follow-up period for patients who crossed-over; they will be followed for an additional 6 months following the initial 3month follow-up. The trial will end when the last subject makes the last visit."|||t|t
1324139|NCT03281824||Single Group Assignment||Other||None (Open Label)||||||
1324140|NCT03281811||Single Group Assignment||Treatment||None (Open Label)||||||
1324141|NCT03281798||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1324142|NCT03281785|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1324143|NCT03281772|||Case-Only||Prospective|||||||
1324144|NCT03281759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324145|NCT03281746|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324146|NCT03281733|||Cohort||Retrospective|||||||
1324147|NCT03281720||Single Group Assignment||Treatment||None (Open Label)||||||
1324148|NCT03281707|||Cohort||Prospective|||||||
1324149|NCT03281694||Single Group Assignment||Basic Science||None (Open Label)|The study will be double-blind. Only the statistician performing randomization and the dispensing pharmacist will know the sequence of test conditions.|||||
1324150|NCT03281681||Single Group Assignment||Treatment||None (Open Label)||||||
1324151|NCT03281668||Single Group Assignment||Treatment||None (Open Label)||Single Group assignment||||
1324152|NCT03281655||Single Group Assignment||Treatment||None (Open Label)||Single cohort study||||
1324153|NCT03281642|||Other||Other|||||||
1324154|NCT03281629|Randomized|Parallel Assignment||Other||Double|||t|||t
1324155|NCT03281616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324156|NCT03281603|Randomized|Parallel Assignment||Treatment||Single|The Principal investigator, main supervisors and co-supervisor cannot be blinded as the trial will include digital designing of complete dentures on the CAD software and in the steps of the manufacturing techniques.||t|||
1324158|NCT03281577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324159|NCT03281564|||Case-Only||Prospective|||||||
1324160|NCT03281551||Single Group Assignment||Treatment||None (Open Label)||||||
1324161|NCT03281538||Single Group Assignment||Treatment||None (Open Label)||||||
1324162|NCT03281525|||Other||Other|||||||
1324163|NCT03281512|||Cohort||Prospective|||||||
1324164|NCT03281499||Single Group Assignment||Treatment||None (Open Label)|No masking will be used in this study for both participants and the study team|There will only be a single group of participants in this study||||
1324165|NCT03281486|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1324166|NCT03281473|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1324167|NCT03281460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324168|NCT03281447|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1324169|NCT03281434|Randomized|Parallel Assignment||Other||Double|Double blind|Parallel group design (with repeated measurements within each group)|t|||t
1324170|NCT03281421|Randomized|Parallel Assignment||Treatment||Single|||||t|
1324171|NCT03281408|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||80 patients at risk for OSA complications are cared for after surgery following current hospital protocol. Subsequent to that, 80 more patients are cared for with an updated hospital protocol that is more intense.||||
1324172|NCT03281395|||Case-Control||Retrospective|||||||
1324173|NCT03281382||Single Group Assignment||Treatment||None (Open Label)||||||
1324174|NCT03281369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324175|NCT03281356||Single Group Assignment||Prevention||None (Open Label)||||||
1324176|NCT03281343|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324177|NCT03281330|||Cohort||Prospective|||||||
1324178|NCT03281317|||Cohort||Prospective|||||||
1324179|NCT03281304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324180|NCT03281291|||Cohort||Prospective|||||||
1324181|NCT03281278|||Cohort||Prospective|||||||
1324182|NCT03281265|||Cohort||Retrospective|||||||
1324183|NCT03281252|||Cohort||Prospective|||||||
1324184|NCT03281239||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324185|NCT03281226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324186|NCT03281213|||Other||Retrospective|||||||
1324187|NCT03281200|||Other||Retrospective|||||||
1324188|NCT03281187|Randomized|Parallel Assignment||Treatment||Double|Due to the differences on test and comparator product a double-dummy design will be used retaining the blind of the study. Therefore each participant will receive an active product and inactive medication (placebo).||t||t|
1324189|NCT03281174|||Other||Prospective|||||||
1324190|NCT03281161|Randomized|Parallel Assignment||Prevention||Single|Participants were not aware of the condition in which their organization was enrolled.||t|||
1324191|NCT03281148|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324192|NCT03281135|Randomized|Parallel Assignment||Screening||None (Open Label)||A cluster randomized trial will be conducted in the Health and Demographic Surveillance Site (HDSS) of Addis Ababa University, School of Public Health which is located in Butajira district. The study population consists of women aged 30-49 who are found among the catchment population of ten Kebele's(Smallest Administrative Unit). Each Kebele will have 2 or more clusters based on the community health workers structure and size. A total of 22 clusters will then be randomized in to two arms. A total of 1760 women will be grouped in to 22 clusters, each comprises 80 women.||||
1324193|NCT03281122|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1324194|NCT03281109|||Case-Only||Prospective|||||||
1324195|NCT03281096|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1324196|NCT03281083||Single Group Assignment||Treatment||None (Open Label)||Single arm study.||||
1324197|NCT03281070|||Cohort||Retrospective|||||||
1324198|NCT03281057|Randomized|Parallel Assignment||Treatment||Single||Cluster randomization Clinical trial with 3 arms - individual, group, and self-help intervention.|t|||
1324199|NCT03281044|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1324200|NCT03281031||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324201|NCT03281018|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324202|NCT03281005|||Case-Control||Prospective|||||||
1324203|NCT03280992|||Cohort||Prospective|||||||
1324204|NCT03280979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324205|NCT03280953|||Case-Only||Prospective|||||||
1324206|NCT03280940|||Other||Retrospective|||||||
1324207|NCT03280927||Single Group Assignment||Treatment||None (Open Label)||||||
1324208|NCT03280914|||Case-Control||Prospective|||||||
1324209|NCT03280901|Randomized|Crossover Assignment||Treatment||None (Open Label)||monocentric, block randomized, open, crossover study||||
1324210|NCT03280888|||Other||Prospective|||||||
1324211|NCT03280875||Single Group Assignment||Other||None (Open Label)||||||
1324212|NCT03280862|Randomized|Parallel Assignment||Treatment||Quadruple|Patients are unaware of treatment arm. All patients undergo the same pre-implant program and follow-up. Healthcare personel performing follow-up are blinded for treatment arm. Outcome events are evaluated by a committee blinded for treatment arm.|"Double-blind randomised controlled trial. Patients are included and randomised 1:1 into two groups for implantation of either~a CRT-D/P device with the LV lead positioned according to the latest electrical activation in the CS (intervention group) or~a CRT-D/P device with the LV lead positioned preferentially in a posterolateral, non-apical position (control group)"|t|t|t|t
1324213|NCT03280849||Single Group Assignment||Treatment||None (Open Label)||Use of a novel bilaminar chitosan scaffold in the repair of the sellar floor after an endoscopic endonasal transsphenoidal surgery for a suspected hipofisary macroadenoma.||||
1324214|NCT03280836|Randomized|Parallel Assignment||Supportive Care||Double||Participants are randomized to the intervention or control arm.||t||t
1324215|NCT03280823|||Other||Prospective|||||||
1324216|NCT03280810|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1324217|NCT03280797|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1324218|NCT03280784|||Case-Only||Prospective|||||||
1324219|NCT03280771|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324220|NCT03280758|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will not know the intervention of each subjects|||||t
1324221|NCT03280745|Randomized|Parallel Assignment||Prevention||Quadruple|double-blind|At admission to the ICU patients will receive 5ml/kg body weight of 7.3% NaCl or 0.9% NaCl by infusion pump over 60 minutes. If necessary, fluid resuscitation will be performed with Ringer`s lactate to normalize peripheral perfusion and to allow weaning of vasopressors.|t|t|t|t
1324222|NCT03280732||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324223|NCT03280719|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1324224|NCT03280706|Randomized|Parallel Assignment||Supportive Care||Double|Investigator and outcomes assessor will not know to which group each woman was allocated||||t|t
1324225|NCT03280693|||Case-Only||Retrospective|||||||
1324226|NCT03280680|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324227|NCT03280667||Single Group Assignment||Treatment||None (Open Label)||Single-arm, multicentre, phase 2 trial||||
1324228|NCT03280654|||Other||Cross-Sectional|||||||
1324229|NCT03280641|||Cohort||Prospective|||||||
1324230|NCT03280628|Randomized|Parallel Assignment||Treatment||Single|The Plastic Surgeons who rate all 90 scars at the end of the study are blinded to the closure method.|||||t
1324231|NCT03280615|Randomized|Parallel Assignment||Treatment||Triple|Identical sachets containind the study supplement or corn oil will be number coded and provided to participants|Participants will be randomly selected to receive 3.7 g of a supplement containing docosahexanoic and eicosapentanoic acids or a supplement containing corn oil. The supplements will be provided for 12 weeks|t|t|t|
1324232|NCT03280602|Randomized|Parallel Assignment||Treatment||Single|Semi-blinded|||||t
1324233|NCT03280589|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1324234|NCT03280576|||Cohort||Prospective|||||||
1324235|NCT03280563|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1324236|NCT03280550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324237|NCT03280537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324238|NCT03280524|Randomized|Parallel Assignment||Supportive Care||Double|To ensure the blinding, the study included an interventionist enabled for application of foot reflexology.|The patients will be taken to a room reserved for the procedure. First, the patients answer the research instruments and then they will be asked to lie supine on a stretcher. The feet of the patients will be cleaned with water (37ºC) and mild soap and then will be dry with paper towels. The next phase consists in the application of foot massage, that will follow the Lourenço's Protocol (2012), which consists of 14 steps of relaxation massage. Each step will have duration of 1 minute, 3 procedures by week, by 4 consecutive weeks. The research instruments, SF-36 and Stanford Health Assessment Questionnarie will be applied before the first and after the last procedure.|t||t|
1324239|NCT03280511||Single Group Assignment||Prevention||None (Open Label)||Non-randomized, non-blinded phase 2 cohort study||||
1324240|NCT03280498||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324241|NCT03280485|||Cohort||Prospective|||||||
1324242|NCT03280472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324243|NCT03280459|||Cohort||Prospective|||||||
1324244|NCT03280446||Single Group Assignment||Treatment||None (Open Label)||||||
1324245|NCT03280433|||Cohort||Prospective|||||||
1324246|NCT03280420|Randomized|Parallel Assignment||Treatment||None (Open Label)||All patients were catheterized and received urinary antiseptic and then randomly divided into two groups : Group I :30 patients received Tamsulosin 0.4 mg once daily and catheter removed after 3 days. Group II :30 patients received Tamsulosin 0.4 mg once daily and catheter removed after 7 days.||||
1324247|NCT03280407|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is an open label, randomized phase II screening trial allocating eligible patients to either standard treatment for rectal cancer or experimental preoperative combination chemotherapy.||||
1324248|NCT03280394|||Cohort||Prospective|||||||
1324249|NCT03280381|Randomized|Crossover Assignment||Other||Single||Investigators will conduct a randomized crossover trial in mothers/caregivers with a preterm infant in the mother-baby unit at Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana. Each caregiver/infant pair will use the Nifty Feeding Cup for two feeds and the standardized generic cup for two feeds. Cross-over means each caregiver/infant pair will use both cups, with the order of the cup used first and second randomized.|||t|
1324250|NCT03280368|||Cohort||Prospective|||||||
1324251|NCT03280355|Randomized|Parallel Assignment||Supportive Care||Double|Assessor (nurse) is masked, primary investigator is masked|Non-pharmacologisal, intervention based, group randomised (cluster randomised) controlled trial, 2 arms (intervention and active control group)|||t|t
1324252|NCT03280342|Randomized|Crossover Assignment||Treatment||Single||a crossover, randomized, double blind design in conjunction with intensive pharmacokinetic sampling and multiple administrations of a neurocognitive test battery to directly compare the effects on cognition of IR-TPM to XR-TPM in adults with migraine. The dose will begin at 25mg and titrated in 25mg increments to reach target dose of 100mg.|t|||
1324253|NCT03280329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324254|NCT03280316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324255|NCT03280303|||Cohort||Prospective|||||||
1324256|NCT03280290|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1324257|NCT03280277||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324258|NCT03280264||Single Group Assignment||Treatment||None (Open Label)||||||
1324259|NCT03280251|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1324260|NCT03280238||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324261|NCT03280225|||Other||Prospective|||||||
1324262|NCT03280212|Randomized|Parallel Assignment||Treatment||Single||||||t
1324263|NCT03280199|Randomized|Factorial Assignment||Other||Single||||||t
1324264|NCT03280186||Single Group Assignment||Treatment||None (Open Label)||||||
1324265|NCT03280173|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1324266|NCT03280160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1324267|NCT03280147|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor will be provided objective clinical information related to episodes of all illnesses during follow-up with all patient identifiers removed and the record identified only by a unique code number. All imaging films and investigation reports provided to the outcome assessor will be similarly bereft of patient identifiers and coded by a unique code number. The outcome assessor will not be involved in the rest of the study. The outcome assessor will adjudicate whether the given episode of illness is a relapse.|Randomized, outcome-assessor blinded, active-controlled, multi-centric, non-inferiority trial||||t
1324268|NCT03280134|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study based on prospective cohort method and concerning on the two groups (whether ALND or not) by predictive model nSLN results.||||
1324269|NCT03280121||Single Group Assignment||Treatment||None (Open Label)||Prospective, investigator initiated, multicenter, non-randomized single arm, open label.||||
1324270|NCT03280108||||||||||||
1324271|NCT03280095|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1324272|NCT03280082|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324273|NCT03280069|||Case-Only||Prospective|||||||
1324274|NCT03280056|Randomized|Parallel Assignment||Treatment||Quadruple|This is a double-blind study where the investigators, participants and all sponsor and CRO personnel involved in the conduct, data management or analysis of the study will remain blinded to the treatment assignments|Randomized, Double-Blind, Placebo-Controlled Multicenter Study|t|t|t|t
1324275|NCT03280043|||Case-Control||Retrospective|||||||
1324276|NCT03280030|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324277|NCT03280017|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1324278|NCT03280004|||Cohort||Prospective|||||||
1324279|NCT03279991|||Cohort||Cross-Sectional|||||||
1324280|NCT03279978|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324281|NCT03279965|||Case-Only||Prospective|||||||
1324282|NCT03279952||Single Group Assignment||Treatment||None (Open Label)||||||
1324283|NCT03279939||||||||||||
1324284|NCT03279926|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1324285|NCT03279913||Single Group Assignment||Treatment||None (Open Label)||||||
1324286|NCT03279900|||Cohort||Cross-Sectional|||||||
1324287|NCT03279887|||Cohort||Prospective|||||||
1324288|NCT03279874|||Case-Only||Prospective|||||||
1324289|NCT03279861|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1324290|NCT03279848|||Cohort||Cross-Sectional|||||||
1324291|NCT03279835|||Other||Prospective|||||||
1324292|NCT03279822|||Ecologic or Community||Retrospective|||||||
1324293|NCT03279809|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1324294|NCT03279796|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324295|NCT03279783|Randomized|Sequential Assignment||Diagnostic||Single||Participants scheduled for colonoscopy for the assessment of symptoms or for colorectal cancer screening/surveillance receive the examination of the right colon twice, in a back-to-back fashion, with standard white light (WL) and with LCI (Linked Color Imaging). Patients are randomly assigned (1:1), via computer-generated randomisation with block size of 20, to which procedure is done first.|t|||
1324296|NCT03279770|||Case-Only||Retrospective|||||||
1324297|NCT03279757|Randomized|Factorial Assignment||Treatment||Single|||t|||
1324298|NCT03279744||Single Group Assignment||Treatment||None (Open Label)||||||
1324299|NCT03279731|Randomized|Crossover Assignment||Treatment||Quadruple|"Novo Nordisk's Clinical Services (CS) will label, package, and ship the labelled study drugs to the Penn's Investigational Drug Service (IDS). Dr. Rockwell from Penn's IDS service will generate the randomization code using a 1:1 randomization scheme of liraglutide and placebo. The first subject to meet the treatment criteria will be assigned the first number in the sequence; each subsequent subject to meet treatment criteria will be assigned the next number in the sequence. Unblinding of the treatment codes will occur after all data have been verified and deemed clean by the data managers and statistician, and right before analysis of the data occurs.~The code for a particular subject may be broken in a medical emergency if knowing the identity of the treatment allocation would influence the treatment of the subject or if demanded by the subject. Whenever a code is broken, the staff-member breaking the code will record the time, date and reason."|Single-center, double-blind, randomized placebo-controlled trial with parallel groups.|t|t|t|t
1324300|NCT03279718|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324301|NCT03279705|Randomized|Parallel Assignment||Diagnostic||None (Open Label)|These codes were contained in pre-arranged opaque envelopes, which were opened immediately before insertion of the colonoscope.|A total of 120 patients were allocated into one of two groups by computerized randomization. In group A (Two-channel group), clear water was infused through the water jet channel and dirty water was sucked form the accessy channel. In group B (One-channel group), water exchange was done by using the accessory channel for both infusing and suctioning of water.||||
1324302|NCT03279692||Single Group Assignment||Treatment||None (Open Label)||||||
1324303|NCT03279679|Randomized|Parallel Assignment||Treatment||Double||costoclavicular group and paracoracoid group|t|||t
1324304|NCT03279666|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1324305|NCT03279653|||Cohort||Prospective|||||||
1324306|NCT03279640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324307|NCT03279627|||Other||Prospective|||||||
1324308|NCT03279614||Single Group Assignment||Treatment||None (Open Label)||||||
1324309|NCT03279601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324310|NCT03279588|||Cohort||Prospective|||||||
1324311|NCT03279575|Randomized|Parallel Assignment||Treatment||Single|We will mask the intervention status of participants when analyzing the data.|1:1:1:1 allocation||||t
1324312|NCT03279562||Single Group Assignment||Treatment||None (Open Label)||Pilot, open label, non-randomized clinical trial||||
1324313|NCT03279549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324314|NCT03279536|Randomized|Parallel Assignment||Treatment||Single||Group A will receive oral lactoferrin & group B will receive Total dose infusion|t|||
1324315|NCT03279523||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324316|NCT03279510||Single Group Assignment||Treatment||None (Open Label)||||||
1324317|NCT03279497|Randomized|Parallel Assignment||Other||Single|||t|||
1324318|NCT03279484||Single Group Assignment||Treatment||None (Open Label)||"NAVIGO 4LV LV leads are available as S shaped(NAVIGO 4LV 2D) , U shaped (NAVIGO 4LV ARC) and straight( NAVIGO 4LV Pilot) models. All the models are available in 78 cm and 88 cm long versions. All models are designed for multipolar pacing (4 electrodes) and all of them have a quadripolar IS4 connector (IS4_LLLL).~The NAVIGO 4LV leads are steroid eluting to avoid adverse effects due to inflammation reaction of the myocardium after positioning of the lead, and therefore to limit the acute pacing threshold peak. The steroid collar design is the same as the one used in all other LIVANOVA leads"||||
1324319|NCT03279471|Randomized|Parallel Assignment||Treatment||Triple|participants do not know what interventions others receive; med arm care providers don't know what interventions their patients receive; assessors don't know what treatments the participants they asses receive|3 Arm trial comparing manualized CBT/social skills training versus sertraline versus pill placebo|t|t||t
1324320|NCT03279458|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1324321|NCT03279445|||Ecologic or Community||Other|||||||
1324322|NCT03279432|||Cohort||Prospective|||||||
1324323|NCT03279419|||Case-Control||Prospective|||||||
1324324|NCT03279406|||Case-Only||Prospective|||||||
1324325|NCT03279393|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1324326|NCT03279380|Randomized|Crossover Assignment||Treatment||Single||||||t
1324327|NCT03279367|||Cohort||Prospective|||||||
1324328|NCT03279354|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1324329|NCT03279341|Randomized|Crossover Assignment||Other||Double||open-label, randomized, reader-blinded, 3-period cross-over study|||t|t
1324330|NCT03279328|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1324331|NCT03279315||Single Group Assignment||Basic Science||None (Open Label)||Participants received a diet with iodized table salt or non-iodized table salt||||
1324332|NCT03279302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324333|NCT03279289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324334|NCT03279276|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial||||t
1324335|NCT03279263|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1324336|NCT03279250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324337|NCT03279237||Single Group Assignment||Treatment||None (Open Label)||||||
1324338|NCT03279224|Randomized|Parallel Assignment||Treatment||Quadruple|Both the patient and the study team (clinical team, study coordinator, data analyst) will be blinded to group assignments.|Adults with BD depression being treated with an approved medication will be assigned to either allogenic FMT (from a healthy, screened individual with no personal or family history of an Axis 1 disorder) or autologous FMT (re-infusion of own feces)|t|t|t|t
1324339|NCT03279211|Randomized|Parallel Assignment||Basic Science||None (Open Label)||3 groups, one for each protein sources (zein and whey) and one for determination of endogenous amino acid losses (protein-free meal)||||
1324340|NCT03279198|Randomized|Factorial Assignment||Prevention||None (Open Label)||We propose a prospective randomized 2x2 factorial design: 1)usual care; 2) a TIWeb; 3) a Cancer Screening Call (CSC), and 4 a TIWEB+ a Cancer Screening Call (CSC). The intervention will be tested in 2 groups of women. Group A will include women who are nonadherent to CRC but adherent to BC screening guidelines. Group B will include women who are nonadherent to both CRC and BC screening guidelines.||||
1324341|NCT03279185|||Cohort||Prospective|||||||
1324342|NCT03279172|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1324343|NCT03279159||Single Group Assignment||Treatment||None (Open Label)||||||
1324344|NCT03279146|Randomized|Crossover Assignment||Other||None (Open Label)||Drug: Tenofovir Exalidex (TXL) oral formulations Other names: Lipid conjugateTFV||||
1324345|NCT03279133||Single Group Assignment||Treatment||None (Open Label)||This is an open-label pilot, safety, feasibility study to treat candidates for HCT infected with hepatitis C prior to the transplantation to reduce the complications associated with hepatitis C in the post-transplant setting.||||
1324346|NCT03279120|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1324347|NCT03279107|Randomized|Crossover Assignment||Other||Single|Single Participant|randomized|t|||
1324348|NCT03279094||Single Group Assignment||Treatment||None (Open Label)||||||
1324349|NCT03279081|Randomized|Parallel Assignment||Treatment||Quadruple|Participant, Care Provider, Investigator, Outcomes Assessor|Parallel assignment|t|t|t|t
1324350|NCT03279068|||Cohort||Prospective|||||||
1324351|NCT03279055||Single Group Assignment||Supportive Care||None (Open Label)||||||
1324352|NCT03279042|Randomized|Parallel Assignment||Treatment||Single||||||t
1324353|NCT03279029|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1324354|NCT03279016|||Other||Retrospective|||||||
1324355|NCT03279003||Single Group Assignment||Treatment||None (Open Label)||||||
1324356|NCT03278990|Randomized|Parallel Assignment||Prevention||Double|Participants are randomly assigned to treatment or control exercises involving writing for 5 minutes. Participants do not know there is another writing condition. Care providers do not see the written content provided by the participant. Neither the participants nor the care provider will know which condition the participant is in.|This is a parallel group randomized trial with 2 arms—a control arm with allocation ratio of 50%, and an intervention arm (future self-value affirmation) with an allocation ratio of 50%.|t|t||
1324357|NCT03278977|Non-Randomized|Parallel Assignment||Basic Science||Single|Blood sample analysis will be blinded|||||t
1324358|NCT03278964|Randomized|Parallel Assignment||Treatment||Triple|Participants and investigators do not know which orbital decompression technique will be done until 6 months of postoperative period.|Patients with Graves orbitopathy will be randomly divided in two groups. One group will be submmited to orbital decompression by antro-ethmoidal technique. The other group will be treated by lateral wall technique.|t||t|t
1324359|NCT03278951|Randomized|Parallel Assignment||Other||Single|Following baseline visits, participants were randomized to a viideo conference (VC(, in person (IP) or control (CG) groups via the website https://www.randomlists.com/team-generator.|All participants were randomized in a balanced fashion and stratified by sex into either one of the two intervention groups (VC or in-person group) or a control group.|t|||
1324360|NCT03278938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||treatment in this study was determined by treatment received in prior study; i.e., those who had received escitalopram then receive escitalopram + bupropion; those initially taking bupropion then receive escitalopram + bupropion||||
1324361|NCT03278925||Single Group Assignment||Prevention||None (Open Label)||||||
1324362|NCT03278912|||Cohort||Prospective|||||||
1324363|NCT03278899|||Cohort||Prospective|||||||
1324364|NCT03278886|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1324365|NCT03278873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1324366|NCT03278860|Randomized|Crossover Assignment||Basic Science||Triple||Randomized placebo-controlled double-blind within-subject design|t||t|t
1324367|NCT03278847|||Cohort||Retrospective|||||||
1324368|NCT03278834|Randomized|Factorial Assignment||Treatment||Double||Treatment and intervention group|t|||t
1324369|NCT03278821|Randomized|Parallel Assignment||Treatment||Single||||t||
1324370|NCT03278808|Randomized|Parallel Assignment||Treatment||None (Open Label)|"Because placebo for both products is difficult to obtain and because the primary endpoint of symptomatic parasitemia is an objective measure, treatment will be open-label. Microscopists reading the smears will be blinded to the group, but will be aware of whether or not a particular sample is from a symptomatic subject.~Although symptoms are a subjective measure and part of the primary endpoint of symptomatic parasitemia, subjects will not be told if they are parasitemic prior to treatment initiation thus making symptomatic complaints and this endpoint more reliable."|Subjects will be randomized to either the CQ/AZ group (Group 1 of 15 subjects: 2 g AZ (Zithromax) plus 300 mg CQ base weekly for 6 weeks), or the CQ control group (Group 2 of 8 subjects: 300 mg chloroquine base weekly for 6 weeks)||||
1324371|NCT03278795|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"The study group will be assigned to SIMV-VC for at least 48 hours . Patients will be assessed daily for fulfillment of criteria of readiness to wean according to European Respiratory Society guidelines (ERS guidelines ).~After fulfillment of ERS weaning criteria patients will be consequently divided into two equal groups: 1. 25 patients will be assigned to PSV weaning mode.~2. 25 patients will be assigned to VSV weaning mode. In PSV weaning group , PS will be adjusted 8 cm H2O. In VSV weaning group ,VT will be adjusted 6 ml/ Kg. Extubation will be done after successful spontaneous breathing trial according to ERS guidelines ."||||
1324372|NCT03278782|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Up to 3 groups of up to 6 participants will be enrolled in Phase 1 of the study, and up to 21 participants will be enrolled in Phase 2.||||
1324373|NCT03278769||Single Group Assignment||Basic Science||None (Open Label)||||||
1324374|NCT03278756|Randomized|Parallel Assignment||Prevention||Quadruple||Between subjects-design with two training conditions. The training condition is the only difference between the two groups during the study.|t|t|t|t
1324375|NCT03278743|||Cohort||Prospective|||||||
1324376|NCT03278730|Randomized|Parallel Assignment||Prevention||Quadruple||The objective is to evaluate, whether p-Tyr supplementation reduces the ICU mortality of the patients with sepsis comparing to placebo group|t|t|t|t
1324377|NCT03278717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324378|NCT03278704|Randomized|Parallel Assignment||Basic Science||None (Open Label)||This is an exploratory randomized controlled trial. Participants will complete a parallel designed study, in which they will be randomly assigned to a resistance exercise (RE) only or concurrent RE and high-intensity interval training (RE + HIIT) group.||||
1324379|NCT03278691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324380|NCT03278678|||Other||Prospective|||||||
1324381|NCT03278665||Single Group Assignment||Treatment||None (Open Label)||||||
1324382|NCT03278652|||Case-Only||Prospective|||||||
1324383|NCT03278639|Randomized|Parallel Assignment||Treatment||Double|Both investigators taking care of patients and outcomes assessors will be blinded.|randomized, prospective, blind, controlled clinical trial|||t|t
1324384|NCT03278626||Single Group Assignment||Treatment||None (Open Label)||||||
1324385|NCT03278613|Randomized|Parallel Assignment||Treatment||Single|Participants will remain masked to subject treatment assignment throughout the trial. To maintain masking of participants, the duration of treatment sessions for both the PTNS and sham groups will be 30 minutes and will be conducted with subjects in a supine position with the knees comfortably abducted and flexed. The leg and foot involved in treatment will be obscured from the subject's view with a portable anesthesia drape frame to which an exam sheet will be secured.||t|||
1324386|NCT03278600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324387|NCT03278587|Randomized|Parallel Assignment||Prevention||Single||||||t
1324388|NCT03278574|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1324389|NCT03278561|||Cohort||Cross-Sectional|||||||
1324390|NCT03278548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324391|NCT03278535|||Cohort||Prospective|||||||
1324392|NCT03278522|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1324393|NCT03278509|Randomized|Parallel Assignment||Treatment||None (Open Label)||A registry-based, randomized, parallel, open-label, multicenter trial||||
1324394|NCT03278496|Randomized|Parallel Assignment||Treatment||Single||||||t
1324395|NCT03278483|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Arm Isoniacid Diabetic patients with a positive TST of >10mm, who wil be randomly assigned to receive treatment with isoniazid tablets 300mg daily plus pyridoxine 50mg daily~Arm B Diabetic patients with a positive TST of >10mm, who wil be randomly assigned to receive treatment with rifampin capsules 600mg daily"||||
1324396|NCT03278470|Randomized|Sequential Assignment||Other||Quadruple|||t|t|t|t
1324397|NCT03278457|||Cohort||Other|||||||
1324398|NCT03278444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324399|NCT03278431|Randomized|Parallel Assignment||Treatment||Single|Single-blind||t|||
1576000|NCT00016796||||||||||||
1324400|NCT03278418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324401|NCT03278405||Single Group Assignment||Treatment||None (Open Label)||||||
1324402|NCT03278392|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1324403|NCT03278379||Single Group Assignment||Treatment||None (Open Label)||||||
1324404|NCT03278366|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324405|NCT03278353||Single Group Assignment||Other||None (Open Label)||Prospective cases series||||
1324406|NCT03278340|Randomized|Parallel Assignment||Prevention||Single|Participants will not be aware of the condition in which their organization is assigned.||t|||
1324407|NCT03278327||Single Group Assignment||Treatment||None (Open Label)||||||
1324408|NCT03278314||||||||||||
1324409|NCT03278301|||Cohort||Prospective|||||||
1324410|NCT03278288|Randomized|Parallel Assignment||Health Services Research||Single|Family participants are masked and control group is not aware of the intervention condition. PHN participants are not masked.|Two-arm cluster randomized controlled trial and conducted in four municipalities located in the Southwest Finland. The unit of randomization is one cluster, with one municipality with its Child health clinics representing one cluster. Two municipalities with all together eight Child health clinics are randomly allocated into the intervention arm and two municipalities with all together seven Child health clinics are randomly allocated into the control arm.|t|||
1324411|NCT03278275||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324412|NCT03278262|||Cohort||Retrospective|||||||
1324413|NCT03278249||Single Group Assignment||Treatment||None (Open Label)||||||
1324414|NCT03278236||Single Group Assignment||Prevention||None (Open Label)||||||
1324415|NCT03278223|Randomized|Parallel Assignment||Other||Double|||t||t|
1324416|NCT03278210|||Case-Control||Prospective|||||||
1324417|NCT03278197|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1324418|NCT03278184|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1324419|NCT03278171|||Cohort||Prospective|||||||
1324420|NCT03278158|Randomized|Parallel Assignment||Treatment||Single|The type of treatment is blinded for the subjects.|Each subject will be randomised to one of four treatments, placebo and three different single oral doses of XEN-D0501. Cohorts of 8 patients are run subsequently where of 2 patients receive placebo and 6 patients receive XEN-D0501 beginning with the 1 mg dose followed by the 2 and 4 mg dose groups. Each treatment step will be completed consecutively and progression to next dose level depend on good safety and tolerability on the previous dose level.|t|||
1324421|NCT03278145|||Cohort||Prospective|||||||
1324422|NCT03278132|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324423|NCT03278119|||Cohort||Prospective|||||||
1324424|NCT03278106||Single Group Assignment||Treatment||None (Open Label)||||||
1324425|NCT03278093|||Cohort||Cross-Sectional|||||||
1324426|NCT03278080||Single Group Assignment||Other||None (Open Label)||||||
1324427|NCT03278067|||Other||Prospective|||||||
1324428|NCT03278054|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1324429|NCT03278041|Randomized|Parallel Assignment||Treatment||None (Open Label)|"Because the two interventions used in this trial are clearly different and easly recognized by the participants and investigators, neither investigator AlAdashi O nor Participants can be blinded.~Similarly, the Assessor (Participants) can't be blinded. The statistician will be blinded."|||||
1324430|NCT03278028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324431|NCT03278015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324432|NCT03278002|||Other||Prospective|||||||
1324433|NCT03277989|||Other||Prospective|||||||
1324434|NCT03277976|||Cohort||Prospective|||||||
1324435|NCT03277963|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1324436|NCT03277950|Randomized|Parallel Assignment||Treatment||Single|||||t|
1324437|NCT03277937||Single Group Assignment||Treatment||None (Open Label)||||||
1324438|NCT03277924||Single Group Assignment||Treatment||None (Open Label)||Phase I-II, single-arm, non-randomized, open-label, multicenter, international clinical trial||||
1324439|NCT03277911|||Case-Control||Cross-Sectional|||||||
1324440|NCT03277898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324441|NCT03277885|||Cohort||Retrospective|||||||
1324442|NCT03277872|Randomized|Parallel Assignment||Other||None (Open Label)||"In this study, each patient will be exposed to three laryngoscopies; one with the single use blade for the GlideScope and without ETT; one with the Macintosh laryngoscopy and without ETT; and one with the ETT insertion (laryngoscopy done with either GlideScope or Macintosh according to second randomization). The order in which will be used either the GlideScope or the MAC blade for the first two laryngoscopies will be decided according to the first randomization.~This will lead to 2 different groups for the first randomization process regarding our primary objective:~GVL / MAC-DL / GVL or MAC-DL+ETT,~MAC-DL / GVL / GVL or MAC-DL+ETT.~The tool used for the third laryngoscopy will be decided according to a second randomization, necessary to one of our secondary objectives.~Each patient will be its own control when comparing nociceptive response to different laryngoscopy/intubation tool (no need for control group)."||||
1324443|NCT03277859|Randomized|Crossover Assignment||Treatment||Single||Participants will be block randomized in a stratified manner to SAA-TBI or a waitlist using a 1:1 ratio. The waitlist group will initially receive 8 weeks of enhanced treatment as usual (ETU).||||t
1324444|NCT03277846|Randomized|Parallel Assignment||Treatment||Quadruple|All participants and investigators are blind to condition.|A 2x2 factor Randomized Controlled Trial with block randomization|t|t|t|t
1324445|NCT03277833|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1324446|NCT03277820|Randomized|Parallel Assignment||Basic Science||Single|Investigator does not know which subjects administered probiotics||||t|
1324447|NCT03277807|||Cohort||Prospective|||||||
1324448|NCT03277794|Randomized|Parallel Assignment||Treatment||Single||||||t
1324449|NCT03277781|||Other||Cross-Sectional|||||||
1324450|NCT03277768|||Cohort||Prospective|||||||
1324451|NCT03277755|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1576187|NCT00011804||||Treatment||||||||
1324452|NCT03277742|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324453|NCT03277729||Single Group Assignment||Treatment||None (Open Label)||||||
1324454|NCT03277716||Single Group Assignment||Treatment||None (Open Label)||Microwave Ablation Combined With TACE in the Treatment of Non-resectable Huge Hepatocellular Carcinoma||||
1324455|NCT03277703|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324456|NCT03277690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324457|NCT03277677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324458|NCT03277664|Randomized|Parallel Assignment||Health Services Research||Double|Due to the nature of the intervention, the caregivers of the participants and follow-up nurse were not blinded. But the doctors and statisticians were blinded. Both in the intervention group and control group, adherence data were not available to clinicians.|The Study of Asthma Adherence study was a multicentre, single-blind, parallel group randomised controlled trial, with an allocation ratio of 1:1.|||t|t
1324459|NCT03277651|||Cohort||Prospective|||||||
1324460|NCT03277638|Randomized|Parallel Assignment||Treatment||None (Open Label)|Because this is an open-label, safety and tolerability study in which all enrolled subjects will receive Pembrolizumab in Combination with LITT, this study is unblinded.|Three parallel groups given Pembrolizumab injections at different timepoints||||
1324461|NCT03277625|||Case-Only||Prospective|||||||
1324462|NCT03277612|||Cohort||Prospective|||||||
1324463|NCT03277599|Randomized|Parallel Assignment||Treatment||Single||prospective,randomized,single blind||||t
1324464|NCT03277586|Randomized|Parallel Assignment||Treatment||Quadruple||16-week Double-blind randomized placebo-controlled dual-phase trial|t|t|t|t
1324465|NCT03277573|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind study. Only investigational pharmacist will be unblinded.|Randomized, Double-Blind, Placebo-Controlled|t|t|t|
1324466|NCT03277560|||Cohort||Prospective|||||||
1324467|NCT03277547|||Cohort||Prospective|||||||
1324468|NCT03277534|Randomized|Parallel Assignment||Other||Single|||t|||
1324469|NCT03277521|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1324470|NCT03277508|Randomized|Parallel Assignment||Treatment||Single|The blinding will be carried out in such a way that the therapist will provide conventional therapy and assess the arm function without knowing the group that the patients belong to. The BCI Robot and Passive Robot will be administered by other study team member. A third party study team member not participating in the intervention will keep the log book which contains information regarding patients study ID and group. Randomization codes will be broken when all interventional and follow-up sessions were completed or when the patient decides to quit participation. The third party team member will unmask according to PI's request in this occasion.|A randomization stratification method, with a computer generated random sequence will be used. Subjects will be grouped in strata according to their Fugl-Meyer scores(0-28 vs 29-45) and randomized separately according to a block randomization to receive either of following treatments:(1) Treatment A: 18 sessions for 6 weeks of 60 minutes of passive robot-assisted hand therapy+ 30 minutes of standard hand therapy.(2) Treatment B: 18 sessions for 6 weeks of 60 minutes of BCI controlled robot-assisted hand therapy + 30 minutes of standard hand therapy.||||t
1324471|NCT03277495|Randomized|Parallel Assignment||Treatment||Quadruple||Participants will be stratified by sex and use of menthol cigarettes and randomly assigned with a 2:1 allocation ratio to one of two conditions: 1) nicotine SREC (N = 120); and 2) placebo SREC (N = 60).|t|t|t|t
1324472|NCT03277482|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1324473|NCT03277469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324474|NCT03277456||Single Group Assignment||Prevention||None (Open Label)||||||
1324475|NCT03277443|Randomized|Single Group Assignment||Treatment||Double||SM and VSM|t||t|
1324476|NCT03277430|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324477|NCT03277417|||Case-Control||Prospective|||||||
1324478|NCT03277404|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1324479|NCT03277391|Randomized|Parallel Assignment||Treatment||Single|Random attribution by computer||t|||
1324480|NCT03277378|||Cohort||Prospective|||||||
1324481|NCT03277365||Single Group Assignment||Other||None (Open Label)||||||
1324482|NCT03277352||Single Group Assignment||Treatment||None (Open Label)||||||
1324483|NCT03277339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324484|NCT03277326|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1324485|NCT03277313|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1324486|NCT03277300|||Cohort||Prospective|||||||
1324487|NCT03277287|Non-Randomized|Factorial Assignment||Treatment||Single||Prospective comparative study|t|||
1324488|NCT03277274|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1324489|NCT03277261|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinded, active-controlled study|Randomized, multi-center, double-blinded, active-controlled study|t|t|t|t
1324490|NCT03277248|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinded, active-controlled study|Randomized, multi-center, double-blinded, active-controlled study|t|t|t|t
1324491|NCT03277235|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1324492|NCT03277222|Randomized|Parallel Assignment||Treatment||Quadruple|This is a prospective dose-ranging double-blinded pilot study over 4 months. At enrolment, participants and their physicians will be blinded to treatment.|"Arm 1: Drug: IN insulin Dose: Twice daily IN insulin R at 20 IU (n=15) twice daily using a nasal delivery device. IN insulin R diluted with Lilly diluent will be administered by dose escalation over 4 weeks (10→20 IU). Each escalated dose will be given for 1 week.~Arm 2: Drug: IN insulin Dose: Twice daily IN insulin R at 40 IU (n=15), twice daily using a nasal delivery device. IN insulin R diluted with Lilly diluent will be administered by dose escalation over 4 weeks (10→20 IU). Each escalated dose will be given for 1 week.~Arm 3: Drug: IN Lilly diluent Dose: Placebo (Lilly diluent, matched volume; (n=15) twice daily using nasal delivery device."|t|t|t|t
1324493|NCT03277209||Single Group Assignment||Treatment||None (Open Label)||||||
1324494|NCT03277196|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324645|NCT03275233|||Case-Only||Prospective|||||||
1324495|NCT03277183|Randomized|Parallel Assignment||Prevention||Single|The outcome is the progression of carotid plaque. John Forder, PhD, who will read the MRIs will be blinded to the subject and treatment group.|Patients will be randomly assigned two different erythropoietin dosing strategies. One group will be given more frequent, low-doses of EPO and the other group will be given the same, cumulative dose given every 2 weeks.||||t
1324496|NCT03277170|Randomized|Parallel Assignment||Treatment||Quadruple|Study drug (montelukast granules) and identical control will be prepared by the Vanderbilt Investigational Drug service. Participants will be randomized by computerized program by study biostatistician.|Two-arm, parallel randomized controlled trial|t|t|t|t
1324497|NCT03277157|Randomized|Crossover Assignment||Other||Quadruple|The B. lactis and placebo will be provided in identical capsules.||t|t|t|t
1324498|NCT03277144|Randomized|Parallel Assignment||Prevention||None (Open Label)||All gastric cancer patients who meet the inclusion/exclusion criteria and give the informed consent to participate are registered into the central trial database and centrally permuted-block randomized to one of the two arms (a. Duodenal Stump Closure with TriStaple Technology - TST or b. Duodenal Stump closure with other conventional techniques - OCT ).||||
1324499|NCT03277131||Single Group Assignment||Treatment||None (Open Label)||||||
1324500|NCT03277118|||Cohort||Prospective|||||||
1324501|NCT03277105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324502|NCT03277092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324503|NCT03277079|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324504|NCT03277066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324505|NCT03277053|Randomized|Parallel Assignment||Treatment||Double||||t||t
1324506|NCT03277040|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324507|NCT03277027||Single Group Assignment||Supportive Care||None (Open Label)||Non-randomized single group Accelerometer was weared for a week to check physical activity and sleep in children with cerebral palsy.||||
1324508|NCT03277014|||Cohort||Retrospective|||||||
1324509|NCT03277001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324510|NCT03276988|Randomized|Crossover Assignment||Diagnostic||Double|At Part B, Both independent central efficacy assessors and participants will be masked. Investigators will be unmasked. (The Part A was open-label.)|The Part A (Phase 1) of study has been completed in which 3 single or multiple sequentially assenting doses of GX-30 were investigated. The Part B (Phase 2) is recruiting in current in which each study participant will receive the same multiple doses of GX-30 and THYROGEN® but at different period.|t|||t
1324511|NCT03276975|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1324512|NCT03276962|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324513|NCT03276949|||Other||Other|||||||
1324514|NCT03276936||Single Group Assignment||Treatment||None (Open Label)||||||
1324515|NCT03276923|||Cohort||Prospective|||||||
1324516|NCT03276910|Randomized|Parallel Assignment||Treatment||Triple||"3 different conditions:~Eprex 20 UI/kg~Eprex 50 UI/kg~Placebo"|t||t|t
1324517|NCT03276897||Single Group Assignment||Treatment||None (Open Label)||||||
1324518|NCT03276884|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1324519|NCT03276871|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324520|NCT03276858|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind study|Single and multiple-dose cohorts are placebo-controlled. The midazolam cohort does not have placebo.|t|t|t|t
1324521|NCT03276845||Single Group Assignment||Diagnostic||||||||
1324522|NCT03276832||Single Group Assignment||Treatment||None (Open Label)||||||
1324523|NCT03276819|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Cohort A : Patients with OPML Cohort B : Patients with resectable HNSCC requiring postoperative radiotherapy or chemoradiation and which are either current smokers motivated to quit or reformed smokers within 3 months before the diagnosis of a resectable HNSCC Cohort C : Patients with resectable HNSCC wich are not eligible to cohort B||||
1324524|NCT03276806|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1324525|NCT03276793||Single Group Assignment||Basic Science||None (Open Label)||||||
1324526|NCT03276780|Randomized|Single Group Assignment||Treatment||None (Open Label)||In vivo or standard of care||||
1324527|NCT03276767|Randomized|Parallel Assignment||Prevention||None (Open Label)|The recruitment procedure and the treatment is fully automated and delivered by web, e-mail and SMS-textmessages - i.e., the participant is not contacted by any care providers, investigators or assessors during recruitment or treatment.|Participants receive one out of two versions of a web-based smoking cessation program. The only difference between the two versions is the medium of the reminder: either SMS-textmessage or e-mail.||||
1324528|NCT03276754|||Cohort||Prospective|||||||
1324529|NCT03276741|Randomized|Parallel Assignment||Supportive Care||Single|Personal identification removed (use of personal identification code)|quantitative, randomized experimental design study||||t
1324530|NCT03276728|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinded|Double-blind, placebo-controlled|t|t|t|t
1324531|NCT03276715|||Cohort||Prospective|||||||
1324532|NCT03276702|||Cohort||Prospective|||||||
1324533|NCT03276689|Randomized|Parallel Assignment||Treatment||Quadruple|All personnel and patients will be blinded to the given treatment (double-blind design). The person conducting the immediate and the long term follow up will not know what the results were of the pre-treatment assessments.|Treatments The patients will take 2 tab/d of either (i) duloxetine 60mg or (ii) pregabaline 150mg x 2/day or (iii) placebo for 8 weeks. In the first 7 days dose of duloxetine will be 30mg/day in order to lower side effects and improve compliance. In line, the initial 7-days dose of pregabaline will 75mg x 2. For duloxetine, the morning dose will be a sham pill. Study nurse will be available for the patients regarding any side effects or issues arising, and communicate the relevant data to the PI. All personnel and patients will be blinded to the given treatment (double-blind design). The person conducting the immediate and the long term follow up will not know what the results were of the pre-treatment assessments.|t|t|t|t
1324534|NCT03276676||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324535|NCT03276663|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Open-label, two-arm||||
1324536|NCT03276650|||Cohort||Retrospective|||||||
1324537|NCT03276637||Single Group Assignment||Health Services Research||None (Open Label)||Whole exome sequencing (WES) will be performed on 75 ostensibly healthy, active-duty Airmen (patient-participants) who receive medical care in military Primary Care, Internal Medicine and/or Family Practice settings who in their baseline survey expressed interest in receiving WES. Military healthcare providers who have received brief genomics traning will return results to the patient-participants and the WES reports will be permanently integrated into their electronic medical record.||||
1324538|NCT03276624||Single Group Assignment||Treatment||None (Open Label)||||||
1324539|NCT03276611|||Cohort||Prospective|||||||
1324540|NCT03276598|Randomized|Crossover Assignment||Treatment||Quadruple|The placebo tablets and drugs are packed in similar gelatin capsules.|The design of the study is a randomized placebo-controlled cross-over study. The study starts with a run-in placebo period lasting for four weeks. The four monotherapy treatment periods last for four weeks and they are separated by placebo periods lasting also for four weeks. Randomization occurs after the first placebo period in blocks of 24 (all possible drug sequences).|t|t|t|t
1324541|NCT03276585|||Cohort||Cross-Sectional|||||||
1324542|NCT03276572||Single Group Assignment||Treatment||None (Open Label)||||||
1324543|NCT03276559|Randomized|Parallel Assignment||Treatment||Single||Open trial pilot and stakeholder feedback followed by randomized controlled trial||||t
1324544|NCT03276546||Single Group Assignment||Prevention||None (Open Label)||||||
1324545|NCT03276533|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1324546|NCT03276520|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1324547|NCT03276507|||Case-Only||Prospective|||||||
1324548|NCT03276494||Single Group Assignment||Treatment||None (Open Label)||||||
1324549|NCT03276481|||Cohort||Prospective|||||||
1324550|NCT03276468||Single Group Assignment||Treatment||None (Open Label)||This study is a multicentric open-label phase II trial in 3 cohorts of patients||||
1324551|NCT03276455||Single Group Assignment||Treatment||None (Open Label)||||||
1324552|NCT03276442|Randomized|Crossover Assignment||Basic Science||None (Open Label)|In the crossover subgroup condition, participants will not be briefed about what diet they will receive before the actual onset of the dietary intervention|"Participants will be studied in a crossover design both after a healthy diet, and after an unhealthy diet"||||
1324553|NCT03276429|||Cohort||Retrospective|||||||
1324554|NCT03276416|||Other||Prospective|||||||
1324555|NCT03276403|||Cohort||Prospective|||||||
1324556|NCT03276390|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Two group comparison (intervention vs. control) and pre-post comparison (within each site).||||
1324557|NCT03276377|||Case-Control||Retrospective|||||||
1324558|NCT03276364|||Cohort||Prospective|||||||
1324559|NCT03276351|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded so that they do not know what type of implant construct they received. It will not be possible to blind the surgeon or the individual performing the RSA image processing.|Patients will be randomized to one of the three groups by block randomization using concealed envelopes, with the randomization and group assignment performed by a study coordinator at the time of surgery.|t|||
1324560|NCT03276338|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1324561|NCT03276325|Randomized|Parallel Assignment||Other||Double|Double blind|||t||t
1324562|NCT03276312|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled study||||
1324563|NCT03276299|Randomized|Crossover Assignment||Basic Science||Single||||||t
1324564|NCT03276286||Single Group Assignment||Device Feasibility||None (Open Label)||Nativis Voyager combined with standard radiotherapy and temozolomide||||
1324565|NCT03276273|||Cohort||Prospective|||||||
1324566|NCT03276260|||Cohort||Cross-Sectional|||||||
1324567|NCT03276247|||Cohort||Cross-Sectional|||||||
1324568|NCT03276234|||Other||Prospective|||||||
1324569|NCT03276221|Randomized|Parallel Assignment||Other||None (Open Label)||Cannabis users are randomized either to 30 days of cannabis abstinence or 30 days of monitoring with no abstinence requirement. Non-users are not randomized.||||
1324570|NCT03276208|Randomized|Parallel Assignment||Other||Single|During initial telephone screening participants will be randomized to either intervention or control group||t|||
1324571|NCT03276195|||Family-Based||Prospective|||||||
1324572|NCT03276182||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324573|NCT03276169|Randomized|Parallel Assignment||Treatment||Double|The researchers will participate in the operation to record operative parameters such as LA pressure. Other researchers including follow-up personnel and the ultrasonic data analyst are uninformed about the random situation of the patients (patient information is recorded according to the random number. Random numbers corresponding to the random allocation list are stored in the research center. After follow-up of the last patient is completed, the random allocation list is published by the random number designer; and the designer does not participate in the data collection and statistics.)|A total of 105 patients with persistent atrial fibrillation(AF), who are persistented more than one year and planned to undergo surgical treatment, will be allocated into two groups. These patients will receive left atrial appendage closure, radiofrequency ablation under the guidance of 3D mapping and left atrial appendage closure combined with radiofrequency ablation, respectively (allocation ratio, 1:1:1).|t|||t
1324574|NCT03276156||Single Group Assignment||Treatment||None (Open Label)||||||
1324575|NCT03276143|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1324576|NCT03276130|||Cohort||Retrospective|||||||
1324577|NCT03276117|||Cohort||Prospective|||||||
1324578|NCT03276104|Randomized|Parallel Assignment||Treatment||Single|Masking of research optometrists to group affiliation at the postoperative examinations will be endeavored. A physician will perform slit lamp examinations at the postoperative visits, hence he/she cannot be masked, nor can the surgeon. The investigator will be masked during the image analysis.|Randomized clinical trial||||t
1324579|NCT03276091||Single Group Assignment||Other||None (Open Label)||||||
1324580|NCT03276078||Single Group Assignment||Treatment||None (Open Label)||||||
1324581|NCT03276065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324646|NCT03275220|||Cohort||Cross-Sectional|||||||
1324582|NCT03276052|Randomized|Parallel Assignment||Treatment||None (Open Label)||An ascending dose, incomplete block cross-over||||
1324583|NCT03276039|||Case-Control||Cross-Sectional|||||||
1324584|NCT03276026|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1324585|NCT03276013||Single Group Assignment||Treatment||None (Open Label)||Non-randomized, single arm, multi-center, phase II study||||
1324586|NCT03276000|Randomized|Parallel Assignment||Other||Single||||t||
1324587|NCT03275987|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1324588|NCT03275974||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324589|NCT03275961||Single Group Assignment||Treatment||None (Open Label)||||||
1324590|NCT03275948|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1324591|NCT03275935|||Cohort||Prospective|||||||
1324592|NCT03275922|Randomized|Crossover Assignment||Treatment||Quadruple||A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study|t|t|t|t
1324593|NCT03275909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324594|NCT03275896||Single Group Assignment||Treatment||None (Open Label)||||||
1324595|NCT03275883|||Cohort||Other|||||||
1324596|NCT03275870||Single Group Assignment||Treatment||None (Open Label)||||||
1324597|NCT03275857||Single Group Assignment||Treatment||None (Open Label)||||||
1324598|NCT03275844|||Other||Cross-Sectional|||||||
1324599|NCT03275831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324600|NCT03275818||Single Group Assignment||Treatment||None (Open Label)||||||
1324601|NCT03275805|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324602|NCT03275792|Randomized|Parallel Assignment||Treatment||Single||||||t
1324603|NCT03275779|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1324604|NCT03275766|Randomized|Parallel Assignment||Basic Science||Double|double-blind||t|||t
1324605|NCT03275753|||Cohort||Cross-Sectional|||||||
1324606|NCT03275740|Randomized|Parallel Assignment||Treatment||Double|Double blind (investigator and subject), sponsor open|single ascending dose study|t||t|
1324607|NCT03275727|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1324608|NCT03275714|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1324609|NCT03275701||Single Group Assignment||Treatment||None (Open Label)||||||
1324610|NCT03275688|||Case-Control||Prospective|||||||
1324611|NCT03275675|||Other||Prospective|||||||
1324612|NCT03275662|Randomized|Parallel Assignment||Prevention||Single||||||t
1324613|NCT03275649|||Other||Prospective|||||||
1324614|NCT03275636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324615|NCT03275623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324616|NCT03275610|||Cohort||Prospective|||||||
1324617|NCT03275597||Single Group Assignment||Treatment||None (Open Label)||||||
1324618|NCT03275584||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324619|NCT03275571||Single Group Assignment||Treatment||None (Open Label)||||||
1324620|NCT03275558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324621|NCT03275545|||Case-Control||Prospective|||||||
1324622|NCT03275532||||||||||||
1324623|NCT03275519|Randomized|Parallel Assignment||Treatment||None (Open Label)||Using the block randomization procedures, a subject was assigned to a study group by computer using the REDCap randomization module. Subjects were randomized to receive post operative antibiotics or to not receive any antibiotics postoperative.||||
1324624|NCT03275506|Randomized|Parallel Assignment||Treatment||None (Open Label)||open-label, multicentric||||
1324625|NCT03275493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324626|NCT03275480|||Cohort||Other|||||||
1324627|NCT03275467||Single Group Assignment||Treatment||None (Open Label)||||||
1324628|NCT03275454||Single Group Assignment||Treatment||None (Open Label)||||||
1324629|NCT03275441|||Cohort||Prospective|||||||
1324630|NCT03275428|||Case-Control||Prospective|||||||
1324631|NCT03275415|Randomized|Parallel Assignment||Prevention||Triple|This is a double blind randomized trial. The infants will be randomly assigned into 2 groups: Control (C) (curosurf + saline) and Intervention (I) (curosurf+ budesonide).|This is a double blind randomized trial. The infants will be randomly assigned into 2 groups: Control (C) (curosurf + saline) and Intervention (I) (curosurf+ budesonide).|t|t|t|
1324632|NCT03275402||Single Group Assignment||Treatment||None (Open Label)||Patients will receive up to two cycles of intracerebroventricular 131I-omburtamab. Safety and efficacy will be investigated with short-term follow-up at 26 weeks after treatment and with long-term follow-up for up to 3 years following treatment.||||
1324633|NCT03275389|Randomized|Parallel Assignment||Prevention||Triple|"The site staff will work in an observer-blind manner during the entire study. As the vaccines appearance and preparation are different, two teams of study personnel will be set up:~A team of unblinded personnel (responsible for the reception, preparation and administration of the vaccines).~A team of blinded personnel (responsible for the clinical safety evaluation of the subjects)."||t||t|t
1324634|NCT03275376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324635|NCT03275363|||Cohort||Prospective|||||||
1324636|NCT03275350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324637|NCT03275337|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1324638|NCT03275324|||Cohort||Prospective|||||||
1324639|NCT03275311|||Cohort||Retrospective|||||||
1324640|NCT03275298|||Cohort||Retrospective|||||||
1324641|NCT03275285|Randomized|Parallel Assignment||Treatment||Single||||||t
1324642|NCT03275272|Randomized|Single Group Assignment||Screening||None (Open Label)|Measurment of blood level of IGF-1 and Maternal BMI|Measurment of maternal BMI and serum level if IGF-1 in infant||||
1324643|NCT03275259||Single Group Assignment||Treatment||None (Open Label)|The participants and evaluator are blinded. They will not be informed about the parameters applied in this study.|||||
1324644|NCT03275246||Single Group Assignment||Treatment||None (Open Label)||||||
1324647|NCT03275207|Randomized|Parallel Assignment||Prevention||Double||paitents undergoing breast or thoracic surgery|t||t|
1324648|NCT03275194|Randomized|Parallel Assignment||Treatment||Single|"The data will be evaluated for a external person with the groups labeled as A and B for all outcomes."|||||t
1324649|NCT03275181|||Case-Control||Prospective|||||||
1324650|NCT03275168|Randomized|Parallel Assignment||Prevention||Double|Single blind||||t|t
1324651|NCT03275155|||Cohort||Prospective|||||||
1324652|NCT03275142|Non-Randomized|Crossover Assignment||Basic Science||Double|Only the Investigator will be interpreting outcomes. The technician/care provider will perform all testing and will mask the investigator to which eye tonometry was performed.||||t|t
1324653|NCT03275129||Single Group Assignment||Diagnostic||None (Open Label)||Patients over the age of 18 who arrive to the hospital requiring surgery for hip fracture repair.||||
1324654|NCT03275116|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1324655|NCT03275103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1324656|NCT03275090|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1324657|NCT03275077|||Case-Control||Prospective|||||||
1324658|NCT03275064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324659|NCT03275051||Single Group Assignment||Treatment||None (Open Label)|No study treatment will be administered.|No study treatment will be administered in this study. Subjects who have received treatment with GSK2696277 in and completed study TIGET-BTHAL will be included in this study.||||
1324660|NCT03275038|Randomized|Parallel Assignment||Prevention||Single|||||t|
1324661|NCT03275025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324662|NCT03275012|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1324663|NCT03274999|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1324664|NCT03274986||||||||||||
1324665|NCT03274973|||Cohort||Prospective|||||||
1324666|NCT03274960|Randomized|Parallel Assignment||Prevention||Double|The investigator will not be aware of study group at analysis stage of results. The assessors of outcome will be blinded to study arm as they analyse data to reduce risk of bias.|The control group shall be receiving the usual current antenatal services which do not include any screening at all for asymptomatic bacteriuria. Control group participants will however be treated as routinely being done when a woman presents with symptoms of a UTI. Control group will therefore continue to get the routine antenatal care service as currently being done at the clinics. Participants in the intervention group will each be screened for asymptomatic bacteriuria once in each trimester using the Griess test. A culture test will be done which will confirm diagnosis of bacteriuria. participants in intervention group who will present with symptoms and who will test positive for bacteriuria with the Griess and culture test will be treated with antibiotics as per usual treatment protocol. A comparison about number of preterm births for intervention group and control group will be done to reveal the effect of the study intervention.|||t|t
1324667|NCT03274947|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324668|NCT03274934|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Treatment, Parallel assessment, Randomized, Efficacy study||||
1324669|NCT03274921|||Cohort||Prospective|||||||
1324670|NCT03274908|||Case-Only||Other|||||||
1324671|NCT03274895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324672|NCT03274882||Single Group Assignment||Treatment||None (Open Label)||||||
1324673|NCT03274869|||Cohort||Prospective|||||||
1324674|NCT03274856|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1324675|NCT03274843||Single Group Assignment||Other||None (Open Label)||||||
1324676|NCT03274830|||Case-Only||Prospective|||||||
1324677|NCT03274817|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1324678|NCT03274804||Single Group Assignment||Treatment||None (Open Label)||||||
1324679|NCT03274791|||Case-Control||Retrospective|||||||
1324680|NCT03274778||Single Group Assignment||Treatment||None (Open Label)||||||
1324681|NCT03274765|||Cohort||Prospective|||||||
1324682|NCT03274752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324683|NCT03274739|||Cohort||Prospective|||||||
1324684|NCT03274726|||Other||Cross-Sectional|||||||
1324685|NCT03274713|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1324686|NCT03274700|Randomized|Parallel Assignment||Treatment||Single|||||t|
1324687|NCT03274687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324688|NCT03274674|Randomized|Parallel Assignment||Treatment||Double||Blinded, Parallel group, Randomized Controlled Trial|||t|t
1324689|NCT03274661||Single Group Assignment||Treatment||None (Open Label)||Eligible participants will receive pembrolizumab intravenously at a dose of 200 mg every 3 weeks.||||
1324690|NCT03274648|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Behçet's will be assigned to one of the following treatments:~vegetarian diet containing inulin and resistant starch-rich foods, including no meat and fish, but containing eggs and dairy products~habitual diet supplemented with 2.4g/day of oral butyrate~habitual diet without supplementation"||||
1324691|NCT03274635|Randomized|Factorial Assignment||Prevention||Single|||t|||
1324692|NCT03274622|Randomized|Parallel Assignment||Treatment||Double|The assessors and coders are blind to treatment assignment. This will be achieved by using different people to conduct the treatment vs assessment and coding. Additionally, these different staff members have offices on different floors.||||t|t
1324693|NCT03274609|||Cohort||Prospective|||||||
1324694|NCT03274596|Randomized|Parallel Assignment||Prevention||Quadruple|The placebo was made by a pharmacologist and was the only person who knows the treatment of A and B. The placebo was administered by nursing staff and had the same appearance and amount as vitamin E. Neither the parents of the participants nor the researchers involved in the care or analysis of the data knew the content of the treatment and B until the end of the study.|participants were randomly assigned to one of two treatmenst (A and B) using a computarized random number generator sequence; this process was handled by the hospital pharmacy staff. Group A: received vitamin E 12.5 IU orally every 12 hours, from 72 h after birth until 28 days of age, Group B: received orally sterile water (placebo) orally every 12 hours, from 72 h after birth until 28 days of age,|t|t|t|t
1324695|NCT03274583|||Case-Control||Prospective|||||||
1324696|NCT03274570|||Case-Only||Cross-Sectional|||||||
1324697|NCT03274557|Randomized|Parallel Assignment||Treatment||Single||To evaluate improvement of VAS and functionality before and after treatment of Achilles tendinose using radiofrequency-plasma based microtenotomy in comparison to traditional physical therapy.|t|||
1324698|NCT03274544||Single Group Assignment||Treatment||None (Open Label)||||||
1324699|NCT03274531|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, cluster randomized, controlled trial||||
1324700|NCT03274518|Randomized|Crossover Assignment||Treatment||Single|Investigator who collects laboratorial, hemodynamics and bioimpedance data will be blinded for intervention (online hemodiafiltration or expanded hemodialysis)||||t|
1324701|NCT03274505|||Cohort||Cross-Sectional|||||||
1324702|NCT03274492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324703|NCT03274479|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1324704|NCT03274466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324705|NCT03274453|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1324706|NCT03274440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1324707|NCT03274427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324708|NCT03274414||Single Group Assignment||Treatment||None (Open Label)||||||
1324709|NCT03274401|Randomized|Parallel Assignment||Screening||None (Open Label)||Patients with newly diagnosed pulmonary embolism will be randomized to screening for atrial fibrillation or standard of care||||
1324710|NCT03274388|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|"Masking is not possible, since the intervention group receives exercise intervention in addition to protein-rich nutritional therapy."|parallel group, controlled pilot study||||
1324711|NCT03274375||Single Group Assignment||Treatment||None (Open Label)||||||
1324712|NCT03274362|Randomized|Parallel Assignment||Treatment||None (Open Label)|The study is a prospective, randomized, non-blinded comparative group clinical trial.|The study will use a parallel study model that consists of a treatment arm (ie. Headspace mindfulness app group) and a control arm (ie. standard care where patients receive a list of resources on mindfulness and health).||||
1324713|NCT03274349|Non-Randomized|Parallel Assignment||Supportive Care||Single|The patients will be coded by a consecutive numbering. Data will be saved only with this number. Access to the data will only be provided to authorized personnel (study nurses) and will be retained in inaccessable and locked rooms.|Prospective, controlled pilot study||||t
1324714|NCT03274336|Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1324715|NCT03274323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324716|NCT03274310|Randomized|Parallel Assignment||Prevention||Single||||||t
1324717|NCT03274297|Randomized|Crossover Assignment||Other||Double|||t||t|
1324718|NCT03274284||Single Group Assignment||Treatment||None (Open Label)||||||
1324719|NCT03274271|Randomized|Factorial Assignment||Prevention||Single|The different participants will receive different website links to the intervention website, according to their group. The link will not provide information about their group.|2x2x2 design with 3 behaviour change techiques provided or not provided|t|||
1324720|NCT03274258||Single Group Assignment||Treatment||None (Open Label)||||||
1324721|NCT03274245|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1324722|NCT03274232||Single Group Assignment||Treatment||None (Open Label)||||||
1324723|NCT03274219||Single Group Assignment||Treatment||None (Open Label)||||||
1324724|NCT03274206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324725|NCT03274193|Randomized|Parallel Assignment||Treatment||Single||||||t
1324726|NCT03274180|Randomized|Parallel Assignment||Prevention||Single||Experimental arm: Nurse consultation Non interventional arm: the medical consultation.|t|||
1324727|NCT03274167|Randomized|Parallel Assignment||Treatment||||||||
1324728|NCT03274154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324729|NCT03274141|||Cohort||Prospective|||||||
1324730|NCT03274128|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324731|NCT03274115|Randomized|Parallel Assignment||Diagnostic||Single||Patients with at least one polyp <1 cm in size will be randomized in two groups. In the Group 1 (White Light Group), all polyps <10mm will be evaluated with white light and prediction of histology (hyperplastic versus adenomatous) will be made. In the Group 2 (BLI Group) , all polyps <10mm in size will be evaluated with BLI and scored as hyperplastic (type 1) or adenomatous (type 2) by applying the NICE ( Narrow-band Imaging International Colorectal Endoscopic) classification. The level of endoscopist's confidence in predicting real-time histology (high or low confidence) for any polyp will be also recorded.|t|||
1324732|NCT03274102|Randomized|Parallel Assignment||Prevention||None (Open Label)|open-labelled|||||
1324733|NCT03274089|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1324734|NCT03274076|Randomized|Parallel Assignment||Treatment||Double|The study staff (with the exception of the study pharmacist) and the patient are blinded to the treatment assignment.|Eligible subjects will be randomized to tofacitinib or placebo in a 2:1 manner.|t||t|
1324735|NCT03274063|Randomized|Parallel Assignment||Treatment||Single|Laboratory staff measuring biochemical traits will be blind to treatment allocation.|Participants will be randomised in a ratio of 2:1 to either supported self management or usual care.||||t
1324736|NCT03274050|||Case-Control||Other|||||||
1324737|NCT03274037||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324738|NCT03274024|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324739|NCT03274011||Single Group Assignment||Treatment||None (Open Label)||||||
1324740|NCT03273998|||Case-Only||Prospective|||||||
1324741|NCT03273985|Randomized|Parallel Assignment||Treatment||Single||||||t
1324820|NCT03272932|||Case-Only||Prospective|||||||
1324821|NCT03272919|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324822|NCT03272906|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1324823|NCT03272893|||Cohort||Prospective|||||||
1324912|NCT03271736|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1324742|NCT03273972|Randomized|Parallel Assignment||Basic Science||Double|"Independent CRF research nurse to perform the drug administration. CRF nurse will be unblinded whilst the rest of the study team (including the CI/PI) are blinded. This will involve the ACRC nurse bringing the injection in a sealed box to the room, preparing a shield (so the volunteer is blinded), administering the injection (via alirocumab pen or placebo - saline in insulin syringe) and then putting the syringe back in the sealed box and removing the screen. They have to ensure none of the study team are aware of the Rx as well as the patient.~CRF nurses will also have to collect and store medication in their building. Statin can be stored in a locked cupboard (open label)."|"Randomisation to be performed to a 1:1 ratio.~Alirocumab treatment arm:~V2: Alirocumab (150mg)~V3: Alirocumab (150mg) & Atorvastatin (20mg)~Comparator treatment arm~V2: Placebo~V3: Placebo & Atorvastatin (20mg)"|t||t|
1324743|NCT03273959|Randomized|Parallel Assignment||Treatment||Single|The evaluator who will apply the tests at the beginning and end of the hospital stay will be blinded. The evaluator who will apply the tests at the beginning and end of the hospital stay will be blinded. Another health professional who will participate in the research will apply the protocol of supervised exercises in patients who are randomized to the intervention group.|Patients will be randomized into two groups: control and intervention.|||t|
1324744|NCT03273946|||Cohort||Prospective|||||||
1324745|NCT03273933|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1324746|NCT03273920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324747|NCT03273907||Single Group Assignment||Treatment||None (Open Label)||||||
1324748|NCT03273894|||Cohort||Prospective|||||||
1324749|NCT03273881|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324750|NCT03273868|Randomized|Crossover Assignment||Other||Double|||t|||t
1324751|NCT03273855|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinded||t|t|t|t
1324752|NCT03273842|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1324753|NCT03273816|Randomized|Parallel Assignment||Supportive Care||Single|The primary endpoint is taken by a nurse who does not know the randomization arm.|Randomized, controlled, bi-centric (national), superiority, open-label, blind-blind (evaluator) trial comparing sophrology to routine care in preparation for deep brain stimulation. The distribution of patients will be balanced between the two groups.||||t
1324754|NCT03273803|||Case-Only||Cross-Sectional|||||||
1324755|NCT03273790|||Cohort||Retrospective|||||||
1324756|NCT03273777|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324757|NCT03273764|||Cohort||Prospective|||||||
1324758|NCT03273751|Randomized|Parallel Assignment||Prevention||Quadruple|Participants, care providers, investigators and outcome assessors will be blinded to group allocation.|A prospective, randomized, parallel group, controlled study|t|t|t|t
1324759|NCT03273738|||Case-Control||Retrospective|||||||
1324760|NCT03273725|||Other||Prospective|||||||
1324761|NCT03273712||Single Group Assignment||Treatment||None (Open Label)||||||
1324762|NCT03273699|Randomized|Parallel Assignment||Treatment||None (Open Label)||A repeated measures multivariate analysis of variance (MANOVA) will be conducted with the two groups (guided mindfulness meditation or control wait list group) as the between-group variable and OCD symptom scores as the dependent variables. A mediation analysis will examine whether obsessive beliefs, engagement in thought control strategies, psychological flexibility, and mind wandering mediates treatment related changes in OCD symptom scores (YBOCS, OCI). Daily practice data from the EEG headsets will be automatically uploaded to an encrypted server. These data will be made anonymous from the start of the study; subjects will be identified using their subject I.D. EEG data will be preprocessed and analyzed using EEG Lab (Delorme & Makeig, 2004).||||
1324763|NCT03273686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324764|NCT03273673|Randomized|Parallel Assignment||Treatment||Double|To reduce the possibility of bias, the biofeedback intervention will be completed by a single individual (clinician - Athletic trainer) and the biomechanical assessments will be completed by a second individual who will be blinded to the subject's group assignment (research technician).|This study involves one active intervention group and an attention control group||t||t
1324765|NCT03273660||Single Group Assignment||Treatment||None (Open Label)||||||
1324766|NCT03273647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324767|NCT03273634|Randomized|Parallel Assignment||Treatment||Double|"Similarly looking tablets and placebo with care providers not knowing which is which. Packets are marked heads and tails for randomization"||t|t||
1324768|NCT03273621|||Case-Only||Prospective|||||||
1324769|NCT03273608|||Case-Only||Prospective|||||||
1324770|NCT03273595|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324771|NCT03273569||Single Group Assignment||Prevention||None (Open Label)||Women with placenta accreta at the time of Cesarean delivery||||
1324772|NCT03273556||Single Group Assignment||Treatment||None (Open Label)||||||
1324773|NCT03273543|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324774|NCT03273530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324775|NCT03273517|||Cohort||Prospective|||||||
1324776|NCT03273504||Single Group Assignment||Treatment||None (Open Label)||||||
1324777|NCT03273491|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324778|NCT03273478|||Cohort||Prospective|||||||
1324779|NCT03273465|Randomized|Parallel Assignment||Treatment||Triple|Double Blind (Subject, Caregiver, Investigator)|This is a placebo-controlled, double blinded interventional study evaluating oral, fecal microbiota transplantation, administered in patients with mild-moderate UC.|t|t|t|
1324780|NCT03273452||Single Group Assignment||Treatment||None (Open Label)||single arm trial, patients enrolled would be treated in this arm.||||
1324824|NCT03272880||Single Group Assignment||Supportive Care||None (Open Label)||This will be a pre-post intervention observational study utilizing a mixed methods approach||||
1324825|NCT03272867|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1324826|NCT03272854|||Cohort||Prospective|||||||
1324827|NCT03272841|||Cohort||Prospective|||||||
1324828|NCT03272828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324913|NCT03271723|||Cohort||Prospective|||||||
1324781|NCT03273439|Randomized|Parallel Assignment||Treatment||Single|This was a single-institution, randomized controlled, double blinded trial. Participants were randomized to receive, over 4 weeks, 20 sessions of either active or sham rTMS. Clinical assessment was performed at baseline, 4 weeks and 8 weeks by 2 psychiatrists blinded to the treatment assigned. Inter-rater reliability was satisfactory (κa=0.86).|In this study, we assessed the therapeutic effects and safety of left dorsolateral prefrontal cortex (DLPFC) high-frequency repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia. We evaluated the efficacy of rTMS on cognition in patients with chronic schizophrenia.|t|||
1324782|NCT03273426||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324783|NCT03273413|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, double-blind, placebo-controlled, parallel study design.|t|t|t|t
1324784|NCT03273400|Non-Randomized|Crossover Assignment||Treatment||Single||The study will be a cross-over design. A pre-test post-test design will be used to evaluate the sEMG activity of the Erector Spinae muscle group and the Hamstring muscle (Biceps Femoris). Lumbar flexion range of motion and hamstring length will be tested prior too mobilisations and post intervention immediate and at intervals of 5, 10, 15, 20, 30, 60 minutes. Participants will be receive non-intervention one week and mobilisations the following week.|t|||
1324785|NCT03273387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324786|NCT03273374||Single Group Assignment||Treatment||None (Open Label)||||||
1324787|NCT03273361|Randomized|Crossover Assignment||Basic Science||Single|Subjects were randomly assigned to a pedaling sequence based on the Graeco Latin squares design. They were blinded regarding which pedaling sequence they were assigned to.||t|||
1324788|NCT03273348||Single Group Assignment||Treatment||None (Open Label)||"This study aim to evaluate the outcome on oncological side and patient satisfaction on the aesthetic side with skin-sparing mastectomy and immediate breast reconstruction for patients with early breast cancer .~The obtained results may contribute to the formulation of guidelines achieving low morbidity, high levels of patient satisfaction and oncological safety in breast cancer patients."||||
1324789|NCT03273335|||Cohort||Prospective|||||||
1324790|NCT03273322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324791|NCT03273309|Randomized|Parallel Assignment||Treatment||Single|||||t|
1324792|NCT03273296|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1324793|NCT03273283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324794|NCT03273270|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1324795|NCT03273257|Randomized|Parallel Assignment||Treatment||Double|Double-blind||t||t|
1324796|NCT03273244|||Other||Prospective|||||||
1324797|NCT03273231|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1324798|NCT03273218|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1324799|NCT03273205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324800|NCT03273192|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1324801|NCT03273179|||Case-Only||Retrospective|||||||
1324802|NCT03273166||||||||||||
1324803|NCT03273153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324804|NCT03273140|Randomized|Parallel Assignment||Other||None (Open Label)|Assessor blinding is not possible as the researcher is involved in the whole process from recruitment to data analysis as part of her doctorate study. However, a research assistant (RA) will assist in arranging the sequence of the envelopes as part of allocation concealment, double-checking of the data entry and analysis of the report. To highlight, the RA will also not know which is the 'control' and 'intervention' group, as both groups will be de-identified as group A and B during the process of data entry and analysis.|The study adopted a randomized controlled trial (RCT) design, comparing between intervention group (receiving GDEP) and control group (current practice). In this study, the RCT study design allows comparison between the intervention (GDEP), which will then prove the hypotheses and serves to address the aim of this study.||||
1324805|NCT03273127|Randomized|Parallel Assignment||Treatment||Single|This study is single-blind with regard to treatment (abediterol or placebo).||t|||
1324806|NCT03273114|Randomized|Parallel Assignment||Treatment||Double|Clinical outcomes will be obtained in the evaluations carried out by a blinded assessor 8 weeks, 6 and 12 months after randomization. Both arms include active treatments, and participants will not know whether they are in the experimental group or control group.|Randomized controlled trial with concealed allocation, blinded assessor, blinded participants and intention to treat analysis. Patients will be evaluated at baseline, 8 weeks, 6 and 12 months after randomization, to assess the maintenance of any effect of treatment. The patients in the CFT group will be treated by a physical therapists that attended twice the CFT workshops with two of the tutors of the method. She completed 106 hours of training including workshops, patient examinations and a pilot study with the supervision of a physical therapist with more than three years of clinical experience in CFT. Patients in CORE group will be treated by a physical therapist with clinical experience in manual therapy and core training exercises.|t|||t
1324807|NCT03273101|Randomized|Parallel Assignment||Treatment||Single||||||t
1324808|NCT03273088|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1324809|NCT03273075|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1324810|NCT03273062|Randomized|Crossover Assignment||Treatment||Quadruple|"The participant, respective care provider, as well as the investigator and research coordinator (outcomes assessor) will all be blind to the order of placebo or medication (Tolcapone) administration in this two-arm, crossover study."|Interventional clinical trial with a double-blind, randomized placebo-controlled crossover design|t|t|t|t
1324811|NCT03273049|||Other||Prospective|||||||
1324812|NCT03273036|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1324813|NCT03273023|||Case-Only||Prospective|||||||
1324814|NCT03273010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324815|NCT03272997|||Cohort||Retrospective|||||||
1324816|NCT03272984|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a parallel, open-label randomized controlled trial.||||
1324817|NCT03272971||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1324818|NCT03272958|||Cohort||Prospective|||||||
1324819|NCT03272945|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1324829|NCT03272815|Non-Randomized|Single Group Assignment||Diagnostic||Single|Radiologists are unaware of the intervention or the nature of the study.|A prospective clinical feasibility cohort study.||||t
1324830|NCT03272802|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324831|NCT03272789||Single Group Assignment||Other||None (Open Label)||||||
1324832|NCT03272776|||Cohort||Prospective|||||||
1324833|NCT03272763||||||||||||
1324834|NCT03272750|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324835|NCT03272737|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324836|NCT03272724|||Cohort||Other|||||||
1324837|NCT03272711|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324838|NCT03272698|Randomized|Parallel Assignment||Treatment||Single|Patients will be randomized to either the HIKER or EAST arms, but due to the different frequencies of treatment, patient and physician blinding will not be possible. Outcome assessor will also not be blinded. As patients were not blinded, they could easily divulge their treatment allocation. The outcome assessor can also deduce treatment allocation from communications with nursing staff or study personnel. However, the follow up assessment at 30 days post-final treatment will be performed by a different study team member who will remain blinded.|Patients in the EAST arm will receive eight ECT sessions (on a bi/triweekly schedule, weekdays only) with ketamine-based general anesthetic (ketamine 0.75 mg/kg, remifentanil 1 mcg/kg, and succinylcholine 0.75 mg/kg for safety. Patients in the HIKER arm will receive a single dose of ketamine 0.75 mg/kg, on 8 successive weekdays. Since ketamine without ECT is not the standard of care for TRD, patients in the HIKER arm who do not achieve a 25% reduction in the Montgomery-Asberg Depression Rating Scale (MADRS) after the third treatment will be deemed non-responsive to ketamine and switched to a standard 8 treatment course of ECT with ketamine-based GA as described in the EAST arm - this will be called rescue ECT. The attending psychiatrist may discontinue therapy for either arm if the patient achieves remission or treatment is ineffective based on clinical judgment.|||t|
1324839|NCT03272685|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Phase III randomized, open label, multi-center study that will examine the impact of very low nicotine content (VLNC) cigarettes using an experimental marketplace that contains tobacco and nicotine products, simulating a real world environment. There are three phases: Phase 1 is smoking usual brand cigarettes. Phase 2 is access to a marketplace with usual brand cigarettes and other non-combusted nicotine and tobacco products. Phase 3 involves access to a marketplace with study cigarettes and other non-combusted nicotine and tobacco products.||||
1324840|NCT03272672|Randomized|Crossover Assignment||Basic Science||Single|A blinded investigator will segment all Ultrasound images.|||||t
1324841|NCT03272659||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324842|NCT03272646|||Cohort||Prospective|||||||
1324843|NCT03272633|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324844|NCT03272620|||Cohort||Prospective|||||||
1324845|NCT03272607|Randomized|Sequential Assignment||Supportive Care||Single|Medical chart abstracts compiled at discharge (including any subsequent visits within 30 days) will be combined with the patient telephone interview into a case summary report which will be reviewed independently by two trained and blinded clinician reviewers who will be made up of pharmacists and physicians from each study site (but who will not adjudicate any patients from their own site).|"The duration of the project will be a total of (approx.) 96 weeks. This is a stepped wedge cluster randomized trial study design (see PDF attachment entitled MedSafer, Figure 1 - note start date will be August 2017 not July 2016). The intervention component will be administered sequentially to six (6) clusters (by city). A randomly selected single cluster will move from control data collection to intervention data collection every 200 patients or roughly every 12 weeks (96 total weeks), which will be followed by 12 weeks to complete follow up and another 36 to analyze data.~Please see PDF attachment entitled MedSafer, Figure 2 which refers to both parts of the study (quality improvement and follow up components). It describes the follow up component of the study (a 30-day telephone follow-up to ascertain adverse drug events- please note the gray-shaded boxes refer to the Quality Improvement Project-Part 1)."||||t
1324846|NCT03272594|Randomized|Parallel Assignment||Treatment||Single|Two research assistants (RA1, RA2) who are blinded to the intervention condition will be hired to complete facial coding and calculation of infant PIPP-R scores. Each research assistant will only code data for infants in the breastfeeding condition (RA1) or the sucrose condition (RA2) and will not be aware of whether they are watching infant responses to noxious or non-noxious stimulation. To minimize observer bias, research assistants will not be informed of the study design, will not be permitted to attend data collection sessions, and will not share datasets or communicate with the other research assistant regarding the study. During data collection, up close video recording of only the infants face will be completed to attempt to keep coders blind to the nature of the intervention.|||||t
1324847|NCT03272581|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324848|NCT03272568|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||During interventional portion of the study, participants will be infused with either Eloctate (hemophilia A carriers) or Alprolix (hemophilia B carriers) to maintain FVIII or FIX >48hours. Five out of the 16 enrolled patients will self-perform a hemoglobin check every other day using a novel device Anemocheck during 2 consecutive menstrual cycles.||||
1324849|NCT03272555||Single Group Assignment||Other||None (Open Label)||||||
1324850|NCT03272542|Randomized|Parallel Assignment||Other||Quadruple||Randomized, placebo-controlled pilot trial with a parallel-arm design|t|t|t|t
1324851|NCT03272529|||Cohort||Prospective|||||||
1324906|NCT03271814|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1324907|NCT03271801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324908|NCT03271788||Single Group Assignment||Treatment||None (Open Label)||||||
1324909|NCT03271775|Randomized|Parallel Assignment||Treatment||Single||"After the initial test, subjects will randomly distribute into three different research groups.~Each subgroup will include 30 patients."||||t
1324910|NCT03271762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324911|NCT03271749|Randomized|Parallel Assignment||Treatment||Single|It's impossible to mask the participants, care providers and investigators, because of the apparent differences in both techniques. For this reason the data analysis will be masked to avoid influences by the other participants during the analysis.|Randomized controlled Trial||||t
1324970|NCT03270982|||Cohort||Other|||||||
1324852|NCT03272516|Randomized|Parallel Assignment||Health Services Research||Single|The investigator will contact all participants in both groups via email or telephone to ask them to answer questionnaires.The investigator will not have information about which group which participant is. Participants will be contacted and invited to answer a questionnaire before, after, 6 and 18 months after 8 weeks of TAU and TAU plus MBCT.|"Randomized clinical trial, where patients are randomized to two groups. Group 1 receives treatment as usual, group 2 receives treatment as usual plus Mindfulness Based Cognitive Therapy (MBCT) for symptoms of mild to moderate depression or anxiety.~Our primary aim is to investigate whether MBCT added to TAU is more effective than TAU alone in reducing mild to moderate symptoms of depression and/or anxiety among primary care patients.~Our secondary aim is to investigate whether MBCT added to TAU is more effective than TAU alone in:~Increasing subjective wellbeing~Reducing antidepressant/anxiolytica use for primary care patients, with mild to moderate symptoms of depression and/or anxiety."|||t|
1324853|NCT03272503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324854|NCT03272490|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324855|NCT03272477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324856|NCT03272464||Single Group Assignment||Treatment||None (Open Label)||||||
1324857|NCT03272451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324858|NCT03272438|Randomized|Parallel Assignment||Supportive Care||Single|Participants are not aware of whether they are in an experimental or control condition.|Participants will be randomly assigned to one of three between-subjects conditions: consistent schedule, inconsistent schedule, no schedule. The study is a longitudinal study over 9 weeks, including a baseline week, a 4-week intervention and a follow-up assessment 4 weeks after the intervention.|t|||
1324859|NCT03272425|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1324860|NCT03272412|||Cohort||Prospective|||||||
1324861|NCT03272399|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1324862|NCT03272386|||Other||Prospective|||||||
1324863|NCT03272373|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||2 single arms being analyzed separately||||
1324864|NCT03272360|||Cohort||Prospective|||||||
1324865|NCT03272347|Randomized|Parallel Assignment||Treatment||Double|Masking in Part 1, including matching placebo. Masking only to dose in Part 2. No masking in Part 3.||t||t|
1324866|NCT03272334|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Pembrolizumab administered in combination with HER2 Bispecific Antibody Armed Activated T-Cell (BATs) infusions||||
1324867|NCT03272321|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1324868|NCT03272308||||||||||||
1324869|NCT03272295|Randomized|Crossover Assignment||Other||Double|A double-blind study in respect of the site (except pharmacy) and subjects.||t||t|
1324870|NCT03272282|||Case-Crossover||Prospective|||||||
1324871|NCT03272269|Randomized|Sequential Assignment||Treatment||Triple|Double-blind, placebo controlled||t|t|t|
1324872|NCT03272256||Sequential Assignment||Treatment||None (Open Label)||||||
1324873|NCT03272243|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1324874|NCT03272230|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1324875|NCT03272217|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-Label|||||
1324876|NCT03272204|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1324877|NCT03272191|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1324878|NCT03272178|||Cohort||Prospective|||||||
1324879|NCT03272165|Randomized|Parallel Assignment||Treatment||Quadruple||Subjects are randomised to one of two groups within a cohort of 8 subjects (N=6 MEDI1341; N=2 placebo)|t|t|t|t
1324880|NCT03272152|||Case-Control||Prospective|||||||
1324881|NCT03272139|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1324882|NCT03272126|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1324883|NCT03272113|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Behaviour change||||
1324884|NCT03272100|||Case-Control||Prospective|||||||
1324885|NCT03272087|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1324886|NCT03272074|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324887|NCT03272061|Randomized|Crossover Assignment||Prevention||Single||Participants will follow in randomized order a tightly controlled, progressive, aerobic-based exercise program or control program for eight weeks, separated by a washout period of twelve weeks.||||t
1324888|NCT03272048|Randomized|Parallel Assignment||Prevention||Single|||t|||
1324889|NCT03272035|||Other||Cross-Sectional|||||||
1324890|NCT03272022|||Cohort||Prospective|||||||
1324891|NCT03272009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324892|NCT03271996|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled study||||
1324893|NCT03271983|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1324894|NCT03271970|||Cohort||Prospective|||||||
1324895|NCT03271957|||Cohort||Prospective|||||||
1324896|NCT03271944||Single Group Assignment||Treatment||None (Open Label)||||||
1324897|NCT03271931|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1324898|NCT03271918|Randomized|Parallel Assignment||Treatment||None (Open Label)||A Single Center, Open Label and Randomized Clinical Trial.||||
1324899|NCT03271905|Randomized|Crossover Assignment||Treatment||Triple|The participant is blind about the procedures. The investigator is blind about order of procedure and outcomes assessor is blind about procedures.||t||t|t
1324900|NCT03271892|||Cohort||Prospective|||||||
1324901|NCT03271879|Randomized|Crossover Assignment||Treatment||Double||Patients will receive study drug: empagliflozin or placebo for an exposure period of up to 16 weeks - at the two treatment periods in a crossover design.|t||t|
1324902|NCT03271866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324903|NCT03271853|||Cohort||Prospective|||||||
1324904|NCT03271840|||Cohort||Prospective|||||||
1324905|NCT03271827|Randomized|Parallel Assignment||Prevention||Single|||t|||
1324971|NCT03270969||Single Group Assignment||Other||None (Open Label)||||||
1324914|NCT03271710||Single Group Assignment||Treatment||None (Open Label)||||||
1324915|NCT03271697|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1324916|NCT03271684|Randomized|Parallel Assignment||Treatment||Double|Double-blinded, participant and assessor blinded, randomised trial.||t|||t
1324917|NCT03271671|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled trial comparing two modes of non invasive ventilation|||t|t
1324918|NCT03271658|Randomized|Parallel Assignment||Health Services Research||Double|The doctor will not be told which intervention was used with the patient. The patient/family are told that they will have one of two ways to see the information about life support, but are blind to which is classified as the study intervention and standard care.|This study includes 1) a randomized controlled trial and 2) an embedded observational qualitative study. The randomized control trial will compare a convenience cohort of participants who receive usual care (approximately n=60 patients or patient/surrogate pairs) to a cohort of participants who receive the intervention (approximately n=60 patients or patient/surrogate pairs).|t|t||
1324919|NCT03271645|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324920|NCT03271632||Single Group Assignment||Treatment||None (Open Label)||||||
1324921|NCT03271619|||Cohort||Prospective|||||||
1324922|NCT03271606|Randomized|Parallel Assignment||Prevention||Single|||t|||
1324923|NCT03271593|||Ecologic or Community||Retrospective|||||||
1324924|NCT03271580|||Cohort||Prospective|||||||
1324925|NCT03271567|||Case-Only||Prospective|||||||
1324926|NCT03271554|||Cohort||Prospective|||||||
1324927|NCT03271541||Single Group Assignment||Treatment||None (Open Label)||||||
1324928|NCT03271528|Randomized|Crossover Assignment||Treatment||Quadruple|This study is double-blind. Medications are over-encapsulated.|This is a double-blind, randomized, placebo-controlled, crossover design trial that will test the effect of lacosamide on alcohol self-administration and craving following a priming dose of alcohol.|t|t|t|t
1324929|NCT03271515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324930|NCT03271502|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1324931|NCT03271489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324932|NCT03271476||Single Group Assignment||Supportive Care||None (Open Label)||All the women will receive the same intervention.||||
1324933|NCT03271463|||Cohort||Prospective|||||||
1324934|NCT03271450|||Cohort||Other|||||||
1324935|NCT03271437|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324936|NCT03271424|Non-Randomized|Sequential Assignment||Other||None (Open Label)||"Qualitative focus group discussions (FGDs) with male and female community members aged 18 - 24~In-clinic observation of HIV self-testing and completion of a brief CAPI/ACASI interview with male and female community members aged 18 - 24"||||
1324937|NCT03271411|Randomized|Parallel Assignment||Treatment||Single||||||t
1324938|NCT03271398|||Cohort||Other|||||||
1324939|NCT03271385|||Case-Control||Prospective|||||||
1324940|NCT03271372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324941|NCT03271359|Randomized|Parallel Assignment||Treatment||Single||||||t
1324942|NCT03271346|||Case-Only||Prospective|||||||
1324943|NCT03271333|||Cohort||Prospective|||||||
1324944|NCT03271320|||Case-Control||Prospective|||||||
1324945|NCT03271307|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||The study will be a cluster-randomized trial comparing three HIV testing strategies. Clusters will be comprised of individual hospitals/health centres in Malawi.||||
1324946|NCT03271294||Single Group Assignment||Treatment||None (Open Label)||||||
1324947|NCT03271281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1324948|NCT03271268|||Cohort||Prospective|||||||
1324949|NCT03271255|Randomized|Parallel Assignment||Treatment||None (Open Label)||Head-to-head comparison of apatinib versus bevacizumab plus sencond-line chemotherapy regimen FOLFIRI for treatment of metastatic colorectal cancer||||
1324950|NCT03271242|||Cohort||Prospective|||||||
1324951|NCT03271229|Randomized|Parallel Assignment||Treatment||Single|||t|||
1324952|NCT03271216|||Cohort||Retrospective|||||||
1324953|NCT03271203|||Cohort||Cross-Sectional|||||||
1324954|NCT03271190|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1324955|NCT03271177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324956|NCT03271164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324957|NCT03271151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324958|NCT03271138|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1324959|NCT03271125|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial||||t
1324960|NCT03271112||Single Group Assignment||Prevention||None (Open Label)||Pilote study||||
1324961|NCT03271099|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1324962|NCT03271086|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1324963|NCT03271073||Single Group Assignment||Treatment||None (Open Label)||||||
1324964|NCT03271060|Randomized|Single Group Assignment||Treatment||None (Open Label)||Posterior inter body fusion and inter transverse process bone graft||||
1324965|NCT03271047|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||In phase 1 it is sequential and then in phase 2 it is parallel.||||
1324966|NCT03271034||Single Group Assignment||Treatment||None (Open Label)||||||
1324967|NCT03271021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324968|NCT03271008|Randomized|Parallel Assignment||Supportive Care||Double|Following informed consent participants are randomised into one of the device groups and general anaesthesia is induced. Primary intubation attempt is carried out with the randomised device. We do not disclose the result of randomisation with our participants prior to anaesthesia induction. Participants are already in surgical anaesthesia with muscle relaxation during the intubation attempt. As providers are the users of the intubation device masking is not possible in this regard. During outcome assessment we plan not to disclose which device was used for a certain group.||t|||t
1324969|NCT03270995|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1324972|NCT03270956||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1324973|NCT03270943|Randomized|Parallel Assignment||Prevention||Single|The nature of the interventions tested in this study does not allow for masking of subjects, instructors, or other personnel involved in program delivery. To preserve unbiased outcome assessments, study personnel involved in clinical assessments or data analysis will be masked with respect to group assignment. To minimize differences in subject expectancy, the programs will be described to participants as two programs, both of which have been previously found to be beneficial to teens.|Participants will be randomized to one of two groups: a mindful self-compassion program or an active attention control program. Randomization will be stratified by gender. As soon as 20 eligible adolescents qualify for enrollment, they will be allocated to either the MFY or healthy lifestyle groups, using a specially-designed computer program which utilizes a random number generator with a permuted block design to ensure that the number of subjects allocated to the two arms over time are equal and to conceal the allocation. This will continue through 4 cohorts of adolescents (n=80). This study is a planning grant for development of an adequately powered clinical trial. Randomization is designed to assess feasibility of our randomization plan, in addition to general feasibility issues of the delivery of the educational programs.||||t
1324974|NCT03270930|||Cohort||Prospective|||||||
1324975|NCT03270917|Randomized|Parallel Assignment||Treatment||Double|The patient, ward physician and research investigator are blinded to the treatment intervention. A large abdominal dressing will be used to cover the incision(s) until postoperative day 4. Obviously, the surgeon and anaesthesiology team can not be blinded.|Patients will be randomised to either the open or the laparoscopic treatment arm.|t||t|
1324976|NCT03270904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324977|NCT03270891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1324978|NCT03270878|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1324979|NCT03270865||Single Group Assignment||Other||None (Open Label)||||||
1324980|NCT03270852|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1324981|NCT03270839|Non-Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1324982|NCT03270826|||Other||Cross-Sectional|||||||
1324983|NCT03270813|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1324984|NCT03270800|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1324985|NCT03270787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1324986|NCT03270774|||Cohort||Prospective|||||||
1324987|NCT03270761|||Case-Only||Cross-Sectional|||||||
1324988|NCT03270748||Single Group Assignment||Treatment||None (Open Label)||||||
1324989|NCT03270735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1324990|NCT03270722|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1324991|NCT03270709|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A total of 44 subjects (11 per group, smokers and non-smokers, HIV+, HIV-) will be enrolled.||||
1324992|NCT03270696|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1324993|NCT03270683|||Case-Control||Prospective|||||||
1324994|NCT03270670|||Case-Only||Prospective|||||||
1324995|NCT03270657||Single Group Assignment||Other||None (Open Label)||||||
1324996|NCT03270644|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1324997|NCT03270631|Randomized|Parallel Assignment||Treatment||Quadruple|Participant are not aware which treatment and exercises they will have, physical therapist who perform treatments and exercise prescription were blinded for measurements and each others work. Outcome assessor was blinded for baseline study results and treatment groups. Investigator was blinded for all the work done by others.|Five groups: 1) control, 2) fascial manipulation (FM) + movement control exercise (MCE), 3) FM + sham-MCE, 4) MCE + sham-FM and 5) sham-FM and sham-MCE|t|t|t|t
1324998|NCT03270618||Single Group Assignment||Treatment||None (Open Label)||||||
1324999|NCT03270605|||Cohort||Retrospective|||||||
1325000|NCT03270592||Single Group Assignment||Supportive Care||None (Open Label)||||||
1325001|NCT03270579|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1325002|NCT03270566|Randomized|Parallel Assignment||Prevention||Single||||||t
1325003|NCT03270553|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1325004|NCT03270540|||Case-Only||Prospective|||||||
1325005|NCT03270527||Sequential Assignment||Prevention||None (Open Label)||||||
1325006|NCT03270514|Randomized|Parallel Assignment||Treatment||Quadruple|Paticipant, care provider, investigator, and outcomes assessor are all blinded to the treatment allocation in double-blind fashion||t|t|t|t
1325007|NCT03270501||Single Group Assignment||Treatment||None (Open Label)||||||
1325008|NCT03270488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325009|NCT03270475||Single Group Assignment||Basic Science||None (Open Label)||||||
1325010|NCT03270462||Single Group Assignment||Treatment||None (Open Label)||||||
1325011|NCT03270449|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1325012|NCT03270436|Randomized|Parallel Assignment||Prevention||None (Open Label)||Comparison of two diabetes prevention curricula in the Marshallese population.||||
1325013|NCT03270423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325014|NCT03270410|||Cohort||Prospective|||||||
1325015|NCT03270397|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1325016|NCT03270384||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1325017|NCT03270371|Randomized|Crossover Assignment||Treatment||None (Open Label)|no masking|Medium cut off Dialyzer compared with standard of care High-Flux Dialyzer (Fx Cor Diax 60®). No others changes in our standard of care maintenance dialysis is planned, dialysis specific parameters such as blood flow will be kept unchanged during the study period).||||
1325018|NCT03270358|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1325019|NCT03270345|||Cohort||Cross-Sectional|||||||
1325020|NCT03270332|Randomized|Crossover Assignment||Treatment||Triple|double-blind|The patients will be randomized to receive either placebo or albuterol on visit 2 and the alternate treatment on visit 3|t|t|t|
1325021|NCT03270319|||Cohort||Prospective|||||||
1325022|NCT03270306|||Case-Control||Cross-Sectional|||||||
1325023|NCT03270293||Single Group Assignment||Treatment||None (Open Label)||||||
1325024|NCT03270280|Randomized|Parallel Assignment||Health Services Research||Quadruple|Triple Blind|Healthy Individuals with Chronic Periodontitis Only|t|t|t|t
1325025|NCT03270267|||Case-Only||Prospective|||||||
1325026|NCT03270254|Randomized|Single Group Assignment||Treatment||Single|The patient and Dentist will both be aware of the type of treatment, The researcher analysing the collected samples will be blind to treatment|Randomised Split mouth||||t
1325027|NCT03270241||Single Group Assignment||Treatment||None (Open Label)||Participants diagnosed with Vitiligo who are enrolled in the study will receive phototherapy (NB-UVB), with the starting dose of 250 mJ/cm2. The dose will be increased by 10% with each treatment. Small skin samples will be collected before and after NB-UVB treatment.||||
1325028|NCT03270228|||Cohort||Retrospective|||||||
1325029|NCT03270215|||Cohort||Retrospective|||||||
1325030|NCT03270202|Randomized|Parallel Assignment||Prevention||Single||||||t
1325031|NCT03270189|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325032|NCT03270176||Single Group Assignment||Treatment||None (Open Label)||||||
1325033|NCT03270163||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325034|NCT03270150||Single Group Assignment||Treatment||None (Open Label)||||||
1325035|NCT03270137|Randomized|Parallel Assignment||Treatment||Single|Single Blind (Investigator)|Parallel Assignment|||t|
1325036|NCT03270124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325037|NCT03270111|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325038|NCT03270098|Randomized|Parallel Assignment||Treatment||Single||This study is a single-blind, parallel assignment, multi-site randomized clinical trial designed to examine the impact of exercise on cognition, daily functioning, and biomarkers of cognitive change in people with schizophrenia.||||t
1325039|NCT03270085|Randomized|Sequential Assignment||Other||Triple|30 subjects with irritable bowel syndrome and diarrhea and bile acid malabsorption will be randomized into 15 people per group in 4-week double-blind, parallel-group trial to Colesevelam or placebo.|This is the third specific aim of a program on IBS-D with increased fecal bile acid excretion.|t|t|t|
1325040|NCT03270072|||Cohort||Prospective|||||||
1325041|NCT03270059|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1325042|NCT03270046|Randomized|Parallel Assignment||Diagnostic||Single||In this study, participants will be randomised 1:1 to water enema group or no water enema group using blocked randomization with random block sizes.|||t|
1325043|NCT03270033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325044|NCT03270020||Single Group Assignment||Treatment||None (Open Label)||"The investigational arm will recruit patients who will receive denosumab 120mg sc every 2 months. The estimated duration of the recruitment period is 12 months.~The treatment period would be 6 months (denosumab administration on months: 0, 2, 4, 6) and the follow-up period would be 12 months."||||
1325045|NCT03270007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325046|NCT03269994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325047|NCT03269981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325048|NCT03269968|Randomized|Parallel Assignment||Prevention||Single||Study participants will be enrolled in a 1:1 ratio to either Negative Pressure Wound Therapy or standard dressing. Randomization will occur prior to delivery using a computer randomization system.||||t
1325049|NCT03269955|Randomized|Parallel Assignment||Prevention||Single|||t|||
1325050|NCT03269942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325051|NCT03269929|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1325052|NCT03269916|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1325053|NCT03269903||Single Group Assignment||Treatment||None (Open Label)||Multicenter non-randomized prospective clinical study in 30 patients with malignant dysphagia||||
1325054|NCT03269890|Randomized|Parallel Assignment||Other||Single||||||t
1325055|NCT03269877|||Case-Crossover||Cross-Sectional|||||||
1325056|NCT03269864|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||two arms, one will be managed by pedicled perforator flaps the other will be managed by free perforator flaps||||
1325057|NCT03269851|||Case-Only||Cross-Sectional|||||||
1325058|NCT03269838|||Cohort||Cross-Sectional|||||||
1325059|NCT03269825|||Cohort||Retrospective|||||||
1325060|NCT03269812|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325061|NCT03269799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325062|NCT03269786|||Cohort||Cross-Sectional|||||||
1325063|NCT03269773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325064|NCT03269760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325065|NCT03269747|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1325066|NCT03269734|||Case-Only||Cross-Sectional|||||||
1325067|NCT03269721|||Cohort||Prospective|||||||
1325068|NCT03269708|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1325069|NCT03269695|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1325070|NCT03269682|||Case-Only||Cross-Sectional|||||||
1325071|NCT03269669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325072|NCT03269656|||Cohort||Prospective|||||||
1325073|NCT03269643||||||||||||
1325074|NCT03269630|||Other||Prospective|||||||
1325075|NCT03269617|Randomized|Crossover Assignment||Basic Science||Triple|Samples were provided in coded bottles whose identity is known only to the product manufacturer. Blinding will persist until all samples have been processed and the data statistically analyzed.|The PHAGE Study is a randomized, double-blind, placebo controlled crossover trial that investigates the utility of four supplemental bacteriophage strains (LH01-Myoviridae, LL5-Siphoviridae, T4D-Myoviridae, and LL12-Myoviridae) to modulate the gut microbiota, and therefore ameliorate common inflammation-related GI distress symptoms (e.g., gas, bloating, diarrhea, constipation, etc) experienced by healthy individuals.|t||t|t
1325126|NCT03268954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325076|NCT03269604|Randomized|Parallel Assignment||Prevention||Double|"A single blinding will be performed. To the database will be categorized the variable duration of prophylaxis so that the person in charge of analysing the data, does not know the true allocation of each of the participants. At the end of the tabulation and analysis of the data, the true allocation will be known."||||t|t
1325077|NCT03269591|Randomized|Parallel Assignment||Treatment||Double|(Participant, Outcomes Assessor)||t|||t
1325078|NCT03269578|||Other||Retrospective|||||||
1325079|NCT03269565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325080|NCT03269552||Single Group Assignment||Treatment||None (Open Label)||||||
1325081|NCT03269539|||Cohort||Prospective|||||||
1325082|NCT03269526||Single Group Assignment||Treatment||None (Open Label)||Standard of care chemotherapy followed by Anti-CD3 x anti-EGFR-Bispecific Antibody Armed Activated T-cells||||
1325083|NCT03269513|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1325084|NCT03269500|||Cohort||Prospective|||||||
1325085|NCT03269487|||Other||Other|||||||
1325086|NCT03269474|||Cohort||Prospective|||||||
1325087|NCT03269461|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1325088|NCT03269448|||Other||Cross-Sectional|||||||
1325089|NCT03269435|Randomized|Parallel Assignment||Treatment||Quadruple|Double dummy design with IV placebo and placebo nerve block||t|t|t|t
1325090|NCT03269422||Single Group Assignment||Treatment||None (Open Label)||||||
1325091|NCT03269409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325092|NCT03269396||Single Group Assignment||Treatment||None (Open Label)||||||
1325093|NCT03269383|Randomized|Parallel Assignment||Prevention||Quadruple|Study drugs will be randomized and prepared by the institutional pharmacy. The research coordinator will maintain the log tracking which patients received treatment vs placebo.|Randomized Controlled Trial with 2 arms, treatment and placebo|t|t|t|t
1325094|NCT03269370|Randomized|Parallel Assignment||Prevention||None (Open Label)|There is no masking in this study.|"RCT with 4 arms, one being a waitlist arm that allows for re-randomization into one of the 3 active study arms."||||
1325095|NCT03269357|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster randomised trial||||
1325096|NCT03269344|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1325097|NCT03269331|||Cohort||Prospective|||||||
1325098|NCT03269318|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be allocated to one of two groups as per block randomisation, with no stratification or minimisation to Group 1; Personalised Medicine who will be prescribed controller medication based on genetic test, Arg/Arg or Arg/Gly - montelukast (LTRA) or Gly/Gly -salmeterol (LABA). While Group 2, Standard Care will be prescribed controller medication based on guidelines.||||
1325099|NCT03269305|||Other||Prospective|||||||
1325100|NCT03269292|||Cohort||Prospective|||||||
1325101|NCT03269279||Single Group Assignment||Treatment||None (Open Label)||||||
1325102|NCT03269266|||Other||Prospective|||||||
1325103|NCT03269253|||Cohort||Prospective|||||||
1325104|NCT03269240|Randomized|Parallel Assignment||Health Services Research||Single|The assessors will blinded with respect to which study arm the participants (health care workers) were assigned to.|Cluster randomized control trial||||t
1325105|NCT03269227||Single Group Assignment||Treatment||None (Open Label)||||||
1325106|NCT03269214|Randomized|Parallel Assignment||Treatment||Double|Neither patients nor investigators were unaware about treatment and control groups.|Patients who had bisphosphonate-related osteonecrosis of the jaw of the mandible randomly allocated in 2 groups. Group 1 underwent debridement of necrotic bone and the involved area closed primary and in group 2 ,patients received topical Phenytoin 5%+ Tetracycline|t||t|
1325107|NCT03269201|||Case-Only||Cross-Sectional|||||||
1325108|NCT03269188|||Cohort||Prospective|||||||
1325109|NCT03269175|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325110|NCT03269162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325111|NCT03269149|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325112|NCT03269136||Sequential Assignment||Treatment||None (Open Label)||||||
1325113|NCT03269123||Single Group Assignment||Treatment||None (Open Label)||Clinical trial with a single arm||||
1325114|NCT03269110|||Cohort||Prospective|||||||
1325115|NCT03269097||||||||||||
1325116|NCT03269084|||Cohort||Prospective|||||||
1325117|NCT03269071|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1325118|NCT03269058|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325119|NCT03269045||Single Group Assignment||Treatment||None (Open Label)||||||
1325120|NCT03269032|Non-Randomized|Crossover Assignment||Treatment||Single||The study will have two phases, Phase 1 will study healthy subjects, who will follow a typical American diet for 2 weeks, and then cross-over to a Mediterranean-style diet for 2 weeks. Phase 2 will study subjects who have IBS-D. As above, they will first eat a typical American diet for 2 weeks, and then cross-over to a Mediterranean-style diet.|t|||
1325121|NCT03269019|||Cohort||Prospective|||||||
1325122|NCT03269006|Randomized|Parallel Assignment||Prevention||None (Open Label)||A randomized control trial will be performed with Inesfly 5AIGRNG TM, commercial available durable wall lining (DWL), impregnated of existing bed-net with insecticide tablet, KO TAB 123, indoor residual spraying (IRS) with Delthamethrin vs a control group (study with 5 arms). The study will be carried out in villages located in Mymensingh District. Four high endemic villages will be selected for the study. As per sample size calculation we need minimum 31 households to see the efficacy of the interventions. We will include 50 households for each intervention and 50 for control (No intervention). 18 households from each cluster will be selected randomly for entomological analysis which includes sand fly density measurement at base line and 1, 3, 6, 9, 12, 15, 18, 21 and 24 months after intervention, and WHO Cone bio-assay on the intervention surfaces and the control surfaces at 1, 3, 6, 9, 12, 15, 18, 21 and 24 months after intervention.||||
1325123|NCT03268993||Single Group Assignment||Basic Science||None (Open Label)||||||
1325124|NCT03268980|||Cohort||Prospective|||||||
1325125|NCT03268967|Non-Randomized|Sequential Assignment||Health Services Research||Single|Data analysis|Before and after interventional study||||t
1325127|NCT03268941|Randomized|Parallel Assignment||Other||Triple|The study has two parts: Part 1 (double-blind) and Part 2 (open-label).||t|t|t|
1325128|NCT03268928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325129|NCT03268915||Single Group Assignment||Diagnostic||None (Open Label)||"The investigators want to test the reproductibility of a 3 minutes sit-to-stand test in patients with idiopathic pulmonary fibrosis.~For this, patient perform the test during 2 visits and the investigators are going to compare the results of the two visits."||||
1325130|NCT03268902|Randomized|Factorial Assignment||Treatment||Quadruple|Both participants and investigators will be blinded to the treatments allocated to each participant. The members of the DSMB will also be blinded.|Each intervention will be assigned independently. Intervention domains will be randomized separately on an individual basis. This will provide 4 different combinations of interventions: 1). Nicotinamide, azithromycin and nitazoxanide 2). Azithromycin and nitazoxanide 3). Nicotinamide only 4). No active treatment.|t|t|t|t
1325131|NCT03268889||Single Group Assignment||Treatment||None (Open Label)||||||
1325132|NCT03268876|||Cohort||Prospective|||||||
1325133|NCT03268863|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1325134|NCT03268850|Randomized|Parallel Assignment||Other||Double|Allocation will be concealed from the study investigators; however, research assistants conducting the assessments will not be blinded since the assessment protocol differs based on group assignment. Study participants will know which arm they are in, but not the reimbursement amount of the other arm.|Candidates will be randomized 1:1 to the LW-A or LW-B arm, with stratification for race. The investigators will prepare the randomization schedule using permuted blocks of randomly varying size to limit predictability and imbalances in arm assignment throughout the study. KT candidates will be informed of group assignment immediately after consenting to the study.||t|t|
1325135|NCT03268837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325136|NCT03268824|||Other||Cross-Sectional|||||||
1325137|NCT03268811||Single Group Assignment||Treatment||None (Open Label)||||||
1325138|NCT03268798||Single Group Assignment||Treatment||None (Open Label)||||||
1325139|NCT03268785|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1325140|NCT03268772||Single Group Assignment||Treatment||None (Open Label)||||||
1325141|NCT03268759|||Cohort||Prospective|||||||
1325142|NCT03268746||||||||||||
1325143|NCT03268733|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open trial||||
1325144|NCT03268720|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||Participants consume a two week lasting low FODMAP diet, followed by 5 days washout, and subsequent two week gluten-free diet.||||
1325145|NCT03268707|Randomized|Sequential Assignment||Other||None (Open Label)||||||
1325146|NCT03268694||Single Group Assignment||Basic Science||None (Open Label)||||||
1325147|NCT03268681|||Case-Only||Cross-Sectional|||||||
1325148|NCT03268668|||Case-Only||Cross-Sectional|||||||
1325149|NCT03268655|Randomized|Parallel Assignment||Basic Science||Double|Double blind|Pilot. Double-blind placebo-controlled randomized trial|t||t|
1325150|NCT03268642|||Cohort||Retrospective|||||||
1325151|NCT03268629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325152|NCT03268616|Non-Randomized|Parallel Assignment||Other||Double|||t|||t
1325153|NCT03268603||Single Group Assignment||Treatment||None (Open Label)||||||
1325154|NCT03268590|Non-Randomized|Crossover Assignment||Basic Science||Double||Participants will undergo neuroimaging (MRI) with electroencephalographic (EEG) cortical network mapping and cognitive assessments during room air breathing (placebo). Room air (21% inspired oxygen) will be delivered via non-rebreather face mask. Persons will serve as their own control and undergo neuroimaging (MRI) with electroencephalographic (EEG) cortical network mapping and cognitive assessments during pure oxygen breathing. Pure oxygen (100% inspired oxygen) will be delivered via non-rebreather face mask|t|||t
1325155|NCT03268577|||Cohort||Prospective|||||||
1325156|NCT03268564||Single Group Assignment||Prevention||None (Open Label)||||||
1325157|NCT03268551|||Cohort||Prospective|||||||
1325158|NCT03268538|||Cohort||Prospective|||||||
1325159|NCT03268525|Randomized|Parallel Assignment||Supportive Care||Quadruple|The surgeons, the pain assessing researchers, and the participating women will all be blinded to what the syringes contain.|Drug group versus placebo group|t|t|t|t
1325160|NCT03268512|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1325161|NCT03268499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325162|NCT03268486|||Case-Only||Prospective|||||||
1325163|NCT03268473|Randomized|Parallel Assignment||Treatment||Double||It's an assessor blinded, parallel group, randomized controlled trial aimed at investigate whether the non-surgical periodontal treatment of patients with periodontitis and obstructive sleep apnea syndrome (OSAS) affects the prognosis of OSAS positively with polysomnographic, serum and saliva parameters.|||t|t
1325164|NCT03268460|||Case-Only||Cross-Sectional|||||||
1325165|NCT03268447|Randomized|Parallel Assignment||Treatment||Triple||Placebo and P8 will be administered via a parallel design|t|t|t|
1325166|NCT03268434|Randomized|Parallel Assignment||Treatment||Double|Double Blind (Investigator, Outcome Assessor)||||t|t
1325167|NCT03268421|Randomized|Parallel Assignment||Treatment||Double||Non-pharmacologic trial comparing behavioral and exercise-based treatments|||t|t
1325168|NCT03268408|||Ecologic or Community||Prospective|||||||
1325169|NCT03268395||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325170|NCT03268382||Single Group Assignment||Treatment||None (Open Label)||||||
1325171|NCT03268369|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1325172|NCT03268356||||||||||||
1325173|NCT03268343|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1325174|NCT03268330|||Cohort||Prospective|||||||
1325175|NCT03268317|||Cohort||Prospective|||||||
1325176|NCT03268304|||Cohort||Prospective|||||||
1325177|NCT03268291|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"The study will include 2,000 patients. Patients will be randomized into two groups: standard outpatient observation (n = 1 000), the Trust program (n = 1 000)."||||
1576188|NCT00011791||||||||||||
1325178|NCT03268278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325179|NCT03268265||||||||||||
1325180|NCT03268252|||Other||Prospective|||||||
1325181|NCT03268239||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325182|NCT03268226||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1325183|NCT03268213||Single Group Assignment||Treatment||None (Open Label)||FMT is offered as a treatment to eligible patients||||
1325184|NCT03268200|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1325185|NCT03268187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325186|NCT03268174|Randomized|Parallel Assignment||Other||Quadruple|AO+ Mist (or placebo) are supplied in white 100mL metered spray bottles. Test products are blinded and labeled for application to the LEFT or RIGHT side of the body|This is a bilateral study. Each subject will apply appropriately labeled test product to the left and right arm.|t|t|t|t
1325187|NCT03268161|||Cohort||Retrospective|||||||
1325188|NCT03268148|Randomized|Parallel Assignment||Prevention||Single|Two independent assessors blinded to intervention read the video, and then record vital signs and pain score. The videos are cut from heel-lancing to the end so that the assessors do not know whether the neonate receive low level laser or breast milk.|low level laser group and breast milk group||||t
1325189|NCT03268135|||Case-Control||Retrospective|||||||
1325190|NCT03268122|Randomized|Crossover Assignment||Prevention||Single||Multiple-crossover, cluster-randomized, controlled trial||||t
1325191|NCT03268109|||Other||Cross-Sectional|||||||
1325192|NCT03268096|||Case-Only||Cross-Sectional|||||||
1325193|NCT03268083|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325194|NCT03268070|Randomized|Crossover Assignment||Treatment||Double|Subjects will be blinded to the type of TMS that they receive on each day.||t|||t
1325195|NCT03268057||Sequential Assignment||Treatment||None (Open Label)||A dose escalation phase based on the use of a 3 + 3 design and treament of up to 6 subjects in each of three VX15/2503 dose levels; a fixed dose of avelumab will be employed. Once the recommended phase two dose is determined, subjects will receive that dose of VX15/205 combined with avelumab moving forward.||||
1325196|NCT03268044|||Cohort||Retrospective|||||||
1325197|NCT03268031|||Case-Only||Cross-Sectional|||||||
1325198|NCT03268018||Single Group Assignment||Treatment||None (Open Label)||||||
1325199|NCT03268005|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures.||t|t|t|t
1325200|NCT03267992|||Case-Only||Other|||||||
1325201|NCT03267979||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325202|NCT03267966|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1325203|NCT03267953|Randomized|Sequential Assignment||Supportive Care||Single|||||t|
1325204|NCT03267940|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1325205|NCT03267927||Single Group Assignment||Treatment||None (Open Label)||||||
1325206|NCT03267914|Randomized|Parallel Assignment||Prevention||None (Open Label)||Subjects will be randomly assigned to receive fluoride therapy with either custom trays (Tray group) or by application with a toothbrush (Brush group).||||
1325207|NCT03267901|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1325208|NCT03267888||Single Group Assignment||Treatment||None (Open Label)||||||
1325209|NCT03267875||Single Group Assignment||Health Services Research||None (Open Label)||||||
1325210|NCT03267862|||Cohort||Cross-Sectional|||||||
1325211|NCT03267849||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325212|NCT03267836||Single Group Assignment||Treatment||None (Open Label)||||||
1325213|NCT03267823|||Cohort||Prospective|||||||
1325214|NCT03267810|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1325215|NCT03267797|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1325216|NCT03267784||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment Interventional, single arm, multicenter, phase I/IIa clinical trial||||
1325217|NCT03267771|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325218|NCT03267758|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1325219|NCT03267745|Randomized|Parallel Assignment||Basic Science||Triple|Sachets with the supplement will be blinded to the participant, and research assistants. Outcomes assessors will be blinded to condition as well.|2 groups of 10 each will be randomized to receive amino acid supplementation or placebo for 28 days during which they will have one leg immobilized by a removable brace.|t|t||t
1325220|NCT03267732|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1325221|NCT03267719||Single Group Assignment||Treatment||None (Open Label)||||||
1325222|NCT03267706|Randomized|Parallel Assignment||Supportive Care||Single|Patients and caregivers are blinded as to whether their clinician received training and access to the newly introduced comprehensive palliative care tool. Clinicians delivering care are not blinded to use of the tool, outcome assessors are not blinded to the data|Pilot prospective randomized controlled trial|t|||
1325223|NCT03267693|||Other||Cross-Sectional|||||||
1325224|NCT03267680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325225|NCT03267667|||Case-Control||Cross-Sectional|||||||
1325226|NCT03267654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325227|NCT03267641|||Cohort||Prospective|||||||
1325228|NCT03267628|Randomized|Parallel Assignment||Supportive Care||Quadruple|Double blinded|4 groups of 25 patients each. All patients will receive a spinal and a quadratus lumborum type 2 block. The groups will have a combination of ITM / QLB or both or neither.|t|t|t|t
1325229|NCT03267615|||Cohort||Prospective|||||||
1325230|NCT03267602||Single Group Assignment||Treatment||None (Open Label)||||||
1325231|NCT03267589|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Part 1: single cohorts of novel agents Part 2: randomized phase 2 against standard of care.||||
1325232|NCT03267576|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1325233|NCT03267563|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Sequential, multiple assignment, randomized trial (SMART) design||||
1325234|NCT03267550||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1325235|NCT03267537|Randomized|Parallel Assignment||Treatment||Double|Observers will be blinded to subjects group assignment|Randomized Controlled Trial|||t|t
1325236|NCT03267524||Single Group Assignment||Supportive Care||None (Open Label)||||||
1325237|NCT03267511|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1325238|NCT03267498||Single Group Assignment||Treatment||None (Open Label)||Single-arm, open label clinical trial of concurrent and adjuvant nivolumab, including a run-in phase to establish basic feasibility of the nivolumab schedule followed by expansion.||||
1325239|NCT03267485|||Cohort||Prospective|||||||
1325240|NCT03267472|||Case-Control||Retrospective|||||||
1325241|NCT03267459|||Case-Only||Prospective|||||||
1325242|NCT03267446||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325243|NCT03267433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325244|NCT03267420|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1325245|NCT03267407|||Cohort||Prospective|||||||
1325246|NCT03267394|||Cohort||Prospective|||||||
1325247|NCT03267381|||Case-Control||Prospective|||||||
1325248|NCT03267368||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-randomized, intervention, outcome||||
1325249|NCT03267355||Single Group Assignment||Health Services Research||None (Open Label)||||||
1325250|NCT03267342||Single Group Assignment||Treatment||None (Open Label)||Investigators will be testing four main interventions for clients of a Community Mental Health Center (CMHC) with serious mental illnesses who currently have control of their finances, based on our study of the literature on financial health and our preliminary research at CMHC. Participating clients will be free to choose which of the services to access and will be free to withdraw at any time.||||
1325251|NCT03267329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325252|NCT03267316|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Part I of the study is designed to define the Maximum Tolerated Dose/ Recommended Phase 2 Dose (MTD/RP2D) of CAN04 in subjects with relapsed or refractory Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma (PDAC), Triple Negative Breast Cancer (TNBC) or Colorectal Cancer (CRC).~Part II consists of three treatment arms and aims to establish the safety and tolerability of CAN04 as monotherapy and in combination with the standard of care in subjects with NSCLC or PDAC, as well as to investigate early signs of efficacy."||||
1325253|NCT03267303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325254|NCT03267290||Single Group Assignment||Other||None (Open Label)||||||
1325255|NCT03267277||Single Group Assignment||Treatment||None (Open Label)||||||
1325256|NCT03267264|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1325257|NCT03267251|Randomized|Parallel Assignment||Prevention||None (Open Label)||This research project will compare usual care clinic-based communication about HPV vaccination (UC) to usual care plus web-based dissemination (UC+GHG) of information on HPV vaccination to parents and adolescent girls using a pair-matched group-randomized pretest-posttest design protocol. Pediatric/family practice clinics in New Mexico (n=30 clinics) will be pair-mated and one clinic per pair will be randomized to UC+GHG condition via the website, GoHealthyGirls.org. The remaining clinic will continue to receive UC only. Assessment protocols will be conducted at pretest, 3-month follow-up, and 9-month follow-up points, measuring knowledge, compatibility and relative advantage principles in DI, shared decision making, and vaccine adoption by girls. Thus, the proposed trial design will be a 2 (UC v. UC+GHG) intervention x 3 (level of time - pretest vs. 3-month follow-up vs. 9-month follow-up) mixed factorial design with participants nested within clinics.||||
1325258|NCT03267238||Single Group Assignment||Treatment||None (Open Label)||||||
1325259|NCT03267225|||Other||Prospective|||||||
1325260|NCT03267212|Randomized|Crossover Assignment||Treatment||Quadruple|Investigators and technicians helping for performing the test and encouraging the patient will be blind. Only one investigator will monitor the ventilation during the test and won't be blind but won't be participating to any encouragement or data acquisition.||t|t|t|t
1325261|NCT03267199|||Cohort||Prospective|||||||
1325262|NCT03267186||Single Group Assignment||Prevention||None (Open Label)||||||
1325263|NCT03267173||Single Group Assignment||Treatment||None (Open Label)||||||
1325264|NCT03267160|||Cohort||Prospective|||||||
1325265|NCT03267147|||Cohort||Prospective|||||||
1325266|NCT03267134||||||||||||
1325267|NCT03267121||Single Group Assignment||Treatment||None (Open Label)||||||
1325268|NCT03267108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325269|NCT03267095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325270|NCT03267082||Single Group Assignment||Treatment||None (Open Label)||||||
1325271|NCT03267069|||Cohort||Prospective|||||||
1325272|NCT03267056|||Cohort||Prospective|||||||
1325273|NCT03267043|Non-Randomized|Sequential Assignment||Other||Single||||||t
1325274|NCT03267030||Single Group Assignment||Treatment||None (Open Label)||||||
1325275|NCT03267017|||Cohort||Prospective|||||||
1325276|NCT03267004|Randomized|Factorial Assignment||Screening||Single|The project staffs who will be analyzing the digital images taken by Sony Smarteyeglass during meal sessions will be masked including the types of foods and volume provided to the participants.|A 2x2x2x2x3 mixed factorial design will be used, with a between-subject factor of the order of meals (Order 1 and 2) and within-subject factors of food shapes (Regular and Irregular), food complexities (Single food and Mixed food), meals (Meal A and B), and methods of measurement (DietCam, weighed food intake, and 24-hour dietary recall).|||t|
1325277|NCT03266991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325278|NCT03266978|||Cohort||Prospective|||||||
1325279|NCT03266965||Single Group Assignment||Treatment||None (Open Label)||||||
1325280|NCT03266952|||Cohort||Prospective|||||||
1325281|NCT03266939|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1325282|NCT03266926|||Cohort||Prospective|||||||
1325283|NCT03266913|Randomized|Parallel Assignment||Treatment||Single||||||t
1325284|NCT03266900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325285|NCT03266887|||Cohort||Prospective|||||||
1325286|NCT03266874|||Cohort||Prospective|||||||
1325287|NCT03266861|||Cohort||Prospective|||||||
1325288|NCT03266848|||Cohort||Prospective|||||||
1325289|NCT03266835||Single Group Assignment||Treatment||None (Open Label)||||||
1325290|NCT03266822|||Case-Control||Prospective|||||||
1325291|NCT03266809|||Cohort||Prospective|||||||
1325292|NCT03266796|||Other||Cross-Sectional|||||||
1325293|NCT03266783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325294|NCT03266770||Single Group Assignment||Treatment||None (Open Label)||||||
1325295|NCT03266757|||Cohort||Prospective|||||||
1325296|NCT03266744|Non-Randomized|Parallel Assignment||Other||Single|The reporting radiologist of the WB-MRI will be blinded to the results of the CT. The reporting radiologist of the CT will also be blinded to the results of the WB-MRI. Neither treating clinicians nor patients will be blinded at any point.|||||t
1325297|NCT03266731||Single Group Assignment||Treatment||None (Open Label)||||||
1325298|NCT03266718|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325299|NCT03266705|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1325300|NCT03266692||Single Group Assignment||Treatment||None (Open Label)||||||
1325301|NCT03266679||Single Group Assignment||Treatment||None (Open Label)||Case-Series Design||||
1325302|NCT03266666||Single Group Assignment||Health Services Research||None (Open Label)||||||
1325303|NCT03266653||Single Group Assignment||Treatment||None (Open Label)||All patients given identical treatment with CTLs for refractory EBV.||||
1325304|NCT03266640||Single Group Assignment||Treatment||None (Open Label)||All eligible patients will be given CMV specific CTLs and dose is based on donor source: HLA matched and HLA mismatced||||
1325305|NCT03266627||Single Group Assignment||Treatment||None (Open Label)||All eligible patients will receive one dose of CTLs at the same dose. Patients who meet the criteria may need additional CTL doses up to 5 total.||||
1325306|NCT03266614|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1325307|NCT03266601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325308|NCT03266588||Single Group Assignment||Treatment||None (Open Label)||||||
1325309|NCT03266575|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||randomized to pulmonary rehab vs home based exercise rpogram||||
1325310|NCT03266562||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325311|NCT03266549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325312|NCT03266536|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1325313|NCT03266523|||Cohort||Prospective|||||||
1325314|NCT03266510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325315|NCT03266497|||Other||Cross-Sectional|||||||
1325316|NCT03266484|Randomized|Parallel Assignment||Diagnostic||Triple|Will be a double blinded randomized controlled trial. Masking will be done by the provider of the probiotics/placebo||t|t|t|
1325317|NCT03266471|||Case-Control||Prospective|||||||
1325318|NCT03266458|||Cohort||Prospective|||||||
1325319|NCT03266445|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomly assigned to be maintained on their daily dose of buprenorphine/naloxone or to have their buprenorphine/naloxone reduced to 8mg prior to surgery. Each group will have identical perioperative treatment plans. Primary outcome measured is pain scores following surgery.||||
1325320|NCT03266432||Single Group Assignment||Prevention||None (Open Label)||||||
1325321|NCT03266419|Randomized|Parallel Assignment||Treatment||Double|Researchers who evaluate postoperative pain will be blinded to the patient's allocation|This study is investigator-initiated, randomized, double blinded clinical trial.|t|||t
1325322|NCT03266406||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325323|NCT03266393|Randomized|Crossover Assignment||Treatment||None (Open Label)||"Once enrolled, patients will be randomized 1:1 to immediate release tacrolimus that the patient had been maintained on prior to the study (twice daily formulation) or Envarsus XR® using a permuted block randomization sequence to improve the likelihood of balance between groups. Following randomization, and independent of the formulation of tacrolimus, each patient will have a run-in period of 14 days to optimize the dose to reach a tacrolimus trough level of 5 to 8 ng/ml. Randomization will be stratified based on each patient's follow-up period post-transplant in 2 stratification groups."||||
1325324|NCT03266380|||Cohort||Prospective|||||||
1325325|NCT03266367|||Case-Control||Prospective|||||||
1325326|NCT03266354|||Case-Only||Prospective|||||||
1325327|NCT03266341|||Case-Only||Prospective|||||||
1325328|NCT03266328|||Case-Only||Prospective|||||||
1325329|NCT03266315|Randomized|Single Group Assignment||Prevention||Single|||||t|
1325330|NCT03266302|Randomized|Sequential Assignment||Prevention||Single|Participant will not be informed about group allocation|two-arm randomized-controlled group sequential (Pocock) design for assessing superiority and safety|t|||
1325331|NCT03266289|||Other||Prospective|||||||
1325332|NCT03266276|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Randomized Controlled Trial~After completing HNC staff interprofessional team training in PSO and PC, an RCT will be used to examine the impact of using a standardized PSOPC pathway approach, prompted follow up with patients and documentation. Participants will be recruited and randomized into (1) care as usual group and (2) intervention PSOPC pathway group."||||
1325333|NCT03266263|Randomized|Parallel Assignment||Treatment||Single||||||t
1325334|NCT03266250|||Other||Prospective|||||||
1325335|NCT03266237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325336|NCT03266224|||Case-Only||Cross-Sectional|||||||
1325337|NCT03266211|||Other||Prospective|||||||
1325338|NCT03266198|||Cohort||Retrospective|||||||
1325339|NCT03266185|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325340|NCT03266172|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1325396|NCT03265444||Single Group Assignment||Treatment||None (Open Label)||||||
1325397|NCT03265431|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1325398|NCT03265418||Single Group Assignment||Treatment||None (Open Label)||||||
1325341|NCT03266159|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|This will be an open-label study. Hence, masking will not be performed.|A sequential combined therapy of GSK525762 plus trametinib will be given to the subjects. Subjects will receive escalating doses in part 1 and the dose combination selected at the end of part 1 will be provided in part 2.||||
1325342|NCT03266146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325343|NCT03266133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325344|NCT03266120|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1325345|NCT03266107||Single Group Assignment||Treatment||None (Open Label)||||||
1325346|NCT03266094||Single Group Assignment||Treatment||None (Open Label)||||||
1325347|NCT03266081||Single Group Assignment||Treatment||None (Open Label)||||||
1325348|NCT03266068|||Case-Control||Prospective|||||||
1325349|NCT03266055|Randomized|Parallel Assignment||Prevention||Single|||t|||
1325350|NCT03266042|||Other||Other|||||||
1325351|NCT03266029|||Cohort||Prospective|||||||
1325352|NCT03266016|Randomized|Parallel Assignment||Prevention||Single|Analysis Blinded|Randomized Controlled Trial||||t
1325353|NCT03266003|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1325354|NCT03265990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325355|NCT03265977|Randomized|Parallel Assignment||Prevention||Triple|Random numbers generated by IWRS; Stratified by site. Syringes are masked with a translucent colored label, in order to maintain the study blind.|Participants will be enrolled in two cohorts. Within each cohort participants will be randomized in a 1:1 ratio to receive either H56:IC31 (5 ug H56/500 nmol IC31) or placebo intramuscularly (IM) on Days 0 and 56.|t|t|t|
1325356|NCT03265964|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1325357|NCT03265951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325358|NCT03265938|||Case-Only||Prospective|||||||
1325359|NCT03265925|||Cohort||Prospective|||||||
1325360|NCT03265912|||Cohort||Prospective|||||||
1325361|NCT03265899|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1325362|NCT03265886|Randomized|Parallel Assignment||Supportive Care||Double|Double-blind design||t|t||
1325363|NCT03265873|||Case-Only||Cross-Sectional|||||||
1325364|NCT03265860|||Case-Only||Prospective|||||||
1325365|NCT03265847|Randomized|Parallel Assignment||Prevention||Single|||t|||
1325366|NCT03265834|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1325367|NCT03265821|||Cohort||Retrospective|||||||
1325368|NCT03265808|Randomized|Parallel Assignment||Treatment||Double||Subjects will be randomized in a 1:1 blinded fashion|t||t|
1325369|NCT03265795||Single Group Assignment||Treatment||None (Open Label)||||||
1325370|NCT03265782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325371|NCT03265769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325372|NCT03265756|||Cohort||Prospective|||||||
1325373|NCT03265743|||Other||Prospective|||||||
1325374|NCT03265730|||Cohort||Prospective|||||||
1325375|NCT03265717|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325376|NCT03265704|||Cohort||Retrospective|||||||
1325377|NCT03265691|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1325378|NCT03265678|||Other||Other|||||||
1325379|NCT03265665|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325380|NCT03265652|Randomized|Parallel Assignment||Treatment||Single|Subjects in the study arm will receive a series of IPL pulses using the M22 IPL handpiece. In subjects of the control arm, the device will be disabled. The subject will feel the lightguide on the skin, will hear clicking sounds, but no light will be actually produced by the M22 device. Since during treatment both eyes of the subject will be fully occluded, no subject will be able to see if the treatment is actual or sham. There is no way to completely mask the subjects, since the IPL generally causes slight redness of the skin, and in some patients is may also cause some discomfort|Subjects will be randomized 1:1 to a study arm and a control arm. Subjects in the study arm will be treated with IPL and meibomian gland expression. Subjects in the control arm will be treated with sham and meibomian gland expression.|t|||
1325381|NCT03265639|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)|Open label|||||
1325382|NCT03265626|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Community based three arm quasi-experimental design will be employed using mixed methods (quantitative and qualitative). Study participants will be allocated to the intervention and control groups to piloting the feasibility and effectiveness of community based intervention to avert domestic violence against women (15-49 years). Married or cohabited women, husbands/partner, community representatives (such as leaders/local politicians, religious leaders and elders), health care providers, police, women association and women affair office representatives will be involved in this implementation research.||||
1325383|NCT03265613||Single Group Assignment||Treatment||None (Open Label)||||||
1325384|NCT03265600|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two arms, intervention and low-dose comparator, which are randomly assigned at the same time and are implemented in parallel.||||
1325385|NCT03265587|||Cohort||Prospective|||||||
1325386|NCT03265574|Randomized|Parallel Assignment||Prevention||Single||||||t
1325387|NCT03265561|Randomized|Parallel Assignment||Treatment||None (Open Label)||Bone allograft group will receive bone structural allograft; Auto and allograft group will receive bone structural allograft plus spongy autograft.||||
1325388|NCT03265548|Randomized|Sequential Assignment||Device Feasibility||None (Open Label)||||||
1325389|NCT03265535|||Other||Prospective|||||||
1325390|NCT03265522|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325391|NCT03265509|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1325392|NCT03265496||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325393|NCT03265483|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1325394|NCT03265470|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1325395|NCT03265457|||Case-Control||Prospective|||||||
1576189|NCT00011778||||Treatment||||||||
1325399|NCT03265405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325400|NCT03265392|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1325401|NCT03265379|||Cohort||Prospective|||||||
1325402|NCT03265366|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1325403|NCT03265353|Randomized|Crossover Assignment||Prevention||None (Open Label)||All participants will complete each arm. It is a crossover, randomized design.||||
1325404|NCT03265340|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1325405|NCT03265327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325406|NCT03265314|Randomized|Parallel Assignment||Prevention||Double||Person-level random control trial. Participants randomly assigned to intervention (LeadHer) OR control (Sassy Science). Unit of analysis is individual (not groups/clusters). Baseline data collection is before randomization, in enrollment sessions, to prevent differential attrition post-randomization. Randomization via database developed for project. Evaluation Strategies (AFG's independent partner) developed an automated randomization method via random number generator. All randomized participants are tracked for study duration. In database, the button disappears once randomization occurs. The button is not active until consent/assent and all baseline measures are input to database. This randomization will occur after enrollment session, once enough participants for a cohort are enrolled. This helps prevent post-random sample loss. Randomization is electronic, via database, before first session. Once randomization occurs, AFG contacts enrolled girls about which their assigned program.|t|t||
1325407|NCT03265301|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325408|NCT03265288|Randomized|Parallel Assignment||Treatment||Quadruple|Patients will be randomly assigned to take either the active drug (fenretinide capsule) or a matching inactive placebo (inactive capsule).|Double-blind, randomized, parallel groups and placebo-controlled trial.|t|t|t|t
1325409|NCT03265275|||Cohort||Prospective|||||||
1325410|NCT03265262||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325411|NCT03265249|Randomized|Parallel Assignment||Treatment||None (Open Label)||two groups where randomization is either to device or SOC||||
1325412|NCT03265236|||Case-Control||Prospective|||||||
1325413|NCT03265223|Randomized|Parallel Assignment||Treatment||Triple|Triple blinding was done i.e. neither the operating surgeon nor the investigator and nor the patient knew to which study group patient belong to.|Three study groups: Controls received no drug, intraperitoneal group received drug along right hemidiaphragm and in gallbladder fossa while intraincisional group received drug by infiltration at trocar site|t|t|t|
1325414|NCT03265210|Randomized|Parallel Assignment||Treatment||Single|Research assistants will be blind to who is receiving Relief and who is not.|||||t
1325415|NCT03265197|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1325416|NCT03265184|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1325417|NCT03265171||||||||||||
1325418|NCT03265158|||Other||Prospective|||||||
1325419|NCT03265145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325420|NCT03265132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325421|NCT03265119|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325422|NCT03265106||Single Group Assignment||Treatment||None (Open Label)||||||
1325423|NCT03265093|Randomized|Parallel Assignment||Treatment||Single|Investigator, Outcomes Assessor|Blinded, Parallel group, randomized controlled trial|||t|
1325424|NCT03265080|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|Open label|Personalized immunotherapy treatment design||||
1325425|NCT03265067|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Before and after phase study||||
1325426|NCT03265054|||Cohort||Retrospective|||||||
1325427|NCT03265041|||Other||Retrospective|||||||
1325428|NCT03265028|Randomized|Sequential Assignment||Treatment||Triple||Cluster-randomised controlled trial with stepped-wedge design|t|t||t
1325429|NCT03265015|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1325430|NCT03265002|Randomized|Crossover Assignment||Basic Science||Double|"Participants will be blind to the fibre product taken on each study visit. Masking will be assisted by adding lemon juice to the vehicle drink.~The staff responsible for preparing this food will be members of the digestive diseases unit at the NIHR Nottingham Biomedical Research Centre and will not be involved in the study otherwise. The investigators responsible for MRI and symptom analysis will be kept blind to the intervention as data will be coded by date of study day, rather than by product received. Additionally MRI data will be assigned a 'scanning number' through the Sir Peter Mansfield Imaging Centre. This will pseudo-anonymise MRI data within the study so that associations between participants and scans will not be immediately obvious."|single-centre, 4 period, 4 treatment, placebo-controlled crossover trial.|t||t|
1325431|NCT03264989||Single Group Assignment||Treatment||None (Open Label)||||||
1325432|NCT03264976|||Case-Control||Prospective|||||||
1325433|NCT03264963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325434|NCT03264950||Single Group Assignment||Diagnostic||None (Open Label)||Patients (<18 years) will be recruited from from the Children's Hospital Winnipeg CF clinic. Charts will be reviewed for demographic and clinical data including blood work. Each patient will undergo shear wave elastography by a trained operator.||||
1325435|NCT03264937|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325436|NCT03264924|||Case-Only||Prospective|||||||
1325437|NCT03264911|Randomized|Parallel Assignment||Treatment||Quadruple||prospective, randomized, interventional, placebo-controlled, double-blinded, multicentric clinical trial|t|t|t|t
1325438|NCT03264898|||Cohort||Prospective|||||||
1325439|NCT03264885|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1325440|NCT03264872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325441|NCT03264859|||Cohort||Prospective|||||||
1325442|NCT03264846|||Other||Cross-Sectional|||||||
1325443|NCT03264833|||Cohort||Prospective|||||||
1325444|NCT03264820|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Monocentric, prospective, non-randomized study 11 healthy volonteer 33 patients||||
1325445|NCT03264807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576190|NCT00011765||||Treatment||||||||
1325446|NCT03264794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325447|NCT03264781|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1325448|NCT03264768|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325449|NCT03264755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325450|NCT03264742|||Cohort||Prospective|||||||
1325451|NCT03264729|Randomized|Crossover Assignment||Treatment||Single|||t|||
1325452|NCT03264716||Single Group Assignment||Treatment||None (Open Label)||||||
1325453|NCT03264703|||Cohort||Prospective|||||||
1325454|NCT03264690|||Cohort||Prospective|||||||
1325455|NCT03264677|Randomized|Parallel Assignment||Other||Triple|"Since this will be a blind study, the product randomization codes will be generated by study team member different from Study Manager, Study Director, Principle Investigator and any data producers or influencer. The product randomization codes and the corresponding product information (i.e. product name, formula number, batch number, manufacturing/expiry date, etc.) will be sealed in an envelope and before study filed work complete kept by PI until there is a unblinding needs due to medical emergency or report drafting.~In this study, in total 4 IPs include 3 facial creams and 1 facial cleanser will be evaluated. Subjects will be assigned to 3 groups randomly and evenly with different facial product regimens (one cleanser + one cream). The product regimens will be applied on the whole face for on-site study and the 8-week HUT. For each subject, left or right cheek area will be randomly chosen as experimental area for evaluation and middle upper chest will be the untreated control area"|"Subjects will be randomly and evenly divided into 3 groups (approx. 40 subjects per group) with different facial care regimens during the 8-week home use study.~Group 1: NTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Kiwi Water Gel Group 2: NTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Water Gel Group 3: NTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Extra Dry Emulsion"|t||t|t
1325456|NCT03264664||Single Group Assignment||Treatment||None (Open Label)||||||
1325457|NCT03264651||Single Group Assignment||Treatment||None (Open Label)||A single armed group of premenopausal women receiving open labeled medication||||
1325458|NCT03264638|Randomized|Parallel Assignment||Treatment||None (Open Label)||One third of participanta will receive Dingkun Dan Pills, one third of participanta will receive Diane-35 Pills, and the another third will receive Dingkun Dan pills and Diane-35 in combination.||||
1325459|NCT03264625|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325460|NCT03264612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325461|NCT03264599|||Cohort||Prospective|||||||
1325462|NCT03264586|Randomized|Parallel Assignment||Prevention||Single|||t|||
1325463|NCT03264573|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized controlled trial||||
1325464|NCT03264560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325465|NCT03264547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325466|NCT03264534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325467|NCT03264521|||Cohort||Cross-Sectional|||||||
1325468|NCT03264508|Randomized|Parallel Assignment||Basic Science||Single|Investigators collecting and analyzing data will be blinded to subject treatment arms. It is not possible to blind subjects.|Randomized, controlled (parallel design), single-blind|||t|
1325469|NCT03264495|||Other||Prospective|||||||
1325470|NCT03264482|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325471|NCT03264469|||Case-Only||Prospective|||||||
1325472|NCT03264456||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325473|NCT03264443|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1325474|NCT03264430|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1325475|NCT03264417|||Cohort||Retrospective|||||||
1325476|NCT03264404||Single Group Assignment||Treatment||None (Open Label)||||||
1325477|NCT03264391|||Case-Only||Cross-Sectional|||||||
1325478|NCT03264378|Randomized|Parallel Assignment||Health Services Research||Triple|None of participants, care providers, or outcome assessor knows whether which participants have been assigned to intervention or control condition.|The experimental group will receive physical exercise intervention (PEI) that is supported by standardized administrative procedures plus the GTO-ThAI implementation support system designed to improve the quality of implementation of the PEI program. The active comparator group will receive PEI that is supported only by standardized administrative procedures that the Thai government typically uses to promote policy-driven initiatives.|t|t||t
1325479|NCT03264365|Randomized|Parallel Assignment||Supportive Care||Single|Data analyses|Pragmatic, non-blinded, multicenter, parallel-group randomized controlled trial||||t
1325480|NCT03264352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325481|NCT03264339||Single Group Assignment||Treatment||None (Open Label)||Single-subject research design (SSRD) will be used with each participant serving as his/her own control.||||
1325482|NCT03264326|Randomized|Parallel Assignment||Treatment||Double|Participant blinded to group assignment, assessor blinded to group assignment, investigator blinded to analysis.||t|||t
1325483|NCT03264313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325484|NCT03264300|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1325485|NCT03264287|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1325486|NCT03264274||Single Group Assignment||Treatment||None (Open Label)|No masking|Single arm study||||
1325487|NCT03264261|Randomized|Parallel Assignment||Treatment||Single|Outcome measures of each subject will be evaluated before training, after 6 weeks of training, and at 8 weeks after the end of training by a physical therapist who is blinded by subject group assignment, and subjects will be requested not to disclose his/her group assignment to this physical therapist.|Subjects will be blocked by gait speed into slow (< 0.4 m/s) or fast (≥ 0.4 m/s) subgroups and randomized to either the CIMT or treadmill training only groups at the initial test.||||t
1325488|NCT03264248||Single Group Assignment||Treatment||None (Open Label)||||||
1325535|NCT03263637|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a multicentre, open-label, first in human, non-randomized, dose-escalation study including an intra-subject ramp-up. The study will consist of two, parallel dose escalation arms||||
1576191|NCT00011752||||||||||||
1325489|NCT03264235|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized into one of two groups. Group 1 will wear the exoskeleton device while completing all training sessions and will participate in 30 minutes of stair training in the device. Group 2 will not wear the exoskeleton device during training sessions and will be participate in 30 minutes of stair training without the device.||||
1325490|NCT03264222||Single Group Assignment||Prevention||None (Open Label)||Prospective cohort study.||||
1325491|NCT03264209|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1325492|NCT03264196|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised Controlled Trial||||
1325493|NCT03264183|||Case-Only||Prospective|||||||
1325494|NCT03264170|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||All participating women will be randomised to one of two groups at the time of recruitment. The intervention group will receive the prediction score. The control group will not receive the prediction score.||||
1325495|NCT03264157|Randomized|Parallel Assignment||Treatment||Double|Double-blind study|Treatment A: BPL HRIG + active rabies vaccine Treatment B: Comparator HRIG + active rabies vaccine|t||t|
1325496|NCT03264144|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325497|NCT03264131||Single Group Assignment||Treatment||None (Open Label)||||||
1325498|NCT03264118|Randomized|Parallel Assignment||Treatment||Double||Split-mouth design. One side of mouth is test and the other is control side.|t|||t
1325499|NCT03264105|Non-Randomized|Parallel Assignment||Other||Single|The primary assessors will not be blind to intervention/control material due to different in material shade. However, the other assessors will be blind from the type of material they will evaluate the retention rate of the restoration; it will not be allowed amongst the assessor to exchange any information throughout the entire study period.|||||t
1325500|NCT03264092|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1325501|NCT03264079||Single Group Assignment||Treatment||None (Open Label)||"All participants are placed into a one group to receive two interventions: one intervention during Period 1 and a second intervention during Period 2.~For Period 1, all qualified subjects shall receive a single oral dose of bardoxolone methyl (10 mg) on Day 1.~For Period 2, following a washout of 14 days, itraconazole (SPORANOX®) capsules (100 mg) will be administered as a 200-mg single daily dose on Study Days 15 through 27, with bardoxolone methyl (10 mg) administered on Day 18 (1 hour after itraconazole administration)"||||
1325502|NCT03264066|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325503|NCT03264053|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325504|NCT03264040|||Cohort||Prospective|||||||
1325505|NCT03264027|Randomized|Parallel Assignment||Treatment||Double|Both the participant and the outcome assessor will be blinded to the study intervention.||t|||t
1325506|NCT03264014|||Other||Retrospective|||||||
1325507|NCT03264001|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1325508|NCT03263988|||Cohort||Prospective|||||||
1325509|NCT03263975|Randomized|Parallel Assignment||Treatment||None (Open Label)||Between groups design||||
1325510|NCT03263962|||Cohort||Retrospective|||||||
1325511|NCT03263949|||Cohort||Prospective|||||||
1325512|NCT03263936||Single Group Assignment||Treatment||None (Open Label)||||||
1325513|NCT03263923|Randomized|Parallel Assignment||Treatment||Single|Participants randomly assigned to groups|Randomized controlled clinical trial|t|||
1325514|NCT03263910|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1325515|NCT03263897|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325516|NCT03263884|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325517|NCT03263871|Randomized|Parallel Assignment||Treatment||Double||||t||t
1325518|NCT03263858||Single Group Assignment||Treatment||None (Open Label)||consecutive enrolment of cohort 1 (primary endpoint at 1 month), and cohort 2 (primary endpoint at 9 months)||||
1325519|NCT03263845|||Case-Only||Prospective|||||||
1325520|NCT03263832|||Case-Control||Prospective|||||||
1325521|NCT03263819|||Case-Control||Prospective|||||||
1325522|NCT03263806|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1325523|NCT03263793||Single Group Assignment||Treatment||None (Open Label)||||||
1325524|NCT03263780||Single Group Assignment||Other||None (Open Label)||||||
1325525|NCT03263767|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1325526|NCT03263754|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325527|NCT03263741||Single Group Assignment||Treatment||None (Open Label)||||||
1325528|NCT03263728||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325529|NCT03263715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325530|NCT03263702||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325531|NCT03263689|Randomized|Parallel Assignment||Treatment||Single|The subjects were randomly assigned to a study group (intrathecal morphine - ITM group - or TAP - TAP group) by a computer random number generator. Patients were blinded to their study allocation. Those in the ITM group were given 100 micrograms of preservative-free morphine in addition to the local anaesthesia (plain hyperbaric bupivacaine 10mgs) intrathecally during the spinal anaesthesia. The TAP group were given only local anaesthesia (plain hyperbaric bupivacaine 10 mgs) during the spinal anaesthesia.|The patients in the intrathecal morphine (ITM group) were given a sham block, while the patients in the TAP group were given a TAP block. Sham blocks consisted of a non-invasive ultrasound scan. A blunt needle was gently pressed on either side of the abdomen. Bilateral TAP blocks were placed after ultrasound location of the transversus abdominis and internal oblique muscles, with the injection sites in the Triangle of Petit located at the lateral edge of the mid-abdomen. Following negative aspiration for blood, the local anaesthetic (0.25% bupivacaine with 1:200000 epinephrine) was injected in the transversus abdominis plane under ultrasound visualization in 5 cc aliquots for a total volume of 15cc per side.|t|||
1325532|NCT03263676|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1325533|NCT03263663|||Case-Control||Prospective|||||||
1325534|NCT03263650|Randomized|Sequential Assignment||Treatment||None (Open Label)||All participants will receive 6 cycles of cabazitaxel and carboplatin before being randomized 2:1 to olaparib maintenance versus observation.||||
1325536|NCT03263624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325537|NCT03263611|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1325538|NCT03263598|||Cohort||Prospective|||||||
1325539|NCT03263585|Randomized|Sequential Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1325540|NCT03263572|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325541|NCT03263559||Single Group Assignment||Treatment||None (Open Label)||||||
1325542|NCT03263546|Randomized|Parallel Assignment||Treatment||Single||||||t
1325543|NCT03263533|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1325544|NCT03263520|Randomized|Parallel Assignment||Supportive Care||Double|The outcomes assessor and investigator does not have contact with the patient or care provider at the moment of randomization and the study purpose. The investigator just apply the bioelectrical impedance analysis and helps the patient about doubts on the Quality of Life questionnaire of EORTC ( QLQ-C30)|"Randomization will be made at the time of study enrollment by , where patients randomly selected as even number will be included in group 1 and those selected as odd number in group 2Group 1 (G1): the patient will receive an application of anabolic nandrolone decanoate at a dose of 50 mg (males) and 25 mg (females), intra-muscular form, in the first and fifteenth days. In addition to the anabolic steroid, the patient will use corticosteroids (dexamethasone) at home at a dose of 4 mg daily for both sexes.~Group 2 (G2): The patient will use corticosteroids (dexamethasone) at a dose of 4 mg daily."|||t|t
1325545|NCT03263507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325546|NCT03263494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325547|NCT03263481||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325548|NCT03263468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325549|NCT03263455|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1325550|NCT03263442|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1325551|NCT03263429||Single Group Assignment||Treatment||None (Open Label)||||||
1325552|NCT03263416|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1325553|NCT03263403|Randomized|Parallel Assignment||Prevention||Double|Since the test and comparator drugs used in this clinical study have different package of vial, a double blind design is not appropriate. Study investigators along with study staffs involved in safety evaluation and laboratory analysis will be blinded regarding the assigned treatment of the participant. The vaccine administration team will be unblinded to the treatment assignment list. The vaccine administrator team members will not be involved in the evaluation of vaccine safety and laboratory analysis.|Eligible participants will be assigned to receive the Ingovax ACWY Vaccine and Quadri Meningo Vaccine, in a 1:1 ratio across the target population according to the randomization schedule. 44 participants will receive locally produced Ingovax ACWY and 44 participants of comparator groups will receive Quadri Meningo which is produced by BiO-MeD Private Limited.|||t|t
1325554|NCT03263390|||Case-Only||Retrospective|||||||
1325555|NCT03263377|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1325556|NCT03263364|||Cohort||Prospective|||||||
1325557|NCT03263351|Randomized|Parallel Assignment||Prevention||Single|Research staff who assess outcomes will be blinded to condition assignment.|This is a randomized controlled behavioral trial with two conditions - cognitive-behavioral therapy group or health education group - run in parallel.||||t
1325558|NCT03263338|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325559|NCT03263325|||Cohort||Prospective|||||||
1325560|NCT03263312||Single Group Assignment||Treatment||None (Open Label)||||||
1325561|NCT03263299|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1325562|NCT03263286||Single Group Assignment||Treatment||None (Open Label)||||||
1325563|NCT03263273|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325564|NCT03263260|||Other||Prospective|||||||
1325565|NCT03263247|Randomized|Parallel Assignment||Other||Single||||||t
1325566|NCT03263234|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1325567|NCT03263221|||Cohort||Prospective|||||||
1325568|NCT03263208||Single Group Assignment||Treatment||None (Open Label)||||||
1325569|NCT03263195|||Cohort||Prospective|||||||
1325570|NCT03263182|||Cohort||Prospective|||||||
1325571|NCT03263169|||Cohort||Prospective|||||||
1325572|NCT03263156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325573|NCT03263143|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1325574|NCT03263130|||Case-Only||Cross-Sectional|||||||
1325575|NCT03263117|Randomized|Parallel Assignment||Treatment||Single||||||t
1325576|NCT03263104|Randomized|Parallel Assignment||Prevention||Triple|Double Blind (Participant, Investigator,Outcomes Assessor)|Single-centre, prospective, randomised, placebo-controlled, parallel-group design to determine the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults|t||t|t
1325577|NCT03263091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325578|NCT03263078|Randomized|Parallel Assignment||Other||Single|||t|||
1325579|NCT03263065|Randomized|Crossover Assignment||Basic Science||Single|Data analysis will be blinded|This will be a three-period, three-treatment crossover trial with blinding of data analysis||||t
1325580|NCT03263052|||Case-Crossover||Prospective|||||||
1325581|NCT03263039||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325627|NCT03262441||Single Group Assignment||Treatment||None (Open Label)||"This is an open-label, randomized pilot trial to determine whether MMF given over 22 months meaningfully decreases the size of the HIV reservoir. Study participants will be followed closely for at least 22 months with safety labs and serial measurements of the HIV reservoir (specifically, cell-associated HIV DNA and mRNA (ca-DNA & ca-RNA), quantitative viral outgrowth assay (QVOA), and single copy plasma viral load (scVL)). Go/no-go decision will occur after 12 months based on pre-defined thresholds of reduction in the HIV reservoir measured with ca-DNA."||||
1325628|NCT03262428|||Other||Prospective|||||||
1325629|NCT03262415|||Cohort||Cross-Sectional|||||||
1325630|NCT03262402|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325582|NCT03263026|Randomized|Parallel Assignment||Treatment||Triple|Denovo Biopharma, the study Sponsor, will also be blinded.|"Subjects will be randomly assigned to receive one of the following: R-CHOP plus enzastaurin or R-CHOP plus placebo, during two treatment periods: induction and maintenance. Induction phase: all subjects will receive R-CHOP for up to six, 21-day cycles. Subjects in the enzastaurin arm will receive a 1125 mg loading dose on Day 2 followed by 500 mg daily. Subjects in the placebo arm will take an identical number of tablets.~After 4-<6 cycles of induction therapy treatment assignment will be unblinded. Subjects in the enzastaurin arm who have achieved a response will have the opportunity to continue in the single-agent, maintenance phase of the study, and will receive single-agent enzastaurin at 500 mg/day for up to 2 years. Eligible subjects must begin the maintenance phase of the study within 6 weeks of completing induction therapy."|t|t|t|
1325583|NCT03263013|||Case-Only||Prospective|||||||
1325584|NCT03263000|||Case-Control||Cross-Sectional|||||||
1325585|NCT03262987|||Cohort||Prospective|||||||
1325586|NCT03262974|||Case-Control||Retrospective|||||||
1325587|NCT03262961|Randomized|Parallel Assignment||Treatment||Quadruple|- It's a double blinded, randomized, placebo-controlled trial.|- Double blinded, randomized, placebo-controlled trial.|t|t|t|t
1325588|NCT03262948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325589|NCT03262935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325590|NCT03262922|||Cohort||Other|||||||
1325591|NCT03262909|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325592|NCT03262896|||Cohort||Prospective|||||||
1325593|NCT03262883|||Cohort||Retrospective|||||||
1325594|NCT03262870|||Case-Control||Prospective|||||||
1325595|NCT03262857|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325596|NCT03262844|Randomized|Parallel Assignment||Treatment||Single|The statistical analysist do not know the group assignment.|||||t
1325597|NCT03262831|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325598|NCT03262818||Single Group Assignment||Diagnostic||None (Open Label)||||||
1325599|NCT03262805|Randomized|Parallel Assignment||Treatment||Triple||Randomized, double-blind, placebo-controlled, parallel group study.|t||t|t
1325600|NCT03262792|Randomized|Parallel Assignment||Treatment||Triple||Randomized, double-blind, placebo controlled, parallel groups study.|t||t|t
1325601|NCT03262779||Single Group Assignment||Treatment||None (Open Label)||This a phase II study employing a Simon two-stage design. If there is at least one response or prolonged stability (> 24 weeks) using immune related Response Criteria (irRC) appreciated in the first 10 patients who initiate trial therapy, a total of 40 patients will be enrolled. An additional 10 patients with acquired resistance to anti-PD-1 axis therapy will be enrolled in an exploratory cohort receiving the same therapy.||||
1325602|NCT03262766|Randomized|Factorial Assignment||Treatment||Double|This is a blinded study, which means the participant will not know which treatment they are receiving. They will either receive intermittent periods of low oxygen (hypoxia) or a session composed of only normal room air. They will be randomly assigned to a treatment based on chance, like a flip of a coin. Neither you nor the researcher chooses your assigned group. They will have an equal chance of being in either group. Upon acceptance into the study, subjects will be assigned an identification number. Data pertaining to each subject will only be identified by this number. Any forms/files containing the subject's personal information and their ID number will be housed in a locked office/laboratory space. The outcomes assessor will also be blinded to the intervention the subject received.|"Subjects will then be randomized to one of the four arms. The four arms of interventions are:~Acute intermittent hypoxia (AIH) therapy~AIH therapy + Upper extremity training~Sham AIH therapy + Upper extremity training~Sham Hypoxia"|t|||t
1325603|NCT03262753|||Cohort||Prospective|||||||
1325604|NCT03262740||Single Group Assignment||Treatment||None (Open Label)||||||
1325605|NCT03262727||Single Group Assignment||Treatment||None (Open Label)||||||
1325606|NCT03262714|Randomized|Parallel Assignment||Prevention||Single||||||t
1325607|NCT03262701|Randomized|Parallel Assignment||Treatment||Single||||||t
1325608|NCT03262688|Randomized|Parallel Assignment||Treatment||Single|Participant, legal guardian and study personnel involved in the assessment of efficacy and safety are blinded to treatment, whenever possible.|Randomized, controlled|t|||
1325609|NCT03262675|||Cohort||Prospective|||||||
1325610|NCT03262662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325611|NCT03262649|||Cohort||Prospective|||||||
1325612|NCT03262636|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325613|NCT03262623|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1325614|NCT03262610||||||||||||
1325615|NCT03262597||Single Group Assignment||Health Services Research||None (Open Label)||Repeated-measures design with generalized latin square arrangement. Each participant will complete 4 separate trials.||||
1325616|NCT03262584|||Cohort||Prospective|||||||
1325617|NCT03262571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325618|NCT03262558|||Cohort||Prospective|||||||
1325619|NCT03262545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325620|NCT03262532|||Cohort||Prospective|||||||
1325621|NCT03262519|||Cohort||Prospective|||||||
1325622|NCT03262506||Single Group Assignment||Treatment||None (Open Label)||||||
1325623|NCT03262493|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325624|NCT03262480|Randomized|Parallel Assignment||Treatment||Triple|The management will be carried out by a member of research team only aware of allocation group. The attending anesthesiologist, surgeons and nursing staff will be totally blind of randomization schedule or the hydration regimen used. All postoperative clinical staff handling patient care will be also unaware of the aim of the work.|"Two groups:~Stroke volume optimization group (SVO group).~Central venous pressure dynamic group(CVPdyngroup)."|t|t||t
1325625|NCT03262467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325626|NCT03262454||Single Group Assignment||Treatment||None (Open Label)||||||
1325631|NCT03262389||Single Group Assignment||Basic Science||None (Open Label)||||||
1325672|NCT03261856|||Case-Only||Retrospective|||||||
1325708|NCT03261388|||Other||Prospective|||||||
1325632|NCT03262376|Randomized|Parallel Assignment||Treatment||Triple|This study is double-blinded. The supplement manufacturer will independently create codes for the 4 treatment conditions. The study statistician will use the treatment codes generated to allocate participants to treatments. Researchers and participants will be blind treatment allocation.|The study conforms to a double blind, quasi-randomised (randomisation will be balanced across condition based on age and sex), placebo controlled, parallel group design comprising 4 treatment conditions|t|t|t|
1325633|NCT03262363|Randomized|Parallel Assignment||Treatment||Triple|"Patient Blinding: Patients with EDN will be blinded to the intervention they will receive Evaluator Blinding: The principal investigator will be blinded to the intervention that patients will receive (curcumin or placebo), but will know the genotype distribution in both Experimental and Placebo groups. The external investigator will be blinded to the knowledge of the patients genotype, but will know the intervention group to which each patient was assigned according to a registry (but will not know the identity of the patients). The Doctorate Program Student will be blinded to the distribution of patients genotype and the type of intervention patients will receive.~Statistical Blinding: An associated researcher will be blinded to the distribution of patients genotype and the type of intervention patients will receive, but not to the knowledge of the database."|"The study starts from the classification of patients according to the genotype for the rs35652124 polymorphism (-653G>A) of the NFE2L2 gene. Two Experimental groups and two Control groups will be formed according to the following:~Experimental group 1: Diabetic patients with early CKD homozygous for the -653G (G/G) allele of the NFE2L2 gene that will receive curcumin.~Experimental group 2: Diabetic patients with early CKD carrying the allele -653A (G/A or A/A) of the NFE2L2 gene that will receive curcumin.~Control group 1: Diabetic patients with early CKD homozygous for the -653G (G/G) allele of the NFE2L2 gene receiving placebo.~Control group 2: Diabetic patients with early CKD carrying the allele -653A (G/A or A/A) of the NFE2L2 gene who will receive placebo."|t|t|t|
1325634|NCT03262350|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325635|NCT03262337|||Cohort||Prospective|||||||
1325636|NCT03262324|||Case-Crossover||Prospective|||||||
1325637|NCT03262311||Single Group Assignment||Basic Science||None (Open Label)||||||
1325638|NCT03262298||Single Group Assignment||Treatment||None (Open Label)||||||
1325639|NCT03262285|||Case-Only||Prospective|||||||
1325640|NCT03262272|Randomized|Crossover Assignment||Treatment||None (Open Label)||Prospective randomized cross-over study||||
1325641|NCT03262259|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Nine pairs of intervention and comparison cities followed over multiple years.||||
1325642|NCT03262246|||Cohort||Retrospective|||||||
1325643|NCT03262233|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1325644|NCT03262220||Single Group Assignment||Treatment||None (Open Label)||||||
1325645|NCT03262207|||Other||Other|||||||
1325646|NCT03262194|||Case-Only||Prospective|||||||
1325647|NCT03262181|Randomized|Crossover Assignment||Treatment||Double|Participants are masked to their group assignment until the end of the study. Investigator is masked to intervention condition.||t||t|
1325648|NCT03262168|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Participants compete a six minute walk test (6MWT). Those who achieve less than 450 metres will be assigned to study group one. Participants who achieve greater than 450 metres on 6MWT will be assigned to study group two.||||
1325649|NCT03262155|||Cohort||Prospective|||||||
1325650|NCT03262142|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1325651|NCT03262129|||Cohort||Prospective|||||||
1325652|NCT03262116|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1325653|NCT03262103|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1325654|NCT03262090|Randomized|Parallel Assignment||Prevention||Triple||The aim of the present preliminary study was to determine the safety and efficacy of of intraoperative infusion of dexmedetomidine (DEX) that would prevent postoperative EA and ED in children undergoing day surgery with desoflurane anesthesia. Subjects who underwent day surgery were stratified into two age groups as follows: low to 3 years, and 3-9 years. Then they were randomly assigned to receive one of six doses of intravenous dexmedetomidine: 0,0.2, 0.4, 0.6, 0.8 ,1.0ug/kg before skin incision.||t|t|t
1325655|NCT03262077|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1325656|NCT03262064|||Cohort||Prospective|||||||
1325657|NCT03262051|||Cohort||Prospective|||||||
1325658|NCT03262038|Randomized|Parallel Assignment||Prevention||Quadruple|Study drug (ondansetron/placebo) will be masked for all but the pharmacist|Randomized, double blinded, placebo-controlled trial of ondansetron to prevent pruritus in children who receive intrathecal morphine|t|t|t|t
1325659|NCT03262025|||Case-Only||Retrospective|||||||
1325660|NCT03262012|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t||t|
1325661|NCT03261999||Single Group Assignment||Treatment||None (Open Label)||||||
1325662|NCT03261986||Single Group Assignment||Other||None (Open Label)||||||
1325663|NCT03261973||Single Group Assignment||Prevention||None (Open Label)||||||
1325664|NCT03261960|Randomized|Parallel Assignment||Treatment||Single||||||t
1325665|NCT03261947||Single Group Assignment||Treatment||None (Open Label)||||||
1325666|NCT03261934|||Other||Prospective|||||||
1325667|NCT03261921|Randomized|Factorial Assignment||Diagnostic||Triple|The Patients allocated to study groups using computer generated random list & group assignment was sealed in sequentially numbered opaque envelopes that opened after induction of anesthesia.|"Sixty-three patients with ASA I-II aged from 1-6 years scheduled for hypospadias surgery in Abu El-Resh pediatric Hospital-Cairo university, were included in this prospective randomized double-blinded clinical study. Patients with contraindication to caudal anesthesia, cardiovascular diseases, drug allergy, type I diabetes, clotting disorders, mentally retarded children or those whose families did not approve inclusion in the study were excluded from the study.~Patients were randomly divided on the morning of surgery into three groups group I( dexamethasone 21 patients), Group II ( Dexmedetomidine 21 patients) and group III(Dexmedetomidine and dexamethasone 21 patients)."|t|t|t|
1325668|NCT03261908|||Cohort||Other|||||||
1325669|NCT03261895|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1325670|NCT03261882|||Other||Cross-Sectional|||||||
1325671|NCT03261869|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1325673|NCT03261843|Randomized|Parallel Assignment||Treatment||Single|the person performing the statistical analysis shall be masked|single center, prospective randomized comparative trial||||t
1325674|NCT03261830|Randomized|Parallel Assignment||Prevention||Triple|Randomization envelops will be created. Attending surgeons/Investigators will be blinded. Participant will be blinded.|Patients will be randomized in that one group receives one dose of pre-operative antibiotics or one that does not.|t||t|t
1325675|NCT03261817|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Randomization will be centralized and will be established for SCZ; Healthy Controls (HV) will be recruited by being matched to patients on age (according to 4 categories (18-25 years, 25-35 years, 35-50 years and> 50 years), gender and level of activity estimated by the self-administered questionnaire of Ricci and Gagnon.~Randomization will be carried out in two arms:~interventional (adapted physical activity APA)~control (health education program)"||||
1325676|NCT03261804|||Family-Based||Cross-Sectional|||||||
1325677|NCT03261791||Single Group Assignment||Treatment||None (Open Label)||||||
1325678|NCT03261778|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325679|NCT03261765|||Other||Cross-Sectional|||||||
1325680|NCT03261752|||Case-Control||Prospective|||||||
1325681|NCT03261739|Randomized|Sequential Assignment||Treatment||Quadruple|Double blind, placebo controlled|Randomized, placebo controlled, with 3 sequential cohorts|t|t|t|t
1325682|NCT03261726||Single Group Assignment||Treatment||None (Open Label)||||||
1325683|NCT03261713|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor does not know the participant's intervention group allocation.|A prospective, single-site, single-blinded, parallel-group (1:1 ratio) randomized feasibility trial on the use of VRT for ongoing stroke rehabilitation after discharge from inpatient or outpatient stroke rehabilitation.||||t
1325684|NCT03261700|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|For the RCT (Aim 3), participants will be randomized to RISE or an information and referral condition.||||
1325685|NCT03261687|Randomized|Parallel Assignment||Treatment||None (Open Label)||a randomised controlled feasibility study||||
1325686|NCT03261674|Randomized|Parallel Assignment||Treatment||Single||Parallel: participants are assigned to one of two or more groups in parallel for the duration of the study.||||t
1325687|NCT03261661|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Random assignment through stratification on the screening score to one of three groups: Study 1: (a) Reading Intervention Plus Mindset, (b) Reading Intervention, or (c) Business as Usual comparison.~Study 2: (a) Reading Intervention Embedded with Mindset; (b) Reading Intervention or Reading Intervention Plus Mindset (dependent on Study 1 results), or (c) Business as Usual comparison."||||
1325688|NCT03261648|||Other||Prospective|||||||
1325689|NCT03261635|Randomized|Parallel Assignment||Treatment||None (Open Label)||This was a prospective, randomized, pilot study in 58 patients with naï ve CNV. Patients were randomized 1:1 into 2 groups: ranibizumab monotherapy (RM group) and ranibizumab plus indomethacin (RI group). All patients received monthly 0.5 mg ranibizumab intravitreal injections for 3 months, after which monthly injections were administered pro re nata. RI patients also self- administered one drop of indomethacin three times a day for 12 months. All patients were followed up for 12 months.||||
1325690|NCT03261622|Randomized|Parallel Assignment||Basic Science||Double|Alle patients are stimulated sub-sensory in (3x4 weeks) and will be blinded. The investigators will not participate in the randomization, and setting of the stimulation amplitude.|Patients will be randomized to either control group (Stimulation amplitude at 90% of sensory threshold) or intervention arm (different stimulation amplitude - 0.05 V, 50 and 90% of sensory threshold)|t||t|
1325691|NCT03261609|||Case-Control||Cross-Sectional|||||||
1325692|NCT03261596|Randomized|Parallel Assignment||Treatment||Single|Study drug will be maintained and dispensed to the participant by a qualified un-blinded study staff member and witnessed by another un-blinded study staff member. The blinding of laboratory staff will be maintained throughout the trial until data entry and processing are complete and the data have been verified.|The study will be a single site Phase 4, open-label, randomized controlled study. Subjects will be randomized 1:1 to one of two treatment allocations: 150 to receive a single dose of 500 mg mebendazole and 150 to receive a multi-dose of 100 mg mebendazole twice a day for three days.|t|||
1325693|NCT03261583|||Cohort||Prospective|||||||
1325694|NCT03261570|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1325695|NCT03261557|Randomized|Parallel Assignment||Treatment||Single||||||t
1325696|NCT03261544|||Cohort||Prospective|||||||
1325697|NCT03261531||Single Group Assignment||Basic Science||None (Open Label)||||||
1325698|NCT03261518|||Case-Only||Prospective|||||||
1325699|NCT03261505|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1325700|NCT03261492|Randomized|Crossover Assignment||Prevention||None (Open Label)||The investigators will identify, recruit, and randomize ECEC to the SAGE intervention or a child safety attention comparison. After 16 weeks, intervention and comparison will cross over, allowing us to continue to investigate longitudinal and carry over effects. One ECEC of each pair will be randomized to the SAGE intervention and the other to the child safety attention comparison. ECEC will cross over and receive the treatment that they did not receive to ensure that all ECEC receive both curriculums.||||
1325701|NCT03261479|||Cohort||Prospective|||||||
1325702|NCT03261466|Randomized|Crossover Assignment||Treatment||Quadruple|The study is a triple blind study in which the treatment or intervention is unknown to the research participant, the individuals who administer the treatment or intervention, and the researchers who assess the outcomes.|In the first part of the study (Study 1, V0-V1) patients will be randomized in a open-label, into two groups homogeneous for number and sex of the subjects. One group will receive a supplementation of probiotic containing Bifidobacterium breve B632 and Bifidobacterium breve BR03, 15 gtt/die (3x108 CFU/die) and one group will receive a placebo for a total of 2 months of treatment. For patients who wants to continue the study there will be a cross-over study (study 2, V2-V3) after one month of wash-out.|t|t|t|t
1325703|NCT03261453|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1325704|NCT03261440|||Other||Prospective|||||||
1325705|NCT03261427|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1325706|NCT03261414|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325707|NCT03261401|Randomized|Parallel Assignment||Other||Double|||t||t|
1325709|NCT03261375|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325710|NCT03261362|Randomized|Crossover Assignment||Prevention||Double||||||
1325711|NCT03261349||Single Group Assignment||Treatment||None (Open Label)||New Direct-Acting Antiviral Agent, HARVONI® (ledipasvir/sofosbuvir)||||
1325712|NCT03261336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Calcitriol 10mcg QD X3, weekly + Ketoconazole 400mg po TID and Hydrocortisone 20mg AM, 10mg PM||||
1325713|NCT03261323|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325714|NCT03261310|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1325715|NCT03261297|||Cohort||Prospective|||||||
1325716|NCT03261284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325717|NCT03261271|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1325718|NCT03261258|||Cohort||Prospective|||||||
1325719|NCT03261245|||Case-Control||Retrospective|||||||
1325720|NCT03261232|||Cohort||Retrospective|||||||
1325721|NCT03261219|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1325722|NCT03261206|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1325723|NCT03261193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325724|NCT03261180|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325725|NCT03261167|Randomized|Parallel Assignment||Treatment||Double|This study will contain a double blind treatment period (Part 1) followed by open-label treatment period (Part 2/Part3/Part4).|Subjects will receive either 400 units of botulinum toxin A injection or 240 units of botulinum toxin A injection plus placebo in double blind phase. Eligible subjects for open-label treatment period will receive 400 units of botulinum toxin A injection.|t||t|
1325726|NCT03261154|||Case-Only||Retrospective|||||||
1325727|NCT03261141|||Case-Control||Cross-Sectional|||||||
1325728|NCT03261128|||Cohort||Prospective|||||||
1325729|NCT03261115|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325730|NCT03261102|Randomized|Parallel Assignment||Treatment||Triple|Some of the participants, care providers and investigators will eventually, in the course of the study, have knowledge of the arm they were assigned.||t|t|t|
1325731|NCT03261089|||Cohort||Prospective|||||||
1325732|NCT03261076||Single Group Assignment||Treatment||None (Open Label)||This study uses a multiple baseline design, in which participants enter into the single-arm intervention at different times, yet have data collected at all time points. Approximately one third of participants will have their entry into the intervention shifted later by one week, and approximately another third will have their entry shifted by two weeks. This will happen on a rotating basis. All individuals will receive progress monitoring during the weeks that the other individuals are receiving intervention and/or assessments. The multiple baseline design allows for all individuals to receive the study intervention, and still provides a mechanism for monitoring change (or lack thereof) during non-intervention periods before and after intervention.||||
1325733|NCT03261063||Single Group Assignment||Treatment||None (Open Label)||||||
1325734|NCT03261050|||Cohort||Prospective|||||||
1325735|NCT03261037||Single Group Assignment||Other||None (Open Label)||||||
1325736|NCT03261024|Randomized|Parallel Assignment||Treatment||Single||||||t
1325737|NCT03261011||Single Group Assignment||Treatment||None (Open Label)|Open-label|||||
1325738|NCT03260998|||Case-Control||Prospective|||||||
1325739|NCT03260985|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1325740|NCT03260972|Randomized|Parallel Assignment||Treatment||Triple|The investigator and patients will be masked from the treatment options. The care providers will not be masked.|"Patients admitted for cesarean section and meeting inclusion criteria will be approached for consent. Consented patients will then be randomized into two groups.~Group 1: (intraabdominal chloroprocaine administration): These participants will have intraabdominal chloroprocaine administration at the time of cesarean section before fascial closure.~Group 2: (Intraabdominal instillation of placebo (sterile water): These participants will have placebo (normal saline) administered at the time of cesarean section before fascial closure. Cesarean section will proceed traditionally, including fascial and skin closure."|t||t|t
1325741|NCT03260959|||Other||Prospective|||||||
1325742|NCT03260946|||Cohort||Prospective|||||||
1325743|NCT03260933|||Other||Cross-Sectional|||||||
1325744|NCT03260920|Randomized|Crossover Assignment||Treatment||Quadruple|Double Blind|A Proof-of-Concept Double Blind Randomized Controlled, Cross-Over Adaptive Design Trial|t|t|t|t
1325745|NCT03260907|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1325746|NCT03260894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325747|NCT03260881|Randomized|Parallel Assignment||Treatment||Double|This will be a double-blind, parallel group, placebo controlled study. The method of allocation generation will be a computerized random-number generator. The sequence will be generated by the process of restricted randomization. Computer-based randomization process will be managed by the UM Research pharmacy.|Double-blind, parallel group, placebo controlled study.|t||t|
1325748|NCT03260868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325749|NCT03260855||Single Group Assignment||Prevention||None (Open Label)||||||
1325750|NCT03260842|||Cohort||Prospective|||||||
1325751|NCT03260829|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1325752|NCT03260816|Randomized|Parallel Assignment||Treatment||Single|Independent evaluators and coders assessing response over time are kept unaware of the condition to which each participant is assigned.|Randomized control trial in which participants are randomly assigned to either receive Internet-delivered Parent-Child Interaction Therapy (I-PCIT) or referrals as usual (RAU).||||t
1325753|NCT03260803|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1325754|NCT03260790|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325755|NCT03260777|||Case-Only||Cross-Sectional|||||||
1325756|NCT03260764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325757|NCT03260751|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1325758|NCT03260738|Randomized|Parallel Assignment||Device Feasibility||Single||||||t
1325759|NCT03260725|Randomized|Parallel Assignment||Treatment||Single||Internet-delivered treatment v. clinic-delivered treatment||||t
1325760|NCT03260712||Single Group Assignment||Treatment||None (Open Label)||||||
1325761|NCT03260699|Randomized|Parallel Assignment||Treatment||Single|||||t|
1325762|NCT03260686|Randomized|Parallel Assignment||Treatment||Single||||||t
1325763|NCT03260673|||Case-Control||Retrospective|||||||
1325764|NCT03260660|||Cohort||Prospective|||||||
1325765|NCT03260647|||Case-Only||Prospective|||||||
1325766|NCT03260634|||Other||Other|||||||
1325767|NCT03260621|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1325768|NCT03260608|Randomized|Parallel Assignment||Supportive Care||Single|The individual who evaluates the outcome(s) of interest in this case the applicators of scales and questionnaires|"We will select 148 caregivers. Patients will be divided into two groups, both groups will receive printed materials about problematics behaviors in dementia.~Participants in the intervention group will receive weekly telephone contacts over a period of eight weeks, previously scheduled with psychoeducational and support in the management of their relatives with dementia. Caregivers in the intervention group will have access to a number of phones to spontaneously contact specific guidelines during the eight weeks of intervention.~Patients from both groups will be interviewed in the baseline, at 8 weeks and 16 weeks."||||t
1325769|NCT03260595|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1325770|NCT03260582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325771|NCT03260569|Randomized|Parallel Assignment||Treatment||Triple|Both nitric oxide and placebo nitrogen will be made available in unmarked cylinders.|Following initial non-invasive measurements, patients will be randomized to either an active treatment (inhaled nitric oxide at 30 parts per million) or placebo (nitrogen only). After two hours, measurements will be reassessed. If the patient remains on the mechanical ventilator at 72 hours post-admission, a third set of non-invasive measurements will be taken.|t|t|t|
1325772|NCT03260556|Randomized|Parallel Assignment||Treatment||Triple|Placebo controlled|Double blind placebo controlled trial|t|t|t|
1325773|NCT03260543|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1325774|NCT03260530|||Cohort||Prospective|||||||
1325775|NCT03260517||Single Group Assignment||Treatment||None (Open Label)||||||
1325776|NCT03260504||Single Group Assignment||Treatment||None (Open Label)||||||
1325777|NCT03260491||Single Group Assignment||Treatment||None (Open Label)||||||
1325778|NCT03260478|Randomized|Parallel Assignment||Treatment||Single|Open-label with blinded outcome evaluation.|||||t
1325779|NCT03260465|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective, randomised single-center study with 2 treatment arms.||||
1325780|NCT03260452||Single Group Assignment||Basic Science||None (Open Label)|All laboratory analyses will be performed blindly.|"20 male volunteers: 10 overweight/obese subjects with T2D and 10 healthy volunteers, age-matched.~All volunteers will be treated in the same way."||||
1325781|NCT03260439|Randomized|Parallel Assignment||Other||Triple||Randomized, controlled and double blind assignment|t||t|t
1325782|NCT03260426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325783|NCT03260413|||Case-Only||Retrospective|||||||
1325784|NCT03260400|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1325785|NCT03260387|||Cohort||Prospective|||||||
1325786|NCT03260374|||Case-Only||Cross-Sectional|||||||
1325787|NCT03260361|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325788|NCT03260348|||Cohort||Prospective|||||||
1325789|NCT03260335||Single Group Assignment||Supportive Care||None (Open Label)||Single Case Experimental Design combining withdrawal (ABA) and multiple baseline design,||||
1325790|NCT03260322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325791|NCT03260309|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1325792|NCT03260296|||Other||Cross-Sectional|||||||
1325793|NCT03260283|Randomized|Parallel Assignment||Other||Triple||Double blind randomized control trial|t|t|t|
1325794|NCT03260270|||Case-Only||Prospective|||||||
1325795|NCT03260257||Single Group Assignment||Treatment||None (Open Label)||||||
1325796|NCT03260244|||Cohort||Prospective|||||||
1325797|NCT03260231|Randomized|Parallel Assignment||Treatment||Double|Single blind|"This study is a parallel, randomized, single blind, controlled, 5-months nutritional intervention, investigating health effects of dietary intake of milled mix of flax/sesame pumpkin seeds in sour milk, in patients with NHL undergoing chemotherapy.~At the beginning of the study, all patients received nutritional counselling, where half of the study subjects are randomly assigned to a treatment arm with milled seed mix consumption, or control arm without seed mix. Treatment arm is provided with 450g of milled seed mix and instructed to consume 30g of the mix daily (18g flax seed, 6g pumpkin seeds, and 6 g sesame) in 180 mL of sour milk. Control arm is instructed to consume180 mL of sour milk."||t|t|
1325798|NCT03260218|||Case-Only||Prospective|||||||
1325799|NCT03260205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325800|NCT03260192|||Cohort||Prospective|||||||
1325801|NCT03260179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325802|NCT03260166||Single Group Assignment||Treatment||None (Open Label)||||||
1325803|NCT03260153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325804|NCT03260140|Randomized|Parallel Assignment||Treatment||Single||The investigators will randomly assign participants to one of two groups.||||t
1325805|NCT03260127|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1325806|NCT03260114|Randomized|Factorial Assignment||Treatment||None (Open Label)||We aim to recruit 30 persons who meet the eligibility criteria. Eligible participants will be randomized 1:1:1 to usual care (control group), to two different PAI eHealth Programs (PAI ≥ 100 and PAI = 50 to <100) (N = 10). To provide balance across the trial arms for sex, and age groups (<40, 40-55, >55 years), participants will be allocated remotely by concealed minimisation.||||
1325807|NCT03260101|||Other||Prospective|||||||
1325808|NCT03260088|||Cohort||Prospective|||||||
1325809|NCT03260075|||Cohort||Cross-Sectional|||||||
1325810|NCT03260062|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325811|NCT03260049|||Case-Only||Retrospective|||||||
1325812|NCT03260036|||Cohort||Prospective|||||||
1325813|NCT03260023||Single Group Assignment||Treatment||None (Open Label)||||||
1325814|NCT03260010||Single Group Assignment||Treatment||None (Open Label)||In this open prospective interventional clinical study patients with hip, knee or shoulder PJI (as defined below) caused by fosfomycin-susceptible staphylococci, streptococci, enterococci or gram-negative bacilli will be included. After inclusion and PJI-surgery, intravenous fosfomycin will be given 5 g every 8 hours for 1, 2, 3-or -4 weeks according to the pathogen and surgery procedure and generally as a part of the antibiotic combination therapy of the treatment algorithm. This Treatment is followed by oral antibiotics for a total of 3 months.||||
1325815|NCT03259997|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1325816|NCT03259984|||Cohort||Prospective|||||||
1325817|NCT03259971|Randomized|Parallel Assignment||Treatment||Quadruple|Randomized double blind placebo-controlled||t|t|t|t
1325818|NCT03259958|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1325819|NCT03259945|||Case-Only||Retrospective|||||||
1325820|NCT03259932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325821|NCT03259919|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1325822|NCT03259906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325823|NCT03259893|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325824|NCT03259880|||Cohort||Prospective|||||||
1325825|NCT03259867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||One arm for HCC, CRC, gastric cancer and NSCLC each. All enrolled patients will receive the same treatment with TATE and a PD-1 inhibitor until disease progression||||
1325826|NCT03259854|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325827|NCT03259841|||Cohort||Prospective|||||||
1325828|NCT03259828||Single Group Assignment||Treatment||None (Open Label)||||||
1325829|NCT03259815|Randomized|Parallel Assignment||Treatment||Single|"Operator blinded pre and post PCI coronary physiology measurements will be performed in both arms of the study.~Post-PCI FFR results <0.90 in the interventional arm will be disclosed to the operator to allow further intervention"|Randomised Controlled Trial||t||
1325830|NCT03259789|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1325831|NCT03259776|||Other||Other|||||||
1325832|NCT03259763|Randomized|Parallel Assignment||Treatment||Single||Patients will be randomly allocated with a 1:1 ratio to one of the study arms (EUS-GE or ES)|t|||
1325833|NCT03259750|||Case-Crossover||Prospective|||||||
1325834|NCT03259737|||Cohort||Retrospective|||||||
1325835|NCT03259724|||Other||Other|||||||
1325836|NCT03259711|||Case-Only||Retrospective|||||||
1325837|NCT03259698|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1325838|NCT03259685|Randomized|Parallel Assignment||Prevention||Single|||t|||
1325839|NCT03259672|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1325840|NCT03259659|||Case-Control||Prospective|||||||
1325841|NCT03259646|Randomized|Parallel Assignment||Treatment||Single||cluster randomized trial|t|||
1325842|NCT03259633||||||||||||
1325843|NCT03259620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325844|NCT03259607|Randomized|Crossover Assignment||Other||None (Open Label)||single-center, randomized, single-dose, open-label, cross-over study||||
1325845|NCT03259594|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to two groups.One group participants are with endophytic simple renal cysts, and the other are with exophytic simple renal cysts.||||
1325846|NCT03259581||Single Group Assignment||Treatment||None (Open Label)||||||
1325847|NCT03259568|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1325848|NCT03259555|Randomized|Parallel Assignment||Treatment||Quadruple||Subjects will receive a dose of brexpiprazole or placebo and be evaluated throughout the duration of the study; a maximum of 21 days.|t|t|t|t
1325849|NCT03259542||Single Group Assignment||Other||None (Open Label)||||||
1325850|NCT03259529|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||There will be 2 parts in this study. In Part 1, the safety of combination treatment will be evaluated prior to expansion of enrollment to evaluate treatment effect in Part 2. The arms in Part 1 include 3 different dosage regimens of gemcitabine (500 / 700 / 1000). Part 2 of the study will further characterize the safety and evaluate the antitumor activity of drug combination by enrolling patients at the recommended dose schedule determined in Part 1.||||
1325851|NCT03259516|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325852|NCT03259503||Single Group Assignment||Treatment||None (Open Label)||||||
1325853|NCT03259490|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1325854|NCT03259477|Randomized|Parallel Assignment||Prevention||None (Open Label)||Some participants with clinical T1 renal cell carcinoma(RCC) undergo precise segmental during laparoscopic partial nephrectomy and the others undergo complete renal arterial clamping.||||
1325855|NCT03259464|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325856|NCT03259451|||Cohort||Retrospective|||||||
1325857|NCT03259438|Randomized|Parallel Assignment||Treatment||Double|"Participants will not find out what interventional group they are placed in (qigong vs. healthy living) until after they have completed their first testing session.~Pre intervention data collection and post intervention data analysis will be completely masked."|This parallel, randomized non-inferiority trial will test whether qigong is not inferior to an exercise/nutrition active comparator group in terms of reducing fatigue in female cancer survivors. If non-inferiority is demonstrated during analysis, a secondary analysis will test whether qigong can be considered superior to the exercise-nutrition comparator|||t|t
1325858|NCT03259425||Single Group Assignment||Treatment||None (Open Label)||This is a single-arm, open label, Phase II||||
1325859|NCT03259412|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1325860|NCT03259399|||Cohort||Other|||||||
1325861|NCT03259386|||Cohort||Prospective|||||||
1325862|NCT03259373|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325863|NCT03259360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325864|NCT03259347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325865|NCT03259334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325866|NCT03259321|||Cohort||Prospective|||||||
1325867|NCT03259308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325868|NCT03259295|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325869|NCT03259282|||Case-Only||Retrospective|||||||
1325870|NCT03259269|||Cohort||Prospective|||||||
1325871|NCT03259256||Single Group Assignment||Treatment||None (Open Label)||||||
1325872|NCT03259243|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1325873|NCT03259230|||Case-Control||Other|||||||
1325874|NCT03259217||Single Group Assignment||Treatment||None (Open Label)||||||
1325875|NCT03259204|Randomized|Parallel Assignment||Prevention||Double||||t||t
1325876|NCT03259191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325877|NCT03259178|||Case-Only||Prospective|||||||
1325878|NCT03259165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325879|NCT03259152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1325880|NCT03259139|Randomized|Single Group Assignment||Other||Single|Participants did not know which condition they were in. Participants' parents were aware of the deception (hidden guns) and what condition their children were in. Research personnel knew conditions as well. Research assistants who transcribed recorded laboratory sessions did not know what condition they were coding (eg. what type of game they played)|Participants are randomly assigned to play a non-violent video game, a violent video game containing swords, or a violent video game containing guns.|t|||
1325881|NCT03259126|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparison of operator radiation dose at pelvic level during percutaneous coronary procedures through transradial access with or without an extension of the leaded curtain under table||||
1325882|NCT03259113||Single Group Assignment||Diagnostic||None (Open Label)||Consecutive insertable cardiac monitors in 30 patients with hypertrophic cardiomyopathy||||
1325883|NCT03259100|||Ecologic or Community||Retrospective|||||||
1325884|NCT03259087|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325885|NCT03259074|Randomized|Parallel Assignment||Treatment||Single|The Participant, Care Provider, Investigator and Sponsor are blinded to Secukinumab dose|||||t
1325886|NCT03259061|||Cohort||Prospective|||||||
1325887|NCT03259048|||Cohort||Prospective|||||||
1325888|NCT03259035||Single Group Assignment||Treatment||None (Open Label)||This is a two staged, single arm phase II trial of chemotherapy (FOLFOX or CAPOX) followed by tumour excision in patients with early stage rectal cancer||||
1325889|NCT03259022|||Cohort||Prospective|||||||
1325890|NCT03259009|||Cohort||Prospective|||||||
1325891|NCT03258996|Randomized|Parallel Assignment||Treatment||Triple|"Participant: Initially, the subject will not know what technique has been received, the complete information regarding the surgical technique used, as the results obtained in his case, will be given in the last visit of the year.~Observer: Another periodoncist (R.E.), outside the intervention, would be in charge of recording the clinical parameters.~Analyst: The statistician (X.M.) does not know which treatment corresponds to each variable."|We will perform the experimental or control technique according to the randomization sequence.|t||t|t
1325892|NCT03258983|||Cohort||Prospective|||||||
1325893|NCT03258970|||Cohort||Prospective|||||||
1325894|NCT03258957||Single Group Assignment||Prevention||None (Open Label)||||||
1325895|NCT03258944||Single Group Assignment||Other||None (Open Label)||||||
1325896|NCT03258931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325897|NCT03258918||Single Group Assignment||Prevention||None (Open Label)||||||
1325898|NCT03258905|Randomized|Parallel Assignment||Treatment||Single|||||t|
1325899|NCT03258892|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1325900|NCT03258879|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1325901|NCT03258866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325902|NCT03258853|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1325903|NCT03258840|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1325904|NCT03258827|Non-Randomized|Parallel Assignment||Treatment||Single|The assistant who doesn't know the group which patients belong to will evaluate the functional performance of the patients three times, such as before training, after training, post-training 3 months.|We randomize these 60 older adults into 2 groups (experimental group and control group) and there are 30 older adults in each group. Those older adults are age above 65 year-old, have lower grip strength and slower walking speed. Experimental group receive this exercise program training, 60 minutes/time, 3 times/week, total duration: 3 months. Home-based program focuses on walking activity at fast speed, 3 times/week, 60 minutes/times, would be assigned for Control group. Total duration is 3 months.||||t
1325905|NCT03258814|||Cohort||Prospective|||||||
1325906|NCT03258801|||Cohort||Prospective|||||||
1325907|NCT03258788|||Cohort||Prospective|||||||
1325908|NCT03258775|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1325909|NCT03258762|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325910|NCT03258749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325911|NCT03258736|Randomized|Crossover Assignment||Treatment||Double||||t||t
1325912|NCT03258723|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Patient Recruitment:~The investigators are targeting the highest risk pre-diabetic patients for this study. Patient recruitment will occur through the involved health clinics.~Control Participants Control participants in existing ECHORN sites (Puerto Rico, Barbados and Trinidad) will be recruited from the ECHORN Cohort Study (ECS).~ECS does not have a recruitment site in New York; therefore, the New York LIME sites will need to recruit their own control participants, through random assignment of consented participants into the intervention and control groups. These participants will be offered a delayed intervention at the end of 2.5years, given the evidence supporting behavioral modification for diabetes prevention."||||
1325999|NCT03257592|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1326008|NCT03257475|||Case-Only||Prospective|||||||
1325913|NCT03258710||Single Group Assignment||Treatment||None (Open Label)||This is a single arm study where on-going ETV treatment is switched to TDF treatment. There is no randomization in this study.||||
1325914|NCT03258697|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1325915|NCT03258684|Randomized|Parallel Assignment||Treatment||Double||The participants in treatment group receive intravenous vitamin C, hydrocortisone, and thiamine. The participants in control group receive normal saline.|t|||t
1325916|NCT03258671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325917|NCT03258658||Single Group Assignment||Treatment||None (Open Label)||||||
1325918|NCT03258645|||Case-Only||Retrospective|||||||
1325919|NCT03258632|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1325920|NCT03258619|||Case-Only||Prospective|||||||
1325921|NCT03258606|||Case-Only||Retrospective|||||||
1325922|NCT03258593|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1325923|NCT03258580|||Other||Prospective|||||||
1325924|NCT03258567|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325925|NCT03258554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325926|NCT03258541||Single Group Assignment||Treatment||None (Open Label)||||||
1325927|NCT03258528|Randomized|Parallel Assignment||Prevention||None (Open Label)||2||||
1325928|NCT03258515|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1325929|NCT03258502|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1325930|NCT03258489|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1325931|NCT03258476|Randomized|Parallel Assignment||Treatment||Double||The proposed study has two parts: (1) a randomized, double-blind controlled clinical trial of GXR vs. placebo for up to 7 weeks followed by, (2) 10 weeks of either GXR and Mindfulness psychotherapy (as a group or individual) or placebo and Mindfulness psychotherapy (as a group or individual).|t|t||
1325932|NCT03258463|||Other||Retrospective|||||||
1325933|NCT03258450|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325934|NCT03258437|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1325935|NCT03258424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325936|NCT03258411|Randomized|Parallel Assignment||Treatment||Single||||||t
1325937|NCT03258398|Randomized|Parallel Assignment||Treatment||None (Open Label)||In Part 1, subjects will receive eFT508 in combination with a fixed dose of avelumab. Once the recommended dose of eFT508 in combination with avelumab is determined in Part 1, enrollment in Part 2 will begin. Subjects will be randomized in approximately a 2:1 ratio to receive eFT508 in combination with avelumab or eFT508 monotherapy.||||
1325938|NCT03258385|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1325939|NCT03258372|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1325940|NCT03258359||Single Group Assignment||Treatment||None (Open Label)||||||
1325941|NCT03258346|Randomized|Parallel Assignment||Prevention||Double|Pomegranate juice will be administered in double blind placebo controlled method. Coding will be established by POM Wonderful, LLC.||t||t|
1325942|NCT03258333|||Cohort||Prospective|||||||
1325943|NCT03258320|Randomized|Parallel Assignment||Treatment||Double|Both the participants and care providers will be blind to the agents, but the investigators will be aware of and keep track of the whole regime and agents.|Chemotherapy (single agent of CDMS) will be performed 45 days before surgery for patients who are diagnosed with prostate cancer without distant metastasis. The chemotherapy using CDMS will done for 4 cycles within 30 days after first diagnosis of prostate cancer.|t|t||
1325944|NCT03258307|Non-Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1325945|NCT03258294|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1325946|NCT03258281|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1325947|NCT03258268|Randomized|Parallel Assignment||Treatment||Double|A double-blind design is not feasible due to the need for physicians to use respectively not use the EASY DSS.|Multicenter, randomized controlled trial||t||t
1325948|NCT03258255|Randomized|Parallel Assignment||Treatment||Double||||t||t
1325949|NCT03258242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325950|NCT03258229|Randomized|Crossover Assignment||Prevention||Double||2×2 cross-over Assignment|t||t|
1325951|NCT03258216|||Case-Control||Cross-Sectional|||||||
1325952|NCT03258203|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1325953|NCT03258190|Randomized|Parallel Assignment||Prevention||Single|LPR and Placebo were prepared in the same containers with code that was provided by investigators|Randomized control trial|t|||
1325954|NCT03258177|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1325955|NCT03258164|Randomized|Parallel Assignment||Treatment||Double||||t||t
1325956|NCT03258151|||Cohort||Other|||||||
1325957|NCT03258138|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|The amount of exposure to the programs will be known to participants and providers.|Enrolled participants will be allocated to one of the two intervention groups for the duration of the study. One group will be assigned to the more intensive program (MIP= usual care plus healthy lifestyles program) and the other group will be assigned to the less intensive program (LIP= usual care plus health goal development).||||
1325958|NCT03258125|||Case-Control||Retrospective|||||||
1325959|NCT03258112||Single Group Assignment||Treatment||None (Open Label)||||||
1325960|NCT03258099|||Cohort||Other|||||||
1325961|NCT03258086||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326000|NCT03257579|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1326001|NCT03257566|||Case-Control||Cross-Sectional|||||||
1326002|NCT03257553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326003|NCT03257540|||Case-Only||Prospective|||||||
1326004|NCT03257527|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1326005|NCT03257514|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1326006|NCT03257501|||Cohort||Prospective|||||||
1326007|NCT03257488|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1325962|NCT03258073||Single Group Assignment||Other||None (Open Label)|No masking will be done|Investigators will conduct a cohort study among medical and nursing students and follow groups of students according to their rotation in the four major clinical disciplines. A cohort will represent a group of students who start a clinical rotation and complete their clinical year together. A total of 4 rotations exist concurrently every academic year in a year of study (Pediatrics, Internal medicine, Surgery and Obstetrics). During each rotation, a cohort will be exposed to at least 1 simulation scenario relevant to the discipline of the rotation. Investigators hypothesize that repeated exposure to simulation scenario execution will improve CTS scores. Therefore in this cohort study, investigators will measure CTS scores before and after exposure to simulation scenario training.||||
1325963|NCT03258060|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1325964|NCT03258047||Single Group Assignment||Treatment||None (Open Label)||||||
1325965|NCT03258034||Single Group Assignment||Treatment||None (Open Label)||||||
1325966|NCT03258021|||Other||Prospective|||||||
1325967|NCT03258008||Single Group Assignment||Treatment||None (Open Label)||||||
1325968|NCT03257995|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1325969|NCT03257982||Single Group Assignment||Supportive Care||None (Open Label)||||||
1325970|NCT03257969|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1325971|NCT03257956||||||||||||
1325972|NCT03257943|Randomized|Parallel Assignment||Treatment||Single|||t|||
1325973|NCT03257930||Single Group Assignment||Treatment||None (Open Label)||||||
1325974|NCT03257917|||Cohort||Cross-Sectional|||||||
1325975|NCT03257904|||Cohort||Prospective|||||||
1325976|NCT03257891||Single Group Assignment||Treatment||None (Open Label)||A prospective, non-randomized, multicentre, open label, single arm, phase II study will be conducted in patients with advanced ACC treated with Cabazitaxel||||
1325977|NCT03257878|||Other||Prospective|||||||
1325978|NCT03257865|Randomized|Parallel Assignment||Treatment||Quadruple||Subjects will receive a dose of brexpiprazole or placebo and be evaluated throughout the duration of the study; a maximum of 21 days.|t|t|t|t
1325979|NCT03257852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325980|NCT03257839|||Other||Prospective|||||||
1325981|NCT03257826||Single Group Assignment||Treatment||None (Open Label)||||||
1325982|NCT03257813|Randomized|Crossover Assignment||Treatment||Double|"Masking will be carried out using identical boxes in the primary package in both groups.~Blinding for the research subject and the investigator will be carried out by using labels containing the assignation number, which will replace the original labels in the case of the comparator. Due to the nature of the primary containers of the research products, single-dose vials and multidose bottle, it is not possible to use identical labels."|"60 subjects with diagnosis of open angle primary glaucoma with mild, moderate or severe damage and / or with intraocular hypertension users of Krytantek Ofteno® at least two previous months and are under control Of the corresponding IOP target.~a study group A or B will be randomly assigned, in group A, therapy with Krytantek Ofteno® will be continued for 30 days, in which the subject will be evaluated again and switched from therapy to solution PRO-122 which will be used for 30 days until the 60th day, date of the final visit.~In the case of those assigned to group B on day 1, the change to PRO-122 solution will be made for 30 continuous days until the date of revision on day 30, the day on which treatment with Krytantek Ofteno® will be restored to continue until the Day 60 for the final evaluation.~The selected subjects will be observed for 60 days."|t||t|
1325983|NCT03257800|Randomized|Parallel Assignment||Other||Triple||Randomized, controlled and double blind assignment|t||t|t
1325984|NCT03257787||Single Group Assignment||Basic Science||None (Open Label)||||||
1325985|NCT03257774||Single Group Assignment||Basic Science||None (Open Label)||||||
1325986|NCT03257761||Single Group Assignment||Treatment||None (Open Label)||||||
1325987|NCT03257748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1325988|NCT03257735|||Case-Only||Prospective|||||||
1325989|NCT03257722|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"This is an open labeled, single arm, interventional study combining standard pembrolizumab (MK-3475, trade name: Keytruda) with investigational agent, idelalisib (trade name: Zydelig) in non-small cell lung cancer (NSCLC). The study will enroll patients in two phases: a dose finding/tolerability assessment phase and an efficacy assessment phase.~The Phase 1b (modified 3+3 dose escalation) assessment will determine the safe dose of idelalisib in combination with pembrolizumab that down-regulates the activity of T-regulatory function (Treg).~The Phase 2 efficacy assessment will enroll patients to detect whether idelalisib added to pembrolizumab at the phase 2 recommended dose (P2RD) will result in further objective response."||||
1325990|NCT03257709|Randomized|Parallel Assignment||Treatment||Single||||||t
1325991|NCT03257696|||Case-Only||Prospective|||||||
1325992|NCT03257683|||Case-Only||Prospective|||||||
1325993|NCT03257670|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be randomized to two treatment cohorts (each with 35 patients): (1) treatment with the CO2RE laser or; (2) treatments of 4% aqueous lidocaine applied to the vulvar vestibule for 3 minutes before vaginal penetration. Both cohorts will have four follow-up assessments following initiation of treatment: (1) One-week post treatment initiation; (2) 1-month post treatment initiation; (3) 3-months post treatment initiation and; (4) 6-months post laser-only treatment initiation. At the 3-month assessment, subjects in the lidocaine arm will be allowed to try the CO2RE laser therapy. In doing this, an imbedded crossover trial is included that will allow assessment of subject decision-satisfaction between the two therapy approaches. The primary outcome will be the overall and lubrication, satisfaction, and pain domain scores on the Female Sexual Function Index instrument. Secondary outcomes will be other validated pain and pelvic floor symptom instruments.||||
1325994|NCT03257657|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a pilot, randomized controlled trial. The investigators will pilot a multi-component intervention delivered in a WIC (Women, Infants, children) setting.||||
1325995|NCT03257644|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1325996|NCT03257631||Single Group Assignment||Treatment||None (Open Label)||||||
1325997|NCT03257618||Single Group Assignment||Treatment||None (Open Label)||||||
1325998|NCT03257605|||Cohort||Retrospective|||||||
1576192|NCT00011739||||||||||||
1326009|NCT03257462|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1326010|NCT03257449|||Other||Prospective|||||||
1326011|NCT03257436||Single Group Assignment||Other||None (Open Label)||||||
1326012|NCT03257423|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Patients are enrolled in conjuction with APPAC II (NCT03236961) and APPAC III (NCT 03234296) trials, all patients with uncomplicated or complicated acute appendicitis are evaluated for MAPPAC enrollment. MAPPAC study groups: complicated acute appendicitis (samples: rectal swabs, serum, removed appendix), APPAC II patients in two groups according to APPAC II randomized antibiotic therapy (uncomplicated acute appendicitis, samples: rectal swabs, serum and in cases of antibiotic treatment failure or appendicitis recurrence also removed appendix), APPAC III patients in two groups according to APPAC III randomized group of antibiotc or placebo therapy (uncomplicated acute appendicitis, samples: rectal swabs, serum and in cases of antibiotic or placebo treatment failure or appendicitis recurrence also removed appendix), and patients with uncomplicated acute appendicitis declining to participate in APPAC II or III trials undergoing appendectomy||||
1326013|NCT03257410||||||||||||
1326014|NCT03257397|Randomized|Parallel Assignment||Treatment||Single||||||t
1326015|NCT03257384|||Cohort||Prospective|||||||
1326016|NCT03257371|||Cohort||Prospective|||||||
1326017|NCT03257358|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Two-cohort, non-randomized, open-label multicenter||||
1326018|NCT03257345|||Case-Only||Prospective|||||||
1326019|NCT03257332|||Cohort||Prospective|||||||
1326020|NCT03257319|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326021|NCT03257306|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomized, single-blinded, multi-institutional, non-inferiority study||||
1326022|NCT03257293|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1326023|NCT03257280|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1326024|NCT03257267|Randomized|Parallel Assignment||Treatment||None (Open Label)||The treatment period begins with randomization to 1 of the treatment arms. Cycle length is 6 weeks; Planned treatment is for up to 96 weeks. The treatment phase ends when the patient discontinues study therapy. After completion of the treatment period, patients enter the follow up period, which continues until death or study completion, per the sponsor and the Gynecologic Oncology Group (GOG). Study closeout procedures will be implemented after the 330th OS event has been reported.||||
1326025|NCT03257254|||Cohort||Prospective|||||||
1326026|NCT03257241|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparison of the efficacy of two standard induction treatment protocols (DA-90 and DAC) in patients with newly-diagnosed AML (with the exception of acute promyelocytic leukemia). Comparison of the efficacy of two standard reinduction treatment protocols (CLAG-M and FLAG-IDA) in patients with refractory and relapsed AML.||||
1326027|NCT03257228|||Cohort||Prospective|||||||
1326028|NCT03257215|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1326029|NCT03257202|Randomized|Parallel Assignment||Prevention||None (Open Label)||Healthy volunteers||||
1326030|NCT03257189||Single Group Assignment||Other||None (Open Label)||||||
1326031|NCT03257176||Single Group Assignment||Prevention||None (Open Label)||||||
1326032|NCT03257163||Single Group Assignment||Treatment||None (Open Label)||||||
1326033|NCT03257150||Single Group Assignment||Treatment||None (Open Label)||||||
1326034|NCT03257137|Randomized|Crossover Assignment||Other||Double|Participants will undergo both diet pattern conditions but not be informed of their differences. The technologist scoring the sleep studies and actiwatches will be blinded to the condition||t|||t
1326035|NCT03257124||Single Group Assignment||Treatment||None (Open Label)||"Brain Metastasis cohort (BM cohort)~Leptomeningeal Metastasis cohort (LM cohort)"||||
1326036|NCT03257111|||Cohort||Prospective|||||||
1326037|NCT03257098||Single Group Assignment||Treatment||None (Open Label)||Interventional, single arm, multicenter, phase I/IIa clinical trial||||
1326038|NCT03257085|Randomized|Parallel Assignment||Prevention||None (Open Label)|Due to the nature of the low-carbohydrate, high-fat and high-carbohydrate, moderate-fat diets masking is not feasible.|Randomised pilot study||||
1326039|NCT03257072|Randomized|Parallel Assignment||Diagnostic||Triple|double-blind|double-blind, placebo-controlled, dose-escalation trial|t|t|t|
1326040|NCT03257059|Randomized|Crossover Assignment||Other||None (Open Label)||Randomised, crossover study with two treatments||||
1326041|NCT03257046|Randomized|Parallel Assignment||Treatment||Quadruple||Multiple rising dose in sequential cohorts of 8 patients randomized in a 6:2 ratio to receive ITI-214 or placebo|t|t|t|t
1326042|NCT03257033|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects with stable or responding disease after approximately four months of induction therapy, and who are not surgical candidates will then be randomized to be in either the test group or control group. Crossovers are not allowed.||||
1326043|NCT03257020|||Case-Control||Retrospective|||||||
1326044|NCT03257007|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Participants are blind to study hypotheses.|Participants will be assigned in equal numbers using block randomization to the mindfulness intervention or usual care. The course curriculum for the mindfulness intervention is modeled on the Mindfulness-Based Stress Reduction program which involves intensive experiential training of participants in secular mindfulness meditation practices (i.e., body scan, sitting meditation, gentle hatha yoga with chair adaptations, compassion meditation), with an emphasis on embodying interpersonal mindfulness in dialogue.||||
1326045|NCT03256994|||Cohort||Prospective|||||||
1326046|NCT03256981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326047|NCT03256968||Single Group Assignment||Treatment||None (Open Label)||||||
1326048|NCT03256955||Single Group Assignment||Other||None (Open Label)||||||
1326049|NCT03256942|Randomized|Parallel Assignment||Treatment||Single||||||t
1326050|NCT03256929|Randomized|Parallel Assignment||Treatment||Single||The first stage will be mapping all of the aged population of the research area, who will be interviewed (after receiving their consent) in order to determine those who are depressed. 200 depressed individuals (according to the GDS) will be chosen, and divided randomly into two groups- one will undergo the diet- driven microbiota adjustment personalized-intervention (nutrition advisory), and the other will get general information on nutrition and health .|t|||
1326051|NCT03256916|Randomized|Parallel Assignment||Treatment||None (Open Label)||There will be two study arms. If patient is randomized to standard arm patient will receive concurrent chemoradiation and brachytherapy. If patient is randomized to nelfinavir arm then nelfinavir will be started at the dose of 1250 mg bid 5-7 days prior to standard treatment||||
1326052|NCT03256903|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase IIIb open randomized clinical trial||||
1326053|NCT03256890|Randomized|Parallel Assignment||Treatment||Triple|The study will implement blinding of staff performing participant assessments and data analysts performing statistical analyses. The principal investigator will be blinded to group allocation, except for participants that he is involved with instructing in the MB-BP intervention (there are multiple instructors). The prinicipal investigator has no access to the master data file. Equipoise is emphasized for all staff who interact with participants.|||t|t|t
1326054|NCT03256877|||Cohort||Prospective|||||||
1326055|NCT03256864|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1326056|NCT03256851|Randomized|Parallel Assignment||Treatment||Single||||||t
1326057|NCT03256838||Single Group Assignment||Other||None (Open Label)||||||
1326058|NCT03256825|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1326059|NCT03256812|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1326060|NCT03256799|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1326061|NCT03256786|||Case-Control||Prospective|||||||
1326062|NCT03256773|||Cohort||Prospective|||||||
1326063|NCT03256760|Randomized|Parallel Assignment||Other||Triple|Blinded infusion|Endotoxin vs. Placebo|t|t||t
1326064|NCT03256747|Randomized|Parallel Assignment||Treatment||Single|GCMS record will be coded and analyzed by a blinded investigator|||||t
1326065|NCT03256734|||Cohort||Retrospective|||||||
1326066|NCT03256721|Randomized|Parallel Assignment||Treatment||Double||"Group A: Apatinib 500mg QD PO d1-21 + Docetaxel (75mg/m2 IV d1)/Pemetrexed (500 mg/m2 IV d1), q21d~Group B: Docetaxel (75mg/m2 IV d1)/Pemetrexed (500 mg/m2 IV d1), q21d"|t||t|
1326067|NCT03256708|Randomized|Parallel Assignment||Prevention||Double||Double-blind parallel placebo-controlled randomized study|t||t|
1326068|NCT03256695||Single Group Assignment||Treatment||None (Open Label)||||||
1326069|NCT03256682|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Healthy individuals recruited through advertisement||||
1326070|NCT03256669||Single Group Assignment||Treatment||None (Open Label)||||||
1326071|NCT03256656|Non-Randomized|Parallel Assignment||Basic Science||||||||
1326072|NCT03256643|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1326073|NCT03256630|||Case-Only||Prospective|||||||
1326074|NCT03256617||Single Group Assignment||Health Services Research||None (Open Label)||"Pre-post test design for the therapists followed by a prospective cohort of patients.~We anticipate 50 physical therapy providers and 150 patients for a total of 200 participants."||||
1326075|NCT03256604|||Cohort||Retrospective|||||||
1326076|NCT03256591|Randomized|Parallel Assignment||Other||None (Open Label)|No masking will be done|Investigators will conduct a prospective, randomized controlled trial to determine if the implementation of a simulation facilitator training program for HBB compared with no facilitator training in simulation is superior in terms of the acquisition of knowledge, acute care skills, and teamwork skills of pre-service medical students. Investigators will randomly randomly assign study participants to either intervention or control arm in a 1:1 ratio.||||
1326077|NCT03256578|Randomized|Parallel Assignment||Health Services Research||Single|The waveform data and videos captured during the study intervention will be centralized to Leiden University Medical Center. The team at Leiden University Medical Center assessing the outcomes will be will be blinded to the randomization allocation of the infant.|Eligible infants are either randomized to the intervention, where the clinical team will be able to directly observe the monitor or randomized to the RFM-masked display arm, where they will only see a black screen.||||t
1326078|NCT03256565|||Case-Control||Retrospective|||||||
1326079|NCT03256552|Randomized|Crossover Assignment||Treatment||Quadruple||randomized, double-blind, chronic-dosing (7-day), four-period, four-treatment, placebo-controlled, crossover, multi-center|t|t|t|t
1326080|NCT03256539|Randomized|Parallel Assignment||Other||Double|||t|||t
1326081|NCT03256526|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1326082|NCT03256513|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326083|NCT03256500|Non-Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1326084|NCT03256487|Randomized|Parallel Assignment||Treatment||Quadruple|The provider, nurse administering the medication, patient, and research assistant will be masked to the randomization and the drug provided. We will ensure masking by the following mechanisms: drugs will be prepared by the pharmacy staff in identical 10mL syringes; the medication will be diluted to a volume of 10mL with normal saline (NS); and both medications are clear so the syringes will appear identical. Both drugs will be administered over the same period of time, 3-5 minutes.||t|t|t|t
1326085|NCT03256474|||Cohort||Retrospective|||||||
1326086|NCT03256461|Randomized|Parallel Assignment||Treatment||Double||This trial is a prospective, multicenter, single-blind, parallel-group, central-randomized, controlled trial|t|||t
1326087|NCT03256435|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326088|NCT03256422|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, randomized trial in 2 parallel groups||||
1326133|NCT03255837|Randomized|Parallel Assignment||Supportive Care||Single|Participants will be unaware of the order in which they receive the transcranial stimulation condition (anodal, cathodal, sham).|Each participant will receive the same 3 kinds of transcranial stimulation. However, the order in which they receive them will be randomly allocated.|t|||
1326134|NCT03255824|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1326173|NCT03255317||Single Group Assignment||Other||None (Open Label)||"At each time point at which a participant is eligible to receive an engagement strategy, the participant is randomized to either receive the strategy or not receive the strategy. Participants are only eligible to potentially receive some engagement strategies after completing their self-report survey questions and/or active tasks that day (see intervention section for more information)."||||
1326174|NCT03255304|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1326089|NCT03256409|Randomized|Parallel Assignment||Treatment||Single|The working protocol for determining the BOD Ra and BJOD Ra and the adhesion of molds and yeasts and mesophyll aerobics was carried out entirely by an investigator and the following working methodology was considered: Information to the patient and obtainment of clinical data and patient informed consent. Patients were randomly assigned to group 1 and group 2. The saliva sample was obtained in each patient for the microbiological before the installation of the overdentures. BODs and BJODs were installed in each patient and according to each case. The BOD and BJOD were removed at 30 days for surface roughness evaluation (Ra:ųm) and the evaluation of the adhesion of mold and yeast and mesophyll aerobe (CFU/ml). For the study at 180 days the BODs and the BJODs were installed in each patient. BODs and BJODs were removed after this time to proceed to the evaluation of surface roughness and adhesion of mold and yeast and mesophyll aerobe under the same parameters mentioned above.|The study presents the results of a sample of ten patients randomly assigned to receive implant-retained overdentures and divided into two parallel groups of five participants in a single-blind trial at a follow-up period of 30 - 180 days permanence in the mouth. Five overdentures were made for each group: Group 1: BOD: five systems titanium bar CARES® and synOcta® Straumann® Dental Implant System, Holding AG Inc., Basel, Switzerland (BOD). Group 2: BJOD: five systems ball joint Klockner® Implant System; Soadco Inc., Escaldes-Engordany, Andorra were used in two parallel groups of five participants, in an essay to simple blind person.|||t|
1326090|NCT03256396|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326091|NCT03256383|||Case-Only||Cross-Sectional|||||||
1326092|NCT03256370|||Case-Control||Prospective|||||||
1326093|NCT03256357|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1326094|NCT03256344||Single Group Assignment||Other||None (Open Label)||||||
1326095|NCT03256331||Sequential Assignment||Treatment||None (Open Label)||A sequential Dose Escalation Part of four doses following a 3 + 3 design.||||
1326096|NCT03256318|||Case-Control||Prospective|||||||
1326097|NCT03256305|Randomized|Parallel Assignment||Treatment||Single||Care Provider, Investigator, Outcomes Assessor|t|||
1326098|NCT03256292|||Cohort||Cross-Sectional|||||||
1326099|NCT03256279|Randomized|Parallel Assignment||Health Services Research||Double|Only one of the investigators are going to know the archwire assigment, the other ones who are going to do the measures are going to be blinded.||t|||t
1326100|NCT03256266|||Cohort||Prospective|||||||
1326101|NCT03256253||Single Group Assignment||Treatment||None (Open Label)||open label pilot study||||
1326102|NCT03256240|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomized to undergo either the Kono-S anastomosis or the side-to-side functional end anastomosis.||||
1326103|NCT03256227|Randomized|Parallel Assignment||Treatment||Single|Assessors are blinded to treatment condition|effectiveness-implementation Hybrid 1, 2-arm, pragmatic randomized controlled trial||||t
1326104|NCT03256214|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1326105|NCT03256201|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1326106|NCT03256188||Single Group Assignment||Prevention||None (Open Label)||||||
1326107|NCT03256175|Randomized|Parallel Assignment||Basic Science||Double|Both medical air and oxygen were supplied in compressed liquid form and available throughout the hospital. During the study, the medical gas cylinders shielded using an opaque temporary cover. Similarly the oxygen saturation was not displayed, but instead monitored by an independent third party.||t|||t
1326108|NCT03256162|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1326109|NCT03256149|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1326110|NCT03256136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326111|NCT03256123|Randomized|Parallel Assignment||Treatment||Double||In this study, the subjects will be randomly assigned to two groups: a group receiving biscuits with red palm oil and a control group receiving biscuits with palm shortening with corresponding fatty acids.|t|t||
1326112|NCT03256110|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Cluster-randomized design with providers randomized to intervention or control and patients nested within provider.||||
1326113|NCT03256097|Randomized|Crossover Assignment||Treatment||Single|||t|||
1326114|NCT03256084||Single Group Assignment||Basic Science||None (Open Label)||||||
1326115|NCT03256071|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326116|NCT03256058|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1326117|NCT03256045||Single Group Assignment||Treatment||None (Open Label)||||||
1326118|NCT03256032|||Other||Cross-Sectional|||||||
1326119|NCT03256019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326120|NCT03256006|||Cohort||Prospective|||||||
1326121|NCT03255993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326122|NCT03255980|Randomized|Parallel Assignment||Other||None (Open Label)||MONOCENTER, OPEN LABEL CLINICAL INVESTIGATION||||
1326123|NCT03255967|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326124|NCT03255954||Single Group Assignment||Other||None (Open Label)||||||
1326125|NCT03255941|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Women who are new users of injectable contraception will be randomly assigned to receive services from an LHW or an LHV and will be randomly assigned to receive either intramuscular DMPA or the subcutaneous formulation, Sayana Press.||||
1326126|NCT03255928|||Cohort||Prospective|||||||
1326127|NCT03255915|Randomized|Crossover Assignment||Prevention||Triple||Randomized order, placebo-controlled, double blind, crossover|t||t|t
1326128|NCT03255902||Single Group Assignment||Supportive Care||None (Open Label)||This feasibility study will be a mixed methods non-randomized trial to examine the feasibility of combining a parent skill training intervention with a family evening routine intervention. Evidence of feasibility will include attendance, activities completed, and interviews.||||
1326129|NCT03255889|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1326130|NCT03255876|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1326131|NCT03255863||Single Group Assignment||Supportive Care||None (Open Label)||||||
1326132|NCT03255850|||Cohort||Cross-Sectional|||||||
1326209|NCT03254849|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1326135|NCT03255811||Single Group Assignment||Treatment||None (Open Label)||At present, apatinib was approved for the treatment of advanced gastric cancer after second-line or gastroesophageal junction adenocarcinoma, is in the second one, experience of medication, clinical data, no chemotherapy so now intends to carry out 40 cases of small sample exploratory research, in the conventional chemotherapy after the onset, with APA for Nigeria maintenance treatment, with a preliminary understanding of apatinib in first-line advanced gastric cancer to maintain the efficacy and safety of the treatment, and explore the feasibility of anti generate small molecule targeted therapy in advanced gastric cancer vascular pattern.||||
1326136|NCT03255798||Single Group Assignment||Treatment||None (Open Label)|IOP outcome is masked|G2 and G3||||
1326137|NCT03255785||Single Group Assignment||Treatment||None (Open Label)|IOP outcome masked|iStent and iStent Supra||||
1326138|NCT03255772|||Cohort||Prospective|||||||
1326139|NCT03255759|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1326140|NCT03255746|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1326141|NCT03255733||Single Group Assignment||Treatment||None (Open Label)|Investigator was blinded to the Patient Reported Outcome Measure Survey details and analysis.|Patients age 18 - 85, previously diagnosed with Chronic Lateral Epicondylitis, with symptoms exceeding 90 days, and where Standard of Care treatments have failed to resolve the symptoms.||||
1326142|NCT03255720|||Case-Control||Prospective|||||||
1326143|NCT03255707|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients of the study will be recruited from the ophthalmology outpatient clinic of Ain Shams University Hospital.100 patients of both sexes with amblyopia will be enrolled. Informed consents will be obtained from adult patients and children's parents.~Patients will be assigned randomly:~Group A:50 patients will receive the gold standard occlusion therapy while playing a video game (Lazy Eye Tetris games such as Lazy Eye Blocks ®).Group B:50 patients will receive dichoptic treatment in the form of playing a video game (Lazy Eye Tetris games such as Lazy Eye Blocks ®) while wearing a red/green goggle.Each group will be subdivided according to age:~1)4 to 7 years. 2)>7 to 12 years. 3)>12 to 30 years.~Hours of occlusion /dichoptic treatment will be classified according to the degree of amblyopia:~Mild to moderate amblyopia (Best corrected visual acuity (BCVA)< 0.2) : 2-4 hours~Severe (BCVA> 0.2) : 4-6 hours~All patients will undergo full ophthalmological examination"||||
1326144|NCT03255694||Single Group Assignment||Treatment||None (Open Label)||||||
1326145|NCT03255681|Randomized|Single Group Assignment||Treatment||None (Open Label)|No masking.|The study treatment group will have one half of their face treated with PRP filler and the other half of the face treated with PRP with CaCl2. Using a VectraH1 3D camera, the degree of volume achieved, measured in cm3 using VECTRA Capture Analysis module software, will be assessed at one, three and six and twelve month intervals and compared to the pre-procedure imaging. This is therefore a pilot study and results will need to be reviewed after performing this protocol on 50 subjects.||||
1326146|NCT03255668|||Other||Cross-Sectional|||||||
1326147|NCT03255655|Randomized|Parallel Assignment||Treatment||Single|"Investigator was blinded to the treated vs. control/sham treated patient identity and to the treated foot.~Researchers were blinded to the Investigators physical exam finding and patient outcome measure reports"|Adult Patients (age 18 - 85) of either gender diagnosed with chronic plantar fasciitis pain (>90 days) where Standard of Care treatments had failed to reduce pain.|||t|
1326148|NCT03255642|Randomized|Parallel Assignment||Treatment||Single|Mask treatment arm when analyzing polysomnography.|Prospective Randomized Open-label Cross-over study||||t
1326149|NCT03255629|Randomized|Crossover Assignment||Prevention||Quadruple|Study medication will be provided in vials which are labeled with randomization information only but not contents of vial.|A randomization scheme will be devised to assign half the subjects to receive glucagon during their first challenge visit and the other half to receive vehicle during their first challenge visit. At their second challenge subjects will be assigned to the product not received during their first challenge. The label will include a subject randomization number and information as to which vial should be administered during the first challenge and which should be administered during the second challenge.|t|t|t|t
1326150|NCT03255616|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1326151|NCT03255603|Randomized|Parallel Assignment||Other||Single|||t|||
1326152|NCT03255590|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1326153|NCT03255577||Single Group Assignment||Treatment||None (Open Label)||This will be a prospective single-arm study design.||||
1326154|NCT03255564|||Other||Prospective|||||||
1326155|NCT03255551|||Case-Control||Prospective|||||||
1326156|NCT03255538|Randomized|Crossover Assignment||Treatment||Single|||t|||
1326157|NCT03255525|Randomized|Crossover Assignment||Treatment||Single|||t|||
1326158|NCT03255512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326159|NCT03255499|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1326160|NCT03255486||Single Group Assignment||Prevention||None (Open Label)||||||
1326161|NCT03255473|Randomized|Parallel Assignment||Treatment||None (Open Label)||Compare hearing outcomes between treatment with dexamethasone versus prednisone in participants who have been diagnosed with unilateral SSNHL within six weeks, and compare side effect profiles between the two treatment regimens of either dexamethasone or prednisone.||||
1326162|NCT03255460|||Case-Control||Cross-Sectional|||||||
1326163|NCT03255447||Single Group Assignment||Treatment||None (Open Label)||||||
1326164|NCT03255434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326165|NCT03255421|||Cohort||Prospective|||||||
1326166|NCT03255408|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1326167|NCT03255395||Single Group Assignment||Treatment||None (Open Label)||A single group feasibility study||||
1326168|NCT03255382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326169|NCT03255369|||Cohort||Prospective|||||||
1326170|NCT03255356|||Cohort||Prospective|||||||
1326171|NCT03255343||Single Group Assignment||Treatment||None (Open Label)||10 patients with liver tumor non operable, with resistance to other classical chemotherapy, injected a single dose of IMDENDRIM 10 mCi per 1 cm²||||
1326172|NCT03255330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326210|NCT03254836|||Cohort||Prospective|||||||
1326211|NCT03254823|||Other||Other|||||||
1326175|NCT03255291|Randomized|Crossover Assignment||Prevention||Single|-The research staff will be blinded to participants' risk presentation conditions, but they will be unblinded to mental imagery condition.||||t|
1326176|NCT03255278|Randomized|Single Group Assignment||Prevention||Single||"The clinical trial study of the GamTBvac vaccine against the tuberculosis is a comparative placebo-controlled study with a two-fold increase of an applied dose among healthy volonteers aged 18-49 years."|t|||
1326177|NCT03255265|||Cohort||Prospective|||||||
1326178|NCT03255252||Single Group Assignment||Treatment||None (Open Label)||radiothérapy with concomittant chemotherapy||||
1326179|NCT03255239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326180|NCT03255226||Single Group Assignment||Treatment||None (Open Label)||||||
1326181|NCT03255213||Single Group Assignment||Treatment||None (Open Label)||||||
1326182|NCT03255200|||Cohort||Prospective|||||||
1326183|NCT03255187|Randomized|Parallel Assignment||Prevention||Quadruple||Participants are randomly assigned to two parallel groups at enrollment using a random-number table. And the investigators randomly assign the two groups in a double-blind fashion receive either ﬁsh oil or sunflower seed oil for 4 months.|t|t|t|t
1326184|NCT03255174||Single Group Assignment||Treatment||None (Open Label)||||||
1326185|NCT03255161|Randomized|Crossover Assignment||Supportive Care||Double|||||t|t
1326186|NCT03255148|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1326187|NCT03255135||Single Group Assignment||Treatment||None (Open Label)||||||
1326188|NCT03255122|Randomized|Parallel Assignment||Treatment||Single|Independent evaluators masked to each participating family's treatment condition will perform all structured diagnostic interviews and generate responder status data|Families are randomly designed to receive either immediate treatment (I-CALM) or waitlist and then I-CALM||||t
1326189|NCT03255109|||Cohort||Prospective|||||||
1326190|NCT03255096|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1326191|NCT03255083||Single Group Assignment||Treatment||None (Open Label)||||||
1326192|NCT03255070|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"This is a 2-part, Phase 1, open-label study. Phase 1a is designed to determine the recommended Phase 2 dose (RP2D) in subjects with advanced cancer whose HER2 test results are in situ hybridization (ISH) positive or immunohistochemistry (IHC) 3+.~The IMP, ARX788, will be administered every 3 weeks or every 4 weeks via IV infusion. Five sequential dose escalation cohorts are planned. Cohort 1 and Cohort 2 will each enroll 3 subjects following a 3+3 design with possible expansion to 6 subjects as determined by the Safety Monitoring Committee based on dose-limiting toxicity assessment and comprehensive reviews of safety, tolerability and PK data. Cohort 3, Cohort 4 and Optional Cohort 5 will enroll 6 subjects each without planned expansion.~Phase 1b is designed to investigate the RP2D, from Phase 1a, to assess anticancer activity and safety in 2 advanced breast cancer expansion cohorts: 1) tested tumors HER2 ISH positive or IHC 3+ and 2) tested tumors HER2 ISH negative with IHC 2+."||||
1326193|NCT03255057|Randomized|Parallel Assignment||Treatment||Single|Due to the nature of the interventional device and treatment, the study participants, care providers, and investigators will not be masked. However, an independent Clinical Endpoint Committee will be masked for adjudication of the primary endpoint and serious adverse events. An independent Data and Safety Monitoring Board will make study continuation recommendations based on the statistical analysis plan and the overall safety and efficacy endpoints without masking.|Prospective, multi-center, randomized, controlled, two-arm, open-label, adaptive, two-strata, pivotal trial||||t
1326194|NCT03255044|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326195|NCT03255031|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1326196|NCT03255018||Single Group Assignment||Treatment||None (Open Label)||||||
1326197|NCT03255005|Randomized|Sequential Assignment||Treatment||None (Open Label)||Group A: treatment J0 + Diet 1 year Group B: Diet 6 months - Treatment - Diet 1 year||||
1326198|NCT03254992|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1326199|NCT03254979|Randomized|Parallel Assignment||Health Services Research||Double|Since the new program is an optimization of the type-2 diabetes prevention services already offered in Osakidetza, it is expected that the participating patients will be blind to group allocation.|The implementation strategy to facilitate the adoption of the recommended clinical intervention in primary prevention of T2DM will be common to both comparison groups. In order to differentiate and isolate the effect of the procedure of creation of the Multi-professional Community of Practice, the centers have been randomly assigned to two comparison groups: 5 centers assigned to the sequential procedure and the other 4 centers to the group procedure.|t|||t
1326200|NCT03254966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326201|NCT03254953|Randomized|Parallel Assignment||Treatment||None (Open Label)||12-week randomized controlled trial to compare 3 self-monitoring approaches for weight loss in a digital health intervention for adults who are overweight or obese||||
1326202|NCT03254940|Randomized|Factorial Assignment||Treatment||Single||The investigators will use a full factorial design to randomize participants to experimental conditions that reflect the texting intervention components: motivational messaging (self- vs expert-generated), texting frequency (daily vs weekly), reminders (one reminder v. multiple reminders), feedback type (summary score v. specific feedback) and comparison unit (to self v. to a group of people). The full factorial design is power efficient, logistically feasible (because we manipulate conditions using technology) and will allow the investigators to examine the most important main and interaction effects among components.|||t|
1326203|NCT03254927||Single Group Assignment||Treatment||None (Open Label)||||||
1326204|NCT03254914|||Cohort||Prospective|||||||
1326205|NCT03254901|||Other||Cross-Sectional|||||||
1326206|NCT03254888|||Case-Control||Retrospective|||||||
1326207|NCT03254875|Randomized|Parallel Assignment||Supportive Care||Single|Intervention status will be blinded in analyses.|During a 2-year period, 758 patients newly diagnosed with breast cancer will be screened for inclusion at the Section of Breast Surgery at Rigshospitalet, Copenhagen. Of these 324 participants enter the RCT and are randomized in a computer-generated sequence of 1:1 to the intervention (nurse-navigation) or control group (standard care). A total of 432 participants will enter an observational questionnaire study. All participants are followed for 1,5 years.||||t
1326208|NCT03254862|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1326212|NCT03254810|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1326213|NCT03254797|Randomized|Parallel Assignment||Treatment||Single||||||t
1326214|NCT03254784|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1326215|NCT03254771|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Open label|||||
1326216|NCT03254758||Single Group Assignment||Treatment||None (Open Label)||||||
1326217|NCT03254745|Randomized|Parallel Assignment||Health Services Research||Double|Investigator will be blinded.||||t|t
1326218|NCT03254732||Single Group Assignment||Treatment||None (Open Label)||||||
1326219|NCT03254719||Single Group Assignment||Other||None (Open Label)||Chiropractic care will be administered by licensed DCs who are current employees of the Iowa City VA Health Care System (ICVAHCS). Participants will receive chiropractic care at a frequency of 1-2 visits per week for a duration up to 10 weeks, with the frequency and duration of care individualized within established VA parameters. For this trial, the minimum treatment dose is 1 visit to the DC, while the maximum treatment dose is 12 visits.||||
1326220|NCT03254706|Randomized|Crossover Assignment||Treatment||Double|A staff member not involved in the research protocol performed the randomization process with computer-generated tables. Details of the allocated groups were recorded on cards contained in sequentially numbered, opaque, sealed envelopes. Opening the envelope only on the day of the restorative procedure guaranteed the concealment of the random sequence. The examiners were not involved with the restoration procedures and therefore blinded to the group assignment, performed the clinical evaluation. Patient were also blinded to group assignment in a double-blind randomized clinical trial design.|This was a double-blind, superiority, split-mouth randomized clinical trial. The study was carried out in the clinics of the School of Dentistry at the local University from August 2015 to August 2017.|t|||t
1326221|NCT03254693|Randomized|Crossover Assignment||Other||Double|staff member not involved in the research protocol performed the randomization process with computer-generated tables. Details of the allocated groups were recorded on cards contained in sequentially numbered, opaque, sealed envelopes. Opening the envelope only on the day of the restorative procedure guaranteed the concealment of the random sequence. The examiners were not involved with the restoration procedures and therefore blinded to the group assignment, performed the clinical evaluation. Patient were also blinded to group assignment in a double-blind randomized clinical trial design.|This was a double-blind, equivalence superiority, split-mouth randomized clinical trial. The restoration procedures were carried out within the clinics of the Dental School of the Federal University of Rio de Janeiro in Rio de Janeiro (Rio de Janeiro, Brazil) and at the State University Oeste do Paraná in Cascavel (Paraná, Brazil) from July 2016 to August 2017.|t|||t
1326222|NCT03254680||Single Group Assignment||Treatment||None (Open Label)||||||
1326223|NCT03254667|||Cohort||Prospective|||||||
1326224|NCT03254654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326225|NCT03254641|||Case-Only||Prospective|||||||
1326226|NCT03254628|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1326227|NCT03254615|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Experimental, analytical, longitudinal, and prospective designs will be employed. The assignment will be conducted by each school.||||
1326228|NCT03254602||Single Group Assignment||Treatment||None (Open Label)||Open label||||
1326229|NCT03254589|Randomized|Parallel Assignment||Treatment||Single||||||t
1326230|NCT03254576|||Cohort||Prospective|||||||
1326231|NCT03254563|||Other||Cross-Sectional|||||||
1326232|NCT03254550|||Cohort||Prospective|||||||
1326233|NCT03254537|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1326234|NCT03254524|||Ecologic or Community||Retrospective|||||||
1326235|NCT03254511|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326236|NCT03254498|Randomized|Parallel Assignment||Diagnostic||Single||It is a randomised back to back study to compare the performance of cap assisted colonoscopy (CAC) and Endocuff assisted colonoscopy (EAC)|||t|
1326237|NCT03254485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326238|NCT03254472|||Case-Only||Retrospective|||||||
1326239|NCT03254459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326240|NCT03254446|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind|Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-centre, Multinational Study|t|t|t|t
1326241|NCT03254433|Randomized|Parallel Assignment||Other||Single||Participants are randomized to one of two counseling conditions (BAS+ or SC) as part of the main (parent) study.|t|||
1326242|NCT03254420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326243|NCT03254407||Single Group Assignment||Health Services Research||None (Open Label)||||||
1326244|NCT03254394|Randomized|Parallel Assignment||Prevention||Quadruple|At enrollment, each patient will be assigned a study number, which will match a previously prepared computer-generated list of randomization numbers to determine the interventions. The participants and all other study personnel will be blinded to the treatment allocation.|Tolerability phase: prospective, open-label Efficacy pilot study: randomized, parallel, double blind, placebo controlled|t|t|t|t
1326245|NCT03254381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326246|NCT03254368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326247|NCT03254355|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326248|NCT03254342|||Other||Prospective|||||||
1326249|NCT03254329|||Family-Based||Prospective|||||||
1326250|NCT03254316|||Cohort||Prospective|||||||
1326251|NCT03254303|Randomized|Crossover Assignment||Other||Triple|particippant, investigator, outcomes assessor|randomized and crossover assignemnt|t||t|t
1326293|NCT03253757|||Other||Prospective|||||||
1326294|NCT03253744|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326295|NCT03253731|||Cohort||Prospective|||||||
1326296|NCT03253718|||Cohort||Prospective|||||||
1326297|NCT03253705|||Other||Other|||||||
1326298|NCT03253692|||Case-Only||Cross-Sectional|||||||
1326299|NCT03253679||Single Group Assignment||Treatment||None (Open Label)||||||
1326300|NCT03253666|||Cohort||Prospective|||||||
1576284|NCT00009581||||Treatment||||||||
1326252|NCT03254290|Randomized|Single Group Assignment||Treatment||Single|The teeth treated with each specific material will be randomly assigned by drawing a random number from a manilla folder|Children between the ages of 2 ½ and 9 years of age and be ASA I or ASA II. Patient must have two, primary teeth that are matched for, size of carious lesion (same level of approximation of carious lesion to the pulp) and are that are treatment planned for a pulpotomy. The teeth selected for the study must be vital and asymptomatic both clinically and radiographically or only display symptoms consistent with reversible pulptitis The teeth selected for the study must be anticipated to be retained in the mouth for at least eighteen months|t|||
1326253|NCT03254277|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326254|NCT03254264|Randomized|Parallel Assignment||Treatment||Single||"ESDM is a comprehensive relational, developmental and behavioral intervention. It's described in a manual for professional (Rogers et al, 2010).~Children receive ESDM at minimum 12H per week by trained therapist. Therapist work in collaboration with parents (at home) and preschool or nursery."||||t
1326255|NCT03254251|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1326256|NCT03254238|||Cohort||Prospective|||||||
1326257|NCT03254225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326258|NCT03254212||Single Group Assignment||Treatment||None (Open Label)||Fixed nightime oxygen therapy throughout the study duration||||
1326259|NCT03254199|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1326260|NCT03254186|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1326261|NCT03254173|Randomized|Parallel Assignment||Treatment||Triple|"Treatment allocation will be concealed from patients, investigators, and study coordinators enrolling the participants.~The pills used in the study ( either remeron or placebo ) will be kept into opaque containers , in order to be concealed from patients , investigators and study coordinators."|double-blinded randomized controlled trial.|t|t|t|
1326262|NCT03254160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326263|NCT03254147|||Cohort||Retrospective|||||||
1326264|NCT03254134|||Cohort||Retrospective|||||||
1326265|NCT03254121|||Cohort||Other|||||||
1326266|NCT03254108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326267|NCT03254095|||Cohort||Prospective|||||||
1326268|NCT03254082|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1326269|NCT03254069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326270|NCT03254056|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1326271|NCT03254043|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1326272|NCT03254030|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Participants are randomised to undergo the flexible sigmoidoscopy screening examination either for control or intervention group. Control group is to undergo inspection of colonic mucosa only during withdrawal phase of the examination. Intervention group will undergo the examination during which the colonic mucosa will be inspected during inspection and withdrawal phase.||||
1326273|NCT03254017||Single Group Assignment||Treatment||None (Open Label)||all subjects will receive bilateral surgical implantation of DBS system.||||
1326274|NCT03254004||Single Group Assignment||Treatment||None (Open Label)||Pembrolizumab 200mg injection||||
1326275|NCT03253991||Single Group Assignment||Treatment||None (Open Label)||Prospective multi-site, single-arm study||||
1326276|NCT03253978|Randomized|Single Group Assignment||Treatment||None (Open Label)|Not applicable - no masking|A randomised feasibility study||||
1326277|NCT03253965|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1326278|NCT03253952|||Cohort||Prospective|||||||
1326279|NCT03253939|||Case-Control||Retrospective|||||||
1326280|NCT03253926|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1326281|NCT03253913||Single Group Assignment||Treatment||None (Open Label)||||||
1326282|NCT03253900||Single Group Assignment||Basic Science||None (Open Label)|The investigator who processed the acquired data was blinded for rowing interventions and subject information.|All participants in the study will complete the measurements for all the three rowing interventions; in a random order.||||
1326283|NCT03253887|Randomized|Parallel Assignment||Prevention||Single||It's a randomized controlled clinical trial.||||t
1326284|NCT03253874|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1326285|NCT03253861|||Case-Control||Retrospective|||||||
1326286|NCT03253848|||Case-Only||Prospective|||||||
1326287|NCT03253835|||Cohort||Prospective|||||||
1326288|NCT03253822|Randomized|Parallel Assignment||Screening||None (Open Label)|"Since baseline questionnaire is filled out before randomizasion, and citizens will know if they receive the DA or not, participants will not be masked.~No care providers are involved in the screening program in the phases we study (invitation, reminder, and stool sample), hence no masking in this groups.~The outcomes are assessed via questionnaire data or from registries (Statistics Denmark and the screening IT system), and no masking is necessary in neither investigators nor outcomes assessors."|"The LEAD trial is conducted as a two arm, randomised controlled trial nested into a population-based, organized CRC screening programme conducted in the Central Denmark Region. Citizens who are scheduled to be invited for CRC screening within the study period will be randomly allocated into one two study arms. Further, a historic study arm will be included, in order to be able to assess the effect of receiving the baseline questionnaire:~To receive the DA along with the screening reminder and to receive both baseline and follow-up questionnaires (intervention group)~To receive both baseline and follow-up questionnaires (control group)~To receive a questionnaire comprisng scales from both baseline and follow-up questionnaires (historic cohort)~Regardless of study arm, all citizens receive standard CRC screening information material according to the CRC screening program procedures."||||
1326289|NCT03253809||Single Group Assignment||Basic Science||None (Open Label)||Nonrandomized survey of different pacing sites in the coronary veins.||||
1326290|NCT03253796|Randomized|Parallel Assignment||Treatment||Double||"To evaluate the effect of treatment withdrawal vs continued treatment with golimumab (either every month [QM] or every 2 months [Q2M]) on the incidence of a flare during up to 12 months in Period 2 (blinded therapy)."|t||t|
1326291|NCT03253783||||Prevention||None (Open Label)||||||
1326292|NCT03253770|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326301|NCT03253653||Parallel Assignment||Other||None (Open Label)||The investigators will employ a repeated measures design. A sample of 50 adult male and female exclusive WP smokers and a control sample of 25 male and female non-smokers will be recruited. Over a 3-week study, WP smokers will smoke one WP tobacco head during each of 3 separate WP smoking sessions with a 7-day washout period before each session. Session 1, WP smokers will smoke using 1 quick-light charcoal and room temperature water in the WP jar; Session 2, WP smokers will smoke using 1 quick-light charcoal but adding ice cubes to the water in the WP jar; Session 3, WP smokers will smoke WP tobacco without charcoal using an electric WP head and room temperature water. Physiological effects, carbon monoxide exposure and biomarkers of toxicants and carcinogens related to WP tobacco smoking practices will be compared.||||
1326302|NCT03253640|||Cohort||Prospective|||||||
1326303|NCT03253627|Randomized|Parallel Assignment||Supportive Care||Double|Participants will complete the baseline assessment and be randomly assigned to study group in a permuted block design stratified by receipt of chemotherapy (i.e., two strata). It will not be possible to blind study participants or interventionists to group assignment. To reduce bias, research staff who conduct assessments, including the PI, will be blinded to group assignment (i.e., single blind). Participants will be reminded not to reveal their group assignment to study staff conducting assessments. The study biostatistician will have no direct contact with study participants and will not be blinded to group assignment. The biostatistician will produce and maintain the randomization codes for the permuted blocks. Randomization may only be unmasked by the biostatistician at the completion of analysis of the primary outcome, or for reporting of serious adverse events or unanticipated problems for which it will be essential to provide information to the PI on group assignment.|A pilot, single-center randomized controlled trial of the preliminary efficacy of an eight-week, group-based Mindfulness-Based Stress Reduction intervention versus Health Enhancement Program active control (i.e., two groups, parallel design) to improve neural markers of changes in cognitive function in postmenopausal women receiving aromatase inhibitor therapy for breast cancer. Participants will be stratified in a permuted block design by receipt of chemotherapy (i.e., two strata). Data will be collected at up to three time points using a repeated measures design (i.e., pre-intervention, post-intervention, approximately three months after the intervention). The study groups will meet at NYU for MBSR or HEP. Neuropsychological, self-report, and biospecimen data collection will be conducted at the Bluestone Center. Neuroimaging data will be collected at the NYU Center for Brain Imaging.|||t|t
1326304|NCT03253614|||Cohort||Prospective|||||||
1326305|NCT03253601|Randomized|Parallel Assignment||Treatment||Single||||||t
1326306|NCT03253588|||Case-Control||Retrospective|||||||
1326307|NCT03253575|||Cohort||Prospective|||||||
1326308|NCT03253562|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326309|NCT03253549|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants are randomized to SMArTVIEW or Standard Care.||||
1326310|NCT03253536|||Cohort||Prospective|||||||
1326311|NCT03253523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326312|NCT03253510|Randomized|Parallel Assignment||Treatment||Double||Participants are assigned to two more groups in parallel for the duration of the study|t|||t
1326313|NCT03253497|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1326314|NCT03253484|Randomized|Parallel Assignment||Treatment||Single|the outcome assessor will not know which side is the treated side of scar|split scar study||||t
1326315|NCT03253471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326316|NCT03253458||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326317|NCT03253445|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1326318|NCT03253432|||Cohort||Prospective|||||||
1326319|NCT03253419||Single Group Assignment||Health Services Research||None (Open Label)||To evaluate the use of the Home for Life mobile application to examine home safety and perceived fall risk and actual falls within 2 weeks of hospital discharge for participants who have undergone hip replacement surgery.||||
1326320|NCT03253406|Randomized|Parallel Assignment||Prevention||Single|Every attempt will be made to ensure participants do not know the group with which they have been randomized, accomplished by advertising to potential college student participants that two novel, technology-based interventions will be employed in the study, with no more detail provided. After screening and randomization, participants will be informed of study intervention procedures in an identical manner regardless of group allocation via the use of a study script repeated to each participant by the study's primary investigator. The only difference between the scripts will be a discussion with experimental group participants regarding how to use the Polar M400 smartwatch during the study intervention period. Importantly, college students will be brought into the Lab for screening and baseline testing on an individual basis ensuring the individuals from different groups have no idea of the differing intervention procedures utilized between the experimental and comparison groups.|A two-arm randomized pilot trial design will be used, with one Experimental Group and one Comparison Group. A random numbers table will be used to randomize participants with a 1:1 allocation ratio.|t|||
1326321|NCT03253393|Randomized|Parallel Assignment||Basic Science||Single||Contralateral study|||t|
1326322|NCT03253380||Single Group Assignment||Treatment||None (Open Label)||||||
1326323|NCT03253367|||Cohort||Other|||||||
1326324|NCT03253354|Randomized|Parallel Assignment||Treatment||Single|Patient blinding|4 arm randomised single dose study|t|||
1326325|NCT03253341|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326326|NCT03253328|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326327|NCT03253315|||Other||Other|||||||
1326328|NCT03253302|||Case-Only||Prospective|||||||
1326329|NCT03253289||Single Group Assignment||Treatment||None (Open Label)||||||
1326330|NCT03253276|Randomized|Crossover Assignment||Basic Science||Double|Codes (OCA or placebo) will be opened after final examination of final patient|Double blind placebo-controlled crossover|t||t|
1326331|NCT03253263|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326332|NCT03253250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326333|NCT03253237|||Cohort||Prospective|||||||
1326334|NCT03253224|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1326335|NCT03253211|||Cohort||Prospective|||||||
1576285|NCT00009568||||||||||||
1326336|NCT03253198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326337|NCT03253185||Single Group Assignment||Treatment||None (Open Label)||||||
1326338|NCT03253172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326339|NCT03253159|Randomized|Parallel Assignment||Prevention||None (Open Label)||Hypnosis before intravenous anesthesia versus no preparation before intravenous anesthesia||||
1326340|NCT03253146|||Case-Only||Prospective|||||||
1326341|NCT03253133||Single Group Assignment||Treatment||None (Open Label)||||||
1326342|NCT03253120|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will drink 5dl of water. Healthy volunteers will drink 5dl of water.||||
1326343|NCT03253107|||Case-Control||Prospective|||||||
1326344|NCT03253094|Randomized|Parallel Assignment||Treatment||Quadruple||randomized, double-blind, double-dummy, active-controlled, dose-finding|t|t|t|t
1326345|NCT03253081|Randomized|Parallel Assignment||Treatment||Single||||||t
1326346|NCT03253068||Single Group Assignment||Treatment||None (Open Label)||||||
1326347|NCT03253055|||Case-Control||Cross-Sectional|||||||
1326348|NCT03253042|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1326349|NCT03253029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326350|NCT03253016|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1326351|NCT03253003||Single Group Assignment||Other||None (Open Label)||A line extension of the Phonak Audéo B hearing aid product family will be fitted to the participants individual hearing loss.||||
1326352|NCT03252990|||Cohort||Cross-Sectional|||||||
1326353|NCT03252977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326354|NCT03252964||Single Group Assignment||Supportive Care||None (Open Label)||||||
1326355|NCT03252951|Randomized|Parallel Assignment||Treatment||Single||||||t
1326356|NCT03252938|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1326357|NCT03252925|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1326358|NCT03252912||Single Group Assignment||Prevention||None (Open Label)||||||
1326359|NCT03252899|||Other||Prospective|||||||
1326360|NCT03252886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326361|NCT03252873|||Cohort||Retrospective|||||||
1326362|NCT03252860|||Cohort||Prospective|||||||
1326363|NCT03252847|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Biological||||
1326364|NCT03252834|||Cohort||Prospective|||||||
1326365|NCT03252821|Randomized|Parallel Assignment||Treatment||Single||||||t
1326366|NCT03252808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326367|NCT03252795||Single Group Assignment||Treatment||None (Open Label)||||||
1326368|NCT03252782|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||2-arm parallel-group||||
1326369|NCT03252769||Single Group Assignment||Prevention||None (Open Label)||||||
1326370|NCT03252756|Randomized|Parallel Assignment||Treatment||Double||Double-blind, randomized proof-of-concept study|t|t||
1326371|NCT03252743||Single Group Assignment||Treatment||None (Open Label)||Open trial without control group to test feasibility and evaluate preliminary effects.||||
1326372|NCT03252730||Single Group Assignment||Treatment||None (Open Label)||||||
1326373|NCT03252717||Single Group Assignment||Prevention||None (Open Label)||||||
1326374|NCT03252704|Randomized|Crossover Assignment||Basic Science||Double|Study products were concealed in opaque foil envelopes. The treatments were identified by alphanumeric code. The subjects and investigators did not know the identity of the treatments.||t||t|
1326375|NCT03252691|||Cohort||Prospective|||||||
1326376|NCT03252678|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1326377|NCT03252665|Randomized|Parallel Assignment||Treatment||Single||||||t
1326378|NCT03252652|||Other||Cross-Sectional|||||||
1326379|NCT03252639|||Cohort||Prospective|||||||
1326380|NCT03252626|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1326381|NCT03252613|||Cohort||Prospective|||||||
1326382|NCT03252600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326383|NCT03252587|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326384|NCT03252574|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1326385|NCT03252561|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1326386|NCT03252548|||Case-Only||Prospective|||||||
1326387|NCT03252535|Randomized|Parallel Assignment||Treatment||Triple|The study drugs will be provided in identical packages to maintain the study masking. Neither the Investigator nor the study team will know which drug the subject is receiving. In addition, the external outcome evaluator will receive the results in a codified manner (concealed).||t||t|t
1326388|NCT03252522|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo-controlled; randomization created by statistician, all involved in the study and assessment are blinded||t|t|t|t
1326389|NCT03252509||Single Group Assignment||Supportive Care||None (Open Label)||Pre a post interventional study, in patients with head and neck neoplasms, eligible for an outpatient procedure.||||
1326390|NCT03252496|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1326391|NCT03252483|Randomized|Parallel Assignment||Screening||Single|||t|||
1326392|NCT03252470|||Cohort||Prospective|||||||
1326393|NCT03252457|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1326394|NCT03252444|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1326395|NCT03252431|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1326396|NCT03252418|Randomized|Parallel Assignment||Treatment||Single|when measuring the gingival brightness and MAF of melanosomes|treating of gingival hyperpigmentation by two different methods||||t
1326397|NCT03252405|Randomized|Parallel Assignment||Prevention||Double|double blind||||t|t
1326398|NCT03252392|||Case-Control||Cross-Sectional|||||||
1326450|NCT03251716||Single Group Assignment||Treatment||None (Open Label)||||||
1326451|NCT03251703|||Other||Retrospective|||||||
1326452|NCT03251690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326399|NCT03252379|Randomized|Parallel Assignment||Treatment||Single||"Patients will be randomized into three groups according to the surgical procedure performed as follows:~Group A: Patients undergoing modified hepaticojejunostomy with gastric access loop~Group B: Patients undergoing modified hepaticojejunostomy with subcutaneous access loop~Group C: Patients undergoing standard hepaticojejunostomy with no endoscopic access loop"|t|||
1326400|NCT03252366|Randomized|Parallel Assignment||Treatment||Single||||||t
1326401|NCT03252353|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1326402|NCT03252340|||Case-Only||Other|||||||
1326403|NCT03252327|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1326404|NCT03252314|||Cohort||Prospective|||||||
1326405|NCT03252301|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1326406|NCT03252288|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||A random event (scheduled vaccination date for a child based on date of birth) will determine whether a women does not receive an intervention (before a certain calendar date) or receives an intervention (after a certain calendar date).||||
1326407|NCT03252275|Randomized|Parallel Assignment||Other||None (Open Label)||We will conduct a parallel comparison of intervention and control arms to measure study endpoints||||
1326408|NCT03252262|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1326409|NCT03252249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326410|NCT03252236|Randomized|Parallel Assignment||Treatment||Single||||||t
1326411|NCT03252223|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1326412|NCT03252210||Single Group Assignment||Other||None (Open Label)|Eventhough only one group of participants，different investigators perform two kinds of localization techniques.|Single group self-control study||||
1326413|NCT03252197|Randomized|Parallel Assignment||Treatment||Single|Blinded to study arm, Outcome assessor measured outcome variables based on recorded images.|||||t
1326414|NCT03252184|Randomized|Crossover Assignment||Treatment||Double||Individuals will be randomly assigned to: group 1 (energy dose of 2J), group 2 (energy dose of 4J), group 3 (energy dose of 6J), and group 4 (placebo). Group 4 intervention will be performed with the device switched off. Because it is a Randomized and Crossed Clinical Trial, all subjects will receive all energy doses, including placebo, to verify if vascular endothelial response is not only in response to the technique Assessment of vasodilation or to the contact of the laser with the individual's skin.|t|||t
1326415|NCT03252171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326416|NCT03252158|Randomized|Crossover Assignment||Basic Science||None (Open Label)||"An adapted multiple treatment reversal design will be used, in which the number of slots containing (i) less healthy items and (ii) healthier items are altered over eight 4-week periods.~Vending machines will be randomly allocated to one of two groups: (1) decreasing less healthy foods first or (2) decreasing healthier foods first."||||
1326417|NCT03252145|Randomized|Parallel Assignment||Treatment||Single||||||t
1326418|NCT03252132|Randomized|Parallel Assignment||Other||Double||International, randomized controlled training trial|||t|t
1326419|NCT03252119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326420|NCT03252106||Single Group Assignment||Treatment||None (Open Label)||||||
1326421|NCT03252093|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1326422|NCT03252080|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1326423|NCT03252067|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1326424|NCT03252054|||Cohort||Cross-Sectional|||||||
1326425|NCT03252041|||Cohort||Prospective|||||||
1326426|NCT03252028|||Cohort||Prospective|||||||
1326427|NCT03252015|Randomized|Sequential Assignment||Basic Science||Double|||t||t|
1326428|NCT03252002|Randomized|Parallel Assignment||Other||Single|||t|||
1326429|NCT03251989|||Cohort||Prospective|||||||
1326430|NCT03251976|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1326431|NCT03251963|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Participants enrolled in months 1-6 of the study will all receive a fixed dose of enoxaparin. Patients enrolled in months 7-12 of the study will all receive a variable dose of enoxaparin.||||
1326432|NCT03251950|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326433|NCT03251937||Single Group Assignment||Treatment||None (Open Label)||||||
1326434|NCT03251924|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326435|NCT03251911||Single Group Assignment||Treatment||None (Open Label)||||||
1326436|NCT03251898|||Cohort||Prospective|||||||
1326437|NCT03251885|||Cohort||Prospective|||||||
1326438|NCT03251872||Single Group Assignment||Treatment||None (Open Label)||The design is open-label. A 4-week pre-treatment phase will allow ensuring that patients are on stable doses of medication. Patients will be given progressive doses of olaparib up to 400mg BID for 16 weeks.||||
1326439|NCT03251859|Randomized|Parallel Assignment||Treatment||Single||||||t
1326440|NCT03251846||Single Group Assignment||Treatment||None (Open Label)||prospective, single-arm, single-subject clinical trial||||
1326441|NCT03251833|||Other||Cross-Sectional|||||||
1326442|NCT03251820|||Cohort||Prospective|||||||
1326443|NCT03251807|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1326444|NCT03251794|||Cohort||Prospective|||||||
1326445|NCT03251781||Single Group Assignment||Treatment||None (Open Label)||||||
1326446|NCT03251768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326447|NCT03251755|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-labelled, randomized, study||||
1326448|NCT03251742|Non-Randomized|Parallel Assignment||Other||None (Open Label)||This is a cross-sectional study designed to evaluate the immediate impact of negative pressure ventilation (NPV) in an ambulatory Fontan population using cardiovascular magnetic resonance imaging (CMR) for assessment of cardiovascular flows.||||
1326449|NCT03251729|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized trial of cerclage versus no cerclage in singleton pregnancies without prior spontaneous preterm birth and with a short transvaginal ultrasound cervical length||||
1326729|NCT03248089|||Other||Other|||||||
1326453|NCT03251677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326454|NCT03251664|||Case-Control||Cross-Sectional|||||||
1326455|NCT03251651|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1326456|NCT03251638|||Other||Prospective|||||||
1326457|NCT03251625|Randomized|Parallel Assignment||Treatment||Double|Participants divided into two groups by randomization software, consisting of 200 in each group.|a randomized, double-blind, placebo-controlled clinical trial|t||t|
1326458|NCT03251612||Single Group Assignment||Treatment||None (Open Label)||||||
1326459|NCT03251599|Randomized|Parallel Assignment||Other||Quadruple|"The randomization will be via enclosed envelope technique. The anesthetic management of the patient will be provided by an anesthesiologist other than the investigator. This anesthesiologist will not be blinded to the dose of the study drug, and will be responsible from the administration of the appropriate dose of the study drug.~The perfusionist, who is the main care provider during the rewarming period of the cardiopulmonary bypass, will be blinded to the dose of the study drug.~The investigator will be blinded, and will be responsible from the collection, and validation of the data."|Intervention type is drug dosage. Patients will be assigned to 2 arms, where they will receive different doses of the same drug. The study will end when both of the arms will have at least 48 patients each.|t|t|t|t
1326460|NCT03251586|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1326461|NCT03251573|||Cohort||Prospective|||||||
1326462|NCT03251560|Randomized|Parallel Assignment||Treatment||Double||half of the participants will receive Fuke Qianjin capsule, the other half participants will receive placebo|t||t|
1326463|NCT03251547|||Cohort||Retrospective|||||||
1326464|NCT03251534|||Cohort||Prospective|||||||
1326465|NCT03251521|||Case-Only||Retrospective|||||||
1326466|NCT03251508||Single Group Assignment||Treatment||None (Open Label)||||||
1326467|NCT03251495||Single Group Assignment||Prevention||None (Open Label)||||||
1326468|NCT03251482|Randomized|Parallel Assignment||Prevention||Double||Double Blinded|t||t|
1326469|NCT03251469|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1326470|NCT03251456|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326471|NCT03251443||Single Group Assignment||Treatment||None (Open Label)||||||
1326472|NCT03251430|||Cohort||Prospective|||||||
1326473|NCT03251417||Single Group Assignment||Treatment||None (Open Label)||||||
1326474|NCT03251404|Randomized|Parallel Assignment||Prevention||Single|Outcomes assessors (performance tests and neuromuscular function) blinded to group allocation|Two-armed cluster randomized parallel trial||||t
1326475|NCT03251391|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326476|NCT03251378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1326477|NCT03251365|Randomized|Parallel Assignment||Treatment||Double|"After explaining the treatment to develop once informed of the characteristics of pancreatic cancer to the patient, we will explain in detail the clinical trial that we are going to develop. After obtaining the informed consent, authors will start the randomly distribution of patients A list of randomization to 42 patients will be developed by a computer program that simulates the extraction procedure of numbered balls and the correlative allocation to each of the codes.~Randomization is by block, thereby ensuring a balanced number of subjects per treatment. Then a scrambling code in which randomly assigned treatment to each code will be developed.~The randomization code and study randomization list shall be kept only for the person that will carry the allocation of treatments.Randomization of patients will be performed centrally. Each patient is assigned to a sequential number of the centralized list of inclusion and appropriate treatment."|Characteristics of the Trial: This is a randomized,interventional, multidisciplinary study,phase II-III, involving several Services as General Surgery, Pathology, Oncology, Pharmacy, Gastroenterology and Radiology at the University General Hospital of Ciudad Real and the Faculty of Medicine, and Translational Research Unit,HGUCR.The study is opened to the incorporation of other centers that increase the power of the obtained results.|t||t|
1326478|NCT03251352|||Cohort||Prospective|||||||
1326479|NCT03251339|Randomized|Parallel Assignment||Other||Double|||t||t|
1326480|NCT03251326|Randomized|Crossover Assignment||Basic Science||Double||All patients will contribute to each of 4 drug conditions (placebo, nabilone, smoked cannabis, and propranolol).|t||t|
1326481|NCT03251313|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326482|NCT03251300|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326483|NCT03251287|Randomized|Crossover Assignment||Other||Quadruple|This will be a double blind study. The placebo and active treatments will appear identical and will be dispensed in identical containers. All trial patients, care providers, outcome assessors and data analysts will remain blind throughout the study.|This is a placebo-controlled, random-order mechanistic study of oral inorganic sodium nitrate versus placebo in cross-over fashion in patients with non obstructive hypertrophic cardiomyopathy and exercise limitation.|t|t|t|t
1326484|NCT03251274|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||machine bathing group traditional bathing group||||
1326485|NCT03251261|||Cohort||Prospective|||||||
1326486|NCT03251248|Randomized|Crossover Assignment||Other||Double|||t||t|
1326487|NCT03251235|Randomized|Parallel Assignment||Basic Science||Single|The care provider is not aware of whether a patient is allocated to the treatment group or the waiting group.|||t||
1326488|NCT03251222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326489|NCT03251209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326490|NCT03251196|||Cohort||Prospective|||||||
1326491|NCT03251183|||Cohort||Prospective|||||||
1326492|NCT03251170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326493|NCT03251157|||Other||Cross-Sectional|||||||
1326494|NCT03251144||Single Group Assignment||Basic Science||None (Open Label)||||||
1326495|NCT03251131|Randomized|Parallel Assignment||Treatment||Single||||||t
1326496|NCT03251118|||Cohort||Other|||||||
1326497|NCT03251105|Randomized|Parallel Assignment||Treatment||None (Open Label)||Infants, who were scheduled to undergo lower abdominal surgery and to receive anaesthesia||||
1326498|NCT03251092|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1326499|NCT03251079||||||||||||
1326500|NCT03251066||Single Group Assignment||Treatment||None (Open Label)||"Every participant of the study will specify at the beginning of the investigation his subjective starting situation concerning the nasal discomfort.The participant records his/ her personal impression on the change of severity of the general symptoms or selected individual symptoms of unspecific nasal discomfort following the single administration of Proponent Nasal Spray. Every Patient serves as his own control."||||
1326501|NCT03251053|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1326502|NCT03251040||Single Group Assignment||Prevention||None (Open Label)||Pilot study||||
1326503|NCT03251027||Single Group Assignment||Treatment||None (Open Label)||||||
1326504|NCT03251014|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1326505|NCT03251001|Randomized|Parallel Assignment||Treatment||Single|All clinical parameters were evaluated by a calibrated examiner (intraclass correlation coefficient = 0.98) blind to test and control groups.|Split-mouth design. One side of mouth was test group, other side was control group.||||t
1326506|NCT03250988|||Cohort||Cross-Sectional|||||||
1326507|NCT03250975||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326508|NCT03250962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326509|NCT03250949|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1326510|NCT03250936|||Cohort||Prospective|||||||
1326511|NCT03250923||Single Group Assignment||Treatment||None (Open Label)||||||
1326512|NCT03250910|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326513|NCT03250897|||Cohort||Prospective|||||||
1326514|NCT03250884|||Cohort||Prospective|||||||
1326515|NCT03250871|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1326516|NCT03250858|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326517|NCT03250845|||Cohort||Prospective|||||||
1326518|NCT03250832|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326519|NCT03250819|||Cohort||Other|||||||
1326520|NCT03250806|||Cohort||Prospective|||||||
1326521|NCT03250793||Single Group Assignment||Other||None (Open Label)||||||
1326522|NCT03250780|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1326523|NCT03250767|||Case-Only||Prospective|||||||
1326524|NCT03250754|||Case-Control||Retrospective|||||||
1326525|NCT03250741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326526|NCT03250728|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1326527|NCT03250715|Randomized|Parallel Assignment||Treatment||Single||||||t
1326528|NCT03250702|||Cohort||Prospective|||||||
1326529|NCT03250689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326530|NCT03250676|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326531|NCT03250663|Randomized|Parallel Assignment||Health Services Research||Double|adherence data of the randomized subjects|All subjects will receive study medication. Groups will be randomized to receive online treatment response surveys.|t||t|
1326532|NCT03250650|Randomized|Parallel Assignment||Treatment||Single|All the questionnaires (OABV-8, King´s Health, Anamnesis), Function Avaliation of Pelvic Floor Muscles, before and after treatment will be conduced by other person who is not the responsable for the research.|Group 1: will be treated receiving Transcutaneous Tibial Electric Stimulation Group 2: will be treated receiving TTNS and Transvaginal Electric Stimulation||||t
1326533|NCT03250637|||Other||Prospective|||||||
1326534|NCT03250624|Randomized|Parallel Assignment||Other||Single|||||t|
1326535|NCT03250611||Single Group Assignment||Treatment||None (Open Label)||||||
1326536|NCT03250598|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1326537|NCT03250585|||Case-Only||Prospective|||||||
1326538|NCT03250572|||Case-Control||Prospective|||||||
1326539|NCT03250559|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326540|NCT03250546|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized prospective Phase II Clinical Trial||||
1326541|NCT03250533|Randomized|Parallel Assignment||Treatment||Double||"Volunteers will also be randomized between groups:~LED treatment group 620 nm (G-LED 620; n = 13)~Treatment group with LED 940 nm (G-LED 940; n = 13)~Treatment group with fixed diphasic current (G-DF; n = 13)~Control group (G-C; n = 13)"|||t|t
1326542|NCT03250520|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1326543|NCT03250507|Randomized|Parallel Assignment||Treatment||Quadruple|The patient, surgical team, nursing team, anesthesia team, and outcomes assessor will be blinded to the group assignment. The anesthetist performing the TAP block will not be blinded to the group assignment.|Patients will be randomized to one of three study groups.|t|t|t|t
1326544|NCT03250494|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1326545|NCT03250481|Randomized|Parallel Assignment||Treatment||Single||||t||
1326546|NCT03250468|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1326547|NCT03250455|||Cohort||Prospective|||||||
1326548|NCT03250442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326549|NCT03250429|||Cohort||Prospective|||||||
1326550|NCT03250416|||Case-Only||Prospective|||||||
1326551|NCT03250403|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1326552|NCT03250390|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1326553|NCT03250377||Single Group Assignment||Treatment||None (Open Label)||||||
1326554|NCT03250364|Randomized|Parallel Assignment||Treatment||Double||5 goups: Multilayer bandage group; Double compression bandage group; Cohesive bandage group; Adhesive compression bandage group; Kinesiotaping bandage group|||t|t
1326555|NCT03250351|Randomized|Parallel Assignment||Treatment||Triple|As masking techniques, the people responsible for randomization of intervention in each group, the evaluation of subjects and data collection, the analysis of data will be independent. Participants are also masked, since we think they are unable to distinguish between NDG and CG interventions.|Two groups: Experimental group & Control grup|t||t|t
1326556|NCT03250338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326557|NCT03250325||Sequential Assignment||Treatment||None (Open Label)||||||
1326558|NCT03250312|Randomized|Parallel Assignment||Basic Science||Single|The investigators who determine the expression profile of the 60 immune cell biomarkers would not know which group does each sample belong to|Participants will be randomly assigned into two groups, control or OMT using a random number generator. Males and females will be randomized separately to ensure equal distribution into the two study groups.|||t|
1326559|NCT03250299|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Dose Escalation study Starting dose, 8mg with 3 escalations 15,20, 25mg.||||
1326560|NCT03250286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326561|NCT03250273|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326562|NCT03250260|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomised Controlled Trial||||
1326563|NCT03250247|Randomized|Parallel Assignment||Treatment||Single|"Clinical assessments for PTS will be obtained at baseline (pre-randomization) and at the 6, 12, 18 and 24-month follow-up visits. Examining clinicians will complete PTS training to ensure accuracy across all Clinical Centers. The examiners for PTS must be blinded to the subjects' treatment allocation. Subjects will be reminded not reveal to clinic staff which therapy they received (EVT or No-EVT). Subjects should be examined in the afternoon (the later the better) to allow the symptoms and signs of PTS to manifest. The assessment is performed as follows:~The subject should be asked to rate the 5 symptoms on the Villalta PTS scale for each leg, record his/her ratings on the CRF.~The subject's legs should be unclothed and he/she should be seated facing the blinded clinician (nurse or physician).The 5 signs of PTS and VCSS measures will be recorded by the blinded clinician. Leg ulcers (if present) will be assessed and measured."|This is an NIH-funded, Phase III, multicenter, randomized, open-label, assessor-blinded, parallel two-arm, controlled clinical trial.||||t
1326564|NCT03250234|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1326565|NCT03250221|||Cohort||Retrospective|||||||
1326566|NCT03250208|Randomized|Parallel Assignment||Basic Science||Quadruple|All participants and research team members are masked in this randomized placebo-controlled trial. The investigational pharmacist is unmasked.|Participants are randomized to receive placebo or a probiotic using a 1:2 allocation, respectively|t|t|t|t
1326567|NCT03250195||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326568|NCT03250182||Single Group Assignment||Treatment||None (Open Label)||||||
1326569|NCT03250169|||Cohort||Prospective|||||||
1326570|NCT03250156|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||"We aim to recruit three groups. Two groups will receive mindfulness training (MBAT) but will differ in their level of duty day support to engage in daily assigned mindfulness exercises. The Proctored group (n = 45) will receive mindfulness training and complete assigned exercises during the duty day, integrated into their daily physical training. The Non-Proctored group (n = 45) will receive identical mindfulness training, but complete their assigned exercises on their own time. These participants will not receive additional duty day support for their practice. A third group will receive no training and serve as a control group (No-Training Control, n = 45).~The design relies on group randomization at the level of individual platoons. This is due to the military requirement that organic unit structure is maintained during testing and course session scheduling. The number of participants is based on prior research (Jha et al., 2017)."||||
1326571|NCT03250143|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized prospective study||||
1326572|NCT03250130||Single Group Assignment||Prevention||None (Open Label)||||||
1326573|NCT03250117|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1326574|NCT03250104|||Cohort||Prospective|||||||
1326575|NCT03250091|||Cohort||Prospective|||||||
1326576|NCT03250078|||Cohort||Prospective|||||||
1326577|NCT03250065||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326578|NCT03250052|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1326579|NCT03250039|Non-Randomized|Crossover Assignment||Other||None (Open Label)||This study will be an open label, non randomized, 2 period, fixed sequence, single dose study to characterize the absorption, metabolism and excretion of 14C- PF-04965842 and to evaluate the absolute oral bioavailability (F) and fraction absorbed (Fa) of PF-04965842 following oral administration of unlabeled PF-04965842 and IV and oral administration of 14C-PF-04965842 to healthy male subjects.||||
1326580|NCT03250026|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pragmatic randomised controlled trial; randomisation on primary care centre level||||
1326581|NCT03250013|||Cohort||Prospective|||||||
1326582|NCT03250000|||Cohort||Prospective|||||||
1326583|NCT03249987|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1326584|NCT03249974|||Case-Only||Prospective|||||||
1326585|NCT03249961|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1326586|NCT03249948|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a cluster randomized study, with cluster units defined by EMS agency. Each cluster will crossover at three times during the one year trial so that each agency will spend 4 months in each arm of the study.||||
1326587|NCT03249935||Single Group Assignment||Treatment||None (Open Label)||||||
1326588|NCT03249922|||Case-Only||Prospective|||||||
1326589|NCT03249909||Single Group Assignment||Treatment||None (Open Label)|Open Label|"The first eligible 50 subjects will be assigned by the investigator to Exufiber Ag+, Subjects 51 to 65 will be assigned to Exufiber, Subjects 66 to 85 will be assigned to Aquacel Ag Extra.~The statistical analysis of the groups treated with Exufiber Ag +, Exufiber or Aquacel Ag Extra will be analysed separately with the same statistical methods."||||
1326590|NCT03249896|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a prospective, randomised, controlled, parallel-group, single centre study. Study subjects will be randomised into either the intervention or the control arm in a 1:1 ratio. The randomisation will be stratified by ethnicity (Chinese or non-Chinese) and pre-pregnancy BMI (BMI of <25kg/m2 or ≥25kg/m2), and will be performed using computer-generated randomisation.||||
1326591|NCT03249883|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t||t
1326592|NCT03249870||Single Group Assignment||Treatment||None (Open Label)||||||
1326593|NCT03249857|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1326594|NCT03249844|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor don't know patient treatment|||||t
1326595|NCT03249831||Single Group Assignment||Treatment||None (Open Label)||||||
1326596|NCT03249818||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1326597|NCT03249805|Randomized|Parallel Assignment||Treatment||Single||This will be a hospital-based study with single blinding of the investigator. Subjects will be randomized in order to prevent systematic differences between the groups to prevent bias. Our groups will be parallel, there will be no crossover. The two parallel groups will use two different versions of FABs; the Steenbeek Foot Abduction Brace (SFAB) and the MiracleFeet Foot Abduction Brace (mFAB). Both types of FAB will be equipped with discretely hidden sensors; subjects and their families will not be aware of the actual function of the sensor to avoid increased compliance due to the sensor. Due to practical constraints (the brace being visibly identifiable), the study will not be blind. This study will use number of recurrences in the two groups as the primary outcome of interest. Recurrence will be checked for at each scheduled follow-up visit (see schedule below) and recorded in event of occurrence. A process of rolling recruitment will be used until our groups are complete.|||t|
1326598|NCT03249792|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326599|NCT03249779||Single Group Assignment||Treatment||None (Open Label)||||||
1326600|NCT03249766|||Cohort||Prospective|||||||
1326601|NCT03249753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326602|NCT03249740|Randomized|Parallel Assignment||Treatment||Triple|Masking is relevant to Phase 2 only|Phase 1: open-label GB-102 dose cohorts are initiated sequentially Phase 2: assignment to and initiation of cohorts occur in parallel|t|t||t
1326603|NCT03249727||Single Group Assignment||Screening||Single|Endoscopist will not be provided the results of either the FIT or NK Vue tests performed as part of the trial; biochemist will not be provided the results of the colonoscopy|All subjects will have a FIT (OC FIT-CHEK, Polymedco) and NK Vue test prior to colonoscopy||||t
1326604|NCT03249714||Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326605|NCT03249701|Randomized|Parallel Assignment||Prevention||Quadruple|The intervention administered randomly to the participants. The participants, care providers, investigator, outcomes assessor done their job, separately. The blind will be controlled by a assigned investigator.|The participants divided into 3 groups randomized, one group receive transcutaneous electrical acupoint stimulation, one group receive electroacupuncture, the third group only connect to acupoints without stimulation.|t|t|t|t
1326606|NCT03249688|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1326607|NCT03249675|||Cohort||Prospective|||||||
1326608|NCT03249662|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1326609|NCT03249649|||Ecologic or Community||Cross-Sectional|||||||
1326610|NCT03249636|||Cohort||Prospective|||||||
1326611|NCT03249623|Randomized|Sequential Assignment||Treatment||Single||After randomisation, for patients randomised in the Beacon group, the Beacon system will actively advice clinicians on ventilatory settings to adapt the ventilator to patient's individual clinical situation and corresponding clinical intervention.|t|||
1326612|NCT03249610|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326613|NCT03249597|||Cohort||Prospective|||||||
1326614|NCT03249584||Single Group Assignment||Treatment||None (Open Label)||Enrollment/Baseline visit, OsteoCool procedure visit and 5 post-procedure visits (3 days, 1 week, 1-, 3-, and 6-month clinic visits) and a final post-procedure study visit (12 months) for a total of 8 study related visits.||||
1326615|NCT03249571|Randomized|Parallel Assignment||Treatment||Double|Flavonoid or placebo in capsules|Randomized, parallel group design|t||t|
1326616|NCT03249558|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1326617|NCT03249545|||Cohort||Prospective|||||||
1326618|NCT03249532|Randomized|Crossover Assignment||Treatment||Single|treatment period will not be available to the assessors of secondary outcomes.|prospective, cross over, randomized order||||t
1326619|NCT03249519||Single Group Assignment||Treatment||None (Open Label)||||||
1326620|NCT03249506|||Cohort||Retrospective|||||||
1326621|NCT03249493|||Cohort||Prospective|||||||
1326622|NCT03249480||Single Group Assignment||Treatment||None (Open Label)||||||
1326623|NCT03249467|||Case-Only||Prospective|||||||
1326624|NCT03249454|Randomized|Crossover Assignment||Treatment||Triple||Crossover design with 3 arms: Anodal tsDCS, Cathodal tsDCS, Sham tsDCS|t||t|t
1326625|NCT03249441|Randomized|Parallel Assignment||Treatment||Single|Clients are randomly assigned to one of two groups, Treatment as Usual (TAU) or Compassion-focused therapy plus Treatment as Usual (CFT). The outcomes assessor is blind to which of the two groups participants are assigned to.|This study utilised a randomised controlled trial (RCT) research design to investigate the efficacy of a group based CFT intervention programme. Participants were randomly allocated to one of the two groups, CFT plus Treatment as Usual (CFT) or Treatment As Usual (TAU), and psychological measures were administered at three time points (pre-intervention, post-intervention and follow-up assessment at three months follow up). The primary outcomes included self-compassion, shame and self-criticism. Emotional eating and depressive symptoms were assessed as secondary outcomes.||||t
1326626|NCT03249428|Randomized|Crossover Assignment||Treatment||Double|Research staff analyzing the data and members of the data and safety monitoring committee will be blinded to the treatment. allotment.|3-yr multi-centre pragmatic Randomized Controlled Trial (RCT) to compare effectiveness of nicotine e-cigarettes (e-cigs) (with counseling) with peer-led PROMPT strategy (nicotine replacement therapy (NRT) and counseling) for tobacco dependence in the inner city population.|||t|t
1326627|NCT03249415|||Case-Control||Prospective|||||||
1326628|NCT03249402||Single Group Assignment||Other||None (Open Label)||||||
1326629|NCT03249389||Single Group Assignment||Prevention||None (Open Label)||||||
1326630|NCT03249376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326631|NCT03249363|Randomized|Parallel Assignment||Prevention||Single|||t|||
1326632|NCT03249350|Randomized|Parallel Assignment||Treatment||Single||||||t
1326633|NCT03249337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326634|NCT03249324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326635|NCT03249311|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1326730|NCT03248076|||Case-Only||Prospective|||||||
1326731|NCT03248063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326636|NCT03249298|Randomized|Parallel Assignment||Treatment||None (Open Label)||one group will get crystalloids and one grou will get colloids for fluid optimisation||||
1326637|NCT03249285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326638|NCT03249272|Randomized|Parallel Assignment||Basic Science||Single|The reader of the CMR scan will be blinded to the stress agent used.|Participants undergoing cardiovascular magnetic resonance stress testing will be recruited and randomized to receive either regadenoson or adenosine.||||t
1326639|NCT03249259|Randomized|Parallel Assignment||Treatment||Double|double blind placebo controlled study.||t||t|
1326640|NCT03249246|||Cohort||Cross-Sectional|||||||
1326641|NCT03249233|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326642|NCT03249220||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1326643|NCT03249207|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326644|NCT03249194||Single Group Assignment||Treatment||None (Open Label)||||||
1326645|NCT03249181|Randomized|Parallel Assignment||Treatment||None (Open Label)||An open-label, multi-centre randomised controlled trial||||
1326646|NCT03249168|Randomized|Parallel Assignment||Prevention||Double|double-blind|||t||t
1326647|NCT03249155|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1326648|NCT03249142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326649|NCT03249129|||Cohort||Prospective|||||||
1326650|NCT03249116|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1326651|NCT03249103|Non-Randomized|Parallel Assignment||Treatment||Single||All subjects will receive NYX-2925 Low Dose, NYX-2925 High Dose, and placebo PO QD for 2 week treatment periods, then go into Follow-up for 1 week.|t|||
1326652|NCT03249090|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1326653|NCT03249077|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1326654|NCT03249064|||Case-Control||Prospective|||||||
1326655|NCT03249051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326656|NCT03249038|||Cohort||Prospective|||||||
1326657|NCT03249025||Single Group Assignment||Treatment||None (Open Label)||||||
1326658|NCT03249012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326659|NCT03248999||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326660|NCT03248986|||Cohort||Prospective|||||||
1326661|NCT03248973|||Case-Only||Retrospective|||||||
1326662|NCT03248960||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326663|NCT03248947||Single Group Assignment||Treatment||None (Open Label)||||||
1326664|NCT03248934|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1326665|NCT03248921|||Cohort||Prospective|||||||
1326666|NCT03248908|Randomized|Parallel Assignment||Treatment||Triple|The patient, the performer of the pupillary reflex measurement, and the postoperative health care provider are masked for the study arms.|Double blinded randomized controlled trial|t|t||t
1326667|NCT03248895|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"A randomised intervention trial will be used. Participants will be randomised to either an immediate (I-med) or a delayed (D-med) intervention. Randomisation will be restricted based on two factors including age and patient gender.~Both subject groups will receive standard-of-practice asthma education and management in the Asthma Clinic prior to study enrolment. Participants allocated to the I-med group will take part in the mobile technology DOT intervention for the first 6 weeks. Outcomes will be evaluated at the start (week 0) and end of the 6 week intervention period and during clinic visits at weeks 12 and 18 for follow-up. Those participants allocated to the D-med group will have the DOT intervention started after a 6 week intervention-free interval with usual Asthma Clinic care."||||
1326668|NCT03248882|Randomized|Parallel Assignment||Treatment||Double|Double-Blind|C1171002 is a randomized, double blind, placebo controlled, 5 arm (placebo, plus 4 active doses of PF 05221304), parallel group study.|t||t|
1326669|NCT03248869|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||"A/B testing is a randomized statistical experiment with intervention and control study arms, A and B. New users, as of December 2015, will be stratified and randomized to different daily survey formats in order to test differences in daily survey participation rates. Since this was a mobile app based study, a first of its kind - which was available in the App store, it was possible to recruit widely in large numbers. Therefore, even though this was a feasibility study, the sample size was large."||||
1326670|NCT03248856|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1326671|NCT03248843||Single Group Assignment||Treatment||None (Open Label)||Cohorts of 3-6 subjects will be enrolled sequentially at escalating doses of 1.0, 2.5, 5.0 and 10 mg/kg of KN035 weekly.||||
1326672|NCT03248830|||Cohort||Prospective|||||||
1326673|NCT03248817|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1326674|NCT03248804|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects are assigned either to the soy group or the non-soy group.||||
1326675|NCT03248791|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1326676|NCT03248778|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The investigators will assess feasibility and acceptability and get a broad sense of the initial efficacy of the intervention with a two-arm RCT implemented with 10 HIV+ mothers: 5 will be randomly assigned to the disclosure-support counseling intervention and 5 to a treatment-as-usual (TAU) condition.||||
1326677|NCT03248765|||Case-Control||Prospective|||||||
1326678|NCT03248752|Randomized|Parallel Assignment||Other||Single||||||t
1326679|NCT03248739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326680|NCT03248726|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1326681|NCT03248713|Randomized|Crossover Assignment||Health Services Research||Double|This is a double blind randomized study|The primary analyses will use linear mixed models (LMMs). LMMs can handle continuous and dichotomous outcomes, as well as missing data. Analyses will include baseline (pre-treatment) measures of these variables as covariates and other baseline variables where appropriate.|t||t|
1326682|NCT03248700||Single Group Assignment||Basic Science||None (Open Label)||||||
1326732|NCT03248050|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1326683|NCT03248687|Randomized|Parallel Assignment||Health Services Research||Single|The outcomes assessor will not know if the patient was followed at home or by a primary care provider.|Enrolled patients will be randomized to one of two follow up arms||||t
1326684|NCT03248674|||Cohort||Prospective|||||||
1326685|NCT03248661|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1326686|NCT03248648|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)||t|t|t|t
1326687|NCT03248635|||Other||Cross-Sectional|||||||
1326688|NCT03248622|||Case-Only||Retrospective|||||||
1326689|NCT03248609|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1326690|NCT03248596|||Case-Only||Prospective|||||||
1326691|NCT03248583|Randomized|Parallel Assignment||Prevention||Single|||t|||
1326692|NCT03248570|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"After determination of DNA damage repair status, subjects will be assigned to one of two treatment groups:~Group 1 (DNA damage repair proficient group): Twenty-five subjects~Group 2 (DNA damage repair deficient group): Twenty-five subjects~All subjects will receive pembrolizumab 200mg IV every 3 weeks until disease progression or unacceptable toxicity."||||
1326693|NCT03248557|||Cohort||Other|||||||
1326694|NCT03248544|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1326695|NCT03248531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326696|NCT03248518|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1326697|NCT03248505|Randomized|Parallel Assignment||Treatment||None (Open Label)||3x6||||
1326698|NCT03248492|Randomized|Sequential Assignment||Treatment||None (Open Label)|In Part 1, about 60 T-DM1 resistant/refractory patients initially will be randomized into three treatment groups (low, medium and high doses) for Pharmacokinetics (PK), then about another 60 will be randomized into low and high doses to determine recommended dose (RD). After that, about 100 will receive the recommended dose in an open-label continuation stage (Part 2). About 10 TDM-1 intolerant patients will join the continuation stage as an exploratory only arm.|HER2-positive patients will be classified into two groups: T-DM1 resistant/refractory (experimental) and T-DM1 intolerant (exploratory only).||||
1326699|NCT03248479|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326700|NCT03248466|Non-Randomized|Parallel Assignment||Treatment||Single||diabetic foot ulcer which Wagner classification at 2-3 grade.||||t
1326701|NCT03248453|Randomized|Parallel Assignment||Other||Single|||t|||
1326702|NCT03248440|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326703|NCT03248427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326704|NCT03248414|Randomized|Parallel Assignment||Treatment||Double|Double blinded||t||t|
1326705|NCT03248401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326706|NCT03248388||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1326707|NCT03248375||Single Group Assignment||Treatment||None (Open Label)||Individuals with the targeted medical condition is given the experimental therapy and then followed over time to observe their response.||||
1326708|NCT03248362|Randomized|Parallel Assignment||Treatment||Triple|Participants & primary researchers will be blinded to group allocation|A pragmatic, multicentre, placebo controlled randomised parallel group trial|t||t|t
1326709|NCT03248349|||Cohort||Prospective|||||||
1326710|NCT03248336||Single Group Assignment||Treatment||None (Open Label)||Eligible participants received 12 weeks of office vergence/accommodative therapy||||
1326711|NCT03248323|||Case-Only||Prospective|||||||
1326712|NCT03248310|||Case-Control||Prospective|||||||
1326713|NCT03248297|Randomized|Parallel Assignment||Prevention||Quadruple||Randomized Controlled Trial|t|t|t|t
1326714|NCT03248284|||Cohort||Prospective|||||||
1326715|NCT03248271|||Cohort||Prospective|||||||
1326716|NCT03248258|||Other||Prospective|||||||
1326717|NCT03248245|Randomized|Single Group Assignment||Treatment||Single|While the school owners, school leaders, teachers and collaborators are aware of whether their respective school have been randomized to experimental or control group, the pupils are masked for this information. They are aware that the schools participate in an intervention related to interprofessional team collaboration, but they do not know whether their school have been randomized to experimental or control group.|"Cluster-randomized study. After baseline, schools will be randomized to experimental and control groups schools. The LOG-model is implemented in experimental schools, while control group schools continues with their ordinary practices (treatment as usual). Effects on teachers are analyzed on the follow up areas: interprofessional team collaboration, teachers working hours, teacher's self-efficacy. Effects on pupils are analyzed on the follow up areas: learning environment- and outcome, early intervention. Effects on school level are analyzed on the follow up areas: special needs education, pupils learning outcome."|t|||
1326718|NCT03248232|||Cohort||Prospective|||||||
1326719|NCT03248219|||Case-Only||Prospective|||||||
1326720|NCT03248206|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1326721|NCT03248193|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||"This study will consist of two parts:~A) Healthy subjects: To assess safety and tolerability of scalp and limb hypothermia, as well as to determine the optimal temperature and pressure to be used. Establishing the occurrence or lack of core hypothermia will be studied.~B) Cancer patients: Once the optimal temperature and pressure of scalp and limb hypothermia is established in healthy patients, a group of cancer patients will undergo concomitant scalp and limb hypothermia over multiple cycles of chemotherapy to establish safety and tolerability of repeated therapy."||||
1326722|NCT03248180|||Case-Control||Prospective|||||||
1326723|NCT03248167|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326724|NCT03248154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326725|NCT03248141|||Cohort||Other|||||||
1326726|NCT03248128|Randomized|Parallel Assignment||Treatment||Double|This will be a double blind study. Subjects and investigator will be masked.|Subjects will be randomized to receive FDC of FF/VI inhalation powder compared to FF inhalation powder, once daily in cohort A and cohort B.|t||t|
1326727|NCT03248115||Single Group Assignment||Basic Science||None (Open Label)||||||
1326728|NCT03248102||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326733|NCT03248037|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1326734|NCT03248024|||Cohort||Retrospective|||||||
1326735|NCT03248011|Randomized|Parallel Assignment||Prevention||Single|Group assignment will be masked to investigator.|This is a prospective, randomized, repeated measures single- blind clinical trial.|||t|
1326736|NCT03247998|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor who will analyze the outcome variables for this study (consciousness, motor function, sensation, speech, coordination, standard of care follow up assessments etc.) that may be impacted by choice of anesthesia/analgesia will be blinded to the treatment group of the participants to ensure unbiased reporting.|There will be two arms of this study. In the first arm, the patients who meet the inclusion criteria of the study will be randomized to receive general anesthesia during endovascular treatment for stroke. In the second arm of the study, patients will receive general sedation during endovascular treatment.||||t
1326737|NCT03247985|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326738|NCT03247972|||Case-Only||Prospective|||||||
1326739|NCT03247959|Randomized|Parallel Assignment||Treatment||Single||||||t
1326740|NCT03247946|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||3 month old infants were recruited from 2 Mother-Child-Health clinics and followed for 12 months. Mothers from intervention group were instructed to feed their babies (88 infants) with their head in upright position. Mothers from control group (75 infants) fed their infant regularly without any instructions . Respiratory and ear morbidity were evaluated during the following 12 month period.||||
1326741|NCT03247933|Randomized|Parallel Assignment||Treatment||Single|Coded databases|||||t
1326742|NCT03247920|Randomized|Parallel Assignment||Treatment||Single||Multicenter prospective randomized controlled non-inferiority trial||||t
1326743|NCT03247907|Randomized|Crossover Assignment||Other||Single|||t|||
1326744|NCT03247894|||Cohort||Other|||||||
1326745|NCT03247881|Randomized|Crossover Assignment||Other||Double|||||t|t
1326746|NCT03247868||Sequential Assignment||Treatment||None (Open Label)||||||
1326747|NCT03247855||Single Group Assignment||Treatment||None (Open Label)||||||
1326748|NCT03247842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326749|NCT03247829|||Cohort||Prospective|||||||
1326750|NCT03247816|||Cohort||Cross-Sectional|||||||
1326751|NCT03247803|Randomized|Parallel Assignment||Treatment||Double|Each study subject will be blinded to the study device they receive; however, the anesthesia provider will not be blinded to the study device and will have access to all monitors deemed appropriate by the primary anesthesia team caring for the subject.|Adult patients presenting for a surgical or interventional procedure requiring general anesthesia and tracheal intubation, who do not meet any of the study exclusion criteria, and who give their informed consent, will be randomly allocated to receive either an air-Q SP or Williams Intubating Airway as a conduit to aid flexible bronchoscopic intubation.|t|||t
1326752|NCT03247790|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||Multi-center, open-label study with 2 study periods.||||
1326753|NCT03247777|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326754|NCT03247764|||Other||Prospective|||||||
1326755|NCT03247751||Single Group Assignment||Treatment||None (Open Label)||||||
1326756|NCT03247738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326757|NCT03247725|Randomized|Parallel Assignment||Treatment||None (Open Label)|Patients will be informed of the condition they have been assigned to.|Three conditions. Patients will be randomly assigned to one of the three conditions.||||
1326758|NCT03247712|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1326759|NCT03247699|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1326760|NCT03247686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326761|NCT03247673|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1326762|NCT03247660|Randomized|Parallel Assignment||Prevention||Double||3 groups: 2 experimental groups and 1 control group|||t|t
1326763|NCT03247647|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326764|NCT03247634||Single Group Assignment||Prevention||None (Open Label)||Interrupted Time Series - All cohorts will receive the Getting Ahead program||||
1326765|NCT03247621|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326766|NCT03247608||Single Group Assignment||Prevention||None (Open Label)||||||
1326767|NCT03247595|Randomized|Parallel Assignment||Screening||Single|The endoscopist who reports colon cleanliness is blinded to the subject's assignment.|One arm receives Polyethelyne Glycol colonoscopy preparation and the other arm receives magnesium citrate capsules colonoscopy preparation.|||t|
1326768|NCT03247582|||Cohort||Prospective|||||||
1326769|NCT03247569|||Cohort||Prospective|||||||
1326770|NCT03247556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326771|NCT03247543|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind||t|t|t|t
1326772|NCT03247530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326773|NCT03247517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326774|NCT03247504|||Cohort||Cross-Sectional|||||||
1326775|NCT03247491|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1326776|NCT03247478|||Cohort||Prospective|||||||
1326777|NCT03247465|Non-Randomized|Parallel Assignment||Other||None (Open Label)||The 20 first included patients will be control group, the 20 following patients will be the fusion group.||||
1326778|NCT03247452|Randomized|Parallel Assignment||Other||Single|Only the endoscopists in charged of rating cleansing quality during colonoscopy will be masked.||||t|
1326779|NCT03247439||Single Group Assignment||Treatment||None (Open Label)||||||
1326780|NCT03247426|||Cohort||Prospective|||||||
1326781|NCT03247413|Randomized|Parallel Assignment||Prevention||Triple|The patient, care providers, and principle investigator will be blinded.|Each patient serves as his or her own control. Investigators are recruiting patients who are undergoing bilateral procedures. Each patient will receive dexamethasone at each lesion site post-ablation on one side, and placebo (saline) on the other.|t|t|t|
1326782|NCT03247400|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326783|NCT03247387|||Case-Only||Prospective|||||||
1326784|NCT03247374|Randomized|Parallel Assignment||Treatment||None (Open Label)||simple randomization into two groups||||
1326785|NCT03247361|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1326786|NCT03247348|||Case-Only||Prospective|||||||
1326787|NCT03247335|||Other||Other|||||||
1326788|NCT03247322|Randomized|Parallel Assignment||Other||Single|In order to minimize bias, data for outcomes will be collected by a blinded study coordinator.|||||t
1326789|NCT03247309||Single Group Assignment||Treatment||None (Open Label)||||||
1326790|NCT03247296|||Cohort||Prospective|||||||
1326791|NCT03247283||Single Group Assignment||Health Services Research||None (Open Label)||||||
1326792|NCT03247270|Randomized|Parallel Assignment||Treatment||Double||RCT|t|||t
1326793|NCT03247257|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1326794|NCT03247244|Randomized|Crossover Assignment||Treatment||Triple|The participants, investigators and analysts will be masked as to the treatment arm and product of each participant and visit. Only the pharmacists will be aware of the strain.|There are four treatment schemes. All subjects will be randomized in a 1:1:1:1 ratio to one of the four treatment schemes. Participants will receive a single dose of each of the 3 cannabis products + placebo, with the order determine by their assigned treatment arm.|t||t|t
1326795|NCT03247231|||Cohort||Prospective|||||||
1326796|NCT03247218||Single Group Assignment||Treatment||None (Open Label)||a single center and open label study||||
1326797|NCT03247205||Single Group Assignment||Supportive Care||None (Open Label)||All participants will receive the intervention||||
1326798|NCT03247192|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1326799|NCT03247179|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomly assigned to either the experimental condition (PTSD Coach app usage), or the treatment as usual condition.||||
1326800|NCT03247166||Single Group Assignment||Treatment||None (Open Label)||||||
1326801|NCT03247153||Single Group Assignment||Basic Science||None (Open Label)||||||
1326802|NCT03247140|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1326803|NCT03247127||Single Group Assignment||Supportive Care||None (Open Label)||Hippocampal avoidance -whole brain radiotherapy(HA-WBRT), which delivers radiation to whole brain and moreover, to reduce mean dose to hippocampal neural stem-cell compartment to minimize the neurocognitive function impairment||||
1326804|NCT03247114|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1326805|NCT03247101|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1326806|NCT03247088|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1326807|NCT03247075|Randomized|Parallel Assignment||Treatment||Single||||||t
1326808|NCT03247062||Sequential Assignment||Other||None (Open Label)||Quality improvement project - before after design||||
1326809|NCT03247049|||Case-Only||Cross-Sectional|||||||
1326810|NCT03247036|||Cohort||Cross-Sectional|||||||
1326811|NCT03247023|||Case-Only||Prospective|||||||
1326812|NCT03247010|||Cohort||Prospective|||||||
1326813|NCT03246997|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Participants are enrolled in the study and randomly assigned to the immediate intervention or the delayed intervention group. Participants in the immediate intervention group will receive the intervention for 6 months with a 6-month and 12-month follow-up starting from day one of enrollment. Participants in the delayed intervention group will receive the intervention beginning 6 months after enrollment with a 6-month and 12-month follow-up starting from day one of enrollment.||||
1326814|NCT03246984||Single Group Assignment||Treatment||None (Open Label)||||||
1326815|NCT03246971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326816|NCT03246958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326817|NCT03246945|Randomized|Parallel Assignment||Diagnostic||Double|Dermatologist providing remote diagnosis was blinded to whether parents were provided instructions, which phone they took and the diagnosis provided by the in-person dermatologist|Patient/parent dyads visiting a pediatric dermatology clinic were invited to participate. After consent, patient/parent dyads were randomly assigned to photography instruction versus no instruction. In both arms, parents photographed their child's skin condition (via smart phone) and provided medical history. Images were uploaded securely to the child's electronic health record for independent diagnosis by a dermatologist not involved in the patient's care.||t|t|
1326818|NCT03246932|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will be blinded to the group assignments.|||||t
1326819|NCT03246919|Randomized|Parallel Assignment||Treatment||Triple|Double blind: Obstetricians, Anesthesiologists and patients will be blinded. Only nurses will be aware of timing of oxytocin administration||t|t|t|
1326820|NCT03246906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326821|NCT03246893|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1326822|NCT03246880|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1326823|NCT03246867|Randomized|Parallel Assignment||Treatment||Single|All of participants must have subacromial impingement syndrome with glenohumeral internal rotation deficit.|There are 3 groups. First group will receive isolytic stretching in modified cross body position. Second group will receive static stretching in modified cross body position. The stretching exercise will be applied five times each for 15 seconds. After each stretching there will be a resting period for 5 seconds. Control group will receive no stretching. They will be handed a brochure about the stretching techniques and its role in injury prevention. Isolytic and static stretching groups will be evaluated before and just after stretching exercise. Control group will be evaluated for the first time and then will be passively waited until the duration of the stretching exercise program (approximately 4-5 min). Afterwards, second evaluation will be performed.|t|||
1326824|NCT03246854||Single Group Assignment||Treatment||None (Open Label)||||||
1326825|NCT03246841||Single Group Assignment||Prevention||None (Open Label)||||||
1326826|NCT03246828||Single Group Assignment||Treatment||None (Open Label)||||||
1326827|NCT03246815|||Case-Control||Cross-Sectional|||||||
1326828|NCT03246802||Single Group Assignment||Treatment||None (Open Label)||High Dose Rate brachytherapy||||
1326907|NCT03245775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326829|NCT03246789|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Investigators will randomly assign four senior centers to offer either Engage-M (N=40), the treatment offered by REDS (1 individual and 8 weekly group sessions) or 8 group sessions Wellness in Mind and Body plus mental health referral (W-MH; N=20). Participants will have clinically significant depressive symptoms (PHQ-9>10) and will be older and middle-aged adults (55+). Clients will be identified by senior center staff trained in SMART-MH strategies. Investigators will offer additional training to staff of all centers on SMART-MH outreach, depression screening, and treatment engagement. Investigators will train and provide weekly supervision to 2 or more LCSWs per center of the two centers assigned to Engage-M. Investigators will not offer training or supervision to senior center staff leading the groups of W-MH but will provide oversight so that clients receive mental health referrals and are encouraged to attend weekly Wellness group meetings."||||
1326830|NCT03246776||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1326831|NCT03246763|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The investigators will conduct a mixed-methods study using focus groups and interviews to explore the facilitators and barriers to program implementation, and a time-series analysis to examine program engagement and individual health outcomes. This study design will be repeated at each of the four sites. Aim 1 will consent and enroll program providers to obtain qualitative feedback on program design and implementation; Aim 2 will collect de-identified program-level data on attendance and program components; Aim 3 will consent patients for individual-level baseline and outcomes data.Subjects will be enrolled at our community sites. A research assistant will conduct all the enrollment, consent, and data collection. Where needed, the investigators will report or obtain required IRB authorization agreements for each site, including Federal Wide Assurances, Data Transfer Agreements, or other documents as required by federal regulation.||||
1326832|NCT03246750||Single Group Assignment||Treatment||None (Open Label)||3+3 dose escaltion design||||
1326833|NCT03246737|||Cohort||Prospective|||||||
1326834|NCT03246724|Randomized|Parallel Assignment||Health Services Research||Triple|The subject and their entire medical team (including the anesthesiologist and surgeon) will all be masked to the subject's randomized intervention group. The randomization groups will be assigned by the statistician who will be unmasked. All medications will be provided to the medical team on the day of the procedure completely masked. The clinical research coordinator, the clinical research assistant, and the pharmacy will be unmasked to the intervention group. Any member of the medical team can be unmasked at any time after the intervention is administered in the case of an emergency resulting in a serious adverse event or an unanticipated problem.|"Interventions: triazolam oral sedation with sodium chloride 0.9% IV placebo or microcrystalline cellulose oral placebo with midazolam IV sedation~Subjects will be randomized (1:1) to one of the two study arms listed above. On the day of surgery, the subject, anesthesiologist/CRNA, and surgeon will be blinded to the treatment assignment. The anesthesiologist/CRNA or pre-operative nurses will administer the blinded oral medication approximately 30 minutes before the procedure beings. The anesthesiologist/CRNA will administer the blinded IV medication approximately 5 minutes before the procedure begins. At the completion of the procedure, the anesthesiologist/CRNA and the surgeon will complete a satisfaction survey. The subject will then return within 2 days for their first post-operative clinical visit and complete a satisfaction survey."|t|t|t|
1326835|NCT03246711|||Cohort||Prospective|||||||
1326836|NCT03246698|Randomized|Parallel Assignment||Treatment||Single|All of participants must have subacromial impingement syndrome with glenohumeral internal rotation deficit.|There are 3 groups. First group will receive isolytic stretching in modified cross body stretching position and standard physiotherapy program. Second group will receive static stretching in modified cross body stretching position and standard physiotherapy program. Control group will receive only standard physiotherapy program. In standard physiotherapy program, there are TENS, hotpack, posture and strengthening training program. Treatment program will last four weeks.|t|||
1326837|NCT03246685|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326838|NCT03246672||Single Group Assignment||Treatment||None (Open Label)||All participants receive the intervention||||
1326839|NCT03246659|Randomized|Sequential Assignment||Treatment||Single|||t|||
1326840|NCT03246646||Single Group Assignment||Other||None (Open Label)||The intervention will be 10-15, 30-45 min. telephone sessions, every 2-3 weeks, with a target number ~12 and will last between 4 and 6 months. The Coach will introduce the ideas behind the content of each VA-CRAFT website module with the CSO, give the CSO an opportunity to view and read the content, and then discuss and individualize/ personalize the content in the next telephone conversation. The VA-CRAFT course for substance misuse has 8 modules that follow the original CRAFT intervention: 1) Introduction to CRAFT, 2) Overview of CRAFT, 3) Getting Started with CRAFT: Safety Planning, 4) Understanding substance abuse, 5) How to respond to substance abuse, 6) How to rebuild your life together, 7) How to help someone consider treatment, 8) Wrapping up. The goals include understanding triggers and long-term reinforcement of substance misuse, ignoring unhealthy behaviors and rewarding healthy behaviors, getting support, and how to help the CSO caller help the Veteran enter treatment.||||
1326841|NCT03246633||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326842|NCT03246620|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1326843|NCT03246607|||Cohort||Prospective|||||||
1326844|NCT03246594|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326845|NCT03246581|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1326846|NCT03246568|Randomized|Parallel Assignment||Treatment||None (Open Label)||Research on the Basis of Earlier Theory Renal artery sympathetic denervation (RND) by catheter ablation has been shown in a preliminary study to improve outcome of electrical isolation of the pulmonary vein (PVI) in patients with paroxysmal and/or persistent AF with concomitant refractory hypertension and the same group later showed renal sympathetic denervation improved outcome of PVI in the cohort of paroxysmal and/or persistent AF patients with moderate hypertension. In patients with renal impairment, RND also conferred benefit in reducing AF recurrence after PVI.The initial indication for catheter-based RND is for blood pressure control in patients with resistant hypertension. Early data from clinical trials without sham controls was promising - demonstrating large blood pressure reductions in patients with treatment-resistant hypertension.||||
1326847|NCT03246555|Randomized|Parallel Assignment||Treatment||Triple||Parallel Assignment|t|t|t|
1326848|NCT03246542|||Cohort||Prospective|||||||
1327006|NCT03244488|||Case-Crossover||Cross-Sectional|||||||
1326849|NCT03246529|Randomized|Parallel Assignment||Treatment||Triple||subjects will be randomized using a 2:1 ratio to receive G-CSF + BL-8040 or G-CSF + Placebo, respectively. Randomization will use permuted blocks stratifying subjects by US geographical region (NorthEast, SouthEast, MidWest, SouthWest and NorthWest), remission status (CR vs. PR), and baseline platelet count (< 200 X 109/L or ≥ 200 X 109/L).|t|t|t|
1326850|NCT03246516||Single Group Assignment||Prevention||None (Open Label)||||||
1326851|NCT03246503||||||||||||
1326852|NCT03246490||Single Group Assignment||Other||None (Open Label)||||||
1326853|NCT03246477|||Cohort||Retrospective|||||||
1326854|NCT03246464|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized controled clinical interventional trial||||
1326855|NCT03246451|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1326856|NCT03246438|Randomized|Parallel Assignment||Screening||Single|||||t|
1326857|NCT03246425|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1326858|NCT03246412|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1326859|NCT03246399|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1326860|NCT03246386|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Comparing a 2 groups of obese subjects vs 1 group of non-obese subjects.||||
1326861|NCT03246373|||Cohort||Prospective|||||||
1326862|NCT03246360|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1326863|NCT03246347||Single Group Assignment||Treatment||None (Open Label)||||||
1326864|NCT03246334|||Cohort||Prospective|||||||
1326865|NCT03246321||Single Group Assignment||Treatment||None (Open Label)||||||
1326866|NCT03246308|||Other||Prospective|||||||
1326867|NCT03246295|||Cohort||Prospective|||||||
1326868|NCT03246282||Single Group Assignment||Supportive Care||None (Open Label)||||||
1326869|NCT03246269|||Cohort||Prospective|||||||
1326870|NCT03246256|||Other||Prospective|||||||
1326871|NCT03246243|||Cohort||Prospective|||||||
1326872|NCT03246230|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Newborn infants will have delayed immunization, with catch-up immunization at day of life 7 (DOL7), or immunization at birth with hepatitis B vaccine (HBV), Bacille Calmette-Guérin (BCG) or (HBV +BCG). All participants will have peripheral blood collected at birth (DOL0) and each group will be divided into sub-groups with follow-up peripheral blood collection at DOL1, DOL3, or DOL7.||||
1326873|NCT03246217|Randomized|Parallel Assignment||Treatment||Single||||||t
1326874|NCT03246204|||Cohort||Prospective|||||||
1326875|NCT03246191|||Other||Cross-Sectional|||||||
1326876|NCT03246178|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|no masking|Patients with SAA||||
1326877|NCT03246165|||Case-Control||Prospective|||||||
1326878|NCT03246152||Single Group Assignment||Treatment||None (Open Label)||||||
1326879|NCT03246139|Randomized|Parallel Assignment||Treatment||Single||||||t
1326880|NCT03246126||Single Group Assignment||Treatment||None (Open Label)||||||
1326881|NCT03246113||Single Group Assignment||Treatment||None (Open Label)||||||
1326882|NCT03246100|Randomized|Parallel Assignment||Health Services Research||Single||"Patients will be randomized within practices to one of 3 arms:~Standard of care control~Autodialer (3 reminders)- with brief education message + practice name + practice phone # (see autodialer scripts)~Mailed reminder (3 reminders)-- with brief education message + practice name + practice phone # (see postcards)"|t|||
1326883|NCT03246087|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1326884|NCT03246074||Single Group Assignment||Treatment||None (Open Label)||||||
1326885|NCT03246061|Randomized|Crossover Assignment||Treatment||None (Open Label)||RF Ablation arm vs Control arm||||
1326886|NCT03246048|||Cohort||Prospective|||||||
1326887|NCT03246035|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1326888|NCT03246022||Single Group Assignment||Treatment||None (Open Label)||||||
1326889|NCT03246009|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326890|NCT03245996||Single Group Assignment||Basic Science||Single||||||
1326891|NCT03245983||Single Group Assignment||Supportive Care||None (Open Label)||||||
1326892|NCT03245970|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomization to treatment or non treatment group||||
1326893|NCT03245957|||Case-Only||Prospective|||||||
1326894|NCT03245944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326895|NCT03245931|||Cohort||Prospective|||||||
1326896|NCT03245918|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1326897|NCT03245905||Single Group Assignment||Treatment||None (Open Label)||||||
1326898|NCT03245892||Single Group Assignment||Treatment||None (Open Label)||Single center, non-randomized, open label, pilot study to evaluate the safety and tolerability of neoadjuvant and post-surgical dose dense paclitaxel and carboplatin chemotherapy in combination with nivolumab for the treatment of advanced high grade serous cancers of ovarian, fallopian tube, or primary peritoneal origin.||||
1326899|NCT03245879|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1326900|NCT03245866|||Cohort||Prospective|||||||
1326901|NCT03245853||Single Group Assignment||Treatment||None (Open Label)||Subjects with a diagnosis of progressive keratoconus will be evaluated for suitability as a candidate for CXL. Subjects that are candidates for CXL will be asked to participate in this study and will undergo required screening testing. Informed consent will be obtained from each subject prior to study-oriented testing.||||
1326902|NCT03245840||Single Group Assignment||Treatment||None (Open Label)||||||
1326903|NCT03245827|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326904|NCT03245814|Non-Randomized|Parallel Assignment||Supportive Care||Single|Clinician Administered PTSD Scale for DSM-V (CAPS-5) assessments will be completed via telephone by a trained CAPS-5 rater who will be masked to the intervention and treatment arm of each participant.|||||t
1326905|NCT03245801|||Cohort||Prospective|||||||
1326906|NCT03245788|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|No masking occurs.|There will be six groups in each arm which reflects the six different cancer types.||||
1326908|NCT03245762|Randomized|Parallel Assignment||Basic Science||Double|This will be a double-blinded study, as no studies to date have compared this treatment in infants with placebo. Board-certified speech and language pathologist who will be blinded to the treatment arm of each patient.|||t||t
1326909|NCT03245749|||Cohort||Cross-Sectional|||||||
1326910|NCT03245736||Single Group Assignment||Treatment||None (Open Label)||||||
1326911|NCT03245723|||Cohort||Cross-Sectional|||||||
1326912|NCT03245710|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326913|NCT03245697|||Ecologic or Community||Other|||||||
1326914|NCT03245684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326915|NCT03245671|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1326916|NCT03245658|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1326917|NCT03245645|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1326918|NCT03245632|||Case-Control||Prospective|||||||
1326919|NCT03245619|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1326920|NCT03245606|||Case-Only||Prospective|||||||
1326921|NCT03245593|||Case-Only||Prospective|||||||
1326922|NCT03245580|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||prospective, randomized, multicenter study||||
1326923|NCT03245567|Randomized|Parallel Assignment||Other||None (Open Label)||Prospective, randomized, open-label study||||
1326924|NCT03245554||Single Group Assignment||Treatment||None (Open Label)||||||
1326925|NCT03245541||Single Group Assignment||Treatment||None (Open Label)||||||
1326926|NCT03245528||||||||||||
1326927|NCT03245515||Single Group Assignment||Treatment||None (Open Label)||||||
1326928|NCT03245502|||Case-Control||Prospective|||||||
1326929|NCT03245489|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1326930|NCT03245476|Randomized|Parallel Assignment||Treatment||Single||corticoid injection + physiotherapy with a focus on manual therapy and home-exercises versus corticosteroid injection + physiotherapy with focus on education and supported home exercises||||t
1326931|NCT03245463|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1326932|NCT03245450||Single Group Assignment||Treatment||None (Open Label)||||||
1326933|NCT03245437|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind Placebo controlled||t|t|t|t
1326934|NCT03245424||||||||||||
1326935|NCT03245411|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized Controlled Trial (RCT) Single Center||||
1326936|NCT03245398|Randomized|Parallel Assignment||Treatment||Quadruple|Participants, physicians, nurses and investigators will all be blinded. Based on the randomization list, individual envelopes with the correct combination of mebendazole tablets and placebos will be prepared. The randomization code is then sealed in an envelope. Unblinding will only occur in case of a SAE, SUSAR or other kind of emergency.||t|t|t|t
1326937|NCT03245385||Single Group Assignment||Treatment||None (Open Label)||Open label, single treatment arm study||||
1326938|NCT03245372|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1326939|NCT03245359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326940|NCT03245346|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1326941|NCT03245333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326942|NCT03245320|||Case-Control||Other|||||||
1326943|NCT03245307||Single Group Assignment||Treatment||None (Open Label)||||||
1326944|NCT03245294|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1326945|NCT03245281|Non-Randomized|Crossover Assignment||Other||None (Open Label)||According to the enrolment chronological order, each subject will be allocated to Diuretic Suspension group (DS), Diuretic Increase (DI) or Diuretic+MRA medication Suspension (DMS), which will define the medication regimen before the follow-up visit.||||
1326946|NCT03245268|||Cohort||Prospective|||||||
1326947|NCT03245255||Single Group Assignment||Diagnostic||None (Open Label)||||||
1326948|NCT03245242|||Case-Only||Prospective|||||||
1326949|NCT03245229|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1326950|NCT03245216|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1326951|NCT03245203|Randomized|Parallel Assignment||Treatment||Single||70 patients with rectal adenocarcinoma clinical staging in Stage II or Stage III were included for neoadjuvant therapy followed by TME, of which 35 underwent neoadjuvant radiotherapy, and other 35 underwent neoadjuvant chemotherapy+beacizumab.|t|||
1326952|NCT03245190||Single Group Assignment||Treatment||None (Open Label)||||||
1326953|NCT03245177||Single Group Assignment||Treatment||None (Open Label)||||||
1326954|NCT03245164|Randomized|Parallel Assignment||Treatment||Single||||||t
1326955|NCT03245151|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326956|NCT03245138|Randomized|Parallel Assignment||Treatment||Single||||||t
1326957|NCT03245125|||Cohort||Prospective|||||||
1326958|NCT03245112|||Case-Only||Other|||||||
1326959|NCT03245099|||Other||Cross-Sectional|||||||
1326960|NCT03245086|||Case-Control||Prospective|||||||
1326961|NCT03245073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326962|NCT03245060|Randomized|Parallel Assignment||Treatment||Single|The Research Assistant will complete the psychosocial outcome measures at all time points in face to face interview format. The Research Assistant will be blinded to treatment allocation.|"Wait-list control feasibility study with nested qualitative research.~Participants will be randomly assigned to the intervention group or wait-list control group. Both groups will be assessed on psychosocial outcome measures at T1 (baseline, prior to randomisation), T2 (three months post randomisation) and T3 (six months post randomisation). Participants will also take part in in-depth interviews at T3 exploring their experiences of taking part in the project as well as complete a resource use questionnaire. All participants will receive all usual care, and up to six SFBT sessions spaced over three months delivered by Speech and Language Therapists (SLTs). The intervention group will receive the therapy immediately post randomisation, while the wait-list control group will be offered the intervention after T3. The wait-list control will additionally be reassessed at T4 (nine months post randomisation)."||||t
1576286|NCT00009529||||||||||||
1326963|NCT03245047|Randomized|Parallel Assignment||Supportive Care||Triple|This study is double-blinded, i.e., during the study, neither the investigator(s), study and appropriate Abbott Nutrition staff, nor participants will be informed of the identity of any of the study products. Study center personnel will not analyze the contents of the study products or in any way seek to learn the identity of the study products. The investigator should ensure that if it becomes necessary, blinding is broken only in accordance with the protocol.|This is a prospective, randomized, placebo controlled, double-blind, parallel design, multi-center study. Eligible participants will be randomly allocated to one of two groups: oral nutritional supplement with dietary counseling group or placebo supplement with dietary counseling group. Randomization will be stratified by MUST malnutrition status (medium risk or high risk) and site of recruitment. All participants, including both recently discharged patients from the hospital or elderly recruited from the polyclinics.|t||t|t
1326964|NCT03245034||Single Group Assignment||Prevention||None (Open Label)||||||
1326965|NCT03245021||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1326966|NCT03245008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1326967|NCT03244995|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1326968|NCT03244982|Randomized|Parallel Assignment||Diagnostic||Single|The primary outcomes assessors will be retinal surgeons, masked to the dosing of fluorescein. They will assess the subjective quality of images.|Patients will be randomly assigned to receive either a half-dose (250mg) or a full-dose (500mg) of intravenous fluorescein prior to their angiography procedure. If they return for a second fluorescein angiography study during the proceeding four months, they will receive the dose of fluorescein (250mg or 500mg) which they did not receive during their first study. Images will be evaluated objectively using image-correlation technology and subjectively by a masked panel of retinal surgeons for image quality, and image quality will be compared between images.||||t
1326969|NCT03244969|||Cohort||Prospective|||||||
1326970|NCT03244956|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a multicentric prospective non-randomized phase II trial, with two independent arms: one for patients with RAS mutation and one for patients with BRAFV600E mutation||||
1326971|NCT03244943|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||40 patients were allocated: Chronic periodontitis patients (P) (n=20) and breast cancer with chronic periodontitis patients (CAN/P) (n=20). The clinical parameters: probing depth (PD), clinical attachment level (CAL), plaque index (PI), gingival index (GI) and levels of IFN-γ, IL-4, IL-10, TGF-β, IL-17, IL-2, IL-6, IL-1β and TNF-α in gingival crevicular fluid (GCF) were evaluated at baseline, 45 and 180 days after therapy.||||
1326972|NCT03244930||Single Group Assignment||Treatment||None (Open Label)||Prospective, open-labeled, single-arm study||||
1326973|NCT03244917|Randomized|Parallel Assignment||Health Services Research||Quadruple|The research assistants collecting outcome data through chart reviews and follow-up proxy interviews will be blinded to nursing home randomization. The Principal Investigator, data programmers, and statistician will be blinded to treatment assignment|Cluster Randomized Clinical Trial|t|t|t|t
1326974|NCT03244904|||Cohort||Prospective|||||||
1326975|NCT03244891||Sequential Assignment||Basic Science||None (Open Label)||||||
1326976|NCT03244878|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are randomized to either the wait-list controlled group or intervention group. Intervention period is 8 weeks. Data collection occurs at baseline, 4 weeks, and 8 weeks, with longer-term follow-up assessments.||||
1326977|NCT03244865|||Other||Other|||||||
1326978|NCT03244852|||Cohort||Retrospective|||||||
1326979|NCT03244839|||Case-Only||Prospective|||||||
1326980|NCT03244826|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1326981|NCT03244813|Randomized|Parallel Assignment||Other||Single|The medical team assessing patient functional capacities and caregiver burden at 3 and 6 months will not know which treatment the patient received|||||t
1326982|NCT03244800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1326983|NCT03244787|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1326984|NCT03244774||Single Group Assignment||Treatment||None (Open Label)||||||
1326985|NCT03244761|||Case-Crossover||Prospective|||||||
1326986|NCT03244748|||Cohort||Prospective|||||||
1326987|NCT03244735||Single Group Assignment||Treatment||None (Open Label)||Case series||||
1326988|NCT03244722|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1326989|NCT03244709||Sequential Assignment||Treatment||None (Open Label)||||||
1326990|NCT03244696|Randomized|Parallel Assignment||Treatment||Single|||t|||
1326991|NCT03244683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326992|NCT03244670|||Cohort||Prospective|||||||
1326993|NCT03244657|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1326994|NCT03244644|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1326995|NCT03244631|Randomized|Parallel Assignment||Prevention||Single||Prospective randomized||||t
1326996|NCT03244618|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1326997|NCT03244605|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1326998|NCT03244592|Randomized|Parallel Assignment||Treatment||Triple|Double Blind||t||t|t
1326999|NCT03244579|Randomized|Parallel Assignment||Treatment||Single||||||t
1327000|NCT03244566|||Cohort||Prospective|||||||
1327001|NCT03244553||Single Group Assignment||Treatment||None (Open Label)||||||
1327002|NCT03244540|Randomized|Parallel Assignment||Treatment||Single|||t|||
1327003|NCT03244527|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327004|NCT03244514|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1327005|NCT03244501|Randomized|Crossover Assignment||Basic Science||Double|This is a double-blind study, meaning that neither the participant nor the experimenter knows what kind of stimulation the participant is receiving. An unblinded monitor (separate from the staff that interacts with the participant) is responsible for providing the study coordinator with the active and sham magnet sequence. Each magnet has a number; the study coordinator is not aware which number corresponds to active or sham magnets.|All participants will receive three stimulations: left frontal, right frontal, and sham tSMS.|t||t|
1327007|NCT03244475|Randomized|Parallel Assignment||Treatment||Double|Sham treatment, double-blind design: During the sham treatment, we will prep and preplace the electrodes for common reference, A-, B-, plus the set of electrodes on the scalp of the participant following the 10-20 EEG configuration for A+ and A-, just like the procedure for real IASIS treatment. However, no LIP-tES pulses will be sent from the system during sham treatment, based a code entered to the system. A staff member (SRA #1) will assign a mTBI Veteran to either the mTBI-IASIS or the mTBSham group, with an attached code from an existing code bank. Then, the IASIS treatment operator (SRA #2) who is blind to the group assignment will enter the code to the IASIS system during treatments. Based on the code, the system automatically loads the protocol for either IASIS or Sham treatment. Only at the end of the study (after V16), the group assignment is revealed. Therefore, both the participant and IASIS treatment operator (SRA #2) are blind to the group assignment during the study.|After consent, Visit 1 (V1) for all three groups will include baseline NP and MHA. Then, baseline rs- MEG and MRI will be performed in V2 for all groups. At V3 the mTBI Veterans in IASIS and sham groups will undergo a pre-session MEG, the first IASIS/Sham treatment Session (S1), and a post-session MEG. Next, the mTBI Veterans continue their IASIS/Sham treatments S2-6 in V4-8. During the mid-treatment V9, another pair of pre- and post-MEG exams and NP will be performed. The mTBI Veterans will continue treatments S8-11 in V10-13. During the final treatment V14, the third pair of pre- and post-MEG exams will be performed. One week after the Veterans finish their final IASIS/Sham treatment S12, a one-week follow-up MEG and NP will be conducted during V15. A subset of IASIS group will be tested one month after the final treatment for a follow-up MEG V16. Veterans initially in the mTBI-sham group will also be offered the real IASIS treatment, but no MEG or behavioral data will be collected.|t|t||
1327008|NCT03244462|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1327009|NCT03244449|||Ecologic or Community||Cross-Sectional|||||||
1327010|NCT03244436|||Other||Retrospective|||||||
1327011|NCT03244423|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1327012|NCT03244410|||Other||Other|||||||
1327013|NCT03244397|Randomized|Parallel Assignment||Treatment||Double||Two groups: Experimental group and Control group|||t|t
1327014|NCT03244384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327015|NCT03244371||Single Group Assignment||Prevention||None (Open Label)||||||
1327016|NCT03244358||Single Group Assignment||Treatment||None (Open Label)||||||
1327017|NCT03244345||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327018|NCT03244332|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"The investigators aim to start a prospective and observational study over a 2 years period.~First, the investigators will identify all children suffering from cirrhosis irrespective of underlying etiology and/or portal hypertension coming into the pediatric hepatogastroenterology unit at Saint-Luc University Clinics. Any patient with a congenital or acquired thrombophilia/haemorrhaegic disorder will be excluded."||||
1327019|NCT03244319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327020|NCT03244306||Single Group Assignment||Treatment||None (Open Label)||||||
1327021|NCT03244293|||Case-Only||Prospective|||||||
1327022|NCT03244280||Single Group Assignment||Other||None (Open Label)||||||
1327023|NCT03244267|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327024|NCT03244254|||Cohort||Prospective|||||||
1327025|NCT03244241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327026|NCT03244228|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1327027|NCT03244215|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327028|NCT03244202|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327029|NCT03244189|Randomized|Parallel Assignment||Prevention||Single|The Principal Investigator and site investigators, along with the primary study statistician will remind blinded throughout the trial.||||t|
1327030|NCT03244176||Single Group Assignment||Treatment||None (Open Label)||||||
1327031|NCT03244163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327032|NCT03244150|||Cohort||Prospective|||||||
1327033|NCT03244137|||Cohort||Prospective|||||||
1327034|NCT03244124|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327035|NCT03244111|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The MOCA is a one page test that assesses cognition. The MOCA will be administered and participants with total scores <= 25 will be in the lower cognition group, whereas participants with total scores > 25 will be in the higher cognition group. These are recommended cut off scores to detect mild cognitive impairment (MCI).||||
1327036|NCT03244098|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327037|NCT03244085|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1327038|NCT03244072|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1327039|NCT03244059|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinded placebo controlled randomized clinical trial|Patients will be randomly assigned to receive active:placebo in a ratio of 2:1.|t|t|t|t
1327040|NCT03244046|Randomized|Parallel Assignment||Treatment||Single||||||t
1327041|NCT03244033|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1327042|NCT03244020|Randomized|Parallel Assignment||Prevention||None (Open Label)||Three separate patient categories are being investigated in this trial. All patients are undergoing pelvic and/or lower extremity surgery for one of three possible conditions: 1) soft tissue sarcoma; 2) primary bone sarcoma; 3) metastatic bone disease. Within each of these groups, patients will be randomized to either aspirin or low molecular weight heparin (enoxaparin) for venous thromboembolism prophylaxis post operatively.||||
1327043|NCT03244007|||Case-Control||Retrospective|||||||
1327044|NCT03243994|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||All patients had Chronic Obstructive Lung Disease. Those with additional Cor pulmonale was compared to those without||||
1327045|NCT03243981||Single Group Assignment||Other||None (Open Label)||Application of Skintyte and/or broadband light to skin||||
1327046|NCT03243968|||Other||Cross-Sectional|||||||
1327047|NCT03243955|Randomized|Parallel Assignment||Treatment||Quadruple|the patient is unaware which group he is assigned to the researchers discussing this with the patients are unaware of group assignment the investigator is unaware of group assignment the outcomes assessor is unaware of group assignment until data analysis is complete||t|t|t|t
1327048|NCT03243942||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327049|NCT03243929|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1576287|NCT00009256||||||||||||
1327050|NCT03243916||Single Group Assignment||Treatment||None (Open Label)||||||
1327051|NCT03243903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327052|NCT03243890|Randomized|Parallel Assignment||Prevention||Quadruple|The randomization-list is available to the data and safety monitoring board, but patients, nurses, physicians and other data collectors are kept blinded to the allocation during the study.|Subjects will be randomized 1:1 after stratiﬁcation for site, AVC score (300-599 or ≥600) and statin-use. Each site will be provided with sequentially numbered, opaque and sealed envelopes containing randomly generated treatment allocations. Four different types of envelopes are provided; 1) AVC 300-599, no statin-use; 2) AVC 300-599, statin-use; 3) AVC ≥600, no statin-use; and 4) AVC ≥600, statin-use.|t|t|t|t
1327053|NCT03243877|||Cohort||Prospective|||||||
1327054|NCT03243864|||Case-Only||Prospective|||||||
1327055|NCT03243851|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded|Arm 1 : Low dose temozolomide+metformin Arm 2 : Low dose temozolomide+placebo|t|t|t|t
1327056|NCT03243838||Single Group Assignment||Treatment||None (Open Label)||||||
1327057|NCT03243825|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327058|NCT03243812|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327059|NCT03243799|Randomized|Parallel Assignment||Treatment||Single||||||t
1327060|NCT03243786|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327061|NCT03243773|||Cohort||Prospective|||||||
1327062|NCT03243760|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327063|NCT03243747|||Cohort||Prospective|||||||
1327064|NCT03243734||Single Group Assignment||Supportive Care||None (Open Label)||||||
1327065|NCT03243721|Non-Randomized|Parallel Assignment||Other||None (Open Label)|There is no masking in this study.|There will be two groups running in parallel. One will be MS patients (15) and the other will be control patients (5). Both groups will receive the same interventions.||||
1327066|NCT03243708|Randomized|Sequential Assignment||Prevention||None (Open Label)||Step-Wedge Randomized controlled trial (RCT)||||
1327067|NCT03243695|Randomized|Parallel Assignment||Treatment||Single|due to the nature of the study only the participant could be blinded||t|||
1327068|NCT03243682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327069|NCT03243669|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1327070|NCT03243656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327071|NCT03243643||Single Group Assignment||Other||None (Open Label)||||||
1327072|NCT03243630|Randomized|Crossover Assignment||Health Services Research||Double|The participant and medical professional will be blinded to the condition per day.|Mixed-effects models will be used to test the study hypotheses. These models allow for different numbers of observations per subject, use all available data on each subject, and are unaffected by randomly missing data.|t||t|
1327073|NCT03243617|Randomized|Parallel Assignment||Other||Double|AO+ Mist (or placebo) are supplied in white 100mL metered spray bottles. Test products are blinded and labeled for application to the LEFT or RIGHT side of the body.|Bi-Lateral study|t|t||
1327074|NCT03243604|||Case-Only||Retrospective|||||||
1327075|NCT03243591|Randomized|Parallel Assignment||Treatment||Triple|Gels are in coded opaque tubes created at the manufacturer|prospective, randomized, controlled, double-blind, single center|t||t|t
1327076|NCT03243578|||Cohort||Prospective|||||||
1327077|NCT03243565|Randomized|Parallel Assignment||Prevention||Quadruple|Randomization will be done by throwing the coin. Family of patients and doctor (Coordinator / Responsible Investigator Serap Ozmen and Associate Investigator Soner Sahin) will be blind; Researcher Ilknur Bostanci and assistant researcher Gulay Senel will appoint drugs and placebo.|"A randomised, double-blind, placebo-controlled, parallel group, phase IV study. First group will receive OM-85 (first 10 day consecutive 3 months; standard treatment regimen) Second group will receive matching placebo at the same posology (first 10 day consecutive 3 months).~A second cure of treatment will be given 6 months after inclusion. Patients will be recruited from 01 August 2017 to 01 February 2018. The trial will begin in August 2017 and will be completed in February 2019.~By this way every patient will be studied over all seasons (1 year study) ."|t|t|t|t
1327078|NCT03243552|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind|Phase IIa Proof of Mechanism 16-week, randomized, double-blind, controlled trial of L-DOPA versus placebo.|t|t|t|t
1327079|NCT03243539||Single Group Assignment||Treatment||None (Open Label)||||||
1327080|NCT03243526|Randomized|Parallel Assignment||Supportive Care||Double|patient will be blinded and person who will do lung ultrasound|two groups one recieve fluid guided by CVP and othe by PPV|t|||t
1327081|NCT03243513|||Other||Retrospective|||||||
1327082|NCT03243500|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1327083|NCT03243487|Randomized|Parallel Assignment||Treatment||Single|Study participants and study staff cannot be blinded to the treatment arm to which they are randomized. Data analysis will be blinded and conducted without revealing the treatment group assignment.|After undergoing screening and enrollment, participants will be assigned to either standard care follow-up or to the patient adherence monitoring service (PAMS).||||t
1327084|NCT03243474|||Case-Crossover||Prospective|||||||
1327085|NCT03243461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327086|NCT03243448|||Case-Control||Prospective|||||||
1327087|NCT03243435|||Case-Only||Prospective|||||||
1327088|NCT03243422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327089|NCT03243409|||Case-Only||Retrospective|||||||
1327090|NCT03243396|Randomized|Crossover Assignment||Treatment||None (Open Label)|No masking--Participants will be able to tell which arm they belong to based on where they are receiving the treatment (therapy sessions)|Stepped wedge with 7 steps; Participants are randomized to receive the treatment (therapy sessions) in either a community or school setting||||
1327091|NCT03243383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327092|NCT03243370|||Cohort||Prospective|||||||
1327093|NCT03243357|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327094|NCT03243344|Randomized|Parallel Assignment||Prevention||Single||||t||
1327174|NCT03242304|||Case-Control||Prospective|||||||
1327095|NCT03243331||Sequential Assignment||Treatment||None (Open Label)||Study will enroll 3 patients to the cohort 1 dose level. If 0 of 3 patients experience a DLT, the study will proceed to cohort 2. If 1 patient experiences a DLT, 3 additional patients will be enrolled into cohort 1. If 1 of 6 patients experience a DLT, the study will proceed and 3 patients will be enrolled to the cohort 2 dose level. If 0 patients experience a DLT in cohort 2, the study will proceed to cohort 3. If 1 patient experiences a DLT at cohort 2, 3 additional patients will be enrolled into cohort 2. If the study proceeds to cohort 3, 3 patients will be enrolled at this dose level. If 0 patients experience a DLT, the study will enroll an additional 3 patients at the cohort 3 dose level to better define the safety profile. If 1 of 3 patients experiences a DLT at cohort 3, 3 additional patients will still be enrolled into cohort 3. If 1 of 6 patients experience a DLT, the study will complete.||||
1327096|NCT03243318|||Cohort||Prospective|||||||
1327097|NCT03243305||Single Group Assignment||Prevention||None (Open Label)||Single Arm, unblinded||||
1327098|NCT03243292|||Case-Only||Prospective|||||||
1327099|NCT03243279|||Cohort||Prospective|||||||
1327100|NCT03243266|||Cohort||Cross-Sectional|||||||
1327101|NCT03243253|||Ecologic or Community||Retrospective|||||||
1327102|NCT03243240|||Case-Only||Cross-Sectional|||||||
1327103|NCT03243227|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1327104|NCT03243214|Randomized|Sequential Assignment||Treatment||Triple|"The participant and investigator do not know what treatment is applied (TMS stimulation or Sham-TMS stimulation with a different coil).~The outcomes assessor will also be blinded."|This is a randomized double blind trial.|t||t|t
1327105|NCT03243201|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327106|NCT03243188|||Other||Other|||||||
1327107|NCT03243175|Randomized|Parallel Assignment||Prevention||Single|PROBE design|1:1:1||||t
1327108|NCT03243162|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1327109|NCT03243149|Randomized|Parallel Assignment||Treatment||Single|Participants will be unaware of whether the thermometer ratings they see while in the scanner are false feedback consisting of noise or true activation.|The investigators will test (1) the efficacy of neurofeedback in subjects with PTSD attempting to upregulate ventral medial PFC and simultaneously downregulate amygdala, and (2) determine the number of neurofeedback sessions (dose) needed for target engagement and transfer. Prior to the neurofeedback training, participants' baseline ability to regulate in the absence of neurofeedback from real-time fMRI will be ascertained. Then during session, participants will receive veridical real-time feedback in the scanner indicating the activation level of ventromedial PFC minus amygdala. Participants will attempt to regulate to achieve a predetermined target level known to the participant.|t|||
1327110|NCT03243136|||Cohort||Prospective|||||||
1327111|NCT03243123||Single Group Assignment||Treatment||None (Open Label)||||||
1327112|NCT03243110|||Case-Only||Prospective|||||||
1327113|NCT03243097||Sequential Assignment||Device Feasibility||None (Open Label)||||||
1327114|NCT03243084|Randomized|Crossover Assignment||Basic Science||Double|This is a double-blind study, meaning that neither the participant nor the experimenter knows what kind of stimulation the participant is receiving. An unblinded monitor (separate from the staff that interacts with the participant) is responsible for creating the stimulation codes that run each session and for ensuring that these codes worked correctly.|Each participant will receive sham stimulation and 10Hz tACS stimulation at two separate sessions. The order will be randomized (ie, half the participants will receive sham stimulation at the first session and 10Hz tACS stimulation at the second session, and the other half will receive 10Hz tACS stimulation at the first session and sham stimulation at the second session).|t||t|
1327115|NCT03243071|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327116|NCT03243058|Randomized|Parallel Assignment||Treatment||Triple|The randomization will be performed by the Coordinating Center at the University of Miami. The participants will not be informed regarding the intervention assignment until the end of the study. The investigators and clinic personnel will also be masked as to study assignment. Laboratories performing assays for this protocol will be masked as to the identity and group assignment of biological materials to be studied.|Eligible subjects will be invited to participate in the intervention trial and randomized to treatment with Proleukin® or placebo. Fifty-four patients will be enrolled, aged 12-21 years, both genders, and randomized to treatment or placebo in a 2:1 ratio. Participation for each subject will last approximately 2 years. The 18 patients randomized to the control arm will receive placebo for two years. At the end of the first year, the 36 patients randomized to the treatment arm will be randomized 1:1 to continued treatment or placebo. Thus, among the 36 patients who received treatment during the first year, 18 patients will continue therapy and 18 patients will switch to placebo until the end of the study.|t|t|t|
1327117|NCT03243045|||Case-Only||Prospective|||||||
1327118|NCT03243032|Randomized|Parallel Assignment||Treatment||Single|Patients will not know which arm they will be in initially. At the 2 week post-operative visit they may be notified of which arm they participated in if they so choose to find out.|Randomized, parallel arms, double-blinded, placebo-controlled trial|t|||
1327119|NCT03243019||Single Group Assignment||Treatment||None (Open Label)||||||
1327120|NCT03243006|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1327121|NCT03242993||Single Group Assignment||Diagnostic||None (Open Label)||This is a single arm study. No placebo or other comparator will be used. [18F]-AzaFol is used as a PET tracer, all patients successfully enrolled will be assigned to the treatment group.||||
1327122|NCT03242980|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||To ensure that the effect of this intervention is measured and to avoid a long delay in adopting the intervention, a stepped wedge design was chosen. In addition the study would thus not disrupt the on-going staggered roll-out of routine viral load provision to patients on ART at the 12 health facilities. Stepped wedge designs are a form of clustered study in which the intervention is delivered to groups rather than individuals.||||
1327123|NCT03242967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327175|NCT03242291|Randomized|Parallel Assignment||Prevention||Single||||||t
1327176|NCT03242278|||Cohort||Retrospective|||||||
1327177|NCT03242265||Single Group Assignment||Screening||Single|NK cell activity not provided to investigator prior to biopsy; results of biopsy not provided to biochemistry lab|||||t
1328653|NCT03223051||Single Group Assignment||Other||None (Open Label)||||||
1327124|NCT03242954|Randomized|Parallel Assignment||Other||None (Open Label)||"Consent 2.0 has a parallel group-like design for adolescents. Adolescents will be randomized into 1 of 3 consent conditions using a randomized block design that is stratified by study site and the adolescent's natal sex. The order in which the hypothetical trials are presented to adolescents will be randomized using a block design. A subset of 6-8 adolescents per site will be selected for a debriefing interview.~Consent 2.0 has a crossover-like design for parents. Parents will provide feedback on all three consent conditions and for both hypothetical trials. The order in which the hypothetical trials are presented to parents will be determined using a randomized block design that is stratified by study site and the parent's adolescent's natal sex. The presentation order for the 3 consent condition vignettes for each hypothetical trial will be determined using a randomized block design. A subset of 6-8 parents by site will be selected for debriefing interview."||||
1327125|NCT03242941|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||Approximately 15 subjects with AF indicated for ablation of the pulmonary vein will be enrolled in the study. Participants will attend the Baseline visit and the Procedure visit. The baseline visit can be on the same day as the ablation procedure. Since it is an acute study, no follow-up visit will occur. The research procedure will be performed during an already scheduled ablation procedure. Subjects will be enrolled over a period of approximately 18 months||||
1327126|NCT03242928||Parallel Assignment||Treatment||Double|||t||t|
1327127|NCT03242915||Single Group Assignment||Treatment||None (Open Label)||||||
1327128|NCT03242902|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327129|NCT03242889||Single Group Assignment||Treatment||None (Open Label)||||||
1327130|NCT03242876|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1327131|NCT03242863|Randomized|Crossover Assignment||Prevention||Single|||t|||
1327132|NCT03242850|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327133|NCT03242837|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327134|NCT03242824||Single Group Assignment||Treatment||None (Open Label)||||||
1327135|NCT03242811||Single Group Assignment||Basic Science||None (Open Label)||||||
1327136|NCT03242798|||Cohort||Prospective|||||||
1327137|NCT03242785|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327138|NCT03242772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327139|NCT03242759|||Cohort||Prospective|||||||
1327140|NCT03242746|||Cohort||Prospective|||||||
1327141|NCT03242733|||Cohort||Prospective|||||||
1327142|NCT03242720|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1327143|NCT03242707|Randomized|Parallel Assignment||Treatment||None (Open Label)|Patients will know which group they have been assigned to|Participants will be randomly assigned to receive either a single autologous fat injection or a single hyaluronic acid injection.||||
1327144|NCT03242694|||Cohort||Prospective|||||||
1327145|NCT03242681|Randomized|Parallel Assignment||Treatment||Single||||||t
1327146|NCT03242668||Single Group Assignment||Treatment||None (Open Label)||30 patients, with American Society of Anesthesiologists class I to III risk undergoing elective VATS, aged 32-72 years, scheduled for lung resection surgery , were enrolled in this randomised observer blinded prospective clinical study. Patients who refused to participate, less than 18 years of age, ASA physical status 3 or more, allergy to any of the study drugs, patients having any contraindication for paravertebral block, kyphoscoliosis, presence of acute herpes zoster, chronic pain syndrome, chronic analgesic use and psychiatric disease were excluded from this study.||||
1327147|NCT03242655|Randomized|Parallel Assignment||Treatment||None (Open Label)||RCT||||
1327148|NCT03242642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327149|NCT03242629|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327150|NCT03242616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327151|NCT03242603||Single Group Assignment||Treatment||None (Open Label)||To determine the feasibility, safety and effectiveness of anti-GD2 in combination with expanded, activated NK cells in research participants with Neuroblastoma||||
1327152|NCT03242590||Single Group Assignment||Treatment||None (Open Label)||||||
1327153|NCT03242577|||Other||Cross-Sectional|||||||
1327154|NCT03242564||Single Group Assignment||Treatment||None (Open Label)||||||
1327155|NCT03242551||Sequential Assignment||Treatment||None (Open Label)||epirubicin, paclitaxol, cyclophosphamide, trastuzumab||||
1327156|NCT03242538||Single Group Assignment||Prevention||None (Open Label)||||||
1327157|NCT03242525|||Case-Control||Prospective|||||||
1327158|NCT03242512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327159|NCT03242499|Randomized|Parallel Assignment||Other||Double|||t||t|
1327160|NCT03242486||Single Group Assignment||Treatment||None (Open Label)||||||
1327161|NCT03242473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327162|NCT03242460||Single Group Assignment||Treatment||None (Open Label)||the transplant-ineligible patients with Relapsed and/or refractorY multiple myeloma (MM) who had lenalidomide+dexamethasone (LD) following frontline bortezomib combined chemotherapy||||
1327163|NCT03242447|Randomized|Parallel Assignment||Prevention||None (Open Label)||participants are assigned to one of two or more groups in parallel for the duration of the study||||
1327164|NCT03242434|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327165|NCT03242421|||Other||Prospective|||||||
1327166|NCT03242408||Single Group Assignment||Treatment||None (Open Label)||||||
1327167|NCT03242395|||Cohort||Prospective|||||||
1327168|NCT03242382||Single Group Assignment||Treatment||None (Open Label)||||||
1327169|NCT03242369|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1327170|NCT03242356|||Cohort||Prospective|||||||
1327171|NCT03242343||Single Group Assignment||Treatment||None (Open Label)||||||
1327172|NCT03242330|Randomized|Parallel Assignment||Treatment||None (Open Label)|After assignment to interventions, blinding of trial participants, care providers and outcome assessors is not applicable. Data analysts will be blinded.|||||
1327173|NCT03242317||Single Group Assignment||Prevention||None (Open Label)||||||
1576288|NCT00009243|||Cohort||Other|||||||
1327178|NCT03242252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327179|NCT03242239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1327180|NCT03242226|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327181|NCT03242213|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327182|NCT03242200||Single Group Assignment||Supportive Care||None (Open Label)||This project is a longitudinal one-group pilot study evaluating the use of a Mobile Health (mHealth) app intervention. This study will examine: 1) the amount/type of usage, 2 ) compliance with study evaluations and 3) the association of this mHealth app use with perceived self-efficacy in managing survivorship related needs, perceived health illness and health related quality of life. The study period will be nine months, with four measurement points to assess the study's outcomes: baseline, three, six, and nine months post initiation of the mHealth app.||||
1327183|NCT03242187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327184|NCT03242174|||Ecologic or Community||Retrospective|||||||
1327185|NCT03242161||Single Group Assignment||Device Feasibility||None (Open Label)||All participants assigned to have a lab patch-alcohol applied to skin and then receive a single dose of alcohol and then the patch measures how much alcohol appears in interstitial fluid. This is compared to the blood alcohol concentrations.||||
1327186|NCT03242148||||||||||||
1327187|NCT03242135|||Cohort||Prospective|||||||
1327188|NCT03242122|Randomized|Crossover Assignment||Other||Single|||t|||
1327189|NCT03242109|||Cohort||Prospective|||||||
1327190|NCT03242096|Randomized|Parallel Assignment||Treatment||Single|Blinded QCA for primary outcome|"Experimental intervention: Predilatation of coronary ISR with POBA followed by a sirolimus coated SeQuent® SCB balloon balloon (sirolimus 4.0 μg/mm²)~Control intervention: Predilatation of coronary ISR with POBA followed by a paclitaxel coated SeQuent® Please balloon or SeQuent® Please NEO balloon (paclitaxel 3.0 μg/mm²)"||||t
1327191|NCT03242083|||Cohort||Prospective|||||||
1327192|NCT03242070|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||A two-arm parallel-group RCT||||
1327193|NCT03242057|Randomized|Parallel Assignment||Treatment||None (Open Label)|provider and PI is masked for randomization but then no masking once treatment (mode of ventilation) is applied|||||
1327194|NCT03242044||Single Group Assignment||Treatment||None (Open Label)||This is a pilot feasibility study that will assess maternal and infant tolerance to the protocols as well as the optimal method for performing an advanced resuscitation with an intact umbilical cord. The investigators have randomly chosen 10 study participant to make this assessment and determine methodologies. For this reason study participants will not be randomized. Pregnant women greater than 18 years of age that consent to the protocol will be enrolled in the study arm.||||
1327195|NCT03242031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327196|NCT03242018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327197|NCT03242005|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1327198|NCT03241992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327199|NCT03241979|||Cohort||Prospective|||||||
1327200|NCT03241966|||Case-Only||Cross-Sectional|||||||
1327201|NCT03241953|Randomized|Parallel Assignment||Treatment||Single|||t|||
1327202|NCT03241940||Single Group Assignment||Treatment||None (Open Label)||||||
1327203|NCT03241927|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327204|NCT03241914|Randomized|Parallel Assignment||Treatment||Single||||||t
1327205|NCT03241901|Randomized|Parallel Assignment||Treatment||Single|"Due to the objectives of the study, the identity of test and control treatments will be known only to investigators, research staff, but NOT patients. The following study procedures will be in place to ensure single-blind administration of study treatments.~Access to the randomization code will be strictly controlled.~A taste-matching agent for the placebo.~Packaging and labeling of test and control treatments will be identical to maintain the blind.~During the study, the blind may be broken only in emergencies when knowledge of the patient's treatment group is necessary for further patient management. When possible, the Investigator should discuss the emergency with the Medical Monitor prior to un-blinding"||t|||
1327206|NCT03241888|Randomized|Parallel Assignment||Treatment||Single||||||t
1327207|NCT03241875|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1327208|NCT03241862||Single Group Assignment||Other||None (Open Label)||||||
1327209|NCT03241849||Single Group Assignment||Prevention||None (Open Label)||||||
1327210|NCT03241836|||Case-Only||Cross-Sectional|||||||
1327211|NCT03241823|||Cohort||Prospective|||||||
1327212|NCT03241810|Randomized|Parallel Assignment||Treatment||Triple|This is a multi-center, randomized, double-blind, placebo-controlled Phase 2 Study.|Patients will be randomized in a 1:1 ratio (experimental arm versus active comparator arm) using an Interactive Web Response System (IWRS). Randomization will be stratified based on bone-only disease (yes, no) and geographic region (US, non-US).|t|t|t|
1327213|NCT03241797||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327214|NCT03241784||Single Group Assignment||Treatment||None (Open Label)||Autologous infusion of expanded T-regulatory lymphocytes during early and late phases of ALS disease in patients with varying rates of disease progression.||||
1327215|NCT03241771|Randomized|Parallel Assignment||Prevention||Single||||||t
1327216|NCT03241758|||Case-Crossover||Prospective|||||||
1327217|NCT03241745||Single Group Assignment||Treatment||None (Open Label)||This is an MSKCC investigator-initiated, single-center, non-randomized, open-label, phase 2 study.||||
1327218|NCT03241732|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)|This is an Open Label study.|"There are two intervention arms of the study. One arm will focus on adjusting dietary practices to eat foods that have a lower amount of inflammatory molecules that might help reduce overall inflammation in the brain and body.~The second arm is the N-acetyl cysteine group to provide patients with a natural supplement that support antioxidants in the body."||||
1327219|NCT03241719||Single Group Assignment||Treatment||None (Open Label)||||||
1327220|NCT03241706|Randomized|Crossover Assignment||Basic Science||Single|The subjects will not be informed which treatment they will receive for a given trial.||t|||
1327221|NCT03241693|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1327222|NCT03241680|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327223|NCT03241667|||Case-Only||Prospective|||||||
1327224|NCT03241654|||Case-Crossover||Prospective|||||||
1327225|NCT03241641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327226|NCT03241628|||Case-Only||Prospective|||||||
1327227|NCT03241615|||Cohort||Prospective|||||||
1327228|NCT03241602|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1327229|NCT03241589|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||The study uses a stepped wedge cluster randomized trial (SW-CRT) in both trials. Each facility, the participant in the study, represents a cluster of patients who receive care at the respective VA Medical Center and associated CBOCs. The trial is a cross-sectional SW-CRT, since facilities are not measured repeatedly over the course of the study. The investigators will retrospectively measure outcomes during the 6-month baseline period. The trial will be rolled out over a 24 month period. After each (randomly selected) set of facilities switches to the intervention at each step, a 3-month implementation phase occurs, during which outcomes will not be measured in the analysis. Every 3 months, a new group of clusters will implement the apps until all are using the apps. This leads to a total of 6 cross-over points over the whole rollout period.||||
1327230|NCT03241576|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327231|NCT03241563|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327232|NCT03241550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327233|NCT03241537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327234|NCT03241524||Single Group Assignment||Prevention||None (Open Label)||Perineal floor muscle performance and participants' sexual functions were evaluated in three successive situations: (1) Initial evaluation; (2) after 4 weeks (intermediate evaluation), and (3) 8 weeks (final evaluation) from the start of the training program.||||
1327235|NCT03241511|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1327236|NCT03241498|Randomized|Single Group Assignment||Health Services Research||Single||"A prospective, multi-centre, randomised intervention study will be conducted simultaneously in four different regions of the United Kingdom (UK), namely:~Northern Health and Social Care Trust (NHSCT) and Western Health and Social Care Trust (WHSCT), Northern Ireland~North West Coast Academic Health Science Network (AHSN), England~Wessex AHSN, England~Eastern AHSN, England~Two GP practices will participate in the research in each of these four geographical areas. The pragmatic sample size at each site will be 50 intervention patients and 50 control patients completing a six month follow-up period i.e. a total of 800 patients (400 intervention and 400 control patients) across the eight participating GP practices. An over-recruitment of 20%, i.e. 60 each of both control and interventions patients per practice, will be recruited into the study to take account of patients who drop out of the study and/or are lost to follow up."||||t
1327237|NCT03241485|Randomized|Parallel Assignment||Treatment||Quadruple|All patients will receive intrathecal intervention and will not know which group they are assigned to. The provider performing the procedure and collecting the data will also be blinded to the intervention assignment.|The patients will be randomized into 2 groups. The placebo group will receive intrathecal saline. The morphine group will receive intrathecal morphine.|t|t|t|t
1327238|NCT03241472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327239|NCT03241459|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327240|NCT03241446|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1327241|NCT03241433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327242|NCT03241420|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Determine the utility and sensitivity of the lung clearance index (LCI) technique as a marker of lung injury/small airways disease in adults with chronic lung conditions compared to healthy adults, adjusting for age, sex, and smoking status.||||
1327243|NCT03241407|Randomized|Crossover Assignment||Treatment||Triple||This investigation was designed as double-blind, randomized, crossover study|t||t|t
1327244|NCT03241394|||Other||Cross-Sectional|||||||
1327245|NCT03241381|||Case-Control||Cross-Sectional|||||||
1327246|NCT03241368|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1327247|NCT03241355|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1327248|NCT03241342|Randomized|Parallel Assignment||Treatment||Double||Double-blind, placebo-controlled, parallel design, randomized, multicenter, Phase 2 study consisting of the following periods: screening period, treatment period, and follow-up period.|t||t|
1327249|NCT03241329|||Case-Control||Prospective|||||||
1327250|NCT03241316|||Ecologic or Community||Other|||||||
1327251|NCT03241303|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1327252|NCT03241290|||Cohort||Prospective|||||||
1327253|NCT03241277|Randomized|Parallel Assignment||Treatment||None (Open Label)||Non surgical periodontal treatment||||
1327254|NCT03241264|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1327255|NCT03241251|||Cohort||Prospective|||||||
1327256|NCT03241238|Randomized|Crossover Assignment||Other||Single|||t|||
1327257|NCT03241225|Randomized|Parallel Assignment||Treatment||Single|Standardized assessments will be conducted by trained raters blind to participant assignment.|The investigators will compare the effectiveness and target engagement of EM/PROTECT with EM enriched with training of EM staff in linking EM victims to mental health services (EM/MH) in order to position us for a fully powered R01. To ensure rigor and reproducibility, EM/PROTECT or EM/MH will be offered to randomly assigned depressed EM victims, and standard assessments will be conducted by trained raters blind to participant assignment and our hypotheses.||||t
1327258|NCT03241212|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327259|NCT03241199||Single Group Assignment||Treatment||None (Open Label)||||||
1327260|NCT03241186||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1327261|NCT03241173|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327262|NCT03241160|||Cohort||Prospective|||||||
1327263|NCT03241147|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327264|NCT03241134|Randomized|Parallel Assignment||Other||Double|||t|||t
1327361|NCT03239873|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1327265|NCT03241121|Randomized|Parallel Assignment||Treatment||None (Open Label)||Study Part 1: Prospective longitudinal observational study. Study Part 2/3: Open-label randomized controlled trial.||||
1327266|NCT03241108|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327267|NCT03241095|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1327268|NCT03241082|||Cohort||Prospective|||||||
1327269|NCT03241069|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1327270|NCT03241056|Randomized|Parallel Assignment||Treatment||Single||||||t
1327271|NCT03241043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1327272|NCT03241030|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1327273|NCT03241017||Single Group Assignment||Treatment||None (Open Label)||Interventional, prospective, single-center, open-label, single-arm, non-comparative and non-randomized phase II study||||
1327274|NCT03241004|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327275|NCT03240991|||Case-Only||Prospective|||||||
1327276|NCT03240978|Randomized|Factorial Assignment||Prevention||Single||||||t
1327277|NCT03240965|||Case-Only||Prospective|||||||
1327278|NCT03240952|||Cohort||Cross-Sectional|||||||
1327279|NCT03240939|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1327280|NCT03240926||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1327281|NCT03240913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327282|NCT03240900|Randomized|Single Group Assignment||Treatment||Quadruple|Only the surgeon will be aware of the laterality of the intervention. The patient will not be performed. All outcomes will be assessed by the investigators, who will be masked to the laterality until the completion of the study when the surgeon will unmask.|Patients will receive the intervention to one breast and not the other, therefore acting as their own internal control. The laterality of the intervention will be randomized by a coin flip.|t|t|t|t
1327283|NCT03240887|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327284|NCT03240874|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Two phases of study: focus groups followed by individual usability testing (single arm)||||
1327285|NCT03240861||Single Group Assignment||Treatment||None (Open Label)||||||
1327286|NCT03240848|Randomized|Parallel Assignment||Diagnostic||Double|Slit-lamp photography and patient recruitment will be performed in each participating clinic by trained clinical staffs. The clinical staffs, investigators involved in data management and analysis, and experts providing the gold standard diagnosis by consensus in each clinic will be blinded to the group assignment. The study participants, the coordinator, senior consultants, and study personnel responsible for randomisation will not be masked.||||t|t
1327287|NCT03240835|||Case-Only||Prospective|||||||
1327288|NCT03240822|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||All subjects receive transplant and immunosuppression therapy||||
1327289|NCT03240809|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327290|NCT03240796|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327291|NCT03240783|Randomized|Parallel Assignment||Treatment||Quadruple|Participant, care-provider (general-practitioner and/or specialist), investigator, and outcomes assessor are masked to the treatment arms. All personnel except the radiologist delivering the procedure and the investigator responsible for randomisation will be masked to the randomisation arm. The participant, study personnel, other investigators, participant's treating physician and study analyst will be blind to the results.|Randomised 1:1:1:1|t|t|t|t
1327292|NCT03240770|Randomized|Parallel Assignment||Treatment||Single||||||t
1327293|NCT03240757|Randomized|Parallel Assignment||Other||None (Open Label)||randomized-crossover in healthy subjects||||
1327294|NCT03240744||Single Group Assignment||Prevention||None (Open Label)||Inactivated EV71 vaccine (KMB-17 cells)||||
1327295|NCT03240731||Single Group Assignment||Other||None (Open Label)||Haploidentical Marrow Transplants||||
1327296|NCT03240718|Randomized|Parallel Assignment||Treatment||Single||||||t
1327297|NCT03240705|Randomized|Parallel Assignment||Prevention||Double|The questionnaires will be coded as to not be able to identify study arm.||||t|t
1327298|NCT03240692||Single Group Assignment||Treatment||None (Open Label)||||||
1327299|NCT03240679|Randomized|Parallel Assignment||Prevention||None (Open Label)||Pilot study 10 in each group||||
1327300|NCT03240666|||Cohort||Other|||||||
1327301|NCT03240653|||Cohort||Retrospective|||||||
1327302|NCT03240640|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327303|NCT03240627|Randomized|Parallel Assignment||Treatment||Single||Randomised, double-blind, vehicle-controlled multicentre trial in parallel groups.|||t|
1327304|NCT03240614|Non-Randomized|Crossover Assignment||Treatment||Single|Interventions will be labeled using a Letter key so the analysis of the dataset by our statistician will be blinded|Will test preoxygenation using High Flow Nasal Cannulae, Non-rebreather mask and Bag-Valve-Mask||||t
1327305|NCT03240601|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1327306|NCT03240588|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327307|NCT03240575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1327308|NCT03240562|Randomized|Parallel Assignment||Treatment||Double||||t||t
1327309|NCT03240549|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||Prospective cohort study||||
1327310|NCT03240536|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized Study||||
1327311|NCT03240523|Randomized|Parallel Assignment||Treatment||None (Open Label)|No new subjects will be randomized to group A3 and group B after implementation of Protocol version 5.0. All subjects originally assigned to those groups will receive open-label treatment with Vilaprisan only.New treatment group is called A3/B.|||||
1327312|NCT03240510|||Case-Only||Prospective|||||||
1327357|NCT03239925|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Experimental group: we planned that all participants in this group would hold a cell phone to their left ears in their left hands, in 'on' mode, for 15 min, and that they would thus be exposed to a 900-1800 MHz magnetic field (EMW) for 15 min.~Control group: these would hold a cell phone to their left ears in their left hands for 15 min in 'off' mode."||||
1327313|NCT03240497|Randomized|Parallel Assignment||Basic Science||Single|We employ a PROBE design (Prospective Randomized Open Blinded End-point) [41]. All subjects will receive a code number. Almost all of our end-points, especially the most important ones including the primary endpoint, are laboratory measurements, which will be performed blinded for the treatment of the subjects.|A parallel randomized controlled explorative study in healthy male volunteers during experimental endotoxemia.||||t
1327314|NCT03240484|||Case-Control||Prospective|||||||
1327315|NCT03240471|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized clinical trial||||
1327316|NCT03240458|||Other||Prospective|||||||
1327317|NCT03240445|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1327318|NCT03240432|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327319|NCT03240419|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1327320|NCT03240406|Randomized|Parallel Assignment||Prevention||Single|The research clinician who assesses cognitive status needs to be blinded to assignment.|This is a pilot randomized clinical trial to the effects of an anti-inflammatory diet on cognition in a middle-aged cohort. The comparison arm will receive information on self-care matters such as aches and pains of aging.||||t
1327321|NCT03240393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327322|NCT03240380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327323|NCT03240367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327324|NCT03240354|Randomized|Parallel Assignment||Treatment||Double|"Participants will be split into two age groups, 'under 8 years' and '8 years and over', and a stratified randomisation method will be used to randomise each group, using a previously verified, sealed envelope, method and using blocks of unequal size.~Envelopes will be prepared using a random number table by an individual with no further role in the study~Each participant will be given a unique randomisation code matching the randomisation list~A record of each randomisation will be recorded on the Enrolment Log (TAFR01502)"|Prospective, blinded, randomised, parallel group control trial|t|||t
1327325|NCT03240341||Single Group Assignment||Supportive Care||None (Open Label)||||||
1327326|NCT03240328|Randomized|Parallel Assignment||Treatment||None (Open Label)||The control arm includes HIV-infected patients without receiving celluar therapy whose HIV has been successfully suppressed after cART.||||
1327327|NCT03240315|||Cohort||Prospective|||||||
1327328|NCT03240302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1327329|NCT03240289||Single Group Assignment||Other||None (Open Label)||Single arm feasibility and pilot testing study of a curriculum||||
1327330|NCT03240276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1327331|NCT03240263|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327332|NCT03240250|||Cohort||Prospective|||||||
1327333|NCT03240237||Single Group Assignment||Other||None (Open Label)||This pilot study is designed and powered for evaluating the efficacy and safety of CCM therapy in heart failure patients with baseline EF≥50% (HFpEF) who have NYHA Class II or III symptoms despite appropriate medication, for potential expansion of the CE Mark indication for use in the HFpEF population.||||
1327334|NCT03240224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327335|NCT03240211|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"This is a multicenter, international, phase Ib, 3 x 3 dose-escalation study with an initial phase I followed by an expansion phase.~There will be 3 treatment arms in this study."||||
1327336|NCT03240198|||Case-Control||Prospective|||||||
1327337|NCT03240185|||Cohort||Prospective|||||||
1327338|NCT03240172|||Case-Control||Retrospective|||||||
1327339|NCT03240159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327340|NCT03240146|Randomized|Parallel Assignment||Other||Quadruple|Devices will be coded, the placebo device is Identical to the active device in all ways except emitting the electromagnetic field. The energy emitted causes no sensation so can not be unmasked by user.||t|t|t|t
1327341|NCT03240133|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1327342|NCT03240120||Single Group Assignment||Treatment||None (Open Label)||||||
1327343|NCT03240107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327344|NCT03240094|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327345|NCT03240081|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind||t|t|t|t
1327346|NCT03240068|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1327347|NCT03240055|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1327348|NCT03240042|Randomized|Parallel Assignment||Prevention||Double||Participants are randomly allocated into one of the two group: nasoendotracheal and oroendotracheal group||t||t
1327349|NCT03240029|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327350|NCT03240016||Single Group Assignment||Treatment||None (Open Label)||||||
1327351|NCT03240003|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1327352|NCT03239990|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomize Controlled Trial with intervention and control groups (TAU)||||
1327353|NCT03239977|Randomized|Parallel Assignment||Prevention||Double||Longitudinal Randomized Clinical Trial|t|||t
1327354|NCT03239964|Randomized|Parallel Assignment||Prevention||Single||||||t
1327355|NCT03239951|Randomized|Parallel Assignment||Treatment||Single|||t|||
1327356|NCT03239938|Randomized|Parallel Assignment||Treatment||Triple||The trial will randomize 120 patients with chronic WAD, aged between 18 and 65 years, to the experimental (modern neuroscience approach including 3 sessions of therapeutic pain neuroscience education followed by 15 sessions of dynamic and functional cognition-targeted exercise therapy and stress management techniques (n = 60)) or the control treatment (usual care physiotherapy: 3 sessions of neck school followed by 15 sessions of exercise therapy focusing on strength, flexibility, endurance, and ergonomic principles (n= 60)).|t||t|t
1327358|NCT03239912|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327359|NCT03239899||Single Group Assignment||Other||None (Open Label)||||||
1327360|NCT03239886||Single Group Assignment||Treatment||None (Open Label)||single-arm study; all patients will discontinue imatinib (intervention)||||
1576893|NCT00005363||||||||||||
1327362|NCT03239860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327363|NCT03239847|Non-Randomized|Sequential Assignment||Health Services Research||Single|Anesthesia team will not be made aware of the purpose of the trial.|||t||
1327364|NCT03239834|||Cohort||Prospective|||||||
1327365|NCT03239821|Randomized|Crossover Assignment||Diagnostic||Double||A single-blinded, monocenter, randomized crossover investigation in healthy volunteers.|t|||t
1327366|NCT03239808|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a prospective, multicenter, randomized clinical trial. It has two strata: for age (≥or< 75 years old) and for KrU21 (≥or< 5,5 ml/min/1.73m2). It is controlled through usual clinical practice.~Intervention consists in reducing the frequency or number of sessions per week with which patients start the HD treatment. The experimental group will start with one session/week, then the number of weekly sessions will be increased to two and later to three as per criteria for progression."||||
1327367|NCT03239795|Randomized|Parallel Assignment||Prevention||Single|Patients were identified by a number|Registry based cluster randomized trial. The population was the patients aged over 16 of 75 FPs, with an indication for seasonal influenza immunization (pregnancy, long lasting disease, age over 65). The main outcome is the proportion of vaccinated patients, based on the number of vaccination units dispensed in community pharmacies. This number is retrieved from the SIAM-ERASME claim database of the Lille-Douai Health Insurance Fund.|t|||
1327368|NCT03239782||Single Group Assignment||Basic Science||None (Open Label)||||||
1327369|NCT03239769|Randomized|Parallel Assignment||Treatment||None (Open Label)||These patients were individually randomly assigned (1:1:1 ratio) into the conventional access group (CA), the aesthetic principles access group (APA) or the minimally invasive access group (MIA).||||
1327370|NCT03239756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327371|NCT03239743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327372|NCT03239730|||Cohort||Prospective|||||||
1327373|NCT03239717|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1327374|NCT03239704|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327375|NCT03239691|Non-Randomized|Single Group Assignment||Other||Single|||t|||
1327376|NCT03239678|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1327377|NCT03239665|Randomized|Parallel Assignment||Prevention||None (Open Label)||The design is a randomized trial with randomization to PHARM or PEER performed at the program date level.||||
1327378|NCT03239652||Single Group Assignment||Treatment||None (Open Label)||||||
1327379|NCT03239639|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants are assigned in 1:1 ratio to intervention or wait list control group||||
1327380|NCT03239626||Single Group Assignment||Treatment||None (Open Label)||One group for hypofractionaed IMRT for adjvuant cervical cancer patients||||
1327381|NCT03239613||Single Group Assignment||Treatment||None (Open Label)||||||
1327382|NCT03239600|Randomized|Parallel Assignment||Treatment||Quadruple|This is a randomized, double blind (sponsor unblind) study and masking will be performed.|This is a parallel assignment where in Part II of the study, randomized subject will receive GSK2618960 and placebo drug simultaneously.|t|t|t|t
1327383|NCT03239587|||Case-Control||Prospective|||||||
1327384|NCT03239574||||||||||||
1327385|NCT03239561||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327386|NCT03239548|||Other||Other|||||||
1327387|NCT03239535|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1327388|NCT03239522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1327389|NCT03239509|||Cohort||Retrospective|||||||
1327390|NCT03239496|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327391|NCT03239483|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1327392|NCT03239470|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1327393|NCT03239457|||Case-Only||Prospective|||||||
1327394|NCT03239444||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1327395|NCT03239431|||Cohort||Prospective|||||||
1327396|NCT03239418|Randomized|Parallel Assignment||Treatment||Triple|Participants in treatment and sham group undergo all of the same procedures except a sham NMES treatment is provided to the control group. Only the treating clinician is aware of group allocation. The investigator and outcomes assessor are unaware of group allocation.|Active treatment vs. Sham control|t||t|t
1327397|NCT03239405|||Other||Other|||||||
1327398|NCT03239392||Single Group Assignment||Treatment||None (Open Label)||||||
1327399|NCT03239379|Randomized|Parallel Assignment||Treatment||Triple|Single-blind, placebo-controlled||t|t||t
1327400|NCT03239366|Randomized|Parallel Assignment||Treatment||Quadruple|This study is double blind, randomized and placebo controlled. The clinical and operational teams from both MHI and BioK+ are blinded. Treatment codes will be available at the research pharmacy from the MHI.|This study will evaluate the effects of Bio-K+50B® at a dosage of 100 billion (B) colony forming units (CFU) daily for 12 weeks in improving glycemic control in patients with Type 2 diabetes (T2D) population when compared to placebo.|t|t|t|t
1327401|NCT03239353|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1327402|NCT03239340||Single Group Assignment||Treatment||None (Open Label)||||||
1327403|NCT03239327|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327404|NCT03239314|Randomized|Parallel Assignment||Treatment||Single|||t|||
1327405|NCT03239301|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1327453|NCT03238677|Randomized|Factorial Assignment||Treatment||Single|Individuals who conduct the phonetic transcriptions that will be used for the primary outcome data will be blinded as to whether the recordings were collected before or after treatment, and also blinded as to the group assignment of the participant.|2 x 2 design Scheduling: Mass-->Distributed vs. Distributed only Visual feedback: Sequenced Ultrasound Biofeedback vs. No biofeedback||||t
1327454|NCT03238664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327455|NCT03238651|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327456|NCT03238638||Parallel Assignment||Treatment||None (Open Label)||||||
1327457|NCT03238625|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1327406|NCT03239288|Randomized|Crossover Assignment||Other||Quadruple||"Randomized, controlled, double-blind, crossover trial that includes one screening visit and two test visits separated by a washout period of 4-7 days. At Visit 1 (day -7), subjects will provide informed consent and undergo screening assessments. Test day instructions will also be provided.~At Visit 2 (day 0), subjects will arrive at the clinic fasted (10-14 h, water only, anchored to the t = -15 min blood draw), to undergo clinic visit procedures. Eligible subjects will be randomly assigned to a randomization sequence and will undergo the glycemic and insulinemic response test with blood glucose concentrations assessed via capillary measurement and insulin concentrations assessed via venous measurement.~At Visit 3 (day 7), subjects will return to the clinic for clinic visit procedures. Subjects will then crossover to the next study product in their test sequence and repeat the glycemic/insulinemic response test described above for Visit 2."|t|t|t|t
1327407|NCT03239275|Randomized|Parallel Assignment||Treatment||Single||||||t
1327408|NCT03239262|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two groups of patients undergoing standard treatment have been compared retrospectively.||||
1327409|NCT03239249|Randomized|Parallel Assignment||Treatment||Single|Students and guardians are masked for experimental condition, teachers and collaborating professionals are not.|Of all schools (42) in four counties, 20 have been randomized to experimental and 22 have been randomized to control condition. Schools randomized to experimental condition implement the IKO-model, while schools randomized to control condition work with drop-out as previously.|t|||
1327410|NCT03239236|Randomized|Parallel Assignment||Treatment||Single|||||t|
1327411|NCT03239223|Randomized|Sequential Assignment||Treatment||Triple||Up to two ascending dose cohorts (8 subjects per cohort) may receive multiple doses in 2 ascending dose strengths of ABI-1968 Topical Cream. After completing the multiple ascending dose portion a Cohort Expansion group of 32 to 40 subjects will be initiated.|t|t|t|
1327412|NCT03239210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327413|NCT03239197|||Family-Based||Prospective|||||||
1327414|NCT03239184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327415|NCT03239171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327416|NCT03239158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327417|NCT03239145|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327418|NCT03239132|Randomized|Parallel Assignment||Treatment||Single||||||t
1327419|NCT03239119|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1327420|NCT03239106||Single Group Assignment||Treatment||None (Open Label)||open label||||
1327421|NCT03239093|||Ecologic or Community||Retrospective|||||||
1327422|NCT03239080|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327423|NCT03239067|||Cohort||Prospective|||||||
1327424|NCT03239054|Randomized|Parallel Assignment||Prevention||None (Open Label)||participants will be randomized in a 1:1 fashion into the study group or the control group.||||
1327425|NCT03239041|Randomized|Parallel Assignment||Other||Single||||||t
1327426|NCT03239028|||Cohort||Prospective|||||||
1327427|NCT03239015||Single Group Assignment||Treatment||None (Open Label)||||||
1327428|NCT03239002|||Cohort||Prospective|||||||
1327429|NCT03238989|||Cohort||Prospective|||||||
1327430|NCT03238976|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327431|NCT03238963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1327432|NCT03238950|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327433|NCT03238937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327434|NCT03238924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327435|NCT03238911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327436|NCT03238898|Randomized|Parallel Assignment||Treatment||Single|double-blind|randomized, double-blind and placebo-controlled study|t|||
1327437|NCT03238885|||Cohort||Prospective|||||||
1327438|NCT03238872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327439|NCT03238859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327440|NCT03238846|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||A prospective, parallel, cluster randomized noninferiority trial with three study arms will be conducted. In this study, a health facility is a cluster or site. Study sites were purposively selected from Chitungwiza Municipality, Masvingo Provincial districts, Matebeleland South Provincial districts, and Mberengwa district where USAID partners are currently implementing CARGs. Thirty clusters were selected and randomized in two strata per geographic location (urban and rural) to the three study arms. Outcomes will be assessed after 12 and 24 months,||||
1327441|NCT03238833|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327442|NCT03238820||Single Group Assignment||Treatment||None (Open Label)||This is a single group, open study.||||
1327443|NCT03238807|Randomized|Parallel Assignment||Prevention||Double|Double-Blinded|Randomized Controlled Trial|t|t||
1327444|NCT03238794|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327445|NCT03238781|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1327446|NCT03238768|Randomized|Parallel Assignment||Health Services Research||Double|Parents, participant and Outcomes assessor will be blinded to the nutritional intervention group.|Infants will be randomized to receive either standard parenteral nutrition via the NICU protocol or enhanced parenteral nutrition via the Study protocol during their first week of life through higher initial macronutrient provision and faster advancement of macronutrient provision.|t|||t
1327447|NCT03238755|||Cohort||Prospective|||||||
1327448|NCT03238742|Randomized|Parallel Assignment||Treatment||Triple|Blind (Participant, Investigator, Outcomes Assessor)|Parallel Assignment|t||t|t
1327449|NCT03238729|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327450|NCT03238716|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327451|NCT03238703||Single Group Assignment||Treatment||None (Open Label)||||||
1327452|NCT03238690||Single Group Assignment||Treatment||None (Open Label)||||||
1327458|NCT03238612|Randomized|Parallel Assignment||Treatment||Double|Double-blind|Prospective Randomised Controlled Trial|t||t|
1576894|NCT00005362||||||||||||
1327459|NCT03238599||Single Group Assignment||Other||None (Open Label)||Non-randomized prospective non-blinded single-arm clinical phase II study||||
1327460|NCT03238586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327461|NCT03238573|||Cohort||Prospective|||||||
1327462|NCT03238560|||Other||Prospective|||||||
1327463|NCT03238547|||Other||Cross-Sectional|||||||
1327464|NCT03238534|Randomized|Parallel Assignment||Treatment||Triple|Double Blind (patient+investigator)||t||t|t
1327465|NCT03238521|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327466|NCT03238508|||Case-Control||Prospective|||||||
1327467|NCT03238495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327468|NCT03238482|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1327469|NCT03238469|Randomized|Parallel Assignment||Treatment||Single||Randomized intra-patient controlled trial.||||t
1327470|NCT03238456|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327471|NCT03238443|||Cohort||Prospective|||||||
1327472|NCT03238430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327473|NCT03238417|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Dynamic waitlist control design with seven VA facilities randomly allocated to Evidence-Based Quality Improvement (EBQI) in Year 1 (with 14 VA facilities serving as waitlist controls), a second seven VA facilities randomly allocated to EBQI in Year 2 (with 7 remaining VA facilities continuing to serve as waitlist controls), and the final 7 VA facilities getting EBQI in Year 3 (no waitlist controls remaining).||||
1327474|NCT03238404|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a single-center, parallel, open-label randomized controlled trial.||||
1327475|NCT03238391|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1327476|NCT03238378||Single Group Assignment||Treatment||None (Open Label)||||||
1327477|NCT03238365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327478|NCT03238352|Randomized|Parallel Assignment||Treatment||Single|||||t|
1327479|NCT03238339|||Case-Control||Prospective|||||||
1327480|NCT03238326||Single Group Assignment||Supportive Care||None (Open Label)||||||
1327481|NCT03238313|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327482|NCT03238300|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1327483|NCT03238287|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327484|NCT03238274|||Cohort||Prospective|||||||
1327485|NCT03238261|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327486|NCT03238248||Single Group Assignment||Treatment||None (Open Label)||||||
1327487|NCT03238235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327488|NCT03238222|Randomized|Parallel Assignment||Treatment||Single||||||t
1327489|NCT03238209||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327490|NCT03238196|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1327491|NCT03238183|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327492|NCT03238170||Single Group Assignment||Treatment||None (Open Label)||||||
1327493|NCT03238157|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized to either observation (2:1) (standard of care) or intravitreal Fluocinolone Acetonide (FA) implant||||
1327494|NCT03238144||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327495|NCT03238131|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327496|NCT03238118|Randomized|Parallel Assignment||Treatment||Triple|Participants and caregivers will be blinded to the intervention and control groups. They will not be blinded to the psychoeducation group.|"A) The first sub-group (n=60) will participate in the intervention group (the attention bias modification training) and will receive psychoeducation; B) The second sub-group (n=60 children) will participate in the attention control condition and will receive psychoeducation; C) The third sub-group (n= 20) will receive only psychoeducation. Children will be randomly assigned to one of these three groups. Both children and parents will be blind to group assignment.~Parents will provide written informed consent for children's participation. This study was approved by the Ethics Committee of Hospital de Clinicas de Porto Alegre."|t|t||t
1327497|NCT03238105|Randomized|Single Group Assignment||Treatment||Single|There will be 2 blinded evaluators who will not know which side of the periorbital hyperchromia (right or left) received which treatment (IPL or peeling of 10% thioglycolic acid). They will do the evaluation through photographs, comparing the photos before the treatments with the photos after 1, 2 and 3 sessions after the treatments, without knowing what therapeutic modality was adopted in each periorbital region.|The selected patients will have each region of periorbital hyperchromia (right and left) randomized to one of the treatments (split face study).||||t
1327498|NCT03238092|Randomized|Parallel Assignment||Treatment||None (Open Label)||As a pre-treatment for in vitro fertilization, one arm will receive transdermic testosterone , one arm will receive oral estradiol and a third arm will be the control group, without pre-treatment||||
1327499|NCT03238079||Single Group Assignment||Treatment||None (Open Label)||||||
1327500|NCT03238066||Single Group Assignment||Treatment||None (Open Label)||||||
1327501|NCT03238053|Randomized|Parallel Assignment||Supportive Care||Single|Laser probe perform similar noise and movement without providing rays|Four Groups of women randomized for thre months to either laser og sham treatment|t|||
1327502|NCT03238040|||Cohort||Prospective|||||||
1327531|NCT03237663|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1327532|NCT03237650|||Case-Crossover||Cross-Sectional|||||||
1327533|NCT03237637|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1327534|NCT03237624|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1327535|NCT03237611||Single Group Assignment||Treatment||None (Open Label)||Patient scheduled for the first cycle of carboplatin-based chemotherapy will be offered to receive 125mg of oral aprepitant or 115mg of fosaprepitant intravenously for prevention of chemotherapy-induced nausea and vomiting||||
1327536|NCT03237598|||Other||Cross-Sectional|||||||
1327537|NCT03237585|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1576895|NCT00005361||||||||||||
1327503|NCT03238027|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Initially in both phases, 3 patients will receive SNDX-6352 at 1 mg/kg IV on C1D1 and again on C1D15 of a 28-day cycle. Phase 1b only will also receive a fixed dose of 1500mg durvalumab IV on C1D1. If no DLTs are noted, 3 more patients will be treated at the next higher dose level (3 mg/kg). If 1 DLT is observed in 1 of 3 patients, 3 more patients will be treated at that starting dose level (1 mg/kg). If 2 or more DLTs are observed in 3-6 patients at the starting dose, the study will be terminated or a lower dose will be considered. If the safety profile is acceptable, escalation to SNDX-6352 doses of 3, 6 and 10mg/kg are planned for the 1a and for the 1b, doses of 3 and 6 mg/kg of SNDX-6352 in combination with a fixed dose of 1500mg of durvalumab are planned. The MTD will be considered to have been exceeded if 2 or more patients in a dose group experience a DLT; in this case, the next lower dose group which has been evaluated will be considered as the MTD.||||
1327504|NCT03238014|Randomized|Crossover Assignment||Treatment||Double||||t||t
1327505|NCT03238001||Single Group Assignment||Screening||None (Open Label)||This study uses a paired design in which each subject undergoes blinded testing by separate testers administering DCTclock and a battery of reference standard tests to determine cognitive state.||||
1327506|NCT03237988|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1327507|NCT03237975|Randomized|Parallel Assignment||Supportive Care||Single||Participants were assigned to two groups in parallel for the duration of the study. One group received usual care for diabetes patients. One group received strengths-based intervention.||||t
1327508|NCT03237962|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327509|NCT03237949|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327510|NCT03237936||Single Group Assignment||Treatment||None (Open Label)||||||
1327511|NCT03237923|||Other||Prospective|||||||
1327512|NCT03237910|Randomized|Parallel Assignment||Treatment||Single||||||t
1327513|NCT03237897|||Case-Control||Prospective|||||||
1327514|NCT03237884|||Cohort||Prospective|||||||
1327515|NCT03237871||Single Group Assignment||Other||None (Open Label)||||||
1327516|NCT03237858|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1327517|NCT03237845|Randomized|Parallel Assignment||Treatment||Triple|Double-blind to Sponsor, Investigator and Subject|Double-blind to Sponsor, Investigator and Subject|t|t|t|
1327518|NCT03237832|Randomized|Parallel Assignment||Health Services Research||Quadruple|The pharmacist preparing the doses was unblended and was responsible for all drug accountability issues, including preparing, labeling, and dispensing study drug according to the randomization code provided. The unblinded pharmacists were responsible for maintaining the blind, consistent with protocol design, throughout the study. All documentation was filed in the Pharmacy Manual, and access to this manual was restricted to the unblinded pharmacists. The subjects, Principal Investigator, and all other personnel involved with subject assessments were blinded to the actual treatment assignments of the subjects (ARN-6039 or placebo) during the study.|Determine safety and tolerability of ARN-6039 ascending doses compared to placebo|t|t|t|t
1327519|NCT03237819|Randomized|Parallel Assignment||Treatment||Quadruple|"For each day of treatment, 4 ampoules of 10 ml will be distributed to the patient's nurse (4 ampoules of 1.5g of magnesium sulphate or 3 ampoules of 5% glucose as placebo).~The bulbs will be labeled identically so that the blind can be maintained Moreover, in order to preserve the blind, the dosage of magnesemia should not be performed outside of a necessity judged by the clinician in charge of the patient"|multicentre double-blind randomized clinical trial|t|t|t|t
1327520|NCT03237806|Randomized|Crossover Assignment||Screening||None (Open Label)|No Masking|Self control||||
1327521|NCT03237793|Randomized|Parallel Assignment||Treatment||Double|A unified stratified randomization, double blind controlled parallel designed was the type generated the allocation sequence. A skilled assistant enrolled the participants and assigned the participants to interventions.|The present study was designed as a randomised controlled clinical trial which was unicenter, double-blinded, parallel designed study, according to the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.|t|||t
1327522|NCT03237780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327523|NCT03237767|Randomized|Crossover Assignment||Treatment||None (Open Label)|The present study will be a pilot, counter-balanced, cross-over trial in individuals with CF.|The present study will be a pilot, counter-balanced, cross-over trial in individuals with CF.||||
1327524|NCT03237754|Randomized|Parallel Assignment||Basic Science||Double|double-blind|Patients receive either Placebo or real neurostimulation|t||t|
1327525|NCT03237741|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1327526|NCT03237728|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327527|NCT03237715|||Case-Control||Prospective|||||||
1327528|NCT03237702||Single Group Assignment||Screening||None (Open Label)||"A total of 600 male patients who are planning to have prostate biopsy will be enrolled in the first stage of this study for measuring urine metabolomics. Only the patients who have non-metastatic significant prostate cancer, insignificant prostate cancer, ASAP/PIN, or benign prostate proved by prostate biopsy are enrolled into the second stage in which MCS supplementation will be used for 8 weeks.~In addition, 20 men and 20 women will be enrolled as a healthy control without any further medication."||||
1327529|NCT03237689|Randomized|Parallel Assignment||Basic Science||Quadruple|The only entity knowledgeable of randomization is the Johns Hopkins University Investigational Drug Service Pharmacy. They are responsible for randomizing and encapsulating the drug and placebo tablets|"The design is a two-phase study of HIV+ women who: 1) first participate in a double-blind, placebo-controlled cross-over study of a single, low dose (10 mg) of hydrocortisone versus placebo on cognition; and 2) then participate in a mechanistic, randomized, double-blind, placebo controlled trial of daily LDH for 4 weeks on cognition and side effects.~Below includes the number of arms for the second study phase and is the phase of the study being considered a Phase 0 clinical trial. All information to follow will pertain to this phase of the study."|t|t|t|t
1327530|NCT03237676|Randomized|Parallel Assignment||Treatment||Triple|"Participants are randomised on treatment arm. Co-investigators are blinded from knowing which participant receives which treatment arm.~Cognitive outcome assessor is blinded from knowing which participant receives which treatment arm."|intervention group receives structured cognitive rehabilitation therapy, control group receives conventional/pre-existing cognitive rehabilitation therapy.|t||t|t
1576896|NCT00005360||||||||||||
1327538|NCT03237572|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pilot, 2-arm randomized study||||
1327539|NCT03237559|||Family-Based||Other|||||||
1327540|NCT03237546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327541|NCT03237533|Randomized|Parallel Assignment||Treatment||Single||||||t
1327542|NCT03237520|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will be masked to the group allocation and the intervention|An open labeled, randomized controlled, parallel design, superiority trial||||t
1327543|NCT03237507|||Cohort||Prospective|||||||
1327544|NCT03237494|||Case-Control||Prospective|||||||
1327545|NCT03237481|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1327546|NCT03237468||Single Group Assignment||Prevention||None (Open Label)||||||
1327547|NCT03237455|Randomized|Parallel Assignment||Diagnostic||Single|Reader of the MRI studies will be blinded to the patients diagnoses|case control study||||t
1327548|NCT03237442|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1327549|NCT03237429|||Cohort||Prospective|||||||
1327550|NCT03237416||Single Group Assignment||Other||None (Open Label)||||||
1327551|NCT03237403|||Cohort||Retrospective|||||||
1327552|NCT03237390||Single Group Assignment||Treatment||None (Open Label)||||||
1327553|NCT03237377|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1327554|NCT03237364||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327555|NCT03237351|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327556|NCT03237338|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1327557|NCT03237325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327558|NCT03237312|Randomized|Parallel Assignment||Treatment||Single|||t|||
1327559|NCT03237299|||Case-Control||Prospective|||||||
1327560|NCT03237286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327561|NCT03237273||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327562|NCT03237260||Single Group Assignment||Treatment||None (Open Label)||||||
1327563|NCT03237247|||Case-Only||Cross-Sectional|||||||
1327564|NCT03237234|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1327565|NCT03237221|||Case-Only||Prospective|||||||
1327566|NCT03237208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327567|NCT03237195|||Case-Crossover||Retrospective|||||||
1327568|NCT03237182|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients randomized to the intervention receive a individualized tuberculosis treatment based on whole genome sequencing and the patients randomized to the control receive the standard of care tuberculosis treatment||||
1327569|NCT03237169|||Cohort||Prospective|||||||
1327570|NCT03237156|Randomized|Parallel Assignment||Other||Double|||t||t|
1327571|NCT03237143|||Cohort||Retrospective|||||||
1327572|NCT03237130|||Cohort||Prospective|||||||
1327573|NCT03237117|Randomized|Parallel Assignment||Treatment||Double|The assignments are concealed in sealed opaque envelopes until the time of enrollment: group I (GH patients) and group II (non-GH patients). All injections are performed by an independent nurse who is informed by the trial coordinator of each woman´s number and the treatment allocation. Consequently, both the clinician and the patients are blinded as to the treatment received.|105 infertile women are enrolled in the randomized controlled trial: 70 women are with a history of RIF with donated oocytes and 35 infertile women undergoe the first oocyte donation attempt. 35 RIF patients are treated with GH (GH patients, study group) while the rest 35 RIF patients (non-GH patients, negative control group) and 35 first-attempt patients (positive control group) are not.|t|t||
1327574|NCT03237104|||Case-Control||Prospective|||||||
1327575|NCT03237091|Randomized|Crossover Assignment||Treatment||Double||This is a a randomized, sham-controlled crossover study in which all participants will participate in a single session of each type of intervention.|t|||t
1327576|NCT03237078||Single Group Assignment||Treatment||None (Open Label)||||||
1327577|NCT03237065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327578|NCT03237052|Randomized|Parallel Assignment||Treatment||Single||||||t
1327579|NCT03237039||Single Group Assignment||Screening||None (Open Label)||symptomatic elderly subjects||||
1327580|NCT03237026|||Cohort||Prospective|||||||
1327581|NCT03237013|Randomized|Parallel Assignment||Prevention||None (Open Label)||At initial visit, participants were screened for study eligibility, consented, and randomized to a study condition. Participants first completed baseline assessment. Following, all participants completed intervention as determined by randomized assignment (i.e., control, facial morphing or mindfulness). At the initial visit, all subjects were assigned a subject ID number. Each subject ID was pre-assigned to a study condition, determined by an online randomization program, prior to recruitment. Each eligible participant had a 1/3 chance to be assigned to each of the three study conditions. Immediately after intervention, participants completed acute assessment, also consisting of self-report questionnaires. At the end of the initial visit, participants provided researchers a valid email address to be sent a subsequent follow-up survey. Approximately one month from the intervention date, participants received and completed the online follow-up survey.||||
1327582|NCT03237000||Single Group Assignment||Diagnostic||None (Open Label)||"Magnesium sulphate was administered by continuous intravenous infusion according to our hospital protocol as follows:~Loading dose: 4-6 gm of magnesium sulphate diluted in 100 mL of IV fluid administered over 15-20 min.~Maintenance dose: 2 gm/hr in 100 mL of IV infusion to be continued for 24 hours after delivery."||||
1327583|NCT03236987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327584|NCT03236974|Randomized|Parallel Assignment||Treatment||None (Open Label)|Not applicable, thisis an open-label study.|||||
1327585|NCT03236961|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-label|||||
1327586|NCT03236948|Randomized|Parallel Assignment||Prevention||None (Open Label)||Individual level randomised trial, with intervention and control group||||
1327587|NCT03236935||Single Group Assignment||Treatment||None (Open Label)||||||
1327588|NCT03236922|Randomized|Parallel Assignment||Prevention||Single||||||t
1327589|NCT03236909||Single Group Assignment||Treatment||None (Open Label)||||||
1327590|NCT03236896|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327591|NCT03236883|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327592|NCT03236870|||Cohort||Prospective|||||||
1327593|NCT03236857||Single Group Assignment||Treatment||None (Open Label)||||||
1327594|NCT03236844|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327595|NCT03236831||Single Group Assignment||Prevention||None (Open Label)||Open label single group interventional study||||
1327596|NCT03236818||Single Group Assignment||Treatment||None (Open Label)||||||
1327597|NCT03236805|Randomized|Parallel Assignment||Treatment||Single|||t|||
1327598|NCT03236792||Sequential Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1327599|NCT03236779|Randomized|Parallel Assignment||Treatment||Double|Participants who fulfill the inclusion criteria will receive the standardized oral and written information, and, once they consent to participate in the trial, will be randomized in a block system by blocks of 10 patients. Allocation to the groups will be achieved using a computer program (Randomizer, https://www.randomizer.org/) generated a random patient file numbers sequence by a third person not involved in the study from the file section in Kuwait. This person will be responsible for guarding the envelope with the information of the randomization. The envelopes will be closed until the moment of the intervention to maintain the blinding. This professional also will ask the patients for informed consent. The consent form is recruited upon the ethical medical committee at the ministry of health in the state of Kuwait.|This study is a prospective, two parallel-groups (participant) randomized controlled trial with blinded outcome assessment at baseline, and at 4, 8, 12, 26 and 52 weeks. The study flow chart shown in Figure 1 conforms to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines for nonpharmacological studies|t|||t
1327600|NCT03236766||Single Group Assignment||Health Services Research||None (Open Label)||||||
1327601|NCT03236753|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327602|NCT03236740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327603|NCT03236727|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1327604|NCT03236714|||Other||Prospective|||||||
1327605|NCT03236701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327606|NCT03236688|||Cohort||Prospective|||||||
1327607|NCT03236675|||Cohort||Prospective|||||||
1327608|NCT03236662||Single Group Assignment||Treatment||None (Open Label)||||||
1327609|NCT03236649|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open, randomized controlled, multicenter||||
1327610|NCT03236636|Randomized|Parallel Assignment||Treatment||Quadruple||multicenter, randomized, double-blind, double-dummy|t|t|t|t
1327611|NCT03236623|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a study with an experimental research design, such as a randomizedclinical trial, parallel, prospective and monocentric.||||
1327612|NCT03236610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327613|NCT03236597|Randomized|Crossover Assignment||Treatment||None (Open Label)||"A within-person, cross-over design will be used. Twenty overweight and obese participants will take part in two interventions: 1) the treadmill desk: this intervention will allow for 1hr+ per day at a treadmill desk for four weeks; and 2) the sit/stand desk: a sit/stand workstation will be installed at the desk for four weeks. Participants will be randomly assigned to their initial intervention condition after baseline measures have been collected. In addition to the two intervention months, there will be a one-week baseline period (to collected information on habitual activity level at work) and a four-week washout period in between intervention months."||||
1327614|NCT03236584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327615|NCT03236571||Single Group Assignment||Supportive Care||None (Open Label)||||||
1327616|NCT03236558||Single Group Assignment||Basic Science||None (Open Label)||||||
1327617|NCT03236545|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327618|NCT03236532|Randomized|Crossover Assignment||Other||Double|The substances were packed in sachets containing GDP (glutamine) or maltodextrin (placebo). The packages were identical and the substances used had a similar color and texture. An external subject organized group division and substances delivery.|In the first stage, the participants were initially randomly separated in a double-blind way in order to ingest either the GDP (Condition 1) or maltodextrin as a placebo (Condition 2) for seven days. On the seventh and last day of supplementation, they were submitted to the resistance training session. Before and immediately after the exercise session, the cognitive tests were applied. After these procedures there was a one-week rest period (step 2). Then the procedures performed in the first step were repeated (step 3). However, the group that had received GDP started to receive maltodextrin, and the group who had received maltodextrin started to receive GDP, adopting, thus, a randomized double-blind crossover design.|t||t|
1327619|NCT03236519||||||||||||
1327620|NCT03236506|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised, un-blinded trial||||
1327621|NCT03236493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1327622|NCT03236480|||Case-Control||Prospective|||||||
1327623|NCT03236467||Single Group Assignment||Treatment||None (Open Label)||Using an innovative translational research approach to study whether a 12 week-progressive - exercise program will reduce FM pain in patients with PTSD and to elucidate and modify potential PTSD-related deficiencies in neurobiological and psychological responses to exercise||||
1327624|NCT03236454|Randomized|Parallel Assignment||Treatment||Single|Sham Stimulation: Ramping up over 50 seconds at the beginning and an equal amount of time for tapering off at the end||t|||
1327625|NCT03236441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327626|NCT03236428||Single Group Assignment||Treatment||None (Open Label)||||||
1327627|NCT03236415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327628|NCT03236402|||Cohort||Cross-Sectional|||||||
1327629|NCT03236389||Single Group Assignment||Screening||None (Open Label)||||||
1327630|NCT03236376|Randomized|Parallel Assignment||Treatment||Single|The assessor will be masked for treatment group|Randomized controlled Trial with two therapy groups ( experimental and control therapy) and one healthy control group||||t
1327631|NCT03236363|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327632|NCT03236350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327633|NCT03236337|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327634|NCT03236324|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327635|NCT03236311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327636|NCT03236298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327637|NCT03236285|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327638|NCT03236272|||Case-Control||Prospective|||||||
1327639|NCT03236259|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1327640|NCT03236246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327641|NCT03236233|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1327642|NCT03236220||Single Group Assignment||Prevention||None (Open Label)|Open Label|||||
1327643|NCT03236207|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1327644|NCT03236194|||Cohort||Prospective|||||||
1327645|NCT03236181|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1327646|NCT03236168||Single Group Assignment||Treatment||None (Open Label)||||||
1327647|NCT03236155|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327648|NCT03236142|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327649|NCT03236129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1327650|NCT03236116|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327651|NCT03236103||Single Group Assignment||Prevention||None (Open Label)||Open label single group interventional study||||
1327652|NCT03236090|Randomized|Parallel Assignment||Treatment||Single|Placebo (we evaluate the probiotic Vivomixx® vs placebo as adjunctive in addition to the standard of care)|"Decompensated patients with cirrhosis:~Outpatients with refractory ascites (substudy 1) (n=20)~Patients hospitalized because bacterial infection (substudy 2) (n=30)"|t|||
1327653|NCT03236077|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327654|NCT03236064||Single Group Assignment||Treatment||None (Open Label)||||||
1327655|NCT03236051|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a randomized, parallel, controlled, open study.||||
1327656|NCT03236038|||Other||Prospective|||||||
1327657|NCT03236025|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1327658|NCT03236012||Single Group Assignment||Treatment||None (Open Label)|Open label|"For this study, subjects will be recruited from the amputee clinics held at the Salt Lake Veteran Affairs (VA) Medical Center or the University of Utah. Combined, these clinics serve approximately 500 patients and see approximately 75 new patients each year.~We plan to recruit a total of 25 subjects to this project from the two study sites. It is expected that we will enroll equal numbers from both the University of Utah and VA Medical Center."||||
1327659|NCT03235999|||Cohort||Prospective|||||||
1327660|NCT03235986|Randomized|Parallel Assignment||Treatment||None (Open Label)||Part I is an ascending dose scheme of IMP versus nCPAP alone. Part II is a parallel group with 2 doses of IMP versus nCPAP alone||||
1327661|NCT03235973||Single Group Assignment||Treatment||None (Open Label)||||||
1327662|NCT03235960|||Case-Only||Prospective|||||||
1327663|NCT03235947|Randomized|Parallel Assignment||Prevention||Quadruple||This is a randomized, parallel-group, controlled clinical trial conducted in a single center that will include renal transplant recipients over the age of 18 to assess the efficacy and safety of disodium fosfomycin in the perioperative period of renal transplantation. The intervention group will receive intravenous fosfomycin 4 g disodium three hours prior to: renal transplant surgery, removal of the urinary catheter and withdrawal of the ureteral catheter. The control group will receive placebo at the same time. Both groups will receive standard prophylaxis consisting of trimethoprim / sulfamethoxazole (160/800 mg) orally every 24 hours when the GFR is greater than 30 mL / min / 1.73m2.|t|t|t|t
1327664|NCT03235934|||Cohort||Prospective|||||||
1327665|NCT03235921|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"To avoid significant hypotension during nitroglycerin administration, each patient was evaluated for adequate intravascularvolume as evidenced by repeated volume challenges(250 mL of crystalloid over 10 minutes) up to appoint at which central venous pressure raised by more than 2 mmHg.~When the systolic blood pressure reaches 90mmHg or more we can apply the nitroglycerin patch of 2.5 mg alongside with continuous resuscitation the dose can be doubled according to the change in the peripheral perfusion parameters. Time between administration of nitroglycerin patch and peak of its action will be calculated.~Nitroglycerin patch will be removed if the patient developed significant hypotension (mean arterial pressure of less than 50 mm Hg ) however its action may persist up to 45minutes after removal.~During the study, infusion rates of noradrenaline or other vasoactive drugs were not changed and no additional fluids were administered."||||
1327666|NCT03235908|||Cohort||Prospective|||||||
1327667|NCT03235895|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327668|NCT03235882|||Cohort||Prospective|||||||
1327669|NCT03235869||Single Group Assignment||Treatment||None (Open Label)||||||
1327670|NCT03235856|||Other||Retrospective|||||||
1327671|NCT03235843|Randomized|Crossover Assignment||Treatment||Double|The pacing mode set by the pacemaker technician will not be disclosed to either patients or the study physician.|Patients enter a double blind randomized cross-over pilot study and will be randomized in a 1:1 fashion to either rate responsive (MV sensor only) function on or off. After 3 months the pacing mode will be switched to the opposite mode.|t||t|
1327711|NCT03235323|Randomized|Parallel Assignment||Treatment||Single||A standard ECP protocol involves 35 one-hour sessions (once per day, 5 days a week) and continuous for 7 weeks. ECP consists of three sets of pneumatic cuffs attached to each of the patient's legs at the calf and lower and upper thigh. The inflation of the cuffs is triggered by a computer, and timing of the inflation is based on the R wave of the electrocardiogram. The ECP therapist adjusts the inflation and deflation timing to provide optimal blood movement per a finger plethysmogram waveform reading.||||t
1327712|NCT03235310|||Cohort||Prospective|||||||
1327713|NCT03235297|||Cohort||Prospective|||||||
1327714|NCT03235284|Randomized|Parallel Assignment||Treatment||Single|Single Blind (Outcomes Assessor)|||||t
1327715|NCT03235271|||Cohort||Prospective|||||||
1327672|NCT03235830|Randomized|Parallel Assignment||Health Services Research||Triple|Following the initial visit where consent, demographic information, and the NVS were obtained, participants were randomly assigned, by computer, to one of two groups: (1) caregiver receives only enhanced standard of care documents (ESoC), or (2) caregiver receives text messages in addition to enhanced standard of care documents (ESoC + Text). Both research team members and participants were blind to group assignment at the time of consent and enrollment. Clinic staff and providers were not aware of group assignment unless revealed by the participant.|"Caregivers of newborns (0-10 weeks of age) whose child received primary care at an urban, academic primary care clinic were approached for participation. Inclusion required reliable cellular and text messaging service and the ability to speak English. At intake, caregivers completed a brief demographic survey and were given a researcher-administered health literacy test called the Newest Vital Sign (NVS).~Following the initial visit where consent, demographic information, and the NVS were obtained, participants were randomly assigned, by computer, to one of two groups: (1) caregiver receives only enhanced standard of care documents (ESoC), or (2) caregiver receives text messages in addition to enhanced standard of care documents (ESoC + Text). Both research team members and participants were blind to group assignment at the time of consent and enrollment. Clinic staff and providers were not aware of group assignment unless revealed by the participant."||t|t|t
1327673|NCT03235817|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327674|NCT03235804|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327675|NCT03235791||||||||||||
1327676|NCT03235778|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1327677|NCT03235765|||Cohort||Prospective|||||||
1327678|NCT03235752|Randomized|Parallel Assignment||Treatment||Quadruple|Randomized, Double-blind, Placebo-controlled|Randomized, Double-blind, Placebo-controlled|t|t|t|t
1327679|NCT03235739|Randomized|Parallel Assignment||Treatment||Triple||Effect of Naloxegol on reversing opioid-related side effects in patients recovering from elective primary hip surgery under spinal anesthesia who will be randomly assigned to oral Naloxegol or placebo for two postoperative days or until the date of discharge, whichever occurs earlier. The design will be a randomized, double-blind, placebo-controlled trial of oral Naloxegol in adults having elective primary hip or knee surgery under spinal anesthesia. The study will be performed at the Cleveland Clinic hospitals.|t|t|t|
1327680|NCT03235726|Randomized|Parallel Assignment||Treatment||Double|This is a double blind, randomized study and subject and investigator will be blinded.|In this study, subjects will be randomized to receive either study drug or placebo in a parallel manner.|t||t|
1327681|NCT03235713|||Ecologic or Community||Prospective|||||||
1327682|NCT03235700|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1327683|NCT03235687|Randomized|Parallel Assignment||Screening||Triple||This is a prospective, randomized blinded, shared decision-impact and health-economic assessment study. 1000 appropriately screened consecutive patients seen during planning for a prostate biopsy will be enrolled. 500 patients will be randomized (blinded) to have the ExoDx Prostate (IntelliScore) test (Cohort A) and 500 (Cohort B) will proceed with conventional standard of care. At time of enrollment, neither the patient nor the urologist will be made aware of whether the patient will have an ExoDx Prostate (IntelliScore) test as part of their work-up. Cohort A EPI test results will be sent to the urologist for assessment and ultimately shared with the patient.|t|t|t|
1327684|NCT03235674|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327685|NCT03235661|Randomized|Parallel Assignment||Treatment||Quadruple||BiPAP and nCPAP are used as primary mode of ventilation in preterm twins infants with RDS|t|t|t|t
1327686|NCT03235648||Single Group Assignment||Treatment||None (Open Label)||||||
1327687|NCT03235635|||Cohort||Prospective|||||||
1327688|NCT03235622|||Cohort||Retrospective|||||||
1327689|NCT03235609|Randomized|Parallel Assignment||Treatment||Double|double blind||t||t|
1327690|NCT03235596||Single Group Assignment||Treatment||None (Open Label)||It's an interventional, prospective and monocentric pilot study.||||
1327691|NCT03235583||Single Group Assignment||Other||None (Open Label)||||||
1327692|NCT03235570||Single Group Assignment||Treatment||None (Open Label)||||||
1327693|NCT03235557|||Cohort||Prospective|||||||
1327694|NCT03235544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327695|NCT03235531|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327696|NCT03235518|||Other||Cross-Sectional|||||||
1327697|NCT03235505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327698|NCT03235492||Single Group Assignment||Other||None (Open Label)||||||
1327699|NCT03235479|Randomized|Parallel Assignment||Treatment||Triple|Double-blind to Sponsor, Investigator and Subject|Double-blind to Sponsor, Investigator and Subject Randomized Controlled Trial|t|t|t|
1327700|NCT03235466|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial of 3 groups: 1) standard voice therapy 2) voice therapy and heart rate variability biofeedback and 3) heart rate variability biofeedback|t|||
1327701|NCT03235453|Randomized|Factorial Assignment||Treatment||Double||Randomized clinical trial, two arm study (group 1 - Binary Rhythm; group 2 - Quaternary Rhythm|t||t|
1327702|NCT03235440||Single Group Assignment||Prevention||None (Open Label)||||||
1327703|NCT03235427|||Case-Control||Prospective|||||||
1327704|NCT03235414||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327705|NCT03235401|||Case-Only||Cross-Sectional|||||||
1327706|NCT03235388|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327707|NCT03235375|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327708|NCT03235362|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1327709|NCT03235349||Single Group Assignment||Treatment||None (Open Label)||||||
1327710|NCT03235336|||Cohort||Prospective|||||||
1327716|NCT03235258|||Cohort||Prospective|||||||
1327717|NCT03235245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327718|NCT03235232|Randomized|Parallel Assignment||Treatment||Single|||||t|
1327719|NCT03235219|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327720|NCT03235206||Single Group Assignment||Treatment||None (Open Label)||||||
1327721|NCT03235193|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1327722|NCT03235180||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327723|NCT03235167|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1327724|NCT03235154||Single Group Assignment||Treatment||None (Open Label)||||||
1327725|NCT03235141|Randomized|Crossover Assignment||Treatment||Double||"There are 8 subjects will be enrolled in pre-test, each subject was sampled in two eyes and each subject participated in two cycles of the trial. 8 subjects, 16 eyes participated in the study, 32 samples of tears total .~There are 48 subjects will divided into group A and group B randomly . subjects of Group A will given the first test drug, elution after the control drug; Subjects of Group B will given the first control drug, elution given to the test drug."|t||t|
1327726|NCT03235128|||Case-Control||Retrospective|||||||
1327727|NCT03235115|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1327728|NCT03235102|||Ecologic or Community||Cross-Sectional|||||||
1327729|NCT03235089||||||||||||
1327730|NCT03235076|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1327731|NCT03235063|||Cohort||Prospective|||||||
1327732|NCT03235050|Randomized|Parallel Assignment||Treatment||Triple|The study will be conducted in a double-blind fashion for MEDI0382 and placebo. The sponsor staff, the subjects, and the Investigators involved in the treatment of subjects or in the clinical evaluation of subjects will not be aware of the treatment received. Liraglutide will be provided in an open-label active comparator arm.|Randomised, parallel, double-blind, placebo-controlled study with an open-label active comparator.|t|t|t|
1327733|NCT03235037||Single Group Assignment||Treatment||None (Open Label)||This is an open label study to assess the motor and cognitive and developmental effects of carbidopa/levodopa when administered orally in doses of 1 -10mg per kg per day. This study will recruit and monitor patients over a 2 year period.||||
1327734|NCT03235024|Randomized|Parallel Assignment||Treatment||Quadruple|"This is a double blind study. Participants will be assigned to study treatment in accordance with the randomization schedule generated for the allocation of vehicle or B244 prior to the initiation of the trial. Randomization will be centrally-based and performed using an appropriate IWRS (an automated randomization system).~Each participant scheduled to receive investigational product (IP) will receive a randomization number at the time of randomization. The randomization number will be used to identify the study medication kit assigned to the participant and indicate the treatment to be administered to that participant."|Randomization will be 1:1 so that equal number of patients will be treated in each Arm of the study.|t|t|t|t
1327735|NCT03235011|||Cohort||Prospective|||||||
1327736|NCT03234998|Randomized|Parallel Assignment||Treatment||Single||||||t
1327737|NCT03234985|||Other||Prospective|||||||
1327738|NCT03234972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327739|NCT03234959|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1327740|NCT03234946|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Relatives of CAIPaDi patients that present on their initial evaluation either overweight, obesity, hypertension, glucose intolerance and/or secondary dyslipidemia will be invited to participate.~Those who accept will require to attend the center twice. On the first visit, an anthropometric evaluation and laboratory studies will be performed; an oral glucose tolerance (OGTT) test will be carried out if the glucose value is over 100 mg/dl. If the OGTT results are abnormal, the individual will be included in the study sample.~Those who have an abnormal OGTT and are included in the study sample will be randomized into two groups.~The change of the main variables (weight, waist circumference, serum glucose, glycated hemoglobin, blood pressure, triglycerides and non-HDL cholesterol) will be assessed 3 months later, along with the effect on patients with diabetes parameters."||||
1327741|NCT03234933||Single Group Assignment||Supportive Care||None (Open Label)||||||
1327742|NCT03234920|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1327743|NCT03234907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327744|NCT03234894||||||||||||
1327745|NCT03234881|Randomized|Parallel Assignment||Treatment||Single|Treating therapists will be blind to outcome data|This is a randomized RCT in which one half of participants will be assigned to MOVE! (treatment-as-usual weight management) and the other half will be assigned to MOVE! plus the experimental condition (guided self-help Cognitive Behavioral Therapy).||t||
1327746|NCT03234868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327747|NCT03234855|||Other||Prospective|||||||
1327748|NCT03234842|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327749|NCT03234829|||Case-Only||Cross-Sectional|||||||
1327750|NCT03234816|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1327751|NCT03234803|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1327752|NCT03234790|Randomized|Crossover Assignment||Screening||Triple|||t||t|t
1327753|NCT03234777|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1327754|NCT03234764|||Cohort||Prospective|||||||
1327755|NCT03234751|Randomized|Crossover Assignment||Basic Science||Double||This study is prospective randomized, double masked, 2-period cross over design, proof of concept study of the effects of intravenously administered rhBNP (nesiritide) on insulin sensitivity in otherwise healthy obese nondiabetic insulin resistant subjects.|t||t|
1327756|NCT03234738|Randomized|Sequential Assignment||Other||Quadruple|IV bags and lines are covered to prevent unblinding.|Five Multiple-Ascending Doses|t|t|t|t
1327757|NCT03234725|||Cohort||Prospective|||||||
1327758|NCT03234712||Single Group Assignment||Treatment||None (Open Label)||||||
1327759|NCT03234699||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1327760|NCT03234686|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1327761|NCT03234673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327762|NCT03234660|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1327763|NCT03234647||Single Group Assignment||Treatment||None (Open Label)||||||
1327764|NCT03234634|Randomized|Factorial Assignment||Treatment||Single||Patients will be dichotomized into good collateral (group 1) and poor collateral group (group 2) according to collateral status assessed on multiphase CT angiography.||||t
1576897|NCT00005359||||||||||||
1327765|NCT03234621|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1327766|NCT03234608|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||We will conduct the study in primary care clinics within three health systems. We will compare data from patients in 7 intervention clinics to patients from matched control clinics within the same systems.||||
1327767|NCT03234595||Single Group Assignment||Other||None (Open Label)||||||
1327768|NCT03234582|||Other||Prospective|||||||
1327769|NCT03234569||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327770|NCT03234556|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1327771|NCT03234543|Randomized|Parallel Assignment||Prevention||Triple|"The study will be conducted in a double-masked fashion. Investigative team member/s that will carry out randomization and administer the intervention will not be involved in evaluation of clinical and laboratory outcomes. The primary surgical team, nurses, and any consulting services caring for the patient will be unaware of the group assignment. Other care providers will not be informed of the group assignment. Outcome assessors will not be involved in randomization and administration of the RIC intervention. Adequate steps are in place to mask the outcome assessors (clinical and laboratory) from knowing group assignment.~Subjects will be masked from recognizing which group they are in in the following manner: a) Subjects will not be informed of the group assignment throughout their participation in the study; b) subjects randomized to No RIPC will have a tourniquet placed on the thigh and inflated."|A prospective, randomized, double - masked clinical trial of RIC will be conducted in adult patients undergoing major abdominal surgery at University Hospital in Newark, NJ. Participants will be randomized into two groups: RIC and No RIC.|t|t||t
1327772|NCT03234530|||Case-Control||Cross-Sectional|||||||
1327773|NCT03234517|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1327774|NCT03234504|||Other||Prospective|||||||
1327775|NCT03234491|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1327776|NCT03234478|||Cohort||Prospective|||||||
1327777|NCT03234465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327778|NCT03234452|Randomized|Crossover Assignment||Treatment||Quadruple|double-blind|randomized, double-blind, placebo-controlled, cross-over trial performed at one centre|t|t|t|t
1327779|NCT03234439|Randomized|Parallel Assignment||Supportive Care||Single||Double-arm, waitlist control trail with 1:1 randomization|||t|
1327780|NCT03234426|Randomized|Crossover Assignment||Treatment||Single||||||t
1327781|NCT03234413|||Case-Only||Retrospective|||||||
1327782|NCT03234400|Randomized|Parallel Assignment||Prevention||Single|||t|||
1327783|NCT03234387|||Cohort||Cross-Sectional|||||||
1327784|NCT03234374|Randomized|Parallel Assignment||Other||Single|This is a single-blind study in which the study subject is blinded to treatment group. All precautions will be taken to ensure that the blinding of the treatment group is maintained throughout the study period. Unblinding to the subject will not be permitted unless it is deemed necessary for appropriate treatment of a medical emergency.||t|||
1327785|NCT03234361|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1327786|NCT03234348|Randomized|Parallel Assignment||Treatment||Double|Neither the participant ot the outcomes assessor will be aware of the treatment received. The patient will be blinded until the primary endpoint is reached (1 year follow-up).|"Patients will be randomised to one of two groups:~MAGMARIS stent arm or ORSIRO stent arm in the ratio of 1:1"|t|||t
1327787|NCT03234335|||Cohort||Prospective|||||||
1327788|NCT03234322|Randomized|Parallel Assignment||Prevention||Double||A pragmatic blinded parallel group superiority cluster randomized controlled trial. Clusters are PCPs (general practitioners, medical practitioners and internists working as general practitioners).|t|||t
1327789|NCT03234309||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327790|NCT03234296|Randomized|Parallel Assignment||Treatment||Triple|Double-blinded RCT, no care providers, patients or researchers are aware of the randomised treatment. Separate safety monitoring committee and preplanned interim analysis.|Anticipated enrollment delays > three alternate scenarios for sample size calculations, please see prtocol for details.|t|t|t|
1327791|NCT03234283||Single Group Assignment||Other||None (Open Label)||A prospective, open label, non-randomized, safety and feasibility study.||||
1327792|NCT03234270|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1327793|NCT03234257||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327794|NCT03234244|Randomized|Crossover Assignment||Other||Double|||t||t|
1327795|NCT03234231|Randomized|Parallel Assignment||Health Services Research||Double|data entered by independent clerical staff with no information of the detail of the study outcomes assessor will not be told which group of subjects are examined but there is a chance that the subjects tell him/her|Cluster randomized controlled trial|||t|t
1327796|NCT03234218|||Cohort||Prospective|||||||
1327797|NCT03234205||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1327798|NCT03234192|Randomized|Single Group Assignment||Treatment||Single|||t|||
1327799|NCT03234179|||Family-Based||Prospective|||||||
1327800|NCT03234166|||Cohort||Retrospective|||||||
1327801|NCT03234153||Single Group Assignment||Treatment||None (Open Label)||Single Arm open-Label prospective Phase II||||
1327802|NCT03234140|||Cohort||Retrospective|||||||
1327803|NCT03234127|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327804|NCT03234114|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327805|NCT03234101|||Cohort||Prospective|||||||
1327806|NCT03234088||Single Group Assignment||Health Services Research||None (Open Label)||||||
1327807|NCT03234075|||Other||Other|||||||
1327856|NCT03233425|||Case-Only||Prospective|||||||
1327944|NCT03232281|Randomized|Parallel Assignment||Treatment||Single||||||t
1327945|NCT03232268||Single Group Assignment||Treatment||None (Open Label)||||||
1327946|NCT03232255||Single Group Assignment||Treatment||None (Open Label)||||||
1327947|NCT03232242|||Cohort||Prospective|||||||
1327948|NCT03232229|||Cohort||Cross-Sectional|||||||
1327949|NCT03232216|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1327950|NCT03232203|||Cohort||Cross-Sectional|||||||
1576898|NCT00005358||||||||||||
1327808|NCT03234062|Randomized|Crossover Assignment||Screening||Triple|Participant dietary arm assignment is randomized by a randomization plan created by the study coordinator at www.randomization.com. Each of the 3 hormonal related demographic groups (male, premenopausal females, and postmenopausal females) will have a list of the same order of diets created by the randomizer. Each participant will be assigned upon entry into the study into the next open diet for their group as ordered by the randomizer. No one collecting or processing data will be informed of the choline levels the participant is experiencing in their dietary arms at any given time to attempt to eliminate bias and ensure appropriate data collection. All staff who interact with participants or who are handling samples/data, will not be informed of the code linking dietary choline levels to diet order.|Healthy volunteers (n=20), will consume meals, provided by the investigator, in two week intervals with 3 different levels of choline (Cho). Participants will receive 100% of the recommended daily intake (RDI) of Cho (550 mg Cho/day); 50% of the RDI of Cho (275mg/day); and 25% of the RDI of Cho (137.5 mg/day). The meal order will be randomly assigned and all participants will receive all diets at some point in the study. There will be a minimum of a two week washout between diet intervals where participants return to their regular diets. Both participants and researchers will be blinded to the diet order.|t||t|t
1327809|NCT03234049|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1327810|NCT03234036|Randomized|Crossover Assignment||Treatment||Double|Part 1 of the study will be open label and thus not be blinded. Part 2 of the study will be single blinded because of the unavailability of matching placebo tablets. The Principal Investigator and the subject will be completely blinded to specific treatment assignment.|The randomization number will determine the allocation of treatment sequences (ABC or BAC) for Part 1, and of treatment (GSK2838232 without RTV or placebo) for Part 2. Allocation to treatment for Part 1A or Part 1B (with Part 2 being fixed) will be according to a predetermined random order.|t||t|
1327811|NCT03234023|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327812|NCT03234010|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327813|NCT03233997|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327814|NCT03233984|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327815|NCT03233971|||Other||Prospective|||||||
1327816|NCT03233958|||Case-Only||Prospective|||||||
1327817|NCT03233945||||||||||||
1327818|NCT03233932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327819|NCT03233919|Randomized|Parallel Assignment||Treatment||Single||||||t
1327820|NCT03233906|Randomized|Parallel Assignment||Treatment||None (Open Label)||Human subjects- females (18-45 y.o.) with a BMI greater than or equal to 26.||||
1327821|NCT03233893|Randomized|Parallel Assignment||Treatment||Double|The patient and the outcome assessor will be blinded in this study||t|||t
1327822|NCT03233880|Randomized|Parallel Assignment||Prevention||Double|double blind|randomized, double blinded controlled trial|t|t||
1327823|NCT03233867|||Case-Only||Cross-Sectional|||||||
1327824|NCT03233854||Single Group Assignment||Treatment||None (Open Label)||||||
1327825|NCT03233841|||Cohort||Other|||||||
1327826|NCT03233828|Randomized|Parallel Assignment||Prevention||Triple||Patients will be given either intralesional IL-2 or intralesional saline as a control|t|t|t|
1327827|NCT03233815|||Cohort||Cross-Sectional|||||||
1327828|NCT03233802|Randomized|Parallel Assignment||Treatment||Single|Investigators are blind to treatment conditions|3 Group randomized clinical trial with parallel treatments|||t|
1327829|NCT03233789|||Other||Cross-Sectional|||||||
1327830|NCT03233776||Sequential Assignment||Supportive Care||None (Open Label)||3+3 design||||
1327831|NCT03233763|||Cohort||Prospective|||||||
1327832|NCT03233750|Randomized|Parallel Assignment||Treatment||Single|Group assignment will be masked from the assessors of performance. Expert educators will score videotaped performances of the participants obtained pre and post intervention. Assessors will be blinded to group allocation as well as to whether the video they are scoring is of the pre or the post intervention scenario.|This is a cohort study, comparing two interventions aimed at decreasing stress responses during acute events, with a pre and a post intervention assessment.||||t
1327833|NCT03233737|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1327834|NCT03233724|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1327835|NCT03233711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327836|NCT03233685|Randomized|Parallel Assignment||Treatment||Single|The participant will be blind regarding the aim of the study|Randomized control trial.|t|||
1327837|NCT03233672||Single Group Assignment||Treatment||None (Open Label)||||||
1327838|NCT03233659|||Cohort||Prospective|||||||
1327839|NCT03233646|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1327840|NCT03233633||Single Group Assignment||Supportive Care||None (Open Label)||||||
1327841|NCT03233620||Single Group Assignment||Treatment||None (Open Label)||||||
1327842|NCT03233607|||Cohort||Prospective|||||||
1327843|NCT03233594|||Other||Prospective|||||||
1327844|NCT03233581|Randomized|Parallel Assignment||Treatment||Single|||||t|
1327845|NCT03233568|||Case-Control||Retrospective|||||||
1327846|NCT03233555|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327847|NCT03233542|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants meeting study criteria for Panic Disorder will be randomized to an intervention arm (CBT) or waiting list arm (which is followed by CBT after completion of the study procedures); participants meeting study criteria for the anxious control group will be allocated to an intervention (CBT) arm. The study aims to have equal numbers of participants in each of the 3 arms.||||
1327848|NCT03233529|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1327849|NCT03233516|||Case-Control||Prospective|||||||
1327850|NCT03233503|||Other||Cross-Sectional|||||||
1327851|NCT03233490|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1327852|NCT03233477|||Cohort||Prospective|||||||
1327853|NCT03233464|||Other||Cross-Sectional|||||||
1327854|NCT03233451|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1327855|NCT03233438|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327857|NCT03233412|Randomized|Parallel Assignment||Treatment||Single||Patients between 25 and 50 years old with histological diagnosis of high-grade intraepithelial lesion, obtained through satisfactory colposcopy and without previous treatment, who will be selected in the preventive clinic of the Hospital de Cancer de Barretos-SP (HCB ). Eligible patients will be identified at the return visit, when they will come to the hospital to check the result of the examination. In this study the patients will be randomized into two groups: Group 1: Control, where standard treatment will be offered, which is the conization of the uterine cervix with loop electrosurgical excision procedure(LEEP); Group 2: experimental group, which will receive topical treatment in the uterine cervix with immunomodulator (Imiquimod), for a period of 12 weeks, with weekly applications (1x / week). 30 to 60 days after immunomodulatory treatment the patient will be submitted to standard treatment with cervical conization with LEEP.||||t
1327858|NCT03233399|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327859|NCT03233386|||Ecologic or Community||Prospective|||||||
1327860|NCT03233373|||Other||Cross-Sectional|||||||
1327861|NCT03233360|||Cohort||Other|||||||
1327862|NCT03233347||Single Group Assignment||Treatment||None (Open Label)||||||
1327863|NCT03233334||Single Group Assignment||Supportive Care||None (Open Label)||||||
1327864|NCT03233321|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327865|NCT03233308|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327866|NCT03233295||Single Group Assignment||Treatment||None (Open Label)||||||
1327867|NCT03233282|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327868|NCT03233269||Single Group Assignment||Treatment||None (Open Label)||||||
1327869|NCT03233256||Single Group Assignment||Diagnostic||None (Open Label)||Healthy adults (18-45 yrs.) will be recruited from the local Denver area. The investigators have elected to study a relatively homogenous sample to limit the impact of age, weight, and chronic disease on isotope fractionation in breath.||||
1327870|NCT03233243|Non-Randomized|Single Group Assignment||Prevention||Double||||t||t
1327871|NCT03233230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327872|NCT03233217|Randomized|Sequential Assignment||Prevention||Double|QHD00008 will be a modified double-blind study in which only a designated administrator at each study site will know which vaccine has been administered to the participants. The participants and the Investigator/Sub-investigator in charge of the safety assessment will be blinded in order to decrease the potential bias in safety assessment.|"Safety and tolerability will be initially assessed in the first 10 participants in a smaller cohort (Cohort 1). Participants will be randomized 1:1 into 2 groups in Cohort 1: QIV-HD by intramuscular (IM) route (n=5) and QIV-HD by subcutaneous (SC) route (n=5).~After review of the local and systemic adverse events, the remaining 165 participants will be enrolled (Cohort 2). Participants will be randomized 1:1:1 into 3 groups in Cohort 2: QIV-HD by IM route (n=55), QIV-HD by SC route (n=55), and standard-dose Quadrivalent Influenza Vaccine (QIV-SD) by SC route (n=55)."|t||t|
1327873|NCT03233204||Single Group Assignment||Treatment||None (Open Label)||||||
1327874|NCT03233191|Randomized|Parallel Assignment||Screening||None (Open Label)||Participants will be randomized to either Digital Breast Tomography (TM) or Full Field Digital Mammography (DM)||||
1327875|NCT03233178|||Cohort||Retrospective|||||||
1327876|NCT03233165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327877|NCT03233152||Single Group Assignment||Treatment||None (Open Label)||||||
1327878|NCT03233139|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1327879|NCT03233126||Single Group Assignment||Treatment||None (Open Label)||||||
1327880|NCT03233113|Randomized|Parallel Assignment||Treatment||Single|Pre-determined condition allocation was listed in an Excel spreadsheet and concealed with black cell masking color. Interested individuals who met initial eligibility criteria during a pre-enrollment phone screening were entered in the order of screening in the assignment Excel spreadsheet (that was already masked to conceal condition assignment). Only the participant's therapist viewed the allocated condition immediately prior to the first treatment session by temporarily lifting the cell mask.|The current study follows a two-arm, parallel group RCT study design. Participants are randomized to either the active control arm (Exposure and Response Prevention) or the experimental arm (Exposure with Judicious Safety Behaviors). Participants are not offered the opportunity to choose their study condition, nor are they provided with an explanation of the difference between their assigned treatment arm and the alternative treatment arm. Randomization was achieved prior to initial participant recruitment via a random number generator with the condition that an equal number of participants be randomized to each condition.||||t
1327881|NCT03233100||Single Group Assignment||Treatment||None (Open Label)||||||
1327882|NCT03233087|||Cohort||Other|||||||
1327883|NCT03233074|||Case-Control||Prospective|||||||
1327884|NCT03233061|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Women OBESE group VS Women NON-OBESE group||||
1327885|NCT03233048||Single Group Assignment||Treatment||None (Open Label)||||||
1327886|NCT03233035|Randomized|Parallel Assignment||Treatment||Triple|Ketamine versus placebo as a double blind study|Double Blind Study|t|t|t|
1327887|NCT03233022|Randomized|Parallel Assignment||Other||None (Open Label)||Users are randomly assigned between arms after completing baseline assessment and stay in that arm for the duration of the study.||||
1327888|NCT03233009|Randomized|Parallel Assignment||Basic Science||Single||||||t
1327889|NCT03232996||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1327890|NCT03232983|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1327891|NCT03232970|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Control Trial||||
1327892|NCT03232957|Randomized|Parallel Assignment||Treatment||Double|In the anesthetic record, 0.5% isobaric bupivacaine with study drug is recorded.||t|||t
1327893|NCT03232944|||Cohort||Prospective|||||||
1327939|NCT03232346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327940|NCT03232333|||Cohort||Prospective|||||||
1327941|NCT03232320|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1327942|NCT03232307||Single Group Assignment||Treatment||None (Open Label)||||||
1327943|NCT03232294|||Cohort||Prospective|||||||
1327894|NCT03232931|Randomized|Parallel Assignment||Treatment||Single|Except for parent reports, all measures will be administered by masked examiners.|A randomized controlled trial design with intent-to-treat analysis in hospitalized preterm infants between 32 and 36 weeks post-menstrual age. Both the control and intervention groups will receive routine neonatal intensive care protocols (including skin-to-skin care by parent when available and daily sessions of exposure to recorded parent's voice). In addition to routine care, the parent-supported multisensory intervention consists of 10 sessions of standardized, therapist-administered, auditory-tactile stimulation that combines contingent recorded mother's voice delivered using a pacifier-activated system, during holding with supportive tactile containment against the therapist's chest, covered by cloth imprinted with mother's scent. Possible covariates, multi- and uni- sensory processing, will be measured at entry into the study and immediately after the treatment phase. Sensory reactivity will be measured at 1 year and language and motor outcomes will be assessed at 2 years.||||t
1327895|NCT03232918|Randomized|Parallel Assignment||Treatment||Triple|The labor room nurse will be aware of the patient group assignment and will adjust the dose of the drug based on group assignment. The Investigator, Physician Provider and Outcome Assessor will be blinded.||t||t|t
1327896|NCT03232905|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1327897|NCT03232892||Single Group Assignment||Treatment||None (Open Label)|No masking|Phase 2, single-arm, open label, multicenter clinical trial.||||
1327898|NCT03232879|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1327899|NCT03232866|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327900|NCT03232853|||Other||Prospective|||||||
1327901|NCT03232840|||Other||Prospective|||||||
1327902|NCT03232827|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1327903|NCT03232814||Single Group Assignment||Supportive Care||None (Open Label)||||||
1327904|NCT03232801|Randomized|Parallel Assignment||Other||Single||||||t
1327905|NCT03232788|Randomized|Parallel Assignment||Treatment||Single|||||t|
1327906|NCT03232775|Randomized|Parallel Assignment||Supportive Care||Single|The medical examination teams (one chief medical resident and one nurse) will be blind to the study aim.|||t||
1327907|NCT03232762|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327908|NCT03232749||Single Group Assignment||Treatment||None (Open Label)||||||
1327909|NCT03232736|Randomized|Crossover Assignment||Other||Double|Patients and study staff will be blinded to the pacemaker adjustment setting||t||t|
1327910|NCT03232723||Single Group Assignment||Basic Science||None (Open Label)||||||
1327911|NCT03232710|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1327912|NCT03232697|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Different populations including subjects with or without cognitive impairment will be used to determine the accuracy of a short version of the MOCA as compared to the full version of this scale.||||
1327913|NCT03232684|||Cohort||Prospective|||||||
1327914|NCT03232671|||Case-Control||Prospective|||||||
1327915|NCT03232658|||Cohort||Retrospective|||||||
1327916|NCT03232645||Single Group Assignment||Treatment||None (Open Label)||||||
1327917|NCT03232632||Single Group Assignment||Supportive Care||None (Open Label)||||||
1327918|NCT03232619|Randomized|Parallel Assignment||Treatment||None (Open Label)||Enrolled patients will receive CD19-CART cell immunotherapy.||||
1327919|NCT03232606|||Case-Only||Prospective|||||||
1327920|NCT03232593|||Cohort||Prospective|||||||
1327921|NCT03232580||Single Group Assignment||Diagnostic||None (Open Label)||||||
1327922|NCT03232567|Randomized|Sequential Assignment||Prevention||Triple||Single ascending dose study|t|t|t|
1327923|NCT03232554|Randomized|Parallel Assignment||Treatment||Double||One third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Ferrous Sulfate，and the another third will receive Buxue Yimu Pills and Ferrous Sulfate in combination.|t||t|
1327924|NCT03232541|Randomized|Factorial Assignment||Supportive Care||Triple|All other care providers beside the acupuncture/sham providing therapists are blinded to randomization group. For example, care providers providing the standard care antiemetic treatment and the chemotherapy per se are blinded for randomization group.||t||t|t
1327925|NCT03232528|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1327926|NCT03232515||Single Group Assignment||Supportive Care||None (Open Label)||Non-randomized pre-test / post-test clinical trial||||
1327927|NCT03232502|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1327928|NCT03232489|||Case-Only||Prospective|||||||
1327929|NCT03232476||Single Group Assignment||Other||None (Open Label)||||||
1327930|NCT03232463|||Case-Only||Prospective|||||||
1327931|NCT03232450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1327932|NCT03232437|||Other||Cross-Sectional|||||||
1327933|NCT03232424||Single Group Assignment||Treatment||None (Open Label)||Prospective, single arm, non-randomized, open label pilot||||
1327934|NCT03232411|||Case-Only||Retrospective|||||||
1327935|NCT03232398|Randomized|Parallel Assignment||Treatment||Single|The primary efficacy endpoint will be the presence of LV thrombus as assessed be echocardiography after 3 months of treatment. Echocardiography images will be reviewed for the presence of LV thrombus by two experts who will be blinded to the study drug.|||||t
1327936|NCT03232385|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327937|NCT03232372|Randomized|Parallel Assignment||Prevention||Single|Blind study The RX examiner and the person performing the resonance frequency measurements would be independent of the surgeons who placed the implants.|"To randomize we will use the application created by a computer programmer that generates random numbers.~In each jaw, each edentulous space will be randomly assigned (A, B, C, D, ..). Following the alphabetical order to each letter will be assigned randomly the connection to use, as detailed below:~2 edentulous spaces: A: c. External or c. Internal (random) B: the one that is pending (The type of internal connection (crestal or infracrestal) will be chosen at random.)~3 edentulous spaces: A: c. External, c. Crestal or infracrestal internal B: randomly choose between the two remaining options C: the one that is pending"|t|||
1327938|NCT03232359|||Cohort||Prospective|||||||
1328042|NCT03230994|||Cohort||Prospective|||||||
1327951|NCT03232190|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1327952|NCT03232177||Single Group Assignment||Treatment||None (Open Label)||||||
1327953|NCT03232164||Single Group Assignment||Diagnostic||None (Open Label)||Single center, open label, single-arm, pilot study||||
1327954|NCT03232151||Single Group Assignment||Diagnostic||None (Open Label)||Single center, open label, single-arm, pilot study||||
1327955|NCT03232138|Randomized|Parallel Assignment||Prevention||Quadruple|Double Blind||t|t|t|t
1327956|NCT03232125|Randomized|Parallel Assignment||Prevention||Triple|Participants, care provider and investigator are blinded to group assignment.|Randomly selected patients of the ramoseton group are given a 0.3 mg of ramosetron after induction. In contrast, patients in the control group are given the same volume of normal saline after induction and given a 0.3 mg of ramosetron after measurement of QTc interval.|t|t|t|
1327957|NCT03232112|Randomized|Parallel Assignment||Treatment||Triple|An un-blinded nurse will be responsible for carrying out the randomization of the patients in REDCap. When randomization is carried out, the nurse will ensure that the patient gets the treatment that he/she is allocated to. Patients, investigators, other care givers performing assessments and persons performing data analysis will remain blinded from the time of randomization until time of database unlock. In order to maintain the blinding of the patients, the nurse will prepare the injection in a separate room and the patients will be blindfolded as the injection is given.|Double-blinded, randomized, placebo-controlled.|t||t|t
1327958|NCT03232099|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||Forty two men with established atherosclerotic disease will be studied:after a 2 week washout period, each subject receives both treatments, intervention and control||||
1327959|NCT03232086|Randomized|Crossover Assignment||Basic Science||Double||"Clean Air~Concentrated PM2.5"|t||t|
1327960|NCT03232073||Single Group Assignment||Treatment||None (Open Label)||This is a single-group open-label extension study to investigate long-term safety, tolerability and control of disease of ponesimod 20 mg in subjects with RMS. Statistical analyses will be descriptive and therefore all endpoints are exploratory in nature. All exploratory endpoints are listed under primary outcomes.||||
1327961|NCT03232047|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1327962|NCT03232034|Randomized|Crossover Assignment||Basic Science||Double|Participants and Researchers will be blinded to the interventions.||t||t|
1327963|NCT03232021|Randomized|Parallel Assignment||Prevention||Quadruple||Prospective, double-blind,randomized, placebo controlled trial|t|t|t|t
1327964|NCT03232008|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1327965|NCT03231995||Single Group Assignment||Other||None (Open Label)||||||
1327966|NCT03231982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1327967|NCT03231969|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327968|NCT03231956|||Case-Control||Prospective|||||||
1327969|NCT03231943|Randomized|Sequential Assignment||Treatment||Double|This will be a double-blind study with subjects and the site-staff blinded and sponsor unblinded.|This is a dose-escalation study and dose will be escalated based on the safety data of the initial dose.|t||t|
1327970|NCT03231930||Single Group Assignment||Diagnostic||None (Open Label)||All participants will receive the same intervention, which is rapid point of care testing for hepatitis C antibodies using the OraQuick test with oral fluid , followed by point of care testing for the detection of hepatitis C virus RNA using the Cepheid Xpert HCV RNA viral load test on the GeneXpert system. Participants who are found to have current HCV infection will be worked up for treatment at ths clinic and referred to appropriate practitioners for HCV treatment. All results will be confirmed with standard laboratory testing as these devices are not yet approved for diagnostic use in Australia.||||
1327971|NCT03231917|Randomized|Parallel Assignment||Screening||None (Open Label)||In one randomized group, water infusion will be employed as the first method for mucosal inspection while in a second group, CO2 insufflation will be used first. This study will be different than usual care since the participants will receive two successive or tandem colonoscopies versus one||||
1327972|NCT03231904|||Cohort||Prospective|||||||
1327973|NCT03231891|||Cohort||Prospective|||||||
1327974|NCT03231878|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1327975|NCT03231865|||Cohort||Prospective|||||||
1327976|NCT03231852|||Cohort||Prospective|||||||
1327977|NCT03231839|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1327978|NCT03231826|||Cohort||Prospective|||||||
1327979|NCT03231813|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1327980|NCT03231800|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind|This is a randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study in children with ADHD in a laboratory classroom setting|t|t|t|t
1327981|NCT03231787|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1327982|NCT03231774|||Cohort||Prospective|||||||
1327983|NCT03231761|Randomized|Parallel Assignment||Other||Single|||t|||
1327984|NCT03231748|||Cohort||Prospective|||||||
1327985|NCT03231735|Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a randomized controlled trial with a 1:1 parallel allocation of infants to mid or standard frequency ventilation using stratified permuted block design.||||
1327986|NCT03231722|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|||||
1327987|NCT03231709|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1327988|NCT03231696|||Cohort||Retrospective|||||||
1327989|NCT03231683|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1327990|NCT03231670|||Case-Only||Prospective|||||||
1327991|NCT03231657|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1327992|NCT03231644|||Cohort||Cross-Sectional|||||||
1327993|NCT03231631|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1327994|NCT03231618|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1327995|NCT03231605|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1327996|NCT03231592|Randomized|Parallel Assignment||Prevention||Single||||||t
1327997|NCT03231579|||Cohort||Prospective|||||||
1328043|NCT03230981||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1327998|NCT03231566|Randomized|Parallel Assignment||Treatment||Quadruple|Outcome measures were mailed by patients in prepaid envelopes||t|t|t|t
1327999|NCT03231553|Randomized|Parallel Assignment||Other||Single|||||t|
1328000|NCT03231540|Randomized|Parallel Assignment||Prevention||Single||||||t
1328001|NCT03231527|||Cohort||Retrospective|||||||
1328002|NCT03231514|Non-Randomized|Parallel Assignment||Other||Single|Participants are blinded to the pre-workout drink content.|Semi-randomized, parallel-group, single-blind diet and exercise intervention|t|||
1328003|NCT03231501||Single Group Assignment||Treatment||None (Open Label)||This is a single arm, open label study with fixed dose.||||
1328004|NCT03231488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328005|NCT03231475||Single Group Assignment||Treatment||None (Open Label)||||||
1328006|NCT03231462|||Cohort||Prospective|||||||
1328007|NCT03231449|||Cohort||Prospective|||||||
1328008|NCT03231436|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1328009|NCT03231423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328010|NCT03231410|||Case-Control||Prospective|||||||
1328011|NCT03231397|Randomized|Factorial Assignment||Basic Science||None (Open Label)||"Eligible subjects in this study will have either a known abdominal aortic aneurysm (AAA) or because they do not have an AAA (control group).~The purpose of this research study is to further study, through FEA, changes that occur in the mechanical properties of the aortic wall. The investigator will compare two radiotracers, 18F-FDG and 11C-PBR28 to determine if one provides more useful and reliable information about inflammation. 18F-FDG and 11C-PBR28 are radioactive drugs that will be used for imaging during the PET-CT scan. The investigator will also compare the results describing the mechanical properties of the AAA wall to the degree of inflammation in that wall as determined by PET-CT imaging to define new and better predictors of AAA growth and/or rupture."||||
1328012|NCT03231384|Randomized|Parallel Assignment||Treatment||Single||||||t
1328013|NCT03231371||Single Group Assignment||Diagnostic||None (Open Label)||||||
1328014|NCT03231358|Randomized|Parallel Assignment||Prevention||Single||We will randomize adolescents (with parents) to an intervention arm (testing Our Family Our Future, n=440) or a control arm (n=440) of usual care (consisting of a packet of existing available brochures on HIV, STIs, mental health including places to access care). We will randomize based on permuted blocked randomization.||||t
1328015|NCT03231345||Single Group Assignment||Other||None (Open Label)||This study utilizes a convenience sample of patient who have difficult venous access with at least 2 attempts by nursing to achieve venous access. The patient will be consented and a physician placed ultrasound-guided peripheral IV will be placed in the internal jugular vein.||||
1328016|NCT03231332|Randomized|Parallel Assignment||Treatment||None (Open Label)|Active treatment will be provided unmasked in the treatment groups|Comparison between intervention groups and the group without intervention will be made||||
1328017|NCT03231319|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1328018|NCT03231306||Single Group Assignment||Treatment||None (Open Label)||||||
1328019|NCT03231293|||Case-Only||Prospective|||||||
1328020|NCT03231280|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328021|NCT03231267|||Case-Control||Prospective|||||||
1328022|NCT03231254|||Case-Only||Cross-Sectional|||||||
1328023|NCT03231241|||Ecologic or Community||Cross-Sectional|||||||
1328024|NCT03231228|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|n/a, this is an open label study|Approximately 110 subjects will be enrolled and assigned to 1 of the 2 dose groups in a 1:1 ratio (55 subjects in each group). Subjects with a weight of at least 25 kg but less than 60 kg will receive a single IV dose of 1 g cefazolin. Subjects with a weight of at least 60 kg will receive a single IV dose of 2 g cefazolin. Dose groups will not be balanced by age or gender.||||
1328025|NCT03231215|Randomized|Parallel Assignment||Treatment||Single|||||t|
1328026|NCT03231202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328027|NCT03231189|||Cohort||Prospective|||||||
1328028|NCT03231176||Single Group Assignment||Treatment||None (Open Label)||||||
1328029|NCT03231163|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1328030|NCT03231150|Randomized|Single Group Assignment||Treatment||Double|Participants that do not experience at least a 50% reduction in pain following phase 1 will undergo randomization to either USGI or ATGI, both injections consisting of 0.5 ml 0.25% bupivacaine plain, 0.5 ml dexamethasone phosphate, and 0.5 ml triamcinolone acetonide 40 mg/ml. Execution of the USGI will employ an actual diagnostic US machine (Voluson E8 Expert, General Electric Company, Boston, MA) and a plantarmedial approach, whereas execution of the ATGI will employ a sham diagnostic US machine and a plantarmedial approach. The patients will be randomized into these groups by a specialized statistical computerized system that randomly selects a number to the participant. An even or an odd number represents which form of injection the patient is to receive.|This investigation will be chronologically divided into four stages that will commence after procurement of institutional review board (IRB) approval and funding, namely: 1) screening and enrollment, 2) random treatment allocation and treatment, 3) data collection and analysis, and 4) presentation and publication. We anticipate that it will take approximately 23.5 months to execute the clinical experiment and to prepare the report for publication.||t|t|
1328031|NCT03231137|Randomized|Parallel Assignment||Treatment||Single||||||t
1328032|NCT03231124|Randomized|Parallel Assignment||Treatment||Double|LEO 32731 and Placebo tablets are of identical appearance. The packaging and labelling of the IMPs and Placebo contain no evidence of their identity. It is not considered possible to differentiate between the IMPs solely by sensory evaluation.||t||t|
1328033|NCT03231111|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328034|NCT03231098|||Case-Only||Prospective|||||||
1328035|NCT03231085|Randomized|Parallel Assignment||Treatment||Single||||t||
1328036|NCT03231072||Single Group Assignment||Diagnostic||None (Open Label)||||||
1328037|NCT03231059|||Cohort||Retrospective|||||||
1328038|NCT03231046|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1328039|NCT03231033||Single Group Assignment||Basic Science||None (Open Label)||||||
1328040|NCT03231020|||Family-Based||Prospective|||||||
1328041|NCT03231007|||Other||Cross-Sectional|||||||
1328044|NCT03230968|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1328045|NCT03230955|Randomized|Parallel Assignment||Supportive Care||Single|Participants and hospital clinicians will be blind|"Participants will be randomized into IG and CG with 2:1 allocation using mapping software, because it is expected a larger number of losses to follow-up in the CG. GI patients will be contacted by a nurse of the 061CatSalut Respon quit line who will have received specific training in intervening smokers with mental disorders. The call will take place within the first 48 h after discharge from the hospitals. The patients of the CG will be contacted by a team of the 061 CatSalut Respon in order to provide a brief counselling (first call) and evaluate their use of tobacco during the 1st, 6th and 12th month."|t|||
1328046|NCT03230942|Randomized|Parallel Assignment||Supportive Care||Triple|All patients will be assessed for functional outcomes by a rater blinded to the study arm||t||t|t
1328047|NCT03230929||Single Group Assignment||Screening||None (Open Label)||||||
1328048|NCT03230916||Single Group Assignment||Treatment||None (Open Label)||||||
1328049|NCT03230903|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1328050|NCT03230890||Single Group Assignment||Treatment||None (Open Label)||Single site, non-randomized, single arm, open label design,with collection of outcome measures before, and at intervals after the intervention||||
1328051|NCT03230877||||||||||||
1328052|NCT03230864|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328053|NCT03230851|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328054|NCT03230838|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328055|NCT03230825|Randomized|Parallel Assignment||Treatment||Single|Data analysis will be performed according to group code .|"Once informed consent forms are signed, the patient will be randomized (using a randomization table handled by a 3rd party) into one of 2 groups:~Expectant management of 3 weeks and a follow up visit a week after.~Oral contraceptive agent, given for free, for 3 weeks and a follow up visit a week after treatment withdrawal."||||t
1328056|NCT03230812|Non-Randomized|Parallel Assignment||Prevention||Single||"One group with type 2 diabetic patients with an initially low carnitine status One group with type 2 diabetic patients with an initially high carnitine status~Both groups will undergo oral L-carnitine supplementation for 96 days"|t|||
1328057|NCT03230799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328058|NCT03230786|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328059|NCT03230773|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, randomised study with volunteers randomised to use one of six different defibrillator designs.||||
1328060|NCT03230760||Single Group Assignment||Treatment||None (Open Label)||||||
1328061|NCT03230747||||||||||||
1328062|NCT03230734|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1328063|NCT03230721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328064|NCT03230708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328065|NCT03230695|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1328066|NCT03230682|||Cohort||Prospective|||||||
1328067|NCT03230669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328068|NCT03230656|Randomized|Factorial Assignment||Screening||None (Open Label)||Each participant diagnosed with concussion/mild traumatic brain injury will be screened for cognitive and communication abilities at two weeks post-injury and then four weeks post-injury. Standardized scores of the screening measures will identify subjects that are below one standard deviation below the mean. Subjects that continue to exhibit deficits after one month will be randomly placed into an early cognitive-communication therapy group (one month post-injury) or waitlist control group who receive therapy two month post-injury.||||
1328069|NCT03230643|||Case-Control||Prospective|||||||
1328070|NCT03230630|||Cohort||Other|||||||
1328071|NCT03230617|||Other||Cross-Sectional|||||||
1328072|NCT03230604|Randomized|Parallel Assignment||Treatment||Quadruple||"Intervention: Bulk full composite (3M) bulk fill composite in posterior class one cavities bulk fill composite in posterior class two cavities bulk fill composite in posterior class five cavities~Intervention:Bulk full composite (Ivoclar-Vivadent) bulk fill composite in posterior class one cavities bulk fill composite in posterior class two cavities bulk fill composite in posterior class five cavities Other: bulk fill composite Intervention Control: Nano resin composite (K Z350 xt) Restoration in class one cavities Restoration in class Two cavities Restoration in class five cavities"|t|t|t|t
1328073|NCT03230591|||Case-Only||Prospective|||||||
1328074|NCT03230578|||Other||Cross-Sectional|||||||
1328075|NCT03230565|Randomized|Parallel Assignment||Treatment||Triple|Investigators and participants will be masked to treatment group. Care providers will be necessarily unmasked.|Comparison of two groups: 1) Continuous infusion group 2) Bolus Infusion group|t||t|t
1328076|NCT03230552|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized control trial||||
1328077|NCT03230539|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||A proof-of concept, randomized 3-month study to evaluate the effects of three contraceptive intrauterine systems delivering Copper and a daily dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)||||
1328078|NCT03230526|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1328079|NCT03230513|Randomized|Parallel Assignment||Treatment||Single|The Primary Investigator (PI) was blinded as to the exercise type that the patient had learned and used and evaluates all the outcomes of the study.|"Participants were assigned to either the SEM group (written as Group A) or the BDE group (written as Group B) throughout the duration of the study."|||t|
1328080|NCT03230500|Randomized|Parallel Assignment||Treatment||Single|due to the nature of the trial only the outcome assessror will be masked from the intervention or control group|assignment||||t
1328081|NCT03230487|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328082|NCT03230474|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328083|NCT03230461|Randomized|Sequential Assignment||Treatment||Double|Participants and researchers are blinded to the actual depth achieved during each CPR run.|Prospective, randomised.|t||t|
1328084|NCT03230448|||Other||Prospective|||||||
1328085|NCT03230435|||Case-Control||Cross-Sectional|||||||
1328226|NCT03228602|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1328086|NCT03230422|Randomized|Parallel Assignment||Treatment||Single|residents, fellows and attending with different level of experience||t|||
1328087|NCT03230409|Non-Randomized|Factorial Assignment||Treatment||Single|||t|||
1328088|NCT03230396|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1328089|NCT03230383|Randomized|Sequential Assignment||Basic Science||Double|||t||t|
1328090|NCT03230370|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1328091|NCT03230357||Single Group Assignment||Supportive Care||None (Open Label)||||||
1328092|NCT03230344|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328093|NCT03230331|||Case-Control||Prospective|||||||
1328094|NCT03230318||Single Group Assignment||Treatment||None (Open Label)||||||
1328095|NCT03230305|||Cohort||Prospective|||||||
1328096|NCT03230292||Single Group Assignment||Treatment||None (Open Label)||||||
1328097|NCT03230279|Randomized|Parallel Assignment||Treatment||Single||"Study Population: Chronic SIJ dysfunction patients presenting at selected Ochsner Health System healthcare centers~Recruiting mode: Participation will be offered by the principal investigator or the sub-investigators during an outpatient visit in the neurosurgery or pain management clinic."||||t
1328098|NCT03230266||Single Group Assignment||Other||None (Open Label)||||||
1328099|NCT03230253|Randomized|Parallel Assignment||Treatment||Single||||||t
1328100|NCT03230240|||Cohort||Prospective|||||||
1328101|NCT03230227|Randomized|Parallel Assignment||Treatment||Double||post open heart surgery pain alleviation|t||t|
1328102|NCT03230214|||Cohort||Prospective|||||||
1328103|NCT03230201|Randomized|Single Group Assignment||Treatment||Single||||||t
1328104|NCT03230188|||Cohort||Prospective|||||||
1328105|NCT03230175||Single Group Assignment||Treatment||None (Open Label)||||||
1328106|NCT03230162|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328107|NCT03230149|||Case-Only||Prospective|||||||
1328108|NCT03230136|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328109|NCT03230123|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with diabetes and Pre-diabetes were randomly allocated to receive diet alone or diet plus green banana biomass suplementation during a six-month intervention period.||||
1328110|NCT03230110|||Case-Control||Prospective|||||||
1328111|NCT03230097|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1328112|NCT03230084||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1328113|NCT03230071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328114|NCT03230058|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328115|NCT03230045|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1328116|NCT03230032|Randomized|Parallel Assignment||Prevention||Double||There participants will be randomized to two groups: PAL (pacifier and mother's voice provided contingently on sucking behavior) or Sounds of Love (listening to mother's voice not contingent upon sucking behavior on the pacifier, but pacifier available, per standard of care). To allow for high repetitiveness of the treatment, participants in both groups will receive 2 daily 15-min sessions of the intervention or control treatments for a total of 20 sessions. Sessions occur 15-30 min prior to feeding.||t||t
1328117|NCT03230019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328118|NCT03230006|Randomized|Parallel Assignment||Treatment||Single||Participants will be randomized to one of two conditions: 1) treatment with the UP or 2) treatment with therapist-guided Take Control (TC; a computerized alcohol reduction program). In addition, in a subset of twenty-five participants, functional magnetic resonance scanning (fMRI) will be used to examine the effects of the UP on changes in brain activity in areas important to regulation of emotional and reward processes implicated in excessive alcohol consumption.||||t
1328119|NCT03229993|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328120|NCT03229980|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328121|NCT03229967|||Cohort||Prospective|||||||
1328122|NCT03229954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328123|NCT03229941|Randomized|Parallel Assignment||Other||Single|||t|||
1328124|NCT03229928|||Cohort||Prospective|||||||
1328125|NCT03229915|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Group 1: PTSD patients Group 2: trauma-exposed control Group 3: no trauma healthy control Group 1 and 2 will undergo CPT.||||
1328126|NCT03229902||Sequential Assignment||Treatment||None (Open Label)||single-case research design involving a series of AB designs||||
1328127|NCT03229889|Randomized|Factorial Assignment||Treatment||Triple|Both patients and treating surgeons (who are also on the study team) will be blinded. None physician researchers will be unblinded to tract and randomize patients.|Patients will be randomized into 1 of 4 groups: Flomax + Placebo, Cialis + Placebo, Cialis + Flomax, Placebo + Placebo.|t|t|t|
1328128|NCT03229876||Sequential Assignment||Treatment||None (Open Label)||||||
1328129|NCT03229863|Randomized|Crossover Assignment||Treatment||None (Open Label)||This study is designed as a combined randomized, crossover interventional and observational trial. At the start of the study, infants will enter a 7-day lead-in period to establish gut microbiome and GI tolerability baselines. After the 7-day lead-in period, infants will be randomized into one of two feeding arms comprised of two commercially available baby foods: sweet potato (SP) (Plum Organics, Just Sweet Potato) and pears (P) (Earth's Best, First Pears). The first food, either sweet potato or pears, will be consumed for 7 days followed by a 4-day washout period of exclusive breast milk before initiating the alternate 7-day feeding arm of pears or sweet potato, respectively. The second feeding arm will be followed by an additional 4-day washout period of exclusive breast milk before the introduction of any other solid foods. Once the first month of the study is complete, infants will enter an observational phase for the remainder of the study.||||
1328130|NCT03229850|Randomized|Crossover Assignment||Treatment||Double|During one euglycemic clamp study, insulin lispro will be injected subcutaneously into an area of subclinical lipohypertrophy of the abdomen identified by ultrasound, during the other insulin lispro will be injected to an area with no subclinical lipohypertrophy.||||t|t
1328131|NCT03229837|||Cohort||Prospective|||||||
1328132|NCT03229824|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1576899|NCT00005357||||||||||||
1328133|NCT03229811|Randomized|Parallel Assignment||Health Services Research||Single||Comprehensive pre-dialysis program incorporating advance care planning|||t|
1328134|NCT03229798|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1328135|NCT03229785||Single Group Assignment||Supportive Care||None (Open Label)||||||
1328136|NCT03229772||Single Group Assignment||Other||None (Open Label)||||||
1328137|NCT03229759|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1328138|NCT03229746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328139|NCT03229733|Randomized|Parallel Assignment||Treatment||Single||||||t
1328140|NCT03229720|Randomized|Parallel Assignment||Supportive Care||Single|The statistician is blinded by naming the groupes into group A and group B|||||t
1328141|NCT03229707|Randomized|Parallel Assignment||Screening||Double|||t|||t
1328142|NCT03229694|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1328143|NCT03229681|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328144|NCT03229668|Randomized|Parallel Assignment||Prevention||Quadruple||Prospective, double-blind,randomized, placebo controlled trial|t|t|t|t
1328145|NCT03229655|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized prospective study||||
1328146|NCT03229642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328147|NCT03229629|Randomized|Factorial Assignment||Treatment||None (Open Label)||Cluster randomised controlled trial Clustered at the village level, 5 treatment arms and one control group Within three treatment arms, voucher will be individually randomised||||
1328148|NCT03229616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328149|NCT03229603||Single Group Assignment||Prevention||None (Open Label)||||||
1328150|NCT03229590|||Cohort||Prospective|||||||
1328151|NCT03229577|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1328152|NCT03229564||Single Group Assignment||Treatment||None (Open Label)||||||
1328153|NCT03229551|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1328154|NCT03229538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328155|NCT03229525|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328156|NCT03229512||Single Group Assignment||Prevention||None (Open Label)||||||
1328157|NCT03229499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328158|NCT03229486|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1328159|NCT03229473|||Cohort||Prospective|||||||
1328160|NCT03229460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328161|NCT03229447|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will develop and test the feasibility of an interactive eLearning modality and an eLearning + an organizational approach (change team intervention; a Technology Transfer model) to advance knowledge and facilitate inclusion of MAT in the criminal justice system for opioid-addicted clients. Courts recruited for the study will receive eLearning and half of these courts will be randomly assigned to the change team.||||
1328162|NCT03229434|Randomized|Crossover Assignment||Basic Science||Single|pseudonymes|||||t
1328163|NCT03229421|||Case-Only||Prospective|||||||
1328164|NCT03229408|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1328165|NCT03229395|||Other||Prospective|||||||
1328166|NCT03229382||Single Group Assignment||Treatment||None (Open Label)||||||
1328167|NCT03229369|Randomized|Parallel Assignment||Treatment||Single|Surgeons and participants of the study will not be blinded due to the intrinsic characteristics of the intervention trials, in which it is impossible to blind surgeons and avoid acknowledgement of the participants of which procedure they were assigned. However, outcome evaluation will be performed by an individual who will not have acknowledgement of which group the patient was allocated.|||||t
1328168|NCT03229356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328169|NCT03229343|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Experimental arm : supportive care, systematic and joint to pneumological consultation, monthly, starting at M0 and continuing up to M6.~Non interventionnel arm: only pneumological consultation performed at M0, M3 and M6."||||
1328170|NCT03229330|Randomized|Parallel Assignment||Treatment||None (Open Label)|All subjects involved are aware of the procedures applied due to the features of the therapies used.|||||
1328171|NCT03229317|||Cohort||Prospective|||||||
1328172|NCT03229304|||Cohort||Prospective|||||||
1328173|NCT03229291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328174|NCT03229278||Single Group Assignment||Treatment||None (Open Label)||||||
1328175|NCT03229265||Single Group Assignment||Treatment||None (Open Label)||||||
1328176|NCT03229252|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind||t|t|t|t
1328177|NCT03229239||Single Group Assignment||Treatment||None (Open Label)||||||
1328178|NCT03229226|||Case-Only||Other|||||||
1328179|NCT03229213|||Case-Control||Cross-Sectional|||||||
1328180|NCT03229200||Single Group Assignment||Treatment||None (Open Label)||||||
1328181|NCT03229187|||Other||Prospective|||||||
1328182|NCT03229174|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328183|NCT03229161|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"This open-label randomized controlled trial aims to enroll 20 patients randomized (1:1) to a control- (Con) or IWT-group. Patients in both the IWT- and Con-group follows the standardized GDM care program for GDM patients at OUH through the 6-week intervention period, which consists of instruction of self-monitoring of BG levels, dietary guidance, and in some cases, insulin treatment. Additionally, the program also consists of close obstetric control visits and exercise guidance. All patients are instructed not to start any new type of PA after inclusion and continue their lives without any changes.~Patients randomized to the IWT-group goes through a 6-week non-supervised IWT-program, where they are prescribed to conduct 3 IWT sessions per week of 40-50 minutes each.~Before and after the 6-week intervention, maternal blood glucose (BG) levels is measured by continuous glucose monitoring, PA level measured using accelerometers and physical fitness measured using two walking tests."||||
1328227|NCT03228589|Randomized|Parallel Assignment||Prevention||Quadruple||Aspirin challenge model|t|t|t|t
1328228|NCT03228576|||Cohort||Prospective|||||||
1328184|NCT03229148|Randomized|Parallel Assignment||Treatment||Single|It is an open label trial because it is not possible to maintain the anesthesiologist and patient blinded during the procedure. However, all subsequent evaluations will be conducted by clinical research staff blinded to the randomization group.|Multicentic, prospective, open, in parallel groups, stratified and randomised study.||||t
1328185|NCT03229135|||Case-Control||Retrospective|||||||
1328186|NCT03229122|||Cohort||Cross-Sectional|||||||
1328187|NCT03229109|||Cohort||Prospective|||||||
1328188|NCT03229096||Single Group Assignment||Treatment||None (Open Label)||||||
1328189|NCT03229083||Single Group Assignment||Supportive Care||None (Open Label)||||||
1328190|NCT03229070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328191|NCT03229057|Randomized|Parallel Assignment||Treatment||Triple||This will be a three-arm, double-blind, double-dummy, multicenter, prospective, randomized clinical trial comparing OCP vs. Metformin vs. OCP + Metformin on the prevalence of MetS in women with PCOS. This 6-month study will consist of a screening visit, followed by 6 study visits. No longer term follow-up is planned.|t|t|t|
1328192|NCT03229044|||Case-Only||Retrospective|||||||
1328193|NCT03229031|Randomized|Parallel Assignment||Treatment||Triple|Randomized, Double-blind||t||t|t
1328194|NCT03229018||Single Group Assignment||Diagnostic||None (Open Label)||||||
1328195|NCT03229005|||Cohort||Prospective|||||||
1328196|NCT03228992|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328197|NCT03228979|Randomized|Parallel Assignment||Prevention||Single|Blinded end-point clinical trial|Study is a multicenter, randomized, parallel-design, adaptive and blinded end-point clinical trial of sub-acute stroke patients||||t
1328198|NCT03228966|||Cohort||Cross-Sectional|||||||
1328199|NCT03228953|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1328200|NCT03228940||Single Group Assignment||Treatment||None (Open Label)||Open-label exploratory||||
1328201|NCT03228927|||Cohort||Cross-Sectional|||||||
1328202|NCT03228914|Randomized|Parallel Assignment||Treatment||Single||||||t
1328203|NCT03228901|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1328204|NCT03228888|Randomized|Parallel Assignment||Treatment||Quadruple||Participants were randomly assigned to one of the two groups (artificial or ecological RAS) and were evaluated in three moments: before the rehabilitative treatment (T0), at the end of the 5 week rehabilitative treatment (T5), and 3 months after the end of the treatment, namely 17 weeks after the first assessment (T17).|t|t|t|t
1328205|NCT03228875|||Cohort||Prospective|||||||
1328206|NCT03228862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328207|NCT03228849|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients were randomly assigned to surgical or conservative groups. After 6 weeks patients in both groups were started on the same rehabilitation protocol.||||
1328208|NCT03228836||Single Group Assignment||Treatment||None (Open Label)||||||
1328209|NCT03228823|Randomized|Parallel Assignment||Treatment||None (Open Label)||PVC suppression with either antiarrhythmic drugs or radiofrequency ablation||||
1328210|NCT03228810|||Case-Only||Prospective|||||||
1328211|NCT03228797|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||comparative study between 3 groups using ropivacaine||||
1328212|NCT03228784||Single Group Assignment||Diagnostic||None (Open Label)||||||
1328213|NCT03228771|Randomized|Parallel Assignment||Treatment||Single||3 Groups: Group 1: statin loaded in PRGF Group 2: statin loaded in methylcellulose gel Group 3: control||||t
1328214|NCT03228758|Randomized|Parallel Assignment||Treatment||Single|Subjects will not be made aware of the orientation approach to the endoscopic myotomy.|Subjects will be randomized to either the anterior or posterior orientation approach to the endoscopic myotomy.|t|||
1328215|NCT03228745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328216|NCT03228732|Randomized|Parallel Assignment||Other||Double||Participants will be randomized into 2 groups. Group 1 will consist of a random order of Protocol 1 and Protocol 5. Group 2 will consist of a randomized order of Protocols 2, 3, 4|t||t|
1328217|NCT03228719|Randomized|Parallel Assignment||Treatment||Single||||||t
1328218|NCT03228706|Randomized|Parallel Assignment||Other||Triple|A person who is independent of this study and invited by principal investigator will carry out the randomization based on the list of participants who are eligible and agreed to participate. The list of participants with their randomization information will be kept by the committee member without informing any of the researchers including principal investigator or respondents to assure the blinding of both parties throughout the study. On the day of the intervention, that person will register the attendance of respondents and inform them about the actual venue of the program without informing the researchers or the facilitators of the KYM-TIFH. Each HCKS and HCKS will have two venues prepared and available during the period of the study with one venue allocated for intervention group and the other one with for control group. None of the respondents were aware of the difference between the with assigned.|To achieve the objectives, positivist approach with experimental study design will be employed. In specific, it is a double blinded, randomized controlled trial (RCT) which involve two study sites. Nonetheless, the reporting of the SGBI will be in accordance with the checklist recommended by Borek et al. (2015).|t||t|t
1328219|NCT03228693|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1328220|NCT03228680|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1328221|NCT03228667|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328222|NCT03228654|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328223|NCT03228641||Single Group Assignment||Treatment||None (Open Label)|subject is blinded to the needle gauge and density of treatment|||||
1328224|NCT03228628|Randomized|Parallel Assignment||Treatment||Double|double blinding. Gaz bottles are in undistinguishable boxes. Neither the patients nor the person doing the LP and the evaluation of pain and anxiety will know the treatment used|1:1 randomization to receive experimental treatment (50% N2O - 50% O2) or placebo (Medical Air: 22% O2 - 78% N2)|t|||t
1328225|NCT03228615|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||This clinical trial uses prospective repeated measures in a before-after study design. Following enrollment of the usual care group (i.e., 50% recruitment goal has been reached), physicians will be trained to use the intervention. We will then enroll the intervention group.||||
1328229|NCT03228563||Single Group Assignment||Treatment||None (Open Label)||||||
1328230|NCT03228550|Randomized|Factorial Assignment||Prevention||Triple|Participants blinded to dietary intervention, but not exercise. Outcomes assessor blinded to both intervention and exercise group.|There are two interventions, a multi-nutrient dietary supplement and exercise. The study will have four groups; 1. multi-nutrient supplement and exercise, 2. multi-nutrient non-exercise, 3. placebo supplement and exercise and 4. placebo supplement non-exercise.|t||t|t
1328231|NCT03228537||Single Group Assignment||Treatment||None (Open Label)||||||
1328232|NCT03228524|Randomized|Parallel Assignment||Treatment||None (Open Label)||Recruited patients will be randomized to receive 2660 mg D-aspartate oral dosing once daily or placebo, in addition to the conventional treatment provided by the relevant staff, for a period of 6 weeks. Patients will also be undergoing a Therapeutic Exercise Program (ET). All conventional therapies taken by patients will be recorded by the operators. Patients will be divided into two D-aspartate + ET and Placebo + ET groups and will be evaluated at zero time before starting treatment (T-0W) after 6 weeks to evaluate the effects at the end of treatment (T-6W) , And at 12 weeks (T-12W) to evaluate the maintenance of long-term effects.||||
1328233|NCT03228511||Single Group Assignment||Treatment||None (Open Label)||||||
1328234|NCT03228498|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind (Participant, Investigator)||t|t|t|t
1328235|NCT03228485|||Cohort||Prospective|||||||
1328236|NCT03228472|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will undergo a cerebral pacing program listed below and differentiated according to the type of symptom presented. All conventional therapies taken by patients will be recorded by the operators. Patients will be divided into Stimulation and Sham (control) groups and will be evaluated at zero time before starting treatment (T-0W) after 6 weeks to evaluate the effects at the end of treatment (T-6W) and at 12 weeks (T-12W) to evaluate the maintenance of long-term effects. Randomization will be balanced in accordance with age, sex and schooling.||||
1328237|NCT03228459|Randomized|Parallel Assignment||Prevention||None (Open Label)||A randomized interventional study with 2 arms that will include 14,600 individuals with at least one CV risk factor, registered in Primary care in the province of Lleida, between January 2015 and December 2017, who will subsequently be followed up until December 2027.||||
1328238|NCT03228446|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1328239|NCT03228433|Randomized|Sequential Assignment||Other||Quadruple|||t|t|t|t
1328240|NCT03228420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328241|NCT03228407|Non-Randomized|Parallel Assignment||Diagnostic||Single|Investigator in the lab performing Ussing's chamber analysis will be blinded to the diagnosis of the patient||||t|
1328242|NCT03228394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328243|NCT03228381||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1328244|NCT03228368|||Case-Only||Prospective|||||||
1328245|NCT03228355|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1328246|NCT03228342|Randomized|Parallel Assignment||Other||Double|||t|||t
1328247|NCT03228329||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1328248|NCT03228316|Randomized|Parallel Assignment||Treatment||Single|prospective interventional|||t||
1328249|NCT03228303|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328250|NCT03228290|||Cohort||Prospective|||||||
1328251|NCT03228277||Single Group Assignment||Treatment||None (Open Label)||||||
1328252|NCT03228264|Randomized|Parallel Assignment||Treatment||Single||This study is designed as a randomized, controlled, evaluator-blinded multi-center superiority trial with two parallel groups and with word finding ability as primary endpoint at the end of the intervention. Aphasia outpatients will be recruited and randomly assigned to the experimental or control group. The randomization will be stratified by the study centre (Bern, Luzern) and the severity of aphasia (mild with a raw value/T-value smaller than 5/52, severe with a raw value/T-value greater or equal to 5/52 for the Token Test). Both groups will do a four weeks intensive tablet-delivered telerehabilitation training (2 hours a day).||||t
1328253|NCT03228251|||Cohort||Cross-Sectional|||||||
1328254|NCT03228238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328255|NCT03228225||Single Group Assignment||Treatment||None (Open Label)||single arm non-blinded remote monitored multidisciplinary secondary prevention intervention||||
1328256|NCT03228212|Randomized|Crossover Assignment||Treatment||Single|||t|||
1328257|NCT03228199|Randomized|Parallel Assignment||Health Services Research||Double|Main outcome and masking: The daily mean weight of tea picked will be calculated for each worker for the 4 weeks baseline and for the 12 weeks evaluation period. The difference between these two means will be calculated for each worker, and the mean of this value will be calculated for each randomised group, with the main study outcome being the difference between these values for each group. It will not be practical to mask participants as to their study group assignment (the investigators do not feel that providing sham near correction of Plano power is ethical). However, the APPL staff measuring the weight and quality outcomes will be masked to a worker's group assignment by having an intermediate person receive the tea from the worker and carry it to the weighing station each day.|"Randomization, Balancing, and Intervention: Eligible workers completing baseline productivity assessment will be enrolled into the study, and assigned at random to one of the below groups:~Intervention Group: Will immediately receive a free pair of presbyopic glasses through the Clear Vision Workplace program. These glasses will correct the worker's vision at their usual working distance by placing the vision chart on the top of a tea bush and directing the participant to stand as usual in picking tea. The gasses will not correct astigmatism. Distance refractive errors will be corrected for those with uncorrected VA < 6/12 in the better-seeing eye.~Control Group: Will be deferred to receive free presbyopic spectacles after the 12 weeks evaluation period."|||t|t
1328258|NCT03228186||Single Group Assignment||Treatment||None (Open Label)||||||
1328259|NCT03228173|||Cohort||Cross-Sectional|||||||
1328260|NCT03228160|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1328261|NCT03228147||Single Group Assignment||Supportive Care||None (Open Label)||||||
1328262|NCT03228134|Randomized|Parallel Assignment||Treatment||Triple|Double-blind trial|All treatment group received traditional chinese medicine plus a standard anti-asthma treatment on study entry, and the control group received placebo and standard anti-asthma treatment.|t|t||t
1328263|NCT03228121|Randomized|Crossover Assignment||Treatment||Double|Only the on-site PI and research nurse administering the treatment or placebo will know which group the participant belongs to. Patients are blinded. All follow-up contact and measurement of outcomes will be done by off-site research nurses who are blinded.|"0 participants will be recruited for each arm of the study.~Cohort A will receive three days of cell therapy using the venous procedure (three consecutive days of blood harvest, cell separation and cell application). Cohort A will return in three months and receive three consecutive days of placebo.~Cohort B will receive three consecutive days of placebo. Cohort B will return in three months and receive three consecutive days of cell therapy using the venous procedure."|t|||t
1328264|NCT03228108|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328265|NCT03228095|||Cohort||Prospective|||||||
1328266|NCT03228082|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||Participants will be randomized at the end of the baseline visit to self-measurement of bloodpressure at home (intervention group) or usual care (control group).||||
1328267|NCT03228069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The volunteers who participated in the previous clinical trials were invited to join this study. Of which, there were 2 groups, one received a single visit 4-site intradermal rabies booster vaccination. The another received a conventional intramuscular rabies booster vaccination on day 0 and 3.||||
1328268|NCT03228056|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1328269|NCT03228043|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1328270|NCT03228030|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1328271|NCT03228017|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328272|NCT03228004||Single Group Assignment||Treatment||None (Open Label)||||||
1328273|NCT03227991|Randomized|Parallel Assignment||Prevention||Single||||||t
1328274|NCT03227978||Single Group Assignment||Treatment||None (Open Label)||||||
1328275|NCT03227965||Single Group Assignment||Prevention||None (Open Label)||||||
1328276|NCT03227952|Randomized|Crossover Assignment||Treatment||Quadruple|a sham device identical to the active device|Parallel Assignment|t|t|t|t
1328277|NCT03227939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328278|NCT03227926|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Patiens will be first enrolled in a Molecular Screening (MS) Phase to determine the molecular eligibility of the patients for third line panitumumab re-challenge. During MS phase, patients will be liquid biopsied (LB) at different check-points (BML, Basal Mutational Load and RML, Rechallenge Mutational Load) and their ctDNA tested by ddPCR to monitor the emergency, and subsequent decay, of RAS altered clones. Patients showing a >50% drop in RAS mutational load at RML compared to BML will be declared molecularly eligible for the Trial Phase.~Patients resulting molecularly eligible at the RML checkpoint, upon Informed Consent signature and having satisfied all other eligibility criteria, will be treated in the Trial Phase with panitumumab monotherapy at standard dose until documented radiological progression or unacceptable toxicity or any other reason (See Section 9.2.3) whichever comes first."||||
1328279|NCT03227913|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1328280|NCT03227900|Randomized|Crossover Assignment||Basic Science||Double|Masking of participant and investigator|Double blind randomized cross over trial|t||t|
1328281|NCT03227887|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1328282|NCT03227874|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1328283|NCT03227861||Single Group Assignment||Treatment||None (Open Label)||||||
1328284|NCT03227848|||Cohort||Cross-Sectional|||||||
1328285|NCT03227835|||Cohort||Prospective|||||||
1328286|NCT03227822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328287|NCT03227809|Randomized|Parallel Assignment||Prevention||None (Open Label)||Two experimental groups (one group receives a handbook, one group receives a handbook plus text messages) and one control group (no intervention)||||
1328288|NCT03227796|Randomized|Parallel Assignment||Other||Quadruple|Double-blind|First-in-human, phase 1, single centre, placebo-controlled, double-blind, single ascending dose study in heathy volunteers and osteoarthritis patients|t|t|t|t
1328289|NCT03227783|Randomized|Parallel Assignment||Treatment||Triple||Randomized, Parallel, Sham-controlled, single-blinded study|t|t||t
1328290|NCT03227770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328291|NCT03227757||Single Group Assignment||Treatment||None (Open Label)||||||
1328292|NCT03227744|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1328293|NCT03227731|Randomized|Parallel Assignment||Other||None (Open Label)||Pregnant women considered at high risk for HIV infection will be randomized to commencing PrEP in pregnancy with continued use throughout breastfeeding or deferred PrEP until breastfeeding cessation. Women in either group will receive the standard of care for prevention of HIV and other sexually transmitted infections.||||
1328294|NCT03227718|||Cohort||Prospective|||||||
1328295|NCT03227705|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized, controlled clinical trial.||||
1328296|NCT03227692|Randomized|Parallel Assignment||Supportive Care||Quadruple|Persona TKA with iASSIST Knee system (Investigational group) or Persona TKA with conventional instrumentation (Control group). The randomization scheme is based on equal numbers per group. The randomization will occur via a random number generator (computer) using blocked randomization procedure. The PI or his/her team does not have influence on the randomization scheme. Sealed opaque envelopes, which will be prepared based on predetermined randomization assignment, will be provided to each study site before study initiation.|At surgery, intervention group using iASSIST Knee system. At surgery, conventional group not using iASSIST Knee system.|t|t|t|t
1328297|NCT03227679|Randomized|Crossover Assignment||Health Services Research||Triple|Participant, Nurse, and RAs all blinded to random Arm assignment, none blinded to medication prescription|Parallel arm pilot trial with a single-arm crossover design|t|t||t
1328298|NCT03227666|Randomized|Parallel Assignment||Prevention||Single||Intervention group recieving exercise and control group recieving no exercise||||t
1328299|NCT03227653|||Cohort||Cross-Sectional|||||||
1328300|NCT03227640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328400|NCT03226340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328301|NCT03227627|Randomized|Parallel Assignment||Treatment||None (Open Label)||One group of children (Group A) will receive 24 sessions of NMES for combined with traditional therapy including oral motor exercises and laryngeal exercises will be performed to the participants. The other group (Group B) will be receiving 24 sessions of traditional dysphagia therapy. After the 24 sessions, participants will have a repeat MBSS and results will be scored using the Pen-Asp scale and FOIS scale. Both the control group and experimental group will answer the PSI-4 after the repeat MBSS.||||
1328302|NCT03227614|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1328303|NCT03227601||Single Group Assignment||Treatment||None (Open Label)||||||
1328304|NCT03227588|||Case-Only||Prospective|||||||
1328305|NCT03227575|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328306|NCT03227562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||All subjects are under 0.5mg risperidone (one group). Accordin to their response to treatment (responder vs. non responder) the 2 experimental groups will be created.||||
1328307|NCT03227549|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial||||t
1328308|NCT03227536|||Cohort||Retrospective|||||||
1328309|NCT03227523|||Case-Control||Cross-Sectional|||||||
1328310|NCT03227510|||Case-Control||Cross-Sectional|||||||
1328311|NCT03227497|Randomized|Crossover Assignment||Prevention||None (Open Label)|Independent researcher will perform statistical analyses, without prior knowledge on study treatment allocation.|"This study is a randomized, cross-over, controlled, 5-week nutritional intervention, investigating health effects of dietary intake of whole walnuts, as a replacement meal within habitual diet and lifestyle.~At the beginning of the study, half of the study subjects are randomly assigned to a treatment arm with walnut consumption, or control arm without study intervention. Treatment arm considers consumption of pre-packed 56 g of whole walnuts daily, as a replacement meal. After 5 weeks, study subjects are crossed, for additional 5 weeks. At the beginning of the study, all subjects are instructed to continue with their habitual diet and physical activity during the study period of 10 weeks."||||
1328312|NCT03227484|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1328313|NCT03227471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328314|NCT03227458|Randomized|Parallel Assignment||Prevention||Triple|Study drug will be masked. 50 mg DHEA or placebo: double-blinded. Exercise will not be masked.|All participants will take 1 study pill (50 mg DHEA or placebo: double-blinded) daily for 36 weeks. The research pharmacist will dispense study drug according to the randomization code and maintain drug dispensation records, which will be monitored by the study biostatistician. Two-thirds of participants will engage in bone-loading exercise 3 days per week for the 36 weeks.|t|t|t|
1328315|NCT03227445|Randomized|Crossover Assignment||Treatment||None (Open Label)|This will an open-label study and blinding will not be performed.|Subjects will be randomized to receive a placebo ELLIPTA inhaler QD or a placebo DISKUS BID with placebo HandiHaler QD inhaler at Visit 1 and Visit 2 in a cross-over manner.||||
1328316|NCT03227432|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328317|NCT03227419|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, multicentric, randomized, open-label, superiority trial.||||
1328318|NCT03227406|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1328319|NCT03227393|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1328320|NCT03227380||Single Group Assignment||Other||None (Open Label)||patients undergo anatomic segmentectomy by video-assisted thoracoscopic surgery (VATS)||||
1328321|NCT03227367|Randomized|Parallel Assignment||Other||None (Open Label)||"Control group: (Healthy individuals) comprised of 25 participants with clinically healthy periodontium.~Test group: (Chronic periodontitis patients) comprised of 25 participants with signs of clinical inflammation and bone loss."||||
1328322|NCT03227354|||Cohort||Prospective|||||||
1328323|NCT03227341|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1328324|NCT03227328|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, open label, multicenter,||||
1328325|NCT03227315|||Case-Only||Prospective|||||||
1328326|NCT03227302|||Cohort||Prospective|||||||
1328327|NCT03227289|||Cohort||Prospective|||||||
1328328|NCT03227276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328329|NCT03227263|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328330|NCT03227250|||Cohort||Prospective|||||||
1328331|NCT03227237|||Case-Control||Retrospective|||||||
1328332|NCT03227224|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328333|NCT03227211|||Cohort||Prospective|||||||
1328334|NCT03227198|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328335|NCT03227185|Randomized|Crossover Assignment||Basic Science||Double||Participants will be randomly assigned to two possible sequences of stimulation conditions. Group 1 will receive real tDCS stimulation to the left dlPFC during encoding on the first day and sham stimulation on the second day, and group 2 will receive sham stimulation during encoding on the first day and real tDCS on the second day. The participants will be randomized with equal probability to each of the two groups, using block randomization..|t||t|
1328336|NCT03227172|||Cohort||Retrospective|||||||
1328337|NCT03227159|||Cohort||Prospective|||||||
1328338|NCT03227146||Single Group Assignment||Treatment||None (Open Label)||||||
1328339|NCT03227133||Single Group Assignment||Other||None (Open Label)||||||
1328340|NCT03227120|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomized controlled trial with repeated measures pre and post-surgery. Consecutive patients which meet inclusion and exclusion criteria and consent to participate will be evaluated two months or more pre-operatively. After completion of office testing at the pre-surgery/pre-exercise time point, randomization will be completed using a gender stratified randomized sequence generated prior to subject recruitment.||||
1328341|NCT03227107|||Cohort||Prospective|||||||
1328342|NCT03227094|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1328343|NCT03227081|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1328401|NCT03226327||Single Group Assignment||Prevention||None (Open Label)||||||
1328402|NCT03226314|||Ecologic or Community||Prospective|||||||
1576900|NCT00005356||||||||||||
1328344|NCT03227068|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||All subjects in both groups will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge including a list of home medications, and information regarding whom to call for emergencies. The PEDSS - symptom management and PEDSS - support for the caregiver are additional tools designed to reinforce care after the initial hospital discharge.||||
1328345|NCT03227055|||Cohort||Prospective|||||||
1328346|NCT03227042|||Other||Prospective|||||||
1328347|NCT03227029|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1328348|NCT03227016||Single Group Assignment||Treatment||None (Open Label)||||||
1328349|NCT03227003|||Other||Cross-Sectional|||||||
1328350|NCT03226990|Randomized|Parallel Assignment||Prevention||Double||The measurements are done on the day of denture insertion with no follow up timing intervals|t|||t
1328351|NCT03226977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328352|NCT03226964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328353|NCT03226951||Single Group Assignment||Treatment||None (Open Label)||||||
1328354|NCT03226938|||Cohort||Cross-Sectional|||||||
1328355|NCT03226925|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||One group of patients with healthy volunteers and two groups with lung/upper abdomen cancer patients||||
1328356|NCT03226912|||Cohort||Other|||||||
1328357|NCT03226899|Randomized|Parallel Assignment||Treatment||Triple|active vs placebo visually identical tablets|Randomized, Double-Blind, Multicenter, Placebo-Controlled|t|t|t|
1328358|NCT03226886|||Other||Prospective|||||||
1328359|NCT03226873||Single Group Assignment||Prevention||None (Open Label)||||||
1328360|NCT03226860|Randomized|Parallel Assignment||Treatment||Single||||||t
1328361|NCT03226847||Single Group Assignment||Treatment||None (Open Label)||||||
1328362|NCT03226834|Randomized|Parallel Assignment||Prevention||Double|blindness concerns medical staff: nurses in charge of the blood parameters measurements as well as anxiety evaluation are not informed of the allocation of the patients|control randomized, single blind, monocentric||t|t|
1328363|NCT03226821||Single Group Assignment||Treatment||None (Open Label)||||||
1328364|NCT03226808||Single Group Assignment||Treatment||None (Open Label)||||||
1328365|NCT03226795||Single Group Assignment||Health Services Research||None (Open Label)||||||
1328366|NCT03226782|Non-Randomized|Parallel Assignment||Other||Single||||||t
1328367|NCT03226769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328368|NCT03226756||Single Group Assignment||Treatment||None (Open Label)||||||
1328369|NCT03226743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328370|NCT03226730|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1328371|NCT03226717|||Cohort||Prospective|||||||
1328372|NCT03226704|||Cohort||Prospective|||||||
1328373|NCT03226691||Single Group Assignment||Supportive Care||None (Open Label)||||||
1328374|NCT03226678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328375|NCT03226665|||Cohort||Prospective|||||||
1328376|NCT03226652|||Cohort||Prospective|||||||
1328377|NCT03226639|||Cohort||Prospective|||||||
1328378|NCT03226626|Randomized|Parallel Assignment||Prevention||Single|"Persons making decision to categorize the outcome as either Infection Occurred or No Infection Occurred will be masked with respect to whether or not the subject received Standard pre-operative IV antibiotics alone or received both IV antibiotics and tumescent anesthesia & antibiotic delivery (TAAD)."|Prospective Meta-Analysis Multicenter Randomized Clinical Trial||||t
1328379|NCT03226613||Single Group Assignment||Diagnostic||None (Open Label)|Investigators conducting the ultrasound study will be masked as to the characteristics/location of patient's tumor in order to determine feasibility of identifying oropharyngeal cancers as a sole imaging technique.|||||
1328380|NCT03226600|Randomized|Parallel Assignment||Treatment||Triple||Randomized Controlled Trial between two treatment modalities for gingival recession with 6 month follow-up|t||t|t
1328381|NCT03226587|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1328382|NCT03226574||Sequential Assignment||Treatment||None (Open Label)||"The design uses a traditional 3+3 rule-based design that does not stipulate any prior assumption of the dose-toxicity curve. Dose escalation is permitted between successive cohorts based upon a specified algorithm, using discrete dosage steps."||||
1328383|NCT03226561|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1328384|NCT03226548|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Controlled Trial||||
1328385|NCT03226535|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1328386|NCT03226522|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328387|NCT03226509|||Other||Prospective|||||||
1328388|NCT03226496|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328389|NCT03226483||Single Group Assignment||Treatment||None (Open Label)||||||
1328390|NCT03226470|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328391|NCT03226457|Randomized|Crossover Assignment||Treatment||Quadruple|Double-Blind|6 week period of Investigational Medicinal Product (Empagliflozin 25 mg od) or placebo. A 2 week washout period will then be observed, followed by the second arm with a further 6 week period of placebo or IMP. At week 1 and week 6 of each arm, detailed Renal Physiology Test days will be performed.|t|t|t|t
1328392|NCT03226444|Randomized|Parallel Assignment||Treatment||Triple|Double-masked||t|t|t|
1328393|NCT03226431||Single Group Assignment||Treatment||None (Open Label)||||||
1328394|NCT03226418|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328395|NCT03226405|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1328396|NCT03226392|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328397|NCT03226379|||Other||Other|||||||
1328398|NCT03226366|||Cohort||Retrospective|||||||
1328399|NCT03226353||Single Group Assignment||Treatment||None (Open Label)||||||
1328403|NCT03226301|Randomized|Crossover Assignment||Treatment||None (Open Label)||All patients receive ibrutinib + venetoclax (with delayed start and ramp up of venetoclax from cycle 3) for the 15 cycles. Patients not achieving MRD negativity after cycle 12 (PB) AND/OR cycle 15 (PB+BM) continue on ibrutinib maintenance (non-randomized group). Patients achieving MRD negativity after cycle 12 (PB) AND cycle 15 (PB+BM) are randomized 1:2 between ibrutinib maintenance (arm A) and stopping treatment (observation, arm B).||||
1328404|NCT03226288|||Case-Control||Prospective|||||||
1328405|NCT03226275|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1328406|NCT03226262|||Cohort||Prospective|||||||
1328407|NCT03226249||Single Group Assignment||Treatment||None (Open Label)||||||
1328408|NCT03226236||Single Group Assignment||Treatment||None (Open Label)||||||
1328409|NCT03226223|Randomized|Crossover Assignment||Basic Science||Single|Participants and study staff conducting the lab sessions will be blinded to the treatment condition (i.e., naltrexone 0 mg or 50 mg)|Participants will complete two testing sessions in which the effects of oral naltrexone (0 mg & 50 mg) will be tested in combination with intranasal methamphetamine. Participants will complete two testing sessions (naltrexone 0 mg + Methamphetamine & naltrexone 50 mg + methamphetamine), in randomized order.|t|||
1328410|NCT03226210|Randomized|Parallel Assignment||Treatment||Single|||||t|
1328411|NCT03226197||Single Group Assignment||Other||None (Open Label)||||||
1328412|NCT03226184|||Case-Control||Prospective|||||||
1328413|NCT03226171||Single Group Assignment||Treatment||None (Open Label)||||||
1328414|NCT03226158|||Cohort||Prospective|||||||
1328415|NCT03226145|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1328416|NCT03226132|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1328417|NCT03226119|Non-Randomized|Parallel Assignment||Diagnostic||Single|Clinical Sites and the Reference Core-Lab will be masked of specimen disease state|Cohort A: 100 Neurological Disorder Specimens Cohort B: 50 HTLV Known Positive Specimens|||t|
1328418|NCT03226106|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial; Two groups.||||t
1328419|NCT03226093||Single Group Assignment||Treatment||None (Open Label)||||||
1328420|NCT03226080|Randomized|Parallel Assignment||Treatment||Triple|The investigators, surgeons, intraoperative anesthesiology providers, and patients will be blinded.|84 patient under GA with spinal anesthesia will be block randomized to either neuromuscular blockade or placebo. Randomization will be tracked by the research pharmacist at Loyola University|t||t|t
1328421|NCT03226067|Randomized|Parallel Assignment||Treatment||Triple|This is a double-blind study: the Sponsor, subjects, investigator staff, persons performing the assessments and data reviewers and statisticians will remain blinded to the identity of the study treatments.|This will be a double-blind, randomized, placebo-controlled, multicenter, parallel group phase 2 trial. A total of 102 subjects will be randomized and allocated to placebo or one of the 2 active treatment arms, according to a 1:1:1 randomization ratio, stratified at study entry by disease severity defined as baseline serum gamma glutamyl transferase (GGT) < 2.5 x ULN or ≥ 2.5 x ULN). Accordingly, approximately 34 subjects will be allocated to each of the 3 treatment arms.|t|t|t|
1328422|NCT03226054||Single Group Assignment||Prevention||None (Open Label)||Prospective Cohort||||
1328423|NCT03226041||Single Group Assignment||Diagnostic||None (Open Label)||||||
1328424|NCT03226028||Single Group Assignment||Treatment||None (Open Label)||||||
1328425|NCT03226015|||Case-Only||Prospective|||||||
1328426|NCT03226002|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1328427|NCT03225989||Single Group Assignment||Treatment||None (Open Label)||||||
1328428|NCT03225976|Randomized|Parallel Assignment||Other||Triple||"Athletes will be randomized allocated the following groups:~Infrared LED group (G-I; n = 12)~Red LED group (G-V; n = 12)~Infrared plus Red LED group (G-IV; n = 12)~Sham Group (G-S; n = 12)"||t|t|t
1328429|NCT03225963|||Cohort||Prospective|||||||
1328430|NCT03225950|||Case-Control||Cross-Sectional|||||||
1328431|NCT03225937|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||two sequential cohorts: cohort A (lapatinib + trastuzumab); cohort B (pertuzumab + trastuzumab-emtansine).||||
1328432|NCT03225924||Single Group Assignment||Treatment||None (Open Label)||||||
1328433|NCT03225911|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328434|NCT03225898|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1328435|NCT03225885|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized controlled trial where participants are assigned to 1 of 2 groups for the duration of the study. One group will receive verbal counseling and a printed gestational age handout. The other group will receive verbal counseling and a bedside iPad with the multimedia information about prematurity.||||
1328436|NCT03225872|||Family-Based||Retrospective|||||||
1328437|NCT03225859||Single Group Assignment||Treatment||None (Open Label)|As everyone in the study will receive the same intervention, no masking is being employed|The study non-randomized, open-trial pilot test of the intervention with twelve Veterans who will all receive the study intervention.||||
1328438|NCT03225846|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1328439|NCT03225833|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1328440|NCT03225820|||Cohort||Other|||||||
1328441|NCT03225807|||Cohort||Prospective|||||||
1328442|NCT03225794|||Cohort||Cross-Sectional|||||||
1328443|NCT03225781||Single Group Assignment||Treatment||None (Open Label)||||||
1328444|NCT03225768||Single Group Assignment||Treatment||None (Open Label)||||||
1328445|NCT03225755|||Cohort||Prospective|||||||
1328446|NCT03225742|||Cohort||Prospective|||||||
1328447|NCT03225729|Randomized|Parallel Assignment||Treatment||Single||||||t
1328448|NCT03225716||Single Group Assignment||Treatment||None (Open Label)||||||
1328449|NCT03225703|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants will complete a unilateral exercise intervention and be randomly assigned an exercise leg. This allows for internal control, non exercise leg. The exercise and control leg will be analysed for significant differences following completion of the intervention.||||
1328450|NCT03225690|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1328451|NCT03225677|||Case-Control||Other|||||||
1328452|NCT03225664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328453|NCT03225651|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1328454|NCT03225638|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1328455|NCT03225625|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"There will be 3 Arms:~Arm 1: BMSC Paraspinal, IV, Intranasal . Arm 2: BMSC Paraspinal,IV,Intranasal + exoskeleton or equivalent . Arm 3: BMSC Paraspinal, IV, Intranasal + virtual reality or equivalent ."||||
1328456|NCT03225612||Single Group Assignment||Treatment||None (Open Label)||||||
1328457|NCT03225599|Non-Randomized|Single Group Assignment||Treatment||Single||||t||
1328458|NCT03225586|||Cohort||Prospective|||||||
1328459|NCT03225573|||Other||Retrospective|||||||
1328460|NCT03225560|Randomized|Parallel Assignment||Treatment||Triple|"Patients will be aware of the arm they were assigned to. Colonoscopist performing the colonoscopy will be masked to the intervention and will be providing the assessment of the quality of bowel preparation.~The investigators will be masked to the assignment."|Randomized Controlled Trial||t|t|t
1328461|NCT03225547|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The first 10 patients will receive the same treatment. Enrollment will be paused to undergo a safety evaluation. After which, enrollment will continue and two cohorts will be preformed in parallel.||||
1328462|NCT03225534|||Cohort||Prospective|||||||
1328463|NCT03225521||Single Group Assignment||Treatment||None (Open Label)||Each participant-time point is randomized between intervention or no intervention (delivery of a contextually tailored activity suggestion or no suggestion; planning or no planning)||||
1328464|NCT03225508|||Other||Prospective|||||||
1328465|NCT03225495|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1328466|NCT03225482|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessors will be blind to treatment group assignment.|Two group randomized controlled trial.||||t
1328467|NCT03225469|Randomized|Parallel Assignment||Health Services Research||Double|The patients and the associated family members know which group they are assigned，while the colonoscopist, information collector are blinded to group assignment.|reinforced family member education group, regular education (control) group|||t|t
1328468|NCT03225456|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1328469|NCT03225443|||Case-Control||Prospective|||||||
1328470|NCT03225430|Randomized|Parallel Assignment||Treatment||Double|Assessors will receive no information on participant history and psychopathology. All evaluation sessions will be audio-recorded for reliability and to ensure that treatment status is not divulged. The Assessors will be separated from the therapists by geographical location site and will sign agreements not to discuss cases in the study with any other team member. Child and adult participants will agree not to discuss treatment or therapy during evaluation. Management of assessors will be delegated to a separate clinical coordinator who will assume overall responsibility for evaluations and preempting any direct contact between the principal investigator and Co-investigators and the assessors.||||t|t
1328471|NCT03225417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328472|NCT03225404|Randomized|Parallel Assignment||Treatment||Single|Outcomes assesor|A specialist physician will be diagnosed the epicondylitis|t|||
1328473|NCT03225391|Randomized|Crossover Assignment||Prevention||Single|At the moment of running the Iowa Gambling Task and the Psychomotor Visual Test the investigator does not know the schedule of the nap.||||t|
1328474|NCT03225378|||Cohort||Prospective|||||||
1328475|NCT03225365|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1328476|NCT03225352|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1328477|NCT03225339|Randomized|Parallel Assignment||Treatment||Single|All analyses conducted will be blinded.|||||t
1328478|NCT03225326|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1328479|NCT03225313|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1328480|NCT03225300||Single Group Assignment||Treatment||None (Open Label)||A prospectively single arm in single institution.||||
1328481|NCT03225287||Single Group Assignment||Treatment||None (Open Label)||||||
1328482|NCT03225274|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328483|NCT03225261|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1328484|NCT03225248|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328485|NCT03225235||Single Group Assignment||Treatment||None (Open Label)||||||
1328486|NCT03225222|||Cohort||Prospective|||||||
1328487|NCT03225209||Single Group Assignment||Treatment||None (Open Label)||"Proof of concept study"||||
1328488|NCT03225196|||Cohort||Cross-Sectional|||||||
1328489|NCT03225183|||Cohort||Retrospective|||||||
1328490|NCT03225170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328491|NCT03225157|||Cohort||Other|||||||
1328492|NCT03225144|||Cohort||Cross-Sectional|||||||
1328493|NCT03225131|||Cohort||Prospective|||||||
1328494|NCT03225118|||Cohort||Prospective|||||||
1328495|NCT03225105||Sequential Assignment||Treatment||None (Open Label)||Subsequent cohorts of patients treated at different dose levels.||||
1328496|NCT03225092||Single Group Assignment||Treatment||None (Open Label)||Observational pilot study||||
1328497|NCT03225079|||Other||Other|||||||
1328523|NCT03224741|Randomized|Factorial Assignment||Screening||Single|The subject receives the script and actions associated with the experimental condition she/he is assigned to according to the randomization. The subject receives a card consisting of three detachable parts. Each part includes a numerical ID that uniquely identifies each participant. The first part of the card will remain with the researchers. The second part of the card does to the medical personnel at the health facility if and when they go there to get tested. The third part of the card will remain with the participant. This procedure and the study ID will enable the research team to (a) associate participants to the treatment conditions and (b) determine the outcomes (whether they got tested or not, and what the results were), while preserving the anonymity of the participants.|Randomized Control Trial|t|||
1328524|NCT03224728|||Cohort||Prospective|||||||
1328525|NCT03224715||Single Group Assignment||Supportive Care||None (Open Label)||||||
1576901|NCT00005355||||||||||||
1328498|NCT03225066||Single Group Assignment||Treatment||None (Open Label)|P.S. To assess the efficacy of Sculptra, via adapted Global Aesthetic Improvement Scale score determined by blind evaluator (Outcomes assessor ), in the treatment of skin flaccidity on the anteromedial region of arm and gluteal region, 4 months after initiating the treatment, based on the assessment of the corporal side randomized to be the first to receive treatment. I input as NO MASKING because appears ERROR when I included Outcomes assessor.|"The study sample will be stratified to include 50% of subjects, who will receive Sculptra treatment on the antero-medial side of the arms and approximately 50% of subjects, who will receive Sculptra treatment in the gluteal area, in order to exploratory analyzes by subgroup.~During the study, the subjects should come to the research site up to nine times: one for the screening/inclusion visit (SV), three treatment visits (TVs) for Side 1 (from 1 to 14 days after SV, and from 1 to 2 months after first session), three TVs for Side 2 (4, 5 and 6 months after the first S1 treatment session), one follow-up visit (FUV), 6 months after the first S2 treatment session) and a final visit (FV) (12 months after the first S1 session). After 4 months of the first treatment we will compare the results between the first treated side and non-treated side."||||
1328499|NCT03225053||Single Group Assignment||Treatment||None (Open Label)||After the initial evaluation, the investigator 2 will conduct the experimental procedures in the different groups, which will be submitted to the following protocols: G1 (n = 15) called LMF will be submitted to the myofascial release technique consisting of: , Deep sliding, pumping-kneading, thumb and four-finger rubbing, and sliding) applied to the musculature of the most painful region for 15 minutes. G2 (n = 15) will be applied to the MEP® technique, in which needles will be introduced on three occasions during each session, at different points of the musculature of the most painful region, for a total of 3 minutes. The G3 (n = 15) will be performed the two techniques above, being applied first Miofascial Release and later to MEP®. G4 (n = 15) will be the control group, not performing any of the interventions. The reevaluations will occur immediately and after 48 hours of the intervention.||||
1328500|NCT03225040|||Cohort||Cross-Sectional|||||||
1328501|NCT03225027|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||One experimental procedure proposed to three groups of participants||||
1328502|NCT03225014|Randomized|Crossover Assignment||Device Feasibility||Double||||t||t
1328503|NCT03225001||Single Group Assignment||Treatment||None (Open Label)||||||
1328504|NCT03224988|||Case-Control||Prospective|||||||
1328505|NCT03224975|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Two groups: 20 patients and 20 healthy volunteers||||
1328506|NCT03224962|||Other||Other|||||||
1328507|NCT03224949|||Case-Control||Prospective|||||||
1328508|NCT03224936|||Cohort||Prospective|||||||
1328509|NCT03224923|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1328510|NCT03224910|||Case-Only||Cross-Sectional|||||||
1328511|NCT03224897|Randomized|Parallel Assignment||Basic Science||Double|The tDCS device was placed at the back of the participants, so they could not see the parameters of stimulation. The participants of the sham stimulation group received anode stimulation for 30s, and then the device was turned off. The participants feel the initial itching in all conditions, so the are not able to distinguish to which condition of stimulation they are submitted.|The 60 participants will be divided into 3 groups: anodal, cathodal and sham stimulation. While receiving the transcranial direct current (tDCS) stimulation, participants will perform a reappraisal task. Four series of 15 IAPS pictures will be randomly passed on a computer screen. 3 of the 4 sets of pictures contain negative pictures, matched according to valence and arousal of the IAPS norm ratings (p<0.05) and were assigned to one of instruction condition (upregulate, downregulate or maintain). The other set will contain neutral pictures with the instruction maintain. Participants will be asked to apply the instruction assigned to each picture and then rank the intensity of negative emotional arousal felt after using the reappraisal strategy, varying from 1 (weak) to 7 (strong). ANOVA will be used to compare the median subjective emotion intensity evaluation for each strategy intra-subjects and inter-groups.|t|||t
1328512|NCT03224884|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1328513|NCT03224871|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||All patients will go through the same process except that some patients will be on nivolumab as checkpoint blockade and some patients will be on pembrolizumab as checkpoint blockade.||||
1328514|NCT03224858|Randomized|Parallel Assignment||Health Services Research||Triple|Participants, care providers, investigator, and initial trained research assistant will be blinded initially during consent and baseline interview survey procedures. Once, randomization has occurred, the participants, care provider, investigator, and subsequent outcomes assessor will not be blinded.|"This is a pragmatic wait-list control design. Participants will be consented and baseline survey administered after which patient will be randomized by computer generated algorithm into 2 arms: immediate or 6-month 'wait-list.' Immediate group will start intervention and be followed at 6 month intervals for 12 months. 'Wait-list' group will resume usual care for 6-months, after which they will cross-over to the intervention group for 12 months."|t|t|t|
1328515|NCT03224845|Randomized|Parallel Assignment||Prevention||Single||||||t
1328516|NCT03224832|Randomized|Parallel Assignment||Treatment||Single|the cases which will come to general surgery outpatient clinic will be subjected to standard approach while the cases which will come to our EL Rajhi outpatient clinic will be subjected to artery-first approach|one group will be subjected to artery fgirst approach at EL Rajhi hospital and the other group will be subjected to standard approach at the main general surgery department at Assiut university hospital|t|||
1328517|NCT03224819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Bayesian Model||||
1328518|NCT03224806|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1328519|NCT03224793|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328520|NCT03224780|||Cohort||Prospective|||||||
1328521|NCT03224767||Single Group Assignment||Treatment||None (Open Label)||||||
1328522|NCT03224754|||Case-Only||Cross-Sectional|||||||
1328526|NCT03224702|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328527|NCT03224689||Single Group Assignment||Other||None (Open Label)||||||
1328528|NCT03224676|||Other||Prospective|||||||
1328529|NCT03224663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328530|NCT03224650|||Cohort||Prospective|||||||
1576902|NCT00005354||||||||||||
1328531|NCT03224637|Randomized|Parallel Assignment||Treatment||Single|||||t|
1328532|NCT03224624|Randomized|Parallel Assignment||Health Services Research||Single|The outcome (in clinic blood pressure) will be assessed without knowledge of which group participants were assigned.|Participants will be randomized to either usual care or self-management of blood pressure using a stepped approach which participants can trigger using their home blood pressure measures.||||t
1328533|NCT03224611|Randomized|Parallel Assignment||Other||Double|||t|||t
1328534|NCT03224598||Single Group Assignment||Treatment||None (Open Label)||||||
1328535|NCT03224585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328536|NCT03224572|Randomized|Parallel Assignment||Treatment||Double|double-blinded|Parallel Assignment Randomized double-blinded controlled trial|t|t||
1328537|NCT03224559|||Cohort||Prospective|||||||
1328538|NCT03224546|Randomized|Factorial Assignment||Basic Science||Triple|||t|t||t
1328539|NCT03224533|||Case-Control||Cross-Sectional|||||||
1328540|NCT03224520|Randomized|Factorial Assignment||Treatment||Double||Using a 2×2 factorial design, we will compare individually and collectively the enhancements (recruitment, use, and effectiveness) offered by the S2S functions over the standard version of Decide2Quit (online recruitment and standard CTHC), an active comparison group that was demonstrated to be effective in our previous trial.|t||t|
1328541|NCT03224507|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The study has four cycles (28-days each) of drug therapy prior to being evaluated for auto-HCT. After the completion of induction therapy, the patient will be evaluated for a transplant of their own hematopoietic stem cells. If, after the transplant, the patient still has detectable multiple myeloma, the patient will proceed to a series of consolidation blocks, up to three, consisting of four cycles of the KRdD at specified dosages and time frames. After completion of consolidation therapy, maintenance therapy will begin until disease progression or intolerance.||||
1328542|NCT03224494|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1328543|NCT03224481|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1328544|NCT03224468|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1328545|NCT03224455|||Other||Other|||||||
1328546|NCT03224442|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1328547|NCT03224429|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1328548|NCT03224416|Randomized|Parallel Assignment||Basic Science||Single|Masking only applies to those participants who are randomly assigned to the placebo condition, which is described in detail above.|"The alcohol/placebo/nonalcohol design involves three conditions. In the alcohol condition (target BrAC = 0.080g%), the participant will be told he is receiving alcohol and will receive beverages of 1:4 parts vodka and tonic water with dashes of lime juice and mint, all mixed in his presence. In the placebo condition (target BrAC = 0.000g%), the participant will be told he is receiving alcohol but will receive beverages of 1:4 parts flat tonic water (served from a vodka bottle) and tonic water, with a minimal amount of vodka floated on the surface (using a lime juice bottle) to provide the smell and taste of vodka, with lime juice and mint, all mixed in his presence and served in glasses with vodka-soaked rims. In the true control (or nonalcohol) condition, the participant will be told he is receiving no alcohol and will be given water (poured in his presence) in a volume comparable to the other conditions."|t|||
1328549|NCT03224403|Randomized|Parallel Assignment||Treatment||Quadruple||Post-operative dental pain following third molar extraction.|t|t|t|t
1328550|NCT03224390|Randomized|Parallel Assignment||Health Services Research||Double||"The service (intervention) is available to anyone living in the catchment area, so it is not possible to randomly assign access to the service and estimate impact through a traditional randomized controlled trial (RCT). Likewise, at this early stage it is not be feasible to randomize access at a higher level, such as counties or subcounties. In situations like this, a variation on the traditional randomized controlled trial called a randomized encouragement design can be very effective.~In a randomized encouragement design (RED), participants are randomized to receive an invitation or special encouragement to receive a treatment. Not everyone who is encouraged will take up the service, but as long as those randomly selected to receive the encouragement (the treatment group) use the service at a higher rate than the control group, the impact of the service can be estimated.~For more details, see http://bit.ly/RED17protocol (linked in this record)."||t||t
1328551|NCT03224377|||Case-Control||Prospective|||||||
1328552|NCT03224364|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328553|NCT03224351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328554|NCT03224338||Single Group Assignment||Treatment||None (Open Label)||||||
1328555|NCT03224325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328556|NCT03224312|||Cohort||Prospective|||||||
1328557|NCT03224299|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1328558|NCT03224286|||Other||Prospective|||||||
1328559|NCT03224273|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328560|NCT03224260|Randomized|Sequential Assignment||Other||Quadruple|||t|t|t|t
1328561|NCT03224247|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328562|NCT03224234|Randomized|Crossover Assignment||Treatment||None (Open Label)||At midpoint (week 12), patients will be converted to the alternate arm (cross-over design).||||
1328563|NCT03224221|Randomized|Parallel Assignment||Treatment||Single||||||t
1328564|NCT03224208||Single Group Assignment||Treatment||None (Open Label)||||||
1328565|NCT03224195|||Other||Prospective|||||||
1328566|NCT03224182|Randomized|Parallel Assignment||Treatment||Triple|Double-blind|This is a randomized, multicenter, two-arm, double-blind, placebo-controlled study of Qapzola in patients with low- to intermediate-risk NMIBC.|t|t|t|
1328567|NCT03224169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328568|NCT03224156|||Cohort||Prospective|||||||
1328599|NCT03223753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328600|NCT03223740|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1328601|NCT03223727|||Cohort||Prospective|||||||
1328602|NCT03223714|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1328652|NCT03223064||Single Group Assignment||Diagnostic||None (Open Label)||||||
1576903|NCT00005353||||||||||||
1328569|NCT03224143|Randomized|Parallel Assignment||Supportive Care||Single|To ensure blinding, the psychologist who will administer the NPI-NH will not be aware of the arm to which the subjects belong.|"Each participant will undergo daily sessions of DTI or SI, lasting an hour at most, led by a trained professional caregiver. The DTI involves the presentation of a doll produced by a Swedish brand conceived for Doll Therapy use. The SI group will attend similar daily sessions, but in place of the doll, it will be presented with a non-anthropomorphic object, i.e., a soft foam rubber cube covered with a coloured and velvety textile. The 1st and 30th session of all participants will be videotaped by a trained psychologist as described below. The experimental protocol is described in detail in Pezzati et al. (2014) and it is structured with the goal of recreating a situation of (1) separation from a known figure and (2) interaction with the environment in order to partially recreate the prototypical phases of the Strange situation (Ainsworth et al., 1978)."||||t
1328570|NCT03224130|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1328571|NCT03224117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328572|NCT03224104|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328573|NCT03224091|||Cohort||Prospective|||||||
1328574|NCT03224078|||Other||Prospective|||||||
1328575|NCT03224065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328576|NCT03224052|||Cohort||Prospective|||||||
1328577|NCT03224039|Randomized|Parallel Assignment||Treatment||Triple|Assignment of treatment will be based on randomization. Each patient will be assigned a study number that would correspond to a specific treatment. Only the primary investigator (B.Sin) and the pharmacist procuring the study intervention will be unblinded to the treatment. The physician, nurse, research associate responsible for collecting data, and independent biostatistician responsible for interpreting the data will be blinded. Assignment of treatment will be placed in a opaque envelope where it would be opened only by the pharmacist will who be procuring the intervention.||t|t||t
1328578|NCT03224026|||Cohort||Prospective|||||||
1328579|NCT03224013|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"Interventional prospective consecutive comparative case control series of cases; 50 eyes of 25 patients with mean age 35.7 ± 12.4 (Range 18-61years) with hyperopia or hyperopic astigmatism underwent customized LASIK with concurrent prophylactic high-fluence cross-linking in right eye (group 1) and customized LASIK only in left eye (group 2). Cases with hyperopia +1D to +6D or hyperopic astigmatism up to 4D were included in the study. Patients with previous intraocular or corneal surgery, active corneal disease were excluded from the study.~Main outcome measures were uncorrected visual acuity (UCVA), manifest refractive spherical equivalent (MRSE), cycloplegic refractive spherical equivalent (CRSE), keratometric measurments and spherical aberrations at 4 mm and maximum pupilnand their ecolution along 6 months postoperatively."||||
1328580|NCT03224000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328581|NCT03223987|Non-Randomized|Single Group Assignment||Basic Science||Single|First letter of prename, second and third letter of name.|Before-after intervention, open label study||t||
1328582|NCT03223974|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1328583|NCT03223961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||randomazed study||||
1328584|NCT03223948|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The patients recruited will be divided into 3 groups according to their oxygen (O2) requirements at recruitment (low, medium and high).~All recruited patients will then be given supplementary O2 using the Optiflow system. Patients from all three recruitment oxygen requirements (low, medium and high) will be randomised to 30 litres, 45 litres or 60 litres per minute with initial a fractional inspired O2 concentration(FiO2) of 0.90 (90% oxygen). The FiO2 is then decreased in 0.05 increments every 5 minutes and the minimum oxygen saturation recorded until it reaches 94%."||||
1328585|NCT03223935|Randomized|Crossover Assignment||Other||None (Open Label)||Randomized, controlled cross-over acute trial||||
1328586|NCT03223922||Single Group Assignment||Treatment||None (Open Label)||Patients will be treated to a total dose of 30 Gy with a once daily fractionation schedule of 3 Gy per fraction, administered five days per week.||||
1328587|NCT03223909|Randomized|Parallel Assignment||Treatment||Double|The double-blind study is a procedure in which the patient and the treating doctor ignore to which intervention group the study patient was assigned. To achieve the blinding of both the drug in research and both comparator drugs, these will be labeled in the same way (masking). Besides the figure of an unblinded pharmacist, who is responsible for the delivery of the medication to the patient, will be added. Blinding codes are protected by an outsider appointed by the study sponsor. The codes are also available in the research center (fully sealed), so that they can be consulted by the investigator in case a subject presents a serious adverse event, prior authorization from the study sponsor; the blinding also continues rigorous during the data analysis and interpretation.|Controlled, double-blind, randomized, clinical trial comparing the safety and efficacy parameters between a group of subjects with a diagnose of mild to moderate tear film dysfunction syndrome under a regimen of ophthalmic solution lubricant drops PRO-087 versus subject under Systane® Ultra or Systane® Ultra preservative free, with the same diagnosis, with a follow-up of 90 days.|t||t|
1328588|NCT03223896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Group A: max 8 mg/per day naloxone nasal spray~Group B: max 16 mg/per day naloxone nasal spray"||||
1328589|NCT03223883|Randomized|Parallel Assignment||Treatment||Quadruple|Patient, providers, and the investigative team will all be blinded to the randomization.|Randomized Double-Blind Placebo-Controlled Clinical Trial|t|t|t|t
1328590|NCT03223870|||Other||Prospective|||||||
1328591|NCT03223857|||Other||Prospective|||||||
1328592|NCT03223844||Single Group Assignment||Basic Science||None (Open Label)||||||
1328593|NCT03223831|Randomized|Parallel Assignment||Treatment||Single|Recruited patients would not be informed of the type of stent that was inserted|Recruited patients would be randomized to receive either uncovered duodenal stents or partially covered duodenal stents.|t|||
1328594|NCT03223818|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1328595|NCT03223805|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1328596|NCT03223792|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1328597|NCT03223779||Single Group Assignment||Treatment||None (Open Label)||||||
1328598|NCT03223766|||Cohort||Prospective|||||||
1328651|NCT03223077|||Case-Only||Prospective|||||||
1328603|NCT03223701||Single Group Assignment||Treatment||None (Open Label)||This is a prospective, single-center clinical study. Ten patients will be enrolled and undergo an Transforaminal Lumbar Interbody Fusion (TLIF) with a spinal fixation system and receive Solum IV (Celling Biosciences) and patient's bone marrow concentrate with general fluid concentrate (GFC).||||
1328604|NCT03223688|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328605|NCT03223675||Single Group Assignment||Treatment||None (Open Label)||||||
1328606|NCT03223662||Single Group Assignment||Treatment||None (Open Label)||||||
1328607|NCT03223649|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328608|NCT03223636|||Cohort||Prospective|||||||
1328609|NCT03223623|||Case-Control||Prospective|||||||
1328610|NCT03223610||Sequential Assignment||Treatment||None (Open Label)||||||
1328611|NCT03223597|||Cohort||Prospective|||||||
1328612|NCT03223584|||Case-Only||Cross-Sectional|||||||
1328613|NCT03223571|||Cohort||Retrospective|||||||
1328614|NCT03223558|Randomized|Parallel Assignment||Treatment||Single|"researchers will be blinded during baseline assessment prior to group allocation.~Participants and the clinical CR team will know the group allocation and therefore cannot be blinded. University hospitals for Coventry and Warwickshire NHS trust research and design department will generate the randomisation sequence remotely using permuted block randomisation."|A single blinded parallel group randomised controlled trial will be used to determine non-inferiority of early (2 weeks post operation) vs usual care (6 weeks post operation ) CR for a period of 8 weeks.||||t
1328615|NCT03223545|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328616|NCT03223532|Randomized|Parallel Assignment||Prevention||None (Open Label)||A Prospective, Randomized, Open Label Trial.||||
1328617|NCT03223519|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328618|NCT03223506||Single Group Assignment||Treatment||None (Open Label)||||||
1328619|NCT03223493|||Ecologic or Community||Cross-Sectional|||||||
1328620|NCT03223480||Single Group Assignment||Treatment||None (Open Label)|No masking|All patients recruited will receive EUS-guided gastrojejunostomy using the double balloon occluder||||
1328621|NCT03223467|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients in this study underwent either gastric bypass, gastric sleeve or biliopancreatic diversion. Some patient choose not to undergo bariatric surgery and function as a control arm.||||
1328622|NCT03223454|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328623|NCT03223441|||Cohort||Prospective|||||||
1328624|NCT03223428|||Cohort||Prospective|||||||
1328625|NCT03223415|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328626|NCT03223402||Single Group Assignment||Treatment||None (Open Label)||Pilot study, one arm. We do not evaluate a specific drug. It is an Evaluation of a combination with just two instead of three drugs for the Treatment of HIV||||
1328627|NCT03223389|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1328628|NCT03223376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328629|NCT03223363|Randomized|Factorial Assignment||Diagnostic||Quadruple|||t|t|t|t
1328630|NCT03223350|Randomized|Parallel Assignment||Treatment||Quadruple|Identical appearing placebo cream used for control||t|t|t|t
1328631|NCT03223337|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|This will be an open-label study and no blinding will be performed.|All subjects will receive 6 mg of daprodustat as a single oral dose in parallel way throughout the study period.||||
1328632|NCT03223324|||Cohort||Prospective|||||||
1328633|NCT03223311|||Other||Other|||||||
1328634|NCT03223298|Randomized|Parallel Assignment||Treatment||Triple|Randomization will be carried out by the biostatistics team at Weill Cornell. This will provide assurance that there will be equal patient allocation to both study arms, at each participating site, in the event that the target sample size is not reached. The list will be maintained by the investigational pharmacy. A designated research assistant will be identified at each site to prepare the interventional medication (botulinum versus normal saline). The identity of the agent injected will be unknown to the surgeon as the agent will be drawn up by an assistant in a masked syringe immediately prior to each procedure and labeled with the patient's identifier. Only one assistant at each site will know the identity of the agents during the trial.|Study participants will be randomly allocated to one of two treatment arms (injection of botulinum versus placebo). Blocked randomization will be performed at each of the participating sites. They will be stratified based on study site.|t|t|t|
1328635|NCT03223285|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328636|NCT03223272||Single Group Assignment||Treatment||None (Open Label)||Open-label, dose titration study||||
1328637|NCT03223259||Single Group Assignment||Prevention||None (Open Label)||||||
1328638|NCT03223246|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1328639|NCT03223233|||Cohort||Cross-Sectional|||||||
1328640|NCT03223220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328641|NCT03223207|||Cohort||Prospective|||||||
1328642|NCT03223194|Randomized|Sequential Assignment||Treatment||None (Open Label)||Up to four subjects will be enrolled at each dose level including up to1 subject at each dose level randomized to control with delayed initiation of treatment. One of the dose levels will be chosen for dose expansion and all control subjects will then be treated at the chosen dose level.||||
1328643|NCT03223181|||Case-Crossover||Prospective|||||||
1328644|NCT03223168||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1328645|NCT03223155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328646|NCT03223142||Single Group Assignment||Treatment||None (Open Label)||||||
1328647|NCT03223129|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Patients with either normal glucose tolerance, impaired glucose tolerance or with diagnosed type 2 diabetes mellitus will undergo oral glucose tolerance tests with an increasing load of glucose and thereafter isoglycemic intravenous glucose infusion.||||
1328648|NCT03223116||Single Group Assignment||Treatment||None (Open Label)||||||
1328649|NCT03223103||Single Group Assignment||Treatment||None (Open Label)||||||
1328650|NCT03223090|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1576904|NCT00005352||||||||||||
1328654|NCT03223038|||Cohort||Prospective|||||||
1328655|NCT03223025|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1328656|NCT03223012|||Cohort||Prospective|||||||
1328657|NCT03222999|||Case-Only||Prospective|||||||
1328658|NCT03222986|||Cohort||Prospective|||||||
1328659|NCT03222973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328660|NCT03222960|Randomized|Parallel Assignment||Prevention||Single|||t|||
1328661|NCT03222947|||Cohort||Retrospective|||||||
1328662|NCT03222934|||Other||Cross-Sectional|||||||
1328663|NCT03222921|||Cohort||Prospective|||||||
1328664|NCT03222908|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized control||||
1328665|NCT03222895|||Cohort||Prospective|||||||
1328666|NCT03222882||Single Group Assignment||Treatment||None (Open Label)||||||
1328667|NCT03222869|||Cohort||Prospective|||||||
1328668|NCT03222856||Single Group Assignment||Treatment||None (Open Label)||A phase II, multicenter, open-label study of pembrolizumab and eribulin in patients with HR- positive/HER2-negative metastatic breast cancer previously treated with anthracyclines and taxanes.||||
1328669|NCT03222843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328670|NCT03222830||Single Group Assignment||Treatment||None (Open Label)||||||
1328671|NCT03222817||Single Group Assignment||Screening||None (Open Label)||||||
1328672|NCT03222804|Non-Randomized|Parallel Assignment||Other||None (Open Label)||The feeding patterns of eighty eligible infants (8 to 12 weeks in age) will be characterized based on a 7-day diet record that will be filled out by their mothers during the 7-day lead-in period starting with Day -7 and ending with Day -1. Of the eighty infants, twenty will be exclusive breast feeders (BF), twenty will be exclusive formula feeders (FF) and forty will be mixed-feeders (MF). Infants in all three feeding groups will consume B. infantis for twenty-one consecutive days. Participants will then enter the observational phase until their infant turns 1 year old.||||
1328673|NCT03222791|Randomized|Parallel Assignment||Prevention||Single|||t|||
1328674|NCT03222778|||Case-Control||Prospective|||||||
1328675|NCT03222765|Randomized|Parallel Assignment||Treatment||Quadruple|Two groups (linagliptin vs placebo) double-blind Two groups (metformin & metformin+linagliptin) single-blind|Randomized, parallel , single-blind, placebo controlled|t|t|t|t
1328676|NCT03222752|Randomized|Parallel Assignment||Treatment||Triple|Treatment device will deliver subsensory treatment while the sham device will deliver no treatment.|A single site, 6 week, randomized, double-blind, placebo controlled evaluation of efficacy and tolerability of cranial electrotherapy stimulation (CES) for the treatment of adults from 18-65 years of age with treatment resistant Major Depressive Disorder (MDD) with a 2 week open label extension phase.|t|t|t|
1328677|NCT03222739||Single Group Assignment||Other||None (Open Label)||A single-arm unblinded group of patients will receive ultrasound imaging of spine.||||
1328678|NCT03222726|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||corhort study||||
1328679|NCT03222713|Randomized|Parallel Assignment||Other||None (Open Label)||The participants were randomly assigned into three groups: Condition I followed the health school program (PSE), Condition II group followed the PSE and the Self-regulation Health - SRH program, and the control group did not enroll in either of the health promotion programs||||
1328680|NCT03222700|||Case-Only||Prospective|||||||
1328681|NCT03222687||Single Group Assignment||Treatment||None (Open Label)||||||
1328682|NCT03222674||Single Group Assignment||Treatment||None (Open Label)||||||
1328683|NCT03222661|||Other||Prospective|||||||
1328684|NCT03222648||Single Group Assignment||Treatment||None (Open Label)||single cohort pilot study||||
1328685|NCT03222635||Single Group Assignment||Treatment||None (Open Label)||||||
1328686|NCT03222622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328687|NCT03222609||Single Group Assignment||Treatment||None (Open Label)||||||
1328688|NCT03222596|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Participants will be randomly selected into 2 groups: ambulatory and non-ambulatory (wheelchair) MS individuals that will exercise - group (MSE), with related control group (ambulatory and non-ambulatory (wheelchair) individuals who will not exercise) (MSC). In addition, a group of healthy control subjects without MS (HC) will be evaluated.~Ambulatory and non-ambulatory group of individuals will exercise under the guidance of a physiotherapist."||||
1328689|NCT03222583|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328690|NCT03222570|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1328691|NCT03222557|Randomized|Parallel Assignment||Treatment||Triple|The acupuncturist is the only individual who is aware of the treatment allocation; the patients randomized to the EA/SA groups and the outcome assessor are blinded to the treatment allocation.||t|t||t
1328692|NCT03222544|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1328693|NCT03222531|||Other||Prospective|||||||
1328694|NCT03222518|Randomized|Parallel Assignment||Treatment||Double|"study medications consists of identical shape pills of each study medication randomization is made by sealed envelops and a randomly sequence generated numbers.~patients, physicians and nurses are blinded from the study group"|"Subjects are randomized in 3 arms:~paracetamol + placebo group~NSAID + placebo group~paracetamol + NSAID group"|t|t||
1328695|NCT03222505|Randomized|Crossover Assignment||Treatment||Single|||t|||
1328696|NCT03222492|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328697|NCT03222479||Single Group Assignment||Supportive Care||None (Open Label)||Healthy individuals recruited through advertisement||||
1328698|NCT03222466|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1328699|NCT03222453|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1328700|NCT03222440||Single Group Assignment||Treatment||None (Open Label)||||||
1328701|NCT03222427|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)|Open label|||||
1328702|NCT03222414|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1328754|NCT03221725|||Case-Control||Prospective|||||||
1328755|NCT03221712|||Cohort||Retrospective|||||||
1328756|NCT03221699|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1329098|NCT03217240|||Cohort||Prospective|||||||
1328703|NCT03222401|Randomized|Sequential Assignment||Prevention||Single|All doses of F598 will be administered on an open-label basis. Investigators will be unblinded, and subjects will be aware if they are randomized to the control group or one of the active dose groups; however, subjects in one of the active dose groups will not be informed of their randomized dosage.|"Subjects will be enrolled in 6 identical cohorts of 4 subjects each. Within each cohort, subjects will be randomized to:~Control (n=1)~F598, 1 mg/kg (n=1)~F598, 3 mg/kg (n=1)~F598, 10 mg/kg (n=1)"|t|||
1328704|NCT03222388|||Case-Only||Prospective|||||||
1328705|NCT03222375|||Cohort||Prospective|||||||
1328706|NCT03222362|||Cohort||Retrospective|||||||
1328707|NCT03222349|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||This study uses a multicenter, open-label crossover design with the following periods : 1) Screening visit 2) Treatment Period A (Interictal DBSF dosing and Pharmacokinetic evaluation) 3)Treatment Period B (ictal/ peri-ictal DBSF dosing and pharmacokinetic evaluation) and 4) Follow up visit.||||
1328708|NCT03222336|||Case-Only||Retrospective|||||||
1328709|NCT03222323|Randomized|Parallel Assignment||Treatment||Quadruple||The participants will attend two trial days and receive two treatments on each trial days|t|t|t|t
1328710|NCT03222310||Single Group Assignment||Treatment||None (Open Label)||||||
1328711|NCT03222297|||Case-Control||Prospective|||||||
1328712|NCT03222284|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1328713|NCT03222271|Randomized|Parallel Assignment||Treatment||Single||"All patients will be subjected to history and clinical examination,severity assessment(mMRC dyspnea scale,APACHE II Score and CAT score).~A) Extubation to NIV: SBT will be attempted once the patients achieve stability regarding clinical, neurological and biochemical parameters.Failure of SBT is considered if:pH < 7.35,PaCO2 > 15-20% increase above baseline,PaO2 < 50 mmHg.Heart rate > 100 bpm or respiratory rate > 35 cycle/min.~RSBI and P 0.1. will be recorded while on SBT~B) The patients will be randomized to receive NIV using either ST or iVAPS mode.~C) The patients will be categorized in analysis into 3 groups,Group I: Simple weaning ,Group II: Difficult weaning and Group III: Prolonged weaning.~-The following parameters will be recorded for the patients at the beginning of the study and at 1, 2, 12, 24 and 48 hours after initiation of NIV therapy:GCS,Vital signs (HR, SBP& DBP,RR), ABG analysis and Patient's comfort."|t|||
1328714|NCT03222258|||Cohort||Prospective|||||||
1328715|NCT03222245|||Cohort||Prospective|||||||
1328716|NCT03222232|||Cohort||Retrospective|||||||
1328717|NCT03222219|||Cohort||Prospective|||||||
1328718|NCT03222206|Randomized|Parallel Assignment||Treatment||Double|Double-Blind|Salsalate (2g/d), Place (2g/d)|t||t|
1328719|NCT03222193||Single Group Assignment||Treatment||None (Open Label)||||||
1328720|NCT03222180|Randomized|Factorial Assignment||Health Services Research||Single|Persons administering and scoring study questionnaires will be blinded to the participants' group assignments,|The study design consists of randomization of parents of 150 children with T1D to either Website (n=100) or Usual Care (n=50) for 6 months followed by all participants reverting to the Website condition for the subsequent 6 months.||||t
1328721|NCT03222167||Single Group Assignment||Treatment||None (Open Label)||||||
1328722|NCT03222154|Randomized|Parallel Assignment||Treatment||Triple||3 groups: Control (n = 20), without intervention; Placebo (n = 20), simulation of the application of shock wave therapy; And shock wave therapy (n = 20).|t||t|t
1328723|NCT03222141||Single Group Assignment||Treatment||None (Open Label)||||||
1328724|NCT03222128||Single Group Assignment||Treatment||None (Open Label)||||||
1328725|NCT03222102|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328726|NCT03222089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328727|NCT03222076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328728|NCT03222063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328729|NCT03222050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328730|NCT03222037|Randomized|Crossover Assignment||Treatment||Single|||t|||
1328731|NCT03222024|||Cohort||Prospective|||||||
1328732|NCT03222011|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label study|Randomised controlled trial||||
1328733|NCT03221998|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is designed as a population-based prospective randomized cohort study. A prospective cohort of patients admitted to laparoscopic sleeve gastrectomy due to morbid obesity||||
1328734|NCT03221985||Single Group Assignment||Basic Science||None (Open Label)||||||
1328735|NCT03221972|||Other||Cross-Sectional|||||||
1328736|NCT03221959|||Case-Only||Prospective|||||||
1328737|NCT03221946|Randomized|Parallel Assignment||Treatment||None (Open Label)||3 arms with 3 groups of 30 patients each evaluated for diclofenac sodium oral tablets, transdermal patch and injection of same drug for dental pain disorders||||
1328738|NCT03221933|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328739|NCT03221920|Randomized|Parallel Assignment||Supportive Care||Single|Care provider are not told whether the patient belongs to intervention or control group|Patients were randomized in to two groups, with very low carbohydrate diet and with normal diet||t||
1328740|NCT03221907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328741|NCT03221894|||Cohort||Retrospective|||||||
1328742|NCT03221881||Single Group Assignment||Treatment||None (Open Label)||||||
1328743|NCT03221868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328744|NCT03221855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328745|NCT03221842|Randomized|Sequential Assignment||Treatment||Quadruple||Randomized-withdrawal|t|t|t|t
1328746|NCT03221829|||Other||Retrospective|||||||
1328747|NCT03221816|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1328748|NCT03221803|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328749|NCT03221790||Sequential Assignment||Basic Science||None (Open Label)||||||
1328750|NCT03221777|||Cohort||Prospective|||||||
1328751|NCT03221764||Single Group Assignment||Treatment||None (Open Label)||||||
1328752|NCT03221751|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1328753|NCT03221738||Single Group Assignment||Treatment||None (Open Label)||||||
1576905|NCT00005351||||||||||||
1328757|NCT03221686|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1328758|NCT03221673|||Cohort||Cross-Sectional|||||||
1328759|NCT03221660||Single Group Assignment||Treatment||None (Open Label)||||||
1328760|NCT03221647|||Case-Control||Cross-Sectional|||||||
1328761|NCT03221634||Single Group Assignment||Treatment||None (Open Label)||||||
1328762|NCT03221621|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be treated with either the combination of adalimumab and surgery or adalimumab monotherapy for two years, both according to normal clinical practice. Patients on adalimumab monotherapy will be given the possibility to crossover into Group B when they do not achieve the HiSCR after 6 months of treatment. Additionally patients will be offered treatment with infliximab, according to clinical practice, until he last surgery.||||
1328763|NCT03221608|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1328764|NCT03221595|Randomized|Parallel Assignment||Other||None (Open Label)||randomized, controlled trial||||
1328765|NCT03221582|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328766|NCT03221569|Randomized|Parallel Assignment||Treatment||Triple|Aside from primary investigator (B.Sin) and pharmacist procuring the study interventions, blinding will be applied to patient, physicians, nurses, research associates responsible for collect data and also the independent biostatistician responsible for evaluating the data. Patients will be randomized to receive study numbers that corresponds to treatment arms.|Arm A would include 0.3mg/kg intravenous piggyback ketamine and 1cc normal saline as placebo via intravenous push while Arm B would receive 50ml normal saline and ketorolac 30mg.|t|t||t
1328767|NCT03221556|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1328768|NCT03221543||Single Group Assignment||Treatment||None (Open Label)||||||
1328769|NCT03221530|Randomized|Parallel Assignment||Treatment||Single||||||t
1328770|NCT03221517|Non-Randomized|Parallel Assignment||Other||Single||||||t
1328771|NCT03221504|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328772|NCT03221491|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1328773|NCT03221478|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1328774|NCT03221465|Randomized|Parallel Assignment||Supportive Care||Single|Principal Investigators are neither given names of particular participants nor assignment to study arms.||||t|
1328775|NCT03221452||Single Group Assignment||Other||None (Open Label)||Single group study for intervention feasibility||||
1328776|NCT03221439|Randomized|Parallel Assignment||Treatment||Double|Clinical outcomes will be obtained in the evaluations carried out by a blinded assessor 3, 6 and 12 months after randomization. Both arms include active treatments, and participants will not know whether they are in the experimental group or control group.|Randomized controlled trial with concealed allocation, blinded assessor, blinded participants and intention to treat analysis. Patients will be evaluated at baseline, immediately after the end of the intervention (12 weeks), as in 6 and 12 months after randomization, to assess the maintenance of any effect of treatment. The patients in the CFT group will be treated by two physical therapists that attended twice the CFT workshops with two of the tutors of the method. They completed 106 hours of training including workshops, patient examinations and a pilot study with the supervision of a physical therapist with more than three years of clinical experience in CFT. Patients in MT-EX group will be treated by two physical therapists with more than 8 years of clinical experience in manual therapy and motor control exercises.|t|||t
1328777|NCT03221426|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind study||t|t|t|t
1328778|NCT03221413|Randomized|Crossover Assignment||Treatment||Single|||t|||
1328779|NCT03221400||Single Group Assignment||Treatment||None (Open Label)||||||
1328780|NCT03221387||Single Group Assignment||Treatment||None (Open Label)||||||
1328781|NCT03221374|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1328782|NCT03221361|Randomized|Parallel Assignment||Health Services Research||Triple|"The study will be blinded regarding the statistician who is responsible for data analysis.~The participant patients will be blinded. The outcome assessor for biting force can be blinded during the measurement, the operator cannot be blinded."|prospective , parallel , randomized clinical trial|t|t||t
1328783|NCT03221348||Sequential Assignment||Treatment||None (Open Label)||3+3 sequential cohort design||||
1328784|NCT03221335||Single Group Assignment||Treatment||None (Open Label)||||||
1328785|NCT03221322|||Case-Control||Cross-Sectional|||||||
1328786|NCT03221309|||Cohort||Prospective|||||||
1328787|NCT03221296|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328788|NCT03221283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328789|NCT03221270|Randomized|Crossover Assignment||Treatment||Quadruple|This is a double blind, randomized clinical trial.|Participants will initially be randomized to either sham or 10 Hz tACS for the 5 consecutive days of stimulation. Participants will then be re-randomized to either sham or 10 Hz tACS for the 8 weeks of maintenance stimulation.|t|t|t|t
1328790|NCT03221257|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1328791|NCT03221244|Randomized|Parallel Assignment||Treatment||Single|"Participants will not be told in detail about the specific differences between the VR Treatment and the VR Active Control. Therefore participants will not know which VR condition they received."|"Participants are randomly assigned to one of two groups. Group 1: the treatment arm is the VR Treatment which presents distractors with increasing intensity as performance on attention measures improves. Group 2: in this active control arm (VR Active Control) participants interact with the VR classroom with no distractors presented."|t|||
1328792|NCT03221231|Randomized|Parallel Assignment||Basic Science||Double||RCT|t|t||
1328793|NCT03221218|Randomized|Parallel Assignment||Health Services Research||Double|Patients will be blinded to their group assignment. Family physicians will not be aware that they are involved in a research study until the completion of the study.||t|t||
1328794|NCT03221205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328795|NCT03221192|||Cohort||Cross-Sectional|||||||
1328796|NCT03221179|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1328797|NCT03221166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328981|NCT03218761|||Cohort||Prospective|||||||
1576906|NCT00005350||||||||||||
1328798|NCT03221153|Randomized|Parallel Assignment||Other||Single|Masking only at the level of outcome assessor as this is an educational intervention.|Randomized controlled trial of two educational interventions||||t
1328799|NCT03221140|||Cohort||Prospective|||||||
1328800|NCT03221127|||Cohort||Prospective|||||||
1328801|NCT03221114|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blind to intervention assignment and will only collect clinical data at baseline, 8-, and 12-weeks.|Cluster-randomized control trial||||t
1328802|NCT03221101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328803|NCT03221088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328804|NCT03221075|||Case-Only||Prospective|||||||
1328805|NCT03221062|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328806|NCT03221049|||Cohort||Prospective|||||||
1328807|NCT03221036|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328808|NCT03221023|Randomized|Parallel Assignment||Prevention||Double|Both patient and surgeon will be blinded to the treatment.|The subjects meeting the inclusion criteria will be randomized to either the treatment arm or the control arm by site in a 1:1 ratio.|t|t||
1328809|NCT03221010|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328810|NCT03220997|Randomized|Parallel Assignment||Treatment||Double|Research midwives will attend consent, randomise, collect baseline data and provide the accompanying information and carbohydrate sachets to subjects. The research fellows will be blinded but will collect the data for participants. The research midwives will complete study compliance. To achieve this, participants will bring to ward a completed compliance form ( given at randomisation) in a sealed envelope this will ensure the research investigators remain blinded during their pre op assessments and data collection.||||t|t
1328811|NCT03220984||Single Group Assignment||Treatment||None (Open Label)||||||
1328812|NCT03220971|||Cohort||Retrospective|||||||
1328813|NCT03220958|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328814|NCT03220945|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1328815|NCT03220932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328816|NCT03220919|Randomized|Parallel Assignment||Treatment||Single||randomised controlled trial|t|||
1328817|NCT03220906|||Case-Only||Prospective|||||||
1328818|NCT03220893|||Case-Only||Prospective|||||||
1328819|NCT03220880|||Cohort||Prospective|||||||
1328820|NCT03220867|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1328821|NCT03220854||Single Group Assignment||Treatment||None (Open Label)||Steriotactic Radiotherapy followed by a commercially available PD-1 or PD-L1 inhibitor drug||||
1328822|NCT03220841|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label study|Randomised controlled trial||||
1328823|NCT03220828|Randomized|Parallel Assignment||Prevention||Single||||||t
1328824|NCT03220815|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328825|NCT03220802||Single Group Assignment||Treatment||None (Open Label)||||||
1328826|NCT03220789|Randomized|Parallel Assignment||Treatment||Single||Assignment|t|||
1328827|NCT03220776|Randomized|Crossover Assignment||Basic Science||Quadruple|Double-Blind||t|t|t|t
1328828|NCT03220763|||Cohort||Prospective|||||||
1328829|NCT03220750|||Cohort||Prospective|||||||
1328830|NCT03220737|Randomized|Crossover Assignment||Prevention||Quadruple|The study will be conducted as a double-blind study through 181, where neither the sponsor, the statistical team, study volunteer subjects, nor clinical site personnel (except for the unblinded staff) will know subjects' treatment assignment. Once each subject has reached their Day 181 visit they will be individually unblinded.|"This is a randomized, placebo-controlled, double-blind, single-crossover study with three age cohorts and two treatment groups within each cohort.~The main study consists of a screening period of 30 days, a treatment period from Day 1 to Day 29, and a follow-up period through Day 181. Cohort 1 has an optional sub-study consisting of a long-term follow-up period through Day 730."|t|t|t|t
1328831|NCT03220724|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1328832|NCT03220711||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1328833|NCT03220698|||Case-Control||Prospective|||||||
1328834|NCT03220685|||Cohort||Prospective|||||||
1328835|NCT03220672||Single Group Assignment||Treatment||None (Open Label)||||||
1328836|NCT03220659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328837|NCT03220646|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||This is an open-label, non-randomized, phase II trial of single-agent abemaciclib administered at previously defined MTD/RP2D in three cohorts of patients with primary brain tumors.||||
1328838|NCT03220633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328839|NCT03220620|||Cohort||Prospective|||||||
1328840|NCT03220607|||Cohort||Prospective|||||||
1328841|NCT03220594|||Case-Control||Prospective|||||||
1328842|NCT03220581|Randomized|Parallel Assignment||Treatment||Single||||||t
1328843|NCT03220568|||Cohort||Prospective|||||||
1328844|NCT03220555|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1328845|NCT03220542|Randomized|Factorial Assignment||Treatment||Single|||t|||
1328846|NCT03220529|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1328847|NCT03220516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328848|NCT03220503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328849|NCT03220490|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1328850|NCT03220477||Single Group Assignment||Treatment||None (Open Label)||Single-arm, open-label, multi-center, therapeutic study. All patients will be assigned to receive all three study therapies. The phase 1 portion of the study will proceed as a 3+3 dose-escalation with escalating doses of guadecitabine and mocetinostat, along with fixed dose of pembrolizumab.||||
1328851|NCT03220464||Single Group Assignment||Screening||None (Open Label)||||||
1328852|NCT03220451||Single Group Assignment||Treatment||None (Open Label)||||||
1328853|NCT03220438|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1328854|NCT03220425|Randomized|Parallel Assignment||||None (Open Label)||||||
1328855|NCT03220412|Randomized|Single Group Assignment||Other||Single|Participants did not know which condition they were in. Participants' parents were aware of the deception (hidden gun) and what condition their children were in (with or without guns). Research personnel knew conditions as well. Research assistants who transcribed recorded laboratory sessions did not know what condition they were coding (eg. what type of movie participants watched)|Participants are randomly assigned to watch a movie containing guns, or a movie not containing guns.|t|||
1328856|NCT03220399|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1328857|NCT03220386||Single Group Assignment||Prevention||None (Open Label)||Patients screened positive for nasal MSSA or MRSA colonization during their treatment in the emergency department receive a standardized decolonization Treatment (Octinidin nasal ointment and skin washing)||||
1328858|NCT03220373|||Cohort||Prospective|||||||
1328859|NCT03220360|Randomized|Sequential Assignment||Treatment||Double|||t|||t
1328860|NCT03220347||Single Group Assignment||Treatment||None (Open Label)||||||
1328861|NCT03220334|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328862|NCT03220321|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328863|NCT03220308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328864|NCT03220295|Randomized|Parallel Assignment||Treatment||Triple|Double-blind safety study. The pharmacist is unblinded.||t|t|t|
1328865|NCT03220282|Randomized|Parallel Assignment||Prevention||Single|Participant, PI, enrolling nurse and clinical care team will not be blinded as to treatment assignment. Outcomes will be assessed by blinded investigators.|Randomized controlled trial with 2 arms||||t
1328866|NCT03220269|||Cohort||Prospective|||||||
1328867|NCT03220256||Single Group Assignment||Prevention||None (Open Label)||||||
1328868|NCT03220243||Single Group Assignment||Treatment||None (Open Label)||||||
1328869|NCT03220230|||Cohort||Cross-Sectional|||||||
1328870|NCT03220217|Randomized|Parallel Assignment||Diagnostic||Single|All the primary and secondary imaging endpoints are read by third-party independent readers. Most of the reading will be conducted in blinded manner.|||||t
1328871|NCT03220204|Randomized|Parallel Assignment||Treatment||Single|Participants and treating study staff will be aware of the participant's treatment condition. However, follow-up assessments will be performed by a study staff member that is masked to the participant's treatment condition.|Randomized, single-blinded, controlled trial||||t
1328872|NCT03220191||Sequential Assignment||Basic Science||None (Open Label)||the subjects will receive palbociclib alone in period 1, and receive palbociclib with rabeprazol in period 2||||
1328873|NCT03220178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328874|NCT03220165||Single Group Assignment||Treatment||None (Open Label)||||||
1328875|NCT03220152||Single Group Assignment||Prevention||None (Open Label)||||||
1328876|NCT03220139|||Cohort||Prospective|||||||
1328877|NCT03220126|Randomized|Parallel Assignment||Basic Science||None (Open Label)|Open|Treatments 2 and 3 of LY900021 will be administered in parallel with LY3074828. Treatments 2, 3, and 4 of LY900021 will be administered sequentially pending a safety review after administration of Treatments 2 and 3.||||
1328878|NCT03220113||Single Group Assignment||Treatment||None (Open Label)||Prospective Open Label Study||||
1328879|NCT03220100||Single Group Assignment||Supportive Care||None (Open Label)||||||
1328880|NCT03220087|||Case-Control||Retrospective|||||||
1328881|NCT03220074||Single Group Assignment||Treatment||None (Open Label)||Open labelled study||||
1328882|NCT03220061|Randomized|Parallel Assignment||Prevention||None (Open Label)||music therapy was soft and relaxing instrumental piano music which was given among haemodialysis patients for 30 minutes||||
1328883|NCT03220048|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1328884|NCT03220035||Single Group Assignment||Treatment||None (Open Label)||||||
1328885|NCT03220022||Single Group Assignment||Treatment||None (Open Label)||||||
1328886|NCT03220009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328887|NCT03219996|||Case-Control||Retrospective|||||||
1328888|NCT03219983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328889|NCT03219970|||Cohort||Retrospective|||||||
1328890|NCT03219957|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1328891|NCT03219944|Randomized|Parallel Assignment||Treatment||Single||||||t
1328892|NCT03219931|Randomized|Parallel Assignment||Treatment||Quadruple|The study is a triple blind study in which the treatment or intervention is unknown to the research participant, the individuals who administer the treatment or intervention, and the researchers who assess the outcomes.|During the 90 days of the study, parents were asked to give 5 drops of active product (108 viable cells/strain) or placebo and to daily take note of minutes of crying, number, color, and consistency of evacuations, and number of regurgitations or vomits.|t|t|t|t
1328893|NCT03219918|Randomized|Parallel Assignment||Diagnostic||Double|It is partially blinded in the way that the endoscopist knows whether the procedure is performed with or without the EndoRings but neither patient, pathologist nor investigators will have this information, which is only to be revealed to the investigators at the end of data processing.|"The study is a single-centre prospective randomised clinical trial. Patients are included if they meet the specified inclusion criteria and accept to take part in the study after proper oral and written information (see patient information below).~Specimens i.e. removed adenomas and biopsies of suspected malignancies are analysed by pathologists according to standard procedure. The pathologist will not know the nature of specimen collection (colonoscopy with or without EndoRings). The specimens are not saved for any other study related activities."|||t|t
1328894|NCT03219905|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1328895|NCT03219892|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328896|NCT03219879|Randomized|Parallel Assignment||Treatment||Single||||||t
1328897|NCT03219866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328898|NCT03219853|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1328899|NCT03219840|Randomized|Crossover Assignment||Prevention||Quadruple||A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial|t|t|t|t
1328900|NCT03219827|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1328901|NCT03219814|Randomized|Parallel Assignment||Prevention||Double|Participants will be unaware until completion of study as to which group they were assigned to (all participants who sign up are only given the information that they will be engaging in an eyetracking task and discussions about the media). The assessments consist of self-report questionnaires (which will be scores by a masked assessor), and eye-tracking, which is an objective measure of time spent gazing at various stimuli.||t|||t
1328902|NCT03219801||Single Group Assignment||Treatment||None (Open Label)||||||
1328903|NCT03219788|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1328904|NCT03219775||Single Group Assignment||Treatment||None (Open Label)||||||
1328905|NCT03219762||Single Group Assignment||Health Services Research||None (Open Label)||Open label, multicentre, study||||
1328906|NCT03219749||Single Group Assignment||Treatment||None (Open Label)||||||
1328907|NCT03219736|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328908|NCT03219723|||Cohort||Prospective|||||||
1328909|NCT03219710|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1328910|NCT03219697|Randomized|Parallel Assignment||Prevention||Single||||||t
1328911|NCT03219684|||Cohort||Cross-Sectional|||||||
1328912|NCT03219671||Single Group Assignment||Treatment||None (Open Label)||||||
1328913|NCT03219658|Randomized|Parallel Assignment||Treatment||Single||||||t
1328914|NCT03219645|Randomized|Parallel Assignment||Treatment||Single||||||t
1328915|NCT03219632|||Case-Control||Prospective|||||||
1328916|NCT03219619|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1328917|NCT03219606||Single Group Assignment||Other||None (Open Label)||||||
1328918|NCT03219593||Single Group Assignment||Treatment||None (Open Label)||Apatinib Monotherapy||||
1328919|NCT03219580|Randomized|Parallel Assignment||Prevention||Double|Both patients and physicians are blinded in this study. The study log is maintained by a study nurse who maintains the log of which side is randomized to placebo and active treatment arm respectively. The study nurse is also responsible for preparing the 2 arms in identical syringes, ensuring each arm is injected into its respective laterality|Patients who undergo bilateral direct brow ptosis repair will be randomized to have one brow as the placebo arm and one arm as the active treatment arm. This original randomization will be maintained throughout the study.|t||t|
1328920|NCT03219567||||||||||||
1328921|NCT03219554||Single Group Assignment||Treatment||None (Open Label)||||||
1328922|NCT03219541|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328923|NCT03219528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328924|NCT03219515|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1328925|NCT03219502|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1328926|NCT03219489|Randomized|Parallel Assignment||Other||Single|||t|||
1328927|NCT03219476||Single Group Assignment||Treatment||None (Open Label)||||||
1328928|NCT03219463|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1328929|NCT03219450|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1328930|NCT03219437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328931|NCT03219424|||Cohort||Prospective|||||||
1328932|NCT03219411|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1328933|NCT03219398|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1328934|NCT03219385||Single Group Assignment||Treatment||None (Open Label)||||||
1328935|NCT03219372|Randomized|Parallel Assignment||Prevention||Triple|double-blind|1:1 drug versus placebo|t|t|t|
1328936|NCT03219359||Single Group Assignment||Treatment||None (Open Label)||||||
1328937|NCT03219346|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1328938|NCT03219333||Single Group Assignment||Treatment||None (Open Label)||single-arm, open-label, multi-cohort, multicenter study||||
1328939|NCT03219320|Randomized|Parallel Assignment||Supportive Care||Triple|Treatment arms, dose levels, and randomization algorithm are masked.|Subjects will be randomized to receive placebo or NYX-2925.|t|t|t|
1328940|NCT03219307||Single Group Assignment||Treatment||None (Open Label)||||||
1328941|NCT03219294|Randomized|Parallel Assignment||Other||Double|The anesthesiologist will NOT be blinded, but the orthopedic surgeon performing the hip replacement surgery will be.||t|||t
1328942|NCT03219268||Single Group Assignment||Treatment||None (Open Label)||Dose escalation followed by Cohort Expansion Phase at the MTD.||||
1328943|NCT03219255|||Cohort||Prospective|||||||
1328944|NCT03219242||Single Group Assignment||Basic Science||None (Open Label)||||||
1328945|NCT03219229|||Cohort||Prospective|||||||
1328946|NCT03219216|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328947|NCT03219203|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328948|NCT03219190|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328949|NCT03219177|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1328950|NCT03219164|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1328951|NCT03219151|Randomized|Parallel Assignment||Other||Single||||||t
1328982|NCT03218748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328983|NCT03218735|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1328984|NCT03218722|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1328985|NCT03218709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328986|NCT03218696|Randomized|Parallel Assignment||Treatment||Quadruple|According to a predertermined list, the two products are provided in identical bottles and cartons appropriately labelled so as to ensure respect of the randomization list as well as blinding of all study participants.|Parallel randomized double blind|t|t|t|t
1328987|NCT03218683||Single Group Assignment||Treatment||None (Open Label)||This study is a multicenter, open-label, nonrandomized, sequential group, dose-escalation study to assess safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ascending doses of AZD5991 in subjects with relapsed or refractory hematologic malignancies.||||
1328988|NCT03218670|||Cohort||Cross-Sectional|||||||
1328952|NCT03219138|Non-Randomized|Single Group Assignment||Diagnostic||Single|"Immediately after extubation the blinded anaesthesiologist (care provider), who performs anesthesia, tests the patient in the operating room.~The blinded anaesthesiologist is unable to see the data on the EMG monitor and the movement of the adductor pollicis muscle."|"During anaesthesia calibrated neuromuscular function is monitored using evoked EMG of the adductor pollicis muscle (immobilised forearm) with a NMT module by a non-blinded investigator. During surgery, the (blinded) attending anaesthesiologist administers maintenance doses of atracurium according to clinical needs, i.e. without knowing the TOFR.~After surgery patients' trachea is extubated according to clinical judgement. Immediately after extubation blinded anaesthesiologist tests the patient. The postoperative evaluation of neuromuscular function consists of eight clinical tests applied in a random order.~Thereafter, an uncalibrated acceleromyography (50 mA, 2 Hz) is started on the contralateral arm and TOF ratio is measured.~During the validation part of the developed algorithm the anaesthesiologist additionally had to judge tactile fading of the adductor pollicis.~If a patient had any clinical signs of neuromuscular dysfunction, reversal with neostigmine is administered."||t||
1328953|NCT03219125|||Case-Control||Prospective|||||||
1328954|NCT03219112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328955|NCT03219099|||Other||Cross-Sectional|||||||
1328956|NCT03219086|Randomized|Parallel Assignment||Other||Triple|The spinal solution will be prepared by an independent anaesthetist, anaesthetist trainee or research nurse on a sterile table after opening the sealed envelope with the appointed study group. The patient, the anaesthetist performing the CSE and the observer are not aware of the local anaesthetic solution administered.|prospective double blind randomised|t||t|t
1328957|NCT03219073|Randomized|Parallel Assignment||Treatment||Double|Patients and assessing investigator will be blinded to group allocation while the treating investigator, who has to set the tDCS or sham-stimulation protocol on the stimulator, will be the only person aware of the stimulation condition. To minimize communication between blinded and non-blinded participants, the treating investigator will be instructed not to talk to patients and the assessing investigator about the study protocol.|Two age and sex matched groups, each n =8, will be randomized to receive either tDCS or SHAM stimulation.|t|t||
1328958|NCT03219060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328959|NCT03219047|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328960|NCT03219034|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1328961|NCT03219021|||Other||Cross-Sectional|||||||
1328962|NCT03219008|Randomized|Parallel Assignment||Treatment||Double|patients with depressive disorder were randomly assigned to different therapy groups or TAU therapy group based on different depressive disorders subtypes.|"Part 2: all patients before receiving any medicine treatment are divided into four groups which adopt different therapy strategies :treatment with fluvoxamine, fluoxetine, mirtazapine and treatment as usual(TAU).Meanwhile，patients with different subtypes of depressive disorder were randomly assigned to different therapy groups.Each therapy groups contains 50 participants.Therefore, the total sample size is 50*12+200=800.~Part3:To find out efficiency of different kinds of therapy strategies.p=60%, error=5%,a-0.05,the amount of samples nearly is:867,considering the nearly 30% expulsion rate, the final total sample size is 867+260=1127.Therefore,sample size in each group is nearly 376.~Part4:p=60%,error=0.05, a=0.05, exculsion rate=30%,N=867+260=1127.the amount of samples of each group is 1127/3=nearly 400."|t|||t
1328963|NCT03218995||Single Group Assignment||Treatment||None (Open Label)||||||
1328964|NCT03218982|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Families will then be randomized (as a team) to either the active intervention or the control condition. Caregivers in the active intervention will then be scheduled for six weekly intervention sessions, lasting about 2 hours each. Following the completion of the sessions, primary caregivers will complete assessment measures (that they completed at baseline) immediately after the intervention (post) and at three months. This is expected to take one hour for each assessment. Primary caregivers assigned to the control condition will also complete these assessment measures around the same those in the active intervention complete them. These caregivers will also have the option of participating in the active intervention after the three-month follow up.||||
1328965|NCT03218969|Randomized|Crossover Assignment||Treatment||Double|placebo||t||t|
1328966|NCT03218956||Single Group Assignment||Other||None (Open Label)||||||
1328967|NCT03218943|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||A randomized controlled study with cross-over design.||||
1328968|NCT03218930||Single Group Assignment||Other||None (Open Label)||||||
1328969|NCT03218917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328970|NCT03218904|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1328971|NCT03218891|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Optimized clinical treatment group + physical training for 12 weeks (TF);~optimized clinical treatment group (CT);~Group with coronary insufficiency without angina (CD);~Group normal healthy subjects"||||
1328972|NCT03218878|||Cohort||Prospective|||||||
1328973|NCT03218865|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective multicenter controlled and randomized protocol study||||
1328974|NCT03218852|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1328975|NCT03218839||Single Group Assignment||Health Services Research||None (Open Label)||The study is a one arm, open label, prospective, cohort field study to assess the safety and acceptability of PrePex device circumcision device when performed by certified PrePex circumcision providers (physicians & nurses) in a HIV-infected male population.||||
1328976|NCT03218826||Single Group Assignment||Treatment||None (Open Label)||||||
1328977|NCT03218813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will adopt a non-randomised prospective intervention cohort design (i.e. controlled before-and-after (CBA) study). Two cohorts of patients will be recruited from a single NHS site over two recruitment periods. Pharmacists will be trained between these recruitment periods to deliver an intervention, thus creating two comparable groups (control/'before' group vs. intervention/'after' group).||||
1328978|NCT03218800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328979|NCT03218787||Single Group Assignment||Treatment||None (Open Label)||||||
1328980|NCT03218774|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blinded to group assignment. It is not possible to blind the participants or the care providers.|||||t
1328989|NCT03218657|Randomized|Parallel Assignment||Treatment||Single|||t|||
1328990|NCT03218644|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1328991|NCT03218631||Single Group Assignment||Treatment||None (Open Label)||"Male~Age 18 to 35 years (inclusive) at the time of screening~Body mass index [BMI, body weight (kg)/height (m)2] below 30 kg/m2~Medically healthy"||||
1328992|NCT03218618|||Ecologic or Community||Prospective|||||||
1328993|NCT03218605||Single Group Assignment||Prevention||None (Open Label)||||||
1328994|NCT03218592|Randomized|Sequential Assignment||Other||None (Open Label)||Observational, Prospective. Single-center, open-label, 3-arm, triple stage study||||
1328995|NCT03218579|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1328996|NCT03218566||Single Group Assignment||Treatment||None (Open Label)||||||
1328997|NCT03218553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1328998|NCT03218540|Randomized|Parallel Assignment||Treatment||Double|The patient is anesthetized, thus unaware type of treatment. The assessor is blinded of the monitor|Group SVV: fluid management guided by stroke volume variation (SVV) protocol Group CVP: fluid management guided by central venous pressure (CVP) protocol|t|||t
1328999|NCT03218527|||Cohort||Prospective|||||||
1329000|NCT03218514|||Cohort||Prospective|||||||
1329001|NCT03218501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329002|NCT03218488|||Cohort||Prospective|||||||
1329003|NCT03218475||Single Group Assignment||Other||None (Open Label)||||||
1329004|NCT03218462|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1329005|NCT03218449|||Cohort||Retrospective|||||||
1329006|NCT03218436|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329007|NCT03218423|||Other||Prospective|||||||
1329008|NCT03218410|Randomized|Parallel Assignment||Treatment||None (Open Label)||Monocentric, randomized, open-label, controlled, clinical, non-inferiority trial.||||
1329009|NCT03218397|Randomized|Parallel Assignment||Diagnostic||Single|Primary service/provider: The primary service, including the prescribing provider, will be unaware of group assignment at the time of randomization, so initial antibiotic choice will not be affected by group assignment. Once rapid results become available and/or AS interventions are made, treating providers may become aware of group assignment.|||t||
1329010|NCT03218384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329011|NCT03218371|||Cohort||Retrospective|||||||
1329012|NCT03218358|||Case-Only||Prospective|||||||
1329013|NCT03218345||Single Group Assignment||Treatment||None (Open Label)||||||
1329014|NCT03218332|||Case-Control||Prospective|||||||
1329015|NCT03218319||Single Group Assignment||Prevention||None (Open Label)||||||
1329016|NCT03218306|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1329017|NCT03218293|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329018|NCT03218280|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1329019|NCT03218267|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1329020|NCT03218254|Randomized|Crossover Assignment||Treatment||Quadruple|Identical placebo tablets are produced. Study pharmacy produces study medication containers and randomizes patients, and keeps track of unique study IDs. Unblinding is only done after completion or in emergency situations|Methylphenidate or Placebo titrated according to effect and toxicity week 1-6 followed by 1 week of washout and then crossover followed by repeated procedures with the other treatment for week 8-13.|t|t|t|t
1329021|NCT03218241|Randomized|Single Group Assignment||Other||Double|||t||t|
1329022|NCT03218228|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1329023|NCT03218215|||Cohort||Cross-Sectional|||||||
1329024|NCT03218202|||Cohort||Prospective|||||||
1329025|NCT03218189|||Ecologic or Community||Cross-Sectional|||||||
1329026|NCT03218176|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1329027|NCT03218163||Single Group Assignment||Treatment||None (Open Label)||||||
1329028|NCT03218150|||Cohort||Prospective|||||||
1329029|NCT03218137||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329030|NCT03218124||Single Group Assignment||Other||None (Open Label)|Patient under general anesthesia unaware of the effect site concentration of remifentanil before extubation|Prospective observational study. Decreasing/increasing remifentanil effect site concentrations (Dixon's up and down model) to obtain cough-free extubation after thyroidectomy||||
1329031|NCT03218111||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329032|NCT03218098|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1329033|NCT03218085|||Cohort||Prospective|||||||
1329034|NCT03218072|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329035|NCT03218059|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1329036|NCT03218046||Single Group Assignment||Treatment||None (Open Label)||||||
1329037|NCT03218033|Randomized|Parallel Assignment||Other||Single|||||t|
1329038|NCT03218020|||Cohort||Prospective|||||||
1329039|NCT03218007||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329040|NCT03217994|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1329041|NCT03217981|||Cohort||Retrospective|||||||
1329042|NCT03217968||Single Group Assignment||Treatment||None (Open Label)||||||
1329090|NCT03217344|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective randomized without restrictions||||
1329091|NCT03217331||Single Group Assignment||Treatment||None (Open Label)||||||
1329092|NCT03217318|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1329093|NCT03217305||Single Group Assignment||Treatment||None (Open Label)|The investigator works as physician at the Department of Intensive Care. The participants are patients.|Control-Intervention-Control||||
1329094|NCT03217292|Randomized|Parallel Assignment||Treatment||Single||Prospective, randomized, controlled, single-blind||||t
1329095|NCT03217279|||Cohort||Prospective|||||||
1329096|NCT03217266||Single Group Assignment||Treatment||None (Open Label)||||||
1329097|NCT03217253||Single Group Assignment||Treatment||None (Open Label)||||||
1329043|NCT03217955|Randomized|Parallel Assignment||Treatment||Triple|Randomisation is coordinated a staff member of the psychosis department who is not involved in the research team and not familiar with both the assessments or intervention procedure. The results of the randomization is concealed from the assessors. Every effort has been made to keep assessors blind to treatment condition, using the following strategies: research workers were not involved in the randomization process, therapists and research workers made use of different (secured) agendas, and work locations / rooms in order tot minimize the chance of potential blind breaks; patients will be frequently reminded by assessors not to talk about treatment allocation.|"The present study entails a single-blind two-level RCT directed at patients with recent onset schizophrenia. Participants are randomly assigned to intervention condition (Cognitive Behavioral Therapy- Social Activation (CBTsa) plus Standard Treatment (ST)), or to the control condition (ST alone).~A baseline test battery is employed to examine causes of social withdrawal and interaction with treatment outcome. Follow-up assessments (repetition test battery) will take place directly after the intervention period and 6 months post-treatment."|t||t|t
1329044|NCT03217942|Randomized|Single Group Assignment||Basic Science||Double|Double blind||t||t|
1329045|NCT03217929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329046|NCT03217916|||Case-Control||Cross-Sectional|||||||
1329047|NCT03217903||Single Group Assignment||Screening||None (Open Label)||||||
1329048|NCT03217890|||Other||Other|||||||
1329049|NCT03217877|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329050|NCT03217864|||Cohort||Prospective|||||||
1329051|NCT03217851|||Other||Cross-Sectional|||||||
1329052|NCT03217838|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329053|NCT03217825|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1329054|NCT03217812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329055|NCT03217799|||Case-Control||Prospective|||||||
1329056|NCT03217786|||Other||Prospective|||||||
1329057|NCT03217773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329058|NCT03217760|||Cohort||Prospective|||||||
1329059|NCT03217747|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329060|NCT03217734|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1329061|NCT03217721|||Cohort||Retrospective|||||||
1329062|NCT03217708|||Cohort||Prospective|||||||
1329063|NCT03217695||Single Group Assignment||Treatment||None (Open Label)||||||
1329064|NCT03217682|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||After the patient has been registered into the study, they will be assigned to either the music therapy or massage therapy cohort. The music therapy cohort will be available to the first 30 patients and 30 caregivers accrued. Upon reaching 60 subjects enrolled, the music therapy cohort will close to accrual and the massage therapy cohort will open to accrual. Once the massage therapy cohort has enrolled 30 patients and 30 caregivers, the massage therapy cohort will close to accrual and the study will be closed to all further accrual.||||
1329065|NCT03217669|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||For the Dose Escalation cohort: Traditional 3+3 dose escalation design. For the Dose Expansion cohort: Once recommended phase two dose (RP2D) is defined by the PI, a total of 10 NSCLC patients who meet eligibility will be enrolled in the dose expansion cohort. If RP2D is not defined for any reason, the study will be terminated.||||
1329066|NCT03217656|||Cohort||Prospective|||||||
1329067|NCT03217643||Single Group Assignment||Treatment||None (Open Label)||||||
1329068|NCT03217630|||Cohort||Prospective|||||||
1329069|NCT03217617||Single Group Assignment||Treatment||None (Open Label)||||||
1329070|NCT03217604|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1329071|NCT03217591|Randomized|Parallel Assignment||Treatment||Triple||Phase 2, randomized, double-blind, placebo-controlled, parallel-group study|t|t|t|
1329072|NCT03217578|||Cohort||Prospective|||||||
1329073|NCT03217565|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329074|NCT03217552|||Cohort||Prospective|||||||
1329075|NCT03217539|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1329076|NCT03217526|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1329077|NCT03217513|||Cohort||Prospective|||||||
1329078|NCT03217500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329079|NCT03217487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329080|NCT03217474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329081|NCT03217461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329082|NCT03217448|Randomized|Parallel Assignment||Treatment||Single||||||t
1329083|NCT03217435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329084|NCT03217422|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind, placebo-controlled||t|t|t|t
1329085|NCT03217409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329086|NCT03217396|||Case-Control||Other|||||||
1329087|NCT03217383||Single Group Assignment||Device Feasibility||None (Open Label)|Though the study only has one study arm, the participant, medical PI, dental PI will be blinded to the test prediction.|||||
1329088|NCT03217370||Single Group Assignment||Treatment||None (Open Label)||observational cross-sectional study with pre and post measurement and in between an interventional phase with education, IT implementations etc.||||
1329089|NCT03217357|Randomized|Parallel Assignment||Basic Science||Quadruple|"The subject will be blind of the treatment he receives (active or placebo).~- The experimenter will also be blinded from stimulation (active or placebo) Each subject will be assigned a randomization code, corresponding to the code to enter the tDCS device. This system allows the person who administers tDCS and the subject receiving the stimulation to be blind ."|In a randomized controlled double blind study, 30 subjects, first-degree relatives of schizophrenic patients, were randomly assigned to 2 groups. A group of 15 participants will receive 30 minutes of active tDCS (2mA, 30 minutes with the anode at the left DLPFC and the cathode at the right DLPFC); A group of 15 participants will receive 30 minutes of placebo stimulation. During this stimulation session, all participants will undergo a standardized stress test combining psychosocial stress and physical stress|t|t|t|t
1329099|NCT03217227|||Cohort||Prospective|||||||
1329100|NCT03217214|||Case-Control||Prospective|||||||
1329101|NCT03217201|Randomized|Parallel Assignment||Supportive Care||Single|The participant does not know his or her study condition.|Stratified by adjuvant and neoadjuvant chemotherapy treatments, then randomly assigned to one of two light treatment conditions.|t|||
1329102|NCT03217188|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a phase II study evaluating proton reirradiation for patients who have a recurrent or a second primary head and neck cancer.||||
1329103|NCT03217175|Randomized|Crossover Assignment||Treatment||Single|The study will be performed in single-blind fashion in that the participant will not know whether the bionic pancreas glucagon pump is filled with glucagon or placebo during the exercise visits. Study staff will fill the tandem t:slim glucagon pump with either glucagon or placebo according to the subject's randomization order. The subject will not be aware of their randomization. New infusion sets for both the glucagon/placebo and insulin pumps will be placed using an FDA approved steel cannula infusion set.|Once the subject has been enrolled and eligibility of subjects has been established, subjects will be randomized to one of the possible two visit-orders. In random order, subjects will complete an insulin only exercise visit and a bi-hormonal exercise visit. The outpatient run-in period for both exercise visits will use the bi-hormonal bionic pancreas.|t|||
1329104|NCT03217162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329105|NCT03217149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329106|NCT03217136|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1329107|NCT03217123||Sequential Assignment||Treatment||Triple|Patients were blind to the study phase (contact and parameters of stimulation).|The study meets a double-blind, longitudinal design. Stimulation contact was set following a random series known only by the neurosurgeon, with patient, psychiatry and neuropsychology teams blind. Psychiatric assessment was conducted each month, and neuropsychological testing was performed after each activation and washout period|t|t|t|
1329108|NCT03217110|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1329109|NCT03217097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329110|NCT03217084|Randomized|Parallel Assignment||Treatment||Single||||||t
1329111|NCT03217071|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1329112|NCT03217058|||Other||Prospective|||||||
1329113|NCT03217045|||Case-Control||Retrospective|||||||
1329114|NCT03217032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1329115|NCT03217019|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329116|NCT03217006|Randomized|Parallel Assignment||Treatment||Single|The endpoint assessors will be blinded to treatment allocation (PROBE).|Patients undergoing coronary artery bypass surgery will be in one of two groups. One group will receive a single arterial graft and the second group will receive two or more arterial grafts.||||t
1329117|NCT03216993|Randomized|Parallel Assignment||Other||Single|||t|||
1329118|NCT03216980|Non-Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1329119|NCT03216967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329120|NCT03216954|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1329121|NCT03216941|Randomized|Parallel Assignment||Treatment||Single|care provider were masked with regard to the patient's treatment assignment, and patients were instructed not to reveal their current treatment to the investigators.|double-blind controlled trial to compare the effectiveness of intramuscular olanzapine and ketamine as first medication(s) used to treat patients with agitation caused by psychosis.||t||
1329122|NCT03216928|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1329123|NCT03216915|||Cohort||Prospective|||||||
1329124|NCT03216902|Randomized|Parallel Assignment||Treatment||Single||||||t
1329125|NCT03216889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329126|NCT03216876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1329127|NCT03216863||Single Group Assignment||Other||None (Open Label)||Patients with advanced or metastatic non-small cell lung cancer treated with oral targeted therapy (tyrosine kinase (TKI) inhibitors of EGF-R and ALK inhibitors), regardless of the treatment line.||||
1329128|NCT03216850|||Cohort||Prospective|||||||
1329129|NCT03216837|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1329130|NCT03216824|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||One group will maintain a dressing on the CVAD exit site as per institutional practice. The second group will not cover the CVAD exit site with a dressing (i.e. no-dressing).||||
1329131|NCT03216811||Single Group Assignment||Treatment||None (Open Label)||Subjects that meet the inclusion/exclusion criteria and have provided informed consent will undergo a 4-week period of lifestyle advice and changes. If, after the 4 weeks, LDL values are confirmed above the established cutoffs, the subjects receive CARDIOVIS COLESTEROLO 3 mg for 8 weeks. After the 8-week treatment period, all biological paprameters will be reassessed. Finally, a last blood samples to assess a potential rebound effect after nutraceutical suspension is collected 4 weeks after the treatment stop.||||
1329132|NCT03216798|||Cohort||Prospective|||||||
1329133|NCT03216785|||Cohort||Prospective|||||||
1329134|NCT03216772||Single Group Assignment||Treatment||None (Open Label)||||||
1329135|NCT03216759|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1329136|NCT03216746|Randomized|Parallel Assignment||Prevention||Single||||||t
1329137|NCT03216733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329138|NCT03216720|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1329139|NCT03216707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329140|NCT03216694|||Cohort||Retrospective|||||||
1329141|NCT03216681|||Cohort||Prospective|||||||
1329142|NCT03216668|Randomized|Parallel Assignment||Treatment||None (Open Label)||Block randomization||||
1329143|NCT03216655|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1329144|NCT03216642|||Case-Only||Other|||||||
1329145|NCT03216629|Randomized|Crossover Assignment||Treatment||Single||||||t
1329146|NCT03216616||Single Group Assignment||Treatment||None (Open Label)||||||
1329147|NCT03216603|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1329148|NCT03216590|Randomized|Parallel Assignment||Prevention||None (Open Label)||After signing an informed consent participants will be randomised to one of the two study groups.||||
1329149|NCT03216577|||Case-Control||Prospective|||||||
1329150|NCT03216564|Randomized|Parallel Assignment||Treatment||Single||||||t
1329151|NCT03216551|||Cohort||Prospective|||||||
1329152|NCT03216538|Randomized|Parallel Assignment||Treatment||Triple|Patients, caregivers and Investigators will be masked to the nature of the treatment until all patients completed participation in the study.|On day 1 patients will be randomly allocated to one of the two following study arms in a 1:1 ratio and in a masked manner: (1) AS101 1% oral solution (2) Placebo oral solution. Patients of both study arms will be instructed on how to administer orally the drug at home once daily for 24 weeks. Patients will stop taking the study oral solution at week 24 treatment visit.|t|t|t|
1329153|NCT03216525|Randomized|Parallel Assignment||Treatment||Double|double blind design.|This is a prospective, randomized, single-center double blind trial of Alvimopan versus placebo for improving patient outcomes and cost during radical cystectomy and urinary diversion.|t||t|
1329154|NCT03216512|Randomized|Crossover Assignment||Other||Single|The participant won't know whether they are receiving the noise cancelling headphones or the sham control.|Proof-of-concept, randomized, within-subject cross-over design.|t|||
1329155|NCT03216499||Single Group Assignment||Treatment||None (Open Label)||||||
1329156|NCT03216486||Single Group Assignment||Treatment||None (Open Label)||Single arm, open-label||||
1329157|NCT03216473|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329158|NCT03216460||Single Group Assignment||Device Feasibility||None (Open Label)||This study is a single-arm, multi-center, observational clinical study.||||
1329159|NCT03216447|Randomized|Parallel Assignment||Treatment||None (Open Label)|open labeled|||||
1329160|NCT03216434|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1329161|NCT03216421|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329162|NCT03216408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329163|NCT03216395|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients are randomized in a 1:1 ratio to receive; endoscopic treatment using OTSC or standard therapies Stratified randomization according to size of ulcers and non-ulcer lesions~size smaller than10mm in diameter~size equal to 10mm and less than 20mm in diameter~size equal or greater than 20mm in diameter~non-ulcer lesions"||||
1329164|NCT03216382|Randomized|Parallel Assignment||Treatment||Single||Baseline outcome measures will be completed at the first visit to the lab. Participants will then engage in a week of reporting on their worry and attention on their own, before coming back to the lab to recomplete the outcome measures. They will then be randomly assigned to the intervention or control condition and will engage in a week of daily listening to the corresponding recording for their condition on their own, while reporting on their worry and attention again during that week. Outcome measures will be completed again at the lab immediately following the intervention.|t|||
1329165|NCT03216369|||Case-Only||Cross-Sectional|||||||
1329166|NCT03216356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329167|NCT03216343||Single Group Assignment||Treatment||None (Open Label)||||||
1329168|NCT03216330|||Case-Control||Prospective|||||||
1329169|NCT03216317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329170|NCT03216304|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1329171|NCT03216291|Randomized|Parallel Assignment||Treatment||Triple|Everyone is masked to the assignment of home or office biofeedback training. Once the subject makes it to their treatment session, then everyone will know which one the subject has been allocated to.||t||t|t
1329172|NCT03216278|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1329173|NCT03216265|Randomized|Parallel Assignment||Treatment||Single||||||t
1329174|NCT03216252||Single Group Assignment||Basic Science||None (Open Label)||||||
1329175|NCT03216239|||Other||Retrospective|||||||
1329176|NCT03216226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329177|NCT03216213|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1329178|NCT03216200||Single Group Assignment||Treatment||None (Open Label)||single center open-label study||||
1329179|NCT03216187|Randomized|Parallel Assignment||Prevention||Quadruple|"study drugs (including identical placebos) and randomisation lists are prepared by the hospital pharmacy and are kept secret from the investigators until the end of the study and the freezing of the electronic data base"|double-blinded, randomized, placebo-controlled trial|t|t|t|t
1329180|NCT03216174||Single Group Assignment||Treatment||None (Open Label)||||||
1329181|NCT03216161|||Cohort||Cross-Sectional|||||||
1329182|NCT03216148||Single Group Assignment||Diagnostic||None (Open Label)||All pediatric patients with brain Tumor receive a FET-PET Investigation in Addition to conventional MRI at the end of the first-line therapy. In case of Progression or Relapse patients may receive a second FET-PET Investigation in Addition to Routine surveillance MRI.||||
1329183|NCT03216135|||Case-Control||Prospective|||||||
1329184|NCT03216122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329185|NCT03216109|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1329186|NCT03216096||Single Group Assignment||Treatment||None (Open Label)||||||
1329187|NCT03216083|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1329188|NCT03216070||Single Group Assignment||Treatment||None (Open Label)||||||
1329189|NCT03216057|Randomized|Parallel Assignment||Treatment||Double|The Masking intervention had made for investigation subjects and researchers|Randomized, double-blind, placebo-controlled clinical trial|t||t|
1329190|NCT03216044|||Cohort||Prospective|||||||
1329243|NCT03215342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329244|NCT03215329|||Cohort||Prospective|||||||
1329245|NCT03215316|||Cohort||Prospective|||||||
1329288|NCT03214757|||Cohort||Prospective|||||||
1329289|NCT03214744|||Case-Only||Prospective|||||||
1329290|NCT03214731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1577056|NCT00005199||||||||||||
1329191|NCT03216031||Single Group Assignment||Prevention||None (Open Label)||In the implementation phase, a falls prevention gardening group will be implemented. Staff members of the Integrated Falls and Bone Health Service will offer their patients who decline to take part in the standard prevention exercise programme or who have completed the other prevention classes to participate in a gardening programme. The goal is to recruit 30 patients as participants of the gardening programme and to engage them in weekly gardening activities for 8 weeks (either 8 weeks in a row or 8 attendances over 3 months to allow for sickness / other reasons for non-attendance). 3 groups with up to 10 patients and 2-4 students/staff members each should meet once per week for about 1 hour to engage in gardening activities at the new growing site. Only participants who have passed the risk screening of the Integrated Falls and Bone Health Service and who meet all inclusion criteria will be invited to join the gardening programme.||||
1329192|NCT03216018|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329193|NCT03216005||Single Group Assignment||Treatment||None (Open Label)||prospective, non-randomized, multicenter pre-market feasibility study||||
1329194|NCT03215992|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1329195|NCT03215979|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329196|NCT03215966|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1329197|NCT03215953|Randomized|Parallel Assignment||Treatment||Single||||||t
1329198|NCT03215940|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329199|NCT03215927|Randomized|Parallel Assignment||Treatment||Quadruple|Only the site pharmacist is unblinded.|A 1:1 randomization scheme for abatacept 125 mg vs. placebo as a weekly SQ injection for 24 weeks.|t|t|t|t
1329200|NCT03215914||Single Group Assignment||Treatment||None (Open Label)|No masking.|Open label, single-arm trial of the effect of hybrid closed-loop insulin delivery on glucose counterregulatory mechanisms assessed by the stepped- hyperinsulinemic hypoglycemic clamp in patients with long standing type 1 diabetes complicated by hypoglycemia unawareness.||||
1329201|NCT03215901|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1329202|NCT03215888|||Case-Control||Prospective|||||||
1329203|NCT03215875|Randomized|Crossover Assignment||Treatment||None (Open Label)||60mg ER Torsemide study in fed and fasting conditions||||
1329204|NCT03215862|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1329205|NCT03215849|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1329206|NCT03215836|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||"This is a cross sectional pilot study comparing specific metabolic pathways in bronchial airway epithelial cells and the nasal epithelium across the following patient groups:~Obese (BMI ≥ 30) asthmatics without metabolic syndrome,~Obese asthmatics with metabolic syndrome,~Obese non-asthmatics, and~Non - obese (lean > 18 <= 25, OW > 25 - <30) asthmatics."||||
1329207|NCT03215823|||Cohort||Prospective|||||||
1329208|NCT03215810||Single Group Assignment||Treatment||None (Open Label)||||||
1329209|NCT03215797|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329210|NCT03215784|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329211|NCT03215771||Single Group Assignment||Treatment||None (Open Label)||||||
1329212|NCT03215758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329213|NCT03215745|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1329214|NCT03215732|||Other||Cross-Sectional|||||||
1329215|NCT03215719||Single Group Assignment||Treatment||None (Open Label)||||||
1329216|NCT03215706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329217|NCT03215693||Single Group Assignment||Treatment||None (Open Label)||||||
1329218|NCT03215680|||Cohort||Prospective|||||||
1329219|NCT03215667||Single Group Assignment||Treatment||None (Open Label)||||||
1329220|NCT03215654|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1329221|NCT03215641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329222|NCT03215628|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1329223|NCT03215615|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1329224|NCT03215602|Randomized|Parallel Assignment||Treatment||Triple|One blinded outcome assessor (physiotherapists) will perform measurements of muscle strength, functional capacity and pain sensitization. The MRI scans will be performed by blinded radiologists. Patients in both groups will be blinded for parallel group assignments. Statistical analysis will be performed by a blinded statistician and a blinded interpretation of the results will be performed before breaking the randomization code.|Parallel group, assessor- and patient blinded randomized controlled trial|t||t|t
1329225|NCT03215589|||Cohort||Prospective|||||||
1329226|NCT03215563|||Cohort||Prospective|||||||
1329227|NCT03215550|||Cohort||Prospective|||||||
1329228|NCT03215537|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1329229|NCT03215524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329230|NCT03215511||Single Group Assignment||Treatment||None (Open Label)||||||
1329231|NCT03215498|Randomized|Crossover Assignment||Treatment||Quadruple|Sponsor staff involved in the clinical trial is masked according to company standard procedures||t|t|t|t
1329232|NCT03215485|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||There is one intervention group and one comparison group.||||
1329233|NCT03215472|Randomized|Parallel Assignment||Treatment||None (Open Label)||3-month randomized controlled trial to test the initial feasibility of DASH Cloud, a digital health intervention for women at risk for CVD||||
1329234|NCT03215459|||Cohort||Prospective|||||||
1329235|NCT03215446|Randomized|Parallel Assignment||Prevention||Single|||t|||
1329236|NCT03215433|||Cohort||Prospective|||||||
1329237|NCT03215420||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329238|NCT03215407|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1329239|NCT03215394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329240|NCT03215381||Single Group Assignment||Other||None (Open Label)|No Masking|||||
1329241|NCT03215368|||Cohort||Prospective|||||||
1329242|NCT03215355||Single Group Assignment||Treatment||None (Open Label)||||||
1329246|NCT03215303|Randomized|Crossover Assignment||Treatment||Double|The randomization process will be kept confidential with a single investigator, not involved in data collection or recruitment, so that all other investigators involved will be blinded to the experimental groups throughout the study period.|Patients will be randomized, through a sealed envelope, to initially compose the intervention group or the control group. The sequential order of randomization will be kept confidential with a single investigator, so that the other professionals involved and responsible for data collection will be blinded throughout the study period. Individuals who initially composed the intervention group will then perform, in a second moment, the procedures of the control group.|||t|t
1329247|NCT03215290|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329248|NCT03215277|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1329249|NCT03215264||Single Group Assignment||Treatment||None (Open Label)||||||
1329250|NCT03215251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329251|NCT03215238|||Cohort||Prospective|||||||
1329252|NCT03215225|||Cohort||Prospective|||||||
1329253|NCT03215212|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1329254|NCT03215199|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1329255|NCT03215186|||Cohort||Prospective|||||||
1329256|NCT03215173|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329257|NCT03215160|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329258|NCT03215147|||Cohort||Prospective|||||||
1329259|NCT03215134||Single Group Assignment||Other||None (Open Label)||uncontrolled pilot study of 1 intervention||||
1329260|NCT03215121|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Childrenwith documented obstructive sleep apnea (by sleep study or history obtained from the parent) due to enlarged tonsils and adenoid scheduled for tonsillectomy and adenoidectomy surgery will be enrolled in the study. Children will be randomly divided in two groups of 20 each based on the induction technique used:~Group --1: Induction of anesthesia started as follows while children are breathing spontaneously: One handed mask airway + chin lift - 20 sec and then switch to two hands + jaw thrust - 20 sec Group - 2: Induction of anesthesia started as follows while children are breathing spontaneously: Two handed mask airway + jaw thrust - 40 sec.~Group 3 - Induction of anesthesia started as follows while children are breathing spontaneously. Two handed mask airway + jaw thrust - 20 sec. then switch to one hand + chin lift - 20 sec."||||
1329261|NCT03215108|Randomized|Parallel Assignment||Treatment||Double||Flower-CSEMS vs. Conventional-CSEMS|t||t|
1329262|NCT03215095||Single Group Assignment||Treatment||None (Open Label)||This is a pilot study with the primary objective to assess the safety of administering the PD-L1 targeting agent durvalumab in combination with recombinant human thyroid stimulating hormone (rhTSH, Thyrogen) stimulated/prepared radioiodine (RAI; 131I) therapy in patients with RAI-avid (RAIA) recurrent and/or metastatic (R/M) thyroid cancer.||||
1329263|NCT03215082|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1329264|NCT03215069|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1329265|NCT03215056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329266|NCT03215043|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1329267|NCT03215030|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1329268|NCT03215017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329269|NCT03215004|||Case-Only||Prospective|||||||
1329270|NCT03214991|||Cohort||Prospective|||||||
1329271|NCT03214978|||Cohort||Retrospective|||||||
1329272|NCT03214965|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants are assigned to participate into one of two groups (control group or intervention group) in parallel for the duration of the study. The control group receives no form of intervention or education. The intervention group participates into a closed facebook group.||||
1329273|NCT03214952|||Cohort||Prospective|||||||
1329274|NCT03214939||Single Group Assignment||Treatment||None (Open Label)||Patients with colorectal cancer receive a cellular preparation consisting of dendritic cells loaded with tumor lysate antigens and activated mononuclear cells.||||
1329275|NCT03214926||Single Group Assignment||Device Feasibility||None (Open Label)||Prospective uncontrolled pilot study||||
1329276|NCT03214913|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329277|NCT03214900|||Cohort||Prospective|||||||
1329278|NCT03214887|Randomized|Parallel Assignment||Treatment||None (Open Label)||"RV-P1501-4: Gel-like product with 10 thousand BMMNCs in each ml of 1% hyaluronan (HA) solution~RV-P1501-5: Gel-like product with 100 thousand BMMNCs in each ml of 1% hyaluronan (HA) solution~RV-P1501-6: Gel-like product with 1 million BMMNCs in each ml of 1% hyaluronan (HA) solution"||||
1329279|NCT03214874|Randomized|Crossover Assignment||Treatment||None (Open Label)||Fully Replicate double-crossover||||
1329280|NCT03214861|||Cohort||Prospective|||||||
1329281|NCT03214848|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1329282|NCT03214835|Randomized|Parallel Assignment||Screening||Single||||||t
1329283|NCT03214822|Randomized|Parallel Assignment||Basic Science||Double|Masking of care providers is not feasible since the procedures of preparation for HMF and H2MF are different. Outcome assessors (personnel analyzing microbiome profiles and oxidative stress biomarkers) will be masked.|Using a randomized, controlled, un-blinded parallel design we will enroll 30 VLBW premature neonates (birth weight < 1250 grams, gestational age 26+0 to 30+0 weeks) from the NICU at the Health Sciences Centre Children's Hospital in Winnipeg, MB, Canada. Currently, H2MF is not routinely used in this population at this centre.|||t|t
1329284|NCT03214809|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||When the MET team arrives first assessment will be done according to the abcde algorithm. If immediate interventions are needed (intubation, CPR etc) this will be done first (and noted). After the abcde assessment an initial diagnosis is noted. In the even weeks the thoracic ultrasound protocol will be done, in the uneven weeks not. After the use of ultrasound various variables are noted.||||
1329285|NCT03214796|||Cohort||Prospective|||||||
1329286|NCT03214783|||Case-Control||Retrospective|||||||
1329287|NCT03214770|Randomized|Parallel Assignment||Treatment||Single|It will be a single-blinded study so that the participant will be blinded, the researcher and the data analysis will be unblinded.||t|||
1329291|NCT03214718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329292|NCT03214705|||Cohort||Prospective|||||||
1329293|NCT03214692||Single Group Assignment||Treatment||None (Open Label)||Daily ingestion of Gum Arabic for 12 weeks||||
1329294|NCT03214679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329295|NCT03214666|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1329296|NCT03214653|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1329297|NCT03214640|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1329298|NCT03214627||Single Group Assignment||Other||None (Open Label)||The trial will consist of a retrospective control period and a prospective period. During the prospective period, the ACM will be used to facilitate the Investigators' decision making and will help the Investigators to administer a personalised IV iron and ESA therapy, whereas treatment according to standard of care will be documented retrospectively for the same patients during the retrospective (historical) period of the trial. Thus, patients can serve as their own control.||||
1329299|NCT03214614|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1329300|NCT03214601||Single Group Assignment||Treatment||None (Open Label)||The Relay Branch System is intended for treating thoracic aortic arch pathologies requiring coverage of the innominate and left common carotid arteries. The system includes a graft with a proximal landing zone in the proximal aorta and branch grafts that extend into the innominate and left common carotid arteries. The arch graft and branch grafts are composed of self-expanding nitinol stents sutured to polyester vascular graft fabric, creating an exoskeleton||||
1329301|NCT03214588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329302|NCT03214575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329303|NCT03214562|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329304|NCT03214549|Randomized|Parallel Assignment||Treatment||Single|||||t|
1329305|NCT03214536||Single Group Assignment||Other||None (Open Label)||observational feasibility trial||||
1329306|NCT03214523|Randomized|Parallel Assignment||Other||Double|Participants were recruited without emphasis on study arm. All outcomes will be assessed without knowledge of the treatment arm.|Half the subjects will be followed without any attempt to improve sleep, and half will undergo a brief educational intervention to try to improve sleep.|t|||t
1329307|NCT03214510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329308|NCT03214497|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329309|NCT03214484|Randomized|Parallel Assignment||Prevention||Single||"In total, 80 patients (40 for the Electronc Tablet group, 40 for the computeur group) will be included in the study.~Using the pre-established randomization list, in order of inclusion in the study, each patient will be assigned to one of the 2"|t|||
1329310|NCT03214471|Randomized|Parallel Assignment||Supportive Care||Single|The investigator who will conduct the follow-up assessments at each visit will be blinded to participants' allocation and will not be involved in delivering any of the intervention. The statistician conducting the data analysis will be blind to group allocation.|The trial will be a two-arm, parallel group, single-blinded, single site RCT (embedded within an observational cohort study) conducted in London, United Kingdom (UK). A two-staged randomised consent design will be applied (See 8.2 Randomisation procedures). Recruitment will take place at the Bariatric Centre for Weight Management and Metabolic Surgery, University College London Hospitals (UCLH) and the Bariatric and Obesity Surgery Clinic at the Whittington Hospital. The trial will be carried out by the Centre for Obesity Research, Division of Medicine, University College London (UCL) at UCLH, which will be commenced in August 2017 with the expected total duration of 36 months. The total duration of each participation in the trial is approximately 12-16 months (12 months from the day of surgery). All participants will have to attend 4 research visits; baseline visit (approximately 6 weeks before surgery), then at approximately 3, 6, and 12-month post-surgery.||||t
1329311|NCT03214458||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1329312|NCT03214445|Randomized|Parallel Assignment||Treatment||Quadruple|The evaluated restorations will be coded, and the data will be delivered in sealed envelopes without any identification of the patient, the data will be processed without identification of the groups. The sealant and the resin will be the same color so the evaluator will not be able to differentiate the treatments|prospective, double blind randomized clinical trial under the recommendations of CONSORT. The statistical unit was considered the patient (n=60), with at least 3 composite resins with marginal defects , randomized into 3 groups A=Sealed with flow composite reinforced with nanofiller , B= Sealed with resin sealant , and C=Control, without intervention.|t|t|t|t
1329313|NCT03214432|||Cohort||Retrospective|||||||
1329314|NCT03214419|||Other||Retrospective|||||||
1329315|NCT03214406|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1329316|NCT03214393|||Cohort||Prospective|||||||
1329317|NCT03214380|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329318|NCT03214367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329319|NCT03214354||Single Group Assignment||Treatment||None (Open Label)||Phase II pilot, non-randomized, prospective study to evaluate the safety and efficacy of a nonmyeloablative conditioning allogeneic stem cell transplantation for patients with sickle cell disease who have a matched related major ABO-incompatible donor.||||
1329320|NCT03214341|||Case-Crossover||Cross-Sectional|||||||
1329321|NCT03214328|||Cohort||Prospective|||||||
1329322|NCT03214315|||Cohort||Prospective|||||||
1329323|NCT03214302|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329324|NCT03214289||Single Group Assignment||Treatment||None (Open Label)||||||
1329325|NCT03214276|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1329326|NCT03214263|||Cohort||Prospective|||||||
1329327|NCT03214250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329328|NCT03214237|||Other||Cross-Sectional|||||||
1329329|NCT03214224|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"This study has two parts~A self-controlled validation study of experimental remote PFT assessment vs standard of care~A longitudinal parallel group study of repeated measures of remote PFTs and their impact on care decisions."||||
1329330|NCT03214211|||Cohort||Prospective|||||||
1329331|NCT03214198|||Cohort||Prospective|||||||
1329332|NCT03214185|Randomized|Parallel Assignment||Treatment||Single||||||t
1329333|NCT03214172|||Cohort||Retrospective|||||||
1329334|NCT03214159|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1329335|NCT03214146||Single Group Assignment||Treatment||None (Open Label)||||||
1329336|NCT03214133|Randomized|Crossover Assignment||Other||Double|"Alkalized (0.01 mg epicatechin/g) ) and non alkalized cocoa (4.1 mg epicaetchin/g) will be mixed in various ratios to achieve the desired 0, 1, 2, 3 mg/ kg body mass but maintaining equally weighed dose of cocoa for each intervention.~For Arm 2, the same quantity of either alkalized or non alkalized cocoa will be given to achieve the optimized dosed of epicatechin."|Arm 1 of the project will employ a randomized single-blinded crossover design with subjects completing all 4 of the epicatechin-rich chocolate trials (0, 1, 2 and 3 mg.kg-1). Arm 2 will use a randomized parallel double-blind design with neither the subjects nor the investigators knowing who is on which treatment (optimized epicatechin-rich chocolate dose or Dutch processed/epicatechin depleted placebo.|t||t|
1329337|NCT03214120|||Cohort||Prospective|||||||
1329338|NCT03214107|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1329339|NCT03214094|||Cohort||Prospective|||||||
1329340|NCT03214081|||Cohort||Prospective|||||||
1329341|NCT03214068|||Case-Control||Other|||||||
1329342|NCT03214055|||Case-Only||Prospective|||||||
1329343|NCT03214042||Single Group Assignment||Treatment||None (Open Label)||||||
1329344|NCT03214029|||Cohort||Prospective|||||||
1329345|NCT03214016|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1329346|NCT03214003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329347|NCT03213990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329348|NCT03213977|Randomized|Factorial Assignment||Treatment||None (Open Label)|Open Label|||||
1329349|NCT03213964||Single Group Assignment||Treatment||None (Open Label)||||||
1329350|NCT03213951|||Case-Only||Prospective|||||||
1329351|NCT03213938|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329352|NCT03213925|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1329353|NCT03213912|||Case-Only||Prospective|||||||
1329354|NCT03213899|||Cohort||Prospective|||||||
1329355|NCT03213886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329356|NCT03213873|Randomized|Parallel Assignment||Treatment||Triple|Investigator and outcome assessors are masked to group allocation at baseline assessment. Care providers are masked to results of the assessments.|||t|t|t
1329357|NCT03213860|Randomized|Parallel Assignment||Treatment||Single|While it is not possible to blind participants and clinical staff to the assigned interventions, the assessments will be undertaken by a researcher blinded to group allocation.|||||t
1329358|NCT03213847||Single Group Assignment||Diagnostic||None (Open Label)||prospective cohort study||||
1329359|NCT03213834|Randomized|Parallel Assignment||Treatment||Single|Change in pleural fluid volume on chest CT scan from randomization (day 0) to prior to chest tube removal will be measured by a radiologist blinded to treatment allocation using image J software|Subjects will be randomly assigned to receive one of two standard-of-care treatments for severe pleural infection.||||t
1329360|NCT03213821|Randomized|Parallel Assignment||Treatment||Triple||Study design A randomized, parallel-arm, controlled pilot study is designed. Sample size is determined 50 participants per treatment arm using the stepped rules of thumb, with standardized effect sizes of 0.1 or less and power 80% for main trial (n=100). After baseline assessments, balanced permuted block method will be used for randomization. Concealment of the randomization sequence will be performed by the RCT center of Rajaie Cardiovascular, Medical and Research Center. Intervention will be according to the randomization sequence.|t|t||t
1329361|NCT03213808|||Other||Retrospective|||||||
1329362|NCT03213795|||Other||Retrospective|||||||
1329363|NCT03213782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329364|NCT03213769|Randomized|Parallel Assignment||Treatment||Double|double blind|controlled randimized clinical trial|t||t|
1329365|NCT03213756|Randomized|Parallel Assignment||Prevention||None (Open Label)||Open-label, prospective, controlled, randomized, multicenter study in parallel groups, where in the preoperative AVF period, one group of patients will perform an isometric exercise protocol for 8 weeks and will be compared with a control group of patients that will not perform this preoperative exercise||||
1329366|NCT03213743||Single Group Assignment||Basic Science||None (Open Label)||||||
1329367|NCT03213730|Randomized|Parallel Assignment||Treatment||Single||||||t
1329368|NCT03213717|Randomized|Crossover Assignment||Treatment||Triple|"We will recruit healthy individuals who work at or close to the Institution of Neuroscience and Physiology at the Sahlgrenska Academy. We will ask healthy people who do not know the hypothesis of the study. Each study subject will be given a randomized code to use for the study. Only the study subject and the investigator will be able to connect each study subject with their randomized code. This will only be used under special circumstances, for example, if a study subject requests removal of his or her study data.~As this study uses a cross-over design each subject will then be its own matched control.~Subject eligibility will be established before enrolment and randomization. Subjects will be randomized strictly sequentially, as subjects are eligible for randomization. If a subject discontinues from the study, the subject number will not be reused, and the subject will not be allowed to re-enter the study."|"The study is executed with all 15 study subjects over three study days with one week between each study day. In order to decrease the variation of the measurement values and increase the power of the study we will use a cross-over study design. The study subjects will on one of the days wear a weight vest with 10 % of body weight in the standing position, on one of the days the same study subject will wear a weight vest with 1 % of body weight in the standing position and on one of the days the same study subject will wear a weight vest with 1 % of body weight in the sitting position.~Hence, three procedures are included in the study. Each of the procedure corresponds to a separate day."||t|t|t
1329369|NCT03213704||Single Group Assignment||Treatment||None (Open Label)||||||
1329370|NCT03213691||Single Group Assignment||Treatment||None (Open Label)||||||
1329371|NCT03213678||Single Group Assignment||Treatment||None (Open Label)||||||
1329372|NCT03213665||Single Group Assignment||Treatment||None (Open Label)||||||
1329373|NCT03213652||Single Group Assignment||Treatment||None (Open Label)||||||
1329374|NCT03213639|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1329375|NCT03213626||Single Group Assignment||Treatment||None (Open Label)||||||
1329376|NCT03213613|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1329377|NCT03213600|Randomized|Parallel Assignment||Basic Science||Quadruple||The investigators will enroll 150 subjects comprising three population groups SZ, At Risk and HS.) Immediately after inclusion, participants will be randomized into 2 equal groups via random generation of two binary integer's reflecting tDCS-treatment condition or the tDCS control (sham) resulting in random allocation into one of 2 study arms. This randomization will be stratified per population group to insure that both conditions are equally reflected across all three groups.|t|t|t|t
1329378|NCT03213587||Single Group Assignment||Treatment||None (Open Label)||||||
1329379|NCT03213574|Randomized|Parallel Assignment||Treatment||Single||||t||
1329380|NCT03213561||Sequential Assignment||Supportive Care||None (Open Label)||||||
1329381|NCT03213548|Randomized|Parallel Assignment||Treatment||None (Open Label)||double blind clinical trial||||
1329382|NCT03213535|||Case-Only||Prospective|||||||
1329383|NCT03213522|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1329384|NCT03213509|||Cohort||Retrospective|||||||
1329385|NCT03213496|Randomized|Parallel Assignment||Supportive Care||Double|Data of outcomes will be evaluated by statisticians.|Adult patients programmed for elective non-cardiac surgery, prior informed consent, will be randomized to an intervention (prescription of a programed walking) in the period of 2-3 weeks before surgery or will be assigned to a control group/conventional care.|||t|t
1329386|NCT03213483|Randomized|Parallel Assignment||Treatment||Double|"Single blinded:~Blinding of the participants is not applicable.~Blinding of the operator is not applicable.~Outcome assessor (primary and secondary outcomes) & biostatistician will be blinded."|Parallel groups, randomized clinical trial||t||t
1329387|NCT03213470||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329388|NCT03213457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329389|NCT03213444|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with stage II disease undergoing adjuvant 5-FU treatment will be allocat in chemotherapy-1 group, while stage III patients undergoing combined adjuvant chemotherapy (5FU + Oxaliplatin) will be allocat to the Chemotherapy group -2.||||
1329390|NCT03213431|||Cohort||Prospective|||||||
1329391|NCT03213418||Single Group Assignment||Basic Science||None (Open Label)||||||
1329392|NCT03213405|Randomized|Sequential Assignment||Prevention||Quadruple|||t|t|t|t
1329393|NCT03213392|||Cohort||Prospective|||||||
1329394|NCT03213379|Randomized|Parallel Assignment||Supportive Care||Single|A unique code is given to each patient enrolled in the study. Neither the name nor the surname of patient are mentioned.||t|||
1329395|NCT03213366|Randomized|Parallel Assignment||Prevention||Double|Both Peer Leaders and participants will be masked to the group randomized to. The statistician, who will be analyzing the data, will also be masked to group assignment.|There will be two groups of Peer Leaders recruited. One group of Peer Leaders will be randomized to deliver the E-PrEP intervention and the second group of peer leaders will be randomized to deliver a general health campaign (control).|t|||t
1329396|NCT03213353|Randomized|Crossover Assignment||Other||Single||||||t
1329397|NCT03213340|Randomized|Crossover Assignment||Other||Single||3 cohorts, crossover within cohort|t|||
1329398|NCT03213327||Single Group Assignment||Health Services Research||None (Open Label)||"Patients are examined at two time points: baseline and 12 weeks after the Intervention.~The Intervention consists of health-promoting advices provided by the software algorithm. The effect of this intervention is evaluated 12 weeks after."||||
1329399|NCT03213314|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Nested cohort study||||
1329400|NCT03213301||Single Group Assignment||Treatment||None (Open Label)||Prospective 2-stage single-arm open-label multicenter phase II trial.||||
1329401|NCT03213288|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1329402|NCT03213275|||Cohort||Prospective|||||||
1329403|NCT03213262|||Case-Only||Prospective|||||||
1329404|NCT03213249|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1329405|NCT03213236||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329406|NCT03213223|||Cohort||Prospective|||||||
1329407|NCT03213210||Single Group Assignment||Treatment||None (Open Label)||||||
1329408|NCT03213197||Single Group Assignment||Supportive Care||None (Open Label)||Feasibility of a Standardized Video for Patient Education and as a Decision Aid on Code Status for Patients in the Emergency Department pending Admission to the Hospital||||
1329409|NCT03213184|||Cohort||Prospective|||||||
1329410|NCT03213171|Randomized|Sequential Assignment||Other||Double||Stepped-wedge cluster randomized trial|t|||t
1329411|NCT03213158|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1329412|NCT03213145|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||2-Part Single Group study.||||
1329413|NCT03213132|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329414|NCT03213119|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1329415|NCT03213106|Randomized|Crossover Assignment||Treatment||Quadruple||5 sessions of active and sham rTMS separated by at least 4 weeks washout.|t|t|t|t
1329416|NCT03213093||Single Group Assignment||Screening||None (Open Label)||||||
1329417|NCT03213080|||Cohort||Prospective|||||||
1329418|NCT03213067|||Cohort||Cross-Sectional|||||||
1329419|NCT03213054||Single Group Assignment||Treatment||None (Open Label)||||||
1329420|NCT03213041||Single Group Assignment||Treatment||None (Open Label)||||||
1329421|NCT03213028||Single Group Assignment||Health Services Research||None (Open Label)||||||
1329422|NCT03213015||Sequential Assignment||Diagnostic||None (Open Label)||||||
1329423|NCT03213002||Single Group Assignment||Treatment||None (Open Label)||||||
1329424|NCT03212989||Single Group Assignment||Treatment||None (Open Label)||||||
1329425|NCT03212976|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1577057|NCT00005198||||||||||||
1329426|NCT03212963||Single Group Assignment||Other||None (Open Label)||Open label study to evaluate adrenal suppression potential and pharmacokinetics of halobetasol lotion 0.05%||||
1329427|NCT03212950|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1329428|NCT03212937||Single Group Assignment||Treatment||None (Open Label)||||||
1329429|NCT03212924||Single Group Assignment||Treatment||None (Open Label)||||||
1329430|NCT03212911|Randomized|Parallel Assignment||Prevention||None (Open Label)|No masking|Open-label, randomized controlled trial (RCT) with 1:1 allocation in parallel arms||||
1329431|NCT03212898|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1329432|NCT03212885|Randomized|Crossover Assignment||Treatment||Single||||||t
1329433|NCT03212872||Single Group Assignment||Screening||None (Open Label)||||||
1329434|NCT03212859|Randomized|Crossover Assignment||Treatment||Single||stepped wedge cluster randomised trial and mixed methods process analysis|t|||
1329435|NCT03212846|Randomized|Parallel Assignment||Treatment||Single|Single blind|Radomized controlled trial with two groups: intervention group (hippotherapy + conventional treatment) and control group (conventional treatment).||||t
1329436|NCT03212833||||||||||||
1329437|NCT03212820|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329438|NCT03212807||Single Group Assignment||Treatment||None (Open Label)||||||
1329439|NCT03212794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329440|NCT03212781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329441|NCT03212768|||Case-Only||Prospective|||||||
1329442|NCT03212755|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1329443|NCT03212742||Sequential Assignment||Treatment||None (Open Label)||||||
1329444|NCT03212729|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329445|NCT03212716|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1329446|NCT03212703|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329447|NCT03212690|||Cohort||Prospective|||||||
1329448|NCT03212677|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1329449|NCT03212664||Single Group Assignment||Treatment||None (Open Label)||||||
1329450|NCT03212651||Single Group Assignment||Treatment||None (Open Label)||||||
1329451|NCT03212638|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1329452|NCT03212625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329453|NCT03212612|||Case-Control||Other|||||||
1329454|NCT03212599|||Case-Control||Prospective|||||||
1329455|NCT03212586|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1329456|NCT03212573|Randomized|Parallel Assignment||Supportive Care||Single|Nurse evaluating postoperative pain is blinded to the protocol applied|||||t
1329457|NCT03212560|||Case-Control||Cross-Sectional|||||||
1329458|NCT03212547|Randomized|Parallel Assignment||Treatment||Single|Simple blind masking method. A group of certified external evaluators will assess a video recorded to detect social withdrawal in moderate and late preterm infantes. The video will be recorded during the medical check-up at 2, 6 and 12 months of corrected gestational age.||||t|
1329459|NCT03212534|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1329460|NCT03212521||Single Group Assignment||Treatment||None (Open Label)||||||
1329461|NCT03212508|||Case-Crossover||Prospective|||||||
1329462|NCT03212495|Randomized|Parallel Assignment||Treatment||Double|, Patients were randomly allocated (using random table assignment) into two groups to receive one of the following intra-articular solutions (prepared by an individual not involved in the study) which were injected into the knee joint through the cannular sheath after withdrawal of camera, by the orthopaedic surgeon (who was also unaware of the nature of the study drugs) before the arthroscope removed.|Patients will be randomly allocated to one of two groups each including 50 patients; the group received either intraarticular dexametomidine or neostigmine .|t|t||
1329463|NCT03212482|||Cohort||Prospective|||||||
1329464|NCT03212469|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The study is an open label, paucicentric, Phase I/II trial||||
1329465|NCT03212456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329466|NCT03212443|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329467|NCT03212430|Non-Randomized|Crossover Assignment||Other||Double||Pilot, Open label|t|t||
1329468|NCT03212417||Single Group Assignment||Screening||None (Open Label)||||||
1329469|NCT03212404||Single Group Assignment||Treatment||None (Open Label)||||||
1329470|NCT03212391|Randomized|Parallel Assignment||Treatment||None (Open Label)||Monocentric unblinded two parallel-group randomized controlled trial||||
1329471|NCT03212378|||Cohort||Prospective|||||||
1329472|NCT03212365|Randomized|Parallel Assignment||Other||Double||Patients will be randomized into one of two groups (enoxaparin 40mg twice daily or enoxaparin 0.5mg/kg twice daily, rounded to the nearest milligram).|t||t|
1329473|NCT03212352|Randomized|Parallel Assignment||Treatment||Double||Before medical treatment with misoprostol (two doses 400mcg (four hours apart), repeated after 24 hours if no tissue is lost), patients will be randomized to oral mifepristone (600mg) or oral placebo (identical in appearance).|t|t||
1329474|NCT03212339|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1329475|NCT03212326||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329476|NCT03212313|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1329477|NCT03212300|Randomized|Parallel Assignment||Treatment||Single||||||t
1329478|NCT03212287|||Case-Only||Prospective|||||||
1329479|NCT03212274||Single Group Assignment||Treatment||None (Open Label)||||||
1329480|NCT03212261||Single Group Assignment||Supportive Care||None (Open Label)||||||
1329481|NCT03212248|||Case-Only||Prospective|||||||
1329482|NCT03212235||Single Group Assignment||Treatment||None (Open Label)||||||
1329483|NCT03212222|Randomized|Crossover Assignment||Screening||None (Open Label)||Patient randomly assigned to either be screened first with standard clinic technique or cell phone application. Patient is then screened with other method.||||
1577058|NCT00005197||||||||||||
1329484|NCT03212209|Randomized|Crossover Assignment||Treatment||Double|Participants have never had contact with CPAP, therefore were not aware of PAP modality prescribed. Investigator were also naive, as well as sleep specialist responsible for Polysomnography reports. Only respiratory therapist who was assigned to CPAP clinic was aware of patient´s treatment condition.|This is a crossover study comparing different CPAP modalities in a group of patients with moderate to severe OSA.|t||t|
1329485|NCT03212196|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1329486|NCT03212183|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1329487|NCT03212170||Single Group Assignment||Diagnostic||None (Open Label)||Single Group Assignment||||
1329488|NCT03212157|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1329489|NCT03212144|Randomized|Crossover Assignment||Treatment||Single|Data collection staff is masked||||t|
1329490|NCT03212131|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Sponsor staff involved in the clinical trial is masked according to company standard procedures|||||
1329491|NCT03212118|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1329492|NCT03212105|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1329493|NCT03212092|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo with the appearance as the dietary supplements|The study is a pragmatic multicenter randomized double-blind placebo-controlled intervention trial with an intervention period of 4 months. Since the washout period of several components of dietary supplements is unknown we chose a parallel design.|t|t|t|t
1329494|NCT03212079|Randomized|Parallel Assignment||Other||Single||This is a single center three arms randomized trial.||||t
1329495|NCT03212066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329496|NCT03212053||Single Group Assignment||Screening||None (Open Label)||||||
1329497|NCT03212040|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Comparison of 12 vs 14 gauge needles||||
1329498|NCT03212027|||Case-Only||Prospective|||||||
1329499|NCT03212014|Randomized|Parallel Assignment||Treatment||Single||||||t
1329500|NCT03212001|||Other||Other|||||||
1329501|NCT03211988||Single Group Assignment||Treatment||None (Open Label)||Simon 2-stage design (optimum version)||||
1329502|NCT03211975|||Cohort||Prospective|||||||
1329503|NCT03211962|||Cohort||Prospective|||||||
1329504|NCT03211949||Single Group Assignment||Other||None (Open Label)||||||
1329505|NCT03211936|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1329506|NCT03211923|||Case-Control||Cross-Sectional|||||||
1329507|NCT03211910|Randomized|Parallel Assignment||Prevention||None (Open Label)||Sacral Savers is a combination of a strong bubble wrap sheet with a fold at the head end and a nylon sham with a pocket into which the bubble wrap sheet is inserted. This combination is then placed under the fitted sheet on the patient's • Intervention:: medical device: Bubble wrap mattress has been successful in enhancing wound healing. Wound healing is greater than 20% healing within two weeks documented by measurement of the wound bed or wound healing to less than the dermal layer documented by photography and agreement of healing between research associate and physician . The bubble wrap mattress will be place underneath the participant. Follow-up will occur weekly for 6 weeks.||||
1329508|NCT03211897|||Cohort||Prospective|||||||
1329509|NCT03211884|Randomized|Parallel Assignment||Treatment||None (Open Label)|Self-administered on-line surveys which preclude the need for a masked outcomes assessor.|Randomized Clinical Trail.||||
1329510|NCT03211871|Randomized|Parallel Assignment||Treatment||None (Open Label)||After the primary patient assessment, eligible participants were assigned in a 1:1 ratio to either the intervention (Group D) or control (Group C) groups using random assignment in blocks of four.||||
1329511|NCT03211858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329512|NCT03211845||Single Group Assignment||Prevention||None (Open Label)||||||
1329513|NCT03211832|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1329514|NCT03211819|Randomized|Parallel Assignment||Treatment||Single|due to the nature of the trial only the outcome assessror will be masked from the intervention or control group|||||t
1329515|NCT03211806|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants will be randomized to the sedentary behavior intervention or the monitoring-only control group||||
1329516|NCT03211793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329517|NCT03211780||Single Group Assignment||Device Feasibility||None (Open Label)||Shear wave vibrometry and B-mode imaging will be performed after esophageal distension with a fluid filled balloon intra-operatively.||||
1329518|NCT03211767|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1329519|NCT03211754||Single Group Assignment||Basic Science||None (Open Label)||||||
1329520|NCT03211741||Single Group Assignment||Treatment||None (Open Label)||||||
1329521|NCT03211728|Randomized|Parallel Assignment||Prevention||Quadruple||Candidate for arthroscopic ACL reconstruction are divided into two groups of pregabalin and placebo with 48 patients in each group. The intervention group receive pregabalin 150 mg 1 hour before surgery and 12 hours after initial dose and a placebo is administered in control group.|t|t|t|t
1329522|NCT03211715|||Cohort||Prospective|||||||
1329523|NCT03211702|||Cohort||Prospective|||||||
1329524|NCT03211689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329525|NCT03211676|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1329526|NCT03211663||Single Group Assignment||Treatment||None (Open Label)||||||
1329527|NCT03211650|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1329528|NCT03211637|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1329529|NCT03211624|||Case-Control||Prospective|||||||
1329530|NCT03211611|||Other||Prospective|||||||
1329531|NCT03211598||Single Group Assignment||Other||None (Open Label)||||||
1329532|NCT03211585||Single Group Assignment||Treatment||None (Open Label)||||||
1329533|NCT03211572||Single Group Assignment||Other||None (Open Label)||The clinical trial will be a prospective, two-strata, non-blinded, single institution Health Canada approved window of opportunity trial with 2 weeks of pre-surgical endocrine therapy using either anastrozole or tamoxifen.||||
1329534|NCT03211559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329535|NCT03211546|||Cohort||Prospective|||||||
1329536|NCT03211533|||Cohort||Prospective|||||||
1329537|NCT03211520|||Case-Only||Prospective|||||||
1329538|NCT03211507|||Case-Control||Prospective|||||||
1329539|NCT03211494|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1329540|NCT03211481|||Cohort||Prospective|||||||
1329541|NCT03211468|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1329542|NCT03211455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329543|NCT03211442|||Cohort||Retrospective|||||||
1329544|NCT03211429|Randomized|Parallel Assignment||Other||None (Open Label)|No Masking|||||
1329545|NCT03211416||Single Group Assignment||Treatment||None (Open Label)||||||
1329546|NCT03211403|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1329547|NCT03211390|||Cohort||Cross-Sectional|||||||
1329548|NCT03211377|||Cohort||Prospective|||||||
1329549|NCT03211364|Randomized|Crossover Assignment||Treatment||Single|Patients do not know what are the intervention techniques or what is the control technique.||t|||
1329550|NCT03211351|Randomized|Parallel Assignment||Treatment||Single||||||t
1329551|NCT03211338|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1329552|NCT03211325|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1329553|NCT03211312|||Case-Only||Prospective|||||||
1329554|NCT03211299|||Other||Cross-Sectional|||||||
1329555|NCT03211286|Randomized|Parallel Assignment||Treatment||Quadruple|Patients will be allocated into two groups based on randomized 20-block method by an independent assistant using computer generated randomization. Both patients and the treating surgeons will be blinded with regard to placebo vs. treatment until completion of the study|"Patients will be treated surgically with a long trochanteric femoral nail (TFN) or hemiarthroplasty The two patient groups will include: 1) Study group treated with tranexamic acid at the time of surgical incision; 2) Control group treated with placebo injection (saline solution).~Blood transfusion criteria will remain consistent with hospital standards. Deep vein thrombosis (DVT) prophylaxis will remain consistent with hospital standards (subcutaneous heparin from admission until 12 hours prior to surgery and beginning 6 hours after surgery). After discharge, .....~Patients will be followed at regular intervals (1mo, 3mo, and at least 6mo) and at each time point the patient will be asked to report any adverse events (DVT, PT, Stroke, myocardial infarction, infection, hospitalization). Diagnostic studies to assess for thromboembolic events (i.e. DVT, pulmonary embolism (PE), and stroke) will be ordered only if the patient develops clinical signs or symptoms that justify their use."|t|t|t|t
1329556|NCT03211273|||Cohort||Prospective|||||||
1329557|NCT03211260||Single Group Assignment||Treatment||None (Open Label)||||||
1329558|NCT03211247|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1329559|NCT03211234|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1329560|NCT03211221|Randomized|Parallel Assignment||Treatment||Triple|Participants, the investigators and the outcome assessor will be blind to the type of intervention (TMS or SHAM). The TMS operator will be unblinded.|Patients will be randomized to receive 15 sessions of active rTMS or sham rTMS over the bilateral pre-SMA with a 1:1: ratio. After the randomized phase, all patients will undergo a 4 weeks washout phase. At the end of the wash phase each patient will be classified as responder, partial responder or non-responder. After the washout phase responder patients will enter a follow-up phase up to 12 months while partial responders or non-responders in both the active and sham rTMS groups, will undergo an open phase of 15 sessions of active rTMS over the bilateral pre-SMA. Partial responders and non-responders after the randomized phase who will choose not to go into the open phase will end the study.|t||t|t
1329561|NCT03211208|||Case-Control||Prospective|||||||
1329562|NCT03211195|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1329563|NCT03211182|Randomized|Parallel Assignment||Prevention||Single|||t|||
1329564|NCT03211169|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Randomized prospective study||||
1329565|NCT03211156|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329566|NCT03211143|Randomized|Crossover Assignment||Treatment||Single|||t|||
1329567|NCT03211130|Randomized|Parallel Assignment||Prevention||Single|||t|||
1329568|NCT03211117|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329569|NCT03211104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329570|NCT03211091|||Cohort||Prospective|||||||
1329571|NCT03211078||Single Group Assignment||Treatment||None (Open Label)||||||
1329572|NCT03211065||Single Group Assignment||Treatment||None (Open Label)||||||
1329573|NCT03211052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329574|NCT03211039|Randomized|Parallel Assignment||Diagnostic||Triple|Patients and their families, the patient's providers, and the enrollment staff will be blinded to the randomization arm they receive.|The initial symptom-driven analysis will be conducted on the patient's sample only (singleton analysis). Patients will be randomized to receive either whole genome sequencing or whole exome sequencing. If a diagnosis is not found promptly (within 24 hours) via singleton analysis, sequential analysis of the family (or any combination of parents and/or other family members) will be analyzed using the same technology that the patient was randomized to receive.|t|t|t|
1329575|NCT03211026|||Cohort||Prospective|||||||
1329576|NCT03211013|Randomized|Crossover Assignment||Basic Science||Triple|Blinding of oxytocin drug container + randomization of oxytocin/placebo ordering over sessions|Randomized double-blind crossover design, in which all participants will undergo 2 sessions, receiving either oxytocin nasal spray or placebo nasal spray in random order.|t||t|t
1329577|NCT03211000|||Cohort||Cross-Sectional|||||||
1329578|NCT03210987|Randomized|Parallel Assignment||Other||Single||On the day before the ward round, patients will be randomized 1:1 into one of both study arms. In one study arm, patient case presentation will be performed at bedside. In the other study arm, patient case presentation will be performed outside the room.||||t
1329579|NCT03210974|||Cohort||Retrospective|||||||
1329639|NCT03210194|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1577059|NCT00005196||||||||||||
1329580|NCT03210961|Randomized|Sequential Assignment||Treatment||Quadruple|Double blind treatment|Combination single and multiple ascending dose design. Cohorts of participants are assigned to receive interventions based on acceptable safety, tolerability, and pharmacokinetics of previous dose cohort|t|t|t|t
1329581|NCT03210948|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1329582|NCT03210935|||Cohort||Prospective|||||||
1329583|NCT03210922|Randomized|Parallel Assignment||Prevention||Single|The anesthetic induction and nasotracheal induction are performed by one anesthesiologist. Another anesthesiology calculated the intubation time according to the video recording.|The patients are randomized into one of the two group: the collar group or the non-collar group before anesthetic induction. In the collar group, the patient was put on a Miami cervical collar and then anesthetic induction and nasotracheal intubation are performed. the non-collar group receive the same anesthetic care without a collar as a control.||||t
1329584|NCT03210909||Single Group Assignment||Treatment||None (Open Label)||||||
1329585|NCT03210896|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1329586|NCT03210883|||Cohort||Retrospective|||||||
1329587|NCT03210870|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329588|NCT03210857||Single Group Assignment||Basic Science||None (Open Label)||Subject will realize an apnea of 2 minutes or more, depending on his abilities, and some parameters will be measured.||||
1329589|NCT03210844|||Cohort||Retrospective|||||||
1329590|NCT03210831|||Cohort||Prospective|||||||
1329591|NCT03210818|||Cohort||Prospective|||||||
1329592|NCT03210805||Single Group Assignment||Basic Science||None (Open Label)||||||
1329593|NCT03210792|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329594|NCT03210779|Randomized|Crossover Assignment||Supportive Care||Double|Double Blind (Participant, Care Provider, Investigator)|Cross-over pilot trial|t|t||
1329595|NCT03210766|||Cohort||Retrospective|||||||
1329596|NCT03210753|||Cohort||Retrospective|||||||
1329597|NCT03210740|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1329598|NCT03210727||Single Group Assignment||Supportive Care||None (Open Label)||a single arm design will be used to pilot test the Ready to CARE program with 20 caregivers (while also measuring outcomes in the 20 patients receiving HSCT)..||||
1329599|NCT03210714||Single Group Assignment||Treatment||None (Open Label)||||||
1329600|NCT03210701||Single Group Assignment||Screening||None (Open Label)||||||
1329601|NCT03210688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329602|NCT03210675|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Interventional, comparative, open label, multi-center study||||
1329603|NCT03210662|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329604|NCT03210649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329605|NCT03210636||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1329606|NCT03210623|Randomized|Parallel Assignment||Treatment||Single||prospective, stratified-randomized, single-blind, parallel assignment, active control|t|||
1329607|NCT03210610|||Cohort||Cross-Sectional|||||||
1329608|NCT03210597|Randomized|Parallel Assignment||Treatment||Double|"Participant: During the training period the subjects were not informed about the training modality they were performing and also were not informed about the modalities of the other subjects, only they were informed that hydrogymnastic sessions would be performed.~Outcomes assessor:The team evaluating the outcomes was blinded, not receiving information about the intervention received by the subjects participating in the study"||t|||t
1329609|NCT03210584|||Cohort||Prospective|||||||
1329610|NCT03210571||Single Group Assignment||Treatment||None (Open Label)||||||
1329611|NCT03210558|Randomized|Parallel Assignment||Basic Science||Quadruple|The testosterone cream and the placebo cream will be of identical appearance and will have the same texture to maintain double blind treatment.|A double-blind, randomized, placebo-controlled, phase II trial of in total 50 women randomized to two parallel groups (1:1): Group A treated with transdermal testosterone or Group B treated with placebo for ten weeks.|t|t|t|t
1329612|NCT03210545|Randomized|Crossover Assignment||Treatment||Single|||t|||
1329613|NCT03210532|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329614|NCT03210519|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1329615|NCT03210506|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329616|NCT03210493|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329617|NCT03210480|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, multicenter, prospective study.||||
1329618|NCT03210467|||Cohort||Prospective|||||||
1329619|NCT03210454|Randomized|Parallel Assignment||Other||None (Open Label)||The randomization occurs at the farmer's association level.||||
1329620|NCT03210441|||Cohort||Prospective|||||||
1329621|NCT03210428|||Other||Prospective|||||||
1329622|NCT03210415|||Cohort||Prospective|||||||
1329623|NCT03210402|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329624|NCT03210389||Single Group Assignment||Treatment||None (Open Label)||||||
1329625|NCT03210376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329626|NCT03210363||Single Group Assignment||Other||None (Open Label)||||||
1329627|NCT03210350|||Case-Only||Prospective|||||||
1329628|NCT03210337|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329629|NCT03210324|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1329630|NCT03210311|Randomized|Parallel Assignment||Treatment||Single||||t||
1329631|NCT03210298|||Cohort||Prospective|||||||
1329632|NCT03210285|||Case-Control||Other|||||||
1329633|NCT03210272|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329634|NCT03210259|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329635|NCT03210246|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1329636|NCT03210233|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1329637|NCT03210220|||Case-Control||Prospective|||||||
1329638|NCT03210207|||Case-Only||Retrospective|||||||
1577060|NCT00005195||||||||||||
1329640|NCT03210181|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1329641|NCT03210168||Single Group Assignment||Supportive Care||None (Open Label)||Escalating consumption of BioFe in a single cohort of up to 40 subjects with iron deficiency.||||
1329642|NCT03210155|Randomized|Parallel Assignment||Treatment||Quadruple|The blocked randomization method will be used to assign participants to active and sham groups. Participants will be assigned to CES treatment or sham CES using a 1:1 ratio. Electromedical Products International, Inc. (EPI) will randomize the assignment of appropriate devices to active or sham groups by using a random list of computer generated numbers (1 for active and 2 for sham) in randomly selected block sizes. The PI and participants are blinded to which participants have Alpha-Stim® CES active or sham devices until data analysis is complete. After the completion of data analysis, blinding will be broken.|The design for the proposed study is a matched-pair, quasi-experimental, 1:1 randomized, double-blind, sham-controlled clinical trial with a longitudinal component. The analytic technique employed to answer the research questions will be repeated measures analysis of covariance.|t|t|t|t
1329643|NCT03210142||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1329644|NCT03210129|Randomized|Parallel Assignment||Prevention||Double|"Every patient will be given a person-specific code and every information collected will be pseudonymised.~The group assignment will be hidden to the investigator and to the scientific collaborators who will collect, record and analyse the data. However, both patients and the two motivational interviewing counsellors will be aware of the group assignment."|The patients will be randomly assigned to the experimental group with motivational interviewing or the control group. Group assignment will be done by a motivational interviewing counsellor using randomization lists generated by the Competence Center in Methodology and Statistics (Luxembourg Institute of Health). For each type of cancer, a separate randomisation list will be used.|||t|t
1329645|NCT03210103|Randomized|Parallel Assignment||Treatment||None (Open Label)||2 Arm study randomized in a 1:1 ratio||||
1329646|NCT03210090|||Cohort||Prospective|||||||
1329647|NCT03210077|||Cohort||Prospective|||||||
1329648|NCT03210064|Randomized|Parallel Assignment||Treatment||Single||Experimental: apatinib combined with 5-Fu|t|||
1329649|NCT03210051||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1329650|NCT03210038|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Pain assessment 4 randomly assigned groups of women divided by type of cystoscope and type of local anesthesia.||||
1329651|NCT03210025|Randomized|Crossover Assignment||Other||None (Open Label)|Open label|Single-dose, two-treatment, two-period, two-sequence crossover||||
1329652|NCT03210012|||Case-Only||Prospective|||||||
1329653|NCT03209999|||Ecologic or Community||Cross-Sectional|||||||
1329654|NCT03209986|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be blind to the randomization results of the participants.|||||t
1329655|NCT03209973||Single Group Assignment||Treatment||None (Open Label)||||||
1329656|NCT03209960|||Cohort||Cross-Sectional|||||||
1329657|NCT03209947||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329658|NCT03209934|||Cohort||Retrospective|||||||
1329659|NCT03209921|||Cohort||Retrospective|||||||
1329660|NCT03209908|||Case-Control||Prospective|||||||
1329661|NCT03209895|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1329662|NCT03209882|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1329663|NCT03209869||Single Group Assignment||Treatment||None (Open Label)||||||
1329664|NCT03209856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329665|NCT03209843||Single Group Assignment||Treatment||None (Open Label)||||||
1329666|NCT03209830|Randomized|Parallel Assignment||Treatment||Double||Double-blind, randomised, placebo-controlled study|t||t|
1329667|NCT03209817|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1329668|NCT03209804|Non-Randomized|Parallel Assignment||Treatment||Single||"Traditional therapy group：traditional management of AVMs, such as unsimultaneous endovascular interventional embolisation, radiotherapy followed by microsurgical resection, will be conducted to patients involved in this group.~Hybrid operation group: A one-stage hybrid operation combining endovascular intervention and microsurgical techniques will be conducted simultaneously to patients in this group."||||t
1329669|NCT03209791|||Case-Control||Cross-Sectional|||||||
1329670|NCT03209778|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1329671|NCT03209765|Randomized|Parallel Assignment||Screening||Single|||t|||
1329672|NCT03209752|||Cohort||Prospective|||||||
1329673|NCT03209739|Randomized|Parallel Assignment||Diagnostic||Single|Endoscopists will be masked if the patients have received WhatsApp reminder prior colonoscopy|||||t
1329674|NCT03209726|||Cohort||Cross-Sectional|||||||
1329675|NCT03209713|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329676|NCT03209700||Single Group Assignment||Treatment||None (Open Label)||||||
1329677|NCT03209687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329678|NCT03209674|||Cohort||Prospective|||||||
1329679|NCT03209661|Randomized|Crossover Assignment||Other||Single|E-cigarettes being utilized are of the same brand and design. Additionally, the device will be covered by a sheath to ensure labeling is not visible to the subject.|Subjects will be asked to inhale one of three mediums; 5.4% NBV e-ciggarette, 0% NBV cigarette, and sham menthol inhaler (no vapor). Baseline measurements will be conducted upon arrival and followed immediately post inhalation, 1-hour post, and finally 2-hours post. All trials will require a minimum of 48 hours washout.|t|||
1329680|NCT03209648||Single Group Assignment||Treatment||None (Open Label)||||||
1329681|NCT03209635|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1329682|NCT03209622|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Participants hospitalized for acute coronary syndrome were randomly assigned to either group A, initiating Nicotine replacement therapy (NRT) in intra-hospitalization or a control group B that received NRT after hospital discharge."||||
1329683|NCT03209609|Randomized|Parallel Assignment||Prevention||None (Open Label)||In each patient, one SVG bypass will be randomized to be supported by the VEST, while another will not be supported and serve as control.||||
1329731|NCT03208972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329684|NCT03209596|Randomized|Parallel Assignment||Supportive Care||Triple|All assignments and group randomization were performed by a research team member who was not directly involved in the study. The masking of the volunteers was performed by the control drink. For statistical analysis of the results, the masking was maintained by conferring fictitious names to the groups.||t||t|t
1329685|NCT03209583|||Cohort||Other|||||||
1329686|NCT03209570|Randomized|Parallel Assignment||Treatment||Single||||||t
1329687|NCT03209557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329688|NCT03209544|Randomized|Parallel Assignment||Treatment||||||||
1329689|NCT03209531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329690|NCT03209518|||Cohort||Prospective|||||||
1329691|NCT03209505|Randomized|Parallel Assignment||Basic Science||Double|Subjects will be masked to the contact lens brand fit in each eye. The subject's Lid Wiper Epitheliopathy will be graded using photographs of the eyelid, where the grader is masked to the lens type in each eye.|Subjects will be fit in a different contact lens brand in each eye. Assignment of the contact lens to each eye will be randomized. One eye will be fit in a contact lens with a low coefficient of friction while the contralateral eye will be fit in a contact lens with a high coefficient of friction.|t|||t
1329692|NCT03209492|||Cohort||Prospective|||||||
1329693|NCT03209479|||Cohort||Prospective|||||||
1329694|NCT03209466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329695|NCT03209453|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1329696|NCT03209440|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||a 6-site, pre/posttest, randomized, controlled 4-step, stepped-wedge design to compare the effects of usual outpatient palliative care (arm 1) and usual outpatient palliative care along with nurse-led (arm 2) or chaplain-led (arm 3) DT on patient outcomes and palliative care processes. The study team will assign the 6 sites to usual care during the first-step period (approximately 12 months), and randomly assign 2 sites per step to begin and continue DT during each of the next 3 steps (12 months each).||||
1329697|NCT03209427|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1329698|NCT03209414|||Cohort||Prospective|||||||
1329699|NCT03209401||Sequential Assignment||Treatment||None (Open Label)||"The Phase Ia portion of the trial will be conducted in a 3+3 design, enrolling patients in cohorts of 3 patients each to insure safety and tolerability.~There will be a Phase Ib expansion cohort including 20 patients to further assess the efficacy of niraparib plus carboplatin, using the RP2D and schedule from Phase Ia."||||
1329700|NCT03209375|||Cohort||Prospective|||||||
1329701|NCT03209362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329702|NCT03209349|Randomized|Parallel Assignment||Screening||Triple|"The study interviewer and the patient will be blinded to the procedure type both during and following the procedure type both during and following the procedure by concealing the monitors and relevant equipment from their sight.~The physician performing the procedure will be blinded to the procedure type until the patient is brought into the procedure room. They will open the allocation envelope once the patient has been placed and positioned on the procedure bed.~Neither the patient, the RN, nor the research assistant, who will be conducting the follow-up interviews, will be informed of the study arm. Patient assignment will be managed by the study project manager and will be kept in a password protected file and will remain separate from other study data until the time of the final analysis."||t|t|t|
1329703|NCT03209336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329704|NCT03209323|Randomized|Parallel Assignment||Diagnostic||Single|The EEGs recorded before and during the general anaesthesia induction analysed offline by a neurophysiologist with an expertise in anaesthetic EEGs, the recording technique, and the anaesthetic agent used unaware of group allocation of the participant.||t|||
1329705|NCT03209310|||Other||Other|||||||
1329706|NCT03209297|Randomized|Parallel Assignment||Treatment||Triple||One study arm will be treated immediately after inclusion. The other study arm will be treated after a delay of 9 weeks. During these 9 weeks patients will be on a waiting list.|t|t||t
1329707|NCT03209284|||Cohort||Prospective|||||||
1329708|NCT03209271|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Unblinded (unable to blind subjects)|Crossover study of 2 different temperatures of crystalloid fluid bolus.||||
1329709|NCT03209258|Randomized|Sequential Assignment||Treatment||Single||Stepped-wedge Cluster Randomised Trial||||t
1329710|NCT03209245|Randomized|Parallel Assignment||Treatment||Single|Treatment with placebo - placebo groub|Treatment of AIT- active group|||t|
1329711|NCT03209232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329712|NCT03209219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329713|NCT03209206|Randomized|Parallel Assignment||Prevention||None (Open Label)||Prospective Randomized Phase II Trial||||
1329714|NCT03209193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329715|NCT03209180|Randomized|Parallel Assignment||Treatment||Triple||PROBE and NON-INFERIORITY DESIGN for Slow Release CarVeDilol-SR to Rapid Release Carvedilol-IR|t|t|t|
1329716|NCT03209167|||Case-Control||Retrospective|||||||
1329717|NCT03209154|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1329718|NCT03209141|||Case-Control||Cross-Sectional|||||||
1329719|NCT03209128|||Cohort||Prospective|||||||
1329720|NCT03209115|Randomized|Parallel Assignment||Treatment||Double||Intracanal medication|t|t||
1329721|NCT03209102|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1329722|NCT03209089|||Cohort||Other|||||||
1329723|NCT03209076|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomized trial||||
1329724|NCT03209063|||Case-Control||Prospective|||||||
1329725|NCT03209050||Single Group Assignment||Treatment||None (Open Label)||patients requiring venous access||||
1329726|NCT03209037|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329727|NCT03209024|Randomized|Parallel Assignment||Other||None (Open Label)||open, randomized controlled trial||||
1329728|NCT03209011|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329729|NCT03208998|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329730|NCT03208985||Single Group Assignment||Other||None (Open Label)||||||
1329732|NCT03208959|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329733|NCT03208946|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1329734|NCT03208933||Single Group Assignment||Treatment||None (Open Label)||||||
1329735|NCT03208920|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1329736|NCT03208907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329737|NCT03208894|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329738|NCT03208881|||Cohort||Prospective|||||||
1329739|NCT03208868|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329740|NCT03208855|Randomized|Parallel Assignment||Treatment||Single||||||t
1329741|NCT03208842|||Cohort||Prospective|||||||
1329742|NCT03208829|Randomized|Parallel Assignment||Treatment||Double|The random allocation step will be conducted through Randomizers - www.random.org by a research assistant. The assistant responsible for randomization will not be involved in any other phase of the study and the secrecy of the allocation will be maintained through opaque envelopes. A second independent assistant will administer the agenda and all communication between the participants and the researchers involved|Patients with total hip arthroplasty, will be assigned to two different treatment groups.|t|||t
1329743|NCT03208816||Single Group Assignment||Supportive Care||None (Open Label)||a non-pharmacological, telephone-delivered, symptom management program for chemotherapy patients.||||
1329744|NCT03208803|||Case-Only||Other|||||||
1329745|NCT03208790|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1329746|NCT03208777|||Case-Control||Cross-Sectional|||||||
1329747|NCT03208764||Single Group Assignment||Treatment||None (Open Label)||||||
1329748|NCT03208751||Single Group Assignment||Prevention||None (Open Label)||A single-arm intervention with exercise training as secondary prevention strategy||||
1329749|NCT03208738|Randomized|Parallel Assignment||Treatment||None (Open Label)|NA: All study measures are self-report.|||||
1329750|NCT03208725|||Cohort||Prospective|||||||
1329751|NCT03208712||Single Group Assignment||Treatment||None (Open Label)||Pilot Study||||
1329752|NCT03208699|||Case-Only||Cross-Sectional|||||||
1329753|NCT03208686||Single Group Assignment||Supportive Care||None (Open Label)||||||
1329754|NCT03208673||Single Group Assignment||Treatment||None (Open Label)||||||
1329755|NCT03208660|||Cohort||Retrospective|||||||
1329756|NCT03208647|||Case-Control||Retrospective|||||||
1329757|NCT03208634||Single Group Assignment||Treatment||None (Open Label)||||||
1329758|NCT03208621|||Cohort||Prospective|||||||
1329759|NCT03208608|||Cohort||Cross-Sectional|||||||
1329760|NCT03208595|||Cohort||Prospective|||||||
1329761|NCT03208582||Single Group Assignment||Basic Science||None (Open Label)||||||
1329762|NCT03208569|||Cohort||Prospective|||||||
1329763|NCT03208556||Single Group Assignment||Treatment||None (Open Label)||||||
1329764|NCT03208543||Single Group Assignment||Treatment||None (Open Label)||Patients meeting inclusion criteria will be enrolled to receive seven treatment sessions with thermotherapy (HECT-CL device) and will be reassessed during follow up visits at day 15, 30, 60, 90 and 180||||
1329765|NCT03208530||Single Group Assignment||Health Services Research||None (Open Label)||||||
1329766|NCT03208517|Randomized|Factorial Assignment||Treatment||Single||||||t
1329767|NCT03208504||Single Group Assignment||Treatment||None (Open Label)||Prospective, open-label, non-randomized, interventional clinical study. All subjects will be treated by implantation of the Single Branch Nexus™ Aortic Arch Stent graft System.||||
1329768|NCT03208491|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329769|NCT03208478|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1329770|NCT03208465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329771|NCT03208452|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1329772|NCT03208439|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1329773|NCT03208426|Randomized|Parallel Assignment||Treatment||Single|The technicians who performed the UBT test are blind to the treatment allocation|||||t
1329774|NCT03208413||Single Group Assignment||Treatment||None (Open Label)||||||
1329775|NCT03208400||Single Group Assignment||Treatment||None (Open Label)||||||
1329776|NCT03208387|||Case-Control||Prospective|||||||
1329777|NCT03208374|||Cohort||Prospective|||||||
1329778|NCT03208361|Randomized|Parallel Assignment||Treatment||Quadruple||Arm 1: Penicillin V (phenoxymethylpenicillin) Arm 2: Amoxicillin (control)|t|t|t|t
1329779|NCT03208348||Single Group Assignment||Supportive Care||None (Open Label)||A single group will pilot test a virtual reality system that is designed to support mental health treatment.||||
1329780|NCT03208335||Single Group Assignment||Treatment||None (Open Label)||||||
1329781|NCT03208322|||Case-Only||Prospective|||||||
1329782|NCT03208309|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1329783|NCT03208296|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This is a dose escalation study to determine the safety and efficacy of ASN-002 in treatment of BCCs in BCNS patients.||||
1329784|NCT03208283|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1329785|NCT03208270|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1329786|NCT03208257||Single Group Assignment||Treatment||None (Open Label)||||||
1329787|NCT03208244||Single Group Assignment||Prevention||None (Open Label)||||||
1329788|NCT03208231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329789|NCT03208218|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1329790|NCT03208205|||Case-Only||Retrospective|||||||
1329791|NCT03208192|Randomized|Parallel Assignment||Treatment||None (Open Label)||"two groups will be compared. Group 1: liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).~Group 2: liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)"||||
1329883|NCT03206996|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Single-subjects design (baseline, treatment and follow-up)||||
1329792|NCT03208179|Randomized|Parallel Assignment||Prevention||Quadruple|The study will be a partially placebo-controlled involving a single placebo for AZ. To further minimise bias, an objective primary outcome measure will be used and all staff will be masked to the treatment assignment of individual women. The trial statistician will also be masked in regard to the treatment code when he develops the statistical analysis plan and writes the statistical programmes, which will be validated and completed using dummy randomisation codes. The actual allocation will only be provided to the study team after locking of the database and approval of the statistical analysis plan by the independent Data Monitoring and Ethics Committee (DMEC) before they review any trial results. The study statistician conducting the interim analysis will remain masked throughout the analysis.||t|t|t|t
1329793|NCT03208166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329794|NCT03208153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329795|NCT03208140|||Case-Only||Prospective|||||||
1329796|NCT03208127||Single Group Assignment||Prevention||None (Open Label)||||||
1329797|NCT03208114|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||A total mother-infant pairs enrolled will be randomized to either receive the written information of the name of a breast milk substitute on the infant's discharge documents (group A) or not to receive it (group B).||||
1329798|NCT03208101|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329799|NCT03208088||||||||||||
1329800|NCT03208075|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1329801|NCT03208062|||Cohort||Prospective|||||||
1329802|NCT03208049|Randomized|Parallel Assignment||Treatment||None (Open Label)||Our hypotheses will be tested in a randomized parallel groups design. Randomization will be based on type of treatment assignment: either to Sleep Restriction (SR) or to Cognitive Therapy (CT). After screening and randomization in the 2-week baseline phase, subjects will receive SR or CT in the 6-week treatment phase. There will be no more treatment after this point. At the end of the 6-week treatment, subjects will return to repeat many of the psychological tests.||||
1329803|NCT03208036|Randomized|Parallel Assignment||Treatment||Triple|Participants, interventionists, and the outcome assessors will be blind to participant condition. The neuromodulation device can be pre-programmed to deliver either tDCS or sham stimulation when an ID code is entered. The study personnel randomizing participants and programming the equipment will not have contact with participants.|This is a double-blind, double-baseline, sham-controlled study in which participants are randomized to receive either tDCS or sham stimulation concurrent with cognitive training.|t|t||t
1329804|NCT03208023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329805|NCT03208010|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329806|NCT03207997|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1329807|NCT03207984|Randomized|Parallel Assignment||Treatment||Single||||||t
1329808|NCT03207971|Randomized|Parallel Assignment||Treatment||Single||||||t
1329809|NCT03207958||Single Group Assignment||Treatment||None (Open Label)||||||
1329810|NCT03207945|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329811|NCT03207932|||Case-Control||Prospective|||||||
1329812|NCT03207919|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1329813|NCT03207906|Randomized|Parallel Assignment||Treatment||Quadruple|The randomization will be done centrally by a randomization programmer/statistician who will be the only un-blinded participant. That person will not have any part in the decisions regarding patient populations and/or protocol violations.|Once subjects have been determined to be eligible for participation in the study, they will be randomized to one of the three treatment arms. The randomization number will be generated according to the randomization schedule prepared prior to the start of the study. Participants will be assigned to receive assign treatment solution VBP-926 (either lower or higher concentration) or vehicle in 1:1:1 ratio using the IWRS system.|t|t|t|t
1329814|NCT03207893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329815|NCT03207880||Single Group Assignment||Health Services Research||None (Open Label)||||||
1329816|NCT03207867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329817|NCT03207854|||Case-Control||Retrospective|||||||
1329818|NCT03207841|Randomized|Parallel Assignment||Other||Single||||||t
1329819|NCT03207828|Randomized|Parallel Assignment||Treatment||Quadruple|Participants: blind to hypothesis and blind regarding which conditions they have been assigned. To mask the condition, participants of both arms will receive the experimental intervention. Control participants will need to wait to receive the intervention. Control participants will know that the time waiting to be attended can vary among participants (and that even participants in the experimental group may have to wait). They also would know that (while waiting to be intervened) participants will need to attend to a series of assessments, and that five month is the longest period they will need to wait. Care providers: blind to all the study aspects but not to its aims. Investigators: blind to the subject treatment assignment and the outcomes. Outcomes assessors: blind to all aspects. Interventionist: blind to hypothesis and outcomes. Research assistant: blind to everything but not to aims and implementation.|Patients with Fibromialgia and mayor depression will be randomized to two treatment conditions.|t|t|t|t
1329820|NCT03207815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329821|NCT03207802|||Cohort||Retrospective|||||||
1329822|NCT03207789|||Cohort||Cross-Sectional|||||||
1329823|NCT03207776|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1329824|NCT03207763|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1329825|NCT03207750|Randomized|Parallel Assignment||Prevention||Single|||t|||
1329826|NCT03207737|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1329827|NCT03207724||Single Group Assignment||Treatment||None (Open Label)||||||
1329828|NCT03207711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329829|NCT03207698|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1329830|NCT03207685||Single Group Assignment||Supportive Care||None (Open Label)||||||
1329831|NCT03207672|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329832|NCT03207659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329833|NCT03207646|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomized 1:1 to either the experimental arm or the 'no intervention' (control) arm.||||
1329834|NCT03207633|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1329835|NCT03207620|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329836|NCT03207607|Randomized|Crossover Assignment||Prevention||Double|Coded snacks in shaded tetrapaks were provided to participants||t|||t
1329837|NCT03207594||Single Group Assignment||Health Services Research||None (Open Label)||||||
1329838|NCT03207581|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1329839|NCT03207568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Relay Pro and Relay NBS Pro device||||
1329840|NCT03207555||Single Group Assignment||Treatment||None (Open Label)||||||
1329841|NCT03207542|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1329842|NCT03207529||Single Group Assignment||Treatment||None (Open Label)||||||
1329843|NCT03207516|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1329844|NCT03207503|||Case-Control||Prospective|||||||
1329845|NCT03207490||Single Group Assignment||Treatment||None (Open Label)||Intervention is provided by a robotic device for hand motion, controlled by closed loop surface electromyography (sEMG)||||
1329846|NCT03207477|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||Longitudinal cohort study with a control group||||
1329847|NCT03207464|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1329848|NCT03207451|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1329849|NCT03207438|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1329850|NCT03207425|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1329851|NCT03207412|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1329852|NCT03207399||Single Group Assignment||Treatment||None (Open Label)||||||
1329853|NCT03207386||Sequential Assignment||Prevention||None (Open Label)||Multiple baseline survey design across three years including two baseline surveys prior to prevention programming and rollout of doses of programming across two years. Additionally, a matched comparison design in which students in a demographically similar city not receiving the programming will be compared over time with students in the city receiving the programming.||||
1329854|NCT03207373||Single Group Assignment||Screening||None (Open Label)||||||
1329855|NCT03207360||Single Group Assignment||Treatment||None (Open Label)||Single group assignment||||
1329856|NCT03207347|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients in both cohorts will receive niraparib.||||
1329857|NCT03207334||Single Group Assignment||Treatment||None (Open Label)||All patients will receive midostaurin and cytarabine.||||
1329858|NCT03207321|||Case-Control||Retrospective|||||||
1329859|NCT03207308||Single Group Assignment||Basic Science||None (Open Label)||||||
1329860|NCT03207295|Randomized|Parallel Assignment||Treatment||Single|||t|||
1329861|NCT03207282|||Cohort||Prospective|||||||
1329862|NCT03207269|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1329863|NCT03207256|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329864|NCT03207243|Randomized|Parallel Assignment||Treatment||Double|This is a double blind study and subjects and investigator will be masked.|This will be a parallel intervention model in which GSK3772847 and placebo will be administered in parallel manner to randomized subjects.|t||t|
1329865|NCT03207230||Single Group Assignment||Other||None (Open Label)||All participants enrolled in the study will receive the wearables and will be evaluated for the relationship between daily physical activity levels and functional capacity (VO2 peak).||||
1329866|NCT03207217|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1329867|NCT03207204|Randomized|Parallel Assignment||Treatment||Single||||||t
1329868|NCT03207191||Single Group Assignment||Treatment||None (Open Label)||||||
1329869|NCT03207178||Sequential Assignment||Treatment||None (Open Label)||||||
1329870|NCT03207165|Randomized|Parallel Assignment||Treatment||Quadruple|The study participants, treating medical team and research team will be blinded to randomization; the pharmacy staff, CCU nurses and allied healthcare team members will not be blinded to the randomization.|Consecutive patients admitted to the Coronary Care Unit (CCU) at the Ottawa Heart Institute from start of study (tentatively set for August 2017 with anticipated end date of June 2020) and identified by the treating medical team as requiring initiation of inotrope therapy will be screened and randomized based on the healthcare team's clinical assessment of predominantly LV or RV systolic dysfunction (biventricular dysfunction will be assigned to predominantly LV dysfunction). All decisions to initiate inotrope therapy will be made by the primary care team with no involvement from the research team.|t|t|t|t
1329871|NCT03207152||Single Group Assignment||Basic Science||None (Open Label)||||||
1329872|NCT03207139||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329873|NCT03207126||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329874|NCT03207113||Single Group Assignment||Supportive Care||None (Open Label)||||||
1329875|NCT03207100|Randomized|Parallel Assignment||Treatment||Single|This study uses a single-blinded design in which only the investigators and not the subjects know the method of intervention.|Subjects are grouped into the analgesia-first minimal sedation group (experimental group) or antihypertensive drug treatment group (control group) using the central randomization system upon enrollment. Antihypertensive intervention is performed on the subjects in accordance to the protocol of each group.|t|||
1329876|NCT03207087||Single Group Assignment||Treatment||None (Open Label)|Open label|Single group assignment||||
1329877|NCT03207074||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329878|NCT03207061||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329879|NCT03207048|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1329880|NCT03207035|Randomized|Parallel Assignment||Other||Single||||||t
1329881|NCT03207022|Randomized|Parallel Assignment||Other||Single||||||t
1329882|NCT03207009||Single Group Assignment||Treatment||None (Open Label)||||||
1330430|NCT03199859|||Cohort||Prospective|||||||
1329884|NCT03206983||Single Group Assignment||Treatment||None (Open Label)||||||
1329885|NCT03206970||Single Group Assignment||Treatment||None (Open Label)||||||
1329886|NCT03206957|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Interventional controlled cross-sectional study||||
1329887|NCT03206944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329888|NCT03206931||||||||||||
1329889|NCT03206918||Single Group Assignment||Treatment||None (Open Label)||||||
1329890|NCT03206905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329891|NCT03206892|Randomized|Parallel Assignment||Diagnostic||Double|using sequentially numbered, opaque sealed enveloped; each envelope contains the method of intervention according to the random sequence and will be opened just before the intervention.|women fulfilled the inclusion criteria and consented will be included in the study and randomly assigned into two groups using computer random sequence generator.|t|||t
1329892|NCT03206879|||Cohort||Prospective|||||||
1329893|NCT03206866|||Other||Other|||||||
1329894|NCT03206853|Non-Randomized|Parallel Assignment||Treatment||Single||"Traditional therapy group：the aneurysms will be executed by traditional procedure, including microsurgical clipping, endovascular coiling or stenting, etc.~Hybrid operation group: Intervene with hybrid operating techniques, eg. microsurgical clipping+endovascular coiling or with the assistant of balloon occlusion."||||t
1329895|NCT03206840|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1329896|NCT03206827|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329897|NCT03206814|Randomized|Parallel Assignment||Treatment||Single|Centralized reading of ECG, echocardiography and ABPM, blinded for treatment group assignment|||||t
1329898|NCT03206801|Randomized|Parallel Assignment||Screening||Single|The assessor of the primary outcome will be masked. As the intervention involves a study biopsy, based on an elevated urine CXCL10, it is not possible to blind the participant, care provider or investigator.|This is a Phase II-III multi-center prospective randomized controlled clinical trial of incident adult renal transplant patients. Patients with elevated urine CXCL10 will be randomized 1:1 to the intervention and control arms, stratified by center (~ 420 enrolled to urine CXCL10 screening for n=250 randomized participants).||||t
1329899|NCT03206788|Randomized|Parallel Assignment||Treatment||Triple|losartan and matching placebo||t||t|t
1329900|NCT03206775|||Cohort||Prospective|||||||
1329901|NCT03206762|Randomized|Parallel Assignment||Treatment||Single||255 subjects are planned for enrollment (with a block 2:1 randomization)|t|||
1329902|NCT03206749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329903|NCT03206736||Single Group Assignment||Other||None (Open Label)||||||
1329904|NCT03206723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329905|NCT03206710|||Case-Control||Prospective|||||||
1329906|NCT03206697|||Cohort||Prospective|||||||
1329907|NCT03206684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329908|NCT03206671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329909|NCT03206658|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1329910|NCT03206645||Single Group Assignment||Treatment||None (Open Label)||This trial will utilize a traditional 3+ 3 design with dose escalation.||||
1329911|NCT03206632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329912|NCT03206619|||Cohort||Prospective|||||||
1329913|NCT03206606|||Cohort||Prospective|||||||
1329914|NCT03206593|||Cohort||Prospective|||||||
1329915|NCT03206580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329916|NCT03206567|Randomized|Parallel Assignment||Treatment||Triple|Double-blind study||t|t|t|
1329917|NCT03206554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329918|NCT03206541|||Case-Control||Prospective|||||||
1329919|NCT03206528|||Cohort||Prospective|||||||
1329920|NCT03206515|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1329921|NCT03206502||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329922|NCT03206489|Randomized|Parallel Assignment||Treatment||Double||noninvasive high-frequency ventilation (nHFOV) and nasal continuous positive airway pressure (nCPAP) are used as primary mode of ventilation in preterm twins infants with RDS|||t|t
1329923|NCT03206476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329924|NCT03206463|Randomized|Crossover Assignment||Basic Science||Quadruple||The study is a double-blind, randomized, placebo-controlled, crossover laboratory evaluation of the acute subjective, cognitive and psychophysiological effects of 2 mg and 4 mg inhaled THC in Healthy Control individuals and individuals with euthymic Bipolar Disorder.|t|t|t|t
1329925|NCT03206450||||||||||||
1329926|NCT03206437|Randomized|Parallel Assignment||Treatment||Double|Since this study is focusing on a mind-body skill as a treatment it will be impossible to mask the participant.||||t|t
1329927|NCT03206424|||Case-Only||Cross-Sectional|||||||
1329928|NCT03206411|||Case-Crossover||Cross-Sectional|||||||
1329929|NCT03206398||Single Group Assignment||Treatment||None (Open Label)||anti-gravity treadmill for a total of 40 days in addition to physiotherapy||||
1329930|NCT03206385|||Cohort||Prospective|||||||
1329931|NCT03206372|||Family-Based||Cross-Sectional|||||||
1329932|NCT03206359|||Case-Control||Prospective|||||||
1329933|NCT03206346|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1329934|NCT03206333|||Cohort||Retrospective|||||||
1329935|NCT03206320|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1329936|NCT03206307|||Cohort||Cross-Sectional|||||||
1329937|NCT03206294||Single Group Assignment||Health Services Research||None (Open Label)||||||
1329938|NCT03206281|||Case-Control||Prospective|||||||
1329939|NCT03206268|||Cohort||Prospective|||||||
1329940|NCT03206255|||Cohort||Prospective|||||||
1329941|NCT03206242|||Cohort||Prospective|||||||
1329942|NCT03206229|Randomized|Crossover Assignment||Treatment||Double|This is double blind study so participat healthy subjects and investigators both would be blinded|This study is a Randomized, Double Blind, Single-Dose, Two-Period Crossover Comparative Pharmacology Study|t||t|
1577061|NCT00005194||||||||||||
1329943|NCT03206216|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1329944|NCT03206203|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1329945|NCT03206190|Non-Randomized|Parallel Assignment||Diagnostic||Triple|Two Arms are blinded (mutation carriers vs. non mutation carriers) the third arm is an open-arm for presymptomatic tested mutation carriers||t|t|t|
1329946|NCT03206177||Single Group Assignment||Treatment||None (Open Label)||||||
1329947|NCT03206164|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"Methods: We will convert the evidence based HealthMatters Train the Trainer Workshop for Instructors, synchronous, live webinar training course into HealthMatters@24/7, an asynchronous, e-learning training course for staff to plan, conduct, and evaluate the HealthMatters Program for people with IDD in residential and day/employment community-based organizations (CBOs).~Design. We will utilize a two-group (Table 1) pre-test/post test quasi-experimental design wherein the Experimental Group will receive HealthMatters@24/7 training and the Control Group will receive the customary real-time (live) webinar training (HealthMatters Train the Trainer Workshop)."||||
1329948|NCT03206151|Randomized|Parallel Assignment||Treatment||Single||||||t
1329949|NCT03206138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329950|NCT03206125|||Case-Control||Other|||||||
1329951|NCT03206112|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1329952|NCT03206099|||Case-Only||Prospective|||||||
1329953|NCT03206086||Single Group Assignment||Treatment||None (Open Label)||||||
1329954|NCT03206073|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1329955|NCT03206060||Single Group Assignment||Treatment||None (Open Label)||||||
1329956|NCT03206047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329957|NCT03206034|Randomized|Parallel Assignment||Treatment||Triple||Double blind placebo controlled randomized control trial|t||t|t
1329958|NCT03206021|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329959|NCT03206008|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1329960|NCT03205995||Single Group Assignment||Treatment||None (Open Label)||||||
1329961|NCT03205982|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1329962|NCT03205969||Single Group Assignment||Supportive Care||None (Open Label)||||||
1329963|NCT03205956||Single Group Assignment||Other||None (Open Label)||All participants receive oral carbidopa before, and i.v. levodopa during brain imaging, to measure regional cerebral blood flow responses to levodopa.||||
1329964|NCT03205943|||Case-Only||Prospective|||||||
1329965|NCT03205930||Single Group Assignment||Treatment||None (Open Label)|Open clinical study|Single center single arm clinical study||||
1329966|NCT03205917|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1329967|NCT03205904|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329968|NCT03205891||Single Group Assignment||Treatment||None (Open Label)||||||
1329969|NCT03205878|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1329970|NCT03205865|||Cohort||Prospective|||||||
1329971|NCT03205852|||Case-Crossover||Prospective|||||||
1329972|NCT03205839|Randomized|Parallel Assignment||Treatment||None (Open Label)|Entire study completed online, including randomisation.|||||
1329973|NCT03205826||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329974|NCT03205813|||Cohort||Prospective|||||||
1329975|NCT03205800|Randomized|Parallel Assignment||Treatment||Single||a split-mouth design||||t
1329976|NCT03205787||Single Group Assignment||Basic Science||None (Open Label)||||||
1329977|NCT03205774|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1329978|NCT03205761||Single Group Assignment||Treatment||None (Open Label)||||||
1329979|NCT03205748|||Cohort||Prospective|||||||
1329980|NCT03205735|||Cohort||Prospective|||||||
1329981|NCT03205722|||Cohort||Retrospective|||||||
1329982|NCT03205709|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1329983|NCT03205696|||Case-Control||Prospective|||||||
1329984|NCT03205683|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1329985|NCT03205670||Single Group Assignment||Treatment||None (Open Label)||||||
1329986|NCT03205657|||Other||Retrospective|||||||
1329987|NCT03205631|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1329988|NCT03205618|||Cohort||Retrospective|||||||
1329989|NCT03205605|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1329990|NCT03205592|||Cohort||Prospective|||||||
1329991|NCT03205579|Randomized|Parallel Assignment||Treatment||Single||||t||
1329992|NCT03205566|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1329993|NCT03205553|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1329994|NCT03205540|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1329995|NCT03205527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1329996|NCT03205514|||Cohort||Prospective|||||||
1329997|NCT03205501||Single Group Assignment||Diagnostic||None (Open Label)||||||
1329998|NCT03205488|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1329999|NCT03205475|Randomized|Parallel Assignment||Treatment||Single||JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) is a play based targeted social communication intervention. Sessions will be delivered one on one by an interventionist in training with a child age 2.0-8.11 years who has autism.|t|||
1330000|NCT03205462|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The current Phase I clinical trial has been developed to assess the safety and tolerability of the Fluorothyazinone drug used as a single-dose administration and a treatment course in healthy volunteers. This dose-escalation trial will be conducted with sequential enrollment of volunteers||||
1330001|NCT03205449|Randomized|Parallel Assignment||Prevention||Double||This study will use a randomised controlled trial design to test the effects of the Masayang Pamilya programme in comparison to participants allocated to a treatment as usual control group (N = 120 parents of children ages 2 to 6 years; 1:1 intervention to control group ratio).|||t|t
1330002|NCT03205436||Single Group Assignment||Treatment||None (Open Label)||||||
1330003|NCT03205423|Randomized|Parallel Assignment||Basic Science||Double||Participants will be randomized to first receive one of two treatment conditions: gabapentin 0 mg or gabapentin 1800 mg/day.|t|||t
1330004|NCT03205410|Randomized|Parallel Assignment||Prevention||Single|Patients were randomly assigned in 1:1 ratio to either the RIPC group or the control group by means of a computerized randomization table.||||t|
1330005|NCT03205397|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330006|NCT03205384|||Cohort||Prospective|||||||
1330007|NCT03205371|Randomized|Parallel Assignment||Prevention||Single|The study has an open-label design; however, as per the protocol, the laboratory technicians who are responsible for performing the serological testing will remain blinded to the participants' group allocations throughout the entire study to avoid any bias.|Phase III, open-label, randomized, parallel-group, active-controlled, multicenter study||||t
1330008|NCT03205358|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330009|NCT03205345|Randomized|Parallel Assignment||Treatment||Triple|Study drug will be double-blind with matching placebo. Emricasan at 25 mg or 5 mg or matching placebo will be administered orally twice a day.||t||t|t
1330010|NCT03205332|Randomized|Parallel Assignment||Treatment||None (Open Label)|Eligibility Assessor|||||
1330011|NCT03205319|Randomized|Parallel Assignment||Other||None (Open Label)|Masking will be impossible in this study|Multicenter, randomised controlled, open label||||
1330012|NCT03205306|||Cohort||Retrospective|||||||
1330013|NCT03205293|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a randomized control program trial, pre-post study||||
1330014|NCT03205280|||Cohort||Prospective|||||||
1330015|NCT03205267||Single Group Assignment||Treatment||None (Open Label)||||||
1330016|NCT03205254|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Randomized two-way crossover design||||
1330017|NCT03205241|Randomized|Crossover Assignment||Basic Science||Double||Randomised, placebo-controlled, double blind, crossover design study|t||t|
1330018|NCT03205228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330019|NCT03205215|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330020|NCT03205202|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1330021|NCT03205189|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a randomized, prospective, study||||
1330022|NCT03205176|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1330023|NCT03205163|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1330024|NCT03205150|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330025|NCT03205137|||Cohort||Retrospective|||||||
1330026|NCT03205124|Randomized|Parallel Assignment||Treatment||Triple||Three arm randomized controlled study|t||t|t
1330027|NCT03205111|||Case-Crossover||Prospective|||||||
1330028|NCT03205098|||Other||Prospective|||||||
1330029|NCT03205085|Non-Randomized|Parallel Assignment||Other||Single|||||t|
1330030|NCT03205072|||Cohort||Prospective|||||||
1330031|NCT03205059|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330032|NCT03205046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330033|NCT03205033|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1330034|NCT03205020|||Case-Control||Prospective|||||||
1330035|NCT03205007||Single Group Assignment||Prevention||None (Open Label)||Pre-Post changes in dietary behavior||||
1330036|NCT03204994||Single Group Assignment||Treatment||None (Open Label)||||||
1330037|NCT03204981||Single Group Assignment||Diagnostic||None (Open Label)||||||
1330038|NCT03204968|Randomized|Parallel Assignment||Prevention||Single||||||t
1330039|NCT03204955|Randomized|Parallel Assignment||Treatment||Quadruple|A double-blinded-double-dummy design, where each dose of hypertonic solution will be administered along with a balanced solution in order to mask the difference in the volume between the two solutions.|Once consented to the study, patients' serum chloride will be followed daily. Patients who will have a chloride concentration of 109mg/dL or above will be randomized to receive the blinded hypertonic solutions.|t|t|t|t
1330040|NCT03204942|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1330041|NCT03204929||Single Group Assignment||Treatment||None (Open Label)||||||
1330042|NCT03204916||||||||||||
1330043|NCT03204903|Randomized|Parallel Assignment||Treatment||Double|Sham laser acupuncture: laser acupuncture without laser output.|Subjects with dry eye are enrolled at two ophthalmic centers and randomly assigned to a laser acupuncture group and control group under conventional treatment with artificial tears. The subjects are treated at acupoints including BL2, TE23, ST2, LI4, ST36, and GB37 using verum or sham laser acupuncture during 3 sessions per week. After 4 and 12 weeks of treatment, the differences in the Tear film break-up time, Schirmer test, visual analogue scale, Ocular Surface Disease Index of the patients are analyzed, and compared between the laser acupuncture and control groups using paired t-test and one way ANOVA.|t|||t
1330044|NCT03204890||Single Group Assignment||Treatment||None (Open Label)||||||
1330045|NCT03204877|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1330046|NCT03204864|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Phase 1. Conventional CS lead placement~Phase 2. CS placement guided by RLD measurement"||||
1330047|NCT03204851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1330048|NCT03204838|||Case-Only||Prospective|||||||
1330049|NCT03204825|Randomized|Parallel Assignment||Other||Double|Primary outcome assessors will be blinded for patient group allocation|2x2 randomised feasibility controlled trial blinded for primary outcome|t|||t
1330050|NCT03204812||Single Group Assignment||Treatment||None (Open Label)||This is an open-label, single center, pilot study.||||
1330051|NCT03204799|||Cohort||Prospective|||||||
1330052|NCT03204786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330053|NCT03204773|||Case-Control||Cross-Sectional|||||||
1330097|NCT03204188||Single Group Assignment||Treatment||None (Open Label)||||||
1330098|NCT03204175|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1330054|NCT03204760|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Children with mild to moderate asthma exacerbation will be given the first dose of salbutamol and will be reassessed after 20 min by the emergency department attending. If further salbutamol is needed, subjects automatically will receive the second dose 20 min apart and receive either single dose of intramuscular dexamethasone (0.6 mg/kg to a maximum of 18 mg) or prednisolone for 3 days (1 mg/kg to a maximum of 40 mg), given orally in two devided doses .~A repeat physical examination will be performed, including oxygen saturation, vital signs, PRAM, PEFR after the 3rd dose of salbutamol and at the end of the third day to evaluate the effect of prednisolone and dexamethasone on the improvement of asthma scores. Patient compliance to prednisolone therapy for three days will be also recorded."||||
1330055|NCT03204747|||Cohort||Prospective|||||||
1330056|NCT03204734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330057|NCT03204721|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients admitted for allogeneic stamcelltransplantation who consent participation in the study are randomized 1:1, either to receive ECP or no-ECP||||
1330058|NCT03204708|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330059|NCT03204695||Single Group Assignment||Prevention||None (Open Label)||||||
1330060|NCT03204682||Single Group Assignment||Treatment||None (Open Label)|Open|All participants receive the same intervention throughout the protocol||||
1330061|NCT03204669|||Cohort||Retrospective|||||||
1330062|NCT03204656|||Other||Prospective|||||||
1330063|NCT03204643|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1330064|NCT03204630|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1330065|NCT03204617|Randomized|Parallel Assignment||Basic Science||Triple|•Double Blind: two or more parties are unaware of the intervention assignment|||t|t|t
1330066|NCT03204604|Randomized|Crossover Assignment||Basic Science||Triple|Visits are listed at Challenge A or Challenge B. This serves as a double blind crossover intervention for participants and clinic staff.|Challenge A - low calorie Ensure® shake Challenge B - low calorie Ensure® shake with ketone esters|t|t|t|
1330067|NCT03204591|||Cohort||Prospective|||||||
1330068|NCT03204578|Randomized|Crossover Assignment||Treatment||None (Open Label)||Open-label, randomised, single-dose crossover design||||
1330069|NCT03204565|Randomized|Parallel Assignment||Treatment||Single||||||t
1330070|NCT03204552|||Cohort||Prospective|||||||
1330071|NCT03204539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330072|NCT03204526||Single Group Assignment||Treatment||None (Open Label)||||||
1330073|NCT03204513|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||"Upon screening and enrollment participants return for up to 8 prosthetic fitting sessions and up to 12 physical therapy training sessions using their own microprocessor (MP) knee prosthesis and the powered knee-ankle (PKA) prosthesis. Once training is complete participants will return for up to 6 post-training assessment sessions per device. The device participants begin with will be randomly selected but there will be equal opportunity to train with both devices. In between training, there will be an 8 week wash out period to allow normalization to use of the device, reducing carryover effects. After wash-out period protocol will be repeated with second device."||||
1330074|NCT03204500|Randomized|Parallel Assignment||Treatment||Double|This is a prospective randomized double-blind placebo-controlled trial. The randomization is made in blocks of 4 treatments (2 active and 2 placebo). Only the 4-digit numbers on the bottle label will identify the type of treatment.|Twenty ALS patients under active treatment vs. twenty ALS patients under placebo treatment. 21 months follow-up whith clinimetry and biomarkers|t||t|
1330075|NCT03204487||Single Group Assignment||Treatment||None (Open Label)||||||
1330076|NCT03204474|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1330077|NCT03204461|||Other||Prospective|||||||
1330078|NCT03204448|||Cohort||Retrospective|||||||
1330079|NCT03204435|Non-Randomized|Parallel Assignment||Treatment||Single||"Patients of intracranial aneurysms with coexistence of cerebrovascular stenosis, coincident with inclusion and exclusion criterion, will be distributed into traditional therapy group(control group) and hybrid operating group(test group), and conduct with traditional neurosurgical management or one-stage hybrid operating management separately.~Traditional therapy group: intervene the aneurysms and vascular stenosis unsimultaneously. Clipping procedure is preferred to aneurysms, while endovascular intervention is preferred to stenosis.~Hybrid operation group: one-stage hybrid operating technique is conducted. The aneurysms and vascular stenosis will be executed via the cooperation of microsurgical procedure and endovascular interventional techniques."||||t
1330080|NCT03204422|||Other||Cross-Sectional|||||||
1330081|NCT03204409|||Cohort||Prospective|||||||
1330082|NCT03204396|Randomized|Parallel Assignment||Treatment||Quadruple||randomized, double-blind, placebo-controlled trial|t|t|t|t
1330083|NCT03204370|||Cohort||Prospective|||||||
1330084|NCT03204357|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study design is a prospective randomized interventional trial of transfusion of fresh autologous whole blood versus standard of care expectant management of bleeding during elective cardiac surgery.||||
1330085|NCT03204344|Randomized|Parallel Assignment||Prevention||Single|Outcomes assessor who perform postoperative follow-up is masked to group assignment.|This is a outcomes assessor-blinded, randomized controlled trial with two parallel arms.||||t
1330086|NCT03204331|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330087|NCT03204318|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330088|NCT03204305|Non-Randomized|Parallel Assignment||Basic Science||Single|marijuana THC content (dose) is masked for participant|Two groups will be recruited. Marijuana users and nonusers.|t|||
1330089|NCT03204292|||Other||Prospective|||||||
1330090|NCT03204279|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1330091|NCT03204266|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330092|NCT03204253|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330093|NCT03204240|Randomized|Crossover Assignment||Other||Single||||||t
1330094|NCT03204227|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1330095|NCT03204214|||Case-Control||Retrospective|||||||
1330096|NCT03204201||Single Group Assignment||Other||None (Open Label)||||||
1330099|NCT03204162|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1330100|NCT03204149|Randomized|Parallel Assignment||Other||Double|||t||t|
1330101|NCT03204136|||Case-Control||Retrospective|||||||
1330102|NCT03204123|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1330103|NCT03204110|||Cohort||Prospective|||||||
1330104|NCT03204097|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330105|NCT03204084|||Case-Control||Prospective|||||||
1330106|NCT03204071|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330107|NCT03204058|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330108|NCT03204045|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1330109|NCT03204032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330110|NCT03204019|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1330111|NCT03204006|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1330112|NCT03203993|||Case-Crossover||Prospective|||||||
1330113|NCT03203980|||Cohort||Prospective|||||||
1330114|NCT03203967|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1330115|NCT03203954|Randomized|Parallel Assignment||Other||Double|||t|||t
1330116|NCT03203941||||||||||||
1330117|NCT03203928|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two group randomized controlled study||||
1330118|NCT03203915|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1330119|NCT03203902|Randomized|Parallel Assignment||Treatment||Single|Participants receiving sham and authentic therapeutic touch will be masked.|Three arm, randomized controlled design|t|||
1330120|NCT03203889|Randomized|Parallel Assignment||Treatment||None (Open Label)||Native American participants will be randomly assigned to one of the two arms: (1) culturally adapted CRAFT or (2) twelve-step facilitation for concerned significant others (TSF-CSO). Follow ups will be conducted at 3- and 6-months.||||
1330121|NCT03203876|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330122|NCT03203863|||Other||Cross-Sectional|||||||
1330123|NCT03203850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330124|NCT03203837|||Cohort||Prospective|||||||
1330125|NCT03203824|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1330126|NCT03203811|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330127|NCT03203798|Randomized|Parallel Assignment||Treatment||Single|||||t|
1330128|NCT03203785|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1330129|NCT03203772||Single Group Assignment||Treatment||None (Open Label)||||||
1330130|NCT03203759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330131|NCT03203746|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|Total subjects selected were allocated into three study groups, Group I (Test group), Group II (Positive control group) and Group III (Negative control group). Group I: Included 8 patients with severe chronic periodontitis managed by Scaling and root planing (SRP) and local delivery of lycopene loaded in solid lipid microparticles. Group II: Included 8 patients with severe chronic periodontitis managed by Scaling and root planing (SRP) only. Group III: Included 8 patients with clinically healthy periodontium.||||
1330132|NCT03203733|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330133|NCT03203720|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessors blind to treatment group of participants.|Randomized trial comparing Brief Motivational Intervention + Standard Care versus Standard Care Alone||||t
1330134|NCT03203707|Randomized|Parallel Assignment||Prevention||Single|Participants and parents complete clinical monitoring assessments with an evaluator blind to treatment condition.|Randomized trail comparing Data-Informed Referral (DIR) for any clinical condition detected at intake assessment versus DIR + Brief Interpersonal Social Rhythm Therapy (IPSRT)||||t
1330135|NCT03203694|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be assigned to either a walking, unilateral leg heating, or no intervention for 8 weeks.||||
1330136|NCT03203681||Single Group Assignment||Treatment||None (Open Label)||||||
1330137|NCT03203668||Single Group Assignment||Diagnostic||None (Open Label)||||||
1330138|NCT03203655|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330139|NCT03203642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330140|NCT03203629|||Cohort||Prospective|||||||
1330141|NCT03203616||Single Group Assignment||Treatment||None (Open Label)||||||
1330142|NCT03203603|||Case-Control||Prospective|||||||
1330143|NCT03203590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330144|NCT03203577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330145|NCT03203564|Randomized|Single Group Assignment||Other||Triple|IMP (Modufolin® for Injection, 100 mg) and Placebo are not identical in appearance and all efforts will be made at the clinic in order to maintain the blind. Both the IMP and the placebo will be masked in such a way that study subjects and study staff will remain blinded during the study. An un-blinded study nurse will prepare the IMP/placebo for injection and will administer the IMP/placebo to the study subject. The un-blinded study nurse performing the dose administration will not be involved in any study-specific assessments or evaluations.|An adaptive, randomized, double-blind, single-center, placebo-controlled|t||t|t
1330146|NCT03203551|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1330183|NCT03203070|Randomized|Parallel Assignment||Prevention||Double|Patient and nursery staff evaluating postoperative pain do not know the applied intervention.||t|||t
1330184|NCT03203057|||Cohort||Prospective|||||||
1330185|NCT03203044|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants are separated into two diet arms. The regular diet arm remains on a self-reported regular diet for the duration of the study. The Soylent diet arm maintains a regular diet for two days, switches to an all Soylent and water diet for four days, and returns to a regular diet for four days.||||
1330186|NCT03203031|||Case-Only||Prospective|||||||
1330187|NCT03203018||Single Group Assignment||Prevention||None (Open Label)||This is a pre/post study.||||
1330188|NCT03203005||Single Group Assignment||Treatment||None (Open Label)||||||
1330147|NCT03203538|Randomized|Crossover Assignment||Supportive Care||Single|Participants will not be given information on the hypotheses/ expected effects from the different interventions (light conditions).|"Three related night shift studies have been planned. Each study investigates how different lighting conditions, administered through LED-based bright light integrated standard room lighting, affects adaptation to simulated night shifts and re adaptation to a day oriented schedule.~In each study, 28 participants (84 in total) will be exposed to the interventions (light conditions) in a randomized, blinded, controlled, crossover study.~The simulated night shifts will last from 11pm to 7am. The specific light conditions will last from 11pm to 5am (study 1: 1000 lux vs. 100 lux; study 2: 7000 K vs. 2500 K; study 3: 455 nm vs. 615 nm) where after (from 5am to 7am) all participants will be exposed to the same light conditions (200 lux, 4000 K). After completion of one bout of night work (three consecutive shifts for study 1 and 2; one night shift for study 3) there will be a washout period of four weeks before the participants cross over."|t|||
1330148|NCT03203525|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330149|NCT03203512|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1330150|NCT03203499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330151|NCT03203486||Single Group Assignment||Other||None (Open Label)||non-randomised, open-label study||||
1330152|NCT03203473|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330153|NCT03203460|Randomized|Parallel Assignment||Supportive Care||Single|The outcome assessor will be blinded to group assignment for the primary outcome of natural killer cell cytotoxic activity and the secondary outcomes of other circulating biomarkers.|||||t
1330154|NCT03203447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330155|NCT03203434|||Cohort||Prospective|||||||
1330156|NCT03203421|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1330157|NCT03203408|Randomized|Parallel Assignment||Treatment||Double|To prevent the patients from knowing the nature of their treatment, the investigational products OSTENIL PLUS and SYNVISC-ONE were packed in identical neutral packs. OSTENIL PLUS and SYNVISC-ONE differ in appearance (product volume and viscosity, prefilled syringe) and were therefore readily identifiable by the investigator administering the investigational product (i.e. injecting investigator). The double-blind masking could be ensured thanks to the intervention of an observer who did not know the nature of the treatment, namely the evaluating investigator. The treatment was therefore administered blind to the evaluating investigator and the patient but not to the injecting investigator.|This study was a multicentre, prospective, double-blind, randomised, controlled non-inferiority study in two parallel groups of patients followed up for six months.|t|||t
1330158|NCT03203395||Single Group Assignment||Screening||None (Open Label)||||||
1330159|NCT03203382|||Cohort||Prospective|||||||
1330160|NCT03203369|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330161|NCT03203356|||Case-Control||Prospective|||||||
1330162|NCT03203343|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330163|NCT03203330|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1330164|NCT03203317|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1330165|NCT03203304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330166|NCT03203291||Single Group Assignment||Treatment||None (Open Label)||||||
1330167|NCT03203278|Randomized|Parallel Assignment||Treatment||Single||||||t
1330168|NCT03203265|Non-Randomized|Parallel Assignment||Screening||Single||Prospective study to evaluate the first-time HIV testing, successful referral to HIV treatment, retention HIV testing among 3 different study groups. A participants will receive offline HIV testing,counseling and conventional retention strategies. HIV-positive result in A can choose to have either online or offline to HIV treatment. B1 participants will be guided to access services at the 'Adam's Love Clinic, that set up specifically to provide private, fast HIV testing and post-test counseling. B2 participants will be mailed a rapid HIV test kit. Counselor will guide the participant through an online HIV testing process. Post-test counseling will provided HIV test result online. Participants can choose one of two HIV testing and post-test counseling options. HIV-positive participants in B1 and B2 can choose again to refer to HIV treatment either online or offline. All participants in B1 and B2 will receive an online retention strategy.|t|||
1330169|NCT03203252|||Case-Only||Retrospective|||||||
1330170|NCT03203239||Single Group Assignment||Basic Science||None (Open Label)||This is a single group study in which the subject undergoes a single exposure to red light.||||
1330171|NCT03203226|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Participants will be recruited at a company which provides supported employment. The primary recruitment strategy will be the information provided to the potential participants and legal guardians by the medical staff of the company. Informed consent will be obtained from the participants and their legal guardians. Afterwards they will be randomly assigned (1:1 ratio) by centre through sealedopaque envelopes to either the control or the intervention group by coin-tossing sequence generation.~It has been designed an experimental multicentre simple randomized study, with random allocation to a control group (CG) or to an experimental group (EG). This study is an open-label trial as the assessors who were experienced specialist in working with people with ID (psychologists, nurses, physicians, physiotherapists) are not blinded to group allocation."||||
1330172|NCT03203213||Single Group Assignment||Prevention||None (Open Label)||monocentric study||||
1330173|NCT03203200|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330174|NCT03203187|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330175|NCT03203174|Randomized|Parallel Assignment||Treatment||Triple||Subject's received treatment to one palm and the other palm was used as a control.|t||t|t
1330176|NCT03203161|||Cohort||Prospective|||||||
1330177|NCT03203148|||Case-Only||Prospective|||||||
1330178|NCT03203135|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330179|NCT03203122|Randomized|Parallel Assignment||Treatment||Double|Outcome assesor and primary invstigator are blinded and not present at treatments.|Patients are randomized to treatment in either left or right side, using the other side as control.|||t|t
1330180|NCT03203109|||Cohort||Retrospective|||||||
1330181|NCT03203096|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330182|NCT03203083|||Cohort||Cross-Sectional|||||||
1577062|NCT00005193||||||||||||
1330189|NCT03202992|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The study will be conducted in 2 Phases: Part A, up to 5 cohorts of 3 subjects each will receive a single dose of ABI-1968 Topical Cream. In Part B, three cohorts (3 subjects per cohort) will receive multiple doses in 3 ascending dose strengths of ABI-1968 Topical Cream. After completing the ascending dose multiple-dosing cohorts, a multiple-dosing Cohort Expansion group of 30 subjects will be initiated.||||
1330190|NCT03202979|Randomized|Parallel Assignment||Treatment||Double|The present study will be performed in double blind conditions. During the study, neither the Investigator nor the patient will be aware of the treatment assigned.|Double-blind, placebo controlled, double-dummy, dose finding, multicentre, international, prospective, pilot study.|t||t|
1330191|NCT03202966||Single Group Assignment||Prevention||None (Open Label)||||||
1330192|NCT03202953|Randomized|Parallel Assignment||Prevention||Triple|participants, investicator, outcome assessors will be blinded for group allocation.|"1:1 I:E ratio VCV group~autoflow VCV group"|t||t|t
1330193|NCT03202940||Single Group Assignment||Treatment||None (Open Label)||||||
1330194|NCT03202927|Randomized|Parallel Assignment||Treatment||Single|As this is single blind study so study participants would be blinded in the study|This is a single blind parallel comparative immunogenicity study|t|||
1330195|NCT03202914|Randomized|Parallel Assignment||Prevention||Single|During the original MDRD Study, clinical center personnel as well as study participants were masked to the results of the outcome assessment during the follow-up period.|"The present study consists of a secondary data analysis of the MDRD Study. Planned analyses will be limited to participants with available stored specimens.~The original MDRD Study was a 2 x 2 factorial study design, in which individuals were randomized to amounts of protein and phosphorus intake and levels of blood pressure control. In this secondary data analysis, we will analyze metabolites according to level of protein intake and will adjust for the blood pressure intervention."||||t
1330196|NCT03202901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330197|NCT03202888||Single Group Assignment||Health Services Research||None (Open Label)||||||
1330198|NCT03202875|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1330199|NCT03202862||Single Group Assignment||Treatment||None (Open Label)||||||
1330200|NCT03202849|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330201|NCT03202836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330202|NCT03202823|||Case-Control||Prospective|||||||
1330203|NCT03202810|||Cohort||Prospective|||||||
1330204|NCT03202797|||Cohort||Prospective|||||||
1330205|NCT03202784|Randomized|Crossover Assignment||Treatment||None (Open Label)||Three way crossover to evaluate two formulations of BCX7353 and to determine if there is a food effect||||
1330206|NCT03202771|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1330207|NCT03202758||Single Group Assignment||Treatment||None (Open Label)||"Step 1: Phase Ib with the aim to confirmed the safety of the association of Durvalumab (q2w 750mg) + Tremelimumab (q4w 75mg) + FOLFOX~Step 2: Phase II with the aim to assess efficacy of the association of Durvalumab (q2w 750mg) + Tremelimumab (q4w 75mg) + FOLFOX"||||
1330208|NCT03202745|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1330209|NCT03202732|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330210|NCT03202719|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330211|NCT03202706|||Cohort||Prospective|||||||
1330212|NCT03202693||Single Group Assignment||Treatment||None (Open Label)||||||
1330213|NCT03202680|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1330214|NCT03202667|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1330215|NCT03202654|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1330216|NCT03202641||Single Group Assignment||Treatment||None (Open Label)||Physiologic crossover study. There is no randomization.||||
1330217|NCT03202628||Single Group Assignment||Treatment||None (Open Label)||||||
1330218|NCT03202615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330219|NCT03202602|||Cohort||Prospective|||||||
1330220|NCT03202589|||Other||Prospective|||||||
1330221|NCT03202576|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Evaluate the securement of the Nasogastric tube either by standard securement or using a Nasal Bridal securement method.||||
1330222|NCT03202563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330223|NCT03202550|Randomized|Parallel Assignment||Treatment||Quadruple|The participant, provider, and nursing staff will be blinded to the intervention. The pharmacy will prepare the treatment drugs and placebos.. Randomization will be stratified by gestational age (>= 20 weeks or <20 weeks) and the randomization allocation sequence will be computer-generated with a random number generator by a statistician. The pharmacist will be aware of the randomization sequence and will dispense the drugs as appropriate, while keeping track of which arms participants were randomized to.|Randomized controlled trial|t|t|t|t
1330224|NCT03202537||Single Group Assignment||Other||None (Open Label)||||||
1330225|NCT03202524|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Control Trial||||
1330226|NCT03202511|Randomized|Crossover Assignment||Basic Science||None (Open Label)|This will be an open-label study.|Subjects will be randomly allocated to enter the study in either the control or treatment arm using a blocked design to ensure equal numbers of subjects in each sequence group (n=8, control to treatment; n=8, treatment to control). Following a washout period of at least 6 weeks, each individual will crossover to the next study phase. The randomization table will be constructed prior to subject enrollment by the Principal Investigator using the Statistical Analysis Software (SAS®) randomization procedure. In the event that an individual is withdrawn from the study, an alternate participant will replace that individual using an identical study sequence to maintain the block design. A total of 16 subjects will be initially enrolled in an effort to ensure that at least 14 subjects complete the entire study. If needed, additional subjects will be screened and enrolled until the target enrollment of n=14 subjects have completed the entire study.||||
1330282|NCT03201783|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking because of the nature of the intervention|||||
1330283|NCT03201770||Single Group Assignment||Treatment||None (Open Label)||||||
1577063|NCT00005192||||||||||||
1330227|NCT03202498|Randomized|Sequential Assignment||Device Feasibility||Quadruple|Placebo|"Cohort 1 (1:1 randomization):~Standard medical treatment + Yaq-001 (4 g/ day) - n= 14.~Standard medical treatment + placebo-control (placebo for 4 g of Yaq-001/ day) - n= 14.~Cohort 2 (1:1 randomization):~Standard medical treatment + Yaq-001 (8 g/ day) - n= 14.~Standard medical treatment + placebo-control (placebo for 8 g of Yaq-001/ day) - n= 14."|t|t|t|t
1330228|NCT03202485|Non-Randomized|Parallel Assignment||Treatment||Single||Prospective comparative case series||||t
1330229|NCT03202472||Single Group Assignment||Diagnostic||None (Open Label)||||||
1330230|NCT03202459|Randomized|Parallel Assignment||Other||Double|||t||t|
1330231|NCT03202446|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330232|NCT03202433|Randomized|Parallel Assignment||Treatment||Single|Blocks swapped.|Allocation of two groups (Study and Control)||||t
1330233|NCT03202420||Single Group Assignment||Treatment||None (Open Label)||||||
1330234|NCT03202407|Randomized|Parallel Assignment||Treatment||Single|single blinded|parallel group|t|||
1330235|NCT03202394|Randomized|Parallel Assignment||Treatment||Quadruple||Patients will be randomized in a 1:1 ratio to either BIO 11006 125 mg twice daily (intervention) plus standard of care ventilation or placebo BID plus standard of care ventilation. Patients randomized to receive BIO 11006 or placebo will start dosing at the time of ventilation and continue for up to 30 days or length of ventilation (if shorter).|t|t|t|t
1330236|NCT03202381||Single Group Assignment||Other||None (Open Label)||||||
1330237|NCT03202368||Single Group Assignment||Treatment||None (Open Label)||||||
1330238|NCT03202355|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a two-arm, parallel, open-label, non-randomized, controlled, private practice study designed to evaluate the intended purposes of the investigation.||||
1330239|NCT03202342|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1330240|NCT03202329|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330241|NCT03202316||Single Group Assignment||Treatment||None (Open Label)||||||
1330242|NCT03202303|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind|Phase 2, 12-week double-blind, randomized, placebo-controlled trial|t|t|t|t
1330243|NCT03202290|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330244|NCT03202277|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized controlled trial||||
1330245|NCT03202264|||Cohort||Prospective|||||||
1330246|NCT03202251|||Cohort||Prospective|||||||
1330247|NCT03202238|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1330248|NCT03202225|||Cohort||Retrospective|||||||
1330249|NCT03202212|Randomized|Parallel Assignment||Prevention||None (Open Label)||30 patients treated with a standard 3-time per week bicarbonate high-flux hemodialysis will be randomized 1:1 to continue the treatment or to be switched to mixed on-line hemodiafiltration for 9 months||||
1330250|NCT03202199||Single Group Assignment||Diagnostic||None (Open Label)||||||
1330251|NCT03202186|Randomized|Parallel Assignment||Treatment||Triple|Double blind, placebo controlled|Placebo controlled parallel arm study for 12 weeks|t|t|t|
1330252|NCT03202173|Non-Randomized|Single Group Assignment||Diagnostic||Triple|||t|t||t
1330253|NCT03202160|||Case-Only||Cross-Sectional|||||||
1330254|NCT03202147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330255|NCT03202134|||Cohort||Prospective|||||||
1330256|NCT03202121|||Other||Prospective|||||||
1330257|NCT03202108||Single Group Assignment||Treatment||None (Open Label)||||||
1330258|NCT03202095||Single Group Assignment||Treatment||None (Open Label)||||||
1330259|NCT03202082|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1330260|NCT03202069|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330261|NCT03202056|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330262|NCT03202043|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330263|NCT03202030|Randomized|Parallel Assignment||Treatment||Single|||||t|
1330264|NCT03202017|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1330265|NCT03202004|Randomized|Parallel Assignment||Treatment||Double|The investigator, study center staff, subject, and sponsor will be blinded to randomized study treatment assignments.||t||t|
1330266|NCT03201991||Single Group Assignment||Prevention||None (Open Label)||||||
1330267|NCT03201978|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1330268|NCT03201965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330269|NCT03201952|Randomized|Crossover Assignment||Basic Science||Single||Each volunteering subject will participate in 2 study visits, receiving the placebo at one visit and investigation medication at the other visit. The order of these visits will be randomized.|t|||
1330270|NCT03201939|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind, placebo-controlled RCT|Double-blind, placebo-controlled RCT|t|t|t|t
1330271|NCT03201926|Randomized|Parallel Assignment||Other||Single|||t|||
1330272|NCT03201913||Single Group Assignment||Treatment||None (Open Label)||Open-label, accelerated dose escalation study.||||
1330273|NCT03201900||Single Group Assignment||Treatment||None (Open Label)||||||
1330274|NCT03201887|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1330275|NCT03201874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330276|NCT03201861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330277|NCT03201848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330278|NCT03201835|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1330279|NCT03201822|Randomized|Crossover Assignment||Basic Science||Quadruple||Randomized, double-masked and cross-over dietary intervention study in healthy young adult males|t|t|t|t
1330280|NCT03201809|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two groups, conventional treatment versus experimental treatment; blocked randomization scheme||||
1330281|NCT03201796|Randomized|Parallel Assignment||Treatment||Double|The present study will be performed in double blind condition. Consequently, during the study, neither the Investigator nor the patient will be aware of the treatment assigned.|Double-blind, levofloxacin controlled, multicentre, international, prospective study.|t||t|
1330284|NCT03201757||Single Group Assignment||Treatment||None (Open Label)||Open-label||||
1330285|NCT03201744|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330286|NCT03201731|||Case-Control||Cross-Sectional|||||||
1330287|NCT03201718|||Cohort||Prospective|||||||
1330288|NCT03201705||Single Group Assignment||Treatment||None (Open Label)||||||
1330289|NCT03201692|Randomized|Parallel Assignment||Treatment||Single||||||t
1330290|NCT03201679|||Case-Control||Retrospective|||||||
1330291|NCT03201666|||Other||Prospective|||||||
1330292|NCT03201653|Randomized|Parallel Assignment||Treatment||Triple||SURGICEL group comparisons to traditional group (each performed at a nominal alpha of 0.05 and power of 0.80) in a 2:1 allocation ratio|t|t||t
1330293|NCT03201640|Randomized|Parallel Assignment||Other||Single|||||t|
1330294|NCT03201627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1330295|NCT03201614||||||||||||
1330296|NCT03201601|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330297|NCT03201588|Randomized|Parallel Assignment||Prevention||None (Open Label)||A randomized intervention study of 105+105 (number based on power analysis regarding up to date ROP frequency, see 5.1 and 11.1) infants without major malformations born with a gestational age less than 28 weeks + 0 days will be performed.||||
1330298|NCT03201575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330299|NCT03201562|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1330300|NCT03201549||Single Group Assignment||Other||None (Open Label)||||||
1330301|NCT03201536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330302|NCT03201523||Single Group Assignment||Prevention||None (Open Label)||This is a quasi-experimental, pre-post study.||||
1330303|NCT03201510|||Cohort||Prospective|||||||
1330304|NCT03201497|||Cohort||Prospective|||||||
1330305|NCT03201484|||Cohort||Prospective|||||||
1330306|NCT03201471||Single Group Assignment||Treatment||None (Open Label)||||||
1330307|NCT03201458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330308|NCT03201445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330309|NCT03201432|Randomized|Parallel Assignment||Treatment||None (Open Label)|No Masking|||||
1330310|NCT03201419|Randomized|Parallel Assignment||Treatment||Double|Each subject will receive 2 medications (an oral solution and an orally disintegrating tablet (ODT) formulation) throughout the trial, in order to keep the treatment blinded.|Following randomisation, the first 125 subjects will be treated daily with placebo, FE 201836 or desmopressin for up to 12 weeks. Subjects may hereafter be randomised to one of 8 treatment groups for 12 weeks: placebo, 6 different doses of FE 201836, or desmopressin|t||t|
1330311|NCT03201406|||Case-Only||Retrospective|||||||
1330312|NCT03201393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330313|NCT03201380|||Cohort||Retrospective|||||||
1330314|NCT03201367|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|40 patients received rivaroxaban||||
1330315|NCT03201354|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330316|NCT03201341|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1330317|NCT03201328|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330318|NCT03201315|||Cohort||Prospective|||||||
1330319|NCT03201302|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330320|NCT03201289|||Cohort||Other|||||||
1330321|NCT03201276|||Case-Only||Prospective|||||||
1330322|NCT03201263|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised controlled trial, 2 groups, 1:1 randomisation||||
1330323|NCT03201250||Single Group Assignment||Treatment||None (Open Label)||||||
1330324|NCT03201237|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330325|NCT03201224|||Cohort||Prospective|||||||
1330326|NCT03201211|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330327|NCT03201198|Randomized|Parallel Assignment||Other||Single||||||t
1330328|NCT03201185|Randomized|Parallel Assignment||Treatment||Single||Open-label||||t
1330329|NCT03201172|||Cohort||Retrospective|||||||
1330330|NCT03201159|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This is a dose escalating Phase Ib study, in which up to 3 doses of VLX103 will be assessed for safety, pharmacodynamics and pharmacokinetics in separate patient cohorts receiving sequentially increasing doses of VLX103. A maximum of 18 well-defined moderate ASH patients will be enrolled and treated in the study, i.e. 6 per dosing cohort.||||
1330331|NCT03201146|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330332|NCT03201133|||Case-Control||Retrospective|||||||
1330333|NCT03201120|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1330334|NCT03201107|Randomized|Parallel Assignment||Treatment||Triple|"The assignment to the groups will be of simple random type and hidden. Those responsible for admitting patients to the intervention phase will not know what group has been assigned each. This assignment will be made in advance by a researcher who will not intervene in the later stages of evaluation, intervention, data recording and elaboration of database. The assignment will be communicated through sealed and totally opaque envelopes.~All measurements given above will be made both to the control group and to the experimental group just prior to the start of the intervention, and immediately after and six months after the end of this period, and the results will be recorded in a data record"|Randomized controlled trial||t|t|t
1330335|NCT03201094|Randomized|Parallel Assignment||Treatment||Single||||||t
1330336|NCT03201081|Non-Randomized|Parallel Assignment||Basic Science||Single||A quasi-experimental design (2x2) was developed, dividing the participants into two groups; one experimental and one control. In this design, an initial measurement prior to the intervention (pre-test) and a measurement after the intervention (post-test) were conducted. The sampling was natural and intentional.|||t|
1330337|NCT03201068|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1330338|NCT03201055||Single Group Assignment||Treatment||None (Open Label)||||||
1330339|NCT03201042|||Cohort||Prospective|||||||
1330340|NCT03201029|||Other||Cross-Sectional|||||||
1330341|NCT03201016|||Cohort||Prospective|||||||
1330342|NCT03201003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330343|NCT03200990|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330344|NCT03200977|||Cohort||Other|||||||
1330345|NCT03200964|||Cohort||Prospective|||||||
1330346|NCT03200951|Randomized|Parallel Assignment||Treatment||Double|Participants and investigator are blinded to group assignment.|Randomly selected patients of the bolus group are given 0.3 ml/kg bolus of 0.15% ripivacaine for epidudral block. In contrast, patients in the infusion group are given 0.3 ml/kg/hr 0.15% ripivacaine for epidural block.|t||t|
1330347|NCT03200938|Randomized|Parallel Assignment||Treatment||Triple|Blind study, the patient is masked|Comparative study with same series for the two groups|t||t|t
1330348|NCT03200925|Randomized|Parallel Assignment||Health Services Research||Single|Patients will not know which arm of the trial they will be apart of until after they have consented to participate||t|||
1330349|NCT03200912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330350|NCT03200899|Randomized|Parallel Assignment||Supportive Care||Double|Care providers are not informed of the participant's participation in a particular arm. Staff collecting outcome data are not aware of the participant's assignment to intervention or usual care.|||t||t
1330351|NCT03200886|||Case-Control||Retrospective|||||||
1330352|NCT03200873|Randomized|Crossover Assignment||Treatment||Single|using a shall coil to mimic the active stimulation|crossover (real and sham stimulation) design with randomised allocation of outcome examination|t|||
1330353|NCT03200860|Randomized|Parallel Assignment||Treatment||Quadruple|double blind, placebo controlled|randomized, placebo-controlled, double-blind, parallel group, multicenter study|t|t|t|t
1330354|NCT03200847||Single Group Assignment||Treatment||None (Open Label)||||||
1330355|NCT03200834|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330356|NCT03200821|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized, open, parallel group, active comparator||||
1330357|NCT03200808||Single Group Assignment||Treatment||None (Open Label)||Pations with nonneoplastic epithelial disorders（NNEDS） of vulva.||||
1330358|NCT03200795|Randomized|Factorial Assignment||Treatment||Single|To eliminate bias, the assessment of outcome will be performed by (experienced) blinded assessors, who will be blinded to the type of intervention as well as the intervention groups of the participants. Participants will also be instructed not to disclose their individual intervention groups to the assessors|There will be 3 group, the rebound exercise group, circuit training group and the control group. The rebound exercises group will received rebound exercise therapy while circuit training will received circuit exercises that comprises progressive resistance exercise and aerobic exercises, while control group will be treated based on the guideline of the management of diabetes by international diabetes federation. Also the two exercise group will received their routine care plus exercises.|t|||
1330359|NCT03200782|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1330360|NCT03200769|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330361|NCT03200756|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330362|NCT03200743|||Case-Control||Prospective|||||||
1330363|NCT03200730|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomization will be conducted by an independent statistician. Treatment allocation (Family-oriented Dignity Intervention or Control) will be performed by block randomization with a fixed block size of two; each block will comprise of two patients with comparable terminal illness, along with their family caregiver, to reduce potential confounding effects of different illness types. Allocation concealment is facilitated by using sequentially number opaque sealed envelopes for consecutive and eligible families. To reduce the risk of bias, the researcher opens the next envelope to ascertain which group the family has been allocated to after baseline measures have been collected.||||
1330364|NCT03200717||Single Group Assignment||Treatment||None (Open Label)||||||
1330365|NCT03200704|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, open label, within patient study||||
1330366|NCT03200691||Single Group Assignment||Treatment||None (Open Label)||||||
1330367|NCT03200678|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1330368|NCT03200665|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1330369|NCT03200652||Single Group Assignment||Other||None (Open Label)||Each subject will randomly receive 3 levels of lysine provided as free amino acids, wheat, or wheat combined with lentils for a total of 8 studies x 3 days per study.||||
1330370|NCT03200639|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330371|NCT03200626|||Cohort||Prospective|||||||
1330372|NCT03200613|Randomized|Parallel Assignment||Prevention||Single|Open Label|||||t
1330373|NCT03200600|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1330374|NCT03200587||Single Group Assignment||Treatment||None (Open Label)||A phase 1B, open label, dose-finding study||||
1330375|NCT03200574||Single Group Assignment||Treatment||None (Open Label)||Prospective, multi-center trial||||
1330376|NCT03200561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330377|NCT03200548|Randomized|Parallel Assignment||Treatment||Triple|"The three acupressure formulas will be labeled acupressure set A, set B, and set C. Acupressure educators, outcome assessors, study participants, and study investigators (who will not interact with any of the study participants) will be blinded as to acupressure allocation. Only after data analysis is completed will the randomization code be unblinded. Those randomized to usual care will know that they are not receiving acupressure."|The investigators propose to perform a randomized, single-blind parallel clinical trial. This will be parallel design with four arms (relaxing acupressure plus usual care, stimulating acupressure plus usual care, sham acupressure plus usual care and usual care alone) for persistent fatigue in SLE.|t|t||t
1330378|NCT03200535|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Individuals with a body mass index between 25 and 30 are randomized 1:1 to the Usual Care or EHR Gap arms. Individuals with a body mass index >=30 are randomized to all 4 arms, with n=1000 for the Personalized Outreach arm and 1:1:1 for the other three arms.||||
1330427|NCT03199898|||Case-Only||Cross-Sectional|||||||
1330428|NCT03199885|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330429|NCT03199872||Single Group Assignment||Treatment||None (Open Label)||||||
1330379|NCT03200522|Randomized|Crossover Assignment||Other||Double|Participants and nutrition staff will be aware of randomization assignments. All other study staff and the investigators will be blinded to assignment during the study.|This is a randomized crossover pilot trial to evaluate the feasibility of a Western and prudent diet feeding study in Baltimore City adults with asthma.|||t|t
1330380|NCT03200509|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330381|NCT03200496|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1330382|NCT03200483|Randomized|Crossover Assignment||Other||Single|||t|||
1330383|NCT03200470|||Cohort||Prospective|||||||
1330384|NCT03200457||Single Group Assignment||Other||None (Open Label)||||||
1330385|NCT03200444||Single Group Assignment||Basic Science||None (Open Label)||||||
1330386|NCT03200431||Single Group Assignment||Basic Science||None (Open Label)||||||
1330387|NCT03200418||Single Group Assignment||Basic Science||None (Open Label)||||||
1330388|NCT03200405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330389|NCT03200392|Randomized|Parallel Assignment||Treatment||Single|Masking of investigator and participitants was not applicable due to surgical procedure and use of laser either for root surface bio-modification or during connective tissue harvesting. The blinded outcome assessor performed the clinical measurements at each selected defect site during the study period. She was not involved in any other part of the study protocol.|||||t
1330390|NCT03200379|||Cohort||Prospective|||||||
1330391|NCT03200366|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1330392|NCT03200353||Single Group Assignment||Other||None (Open Label)||||||
1330393|NCT03200340|Randomized|Sequential Assignment||Treatment||Double|Subjects and investigators will be blinded to treatment assignments|"2 stages: Stage 1 is a blinded parallel group safety study of 4 cohorts of 24 subjects randomized (1:1:1:1) to receive either EC-18 500 mg, 1000 mg, 2000 mg, or placebo.~Dosing will commence on the first day of radiation and continue until the last day of radiation. After of 4 weeks, an independent Data Safety Monitoring Board (DSMB) will evaluate safety endpoints in blinded fashion. DSMB assessment will be repeated after completion of dosing. Stage 2 of the study will evaluate both safety and efficacy.~Sixty (60) subjects will be randomized in a 1:1 scheme to receive placebo or EC-18 at the dose determined in Stage 1. The design of stage 2 is the same as stage 1."|t||t|
1330394|NCT03200327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330395|NCT03200314|||Cohort||Prospective|||||||
1330396|NCT03200301|Randomized|Parallel Assignment||Prevention||Single||||||t
1330397|NCT03200288|Randomized|Parallel Assignment||Treatment||Quadruple|During the course of the study only the physicians who will perform the intra-articular injection (injectors) will be unblinded. All the other physicians (assessors) and study participants will be blinded||t|t|t|t
1330398|NCT03200275|||Case-Only||Cross-Sectional|||||||
1330399|NCT03200262|||Other||Other|||||||
1330400|NCT03200249||Single Group Assignment||Treatment||None (Open Label)||||||
1330401|NCT03200236|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1330402|NCT03200223|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330403|NCT03200210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330404|NCT03200197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330405|NCT03200184||Single Group Assignment||Treatment||None (Open Label)||||||
1330406|NCT03200171|||Case-Control||Prospective|||||||
1330407|NCT03200158||Single Group Assignment||Other||None (Open Label)||||||
1330408|NCT03200145|||Cohort||Prospective|||||||
1330409|NCT03200132|||Case-Only||Cross-Sectional|||||||
1330410|NCT03200119|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330411|NCT03200106|||Case-Control||Retrospective|||||||
1330412|NCT03200093|Randomized|Parallel Assignment||Prevention||Quadruple|After enrollment, study pharmacists will randomize the participants to receive either oral vancomycin or placebo. Participants, care providers, investigators, and outcomes assessors will be masked.|Randomized, placebo-controlled|t|t|t|t
1330413|NCT03200080|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1330414|NCT03200067|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330415|NCT03200054|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1330416|NCT03200041|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1330417|NCT03200028||Single Group Assignment||Treatment||None (Open Label)||||||
1330418|NCT03200015||Single Group Assignment||Treatment||None (Open Label)||||||
1330419|NCT03200002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330420|NCT03199989|Randomized|Parallel Assignment||Treatment||None (Open Label)||a prospertive randomized clinical trial||||
1330421|NCT03199976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330422|NCT03199963|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, double blind, placebo controlled|t|t|t|t
1330423|NCT03199950|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1330424|NCT03199937|Randomized|Crossover Assignment||Treatment||Single|"Assessor and observers will be blind to the treatment. Classroom observations will be conducted by partially blind classroom observers. Though the observer will not be told which schools are assigned to which treatment condition, we found that in our last trial occasionally an observer saw treatment materials that suggested which treatment the school had been assigned to. We will make every effort to minimize this, but it may occasionally happen. The pre-post direct child assessments will also be conducted by treatment-blind assessors, as much as possible."|||||t
1330425|NCT03199924|Randomized|Parallel Assignment||Treatment||Double||Double blind study|t|t||
1330426|NCT03199911|Randomized|Parallel Assignment||Prevention||None (Open Label)|Randomization to one of two intervention arms (i.e. antibiotic ointment vs. placebo artificial tear ointment) will be performed prior to study recruitment by a qualified statistician. Patients' randomization assignments will be revealed at the initial pre-operative visit or at time that procedure consent is obtained; the study team will not be aware of a subject's randomization assignment prior to that time.|Patients will be randomized to one of two intervention arms (i.e. antibiotic ointment vs. placebo artificial tear ointment) and will not at any point cross over to the other arm.||||
1330431|NCT03199846|||Cohort||Retrospective|||||||
1330432|NCT03199833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330433|NCT03199820|Randomized|Parallel Assignment||Health Services Research||Single|The trial statistician will be blinded to group allocation.|A randomised controlled trial of feasibility||||t
1330434|NCT03199807||Single Group Assignment||Treatment||None (Open Label)||NRT+radiotherapy||||
1330435|NCT03199794|||Cohort||Prospective|||||||
1330436|NCT03199781||Single Group Assignment||Treatment||None (Open Label)||||||
1330437|NCT03199768|||Cohort||Prospective|||||||
1330438|NCT03199755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330439|NCT03199742|Randomized|Parallel Assignment||Treatment||Single||Participants are randomized to receive one of 2 forms of the mobile phone application being tested in this study: with and without personalized coaching. Among those who receive coaching, participants will receive either peer-based coaching messages, clinician-based coaching messages, or automated messages.|t|||
1330440|NCT03199729|Randomized|Parallel Assignment||Treatment||None (Open Label)||Controlled design to understand the mechanisms of adaptive interference and generalization, their interaction with retention, and how these can be applied to maximize training effects for minimizing falls-risk among older adults.||||
1330441|NCT03199716|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330442|NCT03199703|Randomized|Parallel Assignment||Treatment||None (Open Label)||150 patients will be randomized in a 1:1, single-blinded fashion to 1 of 2 transseptal groups.||||
1330443|NCT03199690||Sequential Assignment||Treatment||None (Open Label)||open label, single centre, sequential pharmacokinetic study||||
1330444|NCT03199677||Single Group Assignment||Treatment||None (Open Label)|no parallel,no control|single group,apatinib 500mg po qd,d1-28||||
1330445|NCT03199664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330446|NCT03199651|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1330447|NCT03199638|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1330448|NCT03199625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330449|NCT03199612|Randomized|Parallel Assignment||Treatment||Quadruple||Placebo controlled randomized trial with 1:1 enrollment in each study arm.|t|t|t|t
1330450|NCT03199599|||Cohort||Prospective|||||||
1330451|NCT03199586||Single Group Assignment||Treatment||None (Open Label)||||||
1330452|NCT03199573|||Case-Only||Cross-Sectional|||||||
1330453|NCT03199560|Randomized|Parallel Assignment||Diagnostic||Triple|A double-blind study. Study compound will be masked before dispensing to care team.|double-blinded randomized control trial|t|t|t|
1330454|NCT03199547|Randomized|Parallel Assignment||Prevention||Triple|The active study drug and placebo will look identical and will not be identifiable. The study drugs will be allocated to the participants according to the randomisation number|This is a Phase III, double-blind, placebo controlled randomized clinical trial. Women attending the study health facilities in labour will be randomized to receive either a single dose of oral AZI (2g) or placebo (1:1)|t||t|t
1330455|NCT03199534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330456|NCT03199521|||Cohort||Prospective|||||||
1330457|NCT03199508|Randomized|Parallel Assignment||Diagnostic||Single|According to cluster randomization, several centers use the 3-day voiding diary and the other centers use the 7-day voiding diary. Participants will be randomly assigned and don't know they are in which cluster.|The investigators use two sets of parallel controls. The experimental group use the 3-day voiding diary and the control group use the 7-day voiding diary.|t|||
1330458|NCT03199495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330459|NCT03199482|Randomized|Parallel Assignment||Treatment||Double|investigator|dexamethazone|t|t||
1330460|NCT03199469|Randomized|Sequential Assignment||Treatment||None (Open Label)||Four subjects will be enrolled at each dose level including 1 subject at each dose level randomized to control with delayed initiation of treatment. One of the dose levels will be chosen for dose expansion and all control subjects will then be treated at the chosen dose level.||||
1330461|NCT03199456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330462|NCT03199443|||Cohort||Prospective|||||||
1330463|NCT03199430|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1330464|NCT03199417|Randomized|Parallel Assignment||Treatment||Quadruple|Patients will be randomized using a random number generator to either intervention. Interventions will be identically packaged and labeled either A or B by a pharmacist who will be uninvolved with the trial administration. Participants and study personnel will be blinded to the treatment groups.|Single center blinded randomized controlled trial with a random number generator determining the allocation of patients to either the placebo or intervention groups.|t|t|t|t
1330465|NCT03199404|||Cohort||Prospective|||||||
1330466|NCT03199391|||Cohort||Prospective|||||||
1330467|NCT03199378|||Ecologic or Community||Prospective|||||||
1330468|NCT03199365|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330469|NCT03199352|||Other||Prospective|||||||
1330470|NCT03199339|Randomized|Sequential Assignment||Treatment||Single|Part 1 and Part 2 participants will be masked, Part 3 participants will not be masked.||t|||
1330471|NCT03199326|Randomized|Parallel Assignment||Supportive Care||Single|Surveys will be collected without knowledge of intervention assignment|||||t
1330472|NCT03199313|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330473|NCT03199300|||Case-Control||Cross-Sectional|||||||
1330474|NCT03199287|||Cohort||Prospective|||||||
1330475|NCT03199274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330476|NCT03199261|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1330477|NCT03199248|||Case-Only||Retrospective|||||||
1330478|NCT03199235|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1330479|NCT03199222|Randomized|Parallel Assignment||Other||Single||||||t
1330480|NCT03199209|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330481|NCT03199196|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330482|NCT03199183|||Cohort||Other|||||||
1330483|NCT03199170|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1330484|NCT03199157|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1330485|NCT03199144||Single Group Assignment||Treatment||None (Open Label)||||||
1330486|NCT03199131|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1330487|NCT03199118|Randomized|Parallel Assignment||Treatment||Single||||||t
1330488|NCT03199105|Randomized|Parallel Assignment||Treatment||Double||||t||t
1330489|NCT03199092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330490|NCT03199079|||Case-Control||Prospective|||||||
1330491|NCT03199066|||Case-Only||Prospective|||||||
1330492|NCT03199053|Randomized|Parallel Assignment||Treatment||Double|sponsor|Eligible subjects with HbA1c of 6.5% to 10.5% at screening will be randomized 1:1:1 to receive dapagliflozin 5 mg, saxagliptin 2.5 mg, or placebo. Blinded HbA1c assessment will be performed at Week 12. All subjects with Week 12 HbA1c < 7% will remain on previously assigned randomized treatment. Subjects taking dapagliflozin with Week 12 HbA1c ≥ 7% will be re-randomized in a 1:1 ratio to continue on the low-dose treatment (dapagliflozin 5 mg) or up titrate to the high-dose treatment (dapagliflozin 10 mg). Subjects taking saxagliptin with Week 12 HbA1c ≥ 7% will be re-randomized in a 1:1 ratio to continue on the low-dose treatment (saxagliptin 2.5 mg) or up-titrate to the high-dose treatment (saxagliptin 5 mg). Subjects taking placebo with Week 12 HbA1c ≥ 7% will continue on placebo treatment. All placebo subjects and all subjects taking saxagliptin or dapagliflozin with HbA1c < 7% at Week 12 will go through a dummy 2nd randomization process for maintaining the blinding.|t||t|
1330493|NCT03199040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330494|NCT03199027|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1330495|NCT03199014|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330496|NCT03199001|||Cohort||Prospective|||||||
1330497|NCT03198988||||||||||||
1330498|NCT03198975|||Cohort||Prospective|||||||
1330499|NCT03198962|||Cohort||Prospective|||||||
1330500|NCT03198949|Randomized|Crossover Assignment||Treatment||Quadruple|During baseline phase and core phase, double-blind is maintained. Only one independent investigator who check trough drug level of everolimus and and one pharmacist who dispenes IND will be exposed. All the rest of the researchers will be masked.|This is a prospective, randomized, double-blind, placebo-controlled cross over study to evaluate the efficacy and safety of everolimus (trough 5-15 ng/mL) given as adjunctive therapy in patients with FCDII who already failed more than 2 antiepileptic drugs and surgery.|t|t|t|t
1330501|NCT03198936|Randomized|Parallel Assignment||Health Services Research||Triple|Double Blind||t||t|t
1330502|NCT03198923||Single Group Assignment||Treatment||None (Open Label)||||||
1330503|NCT03198910|||Other||Retrospective|||||||
1330504|NCT03198897|||Cohort||Prospective|||||||
1330505|NCT03198884|||Case-Control||Retrospective|||||||
1330506|NCT03198871|Randomized|Parallel Assignment||Treatment||Quadruple|Participant, care provider, outcomes assessor and investigator are all blinded to the treatment allocation||t|t|t|t
1330507|NCT03198858|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1330508|NCT03198845|Randomized|Parallel Assignment||Treatment||Single|||||t|
1330509|NCT03198832|Non-Randomized|Parallel Assignment||Treatment||Double||Prospective double-blind controlled clinical study with a 6-month follow-up.|t|||t
1330510|NCT03198819|||Case-Control||Prospective|||||||
1330511|NCT03198806|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1330512|NCT03198793||Single Group Assignment||Treatment||None (Open Label)||||||
1330513|NCT03198780||Single Group Assignment||Device Feasibility||None (Open Label)||pilot study||||
1330514|NCT03198767|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1330515|NCT03198754|Randomized|Parallel Assignment||Supportive Care||Double|Neither the study participant nor the research coordinator know that study condition of the patient.||t|t||
1330516|NCT03198741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330517|NCT03198728|Randomized|Parallel Assignment||Treatment||Single|Open label||t|||
1330518|NCT03198715|Randomized|Sequential Assignment||Treatment||Single|||t|||
1330519|NCT03198702|Randomized|Parallel Assignment||Treatment||Double||"First group or toxin group: the babies will receive BOTOX injections at the age of 12 months in the shoulder muscles.~Second group or sham group:the babies receive the same procedure but no injection."|t||t|
1330520|NCT03198689||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1330521|NCT03198676|Randomized|Sequential Assignment||Diagnostic||Single||Randomised partially blinded, partially placebo controlled, repeat dose|t|||
1330522|NCT03198663|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330523|NCT03198650||Single Group Assignment||Treatment||None (Open Label)||||||
1330524|NCT03198637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330525|NCT03198624|Randomized|Parallel Assignment||Treatment||Triple|Part A open label, Part B double blind.||t|t|t|
1330526|NCT03198611|||Cohort||Prospective|||||||
1330527|NCT03198598|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330528|NCT03198585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330529|NCT03198572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330530|NCT03198559||Single Group Assignment||Treatment||None (Open Label)|Open Label|Single arm, single site,||||
1330531|NCT03198546||Single Group Assignment||Treatment||None (Open Label)||||||
1330532|NCT03198533|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330533|NCT03198520||Single Group Assignment||Treatment||None (Open Label)||||||
1330534|NCT03198507|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330535|NCT03198494|Randomized|Crossover Assignment||Treatment||Single|||t|||
1330536|NCT03198481|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330537|NCT03198468||Single Group Assignment||Treatment||None (Open Label)||||||
1330538|NCT03198455|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1330539|NCT03198442||Single Group Assignment||Health Services Research||None (Open Label)||Small cohort.||||
1330540|NCT03198429|Randomized|Factorial Assignment||Treatment||Single||Randomly assigned groups are: 1) treatment as usual; 2) embedded father intervention; 3) embedded mother-child intervention; 4) embedded father and mother-child intervention||||t
1330541|NCT03198416||Single Group Assignment||Device Feasibility||None (Open Label)||All patients who meet eligiblity will undergo HRM at the same time as the operative DISE procedure.||||
1330542|NCT03198403|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Pilot Study||||
1330543|NCT03198390|||Case-Control||Prospective|||||||
1330544|NCT03198377|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1330545|NCT03198364|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1330546|NCT03198351|||Cohort||Prospective|||||||
1330547|NCT03198338|Randomized|Parallel Assignment||Treatment||Quadruple|Drugs that are not directly involved in the study are delivered to the practitioner without specific labeling of the drug to be used in the block. The practitioner, the patient, and the observer all undergo TAP block without knowing which group the patient belongs to.|Randomized Double Blind study|t|t|t|t
1330548|NCT03198325||Single Group Assignment||Other||None (Open Label)||||||
1330549|NCT03198312|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1330550|NCT03198299|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1330551|NCT03198286||Single Group Assignment||Health Services Research||None (Open Label)||||||
1330552|NCT03198273|Randomized|Parallel Assignment||Treatment||Single|||||t|
1330553|NCT03198260|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1330554|NCT03198247|Randomized|Parallel Assignment||Treatment||Single||||||t
1330555|NCT03198234|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1330556|NCT03198221|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Participants will be receive either Golytely or Clenpiq bowel prep solutions. Both agents will either be administered as full dose the evening before or as split-dose on the evening before and on the day of the colonoscopy procedure.||||
1330557|NCT03198208|||Cohort||Prospective|||||||
1330558|NCT03198195|||Other||Prospective|||||||
1330559|NCT03198182|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1330560|NCT03198169|Randomized|Factorial Assignment||Treatment||Quadruple|Active product containers and placebo product containers will have identical labels. Product numbers to differentiate active versus placebo will be assigned and known only by the statistician.||t|t|t|t
1330561|NCT03198156|Randomized|Parallel Assignment||Treatment||Triple||"This is a 5 week randomized, sham-controlled, parallel group study involving subjects with any of the following diagnoses: Idiopathic Hypersomnia, Narcolepsy without Cataplexy, Hypersomnia in OSA patients adequately treated with PAP therapy or dental device, Posttraumatic hypersomnia, Hypersomnia, unspecified. Subjects with idiopathic hypersomnia with an MSLT mean sleep latency of >8 minutes will undergo actigraphy and those with an average sleep time of >10 hours per day will continue with the study while those with <10 hours sleep time will be excluded. OSA subjects with complaints of hypersomnia with an ESS score <10 will be excluded. Female subjects of child bearing age and not menopausal will have a pregnancy test performed.~Subjects will receive either active tDCS or sham stimulation for 30 minutes daily for 4 sessions. Subjects will be blinded as to whether they are receiving sham or active tDCS treatments."|t|t|t|
1330562|NCT03198143|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1330563|NCT03198130||Single Group Assignment||Treatment||None (Open Label)||||||
1330564|NCT03198117|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1330565|NCT03198104|||Cohort||Prospective|||||||
1330566|NCT03198091||Single Group Assignment||Treatment||None (Open Label)||||||
1330567|NCT03198078|Randomized|Parallel Assignment||Treatment||Quadruple||Subjects randomized 1:1:1 to 1 of 3 double-blind treatment arms to evaluate safety & efficacy|t|t|t|t
1330568|NCT03198065|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330569|NCT03198052||Single Group Assignment||Treatment||None (Open Label)||||||
1330570|NCT03198039|Randomized|Factorial Assignment||Prevention||Single||||||t
1330571|NCT03198026||Single Group Assignment||Treatment||None (Open Label)||||||
1330572|NCT03198013|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1330573|NCT03198000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330574|NCT03197987|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1330575|NCT03197974|Randomized|Parallel Assignment||Other||Double|"Outcomes Assessors will be blinded as to treatment allocation. To maintain blinding, the Assessor will not be involved in intervention delivery and participants will be instructed not to discuss treatment with their interviewer. When an interview leads to unblinding, the assessor will be replaced.~Participants will be blinded as to the primary hypothesis of which website will have superior benefits for QoL, but will of course be aware of the intervention they receive."|It is a prospective, parallel group, rater-blind, superiority RCT with a 1:1 allocation ratio comparing two websites designed to improve QoL in late stage bipolar disorder. Follow-up time points are immediate post-treatment (primary outcome timepoint), 3-month and 6-month follow-ups. To minimise the risk of bias, we are not publicising which arm is expected to be superior in terms of the primary outcome. Note that we expect that both arms will lead to QoL benefits, and the statistical analysis plan is agnostic about the superiority of the experimental intervention over active control on a number of secondary outcome variables. In both arms, usual management will continue throughout, with medication and psychosocial intervention changes monitored at follow-up interviews. The study setting is online, and participation in both arms will be through a secure server at Swinburne University's National eTherapy Centre (NetC).|t|||t
1330576|NCT03197961||Sequential Assignment||Other||None (Open Label)||This is a biphasic steady state pharmacokinetic and pharmacodynamic study of healthy women to evaluate the concentrations and activity of tenofovir and emtricitabine in different compartments before and after the administration of DMPA. Each participant will receive the study medications in the same order, i.e. TDF/FTC alone for 14 days followed by TDF/FTC for 14 days after having received DMPA.||||
1330577|NCT03197948|||Cohort||Prospective|||||||
1330578|NCT03197935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330668|NCT03196765||Sequential Assignment||Treatment||None (Open Label)||Sequential dose escalation||||
1330579|NCT03197922|Randomized|Parallel Assignment||Treatment||Single|Outcome measures, including the Parent-nominated Target Problem (PTP), will be conducted by separate independent evaluators (IE) each of who are blind to treatment assignment.|60 participants will be assigned to 2 weeks of the Multidisciplinary Intervention for Encopresis (MIE) treatment, 60 will be assigned to 1 week of treatment with MIE, and 30 will be assigned to treatment as usual (TAU) as a control group.||||t
1330580|NCT03197909|||Case-Control||Retrospective|||||||
1330581|NCT03197896|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1330582|NCT03197883|Randomized|Parallel Assignment||Treatment||Single||||||t
1330583|NCT03197870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330584|NCT03197857|Randomized|Crossover Assignment||Prevention||None (Open Label)|open|||||
1330585|NCT03197844|||Cohort||Prospective|||||||
1330586|NCT03197831|||Ecologic or Community||Retrospective|||||||
1330587|NCT03197818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330588|NCT03197805||Single Group Assignment||Diagnostic||None (Open Label)||Cohort longitudinal follow up||||
1330589|NCT03197792||Single Group Assignment||Screening||None (Open Label)||Patients with chronic post-embolic pulmonary hypertension eligible to pulmonary endarterectomy surgery will be evaluated for venous congestion and right ventricular failure after weaning of cardiopulmonary bypass, and followed until the 7th postoperative day for the development of postoperative organ dysfunction and/or death.||||
1330590|NCT03197779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330591|NCT03197766|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330592|NCT03197753|Randomized|Parallel Assignment||Prevention||Single|Outcomes assessor|Parallel||||t
1330593|NCT03197740|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330594|NCT03197727||Single Group Assignment||Diagnostic||None (Open Label)||||||
1330595|NCT03197714||Single Group Assignment||Treatment||None (Open Label)||Phase Ib, open-label, dose-escalation clinical trial to evaluate the best-tolerated doses in AML relapsed or refractory to chemotherapy||||
1330596|NCT03197701|||Other||Cross-Sectional|||||||
1330597|NCT03197688|||Cohort||Retrospective|||||||
1330598|NCT03197675|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330599|NCT03197662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330600|NCT03197649|Randomized|Parallel Assignment||Treatment||Single|Participant is blinded|The study patient will have one portion of their scar, measuring 5x5 cms (or 50% of the scar, for scars smaller than 5x10 cms) left untreated at the time of the study.|t|||
1330601|NCT03197636|||Cohort||Retrospective|||||||
1330602|NCT03197623|Randomized|Sequential Assignment||Treatment||Triple||Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study|t|t|t|
1330603|NCT03197610|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330604|NCT03197597|||Cohort||Retrospective|||||||
1330605|NCT03197584||Single Group Assignment||Treatment||None (Open Label)||||||
1330606|NCT03197571||Single Group Assignment||Treatment||None (Open Label)||||||
1330607|NCT03197558||||||||||||
1330608|NCT03197545|||Cohort||Other|||||||
1330609|NCT03197532|||Cohort||Prospective|||||||
1330610|NCT03197519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330611|NCT03197506||Single Group Assignment||Treatment||None (Open Label)||||||
1330612|NCT03197493|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients who complete 3 months of escalation dose carbidopa-levodopa, will receive 9 additional months of therapy with the highest dose used in protocol 0002, carbidopa-levodopa 25-100 mg 2 tablets TID. If that dose was not well tolerated in study 0002, the patient will receive the intermediate dose, carbidopa-levodopa 25-100 mg, 1 tablet TID.||||
1330613|NCT03197480|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a prospective interventional non-comparative clinical trial. Treatment received will be based on study design. All study eyes will receive intravitreal aflibercept with the initial injection given on within 2 weeks of the screening visit and x 4 monthly injections including at month 3. Patients will be evaluated 2 weeks after month 3 injection and stratified into limited/ non responder group and rapid responder group.~In the non responder group - patients will undergo ozurdex injection at month 4, followed by a monthly PRN protocol of aflibercept for month 5. Retreatment criteria is any fluid/cyst on OCT.~In responder group - patients will undergo month 4 aflibercept followed by a PRN protocol for month 5. Retreatment criteria is any fluid/cyst on OCT."||||
1330614|NCT03197467||Single Group Assignment||Treatment||None (Open Label)||||||
1330615|NCT03197454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330616|NCT03197441||Single Group Assignment||Treatment||None (Open Label)||||||
1330617|NCT03197428|Randomized|Parallel Assignment||Treatment||Single||||||t
1330618|NCT03197415||Single Group Assignment||Treatment||None (Open Label)||||||
1330619|NCT03197402|Randomized|Parallel Assignment||Treatment||Double|Double Blind|parallel group design (with repeated measurements within each group)|t||t|
1330620|NCT03197389|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1330621|NCT03197376|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1330622|NCT03197363|||Cohort||Prospective|||||||
1330623|NCT03197350|Non-Randomized|Parallel Assignment||Other||None (Open Label)||The investigators will compare two different groups: controles and HFpEF patients, in order to better understand pathophysiology in HF with preserved ejection fraction.||||
1330624|NCT03197337|Randomized|Parallel Assignment||Diagnostic||Single|The participants will not be informed prior to the experiment if they will first undergo the control manipulation or the study manipulation.||t|||
1330625|NCT03197324|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1330626|NCT03197311|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330627|NCT03197298|||Cohort||Prospective|||||||
1330628|NCT03197285|Randomized|Parallel Assignment||Treatment||Single||||||t
1330669|NCT03196752||Single Group Assignment||Other||None (Open Label)||||||
1330670|NCT03196739||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1577064|NCT00005191||||||||||||
1330629|NCT03197272|Randomized|Single Group Assignment||Treatment||Single|The participants are not aware which eye will receive the homogeneous zone treatment and which eye will receive the ring-shaped treatment.|"Prospective, single-masked intraindividually comparing randomized controlled trial. Participants will be randomized to receive ultraviolet (UV) light according to protocol A in one eye and protocol B in the other, which is masked to the participant. Both eyes will be treated during the same visit.~Protocol A: UV irradiation in a central 4 mm homogenous zone of the cornea. Protocol B: UV irradiation in a central ring-shaped 4 mm area of the cornea. Patients are randomized utilizing a computer list of unique random numbers between 1 and 120; an even number will be treated with a homogeneous zone in the right eye; an uneven number with a homogeneous zone in the left eye."|t|||
1330630|NCT03197259|||Other||Prospective|||||||
1330631|NCT03197246|Randomized|Parallel Assignment||Other||Single|The radiologist is masked/blinded in this clinical trial.|RCT, two groups||||t
1330632|NCT03197233|||Cohort||Prospective|||||||
1330633|NCT03197220|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330634|NCT03197207|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330635|NCT03197194|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330636|NCT03197181|Randomized|Crossover Assignment||Basic Science||Single|The participants are blind to whether the participants receive anodal or sham stimulation in a session.|In two separate sessions, participants receive either anodal or sham transcranial direct current stimulation while the participants are performing a decision-making task on the computer.|t|||
1330637|NCT03197168|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1330638|NCT03197155|||Cohort||Retrospective|||||||
1330639|NCT03197142|||Case-Only||Prospective|||||||
1330640|NCT03197129|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1330641|NCT03197116|Randomized|Parallel Assignment||Screening||Single|||t|||
1330642|NCT03197103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330643|NCT03197090|Randomized|Parallel Assignment||Screening||Single|||t|||
1330644|NCT03197077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330645|NCT03197064||Single Group Assignment||Treatment||None (Open Label)||A single group of up to 50 patients will be administered a standard dose of fosaprepitant 150 mg IV after induction of anesthesia. A standard neuromonitoring setup utilizing motor evoked potentials, and somatosensory evoked potentials will be used as indicated for the type of surgery. After baseline neuromonitoring measurements have been made, but prior to surgery starting, we will administer the fosaprepitant to determine if there are any effects on the motor evoked potentials or somatosensory evoked potentials measurements.||||
1330646|NCT03197051|||Other||Prospective|||||||
1330647|NCT03197038|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, controlled design with a 1:1 allocation||||
1330648|NCT03197025|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1330649|NCT03197012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"Main study: All participants will receive a single administration of intra-arterial 90Y-DOTA-TOC.~There will be a sub-study involving 10 patients from the main study who will undergo additionally correlative imaging to compare IA vs IV administration (intra-arterial 68Ga-DOTA-TOC administration and subsequent PET imaging)."||||
1330650|NCT03196999|Randomized|Parallel Assignment||Supportive Care||Single|Participants will be blind to which condition they will be in.|Participants will be assigned to either a threat attention bias modification training or a neutral bias modification training.|t|||
1330651|NCT03196986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330652|NCT03196973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330653|NCT03196960|||Cohort||Prospective|||||||
1330654|NCT03196947||Single Group Assignment||Treatment||None (Open Label)||Dose Escalation followed by an extension phase using the recommended dosage||||
1330655|NCT03196934||||||||||||
1330656|NCT03196921|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Patients with symptomatic cryptococcal meningitis will be enrolled in treatment arm Patients that are CRAG positive will be enrolled the in prevention arm||||
1330657|NCT03196908|Randomized|Crossover Assignment||Other||Double|||t||t|
1330658|NCT03196895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330659|NCT03196882|Randomized|Parallel Assignment||Prevention||Quadruple|"The study will be triple blind: the participant, the health-care professional, and the investigator-statistician. The treatment drug will be administered blind i.e. the doses are not identifiable since the packaging has the same format, presentation, and visual characteristics. For Stratum 1, the treatments will be designated as A or B, and for Stratum 2 they will be designated as C or D. The laboratory of MEIJI TEDEC FARMA, SA will be responsible for manufacturing, packaging and labeling the study medications. Only MEIJI TEDEC FARMA, SA and the Clinical Pharmacology Service of the Vall d'Hebron Hospital in Barcelona will know the distribution codes and the composition of each of the treatments."|"Multi-centered, parallel groups, controlled, triple blind, randomized clinical trial (RCT) subdivided in 2 strata as a function of the hemoglobin (Hb) levels at the start of the pregnancy:~Stratum 1: If Hb from 110 to 130 g/L, randomly assigned at week 12 to receive iron supplement of 40 or 80 mg/d.~Stratum 2: If Hb >130 g/L, randomly assigned at week 12 to receive iron supplement of 40 or 20 mg/d.~The study is structured as a RCT with 2 stratum, depending on the Hb levels before week 12 of gestation. In each stratum there are two arms of intervention. Total 4 arms."|t|t|t|t
1330660|NCT03196869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330661|NCT03196856|Randomized|Parallel Assignment||Treatment||None (Open Label)|Participants will be randomly selected to the yogurt group or a placebo group. Although participants within the yogurt group will be aware that they are consuming yogurt, the placebo group will not be aware of the contents of the placebo supplement.|Randomized Controlled Trial||||
1330662|NCT03196843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330663|NCT03196830||Single Group Assignment||Treatment||None (Open Label)||||||
1330664|NCT03196817|Randomized|Crossover Assignment||Treatment||Single|||||t|
1330665|NCT03196804|Randomized|Parallel Assignment||Treatment||Double|Double-blind||t||t|
1330666|NCT03196791|Randomized|Parallel Assignment||Other||Double|||t||t|
1330667|NCT03196778||Single Group Assignment||Treatment||None (Open Label)||||||
1330671|NCT03196726|Randomized|Parallel Assignment||Treatment||Double|"Participants randomized by offering 2 opaque envelope to group them into either as control or intervention group.~Medical officers were responsible in the management of all participants using standard Clinical Practice Guideline (CPG). Participants from intervention group will see Medical Officer first before being given CBT by nurse"|Management of postnatal depression mothers at primary care clinics using Cognitive-behavioural therapy treatment by nurses as adjunct to management by Medical Officer in intervention arm, compared to management by Medical Officer alone in control arm.|t|t||
1330672|NCT03196713|Randomized|Parallel Assignment||Health Services Research||Single||Pragmatic RCT||||t
1330673|NCT03196700||Single Group Assignment||Treatment||None (Open Label)||||||
1330674|NCT03196687|||Cohort||Prospective|||||||
1330675|NCT03196674|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1330676|NCT03196661|Randomized|Parallel Assignment||Health Services Research||Quadruple|This trial achieved the goal of random and blind method through blinded method for vaccine. All the testing vaccines and reference vaccines are provided by sponsor, and entrust Medical statistics unit to blind.|Subjects were inoculated with influenza A (H7N9) virus inactivated vaccine/split influenza vaccine or placebo.|t|t|t|t
1330677|NCT03196648|Randomized|Parallel Assignment||Treatment||Single||||t||
1330678|NCT03196635||Single Group Assignment||Screening||None (Open Label)||||||
1330679|NCT03196622||Single Group Assignment||Prevention||None (Open Label)|Open|||||
1330680|NCT03196609||Single Group Assignment||Diagnostic||None (Open Label)||"This cohort will consist of 55 patients as described below:~non-small cell lung cancer (NSCLC)~hepatocellular cancer:~colorectal cancer~breast cancer~prostate cancer~glioblastoma"||||
1330681|NCT03196596|||Cohort||Prospective|||||||
1330682|NCT03196583||Single Group Assignment||Treatment||None (Open Label)||Monocentric, prospective, open-label, interventional, exploratory pilot study.||||
1330683|NCT03196570|Randomized|Parallel Assignment||Prevention||Single||||||t
1330684|NCT03196557|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1330685|NCT03196544|Randomized|Parallel Assignment||Treatment||Single||||||t
1330686|NCT03196531|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1330687|NCT03196518||Single Group Assignment||Diagnostic||None (Open Label)||This is a pilot study evaluating the safety, radiation dosimetry and detection capability of 18F-tetrafluoroborate (18F-TFB), a novel tracer for sodium-iodine symporter (NIS) imaging.||||
1330688|NCT03196505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330689|NCT03196492|||Cohort||Prospective|||||||
1330690|NCT03196479|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330691|NCT03196466|||Cohort||Retrospective|||||||
1330692|NCT03196453|Randomized|Parallel Assignment||Treatment||Triple||double blind, placebo controlled,|t||t|t
1330693|NCT03196440|||Other||Cross-Sectional|||||||
1330694|NCT03196427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330695|NCT03196414||Single Group Assignment||Treatment||None (Open Label)||||||
1330696|NCT03196401||Single Group Assignment||Treatment||None (Open Label)||This is an open-label, single center, single-arm pilot study of checkpoint blockade therapy (anti-PD-L1) plus radiation.||||
1330697|NCT03196388||Single Group Assignment||Treatment||None (Open Label)||||||
1330698|NCT03196375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330699|NCT03196362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330700|NCT03196349|Randomized|Parallel Assignment||Treatment||Single||||||t
1330701|NCT03196336|Randomized|Parallel Assignment||Health Services Research||Single||Pharmacotherapeutic follow-up care known as Pharmacotherapy Workup.|t|||
1330702|NCT03196323|||Cohort||Prospective|||||||
1330703|NCT03196310|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded to therapy they receive||t|||
1330704|NCT03196297||Single Group Assignment||Treatment||None (Open Label)||||||
1330705|NCT03196284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330706|NCT03196271||Single Group Assignment||Other||None (Open Label)||||||
1330707|NCT03196258|Randomized|Parallel Assignment||Prevention||None (Open Label)|Eligible participants will be randomized to 1 of 2 groups: 1) CBT intervention or 2) standard of care. Due to the nature of the intervention, it will not be feasible to blind participants, treating surgeons, or CBT therapists to treatment allocation. The data analyst and Steering Committee will be blinded to treatment allocation|Participants with operatively managed extremity fractures who screen positive for unhelpful illness beliefs (SPOC scores ≥78) 6-weeks post-fracture fixation will be randomized to receive either 6 weekly one-on-one, 1-hour sessions of cognitive behavioral therapy (CBT) or standard of care (control). Outcomes will be assessed at 3 months, 6 months, 9 months, and 12 months' post-fracture||||
1330708|NCT03196245|||Cohort||Prospective|||||||
1330709|NCT03196232||Single Group Assignment||Treatment||None (Open Label)||||||
1330710|NCT03196219|Randomized|Sequential Assignment||Treatment||Single|In the single-blind Study Arm 2, active and placebo will be identical in appearance and labeled in a blinded fashion|Study Arms 1 and 2 will be enrolled in parallel followed by Study Arm 3.|t|||
1330711|NCT03196206|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330712|NCT03196193|Randomized|Parallel Assignment||Treatment||Quadruple|(Investigational group) or ZMM CM Asia without AS2 technique (Control group). The randomization scheme is based on equal numbers per group. The randomization will occur via a random number generator (computer) using a blocked randomization procedure. The block size will not be disclosed to the sites, and the doctor or other health care professional will not have influence on the randomization scheme. Sealed opaque envelopes, which will be prepared based on predetermined randomization assignment, will be provided to each study site before study initiation.|At surgery, intervention group using ZNN CM Asia with AS2 technique. At surgery, conventional group using ZNN CM Asia without AS2 technique.|t|t|t|t
1330713|NCT03196180||Single Group Assignment||Treatment||None (Open Label)||||||
1330794|NCT03195127|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||Up to 75 patients will be screened with a goal of enrolling 40 for participate in the intervention trial (20 in the multimodal treatment arm and 20 in a group receiving usual care).||||
1330714|NCT03196167|Randomized|Parallel Assignment||Supportive Care||Quadruple|The administration of the study and placebo compounds will be performed by CTICU nurses who will receive the drugs in a blinded fashion from the departmental research pharmacy.|Patients will be enrolled using 1:1 randomization between active ingredient (intervention) and control arms, to be assigned randomly using a computer generated algorithm.|t|t|t|t
1330715|NCT03196154|||Case-Control||Cross-Sectional|||||||
1330716|NCT03196141|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||3 groups: healthy volunteers (15) and normotensive (10) and pre-eclamptic (10) pregnant women during their visit to labor floor.||||
1330717|NCT03196128|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330718|NCT03196115|||Cohort||Prospective|||||||
1330719|NCT03196102|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330720|NCT03196089|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1330721|NCT03196076|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1330722|NCT03196063|Randomized|Parallel Assignment||Treatment||Single||||||t
1330723|NCT03196050|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1330724|NCT03196037||Single Group Assignment||Other||None (Open Label)||A single-arm pre-/post-test non-randomized study design.||||
1330725|NCT03196024|Randomized|Parallel Assignment||Prevention||Triple|Participants, community health workers, and assessors are blinded to which arm is the active intervention and which arm is the active comparator. Participants, community health workers, and assessors will be blinded to hypotheses regarding group differences and will be informed that both groups are intervention groups and that we are examining how well both intervention types perform.|We will conduct a randomized controlled trial with Hispanic family dyads using a 2-group design (Corazón de la Familia active intervention versus control condition) to test effects of a type 2 diabetes and CVD risk reduction intervention at 3 (short-term) and 12 (long-term) months. For dyads randomized to the active intervention, the participant with 2 or more CVD or type 2 diabetes risk factors (index participant) and their co-participating family member will attend 8 sessions that provide type 2 diabetes and CVD risk reduction and lifestyle modification education. For dyads randomized to the control condition, only the index participant will attend 8 educational lifestyle modification sessions. Participants in both groups will receive monthly follow up phone calls up through 12 months post-baseline. The sessions for both the intervention and the control group and the monthly post-intervention phone calls will be provided by community health workers.|t|t||t
1330726|NCT03196011|Randomized|Parallel Assignment||Treatment||Double||Prospective, randomised controlled trial with 2 intervention arms|t|||t
1330727|NCT03195998|||Case-Only||Prospective|||||||
1330728|NCT03195985|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330729|NCT03195972|||Cohort||Prospective|||||||
1330730|NCT03195959|||Case-Control||Cross-Sectional|||||||
1330731|NCT03195946||Single Group Assignment||Treatment||None (Open Label)||||||
1330732|NCT03195933|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1330733|NCT03195920||Single Group Assignment||Treatment||None (Open Label)||Single arm trial with the Enhanced Lithotripsy System||||
1330734|NCT03195907|||Case-Control||Prospective|||||||
1330735|NCT03195894|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||A randomized, controlled, open study to compare conventional treatment with and without addition of TripleA||||
1330736|NCT03195881|||Cohort||Prospective|||||||
1330737|NCT03195868||Single Group Assignment||Treatment||None (Open Label)||Single group, prospective cohort||||
1330738|NCT03195855|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1330739|NCT03195842|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1330740|NCT03195829|Randomized|Parallel Assignment||Prevention||Double||Randomized controlled pilot study, single blind|t|||t
1330741|NCT03195816|Randomized|Parallel Assignment||Prevention||Double||Comparison between experimental group and control group.|t|||t
1330742|NCT03195803|Non-Randomized|Parallel Assignment||Prevention||Double||Comparison, non-randomized single blind study|||t|t
1330743|NCT03195790|Randomized|Parallel Assignment||Treatment||Double|Outcomes assessors, PI, and some co-investigators will be blinded to group assignment.|Randomized controlled trial|||t|t
1330744|NCT03195777||Single Group Assignment||Diagnostic||None (Open Label)|Investigators who are analyzing images will be blinded to all clinical data, including clinical follow-up data to determine PTS|This study is a one-center observational study examining DVT with FDG- PET/CT. 80 individuals with DVT will be imaged with PET/CT and followed for development of PTS||||
1330745|NCT03195764||Single Group Assignment||Treatment||None (Open Label)||||||
1330746|NCT03195751|||Cohort||Prospective|||||||
1330747|NCT03195738||Single Group Assignment||Treatment||None (Open Label)||||||
1330748|NCT03195725|||Cohort||Retrospective|||||||
1330749|NCT03195712|||Cohort||Retrospective|||||||
1330750|NCT03195699||Single Group Assignment||Treatment||None (Open Label)||||||
1330751|NCT03195686|||Case-Only||Prospective|||||||
1330752|NCT03195673|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1330753|NCT03195660||Single Group Assignment||Treatment||None (Open Label)||Prospective, single-arm, un-blinded, multi-center||||
1330754|NCT03195647|Randomized|Parallel Assignment||Treatment||Single||||||t
1330755|NCT03195634|||Cohort||Prospective|||||||
1330756|NCT03195621|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||2 groups||||
1330757|NCT03195608||Single Group Assignment||Device Feasibility||None (Open Label)|Outcomes assessor will be masked regarding the pre or post-test status of the assessment.|||||
1330758|NCT03195595|||Case-Control||Retrospective|||||||
1330795|NCT03195114|||Cohort||Prospective|||||||
1330796|NCT03195101||Single Group Assignment||Treatment||None (Open Label)||Incisional or excisional biopsy of orbital tumors via transconjunctival approach||||
1330797|NCT03195088|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330837|NCT03194568||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1330838|NCT03194555|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1330759|NCT03195582|Randomized|Parallel Assignment||Prevention||Double|The study will be single blinded. The examiners of the clinical measurements, ELISA samples and the radiographs will be blinded to the patient's group.|"patients will be divided randomly in to 2 groups:~Control: following uncovering of the implant a 4 mm height healing abutment will be screwed to the implant (the standard treatment modality) without using CHX gel or any other gel.~Test group: following implant exposure this group will receive CHX 1% gel (Corsodyl®) the gel will be applied on the abutment as well as on the implant internal hex and then a 4 mm healing abutment will be connected."|||t|t
1330760|NCT03195569|||Case-Control||Prospective|||||||
1330761|NCT03195556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1330762|NCT03195543|||Cohort||Prospective|||||||
1330763|NCT03195530|||Cohort||Prospective|||||||
1330764|NCT03195517|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This was an interventional, single group assignment study in which the subjects were first assigned to the control group and, after 1-month interval with no physical training, were shifted into the 3-months exercise intervention group. Thus, the subjects acted as their own control at the end of the study.||||
1330765|NCT03195504|Randomized|Parallel Assignment||Treatment||Single||Consented patients will be randomly assigned either to the interventional group (High Flow Nasal Cannula- HFNC) or to the control group (CON). The Group HFNC will be preoxygenated using HFNC and the Group CON will receive standard preoxygenation.|t|||
1330766|NCT03195491||Single Group Assignment||Treatment||None (Open Label)||||||
1330767|NCT03195478|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330768|NCT03195465||Single Group Assignment||Supportive Care||None (Open Label)||||||
1330769|NCT03195452||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1330770|NCT03195439||Single Group Assignment||Diagnostic||None (Open Label)||||||
1330771|NCT03195426||Single Group Assignment||Treatment||None (Open Label)||This study aims at assessing the effectiveness of combined SSNB, ICB and supraclavicular nerve block (SCNB) as surgical anesthesia for patients scheduled for arthroscopic shoulder surgery. The secondary objective was to test the hypothesis that SSNB-ICB-SCNB combination could spare phrenic nerve.||||
1330772|NCT03195413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330773|NCT03195400|||Cohort||Prospective|||||||
1330774|NCT03195387|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1330775|NCT03195374|||Other||Prospective|||||||
1330776|NCT03195361||Single Group Assignment||Treatment||None (Open Label)||||||
1330777|NCT03195348||Single Group Assignment||Diagnostic||None (Open Label)||||||
1330778|NCT03195335|||Case-Only||Prospective|||||||
1330779|NCT03195322||Single Group Assignment||Treatment||None (Open Label)||||||
1330780|NCT03195309|Randomized|Parallel Assignment||Treatment||Triple|Participant do not know which formula they are receive. Nor do the daily care providers.|All patients were received epidural anesthesia with 2% Lidocaine and patient-controlled epidural analgesia (PCEA) for post- operative pain control. PCEA randomly allocated into three groups. Group A patients received 0.08% ropivacaine plus 4 mcg /mL fentanyl, Group B patients received 0.08% ropivacaine plus 2mcg /mL fentanyl, and Group C patients received 0.16 % ropivacaine plus 2 mcg /mL fentanyl. Dermographic data, dosage of PCEA during first 48 hours post-operation，NRS scores, patient satisfaction and the intensity of motor block will be recorded and analyzed.|t|t|t|
1330781|NCT03195296|||Case-Only||Prospective|||||||
1330782|NCT03195283|||Cohort||Prospective|||||||
1330783|NCT03195270||Single Group Assignment||Diagnostic||None (Open Label)||Participants will be recruited based on established criteria for chronic pain. For the PET/MRI scan, the participants will be injected with 10 mCi±1 mCi of [18F]FTC-146 via the antecubital vein in a bolus injection. PET and MRI scans will be acquired simultaneously using a hybrid PET/MRI scanner. Following the scan, participants will be contacted to check for adverse drug events, and any events will be recorded in the case report. The biodistribution of radiotracer will be analyzed using regions of interest (ROI) marked on anatomical structures on magnetic resonance images and quantifying the signal in PET images within the same ROIs. Pharmacokinetic information will be derived using mathematical modeling. Data from chronic pain patients will be compared to historical data from asymptomatic controls.||||
1330784|NCT03195257|Randomized|Crossover Assignment||Basic Science||Triple|Randomized, double-blinded, cross-over study with 5 study days.||t|t|t|
1330785|NCT03195244|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330786|NCT03195231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330787|NCT03195218||Single Group Assignment||Diagnostic||None (Open Label)||Trial with a single arm||||
1330788|NCT03195205||Single Group Assignment||Diagnostic||None (Open Label)||||||
1330789|NCT03195192||Single Group Assignment||Other||None (Open Label)|Open-label|||||
1330790|NCT03195179|||Cohort||Prospective|||||||
1330791|NCT03195166||Single Group Assignment||Diagnostic||None (Open Label)|consecutive patient|"The aim of this study was to investigate the hemodynamic effects of continuous spinal anesthesia in elderly patients. An oral intake of 250 ml of water was taken 2 hours before surgery.~Radial arterial catheter was putted under local anesthesia and connected to the FloTrac sensor/Vigileo haemodynamic monitoring system.~Fluid therapy was limited to 4 ml/kg/h until tourniquet release.~Subarachnoid puncture was performed at the L3-S1 interspace. An initial dose of 2,5 mg isobaric 0,5% bupivacaine was injected. Additional 2,5 mg isobaric 0,5% bupivacaine doses were injected every 10 minutes until sensory blockade reached T10.~Ephedrine 6 to 9 mg was given if systolic arterial pressure < 90 mmHg. Investigators measured blood pressure (systolic, diastolic and mean), stroke volume and cardiac output every 5 minutes from beginning of the operation and until 2 hours after the end.~Number of hypotension episodes and ephedrine consumption were noted."||||
1330792|NCT03195153|Randomized|Crossover Assignment||Treatment||Single|||||t|
1330793|NCT03195140|Randomized|Crossover Assignment||Treatment||None (Open Label)||"Multi-center, randomized, crossover design, consisting of two 3-week periods, with the PLGS System used during one period and SAP therapy used during the other period. The crossover trial will be preceded by a run-in phase in which participants may receive training using the study devices.~For 10 adult participants, a PLGS Pilot Period will proceed to the crossover trial to ensure safety and usability objectives are met prior to the start of the crossover trial."||||
1330928|NCT03193385|||Cohort||Prospective|||||||
1330798|NCT03195075|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will include 40 consecutive jaundiced patients with distal malignant biliary obstruction after failed endoscopic retrograde cholangio-pancreaticography. Twenty patients with failed endoscopic retrograde cholangio-pancreaticography will be subjected to endoscopic ultrasonography-guided biliary drainage will be performed by single endoscopist and another 20 patients with failed endoscopic retrograde cholangio-pancreaticography for percutaneous trans-hepatic biliary drainage.||||
1330799|NCT03195062||Single Group Assignment||Basic Science||None (Open Label)||||||
1330800|NCT03195049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330801|NCT03195036|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This study utilizes a cluster-randomized trial (CRT) design in order to evaluate the impact of the KIDSS ECD program delivered by Catholic Relief Services, specifically the home visiting component, on child development outcomes and utilization of HIV testing services. The main reason for including randomization is to reduce the risk of selection bias. The unit of inference for this CRT is at the individual level but the unit of randomization is the health facility (cluster) level due to issues of program feasibility.||||
1330802|NCT03195023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330803|NCT03195010|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330804|NCT03194997|Randomized|Factorial Assignment||Treatment||Double||Randomized clinical trial, three arm study (group 1 - Dance; group 2 - Pilates and group 3 - Control), doubled blinded.|t||t|
1330805|NCT03194984|Randomized|Parallel Assignment||Treatment||Triple|the patient did not know in which region each gel was applied the investigator did not know in which region each gel was applied the outcomes assessor did not know in which region each gel was applied|range of patients aged 18 to 25 years receiving two types of geis and range of patients aged 40-65 years receiving two types of geis|t||t|t
1330806|NCT03194971|||Other||Retrospective|||||||
1330807|NCT03194958|Randomized|Factorial Assignment||Health Services Research||Double|||t|||t
1330808|NCT03194945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330809|NCT03194932||Single Group Assignment||Treatment||None (Open Label)||Participants receive venetoclax plus cytarabine alone or combination chemotherapy of cytarabine plus idarubicin.||||
1330810|NCT03194919|Randomized|Parallel Assignment||Prevention||None (Open Label)|"The recruitment procedure and the treatment is fully automated and delivered by web, e-mail and SMS-textmessages - i.e., the participant is not contacted by any care providers, investigators or assessors during recruitment or treatment~- and data are collected by means of web-based questionnaires."|Participants receive one out of two versions of a web-based smoking cessation program. Either with or without the option of negotiating and re-negotiating the quit date.||||
1330811|NCT03194906|Randomized|Parallel Assignment||Supportive Care||Quadruple||Randomized, double-blind, placebo-controlled trial design.|t|t|t|t
1330812|NCT03194893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1330813|NCT03194880|||Cohort||Prospective|||||||
1330814|NCT03194867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330815|NCT03194854|Randomized|Parallel Assignment||Treatment||Double|Participants who have completed the full online T1 battery will be randomly assigned in real-time by the computer to either the intervention condition or the UC control condition. Randomization, group assignment, and assessments will be conducted solely by the computer program, so researchers will be blind to participant randomization, group assignment, and participant group identity during assessment times. With regard to group size and power, experience from our prior efficacy study of FFW indicates that for the current study, the computer program will use a 1:1 randomization algorithm.|The intervention group will be compared to a usual care (UC) control group on outcomes of self-efficacy, physical activity, and well-being. The intervention group will participate in online activities for 30 days while UC control group participants will be asked to conduct their lives as usual for the same 30 day period. Both groups will complete assessments during this time period. The UC group will be given access to the intervention for 30 days after all study participants have completed the three survey battery administrations.|||t|t
1330816|NCT03194841||Single Group Assignment||Supportive Care||None (Open Label)||||||
1330817|NCT03194828|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1330818|NCT03194815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330819|NCT03194802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330820|NCT03194789|Randomized|Parallel Assignment||Treatment||Single|Randomized single blinded (evaluator) controlled trial. The outcomes assessor will be masked in the study. Assessor will be independent of randomization, trial coordination and care providers.|Single blinded (evaluator), single-center, randomized controlled trial Interventional and Control group.||||t
1330821|NCT03194776|Randomized|Parallel Assignment||Treatment||Double||Randomized, patient and investigator-blinded, placebo controlled, parallel group study|t||t|
1330822|NCT03194763|||Case-Only||Prospective|||||||
1330823|NCT03194750|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1330824|NCT03194737|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330825|NCT03194724|||Case-Only||Cross-Sectional|||||||
1330826|NCT03194711|||Case-Only||Retrospective|||||||
1330827|NCT03194698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330828|NCT03194685|Randomized|Sequential Assignment||Treatment||None (Open Label)|Open Label|||||
1330829|NCT03194672|Randomized|Parallel Assignment||Other||Single||||||t
1330830|NCT03194659|Randomized|Parallel Assignment||Basic Science||Triple|All investigators interacting with participants will be masked to the study arm assignment. Only the Primary Investigator and Laboratory Manager (prepares supplements) will have access to participant's study assignment.||t|t||t
1330831|NCT03194646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330832|NCT03194633|||Cohort||Prospective|||||||
1330833|NCT03194620|Randomized|Crossover Assignment||Basic Science||Quadruple||Randomized, double-masked and cross-over dietary intervention study in healthy young adult males|t|t|t|t
1330834|NCT03194607|||Other||Prospective|||||||
1330835|NCT03194594|Randomized|Parallel Assignment||Treatment||Quadruple|double blinded||t|t|t|t
1330836|NCT03194581|||Case-Only||Prospective|||||||
1330839|NCT03194542||Single Group Assignment||Treatment||None (Open Label)||||||
1330840|NCT03194529||Single Group Assignment||Other||None (Open Label)||Primary outcome is safety in children with Crohn's disease in remission.||||
1330841|NCT03194516|||Case-Only||Prospective|||||||
1330842|NCT03194503|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330843|NCT03194490|Randomized|Parallel Assignment||Treatment||Single||||||t
1330844|NCT03194477|Randomized|Parallel Assignment||Health Services Research||Single|Care providers and investigators will not know which patients are randomized to intervention or control.|Mobile-enhanced engagement interventions (MEI) to support 1) HIV viral suppression among HIV-positive, not virally suppressed participants; 2) HIV-PrEP uptake among high-risk HIV-negative participants; and 3) engagement in substance abuse treatment for HIV-positive and HIV-negative participants.||t||
1330845|NCT03194464|||Cohort||Cross-Sectional|||||||
1330846|NCT03194451|||Case-Only||Prospective|||||||
1330847|NCT03194438||Single Group Assignment||Treatment||None (Open Label)||Single cohort of sample with repeated measure assessment of symptoms.||||
1330848|NCT03194425|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1330849|NCT03194412|Non-Randomized|Factorial Assignment||Supportive Care||None (Open Label)||"The group of participants involved to the study:~n=60 ( at least 30) to diet /nutritional - intervention group 1~n=60 ( at least 30) to physical activity - intervention group 2~n=60 ( at least 30) to comprehensive therapy (diet/nutritional+physical activity training) - intervention group 3~n=30 (at least 15) formal and informal caregivers of elderly - intervention group 4~n=60 ( at least 30) to control group without intervention - group 5~Evaluation process:~Screening Evaluation (stage 1)- investigated within 0~Baseline Evaluation (stage 2) - after 3 months from 0~Final Evaluation (stage 3) - after 6 months from 0 Professionals involved in the interventions: physicians, general practitioners, physiotherapists, rehabilitation professionals, educators, nurses, volunteers, nutrition consultant."||||
1330850|NCT03194399||Single Group Assignment||Supportive Care||None (Open Label)||||||
1330851|NCT03194386|Randomized|Parallel Assignment||Prevention||Single|Investigator / Outcomes Assessor||||t|
1330852|NCT03194373||Single Group Assignment||Treatment||None (Open Label)||||||
1330853|NCT03194360|||Case-Control||Retrospective|||||||
1330854|NCT03194347|||Cohort||Prospective|||||||
1330855|NCT03194334|Randomized|Parallel Assignment||Basic Science||Triple|A co-worker, not involved in the study design and analysis, will perform the randomisation and will prepare the containers with supplements. Only the control group will know that they are part of the control group (continuing omnivorous diet). For the vegetarian groups, subject will not know whether they are in the supplemented group or not because placebo supplements will be used|The study was scheduled over a period of 6 months. Of the 40 subjects, 10 women will continue their omnivorous diet throughout the entire study (controls) and the other 30 subjects will switch to a lacto-ovo-vegetarian diet for 6 months. The vegetarian group will be split in 2 groups, matched for age, weight, height and baseline carnosine concentrations in soleus and gastrocnemius medialis muscles. Fifteen of them will be supplemented with beta-alanine and creatine (Veg+Suppl) and the other 15 women will receive a placebo (Veg+Pla).|t||t|t
1330856|NCT03194321||Single Group Assignment||Treatment||None (Open Label)||||||
1330857|NCT03194308|||Cohort||Prospective|||||||
1330858|NCT03194295|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1330859|NCT03194282|Randomized|Crossover Assignment||Screening||Single|||t|||
1330860|NCT03194269||Single Group Assignment||Treatment||None (Open Label)||||||
1330861|NCT03194256|Randomized|Parallel Assignment||Other||Triple|Participants will be blind to the nicotine content of their assigned study cigarette and the nicotine dose of the e-liquid in the study vaping device. Investigators, research staff, and biostatisticians will also be blind to the conditions. E-liquid flavors will not be blinded.|Mixed between subjects and within-subjects design. Random assignment to the between subjects factor (nicotine content in cigarettes), within-subjects manipulation of nicotine concentration and flavors in e-liquid in the electronic cigarettes|t||t|t
1330862|NCT03194243|||Cohort||Prospective|||||||
1330863|NCT03194230|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330864|NCT03194217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330865|NCT03194204|||Case-Control||Prospective|||||||
1330866|NCT03194191|Randomized|Parallel Assignment||Treatment||Single|Single blind (patient blinded to intervention)|"Randomized controlled trial with regular acupuncture needles vs. sham needles. In addition, the sham needles will be placed in areas that do not correspond to any known acupuncture point.~5 bilateral acupoints or placebo acupoints,"|t|||
1330867|NCT03194178|||Case-Only||Prospective|||||||
1330868|NCT03194165|||Cohort||Retrospective|||||||
1330869|NCT03194152|Randomized|Parallel Assignment||Prevention||None (Open Label)||Parallel design with two intervention arms||||
1330870|NCT03194139|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1330871|NCT03194126|Randomized|Parallel Assignment||Other||Single|The primary outcome will be evaluated by a blinded evaluator: the laminaria placement is performed by the on-call team at Day-1, whilst the delivery is performed by a different team at Day 0, with the laminaria removed in the morning.|||||t
1330872|NCT03194113|Randomized|Parallel Assignment||Treatment||Single||||||t
1330873|NCT03194100|||Case-Control||Prospective|||||||
1330874|NCT03194087|||Cohort||Prospective|||||||
1330875|NCT03194074|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1330876|NCT03194061||Single Group Assignment||Treatment||None (Open Label)||||||
1330877|NCT03194048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330878|NCT03194035|||Cohort||Prospective|||||||
1330879|NCT03194022|||Cohort||Prospective|||||||
1330880|NCT03194009|Randomized|Parallel Assignment||Prevention||None (Open Label)||Primary health care clinics will be allocated to one of the two arms of the intervention. A) lifestyle modification, B) Metformin and lifestyle modification||||
1330881|NCT03193996||Single Group Assignment||Diagnostic||None (Open Label)||||||
1330926|NCT03193411|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330927|NCT03193398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1330882|NCT03193983|Randomized|Parallel Assignment||Treatment||None (Open Label)||"two groups Surgical group will undergo surgical coverage of the fingertip defect by V-Y flap using the skin on the volar aspect of the same finger designed as V shaped then mobilized dorsally to cover the defect and stitches to be Y shaped. Stitches are removed after 2 weeks.~Conservative group will undergo minimal trimming of the bone end and an occlusive dressing that is changed on a weekly basis till complete healing of the defect that occurs after 6 weeks."||||
1330883|NCT03193970|||Cohort||Prospective|||||||
1330884|NCT03193957||Single Group Assignment||Other||None (Open Label)||||||
1330885|NCT03193944|Randomized|Parallel Assignment||Treatment||None (Open Label)||A detailed explanation on research design, location and population, sampling technique, sample size, instrument, data collection, data analysis and potential limitations of the study are outlined in the following sections. This study aims to find relationships between food insecurity, vitamin D intakes and its impact on metabolic syndrome among older adults in a city in Alborz province in Iran, known as Karaj. This study has 2 parts; the first part is to determine the prevalence of food insecurity and vitamin D deficiency among older adults in Karaj city. The second part is an intervention study examining effects of vitamin D supplementation on metabolic syndrome (diabetes, obesity, hypertension, and dyslipidaemia) among older adults who has at least have risk factors of metabolic syndrome, food insecure and vitamin D deficient. The intervention group will receive vitamin D supplementation 50000 IU for 8 weeks.||||
1330886|NCT03193931|Randomized|Parallel Assignment||Treatment||None (Open Label)|opern label|Patients recieve pembrolizumab or methotrexate||||
1330887|NCT03193918||Single Group Assignment||Treatment||None (Open Label)||||||
1330888|NCT03193905|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330889|NCT03193892|||Cohort||Prospective|||||||
1330890|NCT03193879|||Cohort||Prospective|||||||
1330891|NCT03193866|||Cohort||Other|||||||
1330892|NCT03193853||Single Group Assignment||Treatment||None (Open Label)||Patients with metastatic TNBC who meet the enrollment criteria will receive TAK-228 and TAK-117 until disease progression followed by nab paclitaxel plus cisplatin.||||
1330893|NCT03193840||Single Group Assignment||Treatment||None (Open Label)||||||
1330894|NCT03193827|Randomized|Parallel Assignment||Prevention||Double||Two hundred and sixty-eight patients undergoing surgery are randomised 1:1 to in-line filtration (study group) and standard care (control group). For patients randomize to in-line filtration, in-line filters (Pall, Dreieich, Germany) are used during anaesthesia and the following 96 postoperative hours. Patients randomize to standard care (control group) are managed without an in-line filter and according to local routine practice for intravenous drug administration in the adult patient. The incidence and severity of phlebitis are evaluated using the Visual Infusion Phlebitis (VIP) Score23 every 12 hrs from the end of surgery until 96 hrs postoperatively in both groups. Time and severity of phlebitis and time and causes for venous cannula removal are all compared between groups.||t|t|
1330895|NCT03193814||Single Group Assignment||Treatment||None (Open Label)||||||
1330896|NCT03193801||Single Group Assignment||Treatment||None (Open Label)||||||
1330897|NCT03193788|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|||||
1330898|NCT03193775|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|"Group I: inactive carriers (n=100). Group II: CHB exposed to nucleos(t)ides (n=120) till 6 months after HBe seroconversion and HBV DNA disappearance in HBeAg positive (n=60) or DNA disappearance in HBeAg negative patients (n=60). All showed persistent HBs antigenemia.~-A control group (n=100) did not receive HBV vaccine"||||
1330899|NCT03193762|||Case-Only||Prospective|||||||
1330900|NCT03193749|Randomized|Parallel Assignment||Treatment||Quadruple|Matching placebo||t|t|t|t
1330901|NCT03193736||Single Group Assignment||Treatment||None (Open Label)||||||
1330902|NCT03193723|Randomized|Parallel Assignment||Treatment||Triple|Single blinded|A Randomized Controlled study.|t||t|t
1330903|NCT03193710|||Case-Control||Prospective|||||||
1330904|NCT03193697|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330905|NCT03193684|Randomized|Parallel Assignment||Basic Science||Double|the study is placebo controlled double blinded. randomization will be made by pharmacist and the randomization code will be kept in the pharmacy|subjects will receive in parallel a treatment with dapagliflozin or placebo for 3 months hepatic glucose metabolism and norepinephrine turnover will be studied before and after treatment|t||t|
1330906|NCT03193671|||Cohort||Prospective|||||||
1330907|NCT03193658|Randomized|Parallel Assignment||Supportive Care||Quadruple||Randomized controlled double blinded study|t|t|t|t
1330908|NCT03193645|||Cohort||Prospective|||||||
1330909|NCT03193632|||Cohort||Prospective|||||||
1330910|NCT03193619|||Cohort||Prospective|||||||
1330911|NCT03193606|Randomized|Parallel Assignment||Treatment||Triple||split mouth randomized clinical trial|t|t||t
1330912|NCT03193593|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1330913|NCT03193580|Randomized|Parallel Assignment||Other||Double||Participants will be assigned to one of three groups (sham, tDCS, HD-tDCS) throughout the duration of the study.|t|||t
1330914|NCT03193567||Single Group Assignment||Treatment||None (Open Label)||||||
1330915|NCT03193554|||Case-Control||Cross-Sectional|||||||
1330916|NCT03193541|||Cohort||Prospective|||||||
1330917|NCT03193528|||Cohort||Prospective|||||||
1330918|NCT03193515|||Cohort||Prospective|||||||
1330919|NCT03193502||Single Group Assignment||Treatment||None (Open Label)||||||
1330920|NCT03193489||Single Group Assignment||Treatment||None (Open Label)||||||
1330921|NCT03193476|||Other||Other|||||||
1330922|NCT03193463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"There will be 3 arms to this study, and they will accrue independently of each other as they reflect distinctly separable populations of patients with rHGG.~Arm 1: Predominantly enhancing mass with volume of 8 cc or less. Arm 2: Predominantly enhancing mass with volume of > 8 cc Arm 3: Predominantly non-enhancing mass"||||
1330923|NCT03193450|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1330924|NCT03193437||Single Group Assignment||Treatment||None (Open Label)||||||
1330925|NCT03193424|Randomized|Parallel Assignment||Treatment||Single||Double Group Assignment,apatinib plus docetaxel comparison to docetaxel.|||t|
1577065|NCT00005190||||||||||||
1330929|NCT03193372|||Cohort||Prospective|||||||
1330930|NCT03193359||Single Group Assignment||Prevention||None (Open Label)||||||
1330931|NCT03193346|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1330932|NCT03193333|Randomized|Parallel Assignment||Treatment||Double|Blinding will be performed by the personnel assigned by the Laboratorios Sophia S.A. de C.V. Clinical Operations Management. The blinding will consist in the elimination of the primary label (commercial) for Krytantek Ofteno® and the triple concomitant therapy and the placement of a label identical to those of the other interventions. Since the bottles in which Krytantek Ofteno® and the concomitant therapies are different in color and cap shape to the ones used for the placebo and the PRO-122, a masking will be performed in the primary packaging, which shall be identical for all three interventions.|A non-inferiority, phase III, double-blind, randomized, controlled, parallel, clinical trial|t||t|
1330933|NCT03193320|Randomized|Parallel Assignment||Supportive Care||Double|Participants will be under general anesthesia during the interventions. Outcome assessors (nurses) will be blinded to the treatment provided in the operating rooms||t|||t
1330934|NCT03193307||Single Group Assignment||Treatment||None (Open Label)||||||
1330935|NCT03193294|Randomized|Parallel Assignment||Diagnostic||Triple|Participants are randomised to a 'Disclosed group' (Intervention group) or a 'Not disclosed group' (Standard Care). In the standard care group, coronary function parameters are measured but the results are not disclosed to the attending clinician or the participant.|Randomized, double-blind, parallel group, prospective|t|t||t
1330936|NCT03193281||Single Group Assignment||Treatment||None (Open Label)||"A Phase II, multicentre, open-label, prospective non-randomised study of treatment modification in response to maintenance of MR3.0 at 12 months.~Molecular response will be measured 3 monthly. Patients who achieve MR3.0 by 12 months, with a confirmed response at 13 months on treatment, will switch treatment to imatinib. Those patients who do not achieve this confirmed response will remain on dasatinib.~For patients who achieve confirmed MR3.0 by 13 months we define two study stages. Stage 1 is the first 12 months after recruitment (i.e. before the possible switch to imatinib) and Stage 2 includes the months 13 - 37."||||
1330937|NCT03193268|Randomized|Parallel Assignment||Treatment||Single|||||t|
1330938|NCT03193255|Randomized|Parallel Assignment||Treatment||Single||||||t
1330939|NCT03193242|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1330940|NCT03193229|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1330941|NCT03193216||Single Group Assignment||Treatment||None (Open Label)||This is a pilot prospective cohort study at a single tertiary center who will be compared to historical controls.||||
1330942|NCT03193203|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1330943|NCT03193190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330944|NCT03193177||Single Group Assignment||Basic Science||None (Open Label)||A single group will be recruited to participate in the 21-day fasting diet.||||
1330945|NCT03193164|Randomized|Crossover Assignment||Treatment||Single|The blood samples will be mask analyses|This study will be randomized crossover clinical trial.|||t|
1330946|NCT03193151|||Cohort||Prospective|||||||
1330947|NCT03193138|||Case-Only||Retrospective|||||||
1330948|NCT03193125|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1330949|NCT03193112|||Cohort||Prospective|||||||
1330950|NCT03193099|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330951|NCT03193086|||Cohort||Prospective|||||||
1330952|NCT03193073|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"two groups of patients (group A: CKD and group B newly transplanted patients) are assigned for detailed echocardiography , serum FGF-23, flow mediated dilatation of the forearm before anaemia correction in group A and renal transplant in group B .~Also assesment of FGF-23 in different stages of group A, assessment of FGF-23 before and after renal transplant"||||
1330953|NCT03193060|||Case-Control||Prospective|||||||
1330954|NCT03193047|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330955|NCT03193034||Single Group Assignment||Treatment||None (Open Label)|An independent radiographic reviewer will be assessing all radiographs from the study.|||||
1330956|NCT03193021|Randomized|Parallel Assignment||Treatment||Single|Data Safety Monitoring Committee will adjudicate endpoint events, blinded to treatment assignment when possible|Subjects randomized in 1:1 fashion to either Cardiva Mid-Bore Venous Vascular Closure Device (VVCD) or manual compression for multiple venous access site hemostasis||||t
1330957|NCT03193008|||Case-Only||Retrospective|||||||
1330958|NCT03192995|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1330959|NCT03192982|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized prospective study||||
1330960|NCT03192969|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330961|NCT03192956|||Cohort||Prospective|||||||
1330962|NCT03192943||Single Group Assignment||Treatment||None (Open Label)||||||
1330963|NCT03192930|||Cohort||Prospective|||||||
1330964|NCT03192917|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1330965|NCT03192904|Randomized|Parallel Assignment||Treatment||Single|||t|||
1330966|NCT03192891|||Case-Only||Retrospective|||||||
1330967|NCT03192878|||Case-Only||Prospective|||||||
1330968|NCT03192865|||Cohort||Prospective|||||||
1330969|NCT03192852|Randomized|Parallel Assignment||Treatment||Triple|We will use a gel with no effect only in the fourth session of group 3 to match the number of sessions in relation to the other groups||t||t|t
1330970|NCT03192839|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1330971|NCT03192826|Randomized|Parallel Assignment||Prevention||Double|Patients are masked to their assignment by covering the labels on the bottles of the drugs administered The investigator responsible for the measurement of the intraocular pressure is also masked to the intervention administered to each patient.|This is a prospective, randomized, double masked comparative study|t||t|
1330972|NCT03192813|||Case-Control||Prospective|||||||
1330973|NCT03192800|||Cohort||Prospective|||||||
1330974|NCT03192787|||Cohort||Prospective|||||||
1330975|NCT03192774|||Cohort||Prospective|||||||
1331067|NCT03191578|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1331076|NCT03191461|||Case-Control||Cross-Sectional|||||||
1330976|NCT03192761|Randomized|Parallel Assignment||Treatment||Double|Outcome assessor is not involved in the surgical procedures. Participants wear long trousers at follow-up procedures to mask surgical incisions.|When the patient has been anaesthetized for surgery, the method of reconstruction is defined by opening a sealed envelope in the operating theatre.|||t|t
1330977|NCT03192748|||Cohort||Prospective|||||||
1330978|NCT03192735||Single Group Assignment||Treatment||None (Open Label)||||||
1330979|NCT03192722|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1330980|NCT03192709|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1330981|NCT03192696||Single Group Assignment||Treatment||None (Open Label)||||||
1330982|NCT03192683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330983|NCT03192670|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1330984|NCT03192657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330985|NCT03192644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330986|NCT03192631|Randomized|Crossover Assignment||Other||None (Open Label)||Cross-over study of 20 patients randomized to two arms, 9 month before cross-over.||||
1330987|NCT03192618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1330988|NCT03192605|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1330989|NCT03192592||Single Group Assignment||Prevention||None (Open Label)||This study aim to verify the improvement of texture, elasticity and general appearance of the skin through the application of the cosmetic product Apotech®.||||
1330990|NCT03192579|Randomized|Parallel Assignment||Treatment||Double||Consecutive patients with stent implantation who were performed coronary angiography and OCT follow-up of the coronary arteries were screened. The patients with neoatherosclerosis were randomly assigned to either 2.5-5mg/day of rosuvastatin therapy or 10mg/day(up to 20mg) of rosuvastatin and 1800mg/day of eicosapentaenoic acid therapy at a 1:1 ratio for 12 months.|||t|t
1330991|NCT03192566||Single Group Assignment||Treatment||None (Open Label)||Determine the single dose pharmacokinetics of acetaminophen and its metabolites (glucuronide, sulphate, cystein and mercapturic acid) in obese children and adolescents||||
1330992|NCT03192553|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be assigned to a doffing protocol chronologically starting with the double glove and ending with the control until 100 volunteers have participated. Only one volunteer with participate in each simulation session.||||
1330993|NCT03192540||Single Group Assignment||Other||None (Open Label)||||||
1330994|NCT03192527|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1330995|NCT03192514|Randomized|Parallel Assignment||Prevention||Double|Randomization||t|t||
1330996|NCT03192501|||Case-Control||Prospective|||||||
1330997|NCT03192488|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1330998|NCT03192475|Randomized|Parallel Assignment||Prevention||None (Open Label)||An initial translational Group Lifestyle Balance (GLB) in person, lifestyle intervention designed to mitigate cardiometabolic risk in older adults is delivered to all participants between 0 and 4-months. Subsequently, one-half of the enrolled sample is randomized to either (1) 8-group telephone contacts (8-TC) for the remainder of 12-months; the other one-half is randomized to a newsletter control condition (NC) during this time period.||||
1330999|NCT03192462|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is designed as a fixed-dose pilot study to evaluate the safety and feasibility and efficacy of up to 6 intravenous infusions of multiTAA-specific T cells in pancreas cancer patients with metastatic, locally advanced unresectable, or resectable disease.||||
1331000|NCT03192449||Single Group Assignment||Other||None (Open Label)||Pharmacokinetics||||
1331001|NCT03192436|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1331002|NCT03192423|||Cohort||Prospective|||||||
1331003|NCT03192410|||Cohort||Prospective|||||||
1331004|NCT03192397||Single Group Assignment||Prevention||None (Open Label)||||||
1331005|NCT03192384|||Ecologic or Community||Retrospective|||||||
1331006|NCT03192371|Randomized|Parallel Assignment||Prevention||None (Open Label)||Subjects will be stratified into age subsets of equal numbers within each age cohort (children: 6 to11 years of age and 12 to 17 years of age). Within each age subset, subjects will be assigned randomly in a 1:1 ratio, to one of the two regimens: Zagreb (2-1-1) Group and Essen (1-1-1-1-1) Group.||||
1331007|NCT03192358|||Cohort||Cross-Sectional|||||||
1331008|NCT03192345|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Escalation monotherapy and escalation combination followed by expansion monotherapy and expansion combination.~Escalation phases will not be randomized while expansion phases will be randomized."||||
1331009|NCT03192332|Randomized|Parallel Assignment||Treatment||Single|Assessment of the primary outcome will be performed by an independent and blinded person.|Prospective, randomized, open label, blinded endpoint (PROBE)||||t
1331010|NCT03192319|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331011|NCT03192306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331012|NCT03192293||Single Group Assignment||Treatment||None (Open Label)||||||
1331013|NCT03192280||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331014|NCT03192267|||Cohort||Prospective|||||||
1331015|NCT03192254|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1331016|NCT03192241|Randomized|Parallel Assignment||Health Services Research||Double||Enrollment will be of 60 mother-infant dyads.|||t|t
1331017|NCT03192228|||Cohort||Prospective|||||||
1331068|NCT03191565|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1331069|NCT03191552|Randomized|Parallel Assignment||Treatment||Double||Observational Model: Cohort Time Perspective: Prospective Randomized controlled trial|||t|t
1331070|NCT03191539||Single Group Assignment||Treatment||None (Open Label)||||||
1331071|NCT03191526|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331072|NCT03191513|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1331073|NCT03191500||Single Group Assignment||Treatment||None (Open Label)||||||
1331074|NCT03191487|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331075|NCT03191474|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331018|NCT03192215|Randomized|Parallel Assignment||Prevention||Quadruple|Eligible patients will be allocated in a 1:1 ratio to apixaban or aspirin using the minimal sufficient balance randomization method to prevent serious treatment imbalances by study site.|"Active treatment will be either apixaban 5 mg or aspirin 81 mg. An adjusted dose of apixaban 2.5 mg will be used for subjects with at least two of the following: age greater than or equal to 80 years, body weight less than or equal to 60 kg, or known serum creatinine greater than or equal to 1.5 mg/dL. There will be six possible study tablets: apixaban 5 mg (regular dose), apixaban 2.5 mg (adjusted dose), apixaban 5 mg placebo, apixaban 2.5 mg placebo, aspirin 81 mg, and aspirin placebo.~All subjects will be randomized to receive active treatment with either active apixaban or active aspirin. Study treatments will be supplied in a double-dummy fashion as apixaban 5 mg (2.5 mg for the adjusted dose) or matching placebo, and aspirin 81 mg or matching placebo."|t|t|t|t
1331019|NCT03192202|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1331020|NCT03192189|||Case-Only||Prospective|||||||
1331021|NCT03192176|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1331022|NCT03192163|||Case-Only||Cross-Sectional|||||||
1331023|NCT03192150|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331024|NCT03192137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331025|NCT03192124|||Cohort||Prospective|||||||
1331026|NCT03192111|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1331027|NCT03192098|Randomized|Parallel Assignment||Treatment||Single|Participant will be blinded for dilation strategy.|randomized controlled patient groups|t|||
1331028|NCT03192085|Randomized|Crossover Assignment||Diagnostic||Double||Randomised crossover trial of diagnostic test with assessment of comparative accuracy - feasibility study.|t||t|
1331029|NCT03192072||||||||||||
1331030|NCT03192059||Single Group Assignment||Treatment||None (Open Label)||||||
1331031|NCT03192046|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a randomized, repeated measures, matched group study.||||
1331032|NCT03192033|Randomized|Parallel Assignment||Other||None (Open Label)||A duplex scan guided retrograde femoral puncture is performed followed by the use of a closure arterial device to ensure hemostasis. Patients are randomly assigned to be closed by Proglide® (Abbott) versus Femoseal® (Terumo)||||
1331033|NCT03192020|Randomized|Parallel Assignment||Treatment||Single||||||t
1331034|NCT03192007|||Cohort||Prospective|||||||
1331035|NCT03191994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||MDD exercise group, MDD control group, Healthy exercise group, Healthy control group||||
1331036|NCT03191981||Single Group Assignment||Treatment||None (Open Label)||Phase I/II trial with an initial dose finding phase for cyclophosphamide and lenalidomide combined with fixed dose pembrolizumab||||
1331037|NCT03191968|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1331038|NCT03191955|||Cohort||Prospective|||||||
1331039|NCT03191942|Randomized|Parallel Assignment||Treatment||Single||||||t
1331040|NCT03191929|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331041|NCT03191916|Randomized|Parallel Assignment||Treatment||Double|The participant and their care provider will be blinded as to which intervention is being used.|Participants will be randomly assigned to an experimental group (receives stimulation) or a sham group (is set up with tDCS, but no stimulation is received)|t|t||
1331042|NCT03191903|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331043|NCT03191890|||Cohort||Prospective|||||||
1331044|NCT03191877|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1331045|NCT03191864|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind||t|t|t|t
1331046|NCT03191851|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1331047|NCT03191838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331048|NCT03191825|Randomized|Parallel Assignment||Prevention||None (Open Label)|The recruitment procedure and the treatment is fully automated and delivered by web, e-mail and SMS-textmessages - i.e., the participant is not contacted by any care providers, investigators or assessors during recruitment or treatment - and data are collected by means of web-based questionnaires. However, non-responders to the questionnaires will be contacted by phone for telephone interview.|All participants receive one out of three versions of a web-based smoking cessation program. Two of the versions includes a lapse management system that are based on a day-to-day logging of target behavior. In one version the logging is done on the web, while on the other version, logging is done by SMS-textmessages.||||
1331049|NCT03191812|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1331050|NCT03191799||Single Group Assignment||Treatment||None (Open Label)||||||
1331051|NCT03191786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331052|NCT03191773||Single Group Assignment||Treatment||None (Open Label)||||||
1331053|NCT03191760||Single Group Assignment||Treatment||None (Open Label)||||||
1331054|NCT03191747|||Case-Only||Cross-Sectional|||||||
1331055|NCT03191734||Single Group Assignment||Treatment||None (Open Label)||||||
1331056|NCT03191721|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1331057|NCT03191708|||Cohort||Prospective|||||||
1331058|NCT03191695|||Case-Only||Prospective|||||||
1331059|NCT03191682||Single Group Assignment||Treatment||None (Open Label)||||||
1331060|NCT03191669|||Cohort||Prospective|||||||
1331061|NCT03191656|||Case-Only||Prospective|||||||
1331062|NCT03191643|||Cohort||Retrospective|||||||
1331063|NCT03191630|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants in the intervention group will receive the combination of the SystemCHANGE and activity tracker intervention while participants in the control group will use activity trackers only. Intervention and control groups will receive the same instruction on use of the activity tracker, and have the same number of study contacts.||||
1331064|NCT03191617|Randomized|Parallel Assignment||Treatment||Single||||t||
1331065|NCT03191604|||Cohort||Prospective|||||||
1331066|NCT03191591||Single Group Assignment||Prevention||None (Open Label)||The First 1,000 Days program is a systems-level program that will reach all expectant mothers and families with 0-2 year olds receiving care at 3 Boston-area community health centers.||||
1331077|NCT03191448||Single Group Assignment||Other||None (Open Label)||This study will document the use of standard care treatment using FDA approved material used in an FDA approved fashion.||||
1331078|NCT03191435|Randomized|Parallel Assignment||Treatment||Double||Parallel Randomized clinical trial|t|||t
1331079|NCT03191422||Single Group Assignment||Treatment||None (Open Label)|Outcome Assessor's for 2 of the outcome measures were blinded to the order of the pre and post assessment videos for rating, as well as being unfamiliar with the intervention protocol.|Single-Case experimental design One repetition||||
1331080|NCT03191409|||Cohort||Prospective|||||||
1331081|NCT03191396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331082|NCT03191383|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1331083|NCT03191370|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1331084|NCT03191357|||Cohort||Prospective|||||||
1331085|NCT03191344|||Cohort||Prospective|||||||
1331086|NCT03191331|Randomized|Parallel Assignment||Prevention||None (Open Label)||intervention group and control group.||||
1331087|NCT03191318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331088|NCT03191305|Non-Randomized|Parallel Assignment||Health Services Research||Single|Only Participants would not know about the any other choice of the Drug available.|Patients of CVT from Fauji Foundation would be be in Coumadin Arm ,and patients of CVT from Pakistan Institute of Medical Sciences Hospital would be in Rivroxaban arm.|t|||
1331089|NCT03191292|||Cohort||Retrospective|||||||
1331090|NCT03191279|||Cohort||Prospective|||||||
1331091|NCT03191266|Randomized|Parallel Assignment||Treatment||Quadruple|A double-blind randomized clinical trial with two groups: Active rTMS Treatment Group (Active rTMS) - will receive four to five treatments (two treatments per day) each week for 2 weeks. Sham Control Treatment group (i.e., identical rTMS experimental procedure, but no active stimulation) will receive the same frequency and duration of rTMS sessions.|A double-blind randomized clinical trial with two groups: Active rTMS Treatment Group (Active rTMS) - will receive four to five treatments (two treatments per day) each week for 2 weeks. Sham Control Treatment group (i.e., identical rTMS experimental procedure, but no active stimulation) will receive the same frequency and duration of rTMS sessions. The proposed rTMS protocol is consistent with the FDA approved treatment regimen employed for major depressive disorders.|t|t|t|t
1331092|NCT03191253|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||We will randomize 200 participants to the intervention (n=100) or control (n=100). The intervention consists of providing comprehensive, medically-appropriate food support, individual nutritional counseling, and group-based nutritional education over 6 months to low-income clients who have been diagnosed with HIV in order to improve their viral load and health-related quality of life (primary outcomes) as well as depression, ART adherence, food security and diet quality (secondary outcomes).||||
1331093|NCT03191240|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1331094|NCT03191227|||Cohort||Cross-Sectional|||||||
1331095|NCT03191214|||Case-Control||Prospective|||||||
1331096|NCT03191201|Randomized|Parallel Assignment||Other||Double|"To ensure that patients are unaware of the study drug they are receiving, the infusion pouch will be prepared in a separate room by members of the pharmacy unit and opaque bags will cover the infusion kits and infusions will be done via dark coloured infusion sets. Finally, a curtain will be used to shield the injection site from the patient's view.~To ensure that Outcomes Assessors are unaware of the study drug the patient is receiving, a seperate team of care providers will supervise the infusion of the investigation product and collect and/or manage adverse events (AEs) and serious adverse events (SAEs). The Outcome Assessor will not have access to participant related data during the randomised part of the study."|"Double blind randomised placebo-controlled, parallel group comparative inferiority study with open-label extension divided in two parts:~A first randomised and double-blind part in which FCM or placebo will be administered at baseline and post-baseline parameters assessed.~A second non-randomised, non-blinded open-label extension part starting at the end of part 1, in which participants randomised to the placebo group will receive a FCM injection and post-baseline parameters assessed."|t|||t
1331097|NCT03191188|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331098|NCT03191175|||Other||Prospective|||||||
1331099|NCT03191162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331100|NCT03191149||Single Group Assignment||Treatment||None (Open Label)||||||
1331101|NCT03191136|Randomized|Crossover Assignment||Treatment||None (Open Label)||A randomized, open-label, single dose, cross-over clincial trial||||
1331102|NCT03191123|Randomized|Parallel Assignment||Treatment||Double||||t||t
1331103|NCT03191110|||Cohort||Prospective|||||||
1331104|NCT03191097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331105|NCT03191084|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1331106|NCT03191071|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Randomized clustered pragmatic trial||||
1331107|NCT03191058|Randomized|Parallel Assignment||Treatment||Triple|Participants will be randomized into the study using a permuted block method with a random number generator. The study statistician will prepare the randomization scheme. The block size will be fixed and study personnel will be blinded to the randomization block size.|The study is a randomized, double blind, parallel--group clinical trial with two treatment arms conducted both at the University of Texas Southwestern in Dallas, Texas and at the Temerty Centre for Therapeutic Brain Intervention based at CAMH in Toronto, Canada. Both sites aim to recruit 130 participants each.|t|t||t
1331108|NCT03191045|||Cohort||Prospective|||||||
1331109|NCT03191032|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1331110|NCT03191019|Randomized|Parallel Assignment||Treatment||Double|Eligible participants will be randomized to the intervention group or control group using a computerized and automated process. An email will be automatically sent to the participants with the link to download the corresponding version of the mobile-phone app (intervention app or control app). Researchers who will gather data and those who will measure carbon monoxide in exhaled air will be masked to treatment allocation.|Two-arm, randomized clinical trial of a smoking cessation intervention based on a mobile-phone app. Participants will be randomly assigned to the intervention group or control group, in parallel for the duration of the study (6 months follow-up).|||t|t
1331111|NCT03191006|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1331112|NCT03190993|Randomized|Parallel Assignment||Prevention||Single||A randomized parallel arm design trial examining solid sugar vs. SSB treatments will be performed.|||t|
1331113|NCT03190980|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1331114|NCT03190967|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1331115|NCT03190954||Parallel Assignment||Basic Science||None (Open Label)||||||
1331116|NCT03190941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331117|NCT03190928|||Cohort||Prospective|||||||
1331118|NCT03190915||Single Group Assignment||Treatment||None (Open Label)||||||
1331119|NCT03190902|Randomized|Parallel Assignment||Treatment||Double||Single center, double blind, randomized clinical trial (RCT).|t|||t
1331120|NCT03190889|Randomized|Parallel Assignment||Treatment||Single|Subjects are masked from group assignment. Group assignment is randomized.|Overall Strategy. This is a prospective, randomized, repeated measures single- blind clinical trial. The purposes of this study are to 1) stratify patient risk for second ACL injury, and 2) determine the effects of differential treatment intervention, including targeted neuromuscular training (TNMT), home program only (HOME) and standard clinical (STAN) training, on clinical, biomechanical, and neuromuscular performance measures associated with an increased ACL injury risk. After the initial ACL injury and study enrollment, all patients will participate in standardized pre-operative rehabilitation. They will then undergo surgery by a fellowship-trained sports medicine surgeon at Mayo Clinic, Rochester, MN. Data for Aim 1 will be obtained from biomechanical, neuromuscular and clinical testing performed during Pre-Testing. Data for Aim 2 and the Exploratory Aim will be obtained from biomechanical and clinical test results obtained from Pre- and Post-Testing time points.|t|||
1331121|NCT03190876|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331122|NCT03190863|Randomized|Parallel Assignment||Treatment||Single||||||t
1331123|NCT03190850|Randomized|Parallel Assignment||Treatment||Single|The investigator will not know the final result of the tests performed until the end of the study||||t|
1331124|NCT03190837|||Other||Prospective|||||||
1331125|NCT03190824||Single Group Assignment||Treatment||None (Open Label)||||||
1331126|NCT03190811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331127|NCT03190798|Randomized|Parallel Assignment||Basic Science||Double||Randomized, Double-Blind, Placebo-Controlled, Single-Center, Mechanistic Study|t|t||
1331128|NCT03190785||Single Group Assignment||Treatment||None (Open Label)||Pre/post exposure comparison||||
1331129|NCT03190772|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1331130|NCT03190759|||Other||Prospective|||||||
1331131|NCT03190746|||Cohort||Cross-Sectional|||||||
1331132|NCT03190733|Randomized|Parallel Assignment||Prevention||Single|||t|||
1331133|NCT03190720|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||two different single-arm study||||
1331134|NCT03190707|Randomized|Parallel Assignment||Prevention||Double||The study population will be stratified randomized on an individual level, thus half of the women, who agree to participate, is being randomized to the intervention group and the other half is being randomized to the control group. The trial participants will be allocated within each municipality to either control- or intervention group. The project personnel visiting the families to collect baseline data carry out the randomization. The project personnel bring a sealed envelope when visiting the families. In the envelope, the randomization group is stated together with a randomization number. The envelope is packed by a third party individual who receives a computer generated allocation list from another researcher. The envelopes get the numbers from this random sequence. The researcher generates the allocation list by block randomization with random block sizes of 2. The random allocation list is generated once and will be destroyed after the sealed envelopes are packed.|||t|t
1331135|NCT03190694|Randomized|Crossover Assignment||Prevention||Double||A Randomized Double Blind 6-Weeks Cross-over|t||t|
1331136|NCT03190681|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1331137|NCT03190668|Randomized|Parallel Assignment||Prevention||None (Open Label)||Simple randomization will be used with each patient has probability 0.5 to be assigned in Group I or Group II. Computer program will generate a uniform random variable between 0 to 1, with subject assigned to Group I if the value is less than 0.5 and assigned to Group II if the value is greater than 0.5.||||
1331138|NCT03190655|Randomized|Parallel Assignment||Treatment||Double|The person that assess the degree of epithelization will be presented with photos of the burn conditions and will not be given information of the patient's treatment.|Patients who attend the clinical sites, presenting with untreated partial thickness burns less than 4 hours, and meet the inclusion and exclusion criteria||t||t
1331139|NCT03190642|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331140|NCT03190629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331141|NCT03190616||Single Group Assignment||Treatment||None (Open Label)||||||
1331142|NCT03190603||Sequential Assignment||Treatment||None (Open Label)||||||
1331143|NCT03190590|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1331144|NCT03190577||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331145|NCT03190564||||||||||||
1331146|NCT03190551|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1331147|NCT03190538|||Cohort||Prospective|||||||
1331148|NCT03190525|||Case-Only||Prospective|||||||
1331149|NCT03190512|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331150|NCT03190499|||Other||Prospective|||||||
1331151|NCT03190486|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"20 men and 20 women : group non parent 20 father and 20 mother : group parent"||||
1331152|NCT03190473|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331153|NCT03190460|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1331154|NCT03190447|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331155|NCT03190434|||Case-Only||Retrospective|||||||
1331156|NCT03190421|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Expanded Quantitative Urinary Culture (EQUC) versus Standard Culture (SUC) Techniques||||
1331157|NCT03190408|||Cohort||Prospective|||||||
1331298|NCT03188562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331158|NCT03190395|Randomized|Parallel Assignment||Treatment||None (Open Label)||Contorol Group:Pure Circumferential pulmonary vein isolation(CPVI) Experimental Group:Circumferential pulmonary vein isolation combine with Left atrium roofline ablation(CPVI+LARA)||||
1331159|NCT03190382||Single Group Assignment||Other||None (Open Label)||||||
1331160|NCT03190369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331161|NCT03190356|||Case-Only||Prospective|||||||
1331162|NCT03190343|||Cohort||Prospective|||||||
1331163|NCT03190330||Single Group Assignment||Other||None (Open Label)||||||
1331164|NCT03190317|||Cohort||Other|||||||
1331165|NCT03190304|Randomized|Parallel Assignment||Treatment||Quadruple||double-blind, randomized clinical trial|t|t|t|t
1331166|NCT03190278|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331167|NCT03190265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331168|NCT03190252|||Cohort||Prospective|||||||
1331169|NCT03190239||Single Group Assignment||Treatment||None (Open Label)||||||
1331170|NCT03190226|Randomized|Single Group Assignment||Treatment||None (Open Label)||split-mouth trial||||
1331171|NCT03190213||Single Group Assignment||Treatment||None (Open Label)||This is an open label, non-randomized phase 2 study||||
1331172|NCT03190200|||Cohort||Prospective|||||||
1331173|NCT03190187|Randomized|Parallel Assignment||Treatment||Triple|Patients will be randomly allocated to spinal manipulation group or sham group.|Single blind parallel clinical trial|t|t||t
1331174|NCT03190174||Single Group Assignment||Treatment||None (Open Label)||||||
1331175|NCT03190161||Single Group Assignment||Supportive Care||None (Open Label)||||||
1331176|NCT03190148|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331177|NCT03190135|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331178|NCT03190122|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331179|NCT03190109|||Cohort||Cross-Sectional|||||||
1331180|NCT03190096|||Other||Prospective|||||||
1331181|NCT03190083||Single Group Assignment||Diagnostic||None (Open Label)||The radiologist reviewing the tomosynthesis images will be separate and blinded from the radiologist who reviewed the initial 2-D mammogram||||
1331182|NCT03190070||Single Group Assignment||Other||None (Open Label)||Physiological study to measure the change in glomerular filtration rate after an oral protein load||||
1331183|NCT03190057|||Cohort||Prospective|||||||
1331184|NCT03190044|Randomized|Parallel Assignment||Prevention||Single|Placebo and 'verum' pills have the similar shape and colour.|||t||
1331185|NCT03190031|Randomized|Parallel Assignment||Treatment||None (Open Label)||The patients will be randomized in 2 different groups, one being involved in an endurance respiratory muscle training program, the other being involved in resistance inspiratory muscle training.||||
1331186|NCT03190018||Single Group Assignment||Supportive Care||None (Open Label)||Intervention study, pilot/feasibility for proof of concept of peritoneal dialysis with the Carry Life System for Peritoneal Dialysis (CLS PD)||||
1331187|NCT03190005|Randomized|Parallel Assignment||Basic Science||Single||PRU after DAPT||t||
1331188|NCT03189992|Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1331189|NCT03189979||Single Group Assignment||Treatment||None (Open Label)||||||
1331190|NCT03189966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331191|NCT03189953||Single Group Assignment||Diagnostic||None (Open Label)||Comparison of 68Ga-NODAGA-exendin PET/CT with standard diagnostic methods||||
1331192|NCT03189940|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331193|NCT03189927||Single Group Assignment||Treatment||None (Open Label)||||||
1331194|NCT03189914||Single Group Assignment||Treatment||None (Open Label)||||||
1331195|NCT03189901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331196|NCT03189888||Single Group Assignment||Treatment||None (Open Label)||||||
1331197|NCT03189875|||Cohort||Prospective|||||||
1331198|NCT03189862|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1331199|NCT03189849|||Cohort||Prospective|||||||
1331200|NCT03189836||Single Group Assignment||Treatment||None (Open Label)||||||
1331201|NCT03189823|||Cohort||Prospective|||||||
1331202|NCT03189810|Randomized|Parallel Assignment||Treatment||Quadruple|The rTMS technicians, participants, research analysts and investigators involved in the study will be blind to the rTMS treatment assignment.|Double-blind, placebo-controlled trial|t|t|t|t
1331203|NCT03189797|Randomized|Parallel Assignment||Prevention||None (Open Label)||"After defining the individual patient's likelihood risk status and the diagnosis for each lesion, ICCMS presents a management element to build a comprehensive patient care plan as follow:~Homecare program:~Tooth brushing 2/day with a higher efficacy fluoride toothpaste (≥ 1,450 ppm F-), or High F- prescription toothpaste following the dental team instructions~Prescribed F- mouth rinse~Clinical approaches :~Motivational engagement (discuss with patients how to improve oral health behaviours - including amount of sugar), maintain dental visits at risk-based intervals .~Sealants~F- varnish 2 times /6months .~F- gels or solution (2% NaF) .~Recalls up to every 3 months: professional cleaning & topical F- application on active lesions~Dietary intake interventions~Altering medication-induced hyposalivation if exists"||||
1331204|NCT03189784|Randomized|Parallel Assignment||Treatment||Triple||randomized controlled trial||t|t|t
1331205|NCT03189771|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331206|NCT03189758||Sequential Assignment||Treatment||None (Open Label)||Observational control followed by dietary intervention||||
1331207|NCT03189745||Parallel Assignment||Prevention||None (Open Label)||||||
1331208|NCT03189732|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1331209|NCT03189719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331210|NCT03189706||Single Group Assignment||Treatment||None (Open Label)||This is a pilot study of HITS in patients with resistant NB.||||
1331211|NCT03189693|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1331299|NCT03188549|Randomized|Crossover Assignment||Prevention||None (Open Label)||Comparative research, Cross-Over, with a quasi-experimental component, comparing trial products to the use of Septol over the course of the year before the research.||||
1331212|NCT03189680|Randomized|Parallel Assignment||Treatment||Single||The single-arm, 3-week-long intervention, administered daily, targeted postural instability and mobility using at-limit intensity sensorimotor and visuomotor agility training (n = 35, 17 males) conceptualized but seldom implemented previously. Each of the 15 training sessions lasted 60 minutes. Patients performed each exercise under increasingly difficult conditions and speed according to principles of periodization. All patients kept an exercise log detailing the positive and negative effects of the intervention on clinical and motor symptoms. The logs and attendance were checked daily. The no-intervention control, consisting of PD patients (n = 20, 12 males) received unsupervised standard care, consisting of the prescribed medications and daily, unsupervised 30 minutes of exercises at home.|||t|
1331213|NCT03189667|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label randomized clinical trial||||
1331214|NCT03189654|||Cohort||Prospective|||||||
1331215|NCT03189641||Single Group Assignment||Treatment||None (Open Label)||||||
1331216|NCT03189628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331217|NCT03189615|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331218|NCT03189602|||Case-Only||Retrospective|||||||
1331219|NCT03189589|Randomized|Parallel Assignment||Treatment||Double|This is a double-blind study and subjects and investigator will be blinded.|Healthy subjects will be randomized to receive GSK2269557 750 µg or GSK2269557 500 µg.|t||t|
1331220|NCT03189576||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331221|NCT03189563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331222|NCT03189550|||Cohort||Other|||||||
1331223|NCT03189537|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1331224|NCT03189524||Single Group Assignment||Treatment||None (Open Label)||||||
1331225|NCT03189511||Sequential Assignment||Basic Science||None (Open Label)||Open-label non-randomized historic control (before-after) trial||||
1331226|NCT03189498|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1331227|NCT03189485||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331228|NCT03189472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331229|NCT03189459|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||prospective cohort study (Aims 1 & 2) stepped wedge trial of caregiver peer mentoring (Aim 3)||||
1331230|NCT03189446||Single Group Assignment||Treatment||None (Open Label)||||||
1331231|NCT03189433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331232|NCT03189420|||Cohort||Prospective|||||||
1331233|NCT03189407||Single Group Assignment||Treatment||None (Open Label)||||||
1331234|NCT03189394|Randomized|Parallel Assignment||Prevention||Single|Participants will be aware that there are online and in-person aspects of the study as seen in the consent form, but will be randomized to a group and unaware of which arm they are in.|On completion of the baseline survey and testing, couples will be randomized to one of the three arms of the study (PRIDE, ePRIDE, or Men's Health). Couples will be randomized in blocks with the block size randomly permuted via a SAS computer program based on a pseudo-random number generator. Each arm of the intervention will begin on the same date and run for two weeks. Couples randomized to ePRIDE will be sent a link on the same day that PRIDE and Men's Health sessions are scheduled and will have two weeks to complete the program.|t|||
1331235|NCT03189381|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1331236|NCT03189368|||Case-Crossover||Prospective|||||||
1331237|NCT03189355||Single Group Assignment||Prevention||None (Open Label)||||||
1331238|NCT03189342|Randomized|Parallel Assignment||Prevention||None (Open Label)||Exercise training The volunteers were assigned to one of three interventions for 4 weeks. Group 1 performed balance and gait exercises. Group 2 performed cognitive activity simultaneously with balance and gait exercises. Group 3 performed cognitive, balance and gait activity training asynchronously at different times during the same day.||||
1331239|NCT03189329|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1331240|NCT03189316|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1331241|NCT03189303|||Cohort||Prospective|||||||
1331242|NCT03189290|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1331243|NCT03189277|||Other||Cross-Sectional|||||||
1331244|NCT03189264|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331245|NCT03189251|||Cohort||Retrospective|||||||
1331246|NCT03189238|Randomized|Parallel Assignment||Treatment||Double||This will be a single center study with 40 female patients; twenty placebo and twenty active treatment patients.|t|t||
1331247|NCT03189225||Single Group Assignment||Basic Science||None (Open Label)||||||
1331248|NCT03189212|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1331249|NCT03189199|||Cohort||Prospective|||||||
1331250|NCT03189186||Single Group Assignment||Treatment||None (Open Label)||This is a longitudinal single armed open-label trial for advanced (stage II and above with multiple tumors or vena cava) and metastatic Renal Cell Carcinoma.||||
1331251|NCT03189173||Single Group Assignment||Treatment||None (Open Label)|"Supplemental oxygen versus air assignment nights will be blinded to participants, but will be known by the investigator. Oral appliances will be open label."|Subjects will receive mandibular advancement, supplemental oxygen, mandibular advancement plus supplemental oxygen, and no treatment in randomized order. On nights without supplemental oxygen, subjects will be administered sham (air, single blinded). Oral appliance use will not be masked.||||
1331252|NCT03189160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331253|NCT03189147|Randomized|Parallel Assignment||Treatment||Single||||||t
1331254|NCT03189134||Single Group Assignment||Basic Science||None (Open Label)||||||
1331255|NCT03189121|||Cohort||Cross-Sectional|||||||
1331256|NCT03189108|||Cohort||Prospective|||||||
1331300|NCT03188536|||Cohort||Retrospective|||||||
1331301|NCT03188523|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331302|NCT03188510|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1331346|NCT03187938|||Cohort||Prospective|||||||
1331347|NCT03187925|||Cohort||Prospective|||||||
1331348|NCT03187912|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1331257|NCT03189095|Randomized|Parallel Assignment||Prevention||None (Open Label)||The investigators opted to use a wait-list control group to serve as an untreated comparison for the experimental group. From the investigators' perspective, people calling about an exercise trial want to receive an intervention, and thus, they believe it would be unethical to deny access to the intervention. Control group participants will be asked to continue their current activity level over the 16 weeks and following their posttest, they will be invited to participate in the WOWii program in full. The investigators will examine whether differential dropouts occur between those assigned to the experimental and wait-list control groups. The investigators previous exercise study conducted among women with mobility impairment indicated slightly lower attrition in the wait list control group, with no significant differences between those who withdrew and those who remained in the study by six months.||||
1331258|NCT03189082||Single Group Assignment||Treatment||None (Open Label)||||||
1331259|NCT03189069|||Cohort||Retrospective|||||||
1331260|NCT03189056|||Ecologic or Community||Prospective|||||||
1331261|NCT03189043|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1331262|NCT03189030||Single Group Assignment||Treatment||None (Open Label)||||||
1331263|NCT03189017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331264|NCT03189004|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1331265|NCT03188991|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-label, dose rising trial with a dose escalation phase and a dose confirmation phase. During the dose escalation phase, subjects will be enrolled in sequential cohorts of NanoPac®. Each cohort will have three subjects, with cohorts enrolled sequentially starting at the lowest concentration. Following DSMB review of the cohort data, the next cohort may begin enrolling, an additional three subjects at the current dose may be enrolled, or, if the first dose does not provide adequate safety and tolerability, the study may be halted. In the dose confirmation phase, the dose determined to be the most suitable for further evaluation, defined as the highest dose with an acceptable safety and tolerability profile (as determined by the DSMB), will enroll additional subjects to provide a total of 12 subjects at that dose level.||||
1331266|NCT03188978|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331267|NCT03188965|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1331268|NCT03188952|Randomized|Parallel Assignment||Diagnostic||Single|The assessors will not be blind to intervention/control assessment methods. However it will not be allowed amongst the examiners to exchange any information throughout the entire study period|||||t
1331269|NCT03188939|Randomized|Parallel Assignment||Supportive Care||Double||"For the 3 techniques , we will prepare 20 gauge 10cm block needle and portable ultrasound machine , In single-injection technique using in plane method and lateral to medial direction, local anesthetic is injected at the point where the subclavian artery meets the first rib. In intra- cluster-injection technique using in plane method and lateral to medial direction , the local anesthetic is injected inside main and satellite neural cluster.~In double-injection technique using in plane method and lateral to medial direction half the volume of local anesthetic is injected at intersection of first rib and subclavian artery and another half is injected supero- lateral to subclavian artery to assure spread of the local anesthetic solution in all planes containing brachial plexus."|t|||t
1331270|NCT03188926|||Case-Only||Prospective|||||||
1331271|NCT03188913|||Case-Only||Prospective|||||||
1331272|NCT03188900|||Case-Control||Prospective|||||||
1331273|NCT03188887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331274|NCT03188874|||Case-Only||Prospective|||||||
1331275|NCT03188861|||Cohort||Prospective|||||||
1331276|NCT03188848|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1331277|NCT03188835|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1331278|NCT03188822|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331279|NCT03188809|Randomized|Parallel Assignment||Treatment||Triple||double blind, randomised, controlled train|t||t|t
1331280|NCT03188796|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1331281|NCT03188783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331282|NCT03188770|||Cohort||Prospective|||||||
1331283|NCT03188757||Single Group Assignment||Prevention||None (Open Label)||||||
1331284|NCT03188744|||Cohort||Prospective|||||||
1331285|NCT03188731|||Cohort||Prospective|||||||
1331286|NCT03188718||Single Group Assignment||Diagnostic||None (Open Label)|Blinded to the subject's diagnosis|||||
1331287|NCT03188705||Single Group Assignment||Basic Science||None (Open Label)||The investigators will enroll 50 healthy Amish participants who have been identified through existing whole genome and exome sequencing along with bioinformatic approaches that have genetic variants that are predicted to significantly impact CES1 expression or catalytic function. Enrolled participants will undergo a two-stage intervention with clopidogrel (300 mg loading dose then 75 mg per day for the next 6 days), followed by clopidogrel (75 mg) plus aspirin 324 mg for 1 day. Platelet aggregation studies and other measures of platelet function will be performed before and after each intervention. In combination with previously collected data as part of the PAPI Study, the investigators will then characterize the impact of genetic variation in CES1 on clopidogrel and dual antiplatelet therapy response through single- and multi-variant association modeling.||||
1331288|NCT03188692||Single Group Assignment||Prevention||None (Open Label)||||||
1331289|NCT03188679||Single Group Assignment||Basic Science||None (Open Label)||Patients with seroconversion for CMV undergo amniocentesis. RNA markers for neurological outcome in amniotic fluid CMV PCR negative foetuses are compared with those with amniotic fluid CMV positive PCR.||||
1331290|NCT03188666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331291|NCT03188653|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1331292|NCT03188640||Single Group Assignment||Treatment||None (Open Label)||With-in group comparison of pre- and postoperative data.||||
1331293|NCT03188627|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331294|NCT03188614|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1331295|NCT03188601|||Cohort||Prospective|||||||
1331296|NCT03188588|||Cohort||Prospective|||||||
1331297|NCT03188575|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331303|NCT03188497|Randomized|Sequential Assignment||Treatment||Single||The initial dose was 25mg/m2 on d1,d22,d43 for 1 cycles; if no obvious toxicity was observed,follow 30mg/m2,35mg/m2,40mg/m2,45mg/m2, and 50mg/m2 gradients into the next dose group until the maximum tolerated dose or 50mg/m2|||t|
1331304|NCT03188484|||Ecologic or Community||Prospective|||||||
1331305|NCT03188471|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331306|NCT03188458||Single Group Assignment||Prevention||None (Open Label)||||||
1331307|NCT03188445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331308|NCT03188432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331309|NCT03188419|||Cohort||Retrospective|||||||
1331310|NCT03188406|||Case-Control||Cross-Sectional|||||||
1331311|NCT03188393||Single Group Assignment||Other||None (Open Label)||||||
1331312|NCT03188380|||Cohort||Prospective|||||||
1331313|NCT03188367|Randomized|Crossover Assignment||Diagnostic||Triple||Randomized, dose-finding, double-blind, placebo-controlled, crossover gluten challenge trial|t|t|t|
1331314|NCT03188354||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331315|NCT03188341|||Cohort||Prospective|||||||
1331316|NCT03188328||Single Group Assignment||Treatment||None (Open Label)||3 + 3 dose escalation design||||
1331317|NCT03188315|Non-Randomized|Parallel Assignment||Basic Science||Single||||t||
1331318|NCT03188302||Single Group Assignment||Other||None (Open Label)||||||
1331319|NCT03188289|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1331320|NCT03188276|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)|Thr care provider, participant, investigator and outcomes assessor all konw the process.|There are 32 treatment-naive CHC patients who treated by Ledipasvir-Sofosbuvir or Daclatasvir-Sofosbuvir.||||
1331321|NCT03188263|Randomized|Parallel Assignment||Treatment||Triple||half will receive active light treatment device, the other half will receive a placebo device|t||t|t
1331322|NCT03188250|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1331323|NCT03188237|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||AfyaJamii is a group care model in pregnancy facilitated by Government of Kenya (GOK) Community Health Volunteers (CHVs) and Ministry of Health (MOH) nurses. Pregnant women are assigned to specific care groups according to their Expected Date of Delivery (EDD) and meet 3 times antenatally and 4 times postnatally. These groups are meant to provide women with antenatal and postnatal care, peer support, and knowledge to improve their health outcomes and the health outcomes of their infants. This model of group prenatal and postnatal care is being evaluated as an alternative to the existing policy of focused antenatal care that individualizes care to a single woman at a time.||||
1331324|NCT03188224|Randomized|Parallel Assignment||Supportive Care||Single||After completing the baseline assessment, participants will be randomized into one of two groups: intervention or control. Those in the control group will be thanked for their time and informed that the research coordinator will be in touch to set up the follow-up visits (3- and 6-months following baseline). Those in the intervention group will be provided access to the MyTransition app (intervention). The research coordinator will help them navigate through the app and will instruct them on how to use it. These participants will also receive monthly reminder messages from the research coordinator to promote the use of the app.||||t
1331325|NCT03188211|Randomized|Parallel Assignment||Other||Single||cluster randomized controlled trial||||t
1331326|NCT03188198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331327|NCT03188185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331328|NCT03188172||Single Group Assignment||Treatment||None (Open Label)||The trial is designed as a single arm phase II trial with interim assessments for futility, using a Bayesian strategy for monitoring multiple outcomes.||||
1331329|NCT03188159||Single Group Assignment||Treatment||None (Open Label)||||||
1331330|NCT03188146|||Cohort||Prospective|||||||
1331331|NCT03188133|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1331332|NCT03188120|||Cohort||Prospective|||||||
1331333|NCT03188107|||Case-Control||Prospective|||||||
1331334|NCT03188094|||Other||Prospective|||||||
1331335|NCT03188081|||Cohort||Prospective|||||||
1331336|NCT03188068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331337|NCT03188055|Non-Randomized|Crossover Assignment||Other||Single|||t|||
1331338|NCT03188042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331339|NCT03188029||Single Group Assignment||Diagnostic||None (Open Label)||"The aim of this study is to investigate the effect of repeated doses of etomidate on the adrenocortical synthesis of corticosteroids in patients scheduled to electroconvulsive therapy every 2 days for 3 to 4 weeks.~Anesthesia protocol is standardized with 0.5 mg/kg propofol, 0.3 mg/kg etomidate and 0.5 mg/kg succinylcholine.~Blood samples for cortisol dosage are performed immediately before the first session, 24 hours after the first session, 24 hours after the third session and 24 hours after the sixth session. All blood samples are performed at 9 AM.~Samples were analyzed at the end of the recruitment, using the Electrochimiluminescence ECLIA -Cobas - Roche. The normal value are between 6.2-19.4 µg/dL."||||
1331340|NCT03188016|Randomized|Parallel Assignment||Treatment||Double|Participants are effectively masked since their parents/carers giving consent on their behalf will be masked regarding which arm their children are assigned to. (Participants themselves lack intellectual capacity to understand or consent to study participation)|Homogenous group randomly split into experimental and control groups to receive same number and duration of treatments|t|||t
1331341|NCT03188003|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1331342|NCT03187990|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||In both arms PET/MR is compared to mpMRI for diagnostic accuracy for PCA detection.||||
1331343|NCT03187977|Randomized|Parallel Assignment||Supportive Care||Single|The study examiner (clinical research assistants or psychological examiners) will not know which group of participants is associated with each arm.|Participants will be randomized to either the intervention group to receive cognitive training or to the standard of care group who will not receive cognitive training.||||t
1331344|NCT03187964|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1331345|NCT03187951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331349|NCT03187899|Randomized|Parallel Assignment||Prevention||Single|The patient will be blinded as to which block they receive to prevent bias. The Attending performing/overseeing the block will not be blinded to which block is being performed.|"Participants will be randomized to receive either an interscalene brachial plexus block plus sham superficial cervical plexus block or an interscalene brachial plexus block plus a superficial cervical plexus block. The patient will be blinded as to which block they receive to prevent bias. The Attending performing/overseeing the block will not be blinded to which block is being performed. Patients receiving a traditional interscalene block and a sham superficial plexus block with 5-10cc of normal saline N = 20. Patients group receiving both an interscalene and a superficial plexus block N = 20."|t|||
1331350|NCT03187886|||Cohort||Retrospective|||||||
1331351|NCT03187873|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1331352|NCT03187860|||Other||Cross-Sectional|||||||
1331353|NCT03187847|||Cohort||Prospective|||||||
1331354|NCT03187834|Randomized|Parallel Assignment||Treatment||Quadruple|double blind|Households will be randomized to one of four treatment arms (azithromycin, cotrimoxazole, amoxicillin, or placebo), and each child age 6-59 months in the household will receive 5 days of treatment. One child within each of the antibiotic households will be randomly selected to receive placebo instead of the antibiotc, to allow for study of indirect effects of antibiotic use|t|t|t|t
1331355|NCT03187821|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331356|NCT03187808|Randomized|Parallel Assignment||Treatment||Single||||||t
1331357|NCT03187795|Randomized|Crossover Assignment||Treatment||Quadruple|All study investigators, participants, and assessors will be blind to group assignment. Blinding code will only be broken in emergency situations for reasons of subject safety, where knowledge of the treatment administered is necessary for the treatment of the adverse event under Good Clinical Practices (GCPs), or when required by local regulatory authorities.|After a two-day washout period, participants will be randomly assigned to one of two treatment groups: 1) an escalating dose of mirabegron for 6 weeks (25 mg once daily plus two placebo pills for 2 weeks, followed by 50 mg once daily plus 2 placebo pills for 4 weeks); or 2) Oxybutynin IR (5 mg orally three times daily) for 6 weeks. All participants will then be switched to the opposite study treatment for 6 weeks. Assessments will be performed at Baseline, Week 6 (completion of first study medication and prior to administration of second study medication), and Week 12 (completion of second study medication).|t|t|t|t
1331358|NCT03187782|||Case-Only||Cross-Sectional|||||||
1331359|NCT03187769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331360|NCT03187756||Single Group Assignment||Treatment||None (Open Label)||||||
1331361|NCT03187743||Single Group Assignment||Treatment||None (Open Label)||||||
1331362|NCT03187730|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1331363|NCT03187717|||Case-Control||Retrospective|||||||
1331364|NCT03187704|Randomized|Crossover Assignment||Prevention||Double|Participants were blinded as to filtration and no filtration. The lab was blinded as to which samples were from filtration or no filtration periods.|Randomized cross-over|t|||t
1331365|NCT03187691|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Non-randomized, open uncontrolled||||
1331366|NCT03187678||Single Group Assignment||Treatment||None (Open Label)||||||
1331367|NCT03187665|||Case-Only||Prospective|||||||
1331368|NCT03187652|||Cohort||Prospective|||||||
1331369|NCT03187639|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||FORECAST is a randomised controlled trial comparing 1400 patients with new onset pain who are assigned to either routine assessment or FFRct assessment (n=700 per group)||||
1331370|NCT03187626|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331371|NCT03187613|||Cohort||Prospective|||||||
1331372|NCT03187600|Randomized|Parallel Assignment||Treatment||Double|Patients will not be told what procedure they have received until after completion int he study. Speech language pathologists performing assessments will not be made aware of what procedure the patients have received. Nasovideo endoscopy will be reviewed in a blinded fashion without knowledge of what procedure the patient received.|1 group will receive a pharyngeal flap procedure comprised of pharyngeal muscle while the other group will receive of a procedure with only mucosa/submucosa.|t|||t
1331373|NCT03187587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331374|NCT03187574|||Case-Control||Prospective|||||||
1331375|NCT03187561|Randomized|Factorial Assignment||Prevention||Double|All participants will be informed that they are being recruited into an intervention study targeting coparenting, but participants will not be informed about which arm of the study to which they have been assigned. Data collectors and outcome assessors will not be informed about which arm of the study to which participants have been assigned, to assure that all outcomes and evaluations of intervention are conducted blindly, to avoid experimenter bias.|In the proposed 3-arm RCT, in one arm families will experience Family Foundations (FF) intervention as originally formulated; in the second, families will receive an adapted FF (FF+) program that emphasizes coparenting in infant sleep contexts; the third arm will serve as controls.|t|||t
1331376|NCT03187548||Single Group Assignment||Prevention||None (Open Label)||||||
1331377|NCT03187535|Randomized|Parallel Assignment||Prevention||Quadruple|Participant will be blinded to the treatment arm; all investigators and care providers will be blinded to the treatment arm. Only the anesthesiologist trained in acupuncture and administering the treatment will know the randomization group.||t|t|t|t
1331378|NCT03187522||Single Group Assignment||Treatment||None (Open Label)||This is a prospective, multi-center, post-market clinical follow-up, non-randomized registry of patients treated with the TREO stent-graft||||
1331379|NCT03187509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331380|NCT03187496||Single Group Assignment||Basic Science||None (Open Label)||||||
1331381|NCT03187483|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1331382|NCT03187470|Non-Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1331383|NCT03187457|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1331384|NCT03187444||Single Group Assignment||Other||None (Open Label)|Open|all participants receive the same intervention throughout the protocol||||
1331385|NCT03187431||Single Group Assignment||Treatment||None (Open Label)||||||
1331478|NCT03186222|||Case-Control||Prospective|||||||
1331386|NCT03187418||Single Group Assignment||Treatment||None (Open Label)||Prospective, interventional and monocentric study based in a university hospital setting||||
1331387|NCT03187405|Randomized|Parallel Assignment||Treatment||Single|To minimize bias, the randomization and the treatment from V0 to the end of treatment will be performed by the local intensivist designed as investigator. The follow-up until day 4 (V1) to 6 months (V4), so the judgement criteria will be collected by the local neurosurgeon designed as investigator, who will be blinded to the treatment received.|We plan to perform a pragmatic randomized controlled trial: compare the standard of care, i.e. the EVD alone, to the experimental treatment, i.e. IVF. As the standard treatment does not include injection within the EVD, the trial will not include injection through the EVD in the control group, so the trial will have an open design.||||t
1331388|NCT03187392|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331389|NCT03187379|Randomized|Parallel Assignment||Treatment||Single||||||t
1331390|NCT03187366|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331391|NCT03187353|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1331392|NCT03187340|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331393|NCT03187327|||Case-Only||Prospective|||||||
1331394|NCT03187314||Single Group Assignment||Treatment||None (Open Label)||||||
1331395|NCT03187301|Randomized|Crossover Assignment||Treatment||Quadruple|Double blind period||t|t|t|t
1331396|NCT03187288||Single Group Assignment||Treatment||None (Open Label)||||||
1331397|NCT03187275|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1331398|NCT03187262||Single Group Assignment||Treatment||None (Open Label)||||||
1331399|NCT03187249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331400|NCT03187236|||Cohort||Prospective|||||||
1331401|NCT03187223|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized prospective non-blinded clinical phase II trial investigating the drugs bendamustine hydrochloride and melphalan.||||
1331402|NCT03187210|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The BAL trial consists in two parts:~single arm prospective phase I part;~randomized two-arm open-label prospective phase II part."||||
1331403|NCT03187197|||Cohort||Prospective|||||||
1331404|NCT03187184||Single Group Assignment||Diagnostic||None (Open Label)||This is a single arm proof of concept trial. Sequential boundaries will be used to monitor late PGx test returns (failure to receive OneOme RightMed® pharmacogenomic test results before initiating chemotherapy). The concept will be considered a failure if excessive numbers of late PGx test returns are seen, that is, if the number of late PGx test returns is equal to or exceeds bn out of n patients (see table below). This Pocock-boundary is based upon the probability of early failure when the rate of late PGx test returns is equal to the acceptable rate [event probability θ]. In this trial crossing the boundary will not result in early stopping, because chemotherapy treatment is not dependent upon receipt of PGx test results prior to treatment initiation, but may be used to revise future protocol methodology.||||
1331405|NCT03187171|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective randomized comparative outcomes study, in which all subjects who fit the inclusion and exclusion criteria and who agreed to be part of the study will be randomized to either Allograft or Cohere PEEK fusion group and will be followed for approximately 12 months following surgery according to the standard-of-care.||||
1331406|NCT03187158|||Cohort||Cross-Sectional|||||||
1331407|NCT03187145|||Cohort||Prospective|||||||
1331408|NCT03187132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331409|NCT03187119|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1331410|NCT03187106|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded||t|t|t|t
1331411|NCT03187093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331412|NCT03187080|Randomized|Sequential Assignment||Treatment||Triple|Participants will be blinded as to which treatment arm within their group that they are allocated. The surgery team including the surgeon (PI) and resident will be blinded as well. Anesthesiologists will not be blinded.|There are four serial aims of this study. The overarching goal is to prospectively assess the use of PVB as an adjunct for postoperative pain control both alone and in the setting of related ERABS strategies in elective breast surgery (both breast reduction and breast augmentation, two of the most common non-oncologic breast operations performed in an ambulatory setting). The methodologies used to assess postoperative pain, the set of collective ERABS strategies, the potential risks and benefits of study participation, and the inclusion/exclusion criteria will be the same in the groups studying breast reduction and those studying breast augmentation. As both operations are performed on a regular basis in the PI's practice, we feel it essential to evaluate both operations.|t|t|t|
1331413|NCT03187067|||Cohort||Prospective|||||||
1331414|NCT03187054|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331415|NCT03187041||Single Group Assignment||Basic Science||None (Open Label)||In order to acquire our data, a Microlab PicoPress device will be employed. It has been shown to provide accurate, linear, and reproducible measures of surface pressure between the skin and device. For tourniquets, the investigators will be using a MedSource perforated tourniquet, which is the type of elastic tourniquet the phlebotomists are accustomed to using in their daily practice. For each experiment throughout both phases of the study, the PicoPress pressure sensor will be folded in half and taped over the lateral aspect of the right arm, approximately 2 inches distal to the deltoid muscle along the brachialis muscle. Arm circumferences will be taken prior to experimentation at this same location. For each trial, the phlebotomists will tie the 2.5cm elastic tourniquet around the arm and pressure sensor while ensuring that the tourniquet is not knotted directly on top of the sensor. The study will be divided into two phases of experimentation conducted sequentially.||||
1331416|NCT03187028|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331417|NCT03187015||Single Group Assignment||Other||None (Open Label)||||||
1331418|NCT03187002|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331419|NCT03186989|Randomized|Parallel Assignment||Other||Double|||t||t|
1331420|NCT03186976|Randomized|Parallel Assignment||Prevention||None (Open Label)||This will be a parallel group, open label randomized clinical trial, with blinded endpoint evaluation (PROBE design)||||
1331421|NCT03186963|Randomized|Parallel Assignment||Treatment||Single||||||t
1331422|NCT03186950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331423|NCT03186937||Single Group Assignment||Basic Science||None (Open Label)||||||
1331424|NCT03186924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331425|NCT03186911||Single Group Assignment||Basic Science||None (Open Label)||||||
1331426|NCT03186898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331427|NCT03186885|Randomized|Parallel Assignment||Prevention||Double||||t||t
1331428|NCT03186872|Randomized|Parallel Assignment||Other||None (Open Label)||Comparison between cognitive behavioral app and care as usual.||||
1331429|NCT03186859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331430|NCT03186846|Randomized|Parallel Assignment||Prevention||Single|||t|||
1331431|NCT03186833|||Case-Only||Prospective|||||||
1331432|NCT03186820||Single Group Assignment||Prevention||None (Open Label)||Prospective monocentric comparative study||||
1331433|NCT03186807|||Cohort||Prospective|||||||
1331434|NCT03186794||Single Group Assignment||Supportive Care||None (Open Label)||||||
1331435|NCT03186781|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331436|NCT03186768|Randomized|Parallel Assignment||Other||Single|School group (intervention or control) will be blinded for data analysis.|School-randomized controlled trial||||t
1331437|NCT03186755|Randomized|Parallel Assignment||Treatment||Double||Prospective, Monocentric, Randomized Controlled Trial, Parallel-group, Single-masked for assessors||t||t
1331438|NCT03186742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331439|NCT03186729|Randomized|Parallel Assignment||Prevention||Single||Randomised-controlled trial, parallel groups||||t
1331440|NCT03186716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331441|NCT03186703|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1331442|NCT03186690|Randomized|Parallel Assignment||Treatment||Single|Participants were not aware of type of capping material used.|This prospective longitudinal, parallel-design, randomized clinical trial was set up and is reported according to CONSORT statement|t|||
1331443|NCT03186677|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1331444|NCT03186664|Randomized|Parallel Assignment||Treatment||Single||||||t
1331445|NCT03186651|Randomized|Parallel Assignment||Other||None (Open Label)|Open Lable|||||
1331446|NCT03186638|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1331447|NCT03186625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331448|NCT03186612|Randomized|Parallel Assignment||Treatment||Single|All assessments were conducted by masked evaluators. They were not related to the interventions.|It will be conducted a blinded randomized controlled trial (RCT). Non-probabilistic sampling of consecutive cases will be used.||||t
1331449|NCT03186599|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331450|NCT03186586|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1331451|NCT03186573|Randomized|Parallel Assignment||Prevention||Double|Double blind study|Randomized clinical trial|t||t|
1331452|NCT03186560|Non-Randomized|Crossover Assignment||Other||None (Open Label)||Geko device will be provided||||
1331453|NCT03186547|Randomized|Parallel Assignment||Treatment||Single|single blind|||||t
1331454|NCT03186534|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1331455|NCT03186521|||Other||Prospective|||||||
1331456|NCT03186508|Randomized|Parallel Assignment||Prevention||Single||||||t
1331457|NCT03186495|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331458|NCT03186482|Non-Randomized|Sequential Assignment||Health Services Research||Single|||t|||
1331459|NCT03186469|Randomized|||Prevention||Single|Data collector will be blinded as to which arm study participants are enrolled|||||t
1331460|NCT03186456|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331461|NCT03186443|Randomized|Parallel Assignment||Prevention||None (Open Label)||control group is to oral gabapentin 0.4 tid； experiment group is to oral pregabalin 300mg q 12h||||
1331462|NCT03186430|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This study uses a cluster-randomized design where six health provider practices are randomized to the intervention or control arm where all participants in the respective practices will receive the behavioral intervention or the standard information.||||
1331463|NCT03186417|Randomized|Sequential Assignment||Treatment||Quadruple||This is a dose escalation study using three groups (or cohorts) of patients randomly assigned within treatment groups to MSCs or placebo. The first group will consist of 5 patients who receive MSCs and one patient who receives placebo, the second and third group will consist of five patients each who receive MSCs and two patients who receive placebo. The three doses are 2 million hMSCs/kg (Cohort 1), 4 million hMSCs/kg (Cohort 2), and 6 million hMSCs/kg (Cohort 3) and placebo control of normal saline.|t|t|t|t
1331464|NCT03186404|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331465|NCT03186391|||Cohort||Prospective|||||||
1331466|NCT03186378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Open label||||
1331467|NCT03186365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331468|NCT03186352||Single Group Assignment||Supportive Care||None (Open Label)||Sample for microbiological evaluation is to be taken from each patient before and after intervention (PAD). Before-After Study Type.||||
1331469|NCT03186339|||Cohort||Prospective|||||||
1331470|NCT03186326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331471|NCT03186313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331472|NCT03186300||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1331473|NCT03186287|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331474|NCT03186274|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1331475|NCT03186261|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331476|NCT03186248|Randomized|Parallel Assignment||Other||Double|Double blind randomized clinical trial|Double blind randomized clinical trial|t||t|
1331477|NCT03186235|||Other||Cross-Sectional|||||||
1577066|NCT00005189||||||||||||
1331479|NCT03186209|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1331480|NCT03186196|Randomized|Parallel Assignment||Prevention||Single|||||t|
1331481|NCT03186183||Single Group Assignment||Prevention||None (Open Label)||||||
1331482|NCT03186170|Randomized|Parallel Assignment||Treatment||Single||We propose to assess one method of sperm selection based on the characteristics of spermatozoa recently introduced: Sperm Selection Assay, which used a gradient of concentration of progesterone to act as chemoatractant of spermatozoa of better quality. We will assess in vitro fertilization with two techniques (SSSA versus traditional technique of swin up) as well as embryo development.|t|||
1331483|NCT03186157|||Cohort||Prospective|||||||
1331484|NCT03186144||||Diagnostic||None (Open Label)||||||
1331485|NCT03186131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331486|NCT03186118|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects are assessed during the parent study for total CD 19 load in bone marrow. Participants meeting eligibility criteria are transitioned into one of 3 arms in PLAT-03.||||
1331487|NCT03186105||Single Group Assignment||Other||None (Open Label)||||||
1331488|NCT03186092|Randomized|Parallel Assignment||Treatment||Single||||||t
1331489|NCT03186079|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1331490|NCT03186066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331491|NCT03186053|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1331492|NCT03186040||Single Group Assignment||Treatment||None (Open Label)||Before and after comparison||||
1331493|NCT03186027|Randomized|Parallel Assignment||Treatment||Triple|The investigator, care provider and participants do not know which individuals have been assigned in each arm or comparison group.|"Active Dietary Supplement: ReConnect (CoQ10 plus NADH) and excipients. ReConnect supplementation (CoQ10: 200mg/day plus NADH 20 mg/day) divided into 2 daily dose (2 tablets/ before breakfast and 2 tablets/ before lunch).~Excipient Dietary Supplement: Placebo (serine plus vitamin C) Placebo supplementation divided into two daily dose (2 tablets/before breakfast and 2 tablets/ before lunch)"|t|t|t|
1331494|NCT03186014||Single Group Assignment||Treatment||None (Open Label)||||||
1331495|NCT03186001|Randomized|Parallel Assignment||Treatment||Double|double blind||t|||t
1331496|NCT03185988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331497|NCT03185975|Randomized|Parallel Assignment||Prevention||Single|||t|||
1331498|NCT03185962|||Cohort||Prospective|||||||
1331499|NCT03185949||||||||||||
1331500|NCT03185936||Single Group Assignment||Treatment||None (Open Label)||||||
1331501|NCT03185923|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331502|NCT03185910|Randomized|Parallel Assignment||Prevention||Single||||||t
1331503|NCT03185897|||Cohort||Prospective|||||||
1331504|NCT03185884|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1331505|NCT03185871||Single Group Assignment||Basic Science||None (Open Label)|Due to the characteristics of the design of this clinical trial, the patient will not be blinded but the researcher completing analysis will be. The researcher will be handling deidentified patient samples and comparing whether there are changes of biological markers within the same patient before and after celecoxib intake. It is important that the researcher be as unbiased as possible when analyzing collagen alignment and amount of other breast cancer biological markers.|||||
1331506|NCT03185858|Randomized|Parallel Assignment||Prevention||Single|Outcomes assessors (staffs from a nearby county) are masked with no information on which villages will be assigned to intervention group or control group.|The SINEMA model, cognizant of health system's organization around primary, secondary and tertiary healthcare levels in China, adopts the principles of cascade training with feedback and task-sharing, and relies on existing human resources available at the community level. It also proposes the use of innovative mobile technology as tools (in the form of an Android-based SINEMA APP for village doctors and cellphone voice messages for participants). The overarching aim is to strengthen the capacity of village doctors on delivering services for the secondary prevention of stroke and promoting medication adherence and physical activity among stroke survivors.||||t
1331507|NCT03185845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331508|NCT03185832|||Cohort||Prospective|||||||
1331509|NCT03185819|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331510|NCT03185806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331511|NCT03185793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331512|NCT03185780||Single Group Assignment||Supportive Care||None (Open Label)||Patients with high grade glioma undergoing adjuvant (post-surgical) chemo-radiation treatment will be treated with acupuncture and/or touch therapies, this in parallel to their conventional treatment regimen. The primary study outcome will be the scores on four Patient-Reported Outcome Measures (PROMs): the Measure Yourself Concerns and Wellbeing (MYCAW) study tool; the Functional Assessment of Cancer Therapy, Brain Cancer (FACT-Br) questionnaire; the Edmonton Symptom Assessment Scale (ESAS); and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-c30). Secondary study outcomes will include the safety of the complementary medicine treatments, and adherence to the planned oncology treatment regimen, as measured by the Relative Dose Intensity (RDI) calculation.||||
1331513|NCT03185767|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1331514|NCT03185754||Single Group Assignment||Treatment||None (Open Label)||||||
1331515|NCT03185741|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1331516|NCT03185728|Randomized|Sequential Assignment||Prevention||None (Open Label)||Childcare sites will be randomized to one of 3 study arms, and we will use a stepped wedge design to recruit patients to complete one of two interventions. During the first year of implementation, 1/3 of participants will not be contacted (Control arm). In the other 2 arms, participants will be recruited to complete either the iLookOut intervention or the Standard online mandated reporter training. The next year, participants in the Standard arm will then be asked to complete the iLookOut intervention, and participants in the Control arm will, again, not be incentivized to complete any training. In the final year, participants in the Control arm will be recruited to complete the iLookOut intervention.||||
1331517|NCT03185715||Single Group Assignment||Other||None (Open Label)||||||
1331518|NCT03185702|||Cohort||Prospective|||||||
1331519|NCT03185689|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||DSME is model assumed to empower diabetes patients in the area of self-care practice. To bring this behavioral change it has been hypothesized that an intensified DSME which is given in organized, interlinked and supported by take home activities is effective in glycemic control. As a teaching material, illustrative booklet was prepared in two local languages. Similarly, fliers have been given following each DSME session. Specifically for educational sessions, copy of the booklet was prepared in larger posters. The education is not only one way type of education, rather there have been a vast experience sharing among the patient, whether they have been doing in the recommended way or not. Then the facilitator educate them what is right and recommended. Local culture, values and beliefs were taken into account on each of the sessions.||||
1331520|NCT03185676|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331521|NCT03185663|Randomized|Parallel Assignment||Other||None (Open Label)||a pillow between the legs versus traction-stuck||||
1331522|NCT03185650|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||Healthy subjects will use each nebulizer device in random order at separate study visits.||||
1331523|NCT03185637|||Cohort||Prospective|||||||
1331524|NCT03185624|Randomized|Parallel Assignment||Prevention||Single||||||t
1331525|NCT03185611|Randomized|Parallel Assignment||Prevention||Single||||||t
1331526|NCT03185598|||Cohort||Retrospective|||||||
1331527|NCT03185585|||Ecologic or Community||Cross-Sectional|||||||
1331528|NCT03185572|||Cohort||Prospective|||||||
1331529|NCT03185559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331530|NCT03185546|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1331531|NCT03185533|||Case-Only||Prospective|||||||
1331532|NCT03185520|||Cohort||Prospective|||||||
1331533|NCT03185507|Randomized|Parallel Assignment||Treatment||Single|The was a randomized single-blind study. Only the clinician was blinded to which intervention was administered to each randomly assigned participant.|Thirty-four healthy participants were recruited from a large urban university. Participants were included if they were healthy and between the age of 18 and 25 years old. After obtaining consent, participants completed symptom, mood and medical history inventories. After determining if a participant met inclusion criteria, the subject remained seated at a testing station for a 10-minute rest period prior to NIRS data collection. Randomization was performed a priori using a random number generator and was stratified on sex. Participants either received superficial cryotherapy or sat quietly for 20 minutes.|||t|
1331534|NCT03185494||Single Group Assignment||Treatment||None (Open Label)||||||
1331535|NCT03185481|Randomized|Parallel Assignment||Treatment||Triple|During the titration phase, the allocation to treatment will be double blind to protect the blind of the parent study (B7601003). After completing the titration phase, the treatment assignment becomes open label.|"Depending on the actual treatment the subject received in B7601003, subjects will be randomized to one of 4 treatment groups (15 mg QD, 7 mg QD, 3 mg QD, or 1 mg QD group) and titrated up to 15 mg QD over a 3 week period, as appropriate.~All subjects who were blindly down-titrated during the parent study (B7601003) will remain at/or be titrated to 7 mg QD only and remain at that dose for the rest of the B7601017 study in order to protect the blind for the parent study. Subjects who successfully titrate to 15 mg QD will enter the Adjustment Period at that dose. Subjects who cannot tolerate 15 mg QD at any time during the study will be allowed to down-titrate to 7 mg QD (but not lower) and will stay at that dose for the rest of the study. Subjects who cannot remain at a stable dose (7 mg or 15 mg QD) will be discontinued."|t|t|t|
1331536|NCT03185468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1331537|NCT03185455|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The study will be a randomized, two arm trial. Patient will be randomized to usual one time office visit based blood pressure check or to text-message based remote surveillance for two weeks. Randomization will be performed using a computer generated sequence using REDCAP. Demographic information will be collected from those who decline randomization or are ineligible in order to assess patient characteristics of those willing to be randomized and who meet eligibility.||||
1331538|NCT03185442||Single Group Assignment||Basic Science||None (Open Label)||||||
1331539|NCT03185429||Single Group Assignment||Treatment||None (Open Label)||||||
1331540|NCT03185416|Randomized|Parallel Assignment||Prevention||None (Open Label)||The present study is a randomized single-center therapeutic clinical trial including the following two prospective groups: Control group and the intervention group.||||
1331541|NCT03185403|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1331542|NCT03185390||Single Group Assignment||Diagnostic||None (Open Label)||All cases admitted in Assuit university hospital with periampullary lesions detected by ERCP with ERCP guided biopsy or brush cytology within the period of the study.||||
1331543|NCT03185377|||Cohort||Prospective|||||||
1331544|NCT03185364|Randomized|Parallel Assignment||Treatment||Triple||23 patients use placebo and 23 patients use sidenafil for 12 weeks' treatment|t|t|t|
1331545|NCT03185351|Randomized|Parallel Assignment||Prevention||Quadruple||"Group A: patients will receive 20 ml of 0.5% bupivacaine + 5 ml normal saline (0.9%) using supraclavicular BPB.~Group B: patients will receive 20 ml of 0.5% bupivacaine + midazolam 0.03 mg/kg dissolved in 5 ml normal saline (0.9%) using supraclavicular BPB.~Group C: patients will receive 20 ml of 0.5% bupivacaine + 5 ml normal saline (0.9%) using supraclavicular BPB + 0.03 mg/kg of midazolam by I.V. route at the same time of the block."|t|t|t|t
1331546|NCT03185338|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331547|NCT03185325|||Other||Cross-Sectional|||||||
1331548|NCT03185312|||Case-Control||Prospective|||||||
1331549|NCT03185299|Randomized|Parallel Assignment||Treatment||Single|||||t|
1331550|NCT03185286||Single Group Assignment||Treatment||None (Open Label)||||||
1331551|NCT03185273|||Cohort||Prospective|||||||
1331552|NCT03185260|||Case-Only||Prospective|||||||
1331553|NCT03185247||Single Group Assignment||Treatment||None (Open Label)||||||
1331554|NCT03185234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331555|NCT03185221|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331595|NCT03184701||Single Group Assignment||Health Services Research||None (Open Label)||||||
1331596|NCT03184688|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331556|NCT03185208|Randomized|Parallel Assignment||Prevention||Quadruple|Participants, investigators (who will also be prescribers/care providers), and both clinical and cognitive raters will be blind to treatment. A non-blind physician not providing care or ratings will receive real and generate false blood levels to communicate to other investigators for the purpose of titration of the lithium/placebo. Measures for emergency unblinding will be available as well for safety.|Longitudinal, randomized, double-blind, placebo-controlled experimental trial|t|t|t|t
1331557|NCT03185195|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)|Open-Label|||||
1331558|NCT03185182||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331559|NCT03185169||Single Group Assignment||Treatment||None (Open Label)||Observational, prospective open label trial||||
1331560|NCT03185156|Randomized|Parallel Assignment||Prevention||Double||60 maternal aged 20-40 years will be collected|t||t|
1331561|NCT03185143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331562|NCT03185130|Randomized|Parallel Assignment||Treatment||Single|By necessity the subject will be blinded but the RN administering the IV fluids will need to know the rate of infusion.|This will be a single center, prospective, single blinded randomized controlled trial on a convenience sample of patients presenting to the adult or pediatric ED with a chief complaint of headache.|t|||
1331563|NCT03185117|||Cohort||Prospective|||||||
1331564|NCT03185104|Randomized|Parallel Assignment||Prevention||Triple|Application of the SDF/placebo is conducted by a dentist who is not involved in the clinical data collection.|Removable partial denture wearers are randomized assigned to either the fluoride group or the placebo group. The fluoride group receives semi-annually professionally applied 38% SDF solution to all exposed tooth and root surfaces while the placebo group receives distilled water using the same application method.|t||t|t
1331565|NCT03185091||Single Group Assignment||Other||None (Open Label)||||||
1331566|NCT03185078|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331567|NCT03185065|Randomized|Crossover Assignment||Treatment||Quadruple|Double-blind|randomized, placebo‐controlled, crossover, 4‐sequence, 4‐period, double‐blind, multicenter trial of 3 commonly used medications for treatment of Multiple Sclerosis related fatigue versus placebo in fatigued subjects with MS.|t|t|t|t
1331568|NCT03185052||Single Group Assignment||Other||None (Open Label)||||||
1331569|NCT03185039||Single Group Assignment||Basic Science||None (Open Label)||||||
1331570|NCT03185026|Randomized|Parallel Assignment||Prevention||Single||||||t
1331571|NCT03185013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331572|NCT03185000|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1331573|NCT03184987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331574|NCT03184974|||Cohort||Prospective|||||||
1331575|NCT03184961||Single Group Assignment||Other||None (Open Label)||||||
1331576|NCT03184948|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Hospitals (i.e., participants) receive the intervention (i.e., Brilliance phototherapy device) at different times in the study. In the first phase, a set of hospital facilities receive the device. After three months of using the device, another set of hospital facilities receive the device. And after an additional three months (approximately 6 months after the first set of hospitals implemented their device), all hospitals will have been provided with the intervention.||||
1331577|NCT03184935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331578|NCT03184922|Randomized|Parallel Assignment||Treatment||Double|"The patients will be informed they will not be told which arm of the study they are allocated to.~The outcomes assessor for the KT1000 will be a physiotherapist not a surgeon and will not be told which type of surgery the patient has undergone"|This is a blinded randomised controlled trial with 1 arm of the study having femoral side cortical fixation using a fixed length suspensory loop and the other an adjustable loop|t|||t
1331579|NCT03184909|Randomized|Parallel Assignment||Supportive Care||Quadruple|Concealment of allocation and blinding of active versus placebo and blinded assessment||t|t|t|t
1331580|NCT03184896|||Cohort||Prospective|||||||
1331581|NCT03184883|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331582|NCT03184870|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331583|NCT03184857|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331584|NCT03184844||Single Group Assignment||Treatment||None (Open Label)||||||
1331585|NCT03184831|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331586|NCT03184818|||Other||Prospective|||||||
1331587|NCT03184805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331588|NCT03184792|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1331589|NCT03184779|Randomized|Parallel Assignment||Prevention||Double|"Participants (including the teachers and students) will not be told by the research team if the video assigned to their class is the control or intervention. During the consent process though, they will be made aware that they are going to be randomly assigned to either the control or intervention video.~Furthermore, when the two observers go to the ski hill to collect data on observed unsafe behaviours, they will be blinded to the intervention/control status of the school at the ski area that day to prevent observer bias."|Schools will be stratified by grade and half of the schools in each stratum will be randomly assigned to the intervention and the other half will be assigned to the control group. Stratification by grade is necessary to ensure that groups are similar enough to ensure less biased comparisons. The research team will also ensure that schools going on their outing to COP on the same day are assigned to the same group. This is to ensure that research assistants can assume that all students observed on the hill for that particular day have the same intervention or control status since it may be challenging to distinguish which school group each student belongs to strictly through observation. That way the research team can accurately ascertain the intervention and control status of each student for the behavior observation component of the study.|t|||t
1331590|NCT03184766|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1331591|NCT03184753||Single Group Assignment||Treatment||None (Open Label)||||||
1331592|NCT03184740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331593|NCT03184727|||Cohort||Prospective|||||||
1331594|NCT03184714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||non-invasive positive pressure ventilation||||
1331597|NCT03184675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331598|NCT03184662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331599|NCT03184649|Randomized|Parallel Assignment||Prevention||None (Open Label)|statistician will be blind only|three groups, two for intervention and one for comparative group||||
1331600|NCT03184636|||Cohort||Prospective|||||||
1331601|NCT03184623|||Cohort||Prospective|||||||
1331602|NCT03184610|||Case-Control||Cross-Sectional|||||||
1331603|NCT03184597|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331604|NCT03184584||Single Group Assignment||Treatment||None (Open Label)||||||
1331605|NCT03184571||Single Group Assignment||Treatment||None (Open Label)||Extension to Simon's 2-stage design allowing termination at the end of Stage 1 for either futility or efficacy.||||
1331606|NCT03184558||Single Group Assignment||Treatment||None (Open Label)||Extension to Simon's 2-stage design allowing termination at the end of Stage 1 for either futility or efficacy.||||
1331607|NCT03184545|Randomized|Parallel Assignment||Treatment||Single|The examiner who will be evaluating and assessing the outcome scores on each visit will be blinded to the patient's group.|It's a phase III study. A randomized, observer blinded, single center study. Patients will be divided in two groups based on randomization. One group will receive electrical muscle stimulation and Physical therapy and other group will receive only physical therapy. Assessment and follow up will be performed before start of treatment, at 3 weeks, 6 weeks, 12 weeks, 6 months and 12 months post-start of treatment . Assessment will be done at each visit based on Kujala patellofemoral score, pain visual analog scale (VAS) during activities of daily life and isometric strength measurement.||||t
1331608|NCT03184532|||Case-Control||Prospective|||||||
1331609|NCT03184519||Single Group Assignment||Diagnostic||None (Open Label)||All the patients will undergo 3 blood samples for analyses to determine pregnancy.||||
1331610|NCT03184506|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331611|NCT03184493|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1331612|NCT03184480|||Cohort||Prospective|||||||
1331613|NCT03184467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331614|NCT03184454||Single Group Assignment||Treatment||None (Open Label)||||||
1331615|NCT03184441||Single Group Assignment||Prevention||None (Open Label)||||||
1331616|NCT03184428|||Cohort||Retrospective|||||||
1331617|NCT03184415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331618|NCT03184402|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331619|NCT03184389|Randomized|Single Group Assignment||Prevention||None (Open Label)||Each time point when participant is available (i.e., not driving, not physically active, a stress classification is possible, hasn't recently received an ecological momentary assessment (EMA) or an intervention prompt) is randomly assigned to intervention prompt or no prompt.||||
1331620|NCT03184376|Randomized|Parallel Assignment||Treatment||Single|Participants were blinded to the treatment allocation. Oligofructose and maltodextrin taste and look the same (white powder) and both were placed in identical foil packaging.|Single-blind, placebo controlled, randomized trial|t|||
1331621|NCT03184363||Single Group Assignment||Treatment||None (Open Label)||||||
1331622|NCT03184350||Single Group Assignment||Treatment||None (Open Label)||Patients will receive a dose of 45-50.4 Gray in 1.8 Gray fractions 5-6 times per week using active raster-scanning pencil beam proton radiation. Platinum-based chemotherapy can be administered if indicated. For treatment planning rectum, sigma, large and small bowel, bladder and femoral heads are defined as organs at risk. The CTV is defined according to the EORTC consensus guidelines. Treatment-associated toxicity and Quality of life will be evaluated regularly.||||
1331623|NCT03184337|Non-Randomized|Parallel Assignment||Treatment||Single||Participants will be assigned to one of two groups.|t|||
1331624|NCT03184324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331625|NCT03184311|Randomized|Parallel Assignment||Treatment||Single|Study personnel involved in the study measurements will be blinded to whether patients are allocated to the intervention or control group. Furthermore, the statistician will be blinded to treatment allocation. To ensure blinding, the study measurements will be performed in different rooms and by different staff than those involved in the training intervention. It is not possible to blind participating patients and investigators performing the randomization and training sessions.|"Intervention group: 12-week high-intensity interval training on a bicycle ergometer.~Control group: usual care, health recommendations for patients with chronic heart failure."||||t
1331626|NCT03184298|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331627|NCT03184285||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331628|NCT03184272||Single Group Assignment||Diagnostic||None (Open Label)||evaluate direct impacts of preventive measurement||||
1331629|NCT03184259|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331630|NCT03184246|Randomized|Parallel Assignment||Prevention||Double||Interventional group will be intubated by videolaryngoscopy, control group by direct laryngoscopy|t|||t
1331631|NCT03184233|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients undergoing elective cerebral aneurysm clipping surgery or arteriovenous malformation surgery will be asked to take part and give informed consent.~A control group of patients undergoing craniotomy without the use of RVP will be built in, having the same exclusion criteria. Both study groups receive a Magnetic Resonance Imaging of the brain pre-and postoperatively as standard of care."||||
1331632|NCT03184220|Randomized|Parallel Assignment||Treatment||Single|Blind researcher|RANDOMIZED CLINICAL TRIAL WITH BLIND EVALUATION BY THIRD PARTIES, LONGITUDINAL AND PROSPECTIVE.|||t|
1331633|NCT03184207|||Cohort||Prospective|||||||
1331634|NCT03184194|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1331635|NCT03184181|Randomized|Parallel Assignment||Treatment||Single||A specialist physician will be diagnosed the supraspinatus tendinopathy.||||t
1331636|NCT03184168||Single Group Assignment||Basic Science||None (Open Label)||Open-label, radiolabeled, single-dose study of an oral solution of [14C]lorlatinib (100 mg/100 µCi) in 6 healthy male volunteers. Confinement from Day -1 through Day 14 (or until 1 of 2 early release criteria is met). No returns; one follow-up phone call (at 28 to 35 days post dose).||||
1331637|NCT03184155|Randomized|Parallel Assignment||Treatment||Triple||Randomized double blind, placebo controlled, study|t|t|t|
1331638|NCT03184142|Randomized|Parallel Assignment||Prevention||Double|Students cannot be masked as an arm undergoes a simulation intervention. The researcher evaluating the outcomes through the questionnaires will be blinded.|Single-blind randomised controlled trial with two experimental arms and a control arm|||t|t
1331639|NCT03184129|Randomized|Parallel Assignment||Treatment||Single||||||t
1331640|NCT03184116|Randomized|Parallel Assignment||Prevention||Single||||||t
1331641|NCT03184103|||Case-Only||Prospective|||||||
1331642|NCT03184090||Single Group Assignment||Treatment||None (Open Label)||||||
1331643|NCT03184077|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331644|NCT03184064|Randomized|Crossover Assignment||Prevention||Double||Incomplete block cross-over design. Each participant receives placebo plus 3 out of 4 active treatments.|t||t|
1331645|NCT03184051|||Cohort||Prospective|||||||
1331646|NCT03184038||Single Group Assignment||Supportive Care||None (Open Label)||||||
1331647|NCT03184025||Single Group Assignment||Treatment||||||||
1331648|NCT03184012|Randomized|Parallel Assignment||Treatment||None (Open Label)||one group assigned to be treated with Zirconia crowns, the other group assigned to be treated with resin composite strip crowns||||
1331649|NCT03183999|Randomized|Parallel Assignment||Supportive Care||Double|"Participant masking:~To intervention arm, capsules including 160mg of fermented ginseng(GINST) ingredients will be provided. To control arm, capsules of the same shape and weight as GINST capsules will be provided. These apsules are made of a cellulose component.~Care provider masking The care providers will be unaware which participant belonged to the experimental group or control group during stuty period."|Randomized, double-blind, placebo-controlled trial for evaluation of sperm motility improvement effect of fermented ginseng|t|t||
1331650|NCT03183986|Randomized|Single Group Assignment||Treatment||None (Open Label)||Infants are randomised to phototherapy with blue LED's with wavelength of 478 or 459 nm. The decrease of TSB between the groups is compared.||||
1331651|NCT03183973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331652|NCT03183960|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1331653|NCT03183947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331654|NCT03183934|||Case-Only||Prospective|||||||
1331655|NCT03183921|||Cohort||Prospective|||||||
1331656|NCT03183908|Randomized|Parallel Assignment||Prevention||Triple|Subject, study coordinators, and investigators will be blinded to the type of flu vaccine administered. Only the vaccinator will be unblinded.||t||t|t
1331657|NCT03183895||Single Group Assignment||Treatment||None (Open Label)||||||
1331658|NCT03183882|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1331659|NCT03183869|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a prospective, cross-over, open label, randomized 1:1 early versus delayed groups, interventional [FMT] versus no interventional [no FMT] controlled trial to explore the effects of FMT from a healthy donor to RMS patients and investigate whether this can influence disease activity based on a panel of biological markers.||||
1331660|NCT03183856|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1331661|NCT03183843|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331662|NCT03183830|Randomized|Parallel Assignment||Basic Science||Triple|All members of the study team and volunteer participants will be blinded to treatment versus placebo arm|Double-blind randomised-control parallel two-limb study|t||t|t
1331663|NCT03183817|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331664|NCT03183804|||Case-Only||Prospective|||||||
1331665|NCT03183791|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1331666|NCT03183778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1331667|NCT03183765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331668|NCT03183752|Randomized|Parallel Assignment||Treatment||Double|The same researcher blinded regarding location group will access thyroid volume and thyroid nodule volume by ultrasound, in the beginning, six months and one year after randomization|A randomized clinical trial with two groups: to use placebo or Metformine|t|||t
1331669|NCT03183739|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1331670|NCT03183726|||Case-Only||Prospective|||||||
1331671|NCT03183713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331672|NCT03183700|Randomized|Parallel Assignment||Screening||||||||
1331673|NCT03183687|||Cohort||Retrospective|||||||
1331674|NCT03183674|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1331675|NCT03183661|||Case-Only||Prospective|||||||
1331676|NCT03183648|||Case-Only||Prospective|||||||
1331677|NCT03183635|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331678|NCT03183622|||Case-Only||Prospective|||||||
1331679|NCT03183609|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized double blind trial|t|t|t|t
1331680|NCT03183596|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"There has been no large, randomized study to define optimal location of injection based on analgesia and duration. Patients will be randomized to receive a deep Serratus Anterior Block (DSAB) where local anesthetic is deposited deep to the serratus or a superficial Serratus Anterior Block (SSAB) where the local anesthetic is placed between serratus and latissimus dorsi."||||
1331681|NCT03183583|||Cohort||Retrospective|||||||
1331682|NCT03183570||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331683|NCT03183557|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331684|NCT03183544||Single Group Assignment||Diagnostic||None (Open Label)||5 patients with limited recurrent prostate cancer and 3 healthy volunteers will be enrolled in this clinical trial||||
1331685|NCT03183531|||Case-Only||Retrospective|||||||
1331686|NCT03183518|Randomized|Parallel Assignment||Basic Science||Single||||||t
1331687|NCT03183505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331688|NCT03183492||Single Group Assignment||Prevention||None (Open Label)||||||
1331732|NCT03182920|Randomized|Crossover Assignment||Basic Science||Double||2 Groups: Group 1 - Double-blind Randomized 2-Period Crossover, Group 2 - Open-label single dose|t||t|
1331733|NCT03182907|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1331689|NCT03183479|Randomized|Parallel Assignment||Prevention||Triple|After randomization, the unblinded independent investigator will be in charge of fibrinogen concentrate (drug) or placebo preparation, which will be performed in a laboratory next to the operating room. When the patient meets the inclusion criteria and is enrolled in the study, the functional fibrinogen tests will be done in the same laboratory by the same researcher, and drug or placebo will be prepared in sterile bags with opaque covers afterwards. Fibrinogen concentrate will be diluted in 100mL of sterile water or an equivalent volume of 0.9% saline solution as placebo and will be delivered to the operating room by the investigator. The anesthesiologists, the surgical staff, and the patients will all be blinded.||t|t||t
1331690|NCT03183466||||Treatment||||||||
1331691|NCT03183453|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331692|NCT03183440|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1331693|NCT03183427|||Case-Control||Retrospective|||||||
1331694|NCT03183414|||Cohort||Prospective|||||||
1331695|NCT03183401|||Cohort||Prospective|||||||
1331696|NCT03183388||Single Group Assignment||Treatment||None (Open Label)||It is planned that 52 subjects who meet criteria for bipolar disorder (BDI, BDII, BD-OS) will complete this combined psychotherapy (BE-SMART) and imaging study. There will be variation of therapies, but no comparison between groups.||||
1331697|NCT03183375|Randomized|Parallel Assignment||Treatment||None (Open Label)||One is intervention arm which will be given investigational drug along with standard treatment and one will be control arm which will be given standard treatment only. Both groups will be assigned to only one treatment parallelly.||||
1331698|NCT03183362|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1331699|NCT03183349|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331700|NCT03183336|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331701|NCT03183323|Randomized|Parallel Assignment||Treatment||Single|"Group assignment is not masked at performance tests. Group assignment is masked to the echo/MRI technican, and for investigators interpreting the recordings.~Masking is not relevant for laboratory analysis."|RCT, 1:1 into telerehabilitation or standard care. Patients will be stratified by EF >/< 40 %, age >/< 60 years and by sex.||||t
1331702|NCT03183310|Randomized|Crossover Assignment||Other||Triple|Sessions will run in a double-blind randomized-controlled way. The order of placebo and chlorpromazine administration will be randomized by an online randomization tool (http://www.randomization.com/). The randomization scheme will be carried out by an experienced independent researcher or study nurse, this person will prepare and inject chlorpromazine or placebo. In this way, the investigator performing the actual study and data analysis will be blinded until termination of the study.|a randomized, double-blind, placebo-controlled study|t||t|t
1331703|NCT03183297|Randomized|Crossover Assignment||Prevention||Triple||A Double-Blind, Placebo-Controlled, 4-Way Crossover Study|t|t|t|
1331704|NCT03183284|||Cohort||Prospective|||||||
1331705|NCT03183271||Single Group Assignment||Treatment||None (Open Label)||||||
1331706|NCT03183258||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331707|NCT03183245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331708|NCT03183232|Randomized|Parallel Assignment||Treatment||Single|||||t|
1331709|NCT03183219|Randomized|Parallel Assignment||Treatment||Single|||||t|
1331710|NCT03183206|Randomized|Parallel Assignment||Treatment||Single|||||t|
1331711|NCT03183193|Randomized|Parallel Assignment||Treatment||Single||The participants are randomly assigned to Control or FLiO strategy.|t|||
1331712|NCT03183180|||Cohort||Retrospective|||||||
1331713|NCT03183167|||Cohort||Retrospective|||||||
1331714|NCT03183154|||Other||Other|||||||
1331715|NCT03183141||Single Group Assignment||Treatment||None (Open Label)||||||
1331716|NCT03183128|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331717|NCT03183115|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331718|NCT03183102|Randomized|Parallel Assignment||Basic Science||Single|Biological samples will be masked for endpoint analysis|||||t
1331719|NCT03183089|Randomized|Parallel Assignment||Treatment||Single|||||t|
1331720|NCT03183076|Randomized|Parallel Assignment||Supportive Care||Single|MD María Ingrid Alanis Guevara. Neurologist Hospital of the Western National Medical Center. Guadalajara. Mexico|Clinical trial, Parallel, controled|||t|
1331721|NCT03183063|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||"Patients will be imaged with SPECT/CT and 4DCT to compare perfusion with the respiratory induced blood mass changed (RIBMC) defect. Each patient will have both imaging studies performed on the same day.~15 subjects will be enrolled into Cohort 1 and will receive SPECT/CT and 4DCT imaging as described. After those are enrolled another 5 subjects will be enrolled into Cohort 2 and will receive SPECT/CT and 4DCT imaging as previously described with the first 4DCT being obtained with normal breathing and the second scan being obtained with positive pressure breathing via BiPAP. Cohort 3 will enroll 124 participants with clinical suspicion of PE, who will be or have had CTA imaging. 4DCT imaging will be performed for these study participants."||||
1331722|NCT03183050||Single Group Assignment||Supportive Care||None (Open Label)||||||
1331723|NCT03183037|Randomized|Parallel Assignment||Treatment||Double||Three - arm pilot randomized controlled trial|t|||t
1331724|NCT03183024|Non-Randomized|Parallel Assignment||Treatment||Single|single-blind||t|||
1331725|NCT03183011||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331726|NCT03182998|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331727|NCT03182985||Single Group Assignment||Prevention||None (Open Label)||||||
1331728|NCT03182972|Randomized|Parallel Assignment||Health Services Research||Double|Both the patients and the pharmacists recruited for the study will not be informed whether they are in the control or intervention group|University College Hospital, Ibadan will serve as the intervention group while University of Ilorin Teaching Hospital, Ilorin will serve as the control group.|t|t||
1331729|NCT03182959|Randomized|Crossover Assignment||Prevention||None (Open Label)||Participants will be randomized to receive either 50 mg glucoraphanin (GR) in Cycle 1 and 100 mg GR in cycle 2, or 100 mg GR in Cycle 1 and 50 mg GR in Cycle 2, but all participants will receive both doses.||||
1331730|NCT03182946|||Cohort||Prospective|||||||
1331731|NCT03182933|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1331734|NCT03182894||Single Group Assignment||Treatment||None (Open Label)||||||
1331735|NCT03182881|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331736|NCT03182868||||||||||||
1331737|NCT03182855|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized trial. No blinding||||
1331738|NCT03182842|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1331739|NCT03182829|||Other||Prospective|||||||
1331740|NCT03182816||Single Group Assignment||Treatment||None (Open Label)||||||
1331741|NCT03182803||Single Group Assignment||Treatment||None (Open Label)||||||
1331742|NCT03182790|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1331743|NCT03182777|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1331744|NCT03182764|||Cohort||Cross-Sectional|||||||
1331745|NCT03182751|Randomized|Parallel Assignment||Treatment||Quadruple|Using dynamic allocation will ensure that the study subjects will remain balanced on the stratification factors and the treatment group assignment throughout the entire subject accrual phase. This system will be utilized by Central pharmacy personnel to generate the treatment group assignments. Medications will then be delivered from the Central Pharmacy to the emergency department in packaging that does not delineate whether it contains placebo or tranexamic acid. Thus, the patient, treating surgeon, emergency department physician, residents, hospitalist group, anesthesiologist, and data collectors will remain blinded to the treatment assignment.|Subjects will be randomized into one of two study groups: TXA administration (treatment) or placebo (control). In order to ensure balance on the subject demographics between the two study groups, the subjects will be stratified on gender, age group (<75 vs. ≥75) and body mass index (<30 vs. ≥30). Within each stratum, subjects will be assigned to either the treatment group or control group using an electronic dynamic allocation program housed in a computer application developed by personnel in the Division of Biomedical Statistics and Informatics.|t|t|t|t
1331746|NCT03182738|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1331747|NCT03182725|Randomized|Crossover Assignment||Treatment||Quadruple||20 patients with POTS will receive Ivabradine treatment vs placebo for one month. Then there will be a one-month wash out period prior to the cross over in which patients who received Ivabradine will receive the placebo, and patients who initially were on placebo will now receive Ivabradine.|t|t|t|t
1331748|NCT03182712|Randomized|Parallel Assignment||Basic Science||Single||"The selected subjects were referred to the University laboratory. During their first visit, the subjects were submitted to perform the first high intensity sub-maximal test. In the same day, volunteers received the supplementation capsules that should be taken throughout eight weeks, as described in the supplementation section.~The subjects were randomly assigned to two groups: (1) group placebo and (2) n-3 PUFA group. After the supplementation period, all subjects reported back to hospital to biochemical testing and thereafter to the university exercise laboratory for the second high intensity sub-maximal test, following the same protocol described above."|t|||
1331749|NCT03182699|Randomized|Parallel Assignment||Treatment||Double|"Radiologist investigating the cMRI and physician performing the echocardiography will be blinded.~Patients will also be blinded"||t|||t
1331750|NCT03182686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331751|NCT03182673||Single Group Assignment||Treatment||None (Open Label)||SHR7390 and SHR-1210||||
1331752|NCT03182660||||||||||||
1331753|NCT03182647|||Cohort||Retrospective|||||||
1331754|NCT03182634|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1331755|NCT03182621|Randomized|Parallel Assignment||Other||Single|||t|||
1331756|NCT03182608|Randomized|Crossover Assignment||Diagnostic||Double|An investigator evaluate the interspinous level using anatomic landmarks, then other independent investigator assess the consistency of the landmarks-guided interspinous level with the actual one using ultrasonography. Participants are blinded to the assessment results.|Crossover|t|||t
1331757|NCT03182595||Single Group Assignment||Basic Science||None (Open Label)||||||
1331758|NCT03182582|Randomized|Crossover Assignment||Treatment||Single|The investigator is blinded to which patient is receiving sharp or laser debridement as his/her first treatment.|A portion of the patients will be randomized to sharp debridement first, then laser for the second debridement. The other portion will undergo this in the opposite order.|||t|
1331759|NCT03182569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331760|NCT03182556|Randomized|Parallel Assignment||Treatment||Single|||||t|
1331761|NCT03182543|Randomized|Crossover Assignment||Prevention||None (Open Label)||The prescription of the treatments (AM1, AM2) and control (water) was randomized. The subject consumed 600mL of AM1, AM2 or water. 2 hours later subject performed the exercise test. Next treatment was evaluated after a week of wash-out.||||
1331762|NCT03182530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331763|NCT03182517|||Other||Cross-Sectional|||||||
1331764|NCT03182504||Single Group Assignment||Treatment||None (Open Label)||||||
1331765|NCT03182491|||Other||Prospective|||||||
1331766|NCT03182478|Randomized|Parallel Assignment||Treatment||Single|Patients will be evaluated through scales applied before and after intervention by investigators that will be blinded about the intervention arm of the patient (individual or group format)|Intervention with Rothbaum protocol adapted to skin picking disorder, in individual or group format, consisting of eight weekly sessions, each session during 45 minutes in individual format and 90 minutes in group format||||t
1331767|NCT03182465||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331768|NCT03182452|||Cohort||Prospective|||||||
1331769|NCT03182439|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1331770|NCT03182426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331771|NCT03182413|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1331772|NCT03182400||Single Group Assignment||Basic Science||None (Open Label)||||||
1331773|NCT03182387|||Other||Prospective|||||||
1331820|NCT03181776||Single Group Assignment||Prevention||None (Open Label)||The study will investigate the effect of different tilting angles on the hemodynamics of full term pregnants before and after spinal anesthesia||||
1331870|NCT03181126||Single Group Assignment||Treatment||None (Open Label)||||||
1331871|NCT03181113|||Cohort||Cross-Sectional|||||||
1577067|NCT00005188||||||||||||
1331774|NCT03182374|Randomized|Crossover Assignment||Treatment||Quadruple|This is a double-blind study where subjects and evaluators are blinded to treatment up to 12-months. During the long-term follow-up phase (12 - 60 months), only subjects will be blinded to the study treatment resulting in single-blind design following 12-month follow-up time point.|During the long-term follow-up phase (12 - 60 months), subjects may also elect to cross over to the other treatment arm and receive additional injections of the other treatment as frequently as needed, provided they did not experience any significant clinical concerns after previous treatment administrations and are benefiting from it, as determined by the investigator. Subjects may only cross over from their originally assigned treatment group to the other treatment group one time during the study.|t|t|t|t
1331775|NCT03182361||Single Group Assignment||Treatment||None (Open Label)||||||
1331776|NCT03182348|||Cohort||Prospective|||||||
1331777|NCT03182335|||Cohort||Prospective|||||||
1331778|NCT03182322|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1331779|NCT03182309|||Case-Control||Prospective|||||||
1331780|NCT03182296|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Comparison of women with and without a history of gestational diabetes||||
1331781|NCT03182283|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Non-randomized before and after design.||||
1331782|NCT03182270||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331783|NCT03182257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1331784|NCT03182244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331785|NCT03182231||Sequential Assignment||Basic Science||None (Open Label)||Patients will receive an 68Ga-NODAGA-exendin-4 PET/CT scan before RYGB and 1 year after RYGB||||
1331786|NCT03182218|||Other||Prospective|||||||
1331787|NCT03182205|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1331788|NCT03182192|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Comparison of patients with hypoglycemia to control patients||||
1331789|NCT03182179|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1331790|NCT03182166||Single Group Assignment||Treatment||None (Open Label)||||||
1331791|NCT03182153|||Case-Only||Prospective|||||||
1331792|NCT03182140|||Cohort||Prospective|||||||
1331793|NCT03182127||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331794|NCT03182114|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1331795|NCT03182101||Single Group Assignment||Treatment||None (Open Label)||||||
1331796|NCT03182088|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331797|NCT03182075|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1331798|NCT03182062|Randomized|Parallel Assignment||Prevention||Single|||t|||
1331799|NCT03182049|||Cohort||Prospective|||||||
1331800|NCT03182036||Single Group Assignment||Treatment||None (Open Label)||||||
1331801|NCT03182023|||Case-Only||Retrospective|||||||
1331802|NCT03182010|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1331803|NCT03181997|||Cohort||Other|||||||
1331804|NCT03181984||Single Group Assignment||Treatment||None (Open Label)||||||
1331805|NCT03181971|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1331806|NCT03181958|Randomized|Parallel Assignment||Treatment||Double|Blinding towards the caregivers is impossible and blinding towards the patients makes no sense. However, outcomes' assessors will be blinded, as endpoints will be recorded by investigators not involved in patients' care. An assessor per each participating NICU will be nominated. Moreover, investigators performing the final statistical analyses will be blinded to the treatment allocation, as data collected by assessors will be inserted in the dedicated website and the arms' allocation will be re-coded.|"When the neonate had fulfilled the extubation criteria, extubation will took place with a gentle intratracheal suction. Upper airways will then be suctioned and intervention will be started immediately as follows:~Ventilators~CPAP: CPAP will be provided by either variable flow or continuous flow devices, as there is no evidence that one type of CPAP generator would be better than any other.~NIPPV: NIPPV will be provided by any type of neonatal ventilator. Synchronization will not be applied, as many currently marketed neonatal ventilators usually do not provide it for NIPPV.~NHFOV: NHFOV will only be provided with piston/membrane oscillators able to provide a real oscillatory pressure with active expiratory phase (that is, Acutronic FABIAN-III, SLE 5000, Loweinstein Med LEONI+, Sensormedics 3100A). Other machines providing high frequency ventilations will not be used.~Importantly, the randomization should be done within one hour from the extubation to avoid bias."|||t|t
1331807|NCT03181945|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label study|Whether 4 weeks anti-epileptic drug is as efficacious as 12 weeks anti-epileptic drug therapy for Acute Encephalitis syndrome||||
1331808|NCT03181932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331809|NCT03181919|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331810|NCT03181906|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1331811|NCT03181893|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1331812|NCT03181880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331813|NCT03181867|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1331814|NCT03181854|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331815|NCT03181841|Randomized|Parallel Assignment||Basic Science||Quadruple|double-blind||t|t|t|t
1331816|NCT03181828|Randomized|Crossover Assignment||Treatment||None (Open Label)||This pilot randomized crossover study will first evaluate the impact of AHA versus non-AHA primarily on intestinal flora cleavage of an infused bolus of 13C-Urea and secondarily on other biomarkers in healthy adults before applying the same crossover design to UCD subjects.||||
1331817|NCT03181815||Single Group Assignment||Treatment||None (Open Label)||||||
1331818|NCT03181802|Randomized|Crossover Assignment||Treatment||Double||This study was a randomized, double-blinded, placebo-controlled phase 3 trial comparing Intramuscular injections of botulinum toxin A to a placebo in patients with chronic low-back pain (LBP)|t||t|
1331819|NCT03181789|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331869|NCT03181139|||Cohort||Retrospective|||||||
1331821|NCT03181763|Randomized|Parallel Assignment||Basic Science||Double||Blinded, placebo between group; all participants undergo fear conditioning, with half randomized to receive 100 mg MDMA and half receiving inactive placebo|t||t|
1331822|NCT03181750|Randomized|Parallel Assignment||Supportive Care||Double|Principal Investigator and outcomes assessor blinded to group allocation.|Multi-site Randomized Controlled Trial|||t|t
1331823|NCT03181737|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331824|NCT03181724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331825|NCT03181711|||Case-Only||Prospective|||||||
1331826|NCT03181698|||Case-Control||Prospective|||||||
1331827|NCT03181685|Randomized|Crossover Assignment||Supportive Care||Single||This is randomized, controlled, prospective, crossover, open-label, two-treatments, two-period trial|||t|
1331828|NCT03181672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331829|NCT03181659|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1331830|NCT03181646|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1331831|NCT03181633||Single Group Assignment||Treatment||None (Open Label)||||||
1331832|NCT03181620|Randomized|Parallel Assignment||Treatment||None (Open Label)||Un-blinded, Prospective, Randomized Control Trial||||
1331833|NCT03181607|||Case-Control||Prospective|||||||
1331834|NCT03181594||Single Group Assignment||Treatment||None (Open Label)||||||
1331835|NCT03181581|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1331836|NCT03181568|Randomized|Parallel Assignment||Supportive Care||Double|Investigator will be blinded to study Clinical staff that will evaluate wounds at baseline, 2, 4, 6, 8, 10 and 12 weeks after date of randomisation and therapy initiation will be blinded|This will be a single blinded randomised trial where the control group will be receiving a standard wound care whereas the treatment group would also be receiving standard wound care but under the guidance of the imaging device.||t|t|
1331837|NCT03181555||Single Group Assignment||Basic Science||None (Open Label)|No masking. A convenience sample of pregnant AA women will be recruited based on race/ethnicity and body mass index.|||||
1331838|NCT03181542|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized, controlled trial||||
1331839|NCT03181529|Randomized|Parallel Assignment||Treatment||Single|Primary outcome measure (GRID-HAMD) will be assessed by raters blinded to randomization condition.|||||t
1331840|NCT03181516|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1331841|NCT03181503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331842|NCT03181490|||Cohort||Cross-Sectional|||||||
1331843|NCT03181477||Single Group Assignment||Treatment||None (Open Label)||||||
1331844|NCT03181464|Randomized|Crossover Assignment||Treatment||Double||Randomized, double-blind, placebo-controlled cross-over trial|t||t|
1331845|NCT03181451|Randomized|Parallel Assignment||Other||None (Open Label)||Subjects will be randomized in a 1:1:1 ratio and stratified by co-variates for age and sex. This will ensure that a minimum of 25% of each gender and at least 3 children per age group are enrolled in each Ferric Maltol dose group.||||
1331846|NCT03181438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1331847|NCT03181425|||Cohort||Prospective|||||||
1331848|NCT03181412|||Cohort||Retrospective|||||||
1331849|NCT03181399||Single Group Assignment||Treatment||None (Open Label)||All subjects will receive supplementation at the maximum tolerated dose.||||
1331850|NCT03181386|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1331851|NCT03181373|||Case-Only||Prospective|||||||
1331852|NCT03181360|Randomized|Parallel Assignment||Treatment||Single||||||t
1331853|NCT03181347|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331854|NCT03181334|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1331855|NCT03181321|Randomized|Crossover Assignment||Prevention||None (Open Label)||The investigators will conduct a 6 month, two-arm, CRCT: TF20 vs. Control (which will receive delayed treatment after 6 months). Eligible fire departments volunteering for the trial will be randomized to one of the two study treatment arms. Treatment outcomes will be assessed at baseline and 6 months by our staff.||||
1331856|NCT03181308||Single Group Assignment||Treatment||None (Open Label)||||||
1331857|NCT03181295|Randomized|Sequential Assignment||Health Services Research||Single||Single-centre, pilot step wedge trial, with graduated, random intervention roll-out across the clinical setting in four steps||||t
1331858|NCT03181282|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor will be blinded to group assignment.|||||t
1331859|NCT03181269|Randomized|Parallel Assignment||Other||Double|||t|||t
1331860|NCT03181256|||Case-Only||Prospective|||||||
1331861|NCT03181243|Randomized|Parallel Assignment||Treatment||Single||Because the length of sperm retrieval procedure is significantly different between groups, we use matched pairs based on the length of procedure as the matching variable for the primary outcome (pain relief) by specify two in one block. We create a block 2 to assign sample numbers equally to each group (MadaJet or needle injection) and assign equitably the block to each procedure (TESE or PESA). Therefore, patients will be randomized, using a computer-generated randomization list in a 1:1 ratio and block 2, to either the MadaJet group or to needle injection group after the assessment of eligibility and signing informed consents. Allocation of patients will be done by a third-party via telephone according to the specified list. The patients don't know which anaesthesia technique will be performed.|t|||
1331862|NCT03181230|||Case-Only||Cross-Sectional|||||||
1331863|NCT03181217|Randomized|Crossover Assignment||Basic Science||Single||||||t
1331864|NCT03181204|||Other||Cross-Sectional|||||||
1331865|NCT03181191|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1331866|NCT03181178|Randomized|Parallel Assignment||Prevention||Single|Single blind cluster randomized trial - all participants in a community received the same treatment.|The study has three intervention arms and one cross sectional growth monitoring follow up group.|t|||
1331867|NCT03181165|Randomized|Parallel Assignment||Treatment||None (Open Label)|Participants will know group assignments|Pragmatic effectiveness trial of diet intervention led by community pharmacists versus treatment-as-usual waitlist control.||||
1331868|NCT03181152|||Cohort||Prospective|||||||
1331872|NCT03181100|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331873|NCT03181087||Single Group Assignment||Treatment||None (Open Label)||||||
1331874|NCT03181074|||Cohort||Prospective|||||||
1331875|NCT03181061|||Other||Other|||||||
1331876|NCT03181048|Randomized|Parallel Assignment||Treatment||Single|"Patients will be randomized in a 1:1 fashion. The first arm will be the PAO alone group who will receive a standard periacetabular osteotomy (PAO) on the day of surgery. The second arm will be the PAO + HA group who will receive a PAO and hip arthroscopy (HA) on the day of surgery. Any pathology if present that can be corrected with the arthroscope (cartilage and labral abnormalities) will be addressed. This will be followed by a standard PAO. Patients from both groups will have dressings placed in the location of hip arthroscopy portals to remain blinded to the treatment arm during the perioperative period. Only patients in the PAO + HA group will have incisions and sutures under these dressings. The dressings will come off for all patients after 2 weeks, which is standard of care. All other study team members will remain unblinded."||t|||
1331877|NCT03181035||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331878|NCT03181022|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1331879|NCT03181009|Randomized|Parallel Assignment||Treatment||Double|Blinded labeling (Individual dosing cups will mention a choice of two doses the participant could be assigned to). Oat flour is used as the filler to create equal volumes for all doses|This is a phase 2 multi site study that will be conducted at two centers in the U.S. All subjects will receive oral immunotherapy for their specific food allergies (peanut, egg, milk, wheat, soy, cashew, walnut, almond, hazelnut, sesame seed, cod, salmon and shrimp). All participants will receive three doses of Omalizumab 4 weeks apart over 8 weeks. The subject's allergens will be introduced after receiving the third omalizumab dose. Subjects will return to clinic to escalate the dose of their allergens until 300 mg (group A) vs. 1200 mg (group B) total protein daily dose is reached. There will be equivalent allergen protein portions depending on test allergen per each subject's history. Subjects will be randomized 1:1 to either group A or group B after meeting eligibility criteria. All subjects and study personnel will be blinded to group A vs B.|t||t|
1331880|NCT03180996|||Cohort||Prospective|||||||
1331881|NCT03180983|Randomized|Parallel Assignment||Other||None (Open Label)||CLUSTER RANDOMIZED STUDY||||
1331882|NCT03180970|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1331883|NCT03180957|Randomized|Parallel Assignment||Treatment||Quadruple|During Dose Response part of the trial the Investigator will be blinded. During the Early Disease part of the trial the Investigator will not be blinded but will not carry out any outcome assessments.||t|t|t|t
1331884|NCT03180944|Randomized|Parallel Assignment||Screening||Double|||||t|t
1331885|NCT03180931|||Case-Only||Cross-Sectional|||||||
1331886|NCT03180918||Single Group Assignment||Prevention||None (Open Label)||||||
1331887|NCT03180905|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1331888|NCT03180892|||Cohort||Other|||||||
1331889|NCT03180879|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1331890|NCT03180866|Randomized|Single Group Assignment||Treatment||Double|The subject will act as their own control as one target plaque will receive treatment and one will not. This information will not be made available to the Investigators or the bio-statistician.||||t|t
1331891|NCT03180853|||Cohort||Prospective|||||||
1331892|NCT03180840||Single Group Assignment||Treatment||None (Open Label)||Switch over study in patients previously receiving either agalsidase alfa or agalsidase beta and switched to pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease.||||
1331893|NCT03180827||Single Group Assignment||Prevention||None (Open Label)||||||
1331894|NCT03180814|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1331895|NCT03180801|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331896|NCT03180788|Randomized|Parallel Assignment||Treatment||Single|Randomisation to either traction assisted ESD or traditional ESD|Prospective randomiced Clinical trial|||t|
1331897|NCT03180775|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1331898|NCT03180762|Randomized|Parallel Assignment||Other||Double|||t||t|
1331899|NCT03180749|||Cohort||Prospective|||||||
1331900|NCT03180736|Randomized|Parallel Assignment||Treatment||Single|Masking: Open Label|Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment|t|||
1331901|NCT03180723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331902|NCT03180710|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1331903|NCT03180697|||Cohort||Prospective|||||||
1331904|NCT03180684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331905|NCT03180671|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1331906|NCT03180658|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331907|NCT03180645|Randomized|Parallel Assignment||Treatment||Single||||||t
1331908|NCT03180632|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1331909|NCT03180619||Single Group Assignment||Treatment||None (Open Label)||||||
1331910|NCT03180606|||Case-Control||Prospective|||||||
1331911|NCT03180593|Randomized|Parallel Assignment||Prevention||Single|alternating|Prospective, randomized, open label, blinded-endpoint (PROBE)|||t|
1331912|NCT03180580||Single Group Assignment||Other||None (Open Label)||||||
1331913|NCT03180567|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1331967|NCT03179852||Sequential Assignment||Treatment||None (Open Label)||||||
1331968|NCT03179839|Randomized|Parallel Assignment||Treatment||Single|||||t|
1331969|NCT03179826|||Case-Only||Cross-Sectional|||||||
1331970|NCT03179813|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1331971|NCT03179800|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1331972|NCT03179787|||Cohort||Prospective|||||||
1331973|NCT03179774|Randomized|Parallel Assignment||Treatment||None (Open Label)||Part 1: Clinical registry study (Optimal medical therapy group vs. Endovascular revascularization and optimal medical therapy) Part 2: Randomized control trial (Optimal medical therapy group vs. Endovascular revascularization and optimal medical therapy)||||
1577068|NCT00005187||||||||||||
1331914|NCT03180554|Randomized|Factorial Assignment||Treatment||Single|All statistical analyses will be performed blinded by a statistician who is blinded by participants' ID and health record.|This study will use a single blind randomized controlled experimental design. A total of N=84 consenting CWP patients will be consecutively recruited and randomized from the Department of Pain Management and Research at Oslo University Hospital, Norway. Participants will be randomized to either an experimental tVNS group, a sham tVNS group, an experimental MNRB group, or a sham MNRB group. Both active and sham treatment interventions will be delivered at home, twice a day, for 15 min in the morning and for 15 min in the evening, for a total duration of 4 weeks. The participants' adherence to both interventions will be monitored electronically. An 80 % completion of tVNS stimulation and MNRB training will be regarded as adequate adherence in this project. Participants are invited to the clinic twice for pre- and post-intervention data collection.||||t
1331915|NCT03180541|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331916|NCT03180528||Single Group Assignment||Treatment||None (Open Label)||||||
1331917|NCT03180515||Single Group Assignment||Basic Science||None (Open Label)||||||
1331918|NCT03180502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331919|NCT03180489|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1331920|NCT03180476||Single Group Assignment||Treatment||None (Open Label)||||||
1331921|NCT03180463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331922|NCT03180450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331923|NCT03180437|Randomized|Parallel Assignment||Treatment||Single|||||t|
1331924|NCT03180424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331925|NCT03180411|||Cohort||Prospective|||||||
1331926|NCT03180398||Single Group Assignment||Treatment||None (Open Label)||||||
1331927|NCT03180385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331928|NCT03180372||Single Group Assignment||Treatment||None (Open Label)||||||
1331929|NCT03180359||Single Group Assignment||Other||None (Open Label)||||||
1331930|NCT03180346|Randomized|Parallel Assignment||Prevention||Single||||||t
1331931|NCT03180333|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1331932|NCT03180320|Randomized|Parallel Assignment||Treatment||None (Open Label)|Given the nature of the intervention, it is not possible to blind the patients and personnel involved in conducting the programs.|||||
1331933|NCT03180307|Randomized|Parallel Assignment||Other||Single|||t|||
1331934|NCT03180294|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1331935|NCT03180281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331936|NCT03180268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331937|NCT03180255|Randomized|Parallel Assignment||Treatment||Quadruple|Sponsor, investigator, subject will all be masked to study treatment assignment.|Double-masked, randomized, placebo-controlled, multi-center, Phase 2b clinical trial designed to evaluate the efficacy and safety of transcleral iontophoretic delivery of dexamethasone phosphate ophthalmic solution in patients having undergone cataract surgery with implantation of a monofocal posterior chamber IOL.|t|t|t|t
1331938|NCT03180242|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1331939|NCT03180229|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1331940|NCT03180216||Single Group Assignment||Treatment||None (Open Label)||||||
1331941|NCT03180203|Randomized|Parallel Assignment||Treatment||Single|"The participant will not know which ventilation mode will be or is used. The primairy investigator and care providers are aware of which ventilation mode is used since it is not possible to blind the care providers because they will need to change ventilating parameters if necessary.~The outcome assesor for the percentages of time will be masked. Also are the radiologists, who judge the postoperative thoracic x-ray, masked."|||||t
1331942|NCT03180190|||Case-Only||Cross-Sectional|||||||
1331943|NCT03180177|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331944|NCT03180164||Single Group Assignment||Screening||None (Open Label)||||||
1331945|NCT03180151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331946|NCT03180138|Randomized|Parallel Assignment||Health Services Research||Single|Study team members are blinded to group assignments.|Single blinded prospective study|||t|
1331947|NCT03180125|Randomized|Parallel Assignment||Treatment||Single|||||t|
1331948|NCT03180112|||Case-Control||Cross-Sectional|||||||
1331949|NCT03180099|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1331950|NCT03180086||Single Group Assignment||Health Services Research||None (Open Label)||||||
1331951|NCT03180073|||Case-Only||Prospective|||||||
1331952|NCT03180060|||Other||Other|||||||
1331953|NCT03180034|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1331954|NCT03180021|||Case-Control||Prospective|||||||
1331955|NCT03180008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331956|NCT03179995|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1331957|NCT03179982|Randomized|Parallel Assignment||Prevention||Single|Single Blind|||||t
1331958|NCT03179969|||Cohort||Prospective|||||||
1331959|NCT03179956||Single Group Assignment||Basic Science||None (Open Label)||||||
1331960|NCT03179943||Single Group Assignment||Treatment||None (Open Label)||||||
1331961|NCT03179930||Single Group Assignment||Treatment||None (Open Label)||This is a protocol comprised of a single institution phase II study in FL and HL||||
1331962|NCT03179917||Single Group Assignment||Treatment||None (Open Label)||This phase II study will use an optimal Simon two-stage design.||||
1331963|NCT03179904||Single Group Assignment||Treatment||None (Open Label)||||||
1331964|NCT03179891|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a multi-center, open label, single-dose study that consists of 4 periods: Screening Period, Treatment Period A (interictal pharmacokinetic evaluation), Treatment Period B (ictal/peri-ictal pharmacokinetic evaluation), and Follow-up Period.||||
1331965|NCT03179878|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind|Randomized, Double-blinded, Placebo controlled|t|t|t|t
1331966|NCT03179865|||Case-Only||Cross-Sectional|||||||
1577069|NCT00005186||||||||||||
1331974|NCT03179761|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1331975|NCT03179748|||Cohort||Prospective|||||||
1331976|NCT03179735|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1331977|NCT03179722|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Parallel group intervention study. In a subset of 140 patients, a pre-post study design is used.||||
1331978|NCT03179709|||Other||Cross-Sectional|||||||
1331979|NCT03179696||Single Group Assignment||Treatment||None (Open Label)||||||
1331980|NCT03179683|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study was planned as randomized controlled split-mouth clinical study. Bilateral sinus bone augmentation and dental implant surgeries were done simultaneously. Low level laser therapy (LLLT) was (λ= 630-660 nm, 25 mw / cm², 6 mins) applied for just one operation side at first, third, fifth and seventh days. Treatment side were randomly selected by another surgeon who applied LLLT and no treatment were applied to other group(control group)||||
1331981|NCT03179670|||Other||Prospective|||||||
1331982|NCT03179657|||Cohort||Prospective|||||||
1331983|NCT03179644||Single Group Assignment||Other||None (Open Label)||Adult patient admitted in the Respiratory Distress and Severe Infections Intensive Care Unit in the postoperative period following a double lung transplant, the objective is to To assess the correlation between the mean pleural pressure and esophageal pressure||||
1331984|NCT03179631|Randomized|Parallel Assignment||Treatment||Quadruple|A randomized, double-blind, placebo-controlled,72-week study and its 72-week open-label extension|This study describes the randomized, double-blind, placebo-controlled, 72-week study and its 72-week open-label extension|t|t|t|t
1331985|NCT03179618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331986|NCT03179605||Sequential Assignment||Treatment||None (Open Label)||In the first stage, subjects who are at least 12 years of age and not more than 16.9 years (16 years and 11 months) of age with moderate to severe plaque psoriasis will be treated with DFD-06 (at least 20 completed subjects). In the second stage subjects who are at least 6 years of age and not more than 11.9 years (11 years and 11 months) of age with moderate to severe plaque psoriasis will be treated with DFD-06 (at least 20 completed subjects).||||
1331987|NCT03179592||Single Group Assignment||Diagnostic||None (Open Label)||Patients will undergo their CCTA scan using our clinically established CT scanning protocols with a modified patient-specific contrast injection protocol that is dependent on the tube voltage that is selected by the scanner to be used for the CCTA acquisition.||||
1331988|NCT03179579|Randomized|Parallel Assignment||Treatment||Single|||t|||
1331989|NCT03179566|Randomized|Parallel Assignment||Other||None (Open Label)||A run-in period will precede the randomization sequence. Individuals will be randomized to one of two groups based on the day of their surgery.||||
1331990|NCT03179553|||Cohort||Prospective|||||||
1331991|NCT03179540||Single Group Assignment||Treatment||None (Open Label)||||||
1331992|NCT03179527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331993|NCT03179514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1331994|NCT03179501|Randomized|Parallel Assignment||Basic Science||Quadruple|Double-blind|Single-site, randomized, double-blind, placebo-controlled|t|t|t|t
1331995|NCT03179488|Randomized|Crossover Assignment||Treatment||Double||Randomized, double-blind, placebo-controlled, crossover trial|t|||t
1331996|NCT03179475||Single Group Assignment||Treatment||None (Open Label)||||||
1331997|NCT03179462|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1331998|NCT03179449||Single Group Assignment||Diagnostic||None (Open Label)||||||
1331999|NCT03179436|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332000|NCT03179423|Randomized|Parallel Assignment||Treatment||Quadruple||The first part of the trial is double-blind and the second part is open-label with all participants receiving the active treatment.|t|t|t|t
1332001|NCT03179410||Single Group Assignment||Treatment||None (Open Label)||||||
1332002|NCT03179397|Randomized|Parallel Assignment||Treatment||Single|Enrolled subjects will not be told which IOL they have received until the end of the study||t|||
1332003|NCT03179384||Single Group Assignment||Other||None (Open Label)||||||
1332004|NCT03179371|||Other||Prospective|||||||
1332005|NCT03179358||Single Group Assignment||Treatment||None (Open Label)||||||
1332006|NCT03179345|Randomized|Crossover Assignment||Other||||||||
1332007|NCT03179332|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1332008|NCT03179319|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332009|NCT03179306|||Cohort||Prospective|||||||
1332010|NCT03179293|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1332011|NCT03179280|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332012|NCT03179267||Single Group Assignment||Diagnostic||None (Open Label)||Addition to standard care||||
1332013|NCT03179254|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332014|NCT03179241|||Cohort||Prospective|||||||
1332015|NCT03179228||Single Group Assignment||Treatment||None (Open Label)||Prospective Single Center||||
1332016|NCT03179215|||Case-Crossover||Prospective|||||||
1332017|NCT03179202||Single Group Assignment||Treatment||None (Open Label)||||||
1332018|NCT03179189|||Cohort||Prospective|||||||
1332019|NCT03179176||Single Group Assignment||Basic Science||None (Open Label)||||||
1332020|NCT03179163|Randomized|Parallel Assignment||Basic Science||Double|Investigator and Outcomes Assessor are masked according to treatment.|Subjects are grouped as normal (<120/80 mmHg) and hypertensive (≥140/90 mmHg and <160/110 mmHg). All subjects undergo one round of experiments. Hypertensive subjects received randomly-assigned antihypertension medication (ACEi+SH, ACEi, or diuretic) for 16 weeks and then repeat experiments. Normotensive subjects receive no intervention and repeat experiments16 weeks after initial experiments as a time control.|||t|t
1332021|NCT03179150|||Cohort||Retrospective|||||||
1332022|NCT03179137|||Case-Only||Prospective|||||||
1332023|NCT03179124|||Case-Control||Prospective|||||||
1332077|NCT03178422|Randomized|Parallel Assignment||Treatment||None (Open Label)||combination product||||
1332078|NCT03178409|||Case-Control||Retrospective|||||||
1577070|NCT00005185||||||||||||
1332024|NCT03179111|Randomized|Parallel Assignment||Treatment||Double|This will be a double blind study. Neither the participant (patient) nor the investigator (surgeon) will know which group the particular participant will be assigned.|There will be two arms in this study. One arm will be the low pressure pneumoperitoneum group (8-10mmHg) where else the other arm will be the standard pressure pneumoperitoneum group (12-15mmHg).|t||t|
1332025|NCT03179098|Randomized|Crossover Assignment||Treatment||Single|||t|||
1332026|NCT03179085|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||Participants randomized to control group will receive standard care for 12 months before entering into the delayed intervention. Participants randomized to the intervention will receive the intervention during the first 12 months.||||
1332027|NCT03179072|||Cohort||Cross-Sectional|||||||
1332028|NCT03179059|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1332029|NCT03179046|||Case-Only||Cross-Sectional|||||||
1332030|NCT03179033|||Cohort||Prospective|||||||
1332031|NCT03179020|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||In the present study ICUs will be randomized to manage potential organ donors through the use of a evidence-based checklist or to manage potential organ donors according usual care.||||
1332032|NCT03179007||Single Group Assignment||Treatment||None (Open Label)||||||
1332033|NCT03178994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332034|NCT03178981|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1332035|NCT03178968|Randomized|Parallel Assignment||Other||Single|single-blind, randomised intervention study (blinded for the surface roughness measurements, step height measurements and microhardness testing)|||||t
1332036|NCT03178955|||Case-Only||Prospective|||||||
1332037|NCT03178942|Randomized|Parallel Assignment||Treatment||Quadruple|The study product will be randomized, packaged and blinded so that the packaging for both treatments look identical.|Patients will be assigned to the test or reference permethrin to treat scabies.|t|t|t|t
1332038|NCT03178929|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332039|NCT03178916|||Cohort||Prospective|||||||
1332040|NCT03178903|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332041|NCT03178890||Single Group Assignment||Treatment||None (Open Label)||Prospective study. Each patient is his/her own control.||||
1332042|NCT03178877|||Ecologic or Community||Cross-Sectional|||||||
1332043|NCT03178864|Randomized|Parallel Assignment||Treatment||Single||||||t
1332044|NCT03178851|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332045|NCT03178838|||Other||Retrospective|||||||
1332046|NCT03178825||Single Group Assignment||Treatment||None (Open Label)||||||
1332047|NCT03178812|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||One arm containing patients with pancreatic lesion and one control group arm of healthy volunteers||||
1332048|NCT03178799|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1332049|NCT03178786|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1332050|NCT03178773|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1332051|NCT03178760|||Cohort||Prospective|||||||
1332052|NCT03178747|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1332053|NCT03178734|Randomized|Parallel Assignment||Other||None (Open Label)||This study aim is to compare UTI rates and patient satisfaction associated with indwelling Foley catheter vs a valved catheter in patients who are being discharged home with a catheter after urogynecologic proecures via a Randomized Clinical Trial.||||
1332054|NCT03178721|||Case-Crossover||Other|||||||
1332055|NCT03178708|Randomized|Parallel Assignment||Treatment||None (Open Label)||the role of preoperative administration of Amantadine Sulphate on the duration of wake up test and postoperative opiod consumption in patients undergoing major spine deformities corrective surgeries.||||
1332056|NCT03178695|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A study group receives the intervention, which is compared in terms of efficacy against a matched group of control patients.||||
1332057|NCT03178682|||Cohort||Prospective|||||||
1332058|NCT03178669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332059|NCT03178656|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1332060|NCT03178643|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332061|NCT03178630|||Cohort||Prospective|||||||
1332062|NCT03178617|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332063|NCT03178604|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1332064|NCT03178591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332065|NCT03178578|||Case-Only||Prospective|||||||
1332066|NCT03178565|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Mechanically ventilated patients will be randomized to receive respiratory physiotherapy using a mechanical insufflation-exsufflation device (intervention group) or to receive standard respiratory physiotherapy without the use of a mechanical insufflation-exsufflation device (control group).||||
1332067|NCT03178552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332068|NCT03178539|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1332069|NCT03178526|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1332070|NCT03178513|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332071|NCT03178500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332072|NCT03178487|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1332073|NCT03178474|Randomized|Parallel Assignment||Prevention||Single|Researchers involved in laboratory tests will be blinded to the group status|||||t
1332074|NCT03178461|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomization two 2 groups according to temperature of IV fluids. One group will receive room temperature fluids and the other group will receive body temperature fluids.||||
1332075|NCT03178448|||Cohort||Prospective|||||||
1332076|NCT03178435|Randomized|Parallel Assignment||Prevention||None (Open Label)||interventional cluster randomised trial -pilot /feasibility study||||
1332133|NCT03177694|||Case-Only||Prospective|||||||
1332079|NCT03178396|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332080|NCT03178383|Randomized|Parallel Assignment||Prevention||Single|||t|||
1332081|NCT03178370|||Cohort||Prospective|||||||
1332082|NCT03178357|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332083|NCT03178344|Randomized|Crossover Assignment||Basic Science||Double|This study will follow a double-blind experimental design, so neither the participant nor the experimenter will know what kind of stimulation the participant is receiving at what session. A separate unblinded monitor, who will not interact with the participants, will be responsible for creating the stimulation codes for each session.|Each participant will receive sham stimulation or 10 Hz tACS stimulation at two separate sessions. The order will be randomized (ie, half the participants will receive sham stimulation at the first session and 10 Hz tACS stimulation at the second session, and the other half will receive 10 Hz tACS stimulation at the first session and sham stimulation at the second session).|t||t|
1332084|NCT03178331|||Cohort||Prospective|||||||
1332085|NCT03178318||Single Group Assignment||Basic Science||None (Open Label)||Healthy volunteers||||
1332086|NCT03178305|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized controlled trial where patients will be randomly (2:2) assigned to the intervention vs control group.||||
1332087|NCT03178292|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332088|NCT03178279||Single Group Assignment||Health Services Research||None (Open Label)||The study will take place in 2 community mental health teams and have 3 main stages. Stage 1: The investigators will undertake focus groups with service users and staff to test out the assumptions in the Theory of Change. Stage 2: The PHP will be available as a paper version and on iPad and smartphone. Each team will be asked to work with all of the people on their caseload to complete the PHP. Service users will be encouraged to complete the PHP whilst waiting for their appointment with their care co-ordinator. The completed PHP will then be emailed to the service user and to their care co-ordinator and they will then be asked to develop an action plan to address any gaps in the completed PHP. Each action plan and the progress made with the action plan will be recorded. This exploratory trial will last six months. Stage 3 The investigators will evaluate the experience of using the PHP using interviews with a random selection of service users and clinical staff.||||
1332089|NCT03178266|||Case-Control||Prospective|||||||
1332090|NCT03178253|||Case-Control||Prospective|||||||
1332091|NCT03178240|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332092|NCT03178227|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332093|NCT03178214|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332094|NCT03178201||Single Group Assignment||Treatment||None (Open Label)||||||
1332095|NCT03178188|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1332096|NCT03178175|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332097|NCT03178162|||Other||Prospective|||||||
1332098|NCT03178149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332099|NCT03178136|||Cohort||Prospective|||||||
1332100|NCT03178123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332101|NCT03178110||Single Group Assignment||Treatment||None (Open Label)||The methodology of a single subject design will be used with multiple baseline and during treatment measures to determine the effectiveness of the treatment protocol.||||
1332102|NCT03178097|||Other||Prospective|||||||
1332103|NCT03178084|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)||t|t|t|t
1332104|NCT03178071||||||||||||
1332105|NCT03178058|||Cohort||Prospective|||||||
1332106|NCT03178045|||Cohort||Prospective|||||||
1332107|NCT03178032||Single Group Assignment||Treatment||None (Open Label)||||||
1332108|NCT03178019|||Other||Cross-Sectional|||||||
1332109|NCT03178006|||Case-Crossover||Cross-Sectional|||||||
1332110|NCT03177993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332111|NCT03177980|||Case-Only||Prospective|||||||
1332112|NCT03177967|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332113|NCT03177954||Single Group Assignment||Treatment||None (Open Label)||||||
1332114|NCT03177941|Randomized|Parallel Assignment||Prevention||Single||2 Group Random Clinical Trial|||t|
1332115|NCT03177928|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332116|NCT03177915|Randomized|Parallel Assignment||Treatment||Double||Investigate if, and to what extent, hydro-dissection using Hyalase versus saline, under ultrasound guidance, can improve the clinical condition, change in nerve conduction parameters of patients with CTS and delay or avoid the surgical intervention.|t|||t
1332117|NCT03177902|||Cohort||Prospective|||||||
1332118|NCT03177889|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332119|NCT03177876|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332120|NCT03177863||Single Group Assignment||Treatment||None (Open Label)||||||
1332121|NCT03177850|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332122|NCT03177837|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332123|NCT03177824|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1332124|NCT03177811|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332125|NCT03177798|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1332126|NCT03177785|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1332127|NCT03177772|||Ecologic or Community||Prospective|||||||
1332128|NCT03177759|||Cohort||Prospective|||||||
1332129|NCT03177746||Single Group Assignment||Treatment||None (Open Label)||||||
1332130|NCT03177733|||Cohort||Prospective|||||||
1332131|NCT03177720|Randomized|Parallel Assignment||Other||None (Open Label)||24 patients and 18 healthy volunteers are included. 12 patients and 9 volunteers are receiving imipenem as study drug, the other 12 patients and 9 volunteers receive ciprofloxacin.||||
1332132|NCT03177707|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||Couples will be randomized to an immediate or delayed treatment group; the delayed treatment couples will be considered the waitlist control group in this study.||||
1332134|NCT03177681|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332135|NCT03177668||Single Group Assignment||Treatment||None (Open Label)||||||
1332136|NCT03177655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332137|NCT03177642|||Cohort||Prospective|||||||
1332138|NCT03177629|Randomized|Parallel Assignment||Treatment||None (Open Label)||"treatment group vs control group Patients in treatment group will be treated with antibiotics for H. pylori eradication at visit 1.~Control group has 2 stage. Fot the 1st stage (for 3 months), the patient will be observed without any treatment. And at visit 4, at 2nd stage, they will be treated with the same regimen for H. pylori eradication."||||
1332139|NCT03177616|Randomized|Parallel Assignment||Treatment||Single||||||t
1332140|NCT03177603|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332141|NCT03177590||Single Group Assignment||Other||None (Open Label)||||||
1332142|NCT03177577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332143|NCT03177564|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332144|NCT03177551|||Cohort||Prospective|||||||
1332145|NCT03177538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332146|NCT03177525|Randomized|Parallel Assignment||Treatment||Single||||||t
1332147|NCT03177512|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332148|NCT03177499||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332149|NCT03177486|||Case-Crossover||Retrospective|||||||
1332150|NCT03177473|||Cohort||Prospective|||||||
1332151|NCT03177460|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332152|NCT03177447||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332153|NCT03177434|Randomized|Parallel Assignment||Treatment||Single|||||t|
1332154|NCT03177421|Randomized|Parallel Assignment||Health Services Research||Double||Midway through the study, participants from the control group will be folded into the intervention group.|t|t||
1332155|NCT03177408|||Case-Control||Prospective|||||||
1332156|NCT03177395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332157|NCT03177382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332158|NCT03177369|||Cohort||Retrospective|||||||
1332159|NCT03177356|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332160|NCT03177343|||Cohort||Retrospective|||||||
1332161|NCT03177330|||Case-Only||Retrospective|||||||
1332162|NCT03177317||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332163|NCT03177304||Single Group Assignment||Other||None (Open Label)||||||
1332164|NCT03177291|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332165|NCT03177278||Single Group Assignment||Treatment||None (Open Label)||||||
1332166|NCT03177265|Randomized|Sequential Assignment||Treatment||Double||The investigators will first randomize each Veteran, stratified by site, to: a) Text-to-Engage vs. standard Proactive Outreach (PrO). For those who enroll in counseling, the investigators will then randomize them to: b) Text-to-Enhance + Telephone Counseling vs. Telephone Counseling alone (TelC). Primary outcomes will be the rate of enrollment in counseling and cotinine-verified quit rate at 12 months.|||t|t
1332167|NCT03177252|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1332168|NCT03177239||Single Group Assignment||Treatment||None (Open Label)||||||
1332169|NCT03177226|Non-Randomized|Crossover Assignment||Device Feasibility||Single|||t|||
1332170|NCT03177213|||Cohort||Prospective|||||||
1332171|NCT03177200|||Cohort||Prospective|||||||
1332172|NCT03177187|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Open label|||||
1332173|NCT03177174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332174|NCT03177161|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Participants will not be made aware of the other modes of delivery available and will be assigned a single method of delivery prior to consent.|||||
1332175|NCT03177148|Randomized|Crossover Assignment||Treatment||None (Open Label)||After two years of intervention arm study, the usual care arm will receive MI training.||||
1332176|NCT03177135||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332177|NCT03177122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332178|NCT03177109|Randomized|Factorial Assignment||Treatment||Single||||||t
1332179|NCT03177096||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332180|NCT03177083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332181|NCT03177070||Single Group Assignment||Other||None (Open Label)||||||
1332182|NCT03177057|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1332183|NCT03177044||Single Group Assignment||Treatment||None (Open Label)|All assessments are conducted by an assessor not providing the intervention|Prospective cohort||||
1332184|NCT03177031|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332185|NCT03177018||Single Group Assignment||Diagnostic||None (Open Label)||Exploratory, monocentric and prospective study||||
1332186|NCT03177005||||||||||||
1332187|NCT03176992|Randomized|Parallel Assignment||Treatment||||||||
1332188|NCT03176979||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332189|NCT03176966|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1332190|NCT03176953|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind study. Only pharmacist will have access to randomization table.|Participants randomly assigned to one of two conditions.|t|t|t|t
1332228|NCT03176459|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind Study||t|t||t
1332229|NCT03176446|Randomized|Factorial Assignment||Device Feasibility||Single|||||t|
1332230|NCT03176433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1332231|NCT03176420||Single Group Assignment||Treatment||None (Open Label)||||||
1332232|NCT03176407||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1332233|NCT03176394|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1332191|NCT03176940|Non-Randomized|Sequential Assignment||Basic Science||Double|The dietary supplement will be delivered to the Clinical Research Center by the Investigational Pharmacy at Vanderbilt University Medical Center. Staff nurses and participants will be blinded to the capsule dosage content.|The 3+3 design will be employed for this trial. At least 3 volunteers will be studied at each dose level and evaluated for adverse effects. If 0 of 3 volunteers experiences adverse events (AE), the dose is escalated. If 1 of 3 volunteers experiences an AE, 3 additional volunteers are treated. If none of the additional volunteers develop an AE, the dose is escalated, otherwise escalation ceases. If 2 of 3 or 2 of 6 volunteers experience an AE, the maximum tolerated dose (MTD) has been exceeded.|t|t||
1332192|NCT03176927|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1332193|NCT03176914|Randomized|Parallel Assignment||Prevention||Single|The data analysts will be provided with coded data that doesn't reflect which arm the data is from.|The study will have an intervention arm under which the study intervention will be implemented and this will be compared with the outcomes in the conventional intervention arm. Each arm will have 11 clusters of an average size of 50.||||t
1332194|NCT03176901|Randomized|Parallel Assignment||Other||Single|This is a blinded, randomized controlled trial. Participants are blinded to condition.|Two armed study with intervention and comparison groups running parallel to one another|t|||
1332195|NCT03176888|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized controlled trial||||
1332196|NCT03176875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332197|NCT03176862|||Cohort||Cross-Sectional|||||||
1332198|NCT03176849|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients enrolled in the study will be randomized to either a control or intervention arm prior to the start of transplant using block randomization of blocks of 6. Those randomized to the intervention arm will receive the intervention (Stoss Therapy dosing of vitamin D) at the start of transplant followed by maintenance supplementation of vitamin D according to standard of care. Those randomized into the control arm will receive only maintenance supplementation of vitamin D according to standard of care throughout transplant.||||
1332199|NCT03176836||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332200|NCT03176823|Randomized|Parallel Assignment||Treatment||Triple|While it is not technically possible to mask participants to the application of RIC versus sham therapies, all participants in this trial by design will be intubated in an intensive care unit with severe traumatic brain injury; it is improbable that our inability to mask the patients will compromise outcomes or induce bias as patients are unlikely to have consciousness or memory of the therapy.|This trial is a prospective double-blind parallel cohort study of patients undergoing either standard of care plus placebo (sham-RIC) or standard treatment plus a single session of upper extremity remote ischemic conditioning.||t|t|t
1332201|NCT03176810|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1332202|NCT03176797||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332203|NCT03176784|Randomized|Factorial Assignment||Treatment||Double|Active and placebo medications are identical in appearance. Medication labeling and the dispensing protocol are designed to prevent participants and care providers from knowing if the medication is active or placebo.|Double Blinded Placebo Controlled Factorial|t|t||
1332204|NCT03176771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332205|NCT03176758|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The participant will be non-randomly enrolled into two groups. The default treatment, which was found as the preferred method by numerous investigators will be offered to all participants. Those who will ask for the second option (general anesthesia) or those who will not be aligble for spinlal block will be enrolled in the second group.||||
1332206|NCT03176745|||Cohort||Cross-Sectional|||||||
1332207|NCT03176732|||Case-Control||Prospective|||||||
1332208|NCT03176719|||Ecologic or Community||Cross-Sectional|||||||
1332209|NCT03176706|||Cohort||Cross-Sectional|||||||
1332210|NCT03176693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332211|NCT03176680|Randomized|Parallel Assignment||Treatment||Single||||t||
1332212|NCT03176667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332213|NCT03176654|Randomized|Parallel Assignment||Basic Science||Single||Experimental Group (HVLAT manipulation) Control Group (sham HVLAT manipulation)|t|||
1332214|NCT03176641|Randomized|Parallel Assignment||Treatment||Single||||||t
1332215|NCT03176628|Randomized|Parallel Assignment||Other||Triple|Placebo capsules are identical in appearance to active agent.|Randomized 5 subjects in active arm (Basis) : 1 subject in control (placebo)|t|t|t|
1332216|NCT03176615|Randomized|Crossover Assignment||Prevention||None (Open Label)||Participants will consume a high-fat meal and a low-fat meal served seperately in a randomized order on two seperate days (two-seven days apart)||||
1332217|NCT03176602|||Cohort||Prospective|||||||
1332218|NCT03176589|Randomized|Crossover Assignment||Treatment||Double|tube without resistance|PEP|||t|t
1332219|NCT03176576|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332220|NCT03176563|||Cohort||Prospective|||||||
1332221|NCT03176550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1332222|NCT03176537|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo|"Placebo and TRT groups"|t|t|t|t
1332223|NCT03176524|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1332224|NCT03176511|Randomized|Parallel Assignment||Treatment||Single|"As with any active intervention, participants will know their group assignment and double-blinding is not possible. Of note, our primary outcome measures are objective and require post-processing, thus study staff collecting the data will be blinded to participant results. Further, our bio-engineer post-processor will be blinded to study assignment."|The proposed pilot study will employ a single-blind, two-group randomized clinical trial. We will randomly assign 24 community-dwelling older adults (≥ 60 years) from an underserved population who are at high fall risk to either: A.) 4-week MOB+DTBC intervention, or B.) 4-week MOB only intervention (n=12/group).||||t
1332225|NCT03176498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332226|NCT03176485|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332227|NCT03176472|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind|Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study|t|t|t|t
1332234|NCT03176381|||Cohort||Prospective|||||||
1332235|NCT03176368||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332236|NCT03176355||Single Group Assignment||Treatment||None (Open Label)||||||
1332237|NCT03176342||Single Group Assignment||Other||None (Open Label)||||||
1332238|NCT03176329|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Prospective randomized crossover study||||
1332239|NCT03176316||Single Group Assignment||Prevention||None (Open Label)||A paired t-test will be used to estimate the mean difference in hours to first feces between the active cohort and historical control cohort. If necessary, a Wilcoxon signed ranks test will be used to compare the two distributions.||||
1332240|NCT03176303|||Cohort||Prospective|||||||
1332241|NCT03176290|||Case-Only||Prospective|||||||
1332242|NCT03176277||Single Group Assignment||Treatment||None (Open Label)||||||
1332243|NCT03176264||Single Group Assignment||Treatment||None (Open Label)||Phase Ib study, safety run-in (N=~6 pts) followed with an expansion (N=~86 pts). One single arm: PDR001 in combination with bevacizumab and mFOLFOX6||||
1332244|NCT03176251|Randomized|Parallel Assignment||Other||Double||Randomized, two-arm, single-blinded|||t|t
1332245|NCT03176238||Single Group Assignment||Treatment||None (Open Label)||||||
1332246|NCT03176225|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332247|NCT03176212|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1332248|NCT03176199|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332249|NCT03176186|Randomized|Parallel Assignment||Treatment||Single||||||t
1332250|NCT03176173|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332251|NCT03176160|||Cohort||Prospective|||||||
1332252|NCT03176147|||Cohort||Prospective|||||||
1332253|NCT03176134|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1332254|NCT03176121||Single Group Assignment||Treatment||None (Open Label)||||||
1332255|NCT03176108|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332256|NCT03176095|Randomized|Parallel Assignment||Prevention||Triple|Double-blind||t|t|t|
1332257|NCT03176082|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1332258|NCT03176069|Randomized|Parallel Assignment||Other||Single|||||t|
1332259|NCT03176056|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized controlled trial||||
1332260|NCT03176043|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||||||
1332261|NCT03176030|||Cohort||Prospective|||||||
1332262|NCT03176017|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332263|NCT03176004|Randomized|Parallel Assignment||Basic Science||Double|Research assistants assign participants to condition; the investigator is unaware of the assignment. Participants are unaware of the distinction between ABM and CC, though they would know if they were in the wait list group.|Adolescents are randomized to either a game that trains attention away from threat (attention bias modification), a game that trains attention but unrelated to threat (control condition), or a wait list group.|t||t|
1332264|NCT03175991|||Other||Cross-Sectional|||||||
1332265|NCT03175978||Single Group Assignment||Treatment||None (Open Label)||||||
1332266|NCT03175965|||Cohort||Prospective|||||||
1332267|NCT03175952|||Cohort||Prospective|||||||
1332268|NCT03175939||Single Group Assignment||Treatment||None (Open Label)||||||
1332269|NCT03175926|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1332270|NCT03175913|Randomized|Parallel Assignment||Treatment||Double||||t||t
1332271|NCT03175900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332272|NCT03175887|Randomized|Parallel Assignment||Treatment||Single||||||t
1332273|NCT03175874|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Quantification of autophagy (LC3II and SQSTM1 / p62) by Western blotting of purified OST proteins from a bone sample from resected femoral heads during laying of a total hip prosthesis.||||
1332274|NCT03175861|||Case-Only||Prospective|||||||
1332275|NCT03175848||Single Group Assignment||Treatment||None (Open Label)||||||
1332276|NCT03175835||Single Group Assignment||Treatment||None (Open Label)||||||
1332277|NCT03175822|Randomized|Parallel Assignment||Treatment||Double|Teacher||t|||t
1332278|NCT03175809|Randomized|Parallel Assignment||Treatment||Triple|Single-blinded (outcome assessor)|Randomized clinical trial||t|t|t
1332279|NCT03175796|Randomized|Parallel Assignment||Treatment||None (Open Label)||"IMH-HV is a relationship-focused mental health intervention that aims to improve caregiver and child outcomes, including: improved caregiver mental health; enhanced positive parenting; decreased risk for physical/emotional neglect and/or abuse; and reduced risk for negative child outcomes including impaired development, cognitive delay and behavioral problems. In addition, IMH-HV services aim to reduce the probability of intergenerational transmission of the effects of unresolved loss and trauma in parents.~The IMH-HV Model uses a range of strategies for intervention, such as:~attending to the health and basic material needs of the infant/toddler, parent(s), and family members;~providing developmental guidance for positive parenting behavior;~providing counseling/emotional support for the parents;~developing parents' life coping skills and social support; and~providing infant/parent psychotherapy."||||
1332280|NCT03175783|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1332281|NCT03175770|||Cohort||Prospective|||||||
1332282|NCT03175757|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1332283|NCT03175744|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332284|NCT03175731|Randomized|Parallel Assignment||Treatment||Single||||||t
1332334|NCT03175081|Randomized|Parallel Assignment||Treatment||Double||The study will involve two groups with equal allocation of patients in the test group (local anaesthesia) and control group (normal saline) by randomization. All patients who agree to participate in this study will be randomized into one of the study groups.|t||t|
1332335|NCT03175068|Randomized|Parallel Assignment||Basic Science||Single||||||t
1332336|NCT03175055||Single Group Assignment||Other||None (Open Label)||||||
1332337|NCT03175042|||Cohort||Prospective|||||||
1332338|NCT03175029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332285|NCT03175718|Randomized|Parallel Assignment||Treatment||Double|The operative team will remain blinded to the dressing until the time of application. This trial will not be blinded to any clinical staff involved due to logistical difficulties in blinding postoperative wound dressings involving a NPWT device. The Research Coordinator/Outcomes Assessor conducting the QoL and Functional Assessment components will be blinded to which arm the participant was in.|This is a Canadian multicenter superiority randomized clinical trial in patients who are scheduled to undergo surgical resection of a soft tissue sarcoma treated with either preoperative or postoperative radiation therapy and a primary closure. The participants are randomized to two weeks of Incisional Negative Pressure Wound Therapy (Acelity) or conventional gauze dressing; the current standard of care.|t|||t
1332286|NCT03175705||Single Group Assignment||Treatment||None (Open Label)||||||
1332287|NCT03175692|||Case-Only||Cross-Sectional|||||||
1332288|NCT03175679||Single Group Assignment||Treatment||None (Open Label)||Three planned infusions for 18 patients||||
1332289|NCT03175666||Single Group Assignment||Treatment||None (Open Label)||||||
1332290|NCT03175653|Randomized|Parallel Assignment||Other||None (Open Label)|Participants and investigators will be aware of the arm to which they have been assigned.|Randomized Controlled Trial||||
1332291|NCT03175640||Single Group Assignment||Health Services Research||None (Open Label)||||||
1332292|NCT03175627|Randomized|Parallel Assignment||Treatment||Triple|Double blind (Subject, Investigator, Outcomes Assessor)|In a split-mouth design, each participant will receive 2 matched restorations, one of each material.|t||t|t
1332293|NCT03175614|Randomized|Parallel Assignment||Prevention||Single||||||t
1332294|NCT03175601|||Cohort||Cross-Sectional|||||||
1332295|NCT03175588|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||There will be three groups in this study. Two intervention and one control gruop to be compared after the intervention.||||
1332296|NCT03175575|||Case-Only||Cross-Sectional|||||||
1332297|NCT03175562|Randomized|Parallel Assignment||Basic Science||Single||||||t
1332298|NCT03175549|Randomized|Parallel Assignment||Other||Quadruple||Parallel Assignment, Double Blind, Randomized|t|t|t|t
1332299|NCT03175536|||Cohort||Retrospective|||||||
1332300|NCT03175523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332301|NCT03175510|||Other||Retrospective|||||||
1332302|NCT03175497||Single Group Assignment||Treatment||None (Open Label)||This study is comprised of two stages. The 1st stage will follow the traditional 3+3 dose-escalation design in patients with advanced solid tumor The 2nd phase will be conduced in Gastric cancer patients, primarily for PK data collection The||||
1332303|NCT03175484|||Cohort||Prospective|||||||
1332304|NCT03175471|||Cohort||Prospective|||||||
1332305|NCT03175458|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332306|NCT03175445|||Other||Retrospective|||||||
1332307|NCT03175432|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332308|NCT03175419|||Cohort||Prospective|||||||
1332309|NCT03175406|||Cohort||Prospective|||||||
1332310|NCT03175393|||Case-Only||Cross-Sectional|||||||
1332311|NCT03175380||Single Group Assignment||Basic Science||None (Open Label)||All participants (N=17) will receive BCG on Study Day 0 and Study Day 180 by intradermal administration.||||
1332312|NCT03175367|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1332313|NCT03175354|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1332314|NCT03175341|Randomized|Parallel Assignment||Treatment||Single|Single Blind (Participant)|Randomized Parallel Assignment|t|||
1332315|NCT03175328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332316|NCT03175315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332317|NCT03175302|||Cohort||Other|||||||
1332318|NCT03175289|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332319|NCT03175276|||Cohort||Prospective|||||||
1332320|NCT03175263|||Cohort||Retrospective|||||||
1332321|NCT03175250|Randomized|Parallel Assignment||Screening||Quadruple|"Participants were randomly assigned by computer algorithm to three different conditions, and the intervention took place over individually assigned computers with screens that were not observable by the care provider, investigator, or outcome assessor. The two control groups were designed to be active, that is, designed to have some effects. Thus, there was no indication of which intervention might be more effective."|Participants were randomly assigned at the individual level to one of three different conditions within each drug diversion class.|t|t|t|t
1332322|NCT03175237|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332323|NCT03175224||Single Group Assignment||Treatment||None (Open Label)|Open Label|Subjects will be assigned to a dose level in the order of study entry. Treatment includes five planned dose levels (100 mg, 200 mg, 300 mg, 400 mg, 550 mg).||||
1332324|NCT03175211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332325|NCT03175198|||Cohort||Prospective|||||||
1332326|NCT03175185|||Case-Control||Retrospective|||||||
1332327|NCT03175172||Single Group Assignment||Treatment||None (Open Label)||||||
1332328|NCT03175159|Randomized|Factorial Assignment||Prevention||Single|The outcome assessor will not be aware of the intervention assignment.|"Three-arm RTC, randomized 2:2:1 to three arms: (1) the Project IMPACT intervention, BA-RR (behavioral activation and HIV risk reduction) counseling, which lasts ten sessions; (2) the time- and intensity-matched control condition, including ten sessions of relaxation therapy with educational support; and (3) the standard of care comparison condition, including two equivalent sexual risk reduction counseling sessions."||||t
1332329|NCT03175146||Single Group Assignment||Treatment||None (Open Label)||||||
1332330|NCT03175133||Single Group Assignment||Treatment||None (Open Label)||||||
1332331|NCT03175120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332332|NCT03175107||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1332333|NCT03175094|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332339|NCT03175016||Single Group Assignment||Treatment||None (Open Label)||||||
1332388|NCT03174379|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332389|NCT03174366||Single Group Assignment||Treatment||None (Open Label)||||||
1332340|NCT03175003|Randomized|Parallel Assignment||Prevention||Double|Products will look and taste similar, and will be provided in coded packaging|Double blind, controlled, 4 parallel arm design|t||t|
1332341|NCT03174990|||Cohort||Prospective|||||||
1332342|NCT03174977||Single Group Assignment||Other||None (Open Label)||||||
1332343|NCT03174964|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332344|NCT03174951|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332345|NCT03174938|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1332346|NCT03174925||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332347|NCT03174912|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332348|NCT03174899|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1332349|NCT03174886|Randomized|Parallel Assignment||Treatment||Single|Patients are unaware of the dosage strength they are receiving. The AADvac1 vials are numbered, and the coding unknown to the patient. The investigator handles the vaccine vials and administers the IMP.|Patients will be allocated to one of two dosage strengths of AADvac1. No placebo is used. No active comparator is used.|t|||
1332350|NCT03174873||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332351|NCT03174860|Randomized|Parallel Assignment||Prevention||Quadruple||"The patients will be randomly divided into 2 groups:~Experimental group:~Diclofenac Potassium (50 mg, Cataflam) to be administered one hour before treatment.~Control group:~Placebo to be administered one hour before treatment."|t|t|t|t
1332352|NCT03174847|||Cohort||Prospective|||||||
1332353|NCT03174834||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332354|NCT03174821|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Normal group (NC) and Type 2 diabetic (DM) group||||
1332355|NCT03174808||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332356|NCT03174795||Single Group Assignment||Treatment||None (Open Label)||||||
1332357|NCT03174782|Randomized|Parallel Assignment||Treatment||Triple|To randomize patients, consent forms will be pre-labeled with a random subject identification number. This number will serve as the participants' study ID for all data collection in order to maintain privacy and confidentiality. Additionally, this number will be linked to a sealed envelope containing the random treatment group. The study coordinator will create the labels and assemble the envelopes to ensure all investigators remain blind to the treatment groups. This sealed envelope will be given to the anesthesia providers for the amputation. The anesthesia team will then administer the assigned treatment prior to induction of general anesthesia. Half of the patients will be randomized into the treatment group, and half of the patients will be randomized into the control group.||t|t|t|
1332358|NCT03174769|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1332359|NCT03174756|Randomized|Parallel Assignment||Treatment||Quadruple|The treatment codes of the study were not accessible to the investigators and to the examiner until the data were analyzed|A double-blind randomized controlled trial with 75 participants was conducted. Participants were assigned using block randomization in five groups: HOCl 0.025% and 0.05%, CHX 0.12% and 0.2% and sterile water as placebo. Participants were instructed to use each rinse solution for 30 seconds after dental prophylaxis. Samples of saliva were taken at baseline and after 30 seconds, 1, 3.5 and 7 hours to assess substantivity establishing the bacterial viability by the fluorescence method.|t|t|t|t
1332360|NCT03174743|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1332361|NCT03174730|Randomized|Parallel Assignment||Treatment||Single|In order to control for expectancy or placebo effects, participants will be told that the study is designed to test the method of delivery of content (email vs. smartphone). They will not be aware that one group is getting something extra that the control group is not getting.|All participants will gain access to SmartQuit, a smartphone based app with tools for quitting smoking. In order to test whether the growth mindset intervention is effective, smokers will be randomly assigned to either an experimental group, where they will additionally get growth mindset content or to a control group.|t|||
1332362|NCT03174717||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332363|NCT03174704|||Cohort||Prospective|||||||
1332364|NCT03174691||Single Group Assignment||Treatment||None (Open Label)||IVF patients triggered with hCG||||
1332365|NCT03174678|Randomized|Parallel Assignment||Prevention||Single|Investigator|Retrospective study|||t|
1332366|NCT03174665|||Cohort||Retrospective|||||||
1332367|NCT03174652|||Cohort||Retrospective|||||||
1332368|NCT03174639||Single Group Assignment||Treatment||None (Open Label)||||||
1332369|NCT03174626|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332370|NCT03174613|Randomized|Parallel Assignment||Basic Science||Double|Double blind||t||t|
1332371|NCT03174600|||Cohort||Prospective|||||||
1332372|NCT03174587||Single Group Assignment||Treatment||None (Open Label)||||||
1332373|NCT03174574|||Family-Based||Prospective|||||||
1332374|NCT03174561|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332375|NCT03174548|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332376|NCT03174535|||Other||Prospective|||||||
1332377|NCT03174522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332378|NCT03174509|Randomized|Parallel Assignment||Treatment||Double|"The pre and post extubation parameters are recorded by an outcome assessor who do not know the assigned extubation method.~The assigned extubation method is coded to minimize potential bias during data analysis."|Non-inferiority trial|||t|t
1332379|NCT03174496|||Other||Prospective|||||||
1332380|NCT03174483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332381|NCT03174470||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1332382|NCT03174457|||Case-Only||Prospective|||||||
1332383|NCT03174444|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Individual randomized controlled trial with two arms.||||
1332384|NCT03174431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332385|NCT03174418|||Cohort||Prospective|||||||
1332386|NCT03174405||Single Group Assignment||Treatment||None (Open Label)||||||
1332387|NCT03174392|Randomized|Parallel Assignment||Basic Science||Single||||||t
1577071|NCT00005184||||||||||||
1332390|NCT03174353||Single Group Assignment||Prevention||None (Open Label)||||||
1332391|NCT03174340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332392|NCT03174327||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332393|NCT03174314|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332394|NCT03174301|||Other||Prospective|||||||
1332395|NCT03174288|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1332396|NCT03174275|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332397|NCT03174262|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1332398|NCT03174249||Single Group Assignment||Treatment||None (Open Label)||A series of case-studies||||
1332399|NCT03174236|Randomized|Factorial Assignment||Treatment||Quadruple|"Metronidazole and its placebo will be masked. They will both be contained in similar bottles labelled with sequential study numbers according to a prepared blocked randomisation list before the trial begins. They will also be of similar appearance.~Ceftriaxone and penicillin + gentamicin will not be masked."|The trial will investigate two separate antimicrobial interventions in a 2x2 factorial design randomised controlled clinical trial. A factorial design allows more than one intervention to be tested and is useful in assessing a potential package of care. Two randomisations will be made. The two interventions will be analysed separately. Ceftriaxone and metronidazole is an effective and commonly used antibiotic combination, hence major interactions that interfere with efficacy are considered unlikely. However, evidence for interaction between the two interventions will be tested.|t|t|t|t
1332400|NCT03174223|||Case-Control||Retrospective|||||||
1332401|NCT03174210|Randomized|Crossover Assignment||Treatment||Double||patients will be randomized into two different Groups (prospective cross-over design)|t|||t
1332402|NCT03174197|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332403|NCT03174184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332404|NCT03174171||Single Group Assignment||Treatment||None (Open Label)||||||
1332405|NCT03174158|Randomized|Parallel Assignment||Treatment||None (Open Label)||4 arm randomized controlled trial||||
1332406|NCT03174145|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1332407|NCT03174132|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332408|NCT03174119|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1332409|NCT03174106|Randomized|Parallel Assignment||Supportive Care||Double|The cardiologist, physical therapist and the physiologist at NIMI and Feiring will be masked.|Randomization to two different arms, intervention- or control-group||t||t
1332410|NCT03174093|Randomized|Parallel Assignment||Treatment||Single||||||t
1332411|NCT03174080|||Other||Prospective|||||||
1332412|NCT03174067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332413|NCT03174054|||Cohort||Prospective|||||||
1332414|NCT03174041|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1332415|NCT03174028|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1332416|NCT03174015|Randomized|Parallel Assignment||Prevention||Single|The study will be partially single blinded. Participants and investigators cannot be masked to the intervention but outcome assessors will not know where the intervention has taken place and will be given only minimal information to enable assessment of intervention exposure at the end of the survey.|A random sample of plots will be selected in Bauleni Compound and invited to participate. Intervention allocation will also be randomized, with approximately equal numbers of plots allocated to the intervention and control arms. Within the chosen plots, resident landlord households will receive the intervention and resident landlord households and one randomly selected tenant household will be chosen for data collection for both intervention and control plots.||||t
1332417|NCT03174002|Randomized|Parallel Assignment||Prevention||Single||||||t
1332418|NCT03173989|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332419|NCT03173976||Single Group Assignment||Treatment||None (Open Label)||This is a single arm open label phase 1b clinical trial assessing the safety and efficacy of neoadjuvant zoledronic acid in patients with resectable any grade chondrosarcoma as measured by pathological characteristics and recurrence free survival.||||
1332420|NCT03173963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332421|NCT03173950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332422|NCT03173937||Single Group Assignment||Treatment||None (Open Label)||||||
1332423|NCT03173924||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332424|NCT03173911|Randomized|Parallel Assignment||Other||Single||Randomized clinical trial where participants will be allocated into four intervention groups: G1 (n = 12) will receive therapeutic elastic bandage by the Therapy Taping® method (BET) in the ankles; G2 (n = 12) will receive the application of the BET in the lumbar region and G4 (n = 12) will receive the application for all the strategies. The individuals' balance will be evaluated in four moments: pre-intervention (Pre), immediately (Ime), 24 and 48 hours after intervention (24h and 48h). The main equilibrium parameters analyzed will be: ellipse area (95%) of COP in square centimeters (A-COP in cm2), average speed in centimeters per second (VM in cm / s) and average frequency in Hertz (FM in Hz) Of COP oscillations in the anterior-posterior (A / P) and mid-lateral (M / L) directions, during three postural control tasks: open-eye semitandem (STOA) and right and left unipodal support (UNPD And UNPE).|t|||
1332425|NCT03173898|Randomized|Parallel Assignment||Supportive Care||Quadruple|The method of anesthesia used for the left or right sides was blinded to the patient and determined randomly by the same surgeon (MA) who was not involved in the extraction. the extraction procedure was randomly commenced by the same resident who was blinded to the anesthetic technique administered randomly by the surgeon.participiants were also blinded to the type of technique applied on each side.|a prospective randomized double blinded, split mouth study|t|t|t|t
1332426|NCT03173885|Randomized|Parallel Assignment||Treatment||None (Open Label)||RCT (randomized controlled trial)||||
1332427|NCT03173872||Single Group Assignment||Treatment||None (Open Label)||A short prospective, exploratory one group study to assess the acceptance of Reiki in 30 military healthcare beneficiaries, by comparing pre and post Reiki intervention measures.||||
1332428|NCT03173859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332429|NCT03173846|||Cohort||Prospective|||||||
1332430|NCT03173833|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1332431|NCT03173820|Randomized|Parallel Assignment||Treatment||None (Open Label)||genotype guided vs conventional tacrolimus dosage regimen||||
1332432|NCT03173807|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a pilot study that will employ a randomized, 2-arm wait-control design||||
1332433|NCT03173794|Randomized|Parallel Assignment||Other||Single||||t||
1332434|NCT03173781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332435|NCT03173768|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1332436|NCT03173755|||Case-Control||Prospective|||||||
1332437|NCT03173742|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332438|NCT03173729|||Cohort||Prospective|||||||
1332439|NCT03173716|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1332440|NCT03173703|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332441|NCT03173690|Randomized|Parallel Assignment||Supportive Care||Single|The care provider performing medicines reconciliation at ward is semimasked. The masking might be broken if the patients tells if he/she has been interviewed earlier in the study|The included patients are randomized to either intervention or control group. The intervention group receives medicines reconciliation at the intensive care unit. The control group receive standard pharmaceutical care, which now does not include medicines reconciliation. After the patients are transferred to care at the ward, medicines reconciliation is performed for all patients.||t||
1332442|NCT03173677|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1332443|NCT03173664|||Cohort||Prospective|||||||
1332444|NCT03173651|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||prospective randomized trial||||
1332445|NCT03173638||Single Group Assignment||Treatment||None (Open Label)||||||
1332446|NCT03173625|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1332447|NCT03173612||Single Group Assignment||Treatment||None (Open Label)||||||
1332448|NCT03173599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332449|NCT03173586|||Cohort||Prospective|||||||
1332450|NCT03173573|Randomized|Parallel Assignment||Treatment||Triple|Part 1,3,4: Double blind; Part 2, 5: open label.|5-part study. Part 1,3,4: parallel assignment; Part 2: cross over assignment; Part 5: single assignment|t|t|t|
1332451|NCT03173560|Randomized|Parallel Assignment||Treatment||None (Open Label)|Study was initially double-blind.|||||
1332452|NCT03173547|Randomized|Parallel Assignment||Treatment||Double||Placebo controlled|t||t|
1332453|NCT03173534|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients will be randomized in a 1:1 allocation ratio to the following treatment arms TAVR + Medical Therapy (n=156) or simultaneous TAVR + WATCHMAN (n=156)||||
1332454|NCT03173521||Single Group Assignment||Treatment||None (Open Label)||Open Label||||
1332455|NCT03173508|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332456|NCT03173495|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1332457|NCT03173482|||Cohort||Prospective|||||||
1332458|NCT03173469|||Other||Prospective|||||||
1332459|NCT03173456|Randomized|Parallel Assignment||Treatment||Quadruple|A pharmacist working in an area inaccessible to ED staff will ensure blinding of the study by masking the medication and inserting it into indentical unmarked gel capsules, filling any void with small amounts of lactose. Randomization will be performed in blocks of 10 determined by a sequence generated at http://www.randomization.com. The pharmacist will make up numbered research packets based on the random allocation list, each with 5 tablets containing the masked investigational medication. Research packets will be removed sequentially by the nurse from the Pyxis automated medical dispensing system and administered to the study patients in the ED.|Randomized controlled trial|t|t|t|t
1332460|NCT03173443|Randomized|Parallel Assignment||Device Feasibility||Double|||t|||t
1332461|NCT03173430||Single Group Assignment||Treatment||None (Open Label)||||||
1332462|NCT03173417||Single Group Assignment||Treatment||None (Open Label)||||||
1332463|NCT03173404|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Randomized open-label clinical trial. Women scheduled for their first or second IVF/ICSI cycle and with no abnormality detected in transvaginal ultrasound examination, were randomized to two groups.~In the first group (group I): 31 patients underwent hysteroscopy examination before IVF cycle.~The second group (group II): 37 patients underwent direct cycle without previous hysteroscopy."||||
1332464|NCT03173391|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332465|NCT03173378|||Case-Control||Cross-Sectional|||||||
1332466|NCT03173365||Single Group Assignment||Treatment||None (Open Label)||The respective palm to be treated will be randomly assessed and will be matched for handedness to include equal numbers of dominant and non‐dominant treated palms.||||
1332467|NCT03173352|||Cohort||Prospective|||||||
1332468|NCT03173339|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1332469|NCT03173326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332470|NCT03173313|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332471|NCT03173300|||Cohort||Prospective|||||||
1332472|NCT03173287||Single Group Assignment||Diagnostic||None (Open Label)|Open|||||
1332473|NCT03173274|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1332474|NCT03173261||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332475|NCT03173248|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1332476|NCT03173235|||Case-Control||Prospective|||||||
1332477|NCT03173222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332478|NCT03173209||Single Group Assignment||Prevention||None (Open Label)||A one-group (N 93) mixed-methods design using a pretest-posttest survey and qualitative analysis of written reﬂections was used to explore the meaning and outcomes of the Calm Moments Cards program.||||
1332479|NCT03173196|||Case-Control||Prospective|||||||
1332480|NCT03173183|Randomized|Parallel Assignment||Treatment||Double||The research is designed by randomized, double-blind, placebo and parallel clinical control.|t||t|
1332481|NCT03173170||Single Group Assignment||Other||None (Open Label)||||||
1332482|NCT03173157||Single Group Assignment||Health Services Research||None (Open Label)||||||
1332483|NCT03173144|||Cohort||Prospective|||||||
1332484|NCT03173131|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1332485|NCT03173118|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332486|NCT03173105|Randomized|Parallel Assignment||Treatment||Triple|The participants won´t know if they will be using the activated tDCS or Sham . The care provider also won´t know whether the participant used the tDCS or Sham as well as the outcome evaluator won´t know which is the patient´s condition.|Participants will be randomly allocated to four groups: Group 1 (G1) - active tDCS + dynamic proprioceptive exercises; Group 2 (G2) - sham tDCS + dynamic proprioceptive exercises; Group 3 (G3)- active tDCS + static proprioceptive exercises; and Group 4 (G4) - sham tDCS + static proprioceptive exercises. Randomization will be performed with the use of sealed opaque envelopes containing a card stipulating to which group the volunteer will be allocated (G1, G2, G3 or G4).|t|t||t
1332487|NCT03173092||Single Group Assignment||Treatment||None (Open Label)||||||
1332488|NCT03173079|||Cohort||Prospective|||||||
1332489|NCT03173066||Single Group Assignment||Diagnostic||None (Open Label)||single-arm, open label||||
1332490|NCT03173053|Randomized|Parallel Assignment||Prevention||None (Open Label)||Multicenter, randomized controlled, open label superiority trial||||
1332491|NCT03173040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332492|NCT03173027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332493|NCT03173014|||Case-Only||Prospective|||||||
1332494|NCT03173001|||Cohort||Prospective|||||||
1332495|NCT03172988|Randomized|Factorial Assignment||Supportive Care||Quadruple|||t|t|t|t
1332496|NCT03172975|Randomized|Parallel Assignment||Prevention||Quadruple|Participants and investigators will be blinded to study product allocation.||t|t|t|t
1332497|NCT03172962|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1332498|NCT03172949||||||||||||
1332499|NCT03172936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is comprised of two treatment arms.~Group A will include patients with accessible solid tumors and lymphomas. This group will receive a fixed dose of PDR001 intravenous on day 1 of every 28 day cycle and intratumoral injections of MIW815 (ADU-S100) on days 1, 8 and 15 of every 28 day cycle.~Group B will include patients with accessible solid tumors and lymphomas. This group will receive a fixed dose of PDR001 intravenous on day 1 of every cycle and an intratumoral injection of MIW815 (ADU-S100) on day 1 of every cycle.~Once the maximum tolerated dose and/or recommended dose for expansion is determined, the expansion part of the study will open."||||
1332500|NCT03172923|Randomized|Parallel Assignment||Treatment||Single|outcome assessor is blinded to treatment given|randomised controlled trial||||t
1332501|NCT03172910|Randomized|Sequential Assignment||Treatment||Single|||t|||
1332502|NCT03172897|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332503|NCT03172884|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332504|NCT03172871|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1332505|NCT03172858|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized controlled trial||||
1332506|NCT03172845|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1332507|NCT03172832|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized comparative effectiveness trial||||
1332508|NCT03172819||Single Group Assignment||Treatment||None (Open Label)||||||
1332509|NCT03172806|||Cohort||Prospective|||||||
1332510|NCT03172793|Non-Randomized|Sequential Assignment||Other||None (Open Label)||This pharmacokinetic study uses a sequential, adaptive design to determine the pharmacokinetics and safety/tolerability of increasing weight based doses of telavancin. During Arm 1, participants will receive 7.5 mg/kg daily. Upon completion of data collection and assessment of safety/tolerability, Arm 2 participants will receiving 10 mg/kg daily. After completion of Arms 1 and 2, a preliminary pharmacokinetic and pharmacodynamic analysis will be conducted. These results, combined with the safety/tolerability of the 10mg/kg dose, will provide decision support to select a PK/PD optimized dose for Arm 3.||||
1332511|NCT03172780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332512|NCT03172767|||Case-Control||Prospective|||||||
1332513|NCT03172754|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332514|NCT03172741|Randomized|Parallel Assignment||Basic Science||Triple|Double blind placebo controlled||t||t|t
1332515|NCT03172728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332516|NCT03172715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332517|NCT03172702||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332518|NCT03172689||Single Group Assignment||Diagnostic||None (Open Label)||children with an clinical indication for cardiac output monitoring in ICU or OR||||
1332519|NCT03172676|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332520|NCT03172663|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1332521|NCT03172650|||Case-Control||Prospective|||||||
1332522|NCT03172637|||Case-Control||Cross-Sectional|||||||
1332523|NCT03172624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a phase II study evaluating the efficacy of nivolumab in combination with ipilimumab in patients with recurrent and/or metastatic (R/M) salivary gland cancers (SGCs). Patients will be enrolled to two cohorts: Cohort 1, patients with R/M adenoid cystic carcinoma (ACC group), and Cohort 2: patients with R/M SGC of any histology, except ACC (non-ACC group)."||||
1332524|NCT03172611||Single Group Assignment||Treatment||None (Open Label)||||||
1332525|NCT03172598|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1332526|NCT03172585||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332527|NCT03172572|||Cohort||Retrospective|||||||
1332528|NCT03172559|Randomized|Parallel Assignment||Treatment||Single|The data manager uploading the data into a database and the statistician analyzing the data will be blinded to the allocation.|Explanatory, multicenter, open label, 2-arm parallel group superiority randomized trial with stratification by center and blood group, random permuted blocks (lengths of 4 or 6) and balanced allocation (1:1).||||t
1332529|NCT03172546|||Cohort||Prospective|||||||
1577072|NCT00005183||||||||||||
1332530|NCT03172533|Randomized|Parallel Assignment||Treatment||Quadruple|double-blinded study|randomized, placebo-controlled Phase IIa clinical trial in patients with anorexia nervosa|t|t|t|t
1332531|NCT03172520||Single Group Assignment||Other||None (Open Label)||||||
1332532|NCT03172507|||Case-Control||Prospective|||||||
1332533|NCT03172494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332534|NCT03172481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332535|NCT03172468|||Cohort||Prospective|||||||
1332536|NCT03172455||||||||||||
1332537|NCT03172442|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking could be applied|The patients will be randomly assigned to one of the two groups, case or control.||||
1332538|NCT03172429|||Case-Control||Prospective|||||||
1332539|NCT03172416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1332540|NCT03172403||Single Group Assignment||Basic Science||None (Open Label)||||||
1332541|NCT03172390||Single Group Assignment||Diagnostic||None (Open Label)||Prospective cohort||||
1332542|NCT03172377|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, randomized controlled, open label non-inferiority trial||||
1332543|NCT03172364|Randomized|Parallel Assignment||Basic Science||Single||||||t
1332544|NCT03172351|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332545|NCT03172338|||Cohort||Prospective|||||||
1332546|NCT03172325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332547|NCT03172312|||Case-Only||Prospective|||||||
1332548|NCT03172299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332549|NCT03172286|Randomized|Parallel Assignment||Treatment||Double||Double blind study|t||t|
1332550|NCT03172273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332551|NCT03172260|||Case-Control||Prospective|||||||
1332552|NCT03172247|||Cohort||Prospective|||||||
1332553|NCT03172234|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332554|NCT03172221|||Case-Only||Cross-Sectional|||||||
1332555|NCT03172208|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1332556|NCT03172195||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332557|NCT03172182|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1332558|NCT03172169|||Cohort||Prospective|||||||
1332559|NCT03172156|||Cohort||Prospective|||||||
1332560|NCT03172143|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients with Crohns Disease will be randomized in a 1:1 ratio for mesenteric sparing versus high ligation of the ileocolic artery when performing an ileocolic resection for Crohn's disease.||||
1332561|NCT03172130|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332562|NCT03172117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332563|NCT03172104|||Cohort||Prospective|||||||
1332564|NCT03172091|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1332565|NCT03172078|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332566|NCT03172065|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1332567|NCT03172052|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1332568|NCT03172039|||Cohort||Retrospective|||||||
1332569|NCT03172026|Randomized|Parallel Assignment||Treatment||Quadruple||We plan a parallel group, randomized controlled pilot trial at two sites, UCLA and Burke Rehabilitation Center in White Plains, NY, to gather enough entries in a shorter time and to better generalize the results of this phase II/III pilot trial.|t|t|t|t
1332570|NCT03172013|||Case-Control||Retrospective|||||||
1332571|NCT03172000|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1332572|NCT03171987|Randomized|Parallel Assignment||Treatment||Double|The investigator and care provider will be blind to group. Participant will know their treatment.|"Lidocaine patch group: 1 piece lidocaine patch per day at back pain area.~Flurbiprofen patch group: 1 piece flurbiprofen patch per day at back pain area. Treatment last for 28 days."||t|t|
1332573|NCT03171974||Single Group Assignment||Treatment||None (Open Label)||one treatment group||||
1332574|NCT03171961|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332575|NCT03171948|Randomized|Parallel Assignment||Treatment||Single||Almond Group (AG) are asked to have a 30 gr. almond every day in their afternoon snack plus following the hypoenergetic diet Nut Free group (NFG), as control group, who continue their diet without any nut consumption.|t|||
1332576|NCT03171935|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332577|NCT03171922|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332578|NCT03171909|||Cohort||Prospective|||||||
1332579|NCT03171896|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332580|NCT03171883|||Case-Only||Cross-Sectional|||||||
1332581|NCT03171870||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332582|NCT03171857|||Case-Only||Prospective|||||||
1332583|NCT03171844||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332584|NCT03171831||Single Group Assignment||Treatment||None (Open Label)||||||
1332585|NCT03171818|Randomized|Parallel Assignment||Treatment||Quadruple|This will be a double-blinded study, meaning that both the patient (and his/her parents) and the health care providers, including neonatologist, pediatrician, nurses, physiotherapists, etc, are not allowed to know what treatment the patient has been given. Those that collect outcome parameters, such as MRI data and neurodevelopmental outcome, are also unaware of treatment allocation, meaning that blinding will be maintained during the full study-period of 18 months.|An international multicenter, randomized placebo controlled intervention study|t|t|t|t
1332586|NCT03171805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332587|NCT03171792|||Cohort||Cross-Sectional|||||||
1332588|NCT03171779|||Cohort||Prospective|||||||
1332589|NCT03171766|||Cohort||Prospective|||||||
1332590|NCT03171753|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1332684|NCT03170531|||Cohort||Prospective|||||||
1332685|NCT03170518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332686|NCT03170505|||Cohort||Prospective|||||||
1332591|NCT03171740|Randomized|Parallel Assignment||Prevention||Quadruple|Participants will not know which group they will be allocated. The anesthesia care provider will not know which premedication the patient received because another professional, who is not from the research team, will provide it to the child. The investigator and outcome assessor will only know the allocated group latter by a code which will be revealed after the end of the analysis.|All participants will receive an intranasal and an oral drug. One group will receive oral midazolam and intranasal saline, the other will receive oral saline and intranasal dexmededomedine.|t|t|t|t
1332592|NCT03171727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332593|NCT03171714|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Phase 1 - Pilot Trial:~As this device has never been used on humans, the investigators will first deploy a pilot, uncontrolled trial of 10 subjects to assess for safety, and further refine outcome measures. The same protocol will be followed as the controlled trial, except the randomization.~Phase 2 - Controlled Trial: 25 patients in each arm:~Novel silicon packing device~Usual Care, cotton gauze packing"||||
1332594|NCT03171701|||Cohort||Other|||||||
1332595|NCT03171688|||Cohort||Prospective|||||||
1332596|NCT03171675|||Case-Control||Retrospective|||||||
1332597|NCT03171662||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332598|NCT03171649|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1332599|NCT03171636|||Cohort||Prospective|||||||
1332600|NCT03171623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332601|NCT03171610|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332602|NCT03171597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332603|NCT03171584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332604|NCT03171571||Single Group Assignment||Other||None (Open Label)||||||
1332605|NCT03171558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332606|NCT03171545|Randomized|Factorial Assignment||Prevention||None (Open Label)||The study is a 2X2 factorial design, such that seven facilities will get the provider education only; seven will get the patient activation intervention only; seven will get both interventions; and seven will get no interventions.||||
1332607|NCT03171532|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332608|NCT03171519|Randomized|Parallel Assignment||Treatment||Single||||||t
1332609|NCT03171506|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study is a randomized clinical trial with a parallel arm design to evaluate the effects of 12 weeks of usual care plus AND or usual care plus KD on women with ovarian and endometrial cancer.||||
1332610|NCT03171493||Single Group Assignment||Treatment||None (Open Label)||||||
1332611|NCT03171480|Randomized|Parallel Assignment||Prevention||Quadruple|A double blinded, placebo controlled, randomized clinical trial of patients undergoing induction of labor for preeclampsia. Study drug or identical appearing placebo will be delivered to labor floor by pharmacist, after randomization.||t|t|t|t
1332612|NCT03171467||Single Group Assignment||Other||None (Open Label)||||||
1332613|NCT03171454|Randomized|Parallel Assignment||Prevention||Single|||t|||
1332614|NCT03171441|||Other||Cross-Sectional|||||||
1332615|NCT03171428|||Case-Control||Retrospective|||||||
1332616|NCT03171415|Randomized|Sequential Assignment||Treatment||Triple|Double Blind, Randomized, Placebo Controlled|This is a consecutive 4 cohort, dose escalation placebo-controlled clinical trial|t|t|t|
1332617|NCT03171402|||Other||Cross-Sectional|||||||
1332618|NCT03171389|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332619|NCT03171376|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332620|NCT03171363||Single Group Assignment||Treatment||None (Open Label)||||||
1332621|NCT03171350||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332622|NCT03171337|Randomized|Parallel Assignment||Other||Triple||The parallel group includes the positive and negative controls, the positive control is Fu's Subcutaneous Needling group and the negative is Sham acupuncture group. And the other parallel control is the fMRI of patients with CTTH VS fMRI of healthy people.|t|t|t|
1332623|NCT03171324|Randomized|Parallel Assignment||Other||Single|||t|||
1332624|NCT03171311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332625|NCT03171298||Single Group Assignment||Treatment||None (Open Label)||||||
1332626|NCT03171285|||Case-Only||Retrospective|||||||
1332627|NCT03171272|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1332628|NCT03171259|||Cohort||Prospective|||||||
1332629|NCT03171246||Single Group Assignment||Treatment||None (Open Label)||||||
1332630|NCT03171233|Randomized|Parallel Assignment||Treatment||Single||||||t
1332631|NCT03171220||Single Group Assignment||Treatment||None (Open Label)||||||
1332632|NCT03171207|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332633|NCT03171194||Single Group Assignment||Treatment||None (Open Label)||||||
1332634|NCT03171181|Non-Randomized|Single Group Assignment||Basic Science||Single||Longitudinal case-control study. Accidental sampling. Single - centre study (Hospital Universitario Miguel Servet, Zaragoza. Spain)||||t
1332635|NCT03171168|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor is the only one masked in the study. Assessor is independent of the randomization, trial coordination, and care providers.|Single blinded (evaluator), single-center, randomized controlled trial. Interventional and Control group with option for Control group to Cross over.||||t
1332636|NCT03171155||Single Group Assignment||Treatment||None (Open Label)||Implantation of the XPro System||||
1332637|NCT03171142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332638|NCT03171129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332639|NCT03171116|||Cohort||Cross-Sectional|||||||
1332640|NCT03171103|||Case-Only||Prospective|||||||
1332641|NCT03171090|Randomized|Parallel Assignment||Treatment||Double||||t||t
1332642|NCT03171077|Randomized|Parallel Assignment||Treatment||Single||||||t
1332643|NCT03171064|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332784|NCT03169231|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332644|NCT03171051|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||All subjects to receive the same treatments - right flank of abdomen with the experimental LED device and the left flank of the abdomen with the active comparator diode laser device.||||
1332645|NCT03171038|Randomized|Parallel Assignment||Treatment||Double||Prospective, multi-center randomized controlled trial|||t|t
1332646|NCT03171025||Single Group Assignment||Treatment||None (Open Label)||This is a phase 2, single arm, open label trial||||
1332647|NCT03171012|Randomized|Parallel Assignment||Treatment||Double|Randomization will be by randomization.com software, where a third person, who will not participate in the other stages of the survey, execute the process and deliver the opaque and numbered envelopes to the researcher responsible for the training, thus ensuring the confidentiality of the allocation. The patient may be allocated to the LL's CRT + PNF group, LL's CRT + Breathing, UL's CRT + PNF or UL's CRT + Breathing.|"Forty individuals into four groups: Experimental Lower Limbs (LL's CRT with PNF); Group control Lower Limbs (LL's CRT with respiration). Experimental Upper Limbs (UP's CRT with PNF) and Group control Upper Limbs (UP's CRT with respiration). Individuals will be assessed before and immediately after 20 program sessions and one month after the end of treatment.~The treatment program will have the full duration of One hour including: ten minutes of stretching (five minutes before and five Minutes after the therapeutic intervention), ten minutes of rest and 40 minutes of Aerobic treatment associated with PNF or to respiration, being performed in 20 Sessions three times a week. For therapy with the CRT used the cycle ergometer for lower or upper limbs, Based on the criteria of the ACSM and monitoring Constant blood pressure, oxygen saturation and perceived exertion. The PNF patterns will be performed in seated, dorsal, ventral and Side."|t||t|
1332648|NCT03170999|||Cohort||Prospective|||||||
1332649|NCT03170986|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1332650|NCT03170973|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Will be included 66 women, randomly divided into two groups, control and experiment, overweight, sedentary and aged 18-30 years. After a 12-hour fast, baseline blood collection will be performed in both groups. The experiment group, 12 hours after the first collection, will be submitted to a physical exercise session with energy expenditure of 250Kcal. The volunteers in the control and experiment group will make a second blood collection 24 hours after the first one.||||
1332651|NCT03170960|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose Escalation followed by Dose Expansion||||
1332652|NCT03170947|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332653|NCT03170934|||Case-Only||Prospective|||||||
1332654|NCT03170921|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1332655|NCT03170908|||Ecologic or Community||Prospective|||||||
1332656|NCT03170895||Single Group Assignment||Treatment||None (Open Label)||||||
1332657|NCT03170882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332658|NCT03170869||Single Group Assignment||Treatment||None (Open Label)||Fifty (50) subjects will be enrolled in the prospective arm.||||
1332659|NCT03170856|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomly assigned to either the exercise intervention group or the usual care group.||||
1332660|NCT03170843|Randomized|Parallel Assignment||Prevention||Single|Each participant will be under the general anesthesia without knowing which group is assigned to.|The experimental group will be using the plastic wound retractor, while the control group will use a conventional surgical pad for wound protection.|t|||
1332661|NCT03170830|Non-Randomized|Parallel Assignment||Diagnostic||Single|Sample inspector||t|||
1332662|NCT03170817|||Cohort||Prospective|||||||
1332663|NCT03170804|||Cohort||Prospective|||||||
1332664|NCT03170791||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1332665|NCT03170778|||Case-Only||Prospective|||||||
1332666|NCT03170765|Randomized|Parallel Assignment||Prevention||Double|The participants are infants ranging from 6-9 months of age. They are expected to be unaware of the intervention. The laboratory personnel performing the antibody level measurements will be blinded by sending the samples with only a four digit code that does not reveal the intervention received.|THREE ARM RCT|t|||t
1332667|NCT03170752|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1332668|NCT03170739|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1332669|NCT03170726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332670|NCT03170713|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1332671|NCT03170700|Randomized|Parallel Assignment||Prevention||Single|Assessments will be conducted by staff blind to group membership.|Participants will be randomly assigned to one of three conditions: 1) Nutrition Program (Eating Smart • Being Active) alone (control); 2) Nutrition program with parental feeding content (In-person); or 3) Nutrition program with parental feeding content (online).||||t
1332672|NCT03170687|Randomized|Parallel Assignment||Treatment||Single||||||t
1332673|NCT03170674|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332674|NCT03170661|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1332675|NCT03170648||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332676|NCT03170635||Single Group Assignment||Health Services Research||None (Open Label)||The Refreshing Recess program was provided one day/week for 6 consecutive weeks.||||
1332677|NCT03170622|||Cohort||Prospective|||||||
1332678|NCT03170609|Randomized|Sequential Assignment||Prevention||Double|||t||t|
1332679|NCT03170596|Randomized|Parallel Assignment||Treatment||Single|An independant senior dermatologist who is blinded regarding the modality used for atrophic acne scarring in each half of the face, will be assessing the outcome scores.|Microneedling procedure will be done on one half of the face and patients will be instructed to apply tazarotene 0.1% gel on the other half of the face||||t
1332680|NCT03170583|||Cohort||Prospective|||||||
1332681|NCT03170570||Single Group Assignment||Treatment||None (Open Label)||||||
1332682|NCT03170557|Randomized|Parallel Assignment||Treatment||Double|The statistician in charge for data analysis will be blind with respect to the identity of the assignment Groups (that will be coded so as not to be recognized) and will not be involved in filling data in the database to be analyzed.|Randomized comparative trial|t|||t
1332683|NCT03170544|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332687|NCT03170492|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Control Trial||||
1332688|NCT03170479|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1332689|NCT03170466|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1332690|NCT03170453|Randomized|Parallel Assignment||Treatment||Single||||||t
1332691|NCT03170440|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1332692|NCT03170427|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1332693|NCT03170414|||Cohort||Prospective|||||||
1332694|NCT03170401|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1332695|NCT03170388|Randomized|Parallel Assignment||Treatment||Triple||Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group|t|t|t|
1332696|NCT03170375|Randomized|Sequential Assignment||Prevention||Double||Phase 1 of study: randomized crossover design, 14 days each of control vs. sodium-restricted DASH diet Phase 2 of study: randomized assignment, 6 months of motivational interviewing vs. motivational interviewing plus mobile application-based promotion of dietary adherence|||t|t
1332697|NCT03170362|Randomized|Parallel Assignment||Treatment||Single||The study intervention is the provision of pharmacogenetic test results which can then be used to choice appropriate medication.||||t
1332698|NCT03170349||Single Group Assignment||Treatment||None (Open Label)||||||
1332699|NCT03170336|Randomized|Crossover Assignment||Treatment||Double||All patients need to be on an angiotensin converting enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB) daily at least four weeks prior to the study. The baseline data would be recorded. Patients enrolled will receive either amiloride or hydrochlorothiazide first for 8 weeks.Then the patients will discontinue amiloride or hydrochlorothiazide for a washout for 4 weeks, but continue with ACEI or ARB. After that patients will cross over to receive another medication for another 8 weeks.|t||t|
1332700|NCT03170323|Randomized|Parallel Assignment||Treatment||None (Open Label)||Drug: Mycophenolate mofetil, high dose steroid Drug: Cyclosporin, low dose steroid||||
1332701|NCT03170310||Single Group Assignment||Treatment||None (Open Label)||||||
1332702|NCT03170297|||Case-Control||Prospective|||||||
1332703|NCT03170284|||Cohort||Prospective|||||||
1332704|NCT03170271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332705|NCT03170258|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1332706|NCT03170245|||Case-Control||Prospective|||||||
1332707|NCT03170232|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1332708|NCT03170219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332709|NCT03170206|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 1 is a single group standard 3+3 dose escalation Phase 2 is a 3 arms randonmization||||
1332710|NCT03170193|Randomized|Parallel Assignment||Treatment||Quadruple||"This is a randomized, double-blind, placebo-controlled, ascending single-dose study in healthy subjects, which will be conducted at 1 to 3 sites in the United States.~Approximately 48 subjects will enroll in 1 of 6 dose cohorts (8 per cohort)."|t|t|t|t
1332711|NCT03170180|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332712|NCT03170167|||Other||Prospective|||||||
1332713|NCT03170154||||||||||||
1332714|NCT03170141||Single Group Assignment||Treatment||None (Open Label)||Patients with GBM will be treated with tumor targeting IgT cells expressing immune modulatory genes||||
1332715|NCT03170128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332716|NCT03170115|Randomized|Parallel Assignment||Treatment||Quadruple||preoperative induction chemotherapy followed by combined radiochemotherapy with capecitabine and aspirin|t|t|t|t
1332717|NCT03170102||Single Group Assignment||Health Services Research||None (Open Label)||A The study involved a one-group (n=19) mixed methods design using using pretest-posttest surveys and qualitative analysis of written reflections.||||
1332718|NCT03170089|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332719|NCT03170076|||Case-Control||Prospective|||||||
1332720|NCT03170063|||Cohort||Cross-Sectional|||||||
1332721|NCT03170050|Randomized|Single Group Assignment||Treatment||Double||The Subjects are injected investigational devide(YYD701-2 or Restylane Perlane Lidocaine) in right or left nasolabial folds|t|||t
1332722|NCT03170037|Randomized|Single Group Assignment||Other||None (Open Label)||Comparison of 2 two-handed mask ventilation techniques' ease to anesthesia providers||||
1332723|NCT03170024|||Case-Only||Prospective|||||||
1332724|NCT03170011||Single Group Assignment||Treatment||None (Open Label)||This cohort design study will examine the effects of a six week training program using the Biodex Sit2Stand Trainer.||||
1332725|NCT03169998|||Case-Control||Other|||||||
1332726|NCT03169985|Randomized|Parallel Assignment||Treatment||Single|The obtained intravascular ultrasound(IVUS) data will be stored through the storage device in the core lab of Heart Center of Heart Vascular Stroke Institute in Samsung Medical Center, and the treatment group to which the patient belongs would not be known. Subsequent baseline and follow-up IVUS data will be analyzed together by independent experts without knowledge of the patient's treatment group.|Prospective, open label, two-arm, randomized controlled trial||||t
1332727|NCT03169972|||Cohort||Prospective|||||||
1332728|NCT03169959|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332729|NCT03169946|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332730|NCT03169933||Single Group Assignment||Treatment||None (Open Label)||||||
1332731|NCT03169920|Randomized|Parallel Assignment||Treatment||Single||||||t
1332732|NCT03169907||Single Group Assignment||Diagnostic||None (Open Label)||This will be a prospective study. Patients will be selected from Rh isoimmunized patients (positive titre of indirect coomb's test) who are scheduled to have intrauterine blood transfusion.Selected patients will be monitored weekly from 15 weeks gestational age till 28 weeks of gestational age.||||
1332733|NCT03169894||Single Group Assignment||Treatment||None (Open Label)||||||
1332785|NCT03169218|Randomized|Parallel Assignment||Treatment||Triple|Double Blind||t||t|t
1332786|NCT03169205|||Cohort||Prospective|||||||
1332787|NCT03169192|||Cohort||Prospective|||||||
1332788|NCT03169179||Single Group Assignment||Other||None (Open Label)||Single group pre- and post- intervention, mixed methods exploratory trial||||
1332734|NCT03169881|Randomized|Parallel Assignment||Treatment||Quadruple|Primary providers and bedside caregivers will be blinded to randomization group. If the dose will be administered IV, the study drug will be administered slow IV push by the bedside nurse. If the dose will be administered subcutaneously, the study drug will be brought to the bedside in a closed container, and injections will be shielded behind screens and out of earshot from caregivers and parents. An adhesive bandage (or 2x2 gauze) will be placed over the true and sham injection sites and either taped or held in place until no evidence of the injection is visible. The parents, medical providers, data collection staff and neurodevelopmental follow up personnel will be masked to the treatment arm.|Randomized, masked, placebo-controlled trial|t|t|t|t
1332735|NCT03169868|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1332736|NCT03169855|||Other||Prospective|||||||
1332737|NCT03169842||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332738|NCT03169829||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332739|NCT03169816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332740|NCT03169803||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1332741|NCT03169790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1332742|NCT03169777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1332743|NCT03169764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1332744|NCT03169751|||Cohort||Prospective|||||||
1332745|NCT03169738|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1332746|NCT03169725|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1332747|NCT03169712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332748|NCT03169699|||Case-Control||Prospective|||||||
1332749|NCT03169686|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1332750|NCT03169673|||Cohort||Cross-Sectional|||||||
1332751|NCT03169660||Single Group Assignment||Treatment||None (Open Label)||||||
1332752|NCT03169647|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1332753|NCT03169634|Randomized|Parallel Assignment||Treatment||Double|Participants will be blinded to study arm allocation. The physiotherapists performing the functional assessments will be blinded to study arm allocation. T|This is a 3 armed study in which participants are randomised to receive 1 of 3 types of revision total knee arthroplasty|t|||t
1332754|NCT03169621|||Other||Prospective|||||||
1332755|NCT03169608|||Cohort||Prospective|||||||
1332756|NCT03169595|||Case-Only||Retrospective|||||||
1332757|NCT03169582|Randomized|Crossover Assignment||Treatment||None (Open Label)||non- inferiority, randomized, crossover, open clinical trial||||
1332758|NCT03169569|Randomized|Parallel Assignment||Prevention||Single|Randomization immediately after ESD|All procedures were performed according to the standard procedure sequence in the hemostatic powder group and control group. The Only difference between two groups was hemostatic powder (Endo-clot™) application after standard hemostasis using hemostatic forceps in the hemostatic powder group. For patients in the study group, after hemostasis on the post-resection ulcer using conventional method and removal of specimen, Endo-clot™ (EndoClot Plus, Unc., Santa Clara, CA, USA) was applied immediately onto the post-resection surface.|||t|
1332759|NCT03169556|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332760|NCT03169543||Single Group Assignment||Basic Science||None (Open Label)||||||
1332761|NCT03169530|Randomized|Parallel Assignment||Prevention||Single|Clinical outcome events will be assessed through medical record review by a masked Medical Safety Officer (MSO).|Balanced-design randomized trial, comparing the effects of one standard serving (~15 grams) of alcohol intake daily to abstention.||||t
1332762|NCT03169517|||Cohort||Prospective|||||||
1332763|NCT03169504|Randomized|Parallel Assignment||Treatment||Single||||||t
1332764|NCT03169491|Randomized|Parallel Assignment||Prevention||Double|The CPAP equipment will be programed by the technician, not knowing the children, the parents or the main researcher whether the pressure is suboptimal or therapeutic.|All recruited children with diagnosis of mild to moderate OSAS will be randomized to suboptimal (CPAP at 4 cmH2O) or therapeutical (CPAP auto from 4 to 15 cmH2O) arms, from a predetermined list in two groups of 50, blocks of 10 patients. All patients with diagnosis of severe OSAS will receive therapeutic pressure, and are considered as part of a third arm not included in the sample size.|t||t|
1332765|NCT03169478|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332766|NCT03169465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332767|NCT03169452|||Other||Cross-Sectional|||||||
1332768|NCT03169439||Single Group Assignment||Treatment||None (Open Label)||||||
1332769|NCT03169426|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1332770|NCT03169413|||Case-Control||Retrospective|||||||
1332771|NCT03169400|||Case-Control||Cross-Sectional|||||||
1332772|NCT03169387|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1332773|NCT03169374||Single Group Assignment||Treatment||None (Open Label)||||||
1332774|NCT03169361|||Cohort||Prospective|||||||
1332775|NCT03169348||Single Group Assignment||Treatment||None (Open Label)||||||
1332776|NCT03169335|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332777|NCT03169322|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332778|NCT03169309||Single Group Assignment||Supportive Care||None (Open Label)||Pre- and post- intervention trial||||
1332779|NCT03169296|||Cohort||Prospective|||||||
1332780|NCT03169283|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1332781|NCT03169270|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332782|NCT03169257|Non-Randomized|Single Group Assignment||Treatment||Single|A sonographer will perform cardiovascular imaging. Images will be reviewed by an expert pediatric cardiologist and an expert vascular surgeon blinded to patients' clinical data.|Only one group, the obese children group (OB) will be followed for one year. At baseline they received a behavioral intervention which comprises a Mediterranean balanced diet plus daily aerobic training.||||t
1332783|NCT03169244|Randomized|Parallel Assignment||Treatment||Quadruple|The design is a 1:1 random assignment to placebo or bupropion XL (300mg/d).||t|t|t|t
1332789|NCT03169166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332790|NCT03169153|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1332791|NCT03169140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332792|NCT03169127||Single Group Assignment||Supportive Care||None (Open Label)||Two Hundred healthy volunteers underwent removal of one lower third molar, will be treated to control pain, swelling and trismus with ibuprofen 600mg. Therefore, these 200 patients will be genotyped and phenotyped for these genes and their postoperative records with all data collected will be compared with the haplotypes found in the Brazilian population.||||
1332793|NCT03169114|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors - Histopathologists will be masked in terms of allocation of the study participants, when reporting histology specimen of appendix removed.|Non-Inferiority Randomized Controlled Trial||||t
1332794|NCT03169101|||Case-Control||Prospective|||||||
1332795|NCT03169088||Single Group Assignment||Other||None (Open Label)||monocentric study||||
1332796|NCT03169075|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332797|NCT03169062||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332798|NCT03169049|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1332799|NCT03169036|||Cohort||Other|||||||
1332800|NCT03169023|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332801|NCT03169010|||Cohort||Prospective|||||||
1332802|NCT03168997|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1332803|NCT03168984|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1332804|NCT03168971|Randomized|Parallel Assignment||Treatment||Single||Patient-caregiver dyads will be randomly assigned to the intervention or a usual care control condition.||||t
1332805|NCT03168958|Randomized|Parallel Assignment||Treatment||Quadruple|Study drugs will be prepared by the operating room pharmacy. All patients and care providers will be blinded to group assignment|Patients will be randomized to receieve either methadone or saline-control|t|t|t|t
1332806|NCT03168945|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1332807|NCT03168932|||Cohort||Cross-Sectional|||||||
1332808|NCT03168919||Single Group Assignment||Diagnostic||None (Open Label)||One arm study||||
1332809|NCT03168906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332810|NCT03168893|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1332811|NCT03168880|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study will test platinum based chemotherapy against the standard taxane based chemotherapy in the neo adjuvant setting as below:~Arm A: Paclitaxel (weekly *8) + AE/EC 3 weekly *4 followed by Surgery + RT Arm B: Paclitaxel+ Carboplatin (weekly *8) + AE/EC 3 weekly *4 followed by Surgery+ RT"||||
1332812|NCT03168867|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1332813|NCT03168854|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332814|NCT03168841||Single Group Assignment||Treatment||None (Open Label)||||||
1332815|NCT03168828||Single Group Assignment||Treatment||None (Open Label)||||||
1332816|NCT03168815|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients will be randomized to either HFNC delivered at 50 L/min with FiO2 50% delivered for at least 5 min prior to FOB and throughout the procedure; or to conventional supplemental LFNC delivered at 6L/min applied for at least 5 minutes prior to FOB and throughout the procedure.||||
1332817|NCT03168802|Randomized|Parallel Assignment||Treatment||None (Open Label)||50 patients in each arm.||||
1332818|NCT03168789|Randomized|Parallel Assignment||Prevention||Single||||||t
1332819|NCT03168776|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332820|NCT03168763|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1332821|NCT03168750||Single Group Assignment||Treatment||None (Open Label)||Masterloc femoral component (K151531) and MPACT acetabular shell (K103721, K132879, K122641, K143453, K143453, K131458) with Highcross PE liner.||||
1332822|NCT03168737|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332823|NCT03168724|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332824|NCT03168711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332825|NCT03168698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332826|NCT03168685||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1332827|NCT03168672||Single Group Assignment||Treatment||None (Open Label)||||||
1332828|NCT03168659||Single Group Assignment||Treatment||None (Open Label)||||||
1332829|NCT03168646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332830|NCT03168633||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332831|NCT03168620|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1332832|NCT03168607||Single Group Assignment||Treatment||None (Open Label)||||||
1332833|NCT03168594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332834|NCT03168581||Single Group Assignment||Treatment||None (Open Label)||||||
1332835|NCT03168568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332836|NCT03168555||Single Group Assignment||Diagnostic||None (Open Label)||||||
1332837|NCT03168542|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||While this study utilizes two contact lenses, the purpose was to evaluate the JJVC fitting guide. This was a non-randomized study in which eye care practitioners used the JJVC fitting guide to fit subjects with a study contact lens. Subjects may fit either in a bilateral or a contralateral fashion.||||
1332888|NCT03167879|Randomized|Factorial Assignment||Prevention||None (Open Label)||This 3-arm cluster RCT will compare (1) a multi-component intervention that integrates safer conception counseling (SCC) into existing family planning (FP) services and provides intensive training and supervision (SCC1), (2) the integration of the same intervention as in (1) into FP services but with a less intensive training and supervision model that mimics the Ministry of Health approach, and (3) usual care FP services, at 6 HIV clinics (2 per arm) operated by TASO Uganda.||||
1332889|NCT03167866|Randomized|Parallel Assignment||Diagnostic||Triple|Randomization will be by study personell that is not in contact with participants||t|t|t|
1577298|NCT00004661||||Screening||||||||
1332838|NCT03168529|Randomized|Parallel Assignment||Treatment||Quadruple|"Subjects will be randomized at baseline, then at discharge dispensed a uniquely coded IP bottle. The randomization numbers to each IP bottle will be generated and maintained in an outside dataset or randomization key. The subject ID and corresponding randomization number, recorded in REDCap, will correlate which subjects are in each group, Ivabradine or placebo.~In the case of an emergent medical event, where the unblinding of a subject is deemed medically necessary by the study PIs, the unblinded study personnel will consult the randomization key to unblind study treatment. Once a subject has been unblinded, the date, time and reason(s) for un-blinding will be recorded in the source documents and eCRF."|Prospective, randomized (1:1), placebo-controlled, double blind, study of ivabradine (Corlanor®)|t|t|t|t
1332839|NCT03168516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332840|NCT03168503|Randomized|Crossover Assignment||Prevention||Triple|Double Blind (Participant, Investigator,Outcomes Assessor)|Crossover assignment|t||t|t
1332841|NCT03168490|Randomized|Parallel Assignment||Prevention||Triple|(Participant, Investigator, Outcomes Assessor)|A single-centre, prospective, randomised, placebo-controlled, parallel-group trial|t||t|t
1332842|NCT03168477|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332843|NCT03168464||Single Group Assignment||Treatment||None (Open Label)||Eligible patients will receive on Day 1 ipilimumab 3mg/kg concurrently with Radiation therapy (6GY x 5 fractions). On Day 22, patients will receive nivolumab 240mg (every 2 weeks) in addition to ipilimumab (1mg/kg). Patients will be evaluated for response at Day 70 (+/- 7 days) for progression.||||
1332844|NCT03168451|Randomized|Parallel Assignment||Treatment||Single||The intervention group will receive data collection messages and culturally tailored messages encouraging them to quit smoking. The control group will only receive data collection messages.|t|||
1332845|NCT03168438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332846|NCT03168425|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants were randomized to either a personalized prescribing algorithm based off of inpatient opioid use versus standard discharge opioid prescribing.||||
1332847|NCT03168412|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332848|NCT03168399||Single Group Assignment||Treatment||None (Open Label)||||||
1332849|NCT03168386||Single Group Assignment||Treatment||None (Open Label)||Intenstive motor rehabilitation||||
1332850|NCT03168373|Randomized|Parallel Assignment||Treatment||Single||||||t
1332851|NCT03168360|Randomized|Parallel Assignment||Treatment||Single||||||t
1332852|NCT03168347|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1332853|NCT03168334|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1332854|NCT03168321|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1332855|NCT03168308|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1332856|NCT03168295|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Post renal transplant type 2 diabetes mellitus patients and type 2 diabetes mellitus patients without renal transplant||||
1332857|NCT03168282|||Other||Cross-Sectional|||||||
1332858|NCT03168269|||Cohort||Prospective|||||||
1332859|NCT03168256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332860|NCT03168243||Single Group Assignment||Supportive Care||None (Open Label)||This is a prospective, single arm, longitudinal, interventional, multi-centre study.||||
1332861|NCT03168230|||Cohort||Prospective|||||||
1332862|NCT03168217|||Cohort||Retrospective|||||||
1332863|NCT03168204|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332864|NCT03168191|Randomized|Crossover Assignment||Other||Double|||t|t||
1332865|NCT03168178|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Low risk women will be randomized to standard antibiotic treatment versus no antiobiotics.||||
1332866|NCT03168165|Randomized|Parallel Assignment||Treatment||None (Open Label)||Cluster randomized trial||||
1332867|NCT03168152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332868|NCT03168139||Single Group Assignment||Treatment||None (Open Label)||||||
1332869|NCT03168126|||Cohort||Prospective|||||||
1332870|NCT03168113|||Case-Control||Prospective|||||||
1332871|NCT03168100||Single Group Assignment||Treatment||None (Open Label)||||||
1332872|NCT03168087|||Case-Control||Cross-Sectional|||||||
1332873|NCT03168074||Single Group Assignment||Treatment||None (Open Label)||A Phase II window-of-opportunity study of single agent lenvatinib in estrogen receptor positive early stage breast cancer||||
1332874|NCT03168061||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1332875|NCT03168048||Single Group Assignment||Device Feasibility||None (Open Label)||Single-center prospective exploratory study||||
1332876|NCT03168035||Single Group Assignment||Treatment||None (Open Label)||||||
1332877|NCT03168022|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1332878|NCT03168009||Single Group Assignment||Basic Science||None (Open Label)||||||
1332879|NCT03167996|Randomized|Parallel Assignment||Prevention||None (Open Label)||Group A Control Group B HealthPals||||
1332880|NCT03167983|||Case-Control||Prospective|||||||
1332881|NCT03167970|||Other||Prospective|||||||
1332882|NCT03167957|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel assignment||||
1332883|NCT03167944|Randomized|Parallel Assignment||Device Feasibility||Single|||t|||
1332884|NCT03167931|Randomized|Parallel Assignment||Basic Science||Double|"Each participant is included for 2 neuromodulation sessions: one session where neurostimulation is effective, one session where neurostimulation is simulated. Sessions are performed blind for the participant and the outcome assessor.~Sessions order is randomized for each participant (no arm randomization)."|outcoume measure comparison is done between both age groups (18-49 years and 50-85 years).|t|||t
1332885|NCT03167918|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332886|NCT03167905|Randomized|Parallel Assignment||Treatment||Single||Cross over or switch to the other group of analgesia is allowed.||||t
1332887|NCT03167892|Randomized|Parallel Assignment||Treatment||Double||RCT|||t|t
1332890|NCT03167853||Single Group Assignment||Treatment||None (Open Label)||||||
1332891|NCT03167840|Randomized|Parallel Assignment||Prevention||Single||||||t
1332892|NCT03167827|Randomized|Parallel Assignment||Treatment||Double|Double Blind (Participant, Care Provider)|Parallel Assignment|t|t||
1332893|NCT03167814|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients who fill our study ciriteria are asked to join in on the study and then they are randomized in to two groups, interventional and control group||||
1332894|NCT03167801|||Case-Control||Prospective|||||||
1332895|NCT03167788|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1332896|NCT03167775||Single Group Assignment||Treatment||None (Open Label)||the patients will be treated with the Elemene Injection/Elemene Oral Emulusion in Combination with the best supportive treatment||||
1332897|NCT03167762||Single Group Assignment||Supportive Care||None (Open Label)||||||
1332898|NCT03167749|||Case-Control||Cross-Sectional|||||||
1332899|NCT03167736|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332900|NCT03167723|Randomized|Parallel Assignment||Treatment||Single|Investigator masked to outcomes data.||||t|
1332901|NCT03167710|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332902|NCT03167697|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1332903|NCT03167684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332904|NCT03167671|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor is the only one masked in the study. They are independent of the randomization, trial coordination, and care providers.|Single blinded (evaluator), single-center, randomized controlled trial. Interventional and Control group with option for Control group to Cross over.||||t
1332905|NCT03167658|Randomized|Parallel Assignment||Other||None (Open Label)||Each worksite (and all employees at that site) randomly assigned to Treatment or Control arm.||||
1332906|NCT03167645|Randomized|Parallel Assignment||Treatment||Single||||||t
1332907|NCT03167632|||Other||Cross-Sectional|||||||
1332908|NCT03167619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332909|NCT03167606|Randomized|Parallel Assignment||Prevention||Single|||t|||
1332910|NCT03167593|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332911|NCT03167580|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|Parallel Assignment||||
1332912|NCT03167567|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Women who will agree to be escorted by a medical clown during their first labor will be interviewed after delivery regarding their experience. Their answers will be compared to those of women whe were not escorted by a clown.||||
1332913|NCT03167554|Randomized|Sequential Assignment||Treatment||Triple||Randomized controlled clinical trial.|t|t||t
1332914|NCT03167541|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1332915|NCT03167528||Single Group Assignment||Prevention||None (Open Label)||||||
1332916|NCT03167515||Single Group Assignment||Treatment||None (Open Label)||||||
1332917|NCT03167502|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332918|NCT03167489||Single Group Assignment||Prevention||None (Open Label)||This pilot study includes a pre/post one group design.||||
1332919|NCT03167476|||Cohort||Prospective|||||||
1332920|NCT03167463||Single Group Assignment||Treatment||None (Open Label)||||||
1332921|NCT03167450|||Family-Based||Cross-Sectional|||||||
1332922|NCT03167437|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1332923|NCT03167424|||Cohort||Prospective|||||||
1332924|NCT03167411|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1332925|NCT03167398||Single Group Assignment||Prevention||None (Open Label)||||||
1332926|NCT03167385||Single Group Assignment||Treatment||None (Open Label)||||||
1332927|NCT03167372|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study aims to assess the feasibility of conducting a randomized trial comparing two N-of-1 trials of light therapy in cancer survivors with depressive symptoms. In the first N-of-1 trial, participants will compare bright white light with dim red light therapy. In the second N-of-1 trial, participants will compare dim white light with dim red light. Participants will be randomized in a 2:1 ratio to either the N-of-1 bright white light vs dim red light experimental arm (N=20) or to a dim white vs dim red light therapy active comparator (N=10).||||
1332928|NCT03167359||Single Group Assignment||Treatment||None (Open Label)||||||
1332929|NCT03167346|||Ecologic or Community||Prospective|||||||
1332930|NCT03167333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332931|NCT03167320|||Cohort||Prospective|||||||
1332932|NCT03167307|Randomized|Parallel Assignment||Treatment||Quadruple|placebo-controlled study|A 36-week, multi-centre, double-blind, placebo-controlled randomized superiority Study.|t|t|t|t
1332933|NCT03167294||Single Group Assignment||Treatment||None (Open Label)||||||
1332934|NCT03167281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332935|NCT03167268|Randomized|Parallel Assignment||Supportive Care||Quadruple|Double blind study||t|t|t|t
1332936|NCT03167255|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Low Dose cohort of 40 mg/kg and High Dose cohort of 80 mg/kg||||
1332937|NCT03167242|Randomized|Parallel Assignment||Treatment||Single||||||t
1332938|NCT03167216||Single Group Assignment||Basic Science||None (Open Label)||Comparison of mast cell tryptase levels and changes in symptom scores after treatment with cromolyn sodium and cetirizine hydrochloride||||
1332939|NCT03167203||Single Group Assignment||Treatment||None (Open Label)||||||
1332940|NCT03167190|Randomized|Parallel Assignment||Diagnostic||Single||Participants will be enrolled into the control group (Landmark-based palpation and skin marking) vs the experimental group (ultrasound assisted identification of bony landmarks and skin marking).|t|||
1332941|NCT03167177||Single Group Assignment||Treatment||None (Open Label)||||||
1332942|NCT03167164||Single Group Assignment||Treatment||None (Open Label)||||||
1332943|NCT03167151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332944|NCT03167138||Single Group Assignment||Treatment||None (Open Label)|No masking|Single Group Assignment||||
1332983|NCT03166631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1332984|NCT03166618|Randomized|Parallel Assignment||Treatment||Single||||||t
1332945|NCT03167125|Randomized|Crossover Assignment||Screening||None (Open Label)||"Phase I: The investigators will conduct a three-arm patient-randomized trial to compare 1) usual care, 2) automated prompts, and 3) automated plus live prompts. (Number of Arms: 3)~Phase II: This spread trial will use a stepped-wedge design, which is a variant of a crossover randomized trial, where clinics cross over from usual practice to the best practices program. In the stepped-wedge design, a baseline period controls for the level and rate of change of the outcomes prior to program implementation and the staggered implementation minimizes confounding due to changes in the secular trend. By randomizing practices to when they receive an intervention instead of whether they receive it, the stepped wedge design ensures that all practices eventually receive the intervention, an important consideration for clinic leadership. Furthermore, the wedge-defined clusters act as their own controls as they each receive both intervention conditions. (Number of Arms: 2)"||||
1332946|NCT03167112||Single Group Assignment||Treatment||None (Open Label)||||||
1332947|NCT03167099|Randomized|Parallel Assignment||Treatment||None (Open Label)|Both investigators and participants are aware of the assignment. There is no masking; only randomization.|||||
1332948|NCT03167086|Randomized|Parallel Assignment||Treatment||Double|Principal Investigators and Statisticians performing analyses will be blinded.|The design is a randomized 3-arm study comprised of 2 active psychological treatments (FCR & CBT) and a health education (HE) arm that controls for time and attention.|||t|t
1332949|NCT03167073|Randomized|Parallel Assignment||Other||Quadruple|"The coding team has labeled BFF and the dummy app as BFF-1 and BFF-2. The research team is blinded to which app is BFF-1 and which is BFF-2. Sprint Telecommunications will receive the .apks files for both apps and load one app to each research phone according to the randomization algorithm that researchers at Washington University will provide to them. This algorithm has been created to randomize participants in blocks of four. Sprint will then send the phones to the research team with labels on the box that state the research phone number and app number (ie, phone 18, BFF-2). Participants will be given the phones in a sequential manner. After the study is completed, the researchers will contact the coding team, and the study will be un-blinded."|All participants will receive a complementary android phone with 3 months of complementary internet service upon enrollment at approximately 36 weeks gestation. Women will be randomized to receiving Breastfeeding Friend (BFF; the intervention) or a dummy app (control), which looks identical to BFF but contains limited breastfeeding content available during routine prenatal care.|t|t|t|t
1332950|NCT03167060|Randomized|Parallel Assignment||Treatment||Single|Controls will undergo same treatment with the medical device, but it will be a sham treatment|Post-market clinical study of one or more CE marked devices within intended purposes, involving a change to standard care or randomisation between groups|t|||
1332951|NCT03167047|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1332952|NCT03167034|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1332953|NCT03167021|||Other||Prospective|||||||
1332954|NCT03167008|||Case-Control||Cross-Sectional|||||||
1332955|NCT03166995|Randomized|Factorial Assignment||Treatment||Single|||t|||
1332956|NCT03166982|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open|Participants receive an intervention throughout the protocol||||
1332957|NCT03166969||Single Group Assignment||Prevention||None (Open Label)||||||
1332958|NCT03166956|Randomized|Parallel Assignment||Supportive Care||Quadruple|This is a prospective double-blind randomized study for surgical ICU patients whom can sustain enteral feeding. The test group was provided with glutamine and vitamin C (the GA group); the control (C) group was provided with maltodextrin of equivalent calories as that provided in the GA group.|Randomized controlled trial|t|t|t|t
1332959|NCT03166943|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1332960|NCT03166930|Randomized|Parallel Assignment||Supportive Care||Single||Participants will be randomized to receive one of two exercise programs. Participants will not be masked regarding which group they are in, but they will not be told which group is considered standard of care and which is the intervention.||||t
1332961|NCT03166917|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332962|NCT03166904||Single Group Assignment||Treatment||None (Open Label)||Vistusertib(AZD2014) 50mg BD continuous schedule of a 28 day cycle||||
1332963|NCT03166891||Single Group Assignment||Treatment||None (Open Label)||||||
1332964|NCT03166878||Single Group Assignment||Treatment||None (Open Label)||||||
1332965|NCT03166865|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1332966|NCT03166852||Single Group Assignment||Health Services Research||None (Open Label)||One group performs HIT with techology-based feedback for 5 weeks and the next group do the same||||
1332967|NCT03166839|||Cohort||Prospective|||||||
1332968|NCT03166826|||Cohort||Prospective|||||||
1332969|NCT03166813|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1332970|NCT03166800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332971|NCT03166787|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1332972|NCT03166774|||Cohort||Prospective|||||||
1332973|NCT03166761|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332974|NCT03166748|Randomized|Parallel Assignment||Treatment||Single|||t|||
1332975|NCT03166735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1332976|NCT03166722|Randomized|Parallel Assignment||Diagnostic||Single||investigator-initiated randomised multi-centre multinational clinical trial||||t
1332977|NCT03166709|Randomized|Parallel Assignment||Prevention||None (Open Label)||Stepped wedge - 15 sites randomly divided into 5 groups which are then randomly ordered into 5 steps. Step 1 is all control. During steps 2-6 one group implements the experimental condition in assigned order until all groups are doing experimental condition.||||
1332978|NCT03166696|||Cohort||Prospective|||||||
1332979|NCT03166683|Randomized|Parallel Assignment||Other||None (Open Label)||Prospective, randomized (1:1) study of 2 treatment groups (hemopatch versus standard of care) in liver resection surgery. Non-inferiority study||||
1332980|NCT03166670|||Other||Cross-Sectional|||||||
1332981|NCT03166657|||Case-Only||Cross-Sectional|||||||
1332982|NCT03166644|Randomized|Parallel Assignment||Treatment||Single|Simple Blind : participants are unaware of the intervention assignment; investigators are aware.|Participants receive an intervention throughout the protocol|t|||
1333266|NCT03162952|||Cohort||Other|||||||
1332985|NCT03166605|Randomized|Parallel Assignment||Diagnostic||Double|Randomized control|Control, Sham , Experimental||t||t
1332986|NCT03166592|||Other||Cross-Sectional|||||||
1332987|NCT03166579||Single Group Assignment||Treatment||None (Open Label)||||||
1332988|NCT03166566||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1332989|NCT03166553|Randomized|Parallel Assignment||Treatment||None (Open Label)||One group treated with the Elemene Injection/Elemene Oral Emulusion in Combination with Systematic Chemotherapy including Oxaliplatin , another group treated with Systematic Chemotherapy including Oxaliplatin.||||
1332990|NCT03166540|Randomized|Crossover Assignment||Basic Science||Single|Sample codification, done by the PI, will be hidden to the researchers analysing the samples.|||||t
1332991|NCT03166527||Single Group Assignment||Treatment||None (Open Label)||Each patient with active CIDP will receive Panzyga (immune globulin) at standard and high infusion rates and will act as their own control.||||
1332992|NCT03166514|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||A randomized, cross-over administration of supplements with approximately 5-10 days between testing sessions.||||
1332993|NCT03166501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332994|NCT03166488||Single Group Assignment||Health Services Research||None (Open Label)||||||
1332995|NCT03166475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1332996|NCT03166462|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1332997|NCT03166449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1332998|NCT03166436|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled study||||
1332999|NCT03166423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333000|NCT03166410||Single Group Assignment||Treatment||None (Open Label)||||||
1333001|NCT03166397||Single Group Assignment||Treatment||None (Open Label)||||||
1333002|NCT03166384|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1333003|NCT03166371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333004|NCT03166358|Randomized|Parallel Assignment||Treatment||Single|Yoga instructor is blind to yoga intervention or waitlist group status of participants.|Participants are randomized to either a hatha yoga intervention or a waitlist control condition.||t||
1333005|NCT03166345|Randomized|Parallel Assignment||Other||Single||||||t
1333006|NCT03166332|Randomized|Parallel Assignment||Prevention||Single|Care provider will not know the arm of randomization|Randomized controlled trial with 3 arms of intervention||t||
1333007|NCT03166319||Single Group Assignment||Diagnostic||None (Open Label)||Patients with suspected primary CNS vasculitis.||||
1333008|NCT03166306|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||The investigators propose to enroll 10 patients with known severe idiopathic or familial PAH, 10 individuals with exercise-associated PAH (EPAH), felt to be a milder and early stage of PAH, and 10 healthy volunteers with no evidence of cardiopulmonary disease. Baseline PET-CT scans will be obtained 7 days after the injection of [89Zr]-bevacizumab. Follow- up imaging will be obtained 12 months status post enrollment.||||
1333009|NCT03166293|Randomized|Parallel Assignment||Treatment||Single||Participants will be randomly assigned to receive 3 months of intervention or 3 months of observation. Participants in the observation group will be offered the intervention once the observation period is complete||||t
1333010|NCT03166280|||Other||Cross-Sectional|||||||
1333011|NCT03166267|||Case-Only||Prospective|||||||
1333012|NCT03166254||Single Group Assignment||Treatment||None (Open Label)||||||
1333013|NCT03166241|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1333014|NCT03166228|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333015|NCT03166215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333016|NCT03166202|||Cohort||Cross-Sectional|||||||
1333017|NCT03166189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333018|NCT03166176||Single Group Assignment||Treatment||None (Open Label)||Vistusertib(AZD2014) 50mg BD continuous schedule of a 28 day cycle||||
1333019|NCT03166163|Randomized|Parallel Assignment||Treatment||Double|This was a double -blind study as the investigator was unaware about the sampling of the groups and study subjects were unaware about the mouthwash they were using||t||t|
1333020|NCT03166150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333021|NCT03166137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333022|NCT03166124|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1333023|NCT03166111|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1333024|NCT03166098|||Case-Control||Prospective|||||||
1333025|NCT03166085||Single Group Assignment||Treatment||None (Open Label)||This is an open-label, phase Ib study of PU-H71 plus nab-paclitaxel (Abraxane) in patients with HER2-negative metastatic breast cancer (MBC).||||
1333026|NCT03166072|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1333027|NCT03166059||Single Group Assignment||Supportive Care||None (Open Label)||||||
1333028|NCT03166046|Randomized|Parallel Assignment||Treatment||Quadruple|Coded devices that are identical in appearance and function. Placebo device does not emit electromagnetic field. Active device electromagnetic field is sub-sensory.|Randomized, double blind, placebo controlled trial using an active pulsed shortwave therapy device or placebo pulsed shortwave therapy device|t|t|t|t
1333029|NCT03166033|||Case-Control||Retrospective|||||||
1333030|NCT03166020|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1333031|NCT03166007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333032|NCT03165994||Single Group Assignment||Treatment||None (Open Label)||Non-comparative, open-label pilot study||||
1333033|NCT03165981|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333034|NCT03165968|||Cohort||Prospective|||||||
1333035|NCT03165955||Single Group Assignment||Treatment||None (Open Label)||||||
1333036|NCT03165942|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1333037|NCT03165929|Randomized|Parallel Assignment||Treatment||Single|||||t|
1333038|NCT03165916|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333039|NCT03165903|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333040|NCT03165890|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333041|NCT03165877|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1333042|NCT03165864|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333043|NCT03165851|||Cohort||Retrospective|||||||
1333044|NCT03165838|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1333045|NCT03165825|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333046|NCT03165812|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The study will involve two groups with equal allocation of patients in the intensive medical therapy (IMT) group and Single Anastomosis Duodeno Jejunal Bypass with Sleeve Gastrectomy (SADJB-SG) group with stratification by use of insulin at screening. All patients who agree to participate in this study will be assigned to one of the treatment groups by the doctor without randomization.||||
1333047|NCT03165799|Randomized|Parallel Assignment||Health Services Research||Single|Observers collecting data were blinded to participant treatment/control randomization allocation.|Participating teams were randomized with a 1:1 ratio to receive the intervention.||||t
1333048|NCT03165786|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized controlled trial||||
1333049|NCT03165773|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1333050|NCT03165760|Randomized|Parallel Assignment||Prevention||None (Open Label)||randomization is decided when patients are schedueld and according a randomization table||||
1333051|NCT03165747|Randomized|Parallel Assignment||Prevention||Quadruple|Only the IDS pharmacy will know which dose of probiotic was given to the subject. The study team, parents, subjects, individuals entering the data, statistician, individuals performing laboratory tests and DEXA (dual energy X-ray absorptiometry) scans, research center nurses and investigators will remain blinded as to which treatment the subjects received. Each subject will be assigned a unique identifier, which will be used in the database. In addition, all lab specimens will only include the patient's unique identifier. Permuted block sizes will not be disclosed to the blinded study personnel to minimize the likelihood of their being able to predict the next randomization assignment in the series. Investigators and all study personnel will remain blinded until the final subject has completed her final visit and primary and secondary endpoints have been analyzed.||t|t|t|t
1333052|NCT03165734|Randomized|Parallel Assignment||Treatment||Single||||||t
1333053|NCT03165721|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333054|NCT03165708|||Other||Prospective|||||||
1333055|NCT03165695|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1333056|NCT03165682|||Case-Control||Cross-Sectional|||||||
1333057|NCT03165669|Randomized|Crossover Assignment||Treatment||Double|"The principal investigator will receive the results of outcome measures without any information of the group assignement.~The outcome assessors will be masked on the group assignment, because they will receive only the list of participants,without the group assignment."|"Two groups of patients will be randomized in two parallel arms. At Time zero, the first one will receive education, the second one cervical pillow. After 4 weeks, the 1st follow-up will be done (Time one), and after 4 weeks of wash-out, the 2nd follow-up will be done (Time two). At this moment, the group that received cervical pillow will receive education, and vice versa. After 4 weeks (Time three), the final follow-up will be done.~be done."|||t|t
1333058|NCT03165656|||Case-Control||Prospective|||||||
1333059|NCT03165643|||Case-Control||Retrospective|||||||
1333060|NCT03165630|Randomized|Parallel Assignment||Health Services Research||Single|The 4th month assessor is unaware of the arm participants are assigned to.|||||t
1333061|NCT03165617|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333062|NCT03165604|Randomized|Parallel Assignment||Treatment||Double|Subjects will be given the same drink (water) in different packaging||t|t||
1333063|NCT03165591||Single Group Assignment||Treatment||None (Open Label)||||||
1333064|NCT03165578|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1333065|NCT03165565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333066|NCT03165552||Single Group Assignment||Health Services Research||None (Open Label)||||||
1333067|NCT03165539|||Cohort||Prospective|||||||
1333068|NCT03165526|||Cohort||Retrospective|||||||
1333069|NCT03165513||Single Group Assignment||Treatment||None (Open Label)||Descriptive study||||
1333070|NCT03165500|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The investigadors selected 120 third molars , with the need for exodontia, in patients aged 18 to 30 years, ASA I, and with moderate to high anxiety level according to the Corah Dental Anxiety Scale (DAS). Patients were randomly assigned to three groups of 40 patients and submitted to the following anxiety control protocol:~Group I - Sedation with 5 mg oral Diazepam 30 minutes before surgery;~Group II - Sedation with 7.5 mg oral Midazolam 30 minutes before surgery;~Group III - Inhaled sedation with a mixture of 40% of nitrous oxide and 60% of oxygen (Using the Porter MXR 3000 Flowmeter (Parker Hannifin - Hatfield, PA, Philadelphia)) started 5 minutes before surgery."||||
1333071|NCT03165487|||Cohort||Prospective|||||||
1333072|NCT03165474|Randomized|Parallel Assignment||Device Feasibility||Single|Participants will be randomized into intervention or control arm and will be provided with different orientations.||t|||
1333073|NCT03165461|||Case-Only||Prospective|||||||
1333074|NCT03165448|||Cohort||Prospective|||||||
1333075|NCT03165435|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1333076|NCT03165422|||Cohort||Retrospective|||||||
1333077|NCT03165409|||Case-Only||Retrospective|||||||
1333078|NCT03165396|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1333079|NCT03165383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333080|NCT03165370|||Other||Cross-Sectional|||||||
1333081|NCT03165357|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1333082|NCT03165344|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333083|NCT03165331|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1333084|NCT03165318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333085|NCT03165305|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1577404|NCT00001921||||||||||||
1333086|NCT03165292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333087|NCT03165279|||Case-Only||Prospective|||||||
1333088|NCT03165266|||Case-Only||Prospective|||||||
1333089|NCT03165253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333090|NCT03165240|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1333091|NCT03165227|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1333092|NCT03165214|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333093|NCT03165201|||Cohort||Prospective|||||||
1333094|NCT03165188|||Cohort||Prospective|||||||
1333095|NCT03165175|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1333096|NCT03165162||Single Group Assignment||Other||None (Open Label)||||||
1333097|NCT03165149|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333098|NCT03165136|Randomized|Parallel Assignment||Treatment||Quadruple|Active drug and placebo will be exactly the same|Double Blind Randomized clinical trial|t|t|t|t
1333099|NCT03165123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333100|NCT03165110||Single Group Assignment||Supportive Care||None (Open Label)||||||
1333101|NCT03165097|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1333102|NCT03165084|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1333103|NCT03165071||Single Group Assignment||Other||None (Open Label)||||||
1333104|NCT03165058|||Case-Control||Prospective|||||||
1333105|NCT03165045|||Cohort||Prospective|||||||
1333106|NCT03165032|||Case-Control||Prospective|||||||
1333107|NCT03165019|||Case-Control||Prospective|||||||
1333108|NCT03165006|||Cohort||Retrospective|||||||
1333109|NCT03164993|Randomized|Parallel Assignment||Treatment||Double|Randomization will be performed using the eCRF. The subject will allocated to a randomization number and the randomization number will be sent to the hospital pharmacy. The pharmacy keeps the randomization listing and prepares the infusion according to the given randomization number. The pharmacy will keep a log of all infusions prepared. All other study personell will be blinded to the treatment code.|Randomized, double-blind, placebo-controlled|t||t|
1333110|NCT03164980|||Other||Prospective|||||||
1333111|NCT03164967||Single Group Assignment||Other||None (Open Label)||||||
1333112|NCT03164954|||Cohort||Prospective|||||||
1333113|NCT03164941|||Cohort||Prospective|||||||
1333114|NCT03164928|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1333115|NCT03164915||Single Group Assignment||Treatment||None (Open Label)||||||
1333116|NCT03164902||Single Group Assignment||Treatment||None (Open Label)|Sponsor will be blinded from any interim analysis results (except for safety outcomes) until the final analysis. A data monitoring committee has been formed to review interim analyses for study futility and safety.|||||
1333117|NCT03164889|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333118|NCT03164876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333119|NCT03164863|||Cohort||Retrospective|||||||
1333120|NCT03164850|||Case-Control||Prospective|||||||
1333121|NCT03164837||Single Group Assignment||Diagnostic||None (Open Label)||||||
1333122|NCT03164824|||Other||Retrospective|||||||
1333123|NCT03164811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333124|NCT03164798|||Case-Only||Prospective|||||||
1333125|NCT03164785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333126|NCT03164772|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333127|NCT03164759|||Other||Other|||||||
1333128|NCT03164746|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1333129|NCT03164733|||Cohort||Prospective|||||||
1333130|NCT03164720|||Case-Control||Prospective|||||||
1333131|NCT03164707|||Cohort||Prospective|||||||
1333132|NCT03164694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333133|NCT03164681|||Cohort||Prospective|||||||
1333134|NCT03164668|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1333135|NCT03164655|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333136|NCT03164642|Randomized|Parallel Assignment||Treatment||Single||||||t
1333137|NCT03164629|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1333138|NCT03164616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333139|NCT03164603||Single Group Assignment||Treatment||None (Open Label)||||||
1333140|NCT03164590|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333141|NCT03164577|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333142|NCT03164564|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333143|NCT03164551|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333144|NCT03164538|Randomized|Parallel Assignment||Treatment||Single||||||t
1333145|NCT03164525|||Cohort||Prospective|||||||
1333146|NCT03164512|Randomized|Crossover Assignment||Basic Science||Double|placebo controlled, double-blind||t|||t
1333147|NCT03164499|Randomized|Parallel Assignment||Prevention||Single||||||t
1333148|NCT03164486||Single Group Assignment||Treatment||None (Open Label)||||||
1333149|NCT03164473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333150|NCT03164460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333151|NCT03164447|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333152|NCT03164434|||Case-Only||Prospective|||||||
1333153|NCT03164421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333154|NCT03164408|||Cohort||Retrospective|||||||
1333155|NCT03164395|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized in block fashion to either internal or external cardioversion||||
1333156|NCT03164382|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333157|NCT03164369|||Other||Prospective|||||||
1333158|NCT03164356|Randomized|Sequential Assignment||Diagnostic||Single|||t|||
1577405|NCT00001920||||||||||||
1333159|NCT03164343||Single Group Assignment||Treatment||None (Open Label)||||||
1333160|NCT03164330|Randomized|Parallel Assignment||Prevention||Single|Professionals who implement the biometric screenings, health risk assessments, and wellness courses do no know the exact treatment group of study participants.|Our primary analysis compares outcomes between a control group and six (6) treatment groups. Our secondary analysis compares pre-determined characteristics across members of the treatment group who adopt the intervention and those who do not.||t||
1333161|NCT03164317|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1333162|NCT03164304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333163|NCT03164291||Single Group Assignment||Treatment||None (Open Label)||||||
1333164|NCT03164278|Randomized|Crossover Assignment||Supportive Care||None (Open Label)|Subjects will be choose to be in one of three groups: one group will receive transfer training immediately with no follow up, one group will receive the transfer training immediate with a 1 month & 6 month follow up, and one group that will be randomized to either receive the transfer training immediately or to receive the transfer training after a 6 month wait (with follow ups).|This is a randomized single blind study.||||
1333165|NCT03164265||Single Group Assignment||Other||None (Open Label)||||||
1333166|NCT03164252|Randomized|Parallel Assignment||Treatment||Quadruple|Surgical procedures were always performed by the same surgeon and assistant, who were unaware of the surrogate group that belonged to the patient, as well as the patient himself. This randomization was performed involving numbers and envelopes, being only the investigator's knowledge.|"The sample of this study will be composed of 60 patients between 16 and 40 years old, who need to undergo the extraction of third molars included and / or impacted. The patients will be those who voluntarily seek the Discipline of Buccomaxillofacial Surgery and Traumatology, at the State University of São Paulo Júlio de Mesquita Filho - Unesp, to perform the procedure.~This study will be a randomized, double-blind, prospective clinical trial with the following groups:~Group I (with 20 patients) - laser therapy used in the immediate postoperative period will be intraoral irradiation with 660 nm red diode laser, 30 mW power and 10 J / cm2 fluency.~Group II (with 20 patients) - laser therapy used in the immediate postoperative period will be intraoral irradiation with 660 nm red diode laser, 30 mW power and 30 J / cm2 fluency.~Group III (with 20 patients) - Control Group - Application of laser sham."|t|t|t|t
1333167|NCT03164239|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333168|NCT03164226||Single Group Assignment||Diagnostic||None (Open Label)||Prospective||||
1333169|NCT03164213|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1333170|NCT03164200|Randomized|Parallel Assignment||Other||None (Open Label)|Patients were randomized to either a egg breakfast or a carbohydrate breakfast|||||
1333171|NCT03164187||||||||||||
1333172|NCT03164174|||Cohort||Prospective|||||||
1333173|NCT03164161|Randomized|Parallel Assignment||Screening||Double|||t|||t
1333174|NCT03164148||Single Group Assignment||Other||None (Open Label)||||||
1333175|NCT03164135||Single Group Assignment||Treatment||None (Open Label)||CD34+ hematopoietic stem/progenitor cells from donor are treated with CRISPR/Cas9 before transplantation into the patient.||||
1333176|NCT03164122||Single Group Assignment||Treatment||None (Open Label)||||||
1333177|NCT03164109|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1333178|NCT03164096||Single Group Assignment||Screening||None (Open Label)||evaluating relationship of sensory level and other patient factors||||
1333179|NCT03164083|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1333180|NCT03164070|||Cohort||Prospective|||||||
1333181|NCT03164057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333182|NCT03164044|||Cohort||Prospective|||||||
1333183|NCT03164031|Randomized|Crossover Assignment||Supportive Care||Triple|"Participants will be trialling two different pairs of shorts, where one pair will be designed as an orthoses and the other will look similar but be looser and not designed to support the hips.~The investigator is also the main outcome assessor and they will be blinded to which pair of shorts will be worn at each stage of the study."||t||t|t
1333184|NCT03164018|||Cohort||Prospective|||||||
1333185|NCT03164005|||Case-Only||Cross-Sectional|||||||
1333186|NCT03163992||Single Group Assignment||Treatment||None (Open Label)||Pembrolizumab (MK-3475) 200 mg every 3 weeks (Q3W)||||
1333187|NCT03163979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333188|NCT03163966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333189|NCT03163953|Randomized|Parallel Assignment||Health Services Research||Single|Outcomes assessor will not involve with the process of subject recruitment and allocation into three groups throughout the 6 months follow-up.|||||t
1333190|NCT03163940|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1333191|NCT03163927|Randomized|Parallel Assignment||Other||Single||||||t
1333192|NCT03163914|Randomized|Parallel Assignment||Prevention||Double|Partipicants and care providers will not known which medication will apply.||t|t||
1333193|NCT03163901|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333194|NCT03163888|||Cohort||Prospective|||||||
1333195|NCT03163875|||Case-Control||Cross-Sectional|||||||
1333196|NCT03163862|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1333197|NCT03163849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333198|NCT03163836|||Cohort||Retrospective|||||||
1333199|NCT03163823|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1333200|NCT03163810||Single Group Assignment||Treatment||None (Open Label)||||||
1333201|NCT03163797|||Cohort||Prospective|||||||
1333202|NCT03163784|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1333203|NCT03163771|||Cohort||Prospective|||||||
1333204|NCT03163758|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333205|NCT03163745|||Cohort||Prospective|||||||
1333267|NCT03162926||Single Group Assignment||Treatment||None (Open Label)||||||
1333268|NCT03162913|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1333269|NCT03162900|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1333270|NCT03162887||Single Group Assignment||Screening||None (Open Label)||||||
1333206|NCT03163732|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Arm A: Tumor-based genomics according to the 324 cancer-related genes Next Generation Sequencing (NGS) panel from Foundation One (FOne panel).~Arm B: Tumor-based genomics according to the 87 cancer-related genes NGS panel performed at Centre Leon Berard Unité de Caractérisation Tumorale (CONTROL panel).~Both panels will be performed concomitantly for all patients using the same patient tumor specimen."||||
1333207|NCT03163719|||Other||Prospective|||||||
1333208|NCT03163706|Non-Randomized|Parallel Assignment||Other||None (Open Label)|Open|||||
1333209|NCT03163693|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1333210|NCT03163680|||Cohort||Retrospective|||||||
1333211|NCT03163667|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded, placebo-controlled|This is a double blinded placebo-controlled study where patients will be randomized 2:1 to either CB-839 plus everolimus (CBE) or placebo plus everolimus (PboE)|t|t|t|t
1333212|NCT03163654|Randomized|Parallel Assignment||Treatment||Double|Single Blind|Parallel Assignment|t||t|
1333213|NCT03163641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333214|NCT03163628||Single Group Assignment||Diagnostic||None (Open Label)||||||
1333215|NCT03163615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333216|NCT03163602|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial||||t
1333217|NCT03163589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333218|NCT03163576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333219|NCT03163563|||Other||Prospective|||||||
1333220|NCT03163550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333221|NCT03163537|||Other||Prospective|||||||
1333222|NCT03163524|Randomized|Parallel Assignment||Prevention||Single||||t||
1333223|NCT03163511|Non-Randomized|Sequential Assignment||Other||None (Open Label)||There are two Cohorts in this study design. Cohort 1 enrolls up to 15 subjects total. After Cohort 1 enrollment is completed, Cohort 2 enrollment then occurs with up to an additional 40 subjects.||||
1333224|NCT03163498|||Cohort||Cross-Sectional|||||||
1333225|NCT03163485|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1333226|NCT03163472|Randomized|Parallel Assignment||Other||Single||||||t
1333227|NCT03163459|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1333228|NCT03163446|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333229|NCT03163433|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The intervention takes place at a highly specialized university hospital i Denmark. Two other higly specialized Danish hospitals recruit patients for the control group.||||
1333230|NCT03163420|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333231|NCT03163407|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1333232|NCT03163394|||Case-Control||Prospective|||||||
1333233|NCT03163381||Single Group Assignment||Treatment||None (Open Label)||||||
1333234|NCT03163368||Single Group Assignment||Treatment||None (Open Label)||||||
1333235|NCT03163355|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t||t
1333236|NCT03163342||Single Group Assignment||Diagnostic||None (Open Label)||Open label||||
1333237|NCT03163329|Randomized|Parallel Assignment||Treatment||Single||||||t
1333238|NCT03163316|||Other||Other|||||||
1333239|NCT03163303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333240|NCT03163290|Randomized|Parallel Assignment||Treatment||Single|||||t|
1333241|NCT03163277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333242|NCT03163264|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1333243|NCT03163251||Single Group Assignment||Other||None (Open Label)||This is a single institution, single arm, prospective cohort study stratified by post-graduate training year||||
1333244|NCT03163238|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1333245|NCT03163225|||Cohort||Prospective|||||||
1333246|NCT03163212|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose escalation design||||
1333247|NCT03163199|||Case-Only||Prospective|||||||
1333248|NCT03163186|||Cohort||Prospective|||||||
1333249|NCT03163173||Single Group Assignment||Treatment||None (Open Label)||||||
1333250|NCT03163160|Randomized|Parallel Assignment||Treatment||Single||||||t
1333251|NCT03163147|||Cohort||Prospective|||||||
1333252|NCT03163134|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1333253|NCT03163121|Randomized|Parallel Assignment||Prevention||Quadruple|Stage A is an open label study. Stage B of the clinical study will be double-blinded.||t|t|t|t
1333254|NCT03163108|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1333255|NCT03163095|Randomized|Parallel Assignment||Treatment||Single|Research members in the laboratory will be blinded with participants' clinical data.|Randomization by blocks on a website.||||t
1333256|NCT03163082|Randomized|Parallel Assignment||Other||None (Open Label)||Within-subject design over 2 visits.||||
1333257|NCT03163069|Randomized|Factorial Assignment||Treatment||Double||factorial assignment|t||t|
1333258|NCT03163056|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are randomly assigned to each of the three treatment conditions in accordance with a computer-generated randomization list. The three treatment conditions will be actively running in parallel.||||
1333259|NCT03163043||Single Group Assignment||Basic Science||None (Open Label)||||||
1333260|NCT03163030||Single Group Assignment||Treatment||None (Open Label)||||||
1333261|NCT03163017||Single Group Assignment||Treatment||None (Open Label)||||||
1333262|NCT03163004|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||One intervention and one control condition||||
1333263|NCT03162991|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1333264|NCT03162978|Randomized|Parallel Assignment||Other||Single|||t|||
1333265|NCT03162965|Randomized|Parallel Assignment||Screening||None (Open Label)||Participants randomized to (1) Choice - they get to choose (1a) self-test vs (1b) HCT (HIV testing and counseling at clinic) or (2) they are randomized to HCT.||||
1333271|NCT03162874|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1333272|NCT03162861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333273|NCT03162848|Randomized|Parallel Assignment||Other||Single|||t|||
1333274|NCT03162835|||Other||Cross-Sectional|||||||
1333275|NCT03162822|Randomized|Parallel Assignment||Other||None (Open Label)||Within-subject design over 2 visits||||
1333276|NCT03162809|||Case-Only||Prospective|||||||
1333277|NCT03162796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333278|NCT03162783|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1333279|NCT03162770|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"Behavioral: Mindfulness meditation practice This intervention is based on relaxation, well-being promotion, meditation practices and positive psychology principles. The program is being evaluated in hemodialysis session. It will last for 12 weeks, with trainings of 15 to 25 minutes, three times a week.~No Intervention: Control App This group will observe their psychological and physical condition (levels of stress and well-being) during their daily activities and social interactions."||||
1333280|NCT03162757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333281|NCT03162744|||Case-Only||Cross-Sectional|||||||
1333282|NCT03162731||Single Group Assignment||Treatment||None (Open Label)||||||
1333283|NCT03162718||Single Group Assignment||Treatment||None (Open Label)||The investigators propose a mixed methods,16 single arm feasibility study of an unsupervised, pre-operative exercise prescription (uPEP) augmented by a wearable fitness device. The proposed study of 30 patients scheduled for lung cancer surgery will identify the strengths, weaknesses, and utility of this approach.||||
1333284|NCT03162705|||Cohort||Prospective|||||||
1333285|NCT03162692|||Cohort||Prospective|||||||
1333286|NCT03162679|Randomized|Parallel Assignment||Treatment||Single||||||t
1333287|NCT03162666|||Cohort||Prospective|||||||
1333288|NCT03162653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333289|NCT03162640|||Cohort||Prospective|||||||
1333290|NCT03162627|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333291|NCT03162614|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333292|NCT03162601|||Cohort||Prospective|||||||
1333293|NCT03162588||Single Group Assignment||Treatment||None (Open Label)||||||
1333294|NCT03162575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333295|NCT03162562||Single Group Assignment||Treatment||None (Open Label)||||||
1333296|NCT03162549|||Cohort||Prospective|||||||
1333297|NCT03162536||Sequential Assignment||Treatment||None (Open Label)||"The dose escalation phase of the study follows the 3+3 dose escalation design. Dose escalation will continue until the MTD and/or RP2D is reached based on protocol-defined DLT.~During the dose escalation period, intra-subject dose escalation will be permitted if the following criteria are met:~The next higher dose for the regimen has demonstrated to be safe by at least 3 subjects and the last subject completed one cycle without experiencing any DLT.~The subject who will receive the dose escalation has not experienced a DLT.~Once MTD/RP2D is reached, expanded cohorts will be opened for specified malignancies (e.g., B-cell NHL, WM, and CLL)."||||
1333298|NCT03162523|||Case-Control||Other|||||||
1333299|NCT03162510||Single Group Assignment||Treatment||None (Open Label)||||||
1333300|NCT03162497|Randomized|Parallel Assignment||Treatment||Single|||||t|
1333301|NCT03162484|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1333302|NCT03162471|||Other||Prospective|||||||
1333303|NCT03162458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333304|NCT03162445|||Case-Control||Cross-Sectional|||||||
1333305|NCT03162432||Single Group Assignment||Treatment||None (Open Label)||||||
1333306|NCT03162419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333307|NCT03162406|Randomized|Parallel Assignment||Treatment||Quadruple||Parallel assignment|t|t|t|t
1333308|NCT03162393|||Case-Only||Retrospective|||||||
1333309|NCT03162380|||Cohort||Retrospective|||||||
1333310|NCT03162367|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1333311|NCT03162354|Randomized|Parallel Assignment||Screening||Single|The study statistician will remain blinded to PICU site group membership (control vs. intervention sites).|The stratified cluster randomized trial design will facilitate direct comparison of child abuse evaluations at four, randomly selected, control sites to four matched intervention sites, where investigators will deploy active, multifaceted, implementation strategies designed to promote CDR acceptability and application.||||t
1333312|NCT03162341||Single Group Assignment||Diagnostic||None (Open Label)||||||
1333313|NCT03162328||||||||||||
1333314|NCT03162315|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1333315|NCT03162302|||Cohort||Prospective|||||||
1333316|NCT03162289|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1333317|NCT03162276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333318|NCT03162263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333319|NCT03162250|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333320|NCT03162237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333321|NCT03162224||Single Group Assignment||Treatment||None (Open Label)||||||
1333322|NCT03162211|Randomized|Parallel Assignment||Other||Single||||||t
1333323|NCT03162198|||Case-Control||Cross-Sectional|||||||
1333324|NCT03162185|Randomized|Parallel Assignment||Basic Science||Double|Double-blind||t||t|
1333325|NCT03162172|||Cohort||Retrospective|||||||
1333326|NCT03162159|||Cohort||Retrospective|||||||
1333327|NCT03162146|||Cohort||Retrospective|||||||
1333328|NCT03162133|Randomized|Parallel Assignment||Other||Double|||t|t||
1333329|NCT03162120|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333330|NCT03162107|||Cohort||Prospective|||||||
1333411|NCT03161054||Single Group Assignment||Treatment||None (Open Label)||phase II, multicentre, non-randomized study, single arm study||||
1333412|NCT03161041||Single Group Assignment||Treatment||None (Open Label)||||||
1333331|NCT03162094|Randomized|Parallel Assignment||Treatment||Triple|phase I/II, double-blind|"Phase I: patient will be included on 3 arms of treatment ( Placebo, Low dose or High dose AVX-012) TID~Phase II: Patient will be included on 4 arms of treatment (Placebo/Dose) BID/TID"|t|t|t|
1333332|NCT03162081|||Case-Control||Cross-Sectional|||||||
1333333|NCT03162068|||Case-Control||Prospective|||||||
1333334|NCT03162055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333335|NCT03162042|||Case-Control||Prospective|||||||
1333336|NCT03162029|||Other||Prospective|||||||
1333337|NCT03162016|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1333338|NCT03162003|||Cohort||Prospective|||||||
1333339|NCT03161990|||Cohort||Retrospective|||||||
1333340|NCT03161977|||Case-Only||Prospective|||||||
1333341|NCT03161964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333342|NCT03161951|||Cohort||Prospective|||||||
1333343|NCT03161938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333344|NCT03161925|||Other||Retrospective|||||||
1333345|NCT03161912|||Cohort||Prospective|||||||
1333346|NCT03161899|||Case-Only||Cross-Sectional|||||||
1333347|NCT03161886||Single Group Assignment||Diagnostic||None (Open Label)||||||
1333348|NCT03161873|||Cohort||Prospective|||||||
1333349|NCT03161860|Randomized|Parallel Assignment||Prevention||Single|Due to the type of intervention, coordinators, volunteers and participants will not be blinded to the interventions. However, they will not be informed about the study hypotheses. Research assistants and the statistician responsible for the analysis will be blinded to the intervention until completion of the study.|||||t
1333350|NCT03161847|||Cohort||Prospective|||||||
1333351|NCT03161834|||Other||Prospective|||||||
1333352|NCT03161821|||Other||Prospective|||||||
1333353|NCT03161808|||Cohort||Prospective|||||||
1333354|NCT03161795|||Other||Prospective|||||||
1333355|NCT03161782|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333356|NCT03161769|||Cohort||Prospective|||||||
1333357|NCT03161756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333358|NCT03161743|||Cohort||Prospective|||||||
1333359|NCT03161730|Randomized|Crossover Assignment||Treatment||Single||||||t
1333360|NCT03161717|Randomized|Parallel Assignment||Treatment||None (Open Label)|No Masking|Parallel Assignment||||
1333361|NCT03161704|||Case-Control||Prospective|||||||
1333362|NCT03161691|||Cohort||Prospective|||||||
1333363|NCT03161678|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Ninety healthy Amish subjects (30 CES1 G143E allele carriers, 30 carriers of a risk variant to be determined, and 30 age/sex-matched controls) will be enrolled. We will prospectively evaluate the effect of CES1 genotype on clopidogrel and ticagrelor response, as assessed by agonist-stimulated platelet aggregation, through the completion of a randomized crossover study of clopidogrel (75 mg per day for 7 d) and ticagrelor (90 mg twice daily for 7 d) in 90 healthy Amish individuals stratified by CES1 genotype as described above, with at least a 14-day washout period between drug interventions.||||
1333364|NCT03161665||Single Group Assignment||Supportive Care||None (Open Label)||The BMT Roadmap information system will be tested in 20 caregivers of patients undergoing autologous or allogeneic BMT and 20 patients undergoing autologous or allogeneic BMT.||||
1333365|NCT03161652|Randomized|Parallel Assignment||Treatment||Triple|Patients, care providers, and evaluators are blind to treatment allocation. This reduces the risk of bias in the measurement of outcomes, in the decision to modify or discontinue treatment, or to withdraw from trial or from analysis. The monitoring coordinator allocates the treatment.|The study investigates a medication causing hyperprolactinemia (levosulpiride) to treat diabetic retinopathy (DR) and diabetic macular edema (DME). Subjects are from four different populations, those with DME, non-proliferative DR, those undergoing vitrectomy due to proliferative DR, and those with DME plus standard intravitreal antiangiogenic therapy with ranibizumab. Immediately after baseline, each of the four groups are randomly split into two subgroups: one receiving placebo (sugar pill) and the other levosulpiride. Ophthalmologic and health outcomes between groups 1 and 2 (DME: placebo and levosulpiride), 3 and 4 (DR: placebo and levosulpiride), and 7 and 8 (DME plus ranibizumab: placebo and levosulpiride) evaluate the efficacy and safety of the study medication. Comparison of serum and vitreous prolactin levels between the groups undergoing vitrectomy (DR: placebo and levosulpiride) serve as a proof of principle that prolactin enters the eye to counteract disease progression.|t|t||t
1333366|NCT03161639|Randomized|Parallel Assignment||Treatment||Quadruple|At the end of the canal access, the first operator will leave the surroundings and a second operator will continue. A length measurement will be determined in order to define the working length. After the working measurement length performed by the second operator, the first operator will be informed about the working length of each canal without the knowledge of which method was used for the length measurement . From then on, the first operator will continue the endodontic treatment. A third operator will evaluate the outcomes.|Patients between 6 and 9 years old who search for endodontic treatment in primary teeth. The allocation of subjects to groups will be achieved by randomization. These patients will be randomly divided into 2 groups: G1 - pulpectomy with length measurement performed through radiography and G2 - pulpectomy with length measurement performed with the aid of an apex locator.|t|t|t|t
1333367|NCT03161626|||Case-Control||Retrospective|||||||
1333368|NCT03161613|||Cohort||Prospective|||||||
1333369|NCT03161600|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1333370|NCT03161587|||Case-Only||Cross-Sectional|||||||
1333371|NCT03161574||Single Group Assignment||Treatment||None (Open Label)||||||
1333372|NCT03161561||Single Group Assignment||Basic Science||None (Open Label)||Measurement of the capacity of primary phagocytes (neutrophils, monocytes and macrophages) isolated from COPD patients' blood or alveolar macrophages isolated from patients' lungs to carry out key host defence functions and compare these to similar cells isolated from age and sex-matched non-smokers or smokers without COPD as controls.||||
1333413|NCT03161028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333414|NCT03161015|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Multiple-center, nonrandomized, open-label, parallel group study||||
1333415|NCT03161002|||Cohort||Prospective|||||||
1333373|NCT03161548||Single Group Assignment||Treatment||None (Open Label)||This is an open-label, non-comparative phase II clinical trial to assess efficacy and safety of tongue conservation treatment with sequential doxcetaxel, cisplatin and tegafur/uracil plus leucovorin (DCU) induction chemotherapy, tongue conservation surgery and postoperative CCRT in patients with advanced oral tongue cancer.||||
1333374|NCT03161535|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1333375|NCT03161522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333376|NCT03161509|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||All participants will undergo blood tests for pharmacokinetic of paracetamol before and 6 months after sleeve gastrectomy||||
1333377|NCT03161496|||Cohort||Prospective|||||||
1333378|NCT03161483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333379|NCT03161470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333380|NCT03161457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333381|NCT03161444||Single Group Assignment||Other||None (Open Label)||A blood sample collection for the study will be taken to each participant. Each subject enrolled must have previously participated in the study CHIKVIH.||||
1333382|NCT03161431|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"In this sequential model initially participant groups will enroll to receive SX-682 monotherapy for 21 days in a dose escalation phase. A 3 + 3 participant design will be used to determine the safe dose. After 21 days, at the specified dose of SX-682, SX-682 therapy will be stopped and participants will receive pembrolizumab therapy and continue to be evaluated for 90 days.~After the safe dose of SX-682 monotherapy has been determined, subjects will be enrolled to receive SX-682 and pembrolizumab combination therapy, in a SX-682 dose escalation phase. Again, a 3 + 3 participant design will be used to determine the safe dose. The next higher dose level will be enrolled only after subjects have received the current dose level safely for at least 6 weeks.~Once the safe dose level of SX-682 in combination with pembrolizumab is determined, then participants will be enrolled at the highest safe dose level of SX-682, in combination with pembrolizumab, in an expansion phase."||||
1333383|NCT03161418|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1333384|NCT03161405||Single Group Assignment||Other||None (Open Label)||||||
1333385|NCT03161392|||Cohort||Prospective|||||||
1333386|NCT03161379||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1333387|NCT03161366||Single Group Assignment||Prevention||None (Open Label)||Interventional, single arm, open-label, non-randomized||||
1333388|NCT03161353|Randomized|Parallel Assignment||Treatment||None (Open Label)||This randomized, open-label phase II study will assess the efficacy of the combination of trastuzumab and pertuzumab, ± endocrine therapy according to HR (hormone receptor) status, as exclusive neoadjuvant and adjuvant treatment in patients with HER2-positive breast cancer through a FDG-PET response-adapted strategy.||||
1333389|NCT03161340|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1333390|NCT03161327||Single Group Assignment||Prevention||None (Open Label)||||||
1333391|NCT03161314|||Case-Control||Cross-Sectional|||||||
1333392|NCT03161301|||Cohort||Cross-Sectional|||||||
1333393|NCT03161288|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1333394|NCT03161275|||Other||Prospective|||||||
1333395|NCT03161262|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients will be randomly assigned to either the intervention group or control group. The test group constitutes receiving consistent medication reminders, as per the patient's prescribed frequency, and weekly surveys prompting them to report their pain level and an image of their surgical site for the duration of the full 3 months. The control group will not receive medication reminders or questions regarding their pain or surgical site. Both control and test groups will receive a monthly questionnaire via SMS to assess patient satisfaction with the intervention and changes in medication adherence behaviors.||||
1333396|NCT03161249|Randomized|Parallel Assignment||Treatment||Single|blind evaluators|This is an experimental, randomized and longitudinal study of repeated measures with independent groups (Treatment group or experimental group: EG and control group: CG) which includes pre and post treatment. This randomized clinical trial includes blind evaluators.|||t|
1333397|NCT03161236|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1333398|NCT03161223|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Phase 1: Participants will be assigned to a study arm based on the following principle: 3 patients will be enrolled onto each arm consecutively. If no serious side effects occur, enrollment will continue in each arm for up to 10 patients. A total of 10 patients in each arm is anticipated.~Phase 2: The sample size will be calculated on an optimal 2-stage design. First, 10 patients will be enrolled. If at least 3 objective responses (PR or CR) are seen, then an additional 17 patients will be enrolled. A total of 27 patients per arm is anticipated."||||
1333399|NCT03161210|Randomized|Parallel Assignment||Treatment||Single||||||t
1333400|NCT03161197||Single Group Assignment||Supportive Care||None (Open Label)||Dialysis patients will receive the intervention individually while on dialysis. Dialysis is an optimal time for conducting interventions as patients are there for 3-4 hours every 3 days. For 8-10 weeks (which will begin the week after the baseline interview). Chronic Kidney Disease (CKD) patients will receive the intervention in group setting. Since CKD patients only come to see their nephrologist once a month, all CKD potential participants will be invited to attend eight consecutive weekly sessions.||||
1333401|NCT03161184|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Participants assigned to one of two groups in parallel for the duration of the study||||
1333402|NCT03161171|||Case-Only||Prospective|||||||
1333403|NCT03161158|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, prospective, randomized, parallel-group, controlled||||
1333404|NCT03161145|||Case-Only||Retrospective|||||||
1333405|NCT03161132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Multicentric||||
1333406|NCT03161119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333407|NCT03161106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333408|NCT03161093|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1333409|NCT03161080|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1333410|NCT03161067||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1333416|NCT03160989||Single Group Assignment||Health Services Research||None (Open Label)||||||
1333417|NCT03160976|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1333418|NCT03160963|||Cohort||Cross-Sectional|||||||
1333419|NCT03160950||Single Group Assignment||Treatment||None (Open Label)||||||
1333420|NCT03160937|Randomized|Parallel Assignment||Treatment||Single|One single evaluator who was blinded to the group assignments performed all tests that occurred 5 minutes prior to and 5 minutes after the intervention.|a single NM treatment session on Delayed Onset Muscle pain (DOMS) and to compare them with those of one foam roller (FR) session||||t
1333421|NCT03160924|Randomized|Parallel Assignment||Other||None (Open Label)||This is a randomised controlled study||||
1333422|NCT03160911|Randomized|Parallel Assignment||Treatment||Triple|The participant, the investigator and the outcome assessor would be blinded.|There are two separate interventional arms. In case of treatment failure, the two groups are allowed to crossover to the other group.|t||t|t
1333423|NCT03160898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333424|NCT03160885|Randomized|Parallel Assignment||Treatment||Double|"Neither the subject nor any of the investigator or LEO staff who are involved in the treatment or clinical evaluation and monitoring of the subjects will be aware of the treatment received. The packaging and labelling of the IMPs will contain no evidence of their identity.~Since tralokinumab and placebo are visually distinct and not matched for viscosity, IMP will be handled and administered by a qualified, unblinded HCP at the site who will not be involved in the management of trial subjects and who will not perform any of the assessments."||t||t|
1333425|NCT03160872|||Cohort||Retrospective|||||||
1333426|NCT03160859|Randomized|Parallel Assignment||Supportive Care||Single||This will be a multi-VA site, prospective RCT to compare different methods with 2 arms to determine which is less painful: water alone or water plus cap. Randomization will be based on computer generated random numbers placed inside opaque sealed envelopes. The envelope will be opened to reveal the code when the colonoscopist is ready to insert the endoscope to begin the examination. Patients who are willing to participate will sign an informed consent before starting the colonoscopy procedure. Separate parallel randomization will be set up at each site. Control Method: Involves unsedated colonoscopy with water exchange. Residual air will be removed and water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion. Study method: Involves unsedated colonoscopy with water exchange and the addition of a commercially available accessory fitted onto the colonoscope.|t|||
1333427|NCT03160846|||Cohort||Prospective|||||||
1333428|NCT03160833||Single Group Assignment||Treatment||None (Open Label)||Open-label, Multi-center, Dose Escalation Study||||
1333429|NCT03160820|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1333430|NCT03160807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333431|NCT03160794||Single Group Assignment||Diagnostic||None (Open Label)||||||
1333432|NCT03160781||Single Group Assignment||Treatment||None (Open Label)||||||
1333433|NCT03160768|||Cohort||Prospective|||||||
1333434|NCT03160755|||Other||Other|||||||
1333435|NCT03160742|||Cohort||Prospective|||||||
1333436|NCT03160729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333437|NCT03160716||Single Group Assignment||Treatment||None (Open Label)||||||
1333438|NCT03160703|Randomized|Parallel Assignment||Prevention||Single||Single centre, randomised, examiner blind, parallel design study to evaluate the buildup of extrinsic dental stain over a 4 week treatment period||||t
1333439|NCT03160690|||Cohort||Prospective|||||||
1333440|NCT03160677|Randomized|Parallel Assignment||Prevention||Single||||||t
1333441|NCT03160664|Randomized|Parallel Assignment||Treatment||Single||||||t
1333442|NCT03160651|Randomized|Parallel Assignment||Treatment||Triple|double-blind randomized trial Investigator, patients, and care providers will be masking Only statisticians and pharmacist will not be masking||t|t|t|
1333443|NCT03160638|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, randomized pilot study||||
1333444|NCT03160625|Randomized|Crossover Assignment||Treatment||Triple|Subjects' principal investigator and study team will be blinded to the randomization assignment. However clinical site personnel performing the device programming will not be blinded. Site personnel performing the CPET and 6-min hall walk assessments will be blinded to the randomization assignment.|"To assess whether rate adaptive pacing provides benefit to HFpEF patients, a pool of up to 60 qualifying subjects with pre-existing pacemaker and established diagnosis of HFpEF who demonstrate chronotropic incompetence (CI) with RAP turned off will be enrolled.~Subjects who meet CI criterion during Visit 2 will be randomized. Subjects' principal investigator and study team will be blinded to the randomization assignment. However clinical site personnel performing the device programming will not be blinded. Site personnel performing the CPET and 6-min hall walk assessments will be blinded to the randomization assignment.~Crossover of study subjects will occur during Visit 3, which will occur 12 weeks after subject enrollment. Subjects who were randomized with RAP ON first will have the device programmed to RAP OFF and conversely, subjects who were randomized to RAP OFF first will have the device programmed to RAP ON."|t||t|t
1333445|NCT03160612|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1333446|NCT03160599||Single Group Assignment||Treatment||None (Open Label)||||||
1333447|NCT03160586|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1333448|NCT03160573|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1333449|NCT03160560|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1333450|NCT03160547|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1333451|NCT03160534|Randomized|Parallel Assignment||Treatment||None (Open Label)||A Randomized Controlled Pilot Trial||||
1333452|NCT03160521|Randomized|Parallel Assignment||Treatment||Triple|The study drug will be administered under double-blind conditions so that investigators, site staff, and patients will not be aware about the identity of the study drug (ie, blinded Risperidone ISM 75 mg, Risperidone ISM 100 mg, or placebo) administered to any given patient.||t|t|t|
1333453|NCT03160508|||Case-Only||Prospective|||||||
1333454|NCT03160495|||Other||Prospective|||||||
1333455|NCT03160482|||Cohort||Cross-Sectional|||||||
1333553|NCT03159208|||Cohort||Prospective|||||||
1333456|NCT03160469||Single Group Assignment||Treatment||None (Open Label)||This is a prospective pilot study of 48 patients underwent Elipse balloon insertion by the same surgeon at Faisal polyclinics in Kuwait city during six months period from July 2016 to January 2017. Ethical approval was obtained from the Ministry of Health in Kuwait & national ethics committee.||||
1333457|NCT03160456|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|Randomised parallel group controlled clinical trial||||
1333458|NCT03160443||Single Group Assignment||Other||None (Open Label)||||||
1333459|NCT03160430|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1333460|NCT03160417|||Cohort||Prospective|||||||
1333461|NCT03160404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333462|NCT03160391|Randomized|Parallel Assignment||Basic Science||Triple|Although the type of intervention provided was explicit (dance or music), participants, intervention providers, and outcomes assessors were not aware of the study hypotheses or predicted effects for each intervention. Hence they did not know whether they were in a treatment or control group.||t|t||t
1333463|NCT03160378|Randomized|Parallel Assignment||Treatment||Single||||||t
1333464|NCT03160365||Single Group Assignment||Other||None (Open Label)||The patient will have some exams more than in the current way||||
1333465|NCT03160352||Single Group Assignment||Treatment||None (Open Label)||||||
1333466|NCT03160339|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1333467|NCT03160326|||Case-Only||Cross-Sectional|||||||
1333468|NCT03160313|Randomized|Parallel Assignment||Treatment||Single||||||t
1333469|NCT03160300|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1333470|NCT03160287||Single Group Assignment||Treatment||None (Open Label)||||||
1333471|NCT03160274|||Cohort||Other|||||||
1333472|NCT03160261||Single Group Assignment||Diagnostic||None (Open Label)||Single-group, open-label||||
1333473|NCT03160248|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333474|NCT03160235|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)|Magnetic resonance imaging|Methodological development of new MRI approaches||||
1333475|NCT03160222||Single Group Assignment||Diagnostic||None (Open Label)||||||
1333476|NCT03160209|||Case-Control||Prospective|||||||
1333477|NCT03160196|Randomized|Parallel Assignment||Treatment||Single||||||t
1333478|NCT03160183|||Cohort||Prospective|||||||
1333479|NCT03160170|Randomized|Parallel Assignment||Other||Single|||t|||
1333480|NCT03160157|||Cohort||Prospective|||||||
1333481|NCT03160144|Randomized|Sequential Assignment||Prevention||Triple|||t||t|t
1333482|NCT03160131||Single Group Assignment||Treatment||None (Open Label)||Single-arm trial||||
1333483|NCT03160118||Single Group Assignment||Other||None (Open Label)||||||
1333484|NCT03160105|Randomized|Factorial Assignment||Treatment||None (Open Label)||This is a pragmatic multicentre, 2x2 factorial randomized controlled trial with 1:1:1:1 randomization. A sample size of 92 patients in each group will be required to demonstrate non-inferiority with a non-inferiority (NI) margin of 12%.||||
1333485|NCT03160092||Single Group Assignment||Treatment||None (Open Label)||||||
1333486|NCT03160079||Single Group Assignment||Treatment||None (Open Label)||||||
1333487|NCT03160066|Randomized|Crossover Assignment||Treatment||Single|||t|||
1333488|NCT03160053|Randomized|Parallel Assignment||Treatment||None (Open Label)||Each participant served as his/hers own control.||||
1333489|NCT03160040|||Case-Only||Retrospective|||||||
1333490|NCT03160027|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Participants randomized to the Immediate PBM treatment group will receive 12 weeks of PBM, delivered with the Vielight Neuro device, for 12 weeks, once every other day (e.g., Mon, Wed, Fri), undergo behavioral assessments at baseline, weeks 6 and 12, and undergo 3 Tesla MRI at baseline and week 12.~Participants randomized to the Delayed PBM treatment group will maintain their usual activities for 12 weeks, undergo behavioral assessments at baseline, weeks 6 and 12, and undergo 3 Tesla MRI at baseline and week 12. After the week 12 behavioral and MRI assessments, participants in this group will receive 12 weeks of PBM, delivered with the Vielight Neuro device, for 12 weeks, once every other day (e.g., Mon, Wed, Fri), undergo behavioral assessments at weeks 18 and 24."||||
1333491|NCT03160014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333492|NCT03160001|Randomized|Parallel Assignment||Other||Double||1 patient group and 1 placebo group|t||t|
1333493|NCT03159988||Single Group Assignment||Treatment||None (Open Label)||||||
1333494|NCT03159975|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||"Dose level 1 : GX-70 0.26mg~Dose level 2 : GX-70 1mg~Dose level 3 : GX-70 4mg"||||
1333495|NCT03159962|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective 3-arm parallel group randomized clinical trial with a 1:1:1 allocation ratio||||
1333496|NCT03159949|Randomized|Parallel Assignment||Prevention||None (Open Label)|Participants will know what exercise group they are assigned to.|||||
1333497|NCT03159936||Single Group Assignment||Treatment||None (Open Label)||Tofacitinib citrate will be administered twice a day starting on Day 1 at the Baseline Visit. Subjects will take one 5 mg tablet by mouth in the morning and one tablet by mouth in the evening for the 6-month study duration.||||
1333498|NCT03159923|||Cohort||Prospective|||||||
1333499|NCT03159910|Randomized|Parallel Assignment||Prevention||Single|Outcome assessor will be masked with respect to mechanical shoulder exposures. Statistical analyses will be performed blinded to intervention arm.|||||t
1333500|NCT03159897|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study aims to compare the efficacy of two alternative ABVD-based strategies, the first one (Comparator arm) based on a PET-2-adaptation, the second (Experimental arm) relying on a straight dose- and time-intensified schedule, devoid of any PET-adaptation.||||
1333501|NCT03159884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333502|NCT03159871|Randomized|Parallel Assignment||Device Feasibility||Double|||t|||t
1333503|NCT03159858||||||||||||
1333504|NCT03159845|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Case-control study, open, without placebo||||
1333505|NCT03159832|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577406|NCT00001919||||||||||||
1333506|NCT03159819||Single Group Assignment||Treatment||None (Open Label)||||||
1333507|NCT03159806|||Cohort||Prospective|||||||
1333508|NCT03159793|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1333509|NCT03159780|||Case-Only||Cross-Sectional|||||||
1333510|NCT03159767|Non-Randomized|Crossover Assignment||Device Feasibility||Single|Each physiotherapist rater will have to independently attach the sensors to the participant's spine before testing, and no positioning marks will be left on the patient in between tests or between visits. They will work in different rooms and will not have access to earlier results.|Clinimetric study comparing repeated standardised spinal mobility test protocols by two independent raters on two occasions||||t
1333511|NCT03159754|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333512|NCT03159741|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1333513|NCT03159728|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1333514|NCT03159715|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333515|NCT03159702||Single Group Assignment||Treatment||None (Open Label)||Phase II, open-label study.||||
1333516|NCT03159689|Randomized|Parallel Assignment||Other||None (Open Label)||Randomized Clinical Trial||||
1333517|NCT03159676|||Case-Only||Prospective|||||||
1333518|NCT03159663|||Cohort||Prospective|||||||
1333519|NCT03159650|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1333520|NCT03159637|||Cohort||Prospective|||||||
1333521|NCT03159624|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333522|NCT03159611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333523|NCT03159598|Randomized|Parallel Assignment||Supportive Care||Single|"The study is semi-blind in that patients will not be told which treatment they are receiving. If the patient is assigned to one of the drains groups, she will know post-operatively that she has drains, but she will not know if TissueGlu was utilized. The doctor will be aware of what treatment the patient is receiving, as he or she will administer the drug"|This study has three parallel groups. One experimental and two control groups|t|||
1333524|NCT03159585||Single Group Assignment||Treatment||None (Open Label)||One arm, open label, dose escalation, single dose phase I study of safety and tolerability.||||
1333525|NCT03159572|||Cohort||Retrospective|||||||
1333526|NCT03159559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333527|NCT03159546|||Cohort||Prospective|||||||
1333528|NCT03159533|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Step wedge design, whereby 5 groups of 3 practices will implement the intervention in phases.||||
1333529|NCT03159520|Randomized|Parallel Assignment||Treatment||Single|Not possible to mask due to nature of intervention except for outcome assessor|Randomised parallel clinical trial||||t
1333530|NCT03159507||Single Group Assignment||Prevention||None (Open Label)||Prospective, single arm trial where each participant receives a personalized dose||||
1333531|NCT03159494|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A pilot group of 6 patients with type 2 diabetes tested before and after 6 times of High Intensity Training One group of patients with type 2 diabetes tested before and after 8 times of High Intensity Training.||||
1333532|NCT03159481|Randomized|Parallel Assignment||Treatment||Single|Blinded to arm assignment.|||||t
1333533|NCT03159468|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1333534|NCT03159455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333535|NCT03159442|Randomized|Parallel Assignment||Treatment||Single|This study is single-blind with regards to treatment (AZD8871 or placebo) at each dose level. However, the study centre staff are also blinded only during the clinical conduct of a given cohort prior to the respective safety review committee meeting (SRC).|Single center, randomized, single blind, placebo-controlled study.|t|||
1333536|NCT03159429|Randomized|Parallel Assignment||Treatment||None (Open Label)|Given that the experimental and comparator interventions concern behaviour and exercises, it is not possible to blind participants.|The included population will be randomized into two parallel groups. One group will be assigned the experimental intervention. The other group will be assigned standard care. Outcomes will be compared between the two randomized groups.||||
1333537|NCT03159416|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-Label|||||
1333538|NCT03159403|||Case-Only||Retrospective|||||||
1333539|NCT03159390||Single Group Assignment||Other||None (Open Label)||||||
1333540|NCT03159377|||Cohort||Prospective|||||||
1333541|NCT03159364||Single Group Assignment||Treatment||None (Open Label)||||||
1333542|NCT03159351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333543|NCT03159338|Randomized|Crossover Assignment||Treatment||Single|Investigator will be blunt about side of treatmen and control.None of surgical team will be as an investigator.Patients will unware about which side is treatment or control.|one side of osteotomies randomally will be considered as a treatment group and another side as a control group.|t|||
1333544|NCT03159325|Randomized|Parallel Assignment||Other||Single|||||t|
1333545|NCT03159312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333546|NCT03159299|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1333547|NCT03159286|Randomized|Parallel Assignment||Other||Single|Participants will not know which intervention they are in during the course of the study. They will be debriefed at the end of the study and informed which condition they were a part of.||t|||
1333548|NCT03159273|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1333549|NCT03159260|Randomized|Parallel Assignment||Treatment||Quadruple|Product has come in identical bottles from manufacturer. Both the investigators and statistician will remind blind until the conclusion of the study.||t|t|t|t
1333550|NCT03159247||Single Group Assignment||Health Services Research||None (Open Label)||This is a single group prospective behavioral intervention with a pre-post design. Adherence will be measured for three months at baseline, for an additional one month after an automated reminder system is initiated, for an additional six months during a personalized behavior change intervention and then for one year after the intervention.||||
1333551|NCT03159234||Single Group Assignment||Diagnostic||None (Open Label)||||||
1333552|NCT03159221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333554|NCT03159195|||Cohort||Retrospective|||||||
1333555|NCT03159182|Randomized|Single Group Assignment||Treatment||Single||||||t
1333556|NCT03159169||Single Group Assignment||Treatment||None (Open Label)||||||
1333557|NCT03159156|Randomized|Factorial Assignment||Basic Science||None (Open Label)|Behavioral procedures that cannot be masked to participant or others.|The primary goal is to examine the role of hyperventilation in blood donation-related vasovagal reactions and whether breathing is influenced by two treatments (alone and in combination) for reactions. The study will examine the clinical impact of these treatments but this is not the primary goal of the project.||||
1333558|NCT03159143||Single Group Assignment||Treatment||None (Open Label)||This is a non-randomized Phase II trial in metastatic transitional cell cancer (TCC) of the urothelial tract.||||
1333559|NCT03159130|||Cohort||Prospective|||||||
1333560|NCT03159117||Single Group Assignment||Treatment||None (Open Label)||This is a Phase 1b non-randomized, open-label, single-center, single-arm multiple dose escalation and expansion||||
1333561|NCT03159104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333562|NCT03159091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333563|NCT03159078|Randomized|Parallel Assignment||Treatment||Triple|Double blind, Double dummy|One arm with Polyxyxin B monotherapy and another arm with Polymyxin B plus carbapenem|t|t|t|
1333564|NCT03159065|Randomized|Crossover Assignment||Screening||Quadruple|||t|t|t|t
1333565|NCT03159052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333566|NCT03159039|Randomized|Parallel Assignment||Treatment||Single||"Patients will randomized in 2 groups: group CCP (conventional chest physiotherapy techniques) (n=22) , the technique will made during 5 minutes in each side and after that, endotraqueal aspiration will performed.or group PSE (prolonged slow exhalation technique) (n=21), the technique will made during 10 minutes, 2 times a day.At the end, endotraqueal aspiration will perfomed.~During the protocol the parameters will recorder: respiratory rate, heart rate and peripheral oxygen saturation, exhaled tidal volume, number of days under mechanical ventilation and number of fail times in extubation. In 5 diferent moments."|t|||
1333567|NCT03159026|||Case-Only||Cross-Sectional|||||||
1333568|NCT03159013|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1333569|NCT03159000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333570|NCT03158987|||Case-Only||Retrospective|||||||
1333571|NCT03158974||Single Group Assignment||Treatment||None (Open Label)||||||
1333572|NCT03158961||Single Group Assignment||Treatment||None (Open Label)||||||
1333573|NCT03158948|Randomized|Parallel Assignment||Treatment||Quadruple||Randomised, Double-blind, Two-Stage, Placebo Controlled|t|t|t|t
1333574|NCT03158935|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333575|NCT03158922|||Case-Control||Prospective|||||||
1333576|NCT03158909|Randomized|Parallel Assignment||Prevention||Single||||||t
1333577|NCT03158896||Sequential Assignment||Treatment||None (Open Label)||||||
1333578|NCT03158883|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two groups (n=13) of non-responders and progressors will go through the same treatment regime.||||
1333579|NCT03158870|||Cohort||Retrospective|||||||
1333580|NCT03158857|||Cohort||Prospective|||||||
1333581|NCT03158844|||Cohort||Prospective|||||||
1333582|NCT03158831||Single Group Assignment||Diagnostic||None (Open Label)||Prospective interventional study whereby each eligible patient undergoes a placebo-controlled graded challenge. Each patient receives a placebo prior to undergoing a graded challenge to 1/10 the treatment dose of the challenge drug followed by a full treatment dose of the challenge drug.||||
1333583|NCT03158818|||Cohort||Prospective|||||||
1333584|NCT03158805|Randomized|Parallel Assignment||Treatment||Quadruple||We will conduct a single-center, randomized, placebo-controlled, double-blind, parallel-group, 2-arm clinical trial of liraglutide 3.0 mg sc injection in 60 obese or overweight outpatients with stable BP.|t|t|t|t
1333585|NCT03158792|Randomized|Parallel Assignment||Prevention||Single|||t|||
1333586|NCT03158779||Single Group Assignment||Treatment||None (Open Label)||||||
1333587|NCT03158766|||Cohort||Prospective|||||||
1333588|NCT03158753|||Cohort||Prospective|||||||
1333589|NCT03158740|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The two arms of this intervention study will be the DII-Based Counseling System, including access to our Imagine Healthy Online Portal, and a general health education control. Group-based behavior change programs provide a way for members to share successes and obtain and provide support to one another. Both arms will be composed of 1 wave of 15 individuals. Participants will be required to invite a partner of their choosing to join them in the intervention activities to improve social support for behavioral change. Investigators have experience conducting studies where participants invite partners to participate.||||
1333590|NCT03158727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333591|NCT03158714|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333592|NCT03158701|||Cohort||Prospective|||||||
1333593|NCT03158688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333594|NCT03158675||Single Group Assignment||Treatment||None (Open Label)||"• Methods:-~-In each patient: The lesions on one side of the body will be randomly allocated to group A, and the lesions on the other side to group B.~Group A: will be treated with fractional CO2 laser combined with topical corticosteroid and UVB-NB.~Group B: will be treated with topical corticosteroid and UVB-NB."||||
1333595|NCT03158662|||Case-Only||Cross-Sectional|||||||
1333596|NCT03158649|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1333597|NCT03158636|||Cohort||Prospective|||||||
1333598|NCT03158623|Randomized|Parallel Assignment||Treatment||Double|computer generated randomization|3 groups with identical surgical closures randomized into 2 groups with wound additives and the third group without wound additives.|t|t||
1333599|NCT03158610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333600|NCT03158597|||Case-Control||Cross-Sectional|||||||
1333601|NCT03158584|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333602|NCT03158571|||Cohort||Prospective|||||||
1333603|NCT03158558||Single Group Assignment||Treatment||None (Open Label)||||||
1333604|NCT03158545|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1333605|NCT03158532|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1333606|NCT03158519||Single Group Assignment||Supportive Care||None (Open Label)||||||
1333607|NCT03158506||Single Group Assignment||Treatment||None (Open Label)||||||
1333608|NCT03158493|||Cohort||Prospective|||||||
1333609|NCT03158480|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1333610|NCT03158467|||Cohort||Prospective|||||||
1333611|NCT03158454|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1333612|NCT03158441|||Cohort||Prospective|||||||
1333613|NCT03158428|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1333614|NCT03158415||Single Group Assignment||Other||None (Open Label)||Mixed Methods Exploratory Study||||
1333615|NCT03158402|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333616|NCT03158389|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333617|NCT03158376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333618|NCT03158363|Randomized|Crossover Assignment||Basic Science||None (Open Label)||"Healthy young adults will be randomized to either intervention Endotoxemia, 36 hour immobilization and fasting or overnight fast being the control day."||||
1333619|NCT03158350|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333620|NCT03158337||Single Group Assignment||Other||None (Open Label)||||||
1333621|NCT03158324||Single Group Assignment||Treatment||None (Open Label)||Two parallel cohorts will be implemented: i. patients with tumors predicted to be dependent on oxidative phosphorylation metabolism or oncogene addicted tumors which have developed resistance to primary TKI therapy, or ii. patients with nasopharyngeal carcinoma||||
1333622|NCT03158311|Randomized|Parallel Assignment||Treatment||Single|The free triple combination of salmeterol/fluticasone + tiotropium is open label for which investigators and patients will have full knowledge the patient has been assigned free triple combination comparator treatment. Within the two QVM149 treatment arms patients, investigator staff, and persons performing the assessments, will remain blind to the identity of the actual QVM149 treatment dose but will have full knowledge that the patient has been assigned QVM149 as study treatment. The data analysts and sponsor team will be blinded to Case Report Forms that reveal the treatment arm. Randomization data and treatment codes are kept strictly confidential until the time of unblinding, and will not be accessible by anyone else involved in the study.|Parallel Assignment||||t
1333623|NCT03158298|||Case-Only||Prospective|||||||
1333624|NCT03158285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333625|NCT03158272|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel assignment will only in combination therapy arm.||||
1333626|NCT03158259|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)|Clinical tests and recordings will not be performed by investigator invested in the study.|Prospective controlled intervention study||||
1333627|NCT03158246|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333628|NCT03158233|||Cohort||Prospective|||||||
1333629|NCT03158220|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333630|NCT03158207|Randomized|Crossover Assignment||Other||None (Open Label)||The sequence of standard vs Warters mask will be determined by random number generator. Mask ventilation will be scored with both masks before and after the standard administration of paralytic medication. After grading mask ventilation the study intervention is complete and the remainder of surgical and anesthesia care will be based on the clinical needs and decisions of the care team.||||
1333631|NCT03158194||Single Group Assignment||Treatment||None (Open Label)||Single-subject multiple baseline design.||||
1333632|NCT03158181|||Cohort||Prospective|||||||
1333633|NCT03158168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333634|NCT03158155|||Cohort||Cross-Sectional|||||||
1333635|NCT03158142||Single Group Assignment||Basic Science||None (Open Label)||||||
1333636|NCT03158129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333637|NCT03158116||Single Group Assignment||Treatment||None (Open Label)||two-center, prospective, case control clinical trial||||
1333638|NCT03158103||Single Group Assignment||Treatment||None (Open Label)||The phase I study consists of a dose-escalation cohort and a dose-expansion cohort.||||
1333639|NCT03158090|||Cohort||Other|||||||
1333640|NCT03158077|||Case-Only||Retrospective|||||||
1333641|NCT03158064||Single Group Assignment||Treatment||None (Open Label)||||||
1333642|NCT03158051|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1333643|NCT03158038|Randomized|Parallel Assignment||Prevention||Quadruple|Double-blind||t|t|t|t
1333644|NCT03158025|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1333645|NCT03158012|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1333646|NCT03157999|Randomized|Parallel Assignment||Other||Double|The Research Assistant who will be collecting the outcome measures will be blinded to group allocation (intervention vs. control) for the duration of data collection.|The proposed study design is a pragmatic randomized controlled trial (RCT). A pragmatic design applies RCT methodology in actual care settings to better inform decisions on the likely benefits, harms, and costs of real world implementation. The design is further classified as a Type II hybrid effectiveness-implementation study, which assigns equal weight to assessing program effectiveness and implementation.|t|||t
1333647|NCT03157986|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1333648|NCT03157973|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|The nature of the intervention rules out masking.|||||
1333649|NCT03157960|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Interventional study. Participant will on sex different occasions receive drinks containing fructose (fructose drink, coca-cola or blueberry drink) with and without the addition of a high-fat meal||||
1333650|NCT03157947||Single Group Assignment||Supportive Care||None (Open Label)||||||
1333651|NCT03157934|||Other||Prospective|||||||
1333652|NCT03157921|||Other||Cross-Sectional|||||||
1333653|NCT03157908||Single Group Assignment||Device Feasibility||None (Open Label)||Prospective cohort study||||
1333813|NCT03155815|||Cohort||Retrospective|||||||
1333654|NCT03157895|Randomized|Parallel Assignment||Prevention||Single|Interviewers should be blind to condition.|||||t
1333655|NCT03157882|||Other||Prospective|||||||
1333656|NCT03157869|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1333657|NCT03157856|||Cohort||Prospective|||||||
1333658|NCT03157843|||Case-Control||Cross-Sectional|||||||
1333659|NCT03157830|||Cohort||Prospective|||||||
1333660|NCT03157817|||Case-Control||Cross-Sectional|||||||
1333661|NCT03157804||Single Group Assignment||Treatment||None (Open Label)||||||
1333662|NCT03157791|Randomized|Parallel Assignment||Diagnostic||Double|The endoscopist and endoscopy nurse will not know to which treatment arm the patient belongs as only the interviewing nurse will have taken down this information. This information does not travel with the patient to the endoscopy room. The patient is also instructed to not reveal to the endoscopist or endoscopy nurse if he or she has taken simethicone or not.||||t|t
1333663|NCT03157778|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Obese men versus normal-weight men||||
1333664|NCT03157765|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1333665|NCT03157752|||Cohort||Prospective|||||||
1333666|NCT03157739||Single Group Assignment||Treatment||None (Open Label)||||||
1333667|NCT03157726|Randomized|Parallel Assignment||Treatment||Double||||t||t
1333668|NCT03157713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333669|NCT03157700|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333670|NCT03157687|||Case-Control||Prospective|||||||
1333671|NCT03157674|||Cohort||Retrospective|||||||
1333672|NCT03157661|||Cohort||Prospective|||||||
1333673|NCT03157648|||Case-Control||Prospective|||||||
1333674|NCT03157635|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1333675|NCT03157622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333676|NCT03157609|Non-Randomized|Crossover Assignment||Other||Triple|use of a third person (blinded to study design, population and statistics) which will extract data blindly from the hospital anaesthesia electronic database||t||t|t
1333677|NCT03157596|Randomized|Parallel Assignment||Prevention||Single||||||t
1333678|NCT03157583|Randomized|Parallel Assignment||Treatment||Single||||||t
1333679|NCT03157570|Randomized|Parallel Assignment||Treatment||Double||||t||t
1333680|NCT03157557|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1333681|NCT03157544||Single Group Assignment||Treatment||None (Open Label)||||||
1333682|NCT03157531||||||||||||
1333683|NCT03157518||Single Group Assignment||Other||None (Open Label)||||||
1333684|NCT03157505|Randomized|Parallel Assignment||Treatment||Single||||||t
1333685|NCT03157492|Randomized|Parallel Assignment||Treatment||Single||Participants are randomly assigned to either AR Treatment or Active (Cognitive Training) Control Group. Participants are not told they are in the control group. After the final assessment (two-month post-treatment), control group participants are offered the AR treatment.|t|||
1333686|NCT03157479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333687|NCT03157466|||Cohort||Prospective|||||||
1333688|NCT03157453|||Cohort||Prospective|||||||
1333689|NCT03157440|||Case-Only||Cross-Sectional|||||||
1333690|NCT03157427|Randomized|Parallel Assignment||Treatment||Single||"Patients will be treated on the randomized hand, the other hand is the comparator/control.~Comparison between the treated hand and the control hand will be performed."||||t
1333691|NCT03157414|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1333692|NCT03157401|||Other||Prospective|||||||
1333693|NCT03157388||Single Group Assignment||Basic Science||None (Open Label)||15 patients with alcoholic hepatitis will be consecutively included and compared to a historical cohort of AH patients||||
1333694|NCT03157375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333695|NCT03157362|Randomized|Crossover Assignment||Basic Science||Double|Participants will not be informed of what condition they are assigned to. The research assistants who code the data will also not be informed of condition.|"Each participant will experience four conditions, in a random order, crossing near and far virtual environments, and social presence or no social presence."|t|||t
1333696|NCT03157349|Randomized|Parallel Assignment||Treatment||Double|The placebo and Biofreeze are in identical containers and only the manufacturer know the contents||t||t|
1333697|NCT03157336|Randomized|Parallel Assignment||Prevention||None (Open Label)||We will implement a novel cassava processing method (wetting method, WTM) that safely removes cyanogenic compounds from cassava flour prior to human consumption in a stratified village-cluster randomized non-inferiority trial so as to compare the effectiveness of a peer-led intervention (Arm 1 = women training other women in the WTM) with that by community-health worker specialists (Arm 2= specialist led intervention arm)||||
1333698|NCT03157323||Single Group Assignment||Prevention||None (Open Label)||||||
1333699|NCT03157310||Single Group Assignment||Treatment||None (Open Label)||||||
1333700|NCT03157297||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1333701|NCT03157284|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1333702|NCT03157271|Randomized|Parallel Assignment||Treatment||Single||||||t
1333703|NCT03157258|Randomized|Parallel Assignment||Prevention||Single|||t|||
1333704|NCT03157245|||Case-Only||Prospective|||||||
1333705|NCT03157232||Single Group Assignment||Other||None (Open Label)||||||
1333706|NCT03157219|||Cohort||Prospective|||||||
1333707|NCT03157206|||Cohort||Prospective|||||||
1333708|NCT03157193|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1333709|NCT03157180|||Case-Control||Prospective|||||||
1333710|NCT03157167|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Single dose escalation study to determine safety||||
1333711|NCT03157154|||Case-Only||Prospective|||||||
1333712|NCT03157141|||Cohort||Prospective|||||||
1333713|NCT03157128||Single Group Assignment||Treatment||None (Open Label)||||||
1333714|NCT03157115|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1577407|NCT00001917||||||||||||
1333715|NCT03157102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333716|NCT03157089||Single Group Assignment||Treatment||None (Open Label)||||||
1333717|NCT03157076|Randomized|Crossover Assignment||Treatment||Double||Patients are randomized in two different pacing modes (CLS versus intrinsic rhythm) after one month after enrollment. The cross-over takes place after one month after the randomization.|t||t|
1333718|NCT03157063|||Case-Control||Cross-Sectional|||||||
1333719|NCT03157050|||Other||Prospective|||||||
1333720|NCT03157037||Single Group Assignment||Treatment||None (Open Label)||Open-Label, Single Arm study||||
1333721|NCT03157024|Randomized|Parallel Assignment||Device Feasibility||Single|||t|||
1333722|NCT03157011||Single Group Assignment||Basic Science||None (Open Label)||Global symptom score (GSS) questionary . This questionnaire has the advantage of grading the severity of These digestive symptoms.||||
1333723|NCT03156998|||Cohort||Prospective|||||||
1333724|NCT03156985|||Cohort||Prospective|||||||
1333725|NCT03156972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333726|NCT03156959|Randomized|Parallel Assignment||Treatment||Single||||||t
1333727|NCT03156946|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1333728|NCT03156933|||Other||Retrospective|||||||
1333729|NCT03156920|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1333730|NCT03156907||Single Group Assignment||Treatment||None (Open Label)|Open|||||
1333731|NCT03156894|||Cohort||Retrospective|||||||
1333732|NCT03156881|Randomized|Parallel Assignment||Treatment||Single|"Since this study does not involve a sham treatment, the researcher and Dr. Peltekian have decided to have two consent forms. Patients will be assigned a code number and will be divided randomly into treatment or non-treatment groups via Dr. Peltekian opening up sealed envelops made by researcher Jenna Wilcox. Part one of the study will involve Dr. Peltekian asking potential participants consent to be a part of a study measuring  Quality of life and readiness for management of NAFLD. Upon consent, he/she will fill out the two questionnaires and give consent that their routine blood work can be analysed anonymously. During the same time, Dr. Peltekian will open up a sealed envelope revealing a code number and either an invitation to Part 2 of the study or not to invite and to remain as a control participant. By using this method the control group is not informed of the osteopathic research of the study (Part 2), thus reducing bias."|"24 participants in control group receiving no global osteopathic treatment. Just standard care, baseline blood work every three months, improving their diet and exercise. They will also complete two questionnaires to measure their quality of life and readiness to change.~Experimental group will also do the above with additional four osteopathic treatments to compare the differences in quality of life and liver function in both groups."|t|||
1333733|NCT03156868|||Other||Prospective|||||||
1333734|NCT03156855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333735|NCT03156842|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1333736|NCT03156829|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1333737|NCT03156816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333738|NCT03156803|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333739|NCT03156790||Single Group Assignment||Treatment||None (Open Label)||||||
1333740|NCT03156777|||Case-Only||Prospective|||||||
1333741|NCT03156764|||Other||Prospective|||||||
1333742|NCT03156751|||Case-Only||Prospective|||||||
1333743|NCT03156738|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1333744|NCT03156725|Randomized|Single Group Assignment||Basic Science||Single|When 57Fe was added to a meal an empy capsule was consumed by the subjects. 58Fe and natutal abundace iron associated with A. oryzae was consumed in capsule form.|Subjects were two meals on two consecutive days with the stable isotopes.|t|||
1333745|NCT03156712|Randomized|Crossover Assignment||Treatment||Double|Both investigators and participants were blinded to the iron treatment in this double-blinded, crossover study. Three different iron supplements were given, whereby participants were either administered 10 mg FeSO4, 10 mg ASP Fe, or 20 mg ASP Fe.|Double-blinded, cross-over experimental design, whereby subjects were randomly given three different iron supplements with a meal in three different visits. All three visits (iron treatments) were each separated by two weeks time.|t||t|
1333746|NCT03156699|||Cohort||Retrospective|||||||
1333747|NCT03156686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333748|NCT03156673||Single Group Assignment||Treatment||None (Open Label)||||||
1333749|NCT03156660|Randomized|Parallel Assignment||Treatment||Single||||||t
1333750|NCT03156647|||Case-Only||Prospective|||||||
1333751|NCT03156634|Randomized|Parallel Assignment||Health Services Research||Single|The statistician will be masked to the group assignment.|Participants will be randomized to view materials via one of to systems (Patient Activated Learning System or WebMD)||||t
1333752|NCT03156621|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1333753|NCT03156608|Randomized|Parallel Assignment||Screening||None (Open Label)||Women will be randomized to either standard monitoring with external Doppler and tocodynamometer or monitoring with the Novii Fetal ECG/EMG system using a computer generated randomization scheme through REDCap. Randomization will occur in blocks based on the subject's BMI. Women with a BMI < 30 will be randomized separate from women with a BMI > 30.||||
1333754|NCT03156595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333755|NCT03156582|||Cohort||Retrospective|||||||
1333756|NCT03156569|||Case-Control||Prospective|||||||
1333757|NCT03156556||Single Group Assignment||Treatment||None (Open Label)||8-week pretest/post-test open trial including a 3-month follow-up.||||
1333758|NCT03156543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333759|NCT03156530|Randomized|Single Group Assignment||Other||None (Open Label)|The subjects were randomized between the groups and the auricular stimulation was performed unilaterally, the motor preference side being standardized as the stimulated side|This study is a randomized controlled clinical trial to analyze the influence of auricular points on lower limbs on the equilibrium response assessed by static stabilometry||||
1333811|NCT03155841|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333812|NCT03155828|||Cohort||Prospective|||||||
1333760|NCT03156517|Randomized|Crossover Assignment||Treatment||Double|The doctor who assesses the primary outcome measures at 3 and 6 months and the participant are both unaware of which of the two targets is stimulated in the two randomization periods.|Randomized allocation of half the patients to be stimulated the first 3 months in the VIM-nucleus of the thalamus (VIM) and then 3 months in the posterior subthalamic area (PSA), and for the other half the first 3 months in the PSA and the next 3 months in the VIM|t|||t
1333761|NCT03156504||Single Group Assignment||Basic Science||None (Open Label)||||||
1333762|NCT03156491|||Case-Control||Prospective|||||||
1333763|NCT03156478|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomized in 3 groups: 1) control group, 2) digital lifestyle intervention group and 3) combined digital and face-to-face lifestyle intervention group. Environmental changes will be done within some work places.Part of the participants in each group may be exposed to environmental modification that are aimed for lifestyle changes at work places.||||
1333764|NCT03156465||Single Group Assignment||Treatment||None (Open Label)||repeated-measure, single-subject experiment||||
1333765|NCT03156452|Randomized|Parallel Assignment||Treatment||None (Open Label)||A multicentre, open label randomised clinical trial of MMF with steroid as a first line treatment for patients with ITP against the standard care pathway involving steroids alone as first line treatment.||||
1333766|NCT03156439||Single Group Assignment||Treatment||None (Open Label)||||||
1333767|NCT03156426|||Case-Only||Prospective|||||||
1333768|NCT03156413||Single Group Assignment||Treatment||None (Open Label)||||||
1333769|NCT03156400|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1333770|NCT03156387|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study, designed as a randomized prospective controlled clinical trial, was conducted to compare the clinical outcomes of frenectomies performed using conventional surgery or a diode laser.||||
1333771|NCT03156374||Single Group Assignment||Diagnostic||None (Open Label)||Parallel use of ovulation test and standard hospital monitoring, for agreement of methods||||
1333772|NCT03156361|Randomized|Crossover Assignment||Treatment||Quadruple||This is a single center, double blind, active comparator controlled 2-Way crossover multiple dose safety, tolerability and efficacy study.|t|t|t|t
1333773|NCT03156348|Randomized|Parallel Assignment||Prevention||Single||parallels groups: control arm will receive usual care, intervention arm will receive a Clinical Pharmacist Care||||t
1333774|NCT03156335||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1333775|NCT03156322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333776|NCT03156296|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333777|NCT03156283|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1333778|NCT03156270||Single Group Assignment||Treatment||None (Open Label)||||||
1333779|NCT03156257|||Case-Only||Prospective|||||||
1333780|NCT03156244|||Cohort||Prospective|||||||
1333781|NCT03156231|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333782|NCT03156218|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||In both groups FiO2 will be modulated: FiO2 will be reduced to 21% or until peripheral oxygen saturation of 92%, whatever occurs first. Subsequently FiO2 will be increased up to 100%.||||
1333783|NCT03156205|Randomized|Parallel Assignment||Treatment||Single||||||t
1333784|NCT03156192||Single Group Assignment||Health Services Research||||||||
1333785|NCT03156179|||Case-Only||Cross-Sectional|||||||
1333786|NCT03156166|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1333787|NCT03156153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333788|NCT03156140||Single Group Assignment||Other||None (Open Label)||||||
1333789|NCT03156127|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1333790|NCT03156114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1333791|NCT03156101||Single Group Assignment||Treatment||None (Open Label)||||||
1333792|NCT03156088|||Cohort||Other|||||||
1333793|NCT03156075|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333794|NCT03156062|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1333795|NCT03156049|Randomized|Parallel Assignment||Treatment||Single||||||t
1333796|NCT03156036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333797|NCT03156023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333798|NCT03156010|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||All participants undergo testing with the same three devices. The order of devices will be semi-randomized to eliminate order effects.||||
1333799|NCT03155997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333800|NCT03155984|||Cohort||Prospective|||||||
1333801|NCT03155971||Single Group Assignment||Treatment||None (Open Label)||||||
1333802|NCT03155958|||Case-Crossover||Cross-Sectional|||||||
1333803|NCT03155945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333804|NCT03155932||Single Group Assignment||Treatment||None (Open Label)||Open label||||
1333805|NCT03155919|Randomized|Crossover Assignment||Treatment||Double|The taurine and placebo powder were offered in capsules identified by Taurine A and Taurine B.|A double-blind, crossover, 2-week washout study will be conducted with 20 male triathletes, aged 30 to 45 years, which will be offered during eight weeks capsules containing three grams of taurine or placebo and 400 ml of chocolate milk ready to drink.|t||t|
1333806|NCT03155906|Randomized|Parallel Assignment||Health Services Research||Triple|Even though complete blinding is regarded as difficult, there will be some degree of blinding/masking. Randomisation will be disclosed to physician and other health care staff providing OST treatment, but not to research nurses conducting data collection for outcomes. Patients will be informed of the follow-up they will receive, but not on other follow-up alternatives that are used or the exact hypotheses for the study.|A multicentre, randomised controlled clinical trial.|t||t|t
1333807|NCT03155893|Randomized|Parallel Assignment||Other||Double|||t||t|
1333808|NCT03155880|||Cohort||Cross-Sectional|||||||
1333809|NCT03155867|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1333810|NCT03155854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333814|NCT03155802|||Cohort||Prospective|||||||
1333815|NCT03155789|||Cohort||Prospective|||||||
1333816|NCT03155776|||Case-Only||Prospective|||||||
1333817|NCT03155763|||Cohort||Retrospective|||||||
1333818|NCT03155750|Randomized|Parallel Assignment||Treatment||Single||||||t
1333819|NCT03155737|Randomized|Parallel Assignment||Treatment||Single||||||t
1333820|NCT03155724||Single Group Assignment||Treatment||None (Open Label)||||||
1333821|NCT03155711|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1333822|NCT03155698||Single Group Assignment||Treatment||None (Open Label)||Enrolled subjects will be randomized to treatment with microneedling by using dermapen every two weeks while the contralateral side of the body will be treated by microneedling plus topical PRP every two weeks .Then both sides of the body will receive narrowband UVB twice weekly for 6 month,||||
1333823|NCT03155685|||Cohort||Prospective|||||||
1333824|NCT03155672|||Cohort||Prospective|||||||
1333825|NCT03155659|||Cohort||Prospective|||||||
1333826|NCT03155646|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333827|NCT03155633|Randomized|Parallel Assignment||Other||None (Open Label)||The first one performed rests during the 9 days after the race, the second performed continuous race monitored every 48h from the end of the race, and the third group performed aerobic work on an elliptical machine under the same conditions as the group of Continuous race||||
1333828|NCT03155620|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1333829|NCT03155607|Randomized|Parallel Assignment||Treatment||Single|||||t|
1333830|NCT03155594||Single Group Assignment||Treatment||None (Open Label)||Adult patients in the hospital receiving 4-5 glucometer checks per day||||
1333831|NCT03155581|Randomized|Parallel Assignment||Prevention||None (Open Label)|Women under are those recruited in the intervention targeting women. In addition, 40 GP centers were recruited|One intervention targeting women, the other one targeting health professionals.||||
1333832|NCT03155568|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1333833|NCT03155555|||Cohort||Prospective|||||||
1333834|NCT03155542|||Case-Control||Retrospective|||||||
1333835|NCT03155529|||Case-Control||Other|||||||
1333836|NCT03155516|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1333837|NCT03155503|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind|subjects randomized to drug or placebo|t|t|t|t
1333838|NCT03155490|Randomized|Parallel Assignment||Treatment||Single||||||t
1333839|NCT03155477|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1333840|NCT03155464|Randomized|Parallel Assignment||Other||None (Open Label)||This study will enroll participants in a 1:1 randomized study design. Participants will serve as their own controls. A consecutive series of patients will be randomized to either Group 1 or 2. Randomization will occur through 40 sealed, opaque sequentially numbered envelopes containing the randomization. Those that qualify and sign consent will be randomized 24hrs prior to surgery. The randomization envelopes will be stored in a locked filing cabinet within the clinical research coordinators office. The subject will know what treatment arm they are in prior to surgery.||||
1333841|NCT03155451|||Case-Control||Prospective|||||||
1333842|NCT03155438|||Case-Control||Cross-Sectional|||||||
1333843|NCT03155425||Single Group Assignment||Treatment||None (Open Label)||SHR-1210 injection, 200 mg/dose, intravenous infusion over 30 minutes.||||
1333844|NCT03155412|||Cohort||Cross-Sectional|||||||
1333845|NCT03155399|Randomized|Parallel Assignment||Treatment||Single|The assessment was conducted by two physiotherapists not involved in providing the experimental treatment.|||||t
1333846|NCT03155386|||Cohort||Prospective|||||||
1333847|NCT03155373|||Cohort||Prospective|||||||
1333848|NCT03155360|||Case-Control||Prospective|||||||
1333849|NCT03155347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1333850|NCT03155334|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1333851|NCT03155321|||Other||Cross-Sectional|||||||
1333852|NCT03155308|||Case-Crossover||Cross-Sectional|||||||
1333853|NCT03155295|||Cohort||Prospective|||||||
1333854|NCT03155282|||Case-Control||Cross-Sectional|||||||
1333855|NCT03155269|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1333856|NCT03155256|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333857|NCT03155243|||Cohort||Prospective|||||||
1333858|NCT03155230|||Cohort||Prospective|||||||
1333859|NCT03155217|||Cohort||Retrospective|||||||
1333860|NCT03155204|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1333861|NCT03155191||Single Group Assignment||Treatment||None (Open Label)||"Peripheral blood will be collected from a subject after obtaining a written informed consent. Peripheral blood mononuclear cells (PBMCs) and plasma are obtained from the blood, and T cells contained in the PBMCs are transduced with anti-CD19 CAR gene by using retroviral vector.~Cyclophosphamide will be administered after obtaining a written informed consent and completing registration.~CD19-CAR-T will be administered in the split dose. Phase 2 recommended dose will be applied for phase 1 portion. The investigator assesses efficacy of CD19-CAR-T in accordance with study-specific criteria, at 8 week after the infusion of CD19-CAR-T (or at the time of termination). The investigator also assesses the safety during the follow-up period. Long-term follow-up study is conducted at frequency of once a year for 15 years after the infusion of CD19-CAR-T in reference to guidelines of FDA."||||
1333862|NCT03155178|Randomized|Parallel Assignment||Prevention||Single||||||t
1333863|NCT03155165|||Case-Only||Cross-Sectional|||||||
1333864|NCT03155152|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1333865|NCT03155139|||Ecologic or Community||Prospective|||||||
1333866|NCT03155126|||Cohort||Retrospective|||||||
1333867|NCT03155113||Single Group Assignment||Other||None (Open Label)||||||
1333868|NCT03155100||Single Group Assignment||Treatment||None (Open Label)||||||
1333869|NCT03155087|||Case-Control||Retrospective|||||||
1333870|NCT03155074|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1333871|NCT03155061|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1577408|NCT00001915||||||||||||
1333872|NCT03155048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333873|NCT03155035|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1333874|NCT03155022|Randomized|Parallel Assignment||Treatment||Single||||||t
1333875|NCT03155009||Single Group Assignment||Treatment||None (Open Label)||||||
1333876|NCT03154996||Single Group Assignment||Treatment||None (Open Label)||||||
1333877|NCT03154983||Single Group Assignment||Treatment||None (Open Label)||||||
1333878|NCT03154970|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1333879|NCT03154957|||Cohort||Retrospective|||||||
1333880|NCT03154944|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1333881|NCT03154931|Randomized|Parallel Assignment||Treatment||Single|||t|||
1333882|NCT03154918||Single Group Assignment||Treatment||None (Open Label)||||||
1333883|NCT03154905|||Cohort||Prospective|||||||
1333884|NCT03154892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333885|NCT03154879|||Cohort||Prospective|||||||
1333886|NCT03154866|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1333887|NCT03154853|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1333888|NCT03154840|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||6x3 Crossover Study||||
1333889|NCT03154827||Single Group Assignment||Treatment||None (Open Label)||||||
1333890|NCT03154814|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Retrospective cohort study||||
1333891|NCT03154801||Single Group Assignment||Treatment||None (Open Label)||||||
1333892|NCT03154788|||Ecologic or Community||Prospective|||||||
1333893|NCT03154775||Single Group Assignment||Treatment||None (Open Label)||||||
1333894|NCT03154762|Randomized|Parallel Assignment||Treatment||Double|Similar equipment will be used, the programming of the positive pressure device will be performed by an external person and a cover will be placed on the screen.|Experimental, prospective, longitudinal, comparative, parallel group study|t||t|
1333895|NCT03154749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333896|NCT03154736||Single Group Assignment||Prevention||None (Open Label)||||||
1333897|NCT03154723||Single Group Assignment||Prevention||None (Open Label)||||||
1333898|NCT03154710|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Randomised, open, multicenter prospective trial||||
1333899|NCT03154697|||Case-Only||Cross-Sectional|||||||
1333900|NCT03154684|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1333901|NCT03154671|Randomized|Parallel Assignment||Supportive Care||Single|The outcome assessor and statistician will be blinded to group allocation|||||t
1333902|NCT03154658|Randomized|Parallel Assignment||Treatment||Single||Randomized interventional prospective model to investigate effect of block placement in two treatment arms. Opioid consumption in the first 24 hours after the operation will be main outcome variable.|t|||
1333903|NCT03154645|Randomized|Parallel Assignment||Prevention||Quadruple|visually identical pills|randomized double blind controlled trial|t|t|t|t
1333904|NCT03154632|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1333905|NCT03154619|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333906|NCT03154606|Randomized|Crossover Assignment||Prevention||Double|Double-blind|tightly-controlled, randomized cross-over design|t||t|
1333907|NCT03154593|||Cohort||Prospective|||||||
1333908|NCT03154580|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1333909|NCT03154567|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1333910|NCT03154554|||Cohort||Prospective|||||||
1333911|NCT03154541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Non-randomized, non-blinded single arm cohort study||||
1333912|NCT03154528|||Case-Control||Cross-Sectional|||||||
1333913|NCT03154515|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind||t|t|t|t
1333914|NCT03154502|||Cohort||Cross-Sectional|||||||
1333915|NCT03154489|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1333916|NCT03154476|Randomized|Parallel Assignment||Other||Quadruple|Both the treatment arm (sildenafil) and the placebo arm will receive monthly package of similar pills. Equal number of patients will be randomly assigned to each arm.|Randomized Double-blind Placebo-control study|t|t|t|t
1333917|NCT03154463|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1333918|NCT03154450|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1333919|NCT03154437||||||||||||
1333920|NCT03154424|Randomized|Parallel Assignment||Treatment||Triple|"Patients were randomized by drawing lots currency (Face = A - treatment with fixation non-bridging; Crown = B - Treatment with the method bridging), which were printed and placed in sealed envelopes before the study started."||t|t|t|
1333921|NCT03154411||Single Group Assignment||Basic Science||None (Open Label)|open label|||||
1333922|NCT03154398|||Cohort||Prospective|||||||
1333923|NCT03154385||Single Group Assignment||Treatment||None (Open Label)||||||
1333924|NCT03154372|Randomized|Parallel Assignment||Other||Single||||||t
1333925|NCT03154359|||Cohort||Prospective|||||||
1333926|NCT03154346|||Cohort||Prospective|||||||
1333927|NCT03154333|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333928|NCT03154320|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized in a 1:1 ratio to standard or same-day treatment||||
1333929|NCT03154307|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1333965|NCT03153839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333966|NCT03153826||Single Group Assignment||Basic Science||None (Open Label)||||||
1333967|NCT03153813|Randomized|Parallel Assignment||Other||Double|||t||t|
1333968|NCT03153800||Single Group Assignment||Treatment||None (Open Label)||||||
1333969|NCT03153787||Single Group Assignment||Other||None (Open Label)||||||
1333970|NCT03153774|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)|Open|||||
1333971|NCT03153761|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1333930|NCT03154294|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"The demographic and clinical characteristics of the study patients will be summarized using descriptive statistics~Primary objective: The maximum tolerable dose will be assessed, which is the dose level at which < one-third of patients will experience a dose-limiting toxicity~Secondary objectives:~Adverse events will be defined according to the Common Terminology Criteria for Adverse Events v4 and will be summarized with descriptive statistics~Response rate will be determined according to the Response Evaluation Criteria in Solid Tumors 1.1 response criteria. Number and type of responses will be summarized with descriptive statistics~Exploratory objectives~Response rate and relationship with genomic alterations will be examined by using a two-sided Fisher Exact test due to the small sample sizes~Therapy-Related Symptom Checklist and Health-Related Quality of Life Linear Analogue Self-Assessment scores will be summarized with descriptive statistics"||||
1333931|NCT03154281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||The statistical analysis will be mainly descriptive. Continuous variables will be summarized using descriptive statistics: N, mean, standard deviation, median, minimum and maximum. Categorical variables will be presented using frequencies and percentages. Time-to-event will be described by N, median, range, number censored, and Kaplan-Meier plots. A traditional dose escalation design will be used, beginning with the lowest dose level and escalating to the maximum allowable dose level as specified in the protocol. Three patients will be treated one at a time at a given dose level. A maximum of 4 dosing levels results in a maximum sample size of n=24 subjects.||||
1333932|NCT03154268|||Cohort||Retrospective|||||||
1333933|NCT03154255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333934|NCT03154242|||Other||Prospective|||||||
1333935|NCT03154229|Randomized|Parallel Assignment||Treatment||None (Open Label)||Cluster randomized controlled trial.||||
1333936|NCT03154216|Randomized|Crossover Assignment||Basic Science||Single||||||t
1333937|NCT03154203|||Cohort||Prospective|||||||
1333938|NCT03154190|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1333939|NCT03154177|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1333940|NCT03154164|||Case-Only||Prospective|||||||
1333941|NCT03154151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333942|NCT03154138|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1333943|NCT03154125|Randomized|Parallel Assignment||Other||Single|Neither participants nor site staff will be blinded to SC injection sites. However, laboratory staff analyzing serum MPA specimens and staff at FHI 360 responsible for adjudicating pregnancy outcomes and coding adverse events will be blinded to individual participant injection site assignments for the duration of each participant's follow up.|All participants will receive the same study drug, Sayana® Press. However, women will be randomized to receive their injections in the abdomen, back of the upper arm, or upper thigh to control for potential confounding when assessing relationships between SC injection site, efficacy, and PK. One cohort of N=630 women will be randomized 1:1 to receive their injections in the abdomen or thigh, and a separate PK cohort of N=120 women agreeing to MPA testing will be randomized 1:1:1 to receive their injections in the abdomen, upper thigh, or back of the upper arm. Randomization will be stratified by cohort and site using appropriate randomly permuted block sizes.||||t
1333944|NCT03154112|||Cohort||Prospective|||||||
1333945|NCT03154099|||Cohort||Prospective|||||||
1333946|NCT03154086|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1333947|NCT03154073|Randomized|Parallel Assignment||Prevention||Single||||||t
1333948|NCT03154060||Single Group Assignment||Other||None (Open Label)||open-label, prospective, single-arm study||||
1333949|NCT03154047||Single Group Assignment||Treatment||None (Open Label)||||||
1333950|NCT03154034|||Cohort||Prospective|||||||
1333951|NCT03154021|Randomized|Parallel Assignment||Prevention||Double|The identity of the experimental oral rinse and its placebo will be disguised. Test and control kit boxes will contain toothpaste, a toothbrush, dose cups and a timer. The kit boxes will be labeled with a unique kit number representing the test product or placebo known only to the manufacturer. Kit box labels will also contain the study number, emergency phone number, distributor name/address, appropriate caution statements, content statement and other information as required by internal regulations and clinical SOPs. Kit box content statement will be worded to maintain the study blind.|One half of subjects will be given test product other half will be given placebo.|t||t|
1333952|NCT03154008||Single Group Assignment||Treatment||None (Open Label)||||||
1333953|NCT03153995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333954|NCT03153982||Single Group Assignment||Treatment||None (Open Label)||||||
1333955|NCT03153969|Randomized|Parallel Assignment||Treatment||Single||||||t
1333956|NCT03153956|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Phase I - A prospective, interventional, randomized, double-arm clinical evaluation of patients who have been diagnosed with OA of the knee. The active treatment arm (personally calibrated biomechanical device) will be compared to a control arm (sham-placebo device) (similar shoes without biomechanical elements).~Phase II - Open-label, cross-over study design. After the completion of phase one patients will be un-blinded to their group allocation. Patients that were allocated to the sham-placebo control group will cross to the active group and will receive the AposTherapy treatment. Patients that were allocated to the active group will continue with treatment."||||
1333957|NCT03153943|Randomized|Parallel Assignment||Treatment||Single||Pragmatic randomized trial||||t
1333958|NCT03153930|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Participants will complete a randomized crossover study with 2 conditions: sitting continuously for 3 hours vs. interrupting sitting with 3-minute moderate intensity walking breaks every 30 minutes for 3 hours. A subset will then complete a free-living component wearing a continuous glucose monitor that will consist of habitual activity vs. interrupting periods of 30+ sedentary minutes with short activity breaks.||||
1333959|NCT03153917||Single Group Assignment||Diagnostic||None (Open Label)||||||
1333960|NCT03153904|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1333961|NCT03153891|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1333962|NCT03153878|||Cohort||Prospective|||||||
1333963|NCT03153865|||Case-Only||Prospective|||||||
1333964|NCT03153852||Single Group Assignment||Treatment||None (Open Label)||||||
1333972|NCT03153748|||Case-Only||Prospective|||||||
1333973|NCT03153735|Randomized|Parallel Assignment||Treatment||Single|Subject blind||t|||
1333974|NCT03153722||Single Group Assignment||Health Services Research||None (Open Label)||||||
1333975|NCT03153709|||Cohort||Prospective|||||||
1333976|NCT03153696|Randomized|Parallel Assignment||Prevention||Single||||||t
1333977|NCT03153683|||Other||Prospective|||||||
1333978|NCT03153670||Single Group Assignment||Other||None (Open Label)||||||
1333979|NCT03153657|Randomized|Crossover Assignment||Prevention||Triple|Triple Blind (Participant, Investigator, Outcomes Assessor)||t||t|t
1333980|NCT03153644|||Cohort||Cross-Sectional|||||||
1333981|NCT03153631|||Other||Prospective|||||||
1333982|NCT03153618|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||In a two section clinic, the plan is to invite one section of newly enrolled patients coming to clinic for first visit to participate in interacting with VALIDATE while maintaining the standard of care within the other section for similarly matched patients. Parallel allocation design.||||
1333983|NCT03153605|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1333984|NCT03153592|Randomized|Parallel Assignment||Supportive Care||Single|Patients will not know the arm of assignment. Care providers and investigators will know the arm, making the masking not possible.||t|||
1333985|NCT03153579|Randomized|Crossover Assignment||Treatment||Quadruple|randomized, double-blind, placebo-controlled, crossover|randomized, double-blind, placebo-controlled, crossover|t|t|t|t
1333986|NCT03153566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333987|NCT03153553|Randomized|Parallel Assignment||Other||Double|||t|||t
1333988|NCT03153540|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1333989|NCT03153527|Randomized|Parallel Assignment||Treatment||Quadruple|"Blinding of trial participants, treating physicians, study doctors, study nurses, outcome assessors and data analysts will be ensured by using identical-looking placebo, packaged in identical vials as the prednisone verum. Vials will be labeled with Prednisone or Placebo in an identical fashion."|"Standard treatment arm: Prednisone, a synthetic glucocorticoid with intermediate duration of action (biological half-life 18-35 hrs). The detailed characteristics of the compound, marketed under several brand names, can be found at www.swissmedicinfo.ch: Prednison Streuli (Swissmedic registration number: 29349); Prednison Axapharm (Swissmedic registration number: 58761); Prednison Galepharm (Swissmedic registration number: 50821).~Interventional treatment arm: matching placebo."|t|t|t|t
1333990|NCT03153514||Single Group Assignment||Treatment||None (Open Label)||||||
1333991|NCT03153501||Single Group Assignment||Diagnostic||None (Open Label)|Image guided biopsies Thoracoscopy|||||
1333992|NCT03153488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1333993|NCT03153475||Single Group Assignment||Treatment||None (Open Label)||||||
1333994|NCT03153462||||||||||||
1333995|NCT03153449||Single Group Assignment||Treatment||None (Open Label)||||||
1333996|NCT03153436|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1333997|NCT03153423||Single Group Assignment||Prevention||None (Open Label)||||||
1333998|NCT03153410||Single Group Assignment||Treatment||None (Open Label)||||||
1333999|NCT03153397|Randomized|Parallel Assignment||Treatment||Single||||||t
1334000|NCT03153384|||Case-Control||Prospective|||||||
1334001|NCT03153371|||Case-Control||Prospective|||||||
1334002|NCT03153358||Single Group Assignment||Treatment||None (Open Label)||icotinib and SBRT treat the lung cancer with egfr mutation||||
1334003|NCT03153345|Randomized|Parallel Assignment||Treatment||Single||||||t
1334004|NCT03153332|||Other||Prospective|||||||
1334005|NCT03153319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334006|NCT03153306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334007|NCT03153293||Single Group Assignment||Treatment||None (Open Label)||||||
1334008|NCT03153280||Single Group Assignment||Treatment||None (Open Label)||"Lithium: starting dose: 2x 400mg p.o. per day. Initial target blood concentration (Level 1 = 0.6mmol/L).~Oxaliplatin: 130 mg/m2 in 500 ml normal saline (NS) over 120 minutes on Day 1 of each 3 week cycle.~Capecitabine: 1000 mg/m2 b.i.d po on Days 1 to 14 of each 3 week cycle."||||
1334009|NCT03153267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334010|NCT03153254|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||Phase 1: Healthy persons Phase 2: Stroke patients||||
1334011|NCT03153241|||Cohort||Prospective|||||||
1334012|NCT03153228|||Case-Control||Prospective|||||||
1334013|NCT03153215|Randomized|Parallel Assignment||Other||Double|Patients will randomly be allocated to two groups with 23 patients in each group|"A total of 46 patients with severe early onset intrauterine growth retardation will be enrolled in a randomized placebo control controlled study .~Patients will randomly be allocated to two groups with 23 patients in each group"|t||t|
1334014|NCT03153202|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a non-randomized trial. Patients will be allocated to appropriate cohort A-D per their disease type and time of enrollment to study.||||
1334015|NCT03153189|||Other||Cross-Sectional|||||||
1334016|NCT03153176|Randomized|Parallel Assignment||Other||Double|Allocation, and those who evaluate the outcomes of the main outcome (physical activity, sedentary behavior, dietary intake and body composition) will be blind to baseline group assignment|physical activity and lifestyle intervention|||t|t
1334017|NCT03153163||Single Group Assignment||Treatment||None (Open Label)||||||
1334018|NCT03153150|Randomized|Parallel Assignment||Prevention||Single|PROBE design|1:1 allocation of intervention: comparator, using a minimisation algorithm||||t
1334019|NCT03153137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334020|NCT03153124|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1334021|NCT03153111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334022|NCT03153098|||Ecologic or Community||Prospective|||||||
1334023|NCT03153085||Single Group Assignment||Treatment||None (Open Label)||||||
1334024|NCT03153072||Single Group Assignment||Other||None (Open Label)||||||
1334025|NCT03153059|||Case-Control||Prospective|||||||
1577409|NCT00001913||||||||||||
1334026|NCT03153046|Randomized|Crossover Assignment||Other||Double|Blinding of compounds will be provided by Clasado Ltd., the company supplying the prebiotics and maltodextrin.|24 week cross-over at 12 week involving preiotics and maltodextrin|t||t|
1334027|NCT03153033|||Case-Only||Cross-Sectional|||||||
1334028|NCT03153020|||Cohort||Prospective|||||||
1334029|NCT03153007|||Case-Only||Cross-Sectional|||||||
1334030|NCT03152994|||Cohort||Prospective|||||||
1334031|NCT03152981|Randomized|Parallel Assignment||Treatment||Single||||||t
1334032|NCT03152968|||Ecologic or Community||Cross-Sectional|||||||
1334033|NCT03152955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334034|NCT03152942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334035|NCT03152929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334036|NCT03152916||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1334037|NCT03152903|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1334038|NCT03152890||Single Group Assignment||Treatment||None (Open Label)||The study group receives a linear mixed effects model-proposed dose of insulin when hyperglycemia is noticed after reperfusion of liver graft.||||
1334039|NCT03152877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334040|NCT03152864|Randomized|Parallel Assignment||Other||Double|||||t|t
1334041|NCT03152851|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1334042|NCT03152838|||Case-Control||Retrospective|||||||
1334043|NCT03152825|||Cohort||Prospective|||||||
1334044|NCT03152812|||Cohort||Prospective|||||||
1334045|NCT03152799|Randomized|Single Group Assignment||Treatment||Quadruple|Participants, Care Provider / Clinician Health Professional, Investigator, and Outcomes assessors will be blinded to the allocation and randomisation of study participatants. It is anticipated that|pilot, single-centre, double-blind, sham-controlled (non-clinical trial of investigational medicinal product [non-CTIMP]) study of repeated daily remote ischaemic conditioning vs placebo/sham in the context of acute anterior circulation stroke|t|t|t|t
1334046|NCT03152786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334047|NCT03152773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334048|NCT03152760|||Case-Control||Prospective|||||||
1334049|NCT03152747|||Other||Prospective|||||||
1334050|NCT03152734|||Cohort||Prospective|||||||
1334051|NCT03152721|Randomized|Parallel Assignment||Treatment||Double|Patient not aware of which information has been provided to his/her physician. Post data collection the groups will be assigned coded group names so that the conditions are masked to the assessor.|1:1 randomisation to intervention and control group. The effect of providing the objective measurement and self assessment scales compared to only self assessment scales on the management decisions will be evaluated. A secondary outcome is the ability of the measurement to identify sub-optimally treated individuals in comparison with self assessment scales.|t|||t
1334052|NCT03152708|||Other||Retrospective|||||||
1334053|NCT03152695||Single Group Assignment||Treatment||None (Open Label)||||||
1334054|NCT03152682|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1334055|NCT03152669|||Other||Other|||||||
1334056|NCT03152656|||Case-Only||Prospective|||||||
1334057|NCT03152643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334058|NCT03152630|||Case-Only||Prospective|||||||
1334059|NCT03152617|||Cohort||Prospective|||||||
1334060|NCT03152604|||Cohort||Prospective|||||||
1334061|NCT03152591||Parallel Assignment||Basic Science||Double|||t||t|
1334062|NCT03152578|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1334063|NCT03152565||Single Group Assignment||Treatment||None (Open Label)||||||
1334064|NCT03152552|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1334065|NCT03152539|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Methodological development of new MRI approaches||||
1334066|NCT03152526||Single Group Assignment||Treatment||None (Open Label)||"In summary, the study will take place in two parts:~Stage 1: Enroll 24 patients with 1:1 randomization for NK cell processing (CD3-/CD19- versus CD3-/CD56+) Stage 2: Enroll an additional 17 patients using the optimal NK cell product identified during stage 1.~If neither product achieves success at the end of stage 1, the study will stop and the platform redesigned"||||
1334067|NCT03152513|||Case-Only||Cross-Sectional|||||||
1334068|NCT03152500|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1334069|NCT03152487|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will randomized to either a group that receives Celiac Plexus Neurolysis or Radiofrequency Ablation.||||
1334070|NCT03152474|Randomized|Parallel Assignment||Treatment||Triple|Double Blind (to investigator, subject, hospital care team and study team members except for research pharmacist), Randomized, Placebo Controlled Clinical Trial; Placebos were wrapped in foil and coded to prevent identification of study material.|Double Blind Placebo Controlled|t|t|t|
1334071|NCT03152461|||Cohort||Prospective|||||||
1334072|NCT03152448|||Cohort||Prospective|||||||
1334073|NCT03152435||Single Group Assignment||Treatment||None (Open Label)||||||
1334074|NCT03152422|||Cohort||Retrospective|||||||
1334075|NCT03152409|Randomized|Parallel Assignment||Treatment||Double|Study team will be blinded to participant condition. Pharmacy will be responsible for providing study drug versus identical placebo to participants.|Randomized control trial with about half of all participants receiving placebo.|t||t|
1334076|NCT03152396||Single Group Assignment||Treatment||None (Open Label)||A non-randomized prospective pre-post-intervention design.||||
1334077|NCT03152383|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Children with autism, typically developing children, and children with developmental disabilities will participate in the same intervention.||||
1334078|NCT03152370|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will investigate two neoadjuvant radiotherapy/chemoradiotherapy schedules in combination with E7046 in parallel.||||
1334079|NCT03152357|||Cohort||Retrospective|||||||
1334080|NCT03152344|||Other||Prospective|||||||
1334128|NCT03151720|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1334081|NCT03152331||Single Group Assignment||Treatment||None (Open Label)||All participants will receive receptive awareness training with neurofeedback.||||
1334082|NCT03152318|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||phase I, open-label, single center, dose-escalation, double arm clinical trial of an oncolytic virus called rQNestin||||
1334083|NCT03152305|||Case-Control||Prospective|||||||
1334084|NCT03152292|||Cohort||Prospective|||||||
1334085|NCT03152279|||Case-Control||Prospective|||||||
1334086|NCT03152266|||Cohort||Prospective|||||||
1334087|NCT03152253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334088|NCT03152240|||Cohort||Prospective|||||||
1334089|NCT03152227|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334090|NCT03152214|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334091|NCT03152201|||Case-Only||Prospective|||||||
1334092|NCT03152188|Randomized|Parallel Assignment||Prevention||Double|Single-blind study in which subjects will not be aware whether they will be on placebo or FMT capsulres|Placebo-controlled single-blind randomized trial|t|||t
1334093|NCT03152175|Randomized|Parallel Assignment||Treatment||Double||Repeated measures parallel design.|t||t|
1334094|NCT03152162|||Cohort||Prospective|||||||
1334095|NCT03152149|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1334096|NCT03152136|Randomized|Parallel Assignment||Treatment||Double|"The first two weeks of the study are double-blinded for the treatment and sham arms. The subjects and rating movement disorder neurologists will be blinded to the therapy allocation for the treatment and sham arms. The subjects in the 'no intervention' arm and their rating neurologists will not be blinded to their therapy allocation.~The last two weeks are open-label, and all subjects will be given the option to use the Cala ONE device."|The first two weeks are a 3-arm parallel design (treatment, sham, and 'no intervention'). The second two weeks are open-label (all subjects cross-over to treatment arm).|t|||t
1334097|NCT03152123|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1334098|NCT03152110||Single Group Assignment||Other||None (Open Label)||||||
1334099|NCT03152097|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1334100|NCT03152084|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334101|NCT03152071|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334102|NCT03152058||Single Group Assignment||Prevention||None (Open Label)||||||
1334103|NCT03152045|Randomized|Parallel Assignment||Other||None (Open Label)||"Interventional: to evaluate the effect of Feedback Guides on clinician-adolescent communication about hight-risk behaviors.~Control: standard of care"||||
1334104|NCT03152032||Single Group Assignment||Treatment||None (Open Label)||All study participants attended the vocational training program.||||
1334105|NCT03152019|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1334106|NCT03152006|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1334107|NCT03151993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334108|NCT03151980|Randomized|Parallel Assignment||Other||Single||Each participant will be randomized to receive Hamam on either the left or the right side of the back. The other side will be left untreated. Each individual will thereafter receive a sun exposure of both the Hamam-treated skin and the untreated skin.||||t
1334109|NCT03151967|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1334110|NCT03151954|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1334111|NCT03151941|||Other||Prospective|||||||
1334112|NCT03151928|||Case-Only||Cross-Sectional|||||||
1334113|NCT03151915|||Cohort||Retrospective|||||||
1334114|NCT03151902|||Case-Only||Prospective|||||||
1334115|NCT03151889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334116|NCT03151876||Single Group Assignment||Treatment||None (Open Label)||ChiCGB||||
1334117|NCT03151863|Randomized|Crossover Assignment||Supportive Care||Triple|"The nurse administers to the patient both subcutaneous and intranasal dose, however, one of the two is a placebo. The subcutaneous placebo and the subcutaneous opioids have the same packaging. Similar procedure is done for the intranasal compounds.~Neither medical staff nor patient knows which analgesia is administered before this nursing care."|"This two-sided, superiority, cross-over trial is based on a clinically relevant reduction (≥20%) of primary outcome (ECPA pain score >5) with the Dexmedetomidine treatment versus standard active control (opioids). It requires a sample size of 52 patients for a paired analysis with an intra-patient correlation of 50%.~Type I error: 0.05 and type II error: 0.20. 25% of drop-out are expected. In consequence, 66 patients are required for the study."|t|t|t|
1334118|NCT03151850|||Cohort||Prospective|||||||
1334119|NCT03151837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334120|NCT03151824|||Cohort||Cross-Sectional|||||||
1334121|NCT03151811|Randomized|Parallel Assignment||Treatment||Single||||||t
1334122|NCT03151798|Randomized|Parallel Assignment||Other||None (Open Label)||"In Phase I, liver samples derived from patients undergoing either bariatric surgery or a liver biopsy to diagnose nonalcoholic fatty liver disease, are tested one time in vitro. There is no treatment in Phase I.~In Phase II, only patients with nonalcoholic fatty liver disease (and not those who have had bariatric surgery) are eligible to go into a study in which they are randomly assigned to 1) a lifestyle treatment program or 2) a control group undergoing standard care. Allocation is 2:1 subjects in the treatment vs standard care groups.~Thus, the arms are:~Arm 1: Phase I studies with no treatment, only observational data generated in vitro from the liver samples Arm 2: Phase II lifestyle treatment Arm 3: Phase II control standard of care"||||
1334123|NCT03151785|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334124|NCT03151772|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Bioavailability study with an adaptive design (evaluation after 5 patients up to a total maximum of 20 patients in each arm). Experimental therapy not to be combined and not any comparison between therapies||||
1334125|NCT03151759|||Cohort||Prospective|||||||
1334126|NCT03151746|Randomized|Parallel Assignment||Prevention||Quadruple|Blinded by using placebo or active drug supplied by Investigational Drug Pharmacy.|Double Blind, Randomized, Placebo Controlled Trial|t|t|t|t
1334127|NCT03151733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334129|NCT03151707||Single Group Assignment||Treatment||None (Open Label)||||||
1334130|NCT03151694|||Cohort||Cross-Sectional|||||||
1334131|NCT03151681|Randomized|Crossover Assignment||Treatment||Double|Randomization to 'waitlist group' or 'treatment group' will be done by a blind investigator at the time of the statistical analyses. The randomization scheme will use the permuted-block method with a block size of four, stratified by gender (male and female) and event type (infidelity and other), and a group allocation probability of 50% (Fleiss, 1986). A sensitivity analysis will be conducted by via a cross-over method, whereby the group allocation will be reversed, and all outcome data will be re-analyzed.|Repeated measures open-label clinical trial.|||t|t
1334132|NCT03151668|Randomized|Parallel Assignment||Treatment||||||||
1334133|NCT03151655|Randomized|Parallel Assignment||Treatment||Single||||||t
1334134|NCT03151642|||Cohort||Prospective|||||||
1334135|NCT03151629|||Cohort||Prospective|||||||
1334136|NCT03151616|||Cohort||Retrospective|||||||
1334137|NCT03151603|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334138|NCT03151590||||||||||||
1334139|NCT03151577||Single Group Assignment||Treatment||None (Open Label)||"Intraocular pressure, adverse events, complications, number of medications in mild to moderate glaucoma patients who underwent XEN® Gel Stent implantation were recorded.~Data were collected in a 2 years follow-up."||||
1334140|NCT03151564|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1334141|NCT03151551|Randomized|Parallel Assignment||Treatment||Single||||||t
1334142|NCT03151538|Randomized|Parallel Assignment||Treatment||None (Open Label)||Experimental, Randomized Controlled Study||||
1334143|NCT03151525|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized parallel two-arm prospective open-label study||||
1334144|NCT03151512|||Cohort||Prospective|||||||
1334145|NCT03151499||Single Group Assignment||Treatment||None (Open Label)||||||
1334146|NCT03151486|Randomized|Parallel Assignment||Other||Double|||t||t|
1334147|NCT03151473|||Cohort||Prospective|||||||
1334148|NCT03151460|Randomized|Crossover Assignment||Treatment||None (Open Label)||"All PD patients were examined in two conditions: following the standard dopamineric medication (on) and following a 12-18 hours of treatment wash-out (off). Normal controls were examined twice with no drug assumption."||||
1334149|NCT03151447||Single Group Assignment||Treatment||None (Open Label)||Stereotactic Body Radiation Therapy With Concurrent Anti-PD1antibody (JS001) injected intravenously 120mg or 240mg or 360mg until disease progresses or unacceptable tolerability occurs||||
1334150|NCT03151434|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients randomized to epidural, single shot paravertebral block, and paravertebral catheter||||
1334151|NCT03151421||Single Group Assignment||Prevention||None (Open Label)||||||
1334152|NCT03151408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334153|NCT03151395||Single Group Assignment||Basic Science||None (Open Label)||||||
1334154|NCT03151382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334155|NCT03151369||Single Group Assignment||Screening||None (Open Label)||||||
1334156|NCT03151356|||Cohort||Prospective|||||||
1334157|NCT03151343|Randomized|Parallel Assignment||Treatment||Quadruple||Participants will be treated with either empagliflozin or placebo|t|t|t|t
1334158|NCT03151330||Single Group Assignment||Diagnostic||None (Open Label)||Women who are found to have an elevated risk of preterm birth will receive counseling regarding potential interventions and compared to historical controls||||
1334159|NCT03151317|||Case-Control||Retrospective|||||||
1334160|NCT03151304||Single Group Assignment||Treatment||None (Open Label)||Two-Stage, Open-Label||||
1334161|NCT03151291|Randomized|Parallel Assignment||Other||Single|||t|||
1334162|NCT03151278|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334163|NCT03151265|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|This study is open label, meaning that no masking occurs|The two study groups (LBP group vs. Active in spot group), will receive the same intervention in the same order (i.e. Baseline day with no intervention, then intervention day with ThermaCare intervention).||||
1334164|NCT03151252|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1334165|NCT03151239|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1334166|NCT03151226||Single Group Assignment||Health Services Research||None (Open Label)||||||
1334167|NCT03151213|Randomized|Parallel Assignment||Treatment||Double|Double blinded by closed envelops||t|t||
1334168|NCT03151200|Randomized|Crossover Assignment||Treatment||Single|||t|||
1334169|NCT03151187|Randomized|Sequential Assignment||Other||None (Open Label)||"All programs in Canada utilize a joint OSCE where trainees in all programs do the same OSCE stations twice a year. This allows programs to compare their trainees with the performance of trainees at other centres. This OSCE's typically occur in the Spring and Fall of every year. Our OSCE station will be used as a station in one of these joint OSCE's.~In our study, the timing of the educational intervention will randomized; we will utilize a cluster randomization method by grouping sites by the size of their training program. Sites in each group will then be randomized to have trainees complete the educational intervention either before or after doing the OSCE station we have developed."||||
1334170|NCT03151174|Non-Randomized|Parallel Assignment||Prevention||Triple|Any individuals involved in study measures will also be masked.|Subjects will either receive placebo, 5000IU, or 10000IU per day of Vitamin D for 8-12 weeks.|t||t|t
1334171|NCT03151161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334172|NCT03151148|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1334173|NCT03151135|||Case-Only||Prospective|||||||
1334174|NCT03151122|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1334175|NCT03151109|||Cohort||Cross-Sectional|||||||
1334176|NCT03151096|Randomized|Parallel Assignment||Treatment||Single|Field nurse measuring blood pressure, laboratory and data entry staff will be blinded as to the genotype of the study participants and to the identity of the treatment arm to which a participant is assigned from the time of randomization to the time of unblinding. The placebos are designed to be indistinguishable from the active drugs||||t|
1334220|NCT03150524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334177|NCT03151083||Sequential Assignment||Health Services Research||None (Open Label)||The investigators will employ a hybrid type 3 implementation-effectiveness study design through which the investigator will primarily test the effectiveness of the experimental implementation strategy the investigators are developing and secondarily evaluate the clinical effectiveness of the internet-based self-help program for insomnia. The investigators will use a quasi-experimental pre-/post-cohort design whereby the program will initially be implemented using an enhanced usual care (control) strategy, followed by implementation using the experimental implementation strategy. The program's association with clinical response will be evaluated in an uncontrolled pre-/post-format.||||
1334178|NCT03151070|||Ecologic or Community||Prospective|||||||
1334179|NCT03151057|Randomized|Parallel Assignment||Treatment||Double|Participant, investigator|Idelalisib 100mg or placebo twice daily, starting day +90 (+-/ 10 days) after transplant until day +270.|t||t|
1334180|NCT03151044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334181|NCT03151031|Randomized|Parallel Assignment||Treatment||Single|Participants will not be informed about the reason for performing the star excursion balance test before and after the application of cryotherapy||t|||
1334182|NCT03151018|||Case-Only||Prospective|||||||
1334183|NCT03151005|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1334184|NCT03150992||Single Group Assignment||Supportive Care||None (Open Label)||||||
1334185|NCT03150979|Randomized|Parallel Assignment||Treatment||Double||Prospective, single-blinded, randomized, clinical trial.|||t|t
1334186|NCT03150966|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1334187|NCT03150953|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334188|NCT03150940|||Cohort||Prospective|||||||
1334189|NCT03150927|Randomized|Parallel Assignment||Treatment||Double|Product will be given to subjects in a capsule form. Participant and participants legal guardians, and care providers will not know if the capsule is a placebo or the Probiotic Microbial Composite™|"The Randomized Clinical Trial (RCT) will typically involve 250 subjects randomized into two arms based on age and sex.~Following a positive outcome in the RCT (following 6 months), we envisage converting the study to an observational based study (case-study) based on ethical principles where the placebo arm of the study would be administered the test product. Each subject will be assessed for a total of two years."|t|t||
1334190|NCT03150914|Randomized|Parallel Assignment||Treatment||Triple|Tablets are over-encapsulated. Both participant and care givers are blinded to treatment assignment. Dose adjustments for out of range sirolimus levels are made by a medical monitor at the Data Center. Sham dose adjustments are made in the placebo group|Intention to treat, randomized, placebo controlled, double blind|t|t|t|
1334191|NCT03150901|||Cohort||Prospective|||||||
1334192|NCT03150888|||Cohort||Prospective|||||||
1334193|NCT03150875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334194|NCT03150862|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334195|NCT03150849|||Case-Control||Prospective|||||||
1334196|NCT03150836|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1334197|NCT03150823|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1334198|NCT03150810|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334199|NCT03150797|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1334200|NCT03150784|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Measures taken at Baseline (0 weeks), Post Intervention (6-7 weeks), and follow up (12 weeks)||||
1334201|NCT03150771|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1334202|NCT03150758||Single Group Assignment||Supportive Care||None (Open Label)||||||
1334203|NCT03150745|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1334204|NCT03150732|Randomized|Parallel Assignment||Prevention||Quadruple||Two groups|t|t|t|t
1334205|NCT03150719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334206|NCT03150706||Single Group Assignment||Treatment||None (Open Label)||||||
1334207|NCT03150693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334208|NCT03150680|||Cohort||Prospective|||||||
1334209|NCT03150667|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334210|NCT03150654||Sequential Assignment||Treatment||None (Open Label)||sequential self-controlled clinical trial||||
1334211|NCT03150641|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334212|NCT03150628||Single Group Assignment||Treatment||None (Open Label)||||||
1334213|NCT03150615|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334214|NCT03150602||Single Group Assignment||Treatment||None (Open Label)||||||
1334215|NCT03150589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334216|NCT03150576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334217|NCT03150563|Randomized|Parallel Assignment||Treatment||Single|"The randomization process of the sample will be carried out through the electronic website http://www.randomization.com, carried out by a subject external to the experimental and evaluation procedures. With this data, the site will generate a specific coding for each group and will randomly distribute the subjects into four groups: Control Group (GC), Experiment Group 1 (GE1), Experiment Group (GE2) and Experiment Group 3 (GE3).~The distribution will be kept in an opaque and sealed envelope, being revealed only to P2 only at the time of intervention. The P1, who will carry out the measurements, will not know to which group the individual belongs. To maintain the blinding procedure of the study, each individual at the time of intervention will spend 10 minutes in the intervention room (being 4 minutes for preparation and 6 minutes for intervention) and each group will have a corresponding color for the convenience of P2 White, blue, green and yellow)."||||t|
1334218|NCT03150550|Randomized|Parallel Assignment||Treatment||None (Open Label)|Simple Blind|||||
1334219|NCT03150537|Randomized|Single Group Assignment||Prevention||Double|Observer-blind study|"Eighty healthy adults (18-49 years of age) will be randomized 1:1 to receive:~A single dose of trivalent inactivated influenza vaccine (TIV: Fluviral™: 0.5mL IM)~Half will receive the vaccine using a pre-filled syringe~Half will receive the vaccine using a multi-dose vial~Or,the same vaccine delivered IM using the Medical International Technologies Inc. (MIT) compressed air vaccine delivery system (Med-Jet H4)."|||t|t
1334221|NCT03150511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334222|NCT03150498|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1334223|NCT03150485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||While this study utilizes two contact lenses, the purpose was to evaluate the JJVC fitting guide. This was a non-randomized study in which eye care practitioners used the JJVC fitting guide to fit subjects with a study contact lens. Subjects may fit either in a bilateral or a contralateral fashion.||||
1334224|NCT03150472|Randomized|Parallel Assignment||Treatment||Double|"Only the graft performing sub-investigator and the study coordinator will be un-blinded to the patient allocation. All efforts and measures would be taken by the study team to keep the patient and blinded assessors blinded of allocation (allocation of each extracted site) - semi double blinded study.~Shipment tubes for biopsy (primary endpoint) are labelled with the appropriate blinded coded specimens."|The Ivory Dentin Graft study is a prospective, randomized, semi double blinded with blinded assessments study comparing patients grafted with Ivory Dentin Graft (study arm) and patients grafted with OsteoBiol Gen Os (control arm) for alveolar ridge preservation following tooth extraction.|t|||t
1334225|NCT03150459|Randomized|Parallel Assignment||Treatment||Triple|As the trial is blinded neither the participants or the researchers will know which group the participants has been allocated to. In order to maintain the blind participants will take two tablets once daily for simvastatin. Group one will receive one 20mg tablet of simvastatin and one placebo table, group two will receive two 20 mg tablets of simvastatin and group three will receive two placebo tablets.|Phase II, multicenter, double-blind placebo controlled, randomized clinical trial|t|t|t|
1334226|NCT03150446||Single Group Assignment||Prevention||None (Open Label)||From April 2009 to June 2015, 97 male patients with stones >1.8 cm in the upper ureter underwent intracorporeal double-J stenting of the ureter after laparoscopic ureterolithotomy performed by four different surgeons. The 50 participants was performed with flexible cystoscopy through the urethral route to confirm the position of the double-J stent.||||
1334227|NCT03150433|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be masked to treatment condition|||||t
1334228|NCT03150420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334229|NCT03150407||||||||||||
1334230|NCT03150394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334231|NCT03150381|Randomized|Crossover Assignment||Prevention||Single|Single Blind (Participant)||t|||
1334232|NCT03150368||Single Group Assignment||Treatment||None (Open Label)||After completion of a phase 1 trial with ModraDoc006/r, patients are able to continue weekly treatment with oral docetaxel (ModraDoc006) in combination with ritonavir, for as long as safe clinical benefit from the treatment is experienced, as judged by the treating oncologist.||||
1334233|NCT03150355|||Case-Only||Retrospective|||||||
1334234|NCT03150342|||Case-Only||Retrospective|||||||
1334235|NCT03150329||Single Group Assignment||Treatment||None (Open Label)||||||
1334236|NCT03150316||Single Group Assignment||Treatment||None (Open Label)||||||
1334237|NCT03150303|||Cohort||Prospective|||||||
1334238|NCT03150290|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334239|NCT03150277|Randomized|Crossover Assignment||Other||Single|All the participants will be blinded about the knowledge of the outcomes|Randomized crossover design|t|||
1334240|NCT03150264|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334241|NCT03150251|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1334242|NCT03150238|||Cohort||Cross-Sectional|||||||
1334243|NCT03150225|Randomized|Parallel Assignment||Treatment||Triple|The study will have a double-blind blindness, performed in the process of randomization of the participants, who will not be informed about the allocation of the groups, and in the period of data collection and application of the concurrtent training protocol, in which the Researchers who will carry out the data collection will not participate in the application of the protocol, and vice versa.|The randomization of the men who will participate in the study will be carried out through a computer program; In the two groups that will compose the study: experimental group (GE) - intervention with application of a concurrent training protocol for six months; And control group (CG) - monthly will be contacted via telephone and will be encouraged to maintain their daily activities.|t||t|t
1334244|NCT03150212|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1334245|NCT03150199|Randomized|Parallel Assignment||Treatment||Single||||||t
1334246|NCT03150186|||Ecologic or Community||Cross-Sectional|||||||
1334247|NCT03150173|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized 1:1 to receive the O-BMT intervention or enhanced referral||||
1334248|NCT03150160||Parallel Assignment||Treatment||Double|"Patients, Investigator staff, persons performing the assessments, and data analysts will not be aware of the identity of the masked treatment (brinzolamide 1% / brimonidine 0.2% or placebo) being administered from the time of randomization until database lock, using the following methods:~- Randomization data are kept strictly confidential until the time of unmasking, and will not be accessible by anyone else involved in the study.~- The identity of the treatments will be concealed by the use of masked study drug that are all identical in packaging, labeling, and schedule of administration. Both brinzolamide 1% / brimonidine 0.2% and placebo will be provided in identical masked bottles labeled with the protocol and kit numbers. Each kit will contain 1 bottle of masked study medication."|This is a multicenter, randomized, double-masked, 2-arm, placebo-controlled, parallel-group study in patients with normal tension glaucoma who are insufficiently controlled on travoprost 0.004% monotherapy. Approximately 200 patients will be randomized and treated for up to 11 weeks whilst they will receive double-masked study medication for 6 weeks.|t||t|
1334298|NCT03149510|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334299|NCT03149497|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1334300|NCT03149484|||Cohort||Prospective|||||||
1334301|NCT03149471|||Cohort||Prospective|||||||
1334302|NCT03149458|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized controlled study||||
1334303|NCT03149445|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind|Two-centre, double-blind, placebo-controlled, randomized, and multiple-dose clinical study.|t|t|t|t
1334304|NCT03149432|Randomized|Parallel Assignment||Treatment||Single|The assossor won't know if the participant has received the mirror therapy|||||t
1334249|NCT03150147|Randomized|Parallel Assignment||Other||Double|PGD and ACR assessment will be performed by a blinded access|Initially six patients will be transplanted with the NICHCP method. These will be compared with contemporary control patients transplanted with standard ICSS. An interim assessment will be performed when these six patients has passed 30-days post-transplant. After the interim analysis, the study will become a single center, prospective, open, blinded endpoint, randomized, controlled clinical trial. The continued study will comprise 14 patients in the test group and 14 control patients. The main outcomes will be reported on intention to treat basis. PGD and ACR assessment will be performed by a blinded access. Randomisation will be computer generated and stratified according to donor age (<40 vs >40), using permuted blocks that will differ in size since the study is open.|t|||t
1334250|NCT03150134|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334251|NCT03150121|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1334252|NCT03150108|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1334253|NCT03150095|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334254|NCT03150082|Randomized|Crossover Assignment||Treatment||None (Open Label)|This will be an open-label study. Hence, masking will not be performed.|Crossover assignment: Subjects will receive treatment in one of the two sequences; Treatment A (GR37547 tablet) followed by Treatment B (ciprofloxacin reference tablet) or vice versa separated by a washout period of at least 7 days and not more than 14 days.||||
1334255|NCT03150069|||Cohort||Cross-Sectional|||||||
1334256|NCT03150056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334257|NCT03150043||Single Group Assignment||Diagnostic||None (Open Label)|Since every patient will have the device placed during delivery, there will be no masking. However, the actual values obtained from the monitor will be masked.|All patients who agree to participate in the study will have the non-invasive hemoglobin monitor placed on their finger during delivery. The values obtained from the non invasive monitor will be masked to the clinicians during delivery. No medical decision making will be based on values obtained from the non-invasive monitor. After the patient leaves the recovery room, values obtained from the monitor will be compared to those obtained via blood draw. Patients will be separated into quartiles based on drop in hemoglobin (between pre-op and post-op day 1) and hemoglobin values obtained from the monitor will be compared between the quartiles.||||
1334258|NCT03150030|||Other||Prospective|||||||
1334259|NCT03150017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334260|NCT03150004||Single Group Assignment||Treatment||None (Open Label)||||||
1334261|NCT03149991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334262|NCT03149978|||Cohort||Prospective|||||||
1334263|NCT03149965|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||prospective cohort study||||
1334264|NCT03149952||Single Group Assignment||Other||None (Open Label)||||||
1334265|NCT03149939||Single Group Assignment||Treatment||None (Open Label)||||||
1334266|NCT03149926|||Other||Other|||||||
1334267|NCT03149913|Randomized|Parallel Assignment||Treatment||Single|drug coated balloon versus uncoated balloon|The vessel patency (measured by angiography at 6 months) will be compared after patients have been treated either with paclitaxel coated or uncoated balloons (control) in BTK arteries|t|||
1334268|NCT03149900|||Other||Prospective|||||||
1334269|NCT03149887|Randomized|Parallel Assignment||Supportive Care||Quadruple||Randomized, controlled, parallel|t|t|t|t
1334270|NCT03149874|Randomized|Sequential Assignment||Prevention||None (Open Label)||Patient seuentially randomized to either vaccine||||
1334271|NCT03149861|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1334272|NCT03149848|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a 2-period crossover study in healthy adults||||
1334273|NCT03149835|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1334274|NCT03149822|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|Open-Label|||||
1334275|NCT03149809|Randomized|Parallel Assignment||Treatment||Single|Blinded assessor|Randomized Controlled Non-Inferiority Trial||||t
1334276|NCT03149796|||Case-Control||Retrospective|||||||
1334277|NCT03149783|Randomized|Parallel Assignment||Prevention||Quadruple|"Study drug label of drug"|Randomized Controlled Double Blind Trial|t|t|t|t
1334278|NCT03149770|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1334279|NCT03149757|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1334280|NCT03149744|||Cohort||Prospective|||||||
1334281|NCT03149731|||Case-Only||Prospective|||||||
1334282|NCT03149718|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334283|NCT03149705|||Cohort||Prospective|||||||
1334284|NCT03149692||Sequential Assignment||Other||None (Open Label)||Proof of concept||||
1334285|NCT03149679||Single Group Assignment||Treatment||None (Open Label)||Single center, open labeled, phase 2 clinical trial, where patients are selected for treatment based on upfront TP53 mutation status; i.e. only patients with TP53 mutated tumors may be included in the single treatment arm. The informed consent, however needs to be signed prior to a biopsy for TP53 mutation analyses; thus, all patients are formally enrolled in the study prior to tissue collection, and the full population tested will be accounted for despite the fact that only patients with TP53 mutated tumors may enter the single treatment arm.||||
1334286|NCT03149666|||Other||Cross-Sectional|||||||
1334287|NCT03149653|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1334288|NCT03149640|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1334289|NCT03149627|||Cohort||Prospective|||||||
1334290|NCT03149614|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1334291|NCT03149601|||Case-Control||Cross-Sectional|||||||
1334292|NCT03149588|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1334293|NCT03149575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334294|NCT03149562|||Cohort||Prospective|||||||
1334295|NCT03149549|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334296|NCT03149536|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334297|NCT03149523|||Cohort||Other|||||||
1335359|NCT03135691|||Case-Only||Retrospective|||||||
1334305|NCT03149419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334306|NCT03149406|||Cohort||Prospective|||||||
1334307|NCT03149393|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1334308|NCT03149380|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1334309|NCT03149367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334310|NCT03149354||Single Group Assignment||Other||None (Open Label)||||||
1334311|NCT03149341|||Case-Control||Cross-Sectional|||||||
1334312|NCT03149328|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Process evaluation with two phases (Phase 1: Usability Testing; Phase 2: Evaluation)||||
1334313|NCT03149315||Single Group Assignment||Treatment||None (Open Label)||||||
1334314|NCT03149302|Randomized|Factorial Assignment||Treatment||Double||a 2 x 2 factorial blinded design|||t|t
1334315|NCT03149289|||Cohort||Retrospective|||||||
1334316|NCT03149276|||Case-Control||Prospective|||||||
1334317|NCT03149263|||Other||Prospective|||||||
1334318|NCT03149250|||Cohort||Prospective|||||||
1334319|NCT03149237|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The 12 clinics randomly assigned to the intervention arm will receive a combination of community and clinical services, including: (1) ANC-based couples HIV testing, couples-based treatment enrollment, and clinical care for sero-concordant HIV+ expectant couples; (2) couple-centered treatment in the post-partum period; (3) couples-based education and skills building during the ANC and post-partum period; and (4) treatment continuity support by expert-patient (peer) navigators selected among couples who have successfully navigated EMTCT. The 12 clinics randomized to the control arm will continue to provide standard of care EMTCT services that include: standard HoPS male engagement (male invitation to ANC services and couples HIV testing), opt-out rapid HIV testing of all pregnant women attending ANC, HIV-specific counseling and support for all women who test positive, provision of cotrimoxazole prophylaxis, and universal ART, as per option B+ guidelines.||||
1334320|NCT03149224|||Case-Only||Cross-Sectional|||||||
1334321|NCT03149211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334322|NCT03149198|Randomized|Parallel Assignment||Treatment||Single||||||t
1334323|NCT03149185|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This is a randomized experimental trial designed to evaluate the effects of a 10-week technology-based group cognitive-behavioral stress management intervention (T-CBSM) vs. a health promotion (T-HP) group-based attention matched control condition. This is a 2 x 3 design with group assignment (T-CBSM vs. T-HP) as the between group factor, and time (baseline [T1], 6-months post-T1 [T2], and 12-months post T1 [T3]) as the within-group factor.||||
1334324|NCT03149172|Randomized|Parallel Assignment||Treatment||Single|The surgeon and the subject will not be blinded. The evaluation of the core histology will be done by a blinded investigator.|||||t
1334325|NCT03149159||Single Group Assignment||Treatment||None (Open Label)||||||
1334326|NCT03149146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334327|NCT03149133|Randomized|Parallel Assignment||Screening||Double|The investigator and outcome assessor are blinded to groups.|Randomized controlled trial|||t|t
1334328|NCT03149120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334329|NCT03149107|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1334330|NCT03149094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334331|NCT03149081||Single Group Assignment||Treatment||None (Open Label)||||||
1334332|NCT03149068|||Case-Control||Prospective|||||||
1334333|NCT03149055||Single Group Assignment||Treatment||None (Open Label)||||||
1334334|NCT03149042|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1334335|NCT03149029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334336|NCT03149016|Randomized|Parallel Assignment||Treatment||Single||||||t
1334337|NCT03149003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334338|NCT03148990|Randomized|Parallel Assignment||Prevention||Quadruple||Two intervention groups (MR vaccine and MMR vaccine), with 1 dose of vaccine in each group.|t|t|t|t
1334339|NCT03148977|||Case-Control||Prospective|||||||
1334340|NCT03148964|||Cohort||Prospective|||||||
1334341|NCT03148951|||Cohort||Prospective|||||||
1334342|NCT03148938|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Patients will perform one or two visits at 15 days interval. Healthy volunteers will only perform one visit. Patients and healthy volunteers will be randomly assigned to either traditional/digital group (Group A) or digital/traditional group (Group B), followed by a crossover to the other group at day 15 for patients who will do two visits.||||
1334343|NCT03148925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334344|NCT03148912||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334345|NCT03148899|Randomized|Crossover Assignment||Other||Triple|All members of the research team except the IP dispensing staff will be blinded for the duration of the research study. Once all the subjects have finished in the research study, and all data is data-locked, the outcomes assessor will then unblind the research data for the statistical analysis.||t|t|t|
1334346|NCT03148886||Single Group Assignment||Supportive Care||None (Open Label)||||||
1334347|NCT03148873|||Other||Prospective|||||||
1334348|NCT03148860|Randomized|Parallel Assignment||Treatment||Triple|Methotrexate tablets will be encapsulated equal to Placebo to ensure blinding. Ustekinumab will be open-label|randomised, placebo-controlled, double-blind, multicenter study|t|t|t|
1334349|NCT03148847|||Case-Only||Retrospective|||||||
1334350|NCT03148834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334351|NCT03148821|||Case-Only||Prospective|||||||
1334352|NCT03148808||Single Group Assignment||Treatment||None (Open Label)||NVS Therapy will be delivered to de novo lesions in the superficial femoral artery (SFA) and proximal popliteal artery (PPA) during PTA in patients with symptomatic peripheral artery disease.||||
1334353|NCT03148795||Single Group Assignment||Treatment||None (Open Label)||||||
1334354|NCT03148782||Single Group Assignment||Treatment||None (Open Label)||||||
1334355|NCT03148769|||Cohort||Prospective|||||||
1577410|NCT00001912||||||||||||
1334356|NCT03148756|Randomized|Parallel Assignment||Treatment||Single||||||t
1334357|NCT03148743|||Case-Only||Prospective|||||||
1334358|NCT03148730|Randomized|Parallel Assignment||Supportive Care||Double|single blinded ( outcome assessor)|2 groups one = manually conducted anesthesia second = fully automated anesthesia, analgesia, ventilation and fluid management|t|||t
1334359|NCT03148717|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1334360|NCT03148704|||Cohort||Prospective|||||||
1334361|NCT03148691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334362|NCT03148678|Randomized|Sequential Assignment||Basic Science||Double||A combination of sequential (mindfulness vs. mind wandering intervention) and parallel design (contingent vs. non-contingent RT-fMRI-NF)|t|||t
1334363|NCT03148665|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||Control population (n=150): absence of current or prior oropharyngeal carcinoma, no active cancer diagnosis. Control population includes at least 50 subjects who have smoked at least 100 cigarettes during lifetime Cancer population (n=150): patients with previously untreated oral cavity or oropharynx squamous cell carcinoma with absence of distant metastasis||||
1334364|NCT03148652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334365|NCT03148639|Randomized|Crossover Assignment||Treatment||None (Open Label)||Partial crossover design||||
1334366|NCT03148626|Randomized|Parallel Assignment||Prevention||None (Open Label)||Multi-center cluster randomized controlled trial||||
1334367|NCT03148613||||||||||||
1334368|NCT03148600|Randomized|Parallel Assignment||Treatment||Single||||||t
1334369|NCT03148587|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1334370|NCT03148574|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334371|NCT03148561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334372|NCT03148548|||Cohort||Cross-Sectional|||||||
1334373|NCT03148535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334374|NCT03148522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334375|NCT03148509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334376|NCT03148496|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1334377|NCT03148483|Randomized|Factorial Assignment||Treatment||Single|"This is a multi-component intervention. The participants will be blinded for the milk fortification component of the intervention only.~Participants will receive daily sachets with similar appearance either with vitamin D and calcium (intervention) or flour (control)."|2x2 factorial design|t|||
1334378|NCT03148470|Randomized|Factorial Assignment||Basic Science||Double|||t|||t
1334379|NCT03148457|Randomized|Parallel Assignment||Treatment||Single||||||t
1334380|NCT03148444|Randomized|Parallel Assignment||Prevention||Double|The random assignment will be performed by a researcher from the cardiologic team performing the implantation by means of choosing one of two closed envelopes. The treatment will not be placebo-controlled, and therefore the neither the patients nor the attending physicians will not be blinded to the final results of the assignment.|We propose to organize a randomized open-label study in which patients undergoing de novo implantation or replacement of cardiac implantable devices (single-chamber, dual-chamber and biventricular pacemakers and defibrillators) will be randomly assigned to one of the two groups. Patients in one group will be discharged home with recommendations to take antibiotic treatment for 5 days following the procedure (cefalexin 500 mg qid, or in the presence of beta-lactam sensitivity roxythromycin 150 mg bid) while in the other group no recommendations regarding antibiotic treatment will be given. Both groups will receive antibiotic prophylaxis before the procedure according to the current recommendations. In both groups, the aseptic technique during the procedure will be observed, and proper hygienic measures past the implantation will be taken.|||t|t
1334381|NCT03148431|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1334382|NCT03148418||Single Group Assignment||Treatment||None (Open Label)||||||
1334383|NCT03148392|||Cohort||Prospective|||||||
1334384|NCT03148379|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334385|NCT03148366|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1334386|NCT03148353|Randomized|Parallel Assignment||Treatment||Double|The treatment is double blind to the participants and outcome assessors. Only the physician performs the injection knows which kind of intervention the patients receive.|randomized controlled trial|t|||t
1334387|NCT03148340|||Cohort||Prospective|||||||
1334388|NCT03148327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334389|NCT03148314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334390|NCT03148301|||Cohort||Prospective|||||||
1334391|NCT03148288|Randomized|Single Group Assignment||Other||Double|||t||t|
1334392|NCT03148275||Single Group Assignment||Treatment||None (Open Label)||||||
1334393|NCT03148262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334394|NCT03148249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334395|NCT03148236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334396|NCT03148223|Randomized|Parallel Assignment||Treatment||Triple|Participants will not be informed which group they belong to, intervention or control. Who will apply the treatment will not be blind, since during the treatment it will know if the points to be stimulated must contain seeds of mustard or just plaster, but will not have previous knowledge of the members of the groups. The evaluator, who is responsible for applying the pre- and post-treatment evaluation instruments, will be blind and not aware of the research intervention. The data analyst will also be early for the intervention group.||t||t|t
1334397|NCT03148210|Randomized|Parallel Assignment||Treatment||Single||||||t
1334398|NCT03148197|||Cohort||Prospective|||||||
1334399|NCT03148184|||Cohort||Cross-Sectional|||||||
1334400|NCT03148171|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334401|NCT03148158|||Cohort||Prospective|||||||
1334402|NCT03148145|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334500|NCT03146871||Single Group Assignment||Treatment||None (Open Label)||||||
1334564|NCT03146039||Single Group Assignment||Treatment||None (Open Label)||||||
1577411|NCT00001911||||Treatment||||||||
1334403|NCT03148132|Randomized|Parallel Assignment||Other||Triple|The principal investigator and the outcomes assesor will be blinded, the assignation of the treatment will be randomized. The parents or tutor of the participant will be blinded|Group 1: Patients that fullfil type 1 ROP criteria that will be treated with Bevacizumab Group 2: Patients that fullfil type 1 ROP criteria that will be treated with Ranibizumab|t||t|t
1334404|NCT03148119||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334405|NCT03148106|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1334406|NCT03148093|||Other||Prospective|||||||
1334407|NCT03148080|||Cohort||Cross-Sectional|||||||
1334408|NCT03148067|||Cohort||Prospective|||||||
1334409|NCT03148054|||Case-Only||Prospective|||||||
1334410|NCT03148041|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334411|NCT03148028|||Cohort||Other|||||||
1334412|NCT03148015|||Cohort||Retrospective|||||||
1334413|NCT03148002|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|Patients will be randomized to received the Current Bowel Protocol or the PEG Bowel Protocol||||
1334414|NCT03147989|||Case-Only||Retrospective|||||||
1334415|NCT03147976||Single Group Assignment||Treatment||None (Open Label)||||||
1334416|NCT03147963|Randomized|Parallel Assignment||Treatment||None (Open Label)||patients was divided 1:1 into docetaxel 2-weeks regimen group and docetaxel 3-weeks regimen group||||
1334417|NCT03147950|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334418|NCT03147937|||Cohort||Prospective|||||||
1334419|NCT03147924||Single Group Assignment||Other||None (Open Label)||||||
1334420|NCT03147911|||Cohort||Retrospective|||||||
1334421|NCT03147898|||Cohort||Prospective|||||||
1334422|NCT03147885||Single Group Assignment||Treatment||None (Open Label)||||||
1334423|NCT03147872|Randomized|Parallel Assignment||Treatment||Triple|Patients and care providers will be masked as to which embryo is randomized to each condition. Investigators will be masked until the data are analyzed.|Randomized Controlled Trial|t|t|t|
1334424|NCT03147859||Sequential Assignment||Treatment||None (Open Label)||||||
1334425|NCT03147846|Randomized|Single Group Assignment||Prevention||Double|closed envelop method||t|||t
1334426|NCT03147833|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1334427|NCT03147820||||||||||||
1334428|NCT03147807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334429|NCT03147794||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1334430|NCT03147781|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334431|NCT03147768||Single Group Assignment||Treatment||None (Open Label)||Open Label Combination Product (Laser + Biologic + Drug) regulated as a device||||
1334432|NCT03147755|||Cohort||Prospective|||||||
1334433|NCT03147742||||||||||||
1334434|NCT03147729||Single Group Assignment||Treatment||None (Open Label)||||||
1334435|NCT03147716|Randomized|Parallel Assignment||Prevention||Single|single-blind masking|Participants are randomly assigned to one of five conditions: 1) enrollment flyer only; 2) enrollment flyer + testimonial booklet; 3) enrollment flyer + teacher endorsement; 4) enrollment flyer + provider engagement call; or 5) all four engagement strategies.|t|||
1334436|NCT03147703|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1334437|NCT03147690||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334438|NCT03147677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334439|NCT03147664|||Case-Control||Prospective|||||||
1334440|NCT03147651|||Cohort||Other|||||||
1334441|NCT03147638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Single arm with retrospective arm The retrospective arm is he comparator and they are historic control||||
1334442|NCT03147625|Randomized|Parallel Assignment||Supportive Care||Single|A research nurse not involved in the delivery of SHAPE intervention will be blinded to the participants' group assignment to conduct data collection.|In this two-armed randomized controlled trial, participants will be allocated to either the intervention group or the control group through stratified permuted block randomization. Participants in the intervention will undergo SHAPE while participants assigned to the control group will receive usual care, which refers to existing community services provided by the local community centre, senior activity centre and voluntary welfare organisations.||||t
1334443|NCT03147612||Single Group Assignment||Treatment||None (Open Label)||||||
1334444|NCT03147599|Randomized|Crossover Assignment||Treatment||Single|||t|||
1334445|NCT03147586|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334446|NCT03147573||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334447|NCT03147560|Randomized|Parallel Assignment||Prevention||Single|||t|||
1334448|NCT03147547|Randomized|Parallel Assignment||Prevention||Single|single-blind masking|Participants were randomly assigned to one of two conditions: 1) promotional brochure plus an attention-control research interview or 2) Package Engagement Package|t|||
1334449|NCT03147534|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334450|NCT03147521|Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1334451|NCT03147508|||Cohort||Cross-Sectional|||||||
1334452|NCT03147495|||Case-Control||Retrospective|||||||
1334453|NCT03147482||||||||||||
1334454|NCT03147469|Randomized|Crossover Assignment||Other||Single||"AuraGain will be placed in all patients, and mechanical ventilation will be performed using a volume-controlled mode with a tidal volume of 10 ml/kg.~The expiratory tidal volume, peak inspiratory pressure, oropharyngeal leak pressure, and ventilation score will be assessed first for the neutral head position and then for the extended, flexed, and rotated head positions in a random order.~Fiberoptic bronchoscopic view will be also assessed for each head and neck positions."|t|||
1334559|NCT03146104|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1334560|NCT03146091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334561|NCT03146078|||Cohort||Prospective|||||||
1334562|NCT03146065|Randomized|Sequential Assignment||Basic Science||Triple|||t|t|t|
1334563|NCT03146052|Randomized|Parallel Assignment||Treatment||Single|Blinded endoscopists performed endoscopic procedure and evaluated colon cleansing.|||||t
1334455|NCT03147456|Randomized|Parallel Assignment||Other||Triple|Investigators and researchers in this study will be blinded to the intervention, i.e. they will not be aware of who is on protein supplement and who is on placebo. Patients will also be blinded to the intervention, i.e. they will not know whether they are taking protein or zero protein supplement. For the blinding there will be a dietician who will assign the treatment and the control to patients as per the above randomization results. This dietician will also be responsible for filling the intervention & control ready-to-feed shakes into identical bottles labeled either A or B, the dietician will not have any other responsibility such as data entry or follow up of participants as this will be done by the PI and research team, he will only be responsible for the blinding process.||t|t|t|
1334456|NCT03147443|Randomized|Crossover Assignment||Treatment||Triple|Placebo is made by dextrin, bitter agent, edible pigment etc and added 5% test drug. The test drug and control drug have no differences in dosage form, appearance, color, specification, label, and so forth.|randomized, double-blind, crossover comparisons of individualized herbal decoction with control decoction within individual patients. Each n-of-1 trial has 3 pairs of treatment periods. The duration of each treatment period will be 4 weeks.|t|t||t
1334457|NCT03147430|||Cohort||Prospective|||||||
1334458|NCT03147417||||||||||||
1334459|NCT03147404||Single Group Assignment||Treatment||None (Open Label)||Avelumab 10 mg/kg i.v. every 2 weeks (Q2W)||||
1334460|NCT03147391|||Case-Only||Retrospective|||||||
1334461|NCT03147378|Randomized|Crossover Assignment||Treatment||None (Open Label)||After randomization eight patients will receive ModraDoc006/r in fasting condition week 1 and in fed condition week 2, and another eight patients will receive ModraDoc006/r in fed condition week 1 and in fasting condition week 2||||
1334462|NCT03147365|Randomized|Parallel Assignment||Other||None (Open Label)||Experimental controlled randomization using Block Stratified Randomized Software program, after obtaining informed consent from illegible patient or his caregiver.||||
1334463|NCT03147352|||Cohort||Prospective|||||||
1334464|NCT03147339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334465|NCT03147326||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334466|NCT03147313|Randomized|Parallel Assignment||Treatment||Double|The participant will be wearing an acoustic and visual masking. The outcome assessor won't know if the participant was treated or if he was assigned to the sham group.|Participants will be randomized into three groups: Two treatment groups with different treatment settings and one sham group.|t|||t
1334467|NCT03147300|Randomized|Sequential Assignment||Health Services Research||Single|Participants are blinded to assignment to the control or intervention grouping|A cluster randomised trial with dog leg design|t|||
1334468|NCT03147287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334469|NCT03147274|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"This is a 12-month randomized controlled trial evaluating the impact of a health care delivery intervention (SMART T1D - a 3-session group educational curriculum), compared to standard care, on self-care adherence and transition readiness in adolescents with type 1 diabetes. Intervention (group sessions) and control (standard care) subjects will complete the study on a parallel timeline."||||
1334470|NCT03147261|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334471|NCT03147248|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1334472|NCT03147235|Randomized|Parallel Assignment||Treatment||Single||||||t
1334473|NCT03147222||Single Group Assignment||Supportive Care||None (Open Label)||All participants will receive the intervention.||||
1334474|NCT03147209||Single Group Assignment||Other||None (Open Label)||This is a feasibility pilot study for a health coaching intervention for truck drivers||||
1334475|NCT03147196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334476|NCT03147183|||Cohort||Prospective|||||||
1334477|NCT03147170|||Case-Crossover||Prospective|||||||
1334478|NCT03147157|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334479|NCT03147144|||Cohort||Prospective|||||||
1334480|NCT03147131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334481|NCT03147118|||Case-Only||Prospective|||||||
1334482|NCT03147105|Randomized|Parallel Assignment||Treatment||None (Open Label)||waitlist control||||
1334483|NCT03147092||Single Group Assignment||Treatment||None (Open Label)||A single group of hypertensive individuals will be submitted to same treatment.||||
1334484|NCT03147079|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Open intervention study with 2 control arms||||
1334485|NCT03147066|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1334486|NCT03147053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334487|NCT03147040||Single Group Assignment||Treatment||None (Open Label)||||||
1334488|NCT03147027|||Other||Prospective|||||||
1334489|NCT03147014||Single Group Assignment||Prevention||None (Open Label)||||||
1334490|NCT03147001|Randomized|Crossover Assignment||Health Services Research||Single|Masking was done by providing similar tasting drinks at both trails. One was placebo, one was protein a drink||t|||
1334491|NCT03146988|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1334492|NCT03146975|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1334493|NCT03146962||Single Group Assignment||Treatment||None (Open Label)||||||
1334494|NCT03146949|Randomized|Parallel Assignment||Supportive Care||Double|Primary outcome assessor is masked. The primary outcome involves the analysis of blood concentrations of isoflurane, and the laboratory will not be given information on allocation.||t|||t
1334495|NCT03146936|||Cohort||Prospective|||||||
1334496|NCT03146923|Randomized|Parallel Assignment||Treatment||Single|As with most education based interventions compared to routine care it is difficult to reliably mask either the subjects or the investigators to the proposed intervention. We will attempt to blind patients referring only to the diets as diet A and diet B and avoiding the use of terminology such as old and new. We will reprint the dietary information for both arms so they do not resemble current illustrated formats.|Multicentre Parallel Arm Randomised Controlled Trial|t|||
1334497|NCT03146910|||Cohort||Prospective|||||||
1334498|NCT03146897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334499|NCT03146884|||Cohort||Prospective|||||||
1334501|NCT03146858||Single Group Assignment||Prevention||None (Open Label)||Once patients have been recruited into the trail, they will undertake the first of 4 blood samples. Following the samples the PPCI treatment with begin. The enoxaparin infusion will be set up when the treatment begins. At the end of the PPCI treatment the second blood sample will obtained. The enoxaparin infusion will be commenced after a kidney function check has been performed. The third blood sample will be taken 3 hours into the infusion, and the 4th sample taken at the end of the 6 hour infusion. A 12 hour clinical follow up will then be performed and will mark study completion for the patient.||||
1334502|NCT03146845|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1334503|NCT03146832|Randomized|Parallel Assignment||Treatment||Single|Participants were not aware which experimental condition they were allocated to.|participants are assigned to one of three experimental groups in parallel for the duration of the study|t|||
1334504|NCT03146819|||Case-Control||Other|||||||
1334505|NCT03146806||Single Group Assignment||Supportive Care||None (Open Label)||||||
1334506|NCT03146793|||Cohort||Retrospective|||||||
1334507|NCT03146780|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1334508|NCT03146767|Randomized|Parallel Assignment||Other||Double|||t|t||
1334509|NCT03146754||Single Group Assignment||Basic Science||None (Open Label)||||||
1334510|NCT03146741||Single Group Assignment||Treatment||None (Open Label)||||||
1334511|NCT03146728|||Case-Control||Cross-Sectional|||||||
1334512|NCT03146715|Randomized|Parallel Assignment||Other||Double|||t|t||
1334513|NCT03146702|||Other||Prospective|||||||
1334514|NCT03146689||Single Group Assignment||Other||None (Open Label)||N-of-1 trial series: several within-individual, randomised, multiple cross-over trials aggregated into a series.||||
1334515|NCT03146676|||Other||Prospective|||||||
1334516|NCT03146663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334517|NCT03146650||Single Group Assignment||Treatment||None (Open Label)||||||
1334518|NCT03146637|Randomized|Parallel Assignment||Treatment||Quadruple|With the method of minimum randomized dynamic random by the interactive network response system (IWRS),Participants were randomly assigned to two groups,receive activated CIK or activated CIK armed with anti-CD3-MUC1/CEA/EpCAM/GPC3 bispecific antibody,every participant has a unique identification number and emergency letter which have the information of group.|This is a phase II clinical trial of single-center, randomized (1:1of targeted activation CIK and traditional CIK therapy ).|t|t|t|t
1334519|NCT03146624|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1334520|NCT03146611|||Case-Control||Prospective|||||||
1334521|NCT03146598|||Cohort||Retrospective|||||||
1334522|NCT03146585|||Cohort||Prospective|||||||
1334523|NCT03146572|Randomized|Parallel Assignment||Prevention||Double||||t||t
1334524|NCT03146559|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1334525|NCT03146546|||Cohort||Prospective|||||||
1334526|NCT03146533||Single Group Assignment||Treatment||None (Open Label)||||||
1334527|NCT03146520|||Case-Control||Other|||||||
1334528|NCT03146507|||Cohort||Cross-Sectional|||||||
1334529|NCT03146494|||Cohort||Prospective|||||||
1334530|NCT03146481|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1334531|NCT03146468||Single Group Assignment||Treatment||None (Open Label)||||||
1334532|NCT03146455|||Other||Cross-Sectional|||||||
1334533|NCT03146442|Randomized|Factorial Assignment||Prevention||Triple|Double-blind, the PI and outcomes assessor will be blinded to the intervention arms (which will be designated with code words). The participants in the high protein and normal protein intervention arms will be blinded to the protein content within the breakfast meals (which will be designated with code words).|Participants will be randomly assigned to the following breakfast groups: high protein breakfast (350kcal; 34% protein (30g protein), 40% CHO, and 26% fat); normal protein breakfast (350kcal; 11% protein (10g protein), 63% CHO, and 26% fat); or breakfast skipping (0 kcal)|t||t|t
1334534|NCT03146429|||Cohort||Retrospective|||||||
1334535|NCT03146416|Randomized|Sequential Assignment||Basic Science||Triple|||t||t|t
1334536|NCT03146403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334537|NCT03146390|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1334538|NCT03146377||Single Group Assignment||Treatment||None (Open Label)||||||
1334539|NCT03146364|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1334540|NCT03146351|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||non-randomised clinical trial||||
1334541|NCT03146338|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334542|NCT03146325|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1334543|NCT03146312|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1334544|NCT03146299|Randomized|Parallel Assignment||Treatment||Single||||||t
1334545|NCT03146286|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1334546|NCT03146273|Randomized|Crossover Assignment||Prevention||Single|||t|||
1334547|NCT03146260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334548|NCT03146247||Single Group Assignment||Other||None (Open Label)||||||
1334549|NCT03146234||Single Group Assignment||Treatment||None (Open Label)||||||
1334550|NCT03146221||Single Group Assignment||Other||None (Open Label)||||||
1334551|NCT03146208|||Case-Control||Cross-Sectional|||||||
1334552|NCT03146195|||Case-Control||Retrospective|||||||
1334553|NCT03146182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334554|NCT03146169||Single Group Assignment||Prevention||None (Open Label)||A four-session training workshop is provided to the trainees in order to enhance their competence and performance for conducing and/or assisting the implementation of community -based interventions and activities.||||
1334555|NCT03146156|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1334556|NCT03146143|Randomized|Parallel Assignment||Prevention||Single||||||t
1334557|NCT03146130|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334558|NCT03146117|||Cohort||Prospective|||||||
1577412|NCT00001910||||||||||||
1334565|NCT03146026|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1334566|NCT03146013|||Cohort||Prospective|||||||
1334567|NCT03146000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334568|NCT03145987|Randomized|Parallel Assignment||Prevention||Triple|subjects were randomly allocated to one of two groups treated as follows: Group 1, N = 57 to be treated with Cognigrape capsule (verum 250 mg/day); Group 2, N = 54 to be treated with placebo for 12 weeks. Neither subjects recruited for the study nor investigators knew the content of sachets or were able to differentiate the two different treatments.|Randomized, double-blinded, placebo controlled study.|t|t||t
1334569|NCT03145974|||Cohort||Prospective|||||||
1334570|NCT03145961|Randomized|Parallel Assignment||Treatment||Double|"Patients will undergo blinded serial ctDNA screening every 3 months from the point of registration and completion of primary treatment for their triple negative breast cancer. If a ctDNA positive result occurs on or before their 12 month ctDNA screening assessment the patient will be randomised by the ICR-CTSU in a 2:1 ratio to the pembrolizumab treatment arm or observation arm. The patient and their treating team will only be informed of the randomisation if they are allocated to the treatment arm.~For patients allocated to the observation group, the treating team and patient will not be informed that randomisation has taken place in order to remain blinded to the positive ctDNA result. Such patients will continue to have blood samples collected for ctDNA analysis every 3 months up to 2 years from starting ctDNA screening."||t|t||
1334571|NCT03145948|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1334572|NCT03145935|||Cohort||Prospective|||||||
1334573|NCT03145922|||Cohort||Prospective|||||||
1334574|NCT03145909|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334575|NCT03145896|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334576|NCT03145883|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334577|NCT03145870||Single Group Assignment||Other||None (Open Label)||||||
1334578|NCT03145857||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334579|NCT03145844|||Cohort||Retrospective|||||||
1334580|NCT03145831||Single Group Assignment||Treatment||None (Open Label)||||||
1334581|NCT03145818|||Other||Prospective|||||||
1334582|NCT03145805|||Cohort||Prospective|||||||
1334583|NCT03145792|Randomized|Parallel Assignment||Treatment||Single||||||t
1334584|NCT03145779|||Case-Only||Prospective|||||||
1334585|NCT03145766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334586|NCT03145753|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||"DRIVE study (Diagnóstico Rápido de la Infección por VIH/HCV en España, in English Rapid HIV/HCV testing in Spain) was designed to investigate the different aspects of HIV testing. DRIVE 01 and 02 had been already completed and communicated.~This new study has been designed as a prospective randomized clustered crossover study in one Health Care Area of Madrid Spain, to compare two implementation HIV/HCV testing programs: only EDSUP vs. EDSUP plus a resourced HIV/HCV testing program which provide rapid HIV/HCV tests, and testing staff to conduct all procedures.~Four PCC´c belonging to the influenced area of Ramón y Cajal Area will be randomized 1:1 to receive sequentially any of the two HIV/HCV testing programs."||||
1334587|NCT03145740|Randomized|Parallel Assignment||Treatment||Triple|"The patient´s primary physician in the clinic, the primary occupational therapist, physiotherapist and the nurses were kept blinded for the whole period of the intervention.~The patient´s relatives did know into what group the patient was randomized. The patient himself did not know. The occupational therapists associated to the project were not blinded.~The otolaryngologist, who scored the video recorded FEES examinations was blinded. The colleagues from Germany, who analyse data are blinded."||t|t||t
1334588|NCT03145727|Randomized|Sequential Assignment||Treatment||Single|The participant will be blind to the TENS allocation.|The selection of the investigated will be characterized as non-probabilistic with a convenience approach, whose patients will be included in the study sequentially until the necessary sizing has been achieved. Patients will be included sequentially for convenience (according to the inclusion and exclusion criteria) and non-probabilistic. The included individuals will be randomly randomized by Random Allocation System software in three groups, 1) placebo group; 2) High Frequency Group; 3) Low Frequency Group.|t|||
1334589|NCT03145714|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1334590|NCT03145701|||Cohort||Prospective|||||||
1334591|NCT03145688|Randomized|Parallel Assignment||Prevention||Single|||||t|
1334592|NCT03145675|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Eligible patients are randomized into Planned Staged-dose Group and Planned Single-dose Group.~All patients in the Planned Staged-dose Group will receive enoxaparin 0.5 mg/kg at the beginning of coronary angiography. Those with definite indication for subsequent PCI will be given additional enoxaparin 0.25 mg/kg at the beginning of PCI (Staged-dose PCI Group [0.5+0.25 mg/kg]); while, those have no indication for subsequent PCI will not receive additional anticoagulation (Standard-dose Group [0.5 mg/kg]).~All patients in the Planned Single-dose Group will receive enoxaparin 0.75 mg/kg at the beginning of coronary angiography no matter they will undergo subsequent PCI (Single-dose PCI Group [0.75 mg/kg]) or not (High-dose Group [0.75 mg/kg])."||||
1334593|NCT03145662|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomization to either high pressure balloon or cutting balloon||||
1334594|NCT03145649|||Cohort||Prospective|||||||
1334595|NCT03145636|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1334596|NCT03145623|||Cohort||Retrospective|||||||
1334597|NCT03145610|Randomized|Crossover Assignment||Treatment||Triple||This investigation was designed as double-blind, randomized, crossover study|t||t|t
1334598|NCT03145597|Randomized|Parallel Assignment||Treatment||Single||split mouth comparison|t|||
1334599|NCT03145584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334600|NCT03145571|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Specific output monitored in villages where the program had been implemented, and where it was not implemented||||
1334601|NCT03145558|Randomized|Parallel Assignment||Treatment||Single|Central radiology reviewers are blinded.|1:1 randomization, open label with central radiological review||||t
1334602|NCT03145545||||||||||||
1334649|NCT03144934|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1577413|NCT00001905||||Treatment||||||||
1334603|NCT03145532|Randomized|Crossover Assignment||Treatment||Triple|tDCS will be blinded in that even children in the sham group will receive a low level of stimulation for a brief period.|Children will be randomized to receive either real or sham tDCS plus robotic training. Children in the sham group will be given the opportunity to repeat the protocol and receive real stimulation after they complete the sham protocol.|t|t||t
1334604|NCT03145519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334605|NCT03145506|||Other||Prospective|||||||
1334606|NCT03145493|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334607|NCT03145480|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||parallel assignment based on fitness of participants||||
1334608|NCT03145467|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1334609|NCT03145454||Single Group Assignment||Basic Science||None (Open Label)||||||
1334610|NCT03145441|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334611|NCT03145428|||Cohort||Prospective|||||||
1334612|NCT03145415|Randomized|Parallel Assignment||Supportive Care||Triple|No other parties will be masked.|All Children will be randomly assigned to one of 2 groups of 30 patients each using a computer generated number table.|t|t||t
1334613|NCT03145402|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1334614|NCT03145389|||Case-Control||Prospective|||||||
1334615|NCT03145376|||Case-Control||Prospective|||||||
1334616|NCT03145363|Randomized|Parallel Assignment||Prevention||Single|Participants do not know which group they were randomized into.|Intervention group (receives interactive text messages) and control group (receives informative text messages)|t|||
1334617|NCT03145350|Randomized|Crossover Assignment||Basic Science||Single|PI,and research assistants undertaking measurements will be blinded to the dietary intervention the participant is undertaking.|Randomised crossover with washout period.|||t|
1334618|NCT03145337|Randomized|Parallel Assignment||Treatment||Single|3-4 independent breast surgeons using predefined criteria will assess the aesthetic outcomes of each subject using photographs of their pre-mastectomy and 12 month post-reconstructions. The surgeons will not be apprised of the ADM type or post-mastectomy site/surgeon|Prospective, randomized, controlled||||t
1334619|NCT03145324|||Other||Other|||||||
1334620|NCT03145311|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1334621|NCT03145298|Randomized|Parallel Assignment||Treatment||Triple|Notification of subject randomization will be received by an independent storage/distribution center; the storage/distribution center will have password protected access to the randomization in order to retrieve the treatment assignment. The storage/distribution center will randomly assign an appropriate donor (or placebo) once they receive the designation of active treatment vs. placebo from the interactive system. All Sponsor staff will remain blinded to treatment (CAP-1002 or placebo) assignments. The only time other Sponsor staff will become aware of individual treatments is in the case of an emergency blind break resulting from an SAE.|The study is divided into two portions. The first (Phase 1a) evaluates safety and efficacy of 2 different doses of cells (50 and 100 million cells). The second phase (Phase 1b) takes place after an independent data safety monitoring board has reviewed all the data from Phase 1a and deems it safe and appropriate to proceed to Phase 1b. The latter is a randomized double-blind study in which subjects receive either CAP-1002 or placebo in a 1:1 ratio.|t|t|t|
1334622|NCT03145285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334623|NCT03145272||Single Group Assignment||Treatment||None (Open Label)||||||
1334624|NCT03145259|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1334625|NCT03145246|||Other||Retrospective|||||||
1334626|NCT03145233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334627|NCT03145220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334628|NCT03145207|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1334629|NCT03145194|Randomized|Parallel Assignment||Treatment||Triple|Double blind until the point of primary endpoint.||t|t|t|
1334630|NCT03145181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1334631|NCT03145168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334632|NCT03145155|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1334633|NCT03145142|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334634|NCT03145129|||Case-Control||Prospective|||||||
1334635|NCT03145116||Single Group Assignment||Treatment||None (Open Label)||||||
1334636|NCT03145103||Single Group Assignment||Treatment||None (Open Label)||||||
1334637|NCT03145090|||Cohort||Retrospective|||||||
1334638|NCT03145077|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1334639|NCT03145064||Single Group Assignment||Prevention||None (Open Label)||||||
1334640|NCT03145051|Randomized|Crossover Assignment||Treatment||Single|||||t|
1334641|NCT03145038|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1334642|NCT03145025|||Cohort||Prospective|||||||
1334643|NCT03145012||Single Group Assignment||Basic Science||None (Open Label)||Healthy individuals will be asked to take ranitidine for 6 weeks to determine the effect on peripheral blood immune cells.||||
1334644|NCT03144999|Non-Randomized|Sequential Assignment||Other||None (Open Label)||This is a dose escalation study consisting of a low, mid, and high dose to evaluate the maximum tolerated dose (MTD). An additional 8 patients are enrolled at the MTD.||||
1334645|NCT03144986||Single Group Assignment||Device Feasibility||None (Open Label)||A pilot study to investigate the efficacy and safety of deep-rTMS delivered with the H-coil able to reach insula in subjects with long standing treatment resistant severe anorexia nervosa (TrAN)||||
1334646|NCT03144973|Non-Randomized|Single Group Assignment||Prevention||Single|operating surgeons or surgeons in the surgical ward do not get to know the test result so it won`t affect in patient care|All the patients that have upper-gi surgery in our time frame are asked to join in the study||t||
1334647|NCT03144960||Single Group Assignment||Treatment||None (Open Label)||||||
1334648|NCT03144947|Randomized|Parallel Assignment||Other||None (Open Label)||Non comparative, multi-center, open-label, neoadjuvant, randomized study, the purpose of randomization is to reduce bias owing to patient selection into treatments groups.||||
1334650|NCT03144921|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Dyads will be randomized (assigned by chance) to one of two groups: 10 EPIC A or 2) EPIC B (Wait List Control - WLC. Randomization with stratification by language preference (English vs. Spanish) and geographic setting will occur in sets of 4 to 8 (average 6) eligible dyads.~The RCT ends at T2 with comparison of changes in outcomes between EPIC and WLC participants from Assessment 1 (baseline) to Assessment 2 (3 months post baseline). T2-T5 assessments will be used for within-group and maintenance of gains analyses from about 3 months to 12 months post baseline."||||
1334651|NCT03144908|||Other||Prospective|||||||
1334652|NCT03144895|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334653|NCT03144882|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1334654|NCT03144869|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334655|NCT03144856||Single Group Assignment||Treatment||None (Open Label)||Apatinib single agent||||
1334656|NCT03144843|Randomized|Parallel Assignment||Treatment||Triple||Multicenters ramdomized double-blind phase II study.|t|t|t|
1334657|NCT03144830||Single Group Assignment||Health Services Research||None (Open Label)||||||
1334658|NCT03144817|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334659|NCT03144804||Single Group Assignment||Treatment||None (Open Label)||||||
1334660|NCT03144791|||Case-Only||Prospective|||||||
1334661|NCT03144778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334662|NCT03144765||Single Group Assignment||Treatment||None (Open Label)||||||
1334663|NCT03144752|||Cohort||Prospective|||||||
1334664|NCT03144739|Randomized|Parallel Assignment||Health Services Research||Single|Research assistants contacting families by telephone for be partially masked - they will not know information about the index child's provider or any baseline characteristics - it will not be possible to completely mask the study phase and thus the control/intervention status of the families.|stepped wedge design, hybrid implementation effectiveness||||t
1334665|NCT03144726|Randomized|Parallel Assignment||Prevention||Single||||||t
1334666|NCT03144713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334667|NCT03144700|||Other||Other|||||||
1334668|NCT03144687|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334669|NCT03144674|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334670|NCT03144661|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334671|NCT03144648|||Case-Control||Other|||||||
1334672|NCT03144635||Single Group Assignment||Treatment||None (Open Label)||||||
1334673|NCT03144622|||Cohort||Prospective|||||||
1334674|NCT03144609|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1334675|NCT03144596|Randomized|Parallel Assignment||Treatment||None (Open Label)||prospective, randomized, parallel-group clinical trial||||
1334676|NCT03144583||Single Group Assignment||Other||None (Open Label)|Open label|||||
1334677|NCT03144570|||Cohort||Prospective|||||||
1334678|NCT03144557||Single Group Assignment||Other||None (Open Label)||||||
1334679|NCT03144544|||Cohort||Retrospective|||||||
1334680|NCT03144531||Single Group Assignment||Health Services Research||None (Open Label)||Dyadic intervention for school-age children and a parent||||
1334681|NCT03144518|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1334682|NCT03144505|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1334683|NCT03144492|||Case-Only||Prospective|||||||
1334684|NCT03144479|Non-Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||||||
1334685|NCT03144466|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334686|NCT03144453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334687|NCT03144440|||Other||Retrospective|||||||
1334688|NCT03144427|||Cohort||Prospective|||||||
1334689|NCT03144414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334690|NCT03144401|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1334691|NCT03144388|Randomized|Parallel Assignment||Treatment||Single|Blinded assessors at each measurement|Parallel-group with optional crossover||||t
1334692|NCT03144375|Randomized|Crossover Assignment||Treatment||Single||||t||
1334693|NCT03144362|Randomized|Single Group Assignment||Treatment||||||||
1334694|NCT03144349|||Cohort||Prospective|||||||
1334695|NCT03144336|Randomized|Parallel Assignment||Prevention||Double|The statistician will clean the data and compile the analysis dataset. Before sending on to the principal investigator for the outcome analysis, any information allowing inferring treatment assignment will be removed, in particular the two intervention arms will receive a non-descriptive label such as group A and group B. This way, the analysis can be performed without knowing which group corresponds to the intervention group, and which to control.||||t|t
1334696|NCT03144323|Randomized|Parallel Assignment||Other||Single||||||t
1334697|NCT03144310|||Case-Only||Prospective|||||||
1334698|NCT03144297|||Case-Control||Prospective|||||||
1334699|NCT03144284|||Cohort||Cross-Sectional|||||||
1334700|NCT03144271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334701|NCT03144258|||Cohort||Prospective|||||||
1334702|NCT03144245||Single Group Assignment||Treatment||None (Open Label)||||||
1334703|NCT03144232|Randomized|Parallel Assignment||Treatment||Quadruple|There is a sham rTMS condition that will allow both participants and investigators to be blinded.||t|t|t|t
1334704|NCT03144219|||Case-Control||Prospective|||||||
1334705|NCT03144206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334706|NCT03144193|Randomized|Parallel Assignment||Treatment||Triple|Double-blind|Assessment of efficacy of a novel anti-aging topical treatment compared to a placebo control|t||t|t
1334707|NCT03144180|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1334708|NCT03144167||Single Group Assignment||Other||None (Open Label)||||||
1334747|NCT03143660|Randomized|Parallel Assignment||Treatment||Single||||||t
1334748|NCT03143647|||Case-Control||Prospective|||||||
1335360|NCT03135678|||Cohort||Prospective|||||||
1334709|NCT03144154|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants are randomized into 2 groups: the experimental group receives the intervention immediately while the control group only receives usual care. When the control group has received the intervention and that evaluations have been done for all participants, the control group will receive the intervention (randomized controlled trial).||||
1334710|NCT03144141||Single Group Assignment||Other||None (Open Label)||||||
1334711|NCT03144128|Randomized|Parallel Assignment||Supportive Care||Quadruple|All subjects receive exercise and protein supplementation. Participants, Investigators, Care Providers, and outcome assessors will be blinded to vitamin D vs. placebo capsule allocation|Prospective, double-blinded randomized controlled clinical trial|t|t|t|t
1334712|NCT03144115|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1334713|NCT03144102|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1334714|NCT03144089|Randomized|Crossover Assignment||Treatment||Quadruple|Anesthesia facemasks will be opacified so that the clinical provider will be blinded to which oral airway (Geudel vs AOA) is being used and in what order. The patient will be anesthetised and thus blinded. The Investigator and Outcomes Assessor will only see video of the data on the anesthesia monitor (not the patient/device/etc) and will thus be blinded. The only individuals who will not be blinded are the Research Assistants who will not be involved in data analysis.|Prospective, randomized, crossover design. All patients will receive both interventions during a single anesthetic, with the order of intervention being randomized.|t|t|t|t
1334715|NCT03144076|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1334716|NCT03144063|||Cohort||Prospective|||||||
1334717|NCT03144050|||Cohort||Prospective|||||||
1334718|NCT03144037|||Cohort||Prospective|||||||
1334719|NCT03144024|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334720|NCT03144011|||Cohort||Prospective|||||||
1334721|NCT03143998|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334722|NCT03143985||Single Group Assignment||Treatment||None (Open Label)||||||
1334723|NCT03143972|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||All volunteers will receive 2 standardized anesthesia sessions with a washout period of at least one week between sessions. During the first session volunteers will receive dexmedetomidine, during the second session they will first receive remifentanil and afterwards the combination of drugs will be administered. Anesthetic depth will be evaluated by MOAA/S scores (see table 2), testing of tolerance to electrical stimuli and laryngoscopy. Furthermore multichannel EEG-data will be collected to get insight in the drug dependent characteristics. Measured effects will be related to drug plasma concentrations.||||
1334724|NCT03143959|||Case-Only||Prospective|||||||
1334725|NCT03143946||Single Group Assignment||Treatment||None (Open Label)||||||
1334726|NCT03143933|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1334727|NCT03143920||Single Group Assignment||Treatment||None (Open Label)||Prospective pilot study to test feasibility of treating patients with chronic inflammatory conditions of the urinary bladder with hyperbaric oxygen therapy.||||
1334728|NCT03143907|Randomized|Parallel Assignment||Treatment||Single||Five sites in total are participating. Three of the five sites are following a RCT design (randomized group allocation; treatment and control group). Two of the five sites are following a pre-post design (no randomized allocation and no control group).||||t
1334729|NCT03143894|Randomized|Crossover Assignment||Treatment||Quadruple|Double-blind|Randomized, sham-controlled, double-blind, cross-over|t|t|t|t
1334730|NCT03143881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334731|NCT03143868|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1334732|NCT03143855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334733|NCT03143842||Single Group Assignment||Basic Science||None (Open Label)||"Within-subject design:~To investigate whether VNS can accelerate learning and improve associative memory when learning word pairs, we will investigate the performance of VNS implanted participants on a Verbal Paired-Associate memory task and compare their performance on the words that were learned while paired with VNS in contrast to their performance on the words that were learned while unpaired with VNS and in contrast to their performance on the words that were learned without VNS (i.e. 3 types/groups of words: paired with VNS, unpaired with VNS and without VNS) during the first visit and 1 day,1 week and 1 month after their first visit."||||
1334734|NCT03143829|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants are randomly assigned to either an intervention or wait control group. The intervention group receives an educational intervention at the start of the study. The wait control group receives the intervention at the end.||||
1334735|NCT03143816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334736|NCT03143803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334737|NCT03143790|Randomized|Parallel Assignment||Treatment||Triple|Patient and therapist are blind. Primary investigator is not blind. Unblinding occurs 3 months after the end of treatment|Randomization to active or placebo treatment.|t|t||t
1334738|NCT03143777|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1334739|NCT03143764|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Inactive employees in a selection of public and private corporations in three Norwegian cities were invited to participate. Inclusion criteria were: a desire to cycle to work, residence more than 3km from the workplace, and not physically active according to guidelines. There were 25 participants in the study and we provided them all with electrically assisted bicycles fitted with GPS bike computers to record usage. The participants were followed for three to eight months, 226 days on average||||
1334740|NCT03143751|Randomized|Parallel Assignment||Treatment||Single|Masking: Open label , Masked Roles: Subject and Outcomes assessor||t|||
1334741|NCT03143738|Randomized|Parallel Assignment||Treatment||Single|Participants not aware of the type of continuous blockade.|Two groups of patients randomly allocated: adductor canal group or femoral nerve group|t|||
1334742|NCT03143725|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1334743|NCT03143712|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1334744|NCT03143699|Randomized|Parallel Assignment||Other||Single||||||t
1334745|NCT03143686|||Case-Only||Prospective|||||||
1334746|NCT03143673||Single Group Assignment||Treatment||None (Open Label)||||||
1334749|NCT03143634|Randomized|Parallel Assignment||Treatment||Single|Only the outcome assessor will be masked, as this is a psychological intervention it is not possible to mask the participant, care provider or investigator.|||||t
1334750|NCT03143621|Randomized|Parallel Assignment||Supportive Care||Double|Patients will not be told what group they are assigned to, however, complete masking will be difficult to achieve. The patient's treatment assignment is part of the medical record.|Randomized, parallel-group, controlled clinical trial|t|||t
1334751|NCT03143608|||Cohort||Prospective|||||||
1334752|NCT03143595|||Cohort||Prospective|||||||
1334753|NCT03143582||Single Group Assignment||Other||None (Open Label)||This is an open-label pilot study examining the effects of exercise on mood, learning, memory, attention, stress, and sleeping habits.||||
1334754|NCT03143569|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1334755|NCT03143556|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334756|NCT03143543|Randomized|Parallel Assignment||Treatment||Quadruple||Starting lorcaserin dosage of 10 mg per day for 7 days in one arm, versus placebo for 7 days in parallel arm. An interim analysis will take place after 15 subjects have completed at each arm. Based on the interim analysis, if there is no significant effect and no trend towards significance for the lower dose of lorcaserin in the primary regions of interest for fMRI task, and no significant accumulation of adverse effects, testing will stop for the lower dose of lorcaserin, and testing will begin for the higher dose, which is the FDA approved usual dose for lorcaserin (20 mg per day, given as 10 mg twice per day). The higher dose of lorcaserin will be tested in a two group parallel arm design, initially with 15 subjects in lorcaserin arm and 15 subjects in the parallel placebo arm. Another interim analysis will take place after 15 subjects have completed at each arm in the higher dose lorcaserin study.|t|t|t|t
1334757|NCT03143530|Randomized|Parallel Assignment||Treatment||Quadruple|Participants, care providers, investigators, and observers who record central measurements will be blinded to group allocation.|"Participants will be assigned to one of two of the following groups for the duration of the study.~General anesthesia + pectoralis block with Ropivacaine 30ml of 0.25% (75mg)~General anesthesia + sham block with 30ml of normal saline"|t|t|t|t
1334758|NCT03143517|||Case-Only||Prospective|||||||
1334759|NCT03143504||Single Group Assignment||Diagnostic||None (Open Label)||Single group design.||||
1334760|NCT03143491|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Phase 2, open-label, dose-rising trial. Subjects will enroll in three dose-rising cohorts of three subjects each. he next dose level cohort will enroll upon a finding of safety and tolerability at the previous cohort's first safety review. If a safety or tolerability issue arises in the first three subjects of a cohort, an additional three subjects will be enrolled at the same dose level. If ≥ 1 of the same safety and tolerability issue recurs in the additional 3 subjects, the prior dose-level will be determined to be the highest dose with an acceptable safety and tolerability profile. If no further safety and tolerability issues are identified in the expanded cohort, dose-escalation will continue.||||
1334761|NCT03143478||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1334762|NCT03143465|Randomized|Crossover Assignment||Basic Science||Quadruple|Double Blind||t|t|t|t
1334763|NCT03143452|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1334764|NCT03143439|||Case-Control||Retrospective|||||||
1334765|NCT03143426|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1334766|NCT03143413|||Other||Prospective|||||||
1334767|NCT03143400|Randomized|Parallel Assignment||Other||None (Open Label)|Open|||||
1334768|NCT03143387|Randomized|Parallel Assignment||Treatment||Single|||||t|
1334769|NCT03143374|||Cohort||Prospective|||||||
1334770|NCT03143361|||Cohort||Prospective|||||||
1334771|NCT03143348|||Case-Control||Prospective|||||||
1334772|NCT03143335|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334773|NCT03143322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334774|NCT03143309|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334775|NCT03143296|||Cohort||Prospective|||||||
1334776|NCT03143283|Randomized|Crossover Assignment||Prevention||None (Open Label)||We will use a stepped wedge sample design, a type of cluster randomized crossover design in which different clusters (in our case, hospitals) switch permanently from a control to an intervention state at different time points (steps) (Woertman, 2013). We chose a cluster-randomized design to prevent contamination that would likely occur were providers or patients randomized to receive different interventions within hospitals. All clusters start in the control condition (usual care), with hospitals switching to the intervention at consecutive 3- month time points, where the time of the switch is randomized for every hospital. At the end of the study period, all clusters will have switched from a control to an intervention condition.||||
1334777|NCT03143270|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334778|NCT03143257|||Cohort||Other|||||||
1334779|NCT03143244|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1334780|NCT03143231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334781|NCT03143218|Randomized|Parallel Assignment||Prevention||Triple||"A double-blind, individually randomised trial to compare the incidence of clinical episodes of malaria across three study arms:~Seasonal vaccination with the malaria vaccine RTS,S/AS01~Seasonal malaria chemoprevention with SP/AQ~Combination of these two interventions"|t|t|t|
1334782|NCT03143205|Randomized|Parallel Assignment||Treatment||Single||||||t
1334783|NCT03143192|Randomized|Parallel Assignment||Treatment||Double|Patients and technicians (measuring ocular coherence tomography, fluorescein auto fluorescence and visual acuity) will be masked. The investigator and study coordinator will be unmasked to direct the patient.|This will be a parallel study comparing the results of patients who receive aflibercept and micropulse laser versus those who only receive aflibercept. The second group will receive sham laser to prevent placebo effects.|t|||t
1334784|NCT03143179|||Cohort||Prospective|||||||
1334785|NCT03143166||Single Group Assignment||Treatment||None (Open Label)||||||
1334786|NCT03143153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334787|NCT03143140|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334788|NCT03143127||||||||||||
1334789|NCT03143114|Randomized|Parallel Assignment||Treatment||Single||||||t
1334790|NCT03143101|Randomized|Parallel Assignment||Prevention||Quadruple|Double-blind||t|t|t|t
1334791|NCT03143088|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1334792|NCT03143075|Non-Randomized|Parallel Assignment||Treatment||Triple|"Raters are blind to Inflammation group or Non-inflammation group allocation"|"Match/mismatch design (based on CRP levels), all subjects receive the same dose of EPA, no one receives placebo. Raters are blind to Inflammation group or Non-inflammation group allocation"|t||t|t
1334793|NCT03143062|||Case-Control||Retrospective|||||||
1334794|NCT03143049|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a randomised phase 3 study in Asian patients with relapse multiple myeloma after prior bortezomib and lenalidomide who will be treated by PD or PCD. Randomisation will be 1:1 using a computer algorithm. There will be no blinding. The patient in the 2 arms will be stratified according to ISS stage 1 or 2 versus stage 3.~Cross-over for patients randomised to Pomalidomide and Dexamethasone at progression:~Upon progression, patients randomized to pomalidomide and dexamethasone (PD) can cross-over to the PCD arm and have cyclophosphamide added to their regimen according to the PCD regimen. Cyclophosphamide should be added at the beginning of a cycle. They can continue on PCD until further progression. However for these PD patients that cross-over to PCD, the primary endpoint for analysis will be based on response and progression on PD."||||
1334795|NCT03143036||Single Group Assignment||Treatment||None (Open Label)||This is a phase 2 study of the combination of Daratumumab, thalidomide and dexamethasone in 100 Asian patients with relapse or refractory multiple myeloma.||||
1334796|NCT03143023|Randomized|Parallel Assignment||Prevention||Double||||t||t
1334797|NCT03143010|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1334798|NCT03142997|||Case-Control||Prospective|||||||
1334799|NCT03142984|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1334800|NCT03142971|Randomized|Parallel Assignment||Treatment||Single||||||t
1334801|NCT03142958||Single Group Assignment||Treatment||None (Open Label)||||||
1334802|NCT03142945|Randomized|Parallel Assignment||Treatment||Single|Patients will not be advised of their group until they exit the study|Two randomized groups. One receiving traditional physical therapy treatments for patients with mechanical headaches. The other will receive an MDT- based approach.|t|||
1334803|NCT03142932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334804|NCT03142919|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1334805|NCT03142906|Randomized|Parallel Assignment||Diagnostic||Single|Outcomes assessor blinded to patient assignment.|Randomized parallel group controlled clinical trial||||t
1334806|NCT03142893|Randomized|Crossover Assignment||Basic Science||Triple|3 of the 4 conditions are masked by use of identical injections and pills. However one condition (adrenal testis) is not masked. Hence the study is partially masked.|Blood is sampled every 10 minutes from 4PM to 9PM for future mathematical deconvolution in order to determine hormone pulse characteristics in response to the clamp conditions. These values are the primary endpoints.|t||t|t
1334807|NCT03142880|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334808|NCT03142867|||Other||Prospective|||||||
1334809|NCT03142854|Randomized|Parallel Assignment||Supportive Care||Double||Participants are randomly assigned to group A or B. Participants of group A are given normal bowel preparation, while participants of group B are given personalized regimens according to a predictive model we have established.||t||t
1334810|NCT03142841|Randomized|Parallel Assignment||Supportive Care||Double|The PI and data collectors will be blinded in this study.|A two-arm (8-session intervention vs. standard care), randomized controlled clinical trial with three assessment points will be conducted. Baseline measurements will be conducted with the caregivers prior to the intervention. Post-test assessments will be collected at 1 and 12 weeks post-intervention. In addition, the investigators will obtain pre- and post-test measures of Veteran-related variables via CPRS electronic health records. Qualitative interviews will be conducted to assess caregivers' perceptions of the intervention.|||t|t
1334811|NCT03142828|Randomized|Parallel Assignment||Treatment||Double|Double blindness performed for patients and for statistical analysis|After the first week, the healling abutment will be randomly distributed in a test group with application of chlorhexidine gel or a control group without the application of the chlorhexidine gel.|t|||t
1334812|NCT03142815|||Cohort||Prospective|||||||
1334813|NCT03142802||Single Group Assignment||Diagnostic||None (Open Label)||Patients diagnosed with testicular germ cell cancer will undergo both standard and low dose CT scan of the abdomen and pelvis.||||
1334814|NCT03142789|Randomized|Parallel Assignment||Treatment||Triple|"Please see Model Description"|The study is performed as a blinded, randomized, controlled study. Randomization will be based on a computer-generated block randomization list in a 1:1:1 ratio, block sizes of 9. A person, not otherwise involved in the study, will prepare the randomization list and keep it, locked away in a secure place. 2 sets of consecutively numbered, sealed, opaque, code envelopes will be prepared by the same person.|t|t||t
1334815|NCT03142776|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1334816|NCT03142763|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1334817|NCT03142750||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1334818|NCT03142737|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1334819|NCT03142724||Single Group Assignment||Other||None (Open Label)||||||
1334820|NCT03142711|||Case-Only||Prospective|||||||
1334821|NCT03142698||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334822|NCT03142685|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||This is a prospective pilot randomized control study||||
1334823|NCT03142672|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1334824|NCT03142659|||Other||Prospective|||||||
1334825|NCT03142646||Single Group Assignment||Treatment||None (Open Label)||||||
1334826|NCT03142633|||Cohort||Prospective|||||||
1334827|NCT03142620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334882|NCT03141905|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1334883|NCT03141892|||Cohort||Prospective|||||||
1334884|NCT03141879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334885|NCT03141866|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334828|NCT03142607|Randomized|Factorial Assignment||Treatment||Quadruple|Subjects will be assigned to one of the three study groups using a computer generated randomization list. The recruitment of the patients will be performed by one investigator. All the measurements at the baseline and follow ups will be performed by the second investigator. Patient, the care provider, the investigator who is taking the measurement and the statistician will be blinded about the intervention groups. This will be ensured by giving codes to the intervention groups only known to the principal investigator who is not involved in the measurement and interaction with the patient.|Group A has Metronidazole gel Group B has Chlorhexidene gel Group C has combination of metronidazole and chlorhexidene gel|t|t|t|t
1334829|NCT03142594||||||||||||
1334830|NCT03142581||||||||||||
1334831|NCT03142568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334832|NCT03142555|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1334833|NCT03142542|Randomized|Parallel Assignment||Treatment||Triple|double-blind|placebo-controlled|t|t|t|
1334834|NCT03142529|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334835|NCT03142516||Single Group Assignment||Treatment||None (Open Label)||||||
1334836|NCT03142503|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1334837|NCT03142490|Randomized|Parallel Assignment||Treatment||None (Open Label)||In vitro fertilization patients will be randomized into two groups: treatment group (with complementary acupuncture) and control group (without complementary acupuncture).||||
1334838|NCT03142477|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomized into tree different groups: control, placebo, treatment.||||
1334839|NCT03142464|Randomized|Parallel Assignment||Treatment||None (Open Label)||Controls - convention postoperative IV fluids; intervention arm - no IV fluids postoperative||||
1334840|NCT03142451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334841|NCT03142438||Single Group Assignment||Treatment||None (Open Label)||||||
1334842|NCT03142425|||Cohort||Prospective|||||||
1334843|NCT03142412|||Cohort||Prospective|||||||
1334844|NCT03142399|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1334845|NCT03142386|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1334846|NCT03142373|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1334847|NCT03142360|Randomized|Parallel Assignment||Treatment||None (Open Label)||Treatment group is randomly assigned to start taking 120 mcg of Berasil. On the other hand, the control group does not take anything.||||
1334848|NCT03142347|Randomized|Parallel Assignment||Treatment||Single|||t|||
1334849|NCT03142334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334850|NCT03142321||Single Group Assignment||Treatment||None (Open Label)||||||
1334851|NCT03142308|||Ecologic or Community||Cross-Sectional|||||||
1334852|NCT03142295||Single Group Assignment||Other||None (Open Label)||prospective, open label pilot clinical trial.||||
1334853|NCT03142282|Randomized|Parallel Assignment||Treatment||None (Open Label)||Radiation: SBRT or IMRT Drug: Maintenance chemotherapy||||
1334854|NCT03142269|Randomized|Parallel Assignment||Other||Single|||t|||
1334855|NCT03142256|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334856|NCT03142243|||Case-Only||Cross-Sectional|||||||
1334857|NCT03142230|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334858|NCT03142217||Single Group Assignment||Other||None (Open Label)||||||
1334859|NCT03142204||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334860|NCT03142191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334861|NCT03142178|Randomized|Parallel Assignment||Treatment||Triple|Participant, Investigator|Double-blind, placebo controlled, randomized|t|t|t|
1334862|NCT03142165|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1334863|NCT03142152|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1334864|NCT03142139|||Cohort||Retrospective|||||||
1334865|NCT03142126||Single Group Assignment||Treatment||None (Open Label)||Eligible patients will receive early ambulation.||||
1334866|NCT03142113|||Cohort||Retrospective|||||||
1334867|NCT03142100|||Cohort||Prospective|||||||
1334868|NCT03142087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334869|NCT03142074|||Cohort||Prospective|||||||
1334870|NCT03142061||Single Group Assignment||Treatment||None (Open Label)||||||
1334871|NCT03142048|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1334872|NCT03142035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334873|NCT03142022|||Cohort||Prospective|||||||
1334874|NCT03142009|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|Due to factors that make the randomization of participants to either an intervention or usual and customary treatment group not feasible, the investigators do not use randomization or masking.|The investigators use a two arm non-equivalent control group design with pretest, immediate post- test, and 12 month follow-up assessment points. Among quasi-experimental designs that could be employed, this design carries several advantages over other designs in being able to infer causality. One advantage of this design is that it allows for a more meaningful analysis of the impact of the FL/CP intervention by a comparison of the intervention group with the usual and customary comparison group, an advantage not possible with single-group over time designs. Second, the design provides an analysis of diffusion effects (i.e. the potential influence of the intervention on the comparison group over time). Given the tight social networks and small number of interconnected families in the three participating communities, the investigators expect some degree of program diffusion in the comparison group families.||||
1334875|NCT03141996|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1334876|NCT03141983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334877|NCT03141970|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicentric, Parallel group, Open label randomized controlled trial||||
1334878|NCT03141957|||Case-Control||Cross-Sectional|||||||
1334879|NCT03141944|||Cohort||Other|||||||
1334880|NCT03141931|Randomized|Parallel Assignment||Treatment||Double|Double masked||t||t|
1334881|NCT03141918|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1334886|NCT03141853|Randomized|Parallel Assignment||Treatment||Triple|Participants, care provider, and outcomes assessor will be masked as to which is the intervention and which is the control|Randomized Controlled Trial. One group will receive equine-assisted therapy and the second group will receive arthritis exercise education|t|t||t
1334887|NCT03141840|Randomized|Parallel Assignment||Treatment||Quadruple|Study subjects are randomly assigned to treatment or placebo groups by a predetermined algoritm using sealed envelopes.|Double blind randomized controlled trail comparing ABL01 and placebo.|t|t|t|t
1334888|NCT03141827|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1334889|NCT03141814|||Case-Control||Prospective|||||||
1334890|NCT03141801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334891|NCT03141788||Single Group Assignment||Treatment||None (Open Label)||||||
1334892|NCT03141775|||Cohort||Other|||||||
1334893|NCT03141762|||Cohort||Prospective|||||||
1334894|NCT03141749|||Cohort||Retrospective|||||||
1334895|NCT03141736|Randomized|Parallel Assignment||Prevention||None (Open Label)||Assignment||||
1334896|NCT03141723|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomization at birth followed by randomization at 1 hour||||
1334897|NCT03141710||Single Group Assignment||Other||None (Open Label)||20ml of prebiotic per day for 12 weeks||||
1334898|NCT03141697|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1334899|NCT03141684||Single Group Assignment||Treatment||None (Open Label)||||||
1334900|NCT03141671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334901|NCT03141658|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1334902|NCT03141645|Randomized|Parallel Assignment||Prevention||Single||||||t
1334903|NCT03141632|Randomized|Crossover Assignment||Treatment||Quadruple|Double blind study|Double-blind, placebo control, cross-over design|t|t|t|t
1334904|NCT03141619|||Cohort||Prospective|||||||
1334905|NCT03141606|||Cohort||Prospective|||||||
1334906|NCT03141593|Randomized|Crossover Assignment||Treatment||None (Open Label)||Patient will be recruited by their GPs and allocated to the GP's form (liquid or solid). Patients will be randomly assigned to start weekly or monthly intake for 3 months, and switch to the other frequence for 3 more months.||||
1334907|NCT03141580||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334908|NCT03141567|||Other||Other|||||||
1334909|NCT03141554|Randomized|Sequential Assignment||Prevention||Single||12 healthy volunteers will be randomized into 3 arms with 3 different treatment sequences with 4 healthy volunteers in each arm.||||t
1334910|NCT03141541|Randomized|Parallel Assignment||Treatment||Single|"The invistigator performing the data analysis is unaware of group allocation. Due to the study design (pain management intervention versus usual care) it is not possible to blind patients and care providers.~Furthermore, as outcomes are selfreported, masking of assessors is not possible, as the patients are the assessors."|Parallel group randomised controlled trial|||t|
1334911|NCT03141528|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1334912|NCT03141515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334913|NCT03141502|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1334914|NCT03141489|Randomized|Factorial Assignment||Supportive Care||Triple|Patients and care provider(nurse) will be masked(not informed), Patients will be screened (height and weight) and handgrip strength will be performed by the investigator. Patients will sign a written consent, and then randomized to either the control or an intervention group. Patients will be tested on day 4, 7 and at 3 months by a research assistant/outcome assessor and is blinded treatment allocations. Blood tests are drawn daily. A nurse will administered the tubefeeding according to written orders in the medical journal; nurses are not informed about treatment allocation or the outcome measures. Physicians are informed about the study, but will not know what treatment patients will receive.|Refeeding protocol: Standardised refeeding protocols will be used for each of the patient groups; the control group will start tube feeding at 5 or 10 kcal/kg/day depending on their BMI and increase until needs are met within 7 days. The intervention group will start tube feeding at 20 kcal/kg/day and increase until needs are met within 3 days, but continue feeding minimum of 7days. Electrolytes will be monitored daily The patients will receive100 mg thiamine, and 1 multivitamin/mineral daily, all recorded in the medical journal. The intervention group will receive approximately 40% higher amount of protein and calories compared to the control group in the end of day 7.|t|t||t
1334915|NCT03141476|Randomized|Parallel Assignment||Prevention||None (Open Label)||BMI: <30kg/m*m: 1,5g, 31-50kg/m*m: 3,0g, >50kg/m*m: 4,5g||||
1334916|NCT03141463||Single Group Assignment||Treatment||None (Open Label)||||||
1334917|NCT03141450|||Cohort||Prospective|||||||
1334918|NCT03141437|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1334919|NCT03141424|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1334920|NCT03141411|||Case-Control||Prospective|||||||
1334921|NCT03141398|||Cohort||Prospective|||||||
1334922|NCT03141385|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1334923|NCT03141372|Randomized|Parallel Assignment||Prevention||None (Open Label)||Subjects will be randomized to a backfill void trial following total laparoscopic hysterectomy or an autofill void trial following total laparoscopic hysterectomy||||
1334924|NCT03141359||Single Group Assignment||Treatment||None (Open Label)||||||
1334925|NCT03141346|Randomized|Parallel Assignment||Treatment||Single|||||t|
1334926|NCT03141333|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1334927|NCT03141320|||Cohort||Retrospective|||||||
1334928|NCT03141307|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1334929|NCT03141294|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1334930|NCT03141281|Randomized|Parallel Assignment||Basic Science||Single|Assessors will be blinded to study condition when administering the tests to participants|Random assignment to one of four treatment groups at study entry||||t
1334931|NCT03141268|||Case-Control||Cross-Sectional|||||||
1334932|NCT03141255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334933|NCT03141242|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled Trial||||
1577414|NCT00001901||||Treatment||||||||
1334934|NCT03141229|Randomized|Parallel Assignment||Prevention||Double||Note: Either teacher and pupils are included in this study. We anticipate a number of 100 teacher and 500 pupils participating. Data from teacher and pupils will be analyzed separately.|t|||t
1334935|NCT03141216|Randomized|Parallel Assignment||Treatment||None (Open Label)||A parallel group study is a simple and commonly used clinical design which compares two treatments. Usually a test therapy is compared with a standard therapy. The allocation of subjects to groups is usually achieved by randomisation. The groups are typically named the treatment group and the control group. Parallel group designs do not require the same number of subjects in each group, although often similar numbers are observed. The design is commonly used in randomised controlled trials. Statistical analysis often boils down to a simple t-test of the between group difference in the outcome, which is usually a mean or a proportion.||||
1334936|NCT03141203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1334937|NCT03141190|Randomized|Parallel Assignment||Prevention||Double|Participants do not know we are testing mindfulness only that they will be learning stress-reduction skills for surgeons|Randomized, partially-blinded|t|||t
1334938|NCT03141177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334939|NCT03141164|Randomized|Parallel Assignment||Basic Science||None (Open Label)|Computerized training for all groups. This is a pilot study.|||||
1334940|NCT03141151|Randomized|Parallel Assignment||Treatment||Double|The investigators and data collectors will be blinded to randomization status. Because this is a behavioral intervention, the participants and interventionists will be unblinded.||||t|t
1334941|NCT03141138|Randomized|Parallel Assignment||Prevention||None (Open Label)|This will be an open-label study. The laboratories in charge of testing will be blinded to the experimental arm, and codes will be used to link the subject and study (without any link to the experimental arm attributed to the subject) to each sample.|||||
1334942|NCT03141125|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind randomized placebo controlled trial|Physalis angulata Linn. ethanol extract 3 x 250 mg|t|t|t|t
1334943|NCT03141112|||Other||Retrospective|||||||
1334944|NCT03141099|Randomized|Factorial Assignment||Treatment||Quadruple|"Target blood pressure will be blinded by offsetting the blood pressure measurering module.~The oxygenation- and fever control interventions will be open label. Further life-sustaining treatment will be delivered according to standard procedures and withdrawal of active intensive care will be at the discretion of the treating physicians, but must be delayed for at least 108 hours post ROSC. The steering group and the management group will be blinded to the type of intervention during the entire trial period, when handling the trial database.~Follow-up at 30 days (phone call) and 90 days (meeting) will be performed by personnel unaware of the allocation group, treatment complications at the ICU, if they occurred or specialized neurological rehabilitation."|"Multicenter, randomized trial in 2*2 factorial design allocating comatose OHCA patients to one of two target blood pressures (double blind) and restrictive vs. liberal oxygenation (open label) during ICU stay with blinded outcome evaluation.~Sample size: 800 patients. Patient will be allocated 1:1; for all interventions, no interaction with regards to outcome is expected."|t|t|t|t
1334945|NCT03141086|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1334946|NCT03141073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1334947|NCT03141060||Single Group Assignment||Treatment||None (Open Label)||||||
1334948|NCT03141047|Randomized|Parallel Assignment||Treatment||Single||||||t
1334949|NCT03141034||Single Group Assignment||Treatment||None (Open Label)||||||
1334950|NCT03141021|||Cohort||Other|||||||
1334951|NCT03141008|||Cohort||Prospective|||||||
1334952|NCT03140995|Randomized|Parallel Assignment||Treatment||Single|At baseline assessment demographic information and outcome measures will be collected by a physiotherapist not involved in the intervention and will be blinded to which arm the participant has been allocated to. This will all take place at the Department of Clinical Therapies, University of Limerick.|Single centre, single blinded pilot randomised controlled trial, comparing an aerobic intermittent exercise training intervention (walking programme) against verbal and written instructions regarding the benefits of exercise in RA.||||t
1334953|NCT03140982|Randomized|Parallel Assignment||Diagnostic||Triple|after patient constent, and previos the patient arriving the OR, the care provider (designed anesthestist) using a coin decide the arm (GR or GL). The neurologist and investigator was blind to the arm.|comparison of the neurologic behavior between two group, a fast and a slow anesthesia induction|t||t|t
1334954|NCT03140969||Sequential Assignment||Treatment||None (Open Label)||||||
1334955|NCT03140956|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1334956|NCT03140943||Single Group Assignment||Treatment||None (Open Label)||All patients will continue treatment for 18 cycles (12 induction cycles, 6 maintenance cycles) unless development of adverse events that require early cessation of treatment. Patients will be followed up for progression and survival until 1 year following the completion of the last patient's final cycle of induction therapy.||||
1334957|NCT03140930|Randomized|Crossover Assignment||Prevention||Single|||t|||
1334958|NCT03140917|||Other||Prospective|||||||
1334959|NCT03140904|Randomized|Parallel Assignment||Other||None (Open Label)||"Standard weekly visits at the outpatient therapeutic feeding center until discharge~Monthly visits at the outpatient therapeutic feeding center with caregiver support for home-based surveillance, with visits scheduled at weeks 4, 8, 10 and 12 until discharge."||||
1334960|NCT03140891|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1334961|NCT03140878|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1334962|NCT03140865|||Cohort||Prospective|||||||
1334963|NCT03140852|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1334964|NCT03140839|Randomized|Parallel Assignment||Treatment||Single|Participants will be blind to the condition they receive|Participants will be randomized to receive one of three conditions, either Imaginal Rescripting, Imaginal Exposure, or Supportive Counselling|t|||
1334965|NCT03140826|||Cohort||Prospective|||||||
1334966|NCT03140813|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1334967|NCT03140800|||Case-Control||Prospective|||||||
1334968|NCT03140787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334969|NCT03140774|||Cohort||Prospective|||||||
1334970|NCT03140761|||Case-Only||Prospective|||||||
1334971|NCT03140748|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1334972|NCT03140735|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1334973|NCT03140722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334974|NCT03140709|||Cohort||Prospective|||||||
1334975|NCT03140696|Randomized|Crossover Assignment||Basic Science||None (Open Label)||"The children will be randomly allocated to one of the three types of food (egg alone or egg + RUSF or egg + breast milk) in a crossover design.~Each of the diets (egg alone or egg + RUSF or egg + breast milk) will be offered for 2 days each. The order of diets will be randomly allocated over a period of 6 days. There would be 6 possible permutations and combinations of the order of the diets over this 6 days sequential period."||||
1334976|NCT03140683|||Other||Prospective|||||||
1334977|NCT03140670||Single Group Assignment||Treatment||None (Open Label)||||||
1334978|NCT03140657|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1334979|NCT03140644||Single Group Assignment||Diagnostic||None (Open Label)||||||
1334980|NCT03140631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334981|NCT03140618||Single Group Assignment||Health Services Research||None (Open Label)||||||
1334982|NCT03140605|||Other||Prospective|||||||
1334983|NCT03140592|||Cohort||Prospective|||||||
1334984|NCT03140579|||Cohort||Prospective|||||||
1334985|NCT03140566|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1334986|NCT03140553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1334987|NCT03140540|Randomized|Parallel Assignment||Health Services Research||Single|The intensivist taking care of the patient postoperatively not aware of the intervention|TEE as guide for tailoring perioperative fluid therapy to achieve individualized hemodynamic endpoint , target hemodynamic goals of stroke volume index (SVI) greater than 35 mL/m2 and cardiac index greater than 2.5 L/min/m2 and tissue oxygen delivery. Lactate levels as a surrogate indicator of organ perfusion as measured by arterial blood gas analysis intraoperatively , after 12 hours and 48 hrs postoperatively.||t||
1334988|NCT03140527|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1334989|NCT03140514|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1334990|NCT03140501|Randomized|Parallel Assignment||Supportive Care||Single|Since it is not possible to blind the participants or the interventionists, a single blind study design will be employed in which data collectors are blinded to participants' group allocation.|Mixed-methods, rater-blinded, randomized controlled trial with a stepped wedge design (i.e., delayed intervention control group). The qualitative portion will consist of semi-structured interviews with a sub-sample of the participants.||||t
1334991|NCT03140488|Randomized|Parallel Assignment||Other||Quadruple|"This portion of the study will be carried out by the research pharmacy. Single (low dose) and triple (high dose) concentration of oxytocin will be premixed in the intravenous fluid bag in the pharmacy. Sequence generation for randomization will be created with 1:1 ratio in both the obese and lean group by the Department of Statistics. After the sequence is generated, ths list will be given to the research pharmacy. The premixed oxytocin medication will be sequentially labelled as OPS drug, patient #1, 2, 3 etc. per the allocation. Allocation concealment will also be carried out by pharmacy as these bags will completely appear identical after they are labelled numerically. Once a patient is randomized, the pharmacy will send up the appropriate concentration of oxytocin already premixed in the intravenous fluid bag, labelled as OPS drug, patient #. Lean group will be assigned at # 1-70 and obese group will be assigned at #71-140."|"4 Comparison groups:~Control group: Lean cohort: BMI ≤25, at <20 weeks gestation or BMI ≤28 at a term gestation, low dose oxytocin protocol~Intervention group: Lean cohort: BMI ≤25, at <20 weeks gestation or BMI ≤28 at a term gestation, high dose oxytocin protocol~Control group: Obese cohort: BMI ≥30, at <20 weeks gestation or BMI ≥35 at a term gestation, low dose oxytocin protocol~Intervention group: Obese cohort: BMI ≥30, at <20 weeks gestation or BMI ≥35 at a term gestation, high dose oxytocin protocol"|t|t|t|t
1334992|NCT03140475|||Case-Control||Cross-Sectional|||||||
1334993|NCT03140462|||Case-Only||Retrospective|||||||
1334994|NCT03140449|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1334995|NCT03140436|Randomized|Parallel Assignment||Treatment||Triple|Each group received treatment through a different operator (one operator per one group). Each patient was randomized using sealed envelopes according to treatment side (right or left) using powder grain size 65 µm or 40 µm. The patients and operators were blinded from the type of the powder.|This study was designed as a double-blind, randomized split-mouth design.|t|t|t|
1334996|NCT03140423|Randomized|Parallel Assignment||Prevention||None (Open Label)||Non-inferiority cluster randomized controlled trial||||
1334997|NCT03140410|||Case-Control||Other|||||||
1334998|NCT03140397|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1334999|NCT03140384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335000|NCT03140371||Single Group Assignment||Supportive Care||None (Open Label)||||||
1335001|NCT03140358|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized control trial|t|t|t|t
1335002|NCT03140345|||Other||Cross-Sectional|||||||
1335003|NCT03140332||Single Group Assignment||Other||None (Open Label)||||||
1335004|NCT03140319|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1335005|NCT03140306|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)|the reader of the ct is blinded to the clinical presentation|Split dose CT||||
1335006|NCT03140293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335007|NCT03140280||Single Group Assignment||Treatment||None (Open Label)||||||
1335008|NCT03140267||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335009|NCT03140254|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1335010|NCT03140241||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335011|NCT03140228|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1335012|NCT03140215|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1335123|NCT03138772|||Cohort||Prospective|||||||
1335124|NCT03138759|Randomized|Crossover Assignment||Basic Science||None (Open Label)||This is an open-label, 2-treatment sequence, 2-period, crossover study with a washout between doses and treatment periods||||
1577415|NCT00001899||||||||||||
1335013|NCT03140202|Randomized|Crossover Assignment||Other||None (Open Label)||"In Guide group, participants have a real time feedback (and record) on chest compression quality performed by means of the visuals informations profided by the feedback device.~In Blind group, participants have a real time record of chest compression quality performed by means of the feedback device without feedback information of the performance."||||
1335014|NCT03140189|||Cohort||Prospective|||||||
1335015|NCT03140176|||Cohort||Prospective|||||||
1335016|NCT03140163||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335017|NCT03140150|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1335018|NCT03140137|||Cohort||Retrospective|||||||
1335019|NCT03140124|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Participants receive both conditions, with randomized order||||
1335020|NCT03140111|Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1335021|NCT03140098|||Case-Control||Prospective|||||||
1335022|NCT03140085|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1335023|NCT03140072|Randomized|Parallel Assignment||Treatment||Single||||t||
1335024|NCT03140059|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1335025|NCT03140046||Single Group Assignment||Treatment||None (Open Label)||||||
1335026|NCT03140033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335027|NCT03140020|||Case-Control||Prospective|||||||
1335028|NCT03140007|Randomized|Crossover Assignment||Other||Single|prospective, multi-center, randomized controlled, post market study|prospective, multi-center, randomized controlled, post market study|t|||
1335029|NCT03139994|||Cohort||Prospective|||||||
1335030|NCT03139981|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind study||t|t|t|t
1335031|NCT03139968|Randomized|Parallel Assignment||Treatment||Triple|Patient, operator and investigator are blinded to dummy drape vs RADPAD.||t|t|t|
1335032|NCT03139955|||Cohort||Prospective|||||||
1335033|NCT03139942||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1335034|NCT03139929|||Cohort||Prospective|||||||
1335035|NCT03139916||Single Group Assignment||Treatment||None (Open Label)||||||
1335036|NCT03139903|||Family-Based||Retrospective|||||||
1335037|NCT03139890|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1335038|NCT03139877|||Case-Control||Prospective|||||||
1335039|NCT03139864|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|no masking is used. All involved know the identity of the intervention assignment|||||
1335040|NCT03139851||Single Group Assignment||Treatment||None (Open Label)||||||
1335041|NCT03139838|Randomized|Crossover Assignment||Health Services Research||Double|||t|||t
1335042|NCT03139825||Single Group Assignment||Other||None (Open Label)||||||
1335043|NCT03139812|Randomized|Parallel Assignment||Prevention||Single|Research optometrists conducting eye examinations and technicians conducting fluorometry measurements did not know whether a given subject was in the treatment (irrigating) or control (non-irrigating) group.|161 non-contact lens wearers were fit with silicone hydrogel (SiH) contact lenses and randomized to either a treatment (n = 81) or control (n = 80) group for 30-day continuous wear (CW). Subjects in the treatment group irrigated every morning and whenever dryness symptoms occurred; subjects in the control group did not.|||t|
1335044|NCT03139799|Randomized|Crossover Assignment||Other||Single|"This study will include outcome assessor blinding as recommended in a publication on methodological quality criteria for cognitive rehabilitation research and computer game training in older adults (Bleakley et al., 2015; Cicerone, Azulay, & Trott, 2009).~This will ensure that the person conducting the assessment of outcome measures will be unaware of the participant's treatment condition. For this purpose, a central randomization procedure will be used where a designated staff member not involved in the study will conduct and securely maintain the randomization, contact and allocate participants and use central methods (e.g. phone or secure computer) after the patient is enrolled. This way the treatment assignments are not revealed to the assessors when conducting the outcome assessments. The assessors will also be excluded from any activity pertaining to the intervention activities (e.g. instructing participants, distributing the tablet-computers)."|This study uses a 16-week, assessor blinded, randomized crossover design with two phases of treatment and three waves of measurement. Participants are randomly allocated to either the experimental (group T) or control intervention (group C). Group T will first receive the experimental and then the control intervention (T-C) while group C is given the opposite order of intervention (C-T). In phase I both groups take a baseline measurement (pre-test), then group T is given the casual puzzle game task (experimental intervention) while group C is performing the newspaper reading task (control intervention). After phase I (8 weeks) both groups are post-tested (mid-test). In phase II, groups are switched and the control group C is given the experimental intervention (casual puzzle game task) while the experimental intervention group T now serves as control. After phase II (16 weeks) both groups are post-tested again.||||t
1335045|NCT03139786|||Cohort||Prospective|||||||
1335046|NCT03139773|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1335047|NCT03139760|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1335048|NCT03139747||Single Group Assignment||Treatment||None (Open Label)||||||
1335049|NCT03139734||Single Group Assignment||Treatment||None (Open Label)||||||
1335050|NCT03139721|||Cohort||Prospective|||||||
1335051|NCT03139708|Non-Randomized|Parallel Assignment||Prevention||Single|The PI measuring pupil size will not know the subject assignment.|||||t
1335052|NCT03139695|||Cohort||Prospective|||||||
1335053|NCT03139682|||Cohort||Prospective|||||||
1335054|NCT03139669||Single Group Assignment||Screening||None (Open Label)||||||
1335055|NCT03139656|Randomized|Parallel Assignment||Other||Single|||t|||
1335056|NCT03139643|Randomized|Parallel Assignment||Other||Single|||t|||
1335057|NCT03139630|||Cohort||Prospective|||||||
1335058|NCT03139617|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335059|NCT03139604|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t||t|
1335060|NCT03139591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335125|NCT03138746|||Cohort||Prospective|||||||
1577416|NCT00001898||||||||||||
1335061|NCT03139578|Randomized|Crossover Assignment||Treatment||Double|Both the investigator and the subjects are masked to the identity of the study lenses. Lenses were over-labelled and coded to mask the lens foil. Over-labelling was carried out by the study sponsor following specific SOPs (see ICH GCP guidelines Section 5.13).|Contra-lateral Assignment|t||t|
1335062|NCT03139565|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1335063|NCT03139552|Randomized|Crossover Assignment||Other||Single|Subjects were blind to the differences in recipes when taste testing.|Subjects were asked to taste test 3 versions of test items (in randomized order) and provide a liking score for each.|t|||
1335064|NCT03139539|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335065|NCT03139526|||Cohort||Cross-Sectional|||||||
1335066|NCT03139513|||Cohort||Other|||||||
1335067|NCT03139500|Randomized|Parallel Assignment||Other||Double|||t||t|
1335068|NCT03139487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335069|NCT03139474|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335070|NCT03139461|Randomized|Parallel Assignment||Health Services Research||Single||Cluster-randomized trial||||t
1335071|NCT03139448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335072|NCT03139435||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335073|NCT03139422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335074|NCT03139409|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1335075|NCT03139396|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1335076|NCT03139383|Randomized|Parallel Assignment||Treatment||Double|The patients did not know the type of intravenous fluid they received during the surgery. The outcome assessors were blineded too.|a prospective randomized double-blind controlled study of the incidence and severity of postoperative nausea and vomiting in female participants receiving different types of intravenous fluid solution|t|||t
1335077|NCT03139370||Single Group Assignment||Treatment||None (Open Label)||||||
1335078|NCT03139357|||Other||Prospective|||||||
1335079|NCT03139344|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1335080|NCT03139331||Single Group Assignment||Treatment||None (Open Label)||||||
1335081|NCT03139318||Sequential Assignment||Treatment||None (Open Label)||||||
1335082|NCT03139305|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1335083|NCT03139292|Randomized|Parallel Assignment||Device Feasibility||Double|Sequentially numbered, sealed, opaque envelopes: Participant and Outcome Assessor Blinded|Prospective randomized single blinded parallel group controlled study|t|||t
1335084|NCT03139279|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1335085|NCT03139266|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335086|NCT03139253|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1335087|NCT03139240|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t||t|
1335088|NCT03139227||Single Group Assignment||Supportive Care||None (Open Label)||||||
1335089|NCT03139214|Randomized|Parallel Assignment||Prevention||Single||The intervention involved 7 parenting sessions with mothers and their children that taught nurturant parenting techniques, effective communication skills, and about the importance of developing and following household rules.||||t
1335090|NCT03139201|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1335091|NCT03139188|||Cohort||Other|||||||
1335092|NCT03139175|Non-Randomized|Parallel Assignment||Prevention||Double|||||t|t
1335093|NCT03139162|||Cohort||Retrospective|||||||
1335094|NCT03139149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335095|NCT03139136|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335096|NCT03139123|||Cohort||Prospective|||||||
1335097|NCT03139110|||Cohort||Prospective|||||||
1335098|NCT03139097|||Cohort||Prospective|||||||
1335099|NCT03139084|||Other||Prospective|||||||
1335100|NCT03139071|||Other||Cross-Sectional|||||||
1335101|NCT03139058||Single Group Assignment||Other||None (Open Label)||||||
1335102|NCT03139045|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1335103|NCT03139032||Single Group Assignment||Treatment||None (Open Label)||Proof of concept, open label||||
1335104|NCT03139019|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1335105|NCT03139006|||Cohort||Prospective|||||||
1335106|NCT03138993|Randomized|Parallel Assignment||Other||Single|||t|||
1335107|NCT03138980||Single Group Assignment||Supportive Care||None (Open Label)||||||
1335108|NCT03138967|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1335109|NCT03138954|||Cohort||Prospective|||||||
1335110|NCT03138941|||Cohort||Prospective|||||||
1335111|NCT03138928|||Case-Only||Retrospective|||||||
1335112|NCT03138915||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335113|NCT03138902||Single Group Assignment||Treatment||None (Open Label)||||||
1335114|NCT03138889|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1335115|NCT03138876||Single Group Assignment||Diagnostic||None (Open Label)|There will be blinded EEG assessment in terms of the EEG readers.|Subjects may be treated for NCSE based on EEG cap findings, but only following standard practice. The study is designed to identify NCSE, not to assess treatment of NCSE.||||
1335116|NCT03138863||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1335117|NCT03138850|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335118|NCT03138837|||Cohort||Prospective|||||||
1335119|NCT03138824|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335120|NCT03138811||Parallel Assignment||Treatment||Double|||t||t|
1335121|NCT03138798|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will give consent in the first stage of labor. Randomization will then be performed using sealed envelopes at the time of pushing in the second stage of labor. Duration of the second stage and time spent pushing will be recorded for both groups.||||
1335122|NCT03138785|Randomized|Parallel Assignment||Treatment||Single||||||t
1335126|NCT03138733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335127|NCT03138720||Single Group Assignment||Treatment||None (Open Label)|No masking|There will be two treatment groups: those who are deemed resectable and those that are deemed borderline resectable and with locally advanced pancreas cancer.||||
1335128|NCT03138707|||Case-Control||Retrospective|||||||
1335129|NCT03138694|||Cohort||Prospective|||||||
1335130|NCT03138681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335131|NCT03138668|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1335132|NCT03138655|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335133|NCT03138642||Single Group Assignment||Treatment||None (Open Label)||All the patients receive extended resection to primary tumor and post-surgery RT. The patients are prescribed a EQD2 of 70-77Gy to GTV (residual tumor), 65-70Gy to CTV1(high-risk regions including tumor bed and gross macroscopic residual tumor), 50-55Gy to CTV2(low-risk regions) using Intensity-modulated radiotherapy (IMRT)||||
1335134|NCT03138629||||||||||||
1335135|NCT03138616|Randomized|Parallel Assignment||Treatment||None (Open Label)||intervention group and control group||||
1335136|NCT03138603|Randomized|Parallel Assignment||Treatment||Double|Double blind masking|Single-center, double blinded placebo controlled|t||t|
1335137|NCT03138590|Randomized|Parallel Assignment||Basic Science||Double||participants will be randomly assigned to one of 2 groups: (1) active tDCS (2) sham tDCS|t|||t
1335138|NCT03138577|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"The Continual Reassessment Method (CRM), developed by O'Quigley et al., is a study design for dose-finding/Phase I studies. It is different from traditional dose-escalation studies in that it learns from information gained at earlier time points in order to limit patient exposure to non-efficacious and potentially toxic doses. The estimated dose-response curve (DRC) is updated after each subject's outcome is observed, so that the next patient's dose is based on the information about how the previous patient tolerated the intervention. As the number of subjects grows, the DRC comes to reflect observed data instead of the a-priori assumptions. In this study, the investigators are attempting to define the DRC for the degree of hemidiaphragmatic paresis (HDP) caused by various doses of local anesthetic administered in a supraclavicular block."||||
1335139|NCT03138564|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Dialysis clinics will be randomized to provide the intervention or usual care. Patients of those clinics will be given the opportunity to participate in the study and will receive the intervention or usual care based on which clinic they attend.||||
1335140|NCT03138551||Sequential Assignment||Treatment||None (Open Label)||Single-Case Experimental Design||||
1335141|NCT03138538||Single Group Assignment||Treatment||None (Open Label)||||||
1335142|NCT03138525|||Cohort||Prospective|||||||
1335143|NCT03138512|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335144|NCT03138499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335145|NCT03138473|||Cohort||Cross-Sectional|||||||
1335146|NCT03138460|||Case-Crossover||Retrospective|||||||
1335147|NCT03138447|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The design of this protocol involves a prospective and retrospective cohort. The prospective cohort includes 30 participants. In the retrospective chart review, participants will be matched to the prospective group for age, gender, and baseline A1C. (For this study, the use of the word 'matched' means that the retrospective patient charts will be matched as close as possible from available patient data within the Bay West Endocrinology medical record database and may not always be an exact match to the prospective group for age, gender, and baseline A1c.) The chart review will thus be conducted after the last subject is enrolled in the prospective arm of the study.||||
1335148|NCT03138434|||Cohort||Cross-Sectional|||||||
1335149|NCT03138421|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1335150|NCT03138408|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335151|NCT03138395|||Cohort||Prospective|||||||
1335152|NCT03138382|Randomized|Crossover Assignment||Basic Science||Triple|Double-blind|"Crossover design~Double-blind~Randomized"|t||t|t
1335153|NCT03138369|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind|Parallel Assignment in 1:1 active to control allocation|t|t|t|t
1335154|NCT03138356|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1335155|NCT03138343||||||||||||
1335156|NCT03138330|||Cohort||Cross-Sectional|||||||
1335157|NCT03138317|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335158|NCT03138304|Randomized|Parallel Assignment||Treatment||Single|Group assignment will be masked at the analysis phase.|||||t
1335159|NCT03138291||Single Group Assignment||Other||None (Open Label)||||||
1335160|NCT03138278|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Multicentre study with ≥ 100 ICUs from Europe. Randomisation at ICU level to give support to caregivers or not (cluster-randomisation)||||
1335161|NCT03138265||Single Group Assignment||Basic Science||Single||||||
1335162|NCT03138252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335163|NCT03138239|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1335164|NCT03138226|||Cohort||Prospective|||||||
1335165|NCT03138213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335166|NCT03138200||Single Group Assignment||Supportive Care||None (Open Label)||||||
1335167|NCT03138187|Randomized|Parallel Assignment||Prevention||Single|Participants and physical trainer blinding will not be feasible due to the characteristics of prescribed exercise sessions. However, the evaluators will be blinded to the following endpoints: weight, body composition, appetite, energy intake and laboratorial biomarkers.|||||t
1335168|NCT03138174|||Other||Other|||||||
1335169|NCT03138161||Single Group Assignment||Treatment||None (Open Label)||||||
1335170|NCT03138148|||Cohort||Prospective|||||||
1335171|NCT03138135|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335172|NCT03138122|||Cohort||Prospective|||||||
1335173|NCT03138109|||Other||Retrospective|||||||
1335174|NCT03138096|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335175|NCT03138083|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||A modular, multi-arm, multi-part, first time in patient study||||
1335176|NCT03138070||Single Group Assignment||Treatment||None (Open Label)||||||
1335177|NCT03138057|||Case-Crossover||Prospective|||||||
1335178|NCT03138044||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-randomized and time series clinical trial.||||
1335179|NCT03138031||Single Group Assignment||Treatment||None (Open Label)|No masking|Single Group Assignment. Prospective and non-randomized clinical trial||||
1335180|NCT03138018|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1335181|NCT03138005|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1335182|NCT03137992|Randomized|Crossover Assignment||Treatment||Triple|Double-blind|Double-blind, double-dummy, placebo controlled|t||t|t
1335183|NCT03137979|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335184|NCT03137966|Randomized|Parallel Assignment||Treatment||Single|The drugs (active or placebo) will be supplied by the supervision of Medigelium AB and will have the same appearance.|prospective, randomised, double-blind and placebo-controlled study with parallel groups, multiple centre trial.|t|||
1335185|NCT03137953||Single Group Assignment||Supportive Care||None (Open Label)||Examination of the distance between the skin and the base of the tumour would be evaluated clinically (skin Pinch Test) and by CT/MRI with contrast. Post resection, histopathological examination of tumour margins would confirm if the base of the tumour is free or not. The proportion of cases where skin is preserved would be compared to the proportion of cases where skin would have been preserved based on clinical examination would be assessed.||||
1335186|NCT03137940|Randomized|Crossover Assignment||Other||Quadruple|The medical device randomly assigns, to each subject, the sequence of the type of sessions, so no one knows the kind of session performed.|Each subject receives, randomly, a real session of tDCS and a sham session with BrainStim Stimulator.|t|t|t|t
1335187|NCT03137927|Randomized|Parallel Assignment||Prevention||Single||"The study is dose-escalating, so there will be 3 groups. Group 1: 9 individuals will be vaccinated intranasally with 2,5*108 bacteria (CFU), 3 individuals will get placebo.~Group 2: 9 individuals will be vaccinated intranasally with 109 bacteria cells(CFU), 3 individuals will get placebo.~Group 3: 9 individuals will be vaccinated intranasally with 4*109 bacteria cells(CFU), 3 individuals will get placebo."|t|||
1335188|NCT03137914||Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment The clinical study model adopted is a single experimental group. Ten participants with dentofacial deformities related to severe degenerative TMJ changes, who are candidates for orthognathic surgery to repair these deformities, will be evaluated, who will be submitted to treatment with nasal septum autologous chondrocytes transplantation. There will be no evaluation of the control group in this study, as it is a case report. Injection of the experimental treatment will be done through an ultrasound-guided arthrocentesis.||||
1335189|NCT03137901|||Cohort||Prospective|||||||
1335190|NCT03137888||Single Group Assignment||Treatment||None (Open Label)||||||
1335191|NCT03137875|||Other||Cross-Sectional|||||||
1335192|NCT03137862|Randomized|Parallel Assignment||Other||Double||double blind prospective study|t||t|
1335193|NCT03137849|Randomized|Factorial Assignment||Health Services Research||Double|All participants will be told they are attending to a yoga protocol. All outcomes assessments will be taken by blind investigators to the interventions.||t|||t
1335194|NCT03137836|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335195|NCT03137823||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335196|NCT03137810|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335197|NCT03137797|||Cohort||Prospective|||||||
1335198|NCT03137784|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1335199|NCT03137771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335200|NCT03137758|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1335201|NCT03137745|||Other||Prospective|||||||
1335202|NCT03137732|Randomized|Parallel Assignment||Treatment||Single|Patients will be blinded to the intervention that they are randomized to intraoperatively.||t|||
1335203|NCT03137719|||Cohort||Prospective|||||||
1335204|NCT03137706|||Case-Only||Prospective|||||||
1335205|NCT03137693||Single Group Assignment||Treatment||None (Open Label)||||||
1335206|NCT03137680|Randomized|Single Group Assignment||Treatment||Single|Care Provider i.e., vascular surgeon are blinded to subject randomisation|||t||
1335207|NCT03137667|Randomized|Parallel Assignment||Health Services Research||Single|The investigator is not aware of the allocation at the level of the patient. In addition, the investigator is not involved in vaccine verification (data collection involving patient-level vaccination status)||||t|
1335208|NCT03137654|Randomized|Parallel Assignment||Other||None (Open Label)||The primary design is a 3 (Training Condition: Neutral, Affective, Control) by 2 (Time: Baseline, Post-training) repeated measures design.||||
1335209|NCT03137641|||Cohort||Prospective|||||||
1335210|NCT03137628|||Case-Control||Prospective|||||||
1335211|NCT03137615|||Case-Only||Prospective|||||||
1335212|NCT03137602||Single Group Assignment||Other||None (Open Label)||||||
1335213|NCT03137589|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Stepped-Wedge-Design||||
1335214|NCT03137576|Randomized|Parallel Assignment||Treatment||Double|"Partecipant masking:~Both blocks are performed on the area between the scapula and the vertebral column, employing the same materials, so that the patient is masked about which block is going to be performed.~Care providers: once the block has been performed, a different anesthesiologist will take care of the patient during the procedure, eventually providing dose escalation in systemic analgesic drugs (primary end point). Surgeons performing the procedure are unaware of the type of block. Staff nurses managing post operative pain in terms of both recording (Numeric Rating Scale) and soothing (rescue analgesia distribution) are unaware of the type of block (secondary end points)."|"Eligible patients will be randomized between two groups according to loco regional pain management:~Paravertebral block Erector Spinae Plane Block Allocation to one treatment group or another will be randomized with the aim of create two unbiased groups formed out of the same group of patients. Randomization will be provided by a software."|t|t||
1335215|NCT03137563|||Cohort||Prospective|||||||
1335216|NCT03137550|||Cohort||Prospective|||||||
1335217|NCT03137537|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335354|NCT03135756|||Case-Control||Cross-Sectional|||||||
1335218|NCT03137524|Randomized|Crossover Assignment||Treatment||None (Open Label)||Single Centre Pilot study using a randomised controlled crossover design (aka randomised A-B single-subject design).||||
1335219|NCT03137511|Randomized|Parallel Assignment||Prevention||None (Open Label)||Cluster randomization of MGs corresponding to their exercise sites||||
1335220|NCT03137498|Randomized|Parallel Assignment||Treatment||Quadruple|This is a double-blind placebo-controlled randomized trial where blinding will be conducted and applied to the study investigator, physicians, and nursing staff providing care to the patient. An independent biostatistician will conduct a statistical analysis with blinded data. Only the pharmacists preparing the study interventions will be unblended to the study treatments. The pharmacists procuring the interventions will not be part of data collection or analysis.||t|t|t|t
1335221|NCT03137485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335222|NCT03137472|Randomized|Parallel Assignment||Treatment||Single|Single, blinding of participant||t|||
1335223|NCT03137459|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1335224|NCT03137446|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Trial||||
1335225|NCT03137433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335226|NCT03137420|||Cohort||Prospective|||||||
1335227|NCT03137407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335228|NCT03137394|||Cohort||Prospective|||||||
1335229|NCT03137381|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1335230|NCT03137368|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized, open-label, parallel, active-controlled superiority clinical study||||
1335231|NCT03137355|||Case-Only||Other|||||||
1335232|NCT03137342|Randomized|Sequential Assignment||Prevention||Single|Outcome assessor will be blind to the participant's assigned intervention.|Intervention Condition: Pepped-for-PrEP intervention counseling plus standard of care adherence counseling as part of their PrEP related care via The Miriam Hospital Control Condition: only the standard of care adherence counseling as part of their PrEP related care via The Miriam Hospital.||||t
1335233|NCT03137329|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335234|NCT03137316|||Cohort||Retrospective|||||||
1335235|NCT03137303|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1335236|NCT03137290|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335237|NCT03137277|||Case-Control||Prospective|||||||
1335238|NCT03137264|||Cohort||Prospective|||||||
1335239|NCT03137251|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1335240|NCT03137238|||Case-Control||Cross-Sectional|||||||
1335241|NCT03137225|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomization - the order of modes will be assigned based on a random number table using a 5 block design to match the DSMB reporting needs.||||
1335242|NCT03137212|Randomized|Parallel Assignment||Treatment||None (Open Label)||The patients with STEMI will be divided into two group randomly. Patients of A group will be treated by thrombolysis and then 3-6 hours will be treated by PCI. Patients of B group will be treated by thrombolysis and then 6-24 hours will be treated by PCI.||||
1335243|NCT03137199|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||a first group of 3 patients will receive a lower dose of 20 million hMSCs, followed by a second group of 3 patients to receive a dose of 100 million hMSCs||||
1335244|NCT03137186|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335245|NCT03137173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335246|NCT03137160||Single Group Assignment||Treatment||None (Open Label)||||||
1335247|NCT03137147||Single Group Assignment||Treatment||None (Open Label)||||||
1335248|NCT03137134|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Open-label|||||
1335249|NCT03137121|Randomized|Parallel Assignment||Treatment||Triple|Patients will receive the study drug or placebo in a double-blind fashion.|There will be two groups for the study: Group 1 will receive the study drug and Group 2 will receive a placebo.|t|t|t|
1335250|NCT03137108||Single Group Assignment||Treatment||None (Open Label)||||||
1335251|NCT03137095|||Case-Control||Prospective|||||||
1335252|NCT03137082|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335253|NCT03137069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335254|NCT03137056|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1335255|NCT03137043|||Case-Control||Prospective|||||||
1335256|NCT03137030|Randomized|Crossover Assignment||Treatment||None (Open Label)||For Part 1, the randomization will be realized using a Williams Square with a 4x4 design. For the optional Part 2, a standard 2x2 crossover design will be applied.||||
1335257|NCT03137017|Randomized|Crossover Assignment||Treatment||None (Open Label)||The randomization will be realized using a Williams Square with a 4x4 design.||||
1335258|NCT03137004||Single Group Assignment||Treatment||None (Open Label)||||||
1335259|NCT03136991|Randomized|Parallel Assignment||Treatment||Single|This study will be a randomized, single-blind (site personnel to remain blinded until SRC meeting), placebo-controlled, MAD, sequential group design study in healthy male subjects, performed at a single study center.|"This study will be a randomized, single-blind (site personnel to remain blinded until SRC meeting), placebo-controlled, MAD, sequential group design study in healthy male subjects, performed at a single study center. Up to 60 healthy male subjects aged 18 to 50 years (inclusive) are planned to be investigated in 4 cohorts, but up to 6 cohorts may be included if the SRC considers it necessary to repeat a dose level or if additional dose levels are required.~Up to 10 subjects will participate in each cohort. Within each cohort 8 subjects will be randomly assigned to receive AZD4831 and 2 subjects to receive placebo. AZD4831 or placebo will be administered once daily for a period of 10 days. It is anticipated this will be sufficient to achieve and maintain steady state PK profiles for several days, permitting evaluation of the safety and tolerability of multiple dose administrations at steady state. The subjects will stay at the study center during the whole dosing period and until 48h"|t|||
1335260|NCT03136978|||Case-Control||Prospective|||||||
1335355|NCT03135743|||Cohort||Prospective|||||||
1335356|NCT03135730|||Cohort||Prospective|||||||
1335357|NCT03135717|||Cohort||Cross-Sectional|||||||
1335261|NCT03136965|Randomized|Parallel Assignment||Treatment||Double|Subjects and assessors will be blinded to the subject group allocation. Subjects will be identified to study personnel using a unique study number only and results of the imaging studies will be blinded, batched, and evaluated in a randomized manner.|Double-blinded randomized controlled trial|t|||t
1335262|NCT03136952|||Cohort||Prospective|||||||
1335263|NCT03136939|||Case-Control||Prospective|||||||
1335264|NCT03136926|||Cohort||Prospective|||||||
1335265|NCT03136913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335266|NCT03136900|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1335267|NCT03136887|||Cohort||Prospective|||||||
1335268|NCT03136874|||Case-Only||Prospective|||||||
1335269|NCT03136861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335270|NCT03136848||Single Group Assignment||Other||None (Open Label)||A pilot study of procedural feasibility involving both device and drug (organ perfusate solution).||||
1335271|NCT03136835||Single Group Assignment||Treatment||None (Open Label)||||||
1335272|NCT03136822|Randomized|Parallel Assignment||Treatment||Single|The wound will be assessed by Pathologists who are masked for treatment|Open label, controlled, randomised, parallel arm study||||t
1335273|NCT03136809||Single Group Assignment||Treatment||None (Open Label)||Multicenter, open-label treatment extension study||||
1335274|NCT03136796|||Cohort||Prospective|||||||
1335275|NCT03136783||Single Group Assignment||Other||None (Open Label)||||||
1335276|NCT03136770|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1335277|NCT03136757|||Cohort||Retrospective|||||||
1335278|NCT03136744||Single Group Assignment||Other||None (Open Label)||||||
1335279|NCT03136731|||Cohort||Prospective|||||||
1335280|NCT03136718|||Case-Only||Prospective|||||||
1335281|NCT03136705|Randomized|Factorial Assignment||Treatment||Triple||Double blind, randomized, placebo-controlled, 2x2 factorial|t|t|t|
1335282|NCT03136692|||Cohort||Retrospective|||||||
1335283|NCT03136679|||Case-Control||Prospective|||||||
1335284|NCT03136666||Single Group Assignment||Treatment||None (Open Label)||||||
1335285|NCT03136653||Single Group Assignment||Treatment||None (Open Label)||||||
1335286|NCT03136640||Single Group Assignment||Treatment||None (Open Label)||Three patients will start at the starting dose level. If none of these patients experiences a DLT, another three patients will be added at the same dose level. The dose will be escalated or de-escalated based on safety and pharmacokinetic parameters. The recommended dose level, defined as the maximum tolerated dose (MTD) of docetaxel (as ModraDoc006 10 mg tablets) that can safely be administered in combination with ritonavir to patients with metastatic castration-resistant prostate cancer in a bi-daily weekly schedule without interruption and results in an adequate systemic exposure to docetaxel, will be expanded to at least 20 for toxicity evaluable patients.||||
1335287|NCT03136627||Single Group Assignment||Treatment||None (Open Label)|Open Label|Tivozanib in Combination with Nivolumab||||
1335288|NCT03136614|Non-Randomized|Parallel Assignment||Screening||Single|||t|||
1335289|NCT03136601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335290|NCT03136588|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized in a 1:1 ratio to either Information and Communication Technology (ICT) based centralized clinical trial monitoring system or control group||||
1335291|NCT03136575|Randomized|Parallel Assignment||Prevention||Single|patients who signed inform consent are randomized into qigong group and wait-list control (WLC)|randomized controlled trial|t|||
1335292|NCT03136562|||Cohort||Cross-Sectional|||||||
1335293|NCT03136549|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1335294|NCT03136536|||Cohort||Prospective|||||||
1335295|NCT03136523|||Cohort||Retrospective|||||||
1335296|NCT03136510|Non-Randomized|Parallel Assignment||Screening||Single||"60 patients with two subgroups~30 patients with new diagnosis of atrial fibrillation (vitamin K antagonist treatment shorter than 1 week) : initiated with Apixaban 5 mg~30 patients previously chronically treated by VKA for more than 3 months and switched to Apixaban 5 mg"||||t
1335297|NCT03136497||Single Group Assignment||Treatment||None (Open Label)||||||
1335298|NCT03136484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335299|NCT03136471|||Cohort||Prospective|||||||
1335300|NCT03136458|Randomized|Parallel Assignment||Prevention||Double||Parallel assignment|t||t|
1335301|NCT03136445|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1335302|NCT03136432|||Case-Only||Prospective|||||||
1335303|NCT03136419|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1335304|NCT03136406||Single Group Assignment||Treatment||None (Open Label)||||||
1335305|NCT03136393|Randomized|Parallel Assignment||Prevention||Single||||||t
1335306|NCT03136380|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1335307|NCT03136367|Randomized|Parallel Assignment||Health Services Research||Single|Data analysts will be blinded to the clinician randomization.|Three-arm randomized controlled superiority trial with stratification by SES and randomization at the clinician level. Patient enrollment will occur at five cancer centers in the United States. Patients will be enrolled in one of the three arms based on the clinician they are seeing as a part of their care.||||t
1335308|NCT03136354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335309|NCT03136341|Randomized|Crossover Assignment||Treatment||Triple|Videos will be randomly provided to an outside assessor to determine benefit as a secondary outcome measure|Participants are randomized to receive either study drug or placebo at the initial phase and cross over 12 weeks later and receive the alternative treatment|t||t|t
1335310|NCT03136328||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335311|NCT03136315||Single Group Assignment||Prevention||None (Open Label)||||||
1335312|NCT03136302|||Case-Only||Prospective|||||||
1335313|NCT03136289|||Other||Cross-Sectional|||||||
1335314|NCT03136276|Randomized|Parallel Assignment||Treatment||Double|double blind||t|||t
1335315|NCT03136263|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1335358|NCT03135704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335316|NCT03136250|Randomized|Parallel Assignment||Treatment||Triple|The participant, investigator and outcome assessor are not aware of which treatment group the participant/patient is placed in.|A randomized Controlled trial will be conducted in order to find and compare the effectiveness of conventional stretching and MET stretching (autogenic inhibition and reciprocal inhibition). One Control group (conventional group) and two Experimental groups (Experimental Group A - Autogenic Inhibition & Experimental Group B - Reciprocal Inhibition) will be formed. The participants will be recruited in the study if they meet the inclusion criteria using consecutive sampling from Fauji Foundation Hospital and randomized into the three respective groups. All the groups will receive the gold standard treatment for chronic neck pain including mobilization and modalities. In addition to the gold standard treatment the participants will receive specific stretching protocol based on their interventional group.|t||t|t
1335317|NCT03136237|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||3 parallel treatment assessments||||
1335318|NCT03136224|Non-Randomized|Parallel Assignment||Other||Single|Statistician was masked|Thermocautery group Plastic clamping group Classic (Surgical) circumcision group||||t
1335319|NCT03136211|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Cluster randomized controlled trial||||
1335320|NCT03136198|Randomized|Parallel Assignment||Treatment||Double|A central, independent, Core Lab will review all images.|||t|t|
1335321|NCT03136185||Single Group Assignment||Treatment||None (Open Label)||||||
1335322|NCT03136172|||Cohort||Prospective|||||||
1335323|NCT03136159||Single Group Assignment||Prevention||None (Open Label)||||||
1335324|NCT03136146||Single Group Assignment||Treatment||None (Open Label)||||||
1335325|NCT03136133|Randomized|Crossover Assignment||Treatment||Single|Protein drink With matching placebo|Crossover, placebo controlled|t|||
1335326|NCT03136120|||Cohort||Prospective|||||||
1335327|NCT03136107|Randomized|Parallel Assignment||Treatment||Single|The trained grader responsible for assessing Minimal Erythemal Dose of unprotected skin (MEDu) and Minimal Erythemal Dose of product treated (MEDp) at Visit 5 will be blinded to the product allocation of subjects. The trained grader responsible for assessing the provisional MEDu at Visit 3 will, necessarily, not be blinded since only one test site will be exposed to Ultraviolet (UV) radiation.|||||t
1335328|NCT03136094|Randomized|Parallel Assignment||Prevention||Single|Patients will not be given details about how text messaging differs for the 2 study groups. Instead, patients will be told that the clinic is testing a program to support people who are having hard times, and that they will receive periodic text messages from the Site Coordinator for the next 12 months.|The Investigators will conduct a randomized-control trial to test the effectiveness of an augmented Screening, Brief Intervention, and Referral to Treatment (SBIRT) model that includes sending caring text messages for 12 months after an at-risk patient is identified.|t|||
1335329|NCT03136081|||Case-Only||Prospective|||||||
1335330|NCT03136068|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1335331|NCT03136055||Single Group Assignment||Treatment||None (Open Label)||There are two parts of the study. In Part A, subjects are treated with pembrolizumab alone, and in Part B with pembrolizumab plus chemotherapy (physician's choice, paclitaxel or irinotecan). Adaptive Simon's two-stage design is used. The overall plan hinges on the activity of single agent pembrolizumab in the first stage of Part A. If there is sufficient activity in the first stage of Part A, the study will expand to the second stage of Part A and forgo Part B. If there is insufficient activity in the first stage of Part A, the study will proceed to the first stage of Part B (pembrolizumab plus chemotherapy).||||
1335332|NCT03136042|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients were randomized in first visits into crossover techniques: (i) hypertonic saline (3%) - HS technique; (ii) physiotherapy techniques (oscillatory positive expiratory pressure, forced expiration and acceleration of expiratory flow) - P technique; (iii) hypertonic saline + physiotherapy techniques - HSP technique. All children attended three visits and 90 samples were collected. All patients underwent induced sputum and pulmonary function before and after bronchodilator.||||
1335333|NCT03136029|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1335334|NCT03136016|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1335335|NCT03136003|Randomized|Crossover Assignment||Treatment||None (Open Label)|The randomization of the participant to a study arm will be done prior to the study visit by the pharmacy at the hospital. The Investigator and study team will know the arm each participant is in before the patient's visit. This information will also be provided to the participant before the visit.|||||
1335336|NCT03135990||Single Group Assignment||Treatment||None (Open Label)||Cognitive Behavioral Therapy||||
1335337|NCT03135977||Single Group Assignment||Prevention||None (Open Label)||||||
1335338|NCT03135964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335339|NCT03135951||Single Group Assignment||Treatment||None (Open Label)||||||
1335340|NCT03135938|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335341|NCT03135925||Single Group Assignment||Treatment||None (Open Label)||||||
1335342|NCT03135912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335343|NCT03135899|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1335344|NCT03135886|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This is a cluster randomized controlled trial (RCT) where approximately 51 sites will be randomly inducted into the study. Site randomization to condition will occur on a rolling basis in intervals of approximately 14-18 days. Selected sites will be invited to participate in the study and randomly assigned to one of the three conditions (described below).||||
1335345|NCT03135873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335346|NCT03135860||Single Group Assignment||Treatment||None (Open Label)||Exploratory Single Arm Study||||
1335347|NCT03135847||Single Group Assignment||Other||None (Open Label)||||||
1335348|NCT03135834|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1335349|NCT03135821|Randomized|Parallel Assignment||Treatment||Triple||Placebo vs Traditional Chinese Medication (TCM) Drug A,B,C,D|t||t|t
1335350|NCT03135808|||Cohort||Prospective|||||||
1335351|NCT03135795||Single Group Assignment||Screening||None (Open Label)||||||
1335352|NCT03135782||Single Group Assignment||Health Services Research||None (Open Label)||||||
1335353|NCT03135769||Single Group Assignment||Treatment||None (Open Label)||||||
1335361|NCT03135665||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335362|NCT03135652|Randomized|Parallel Assignment||Treatment||None (Open Label)||adjuvant radiotherapy:SBRT chemotherapy:mFolfox6/ CAPEOX/ Folfiri±cetuximab or bevacizumab||||
1335363|NCT03135639|Randomized|Crossover Assignment||Basic Science||Double|This is a double-blind study, meaning that neither the participant nor the experimenter knows what kind of stimulation the participant is receiving. An unblinded monitor (separate from the staff that interacts with the participant) is responsible for creating the stimulation codes that run each session and for ensuring that these codes worked correctly.|Each participant will receive sham stimulation or stimulation at their individual alpha frequency (8-12 Hz) during a study visit. The order is randomized (i.e., half of participants will receive sham stimulation during the first stimulation session and half will receive sham stimulation during the second stimulation session).|t||t|
1335364|NCT03135626|Randomized|Parallel Assignment||Treatment||Double||Split-mouth study design was used|t|||t
1335365|NCT03135613|Randomized|Factorial Assignment||Treatment||Single||The control group was recruited from healthy subjects. The experimental group was recruited from patients with tumor around knee after microwave ablation with plate internal fixation.||||t
1335366|NCT03135600|Randomized|Factorial Assignment||Basic Science||Single||||||t
1335367|NCT03135587|Randomized|Factorial Assignment||Basic Science||Single||||||t
1335368|NCT03135574|||Case-Only||Cross-Sectional|||||||
1335369|NCT03135561|Randomized|Parallel Assignment||Prevention||Single||||||t
1335370|NCT03135548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335371|NCT03135535||Single Group Assignment||Supportive Care||None (Open Label)||||||
1335372|NCT03135522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335373|NCT03135509|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1335374|NCT03135496|||Case-Control||Prospective|||||||
1335375|NCT03135483|||Cohort||Prospective|||||||
1335376|NCT03135470|||Cohort||Prospective|||||||
1335377|NCT03135457|Randomized|Crossover Assignment||Basic Science||Double|Masking of investigator is not possible due to nature of intervention.|Open-label, prospective cross-over randomized controlled trial.|t|t||
1335378|NCT03135444|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||Initially, health care providers will give feedback on the tool. The tool will be revised and the second segment of the study will be to give the revised tool to patients with pre- and post-tests which measure changes in prostate cancer screening knowledge.||||
1335379|NCT03135431|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two-arm randomized controlled trial||||
1335380|NCT03135418|Randomized|Parallel Assignment||Treatment||Double|"Both group will recevie conventional stroke rehabilitation. Intervention group will receive a Oculus Rift+Leap motion tracking supported upper extremity activities and control group will receive a sham virtual reality on focusing visual scenes without interaction.~Outcomes will be recorded by physical therapist using SPSS and groups would not be specified with letter. Statistical analysis will be conducted by another researcher who does not aware of groups given numbers on SPSS."|Patients' information and contact will be obtaioned from neurologist and willing participant's gender, age and stroke onset data will be processed with a random number generator. Patients will divide into two groups as intervention and control with a normal distrubution of gender, age and stroke onset.|t|||t
1335381|NCT03135405|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1335382|NCT03135392|Randomized|Parallel Assignment||Supportive Care||Single|"Participants who are having implant reconstruction will act as controls for all other breast reconstructions. If the participant is having autologous tissue reconstruction, she will be randomly put into one of the study groups. Neither the study doctor nor the participant can choose the treatment. Assignment is done randomly, like the flip of a coin. If the participant is having only one breast reconstructed, she will be randomly assigned to either receive the nerve reconstruction or not.~If the participant is having both of her breasts reconstructed, one side will receive the nerve reconstruction and one will not. The participant will not know which group you have been assigned to until the completion of the study or if voluntarily withdraw from the study"|This is a prospective cohort study|t|||
1335383|NCT03135379|Randomized|Parallel Assignment||Diagnostic||Single|A heat-resistant glove, ULine Terry Cloth Glove (Appendix F), will be used by the investigators to handle the ultrasound gels.||||t|
1335384|NCT03135366|Randomized|Parallel Assignment||Treatment||Double||"We will employ a randomized controlled trial (RCT) with 600 patients included in the treatment group and 600 patients included in the control group. We have selected this methodology for the following reasons:~RCTs are the gold-standard for providing evidence-based evaluation of medical interventions, and recommended when feasible.~Keheala is a new program, and cannot be studied using existing data.~We are working with researchers from Harvard's Program for Evolutionary Dynamics and Yale's Human Cooperation Lab, who have an established record of designing large-scale RCTs in real-world settings such as ours.~This sample size was chosen to achieve 80% power in detecting improvements of 7.5% or more in the relevant health outcomes. To do this calculation, we employed Monte Carlo simulations of patient outcomes, based on the Kenyan Ministry of Health's 2013 TB Case Findings Report.~Note: The sample size and outcomes were registered in December 2015 with the IRB."||t||t
1335385|NCT03135353|Non-Randomized|Sequential Assignment||Diagnostic||Single|||||t|
1335386|NCT03135340|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will be blinded to the treatment received.|Two groups. One interventional group and one control group with random allocation as described below.||||t
1335387|NCT03135327|||Cohort||Prospective|||||||
1335388|NCT03135314|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1335389|NCT03135301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335390|NCT03135288|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1335391|NCT03135275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335392|NCT03135262|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335393|NCT03135249||Single Group Assignment||Treatment||None (Open Label)||To determine if treatment with alemtuzumab after natalizumab maintains or reduces the ARR in patients with RRMS. The goal of this trial is to establish a disease-free state over a 24 months period in patients who received the natalizumab-alemtuzumab sequential therapy.||||
1335394|NCT03135236||Single Group Assignment||Treatment||None (Open Label)||||||
1335395|NCT03135223|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||One intervention and one control condition||||
1335396|NCT03135210|Randomized|Parallel Assignment||Treatment||None (Open Label)||24 total subjects will be recruited; 12 per group. Approximately 3-5 patients are admitted to UMMC each month who are undergoing ECMO and could be considered for study inclusion.||||
1335397|NCT03135197|||Cohort||Prospective|||||||
1335398|NCT03135184||Single Group Assignment||Treatment||None (Open Label)||Prospective, unblinded, interventional study||||
1335399|NCT03135171||Single Group Assignment||Treatment||None (Open Label)||||||
1335400|NCT03135158|||Cohort||Prospective|||||||
1335401|NCT03135145|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||This is a single group repeated measures cross-over design. The study will include 4 sessions for each participant, with 2 sessions conducted using the Lite Run and 2 sessions conducted using the method of choice of the therapist (Usual Treatment).||||
1335402|NCT03135132|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1335403|NCT03135119|Randomized|Parallel Assignment||Treatment||Single|All individuals collecting and/or handling data will be masked.|||||t
1335404|NCT03135106|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1335405|NCT03135093|||Other||Cross-Sectional|||||||
1335406|NCT03135080|Randomized|Parallel Assignment||Health Services Research||Single|At the end of the rainy season, an independent examiner (not involved in the HEAD START evaluations) will assess the first 1-2 surgeries of the season of all study participants. The assessor will not know whether surgeons had participated in the long-term HEAD START training over the rainy season.|All study participants will have their skill levels on live surgery evaluated at the end of surgical training and again at the start of the surgical season, approximately 6 months later. Fifteen trainees will participate in long-term HEAD START practice and receive feedback throughout this break during the rainy season when surgical activity is low. An additional 15 individuals will be selected for the trainer to assess their skill levels on live surgery at the end of training and again at the start of the surgical season this fall but will not receive additional surgical practice.||||t
1335407|NCT03135067|Randomized|Parallel Assignment||Prevention||None (Open Label)||Female sex worker hotspots and beach communities in the Nyanza region of Kenya will be grouped into clusters that will be randomly assigned to receive the intervention (provision of multiple HIV self-test kits over time) or control (provision of clinic-based HIV testing referral vouchers over time). About 66 clusters, with an average of 30 participants per cluster, will be selected for the study.||||
1335408|NCT03135054||Single Group Assignment||Treatment||None (Open Label)||||||
1335409|NCT03135041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335410|NCT03135028|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1335411|NCT03135015|Randomized|Crossover Assignment||Treatment||Quadruple|Capsule treatments will be fully blinded. Tablet treatments will be open label.|Each subject in 2 subject groups will undergo each of 6 treatments|t|t|t|t
1335412|NCT03135002|||Cohort||Retrospective|||||||
1335413|NCT03134989||||||||||||
1335414|NCT03134976|||Cohort||Prospective|||||||
1335415|NCT03134963|||Case-Control||Prospective|||||||
1335416|NCT03134950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335417|NCT03134937||Single Group Assignment||Diagnostic||None (Open Label)||Every participant will recieve one HFHHNO session, will get 30 mins of oxygen up to 60-70 L/min.||||
1335418|NCT03134924|Randomized|Parallel Assignment||Prevention||Triple|The study statistician did not participate in randomization and the recruiter and laboratory personnel were blinded to the condition assignment. The participant was blind to their condition assignment. The reading of all the slides used to diagnose BV was performed by one trained laboratory technician blinded to the participant condition assignment. In case of unclear reading, the slide was reviewed by a second technician and the chief of the laboratory until an agreement was achieved; both the second technician and the chief of the laboratory were blind to the condition assignment of the participant.|The interventional study model used a parallel design, where an enhanced standard of care and intervention were used.|t||t|t
1335419|NCT03134911|||Other||Cross-Sectional|||||||
1335420|NCT03134898|||Cohort||Prospective|||||||
1335421|NCT03134885|||Cohort||Prospective|||||||
1335422|NCT03134872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335423|NCT03134859|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1335424|NCT03134846|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Phase 1: 3x3 Dose-escalation with 3 different doses Cetuximab-IRDye800CW Phase 2: Prospective cross sectional diagnostic study. After having established the optimal cetuximab-IRDye800CW dose we will extent the study by including up to 70 patients.||||
1335425|NCT03134833|Randomized|Factorial Assignment||Prevention||Single||||||t
1335426|NCT03134820|||Cohort||Prospective|||||||
1335427|NCT03134807|||Cohort||Prospective|||||||
1335428|NCT03134794|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1335429|NCT03134781|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1335430|NCT03134768|||Cohort||Cross-Sectional|||||||
1335431|NCT03134755|||Case-Only||Prospective|||||||
1335432|NCT03134742|||Cohort||Prospective|||||||
1335477|NCT03134157|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335478|NCT03134144|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1335479|NCT03134131||||||||||||
1335480|NCT03134118||Single Group Assignment||Treatment||None (Open Label)||||||
1335580|NCT03132805|Randomized|Factorial Assignment||Prevention||Single|Outcome assessors are blind to intervention status.|Schools are randomly assigned to 1 of 3 conditions, control, universal classroom-based preventive intervention, and universal classroom-based intervention plus an indicated preventive intervention. Data on student outcomes to be collected at pre- post- and 6 month follow-up.||||t
1335581|NCT03132792||Single Group Assignment||Treatment||None (Open Label)||||||
1335582|NCT03132779||Single Group Assignment||Treatment||None (Open Label)||Women with unexplained recurrent spontaneous abortions having increased NKcells activity||||
1577417|NCT00001895||||Treatment||||||||
1335433|NCT03134729|Randomized|Parallel Assignment||Treatment||Double|"Given the trial Design, it would be impossible to blind the caregiver about the type of treatment.~Serratus Plan Block will be performed after the induction of General Anesthesia, the patients will thus be unaware wether being assigned to the Experimental or Control Arm.~Clarification (May 28, 2018):~Nurses assess NRS (Pain Perception) and directly manage rescue doses delivery~Physiotherapists deliver rehab. respiratory exercises and directly assess patient's performance.~Since their reports are directly elicited in Clinical Report Forms, they are considered outcome assessors.~Both Nurses and Physiotherapists are unaware of treatment allocation."|"Eligible patients will be randomized between two groups:~Systemic analgesic therapy only (Endovenous/ Oral)~Systemic analgesic therapy plus loco regional therapy administered under Us. guidance before the procedure (Serratus Plane Block).~Allocation to one treatment group or another will be randomized with the aim of create two unbiased groups formed out of the same group of patients. Randomization will be provided by a software. Group allocation and treatment is overt to the investigators, but not to the patient."|t|||t
1335434|NCT03134716|||Case-Control||Prospective|||||||
1335435|NCT03134703|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335436|NCT03134690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335437|NCT03134677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335438|NCT03134664|Randomized|Parallel Assignment||Treatment||None (Open Label)||Forty patients with femoral neck fractures admitted at Pudong Hospital of Fudan University, China are randomly divided into two groups.||||
1335439|NCT03134651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335440|NCT03134638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1335441|NCT03134625|||Cohort||Prospective|||||||
1335442|NCT03134612|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1335443|NCT03134599|Randomized|Crossover Assignment||Treatment||Single|||t|||
1335444|NCT03134586||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335445|NCT03134573|||Cohort||Prospective|||||||
1335446|NCT03134560|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335447|NCT03134547|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1335448|NCT03134534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335449|NCT03134521|||Cohort||Retrospective|||||||
1335450|NCT03134508|||Cohort||Retrospective|||||||
1335451|NCT03134495|||Cohort||Retrospective|||||||
1335452|NCT03134482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335453|NCT03134469|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1335454|NCT03134456||Single Group Assignment||Treatment||None (Open Label)||||||
1335455|NCT03134443|Randomized|Parallel Assignment||Treatment||Single||Experimental group: Routine treatment for acute tonsillitis + Xiyanping injection Contral group: Routine treatment for acute tonsillitis + Xiyanping injection simulation(0.9% normal saline)|t|||
1335456|NCT03134430|Randomized|Parallel Assignment||Treatment||Quadruple||the patients in treatment group will received reginoal nerve block with 0.35% Ropivacane and 0.5% lidocaine in normal saline under ultrasound guide, while those in control group received equal volume of normal saline.|t|t|t|t
1335457|NCT03134417|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1335458|NCT03134404|||Cohort||Prospective|||||||
1335459|NCT03134391|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1335460|NCT03134378|Randomized|Parallel Assignment||Treatment||Quadruple|Randomized-double blinded Clinical Trials||t|t|t|t
1335461|NCT03134365|Randomized|Crossover Assignment||Other||Single||||||t
1335462|NCT03134352|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335463|NCT03134339|Randomized|Crossover Assignment||Basic Science||Double|Participant and Investigator will not know nicotine dose or rate of infusion.|The effects of different IV nicotine delivery rates of (saline), 0.24, 0.048 and 0.024 mcg/kg/s), as a within-subject factor, on peak change in the intensity of subjective effects as measured by the DEQ, will be used as a measured of a reinforcing threshold.|t||t|
1335464|NCT03134326||Single Group Assignment||Other||||||||
1335465|NCT03134313||Single Group Assignment||Other||None (Open Label)||||||
1335466|NCT03134300|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||2 groups for the same intervention (AT), one from low SES, one from high SES. Cytokine draw periprocedurally, and 3 weeks post procedure||||
1335467|NCT03134287|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1335468|NCT03134274||Single Group Assignment||Health Services Research||None (Open Label)||Assess usability and preference of digital home urine testing with pregnant women. 300 pregnant women will be given a test kit and smartphone application during a clinic visit. Participants are instructed to conduct the test the next day. After conducting the urine test home participants fill out a survey assessing the satisfaction with digital home urine testing.||||
1335469|NCT03134261|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||"Study participants will be allocated to the ongoing project arm at the time of enrollment."||||
1335470|NCT03134248|Randomized|Crossover Assignment||Other||Double|||t||t|
1335471|NCT03134235||Single Group Assignment||Treatment||None (Open Label)||Repeated measures, single group design.||||
1335472|NCT03134222|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335473|NCT03134209|Randomized|Parallel Assignment||Treatment||None (Open Label)||Zipper surgical skin closure device applied to the most superficial layer of skin following a joint arthroplasty will be compared to two groups: 1) Monocryl + Dermabond 2) Polyester mesh + Dermabond||||
1335474|NCT03134196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335475|NCT03134183|Randomized|Parallel Assignment||Treatment||Triple|Computer-generated randomization will be utilized to assign treatment arms and the vaginal misoprostol and buccal placebo and buccal misoprostol and vaginal placebo will be prepared according to randomization scheme by the research pharmacy in opaque-sealed envelopes as to blind participants and providers.||t|t|t|
1335476|NCT03134170|Randomized|Crossover Assignment||Treatment||None (Open Label)||Patients are randomized to the control or intervention group. After 12 months patients in the control group who do not have well controlled diabetes may be crossed over to the interventiobn gorup||||
1577418|NCT00001894||||Treatment||||||||
1335481|NCT03134105|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will enroll patients with recent myocardial infarction being seen in cardiology clinics. All patients will receive wearable fitness trackers and apps that capture this data and transmit it to the coordinating center; patients will also provide information on angina frequency every other week via emailed surveys. Sites will be randomized to have their providers receive either monthly updates on step count and patient reported angina or a single report at the end of the study period. Providers receiving monthly reports will receive a single report with data for each of their patients participating in the study along with summary data for their practice and all patients participating in the study.||||
1335482|NCT03134092|Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1335483|NCT03134079|Randomized|Crossover Assignment||Other||Single|Subjects were blind to what version (recipe) of the taste test item they were tasting.|Subjects were asked to taste test 3 versions of test items (in randomized order) and provide a liking score for each (tastings of each recipe were done on separate occasions separated by one week)|t|||
1335484|NCT03134066|||Cohort||Prospective|||||||
1335485|NCT03134053|Randomized|Parallel Assignment||Treatment||Single||||||t
1335486|NCT03134040|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335487|NCT03134027|||Cohort||Prospective|||||||
1335488|NCT03134014|Randomized|Parallel Assignment||Other||Single|||t|||
1335489|NCT03134001|Randomized|Sequential Assignment||Treatment||None (Open Label)||Study includes 2 groups: test group comprised patients receiving oral analgesics via the PCoA™ Acute and control group of nurse providing analgesics.||||
1335490|NCT03133988||||||||||||
1335491|NCT03133975|Randomized|Parallel Assignment||Treatment||Double|double blinded|Randomized clinical trial VITAMIN D for treatment of dyslipedemia|t||t|
1335492|NCT03133962||Single Group Assignment||Other||None (Open Label)||||||
1335493|NCT03133949|||Case-Control||Retrospective|||||||
1335494|NCT03133936||Single Group Assignment||Basic Science||None (Open Label)||||||
1335495|NCT03133923|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1335496|NCT03133910|||Cohort||Prospective|||||||
1335497|NCT03133897|Randomized|Parallel Assignment||Other||Double|||||t|t
1335498|NCT03133884|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1335499|NCT03133871|||Other||Cross-Sectional|||||||
1335500|NCT03133858|||Cohort||Prospective|||||||
1335501|NCT03133845|Randomized|Parallel Assignment||Treatment||Single||||||t
1335502|NCT03133832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335503|NCT03133819||Single Group Assignment||Prevention||None (Open Label)||||||
1335504|NCT03133806||Single Group Assignment||Treatment||None (Open Label)||The study is a multicenter, prospective, single arm design.||||
1335505|NCT03133793|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335506|NCT03133780|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1335507|NCT03133767|Randomized|Parallel Assignment||Treatment||Double|Fluid being administered to participants will be covered by an opaque bag. The investigator calling the participant for follow-up does not know how the participant was allocated.||t|||t
1335508|NCT03133754|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335509|NCT03133741|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1335510|NCT03133728|||Other||Other|||||||
1335511|NCT03133715|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to receive either laparoscopic or robot-assisted repair of ventral hernia.||||
1335512|NCT03133702|||Cohort||Retrospective|||||||
1335513|NCT03133689|||Cohort||Prospective|||||||
1335514|NCT03133676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335515|NCT03133663|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1335516|NCT03133650||Single Group Assignment||Treatment||None (Open Label)||||||
1335517|NCT03133637||Single Group Assignment||Treatment||None (Open Label)||||||
1335518|NCT03133624|||Cohort||Prospective|||||||
1335519|NCT03133611|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1335520|NCT03133598|||Cohort||Prospective|||||||
1335521|NCT03133585|||Cohort||Prospective|||||||
1335522|NCT03133572|Randomized|Parallel Assignment||Treatment||Single|The neonatologists assessing the Thompson score will be blinded to the intervention arm. Other staff members will know about the arm allocation.|Day by day, infants will be randomized to either of the arms.||||t
1335523|NCT03133559|||Case-Control||Prospective|||||||
1335524|NCT03133546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335525|NCT03133533|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to receive either laparoscopic or robot-assisted repair of inguinal hernia.||||
1335526|NCT03133520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335527|NCT03133507|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1335528|NCT03133494|Randomized|Parallel Assignment||Screening||Double||Arterial blood gas sample was drawn from both the groups and analysed for any change in the desired parameters|t||t|
1335529|NCT03133481|Randomized|Parallel Assignment||Treatment||Single||"The first two groups will have 50 participants each (100 total) the Adductor Canal Nerve Catheter group and the Femoral Nerve Catheter, group. Participants will be randomized using block randomization. The blocks will be assigned randomly based on computer generated numbers."|t|||
1335530|NCT03133468|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1335531|NCT03133455||Single Group Assignment||Other||None (Open Label)||||||
1335571|NCT03132922||Single Group Assignment||Treatment||None (Open Label)||||||
1335572|NCT03132909|||Cohort||Prospective|||||||
1335573|NCT03132896|||Cohort||Prospective|||||||
1335574|NCT03132883|||Cohort||Retrospective|||||||
1335575|NCT03132870|||Cohort||Retrospective|||||||
1335576|NCT03132857|||Cohort||Prospective|||||||
1335577|NCT03132844|||Cohort||Prospective|||||||
1335578|NCT03132831|||Cohort||Retrospective|||||||
1335579|NCT03132818|||Case-Control||Prospective|||||||
1577793|NCT00001166||||||||||||
1335532|NCT03133442|Randomized|Crossover Assignment||Basic Science||Double|"Blinding of the participants is impossible, as the stimulation is easy to perceive and cannot be confused with a baseline night. Therefore, participants are informed about the character of the night (max. 5 minutes) before the moment of lights off. For safety reasons the experimenter that is present is also aware of the condition.~However, data is stored in a coded way, so that during data analysis the experimenter is not aware of the condition."|The study has a two-by-two cross-over design. Participants spend two consecutive baseline nights (without stimulation) and two consecutive movement nights (with stimulation) in the laboratory. The order of baseline and movement nights is randomized.|||t|t
1335533|NCT03133429||Single Group Assignment||Treatment||None (Open Label)||||||
1335534|NCT03133416|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335535|NCT03133390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335536|NCT03133377|Randomized|Parallel Assignment||Prevention||Single||||||t
1335537|NCT03133364|Randomized|Parallel Assignment||Prevention||Triple|"Participants are randomized to the control group (C) and intervention group (I) using the programme Research randomizer. The main supervisor will manage the randomization.~Participants are blinded to whether they receive the control or intervention menu. Each menu will daily consist of a main meal and a between-meal."|"2-armed randomized controlled study which in total runs 12 weeks.~It has been calculated that 106 participants should be completed. With the risk of loss, 150 elderly are screened and invited to join the study, whereas 120 elderly should be included.~Fifty participants are randomized to receive a control menu for 12 weeks and fifty participants are randomized to receive an intervention menu for 12 weeks.~To enhance subject compliance and avoid treatment group contamination the randomization will be done in blocks where each of the 8 departments of the nursing home is randomized to either the Control or Intervention group."|t|t|t|
1335538|NCT03133351|||Cohort||Prospective|||||||
1335539|NCT03133338|||Cohort||Cross-Sectional|||||||
1335540|NCT03133325||Single Group Assignment||Other||None (Open Label)||||||
1335541|NCT03133312|Randomized|Parallel Assignment||Treatment||Triple|Participant will not know which group they have been assigned to. The surgeon and OR staff performing the vaginal preparation will know, but the nursing staff in the recovery area will not. The lab will be blinded toward which type of surgical prep was used.|"Drug: Chlorhexidine Gluconate Applied to vagina pre-operatively for antiseptic; regulated as a drug by FDA~Other Name: CHG~Drug: Povidone-Iodine Scrub and Paint Applied to vagina pre-operatively for antiseptic; regulated as a drug by FDA~Other Name: Betadine"|t|t||t
1335542|NCT03133299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335543|NCT03133286|||Cohort||Prospective|||||||
1335544|NCT03133273|Randomized|Parallel Assignment||Other||Single|The result of Oncogramme® will not give to the patient.|"Patients corresponding to the inclusion criteria and having a histologically proven metastatic CRC on biopsies or primary tumor excision and / or one or more metastatic sites will be recruited prospectively and randomized into two groups.~Usual care group: no Oncogramme will be made.~Oncogramme group: Taking of tumor fragments on the histological piece by an anatomopathological physician at the time of the histological examination and placing samples in the transport medium. The Oncogramme will be performed by Oncomedics on all specimens. Results will be returned to clinicians within 15 days.~For both groups, the adjuvant treatment will be decided in the multidisciplinary consultation meeting (MCM), according to the recommendations in force and adapted to the general medical condition of the patient. For patients in the Oncogramme group, chemotherapy will be adapted to Oncogramme."|t|||
1335545|NCT03133260|||Cohort||Prospective|||||||
1335546|NCT03133247||Single Group Assignment||Treatment||None (Open Label)||||||
1335547|NCT03133234|||Cohort||Retrospective|||||||
1335548|NCT03133221||Single Group Assignment||Treatment||None (Open Label)||||||
1335549|NCT03133208|||Cohort||Prospective|||||||
1335550|NCT03133195|Randomized|Parallel Assignment||Treatment||Quadruple|double blind, placebo-controlled|The patients will be randomized in 1:1 ratio to receive Teriparatide or placebo|t|t|t|t
1335551|NCT03133182|||Cohort||Retrospective|||||||
1335552|NCT03133169|||Cohort||Cross-Sectional|||||||
1335553|NCT03133156|Randomized|Factorial Assignment||Basic Science||None (Open Label)||The current research will consist of 2 different exercise training protocols. Subjects will be randomized into each Arm based on screening criteria and compared to the control (Arm 1)||||
1335554|NCT03133143|Randomized|Parallel Assignment||Supportive Care||Triple|The sequences of allocation will be concealed until interventions will be assigned. Allocation will not be masked to the researchers, who will recruit patients. Outcome assessors (who will not participate in patient randomisation or daily clinical treatment at the same unit) will be masked. The data analyst (the trial statistician) will be kept blinded to the allocation. Allocation: Randomized The trial manager will allocate the patient to one of the three arms of the trial based on a list of computer-generated random numbers (provided by an external clinical trial randomisation service).|A controlled, single-blind clinical trial with a pragmatic, three-arm parallel-group design.|t|t||t
1335555|NCT03133130|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335556|NCT03133117||Single Group Assignment||Basic Science||None (Open Label)||||||
1335557|NCT03133104|||Cohort||Retrospective|||||||
1335558|NCT03133091|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335559|NCT03133078|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1335560|NCT03133065|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335561|NCT03133052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335562|NCT03133039|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335563|NCT03133026|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1335564|NCT03133013|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1335565|NCT03133000|||Cohort||Prospective|||||||
1335566|NCT03132987||Single Group Assignment||Treatment||None (Open Label)||Physical therapy exercises (progressive strengthening program)||||
1335567|NCT03132974|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335568|NCT03132961|||Cohort||Prospective|||||||
1335569|NCT03132948||Single Group Assignment||Supportive Care||None (Open Label)||||||
1335570|NCT03132935|||Other||Retrospective|||||||
1577794|NCT00001165||||Treatment||||||||
1335583|NCT03132766|Randomized|Sequential Assignment||Prevention||None (Open Label)||SMART Design||||
1335584|NCT03132753|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335585|NCT03132740|||Cohort||Prospective|||||||
1335586|NCT03132727|||Cohort||Prospective|||||||
1335587|NCT03132714|Randomized|Parallel Assignment||Treatment||Single||||||t
1335588|NCT03132701|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1335589|NCT03132688|||Case-Only||Retrospective|||||||
1335590|NCT03132675||Single Group Assignment||Treatment||None (Open Label)|Blinded Independent Central Review|Phase 2, Simon 2-stage, non-comparative, open-label, single-arm, multicenter study||||
1335591|NCT03132662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335592|NCT03132649|||Cohort||Prospective|||||||
1335593|NCT03132636|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335594|NCT03132623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335595|NCT03132610|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335596|NCT03132597|Randomized|Crossover Assignment||Prevention||None (Open Label)||"This is an intervention protocol using a randomized controlled clinical trial with cross-over, in order to compare if the implementation of mindfulness for first year medical students will improve their mental health and quality of life in the short term (3 months).~The intervention group will be exposed to mindfulness in the beginning of the medical course and will be compared to a control group, not exposed to mindfulness (exposed to theoretical classes) for 3 months. After that, the intervention group will receive theoretical classes and the control group will be exposed to the mindfulness techniques for 3 months (cross-over). Therefore, both groups will be exposed to mindfulness in the first year of undergraduation. Then, all first year medical students exposed to mindfulness will be compared to another class, which didn't have this mindfulness mandatory course in their formation. They will be compared after 6 months and after one-year of intervention (long-term effect)."||||
1335597|NCT03132584||Single Group Assignment||Treatment||None (Open Label)||This is a phase I study in the standard 3+3 dose escalation design||||
1335598|NCT03132571|Randomized|Parallel Assignment||Treatment||Quadruple|Naltrexone versus Placebo assignment will remain double-blinded for the duration of the study; Bupropion dosing will be open-label and not masked to either participant or investigator.||t|t|t|t
1335599|NCT03132558|||Cohort||Prospective|||||||
1335600|NCT03132545|||Case-Control||Prospective|||||||
1335601|NCT03132532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335602|NCT03132519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335603|NCT03132506|||Other||Prospective|||||||
1335604|NCT03132493|||Cohort||Retrospective|||||||
1335605|NCT03132480||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1335606|NCT03132467||Single Group Assignment||Treatment||None (Open Label)||||||
1335607|NCT03132454|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335608|NCT03132441||Single Group Assignment||Supportive Care||None (Open Label)||Single arm pilot study||||
1335609|NCT03132428|||Cohort||Retrospective|||||||
1335610|NCT03132415|Randomized|Parallel Assignment||Prevention||Single|||t|||
1335611|NCT03132402|||Cohort||Prospective|||||||
1335612|NCT03132389|||Cohort||Prospective|||||||
1335613|NCT03132376||Single Group Assignment||Prevention||None (Open Label)||||||
1335614|NCT03132363||||||||||||
1335615|NCT03132350||||||||||||
1335616|NCT03132337|||Cohort||Prospective|||||||
1335617|NCT03132324|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335618|NCT03132311|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335619|NCT03132298|Randomized|Parallel Assignment||Prevention||Triple||Participants (N=96), ages 12-15 will be randomized to receive one of two a 30-minute, computer-based programs: (1) a 'growth mindset' program, teaching that personal traits and characteristics are malleable; or (2) a control program, designed to mimic 'supportive therapy,' teaching the value of sharing one's feelings with close others.|t||t|t
1335620|NCT03132285||Single Group Assignment||Prevention||None (Open Label)||||||
1335621|NCT03132272||Single Group Assignment||Treatment||None (Open Label)||||||
1335622|NCT03132259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335623|NCT03132246||Single Group Assignment||Diagnostic||Double|The intervention (blood draws) is not masked - every participant and care provider will know that the study uses blood draws to test for the biofilm associated with surgical site infections. But, the results of the blood tests will be masked - neither the patient or the care provider will be informed of the results.||t|t||
1335624|NCT03132233|Randomized|Crossover Assignment||Prevention||Triple|Double-blind||t||t|t
1335625|NCT03132220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335626|NCT03132207|||Cohort||Prospective|||||||
1335627|NCT03132194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335628|NCT03132181|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335629|NCT03132168||Single Group Assignment||Other||None (Open Label)|No masking|All consented subjects will be undergoing elective, scheduled surgeries with standardized anesthesia regimen per protocol. Each participant will complete surveys and procedures as outlined per protocol.||||
1335630|NCT03132155||Single Group Assignment||Treatment||None (Open Label)||||||
1335631|NCT03132142|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1335632|NCT03132129|||Case-Control||Cross-Sectional|||||||
1335633|NCT03132116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335634|NCT03132103|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1335635|NCT03132090|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1335636|NCT03132077|||Cohort||Retrospective|||||||
1335637|NCT03132064|||Cohort||Prospective|||||||
1335638|NCT03132051||Single Group Assignment||Treatment||None (Open Label)||All patients received steroid injection for carpel tunnel syndrome (CTS) and ultrasonographic evaluation before and after steroid injection||||
1335639|NCT03132038||Single Group Assignment||Treatment||None (Open Label)||||||
1335640|NCT03132025|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335641|NCT03132012|Randomized|Parallel Assignment||Prevention||Single|||t|||
1335642|NCT03131999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335643|NCT03131986|||Case-Only||Prospective|||||||
1335644|NCT03131973|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1335645|NCT03131960|Randomized|Parallel Assignment||Treatment||Quadruple|Participants, therapists (care providers), investigators, and outcomes assessors do not know which group (VNS or control VNS) the patients are randomized. Only one person at the site - the programmer who programs the device settings - knows which group the subject is randomized into.|Double blind, randomized, parallel study with partial crossover (control subjects crossover to treatment after randomized portion)|t|t|t|t
1335646|NCT03131947|||Other||Prospective|||||||
1335647|NCT03131934||Single Group Assignment||Treatment||None (Open Label)||||||
1335648|NCT03131921|||Case-Control||Cross-Sectional|||||||
1335649|NCT03131908||Single Group Assignment||Treatment||None (Open Label)||||||
1335650|NCT03131895|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1335651|NCT03131882|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1335652|NCT03131869|||Cohort||Prospective|||||||
1335653|NCT03131856|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients were randomized to either the intervention group or control group.||||
1335654|NCT03131843|Randomized|Parallel Assignment||Treatment||Triple|Participants, parents, care providers and outcomes assessors will not be aware of whether the participant was swabbed in the location of the vaccine injection. Only the investigator will know where alcohol was applied on the skin relative to the vaccine injection site.|Parallel randomized controlled trial|t|t||t
1335655|NCT03131830|||Other||Prospective|||||||
1335656|NCT03131817||Single Group Assignment||Treatment||None (Open Label)||||||
1335657|NCT03131804||Single Group Assignment||Health Services Research||None (Open Label)||||||
1335658|NCT03131791|Randomized|Parallel Assignment||Treatment||Double||group A : shock wave, group B: Botulinum Toxin Injection|||t|t
1335659|NCT03131778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335660|NCT03131765||Single Group Assignment||Treatment||None (Open Label)||YS-ON-001 is a single agent used for this study||||
1335661|NCT03131752|Randomized|Parallel Assignment||Treatment||Single||||||t
1335662|NCT03131739|||Ecologic or Community||Cross-Sectional|||||||
1335663|NCT03131726|Randomized|Parallel Assignment||Treatment||Single|||||t|
1335664|NCT03131713|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335665|NCT03131700|Randomized|Parallel Assignment||Other||Double|||t||t|
1335666|NCT03131687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335667|NCT03131674|Randomized|Parallel Assignment||Treatment||Triple||"We use a delayed treatment design, where both groups receive the same treatment.~One group receives the treatment immediately after the inclusion. The other group receives the treatment after a 9-weeks delay."|t|t||t
1335668|NCT03131661|||Cohort||Prospective|||||||
1335669|NCT03131648|Randomized|Parallel Assignment||Treatment||Double|"Neither the subject nor any of the investigator or LEO staff who are involved in the treatment or clinical evaluation and monitoring of the subjects will be aware of the treatment received. The packaging and labelling of the IMPs will contain no evidence of their identity.~Since tralokinumab and placebo are visually distinct and not matched for viscosity, IMP will be handled and administered by a qualified, unblinded HCP at the site who will not be involved in the management of trial subjects and who will not perform any of the assessments."||t||t|
1335670|NCT03131635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335671|NCT03131622|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335672|NCT03131609|||Cohort||Prospective|||||||
1335673|NCT03131596|Randomized|Parallel Assignment||Prevention||Single|||t|||
1335674|NCT03131583||Single Group Assignment||Treatment||None (Open Label)||||||
1335675|NCT03131570|Randomized|Parallel Assignment||Treatment||Quadruple||To compare the secukinumab-receiving mild psoriasis subjects (Group 1) and the placebo-receiving mild psoriasis subjects (Group 2).|t|t|t|t
1335676|NCT03131557|Randomized|Crossover Assignment||Treatment||Single||Phonak Audéo B and a line extension of the Phonak Audéo B hearing aid product family will be fitted to the participants individual hearing loss.|t|||
1335677|NCT03131544||Single Group Assignment||Treatment||None (Open Label)||||||
1335678|NCT03131531|||Cohort||Prospective|||||||
1335679|NCT03131518|Randomized|Crossover Assignment||Basic Science||None (Open Label)||All participants in the intervention group (n=18) will complete the following intervention arms in random order: (i) 3 months access to an e-bicycle with trailer (n=6), (ii) 3 months access to a longtail bicycle (n=6), and (iii) 3 months access to a regular bicycle with trailer (n=6), in total 9 months. Also, a control group (n=18) maintaining usual transportation and PA habits will be included.||||
1335680|NCT03131505|||Other||Prospective|||||||
1335681|NCT03131492|||Cohort||Prospective|||||||
1335682|NCT03131479|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335683|NCT03131466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335684|NCT03131453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335685|NCT03131440|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1335686|NCT03131427|||Cohort||Prospective|||||||
1335687|NCT03131414|||Cohort||Prospective|||||||
1335688|NCT03131401|||Ecologic or Community||Cross-Sectional|||||||
1335689|NCT03131388|||Cohort||Cross-Sectional|||||||
1335690|NCT03131375|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1335691|NCT03131362|||Cohort||Prospective|||||||
1335692|NCT03131349|||Case-Control||Cross-Sectional|||||||
1335693|NCT03131336|Randomized|Parallel Assignment||Treatment||Double||Prospective, interventional, randomized, controlled, double-blind, parallel group|t||t|
1335694|NCT03131323|||Case-Only||Cross-Sectional|||||||
1335695|NCT03131310|||Case-Only||Other|||||||
1335696|NCT03131297||Single Group Assignment||Other||None (Open Label)||||||
1335697|NCT03131284|Randomized|Parallel Assignment||Prevention||Single|||||t|
1335698|NCT03131271|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335699|NCT03131258||Single Group Assignment||Treatment||None (Open Label)||||||
1335700|NCT03131245|||Case-Only||Prospective|||||||
1335701|NCT03131232|||Cohort||Prospective|||||||
1335702|NCT03131219||Single Group Assignment||Treatment||None (Open Label)||||||
1335703|NCT03131206|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335704|NCT03131193|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1335705|NCT03131180|Randomized|Parallel Assignment||Other||None (Open Label)||This trial is a single center randomized controlled trial to investigate the ability of the RLHS to improve patient-centered outcomes in pediatric patients with complex colorectal diseases. Patients and caregivers are randomized to either receive access to a website that displays the colorectal RLHS dashboard prior to standard consultation or to standard consultation alone.||||
1335706|NCT03131167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335707|NCT03131154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335708|NCT03131141|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|open label|||||
1335709|NCT03131128|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|The researchers will explain the purpose and steps of the study to all the participants and get their informed consent.|The workers with overweight or obesity provided by the company will be randomly assigned to Group A (by MBI) or Group B (by the intervention of health education).||||
1335710|NCT03131115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335711|NCT03131102|||Cohort||Prospective|||||||
1335712|NCT03131089|||Cohort||Prospective|||||||
1335713|NCT03131076|||Cohort||Prospective|||||||
1335714|NCT03131063|||Case-Only||Prospective|||||||
1335715|NCT03131050|Randomized|Parallel Assignment||Treatment||Quadruple||GROUP 1: The patients received intramuscular injection treatment of scopolamine (0.3 mg/ml) at 9 am and 0.9% saline treatment at 3pm. GROUP 2: The patients received intramuscular injection treatment of scopolamine (0.3 mg/ml) at 9 am and 3 PM. GROUP 3: The patients received intramuscular injection treatment of 0.9% saline (1 ml) at 9 am and 3 PM.|t|t|t|t
1335716|NCT03131037||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1335717|NCT03131024|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1335718|NCT03131011|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1335719|NCT03130998|Randomized|Parallel Assignment||Treatment||Single||The study design is a cluster (cluster = clinical practice) randomized trial of FHTs participating in the STOP program. FHTs in the STOP program will be randomly allocated 1:1 to receive either generalized messages (related to depression and smoking) exclusively via email (Group A) or be assigned an eKB who provides personalized support through phone- and email-based check-ins (Group B). Academic affiliation and cluster size will be treated as balancing factors in a stratified allocation or as covariates in the statistical analyses.|||t|
1335720|NCT03130985|||Cohort||Prospective|||||||
1335721|NCT03130972|||Cohort||Retrospective|||||||
1335722|NCT03130959|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335723|NCT03130946|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Two arm, prospective, open label study||||
1335724|NCT03130933|Randomized|Parallel Assignment||Prevention||Quadruple|There was 400 participiants, patients and the same oral surgeon|A RANDOMIZED CONTROLLED TRIAL|t|t|t|t
1335725|NCT03130920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335726|NCT03130907|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1335727|NCT03130894|||Case-Control||Cross-Sectional|||||||
1335728|NCT03130881||Single Group Assignment||Treatment||None (Open Label)||||||
1335729|NCT03130868|||Cohort||Prospective|||||||
1335730|NCT03130855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335731|NCT03130842|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335732|NCT03130829|Randomized|Parallel Assignment||Supportive Care||Quadruple||Randomized, double-blind, multicenter study|t|t|t|t
1335733|NCT03130816||Single Group Assignment||Treatment||None (Open Label)||Patients diagnosed with cerebral palsy volunteered for participation in this study.||||
1335734|NCT03130803|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1335735|NCT03130790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335736|NCT03130777||Single Group Assignment||Treatment||None (Open Label)||Single arm, prospective, multi-center study||||
1335737|NCT03130764||Single Group Assignment||Treatment||None (Open Label)||||||
1335738|NCT03130751||Single Group Assignment||Supportive Care||None (Open Label)||||||
1335739|NCT03130738|Randomized|Parallel Assignment||Treatment||Quadruple|Subjects, investigators, and study staff will not be masked as to the treatment duration assigned to each subject (7 versus 14 days). For subjects receiving the 14-day treatment with study drug, the contents of the study drug (active versus placebo) will be masked to the subject, investigator, and study staff.||t|t|t|t
1335740|NCT03130725|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The study design will be parallel group, equivalence randomized controlled trial. Aim is to determine the equality of the Amalgam sealants retention compared to resin based sealants retention.||||
1335741|NCT03130712||Single Group Assignment||Treatment||None (Open Label)||||||
1335742|NCT03130699|Randomized|Parallel Assignment||Treatment||Single||||||t
1335743|NCT03130686|||Case-Only||Prospective|||||||
1335744|NCT03130673|||Case-Only||Retrospective|||||||
1335745|NCT03130660|Randomized|Parallel Assignment||Prevention||None (Open Label)||patient to be randomized to two groups||||
1335746|NCT03130647||Single Group Assignment||Basic Science||None (Open Label)||Repeated measures sham controlled||||
1335747|NCT03130634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335748|NCT03130621|||Family-Based||Retrospective|||||||
1335749|NCT03130608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335750|NCT03130595|||Ecologic or Community||Prospective|||||||
1335751|NCT03130582|||Cohort||Prospective|||||||
1335752|NCT03130569|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1335753|NCT03130556|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1335754|NCT03130543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335755|NCT03130530|||Other||Retrospective|||||||
1335756|NCT03130517|Randomized|Crossover Assignment||Treatment||None (Open Label)||intervention group will recieve intravenous immunoglobulin and phototherapy and control group that will receive phototherapy only||||
1335757|NCT03130504|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335758|NCT03130491||Single Group Assignment||Other||None (Open Label)||||||
1335759|NCT03130478|||Cohort||Retrospective|||||||
1335760|NCT03130465|||Cohort||Other|||||||
1335761|NCT03130452|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335762|NCT03130439||Single Group Assignment||Treatment||None (Open Label)||||||
1335763|NCT03130426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335764|NCT03130413|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335765|NCT03130400|||Case-Control||Retrospective|||||||
1335766|NCT03130387||Single Group Assignment||Diagnostic||None (Open Label)||Hysteroscopic examination for patients with AUB||||
1335767|NCT03130374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335768|NCT03130361||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1335769|NCT03130348||Single Group Assignment||Treatment||None (Open Label)||||||
1335770|NCT03130335||Single Group Assignment||Treatment||None (Open Label)||||||
1335771|NCT03130322|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1335772|NCT03130309|||Cohort||Retrospective|||||||
1335773|NCT03130296|||Cohort||Prospective|||||||
1335774|NCT03130283|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||quasi experimental study design with propensity score matching||||
1335775|NCT03130270||Single Group Assignment||Treatment||None (Open Label)||||||
1335776|NCT03130257|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1335777|NCT03130244|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1335778|NCT03130231|||Cohort||Prospective|||||||
1335779|NCT03130218|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized by day of week||||
1335780|NCT03130205|||Cohort||Prospective|||||||
1335781|NCT03130192|||Cohort||Prospective|||||||
1335782|NCT03130179|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1335783|NCT03130166|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized controlled trial|t|t|t|t
1335784|NCT03130153|Randomized|Parallel Assignment||Treatment||Single||||||t
1335785|NCT03130140|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1335786|NCT03130127|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335787|NCT03130114|Randomized|Parallel Assignment||Treatment||Quadruple|Active drug (azithromycin) will be delivered as dry powder, in opaque glass bottles. Control children with receive placebo powder that will appear, smell, and taste similar to the active drug. All drug bottles will be coded with participant numbers only, so that no-one will know the contents of the bottle.||t|t|t|t
1335788|NCT03130101|Randomized|Crossover Assignment||Other||None (Open Label)||Patients with type 1 diabetes on insulin pump therapy will remain on their usual insulin regimen. However, we are testing percent basal rate reductions during exercise (e.g. 80% reduction, 50% reduction, and 100% reduction).||||
1335789|NCT03130088|||Cohort||Prospective|||||||
1335790|NCT03130075|||Case-Only||Prospective|||||||
1335791|NCT03130062|Randomized|Parallel Assignment||Supportive Care||Single|The collaborators who carried out these evaluations were unaware of the allocation of volunteers.|The division of the groups was obtained through randomization through a computer program. An opaque envelope containing the group allocation was given to the volunteer by the blind evaluator. After randomization, the sequential numbers were kept in opaque and closed envelopes and, as patients passed the initial evaluations, were allocated to one of the groups.||||t
1335792|NCT03130049|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Pilot study||||
1335793|NCT03130036|Non-Randomized|Parallel Assignment||Basic Science||Single|The PI and cognitive assessor were blinded as to diet condition.||||t|
1335794|NCT03130023||Single Group Assignment||Supportive Care||None (Open Label)||||||
1335795|NCT03130010|Randomized|Parallel Assignment||Prevention||Single||||||t
1335796|NCT03129997|Randomized|Crossover Assignment||Basic Science||Double|volunteers received placebo or gluten corn muffins that are similar in taste and appearance. Investigator does not know who is receiving placebo or gluten muffins. During analyses, each sample is coded to avoid volunteer or phase identification.|crossover double masked model|t||t|
1335797|NCT03129984|||Case-Only||Retrospective|||||||
1335798|NCT03129971|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with atrophic nonunion of femoral shaft fractures, who were treated at the Affiliated Hospital of Qinghai University, China.||||
1335799|NCT03129958|||Case-Only||Cross-Sectional|||||||
1335800|NCT03129945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335801|NCT03129932|Randomized|Crossover Assignment||Basic Science||Double|volunteers will receive placebo or gluten corn muffins that are similar in taste and appearance. Investigator does not know who is receiving placebo or gluten muffins. During analyses, each sample is coded to avoid volunteer or phase identification.|double-masked, crossover, randomized, controlled study|t||t|
1335802|NCT03129919|Randomized|Parallel Assignment||Treatment||Single||||||t
1335803|NCT03129906|Non-Randomized|Sequential Assignment||Basic Science||Single||All participants received placebo capsules and, after that, gluten capsules.|t|||
1335804|NCT03129893|||Other||Prospective|||||||
1335805|NCT03129880|Randomized|Parallel Assignment||Treatment||None (Open Label)||"For purposes of this study participants will be randomized into one of the following two groups:~4-6 weekly standard of care therapy sessions, once a week, for a maximum of six weeks 4-6 standard of care therapy sessions in one day Standard of care treatment may continue past patient enrollment in this study."||||
1335806|NCT03129867|||Cohort||Prospective|||||||
1335807|NCT03129854|Randomized|Parallel Assignment||Treatment||None (Open Label)||One group receive standard of care ADT continually. Another group receive ADT plus prostate cryotherapy||||
1335808|NCT03129841|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335809|NCT03129828||Single Group Assignment||Treatment||None (Open Label)||||||
1335810|NCT03129815|||Cohort||Prospective|||||||
1335811|NCT03129802|||Cohort||Prospective|||||||
1335812|NCT03129789||Sequential Assignment||Other||Single|participants perform ultrasound and the principle investigator is unaware of the identity of the participant||t|||
1335813|NCT03129776|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||Up to ten participants with newly diagnosed FIGO stage IB-IVA cervical cancer that are to receive definitive radiation with or without concurrent cisplatin, are to be recruited for this prospective single institutional study. Participants will receive a hyperpolarized carbon 13 MR spectroscopy and PET scan in addition to the standard imaging that is required for staging. A tumour biopsy will be obtained at the time of the initial clinic visit.||||
1335814|NCT03129763|Randomized|Parallel Assignment||Treatment||Single||This is a prospective randomized controlled trial.||||t
1335815|NCT03129750|||Cohort||Prospective|||||||
1335816|NCT03129737|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335817|NCT03129724|||Cohort||Retrospective|||||||
1335818|NCT03129711|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1335819|NCT03129698||Single Group Assignment||Treatment||None (Open Label)||Patients with untreated extensive-stage small-cell lung cancer||||
1335820|NCT03129685||Single Group Assignment||Treatment||None (Open Label)||Prospective and non-randomized clinical trial||||
1335821|NCT03129672|||Case-Only||Retrospective|||||||
1335822|NCT03129659||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335823|NCT03129646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335824|NCT03129633|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1335825|NCT03129620|||Case-Only||Prospective|||||||
1335826|NCT03129607|||Cohort||Prospective|||||||
1335827|NCT03129594|||Cohort||Other|||||||
1335828|NCT03129581|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized, non-blinded, behavioral intervention pilot study||||
1335829|NCT03129568|Randomized|Parallel Assignment||Treatment||Single||Transcoronary infusion||||t
1335830|NCT03129555|Randomized|Crossover Assignment||Treatment||Single|"The Outcome Assessor will only have a code of each drug and a code for each cluster. Therefore he will not know what drug the clusters have been using. The randomization key will be safely stored at servers at Statens Serums Institute (An institute under the Danish Ministry of Health). After the primary and secondary outcome have been evaluated data will be unblinded."|Cluster randomized cross-over study||||t
1335831|NCT03129542|Randomized|Parallel Assignment||Treatment||Quadruple|The medical provider, nursing staff, study coordinator and patient will be blinded to randomization, only research pharmacist will be aware of randomization.|The Investigators propose a prospective, randomized, double blind, placebo-controlled pilot study on the efficacy and safety of midodrine in the treatment of sepsis.|t|t|t|t
1335832|NCT03129529|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1335833|NCT03129516|||Other||Prospective|||||||
1335834|NCT03129503|||Case-Control||Prospective|||||||
1335835|NCT03129490|Randomized|Crossover Assignment||Prevention||Single|Open label|Cluster randomized cross-over study.||||t
1335836|NCT03129477|Non-Randomized|Parallel Assignment||Treatment||Single|Computorizada randomizados selection|||t||
1335837|NCT03129464|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335838|NCT03129451|||Case-Only||Prospective|||||||
1335839|NCT03129438|Randomized|Parallel Assignment||Diagnostic||Single|Blind assessment of secondary outcomes at 6 months|||||t
1335840|NCT03129425|Non-Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1335841|NCT03129412||Single Group Assignment||Treatment||None (Open Label)||||||
1335842|NCT03129399|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335843|NCT03129386|||Cohort||Prospective|||||||
1335844|NCT03129373|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1335845|NCT03129360|Randomized|Parallel Assignment||Other||Double|||t||t|
1335846|NCT03129347|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1335847|NCT03129334|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1335848|NCT03129321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335849|NCT03129308|||Cohort||Cross-Sectional|||||||
1335850|NCT03129295|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1335851|NCT03129282|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1335852|NCT03129269||Single Group Assignment||Other||None (Open Label)||||||
1335853|NCT03129256||Single Group Assignment||Treatment||None (Open Label)||||||
1335854|NCT03129243|||Cohort||Prospective|||||||
1335855|NCT03129230||Single Group Assignment||Treatment||None (Open Label)||||||
1335856|NCT03129217|||Cohort||Prospective|||||||
1335857|NCT03129204|Randomized|Parallel Assignment||Prevention||None (Open Label)||prospective, randomized, experimental design||||
1335858|NCT03129191|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1335859|NCT03129178|Randomized|Crossover Assignment||Other||Triple|Double blind, randomised control trial. Supplements will be dispensed by nurses or a member of the research team.||t||t|t
1335860|NCT03129165||Single Group Assignment||Health Services Research||None (Open Label)||||||
1335861|NCT03129152||||||||||||
1335862|NCT03129139|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335863|NCT03129126|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1335864|NCT03129113|Randomized|Factorial Assignment||Treatment||Single||2 by 2 factorial randomisation to one of the 4 arms.||||t
1335865|NCT03129100|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335973|NCT03127696|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336145|NCT03125460|||Cohort||Prospective|||||||
1335866|NCT03129087|Randomized|Crossover Assignment||Treatment||Single||The proposed study is a randomized, cross-over, clinical trial involving the comparison of two treatments (A and B) separated by a wash-out period (W). The patient participants will be randomized to one of the following two treatment orders: AWB or BWA.||||t
1335867|NCT03129074||Single Group Assignment||Treatment||None (Open Label)||||||
1335868|NCT03129061|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1335869|NCT03129048|Randomized|Parallel Assignment||Other||Single|||t|||
1335870|NCT03129035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335871|NCT03129022|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335872|NCT03129009|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1335873|NCT03128996||Single Group Assignment||Treatment||None (Open Label)||||||
1335874|NCT03128983|||Cohort||Prospective|||||||
1335875|NCT03128970|Randomized|Parallel Assignment||Other||Double|The gynecologist performing the embryo transfer as well as the patients undergoing frozen embryo transfer will be blinded to group allocation||t|t||
1335876|NCT03128957||Sequential Assignment||Device Feasibility||None (Open Label)||||||
1335877|NCT03128944|||Case-Only||Cross-Sectional|||||||
1335878|NCT03128931||||||||||||
1335879|NCT03128918|||Other||Prospective|||||||
1335880|NCT03128905|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking is used. All involved know the identity of the intervention assignment.|||||
1335881|NCT03128892||||||||||||
1335882|NCT03128879||Single Group Assignment||Treatment||None (Open Label)||||||
1335883|NCT03128866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335884|NCT03128853||||||||||||
1335885|NCT03128840||||||||||||
1335886|NCT03128827||Single Group Assignment||Other||None (Open Label)||||||
1335887|NCT03128814|||Cohort||Prospective|||||||
1335888|NCT03128801|Randomized|Parallel Assignment||Treatment||Single||||||t
1335889|NCT03128788|Randomized|Parallel Assignment||Treatment||Single|||t|||
1335890|NCT03128775|Randomized|Parallel Assignment||Prevention||None (Open Label)||"PAAPPAS Nudge is a randomized community-based, school-based trial designed to promote healthful choices in a low-income scenario, with will be held in 2018 school-year in 18 municipal public schools in the municipality of Duque de Caxias, metropolitan area of Rio de Janeiro, Brazil (http://duquedecaxias.rj.gov.br/portal/). All students from the 5th and 6th grade from the 18 selected schools will be invited to participate to the study.~The study design will be of the factorial type, with 4 group arms:~A) Group 1: control (without any activity); B) Group 2: will receive educational activities in the classroom; C) Group 3: will receive changes in the school environment (nudge strategies); D) Group 4: will receive educational activities and changes in the school environment."||||
1335891|NCT03128762|||Case-Control||Prospective|||||||
1335892|NCT03128749|Randomized|Sequential Assignment||Treatment||Double||||t||t
1335893|NCT03128736|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1335894|NCT03128723||Single Group Assignment||Treatment||None (Open Label)||||||
1335895|NCT03128710|||Cohort||Prospective|||||||
1335896|NCT03128697|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1335897|NCT03128684|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1335898|NCT03128671|Randomized|Parallel Assignment||Prevention||Single|Study personnel evaluating delirium will use standardized tool (CAM-ICU) and will be blinded to subjects' group assignments.|prospective, randomized, experimental design||||t
1335899|NCT03128658|||Cohort||Prospective|||||||
1335900|NCT03128645|||Other||Prospective|||||||
1335901|NCT03128632||||||||||||
1335902|NCT03128619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335903|NCT03128606|Randomized|Sequential Assignment||Basic Science||Quadruple|||t|t|t|t
1335904|NCT03128593||Sequential Assignment||Treatment||None (Open Label)||||||
1335905|NCT03128580|||Cohort||Prospective|||||||
1335906|NCT03128567|||Case-Control||Prospective|||||||
1335907|NCT03128554|Randomized|Parallel Assignment||Other||Single||||||t
1335908|NCT03128541|||Case-Crossover||Prospective|||||||
1335909|NCT03128528|Randomized|Parallel Assignment||Treatment||Triple||Phase II, randomized (2:1), prospective, double-blind, placebo controlled, parallel-group, single center study.|t|t|t|
1335910|NCT03128515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335911|NCT03128502|||Other||Cross-Sectional|||||||
1335912|NCT03128489||Single Group Assignment||Prevention||None (Open Label)||||||
1335913|NCT03128476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335914|NCT03128463|||Cohort||Prospective|||||||
1335915|NCT03128450||Single Group Assignment||Treatment||None (Open Label)||||||
1335916|NCT03128437|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1335917|NCT03128424||Single Group Assignment||Treatment||None (Open Label)||||||
1335918|NCT03128411||Single Group Assignment||Treatment||None (Open Label)||||||
1335919|NCT03128398||||||||||||
1335920|NCT03128385|Randomized|Parallel Assignment||Treatment||Single||||||t
1335921|NCT03128372||Single Group Assignment||Diagnostic||None (Open Label)||||||
1335922|NCT03128359|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335923|NCT03128346|Randomized|Parallel Assignment||Prevention||Single|Participants will be blinded to the randomization|two groups: the nerve block group and the standard of care group|t|||
1335924|NCT03128333|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335925|NCT03128320|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1335926|NCT03128307||Single Group Assignment||Treatment||Double|The data is compiled and analyzed by an outside, independent organization|Patient serves as their own control||t|t|
1335927|NCT03128294|||Case-Only||Retrospective|||||||
1335928|NCT03128281|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336035|NCT03126890|||Other||Prospective|||||||
1336094|NCT03126123||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336269|NCT03123848||Single Group Assignment||Other||None (Open Label)||||||
1335929|NCT03128268||Single Group Assignment||Diagnostic||None (Open Label)||Each participant will receive tradition 2D Cardiac imaging as ordered per standard of care. Then, the participant will receive a 4D image, requiring 6 to 10 additional minutes in the MRI scanner. The 2D and 4D images will be interpreted by readers blinded to the results of the alternate modality. Inter- and intra-reader reliability will be assessed.||||
1335930|NCT03128255|||Case-Control||Prospective|||||||
1335931|NCT03128242|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1335932|NCT03128229|||Cohort||Prospective|||||||
1335933|NCT03128216|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1335934|NCT03128203|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1335935|NCT03128190|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335936|NCT03128177|Randomized|Crossover Assignment||Treatment||Double|Both the participant and investigator are blinded to the diet|Crossover study of high (6 g) and low (1.5 g) sodium diet|t||t|
1335937|NCT03128164||Single Group Assignment||Treatment||None (Open Label)||This study will consist of a dose escalation stage (Stage I) and a dose expansion stage (Stage II). Dose escalation will be performed according to a modified toxicity probability interval scheme-2 (mTPI-2). Expansion stage of the study will enroll 56 patients with B cell lymphoma, including CLL, SLL, FL, MZL, WM, DLBCL, burkitt lymphoma and MCL.||||
1335938|NCT03128151|||Case-Control||Prospective|||||||
1335939|NCT03128138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335940|NCT03128125|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Case-control study, monocentric.||||
1335941|NCT03128112|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1335942|NCT03128099|Randomized|Parallel Assignment||Basic Science||Double|Participants are assigned to low or high dose randomly. They do not know which condition they are in. The research staff who assess symptoms before and after training do not know which condition the participant is assigned to.|"Half the participants play the virtual reality video game for one hour per session (low dose).~The other half play the virtual reality video game for 2 hours per session (high dose).~Both groups visit the lab 10 times ( twice a week for 5 weeks)"|t|||t
1335943|NCT03128086|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1335944|NCT03128073||Single Group Assignment||Supportive Care||None (Open Label)||Intervention study, pilot/ feasibility for proof of concept of peritoneal ultrafiltration with the Carry Life system ultrafiltration (CLS UF)||||
1335945|NCT03128060|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1335946|NCT03128047|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1335947|NCT03128034||Single Group Assignment||Treatment||None (Open Label)||||||
1335948|NCT03128021|Randomized|Parallel Assignment||Treatment||Quadruple|Although this is a double-blinded study, one staff member will be unblinded regarding study randomization. Should the need ever arise, the blind can be instantly broken for the participant's safety and well-being.|"Participants will be randomly assigned to take either escitalopram or levomilnacipran throughout the 12-week trial.~The following information applies to the original study design. Enrollment according to this design was complete as of [date].: During Phase I, participants will be randomly assigned to take escitalopram or placebo daily for 6 weeks. After 6 weeks, participants who are randomly assigned to placebo will be given the option to have an open-label of escitalopram for Phase II. Those who did not respond to escitalopram in Phase I will be referred for alternate treatment. All participants, regardless of outcome will be asked to return for follow-up procedures."|t|t|t|t
1335949|NCT03128008||Single Group Assignment||Treatment||None (Open Label)||||||
1335950|NCT03127995|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1335951|NCT03127982|Randomized|Parallel Assignment||Treatment||Single|The clinical staff participating in the intervention are unaware of the group membership of the subjects; either experimental or wait-list.|Allocation: Randomized Intervention Model: Parallel Assignment Single Blind||t||
1335952|NCT03127969|Randomized|Parallel Assignment||Treatment||Single|||||t|
1335953|NCT03127956||Single Group Assignment||Treatment||None (Open Label)||||||
1335954|NCT03127943|Randomized|Crossover Assignment||Treatment||Double|double blind||t|t||
1335955|NCT03127930|Randomized|Parallel Assignment||Other||Single|Participants and outcomes assessors were not blind to the intervention by nature o the protocol. Investigators and analysts were blinded to study group assignment.|Social Cognitive and Self Efficacy Theory drove the problem-solving tailored intervention delivered via face to face and telephone by either a master's prepared social worker or nurse.|||t|
1335956|NCT03127917|Randomized|Crossover Assignment||Other||Double|Double-blind research study||t||t|
1335957|NCT03127904|Randomized|Parallel Assignment||Treatment||Single|Outcome evaluators and data scientists will be blinded regarding randomization. Blinding will be ensured by asking investigators at the end of the trial if investigators knew the arm to which each subject was going to be allocated prior to opening the envelope.||||t|
1335958|NCT03127891|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1335959|NCT03127878|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised controlled trial||||
1335960|NCT03127865|||Cohort||Prospective|||||||
1335961|NCT03127852|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1335962|NCT03127839|Randomized|Parallel Assignment||Treatment||Single||||||t
1335963|NCT03127826|Randomized|Parallel Assignment||Treatment||Double|Primary care providers will be unaware of risk stratification scores.|||t||t
1335964|NCT03127813|Non-Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1335965|NCT03127800||Single Group Assignment||Supportive Care||None (Open Label)||||||
1335966|NCT03127787|||Cohort||Prospective|||||||
1335967|NCT03127774||Single Group Assignment||Treatment||None (Open Label)||Patients who are successfully debulked will undergo heated intraperitoneal chemotherapy with cisplatin.||||
1335968|NCT03127761|||Cohort||Prospective|||||||
1335969|NCT03127748|||Other||Prospective|||||||
1335970|NCT03127735||Single Group Assignment||Treatment||None (Open Label)||||||
1335971|NCT03127722|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1335972|NCT03127709|||Cohort||Prospective|||||||
1335974|NCT03127683||Single Group Assignment||Other||None (Open Label)||"An AuraGain will be placed in all patients, and mechanical ventilation will be performed using a volume-controlled mode with a tidal volume of 10 ml/kg.~The expiratory tidal volume, peak inspiratory pressure, oropharyngeal leak pressure, and ventilation score will be assessed first for the neutral head position and then for the extended, flexed, and rotated head positions in a random order."||||
1335975|NCT03127670||Single Group Assignment||Treatment||None (Open Label)||Solanum melongena peel extract||||
1335976|NCT03127657||Single Group Assignment||Treatment||None (Open Label)||Topical application of cock's comb extract in the treatment of palmar arsenical keratosis||||
1335977|NCT03127644|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1335978|NCT03127631|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1335979|NCT03127618||||||||||||
1335980|NCT03127605||||||||||||
1335981|NCT03127592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335982|NCT03127579|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1335983|NCT03127566||||||||||||
1335984|NCT03127553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1335985|NCT03127540||||||||||||
1335986|NCT03127527||||||||||||
1335987|NCT03127514|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1335988|NCT03127501||||||||||||
1335989|NCT03127488||||||||||||
1335990|NCT03127475|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1335991|NCT03127462|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"In the first phase of the study 30 patients will receive standard treatment (control group) and in the following phase 30 patients will receive the individualized conversational/educational intervention (intervention group).The rationale for using a historical control group instead of a randomised control group is that it inreal-life setting is unpractical to realize a communicative intervention, because clinicians unintentional can intervene against the control group."||||
1335992|NCT03127449||Single Group Assignment||Treatment||None (Open Label)||||||
1335993|NCT03127436|||Cohort||Prospective|||||||
1335994|NCT03127423|Randomized|Parallel Assignment||Treatment||Single||||||t
1335995|NCT03127410||Single Group Assignment||Diagnostic||None (Open Label)|Investigator is blinded to intervention|||||
1335996|NCT03127397|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1335997|NCT03127384|Randomized|Parallel Assignment||Treatment||Single||||||t
1335998|NCT03127371|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1335999|NCT03127358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336000|NCT03127345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336001|NCT03127332||Single Group Assignment||Supportive Care||None (Open Label)||||||
1336002|NCT03127319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336003|NCT03127306|||Cohort||Prospective|||||||
1336004|NCT03127293|||Case-Control||Prospective|||||||
1336005|NCT03127280|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized control trial||||
1336006|NCT03127267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336007|NCT03127254||Single Group Assignment||Supportive Care||None (Open Label)||||||
1336008|NCT03127241|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1336009|NCT03127228|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1336010|NCT03127215|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|randomized||||
1336011|NCT03127202||Single Group Assignment||Prevention||None (Open Label)||||||
1336012|NCT03127189|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336013|NCT03127176|||Case-Control||Prospective|||||||
1336014|NCT03127163||Single Group Assignment||Treatment||None (Open Label)||Intraestromal corneal ring||||
1336015|NCT03127150|||Cohort||Prospective|||||||
1336016|NCT03127137|Randomized|Parallel Assignment||Treatment||Double|Participant will be blinded to group assignment. Outcome assessor will also be blinded to the randomization.|Prospective Randomized Controlled Trial using control arm plus 2 arm experimental (placebo and active drug)|t|||t
1336017|NCT03127124||Single Group Assignment||Treatment||None (Open Label)||||||
1336018|NCT03127111|||Cohort||Prospective|||||||
1336019|NCT03127098||Sequential Assignment||Treatment||None (Open Label)||ETBX-011 immunization will be administered by subcutaneous (SC) injection. ALT-803 will be administered by SC injection.||||
1336020|NCT03127085|||Cohort||Prospective|||||||
1336021|NCT03127072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336022|NCT03127059|Randomized|Parallel Assignment||Treatment||Double|"Three assessors (physiotherapists) will perform the objective assessment of capacity and lung parameters. Nurses in the outpatient departments will obtain data from medical records. The assessors and the nurses will be blinded for the allocation.~The primary invenstigator will have no access to the data during the period of datacollection.~Primary and most of the secondary outcomes will be patient-reported."|Multi-centre, assessor-blinded, 2-arm randomised controlled trial.|||t|t
1336023|NCT03127046|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1336024|NCT03127033|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1336025|NCT03127020||Single Group Assignment||Treatment||None (Open Label)||||||
1336026|NCT03127007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336027|NCT03126994||Single Group Assignment||Other||None (Open Label)||Prospective validation study to evaluate PWV, PR, and BW accuracy in a sample of subjects representing the US general adult population.||||
1336028|NCT03126981|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1336029|NCT03126968|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1336030|NCT03126955|||Cohort||Prospective|||||||
1336031|NCT03126942|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1336032|NCT03126929|||Cohort||Prospective|||||||
1336033|NCT03126916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336034|NCT03126903||Single Group Assignment||Treatment||None (Open Label)||Single arm, open-label clinical trial||||
1336036|NCT03126877|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||The study will be a prospective, single-center open label clinical trial where a maximum of 40 (20 with optimized ocular surface and 20 without) consecutive non-dominant eyes are implanted with the Raindrop Near Vision Inlay.||||
1336037|NCT03126864|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336038|NCT03126851|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1336039|NCT03126838|||Case-Crossover||Cross-Sectional|||||||
1336040|NCT03126825|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336041|NCT03126812||Single Group Assignment||Treatment||None (Open Label)||||||
1336042|NCT03126799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336043|NCT03126786|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336044|NCT03126773|||Cohort||Prospective|||||||
1336045|NCT03126760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336046|NCT03126747|||Cohort||Prospective|||||||
1336047|NCT03126734|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1336048|NCT03126721|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1336049|NCT03126708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336050|NCT03126695|Randomized|Crossover Assignment||Other||None (Open Label)||A randomized cross-over design has been chosen to minimize the effects of between-subject variability and any period effects on the overall results.||||
1336051|NCT03126682|Randomized|Parallel Assignment||Treatment||Double|Blinding to be done - Outcome assessor and care provider will be blinded to randomization arm of subject|2 Arms of randomization - one wherein patients get Wellbutrin in first ECT and another arm wherein patients get it with second ECT. Counterbalanced randomization||t||t
1336052|NCT03126669|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1336053|NCT03126656|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336054|NCT03126643||||||||||||
1336055|NCT03126630|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1336056|NCT03126617||||||||||||
1336057|NCT03126604|||Cohort||Prospective|||||||
1336058|NCT03126591|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1336059|NCT03126578||Single Group Assignment||Treatment||None (Open Label)||||||
1336060|NCT03126565|Randomized|Parallel Assignment||Other||Single||||||t
1336061|NCT03126552||Single Group Assignment||Other||None (Open Label)||||||
1336062|NCT03126539|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336063|NCT03126526|Randomized|Parallel Assignment||Treatment||None (Open Label)||The model includes two interventions (i.e. inhibitory control training and implementation intentions) that aim to target cognitive processes that have been reported to play a role in the onset and maintenance of eating disorders. Moreover, three arms exist, one for healthy controls including only one EEG assessment, and two interventional arms for participants with eating disorders. Participants in one interventional arm will receive food-specific inhibitory control training, while participants in the other interventional arm will receive general inhibitory control training. These are delivered through a website task (go/no-go training),||||
1336064|NCT03126513||Single Group Assignment||Treatment||None (Open Label)||This a prospective study that evaluates G-POEM in a group of participants with diagnosis of refractory gastroparesis. Participants are sequentially recruited as diagnosed.||||
1336065|NCT03126500|||Other||Cross-Sectional|||||||
1336066|NCT03126487||Single Group Assignment||Treatment||None (Open Label)||||||
1336067|NCT03126474|||Other||Other|||||||
1336068|NCT03126461||Sequential Assignment||Treatment||None (Open Label)||||||
1336069|NCT03126448|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1336070|NCT03126435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336071|NCT03126422|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1336072|NCT03126409|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336073|NCT03126396||Single Group Assignment||Treatment||None (Open Label)||||||
1336074|NCT03126383|||Cohort||Retrospective|||||||
1336075|NCT03126370||Single Group Assignment||Other||None (Open Label)||||||
1336076|NCT03126357|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1336077|NCT03126344|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336078|NCT03126331||Single Group Assignment||Treatment||None (Open Label)||||||
1336079|NCT03126318|Randomized|Parallel Assignment||Treatment||Quadruple|double-blind|randomized, double-blind, placebo-controlled - 4 cohorts of 4 patients each with a dosing regimen of 3:1 (active:placebo)|t|t|t|t
1336080|NCT03126305|||Ecologic or Community||Prospective|||||||
1336081|NCT03126292|Randomized|Parallel Assignment||Prevention||Double||||t||t
1336082|NCT03126279|||Case-Control||Prospective|||||||
1336083|NCT03126266||Single Group Assignment||Treatment||None (Open Label)||||||
1336084|NCT03126253|||Ecologic or Community||Cross-Sectional|||||||
1336085|NCT03126240|||Case-Only||Prospective|||||||
1336086|NCT03126227|Randomized|Parallel Assignment||Treatment||Triple||2:1 randomization|t|t|t|
1336087|NCT03126214|Randomized|Crossover Assignment||Prevention||None (Open Label)||"Prospective, open-label, randomized, stepped wedge trial design. Participants will be randomized to early (day 0-90) versus delayed pharmacist intervention (starting day 90-180)."||||
1336088|NCT03126201|||Case-Only||Retrospective|||||||
1336089|NCT03126188|||Cohort||Prospective|||||||
1336090|NCT03126175|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|Parallel Assignment||||
1336091|NCT03126162|Randomized|Parallel Assignment||Other||Single|Participants will be randomly assigned to one of two groups - A) bladder backfilled group or B) control group. This is a blinded study and the participant will not know which group they were assigned to.|A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing for patients undergoing same-day total laparoscopic hysterectomy|t|||
1336092|NCT03126149|Randomized|Sequential Assignment||Basic Science||Double|||t||t|
1336093|NCT03126136||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336095|NCT03126110|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336096|NCT03126097||Single Group Assignment||Treatment||None (Open Label)||||||
1336097|NCT03126084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336098|NCT03126071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1336099|NCT03126058||Single Group Assignment||Treatment||None (Open Label)||Patients will receive enhanced recovery after surgery programs.||||
1336100|NCT03126045|Randomized|Parallel Assignment||Prevention||Double|Neither patients know the needle used during the spinal punction, nor the person collecting the information.|Arm 1: standard needle Arm 2: Atraumatic needle|t|||t
1336101|NCT03126032|||Case-Control||Prospective|||||||
1336102|NCT03126019|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336103|NCT03126006|Randomized|Parallel Assignment||Other||Double||"It's an assessor blinded, parallel group, randomized controlled trial aimed at determining the superiority of non-surgical periodontal therapy over no dental treatment among pregnant women.~The main objective of this trial is to determine whether the provision of NSPT to pregnant women with periodontitis is effective in reducing the incidence of low birth weight, preterm birth and still birth when compared to the pregnant women who were subjected to no NSPT. Outcomes of interest are pre-term birth (<37 weeks) gestation, low birth weight (<2500g) or still birth with either one occurring being considered as a positive outcome."|||t|t
1336104|NCT03125993||Single Group Assignment||Prevention||None (Open Label)||This study is a prospective 4-month follow-up scheme in which patients were treated with the following intervention: > 10000 steps, > five days, per week. For individual follow-up, body components and metabolic risk factors will be tested before and after the study. Every participants will be followed up in community visits every month.||||
1336105|NCT03125980|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1336106|NCT03125967|Randomized|Parallel Assignment||Treatment||Single||two-arm randomized placebo-controlled study with pre-exposure and post-exposure assessments|t|||
1336107|NCT03125954|||Cohort||Prospective|||||||
1336108|NCT03125941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336109|NCT03125928||Single Group Assignment||Treatment||None (Open Label)||||||
1336110|NCT03125915|Randomized|Factorial Assignment||Prevention||Single|Assignment to video condition is masked with respect to the care provider. The person conducting the CHTC session is unaware of whether couples have viewed the communication skills training video prior to the session.|The study tests two independent variables in a fully-crossed factorial design. Half of the couples complete a substance use module during their CHTC session (half do not); half view communication skills training videos (half do not).||t||
1336111|NCT03125902|Randomized|Parallel Assignment||Treatment||Double|The Sponsor and its agents; the study site personnel, including the investigator; and the participant will be blinded to treatment assignment.||t||t|
1336112|NCT03125889||Single Group Assignment||Treatment||None (Open Label)||||||
1336113|NCT03125876||Single Group Assignment||Treatment||None (Open Label)||||||
1336114|NCT03125863||Single Group Assignment||Treatment||None (Open Label)||||||
1336115|NCT03125850|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1336116|NCT03125837|||Other||Prospective|||||||
1336117|NCT03125824||Single Group Assignment||Treatment||None (Open Label)||Single Group||||
1336118|NCT03125811|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336119|NCT03125798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336120|NCT03125785|||Cohort||Prospective|||||||
1336121|NCT03125772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336122|NCT03125759|||Case-Control||Prospective|||||||
1336123|NCT03125746|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1336124|NCT03125733||Single Group Assignment||Treatment||None (Open Label)||||||
1336125|NCT03125720|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1336126|NCT03125707|||Case-Only||Prospective|||||||
1336127|NCT03125694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336128|NCT03125681|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1336129|NCT03125668|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336130|NCT03125655|||Case-Control||Cross-Sectional|||||||
1336131|NCT03125642|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336132|NCT03125629||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336133|NCT03125616|Randomized|Parallel Assignment||Prevention||None (Open Label)||This will be an open label, phase IV study.||||
1336134|NCT03125603|||Cohort||Other|||||||
1336135|NCT03125590|||Other||Prospective|||||||
1336136|NCT03125577||Single Group Assignment||Treatment||None (Open Label)||||||
1336137|NCT03125564|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336138|NCT03125551|Randomized|Parallel Assignment||Diagnostic||Double|Each participant will be blinded to the dietary supplement which they will be taking. The medical technologist doing the ROTEM will be blinded to the dietary supplements as well.|Five- armed, placebo- controlled ( 4 intervention groups and 1 placebo group)|t|||t
1336139|NCT03125538|Non-Randomized|Crossover Assignment||Health Services Research||Double|Participants sign an informed written consent but are not aware of the expectations of the study. Assessments will be performed by a PhD student who does not know neither to which group each participants belongs, nor the expectations of the study.|To avoid group contamination, a first group of 10 control participants will be completed. Then, an experimental group of 10 patients will be assessed. In order to complete a 40 persons cohort, this will be repeated one time (other 10 control then 10 experimental participants).|t|||t
1336140|NCT03125525|||Case-Only||Prospective|||||||
1336141|NCT03125512|Randomized|Crossover Assignment||Treatment||Single|Research staff assessing the outcomes of the study, the scoring of the sleep studies, and data analyses will be blinded.|8-week randomized crossover trial with a 1 week washout period.||||t
1336142|NCT03125499|||Other||Other|||||||
1336143|NCT03125486||||||||||||
1336144|NCT03125473|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336146|NCT03125447|Non-Randomized|Factorial Assignment||Other||None (Open Label)||Attention capacity will be compared in three situations of posture/mobility in a group of prematurely born children, and compared to the same situations in a group of term born children||||
1336147|NCT03125434||Single Group Assignment||Other||None (Open Label)||||||
1336148|NCT03125421|Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1336149|NCT03125408|||Cohort||Prospective|||||||
1336150|NCT03125395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336151|NCT03125382|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336152|NCT03125369|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336153|NCT03125356||Single Group Assignment||Prevention||None (Open Label)||||||
1336154|NCT03125343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||All patients with complete response defined as described above will be offered to enter the study||||
1336155|NCT03125330|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336156|NCT03125317|||Other||Prospective|||||||
1336157|NCT03125304|Randomized|Parallel Assignment||Treatment||Double||The participants assigned to the treatment groups will receive acupuncture at Sanyinjiao (SP 6), Zhaohai (KI 6) ,Taichong (LR 3) ,Qichong (ST 30) and Guanyuan (CV4), while the control group will receive acupuncture at non-acupoint.|t|||t
1336158|NCT03125291|Randomized|Parallel Assignment||Prevention||Single|The interviewers are blind to the condition assigned to the families.|||||t
1336159|NCT03125278|||Other||Prospective|||||||
1336160|NCT03125265|||Cohort||Prospective|||||||
1336161|NCT03125252|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336162|NCT03125239||Single Group Assignment||Treatment||None (Open Label)||open-label phase 1 study using a 3+3 design with planned dose escalation||||
1336163|NCT03125226||Single Group Assignment||Treatment||None (Open Label)||||||
1336164|NCT03125213|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336165|NCT03125200||Single Group Assignment||Treatment||None (Open Label)||||||
1336166|NCT03125187|Randomized|Crossover Assignment||Other||None (Open Label)||Hospitalizations for intravenous administration of study medications will occur in two periods (visits 1 and 2) for administration of the drugs, and participants who receive the test medication at visit 1 will receive the comparator medication at Visit 2 and vice versa||||
1336167|NCT03125174|||Cohort||Prospective|||||||
1336168|NCT03125161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336169|NCT03125148|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1336170|NCT03125135||||||||||||
1336171|NCT03125122||||||||||||
1336172|NCT03125109||||||||||||
1336173|NCT03125096||||||||||||
1336174|NCT03125083||Single Group Assignment||Basic Science||None (Open Label)||||||
1336175|NCT03125070|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1336176|NCT03125057|Non-Randomized|Sequential Assignment||Treatment||Single||||||t
1336177|NCT03125044||||||||||||
1336178|NCT03125031|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1336179|NCT03125018||Single Group Assignment||Other||None (Open Label)||||||
1336180|NCT03125005||Single Group Assignment||Other||None (Open Label)||||||
1336181|NCT03124992||||||||||||
1336182|NCT03124979||Single Group Assignment||Other||None (Open Label)||||||
1336183|NCT03124966||Single Group Assignment||Other||None (Open Label)||||||
1336184|NCT03124953||||||||||||
1336185|NCT03124940||||||||||||
1336186|NCT03124927||Single Group Assignment||Other||None (Open Label)||||||
1336187|NCT03124914|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336188|NCT03124901||Single Group Assignment||Other||None (Open Label)||||||
1336189|NCT03124888||||||||||||
1336190|NCT03124875||Single Group Assignment||Treatment||None (Open Label)||Prospective, multi-center pilot study||||
1336191|NCT03124862||Single Group Assignment||Other||None (Open Label)||||||
1336192|NCT03124849||||||||||||
1336193|NCT03124836||Single Group Assignment||Other||None (Open Label)||||||
1336194|NCT03124823||Single Group Assignment||Other||None (Open Label)||||||
1336195|NCT03124810||||||||||||
1336196|NCT03124797||Single Group Assignment||Other||None (Open Label)||||||
1336197|NCT03124784||Single Group Assignment||Other||None (Open Label)||||||
1336198|NCT03124771||Single Group Assignment||Other||None (Open Label)||||||
1336199|NCT03124758||Single Group Assignment||Other||None (Open Label)||||||
1336200|NCT03124745||||||||||||
1336201|NCT03124732||||||||||||
1336202|NCT03124719||||||||||||
1336203|NCT03124706||||||||||||
1336204|NCT03124693||Single Group Assignment||Other||None (Open Label)||||||
1336205|NCT03124680|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1336206|NCT03124667|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336207|NCT03124654|||Other||Prospective|||||||
1336208|NCT03124641|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1336209|NCT03124628|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1336210|NCT03124615||Single Group Assignment||Treatment||None (Open Label)||Patients will have commenced standard dose enzalutamide (160mg) daily and dose will be reduced if Grade 3 fatigue or cognition change has occurred and if toxicity is attributed to enzalutamide||||
1336211|NCT03124602||Single Group Assignment||Other||None (Open Label)||||||
1336212|NCT03124589|Randomized|Parallel Assignment||Other||Single|||t|||
1336213|NCT03124576|||Cohort||Prospective|||||||
1336214|NCT03124563|Randomized|Parallel Assignment||Prevention||Single|The participants are aware of the nature of the intervention. They are not aware if they are the experimental or control group.||t|||
1336215|NCT03124550||Single Group Assignment||Supportive Care||None (Open Label)||Participants will use the exergame for 4 weeks Physical activity will be recorded. Participants will receive game-related rewards when they are active.||||
1336270|NCT03123835||Single Group Assignment||Treatment||None (Open Label)||||||
1336271|NCT03123822|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1336216|NCT03124537|Randomized|Parallel Assignment||Prevention||Single|The participants are aware of the nature of the App features they are given. They are not aware of whether they are in an experimental or control condition.|Both conditions will receive the App for use on an iphone. The control group will just have the accelerometer program to set step goals and to count steps. The experimental condition will have the accelerometer to set goals and count steps in addition to the schedule, map and social components.|t|||
1336217|NCT03124524|Randomized|Parallel Assignment||Treatment||Single|||||t|
1336218|NCT03124511|||Cohort||Prospective|||||||
1336219|NCT03124498||Sequential Assignment||Treatment||None (Open Label)||||||
1336220|NCT03124485|Randomized|Crossover Assignment||Treatment||None (Open Label)||This study protocol aims to test the hypothesis that endoscopic sleeve gastroplasty (ESG) IS NOT inferior to conventional laparoscopic surgical sleeve gastrectomy (LSG) in terms of weight loss and improvement of glycemic control for Asian obese patients. It also investigates and compares the safety profile, improvement of co-morbidities, functional outcomes and changes in gut hormone profiles between the two bariatric procedures.||||
1336221|NCT03124472|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336222|NCT03124459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336223|NCT03124446|Randomized|Parallel Assignment||Prevention||Double|Investigators will be blinded to treatment allocation, including staff performing assessments, randomization, and data analyses.|Overall, a superiority randomized controlled trial with parallel groups will be performed with 30 participants per arm. Participants will be randomly assigned to MB-College or health education waitlist control.|||t|t
1336224|NCT03124433||Single Group Assignment||Treatment||None (Open Label)||||||
1336225|NCT03124420|Randomized|Parallel Assignment||Treatment||Single|open labeled, randomized control trial.|Group A: 7-day triple therapy for patients fail to achieve intraluminal eradication Group B: 14-day triple therapy for patients fail to achieve intraluminal eradication|||t|
1336226|NCT03124407|Randomized|Parallel Assignment||Supportive Care||Triple|Study medications were number coded only and identical in physical characteristics. Randomization coding was held only at the manufacturing site until data lock.|Active treatment compared to drug vehicle as placebo|t|t|t|
1336227|NCT03124394|||Cohort||Prospective|||||||
1336228|NCT03124381|Randomized|Parallel Assignment||Treatment||Double|Evaluator-blind||||t|t
1336229|NCT03124368|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1336230|NCT03124355|Randomized|Crossover Assignment||Basic Science||Double|Participants and investigators will be blinded to the study drugs (placebo, galantamine, pyridostigmine). Participants will be blinded to the vagal stimulation (stimulation vs. sham).|Randomized, double-blind, crossover|t||t|
1336231|NCT03124342|Randomized|Parallel Assignment||Prevention||Single||||||t
1336232|NCT03124329|Randomized|Parallel Assignment||Treatment||Single||||||t
1336233|NCT03124316|Randomized|Factorial Assignment||Health Services Research||Double|The randomization schedule will be generated by a statistician on study IDs. The allocation sequence is applied simultaneously to the full set of eligible family physicians so that each is assigned to one of eight experimental conditions. The assignment to study conditions will be concealed from investigators. The data collection system used for the 4 month outcome assessment will be standardized across all study conditions and conducted by personnel at CCO not already involved in the study trial. No un-blinding is planned or permitted.|We will test three components of reminders to family physicians that could be embedded independently, in combinations of two, and all together in a reminder email. Family physicians will be randomly allocated to one of 8 experimental conditions. Each experimental condition comprises a different combination of the behaviour change techniques featured in the redesigned email reminder.|||t|t
1336234|NCT03124303|||Cohort||Prospective|||||||
1336235|NCT03124290|Randomized|Crossover Assignment||Health Services Research||Double|||||t|t
1336236|NCT03124277|Randomized|Parallel Assignment||Treatment||Single||||||t
1336237|NCT03124264||||||||||||
1336238|NCT03124251||||||||||||
1336239|NCT03124238|Randomized|Crossover Assignment||Treatment||None (Open Label)||repeated measures crossover||||
1336240|NCT03124225|||Cohort||Prospective|||||||
1336241|NCT03124212|||Family-Based||Prospective|||||||
1336242|NCT03124199||Single Group Assignment||Treatment||None (Open Label)||||||
1336243|NCT03124186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336244|NCT03124173||Single Group Assignment||Basic Science||None (Open Label)||||||
1336245|NCT03124160|Randomized|Parallel Assignment||Other||Single|||t|||
1336246|NCT03124147|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336247|NCT03124134|Randomized|Crossover Assignment||Prevention||None (Open Label)||4-way crossover with the option for 2 more crossover arms after interim analysis||||
1336248|NCT03124121||Single Group Assignment||Treatment||None (Open Label)||||||
1336249|NCT03124108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336250|NCT03124095|Randomized|Parallel Assignment||Treatment||Single||||||t
1336251|NCT03124082|Randomized|Parallel Assignment||Treatment||Triple||randomized double blind trial|t||t|t
1336252|NCT03124069||||||||||||
1336253|NCT03124056|||Cohort||Prospective|||||||
1336254|NCT03124043|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1336255|NCT03124030|||Cohort||Prospective|||||||
1336256|NCT03124017|Randomized|Parallel Assignment||Prevention||Single|||t|||
1336257|NCT03124004|||Cohort||Prospective|||||||
1336258|NCT03123991|Randomized|Parallel Assignment||Prevention||Single|||||t|
1336259|NCT03123978||Single Group Assignment||Treatment||None (Open Label)||||||
1336260|NCT03123965||||||||||||
1336261|NCT03123952||||||||||||
1336262|NCT03123939||||||||||||
1336263|NCT03123926|||Case-Control||Prospective|||||||
1336264|NCT03123913||Single Group Assignment||Treatment||None (Open Label)||||||
1336265|NCT03123900|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1336266|NCT03123887|||Cohort||Retrospective|||||||
1336267|NCT03123874|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1336268|NCT03123861|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1336272|NCT03123809|Randomized|Parallel Assignment||Treatment||Double|Patient and clinical investigators are going to be blinded in regards to the status of GES (if it is ON or OFF) for 3 months after surgery. One non-clinical investigator is assigned to serve as un-blind person , who is going to generate a master list of participants by dividing them into two groups based on their etiologies (diabetic or idiopathic). All effort would be to include similar numbers of idiopathic and diabetic patients in each intervention group based on a block randomization method, allowing for GES to be turned ON at the surgery, or it will stay OFF for the 3 month during the blind portion of the study.|Based on confidential code set up for this study, there will be a randomized assigment for patients to have their GES devices turn ON or OFF. Half of these patients will be in each arm.|t||t|
1336273|NCT03123796|||Case-Control||Retrospective|||||||
1336274|NCT03123783||Single Group Assignment||Treatment||None (Open Label)||||||
1336275|NCT03123770|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336276|NCT03123757||Single Group Assignment||Other||None (Open Label)||All subjects enrolled in our trial performed the 6-minute walk test and completed an EQ-5D quality of life questionnaire.||||
1336277|NCT03123744||Single Group Assignment||Treatment||None (Open Label)||This is a single-center, open-label, non-randomized Phase II study of palbociclib in adult subjects with recurrent or refractory advanced cancers with aberration(s) in cyclin (CCN/CDK) signaling. Treatment will consist of daily oral administration of palbociclib in 28-day cycles.||||
1336278|NCT03123731|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336279|NCT03123718|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336280|NCT03123705|||Cohort||Prospective|||||||
1336281|NCT03123692|Randomized|Crossover Assignment||Treatment||Single||A randomised, two arm, double-blind, placebo-controlled, cross-over, once daily for 14 days and 28 days follow up|t|||
1336282|NCT03123679|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1336283|NCT03123666|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336284|NCT03123653||Single Group Assignment||Treatment||None (Open Label)||||||
1336285|NCT03123640|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Not possible to mask the intervention|Randomized controlled trial With intervention Group and Control group||||
1336286|NCT03123627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336287|NCT03123614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336288|NCT03123601||Single Group Assignment||Device Feasibility||None (Open Label)||All patients, with chronic neurologic diseases selected from a nursing home, will be invited to participate. At baseline patients will undertake a screening risk assessment and it will be attributed a correspondent risk display. Study duration will be a minimum of 3 months per participant, including daily record of events and monthly interview assessments. Events data will be compared with historical data extracted retrospectively from medical and nursing charts.||||
1336289|NCT03123588|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1336290|NCT03123575|||Other||Retrospective|||||||
1336291|NCT03123562||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1336292|NCT03123549|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1336293|NCT03123536|||Cohort||Prospective|||||||
1336294|NCT03123523|||Case-Control||Prospective|||||||
1336295|NCT03123510|Randomized|Parallel Assignment||Basic Science||Double|Neither the volunteers nor the coaches will be aware|One group will receive a synbiotic supplement and the other placebo capsules.|t|t||
1336296|NCT03123497|||Other||Prospective|||||||
1336297|NCT03123484|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336298|NCT03123471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336299|NCT03123458||Single Group Assignment||Treatment||None (Open Label)||||||
1336300|NCT03123445|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336301|NCT03123432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336302|NCT03123419||Single Group Assignment||Other||None (Open Label)||||||
1336303|NCT03123406|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||CKD Hemodialysis Patients with SHPT||||
1336304|NCT03123393||Single Group Assignment||Treatment||None (Open Label)||||||
1336305|NCT03123380||||||||||||
1336306|NCT03123367|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336307|NCT03123354||Single Group Assignment||Other||None (Open Label)||||||
1336308|NCT03123341||||||||||||
1336309|NCT03123328||Single Group Assignment||Other||None (Open Label)||||||
1336310|NCT03123315||Single Group Assignment||Supportive Care||None (Open Label)||Single-Center Prospective Cohort||||
1336311|NCT03123302|||Cohort||Prospective|||||||
1336312|NCT03123289|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Same patients are scanned with two radiotracers within 24-48 hours. Results of the two scans are compared against each other.||||
1336313|NCT03123276||Single Group Assignment||Other||None (Open Label)||||||
1336314|NCT03123263|||Other||Retrospective|||||||
1336315|NCT03123250||Single Group Assignment||Treatment||None (Open Label)||||||
1336316|NCT03123237|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1336317|NCT03123224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336318|NCT03123211||||||||||||
1336319|NCT03123198||Single Group Assignment||Treatment||None (Open Label)||||||
1336320|NCT03123185|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336321|NCT03123172||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336322|NCT03123159|||Cohort||Prospective|||||||
1336323|NCT03123146|Randomized|Parallel Assignment||Treatment||Single||||||t
1336324|NCT03123133|||Cohort||Prospective|||||||
1336325|NCT03123120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336326|NCT03123107||Single Group Assignment||Basic Science||None (Open Label)||||||
1336327|NCT03123094|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336328|NCT03123081|Randomized|Parallel Assignment||Prevention||Single|Single Blind (Subject)||t|||
1336329|NCT03123068|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo and active treatments will be formulated in identical capsules, and bottled and labeled with coded study numbers that will allow for all parties to remain blinded throughout the data collection phase.||t|t|t|t
1336330|NCT03123055|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||B-701 as monotherapy for first 2 weeks followed by B-701 in combination with pembrolizumab thereafter.||||
1336331|NCT03123042||Single Group Assignment||Treatment||None (Open Label)||||||
1336332|NCT03123029||||||||||||
1336333|NCT03123016||Single Group Assignment||Treatment||None (Open Label)||Enrolled subjects will be randomized to treatment with narrowband UVB two to three times weekly to one half of their body for a total of 16 weeks, while the contralateral side of the body is covered by a special garment to prevent any UVB treatment||||
1336334|NCT03123003||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336335|NCT03122990|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1336336|NCT03122977|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1336337|NCT03122964|||Case-Only||Prospective|||||||
1336338|NCT03122951||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336339|NCT03122938|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1336340|NCT03122925|||Case-Control||Prospective|||||||
1336341|NCT03122912|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1336342|NCT03122899|Randomized|Single Group Assignment||Treatment||None (Open Label)||Minimally invasive sacroiliac joint fusion surgery with iFuse-3D||||
1336343|NCT03122886|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336344|NCT03122873|||Case-Control||Prospective|||||||
1336345|NCT03122860|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336346|NCT03122847|||Cohort||Prospective|||||||
1336347|NCT03122834|||Cohort||Prospective|||||||
1336348|NCT03122821|Randomized|Parallel Assignment||Treatment||Quadruple|transcranial electrical stimulation|Transcranial magnetic stimulation|t|t|t|t
1336349|NCT03122808|||Case-Control||Retrospective|||||||
1336350|NCT03122795||Single Group Assignment||Treatment||None (Open Label)||Patients and donors who meet the inclusion criteria will be recruited and inclueded and put through the study in a cumulative fashion.||||
1336351|NCT03122782|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1336352|NCT03122769||Single Group Assignment||Treatment||None (Open Label)|Open label|All 6 subjects allocated to the study will receive 11C-metformin intravenously.||||
1336353|NCT03122756|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336354|NCT03122743|||Cohort||Prospective|||||||
1336355|NCT03122730||Single Group Assignment||Treatment||None (Open Label)||||||
1336356|NCT03122717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336357|NCT03122704||Single Group Assignment||Screening||None (Open Label)||||||
1336358|NCT03122691|Randomized|Crossover Assignment||Basic Science||Double|Placebo controlled, double blind drug administration||t|||t
1336359|NCT03122678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336360|NCT03122665|Randomized|Crossover Assignment||Treatment||Double|Blinded drug containers.|Volunteers given two doses of nefopam in a crossover protocol.|t||t|
1336361|NCT03122652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336362|NCT03122639|Randomized|Parallel Assignment||Basic Science||Quadruple|Active drug and placebo will be made identical in appearance and given to participants in a blinded fashion.|Randomized double blind design|t|t|t|t
1336363|NCT03122626|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors will be unaware of group assignment|A 2-group randomized controlled trial in which participants are assigned to immediate or delayed participation in a community exercise program||||t
1336364|NCT03122613|Randomized|Parallel Assignment||Other||Double|Double-blinded using identical looking products in both arms||t||t|
1336365|NCT03122600|||Other||Prospective|||||||
1336366|NCT03122587|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1336367|NCT03122574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336368|NCT03122561|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Healthy Volunteers||||
1336369|NCT03122548||Single Group Assignment||Treatment||None (Open Label)||||||
1336370|NCT03122535|Randomized|Parallel Assignment||Other||Single|Each participant will be masked as to which angle of cut is used in which eye. Each patient will receive a 70 degree cut in one eye and a 110 degree cut in the fellow eye||t|||
1336371|NCT03122522||Single Group Assignment||Treatment||None (Open Label)||||||
1336372|NCT03122509|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a Simon two-stage design, phase II study. It will be conducted to determine the efficacy and safety of (1) durvalumab and tremelimumab plus RT in subjects with metastatic CRC who are undergoing RT as standard therapy; and, (2) durvalumab and tremelimumab plus ablation in subjects with metastatic CRC who are undergoing ablation as standard therapy.||||
1336373|NCT03122496||Single Group Assignment||Treatment||None (Open Label)||This is a pilot study evaluating durvalumab (MEDI4736) and tremelimumab in combination with standard-of-care stereotactic body radiotherapy (SBRT) in patients with metastatic anaplastic thyroid cancer.||||
1336374|NCT03122483|||Cohort||Prospective|||||||
1336375|NCT03122470||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336376|NCT03122457||Single Group Assignment||Treatment||None (Open Label)||Application of clindamycin phosphate and benzoyl peroxide 1.2%/3.75% combination gel to treat perimenstrual acne||||
1336377|NCT03122444||Single Group Assignment||Treatment||None (Open Label)||||||
1336378|NCT03122431|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study includes 3 subprojects that will assess serum drug levels for efficacy and toxicity. In the first two subprojects, hydroxychloroquine will be studied in SLE population. In the third subproject, thalidomide and SLE and cutaneous lupus will be studied.||||
1336379|NCT03122418||Single Group Assignment||Other||None (Open Label)||Subjects will receive a personal fitness device and asked to develop an individual exercise program.||||
1336380|NCT03122405||Single Group Assignment||Other||None (Open Label)||||||
1336381|NCT03122392||Single Group Assignment||Treatment||None (Open Label)||Volume and Pressure Profiles in the AMS 800 cuff. The cuff is filled with deionized water and the amount of fluid in it decides the pressure it will apply while wrapped around the urethra. The pressure-volume profiles will be taken from 6 patients consented by the PI and these will be used for the secondary end point.||||
1336382|NCT03122379||||||||||||
1336383|NCT03122366|||Case-Control||Cross-Sectional|||||||
1336384|NCT03122353|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336385|NCT03122340|Randomized|Parallel Assignment||Treatment||Quadruple||Single-center double-blind, randomized, placebo-controlled study|t|t|t|t
1336386|NCT03122327|||Case-Only||Prospective|||||||
1336387|NCT03122314|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1336388|NCT03122301|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1336389|NCT03122288|Randomized|Parallel Assignment||Treatment||None (Open Label)||A pre-post two-group experimental design will be used.||||
1336390|NCT03122275|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1336391|NCT03122262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336392|NCT03122249||Single Group Assignment||Supportive Care||None (Open Label)||All participants will receive the intervention delivered via the internet||||
1336393|NCT03122236|Non-Randomized|Parallel Assignment||Treatment||Double|. To control for intensity, participants will maintain a rating of perceived exertion of 4 (moderate to strong) on the Borg Category/Ratio Scale during walking. Exertion will be adjusted by modifying walking speed and/or by modifying the rest time between walking bouts.|Participants will take part in a 6-week, 18-session neurorehabilitation led by qualified and trained study personnel. Participants will be randomized to one of three groups: 1) standard walking neurorehabilitation with sham tDCS ('standard/sham' group), 2) complex walking neurorehabilitation with sham tDCS ('complex/sham' group), or 3) complex walking neurorehabilitation with active anodal tDCS ('complex/active' group). Training logs will be maintained to gauge the content and intensity of training.|t||t|
1336394|NCT03122223|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1336395|NCT03122210|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1336396|NCT03122197||Single Group Assignment||Basic Science||None (Open Label)||||||
1336397|NCT03122184|Randomized|Parallel Assignment||Treatment||Single|Participants and treating study staff will be aware of the patient's treatment condition. However, follow-up assessments will be performed by a study staff member that is masked to the participant's treatment condition.|Randomized, single-blinded, controlled trial||||t
1336398|NCT03122171|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336399|NCT03122158|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Adolescents with major depressive disorder or anxiety disorders will be recruited into 2 different diagnostic groups. Each group will include 30 participants. The total scores of the relevant assessment tools (Clinical Global Impression scale, Hamilton Rating Scale for Depression and Anxiety Disorders) at the starting point, 2nd and 6th month of the treatment will be compared.||||
1336400|NCT03122145||Single Group Assignment||Basic Science||None (Open Label)||||||
1336401|NCT03122132|||Other||Prospective|||||||
1336402|NCT03122119||Single Group Assignment||Treatment||None (Open Label)||||||
1336403|NCT03122106||Single Group Assignment||Treatment||None (Open Label)||||||
1336404|NCT03122093|||Cohort||Prospective|||||||
1336405|NCT03122080|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1336406|NCT03122067|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1336407|NCT03122054|Randomized|Parallel Assignment||Treatment||None (Open Label)||patients suffering acute pain because of acute cholecystitis||||
1336408|NCT03122041|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336409|NCT03122028||Single Group Assignment||Treatment||None (Open Label)||||||
1336410|NCT03122015|Randomized|Parallel Assignment||Treatment||None (Open Label)||This pilot study will include a group that will receive the intervention of distraction by the therapeutic clown (CT) and the other that will receive the standard treatment. The study will take place at St. Justine's Hospital, precisely at the infectious diseases clinic. Recruitment of participants will be by convenience from parents and children who will be eligible for study. The sample of this pilot project will contain approximately 24 children in addition to parents and the nurse who will perform the painful procedure.||||
1336411|NCT03122002|||Cohort||Prospective|||||||
1336412|NCT03121989|Non-Randomized|Sequential Assignment||Screening||None (Open Label)||"A total of 13 participants will be recruited for this study. Prior to the first study research MRI scan, 3 volunteer participants will be scanned with a known breast malignancy (Group 1). These participants will not have hyperpolarized 13C pyruvate administered. They will be scanned with a 13C phantom in order to test the functionality of the 13C coil.~Subsequently, up to 10 volunteer participants with breast cancer requiring NAC, between 18 and 80 years of age with pathology- and imaging-confirmed breast cancer requiring NAC will be studied (Group 2). Imaging confirmation involves highly suspicious masses on mammography and/or ultrasound. Pathology confirmation involves image-guided core biopsy of the suspicious mass."||||
1336413|NCT03121976|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1336414|NCT03121963|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336415|NCT03121950|Non-Randomized|Parallel Assignment||Treatment||Single|The primary assessor will be blinded to group|Participants will be placed in one of two groups. One group will participate 2 times a week in a dance class. The other group will listen to live music once a week.||||t
1336416|NCT03121937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336417|NCT03121924|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1336463|NCT03121326|||Cohort||Prospective|||||||
1336464|NCT03121313||Single Group Assignment||Treatment||None (Open Label)||Patients with resected squamous cell carcinoma of oral cavity harboring extracapsular spreading of lymph node s/p adjuvant chemoradiotherapy||||
1336465|NCT03121300||Single Group Assignment||Other||None (Open Label)||||||
1336466|NCT03121287||Single Group Assignment||Prevention||None (Open Label)||||||
1336467|NCT03121274|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336468|NCT03121261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336418|NCT03121911|Randomized|Parallel Assignment||Treatment||None (Open Label)||54 patients will be included, divided into three groups with 18 participants each. All will be submitted to several exams applied to the monitoring of cardiac and pulmonary function. Then, groups 1 (IT) and group 2 (IT + IMT) will participate in a physical training program for 12 weeks and will be re-evaluated after this period. In addition, they will be monitored for a 6 month period after discharge, with returns every two months to measure the energy expenditure through an accelerometer, and at the end of this period they will repeat all the tests again. Group 3 (absence of CR), will consist of patients who do not live in the city or those who can not participate in the CR program for any other reason, and will only participate in the evaluations.||||
1336419|NCT03121898|||Cohort||Prospective|||||||
1336420|NCT03121885|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1336421|NCT03121872|Randomized|Parallel Assignment||Treatment||None (Open Label)||In this randomized controlled clinical trial, multiple gingival recessions were treated by T-PRF in 16 patients and by CTG in 18 patients selected by the coin-toss method. All surgical procedures, measurements and follow-up were performed by the same clinician||||
1336422|NCT03121859|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1336423|NCT03121846||Single Group Assignment||Treatment||None (Open Label)||||||
1336424|NCT03121833|Randomized|Parallel Assignment||Treatment||Double||A total of 150 cases, according to 2: 1 random into the group. Among them, 100 cases of Endostar combined chemotherapy group, 50 cases of placebo + chemotherapy group.|t||t|
1336425|NCT03121820|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Open Label|two-way crossover||||
1336426|NCT03121807||Single Group Assignment||Supportive Care||None (Open Label)||||||
1336427|NCT03121794|||Cohort||Prospective|||||||
1336428|NCT03121781|Randomized|Crossover Assignment||Treatment||None (Open Label)||"Randomization will be done by sealed envelopes, ready for use once consent is obtained.Each envelope will contain a card with the assigned treatment group: protocol 1 or protocol 2.~Protocol 1: we start the study on CPAP with binasal prongs. Edi will be recorded while the infant is on nasal CPAP with the binasal prongs, with a PEEP of 5-8 cm H2O, for 2 hours. Then, the infant will be switched the interface to the RAM cannula, with a PEEP 2 cmH2O higher, during 2 hours.~Protocol 2: we start the study on CPAP with RAM cannula. Edi will be recorded while the infant is on nasal CPAP with the RAM cannula with a PEEP 2 cmH20 higher than the levels the infant was receiving before starting the study protocol, for 2 hours. Then, the infant will be switched the interface to the binasal prongs with a PEEP between 5-8 cmH2O, during 2 hours."||||
1336429|NCT03121768|||Cohort||Prospective|||||||
1336430|NCT03121755|||Case-Only||Other|||||||
1336431|NCT03121742|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336432|NCT03121729||Single Group Assignment||Treatment||None (Open Label)||Patients will receive enhanced recovery after surgery programs.||||
1336433|NCT03121716||Single Group Assignment||Treatment||None (Open Label)||||||
1336434|NCT03121703|Randomized|Parallel Assignment||Treatment||Single|||||t|
1336435|NCT03121690|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1336436|NCT03121677||Single Group Assignment||Treatment||None (Open Label)||||||
1336437|NCT03121664||Crossover Assignment||Basic Science||None (Open Label)||||||
1336438|NCT03121651||Single Group Assignment||Device Feasibility||None (Open Label)||Unblinded pilot study with 1 intervention arm||||
1336439|NCT03121638|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336440|NCT03121625||Single Group Assignment||Treatment||None (Open Label)||||||
1336441|NCT03121612|Randomized|Parallel Assignment||Treatment||None (Open Label)|As the machines are phsyically distinct, blinding of participants, care providers and investigators is not feasible. The assessment of most outcomes cannot therefore be blinded, with one exception: x-rays for neonates with suspected pneumothorax will be provided to a radiologist for indpendent verification; the radiologist will not be in the nursery and will therefoer be blinded to treatment allocation.|||||
1336442|NCT03121599||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336443|NCT03121586||Single Group Assignment||Treatment||None (Open Label)||||||
1336444|NCT03121573||Sequential Assignment||Health Services Research||None (Open Label)||||||
1336445|NCT03121560|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||"Prospective cross-over study (each woman will be her own control) on women with peri-menopausal menorrhagia. Each woman, after signing the informed consent, will come into the bleeding clinic where she will undergo both examinations in a random order, in two days time."||||
1336446|NCT03121547|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1336447|NCT03121534||Single Group Assignment||Treatment||None (Open Label)||||||
1336448|NCT03121521|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336449|NCT03121508||Single Group Assignment||Prevention||None (Open Label)||The investigators will utilize an evidence-based self-management program, and all individuals will be assigned to the prevention group to promote healthy lifestyles.||||
1336450|NCT03121495|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1336451|NCT03121482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336452|NCT03121469||Single Group Assignment||Treatment||None (Open Label)||||||
1336453|NCT03121456||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336454|NCT03121443|||Other||Prospective|||||||
1336455|NCT03121430|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336456|NCT03121417||Single Group Assignment||Treatment||None (Open Label)||||||
1336457|NCT03121404|||Case-Control||Prospective|||||||
1336458|NCT03121391|Randomized|Crossover Assignment||Supportive Care||None (Open Label)|All study sites begin in usual care and each site is randomly assigned to crossover to the intervention arm until all sites conclude in the intervention arm.|Stepped wedge cluster randomized trial||||
1336459|NCT03121378|||Case-Control||Prospective|||||||
1336460|NCT03121365|Randomized|Parallel Assignment||Prevention||None (Open Label)||Eligible participants will be stratified by site and randomized 1:1||||
1336461|NCT03121352||Single Group Assignment||Treatment||None (Open Label)||||||
1336462|NCT03121339|Randomized|Parallel Assignment||Other||None (Open Label)||open-label with two tablet sizes labeled with different radioisotopes||||
1336469|NCT03121248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336470|NCT03121235|||Cohort||Prospective|||||||
1336471|NCT03121222|Randomized|Parallel Assignment||Screening||Single|Double blind crossover design||t|||
1336472|NCT03121209|||Other||Prospective|||||||
1336473|NCT03121196|||Other||Cross-Sectional|||||||
1336474|NCT03121183|||Other||Retrospective|||||||
1336475|NCT03121170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336476|NCT03121157|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336477|NCT03121144||||||||||||
1336478|NCT03121131|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1336479|NCT03121118|||Other||Prospective|||||||
1336480|NCT03121105|||Cohort||Retrospective|||||||
1336481|NCT03121092|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1336482|NCT03121079||Single Group Assignment||Prevention||None (Open Label)||Single Group Assignment||||
1336483|NCT03121066|Randomized|Parallel Assignment||Treatment||Double||The design of the study is a randomized, double blind, parallel clinical trial.|t|||t
1336484|NCT03121053|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336485|NCT03121040|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1336486|NCT03121027|||Ecologic or Community||Cross-Sectional|||||||
1336487|NCT03121014||Single Group Assignment||Treatment||None (Open Label)||||||
1336488|NCT03121001||Single Group Assignment||Treatment||None (Open Label)||||||
1336489|NCT03120988||Single Group Assignment||Treatment||None (Open Label)||Lavage with platelet poor plasma||||
1336490|NCT03120975|Randomized|Parallel Assignment||Treatment||Single|Masking for care providers and investigators is unfortunately not feasible. Outcome assessors and data analysts will be blinded to the study arm allocation.|Parallel group, cluster-randomized superiority trial||||t
1336491|NCT03120962|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1336492|NCT03120949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336493|NCT03120936||Single Group Assignment||Other||None (Open Label)||||||
1336494|NCT03120923|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336495|NCT03120910||||||||||||
1336496|NCT03120897||Single Group Assignment||Other||None (Open Label)||||||
1336497|NCT03120884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336498|NCT03120871|||Other||Cross-Sectional|||||||
1336499|NCT03120858|||Other||Prospective|||||||
1336500|NCT03120845|Randomized|Parallel Assignment||Treatment||Single|To compare incidence of post-operative pain and apical healing after single-visit versus two-visit root canal treatment of teeth with necrotic pulp and apical periodontitis. Each participant received a root canal treatment (RTC)|Ibuprofen for post operative pain. after RCT in one visit|t|||
1336501|NCT03120832||Sequential Assignment||Treatment||None (Open Label)||||||
1336502|NCT03120819|Randomized|Parallel Assignment||Supportive Care||Double|Participant are randomized after receiving an exercise recommendation by their oncologist and thus oncologists are masked; however, study staff will administer survey questions including acceptability of the DVD and thus outcomes assessors are not masked|2 x 3 repeated measures design with 2 groups and 3 time points||t|t|
1336503|NCT03120806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336504|NCT03120793|||Cohort||Prospective|||||||
1336505|NCT03120780|Randomized|Parallel Assignment||Prevention||Single|The subject and the research personnel will be blinded to the arm to which they are randomized. Only the clinician assessing the patient and administering epidural doses will be not be blinded to the study group.|Subjects will be randomly assigned to one of two groups: one group will receive lower dose epidural fentanyl (20 micrograms) combined with local anesthetic; and one group will receive higher-dose epidural fentanyl (100micrograms) combined with the same amount of local anesthetic.|t|||
1336506|NCT03120767|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336507|NCT03120754|Randomized|Parallel Assignment||Treatment||None (Open Label)||SPSS statistical analysis system by the deputy director of our department physician, accepted treatment of 80 subjects (test group and control group) randomly arranged, which lists the serial number from 1 to 80 corresponding to the treatment assignment. In the experiment, 1 patients were divided into the exper||||
1336508|NCT03120741|||Case-Control||Other|||||||
1336509|NCT03120728|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336510|NCT03120715|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1336511|NCT03120702||||||||||||
1336512|NCT03120689|Randomized|Factorial Assignment||Other||Single|||t|||
1336513|NCT03120676||Single Group Assignment||Treatment||None (Open Label)||This is a protocol comprised of a single institution phase II study in HL evaluating the efficacy of atezolizumab.||||
1336514|NCT03120663|||Case-Only||Prospective|||||||
1336515|NCT03120650|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1336516|NCT03120637|Randomized|Sequential Assignment||Supportive Care||Double|||t|||t
1336517|NCT03120624||Single Group Assignment||Treatment||None (Open Label)||||||
1336518|NCT03120611|Randomized|Sequential Assignment||Treatment||Single||||||t
1336519|NCT03120598|Randomized|Parallel Assignment||Health Services Research||Single||Cluster Randomized Trial||||t
1336520|NCT03120585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336521|NCT03120572|||Cohort||Prospective|||||||
1336522|NCT03120559|Randomized|Parallel Assignment||Prevention||Single|The researcher was blind to the patients||||t|
1336523|NCT03120546|Randomized|Crossover Assignment||Other||Double|||t|||t
1336524|NCT03120533|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1336525|NCT03120520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336526|NCT03120507|||Cohort||Prospective|||||||
1336527|NCT03120494||Single Group Assignment||Prevention||None (Open Label)||All subjects will receive same treatment with study drug||||
1336528|NCT03120481|||Cohort||Prospective|||||||
1336529|NCT03120468|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1336530|NCT03120455|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336531|NCT03120442|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1336532|NCT03120429|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336533|NCT03120416|Randomized|Parallel Assignment||Treatment||Single||||||t
1336534|NCT03120403|Randomized|Parallel Assignment||Treatment||Double|using opaque sealed envelopes containing computer generated randomization schedule, the opaque sealed envelopes are sequentially numbered that were open before application of anesthetic plan.|intratehcal injection of drug( morphine).|t||t|
1336535|NCT03120390|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336536|NCT03120377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336537|NCT03120364|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1336538|NCT03120351|Randomized|Parallel Assignment||Treatment||||||||
1336539|NCT03120338|Randomized|Parallel Assignment||Supportive Care||Single|Single Blind|||||t
1336540|NCT03120325||Single Group Assignment||Treatment||None (Open Label)||||||
1336541|NCT03120312|||Case-Only||Retrospective|||||||
1336542|NCT03120299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336543|NCT03120286|||Case-Control||Retrospective|||||||
1336544|NCT03120273|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336545|NCT03120260|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336546|NCT03120247|Randomized|Parallel Assignment||Treatment||Double||Pharmacokinetic and pharmacodynamic study of three different doses of oral transmucosal dexmedetomidine|t|||t
1336547|NCT03120234|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1336548|NCT03120221|||Case-Only||Prospective|||||||
1336549|NCT03120208|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|open|||||
1336550|NCT03120195||Single Group Assignment||Treatment||None (Open Label)||||||
1336551|NCT03120182|Randomized|Parallel Assignment||Treatment||Quadruple|double blinded study|randomized, placebo controlled, double blinded study|t|t|t|t
1336552|NCT03120169|Randomized|Parallel Assignment||Treatment||Single||||||t
1336553|NCT03120156|Randomized|Parallel Assignment||Treatment||None (Open Label)|"Sensomotoric insoles and normal insoles or no insoles are not maskable.Patients and all involved persons will be able to easily see which type of insoles are used.~No blinding possible."|Prospective randomized controlled trial||||
1336554|NCT03120143|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336555|NCT03120130|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Study with dose escalation regime, done according to the classic scheme known as 3 + 3"||||
1336556|NCT03120117||Single Group Assignment||Treatment||None (Open Label)||||||
1336557|NCT03120104|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336558|NCT03120091|||Other||Prospective|||||||
1336559|NCT03120078|||Cohort||Prospective|||||||
1336560|NCT03120065||Single Group Assignment||Other||None (Open Label)||||||
1336561|NCT03120052|||Cohort||Prospective|||||||
1336562|NCT03120039|||Ecologic or Community||Prospective|||||||
1336563|NCT03120026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336564|NCT03120013|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1336565|NCT03120000||Single Group Assignment||Treatment||None (Open Label)||||||
1336566|NCT03119987|||Cohort||Retrospective|||||||
1336567|NCT03119974||Single Group Assignment||Treatment||None (Open Label)||||||
1336568|NCT03119961||Single Group Assignment||Treatment||None (Open Label)||||||
1336569|NCT03119948|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336570|NCT03119935|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1336571|NCT03119922|||Cohort||Retrospective|||||||
1336572|NCT03119909|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1336573|NCT03119896|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||"Two groups; one active group receiving the intervention, and one control group receiving standard care without the intervention."||||
1336574|NCT03119883|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1336575|NCT03119870||Single Group Assignment||Basic Science||None (Open Label)||||||
1336576|NCT03119857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336577|NCT03119844|Randomized|Sequential Assignment||Treatment||Double|||||t|t
1336578|NCT03119831|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1336579|NCT03119818||Single Group Assignment||Basic Science||None (Open Label)||||||
1336580|NCT03119805|||Cohort||Prospective|||||||
1336581|NCT03119792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336582|NCT03119779|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336583|NCT03119766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336584|NCT03119753|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1336585|NCT03119740|||Cohort||Retrospective|||||||
1336586|NCT03119727||Single Group Assignment||Other||None (Open Label)||||||
1336587|NCT03119714|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1336588|NCT03119701|Randomized|Parallel Assignment||Prevention||Quadruple||Multicentre, randomised, double-blinded, Phase II, parallel group comparison study of the efficacy and safety of FP-1201-lyo compared to placebo in patients surviving emergency open surgery for an infra-renal ruptured abdominal aortic aneurysm.|t|t|t|t
1336589|NCT03119688|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1336590|NCT03119675||Single Group Assignment||Screening||None (Open Label)||||||
1336591|NCT03119662|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336592|NCT03119649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336593|NCT03119636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1336594|NCT03119623|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1336595|NCT03119610|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1336596|NCT03119597|Randomized|Parallel Assignment||Prevention||Double|Neither the participants nor the researchers will be aware of which participants are receiving treatment or placebo. Participants and their parents will be debriefed on the last test day.|participants will be assigned to either a Placebo or Blueberry (treatment) drink, in parallel for the duration of the study|t||t|
1336597|NCT03119584|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1336598|NCT03119571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336599|NCT03119558||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336600|NCT03119545|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336601|NCT03119532|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336602|NCT03119519|Randomized|Parallel Assignment||Treatment||None (Open Label)||A randomized phase II trial of first line chemotherapy or targeted therapy plus local definitive radiotherapy or not for patients with synchronous oligometastatic non-small cell lung cancer||||
1336603|NCT03119506|||Cohort||Cross-Sectional|||||||
1336604|NCT03119493|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1336605|NCT03119480|||Cohort||Prospective|||||||
1336606|NCT03119467||Single Group Assignment||Treatment||None (Open Label)||||||
1336607|NCT03119454|||Case-Only||Prospective|||||||
1336608|NCT03119441|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1336609|NCT03119428|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1336610|NCT03119415|Randomized|Parallel Assignment||Prevention||None (Open Label)||This research is a comparison between the Cooperative Learning program and services as usual. Approximately twelve middle schools will be randomized to a waitlist-control condition. The intervention group will receive training in Cooperative Learning immediately and the waitlist-control group will receive training at the end fo the project. Teachers will be given training on the basics of Cooperative Learning and will be supported in their efforts to implement it in their classrooms. No curricular changes will be required. The initial training will last two or three days and will confirm to the professional development calendar of the intervention schools (selected at random). The implementation of Cooperative Learning is expected to be on-going for the full duration of the project (two years).||||
1336611|NCT03119402|Randomized|Parallel Assignment||Treatment||Single|Participants are prevented from having knowledge of which experimental condition (active or sham tDCS) they are assigned to.||t|||
1336612|NCT03119389|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336613|NCT03119376|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1336614|NCT03119363|Randomized|Parallel Assignment||Treatment||Single||Potentially eligible ASCT survivors will be identified by HSCT physicians and nurses at each medical center. A research assistant (RA) will be introduced to survivors who express an interest in the research. An RA will explain the study and consent those who are eligible. Once informed consent is obtained, an RA will conduct the screening interview (including the FACIT-Fatigue scale and a psychiatric and sleep disorder screening). An RA will review a checklist of inclusion and exclusion criteria. This information will also be verified by a review of participants' medical charts before participation begins. Eligible study participants will be randomly assigned condition using a block randomization table prepared by our statistician. Participants who do not meet eligibility criteria or who decline participation will be informed that they have completed their participation.|t|||
1336615|NCT03119350||Single Group Assignment||Treatment||None (Open Label)||||||
1336616|NCT03119337|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The investigators will conduct a prospective, un-blinded, randomized control trial (RCT) among VMMC clients in a 1:1 ratio of control to intervention. Study participants and clinic staff are not masked to treatment.||||
1336617|NCT03119324|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336618|NCT03119311|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1336619|NCT03119298|||Case-Control||Cross-Sectional|||||||
1336620|NCT03119285|||Other||Prospective|||||||
1336621|NCT03119272|||Case-Control||Prospective|||||||
1336622|NCT03119259|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1336623|NCT03119246|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336624|NCT03119233||Single Group Assignment||Treatment||None (Open Label)||||||
1336625|NCT03119220|Randomized|Parallel Assignment||Other||None (Open Label)||The overall behavior change goal is defined as increasing physical activity by 15% every other week over 10 weeks based on an initial one week of activity recording establishing an individual's baseline. This will result in a doubling of the initial steps by weeks 10-11, while keeping the demands and goals comparable between individuals. After the first week, informational support will be manipulated by providing one group with information in the form of physical activity monitoring only. The second group will additionally receive individualized information on how to change behavior by providing maps of a participant's neighborhood with distances depicted in steps, lists with age- and health-status appropriate suggestions as to how to increase numbers of steps, as well as medical information linking changes in physical activity to change in health outcomes; and information on health effects of behavior change by monitoring changes in sleep in conjunction with physical activity changes.||||
1336626|NCT03119207|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336627|NCT03119194||Single Group Assignment||Treatment||None (Open Label)||||||
1336628|NCT03119181||||||||||||
1336629|NCT03119168|Randomized|Parallel Assignment||Screening||Double||||t|t|
1336630|NCT03119155|||Case-Only||Cross-Sectional|||||||
1336631|NCT03119142|||Cohort||Prospective|||||||
1336632|NCT03119129|Randomized|Parallel Assignment||Prevention||None (Open Label)||Dynamic wait-listed control group design||||
1336633|NCT03119116|||Cohort||Retrospective|||||||
1336634|NCT03119103||Single Group Assignment||Supportive Care||None (Open Label)||||||
1336635|NCT03119090|||Cohort||Prospective|||||||
1336636|NCT03119077|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1336637|NCT03119064|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1336638|NCT03119051|Randomized|Parallel Assignment||Treatment||Single||||||t
1336639|NCT03119038|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336640|NCT03119025||Single Group Assignment||Treatment||None (Open Label)||||||
1336641|NCT03119012|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, open label, two-arm, randomized controlled trial||||
1336642|NCT03118999|Randomized|Crossover Assignment||Other||None (Open Label)||Single center, open design, randomized, controlled, cross-over trial with 3 test periods and 3 food supplements containing omega3 (one test period per product).||||
1336643|NCT03118986|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1336644|NCT03118973|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with challenging biliary cannulation randomized to either Goff trans-pancreatic septotomy or double wire technique to facilitate biliary cannulation.||||
1336645|NCT03118960|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336646|NCT03118947||Single Group Assignment||Treatment||None (Open Label)||||||
1336647|NCT03118934|Randomized|Parallel Assignment||Other||Single|Subjects are unmasked to the study lenses that are dispensed, but will be masked to the fitting guides used to fit each eye.||t|||
1336648|NCT03118921||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1336649|NCT03118908|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1336650|NCT03118895||Single Group Assignment||Treatment||None (Open Label)|370 high bleeding risk items|||||
1336651|NCT03118882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336652|NCT03118869|||Case-Only||Prospective|||||||
1336653|NCT03118856|||Cohort||Prospective|||||||
1336654|NCT03118843||Single Group Assignment||Treatment||None (Open Label)||||||
1336655|NCT03118830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336656|NCT03118817||Single Group Assignment||Treatment||None (Open Label)||||||
1336657|NCT03118804|||Cohort||Prospective|||||||
1336658|NCT03118791|Randomized|Crossover Assignment||Treatment||Quadruple||Double blind randomized controlled crossover|t|t|t|t
1336659|NCT03118778|||Case-Only||Retrospective|||||||
1336660|NCT03118765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336661|NCT03118752|Randomized|Parallel Assignment||Treatment||Single||This study will be a randomized, controlled, 2-arm, single blinded trial.||||t
1336662|NCT03118739|Randomized|Parallel Assignment||Treatment||Quadruple|RDEA3170 capsules/matching placebo capsules and febuxostat/matching placebo capsules with randomization code printed on each label|Randomized, double-blind, double-dummy, placebo-controlled, parallel, independent groups, repeated measures, multi-center study|t|t|t|t
1336663|NCT03118726|||Cohort||Other|||||||
1336664|NCT03118713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336665|NCT03118700|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1336666|NCT03118687|||Cohort||Prospective|||||||
1336667|NCT03118674||Single Group Assignment||Treatment||None (Open Label)||||||
1336668|NCT03118661||Single Group Assignment||Supportive Care||None (Open Label)||||||
1336669|NCT03118648|||Cohort||Prospective|||||||
1336670|NCT03118635|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336671|NCT03118622|||Case-Control||Prospective|||||||
1336672|NCT03118609||Single Group Assignment||Supportive Care||None (Open Label)||"A single focus group.~A single group will be analyzed based on survey results"||||
1336673|NCT03118596|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336674|NCT03118583||Single Group Assignment||Supportive Care||None (Open Label)||||||
1336675|NCT03118570|Randomized|Parallel Assignment||Treatment||Double|Sponsor will be masked until the primary analysis of the study except for open-label substudy treatment arm. The study site pharmacist will be unmasked to treatment allocation throughout. Study treatment will be monitored by a separate unmasked monitoring team.|Double-blind, Dose-finding Study, incorporating an open-label substudy|t||t|
1336676|NCT03118557||Single Group Assignment||Other||None (Open Label)||||||
1336677|NCT03118544|||Case-Only||Prospective|||||||
1336678|NCT03118531||Single Group Assignment||Treatment||None (Open Label)||||||
1336679|NCT03118518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336680|NCT03118505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336681|NCT03118492||Single Group Assignment||Treatment||None (Open Label)||||||
1336682|NCT03118479|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1336683|NCT03118466||Single Group Assignment||Treatment||None (Open Label)||||||
1336684|NCT03118453|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336685|NCT03118440|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336686|NCT03118427|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336687|NCT03118414|Randomized|Parallel Assignment||Treatment||Single||||||t
1336688|NCT03118401|Randomized|Parallel Assignment||Prevention||None (Open Label)||"At the end of the first 4 weeks of collection of the data on an individual stool diary with usual care of the resident, a randomization will be carried out dividing the patients according to the following groups:~/ Experimental group Implementation period: From the stool diary: - determine the stool profile of each resident over 1 week (W5)~/ Control group: without modification of practices and without data collection from W5 to W6.~At the end of this second period, data were collected on an individual stool diary in each of the two groups for 4 weeks"||||
1336689|NCT03118388|Randomized|Parallel Assignment||Treatment||None (Open Label)||The SEI model was implemented in four stages: 1) Vocational skill acquisition (4 months); 2) Small business skill acquisition (4 months); 3) SEI formation and product distribution (12 months); and 4) Clinical/case-management services, (ongoing for 20 months). The eight IPS principles were implemented over 20 months by an employment specialist, clinician, and case manager.||||
1336690|NCT03118375|||Cohort||Prospective|||||||
1336691|NCT03118362|Randomized|Parallel Assignment||Treatment||Single|the crystalloid infusion solutions will be introduce in Opabag|"Plasmalyte® is a balanced solution containing a low chloride concentration (i.e. 98 mmol/L) which may overcome overwhelm the potential risks associated with hyperchloremic solutions. Plasmalyte® also contains acetate (27 mmol/L) and gluconate (23 mmol/L) as buffer solutions.~Ringer Lactate® is also a balanced solution containing a low chloride concentration (i.e. 111 mmol/L)"|t|||
1336692|NCT03118349|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1336693|NCT03118336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336694|NCT03118323|||Case-Only||Prospective|||||||
1336695|NCT03118310|Randomized|Parallel Assignment||Treatment||Single||||||t
1336696|NCT03118297|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336697|NCT03118284|||Case-Control||Prospective|||||||
1336698|NCT03118271|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336699|NCT03118258|Randomized|Parallel Assignment||Screening||None (Open Label)||"After the prevention consultation women would be included in one of the two groups :~refered to health centers partners for a pap smear test (arm Pap test)~make a vaginal HPV self-sampling, and after that refered to health centers partners for a pap smear (HPV self sampling + Pap test)"||||
1336700|NCT03118245|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336701|NCT03118232|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336702|NCT03118219|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336703|NCT03118206|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336704|NCT03118193||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336705|NCT03118180||Single Group Assignment||Treatment||None (Open Label)||||||
1336706|NCT03118167|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1336707|NCT03118154|||Case-Control||Other|||||||
1336708|NCT03118141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336709|NCT03118128|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1336710|NCT03118115||Single Group Assignment||Basic Science||None (Open Label)||Measurement of the flap bioimpedance before and after clamping of the artery or the vein. For information: All patients will have the vein and the arterial section simulating venous or arterial thrombosis.||||
1336711|NCT03118102|||Case-Control||Prospective|||||||
1336712|NCT03118089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336713|NCT03118076|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1336714|NCT03118063|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1336715|NCT03118050|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1336716|NCT03118037|||Cohort||Prospective|||||||
1336717|NCT03118024|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1336718|NCT03118011|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336719|NCT03117998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336720|NCT03117985||Single Group Assignment||Basic Science||None (Open Label)||||||
1336721|NCT03117972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336722|NCT03117959|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1336723|NCT03117946||Single Group Assignment||Basic Science||None (Open Label)||||||
1336724|NCT03117933|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised open label trial with 3 arms, stratified for prior PARP and prior anti-angiogenic use.||||
1336725|NCT03117920||Single Group Assignment||Treatment||None (Open Label)||Single arm, open label study.||||
1336726|NCT03117907|||Case-Control||Prospective|||||||
1336727|NCT03117894|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336728|NCT03117881|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336729|NCT03117868|||Cohort||Prospective|||||||
1336730|NCT03117855||Single Group Assignment||Treatment||None (Open Label)||||||
1336731|NCT03117842|Randomized|Single Group Assignment||Health Services Research||Single|Statistical Analysis will be conducted without knowledge of the assignment of the groups.|A 12-month randomized controlled trial (RCT) will be conducted to evaluate the Mobile Link intervention, with two arms of 300 FEWs each. FEWs will be equally randomized into one of two groups: (1) no intervention and (2) SMS or VM theory-based behavioral messages.||||t
1336732|NCT03117829||Single Group Assignment||Other||None (Open Label)||||||
1336733|NCT03117816|Randomized|Parallel Assignment||Prevention||Single|A randomized, open-label assessor blinded, multi-center, controlled phase II trial|||||t
1336734|NCT03117803|||Cohort||Prospective|||||||
1336735|NCT03117790|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1336736|NCT03117777|||Cohort||Prospective|||||||
1336737|NCT03117764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336738|NCT03117751|Randomized|Parallel Assignment||Treatment||Single|Only certain outcome measures as indicated will be blinded to the outcomes assessor.|||||t
1336739|NCT03117738|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336740|NCT03117725|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1336741|NCT03117712|||Cohort||Prospective|||||||
1336742|NCT03117699|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1336743|NCT03117686|||Other||Prospective|||||||
1336744|NCT03117673|||Case-Only||Prospective|||||||
1336745|NCT03117660|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Prospective, randomized, parallel group study||||
1336746|NCT03117647|||Case-Only||Prospective|||||||
1336747|NCT03117634|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, 2-arm, Non-inferiority, interventional study||||
1336748|NCT03117621|||Other||Prospective|||||||
1336749|NCT03117608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336750|NCT03117595|Randomized|Parallel Assignment||Treatment||Triple|a double blinded study. The participant and the Physician giving the treatment who would also evaluate the participant during the duration of the study are masked. However, the Assistant who is in charge of the randomization process and has the code and so would prepare the drugs is not blinded. The non-blinded Assistant would be available to break the code in the event of any adverse reactions.|2 groups that would remain with the randomly picked intervention throughout the study duration|t||t|t
1336751|NCT03117582|||Cohort||Prospective|||||||
1336752|NCT03117569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336753|NCT03117556|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||All patients with unresectable pancreatic cancer will be considered for participation in this study. Patients with locally advanced or metastatic cancer that meet inclusion criteria will be randomized into one of two arms, treatment with BTS and narcotic analgesia or treatment with narcotic analgesia alone.||||
1336754|NCT03117543|||Cohort||Cross-Sectional|||||||
1336755|NCT03117530||Single Group Assignment||Treatment||None (Open Label)||||||
1336756|NCT03117517|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1336757|NCT03117504|||Cohort||Cross-Sectional|||||||
1336758|NCT03117491|Randomized|Parallel Assignment||Other||Single|||t|||
1336759|NCT03117478|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1336760|NCT03117465|Randomized|Parallel Assignment||Treatment||None (Open Label)||All the hemiplegic patients were mainly derived from stroke recovery periodical inpatients from September 2015 to September 2016 in rehabilitation unit of shenzhen nanshan district people's hospital, Guangdong Province,China. All subjects were told in detail about the risks and signed informed consent before the experiment.||||
1336761|NCT03117452|Randomized|Parallel Assignment||Treatment||Single|All participants will be assessed on outcomes of interest by trained clinical interviewers who are blind to the treatment condition in which participants are assigned.|Half of the participants will be randomized to receive the computerized visual training, which will be delivered in small groups over a period of 12-14 weeks, and the other half will be assigned to the control condition, which consists of standard Partial Hospital care without visual training.||||t
1336762|NCT03117439|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336763|NCT03117426|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336764|NCT03117413|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Subjects with asymmetric hearing loss treated with a cochlear implant and a control group of normal hearing subjects||||
1336765|NCT03117400|||Cohort||Prospective|||||||
1336766|NCT03117387|||Cohort||Prospective|||||||
1336767|NCT03117374|Non-Randomized|Parallel Assignment||Other||Single||||t||
1336768|NCT03117361||Single Group Assignment||Treatment||None (Open Label)||||||
1336769|NCT03117348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336770|NCT03117335|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind|Parallel Assignment|t|t|t|t
1336771|NCT03117322|Randomized|Factorial Assignment||Treatment||Triple|pediatric neurologist and laboratory staff.|Three interventions in parallel against a control group|t|t|t|
1336772|NCT03117309|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)|Open Label|||||
1336773|NCT03117296|||Cohort||Other|||||||
1336774|NCT03117283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336775|NCT03117270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336776|NCT03117257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336777|NCT03117244|Randomized|Parallel Assignment||Treatment||Single|||||t|
1336778|NCT03117231|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1336779|NCT03117218|||Case-Only||Prospective|||||||
1336780|NCT03117205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336781|NCT03117192|Randomized|Parallel Assignment||Prevention||Triple|Secretary to the department held an envelope that shows sample allocation after randomization. The envelope is only revealed after data gathering is finished.|This interventional study is a randomized controlled trial comparing the parallel provision of zinc and placebo in 2 groups of splenectomized thalassemia major patients.|t|t|t|
1336782|NCT03117179|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1336783|NCT03117166|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1336784|NCT03117153|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1336785|NCT03117140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336786|NCT03117127|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1336787|NCT03117114|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336788|NCT03117101||Single Group Assignment||Treatment||None (Open Label)||||||
1336789|NCT03117088|Randomized|Crossover Assignment||Other||None (Open Label)||two armed cluster randomized crossover three periods prospective single centre pilot study||||
1336790|NCT03117075||Single Group Assignment||Supportive Care||None (Open Label)||||||
1336791|NCT03117062|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1336792|NCT03117049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336793|NCT03117036|||Cohort||Prospective|||||||
1336794|NCT03117023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336795|NCT03117010|||Cohort||Prospective|||||||
1336796|NCT03116997|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1336797|NCT03116984|Randomized|Parallel Assignment||Treatment||Single|||||t|
1336798|NCT03116971|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336799|NCT03116958|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1336800|NCT03116945||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336801|NCT03116932|||Case-Only||Prospective|||||||
1336802|NCT03116919|Randomized|Crossover Assignment||Prevention||None (Open Label)||Crossover feeding trial||||
1336803|NCT03116906|Randomized|Parallel Assignment||Treatment||Single|||t|||
1336804|NCT03116893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1336805|NCT03116880|||Case-Only||Prospective|||||||
1336806|NCT03116867|||Cohort||Prospective|||||||
1336807|NCT03116854|||Cohort||Prospective|||||||
1336808|NCT03116841||Single Group Assignment||Treatment||None (Open Label)||||||
1336809|NCT03116828|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|Arm 1 (ESL as first add-on) Arm 2 (ESL as later add-on)||||
1336810|NCT03116815||Single Group Assignment||Other||None (Open Label)||This single arm study will examine use of the MyChart web-application whereby patients directly record their home blood pressure readings into their electronic health record with this web-based application.||||
1336811|NCT03116802|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1336812|NCT03116789|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized, Parallel, open lable Study||||
1336813|NCT03116776|Randomized|Parallel Assignment||Treatment||Double|outcome assessor and statistician will be blinded||||t|t
1336814|NCT03116763|Randomized|Parallel Assignment||Treatment||Single|||||t|
1336815|NCT03116750|||Cohort||Prospective|||||||
1336816|NCT03116737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336817|NCT03116724||Single Group Assignment||Supportive Care||None (Open Label)||||||
1336818|NCT03116711|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1336819|NCT03116698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336820|NCT03116685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336821|NCT03116672|Randomized|Parallel Assignment||Treatment||Single|"Patient selection.~Fifty-four of sixty-five patients (29 women and 25 men), 18 to 60 years of age with 54 eligible teeth consented to participate in the study. The patients were randomly divided into three groups using a web program. The patient number and group number were recorded. Informed consent was obtained from each patient and the possible discomforts and risks were fully explained.~A total of 54 patients were divided into three groups (n = 18) according to the type of preoperative drug administrated, as follows: Group A: Administration of ketorolac 10mg, Group B: Administration of Diclofenac Na 50mg, and Group C: A placebo (capsule filled with sugar).~After 15 minutes each participant received the treatment."|"Patient selection.~Fifty-four of sixty-five patients (29 women and 25 men), 18 to 60 years of age with 54 eligible teeth consented to participate in the study. The patients were randomly divided into three groups using a web program. The patient number and group number were recorded. Informed consent was obtained from each patient and the possible discomforts and risks were fully explained.~A total of 54 patients were divided into three groups (n = 18) according to the type of preoperative drug administrated."|t|||
1336822|NCT03116659||Single Group Assignment||Treatment||None (Open Label)||||||
1336823|NCT03116646||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336824|NCT03116633|||Cohort||Prospective|||||||
1336825|NCT03116620||Single Group Assignment||Other||None (Open Label)||||||
1336826|NCT03116607|Randomized|Parallel Assignment||Supportive Care||Single||parallels groups: control arm will recieve normal healthcare, intervention arm will recieve a pharmaceutilcal intervention program.||||t
1336827|NCT03116594|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1336828|NCT03116581|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1336829|NCT03116568|||Case-Control||Prospective|||||||
1336830|NCT03116555|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336831|NCT03116542||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336832|NCT03116529||Single Group Assignment||Treatment||None (Open Label)||||||
1336833|NCT03116516|Randomized|Crossover Assignment||Treatment||None (Open Label)||A randomized, open-label, single dose, crossover clinical trial||||
1336834|NCT03116503||Single Group Assignment||Screening||None (Open Label)||Describe the number of diagnosis of bipolar disorder and comorbid depression of suicidal behaviors in the pediatric population.||||
1336835|NCT03116490|||Cohort||Prospective|||||||
1336836|NCT03116464||Single Group Assignment||Treatment||None (Open Label)||"Family based telemental health intervention that incorporates: (1) psychoeducation on dementia, (2) communication and problem solving skills, (3) safety building skills, (4) relationship satisfaction enhancement skills, (5) meaning making (i.e. collaboratively identifying the personal significance of events), (6) identification of core patterns from dyad relationship history, (7) techniques to shift emotional responses, (8) techniques to increase emotional attunement, and (9) techniques to increase attunement to care-recipient needs."||||
1336837|NCT03116451|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Quasi-experimental study design||||
1336838|NCT03116438||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336839|NCT03116425|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1336840|NCT03116412|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1336841|NCT03116399|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1336842|NCT03116386|Non-Randomized|Sequential Assignment||Device Feasibility||None (Open Label)||Run-in period then 6 months control period and then 6 months experimental period with activation of all the functions of Etolya-F® (the device used in the study)||||
1336843|NCT03116373|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1336844|NCT03116360||Single Group Assignment||Screening||None (Open Label)|Subjects will be required to have already undergone the initial step of the traditional diagnostic algorithm with x-ray of the suspicious region. All subjects will then be scheduled to undergo diagnostic ultrasound at a separate appointment with ultrasound procedure performed by a blinded clinical physician. All patients will then undergo a confirmatory MRI of the region of concern. A statistician in the Department of Public Health at the University of Virginia will be performing statistical analysis. All x-ray and MRI obtained for this study will be read by a Radiologist board certified in Musculoskeletal Radiology. Diagnostic ultrasound performance: The physician performing the ultrasound will be blinded to the results of the x-ray and MRI. The physician performing the ultrasound will be informed of the bone in question (ex. Tibia) and will be able to perform a focused history and exam.|Subjects suspected to have an acute stress fracture of the lower extremity will be recruited. Subjects will be required to have already undergone the initial step of the traditional diagnostic algorithm with x-ray as part of clinical care of the suspicious region on the day of enrollment. A physical exam and vital signs will be obtained as part of standard clinical care. All subjects will then be scheduled to undergo diagnostic ultrasound for research purposes at a separate appointment with ultrasound procedure performed by a blinded clinical physician boarded in Physical Medicine and Rehabilitation, competent in performing and reading diagnostic ultrasound. All subjects will then undergo a confirmatory MRI without contrast of the region of concern. The MRI may be ordered as part of clinical care or for research if not required for clinical purposes. MRI screening per standard processes will be done by the MRI staff.||||
1336845|NCT03116347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1336846|NCT03116334|||Cohort||Cross-Sectional|||||||
1336847|NCT03116321|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1336848|NCT03116308||Single Group Assignment||Treatment||None (Open Label)||||||
1336849|NCT03116295|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1336850|NCT03116282|Randomized|Parallel Assignment||Treatment||Single||||||t
1336851|NCT03116269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336852|NCT03116256|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Participant will be randomised into one of the following group:~VLCD (N=12),~VLCD + RET (N=12)~VLCD + HIIT (N=12)"||||
1336853|NCT03116243|||Other||Cross-Sectional|||||||
1336854|NCT03116230|Randomized|Crossover Assignment||Treatment||Single|Participants will be told only that we are comparing two types of treatment for their knee pain.||t|||
1336855|NCT03116217|||Case-Only||Prospective|||||||
1336856|NCT03116204|||Ecologic or Community||Prospective|||||||
1336857|NCT03116191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336858|NCT03116178|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1336859|NCT03116165|Randomized|Parallel Assignment||Prevention||Single||||||t
1336860|NCT03116152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336861|NCT03116139|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336862|NCT03116126|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1336863|NCT03116113|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1336864|NCT03116100|||Cohort||Prospective|||||||
1336865|NCT03116087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336866|NCT03116074|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1336867|NCT03116061|||Cohort||Prospective|||||||
1336868|NCT03116048|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1336869|NCT03116035|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336870|NCT03116022|Randomized|Parallel Assignment||Treatment||Single|||||t|
1336871|NCT03116009|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Two groups of obese pregnant women:~Group 1: They will be screened for diabetes mellitus before 20 weeks of gestation.~Group 2: They will be screened for diabetes mellitus at 24 - 28 weeks."||||
1336872|NCT03115996|Randomized|Parallel Assignment||Basic Science||Quadruple|Double-blinded||t|t|t|t
1336873|NCT03115983|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a multi-center, prospective, concurrently controlled, non-blinded study. Balance between groups will be achieved through sub classification using propensity scores.||||
1336874|NCT03115970|||Cohort||Prospective|||||||
1336875|NCT03115957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336876|NCT03115944||Single Group Assignment||Treatment||None (Open Label)||||||
1336877|NCT03115931|||Cohort||Prospective|||||||
1336878|NCT03115918|Randomized|Parallel Assignment||Treatment||Single|||||t|
1336879|NCT03115905|||Cohort||Prospective|||||||
1336880|NCT03115892|Randomized|Parallel Assignment||Prevention||None (Open Label)|Statistician only will be blind|two group one for intervention and one for control randomize control trail||||
1336881|NCT03115879|Randomized|Parallel Assignment||Treatment||Single|||||t|
1336882|NCT03115866|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||2 interventions evaluated against the other and a control.||||
1336883|NCT03115853|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1336884|NCT03115840|||Cohort||Prospective|||||||
1336885|NCT03115827||Single Group Assignment||Treatment||None (Open Label)|All patients will receive the same treatment.|This is a single-arm study enrolling 15 patients that will all receive the experimental treatment.||||
1336886|NCT03115814|||Other||Prospective|||||||
1336887|NCT03115801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336888|NCT03115788|Randomized|Parallel Assignment||Health Services Research||Double||2 groups; control and treated|t||t|
1336889|NCT03115775|Randomized|Parallel Assignment||Other||Quadruple||Randomized, double-blind, controlled clinical trial|t|t|t|t
1336890|NCT03115762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336891|NCT03115749|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1336892|NCT03115736||Single Group Assignment||Treatment||None (Open Label)||||||
1336893|NCT03115723|||Cohort||Prospective|||||||
1336894|NCT03115710|||Cohort||Prospective|||||||
1336895|NCT03115697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336896|NCT03115684|||Other||Prospective|||||||
1336897|NCT03115671|Randomized|Parallel Assignment||Treatment||Single|Clinicians conducting the study assessments and teachers who will be providing feedback will be blinded to the study arm.|||||t
1336898|NCT03115658||Single Group Assignment||Other||Single||||||t
1336899|NCT03115645|Randomized|Parallel Assignment||Prevention||Single||Cluster randomized controlled trial||||t
1336900|NCT03115632|||Case-Control||Prospective|||||||
1336901|NCT03115619|||Cohort||Prospective|||||||
1336902|NCT03115606|Randomized|Parallel Assignment||Other||Single|||t|||
1336903|NCT03115593||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336904|NCT03115580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336905|NCT03115567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336906|NCT03115554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336907|NCT03115541|||Cohort||Prospective|||||||
1336908|NCT03115528|||Case-Control||Prospective|||||||
1336909|NCT03115515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336910|NCT03115502|||Cohort||Prospective|||||||
1336911|NCT03115489|Randomized|Parallel Assignment||Prevention||Single|||t|||
1336912|NCT03115476|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337051|NCT03113669||Single Group Assignment||Treatment||None (Open Label)||||||
1337052|NCT03113656|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1336913|NCT03115463|Randomized|Parallel Assignment||Treatment||Single|Clinical care team in the neonatal intensive care unit, investigators running the oxidative stress measurements and investigator assessing neurodevelopmental outcomes will be blinded to which arm the infant was randomized to in the delivery room.|||||t
1336914|NCT03115450|||Case-Only||Prospective|||||||
1336915|NCT03115437|Randomized|Parallel Assignment||Prevention||Quadruple|Participants will be stratified according to their sex since body mass depends on sex. Two pre-established randomization list (block size = 40) will be prepared by a statistician not involved in any other part of the study before the beginning of the study. To ensure allocation concealment, the study groups as well as the shoes will be coded and the randomization lists will be uploaded in the TIPPS system by an IT specialist who will not be involved in any other part of the study. The TIPPS system will provide the investigator with a study group code for each participant, according to the randomization lists. The investigator will upload the shoe ID according to shoe size and study group so that a cross validation will be performed by the TIPPS system. The investigators in charge of the recruitment, follow-up and data validity check, as well as the participants, will be blinded regarding the shoe version distributed. The shoe code will be broken after completion of data analysis.||t|t|t|t
1336916|NCT03115424|Randomized|Parallel Assignment||Other||Triple|Double-blind design.||t|t|t|
1336917|NCT03115411||Single Group Assignment||Treatment||None (Open Label)||Patients with benign biliary obstruction who meet all inclusion criteria will be approached to consent for placement of a winged biliary stent for 90 days with appropriate laboratory studies and clinical evaluations.||||
1336918|NCT03115398|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336919|NCT03115385|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1336920|NCT03115372|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336921|NCT03115359|Randomized|Parallel Assignment||Treatment||Single|Although participants, therapists and outcome assessors cannot be blinded to the study intervention, investigators and analysts will be blinded to the group status until the first stages of analysis and reporting are completed.|Comparative effectiveness randomized controlled trial of two behavioral interventions|||t|
1336922|NCT03115346|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||This is a cluster randomized study. Sites will be randomly assigned to the intervention group - (decision aid +survey), or control group (survey only). The randomization scheme is 9:1, for complex and intermediate VA sites.||||
1336923|NCT03115333||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336924|NCT03115320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336925|NCT03115307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336926|NCT03115294||Single Group Assignment||Device Feasibility||None (Open Label)|video analysts do not get information of the clinical data or procedure phase|Patients undergo medication intervention (w/intravenous theophylline) and ventilator volume adjustements, and serial ventricular function parameters are compared (pre-and post-intervention measurements).||||
1336927|NCT03115281|||Cohort||Prospective|||||||
1336928|NCT03115268|Randomized|Crossover Assignment||Treatment||Single||||||t
1336929|NCT03115255||Single Group Assignment||Health Services Research||None (Open Label)||||||
1336930|NCT03115242||Single Group Assignment||Prevention||None (Open Label)||||||
1336931|NCT03115229|Randomized|Parallel Assignment||Prevention||Single|"In the RCT, blindness was done in terms of data collectors and statistician. The data were collected by another investigator (assistant investigator) who did not know who was in the experiment and control group, and the data were recorded by the assistant investigator on the computer, without specifying the experiment and control group.~Experimental and control groups were coded by an assistant investigator. Analysis of the data encoded by groups was done by a statistician.~After the statistical analyzes were made and the research report was written, the assistant investigator explained the coding for the experiment and control group.~In this way, data gathering, statistical analysis and reporting have been blinded.~Note: Two assistant researchers received support from the research process. One of the assistant researcher is a coach who is a graduate of the Faculty of Sport Sciences other than Ph.D. Student of the Department of Public Health Nursing"|||||t
1336932|NCT03115216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336933|NCT03115203|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1336934|NCT03115190|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1336935|NCT03115177|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336936|NCT03115164|||Cohort||Retrospective|||||||
1336937|NCT03115151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336938|NCT03115138||Single Group Assignment||Other||None (Open Label)||||||
1336939|NCT03115125||Single Group Assignment||Other||None (Open Label)||||||
1336940|NCT03115112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336941|NCT03115099|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1336942|NCT03115086|||Cohort||Prospective|||||||
1336943|NCT03115073|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1336944|NCT03115060|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1336945|NCT03115047|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinded randomized study: meperidine and dexmedetomidine will be prepared at the hospital pharmacy in a 10 mL seringue with equivalent dilution in order to gave mL/kg.|Comparing two groups: experimental (dexmedetomidine) versus control (meperidine)|t|t|t|t
1336946|NCT03115034|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336947|NCT03115021|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1336948|NCT03115008|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336949|NCT03114995|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1336950|NCT03114982|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1336951|NCT03114969|||Cohort||Prospective|||||||
1336952|NCT03114956|Randomized|Parallel Assignment||Treatment||Single|The investigator who is analyzing the data will be blinded to the assigned groups to prevent bias.|||||t
1336953|NCT03114943|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1336954|NCT03114930|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336955|NCT03114917|Randomized|Parallel Assignment||Treatment||Single|All Research Assistants will be blinded to treatment allocation. The Research Assistants will be carrying out outcomes assessments at baseline, 6 month and 12 month.|Randomised-control trial||||t
1336956|NCT03114904|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336957|NCT03114891|Randomized|Crossover Assignment||Treatment||Double|The patients will be blinded as to whether or not their site of stimulation is based on the standard targeting method or our novel fMRI-guided targeting method. In addition, staff members administering TMS will not know if the site of stimulation was created based on the standard targeting method or novel fMRI method.|This is a randomized study. All subjects will receive active TMS, so there is no placebo or sham condition. However, the patients will be blinded as to whether or not their site of stimulation is based on the standard targeting method or our novel fMRI-guided targeting method. TMS is administered over to one of these two sites over a two week period, and then TMS will be administered to the other site over a subsequent two-week period. All subjects will receive TMS to both sites as a part of the study, but the order is randomized and counterbalanced.|t|t||
1336958|NCT03114878|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1336959|NCT03114865||Single Group Assignment||Treatment||None (Open Label)||||||
1336960|NCT03114852|||Family-Based||Prospective|||||||
1336961|NCT03114839||Single Group Assignment||Treatment||None (Open Label)||The study is a dietary intervention study with a repeated measures design, comparing the upper gastrointestinal microbiota profiles in healthy male subjects before and after consumption of a probiotic drink containing Lactobacillus casei strain Shirota.||||
1336962|NCT03114826|||Cohort||Retrospective|||||||
1336963|NCT03114813|||Cohort||Prospective|||||||
1336964|NCT03114800||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1336965|NCT03114787|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336966|NCT03114774|||Cohort||Prospective|||||||
1336967|NCT03114761||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336968|NCT03114748|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1336969|NCT03114735|||Case-Only||Prospective|||||||
1336970|NCT03114722|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1336971|NCT03114709|Randomized|Parallel Assignment||Other||Double|||||t|t
1336972|NCT03114696|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1336973|NCT03114683||Single Group Assignment||Treatment||None (Open Label)||||||
1336974|NCT03114670||Single Group Assignment||Treatment||None (Open Label)||||||
1336975|NCT03114657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1336976|NCT03114644||Single Group Assignment||Other||None (Open Label)||||||
1336977|NCT03114631|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336978|NCT03114618|||Cohort||Prospective|||||||
1336979|NCT03114605|Randomized|Parallel Assignment||Prevention||Single||||||t
1336980|NCT03114592|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1336981|NCT03114579|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1336982|NCT03114566|||Cohort||Prospective|||||||
1336983|NCT03114553|||Cohort||Prospective|||||||
1336984|NCT03114540|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Multiple-center, nonrandomized, open-label, parallel group study||||
1336985|NCT03114527|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336986|NCT03114514||Single Group Assignment||Treatment||None (Open Label)||||||
1336987|NCT03114501|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1336988|NCT03114488||||||||||||
1336989|NCT03114475|Randomized|Crossover Assignment||Prevention||Triple|The non-irradiated side of the mouth will receive a placebo light (i.e. not the laser beam).|Split mouth design, the mouth will be split into four quadrants. Two quadrants will receive the active treatment, whereas the opposing two quadrants will receive the placebo.|t||t|t
1336990|NCT03114462||Single Group Assignment||Treatment||None (Open Label)||||||
1336991|NCT03114449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1336992|NCT03114436|||Cohort||Prospective|||||||
1336993|NCT03114423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1336994|NCT03114410||||Prevention||||||||
1336995|NCT03114397|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1336996|NCT03114384||Single Group Assignment||Diagnostic||None (Open Label)||||||
1336997|NCT03114371|Randomized|Parallel Assignment||Treatment||Double|"The packaging, presentation and labelling of the bottles used during the blind phase will guarantee the blindness to the healthcare team and the patient.~The allocation of the treatment arms to each treatment number will be carried out according to the randomization table established beforehand.~Until the end of the study, neither the investigating physician nor the patient will know the group to which the patient has been randomly assigned."|Children will receive after randomization either placebo or oxytocin administration (daily intranasal) for a total duration of 12 consecutive weeks.|t||t|
1336998|NCT03114358|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1336999|NCT03114345||Single Group Assignment||Basic Science||None (Open Label)||||||
1337000|NCT03114332|Randomized|Parallel Assignment||Prevention||Single|||||t|
1337001|NCT03114319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1337002|NCT03114306|Randomized|Parallel Assignment||Treatment||Double|Investigator and treating physicians are different in this trial, that means, the assessor of primary study endpoint will be blinded regarding group allocation. Patients receive either regional-anaesthesiological catheters preoperatively or are treatet with local infiltration technique perioperatively. For the purpose of this trial is would not be feasable to perform sham regional-anaesthesiological procedures and blinding of the treating physisican will not be possible.||||t|t
1337003|NCT03114293|Randomized|Parallel Assignment||Treatment||Double|Rater blinded.|Short, randomised waiting-group controlled explorative studies of a behavioural intervention.|||t|t
1337050|NCT03113682||Single Group Assignment||Treatment||None (Open Label)||There is only one arm in this study - all participants will be in the same arm, as all participants will receive CBT-RD. There is no control group.||||
1337004|NCT03114280||Single Group Assignment||Treatment||None (Open Label)||Fluorouracil (F) and pembrolizumab every 21 days followed by radiotherapy (RT) combined with carboplatin in untreated unresectable locally-advanced Head and Neck Squamous Cell Carcinoma (HNSCC).||||
1337005|NCT03114267|||Cohort||Retrospective|||||||
1337006|NCT03114254||Single Group Assignment||Treatment||None (Open Label)||||||
1337007|NCT03114241|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Eligible patients will be randomized 1:1 to one of the two groups: conventional care group or intervention group. No minimization procedures are used.||||
1337008|NCT03114228||||||||||||
1337009|NCT03114215|Randomized|Parallel Assignment||Other||Quadruple||"The primary objective of the study is to evaluate the safety of biotin at 300 mg/day over placebo in patients with amyotrophic lateral sclerosis.~This is a 6-month double blind randomized 2:1 placebo-controlled study with two arms (placebo, biotin 300 mg/day). The study will be followed by a 6-month extension phase during which all patients will receive biotin 300 mg/day."|t|t|t|t
1337010|NCT03114202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337011|NCT03114189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337012|NCT03114176||Single Group Assignment||Prevention||None (Open Label)||||||
1337013|NCT03114163|||Cohort||Prospective|||||||
1337014|NCT03114150|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1337015|NCT03114137|||Cohort||Prospective|||||||
1337016|NCT03114124|Randomized|Parallel Assignment||Treatment||Single|Variable block sizes will be used to improve the blinding of the clinical team. This information will then be used to design a fully-powered randomized study to compare these two arms. Patients will be randomly assigned to study arms. The project biostatistician and team will generate a set of envelopes which contain the random assignments for each patient. Once a patient has consented to participate, the next envelope will be opened for that patient and the catheter assignment will be revealed. This will maintain the blinding of the clinical team.|Standard ablation catheter vs MIFI catheter|||t|
1337017|NCT03114111|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337018|NCT03114098||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337019|NCT03114085|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337020|NCT03114072|Randomized|Parallel Assignment||Treatment||Double|Consenting participants will be randomized (by www.randomizer.org) to either intervention/control condition. The intervention- and control glasses will be covered in the same looking wrapping, done by a third person, which will blind the investigator as well.||t||t|
1337021|NCT03114059|||Cohort||Prospective|||||||
1337022|NCT03114046||Single Group Assignment||Treatment||None (Open Label)||||||
1337023|NCT03114033|Randomized|Parallel Assignment||Treatment||Triple|A Randomised, Parallel Groups, Assessor Blinded, Clinical Trial|Parallel assignment|t||t|t
1337024|NCT03114020|Randomized|Parallel Assignment||Treatment||Double|treatment has blinded labeling||t||t|
1337025|NCT03114007|Randomized|Parallel Assignment||Prevention||Single||||||t
1337026|NCT03113994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337027|NCT03113981|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337028|NCT03113968|Randomized|Parallel Assignment||Treatment||None (Open Label)|Due to the nature of the study treatments it is not possible to blind patients or investigators.|unblinded prospective randomized open-label||||
1337029|NCT03113955||Single Group Assignment||Treatment||None (Open Label)||||||
1337030|NCT03113942||Single Group Assignment||Treatment||None (Open Label)||Open label, phase 2 trial, single-arm||||
1337031|NCT03113929|||Case-Only||Cross-Sectional|||||||
1337032|NCT03113916|Randomized|Parallel Assignment||Prevention||Double||Trial participants are randomly assigned to one of two conditions: 1) Enhanced usual care control, or 2) a culturally tailored behavioral intervention.|t|||t
1337033|NCT03113903|Non-Randomized|Crossover Assignment||Other||Single|open||t|||
1337034|NCT03113890|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|No Masking|The investigators will enroll 200 inpatient subjects over 2 years who will donate saliva/undergo a cheek swab to collect DNA for the Genecept assay. For 100 patients in the assay-guided group (AGG), study doctors will receive the Genecept report prior to patient discharge and use it to guide psychoeducation and medication management. For the additional 100 inpatients, treating clinicians will not receive the report during the patient's inpatient stay (treatment as usual, TAU). Study Doctors will receive the assay report for patients in the treatment-as-usual group at the 3-month followup period. Thus this group will serve as the control group for the outcomes related to Genecept-guided decision making.||||
1337035|NCT03113877|||Case-Only||Prospective|||||||
1337036|NCT03113864|Randomized|Parallel Assignment||Prevention||Quadruple|All parties involved in the study are blinded|Randomized, Double-Blind, Placebo-Controlled, Parallel Intervention Trial|t|t|t|t
1337037|NCT03113851||Single Group Assignment||Treatment||None (Open Label)||||||
1337038|NCT03113838|||Cohort||Prospective|||||||
1337039|NCT03113825||Single Group Assignment||Treatment||None (Open Label)||Period 1 will enroll approximately 35 patients to evaluate conditions to achieve maximal differences in fluorescent signals between malignant and nonmalignant tissue. Period 2 will enroll approximately 120 patients to test dosing and imaging conditions determined in Period 1 and accuracy of AVB-620 imaging data to distinguish between malignant and nonmalignant tissues.||||
1337040|NCT03113812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337041|NCT03113799||Single Group Assignment||Treatment||None (Open Label)||In this study the subject will act as their own control and will be treated on day one with the standard of care EVD and then on Day 2 treated with the SED.||||
1337042|NCT03113786|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337043|NCT03113773|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1337044|NCT03113760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337045|NCT03113747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337046|NCT03113734|||Other||Prospective|||||||
1337047|NCT03113721|||Cohort||Prospective|||||||
1337048|NCT03113708|Randomized|Parallel Assignment||Diagnostic||Single|Closed envelope|||t||
1337049|NCT03113695||Single Group Assignment||Treatment||None (Open Label)||||||
1337053|NCT03113643||Single Group Assignment||Treatment||None (Open Label)||||||
1337054|NCT03113630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337055|NCT03113617||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337056|NCT03113604|||Cohort||Retrospective|||||||
1337057|NCT03113591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337058|NCT03113578|||Cohort||Prospective|||||||
1337059|NCT03113565|||Cohort||Prospective|||||||
1337060|NCT03113552|||Cohort||Retrospective|||||||
1337061|NCT03113539||Single Group Assignment||Other||None (Open Label)||||||
1337062|NCT03113526|Randomized|Parallel Assignment||Treatment||Single||||t||
1337063|NCT03113513|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study is designed as a RCT.||||
1337064|NCT03113500||Single Group Assignment||Treatment||None (Open Label)||||||
1337065|NCT03113487||Single Group Assignment||Treatment||None (Open Label)||||||
1337066|NCT03113474|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1337067|NCT03113461|Non-Randomized|Parallel Assignment||Treatment||Single||CPAP intervention||||t
1337068|NCT03113448|Randomized|Crossover Assignment||Treatment||Quadruple||Randomized controlled trial, double blind|t|t|t|t
1337069|NCT03113435|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1337070|NCT03113422|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337071|NCT03113409|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1337072|NCT03113396|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1337073|NCT03113383||Single Group Assignment||Treatment||None (Open Label)||||||
1337074|NCT03113370|Randomized|Parallel Assignment||Prevention||Quadruple|Double-blind, placebo controlled|Parallel arm randomized, double-blind, placebo controlled trial|t|t|t|t
1337075|NCT03113357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337076|NCT03113344|||Cohort||Prospective|||||||
1337077|NCT03113331|||Cohort||Prospective|||||||
1337078|NCT03113318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337079|NCT03113305|||Case-Control||Cross-Sectional|||||||
1337080|NCT03113292|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor won't have any knowledge about the study purposes and will be unaware of the group allocation. The statistical analysis will also be performed blinded for group allocation.|This is a randomized controlled clinical trial, characterized by the application of therapeutic exercises, in which subjects will be randomly allocated into two groups: Pilates Method and Home-Based Exercises. The participantes will be individuals with non-specific chronic low back pain. The study will be reported following the recommendations of the CONSORT Statement. For the present study, chronic non-specific back pain was defined as uninterrupted low back pain for more than 12 weeks, with unknown causes.||||t
1337081|NCT03113279|||Cohort||Cross-Sectional|||||||
1337082|NCT03113266||Single Group Assignment||Treatment||None (Open Label)||||||
1337083|NCT03113253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337084|NCT03113240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337085|NCT03113227|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1337086|NCT03113214|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1337087|NCT03113201|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1337088|NCT03113188||Single Group Assignment||Treatment||None (Open Label)||Dose finding cohort plus confirmatory expansion cohort||||
1337089|NCT03113175|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1337090|NCT03113162||Single Group Assignment||Treatment||None (Open Label)||||||
1337091|NCT03113149|||Cohort||Prospective|||||||
1337092|NCT03113136|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1337093|NCT03113123||Single Group Assignment||Prevention||None (Open Label)||||||
1337094|NCT03113110||Single Group Assignment||Treatment||None (Open Label)||||||
1337095|NCT03113097|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337096|NCT03113084|Randomized|Crossover Assignment||Other||None (Open Label)||Hospitalizations for administration of study medications will occur in two periods (visits 1 and 2) for administration of the drugs, and participants who receive the test medication at visit 1 will receive the comparator medication at Visit 2 and vice versa.||||
1337097|NCT03113071|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"For Group#1 a total of 37 patients with newly diagnosed MDL or MDS will be enrolled, including the eligible patients originally enrolled in the phase Ib portion (safe dose group) of the study, with the goal of determining the clinical activity of our experimental regimen. In the phase II segment, all new patients who are enrolled will initially be randomized in a 1 to 1 fashion to receive decitabine alone or decitabine plus digoxin for one cycle before receiving decitabine plus digoxin for all subsequent cycles for a total of 6 cycles.~For Group#2 the target will be to enroll a total of 60 patients with relapsed or refractory AML/MDS, including the eligible patients enrolled in the phase Ib group. This group will have randomization and treatments similar to Group#1."||||
1337098|NCT03113058||Single Group Assignment||Treatment||None (Open Label)||||||
1337099|NCT03113045||Single Group Assignment||Prevention||None (Open Label)|The observer will not be made aware of the time that the patient will sit.|||||
1337100|NCT03113032|Randomized|Parallel Assignment||Treatment||Triple|"The chief investigator who will deliver the exercise protocol will be blinded as to which leg is the intended leg for surgery. This will be done by another member of the medical team allocating the patients in block randomisation as they come in from the waiting list. This list with the respective surgical leg will be kept safely away from the chief investigator until all data is recorded."|Randomised Controlled Feasibility Study||t|t|t
1337101|NCT03113019||Single Group Assignment||Treatment||None (Open Label)||Patients with breast cancer receive a cellular preparation consisting of dendritic cells loaded with tumor lysate antigens and activated mononuclear cells. Patients receive this treatment in the adjuvant mode at IIa-IIIc stages and in neoadjuvant regimen with progression or 4 stages of the disease||||
1337102|NCT03113006|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337147|NCT03112421|||Other||Prospective|||||||
1337103|NCT03112993|Randomized|Parallel Assignment||Treatment||Quadruple|The surgeon, anesthesiologist, operating room staff, patients, personnel in the postanesthesia care unit (PACU) as well as the investigators collecting the postoperative data will be blinded to the group allocation.|Participants will receive (per a randomization schedule) either sugammadex, or neostigmine/glycopyrrolate to reverse neuromuscular blockade at the end of the surgery. The reversal agent will be prepared in a blinded fashion.|t|t|t|t
1337104|NCT03112980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337105|NCT03112967|Randomized|Parallel Assignment||Other||Single|||||t|
1337106|NCT03112954|Randomized|Single Group Assignment||Treatment||None (Open Label)|blind treatment|cohort study.||||
1337107|NCT03112941|Randomized|Parallel Assignment||Treatment||None (Open Label)||164 patients with traumatic incomplete spinal cord injury (SCI) were recruited in the plateau from June 2012 to February 2016.||||
1337108|NCT03112928|Randomized|Parallel Assignment||Treatment||Triple|"Participants will be informed that both treatments have been shown effective in previous studies, and in the present study we are comparing their efficacy.~The person conducting the pain evaluation (outcomes assessor) will not treat the participants and will be unaware of which treatment is given to each participant. The person treating the subject is different than the person evaluating.~The principal and coordinating investigator will receive blinded data from all participating centers to analyze the clinical trial outcomes."|International, multi-centre, double-blind, randomized, controlled clinical trial|t||t|t
1337109|NCT03112915|Randomized|Parallel Assignment||Treatment||Triple|Double-blind randomized controlled trail|Double-blind randomized controlled trail|t||t|t
1337110|NCT03112902|Randomized|Crossover Assignment||Other||Triple|||t|t||t
1337111|NCT03112889||Single Group Assignment||Treatment||None (Open Label)||||||
1337112|NCT03112876|||Case-Control||Cross-Sectional|||||||
1337113|NCT03112863|Randomized|Parallel Assignment||Treatment||Triple||Double blind randomized study comparing the effect of bakuchiol and retinoid|t||t|t
1337114|NCT03112850|Randomized|Crossover Assignment||Treatment||None (Open Label)||"This is a randomised crossover trial with participants randomized into two equal groups to carry out separate crossover experiments. All participants will undergo an individualised auditory training for a period of 6 months, and will be randomly allocated to one of the following groups.~Participants who will be fitted with hearing aids for the first 3 months of auditory training program - Group A~Participants who will be fitted with hearing aids for the last 3 months of auditory training program - Group B Groups will be matched in terms of the degree of hearing loss with one member from each matched pair randomly assigned to Group A and the other member of each matched pair assigned to Group B. A random sequence of binary digits will be used for this purpose."||||
1337115|NCT03112837|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1337116|NCT03112824|Randomized|Parallel Assignment||Treatment||Triple|A designated MD who is not involved in the study design, application, or interpretation will be available to unblind study participants when medically indicated|If the PSS score is than 20, those patients who are interested in participating are consented to the Ashwagandha study. The patients will then be randomized in a double-blind fashion to receive a 31 day supply of study capsules which will be either Ashwagandha 300mg twice a day or identical placebo capsules in a 1:1 ratio. They will be given careful directions into the use of the study capsules and will be asked to mark a daily log (See addendum #3: Treatment Log) of taking the capsules in the morning and at night.|t|t|t|
1337117|NCT03112811|Randomized|Parallel Assignment||Treatment||Single||||||t
1337118|NCT03112798|||Cohort||Prospective|||||||
1337119|NCT03112785|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with bilateral degenerative hip osteoarthritis are operated with a short stem total hip arthroplasty on one side and a conventional stem on the opposite side. Implant selection is randomised on the most symptomatic side, the second side receives the type of stem not used on the first one.||||
1337120|NCT03112772|Randomized|Parallel Assignment||Treatment||Single||||||t
1337121|NCT03112759|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients will be randomized into one of two arms: treatment with cognitive behavioral therapy and narcotics as needed or treatment with conventional narcotic analgesics alone. Patients undergoing CBT intervention will participate in eight weekly therapy sessions.||||
1337122|NCT03112746||Single Group Assignment||Treatment||None (Open Label)||||||
1337123|NCT03112733|||Cohort||Prospective|||||||
1337124|NCT03112720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337125|NCT03112707||Single Group Assignment||Treatment||None (Open Label)||||||
1337126|NCT03112694|||Cohort||Retrospective|||||||
1337127|NCT03112681|Randomized|Parallel Assignment||Treatment||Triple|Double-blind||t|t|t|
1337128|NCT03112668||Single Group Assignment||Supportive Care||None (Open Label)||||||
1337129|NCT03112655||Sequential Assignment||Diagnostic||None (Open Label)|The reference laboratory, generating the results for the index test, is masked for results obtained at the clinical trial site (determining the standard reference).|||||
1337130|NCT03112642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337131|NCT03112629|||Cohort||Prospective|||||||
1337132|NCT03112616|||Cohort||Prospective|||||||
1337133|NCT03112603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337134|NCT03112590||Single Group Assignment||Treatment||None (Open Label)||||||
1337135|NCT03112577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337136|NCT03112564||Single Group Assignment||Treatment||None (Open Label)||||||
1337137|NCT03112551|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1337138|NCT03112538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1337139|NCT03112525|||Cohort||Prospective|||||||
1337140|NCT03112512|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1337141|NCT03112499|Randomized|Parallel Assignment||Other||Single||||||t
1337142|NCT03112486|||Cohort||Prospective|||||||
1337143|NCT03112473|Randomized|Parallel Assignment||Treatment||Double||Parallel Assignment|t|||t
1337144|NCT03112460|||Cohort||Prospective|||||||
1337145|NCT03112447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337146|NCT03112434|||Cohort||Prospective|||||||
1337148|NCT03112408|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1337149|NCT03112395||Single Group Assignment||Treatment||None (Open Label)||||||
1337150|NCT03112382|Randomized|Parallel Assignment||Screening||Single|||t|||
1337151|NCT03112369|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1337152|NCT03112356||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337153|NCT03112343|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized in a 1:1 ratio to either the information and communication technology(ICT)-based intervention group or the conventional intervention group||||
1337154|NCT03112330||Single Group Assignment||Treatment||None (Open Label)||||||
1337155|NCT03112317|||Cohort||Retrospective|||||||
1337156|NCT03112304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337157|NCT03112291||Single Group Assignment||Treatment||None (Open Label)||This investigation is a longitudinal prospective interventional study of a series of cases||||
1337158|NCT03112278|Randomized|Parallel Assignment||Treatment||Triple|Both patient and the evaluators that will asses the performance of the restorations are unaware about the type of material used to fabricate the occlusal veneers||t|t||t
1337159|NCT03112265|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1337160|NCT03112252|||Other||Prospective|||||||
1337161|NCT03112239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337162|NCT03112226|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1337163|NCT03112213|||Cohort||Prospective|||||||
1337164|NCT03112200|Randomized|Parallel Assignment||Treatment||Single|The surgeon will be blinded to the treatment group until the time of surgery to avoid potential selection bias during the screening process. The subject will be blinded to the treatment group. The research coordinator will consult the central randomization list to determine which group the subject is in. Subjects may be randomized prior to surgery to allow for OR set-up. However, randomization should be performed as close to the time of surgery as possible to reduce the risk of randomization failures due to cancelled procedures.|A stratified blocked randomization will be used to assign subjects to either Subchondroplasty with arthroscopy or to arthroscopy alone in a 2:1 ratio. Individual sets of blocks will be determined within study site and lesion polarity status (unipolar vs. bipolar).|t|||
1337165|NCT03112187||Single Group Assignment||Treatment||None (Open Label)||||||
1337166|NCT03112174|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1337167|NCT03112161|Non-Randomized|Sequential Assignment||Other||None (Open Label)||||||
1337168|NCT03112148|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1337169|NCT03112135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337170|NCT03112122|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized, controlled, three-arm, double-blind study||||
1337171|NCT03112109|||Cohort||Prospective|||||||
1337172|NCT03112096|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1337173|NCT03112083|Randomized|Parallel Assignment||Other||Quadruple||two parallel groups (placebo and Krill oil), intervention trial (56 days)|t|t|t|t
1337174|NCT03112070|Randomized|Crossover Assignment||Treatment||Single||||||t
1337175|NCT03112057|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1337176|NCT03112044||Single Group Assignment||Treatment||None (Open Label)||Investigators aim to transplant 20 HCV- recipients with end-stage lung disease from transplant wait-list using lungs from HCV+ donors. Donor lungs will be selected based on usual donor selection criteria evaluating blood gas analysis, chest imaging, bronchoscopy findings, and assessment in the operating room. Once lungs meet criteria for transplantation, they will be retrieved in standard fashion, transported to Toronto General Hospital in cold static preservation, placed on EVLP for 6 hours, and transplanted to consented recipients.||||
1337177|NCT03112031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337178|NCT03112018|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337179|NCT03112005|||Case-Only||Cross-Sectional|||||||
1337180|NCT03111992|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is comprised of 3 treatment arms:~Single agent CJM112 (Arm A)~A fixed dose of PDR001 in combination with CJM112 (Arm B)~A fixed dose of PDR001 in combination with LCL161 (Arm C)~Patients may switch from treatment on Arm A to the corresponding CJM112 dose level on Arm B at the time of disease progression if that dose level has been declared safe, and if patients do not have any DLTs on single agent CJM112. Otherwise, patients will switch to a lower dose level that has been declared safe. No other cross-over between treatment arms is allowed."||||
1337181|NCT03111979|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1337182|NCT03111966|||Cohort||Prospective|||||||
1337183|NCT03111953|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1337184|NCT03111940|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337185|NCT03111927|Randomized|Parallel Assignment||Basic Science||Double|"Double blind - Infant Formula arms are blinded;~Reference Arm - unblinded epidemiological reference arm~Allocation: Randomized for formula arms, efficacy study"|"Single center, double blind, randomized, controlled, parallel group, adaptive group sequential clinical trial, consisting of 2 arms randomized to receive either the investigational or the control product, and a nonrandomized, nonblinded arm of fully breastfed infants.~3 groups: enriched level of myelin-relevant nutrients in an Infant Formula, standard level of myelin-relevant nutrients in an Infant Formula, breastfed infants"|t||t|
1337186|NCT03111914||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337187|NCT03111901|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1337188|NCT03111888||Single Group Assignment||Supportive Care||None (Open Label)||||||
1337189|NCT03111875|Randomized|Parallel Assignment||Supportive Care||Single|"To maintain blinding, the anesthesia record will be sealed in an opaque envelope before patients leave the post-anesthesia care unit. The envelope will be marked Do not open until [date 35 days after surgery]. Some hospitals will have electronic records; in those cases, we will ask investigators evaluating postoperative outcomes not to access the anesthesia record."|||||t
1337190|NCT03111862|||Cohort||Prospective|||||||
1337191|NCT03111849|||Other||Cross-Sectional|||||||
1337192|NCT03111836|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1337193|NCT03111823||Single Group Assignment||Supportive Care||None (Open Label)||||||
1337194|NCT03111810|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1337195|NCT03111797|||Cohort||Prospective|||||||
1337196|NCT03111784|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||Quasi Experimental / non-randomised trial||||
1337197|NCT03111771|||Other||Retrospective|||||||
1337198|NCT03111758|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1337199|NCT03111745|||Cohort||Retrospective|||||||
1337200|NCT03111732||Single Group Assignment||Treatment||None (Open Label)||||||
1337201|NCT03111719|||Cohort||Cross-Sectional|||||||
1337202|NCT03111706|||Cohort||Prospective|||||||
1337203|NCT03111693|||Other||Cross-Sectional|||||||
1337204|NCT03111680|Randomized|Factorial Assignment||Prevention||Double|people collecting data were unaware of study condition|this was a cluster randomized trial, with housing developments randomized to intervention or control||t|t|
1337205|NCT03111667|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Student Participants will be assigned in a 2:1 ratio to the Experimental Teen Marijuana Check Up or a Control Treatment as Usual condition.~Interventionist Participants will be assigned in a 1:1 ratio to Gold Standard or As Needed Coaching"||||
1337206|NCT03111654|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1337207|NCT03111641||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337208|NCT03111628||Single Group Assignment||Treatment||None (Open Label)||Active therapy||||
1337209|NCT03111615|Randomized|Parallel Assignment||Treatment||Triple||Aromatase inibitor therapy to start immediately after biopsy results are available Letrozole 2.5mg or Anastrazol 1 mg|t|t||t
1337210|NCT03111602|Non-Randomized|Parallel Assignment||Treatment||Double|Researchers were blinded to the allocation data of pregnant women in the groups|Clinical trial with a healthy group as comparator.||t|t|
1337211|NCT03111589|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1337212|NCT03111576|||Case-Control||Prospective|||||||
1337213|NCT03111563|Randomized|Parallel Assignment||Prevention||Single|||t|||
1337214|NCT03111550||||||||||||
1337215|NCT03111537|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337216|NCT03111524|Randomized|Parallel Assignment||Treatment||Double|The Principal investigator is blinded to the study. The researcher is able to observe while the research assistants are aware of who is in the control versus intervention groups.|10 schools are included. The schools are assigned to control versus intervention groups|t||t|
1337217|NCT03111511||Single Group Assignment||Other||None (Open Label)||||||
1337218|NCT03111498|Randomized|Parallel Assignment||Other||None (Open Label)||"video-recorded vacuum procedure on a special VAD-training phantom in a randomized setting: (1) theory-based training programme (2) practice-based training programme (one-to-one teaching).~Video-recorded vacuum procedure on the VAD- training phantom before randomization, directly after training programme, 4-8 weeks after training programme in order to determine retention of skills."||||
1337219|NCT03111485|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1337220|NCT03111472||Single Group Assignment||Supportive Care||None (Open Label)||30-40 participants will receive the intervention. The intervention will be a guide to help people with Parkinson's and their caregivers to self-manage falls. There will be no control group.||||
1337221|NCT03111459|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337222|NCT03111446|Randomized|Parallel Assignment||Treatment||Single||||||t
1337223|NCT03111433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337224|NCT03111420|Randomized|Parallel Assignment||Diagnostic||Triple|Platelet function test results are not provided to the participant, care provider, or investigator||t|t|t|
1337225|NCT03111407|Randomized|Parallel Assignment||Treatment||Single|Study patients will not know if their knee prosthesis will be implanted with iAssist or with conventional instrumentation|2 groups of patients: 1 will have the knee prosthesis implanted with iAssist and the other with conventional instrumentation.|t|||
1337226|NCT03111394|||Cohort||Prospective|||||||
1337227|NCT03111381|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1337228|NCT03111368|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1337229|NCT03111355||Single Group Assignment||Basic Science||None (Open Label)||||||
1337230|NCT03111342|Randomized|Parallel Assignment||Treatment||Quadruple|The care provider will open the randomization envelope and will do one of three possible approaches (a intracervical lidocaine injection, a intracervical dry needling or no intervention). Then, a second care provider will insert the intrauterine contraceptive (IUC) blinding for the approach of the first care provider. After IUC insertion, the latter care provider will assess the pain felt by the woman using proper scales. The woman will be also blinded to the approach used before IUC insertion.|Nulligravida women will be block-randomized to one of three groups (intracervical anesthesia, intracervical dry needling or no intervention)|t|t|t|t
1337231|NCT03111329|Randomized|Parallel Assignment||Supportive Care||Single|Open label during intervention, assessor of outcomes will be blinded to group allocations|Randomization into 2 groups (interventional and control) with crossover rescue strategy.||||t
1337232|NCT03111316|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1337233|NCT03111303|||Cohort||Retrospective|||||||
1337234|NCT03111290|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1337235|NCT03111277||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1337236|NCT03111264|Randomized|Factorial Assignment||Prevention||Single|One third of recruited childcare centers (control) will not receive any intervention (EWE nor EFE). The remaining two-thirds of the recruited centers will receive the Enhancing Wellness Environment (EWE) intervention, of those, one third will also receive the Enhancing Family Environment (EFE) and one third will not.|The investigators will examine the impact of an Enhancing the Childcare Center Wellness Environment (EWE) intervention individually and combined with an Enhancing the Family Environment (EFE) intervention versus control on a) child-care center staff wellness-related attitudes and behaviors; b) parent wellness-related attitudes and behaviors; and c) child food tasting, food preferences, growth, and PA/eating behaviors.|t|||
1337237|NCT03111251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337238|NCT03111238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337239|NCT03111225|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The observation stage is a case- control study, the treatment stage is an A-B-A design.||||
1337240|NCT03111212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337241|NCT03111199|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337242|NCT03111186|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients of either sex, greater than 18 years of age, scheduled to undergo elective outpatient soft tissue hand surgery for one of the following procedures: carpal tunnel release, Dupuytren contracture release, trigger digit release, ganglion cyst removal, De Quervain's release, whose primary language is English or Spanish||||
1337243|NCT03111173||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1337244|NCT03111160|Randomized|Parallel Assignment||Treatment||None (Open Label)||Based on the review of literature, we regarded SMILE using energy levels of 115 nJ or higher as 'conventional' energy-SMILE (C-SMILE). Since 500kHz VisuMax femtosecond laser used in this study had a threshold photodisruption energy level of 100 nJ, lowest energy level of L-SMILE was set at 100 nJ. Because the spot distance must be changed by approximately 1 μm when laser energy changed by 50 nJ, we could set the maximum laser energy to 150 (100 + 50) nJ as highest one of C-SMILE while keeping the spot distance constant. Finally, we established two groups divided by different laser energies: L-SMILE group using lower energy levels of 100, 105, and 110 nJ, and C-SMILE group using 'conventional', not higher, energy levels of 115 to 150 nJ.||||
1337245|NCT03111147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337246|NCT03111134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337247|NCT03111121|Randomized|Parallel Assignment||Treatment||Single|SINGLE BLIND: The nurses in PACU will be the only evaluators of the subject who will be blinded to the two groups. The PACU nurses will evaluate ALDRETE discharge criteria and make a note in the electronic medical records for the subject discharge time from PACU.|"Group 1: Inhaled anesthetics: sevoflurane at 1 MAC, remifentanil and intubation with rocuronium at 0.6-1.2 mg/kg (vitals maintained within 20% of baseline). Group 1 will receive reversal with neostigmine (0.04 mg/kg and glycopyrrolate (0.01 mg/kg)~Group 2: Inhaled anesthetics: sevoflurane at 1 MAC, remifentanil and intubation with rocuronium at 0.6 -1.2 mg/kg (vitals maintained within 20% of baseline). Group 2 will receive reversal with sugammadex 4mg/kg"||t||
1337248|NCT03111108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337249|NCT03111095|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337250|NCT03111082|||Cohort||Prospective|||||||
1337251|NCT03111069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337252|NCT03111056|Randomized|Parallel Assignment||Treatment||None (Open Label)|The intervention and assessments are all completed online and therefore masking is not necessary.|||||
1337253|NCT03111043|Non-Randomized|Single Group Assignment||Diagnostic||Double||Pre- post-CT scanning protocol cohort analysis|||t|t
1337254|NCT03111030|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1337255|NCT03111017|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1337256|NCT03111004|||Cohort||Prospective|||||||
1337257|NCT03110991|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1337258|NCT03110978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337259|NCT03110965||Sequential Assignment||Treatment||None (Open Label)|Radiologists are unaware of study.|Patient's change in previous X-ray compared with baseline, and baseline compared with X-ray done 4-10 months later||||
1337260|NCT03110952|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1337261|NCT03110939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337262|NCT03110926||Sequential Assignment||Treatment||None (Open Label)||||||
1337263|NCT03110913||Single Group Assignment||Other||None (Open Label)||Each subject will randomly receive 4 levels of methionine provided as free amino acids, lentils, or lentils combined with rice for a total of 10 studies x 3 days per study.||||
1337264|NCT03110900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337265|NCT03110887|||Cohort||Retrospective|||||||
1337266|NCT03110874|Randomized|Parallel Assignment||Treatment||Single||||t||
1337267|NCT03110861||Single Group Assignment||Treatment||None (Open Label)||||||
1337268|NCT03110848|Randomized|Parallel Assignment||Treatment||Single|Ophthalmologist blinded to treatment||||t|
1337269|NCT03110835|||Case-Control||Prospective|||||||
1337270|NCT03110822||Single Group Assignment||Treatment||None (Open Label)||||||
1337271|NCT03110809|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1337272|NCT03110796|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1337273|NCT03110783|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337274|NCT03110770|Randomized|Sequential Assignment||Prevention||Triple|"Part A is open-label. For Part A, the participant, investigator and outcome assessor will know what the participant received.~Part B injections will be prepared by an unblinded site pharmacist, designee, or otherwise qualified personnel who will not be involved in any participants assessments and who will not discuss randomizations with study clinicians. Subjects, study personnel, site data entry personnel, and laboratory personnel performing immunologic assays will be blinded to the treatment assignment of all product administrations. The IND Sponsor intends to unblind treatment assignments for Part B of the study once 90 cases of ZIKV infection are detected. The DSMB will be consulted prior to unblinding."|Part A participants (n=90) will be randomized to vaccine at a 1:1:1 ratio to receive a 4 mg or 8 mg dose of vaccine split between 2 or 4 injections. In Part B, 2400 participants will be randomized to vaccine or placebo in a 1:1 ratio to receive a 4 mg dose of vaccine or 1 mL of placebo split between 2 injections. The concentration and number of injections in Part B was determined by preliminary data from the Phase 1 trial and Part A.|t||t|t
1337275|NCT03110757|Randomized|Sequential Assignment||Prevention||Double|||t||t|
1337276|NCT03110744||Single Group Assignment||Treatment||None (Open Label)||||||
1337277|NCT03110731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337278|NCT03110718|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337279|NCT03110705|||Ecologic or Community||Prospective|||||||
1337280|NCT03110692|Randomized|Crossover Assignment||Health Services Research||Single|||||t|
1337281|NCT03110679|Randomized|Parallel Assignment||Treatment||Double|cover the syringe to mask the contents|autologous bone marrow concentrate vs. hyaluronic acid.|t||t|
1337282|NCT03110666||Single Group Assignment||Treatment||None (Open Label)||autologous concentrated bone marrow aspirate||||
1337283|NCT03110653|Randomized|Parallel Assignment||Treatment||Triple|Patients, the anesthesiologist and an external observer will be blinded.||t||t|t
1337284|NCT03110640||Single Group Assignment||Treatment||None (Open Label)||||||
1337285|NCT03110627|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||DX AF is a prospective, randomized-controlled, open-label trial. Patients who are identified on clinical grounds for a single-chamber ICD will randomized to a VDD ICD (experimental group) or single chamber ICD (control group).||||
1337286|NCT03110614|||Cohort||Prospective|||||||
1337287|NCT03110601||Single Group Assignment||Treatment||None (Open Label)||||||
1337288|NCT03110588|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The first cohort will administer the following to three patients: prednisone 5 mg orally twice daily, abiraterone 1000 mg orally once daily, enzalutamide 160 mg orally once daily, and cabazitaxel intravenous infusion at 15 mg/m2 every 3 weeks. If there are no dose limiting toxicities, the cabazitaxel will be escalated to 20 mg/m2 in a second cohort. The other three drugs will remain at the same dose.||||
1337289|NCT03110575||Single Group Assignment||Treatment||None (Open Label)||||||
1337290|NCT03110562|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1337291|NCT03110549|Randomized|Sequential Assignment||Treatment||Triple||Five qualifying participants will be enrolled into each of seven dosage Arms - three escalating subcutaneous dosages (Cohort 1), and four escalating intramuscular dosages (Cohort 2). Enrolling participants will be randomized to receive active TMB-607 or placebo. Beginning with the lowest dosage group, a Data Safety Monitoring Board (DSMB) will review available data after four participants have completed two weeks of post-dose follow-up to determine whether escalation to the next dosage group may proceed|t||t|t
1337292|NCT03110536|||Cohort||Prospective|||||||
1337293|NCT03110523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337294|NCT03110510||Single Group Assignment||Treatment||None (Open Label)||D1 Irinotecan 180 mg/m2 IV D1-2 5-FU 400mg/m2 bolus and then 2400mg/m2 continuous infusion D1 Leucovorin 200 mg/m2 Every 2 weeks||||
1337295|NCT03110497||Single Group Assignment||Treatment||None (Open Label)||Phase I/ Phase II single arm study||||
1337296|NCT03110484||Single Group Assignment||Treatment||None (Open Label)||||||
1337297|NCT03110471|||Case-Only||Prospective|||||||
1337298|NCT03110458|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1337299|NCT03110445||Single Group Assignment||Treatment||None (Open Label)||||||
1337300|NCT03110432|||Cohort||Prospective|||||||
1337301|NCT03110419|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1337302|NCT03110406|Randomized|Parallel Assignment||Treatment||Triple||Intervention group and control group|t||t|t
1337303|NCT03110393|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337304|NCT03110380|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337305|NCT03110367|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Participants will include 90 youth scheduled for a pectus repair or a spinal fusion surgery, surgeries associated with high levels of post-surgical pain, and their parents. They will be recruited at the Alberta Children's Hospital. The timelines and measures to be administered to parents and children are listed below. The timelines will include a baseline assessment (1-3 weeks pre-op), in hospital assessment for several days, 1-2 weeks post-op (acute recovery phase), the 2-4 week post-op clinic visit (memory reframing intervention) and 6 weeks post-op.~Participants will be randomized into three groups:~Attention Control Group~Normal Reminiscing~Intervention Group"||||
1337306|NCT03110354||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1337307|NCT03110341|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337308|NCT03110328||Single Group Assignment||Treatment||None (Open Label)||Pembrolizumab (MK-3475) 200 mg every 3 weeks (Q3W)||||
1337309|NCT03110315|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1337310|NCT03110302|Randomized|Parallel Assignment||Treatment||Single||||||t
1337311|NCT03110289|Randomized|Parallel Assignment||Treatment||Quadruple||We will randomly allocate 108 patients with active ulcerative colitis (Mayo score 4-10, endoscopic Mayo score 2 or 3) in a 1:1 ratio, using a pre-established randomization list, to either 'superdonor' faecal microbiota transplantation or autologous fecal microbiota transplantation (=sham)|t|t|t|t
1337312|NCT03110276|Randomized|Sequential Assignment||Treatment||Quadruple|Double-blind study|Planned single doses of 30 mg, 60 mg, 120 mg, 250 mg, 500 mg, and 800 mg, and planned multiple doses of 60 mg, 120 mg, 250 mg, and 500 mg, of EYP001a will be explored in this study. Subjects will be enrolled in dose escalation cohorts that will occur sequentially based upon review of safety and PK parameters.|t|t|t|t
1337313|NCT03110263|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337314|NCT03110250|||Case-Only||Cross-Sectional|||||||
1337315|NCT03110237|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337316|NCT03110224|||Cohort||Other|||||||
1337317|NCT03110211|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1337318|NCT03110198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337319|NCT03110185|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1337320|NCT03110172|Randomized|Parallel Assignment||Treatment||Double||All patients will be randomly divided into two groups. The control group is going to be given celecoxib 200mg/24h to 2 weeks after operation. On the basis of the above scheme, the The treatment group will receive duloxetine 60mg/24h to 8 weeks after operation.|t|||t
1337321|NCT03110159||Single Group Assignment||Treatment||None (Open Label)||||||
1337322|NCT03110146|||Case-Only||Prospective|||||||
1337323|NCT03110133|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1337372|NCT03109496|||Case-Control||Cross-Sectional|||||||
1337373|NCT03109483||Single Group Assignment||Treatment||None (Open Label)||explorative study||||
1337374|NCT03109470|||Other||Prospective|||||||
1337375|NCT03109457|||Cohort||Retrospective|||||||
1337324|NCT03110120|Randomized|Parallel Assignment||Treatment||Triple|"The patient where randomized by the investigator after inform consent was signed The investigator prepared the syringes named serratus and local with levobupivacaine 0.25 or saline according to randomization The care provider injected the prepared syringes respectively in the serratus plane or locally without knowing their contents The outcome assessor evaluated the post operative pain and the 3 months followup without knowing the randomization"|Compare the efficacy of the serratus plane block with local infiltration after thoracic robot-assisted surgery|t|t||t
1337325|NCT03110107|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337326|NCT03110094|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1337327|NCT03110081|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1337328|NCT03110068|||Cohort||Prospective|||||||
1337329|NCT03110055||Single Group Assignment||Treatment||None (Open Label)||This is a single center, open label, prospective pilot study. The study will enroll 20 HCV genotype 1 cirrhotic patients with advanced and un-resectable HCC who are eligible for TACE. The patients will receive Grazoprevir/Elbasvir anti-viral treatment in accordance with established guidelines together with regular TACE treatments. Follow up will be for up to 24 months from TACE initiation.||||
1337330|NCT03110042|||Cohort||Prospective|||||||
1337331|NCT03110029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337332|NCT03110016||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1337333|NCT03110003|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337334|NCT03109990|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337335|NCT03109977||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337336|NCT03109964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337337|NCT03109951|||Case-Only||Prospective|||||||
1337338|NCT03109938|||Cohort||Prospective|||||||
1337339|NCT03109925||Single Group Assignment||Treatment||None (Open Label)|No masking|Single group of patients undergoing prostate artery embolization with a new embolic which is radio-opaque and can give a better idea of embolization distribution (DC Lumi Beads by BTG)||||
1337340|NCT03109912|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1337341|NCT03109899|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337342|NCT03109886||Single Group Assignment||Treatment||None (Open Label)||||||
1337343|NCT03109873|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1337344|NCT03109860|||Cohort||Prospective|||||||
1337345|NCT03109847|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1337346|NCT03109834|Randomized|Parallel Assignment||Treatment||None (Open Label)||2 parallel arms in weight loss phase and weight stabilization phase (1. randomization at baseline I); 2 parallel arms in weight maintanance phase (2. randomization at baseline II)||||
1337347|NCT03109821|||Cohort||Prospective|||||||
1337348|NCT03109808|Randomized|Parallel Assignment||Prevention||Double||"Allocation : Randomized (with stratification on center and gender)~Endpoint Classification : Safety/Efficacy Study~Intervention Model : Parallel Assignment~Masking : Double blind (Operator, Outcomes Assessor)~Primary Purpose : Prevention"|t|t||
1337349|NCT03109795|Randomized|Parallel Assignment||Basic Science||Triple||Randomized, parallel, double-blind|t||t|t
1337350|NCT03109782|||Case-Only||Prospective|||||||
1337351|NCT03109769|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1337352|NCT03109756||Single Group Assignment||Treatment||None (Open Label)||||||
1337353|NCT03109743|Randomized|Parallel Assignment||Other||None (Open Label)||The investigators pilot test efficacy of Sisters-GPS intervention in improving ARV adherence by randomizing 60 HIV+ women of color with suboptimal ARV adherence and detectable HIV viral loads (VL) to Sisters-GPS, group clinical visits, or to an appointment with an adherence counselor. The investigators will collect data from interviews, pill counts, medical and pharmacy records, and blood samples. The study's primary outcome will be ARV adherence assessed by pill count at 8 weeks; secondary outcome will be change in HIV VL from baseline to 8 weeks.||||
1337354|NCT03109730|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1337355|NCT03109717|||Other||Prospective|||||||
1337356|NCT03109704|Randomized|Parallel Assignment||Treatment||Single|participants were made aware of the 3 different interventions being investigated but were not told which technique they were assigned to receive|randomized controlled trial, 3 groups which includes a sham comparator|t|||
1337357|NCT03109691|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1337358|NCT03109678|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||||||
1337359|NCT03109665|||Cohort||Cross-Sectional|||||||
1337360|NCT03109652|Randomized|Parallel Assignment||Treatment||Single||||||t
1337361|NCT03109639|Randomized|Crossover Assignment||Diagnostic||Single|The pathologist will be blinded to the needle used for specimen collection.|The participants will be randomised to one of the two groups. The first group will undergo tissue acquisition using the conventional EUS needle. After this, the lesion will be punctured again using the experimental Acquire EUS FNB needle to obtain tissue. In the second group, the experimental Acquire EUS FNB needle will be used first followed by the conventional needle to acquire tissue.||||t
1337362|NCT03109626|Randomized|Parallel Assignment||Treatment||Triple||double-blind randomised placebo-controlled phase, followed by an open-label phase|t||t|t
1337363|NCT03109613||Single Group Assignment||Treatment||None (Open Label)||||||
1337364|NCT03109600|Randomized|Parallel Assignment||Prevention||Single|||||t|
1337365|NCT03109587|Randomized|Parallel Assignment||Other||Single|The study product will be prepackaged and will supplied labeled only with the Protocol Number.|||||t
1337366|NCT03109574|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1337367|NCT03109561|||Case-Control||Prospective|||||||
1337368|NCT03109548|||Cohort||Prospective|||||||
1337369|NCT03109535|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337370|NCT03109522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337371|NCT03109509|Randomized|Parallel Assignment||Prevention||Single|Research team was blinded to participant group assignment until data analysis.|Two-group, randomized controlled trial.|||t|
1337376|NCT03109444|||Cohort||Prospective|||||||
1337377|NCT03109431|Randomized|Parallel Assignment||Treatment||Single||||||t
1337378|NCT03109418|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1337379|NCT03109405|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1337380|NCT03109392|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1337381|NCT03109379||Single Group Assignment||Treatment||None (Open Label)||||||
1337382|NCT03109366||Single Group Assignment||Health Services Research||None (Open Label)||||||
1337383|NCT03109353||Single Group Assignment||Treatment||None (Open Label)||||||
1337384|NCT03109340|Randomized|Parallel Assignment||Treatment||None (Open Label)||Women with overweight and obesity were assigned to two groups: supervised treadmill walking (Group I) or walking with ECE PEDO (Group II).||||
1337385|NCT03109327|||Cohort||Prospective|||||||
1337386|NCT03109314|Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1337387|NCT03109301|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337388|NCT03109288|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1337389|NCT03109275|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1337390|NCT03109262||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337391|NCT03109249|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1337392|NCT03109236|Randomized|Parallel Assignment||Treatment||Single|Blinding will be maintained by investigators performing analysis of the results. Given the invasive procedure of percutaneous transhepatic cannulation, the investigators felt that it will be unethical to perform sham procedure on control arm patients. Both managing doctors and patient will know which arm they are on but where not inevitable, data collection such as quality of life and results interpretation such as histology and laboratory analysis of results will be performed anonymously.|"This is a 2 arm randomised study patients with decompensated liver cirrhosis involving 33 patients in each arm. Randomisation will be done by statistician to determine which arm patients will be in (control / treatment).~Treatment arm:~Patient will undergo CD133+ cells transplantation at stable compensated state. 5 dose Granulocyte Colony Stimulating Factor (GCSF) will be administered 5 days consecutively before bone marrow harvesting.~Approximately 250ml of bone marrow will be harvested and subjected to CD133 isolation using clinimacs (Miltenyi Biotec) in a closed system~Under ultrasound guidance, 50 mls of 50-100 million CD133 cells will be infused directly through transhepatic route into portal venous circulation of the liver over 5 mins.~Control Arm:~Patients will receive 5 doses of GCSF"||||t
1337393|NCT03109223|Randomized|Parallel Assignment||Other||Quadruple|double blind|Double-blind randomized|t|t|t|t
1337394|NCT03109210|Randomized|Factorial Assignment||Treatment||Single||||||t
1337395|NCT03109197|||Family-Based||Prospective|||||||
1337396|NCT03109184|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337397|NCT03109171|Randomized|Crossover Assignment||Diagnostic||Quadruple|"The allocation sequence, determining which rater (expert vs non-expert) intervenes first or second, will be concealed using the SNOSE strategy (sequentially numbered opaque sealed envelopes). One of the authors (ARB), who has not competing interests will generate the allocation sequence and conceal it in envelopes. While the first rater measures the sensory thresholds (ST) the second rater will be at a different room for blinding purposes. There will be no communication about the testing results between the two raters nor the staff who are helping the testing performance.~To mask the values of the ST, air pulses will be identified by a random combination of three letters instead of by the intensity levels corresponding to the air pulses. The raters will not know the intensity corresponding to each letter combination. At the end of the test, an assistant will replace the letters corresponding to the ST values by the intensity levels of the air pulses in units of force (millinewtons)"|"Subjects participating in the inter-rater reliability evaluation will be evaluated by two raters, an expert and a non-expert rater, each rater performing two measurements of laryngopharyngeal sensory thresholds (ST) two times at each side (right and left) of the corresponding laryngopharyngeal structure. All other subjects, participating in the accuracy evaluation, will be evaluated by only one expert rater who will perform three measurements of laryngopharyngeal ST per subject. The varying degrees of rater experience aims to reproduce common scenarios when a new technique (like the measurement of laryngopharyngeal mechanosensitivity) is introduced to clinical practice.~The two raters will measure the ST sequentially and in a randomized cross-over design in each subject (the order in which each rater intervenes will be randomized) aiming that the sensory tests be started an equal number of times by an expert rater and non-expert rater."|t|t|t|t
1337398|NCT03109158||Single Group Assignment||Treatment||None (Open Label)|Open-Label|||||
1337399|NCT03109145|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337400|NCT03109132|Randomized|Crossover Assignment||Device Feasibility||Triple|This is a double-blind, order randomized study. All cannulas will be numbered. The investigators, the outcomes assessors and the subjects will be blind to the identity of the cannulas. The order of which the subjects will assess the cannulas will be randomized.|This is randomnized crossover study. Every subject will assess all cannulas in randomized order.|t||t|t
1337401|NCT03109119|Randomized|Parallel Assignment||Supportive Care||Double|This is a double blinded study, where the participants are randomly selected using a computer - generated number and allocated to any one of the two groups. Both the patient and the outcome assessor will be blinded.|"All children will be randomly allocated into two groups - group S and P. Children in group S will be anaesthetised with sevoflurane, whereas children in group P will be anaesthetised with propofol.~Peripheral blood samples of 1.5 ml each will be taken immediately after extubation (S-2) , after 48 hours (S-3)and after 120 hours (S-4).A fifth blood sample (S-5) will be taken on the 14th postoperative day.~These blood samples will be evaluated for genomic instability using Alkaline Comet Assay and micronucleus test by the Genetics Lab of our hospital."|t|||t
1337402|NCT03109106|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Will identify eligible patients and controls prospectively in 2 week alternating blocks. Study candidates enrolled during the intervention blocks will receive PCT-guided therapy. Study candidates enrolled during the control periods will receive standard care.||||
1337403|NCT03109093||Single Group Assignment||Treatment||None (Open Label)||||||
1337404|NCT03109080||Single Group Assignment||Treatment||None (Open Label)||||||
1337405|NCT03109067||Single Group Assignment||Screening||None (Open Label)||Same intervention for everyone, two different groups||||
1337406|NCT03109054|||Case-Control||Prospective|||||||
1337407|NCT03109041||Single Group Assignment||Treatment||None (Open Label)||||||
1337408|NCT03109028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337409|NCT03109015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337410|NCT03109002|||Cohort||Retrospective|||||||
1337411|NCT03108989|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1337412|NCT03108976|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1337413|NCT03108963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337414|NCT03108950||Single Group Assignment||Prevention||None (Open Label)||||||
1337415|NCT03108937|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337416|NCT03108924|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337417|NCT03108911|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1337418|NCT03108898|||Case-Only||Prospective|||||||
1337419|NCT03108885|||Case-Only||Prospective|||||||
1337420|NCT03108872|||Case-Control||Prospective|||||||
1337421|NCT03108859|||Cohort||Prospective|||||||
1337422|NCT03108846|Randomized|Parallel Assignment||Treatment||Quadruple|Over-encapsulation||t|t|t|t
1337423|NCT03108833|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337424|NCT03108820|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1337425|NCT03108807|||Cohort||Prospective|||||||
1337426|NCT03108794|||Cohort||Prospective|||||||
1337427|NCT03108781|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1337428|NCT03108768|Randomized|Crossover Assignment||Treatment||Single||Phonak Virto V and the successor of Phonak Virto V will be fitted to the participants individual hearing loss.|t|||
1337429|NCT03108755|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1337430|NCT03108742|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1337431|NCT03108729||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1337432|NCT03108716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The investigators collected data of 28 hamate hook fractures patients, who were treated in the Siping Central People's Hospital and had complete follow-up records.||||
1337433|NCT03108703||Single Group Assignment||Treatment||None (Open Label)||||||
1337434|NCT03108690|Randomized|Factorial Assignment||Treatment||Single||||||t
1337435|NCT03108677|||Cohort||Prospective|||||||
1337436|NCT03108664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337437|NCT03108651|Randomized|Parallel Assignment||Supportive Care||Single|Researchers do not disclose about App and messages to control group|Intervention study with two parallel arms.|t|||
1337438|NCT03108638|||Cohort||Prospective|||||||
1337439|NCT03108625||Single Group Assignment||Treatment||None (Open Label)||||||
1337440|NCT03108612||Single Group Assignment||Diagnostic||None (Open Label)|The care providers that administer the index test and the EPT assessment are not masked. However, the outcomes assesors of the EPT (gold standard) are masked to the results of the WAI (index test). The adminstrators of the WAI are unaware of the EPT result, as this evaluation is conducted after the application of the index test.|Participants are enrolled consecutively in the occupational health care clinic. After signing the informed consent form, the evaluators administer the index diagnostic test (WAI). Subsequently, the study participants are referred to the gold standard (EPT). Study participants, WAI evaluators and EPT evaluators are blinded to the results of the other test.||||
1337441|NCT03108599|Randomized|Parallel Assignment||Prevention||None (Open Label)||In the RCT, participants will be randomly assigned to either the control or intervention groups. Following a baseline period, intervention participants will receive the cab engineering portion of the intervention on its own. Then, for the following intervention phase, intervention participants will participate in the behavioral sleep intervention in addition to continuing the cab engineering intervention.||||
1337442|NCT03108586|Randomized|Parallel Assignment||Diagnostic||Triple|Patients, clinical operators responsible for dental treatment, and the examiner who will assess the outcomes will be blind to the allocation group of the participants.||t|t||t
1337443|NCT03108573|||Case-Only||Cross-Sectional|||||||
1337444|NCT03108560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337445|NCT03108547|||Cohort||Prospective|||||||
1337446|NCT03108534|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1337447|NCT03108521|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1337448|NCT03108508|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1337449|NCT03108495||Single Group Assignment||Treatment||None (Open Label)||||||
1337450|NCT03108482|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1337451|NCT03108469|Randomized|Parallel Assignment||Treatment||Double|At randomization (Visit 2), neither the subject nor the investigator will be aware to which treatment group the subject has been assigned. Investigational product will be drawn and administered in a double blind format. If needed, for safety and proper treatment of the subject, the investigator can unblind the subject's treatment assignment to determine which treatment has been assigned and institute appropriate follow-up care. When possible, Sponsor and Clinvest should be notified prior to unblinding study drug.||t||t|
1337452|NCT03108456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337453|NCT03108443|||Case-Control||Prospective|||||||
1337454|NCT03108430|||Cohort||Prospective|||||||
1337455|NCT03108417||Single Group Assignment||Treatment||None (Open Label)|(none)|||||
1337456|NCT03108404|||Cohort||Retrospective|||||||
1337457|NCT03108391|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parellel Assignment||||
1337458|NCT03108378|||Cohort||Other|||||||
1337459|NCT03108365|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337460|NCT03108352|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1337461|NCT03108339|||Cohort||Prospective|||||||
1337462|NCT03108326|||Cohort||Prospective|||||||
1337552|NCT03107143|Randomized|Parallel Assignment||Prevention||None (Open Label)||A prospective, non-blinded, randomized trial. This cohort was divided into two groups: Control and Treatment.||||
1337553|NCT03107130|||Cohort||Retrospective|||||||
1337463|NCT03108313|Randomized|Parallel Assignment||Prevention||Single|A participant will generate the random allocation sequence. The researcher will enroll the patients but an unbiased participant will assign the intervention/Control identification procedures .The participants will be blinded to intervention/control assessment methods. Also, it will not be allowed among the examiners to exchange any information throughout the entire study period.|||||t
1337464|NCT03108300||Single Group Assignment||Treatment||None (Open Label)||||||
1337465|NCT03108287|Randomized|Parallel Assignment||Treatment||Single|||||t|
1337466|NCT03108274|Randomized|Sequential Assignment||Treatment||None (Open Label)||This will be a 3-part study with each part being an open-label, fixed sequence, 2-treatment study in healthy adult subjects. Part 1, Part 2 and Part 3 may be conducted concurrently or separately and the order of the parts may be determined according to the needs of the ACH-0144471 development program||||
1337467|NCT03108248|||Cohort||Retrospective|||||||
1337468|NCT03108235|Randomized|Parallel Assignment||Other||Single|||t|||
1337469|NCT03108222|||Other||Prospective|||||||
1337470|NCT03108209||Single Group Assignment||Prevention||None (Open Label)||||||
1337471|NCT03108196|Randomized|Parallel Assignment||Treatment||None (Open Label)||Superiority verification based on the ileal neobladder||||
1337472|NCT03108183|||Other||Cross-Sectional|||||||
1337473|NCT03108170|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1337474|NCT03108157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337475|NCT03108144|Randomized|Parallel Assignment||Prevention||Single||Organizations will be randomly allocated in a 1:1 allocation ratio to Group A (Test) or Group B (Control) accounting for rurality, organization type, practice size and academic affiliation.|||t|
1337476|NCT03108131|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337477|NCT03108118|||Cohort||Prospective|||||||
1337478|NCT03108105||Single Group Assignment||Supportive Care||None (Open Label)||||||
1337479|NCT03108092|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337480|NCT03108079||Single Group Assignment||Basic Science||None (Open Label)||Female patients seen at the Pelvic Floor Institute will be offered participation in the study. The study will consist of a pelvic floor MRI at no cost to them or their payors. Women who agree to participate will undergo a standard high resolution, thin slice pelvic floor static/dynamic MRI study, first with a full bladder, and after the bladder is emptied. Bladder filling and drainage will be performed sequentially, using each of the 2 catheter types (A and B above) in sequence. During bladder emptying, a cine video scan will be taken at the midsagittal plane to show the dynamics of the bladder fluid and walls during emptying. Each subject will serve as their own control.||||
1337481|NCT03108066||Single Group Assignment||Treatment||None (Open Label)||This is an open-label Phase 2 study that will be conducted with a 2-stage design.||||
1337482|NCT03108053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337483|NCT03108040|||Cohort||Cross-Sectional|||||||
1337484|NCT03108027|Randomized|Crossover Assignment||Treatment||Quadruple|This is a double-blind masking.|This study is to assess the bronchodilator effects of QVM149 dosed once daily either in the morning or in the evening for 2 weeks compared to placebo. It will provide evidence of the comparability of lung function effects of QVM149 irrespective of the administration schedule|t|t|t|t
1337485|NCT03108014|||Cohort||Prospective|||||||
1337486|NCT03108001|||Cohort||Prospective|||||||
1337487|NCT03107988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1337488|NCT03107975||Single Group Assignment||Treatment||None (Open Label)||||||
1337489|NCT03107962||Single Group Assignment||Treatment||None (Open Label)||||||
1337490|NCT03107949||Single Group Assignment||Device Feasibility||None (Open Label)||LIVE Catheter is temporarily insertied into the left subclavian vein and connected to the LCU for DPTS to be delivered daily. The DPTS includes the LIVE Catheter, LCU and intermediate cable.||||
1337491|NCT03107936||Single Group Assignment||Prevention||None (Open Label)||||||
1337492|NCT03107923|||Cohort||Prospective|||||||
1337493|NCT03107910|Randomized|Parallel Assignment||Screening||Double|Participants and investigator are masked to study intervention assignment. Participants are informed that they are randomly assigned to conditions.|This project is 2 x 2 factorial approach designed to test an intervention that is aimed at increasing HIV/STI testing uptake among BMSM; this approach includes testing HIV/STI stigma focused counseling, and online HIV/STI test counseling with at-home, self-administered HIV and STI test kits.|t||t|
1337494|NCT03107897|Randomized|Parallel Assignment||Prevention||None (Open Label)||Comparing individuals who have prehabilitation prior to their TAVR procedure with those that do not.||||
1337495|NCT03107884|Randomized|Parallel Assignment||Prevention||Triple|drug and placebo will be encapsulated therefore concealing the participant, investigator and outcome assessor to group assignment.||t||t|t
1337496|NCT03107871|Randomized|Parallel Assignment||Treatment||Quadruple|Placebo and active drug will be dispensed in identical amber bottles with identical labeling.||t|t|t|t
1337497|NCT03107858|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1337498|NCT03107845|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337499|NCT03107832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337500|NCT03107819|||Cohort||Prospective|||||||
1337501|NCT03107806|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1337502|NCT03107793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337503|NCT03107780||Single Group Assignment||Treatment||None (Open Label)||||||
1337504|NCT03107767|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||A prospective cohort, following the introduction of an evidence based algorithm, will be compared to a matched historical cohort from the previous years.||||
1337554|NCT03107117|Randomized|Parallel Assignment||Treatment||Single|Blind to treatment condition to which subject is assigned|a computer-assisted adolescent motivational interview plus an online parenting program for substance abuse will be compared to usual care.||||t
1337555|NCT03107104||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337556|NCT03107091||Single Group Assignment||Treatment||None (Open Label)|Open label|Open label prospective study in a cohort of 6 patients||||
1337505|NCT03107754|Randomized|Parallel Assignment||Treatment||Quadruple|"A statistician not involved with the conduct of the study will use a computer random number generator to generate random permuted blocks. This statistician will place allocation assignment cards in sequentially numbered, sealed, opaque envelopes. A different randomization scheme will be used for each location, one at the Kapi'olani office and one at the Queen's office.~A clinic staff member not involved with the conduct of the study will be trained specifically in the opening of the allocation envelopes. The staff member will be trained to open the envelope and remove the study card to read the allocation group: buffered lidocaine or plain lidocaine. The clinic staff member will then prepare the buffered lidocaine or plain lidocaine in an unlabeled syringe, and place it on the surgical tray."|Randomized controlled trial|t|t|t|t
1337506|NCT03107741|Randomized|Factorial Assignment||Treatment||Single|||||t|
1337507|NCT03107728|Randomized|Crossover Assignment||Treatment||Single|||||t|
1337508|NCT03107715|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||Sequential presentation of 2 prototype interventions with pre/post test and follow up||||
1337509|NCT03107702|||Case-Only||Prospective|||||||
1337510|NCT03107689|||Cohort||Prospective|||||||
1337511|NCT03107676|Randomized|Parallel Assignment||Prevention||Double|Outcome assessor will only take the endurance and isokinetic measurements without knowing the participants group. Participants will be tested and assigned only to one group using the assigned arms position.|Four equal groups of physical therapy students|t|||t
1337512|NCT03107663||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337513|NCT03107650|||Cohort||Prospective|||||||
1337514|NCT03107637|||Other||Prospective|||||||
1337515|NCT03107624|||Cohort||Prospective|||||||
1337516|NCT03107611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337517|NCT03107598|Randomized|Parallel Assignment||Prevention||Single|||t|||
1337518|NCT03107585|Randomized|Parallel Assignment||Treatment||Single||||||t
1337519|NCT03107572|||Cohort||Prospective|||||||
1337520|NCT03107559|||Case-Control||Prospective|||||||
1337521|NCT03107546|Randomized|Parallel Assignment||Treatment||Double|The location of each (i.e., radial or ulnar side of the web) will be randomized and blinded. The participant and family will be blinded to which side of the web receives either the full-thickness graft or the skin substitute||t|||t
1337522|NCT03107533|||Cohort||Prospective|||||||
1337523|NCT03107520||Single Group Assignment||Diagnostic||None (Open Label)|The surgeon and musculoskeletal radiologist administering the contrast-enhanced ultrasound will not be blinded at the time of the intervention; however, they will be blinded when comparing the results of the CEUS to standard-of-care perfusion MRI and 1-year postop radiographs.|||||
1337524|NCT03107507|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1337525|NCT03107494||Single Group Assignment||Device Feasibility||None (Open Label)||Treatment with Gala Airway Treatment System||||
1337526|NCT03107481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337527|NCT03107468|Randomized|Parallel Assignment||Treatment||Single|Independent outcome assessors who do not know allocation result will participate in the outcome assessment.|||||t
1337528|NCT03107455|||Cohort||Prospective|||||||
1337529|NCT03107442|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1337530|NCT03107429|Randomized|Crossover Assignment||Prevention||Triple|"Placebo and Acetazolamide tablets were placed into capsules that were the same by the Pharmacy department. A separate investigator generated a randomisation list for 11 volunteers to decide if a placebo or acetazolamide will be taken on Day 1. They then created envelopes with the corresponding medication in Day 1 and the other in Day 2 and these were marked as Volunteer 1, 2, 3 etc. The randomisation list was sealed and kept with each investigator so they could be accessed if required due to any adverse events.~The volunteers will be recruited and both the investigators and the volunteers were blinded to what was received on each study day."|A pilot blinded randomised cross-over study.|t||t|t
1337531|NCT03107416||Single Group Assignment||Treatment||None (Open Label)||||||
1337532|NCT03107403||Single Group Assignment||Basic Science||None (Open Label)||||||
1337533|NCT03107390|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337534|NCT03107377|Randomized|Parallel Assignment||Prevention||Quadruple|double-blind placebo-controlled efficacy trial of Amphora® gel|Phase 2B double-blind placebo-controlled efficacy trial of Amphora® gel for the prevention of acquisition of urogenital Chlamydia trachomatis infection|t|t|t|t
1337535|NCT03107364|||Cohort||Retrospective|||||||
1337536|NCT03107351|Randomized|Crossover Assignment||Device Feasibility||Double||Double blind randomized crossover active vs placebo|t|||t
1337537|NCT03107338|Randomized|Parallel Assignment||Prevention||Triple|The patients and the evaluator of the VAS (MMV) were unaware of the results of the randomization and the treatment received.|This study was conducted as a prospective randomized double-blind study with a placebo. The present study considered the checklist items proposed in the CONSORT statement.|t||t|t
1337538|NCT03107325||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337539|NCT03107312|||Cohort||Cross-Sectional|||||||
1337540|NCT03107299|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337541|NCT03107286||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337542|NCT03107273|||Case-Control||Prospective|||||||
1337543|NCT03107260||Single Group Assignment||Other||None (Open Label)||||||
1337544|NCT03107247||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337545|NCT03107234|||Cohort||Prospective|||||||
1337546|NCT03107221|Randomized|Parallel Assignment||Treatment||Single||||t||
1337547|NCT03107208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337548|NCT03107195||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337549|NCT03107182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337550|NCT03107169|Randomized|Parallel Assignment||Treatment||Single|Patients were randomized by a closed envelope method in a 1: 1 ratio to either oral vancomycin (every 6 h for 10-14 days) or a FMT-FURM||t|||
1337551|NCT03107156||Single Group Assignment||Supportive Care||None (Open Label)||||||
1337557|NCT03107078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337558|NCT03107065||Single Group Assignment||Other||None (Open Label)||||||
1337559|NCT03107052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337560|NCT03107039|Randomized|Factorial Assignment||Treatment||None (Open Label)||2 group||||
1337561|NCT03107026|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind||t|t|t|t
1337562|NCT03107013||Single Group Assignment||Basic Science||None (Open Label)||||||
1337563|NCT03107000|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Two-arm, parallel group comparison||||
1337564|NCT03106987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337565|NCT03106974|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1337566|NCT03106961|||Cohort||Prospective|||||||
1337567|NCT03106948|Randomized|Parallel Assignment||Treatment||None (Open Label)||subjects will be assigned in an open labeled manner to Group 1 (Placebo), Group-2 (Ascorbic Acid), or Group-3 (Ascorbic acid & D-penicillamine). Thus, there will be 10 placebo controls, 10 ascorbic acid patients, and 10 ascorbic acid and D-penicillamine patients. Subjects treated with ascorbic acid in combination with D-penicillamine may have the longest periods between serial angioplasties. Moreover, subjects receiving combination therapy may have greater post-angioplasty luminal diameters.||||
1337568|NCT03106935|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337569|NCT03106922|Randomized|Parallel Assignment||Treatment||Single|During the study a single-blind design with respect to the investigational products will be achieved by providing the randomisation list only to the unblinded study staff personnel who will handle study drug management, preparation, dispensation and collection but who will not be involved in colonoscopy performing. The colonoscopy will be performed by experienced endoscopists who are unaware of the treatment actually being dispensed in each case. The endoscopist will be blinded by instructing all the other involved clinical staff, patients and patients' families to not discuss with him the specifics of the preparation.|||||t
1337570|NCT03106909|||Cohort||Prospective|||||||
1337571|NCT03106896|||Case-Control||Prospective|||||||
1337572|NCT03106883|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337573|NCT03106870|Randomized|Parallel Assignment||Treatment||Single|Sixty-two opaque envelopes were numbered serially and in each envelope the corresponding letter which detect allocated group were put according to randomization then all envelops were closed and put in one box .When the first patient arrives , the first envelope were opened and the patient were allocated according to the letter inside .|"Group I: pregnant women who received oral metformin in addition to insulin therapy.~Group II: pregnant women who received insulin therapy only."|t|||
1337574|NCT03106857|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337575|NCT03106844||Single Group Assignment||Treatment||None (Open Label)||||||
1337576|NCT03106831|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337577|NCT03106818|Randomized|Parallel Assignment||Treatment||Double||pain control in the early postoperative period|t||t|
1337578|NCT03106805|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1337579|NCT03106792|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1337580|NCT03106779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337581|NCT03106766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337582|NCT03106753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337583|NCT03106740|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1337584|NCT03106727|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||The roll-out of this study is designed as a stepped wedge cluster randomised controlled trial. The study consists of six clusters: the first cluster will receive the intervention in March 2017, with a new cluster receiving the intervention every three months thereafter.||||
1337585|NCT03106714|||Cohort||Prospective|||||||
1337586|NCT03106701||Single Group Assignment||Treatment||None (Open Label)||||||
1337587|NCT03106688|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1337588|NCT03106675|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Potential participants are recruited by oncologist from oncology outpatient clinic. Pretreatment imaging with computer tomography and magnetic resonance imaging is performed to evaluate whether the patient is eligible for HIFU-treatment. Those eligible will continue to the treatment and unsuitable participants will continue in the study as a control group receiving radiation therapy.~Participants in these groups will have follow-up MRI:s, ct:s, laboratory exams and fill in VAS (visual analog scale) and health questionnaire SF-36 regularly. Also intake of pain medication will be followed."||||
1337589|NCT03106662||Single Group Assignment||Treatment||None (Open Label)||||||
1337590|NCT03106649|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337591|NCT03106636|Randomized|Factorial Assignment||Prevention||Single||||||t
1337592|NCT03106623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337593|NCT03106610||Single Group Assignment||Treatment||None (Open Label)||||||
1337594|NCT03106597|Randomized|Parallel Assignment||Treatment||Single|Blinded-endpoint|"Manidipine 20mg/day, Amlodipine 10mg/day~Sealed envelope method randomization according to gender and age~25 males under 55 years old~25 males more than 55 years old~25 females under 55 years old~25 females more than 55 years old"|t|||
1337595|NCT03106584|Randomized|Crossover Assignment||Treatment||Quadruple|The supplements provided by Marigot Ltd. will be marked either A or B. No member of the research team will be aware of the ingredients in either of the supplements, the only distinguishing feature will be the labels - A and B. It is for this reason that we can say that the study will be double blind as neither investigators nor participants will have any knowledge of the supplement that they will be consuming.|"The project is a double blind randomized controlled clinical trial (pilot), with a cross-over design. Participants, will be randomized to begin taking either Aquamin-plus or Glucosamine sulphate following medical diagnosis and baseline assessment.~Following 12 weeks of supplementation of Glucosamine sulphate or Aquamin-plus there will be a 4-week washout period before participants consume the other supplement."|t|t|t|t
1337596|NCT03106571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337597|NCT03106558|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1337598|NCT03106545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337599|NCT03106532|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337600|NCT03106519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337601|NCT03106506|Randomized|Parallel Assignment||Prevention||Triple||A sample of 40 individuals with esthetic need implants will be used for the study, where the test group (n = 20) will receive tec graft. (N = 20) will receive only the dental implant without the placement of a sub-epithelial-conjunctive tissue graft.|t|t|t|
1337602|NCT03106493|||Cohort||Prospective|||||||
1337603|NCT03106480|||Cohort||Prospective|||||||
1337604|NCT03106467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337605|NCT03106454|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1337606|NCT03106441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337607|NCT03106428|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337608|NCT03106415||Single Group Assignment||Treatment||None (Open Label)||||||
1337609|NCT03106402|||Case-Only||Retrospective|||||||
1337610|NCT03106389|Randomized|Parallel Assignment||Treatment||None (Open Label)||An open-label, parallel-arm, randomized controlled trial between two groups; each consisting of 54 women, undergoing termination of pregnancy during the second trimester for various medical reasons. The first group will receive 400 micrograms of misoprostol administered vaginally for the first dose, followed after 6 hours by 400 micrograms administered orally, repeated every 6 hours. The second group will receive the same regimen, but in addition will have a transcervical balloon (Foleys') catheter that will be inflated with 30 ml. of fluid; with weighted traction using a 1000 ml fluid-filled bag applying continuous pressure to the cervix. The target sample size is 108 cases randomized in a ratio of 1:1 using a computer-generated random sequence, allocation will be concealed in sealed, opaque consecutively-numbered envelopes. Women are counseled about the procedure, consenting women will be randomly assigned to one of the two groups.||||
1337611|NCT03106376||Single Group Assignment||Basic Science||None (Open Label)||||||
1337612|NCT03106363|Randomized|Crossover Assignment||Other||Double|||t||t|
1337613|NCT03106350|||Case-Control||Prospective|||||||
1337614|NCT03106337||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337615|NCT03106324|||Cohort||Prospective|||||||
1337616|NCT03106311|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1337617|NCT03106298|||Other||Prospective|||||||
1337618|NCT03106285|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1337619|NCT03106272|||Case-Only||Prospective|||||||
1337620|NCT03106259|||Case-Only||Prospective|||||||
1337621|NCT03106246|||Cohort||Prospective|||||||
1337622|NCT03106233|||Cohort||Prospective|||||||
1337623|NCT03106220|Randomized|Crossover Assignment||Prevention||None (Open Label)||home exercise vs standard care with cross-over||||
1337624|NCT03106207||Single Group Assignment||Treatment||None (Open Label)||||||
1337625|NCT03106194||Single Group Assignment||Screening||None (Open Label)||||||
1337626|NCT03106181|Randomized|Parallel Assignment||Treatment||Single||||||t
1337627|NCT03106168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337628|NCT03106155||Single Group Assignment||Treatment||None (Open Label)||Vistusertib monotherapy (50 mg BID per os every 12 hours)||||
1337629|NCT03106142|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Intervention group Control group (usual care)||||
1337630|NCT03106129|||Cohort||Prospective|||||||
1337631|NCT03106116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337632|NCT03106103|||Case-Only||Prospective|||||||
1337633|NCT03106090|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Intervention (group receiving eSCPs) will be compared to 2 control groups: group receiving prior standard of care and standard of care SCP||||
1337634|NCT03106077|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337635|NCT03106064|Randomized|Sequential Assignment||Prevention||Single|||t|||
1337636|NCT03106051|||Cohort||Prospective|||||||
1337637|NCT03106038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337638|NCT03106025||Single Group Assignment||Diagnostic||None (Open Label)|ophthalmologists will be blinded to the ultrasound result and formal ophthalmology assessment will be compared to the ultrasound assessment.|||||
1337639|NCT03106012||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337640|NCT03105999|||Cohort||Prospective|||||||
1337641|NCT03105986|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1337642|NCT03105973||Single Group Assignment||Treatment||None (Open Label)||Open-label trial||||
1337643|NCT03105960|Randomized|Parallel Assignment||Treatment||Double|This was a double-blind study as the investigator was unaware about the sampling of the groups and study subjects were unaware about the mouthwash they were using|A Randomized Clinical Trial parallel|t||t|
1337644|NCT03105947|Randomized|Parallel Assignment||Other||Single|The primary outcome will be blood LDL-cholesterol, secondary outcomes, lipid profile which will be measured in a biochemistry lab by individuals who have no knowledge of the allocation to intervention arms.|Randomized trial of different dietary fats||||t
1337645|NCT03105934||Single Group Assignment||Health Services Research||None (Open Label)||||||
1337646|NCT03105921||Single Group Assignment||Treatment||None (Open Label)||||||
1337647|NCT03105908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337648|NCT03105895|||Cohort||Prospective|||||||
1337649|NCT03105882||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1337650|NCT03105869||Single Group Assignment||Diagnostic||None (Open Label)||test and retest in a single group of patient||||
1337651|NCT03105856|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1337652|NCT03105843|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1337653|NCT03105830||Single Group Assignment||Treatment||None (Open Label)||||||
1337654|NCT03105817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1337655|NCT03105804|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337656|NCT03105791|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1337657|NCT03105778|||Other||Prospective|||||||
1337658|NCT03105765|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1337659|NCT03105752||Single Group Assignment||Health Services Research||None (Open Label)||||||
1337660|NCT03105739|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1337661|NCT03105726|||Cohort||Prospective|||||||
1337662|NCT03105713|Randomized|Crossover Assignment||Health Services Research||Double|Care Providers are masked for patients receiving the intervention. Outcom Assessors are masked for patients receiving the intervention.|Stepped Wedge Cluster RCT is considered to align a cross-over design.||t||t
1337663|NCT03105700||Single Group Assignment||Treatment||None (Open Label)||||||
1337664|NCT03105687|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1337665|NCT03105674|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1337666|NCT03105661|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomization to treatment or non treatment group||||
1337667|NCT03105648|||Case-Control||Retrospective|||||||
1337668|NCT03105635|Non-Randomized|Single Group Assignment||Health Services Research||Double|Participants are patients Care providers are practices||t|t||
1337669|NCT03105622|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1337670|NCT03105609|||Cohort||Prospective|||||||
1337671|NCT03105596||Single Group Assignment||Treatment||None (Open Label)||||||
1337672|NCT03105583|||Cohort||Cross-Sectional|||||||
1337673|NCT03105570||Single Group Assignment||Treatment||None (Open Label)||Single Armed, prospective, open label study||||
1337674|NCT03105557|||Cohort||Prospective|||||||
1337675|NCT03105544|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337676|NCT03105531|||Cohort||Prospective|||||||
1337677|NCT03105518||Single Group Assignment||Treatment||None (Open Label)||Assessment of immediate and delayed postoperative pain||||
1337678|NCT03105505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337679|NCT03105492|||Cohort||Cross-Sectional|||||||
1337680|NCT03105479|Randomized|Parallel Assignment||Treatment||Single|Assessor masking in Part B only (no masking in Part A)|||||t
1337681|NCT03105466||Single Group Assignment||Treatment||None (Open Label)||||||
1337682|NCT03105453|||Cohort||Prospective|||||||
1337683|NCT03105440|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337684|NCT03105427|||Case-Only||Prospective|||||||
1337685|NCT03105414|||Cohort||Prospective|||||||
1337686|NCT03105401|||Other||Cross-Sectional|||||||
1337687|NCT03105388|||Cohort||Prospective|||||||
1337688|NCT03105375|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||SAD and MAD study||||
1337689|NCT03105362||Single Group Assignment||Supportive Care||None (Open Label)||Open label single center pilot study||||
1337690|NCT03105349||Single Group Assignment||Treatment||None (Open Label)||||||
1337691|NCT03105336||Single Group Assignment||Treatment||None (Open Label)||||||
1337692|NCT03105323|||Cohort||Prospective|||||||
1337693|NCT03105310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337694|NCT03105297|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1337695|NCT03105284|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants will act as their own control. Each participant will receive both excision and liposuction of fat.||||
1337696|NCT03105271|||Cohort||Prospective|||||||
1337697|NCT03105245|Randomized|Crossover Assignment||Treatment||Double|Both participants and the outcome assessor (analysing EEGs) will be blinded.|Each participant will receive all four treatment conditions in randomly allocated sequence during their ECT course. That is, participants will receive either short or long anaesthetic-ECT stimulus time interval treatments, and normal or hyperventilation treatments - this results in four possible combinations, which individual participants will cycle through in random order during their ECT course (e.g. short-hyperventilation, long-normal ventilation, short-normal ventilation, long-hyperventilation).|t|||t
1337698|NCT03105232|||Cohort||Prospective|||||||
1337699|NCT03105219|Randomized|Parallel Assignment||Treatment||Single|Urinary albumin excretion at 3 month|||||t
1337700|NCT03105206|||Case-Only||Prospective|||||||
1337701|NCT03105193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337702|NCT03105180|||Case-Control||Cross-Sectional|||||||
1337703|NCT03105167|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337704|NCT03105154|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patient will be randomized sequentially to Prevena alternating with standard of care dressing||||
1337705|NCT03105141|Randomized|Parallel Assignment||Prevention||Double||||t||t
1337706|NCT03105128|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337707|NCT03105115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337708|NCT03105102|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1337709|NCT03105089|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1337710|NCT03105076|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1337711|NCT03105063||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337712|NCT03105050|||Other||Prospective|||||||
1337713|NCT03105037|||Case-Crossover||Prospective|||||||
1337714|NCT03105024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337715|NCT03105011||Sequential Assignment||Supportive Care||None (Open Label)||||||
1337716|NCT03104998||Single Group Assignment||Treatment||None (Open Label)||||||
1337717|NCT03104985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337718|NCT03104972|Randomized|Crossover Assignment||Treatment||Single||randomized controlled crossover study|t|||
1337719|NCT03104959|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1337720|NCT03104946|||Cohort||Retrospective|||||||
1337721|NCT03104933|||Cohort||Prospective|||||||
1337722|NCT03104920|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337723|NCT03104907||Single Group Assignment||Treatment||None (Open Label)||||||
1337724|NCT03104894|Randomized|Parallel Assignment||Treatment||Triple|patient will be assigned to the study/control group by randomization soft ware. The results will be documented and kept by the doctor who preforms the meibomian glands massage/ sham massage. All patients will receive study number. Follow up examination will be preformed by another doctor.||t||t|t
1337725|NCT03104881|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337726|NCT03104868|Randomized|Parallel Assignment||Supportive Care||Double|We will blind: 1) research interviewers involved with outcomes assessment, 2) personnel involved in statistical analyses (Dr. Kwasny, Ms. Patel), 3) principal investigators (Wolf, Ladner). Site project managers will have access to study arm assignments to initiate TAKE IT components to those randomized to receive them.|Participants will be randomized to one of two arms: TAKE IT strategy or usual care.|t||t|
1337727|NCT03104855||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337728|NCT03104842|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337729|NCT03104829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337730|NCT03104816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337731|NCT03104803|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1337732|NCT03104790|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Two groups based on prior vaccination history||||
1337733|NCT03104777|Randomized|Parallel Assignment||Prevention||Single|"Parents and pupils will not be informed that their school is taking part in this research or that anonymous photographs will be taken of the contents of the lunch boxes brought into school by children in years 3 - 6.~Written consent was obtained from the Head Teacher in all participating schools.~Providing parents with information about the study is likely to change their behaviour and it will not be possible to assess whether the intervention itself has had an effect."|cluster randomised controlled trial|t|||
1337734|NCT03104764|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor have not met the patient before assessing the outcome. The assessor has no information about which surgical technique that is used.|Prospective, randomized, controlled, single-blind investigation||||t
1337735|NCT03104751|||Cohort||Prospective|||||||
1337736|NCT03104738|Randomized|Parallel Assignment||Prevention||None (Open Label)||Open-label randomized controlled trial||||
1337737|NCT03104725||Single Group Assignment||Other||None (Open Label)||||||
1337738|NCT03104712|Randomized|Crossover Assignment||Basic Science||Single|The outcomes assessor will be unaware of the intervention associated with the samples being analyzed.|||||t
1337739|NCT03104699||Single Group Assignment||Treatment||None (Open Label)||||||
1337740|NCT03104686|Randomized|Crossover Assignment||Basic Science||Single|Personnel involved in randomization, in the analyses of the samples collected, and who were involved in the data processing were blinded.|||||t
1337741|NCT03104673|||Cohort||Prospective|||||||
1337742|NCT03104660||Single Group Assignment||Treatment||None (Open Label)||CE certified mitral valve repair systems||||
1337743|NCT03104647||Single Group Assignment||Other||None (Open Label)||||||
1337744|NCT03104634|Randomized|Crossover Assignment||Treatment||Quadruple|Matched placebo.||t|t|t|t
1337745|NCT03104621|Randomized|Crossover Assignment||Treatment||Quadruple|Investigators, patients and other study participants were blinded to treatment assignment throughout the study. Evaluator of IOP was also masked to treatment assignment.||t|t|t|t
1337746|NCT03104608|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1337747|NCT03104595|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||3 + 3 dose escalation||||
1337748|NCT03104582|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1337749|NCT03104569|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1337750|NCT03104556|||Cohort||Prospective|||||||
1337751|NCT03104543|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized clinical trial of an educational intervention||||
1337752|NCT03104530|||Case-Control||Cross-Sectional|||||||
1337753|NCT03104517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337754|NCT03104504|Randomized|Parallel Assignment||Prevention||Single||Stepped Wedge Design|t|||
1337755|NCT03104491||Single Group Assignment||Treatment||None (Open Label)||||||
1337756|NCT03104478|||Cohort||Prospective|||||||
1337757|NCT03104465||Single Group Assignment||Other||None (Open Label)||||||
1337758|NCT03104452|||Cohort||Prospective|||||||
1337759|NCT03104439||Single Group Assignment||Treatment||None (Open Label)||||||
1337760|NCT03104426|Randomized|Parallel Assignment||Treatment||None (Open Label)||"RCT with unblinded treatment allocation 1:1 ratio. Either treatment with darbepoetin alfa or standard care. No placebo."||||
1337761|NCT03104413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337762|NCT03104400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337763|NCT03104387|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1337764|NCT03104374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337765|NCT03104361||Single Group Assignment||Treatment||None (Open Label)||Intravesicai injection of platelet-rich plasma||||
1337766|NCT03104348||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337767|NCT03104335||Single Group Assignment||Treatment||None (Open Label)||participants will be advised to recieve 750 mg daily once apatinib for body surface area (BSA) > 1.5 and 500mg daily for BSA <1.5. Half an hour after meal and everyday at the same time is usually advised.||||
1337768|NCT03104322||Single Group Assignment||Other||None (Open Label)||Fixed-order, two-period crossover (2 x 8 weeks), no washout, usual care controlled||||
1337769|NCT03104309||Single Group Assignment||Treatment||None (Open Label)||||||
1337770|NCT03104296|||Cohort||Prospective|||||||
1337771|NCT03104283||Single Group Assignment||Treatment||None (Open Label)||||||
1337772|NCT03104270||Single Group Assignment||Treatment||None (Open Label)||||||
1337773|NCT03104257|||Case-Control||Prospective|||||||
1337774|NCT03104244|||Cohort||Prospective|||||||
1337775|NCT03104231||Single Group Assignment||Prevention||None (Open Label)||||||
1337811|NCT03103763|||Cohort||Prospective|||||||
1337965|NCT03101748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337776|NCT03104218|Randomized|Parallel Assignment||Treatment||Triple|A randomisation list will be established prior to the initiation of the study using a random number generator. The randomisation list will be generated by an independent research assistant not involved in data collection. Allocation will be concealed in sealed and opaque envelopes that will be sequentially numbered. Randomisation will be stratified to ensure balance of the treatment groups with respect to sex. A blocked randomisation will also be used to make sure that two equal groups of 20 participants are obtained. Given that it is possible to blind the treating PT, the participants and the evaluators, a triple-blind design will be used. An independent research assistant from the CIRRIS will open the randomisation envelope indicating the participant's assignment. The research assistant will be blind to the baseline evaluation results. The research assistant will be the one who will set-up the parameters on the tDCS before treatment sessions with tDCS (real or sham tDCS).|This triple-blind (patients, therapist & evaluator), parallel-group RCT will include four evaluation sessions over 3 months (baseline, week 3, week 6, 3-month) and 8 supervised physiotherapy treatments during a 6-week rehabilitation program (3 sessions the 1st week, 2 sessions the 2nd weeks, 3 session in the last 4 weeks). Thereafter, participants will be randomly assigned to one of two intervention groups, and then take part in their assigned 6-week intervention. At week 3, 6, and 12, the self-administered questionnaires will be re-administered, while US measurements will only be re-evaluated at week 6.|t|t||t
1337777|NCT03104205||Single Group Assignment||Health Services Research||None (Open Label)||A single arm pilot intervention||||
1337778|NCT03104192|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||Two Arm Pilot Study||||
1337779|NCT03104179|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337780|NCT03104166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337781|NCT03104153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337782|NCT03104140|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1337783|NCT03104127|Randomized|Parallel Assignment||Other||Double|||||t|t
1337784|NCT03104114|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Pharmacist-led intervention group vs historical-control group||||
1337785|NCT03104101|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337786|NCT03104088|||Case-Control||Prospective|||||||
1337787|NCT03104075|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Randomized assignment to group will be in a 1:1 ratio utilizing block randomization in blocks of 10 to receive Prevnar-13 or Pneumovax 23. Following randomized assignment of vaccine, the study will be open-label.||||
1337788|NCT03104062|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337789|NCT03104049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337790|NCT03104036|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be split into two branches of the study by randomization criteria (gender, imunosupresive therapy). Each branch of the study will have 25-30 patients. The first group will be treated with 4 g mesalazine enema 1x daily for 2 weeks, then every other day until the end of the 6th week. A second group of patients will be applied enema prepared from 50 g of stool of examined donor dissolved in 150 ml of normal saline, the 1st week 5 times, than one time a week until the end of the 6th week.||||
1337791|NCT03104023|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1337792|NCT03104010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337793|NCT03103997|Non-Randomized|Parallel Assignment||Diagnostic||Single|Participants undergo each biopsy in the protocol. The care provider will be directing and performing each needle pass. The outcome assessor will be unaware of each group.|Subjects enrolled will undergo EUS-guided biopsies in the following manner. First pass needle out of package without preparation and full suction. Second pass: needle flushed with heparin, then flushed with air and suction, dry heparin. Third pass: needle flushed with heparin and then 2 cc of liquid added to suction syringe and attached, wet heparin.||||t
1337794|NCT03103984|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337795|NCT03103971||Single Group Assignment||Treatment||None (Open Label)||||||
1337796|NCT03103958|Randomized|Parallel Assignment||Treatment||Double|double-blind|Parallel Assignment|t||t|
1337797|NCT03103945|||Cohort||Prospective|||||||
1337798|NCT03103932|Randomized|Parallel Assignment||Health Services Research||Double|The assigned care pathway will not be revealed to the participant NTproBNP levels will not be revealed to care providers for the group randomized to usual care.|single blind, strategy based, randomized trial consisting of two main study arms|t|t||
1337799|NCT03103919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337800|NCT03103906|Randomized|Parallel Assignment||Treatment||Single||||||t
1337801|NCT03103893||Single Group Assignment||Treatment||None (Open Label)|Clinical assessors are blinded to recruitment and treatment assignment.|Patients will apply lotions containing either rapamycin or vehicle to 2 distinct areas of sun exposed skin.||||
1337802|NCT03103880|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Single arm observation of mobile application used to enable medication adherence tracking with two parallel arms to simultaneously assess usability of two lung function capture techniques.||||
1337803|NCT03103867|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1337804|NCT03103854|Randomized|Factorial Assignment||Prevention||None (Open Label)||This is a 2x2 of burst physical activity (BURST) vs moderate intensity continuous training (MICT) and text message reminders vs no text message reminders. Patients will be randomized to either BURST or MICT and then further randomized to either receive text message reminders or not receive text message reminders.||||
1337805|NCT03103841|||Case-Control||Cross-Sectional|||||||
1337806|NCT03103828|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1337807|NCT03103815||Single Group Assignment||Treatment||None (Open Label)|The evaluating investigators will be blinded to treatment assignment. Patients in our center, include those participate in the trial and those receive standard therapy, will be evaluated by clinicians who do not know the trial.|This is a self-controlled trial. All participants will receive treatment.||||
1337808|NCT03103802|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1337809|NCT03103789|||Case-Control||Prospective|||||||
1337810|NCT03103776|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337812|NCT03103750|Randomized|Crossover Assignment||Treatment||Double||This is a within-subject, two-day four-scan, randomized, double-blind, placebo-controlled study design.|t||t|
1337813|NCT03103737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337814|NCT03103724||Single Group Assignment||Treatment||None (Open Label)||||||
1337815|NCT03103711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337816|NCT03103698|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337817|NCT03103685|Randomized|Parallel Assignment||Treatment||Double|The dentist will be blind wheater the patient takes DAPT or not.||||t|t
1337818|NCT03103672|||Case-Control||Prospective|||||||
1337819|NCT03103659||Single Group Assignment||Supportive Care||None (Open Label)||||||
1337820|NCT03103646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1337821|NCT03103633|Randomized|Parallel Assignment||Prevention||Double|Patients were followed up by an investigator unaware of the patients' achievement or not of the oxygen dynamic goal|"Interventional group:MAP declined with less than 20% of baseline, BIS 45-60, Brain oxygen saturation declined with less than 20% of baseline.~Control group：no intervention beside the same monitoring with MAP, BIS and brain oxygen saturation and receiving standard measures to maintain oxygenation (SpO2≥94%), haemoglobin (>80 g/L), core temperature (≥36°C), and heart rate (<120 beats per min)"|||t|t
1337822|NCT03103620|||Case-Only||Prospective|||||||
1337823|NCT03103607|||Cohort||Prospective|||||||
1337824|NCT03103594|Randomized|Parallel Assignment||Treatment||Single|The patients will not be notified of which arm they are randomized to.||t|||
1337825|NCT03103581||Single Group Assignment||Treatment||None (Open Label)||||||
1337826|NCT03103568|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1337827|NCT03103555||Single Group Assignment||Treatment||None (Open Label)||||||
1337828|NCT03103542||Single Group Assignment||Treatment||None (Open Label)||||||
1337829|NCT03103529|Randomized|Parallel Assignment||Treatment||Single||||||t
1337830|NCT03103516|Non-Randomized|Parallel Assignment||Treatment||Single||200 acute spinal cord injury patients (complete and incomplete) will undergo pre-hospital treatment in the Beijing Emergency Medical Center and Beijing Red Cross Emergency Rescue Center, and will receive in-hospital treatment in the Peking University People's Hospital, Peking University Third Hospital, Beijing Friendship Hospital Affiliated to Capital Medical University, Chaoyang Hospital Affiliated to Capital Medical University, and Chinese PLA General Hospital, China. There were 100 patients undergoing epidural decompression surgery within 24 hours and 100 patients receiving surgery after 24 hours.||||t
1337831|NCT03103503|||Case-Only||Prospective|||||||
1337832|NCT03103490||Single Group Assignment||Diagnostic||None (Open Label)||||||
1337833|NCT03103477|||Cohort||Prospective|||||||
1337834|NCT03103464|Randomized|Parallel Assignment||Treatment||Single|Patient's primary physical therapist will not be aware whether the patient is in the intervention or control group.|||t||
1337835|NCT03103451|Randomized|Factorial Assignment||Treatment||Single|||t|||
1337836|NCT03103438|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1337837|NCT03103425|||Cohort||Prospective|||||||
1337838|NCT03103412|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1337839|NCT03103399|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337840|NCT03103386|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337841|NCT03103373|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"The study is a clinical trial, prospective and random type, in which 60 patients, of both genders, aged between 18 and 80 years, who will undergo major abdominal surgery, divided in two groups.~Patients will be randomly divided into two groups with 35 patients:~Conventional Group, Transthoracic Echocardiogram Group"||||
1337842|NCT03103360|||Case-Only||Prospective|||||||
1337843|NCT03103347|||Cohort||Prospective|||||||
1337844|NCT03103334|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1337845|NCT03103321|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1337846|NCT03103308|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1337847|NCT03103295||Single Group Assignment||Treatment||None (Open Label)|Open|||||
1337848|NCT03103282|||Cohort||Prospective|||||||
1337849|NCT03103269|Randomized|Parallel Assignment||Prevention||Single||||||t
1337850|NCT03103256|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337851|NCT03103243||Single Group Assignment||Treatment||None (Open Label)||||||
1337852|NCT03103230||Single Group Assignment||Other||None (Open Label)||||||
1337853|NCT03103217||Single Group Assignment||Treatment||None (Open Label)||||||
1337854|NCT03103204|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337855|NCT03103191|||Case-Control||Prospective|||||||
1337856|NCT03103178|||Case-Only||Prospective|||||||
1337857|NCT03103152|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1337858|NCT03103139|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337859|NCT03103126|Randomized|Parallel Assignment||Treatment||Single|The conditions/treatments cannot be masked but the outcome assessors will be masked as to the arm that the participants are allocated to.|Randomised controlled trial: control group vs. one intervention arm||||t
1337860|NCT03103113|||Cohort||Retrospective|||||||
1337861|NCT03103100|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1337862|NCT03103087|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1337863|NCT03103074|Randomized|Crossover Assignment||Treatment||Triple|Partcipant and investigator/outcomes assessor are blinded. Treatment will be given after randomization by a secondary investigator.|First treatment - one placebo and one active substance group Thereafter - all patients receive active substance|t||t|t
1337864|NCT03103061||Single Group Assignment||Diagnostic||None (Open Label)||Stress and rest perfusion imaging using Lexiscan as the coronary vasodilator (pharmacological stressor).||||
1337865|NCT03103048|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1337866|NCT03103035|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337867|NCT03103022||Single Group Assignment||Treatment||None (Open Label)||||||
1337868|NCT03103009||Single Group Assignment||Treatment||None (Open Label)||Treatment Plan for an individual patient with pasireotide for Hyperinsulinemic Hypoglycemia (Compassionate Use Protocol for Pasireotide)||||
1337869|NCT03102996|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337870|NCT03102983||Single Group Assignment||Basic Science||None (Open Label)||||||
1337871|NCT03102970|||Case-Only||Prospective|||||||
1337872|NCT03102957|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||2 arms : epileptic patient and healthy volonteers||||
1337873|NCT03102944|||Other||Prospective|||||||
1337874|NCT03102931||Single Group Assignment||Health Services Research||None (Open Label)||||||
1337875|NCT03102918|Randomized|Parallel Assignment||Treatment||Double|This is a double-blind study.|In this randomized, double-blind, placebo-controlled trial, cannabis-dependent subjects ages 18-65 will receive medical management over a 6-week period, with half receiving Epidiolex treatment and half receiving placebo.|t||t|
1337876|NCT03102905|||Cohort||Retrospective|||||||
1337877|NCT03102892|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1337878|NCT03102879|Randomized|Parallel Assignment||Treatment||Triple||"2 interventions:~Endodontic regenerative treatment with Biological product of umbilical cord-derived mesenchymal stem cells encapsulated in a plasma-derived biomaterial.~Endodontic treatment with inert product gutapercha."|t||t|t
1337879|NCT03102866|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1337880|NCT03102853|Randomized|Parallel Assignment||Prevention||||||||
1337881|NCT03102840|||Ecologic or Community||Cross-Sectional|||||||
1337882|NCT03102827|Randomized|Crossover Assignment||Treatment||Single|||t|||
1337883|NCT03102814|Randomized|Sequential Assignment||Treatment||Single|Due to the nature of the study intervention, it is not possible to blind participants or the health care providers. However, the statistician who will perform the main statistical analyses will be blinded to group allocation.|"In order to evaluate the effects of the BRIDGE program, a stepped wedge cluster randomized controlled trial will be conducted. In the trial, participating centres switch from control (current rehabilitation program) to intervention phase (adding the BRIDGE program to the current program) in a randomized order. All centres start the trial simultaneously and act as controls until the point in time they are randomized to crossover from control to intervention, and all centres deliver the intervention by the end of inclusion.~The stepped wedge design is suitable for a phased evaluation approach, where it is difficult to deliver two parallel interventions."|||t|
1337884|NCT03102801|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1337885|NCT03102788|Randomized|Parallel Assignment||Health Services Research||Double|The research assistant who will examine the participants at baseline and follow-ups and the statistician who perform the main effect analysis will be blinded for group allocation.|In this randomized controlled trial, participants will be allocated to receive their first consultation in specialist health care by either an occupational therapy specialist or a rheumatologist. The occupational therapist may thereafter refer the patient to a consultation with a rheumatologist if necessary, and vice versa.|||t|t
1337886|NCT03102775|Randomized|Single Group Assignment||Treatment||Single|While the leaders and family-coordinators are aware of whether the office has been randomized to experimental or control group offices, the families are masked for this information. they are only aware of participating in a family project, but not if experimental or control condition.|Cluster-randomized study. After baseline at office leader and family coordinator level as well as administrative data for families in target group, offices have been randomized to experimental and control group offices. The HOLF-model is implemeted in experimental group offices, while control group offices implement local family projects. Effects on families are analysed on the four main follow-up areas: employment, housing, financial situation and the social situation of the children.|t|||
1337887|NCT03102762|Randomized|Parallel Assignment||Treatment||Double||Prospective, randomized double blind placebo control ( RDBPC) study.|t|t||
1337888|NCT03102749|||Case-Control||Cross-Sectional|||||||
1337889|NCT03102736|Randomized|Parallel Assignment||Treatment||Triple|Both participants and research staff (aside from pharmacy) will be blinded||t||t|t
1337890|NCT03102723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337891|NCT03102710|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1337892|NCT03102697|||Cohort||Prospective|||||||
1337893|NCT03102684|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1337894|NCT03102671|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1337895|NCT03102658|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1337896|NCT03102645|Randomized|Crossover Assignment||Basic Science||Triple|Packaging, randomization and masking of investigational drugs (imipramine and placebo) by Region Hovedstadens Apothecary before delivery to investigator. Sealed envelope with participant ID and drug data will be opened after data analysis.|16 healthy female subjects. Double-blinded, crossover study on two days with 1 week washout. Either placebo or imipramine 50 mg single dose before and after measurement of UOP and AOP.|t||t|t
1337897|NCT03102632|Non-Randomized|Sequential Assignment||Treatment||Single|The radiologist measuring kidney volumes will be masked to the study condition.|Participants will have a period of usual fluid intake and a period of increased water intake over the course of the study.||||t
1337898|NCT03102619|||Other||Prospective|||||||
1337899|NCT03102606|Randomized|Parallel Assignment||Supportive Care||Triple|"Plinabulin and pegfilgrastim are each masked using a double-dummy design in phase 3.~Docetaxel administration is not masked."||t|t|t|
1337900|NCT03102593|Randomized|Parallel Assignment||Treatment||Quadruple||Protocol designed to evaluate one or more interventions for treating a disease, syndrome or condition.|t|t|t|t
1337958|NCT03101839||Single Group Assignment||Treatment||None (Open Label)||||||
1337959|NCT03101826||Single Group Assignment||Basic Science||None (Open Label)|No masking.|All participants will receive the active (filtered music) intervention.||||
1337960|NCT03101813|||Cohort||Other|||||||
1337961|NCT03101800|Randomized|Parallel Assignment||Treatment||Single||||||t
1337962|NCT03101787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337963|NCT03101774|Randomized|Parallel Assignment||Treatment||Single|||t|||
1337964|NCT03101761|||Cohort||Retrospective|||||||
1337901|NCT03102580|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Surgeon offices will be randomized to Usual Care or Intervention sites. During Aim 2, after completing the surveys in the clinic, usual care patients and surgeons will have the ability to see PRO scores, but will NOT receive feedback (no OA Care Plan). This is the current standard of care in orthopedic clinics. For intervention sites, the patient and surgeon will receive the OA Care Plan (currently under development).~During Aim 3, Usual Care sites will receive the OA Care Plan, and Intervention sites will receive the Enhanced OA Care Plan, including access to Patient Peer Support website and PCP reports (currently under development). All surgeons that used the OA Care plan in Aim 2 will be invited to participate in the Enhanced OA Care plan in Aim 3."||||
1337902|NCT03102567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337903|NCT03102554||Single Group Assignment||Diagnostic||None (Open Label)||Longitudinal cohort||||
1337904|NCT03102541|||Case-Control||Prospective|||||||
1337905|NCT03102528|||Cohort||Retrospective|||||||
1337906|NCT03102515|Randomized|Sequential Assignment||Treatment||||||||
1337907|NCT03102502|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel: Patiants with coronary heart disease are assigned to two groups in parallel for the duration of the study.||||
1337908|NCT03102489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337909|NCT03102476||Single Group Assignment||Basic Science||None (Open Label)||||||
1337910|NCT03102463|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1337911|NCT03102450||Single Group Assignment||Treatment||None (Open Label)||||||
1337912|NCT03102437||Single Group Assignment||Treatment||None (Open Label)||Continued Access||||
1337913|NCT03102424|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1337914|NCT03102411|||Other||Cross-Sectional|||||||
1337915|NCT03102398||Single Group Assignment||Treatment||None (Open Label)||||||
1337916|NCT03102385|Randomized|Parallel Assignment||Other||Single|All participants will be informed that they will complete an on-line interview regarding blood donation. They will not be told which of the two interviews they are completing.|Participants will be randomly assigned to either (1) complete an on-line motivational interview about their blood donation experience, or (2) complete an on-line knowledge interview about blood donation.|t|||
1337917|NCT03102372|Randomized|Parallel Assignment||Basic Science||Single|Single blinded|Randomized single blinded, controlled intervention trial|t|||
1337918|NCT03102359|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1337919|NCT03102346|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337920|NCT03102333|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1337921|NCT03102320|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337922|NCT03102307|||Cohort||Prospective|||||||
1337923|NCT03102294|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1337924|NCT03102281|||Cohort||Prospective|||||||
1337925|NCT03102268|||Cohort||Prospective|||||||
1337926|NCT03102255|Randomized|Parallel Assignment||Prevention||Single|||t|||
1337927|NCT03102242||Single Group Assignment||Treatment||None (Open Label)||||||
1337928|NCT03102229||Single Group Assignment||Supportive Care||None (Open Label)||||||
1337929|NCT03102216|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Investigator-initiated, Prospective, Randomised, Control Trial||||
1337930|NCT03102203|||Cohort||Prospective|||||||
1337931|NCT03102190|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1337932|NCT03102177||Single Group Assignment||Other||None (Open Label)||Open label prospective study||||
1337933|NCT03102164|||Case-Control||Prospective|||||||
1337934|NCT03102151|||Ecologic or Community||Prospective|||||||
1337935|NCT03102138||||||||||||
1337936|NCT03102125|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1337937|NCT03102112|||Cohort||Prospective|||||||
1337938|NCT03102099|||Case-Control||Prospective|||||||
1337939|NCT03102086|||Case-Only||Cross-Sectional|||||||
1337940|NCT03102073|||Cohort||Other|||||||
1337941|NCT03102060||Single Group Assignment||Prevention||None (Open Label)||||||
1337942|NCT03102047||Single Group Assignment||Treatment||None (Open Label)||||||
1337943|NCT03102034|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1337944|NCT03102021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337945|NCT03102008|Randomized|Crossover Assignment||Treatment||Single|Independent evaluators to conduct post-treatment evaluations.|Participants are randomly assigned to one of three baseline conditions (2, 3, or 4 week waitlist) and all participants are subsequently treated using the active study intervention (UP-A).||||t
1337946|NCT03101995||Single Group Assignment||Treatment||None (Open Label)||Phase II open, single arm, national, non-randomized clinical trial; to evaluate safety of gemcitabine in patients with locally advanced cervical cancer and renal dysfunction, referring to the INCAN.||||
1337947|NCT03101982|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337948|NCT03101969|||Ecologic or Community||Cross-Sectional|||||||
1337949|NCT03101956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337950|NCT03101943|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1337951|NCT03101930|Randomized|Parallel Assignment||Basic Science||Quadruple|Treatment with liragultide or sitagliptin will be masked using matching placebo.||t|t|t|t
1337952|NCT03101917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||All patients who meet eligibility requirements and choose to participate will undergo the image guided surgical cochlear implantation procedure as described in the protocol.||||
1337953|NCT03101904|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1337954|NCT03101891|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||All eligible patients will be offered participation in the study. Particpants can elect for invasive therapy with amnioinfusions or expectant management.||||
1337955|NCT03101878|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1337956|NCT03101865|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1337957|NCT03101852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1337966|NCT03101735|||Cohort||Prospective|||||||
1337967|NCT03101722|Randomized|Parallel Assignment||Treatment||Double||"The studies were divided into 4 groups: hearing aid, huperzine A, combination of hearing aid and huperzine A intervention and control group.The study is a single-center, double-blind, randomized, placebo controlled trial, with minimized allocation of patients to one of the four groups.~For the study of tinnitus intervention, there is a three to six month follow-up. For the study of hearing and cognitive function protection, there is a three year follow-up."|t|t||
1337968|NCT03101709||Single Group Assignment||Treatment||None (Open Label)||||||
1337969|NCT03101696|||Other||Prospective|||||||
1337970|NCT03101683||Single Group Assignment||Treatment||None (Open Label)||||||
1337971|NCT03101670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1337972|NCT03101657|||Case-Only||Retrospective|||||||
1337973|NCT03101644||Single Group Assignment||Other||None (Open Label)||||||
1337974|NCT03101631|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||Cases and Contols Study||||
1337975|NCT03101618|||Case-Control||Cross-Sectional|||||||
1337976|NCT03101605|Randomized|Parallel Assignment||Other||Single|The physicians evaluating the student performances will be blinded to the randomization|||||t
1337977|NCT03101592|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The study will be a cluster randomized trial comparing three different antiretroviral therapy (ART) dispensing strategies. Clusters will be comprised of individual clinics in Malawi and Zambia. Enrolled individuals will receive standard of care at their site with the exception of the ART dispensing interval based on the assigned randomization. Outcomes will be assessed after 12 months, but all patients will be followed for 36 months.||||
1337978|NCT03101579||Single Group Assignment||Treatment||None (Open Label)||||||
1337979|NCT03101566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1337980|NCT03101553|Randomized|Parallel Assignment||Treatment||Single|||||t|
1337981|NCT03101540||Single Group Assignment||Treatment||None (Open Label)||A single group model was used: pregnant women.||||
1337982|NCT03101527||Single Group Assignment||Treatment||None (Open Label)||A single group model was used: pregnant women.||||
1337983|NCT03101514||Single Group Assignment||Prevention||None (Open Label)||Kanglaite injection + Radiotherapy ± Chemotherapy||||
1337984|NCT03101501||Single Group Assignment||Prevention||None (Open Label)||||||
1337985|NCT03101488||Single Group Assignment||Treatment||None (Open Label)||||||
1337986|NCT03101475||Single Group Assignment||Treatment||None (Open Label)||||||
1337987|NCT03101462|Randomized|Parallel Assignment||Prevention||None (Open Label)||Subjects will be randomized to one of two different groups to receive either licensed trivalent FluMist or inactivated trivalent influenza vaccine from the 2010-2011 season.||||
1337988|NCT03101449|Randomized|Parallel Assignment||Treatment||Single|||||t|
1337989|NCT03101436|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Phase I: Intervention with Diet (Extra Virgin Olive Oil) Washout Period Phase I: Intervention with Diet (Red Wine)||||
1337990|NCT03101423|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1337991|NCT03101410|Randomized|Parallel Assignment||Prevention||Single|single blind||t|||
1337992|NCT03101397|||Cohort||Prospective|||||||
1337993|NCT03101384|||Cohort||Prospective|||||||
1337994|NCT03101371|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Patients with normal UA pre-surgery will be randomized 1:1 to one of two arms prior to surgery:~Aseptic protocol for catheter insertion using Povidone Iodine treated catheter and maintaining plastic sleeve on catheter or~SOC catheter insertion in which catheter is inserted right out of package/non-treated catheter."||||
1337995|NCT03101358|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Phase 1/2, open-label, dose-rising trial of three concentrations of SOR007 (0.15%, 1.0%, 2.0%).~During the dose escalation phase, the study will follow a standard 3+3 dose-ascending design. If a single dose limiting toxicity (DLT) is identified in one of three subjects in the cohort, a further three subjects will be enrolled at the same dose level. If one or more DLT occur in the three additional subjects enrolled in the cohort, dose escalation will stop and the prior dose level will be regarded as the Maximum Tolerated Dose (MTD) and taken forward into the dose expansion phase. If no further DLT are identified, dose escalation will continue, until either a DLT is identified at a higher dose or the top dose of 2% is reached.~In the dose expansion phase, additional subjects will be enrolled up to a maximum of 12 subjects at the dose determined to be the MTD (or the top dose, 2.0% SOR007)."||||
1337996|NCT03101345||Single Group Assignment||Basic Science||None (Open Label)||||||
1337997|NCT03101332||Single Group Assignment||Treatment||None (Open Label)||||||
1337998|NCT03101319|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1337999|NCT03101306||Single Group Assignment||Basic Science||None (Open Label)||Single site, non-randomised basic science study.||||
1338000|NCT03101293|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1338001|NCT03101280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338002|NCT03101267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338003|NCT03101254||Single Group Assignment||Treatment||None (Open Label)||||||
1338004|NCT03101241|Randomized|Parallel Assignment||Treatment||Quadruple||This is a double-blind, placebo-controlled, parallel-group study.|t|t|t|t
1338005|NCT03101228|Randomized|Parallel Assignment||Prevention||Single|Due to the nature of the intervention, masking of the participants is not possible. Analyzing of the obtained data will be masked.|A parallel-group randomised controlled trial||||t
1338006|NCT03101215|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1338007|NCT03101202|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338008|NCT03101189|Randomized|Sequential Assignment||Other||Quadruple|||t|t|t|t
1338009|NCT03101176||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338010|NCT03101163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338011|NCT03101150|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338012|NCT03101137|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1338039|NCT03100786|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1338013|NCT03101124|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||12 participants will be included in each of 3 groups: wound moistening group (skin reduction surgery), wound bolus group (after skin reduction surgery), and (for comparison) a group getting usual intravenous tranexamic acid before orthopedic surgery. It is not possible to conduct a formal power calculation, as it is completely unknown which concentrations could be expected after topical use; however, these concentrations are expected to be considerably lower than after intravenous use. Consequently, it is expected that the AUC values in all subjects in the topical (skin reducing surgery) group are far lower than in all subjects in the intravenous (orthopaedic surgery) group. 12 subjects is therefor considered an appropriate number.||||
1338014|NCT03101111|Randomized|Parallel Assignment||Prevention||Quadruple|"All subjects will receive two intramuscular injections on day 0 and 28 and one subcutaneous injection on day 0.~Subjects randomized to verum will receive MV-CHIK intramuscularely on days 0 and 28 and placebo subcutaneously in the contralateral arm on day 0.~Subjects randomized to the comparator will receive MMR-vaccine subcutaneously on day 0 and placebo (dummy injection) intramuscularely on days 0 and 28 in the contralateral arm."|Prospective, comparator controled, randomized, double-blinded, interventional, safety study|t|t|t|t
1338015|NCT03101098|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1338016|NCT03101085|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1338017|NCT03101072|Randomized|Parallel Assignment||Treatment||Quadruple|Participants, their care providers, and study investigators having contact with participants & their providers will be blinded until the antibiotic therapy is discontinued. Outcomes assessors and data analysts will be fully blinded.|"With day 1 defined as the first day of appropriate (microbiologically efficacious) antibacterial therapy, patients will be randomized 1:1:1 on day 5 (±1) to one of the following three arms:~Fixed long antibiotic course of 14 days (control arm)~Fixed short antibiotic course of 7 days (first intervention arm)~Individualized antibiotic course (second intervention arm): • Starting on day 5, therapy will be discontinued after the patient has been afebrile for 48 hours and the CRP level has decreased from its peak by at least 75% In all arms, the choice and mode of administration (IV vs. PO) of antibiotic(s) will be left to the patient's attending physician and consulting infectious disease specialist and thus will follow usual standards of care."|t|t|t|t
1338018|NCT03101059||Single Group Assignment||Supportive Care||None (Open Label)||||||
1338019|NCT03101046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338020|NCT03101033|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1338021|NCT03101020|Randomized|Parallel Assignment||Treatment||Single|The evaluator will be blind as he will not be present during the intervention. As well as the care provider will not be present during the assessor activities.|Both experimental and control groups will receive standard care physiotherapy for low back pain according to the evidence presented in the study of Delitto et al. The care includes advice for correct postures to perform daily activities; abdominal, pelvic and lumbar muscles re-training and strengthening; and advice to perform exercise regularly. The therapist will treat the participants once a week for a 5-week period, each session will last 40 minutes. Besides the standard care, the therapist will perform cardia mobilization, pylori mobilization, Oddi's sphincter mobilization, dueodeno-jejunal valve mobilization, ileocecal valve mobilization, global technique for the liver, global hemodynamic technique. Each technique will last 1 minutes, with the two last ones repeated 10 times.The placebo intervention involves light touch at the same regions of the techniques as above, and no intention on the part of the therapist to impart any therapeutic technique.||||t
1338022|NCT03101007|Randomized|Parallel Assignment||Treatment||Single||Parallel Assignment|t|||
1338023|NCT03100994|Randomized|Crossover Assignment||Treatment||None (Open Label)||3 group: Group A: without intervention; Group B: Ultrasound-guided transmuscular quadratus lumborum block; Group C: Ultrasound-guided quadratus lumborum type II block||||
1338024|NCT03100981|Randomized|Parallel Assignment||Treatment||Double|Assessors performing introduction calls are masked in the sense that participants will not be randomized until after the introduction call. All questionnaires are completed as online surveys and are hence masked for group allocation.|"After baseline assessment, participants will be randomly assigned to either the intervention or the control group. Both groups will receive online questionnaires at 5 weeks (midway), 10 weeks (post treatment) and 36 weeks (6 months follow-up) after baseline assessment.~The intervention group receives a therapist phone call prior to enrollment in the internet-delivered treatment and then participates in 8 weeks of therapist-assisted internet-delivered Mindfulness-Based Cognitive Therapy. The internet-delivered treatment also comprises weekly distress measures, including suicide risk screening, and assessment of working alliance at week 2, 4, and 7 of the course."|||t|t
1338025|NCT03100968|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||Upon enrollment into the study, participants will be randomized 1:1 to either ultrasound or palpation. Randomization will be performed via random drawing: the provider will randomly select a card assigning the method of midline identification (i.e., ultrasound or palpation). Anesthesia providers will not be randomized. Any qualified provider available to place the epidural will be the person to perform the procedure.||||
1338026|NCT03100955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338027|NCT03100942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338028|NCT03100929||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338029|NCT03100916|Randomized|Crossover Assignment||Treatment||Single|||t|||
1338030|NCT03100903||Single Group Assignment||Treatment||None (Open Label)||||||
1338031|NCT03100890|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1338032|NCT03100877||Single Group Assignment||Treatment||None (Open Label)||||||
1338033|NCT03100864||Single Group Assignment||Treatment||None (Open Label)||||||
1338034|NCT03100851||Single Group Assignment||Treatment||None (Open Label)||||||
1338035|NCT03100838|Randomized|Crossover Assignment||Other||None (Open Label)||A single-dose, randomized, open-label, drug-drug interaction (DDI), 4-way crossover, four-treatment, four-sequence, bioequivalence study||||
1338036|NCT03100825|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1338037|NCT03100812|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338038|NCT03100799||Single Group Assignment||Basic Science||None (Open Label)||Single arm, exploratory non-drug, interventional biomarker study in patients with active osteoarthritis to investigate the degree of senescence-associated disease||||
1338040|NCT03100773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338041|NCT03100760||||||||||||
1338042|NCT03100747|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1338043|NCT03100734|||Cohort||Prospective|||||||
1338044|NCT03100721|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1338045|NCT03100708|||Case-Only||Prospective|||||||
1338046|NCT03100695|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338047|NCT03100682|||Cohort||Prospective|||||||
1338048|NCT03100669|||Cohort||Prospective|||||||
1338049|NCT03100656||Single Group Assignment||Basic Science||None (Open Label)||||||
1338050|NCT03100643|||Cohort||Cross-Sectional|||||||
1338051|NCT03100630|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338052|NCT03100617||Single Group Assignment||Treatment||None (Open Label)||||||
1338053|NCT03100604|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1338054|NCT03100591||Single Group Assignment||Other||None (Open Label)||||||
1338055|NCT03100578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338056|NCT03100565|Randomized|Parallel Assignment||Prevention||Single|The participants will be blinded to the methods used for pain relief.||t|||
1338057|NCT03100552|||Case-Only||Prospective|||||||
1338058|NCT03100539|Randomized|Factorial Assignment||Treatment||Single||||||t
1338059|NCT03100526|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1338060|NCT03100513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338061|NCT03100500|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1338062|NCT03100487|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1338063|NCT03100474|||Other||Prospective|||||||
1338064|NCT03100461|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1338065|NCT03100448||Single Group Assignment||Treatment||None (Open Label)||||||
1338066|NCT03100435|Randomized|Parallel Assignment||Prevention||None (Open Label)||All participants will wear a mouth guard holding 8 titanium discs for 3 days, during which time a natural bacterial biofilm will form on the disc surfaces. After 3 days, the discs will be removed from the mouthguard, and treated ex vivo with different decontamination methods.||||
1338067|NCT03100422|Randomized|Parallel Assignment||Treatment||Double|Lots will be drawn that assign to either robotic therapy or occupational therapy|randomized|||t|t
1338068|NCT03100409|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1338069|NCT03100396|||Cohort||Prospective|||||||
1338070|NCT03100383|||Case-Only||Cross-Sectional|||||||
1338071|NCT03100370|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1338072|NCT03100357|||Cohort||Prospective|||||||
1338073|NCT03100344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338074|NCT03100331||Single Group Assignment||Treatment||None (Open Label)||||||
1338075|NCT03100318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338076|NCT03100305|||Cohort||Prospective|||||||
1338077|NCT03100292||Single Group Assignment||Treatment||None (Open Label)||||||
1338078|NCT03100279||Single Group Assignment||Treatment||None (Open Label)||This study will employ a quasi-experimental open-trial design that includes a comprehensive diagnostic assessments at pre- and post-treatment (diagnostic interview, symptom and functioning measures, and prospective mediators) and continuous assessment throughout an active treatment phase. Anxiety/depression symptoms will be assessed each session and prospective mediators (cognitive, behavioral, and affective variables) will be assessed every four sessions. A two-week baseline period will separate the initial intake from the first treatment session. The traditional ABAB experimental single-case design will not be used because it is not appropriate in clinical situations where the removal of treatment intervention could be harmful to clinical patients (Kazdin, 1992). Each youth who meets inclusion criteria will complete a two-week baseline phase that includes three assessments (intake, phone follow-up, and first session).||||
1338079|NCT03100266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338080|NCT03100253|Randomized|Parallel Assignment||Treatment||Single||||||t
1338081|NCT03100240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338082|NCT03100227|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1338083|NCT03100214|Randomized|Parallel Assignment||Treatment||Single||||||t
1338084|NCT03100201|Randomized|Parallel Assignment||Prevention||Single||Patients will be recruited in three different clinics in Germany and randomised into an intervention and a control group. All patients will receive conventional occupational- and physiotherapy. The intervention group will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks.||||t
1338085|NCT03100188||Single Group Assignment||Treatment||None (Open Label)||one cohort of patients who meet inclusion criteria had intervention and followed for 12 months||||
1338086|NCT03100175|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338087|NCT03100162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338088|NCT03100149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338089|NCT03100136||Single Group Assignment||Other||None (Open Label)||||||
1338090|NCT03100123|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible and consenting subjects will be assigned to one of two study arms. Randomization is stratified by 'high-risk' or 'non-high risk' laboratory criteria and the timing of pregnancy loss (late loss or no late loss).||||
1338091|NCT03100110||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1338092|NCT03100097|Randomized|Parallel Assignment||Treatment||Single||||||t
1338093|NCT03100084|||Cohort||Prospective|||||||
1338094|NCT03100071|||Cohort||Prospective|||||||
1338095|NCT03100058|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1338096|NCT03100045|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Subjects will be enrolled sequentially in each treatment cohort.||||
1338097|NCT03100032|Randomized|Parallel Assignment||Treatment||Single||||||t
1338098|NCT03100019|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1338099|NCT03100006||Single Group Assignment||Treatment||None (Open Label)||||||
1338100|NCT03099993|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338101|NCT03099980||Single Group Assignment||Treatment||None (Open Label)||secukinumab 300 mg (2 x 150 mg pre-filled syringe) administered at Baseline, Weeks 1, 2, 3, 4, and then Q4W for 24 weeks via subcutaneous injections||||
1338102|NCT03099967|||Cohort||Prospective|||||||
1338103|NCT03099954|||Cohort||Cross-Sectional|||||||
1338104|NCT03099941|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338105|NCT03099928|||Other||Other|||||||
1338106|NCT03099915|||Cohort||Prospective|||||||
1338107|NCT03099902|||Case-Control||Retrospective|||||||
1338108|NCT03099889|Randomized|Parallel Assignment||Prevention||Triple|Participant in intervention arm signed an informed consent umasking the exercise intervention, participants in the control arm have already consented to ongoing outcomes assessment and yearly surveys regarding physical activity and other lifestyle activities|randomized consent design||t|t|t
1338109|NCT03099876|||Case-Control||Prospective|||||||
1338110|NCT03099863|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1338111|NCT03099850|||Cohort||Prospective|||||||
1338112|NCT03099837|||Cohort||Prospective|||||||
1338113|NCT03099824||Single Group Assignment||Treatment||None (Open Label)||||||
1338114|NCT03099811|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1338115|NCT03099798|||Cohort||Prospective|||||||
1338116|NCT03099785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338117|NCT03099772||Single Group Assignment||Treatment||None (Open Label)||Open trial||||
1338118|NCT03099759|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338119|NCT03099746|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1338120|NCT03099733||Single Group Assignment||Other||None (Open Label)||||||
1338121|NCT03099720|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338122|NCT03099707|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1338123|NCT03099694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338124|NCT03099681|||Cohort||Prospective|||||||
1338125|NCT03099668|Randomized|Parallel Assignment||Health Services Research||Single|Joint counts at 3 and 6 months will be done by a blinded investigator|1:1 parallel gruop allocation to multidisciplinary vs routine care||||t
1338126|NCT03099655||Single Group Assignment||Treatment||None (Open Label)||The Medtronic Attain Stability Quad MRI SureScan (Model 4798) is a steroid-eluting, quadripolar electrode, transvenous, over-the-wire (OTW), IS4-LLLL compatible, active fixation, cardiac vein pacing LV lead. This lead is similar to the Attain Performa family of quadripolar leads (Models 4298, 4398, and 4598) but also has a side helix for active fixation which is similar to the Attain Stability bipolar lead (Model 20066/4796) (available outside of the United States).||||
1338127|NCT03099642|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1338128|NCT03099629||Single Group Assignment||Prevention||None (Open Label)||||||
1338129|NCT03099616|Randomized|Parallel Assignment||Basic Science||Double|The patient will be blinded to the type of anaesthesia intervention.The attending anaesthesiologist will however not be blinded to the technique utilized to administer GA and recovery immediately after extubation inside the OR. The postoperative patient recovery profile will be evaluated by an independent assessor blinded to the technique of GA.|"40 patients belonging to ASA physical patients status II and III of either sex, scheduled to undergo laparoscopic/robotic bariatric surgery (sleeve gastrectomy, Rouxen- Y gastric bypass) under general anaesthesia. The patients will be randomly allocated by computer generated numbers to one of the following two groups of 20 patients each.~Group-1 [CLADS Group, n=20]: Anaesthesia will be induced and maintained with Propofol administered using the automated CLADS.~Group-2 [Desflurane Group, n=20]: Anaesthesia will be induced with Propofol administered using the automated CLADS and will be maintained with Desflurane."|t|||t
1338130|NCT03099603|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1338131|NCT03099590|Randomized|Parallel Assignment||Treatment||Double|Neither the participants nor the study personnel providing the care/assessments will know whether the treatment received is active or placebo|Half of the enrolled subjects will receive treatment with Alkontrol-herbal, kudzu extract, and half will receive a placebo control.|t|t||
1338132|NCT03099577|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1338133|NCT03099564||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1338134|NCT03099551|Randomized|Parallel Assignment||Other||Single|||||t|
1338135|NCT03099538||Single Group Assignment||Treatment||None (Open Label)||This is a single center, exploratory, open-label, single-arm design study of 12 patients with BP. Treatment naïve and treatment refractory patients with BP will be treated with Ixekizumab. Patients who are non-responders, to physician choice standard of care, will undergo a washout period and will be enrolled in the study.||||
1338136|NCT03099525|||Cohort||Prospective|||||||
1338137|NCT03099512|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338138|NCT03099499||Single Group Assignment||Treatment||None (Open Label)||||||
1338139|NCT03099486||Single Group Assignment||Treatment||None (Open Label)||||||
1338140|NCT03099473|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1338141|NCT03099460|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1338142|NCT03099447|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1338143|NCT03099434|Randomized|Factorial Assignment||Other||Double||Patients will be randomly assigned to one of the 3 arms, where arm 1 is two interventions combined (LDC program + Facebook app), arm 2 is one intervention (Facebook app), and arm 3 is the control group (standard-of-care).||t|t|
1338144|NCT03099421||Single Group Assignment||Treatment||None (Open Label)||||||
1338145|NCT03099408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338146|NCT03099395|||Cohort||Other|||||||
1338147|NCT03099382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338148|NCT03099369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338149|NCT03099356||Single Group Assignment||Treatment||None (Open Label)||||||
1338150|NCT03099343|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338151|NCT03099330||Single Group Assignment||Treatment||None (Open Label)||||||
1338152|NCT03099317|Randomized|Parallel Assignment||Treatment||Double|"Participants will be randomized into sinew acupuncture group and sham acupuncture group in a 1:1 ratio.~Assessors will perform the assessment but not be involved in acupuncture treatment."|A randomized sham controlled, single blinded trial|t|||t
1338153|NCT03099304|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t||t|
1338154|NCT03099291|Randomized|Parallel Assignment||Prevention||Quadruple|Double Blind||t|t|t|t
1338155|NCT03099278||Single Group Assignment||Treatment||None (Open Label)||||||
1338156|NCT03099265||Single Group Assignment||Treatment||None (Open Label)||||||
1338157|NCT03099252|Randomized|Parallel Assignment||Other||None (Open Label)||Two-armed cluster RCT. Hospitals in Ontario providing maternal/newborn care are the units of randomization. The intervention is targeted at the 'cluster' (hospital providing maternal/newborn care) and the maternal and newborn care units within the randomized hospitals. The cluster RCT design is appropriate for this project as it minimizes the risk of contamination, which could occur if individual mothers/parent dyads were randomized to different study arms within one organization. Although the video is publicly available for viewing on YouTube, this alone is a passive means of disseminating knowledge and the effect on clinically important outcomes has not been systematically evaluated.||||
1338158|NCT03099239|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1338159|NCT03099226|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1338160|NCT03099213||Single Group Assignment||Treatment||None (Open Label)||||||
1338161|NCT03099200|||Cohort||Cross-Sectional|||||||
1338162|NCT03099187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338163|NCT03099174|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338164|NCT03099161|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338165|NCT03099148|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1338166|NCT03099135||Single Group Assignment||Other||None (Open Label)||||||
1338167|NCT03099122||Single Group Assignment||Prevention||None (Open Label)||||||
1338168|NCT03099109|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1338169|NCT03099096||Single Group Assignment||Treatment||None (Open Label)||||||
1338170|NCT03099083|||Cohort||Prospective|||||||
1338171|NCT03099070|Randomized|Crossover Assignment||Basic Science||None (Open Label)||2 x 2 randomized crossover design||||
1338172|NCT03099057|||Cohort||Prospective|||||||
1338173|NCT03099044|Randomized|Parallel Assignment||Basic Science||Single|Single blind (subjects unaware of treatment identity)|Healthy adults; three groups: Placebo, vs Single-Dose and Double Dose of Fermented Dairy Beverage consumed for 10 days. Subjected to stressful exercise at beginning and end of study. Primary outcomes: immune/inflammatory markers. Assess changes in treatment vs placebo.|||t|
1338174|NCT03099031|||Cohort||Prospective|||||||
1338175|NCT03099018|||Case-Only||Prospective|||||||
1338176|NCT03099005|Randomized|Crossover Assignment||Treatment||Quadruple|"Participants will receive vaporized cannabis using Volcano vaporizers (Storz and Bickel) with either 3.74% THC + 0.49% CBD, 3.49% THC + 4.17% CBD, or 3.11% THC + 15.76% CBD at each of three visits. Allocation assignment of visits will be assigned using a Web-based random number- generating program, Research Randomizer (http:// www.randomizer.org/). The allocation schedule will be kept in the pharmacy and concealed from other study personnel."|Acutely administered CBD/THC will reduce HIV-neuropathic pain in a stair-step manner; the highest CBD dose will provide the greatest pain reduction (high CBD > medium CBD > low CBD).|t|t|t|t
1338177|NCT03098992|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338178|NCT03098979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338179|NCT03098966|||Other||Retrospective|||||||
1338180|NCT03098953||Single Group Assignment||Treatment||None (Open Label)||||||
1338181|NCT03098940|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338182|NCT03098927|Randomized|Crossover Assignment||Treatment||None (Open Label)||Eight subjects with spinal cord injury (SCI) will be recruited during the sub-acute phase (3-6 months following injury). Four participants will immediately undergo motor imagery training in an immersive virtual reality environment at NASA. EEG assessments and motor function testing will be performed at intervals during the 3-4 week motor imagery training period to assess improvement in cortical signature generation and motor recovery. The other four participants will undergo the same protocol after a 6 week delay, in order to assess the effect of training timing after injury in both cortical signature generation and motor function recovery.||||
1338183|NCT03098914|||Cohort||Prospective|||||||
1338184|NCT03098901||Single Group Assignment||Diagnostic||None (Open Label)||"Patients that suffer of one of the following conditions will be included in the study~Patients suffering of HFpEF not explained by either hypertension or any other clinical condition.~Patients with systolic dysfunction and non-significant coronary artery disease.~Patients with diabetic cardiomyopathy~Patients with otherwise unexplained left ventricular hypertrophy (LVH).~Patients under age of 65 with idiopathic ventricular fibrillation (VF) or multiple ventricular premature beats (VPB) or ventricular tachycardia (VT) with a structurally normal heart.~Patients under age of 65, with unexplained sinus node disease, sinoatrial block, complete or high-degree atrio-ventricular block or significant intraventricular conduction defect, with structurally normal heart whether having or not having received permanent implanted pacemaker."||||
1338185|NCT03098888|||Cohort||Prospective|||||||
1338186|NCT03098875|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1338187|NCT03098862|||Case-Control||Other|||||||
1338188|NCT03098849|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338189|NCT03098836|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338190|NCT03098823|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1338191|NCT03098810|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338192|NCT03098797|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1338193|NCT03098784|||Case-Control||Cross-Sectional|||||||
1338467|NCT03095222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338194|NCT03098771|Randomized|Parallel Assignment||Treatment||None (Open Label)||Inpatients of the Qingdao No. 9 People's Hospital will be recruited. Potential participants can contact the project manager via telephone. After providing informed consent, these potential participants will be screened using the inclusion and exclusion criteria.||||
1338195|NCT03098758|||Cohort||Prospective|||||||
1338196|NCT03098745|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338197|NCT03098732|Randomized|Parallel Assignment||Treatment||Double|"Subjects will be masked with regard to treatment group. Imaging data will be evaluated by independent readers (2) blinded to treatment allocation.~Neurological outcomes will be measured at the 90 Day visit by evaluators blinded to treatment allocation."|Subjects will be randomized 1:1 to receive active treatment or sham. Enrollment will be stratified based upon age (<75 or >/=75) and location of the occlusion (M1, M2 or carotid terminus.)|t|||t
1338198|NCT03098719|Randomized|Parallel Assignment||Prevention||Single||||||t
1338199|NCT03098706|Randomized|Parallel Assignment||Other||Double|||t|||t
1338200|NCT03098693|||Cohort||Prospective|||||||
1338201|NCT03098680|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1338202|NCT03098667|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1338203|NCT03098654|Randomized|Parallel Assignment||Treatment||None (Open Label)||Once two similar HIV Care and Treatment Centers (CTCs) are matched, they will be randomized to receive either the intervention or control condition.||||
1338204|NCT03098641|||Cohort||Retrospective|||||||
1338205|NCT03098628|Randomized|Parallel Assignment||Prevention||Single|This is a single-blind, open-label, randomised trial, with laboratory staff blinded to study group allocation as all the outcome measures that address the study objectives are laboratory based. Laboratory samples will be labelled with a unique trial identification number that does not identify the study group. Given the different timing of the vaccine schedules in the different study arms, the study nurses, vaccine administrators and participants will not be blinded to the study group allocation of each infant.|single-blind, open-label, randomised controlled trial||||t
1338206|NCT03098615||Single Group Assignment||Treatment||None (Open Label)||Topical application of Jublia (Efinaconazole 10% Topical Solution) to patients with distal lateral subungual onychomycosis with dermatophytoma.||||
1338207|NCT03098602||||||||||||
1338208|NCT03098589|||Case-Only||Prospective|||||||
1338209|NCT03098576|||Cohort||Prospective|||||||
1338210|NCT03098563|Randomized|Crossover Assignment||Basic Science||Triple|Within-subjects design. Two pills will be administered at each study visit. Participants and study staff will be blind to the drug(s) administered.|This study will include 4 sessions. Participants will be randomly assigned to the order in which they receive one drug (or combination of drugs) per session at each study visit.|t||t|t
1338211|NCT03098550||Single Group Assignment||Treatment||None (Open Label)||||||
1338212|NCT03098537|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338213|NCT03098524|Randomized|Parallel Assignment||Prevention||Triple|"Patients are ventilated or not during the time they are sedated, so they are blind to their study arm.~Anesthesiologists perform mechanical ventilation or not during cardiopulmonary bypass and log per-operative data (such as number of insufflations) on a separate leaflet of the eCRF. Investigators (cardiologists and critical care specialists) are not aware of the treatment arm as it is performed during surgery."||t||t|t
1338214|NCT03098511||Single Group Assignment||Diagnostic||None (Open Label)|"Participant will be comatose~Care providers, investigators and outcome assessors will be blinded from the results of the CT-Perfusion scan result (for the clinical assessment) and from the clinical assessment results (for the CT-Perfusion scan interpretation)"|||||
1338215|NCT03098498|Randomized|Parallel Assignment||Treatment||Single|The examiner performing the assessment of periodontal attachment gain is not aware of the type of the preceding intervention therapy (one-stage vs. two-stage) provided to the patient.|controlled prospective parallel group intervention trial||||t
1338216|NCT03098485|Randomized|Factorial Assignment||Other||Double|||t||t|
1338217|NCT03098472|||Cohort||Prospective|||||||
1338218|NCT03098459|||Cohort||Prospective|||||||
1338219|NCT03098446|Randomized|Crossover Assignment||Prevention||None (Open Label)||Subjects will be randomly assigned to either the sitting plus exercise or the sitting without exercise group and then, after a one week washout period, complete the other task.||||
1338220|NCT03098433|Randomized|Crossover Assignment||Other||Triple||double blind, crossover|t|t|t|
1338221|NCT03098420|Randomized|Parallel Assignment||Treatment||Double|The anesthesia team that performs the block, along with the supervising PI or sub-investigator, will be blinded to the medication in the injectate.|Patients will be randomly assigned to 1 of 3 groups. They will be assigned to a group prior to being brought back to the operating room. The anesthesia team in the OR will take an envelope that has which group the patient will be randomly assigned to and they will perform the TAP block with the respective dose of dexamethasone. The anesthesia team that performs the block, along with the supervising PI or sub-investigator, will be blinded to the medication in the injectate|t||t|
1338222|NCT03098407|Randomized|Parallel Assignment||Other||None (Open Label)|Open Label|||||
1338223|NCT03098394|Randomized|Parallel Assignment||Diagnostic||Triple|Participants, investigators, and care providers will be masked to the experimental or control arm prior to enrollment in the study. Once the participant has been enrolled in the study, they will be randomized to either the control arm or the experimental arm. Once randomization has occurred, participants, care providers, and the investigators will know which group the participants are in.|This is a prospective, non-blinded, randomized clinical control trial|t|t|t|
1338224|NCT03098381|||Cohort||Prospective|||||||
1338225|NCT03098368|Randomized|Parallel Assignment||Treatment||Quadruple|The active drugs and placebo were labeled from the company and the study nurse would give the drug to participants who were randomized.|"Active group is the group of PD patients who received rotigotine transdermal patch titration from 2 mg/day to maximum effect dose which participants had no side effect or reach 16 mg/day every week.~Placebo group is the group of PD patients who received the placebo patch titration every week the same protocol as the active group."|t|t|t|t
1338226|NCT03098355||Single Group Assignment||Treatment||None (Open Label)||||||
1338227|NCT03098342|Randomized|Parallel Assignment||Treatment||Single||||||t
1338468|NCT03095209|||Case-Control||Prospective|||||||
1338228|NCT03098329||Single Group Assignment||Screening||None (Open Label)||Community based screening of young men for chlamydia and gonorrhea, expedited treatment for positive subjects and their sexual partners||||
1338229|NCT03098316|||Case-Control||Cross-Sectional|||||||
1338230|NCT03098303|||Case-Only||Cross-Sectional|||||||
1338231|NCT03098290|||Cohort||Prospective|||||||
1338232|NCT03098277||Single Group Assignment||Other||None (Open Label)||||||
1338233|NCT03098264|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338234|NCT03098251|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338235|NCT03098238|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1338236|NCT03098225|Randomized|Parallel Assignment||Treatment||Single|Ophthalmology blinded to treatment||||t|
1338237|NCT03098212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338238|NCT03098199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1338239|NCT03098186|Randomized|Parallel Assignment||Supportive Care||Triple|TX2THeart-Colombia is a single-blind trial. The laboratory personnel in charge of measurement LDL-C and 11 dhTxB2 levels will not have access to treatment allocation and they will only have access to internal numerical ID variable. The laboratory results will be conducted once trial follow-up is completed, and results will be sent directly to the database manager, who will link the results to the existing database. The staff in charge of measurement blood-pressure and heart rate will not have access to information on treatment allocation. Measurement of blood pressure and heart rate will be the first activity to be conducted with participants in visits 1 and 3 to minimize any potential subconscious bias introduced as a consequence of patients inadvertently revealing to trial staff the treatment allocation. The only person who will have access to the information of the participants is the engineer in charge of the management of Dimagi-Commcare Plataform.|||t|t|t
1338240|NCT03098173|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel, randomized, superiority trial||||
1338241|NCT03098160||Sequential Assignment||Treatment||None (Open Label)||During the initial phase of the study a maximum tolerated dose will be determined based on the dose escalation scheme in the protocol. Once this dose is established, enrollment will be expanded for each of the 4 disease cohorts at that dose level.||||
1338242|NCT03098147|||Case-Control||Prospective|||||||
1338243|NCT03098134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338244|NCT03098121||Single Group Assignment||Treatment||None (Open Label)||||||
1338245|NCT03098108||Single Group Assignment||Treatment||None (Open Label)||CCPT arm||||
1338246|NCT03098095|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-Label, Randomized, Multicenter, Pilot Study||||
1338247|NCT03098082||Single Group Assignment||Diagnostic||None (Open Label)|Cares providers, patients and study primary investigators will be blinded to 2 hour Urine Trypsinogen dip stick test results. Results will not be released or posted on subject chart.|All enrolled subjects who meet study inclusion /exclusion will have the Urine Trypsinogen dip stick test||||
1338248|NCT03098069|||Other||Prospective|||||||
1338249|NCT03098056||Single Group Assignment||Treatment||None (Open Label)||||||
1338250|NCT03098043|||Cohort||Prospective|||||||
1338251|NCT03098030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338252|NCT03098017|Randomized|Crossover Assignment||Basic Science||Single|Personnel involved in randomization, in the analyses of the samples collected, and who were involved in the data processing were blinded.|||||t
1338253|NCT03098004|Randomized|Crossover Assignment||Other||Single|||t|||
1338254|NCT03097991|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338255|NCT03097978|Randomized|Single Group Assignment||Basic Science||||||||
1338256|NCT03097965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338257|NCT03097952|||Cohort||Prospective|||||||
1338258|NCT03097939||Single Group Assignment||Treatment||None (Open Label)||||||
1338259|NCT03097926|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1338260|NCT03097913|||Case-Only||Prospective|||||||
1338261|NCT03097900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338262|NCT03097887|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1338263|NCT03097874|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1338264|NCT03097861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338265|NCT03097848|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338266|NCT03097835|Randomized|Crossover Assignment||Treatment||Quadruple||This will be a longitudinal study in which patients will be initially treated with hyper-diluted Botox Cosmetic in the superficial dermis or they will be treated 0.9% saline. Then, on day 30 of the study patients initially treated with hyper diluted Botox Cosmetic will be treated with saline and patients initially treated with saline will be treated with hyper-diluted botox.|t|t|t|t
1338267|NCT03097822|||Cohort||Prospective|||||||
1338268|NCT03097809|||Other||Prospective|||||||
1338269|NCT03097796||Single Group Assignment||Prevention||None (Open Label)||||||
1338270|NCT03097783|Randomized|Parallel Assignment||Treatment||Single||||||t
1338271|NCT03097770||Single Group Assignment||Treatment||None (Open Label)||||||
1338272|NCT03097757|Randomized|Parallel Assignment||Diagnostic||Single|The orthopedic surgeon reading the x-rays and determining the degree of angulation and displacement will be blinded to all patient characteristics and to the patient's group assignment.|Prospective randomized, controlled, single blinded study||||t
1338273|NCT03097744|||Case-Only||Retrospective|||||||
1338274|NCT03097731|||Case-Crossover||Prospective|||||||
1338275|NCT03097718|||Case-Control||Cross-Sectional|||||||
1338276|NCT03097705||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338277|NCT03097692|Randomized|Parallel Assignment||Other||Double||intervention group well be pretreated with cardiac preconditioning|t|||t
1338278|NCT03097679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338469|NCT03095196|||Cohort||Retrospective|||||||
1338534|NCT03094351|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|Parallel Assignment||||
1338535|NCT03094338|||Cohort||Prospective|||||||
1338279|NCT03097666||Single Group Assignment||Treatment||None (Open Label)||Patients with previously untreated (by means of ablation therapy) flat type Barrett's Esophagus (BE) (extent BE ≤C3) with Low-Grade Dysplasia (LGD) or High-Grade Dysplasia (HGD), or residual BE after removal of early adenocarcinoma||||
1338280|NCT03097653|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338281|NCT03097640|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1338282|NCT03097627||Single Group Assignment||Device Feasibility||None (Open Label)|There is no masking in this study.|||||
1338283|NCT03097614||Single Group Assignment||Treatment||None (Open Label)||||||
1338284|NCT03097601|||Cohort||Retrospective|||||||
1338285|NCT03097588||Single Group Assignment||Supportive Care||None (Open Label)||||||
1338286|NCT03097575||Single Group Assignment||Other||None (Open Label)||||||
1338287|NCT03097562|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)|"Consecutive patients who underwent cataract surgery using one of the following three types of surgical wound will be compared:~Catalys - Initial wound parameters~Catalys - Revised wound parameters~Standard manual technique (MT control group)"|Post market study (Phase IV)||||
1338288|NCT03097549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338289|NCT03097536|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1338290|NCT03097523||Single Group Assignment||Prevention||None (Open Label)||||||
1338291|NCT03097510|Randomized|Parallel Assignment||Treatment||Double|data collectors and investigators were blind to treatment status of the subject|randomized controlled trial|||t|t
1338292|NCT03097497|Randomized|Parallel Assignment||Treatment||Single||||||t
1338293|NCT03097484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338294|NCT03097471|||Case-Only||Prospective|||||||
1338295|NCT03097458|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized wait-list control design (cross-over).||||
1338296|NCT03097445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338297|NCT03097432|||Cohort||Prospective|||||||
1338298|NCT03097419|Randomized|Parallel Assignment||Treatment||None (Open Label)||We will perform a prospective, randomized-controlled study of 300 patients presenting to the BIDMC ED with a suspected non-ST segment elevation myocardial infarction. After obtaining consent, the patients will be assigned to either the intervention or standard of care group via a computerized block 1:1 randomization process.||||
1338299|NCT03097406|||Cohort||Prospective|||||||
1338300|NCT03097393|||Case-Only||Retrospective|||||||
1338301|NCT03097380|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338302|NCT03097367|||Case-Only||Retrospective|||||||
1338303|NCT03097354|||Cohort||Cross-Sectional|||||||
1338304|NCT03097341|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338305|NCT03097328||Single Group Assignment||Treatment||None (Open Label)||||||
1338306|NCT03097315||Single Group Assignment||Treatment||None (Open Label)||||||
1338307|NCT03097302|||Cohort||Prospective|||||||
1338308|NCT03097289||Single Group Assignment||Other||None (Open Label)||Apheresis platelets will be collected on the Trima Accel system and stored in 65% InterSol/35% plasma for all subjects||||
1338309|NCT03097276||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338310|NCT03097263|||Cohort||Retrospective|||||||
1338311|NCT03097250|||Case-Control||Prospective|||||||
1338312|NCT03097237|Randomized|Parallel Assignment||Treatment||Single||||||t
1338313|NCT03097224|Randomized|Parallel Assignment||Treatment||Single||||||t
1338314|NCT03097211|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1338315|NCT03097198|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1338316|NCT03097185|||Case-Only||Prospective|||||||
1338317|NCT03097172|||Cohort||Prospective|||||||
1338318|NCT03097159|||Case-Control||Prospective|||||||
1338319|NCT03097146||Single Group Assignment||Health Services Research||None (Open Label)||||||
1338320|NCT03097133|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338321|NCT03097120|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338322|NCT03097107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338323|NCT03097094|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1338324|NCT03097081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338325|NCT03097068||Single Group Assignment||Basic Science||None (Open Label)||||||
1338326|NCT03097055|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1338327|NCT03097042|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized Controlled Trial|t|t|t|t
1338328|NCT03097029||Single Group Assignment||Treatment||None (Open Label)||||||
1338329|NCT03097016||Single Group Assignment||Treatment||None (Open Label)||||||
1338330|NCT03097003|||Cohort||Prospective|||||||
1338331|NCT03096990|||Cohort||Prospective|||||||
1338332|NCT03096977||Single Group Assignment||Supportive Care||None (Open Label)||||||
1338333|NCT03096964|Randomized|Parallel Assignment||Treatment||Single||||||t
1338334|NCT03096951|Randomized|Parallel Assignment||Treatment||Single||||||t
1338335|NCT03096938|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1338336|NCT03096925|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients will be consecutively included and randomized to two groups, intervention group or control group. We will use a web-based randomisation procedure, conducted at a place remote from where the study takes place.||||
1338337|NCT03096912||Single Group Assignment||Treatment||None (Open Label)||||||
1338338|NCT03096899|||Case-Only||Prospective|||||||
1338527|NCT03094442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338528|NCT03094429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338529|NCT03094416||Single Group Assignment||Treatment||None (Open Label)||||||
1338532|NCT03094377|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This was a quasi-randomized-controlled pilot. Participants were randomly allocated by admission sequence to a multisensory therapy group or a conventional training group||||
1338339|NCT03096886|Randomized|Parallel Assignment||Treatment||Single|An experienced clinical evaluator with established reliability will assess patients pre-treatment and biweekly (weeks 2-20). All evaluations will be conducted without knowledge of treatment assignment. The evaluator will assess symptom severity according to the MADRS and Hamilton Rating Scale for Depression (HAM-D). Evaluators will have offices remote to the day-to-day operations of the treatment study and will not participate in weekly study management meetings in order to help preserve the blind.|This is a 3-arm, parallel study design. Individuals presenting with MDD will be randomized into either Arm 1: 8-week, Computer-Augmented Cognitive Behavioral Therapy (CCBT) Immediately or Arm 2: 8-week, Waitlist followed by 8-week, CCBT. Arm 3 is a no treatment arm for matched comparison participants (i.e., healthy controls).||||t
1338340|NCT03096873|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1338341|NCT03096860|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1338342|NCT03096847||Single Group Assignment||Treatment||None (Open Label)||||||
1338343|NCT03096834|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1338344|NCT03096821||Single Group Assignment||Treatment||None (Open Label)||||||
1338345|NCT03096808||Single Group Assignment||Treatment||None (Open Label)||||||
1338346|NCT03096795|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1338347|NCT03096782|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338348|NCT03096769||Single Group Assignment||Prevention||None (Open Label)||||||
1338349|NCT03096756|Randomized|Sequential Assignment||Supportive Care||Triple|||t|t|t|
1338350|NCT03096743|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1338351|NCT03096730|Randomized|Parallel Assignment||Prevention||Double|Double Blind||||t|t
1338352|NCT03096717|||Cohort||Prospective|||||||
1338353|NCT03096704|||Case-Control||Prospective|||||||
1338354|NCT03096691|Randomized|Parallel Assignment||Prevention||None (Open Label)||100 pregnant women with a preterm delivery history and / or a cervical length of less than 25 mm will be included among the pregnancies between 16 and 24 weeks of gestation referred to obstetric and perinatology clinics. Information about the use of disease pessaries and treatment success in preventing premature birth of the pessary will be provided. Urine culture and cervical culture samples will be taken from both groups of patients. In the presence of infection, the patient's treatment will be planned and out of work. If no infection is detected and the patient agrees to use the pessary, the pessary will be used to prevent premature birth.||||
1338355|NCT03096678|||Case-Control||Prospective|||||||
1338356|NCT03096665|||Case-Only||Prospective|||||||
1338357|NCT03096652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338358|NCT03096639|Randomized|Parallel Assignment||Treatment||Single|The ultrasound core lab reviewers will be blinded to study allocation groups|1:1 randomization of treatment and control group||||t
1338359|NCT03096626|||Case-Only||Retrospective|||||||
1338360|NCT03096613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338361|NCT03096600|||Case-Only||Prospective|||||||
1338362|NCT03096587|Randomized|Parallel Assignment||Treatment||Single|The patient will be blinded and will not know the group he is in.||t|||
1338363|NCT03096574|||Other||Prospective|||||||
1338364|NCT03096561||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338365|NCT03096548|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338366|NCT03096535|Randomized|Crossover Assignment||Basic Science||Single||||||t
1338367|NCT03096522|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1338368|NCT03096509|||Cohort||Prospective|||||||
1338369|NCT03096496|||Case-Only||Prospective|||||||
1338370|NCT03096483||Single Group Assignment||Other||None (Open Label)||||||
1338371|NCT03096470|||Case-Control||Prospective|||||||
1338372|NCT03096457|Randomized|Parallel Assignment||Treatment||Double|Group 1 (Paromomycin cream) will be compared to Group 3 (Vehicle cream). Both creams will have very similar physical characteristics and package. Group 2 (intralesional injection of pentamidine) will not be masked.|Patients will be randomized between Paromomycin cream applied topically once daily for 20 days (group 1--40 patients), pentamidine administered intralesionally at 120 ug/mm2 on days 1, 3, 5 (group 2—20 patients), and cream vehicle applied topically once daily for 20 days (group 3—20 patients).|t||t|
1338373|NCT03096444|Randomized|Crossover Assignment||Treatment||Double||The antipruritic effect of 4 topical treatments and 1 vehicle treatment will be explored in each subject. Study visit 1 will consist of testing 3 topical formulations, and study visit 2 will test the remaining 2 topical formulations in each subject.|t||t|
1338374|NCT03096431|Randomized|Parallel Assignment||Supportive Care||Double|All participants will be blinded to the study design and will be randomized into one of three treatment arms. Research assistant is blinded to both the study design and to which arm the participants are randomized.||t||t|
1338375|NCT03096418||Single Group Assignment||Treatment||None (Open Label)||||||
1338376|NCT03096405|||Cohort||Retrospective|||||||
1338377|NCT03096392|Randomized|Parallel Assignment||Treatment||Quadruple|All subjects, investigators, monitors, sponsor and sponsor representatives are blinded to the treatment group and treatment to patients are randomized. The group randomizing the subjects, the pharmacist preparing the drug, the party shipping the drug are unblinded but do not have contact with the blinded parties. An unblinded monitor will monitor any activities performed by unblinded parties.|Double blind, active comparator controlled (insulin lispro) to HDV insulin lispro, multiple dose safety, tolerability and efficacy study|t|t|t|t
1338378|NCT03096379|||Cohort||Prospective|||||||
1338379|NCT03096366|Randomized|Parallel Assignment||Treatment||None (Open Label)|Blinding is not possible given the nature of the intervention.|||||
1338380|NCT03096353|||Case-Crossover||Cross-Sectional|||||||
1338381|NCT03096340||Single Group Assignment||Treatment||None (Open Label)||||||
1338530|NCT03094403|Randomized|Parallel Assignment||Treatment||Single||Subjects in this randomized, double-blind, placebo controlled, parallel-group, multiple-center study will be randomly assigned in a 2:2:1 ratio to treatment with the test product, reference product or placebo control, respectively|t|||
1338531|NCT03094390|||Cohort||Prospective|||||||
1339386|NCT03083262|||Cohort||Retrospective|||||||
1338382|NCT03096327|Randomized|Parallel Assignment||Treatment||Double|"To ensure double-blind allocation, the sponsor, who is not directly involved in clinical team will use a random number sequence generated by a computer software to allocate the participant to either the treatment or placebo group. Patients who will be randomized to the treatment group will receive 10 mg montelukast. Patients in placebo group will receive identical looking drug (placebo) produced by same manufactured.~Both products will be packaged in identical plastic bottles identifiable only by the patient allocation number. Patient will be asked to take one montelukast each day. Acceptable compliance will be defined as at least taking medication at least 21 days. The patients will be instructed to leave the remaining tablets in bottle so that they would be counted later."|Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Two arm Parallel Assignment Masking: Double Blind Primary Purpose: Prevention|t|t||
1338383|NCT03096314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338384|NCT03096301|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||It is a prospective trial of clinical and economic analysis. It will include 45 patients to evaluate the effectiveness of the treatments with low-intensity laser and occlusal plate for muscle pain in patients with TMD||||
1338385|NCT03096288|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind, placebo-controlled||t|t|t|t
1338386|NCT03096275|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients were randomly assigned to two treatment arms and were treated for 12 months.||||
1338387|NCT03096262|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338388|NCT03096249|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1338389|NCT03096236|||Cohort||Prospective|||||||
1338390|NCT03096223||Single Group Assignment||Treatment||None (Open Label)||||||
1338391|NCT03096210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338392|NCT03096197|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1338393|NCT03096184||Single Group Assignment||Treatment||None (Open Label)||||||
1338394|NCT03096171|Randomized|Crossover Assignment||Other||None (Open Label)||"Behavioral: Flourishing App Program This intervention is based on relaxation, well-being promotion, meditation practices and positive psychology principles. The program is being evaluated in a classroom format into another project and was adapted for this project in the application format for mobile devices. It will last for 16 weeks, with trainings of 20 minutes, four times a week.~No Intervention: Control App This group will observe their psychological and physical condition (levels of stress and well-being) during their daily activities and social interactions for 8 weeks. After the evaluations, this group will receive the intervention (Flourishing App Program) for more 8 weeks."||||
1338395|NCT03096158|Randomized|Parallel Assignment||Treatment||Single||||||t
1338396|NCT03096145||Single Group Assignment||Other||None (Open Label)||||||
1338397|NCT03096132|Randomized|Parallel Assignment||Treatment||Single||||||t
1338398|NCT03096119|||Cohort||Prospective|||||||
1338399|NCT03096106|||Case-Only||Prospective|||||||
1338400|NCT03096093|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338401|NCT03096080|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1338402|NCT03096067|Randomized|Parallel Assignment||Treatment||Single||||||t
1338403|NCT03096054|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1338404|NCT03096041|Randomized|Parallel Assignment||Supportive Care||Single|Single blind||t|||
1338405|NCT03096028|||Cohort||Cross-Sectional|||||||
1338406|NCT03096015||Single Group Assignment||Treatment||None (Open Label)||Within-subjects Group design||||
1338407|NCT03096002|||Cohort||Prospective|||||||
1338408|NCT03095989|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1338409|NCT03095976|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Prospective Case Series||||
1338410|NCT03095963|Randomized|Parallel Assignment||Other||Single|||||t|
1338411|NCT03095950|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis.|Two arms, parallel group, randomized controlled trial|t|||
1338412|NCT03095937|||Cohort||Prospective|||||||
1338413|NCT03095924|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis|Two arms, parallel group, randomized controlled trial|t|||
1338414|NCT03095911|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis.|Two arms, parallel group, randomized controlled trial|t|||
1338415|NCT03095898|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1338416|NCT03095885||Single Group Assignment||Basic Science||None (Open Label)||||||
1338417|NCT03095872||Single Group Assignment||Supportive Care||None (Open Label)||||||
1338418|NCT03095859|Randomized|Parallel Assignment||Treatment||Double|Single blind study. Treating medical team and therapist delivering standard care will remain blinded to participant allocation. Participants and therapist delivering intensive intervention will be unable to be blinded as they will be receiving / providing intervention. Outcome assessors will be blinded to group allocation.|"Randomized, parallel feasibility trial.~Stratification as per:~<55 years of age~≥ 55 years"||t||t
1338419|NCT03095846|Non-Randomized|Factorial Assignment||Basic Science||Single||||||t
1338420|NCT03095833|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338421|NCT03095820|Randomized|Parallel Assignment||Treatment||Single|Due to the nature of the intervention, we were unable to blind the nurses performing the intervention. However, to achieve double blinding as rigorously as possible, group allocation was not divulged to participants, and symptoms were rated by independent psychologists unaware of the randomization status.|Randomized controlled parallel-design study||||t
1338422|NCT03095807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338423|NCT03095794||Single Group Assignment||Basic Science||None (Open Label)||||||
1338424|NCT03095781||Single Group Assignment||Treatment||None (Open Label)||||||
1338425|NCT03095768||Single Group Assignment||Other||None (Open Label)||||||
1338426|NCT03095755|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338533|NCT03094364|Randomized|Parallel Assignment||Treatment||Single||||||t
1338427|NCT03095742|Randomized|Parallel Assignment||Diagnostic||Triple|Interventions are considered emergency procedures and study blood pressure measurement using the study blood pressure modules should be commenced as soon as possible after sustained ROSC, screening and randomisation. Study target blood pressure will be blinded.|Single center randomized trial with allocation of 60 comatose out-of-hospital cardiac arrest patients undergoing TTM, to normal or high blood pressure target during ICU stay. Secondary a descriptive prospective cohorte study, measuring LP ratio obtained by microdialysis (MD) of the cerebral venous outflow, during the peri-cardiac arrest period|t|t|t|
1338428|NCT03095729|||Cohort||Cross-Sectional|||||||
1338429|NCT03095716|||Other||Cross-Sectional|||||||
1338430|NCT03095703||Single Group Assignment||Treatment||None (Open Label)||A Prospective phase II pilot study with 5 patients with a follow-up of 6 months.||||
1338431|NCT03095690||Single Group Assignment||Other||None (Open Label)||||||
1338432|NCT03095677|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338433|NCT03095664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338434|NCT03095651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338435|NCT03095638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338436|NCT03095625|||Case-Control||Prospective|||||||
1338437|NCT03095612||Single Group Assignment||Treatment||None (Open Label)||This is a phase 1/2 single-arm, non-blinded, multi-institutional study. Selinexor will be administered once weekly starting one week before chemotherapy initiation (to permit pharmacodynamic assessment of selinexor alone and in combination with chemotherapy), in combination with docetaxel. Docetaxel will be given once every 3 weeks. Treatment will be administered in 21-day cycles. Dose limiting toxicities (DLTs) will be assessed based on the first cycle (7-day lead-in plus 21-day cycle = 28 days) toxicity using the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events [NCI CTCAE] version 4.03. A standard 3 + 3 dose escalation paradigm will be used.||||
1338438|NCT03095599|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1338439|NCT03095586|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis.|Two arms, parallel group, randomized controlled trial|t|||
1338440|NCT03095573|Randomized|Crossover Assignment||Diagnostic||Single|The videos will be reviewed by three experts operators blinded about the sequence of capsule examination administration|Each enrolled patients will undergo examination of the small bowel by means of both endoscopic capsule devices (the axial-view PillCam SB3 and the lateral-view CapsoCam) on the same day at approximately 3 hours interval from one another. The order of administration of the two different capsules will be determined by a specific randomization sequence.||||t
1338441|NCT03095560|Randomized|Parallel Assignment||Treatment||Single|||||t|
1338442|NCT03095547|Randomized|Parallel Assignment||Treatment||None (Open Label)||Three arm parallel group evaluation with fourth arm in series||||
1338443|NCT03095534||Single Group Assignment||Prevention||None (Open Label)||Single group with pretest and posttest||||
1338444|NCT03095521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338445|NCT03095508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338446|NCT03095495|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338447|NCT03095482|Randomized|Parallel Assignment||Treatment||Quadruple|Participants, treatment administrators, and outcome assessors will be blind to tDCS condition.|Participants will be randomly assigned to receive either (a) excitatory tDCS of the medial prefrontal cortex and inhibitory tDCS of right dorsolateral prefrontal cortex, (b) the same tDCS electrode positioning, but with reversed polarity, or (c) sham tDCS|t|t|t|t
1338448|NCT03095469|Randomized|Parallel Assignment||Prevention||Triple|all of the participants, operators, investigators and outcomes assessors don't know the grouping situation before the study finished.|coronary artery disease patients with anxiety who receive selective PCI|t|t|t|
1338449|NCT03095456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338450|NCT03095443|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1338451|NCT03095430|||Case-Control||Prospective|||||||
1338452|NCT03095417|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1338453|NCT03095404|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1338454|NCT03095391|||Cohort||Prospective|||||||
1338455|NCT03095378|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor did not have access to patient's records|Interventions in different patients||||t
1338456|NCT03095365|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338457|NCT03095352|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338458|NCT03095339|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a pre-post community-based randomized controlled trial. The unit of randomization is the village (community)||||
1338459|NCT03095326|Randomized|Parallel Assignment||Prevention||Single|The participant are divided into two different groups, which are assigned with either zinc or placebo|All splenectomized thalassemia major subjects were provided with PCV pneumococcal vaccine (Prevenar 13®) at the start of the trial. The subjects were then randomly assigned into one of 2 groups (the zinc group and the placebo group). Zinc was provided in the form of syrup at a dose of 1.5 mg/kg/day, with a maximum of 50 mg/day. The placebo was also provided in the form of syrup, with similar shape and flavor.|||t|
1338460|NCT03095313||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1338461|NCT03095300||Single Group Assignment||Treatment||None (Open Label)||Each enrolled patient will be monitored in the supine position for one hour, placed in the prone position for two hours and re-placed in the supine position for a final 1-hour step||||
1338462|NCT03095287||Single Group Assignment||Treatment||None (Open Label)||||||
1338463|NCT03095274|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||The study includes a combined treatment of Durvalumab plus Tremelimumab||||
1338464|NCT03095261|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1338465|NCT03095248|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||All participants with neurofibromatosis type 2 (NF2) will be stratified based upon tumor type. Vestibular schwannomas are assigned and analyzed as Stratum 1 and all other NF2 associated tumor types will be analyzed as Stratum 2.||||
1338466|NCT03095235||Single Group Assignment||Treatment||None (Open Label)||||||
1338470|NCT03095183|Randomized|Parallel Assignment||Device Feasibility||Triple|Using a computer-generated simple randomization sequence in permuted blocks of 10, numbered study packets that include the surveys and tongue depressor will be prepared in advance. The packets, which will be prepared by a third party not participating in this research study, will include the information sheet, surveys for the investigator, participant and parent, all labeled with the sample number, and a tongue depressor within original packaging. The randomization key will be kept by the third party until the completion of data collection, at which time it will be given to the PI.|All patients registered for evaluation in the Brooke Army Medical Center Pediatric Emergency Department will be screened by evaluation of age, mental status, physical features and history of immunocompromised by the PI or AI as part of their standard triage and care procedures for their evaluation and treatment in the Emergency Department. Potential participants will be identified by the PI and AI from patients who are registered to be seen by the PI or AI. Potential participants who meet the inclusion criteria and who have none of the exclusion criteria will be approached prior to completion of the posterior oropharynx exam for permission to enroll them in this study.|t|t|t|
1338471|NCT03095170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338472|NCT03095157|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338473|NCT03095144|||Cohort||Retrospective|||||||
1338474|NCT03095131||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1338475|NCT03095118||Single Group Assignment||Treatment||None (Open Label)||||||
1338476|NCT03095105|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338477|NCT03095092|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338478|NCT03095079||Single Group Assignment||Treatment||None (Open Label)||||||
1338479|NCT03095066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338480|NCT03095053|Randomized|Parallel Assignment||Treatment||None (Open Label)||single-centre randomized controlled trial||||
1338481|NCT03095040|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1338482|NCT03095027||||||||||||
1338483|NCT03095014|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Cesarean Myomectomy||||
1338484|NCT03095001|Randomized|Parallel Assignment||Treatment||Single|||||t|
1338485|NCT03094988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338486|NCT03094975|||Case-Only||Prospective|||||||
1338487|NCT03094962||Single Group Assignment||Basic Science||None (Open Label)||||||
1338488|NCT03094949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338489|NCT03094936|Randomized|Parallel Assignment||Treatment||Single||||||t
1338490|NCT03094923|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1338491|NCT03094910|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1338492|NCT03094897||Single Group Assignment||Diagnostic||None (Open Label)|Open Label|||||
1338493|NCT03094884||Single Group Assignment||Treatment||None (Open Label)||||||
1338494|NCT03094871|Randomized|Parallel Assignment||Treatment||Single||||||t
1338495|NCT03094858|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1338496|NCT03094845|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338497|NCT03094832||Single Group Assignment||Treatment||None (Open Label)||||||
1338498|NCT03094819|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1338499|NCT03094806|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338500|NCT03094793||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338501|NCT03094780||Single Group Assignment||Supportive Care||None (Open Label)||||||
1338502|NCT03094767|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338503|NCT03094754|||Cohort||Prospective|||||||
1338504|NCT03094741||Single Group Assignment||Health Services Research||None (Open Label)||||||
1338505|NCT03094728|||Cohort||Prospective|||||||
1338506|NCT03094715|Randomized|Parallel Assignment||Treatment||Single||prospective, open label, blinded endpoint (PROBE), European, two-arm, randomized, controlled, post-market study||||t
1338507|NCT03094702|||Cohort||Prospective|||||||
1338508|NCT03094689|Randomized|Parallel Assignment||Treatment||Single|||||t|
1338509|NCT03094676|Randomized|Crossover Assignment||Treatment||Double|The investigator and the assessor will not receive information about the participant, not knowing, from which group the participant has just arrived for intervention in the investigator's case and the assessor will not receive group information in the HRV data packet.||||t|t
1338510|NCT03094663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338511|NCT03094650||Single Group Assignment||Treatment||||||||
1338512|NCT03094637|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338513|NCT03094624|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338514|NCT03094611||Single Group Assignment||Treatment||None (Open Label)||||||
1338515|NCT03094598|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338516|NCT03094585|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338517|NCT03094572|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338518|NCT03094559||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338519|NCT03094546|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1338520|NCT03094533|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1338521|NCT03094520|Randomized|Crossover Assignment||Treatment||Single|||t|||
1338522|NCT03094507|Randomized|Crossover Assignment||Treatment||Single|||t|||
1338523|NCT03094494|||Case-Control||Retrospective|||||||
1338524|NCT03094481|Randomized|Parallel Assignment||Treatment||Quadruple|All parties will be blinded except for the specific anesthesiologist performing the nerve blocks. This person will not be involved in providing further care (administering anesthesia) nor data collection.||t|t|t|t
1338525|NCT03094468|Randomized|Parallel Assignment||Treatment||Triple|Double blind|Vehicle-controlled|t|t|t|
1338526|NCT03094455|Randomized|Parallel Assignment||Treatment||Single||It will be a parallel RCT with a waitlist design||||t
1338536|NCT03094325||Single Group Assignment||Diagnostic||None (Open Label)|Each of the 10 patients will have 4 measurements(OPIE & TEE before cardiopulmonary bypass and OPIE & TEE after cardiopulmonary bypass) in the septum using two techniques (TEE and OPIE Ultrasound Probe).|||||
1338537|NCT03094312||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338538|NCT03094299|||Cohort||Prospective|||||||
1338539|NCT03094286||Single Group Assignment||Treatment||None (Open Label)||Durvalumab will be supplied in glass vials containing 500 mg of liquid solution at a concentration of 50 mg/mL for intravenous(IV) administration||||
1338540|NCT03094273|||Case-Only||Prospective|||||||
1338541|NCT03094260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338542|NCT03094247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338543|NCT03094234|Randomized|Parallel Assignment||Treatment||Single||||t||
1338544|NCT03094221|||Cohort||Prospective|||||||
1338545|NCT03094208|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338546|NCT03094195|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1338547|NCT03094182|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338548|NCT03094169||Single Group Assignment||Treatment||None (Open Label)||Uncontrolled, open label, non-randomized, Enrollment in the order of confirmation of eligibility, Escalating doses of study drug in sequential patient cohorts (Phase 1a).||||
1338549|NCT03094156|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1338550|NCT03094143|Randomized|Parallel Assignment||Treatment||Quadruple|"The result of the cardiac MRI will be blinded to care provider, participant and investigator. Group A will be unblinded, as participants can only enter group A if mid-wall fibrosis is present. Groups B and C will appear identical and the groups combined so the presence of mid-wall fibrosis will be blinded. Group D will be unblinded, as participants can only enter group D if mid-wall fibrosis is not present.~Outcome assessors will be blinded to allocation in all groups where outcome is adjudicated (groups A, B and C)"|Participants are randomised based on the result of the cardiac MRI. Participants who have mid wall fibrosis (heart scarring) are randomised to receive either early surgical intervention (group A) or routine care (group B). Participants who have no mid wall fibrosis are randomised to routine care with study follow up (group C) or without study follow up (group D).|t|t|t|t
1338551|NCT03094130|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis|Two arms, parallel group, randomized controlled trial|t|||
1338552|NCT03094117|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis|Two arms, parallel group, randomized controlled trial|t|||
1338553|NCT03094104|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis.|Two arms, parallel group, randomized controlled trial|t|||
1338554|NCT03094091|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis.|Two arms, parallel group, randomized controlled trial|t|||
1338555|NCT03094078|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis.|Two arms, parallel group, randomized controlled trial|t|||
1338556|NCT03094065|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis.|Two-arms, parallel group, randomized controlled trial|t|||
1338557|NCT03094052||Single Group Assignment||Treatment||None (Open Label)||This is an open-label adjuvant/post-neoadjuvant single arm phase 2 trial. There will be 23 patients recruited. If pertuzumab is approved in the adjuvant setting during the course of the study, the protocol will be amended to allow pertuzumab. This trial will open as a single-institution trial at UCSF and expand to include 1-2 other sites as needed.||||
1338558|NCT03094039|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1338559|NCT03094026|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338560|NCT03094013|||Ecologic or Community||Cross-Sectional|||||||
1338561|NCT03094000|Randomized|Parallel Assignment||Treatment||Single||Following an evaluation and screening process, those who fit the criteria will be allocated randomly to one of the two research groups: experiment or control.||||t
1338562|NCT03093987|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338563|NCT03093974|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338564|NCT03093961||Single Group Assignment||Treatment||None (Open Label)||||||
1338565|NCT03093948|Randomized|Parallel Assignment||Treatment||Single||||||t
1338566|NCT03093935||Single Group Assignment||Treatment||None (Open Label)||Cohort- Prospective, multi-center to collect population specific outcome measures in post-stroke patients||||
1338567|NCT03093922|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a randomized phase II study testing two different schedules of atezolizumab combined with gemcitabine and cisplatin chemotherapy (GC) in patients with metastatic urothelial carcinoma (mUC) who are eligible for cisplatin.||||
1338568|NCT03093909||Single Group Assignment||Treatment||None (Open Label)||||||
1338569|NCT03093896|Randomized|Parallel Assignment||Prevention||Single|||||t|
1338570|NCT03093883|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1338571|NCT03093870|Randomized|Parallel Assignment||Treatment||Double||Treatment: protocol designed to evaluate one or more interventions for treating a disease, syndrome or condition|t||t|
1338572|NCT03093857|||Other||Prospective|||||||
1338573|NCT03093844||Single Group Assignment||Treatment||None (Open Label)||This is a phase 1/phase 2 study.||||
1338574|NCT03093831||Single Group Assignment||Treatment||None (Open Label)||||||
1338575|NCT03093818|Randomized|Crossover Assignment||Prevention||Single|"Causality and severity of recorded ADE will be assessed by a 2nd independent, blinded (unaware of patient allocation) assessor.~Drug-genotype association of the ADE as per the Dutch Pharmacogenomics Working Group guideline will be assessed by a blinded review committee"|||||t
1338576|NCT03093805||Single Group Assignment||Treatment||None (Open Label)||||||
1338577|NCT03093792|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1338578|NCT03093779|||Other||Cross-Sectional|||||||
1338579|NCT03093766|||Cohort||Prospective|||||||
1338580|NCT03093753|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1338625|NCT03093168||Single Group Assignment||Treatment||None (Open Label)||||||
1338581|NCT03093740|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Based on the genotype and viral resistance testing of the donor, that will be determined within the first week, we will initiate a genotype specific regimen for HCV treatment as available by prescription||||
1338582|NCT03093727|||Case-Only||Prospective|||||||
1338583|NCT03093714|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338584|NCT03093701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338585|NCT03093688||Single Group Assignment||Treatment||None (Open Label)||treatment group: receive twice cell infusions in one course of treatment.||||
1338586|NCT03093675||Single Group Assignment||Treatment||None (Open Label)||||||
1338587|NCT03093662|Randomized|Crossover Assignment||Prevention||Single||||||t
1338588|NCT03093649|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338589|NCT03093636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338590|NCT03093623|Randomized|Crossover Assignment||Prevention||Single|||t|||
1338591|NCT03093610|Randomized|Parallel Assignment||Prevention||Single|The operating surgeon does not know to which group the Patient will be attributed to.|Group 1: Removal of the chest tube after air leakage has ceased and fluid Drainage is < 200ml/24h Group 2: Removal of the chest tube after air leakage has ceased and fluid Drainage is < 5ml/kg/24h||t||
1338592|NCT03093597|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1338593|NCT03093584|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1338594|NCT03093571|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1338595|NCT03093558|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1338596|NCT03093545|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338597|NCT03093532|Randomized|Parallel Assignment||Screening||Single|Research Assistants are blinded to study arm assignment of participant when assessing outcomes measures|||||t
1338598|NCT03093519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338599|NCT03093506|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1338600|NCT03093493|||Case-Control||Cross-Sectional|||||||
1338601|NCT03093480||Single Group Assignment||Treatment||None (Open Label)||||||
1338602|NCT03093467|Randomized|Parallel Assignment||Treatment||Single||Open randomized controlled trial in one mental health center.||||t
1338603|NCT03093454|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Randomized study with control group and test group. Using a 1:1 treatment allocation ratio, the total of 40 patients (20 per arm) will be randomly assigned to control or treatment arm. The Statistical Investigator will generate the randomization scheme and monitor the randomization process over the course of the trial. The study will use randomization with random permuted blocks. The test group will receive 50% lavender oil diluted in fractionated coconut oil and the control group will have the current standard of care with no essential oil intervention. Fractionated coconut oil is being used because it is colorless, odorless, does not stain clothing, and has a long shelf life. It also serves as a carrier oil for the essential oil to absorb into the skin instead of evaporating off the skin due to essential oils volatile nature.||||
1338604|NCT03093441|Randomized|Parallel Assignment||Prevention||None (Open Label)||A parallel-group randomized controlled trial will be conducted. Once initial screening is completed, participants will be randomized into one of three arms: 1) MM-HIIT, 2) R-HIIT, and 3) control.||||
1338605|NCT03093428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338606|NCT03093415|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two parallel investigational groups in different community health clinic treatment settings assigned to treatment with elbasvir-grazoprevir as compared to an academic hepatology clinic retrospective cohort treated with elbasvir-grazoprevir.||||
1338607|NCT03093402|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1338608|NCT03093389|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1338609|NCT03093376|Randomized|Parallel Assignment||Treatment||None (Open Label)||Child participants will be randomized to effortful control (EC) training or wait list. If wait list is assigned, children will receive EC training materials after completing pre- and post-wait list assessments.||||
1338610|NCT03093363|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1338611|NCT03093350||Single Group Assignment||Treatment||None (Open Label)||||||
1338612|NCT03093337|Randomized|Parallel Assignment||Treatment||Single||||||t
1338613|NCT03093324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338614|NCT03093311|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1338615|NCT03093298||Single Group Assignment||Basic Science||None (Open Label)||||||
1338616|NCT03093285|||Case-Only||Prospective|||||||
1338617|NCT03093272||Single Group Assignment||Treatment||None (Open Label)||||||
1338618|NCT03093259|Randomized|Parallel Assignment||Treatment||Quadruple|Double-Blind Treatment|Double-blind, placebo-controlled, randomized study|t|t|t|t
1338619|NCT03093246|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1338620|NCT03093233|||Cohort||Retrospective|||||||
1338621|NCT03093220|||Cohort||Prospective|||||||
1338622|NCT03093207|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1338623|NCT03093194|Randomized|Parallel Assignment||Prevention||Double|The study is not double blind, therefore is subjected to the care provider bias. Outcomes assessment might also be over or under evaluated by the physician following the patients outside the hospital.|"Patients will be randomaly assigned into two groups. The experiment group will not undergo vaginal preparation. The control will undergo perioperative vaginal preparation with antiseptic soap and chlorohexidine-alcohol.~All patients participating in this trail will sign a written informed consent. All patients will receive preventative antibiotics peri-operatively according to the our hospital protocol.~Exclusion criteria are a known allergy to antiseptic soap, chlorohexidine-alcohol or shellfish, or patients who had any infection in the perioperative period.~Inclusion criteria: an elective or emergent CS in a woman who did not report having a fever or skin infection signs in the 5 days prior to surgery.~Once a patient is admitted to the delivery room, approximately 7 days to several hours before CS each patient will be assigned randomly to a group using a computerized randomization software."||t||t
1338624|NCT03093181|Randomized|Parallel Assignment||Treatment||Single||||||t
1338626|NCT03093155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338627|NCT03093142|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1338628|NCT03093129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338629|NCT03093116||Single Group Assignment||Treatment||None (Open Label)||||||
1338630|NCT03093103|Randomized|Parallel Assignment||Basic Science||Triple|Placebo and Empagliflozin pills|Randomised placebo-controlled double blind trial|t|t|t|
1338631|NCT03093090|Randomized|Crossover Assignment||Basic Science||None (Open Label)||A four-way randomized crossover PK study||||
1338632|NCT03093077|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1338633|NCT03093064|Randomized|Parallel Assignment||Basic Science||Quadruple||This is an experimental medicine study, the purpose of which is provide a mechanistic understanding of neuroinflammation in schizophrenia by investigating response to natalizumab (phase 1b).|t|t|t|t
1338634|NCT03093051|||Case-Only||Prospective|||||||
1338635|NCT03093038|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338636|NCT03093025|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1338637|NCT03093012|||Other||Prospective|||||||
1338638|NCT03092999|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338639|NCT03092986|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Controlled type, 60 patients randomized with help of randomized number generator in two arms, Arm A and Arm B, each with at least 30 number of patients, research material will be data collection form,Arm A will receive paclitaxel 200 mg/m2 i.v over 3 hrs on D1; carboplatin AUC 6 i.v over 60 minutes on D1 every 3 wks for 2 cycles followed by radiotherapy with 6000 c Gy given in 30 fractions beginning on day 42 , Arm B willl receive - cisplatin (100 mg/m2 BSA i.v over 2 hrs. on days 1 and 29) and vinblastine (5 mg/m2 BSA i.v rapidly push weekly on days 1,8,15,22 and 29) followed by radiotherapy with 6000 cGy given in 30 fractions beginning on day 50 ,data will be analysed and interpreted and result will be drawn on basis of outcome measures which is again based on tumor response RECIST criteria||||
1338640|NCT03092973|||Cohort||Prospective|||||||
1338641|NCT03092960|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1338642|NCT03092947|||Cohort||Prospective|||||||
1338643|NCT03092934|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-Label|||||
1338644|NCT03092921|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1338645|NCT03092908|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338646|NCT03092895|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338647|NCT03092882|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1338648|NCT03092869|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1338649|NCT03092856|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1338650|NCT03092843|||Cohort||Prospective|||||||
1338651|NCT03092830|||Cohort||Prospective|||||||
1338652|NCT03092817|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1338653|NCT03092804|||Cohort||Prospective|||||||
1338654|NCT03092791|Randomized|Parallel Assignment||Prevention||Single|||||t|
1338655|NCT03092778||Single Group Assignment||Treatment||None (Open Label)||||||
1338656|NCT03092765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338657|NCT03092752|||Cohort||Retrospective|||||||
1338658|NCT03092739|||Cohort||Prospective|||||||
1338659|NCT03092726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338660|NCT03092713|Randomized|Parallel Assignment||Treatment||Double|Particpant are blinded to Group allocation, and all assessments are blinded to Group allocation.|Randomized controlled trial with active treatment group compared to treatment as usual|t|||t
1338661|NCT03092700|||Case-Only||Prospective|||||||
1338662|NCT03092687|||Case-Control||Cross-Sectional|||||||
1338663|NCT03092674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338664|NCT03092661|||Cohort||Prospective|||||||
1338665|NCT03092648|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||open, non-random, concurrent control||||
1338666|NCT03092635||Single Group Assignment||Treatment||None (Open Label)||||||
1338667|NCT03092622||Single Group Assignment||Other||None (Open Label)||||||
1338668|NCT03092609|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338669|NCT03092596|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1338670|NCT03092583|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338671|NCT03092570|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1338672|NCT03092557||Single Group Assignment||Other||None (Open Label)||Prospective, interventional, cohort study||||
1338673|NCT03092544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338674|NCT03092531|Randomized|Sequential Assignment||Supportive Care||Single|Block randomization|||||t
1338675|NCT03092518||Single Group Assignment||Treatment||None (Open Label)||||||
1338676|NCT03092505|||Case-Only||Prospective|||||||
1338677|NCT03092492|||Cohort||Prospective|||||||
1338678|NCT03092479|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338679|NCT03092466|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1338680|NCT03092453||Single Group Assignment||Treatment||None (Open Label)||||||
1338681|NCT03092440|||Cohort||Prospective|||||||
1338682|NCT03092427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338683|NCT03092414|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1338684|NCT03092401|||Case-Control||Retrospective|||||||
1338685|NCT03092388|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1338730|NCT03091803|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1338731|NCT03091790|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1338732|NCT03091777|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1338733|NCT03091764|||Cohort||Prospective|||||||
1338734|NCT03091751||Single Group Assignment||Treatment||None (Open Label)||||||
1338686|NCT03092375|Randomized|Crossover Assignment||Treatment||None (Open Label)||"Main Study Up to 225 subjects will be enrolled into 4 study arms A, B, C and D with Glecaprevir/Pibrentasvir (G/P) with or without Ribavirin (RBV).~About 75-90 non-cirrhotic subjects will be randomized in a 2:1 ratio to Arms A and B, and about 110-135 compensated cirrhotic subjects will be randomized in a 1:1 ratio to Arms C and D.~Non-cirrhotic subjects will be randomized 2:1 to:~Arm A: G/P 300 mg/120 mg Once a day for 12 weeks~Arm B: G/P 300 mg/120mg Once a day for 16 weeks~Subjects with compensated cirrhosis will be randomized 1:1 to:~Arm C: G/P 300 mg/120 mg QD + weight-based RBV (Ribavirin) Twice a day (1000 mg or 1200 mg total daily dose) for 12 weeks 4. Arm D: G/P 300 mg/120 mg QD for 16 weeks Retreatment sub-study Up to 11 subjects who still have hepatitis C virus after being treated in the Main study will have the option to enter the Retreatment sub-study and receive G/P plus Sofosbuvir and with or without RBV."||||
1338687|NCT03092362|||Cohort||Prospective|||||||
1338688|NCT03092349|||Cohort||Prospective|||||||
1338689|NCT03092336|Randomized|Parallel Assignment||Treatment||Single|||||t|
1338690|NCT03092323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338691|NCT03092310||Single Group Assignment||Treatment||None (Open Label)||||||
1338692|NCT03092297|||Cohort||Prospective|||||||
1338693|NCT03092284|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338694|NCT03092271|Randomized|Parallel Assignment||Prevention||Single|Assessments will be conducted by assessors who are naive to randomization assignment. Every effort will be made to conceal all information regarding randomization and randomization assignment to staff involved in assessment, recruitment, or other study activities that could lead to bias. It is not possible to conceal randomization status from intervention staff, as they will be delivering the intervention.|Randomization to one of two conditions: 1) Zero suicide Best Practices/Quality Improvement; or 2) Zero suicide Best Practices/Quality Improvement plus stepped care for suicide prevention intervention||||t
1338695|NCT03092258|||Cohort||Prospective|||||||
1338696|NCT03092245|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1338697|NCT03092232|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1338698|NCT03092219||||||||||||
1338699|NCT03092206|Randomized|Parallel Assignment||Treatment||None (Open Label)||Group 1: F/TAF ; oral; Dose: 25/200 mg; Frequency: QD Group 2: E/C/F/TAF; oral; Dose: 150/150/200/10 mg; Frequency: QD Group 3: R/F/TAF; oral; Dose: 25/200/25 mg; Frequency: QD||||
1338700|NCT03092193|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338701|NCT03092180|||Cohort||Prospective|||||||
1338702|NCT03092167|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|Open label|15 idiopathic inflammatory myopathies submmited to physical exercises 15 idiopathic inflammatory myopathies not submmited to physcial exercises 10 healthy individuals||||
1338703|NCT03092154|Non-Randomized|Parallel Assignment||Treatment||Triple||Two groups: with or without lipid-lowering agents|t||t|t
1338704|NCT03092141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Patients will submitted to physical training (12-weeks, twice/week)||||
1338705|NCT03092128|||Case-Only||Retrospective|||||||
1338706|NCT03092115||Single Group Assignment||Treatment||None (Open Label)||||||
1338707|NCT03092102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338708|NCT03092089||Single Group Assignment||Treatment||None (Open Label)||This clinical study is a prospective single-center, single-arm investigation of sonothrombolysis in adult patients presenting with high-risk STEMI within 6 hrs of the onset of clinical symptoms and receiving reperfusion therapy with PCI. All patients will receive standard therapy. Patients will immediately receive an iv infusion of commercially available ultrasound contrast agent (Definity) and myocardial contrast echocardiography will be performed to document the size of the perfusion defect. Loops of 15 cardiac cycles will be recorded using low mechanical index (MI) ultrasound. These recordings will also be used to assess regional wall motion as well as LV volumes and ejection fraction. Immediately after the diagnostic ultrasound, the therapeutic ultrasound will start using the same transducer by applying multiple high MI ultrasound impulses. These pulses will be applied to the apical windows that contained the risk area. The intervals between HMI impulses will vary from 5 to 15 s.||||
1338709|NCT03092076|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338710|NCT03092063|Randomized|Sequential Assignment||Treatment||Single|Raters are blind to treatment condition.|Diabetes Self-Management Education||||t
1338711|NCT03092050|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1338712|NCT03092037|||Case-Control||Prospective|||||||
1338713|NCT03092024|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338714|NCT03092011|Randomized|Parallel Assignment||Treatment||Double|The family of the patient (baby), medical provider team and nursing will be masked to the specific arm. Investigator, unless is an active medical provider at the time, and pharmacist will not be masked.|Randomized double blind prospective trial|t|t||
1338715|NCT03091998|Randomized|Parallel Assignment||Treatment||Triple|The Research Pharmacists will manage the randomization of the study and release information at the conclusion, once all participants have been recruited and completed study measures.|Injection of CD-NP vs Placebo|t|t|t|
1338716|NCT03091985|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1338717|NCT03091972|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338718|NCT03091959|||Other||Retrospective|||||||
1338719|NCT03091946|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1338720|NCT03091933||Single Group Assignment||Treatment||None (Open Label)||exploratory, open-label||||
1338721|NCT03091920|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind||t|t|t|
1338722|NCT03091907|||Case-Control||Retrospective|||||||
1338723|NCT03091894|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1338724|NCT03091881|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1338725|NCT03091868|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1338726|NCT03091855|||Cohort||Prospective|||||||
1338727|NCT03091842|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338728|NCT03091829|||Cohort||Prospective|||||||
1338729|NCT03091816||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338735|NCT03091738||Single Group Assignment||Treatment||None (Open Label)||||||
1338736|NCT03091725|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338737|NCT03091712|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, open label, randomized, controlled, parallel intervention study.||||
1338738|NCT03091699|Randomized|Sequential Assignment||Treatment||None (Open Label)||Sequential two stage trial. Stage 1 will utilize a within-counterbalanced approach while stage 2 will utilize a randomized trial.||||
1338739|NCT03091686|Randomized|Parallel Assignment||Prevention||Single|||t|||
1338740|NCT03091673|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1338741|NCT03091660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338742|NCT03091647|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338743|NCT03091634|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338744|NCT03091621|||Cohort||Prospective|||||||
1338745|NCT03091608|||Cohort||Prospective|||||||
1338746|NCT03091595|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338747|NCT03091582|Randomized|Parallel Assignment||Treatment||None (Open Label)||After being clearly told that participation in the study will not impact subsequent care at CSMC, the patient agrees to participate, the patient will review and sign the informed consent form. Next, the patient will be randomized to either receive CBT or BA therapy, and scheduled for CBT or BA therapy sessions.||||
1338748|NCT03091569|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1338749|NCT03091556|||Cohort||Prospective|||||||
1338750|NCT03091543|Randomized|Crossover Assignment||Treatment||Single|||||t|
1338751|NCT03091530|Randomized|Crossover Assignment||Prevention||Single||||||t
1338752|NCT03091517||Single Group Assignment||Other||None (Open Label)||||||
1338753|NCT03091504||Single Group Assignment||Treatment||None (Open Label)||||||
1338754|NCT03091491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338755|NCT03091478||Single Group Assignment||Treatment||None (Open Label)||||||
1338756|NCT03091465|||Cohort||Retrospective|||||||
1338757|NCT03091452|||Cohort||Prospective|||||||
1338758|NCT03091439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338759|NCT03091426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338760|NCT03091413|||Case-Only||Prospective|||||||
1338761|NCT03091400|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1338762|NCT03091387|||Other||Prospective|||||||
1338763|NCT03091374||Single Group Assignment||Treatment||None (Open Label)||||||
1338764|NCT03091361|||Cohort||Prospective|||||||
1338765|NCT03091348|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338766|NCT03091335|Randomized|Parallel Assignment||Treatment||Single|Participants will be unaware of their randomization group until all pre-operative measures have been acquired.|Randomization into two groups: music-listening vs headphones-only|t|||
1338767|NCT03091322|||Cohort||Prospective|||||||
1338768|NCT03091309|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1338769|NCT03091296|||Case-Control||Cross-Sectional|||||||
1338770|NCT03091283|||Cohort||Prospective|||||||
1338771|NCT03091270|||Case-Crossover||Prospective|||||||
1338772|NCT03091257|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338773|NCT03091244|||Cohort||Prospective|||||||
1338774|NCT03091231|||Cohort||Prospective|||||||
1338775|NCT03091218|||Cohort||Prospective|||||||
1338776|NCT03091205|||Cohort||Prospective|||||||
1338777|NCT03091192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338778|NCT03091179|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1338779|NCT03091166|Randomized|Parallel Assignment||Prevention||Single|||t|||
1338780|NCT03091153|Randomized|Parallel Assignment||Treatment||Single||||||t
1338781|NCT03091140|||Cohort||Prospective|||||||
1338782|NCT03091127|||Cohort||Other|||||||
1338783|NCT03091114|||Cohort||Prospective|||||||
1338784|NCT03091101||Single Group Assignment||Other||None (Open Label)||||||
1338785|NCT03091088|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1338786|NCT03091075|Randomized|Parallel Assignment||Treatment||Quadruple|Allocation will be performed using computer software and will occur at the pharmacy to ensure that all investigators are blinded.|Men and women aged 40 - 75 scheduled for rotator cuff repair, who have failed nonoperative management of chronic, full thickness rotator cuff tears confirmed by MRI, will be randomized into one of two groups, a control group (receiving placebo medication) and an experimental group receiving oral Oxandrolone (males 12 mg BID (24 mg per day) and females 6 mg BID (12 mg per day)), with dosing beginning at time of surgery and continuing for 12 weeks postoperative.|t|t|t|t
1338787|NCT03091062||Single Group Assignment||Treatment||None (Open Label)||||||
1338788|NCT03091049|||Case-Control||Prospective|||||||
1338789|NCT03091036||Single Group Assignment||Prevention||None (Open Label)||||||
1338790|NCT03091023|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1338791|NCT03091010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338792|NCT03090997|Randomized|Parallel Assignment||Treatment||Quadruple|Participant, care provider, investigator and outcomes assesor will be masking using placebo for resveratrol and vitamin C, the three groups will receive the same intervention with the use of placebo. The placebo will be prepared for the Pharmacology Department and packing and label for exclusive use into the protocol study. Any participant, care provider or investigator will know if package content vitamin C, resveratrol or placebo.|Randomized Clinical Trial|t|t|t|t
1338793|NCT03090984|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1338794|NCT03090971||Single Group Assignment||Treatment||None (Open Label)||||||
1338929|NCT03089216|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338930|NCT03089203|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339387|NCT03083249|||Cohort||Prospective|||||||
1338795|NCT03090958||Single Group Assignment||Other||None (Open Label)||In order to assess the feasibility and acceptability of the app. 20 participants will be enrolled in a one month pilot trial. After being screened for eligibility, the research assistant (RA) will meet with participants in person to explain the study in detail, facilitate app download and login onto participants' phones, and provide an app site tour to highlight features. Participants will complete a baseline demographic and risk assessment administered via a computer assisted survey instrument (CASI). At the end of the one-month field trial, participants will undergo a debriefing session to evaluate their experience using the app, overall satisfaction and any problems they encountered.||||
1338796|NCT03090945|||Cohort||Prospective|||||||
1338797|NCT03090932|||Case-Control||Prospective|||||||
1338798|NCT03090919|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be randomized to recieve either a platelet transfusion or a saline transfusion.||||
1338799|NCT03090906|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1338800|NCT03090893||Single Group Assignment||Supportive Care||None (Open Label)||||||
1338801|NCT03090880|Randomized|Parallel Assignment||Prevention||Single||||||t
1338802|NCT03090867|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338803|NCT03090854|||Other||Prospective|||||||
1338804|NCT03090841|||Cohort||Prospective|||||||
1338805|NCT03090828|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1338806|NCT03090815|||Cohort||Prospective|||||||
1338807|NCT03090802|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338808|NCT03090789|||Case-Control||Prospective|||||||
1338809|NCT03090776|Randomized|Sequential Assignment||Prevention||Quadruple|Investigational Drug service will prepare ketamine vs placebo infusion for administration during surgery|arm 1:unenriched for risk of PPMP, ketamine vs placebo arm 2: enriched for risk of PPMP, ketamine vs placebo|t|t|t|t
1338810|NCT03090763|||Case-Control||Prospective|||||||
1338811|NCT03090750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338812|NCT03090737||Single Group Assignment||Treatment||None (Open Label)||||||
1338813|NCT03090724|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338814|NCT03090711|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1338815|NCT03090698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338816|NCT03090685|Randomized|Parallel Assignment||Treatment||Double|The sample randomization procedure will be performed by means of a computer program, which will generate a random sequence to be placed in an opaque envelope by an assistant not involved in the evaluation and treatment.|Prospective, double-blind randomized controlled trial (RCT).|t|||t
1338817|NCT03090672|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338818|NCT03090659||Single Group Assignment||Treatment||None (Open Label)||||||
1338819|NCT03090646|Randomized|Parallel Assignment||Supportive Care||Single|Patients will be aware of which arm they are randomized to; thus, the study will not be blinded to practitioners or patients. However, study personnel performing data analysis will receive de-identified data that does not explicitly describe which group is intervention and which is control, but simply the code without a key. Only the PI and necessary personnel performing data extraction will have the key for the code to minimize bias in data analysis.|This is a single-center, prospective, randomized controlled trial with two arms. Participants in the intervention arm will be flagged in the secure RedCap research database to receive up to three gift cards to a major online retailer in the mail upon completion of 6 month, 1 year, and 2 year required follow-up activities. If local, participants will attend clinic visits with standard of care clinical interview, physical exam, and laboratory draws. If remote, participants will submit a questionnaire documenting their remote standard of care clinic visit and the required laboratory values.||||t
1338820|NCT03090633||Single Group Assignment||Treatment||None (Open Label)||This is a single arm clinical study. All participants will undergo laparotomy with exteriorization of the uterus followed by minimally-invasive, fetoscopic repair of the fetal spina bifida lesion.||||
1338821|NCT03090620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338822|NCT03090607|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1338823|NCT03090594||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338824|NCT03090581|Randomized|Parallel Assignment||Diagnostic||None (Open Label)|A prospective, randomized, comparative study in all patients.|||||
1338825|NCT03090568|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338826|NCT03090555|Non-Randomized|Parallel Assignment||Treatment||Single|Outcomes assessors are blinded to the study arm to which participants are assigned|||||t
1338827|NCT03090542|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338828|NCT03090529|Randomized|Parallel Assignment||Treatment||Single||||||t
1338829|NCT03090516|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338830|NCT03090503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338831|NCT03090490|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338832|NCT03090477|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1338833|NCT03090464|||Case-Only||Prospective|||||||
1338834|NCT03090451|Randomized|Parallel Assignment||Basic Science||None (Open Label)|No masking for this study.|Two main arms: 1) moderate aerobic exercise, 2) intense aerobic exercise. In each arm, subjects will undergo three separate studies, i) at low insulin levels, ii) at medium insulin levels, and iii) at high insulin levels.||||
1338835|NCT03090438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338836|NCT03090425|||Cohort||Prospective|||||||
1338837|NCT03090412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338838|NCT03090399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338839|NCT03090386|||Case-Only||Prospective|||||||
1338889|NCT03089736|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|All patients who referred to the Pain and Rehabilitation Centre at the University Hospital, asked about participation in the study. Of those who agreed to participate every second patient were distributed to the control group versus intervention group.|||||
1338890|NCT03089723|Randomized|Crossover Assignment||Treatment||Single|||t|||
1338840|NCT03090373|Randomized|Parallel Assignment||Prevention||Triple|The UroShield device actuator will activate and create the hum, which is the only sign of its working even in the active device. While the active device will transmit Surface Acoustic Waves, the sham device will work but will not transmit any acoustic waves.|This is a double blinded, randomized controlled trial. All involved will be blinded as to whether the supplied UroShield device is active or a sham.|t|t|t|
1338841|NCT03090360|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1338842|NCT03090347||Single Group Assignment||Basic Science||None (Open Label)||||||
1338843|NCT03090334|Randomized|Parallel Assignment||Other||Single|Care provider will be blinded to result of BG in patients enrolled in the standard of care arm|||t||
1338844|NCT03090321|Randomized|Parallel Assignment||Prevention||Single|||||t|
1338845|NCT03090308|||Cohort||Prospective|||||||
1338846|NCT03090295||Single Group Assignment||Health Services Research||None (Open Label)||||||
1338847|NCT03090282|||Cohort||Prospective|||||||
1338848|NCT03090269||Single Group Assignment||Treatment||None (Open Label)||open-label, single site, national, pilot study, non-comparative before/after||||
1338849|NCT03090256||||||||||||
1338850|NCT03090243|||Cohort||Prospective|||||||
1338851|NCT03090230||Single Group Assignment||Treatment||None (Open Label)||Subject must have a traumatic injury of the descending thoracic aorta that occurred no more than 30 days prior to the planned stent implant procedure. All subjects enrolled, will be included in the patient population for the primary analysis. All subjects implanted with the RelayPro Thoracic Stent-Graft will be included in the patient population for the secondary analyses.||||
1338852|NCT03090217|Randomized|Parallel Assignment||Prevention||Single||||||t
1338853|NCT03090204||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338854|NCT03090191|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338855|NCT03090178|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Investigators will first enroll patients, then healthy volunters. Healthy volunters will be matched to patients on age, sexe and wake up at a programmed time||||
1338856|NCT03090165||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1338857|NCT03090152|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1338858|NCT03090139|||Cohort||Retrospective|||||||
1338859|NCT03090126|||Cohort||Prospective|||||||
1338860|NCT03090113|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338861|NCT03090100|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338862|NCT03090087||Single Group Assignment||Basic Science||None (Open Label)||"The project will be conducted as an open controlled interventional study performed on two days separated by at least one day.~The test persons will be randomly allocated to two groups, one group in which protocol 1 is followed by protocol 2, and the other group with the two protocols performed in the reverse order.~Protocol 1: A) Using a Dynamic Vessel Analyzer, the diameter of a larger retinal vascular arcade arteriole will be recorded for 90 seconds at baseline followed by a similar recording during stimulation with flickering light and a recording during rest, altogether lasting 4.5 minutes. B) Intravenous injection of 0,4 mg regadenoson and repetition of the procedures in step A.~Protocol 2: The procedures are similar to those of protocol 1 but are performed during breathing of a hypoxic gas mixture."||||
1338863|NCT03090074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338864|NCT03090061|Non-Randomized|Parallel Assignment||Diagnostic||Single|The assessors will not be blind about the type of intervention/control assessment methods. However it will not be allowed amongst the examiners to exchange any information throughout the entire study period|||||t
1338865|NCT03090048|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1338866|NCT03090035||Single Group Assignment||Treatment||None (Open Label)||Clinical trial||||
1338867|NCT03090022|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1338868|NCT03090009|Randomized|Parallel Assignment||Diagnostic||Double|Both patient and investigator will blinded to the identity of the medication given.|The study design is random controlled double blind clinical trial|t||t|
1338869|NCT03089996|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1338870|NCT03089983|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1338871|NCT03089970|||Case-Control||Prospective|||||||
1338872|NCT03089957|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1338873|NCT03089944||Single Group Assignment||Treatment||None (Open Label)||||||
1338874|NCT03089931|||Cohort||Prospective|||||||
1338875|NCT03089918|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338876|NCT03089905|Randomized|Parallel Assignment||Treatment||Single|Randomisation 1:1 will be stratified by site and age at exposure (less than 12 months and greater than or equal to 12 months). Randomisation will be in blocks of variable size. The treating anaesthetist will not be blinded to treatment arm. The assessing neuropsychologist and parents will be blinded to treatment arm.|Participants will be randomised to receive either low-dose sevoflurane/dexmedetomidine/remifentanil OR standard dose sevoflurane anaesthesia.||||t
1338877|NCT03089892|||Cohort||Retrospective|||||||
1338878|NCT03089879||Single Group Assignment||Prevention||None (Open Label)||||||
1338879|NCT03089866|||Cohort||Prospective|||||||
1338880|NCT03089853|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a pilot, randomized controlled study where subjects will be randomized in a 2:1 ratio to either receive remote tele pulmonary rehabilitation intervention and NMES or usual care.||||
1338881|NCT03089840||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1338882|NCT03089827|||Cohort||Prospective|||||||
1338883|NCT03089814|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1338884|NCT03089801|||Cohort||Other|||||||
1338885|NCT03089788||Single Group Assignment||Other||None (Open Label)||||||
1338886|NCT03089775|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338887|NCT03089762||Single Group Assignment||Treatment||None (Open Label)||||||
1338888|NCT03089749|||Cohort||Prospective|||||||
1338891|NCT03089710||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338892|NCT03089697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338894|NCT03089671|Randomized|Parallel Assignment||Diagnostic||Double|"Patient packages will be created and assigned a patient number. For those randomized to the vitamin B group, the package will consist of a pill of vitamin B2 that is inside an opaque gelatin capsule that is matched to a litre bag of normal saline that is wrapped in an opaque covering. For those randomized to the D5W group, the package will consist of a pill that is an empty opaque gelatin capsule that is matched to a litre bag of D5W that is wrapped in an opaque covering. These packages will be coupled with the patient according to her randomization group in the preoperative area.~In the preoperative area, all patients will be given the pill in their package by mouth 60 to 120 minutes before the start of surgery. The covered bag will then accompany the patient to the operating room and will be set up as the instillation fluid for cystoscopy. This way, the patient and operating team will be blinded to what agent was used for ureteric visualization."|Double-blinded, randomized controlled trial|t|t||
1338895|NCT03089658||||||||||||
1338896|NCT03089645|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1338897|NCT03089632||Single Group Assignment||Treatment||None (Open Label)||Before and after clinical trial.||||
1338898|NCT03089619|Randomized|Parallel Assignment||Treatment||Single|outcome assessors will be masked during the evaluation period. Subjects will be identified through their randomization number. Patients identification log is stored at the study site and only available to the investigator who is responsible of concealment of these information.|assignment of patients to one of the two treatment arms will be carried out randomly. Randomization process will be monitored and carried out by the center of clinical studies coordination - University Medicine Greifswald. Assignment of patient will be only known to the investigator after blood and urine sample results fulfill the inclusion criteria.||||t
1338899|NCT03089606||Single Group Assignment||Treatment||None (Open Label)||This is a phase 2, single-arm, open-label study.||||
1338900|NCT03089593|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1338901|NCT03089580|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1338902|NCT03089567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338903|NCT03089554||Single Group Assignment||Treatment||None (Open Label)||||||
1338904|NCT03089541||Single Group Assignment||Treatment||None (Open Label)||30 non-treatment seeking young adult e-cigarette/cigarette dual users (15 males/15 females) will participate in a contingency-management reinforced 2-week exclusive e-cigarette use period.||||
1338905|NCT03089528|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prosspective randomised||||
1338906|NCT03089515|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Healthy Controls who were not in the WTC program (n = 20)~Uncontrolled Lower Respiratory Symptoms in WTC Surivivors; ULRS study) with persistent LRS (n = 40)"||||
1338907|NCT03089502|Randomized|Parallel Assignment||Treatment||Single||||||t
1338908|NCT03089489|||Cohort||Prospective|||||||
1338909|NCT03089476|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||Children at high risk of atopy will be followed up to 6 months of age. The investigator will obtain TEWL measurements, skin tape stripping, and questionnaire data each subsequent visit. During the latter 2 visits, skin prick allergy testing will be obtained for milk, egg, and peanut to determine risk of food allergy. Biologic parents will also undergo STS and TEWL measurements on the first visit.||||
1338910|NCT03089463|||Cohort||Prospective|||||||
1338911|NCT03089450|Randomized|Parallel Assignment||Treatment||Single|||t|||
1338912|NCT03089437|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1338913|NCT03089424|Randomized|Parallel Assignment||Treatment||Quadruple|The mode of intervention (active or placebo photobiomodulation) will be coded by an independent researcher. The randomization schedule will contain only codes (not the actual intervention). The output from the laser device is exactly the same from either the active or the placebo interventions. These features will guarantee that participants, therapists and outcomes assessor will be blinded to the treatment arms.||t|t|t|t
1338914|NCT03089411|||Other||Retrospective|||||||
1338915|NCT03089398|Randomized|Parallel Assignment||Treatment||Single|The DCC Research Nurse will be blinded to treatment assignment during follow-up telephone calls and will be blinded to aggregate outcomes data.|This trial is a prospective, multi-center randomized comparative effectiveness trial of HCR compared to multi-vessel PCI with metallic DES in patients with multi-vessel CAD involving the LAD or LM territories.||||t
1338916|NCT03089385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1338917|NCT03089372|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338918|NCT03089359|||Cohort||Prospective|||||||
1338919|NCT03089346||Single Group Assignment||Diagnostic||None (Open Label)||||||
1338920|NCT03089333|Randomized|Crossover Assignment||Treatment||Single||Two-way crossover design|||t|
1338921|NCT03089320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338922|NCT03089307|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients (n=44) will be randomised into 2 groups to receive low intensity extracorporeal shock wave treatment for a 6 weeks period utilising the Dornier Aries ED device.Group A (n=21) will receive 6 sessions (one session per week) and group B (n=21) will receive 12 sessions (2 sessions per week).||||
1338923|NCT03089294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338924|NCT03089281|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1338925|NCT03089268|||Cohort||Prospective|||||||
1338926|NCT03089255|||Cohort||Prospective|||||||
1338927|NCT03089242|||Cohort||Prospective|||||||
1338928|NCT03089229|Randomized|Parallel Assignment||Treatment||Quadruple|The Sponsor will send all washout and test products in compliance with current Good Manufacturing Practices directly to the clinical facility prior to the start of the study. Study procedures will be in place to ensure double-blind administration of study treatments. Access to the randomization code will be strictly controlled. The quantity of all study material shipped to the clinical facility will be documented on the shipping and receiving form included within the shipment. Due to the objectives of the study, the identity of test and control treatments will not be known to investigators, care provider, outcomes assessor, research staff, or patients. Packaging and labeling of test and control treatments will be identical to maintain the blind. Products will be identified with the codes generated by the randomization.||t|t|t|t
1339852|NCT03077178||Single Group Assignment||Other||None (Open Label)||||||
1338931|NCT03089190|Randomized|Crossover Assignment||Prevention||Quadruple|Double-blind|A double-blind, randomized crossover design with four arms including three experimental conditions and placebo|t|t|t|t
1338932|NCT03089177|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1338933|NCT03089164|||Cohort||Prospective|||||||
1338934|NCT03089151|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1338935|NCT03089138|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1338936|NCT03089125|Randomized|Parallel Assignment||Supportive Care||Single|Research staff collecting patient-reported measures will be blind to study assignment group|Nurse administered dyspnea intervention||||t
1338937|NCT03089112|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338938|NCT03089099|||Other||Prospective|||||||
1338939|NCT03089086|Randomized|Parallel Assignment||Prevention||Double||A cluster randomised controlled trial to assess the impact of meningococcal B vaccine 4CMenB on nasopharyngeal carriage of N. Meningitidis|||t|t
1338940|NCT03089073|||Case-Only||Prospective|||||||
1338941|NCT03089060|Randomized|Crossover Assignment||Treatment||None (Open Label)||monocentric, prospective, randomized, controlled, pseudo-cross-over||||
1338942|NCT03089047|Randomized|Parallel Assignment||Basic Science||Triple|Addition of rejuvesol will be performed by the blood bank and only they will know of group assignment|"Prospective randomized healthy volunteer study"|t||t|t
1338943|NCT03089034|||Cohort||Prospective|||||||
1338944|NCT03089021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338945|NCT03089008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338946|NCT03088995|||Case-Only||Prospective|||||||
1338947|NCT03088982|||Cohort||Prospective|||||||
1338948|NCT03088969|||Other||Other|||||||
1338949|NCT03088956|||Cohort||Prospective|||||||
1338950|NCT03088943|Randomized|Crossover Assignment||Basic Science||Single|Echo exams will be stored for later analysis by blinded assessors.|Patients will receive a series of perioperative echocardiographical measurements by TTE as well as TEE prior to induction, postinduction, and post cardiopulmonary bypass||||t
1338951|NCT03088930||Single Group Assignment||Treatment||None (Open Label)||||||
1338952|NCT03088917|||Cohort||Prospective|||||||
1338953|NCT03088904|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338954|NCT03088891|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1338955|NCT03088878|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1338956|NCT03088865|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1338957|NCT03088852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338958|NCT03088839|||Case-Control||Cross-Sectional|||||||
1338959|NCT03088826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338960|NCT03088813|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1338961|NCT03088800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338962|NCT03088787|||Cohort||Prospective|||||||
1338963|NCT03088774|Randomized|Parallel Assignment||Treatment||Triple|The allocation sequence will be delivered by the statistician group at Aalborg University Hospital and delivered to a IT consultant at ProData (Viby, J, Denmark) and integrated in the web-application. The researchers conducting the analysis will be blinded. During the project, data will be stored on a server placed at Aalborg University. Another member of the author Group will prepare a data set with a dummy variable for allocation without free text information from patients and make this data set available for the assessors to analyse. Patients will be aware of their allocation. General practitioners will only be aware of the allocation if the patient chooses to tell it to the general practitioner.|Allocation of patients 1:1 to the new web-application or to Patient's Handbook||t|t|t
1338964|NCT03088761|||Cohort||Prospective|||||||
1338965|NCT03088748|||Cohort||Retrospective|||||||
1338966|NCT03088735|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338967|NCT03088722|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1338968|NCT03088709||Single Group Assignment||Prevention||None (Open Label)||||||
1338969|NCT03088696|Randomized|Parallel Assignment||Prevention||Double|The care provider get's an envelope from the study nurse when going to the patient in the operating room. Only the study nurse knows if an acupuncture needle is in the envelope.|randomized comparative double blind prospective study|t|||t
1338970|NCT03088683|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1338971|NCT03088670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1338972|NCT03088657|||Cohort||Prospective|||||||
1338973|NCT03088644|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1338974|NCT03088631|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1338975|NCT03088618||Single Group Assignment||Treatment||None (Open Label)||||||
1338976|NCT03088605|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338977|NCT03088592||Single Group Assignment||Basic Science||None (Open Label)||||||
1338978|NCT03088579|||Cohort||Prospective|||||||
1338979|NCT03088566|Randomized|Parallel Assignment||Diagnostic||Single|The randomisation will be determined by sequencing patients into on of the two groups following the grouping found in closed envelopes.|Randomised controlled study. One group will be foot screened following the routine described in the web program, the D-Foot. The other group will be foot screened by the use of conventional methods.|t|||
1338980|NCT03088553|||Cohort||Prospective|||||||
1338981|NCT03088540|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1338982|NCT03088527||Single Group Assignment||Treatment||None (Open Label)||||||
1338983|NCT03088514|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339033|NCT03087851|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339034|NCT03087838|||Cohort||Prospective|||||||
1339035|NCT03087825|Randomized|Crossover Assignment||Prevention||None (Open Label)||2 groups : spontaneous breathing and non invasive pressure support ventilation 2 conditions : without inward air leak and with inward air leak||||
1339036|NCT03087812|||Cohort||Prospective|||||||
1338984|NCT03088501|Randomized|Parallel Assignment||Health Services Research||Single|After meeting inclusion criteria, consenting to participate and completing a baseline questionnaire, participants will be immediately assigned to the randomized study arm by the RA who will open one of the sequentially numbered envelopes to determine allocation. Before opening the envelope, the Respondent ID number will be written on the envelope. The assignment schedule will be kept in a locked filing cabinet in the study coordinator's office at the Indian Institute of Public Health. Research staff and pregnant women cannot be blinded because the intervention requires their participation; however, the data analyst will be blinded to the study arm assignment.|Participants will be randomized into each arm on a 1:1:1, using a computer-generated randomization list. Written allocation of assignments will be sealed in individual, sequentially numbered, non-resealable, opaque envelopes that will be used to allocate to the targeted number of participants.Once the participant is assigned to the arm, their unique respondent Identification Number ID(RID) and the arm to which they are allocated are recorded by the research assistants||||t
1338985|NCT03088488|||Case-Control||Cross-Sectional|||||||
1338986|NCT03088475|Randomized|Parallel Assignment||Other||Single|||t|||
1338987|NCT03088462|Randomized|Parallel Assignment||Treatment||Single||||||t
1338988|NCT03088449|||Cohort||Prospective|||||||
1338989|NCT03088436|||Case-Only||Retrospective|||||||
1338990|NCT03088423|||Case-Only||Retrospective|||||||
1338991|NCT03088410|Randomized|Parallel Assignment||Prevention||Double|Single blind - one party, either the investigator or participant, is unaware of the intervention assignment.||t||t|
1338992|NCT03088397|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1338993|NCT03088384|||Case-Only||Prospective|||||||
1338994|NCT03088371|Randomized|Crossover Assignment||Other||Double|||t|||t
1338995|NCT03088358|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1338996|NCT03088345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1338997|NCT03088332||Single Group Assignment||Treatment||None (Open Label)||||||
1338998|NCT03088319|||Cohort||Prospective|||||||
1338999|NCT03088306|Randomized|Parallel Assignment||Treatment||Double||||t||t
1339000|NCT03088293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339001|NCT03088280|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339002|NCT03088267|Randomized|Crossover Assignment||Treatment||Double|placebo-controlled|This is a randomized, double-blind, two treatment, two sequence, placebo-controlled crossover study|t||t|
1339003|NCT03088254|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1339004|NCT03088241|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter (2-12 centers), parallel-group (1:1 allocation), open-label, superiority, prospective randomized clinical study||||
1339005|NCT03088228|||Case-Control||Other|||||||
1339006|NCT03088215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339007|NCT03088202|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|No masking, the randomization applies to institutions, not patients|||||
1339008|NCT03088189|||Case-Control||Prospective|||||||
1339009|NCT03088176||Single Group Assignment||Treatment||None (Open Label)|No masking|Phase 1b single arm single dose level||||
1339010|NCT03088163||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1339011|NCT03088150|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339012|NCT03088137|Randomized|Parallel Assignment||Treatment||Single||||||t
1339013|NCT03088124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339014|NCT03088111||Single Group Assignment||Treatment||None (Open Label)||Open label||||
1339015|NCT03088098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339016|NCT03088085|Randomized|Parallel Assignment||Treatment||Single||||||t
1339017|NCT03088072||Single Group Assignment||Treatment||None (Open Label)||||||
1339018|NCT03088059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339019|NCT03088046||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339020|NCT03088033|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1339021|NCT03088020|||Cohort||Prospective|||||||
1339022|NCT03088007|||Other||Cross-Sectional|||||||
1339023|NCT03087994|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339024|NCT03087981|||Case-Only||Retrospective|||||||
1339025|NCT03087968|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1339026|NCT03087955||Single Group Assignment||Treatment||None (Open Label)||||||
1339027|NCT03087942||Parallel Assignment||Treatment||None (Open Label)||||||
1339028|NCT03087929|||Case-Only||Prospective|||||||
1339029|NCT03087903||Single Group Assignment||Treatment||None (Open Label)||||||
1339030|NCT03087890|Randomized|Parallel Assignment||Prevention||Quadruple|Patients in one study arm will receive 2 tablets daily of Cotrimoxazole (trimethoprim 80mg + sulfamethoxazole 400mg), these tablets are purchased locally in Tanzania, and are the same as used for pneumocystis preventive therapy under the National AIDS control programme. Participants in arm 2 will receive 2 placebo tablets daily. These tablets have been manufactured by Kragero Tablettproduksjon AS, Norway, and care has been taken to make them look as similar as possible to the locally purchased cotrimoxazole tablets from Tanzania. Neither study participants, care providers, investigators or outcome assessors will know which patients receive cotrimoxazole or placebo|Patients with newly diagnosed hiv-1 infection and good immunological status defined as CD4 counts of >350 pr microliter, will be randomised to receive cotrimoxazole (160mg/800mg) daily or placebo for 48 weeks. Rectal and nasal swabs will be collected on day 0, 14, week 24 and week 48. The swabs will be analysed for the presence of bacterial species with focus on certain multidrug-resistant bacteria such as ESBL (extended spectrum beta-lactamase)-producing Gram negative bacteria, MRSA (methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant enterococci). Patients will also be monitored closely on monthly visits to assess for any adverse events.|t|t|t|t
1339031|NCT03087877||Single Group Assignment||Other||None (Open Label)|The system will be blinded to the user, i.e. no glucose values will be displayed to the subject during the study duration.|||||
1339032|NCT03087864||Single Group Assignment||Treatment||None (Open Label)||||||
1339037|NCT03087799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339038|NCT03087786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339039|NCT03087773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339040|NCT03087760||Single Group Assignment||Treatment||||||||
1339041|NCT03087747|||Cohort||Prospective|||||||
1339042|NCT03087734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339043|NCT03087721|Randomized|Parallel Assignment||Treatment||Single||||||t
1339044|NCT03087708|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1339045|NCT03087695|||Cohort||Prospective|||||||
1339046|NCT03087682|||Case-Only||Retrospective|||||||
1339047|NCT03087669||Single Group Assignment||Treatment||None (Open Label)||"LVAD will have a setting of 4800 rounds per minute (RPM). Hemodynamic, echocardiographic and cerebral blood flow measurements will be performed: CO, PCWP, CVP, PAP, MAP, Peripheral and central hemoglobine oxygen saturation (SaO2 and SvO2), Heart Rate (HR), RV outflow tract Velocity Time Integral (RVOT VTI), RV and LV diameter, VTI of LVAD outflow. CBFV of right and left medial cerebral artery (RMCA and LMCA)~The above mentioned measurements will be repeated with LVAD settings of 5200 RPM, 5600 RPM, and 6000 RPM.~With the LVAD fixed to an optimized setting detected by the previous interventions, the blood pressure will be adjusted to MAP 60 mmHg. The above mentioned measurements will be repeated.~Using Noradrenaline the MAP will be adjusted to 70mmHg, 80 mmHg and 90 mmHg. At steady state for each level of MAP with a fixed LVAD flow, all the above mentioned measurements will be repeatedly performed."||||
1339048|NCT03087656|Randomized|Parallel Assignment||Treatment||Double|subjects to be randomized into two arms: antibiotic arm and no antibiotic arm||t||t|
1339049|NCT03087643|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1339050|NCT03087630|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339051|NCT03087617|Randomized|Factorial Assignment||Other||Single|University of Minnesota Office of Measurements Services will administer follow up calls to assess outcomes. Callers will be blinded to the arm to which the patients were assigned.|||||t
1339052|NCT03087604|Randomized|Parallel Assignment||Supportive Care||Double|As the patient will be sedated during epidural catheter placement, they will be blinded to their treatment arm. The investigator that determines if the epidural was successful placed will also be blinded to the patient's treatment arm.||t|||t
1339053|NCT03087591||Single Group Assignment||Treatment||None (Open Label)||||||
1339054|NCT03087578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339055|NCT03087565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339056|NCT03087552|||Cohort||Prospective|||||||
1339057|NCT03087539|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1339058|NCT03087526||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339059|NCT03087513|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1339060|NCT03087500|||Case-Control||Prospective|||||||
1339061|NCT03087487|||Cohort||Retrospective|||||||
1339062|NCT03087474|||Cohort||Retrospective|||||||
1339063|NCT03087461|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1339064|NCT03087448||Single Group Assignment||Treatment||None (Open Label)||||||
1339065|NCT03087435|||Other||Cross-Sectional|||||||
1339066|NCT03087422|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339067|NCT03087409|||Cohort||Retrospective|||||||
1339068|NCT03087396|||Cohort||Other|||||||
1339069|NCT03087383|||Cohort||Other|||||||
1339070|NCT03087370|||Cohort||Other|||||||
1339071|NCT03087357|||Cohort||Prospective|||||||
1339072|NCT03087344||Single Group Assignment||Diagnostic||None (Open Label)|All the above, the patient, provider and investigator and outcome assessor will not know the result of the biopsy to know if the participant does or does not have cirrhosis at the time of the study|Cross sectional diagnostic study of Chronic liver disease patients who have had a liver stiffness measurement performed that is discordant with clinical impression either clinically the patient appears to have cirrhosis but liver stiffness measurement is less than 10 kPa or clinically there is no evidence of cirrhosis but there liver stiffness measurement is more than 15 kPa or the patients liver stiffness measurement is in the grey zone which means patients' liver stiffness measurement is between 10 and 15 kPa to investigate the utility of postprandial postprandial liver and spleen stiffness measurements in the noninvasive diagnosis of cirrhosis||||
1339073|NCT03087331||Single Group Assignment||Health Services Research||None (Open Label)||||||
1339074|NCT03087318|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)|open, proof of concept study in overweight or moderate obese OSA patients,|"Prospective, open, proof of concept study in overweight or moderate obese OSA patients, comparing 3 different programs of sport prescription: patient's referred to a rehabilitation medical center, to a private sport club or to a sport association."||||
1339075|NCT03087305|||Cohort||Prospective|||||||
1339076|NCT03087292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339077|NCT03087279|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339078|NCT03087266|Randomized|Parallel Assignment||Treatment||Double||single-centre randomized controlled clinical trial with a 3- month follow-up|||t|t
1339079|NCT03087253|||Cohort||Prospective|||||||
1339080|NCT03087240|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1339081|NCT03087227|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1339082|NCT03087214|||Cohort||Prospective|||||||
1339083|NCT03087201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339084|NCT03087188|||Case-Only||Prospective|||||||
1339085|NCT03087175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339086|NCT03087162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339087|NCT03087149|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339088|NCT03087136|||Cohort||Prospective|||||||
1339145|NCT03086395||Single Group Assignment||Treatment||None (Open Label)||||||
1339146|NCT03086382|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339147|NCT03086369|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339089|NCT03087123|Randomized|Sequential Assignment||Other||None (Open Label)||In accordance with a single case design approach, where each subject acts as his/her own control, families will be randomized to a 2, 4, or 6-week baseline period before being administered the P-Mobile app based intervention. All families will receive the same P-Mobile intervention following the baseline period.||||
1339090|NCT03087110||Single Group Assignment||Treatment||None (Open Label)||||||
1339091|NCT03087097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339092|NCT03087084||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1339093|NCT03087071|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339094|NCT03087058|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339095|NCT03087045|||Cohort||Prospective|||||||
1339096|NCT03087032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339097|NCT03087019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339098|NCT03087006|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1339099|NCT03086993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339100|NCT03086980|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1339101|NCT03086967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339102|NCT03086954||Single Group Assignment||Treatment||None (Open Label)||||||
1339103|NCT03086941|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1339104|NCT03086928|Randomized|Parallel Assignment||Treatment||Double|double blinded||t|||t
1339105|NCT03086915|||Cohort||Retrospective|||||||
1339106|NCT03086902|Randomized|Parallel Assignment||Treatment||None (Open Label)||Group sample sizes of 44 in Group 1 and 44 in Group 2 achieve 80% power to detect a difference between the group proportions of -0.2000. The proportion in Group 1 (the treatment group) is assumed to be 0.2500 under the null hypothesis and 0.0500 under the alternative hypothesis. The proportion in Group 2 (the control group) is 0.2500. The test statistic used is the two-sided Z test with pooled variance. The significance level of the test was targeted at 0.0500. The significance level actually achieved by this design is 0.0531.||||
1339107|NCT03086889|Randomized|Parallel Assignment||Treatment||Single||||||t
1339108|NCT03086876|Randomized|Parallel Assignment||Treatment||Single||||||t
1339109|NCT03086863|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1339110|NCT03086850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339111|NCT03086837|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339112|NCT03086824||Single Group Assignment||Treatment||None (Open Label)||||||
1339113|NCT03086811|Non-Randomized|Parallel Assignment||Prevention||Single|Mealtime interactions by videotaped home setting feeding were evaluated using the Chatoor feeding scale by blinded to group viewers.|Intervention group got 4 sequential weekly training meetings, in small workshop groups setting, by a highly experience pediatric dietitian and social worker. The program covered nutritional aspects, as well as feeding and parenting topics. Training took place when infants were 4-6 months old. Thereafter, internet-based support continued until infants reached 12 months. The control group received customary support via municipal mother-child health clinics. Mealtime interactions by videotaped home setting feeding were documented at 12-13 months.||||t
1339114|NCT03086798|Randomized|Parallel Assignment||Treatment||Single||||||t
1339115|NCT03086785||Single Group Assignment||Treatment||None (Open Label)||||||
1339116|NCT03086772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339117|NCT03086759|Randomized|Parallel Assignment||Treatment||Single||||||t
1339118|NCT03086746|||Cohort||Prospective|||||||
1339119|NCT03086733||Single Group Assignment||Treatment||None (Open Label)||single center, open label, single arm Phase II study of a pre-operative window of metformin treatment in stages I - IIIA NSCLC||||
1339120|NCT03086720|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t|||t
1339121|NCT03086707|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339122|NCT03086694|||Case-Control||Prospective|||||||
1339123|NCT03086681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339124|NCT03086668|Randomized|Parallel Assignment||Other||Single||||||t
1339125|NCT03086655|Randomized|Parallel Assignment||Other||Single|||t|||
1339126|NCT03086642||Sequential Assignment||Treatment||None (Open Label)||||||
1339127|NCT03086629|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339128|NCT03086616||Single Group Assignment||Treatment||None (Open Label)||||||
1339129|NCT03086603|||Cohort||Prospective|||||||
1339130|NCT03086590|||Other||Cross-Sectional|||||||
1339131|NCT03086577|||Other||Cross-Sectional|||||||
1339132|NCT03086564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339133|NCT03086551|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1339134|NCT03086538||Single Group Assignment||Treatment||None (Open Label)||Pemetrexed 500 mg/m2 IV Q 3 weeks Tarceva 100mg once daily, continous||||
1339135|NCT03086525|||Cohort||Prospective|||||||
1339136|NCT03086512|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to one of two groups. Group I consists of 45 patients receiving a subtalar fusion with fully threaded screws (Acutrak 2® - 7.5). Group II consists of 45 patients receiving a subtalar fusion with partially threaded screws (Synthes® 7.3 Cannulated Screw).||||
1339137|NCT03086499|||Case-Only||Retrospective|||||||
1339138|NCT03086486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339139|NCT03086473|Randomized|Parallel Assignment||Prevention||Triple|The participant and participant's parents, medical care providers, and investigators will remain masked to the randomization.|Each participant is assigned to one of two arms of the study.|t|t|t|
1339140|NCT03086460|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1339141|NCT03086447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339142|NCT03086434|Randomized|Parallel Assignment||Prevention||Single|||t|||
1339143|NCT03086421|||Case-Control||Prospective|||||||
1339144|NCT03086408|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1339148|NCT03086356||Single Group Assignment||Treatment||None (Open Label)||||||
1339149|NCT03086343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339150|NCT03086330|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339151|NCT03086317|Randomized|Parallel Assignment||Treatment||Single|"Pre- and post-treatment computed tomography angiography (CTA) will be compared by independent radiologists who are blinded to the type treatment received.~Pre- and post-treatment echocardiograms will be interpreted by independent cardiologists who are blinded to the type of treatment received."|Participants will be randomized to receive one of two treatments for acute, submassive pulmonary embolism.||||t
1339152|NCT03086304|Randomized|Parallel Assignment||Treatment||Double|Randomised Controlled Trial||||t|t
1339153|NCT03086291||Single Group Assignment||Treatment||None (Open Label)||Simvastatin 5-10mg/kg bid for 7 days and 14 days off treatment for 21 days||||
1339154|NCT03086278||Sequential Assignment||Screening||None (Open Label)||||||
1339155|NCT03086265|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1339156|NCT03086252||Single Group Assignment||Supportive Care||None (Open Label)||||||
1339157|NCT03086239|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339158|NCT03086226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339159|NCT03086213|Randomized|Parallel Assignment||Treatment||Single||||||t
1339160|NCT03086200|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339161|NCT03086187||Single Group Assignment||Basic Science||None (Open Label)||||||
1339162|NCT03086174||Single Group Assignment||Treatment||None (Open Label)||||||
1339163|NCT03086161|Randomized|Parallel Assignment||Prevention||Single|Care providers delivering usual prenatal care are unaware of condition assignment.|||t||
1339164|NCT03086148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339165|NCT03086135||Single Group Assignment||Treatment||None (Open Label)||||||
1339166|NCT03086122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339167|NCT03086109|||Ecologic or Community||Cross-Sectional|||||||
1339168|NCT03086096|||Case-Only||Prospective|||||||
1339169|NCT03086083|Randomized|Parallel Assignment||Health Services Research||Double|"All participants was invited to one session of brief Psychotherapy with a new model.~To the outcome assessor was said to study if was significant difference between those data from two groups α e β."|A randomized, parallel, before-after, blind study was performed. Thirty nine subjects were randomly distributed to two groups: one session of EMDR psychotherapy standard and other with EMDR standard protocol without its typical brain bilateral stimulation. The results of the Beck scales for anxiety, depression and hopelessness and the impact of events test were compared between groups.|t|||t
1339170|NCT03086070|Randomized|Parallel Assignment||Treatment||Quadruple||randomized, double blind, placebo controlled trial|t|t|t|t
1339171|NCT03086057|Randomized|Sequential Assignment||Prevention||Single||||||t
1339172|NCT03086044|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339173|NCT03086031|Randomized|Parallel Assignment||Health Services Research||Double|Due to the nature of the study, it is not possible to blind neither the participants nor the rehabilitation team, but they will be asked not to disclose any details about the allocation, or the content of the VR. The two independent research assistants will be trained to administer the assessments and will be blinded to the allocation when entering data into the database. The researchers and the statistician performing the data analysis are blind to the treatment arm in which the participants are allocated. The rehabilitation team and the research assistants will only be involved in the data collection and will therefore not participate in the data analyses.|In order to avoid confounding between the VR intervention and the control group due to random probability, the number of cases and controls within each of the four municipalities is fixed to be the same (+1/-1). Due to the prospective nature of the inclusion, which practically means that the number of patients included within each municipality is not a priori known, the randomization is performed by randomly assigning the first patient within each municipality to either the VR intervention or the conventional VR program. The following patient (within each municipality) is then assigned consecutive to the other group and so forth. This randomization scheme ensures equal distribution of cases and controls both within each municipality as well as in time avoiding confounding by these two factors.|||t|t
1339174|NCT03086018||Single Group Assignment||Treatment||None (Open Label)|The hardware will be obviously different from the control devices and impossible to blind.|A single group, controlled test design will be used. There are various aspects of testing including lab and field tests.||||
1339175|NCT03086005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339176|NCT03085992||Single Group Assignment||Treatment||None (Open Label)||||||
1339177|NCT03085979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339178|NCT03085966||Single Group Assignment||Treatment||None (Open Label)||||||
1339179|NCT03085953|Randomized|Parallel Assignment||Other||Double|||t||t|
1339180|NCT03085940|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339181|NCT03085927|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339182|NCT03085914|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339183|NCT03085901|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339184|NCT03085888|||Other||Prospective|||||||
1339185|NCT03085875|||Ecologic or Community||Cross-Sectional|||||||
1339186|NCT03085862|||Other||Prospective|||||||
1339187|NCT03085849||Single Group Assignment||Treatment||None (Open Label)||||||
1339188|NCT03085836|Non-Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1339189|NCT03085823|||Cohort||Prospective|||||||
1339190|NCT03085810||Single Group Assignment||Treatment||None (Open Label)||||||
1339191|NCT03085797|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1339192|NCT03085784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339193|NCT03085771|Randomized|Crossover Assignment||Treatment||Quadruple|This is a double-blind study.|This is a randomised, double-blind, placebo-controlled, cross-over, single center study of patients with diabetes mellitus type 1 without chronic complications.|t|t|t|t
1339291|NCT03084497|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1339194|NCT03085758|Randomized|Parallel Assignment||Treatment||Double||Double Blind, Placebo-Controlled, Randomized, Multicenter Proof of Concept and Dose-Finding Phase II Clinical Trial|t||t|
1339195|NCT03085745||Single Group Assignment||Basic Science||None (Open Label)||||||
1339196|NCT03085732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339197|NCT03085719|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339198|NCT03085706||Single Group Assignment||Treatment||None (Open Label)||14 patients conducted at the First Affiliated Hospital of Dalian Medical University, China were eligible if they had definite or probable sporadic amyotrophic lateral sclerosis (ALS).||||
1339199|NCT03085693|||Case-Only||Prospective|||||||
1339200|NCT03085680|Randomized|Parallel Assignment||Prevention||Double|Double-blinded|Randomized placebo-controlled design.|t||t|
1339201|NCT03085667|||Case-Only||Prospective|||||||
1339202|NCT03085654|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1339203|NCT03085641||Single Group Assignment||Treatment||None (Open Label)||prospective one armed uncontrolled intervention pilot study||||
1339204|NCT03085628|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1339205|NCT03085615|Randomized|Parallel Assignment||Supportive Care||Single|Only our lab technicians will be truly blinding to group allocation.|Subjects will be randomized to receive either 25-30 kcals/kg or 12-14 kcals/kg. They will be followed for a maximum of 7 days or until ICU discharge. Blood draws will occur twice daily.||||t
1339206|NCT03085602|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339207|NCT03085589|||Other||Cross-Sectional|||||||
1339208|NCT03085576|||Cohort||Prospective|||||||
1339209|NCT03085563|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339210|NCT03085550|Randomized|Parallel Assignment||Treatment||Single||||||t
1339211|NCT03085537|||Cohort||Prospective|||||||
1339212|NCT03085524|||Case-Only||Prospective|||||||
1339213|NCT03085511|Randomized|Crossover Assignment||Treatment||None (Open Label)||Within subjects comparison will be performed. Subjects will be assigned to either group A (EB first then CB) or group B (CB first then EB) for a week and then reverse to the opposite breakfast the next week||||
1339214|NCT03085498|||Cohort||Cross-Sectional|||||||
1339215|NCT03085485|Randomized|Parallel Assignment||Treatment||Triple|double-blind|The design is a pilot, randomized (3:1, active:placebo), double-blind, placebo-controlled study|t||t|t
1339216|NCT03085472|||Cohort||Prospective|||||||
1339217|NCT03085459|||Cohort||Retrospective|||||||
1339218|NCT03085446|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339219|NCT03085433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339220|NCT03085420|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1339221|NCT03085407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339222|NCT03085394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339223|NCT03085381|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1339224|NCT03085368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339225|NCT03085355|Randomized|Parallel Assignment||Treatment||Single||||||t
1339226|NCT03085342||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339227|NCT03085329|Randomized|Parallel Assignment||Treatment||None (Open Label)|The nature of this comparative study makes masking device assignment impractical. The objectivity of the outcome assessment will rely upon adherence to formally defined criteria for device support failure.|With written informed consent from the mother or parents, infants born at less than 30 weeks gestation and who are capable of breathing spontaneously within the first 72 hours postnatal, will be supported by bubble nasal continuous positive airway pressure (Bn-CPAP), randomized to the standard device from Fisher & Paykel or to Seattle-PAP.||||
1339228|NCT03085316||Single Group Assignment||Treatment||None (Open Label)||All patients who meet eligibility will undergo device implantation surgery and follow up per protocol.||||
1339229|NCT03085303|Randomized|Parallel Assignment||Treatment||Triple|Patients are blinded by wearing tinted glasses for eye protection which disenable distinction of different wave lengths of light. Medical doctors will examine patients in other rooms than those equipped with the investigational medical devices. These examiners are blinded and are therefore not involved in the preparation and process of the irradiation.||t||t|t
1339230|NCT03085290|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1339231|NCT03085277|Randomized|Parallel Assignment||Supportive Care||Double||When a preterm infant is delivered at these hospitals or transferred from other hospitals on the day of birth, responsible neonatologists/PIs/co-PIs will evaluate the infant for its eligibility. If the infant fulfills the recruitment criteria, parent(s) are informed and explained about the study and asked for permission to recruit their babies. After confirmed consent, the infant will be, per hospital, randomized to two groups in a 1:1 ratio. Infants should be recruited and randomized as soon as possible after birth and no later than 48 h. The first supplemental enteral feeding (PF or BC) can be given as soon as the infants are randomized. Randomization will be stratified by birth weight < 1000 g, birth weight ≥ 1000 g, and randomly permuted blocks of size 4 and 6 will be used. A random sequence list will be generated by computer software for each hospital and a corresponding sequence number can only be checked to see allocation after informed consent is given and the baby is enrolled.|t|||t
1339232|NCT03085264|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Controlled Trial||||
1339233|NCT03085251||Single Group Assignment||Other||None (Open Label)||||||
1339234|NCT03085238||Single Group Assignment||Treatment||None (Open Label)||Prospective, multi-center, non-blinded, single-arm study||||
1339235|NCT03085225||Single Group Assignment||Treatment||None (Open Label)|Open Label|This is a multicenter, prospective open-labeled phase Ib trial based on a dose escalation study design (3+3 traditional design) assessing three dose levels of trabectedin when prescribed in combination with durvalumab followed by two expansion cohorts (Soft-tissue sarcomas and ovarian carcinomas) once the MTD is established||||
1339236|NCT03085212|Randomized|Parallel Assignment||Treatment||Single|||||t|
1339237|NCT03085199||Single Group Assignment||Treatment||None (Open Label)||||||
1339238|NCT03085186||||||||||||
1339344|NCT03083808||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1339239|NCT03085173||Single Group Assignment||Treatment||None (Open Label)||"A Phase I Trial of CD19-Targeted EGFRt/19-28z/4-1BBL Armored Chimeric Antigen Receptor (CAR) Modified T Cells in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)"||||
1339240|NCT03085160|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339241|NCT03085147||Single Group Assignment||Diagnostic||None (Open Label)||This is an open label, investigator initiated single arm phase I/II study. The concentration for imaging OSCC is defined in Phase I. Phase II will then use this concentration to obtain preliminary data on the sensivity of PARPi-FL to detect and delinate OSCC.||||
1339242|NCT03085134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339243|NCT03085121|Randomized|Parallel Assignment||Treatment||Double||||t||t
1339244|NCT03085108|||Cohort||Cross-Sectional|||||||
1339245|NCT03085095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339246|NCT03085082|||Other||Prospective|||||||
1339247|NCT03085069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339248|NCT03085056||Single Group Assignment||Treatment||None (Open Label)||This is a 12 patient pilot study that will evaluate the combination of the MEK inhibitor trametinib with paclitaxel in anaplastic thyroid cancer.||||
1339249|NCT03085043||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339250|NCT03085030|Randomized|Parallel Assignment||Treatment||Quadruple|Both the antioxidant and the placebo will be put in sealed envelops with a number on it. the number denotes its order in the randomization process. The investigator, care providers and the outcome assessors will not know the allocated group of the participants. The bio-statistician will prepare the table of random numbers. the pharmacist will prepare the sealed envelopes according to the table of randomization. Independent nurse will bring the sealed envelope of the participant from the pharmacy without knowing whether the envelope contains drug or the placebo.|"The first group will take antioxidant drug orally once daily for one month before IVF/ICSI cycle.~The second group will take placebo with a same regimen as the antioxidant group"|t|t|t|t
1339251|NCT03085017|Randomized|Parallel Assignment||Other||Single|||t|||
1339252|NCT03085004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339253|NCT03084991|||Case-Only||Prospective|||||||
1339254|NCT03084978|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1339255|NCT03084965|||Other||Retrospective|||||||
1339256|NCT03084952|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339257|NCT03084939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339258|NCT03084926||Single Group Assignment||Treatment||None (Open Label)||||||
1339259|NCT03084913|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1339260|NCT03084900|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Intervention Arm 1 versus standard care.||||
1339261|NCT03084887|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339262|NCT03084874|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1339263|NCT03084861|Randomized|Parallel Assignment||Treatment||None (Open Label)||open label||||
1339264|NCT03084848|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339265|NCT03084835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339266|NCT03084822||Single Group Assignment||Prevention||None (Open Label)||||||
1339267|NCT03084809|Randomized|Parallel Assignment||Treatment||None (Open Label)||Group 1: chemotherapy (5-Fluorouridine, leucovorin and oxaliplatin [FOLFOX4]) combined with cytokine-induced killer cells (CIK) Group 2: chemotherapy (5-Fluorouridine, leucovorin and oxaliplatin [FOLFOX4])||||
1339268|NCT03084796|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1339269|NCT03084783|Randomized|Parallel Assignment||Treatment||Single||||||t
1339270|NCT03084770|||Cohort||Prospective|||||||
1339271|NCT03084757||Single Group Assignment||Screening||None (Open Label)||||||
1339272|NCT03084744|Randomized|Parallel Assignment||Treatment||Single|Outcome assessors of the primary outcome will be blinded to treatment assignments.|Participants will be randomly allocated into two groups using a web-based central allocation system. This system will confirm allocation concealment and random sequence generation.||||t
1339273|NCT03084731|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1339274|NCT03084718|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1339275|NCT03084705|Randomized|Parallel Assignment||Treatment||Single||||||t
1339276|NCT03084692||Single Group Assignment||Supportive Care||None (Open Label)||A single group before and after intervention study design will be used for this pilot feasibility trial.||||
1339277|NCT03084679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339278|NCT03084666|Randomized|Parallel Assignment||Prevention||Single||In this study, patients undergoing live donor kidney transplantation will be allocated to the control group or remote ischemic preconditioning group (RIPC). RIPC is the utilization of short periods of ischemia to provide protection of the myocardium or other organ (i.e. kidney) from a subsequent ischemic event.|t|||
1339279|NCT03084653|||Other||Other|||||||
1339280|NCT03084640|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339281|NCT03084627|Randomized|Parallel Assignment||Supportive Care||Single|volunteers (single masking)||t|||
1339282|NCT03084614|||Cohort||Prospective|||||||
1339283|NCT03084601|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1339284|NCT03084588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339285|NCT03084575|Randomized|Parallel Assignment||Supportive Care||Single|assessment will be done by junior stuff who is blind to the technique of intervention|randomization was done using a computer-generated random numbers with proper concealment in opaque sealed envelopes .||||t
1339286|NCT03084562|||Cohort||Prospective|||||||
1339287|NCT03084549|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339288|NCT03084536|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1339289|NCT03084523|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1339290|NCT03084510||Single Group Assignment||Treatment||None (Open Label)||||||
1339385|NCT03083275|Randomized|Parallel Assignment||Prevention||||||||
1339292|NCT03084484|Randomized|Parallel Assignment||Prevention||Triple||Single-centre randomized, parallel design, clinical trial with a 5-month follow||t|t|t
1339293|NCT03084471|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339294|NCT03084458|Randomized|Parallel Assignment||Other||None (Open Label)||A randomized, between subjects design will allow for comparisons between the experimental and control groups.||||
1339295|NCT03084445|||Cohort||Cross-Sectional|||||||
1339296|NCT03084432|||Case-Control||Prospective|||||||
1339297|NCT03084419||Single Group Assignment||Treatment||None (Open Label)||"The investigators will perform a small clinical trial to assess the feasibility of performing a larger randomised controlled trial.~Thirty participants with RA-ILD will be treated with abatacept infusions, which will be given fortnightly for the first 4 weeks, then every 4 weeks for a total of 20 weeks.~Participants will sign informed consent at visit 1 (screening visit). There is then a 28 day window before treatment starts at visit 2 (baseline). Each participants participation in the trial is estimated to last 28 weeks from visit 1."||||
1339298|NCT03084406|Randomized|Parallel Assignment||Other||None (Open Label)||The pilot test will employ a Hybrid Type II study design to simultaneously test the clinical evidence-based program as well as the implementation strategy.||||
1339299|NCT03084393|||Case-Control||Prospective|||||||
1339300|NCT03084380||Single Group Assignment||Treatment||None (Open Label)||||||
1339301|NCT03084367|||Cohort||Prospective|||||||
1339302|NCT03084354|||Other||Cross-Sectional|||||||
1339303|NCT03084341|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1339304|NCT03084328|||Case-Control||Prospective|||||||
1339305|NCT03084315|Randomized|Parallel Assignment||Basic Science||Single|All participants are blinded to intervention group|Stratified (i.e., stratification by menthol status) blocked randomization|t|||
1339306|NCT03084302|||Cohort||Prospective|||||||
1339307|NCT03084289|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339308|NCT03084276|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1339309|NCT03084263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339310|NCT03084250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339311|NCT03084237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339312|NCT03084224|||Case-Only||Other|||||||
1339313|NCT03084211|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1339314|NCT03084198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339315|NCT03084185|||Cohort||Prospective|||||||
1339316|NCT03084172|||Cohort||Prospective|||||||
1339317|NCT03084159|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1339318|NCT03084146|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339319|NCT03084133|Randomized|Parallel Assignment||Prevention||None (Open Label)||"Intervention group means a screening information and education system in which the particularities of the index cases likely to require adaptation of the device will be collected, analyzed and taken into account.~Control group: provision of information on the need for screening colonoscopy in first-degree relatives of case-index patients by the practitioner taking charge of the case-index according to its usual practice and adapted to the level of understanding of Case-index."||||
1339320|NCT03084120|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||a prospective monocentric study, not therapeutic, and physiopathological||||
1339321|NCT03084107||Single Group Assignment||Other||None (Open Label)||||||
1339322|NCT03084094|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339323|NCT03084081|Randomized|Parallel Assignment||Treatment||Single||||||t
1339324|NCT03084068|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1339325|NCT03084055|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1339326|NCT03084042|||Case-Control||Cross-Sectional|||||||
1339327|NCT03084029|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1339328|NCT03084016|||Cohort||Prospective|||||||
1339329|NCT03084003|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1339330|NCT03083990|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339331|NCT03083977||Single Group Assignment||Treatment||None (Open Label)||||||
1339332|NCT03083964|Randomized|Parallel Assignment||Prevention||Double|The outcome assessor is blind to study assignment and investigators do not have access to randomization records.|The participants are randomized to one of two treatment arms, usual care or intervention.|||t|t
1339333|NCT03083951|Randomized|Parallel Assignment||Treatment||Single|The patient does not know the group to which it has been assigned.|Randomized controlled trial, single blind (the patient does not know the group to which it has been assigned) of patients undergoing laparoscopic sigmoid colon cancer resection. In all patients a lymphadenectomy with a high ligation of the Lower Mesenteric Artery will be performed. In patients in group 1A, lymphadenectomy will also include the lymphogranular tissue that accompanies the inferior mesenteric vein from its origin (complete mesocolon excision). In patients in group 1B, a conventional lymphadenectomy will be performed only from the origin of the inferior mesenteric artery without including the lymphatic tissue of the origin of the inferior mesenteric vein.|t|||
1339334|NCT03083938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339335|NCT03083925|||Case-Control||Prospective|||||||
1339336|NCT03083912|||Other||Prospective|||||||
1339337|NCT03083899|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1339338|NCT03083886|Randomized|Parallel Assignment||Treatment||Single|||||t|
1339339|NCT03083873||Single Group Assignment||Treatment||None (Open Label)||||||
1339340|NCT03083860|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||2 groups of 15-45 patients will be recruited in parallel and monitored for 4-6 weeks, than they will be followed for 4-6 weeks. They will receive feedback based on diary information and EEG.||||
1339341|NCT03083847|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339342|NCT03083834|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1339343|NCT03083821||Single Group Assignment||Treatment||None (Open Label)||||||
1339345|NCT03083795|Randomized|Parallel Assignment||Supportive Care||Single||"Participants randomized to the social interaction cohort will meet on a monthly basis for a two hour group session designed to build social connections. In addition, participants will be paired with another study participant in this group, and will be asked to meet on a monthly basis for a minimum of 45 minutes. All participants in the social support cohort will continue to receive best standard diabetes management.~Participants in the control group will be treated with standard diabetes care."||||t
1339346|NCT03083782|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Intervention Model: Crossover Assignment||||
1339347|NCT03083769|||Cohort||Other|||||||
1339348|NCT03083756|||Case-Only||Prospective|||||||
1339349|NCT03083743|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1339350|NCT03083730||Single Group Assignment||Basic Science||None (Open Label)||||||
1339351|NCT03083717|||Case-Control||Prospective|||||||
1339352|NCT03083704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339353|NCT03083691|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The treatment period is subdivided in Treatment Part A and B which differ between the two cohorts:~Cohort 1 (non-squamous NSCLC):~During Treatment Part A nivolumab 240 mg IV q2w as monotherapy is administered. At time of disease progression another re-biopsy is mandatory before initiation of combination therapy (Treatment Part B). Within Treatment Part B, nivolumab is given in a dose of 3 mg/kg q2w together with ipilimumab 1 mg/kg IV q6w.~2. Cohort 2 (SCLC): Within Treatment Part A, nivolumab 1 mg/kg q3w together with ipilimumab 3 mg/kg q3w for a total of four doses is administered. After the four combined doses have been administered, another re-biopsy is mandatory before initiation of Treatment Part B. In Treatment Part B, nivolumab 240 mg q2w monotherapy is administered until disease progression or unacceptable toxicity."||||
1339354|NCT03083678||Single Group Assignment||Treatment||None (Open Label)||||||
1339355|NCT03083665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339356|NCT03083652|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1339357|NCT03083639|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1339358|NCT03083626|||Case-Control||Cross-Sectional|||||||
1339359|NCT03083613||Single Group Assignment||Treatment||None (Open Label)||||||
1339360|NCT03083600|Randomized|Parallel Assignment||Prevention||Quadruple|Double-blind, computer-generated randomisation|56 participants randomised to receive: 5g, 10g, 15g Pea Protein Hydrolysate v placebo 5g, 10g, 15g v Rice Protein Hydrolysate v placebo|t|t|t|t
1339361|NCT03083587|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339362|NCT03083574||Single Group Assignment||Treatment||None (Open Label)||||||
1339363|NCT03083561|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1339364|NCT03083548|||Cohort||Prospective|||||||
1339365|NCT03083535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339366|NCT03083522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339367|NCT03083509|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339368|NCT03083496|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1339369|NCT03083483|Randomized|Parallel Assignment||Other||Double|For the tDCS portion of the protocol, the subject and investigator will be blinded to active vs sham. The configuration and order of FLS tasks will be known to both.|Subjects are randomized into SMA or bilateral M1 tDCS configurations. They are further randomized into active or sham tDCS.|t||t|
1339370|NCT03083470|Randomized|Sequential Assignment||Treatment||Triple||Phase 2, randomized, dose-rising, double-blind trial. Subjects will enroll in four dose-escalating cohorts of eight subjects each. Each cohort will be randomized to SOR007 or Ointment vehicle in a ratio of 3:1. Safety will be assessed in an ongoing manner and formal safety reviews will be conducted four times for each cohort: at Day 8, Day 15, Day 21, and Day 28 for the last subject enrolled in each cohort. The next dose level cohort will enroll upon a finding of safety and tolerability at the previous cohort's second safety review. Once the last cohort has completed the study, all available data, including safety, pharmacokinetics, and preliminary efficacy will be analyzed. The PK blood samples will be analyzed per cohort when the last subject of each cohort completes Day 28.|t|t|t|
1339371|NCT03083457|Randomized|Crossover Assignment||Treatment||Single||"Each patient will be randomized to receive or not scheduled recruiting maneuvers every hour. In each of the two groups, patients will receive mechanical ventilation with 3 different levels of PEEP in a sequential, randomized, cross-over manner: each period will last 40 minutes.~A randomization sequence will be produced by a dedicated software and sealed envelopes will be used to allocate patients to study treatments."|t|||
1339372|NCT03083444|||Cohort||Prospective|||||||
1339373|NCT03083431|Randomized|Parallel Assignment||Prevention||Quadruple|Double-blind Placebo-controlled||t|t|t|t
1339374|NCT03083418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339375|NCT03083405|||Cohort||Prospective|||||||
1339376|NCT03083392||Single Group Assignment||Treatment||None (Open Label)||||||
1339377|NCT03083379|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1339378|NCT03083366|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized non-blinded study of sacral neuromodulation plus standard neurogenic bladder care versus standard neurogenic bladder care in patients with spinal cord injury||||
1339379|NCT03083353|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1339380|NCT03083340||Single Group Assignment||Treatment||None (Open Label)||Deprexis consists of 10 content modules representing different psychotherapeutic approaches, plus one introductory and one summary module, each of which can be completed in 10 to 60 minutes, depending on the user's reading speed, interest, motivation, and individual path through the program (Meyer, et al., 2009).||||
1339381|NCT03083327|Randomized|Parallel Assignment||Prevention||Single|Assessment of bone marrow biopsy to determine transplant success will be undertaken independent of the knowledge of treatment assignment.|||||t
1339382|NCT03083314|Randomized|Parallel Assignment||Treatment||None (Open Label)||The proposed study is a 2-arm (1:1 allocation) prospective randomised trial. The control arm consists of patients randomized to ALND, the study arm is patients randomized to SAD.||||
1339383|NCT03083301|||Cohort||Retrospective|||||||
1339384|NCT03083288||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339388|NCT03083236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339389|NCT03083223|||Case-Only||Cross-Sectional|||||||
1339390|NCT03083210||Single Group Assignment||Treatment||None (Open Label)||Lanreotide, at a dose of 120mg subcutaneous injection every 28 days.||||
1339391|NCT03083197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339392|NCT03083184|Randomized|Single Group Assignment||Prevention||Single||||||t
1339393|NCT03083171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339394|NCT03083158|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339395|NCT03083145|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1339396|NCT03083132|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, placebo-controlled delayed start|t|t|t|t
1339397|NCT03083119|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1339398|NCT03083106||||||||||||
1339399|NCT03083093|||Case-Control||Other|||||||
1339400|NCT03083080||Single Group Assignment||Treatment||None (Open Label)||||||
1339401|NCT03083067|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339402|NCT03083054||Single Group Assignment||Treatment||None (Open Label)||||||
1339403|NCT03083041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339404|NCT03083028|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessor were masked to the treatment allocation of participants|Randomised Controlled Trial with an Observational Cohort||||t
1339405|NCT03083015|Randomized|Parallel Assignment||Treatment||Triple|For the allocation concealment mechanism, each of 66 papers (each paper was eight folded) numbered from 1 to 66 were, individually packed, in opaque envelopes. Each participant picked an envelope at the beginning of the second visit. The number in the envelope determined which procedure was to be performed for the patient. The partner was to decide the procedure for the operator according to that number.|participants are allocated at random to receive one of two interventions according to the research plan. In RCT the outcomes are measured, so it is considered a quantitative study . This trial conforms to the Consolidated Standard of Reporting Trials (CONSORT)statement.|t||t|t
1339406|NCT03083002|||Cohort||Prospective|||||||
1339407|NCT03082989|||Cohort||Prospective|||||||
1339408|NCT03082976|||Cohort||Prospective|||||||
1339409|NCT03082963||Single Group Assignment||Treatment||None (Open Label)||||||
1339410|NCT03082950|||Cohort||Cross-Sectional|||||||
1339411|NCT03082937||Single Group Assignment||Treatment||None (Open Label)||||||
1339412|NCT03082924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339413|NCT03082911|Randomized|Parallel Assignment||Screening||Single||||||t
1339414|NCT03082898|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1339415|NCT03082885|Randomized|Parallel Assignment||Treatment||Single|||||t|
1339416|NCT03082872|Randomized|Parallel Assignment||Treatment||Quadruple|Blinded|Patients with middle proximal fractures of fingers|t|t|t|t
1339417|NCT03082859|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1339418|NCT03082846||Single Group Assignment||Treatment||None (Open Label)||||||
1339419|NCT03082833||Single Group Assignment||Treatment||None (Open Label)||||||
1339420|NCT03082820|||Case-Control||Cross-Sectional|||||||
1339421|NCT03082807|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339422|NCT03082794|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339423|NCT03082781|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339424|NCT03082768||Single Group Assignment||Other||None (Open Label)||||||
1339425|NCT03082755|Randomized|Parallel Assignment||Treatment||Quadruple|The pharmacy, 40 Acres Pharmacy, will maintain records of group assignment. Sealed envelopes with each participant's assignment for a specific home will also be kept in a secure and locked location in each home that can be accessed only by the registered nurse in charge on each shift. The envelopes will be available in each home in the event that unmasking of assignment is needed during hours when 40 Acres Pharmacy is closed (nights, weekends, holidays). These sealed envelopes may be opened only by physician's order. Participants, their legally authorized representatives and families, participants' physicians, nursing home staff, investigators, and all study personnel will be masked to group assignment. Emergency unmasking of group assignment is expected to be rare. The Data Safety and Monitoring Board will develop guidelines for emergency unmasking.|The investigators plan to conduct a pilot, 8-week, double-blind, placebo-controlled randomized clinical trial of GEn versus placebo, in 136 nursing home residents with nighttime agitation, RLS, and moderate to severe Alzheimer's Disease. A placebo arm will allow for a thorough and systematic assessment of the safety of GEn in this specific patient population. A 2-month post-trial follow-up will assess whether RLS treatment is continued by providers and antipsychotics are reduced.|t|t|t|t
1339426|NCT03082742|Randomized|Parallel Assignment||Prevention||Single|||||t|
1339427|NCT03082729||Single Group Assignment||Treatment||None (Open Label)|Imaging data files will be sent to the central core of the National Institutes of Health (NIH) Imaging Lab for measuring the standardized uptake values (SUVs). The NIH central PET/CT readers will be blinded to time point of scan via Digital Imaging and Communication in Medicine (DICOM) file editing applied by the University of Pennsylvania.|||||
1339428|NCT03082716|Randomized|Parallel Assignment||Other||Triple|"Blinding :~Surgeons will know the type of cardioplegia in the OR while other assessor will be blinded ."|"Randomisation :~Computer generated randomisation into two groups based on cardioplegia solution .~if randomised to blood patient will receive blood cardioplegia, delivered by microplegia delivery system by adding potassium to the blood (K= 35 ml eq/L) . The initial dose will be 35ml/ kg, and subsequent doses 20-15 ml/kg given every 20 minutes at a Temperature of 10 - 15 °C, while maintaining a perfusion pressure of 100-125 mmHg.~if randomised to custodial patient will receive single dose of HTK custodiol cardioplegia. at temperature of 4-8°C and will be perfused for 6-8 minutes. Dose will start from 400 up to 1000 ml according to the child's body weight. Perfusion pressure will be kept at 70 - 80 mmHg until the heart is arrested."|t||t|t
1339429|NCT03082703|Randomized|Parallel Assignment||Treatment||Single||||t||
1339430|NCT03082690||Single Group Assignment||Other||None (Open Label)||||||
1339475|NCT03082105|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1339431|NCT03082677||Single Group Assignment||Treatment||None (Open Label)||This is a single arm phase 2 study to evaluate a post-transplant proteasome inhibitor, ixazomib, as prophylaxis against recurrent or late acute and chronic GVHD. Ixazomib will be initiated within days 100 to 150 post-transplant in patient's ≥ 18 years-old with either myeloid or lymphoid hematologic malignancy treated with a RI or NMA HSCT and will have received calcineurin inhibitor based drug (tacrolimus or cyclosporin) and methotrexate as part of their initial GVHD prophylaxis.||||
1339432|NCT03082664|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339433|NCT03082651|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339434|NCT03082638|||Case-Control||Prospective|||||||
1339435|NCT03082625|Randomized|Parallel Assignment||Treatment||Quadruple|Identical delivery systems and appearance of the product|Randomised placebo-controlled|t|t|t|t
1339436|NCT03082612|Randomized|Parallel Assignment||Other||None (Open Label)||Participant dyads (patient and family care giver) will be randomized to receive the intervention or usual care (control arm) for 3 weeks. After the Week 3 data collection, the control arm will receive intervention. Both groups will have follow up data collected at Week 6 and Week 12.||||
1339437|NCT03082599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339438|NCT03082586|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|open label|||||
1339439|NCT03082573|Randomized|Crossover Assignment||Treatment||None (Open Label)|Open Label|||||
1339440|NCT03082560|||Case-Only||Prospective|||||||
1339441|NCT03082547|||Case-Control||Cross-Sectional|||||||
1339442|NCT03082534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Open-label, non-randomized, multi-arm phase II trial of pembrolizumab combined with cetuximab for patients with recurrent/metastatic head and neck squamous cell carcinoma~Cohort 1 (PD-1/PD-L1 inhibitor-naïve, cetuximab-naïve): clinical efficacy defined as overall response rate.~Cohort 2 (PD-1/PD-L1 inhibitor-refractory, cetuximab-naïve): clinical efficacy defined as overall response rate.~Cohort 3 (PD-1/PD-L1 inhibitor-refractory, cetuximab-refractory): clinical efficacy defined as overall response rate.~Cohort 4 (cutaneous HNSCC): clinical efficacy defined as overall response rate."||||
1339443|NCT03082521|||Other||Prospective|||||||
1339444|NCT03082508|Randomized|Parallel Assignment||Treatment||Single||||||t
1339445|NCT03082495|Randomized|Parallel Assignment||Supportive Care||Single|The outcome assessor will be blinded to group assignment for the clinical outcomes including treatment toxicity, treatment completion, treatment response, and surgical complications.|||||t
1339446|NCT03082482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339447|NCT03082469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Inflammatory cytokine removal by Cyto Sorb treatment||||
1339448|NCT03082456||Single Group Assignment||Screening||None (Open Label)||||||
1339449|NCT03082443|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1339450|NCT03082430||Single Group Assignment||Treatment||None (Open Label)|study for knee osteoarthritis patients treated in the center|descriptive study||||
1339451|NCT03082417|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||Stepped Wedge Cluster randomized trial||||
1339452|NCT03082404|Randomized|Parallel Assignment||Treatment||Single||||||t
1339453|NCT03082391|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339454|NCT03082378|||Case-Crossover||Prospective|||||||
1339455|NCT03082365|||Ecologic or Community||Cross-Sectional|||||||
1339456|NCT03082352|Randomized|Crossover Assignment||Other||None (Open Label)|Open Label|||||
1339457|NCT03082339|||Cohort||Prospective|||||||
1339458|NCT03082326|||Other||Prospective|||||||
1339459|NCT03082313||Single Group Assignment||Treatment||None (Open Label)||||||
1339460|NCT03082300|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1339461|NCT03082287|||Case-Control||Cross-Sectional|||||||
1339462|NCT03082274|||Case-Only||Prospective|||||||
1339463|NCT03082261||Single Group Assignment||Treatment||None (Open Label)||Post market, international , multicenter, intervention, prospective, single-arm study.||||
1339464|NCT03082248|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1339465|NCT03082235|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1339466|NCT03082222|||Cohort||Prospective|||||||
1339467|NCT03082209|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339468|NCT03082196|Randomized|Parallel Assignment||Prevention||Quadruple|All study personnel except for designated personnel in the data center will be blinded to the participant treatment assignment. In order to maintain blinding, the caries scoring examinations will precede the application of test varnishes at baseline. The staff member applying these varnishes will not perform the caries scoring exams in order to eliminate examiner bias and ensure blinding to treatment assignment. Test drug and comparator are packaged identically.|Single-center, double-blind, controlled Phase 2 study with parallel groups of children.|t|t|t|t
1339469|NCT03082183||Single Group Assignment||Treatment||None (Open Label)||||||
1339470|NCT03082170|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||The investigators would appreciate the quality of swallowing of participants suffering from sleep apnea that had half a year ago or more robotic resection of tongue base or soft palate surgery. The investigators will use the SDQ self reported questionnaire and the FEES test as tools for assessing the participant's swallowing.||||
1339471|NCT03082157|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a community based, cluster randomized, parallel group longitudinal trial. Each faith-based organization that meets inclusion criteria, agrees to participate and sign the memorandum of agreement will be matched on congregation size and randomized to either: 1) the attention control comparison group or 2) the Mighty Men weight-loss intervention||||
1339472|NCT03082144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339473|NCT03082131|Randomized|Crossover Assignment||Basic Science||Double|Participants and investigators will be blinded to the type of product (i.e. RS wheat or Regular Wheat) the subjects are consuming during each arm of the study.|Randomized, cross-over design consisting of two 1-week dietary intervention periods as well as a 2-week washout period in between|t||t|
1339474|NCT03082118||Single Group Assignment||Treatment||None (Open Label)||All women enrolled are treated.||||
1339476|NCT03082092|Randomized|Parallel Assignment||Treatment||Quadruple|"Patients receiving elective unilateral primary total knee replacement in Queen Elizabeth Hospital during May 2017 to October 2017 will be assessed for eligibility according to the inclusion and exclusion criteria. 50 subjects will be recruited and randomized using computer into intervention group and placebo group by a nurse otherwise not involved in the trial. The randomization will be concealed in an opaque envelope.~On the day of operation, a surgeon otherwise not involved in the trial will prepare the methylprednisolone and saline (placebo). The envelope will be opened by the list anesthetist. The operating surgeons, anesthetists, assessors (physiotherapists) and the patients were all blinded to the allocation."|single-centre, double-blind, placebo-controlled randomized controlled trial|t|t|t|t
1339477|NCT03082079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339478|NCT03082066|||Cohort||Retrospective|||||||
1339479|NCT03082053|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||2 studies of single group in 1 protocol||||
1339480|NCT03082040|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1339481|NCT03082027|||Case-Control||Cross-Sectional|||||||
1339482|NCT03082014|Randomized|Crossover Assignment||Treatment||Single|Cerebrovascular reactivity measures will be assessed centrally by a blinded rater.|TREAT-SVDs is a multi-centre, multinational phase III b clinical trial with a three sequence crossover design. It will be carried out as a rater blinded trial which is also known as PROBE-design (prospective, randomised, open-label trial with blinded endpoint assessment).||||t
1339483|NCT03082001|Randomized|Parallel Assignment||Treatment||Triple||There were two study groups A and B. The enrolled infants were administered either sterile solution of 0.2 ml of 24% sucrose or 0.2 ml of 12% sucrose 2 min prior to the procedure. The procedure involved putting first cannula in the dorm of the right hand. A 24 G needle was inserted into the vein after asepsis 2 min after the neonate had been given the allocated solution. The process was divided into three phases, the pre procedure, intraprocedure and post procedure lasting for 4 minutes. Video recording on the face of the neonate was done using a fixed video camera. The NFCS was used to evaluate and score neonatal pain.It was scored at pre, intra and post procedure 30 sec, 1 min and 2 min of the procedure.|t|t|t|
1339484|NCT03081988|||Cohort||Prospective|||||||
1339485|NCT03081975|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1339486|NCT03081962|Randomized|Parallel Assignment||Prevention||Triple|The election of the intervention will be performed following a randomization model. Only the care provider will know the assigned group.||t||t|t
1339487|NCT03081949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339488|NCT03081936|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1339489|NCT03081923|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, randomized, parallel arm, phase 2 trial||||
1339490|NCT03081910||Single Group Assignment||Treatment||None (Open Label)||||||
1339491|NCT03081897|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339492|NCT03081884||Single Group Assignment||Diagnostic||None (Open Label)||All participants will have the same intervention||||
1339493|NCT03081871|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1339494|NCT03081858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1339495|NCT03081845|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1339496|NCT03081832|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339497|NCT03081819||Sequential Assignment||Other||None (Open Label)||||||
1339498|NCT03081806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339499|NCT03081793|||Cohort||Prospective|||||||
1339500|NCT03081780||Single Group Assignment||Treatment||None (Open Label)||||||
1339501|NCT03081767||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339502|NCT03081754|||Case-Only||Prospective|||||||
1339503|NCT03081741|||Cohort||Prospective|||||||
1339504|NCT03081728|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Two groups: 1- block + GA 2- GA with multimodal analgesia||||
1339505|NCT03081715||Single Group Assignment||Treatment||None (Open Label)|open-label|||||
1339506|NCT03081702||Single Group Assignment||Treatment||None (Open Label)||||||
1339507|NCT03081689||Single Group Assignment||Treatment||None (Open Label)||||||
1339508|NCT03081676|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1339509|NCT03081663|Randomized|Parallel Assignment||Treatment||Double|Participants will not be told which group they have been assigned to until they have reached the final follow-up visit for the study.|Participants will be randomized to undergo their surgery through either the quadriceps-sparing mid-vastus approach or the medial para-patellar approach and with or without a tourniquet. We will stratify based on which type of analgesia will be used post-surgery, either an adductor canal block or local infiltration.|t|||t
1339510|NCT03081650||Single Group Assignment||Treatment||None (Open Label)||The study will be conducted as an open label, non-randomized trial.||||
1339511|NCT03081637|||Cohort||Retrospective|||||||
1339512|NCT03081624|||Case-Control||Prospective|||||||
1339513|NCT03081611|Randomized|Parallel Assignment||Treatment||None (Open Label)|Not possible|Non Inferiority Randomized Control Trial||||
1339514|NCT03081598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339515|NCT03081585|||Cohort||Cross-Sectional|||||||
1339516|NCT03081572|||Case-Control||Cross-Sectional|||||||
1339517|NCT03081559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339518|NCT03081546|||Case-Control||Cross-Sectional|||||||
1339519|NCT03081533|Randomized|Parallel Assignment||Supportive Care||Single|The outcomes assessor will not be aware of the allocation of each subject in the Control Group or Group Intervention.|||||t
1339520|NCT03081520|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339521|NCT03081507|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Study participants will be randomized to an LHW-led small media intervention arm (SM-LHW) or a LHW-led patient navigation plus small media intervention arm (PN-LHW) upon determination of study eligibility and informed consent procedures.||||
1339580|NCT03080714|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1339522|NCT03081494||Single Group Assignment||Treatment||None (Open Label)||Phase 1b study, dose escalation (N=~12). One single arm: PDR001 in combination with regorafenib||||
1339523|NCT03081481||Single Group Assignment||Treatment||None (Open Label)||||||
1339524|NCT03081468|||Case-Only||Cross-Sectional|||||||
1339525|NCT03081455|||Cohort||Prospective|||||||
1339526|NCT03081442|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1339527|NCT03081429|||Cohort||Prospective|||||||
1339528|NCT03081416|Randomized|Parallel Assignment||Treatment||Single|Placebo controlled|Two arm-Randomized placebo controlled|t|||
1339529|NCT03081403|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339530|NCT03081390|Non-Randomized|Parallel Assignment||Other||None (Open Label)||There are four total groups of participants, stratified according to migraine status (yes/no) and obesity status (yes/no). All undergo the same experimental phenotyping procedures.||||
1339531|NCT03081364|||Other||Prospective|||||||
1339532|NCT03081351|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339533|NCT03081338|||Cohort||Prospective|||||||
1339534|NCT03081325||Single Group Assignment||Treatment||None (Open Label)||||||
1339535|NCT03081312|||Cohort||Cross-Sectional|||||||
1339536|NCT03081299|||Other||Prospective|||||||
1339537|NCT03081286|Randomized|Parallel Assignment||Treatment||Triple|During general anesthesia, patients are randomized to either fat grafting or sham grafting with only saline. All patients undergo the same liposuction. Participants are blinded, care providers postoperatively are blinded. The surgeon performing the procedure is not blinded. The outcome assessors 3 and 6 months postoperatively are blinded.||t|t||t
1339538|NCT03081273|||Cohort||Retrospective|||||||
1339539|NCT03081260|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339540|NCT03081247|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339541|NCT03081234|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1339542|NCT03081221|||Cohort||Cross-Sectional|||||||
1339543|NCT03081208|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind||t|t|t|t
1339544|NCT03081195|Randomized|Factorial Assignment||Treatment||None (Open Label)||Schools will be randomly assigned to 3 study conditions: 1) MFG-delivered by trained family peers; 2) MFG-delivered by community health workers; or, 3) Comparison: Mental health and school support materials (books, uniforms).||||
1339545|NCT03081169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339546|NCT03081156|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1339547|NCT03081143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339548|NCT03081130|||Cohort||Prospective|||||||
1339549|NCT03081117|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized double-blind placebo-controlled clinical trial|t|t|t|t
1339550|NCT03081104|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1339551|NCT03081091|Randomized|Parallel Assignment||Treatment||Triple|"Participants are blinded to the intervention. They will be provided with eye masks so that they cannot see which needles are used in their intervention. Moreover, the same type of equipment will be used with all the participants (although the guide tube to insert the needle is not necessary in true acupuncture).~Given the fact that the person who carries out the intervention is different than the one assessing its effects and the latter does not know which group the evaluated subjects belong to, as well as the fact that the person responsible for the statistics is a third person who ignores which of the two groups has received true acupuncture, this is a triple-blind study."||t||t|t
1339552|NCT03081078|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339553|NCT03081065|Randomized|Parallel Assignment||Prevention||Single||||t||
1339554|NCT03081052|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1339555|NCT03081039|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be randomized 1:1 to one of two treatment arms.||||
1339556|NCT03081026|||Cohort||Cross-Sectional|||||||
1339557|NCT03081013|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1339558|NCT03081000|||Case-Only||Cross-Sectional|||||||
1339559|NCT03080987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339560|NCT03080974||Single Group Assignment||Treatment||None (Open Label)||All patients will undergo irreversible electroporation and treatment with Nivolumab||||
1339561|NCT03080961||Single Group Assignment||Prevention||None (Open Label)|Vials with the sample will be coded. The assessor does not know the coding.|Trial participants take extra-genital swabs before and after application of the barrier cream.||||
1339562|NCT03080948|||Case-Control||Prospective|||||||
1339563|NCT03080935||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1339564|NCT03080922||Single Group Assignment||Treatment||None (Open Label)||||||
1339565|NCT03080909|Randomized|Crossover Assignment||Prevention||Quadruple|Double-blind|A double-blind, randomized crossover design with five arms including four experimental conditions and placebo|t|t|t|t
1339566|NCT03080896|Randomized|Crossover Assignment||Treatment||Single|||t|||
1339567|NCT03080883|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1339568|NCT03080870|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339569|NCT03080857||Single Group Assignment||Prevention||None (Open Label)||Cohort study to assess a computer simulated electronic platform||||
1339570|NCT03080844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339571|NCT03080831|Randomized|Parallel Assignment||Supportive Care||Quadruple|Study fluids blinded using opaque bags||t|t|t|t
1339572|NCT03080818|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1339573|NCT03080805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339574|NCT03080792||Single Group Assignment||Supportive Care||None (Open Label)||||||
1339575|NCT03080779|||Cohort||Prospective|||||||
1339576|NCT03080766||Single Group Assignment||Treatment||None (Open Label)||||||
1339577|NCT03080753||Single Group Assignment||Treatment||None (Open Label)||||||
1339578|NCT03080740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339579|NCT03080727|||Other||Other|||||||
1339581|NCT03080701|Randomized|Parallel Assignment||Screening||Single|The randomization sequence will be concealed to everyone except the study biostatistician.|||||t
1339582|NCT03080688|||Case-Only||Prospective|||||||
1339583|NCT03080675|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1339584|NCT03080662|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339585|NCT03080649|Randomized|Crossover Assignment||Treatment||Single|The outcome assessor have not met the patient before assessing the outcome. No information about which excavation method used is available.|prospective, single-blind, randomized and controlled investigation||||t
1339586|NCT03080636|Randomized|Crossover Assignment||Prevention||None (Open Label)||20 healthy adults, public servants (9W and 11M), randomly underwent three experimental sessions in early morning prior to their work routine: a circuit resistance session at 40% of 1RM, a treadmill exercise session at 60-70% of heart rate reserve and a resting control session.||||
1339587|NCT03080623|||Cohort||Prospective|||||||
1339588|NCT03080610|||Other||Other|||||||
1339589|NCT03080597||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1339590|NCT03080584||Single Group Assignment||Treatment||None (Open Label)||comparison of AMH and ovarian response before and after acupuncture||||
1339591|NCT03080571|Randomized|Parallel Assignment||Treatment||Single|PROBE design|test group :Stem cell plus standard care control group : standard care||||t
1339592|NCT03080558||Single Group Assignment||Treatment||None (Open Label)|open|||||
1339593|NCT03080545||Single Group Assignment||Treatment||None (Open Label)||||||
1339594|NCT03080532|||Other||Prospective|||||||
1339595|NCT03080519||Single Group Assignment||Treatment||None (Open Label)||Intervational Therapy||||
1339596|NCT03080506|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1339597|NCT03080493|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized placebo controlled trial, stratified block randomization based on prior vaginal parity (vaginal parity - yes or no). Goal of even distribution of prior vaginal parity between gabapentin and placebo groups as may impact osmotic dilator pain experience|t|t|t|t
1339598|NCT03080480||Single Group Assignment||Treatment||None (Open Label)||||||
1339599|NCT03080467|||Cohort||Prospective|||||||
1339600|NCT03080454|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1339601|NCT03080441|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339602|NCT03080428|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Patients will be identified prior to surgery based on biopsy results. During the post-operative multidisciplinary decision-making meeting, a first therapeutic decision to prescribe or not an adjuvant chemotherapy will be taken according to usual clinical and histopathological markers and official guidelines in use in the center. After the patient has signed the inform consent form, the surgical sample will be sent by the investigator site to a selected genomic platform according to the randomization result.||||
1339603|NCT03080415||Single Group Assignment||Treatment||None (Open Label)||All of the participants will be receiving combined therapy of sofosbuvir and daclatasvir for 12 weeks.||||
1339604|NCT03080402|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||24 female athletes (12 with high KAM; 12 with normal KAM) will be recruited into the intervention/ testing phase of this study. Female athletes with KAM > 25.25 Nm will be classified as high KAM and will receive 12 sessions of mechanically-driven perturbation training and female athletes with KAM < 25.25 Nm will be classified as normal KAM and only participate in baseline performance testing, followed 6 weeks later by another session of drop jump motion analysis and performance testing.||||
1339605|NCT03080389|||Cohort||Prospective|||||||
1339606|NCT03080376|Randomized|Parallel Assignment||Treatment||Double||||t||t
1339607|NCT03080363|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1339608|NCT03080350|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1339609|NCT03080337|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339610|NCT03080324|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1339611|NCT03080311||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1339612|NCT03080298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339613|NCT03080285|Randomized|Parallel Assignment||Treatment||Single||||||t
1339614|NCT03080272|||Cohort||Prospective|||||||
1339615|NCT03080259|Randomized|Parallel Assignment||Prevention||Single|||t|||
1339616|NCT03080246|Randomized|Parallel Assignment||Prevention||Single||||||t
1339617|NCT03080233|||Other||Cross-Sectional|||||||
1339618|NCT03080220|Randomized|Parallel Assignment||Other||Single||||||t
1339619|NCT03080207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339620|NCT03080194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339621|NCT03080181||Single Group Assignment||Treatment||None (Open Label)||||||
1339622|NCT03080168|||Cohort||Prospective|||||||
1339623|NCT03080155||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339624|NCT03080142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339625|NCT03080129|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1339626|NCT03080116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339627|NCT03080103|||Cohort||Prospective|||||||
1339628|NCT03080090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339629|NCT03080077|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339630|NCT03080064||Single Group Assignment||Prevention||None (Open Label)||One-arm intervention trial.||||
1339631|NCT03080051||Single Group Assignment||Other||None (Open Label)||||||
1339632|NCT03080038|Randomized|Parallel Assignment||Treatment||Single||||||t
1339633|NCT03080025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339634|NCT03080012|||Cohort||Prospective|||||||
1339727|NCT03078803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339728|NCT03078790||Single Group Assignment||Treatment||None (Open Label)||||||
1339729|NCT03078777|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1339635|NCT03079999|Randomized|Parallel Assignment||Treatment||Quadruple||In the Randomized Treatment Phase, patients aged 12 years or older with VSs will be identified and recruited into one of two randomized groups who receive either 1) 325 mg aspirin twice daily (81 mg aspirin twice daily for pediatric patients <50 kg); or 2) a placebo. Patients will stay on aspirin/placebo as long as there is no more than 20% increase in VS volume. At tumor progression, patients will enter the Open Label Follow Up Phase. Patients who progress on placebo will receive unblinded aspirin. Patients who progress on aspirin (either blinded or unblinded) will be taken off study drug and followed. All patients will be followed for at least 3.5 years after randomization.|t|t|t|t
1339636|NCT03079986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339637|NCT03079973|Randomized|Parallel Assignment||Treatment||Triple|Double blind||t|t|t|
1339638|NCT03079960||Single Group Assignment||Basic Science||None (Open Label)||Single group, open label||||
1339639|NCT03079947|||Cohort||Prospective|||||||
1339640|NCT03079934|||Cohort||Prospective|||||||
1339641|NCT03079921|Randomized|Factorial Assignment||Basic Science||Quadruple|"Conditions of testing for Group 1 (intra-hepatic islet recipients) will remain double-blind for each subject until their completion of all testing visits, unless for safety concerns, either the PI or Medical Monitor request an unblinding. Groups 2 and 3 will have no masking."|"This study is a within subject and across group mechanistic design.~Islet cell hormonal responses to a hyperinsulinemic euglycemic-hypoglycemic clamp will be assessed in Group 1 on three occasions with randomized, double-blind administration of the α-adrenergic blocker phentolamine, the β-adrenergic blocker propranolol, or placebo.~Responses in Group 1 under the placebo condition will be used for comparison to those obtained from hyperinsulinemic euglycemic-hypoglycemic clamp testing on one occasion in subjects in each of Group 2 and Group 3."|t|t|t|t
1339642|NCT03079908|Randomized|Parallel Assignment||Other||Single||||||t
1339643|NCT03079895|Randomized|Parallel Assignment||Treatment||Single|The primary care physician will not receive feedback about which arm the patient was assigned to.|Randomized controlled trial. Control arm will receive treatment as usual for depression from primary care physician. Intervention arm will also receive treatment as usual, and access to an internet-based self-help tool for treatment of depression, along with coaching emails and/or phone calls, encouraging their participation and answering questions about how to use the program.||t||
1339644|NCT03079882|||Cohort||Prospective|||||||
1339645|NCT03079869||Single Group Assignment||Supportive Care||None (Open Label)||Prospective non-randomized cohort study of 6-9 months duration (active study period 6 months).||||
1339646|NCT03079856|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1339647|NCT03079843|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1339648|NCT03079830|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1339649|NCT03079817|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339650|NCT03079804|Randomized|Sequential Assignment||Treatment||Double|Opaque envelopes||t||t|
1339651|NCT03079791|||Case-Only||Prospective|||||||
1339652|NCT03079778|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized to radiation (RT) or TACE plus RT (TACERT)||||
1339653|NCT03079765|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339654|NCT03079752|Randomized|Parallel Assignment||Prevention||Single|Assessors were not given access to the participants' original treatment assignments|||||t
1339655|NCT03079739|||Cohort||Prospective|||||||
1339656|NCT03079726|||Case-Control||Prospective|||||||
1339657|NCT03079713|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339658|NCT03079700|||Case-Only||Prospective|||||||
1339659|NCT03079687||||||||||||
1339660|NCT03079674|||Cohort||Prospective|||||||
1339661|NCT03079661|||Ecologic or Community||Prospective|||||||
1339662|NCT03079648|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1339663|NCT03079635|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1339664|NCT03079622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339665|NCT03079609|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339666|NCT03079596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339667|NCT03079583|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1339668|NCT03079570|||Cohort||Cross-Sectional|||||||
1339669|NCT03079557||Single Group Assignment||Treatment||None (Open Label)||||||
1339670|NCT03079544|||Case-Only||Other|||||||
1339671|NCT03079531||Single Group Assignment||Treatment||None (Open Label)||||||
1339672|NCT03079518|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1339673|NCT03079505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339674|NCT03079492|||Cohort||Prospective|||||||
1339675|NCT03079479|||Other||Cross-Sectional|||||||
1339676|NCT03079466|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized clinical trial||||
1339677|NCT03079453|Randomized|Crossover Assignment||Prevention||Single||Thirty patients ages 18 to 48 years who underwent tonsillectomy included in this prospective randomized clinical trial. The patients in Group 1 (n:15) were injected with dexamethasone (1 ml, 8 mg) through the uvula and soft palate tissue directly at three points (three points on the connection of the uvula, and palatum molle) before tonsillectomy. Group 2 (n:15) patients had tonsillectomy without dexamethasone injection.Blinded observers made examinations of the groups postoperative on the first and fifth days and evaluated the uvula edema by using the uvula edema scale that the investigators developed.||||t
1339678|NCT03079440||Single Group Assignment||Treatment||None (Open Label)||||||
1339679|NCT03079427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339680|NCT03079414|||Cohort||Prospective|||||||
1339681|NCT03079401|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1339682|NCT03079388|Randomized|Parallel Assignment||Treatment||Single||||||t
1339730|NCT03078764|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1339731|NCT03078751||Single Group Assignment||Treatment||None (Open Label)||The trial used to be a parallel design, it has been amended to a single arm trial.||||
1339683|NCT03079375|Randomized|Factorial Assignment||Supportive Care||Double|the study is dobbelblinded. The pharmacist do not know, whether the patient is randomized to the basic og to the extended intervention before they conduct the medication review. Thats i why the patients in the intervention group are randomized two times.|The combination of pharmacist interventions is compared with medication review alone in comparison to non-intervention (a control group).||t||t
1339684|NCT03079362|||Cohort||Retrospective|||||||
1339685|NCT03079349|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"Subjects were randomized into a control group attending a traditional classroom and a trial group of equal numbers participating in an online synchronous Internet streaming classroom."||||
1339686|NCT03079336|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339687|NCT03079323||Single Group Assignment||Treatment||None (Open Label)||||||
1339688|NCT03079310||Single Group Assignment||Treatment||None (Open Label)||||||
1339689|NCT03079297|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1339690|NCT03079284||Single Group Assignment||Other||None (Open Label)||||||
1339691|NCT03079271||Single Group Assignment||Supportive Care||None (Open Label)||||||
1339692|NCT03079258|Randomized|Parallel Assignment||Other||Single|Collected data at each time point will be blinded to the outcome assessor.|This study comprises of two groups; an exercise and a control group.||||t
1339693|NCT03079245|Randomized|Parallel Assignment||Prevention||None (Open Label)||A pre-post intervention study followed by two years of use of randomly assigned interventions||||
1339694|NCT03079232|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||One group of patients One group of non skin cancer patients||||
1339695|NCT03079219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339696|NCT03079206||Single Group Assignment||Diagnostic||None (Open Label)|In terms of study inclusion there will be no masking. Only the food challenge itself will be masked.|The study intends to compare the outcome of food challenge with hazelnut and the in vitro basophile activation test using hazelnut extract and allergens||||
1339697|NCT03079193|||Case-Control||Prospective|||||||
1339698|NCT03079180|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1339699|NCT03079167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339700|NCT03079154|Randomized|Parallel Assignment||Other||Single|||t|||
1339701|NCT03079141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339702|NCT03079128||Single Group Assignment||Treatment||None (Open Label)||||||
1339703|NCT03079115|Randomized|Parallel Assignment||Treatment||Single||||||t
1339704|NCT03079102|Randomized|Parallel Assignment||Treatment||Quadruple|Gas canisters will be marked with a bar code which will be recorded by the study coordinator and available to the study team. Only the respiratory therapy directors will be aware of the canister content (placebo vs. active drug). Treatment assignment will be revealed upon opening a sealed opaque envelope after enrollment has been confirmed.|Subjects will be randomized 1:1 to either placebo or active study drug (iNO). This will be stratified within blocks of 8 subjects at each center.|t|t|t|t
1339705|NCT03079089||Single Group Assignment||Other||None (Open Label)||Patients with refractory or relaps lymphoid hematological disorders||||
1339706|NCT03079076|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1339707|NCT03079063|Randomized|Crossover Assignment||Treatment||Triple|Blinding is performed by an independent third party operator (nurse/pharmacist, unblinded), who will prepare undistinguishable syringes with patient's dosing and labeling. Central lab operators will be blinded.|Randomized, single dose, double blinded, two-way cross-over study.|t||t|t
1339708|NCT03079050||Single Group Assignment||Treatment||None (Open Label)||||||
1339709|NCT03079037|||Cohort||Prospective|||||||
1339710|NCT03079024|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1339711|NCT03079011|Randomized|Sequential Assignment||Treatment||None (Open Label)||"Step 1: 800 patients screened for circulating blood ESR1 mutation detection at regular intervals will be treated with palbociclib 125 mg once daily for 21 days followed by 7 days off (28-day cycle) + AI (letrozole, anastrozole or exemestane) administered once daily in a continuous scheme (EoT if RECIST tumor progression or ESR1 mutation detection)~Step 2: 160 Patients with a rising circulating ESR1 mutation and without tumor progression will be randomized (1:1):~ARM A: no change in therapy. EoT if tumor progression or possibility of a cross-over (step 3)~ARM B: palbociclib 125 mg + fulvestrant 500 mg administered intramuscularly on D1,15 and 29 and once monthly thereafter. EoT if RECIST tumor progression~Step 3 (cross over): 80 patients who have been randomized in arm A will be offered to be treated by fulvestrant + palbociclib, after having progressed under AI + palbociclib. The EoT will occur at the tumor progression under fulvestrant + palbociclib"||||
1339712|NCT03078998|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339713|NCT03078985||Single Group Assignment||Treatment||None (Open Label)|This an Open Label study.|||||
1339714|NCT03078972|||Cohort||Prospective|||||||
1339715|NCT03078959|||Cohort||Retrospective|||||||
1339716|NCT03078946|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1339717|NCT03078933|Randomized|Factorial Assignment||Device Feasibility||Single|Investigator will be blinded to photgraphs and punch biopsy results|Two or more interventions, each alone and in combination, are evaluated in parallel against a control group|||t|
1339718|NCT03078920||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1339719|NCT03078907|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1339720|NCT03078894|||Cohort||Retrospective|||||||
1339721|NCT03078881|||Cohort||Prospective|||||||
1339722|NCT03078868||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339723|NCT03078855|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1339724|NCT03078842|Randomized|Parallel Assignment||Treatment||Quadruple|All participants will get dispersible zinc tablets that, contain either 20 mg, 10 mg, or 5 mg of zinc. All tablets look and taste the same. Randomization and tablet package labelling was done in Geneva, and no-one at the trial sites knows the actual zinc content of tablets packaged for each participant number.||t|t|t|t
1339725|NCT03078829|||Other||Prospective|||||||
1339726|NCT03078816||Single Group Assignment||Treatment||None (Open Label)||||||
1339732|NCT03078738|Randomized|Sequential Assignment||Treatment||Triple|SAD, MAD and Gender parts: double blind randomized. Food Effect part: open label, crossover design||t|t|t|
1339733|NCT03078725|Randomized|Parallel Assignment||Treatment||None (Open Label)||patients will be randomized to two groups, one receiving glyburide and one receiving metformin.||||
1339734|NCT03078712|Randomized|Parallel Assignment||Treatment||Single||||||t
1339735|NCT03078699||Sequential Assignment||Treatment||None (Open Label)||||||
1339736|NCT03078686|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1339737|NCT03078673|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339738|NCT03078660|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339739|NCT03078647||Single Group Assignment||Treatment||None (Open Label)||||||
1339740|NCT03078634|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1339741|NCT03078621||Single Group Assignment||Treatment||None (Open Label)||||||
1339742|NCT03078608|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339743|NCT03078595|||Case-Control||Cross-Sectional|||||||
1339744|NCT03078582||Single Group Assignment||Treatment||None (Open Label)||||||
1339745|NCT03078569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339746|NCT03078556|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1339747|NCT03078543||Single Group Assignment||Treatment||None (Open Label)||Subject is a candidate for primary total knee arthroplasty due to degenerative joint disease||||
1339748|NCT03078530|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1339749|NCT03078517|Randomized|Parallel Assignment||Prevention||Single|||t|||
1339750|NCT03078504||Single Group Assignment||Treatment||None (Open Label)||||||
1339751|NCT03078491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339752|NCT03078478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339753|NCT03078465|Randomized|Parallel Assignment||Prevention||Single||||||t
1339754|NCT03078452|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1339755|NCT03078439|||Cohort||Prospective|||||||
1339756|NCT03078426|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1339757|NCT03078413|||Cohort||Cross-Sectional|||||||
1339758|NCT03078400|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Arm I: N=6 to 12, Safety Phase, 3 + 3 design with 2 cohorts.~Cohort 1 SPL-108 150 mg daily + 80 mg/m2 PTX weekly on Days 1, 8, and 15 in 28 day cycles~Cohort 2 SPL-108 300 mg daily (150 mg q12 hours) + 80 mg/m2 PTX weekly on Days 1, 8, and 15 in 28 day cycles~Arm II: N=up to 12, Exploratory Expansion Phase~• Cohort 3: SPL-108 daily dose (to be determined in Arm I) + 80 mg/m2 PTX weekly on Days 1, 8, and 15 in 28 day cycles."||||
1339759|NCT03078387|||Case-Only||Retrospective|||||||
1339760|NCT03078374||Single Group Assignment||Treatment||None (Open Label)||||||
1339761|NCT03078361|Randomized|Parallel Assignment||Screening||None (Open Label)||After completion of baseline assessments, participants will be randomized so that the study personnel are unaware of the intervention assignment at the time of the baseline assessment.||||
1339762|NCT03078348|Randomized|Parallel Assignment||Screening||None (Open Label)||"In this modified block random assignment, all individuals recruited from the same geographic unit will receive the intervention assigned to that area in order to reduce intervention contamination. Individuals will not be made aware of their randomization (intervention) condition until after baseline assessment. The research assistants will also be assigned at random to work with one geographic area (i.e., one intervention condition) in order to reduce risk of intervention contamination by study staff."||||
1339763|NCT03078335|Randomized|Crossover Assignment||Prevention||Single|The final adjudication of events will be completed by two of the investigators blinded to study arm, based on a summary report of each event after completion of the pilot.|This pilot study is a single centre NICU based cluster-randomized crossover trial, with 2 crossover periods each lasting 6 months, and a 2-week washout period in between.||||t
1339764|NCT03078322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339765|NCT03078309|Non-Randomized|Parallel Assignment||Basic Science||Single|Electrophysiology will be analyzed by a blinded investigator.|Arm 1 - healthy subjects. Arm 2 - subjects with retinitis pigmentosa All subjects will undergo a full ocular exam and visual functions will be assessed before and after the administration of a single dose of cannabis (THC:CBD 1:40). On the second study day all subjects will receive a single dose of cannabis (THC:CBD 1:1) and undergo the full ocular exam again.||||t
1339766|NCT03078296|||Cohort||Cross-Sectional|||||||
1339767|NCT03078283||Single Group Assignment||Basic Science||None (Open Label)||||||
1339768|NCT03078270|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339769|NCT03078257|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339770|NCT03078244|||Case-Only||Retrospective|||||||
1339771|NCT03078231|||Case-Only||Cross-Sectional|||||||
1339772|NCT03078218|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||"Multicenter controlled before and after study conducted in Nouvelle Aquitaine, including types 1, 2 and 3 maternity wards.~The BEFORE period will be strictly observational in order to assess the current screening strategy as it is conducted in real life.~The AFTER period will be consist in a systematic pulse oximetry screening where all eligible newborns will be included in the same maternity wards as the BEFORE period."||||
1339773|NCT03078205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339774|NCT03078192|Non-Randomized|Sequential Assignment||Diagnostic||Single|The outcomes assessor, the radiologist who is reading the imaging will be blinded to treatment.|This will be a single blinded open label study enrolling volunteers and patients with pure PAH (10 subjects), pure left heart disease (10 subjects) and pure lung disease (10 subjects) in Aim 1; followed by a larger cohort of 92 subject with PAH||||t
1339775|NCT03078179|Non-Randomized|Crossover Assignment||Other||Single|||t|||
1339776|NCT03078166|||Cohort||Prospective|||||||
1339777|NCT03078153|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339778|NCT03078140|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339819|NCT03077607|Non-Randomized|||Treatment||None (Open Label)||||||
1339779|NCT03078127|Randomized|Crossover Assignment||Basic Science||None (Open Label)||All subjects will undergo baseline testing, followed by study procedures for three seperate interventions, with subjects randomized to a sequence in which to complete the studies.||||
1339780|NCT03078114|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339781|NCT03078101|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1339782|NCT03078088|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1339783|NCT03078075|Randomized|Sequential Assignment||Treatment||Quadruple||During the study, participants may or may not be switched to another group due to the adaptive aspect of the study design. Participants appearing to respond well to their original treatment assignment will not be switched.|t|t|t|t
1339784|NCT03078062|Randomized|Parallel Assignment||Other||Quadruple|Patients in both groups will receive the study drug (dexamethasone or placebo) in the same volume of normal saline. The study drug will be prepared by an independent assistant.|Prospective, randomized, double-blind, placebo-controlled study|t|t|t|t
1339785|NCT03078049|||Cohort||Retrospective|||||||
1339786|NCT03078036|||Cohort||Other|||||||
1339787|NCT03078023||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339788|NCT03078010|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a randomized open-label phase II study to assess the association between antibiotic treatment strategies and the change in the relative abundance of Clostridiales.||||
1339789|NCT03077997||Single Group Assignment||Treatment||None (Open Label)||||||
1339790|NCT03077984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339791|NCT03077971|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1339792|NCT03077958|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with degenerative knee disease randomely receive one of two types of total knee prostheses||||
1339793|NCT03077945|Randomized|Parallel Assignment||Basic Science||Single||Participants will be randomized to the intervention or control condition, blocked by age and level of motivation to quit smoking.|t|||
1339794|NCT03077932||Single Group Assignment||Treatment||None (Open Label)||||||
1339795|NCT03077919|Randomized|Parallel Assignment||Treatment||Quadruple||Participants will be centrally randomized to 2:1 active:sham SGB and will be evaluated at Womack Army Medical Center in North Carolina, Tripler Army Medical Center in Hawaii, and Landstuhl Regional Medical Center in Germany. Randomization will be stratified by site so that each will have a 2:1 active:sham ratio. The target population includes active-duty service members and study duration is 10 weeks in the clinical effectiveness trial for which an enrollment of 240 participants is planned.|t|t|t|t
1339796|NCT03077906|||Cohort||Retrospective|||||||
1339797|NCT03077893|Randomized|Parallel Assignment||Treatment||Quadruple|Sham devices will look identical to active devices. This is a double-blind study.|"Subjects deemed responders after active treatment will be randomized in a 1:1 ratio to either active treatment or a sham device."|t|t|t|t
1339798|NCT03077880|||Cohort||Prospective|||||||
1339799|NCT03077867|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339800|NCT03077854|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339801|NCT03077841||Single Group Assignment||Treatment||None (Open Label)||||||
1339802|NCT03077828||Single Group Assignment||Treatment||None (Open Label)||||||
1339803|NCT03077815|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1339804|NCT03077802|Randomized|Parallel Assignment||Other||Double|||t|||t
1339805|NCT03077789||Single Group Assignment||Prevention||None (Open Label)||||||
1339806|NCT03077776||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339807|NCT03077763|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1339808|NCT03077750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339809|NCT03077737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339810|NCT03077724|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind, placebo control with medications dispensed by the Investigational Drug Service|Randomized, double-blinded, placebo controlled trial|t|t|t|t
1339811|NCT03077711|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients diagnosed with recurrent urinary tract infections are recruited into this study.||||
1339812|NCT03077698||Single Group Assignment||Treatment||None (Open Label)||Phase 2, Single Arm, Two Period Study||||
1339813|NCT03077685|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-label, dose-escalating, Phase IIa trial. Subjects will be enrolled in sequential cohorts of a fixed concentration of NanoPac® at a volume correlating up to 20% of calculated tumor volume (with a maximum injection volume of 5 mL per subject). Each cohort will have three subjects, with cohorts enrolled sequentially starting at the lowest concentration. Following DSMB review of the cohort data, the next cohort may begin enrolling, an additional three subjects at the current dose may be enrolled, or if the first dose does not provide adequate safety and tolerability the study may be halted. The dose determined to be most suitable for further evaluation, defined as the highest dose with an acceptable safety and tolerability profile as determined by the Data Safety Monitoring Board (DSMB), will enroll additional subjects to provide a cohort of up to 12 subjects at that dose level.||||
1339814|NCT03077672|||Cohort||Prospective|||||||
1339815|NCT03077659|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-label, dose rising, Phase IIa trial. The study will include a dose escalation phase and a dose confirmation phase. In the dose escalation phase, NanoPac® concentrations of 6, 10, and 15 mg/mL in an injection volume of 20% of the lobe of the prostate containing the dominant lesion will be studied in cohorts of 3, with cohorts enrolled sequentially starting at the lowest concentration. Following DSMB review of the cohort data the next cohort may begin enrolling, or an additional 3 at the current dose may be enrolled, or if the first dose does not provide adequate safety and tolerability the study may be halted. The dose determined to be the most suitable for further evaluation, defined as the highest dose with an acceptable safety and tolerability profile as determined by the DSMB, will enroll additional subjects (dose confirmation phase) to provide a cohort of 12 subjects at that dose level.||||
1339816|NCT03077646|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339817|NCT03077633|Randomized|Parallel Assignment||Prevention||None (Open Label)||Two groups: Cerclage + Progesterone vs. Progesterone alone||||
1339818|NCT03077620|Randomized|Parallel Assignment||Other||Single|||t|||
1339820|NCT03077594|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1339821|NCT03077581|Randomized|Parallel Assignment||Prevention||Single||||||t
1339822|NCT03077568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339823|NCT03077555|Randomized|Parallel Assignment||Other||Triple||two intervention groups||t|t|t
1339824|NCT03077542||Single Group Assignment||Treatment||None (Open Label)||||||
1339825|NCT03077529|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1339826|NCT03077516|||Cohort||Prospective|||||||
1339827|NCT03077503|Randomized|Parallel Assignment||Treatment||Triple|After written informed consents were obtained, all participant was blinded from the study drug. The study drugs (dexmedetomidine and fentanyl) were prepared by anesthetist nurse who not involved in the study. Dexmedetomidine was labeled with group A whereas fentanyl was labeled with group B. The study drug was administrated by the blinded anesthiologist. Blood pressure, mean arterial pressure, and heart rate were recorded by same blinded anesthesiologist|A randomized, double-blinded controlled trial was conducted from September 2015 to September 2016 in Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Thailand. Sixty patients who underwent craniotomy with insertion of skull pin were randomly allocated into group A and B. After patients entered the operative room, blood pressure and heart rate were measured (T1) then repeated measurement again (T2) when started induction, intubation and infusion dexmedetomidine 1 µg/kg over 10 min infusion in group A whereas group B received normal saline. At 3 minutes before skull pin insertion (T3), patient in group B received a single bolus of fentanyl 1 µg/kg whereas group A received normal saline. Then hemodynamic responses were recorded and repeated again at one minute before skull pin insertion (T4). Blood pressure and heart rate were observed at the time of skull pin insertion (T5) then repeated every 1 minutes after skull pin application until 5 minutes (T6 - T10).|t|t||t
1339828|NCT03077490|||Case-Control||Retrospective|||||||
1339829|NCT03077477|Randomized|Parallel Assignment||Treatment||Triple|If subject is given active drug or placebo is masked|"The study is comprised of a total of 8 cohorts; 4 single ascending dose (SAD) cohorts, 1 Food Effect (FE) Crossover cohort, and 3 multiple ascending dose (MAD) cohorts. Tablets will be administered after an overnight fast (10 hours) with at least 250 mL water. No food will be administered (exception for fed subjects, see below) for one hour thereafter.~Each cohort will have a total 6 subjects: SAD and MAD (2 subjects receiving placebo and 4 subjects receiving active AMXT 1501 dicaprate); and FE crossover (6 subjects receiving active AMXT 1501 dicaprate)."|t|t|t|
1339830|NCT03077464|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Non-randomized parallel group design, testing pretest to post-test changes.||||
1339831|NCT03077451||Single Group Assignment||Treatment||None (Open Label)||||||
1339832|NCT03077438|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1339833|NCT03077425|Randomized|Parallel Assignment||Prevention||Single|"Research Assessment- at 6, 12, and 18 months will be conducted by RAs. Data collected include a computerized 24 hour recall: MySmileBuddy (see below); and questionnaires. The T2 interview, in addition, will include the Intra-oral Camera Caries Assessment. Study identifiers will not include indication of group assignment. The REDCap database will include group assignment in a field that is not accessible to RAs~Caries Outcomes- Intra-oral camera images will be transmitted electronically to the University of Rochester; no group assignment identifier will be included.~Obesity Outcomes- RAs will obtained weight and length measures in the home- see above."|randomized controlled clinical trial||||t
1339834|NCT03077412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339835|NCT03077399|||Cohort||Prospective|||||||
1339836|NCT03077386|Randomized|Sequential Assignment||Health Services Research||Single||The investigators will test the effectiveness of the ENCOMPASS program using a parallel, two-arm, pragmatic, cluster-randomized trial in 8 clusters made up of 10 primary care clinics, with a target population size of 800 patients with chronic disease. A CHW will be assigned to each cluster at a ratio of approximately one CHW per five physicians. Consistent with other programs [33], and because the program aims to improve patient activation [34], individual patients will receive the CHW intervention for up to six months unless patient circumstance requires flexibility. Once implemented, the ENCOMPASS program will remain available to clinic patients until the end of the funding period (March 2020). Control patients will continue to receive usual care until their clinic becomes eligible for the program.||||t
1339837|NCT03077373|Randomized|Parallel Assignment||Prevention||Single|||t|||
1339838|NCT03077360|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339839|NCT03077347|Randomized|Crossover Assignment||Basic Science||Double||Sham Stimulation followed by Direct Current Stimulation or Vice-Versa|t||t|
1339840|NCT03077334|||Cohort||Prospective|||||||
1339841|NCT03077321|Randomized|Parallel Assignment||Prevention||Double|The therapists and the parents will not be blinded to group because they will be providing and receiving the intervention. The investigators who are collecting the data will be blinded to arm.|RCT 1:1|||t|t
1339842|NCT03077308|||Cohort||Prospective|||||||
1339843|NCT03077295|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1339844|NCT03077282|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Volunteers will be divided into 2 groups. One will take Prasaprohyai 95% ethanolic extract capsules at a dose of 100 mg three times a day before meals and the other take Prasaprohyai 95% ethanolic extract capsule at a dose of 200 mg 3 times a day before meals for six weeks. After that, they will cease using the drug for 2 weeks (wash out period). All volunteers will be followed up in the third week, sixth week and eighth week to evaluate the safety of the medicines. The researcher will record data such as age, career, BMI, vital signs, signs and symptoms. Safety will be monitored by hematology tests such as liver function test, renal function test, lipid profile and blood sugar.~The first step in this research will be to study group 1 (100 mg). If it proves safe, the group 2 (200 mg) will be studied."||||
1339845|NCT03077269|||Case-Only||Prospective|||||||
1339846|NCT03077256|||Cohort||Prospective|||||||
1339847|NCT03077243|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339848|NCT03077230||Single Group Assignment||Health Services Research||None (Open Label)||||||
1339849|NCT03077217|Randomized|Parallel Assignment||Treatment||Single|||t|||
1339850|NCT03077204||Single Group Assignment||Treatment||None (Open Label)||||||
1339851|NCT03077191|||Cohort||Prospective|||||||
1339853|NCT03077165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339854|NCT03077152|||Case-Only||Prospective|||||||
1339855|NCT03077139||Single Group Assignment||Treatment||None (Open Label)||||||
1339856|NCT03077126||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339857|NCT03077113||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339858|NCT03077100|||Cohort||Retrospective|||||||
1339859|NCT03077087||Single Group Assignment||Treatment||None (Open Label)||||||
1339860|NCT03077074||Sequential Assignment||Basic Science||None (Open Label)||||||
1339861|NCT03077061|Randomized|Parallel Assignment||Treatment||Single|Individuals assessing radiographic parameters will be masked to the intervention.|The study is designed as a two-arm randomized clinical trial.||||t
1339862|NCT03077048|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1339863|NCT03077035|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1339864|NCT03077022|||Cohort||Prospective|||||||
1339865|NCT03077009||Single Group Assignment||Treatment||None (Open Label)||||||
1339866|NCT03076996||Single Group Assignment||Supportive Care||None (Open Label)||Single group pre/post design||||
1339867|NCT03076983|||Cohort||Prospective|||||||
1339868|NCT03076970|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1339869|NCT03076957||Single Group Assignment||Treatment||None (Open Label)||||||
1339870|NCT03076944|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1339871|NCT03076931|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1339872|NCT03076918|Randomized|Sequential Assignment||Treatment||None (Open Label)||Split face intraindividual comparison||||
1339873|NCT03076905||Single Group Assignment||Treatment||None (Open Label)||Assessment of IV pharmacokinetics||||
1339874|NCT03076892|Randomized|Sequential Assignment||Treatment||None (Open Label)||Split Face intra individual comparison||||
1339875|NCT03076879|Randomized|Parallel Assignment||Prevention||Single|Blindness in the study will be done by data collectors and statisticians. The data will be collected by the assistant investigator who does not know who is in the experiment and control group and the data will be recorded on the computer by the assistant investigator without specifying the experiment and control group. The experimental and control groups will be codified by the co-investigator. The analysis of the data encoded by the groups will be done by a statistical expert. Data collectors, statistical analyzes and report writing will be blinded.|||||t
1339876|NCT03076866|||Cohort||Prospective|||||||
1339877|NCT03076853|||Other||Prospective|||||||
1339878|NCT03076840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339879|NCT03076827|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients receiving total hip replacement or hip hemiarthroplasty are divided into two groups: the morning surgery group and the afternoon surgery group. After surgery, cortisol, IL-6, IL-8 and VAS were measured and compared.||||
1339880|NCT03076801|Randomized|Parallel Assignment||Prevention||Single|The investigator will be blind to participant allocation during chart review at 12 months.||||t|
1339881|NCT03076788|||Cohort||Prospective|||||||
1339882|NCT03076775|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339883|NCT03076762|Randomized|Parallel Assignment||Treatment||Triple|Participants, investigator and outcome assessor are blinded to the treatment arm.|Eligible patients will be randomly assigned to receive intravesical injection of 100U of BoNT-A (BOTOX, Allergan, Irvine, CA, USA) into the trigone (the treatment group) or suburothelium (the comparative group) immediately followed by cystoscopic hydrodistention under intravenous general anesthesia in the operation room.|t||t|t
1339884|NCT03076749|||Cohort||Cross-Sectional|||||||
1339885|NCT03076736|Randomized|Parallel Assignment||Treatment||Single||||||t
1339886|NCT03076723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1339887|NCT03076710|||Cohort||Prospective|||||||
1339888|NCT03076697|||Cohort||Prospective|||||||
1339889|NCT03076684|Randomized|Parallel Assignment||Basic Science||None (Open Label)||There are three arms of this study: a diet-treated group, a drug-treated group and a control group.||||
1339890|NCT03076671|Randomized|Parallel Assignment||Treatment||None (Open Label)||"This is a stepped-wedge design, meaning that during the first year all patients enrolled will continue to receive usual care provided by their neurologist, who is also enrolled in the study. During years 2 and 3, every 6 months, 4-5 neurologists will receive training in supportive and palliative care. The timing of the training will be randomly assigned. Once their neurologist has received training, all of their enrolled patients will be switched to the intervention arm, and be eligible for additional care via telemedicine with the university supportive and palliative care team. During the final year of the study, all the neurologists will have received care, and all of their patients will be in the intervention arm.~On a separate level, we will be evaluating the effects of training on the enrolled neurologists through assessments of palliative skills, knowledge, and attitudes before and after the training, as well as through qualitative interviews."||||
1339891|NCT03076658||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339892|NCT03076645||Single Group Assignment||Supportive Care||None (Open Label)||||||
1339893|NCT03076632|Non-Randomized|Crossover Assignment||Device Feasibility||Single|Raw electromyography data assessed while masked to specific conditions.|Each subject will receive combinations of brain stimulation, cervical stimulation, or peripheral nerve stimulation, either with or without performing simultaneous hand exercises.||||t
1339894|NCT03076619|||Other||Other|||||||
1339895|NCT03076606|||Cohort||Prospective|||||||
1339896|NCT03076593|||Other||Cross-Sectional|||||||
1339897|NCT03076580|||Cohort||Prospective|||||||
1339898|NCT03076567|||Other||Other|||||||
1339899|NCT03076554||Single Group Assignment||Treatment||None (Open Label)||||||
1339900|NCT03076541|||Cohort||Retrospective|||||||
1339901|NCT03076528|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1339902|NCT03076515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339903|NCT03076502|||Cohort||Prospective|||||||
1339904|NCT03076489|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339905|NCT03076476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339906|NCT03076463|Randomized|Crossover Assignment||Basic Science||Single||GRAPOM: dried and milled grape pomaces. CTR: control period. All the subjects will pass the two periods: one half will do the CTRL period followed by the GRAPOM period, and the other half will do it inversely. The assignment to each order will be done randomly. Both period will be separated by a four weeks washing period.|||t|
1339907|NCT03076450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339908|NCT03076437||Single Group Assignment||Treatment||None (Open Label)||||||
1339909|NCT03076424|||Case-Control||Cross-Sectional|||||||
1339910|NCT03076411|||Cohort||Prospective|||||||
1339911|NCT03076398|||Other||Prospective|||||||
1339912|NCT03076385|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1339913|NCT03076372||Single Group Assignment||Treatment||None (Open Label)||||||
1339914|NCT03076359|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1339915|NCT03076346|||Cohort||Prospective|||||||
1339916|NCT03076333||Single Group Assignment||Diagnostic||None (Open Label)||||||
1339917|NCT03076320|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1339918|NCT03076307|Non-Randomized|Parallel Assignment||Basic Science||||||||
1339919|NCT03076294|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1339920|NCT03076281|Randomized|Parallel Assignment||Treatment||Single||||||t
1339921|NCT03076268|Randomized|Parallel Assignment||Other||Single|Participants will not be aware of which condition they are enrolled in.|The investigators will deliver the TMP Curriculum to 45 Treatment families. The TMP Curriculum is comprised of 1) 12 educational modules, 2) animations and videos of real parent-child interactions to teach parents about the science behind child brain development, and model strategies for improving parents' child-directed speech, 3) video modeling and collaborative goal setting, and 4) quantitative linguistic feedback from Language ENvironment Analysis (LENA) recordings.|t|||
1339922|NCT03076255||Single Group Assignment||Supportive Care||None (Open Label)||||||
1339923|NCT03076242|||Cohort||Prospective|||||||
1339924|NCT03076229|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1339925|NCT03076216||Single Group Assignment||Treatment||None (Open Label)||||||
1339926|NCT03076203||Single Group Assignment||Treatment||None (Open Label)||||||
1339927|NCT03076190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339928|NCT03076177|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1339929|NCT03076164||Single Group Assignment||Treatment||None (Open Label)||Trametinib 1.5mg + Erlotinib 75mg||||
1339930|NCT03076151||Single Group Assignment||Other||None (Open Label)||||||
1339931|NCT03076138||Single Group Assignment||Treatment||None (Open Label)||||||
1339932|NCT03076125|Randomized|Parallel Assignment||Prevention||Double|data collectors conducting post-intervention and 8-week follow up are blinded to participant treatment groups|randomized controlled two-group pre-post test design|t|||t
1339933|NCT03076112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339934|NCT03076099|Randomized|Parallel Assignment||Treatment||Triple|this investigation is a triple mask study. The patiens, the care providers and Outcome Assessor will not allowed to know the grouping information.|two parallel groups|t|t||t
1339935|NCT03076086||Single Group Assignment||Basic Science||None (Open Label)||||||
1339936|NCT03076073|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1339937|NCT03076060|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1339938|NCT03076047|||Cohort||Prospective|||||||
1339939|NCT03076034|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||Observational||||
1339940|NCT03076021||Single Group Assignment||Other||None (Open Label)||Prospective, pre-post drug interaction study evaluating an approved drug (Phase 4) with a Phase 1 study design.||||
1339941|NCT03076008|||Cohort||Prospective|||||||
1339942|NCT03075995||Single Group Assignment||Treatment||None (Open Label)||It's divided into two stages.For the first stage,the subjects take lapatinib on an empty stomach,the steady state plasa concentration is examined on the 9th and 10th days after lapatinib is administered.The second stage,the subject take lapatinib with hight-fat breakfast,the steady state plasa concentration is examined as the first stage.||||
1339943|NCT03075969|||Case-Only||Prospective|||||||
1339944|NCT03075956|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339945|NCT03075943|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1339946|NCT03075930|||Cohort||Prospective|||||||
1339947|NCT03075917||Single Group Assignment||Prevention||None (Open Label)||||||
1339948|NCT03075904|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339949|NCT03075891|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1339950|NCT03075878|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1339951|NCT03075865|||Cohort||Prospective|||||||
1339952|NCT03075852|||Cohort||Prospective|||||||
1339953|NCT03075839||Single Group Assignment||Other||None (Open Label)||Within-subject design comparing smoking behavior when using menthol vs. non-menthol cigarettes||||
1339954|NCT03075826||Single Group Assignment||Treatment||None (Open Label)||||||
1339955|NCT03075813|Randomized|Parallel Assignment||Prevention||Single|||||t|
1339956|NCT03075800|Randomized|Parallel Assignment||Treatment||None (Open Label)||A pilot, cluster randomized controlled trial was conducted in which ACT teams were randomized to provide either IMR within ACT (ACT+IMR) or standard ACT treatment (ACT-only). The impact of ACT+IMR vs. ACT-only on illness management and recovery outcomes was based on assessments conducted on a subset of randomly selected clients from each team, conducted at baseline, six months, and one year. Randomization to ACT+IMR or ACT-only was stratified by state and by team size, resulting in one large team and one small team assigned to each condition in each state.||||
1339957|NCT03075787|||Cohort||Retrospective|||||||
1339958|NCT03075774|||Case-Only||Prospective|||||||
1339959|NCT03075761|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339960|NCT03075748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339961|NCT03075735|||Cohort||Prospective|||||||
1339962|NCT03075722||Single Group Assignment||Treatment||None (Open Label)||||||
1339963|NCT03075709|||Other||Prospective|||||||
1339964|NCT03075696|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339965|NCT03075683|Randomized|Parallel Assignment||Treatment||Single||Randomised controlled trial|t|||
1339966|NCT03075670|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1339967|NCT03075657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339968|NCT03075644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339969|NCT03075631|||Cohort||Prospective|||||||
1339970|NCT03075618|||Cohort||Prospective|||||||
1339971|NCT03075605|||Cohort||Prospective|||||||
1339972|NCT03075592|||Cohort||Prospective|||||||
1339973|NCT03075579|||Case-Only||Prospective|||||||
1339974|NCT03075566|||Case-Control||Prospective|||||||
1339975|NCT03075553||Single Group Assignment||Treatment||None (Open Label)||||||
1339976|NCT03075540||Single Group Assignment||Screening||None (Open Label)||Single arm trial||||
1339977|NCT03075527||Single Group Assignment||Treatment||None (Open Label)||||||
1339978|NCT03075514|Randomized|Parallel Assignment||Treatment||None (Open Label)||MKD and MCT ketogenic diets||||
1339979|NCT03075501|Randomized|Parallel Assignment||Other||Double|||t|t||
1339980|NCT03075488|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339981|NCT03075475|Randomized|Parallel Assignment||Treatment||Single||||||t
1339982|NCT03075462||Single Group Assignment||Treatment||None (Open Label)||||||
1339983|NCT03075449|||Cohort||Retrospective|||||||
1339984|NCT03075436|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1339985|NCT03075423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1339986|NCT03075410|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1339987|NCT03075397||Single Group Assignment||Basic Science||None (Open Label)||||||
1339988|NCT03075384|||Case-Only||Prospective|||||||
1339989|NCT03075371|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1339990|NCT03075358|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339991|NCT03075345|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1339992|NCT03075332||Sequential Assignment||Prevention||None (Open Label)||This is a longitudinal study of the non-randomized experimental type, presenting a non-probabilistic sample for convenience and independent groups. The sample consisted of 21 individuals divided into 2 groups: Experimental Group (EG) and Control Group (CG). The EG was composed of 11 people living with HIV/AIDS and CG composed of 10 people with no infection||||
1339993|NCT03075319|Randomized|Parallel Assignment||Treatment||Single||||||t
1339994|NCT03075306|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1339995|NCT03075293|||Cohort||Retrospective|||||||
1339996|NCT03075280|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1339997|NCT03075267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1339998|NCT03075254|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1339999|NCT03075241|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340000|NCT03075228|||Cohort||Cross-Sectional|||||||
1340001|NCT03075215|||Other||Prospective|||||||
1340002|NCT03075202|||Cohort||Prospective|||||||
1340003|NCT03075189|Randomized|Parallel Assignment||Prevention||Double|"Two of the study officials will be masked and therefore responsible for testing the participants at baseline, at discharge and follow-up - and in charge of data processing.~Contrary to the masked officials two non-masked officials are responsible for randomization, serving of meals, diet registration and dietary counseling."|Inclusion and testing of intervention and control group is carried out at the same time|||t|t
1340004|NCT03075176|Randomized|Parallel Assignment||Treatment||Single|Participants will be masked as to which type of surgery they receive in either eye.|Each participant will receive wavefront optimized surgery in one eye and topography-guided surgery in the second eye.|t|||
1340005|NCT03075163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340006|NCT03075150|||Cohort||Prospective|||||||
1340007|NCT03075137|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1340008|NCT03075124|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1340009|NCT03075111|||Cohort||Retrospective|||||||
1340010|NCT03075098||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340011|NCT03075085|Randomized|Parallel Assignment||Prevention||Single||Investigators will use a Type 3 Hybrid Design to test the effectiveness of the enhanced implementation strategy (i.e., facilitation) on uptake while also assessing impacts of the intervention on child outcomes. Investigators expect that the effectiveness of WISE on child outcomes will vary by the level of implementation fidelity, and a Hybrid 3 design allows for us to explore this hypothesis. RE-AIM provides an evaluation framework to assess key aspects of intervention programs implemented in real-word settings. Investigators will modify and use The Organizational Readiness to Change Assessment (ORCA) as developed for use with the i-PARiHS framework to assesses change commitment (e.g., We value this change) and change efficacy (e.g., We can keep the momentum going) both prior to and during implementation.|t|||
1340012|NCT03075072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340013|NCT03075059|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1340014|NCT03075046|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340015|NCT03075033|Randomized|Parallel Assignment||Treatment||Single||This prospective, randomized study was approved by the local ethical committee of Alexandria main university hospital. Written informed consent was obtained from all the participants. Sixty patients aged 18-65 year with American Society of Anaesthesiologists physical status I-III with a neurosurgical diagnosis of cervical instability or at risk of secondary cervical injury, who were scheduled for awake intubation and self-positioning prone for elective neurological intervention, were enrolled in this study.|||t|
1340016|NCT03075020|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1340017|NCT03075007|||Cohort||Prospective|||||||
1340018|NCT03074994|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340019|NCT03074981||Single Group Assignment||Treatment||None (Open Label)||||||
1340020|NCT03074968|Randomized|Parallel Assignment||Other||Double|||t|||t
1340021|NCT03074955|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1340022|NCT03074942||Single Group Assignment||Treatment||None (Open Label)||||||
1340023|NCT03074929|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340024|NCT03074916|||Case-Control||Prospective|||||||
1340025|NCT03074903|||Cohort||Prospective|||||||
1340026|NCT03074890|Randomized|Single Group Assignment||Treatment||Single|||t|||
1340027|NCT03074877|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340028|NCT03074864||Single Group Assignment||Treatment||None (Open Label)||EGFR-TKI intercalted with radiotherapy||||
1340029|NCT03074851|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340030|NCT03074838|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A case Control study were patients undergoing two surgical Methods for aortic valve repair is compared||||
1340031|NCT03074825||Single Group Assignment||Treatment||None (Open Label)||||||
1340032|NCT03074812|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340033|NCT03074799|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||We propose a cluster randomized trial to be conducted in 16 decentralized care clinics with existing TB services that will measure the implementation of symptom-based, nurse-led initiation of IPT compared to the current standard of care with TST-based referral to a pediatricians at the district hospital. A baseline assessment of clinic records and procedures will inform clinic stratification prior to randomization. Clinics will be stratified by size (number of patients seen per month) and TB case notifications. The clinics will then be randomized in a 1:1 ratio to receive either the intervention or the current standard of care. Given the intervention will be carried out by a clinic in its entirety, neither the provider nor the patient will be blinded to the study procedure. No additional staff will be provided to the clinics to assist in this process as we wish to evaluate the implementation of IPT for child contacts under 5 years old in a real world, resource-limited setting.||||
1340034|NCT03074786|Randomized|Crossover Assignment||Prevention||None (Open Label)||Phase 2a, open-label, multi-site, two-sequence, crossover, randomized trial||||
1340035|NCT03074773|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1340036|NCT03074760|||Cohort||Retrospective|||||||
1340037|NCT03074747|||Case-Only||Prospective|||||||
1340038|NCT03074734||Single Group Assignment||Basic Science||None (Open Label)||||||
1340039|NCT03074721|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340040|NCT03074708||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340041|NCT03074695|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340042|NCT03074682|Randomized|Parallel Assignment||Other||Single|||t|||
1340043|NCT03074669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340044|NCT03074656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340045|NCT03074643|Randomized|Parallel Assignment||Treatment||Triple||All participants will undergo a 6-month weight loss intervention of caloric restriction and supervised exercise followed by 12 months of follow-up with randomization to one of three groups (n=75/group): 1) Lower protein / higher CHO diet for the 6-month weight loss phase only (RecProt); 2) Higher protein / lower CHO diet for the 6-month weight loss phase only (6-mo HiProt); or 3) Higher protein / lower CHO diet for the 6-month weight loss and 12-month follow-up phases (18-mo HiProt).|t||t|t
1340046|NCT03074630||Single Group Assignment||Basic Science||None (Open Label)|Open Label|||||
1340047|NCT03074617|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1340048|NCT03074604|Randomized|Parallel Assignment||Treatment||Triple||The CANON trial is designed as a randomised, controlled, investigator and patient blinded single center superiority trial with three parallel arms and a primary endpoint being the appearance of new lesions on control brain magnetic resonance imaging 3 days after surgery.|t||t|t
1340049|NCT03074591|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340050|NCT03074578|Randomized|Crossover Assignment||Other||Single|The analysis of heart signal, polysomnography and dream reports analysis will be performed by assessors masked to the group and type of video.|Watching two different videos (one violent, one non-violent), re-exposure after 11h daytime (wake period) or 11h nighttime (sleep period). The order of videos is balanced, in a cross over fashion||||t
1340051|NCT03074565|Randomized|Crossover Assignment||Health Services Research||Double|An investigator, not involved in providing the treatment, will be responsible for randomizing each subject to an initial treatment modality and to which side of the mouth they will receive each treatment. The patient will be masked as to which modality has been used. The care provider cannot be masked as they must use different instrumentation for each treatment type. When assessing outcomes, the investigator will be masked as to the treatment modality and the side of the mouth.|Subjects will be randomized to receive one of two treatment modalities on either the left or right side of the mouth on their first treatment visit. During the second treatment visit, subjects will receive the other treatment modality on the other side of the mouth.|t|||t
1340052|NCT03074552|Randomized|Parallel Assignment||Prevention||Quadruple|A numbered sealed envelope will be used to ensure blinding. Only the pharmacist responsible for the sealed envelopes preparation will be aware of its content, with no further involvement in the study protocol.|The present study will be a multicenter, randomized, double-blind, placebo-controlled trial including data collected from 9 ICUs. Patients will be randomly assigned in a 1:1 ratio to receive probiotic or placebo treatment according to a computer-based table blinded to study investigators and physicians in charge.|t|t|t|t
1340053|NCT03074539|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340054|NCT03074526|Randomized|Parallel Assignment||Treatment||Double||Approximately 180 subjects will be enrolled in one of three dose arms ( 4ml, Saline Placebo and 4ml 2x).|t||t|
1340055|NCT03074513|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340056|NCT03074500|Randomized|Parallel Assignment||Treatment||Double|To ensure group concealment, randomization will be done by using opaque, sealed envelopes which the assessors will be blinded to|Parallel Assignment|t|||t
1340057|NCT03074487|||Case-Only||Prospective|||||||
1340058|NCT03074474||Single Group Assignment||Treatment||None (Open Label)||||||
1340059|NCT03074461|Randomized|Parallel Assignment||Treatment||None (Open Label)|There is no masking in the CSAR Trial|Study participants will be randomized in two parallel study arms regarding their neorectal reconstruction in low anterior resection, the experimental arm using the side-to-end anastomosis and the control group using the transverse coloplasty technique.||||
1340060|NCT03074448|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1340061|NCT03074435|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340062|NCT03074422|Randomized|Single Group Assignment||Treatment||None (Open Label)|No masking|"Patients will be randomly attributed to either the hypnosis group or the control group, by a randomization process. The investigators plan to allocate patients in two groups; in the first group, patients will undergo hypnosis during the fixation of the stereotactic frame. In the second group (control group), the frame disposal will be performed following the actual standard of care, with a LA performed during the procedure."||||
1340063|NCT03074409|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1340064|NCT03074396||Sequential Assignment||Health Services Research||None (Open Label)||||||
1340065|NCT03074383|Randomized|Parallel Assignment||Treatment||Single||||||t
1340066|NCT03074370|||Cohort||Retrospective|||||||
1340067|NCT03074357|||Other||Retrospective|||||||
1340068|NCT03074344|Randomized|Parallel Assignment||Treatment||Single|Visits were carried out in a blind fashion by investigators who were not aware to which group the patients belonged. The patients were allowed to know the brand name of the eye drops they were using.|Randomised, single-masked, parallel-group comparative study.|||t|
1340069|NCT03074331||Single Group Assignment||Treatment||None (Open Label)||||||
1340070|NCT03074318||Single Group Assignment||Treatment||None (Open Label)||||||
1340071|NCT03074305|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, open label, two-arm, randomized controlled trial||||
1340072|NCT03074292|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1340073|NCT03074279|||Case-Control||Retrospective|||||||
1340074|NCT03074266|||Cohort||Prospective|||||||
1340075|NCT03074253|||Cohort||Prospective|||||||
1340076|NCT03074240|Randomized|Parallel Assignment||Treatment||None (Open Label)||Sixty subjects with be randomized to the TAPB or RSB arm upon enrollment, using randomized permutated blocks of six.||||
1340077|NCT03074227|Randomized|Parallel Assignment||Treatment||Quadruple|"Patients will be randomised by a computerised random-number generator to one of the following two treatment arms:~allogeneic faecal infusions at t=0 and t=6.~autologous faecal infusions at t=0 and t=6.~Randomisation and preparation of the faeces will be performed by one of the research assistants. He/she is the only person who will know which treatment the patient will be given and will have no role in further parts of the study.~The randomisation list will be kept under secured access by the Clinical Research Unit of the AMC Amsterdam, who will perform the randomisation. In case of an emergency the study medication can be unblinded after consultation of the principal investigator."|Double-blind, randomised, placebo-controlled pilot study as well as a reversed translational part.|t|t|t|t
1340078|NCT03074214|||Cohort||Prospective|||||||
1340079|NCT03074201||Single Group Assignment||Device Feasibility||None (Open Label)||Prospective feasibility study to evaluate potential for cholangioscopy to facilitate radiation-free ERCP.||||
1340080|NCT03074188|||Ecologic or Community||Cross-Sectional|||||||
1340081|NCT03074175|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340082|NCT03074162|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1340083|NCT03074149|||Other||Prospective|||||||
1340084|NCT03074136|Randomized|Parallel Assignment||Treatment||Triple|Double blind||t||t|t
1340085|NCT03074123||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340086|NCT03074110|Randomized|Sequential Assignment||Other||None (Open Label)||||||
1340087|NCT03074097|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1340088|NCT03074084|||Cohort||Prospective|||||||
1340089|NCT03074071|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Subjects will be offered participation in workshops where techniques are taught for enhancing hopefulness. Validated questionnaires will be administered before and after this intervention to assess efficacy.||||
1340090|NCT03074058|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1340091|NCT03074045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340092|NCT03074032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Single Group Assignment||||
1340093|NCT03074019|Randomized|Parallel Assignment||Prevention||Triple||Randomized, placebo-controlled, 3-arm, parallel, dose ranging study|t|t|t|
1340094|NCT03074006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340095|NCT03073993|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340096|NCT03073980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340097|NCT03073967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340098|NCT03073954|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1340099|NCT03073941|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340100|NCT03073928|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1340101|NCT03073915|||Cohort||Prospective|||||||
1340102|NCT03073902|||Cohort||Prospective|||||||
1340103|NCT03073889|Randomized|Parallel Assignment||Other||Single|||t|||
1340104|NCT03073876|Randomized|Parallel Assignment||Other||Triple|Study drug was prepared by research pharmacist who was the only person privy to group assignment. Drug and Placebo pills looked identical.|Double Blind Placebo Control|t|t|t|
1340105|NCT03073863|Randomized|Parallel Assignment||Prevention||Double|Double-Blind|Parallel Assignment|t||t|
1340106|NCT03073850|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340107|NCT03073837||Single Group Assignment||Basic Science||None (Open Label)||||||
1340108|NCT03073824||Single Group Assignment||Treatment||None (Open Label)||||||
1340109|NCT03073811|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340110|NCT03073798|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1340111|NCT03073785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340112|NCT03073772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340113|NCT03073759||Single Group Assignment||Supportive Care||None (Open Label)||||||
1340114|NCT03073746|Randomized|Parallel Assignment||Other||Single|Healthcare providers will not have knowledge of the interventions assigned to individual participants.|Participants presenting with new symptoms to either an urgent care center or emergency department will be randomized in a 1:1:1 ratio to one of three groups. 1. Access to Health Search (i.e. Google's new health search platform for mobile devices; Health Knowledge Panels and Symptom Search Tool); 2. Access to Standard Search (i.e. prior version of Google search); 3. Usual Care. Groups 1 and 2 will use a tablet or mobile phone to search while group 3 will not.||t||
1340115|NCT03073733|Randomized|Parallel Assignment||Treatment||Double|Subjects, their family members and clinical staff performing key efficacy assessments will be masked to the randomization assignment of subjects. Due to the nature of some safety assessments and the sham treatment, not all personnel can be masked.||t|||t
1340116|NCT03073720|||Other||Prospective|||||||
1340117|NCT03073707|||Ecologic or Community||Prospective|||||||
1340118|NCT03073694|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340119|NCT03073681|||Cohort||Prospective|||||||
1340120|NCT03073668||Single Group Assignment||Treatment||None (Open Label)||||||
1340121|NCT03073655|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1340122|NCT03073642|Randomized|Parallel Assignment||Treatment||Double|Outcomes assessor will not know in which group volunteers are allocated; Care provider will not know outcome measures for any volunteers before study completion.|Double blind randomized controlled trial with 1:1 allocation||t|t|
1340123|NCT03073629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340124|NCT03073616|||Case-Crossover||Prospective|||||||
1340125|NCT03073603|Randomized|Parallel Assignment||Treatment||Single||||||t
1340126|NCT03073590|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||"To determine the impact of Hot lunch, iron -folate tablet and behaviour change communications program on the main outcome (i.e., prevalence of anemia) we used a quasi-experimental, controlled, pre-post design for both sets of interventions.~Intervention Description Two types of interventions was tested against controls in a total of 4 factories. Among factories that already provide a hot lunch to workers, one intervention and one control factory was selected, and among factories that do not provide hot lunches, one intervention and one control factory was selected."||||
1340127|NCT03073577||Single Group Assignment||Treatment||None (Open Label)||||||
1340128|NCT03073564|Randomized|Crossover Assignment||Treatment||None (Open Label)||The first arm of the study consists of the identification of patients who present dynamic hyperinflation (HD) through the incremental cardiopulmonary test for upper limbs. Following the HDP patients will perform a resistance test for the upper limbs with an application of EPAP. A final stage of the study will be a test for the upper limbs with an EPAP application.||||
1340129|NCT03073551|Randomized|Parallel Assignment||Prevention||None (Open Label)||"The control group will receive diabetes treatment and education as per standard of care.~The intervention group will receive diabetes treatment and education as per standard of care, and will also be given a Wii game console to bring home."||||
1340130|NCT03073538|||Cohort||Retrospective|||||||
1340131|NCT03073525|Randomized|Crossover Assignment||Treatment||None (Open Label)||Eligible patients will be randomized to receive two cycles of either Vigil alone or Atezolizumab alone, then followed by combination treatment with the two agents.||||
1340132|NCT03073512||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340133|NCT03073499|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340134|NCT03073486|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340135|NCT03073473|||Case-Control||Prospective|||||||
1340136|NCT03073460||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340137|NCT03073447||Single Group Assignment||Other||None (Open Label)||||||
1340138|NCT03073434|||Cohort||Retrospective|||||||
1340139|NCT03073421||Single Group Assignment||Health Services Research||None (Open Label)||||||
1340140|NCT03073408|Randomized|Parallel Assignment||Treatment||Single||Parallel Assignment|t|||
1340141|NCT03073395|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340142|NCT03073382|||Cohort||Retrospective|||||||
1340143|NCT03073369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340144|NCT03073356|Randomized|Crossover Assignment||Treatment||Triple||Randomized dobbel-blinded crossover|t||t|t
1340145|NCT03073343|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two cohorts of patients will be studied: Cohort 1 (diabetic) will consist of patients with a clinical diagnosis of non-insulin dependent type II diabetes mellitus; Cohort 2 (non-diabetics) will consist of patients without a clinical diagnosis of type 2 diabetes mellitus. 24 patients will be enrolled in each cohort (total of 48 patients enrolled in the study) with an anticipated drop out of 4 subjects per cohort.||||
1340146|NCT03073330|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340147|NCT03073317|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1340148|NCT03073304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340149|NCT03073291|Randomized|Parallel Assignment||Prevention||Double|Participants will be unaware of the psuedo-underage assessment of their retail recreational marijuana store. Pseudo-patron assessment teams will be unaware of the experimental condition to which each retail recreational marijuana store is assigned.||t|||t
1340150|NCT03073278|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|no masking|Group 1 will receive 36 grays (radiation dose unit Gy) in 6 treatments. Group 2 will receive 38 grays (Gy) in 6 treatments and Group 3 will receive 40 grays (Gy) in 6 treatments. If the first group of participants tolerate the treatment well and with minimal side effects, then the next group of participants will be given the same treatment but at the higher dose (38 Gy). If the second group tolerates this higher dose, then the third group of patients will be given a higher dose (40 Gy). This will be the final dose being tested in this investigation.||||
1340151|NCT03073265|||Cohort||Prospective|||||||
1340152|NCT03073252|Randomized|Crossover Assignment||Diagnostic||Triple|Care provider will randomize participants and keep the participant, investigator and outcomes assessor blinded to the randomization.|subject will consume either the 13g or 30g protein breakfast in a randomized cross-over manner|t||t|t
1340153|NCT03073239|||Cohort||Prospective|||||||
1340154|NCT03073226|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1340155|NCT03073213|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1340156|NCT03073200|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340157|NCT03073187|||Case-Only||Cross-Sectional|||||||
1340158|NCT03073174|||Cohort||Prospective|||||||
1340159|NCT03073161|||Cohort||Prospective|||||||
1340160|NCT03073148||||||||||||
1340161|NCT03073135|Randomized|Parallel Assignment||Treatment||Single||||||t
1340162|NCT03073122|||Cohort||Prospective|||||||
1340163|NCT03073109|||Cohort||Prospective|||||||
1340164|NCT03073096||Single Group Assignment||Prevention||None (Open Label)||All melanoma and other skin cancers (merkel cell carcinoma, squamous cell carcinoma as well as sarcoma patients requiring a nodal dissection (groin or axillary) will be offered to have a LVA at time of nodal dissection to prevent lymphedema.||||
1340165|NCT03073083|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1340166|NCT03073070|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340167|NCT03073057|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1340168|NCT03073044|||Cohort||Retrospective|||||||
1340169|NCT03073031|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340170|NCT03073018|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1340171|NCT03073005|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340172|NCT03072992|Randomized|Parallel Assignment||Treatment||Triple|Double Blind||t|t|t|
1340173|NCT03072979|||Cohort||Prospective|||||||
1340174|NCT03072966||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340175|NCT03072953||Single Group Assignment||Treatment||None (Open Label)||Open label||||
1340176|NCT03072940|||Case-Control||Prospective|||||||
1340177|NCT03072927|||Other||Other|||||||
1340178|NCT03072914|Randomized|Parallel Assignment||Prevention||Single||||||t
1340179|NCT03072901|||Cohort||Prospective|||||||
1340180|NCT03072888|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1340181|NCT03072875||Single Group Assignment||Prevention||None (Open Label)||||||
1340182|NCT03072862|||Cohort||Prospective|||||||
1340183|NCT03072849|||Cohort||Prospective|||||||
1340184|NCT03072836|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1340185|NCT03072823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340186|NCT03072810|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Participants will be aware that they are partaking in the programme and the researcher will see which arm each participant is in. However, participants will be allocated an anonymous code that will be used for storing and analysing outcome data.|Randomised wait-list control study||||
1340187|NCT03072797|||Cohort||Prospective|||||||
1340188|NCT03072784|Non-Randomized|Parallel Assignment||Other||Double|||t|||t
1340189|NCT03072771||Single Group Assignment||Treatment||None (Open Label)||||||
1340190|NCT03072758|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340191|NCT03072745||Single Group Assignment||Screening||None (Open Label)||||||
1340192|NCT03072732|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||2-arm study||||
1340193|NCT03072719|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340194|NCT03072706|Randomized|Parallel Assignment||Device Feasibility||Single|The patient assessor will be blinded to the patients' group allocation|Single-centre, patient-assessor blinded, parallel-group, randomised-controlled trial||||t
1340195|NCT03072693|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340196|NCT03072680|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340197|NCT03072667||||||||||||
1340198|NCT03072654|||Cohort||Prospective|||||||
1340199|NCT03072641|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1340200|NCT03072628|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1340201|NCT03072615|||Cohort||Prospective|||||||
1340202|NCT03072602|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Each participant will be enrolled into one of the two groups by race.||||
1340203|NCT03072589||Sequential Assignment||Treatment||None (Open Label)||Dose escalation study||||
1340204|NCT03072576|||Cohort||Prospective|||||||
1340205|NCT03072563|||Cohort||Prospective|||||||
1340206|NCT03072550||Single Group Assignment||Treatment||None (Open Label)||multi-center open-label study||||
1340207|NCT03072537|||Other||Prospective|||||||
1340208|NCT03072524|||Case-Only||Prospective|||||||
1340209|NCT03072511|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340210|NCT03072498|||Case-Control||Prospective|||||||
1340211|NCT03072485|Non-Randomized|Sequential Assignment||Basic Science||Double|||t|||t
1340212|NCT03072472|Randomized|Parallel Assignment||Prevention||Single||||||t
1340213|NCT03072459|||Cohort||Other|||||||
1340214|NCT03072446||Single Group Assignment||Treatment||None (Open Label)||||||
1340215|NCT03072433|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1340216|NCT03072420|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1340217|NCT03072407|Randomized|Parallel Assignment||Treatment||Single||placebo-control , parallel|t|||
1340218|NCT03072394|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1340219|NCT03072381|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340220|NCT03072368|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1340221|NCT03072355|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340222|NCT03072342|Randomized|Parallel Assignment||Treatment||Single||||||t
1340223|NCT03072329||Single Group Assignment||Treatment||None (Open Label)||||||
1340224|NCT03072316|||Case-Control||Retrospective|||||||
1340225|NCT03072303|||Cohort||Prospective|||||||
1340226|NCT03072290|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340227|NCT03072277|Randomized|Parallel Assignment||Prevention||Triple||Randomized, double blinded, parallel arm hospital based trial.|t|t|t|
1340228|NCT03072264|Randomized|Parallel Assignment||Treatment||Single||||||t
1340229|NCT03072251|||Ecologic or Community||Retrospective|||||||
1340230|NCT03072238|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340231|NCT03072225|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340232|NCT03072212|||Cohort||Prospective|||||||
1340233|NCT03072199||Single Group Assignment||Treatment||None (Open Label)||Phase 1/2 unblinded interventional dose escalation study||||
1340234|NCT03072186||||||||||||
1340235|NCT03072173|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1340236|NCT03072160|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340237|NCT03072147|Randomized|Parallel Assignment||Treatment||Quadruple|Researchers, providers, and subjects will be blinded to treatment group so that outcomes will not be influenced by expectations about the experimental treatment.|This is a prospective, randomized, placebo controlled, double blinded study. Interim results will determine if there is a crossover.|t|t|t|t
1340238|NCT03072134|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||A Phase I study of neural stem cell based virotherapy in combination with standard radiation and chemotherapy for patients with newly diagnosed malignant glioma||||
1340239|NCT03072121|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340240|NCT03072108|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1340241|NCT03072095|Randomized|Parallel Assignment||Screening||Single|||||t|
1340242|NCT03072082|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340243|NCT03072069|||Case-Only||Prospective|||||||
1340244|NCT03072056|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1340245|NCT03072043|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Phase 1b Dose Escalation followed by Phase 2 treatment. Participants will be evaluable for inclusion in the Phase 1b and Phase 2 portions of the study if they receive at least one dose of protocol therapy.||||
1340246|NCT03072030|Randomized|Parallel Assignment||Prevention||Double||This clinical trial is designed as a double blind randomized placebo-controlled study|t||t|
1340247|NCT03072017||Single Group Assignment||Treatment||None (Open Label)||||||
1340248|NCT03072004|Randomized|Parallel Assignment||Treatment||Double||"We will analyze leprosy patients with neuropathy. These patients will be randomly divided in: (a) Control: who will receive simulated application sham of LLLT; and (b) LLLT: who will receive LLLT (830 nm, continuous emission, 100mW output power and 3J power density). Treatments will occur in 12 sessions (3 times per week) on the nerves: a)ulnar: around the ulnar nerve at the elbow region, and b)common peroneal: surrounding fibular head. For the inclusion criteria will be selected leprosy patients (tuberculoid and borderline tuberculoid forms) with focal demyelinating neuropathy of the ulnar and common peroneal nerves by electroneuromyography (ENMG); patients without leprosy reactions and corticoid use. We will perform measurements of the following parameters before and after the LLLT protocol application: ENMG Muscle Strength; Tactile Sensitivity measured; Pain Intensity; Incapacity grade; Infrared thermography; Screening of Activity Limitation and Safety Awareness scale."|t||t|
1340249|NCT03071991|||Cohort||Prospective|||||||
1340250|NCT03071978|||Case-Control||Prospective|||||||
1340251|NCT03071965|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1340252|NCT03071952|||Case-Crossover||Prospective|||||||
1340253|NCT03071939||Single Group Assignment||Other||None (Open Label)||One arm in this study comprising 119 patients and one of their relatives||||
1340254|NCT03071926||Single Group Assignment||Treatment||None (Open Label)||||||
1340255|NCT03071913|||Case-Control||Prospective|||||||
1340256|NCT03071900|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1340257|NCT03071887||Single Group Assignment||Other||None (Open Label)||This is an open pilot of the adapted Relaxation Response Resiliency Program (3RP).||||
1340258|NCT03071874||Single Group Assignment||Treatment||None (Open Label)||||||
1340259|NCT03071861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340260|NCT03071848|||Cohort||Retrospective|||||||
1340261|NCT03071835|||Case-Control||Other|||||||
1340262|NCT03071822||Single Group Assignment||Treatment||None (Open Label)||Patient will be given this combination of chemotherapy (cisplatin, ifosfamide, gemcitabine, L-asparaginase, etoposide and dexamethasone) for a total of 6 courses.||||
1340263|NCT03071809|||Case-Control||Prospective|||||||
1340264|NCT03071796|Randomized|Parallel Assignment||Prevention||Double|double-blind||t||t|
1340265|NCT03071783|Randomized|Parallel Assignment||Prevention||Single||||||t
1340266|NCT03071770||Single Group Assignment||Treatment||None (Open Label)||||||
1340267|NCT03071757|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340268|NCT03071744||Single Group Assignment||Supportive Care||None (Open Label)||||||
1340269|NCT03071731|Randomized|Crossover Assignment||Other||Triple|Randomization to decide on which visit the participant will receive the placebo will be generated by a software and managed by the main investigator. Bronchodilators and the placebo will be put in an aerosol of same shape and color so the participants and outcomes assessor won't be able to tell which one is which.|Participants receive one intervention (bronchodilation before performing a functional test) during the initial phase of the study and during the second phase of the study are evaluated in parallel after receiving a placebo or vice versa (random order)|t|t||t
1340270|NCT03071718|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340271|NCT03071705|Randomized|Parallel Assignment||Other||Double|||t||t|
1340272|NCT03071692|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1340273|NCT03071679|Randomized|Factorial Assignment||Other||Quadruple|||t|t|t|t
1340274|NCT03071666|Randomized|Parallel Assignment||Prevention||Quadruple|We will randomize women in a 1:1 ratio. The vitamin B12 supplements and the placebos will be produced specifically for this trial and be identical in taste and appearance. Each woman will be assigned a packet of medicines according to her id number. This packet will only be labeled with general information about the study and a unique id number. The list that links the id number to the randomization code will be kept with the company that produces the intervention and the placebo, and with the scientist who will generate the randomization code. This scientist will otherwise not be involved in the study. None of the investigators will have access to this list until completion of data collection and cleaning of data for the main outcomes.||t|t|t|t
1340275|NCT03071653|Randomized|Parallel Assignment||Other||None (Open Label)||Randomised Control Trial||||
1340276|NCT03071640|||Cohort||Prospective|||||||
1340277|NCT03071627|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis.|Two arms, parallel group, randomized controlled trial|t|||
1340278|NCT03071614|Randomized|Parallel Assignment||Other||Single|Participants will be blinded to the study hypothesis.|Two arms, parallel group, randomized controlled trial|t|||
1340279|NCT03071601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340280|NCT03071588|Randomized|Parallel Assignment||Treatment||Double||Two groups of patients, each group received the investigated intervention at baseline and being followed up in parallel for one year.|t|||t
1340281|NCT03071575|Randomized|Parallel Assignment||Prevention||None (Open Label)|Open label|||||
1340282|NCT03071562|Randomized|Parallel Assignment||Treatment||Single|Cognition, motor function (balance, walking speed), and affective (mental health, quality of life, medication adherence) evaluations will be administered at baseline and post-intervention (12 weeks) by a trained physiotherapist, blinded to the group assignment. The rationale for blinding the assessing physiotherapist is to reduce bias in scoring during the outcome assessment sessions.|||||t
1340283|NCT03071549|Randomized|Parallel Assignment||Treatment||Triple||RCT|t|t||t
1340284|NCT03071536||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340285|NCT03071523|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340286|NCT03071510|||Cohort||Cross-Sectional|||||||
1340287|NCT03071497|||Cohort||Prospective|||||||
1340288|NCT03071484|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340289|NCT03071471|||Cohort||Prospective|||||||
1340290|NCT03071458|||Cohort||Retrospective|||||||
1340291|NCT03071445|||Cohort||Prospective|||||||
1340292|NCT03071432|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Non-diabetic patients, n=15 Diabetic patients with cardiovascular autonomic neuropathy, n=15 Diabetic patients without cardiovascular autonomic neuropathy, n=15||||
1340293|NCT03071419|Non-Randomized|Parallel Assignment||Prevention||Single|The interventionists will not be aware of whether participants are in the intervention or wait-list control group.|||t||
1340294|NCT03071406|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are randomly assigned in a 1:1 ratio to Arm A (nivolumab + ipilimumab), or Arm B (nivolumab + ipilimumab + SBRT).||||
1340295|NCT03071393|Randomized|Crossover Assignment||Treatment||Single|Subjects will be asked to participate in two visits at least 7 days apart. Subjects will be assessed on various clinical outcomes before and after an exposure to one of two treatments. In one visit, subjects will be assessed before and after acute intermittent hypoxia, consisting of brief exposures of breathing low oxygen air, alternated with brief exposures to room air. In the other visit, subjects will be assessed before and after an exposure to a sham treatment, consisting of breathing brief exposures of normal oxygen air, alternated with brief exposures to room air. Subjects will undergo acute intermittent hypoxia or a sham treatment in a randomized order.||t|||
1340296|NCT03071380|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1340297|NCT03071367|Randomized|Parallel Assignment||Other||Double|||||t|t
1340298|NCT03071354|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340299|NCT03071341||Single Group Assignment||Treatment||None (Open Label)||Patients will be assigned to 1.0, 3.0 or 6.0 mg/kg (same dose taken during the previous study, AGT-181-101)||||
1340300|NCT03071328|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340301|NCT03071315|||Cohort||Prospective|||||||
1340302|NCT03071302|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1340303|NCT03071289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340304|NCT03071276||Single Group Assignment||Treatment||None (Open Label)||||||
1340305|NCT03071263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340306|NCT03071250|||Cohort||Retrospective|||||||
1340307|NCT03071237|||Case-Only||Prospective|||||||
1340308|NCT03071224||Single Group Assignment||Other||None (Open Label)||||||
1340309|NCT03071211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340310|NCT03071198|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"This strategy is called neoadjuvant hierarchical treatment based on chemotherapy for rectal cancer. All patients with T3-4N0-2M0 middle and lower rectal caner will firstly receive neoadjuvant chemotherapy consisting of four cycles of XELOX. After four cycles, the patients achieved cCR or cPR will be perform the operation. And the patients who can not achieve cCR or cPR after the four cycles, then concurrent chemoradiotherapy will be added."||||
1340311|NCT03071185|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1340312|NCT03071172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340313|NCT03071159||Single Group Assignment||Supportive Care||None (Open Label)||||||
1340314|NCT03071146|||Cohort||Prospective|||||||
1340315|NCT03071133|||Cohort||Prospective|||||||
1340316|NCT03071120||Single Group Assignment||Treatment||None (Open Label)||One group, pre, post-test||||
1340317|NCT03071107|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340318|NCT03071094||Single Group Assignment||Treatment||None (Open Label)||||||
1340319|NCT03071081|Randomized|Parallel Assignment||Treatment||Quadruple||3 dose groups (2 arms per dose group)|t|t|t|t
1340320|NCT03071068|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340778|NCT03065114|||Cohort||Retrospective|||||||
1340321|NCT03071055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1340322|NCT03071042||Single Group Assignment||Treatment||None (Open Label)||||||
1340323|NCT03071029|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340324|NCT03071016|||Cohort||Prospective|||||||
1340325|NCT03071003|Randomized|Sequential Assignment||Basic Science||Double|||t||t|
1340326|NCT03070990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340327|NCT03070977|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340328|NCT03070964||Single Group Assignment||Treatment||None (Open Label)||||||
1340329|NCT03070951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340330|NCT03070938|||Case-Only||Prospective|||||||
1340331|NCT03070925|||Case-Only||Prospective|||||||
1340332|NCT03070912|||Cohort||Prospective|||||||
1340333|NCT03070899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340334|NCT03070886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340335|NCT03070873|Randomized|Parallel Assignment||Device Feasibility||Double|In the study the operation was performed by three surgeons, the patients received surgery by the doctor when the patients saw in the outpatient clinic.|"The investigators divided the patients randomly into three groups:~The group A was a total of 91 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction combined Perigee and Apogee polypropylene mesh(PA)；~The group B was a total of 97 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction with Gynecare prolift polypropylene mesh；~The group C was a total of 70 patients who accepted transvaginal hysterectomy and anterior and posterior vaginal wall repair without any mesh."|t||t|
1340336|NCT03070860||Single Group Assignment||Basic Science||None (Open Label)||||||
1340337|NCT03070847|Randomized|Parallel Assignment||Supportive Care||Triple|Blinded (participant, care provider, investigator). Computer block randomisation tool will be used (randomisation.com 1 block, 50 subjects per block), 50 notes with '5 mg/kg' or '10 mg/kg' will be put into sealed envelopes.||t|t|t|
1340338|NCT03070834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340339|NCT03070821|Non-Randomized|Parallel Assignment||Treatment||Single|Healthy subjects in the sham feedback condition were not aware of their group membership, but were debriefed at the end of the study.|The design is a pre-test/post-test study with an intervention of three parallel groups. The groups are a healthy elderly experimental group, a patient group and a healthy elderly sham-feedback group.|t|||
1340340|NCT03070808|||Other||Prospective|||||||
1340341|NCT03070795|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340342|NCT03070782|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1340343|NCT03070769|||Case-Control||Cross-Sectional|||||||
1340344|NCT03070756||Single Group Assignment||Treatment||None (Open Label)||||||
1340345|NCT03070743|||Cohort||Prospective|||||||
1340346|NCT03070730|Randomized|Crossover Assignment||Treatment||Triple||"The study design is a double-dummy design. While during two of the three trial arms the patients take an active study drug and a placebo, there is also an arm where patients take only placebo."|t||t|t
1340347|NCT03070717|||Cohort||Prospective|||||||
1340348|NCT03070704|||Cohort||Prospective|||||||
1340349|NCT03070691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340350|NCT03070678||Single Group Assignment||Basic Science||None (Open Label)||||||
1340351|NCT03070665|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1340352|NCT03070652|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340353|NCT03070639|Randomized|Parallel Assignment||Prevention||Single||||||t
1340354|NCT03070626|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1340355|NCT03070613||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340356|NCT03070600|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||We will select 20 clinics from Western Kenya. Ten clinics will be randomized to universal PrEP and ten to targeted PrEP (Table 2). To ensure balance between study arms in terms of key site characteristics, sites will be categorized on HIV prevalence and ANC volume, and restricted randomization will be used for site (cluster) allocation to intervention and control arms (68).||||
1340357|NCT03070587|Randomized|Parallel Assignment||Treatment||Single|||||t|
1340358|NCT03070574|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1340359|NCT03070561||Single Group Assignment||Other||None (Open Label)||Open label, crossover, local pharmacokinetics study||||
1340360|NCT03070548|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340361|NCT03070535|Randomized|Crossover Assignment||Basic Science||Single|Subject is not told which meal, HIGH or LOW, they receive at each meal visit until after they have completed the study. At the conclusion of study participation for each subject (after their second meal), they are told which of their meals was HIGH and which one was LOW.|Subjects will be randomized to receive either the LOW or HIGH meal for their first meal and will cross-over and receive the alternate meal for their next meal. Meals are on separate days.|t|||
1340362|NCT03070522|Randomized|Parallel Assignment||Treatment||Quadruple|placebo|Randomized placebo controlled trial|t|t|t|t
1340363|NCT03070509|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340364|NCT03070496||Single Group Assignment||Basic Science||None (Open Label)||||||
1340365|NCT03070483||Single Group Assignment||Prevention||None (Open Label)||This pilot study is a one arm study which will assess the safety and feasibility of supplementing 15 young adults with African ancestry and low vitamin D levels with 5,000 IU of Cholecalciferol (vitamin D3) combined with 1000 mg of elemental calcium daily for 3 months||||
1340366|NCT03070470|Randomized|Parallel Assignment||Other||Quadruple||"This clinical study consists of 2 parts:~50 subjects in Part 1 will be randomized to receive one of four drugs (ranolazine, verapamil, lopinavir / ritonavir, chloroquine) or placebo over 3 days.~10 subjects in Part 2 will be randomized to receive one of two treatment sequences (1. dofetilide or 2. diltiazem combined with dofetilide) over 3 days, then after washout, the subjects will receive the other treatment sequence over 3 days. Thus, Part 2 will have a cross-over component.~A maximum of 14 additional replacement subjects may be enrolled."|t|t|t|t
1340367|NCT03070457|Randomized|Parallel Assignment||Treatment||Single||||||t
1340368|NCT03070444|Randomized|Parallel Assignment||Treatment||Single||||||t
1340369|NCT03070431||Single Group Assignment||Treatment||None (Open Label)||Single arm study||||
1340370|NCT03070418||Single Group Assignment||Treatment||None (Open Label)||||||
1340371|NCT03070405|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1340372|NCT03070392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340373|NCT03070379|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1340374|NCT03070366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340375|NCT03070353||Single Group Assignment||Treatment||None (Open Label)||Focus on clinical response after receiving treatment||||
1340376|NCT03070340||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340377|NCT03070327||Single Group Assignment||Treatment||None (Open Label)||This is an open-label, dose escalating, nonrandomized, single-center, phase I study of EGFRt/BCMA-41BBz CAR T cells in patients with a diagnosis of MM. Dose escalation will follow a standard 3-by-3 escalation design. Cohorts of 3-6 patients will be infused with escalating doses of EGFRt/BCMA-41BBz CAR T cells to establish the maximum tolerated dose (MTD). After a dose level has been determined safe to escalate (DLT in 0/3 or 1/6 patients), a parallel cohort at that dose level will be conducted while patients are taking Lenalidomide.||||
1340378|NCT03070314||Single Group Assignment||Basic Science||None (Open Label)||The study participants take 5 tablets Echinaforce junior at once one after another per os. registered in Switzerland for children from age of 4 -12 years Six capillary blood draws are taken at the following time points: Start (0), after 15, 30, 60, 90, 270 minutes and then analyzed on the amount of tetraen. Bioavailability parameters will thereafter be calculated.||||
1340379|NCT03070301||Single Group Assignment||Treatment||None (Open Label)||This will be a multicenter, non-randomized, open-label phase II clinical trial.||||
1340380|NCT03070288|||Case-Control||Cross-Sectional|||||||
1340381|NCT03070275|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor is not aware of the treatment modality|Prospective, randomised, single blind, control clinical trial||||t
1340382|NCT03070262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340383|NCT03070249|||Case-Only||Prospective|||||||
1340384|NCT03070236||Single Group Assignment||Supportive Care||None (Open Label)||||||
1340385|NCT03070223|||Cohort||Prospective|||||||
1340386|NCT03070210|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1340387|NCT03070197|||Case-Control||Prospective|||||||
1340388|NCT03070184|Non-Randomized|Parallel Assignment||Other||Single||||||t
1340389|NCT03070171|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1340390|NCT03070158|Non-Randomized|Sequential Assignment||Supportive Care||Single||The assignment of the mothers to each group will be like that: First at all, mother will be assignment to control group. They will received usual care when achieve the total of 74 mothers, the mothers will be assigned to intervention group.|t|||
1340391|NCT03070145|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340392|NCT03070132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340393|NCT03070119|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1340394|NCT03070106|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparison between the functional medicine (FM) group and the usual care group||||
1340395|NCT03070093||||||||||||
1340396|NCT03070080|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1340397|NCT03070067|||Cohort||Prospective|||||||
1340398|NCT03070054|Randomized|Parallel Assignment||Treatment||Double|Participants, anesthesiologists and PACU nurses will be blinded to group assignment, however the surgeon administering the LIA will be unblinded.||t|t||
1340399|NCT03070041||Single Group Assignment||Supportive Care||None (Open Label)||||||
1340400|NCT03070028|Randomized|Parallel Assignment||Treatment||Single||||||t
1340401|NCT03070015|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel Assignment||||
1340402|NCT03070002||Single Group Assignment||Treatment||None (Open Label)||||||
1340403|NCT03069989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340404|NCT03069976||Single Group Assignment||Treatment||None (Open Label)||||||
1340405|NCT03069963|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1340406|NCT03069950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340407|NCT03069937||Single Group Assignment||Treatment||None (Open Label)||||||
1340408|NCT03069924|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1340409|NCT03069911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340410|NCT03069898|Randomized|Parallel Assignment||Prevention||None (Open Label)||Paraticipants are randomly assigned to intervention (TRUE Dads) and Control tracks, assessed at Baseline and again one year later. The intervention primarily involves attendance at 12 3-hour workshops for fathers and their co-parents.||||
1340411|NCT03069885|Randomized|Parallel Assignment||Treatment||None (Open Label)|The study will not be blinded, since the PrevenaTM-device makes a sound, when generating negative pressure, and the dressing looks a lot different compared to the conventional post-operative dressing.|The project is conducted as a randomized controlled trial. Patients included in the study will be randomized to either conventional post-operative dressing or PrevenaTM iNPWT treatment. Patients are allocated in a 1:1 ratio, with 30 patients treated with PrevenaTM and 30 patients treated with conventional post-operative dressing.||||
1340412|NCT03069872||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340413|NCT03069859|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1340414|NCT03069846||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340415|NCT03069833|Randomized|Factorial Assignment||Diagnostic||Double|||t||t|
1340416|NCT03069820||Single Group Assignment||Screening||None (Open Label)||||||
1340460|NCT03069248||Single Group Assignment||Treatment||None (Open Label)||||||
1340461|NCT03069235|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340462|NCT03069222|||Case-Control||Prospective|||||||
1340417|NCT03069807|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Cluster-randomised trial evaluating treatment completion (the primary outcome), uptake, acceptability, safety and cost-effectiveness of treating latent tuberculosis infection (LTBI) in migrants in primary care, compared with secondary care.||||
1340418|NCT03069794||Single Group Assignment||Other||None (Open Label)||||||
1340419|NCT03069781|Randomized|Parallel Assignment||Basic Science||Quadruple|Both forms of supplementation (estrogen and placebo) will be packaged and administered in identical fashion.|Parallel-group, double-blinded, randomized controlled trial.|t|t|t|t
1340420|NCT03069768|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340421|NCT03069755|||Cohort||Retrospective|||||||
1340422|NCT03069742|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340423|NCT03069729|||Other||Prospective|||||||
1340424|NCT03069716|Randomized|Parallel Assignment||Treatment||Triple|"Investigators are blinded.~Study personnel conducting 6MWT and echo will be blinded."|Randomization will occur after a two-week run-in period to improve ability to identify a true baseline step count and account for potential dropout. Participants will be assigned to either the smartphone text messaging or no smartphone text messaging arms in a random manner until 25 participants are enrolled into each arm. Permuted block randomization stratified by functional class (I/II vs. III) will be used to ensure approximate balance of treatment groups within each stratum over time. Randomization will be performed in small blocks, which vary in size. Investigators will be unaware of the size or order of the blocks. Randomization will occur through REDCap by a study coordinator. Although the texting intervention will end after Week 12, subjects in both groups will be asked to continue wearing the Fitbit Charge HR device for an additional 3 weeks to determine whether withdrawal of the texting intervention results in a reduction in step counts.||t|t|t
1340425|NCT03069703|Randomized|Parallel Assignment||Prevention||Single|The central laboratory performing the immunogenicity assessment (ELISA and OPA) will be blinded for the trial arm in order to limit measurement bias.|||||t
1340426|NCT03069690|Randomized|Sequential Assignment||Treatment||None (Open Label)||The intervention model is a nonrestricted sequential multiple assignment randomized trial (SMART). Participants are randomized to intervention or control during pregnant and again postpartum.||||
1340427|NCT03069677|Randomized|Parallel Assignment||Treatment||None (Open Label)||1:1||||
1340428|NCT03069664|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340429|NCT03069651|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340430|NCT03069638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1340431|NCT03069625|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1340432|NCT03069612|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340433|NCT03069599|||Cohort||Prospective|||||||
1340434|NCT03069586|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1340435|NCT03069573|||Case-Crossover||Prospective|||||||
1340436|NCT03069560||Single Group Assignment||Prevention||None (Open Label)||||||
1340437|NCT03069547|Randomized|Parallel Assignment||Treatment||Double|"Investigators, study coordinators, outcome assessors, clinical staff, study staff, and other personnel directly involved in the clinical activities of the study, will be blinded to the group allocation.~Participants and providers of the exercise delivery are not blinded to the group allocation."|"Eligible participants will be randomly assigned (1:1) to one of the two following groups:~QE - quadriceps exercise program~HE - hip exercise program"|||t|t
1340438|NCT03069534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340439|NCT03069521||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1340440|NCT03069508|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340441|NCT03069495|||Case-Control||Cross-Sectional|||||||
1340442|NCT03069482|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||Subjects will be assigned to one of two smoking cessation apps for the duration of the study: Learn to Quit or NCI QuitGuide. One app was designed to address the needs of people with serious mental illness (Learn to Quit) and the other was designed for the general population (NCI QuitGuide).||||
1340443|NCT03069469||Sequential Assignment||Treatment||None (Open Label)||||||
1340444|NCT03069456|Randomized|Crossover Assignment||Treatment||None (Open Label)||Combined sigmoidal Emax models from anesthetic depth monitoring for sedation (ADMS) and combined sigmoidal Emax models from bispectral index (BIS) via population pharmacodynamic approach.||||
1340445|NCT03069443|Randomized|Parallel Assignment||Treatment||Single||||||t
1340446|NCT03069430|||Cohort||Cross-Sectional|||||||
1340447|NCT03069417|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1340448|NCT03069404|||Other||Prospective|||||||
1340449|NCT03069391|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Crossover RCT: participants are randomly assigned to start with one form of intervention and then crossover to another form of the intervention.||||
1340450|NCT03069378||Single Group Assignment||Treatment||None (Open Label)||This is a single-center, phase II study to evaluate the efficacy of the oncolytic herpes virus talimogene laherparepvec, given in combination with pembrolizumab for patients with metastatic and/or locally advanced sarcomas.||||
1340451|NCT03069365|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340452|NCT03069352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340453|NCT03069339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340454|NCT03069326||Single Group Assignment||Treatment||None (Open Label)||This is a multicenter, two stage phase II trial designed to assess the effect of ruxolitinib and thalidomide combination in subjects with Primary, Post Polycythemia Vera, or Post Essential Thrombocythemia Myelofibrosis (PMF, post-PV MF, or post-ET MF).||||
1340455|NCT03069313||Single Group Assignment||Treatment||None (Open Label)||Vitamin B12 is to be taken sublingually on a daily basis for 90 days||||
1340456|NCT03069300|Randomized|Parallel Assignment||Treatment||None (Open Label)||randomized controlled trial||||
1340457|NCT03069287||Single Group Assignment||Supportive Care||None (Open Label)||||||
1340458|NCT03069274|Randomized|Parallel Assignment||Prevention||Single||||||t
1340459|NCT03069261|||Case-Control||Retrospective|||||||
1340463|NCT03069209||Single Group Assignment||Treatment||None (Open Label)||||||
1340464|NCT03069196|||Cohort||Prospective|||||||
1340465|NCT03069183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340466|NCT03069170|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1340467|NCT03069157|Randomized|Parallel Assignment||Prevention||Quadruple|Randomization will be done by computer generated numbers and concealed by serially numbered,opague and sealed envelopes. The details of the series will be unknown to the investigators and the group assignment will be kept in asset of sealed envelopes each bearing only the case number on the outside. Prior to surgery the appropriate numbered envelopes will be opened by the nurse, the card inside will determine the patient group||t|t|t|t
1340468|NCT03069144|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340469|NCT03069131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340470|NCT03069118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340471|NCT03069105|||Cohort||Prospective|||||||
1340472|NCT03069092|Randomized|Parallel Assignment||Prevention||Single||||||t
1340473|NCT03069079||Single Group Assignment||Treatment||None (Open Label)||||||
1340474|NCT03069066||Single Group Assignment||Treatment||None (Open Label)||||||
1340475|NCT03069053|||Cohort||Other|||||||
1340476|NCT03069040|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340477|NCT03069027|Randomized|Parallel Assignment||Prevention||Single|||t|||
1340478|NCT03069014|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340479|NCT03069001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340480|NCT03068988|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340481|NCT03068975|Randomized|Parallel Assignment||Prevention||Triple||Will create a double blind, randomized, parallel design study to evaluate the effectiveness of Alvimopan(post operative dose) in preventing post-operative ileus in poly-traumatized patients|t|t|t|
1340482|NCT03068962|Randomized|Crossover Assignment||Treatment||Single|||t|||
1340483|NCT03068949|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1340484|NCT03068936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340485|NCT03068923|||Cohort||Prospective|||||||
1340486|NCT03068910|Randomized|Crossover Assignment||Basic Science||Quadruple|Treatment allocation will be double-blinded. The blind will be broken in the event of substantial adverse effects that would also lead to study withdrawal. The blind for a given subject will be lifted after the subject completes the study and analysis is complete for that subject.|Randomized, placebo-controlled, crossover study|t|t|t|t
1340487|NCT03068897|Randomized|Parallel Assignment||Treatment||Quadruple|Medications provided to patients are encapsulated. Medications vials are labelled with investigational stickers.||t|t|t|t
1340488|NCT03068884|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1340489|NCT03068871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340490|NCT03068858|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1340491|NCT03068845|Randomized|Parallel Assignment||Treatment||Triple|The participants, referring physicians, outcomes assessors and data analysis team will be masked. The procedurist will not be masked since it is not possible to perform the procedure without masking. The procedurist will not be involved in outcomes assessment.||t|t||t
1340492|NCT03068832||Single Group Assignment||Treatment||None (Open Label)||||||
1340493|NCT03068819||Single Group Assignment||Treatment||None (Open Label)||||||
1340494|NCT03068806|||Case-Control||Cross-Sectional|||||||
1340495|NCT03068793|||Case-Control||Cross-Sectional|||||||
1340496|NCT03068780|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340497|NCT03068767|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Group 1: vitamin D supplement Group 2: controls||||
1340498|NCT03068754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340499|NCT03068741|Randomized|Factorial Assignment||Treatment||Quadruple|The study drug and placebo are prepared in identical masked containers.|"This is a 2x2 factorial RCT, with simultaneous randomization of individual patients into 2 randomized controlled trials.~The first RCT compares administration of 1g of intramuscular ceftriaxone versus placebo. In this RCT, participants, care providers, investigators, and outcome assessors will all be masked to the treatment allocation.~The second RCT compares a liberal fluid resuscitation (up to 2litres of intravenous 0.9% saline) versus conventional resuscitation (administration of intravenous 0.9% saline, started only when systolic blood pressure is <90mmHg and only continued until systolic blood pressure is >= 100mmHg). In this RCT, only participants and outcome assessors will be masked."|t|t|t|t
1340500|NCT03068728|Randomized|Parallel Assignment||Treatment||None (Open Label)||After sinus sugery, the surgeon will randomize the patient to one of six hemostatic agents and place that product in one sinus cavity, while leaving the other sinus cavity without packing.||||
1340501|NCT03068715|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340502|NCT03068702|||Case-Only||Retrospective|||||||
1340503|NCT03068689|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340504|NCT03068676|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340505|NCT03068663|Non-Randomized|Parallel Assignment||Other||None (Open Label)||"2 groups of patients will be follow :~Pchir : Non small cell lung carcinoma patients with an indication of immediate surgery.~Pct-chir : Non small cell lung carcinoma patients with an indication of neoadjuvant chemotherapy before the surgery."||||
1340506|NCT03068650||||||||||||
1340507|NCT03068637||Single Group Assignment||Supportive Care||None (Open Label)||||||
1340508|NCT03068624||Single Group Assignment||Treatment||None (Open Label)||||||
1340509|NCT03068611|Randomized|Parallel Assignment||Treatment||Single||||||t
1340510|NCT03068598||Single Group Assignment||Device Feasibility||None (Open Label)||The subject will receive a watch connected to a smartphone, wear at night and objectively evaluate sleep in ecological conditions||||
1340511|NCT03068585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340512|NCT03068572|||Case-Control||Prospective|||||||
1340513|NCT03068559|||Case-Only||Prospective|||||||
1340514|NCT03068546|||Cohort||Prospective|||||||
1340515|NCT03068533|Randomized|Parallel Assignment||Treatment||Quadruple|similar empty tubes filled by the control and intervention toothpaste then sealed and given a number only.The patients,care provider,outcome assessor and investigator are blinded to the intervention and control toothpaste.||t|t|t|t
1340516|NCT03068520|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||"to use the combined data obtained by PET-MRI scanning regarding amino acid metabolic profile, functional and morphological details in order to:~Distinguish between progressive tumor and treatment related effects~To identify pseudoresponse to antiangiogenic therapy from tumor progression~To optimize the study protocol of PET-MRI for future routine clinical application."||||
1340517|NCT03068507|Randomized|Parallel Assignment||Prevention||Quadruple|The participant didn't know their group allocation. The doctor of assessment was blinded to group allocation.|patients were randomly assigned to the prehabilitation group and control group by computer-based random numbers concealed in sealed envelopes|t|t|t|t
1340518|NCT03068494|||Cohort||Cross-Sectional|||||||
1340519|NCT03068481|Randomized|Parallel Assignment||Other||Single|Healthy volunteer part -Multiple dose: Participant, Healthy volunteer part -Single dose and Patient part: No Masking|Healthy volunteer part -Multiple dose: Parallel, Healthy volunteer part -Single dose and Patient part: Single Group|t|||
1340520|NCT03068468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340521|NCT03068455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340522|NCT03068442||Single Group Assignment||Diagnostic||None (Open Label)||This is a diagnostic-interventional cohort study in patients undergoing carotid endarterectomy for atherosclerotic disease.||||
1340523|NCT03068429||Single Group Assignment||Basic Science||None (Open Label)||4-weeks open label trial of sertraline up to 200mg/day treatment for obsessive compulsive disorder||||
1340524|NCT03068416||Single Group Assignment||Treatment||None (Open Label)||||||
1340525|NCT03068403|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340526|NCT03068390|Randomized|Parallel Assignment||Prevention||Single||2 group randomized controlled trial|t|||
1340527|NCT03068377|Randomized|Parallel Assignment||Supportive Care||Quadruple|randomized double blind|Single-phase, randomized, parallel, double blind , comparative study of LYC-001e versus placebo on ocular blood vessels in healthy individuals|t|t|t|t
1340528|NCT03068364|||Cohort||Retrospective|||||||
1340529|NCT03068351|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1340530|NCT03068338|Randomized|Parallel Assignment||Device Feasibility||Single||||||t
1340531|NCT03068325||Single Group Assignment||Treatment||None (Open Label)||||||
1340532|NCT03068312|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1340533|NCT03068299|Randomized|Parallel Assignment||Prevention||None (Open Label)||The dance protocol will be applied to the experimental group (n=29) in the USFs and the control group (n=29) will receive health care, including guidance on health care and practices||||
1340534|NCT03068286|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340535|NCT03068273|Randomized|Parallel Assignment||Other||Single|||t|||
1340536|NCT03068260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340537|NCT03068247|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1340538|NCT03068234|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340539|NCT03068221|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340540|NCT03068208|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1340541|NCT03068195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340542|NCT03068182|Randomized|Parallel Assignment||Prevention||Double|by a blinded and independent research assistant who opened sealed envelopes that contained a computer-generated randomization card|Parallel assignments|t||t|
1340543|NCT03068169|||Cohort||Prospective|||||||
1340544|NCT03068156|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1340545|NCT03068143|||Case-Only||Prospective|||||||
1340546|NCT03068130||Single Group Assignment||Treatment||None (Open Label)||||||
1340547|NCT03068117|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340548|NCT03068104|||Cohort||Retrospective|||||||
1340549|NCT03068091||Single Group Assignment||Basic Science||None (Open Label)||All participants will undergo CT and pulmonary function testing.||||
1340550|NCT03068078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340551|NCT03068065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340552|NCT03068052|Randomized|Parallel Assignment||Screening||Single|||||t|
1340553|NCT03068039|Randomized|Crossover Assignment||Basic Science||Single|Single blind (Investigator blind)||||t|
1340554|NCT03068026|Randomized|Crossover Assignment||Treatment||None (Open Label)||This is a randomized crossover trial. The two exercise modalities will be separately assessed in different groups of patients, but within each group the intervention (VitaBreath) will be compared to control (pursed-lip breathing).||||
1340555|NCT03068013|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340556|NCT03068000|Randomized|Parallel Assignment||Other||Double|The investigator and the evaluators will be blind as well as the allocation.|Judo training and Ball games|||t|t
1340557|NCT03067987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340558|NCT03067974||Single Group Assignment||Treatment||None (Open Label)||Children who meet inclusion and exclusion criteria will be approached for participation in the study.||||
1340559|NCT03067961|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1340560|NCT03067948||Single Group Assignment||Health Services Research||None (Open Label)||||||
1340561|NCT03067935||||||||||||
1340562|NCT03067922|||Cohort||Prospective|||||||
1340563|NCT03067909|||Cohort||Prospective|||||||
1340564|NCT03067896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340565|NCT03067883||Single Group Assignment||Treatment||None (Open Label)||Prospective, cohort, open label trial||||
1340566|NCT03067870||Single Group Assignment||Treatment||None (Open Label)||||||
1340567|NCT03067857||Single Group Assignment||Treatment||None (Open Label)||||||
1340568|NCT03067844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340569|NCT03067831||Single Group Assignment||Treatment||None (Open Label)||||||
1340570|NCT03067818|Randomized|Crossover Assignment||Treatment||Single|The individual that conducts the tests of arm movement will be unaware of which brain area was stimulated.|Each participant will receive stimulation targeting each brain area. The order in which the stimulation sites are targeted for each participant is randomized and there is a washout period of several weeks between each treatment.||||t
1340571|NCT03067805|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1340572|NCT03067792|Randomized|Parallel Assignment||Treatment||||||||
1340573|NCT03067779||Single Group Assignment||Prevention||None (Open Label)||||||
1340574|NCT03067766|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340575|NCT03067753|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1340576|NCT03067740|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1340577|NCT03067727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340578|NCT03067714|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1340579|NCT03067701||Single Group Assignment||Other||None (Open Label)||||||
1340580|NCT03067688|Randomized|Parallel Assignment||Treatment||Double|Double Blind||t||t|
1340581|NCT03067675|||Cohort||Cross-Sectional|||||||
1340582|NCT03067662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340583|NCT03067649|Randomized|Parallel Assignment||Treatment||Single|Evaluators were unaware of condition assignment|Experimental intervention vs. an information only control||||t
1340584|NCT03067636|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340585|NCT03067623||Single Group Assignment||Treatment||None (Open Label)||||||
1340586|NCT03067610||Single Group Assignment||Treatment||None (Open Label)||radiation therapy||||
1340587|NCT03067597||Single Group Assignment||Treatment||None (Open Label)||||||
1340588|NCT03067584|||Family-Based||Other|||||||
1340589|NCT03067571||Single Group Assignment||Treatment||None (Open Label)||||||
1340590|NCT03067558|||Case-Only||Prospective|||||||
1340591|NCT03067545||Single Group Assignment||Treatment||None (Open Label)||single subject repeated measures design||||
1340592|NCT03067532|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340593|NCT03067519|Randomized|Parallel Assignment||Treatment||Single|Patients were randomly put in group using sealed envelop.||t|||
1340594|NCT03067506|||Cohort||Prospective|||||||
1340595|NCT03067493|Randomized|Parallel Assignment||Treatment||Single||||||t
1340596|NCT03067480|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340597|NCT03067467|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1340598|NCT03067454|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective randomised controlled trial to compare operation and treatment with early mobilisation for metacarpalfractures||||
1340599|NCT03067441||Single Group Assignment||Treatment||None (Open Label)||||||
1340600|NCT03067428|Randomized|Parallel Assignment||Basic Science||Triple||double blind, randomized controlled trial|t||t|t
1340601|NCT03067415|Randomized|Parallel Assignment||Treatment||Triple||Assignment|t|t|t|
1340602|NCT03067402|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Parallel Assignment||||
1340603|NCT03067389|||Case-Control||Prospective|||||||
1340604|NCT03067376||Single Group Assignment||Basic Science||None (Open Label)||||||
1340605|NCT03067363|Randomized|Sequential Assignment||Basic Science||Quadruple||Part 1: single ascending doses Part 2: parallel group|t|t|t|t
1340606|NCT03067350|||Cohort||Prospective|||||||
1340607|NCT03067337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340608|NCT03067324|||Cohort||Prospective|||||||
1340609|NCT03067311|Randomized|Parallel Assignment||Treatment||Single||||||t
1340610|NCT03067298|||Cohort||Prospective|||||||
1340611|NCT03067285|Randomized|Parallel Assignment||Treatment||None (Open Label)||A phase IV, open-label, randomised, pilot clinical trial||||
1340612|NCT03067272||Single Group Assignment||Prevention||None (Open Label)||||||
1340613|NCT03067259|Non-Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1340614|NCT03067246|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1340615|NCT03067233||Single Group Assignment||Basic Science||None (Open Label)||||||
1340616|NCT03067220|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340617|NCT03067207|Randomized|Sequential Assignment||Supportive Care||Single|This study will be a single-blinded study (investigators only). Participants will be coded using Arabic numerals. A research assistant will receive all questionnaires and cortisol samples. Mindfulness facilitators will be unaware of participant identification numbers. Participants will be assigned to one of four groups (experimental arm) or to one of two groups (feasibility arm) following a computer-generated randomization list (permuted block design, using blocks of two or four). The allocation sequence will be generated by a statistician not otherwise involved in the project and passed on to a research assistant after patient identification data has been collected (ensuring that the investigators are kept blind to the allocation of each participant). Allocation sequence will be password-protected and only accessible by the statistician and research assistant.|The study will be conducted as a longitudinal randomized non-inferiority trial comparing two arms: an experimental arm and feasibility arm. Participants living close enough to commit to in-person sessions will be entered in the experimental arm of the study. The feasibility arm, which will only take place if the targeted number of study participants (60) is not reached for the experimental arm, will be offered to participants who are not able to commit to the in-person mode of delivery. It will consist of two groups, one early e-health group and one wait-list e-Health group. At the end of the recruitment period, once participants have been placed in the experimental and feasibility arms, two separate randomizations will take place. The first randomization (experimental arm) will serve to assign participants to one of the four experimental groups and the second randomization (feasibility arm) will assign participants to one of the two feasibility groups.|||t|
1340618|NCT03067194|Randomized|Parallel Assignment||Treatment||Triple||Assignment|t|t|t|
1340619|NCT03067181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340620|NCT03067168|Randomized|Parallel Assignment||Treatment||Quadruple|Subjects will not know if they received an injection of bupivacaine or placebo, i.e., normal saline after completion of surgery. The surgeon, as well as any investigator or study personnel, will be blinded to injection type.||t|t|t|t
1340621|NCT03067155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1340622|NCT03067142|||Case-Control||Other|||||||
1340623|NCT03067129|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340624|NCT03067116|||Cohort||Prospective|||||||
1340625|NCT03067103|Randomized|Sequential Assignment||Treatment||Triple|Patients admitted for tonsillectomy were randomized into 3 groups by means of sealed envelopes. The envelope selected by the caregiver will be open by the registered nurse, who will prepare the infiltration. Neither the surgeon, anesthesiologist the caregiver nor the patient will see what is inside the envelope. The register of the envelope number and patient data will be done by the statistical group|Patientes will be seleted to receive peritonsillar injection of Tramadol, Ketamine or Placebo before tonsillectomy prospective, double-blind, placebo controlles|t|t|t|
1340626|NCT03067090||Single Group Assignment||Treatment||None (Open Label)||||||
1340627|NCT03067077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340628|NCT03067064|||Other||Cross-Sectional|||||||
1340629|NCT03067051||Sequential Assignment||Treatment||None (Open Label)||As result of the accelerated titration design with light dose and verteporfin for injection (VFI), the final number of subjects depends on the outcome of the titration. If all dose levels enroll and complete at the minimum number of subjects, the number of subjects is 12 (1 each at dose levels 1-3, 3 each at dose levels 4-6). If all dose levels enroll and complete at the maximum number of subjects, the number of subjects is 36 (6 subjects at each dose level 1-6). The range is thus 12-36 subjects.||||
1340630|NCT03067038|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340631|NCT03067025|||Case-Control||Prospective|||||||
1340632|NCT03067012||Single Group Assignment||Treatment||None (Open Label)||||||
1340633|NCT03066999|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340634|NCT03066986|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340635|NCT03066973|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340636|NCT03066960|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1340637|NCT03066947||Single Group Assignment||Treatment||None (Open Label)||||||
1340638|NCT03066934|||Cohort||Prospective|||||||
1340639|NCT03066921|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized placebo controlled trial|t|t|t|t
1340640|NCT03066908||Single Group Assignment||Treatment||None (Open Label)||||||
1340641|NCT03066895|Randomized|Crossover Assignment||Device Feasibility||Single||||||t
1340642|NCT03066882|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340643|NCT03066869||Single Group Assignment||Treatment||None (Open Label)||||||
1340644|NCT03066856|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||BRCA mutation carriers, with or without breast cancer, aged 18-70 years and without metastases are eligible. After the baseline examinations, women are randomized to an active dietary intervention or to a control group. The intervention group should attend six full days of activities over the next six months.||||
1340645|NCT03066843|Randomized|Parallel Assignment||Treatment||Single||||||t
1340646|NCT03066830|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340647|NCT03066817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340648|NCT03066804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340649|NCT03066791|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1340650|NCT03066778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340651|NCT03066765||Single Group Assignment||Treatment||None (Open Label)||||||
1340652|NCT03066752|||Case-Control||Prospective|||||||
1340653|NCT03066739|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340654|NCT03066726|||Cohort||Prospective|||||||
1340655|NCT03066713|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1340656|NCT03066700|||Case-Only||Retrospective|||||||
1340657|NCT03066687|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1340658|NCT03066674|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1340659|NCT03066661||||||||||||
1340660|NCT03066648|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is comprised of five combination arms:~Evaluation of a fixed dose of the standard of care agent decitabine, in combination with fixed dose PDR001 (Arm 1)~Evaluation of a fixed dose of the standard of care agent decitabine in combination with escalating dose MBG453 (Arm 2)~Evaluation of a fixed dose of the standard of care agent decitabine in combination with fixed dose of PDR001 and escalating dose of MBG453 (Arm 3) *~Evaluation of an escalating dose of MBG453~Evaluation of a fixed dose of PDR001 in combination with an escalating dose of MBG453~The evaluation of decitabine with the combination of PDR001 and MBG453 (Arm 3) will start after Novartis and Investigator's review of the available safety and tolerability data from each of the first two cohorts in Arm 1 and Arm 2."||||
1340661|NCT03066635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340662|NCT03066622|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label, not blinded, randomized 2-arm trial|This is a prospective, randomized, convenience sample, feasibility trial to test for non-inferiority of oral rapidly dissolving olanzapine versus current emergency department standard of care in providing symptomatic relief to patients presenting with primary headache.||||
1340663|NCT03066609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340664|NCT03066596||Single Group Assignment||Supportive Care||None (Open Label)|Follow up assessments will be collected by blinded interviewers|enhanced Usual Care and Intervention sites||||
1340665|NCT03066583|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340666|NCT03066570||Single Group Assignment||Treatment||None (Open Label)||Randomized replicated sequential single-case design.||||
1340667|NCT03066557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340668|NCT03066544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be a prospective, non-blinded, non-randomized, proof-of-concept study.||||
1340669|NCT03066531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340670|NCT03066518|Randomized|Parallel Assignment||Treatment||Quadruple|Selection for a treatment group was determined by a computer-generated randomization list, in a 1:1 ratio using the randomized permuted blocks method.|A randomized, double-blinded, placebo-controlled study|t|t|t|t
1340671|NCT03066505|Randomized|Parallel Assignment||Treatment||Quadruple|Subjects and clinicians will be blind to treatment condition.|Twenty (20) subjects will receive active treatment with MeRT and the other 20 with sham. Subjects in each study group will be treated 30 min a day, 5 days a week for 4 weeks.|t|t|t|t
1340672|NCT03066492|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340673|NCT03066479||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340674|NCT03066466|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized, two arms||||
1340675|NCT03066453|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1340676|NCT03066440|Randomized|Parallel Assignment||Treatment||Triple|The intravenous fluids administered will all have generic labeling making the study arm assignment unknown to all providers, study personnel and participants. Only the pharmacist filling the orders will known arm assignment.|Single-center randomized double-blinded control trial|t|t|t|
1340677|NCT03066427||Single Group Assignment||Treatment||None (Open Label)||||||
1340678|NCT03066414|||Cohort||Prospective|||||||
1340679|NCT03066401|||Cohort||Prospective|||||||
1340680|NCT03066388||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340681|NCT03066375||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340682|NCT03066362||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340683|NCT03066349|||Case-Control||Prospective|||||||
1340684|NCT03066336||Single Group Assignment||Treatment||None (Open Label)||||||
1340685|NCT03066323|Randomized|Crossover Assignment||Other||Single|||||t|
1340686|NCT03066310|||Case-Control||Cross-Sectional|||||||
1340687|NCT03066297|||Cohort||Prospective|||||||
1340688|NCT03066284|||Case-Only||Other|||||||
1340689|NCT03066271|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1340690|NCT03066258|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||dose escalation||||
1340691|NCT03066245||Single Group Assignment||Treatment||None (Open Label)||||||
1340692|NCT03066232|||Cohort||Prospective|||||||
1340693|NCT03066219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340694|NCT03066206|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340695|NCT03066193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Participants will receive two active medications and will be followed-up bi-weekly for 12 weeks.||||
1340696|NCT03066180|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340697|NCT03066167|||Cohort||Prospective|||||||
1340698|NCT03066154||Single Group Assignment||Treatment||None (Open Label)||||||
1340699|NCT03066141|||Case-Control||Prospective|||||||
1340700|NCT03066128|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340701|NCT03066115|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1340702|NCT03066102||Single Group Assignment||Other||None (Open Label)||||||
1340703|NCT03066089|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340704|NCT03066076|Randomized|Parallel Assignment||Treatment||Single|Observer blinded analysis||||t|
1340705|NCT03066063||||||||||||
1340706|NCT03066050|||Other||Other|||||||
1340707|NCT03066037|||Cohort||Retrospective|||||||
1340708|NCT03066024|||Cohort||Retrospective|||||||
1340709|NCT03066011|||Cohort||Prospective|||||||
1340710|NCT03065998|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1340711|NCT03065985|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1340712|NCT03065972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340713|NCT03065959|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1340714|NCT03065946|||Cohort||Prospective|||||||
1340715|NCT03065933||Single Group Assignment||Treatment||None (Open Label)||Subjects with Bipolar Disorder, mania will receive an extended-release from of clonidine on the second day of this 3-day study. Rating scale, record of sleep, and a questionnaire of adverse effects will be recorded on each of the 3 days.||||
1340716|NCT03065920|||Cohort||Prospective|||||||
1340717|NCT03065907|Randomized|Parallel Assignment||Treatment||Single||||||t
1340718|NCT03065894|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, longitudinal, pragmatic, non-randomized clustered, non-blinded, controlled trial||||
1340719|NCT03065881|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1340720|NCT03065868|Randomized|Parallel Assignment||Treatment||None (Open Label)||open labelled randomized controlled trial. randomization : 2015 September||||
1340721|NCT03065855|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340722|NCT03065842|Randomized|Parallel Assignment||Prevention||None (Open Label)||A quasi-experimental design, which is the Comparison Group Pre-test/Post-test Design, as in the current design. This design is the same as the classic controlled experimental design except that the subjects cannot be randomly assigned to either the experimental or the control group. The design came out because of difficulty of applying the classical natural science method to the social or the researcher cannot control which group will get the treatment, for example interventions targeting school students.||||
1340770|NCT03065218||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340771|NCT03065205||Single Group Assignment||Health Services Research||None (Open Label)||||||
1340772|NCT03065192||Single Group Assignment||Treatment||None (Open Label)||||||
1340773|NCT03065179||Single Group Assignment||Treatment||None (Open Label)||||||
1340774|NCT03065166|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1340775|NCT03065153|||Case-Control||Cross-Sectional|||||||
1340776|NCT03065140|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1340777|NCT03065127|Randomized|Crossover Assignment||Treatment||Single||||||t
1340723|NCT03065829|Randomized|Parallel Assignment||Supportive Care||Double||Our model posits that effective caregiver self-management depends on analytic and emotional processing. The investigators hypothesize the ASSIST intervention will improve analytic processing by improving self-monitoring. ASSIST will expose subjects to mindfulness meditation training and promote self-awareness, which will aid the regulation of their emotional processing and improve proximal outcomes. The investigators expect proximal self-management outcomes to influence the distal outcomes of caregiver health. Our model will also test the mediating effects of decentering, processing, the hypothalamic-pituitary axis (HPA), inflammatory stress response, and cognitive mediators. The influence of potential moderators will be assessed for their effect on the relationship between the self-management intervention and the proximal and distal outcomes.|t||t|
1340724|NCT03065816|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1340725|NCT03065803|Randomized|Parallel Assignment||Prevention||Single||||||t
1340726|NCT03065790|||Cohort||Prospective|||||||
1340727|NCT03065777|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340728|NCT03065764||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340729|NCT03065751|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340730|NCT03065738||Single Group Assignment||Treatment||None (Open Label)||||||
1340731|NCT03065725|||Case-Only||Prospective|||||||
1340732|NCT03065712||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340733|NCT03065699|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||The design is a multi-centre, randomised, controlled, study to generate data for the evaluation of safety (as measured by the percentage of subjects who experience at least one serious adverse event (SAE)) and performance (as measured by lowering of the plasma endotoxin concentrations, and improved albumin function) of DIALIVE in 24 evaluable patients with Acute on Chronic Liver Failure (ACLF) versus standard of care (SOC).||||
1340734|NCT03065686||Single Group Assignment||Basic Science||None (Open Label)||||||
1340735|NCT03065673|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1340736|NCT03065660|Randomized|Parallel Assignment||Treatment||Triple|Participants, investigators, research midwives/nurses and other attending clinicians will remain blind to the trial drug allocation throughout the duration of the trial.|A randomised, parallel group, double-blind, placebo-controlled multicentre study, with health economic and mixed-methods evaluation.|t|t|t|
1340737|NCT03065647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340738|NCT03065634|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1340739|NCT03065621||Single Group Assignment||Treatment||None (Open Label)||||||
1340740|NCT03065608|||Cohort||Prospective|||||||
1340741|NCT03065595|Randomized|Parallel Assignment||Treatment||Triple||Double-blind, randomized controlled trial|t|t|t|
1340742|NCT03065582||Single Group Assignment||Prevention||None (Open Label)||||||
1340743|NCT03065569|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1340744|NCT03065556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340745|NCT03065543|||Cohort||Prospective|||||||
1340746|NCT03065530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340747|NCT03065517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340748|NCT03065504|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1340749|NCT03065491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340750|NCT03065478|||Cohort||Prospective|||||||
1340751|NCT03065465|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340752|NCT03065452|||Cohort||Prospective|||||||
1340753|NCT03065439|Non-Randomized|Parallel Assignment||Diagnostic||Triple|Balance testing will be performed and data saved without the testers knowing the results. Afterwards the testers will ask patients to fill in questionnaires. An assessor (not participating in testing) will be cleaning the data and establishing the models without knowledge of the SBT score. The STarT Back score will be cleaned, saved in another data set and established by another assessor. When agreed upon the model, the two data sets will be merged.|This is a double blinded experimental study comparing sub-groups of patients with low back pain|t||t|t
1340754|NCT03065426|||Cohort||Prospective|||||||
1340755|NCT03065413|||Other||Prospective|||||||
1340756|NCT03065400||Single Group Assignment||Treatment||None (Open Label)||||||
1340757|NCT03065387|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340758|NCT03065374|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340759|NCT03065361|||Case-Control||Cross-Sectional|||||||
1340760|NCT03065348||Single Group Assignment||Other||None (Open Label)||First step: pilot study including 20 patients (intervention ) Second step: inclusion of 11 additional patients. Comparison of the intervention group (n=31) with a historical similar population (control group, n=31)||||
1340761|NCT03065335|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1340762|NCT03065322|||Other||Prospective|||||||
1340763|NCT03065309||Sequential Assignment||Supportive Care||None (Open Label)|Participant will receive propofol before induction|Adaptative clinical trial, Dixon's Up-And-Down Method||||
1340764|NCT03065296||Single Group Assignment||Other||None (Open Label)||||||
1340765|NCT03065283|Randomized|Parallel Assignment||Treatment||Single||The sample was randomly divided by electronic draw in two groups, the intervention group (GI), where two techniques were performed, one for diaphragmatic release and another for relaxation of the diaphragm pillars. In the control group (CG) the same techniques were applied, but in a placebo form.|t|||
1340766|NCT03065270|Randomized|Parallel Assignment||Treatment||Single|||||t|
1340767|NCT03065257|||Cohort||Prospective|||||||
1340768|NCT03065244|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1340769|NCT03065231|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor will be blinded to the type of intervention that took place.|There will be two arms of the study: patients randomly assigned to LD and patients randomly assigned to EVD. Randomization will account for Fisher Grade. The two treatment arms will have CSF diversion for 7 days. For patients treated with lumbar drain, patients will have CSF drainage of 10cc/hour for lumbar drain while patients treated with EVD at 15cm above the tragus.||||t
1340779|NCT03065101|Randomized|Parallel Assignment||Treatment||Single||||||t
1340780|NCT03065088|Randomized|Parallel Assignment||Prevention||Single|Assessors are blinded to group allocation|This is a feasibility study run as a randomised controlled trial (RCT). This is a multi-centre trial with three centres, Trondheim, Amsterdam, and Stuttgart, with two behaviour change exercise programmes (aLiFE and eLiFE) and a control group, with a 6 months intervention period and 6 month follow up.||||t
1340781|NCT03065075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340782|NCT03065062||Single Group Assignment||Treatment||None (Open Label)||||||
1340783|NCT03065049||Single Group Assignment||Treatment||None (Open Label)||||||
1340784|NCT03065036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340785|NCT03065023|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study will be conducted in 2 groups~Group A: subjects with transdermally/transmucosally injectable tumors~Group B: subjects with injectable liver tumors or liver metastases"||||
1340786|NCT03065010||Single Group Assignment||Treatment||None (Open Label)||||||
1340787|NCT03064997|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1340788|NCT03064984|Randomized|Parallel Assignment||Treatment||Quadruple|The products under study are prepared, standardized, controlled and sealed in anonymous frozen vials in the Transfusional Service of the S.Orsola-Malpighi Hospital, our partner and collaborator in the study. The products have same physical and colour characteristics and cannot be visually recognized. Boxes containing the vials report a code of assignement only known by the Transfusion service personnel.|"This is a double-blind, interventional clinical study, randomized, multicenter. The treatments under study comprise topical products prepared from two different sources: umbilical cord blood collected at birth and adult subject donor peripheral blood. The products are prepared, standardized, controlled and sealed in anonymous frozen vials in the Transfusional Service, partner in the study.~The study consists of two phases: Phase 1 is runned for one month treatment. The assignment of the treatment in Phase 1 is performed through a computer based randomization process, blind to the patient and the clinician, only known to the Transfusion Service personnel. The patient enter Phase 2 only in case of a corneal epithelial damage relapse taking place within two months after the end of Phase 1, and the treatment assigned belongs to the remaining arm. In this case also, the treatment is only known to the Transfusion Service personnel, trained to keep data aside."|t|t|t|t
1340789|NCT03064971|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340790|NCT03064958|Randomized|Crossover Assignment||Prevention||Single||||||t
1340791|NCT03064945|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1340792|NCT03064932|Randomized|Crossover Assignment||Prevention||Single|||||t|
1340793|NCT03064919||Single Group Assignment||Health Services Research||None (Open Label)||An evidence-based curriculum for teaching preschool children to eat in response to internal hunger and fullness signals will be developed. The investigators will then conduct an experimental study to determine the effectiveness of this curriculum on children's ability to regulate energy intake in the laboratory. Key outcomes will be children's adjustment in intake in response to a first course (energy compensation) and children's intake of tasty snacks when not hungry (eating in the absence of hunger). Data describing variables likely to impact the success of the curriculum will be collected, for example: child gender/age, parent feeding practices, parent education, infant feeding practices, child/parent weight status, and others.||||
1340794|NCT03064906||Single Group Assignment||Device Feasibility||None (Open Label)||The two-part study schedule consists of a 7±1 day outpatient, open-loop phase, followed by one 54-hour (Option A - Meal Performance and/or Option B - Exercise), hybrid closed-loop phases conducted in a supervised CRC or hotel/rental house setting. Subjects may participate in hybrid closed-loop session Option A and/or Option B.||||
1340795|NCT03064893|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340796|NCT03064880|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1340797|NCT03064867||Single Group Assignment||Treatment||None (Open Label)||||||
1340798|NCT03064854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340799|NCT03064841|||Cohort||Cross-Sectional|||||||
1340800|NCT03064828|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1340801|NCT03064815|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1340802|NCT03064802|||Other||Prospective|||||||
1340803|NCT03064789|||Cohort||Prospective|||||||
1340804|NCT03064776|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340805|NCT03064763||Single Group Assignment||Other||None (Open Label)||||||
1340806|NCT03064750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340807|NCT03064737||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340808|NCT03064724||Single Group Assignment||Treatment||None (Open Label)||||||
1340809|NCT03064711||Parallel Assignment||Basic Science||None (Open Label)||||||
1340810|NCT03064698|||Cohort||Prospective|||||||
1340811|NCT03064685|||Case-Control||Retrospective|||||||
1340812|NCT03064672|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1340813|NCT03064659|||Cohort||Prospective|||||||
1340814|NCT03064646||Single Group Assignment||Treatment||None (Open Label)||||||
1340815|NCT03064633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340816|NCT03064620|||Ecologic or Community||Cross-Sectional|||||||
1340817|NCT03064607|||Cohort||Prospective|||||||
1340818|NCT03064594|||Case-Control||Retrospective|||||||
1340819|NCT03064581|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340820|NCT03064568|Randomized|Single Group Assignment||Prevention||Triple|Randomization to treatment arm done by 3rd party. Randomization will be performed by a third party so that neither the surgeon nor patient will know which intervention was performed, and interventions will be placed in sealed, sequentially numbered, opaque envelopes. The code will only be broken at time of data analysis once all patients have been enrolled.|Prospective double-blinded study completed at a tertiary care center|t|t|t|
1340821|NCT03064555|||Case-Control||Cross-Sectional|||||||
1340822|NCT03064542|||Cohort||Other|||||||
1340823|NCT03064529||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341051|NCT03061565|||Case-Control||Prospective|||||||
1340824|NCT03064516|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340825|NCT03064503||Single Group Assignment||Basic Science||None (Open Label)||||||
1340826|NCT03064490||Single Group Assignment||Treatment||None (Open Label)||||||
1340827|NCT03064477|Randomized|Parallel Assignment||Treatment||Single|Patients (participants) will know the treatment they have been assigned to, but they will not know whether that treatment is considered TAU or experimental (UP). Healthcare professionals and researchers will know the condition each patient has been assigned to (mandatory to provide a given type of intervention).|All consecutive patients with emotional disorders attending any of the collaborating centers will be asked to participate in the present study. Once inclusion criteria are met, each patient will be randomly assigned to one of the two experimental groups: TAU or UP. Randomization will be performed by a researcher unrelated to the study using a computer-generated sequence (Randomizer). Randomization will be stratified according to the severity of the primary measures of depression and anxiety, using the recommended cutoff in the manuals. Stratification will be made to ensure a comparable proportion of severely depressed and anxious individuals in each group. For each subgroup (i.e., severe or less severe depression and/or anxiety), participants will be randomly assigned to the UP or to TAU.|t|||
1340828|NCT03064464|||Case-Only||Prospective|||||||
1340829|NCT03064451||Single Group Assignment||Treatment||None (Open Label)||||||
1340830|NCT03064438|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340831|NCT03064425||Single Group Assignment||Other||None (Open Label)||||||
1340832|NCT03064412||Single Group Assignment||Basic Science||None (Open Label)||||||
1340833|NCT03064399|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340834|NCT03064386|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340835|NCT03064373|||Family-Based||Prospective|||||||
1340836|NCT03064360||||||||||||
1340837|NCT03064347|Randomized|Crossover Assignment||Basic Science||Single||||||t
1340838|NCT03064334|||Other||Other|||||||
1340839|NCT03064321|Randomized|Parallel Assignment||Treatment||None (Open Label)||Two group design||||
1340840|NCT03064308|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340841|NCT03064295|||Other||Prospective|||||||
1340842|NCT03064282|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340843|NCT03064269||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1340844|NCT03064256|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1340845|NCT03064243||Single Group Assignment||Treatment||None (Open Label)||||||
1340846|NCT03064230|||Case-Control||Prospective|||||||
1340847|NCT03064217|Randomized|Parallel Assignment||Treatment||Single||||||t
1340848|NCT03064204|||Cohort||Prospective|||||||
1340849|NCT03064191|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1340850|NCT03064178|||Cohort||Prospective|||||||
1340851|NCT03064165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340852|NCT03064152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340853|NCT03064139|Randomized|Parallel Assignment||Treatment||Single||||||t
1340854|NCT03064126|Randomized|Parallel Assignment||Treatment||Single|Subjects will be blinded to treatment assigned and treatment received until completion of all 12 month follow-up visits (primary endpoint).|The RANGER™ investigational device is coated with the drug paclitaxel.|t|||
1340855|NCT03064113|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1340856|NCT03064100|||Case-Only||Prospective|||||||
1340857|NCT03064087|||Other||Cross-Sectional|||||||
1340858|NCT03064074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340859|NCT03064061|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1340860|NCT03064048|Randomized|Crossover Assignment||Treatment||Triple|Randomization for treatment assignment is by the providing Institution's Investigational Pharmacy Services.|"Active Comparator: Nitric oxide supplement Active Comparator will l not contain nitric oxide supplement.~Placebo Comparator: Placebo Placebo will not contain nitric oxide supplement."|t|t|t|
1340861|NCT03064035|Randomized|Parallel Assignment||Treatment||None (Open Label)||For adults on long-term warfarin therapy who present to the ED with emergent bleeding, or who are in need of urgent invasive surgical procedures: the exposure of interest will be fixed vs. variable dose 4FPCC, to which eligible patients will be randomly assigned in a 1:1 ratio.||||
1340862|NCT03064022|||Cohort||Retrospective|||||||
1340863|NCT03064009|||Case-Only||Prospective|||||||
1340864|NCT03063996|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||This will be a randomized control trial comparing peripheral IJ to standard care of difficult access patients.||||
1340865|NCT03063983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340866|NCT03063970|Randomized|Parallel Assignment||Treatment||Single|Blinded assessor otherwise uninvolved in the study.|Feasibility Randomised Controlled Trial||||t
1340867|NCT03063957|||Cohort||Prospective|||||||
1340868|NCT03063944||Single Group Assignment||Treatment||None (Open Label)||||||
1340869|NCT03063931|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1340870|NCT03063918||Single Group Assignment||Supportive Care||None (Open Label)||||||
1340871|NCT03063905|||Case-Control||Other|||||||
1340872|NCT03063892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340873|NCT03063879||Single Group Assignment||Treatment||None (Open Label)||||||
1340874|NCT03063866|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1340875|NCT03063853|Randomized|Parallel Assignment||Other||Single||||||t
1340876|NCT03063840||Single Group Assignment||Treatment||None (Open Label)||||||
1340877|NCT03063827|||Case-Control||Prospective|||||||
1340878|NCT03063814|Randomized|Parallel Assignment||Prevention||Single||||||t
1340879|NCT03063801|||Cohort||Retrospective|||||||
1340880|NCT03063788|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1340881|NCT03063775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340882|NCT03063762|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1340883|NCT03063749|||Cohort||Prospective|||||||
1340884|NCT03063736|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340885|NCT03063723|||Case-Control||Prospective|||||||
1340886|NCT03063710||||||||||||
1340887|NCT03063697|||Cohort||Prospective|||||||
1340888|NCT03063684|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1340889|NCT03063671|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1340890|NCT03063658|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1340891|NCT03063645|Randomized|Crossover Assignment||Other||None (Open Label)||16 healthy subjects enrolled, each subject will receive 1 dose of each treatment, with a 2 day washout in between.||||
1340892|NCT03063632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1340893|NCT03063619|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1340894|NCT03063606|Randomized|Parallel Assignment||Treatment||Single||||||t
1340895|NCT03063593|||Other||Prospective|||||||
1340896|NCT03063580||Single Group Assignment||Basic Science||None (Open Label)||||||
1340897|NCT03063567|Randomized|Crossover Assignment||Treatment||None (Open Label)||Prospective crossover trial. All patients will undergo a one month trial of each of the 3 interfaces (nasal masks, oronasal masks, nasal cushions) in a randomised order.||||
1340898|NCT03063554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340899|NCT03063541|Randomized|Parallel Assignment||Prevention||Single|observer blinding|controlled open trial, randomized 1:1||||t
1340900|NCT03063528|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340901|NCT03063515|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1340902|NCT03063502|||Cohort||Cross-Sectional|||||||
1340903|NCT03063489||Single Group Assignment||Supportive Care||None (Open Label)||||||
1340904|NCT03063476||Single Group Assignment||Basic Science||None (Open Label)||||||
1340905|NCT03063463|||Case-Only||Prospective|||||||
1340906|NCT03063450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340907|NCT03063437|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340908|NCT03063424|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1340909|NCT03063411|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1340910|NCT03063398|||Cohort||Prospective|||||||
1340911|NCT03063385|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1340912|NCT03063372|Randomized|Parallel Assignment||Other||Double|Phase 1 is not masked, but in phase 2 the participants and investigator will be masked (double blind).|Phase 1 is a single group feasibility pilot in 10 participants, all of whom will receive the nutritional supplement. Phase 2 is a parallel double blinded trial in 40 participants, half of whom will receive the supplement and half of whom will receive a placebo.|t||t|
1340913|NCT03063359|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340914|NCT03063346|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1340915|NCT03063333|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled study with three arms: coping-oriented hypnosis, neutral hypnosis, no hypnosis|t|||t
1340916|NCT03063320|Randomized|Crossover Assignment||Prevention||Single|Person assessing the outcome measures will be blinded to participant allocation|3 period randomized cross over||||t
1340917|NCT03063307|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340918|NCT03063294|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340919|NCT03063281|||Case-Control||Retrospective|||||||
1340920|NCT03063268|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1340921|NCT03063255|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Sixty subjects with be randomized to the obturator block or neuromuscular block arm upon enrollment, using randomized permutated blocks of six.||||
1340922|NCT03063242|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Project I will be used to optimize the dosage and timing of sargramostim administration with regard to the primary and secondary outcomes. Thus, Project II and III treatment will only begin once all 5 Project I participants have completed treatment and the data have been analyzed to guide subsequent dosing||||
1340923|NCT03063229|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1340924|NCT03063216|||Other||Prospective|||||||
1340925|NCT03063203||Single Group Assignment||Treatment||None (Open Label)||||||
1340926|NCT03063190|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340927|NCT03063177|Randomized|Parallel Assignment||Treatment||Single|Participants won't know the SMT dosage they are assigned to.||t|||
1340928|NCT03063164|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eye to eye comparison||||
1340929|NCT03063151|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Two groups of participants: Study and control. Each participant will carry out a single one-hour session of EMG test.||||
1340930|NCT03063138|||Other||Other|||||||
1340931|NCT03063125|||Cohort||Prospective|||||||
1340932|NCT03063112|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1340933|NCT03063099||Single Group Assignment||Treatment||None (Open Label)||||||
1340934|NCT03063086|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1340935|NCT03063073|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1340936|NCT03063060|||Cohort||Retrospective|||||||
1340937|NCT03063047|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1340938|NCT03063034|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1340939|NCT03063021|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340940|NCT03063008|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340941|NCT03062995|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1340942|NCT03062982|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1340943|NCT03062969|||Case-Crossover||Retrospective|||||||
1340944|NCT03062956|Randomized|Sequential Assignment||Treatment||Quadruple|Subjects will be randomized 6:2 to MYK-491:placebo within each cohort.||t|t|t|t
1340945|NCT03062943||Single Group Assignment||Treatment||None (Open Label)||||||
1340946|NCT03062930|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1340947|NCT03062917|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1340948|NCT03062904||Single Group Assignment||Diagnostic||None (Open Label)||||||
1340949|NCT03062891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340950|NCT03062878|||Case-Control||Prospective|||||||
1340951|NCT03062865|||Cohort||Prospective|||||||
1340952|NCT03062852|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340953|NCT03062839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340954|NCT03062826|||Case-Only||Prospective|||||||
1340955|NCT03062813|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340956|NCT03062800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340957|NCT03062787|Randomized|Parallel Assignment||Treatment||Single|||t|||
1340958|NCT03062774||Sequential Assignment||Treatment||None (Open Label)||||||
1340959|NCT03062761|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1340960|NCT03062748|||Case-Only||Cross-Sectional|||||||
1340961|NCT03062735|Randomized|Parallel Assignment||Other||Double|||t||t|
1340962|NCT03062722||Single Group Assignment||Treatment||None (Open Label)||||||
1340963|NCT03062709||Single Group Assignment||Prevention||None (Open Label)||||||
1340964|NCT03062696||Single Group Assignment||Treatment||None (Open Label)||||||
1340965|NCT03062683|||Cohort||Prospective|||||||
1340966|NCT03062670|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1340967|NCT03062657||Single Group Assignment||Treatment||None (Open Label)||||||
1340968|NCT03062644|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind||t|t|t|
1340969|NCT03062631||||||||||||
1340970|NCT03062618|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1340971|NCT03062605|Randomized|Parallel Assignment||Prevention||Single|This was a single blind study. The participants knew which one time treatment they were receiving, but the person doing the saliva sampling and testing did not know which treatment the participant was assigned|Participants were randomly assigned to one of two treatment groups and continued in parallel for the three-month duration of the study.|||t|
1340972|NCT03062592|Randomized|Crossover Assignment||Treatment||Single||Subjects complete three oral glucose tolerance test (OGTT) on different days, with a minimum of one week in between. First visit is a combined screening and baseline OGTT, with no supplementation. The second and third visit subjects are randomly assigned to either 1 g of non-hydrolyzed pine nut oil or 1 g of hydrolyzed pine nut oil.|t|||
1340973|NCT03062579||Single Group Assignment||Treatment||None (Open Label)||||||
1340974|NCT03062566|||Cohort||Prospective|||||||
1340975|NCT03062553|Randomized|Parallel Assignment||Treatment||Single||||||t
1340976|NCT03062540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340977|NCT03062527|Randomized|Crossover Assignment||Treatment||Single|||t|||
1340978|NCT03062514|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1340979|NCT03062501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1340980|NCT03062488|Randomized|Parallel Assignment||Treatment||Triple|"all patients will receive a de-identified PO syrup. The syrup will be prepared by the pharmacy and will contain acetaminophen (15 mg/kg) for the PO acetaminophen group and placebo flavored syrup for the other two groups. This approach will maintain blindness of the peri-operative staff, and patients/parents., all children will receive fentanyl 2 mcg/Kg IV. Intra-op anesthesia team will be blinded to the use of non-opioid IV analgesia and will administer a pharmacy prepared de-identified infusion following intubation that will consist of saline placebo for control groups and IV acetaminophen (15 mg/kg) for the IV acetaminophen group. ,~:A blinded PACU nurse will record degree of agitation using the PAED scale on admission to the PACU"|"Study Design:~Prospective Randomized Study~Study Period: August 2017 - December 2017~Potential participants: 375 - 475 based on 20-25% of 4,459 ENT patients in 2016~Study Population: 50 pediatric patients in each group between 24 months through 7 years of age undergoing adenoidectomy or tonsillectomy with or without adenoidectomy Total Number of Patients: 150"|t|t|t|
1340981|NCT03062475|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340982|NCT03062462|Randomized|Parallel Assignment||Treatment||Single||||||t
1340983|NCT03062449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1340984|NCT03062436||Single Group Assignment||Treatment||None (Open Label)||||||
1340985|NCT03062423|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1340986|NCT03062410||Single Group Assignment||Other||None (Open Label)||||||
1340987|NCT03062397|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1340988|NCT03062384|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1340989|NCT03062371||Single Group Assignment||Treatment||None (Open Label)||||||
1340990|NCT03062358|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1340991|NCT03062345|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||||||
1340992|NCT03062332|||Cohort||Prospective|||||||
1340993|NCT03062319|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1340994|NCT03062306|||Case-Control||Prospective|||||||
1340995|NCT03062293||Single Group Assignment||Treatment||None (Open Label)|Ultrasound image time points are blinded to the assessor by a party not involved in the study|Repeat measures within subject design||||
1340996|NCT03062280||Single Group Assignment||Treatment||None (Open Label)||||||
1340997|NCT03062267|Randomized|Parallel Assignment||Treatment||Single||||||t
1340998|NCT03062254||Single Group Assignment||Basic Science||None (Open Label)||||||
1341052|NCT03061552|Non-Randomized|Crossover Assignment||Treatment||Double|||t|||t
1341053|NCT03061539||Single Group Assignment||Treatment||None (Open Label)||||||
1341054|NCT03061526|||Cohort||Retrospective|||||||
1341055|NCT03061513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341056|NCT03061500|||Case-Only||Prospective|||||||
1341057|NCT03061487|||Case-Control||Prospective|||||||
1341280|NCT03058588|||Family-Based||Prospective|||||||
1340999|NCT03062241|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a Randomized Controlled Trial (RCT), non-blinded, prospective, multicentre performed in up to 4 cardiology centers in Poland. All patients implanted with a dual-chamber implanted cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) with Home Monitoring capabilities and history of paroxysmal, persistent or persistant long-lasting AF will be screened for the study. In patient who fulfill all inclusion and none of the exclusion criteria 1 year after ICD or CRT-D implantation, with exclusion of 1 month directly after implantation, a device check-up and AF burden will be performer and assessed. Randomization will be performed using sealed envelopes and will be conducted in the coordinating center of the study PI in all patients who sign informed consent and met all inclusions and none of the exclusion criteria. The cryoablation of AF will be performed within 1 month from randomization in the invasive treatment group.||||
1341000|NCT03062228|||Cohort||Cross-Sectional|||||||
1341001|NCT03062215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341002|NCT03062202|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1341003|NCT03062189|||Cohort||Prospective|||||||
1341004|NCT03062176||Single Group Assignment||Treatment||None (Open Label)||||||
1341005|NCT03062163|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1341006|NCT03062150|Randomized|Parallel Assignment||Basic Science||Quadruple||randomized double-blind placebo-controlled parallel group design|t|t|t|t
1341007|NCT03062137|||Case-Only||Prospective|||||||
1341008|NCT03062124|||Case-Only||Prospective|||||||
1341009|NCT03062111|Randomized|Parallel Assignment||Other||Single||||||t
1341010|NCT03062098||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1341011|NCT03062085|||Other||Prospective|||||||
1341012|NCT03062072|||Cohort||Prospective|||||||
1341013|NCT03062059|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341014|NCT03062046||Single Group Assignment||Treatment||None (Open Label)||||||
1341015|NCT03062033|||Cohort||Prospective|||||||
1341016|NCT03062020|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1341017|NCT03062007||Single Group Assignment||Treatment||None (Open Label)||||||
1341018|NCT03061994|||Cohort||Prospective|||||||
1341019|NCT03061981|Randomized|Sequential Assignment||Treatment||Quadruple|Double Blind||t|t|t|t
1341020|NCT03061968|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1341021|NCT03061955|||Other||Prospective|||||||
1341022|NCT03061942|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1341023|NCT03061929|||Cohort||Prospective|||||||
1341024|NCT03061916|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1341025|NCT03061903|Randomized|Parallel Assignment||Prevention||None (Open Label)||Subjects will be randomly assigned to either the ciNPT intervention group (Prevena) or the control group (Aquacel) using computer-generated, randomized envelopes with equal numbers in each treatment arm. Both dressings will be applied under sterile conditions at the end of the THA surgery, while still in the operating room, and then removed after 7 days.||||
1341026|NCT03061890|||Cohort||Prospective|||||||
1341027|NCT03061877|||Cohort||Prospective|||||||
1341028|NCT03061864|Randomized|Parallel Assignment||Treatment||Single||||||t
1341029|NCT03061851|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The enrolled patients will be randomly divided into two groups: the trial group and the control group. The estimated sample size was 200 patients for each group.||||
1341030|NCT03061838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341031|NCT03061825|||Cohort||Prospective|||||||
1341032|NCT03061812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341033|NCT03061799|Randomized|Parallel Assignment||Treatment||Triple|"The product manufactured as clinical food and placebo are identical in shape, color and weight. In addition, clinical trial food should be labeled by affixing the same label with placebo so that it remains blind to both subjects and the investigator. Lot number of the label, includes reference number of the test food and reference number of the placebo together.~Dispensing of food and placebo for clinical trials is handled by the management pharmacist.~Clinical tester supplies clinical trial food corresponding the random assignment code assigned to subjects. Except inevitable cases such as occurrence of adverse events resulted by clinical food, the code will not be released until the end of the clinical trial. In case of deficiency or breakage of food for clinical trial, extra clinical food with unique code will provided to subjects, therefore maintain blinding."|This clinical trial will be conducted in parallel with the test group or the control group randomly assigned.|t|t|t|
1341034|NCT03061786|||Cohort||Retrospective|||||||
1341035|NCT03061773|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341036|NCT03061760|||Case-Control||Prospective|||||||
1341037|NCT03061747|||Cohort||Retrospective|||||||
1341038|NCT03061734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341039|NCT03061721|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341040|NCT03061708||Single Group Assignment||Treatment||None (Open Label)||AZD2014 50mg BD continuous schedule of a 28 day cycle||||
1341041|NCT03061695|||Cohort||Prospective|||||||
1341042|NCT03061682||Single Group Assignment||Other||None (Open Label)||||||
1341043|NCT03061669|||Other||Prospective|||||||
1341044|NCT03061656||Single Group Assignment||Treatment||None (Open Label)||||||
1341045|NCT03061643||Single Group Assignment||Treatment||None (Open Label)||||||
1341046|NCT03061630||Single Group Assignment||Treatment||None (Open Label)||||||
1341047|NCT03061617|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1341048|NCT03061604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341049|NCT03061591|Randomized|Parallel Assignment||Treatment||Quadruple|"Placebo and curcumin capsules are identical in appearance, and will be marked as A or B. Study participants and staff will be blinded to the capsule content. A locked file containing the description will remain in a locked file on the study coordinators computer."|6 months of Curcumin vs. placebo treatment outcomes will be compared.|t|t|t|t
1341050|NCT03061578|||Case-Control||Prospective|||||||
1341058|NCT03061474|Randomized|Parallel Assignment||Treatment||Triple|Double-Blind-Randomized||t|t|t|
1341059|NCT03061461|Randomized|Crossover Assignment||Treatment||Triple|"A medical assistant in the Wound Care Unit, Dept on Internal Medicine, Kuala Lumpur Hospital (Kuala Lumpur, Malaysia) will allocate interventions by means of opaque sealed envelopes that will be marked according to the allocation schedule. The medical assistant will be unaware of the size of the blocks.~The randomized intervention assignment as outlined above will be concealed from both patients and health care staff until recruitment will be complete and irrevocable.~Therapists applying the treatments will not be blinded.~All assessments before the first treatment (baseline) and during the follow-up period (either three months after start of the treatments or until complete epithelialization, respectively) will be performed by assessors blind to the intervention."|"Randomized controlled trial (RCT), no blinding of therapists applying the treatments, blinding of patients, blinding of evaluators.~Partial cross-over design: patients in the control group will be offered to be treated with rESWT starting three months after the last sham treatment. This will guarantee that every patient will receive a real rESWT treatment independent of blind allocation to one of the treatment groups."|t||t|t
1341060|NCT03061448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341061|NCT03061435|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1341062|NCT03061422|Randomized|Parallel Assignment||Prevention||Double||||t||t
1341063|NCT03061409|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1341064|NCT03061396|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1341065|NCT03061383|Randomized|Parallel Assignment||Treatment||Triple|It will be a triple blinded study so that the participant, the researcher and the data analysis will be blinded.|Participants will be tested in this study having at least 3 sensitive sound teeth. Participants will be divided into 3 groups, according to the type of desensitizing agents (D); D1 treatment using 8% arginine based toothpaste (Colgate Pro-relief), D2 treatment using 8% strontium acetate based toothpaste (Sensodyne Rapid Action) and D3 control group using placebo (gel without any active ingredient).|t|t||t
1341066|NCT03061370|||Cohort||Retrospective|||||||
1341067|NCT03061357|Randomized|Parallel Assignment||Treatment||Single|All participants in both intervention and control arms were not disclosed to the specific purpose of the study in order to prevent the subject-expectancy effects on study outcomes.||t|||
1341068|NCT03061344||Single Group Assignment||Treatment||None (Open Label)||||||
1341069|NCT03061331|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1341070|NCT03061318|||Cohort||Prospective|||||||
1341071|NCT03061305|||Cohort||Prospective|||||||
1341072|NCT03061292|Randomized|Parallel Assignment||Other||||||||
1341073|NCT03061279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341074|NCT03061266|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1341075|NCT03061253|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1341076|NCT03061240||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341077|NCT03061227|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1341078|NCT03061214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341079|NCT03061201||Sequential Assignment||Treatment||None (Open Label)|Open Label|Dose selection based on safety and observed FVIII levels.||||
1341080|NCT03061188||Single Group Assignment||Treatment||None (Open Label)||||||
1341081|NCT03061175|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341082|NCT03061162||Single Group Assignment||Treatment||None (Open Label)||||||
1341083|NCT03061149|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1341084|NCT03061136|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1341085|NCT03061123|||Other||Cross-Sectional|||||||
1341086|NCT03061110|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be randomly assigned to usual care (palliation of symptoms) or injection of stromal vascular fraction.||||
1341087|NCT03061097|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1341088|NCT03061084|||Cohort||Prospective|||||||
1341089|NCT03061071|Randomized|Crossover Assignment||Treatment||Single|The technician scoring the polysomnograms will be unaware of previous PSG results from the patient to the best of their ability (ie: will not look back in their records for the purpose of reviewing their previous PSGs prior to scoring).|6 week crossover study, randomized to order of treatment||||t
1341090|NCT03061058|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341091|NCT03061045||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341092|NCT03061032|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341093|NCT03061019|Randomized|Parallel Assignment||Treatment||Single||||||t
1341094|NCT03061006|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341095|NCT03060993|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1341096|NCT03060980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341097|NCT03060967|Non-Randomized|Parallel Assignment||Screening||Single|||t|||
1341098|NCT03060954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341099|NCT03060941|Randomized|Parallel Assignment||Prevention||None (Open Label)||The 500 participants in the physical activity intervention will be randomly assigned to one of sixteen intervention groups (see Table below). Randomization will be stratified by clinical site. The randomization scheme will be conducted by the study statistician. The randomization scheme will consist of balanced blocks within each stratum, with block size will be varied and randomly permuted. Allocation will occur following completion of baseline assessments.||||
1341100|NCT03060928|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind||t|t|t|t
1341101|NCT03060915||Single Group Assignment||Other||None (Open Label)||||||
1341102|NCT03060902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341103|NCT03060889|Randomized|Parallel Assignment||Prevention||Single|||t|||
1341104|NCT03060876|||Cohort||Prospective|||||||
1341105|NCT03060863|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1341106|NCT03060850||Single Group Assignment||Treatment||None (Open Label)||||||
1341107|NCT03060837|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1341108|NCT03060824|||Cohort||Prospective|||||||
1341109|NCT03060811|||Cohort||Cross-Sectional|||||||
1341110|NCT03060798|||Cohort||Prospective|||||||
1341111|NCT03060785|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1341112|NCT03060772|Randomized|Parallel Assignment||Treatment||None (Open Label)||Individuals with alcohol use disorder will be randomized to receive the study medication, pioglitazone, or no medication (12 in each group). A third group of healthy individuals who do not have an alcohol use disorder will also be enrolled to serve as an additional comparison group.||||
1341113|NCT03060759|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341114|NCT03060746|||Case-Only||Prospective|||||||
1341115|NCT03060733|||Case-Only||Prospective|||||||
1341116|NCT03060720|||Other||Prospective|||||||
1341117|NCT03060707|Randomized|Parallel Assignment||Other||Double|||t|||t
1341118|NCT03060694|||Case-Control||Cross-Sectional|||||||
1341119|NCT03060681|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1341120|NCT03060668|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341121|NCT03060655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341122|NCT03060642|||Case-Control||Cross-Sectional|||||||
1341123|NCT03060629|Randomized|Parallel Assignment||Prevention||Double|Sponsor will be also blinded||t||t|
1341124|NCT03060616|||Cohort||Prospective|||||||
1341125|NCT03060603|||Cohort||Prospective|||||||
1341126|NCT03060590|||Case-Crossover||Cross-Sectional|||||||
1341127|NCT03060577|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341128|NCT03060564|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341129|NCT03060551||Single Group Assignment||Treatment||None (Open Label)||Autologous adipose tissue-derived stromal vascular fraction(SVF) injected into the subcutaneous tissue of each finger in contact with neurovascular pedicles.||||
1341130|NCT03060538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341131|NCT03060525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341132|NCT03060512|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341133|NCT03060499|||Cohort||Prospective|||||||
1341134|NCT03060486||Single Group Assignment||Treatment||None (Open Label)||||||
1341135|NCT03060473|Randomized|Parallel Assignment||Treatment||Single|Single Blind|Allocation: Randomized Intervention model: Parallel Assignment||||t
1341136|NCT03060460|Randomized|Sequential Assignment||Diagnostic||None (Open Label)||historical control cohort (Group A) and then a randomized prospective study (Group B and C).||||
1341137|NCT03060447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341138|NCT03060434|Randomized|Crossover Assignment||Treatment||Double|The assessor and the investigator are unaware of the sequence of the 15 days treatment with pentoxifylline|Each patient will receive for 1 month: Ibuprofen 600 mg bid; Paracetamol 1g tid if needed; pregabalin 75 mg bid pentoxifylline 400 mg bid will be added for either the first or second 15 days (randomization)|||t|t
1341139|NCT03060421|||Cohort||Retrospective|||||||
1341140|NCT03060408|||Cohort||Retrospective|||||||
1341141|NCT03060395|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1341142|NCT03060382|Randomized|Parallel Assignment||Treatment||Single|||||t|
1341143|NCT03060369|||Cohort||Prospective|||||||
1341144|NCT03060356|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341145|NCT03060343||Single Group Assignment||Treatment||None (Open Label)||||||
1341146|NCT03060330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341147|NCT03060317|||Cohort||Cross-Sectional|||||||
1341148|NCT03060304|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|Parallel Assignment||||
1341149|NCT03060291|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be randomly assigned to one of three conditions: a web/mobile-only condition, a web/mobile + coach condition, or a wait list control group who will receive the web/mobile-only treatment one year after enrolling in the study.||||
1341150|NCT03060278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341151|NCT03060265|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1341152|NCT03060252|||Cohort||Prospective|||||||
1341153|NCT03060239||Single Group Assignment||Other||None (Open Label)||||||
1341154|NCT03060226|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1341155|NCT03060213|Randomized|Parallel Assignment||Treatment||Double|Participants who have completed the full online T1 battery will be randomly assigned in real-time by the computer to either the intervention condition or the UC control condition. Randomization, group assignment, and assessments will be conducted solely by the computer program, so researchers will be blind to participant randomization, group assignment, and participant group identity during assessment times. With regard to group size and power, experience from our prior efficacy study of FFW indicates that for the current study, the computer program will use a 2:1 randomization algorithm so that there are twice as many FFW intervention participants as UC control participants.|The intervention group will be compared to a usual care (UC) control group on outcomes of overall subjective well-being, domain-specific well-being, health-related quality of life, and well-being self-efficacy. The intervention group will participate in online activities for 30 days while UC control group participants will be asked to conduct their lives as usual for the same 30 day period. Both groups will complete assessments during this time period. The UC group will be given access to the intervention for 30 days after all study participants have completed the three survey battery administrations.|||t|t
1341156|NCT03060200|Randomized|Parallel Assignment||Treatment||Single|||||t|
1341157|NCT03060187|||Case-Only||Prospective|||||||
1341158|NCT03060174|Randomized|Parallel Assignment||Prevention||Single|||t|||
1341214|NCT03059446||Single Group Assignment||Treatment||None (Open Label)||||||
1341215|NCT03059433|||Cohort||Prospective|||||||
1341216|NCT03059420|||Cohort||Other|||||||
1341326|NCT03057990||Single Group Assignment||Treatment||None (Open Label)||||||
1341159|NCT03060161||Single Group Assignment||Prevention||None (Open Label)||The present project corresponds to a longitudinal study. Intervention will be performed soon after the initial diagnosis, through nutritional monitoring and individual guidance on regular physical exercise for a period of 12 weeks. Participants will be evaluated for weight loss, body fat reduction, changes in laboratory parameters and eating habits and in relation to the routine of physical activities immediately after the intervention period, and will be retested after six months.||||
1341160|NCT03060148|Non-Randomized|Parallel Assignment||Treatment||Single||Medtronic neurostimulation||||t
1341161|NCT03060135|Randomized|Parallel Assignment||Other||Single|||t|||
1341162|NCT03060122|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1341163|NCT03060109|||Cohort||Prospective|||||||
1341164|NCT03060096|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Participants will be stratified by baseline score ≥15 on the GAD-7 and/or on the PHQ-9, indicating severe significant anxiety or depressive symptom. Participants with moderate symptoms only (10-14 on the PHQ-9 and/or 8-14 on the GAD-7) will be block randomized to either the low-intensity stepped care or to the enhanced usual care (EUC control). Participants with moderate to severe symptoms will be block randomized to either the high-intensity stepped care intervention or the EUC control. Block sizes will be chosen randomly to ensure that future assignments cannot be inferred from previous ones.||||
1341165|NCT03060083|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1341166|NCT03060070|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1341167|NCT03060057|||Cohort||Prospective|||||||
1341168|NCT03060044|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341169|NCT03060031|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1341170|NCT03060018||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341171|NCT03060005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341172|NCT03059992||Single Group Assignment||Treatment||None (Open Label)||open label, non-comparator, single arm||||
1341173|NCT03059979|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341174|NCT03059966|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341175|NCT03059953|||Cohort||Prospective|||||||
1341176|NCT03059940|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341177|NCT03059927|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1341178|NCT03059914|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341179|NCT03059901|Randomized|Parallel Assignment||Prevention||Single|||t|||
1341180|NCT03059888||Single Group Assignment||Treatment||None (Open Label)||||||
1341181|NCT03059875|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341182|NCT03059862|Randomized|Crossover Assignment||Other||Quadruple||All subjects will be following a standardized low-tryptophan diet and randomized to L-tryptophan supplements or placebo, for three weeks. After a 2 weeks washout period, subjects will crossover to the other arm.|t|t|t|t
1341183|NCT03059849|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341184|NCT03059836|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1341185|NCT03059823|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341186|NCT03059810||||||||||||
1341187|NCT03059797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341188|NCT03059784|Randomized|Parallel Assignment||Other||Single||||||t
1341189|NCT03059771|Randomized|Parallel Assignment||Treatment||Single||||||t
1341190|NCT03059758||Single Group Assignment||Basic Science||None (Open Label)||||||
1341191|NCT03059745|||Other||Retrospective|||||||
1341192|NCT03059732|||Case-Only||Retrospective|||||||
1341193|NCT03059719|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341194|NCT03059706|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1341195|NCT03059693|Randomized|Parallel Assignment||Treatment||Quadruple|The Sponsor will send all washout and test products in compliance with current Good Manufacturing Practices directly to the clinical facility prior to the start of the study. Study procedures will be in place to ensure double-blind administration of study treatments. Access to the randomization code will be strictly controlled. The quantity of all study material shipped to the clinical facility will be documented on the shipping and receiving form included within the shipment. Due to the objectives of the study, the identity of test and control treatments will not be known to investigators, care provider, outcomes assessor, research staff, or patients. Packaging and labeling of test and control treatments will be identical to maintain the blind. Products will be identified with the codes generated by the randomization.||t|t|t|t
1341196|NCT03059680|Randomized|Parallel Assignment||Treatment||None (Open Label)|Treating physicians and participants were not blinded to randomization. Investigators performing randomization and analysis of dietary intake were blinded.|||||
1341197|NCT03059667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341198|NCT03059654|Randomized|Parallel Assignment||Device Feasibility||Single||||||t
1341199|NCT03059641|||Cohort||Prospective|||||||
1341200|NCT03059628|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341201|NCT03059615|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"2 stage study:~Dose Range Finder (4 treatment arms)~Dose Confirmation (1 chosen treatment arm)"||||
1341202|NCT03059602|||Other||Prospective|||||||
1341203|NCT03059589|||Case-Only||Prospective|||||||
1341204|NCT03059576|||Cohort||Other|||||||
1341205|NCT03059563|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1341206|NCT03059550|||Other||Prospective|||||||
1341207|NCT03059537||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341208|NCT03059524|||Cohort||Prospective|||||||
1341209|NCT03059511|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341210|NCT03059498|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341211|NCT03059485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341212|NCT03059472|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1341213|NCT03059459|||Cohort||Prospective|||||||
1341217|NCT03059407|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Subjects will be assigned into one of three groups: 1) Canine assisted therapy only; 2) Canine assisted therapy plus standard distraction techniques; and 3) Standard distraction techniques only.||||
1341218|NCT03059394|||Other||Prospective|||||||
1341219|NCT03059381|||Cohort||Prospective|||||||
1341220|NCT03059368||Single Group Assignment||Treatment||None (Open Label)||||||
1341221|NCT03059355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341222|NCT03059342|||Cohort||Prospective|||||||
1341223|NCT03059329|||Cohort||Prospective|||||||
1341224|NCT03059316|Randomized|Sequential Assignment||Supportive Care||Single|||||t|
1341225|NCT03059303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341226|NCT03059290|Randomized|Single Group Assignment||Treatment||Single|||t|||
1341227|NCT03059277||Single Group Assignment||Treatment||None (Open Label)||||||
1341228|NCT03059264|||Cohort||Prospective|||||||
1341229|NCT03059251|||Cohort||Other|||||||
1341230|NCT03059238|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341231|NCT03059225|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1341232|NCT03059212|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1341233|NCT03059199||Single Group Assignment||Prevention||None (Open Label)||||||
1341234|NCT03059186|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341235|NCT03059173|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341236|NCT03059160||Single Group Assignment||Treatment||None (Open Label)||open label study with one doze||||
1341237|NCT03059147||Single Group Assignment||Treatment||None (Open Label)||3 + 3 Designed Phase I study||||
1341238|NCT03059134|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|"The study population consisted of male and female outpatients meeting the legal minimum age requirement of the region with symptoms of OAB for more than 3 months. Patient demographics data will be recorded as detailed as possible, including previous urodynamic study results. The study consisted of four arms:~Mirabegron 25mg once-daily for 4 weeks, and continue the same dose of mirabegron for another 8 weeks~Mirabegron 25mg once-daily for 4 weeks, and increase the dose to 50mg for another 8 weeks~Mirabegron 25mg once-daily for 4 weeks, and shift to solifenacin 5mg for another 8 weeks~Mirabegron 25mg once-daily for 4 weeks, and add-on solifenacin 5mg for another 8 weeks,"||||
1341239|NCT03059121|||Cohort||Prospective|||||||
1341240|NCT03059108|Randomized|Parallel Assignment||Treatment||Single||||||t
1341241|NCT03059095||Single Group Assignment||Treatment||None (Open Label)||||||
1341242|NCT03059082|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1341243|NCT03059069|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341244|NCT03059056||Single Group Assignment||Basic Science||None (Open Label)||||||
1341245|NCT03059043|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1341246|NCT03059030||Single Group Assignment||Treatment||None (Open Label)||||||
1341247|NCT03059017|Randomized|Parallel Assignment||Treatment||None (Open Label)||Volunteers will be divided into two groups; each group contained 10 volunteers who will receive one formula of the selected formulae.||||
1341248|NCT03059004|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessors will not be appraised of treatment arm.|Four arm parallel randomized controlled trial.||||t
1341249|NCT03058991|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341250|NCT03058978|||Cohort||Prospective|||||||
1341251|NCT03058965||Single Group Assignment||Other||None (Open Label)||||||
1341252|NCT03058952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341253|NCT03058939|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1341254|NCT03058926|||Case-Control||Prospective|||||||
1341255|NCT03058913|||Cohort||Prospective|||||||
1341256|NCT03058900|Randomized|Parallel Assignment||Treatment||Triple|Double-Blinded||t|t||t
1341257|NCT03058887|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341258|NCT03058874|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341259|NCT03058861|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341260|NCT03058848||Single Group Assignment||Treatment||None (Open Label)||||||
1341261|NCT03058835||Single Group Assignment||Prevention||None (Open Label)||||||
1341262|NCT03058822|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341263|NCT03058809||Single Group Assignment||Treatment||None (Open Label)||Subjects will be their own controls||||
1341264|NCT03058796|Randomized|Parallel Assignment||Treatment||Single||||||t
1341265|NCT03058783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341266|NCT03058770|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1341267|NCT03058757|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341268|NCT03058744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341269|NCT03058731|||Case-Control||Retrospective|||||||
1341270|NCT03058718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341271|NCT03058705||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1341272|NCT03058692|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1341273|NCT03058679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341274|NCT03058666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341275|NCT03058653||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341276|NCT03058640|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341277|NCT03058627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341278|NCT03058614|Randomized|Parallel Assignment||Diagnostic||Double|The surgical team will be blinded to the randomization outcome of the patient until the day after surgery so as to minimize any bias introduced into their preoperative counseling. After that point, treatment teams will no longer be blinded to randomization.|Randomized control study||t|t|
1341279|NCT03058601|||Cohort||Retrospective|||||||
1341281|NCT03058575|Randomized|Crossover Assignment||Basic Science||Single|Outcomes Assessors will be blind to who is on Arm1 and who is on Arm 2.|This is a randomized, 2-period crossover study.||||t
1341282|NCT03058562|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1341283|NCT03058549|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1341284|NCT03058536|Randomized|Parallel Assignment||Prevention||None (Open Label)||312 twin pregnant women with short cervix between 16 and 27 weeks and 6 days of gestacional age will be randomized in four groups: daily 400mg vaginal progesterone combined with insertion of cervical pessary; isolated use of daily 400mg vaginal progesterone, isolated insertion of cervical pessary or expectant management (no intervention).||||
1341285|NCT03058523|||Other||Other|||||||
1341286|NCT03058510|||Case-Only||Prospective|||||||
1341287|NCT03058497|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1341288|NCT03058484|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341289|NCT03058471|Randomized|Crossover Assignment||Treatment||Single||||||t
1341290|NCT03058458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341291|NCT03058445||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341292|NCT03058432|Randomized|Parallel Assignment||Treatment||None (Open Label)||Concurrent cisplatin based chemoradiotherapy versus radiotherapy alone||||
1341293|NCT03058419||Single Group Assignment||Treatment||None (Open Label)||||||
1341294|NCT03058406|||Cohort||Prospective|||||||
1341295|NCT03058393||Single Group Assignment||Health Services Research||None (Open Label)||||||
1341296|NCT03058380|||Cohort||Prospective|||||||
1341297|NCT03058367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341298|NCT03058354|||Other||Retrospective|||||||
1341299|NCT03058341|Randomized|Parallel Assignment||Treatment||Quadruple|Patients will not be informed about what type of anaesthesia they will receive. A separate investigator assessing the patients for data collection after the operation will be blinded. The anaesthetist providing general anaesthesia will not be involved in data collection.|Patients in the first group (S) will be anaesthetized by inhalational anaesthesia using sevoflurane. The patients in the second group (P) will be anaesthetized using total intravenous propofol.|t|t|t|t
1341300|NCT03058328|||Other||Prospective|||||||
1341301|NCT03058315|||Cohort||Prospective|||||||
1341302|NCT03058302|Randomized|Parallel Assignment||Treatment||Single|until the 4th sessions participants receiving CETA and providers will be masked with respect to whether treatment is short or long CETA.|||||t
1341303|NCT03058289|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|There is no masking and all patients will receive INT230-6 treatments.|There are up to 9 cohorts of subjects in the escalation portion of the protocol. The first is a superficial tumor cohort with a low tumor load (1:4 ratio of drug to tumor). The 2nd,3rd and 4th cohorts are in superficial and deep tumors that escalates the total dose and maximal dose per any one tumor. Cohort 5/6/7 will explore a higher drug load (1:2 ratio) and will escalate the total dose and maximal dose per any one tumor. The 8th cohort is reserved for combinations with anti-PD1 agent(s). The 9th optional cohort will be added if a more frequent schedule would be deemed beneficial. The specific regimens of the more frequent dosing regimen cohorts will be designated by the Study Steering Committee.||||
1341304|NCT03058276|Randomized|Parallel Assignment||Treatment||Double|Double-blinded experiment regarding rTMS treatment is applied to both subjects and investigators. The only non-masked role is for the technician applying either Magstim Rapid or SAM coils to each group of subjects.||t||t|
1341305|NCT03058263|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341306|NCT03058250|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341307|NCT03058237|Randomized|Crossover Assignment||Basic Science||None (Open Label)||The Clinical Trial Authorisation application for this study describes a flexible protocol design using the formulation design space concept to allow decision-making in response to interim PK observations||||
1341308|NCT03058224|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341309|NCT03058211|||Cohort||Prospective|||||||
1341310|NCT03058198||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341311|NCT03058185|||Case-Only||Prospective|||||||
1341312|NCT03058172|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1341313|NCT03058159|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1341314|NCT03058146|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized Controlled Trial with ongoing enrollment into each arm (individual intervention)||||
1341315|NCT03058133||Single Group Assignment||Basic Science||None (Open Label)||||||
1341316|NCT03058120|Randomized|Parallel Assignment||Other||Single|||||t|
1341317|NCT03058107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341318|NCT03058094|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341319|NCT03058081|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341320|NCT03058068|Randomized|Parallel Assignment||Treatment||Double|Masking will apply to the randomized phase.|"Safety run-in phase will have 3 subjects with 2 treatment groups~Randomized phase will have 15 subjects with 3 treatment groups"|t||t|
1341321|NCT03058055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341322|NCT03058042|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Protocol of group I (Outpatient training): Patients will perform 24 outpatient sessions of pelvic floor muscle (PFM) strength training and home training. At the end of one month, the patients will perform PFM evaluation and training progression~Group II protocol (home training): Patients will perform strength training of the pelvic floor muscles daily at home. At the end of one month, the patients will return for consultation, in which the PFM evaluation and training progression will be performed."||||
1341323|NCT03058029|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341324|NCT03058016||Single Group Assignment||Prevention||None (Open Label)||Personalized recommendations for effective diet, lifestyle and activities based on the patient's parameters measurements and reactions will be provided on a bi-weekly basis, all Lab tests and dietician control will be performed twice a month.||||
1341325|NCT03058003|||Case-Control||Cross-Sectional|||||||
1341327|NCT03057977|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341328|NCT03057964|Randomized|Parallel Assignment||Treatment||Single||||||t
1341329|NCT03057951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341330|NCT03057938||Single Group Assignment||Prevention||None (Open Label)||Phase II, open-label clinical trial with a medicinal product.||||
1341331|NCT03057925|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341332|NCT03057912|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|||||
1341333|NCT03057899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341334|NCT03057886|||Case-Control||Prospective|||||||
1341335|NCT03057873|Randomized|Parallel Assignment||Other||Quadruple|Double-blind||t|t|t|t
1341336|NCT03057860|||Cohort||Prospective|||||||
1341337|NCT03057847||Single Group Assignment||Health Services Research||None (Open Label)||Single arm, open-label, prospective observational cohort study||||
1341338|NCT03057834|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This will be determined based on the score on the SPPB.||||
1341339|NCT03057821|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341340|NCT03057808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341341|NCT03057795||Single Group Assignment||Treatment||None (Open Label)||||||
1341342|NCT03057782|||Cohort||Prospective|||||||
1341343|NCT03057769|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1341344|NCT03057756|||Cohort||Prospective|||||||
1341345|NCT03057743|||Cohort||Prospective|||||||
1341346|NCT03057730|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1341347|NCT03057717||Single Group Assignment||Other||None (Open Label)||||||
1341348|NCT03057704|Randomized|Parallel Assignment||Treatment||Single|The participant is not told which group they are randomized to. However, a tourniquet is applied in the experimental group, thus some subjects may reason that they are in the experimental group. The study coordinator is aware which group the subject is in.|A randomized, controlled trial of two methods of administering lidocaine prior to propofol injection|t|||
1341349|NCT03057691|||Cohort||Prospective|||||||
1341350|NCT03057678||Single Group Assignment||Basic Science||None (Open Label)|Open Label|||||
1341351|NCT03057665|||Case-Only||Prospective|||||||
1341352|NCT03057652|Randomized|Crossover Assignment||Treatment||None (Open Label)||Each of the participants will receive training with each of the 3 wearable robotic exoskeletons (WRE) examined in this study, and the order of receipt will be randomized.||||
1341353|NCT03057639|||Case-Only||Prospective|||||||
1341354|NCT03057626||||||||||||
1341355|NCT03057613||Single Group Assignment||Treatment||None (Open Label)||||||
1341356|NCT03057600|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be assigned to one of 4 arms depending on the number of prior lines of therapy they have received and whether or not they have African ancestry||||
1341357|NCT03057587|||Case-Only||Prospective|||||||
1341358|NCT03057574||Single Group Assignment||Treatment||None (Open Label)||||||
1341359|NCT03057561|Randomized|Parallel Assignment||Diagnostic||Single|Blinded reader of scans will not know whether subject received Dotarem or Magnevist.|Evaluating the efficacy of Dotarem enhanced MRI compared to Magnevist enhanced MRI in identifying myocardial fibrosis. Patients will be randomized (in a 1:1 fashion) to receive either Dotarem or Magnevist for LGE-CMR such that there will be 60 patients in the Dotarem cohort and 60 patients in the Magnevist cohort||||t
1341360|NCT03057548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341361|NCT03057535|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1341362|NCT03057522|Randomized|Parallel Assignment||Other||Single||Prospective, randomized, controlled study evaluating whether a home exercise program can increase the running cadence of recreational runners.||||t
1341363|NCT03057509||Single Group Assignment||Treatment||None (Open Label)||||||
1341364|NCT03057496||Single Group Assignment||Other||None (Open Label)|Although this is a single-arm study, participants will be masked in the sense that they will not know whether the device is operating in the active mode (intervention condition), when it gives warnings, or the silent mode (control condition), when it does not give warnings. The device will be programmed to generate a different randomized active/silent schedule for each subject. The investigator conducting the statistical analyses will also be masked as to whether the device was in the active or silent mode|The device will operate in two modes: active mode (intervention condition), when it gives warnings and, silent mode (control condition), when it does not give warnings. The device will be programmed to generate a different randomized active/silent schedule for each subject. Participants will not know whether it is in the active or silent mode.||||
1341365|NCT03057483|||Cohort||Prospective|||||||
1341366|NCT03057470|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341367|NCT03057457|||Cohort||Prospective|||||||
1341368|NCT03057444||Single Group Assignment||Treatment||None (Open Label)||open intervention study||||
1341369|NCT03057431|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1341370|NCT03057418||Single Group Assignment||Treatment||None (Open Label)||||||
1341371|NCT03057405|||Case-Control||Retrospective|||||||
1341372|NCT03057392|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341373|NCT03057379|Randomized|Parallel Assignment||Health Services Research||Double||Participants will be randomized to one of four arms to receive 0,1,2,or 3 reminders for overdue HPV vaccine doses.||t||t
1341374|NCT03057366||Single Group Assignment||Other||None (Open Label)||||||
1341375|NCT03057353|||Case-Only||Retrospective|||||||
1341376|NCT03057340||Single Group Assignment||Treatment||None (Open Label)||||||
1341377|NCT03057327|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||sequential single group||||
1341378|NCT03057314||Single Group Assignment||Treatment||None (Open Label)||||||
1341379|NCT03057301|||Cohort||Prospective|||||||
1341380|NCT03057288||Single Group Assignment||Other||None (Open Label)||Prospective study with one single group of 40 patients||||
1341381|NCT03057275|||Cohort||Prospective|||||||
1341382|NCT03057262|||Cohort||Prospective|||||||
1341383|NCT03057249|||Other||Prospective|||||||
1341384|NCT03057236|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to Standard of Care group or the Intervention (CBCS) group.||||
1341385|NCT03057223||Single Group Assignment||Device Feasibility||None (Open Label)||This is an open-label, prospective, single-arm, and single-center interventional clinical study.||||
1341386|NCT03057210|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1341387|NCT03057197|Randomized|Parallel Assignment||Other||Double|||t|t||
1341388|NCT03057184|Randomized|Parallel Assignment||Treatment||Single||It is an experimental design using random assignment to select 120 family members responsible for the preparation and transfer of the care-recipient from their home to the ADCC: will be randomized to an intervention group or control group (care as usual)..||t||
1341389|NCT03057171|||Case-Only||Prospective|||||||
1341390|NCT03057158|||Other||Prospective|||||||
1341391|NCT03057145||Single Group Assignment||Treatment||None (Open Label)||||||
1341392|NCT03057132||Single Group Assignment||Supportive Care||None (Open Label)||||||
1341393|NCT03057119|Randomized|Parallel Assignment||Screening||Single||A repeated measures randomized control trial design to compare patient outcomes at baseline as well as 3 and 6 months post-intervention|t|||
1341394|NCT03057106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341395|NCT03057093|||Case-Control||Retrospective|||||||
1341396|NCT03057080||Single Group Assignment||Treatment||None (Open Label)||||||
1341397|NCT03057067||Single Group Assignment||Treatment||None (Open Label)||All female patients referred for assessment of chronic pelvic pain at the gynecological outpatient clinic or the Multidisciplinary Pain Clinic at St. Olavs Hospital are eligible for initial assessment||||
1341398|NCT03057054|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1341399|NCT03057041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341400|NCT03057028||Single Group Assignment||Treatment||None (Open Label)||||||
1341401|NCT03057015|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1341402|NCT03057002|||Case-Control||Prospective|||||||
1341403|NCT03056989|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1341404|NCT03056976|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparative effectiveness of thre competing strategies for the edentulous mandible using implants||||
1341405|NCT03056963|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341406|NCT03056950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341407|NCT03056937|||Case-Control||Prospective|||||||
1341408|NCT03056924|||Case-Only||Prospective|||||||
1341409|NCT03056911|||Other||Retrospective|||||||
1341410|NCT03056898|||Ecologic or Community||Cross-Sectional|||||||
1341411|NCT03056885|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341412|NCT03056872|||Cohort||Prospective|||||||
1341413|NCT03056859|||Case-Only||Prospective|||||||
1341414|NCT03056846|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1341415|NCT03056833||Single Group Assignment||Treatment||None (Open Label)||||||
1341416|NCT03056820|Randomized|Parallel Assignment||Health Services Research||Single|The person measuring and recording the study data will be blinded.|||||t
1341417|NCT03056807|Randomized|Parallel Assignment||Health Services Research||Single|"The person measuring and recording the study data (timer) will be blinded."|||||t
1341418|NCT03056794|||Cohort||Other|||||||
1341419|NCT03056781|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1341420|NCT03056768|Randomized|Parallel Assignment||Prevention||Single||||||t
1341421|NCT03056755|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a phase II, multicenter, open-label, two-cohort, non-comparative study of alpelisib plus endocrine therapy (either fulvestrant or letrozole) in patients with HR+, HER2-negative aBC harboring PIK3CA mutation(s) in the tumor whose disease has progressed on or after CDK 4/6 inhibitor containing treatments||||
1341422|NCT03056742||Single Group Assignment||Treatment||None (Open Label)||||||
1341423|NCT03056729|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341424|NCT03056716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341425|NCT03056703|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341426|NCT03056690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341427|NCT03056677|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1341428|NCT03056664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341429|NCT03056651||Single Group Assignment||Treatment||None (Open Label)||||||
1341430|NCT03056638|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible patients with intermediate risk disease will be randomized to ADT with SBRT versus SBRT alone. PSA and testosterone testing every 6 months, Biopsy 24-30 months after SBRT||||
1341431|NCT03056625|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1341432|NCT03056612|||Case-Control||Prospective|||||||
1341433|NCT03056599||Single Group Assignment||Basic Science||None (Open Label)||||||
1341434|NCT03056586|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1341435|NCT03056573|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Portico TF and ALT Delivery System||||
1341436|NCT03056560|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341437|NCT03056547||Single Group Assignment||Basic Science||None (Open Label)||||||
1341438|NCT03056534|||Cohort||Prospective|||||||
1341439|NCT03056521|Randomized|Parallel Assignment||Treatment||Double|The participants and the healthcare providers do not know which patient belongs to which arm||t|t||
1341440|NCT03056508|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1341441|NCT03056495||Single Group Assignment||Basic Science||None (Open Label)||||||
1341495|NCT03055793|||Other||Prospective|||||||
1341496|NCT03055780|||Cohort||Retrospective|||||||
1341497|NCT03055767|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1341498|NCT03055754|Randomized|Parallel Assignment||Treatment||Single||||||t
1341442|NCT03056482|Randomized|Crossover Assignment||Treatment||Quadruple|Participants will be allocated to an intervention via a sealed, opaque envelope system to be opened by an unblinded nurse not otherwise involved in patient care or research procedures will prepare the intervention. The Attending physician, Research personnel and Investigator(s) will all remain blinded to the allocation.|This is a double-blinded, randomized, cross-over clinical trial that will allocate subjects in a 1:1:1 fashion into one of three treatment groups: high- or low-dose haloperidol, or ondansetron, with a minimum 7-day washout period between treatments.|t|t|t|t
1341443|NCT03056469|Randomized|Parallel Assignment||Supportive Care||Single|In one randomization arm the participants submit patient-reported outcomes, and the care providers have access to the patient-reported outcomes. In another randomization arm the participants submit patient-reported outcomes, but the care providers do not have access to the patient-reported outcomes. In the last randomization arm the participants are randomized to standard follow-up, do not complete PRO questionnaires and are thus controls.|||t||
1341444|NCT03056456|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1341445|NCT03056443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341446|NCT03056430|Randomized|Factorial Assignment||Prevention||Single|||t|||
1341447|NCT03056417|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1341448|NCT03056404||Single Group Assignment||Other||None (Open Label)||||||
1341449|NCT03056391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341450|NCT03056378|Randomized|Parallel Assignment||Prevention||Single||||||t
1341451|NCT03056365|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1341452|NCT03056352||Single Group Assignment||Treatment||None (Open Label)||||||
1341453|NCT03056339||Single Group Assignment||Treatment||None (Open Label)||||||
1341454|NCT03056326|Randomized|||Treatment||Quadruple||"Part 1: alternating cross-over design~Part 2: parallel design"|t|t|t|t
1341455|NCT03056313|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341456|NCT03056300||Single Group Assignment||Other||None (Open Label)||||||
1341457|NCT03056287|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1341458|NCT03056274|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341459|NCT03056261|Randomized|Crossover Assignment||Treatment||None (Open Label)||comaring combined general anesthesia and epidural technique to general anaesthsia alone or gastrointestinal recovery and pain managment||||
1341460|NCT03056248|Randomized|Parallel Assignment||Prevention||Triple|Patients and investigators will be blinded to the study|Patients will be randomized to lithium versus placebo and rates of acute kidney injury will be measured|t|t|t|
1341461|NCT03056235|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1341462|NCT03056222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341463|NCT03056209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341464|NCT03056196|||Cohort||Prospective|||||||
1341465|NCT03056183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341466|NCT03056170|Randomized|Parallel Assignment||Basic Science||Quadruple|Double blind||t|t|t|t
1341467|NCT03056157|Randomized|Parallel Assignment||Treatment||Single||||||t
1341468|NCT03056144||Single Group Assignment||Treatment||None (Open Label)||A pilot study with a before and after study design||||
1341469|NCT03056131|Randomized|Parallel Assignment||Treatment||Single||||||t
1341470|NCT03056118|Randomized|Factorial Assignment||Treatment||Single||||||t
1341471|NCT03056105|||Case-Control||Prospective|||||||
1341472|NCT03056092||Single Group Assignment||Treatment||None (Open Label)||This study will include patients with 3 different diseases who will receive the same treatment (ranibizumab injections) but that will be independently analyzed. One population will be composed of patients with neovascular age related macular degeneration, the other of diabetic macular edema and the third of patients with macular edema secondary to retinal vein occlusion.||||
1341473|NCT03056079||Single Group Assignment||Treatment||None (Open Label)||This study will contain 3 populations of patients which will all receive aflibercept injections: one with neovascular age-related macular degeneration, other with diabetic macular edema and a third with macular edema secondary to retinal vein occlusion.||||
1341474|NCT03056066|||Cohort||Prospective|||||||
1341475|NCT03056053||Single Group Assignment||Other||None (Open Label)||||||
1341476|NCT03056040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341477|NCT03056027|||Case-Only||Prospective|||||||
1341478|NCT03056014|Randomized|Parallel Assignment||Treatment||Single|Double blind||t|||
1341479|NCT03056001||Single Group Assignment||Treatment||None (Open Label)||||||
1341480|NCT03055988|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1341481|NCT03055975|||Cohort||Cross-Sectional|||||||
1341482|NCT03055962|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1341483|NCT03055949|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341484|NCT03055936|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341485|NCT03055923|||Case-Control||Cross-Sectional|||||||
1341486|NCT03055910|||Cohort||Prospective|||||||
1341487|NCT03055897||Single Group Assignment||Other||None (Open Label)||||||
1341488|NCT03055884|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1341489|NCT03055871|Randomized|Parallel Assignment||Prevention||Single|||t|||
1341490|NCT03055858||Single Group Assignment||Treatment||None (Open Label)||ADO II AS device||||
1341491|NCT03055845|Randomized|Parallel Assignment||Treatment||Quadruple||Following treatment of 2 patients in each dose group (injections with active drug and placebo, respectively), safety data will be reviewed. If no safety or tolerability concerns are identified, the next 3 patients in each dose group will be treated (active treatment or placebo [2:1]).|t|t|t|t
1341492|NCT03055832|Randomized|Parallel Assignment||Treatment||Single|Meibomian gland score will be assessed by a masked rater|||||t
1341493|NCT03055819||Single Group Assignment||Device Feasibility||None (Open Label)||Single arm, open label, multi-center||||
1341494|NCT03055806|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341499|NCT03055741|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1341500|NCT03055728|||Other||Other|||||||
1341501|NCT03055715|||Cohort||Retrospective|||||||
1341502|NCT03055702|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1341503|NCT03055689|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1341504|NCT03055676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341505|NCT03055663|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-labelled|Prospective, randomized controlled trial||||
1341506|NCT03055650||Single Group Assignment||Treatment||None (Open Label)||||||
1341507|NCT03055637|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1341508|NCT03055624||Single Group Assignment||Treatment||None (Open Label)||||||
1341509|NCT03055611|||Cohort||Prospective|||||||
1341510|NCT03055598||Single Group Assignment||Supportive Care||None (Open Label)||||||
1341511|NCT03055585|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341512|NCT03055572|Randomized|Parallel Assignment||Treatment||Single|Participants assigned to the either of the olfactory training arms will not know if they are in the essential oil arm or the pure fragrance oil arm.|Participants are randomized into one of three study arms: essential oil arm, pure fragrance oil arm, and control arm.|t|||
1341513|NCT03055559|||Case-Only||Prospective|||||||
1341514|NCT03055546|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1341515|NCT03055533|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341516|NCT03055520|Randomized|Parallel Assignment||Treatment||Single||||||t
1341517|NCT03055507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341518|NCT03055494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341519|NCT03055481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341520|NCT03055468|Randomized|Parallel Assignment||Treatment||Quadruple|Random sequence generation will be done by an independent biostatistician|We will have an intervention and a control group.|t|t|t|t
1341521|NCT03055455|||Cohort||Prospective|||||||
1341522|NCT03055442|||Case-Only||Prospective|||||||
1341523|NCT03055429||Single Group Assignment||Other||None (Open Label)||||||
1341524|NCT03055416||Single Group Assignment||Other||None (Open Label)||||||
1341525|NCT03055403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341526|NCT03055390|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1341527|NCT03055377|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind placebo-controlled pharmacotherapy trial|1:1 parallel group allocation randomized placebo controlled trial|t|t|t|t
1341528|NCT03055364|||Case-Only||Prospective|||||||
1341529|NCT03055351|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341530|NCT03055338|Randomized|Parallel Assignment||Treatment||Quadruple|A double-blind/masking technique will be used. MK-8189 and risperidone will be packaged identically relative to their respective matching placebo so that blinding/masking is maintained.|Participants will be randomly assigned to one of three groups in parallel for the duration of the study.|t|t|t|t
1341531|NCT03055325|||Cohort||Prospective|||||||
1341532|NCT03055312|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341533|NCT03055299||Single Group Assignment||Treatment||None (Open Label)||||||
1341534|NCT03055286||Single Group Assignment||Treatment||None (Open Label)||||||
1341535|NCT03055273|Randomized|Parallel Assignment||Other||Double|||||t|t
1341536|NCT03055260|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1341537|NCT03055247||Single Group Assignment||Basic Science||None (Open Label)||||||
1341538|NCT03055234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341539|NCT03055221||Single Group Assignment||Treatment||None (Open Label)||||||
1341540|NCT03055208||Single Group Assignment||Treatment||None (Open Label)||||||
1341541|NCT03055195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341542|NCT03055182|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1341543|NCT03055169|||Cohort||Prospective|||||||
1341544|NCT03055156|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1341545|NCT03055143|Randomized|Crossover Assignment||Treatment||||||||
1341546|NCT03055130|||Case-Control||Cross-Sectional|||||||
1341547|NCT03055117|Randomized|Parallel Assignment||Treatment||Single|||||t|
1341548|NCT03055104|||Cohort||Other|||||||
1341549|NCT03055091|Randomized|Parallel Assignment||Prevention||Quadruple|Participants will be randomized to the treatment arm or control arm and will receive the study product or placebo.|This will be a pragmatic triple blind (participant and parents, practitioners and analyst will be blinded), two arm, superiority, placebo controlled randomized trial with 1:1 allocation.|t|t|t|t
1341550|NCT03055078||Single Group Assignment||Treatment||None (Open Label)||||||
1341551|NCT03055065|||Cohort||Cross-Sectional|||||||
1341552|NCT03055052|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1341553|NCT03055039|||Cohort||Prospective|||||||
1341554|NCT03055026|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1341555|NCT03055013|Randomized|Parallel Assignment||Treatment||Single||||||t
1341556|NCT03055000|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1341557|NCT03054987|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341558|NCT03054974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341559|NCT03054961|||Cohort||Prospective|||||||
1341560|NCT03054948|Randomized|Parallel Assignment||Treatment||Single|||||t|
1341561|NCT03054935|||Case-Only||Cross-Sectional|||||||
1341562|NCT03054922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341563|NCT03054909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341564|NCT03054896||Single Group Assignment||Treatment||None (Open Label)||||||
1341565|NCT03054883|||Case-Only||Prospective|||||||
1341623|NCT03054129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341566|NCT03054870|Non-Randomized|Sequential Assignment||Other||Single|Independent blinded readers will assess all ventilation scintigraphy images. Images will have all subject identifiers removed and will be re-identified with unique random code numbers that will be used to control the order in which images will be displayed for assessment.|Subjects will undergo standard of care Xe-133 ventilation scintigraphy per medical needs followed by investigational Technegas ventilation scintigraphy per protocol||||t
1341567|NCT03054857|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1341568|NCT03054844|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1341569|NCT03054831|Randomized|Parallel Assignment||Treatment||Single||||||t
1341570|NCT03054818|||Cohort||Prospective|||||||
1341571|NCT03054805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341572|NCT03054792||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341573|NCT03054779|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1341574|NCT03054766|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1341575|NCT03054753||Single Group Assignment||Treatment||None (Open Label)||||||
1341576|NCT03054740|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341577|NCT03054727|||Cohort||Prospective|||||||
1341578|NCT03054714|Randomized|Parallel Assignment||Treatment||Single||||t||
1341579|NCT03054701|Randomized|Crossover Assignment||Basic Science||Double|The outcome assessor will be blinded to the order of the exercises and the participants will be blinded to the study-hypothesis.|After providing informed consent the participants will determine which is their most painful knee. This limb will be marked and it will serve as the test limb throughout the study protocol. At the first step of the protocol the participants will be baseline tested with handheld and cuff pressure algometer. Secondly, participants will be randomized to either a hip or a knee exercise. Thirdly, participants will undergo the testing-procedure for the second time. Fourthly, participants will perform exercise focusing on the other joint (hip or knee). Finally, participants will undergo the testing-procedure for the last time. In order to avoid any carryover effect from the testing procedure, there will be at least 15-minutes between each of the three test sessions.|t|||t
1341580|NCT03054688||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341581|NCT03054675|||Case-Control||Prospective|||||||
1341582|NCT03054662|Non-Randomized|Single Group Assignment||Other||None (Open Label)||monocentric prospective study with longitudinal data collection of a single group||||
1341583|NCT03054649||||||||||||
1341584|NCT03054636|||Cohort||Prospective|||||||
1341585|NCT03054623|||Cohort||Prospective|||||||
1341586|NCT03054610|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1341587|NCT03054597|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1341588|NCT03054584|||Other||Prospective|||||||
1341589|NCT03054571|||Other||Cross-Sectional|||||||
1341590|NCT03054558|||Case-Control||Prospective|||||||
1341591|NCT03054545||Single Group Assignment||Treatment||None (Open Label)||||||
1341592|NCT03054532||Single Group Assignment||Treatment||None (Open Label)||Open-label phase II study||||
1341593|NCT03054519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341594|NCT03054506|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341595|NCT03054493|||Other||Cross-Sectional|||||||
1341596|NCT03054480|Randomized|Parallel Assignment||Treatment||Single||RCT||||t
1341597|NCT03054467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341598|NCT03054454|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1341599|NCT03054441|||Case-Control||Prospective|||||||
1341600|NCT03054428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341601|NCT03054415||Single Group Assignment||Other||None (Open Label)||||||
1341602|NCT03054402|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1341603|NCT03054389|||Other||Retrospective|||||||
1341604|NCT03054376|Randomized|Parallel Assignment||Basic Science||None (Open Label)||Parallel randomized to training or no training of non-immobilized leg during immobilization of the other leg||||
1341605|NCT03054363||Single Group Assignment||Treatment||None (Open Label)||||||
1341606|NCT03054350|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1341607|NCT03054337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341608|NCT03054324|||Case-Only||Prospective|||||||
1341609|NCT03054311||Single Group Assignment||Prevention||None (Open Label)||||||
1341610|NCT03054298|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341611|NCT03054285|Randomized|Parallel Assignment||Treatment||None (Open Label)||The intervention study model is a randomized block design using a 1:1 allocation scheme||||
1341612|NCT03054272|||Cohort||Prospective|||||||
1341613|NCT03054259|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1341614|NCT03054246||Single Group Assignment||Other||None (Open Label)||Healthy volunteers||||
1341615|NCT03054233|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341616|NCT03054220|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1341617|NCT03054207|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341618|NCT03054194|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1341619|NCT03054181|||Cohort||Prospective|||||||
1341620|NCT03054168|Randomized|Parallel Assignment||Basic Science||Triple||To achieve our aims we will recruit 16 young healthy males (Age: 18-30 y; BMI: 18-30kg/m2) and 16 older healthy males (Age: 65-75 y; BMI: 18-30kg/m2). Volunteers will then be randomly assigned to a testing group; 1) Young placebo trained (N=10), 2) Young gonadotropin releasing hormone analogue trained (3.6mg Zoladex subcutaneous injection (every 4 weeks) N=10), 3) Old placebo trained (N=10) and 4) Old Testosterone trained (Sustanon 250: 250 mg every 2-3wks intramuscular injection, N=10). All participants will receive whole body resistance exercise training for six weeks.|t||t|t
1341621|NCT03054155|Randomized|Parallel Assignment||Treatment||None (Open Label)||For each patient, one side of the body will serve as the treatment side and the other side as the control||||
1341622|NCT03054142|||Case-Control||Retrospective|||||||
1341624|NCT03054116|||Cohort||Prospective|||||||
1341625|NCT03054103|Randomized|Parallel Assignment||Treatment||Triple|Surgical conditions and patient response not aware of medication given.|Randomized, controlled, double-masked, three-armed clinical comparison|t|t||t
1341626|NCT03054090||Single Group Assignment||Health Services Research||None (Open Label)||||||
1341627|NCT03054077|Randomized|Parallel Assignment||Supportive Care||Single|Blinding occurs through the randomization. Once the assignment to either group 1 (control) or group 2 (intervention) occurs all participants, care providers and investigators will be aware of which group is which.|RCT with a control arm equivalent to current standard of care and an intervention arm that includes standard of care plus the addition of an iPad with downloaded games.|||t|
1341628|NCT03054064||Single Group Assignment||Other||None (Open Label)||||||
1341629|NCT03054051|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341630|NCT03054038||Single Group Assignment||Treatment||None (Open Label)||||||
1341631|NCT03054025||Single Group Assignment||Supportive Care||None (Open Label)||||||
1341632|NCT03054012|||Cohort||Retrospective|||||||
1341633|NCT03053999|||Case-Control||Retrospective|||||||
1341634|NCT03053986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341635|NCT03053973|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel groups non-blinded randomised controlled trial||||
1341636|NCT03053960|||Cohort||Prospective|||||||
1341637|NCT03053947||Single Group Assignment||Treatment||None (Open Label)||||||
1341638|NCT03053934|Randomized|Parallel Assignment||Treatment||Single|||||t|
1341639|NCT03053921|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341640|NCT03053908||Single Group Assignment||Treatment||None (Open Label)||||||
1341641|NCT03053895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341642|NCT03053882|Randomized|Crossover Assignment||Supportive Care||Double|investigator||||t|t
1341643|NCT03053869|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1341644|NCT03053856||Single Group Assignment||Treatment||None (Open Label)||N2 positive stage IIIA non-small cell lung cancer treated with neoadjuvant concurrent chemoradiotherapy followed by curative resection||||
1341645|NCT03053843|Randomized|Parallel Assignment||Treatment||Single|||||t|
1341646|NCT03053830||Single Group Assignment||Treatment||None (Open Label)||||||
1341647|NCT03053817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341648|NCT03053804||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341649|NCT03053791||Single Group Assignment||Treatment||None (Open Label)||Single group of patients with spinal cord injury and spared fibers.||||
1341650|NCT03053778||Single Group Assignment||Prevention||None (Open Label)||||||
1341651|NCT03053765|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341652|NCT03053752||Single Group Assignment||Treatment||None (Open Label)||||||
1341653|NCT03053739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341654|NCT03053726|Randomized|Parallel Assignment||Treatment||Double|Patients and the outcomes assessor are blinded in this study||t|||t
1341655|NCT03053713|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Using a randomized, parallel treatment design, the effects of the Mediterranean diet pattern on symptoms, clinical disease activity, gut microbiome and fecal biomarkers in stable UC patients in remission will be examined. Using this design, we will compare the habitual diet (taken as a control diet) to the Mediterranean diet pattern taken by UC patients over a 12-week period."||||
1341656|NCT03053700|Non-Randomized|Single Group Assignment||Treatment||Single|Physicians will perform assessment of clinical outcome, using clinical photographs .These physicians will be blinded to which half of the face was treated with intense pulsed light.|This is an interventional, prospective single blinded study. Patients would be treated with full face application of bromonide 0.33% gel once daily for three months. In addition half of the patients' face would be subjected to three IPL treatment sessions three weeks apart from each other.||||t
1341657|NCT03053687|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341658|NCT03053674|Randomized|Parallel Assignment||Prevention||None (Open Label)||Case-control study||||
1341659|NCT03053661|||Cohort||Prospective|||||||
1341660|NCT03053648|Randomized|Parallel Assignment||Treatment||Single|All of the assessments in this study will be self-completed. The researchers who perform the assessment and analysis will be blinded to group allocation.|||||t
1341661|NCT03053635||Single Group Assignment||Treatment||None (Open Label)||||||
1341662|NCT03053622|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1341663|NCT03053609|||Case-Only||Retrospective|||||||
1341664|NCT03053596|||Case-Only||Prospective|||||||
1341665|NCT03053583|Randomized|Parallel Assignment||Other||Single||||||t
1341666|NCT03053570|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341667|NCT03053557|Randomized|Parallel Assignment||Treatment||Single|Research assistants who conduct assessments with participants will be blinded as to whether participants have been assigned to the intervention or control group.|Convergent parallel mixed methods||||t
1341668|NCT03053544||Single Group Assignment||Treatment||None (Open Label)||||||
1341669|NCT03053531||Single Group Assignment||Treatment||None (Open Label)||Single-group study, with no control or comparison group.||||
1341670|NCT03053518|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Investigators will recruit approximately 5 cohorts of 4 participants each for the sample size of 20 participants. A new cohort will be randomized approximately every 4 weeks. The maximum number of study participants at any point in the study will be 10.||||
1341671|NCT03053505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341672|NCT03053492|Randomized|Parallel Assignment||Treatment||Single|Blinded raters perform scoring of all assessments|Stroke survivors will either play a custom designed computer game for stroke rehabilitation called Duck Duck Punch or an off the shelf computer game with their weaker arm 3 times per week for 6 weeks. Evaluations will determine whether or not one computer game improved arm movement more than the other.||||t
1341673|NCT03053479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341674|NCT03053466||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1341675|NCT03053453|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a randomized prospective study looking at the impact sensor guidance has on the outcome of patients and comparing to that of patients with a standard technique.||||
1341676|NCT03053440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341677|NCT03053427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341678|NCT03053414|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be randomized to one of four treatment arms for the duration of the study. Labs will be checked every 3 months as part of standard of care to help delineate the best strategy for repletion and maintenance of Vitamin D levels throughout the study.||||
1341679|NCT03053401|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1341680|NCT03053388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341681|NCT03053375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341682|NCT03053362|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Determining the effectiveness of a new tool used to detect changes in cognition among individuals with MDD.||||
1341683|NCT03053349|||Cohort||Prospective|||||||
1341684|NCT03053336|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341685|NCT03053323||Single Group Assignment||Treatment||None (Open Label)||||||
1341686|NCT03053310|||Cohort||Prospective|||||||
1341687|NCT03053297|||Cohort||Prospective|||||||
1341688|NCT03053284|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1341689|NCT03053271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341690|NCT03053258|||Case-Only||Prospective|||||||
1341691|NCT03053245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341692|NCT03053232|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341693|NCT03053219||Single Group Assignment||Treatment||None (Open Label)||||||
1341694|NCT03053206||Single Group Assignment||Treatment||None (Open Label)||||||
1341695|NCT03053193|||Case-Only||Prospective|||||||
1341696|NCT03053180|||Cohort||Prospective|||||||
1341697|NCT03053167||Single Group Assignment||Treatment||None (Open Label)||||||
1341698|NCT03053154|||Case-Control||Cross-Sectional|||||||
1341699|NCT03053141|||Cohort||Prospective|||||||
1341700|NCT03053128|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1341701|NCT03053115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341702|NCT03053102||Single Group Assignment||Treatment||None (Open Label)||||||
1341703|NCT03053089|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Stage 1: 6 adults will be given a single dose, assigned to 0.3, 1.0 or 3.0 mg/kg (with cohort assignment based on order of study entry)~Stage 2: up to 15 children will be given repeat weekly doses for 26 weeks, assigned to 1.0, 3.0 and 6.0 or 9.0 mg/kg (with cohort assignment based on order of study entry). Early term"||||
1341704|NCT03053076|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1341705|NCT03053063|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1341706|NCT03053050|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1341707|NCT03053037|Randomized|Parallel Assignment||Treatment||Double|Similar instrumentation method is used for both groups, therefore participants cannot be aware of the allocation. Data will be de-identified prior to outcome assessment.|randomized clinical trial 2 arms|t|||t
1341708|NCT03053024|||Cohort||Retrospective|||||||
1341709|NCT03053011||Single Group Assignment||Basic Science||None (Open Label)||||||
1341710|NCT03052998|Randomized|Parallel Assignment||Treatment||Single||Randomized clinical trial||||t
1341711|NCT03052985|||Cohort||Prospective|||||||
1341712|NCT03052972|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1341713|NCT03052959|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341714|NCT03052946|Randomized|Parallel Assignment||Treatment||Double||Bulking agents|t||t|
1341715|NCT03052933||Single Group Assignment||Treatment||None (Open Label)||||||
1341716|NCT03052920||Single Group Assignment||Treatment||None (Open Label)||||||
1341717|NCT03052907||Single Group Assignment||Health Services Research||None (Open Label)||||||
1341718|NCT03052894|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1341719|NCT03052881|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel assignment||||
1341720|NCT03052868||Single Group Assignment||Supportive Care||None (Open Label)||||||
1341721|NCT03052855||Single Group Assignment||Other||None (Open Label)||||||
1341722|NCT03052842|Randomized|Sequential Assignment||Treatment||Single||Three dose groups will be enrolled in an ascending dose escalation manner|t|||
1341723|NCT03052829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341724|NCT03052816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341725|NCT03052803|||Cohort||Prospective|||||||
1341726|NCT03052790|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1341727|NCT03052777|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341728|NCT03052764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341729|NCT03052751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341730|NCT03052738|||Cohort||Prospective|||||||
1341731|NCT03052725||Single Group Assignment||Treatment||None (Open Label)||||||
1341732|NCT03052712|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1341733|NCT03052699|||Cohort||Retrospective|||||||
1341734|NCT03052686|||Cohort||Prospective|||||||
1341790|NCT03051958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341791|NCT03051945|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1341792|NCT03051932|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341793|NCT03051919|||Cohort||Prospective|||||||
1341794|NCT03051906||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1341795|NCT03051893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341796|NCT03051880|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1341735|NCT03052673|Randomized|Parallel Assignment||Treatment||Quadruple|The patient and the attending anaesthesiologist will be blinded to the intraoperative infusions used. Postoperative patient recovery profile will also be evaluated by an independent assess or blinded to the intraoperative anaesthesia technique.|"76 patients belonging to ASA physical patients status II and III of either sex, scheduled to undergo laparoscopic bariatric surgery (sleeve gastrectomy, Roux-en-Y gastric bypass) under general anaesthesia. The patients will be randomly allocated by computer generated numbers to one of the following two groups of 38 patients each.~Group 1[Ketamine + Fentanyl Group, n=38]: Pre-induction fentanyl 1-mcg/kg, ketamine 0.5-mg/kg after induction, followed by intraoperative fentanyl infusion of 0.5-mcg/kg/hr + ketamine infusion of 0.2-mg/kg/hr.~Group 2[Fentanyl Group, n=38]:Pre-induction fentanyl 1-mcg/kg, saline after induction followed by intraoperative fentanyl infusion of 0.5-mcg/kg/hr + saline infusion.~Both the groups will receive intravenous PCA of fentanyl post-operatively"|t|t|t|t
1341736|NCT03052660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341737|NCT03052647|Randomized|Parallel Assignment||Treatment||Double|computer randomized list of closure type opened from a sealed envelope on the day of surgery|"A control group of subcuticular closure and the experimental group is skin closure withthe adhesive latch device (dermaclip)"|t||t|
1341738|NCT03052634|Randomized|Parallel Assignment||Treatment||None (Open Label)||The Intervention Model of phase Ib is single group assignment，however ，The Intervention Model of phase II is parallel group assignment.The Experimental of The phase II is RC48-ADC, and the active comparator of RC48-ADC is lapatinib plus capecitabine||||
1341739|NCT03052621|||Cohort||Retrospective|||||||
1341740|NCT03052608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341741|NCT03052595|||Case-Control||Prospective|||||||
1341742|NCT03052582|Randomized|Crossover Assignment||Prevention||Single||||||t
1341743|NCT03052569||||||||||||
1341744|NCT03052556||Single Group Assignment||Screening||None (Open Label)||||||
1341745|NCT03052543|||Case-Control||Prospective|||||||
1341746|NCT03052530||Single Group Assignment||Treatment||None (Open Label)||||||
1341747|NCT03052517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341748|NCT03052504|||Case-Control||Prospective|||||||
1341749|NCT03052491||Single Group Assignment||Prevention||None (Open Label)||Open-label field trial without a placebo.||||
1341750|NCT03052478||Single Group Assignment||Treatment||None (Open Label)||||||
1341751|NCT03052465||Single Group Assignment||Basic Science||None (Open Label)||||||
1341752|NCT03052452|||Cohort||Prospective|||||||
1341753|NCT03052439|Randomized|Parallel Assignment||Treatment||Triple|Participants blinded to randomization of order of reintroduction; Investigators blinded to order of reintroduction|Food items will be blindly reintroduced, and symptoms will be measured.|t||t|t
1341754|NCT03052426|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341755|NCT03052413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341756|NCT03052400|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341757|NCT03052387|Randomized|Parallel Assignment||Treatment||Single||||||t
1341758|NCT03052374|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341759|NCT03052361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341760|NCT03052348|Randomized|Parallel Assignment||Treatment||Triple|Participants will be given creams (containing either the intervention or control regimens - both white in color) in unlabelled opaque containers. Participants, investigators and the outcomes assessor evaluating the outcome of interest (SCORAD) will be blinded to the treatment allocations.|Fusidic acid, polyethylene glycol hexadecyl ether & Betamethasone valerate cream 0.1%|t||t|t
1341761|NCT03052335||Single Group Assignment||Screening||None (Open Label)||||||
1341762|NCT03052322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341763|NCT03052309|||Cohort||Prospective|||||||
1341764|NCT03052296|||Cohort||Prospective|||||||
1341765|NCT03052283|||Case-Control||Prospective|||||||
1341766|NCT03052270|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomization between two arms: short cervix with vaginal progesterone and Arabin pessary (study group) versus short cervix with vaginal progesterone alone (control group)||||
1341767|NCT03052257|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1341768|NCT03052244|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1341769|NCT03052231|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1341770|NCT03052218||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1341771|NCT03052205||Single Group Assignment||Treatment||None (Open Label)||||||
1341772|NCT03052192|||Cohort||Prospective|||||||
1341773|NCT03052179|Randomized|Parallel Assignment||Supportive Care||Double|Either participant or the investigator will be blinded. The key of randomisation will be held by the third statistician party, and the company which supply and labeled the product study.|Double blind, randomized, placebo-controlled|t||t|
1341774|NCT03052166|||Cohort||Prospective|||||||
1341775|NCT03052153|||Case-Only||Retrospective|||||||
1341776|NCT03052140|Randomized|Crossover Assignment||Treatment||Single|||||t|
1341777|NCT03052127|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1341778|NCT03052114|||Case-Only||Cross-Sectional|||||||
1341779|NCT03052101|||Case-Only||Cross-Sectional|||||||
1341780|NCT03052088|||Cohort||Prospective|||||||
1341781|NCT03052075|||Cohort||Retrospective|||||||
1341782|NCT03052062||Single Group Assignment||Treatment||None (Open Label)||||||
1341783|NCT03052049||Single Group Assignment||Treatment||None (Open Label)||||||
1341784|NCT03052036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341785|NCT03052023|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341786|NCT03052010||Single Group Assignment||Prevention||None (Open Label)||||||
1341787|NCT03051997|Randomized|Parallel Assignment||Treatment||Single||||||t
1341788|NCT03051984|Randomized|Parallel Assignment||Other||Double|||||t|t
1341789|NCT03051971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341797|NCT03051867|||Cohort||Prospective|||||||
1341798|NCT03051854|Randomized|Factorial Assignment||Prevention||Single||||||t
1341799|NCT03051841||Single Group Assignment||Treatment||None (Open Label)||||||
1341800|NCT03051828|||Cohort||Prospective|||||||
1341801|NCT03051815|||Case-Only||Prospective|||||||
1341802|NCT03051802||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1341803|NCT03051789|Randomized|Parallel Assignment||Prevention||Double|The investigators cannot mask participants to their treatment (intervention) status due to the nature of interventions provided. However, counsellors conducting the HIV and HSV-2 testing and laboratory technicians will be blinded to the study arm. Investigators and trial statisticians will be masked. Field staff who conduct home visits to confirm dropout will also be masked when feasible. Bias will also be minimised by use of block randomisation stratified by school size and WASH facilities at baseline. An independent person will prepare the sealed envelopes with the study allocation. Study arm allocation will not be recorded in the central database to ensure the trial statistician and data managers remain blinded throughout the study. This information will be recorded separately and only be merged with the main database following approval of the statistical analytics plan (SAP), closure of the databases and submission of a copy to the independent statistician of the DMEC.||||t|t
1341804|NCT03051776|Randomized|Crossover Assignment||Treatment||Single|The statistical analysis will be supervised by staff of the Scientific Support Unit: Epidemiology and Biostatistics (i+12), Hospital Universitario 12 de Octubre with the variables coded to blind the analyst.|"Two treatmet phases, with a four week wash out period bewtween them:~A four week phase with Kinesio Taping~A four week phase with compression garments."||||t
1341805|NCT03051763|||Cohort||Prospective|||||||
1341806|NCT03051750|Randomized|Crossover Assignment||Treatment||Single|The statistical analysis will be supervised by staff of the Scientific Support Unit: Epidemiology and Biostatistics (i+12), Hospital Universitario 12 de Octubre with the variables coded to blind the analyst.|"3-month previous washout period; 3-week treatment phases; 3-month washout period between both treatment phases.~Open design: it is impossible during the treatment to blind the physiotherapists and patients, due to the observable differences between both therapies both during their application and in the hours after their removal, by the marks that leave in the skin.~Interventions: The two therapies compared are:~CPT+ P.~KT."||||t
1341807|NCT03051737|||Other||Retrospective|||||||
1341808|NCT03051724|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341809|NCT03051711|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1341810|NCT03051698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341811|NCT03051685|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1341812|NCT03051672||Single Group Assignment||Treatment||None (Open Label)||||||
1341813|NCT03051659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341814|NCT03051646|Randomized|Crossover Assignment||Treatment||Double|Blinding will be overseen by the CUMC pharmacy; randomization schedule will be submitted to the pharmacy by a third party who is not involved in the study (i.e., non-study personnel). Study investigators will remain blinded until data collection is complete and data have been analyzed.|Design is a within-subject crossover placebo-controlled experiment. Each participant will be seen for two exercise sessions (stationary cycling) on two days separated by one week, and will receive either ASA or placebo (treatment) at each session prior to commencing exercise. Order of treatment will be randomized and counter-balanced. As such, each participant will serve as his/her own control.|t||t|
1341815|NCT03051633|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341816|NCT03051620|||Cohort||Prospective|||||||
1341817|NCT03051607||Single Group Assignment||Treatment||None (Open Label)||Eligible patients will begin dosing with tozadenant at a dose of 120 mg twice daily. At Week 2 or thereafter, the investigator may adjust the patient's IMP dose as clinically indicated; doses of 60 mg BID and 120 mg BID will be permitted.||||
1341818|NCT03051594|Randomized|Parallel Assignment||Device Feasibility||Single|The side to which interventions or control is assigned to will be recorded and all records of all patients will be kept with the main supervisor . The operator will not be blinded as the difference in application protocol of the restorative materials prohibited blinding of the operator; however, the patient, Statisticians and Outcome assessors will be blinded to the material assignment|||||t
1341819|NCT03051581||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341820|NCT03051568||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341821|NCT03051555||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341822|NCT03051542||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341823|NCT03051529|||Cohort||Prospective|||||||
1341824|NCT03051516|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1341825|NCT03051503|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1341826|NCT03051490|Randomized|Parallel Assignment||Treatment||None (Open Label)|unblinded to treatment randomization; blinded to primary efficacy variable|||||
1341827|NCT03051477||Single Group Assignment||Treatment||None (Open Label)||||||
1341828|NCT03051464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341829|NCT03051451|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1341830|NCT03051438|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341831|NCT03051425|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341832|NCT03051412|||Case-Control||Cross-Sectional|||||||
1341833|NCT03051399|Randomized|Parallel Assignment||Treatment||Quadruple|Blinding was ensured by the fact that both capsules (placebo and EpiCor) were opaque and had an identical appearance and were packed in identical bottles by Embria Health Sciences and were labeled as A or B. A ProDigest staff member not participating in the study labelled all bottles and assigned them to each subject in accordance with the randomization list. All study participants, all members of ProDigest staff involved in the study and the Drug Research Unit Ghent (University Hospital Ghent) that actually performed the study, were blinded.|Pilot study performed according to a randomized, double-blind, placebo-controlled parallel design|t|t|t|t
1341834|NCT03051386||Single Group Assignment||Prevention||None (Open Label)||||||
1341835|NCT03051373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341836|NCT03051360|Randomized|Parallel Assignment||Prevention||Quadruple||Prospective, Double blind, Multi-center, Randomized clinical trial|t|t|t|t
1341837|NCT03051347|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1341838|NCT03051334|||Case-Control||Retrospective|||||||
1341839|NCT03051321||Single Group Assignment||Treatment||None (Open Label)||||||
1341840|NCT03051308|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1341841|NCT03051295|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341842|NCT03051282|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1341843|NCT03051269||Single Group Assignment||Treatment||None (Open Label)||||||
1341844|NCT03051256|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1341845|NCT03051243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341846|NCT03051230|||Cohort||Prospective|||||||
1341847|NCT03051217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341848|NCT03051204|||Case-Only||Prospective|||||||
1341849|NCT03051191|||Case-Control||Cross-Sectional|||||||
1341850|NCT03051178||Single Group Assignment||Treatment||None (Open Label)||||||
1341851|NCT03051165||Single Group Assignment||Treatment||None (Open Label)|Interpretation of all tests (sleep tests, ambulatory blood pressure monitoring, vascular test and blood tests) will be done by an outcomes assessor who is blinded to whether treatment is active or withheld at the time of testing.|All participants will undergo the intervention of temporary treatment withdrawal to examine cardiac measurements before treatment, during treatment, and after cessation.||||
1341852|NCT03051152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341853|NCT03051139|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1341854|NCT03051126|||Cohort||Prospective|||||||
1341855|NCT03051113|||Cohort||Prospective|||||||
1341856|NCT03051100|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1341857|NCT03051087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341858|NCT03051074|Randomized|Crossover Assignment||Basic Science||None (Open Label)||On the 2nd session, participants will be randomly assigned to start in the pool condition or comparison condition. Following a 1-week washout period, they will crossover to the other condition.||||
1341859|NCT03051061|||Cohort||Other|||||||
1341860|NCT03051048|||Cohort||Prospective|||||||
1341861|NCT03051035||Single Group Assignment||Treatment||None (Open Label)||||||
1341862|NCT03051022|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1341863|NCT03051009|Randomized|Parallel Assignment||Treatment||Double|"One dose level (25 μg desmopressin OCD) is included for female subjects and will be open-labelled for all female subjects.~Two different dose levels (25 μg desmopressin and 50 μg desmopressin ODT are included for male subjects in a double-blinded manner. Male subjects continuing from trial 000130 will continue their randomised treatment and subjects who received placebo will be randomised to one of the 2 dose levels (25 μg desmopressin or 50 μg desmopressin ODT).~New male subjects will be allocated to receive 50 μg desmopressin ODT in an open-labelled manner."|The trial is designed as partly an extension trial for subjects completing trial 000129 (female subjects) and 000130 (male subjects) and partly as a trial for new female and male subjects.|t||t|
1341864|NCT03050996|||Case-Only||Prospective|||||||
1341865|NCT03050983|||Cohort||Prospective|||||||
1341866|NCT03050970|||Cohort||Prospective|||||||
1341867|NCT03050957|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341868|NCT03050944|||Case-Control||Prospective|||||||
1341869|NCT03050931|||Case-Only||Cross-Sectional|||||||
1341870|NCT03050918|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This is a single center, pragmatic, randomized, controlled clinical trial.||||
1341871|NCT03050905||Single Group Assignment||Treatment||None (Open Label)||||||
1341872|NCT03050892|||Cohort||Prospective|||||||
1341873|NCT03050879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341874|NCT03050866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341875|NCT03050853|Randomized|Parallel Assignment||Other||Single|All follow-up assessments will be conducted by the masked outcome assessor with the exception of the tobacco use and e-cigarette use self report and the satisfaction with e-cigarettes scale administered to the intervention group.|This is a study to learn about the appeal and health impacts of using e-cigarettes in people with serious mental illness who are not currently thinking about qutting smoking. Reduction of craving or quitting are not targets||||t
1341876|NCT03050840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341877|NCT03050827|Randomized|Parallel Assignment||Treatment||Triple|Randomizing and blinding an investigational drug will be done by assigning each patient/subject a study number in the order they are recruited. The patients are randomized using a randomizing web site at (www.randomizer.org). The randomized patient numbers are recorded. This code is then placed in an envelope and sealed. This envelope will remain sealed until the study is concluded. A blinding/randomization patient form will be completed for each patient and sealed in the individual envelopes. The outside of the envelopes will contain patient numbers for identification purposes. This will allow the research coordinator to break the individual blind in emergency situations without compromising the rest of the blinding data. All instances where the blind is broken will be documented appropriately.|The investigators propose a placebo controlled, double blinded study to examine efficacy of topical Gelnique 3%TM (3% oxybutynin) daily for 20 weeks) in improving IENF density in type 2 diabetic subjects with established peripheral neuropathy. Subjects with IENF loss of between 20-75% of normative values11 and thus amenable to therapy-induced recovery, will be randomized into placebo (N=30) or active drug (N=30) arms and instructed in how to apply 84 mg Gelnique 3%TM or hydrogel placebo to cover a 2 in2 region of skin adjacent to the initial biopsy site, as per the manufacturers instructions (http://www.gelnique.com/gel3/). Treatment will continue daily for 20 weeks, with monthly phone calls to monitor compliance. After 20 weeks, subjects will return for a second study visit and will undergo a series of measurements and 3 mm skin biopsy from the treated region of skin.|t|t|t|
1341878|NCT03050814|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1341879|NCT03050801|Non-Randomized|Crossover Assignment||Treatment||Double|||t|||t
1341880|NCT03050788||Single Group Assignment||Diagnostic||None (Open Label)||||||
1341881|NCT03050775|Randomized|Parallel Assignment||Prevention||Double|Patients were randomly assigned to either the treatment group or the control group prior to surgery. Group randomization was performed using a randomization schedule prepared by the Division of Clinical Statistics with patients randomized in blocks of four. For consented and enrolled patients on the day of surgery in the admit areas, a participant was assigned the next sequential participant ID number and the appropriate sealed envelope was opened to reveal the participant's randomized intervention. This occurred before the patient was transferred to the operating suite. Individuals who performed data analysis were blinded to treatment group.|randomized, trial (treatment or no treatment)|t|||t
1341882|NCT03050762|||Case-Only||Prospective|||||||
1341883|NCT03050749||Single Group Assignment||Other||None (Open Label)||Princess® VOLUME||||
1341884|NCT03050736||Single Group Assignment||Treatment||None (Open Label)||||||
1341885|NCT03050723||Single Group Assignment||Other||None (Open Label)||Princess® FILLER||||
1341886|NCT03050710||Single Group Assignment||Other||None (Open Label)||Princess® VOLUME Lidocaine for the correction of nasolabial folds||||
1341887|NCT03050697||||||||||||
1341888|NCT03050684|Randomized|Parallel Assignment||Screening||Quadruple||Randomized Controlled Study|t|t|t|t
1341889|NCT03050671|Randomized|Crossover Assignment||Basic Science||None (Open Label)||There are two different intervension devices planned to be used in each research subject.||||
1341890|NCT03050658|||Cohort||Prospective|||||||
1341891|NCT03050645|||Cohort||Prospective|||||||
1341892|NCT03050632|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1341893|NCT03050619|||Other||Retrospective|||||||
1341894|NCT03050606|Randomized|Parallel Assignment||Treatment||Single||||||t
1341895|NCT03050593|||Cohort||Prospective|||||||
1341896|NCT03050580|Randomized|Parallel Assignment||Treatment||Single||||||t
1341897|NCT03050567|||Cohort||Prospective|||||||
1341898|NCT03050554||Single Group Assignment||Treatment||None (Open Label)||||||
1341899|NCT03050541|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1341900|NCT03050528|Randomized|Parallel Assignment||Treatment||Single|The academic Statistician (Dr Ricardo Segurado) and the Senior Researcher (Maire-Brid Casey) will be blind to group allocation. Dr Segurado will be responsible for data analysis. Máire-Bríd Casey will be responsible for data entry and will assist with data analysis.||||t|
1341901|NCT03050515||Single Group Assignment||Treatment||None (Open Label)||||||
1341902|NCT03050502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341903|NCT03050489|||Cohort||Prospective|||||||
1341904|NCT03050476|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1341905|NCT03050463|||Case-Control||Prospective|||||||
1341906|NCT03050450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341907|NCT03050437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341908|NCT03050424|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind, placebo-controlled, randomised trial||t|t|t|t
1341909|NCT03050411||Single Group Assignment||Treatment||None (Open Label)||||||
1341910|NCT03050398||Single Group Assignment||Other||None (Open Label)||||||
1341911|NCT03050385|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1341912|NCT03050372|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1341913|NCT03050359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341914|NCT03050346|||Other||Prospective|||||||
1341915|NCT03050333|||Case-Only||Prospective|||||||
1341916|NCT03050320|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1341917|NCT03050307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341918|NCT03050294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341919|NCT03050281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341920|NCT03050268|||Family-Based||Prospective|||||||
1341921|NCT03050255|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1341922|NCT03050242|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1341923|NCT03050229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341924|NCT03050216||Single Group Assignment||Treatment||None (Open Label)||||||
1341925|NCT03050203|Randomized|Parallel Assignment||Treatment||Single|||t|||
1341926|NCT03050190||Single Group Assignment||Treatment||None (Open Label)||||||
1341927|NCT03050177|Randomized|Crossover Assignment||Other||Single||||||t
1341928|NCT03050164|Randomized|Crossover Assignment||Other||Single||||||t
1341929|NCT03050151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341930|NCT03050138|||Other||Cross-Sectional|||||||
1341931|NCT03050125|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1341932|NCT03050112||Single Group Assignment||Other||None (Open Label)||||||
1341933|NCT03050099|||Cohort||Prospective|||||||
1341934|NCT03050086|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341935|NCT03050073|||Cohort||Prospective|||||||
1341936|NCT03050060||Single Group Assignment||Treatment||None (Open Label)||||||
1341937|NCT03050047|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1341938|NCT03050034|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pilot perspective controlled randomized open-label single-center study to evaluate the management of critically ill patients hospitalized comparing vital signs wireless monitoring versus conventional monitoring in the first 72 h of hospitalization extendable to 5 days if the MEWS after 72 h is even greater than or equal to 3 and/or the NEWS is greater than or equal to 5.||||
1341939|NCT03050021|||Cohort||Retrospective|||||||
1341940|NCT03050008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341941|NCT03049995|||Case-Only||Prospective|||||||
1341942|NCT03049982||Single Group Assignment||Other||None (Open Label)||||||
1341943|NCT03049969||Single Group Assignment||Treatment||None (Open Label)||20 sessions of cognitive remediation while receiving 20 minutes of up to 2.0 mA tDCS using a DLPFC montage||||
1341944|NCT03049956||Single Group Assignment||Diagnostic|||Blinded diagnostic accuracy study (index test vs. reference standard).|||||
1341945|NCT03049943|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341946|NCT03049930|Randomized|Parallel Assignment||Treatment||Triple|No other parties are masked in the clinical trial|The intervention study model is a randomized block design using a 1:1 allocation scheme|t|t|t|
1341947|NCT03049917|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1341948|NCT03049904|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1341949|NCT03049891|||Cohort||Retrospective|||||||
1341950|NCT03049878|Randomized|Parallel Assignment||Treatment||Triple||A randomized, split-mouth, placebo-controlled, double-blind clinical trial|t||t|t
1341951|NCT03049865|||Cohort||Prospective|||||||
1341952|NCT03049852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1341953|NCT03049839|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341954|NCT03049826|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1341955|NCT03049813|Randomized|Parallel Assignment||Other||Single|Some, but not all, outcomes require masking for the assessor.|||||t
1341956|NCT03049800|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1341957|NCT03049787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341958|NCT03049774|||Case-Only||Retrospective|||||||
1341959|NCT03049761|Randomized|Parallel Assignment||Other||Single||This is a examiner-masked, 3-treatment, randomized clinical trial comparing the safety of different oral hygiene regimens.|||t|
1341960|NCT03049748|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1341961|NCT03049735|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1341962|NCT03049722||Single Group Assignment||Basic Science||None (Open Label)||||||
1341963|NCT03049709|||Cohort||Cross-Sectional|||||||
1341964|NCT03049696|Non-Randomized|Parallel Assignment||Treatment||Single||Control Group: Publically funded bariatric surgery program administered through the Centre for Bariatric and Metabolic Surgery (CMBS).; Matched control group Intervention Group: CMBS Program standard of care plus the ENCOURAGING START Program (University of Manitoba Active Living Centre)||||t
1341965|NCT03049683|||Case-Control||Prospective|||||||
1341966|NCT03049670|||Cohort||Prospective|||||||
1341967|NCT03049657|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1341968|NCT03049644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341969|NCT03049631|Randomized|Crossover Assignment||Other||Single|||t|||
1341970|NCT03049618||Single Group Assignment||Treatment||None (Open Label)||||||
1341971|NCT03049605|Randomized|Parallel Assignment||Treatment||Double|By randomization of participants recruitment||t||t|
1341972|NCT03049592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341973|NCT03049579|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1341974|NCT03049566|||Other||Cross-Sectional|||||||
1341975|NCT03049553|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1341976|NCT03049540|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1341977|NCT03049527||Single Group Assignment||Screening||None (Open Label)||The single group will receive an intervention of enhanced education and incentives aimed at increasing hydration and reducing heat stress.||||
1341978|NCT03049514|||Other||Prospective|||||||
1341979|NCT03049501|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1341980|NCT03049488|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1341981|NCT03049475|||Case-Control||Prospective|||||||
1341982|NCT03049462|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1341983|NCT03049449|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1341984|NCT03049436|||Cohort||Prospective|||||||
1341985|NCT03049423|||Other||Prospective|||||||
1341986|NCT03049410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341987|NCT03049397||Single Group Assignment||Supportive Care||None (Open Label)||||||
1341988|NCT03049384|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to one of two groups in parallel for the duration of the study.||||
1341989|NCT03049371||Single Group Assignment||Treatment||None (Open Label)||||||
1341990|NCT03049358|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1341991|NCT03049345||Single Group Assignment||Diagnostic||None (Open Label)|no masking|human subjects||||
1341992|NCT03049332||Single Group Assignment||Supportive Care||None (Open Label)||The same group of individuals will be measured pre and post intervention.||||
1341993|NCT03049319||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1341994|NCT03049306|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1341995|NCT03049293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1341996|NCT03049280||Single Group Assignment||Treatment||None (Open Label)||||||
1341997|NCT03049267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1341998|NCT03049254|||Family-Based||Prospective|||||||
1341999|NCT03049241|||Other||Prospective|||||||
1342000|NCT03049228|||Cohort||Cross-Sectional|||||||
1342001|NCT03049215|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects will be randomized to either: LAMS alone and undergo EUS-guided transmural placement of an Axios stent with a 15 mm luminal diameter or LAMS plus double pigtail stent and undergo EUS-guided transmural placement of a single Axios stent with a 15 mm luminal diameter||||
1342002|NCT03049202|||Cohort||Cross-Sectional|||||||
1342003|NCT03049189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342004|NCT03049176|||Cohort||Prospective|||||||
1342005|NCT03049163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342006|NCT03049150|||Cohort||Prospective|||||||
1342007|NCT03049137|Randomized|Parallel Assignment||Treatment||Single|Double Blind (Subject, Outcomes Assessor)|||||t
1342008|NCT03049124||Single Group Assignment||Supportive Care||None (Open Label)||||||
1342009|NCT03049111||Single Group Assignment||Basic Science||None (Open Label)||||||
1342010|NCT03049098|||Cohort||Prospective|||||||
1342011|NCT03049085|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1342012|NCT03049072|||Cohort||Prospective|||||||
1342013|NCT03049059|Randomized|Parallel Assignment||Treatment||Single||Randomized split face||||t
1342014|NCT03049046|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342015|NCT03049033|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1342016|NCT03049020|||Cohort||Prospective|||||||
1342017|NCT03049007|||Cohort||Prospective|||||||
1342018|NCT03048994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342019|NCT03048981||Single Group Assignment||Basic Science||None (Open Label)||Before and after||||
1342020|NCT03048968|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342021|NCT03048955|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, multi-center, randomized, controlled||||
1342022|NCT03048942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342023|NCT03048929|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1342024|NCT03048916|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1342025|NCT03048903|Randomized|Parallel Assignment||Treatment||Quadruple||Patients were randomly divided into two groups ,using rheum palmatum or placebo|t|t|t|t
1342026|NCT03048890|||Cohort||Prospective|||||||
1342027|NCT03048877|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, Double-Blind, Placebo-Controlled|t|t|t|t
1342028|NCT03048864|||Case-Only||Prospective|||||||
1342029|NCT03048851|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342030|NCT03048838|Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants will be assigned to either risk-reduction group (Conectado Latinos en Parejas, CLP) or wellness-promotion (WP) control condition||||
1342031|NCT03048825|Randomized|Parallel Assignment||Treatment||Quadruple|double-dummy masking of colchicine and spironolactone in 2x2 factorial||t|t|t|t
1342032|NCT03048812|Randomized|Crossover Assignment||Treatment||Single|The outcome assessment will be blinded for assessment which treatment (O-Ring \Equator) is provided|Participants are randomized to the AB sequence receive treatment A in the first period and treatment B in the second period, whereas experimental units that are randomized to the BA sequence receive treatment B in the first period and treatment A in the second period||||t
1342033|NCT03048799|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342034|NCT03048786|Randomized|Parallel Assignment||Prevention||Single||||||t
1342035|NCT03048773|Randomized|Parallel Assignment||Treatment||Triple|Participant, Investigator, Outcomes Assessor||t||t|t
1342036|NCT03048760||Single Group Assignment||Basic Science||None (Open Label)||||||
1342037|NCT03048747||Single Group Assignment||Treatment||None (Open Label)||||||
1342038|NCT03048734|||Cohort||Prospective|||||||
1342039|NCT03048721|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342040|NCT03048708|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1342041|NCT03048695|Randomized|Parallel Assignment||Treatment||Single||||||t
1342042|NCT03048682|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342043|NCT03048669|Randomized|Parallel Assignment||Health Services Research||Double|The intervention will be implemented at the health facility level by the health facility staff under the supervision of health districts supervisors and investigators. As such, care providers nor investigations cannot be masked from the intervention. however, participant will not be told about the intervention or which study group they are in.||t|||t
1342044|NCT03048656|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1342045|NCT03048643|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1342046|NCT03048630|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342047|NCT03048617|||Case-Only||Prospective|||||||
1342048|NCT03048604||Single Group Assignment||Treatment||None (Open Label)||||||
1342049|NCT03048591|Randomized|Crossover Assignment||Treatment||Single||||||t
1342050|NCT03048578|Randomized|Parallel Assignment||Treatment||Double||Randomization will be 2:1 (drug:placebo) with stratification by gender and percent post-operative TBWL (25%, 25 - 49.9%).|t|t||
1342051|NCT03048565|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342052|NCT03048552|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This study is a randomized control trial. Caregiver-youth dyads are randomized to either the control (standard of care) or experimental (Family CONNECT) group based on the youth's probation officer (randomization occurs at the level of the youth's probation officer). If randomized to the control (standard of care) group, caregiver-youth dyads will work with their probation officer as usual to link to substance use services. If randomized to the experimental (Family CONNECT) group, caregiver-youth dyads will work with a linkage specialist to link to substance use services.||||
1342053|NCT03048539|||Case-Control||Prospective|||||||
1342054|NCT03048526|Randomized|Parallel Assignment||Treatment||Single|||||t|
1342055|NCT03048513|||Case-Only||Retrospective|||||||
1342056|NCT03048500||Single Group Assignment||Treatment||None (Open Label)||||||
1342057|NCT03048487|||Other||Retrospective|||||||
1342058|NCT03048474||Single Group Assignment||Treatment||None (Open Label)||||||
1342059|NCT03048461|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1342060|NCT03048448|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342061|NCT03048435|||Cohort||Prospective|||||||
1342062|NCT03048422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342063|NCT03048409|||Cohort||Retrospective|||||||
1342064|NCT03048396||Single Group Assignment||Other||None (Open Label)||||||
1342065|NCT03048383|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342066|NCT03048370|Randomized|Crossover Assignment||Basic Science||Double|The participant will be blinded to the order of experimental conditions, as well as the person conducting specific ratings assessments.|Each participant will successively receive 8 vestibular stimulation conditions. Side of stimulation will be randomized.|t|||t
1342067|NCT03048357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342068|NCT03048344|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Part 1 of the study is parallel. Part 2 will be an expansion phase.||||
1342069|NCT03048331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342070|NCT03048318|Randomized|Parallel Assignment||Prevention||Single||Subsequent patients undergoing living donor liver transplant with right lobe grafts will be randomised|t|||
1342071|NCT03048305|||Cohort||Prospective|||||||
1342072|NCT03048292|||Cohort||Prospective|||||||
1342073|NCT03048279|||Case-Control||Prospective|||||||
1342074|NCT03048266|||Case-Control||Retrospective|||||||
1342075|NCT03048253|||Cohort||Prospective|||||||
1342076|NCT03048240||Single Group Assignment||Treatment||None (Open Label)||||||
1342077|NCT03048227|Randomized|Crossover Assignment||Treatment||Single|||t|||
1342078|NCT03048214|Randomized|Parallel Assignment||Treatment||Single|||||t|
1342079|NCT03048201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Subjects will receive a commercially available Physica system total knee replacement in one of 3 different configurations: KR (Kinematic Retaining), CR (Cruciate Retaining) and PS (Posterior Stabilized). The assignment of any patient involved in the study is determined by the aetiology preoperatively evaluated by the Investigator and falls within current practice.||||
1342080|NCT03048188||Single Group Assignment||Treatment||None (Open Label)||||||
1342081|NCT03048175|Non-Randomized|Parallel Assignment||Treatment||Double|Code was assigned to each participant. No info on whether they belong to cases or control was given to researchers and statistician.|Case-control intervention trial: cases are treated for pathology. Controls do not have pathology.|||t|t
1342082|NCT03048162|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1342083|NCT03048149|||Case-Only||Retrospective|||||||
1342084|NCT03048136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342085|NCT03048123|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342086|NCT03048110||Single Group Assignment||Other||None (Open Label)||||||
1342087|NCT03048097||Single Group Assignment||Diagnostic||None (Open Label)|images will be interpreted without identification|A comparison will be made between initial images, and images taken 2 weeks later of the same group of individuals.||||
1342088|NCT03048084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342089|NCT03048071|||Case-Control||Retrospective|||||||
1342090|NCT03048058|Randomized|Parallel Assignment||Other||Single|||||t|
1342091|NCT03048045|||Cohort||Retrospective|||||||
1342092|NCT03048032|||Cohort||Prospective|||||||
1342093|NCT03048019|||Cohort||Prospective|||||||
1342094|NCT03048006|||Cohort||Prospective|||||||
1342095|NCT03047993||Single Group Assignment||Treatment||None (Open Label)||||||
1342096|NCT03047980||Single Group Assignment||Treatment||None (Open Label)||||||
1342097|NCT03047967|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1342098|NCT03047954|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1342099|NCT03047941|||Cohort||Prospective|||||||
1342100|NCT03047928||Single Group Assignment||Treatment||None (Open Label)||||||
1342101|NCT03047915|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342102|NCT03047902|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342103|NCT03047889|||Case-Only||Retrospective|||||||
1342104|NCT03047876|||Cohort||Prospective|||||||
1342105|NCT03047863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342106|NCT03047850|||Cohort||Prospective|||||||
1342107|NCT03047837|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1342108|NCT03047824|Randomized|Parallel Assignment||Treatment||Single||||t||
1342109|NCT03047811||Single Group Assignment||Treatment||None (Open Label)||||||
1342110|NCT03047798|Randomized|Crossover Assignment||Treatment||Quadruple|"The experiment was carried out in double-blind manner for the subjects and the examiner by providing the mouthrinses in opaque white bottles, labeled A, B and C."|Subjects were instructed to use the prescribed mouthrinse to gargle their mouth for one minute, twice daily for two weeks. The completion of each experiment regimen was followed by a 2-week washout period, after which the subjects of each group were permutated to the next mouthrinse trial until all three groups underwent the three mouthrinse trial regimen.|t|t|t|t
1342111|NCT03047785|||Cohort||Prospective|||||||
1342112|NCT03047772|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1342113|NCT03047759|Randomized|Parallel Assignment||Prevention||Single|||||t|
1342114|NCT03047746|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342115|NCT03047733|Randomized|Parallel Assignment||Treatment||Single||"A randomized, controlled, split-body, non-inferiority trial.~Patients with stable symmetric vitiligo were enrolled. The paired symmetric vitiliginous lesions were randomized to either the continuous or the cyclic on-off excimer laser treatment.~Total duration of study was 9 months.~In cyclic on-off excimer laser treatment, the cycle was arbitrarily determined that one cycle consists of a 2-month treatment period (on) and a consecutive 1-month intermission period (off)."||||t
1342116|NCT03047720|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1342117|NCT03047707||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342118|NCT03047694|Randomized|Parallel Assignment||Treatment||Single||||||t
1342119|NCT03047681|||Case-Control||Prospective|||||||
1342120|NCT03047668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342121|NCT03047655|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342122|NCT03047642||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342123|NCT03047629|Randomized|Sequential Assignment||Treatment||Quadruple||Phase 1 is a single group; Phase 2 will begin subsequent to the safe completion of Phase 1. Phase 2 patients will undergo randomization for parallel study during one period of observation of the course of the study phase.|t|t|t|t
1342124|NCT03047616|||Cohort||Prospective|||||||
1342125|NCT03047603|||Cohort||Prospective|||||||
1342126|NCT03047590|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342127|NCT03047577|Randomized|Parallel Assignment||Treatment||Single|Unlike other team members, the investigator interviewing the patients will be unaware of the treatment group. The patient will be encouraged not to reveal the treatment group to the investigator.|Patients are randomly assigned to a standard care or an intervention arm||||t
1342128|NCT03047564|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|Randomization to one of two implants||||
1342129|NCT03047551|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1342130|NCT03047538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1342131|NCT03047525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1342132|NCT03047512|Randomized|Parallel Assignment||Prevention||Single||Pilot descriptive study|t|||
1342133|NCT03047499|||Case-Control||Cross-Sectional|||||||
1342134|NCT03047486|||Cohort||Prospective|||||||
1342135|NCT03047473||Single Group Assignment||Treatment||None (Open Label)||single center, add on, open label, single dose, single arm||||
1342136|NCT03047460|||Cohort||Prospective|||||||
1342137|NCT03047447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342138|NCT03047434|||Case-Only||Prospective|||||||
1342139|NCT03047421|||Cohort||Prospective|||||||
1342140|NCT03047408||Single Group Assignment||Prevention||None (Open Label)|open|||||
1342141|NCT03047395||Single Group Assignment||Treatment||None (Open Label)||||||
1342142|NCT03047382|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1342143|NCT03047369|||Cohort||Prospective|||||||
1342144|NCT03047356|Randomized|Parallel Assignment||Treatment||Single|||||t|
1342145|NCT03047343|||Cohort||Retrospective|||||||
1342146|NCT03047330|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1342147|NCT03047317||Single Group Assignment||Treatment||None (Open Label)||||||
1342148|NCT03047304||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342149|NCT03047291|Randomized|Parallel Assignment||Treatment||Triple|The patients, the clinical examiner, the laboratory technician and the statistician did not know the content of the containers (probiotic or placebo).|A randomized controlled, parallel design, triple-blind prospective clinical study with a follow-up of 3 months.|t||t|t
1342150|NCT03047278|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342151|NCT03047265|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1342152|NCT03047252|Randomized|Parallel Assignment||Treatment||Single|All patients will be assessed for clinical outcomes by an independent rater blinded to the study arm|||||t
1342153|NCT03047239||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342154|NCT03047226|||Case-Only||Retrospective|||||||
1342155|NCT03047213||Single Group Assignment||Treatment||None (Open Label)||||||
1342156|NCT03047200||Single Group Assignment||Treatment||None (Open Label)||||||
1342157|NCT03047187|||Case-Only||Cross-Sectional|||||||
1342158|NCT03047174|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342159|NCT03047161|||Case-Control||Retrospective|||||||
1342160|NCT03047148|||Cohort||Retrospective|||||||
1342161|NCT03047135||Single Group Assignment||Treatment||None (Open Label)||||||
1342162|NCT03047122|||Case-Only||Prospective|||||||
1342163|NCT03047109|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1342164|NCT03047096|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342165|NCT03047083|||Cohort||Retrospective|||||||
1342166|NCT03047070|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1342167|NCT03047057|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1342168|NCT03047044|Randomized|Parallel Assignment||Other||Double|||t|||t
1342169|NCT03047031|||Cohort||Other|||||||
1342170|NCT03047018||Single Group Assignment||Treatment||None (Open Label)||||||
1342171|NCT03047005|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1342172|NCT03046992||Single Group Assignment||Treatment||None (Open Label)||||||
1342173|NCT03046979||Single Group Assignment||Treatment||None (Open Label)||||||
1342174|NCT03046966|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1342175|NCT03046953||Single Group Assignment||Treatment||None (Open Label)||Signle Arm trial with basian design||||
1342176|NCT03046940|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1342177|NCT03046927|Randomized|Parallel Assignment||Treatment||Quadruple|Ergocalciferol and placebo will be prepared as identical capsules by Boulevard Pharmaceutical Compounding Center. Randomization will be conducted by the Investigational Drug Services (IDS), UMMS, using a randomization scheme generated by Dr. Barton. Randomization will be 1:1 (ergocalciferol: placebo) and will use a permuted block design with blocking for every 2 or 4 subjects (at random). IDS will maintain blinding information and PI will contact IDS for emergency unblinding.|12-month randomized, double-blind, placebo-controlled, parallel design trial|t|t|t|t
1342178|NCT03046914||Single Group Assignment||Prevention||None (Open Label)||Prospective cases and historical controls||||
1342179|NCT03046901||Single Group Assignment||Prevention||None (Open Label)||The study will be conducted as a prospective open-label pilot study of up to 20 patients who will receive oral vancomycin for 3-12 months as treatment for recurrent PSC after liver transplantation. There will be no masking or randomization.||||
1342180|NCT03046888|Randomized|Parallel Assignment||Treatment||Single||Prospectively randomized study in patients with renal pelvic stones who are candidate to standard PCNL procedure. One to one, controlled clinical trial. Patients will be randomly allocated into two groups, 20 patients in each group. Group A will be scheduled to receive routine standard PCNL. Group B will be scheduled to receive RP.|t|||
1342181|NCT03046875|Non-Randomized|Single Group Assignment||Treatment||Double|||t|||t
1342182|NCT03046862||Single Group Assignment||Treatment||None (Open Label)||||||
1342183|NCT03046849|||Case-Only||Retrospective|||||||
1342184|NCT03046836|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1342185|NCT03046823|||Case-Only||Prospective|||||||
1342186|NCT03046810||Single Group Assignment||Treatment||None (Open Label)||||||
1342187|NCT03046797|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342188|NCT03046784|||Cohort||Prospective|||||||
1342189|NCT03046771|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342190|NCT03046758||Single Group Assignment||Treatment||None (Open Label)||||||
1342191|NCT03046745|||Cohort||Prospective|||||||
1342192|NCT03046732|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342193|NCT03046719|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1342194|NCT03046706|Randomized|Parallel Assignment||Treatment||None (Open Label)||The research group is the group of patients who do not keep voice rest and talk without restrictions or special instructions after surgery.||||
1342195|NCT03046693|Randomized|Parallel Assignment||Treatment||Triple|The allocation of the subject is done by using block randomization. Randomization will be performed by a third party before the study began. Number randomization results will be incorporated into the white envelope sealed and classified into group A (got citcoline) or group B (placebo) in accordance with the results of randomization. Neither the participant, investigator nor the outcome assessor know whether the patient is classified into group A or B.|Sample of 20 people for each treatment group (Group A: citicoline and group B : placebo). Both group were given drug (whether citicoline or placebo) for 60 days.|t||t|t
1342196|NCT03046680|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized clinical trial||||
1342197|NCT03046667|Randomized|Parallel Assignment||Prevention||Quadruple|The beverages are provided to the investigator and volunteers with similar color, taste and bottles, only labelled A or B.||t|t|t|t
1342198|NCT03046654||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342199|NCT03046641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342200|NCT03046628||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342201|NCT03046615|||Case-Only||Prospective|||||||
1342202|NCT03046602|||Cohort||Prospective|||||||
1342203|NCT03046589|Randomized|Sequential Assignment||Treatment||Triple|||t||t|t
1342204|NCT03046576|||Cohort||Other|||||||
1342205|NCT03046563|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1342206|NCT03046550|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1342207|NCT03046537|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||ovulatory women will be compared to women who do not ovulate regularly (PCOS)||||
1342208|NCT03046524|||Cohort||Retrospective|||||||
1342209|NCT03046511|Randomized|Parallel Assignment||Prevention||Single|||t|||
1342210|NCT03046498||Single Group Assignment||Health Services Research||None (Open Label)||||||
1342211|NCT03046485|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1342212|NCT03046472|Randomized|Parallel Assignment||Prevention||Single|One of the investigators has the role of examining the participants before and after the intervention. She will be blinded from the group allocation.|The study will consist of two groups: a Treatment group and a control group. Both groups will get personal meeting once a month and a program of exercising at home every day. Treatment group will have in addition group meeting once a week and control group not.|||t|
1342213|NCT03046459||Single Group Assignment||Other||None (Open Label)||||||
1342214|NCT03046446||Single Group Assignment||Treatment||None (Open Label)||||||
1342215|NCT03046433|||Cohort||Prospective|||||||
1342216|NCT03046420|||Other||Retrospective|||||||
1342217|NCT03046407||Single Group Assignment||Other||None (Open Label)|Open Label|||||
1342218|NCT03046394|Randomized|Sequential Assignment||Device Feasibility||Triple|||t||t|t
1342219|NCT03046381||Single Group Assignment||Treatment||None (Open Label)||||||
1342220|NCT03046368|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1342221|NCT03046355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342222|NCT03046342|||Case-Only||Prospective|||||||
1342223|NCT03046329||Single Group Assignment||Supportive Care||None (Open Label)||||||
1342224|NCT03046316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342225|NCT03046303|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342226|NCT03046290|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1342227|NCT03046277|||Cohort||Retrospective|||||||
1342228|NCT03046264|||Cohort||Cross-Sectional|||||||
1342229|NCT03046251|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342230|NCT03046238|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1342231|NCT03046225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342232|NCT03046212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342233|NCT03046199|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1342234|NCT03046186|||Case-Control||Cross-Sectional|||||||
1342235|NCT03046173|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342236|NCT03046160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342237|NCT03046147|||Case-Only||Prospective|||||||
1342238|NCT03046134|||Cohort||Prospective|||||||
1342239|NCT03046121|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1342240|NCT03046108|Randomized|Parallel Assignment||Treatment||Single||||||t
1342241|NCT03046095|Randomized|Single Group Assignment||Basic Science||None (Open Label)|Investigators and participants will have knowledge or which leg will be undergoing resistance training and which will be immobilized.|The model will be a within-subject intervention. Each subject will have one leg randomized to unilateral resistance exercise (for 10 weeks) and the other to immobilization (for the last 2 weeks of the study).||||
1342242|NCT03046082|||Cohort||Prospective|||||||
1342243|NCT03046069|||Cohort||Prospective|||||||
1342244|NCT03046056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342245|NCT03046043|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342246|NCT03046030||Single Group Assignment||Basic Science||None (Open Label)||||||
1342247|NCT03046017|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1342248|NCT03046004|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1342249|NCT03045991|Randomized|Parallel Assignment||Treatment||Single||||||t
1342250|NCT03045978|||Case-Control||Prospective|||||||
1342251|NCT03045965|Randomized|Parallel Assignment||Prevention||Single|Masking of the intervention is planned to include the one-year follow-up of menopausal symptoms.||t|||
1342252|NCT03045952||Single Group Assignment||Treatment||None (Open Label)||||||
1342253|NCT03045939|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342254|NCT03045926||Single Group Assignment||Other||None (Open Label)||The study is interventional Phase 1 without individual benefit.||||
1342255|NCT03045913|||Cohort||Prospective|||||||
1342256|NCT03045900|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342257|NCT03045887|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1342258|NCT03045874|||Ecologic or Community||Prospective|||||||
1342259|NCT03045861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342260|NCT03045848|||Cohort||Prospective|||||||
1342261|NCT03045835|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342262|NCT03045822||Single Group Assignment||Other||None (Open Label)|open|||||
1342263|NCT03045809|||Other||Cross-Sectional|||||||
1342264|NCT03045796|||Cohort||Prospective|||||||
1342265|NCT03045783|Randomized|Parallel Assignment||Prevention||Single|||t|||
1342266|NCT03045770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342267|NCT03045757|||Cohort||Prospective|||||||
1342268|NCT03045744||Single Group Assignment||Treatment||None (Open Label)||||||
1342269|NCT03045731|||Cohort||Prospective|||||||
1342270|NCT03045718|Randomized|Parallel Assignment||Prevention||Single||||||t
1342271|NCT03045705|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342272|NCT03045692|Randomized|Parallel Assignment||Treatment||Triple||Double blind randomized trial|t|t||t
1342273|NCT03045679|Randomized|Parallel Assignment||Treatment||Single|envelope randomization|prospective randomized controlled trial: RYGB (group A) vs OAGB/MGB (group B)|||t|
1342274|NCT03045666|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1342275|NCT03045653||Single Group Assignment||Treatment||None (Open Label)||||||
1342276|NCT03045640||Single Group Assignment||Treatment||None (Open Label)||||||
1342277|NCT03045627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342278|NCT03045614|||Cohort||Retrospective|||||||
1342279|NCT03045601|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1342280|NCT03045588|Randomized|Parallel Assignment||Other||Single||||||t
1342281|NCT03045575|||Cohort||Prospective|||||||
1342282|NCT03045562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342283|NCT03045549|Non-Randomized|Parallel Assignment||Treatment||Single|All patients will be assessed for clinical outcomes by an independent rater blinded to the study arm|||||t
1342284|NCT03045536|||Cohort||Retrospective|||||||
1342285|NCT03045523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342286|NCT03045510||Single Group Assignment||Treatment||None (Open Label)||||||
1342287|NCT03045497||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342288|NCT03045484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1342289|NCT03045471|||Cohort||Prospective|||||||
1342290|NCT03045458|Randomized|Parallel Assignment||Other||None (Open Label)|Only the surgeon knows detail about the groups of participants. Participant, care provider,outcomes assessor have no knowledge of groups|In the surgical operations, 20 tissue-level and 20 bone-level dental implants 12 mm in length and 4.8 mm in diameter were inserted in Group I and Group II, respectively.||||
1342291|NCT03045445|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1342292|NCT03045432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342293|NCT03045419|||Cohort||Prospective|||||||
1342294|NCT03045406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342295|NCT03045393||Single Group Assignment||Treatment||None (Open Label)||||||
1342296|NCT03045380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342297|NCT03045367|||Case-Only||Prospective|||||||
1342298|NCT03045354|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1342299|NCT03045341|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342300|NCT03045328||Single Group Assignment||Treatment||None (Open Label)||||||
1342301|NCT03045315||Single Group Assignment||Diagnostic||||||||
1342302|NCT03045302||Single Group Assignment||Treatment||None (Open Label)||||||
1342303|NCT03045289|Randomized|Parallel Assignment||Treatment||Single||||||t
1342304|NCT03045276|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1342305|NCT03045263|Randomized|Crossover Assignment||Treatment||Single||||||t
1342306|NCT03045250|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1342307|NCT03045237|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342308|NCT03045224|||Cohort||Prospective|||||||
1342309|NCT03045211|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1342310|NCT03045198||Single Group Assignment||Treatment||None (Open Label)||CF patients receive for 4 weeks Azithromycin. Study measures are assessed before and after 4 weeks||||
1342311|NCT03045185||Single Group Assignment||Treatment||None (Open Label)|Single group so no masking|Prospective interventional uncontrolled trial||||
1342312|NCT03045172|Randomized|Parallel Assignment||Treatment||Double|Dermatopathologist||t|t||
1342313|NCT03045159|Randomized|Parallel Assignment||Prevention||Single|outcomes assessor blinded to study condition|||||t
1342314|NCT03045146|||Case-Only||Prospective|||||||
1342372|NCT03044392|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342373|NCT03044379|Randomized|Parallel Assignment||Other||Double|||t||t|
1342374|NCT03044366|||Case-Control||Retrospective|||||||
1342375|NCT03044353||Single Group Assignment||Treatment||None (Open Label)||||||
1342315|NCT03045133|Randomized|Parallel Assignment||Prevention||Quadruple|"Group assignments were sealed in sequentially numbered opaque envelopes that were opened after patient inclusion in the study. All care providers, researchers, and patients were blinded to group assignments. Study 10-mL syringes will be prepared by an anesthesiologist independent of the study. Methadone 0.1 mg.kg-1 (made up to 10 mL with normal saline) or morphine 0.1 mg.kg-1 (made up to 10 mL with normal saline) will be drawn into each syringe which will be offered to the anesthesia provider after the opaque envelope is opened.~The baseline QoR-40 questionnaire will be provided to subjects after informed consent is obtained in the preoperative holding area and 24 hours after surgery by a blinded investigator."|Prospective, randomized, double-blinded trial|t|t|t|t
1342316|NCT03045120|||Cohort||Prospective|||||||
1342317|NCT03045107|Randomized|Parallel Assignment||Treatment||Triple|A big dressing covering all incisions will be applied at the end of each operation in both arms.||t||t|t
1342318|NCT03045094|||Cohort||Prospective|||||||
1342319|NCT03045081|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342320|NCT03045068|Randomized|Parallel Assignment||Other||None (Open Label)||Prospective Randomized trial in neonates comparing platelet apheresis transfusion prior to termination of CPB versus standard transfusion of platelet apheresis after modified ultrafiltration and protamine administration||||
1342321|NCT03045055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342322|NCT03045042|||Cohort||Prospective|||||||
1342323|NCT03045029|||Cohort||Prospective|||||||
1342324|NCT03045016||Single Group Assignment||Treatment||None (Open Label)||||||
1342325|NCT03045003|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342326|NCT03044990|||Cohort||Prospective|||||||
1342327|NCT03044977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||dose-escalation design||||
1342328|NCT03044964|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342329|NCT03044951|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342330|NCT03044938|Randomized|Crossover Assignment||Prevention||Triple||Randomized Clinical trial, controlled, double-blind and crossover|t|t|t|
1342331|NCT03044925|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342332|NCT03044912|Randomized|Parallel Assignment||Treatment||Single||Randomized open label study|t|||
1342333|NCT03044899|||Cohort||Prospective|||||||
1342334|NCT03044886|Randomized|Factorial Assignment||Supportive Care||Double|||t|t||
1342335|NCT03044873||Single Group Assignment||Basic Science||None (Open Label)||||||
1342336|NCT03044860|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1342337|NCT03044847|||Cohort||Prospective|||||||
1342338|NCT03044834|||Cohort||Retrospective|||||||
1342339|NCT03044821||Single Group Assignment||Treatment||None (Open Label)||||||
1342340|NCT03044808|Randomized|Parallel Assignment||Treatment||Quadruple|"Pharmacy provides the research medicine, it is not possible to see a difference. The envelopes are encrypted. The randomization will only be broken in the end."|2 randomized groups, one getting lidocaine and the other getting saline|t|t|t|t
1342341|NCT03044795|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1342342|NCT03044782|||Case-Only||Cross-Sectional|||||||
1342343|NCT03044769|||Cohort||Prospective|||||||
1342344|NCT03044756|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled study|||t|t
1342345|NCT03044743||Single Group Assignment||Treatment||None (Open Label)||||||
1342346|NCT03044730||Single Group Assignment||Treatment||None (Open Label)||||||
1342347|NCT03044717|||Case-Only||Cross-Sectional|||||||
1342348|NCT03044704|||Cohort||Prospective|||||||
1342349|NCT03044691|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1342350|NCT03044678|Randomized|Parallel Assignment||Prevention||Triple|Masked or blinded to hypotheses||t|t||t
1342351|NCT03044665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342352|NCT03044652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342353|NCT03044639|Randomized|Parallel Assignment||Prevention||Single|No information on the lipid emulsion's type provided neither to the patient nor the leading physician|Randomized, double-blind, multi-centric study performed in four parallel groups|||t|
1342354|NCT03044626|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342355|NCT03044613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1342356|NCT03044600|||Cohort||Prospective|||||||
1342357|NCT03044587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342358|NCT03044574|Randomized|Parallel Assignment||Prevention||Single||A randomized clinical study to assess efficacy and safety of intermittent pneumatic compression device (SCD) application in combined prevention of postoperative VTE in surgical patients at high and extremely high risk receiving graduated compression stockings and early/delayed prophylactic anticoagulation with low-molecular weight heparins.||||t
1342359|NCT03044561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342360|NCT03044548|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342361|NCT03044535|||Other||Prospective|||||||
1342362|NCT03044522|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1342363|NCT03044509|||Cohort||Prospective|||||||
1342364|NCT03044496|||Cohort||Prospective|||||||
1342365|NCT03044483|||Other||Cross-Sectional|||||||
1342366|NCT03044470|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1342367|NCT03044457|Randomized|Parallel Assignment||Treatment||Double|neither the participant nor the outcome assessor know the group. The surgeon of course knows.|"Two groups: reversed gap technique vs. gap technique, randomized"|t|||t
1342368|NCT03044444|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1342369|NCT03044431|||Cohort||Prospective|||||||
1342370|NCT03044418||Single Group Assignment||Other||None (Open Label)||||||
1342371|NCT03044405||Single Group Assignment||Diagnostic||None (Open Label)||Patients who had reduced arterial blood pressure up to 30% from the baseline after major abdominal surgery (gastric resection, gastrectomy, liver resection, pancreatic-duodenal resection, colorectal surgery) were included in the study.||||
1342376|NCT03044340||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1342377|NCT03044327||Single Group Assignment||Basic Science||None (Open Label)||||||
1342378|NCT03044314||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342379|NCT03044301|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342380|NCT03044288||Single Group Assignment||Basic Science||None (Open Label)||||||
1342381|NCT03044275||Single Group Assignment||Basic Science||None (Open Label)||||||
1342382|NCT03044262||Single Group Assignment||Basic Science||None (Open Label)||||||
1342383|NCT03044249|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1342384|NCT03044236|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342385|NCT03044223|||Cohort||Prospective|||||||
1342386|NCT03044210|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1342387|NCT03044197|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Patients will be randomly assigned to arm A or arm B following a 1:1 simple randomization procedure according to a computer-generated randomization list.||||
1342388|NCT03044184|Randomized|Parallel Assignment||Treatment||Double|"Intravenous normal saline or transamine will be administered to subjects. Both will be of equal volume, colour and in similar intravenous fluid packaging.~The outcomes assessor will be unaware of the subject group allocation."|Randomised placebo-controlled parallel group clinical trial|t|||t
1342389|NCT03044171|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1342390|NCT03044158|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1342391|NCT03044145|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||This study follows an NIMH model known as the Stage Model of Intervention Development. The first project is creating a cross-cultural communication intervention designed to improve patient adherence in mental health services through patient and clinician feedback at JHMC and expert consensus with my K23 mentoring team. The second project is testing the intervention in a trial that compares the CFI-EA to treatment as usual.||||
1342392|NCT03044132||Single Group Assignment||Treatment||None (Open Label)||Prospective, multicenter post market product evaluation of study product for deep wounds of the lower extremity||||
1342393|NCT03044119|Randomized|Parallel Assignment||Treatment||Triple|The selected sites would be randomly (coin toss method) assigned into an edentulous area .|The selected sites would be randomly (coin toss method) assigned into an edentulous area allowing for the placement of a minimum of two adjacent dental implants being randomly assigned into (G1) - Dental implant with PRFM and (G2) - Dental implant with peripheral blood mesenchymal stem cells embedded in PRFM.|t||t|t
1342394|NCT03044106|Randomized|Crossover Assignment||Treatment||Double|"Subjects and assessors will be blinded to treatment allocation. The subject will be face down, eyes closed, and wearing protective eyewear that blocks the specific wavelength of the laser light during the intervention.~After each treatment session, the participants will complete a de-blinding questionnaire administrated by the assessor providing a dichotomous 'yes' or 'no' answer as to whether active treatment was received. This response will be followed by a second question regarding how certain they were that active treatment was received on a 0-10 numeric rating scale (NRS), where 0 represents absolutely uncertain and 10 represents absolutely certain."|Subjects who meet the inclusion criteria and give consent will be randomized to one of the following for the first treatment period: 1) active CLRT; or 2) sham laser. At the first intervention visit, the research assistant will enter the subject's assigned ID into an online computer program (selected by study biostatistician) to determine assignment to one of the two periods. The study biostatistician will use computer-generated random numbers to generate the allocation sequence using random blocks of random sizes. There will be a one-week washout period to minimize carryover effects.|t|||t
1342395|NCT03044093|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1342396|NCT03044080|Randomized|Parallel Assignment||Treatment||Double|Double blind|Parallel assignment|t|||t
1342397|NCT03044067|Randomized|Parallel Assignment||Treatment||Single||||||t
1342398|NCT03044054||Single Group Assignment||Treatment||None (Open Label)||||||
1342399|NCT03044041|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1342400|NCT03044028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342401|NCT03044015|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342402|NCT03044002|||Case-Control||Prospective|||||||
1342403|NCT03043989|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342404|NCT03043976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342405|NCT03043963|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1342406|NCT03043950|||Cohort||Prospective|||||||
1342407|NCT03043937|||Other||Prospective|||||||
1342408|NCT03043924|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1342409|NCT03043911|||Case-Only||Prospective|||||||
1342410|NCT03043898|||Case-Control||Cross-Sectional|||||||
1342411|NCT03043885|Randomized|Parallel Assignment||Treatment||Single||||||t
1342412|NCT03043872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342413|NCT03043859|Randomized|Parallel Assignment||Other||Double|Participants who have consented to participate in this study will be assigned a number, those who receive an even number will be assigned to the intervention arm and those who receive an odd number will be in the control arm.|This is a randomized, controlled trial of two arms [intervention (PPLP) and wait-listed controls (CON)]. Baseline data will be collected from all participants. PPLP participants will then receive 5 educational session on healthy eating, behaviour change and lifestyle in addition to usual care, whereas the controls will only receive usual care (no education intervention). Data for primary outcomes will be collected at 3 and 6 month period (from baseline). After the 6 month assessment all participants from the Control group will then recieve intervention and will complete the 3 and 6 month assessments.|t||t|
1342414|NCT03043846|||Cohort||Prospective|||||||
1342415|NCT03043833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342416|NCT03043820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342417|NCT03043807||Single Group Assignment||Treatment||None (Open Label)||||||
1342418|NCT03043794||Single Group Assignment||Treatment||None (Open Label)||SBRT to the breast follow by standard of care surgery||||
1342419|NCT03043781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342420|NCT03043768|||Cohort||Prospective|||||||
1342421|NCT03043755|||Cohort||Prospective|||||||
1342422|NCT03043742||Single Group Assignment||Treatment||None (Open Label)||||||
1342423|NCT03043729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342424|NCT03043716|||Cohort||Prospective|||||||
1342425|NCT03043703||Single Group Assignment||Diagnostic||None (Open Label)||Cohort study||||
1342426|NCT03043690|||Other||Retrospective|||||||
1342427|NCT03043677|||Case-Control||Prospective|||||||
1342428|NCT03043664||Single Group Assignment||Treatment||None (Open Label)||Pembrolizumab 200mg IV every 3 weeks and lanreotide depot 90mg SQ every 3 weeks||||
1342429|NCT03043651||Single Group Assignment||Treatment||None (Open Label)||||||
1342430|NCT03043638|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342431|NCT03043625|Randomized|Parallel Assignment||Treatment||Double||randomized, double-blinded, sham-controlled, study|t|||t
1342432|NCT03043612|Randomized|Parallel Assignment||Device Feasibility||Quadruple|||t|t|t|t
1342433|NCT03043599||Single Group Assignment||Treatment||None (Open Label)||||||
1342434|NCT03043586|||Cohort||Retrospective|||||||
1342435|NCT03043573|Randomized|Parallel Assignment||Prevention||Single||||||t
1342436|NCT03043560|Randomized|Parallel Assignment||Other||Double|Double blind||t||t|
1342437|NCT03043547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342438|NCT03043534|Randomized|Parallel Assignment||Treatment||Single|||||t|
1342439|NCT03043521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342440|NCT03043508|||Cohort||Other|||||||
1342441|NCT03043495|Randomized|Parallel Assignment||Treatment||Quadruple|The patient and the attending anesthetist who will manage the patient intra-operatively and perform the block, will be blinded to the patient group allocation All recorded values will be obtained by personnel blinded to the group allocation of the patient.|"The patients will be randomized to 4 groups:~Group A: N-12 will receive a total volume solution of 20ml: 18ml Bupivacaine 0.5%, 0.5ml (2mg) Dexamethasone, 1.5ml Normal saline.~Group B: N-12 will receive a total volume solution of 20ml: 18ml Bupivacaine 0.5%, 1ml (4mg) Dexamethasone, 1ml Normal saline.~Group C: N-12 will receive a total volume solution of 20ml: 18ml Bupivacaine 0.5%, 2ml (8mg) Dexamethasone.~Group Control: N-12 will receive a total volume solution of 20ml: 18ml Bupivacaine 0.5%, 2ml Normal saline."|t|t|t|t
1342442|NCT03043482|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342443|NCT03043469|||Case-Control||Cross-Sectional|||||||
1342444|NCT03043456|Randomized|Parallel Assignment||Health Services Research||Triple|"The study will be blinded regarding the statistician who is responsible for data analysis.~The participant patients will be blinded. The outcome assessor for patient satisfaction can be blinded during the questionnaire. On the other hand, Microbial count assessor will not be blinded during swab taking while the lab technician can be blinded. but The operator cannot be blinded."|prospective , parallel, randomized clinical trial|t|t||t
1342445|NCT03043443|Randomized|Parallel Assignment||Treatment||Double||Subjects with Alcohol use disorder and sleep problems will be recruited and assigned randomly to the active treatment Melatonin or Placebo arms.|t||t|
1342446|NCT03043430|Randomized|Parallel Assignment||Treatment||Quadruple|Medication (ketamine versus midazolam) will be drawn up in unmarked syringe and applied to the patient by mucosal atomization device by a nurse not directly involved in the investigation or the patient's care.|Subjects will be randomized to one of two treatment arms.|t|t|t|t
1342447|NCT03043417|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1342448|NCT03043404||Single Group Assignment||Treatment||None (Open Label)||||||
1342449|NCT03043391||Single Group Assignment||Treatment||None (Open Label)||Phase Ib study to evaluate feasibility, safety, and preliminary evidence of efficacy of the optimal adult dose in a pediatric population||||
1342450|NCT03043378|||Cohort||Prospective|||||||
1342451|NCT03043365|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1342452|NCT03043352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342453|NCT03043339|||Other||Prospective|||||||
1342454|NCT03043326|||Cohort||Prospective|||||||
1342455|NCT03043313||Single Group Assignment||Treatment||None (Open Label)||||||
1342456|NCT03043300|||Other||Prospective|||||||
1342457|NCT03043287|||Case-Only||Retrospective|||||||
1342458|NCT03043274|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342459|NCT03043261||Single Group Assignment||Other||None (Open Label)||||||
1342460|NCT03043248|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1342461|NCT03043235|||Case-Control||Prospective|||||||
1342462|NCT03043222|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342463|NCT03043209|||Case-Only||Prospective|||||||
1342464|NCT03043196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342465|NCT03043183|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1342466|NCT03043170|||Cohort||Prospective|||||||
1342467|NCT03043157||Single Group Assignment||Supportive Care||None (Open Label)|Participant receives hypnotic (propofol) before we use the drug|Dose-finding using Dixon's up-and-down adaptative clinical trial||||
1342468|NCT03043144|||Cohort||Prospective|||||||
1342469|NCT03043131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342470|NCT03043118|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1342471|NCT03043105||Single Group Assignment||Treatment||None (Open Label)|open-labeled|This will be a single center, single arm, phase-II pilot study.||||
1342472|NCT03043092|||Case-Control||Prospective|||||||
1342473|NCT03043079|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1342474|NCT03043066|Randomized|Parallel Assignment||Treatment||Double||Group A - scaling and root planing Group B - scaling and root planing along with antibiotic intervention of amoxicillin and metronidazole|t||t|
1342475|NCT03043053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342588|NCT03041584|Randomized|Parallel Assignment||Treatment||Single||||||t
1342589|NCT03041571|||Cohort||Prospective|||||||
1342476|NCT03043040|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a non-randomized non-blinded multicenter intervention study with control group. Patients from hospital A and B are included in the intervention group. Patients from hospital C are included in the control group.||||
1342477|NCT03043027|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342478|NCT03043014|Randomized|Parallel Assignment||Treatment||Single||The women will be randomized into two groups: Mifépristone group and Misoprostol group. The main endpoint will be the per-operating pain. The other endpoints are the pre and post-operative pain, the complications (cervical tearing, uterine perforation, hemorrhage requiring the use of blood products or an hemostatic intervention), the surgical time necessary to terminate the pregnancy, the side-effects of the drugs. The amount of per-operating bleeding and the duration of the intervention . We assume that the use of Mifepristone in the cervical preparation of the surgical abortion under LA would reduce the per-operating pain. The number of patients required is 55 in each arm.|||t|
1342479|NCT03043001||Single Group Assignment||Treatment||None (Open Label)||||||
1342480|NCT03042988|Randomized|Crossover Assignment||Treatment||None (Open Label)||randomized, 2-arm crossover study (heat vs sham)||||
1342481|NCT03042975|||Cohort||Cross-Sectional|||||||
1342482|NCT03042962|||Cohort||Cross-Sectional|||||||
1342483|NCT03042949||Single Group Assignment||Device Feasibility||None (Open Label)||Subjects will have their blood pressure measured by standard plethysmography and with a new optical device||||
1342484|NCT03042936||Single Group Assignment||Prevention||None (Open Label)||||||
1342485|NCT03042923|||Case-Control||Prospective|||||||
1342486|NCT03042910|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342487|NCT03042897||Single Group Assignment||Supportive Care||None (Open Label)||||||
1342488|NCT03042884|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342489|NCT03042871|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342490|NCT03042858|||Cohort||Prospective|||||||
1342491|NCT03042845|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1342492|NCT03042832|Randomized|Factorial Assignment||Health Services Research||||||||
1342493|NCT03042819||Single Group Assignment||Treatment||None (Open Label)||||||
1342494|NCT03042806||Single Group Assignment||Screening||None (Open Label)||||||
1342495|NCT03042793||Single Group Assignment||Treatment||None (Open Label)||||||
1342496|NCT03042780||Single Group Assignment||Treatment||None (Open Label)||||||
1342497|NCT03042767|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342498|NCT03042754||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342499|NCT03042741|Randomized|Parallel Assignment||Treatment||Triple|Double-blind study in two groups of patients assigned randomly into experimental and placebo arms|Group on experimental drug compared against group receiving placebo in randomized, blinded phase III study to evaluate effect on lipid profile, i.e., LDL, HDL, triglycerides and total cholesterol|t|t|t|
1342500|NCT03042728|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342501|NCT03042715|||Cohort||Prospective|||||||
1342502|NCT03042702|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1342503|NCT03042689||Single Group Assignment||Treatment||None (Open Label)||||||
1342504|NCT03042676|||Cohort||Prospective|||||||
1342505|NCT03042663||Single Group Assignment||Prevention||None (Open Label)||The study will recruit septic shock patients with hemodynamic instability on vasopressor support and on direct arterial blood pressure monitoring through a radial arterial cannula that is not older than 12 hours.||||
1342506|NCT03042650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342507|NCT03042637|||Case-Only||Prospective|||||||
1342508|NCT03042624|Randomized|Parallel Assignment||Treatment||Triple|Each treatment is numbered consecutively without any reference to the underlying randomization scheme, which is known only to the statistician who generated the list and to the technician who prepared the packages. The packages and their contents are indistinguishable.|Parallel-arm, Randomized, Double-blind Controlled Trial|t|t||t
1342509|NCT03042611|Randomized|Parallel Assignment||Treatment||Triple|Double Blind||t|t|t|
1342510|NCT03042598||Single Group Assignment||Supportive Care||None (Open Label)||This is a single arm interventional feasibility trial to determine if the use of a Biphasic Cuirass Ventilator during the apneic period of intubation will decrease the prevalence of oxygen desaturation in patients undergoing RSI as compared to historical proportions of 20%.||||
1342511|NCT03042585|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Dose-Escalated Total Body Irradiation (TBI) of 4 levels. Palifermin (Kepivance) is being supplied by the sponsor and is FDA approved to decrease the incidence and duration of severe oral mucositis in participants with hematologic malignancies who receive high doses of chemotherapy and radiation therapy followed by stem cell rescue.||||
1342512|NCT03042572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342513|NCT03042559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342514|NCT03042546|Randomized|Parallel Assignment||Treatment||Single|Patients are blinded||t|||
1342515|NCT03042533|Randomized|Parallel Assignment||Treatment||Single|Participant Blinding||t|||
1342516|NCT03042520|||Cohort||Prospective|||||||
1342517|NCT03042507||Single Group Assignment||Treatment||None (Open Label)||||||
1342518|NCT03042494|Randomized|Crossover Assignment||Treatment||Triple||Crossover design with 4 week washout period.|t||t|t
1342519|NCT03042481|||Cohort||Prospective|||||||
1342520|NCT03042468||Single Group Assignment||Treatment||None (Open Label)||||||
1342521|NCT03042455|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342522|NCT03042442|||Case-Control||Prospective|||||||
1342523|NCT03042429|Randomized|Sequential Assignment||Treatment||None (Open Label)|no masking|Randomized, multi-center, non-blinded, prospective, controlled trial||||
1342524|NCT03042416||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342525|NCT03042403|||Other||Prospective|||||||
1342526|NCT03042390|||Case-Control||Retrospective|||||||
1342590|NCT03041558|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1342527|NCT03042377|Randomized|Parallel Assignment||Treatment||Single|The patients were unaware as to which study group they had been allocated.|The patients were assigned to four medication groups randomly with an equal allocation rate between groups.The patients in the groups had same characteristics.|t|||
1342528|NCT03042364|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Randomized clinical trial||||
1342529|NCT03042351||Single Group Assignment||Treatment||None (Open Label)||||||
1342530|NCT03042338|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1342531|NCT03042325||Single Group Assignment||Treatment||None (Open Label)||||||
1342532|NCT03042312|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1342533|NCT03042299|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1342534|NCT03042286|||Cohort||Other|||||||
1342535|NCT03042273|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1342536|NCT03042260|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1342537|NCT03042247|||Case-Only||Prospective|||||||
1342538|NCT03042234|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342539|NCT03042221|||Other||Other|||||||
1342540|NCT03042208|Randomized|Parallel Assignment||Treatment||Single||||||t
1342541|NCT03042195|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342542|NCT03042182||Single Group Assignment||Treatment||None (Open Label)||one arm open label study to last 2 months||||
1342543|NCT03042169|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1342544|NCT03042156|||Cohort||Prospective|||||||
1342545|NCT03042143|Randomized|Parallel Assignment||Treatment||Quadruple|"The cell therapy facility and clinical trials pharmacist will be unblinded. The unblinded individuals will keep the treatment information confidential and will not discuss or release information on treatment allocation to the patient, the investigator, or other unauthorized personnel.~As in prior studies of MSCs, the infusion bag containing either the cell product or placebo will be masked at the time of preparation in the clinical site's cell therapy facility so that the contents of the infusion bag are not visible to the investigators or to the clinicians who are administering the study drug. The contents of the infusion bag will be administered through a masked infusion set."|"The phase 1 trial is an open label dose escalation pilot study in which cohorts of subjects with moderate to severe ARDS will receive increasing doses of a single infusion of Realist Orbcel-C in a 3+3 design. Initially 3 cohorts with 3 subjects/cohort.~After 7 days of follow-up for all study subjects in the phase 1 study is available the TMG will review the data and propose a cell dose for the phase 2 trial. This recommendation will be submitted to the DMEC for approval prior to initiating the phase 2 trial.~The phase 2 trial is a randomized, double-blind, allocation concealed placebo-controlled study using the maximal tolerable dose as determined by the DMEC in patients with moderate to severe ARDS."|t|t|t|t
1342546|NCT03042130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342547|NCT03042117|||Case-Control||Cross-Sectional|||||||
1342548|NCT03042104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342549|NCT03042091|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342550|NCT03042078|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1342551|NCT03042065|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1342552|NCT03042052|||Cohort||Retrospective|||||||
1342553|NCT03042039|||Case-Control||Prospective|||||||
1342554|NCT03042026|||Case-Control||Prospective|||||||
1342555|NCT03042013||Single Group Assignment||Treatment||None (Open Label)||||||
1342556|NCT03042000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342557|NCT03041987|||Cohort||Prospective|||||||
1342558|NCT03041974|||Cohort||Prospective|||||||
1342559|NCT03041961|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1342560|NCT03041948|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1342561|NCT03041935|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1342562|NCT03041922|||Case-Only||Prospective|||||||
1342563|NCT03041909||Single Group Assignment||Other||None (Open Label)||||||
1342564|NCT03041896|||Cohort||Retrospective|||||||
1342565|NCT03041883|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1342566|NCT03041870||Single Group Assignment||Basic Science||None (Open Label)||||||
1342567|NCT03041857|||Case-Control||Cross-Sectional|||||||
1342568|NCT03041844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342569|NCT03041831|||Other||Cross-Sectional|||||||
1342570|NCT03041818||Single Group Assignment||Supportive Care||None (Open Label)||||||
1342571|NCT03041805|||Cohort||Prospective|||||||
1342572|NCT03041792|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1342573|NCT03041779|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342574|NCT03041766|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342575|NCT03041753|||Cohort||Prospective|||||||
1342576|NCT03041740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342577|NCT03041727|Randomized|Parallel Assignment||Treatment||Single|The outcome assessor will be a statistic techinician, with any knowledge about the group composition and the rehabilitative intervention.|Participants are assigned to one of two or more groups in parallel for the duration of the study are evaluated in parallel against a control group.||||t
1342578|NCT03041714|||Case-Control||Cross-Sectional|||||||
1342579|NCT03041701|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1342580|NCT03041688||Single Group Assignment||Treatment||None (Open Label)||||||
1342581|NCT03041675|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1342582|NCT03041662|||Cohort||Prospective|||||||
1342583|NCT03041649|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1342584|NCT03041636||Single Group Assignment||Treatment||None (Open Label)||||||
1342585|NCT03041623|||Cohort||Prospective|||||||
1342586|NCT03041610|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342587|NCT03041597|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1342591|NCT03041545|||Cohort||Prospective|||||||
1342592|NCT03041532|Randomized|Parallel Assignment||Screening||Single|||t|||
1342593|NCT03041519|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342594|NCT03041506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342595|NCT03041493|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||This is a prospective, non-randomized case controlled study of the effects of electronic cigarettes on vascular health. The study population will comprise the three groups based on the criteria EC users (experimental group), (TC) smokers (positive control) and nonsmokers (negative control).||||
1342596|NCT03041480|||Case-Control||Other|||||||
1342597|NCT03041467||||||||||||
1342598|NCT03041454|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1342599|NCT03041441||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342600|NCT03041428||Single Group Assignment||Supportive Care||None (Open Label)||||||
1342601|NCT03041415|Randomized|Parallel Assignment||Prevention||Single|Assessors will not be told the intervention assigned of the participating housing sites|group-randomized design to either a person-level physical activity intervention alone, or the person-level physical activity intervention plus a citizen science intervention aimed at making the local neighborhood more activity-supportive.||||t
1342602|NCT03041402|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1342603|NCT03041389|Randomized|Parallel Assignment||Treatment||Single|The rater of outcomes questionnaires is blinded.|Randomized (1:1 ratio), single-blind, parallel-group, controlled study||||t
1342604|NCT03041376|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342605|NCT03041363||Single Group Assignment||Treatment||None (Open Label)||The trial will use an open-label, standard 3+3 phase 1 design for determining the MTD of orally administered C7 in G1D.||||
1342606|NCT03041350||Single Group Assignment||Health Services Research||None (Open Label)||||||
1342607|NCT03041337|||Other||Prospective|||||||
1342608|NCT03041324|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1342609|NCT03041311|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342610|NCT03041298|||Cohort||Prospective|||||||
1342611|NCT03041285|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|There is no masking.|Group 1 (6 participants) will receive 400mg of Idronoxil (NOX66) daily in the form of one suppository. Group 2 (6 participants) will receive 800mg of Idronoxil daily (two suppositories). Group 2 will only commence once all group 1 participants have completed their treatment course and have experienced no toxicity greater than grade 2 according CTCAE version 4.03 for adverse events assessment.||||
1342612|NCT03041272|||Cohort||Prospective|||||||
1342613|NCT03041259|Randomized|Single Group Assignment||Treatment||Single|||t|||
1342614|NCT03041246|Randomized|Parallel Assignment||Treatment||None (Open Label)||On enrollment, dividing the healthy ( n=40) from the pathological function of the pelvic floor ( n=40). From the second group, randomizing the groups to study group: recieving pelvic floor fascial mobilization (PFFM) treatment (n=20)compared to control group (n=20).||||
1342615|NCT03041233|||Case-Only||Prospective|||||||
1342616|NCT03041220|||Cohort||Retrospective|||||||
1342617|NCT03041207|||Cohort||Prospective|||||||
1342618|NCT03041194|||Cohort||Prospective|||||||
1342619|NCT03041181|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-Label|||||
1342620|NCT03041168|||Case-Only||Prospective|||||||
1342621|NCT03041155|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342622|NCT03041142|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342623|NCT03041129|||Case-Control||Cross-Sectional|||||||
1342624|NCT03041116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342625|NCT03041103|Non-Randomized|Single Group Assignment||Other||None (Open Label)||Single arm not blind||||
1342626|NCT03041090|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1342627|NCT03041077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342628|NCT03041064|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1342629|NCT03041051|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1342630|NCT03041038|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1342631|NCT03041025|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1342632|NCT03041012|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1342633|NCT03040999|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342634|NCT03040986||Single Group Assignment||Treatment||None (Open Label)||||||
1342635|NCT03040973||Single Group Assignment||Treatment||None (Open Label)||||||
1342636|NCT03040960|||Case-Control||Prospective|||||||
1342637|NCT03040947|||Cohort||Prospective|||||||
1342638|NCT03040934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342639|NCT03040921||Single Group Assignment||Other||None (Open Label)||||||
1342640|NCT03040908|||Cohort||Cross-Sectional|||||||
1342641|NCT03040895|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342642|NCT03040882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342643|NCT03040869|||Cohort||Prospective|||||||
1342644|NCT03040856|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1342645|NCT03040843|||Cohort||Prospective|||||||
1342646|NCT03040830|Randomized|Parallel Assignment||Treatment||Double|The randomization|"Double blind Randomized Controlled Trial : the clinicians and the patents were blinded of the allocation group.~A total of 137 embryo transfers (ETs) were randomly allocated into either group A (67 ) starting luteal support as daily intra muscular (IM) injections of 100 mg prontogest on day of egg retrieval, or group B (66) starting the same P4 dose on day of embryo transfer.Transfer technique was blind tactile using Labotect catheter and was considered difficult if the inner ET catheter was blood stained and /or sounding or dilating the cervix was needed. Cervical traction or blood staining of outer sheath did not indicate difficulty"|t|t||
1342647|NCT03040817|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342821|NCT03038555|||Cohort||Retrospective|||||||
1342648|NCT03040804||Single Group Assignment||Treatment||None (Open Label)||Simon two-stage design. In the first stage, 6 patients will be enrolled. If the patients in the study do not meet the termination criteria then the study will extend to a second stage and a maximum of 20 patients will be enrolled.||||
1342649|NCT03040791||Single Group Assignment||Treatment||None (Open Label)||This is a Phase II, two-stage, multi-center, single-arm, and open-label trial of Nivolumab (BMS-936558) in patients with mCRPC who have progressed to a taxane-based chemotherapy regimen previously.||||
1342650|NCT03040778|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1342651|NCT03040765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342652|NCT03040752|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1342653|NCT03040739|||Case-Control||Prospective|||||||
1342654|NCT03040726|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1342655|NCT03040713||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342656|NCT03040700|Randomized|Parallel Assignment||Screening||Single||||||t
1342657|NCT03040687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342658|NCT03040674|||Cohort||Prospective|||||||
1342659|NCT03040661|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342660|NCT03040648|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1342661|NCT03040635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342662|NCT03040622|||Case-Only||Prospective|||||||
1342663|NCT03040609|||Cohort||Prospective|||||||
1342664|NCT03040596|Randomized|Parallel Assignment||Treatment||Single||||||t
1342665|NCT03040583|||Cohort||Prospective|||||||
1342666|NCT03040570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342667|NCT03040557|Randomized|Parallel Assignment||Treatment||Single|||||t|
1342668|NCT03040544|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342669|NCT03040531|Randomized|Parallel Assignment||Prevention||Triple|"Drugs will be labelled as A and B and so will be the groups. Patients and doctors involved will not be aware of the treatment."||t|t|t|
1342670|NCT03040518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342671|NCT03040505|||Other||Prospective|||||||
1342672|NCT03040492|||Case-Control||Cross-Sectional|||||||
1342673|NCT03040479|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||"This is a multicenter, open-label, non-randomized, parallel-group, single dose study.~This study will enroll up to 24 participants and will include 2 hepatic impaired participant groups and one group of control participants with normal hepatic function."||||
1342674|NCT03040466|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants will be assigned to each 3 type of ureteroscope and receive the flexible ureteroscopy. In each ureteroscopy, only one type of ureteroscope will be used; therefore this study will be parallel model.||||
1342675|NCT03040453|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1342676|NCT03040440|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1342677|NCT03040427||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342678|NCT03040414|Randomized|Crossover Assignment||Treatment||None (Open Label)|Open label|Random assignment in a 1:1 ratio to PID AID system versus PID + Fuzzy Logic AID system for 12 weeks, then a 4-week washout period and then to crossover to the opposite arm for 12 weeks.||||
1342679|NCT03040401|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342680|NCT03040388|||Cohort||Prospective|||||||
1342681|NCT03040375|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1342682|NCT03040362||Single Group Assignment||Basic Science||None (Open Label)||||||
1342683|NCT03040349||Single Group Assignment||Treatment||None (Open Label)||||||
1342684|NCT03040336|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342685|NCT03040323|Non-Randomized|Parallel Assignment||Diagnostic||Single|Patients will not be informed of diagnostic arm.|Two interventional arms, selected by day of month; 1) biopsy with Lumason, 2) biopsy with placebos|t|||
1342686|NCT03040310||Single Group Assignment||Treatment||None (Open Label)||||||
1342687|NCT03040297|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1342688|NCT03040284||Single Group Assignment||Diagnostic||None (Open Label)|open|||||
1342689|NCT03040271|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342690|NCT03040258|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342691|NCT03040245|||Other||Other|||||||
1342692|NCT03040232|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1342693|NCT03040219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342694|NCT03040206|||Cohort||Retrospective|||||||
1342695|NCT03040193|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1342696|NCT03040180|Randomized|Parallel Assignment||Treatment||Single||||||t
1342697|NCT03040167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342698|NCT03040154|Randomized|Parallel Assignment||Other||Single|||t|||
1342699|NCT03040141|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1342700|NCT03040128|Randomized|Parallel Assignment||Treatment||Quadruple|random number generator (placebo vs. study drug)||t|t|t|t
1342701|NCT03040115|||Cohort||Cross-Sectional|||||||
1342702|NCT03040102|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342703|NCT03040089|Randomized|Parallel Assignment||Treatment||Single||||||t
1342704|NCT03040076|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342705|NCT03040063|Randomized|Parallel Assignment||Treatment||Single|||||t|
1342706|NCT03040050|Randomized|Single Group Assignment||Prevention||Double|The rPCR results will be provided to the clinical provider for the Interventional group participants. The rPCR results will not be provided to the clinic provider for the control group participants.|||t|t|
1342707|NCT03040037|||Cohort||Prospective|||||||
1342708|NCT03040024|Randomized|Single Group Assignment||Other||Triple|||t|t|t|
1342822|NCT03038542|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342709|NCT03040011|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blinded|Three-arm, double-blinded, placebo-controlled, randomized controlled trial|t|t|t|t
1342710|NCT03039998|||Cohort||Prospective|||||||
1342711|NCT03039985|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342712|NCT03039972|||Cohort||Prospective|||||||
1342713|NCT03039959|||Cohort||Prospective|||||||
1342714|NCT03039946|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342715|NCT03039933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342716|NCT03039920|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1342717|NCT03039907|||Cohort||Prospective|||||||
1342718|NCT03039894|||Case-Control||Prospective|||||||
1342719|NCT03039881|||Cohort||Prospective|||||||
1342720|NCT03039868|||Case-Control||Prospective|||||||
1342721|NCT03039855||Single Group Assignment||Treatment||None (Open Label)||||||
1342722|NCT03039842|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1342723|NCT03039829|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1342724|NCT03039816|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342725|NCT03039803|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342726|NCT03039790||Single Group Assignment||Prevention||None (Open Label)||||||
1342727|NCT03039777|||Cohort||Prospective|||||||
1342728|NCT03039764|Randomized|Parallel Assignment||Treatment||Single||||||t
1342729|NCT03039751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342730|NCT03039738|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1342731|NCT03039725|||Cohort||Retrospective|||||||
1342732|NCT03039712|||Cohort||Prospective|||||||
1342733|NCT03039699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342734|NCT03039686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342735|NCT03039673|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1342736|NCT03039660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342737|NCT03039647|||Cohort||Prospective|||||||
1342738|NCT03039634|||Cohort||Prospective|||||||
1342739|NCT03039621|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342740|NCT03039608|Randomized|Parallel Assignment||Prevention||Single|||t|||
1342741|NCT03039595|||Cohort||Other|||||||
1342742|NCT03039582|||Case-Only||Prospective|||||||
1342743|NCT03039569|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342744|NCT03039556||Single Group Assignment||Basic Science||None (Open Label)||||||
1342745|NCT03039543|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1342746|NCT03039530|Randomized|Parallel Assignment||Treatment||Single||||||t
1342747|NCT03039517|Randomized|Parallel Assignment||Treatment||None (Open Label)||subjects who meet the study entrance criteria will be randomly assigned into one of two groups using block randomization technique in a 1:1 ratio. The control group will receive care using elastic compression stocking and the intervention group will use the ACTitouch device. Stratified randomization will occur based on whether the DVT has iliac or non-iliac involvement.||||
1342748|NCT03039504|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1342749|NCT03039491|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342750|NCT03039478|Randomized|Crossover Assignment||Basic Science||Single||Parallel assignment|t|||
1342751|NCT03039465||Single Group Assignment||Supportive Care||None (Open Label)||A single group of patients undergoing the insertion of the prosthesis would be evaluated for voice quality and fluid leak as a measure of success of the intervention.||||
1342752|NCT03039452||Single Group Assignment||Treatment||None (Open Label)||||||
1342753|NCT03039439|||Case-Control||Prospective|||||||
1342754|NCT03039426|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1342755|NCT03039413||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342756|NCT03039400|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1342757|NCT03039387|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1342758|NCT03039374|||Cohort||Prospective|||||||
1342759|NCT03039361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342760|NCT03039348|||Case-Control||Cross-Sectional|||||||
1342761|NCT03039335|||Cohort||Retrospective|||||||
1342762|NCT03039322|||Case-Control||Cross-Sectional|||||||
1342763|NCT03039309|||Cohort||Prospective|||||||
1342764|NCT03039296|||Cohort||Prospective|||||||
1342765|NCT03039283|||Cohort||Retrospective|||||||
1342766|NCT03039270|Randomized|Parallel Assignment||Treatment||Triple|Neither the color evaluator nor the statistician were aware of the allocation of the hemiarcs, according to the sonic activation or not of them. In the execution of the intervention, the sonic activation was applied in sites such as marginal gingiva, premolars, palatal face of the teeth, in order to mask the treatment.|Randomized, controlled clinical trial, triple-blind, split-mouth type.|t||t|t
1342767|NCT03039257||Single Group Assignment||Treatment||None (Open Label)||||||
1342768|NCT03039244|Randomized|Single Group Assignment||Treatment||Quadruple|A random number table will be generated by a computer program, each of the selected pairs dental receive the following treatments: SRP or SRP + several aPDT episodes. The clinical, immunological and microbiological parameters will be evaluated at baseline (pre-intervention) and after the completion of non-surgical periodontal therapy. The periodontal clinical examinations (pre and post-intervention) will be performed by a single trained and calibrated examiner, who unknown the experimental groups of this study. Examiners are also blind to study the immunological and microbiological analyzes. SRP procedures and use of the aPDT protocol should be performed by other trained operator for these purposes.|The study type will be split mouth with two pairs of contralateral uni-root teeth with proximal periodontal sites presenting probing depth ≥ 5 mm for the clinical, microbiological and immunological assessment. A random number table will be generated by a computer program, each of the selected pairs dental receive the following treatments: SRP or SRP + several aPDT episodes|t|t|t|t
1342769|NCT03039231||Single Group Assignment||Treatment||None (Open Label)||||||
1342770|NCT03039218|Randomized|Parallel Assignment||Treatment||Double|"Study subjects will be randomized in a 2:1 ratio to either active treatment or the control. The investigator and his staff do not know which applicator is the sham/placebo control and which are the active applicators. For the active treatment, a regular EMSE shockwave applicator will be used. The treatment group is further split into two equal groups, with both groups receiving the identical active treatment. In order to preserve the blinding of the investigator, the treatment devices are provided with two applicators (one for each of the active treatment groups), which while identical in function, differ slightly in appearance.~For the sham treatment, a placebo applicator, including an absorber without emitting shockwaves, will be used. However, all three applicators (two to use with the active device and one with the sham) are going to produce exactly the typical shock wave sound with equivalent noise to reduce or eliminate bias from the investigator"|A total of 100 subjects will be randomized to either the Active or Sham/Placebo group. Following completion of the 3 month follow-up visit, subjects will be unblinded. Subjects who received the Placebo/Sham treatment will be offered treatment using the Active device applicator.|t||t|
1342771|NCT03039205|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1342772|NCT03039192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342773|NCT03039179|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342774|NCT03039166|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1342775|NCT03039153|||Cohort||Retrospective|||||||
1342776|NCT03039140||Single Group Assignment||Supportive Care||None (Open Label)||||||
1342777|NCT03039127||Single Group Assignment||Treatment||None (Open Label)||||||
1342778|NCT03039114||Single Group Assignment||Treatment||None (Open Label)||||||
1342779|NCT03039101|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1342780|NCT03039088|||Cohort||Prospective|||||||
1342781|NCT03039075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342782|NCT03039062|||Other||Prospective|||||||
1342783|NCT03039049|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1342784|NCT03039036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342785|NCT03039023|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1342786|NCT03039010|||Cohort||Prospective|||||||
1342787|NCT03038997|||Cohort||Prospective|||||||
1342788|NCT03038984|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||120 IBD patients has been randomized to screen for disease activity and FC either OD or every 3 months. 60 patients in each group||||
1342789|NCT03038971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342790|NCT03038958|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342791|NCT03038945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342792|NCT03038932|||Case-Control||Prospective|||||||
1342793|NCT03038919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342794|NCT03038906|||Cohort||Prospective|||||||
1342795|NCT03038893|Randomized|Parallel Assignment||Diagnostic||Single|Single Blind Masking||||t|
1342796|NCT03038880|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342797|NCT03038867|Randomized|Parallel Assignment||Other||Triple|Participant, investigator, and outcomes assessor are all blinded to participant's assigned group.|Blinded, placebo-controlled, randomized controlled trial|t||t|t
1342798|NCT03038854|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1342799|NCT03038841|||Other||Prospective|||||||
1342800|NCT03038828|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1342801|NCT03038815||Sequential Assignment||Basic Science||None (Open Label)||||||
1342802|NCT03038802|Randomized|Parallel Assignment||Treatment||Triple|Participants, the investigator and outcomes assessors will be blinded as to which vaccine the subject has received||t||t|t
1342803|NCT03038789|||Case-Only||Prospective|||||||
1342804|NCT03038776|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1342805|NCT03038763|||Cohort||Prospective|||||||
1342806|NCT03038750|||Case-Only||Cross-Sectional|||||||
1342807|NCT03038737|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1342808|NCT03038724|Randomized|Parallel Assignment||Screening||Double|The study investigator will not know which arm each patient is assigned to.|Randomised, single-blind study||t|t|
1342809|NCT03038711|Randomized|Parallel Assignment||Screening||Double|||t||t|
1342810|NCT03038698|||Ecologic or Community||Cross-Sectional|||||||
1342811|NCT03038685|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||A pilot, double-arm, pre/post study design with compirason between historical, monocenter cohort (Sint-Janhospital, 2011) and prospective, multicenter cohort (4 Belgian Stroke centers, 2017)||||
1342812|NCT03038672|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1342813|NCT03038659|||Case-Control||Prospective|||||||
1342814|NCT03038646|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1342815|NCT03038633|Non-Randomized|Crossover Assignment||Other||None (Open Label)||Individuals will receive 300 mg capsules of the novel medical food. The iron content of these capsules is 7.4mg. Our initial dose is set at 22.2 mg of iron. This dose was chosen as the initial starting dose because it is within the range of the RDA for iron for adult women (18mg). Thus this dose is considered the minimum that would be utilized in any setting for maintenance of a healthy iron status. The dosing increases to a maximum of 88.8mg of iron per day which is significantly below the standard amount of iron (165-195mg per day) recommended for an iron deficient individual or the amount of iron given intravenously (1000 mg) for some iron deficient conditions. As mentioned, the total element iron given a patient treated with FAS is up to 190mg of iron. Assuming a 10% absorption rate these patients get 19mg of iron. So if our goal is approximately 19mg of iron absorbed per day and we assume a 50% absorption rate then our target dose is 6-9 capsules per day (44.4-66.6 mg iron).||||
1342816|NCT03038620|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1342817|NCT03038607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342818|NCT03038594|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342819|NCT03038581|||Cohort||Retrospective|||||||
1342820|NCT03038568|||Cohort||Prospective|||||||
1342823|NCT03038529|Randomized|Parallel Assignment||Treatment||Single||||||t
1342824|NCT03038516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342825|NCT03038503|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342826|NCT03038490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342827|NCT03038477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342828|NCT03038464|||Cohort||Retrospective|||||||
1342829|NCT03038451||Single Group Assignment||Treatment||None (Open Label)||||||
1342830|NCT03038438||||||||||||
1342831|NCT03038425|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1342832|NCT03038412|||Other||Cross-Sectional|||||||
1342833|NCT03038399|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342834|NCT03038386||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342835|NCT03038373|||Case-Control||Prospective|||||||
1342836|NCT03038360|||Cohort||Prospective|||||||
1342837|NCT03038347|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1342838|NCT03038334||Single Group Assignment||Treatment||None (Open Label)||||||
1342839|NCT03038321|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342840|NCT03038308||Single Group Assignment||Treatment||None (Open Label)|Open-label studies|1) Forced titration dose response PKPD study and 2) A prospective open-label outpatient dose escalation trial of ropinirole for treatment of prolactinomas and hyperprolactinemia.||||
1342841|NCT03038295|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342842|NCT03038282|Randomized|Parallel Assignment||Treatment||Single|Participants, Investigator|||||t
1342843|NCT03038269|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1342844|NCT03038256|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1342845|NCT03038243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342846|NCT03038230||Single Group Assignment||Treatment||None (Open Label)||||||
1342847|NCT03038217|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1342848|NCT03038204|||Cohort||Prospective|||||||
1342849|NCT03038191|||Other||Prospective|||||||
1342850|NCT03038178||Single Group Assignment||Treatment||None (Open Label)||||||
1342851|NCT03038165|||Cohort||Prospective|||||||
1342852|NCT03038152||Single Group Assignment||Treatment||None (Open Label)||||||
1342853|NCT03038139|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342854|NCT03038126|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1342855|NCT03038113|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1342856|NCT03038100|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342857|NCT03038087||Single Group Assignment||Other||None (Open Label)||||||
1342858|NCT03038074||Single Group Assignment||Other||None (Open Label)||||||
1342859|NCT03038061||Single Group Assignment||Supportive Care||None (Open Label)||Single group assignment. Approx. 20 patients during laparoscopic surgery with capnoperitoneum.||||
1342860|NCT03038048|Randomized|Single Group Assignment||Treatment||Single|||t|||
1342861|NCT03038035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342862|NCT03038022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342863|NCT03038009|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342864|NCT03037996|||Cohort||Prospective|||||||
1342865|NCT03037983|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1342866|NCT03037970|Randomized|Parallel Assignment||Treatment||Double|One component of the study drug will be blinded as the study employs a placebo-controlled arm. More specifically, vials containing rhPDGF or saline will be the same Type I, sodium borosilicate vials with rubber stopper, and plastic cap. Each vial will contain 3 ml of clear liquid. The vials will have blinded labels. Type I collagen wound dressings, on the other hand, will all be the same and are not part of the blinding.|This is a randomized, blinded, two-arm, clinical study|t||t|
1342867|NCT03037957|||Case-Only||Prospective|||||||
1342868|NCT03037944|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342869|NCT03037931|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342870|NCT03037918|Randomized|Parallel Assignment||Basic Science||None (Open Label)|Participants will be given a unique identifier, which will not disclose the treatment group. All biological samples will be labelled with only the unique identifier.|Open label, control trial||||
1342871|NCT03037905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342872|NCT03037892|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342873|NCT03037879|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342874|NCT03037866|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342875|NCT03037853|||Cohort||Prospective|||||||
1342876|NCT03037840|||Case-Control||Cross-Sectional|||||||
1342877|NCT03037827|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342878|NCT03037814|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342879|NCT03037801|Randomized|Parallel Assignment||Treatment||Single||||||t
1342880|NCT03037788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342881|NCT03037775||Single Group Assignment||Prevention||None (Open Label)||||||
1342882|NCT03037762|||Cohort||Prospective|||||||
1342883|NCT03037749|Non-Randomized|Factorial Assignment||Basic Science||Single|Participants are given either an alcohol beverage or a placebo beverage.|Distressed violent and distressed nonviolent couples participate in a placebo-controlled alcohol administration study with an emotion-regulation task.|t|||
1342884|NCT03037736|Randomized|Parallel Assignment||Treatment||Quadruple|patients, physicians and evaluators will be masked as to the assignment arm.||t|t|t|t
1342885|NCT03037723||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342886|NCT03037710|||Other||Prospective|||||||
1342887|NCT03037697|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1342888|NCT03037684|||Cohort||Prospective|||||||
1342889|NCT03037671|||Cohort||Prospective|||||||
1342890|NCT03037658|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1342891|NCT03037645||Sequential Assignment||Treatment||None (Open Label)||Phase 1b will evaluate the safety and pharmacology of a range of SNS-062 dose levels administered to the subjects. Based on the pattern of dose limiting toxicities observed in the first cycle (4 weeks), escalation will proceed to define a maximum tolerated dose (MTD) and/or a recommended dose (RD). The Phase 2 portion of the study provides cohort expansion to further explore the clinical activity, safety and pharmacology of SNS-062 monotherapy.||||
1342892|NCT03037632|Randomized|Parallel Assignment||Prevention||Double|Blinded until intervention is assigned to subject.||t||t|
1342893|NCT03037619|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342894|NCT03037606|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342895|NCT03037593|Randomized|Single Group Assignment||Treatment||None (Open Label)||This will be a randomized single-center study with a target study group of 300 women. Women will be followed from enrollment through the remainder of their pregnancy||||
1342896|NCT03037580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342897|NCT03037567||Single Group Assignment||Treatment||None (Open Label)||||||
1342898|NCT03037554|Randomized|Crossover Assignment||Treatment||Triple|Treatment and sham-control sleepwear will be allocated to subjects in a counterbalanced manner by a study administrator who will not otherwise interact with subjects.|Hierarchical linear model evaluating repeated measures nested within subjects|t|t|t|
1342899|NCT03037541|Randomized|Parallel Assignment||Treatment||Single|||||t|
1342900|NCT03037528|Randomized|Factorial Assignment||Treatment||Single||||||t
1342901|NCT03037515|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1342902|NCT03037502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342903|NCT03037489||Single Group Assignment||Treatment||None (Open Label)||||||
1342904|NCT03037476|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342905|NCT03037463|||Case-Control||Prospective|||||||
1342906|NCT03037450||Single Group Assignment||Treatment||None (Open Label)||||||
1342907|NCT03037437|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342908|NCT03037424|Randomized|Parallel Assignment||Treatment||Single||||||t
1342909|NCT03037411|||Cohort||Prospective|||||||
1342910|NCT03037398|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1342911|NCT03037385||Single Group Assignment||Treatment||None (Open Label)||||||
1342912|NCT03037372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342913|NCT03037359|||Cohort||Prospective|||||||
1342914|NCT03037346|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1342915|NCT03037333|Randomized|Parallel Assignment||Treatment||Single||||||t
1342916|NCT03037320|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1342917|NCT03037307|Randomized|Crossover Assignment||Treatment||Single||||||t
1342918|NCT03037294|Randomized|Parallel Assignment||Basic Science||Single||||||t
1342919|NCT03037281|||Case-Control||Prospective|||||||
1342920|NCT03037268|||Cohort||Cross-Sectional|||||||
1342921|NCT03037255|||Cohort||Prospective|||||||
1342922|NCT03037242||Single Group Assignment||Treatment||None (Open Label)||||||
1342923|NCT03037229|||Case-Only||Prospective|||||||
1342924|NCT03037216||Single Group Assignment||Basic Science||None (Open Label)||Single Group Assignment||||
1342925|NCT03037203|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1342926|NCT03037190|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||•The trial is designed as a 2-arm not randomized, open, multicentre study comparing 1 year of gluten free diet with normal diet||||
1342927|NCT03037177|||Other||Retrospective|||||||
1342928|NCT03037164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342929|NCT03037151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342930|NCT03037138||Single Group Assignment||Prevention||None (Open Label)||Use of blood flow profiling for prevention of postdialysis washed-out feeling through same group scale before and after profiling||||
1342931|NCT03037125|Randomized|Parallel Assignment||Treatment||Single||||||t
1342932|NCT03037112|Randomized|Parallel Assignment||Health Services Research||Single|Providers will be randomly assigned to the education or communication skills intervention study arms. Both groups will receive identical training on the appropriate prescribing of antibiotics for ARTIs, but only those in the communication intervention will receive additional training on communication skills. Once providers have been randomized and trained, eligible patients will be enrolled and exposed to one of the interventions based on the provider they see for their visit. Patients will not be informed of their provider's study arm.||t|||
1342933|NCT03037099|Randomized|Parallel Assignment||Treatment||Single|||t|||
1342934|NCT03037086|||Cohort||Retrospective|||||||
1342935|NCT03037073|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1342936|NCT03037060||Single Group Assignment||Basic Science||None (Open Label)||||||
1342937|NCT03037047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342938|NCT03037034||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1342939|NCT03037021|||Other||Prospective|||||||
1342940|NCT03037008|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1342941|NCT03036995|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1342942|NCT03036982|||Cohort||Prospective|||||||
1342943|NCT03036969|||Cohort||Prospective|||||||
1342944|NCT03036956|||Cohort||Prospective|||||||
1342945|NCT03036943||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342946|NCT03036930||Single Group Assignment||Prevention||None (Open Label)||||||
1342947|NCT03036917|||Cohort||Prospective|||||||
1342948|NCT03036904||Single Group Assignment||Treatment||None (Open Label)||||||
1343046|NCT03035630|Randomized|Crossover Assignment||Treatment||None (Open Label)|Open-Label|||||
1343116|NCT03034720|Randomized|Parallel Assignment||Treatment||Single||||||t
1342949|NCT03036891|Randomized|Parallel Assignment||Treatment||Quadruple||The investigators have included a unique aspect of this study to better balance the benefits for patients participating in this randomized double-blind study in which half the patients receive a placebo agent. All patients in the treatment group and the placebo group will be invited to participate in the 4-week open-label extension for this study|t|t|t|t
1342950|NCT03036878||Single Group Assignment||Treatment||None (Open Label)||||||
1342951|NCT03036865|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1342952|NCT03036852||Single Group Assignment||Treatment||None (Open Label)||||||
1342953|NCT03036839|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342954|NCT03036826|||Cohort||Prospective|||||||
1342955|NCT03036813|Randomized|Parallel Assignment||Treatment||Triple|This study is a double-blind study.||t|t|t|
1342956|NCT03036800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342957|NCT03036787|||Family-Based||Prospective|||||||
1342958|NCT03036774|Non-Randomized|Parallel Assignment||Other||Single||||t||
1342959|NCT03036761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1342960|NCT03036748|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)|open label|"Experimental: Kidney transplant recipients with ACR > 300mg/g receiving first a standardized salt diet (150 mmol NaCl/day) for 4 days and then amiloride tablet 20 mg two times daily (morning and afternoon) for one day.~Interventions:◦Dietary Supplement: Standardized salt diet~◦Drug: Amiloride~•Experimental: Kidney transplant recipient with ACR< 30mg/g (Control) receiving a standardized salt diet (150 mmol NaCl/day) for 4 days, then amiloride tablet 20 mg two times daily (morning and afternoon) for 1 day.~Interventions:◦Dietary Supplement: Standardized salt diet~◦Drug: Amiloride"||||
1342961|NCT03036735||Single Group Assignment||Treatment||None (Open Label)|At the end of surgery, the Surgery Fellow will insert either the Drug Eluting Spacer or the Silastic spacer into each side of the subject's nose. The subject will receive one of each spacer. The fellow will record which spacer was placed on which side using a special coding system to keep this information private. This maintains the blinding for the primary surgeon/outcome assessor and subject.|Subjects undergoing endoscopic sinus surgery (ESS) will receive one steroid eluting spacer placed into the surgical site on one side, and one spacer without steroid placed on the other side.||||
1342962|NCT03036722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342963|NCT03036709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342964|NCT03036696|||Cohort||Prospective|||||||
1342965|NCT03036683|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1342966|NCT03036670|||Cohort||Retrospective|||||||
1342967|NCT03036657|Randomized|Parallel Assignment||Other||Double|||t|||t
1342968|NCT03036644|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1342969|NCT03036631|||Case-Control||Prospective|||||||
1342970|NCT03036618|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1342971|NCT03036605|Randomized|Parallel Assignment||Treatment||Single|||||t|
1342972|NCT03036592|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1342973|NCT03036579|Randomized|Parallel Assignment||Treatment||Single|Final surface fabrication was not identified in the treatment process until the crown was milled.|||t||
1342974|NCT03036566||Single Group Assignment||Treatment||None (Open Label)||||||
1342975|NCT03036553|||Cohort||Prospective|||||||
1342976|NCT03036540|||Cohort||Prospective|||||||
1342977|NCT03036527|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342978|NCT03036514|Non-Randomized|Sequential Assignment||Device Feasibility||None (Open Label)||Single center case-control study design||||
1342979|NCT03036501||Single Group Assignment||Treatment||None (Open Label)||||||
1342980|NCT03036488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342981|NCT03036475||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342982|NCT03036462|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1342983|NCT03036449|||Cohort||Prospective|||||||
1342984|NCT03036436||Single Group Assignment||Prevention||None (Open Label)||||||
1342985|NCT03036423|Randomized|Parallel Assignment||Prevention||Single||||||t
1342986|NCT03036410|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1342987|NCT03036397|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1342988|NCT03036384|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1342989|NCT03036371||Single Group Assignment||Treatment||None (Open Label)||||||
1342990|NCT03036358|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1342991|NCT03036345||Single Group Assignment||Diagnostic||None (Open Label)||||||
1342992|NCT03036332|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1342993|NCT03036319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Given the nature of this study, the participant, care provider, investigator, and/or outcome assessors may or may not be blinded to the treatment condition.|||||
1342994|NCT03036306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342995|NCT03036293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342996|NCT03036280|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1342997|NCT03036267|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1342998|NCT03036254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1342999|NCT03036241|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343000|NCT03036228||Single Group Assignment||Treatment||None (Open Label)||||||
1343109|NCT03034811||Single Group Assignment||Treatment||None (Open Label)||||||
1343110|NCT03034798|||Case-Crossover||Prospective|||||||
1343111|NCT03034785|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343112|NCT03034772|Randomized|Parallel Assignment||Treatment||Single|Single-blind||t|||
1343113|NCT03034759||Single Group Assignment||Treatment||None (Open Label)||||||
1343114|NCT03034746|Randomized|Parallel Assignment||Treatment||Single||||||t
1343115|NCT03034733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343001|NCT03036215|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||The pilot study design is a 2-arm randomized clinical trial to test the methods that will be used in a future proposal for a full-scale multi-site clinical trial. The two aims include: 1) evaluate the feasibility of methods to conduct a full-scale multi-site randomized clinical trial comparing the PACT self-management with usual self-care for TMD and, 2) estimate the parameters needed to plan for a larger multi-site trial including the effect size and standard deviation for primary outcomes of pain and function. A traditional self-care control arm is added to determine the acceptability of randomization and the feasibility of collecting baseline and follow-up data from a traditional care control arm for the full-scale study.||||
1343002|NCT03036202|||Case-Only||Prospective|||||||
1343003|NCT03036189|Randomized|Parallel Assignment||Treatment||None (Open Label)||delayed control group design||||
1343004|NCT03036176|Randomized|Parallel Assignment||Other||Single||||||t
1343005|NCT03036163|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1343006|NCT03036150|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343007|NCT03036137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343008|NCT03036124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343009|NCT03036111|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1343010|NCT03036098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343011|NCT03036085|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1343012|NCT03036072|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343013|NCT03036059|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1343014|NCT03036046|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Patients in group low dose fluconazole will be enrolled ahead of group high dose fluconazole. Group posaconazole will be enrolled in parallel according to prevaling practice in the institutions involved in the study||||
1343015|NCT03036033||Single Group Assignment||Device Feasibility||None (Open Label)||Single group, open feasibility study of use of a CE marked and available device.||||
1343016|NCT03036020||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343017|NCT03036007|Randomized|Parallel Assignment||Treatment||Single|Single Blind (Outcomes Assessor)|||||t
1343018|NCT03035994|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1343019|NCT03035981|Randomized|Crossover Assignment||Other||Single|||t|||
1343020|NCT03035968|Randomized|Parallel Assignment||Treatment||Single|The assessor for the secondary outcome (Barthel Index and mRS after 90 days) is blinded. All other outcome assessors have knowledge of the interventions assigned to individual participants.|||||t
1343021|NCT03035955|Randomized|Parallel Assignment||Treatment||Single|The investigator is blinded to which side of face is using the azelaeic acid treatetment|This is a split face, randomized, single blind, single center study. Male and female (non-pregnant, non-nursing) subjects, age 18 or greater, with mild to moderate papulopustular (based on Investigator Global Assessment) facial rosacea, with bilateral facial involvement, and no more than two nodules will be enrolled. Subjects will be randomized 1:1 by the study coordinator using a standard randomization table to receive azelaic acid (Finacea® Gel, 15%) twice daily on either the left side or the right side of the face and no treatment on the other side of the face.|||t|
1343022|NCT03035942|Randomized|Parallel Assignment||Prevention||Quadruple|Group assignments will be sealed in sequentially numbered opaque envelopes that were opened after patient inclusion in the study. All care providers, researchers, and patients will be blinded to group assignments. Study 5-mL syringes will be prepared by a nurse independent of the study. Normal saline (5 mL total volume), dexamethasone (made up to 5 mL with normal saline), or ondansetrone 4 mg (made up to 5 mL with normal saline) will be drawn into each syringe which will be offered to the anesthesia provider after the opaque envelope was opened.|Prospective, randomized, controlled, double-blinded|t|t|t|t
1343023|NCT03035929||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343024|NCT03035916|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1343025|NCT03035903|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1343026|NCT03035890||Single Group Assignment||Treatment||None (Open Label)||||||
1343027|NCT03035877|Randomized|Parallel Assignment||Treatment||Single||||||t
1343028|NCT03035864|Randomized|Parallel Assignment||Treatment||Double|For the whole duration of the trial, treatment was unknown to the patient, the Investigator and the site staff.||t||t|
1343029|NCT03035851|Randomized|Parallel Assignment||Other||Single||||||t
1343030|NCT03035838||Single Group Assignment||Basic Science||None (Open Label)||||||
1343031|NCT03035825|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1343032|NCT03035812||Single Group Assignment||Treatment||None (Open Label)||Clinical and biological evaluation before and after an oral alkalinization||||
1343033|NCT03035799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343034|NCT03035786|||Cohort||Prospective|||||||
1343035|NCT03035773|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1343036|NCT03035760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343037|NCT03035747|||Other||Prospective|||||||
1343038|NCT03035734|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1343039|NCT03035721|Randomized|Parallel Assignment||Other||Single|Anthropometric and body composition measurements were performed by three medical investigators who were blinded to allocated treatment.|||||t
1343040|NCT03035708|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343041|NCT03035695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343042|NCT03035682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343043|NCT03035669|Randomized|Parallel Assignment||Basic Science||Single||||||t
1343044|NCT03035656|Randomized|Parallel Assignment||Supportive Care||Quadruple|Randomization of arms are conducted by the pharmacy department, and drug or saline preparation are prepared by the pharmacy department.|Patients are randomized into either the experimental arm (administration of Ropivaciane) or the control arm (administration of saline).|t|t|t|t
1343045|NCT03035643||Single Group Assignment||Treatment||None (Open Label)||Prospective, non-randomized, non-blinded, single-arm study evaluating the feasibility and safety of the AMDS||||
1343047|NCT03035617|Randomized|Parallel Assignment||Treatment||Quadruple|Allocation will be done by the staff at clinical trial unit which will be kept undisclosed to the investigators, patients and outcome assessors. Clinical Trial Unit will provide the solution for soaking mesh in coded form according to treatment arm allocation.|We propose a parallel design having two arms. In both the arms operative procedure of laparoscopic ventral hernia repair will be the same except solution used to soak the mesh before application. In control arm mesh will be soaked in normal saline solution as is routinely done. In intervention arm mesh will be soaked in .5% bupivacaine solution before application. Twenty ml of .5% bupivacaine will be provided by Institutional Clinical Trial Unit in coded form. Record of the codes will be kept by the clinical trial unit. Soaking will be done for one minute. Participants, investigators and outcome assessors will be blinded of the treatment allocation.|t|t|t|t
1343048|NCT03035604|||Cohort||Prospective|||||||
1343049|NCT03035591||Single Group Assignment||Basic Science||None (Open Label)||||||
1343050|NCT03035578||Single Group Assignment||Basic Science||None (Open Label)||||||
1343051|NCT03035565|Randomized|Factorial Assignment||Treatment||Single||||||t
1343052|NCT03035552|Randomized|Parallel Assignment||Treatment||Double|The assessors and the investigator are masked to the group assignment|Randomized to Pacifier Activated Lullaby (mother's voice contingent on suck, 15 minutes, 5 sessions) before surgery or and Sounds of Love (mother's voice playing freely, 15 minutes, 5 sessions). Arm 2: Sounds of love before surgery, Pacifier activated lullaby after the surgery.|||t|t
1343053|NCT03035539|Randomized|Parallel Assignment||Treatment||Single|Physiotherapists evaluating the physical capacity were masked.|||||t
1343054|NCT03035526|||Cohort||Cross-Sectional|||||||
1343055|NCT03035513|||Other||Cross-Sectional|||||||
1343056|NCT03035500||Single Group Assignment||Supportive Care||None (Open Label)||||||
1343057|NCT03035487||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1343058|NCT03035474|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1343059|NCT03035461|||Cohort||Prospective|||||||
1343060|NCT03035448|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1343061|NCT03035435|||Case-Control||Prospective|||||||
1343062|NCT03035422||Single Group Assignment||Other||None (Open Label)||||||
1343063|NCT03035409||Single Group Assignment||Supportive Care||None (Open Label)||||||
1343064|NCT03035396||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1343065|NCT03035383|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|Non-randomized controlled study||||
1343066|NCT03035370|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1343067|NCT03035357||Single Group Assignment||Treatment||None (Open Label)||||||
1343068|NCT03035344|||Case-Control||Prospective|||||||
1343069|NCT03035331||Single Group Assignment||Treatment||None (Open Label)||||||
1343070|NCT03035318||||||||||||
1343071|NCT03035305|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343072|NCT03035292|||Cohort||Prospective|||||||
1343073|NCT03035279|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1343074|NCT03035266|Randomized|Parallel Assignment||Treatment||Double|Investigators recording thigh girth and isokinetic data will be blinded to group assignment.|This is a prospective, randomized control trial. After consenting, subjects will be randomized to one of two groups by using a computer generated random number.|||t|t
1343075|NCT03035253||Single Group Assignment||Treatment||None (Open Label)||||||
1343076|NCT03035240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343077|NCT03035227|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343078|NCT03035214||Single Group Assignment||Treatment||None (Open Label)||||||
1343079|NCT03035201|||Cohort||Prospective|||||||
1343080|NCT03035188||Single Group Assignment||Treatment||None (Open Label)||||||
1343081|NCT03035175|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343082|NCT03035162|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1343083|NCT03035149|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1343084|NCT03035136|||Case-Control||Cross-Sectional|||||||
1343085|NCT03035123|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343086|NCT03035110||Single Group Assignment||Other||None (Open Label)||||||
1343087|NCT03035097|||Other||Other|||||||
1343088|NCT03035084|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1343089|NCT03035071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343090|NCT03035058|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343091|NCT03035045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343092|NCT03035032||Single Group Assignment||Treatment||None (Open Label)||||||
1343093|NCT03035019||Single Group Assignment||Other||None (Open Label)||||||
1343094|NCT03035006||Single Group Assignment||Treatment||None (Open Label)||||||
1343095|NCT03034993|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1343096|NCT03034980|||Case-Control||Retrospective|||||||
1343097|NCT03034967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343098|NCT03034954|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343099|NCT03034941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343100|NCT03034928||||||||||||
1343101|NCT03034915|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1343102|NCT03034902||||||||||||
1343103|NCT03034889|||Case-Control||Cross-Sectional|||||||
1343104|NCT03034876|||Cohort||Prospective|||||||
1343105|NCT03034863|Randomized|Parallel Assignment||Treatment||Single|The individual who evaluates the outcomes of interest will not know the assigned condition of the participants.|Participants are assigned to one of two groups in parallel for the duration of the study.||||t
1343106|NCT03034850|||Cohort||Prospective|||||||
1343107|NCT03034837|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1343108|NCT03034824|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1343117|NCT03034707||Single Group Assignment||Other||None (Open Label)||||||
1343118|NCT03034694|Randomized|Parallel Assignment||Diagnostic||Double||Routine Care vs The use of teledermatology|t||t|
1343119|NCT03034681|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The patients were recruited as follows: the rehabilitation doctor evaluated and diagnosed the patient and referred them to the Physiotherapy Unit (PTU) with a prescription for TENS or Vojta treatment. It was at the PTU of the health centre where the patient was informed of the possibility of taking part in the study. Patients who agree were allocated alternately in order of arrival to the PTU, in such a way that half of the sample was treated using TENS and the other half with Vojta therapy ."||||
1343120|NCT03034668|Randomized|Factorial Assignment||Other||Triple|||t||t|t
1343121|NCT03034655|Randomized|Parallel Assignment||Prevention||Double|After the first screening visit, the patients who grant their consent will be included in the study and randomised to one of the following study arms. Randomisation will be performed by C.H.U de Santiago Clinical Epidemiology and Biostatistics Unit. Once the informed consent form is signed, the care provider will contact the unit, which will give him the code of the arm to which the patient is assigned. A n= 20 block balanced randomisation sequence will be used. The investigator will analyse results and evolution, being blind type and duration of vestibular rehabilitation.|Experimental study, single-center, open, randomized (balanced blocks of patients) in four branches in parallel, in 220 elderly patients (over 65 years) with high risk of falls; follow-up period: twelve months.|||t|t
1343122|NCT03034642|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||This study will analyze both healthy subjects (never-smokers and current- or ex-smokers) in one arm, and also subjects with COPD (current- or ex-smokers).||||
1343123|NCT03034629||Single Group Assignment||Other||None (Open Label)||||||
1343124|NCT03034616|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1343125|NCT03034603|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1343126|NCT03034590|||Cohort||Prospective|||||||
1343127|NCT03034577|Randomized|Parallel Assignment||Treatment||Single||||||t
1343128|NCT03034564|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343129|NCT03034551|Randomized|Parallel Assignment||Other||Single|||||t|
1343130|NCT03034538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343131|NCT03034525|||Cohort||Retrospective|||||||
1343132|NCT03034512|||Cohort||Prospective|||||||
1343133|NCT03034499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343134|NCT03034486||Single Group Assignment||Treatment||None (Open Label)||||||
1343135|NCT03034473||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343136|NCT03034460|Randomized|Parallel Assignment||Other||Single|||||t|
1343137|NCT03034447||Single Group Assignment||Health Services Research||None (Open Label)||Sleep study and spirometric evaluation of children with asthma||||
1343138|NCT03034434|||Cohort||Prospective|||||||
1343139|NCT03034421|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343140|NCT03034408|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1343141|NCT03034395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343142|NCT03034382|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1343143|NCT03034369|||Ecologic or Community||Prospective|||||||
1343144|NCT03034356|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1343145|NCT03034343|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1343146|NCT03034330|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343147|NCT03034317|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1343148|NCT03034304||Single Group Assignment||Treatment||None (Open Label)||||||
1343149|NCT03034291|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1343150|NCT03034278|||Cohort||Prospective|||||||
1343151|NCT03034265|||Cohort||Prospective|||||||
1343152|NCT03034252|||Cohort||Retrospective|||||||
1343153|NCT03034239|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1343154|NCT03034226|Randomized|Crossover Assignment||Prevention||None (Open Label)||9 diabetic subjects and 9 healthy control subjects will be randomized to undergo either first day 1 + day 2 (two consecutive episode of hypoglycemia) or first day 3 + day 4 (one episode of hypoglycemia).||||
1343155|NCT03034213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343156|NCT03034200||Single Group Assignment||Treatment||None (Open Label)||||||
1343157|NCT03034187|||Cohort||Prospective|||||||
1343158|NCT03034174|||Cohort||Prospective|||||||
1343159|NCT03034161|||Case-Only||Prospective|||||||
1343160|NCT03034148||Single Group Assignment||Screening||None (Open Label)||||||
1343161|NCT03034135||Single Group Assignment||Treatment||None (Open Label)||||||
1343162|NCT03034122|||Cohort||Prospective|||||||
1343163|NCT03034109|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1343164|NCT03034096|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343165|NCT03034083|||Cohort||Prospective|||||||
1343166|NCT03034070||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343167|NCT03034057||Parallel Assignment||Prevention||None (Open Label)||||||
1343168|NCT03034044|||Case-Only||Retrospective|||||||
1343169|NCT03034031|||Cohort||Prospective|||||||
1343170|NCT03034018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343171|NCT03034005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1343172|NCT03033992||Single Group Assignment||Treatment||None (Open Label)||||||
1343173|NCT03033979|||Case-Only||Retrospective|||||||
1343174|NCT03033966|||Cohort||Prospective|||||||
1343175|NCT03033953|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1343176|NCT03033940|||Case-Control||Cross-Sectional|||||||
1343177|NCT03033927|||Cohort||Prospective|||||||
1343240|NCT03033108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343241|NCT03033095||Single Group Assignment||Screening||None (Open Label)||||||
1343178|NCT03033914|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Cohort B will include patients 60 years of age and older with HL (any stage). AVD (adriamycin,vinblastine, dacarbazine)|"Cohort A will include patients less than 60 years of age with advanced stage (Stage III or IV) classical Hodgkin lymphoma (HL) who are at higer risk for relapse due to baseline international prognostic score (IPS) of 3-7 or positive PET scan after 2 cycles of ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) (PET-2 positive)."||||
1343179|NCT03033901|||Cohort||Prospective|||||||
1343180|NCT03033888|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1343181|NCT03033875|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343182|NCT03033862|||Cohort||Prospective|||||||
1343183|NCT03033849||||||||||||
1343184|NCT03033836||Single Group Assignment||Treatment||None (Open Label)||Single Group receiving the same intervention, to evaluate retention at 48 weeks||||
1343185|NCT03033823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343186|NCT03033810|||Cohort||Prospective|||||||
1343187|NCT03033797|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1343188|NCT03033784|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1343189|NCT03033771||Single Group Assignment||Treatment||None (Open Label)||Dragon Study Europe is an international, multicenter, prospective, non-randomized study. It is designed to evaluate safety and performance of the MFM for the treatment of chronic type B aortic dissection. About 35 patients in up to 11 countries will be enrolled and screened per the protocol-required inclusion, exclusion criteria, in order to obtain 30 completed patients. For early demonstration of safety and performance, an interim analysis report will be performed after all patients included will complete their 6-month follow-up||||
1343190|NCT03033758|||Other||Prospective|||||||
1343191|NCT03033745|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343192|NCT03033732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343193|NCT03033719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343194|NCT03033706|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1343195|NCT03033693|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1343196|NCT03033680||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343197|NCT03033667|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1343198|NCT03033654||Single Group Assignment||Prevention||None (Open Label)||||||
1343199|NCT03033641||Single Group Assignment||Treatment||None (Open Label)||||||
1343200|NCT03033628|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1343201|NCT03033615|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1343202|NCT03033602|Randomized|Parallel Assignment||Treatment||Single||||||t
1343203|NCT03033589|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1343204|NCT03033576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343205|NCT03033563|||Case-Only||Retrospective|||||||
1343206|NCT03033550||Single Group Assignment||Prevention||None (Open Label)||||||
1343207|NCT03033537|||Case-Crossover||Prospective|||||||
1343208|NCT03033524|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343209|NCT03033511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343210|NCT03033498|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343211|NCT03033485||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343212|NCT03033472|Randomized|Parallel Assignment||Treatment||Quadruple|Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment||t|t|t|t
1343213|NCT03033459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343214|NCT03033446||Single Group Assignment||Treatment||None (Open Label)||||||
1343215|NCT03033433||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1343216|NCT03033420|Randomized|Parallel Assignment||Treatment||Single||||||t
1343217|NCT03033407|Randomized|Crossover Assignment||Treatment||None (Open Label)|It was open label study.|||||
1343218|NCT03033394|||Cohort||Prospective|||||||
1343219|NCT03033381|Randomized|Parallel Assignment||Diagnostic||Single|Statistician was masking|operated and nonoperated side testis of each patient accepted two different group.||||t
1343220|NCT03033368||Single Group Assignment||Treatment||None (Open Label)||||||
1343221|NCT03033355|||Cohort||Prospective|||||||
1343222|NCT03033342|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1343223|NCT03033329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343224|NCT03033316||Single Group Assignment||Treatment||None (Open Label)||||||
1343225|NCT03033303||Single Group Assignment||Treatment||None (Open Label)||In this phase II single arm trial, patients with HR-NB in first CR or VGPR undergo consolidation by using hu3F8/GM-CSF.||||
1343226|NCT03033290|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1343227|NCT03033277|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343228|NCT03033264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343229|NCT03033251|Randomized|Crossover Assignment||Treatment||None (Open Label)||Participants will receive 2 treatments (non invasive ventilation and high flow nasal cannula). The high flow nasal cannula will be applied with 2 flows (50 L/min and 30 L/min). The order of application of the 2 high flow sequences will be randomized (sealed opaque enveloppes).||||
1343230|NCT03033238|||Cohort||Prospective|||||||
1343231|NCT03033225||Single Group Assignment||Supportive Care||None (Open Label)||||||
1343232|NCT03033212|Randomized|Parallel Assignment||Treatment||Single|||||t|
1343233|NCT03033199|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343234|NCT03033186|||Cohort||Prospective|||||||
1343235|NCT03033173|||Case-Control||Cross-Sectional|||||||
1343236|NCT03033160|Randomized|Crossover Assignment||Treatment||None (Open Label)|Open Label|||||
1343237|NCT03033147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343238|NCT03033134||Single Group Assignment||Prevention||None (Open Label)||||||
1343239|NCT03033121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343242|NCT03033082|||Case-Control||Prospective|||||||
1343243|NCT03033069|Randomized|Parallel Assignment||Treatment||Double||||||
1343244|NCT03033056|||Case-Control||Prospective|||||||
1343245|NCT03033043||Single Group Assignment||Treatment||None (Open Label)||||||
1343246|NCT03033030|||Cohort||Prospective|||||||
1343247|NCT03033017|||Cohort||Prospective|||||||
1343248|NCT03033004|Randomized|Parallel Assignment||Treatment||Single||||||t
1343249|NCT03032991|||Case-Control||Prospective|||||||
1343250|NCT03032978|Randomized|Parallel Assignment||Treatment||Double||||t||t
1343251|NCT03032965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343252|NCT03032952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343253|NCT03032939|||Case-Only||Prospective|||||||
1343254|NCT03032926|||Case-Only||Prospective|||||||
1343255|NCT03032913|||Cohort||Prospective|||||||
1343256|NCT03032900|||Other||Prospective|||||||
1343257|NCT03032887|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1343258|NCT03032874|||Cohort||Prospective|||||||
1343259|NCT03032861||Single Group Assignment||Basic Science||None (Open Label)||||||
1343260|NCT03032848|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1343261|NCT03032835|||Cohort||Prospective|||||||
1343262|NCT03032822|||Cohort||Prospective|||||||
1343263|NCT03032809|||Other||Prospective|||||||
1343264|NCT03032796|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1343265|NCT03032783||Single Group Assignment||Treatment||None (Open Label)||||||
1343266|NCT03032770|||Cohort||Prospective|||||||
1343267|NCT03032757|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343268|NCT03032744|Randomized|Parallel Assignment||Prevention||None (Open Label)||Intervention group will receive the morning dose of their daily preventive asthma medication at school. The student & family will be responsible to administer the evening dose & both doses on non-school days.||||
1343269|NCT03032731|Randomized|Parallel Assignment||Prevention||None (Open Label)|Open label|||||
1343270|NCT03032718|Randomized|Parallel Assignment||Treatment||Single|Blinding against study arm|||||t
1343271|NCT03032705|Randomized|Parallel Assignment||Treatment||Single||||||t
1343272|NCT03032692|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1343273|NCT03032679|||Cohort||Prospective|||||||
1343274|NCT03032666||Single Group Assignment||Treatment||None (Open Label)||||||
1343275|NCT03032653|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343276|NCT03032640|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1343277|NCT03032627||Single Group Assignment||Basic Science||None (Open Label)||||||
1343278|NCT03032614||Single Group Assignment||Treatment||None (Open Label)||||||
1343279|NCT03032601|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1343280|NCT03032588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343281|NCT03032575||Single Group Assignment||Treatment||None (Open Label)||||||
1343282|NCT03032562|||Cohort||Prospective|||||||
1343283|NCT03032549|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1343284|NCT03032536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343285|NCT03032523|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1343286|NCT03032510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343287|NCT03032497||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343288|NCT03032484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343289|NCT03032471|||Cohort||Prospective|||||||
1343290|NCT03032458|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343291|NCT03032445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343292|NCT03032432|Randomized|Parallel Assignment||Treatment||Single|||||t|
1343293|NCT03032419|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1343294|NCT03032406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343295|NCT03032393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343296|NCT03032380|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1343297|NCT03032367|Randomized|Crossover Assignment||Other||None (Open Label)||"Participants are randomized to receive study drug (bedaquiline (BDQ)) in either tablet form or crushed form in one of two sequences:~Sequence 1: BDQ 4 x 100mg administered in a whole tablet form, followed by BDQ 4 x 100mg administered in crushed form as a once only dose~Sequence 2: BDQ 4 x 100mg administered in crushed form, followed by BDQ 4 x 100mg administered in tablet form as a once only dose"||||
1343298|NCT03032354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343299|NCT03032341|||Case-Control||Prospective|||||||
1343300|NCT03032328||Single Group Assignment||Treatment||None (Open Label)||||||
1343301|NCT03032315|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1343302|NCT03032302|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1343303|NCT03032289|||Ecologic or Community||Cross-Sectional|||||||
1343304|NCT03032276|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1343305|NCT03032263|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1343306|NCT03032250||Single Group Assignment||Supportive Care||None (Open Label)||||||
1343307|NCT03032237|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1343308|NCT03032224|||Cohort||Prospective|||||||
1343309|NCT03032211||Single Group Assignment||Treatment||None (Open Label)||||||
1343310|NCT03032198||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343311|NCT03032185|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1343312|NCT03032172||Single Group Assignment||Treatment||None (Open Label)||||||
1343313|NCT03032159|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1343551|NCT03029065|||Cohort||Prospective|||||||
1343314|NCT03032146|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Patients with at least a month of cardiac rehabilitation at The Emek Medical Center, Afula. Rehabilitation includes a multidisciplinary program based on physical exercise.||||
1343315|NCT03032133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343316|NCT03032120|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1343317|NCT03032107||Single Group Assignment||Treatment||None (Open Label)||||||
1343318|NCT03032094|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343319|NCT03032081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343320|NCT03032068||Single Group Assignment||Health Services Research||None (Open Label)||||||
1343321|NCT03032055|||Cohort||Prospective|||||||
1343322|NCT03032042|Randomized|Factorial Assignment||Diagnostic||Quadruple|||t|t|t|t
1343323|NCT03032029|||Cohort||Prospective|||||||
1343324|NCT03032016|||Cohort||Prospective|||||||
1343325|NCT03032003|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343326|NCT03031990|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343327|NCT03031977|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343328|NCT03031964|||Cohort||Prospective|||||||
1343329|NCT03031951|Randomized|Parallel Assignment||Prevention||Single|||t|||
1343330|NCT03031938||Single Group Assignment||Other||None (Open Label)||||||
1343331|NCT03031925|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1343332|NCT03031912|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1343333|NCT03031899|||Case-Control||Cross-Sectional|||||||
1343334|NCT03031886|Randomized|Crossover Assignment||Other||Double|Double blinded, subjects was blinded from knowing if foods were low or high GI, researchers analyzing the data were blinded from food preparation.|A randomized,crossover design with either a low or high GI diet with a 5 day washout period in between the 2 interventions..|t||t|
1343335|NCT03031873||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343336|NCT03031860|||Other||Prospective|||||||
1343337|NCT03031847|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, open-label, controlled trial of CRT-P vs. CRT-D in octogenarians||||
1343338|NCT03031834||||||||||||
1343339|NCT03031821|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1343340|NCT03031808|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1343341|NCT03031795|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1343342|NCT03031782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343343|NCT03031769|||Cohort||Cross-Sectional|||||||
1343344|NCT03031756|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1343345|NCT03031743|||Case-Control||Prospective|||||||
1343346|NCT03031730||Single Group Assignment||Treatment||None (Open Label)||||||
1343347|NCT03031717|||Cohort||Retrospective|||||||
1343348|NCT03031704|||Case-Only||Prospective|||||||
1343349|NCT03031691||Single Group Assignment||Treatment||None (Open Label)||||||
1343350|NCT03031678||Single Group Assignment||Other||None (Open Label)||||||
1343351|NCT03031665|||Case-Control||Cross-Sectional|||||||
1343352|NCT03031652|||Case-Only||Retrospective|||||||
1343353|NCT03031639|||Cohort||Prospective|||||||
1343354|NCT03031626|Randomized|Crossover Assignment||Supportive Care||Triple|The split-night polysomnograms (Arm A, Arm B) will be scored by two independent sleep technologists Three independent sleep physicians will be involved in each case; 1 to perform the initial consult in the sleep clinic, a 2nd to interpret the baseline PSG, and a 3rd to interpret the split-night PSG (with oxygen and medical air). Arm A and Arm B will be analyzed blindly.|"The screening visit will occur during a regularly scheduled clinic visit. The patients that have consented for the study will all undergo the baseline PSG. Only patients with clinically significant CSA after Visit 1 will undergo randomization and complete Visit 2.~Those who have a CAHI greater or equal to 5 will be randomly assigned to Arm A or Arm B. Randomization will be performed using a computer with random numbers drawn. Arm A will receive Medical Air followed by Oxygen and Arm B will receive Oxygen followed by Medical Air."||t|t|t
1343355|NCT03031613|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1343356|NCT03031600|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||This study will use a prospective validation design. In this design, each subject will experience both estimation methods/arms (radiodilution and hematocrit dilution) in a fixed sequence. The fixed order is necessary, as hematocrit dilution would bias the results of radiodilution by iatrogenically increasing plasma volume as part of the estimation process.||||
1343357|NCT03031587||Single Group Assignment||Other||None (Open Label)||||||
1343358|NCT03031574|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343359|NCT03031561||Single Group Assignment||Screening||None (Open Label)||||||
1343360|NCT03031548|||Case-Only||Other|||||||
1343361|NCT03031535|Randomized|Crossover Assignment||Treatment||Quadruple||"This study consists of two study parts. In Study Part 1, 12 subject will be randomized into one of four study arms using a 4x4 modified latin square design.~In Study Part 2, subjects will be randomized into one of two arms using a 2x2 crossover design."|t|t|t|t
1343362|NCT03031522|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1343363|NCT03031509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343364|NCT03031496|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1343365|NCT03031483||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1343366|NCT03031470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343367|NCT03031457|||Cohort||Prospective|||||||
1343368|NCT03031444|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343369|NCT03031431||Single Group Assignment||Supportive Care||None (Open Label)||||||
1343370|NCT03031418|||Cohort||Prospective|||||||
1343371|NCT03031405|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1343372|NCT03031392|||Case-Control||Cross-Sectional|||||||
1343373|NCT03031379|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1343374|NCT03031366|Randomized|Parallel Assignment||Treatment||None (Open Label)||TIPS creation using real-time 3D roadmap||||
1343375|NCT03031353|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1343376|NCT03031340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343377|NCT03031327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343378|NCT03031314|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1343379|NCT03031301|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343380|NCT03031288|Randomized|Crossover Assignment||Treatment||Single|||||t|
1343381|NCT03031275|Non-Randomized|Single Group Assignment||Other||Single|All investigators (radiologist, neuropsychologist, physiotherapist) were masked from all patient details other than the fact that they were treated with ECMO (ie did not know when the patient was treated, for what condition, if any side effects were seen and so on).||||t|
1343382|NCT03031262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343383|NCT03031249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343384|NCT03031236|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343385|NCT03031223|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343386|NCT03031210|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1343387|NCT03031197|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|Open Label|||||
1343388|NCT03031184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343389|NCT03031171|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1343390|NCT03031158|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1343391|NCT03031145|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1343392|NCT03031132|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1343393|NCT03031119|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1343394|NCT03031106|||Case-Only||Prospective|||||||
1343395|NCT03031093|Non-Randomized|Crossover Assignment||Supportive Care||Single||||||t
1343396|NCT03031080|Randomized|Parallel Assignment||Supportive Care||Double|Initial heath-care provider and participant are not masked as would be impossible to do so. Outcome assessor (a different health care provider) and investigators will be masked as to whether the patient is in the splinted or unsplinted cohort.|Randomised Controlled Trial - Block Randomisation|||t|t
1343397|NCT03031067|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||A matched-case analysis was developed: 10 HOPE-ECD livers and kidneys, HOPE-L and -K groups, were matched 1:3 with livers and kidneys preserved with static cold storage (SCS), SCS-L and -K groups respectively.||||
1343398|NCT03031054|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343399|NCT03031041|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343400|NCT03031028||Single Group Assignment||Treatment||None (Open Label)||||||
1343401|NCT03031015|Randomized|Parallel Assignment||Treatment||Quadruple|blinded|Patients with proximal phalangeal fractures of fingers.|t|t|t|t
1343402|NCT03031002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343403|NCT03030989|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1343404|NCT03030976|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1343405|NCT03030963|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1343406|NCT03030950|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343407|NCT03030937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343408|NCT03030924|||Cohort||Prospective|||||||
1343409|NCT03030911|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1343410|NCT03030898||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343411|NCT03030885||Single Group Assignment||Treatment||None (Open Label)||This is a Phase 1, open-label, single-arm, dose ascending, out-patient study to evaluate the radiopharmaceutical 131I-MIP-1095 in men with mCRPC. The study consists of three phases: Screening, Treatment, and a Follow-up Phase. The Screening Phase consists of subject evaluation for study eligibility and dosimetry assessment. The Treatment Phase consists of two parts: Part 1, dose escalation (Cohorts 1-5), and Part 2, an additional cohort at a selected optimized dose based on safety and efficacy.||||
1343412|NCT03030872|||Case-Only||Retrospective|||||||
1343413|NCT03030859|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343414|NCT03030846|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343415|NCT03030833|||Cohort||Prospective|||||||
1343416|NCT03030820||Single Group Assignment||Prevention||None (Open Label)||||||
1343417|NCT03030807|||Cohort||Prospective|||||||
1343418|NCT03030794|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343419|NCT03030781|||Cohort||Retrospective|||||||
1343420|NCT03030768|||Cohort||Prospective|||||||
1343421|NCT03030755|||Cohort||Prospective|||||||
1343422|NCT03030742|||Cohort||Prospective|||||||
1343423|NCT03030729|||Other||Prospective|||||||
1343424|NCT03030716|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1343425|NCT03030703||Single Group Assignment||Prevention||None (Open Label)||||||
1343426|NCT03030690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343427|NCT03030677|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343428|NCT03030664|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1343429|NCT03030651|Randomized|Parallel Assignment||Other||Double|||t|||t
1343430|NCT03030638|||Cohort||Cross-Sectional|||||||
1343431|NCT03030625||Single Group Assignment||Treatment||None (Open Label)||||||
1343432|NCT03030612||Single Group Assignment||Treatment||None (Open Label)||||||
1343433|NCT03030599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343434|NCT03030586|||Cohort||Prospective|||||||
1343435|NCT03030573||Single Group Assignment||Treatment||None (Open Label)||||||
1343436|NCT03030560|Randomized|Parallel Assignment||Treatment||Double|Double Blind|||t|t|
1343437|NCT03030547|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343438|NCT03030534|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Participants are assigned to two groups. that is two locations (study centres) will be selected for the study||||
1343439|NCT03030521|||Cohort||Prospective|||||||
1343440|NCT03030508|||Case-Control||Prospective|||||||
1343441|NCT03030495|||Cohort||Prospective|||||||
1343442|NCT03030482|Randomized|Parallel Assignment||Prevention||Single||||||t
1343443|NCT03030469|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343444|NCT03030456|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343445|NCT03030443|||Cohort||Prospective|||||||
1343446|NCT03030430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343447|NCT03030417||Single Group Assignment||Treatment||None (Open Label)||||||
1343448|NCT03030404|||Case-Only||Prospective|||||||
1343449|NCT03030391||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343450|NCT03030378||Single Group Assignment||Treatment||None (Open Label)||||||
1343451|NCT03030365|||Case-Control||Cross-Sectional|||||||
1343452|NCT03030352|Randomized|Parallel Assignment||Prevention||Single||||||t
1343453|NCT03030339|||Cohort||Prospective|||||||
1343454|NCT03030326|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1343455|NCT03030313||Single Group Assignment||Prevention||None (Open Label)||||||
1343456|NCT03030300||Single Group Assignment||Treatment||None (Open Label)||||||
1343457|NCT03030287||Single Group Assignment||Treatment||None (Open Label)||||||
1343458|NCT03030274||Single Group Assignment||Treatment||None (Open Label)||||||
1343459|NCT03030261||Single Group Assignment||Treatment||None (Open Label)||||||
1343460|NCT03030248|Randomized|Parallel Assignment||Treatment||Triple|The allocation status of patients within this study will be held in sealed envelopes by the research pharmacist on the team. Neither the main care provider, study physicians, or the patient will know of their group, until either the end of the study (after data analysis).|Patients will be divided into two groups, one receiving oral vancomycin capsules, the other receiving oral placebo capsules.|t|t|t|
1343461|NCT03030235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343462|NCT03030222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343463|NCT03030209|||Cohort||Prospective|||||||
1343464|NCT03030196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343465|NCT03030183||Single Group Assignment||Treatment||None (Open Label)||||||
1343466|NCT03030170|Randomized|Parallel Assignment||Other||None (Open Label)||intervention with reinforced medical device, or not||||
1343467|NCT03030157|Randomized|Parallel Assignment||Treatment||Single||||||t
1343468|NCT03030144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343469|NCT03030131||Single Group Assignment||Treatment||None (Open Label)||||||
1343470|NCT03030118|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1343471|NCT03030105|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1343472|NCT03030092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343473|NCT03030079||Single Group Assignment||Treatment||None (Open Label)||||||
1343474|NCT03030066||Single Group Assignment||Basic Science||None (Open Label)||||||
1343475|NCT03030053|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1343476|NCT03030040|Randomized|Parallel Assignment||Treatment||Single|Random allocation of participants to arms will be conducted by a statistician independent of the study.||||t|
1343477|NCT03030027|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1343478|NCT03030014|Randomized|Parallel Assignment||Prevention||Single||||||t
1343479|NCT03030001||Single Group Assignment||Treatment||None (Open Label)||||||
1343480|NCT03029988|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)|Open Label|Injection and imaging will begin with Cohort 1. Cohort 1 and Cohort 2 will receive tilmanocept intravenously.||||
1343481|NCT03029975|Randomized|Parallel Assignment||Basic Science||Double||This study will consist of two groups: one group will be asked to consume 2x the RDA of protein during the 10 week intervention, while the other group will be asked to consume the RDA for protein. Both groups will receive 10 weeks of the same resistance training intervention.|||t|t
1343482|NCT03029962|Randomized|Parallel Assignment||Prevention||Single|||t|||
1343483|NCT03029949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343484|NCT03029936|||Other||Cross-Sectional|||||||
1343485|NCT03029923|Randomized|Parallel Assignment||Other||Single||||||t
1343486|NCT03029910|Randomized|Parallel Assignment||Treatment||Single|||||t|
1343487|NCT03029897|Randomized|Parallel Assignment||Other||None (Open Label)||clusters||||
1343488|NCT03029884|Randomized|Single Group Assignment||Treatment||Single|There will be assigned active intervention and non-active intervention periods for each patient throughout phase 2 and 3 of the study. The participant will not know if he/she is in the active or non-active period of the phase.|All participants (phantom limb and thalamic pain) will participate in the same three phase study.|t|||
1343489|NCT03029871||Sequential Assignment||Treatment||None (Open Label)||Nine subjects (3 cohorts, 3 subjects/cohort)||||
1343490|NCT03029858|||Case-Only||Other|||||||
1343491|NCT03029845|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343492|NCT03029832|Randomized|Parallel Assignment||Treatment||None (Open Label)|The study design has been amended in that the study blinding will not be maintained.|||||
1343493|NCT03029819|Randomized|Parallel Assignment||Treatment||Single||||||t
1343494|NCT03029806|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Heathy volunteers||||
1343495|NCT03029793|||Cohort||Prospective|||||||
1343496|NCT03029780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343497|NCT03029767|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343498|NCT03029754|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1343499|NCT03029741||Single Group Assignment||Treatment||None (Open Label)||||||
1343500|NCT03029728|||Cohort||Prospective|||||||
1343501|NCT03029715|Randomized|Crossover Assignment||Other||Double|||t|||t
1343502|NCT03029702|Randomized|Parallel Assignment||Treatment||Single|Study team members assessing delivery outcomes will be masked to the participant's study assignment|Pilot randomized controlled study||||t
1343503|NCT03029689|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1343504|NCT03029676|Randomized|Parallel Assignment||Treatment||Single|the participant is not performed about the type of premedication performed||t|||
1343505|NCT03029663|||Cohort||Prospective|||||||
1343506|NCT03029650|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1343507|NCT03029637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343508|NCT03029624||Single Group Assignment||Treatment||None (Open Label)||||||
1343509|NCT03029611||Single Group Assignment||Treatment||None (Open Label)||||||
1343510|NCT03029598||Single Group Assignment||Treatment||None (Open Label)||||||
1343511|NCT03029585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343512|NCT03029572|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343513|NCT03029559|Randomized|Factorial Assignment||Treatment||Single|"We will use a Latin square, repeated measures design which will consist of 12 subjects participating in the following four experimental conditions: There will be an interval of 1 week between each of the four conditions, which will serve as a washout period.~IH+ITL: Subjects will be exposed to a session of IH (45 minutes, 2 minutes of hypoxia alternating with 1 minute of hyperoxia) followed by 5 sets of ITL at 80%MIP (10 breaths per set).~IH: Subjects will only be exposed to a session of intermittent hypoxia.~Sham IH +ITL: Subjects will be exposed to a single 45-minute session of sham IH (normoxia). This will consist of the subject breathing room air (FiO2=21%) through a 4 way valve connected to the hypoxicator. Exposure to normoxia will be followed by 5 sets of ITL at 80%MIP (10 breaths per set).~Sham IH: Subjects will be exposed to a single 45-minute session of sham IH (normoxia) alone."|Latin square, repeated measures design to study the effects of IH administered alone and in combination with inspiratory threshold loading on the above stated respiratory parameters.|t|||
1343514|NCT03029546|||Other||Prospective|||||||
1343515|NCT03029533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343516|NCT03029520|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343517|NCT03029507|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343518|NCT03029494|Randomized|Parallel Assignment||Diagnostic||Single|It will be a single-blind interventional study (as placebo splint cannot be mistaken for a stabilization splint by a clinician).|"TMD patients will be randomized into two treatment groups. Each group will have two sets of interventions: one presumably active treatment and other a placebo:~Treatment group 1: stabilization splint and placebo tablet daily. Treatment group 2: placebo (ineffectively designed) splint and 1000 mg Vitamin C tablet (an antioxidant agent) daily."|t|||
1343519|NCT03029481||||||||||||
1343520|NCT03029468|Randomized|Single Group Assignment||Treatment||None (Open Label)||Three-arm feasibility trial||||
1343521|NCT03029455|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1343522|NCT03029442|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1343523|NCT03029429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343524|NCT03029416|Randomized|Parallel Assignment||Treatment||None (Open Label)||30 Gy single fraction SBRT 18 Gy x three fractions||||
1343525|NCT03029403|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343526|NCT03029390|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343527|NCT03029377|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343528|NCT03029364|||Cohort||Cross-Sectional|||||||
1343529|NCT03029351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343530|NCT03029338||Single Group Assignment||Treatment||None (Open Label)||||||
1343531|NCT03029325|||Case-Control||Prospective|||||||
1343532|NCT03029312|Randomized|Parallel Assignment||Treatment||None (Open Label)||Paired randomized controlled study||||
1343533|NCT03029299|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1343534|NCT03029286|Randomized|Parallel Assignment||Prevention||Single|||t|||
1343535|NCT03029273||Single Group Assignment||Treatment||None (Open Label)||"One arm, open label, dose escalation, single dose phase I study of safety and tolerability.~NYESO-1 TCR-T cell are prepared via lentiviral infection. DLT was administered in a dose escalation test according to the 3 + 3 design. Three days prior to infusion of TCR-T cell, subjects receive cyclophosphamide treatment at dose 1 g/day for 2 days and take a rest for one day before infusion.~Patients, who receive an infusion of TAEST16001, will remain in the hospital to be monitored for adverse events until they have recovered from the treatment.~Patients will have frequent follow-up visit to monitor the persistence of modified T cells and efficacy of the treatment."||||
1343536|NCT03029260|Randomized|Parallel Assignment||Other||Single||||||t
1343537|NCT03029247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343538|NCT03029234||Single Group Assignment||Treatment||None (Open Label)||||||
1343539|NCT03029221|||Cohort||Prospective|||||||
1343540|NCT03029208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343541|NCT03029195|Randomized|Parallel Assignment||Treatment||Single||||||t
1343542|NCT03029182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343543|NCT03029169|Randomized|Parallel Assignment||Treatment||Single|Provided by a dedicated study nurse||||t|
1343544|NCT03029156|Randomized|Parallel Assignment||Treatment||Single||||||t
1343545|NCT03029143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343546|NCT03029130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343547|NCT03029117|||Cohort||Prospective|||||||
1343548|NCT03029104|Randomized|Parallel Assignment||Treatment||Single|Visual acuity will be evaluated by an observer who is masked as to the treatment protocol to which study subjects have been assigned.|||||t
1343549|NCT03029091||Single Group Assignment||Treatment||None (Open Label)||This study is an open-label study, which means that all participants receive the study medicine.||||
1343550|NCT03029078||Single Group Assignment||Treatment||None (Open Label)||Pilot study of patients colonized by either CRE or GRE will be enrolled in order to evaluate the impact of fecal microbiota transplant on the eradication of XDR bacteria colonization||||
1343552|NCT03029052|Randomized|Parallel Assignment||Treatment||None (Open Label)||Monocenter, randomized, controlled, pilot study.||||
1343553|NCT03029039|||Case-Control||Prospective|||||||
1343554|NCT03029026|||Cohort||Prospective|||||||
1343555|NCT03029013||Single Group Assignment||Treatment||None (Open Label)||||||
1343556|NCT03029000||Single Group Assignment||Treatment||None (Open Label)||||||
1343557|NCT03028987|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1343558|NCT03028974|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1343559|NCT03028961|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1343560|NCT03028948|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343561|NCT03028935||Single Group Assignment||Prevention||None (Open Label)||||||
1343562|NCT03028922||Single Group Assignment||Treatment||None (Open Label)||||||
1343563|NCT03028909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343564|NCT03028896|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1343565|NCT03028883|||Cohort||Retrospective|||||||
1343566|NCT03028870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343567|NCT03028857|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1343568|NCT03028844|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1343569|NCT03028831|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1343570|NCT03028818|||Cohort||Prospective|||||||
1343571|NCT03028805|Randomized|Factorial Assignment||Treatment||Single|||t|||
1343572|NCT03028792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343573|NCT03028779||Single Group Assignment||Other||None (Open Label)||||||
1343574|NCT03028766|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343575|NCT03028753||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343576|NCT03028740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343577|NCT03028727|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343578|NCT03028714|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343579|NCT03028701||Single Group Assignment||Treatment||None (Open Label)||||||
1343580|NCT03028688|Randomized|Parallel Assignment||Prevention||Single||||||t
1343581|NCT03028675|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||10 patients and 10 age-matched control volunteers||||
1343582|NCT03028662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343583|NCT03028649|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1343584|NCT03028636|||Cohort||Prospective|||||||
1343585|NCT03028623|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343586|NCT03028610||Single Group Assignment||Treatment||None (Open Label)||||||
1343587|NCT03028597|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1343588|NCT03028584|||Case-Only||Prospective|||||||
1343589|NCT03028571|Randomized|Crossover Assignment||Basic Science||Single||Subjects will be studied twice, randomly assigned to star on the intact day (saline) or the blocked day (trimethaphan) and after 1 month cross to the other arm|t|||
1343590|NCT03028558|||Case-Control||Prospective|||||||
1343591|NCT03028545|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343592|NCT03028532||Single Group Assignment||Basic Science||None (Open Label)||||||
1343593|NCT03028519||Single Group Assignment||Treatment||None (Open Label)||||||
1343594|NCT03028506|||Cohort||Retrospective|||||||
1343595|NCT03028493|Non-Randomized|Sequential Assignment||Prevention||Single|Three individuals not involved in intervention delivery will complete pre-post measures.|||||t
1343596|NCT03028480|||Case-Only||Prospective|||||||
1343597|NCT03028467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343598|NCT03028454|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1343599|NCT03028441|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1343600|NCT03028428|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind|A Randomized, Double Blind, Phase-II Study Assessing the Safety and Efficacy of Intraarticular Ex-vivo Cultured Adult Allogeneic Mesenchymal Stem Cells in Patients with Osteoarthritis of Knee|t|t|t|t
1343601|NCT03028415|Randomized|Parallel Assignment||Treatment||Single||||||t
1343602|NCT03028402|||Case-Control||Prospective|||||||
1343603|NCT03028389|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1343604|NCT03028376|||Cohort||Prospective|||||||
1343605|NCT03028363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343606|NCT03028350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343607|NCT03028337|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343608|NCT03028324||Single Group Assignment||Other||None (Open Label)||||||
1343609|NCT03028311|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343610|NCT03028298|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomly assigned to either low dose sildenafil (20mg oral and 10mg intravenous) or high dose sildenafil (60mg oral and 30 mg intravenous)||||
1343611|NCT03028285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343612|NCT03028272|Randomized|Parallel Assignment||Treatment||Single|Participant will be blinded to the type of barrier received.||t|||
1343613|NCT03028259|||Cohort||Retrospective|||||||
1343614|NCT03028246||Single Group Assignment||Treatment||None (Open Label)||||||
1343615|NCT03028233|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343616|NCT03028220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343617|NCT03028207|||Cohort||Cross-Sectional|||||||
1343618|NCT03028194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343619|NCT03028181|||Other||Retrospective|||||||
1343620|NCT03028168|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1343621|NCT03028155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343622|NCT03028142|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1343623|NCT03028129|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1343624|NCT03028116|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1343625|NCT03028103||Single Group Assignment||Treatment||None (Open Label)||||||
1343626|NCT03028090|||Case-Only||Prospective|||||||
1343627|NCT03028077|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1343628|NCT03028064|||Cohort||Prospective|||||||
1343629|NCT03028051|||Cohort||Prospective|||||||
1343630|NCT03028038|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1343631|NCT03028025|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1343632|NCT03028012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343633|NCT03027999|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343634|NCT03027986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343635|NCT03027973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343636|NCT03027960|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1343637|NCT03027947||Single Group Assignment||Treatment||None (Open Label)||||||
1343638|NCT03027934|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1343639|NCT03027921||Single Group Assignment||Screening||None (Open Label)||||||
1343640|NCT03027908|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1343641|NCT03027895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343642|NCT03027882|||Other||Other|||||||
1343643|NCT03027869|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1343644|NCT03027856||Single Group Assignment||Other||None (Open Label)||||||
1343645|NCT03027843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343646|NCT03027830|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1343647|NCT03027817|||Cohort||Prospective|||||||
1343648|NCT03027804|||Other||Other|||||||
1343649|NCT03027791||Single Group Assignment||Health Services Research||None (Open Label)||||||
1343650|NCT03027778|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343651|NCT03027765|||Other||Cross-Sectional|||||||
1343652|NCT03027752|Randomized|Single Group Assignment||Treatment||Single|||t|||
1343653|NCT03027739||Single Group Assignment||Treatment||None (Open Label)||||||
1343654|NCT03027726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343655|NCT03027713|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1343656|NCT03027700|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1343657|NCT03027687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343658|NCT03027674|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1343659|NCT03027661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343660|NCT03027648||Single Group Assignment||Treatment||None (Open Label)||||||
1343661|NCT03027635|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343662|NCT03027622|||Cohort||Prospective|||||||
1343663|NCT03027609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343664|NCT03027596|Randomized|Parallel Assignment||Prevention||Single|||t|||
1343665|NCT03027583|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1343666|NCT03027570|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1343667|NCT03027557|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1343668|NCT03027544||Single Group Assignment||Treatment||None (Open Label)||||||
1343669|NCT03027531|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1343670|NCT03027518|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1343671|NCT03027505||Single Group Assignment||Treatment||None (Open Label)||||||
1343672|NCT03027492|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343673|NCT03027479|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1343674|NCT03027466|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343675|NCT03027453|||Cohort||Prospective|||||||
1343676|NCT03027440|||Cohort||Retrospective|||||||
1343677|NCT03027427|||Case-Only||Prospective|||||||
1343678|NCT03027414|||Case-Only||Prospective|||||||
1343679|NCT03027401|||Case-Only||Prospective|||||||
1343680|NCT03027388||Sequential Assignment||Basic Science||None (Open Label)||||||
1343681|NCT03027375|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1343682|NCT03027362|Randomized|Parallel Assignment||Treatment||Single||||||t
1343683|NCT03027349|||Case-Control||Retrospective|||||||
1343684|NCT03027336|Randomized|Parallel Assignment||Treatment||Quadruple||"The study included two arms: a treatment arm with dietary supplement (Coleosoma) and a placebo arm.~Coleosoma is the name of a new patented dietary supplement composed by Berberin 200 mg, Fermented Red Rice from Monascus purpureus 100 mg (correspondiing at 3 mg of monacolin K), Chitosan 100 mg e Q10 Coenzyme10 mg"|t|t|t|t
1343685|NCT03027323|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1343686|NCT03027310|||Cohort||Prospective|||||||
1343687|NCT03027284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1343688|NCT03027258||Single Group Assignment||Other||None (Open Label)||||||
1343689|NCT03027245|||Cohort||Prospective|||||||
1343690|NCT03027232|||Other||Other|||||||
1343691|NCT03027219|||Case-Only||Prospective|||||||
1343692|NCT03027206|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343693|NCT03027193|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343694|NCT03027180|Randomized|Crossover Assignment||Treatment||Single||||||t
1343695|NCT03027167|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343696|NCT03027154|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1343697|NCT03027141|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343698|NCT03027128||Single Group Assignment||Treatment||None (Open Label)||||||
1343699|NCT03027115|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomization to 1 of 2 possible arms, control and treatment||||
1343700|NCT03027102|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343701|NCT03027089|||Cohort||Prospective|||||||
1343702|NCT03027076|||Cohort||Prospective|||||||
1343703|NCT03027063|Randomized|Parallel Assignment||Treatment||Single||||||t
1343704|NCT03027050|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1343705|NCT03027037|||Cohort||Prospective|||||||
1343706|NCT03027024||Single Group Assignment||Treatment||None (Open Label)||||||
1343707|NCT03027011|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1343708|NCT03026998||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343709|NCT03026985|||Cohort||Prospective|||||||
1343710|NCT03026972|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343711|NCT03026959|Randomized|Parallel Assignment||Prevention||Single|||t|||
1343712|NCT03026946|Randomized|Parallel Assignment||Treatment||Single||||||t
1343713|NCT03026933|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343714|NCT03026920||Single Group Assignment||Treatment||None (Open Label)||||||
1343715|NCT03026907|Randomized|Parallel Assignment||Treatment||Single||||||t
1343716|NCT03026894|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1343717|NCT03026881||Single Group Assignment||Treatment||None (Open Label)||||||
1343718|NCT03026868||Single Group Assignment||Treatment||None (Open Label)||||||
1343719|NCT03026855||Single Group Assignment||Supportive Care||None (Open Label)||||||
1343720|NCT03026842|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343721|NCT03026829||Single Group Assignment||Treatment||None (Open Label)||||||
1343722|NCT03026816||Single Group Assignment||Treatment||None (Open Label)|Masking is done during formal testing of BMCA|All subjects will receive study intervention. Outcome assessments will be tested while the stimulator unit is on (intervention) and off (sham) during the study.||||
1343723|NCT03026803||Single Group Assignment||Treatment||None (Open Label)||||||
1343724|NCT03026790|Randomized|Factorial Assignment||Treatment||Single||||||t
1343725|NCT03026777|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343726|NCT03026764|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1343727|NCT03026751|||Case-Only||Prospective|||||||
1343728|NCT03026738|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343729|NCT03026725|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343730|NCT03026712|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343731|NCT03026699|||Case-Control||Retrospective|||||||
1343732|NCT03026686|||Cohort||Retrospective|||||||
1343733|NCT03026673|||Cohort||Retrospective|||||||
1343734|NCT03026660|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1343735|NCT03026647|||Cohort||Retrospective|||||||
1343736|NCT03026634|||Cohort||Prospective|||||||
1343737|NCT03026621|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1343738|NCT03026608|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1343739|NCT03026595|||Other||Cross-Sectional|||||||
1343740|NCT03026582|||Cohort||Prospective|||||||
1343741|NCT03026569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343742|NCT03026556|||Cohort||Retrospective|||||||
1343743|NCT03026543|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1343744|NCT03026530|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1343745|NCT03026517||Single Group Assignment||Treatment||None (Open Label)||||||
1343746|NCT03026504||Single Group Assignment||Treatment||None (Open Label)||||||
1343747|NCT03026491|||Cohort||Prospective|||||||
1343748|NCT03026478|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343749|NCT03026465|Randomized|Parallel Assignment||Treatment||Single||||||t
1343750|NCT03026452||Single Group Assignment||Treatment||None (Open Label)||||||
1343751|NCT03026439|||Case-Control||Cross-Sectional|||||||
1343752|NCT03026426|Randomized|Parallel Assignment||Treatment||Single|||||t|
1343753|NCT03026413|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343754|NCT03026400|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343755|NCT03026387||Single Group Assignment||Other||None (Open Label)||||||
1343756|NCT03026374|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1343757|NCT03026361|||Cohort||Prospective|||||||
1343758|NCT03026348|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1343759|NCT03026335|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343760|NCT03026322|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343761|NCT03026309|||Cohort||Prospective|||||||
1343762|NCT03026296||Single Group Assignment||Prevention||None (Open Label)||||||
1343763|NCT03026283||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343764|NCT03026270|Randomized|Crossover Assignment||Treatment||Single|||t|||
1343765|NCT03026257|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1343766|NCT03026244|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1343767|NCT03026231|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343768|NCT03026218|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343769|NCT03026205||Single Group Assignment||Other||None (Open Label)||||||
1343770|NCT03026192|||Cohort||Prospective|||||||
1343771|NCT03026179||Single Group Assignment||Health Services Research||None (Open Label)||||||
1343772|NCT03026166|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343773|NCT03026153|Randomized|Parallel Assignment||Screening||Single|||t|||
1344071|NCT03022266|Randomized|Parallel Assignment||Other||Single|||||t|
1343774|NCT03026140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343775|NCT03026127|Randomized|Parallel Assignment||Prevention||Single||||||t
1343776|NCT03026114|||Case-Only||Prospective|||||||
1343777|NCT03026101||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343778|NCT03026088||Single Group Assignment||Treatment||None (Open Label)||||||
1343779|NCT03026075||Single Group Assignment||Screening||None (Open Label)||||||
1343780|NCT03026062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343781|NCT03026049|Randomized|Parallel Assignment||Treatment||Single||||||t
1343782|NCT03026036|||Case-Control||Cross-Sectional|||||||
1343783|NCT03026023||Single Group Assignment||Prevention||None (Open Label)||||||
1343784|NCT03026010|||Cohort||Prospective|||||||
1343785|NCT03025997|Randomized|Crossover Assignment||Prevention||Single|||t|||
1343786|NCT03025984|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343787|NCT03025971||Single Group Assignment||Treatment||None (Open Label)||||||
1343788|NCT03025958||Single Group Assignment||Treatment||None (Open Label)||||||
1343789|NCT03025945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343790|NCT03025932|||Case-Only||Retrospective|||||||
1343791|NCT03025919|||Other||Cross-Sectional|||||||
1343792|NCT03025906|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343793|NCT03025893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343794|NCT03025880||Single Group Assignment||Treatment||None (Open Label)||||||
1343795|NCT03025867||||||||||||
1343796|NCT03025854|||Cohort||Prospective|||||||
1343797|NCT03025841||Single Group Assignment||Treatment||None (Open Label)||||||
1343798|NCT03025828||Single Group Assignment||Treatment||None (Open Label)||||||
1343799|NCT03025815|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1343800|NCT03025802|||Cohort||Prospective|||||||
1343801|NCT03025789||Single Group Assignment||Treatment||None (Open Label)||||||
1343802|NCT03025776|||Cohort||Prospective|||||||
1343803|NCT03025763|||Other||Other|||||||
1343804|NCT03025750|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1343805|NCT03025737|||Case-Control||Prospective|||||||
1343806|NCT03025724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343807|NCT03025711|||Cohort||Retrospective|||||||
1343808|NCT03025698|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343809|NCT03025685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343810|NCT03025672|||Case Control||Retrospective|||||||
1343811|NCT03025659|||Cohort||Prospective|||||||
1343812|NCT03025646|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1343813|NCT03025633|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343814|NCT03025620|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1343815|NCT03025607|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343816|NCT03025594|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343817|NCT03025581|Randomized|Parallel Assignment||||None (Open Label)||||||
1343818|NCT03025568|Randomized|Parallel Assignment||||Triple|||t|t|t|
1343819|NCT03025555|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1343820|NCT03025542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343821|NCT03025529|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)|In the single group pilot study, there is no intervention and no masking-- just obtaining an MRI and a cerebellocortical inhibition measure. There were 8 subjects in this phase of the study. There were no subjects enrolled in the crossover design phase of this study.|This is a crossover design with two groups, preceded by a separate single group of healthy controls in a pilot study to assess feasibility of obtaining the cerebellocortical inhibition measure||||
1343822|NCT03025516|||Cohort||Prospective|||||||
1343823|NCT03025503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343824|NCT03025490|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1343825|NCT03025477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343826|NCT03025464||Single Group Assignment||Screening||None (Open Label)||||||
1343827|NCT03025451||Single Group Assignment||Treatment||None (Open Label)||||||
1343828|NCT03025438|||Case-Only||Retrospective|||||||
1343829|NCT03025425||Single Group Assignment||Treatment||None (Open Label)||||||
1343830|NCT03025412|Randomized|Parallel Assignment||Treatment||Single||||||t
1343831|NCT03025399|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343832|NCT03025386||Single Group Assignment||Other||None (Open Label)||||||
1343833|NCT03025373|||Case-Control||Prospective|||||||
1343834|NCT03025360||||||||||||
1343835|NCT03025347|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1343836|NCT03025334|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1343837|NCT03025321|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343838|NCT03025308|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1343839|NCT03025295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343840|NCT03025282|Randomized|Single Group Assignment||Treatment||Single|||||t|
1343841|NCT03025269|||Case-Only||Prospective|||||||
1343842|NCT03025256||Single Group Assignment||Treatment||None (Open Label)||||||
1343843|NCT03025243|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1343844|NCT03025230|Randomized|Parallel Assignment||Treatment||Single|||||t|
1343845|NCT03025217||Single Group Assignment||Treatment||None (Open Label)||||||
1343846|NCT03025204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343847|NCT03025191||Single Group Assignment||Supportive Care||None (Open Label)||||||
1343848|NCT03025178||Single Group Assignment||Other||None (Open Label)||||||
1343849|NCT03025165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343850|NCT03025152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343851|NCT03025139|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343852|NCT03025126|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1343853|NCT03025113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343854|NCT03025100|||Cohort||Prospective|||||||
1343855|NCT03025087|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343856|NCT03025074|||Cohort||Cross-Sectional|||||||
1343857|NCT03025061|||Other||Prospective|||||||
1343858|NCT03025048|||Cohort||Prospective|||||||
1343859|NCT03025035||Single Group Assignment||Treatment||None (Open Label)||||||
1343860|NCT03025022||Single Group Assignment||Other||None (Open Label)||||||
1343861|NCT03025009|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1343862|NCT03024996|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343863|NCT03024983|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1343864|NCT03024970||||||||||||
1343865|NCT03024957|Randomized|Parallel Assignment||Treatment||Double||||t||t
1343866|NCT03024944||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343867|NCT03024931|||Cohort||Prospective|||||||
1343868|NCT03024918|||Cohort||Prospective|||||||
1343869|NCT03024905|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1343870|NCT03024892|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343871|NCT03024879|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1343872|NCT03024866|||Cohort||Prospective|||||||
1343873|NCT03024853|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343874|NCT03024840|Randomized|Parallel Assignment||Prevention||Single|||t|||
1343875|NCT03024827||Single Group Assignment||Treatment||None (Open Label)||||||
1343876|NCT03024814|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1343877|NCT03024801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343878|NCT03024788|||Cohort||Prospective|||||||
1343879|NCT03024775|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1343880|NCT03024762|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The intervention assessed is the targeted Provider-Initiated Testing and Counselling (tPITC) whereby HIV positive parents receiving HIV services in the hospital are invited to have their children of unknown HIV status tested for HIV. The control arm is the blanket Provider-Initiated Testing and Counselling (bPITC) whereby all children consulting in the hospital (and with unknown HIV status) are invited to test for HIV and this irrespective of the presenting complaint. The study is assessing in the same hospital the effectiveness of tPITC vs bPITC.||||
1343881|NCT03024749|||Cohort||Prospective|||||||
1343882|NCT03024736|||Cohort||Retrospective|||||||
1343883|NCT03024723|||Cohort||Prospective|||||||
1343884|NCT03024710|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1343885|NCT03024697|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1343886|NCT03024684|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1343887|NCT03024671||Single Group Assignment||Other||None (Open Label)||||||
1343888|NCT03024658|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1343889|NCT03024645|Randomized|Parallel Assignment||Prevention||Single|||||t|
1343890|NCT03024632|||Cohort||Retrospective|||||||
1343891|NCT03024619|||Cohort||Retrospective|||||||
1343892|NCT03024606|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343893|NCT03024593|Randomized|Parallel Assignment||Basic Science||||||||
1343894|NCT03024580|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343895|NCT03024567|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1343896|NCT03024554||Single Group Assignment||Treatment||None (Open Label)||||||
1343897|NCT03024541|||Cohort||Prospective|||||||
1343898|NCT03024528|||Cohort||Prospective|||||||
1343899|NCT03024515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343900|NCT03024502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343901|NCT03024489||Single Group Assignment||Treatment||None (Open Label)||||||
1343902|NCT03024476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343903|NCT03024463|||Case-Only||Prospective|||||||
1343904|NCT03024450|||Cohort||Prospective|||||||
1343905|NCT03024437|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1343906|NCT03024424|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1343907|NCT03024411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343908|NCT03024398|||Cohort||Prospective|||||||
1343909|NCT03024385|||Cohort||Prospective|||||||
1343910|NCT03024372|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343911|NCT03024359|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||All subjects receive a dietary intervention with olive oil.||||
1343912|NCT03024333|||Other||Cross-Sectional|||||||
1343913|NCT03024320|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343914|NCT03024307|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343915|NCT03024294||Single Group Assignment||Supportive Care||None (Open Label)||||||
1343916|NCT03024281|||Case-Only||Retrospective|||||||
1343917|NCT03024268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343918|NCT03024255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343919|NCT03024242||Single Group Assignment||Prevention||None (Open Label)||||||
1343920|NCT03024229||Single Group Assignment||Health Services Research||None (Open Label)||Metabolic assessment in Urine and perfusion liquids||||
1343921|NCT03024216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343922|NCT03024203|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343923|NCT03024190|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1343924|NCT03024177|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1343925|NCT03024164|||Case-Only||Prospective|||||||
1343926|NCT03024151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343927|NCT03024138|||Cohort||Prospective|||||||
1343928|NCT03024125|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343929|NCT03024112|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1343930|NCT03024099|Randomized|Factorial Assignment||Treatment||Single||||||t
1343931|NCT03024086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343932|NCT03024073|||Cohort||Prospective|||||||
1343933|NCT03024060|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1343934|NCT03024047|||||Retrospective|||||||
1343935|NCT03024034|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1343936|NCT03024021|||Cohort||Prospective|||||||
1343937|NCT03024008||Single Group Assignment||Treatment||None (Open Label)||||||
1343938|NCT03023995|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343939|NCT03023982|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1343940|NCT03023969|Randomized|Parallel Assignment||Treatment||Single||||||t
1343941|NCT03023956|||Cohort||Retrospective|||||||
1343942|NCT03023943||Single Group Assignment||Treatment||None (Open Label)||||||
1343943|NCT03023930||Single Group Assignment||Health Services Research||None (Open Label)|Note: Care Providers and Research Associates are masked during Baseline Evaluation Period|||||
1343944|NCT03023917|Randomized|Parallel Assignment||Prevention||Single||||||t
1343945|NCT03023904||Single Group Assignment||Treatment||None (Open Label)||||||
1343946|NCT03023891||Single Group Assignment||Other||None (Open Label)||||||
1343947|NCT03023878||Single Group Assignment||Treatment||None (Open Label)||||||
1343948|NCT03023865||Single Group Assignment||Treatment||None (Open Label)||||||
1343949|NCT03023852|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1343950|NCT03023839|||Cohort||Prospective|||||||
1343951|NCT03023826|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1343952|NCT03023813|Randomized|Parallel Assignment||Prevention||None (Open Label)|Only the 2 arm round(s) will be randomized.|Multiple round pilot testing. Some round(s) will have a single group with 1 arm. Other round(s) will be parallel with 2 arms.||||
1343953|NCT03023800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343954|NCT03023787|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1343955|NCT03023774||Single Group Assignment||Treatment||None (Open Label)||||||
1343956|NCT03023761|Non-Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1343957|NCT03023748||Single Group Assignment||Treatment||None (Open Label)||||||
1343958|NCT03023735|||Family-Based||Prospective|||||||
1343959|NCT03023722||Single Group Assignment||Treatment||None (Open Label)||||||
1343960|NCT03023709|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||3-5 participants will receive quadrivalent inactivated flu (IIV4) vaccine as a pilot study to establish protocols for immune cell isolation. Once the pilot study ends, all new participants will receive live, attenuated influenza vaccine and IIV4 will no longer be utilitzed.||||
1343961|NCT03023696|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343962|NCT03023683|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1343963|NCT03023670|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1343964|NCT03023657||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343965|NCT03023644|Randomized|Parallel Assignment||Other||Single||||||t
1343966|NCT03023631||Single Group Assignment||Prevention||None (Open Label)||||||
1343967|NCT03023618|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343968|NCT03023605|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1343969|NCT03023592||Single Group Assignment||Treatment||None (Open Label)||||||
1343970|NCT03023579||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343971|NCT03023566|||Cohort||Prospective|||||||
1343972|NCT03023553|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1343973|NCT03023540|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1343974|NCT03023527|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343975|NCT03023514|Randomized|||||||||||
1343976|NCT03023501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1343977|NCT03023488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343978|NCT03023475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343979|NCT03023462|Randomized|Parallel Assignment||Treatment||Double||||t||t
1343980|NCT03023449|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1343981|NCT03023436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343982|NCT03023423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343983|NCT03023410|||Cohort||Prospective|||||||
1343984|NCT03023397|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1343985|NCT03023384|||Other||Prospective|||||||
1343986|NCT03023371|||Cohort||Prospective|||||||
1343987|NCT03023358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1343988|NCT03023345||Single Group Assignment||Treatment||None (Open Label)||||||
1343989|NCT03023332|Randomized|Parallel Assignment||Other||Double||||t||t
1343990|NCT03023319||Single Group Assignment||Treatment||None (Open Label)||||||
1343991|NCT03023306|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1343992|NCT03023293|||Cohort||Prospective|||||||
1343993|NCT03023280|||Cohort||Prospective|||||||
1343994|NCT03023267|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1343995|NCT03023254|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1343996|NCT03023241||Single Group Assignment||Diagnostic||None (Open Label)||||||
1343997|NCT03023228||Single Group Assignment||Health Services Research||None (Open Label)||||||
1343998|NCT03023215|Randomized|Parallel Assignment||Treatment||Single|||t|||
1343999|NCT03023202|||Case-Only||Prospective|||||||
1344000|NCT03023189|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344001|NCT03023176||Single Group Assignment||Basic Science||None (Open Label)||||||
1344002|NCT03023163|||Case-Control||Cross-Sectional|||||||
1344003|NCT03023150|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344004|NCT03023137|Randomized|Parallel Assignment||Prevention||Single|Participants were not blinded, but visits of the two groups were scheduled so as to not coincide..|||||t
1344005|NCT03023124|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344006|NCT03023111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344007|NCT03023098|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344008|NCT03023085||Single Group Assignment||Treatment||None (Open Label)||||||
1344009|NCT03023072|||Case-Control||Prospective|||||||
1344010|NCT03023059||Single Group Assignment||Treatment||None (Open Label)||||||
1344011|NCT03023046||Single Group Assignment||Treatment||None (Open Label)||||||
1344012|NCT03023033|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344013|NCT03023020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344014|NCT03023007||Single Group Assignment||Treatment||None (Open Label)||||||
1344015|NCT03022994|||Case-Control||Prospective|||||||
1344016|NCT03022981|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344017|NCT03022968|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1344018|NCT03022955|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1344019|NCT03022942|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1344020|NCT03022929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344021|NCT03022916||Single Group Assignment||||None (Open Label)||||||
1344022|NCT03022903||Single Group Assignment||Treatment||None (Open Label)||||||
1344023|NCT03022890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344024|NCT03022877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344025|NCT03022864|||Case Control||Prospective|||||||
1344026|NCT03022851||Single Group Assignment||Treatment||None (Open Label)||||||
1344027|NCT03022838|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1344028|NCT03022825||Single Group Assignment||Treatment||None (Open Label)||||||
1344029|NCT03022812|Randomized|Parallel Assignment||Treatment||Single||||||t
1344030|NCT03022799|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1344031|NCT03022786|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344032|NCT03022773||Single Group Assignment||Other||None (Open Label)||||||
1344033|NCT03022760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344034|NCT03022747|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344035|NCT03022734||Single Group Assignment||Treatment||None (Open Label)||||||
1344036|NCT03022721|||Cohort||Prospective|||||||
1344037|NCT03022708||Single Group Assignment||Treatment||None (Open Label)||||||
1344038|NCT03022695||Single Group Assignment||Treatment||None (Open Label)||||||
1344039|NCT03022682|||Cohort||Prospective|||||||
1344040|NCT03022669|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344041|NCT03022656|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1344042|NCT03022643|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1344043|NCT03022630|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344044|NCT03022617||Single Group Assignment||Treatment||None (Open Label)||||||
1344045|NCT03022604|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1344046|NCT03022591|||Cohort||Retrospective|||||||
1344047|NCT03022578||Single Group Assignment||Treatment||None (Open Label)||||||
1344048|NCT03022565||Single Group Assignment||Treatment||None (Open Label)||||||
1344049|NCT03022552|||Cohort||Prospective|||||||
1344050|NCT03022539|||Cohort||Prospective|||||||
1344051|NCT03022526|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1344052|NCT03022513|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344053|NCT03022500||Single Group Assignment||Treatment||None (Open Label)||||||
1344054|NCT03022487|||Cohort||Prospective|||||||
1344055|NCT03022474|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344056|NCT03022461|||Cohort||Prospective|||||||
1344057|NCT03022448|||Case-Only||Prospective|||||||
1344058|NCT03022435|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1344059|NCT03022422|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1344060|NCT03022409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344061|NCT03022396|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1344062|NCT03022383||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344063|NCT03022370|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1344064|NCT03022357|||Cohort||Prospective|||||||
1344065|NCT03022344|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1344066|NCT03022331|||Cohort||Prospective|||||||
1344067|NCT03022318|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344068|NCT03022305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344069|NCT03022292||Single Group Assignment||Other||None (Open Label)||||||
1344070|NCT03022279|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1344072|NCT03022253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344073|NCT03022240|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344074|NCT03022227|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1344075|NCT03022214|Randomized|Crossover Assignment||Other||Double|||t||t|
1344076|NCT03022201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344077|NCT03022188|||Cohort||Prospective|||||||
1344078|NCT03022175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344079|NCT03022162|||Cohort||Prospective|||||||
1344080|NCT03022149|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344081|NCT03022136||Single Group Assignment||Other||None (Open Label)||||||
1344082|NCT03022123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344083|NCT03022110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344084|NCT03022097|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344085|NCT03022084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344086|NCT03022071|Randomized|Parallel Assignment||Treatment||Single||||||t
1344087|NCT03022058||Single Group Assignment||Other||None (Open Label)||||||
1344088|NCT03022045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344089|NCT03022032|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344090|NCT03022019|Randomized|Parallel Assignment||Treatment||||||||
1344091|NCT03022006||Single Group Assignment||Treatment||None (Open Label)||||||
1344092|NCT03021993||Single Group Assignment||Treatment||None (Open Label)||||||
1344093|NCT03021980|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344094|NCT03021967|||Cohort||Other|||||||
1344095|NCT03021954|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1344096|NCT03021941||Parallel Assignment||Other||None (Open Label)||||||
1344097|NCT03021928|Randomized|Parallel Assignment||Prevention||Single||||||t
1344098|NCT03021915||Single Group Assignment||Treatment||None (Open Label)||||||
1344099|NCT03021902|Randomized|Parallel Assignment||Treatment||Single||||||t
1344100|NCT03021889|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1344101|NCT03021876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344102|NCT03021863|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1344103|NCT03021850|Randomized|Crossover Assignment||Treatment||Single||||||t
1344104|NCT03021837|||Other||Retrospective|||||||
1344105|NCT03021824|||Cohort||Other|||||||
1344106|NCT03021811||Single Group Assignment||Treatment||None (Open Label)||||||
1344107|NCT03021798|||Cohort||Prospective|||||||
1344108|NCT03021785|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344109|NCT03021772|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1344110|NCT03021759|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1344111|NCT03021746|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344112|NCT03021733|||Cohort||Prospective|||||||
1344113|NCT03021720|Randomized|Parallel Assignment||||Single|||t|||
1344114|NCT03021707||||||||||||
1344115|NCT03021694|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1344116|NCT03021681||Single Group Assignment||Treatment||None (Open Label)||||||
1344117|NCT03021668|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344118|NCT03021655|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344119|NCT03021642|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344120|NCT03021629|||Case-Control||Prospective|||||||
1344121|NCT03021616|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1344122|NCT03021603|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1344123|NCT03021590|Randomized|Parallel Assignment||Treatment||Single||||||t
1344124|NCT03021577|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1344125|NCT03021564|||Cohort||Prospective|||||||
1344126|NCT03021551||||||||||||
1344127|NCT03021538|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344128|NCT03021525|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344129|NCT03021512|||Cohort||Retrospective|||||||
1344130|NCT03021499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344131|NCT03021486|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344132|NCT03021473|||Cohort||Prospective|||||||
1344133|NCT03021460||Single Group Assignment||Treatment||None (Open Label)||||||
1344134|NCT03021447|||Cohort||Prospective|||||||
1344135|NCT03021434|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344136|NCT03021421|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344137|NCT03021408|Randomized|Parallel Assignment||Treatment||Single||||||t
1344138|NCT03021395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344139|NCT03021382|||Cohort||Retrospective|||||||
1344140|NCT03021369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344141|NCT03021356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344142|NCT03021343|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344143|NCT03021330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344144|NCT03021317||Single Group Assignment||Treatment||None (Open Label)||||||
1344145|NCT03021304||Single Group Assignment||Treatment||None (Open Label)||||||
1344146|NCT03021291||Single Group Assignment||Treatment||None (Open Label)||||||
1344147|NCT03021278|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1344148|NCT03021265|||Cohort||Prospective|||||||
1344149|NCT03021252|Randomized|Parallel Assignment||Treatment||Single||||||t
1344150|NCT03021239|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344151|NCT03021226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344152|NCT03021213|||Cohort||Prospective|||||||
1344153|NCT03021200|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344154|NCT03021187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344155|NCT03021174|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344156|NCT03021161|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1344157|NCT03021148|||Cohort||Prospective|||||||
1344158|NCT03021135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344159|NCT03021122|Randomized|Crossover Assignment||Treatment||Single|"Blinding to the purpose of the study during recruitment will be maintained to minimize preparation bias. Nurses will be unblinded when the simulated scenario start."||t|||
1344160|NCT03021109||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344161|NCT03021096|||Cohort||Prospective|||||||
1344162|NCT03021083||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344163|NCT03021070|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1344164|NCT03021057||Single Group Assignment||Treatment||None (Open Label)||||||
1344165|NCT03021044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344166|NCT03021031|||Cohort||Prospective|||||||
1344167|NCT03021018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344168|NCT03021005|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1344169|NCT03020992||Single Group Assignment||Treatment||None (Open Label)||||||
1344170|NCT03020979||Single Group Assignment||Treatment||None (Open Label)||||||
1344171|NCT03020966|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344172|NCT03020953|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1344173|NCT03020940|||Case-Only||Retrospective|||||||
1344174|NCT03020927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344175|NCT03020914|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344176|NCT03020901|||Case-Only||Retrospective|||||||
1344177|NCT03020888||Single Group Assignment||Treatment||None (Open Label)||||||
1344178|NCT03020875|Randomized|Parallel Assignment||Treatment||Single|||||t|
1344179|NCT03020862|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1344180|NCT03020849|||Cohort||Prospective|||||||
1344181|NCT03020836|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1344182|NCT03020823||Single Group Assignment||Treatment||None (Open Label)||||||
1344183|NCT03020810||||||||||||
1344184|NCT03020797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344185|NCT03020784|Randomized|||Treatment||Double|||t||t|
1344186|NCT03020771|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1344187|NCT03020758|Randomized|Crossover Assignment||Prevention||Single|||||t|
1344188|NCT03020745|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1344189|NCT03020732|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1344190|NCT03020719|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1344191|NCT03020706|Randomized|Parallel Assignment||||Double|||t|t||
1344192|NCT03020693|Randomized|Parallel Assignment||Treatment||Single|||||t|
1344193|NCT03020680|Randomized|Crossover Assignment||||Double|||t||t|
1344194|NCT03020667|||Cohort||Prospective|||||||
1344195|NCT03020654|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344196|NCT03020641|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1344197|NCT03020628|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1344198|NCT03020615|Randomized|Parallel Assignment||Treatment||Single|||||t|
1344199|NCT03020602||Single Group Assignment||Treatment||None (Open Label)||||||
1344200|NCT03020589|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344201|NCT03020576|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1344202|NCT03020563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344203|NCT03020550|||Cohort||Prospective|||||||
1344204|NCT03020537|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1344205|NCT03020524|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344206|NCT03020511||Single Group Assignment||Other||None (Open Label)||||||
1344207|NCT03020498|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1344208|NCT03020485|Randomized|Crossover Assignment||||Single|||t|||
1344209|NCT03020472||Single Group Assignment||Basic Science||None (Open Label)||||||
1344210|NCT03020459|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344211|NCT03020446||Single Group Assignment||Treatment||None (Open Label)||||||
1344212|NCT03020433|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1344213|NCT03020420|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1344214|NCT03020407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344215|NCT03020394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344216|NCT03020381|||Cohort||Prospective|||||||
1344217|NCT03020368|Randomized|Parallel Assignment||Treatment||Single||||||t
1344218|NCT03020355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344219|NCT03020342|||Case-Only||Prospective|||||||
1344220|NCT03020329||Single Group Assignment||Treatment||None (Open Label)||||||
1344221|NCT03020316|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344222|NCT03020303|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1344223|NCT03020290|||Case-Only||Prospective|||||||
1344224|NCT03020277||Single Group Assignment||||None (Open Label)||||||
1344225|NCT03020264||Single Group Assignment||Other||None (Open Label)||||||
1344226|NCT03020251|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344227|NCT03020238|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1344228|NCT03020225|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344229|NCT03020212|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344230|NCT03020199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344231|NCT03020186|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344232|NCT03020173|||Case Control||Prospective|||||||
1344233|NCT03020160|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344234|NCT03020147|||Cohort||Retrospective|||||||
1344235|NCT03020134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344236|NCT03020121||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344237|NCT03020108|||Cohort||Prospective|||||||
1344238|NCT03020095||Single Group Assignment||Treatment||None (Open Label)||||||
1344239|NCT03020082||Single Group Assignment||Treatment||None (Open Label)||||||
1344240|NCT03020069|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1344241|NCT03020056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344242|NCT03020043|||Cohort||Prospective|||||||
1344243|NCT03020030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344244|NCT03020017||Single Group Assignment||Treatment||None (Open Label)||||||
1344245|NCT03020004||Single Group Assignment||Treatment||None (Open Label)||||||
1344246|NCT03019991|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344247|NCT03019978||Single Group Assignment||Health Services Research||None (Open Label)||||||
1344248|NCT03019965|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1344249|NCT03019952||Single Group Assignment||Health Services Research||None (Open Label)||||||
1344250|NCT03019939||Single Group Assignment||Treatment||None (Open Label)||||||
1344251|NCT03019926|||Cohort||Prospective|||||||
1344252|NCT03019913|||Cohort||Prospective|||||||
1344253|NCT03019900|||||Cross-Sectional|||||||
1344254|NCT03019887||Single Group Assignment||Treatment||None (Open Label)||||||
1344255|NCT03019874|||Cohort||Prospective|||||||
1344256|NCT03019861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344257|NCT03019848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344258|NCT03019835|Randomized|Parallel Assignment||Other||Single|||t|||
1344259|NCT03019822|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1344260|NCT03019809||Single Group Assignment||Treatment||None (Open Label)||||||
1344261|NCT03019796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344262|NCT03019783|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1344263|NCT03019770||Single Group Assignment||Health Services Research||None (Open Label)||||||
1344264|NCT03019757|||Cohort||Cross-Sectional|||||||
1344265|NCT03019744|Randomized|Parallel Assignment||Treatment||Single||||||t
1344266|NCT03019731||Single Group Assignment||Treatment||None (Open Label)||||||
1344267|NCT03019718||Single Group Assignment||Treatment||None (Open Label)||||||
1344268|NCT03019705|||Case-Only||Prospective|||||||
1344269|NCT03019692|||Cohort||Retrospective|||||||
1344270|NCT03019679|||Case-Control||Prospective|||||||
1344271|NCT03019666|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344272|NCT03019653|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1344273|NCT03019640||Single Group Assignment||Treatment||None (Open Label)||||||
1344274|NCT03019627|Randomized|Parallel Assignment||Treatment||Double|The identity of the treatments was concealed from the patient, Investigator, site staff, and Dompé's clinical research personnel until the study was unmasked for the final statistical analysis (after data base lock) except in case of specific events that required unmasking of the patient.||t||t|
1344275|NCT03019614|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344276|NCT03019601||Single Group Assignment||Health Services Research||None (Open Label)||||||
1344277|NCT03019588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344278|NCT03019575||Single Group Assignment||Treatment||None (Open Label)||||||
1344279|NCT03019562|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344280|NCT03019549|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1344281|NCT03019536|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1344282|NCT03019523|Randomized|Crossover Assignment||Other||Double|||t||t|
1344283|NCT03019510|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1344284|NCT03019497|Randomized|Parallel Assignment||Treatment||Single||||||t
1344285|NCT03019484|Non-Randomized|Parallel Assignment||||Single|||t|||
1344286|NCT03019471|||Cohort||Prospective|||||||
1344287|NCT03019458|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344288|NCT03019432|||Cohort||Cross-Sectional|||||||
1344289|NCT03019419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344290|NCT03019406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344291|NCT03019393||Single Group Assignment||Basic Science||None (Open Label)||||||
1344292|NCT03019380||Single Group Assignment||Treatment||None (Open Label)||||||
1344293|NCT03019367|Randomized|Parallel Assignment||Prevention||Triple|"It is not possible to blind the delivering obstetrician, however all other caregivers will be blinded. The procedure will be documented as placental transfusion in the delivery summary or admission-progress notes and all study assessments whether primary (head US) or secondary (neurodevelopmental exams) will be performed by blinded team members."|||t|t|t
1344294|NCT03019354|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344295|NCT03019341|||Cohort||Prospective|||||||
1344296|NCT03019328|||Cohort||Prospective|||||||
1344297|NCT03019315|||Cohort|||||||||
1344298|NCT03019302||Single Group Assignment||Supportive Care||None (Open Label)||||||
1344299|NCT03019289||Single Group Assignment||Other||None (Open Label)||||||
1344300|NCT03019276||Single Group Assignment||Treatment||None (Open Label)||||||
1344301|NCT03019263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344302|NCT03019250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344303|NCT03019237|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1344304|NCT03019224|Randomized|Factorial Assignment||Treatment||Double||||t|t|
1344305|NCT03019211|Randomized|Parallel Assignment||Treatment||Single||||||t
1344306|NCT03019198|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1344307|NCT03019185|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344308|NCT03019172|Randomized|Parallel Assignment||Treatment||Double||Randomized controlled trial, double blind allocation concealment|t||t|
1344309|NCT03019159|||Case Control||Prospective|||||||
1344310|NCT03019146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344311|NCT03019133|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344312|NCT03019120||Single Group Assignment||Treatment||None (Open Label)||||||
1344313|NCT03019107||||||||||||
1344314|NCT03019094||Single Group Assignment||Treatment||None (Open Label)||||||
1344315|NCT03019081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344316|NCT03019068|||Other||Retrospective|||||||
1344317|NCT03019055||Sequential Assignment||Treatment||None (Open Label)||The study will have a Dose Escalation Phase and a Dose Expansion Phase. The first participants will be enrolled on the Dose Escalation Phase. Once the goal dose level is determine the Dose Expansion Phase will open to enrollment and will include patient ages ≥18 and ≤70 years.||||
1344318|NCT03019042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344319|NCT03019029||Single Group Assignment||Diagnostic||None (Open Label)||Participants with biopsy proven peripheral nerve amyloidosis will undergo an F-18 Florbetapir PET/MR scan||||
1344320|NCT03019016|||Cohort||Retrospective|||||||
1344321|NCT03019003||Single Group Assignment||Treatment||None (Open Label)||||||
1344322|NCT03018990|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1344323|NCT03018977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344324|NCT03018964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344325|NCT03018951|||Cohort||Cross-Sectional|||||||
1344326|NCT03018938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344327|NCT03018925|||Case-Only||Prospective|||||||
1344328|NCT03018912|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1344329|NCT03018899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344330|NCT03018886|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1344331|NCT03018873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344332|NCT03018860|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344333|NCT03018847|||Case-Only||Other|||||||
1344334|NCT03018834|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344335|NCT03018821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344336|NCT03018808|||Other||Cross-Sectional|||||||
1344337|NCT03018795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344338|NCT03018782|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1344339|NCT03018769|||||Prospective|||||||
1344340|NCT03018756|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1344341|NCT03018743|||Case-Only||Prospective|||||||
1344342|NCT03018730||Single Group Assignment||Treatment||None (Open Label)||||||
1344343|NCT03018717|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344344|NCT03018704|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344345|NCT03018691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344346|NCT03018678|||Cohort||Prospective|||||||
1344347|NCT03018665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344348|NCT03018652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344349|NCT03018639|||Case-Only||Prospective|||||||
1344350|NCT03018626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344351|NCT03018613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344352|NCT03018600|||Cohort||Prospective|||||||
1344353|NCT03018587||Single Group Assignment||Treatment||None (Open Label)||||||
1344354|NCT03018574|||Case-Control||Retrospective|||||||
1344355|NCT03018561|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1344356|NCT03018548||Single Group Assignment||||None (Open Label)||||||
1344357|NCT03018535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344358|NCT03018522|||Cohort||Prospective|||||||
1344359|NCT03018509|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344360|NCT03018496|Randomized|Crossover Assignment||Prevention||Single|||t|||
1344361|NCT03018483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344362|NCT03018470|||Cohort||Prospective|||||||
1344363|NCT03018457|||Cohort||Prospective|||||||
1344364|NCT03018444|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1344365|NCT03018431|||Cohort||Prospective|||||||
1344366|NCT03018418||Single Group Assignment||Treatment||None (Open Label)||||||
1344367|NCT03018405|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"The maximum number of patients to be enrolled is 146:~36 in the dose escalation segment (cohorts 1-6, 18 per arm),~24 in the additional cohorts 8-11 (12 per arm),~86 patients in the Phase I expansion segment (note that the analysis of this segment will also include a maximum of 12 additional patients from the dose escalation segment)."||||
1344368|NCT03018392||Single Group Assignment||Treatment||None (Open Label)||||||
1344369|NCT03018379|||Cohort||Cross-Sectional|||||||
1344370|NCT03018366|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344371|NCT03018353||Single Group Assignment||Treatment||None (Open Label)||||||
1344372|NCT03018340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344373|NCT03018327|||Case-Control||Prospective|||||||
1344374|NCT03018314|||Cohort||Prospective|||||||
1344375|NCT03018301|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1344376|NCT03018288|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344377|NCT03018275||Single Group Assignment||Treatment||None (Open Label)||||||
1344378|NCT03018262|||Case-Only||Prospective|||||||
1344379|NCT03018249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344380|NCT03018236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344381|NCT03018223||Single Group Assignment||Prevention||None (Open Label)||||||
1344382|NCT03018210|||Cohort||Prospective|||||||
1344383|NCT03018197|Randomized|Parallel Assignment||||None (Open Label)||||||
1344384|NCT03018184|||Case-Only||Cross-Sectional|||||||
1344385|NCT03018171|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344386|NCT03018158|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1344387|NCT03018145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344388|NCT03018132||Single Group Assignment||Screening||None (Open Label)||||||
1344389|NCT03018119|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344390|NCT03018106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344391|NCT03018093||Single Group Assignment||Treatment||None (Open Label)||||||
1344392|NCT03018080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344393|NCT03018067|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344394|NCT03018054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344395|NCT03018041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344396|NCT03018028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344397|NCT03018015|Randomized|Crossover Assignment||||None (Open Label)||||||
1344398|NCT03018002|Randomized|Parallel Assignment||||None (Open Label)||||||
1344399|NCT03017989||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344400|NCT03017976|||Case-Crossover||Cross-Sectional|||||||
1344401|NCT03017963||Single Group Assignment||Treatment||None (Open Label)||||||
1344402|NCT03017950|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344403|NCT03017937||Single Group Assignment||Other||None (Open Label)||||||
1344404|NCT03017924|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344405|NCT03017911|||Cohort||Prospective|||||||
1344406|NCT03017898||Single Group Assignment||Treatment||None (Open Label)||||||
1344407|NCT03017885|||Cohort||Other|||||||
1344408|NCT03017872|Randomized|Parallel Assignment||Treatment||None (Open Label)||A third arm has been incorporated using a multi-arm, multi-stage (MAMS) design. This design allows for the 2-arm study (DTG+DRV/r vs DRV/r+2NRTI) to continue accrual while preparation of the new arm (DTG+2NRTI) is begun in parallel. Once that arm is ready, accrual to it begins and the study switches to the second stage. All participants accrued to Arm 1 and 2 throughout the trial are contemporaneous and can be compared, while the subjects accrued to Arm 3 are compared only to their contemporaries in Arms 1 and 2. The size of Arm 3 is sufficient to allow adequate power comparisons, and stage effects are minimized while non-contemporaneous control data are not required.||||
1344409|NCT03017859||Single Group Assignment||Treatment||None (Open Label)||||||
1344410|NCT03017846||Single Group Assignment||Treatment||None (Open Label)||||||
1344411|NCT03017833||Single Group Assignment||Treatment||None (Open Label)||||||
1344412|NCT03017820||Single Group Assignment||Treatment||None (Open Label)||||||
1344413|NCT03017807||Single Group Assignment||Treatment||None (Open Label)||||||
1344414|NCT03017794|||Cohort||Prospective|||||||
1344415|NCT03017781|||Case-Control||Prospective|||||||
1344416|NCT03017768|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1344417|NCT03017755|||Cohort||Prospective|||||||
1344418|NCT03017742||||||||||||
1344419|NCT03017729|||Cohort||Prospective|||||||
1344420|NCT03017716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344421|NCT03017703|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1344422|NCT03017690|||Cohort||Cross-Sectional|||||||
1344423|NCT03017677|||Other||Prospective|||||||
1344424|NCT03017664|||Cohort||Prospective|||||||
1344425|NCT03017651|Randomized|Crossover Assignment||Other||Single|||t|||
1344426|NCT03017638|||Case-Control||Prospective|||||||
1344427|NCT03017625|||Cohort||Prospective|||||||
1344428|NCT03017612||Single Group Assignment||Treatment||None (Open Label)||||||
1344429|NCT03017599||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344430|NCT03017586|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344431|NCT03017573||Single Group Assignment||Basic Science||None (Open Label)||||||
1344432|NCT03017560|Randomized|Parallel Assignment||Treatment||Single||||||t
1344433|NCT03017547|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1344434|NCT03017534|Randomized|Parallel Assignment||Treatment||Single||||||t
1344435|NCT03017521||Single Group Assignment||Treatment||None (Open Label)||||||
1344436|NCT03017508|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1344437|NCT03017495||Single Group Assignment||Other||None (Open Label)||||||
1344438|NCT03017482|||Case-Only||Prospective|||||||
1344439|NCT03017469|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344440|NCT03017456|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1344441|NCT03017443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344442|NCT03017430|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344443|NCT03017417|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344444|NCT03017404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344445|NCT03017391|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344446|NCT03017378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344447|NCT03017365|Randomized|Parallel Assignment||Treatment||Single||||||t
1344448|NCT03017352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344449|NCT03017339|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344450|NCT03017326|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1344451|NCT03017313|||Cohort||Prospective|||||||
1344452|NCT03017300|Randomized|Parallel Assignment||Treatment||Single|||||t|
1344453|NCT03017287||Single Group Assignment||Treatment||None (Open Label)||||||
1344454|NCT03017274|||Case Control||Prospective|||||||
1344455|NCT03017261||Single Group Assignment||Treatment||None (Open Label)||||||
1344456|NCT03017248|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344457|NCT03017235|Randomized|Parallel Assignment||Other||Single||||||t
1344458|NCT03017222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344459|NCT03017209|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344460|NCT03017196|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344461|NCT03017183|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1344462|NCT03017170|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1344463|NCT03017157|||Cohort||Prospective|||||||
1344464|NCT03017144|||Case-Only||Cross-Sectional|||||||
1344465|NCT03017131||Single Group Assignment||Treatment||None (Open Label)||||||
1344466|NCT03017118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344467|NCT03017105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344468|NCT03017092||Single Group Assignment||Other||None (Open Label)||||||
1344469|NCT03017079|Randomized|Parallel Assignment||Prevention||Single|||t|||
1344470|NCT03017066|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344471|NCT03017053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344472|NCT03017040|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344473|NCT03017027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344474|NCT03017014|||Cohort||Prospective|||||||
1344475|NCT03017001|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1344476|NCT03016988||Single Group Assignment||Treatment||None (Open Label)||||||
1344477|NCT03016975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344478|NCT03016962|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1344479|NCT03016949|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344480|NCT03016936|||Cohort||Prospective|||||||
1344481|NCT03016923||Single Group Assignment||Treatment||None (Open Label)||||||
1344482|NCT03016910|||Cohort||Prospective|||||||
1344483|NCT03016897|||Case-Control||Prospective|||||||
1344484|NCT03016884|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344485|NCT03016871||Single Group Assignment||Treatment||None (Open Label)||||||
1344486|NCT03016858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344487|NCT03016845|||Case-Only||Prospective|||||||
1344488|NCT03016832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344489|NCT03016819|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344490|NCT03016806|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344491|NCT03016793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344492|NCT03016780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344493|NCT03016767|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344494|NCT03016754|||Cohort||Prospective|||||||
1344495|NCT03016741|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344496|NCT03016728|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344497|NCT03016715|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1344498|NCT03016702|Non-Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1344499|NCT03016689|||Case-Only||Prospective|||||||
1344500|NCT03016676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344501|NCT03016663|||Case Control||Prospective|||||||
1344502|NCT03016650|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344503|NCT03016637||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344504|NCT03016624|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344505|NCT03016611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344506|NCT03016598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344507|NCT03016585|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344508|NCT03016572|Randomized|Crossover Assignment||Treatment||Double||||t|t|
1344509|NCT03016559||Single Group Assignment||Other||None (Open Label)||||||
1344510|NCT03016546|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344511|NCT03016533||Single Group Assignment||Treatment||None (Open Label)||||||
1344512|NCT03016520|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1344513|NCT03016507|||||Cross-Sectional|||||||
1344514|NCT03016494|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1344515|NCT03016481|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1344516|NCT03016468||Single Group Assignment||Treatment||None (Open Label)||||||
1344517|NCT03016455|||Case-Control||Prospective|||||||
1344518|NCT03016442|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344519|NCT03016429|||Cohort||Prospective|||||||
1344520|NCT03016416|||Case Control||Cross-Sectional|||||||
1344521|NCT03016403|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344522|NCT03016390|||Case-Crossover||Prospective|||||||
1344523|NCT03016377||Single Group Assignment||Treatment||None (Open Label)||||||
1344524|NCT03016364||Single Group Assignment||Treatment||None (Open Label)||||||
1344525|NCT03016351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344526|NCT03016338||Single Group Assignment||Treatment||None (Open Label)||||||
1344527|NCT03016325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344528|NCT03016312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344529|NCT03016299|||Cohort|||||||||
1344530|NCT03016286||Single Group Assignment||Basic Science||None (Open Label)||||||
1344531|NCT03016273|Randomized|Parallel Assignment||Prevention||Single|||t|||
1344532|NCT03016260|||Cohort||Prospective|||||||
1344533|NCT03016247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344534|NCT03016234|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1344535|NCT03016221|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1344536|NCT03016208|||Cohort|||||||||
1344537|NCT03016195|||Cohort||Cross-Sectional|||||||
1344538|NCT03016182|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1344539|NCT03016169||Single Group Assignment||Treatment||None (Open Label)||||||
1344540|NCT03016156|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1344541|NCT03016143|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1344542|NCT03016130|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344543|NCT03016117||Single Group Assignment||Treatment||None (Open Label)||||||
1344544|NCT03016104|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344545|NCT03016091||Single Group Assignment||Treatment||None (Open Label)||||||
1344546|NCT03016078||Single Group Assignment||Treatment||None (Open Label)||||||
1344547|NCT03016065|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1344548|NCT03016052||Single Group Assignment||Treatment||None (Open Label)||||||
1344549|NCT03016039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344550|NCT03016026||Single Group Assignment||Treatment||None (Open Label)||||||
1344551|NCT03016013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344552|NCT03016000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344553|NCT03015987|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344554|NCT03015974|||Case-Only||Prospective|||||||
1344555|NCT03015961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344556|NCT03015948|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1344557|NCT03015935|||Cohort||Prospective|||||||
1344558|NCT03015922||Single Group Assignment||Treatment||None (Open Label)||||||
1344559|NCT03015909||Single Group Assignment||Treatment||None (Open Label)||||||
1344560|NCT03015896||Single Group Assignment||Treatment||None (Open Label)||||||
1344561|NCT03015883||Single Group Assignment||Treatment||None (Open Label)||||||
1344562|NCT03015870|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344563|NCT03015857|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344564|NCT03015844||||||||||||
1344565|NCT03015831|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1344566|NCT03015818||Single Group Assignment||Other||None (Open Label)||||||
1344567|NCT03015805|Randomized|Parallel Assignment||Treatment||Single||||||t
1344568|NCT03015792||Single Group Assignment||Treatment||None (Open Label)||||||
1344569|NCT03015779||Single Group Assignment||Treatment||None (Open Label)||||||
1344570|NCT03015766|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1344571|NCT03015753|Randomized|Parallel Assignment||Treatment||Single||||||t
1344572|NCT03015740||Single Group Assignment||Treatment||None (Open Label)||||||
1344573|NCT03015727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344574|NCT03015714|Randomized|Parallel Assignment||Treatment||Single||||||t
1344575|NCT03015701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344576|NCT03015688|||Case Control||Cross-Sectional|||||||
1344577|NCT03015675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344578|NCT03015662|Randomized|Parallel Assignment||Treatment||Single||||||t
1344579|NCT03015649||Single Group Assignment||Health Services Research||None (Open Label)||||||
1344580|NCT03015636|Randomized|Parallel Assignment||Treatment||Single|||||t|
1344581|NCT03015623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344582|NCT03015610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344583|NCT03015597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344584|NCT03015584|||Cohort||Prospective|||||||
1344585|NCT03015571|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1344586|NCT03015558|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344587|NCT03015545|Randomized|Crossover Assignment||Treatment||Single||||||t
1344588|NCT03015532|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344589|NCT03015519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344590|NCT03015506|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1344591|NCT03015493|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1344592|NCT03015480||Single Group Assignment||Health Services Research||None (Open Label)||||||
1344593|NCT03015467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344594|NCT03015454|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1344595|NCT03015441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344596|NCT03015428||Single Group Assignment||||None (Open Label)||||||
1344597|NCT03015415|Randomized|Parallel Assignment||Treatment||Single||||||t
1344598|NCT03015402|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1344599|NCT03015389|||Cohort||Cross-Sectional|||||||
1344600|NCT03015376|||Cohort||Prospective|||||||
1344601|NCT03015363|||Case-Control||Prospective|||||||
1344602|NCT03015350|||Case-Control||Prospective|||||||
1344603|NCT03015337||Single Group Assignment||||None (Open Label)||||||
1344604|NCT03015324||Single Group Assignment||Treatment||None (Open Label)||||||
1344605|NCT03015311|Randomized|Parallel Assignment||Treatment||Single||||||t
1344606|NCT03015298|||Cohort||Prospective|||||||
1344607|NCT03015285|Randomized|Parallel Assignment||Treatment||Single||||||t
1344608|NCT03015272|Randomized|Parallel Assignment||Treatment||Single||||||t
1344609|NCT03015259|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344610|NCT03015246|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344611|NCT03015233|||Case-Only||Prospective|||||||
1344612|NCT03015220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344613|NCT03015207|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1344614|NCT03015194||Single Group Assignment||Treatment||None (Open Label)||||||
1344615|NCT03015181|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344616|NCT03015168|||Case-Only||Retrospective|||||||
1344617|NCT03015155|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1344618|NCT03015142|||Cohort||Prospective|||||||
1344619|NCT03015129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344620|NCT03015116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344621|NCT03015103||Single Group Assignment||||Single|||t|||
1344622|NCT03015090||Single Group Assignment||||None (Open Label)||||||
1344623|NCT03015077|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1344624|NCT03015064|||Cohort||Prospective|||||||
1344625|NCT03015051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344626|NCT03015038|||Cohort||Prospective|||||||
1344627|NCT03015025|||Cohort||Prospective|||||||
1344628|NCT03015012|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344629|NCT03014999|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1344630|NCT03014986|||Case-Only||Prospective|||||||
1344631|NCT03014973|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344632|NCT03014960|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344633|NCT03014947|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1344634|NCT03014934|||Case-Control||Prospective|||||||
1344635|NCT03014921|Randomized|Parallel Assignment||||Single|||t|||
1344636|NCT03014908|||Case Control||Cross-Sectional|||||||
1344637|NCT03014895|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1344638|NCT03014882||Single Group Assignment||Treatment||None (Open Label)||||||
1344639|NCT03014869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344640|NCT03014856|||Case Control||Cross-Sectional|||||||
1344641|NCT03014843|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1344642|NCT03014830|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1344643|NCT03014817|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344644|NCT03014804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344645|NCT03014791|||Case-Control||Cross-Sectional|||||||
1344646|NCT03014778|Randomized|Parallel Assignment||Other||Single|||t|||
1344647|NCT03014765||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344648|NCT03014752|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344649|NCT03014739|||Cohort||Prospective|||||||
1344650|NCT03014726||Single Group Assignment||Treatment||None (Open Label)||||||
1344651|NCT03014713|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1344652|NCT03014700|Randomized|Parallel Assignment||Treatment||Single||||t||
1344653|NCT03014687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344654|NCT03014674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344655|NCT03014661|||Cohort||Retrospective|||||||
1344656|NCT03014648||Single Group Assignment||Treatment||None (Open Label)||||||
1344657|NCT03014635|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344658|NCT03014622|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344659|NCT03014609|||Cohort||Prospective|||||||
1344660|NCT03014596|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344661|NCT03014583|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1344662|NCT03014570|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344663|NCT03014557|||Cohort||Prospective|||||||
1344664|NCT03014544|||Cohort||Prospective|||||||
1344665|NCT03014531|Randomized|Parallel Assignment||Treatment||Single||||||t
1344666|NCT03014518|||Case-Control||Prospective|||||||
1344667|NCT03014505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344668|NCT03014492|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344669|NCT03014479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344670|NCT03014466|Randomized|Parallel Assignment||Treatment||Single||||||t
1344671|NCT03014453|||Cohort||Prospective|||||||
1344672|NCT03014440||||||||||||
1344673|NCT03014427|||Other||Prospective|||||||
1344674|NCT03014414|Randomized|Parallel Assignment||Treatment||Single||||||t
1344675|NCT03014401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344676|NCT03014388|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344677|NCT03014375||Single Group Assignment||Treatment||None (Open Label)||||||
1344678|NCT03014362|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344679|NCT03014349|||Case-Only||Retrospective|||||||
1344680|NCT03014336|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344681|NCT03014323|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1344682|NCT03014310|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1344683|NCT03014297||Single Group Assignment||Treatment||None (Open Label)||||||
1344684|NCT03014284|||Case-Only||Prospective|||||||
1344685|NCT03014271|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344686|NCT03014258|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344687|NCT03014245|||Case-Control||Prospective|||||||
1344688|NCT03014232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344689|NCT03014219||Single Group Assignment||Treatment||None (Open Label)||||||
1344690|NCT03014206|||Case-Only||Prospective|||||||
1344691|NCT03014193|||Case-Only||Prospective|||||||
1344692|NCT03014180||Single Group Assignment||Treatment||None (Open Label)||||||
1344693|NCT03014167|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1344694|NCT03014154|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344695|NCT03014141|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1344696|NCT03014128|||Cohort||Prospective|||||||
1344697|NCT03014115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344698|NCT03014102|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344699|NCT03014089|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1344700|NCT03014076|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344701|NCT03014063|||Cohort||Prospective|||||||
1344702|NCT03014050|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344703|NCT03014037|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344704|NCT03014024|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344705|NCT03014011|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1344706|NCT03013998|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344707|NCT03013985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344708|NCT03013972|||Cohort||Prospective|||||||
1344709|NCT03013959|||Case Control|||||||||
1344710|NCT03013946|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344711|NCT03013933||Single Group Assignment||Treatment||None (Open Label)||||||
1344712|NCT03013920|||Cohort||Prospective|||||||
1344713|NCT03013907|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1344714|NCT03013894|||Cohort||Prospective|||||||
1344715|NCT03013881|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1344716|NCT03013868|||Cohort||Prospective|||||||
1344717|NCT03013855|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1344718|NCT03013842||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1344719|NCT03013829|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1344720|NCT03013816|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344721|NCT03013803||Single Group Assignment||Treatment||None (Open Label)||||||
1344722|NCT03013790|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1344723|NCT03013777||Single Group Assignment||Treatment||None (Open Label)||||||
1344724|NCT03013764|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1344725|NCT03013751||Single Group Assignment||Treatment||None (Open Label)||||||
1344726|NCT03013738|Randomized|Parallel Assignment||Treatment||Single||||||t
1344727|NCT03013725|||Cohort||Prospective|||||||
1344728|NCT03013712||Single Group Assignment||Treatment||None (Open Label)||||||
1344729|NCT03013699|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344730|NCT03013686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344731|NCT03013673|||Cohort||Prospective|||||||
1344732|NCT03013660|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1344733|NCT03013647||Single Group Assignment||Treatment||None (Open Label)||||||
1344734|NCT03013634|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1344735|NCT03013621|||||Prospective|||||||
1344736|NCT03013608||Single Group Assignment||Treatment||None (Open Label)||||||
1344737|NCT03013595|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1344738|NCT03013582|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344739|NCT03013569|||Case-Only||Prospective|||||||
1344740|NCT03013556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344741|NCT03013543||Single Group Assignment||Treatment||None (Open Label)||||||
1344742|NCT03013530|||Other||Cross-Sectional|||||||
1344743|NCT03013517||Single Group Assignment||Treatment||None (Open Label)||||||
1344744|NCT03013504|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344745|NCT03013491|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344746|NCT03013478|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1344747|NCT03013465|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1344748|NCT03013452|Randomized|Parallel Assignment||Treatment||None (Open Label)||2 modes of physiotherapy: 1- autogenic drainage; 2- oscillating positive expiratory pressure device||||
1344749|NCT03013439|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344750|NCT03013426||Single Group Assignment||Treatment||None (Open Label)||||||
1344751|NCT03013413||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344752|NCT03013400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344753|NCT03013387||Single Group Assignment||Treatment||None (Open Label)||||||
1344754|NCT03013374|||Cohort||Prospective|||||||
1344755|NCT03013361|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344756|NCT03013348|||Case-Only||Retrospective|||||||
1344757|NCT03013335||Single Group Assignment||Treatment||None (Open Label)||||||
1344758|NCT03013322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344759|NCT03013309|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344760|NCT03013296|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1344761|NCT03013283|||Cohort||Prospective|||||||
1344762|NCT03013270|Randomized|Parallel Assignment||Other||Double|||t||t|
1344763|NCT03013257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344764|NCT03013244|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344765|NCT03013231|||Cohort||Prospective|||||||
1344766|NCT03013218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1344767|NCT03013205|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344768|NCT03013192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344769|NCT03013179|||Cohort||Prospective|||||||
1344770|NCT03013166|||Cohort||Retrospective|||||||
1344771|NCT03013153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344772|NCT03013140|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1344773|NCT03013127||Single Group Assignment||Treatment||None (Open Label)||||||
1344774|NCT03013114||Single Group Assignment||Treatment||None (Open Label)||||||
1344775|NCT03013101||Single Group Assignment||Treatment||None (Open Label)||||||
1344776|NCT03013088||Single Group Assignment||Other||None (Open Label)||||||
1344777|NCT03013075|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344778|NCT03013062|||Cohort||Prospective|||||||
1344779|NCT03013049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344780|NCT03013036|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344781|NCT03013023|Randomized|Parallel Assignment||||Double|||t|||t
1344782|NCT03013010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344783|NCT03012997|Randomized|Parallel Assignment||Screening||Double|||t|||t
1344784|NCT03012984|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1344785|NCT03012971|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1344786|NCT03012958|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344787|NCT03012945|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344788|NCT03012932||Single Group Assignment||Screening||None (Open Label)||||||
1344789|NCT03012919||Single Group Assignment||Treatment||None (Open Label)||||||
1344790|NCT03012906|||Cohort||Prospective|||||||
1344791|NCT03012893|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1344792|NCT03012880||Single Group Assignment||Treatment||None (Open Label)||||||
1344793|NCT03012867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344794|NCT03012854|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344795|NCT03012841||Single Group Assignment||Treatment||None (Open Label)||Arctic Front Advance Cardiac CryoAblation Catheter and Freezor MAX Cardiac CryoAblation Catheter||||
1344796|NCT03012828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344797|NCT03012815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344798|NCT03012802|||Other||Prospective|||||||
1344799|NCT03012789||Single Group Assignment||Treatment||None (Open Label)||||||
1344800|NCT03012776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344801|NCT03012763|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1344802|NCT03012750||Single Group Assignment||Diagnostic||||||||
1344803|NCT03012737||Single Group Assignment||Supportive Care||None (Open Label)||||||
1344804|NCT03012724|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344805|NCT03012711|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1344806|NCT03012698||Single Group Assignment||Treatment||None (Open Label)||||||
1344807|NCT03012685|||Cohort||Prospective|||||||
1344808|NCT03012672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344809|NCT03012659|Randomized|Parallel Assignment||Other||Single|||t|||
1344810|NCT03012646||Single Group Assignment||Treatment||None (Open Label)||||||
1344811|NCT03012633|||Case-Only||Prospective|||||||
1344812|NCT03012620||Single Group Assignment||Treatment||None (Open Label)||||||
1344813|NCT03012607|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344814|NCT03012594||Single Group Assignment||Treatment||None (Open Label)||||||
1344815|NCT03012581||Single Group Assignment||Treatment||None (Open Label)||||||
1344816|NCT03012568|||Case-Only||Prospective|||||||
1344817|NCT03012555|||Cohort||Prospective|||||||
1344818|NCT03012542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344819|NCT03012529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344820|NCT03012516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344821|NCT03012503|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344822|NCT03012490|Randomized|Parallel Assignment||Prevention||Single||||||t
1344823|NCT03012477||Single Group Assignment||Treatment||None (Open Label)||||||
1344824|NCT03012464|||Cohort||Prospective|||||||
1344825|NCT03012451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344826|NCT03012438||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344827|NCT03012425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344828|NCT03012412|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1344829|NCT03012399|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344830|NCT03012386||Single Group Assignment||Basic Science||None (Open Label)||||||
1344831|NCT03012373|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344832|NCT03012360|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344833|NCT03012347||Single Group Assignment||Prevention||None (Open Label)||||||
1344834|NCT03012334|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1344835|NCT03012321|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344836|NCT03012308|||Cohort||Retrospective|||||||
1344837|NCT03012295|||Cohort||Prospective|||||||
1344838|NCT03012282||Single Group Assignment||Other||None (Open Label)||||||
1344839|NCT03012269|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344840|NCT03012256|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344841|NCT03012243|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1344842|NCT03012230||Single Group Assignment||Treatment||None (Open Label)||||||
1344843|NCT03012217|||Case-Only||Prospective|||||||
1344844|NCT03012204|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344845|NCT03012191||Single Group Assignment||Treatment||None (Open Label)||||||
1344846|NCT03012178|||Cohort||Prospective|||||||
1344847|NCT03012165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344848|NCT03012152|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344849|NCT03012139|||Cohort||Cross-Sectional|||||||
1344850|NCT03012126|Randomized|Parallel Assignment||Treatment||Single||||||t
1344851|NCT03012113|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1344852|NCT03012100|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344853|NCT03012087|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344854|NCT03012074||Single Group Assignment||Supportive Care||None (Open Label)||||||
1344855|NCT03012061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344856|NCT03012048|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344857|NCT03012035|Randomized|Parallel Assignment||Other||Single||||||t
1344858|NCT03012022|||Other||Prospective|||||||
1344859|NCT03012009|Randomized|Parallel Assignment||Treatment||Single||||||t
1344860|NCT03011996|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1344861|NCT03011983|||Case-Control||Prospective|||||||
1344862|NCT03011970|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1344863|NCT03011957|||Cohort||Prospective|||||||
1344864|NCT03011944|||Case-Control||Prospective|||||||
1344865|NCT03011931||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344866|NCT03011918|||Case-Only||Retrospective|||||||
1344867|NCT03011905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344868|NCT03011892|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344869|NCT03011879|||Cohort||Prospective|||||||
1344870|NCT03011866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344871|NCT03011853|||Cohort||Prospective|||||||
1344872|NCT03011840|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1344873|NCT03011827||Single Group Assignment||Treatment||None (Open Label)||||||
1344874|NCT03011814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344875|NCT03011801|Randomized|Parallel Assignment||Treatment||Single||||||t
1344876|NCT03011788|Randomized|Parallel Assignment||Screening||Single|||||t|
1344877|NCT03011775|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344878|NCT03011762||Single Group Assignment||Other||None (Open Label)||||||
1344879|NCT03011749||Single Group Assignment||Diagnostic||None (Open Label)||||||
1344880|NCT03011736||Single Group Assignment||Supportive Care||None (Open Label)||||||
1344881|NCT03011723||Single Group Assignment||Supportive Care||None (Open Label)||||||
1344882|NCT03011710|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1344883|NCT03011697|||Cohort||Prospective|||||||
1344884|NCT03011684|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1344885|NCT03011671||Single Group Assignment||Treatment||None (Open Label)||||||
1344886|NCT03011658|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1344887|NCT03011645|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1344888|NCT03011632|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1344889|NCT03011619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344890|NCT03011606||Single Group Assignment||Treatment||None (Open Label)||||||
1344891|NCT03011593||Single Group Assignment||Supportive Care||None (Open Label)||||||
1344892|NCT03011580|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1344893|NCT03011567|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344894|NCT03011554||Single Group Assignment||Supportive Care||None (Open Label)||||||
1344895|NCT03011541|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344896|NCT03011528|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344897|NCT03011515|||Cohort||Prospective|||||||
1344898|NCT03011502||Single Group Assignment||Screening||None (Open Label)||||||
1344899|NCT03011489|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1344900|NCT03011476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344901|NCT03011463|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1344902|NCT03011450|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1344903|NCT03011437|||Case-Only||Prospective|||||||
1344904|NCT03011424||Single Group Assignment||Treatment||None (Open Label)||||||
1344905|NCT03011411|||||Retrospective|||||||
1344906|NCT03011398|||Case-Control||Prospective|||||||
1344907|NCT03011385|Randomized|Parallel Assignment||Prevention||Single|||t|||
1344908|NCT03011372||Single Group Assignment||Treatment||None (Open Label)||||||
1344909|NCT03011359|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1344910|NCT03011346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344911|NCT03011333|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344912|NCT03011320|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1344913|NCT03011307|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344914|NCT03011294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344915|NCT03011281|||Cohort||Prospective|||||||
1344916|NCT03011268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344917|NCT03011255||Single Group Assignment||Treatment||None (Open Label)||||||
1344918|NCT03011242|||Case-Control||Prospective|||||||
1344919|NCT03011229|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1344920|NCT03011216|Randomized|Parallel Assignment||Treatment||Single|||t|||
1344921|NCT03011203|Randomized|Crossover Assignment||Other||Double|||t|||t
1344922|NCT03011190|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1344923|NCT03011177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344924|NCT03011164|||Cohort||Prospective|||||||
1344925|NCT03011151|||Cohort||Prospective|||||||
1344926|NCT03011138|||Cohort||Prospective|||||||
1344927|NCT03011125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1344928|NCT03011112|||Case-Control||Cross-Sectional|||||||
1344929|NCT03011099|Randomized|Parallel Assignment||Treatment||Single||||||t
1344930|NCT03011086|||Cohort||Prospective|||||||
1344931|NCT03011073|||Case-Only||Prospective|||||||
1344932|NCT03011060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344933|NCT03011047|Randomized|Parallel Assignment||Treatment||Single||||||t
1344934|NCT03011034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344935|NCT03011021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344936|NCT03011008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344937|NCT03010995|Non-Randomized|Parallel Assignment||Other||Single|All the outcome measurements will be performed by staff that will be blinded to the participant and their exposure.|||||t
1344938|NCT03010982||Single Group Assignment||Treatment||None (Open Label)||||||
1344939|NCT03010969|||Cohort||Prospective|||||||
1344940|NCT03010956|||Case-Crossover||Prospective|||||||
1344941|NCT03010943||Single Group Assignment||Supportive Care||None (Open Label)||||||
1344942|NCT03010930|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1344943|NCT03010917|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1344944|NCT03010904|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1344945|NCT03010891|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1344946|NCT03010878|Randomized|Parallel Assignment||Treatment||Single|||||t|
1344947|NCT03010865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344948|NCT03010852|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344949|NCT03010839|Randomized|Parallel Assignment||Prevention||Single|||||t|
1344950|NCT03010826|||Case-Control||Prospective|||||||
1344951|NCT03010813||Single Group Assignment||Treatment||None (Open Label)||||||
1344952|NCT03010800|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1344953|NCT03010787|Randomized|Parallel Assignment||||Double|||t||t|
1344954|NCT03010774|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1344955|NCT03010761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344956|NCT03010748|||Case-Crossover||Cross-Sectional|||||||
1344957|NCT03010735|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1344958|NCT03010722|||Cohort||Prospective|||||||
1344959|NCT03010709|||Cohort||Prospective|||||||
1344960|NCT03010696|||Case Control||Cross-Sectional|||||||
1344961|NCT03010683|Randomized|Parallel Assignment||Treatment||Single|||||t|
1344962|NCT03010670|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1344963|NCT03010657|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1344964|NCT03010644|||Cohort||Prospective|||||||
1344965|NCT03010631|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344966|NCT03010618||Single Group Assignment||Treatment||None (Open Label)||||||
1344967|NCT03010605|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1344968|NCT03010592|||Other||Prospective|||||||
1344969|NCT03010579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344970|NCT03010566|||Other||Prospective|||||||
1344971|NCT03010553|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344972|NCT03010540|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1344973|NCT03010527|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344974|NCT03010514|||Cohort||Retrospective|||||||
1344975|NCT03010501|Randomized|Crossover Assignment||Prevention||Single|||t|||
1344976|NCT03010488|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1344977|NCT03010475||Single Group Assignment||Treatment||None (Open Label)||||||
1344978|NCT03010462|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1344979|NCT03010449||Single Group Assignment||Treatment||None (Open Label)||||||
1344980|NCT03010436||Single Group Assignment||Treatment||None (Open Label)||||||
1344981|NCT03010423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344982|NCT03010410|||Cohort||Prospective|||||||
1344983|NCT03010397|||Cohort||Prospective|||||||
1344984|NCT03010384|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1344985|NCT03010371|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1344986|NCT03010358||Single Group Assignment||Treatment||None (Open Label)||||||
1344987|NCT03010345|Randomized|Parallel Assignment||Treatment||Single|||||t|
1344988|NCT03010332||||||||||||
1344989|NCT03010319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344990|NCT03010306|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1344991|NCT03010293|||Cohort||Retrospective|||||||
1344992|NCT03010280|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1344993|NCT03010267|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1344994|NCT03010254||||||||||||
1344995|NCT03010241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344996|NCT03010228|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1344997|NCT03010215||Single Group Assignment||Treatment||None (Open Label)||||||
1344998|NCT03010202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1344999|NCT03010189|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345000|NCT03010176|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345001|NCT03010163|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1345002|NCT03010150|||Cohort||Prospective|||||||
1345003|NCT03010137|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345004|NCT03010124||Single Group Assignment||Basic Science||None (Open Label)||||||
1345005|NCT03010111||Single Group Assignment||Screening||None (Open Label)||||||
1345006|NCT03010098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345007|NCT03010085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345008|NCT03010072|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1345009|NCT03010059|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1345010|NCT03010046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345011|NCT03010033|Randomized|Parallel Assignment||Prevention||Single|||t|||
1345012|NCT03010020|Randomized|Parallel Assignment||Prevention||Single|||t|||
1345013|NCT03010007|||Ecologic or Community||Prospective|||||||
1345014|NCT03009994|Randomized|Parallel Assignment||Prevention||Single|||t|||
1345015|NCT03009981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345016|NCT03009968|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345017|NCT03009955|||Cohort||Prospective|||||||
1345018|NCT03009942|||Case-Only||Prospective|||||||
1345019|NCT03009929|||Cohort||Prospective|||||||
1345020|NCT03009916|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1345021|NCT03009903||||||||||||
1345022|NCT03009890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345023|NCT03009877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345024|NCT03009864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345025|NCT03009851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345026|NCT03009838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345027|NCT03009825|||Cohort||Cross-Sectional|||||||
1345028|NCT03009812|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345029|NCT03009799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345030|NCT03009786|||Cohort||Prospective|||||||
1345031|NCT03009773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345032|NCT03009760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345033|NCT03009747|||Cohort||Prospective|||||||
1345034|NCT03009734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345035|NCT03009721|||Case-Only||Retrospective|||||||
1345036|NCT03009708||Single Group Assignment||Other||None (Open Label)||||||
1345037|NCT03009695|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345038|NCT03009682||Single Group Assignment||Treatment||None (Open Label)||||||
1345039|NCT03009669|||Case-Only||Prospective|||||||
1345040|NCT03009656|||Case-Only||Prospective|||||||
1345041|NCT03009643|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345042|NCT03009630||Single Group Assignment||Treatment||None (Open Label)||||||
1345043|NCT03009617|Randomized|Parallel Assignment||Prevention||Single|||t|||
1345044|NCT03009604|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345045|NCT03009591|Randomized|Crossover Assignment||Treatment||Single||||||t
1345046|NCT03009578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345047|NCT03009565|||Cohort||Cross-Sectional|||||||
1345048|NCT03009552|||Cohort||Prospective|||||||
1345049|NCT03009539|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345050|NCT03009526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345051|NCT03009513||Single Group Assignment||Treatment||None (Open Label)||||||
1345052|NCT03009500|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1345053|NCT03009487|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345054|NCT03009474|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1345055|NCT03009461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345056|NCT03009448|||Case-Only||Retrospective|||||||
1345057|NCT03009435|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345058|NCT03009422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345059|NCT03009409|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1345060|NCT03009396||Single Group Assignment||Treatment||None (Open Label)||||||
1345061|NCT03009383||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345062|NCT03009370|||Cohort||Cross-Sectional|||||||
1345063|NCT03009357|||Cohort||Prospective|||||||
1345064|NCT03009344||Single Group Assignment||Treatment||None (Open Label)||||||
1345065|NCT03009331|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345066|NCT03009318||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345067|NCT03009305||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345068|NCT03009292||Single Group Assignment||Treatment||None (Open Label)||||||
1345069|NCT03009279||||||||||||
1345070|NCT03009266|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1345071|NCT03009253|Randomized|Parallel Assignment||Treatment||Single||||||t
1345072|NCT03009240||Single Group Assignment||Treatment||None (Open Label)||||||
1345073|NCT03009227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345074|NCT03009214||Single Group Assignment||Treatment||None (Open Label)||||||
1345075|NCT03009201||Single Group Assignment||Treatment||None (Open Label)||||||
1345076|NCT03009188|||Family-Based|||||||||
1345077|NCT03009175|||||Prospective|||||||
1345078|NCT03009162|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345079|NCT03009149||Single Group Assignment||Supportive Care||None (Open Label)||||||
1345080|NCT03009136|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1345081|NCT03009123|||Cohort||Retrospective|||||||
1345082|NCT03009110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345083|NCT03009097|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345084|NCT03009084|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345085|NCT03009071|Randomized|Parallel Assignment||Treatment||Single||||||t
1345086|NCT03009058|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345087|NCT03009045||Single Group Assignment||Treatment||None (Open Label)||||||
1345088|NCT03009032|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345089|NCT03009019|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345090|NCT03009006|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345091|NCT03008993|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1345092|NCT03008980|||Cohort||Cross-Sectional|||||||
1345093|NCT03008967|||Cohort||Prospective|||||||
1345094|NCT03008954|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345095|NCT03008941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345096|NCT03008928|Randomized|Parallel Assignment||Other||Single|||t|||
1345097|NCT03008915|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1345098|NCT03008902|||Case-Control||Cross-Sectional|||||||
1345099|NCT03008889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345100|NCT03008876|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1345101|NCT03008863|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1345102|NCT03008850|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1345103|NCT03008837|Randomized|Parallel Assignment||Treatment||Single||Percutaneous electrical neural field stimulator (PENFS) using the military field stimulator, a device that uses small needles inserted in the ear (like auricular acupuncture), which are connected by electrodes to a battery pack that is attached externally using adhesive to the back of the ear. The stimulator is meant to stimulate branches of the cranial nerves via the ear.||||t
1345104|NCT03008824|||Cohort||Prospective|||||||
1345105|NCT03008811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345106|NCT03008798|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1345107|NCT03008785|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1345108|NCT03008772|||Cohort||Other|||||||
1345109|NCT03008759|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1345110|NCT03008746|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345111|NCT03008733|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345112|NCT03008720|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345113|NCT03008707|||Case-Control||Prospective|||||||
1345114|NCT03008694||Single Group Assignment||Treatment||None (Open Label)||||||
1345115|NCT03008681||Single Group Assignment||Supportive Care||None (Open Label)||||||
1345116|NCT03008668|Randomized|Parallel Assignment||Treatment||Single||||||t
1345117|NCT03008655|Randomized|Parallel Assignment||Treatment||Single||||||t
1345118|NCT03008642||Single Group Assignment||Prevention||None (Open Label)||||||
1345119|NCT03008629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345120|NCT03008616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345121|NCT03008603||Single Group Assignment||Treatment||None (Open Label)||||||
1345122|NCT03008590|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1345123|NCT03008577|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345124|NCT03008564|||Case-Only||Prospective|||||||
1345125|NCT03008551|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1345126|NCT03008538|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345127|NCT03008525|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345128|NCT03008512||Single Group Assignment||Treatment||None (Open Label)||||||
1345129|NCT03008499|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1345130|NCT03008486|Randomized|Parallel Assignment||Treatment||Single||||||t
1345131|NCT03008473|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1345132|NCT03008460|Randomized|Parallel Assignment||Other||Single|||||t|
1345133|NCT03008447|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1345134|NCT03008434||Single Group Assignment||Treatment||None (Open Label)||||||
1345135|NCT03008421|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345136|NCT03008408|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1345137|NCT03008395|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345138|NCT03008382|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1345139|NCT03008369||Single Group Assignment||Treatment||None (Open Label)||||||
1345140|NCT03008356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345141|NCT03008343|Randomized|Parallel Assignment||Treatment||Single|||||t|
1345142|NCT03008330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345143|NCT03008317|Randomized|Parallel Assignment||Treatment||Single||||||t
1345144|NCT03008304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345145|NCT03008291|||Cohort||Prospective|||||||
1345146|NCT03008278||Single Group Assignment||Treatment||None (Open Label)||||||
1345147|NCT03008265|||Cohort||Retrospective|||||||
1345148|NCT03008252|||Cohort||Prospective|||||||
1345149|NCT03008239||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345150|NCT03008226|||Case-Only||Prospective|||||||
1345151|NCT03008213||Single Group Assignment||Supportive Care||None (Open Label)||||||
1345152|NCT03008200|||Cohort||Prospective|||||||
1345153|NCT03008187||Single Group Assignment||Treatment||None (Open Label)||||||
1345154|NCT03008174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345155|NCT03008161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345156|NCT03008148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345157|NCT03008135|||Cohort||Prospective|||||||
1345158|NCT03008122|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1345159|NCT03008109||Single Group Assignment||Treatment||None (Open Label)||||||
1345160|NCT03008096||Single Group Assignment||Treatment||None (Open Label)||||||
1345161|NCT03008083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345162|NCT03008070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345163|NCT03008057|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1345164|NCT03008044|Non-Randomized|Sequential Assignment||Device Feasibility||None (Open Label)||"For the first 10 subjects, all sensors will be removed after the end of the clamp measurement day.~The last 2 subjects will continue to wear the three sensors after the clamp study. The second clamp study will take place at Day 7±1. After the second clamp study, the commercial CGM sensor will be removed. The two FiberSense sensors will be worn for up to Day 14."||||
1345165|NCT03008031|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1345166|NCT03008018||Single Group Assignment||Treatment||None (Open Label)||||||
1345167|NCT03008005|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1345168|NCT03007992||Single Group Assignment||Treatment||None (Open Label)||||||
1345169|NCT03007979||Single Group Assignment||Treatment||None (Open Label)||||||
1345170|NCT03007966|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345171|NCT03007953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345172|NCT03007940|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1345173|NCT03007927|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1345174|NCT03007914|||Cohort||Prospective|||||||
1345175|NCT03007901||Single Group Assignment||Other||None (Open Label)||||||
1345176|NCT03007888|Randomized|Crossover Assignment||Treatment||Single||||||t
1345177|NCT03007875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345178|NCT03007862|||Case-Only||Prospective|||||||
1345179|NCT03007849|||Case Control||Prospective|||||||
1345180|NCT03007836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345181|NCT03007823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345182|NCT03007810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345183|NCT03007797|||Cohort||Prospective|||||||
1345184|NCT03007784|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1345185|NCT03007771||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1345186|NCT03007758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345187|NCT03007745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345188|NCT03007732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345189|NCT03007719|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1345190|NCT03007706|||Case-Only||Prospective|||||||
1345191|NCT03007693|Randomized|Single Group Assignment||Other||Double|||t||t|
1345192|NCT03007680|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345193|NCT03007667|||Case-Control||Prospective|||||||
1345194|NCT03007654|Randomized|Parallel Assignment||Prevention||Single|||t|||
1345195|NCT03007641||Single Group Assignment||Health Services Research||None (Open Label)||||||
1345196|NCT03007628|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345197|NCT03007615||Single Group Assignment||||Single|||t|||
1345198|NCT03007602|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1345199|NCT03007589|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1345200|NCT03007576||Single Group Assignment||Treatment||None (Open Label)||||||
1345201|NCT03007563||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345202|NCT03007550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345203|NCT03007537|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1345204|NCT03007524|Randomized|Parallel Assignment||Treatment||Single||||||t
1345205|NCT03007511||Single Group Assignment||Supportive Care||None (Open Label)||||||
1345206|NCT03007498|||||Prospective|||||||
1345207|NCT03007485|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1345208|NCT03007472||Single Group Assignment||Treatment||None (Open Label)||||||
1345209|NCT03007459|||Case-Control||Prospective|||||||
1345210|NCT03007446||Single Group Assignment||Treatment||None (Open Label)||||||
1345211|NCT03007433|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1345212|NCT03007420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345213|NCT03007407||Single Group Assignment||Treatment||None (Open Label)||||||
1345214|NCT03007394|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345215|NCT03007381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345216|NCT03007368|Randomized|Crossover Assignment||||None (Open Label)||||||
1345217|NCT03007355|||Other||Prospective|||||||
1345218|NCT03007342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345219|NCT03007329|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345220|NCT03007316|Randomized|Parallel Assignment||||Single||||||t
1345221|NCT03007303|||Case-Control||Prospective|||||||
1345222|NCT03007290||Single Group Assignment||Health Services Research||None (Open Label)||||||
1345223|NCT03007277|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345224|NCT03007264|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345225|NCT03007251|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1345226|NCT03007238||Single Group Assignment||Treatment||None (Open Label)||||||
1345227|NCT03007225|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345228|NCT03007212||Single Group Assignment||Treatment||None (Open Label)||||||
1345229|NCT03007199|||Case Control||Prospective|||||||
1345230|NCT03007186|||Cohort||Prospective|||||||
1345231|NCT03007173|||Case-Only||Prospective|||||||
1345232|NCT03007160|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345233|NCT03007147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345234|NCT03007134|||Cohort||Retrospective|||||||
1345235|NCT03007121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345236|NCT03007108||Single Group Assignment||Other||None (Open Label)||||||
1345237|NCT03007095|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345238|NCT03007082|||Case-Only||Prospective|||||||
1345239|NCT03007069|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345240|NCT03007056|||Cohort||Retrospective|||||||
1345241|NCT03007043|||Cohort||Prospective|||||||
1345242|NCT03007030||Single Group Assignment||Treatment||None (Open Label)||||||
1345243|NCT03007017|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1345244|NCT03007004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345245|NCT03006991|||Cohort||Retrospective|||||||
1345246|NCT03006978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345247|NCT03006965|||Cohort||Other|||||||
1345248|NCT03006952|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345249|NCT03006939|||Cohort||Prospective|||||||
1345250|NCT03006926||Single Group Assignment||Treatment||None (Open Label)||||||
1345251|NCT03006913|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345252|NCT03006900|Randomized|Parallel Assignment||Treatment||Single||||||t
1345253|NCT03006887||Single Group Assignment||Treatment||None (Open Label)||||||
1345254|NCT03006874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345255|NCT03006861|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1345256|NCT03006848||Single Group Assignment||Treatment||None (Open Label)||||||
1345257|NCT03006835|Randomized|Parallel Assignment||Treatment||Single|||||t|
1345258|NCT03006822|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345259|NCT03006809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345260|NCT03006796|||Cohort||Prospective|||||||
1345261|NCT03006783|||Case-Only||Cross-Sectional|||||||
1345262|NCT03006770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345263|NCT03006757|Randomized|Crossover Assignment||Health Services Research||Single|||||t|
1345264|NCT03006744|Randomized|Parallel Assignment||Basic Science||Single||||||t
1345265|NCT03006731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345266|NCT03006718||Single Group Assignment||Other||None (Open Label)||||||
1345267|NCT03006705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345268|NCT03006692|||Case-Control||Prospective|||||||
1345269|NCT03006679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345270|NCT03006666|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1345271|NCT03006653|||Cohort||Prospective|||||||
1345272|NCT03006640|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345273|NCT03006627|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1345274|NCT03006614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345275|NCT03006601|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345276|NCT03006588||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345277|NCT03006575||Single Group Assignment||Treatment||None (Open Label)||||||
1345278|NCT03006562|Randomized|Parallel Assignment||Prevention||Single||Prospective, single-institution, multi-surgeon, stratified randomized controlled trial. Randomization will be stratified into four groups by procedure approach (open or robotic) and whether patients elect to undergo a screening 30-day lower extremity Duplex (ultrasound or no ultrasound). Patients will then be randomized, within each of the strata, to the two arms (subcutaneous heparin versus no subcutaneous heparin).||||t
1345279|NCT03006549|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345280|NCT03006536|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345281|NCT03006523|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345282|NCT03006510|Randomized|Parallel Assignment||Prevention||Single||||t||
1345283|NCT03006497|Randomized|Parallel Assignment||Treatment||Single||||||t
1345284|NCT03006484|||Case-Only||Prospective|||||||
1345285|NCT03006471|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345286|NCT03006458||||||||||||
1345287|NCT03006445||Single Group Assignment||Treatment||None (Open Label)||||||
1345288|NCT03006432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345289|NCT03006419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345290|NCT03006406|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345291|NCT03006393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345292|NCT03006380|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1345293|NCT03006367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1345294|NCT03006354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345295|NCT03006341|||Cohort||Retrospective|||||||
1345296|NCT03006328|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345297|NCT03006315|||Cohort||Prospective|||||||
1345298|NCT03006302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345299|NCT03006289||||||||||||
1345300|NCT03006276|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345301|NCT03006263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345302|NCT03006250|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1345303|NCT03006237||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345304|NCT03006224|Randomized|Parallel Assignment||Other||Single|||||t|
1345305|NCT03006211|Randomized|Parallel Assignment||Other||Single|||||t|
1345306|NCT03006198|||Cohort||Prospective|||||||
1345307|NCT03006185|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345308|NCT03006172|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1345309|NCT03006159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345310|NCT03006146||Single Group Assignment||Basic Science||None (Open Label)||||||
1345311|NCT03006133|||Other||Cross-Sectional|||||||
1345312|NCT03006120|||Case Control||Retrospective|||||||
1345313|NCT03006107|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345314|NCT03006094|||Cohort||Prospective|||||||
1345315|NCT03006081||Single Group Assignment||Treatment||None (Open Label)||||||
1345316|NCT03006068|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345317|NCT03006055||||||||||||
1345318|NCT03006042|||Case-Only||Prospective|||||||
1345319|NCT03006029||Single Group Assignment||Other||None (Open Label)||||||
1345320|NCT03006016|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1345321|NCT03006003|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345322|NCT03005990|Randomized|Parallel Assignment||Treatment||Single||||||t
1345323|NCT03005977||Single Group Assignment||Screening||None (Open Label)||||||
1345324|NCT03005964|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345325|NCT03005951|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1345326|NCT03005938|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1345327|NCT03005925|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1345328|NCT03005912|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1345329|NCT03005899||Parallel Assignment||Treatment||Double||||||
1345330|NCT03005886|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1345331|NCT03005873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345332|NCT03005860|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1345333|NCT03005847||Single Group Assignment||Treatment||None (Open Label)||||||
1345334|NCT03005834|||Cohort||Prospective|||||||
1345335|NCT03005821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345336|NCT03005808|Randomized|Parallel Assignment||Treatment||Single||||||t
1345337|NCT03005795|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1345338|NCT03005782|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345339|NCT03005769|||Cohort||Retrospective|||||||
1345340|NCT03005756||Single Group Assignment||Treatment||None (Open Label)||||||
1345341|NCT03005743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345342|NCT03005730|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345343|NCT03005717|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345344|NCT03005704|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345345|NCT03005691|||Cohort||Cross-Sectional|||||||
1345346|NCT03005678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345347|NCT03005665|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1345348|NCT03005652|Randomized|Parallel Assignment||Other||Single||"The trial will compare outcomes in two groups of participants randomised to one of two study arms, either receiving:~(i) an 8-week mindfulness-based intervention, using a secular form of mindfulness training; or (ii) an 8-week validated health-educational programme (comparison condition, see section 6.3 for description) The randomization will be performed with a 1:1 allocation. The primary outcome will be change in symptoms of anxiety from baseline to 8 weeks."||||t
1345349|NCT03005639||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1345350|NCT03005626|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345351|NCT03005613|Randomized|Parallel Assignment||Treatment||Single||||||t
1345352|NCT03005600|||Cohort||Prospective|||||||
1345353|NCT03005587|||Cohort||Prospective|||||||
1345354|NCT03005574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345355|NCT03005561|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345356|NCT03005548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345357|NCT03005535|Randomized|Crossover Assignment||Treatment||Single|||t|||
1345358|NCT03005522|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1345359|NCT03005509|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1345360|NCT03005496|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345361|NCT03005483|Randomized|Parallel Assignment||Treatment||Single||||||t
1345362|NCT03005470|Randomized|Factorial Assignment||Treatment||Double|Participants have uncontrolled hypertension under on pharmacological treatment. They will be requested not to change drugs and medicine doses during the trial.|This is a factorial randomized controlled trial (Figure 1) of effectiveness of the use of technologies - smartphones and blood pressure monitoring - to reduce systolic blood pressure and change lifestyle.|||t|t
1345363|NCT03005457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345364|NCT03005444|Randomized|Parallel Assignment||Treatment||Single||||||t
1345365|NCT03005431|Randomized|Parallel Assignment||Treatment||Single||||||t
1345366|NCT03005418|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345367|NCT03005405|Randomized|Parallel Assignment||Treatment||Single||||||t
1345368|NCT03005392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345369|NCT03005379|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1345370|NCT03005366|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345371|NCT03005353|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345372|NCT03005340|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1345373|NCT03005327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345374|NCT03005314|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345375|NCT03005301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345376|NCT03005288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345377|NCT03005275|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1345378|NCT03005262||||||||||||
1345379|NCT03005249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345380|NCT03005236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345381|NCT03005223|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1345382|NCT03005210|Randomized|Crossover Assignment||||None (Open Label)||||||
1345383|NCT03005197|||Cohort||Prospective|||||||
1345384|NCT03005184|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1345385|NCT03005171|Randomized|Parallel Assignment||Treatment||Single||||||t
1345386|NCT03005158|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1345387|NCT03005145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345388|NCT03005132|||Case Control||Retrospective|||||||
1345389|NCT03005119|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345390|NCT03005106||Single Group Assignment||Treatment||None (Open Label)||||||
1345391|NCT03005093|||Cohort||Prospective|||||||
1345392|NCT03005080|||Cohort||Prospective|||||||
1345393|NCT03005067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345394|NCT03005054||Single Group Assignment||Treatment||None (Open Label)||||||
1345395|NCT03005041|Randomized|Crossover Assignment||Other||Single||||||t
1345396|NCT03005028|||Cohort||Retrospective|||||||
1345397|NCT03005015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345398|NCT03005002||Single Group Assignment||Treatment||None (Open Label)||||||
1345399|NCT03004989|||||Retrospective|||||||
1345400|NCT03004976|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345401|NCT03004963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345402|NCT03004950|||Cohort||Retrospective|||||||
1345403|NCT03004937||Single Group Assignment||Screening||None (Open Label)||||||
1345404|NCT03004924|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345405|NCT03004911|Randomized|Parallel Assignment||Treatment||Single||||||t
1345406|NCT03004898||Single Group Assignment||Prevention||None (Open Label)||||||
1345407|NCT03004885|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1345408|NCT03004872|||Cohort||Prospective|||||||
1345409|NCT03004859|||Cohort||Prospective|||||||
1345410|NCT03004846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345411|NCT03004833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345412|NCT03004820||Single Group Assignment||Prevention||None (Open Label)||Patients will receive remote ischemic conditioning||||
1345413|NCT03004807|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1345414|NCT03004794|||Case-Only||Retrospective|||||||
1345415|NCT03004781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345416|NCT03004768||Single Group Assignment||Treatment||None (Open Label)||||||
1345417|NCT03004755|||Cohort||Prospective|||||||
1345418|NCT03004742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345419|NCT03004729||Single Group Assignment||Screening||None (Open Label)||||||
1345420|NCT03004716|||Cohort||Prospective|||||||
1345421|NCT03004703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345422|NCT03004690|Randomized|Parallel Assignment||||None (Open Label)||||||
1345423|NCT03004677|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1345424|NCT03004664|||Cohort||Prospective|||||||
1345425|NCT03004651|||Case-Control||Prospective|||||||
1345426|NCT03004638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345427|NCT03004625||Single Group Assignment||Treatment||None (Open Label)||||||
1345428|NCT03004612|Randomized|Parallel Assignment||Prevention||Double||||t||t
1345429|NCT03004599||Single Group Assignment||Treatment||None (Open Label)||||||
1345430|NCT03004586|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1345431|NCT03004573||Single Group Assignment||Basic Science||None (Open Label)||||||
1345432|NCT03004560|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1345433|NCT03004547|||Cohort||Prospective|||||||
1345434|NCT03004534||Single Group Assignment||Treatment||None (Open Label)||||||
1345435|NCT03004521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345436|NCT03004508|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345437|NCT03004495|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1345438|NCT03004482|||Other||Cross-Sectional|||||||
1345439|NCT03004469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345440|NCT03004456|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345441|NCT03004443|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345442|NCT03004430|Randomized|Parallel Assignment||Treatment||Single||||||t
1345443|NCT03004417|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1345444|NCT03004404|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345445|NCT03004391|||Case-Only||Prospective|||||||
1345446|NCT03004378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345447|NCT03004365|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345448|NCT03004352|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1345449|NCT03004339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345450|NCT03004326|||Cohort||Prospective|||||||
1345451|NCT03004313|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1345452|NCT03004300|Randomized|Parallel Assignment||Treatment||Single||||||t
1345453|NCT03004287||Single Group Assignment||Treatment||None (Open Label)||||||
1345454|NCT03004274|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345455|NCT03004261||Single Group Assignment||Treatment||None (Open Label)||||||
1345456|NCT03004248||Single Group Assignment||Treatment||None (Open Label)||||||
1345457|NCT03004235|||Cohort||Prospective|||||||
1345458|NCT03004222|Randomized|Parallel Assignment||Treatment||Single|||||t|
1345459|NCT03004209||Single Group Assignment||Treatment||None (Open Label)||||||
1345460|NCT03004196|Randomized|Parallel Assignment||Prevention||Single|||t|||
1345461|NCT03004183||Single Group Assignment||Treatment||None (Open Label)||||||
1345462|NCT03004170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345463|NCT03004157|Randomized|Crossover Assignment||Treatment||Single|||t|||
1345464|NCT03004144||Single Group Assignment||Basic Science||None (Open Label)||||||
1345465|NCT03004131|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1345466|NCT03004118|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1345467|NCT03004105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345468|NCT03004092||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345469|NCT03004079|||Case-Only||Prospective|||||||
1345470|NCT03004066|||Cohort||Prospective|||||||
1345471|NCT03004053|||Cohort||Prospective|||||||
1345472|NCT03004040|||Case-Control||Prospective|||||||
1345473|NCT03004027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345474|NCT03004014|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1345475|NCT03004001|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1345476|NCT03003988|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1345477|NCT03003975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345478|NCT03003962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345479|NCT03003949|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1345480|NCT03003936|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1345481|NCT03003923|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1345482|NCT03003910|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345483|NCT03003897|||Cohort||Prospective|||||||
1345484|NCT03003884|Randomized|Parallel Assignment||Other||Single|||t|||
1345485|NCT03003871|Randomized|Parallel Assignment||Prevention||Single||||||t
1345486|NCT03003858|||Cohort||Retrospective|||||||
1345487|NCT03003845|||Other||Prospective|||||||
1345488|NCT03003832|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345489|NCT03003819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345490|NCT03003806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345491|NCT03003793|||Case-Control||Prospective|||||||
1345492|NCT03003780|Randomized|Parallel Assignment||Treatment||Single||||||t
1345493|NCT03003767||||||||||||
1345494|NCT03003754|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345495|NCT03003741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345496|NCT03003728||Single Group Assignment||Treatment||None (Open Label)||||||
1345497|NCT03003715|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1345498|NCT03003702|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1345499|NCT03003689|Randomized|Parallel Assignment||Treatment||Single||||||t
1345500|NCT03003676||Single Group Assignment||Treatment||None (Open Label)||||||
1345501|NCT03003663||Single Group Assignment||Prevention||None (Open Label)||||||
1345502|NCT03003650||Single Group Assignment||Treatment||None (Open Label)||||||
1345503|NCT03003637||Single Group Assignment||Treatment||None (Open Label)||||||
1345504|NCT03003624|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345505|NCT03003611|||Case-Control||Prospective|||||||
1345506|NCT03003598|Randomized|Parallel Assignment||Other||Single|||||t|
1345507|NCT03003585|Randomized|Parallel Assignment||Other||Single|||||t|
1345508|NCT03003572|||Cohort||Prospective|||||||
1345509|NCT03003559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345510|NCT03003546||Single Group Assignment||Treatment||None (Open Label)||||||
1345511|NCT03003533||Single Group Assignment||Treatment||None (Open Label)||||||
1345512|NCT03003520|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345513|NCT03003507|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1345514|NCT03003494|||Cohort||Prospective|||||||
1345515|NCT03003481|||Case-Only||Prospective|||||||
1345516|NCT03003468||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1345517|NCT03003455|Randomized|Parallel Assignment||Treatment||Single||||||t
1345518|NCT03003442|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1345519|NCT03003429||Single Group Assignment||Basic Science||None (Open Label)||||||
1345520|NCT03003416|||Cohort||Prospective|||||||
1345521|NCT03003403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345522|NCT03003390|Randomized|Parallel Assignment||Prevention||None (Open Label)||Eligible subjects will be randomized 1:1 to treatment or control.||||
1345523|NCT03003377|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345524|NCT03003364|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1345525|NCT03003351|||Cohort|||||||||
1345526|NCT03003338|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1345527|NCT03003325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345528|NCT03003312|||Cohort||Prospective|||||||
1345529|NCT03003299|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345530|NCT03003286|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1345531|NCT03003273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345532|NCT03003260|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1345533|NCT03003247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345534|NCT03003234||Single Group Assignment||Basic Science||None (Open Label)||||||
1345535|NCT03003221|Randomized|Parallel Assignment||Treatment||Single||||||t
1345536|NCT03003208||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345537|NCT03003195||Single Group Assignment||Treatment||None (Open Label)||||||
1345538|NCT03003182|||Cohort||Prospective|||||||
1345539|NCT03003169|||Cohort||Prospective|||||||
1345540|NCT03003156|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345541|NCT03003143||Single Group Assignment||Treatment||None (Open Label)||||||
1345542|NCT03003130|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345543|NCT03003117|Randomized|Parallel Assignment||Prevention||Single|||t|||
1345544|NCT03003104|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345545|NCT03003091|Randomized|Parallel Assignment||||Single|||t|||
1345546|NCT03003078||Single Group Assignment||Treatment||None (Open Label)||||||
1345547|NCT03003065||Single Group Assignment||Treatment||None (Open Label)||||||
1345548|NCT03003052|||Cohort||Prospective|||||||
1345549|NCT03003039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345550|NCT03003026|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1345551|NCT03003013|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345552|NCT03003000|Randomized|Parallel Assignment||Treatment||Double||||||
1345553|NCT03002987|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345554|NCT03002974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345555|NCT03002961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345556|NCT03002948|||Cohort||Cross-Sectional|||||||
1345557|NCT03002935||Single Group Assignment||Treatment||None (Open Label)||||||
1345558|NCT03002922||Single Group Assignment||Other||None (Open Label)||||||
1345559|NCT03002909|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1345560|NCT03002896|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1345561|NCT03002883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345562|NCT03002870||Single Group Assignment||Treatment||None (Open Label)||||||
1345563|NCT03002857|Randomized|Crossover Assignment||Other||Double|||t||t|
1345564|NCT03002844|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345565|NCT03002831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345566|NCT03002818|||Cohort||Prospective|||||||
1345567|NCT03002805|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1345568|NCT03002792|||Cohort||Prospective|||||||
1345569|NCT03002779||Single Group Assignment||Treatment||None (Open Label)||||||
1345570|NCT03002766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1345571|NCT03002753|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345572|NCT03002740|||Cohort||Retrospective|||||||
1345573|NCT03002727|||Cohort||Prospective|||||||
1345574|NCT03002714||Single Group Assignment||||None (Open Label)||||||
1345575|NCT03002701|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1345576|NCT03002688|||Other||Prospective|||||||
1345577|NCT03002675||Single Group Assignment||Treatment||None (Open Label)||||||
1345578|NCT03002662|||Case-Control||Prospective|||||||
1345579|NCT03002649||Single Group Assignment||Treatment||None (Open Label)||||||
1345580|NCT03002636|Randomized|Crossover Assignment||Treatment||Single|||||t|
1345581|NCT03002623||Single Group Assignment||Treatment||None (Open Label)||This is a single group assignment. All patients regardless of subtype of thyroid cancer received one single treatment and follow up plan with option to continue the treatment when scan was negative.||||
1345582|NCT03002610|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1345583|NCT03002597|||Other||Prospective|||||||
1345584|NCT03002584|||Cohort||Prospective|||||||
1345585|NCT03002571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345586|NCT03002558|||Cohort||Prospective|||||||
1345587|NCT03002545|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345588|NCT03002532|Randomized|Parallel Assignment||Treatment||Single||||||t
1345589|NCT03002519||Single Group Assignment||Treatment||None (Open Label)||||||
1345590|NCT03002506||Single Group Assignment||Other||None (Open Label)||||||
1345591|NCT03002493||Single Group Assignment||Treatment||None (Open Label)||||||
1345592|NCT03002480||Single Group Assignment||Treatment||None (Open Label)||||||
1345593|NCT03002467|Randomized|Parallel Assignment||||None (Open Label)||||||
1345594|NCT03002454||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345595|NCT03002441|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345596|NCT03002428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345597|NCT03002415|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345598|NCT03002402||Single Group Assignment||Treatment||None (Open Label)||||||
1345599|NCT03002389||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345600|NCT03002376||Single Group Assignment||Treatment||None (Open Label)||||||
1345601|NCT03002363|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1345602|NCT03002350|||Cohort||Prospective|||||||
1345603|NCT03002337|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1345604|NCT03002324|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1345605|NCT03002311|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1345606|NCT03002298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345607|NCT03002285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345608|NCT03002272|||Case-Control||Other|||||||
1345609|NCT03002259|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345610|NCT03002246|||Cohort||Prospective|||||||
1345611|NCT03002233||Single Group Assignment||Treatment||None (Open Label)||||||
1345612|NCT03002220||Single Group Assignment||Treatment||None (Open Label)||||||
1345613|NCT03002207|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1345614|NCT03002194||Single Group Assignment||Treatment||None (Open Label)||||||
1345615|NCT03002181|Randomized|Parallel Assignment||||Double|||||t|t
1345616|NCT03002168|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1345617|NCT03002155|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345618|NCT03002142|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1345619|NCT03002129||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345620|NCT03002116|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1345621|NCT03002103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345622|NCT03002090|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1345623|NCT03002077||Single Group Assignment||Treatment||None (Open Label)||||||
1345624|NCT03002064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345625|NCT03002051||Single Group Assignment||Treatment||None (Open Label)||||||
1345626|NCT03002038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345627|NCT03002025|Randomized|Parallel Assignment||Other||Double|||t||t|
1345628|NCT03002012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345629|NCT03001999||Single Group Assignment||Treatment||None (Open Label)||||||
1345630|NCT03001986||Single Group Assignment||Prevention||None (Open Label)||||||
1345631|NCT03001973|||Cohort||Prospective|||||||
1345632|NCT03001960|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345633|NCT03001947|||Cohort||Prospective|||||||
1345634|NCT03001934|||Cohort||Prospective|||||||
1345635|NCT03001921|||Cohort||Prospective|||||||
1345636|NCT03001908|Randomized|Factorial Assignment||Treatment||Single||||||t
1345637|NCT03001895||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345638|NCT03001882||Single Group Assignment||Treatment||None (Open Label)||||||
1345639|NCT03001869||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345640|NCT03001856|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345641|NCT03001843|Randomized|Parallel Assignment||Other||Single|||t|||
1345642|NCT03001830||Single Group Assignment||Treatment||None (Open Label)||||||
1345643|NCT03001817|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345644|NCT03001804|||Cohort||Prospective|||||||
1345645|NCT03001791|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345646|NCT03001778||Single Group Assignment||Prevention||None (Open Label)||||||
1345647|NCT03001765||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345648|NCT03001752|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1345649|NCT03001739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345650|NCT03001726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345651|NCT03001713|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1345652|NCT03001700||Single Group Assignment||Treatment||None (Open Label)||||||
1345653|NCT03001687|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1345654|NCT03001674|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1345655|NCT03001661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345656|NCT03001648|||Cohort||Retrospective|||||||
1345657|NCT03001635|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345658|NCT03001622||Single Group Assignment||Treatment||None (Open Label)||||||
1345659|NCT03001609||Single Group Assignment||Treatment||None (Open Label)||||||
1345660|NCT03001596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345661|NCT03001583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345662|NCT03001570||Single Group Assignment||Treatment||None (Open Label)||||||
1345663|NCT03001557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345664|NCT03001544||Single Group Assignment||Treatment||None (Open Label)||||||
1345665|NCT03001531|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345666|NCT03001518|||Cohort||Prospective|||||||
1345667|NCT03001505|||Cohort||Other|||||||
1345668|NCT03001492|||Cohort||Prospective|||||||
1345669|NCT03001479|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345670|NCT03001466|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1345671|NCT03001453|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345672|NCT03001440|||Cohort||Cross-Sectional|||||||
1345673|NCT03001427|Randomized|Parallel Assignment||Treatment||Single||||||t
1345674|NCT03001414|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1345675|NCT03001401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345676|NCT03001388|||Cohort||Prospective|||||||
1345677|NCT03001375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345678|NCT03001362||Single Group Assignment||Treatment||None (Open Label)||||||
1345679|NCT03001349||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345680|NCT03001336|||Ecologic or Community||Cross-Sectional|||||||
1345681|NCT03001323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345682|NCT03001310|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1345683|NCT03001297|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345684|NCT03001284|||Cohort||Prospective|||||||
1345685|NCT03001271|Non-Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1345686|NCT03001258|||Ecologic or Community||Cross-Sectional|||||||
1345687|NCT03001245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345688|NCT03001232|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1345689|NCT03001219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345690|NCT03001206|||Cohort||Retrospective|||||||
1345691|NCT03001193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345692|NCT03001180|||Case-Control||Cross-Sectional|||||||
1345693|NCT03001167|||Cohort||Prospective|||||||
1345694|NCT03001154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345695|NCT03001141|||Cohort||Prospective|||||||
1345696|NCT03001128|||Cohort||Prospective|||||||
1345697|NCT03001115|||Cohort||Prospective|||||||
1345698|NCT03001102|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1345699|NCT03001089|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345700|NCT03001076|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345701|NCT03001063|Randomized|Parallel Assignment||Treatment||Single||||||t
1345702|NCT03001050||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345703|NCT03001037|||Case Control||Prospective|||||||
1345704|NCT03001024|Randomized|Parallel Assignment||Prevention||Single||||||t
1345705|NCT03001011|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345706|NCT03000998|Randomized|Parallel Assignment||Prevention||Single||||||t
1345707|NCT03000985|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1345708|NCT03000972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345709|NCT03000959|||Cohort||Prospective|||||||
1345710|NCT03000946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345711|NCT03000933|||Ecologic or Community||Prospective|||||||
1345712|NCT03000920|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1345713|NCT03000907|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345714|NCT03000894|Randomized|Parallel Assignment||Treatment||Single|||||t|
1345715|NCT03000881||Single Group Assignment||Basic Science||None (Open Label)||||||
1345716|NCT03000868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345717|NCT03000855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345718|NCT03000842|Non-Randomized|Crossover Assignment||Basic Science||Single|||||t|
1345719|NCT03000829|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1345720|NCT03000816||Single Group Assignment||Treatment||None (Open Label)||||||
1345721|NCT03000803|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345722|NCT03000790||Single Group Assignment||Treatment||None (Open Label)||||||
1345723|NCT03000777|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345724|NCT03000764||Single Group Assignment||Other||None (Open Label)||||||
1345725|NCT03000751|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1345726|NCT03000738|||Cohort||Prospective|||||||
1345727|NCT03000725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345728|NCT03000712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345729|NCT03000699|Randomized|Parallel Assignment||Treatment||Single||||||t
1345730|NCT03000686|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1345731|NCT03000673|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1345732|NCT03000660||Single Group Assignment||Treatment||None (Open Label)||||||
1345733|NCT03000647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345734|NCT03000634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345735|NCT03000621|||Cohort||Prospective|||||||
1345736|NCT03000608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345737|NCT03000595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345738|NCT03000582|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1345739|NCT03000569||Single Group Assignment||Treatment||None (Open Label)||||||
1345740|NCT03000556|Randomized|Parallel Assignment||Prevention||Single||||||t
1345741|NCT03000543|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1345742|NCT03000530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345743|NCT03000517|||Cohort||Prospective|||||||
1345744|NCT03000504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345745|NCT03000491|||Other||Retrospective|||||||
1345746|NCT03000478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345747|NCT03000465|||Case-Only||Prospective|||||||
1345748|NCT03000452||Single Group Assignment||Treatment||None (Open Label)||||||
1345749|NCT03000439|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1345750|NCT03000426|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345975|NCT02997501||Single Group Assignment||Other||None (Open Label)||||||
1345751|NCT03000413|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1345752|NCT03000400|Randomized|Parallel Assignment||Treatment||Single||||||t
1345753|NCT03000387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345754|NCT03000374||Single Group Assignment||Treatment||None (Open Label)||||||
1345755|NCT03000361||Single Group Assignment||Treatment||None (Open Label)||||||
1345756|NCT03000348|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345757|NCT03000335|||Case-Control||Other|||||||
1345758|NCT03000322||Single Group Assignment||Treatment||None (Open Label)||||||
1345759|NCT03000309||Single Group Assignment||Treatment||None (Open Label)||||||
1345760|NCT03000296||Single Group Assignment||Treatment||None (Open Label)||||||
1345761|NCT03000283||Single Group Assignment||Treatment||None (Open Label)||||||
1345762|NCT03000270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345763|NCT03000257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1345764|NCT03000244|||Cohort||Prospective|||||||
1345765|NCT03000231|||Case-Control||Prospective|||||||
1345766|NCT03000218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345767|NCT03000205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345768|NCT03000192|||Cohort||Prospective|||||||
1345769|NCT03000179||Single Group Assignment||Treatment||None (Open Label)||||||
1345770|NCT03000166|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345771|NCT03000153|Randomized|Parallel Assignment||Treatment||Single|||||t|
1345772|NCT03000140|Non-Randomized|Parallel Assignment||Prevention||Single|||||t|
1345773|NCT03000127||Single Group Assignment||Treatment||None (Open Label)|All patients will receive either testosterone or placebo at some phase of treatment, but which phase will be testosterone and which will be placebo will be unknown (blinded) to participant, care provider, and outcomes assessor.|Single arm, testosterone or placebo will be administered to all patients at some period of study, but which period of study the they will recieve placebo or testosterone gel will be blinded (unknown) to participant, care provider, and outcomes assessor.||||
1345774|NCT03000114|Randomized|Parallel Assignment||Treatment||Single||||||t
1345775|NCT03000101|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1345776|NCT03000088|||Case-Control||Prospective|||||||
1345777|NCT03000075|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345778|NCT03000062|Randomized|Parallel Assignment||Treatment||Single|ID of participating patients are only available through the participating Family phyisican|Cluster randomized controlled trial|t|||
1345779|NCT03000049|||Cohort||Prospective|||||||
1345780|NCT03000036||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345781|NCT03000023|||Cohort||Prospective|||||||
1345782|NCT03000010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345783|NCT02999997|Randomized|Parallel Assignment||Treatment||Single||||||t
1345784|NCT02999984||Single Group Assignment||Treatment||None (Open Label)||||||
1345785|NCT02999971|Randomized|Parallel Assignment||Treatment||Single||||||t
1345786|NCT02999958|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1345787|NCT02999945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345788|NCT02999932|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345789|NCT02999919|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1345790|NCT02999906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345791|NCT02999893||Single Group Assignment||Treatment||None (Open Label)||||||
1345792|NCT02999880|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1345793|NCT02999867|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1345794|NCT02999854|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345795|NCT02999841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345796|NCT02999828||Single Group Assignment||Prevention||None (Open Label)||||||
1345797|NCT02999815|Randomized|Factorial Assignment||Treatment||Double||||t|t|
1345798|NCT02999802||Single Group Assignment||Basic Science||None (Open Label)||||||
1345799|NCT02999789|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1345800|NCT02999776|Randomized|Parallel Assignment||Treatment||Single||||||t
1345801|NCT02999763||Single Group Assignment||Treatment||None (Open Label)||||||
1345802|NCT02999750||Single Group Assignment||Treatment||None (Open Label)||||||
1345803|NCT02999737|Randomized|Parallel Assignment||Treatment||Single||||||t
1345804|NCT02999724|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1345805|NCT02999711|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1345806|NCT02999698|||||Retrospective|||||||
1345807|NCT02999685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345808|NCT02999672|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345809|NCT02999659|||Case-Control||Prospective|||||||
1345810|NCT02999646||Single Group Assignment||Treatment||None (Open Label)||antitumor immunization MVX-ONCO-1||||
1345811|NCT02999633||Single Group Assignment||Treatment||None (Open Label)||||||
1345812|NCT02999620|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1345813|NCT02999607|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1345814|NCT02999594|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345815|NCT02999581|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1345816|NCT02999568|||Case Control||Prospective|||||||
1345817|NCT02999555||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345818|NCT02999542|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1345819|NCT02999529||Single Group Assignment||Other||None (Open Label)||||||
1345820|NCT02999516|Randomized|Parallel Assignment||Basic Science||Single||||||t
1345976|NCT02997488|||Case-Control||Prospective|||||||
1345821|NCT02999503|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345822|NCT02999490|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1345823|NCT02999477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345824|NCT02999464|Randomized|Parallel Assignment||Treatment||Single||||||t
1345825|NCT02999451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345826|NCT02999438|||Case-Control||Cross-Sectional|||||||
1345827|NCT02999425||Single Group Assignment||Other||None (Open Label)||||||
1345828|NCT02999412|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1345829|NCT02999399||Single Group Assignment||Basic Science||None (Open Label)||||||
1345830|NCT02999386|||Cohort||Prospective|||||||
1345831|NCT02999373|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1345832|NCT02999360|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1345833|NCT02999347|||Cohort||Retrospective|||||||
1345834|NCT02999334|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1345835|NCT02999321|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345836|NCT02999308||Single Group Assignment||Treatment||None (Open Label)||||||
1345837|NCT02999295|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345838|NCT02999282|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345839|NCT02999269|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345840|NCT02999256|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1345841|NCT02999243|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1345842|NCT02999230|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1345843|NCT02999217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345844|NCT02999204|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1345845|NCT02999191|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1345846|NCT02999178|Randomized|Parallel Assignment||Treatment||Double||||||
1345847|NCT02999165|||Case Control||Prospective|||||||
1345848|NCT02999152|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345849|NCT02999139|||Cohort||Prospective|||||||
1345850|NCT02999126|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1345851|NCT02999113|||Case-Only||Prospective|||||||
1345852|NCT02999100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345853|NCT02999087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345854|NCT02999074|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1345855|NCT02999061|||Other||Cross-Sectional|||||||
1345856|NCT02999048|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345857|NCT02999035|||Other||Other|||||||
1345858|NCT02999022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345859|NCT02999009||Single Group Assignment||Treatment||None (Open Label)||||||
1345860|NCT02998996|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1345861|NCT02998983||Single Group Assignment||Treatment||None (Open Label)||||||
1345862|NCT02998970|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1345863|NCT02998957|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345864|NCT02998944|||Case-Crossover||Cross-Sectional|||||||
1345865|NCT02998931|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345866|NCT02998918|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1345867|NCT02998905|Randomized|Parallel Assignment||Treatment||Single||||||t
1345868|NCT02998892|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345869|NCT02998879||Single Group Assignment||Treatment||None (Open Label)||||||
1345870|NCT02998866||Single Group Assignment||Treatment||None (Open Label)||||||
1345871|NCT02998853|||Cohort||Prospective|||||||
1345872|NCT02998840|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345873|NCT02998827|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1345874|NCT02998814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345875|NCT02998801|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1345876|NCT02998788|||Cohort||Prospective|||||||
1345877|NCT02998775|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1345878|NCT02998762|||Case-Only||Prospective|||||||
1345879|NCT02998749|||Case Control||Prospective|||||||
1345880|NCT02998736||Single Group Assignment||Prevention||None (Open Label)||||||
1345881|NCT02998723|Randomized|Parallel Assignment||Other||Single||||||t
1345882|NCT02998710|||Case-Only||Prospective|||||||
1345883|NCT02998697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345884|NCT02998684|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345885|NCT02998671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345886|NCT02998658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345887|NCT02998645||Single Group Assignment||Treatment||None (Open Label)||||||
1345888|NCT02998632|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345889|NCT02998619|||Other||Retrospective|||||||
1345890|NCT02998606|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345891|NCT02998593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345892|NCT02998580|Randomized|Parallel Assignment||Treatment||Single||||||t
1345893|NCT02998567|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1345894|NCT02998554|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345895|NCT02998541|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345896|NCT02998528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345897|NCT02998515|Randomized|Crossover Assignment||Treatment||Single|||t|||
1345898|NCT02998502|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1345899|NCT02998489|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345900|NCT02998476|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345901|NCT02998463|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1345902|NCT02998450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345903|NCT02998437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345904|NCT02998424|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1345905|NCT02998411|||Cohort||Prospective|||||||
1345906|NCT02998398|||Cohort||Retrospective|||||||
1345907|NCT02998385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345908|NCT02998372|||Other||Cross-Sectional|||||||
1345909|NCT02998359|Randomized|Parallel Assignment||Treatment||Single||||||t
1345910|NCT02998346|||Cohort||Prospective|||||||
1345911|NCT02998333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345912|NCT02998320||Single Group Assignment||Treatment||None (Open Label)||||||
1345913|NCT02998307|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1345914|NCT02998294||Single Group Assignment||Supportive Care||None (Open Label)||||||
1345915|NCT02998281|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1345916|NCT02998268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345917|NCT02998255|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1345918|NCT02998242|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1345919|NCT02998229||Single Group Assignment||Treatment||None (Open Label)||||||
1345920|NCT02998216|||Cohort||Prospective|||||||
1345921|NCT02998203|Randomized|Crossover Assignment||Other||Single|||||t|
1345922|NCT02998190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345923|NCT02998177|||Case-Only||Prospective|||||||
1345924|NCT02998164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345925|NCT02998151|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1345926|NCT02998138|||Cohort||Prospective|||||||
1345927|NCT02998125|||Cohort||Prospective|||||||
1345928|NCT02998112|Randomized|Parallel Assignment||Treatment||Single|||t|||
1345929|NCT02998099|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1345930|NCT02998086|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1345931|NCT02998073|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345932|NCT02998060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345933|NCT02998047||Single Group Assignment||Treatment||None (Open Label)||||||
1345934|NCT02998034|Randomized|Parallel Assignment||Treatment||Single||||||t
1345935|NCT02998021|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1345936|NCT02998008|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1345937|NCT02997995||Single Group Assignment||Treatment||None (Open Label)||||||
1345938|NCT02997982||Single Group Assignment||Treatment||None (Open Label)||||||
1345939|NCT02997969|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1345940|NCT02997956||Single Group Assignment||Treatment||None (Open Label)||||||
1345941|NCT02997943|Randomized|Factorial Assignment||Treatment||Single||||||t
1345942|NCT02997930||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345943|NCT02997917|Randomized|Parallel Assignment||Other||Single|||t|||
1345944|NCT02997904|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1345945|NCT02997891|||Case-Control||Prospective|||||||
1345946|NCT02997878|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345947|NCT02997865|Randomized|Parallel Assignment||Treatment||Single||||||t
1345948|NCT02997852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345949|NCT02997839|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1345950|NCT02997826||Single Group Assignment||||None (Open Label)||||||
1345951|NCT02997813|||Cohort||Retrospective|||||||
1345952|NCT02997800|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1345953|NCT02997787|||Case Control||Retrospective|||||||
1345954|NCT02997774|Randomized|Crossover Assignment||Other||Single|Neither subjects nor the investigator at the study visits will be blinded; however, analysis of imaging data will be performed with the operator blinded to allocation.|||||t
1345955|NCT02997761||Single Group Assignment||Treatment||None (Open Label)||||||
1345956|NCT02997748|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1345957|NCT02997735|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1345958|NCT02997722|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1345959|NCT02997709||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345960|NCT02997696|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345961|NCT02997683|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1345962|NCT02997670||Single Group Assignment||Treatment||None (Open Label)||||||
1345963|NCT02997657|Randomized|Parallel Assignment||Treatment||Single||||||t
1345964|NCT02997644|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1345965|NCT02997631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345966|NCT02997618|Randomized|Parallel Assignment||Prevention||Single||||||t
1345967|NCT02997605|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1345968|NCT02997592||Single Group Assignment||Treatment||None (Open Label)||||||
1345969|NCT02997579|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1345970|NCT02997566|||Case Control||Cross-Sectional|||||||
1345971|NCT02997553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345972|NCT02997540|||Case-Only||Prospective|||||||
1345973|NCT02997527||Single Group Assignment||Diagnostic||None (Open Label)||||||
1345974|NCT02997514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345977|NCT02997475|||Case-Control||Prospective|||||||
1345978|NCT02997462|||Cohort||Prospective|||||||
1345979|NCT02997449|||Cohort||Prospective|||||||
1345980|NCT02997436||Single Group Assignment||Treatment||None (Open Label)||||||
1345981|NCT02997423|||Other||Prospective|||||||
1345982|NCT02997410|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1345983|NCT02997397|||Case Control||Retrospective|||||||
1345984|NCT02997384|||Cohort||Prospective|||||||
1345985|NCT02997371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345986|NCT02997358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345987|NCT02997345|||Ecologic or Community||Other|||||||
1345988|NCT02997332||Single Group Assignment||Treatment||None (Open Label)||||||
1345989|NCT02997319|||Cohort||Cross-Sectional|||||||
1345990|NCT02997306|Randomized|Parallel Assignment||Treatment||Single||||||t
1345991|NCT02997293|||Cohort||Retrospective|||||||
1345992|NCT02997280||Single Group Assignment||Treatment||None (Open Label)||||||
1345993|NCT02997267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345994|NCT02997254|||Cohort||Retrospective|||||||
1345995|NCT02997241|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1345996|NCT02997228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1345997|NCT02997215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345998|NCT02997202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1345999|NCT02997189|Randomized|Parallel Assignment||Prevention||Single||||||t
1346000|NCT02997176|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346001|NCT02997163|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346002|NCT02997150||Single Group Assignment||Treatment||None (Open Label)||||||
1346003|NCT02997137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346004|NCT02997124|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346005|NCT02997111||Single Group Assignment||Other||None (Open Label)||||||
1346006|NCT02997098|||Cohort||Other|||||||
1346007|NCT02997085|Randomized|Parallel Assignment||Treatment||Single||||||t
1346008|NCT02997072|||Cohort||Prospective|||||||
1346009|NCT02997059|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346010|NCT02997046||Single Group Assignment||Diagnostic||||||||
1346011|NCT02997033|||Cohort||Prospective|||||||
1346012|NCT02997020|||Case-Control||Prospective|||||||
1346013|NCT02997007|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1346014|NCT02996994|||Cohort||Retrospective|||||||
1346015|NCT02996981|||Cohort||Retrospective|||||||
1346016|NCT02996968|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346017|NCT02996955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346018|NCT02996942|||Cohort||Prospective|||||||
1346019|NCT02996929||Single Group Assignment||Treatment||None (Open Label)||||||
1346020|NCT02996916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346021|NCT02996903|||Other||Prospective|||||||
1346022|NCT02996890|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346023|NCT02996877|||Cohort||Prospective|||||||
1346024|NCT02996864|Randomized|Parallel Assignment||Prevention||Single|||||t|
1346025|NCT02996851|||Ecologic or Community||Retrospective|||||||
1346026|NCT02996838||Single Group Assignment||Treatment||None (Open Label)||||||
1346027|NCT02996825||Single Group Assignment||Treatment||None (Open Label)||||||
1346028|NCT02996812|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1346029|NCT02996799|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1346030|NCT02996786|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346031|NCT02996773||Single Group Assignment||Treatment||None (Open Label)||||||
1346032|NCT02996760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346033|NCT02996747|||Case-Only||Retrospective|||||||
1346034|NCT02996734|||Case-Only||Retrospective|||||||
1346035|NCT02996721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346036|NCT02996708|||Cohort||Retrospective|||||||
1346037|NCT02996695|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1346038|NCT02996682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346039|NCT02996669|||Case-Control||Prospective|||||||
1346040|NCT02996656|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346041|NCT02996643|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346042|NCT02996630|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346043|NCT02996617|Randomized|Parallel Assignment||Treatment||Single||||||t
1346044|NCT02996604|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346045|NCT02996591|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346046|NCT02996578|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1346047|NCT02996565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346048|NCT02996552|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346049|NCT02996539|||Case-Only|||||||||
1346050|NCT02996526|||Cohort||Prospective|||||||
1346051|NCT02996513||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346052|NCT02996500|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346053|NCT02996487|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1346054|NCT02996474||Single Group Assignment||Treatment||None (Open Label)||||||
1346055|NCT02996461|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346056|NCT02996448||Single Group Assignment||Basic Science||None (Open Label)||||||
1346057|NCT02996435|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1346058|NCT02996422|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346059|NCT02996409|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346060|NCT02996396|||Cohort||Prospective|||||||
1346061|NCT02996383|Randomized|Parallel Assignment||Treatment||Single||||||t
1346062|NCT02996370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346063|NCT02996357|||Case-Control||Cross-Sectional|||||||
1346064|NCT02996344|Randomized|Parallel Assignment||Prevention||Single||||||t
1346065|NCT02996331|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346066|NCT02996318|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346067|NCT02996305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346068|NCT02996292|Randomized|Parallel Assignment||Treatment||Single||||||t
1346069|NCT02996279|||Cohort||Prospective|||||||
1346070|NCT02996266|Randomized|Parallel Assignment||Treatment||Single||||||t
1346071|NCT02996253|||Cohort||Prospective|||||||
1346072|NCT02996240||Single Group Assignment||Treatment||None (Open Label)||||||
1346073|NCT02996227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346074|NCT02996214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346075|NCT02996201|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1346076|NCT02996188|||Cohort||Prospective|||||||
1346077|NCT02996175|Randomized|Parallel Assignment||Treatment||Single|||||t|
1346078|NCT02996162|||Case-Only||Prospective|||||||
1346079|NCT02996149|||Case-Only||Prospective|||||||
1346080|NCT02996136|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1346081|NCT02996123|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346082|NCT02996110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346083|NCT02996097|Randomized|Parallel Assignment||Treatment||Single||||||t
1346084|NCT02996084|||Cohort||Prospective|||||||
1346085|NCT02996071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1346086|NCT02996058|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346087|NCT02996045|Randomized|Parallel Assignment||Health Services Research||||||||
1346088|NCT02996032|||Cohort||Prospective|||||||
1346089|NCT02996019|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346090|NCT02996006|||Case-Only||Cross-Sectional|||||||
1346091|NCT02995993||Single Group Assignment||Basic Science||None (Open Label)||||||
1346092|NCT02995980|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1346093|NCT02995967|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346094|NCT02995954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346095|NCT02995941|||Cohort||Cross-Sectional|||||||
1346096|NCT02995928|Randomized|Parallel Assignment||Treatment||Single||||||t
1346097|NCT02995915||Single Group Assignment||Treatment||None (Open Label)||||||
1346098|NCT02995902||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346099|NCT02995889||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346100|NCT02995876|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1346101|NCT02995863|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346102|NCT02995850||Single Group Assignment||Prevention||None (Open Label)||||||
1346103|NCT02995837|||Case-Control||Prospective|||||||
1346104|NCT02995824|||Cohort||Retrospective|||||||
1346105|NCT02995811|||Cohort||Prospective|||||||
1346106|NCT02995798|||Case Control||Retrospective|||||||
1346107|NCT02995785|Randomized|Parallel Assignment||||Single|||||t|
1346108|NCT02995772|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346109|NCT02995759|||Cohort||Prospective|||||||
1346110|NCT02995746||Single Group Assignment||Treatment||None (Open Label)||||||
1346111|NCT02995733|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1346112|NCT02995720|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346113|NCT02995707||Single Group Assignment||Treatment||None (Open Label)||||||
1346114|NCT02995694|Randomized|Parallel Assignment||||Double|||t||t|
1346115|NCT02995681|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346116|NCT02995668|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1346117|NCT02995655||Single Group Assignment||Treatment||None (Open Label)||||||
1346118|NCT02995642||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346119|NCT02995629|Randomized|Crossover Assignment||Treatment||Single|||t|||
1346120|NCT02995616||Single Group Assignment||Basic Science||None (Open Label)||||||
1346121|NCT02995603||||||||||||
1346122|NCT02995590||Single Group Assignment||Other||None (Open Label)||||||
1346123|NCT02995577|||Case Control||Prospective|||||||
1346124|NCT02995564||Single Group Assignment||Treatment||None (Open Label)||||||
1346125|NCT02995551|Randomized|Parallel Assignment||Treatment||Single|||||t|
1346126|NCT02995538|||Other||Other|||||||
1346127|NCT02995525|||Case-Only||Prospective|||||||
1346128|NCT02995512||Single Group Assignment||Treatment||None (Open Label)||||||
1346129|NCT02995499|||||Prospective|||||||
1346130|NCT02995486|Randomized|Parallel Assignment||Prevention||Single||||||t
1346131|NCT02995473|Randomized|Parallel Assignment||Treatment||Single|||||t|
1346132|NCT02995460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346133|NCT02995447|||Cohort||Prospective|||||||
1346134|NCT02995434|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1346135|NCT02995421||||||||||||
1346136|NCT02995408|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1346137|NCT02995395|||Case-Only||Prospective|||||||
1346138|NCT02995382||Single Group Assignment||Treatment||None (Open Label)||||||
1346139|NCT02995369|Randomized|Crossover Assignment||||None (Open Label)||||||
1346140|NCT02995356|||Case Control||Cross-Sectional|||||||
1346141|NCT02995343|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346142|NCT02995330||Single Group Assignment||Treatment||None (Open Label)||||||
1346143|NCT02995317|||Cohort||Prospective|||||||
1346144|NCT02995304|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1346145|NCT02995291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346146|NCT02995278|||Other||Other|||||||
1346147|NCT02995265|Randomized|Parallel Assignment||Treatment||Single||||||t
1346148|NCT02995252|||Cohort||Prospective|||||||
1346149|NCT02995239|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346150|NCT02995226|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1346151|NCT02995213||Single Group Assignment||Treatment||None (Open Label)||||||
1346152|NCT02995200|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346153|NCT02995187||Single Group Assignment||Treatment||None (Open Label)||||||
1346154|NCT02995174|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1346155|NCT02995161||Single Group Assignment||Prevention||None (Open Label)||||||
1346156|NCT02995148||Single Group Assignment||Prevention||None (Open Label)||||||
1346157|NCT02995135||Single Group Assignment||Prevention||None (Open Label)||||||
1346158|NCT02995122||Single Group Assignment||Prevention||None (Open Label)||||||
1346159|NCT02995109||Single Group Assignment||Prevention||None (Open Label)||||||
1346160|NCT02995096|||Cohort||Prospective|||||||
1346161|NCT02995083|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346162|NCT02995070|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346163|NCT02995057|||||Prospective|||||||
1346164|NCT02995044||Single Group Assignment||Prevention||None (Open Label)||||||
1346165|NCT02995031||Single Group Assignment||Prevention||None (Open Label)||||||
1346166|NCT02995018||Single Group Assignment||Prevention||None (Open Label)||||||
1346167|NCT02995005||Single Group Assignment||Prevention||None (Open Label)|No masking, just one interventional group.|Single group study.||||
1346168|NCT02994992||Single Group Assignment||Prevention||None (Open Label)||||||
1346169|NCT02994979|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1346170|NCT02994966|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346171|NCT02994953|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1346172|NCT02994940|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346173|NCT02994927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346174|NCT02994914|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1346175|NCT02994901|||Cohort||Cross-Sectional|||||||
1346176|NCT02994888|||Cohort||Prospective|||||||
1346177|NCT02994875|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1346178|NCT02994862|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346179|NCT02994849|||Cohort||Other|||||||
1346180|NCT02994836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346181|NCT02994823|||Case-Crossover||Prospective|||||||
1346182|NCT02994810|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346183|NCT02994797|||Cohort||Prospective|||||||
1346184|NCT02994784||Single Group Assignment||Treatment||None (Open Label)||||||
1346185|NCT02994771|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346186|NCT02994758||Single Group Assignment||Treatment||None (Open Label)||||||
1346187|NCT02994745|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346188|NCT02994732||Single Group Assignment||Other||None (Open Label)||||||
1346189|NCT02994719|||Case-Control||Cross-Sectional|||||||
1346190|NCT02994706|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346191|NCT02994693||Single Group Assignment||Screening||None (Open Label)||||||
1346192|NCT02994680|Randomized|Parallel Assignment||Prevention||Double|The clinical team is masked in this study, and a portion of the investigators.|||t|t|
1346193|NCT02994667|||Cohort||Prospective|||||||
1346194|NCT02994654|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346195|NCT02994641|||Cohort||Prospective|||||||
1346196|NCT02994628|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346197|NCT02994615|||Case-Control||Prospective|||||||
1346198|NCT02994602||Single Group Assignment||Other||None (Open Label)||||||
1346199|NCT02994589|Randomized|Factorial Assignment||Treatment||Single|||t|||
1346200|NCT02994576||Single Group Assignment||Treatment||None (Open Label)||||||
1346201|NCT02994563||Single Group Assignment||Treatment||None (Open Label)||||||
1346202|NCT02994550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346203|NCT02994537|||Cohort||Prospective|||||||
1346204|NCT02994524||Single Group Assignment||Treatment||None (Open Label)||||||
1346205|NCT02994511|||Other||Prospective|||||||
1346206|NCT02994498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346207|NCT02994485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346208|NCT02994472||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346209|NCT02994459|||Cohort||Cross-Sectional|||||||
1346210|NCT02994446||Single Group Assignment||Treatment||None (Open Label)||||||
1346211|NCT02994433|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1346212|NCT02994420|||Case-Control||Cross-Sectional|||||||
1346213|NCT02994407||Single Group Assignment||Treatment||None (Open Label)||||||
1346214|NCT02994394|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346215|NCT02994381||Single Group Assignment||Treatment||None (Open Label)||||||
1346216|NCT02994368|||Cohort||Prospective|||||||
1346217|NCT02994355|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1346218|NCT02994342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346219|NCT02994329|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346220|NCT02994316|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346221|NCT02994303|||Case-Only||Prospective|||||||
1346222|NCT02994290|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1346223|NCT02994277||Single Group Assignment||Treatment||None (Open Label)||||||
1346224|NCT02994264|||Case-Only||Retrospective|||||||
1346225|NCT02994251||Single Group Assignment||Treatment||None (Open Label)||||||
1346226|NCT02994238|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346227|NCT02994225||Single Group Assignment||Treatment||None (Open Label)||||||
1346228|NCT02994212||Single Group Assignment||Treatment||None (Open Label)||||||
1346229|NCT02994199||Single Group Assignment||Other||None (Open Label)||||||
1346230|NCT02994186|||Cohort||Prospective|||||||
1346231|NCT02994173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346232|NCT02994160||Single Group Assignment||Basic Science||None (Open Label)||||||
1346233|NCT02994147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346234|NCT02994134|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1346235|NCT02994121|||Cohort||Prospective|||||||
1346236|NCT02994108|Randomized|Parallel Assignment||Prevention||Single|||t|||
1346237|NCT02994095||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346238|NCT02994082|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1346239|NCT02994069|Randomized|Parallel Assignment||Treatment||None (Open Label)|Unblinded trial|||||
1346240|NCT02994056||Single Group Assignment||Treatment||None (Open Label)||||||
1346241|NCT02994043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346242|NCT02994030|||Cohort||Prospective|||||||
1346243|NCT02994017||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346244|NCT02994004|||||Prospective|||||||
1346245|NCT02993991||Single Group Assignment||Treatment||None (Open Label)||||||
1346246|NCT02993978|||Case Control||Prospective|||||||
1346247|NCT02993965|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1346248|NCT02993952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346249|NCT02993939|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1346250|NCT02993926|||Cohort||Retrospective|||||||
1346251|NCT02993913||Single Group Assignment||||None (Open Label)||||||
1346252|NCT02993900||Single Group Assignment||Treatment||None (Open Label)||||||
1346253|NCT02993887|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1346254|NCT02993874|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346255|NCT02993861|||Cohort||Prospective|||||||
1346256|NCT02993848|||Cohort||Prospective|||||||
1346257|NCT02993835|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1346258|NCT02993822|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346259|NCT02993809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346260|NCT02993796|||Cohort||Prospective|||||||
1346261|NCT02993783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346262|NCT02993770|Randomized|Parallel Assignment||Treatment||Single||||||t
1346263|NCT02993757|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346264|NCT02993744|||Cohort||Prospective|||||||
1346265|NCT02993731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346266|NCT02993718|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1346267|NCT02993705||Single Group Assignment||Treatment||None (Open Label)||||||
1346268|NCT02993692|Randomized|Parallel Assignment||Other||Single|||||t|
1346269|NCT02993679|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346270|NCT02993666|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346271|NCT02993653||Single Group Assignment||Treatment||None (Open Label)||||||
1346272|NCT02993640||Single Group Assignment||Basic Science||None (Open Label)||||||
1346273|NCT02993627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346274|NCT02993614|||Cohort||Prospective|||||||
1346275|NCT02993601|||Case-Control||Prospective|||||||
1346276|NCT02993588|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1346277|NCT02993575|||Case-Only||Prospective|||||||
1346278|NCT02993562|||Case-Control||Prospective|||||||
1346279|NCT02993549|||Cohort||Prospective|||||||
1346280|NCT02993536|||Cohort||Prospective|||||||
1346281|NCT02993523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346282|NCT02993510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346283|NCT02993497||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346284|NCT02993484|Randomized|Parallel Assignment||Basic Science||Single||||||t
1346285|NCT02993471|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1346286|NCT02993458|Randomized|Crossover Assignment||Prevention||Single||||||t
1346287|NCT02993445|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346288|NCT02993432|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1346289|NCT02993419|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346290|NCT02993406|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346291|NCT02993393|||||Cross-Sectional|||||||
1346292|NCT02993380|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346293|NCT02993367|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346294|NCT02993354|||Cohort||Prospective|||||||
1346295|NCT02993341|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346296|NCT02993328|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346297|NCT02993315|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346298|NCT02993302|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346299|NCT02993289|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1346300|NCT02993276|||Cohort||Prospective|||||||
1346301|NCT02993263||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346302|NCT02993250|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346303|NCT02993237|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1346304|NCT02993224||Single Group Assignment||Other||None (Open Label)||||||
1346305|NCT02993211|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1346306|NCT02993198|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346307|NCT02993185|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346308|NCT02993172|||Cohort||Prospective|||||||
1346309|NCT02993159|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346310|NCT02993146||Single Group Assignment||Treatment||None (Open Label)||||||
1346311|NCT02993133||Single Group Assignment||Treatment||None (Open Label)||||||
1346312|NCT02993120|||Cohort||Other|||||||
1346313|NCT02993107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346314|NCT02993094||Single Group Assignment||Treatment||None (Open Label)||||||
1346315|NCT02993081||||||||||||
1346316|NCT02993068|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346317|NCT02993055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346318|NCT02993042||Single Group Assignment||Treatment||None (Open Label)||||||
1346319|NCT02993029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346320|NCT02993016|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346321|NCT02993003|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1346322|NCT02992990||Single Group Assignment||||None (Open Label)||||||
1346323|NCT02992977||Single Group Assignment||Treatment||None (Open Label)||||||
1346324|NCT02992964||Single Group Assignment||Treatment||None (Open Label)||||||
1346325|NCT02992951|Randomized|Parallel Assignment||Prevention||Single||||||t
1346326|NCT02992938|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346327|NCT02992925|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346328|NCT02992912||Single Group Assignment||Treatment||None (Open Label)||||||
1346329|NCT02992899|Randomized|Parallel Assignment||Other||Single|||t|||
1346330|NCT02992886||Single Group Assignment||Treatment||None (Open Label)||||||
1346331|NCT02992873|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1346332|NCT02992860||Single Group Assignment||Treatment||None (Open Label)||||||
1346333|NCT02992847|||Cohort||Retrospective|||||||
1346334|NCT02992834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346335|NCT02992821||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346336|NCT02992808|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346337|NCT02992795|||Cohort||Prospective|||||||
1346338|NCT02992782|Randomized|Crossover Assignment||Treatment||Single||||||t
1346339|NCT02992769|||Cohort||Prospective|||||||
1346340|NCT02992756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346341|NCT02992743||Single Group Assignment||Treatment||||||||
1346342|NCT02992730|||Cohort||Cross-Sectional|||||||
1346343|NCT02992717|||Cohort||Prospective|||||||
1346344|NCT02992704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346345|NCT02992691|Randomized|Crossover Assignment||Treatment||||||||
1346346|NCT02992678|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1346347|NCT02992665|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346348|NCT02992652|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346349|NCT02992639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346350|NCT02992626|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1346351|NCT02992613|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346352|NCT02992600|||Case-Control||Prospective|||||||
1346353|NCT02992587|||Cohort||Prospective|||||||
1346354|NCT02992574|Randomized|Parallel Assignment||Treatment||None (Open Label)||Arm Experimental Post Mastectomy Radiotherapy Arm No Intervention: No Post Mastectomy Radiotherapy||||
1346355|NCT02992561|Randomized|Parallel Assignment||Treatment||Single||||||t
1346356|NCT02992548||Single Group Assignment||Treatment||None (Open Label)||||||
1346357|NCT02992535||Single Group Assignment||Treatment||None (Open Label)||||||
1346358|NCT02992522||Single Group Assignment||Treatment||None (Open Label)||||||
1346359|NCT02992509||Single Group Assignment||Treatment||None (Open Label)||||||
1346360|NCT02992496|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1346361|NCT02992483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1346362|NCT02992470|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1346363|NCT02992457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346364|NCT02992444||Single Group Assignment||Basic Science||None (Open Label)||||||
1346365|NCT02992431|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346366|NCT02992418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346367|NCT02992405|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346368|NCT02992392|Randomized|Parallel Assignment||Treatment||Single||||||t
1346369|NCT02992379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346370|NCT02992366|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346371|NCT02992353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346372|NCT02992340||Single Group Assignment||Treatment||None (Open Label)||||||
1346373|NCT02992327|||Cohort||Prospective|||||||
1346374|NCT02992314|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1346375|NCT02992301||Single Group Assignment||Treatment||None (Open Label)||||||
1346376|NCT02992288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346377|NCT02992275||Single Group Assignment||Treatment||None (Open Label)||||||
1346378|NCT02992262||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346379|NCT02992249|||Case-Only||Prospective|||||||
1346380|NCT02992236|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1346381|NCT02992223|||Cohort||Retrospective|||||||
1346382|NCT02992210||Single Group Assignment||Treatment||None (Open Label)||||||
1346383|NCT02992197|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346384|NCT02992184|||Case Control||Retrospective|||||||
1346385|NCT02992171||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346386|NCT02992158|Randomized|Parallel Assignment||Treatment||Single||||||t
1346387|NCT02992145|||Case Control||Retrospective|||||||
1346388|NCT02992132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346389|NCT02992119|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized 7 groups||||
1346390|NCT02992106|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1346391|NCT02992093|||||Prospective|||||||
1346392|NCT02992080|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346393|NCT02992067|||Case-Control||Prospective|||||||
1346394|NCT02992054|||Case Control||Prospective|||||||
1346395|NCT02992041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346396|NCT02992028|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1346397|NCT02992015||Single Group Assignment||Basic Science||None (Open Label)||||||
1346398|NCT02992002|||Cohort||Prospective|||||||
1346399|NCT02991989|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1346400|NCT02991976|Randomized|Parallel Assignment||Prevention||Single|||t|||
1346401|NCT02991963|||Case-Control||Prospective|||||||
1346402|NCT02991950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346403|NCT02991937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346404|NCT02991924|||Case-Only||Prospective|||||||
1346405|NCT02991911|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1346406|NCT02991898||Single Group Assignment||Treatment||None (Open Label)||||||
1346407|NCT02991885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346408|NCT02991872||Single Group Assignment||Prevention||None (Open Label)||||||
1346409|NCT02991859|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1346410|NCT02991846|||Cohort||Prospective|||||||
1346411|NCT02991833|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1346412|NCT02991820|Randomized|Parallel Assignment||Other||||||||
1346413|NCT02991807|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346414|NCT02991794|||Cohort||Prospective|||||||
1346415|NCT02991781|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346416|NCT02991768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346417|NCT02991742|||Cohort||Prospective|||||||
1346418|NCT02991729|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346419|NCT02991716|||Cohort||Prospective|||||||
1346420|NCT02991703|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346421|NCT02991690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346422|NCT02991677|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1346423|NCT02991664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346424|NCT02991651|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346425|NCT02991638||Single Group Assignment||Treatment||None (Open Label)||||||
1346426|NCT02991625|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1346427|NCT02991612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346428|NCT02991599|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346429|NCT02991586|Randomized|Parallel Assignment||Treatment||Single||||||t
1346430|NCT02991573|Randomized|Parallel Assignment||Other||Double|||t|||t
1346431|NCT02991560|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1346432|NCT02991547|||Cohort||Prospective|||||||
1346433|NCT02991534||Single Group Assignment||Health Services Research||None (Open Label)||||||
1346434|NCT02991521||Single Group Assignment||Treatment||None (Open Label)||||||
1346435|NCT02991508|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346436|NCT02991495|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1346437|NCT02991482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346438|NCT02991469||Single Group Assignment||Treatment||None (Open Label)||||||
1346439|NCT02991456|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1346440|NCT02991443||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346441|NCT02991430|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346442|NCT02991417||Single Group Assignment||Prevention||None (Open Label)||||||
1346443|NCT02991404|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1346444|NCT02991391|||Cohort||Prospective|||||||
1346445|NCT02991378|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346446|NCT02991365|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1346447|NCT02991352||Single Group Assignment||Treatment||None (Open Label)||||||
1346448|NCT02991339|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346449|NCT02991326|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346450|NCT02991313||Single Group Assignment||Treatment||None (Open Label)||||||
1346451|NCT02991300|||Case-Only||Other|||||||
1346452|NCT02991287|||Cohort||Prospective|||||||
1346453|NCT02991274||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346454|NCT02991261|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346455|NCT02991248|Randomized|Parallel Assignment||Treatment||Single||||||t
1346456|NCT02991235|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1346457|NCT02991222|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346458|NCT02991209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346459|NCT02991196||Single Group Assignment||Basic Science||None (Open Label)||||||
1346460|NCT02991183||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346461|NCT02991170|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346462|NCT02991157|||Cohort||Prospective|||||||
1346463|NCT02991144|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346464|NCT02991131|||Cohort||Prospective|||||||
1346465|NCT02991118|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346466|NCT02991105|||Cohort||Retrospective|||||||
1346467|NCT02991092|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1346468|NCT02991079|Randomized|Parallel Assignment||Prevention||Single||||||t
1346469|NCT02991066|||Case-Control||Prospective|||||||
1346470|NCT02991053|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1346471|NCT02991040||Single Group Assignment||Treatment||Double|The side of the face for each product was randomly assigned. The investigator performing the evaluations and the subject were blinded to the treatment; injections of the study product were performed by an unblinded injecting investigator.|Subjects were treated with Revanesse Ultra in the NLF on one side of the face and Revanesse Ultra+ in the NLF on the other side of the face. The side of the face for each study product was randomly assigned.|t|||t
1346472|NCT02991027||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346473|NCT02991014|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346474|NCT02991001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346475|NCT02990988|||Other||Prospective|||||||
1346476|NCT02990975|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1346477|NCT02990962|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346478|NCT02990949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346479|NCT02990936|||Cohort||Prospective|||||||
1346480|NCT02990923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346481|NCT02990910|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346482|NCT02990897|Randomized|Parallel Assignment||Prevention||Single|||t|||
1346483|NCT02990884|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1346484|NCT02990871|||Case Control||Retrospective|||||||
1346485|NCT02990858||Single Group Assignment||Treatment||None (Open Label)||||||
1346486|NCT02990845||Single Group Assignment||Treatment||None (Open Label)||||||
1346487|NCT02990832||Single Group Assignment||Treatment||None (Open Label)||||||
1346488|NCT02990819|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346489|NCT02990806|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1346490|NCT02990793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346491|NCT02990780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346492|NCT02990767|||Cohort||Prospective|||||||
1346493|NCT02990754||Single Group Assignment||Prevention||None (Open Label)||||||
1346494|NCT02990741|||Cohort||Prospective|||||||
1346495|NCT02990728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346496|NCT02990715|Non-Randomized|Parallel Assignment||Diagnostic||Double|The colonoscopists will be blinded to the C-Scan system results and FIT results and the reviewers of C-Scan system results will be blinded to Fit and colonoscopy results|||t|t|
1346497|NCT02990702|Randomized|Parallel Assignment||||Double|||||t|t
1346498|NCT02990689|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346499|NCT02990676|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1346500|NCT02990663|Randomized|Parallel Assignment||Treatment||Single||||||t
1346501|NCT02990650|Randomized|Parallel Assignment||Treatment||Single||||||t
1346502|NCT02990637|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1346503|NCT02990624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346504|NCT02990611|||Cohort||Prospective|||||||
1346505|NCT02990598|||Other||Prospective|||||||
1346506|NCT02990585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346507|NCT02990572|||Other||Other|||||||
1346508|NCT02990559|||Other||Prospective|||||||
1346509|NCT02990546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346510|NCT02990533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346511|NCT02990520|||Cohort||Prospective|||||||
1346512|NCT02990507||Single Group Assignment||Other||None (Open Label)||||||
1346513|NCT02990494|Randomized|Parallel Assignment||Treatment||Single||||||t
1346514|NCT02990481|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1346515|NCT02990468||Single Group Assignment||Treatment||None (Open Label)||||||
1346516|NCT02990455|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1346517|NCT02990442||Single Group Assignment||Treatment||None (Open Label)||||||
1346518|NCT02990429|Randomized|Crossover Assignment||Health Services Research||Triple|||t||t|t
1346519|NCT02990416||Single Group Assignment||Treatment||None (Open Label)||||||
1346520|NCT02990403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346521|NCT02990390|||Cohort|||||||||
1346522|NCT02990377|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346523|NCT02990364|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1346524|NCT02990351|||Cohort||Retrospective|||||||
1346525|NCT02990338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346526|NCT02990325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346527|NCT02990312||Single Group Assignment||Treatment||None (Open Label)||||||
1346528|NCT02990299|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1346529|NCT02990286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346530|NCT02990273|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346531|NCT02990260|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1346532|NCT02990247||Single Group Assignment||Health Services Research||None (Open Label)||||||
1346533|NCT02990234|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346534|NCT02990221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346535|NCT02990208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346536|NCT02990195||Single Group Assignment||Other||None (Open Label)||||||
1346537|NCT02990182|||Cohort||Prospective|||||||
1346538|NCT02990169|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346539|NCT02990156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346540|NCT02990143|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346541|NCT02990130|||Cohort||Prospective|||||||
1346542|NCT02990117|||||Cross-Sectional|||||||
1346543|NCT02990104|||Case-Only||Retrospective|||||||
1346544|NCT02990091|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1346545|NCT02990078|||Cohort||Prospective|||||||
1346546|NCT02990065|Randomized|Parallel Assignment||Prevention||Single|||t|||
1346547|NCT02990052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346548|NCT02990039|Randomized|Parallel Assignment||||Single|||t|||
1346549|NCT02990026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346550|NCT02990013||Single Group Assignment||Basic Science||None (Open Label)||||||
1346551|NCT02990000|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1346552|NCT02989987|Randomized|Parallel Assignment||Treatment||Single||||||t
1346553|NCT02989974|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346554|NCT02989961|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1346555|NCT02989948||Single Group Assignment||Treatment||None (Open Label)||||||
1346556|NCT02989935||Single Group Assignment||Basic Science||None (Open Label)||Study of RELVAR drug effect on respiratory physiology variables including breathing pattern, and EMG.||||
1346557|NCT02989922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346558|NCT02989909|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346559|NCT02989896|||Cohort||Prospective|||||||
1346560|NCT02989883||Single Group Assignment||Treatment||None (Open Label)||||||
1346561|NCT02989870||Single Group Assignment||Treatment||None (Open Label)||||||
1346562|NCT02989857|Randomized|Parallel Assignment||Treatment||Double||Patients randomized in a 2:1 allocation (AG-120 vs Placebo)|t||t|
1346563|NCT02989844||Single Group Assignment||Treatment||None (Open Label)||||||
1346564|NCT02989831|Non-Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1346565|NCT02989818|||Cohort||Prospective|||||||
1346566|NCT02989805|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346567|NCT02989792||Single Group Assignment||Basic Science||None (Open Label)||||||
1346568|NCT02989779|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1346569|NCT02989766|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346570|NCT02989753|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346571|NCT02989740|||Cohort||Prospective|||||||
1346572|NCT02989727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346573|NCT02989714||Single Group Assignment||Treatment||None (Open Label)||||||
1346574|NCT02989701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1346575|NCT02989688|Randomized|Crossover Assignment||Treatment||Single|||t|||
1346576|NCT02989675|Randomized|Parallel Assignment||Treatment||Single||||||t
1346577|NCT02989662|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1346578|NCT02989649|||Cohort||Prospective|||||||
1346579|NCT02989636|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346580|NCT02989623||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346581|NCT02989610|||Case-Crossover||Prospective|||||||
1346582|NCT02989597|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346583|NCT02989584||Single Group Assignment||Treatment||None (Open Label)||||||
1346584|NCT02989571|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1346585|NCT02989558|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346586|NCT02989545|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346587|NCT02989519|Randomized|Parallel Assignment||Prevention||Single||||||t
1346588|NCT02989493|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346589|NCT02989480|||Other||Prospective|||||||
1346590|NCT02989467|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346591|NCT02989454|||Case-Only||Retrospective|||||||
1346592|NCT02989441|||Cohort||Prospective|||||||
1346593|NCT02989428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346594|NCT02989415|||Cohort||Prospective|||||||
1346595|NCT02989402||Single Group Assignment||Treatment||None (Open Label)||||||
1346596|NCT02989389|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1346597|NCT02989376||Single Group Assignment||Treatment||None (Open Label)||||||
1346598|NCT02989363|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346599|NCT02989350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346600|NCT02989337|||Case Control||Cross-Sectional|||||||
1346601|NCT02989324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346602|NCT02989311|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1346603|NCT02989298|||Cohort||Prospective|||||||
1346604|NCT02989285|||Cohort||Prospective|||||||
1346605|NCT02989272|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346606|NCT02989259||Single Group Assignment||Treatment||None (Open Label)||||||
1346607|NCT02989246||Single Group Assignment||Treatment||None (Open Label)||||||
1346608|NCT02989233|Non-Randomized|Parallel Assignment||Prevention||Double|||t||t|
1346609|NCT02989220|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346610|NCT02989207|Randomized|Parallel Assignment||Treatment||Single||||||t
1346611|NCT02989194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346612|NCT02989181|Randomized|Parallel Assignment||Treatment||Single|||||t|
1346613|NCT02989168||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346614|NCT02989155|||Other||Retrospective|||||||
1346615|NCT02989142|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346616|NCT02989129|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346617|NCT02989116|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1346618|NCT02989103|||Cohort||Prospective|||||||
1346619|NCT02989090|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346620|NCT02989077|||Case Control||Cross-Sectional|||||||
1346621|NCT02989064||Single Group Assignment||Treatment||None (Open Label)||||||
1346622|NCT02989051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346623|NCT02989038|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1346624|NCT02989025||Single Group Assignment||Treatment||None (Open Label)||||||
1346625|NCT02989012|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1346626|NCT02988999|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346627|NCT02988986||Single Group Assignment||Treatment||None (Open Label)||||||
1346628|NCT02988973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346629|NCT02988960|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346630|NCT02988947|Randomized|Parallel Assignment||Prevention||Single||||||t
1346631|NCT02988934|||Cohort||Prospective|||||||
1346632|NCT02988921||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346633|NCT02988908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346634|NCT02988895||Single Group Assignment||Treatment||None (Open Label)||||||
1346635|NCT02988882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346636|NCT02988869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346637|NCT02988856||Single Group Assignment||Treatment||None (Open Label)||||||
1346638|NCT02988843||Single Group Assignment||Treatment||None (Open Label)||||||
1346639|NCT02988830||Single Group Assignment||Treatment||None (Open Label)||||||
1346640|NCT02988817||Single Group Assignment||Treatment||None (Open Label)||||||
1346641|NCT02988804|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346642|NCT02988791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346643|NCT02988778|Randomized|Parallel Assignment||Treatment||Single|||||t|
1346644|NCT02988765||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346645|NCT02988752|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1346646|NCT02988739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346647|NCT02988726||Single Group Assignment||Treatment||None (Open Label)||||||
1346648|NCT02988713||Single Group Assignment||Basic Science||None (Open Label)||||||
1346649|NCT02988700|Randomized|Parallel Assignment||Treatment||Double||||t||t
1346650|NCT02988687|||Cohort||Prospective|||||||
1346651|NCT02988674|||Cohort||Prospective|||||||
1346652|NCT02988661|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346653|NCT02988648||Single Group Assignment||Treatment||None (Open Label)||||||
1346654|NCT02988635|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346655|NCT02988622||Single Group Assignment||Treatment||None (Open Label)||||||
1346656|NCT02988609|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1346657|NCT02988596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346658|NCT02988583|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346659|NCT02988570||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346660|NCT02988557||Single Group Assignment||Treatment||None (Open Label)||||||
1346661|NCT02988544|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346662|NCT02988531||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346663|NCT02988518||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346664|NCT02988505|||Cohort||Prospective|||||||
1346665|NCT02988492||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346666|NCT02988479|||Cohort||Prospective|||||||
1346667|NCT02988466|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346668|NCT02988453|Randomized|Parallel Assignment||Treatment||Single||||||t
1346669|NCT02988440|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1346670|NCT02988427|||Case-Control||Cross-Sectional|||||||
1346671|NCT02988414|||Cohort||Other|||||||
1346672|NCT02988401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346673|NCT02988388|||Case-Only||Cross-Sectional|||||||
1346674|NCT02988375|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346675|NCT02988362|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346676|NCT02988349|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346677|NCT02988336|||Cohort||Prospective|||||||
1346678|NCT02988323|Randomized|Parallel Assignment||Treatment||Single||||||t
1346679|NCT02988310|||||Cross-Sectional|||||||
1346680|NCT02988297|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346681|NCT02988284|||||Cross-Sectional|||||||
1346682|NCT02988271|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346683|NCT02988258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1346684|NCT02988245|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346685|NCT02988232|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346686|NCT02988219|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346687|NCT02988206|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1346688|NCT02988193|Randomized|Parallel Assignment||Other||None (Open Label)|No masking was used. This is not a drug efficacy trial, but a approved drugs medication optimization trial.|The Drug intervention between arms differs in that the optima4BP arm uses an artificial intelligence algorithm to optimize drug treatment.||||
1346689|NCT02988180|Randomized|Parallel Assignment||||Single|||||t|
1346690|NCT02988167|||Case-Only||Prospective|||||||
1346691|NCT02988154|||Other||Prospective|||||||
1346692|NCT02988141|||Other||Prospective|||||||
1346693|NCT02988128|||Cohort||Prospective|||||||
1346694|NCT02988115|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346695|NCT02988102|||Cohort||Prospective|||||||
1346696|NCT02988089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346697|NCT02988076|Randomized|Parallel Assignment||Treatment||Double|The subject is masked as to assignment to Control or Treatment Group. The subject acts as the blinded rater - providing the primary outcome measure - the Quick Inventory of Depressive Symptomatology - 16 Item Self report||t|||t
1346698|NCT02988063||Single Group Assignment||Treatment||None (Open Label)||||||
1346699|NCT02988050|Randomized|Crossover Assignment||||Double|||t|||t
1346700|NCT02988037||Single Group Assignment||Treatment||None (Open Label)||||||
1346701|NCT02988024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346702|NCT02988011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346703|NCT02987998||Single Group Assignment||Treatment||None (Open Label)||||||
1346704|NCT02987985|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1346705|NCT02987972|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1346706|NCT02987959||Single Group Assignment||Treatment||None (Open Label)||||||
1346707|NCT02987946|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346708|NCT02987933|||Case Control||Prospective|||||||
1346709|NCT02987920|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346710|NCT02987907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346711|NCT02987894|||Cohort||Prospective|||||||
1346712|NCT02987881||Single Group Assignment||Supportive Care||None (Open Label)|Open Label|||||
1346713|NCT02987868|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1346714|NCT02987855|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1346715|NCT02987842|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346716|NCT02987829||Single Group Assignment||Treatment||None (Open Label)||||||
1346717|NCT02987816|Randomized|Parallel Assignment||Other||Double|||t|||t
1346718|NCT02987803|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1346719|NCT02987790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346720|NCT02987777|||Case-Only||Retrospective|||||||
1346721|NCT02987764|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1346722|NCT02987751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346723|NCT02987738|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1346724|NCT02987725|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346725|NCT02987712|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346726|NCT02987699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346727|NCT02987686|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346728|NCT02987673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346729|NCT02987660|Randomized|Parallel Assignment||Treatment||Single||||||t
1346730|NCT02987647|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346731|NCT02987634|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346732|NCT02987621|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1346733|NCT02987608|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346734|NCT02987595|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1346735|NCT02987582||Single Group Assignment||Treatment||None (Open Label)||||||
1346736|NCT02987569|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346737|NCT02987556|Randomized|Crossover Assignment||Treatment||None (Open Label)||Closed loop vs. Open loop,||||
1346738|NCT02987543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346739|NCT02987530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346740|NCT02987517|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346741|NCT02987504||Single Group Assignment||Treatment||None (Open Label)||||||
1346742|NCT02987491|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1346743|NCT02987478|||Cohort||Prospective|||||||
1346744|NCT02987465|||Case-Control||Prospective|||||||
1346745|NCT02987452|Randomized|Crossover Assignment||Treatment||Single|||||t|
1346746|NCT02987439|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346747|NCT02987426|Randomized|Parallel Assignment||Supportive Care||Single||Mindfulness Intervention||||t
1346748|NCT02987413||Single Group Assignment||Treatment||None (Open Label)||||||
1346749|NCT02987400||Single Group Assignment||Treatment||None (Open Label)||||||
1346750|NCT02987387||Single Group Assignment||Treatment||None (Open Label)||||||
1346751|NCT02987374||Single Group Assignment||Basic Science||None (Open Label)||||||
1346752|NCT02987361|Randomized|Factorial Assignment||||Double|||t||t|
1346753|NCT02987348|||Cohort||Retrospective|||||||
1346754|NCT02987335|||Case-Control||Prospective|||||||
1346755|NCT02987322||Single Group Assignment||Treatment||None (Open Label)||||||
1346756|NCT02987309|||Cohort||Prospective|||||||
1346757|NCT02987296|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346758|NCT02987283|||Cohort||Prospective|||||||
1346759|NCT02987270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346760|NCT02987257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346761|NCT02987244||Single Group Assignment||Treatment||None (Open Label)||||||
1346762|NCT02987231|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346763|NCT02987218|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1346764|NCT02987205|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1346765|NCT02987192|Randomized|Parallel Assignment||Treatment||Single||||||t
1346766|NCT02987179|||Cohort||Prospective|||||||
1346767|NCT02987166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346768|NCT02987153||Single Group Assignment||Treatment||None (Open Label)||||||
1346769|NCT02987140|Randomized|Factorial Assignment||Screening||Single||||||t
1346770|NCT02987127|||Case-Only||Prospective|||||||
1346771|NCT02987114||Single Group Assignment||Treatment||None (Open Label)||||||
1346772|NCT02987101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346773|NCT02987088||Single Group Assignment||Treatment||None (Open Label)||||||
1346774|NCT02987075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346775|NCT02987062|||Cohort||Retrospective|||||||
1346776|NCT02987049|||Cohort||Prospective|||||||
1346777|NCT02987036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346778|NCT02987023|||Cohort||Prospective|||||||
1346779|NCT02987010|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346780|NCT02986997|||Other||Retrospective|||||||
1346781|NCT02986984|||Cohort||Prospective|||||||
1346782|NCT02986971||Single Group Assignment||Health Services Research||None (Open Label)||||||
1346783|NCT02986958|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1346784|NCT02986945|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346785|NCT02986932||Single Group Assignment||Treatment||None (Open Label)||Transcranial ExAblate||||
1346786|NCT02986919||Single Group Assignment||Treatment||None (Open Label)||||||
1346787|NCT02986906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346788|NCT02986893|Randomized|Parallel Assignment||Treatment||Single||||||t
1346789|NCT02986880|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346790|NCT02986867||Single Group Assignment||Basic Science||None (Open Label)||||||
1346791|NCT02986854|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346792|NCT02986841|||Ecologic or Community||Prospective|||||||
1346793|NCT02986828|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346794|NCT02986815||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346795|NCT02986802|||Cohort||Prospective|||||||
1346796|NCT02986789||||||||||||
1346797|NCT02986776|Randomized|Parallel Assignment||Treatment||Single||||||t
1346798|NCT02986763|||Cohort||Cross-Sectional|||||||
1346799|NCT02986750|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1346800|NCT02986737||Single Group Assignment||Device Feasibility||None (Open Label)||Medical device trial||||
1346801|NCT02986724|||Cohort||Prospective|||||||
1346802|NCT02986711|Randomized|Parallel Assignment||Treatment||Single|||||t|
1346803|NCT02986698||Single Group Assignment||Treatment||None (Open Label)||||||
1346804|NCT02986685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346805|NCT02986672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346806|NCT02986659|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1346807|NCT02986646|||Case-Only||Prospective|||||||
1346808|NCT02986633|||Cohort||Prospective|||||||
1346809|NCT02986620|||Case-Only||Prospective|||||||
1346810|NCT02986607||Single Group Assignment||Basic Science||None (Open Label)||||||
1346811|NCT02986594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346812|NCT02986581|||Cohort||Prospective|||||||
1346813|NCT02986568|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346814|NCT02986555|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1346815|NCT02986542|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1346816|NCT02986529|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1346817|NCT02986516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346818|NCT02986503|||||Prospective|||||||
1346819|NCT02986490||Single Group Assignment||Prevention||None (Open Label)||||||
1346820|NCT02986477||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346821|NCT02986464|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346822|NCT02986451||Single Group Assignment||Treatment||None (Open Label)||||||
1346823|NCT02986438|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346824|NCT02986425|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346825|NCT02986412||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346826|NCT02986399|||Cohort||Retrospective|||||||
1347060|NCT02983357|||Case-Only||Prospective|||||||
1346827|NCT02986386|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346828|NCT02986373||Single Group Assignment||Treatment||None (Open Label)||||||
1346829|NCT02986360|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1346830|NCT02986347|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|open label|||||
1346831|NCT02986334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346832|NCT02986321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346833|NCT02986308|||Case-Control||Prospective|||||||
1346834|NCT02986295|||Cohort||Prospective|||||||
1346835|NCT02986282||Single Group Assignment||Diagnostic||None (Open Label)||||||
1346836|NCT02986269|Randomized|Parallel Assignment||||Single||||||t
1346837|NCT02986256|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346838|NCT02986243||Single Group Assignment||Treatment||None (Open Label)||||||
1346839|NCT02986230|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1346840|NCT02986217|Randomized|Parallel Assignment||Other||Single||||||t
1346841|NCT02986204|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346842|NCT02986191|Randomized|Crossover Assignment||Treatment||Single||||||t
1346843|NCT02986178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346844|NCT02986165|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1346845|NCT02986152|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346846|NCT02986139|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1346847|NCT02986126|Randomized|Parallel Assignment||Prevention||Single||||||t
1346848|NCT02986113|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1346849|NCT02986100||Single Group Assignment||Other||None (Open Label)|Open Label|||||
1346850|NCT02986087||Single Group Assignment||Treatment||None (Open Label)||||||
1346851|NCT02986074|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1346852|NCT02986061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346853|NCT02986048|||Cohort||Prospective|||||||
1346854|NCT02986035||Single Group Assignment||Treatment||None (Open Label)||||||
1346855|NCT02986022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346856|NCT02986009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346857|NCT02985996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346858|NCT02985983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346859|NCT02985970|||Other||Prospective|||||||
1346860|NCT02985957|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346861|NCT02985944|||Cohort||Prospective|||||||
1346862|NCT02985931|||Cohort||Prospective|||||||
1346863|NCT02985918|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346864|NCT02985905|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346865|NCT02985892|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1346866|NCT02985879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1346867|NCT02985866|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1346868|NCT02985853|||Case Control||Prospective|||||||
1346869|NCT02985840|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346870|NCT02985827|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1346871|NCT02985814|||Other||Prospective|||||||
1346872|NCT02985801|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1346873|NCT02985788|||Other||Prospective|||||||
1346874|NCT02985775||Single Group Assignment||Prevention||None (Open Label)||||||
1346875|NCT02985762||Single Group Assignment||Treatment||None (Open Label)||||||
1346876|NCT02985749||Single Group Assignment||Treatment||None (Open Label)||||||
1346877|NCT02985736||Single Group Assignment||Treatment||None (Open Label)||||||
1346878|NCT02985723||Single Group Assignment||Treatment||None (Open Label)||||||
1346879|NCT02985710|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1346880|NCT02985697|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1346881|NCT02985684||Single Group Assignment||Treatment||None (Open Label)||||||
1346882|NCT02985671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346883|NCT02985658||||||||||||
1346884|NCT02985645||Single Group Assignment||Treatment||None (Open Label)||||||
1346885|NCT02985632|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346886|NCT02985619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346887|NCT02985606|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1346888|NCT02985593|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346889|NCT02985580|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1346890|NCT02985567|||Cohort||Prospective|||||||
1346891|NCT02985554||Single Group Assignment||Treatment||None (Open Label)||||||
1346892|NCT02985541||Single Group Assignment||Treatment||None (Open Label)||||||
1346893|NCT02985528|||Case-Only||Prospective|||||||
1346894|NCT02985515||Single Group Assignment||Treatment||None (Open Label)||||||
1346895|NCT02985502|||Case-Only||Cross-Sectional|||||||
1346896|NCT02985489|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1346897|NCT02985476|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1346898|NCT02985463|||Cohort||Prospective|||||||
1346899|NCT02985450|||Cohort||Prospective|||||||
1346900|NCT02985437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346901|NCT02985424|||Cohort||Prospective|||||||
1346902|NCT02985411|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1346903|NCT02985398||Single Group Assignment||Prevention||None (Open Label)||||||
1346904|NCT02985385|||Cohort||Prospective|||||||
1346905|NCT02985372||Single Group Assignment||Treatment||None (Open Label)||||||
1346906|NCT02985359|||Other||Cross-Sectional|||||||
1346907|NCT02985346|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346908|NCT02985333||Single Group Assignment||Treatment||None (Open Label)||||||
1346909|NCT02985320|Randomized|Parallel Assignment||Prevention||Single|||t|||
1346910|NCT02985307|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346911|NCT02985294|||Cohort||Prospective|||||||
1346912|NCT02985281|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1346913|NCT02985268|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1346914|NCT02985255||Single Group Assignment||Treatment||None (Open Label)||||||
1346915|NCT02985242|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346916|NCT02985229||Single Group Assignment||Treatment||None (Open Label)||||||
1346917|NCT02985216|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346918|NCT02985203|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346919|NCT02985190||Single Group Assignment||Treatment||None (Open Label)||||||
1346920|NCT02985177|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346921|NCT02985164|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346922|NCT02985151|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1346923|NCT02985138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346924|NCT02985125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1346925|NCT02985112|||Cohort||Prospective|||||||
1346926|NCT02985099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346927|NCT02985086|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346928|NCT02985073|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346929|NCT02985060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346930|NCT02985047|Randomized|Parallel Assignment||Treatment||Single||||||t
1346931|NCT02985034|||Cohort||Prospective|||||||
1346932|NCT02985021||Single Group Assignment||Treatment||None (Open Label)||||||
1346933|NCT02985008|||Cohort|||||||||
1346934|NCT02984995||Single Group Assignment||Treatment||None (Open Label)||||||
1346935|NCT02984982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346936|NCT02984969|||Cohort||Prospective|||||||
1346937|NCT02984956|||Cohort||Prospective|||||||
1346938|NCT02984943||Single Group Assignment||Treatment||None (Open Label)||||||
1346939|NCT02984930|Randomized|Single Group Assignment||Treatment||Single|||t|||
1346940|NCT02984917|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1346941|NCT02984904|||||Cross-Sectional|||||||
1346942|NCT02984891|||Cohort||Prospective|||||||
1346943|NCT02984878||Single Group Assignment||Treatment||None (Open Label)||||||
1346944|NCT02984865|Randomized|Parallel Assignment||Treatment||Triple||The first group was designed to observe the advantage of transversus abdominis plane (TAP) block combined with rectus sheath (RS) block in PD catheter placement surgery, which is independent from other 4 groups.|t|t||t
1346945|NCT02984852|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346946|NCT02984839|||Other||Cross-Sectional|||||||
1346947|NCT02984826|Randomized|Parallel Assignment||||Single||||||t
1346948|NCT02984813|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1346949|NCT02984800|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1346950|NCT02984787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346951|NCT02984774|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1346952|NCT02984761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346953|NCT02984748|||Cohort||Prospective|||||||
1346954|NCT02984735|||Cohort||Cross-Sectional|||||||
1346955|NCT02984722|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346956|NCT02984709|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1346957|NCT02984696||Single Group Assignment||Treatment||None (Open Label)||||||
1346958|NCT02984683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346959|NCT02984670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346960|NCT02984657|||Cohort||Retrospective|||||||
1346961|NCT02984644|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346962|NCT02984631|Non-Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1346963|NCT02984618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346964|NCT02984605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346965|NCT02984592|||Cohort||Cross-Sectional|||||||
1346966|NCT02984579|||Other||Cross-Sectional|||||||
1346967|NCT02984566||Single Group Assignment||Treatment||None (Open Label)||||||
1346968|NCT02984553|||Case-Only||Cross-Sectional|||||||
1346969|NCT02984540|Randomized|Crossover Assignment||Treatment||Single||||||t
1346970|NCT02984527|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1346971|NCT02984514||Single Group Assignment||Basic Science||None (Open Label)||||||
1346972|NCT02984501||Single Group Assignment||Treatment||None (Open Label)||||||
1346973|NCT02984488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346974|NCT02984475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346975|NCT02984462|Randomized|Parallel Assignment||Treatment||Single|||t|||
1346976|NCT02984449|Randomized|Parallel Assignment||Treatment||Single|Double blinding (researcher and participants) is not possible because of logistic reasons. However, the primary endpoint is evaluated by an independent end-point committee, blinded for group allocation.|||||t
1346977|NCT02984436|||Cohort||Prospective|||||||
1346978|NCT02984423|||Cohort||Prospective|||||||
1346979|NCT02984410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346980|NCT02984397|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1346981|NCT02984384|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1346982|NCT02984371|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346983|NCT02984358|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1346984|NCT02984345|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1346985|NCT02984332||Single Group Assignment||Basic Science||None (Open Label)||||||
1346986|NCT02984319|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1346987|NCT02984306|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1346988|NCT02984293|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1346989|NCT02984280|||Ecologic or Community||Retrospective|||||||
1346990|NCT02984267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1346991|NCT02984254|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1346992|NCT02984241|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1346993|NCT02984228|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1346994|NCT02984215|||||Retrospective|||||||
1346995|NCT02984202||Single Group Assignment||Treatment||None (Open Label)||||||
1346996|NCT02984189|Randomized|Parallel Assignment||||Double|||t||t|
1346997|NCT02984176|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1346998|NCT02984163||Single Group Assignment||Supportive Care||None (Open Label)||||||
1346999|NCT02984150|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1347000|NCT02984137|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1347001|NCT02984124|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1347002|NCT02984111|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1347003|NCT02984098|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1347004|NCT02984085||Single Group Assignment||Treatment||None (Open Label)||||||
1347005|NCT02984072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347006|NCT02984059|||Case Control||Prospective|||||||
1347007|NCT02984046||Single Group Assignment||Treatment||None (Open Label)||||||
1347008|NCT02984033|||Cohort||Prospective|||||||
1347009|NCT02984020|||Case-Only||Prospective|||||||
1347010|NCT02984007|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347011|NCT02983994|||Other||Prospective|||||||
1347012|NCT02983981||Single Group Assignment||Treatment||None (Open Label)||||||
1347013|NCT02983968|||Cohort||Retrospective|||||||
1347014|NCT02983955||Single Group Assignment||||None (Open Label)||||||
1347015|NCT02983942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347016|NCT02983929||||||||||||
1347017|NCT02983916|||Cohort||Prospective|||||||
1347018|NCT02983903||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347019|NCT02983890|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347020|NCT02983877|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1347021|NCT02983864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347022|NCT02983851|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347023|NCT02983838|||Case Control||Prospective|||||||
1347024|NCT02983825||Single Group Assignment||Treatment||None (Open Label)||||||
1347025|NCT02983812|||Cohort||Prospective|||||||
1347026|NCT02983799|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347027|NCT02983786|||Other||Prospective|||||||
1347028|NCT02983773|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1347029|NCT02983760|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1347030|NCT02983747|Randomized|Parallel Assignment||Treatment||Single||||||t
1347031|NCT02983734|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347032|NCT02983721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347033|NCT02983708|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1347034|NCT02983695||Single Group Assignment||Treatment||None (Open Label)||||||
1347035|NCT02983682||Single Group Assignment||Treatment||None (Open Label)||||||
1347036|NCT02983669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347037|NCT02983656|||Case-Only||Retrospective|||||||
1347038|NCT02983643|||Cohort||Retrospective|||||||
1347039|NCT02983630|||Cohort||Prospective|||||||
1347040|NCT02983617|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347041|NCT02983604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347042|NCT02983591|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347043|NCT02983578|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347044|NCT02983565|Randomized|Crossover Assignment||Treatment||Single|||t|||
1347045|NCT02983552|Randomized|Parallel Assignment||Treatment||Single||||||t
1347046|NCT02983539|||Cohort||Prospective|||||||
1347047|NCT02983526||Parallel Assignment||Treatment||None (Open Label)||||||
1347048|NCT02983513|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1347049|NCT02983500|||Cohort||Prospective|||||||
1347050|NCT02983487|||Cohort||Prospective|||||||
1347051|NCT02983474|||Cohort||Prospective|||||||
1347052|NCT02983461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347053|NCT02983448|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1347054|NCT02983435|Randomized|Crossover Assignment||Treatment||Single|||||t|
1347055|NCT02983422|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347056|NCT02983409|||Case-Only||Retrospective|||||||
1347057|NCT02983396||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347058|NCT02983383|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1347059|NCT02983370||Single Group Assignment||Other||None (Open Label)||||||
1347061|NCT02983344|Randomized|Parallel Assignment||Treatment||Single||||||t
1347062|NCT02983331|||||Retrospective|||||||
1347063|NCT02983318|||Other||Cross-Sectional|||||||
1347064|NCT02983305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347065|NCT02983292|||Cohort||Other|||||||
1347066|NCT02983279||Single Group Assignment||Treatment||None (Open Label)||||||
1347067|NCT02983266|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1347068|NCT02983253|||Cohort||Cross-Sectional|||||||
1347069|NCT02983240|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347070|NCT02983227||Single Group Assignment||Treatment||None (Open Label)||||||
1347071|NCT02983214|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347072|NCT02983201|Randomized|Parallel Assignment||Treatment||Single||||||t
1347073|NCT02983188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347074|NCT02983175||Single Group Assignment||Prevention||None (Open Label)||||||
1347075|NCT02983162|||Cohort||Cross-Sectional|||||||
1347076|NCT02983149|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347077|NCT02983136|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347078|NCT02983123|||Cohort||Prospective|||||||
1347079|NCT02983110|||Cohort||Prospective|||||||
1347080|NCT02983097||Single Group Assignment||Treatment||None (Open Label)||||||
1347081|NCT02983084|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1347082|NCT02983071|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347083|NCT02983058||Single Group Assignment||Basic Science||None (Open Label)||||||
1347084|NCT02983045|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347085|NCT02983032||Single Group Assignment||Supportive Care||None (Open Label)||||||
1347086|NCT02983019|||Cohort||Prospective|||||||
1347087|NCT02983006||Single Group Assignment||Treatment||None (Open Label)||||||
1347088|NCT02982993|||Cohort||Prospective|||||||
1347089|NCT02982980|Randomized|Factorial Assignment||Treatment||Single|||||t|
1347090|NCT02982967||Single Group Assignment||Prevention||None (Open Label)||||||
1347091|NCT02982954|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347092|NCT02982941||Single Group Assignment||Treatment||None (Open Label)||||||
1347093|NCT02982928|||Cohort||Prospective|||||||
1347094|NCT02982915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347095|NCT02982902||Single Group Assignment||Supportive Care||None (Open Label)||||||
1347096|NCT02982889|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1347097|NCT02982876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347098|NCT02982863|||Cohort||Retrospective|||||||
1347099|NCT02982850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347100|NCT02982837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347101|NCT02982824|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1347102|NCT02982811|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347103|NCT02982798|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347104|NCT02982785|||Cohort||Prospective|||||||
1347105|NCT02982772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347106|NCT02982759|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1347107|NCT02982746|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347108|NCT02982733|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347109|NCT02982720||Single Group Assignment||Treatment||None (Open Label)|Open-Label|||||
1347110|NCT02982707|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347111|NCT02982694||Single Group Assignment||Treatment||None (Open Label)||||||
1347112|NCT02982681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347113|NCT02982668|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1347114|NCT02982655|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347115|NCT02982642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347116|NCT02982629|Randomized|Parallel Assignment||||None (Open Label)||||||
1347117|NCT02982616|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1347118|NCT02982603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347119|NCT02982590|Randomized|Parallel Assignment||Treatment||Single||||||t
1347120|NCT02982577|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1347121|NCT02982564|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1347122|NCT02982551||Single Group Assignment||Basic Science||None (Open Label)||||||
1347123|NCT02982538|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1347124|NCT02982525|Randomized|Parallel Assignment||Prevention||Single|||||t|
1347125|NCT02982512|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1347126|NCT02982499|||Case-Control||Prospective|||||||
1347127|NCT02982486||Single Group Assignment||Treatment||None (Open Label)||||||
1347128|NCT02982473|||Cohort||Retrospective|||||||
1347129|NCT02982460|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1347130|NCT02982447|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1347131|NCT02982434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347132|NCT02982421|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1347133|NCT02982408|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1347134|NCT02982395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347135|NCT02982382|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347136|NCT02982369|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347137|NCT02982356|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347138|NCT02982343|Randomized|Parallel Assignment||Treatment||Single|||||t|
1347139|NCT02982330|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347140|NCT02982317|||Cohort||Prospective|||||||
1347141|NCT02982304|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1347142|NCT02982291|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347143|NCT02982278|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1347144|NCT02982265|||Cohort||Other|||||||
1347145|NCT02982252|Randomized|Parallel Assignment||Treatment||Single||||||t
1347146|NCT02982239|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1347147|NCT02982226|Randomized|Crossover Assignment||Treatment||Single|||t|||
1347148|NCT02982213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347149|NCT02982200|||Cohort||Prospective|||||||
1347150|NCT02982187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347151|NCT02982174||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347152|NCT02982161|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1347153|NCT02982148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347154|NCT02982135|Non-Randomized|Factorial Assignment||Treatment||Single||||||t
1347155|NCT02982122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347156|NCT02982109|||Cohort||Prospective|||||||
1347157|NCT02982096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347158|NCT02982083|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1347159|NCT02982070|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347160|NCT02982057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347161|NCT02982044||Single Group Assignment||Basic Science||None (Open Label)||||||
1347162|NCT02982031|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1347163|NCT02982018|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347164|NCT02982005|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1347165|NCT02981992|||Cohort||Prospective|||||||
1347166|NCT02981979|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1347167|NCT02981966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347168|NCT02981953||Single Group Assignment||Treatment||None (Open Label)||||||
1347169|NCT02981940|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347170|NCT02981927|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1347171|NCT02981914||Single Group Assignment||Treatment||None (Open Label)||||||
1347172|NCT02981901|||Cohort||Retrospective|||||||
1347173|NCT02981888|||Case-Control||Prospective|||||||
1347174|NCT02981875|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347175|NCT02981862||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347176|NCT02981849|||Cohort||Cross-Sectional|||||||
1347177|NCT02981836|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1347178|NCT02981823||Single Group Assignment||Treatment||None (Open Label)||||||
1347179|NCT02981810|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347180|NCT02981797|||Case-Only||Prospective|||||||
1347181|NCT02981784|||Cohort||Retrospective|||||||
1347182|NCT02981771|Randomized|Parallel Assignment||Prevention||Single||||||t
1347183|NCT02981758|||Cohort||Retrospective|||||||
1347184|NCT02981745||Single Group Assignment||Treatment||None (Open Label)||||||
1347185|NCT02981732|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347186|NCT02981719||Single Group Assignment||Treatment||None (Open Label)||||||
1347187|NCT02981706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347188|NCT02981693|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347189|NCT02981680|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1347190|NCT02981667|||Case-Crossover||Prospective|||||||
1347191|NCT02981654||Single Group Assignment||Treatment||None (Open Label)||||||
1347192|NCT02981641|Randomized|Parallel Assignment||Treatment||Single||||||t
1347193|NCT02981628||Single Group Assignment||Treatment||None (Open Label)||||||
1347194|NCT02981615|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1347195|NCT02981602|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347196|NCT02981589|||Cohort||Prospective|||||||
1347197|NCT02981576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347198|NCT02981563||Single Group Assignment||Health Services Research||None (Open Label)||||||
1347199|NCT02981550|||Case-Only||Prospective|||||||
1347200|NCT02981537|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347201|NCT02981524||Single Group Assignment||Treatment||None (Open Label)||||||
1347202|NCT02981511||Single Group Assignment||Basic Science||None (Open Label)||||||
1347203|NCT02981498||Single Group Assignment||Treatment||None (Open Label)||||||
1347204|NCT02981485||Single Group Assignment||Treatment||None (Open Label)||||||
1347205|NCT02981472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347206|NCT02981459||Single Group Assignment||Treatment||None (Open Label)||||||
1347207|NCT02981446|Randomized|Parallel Assignment||Treatment||Single|||||t|
1347208|NCT02981433|||Case-Only||Prospective|||||||
1347209|NCT02981420|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347210|NCT02981407|Randomized|Parallel Assignment||Treatment||Single||||||t
1347211|NCT02981394|||Case-Only||Prospective|||||||
1347212|NCT02981381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347213|NCT02981368||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347214|NCT02981355|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1347215|NCT02981342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347216|NCT02981329|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347217|NCT02981316|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347218|NCT02981303|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347219|NCT02981290|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347220|NCT02981277|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1347221|NCT02981264|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1347222|NCT02981251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347223|NCT02981238|||Case-Only||Prospective|||||||
1347224|NCT02981225|||Cohort||Prospective|||||||
1347225|NCT02981212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347226|NCT02981199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347227|NCT02981186|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347228|NCT02981173|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1347229|NCT02981160|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1347230|NCT02981147||Single Group Assignment||Treatment||None (Open Label)||||||
1347231|NCT02981134|||Cohort||Prospective|||||||
1347232|NCT02981121|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347233|NCT02981108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347234|NCT02981095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347235|NCT02981082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347236|NCT02981069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347237|NCT02981056|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1347238|NCT02981043|||Cohort||Prospective|||||||
1347239|NCT02981030||Single Group Assignment||Health Services Research||None (Open Label)||||||
1347240|NCT02981017|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347241|NCT02981004|||Case-Only||Prospective|||||||
1347242|NCT02980991||Single Group Assignment||Treatment||None (Open Label)||||||
1347243|NCT02980978|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347244|NCT02980965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347245|NCT02980952|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1347246|NCT02980939|Randomized|Crossover Assignment||Prevention||Single|||t|||
1347247|NCT02980926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347248|NCT02980913|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1347249|NCT02980900|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1347250|NCT02980887|||Cohort||Prospective|||||||
1347251|NCT02980874|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1347252|NCT02980861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347253|NCT02980848|||Cohort||Prospective|||||||
1347254|NCT02980835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347255|NCT02980822|||Cohort||Prospective|||||||
1347256|NCT02980809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347257|NCT02980796|Randomized|Parallel Assignment||Basic Science||Single||||||t
1347258|NCT02980783||Single Group Assignment||Treatment||None (Open Label)||||||
1347259|NCT02980770|||Cohort||Prospective|||||||
1347260|NCT02980757|Randomized|Crossover Assignment||||None (Open Label)||||||
1347261|NCT02980744||Single Group Assignment||Prevention||None (Open Label)||||||
1347262|NCT02980731||Single Group Assignment||Treatment||None (Open Label)||||||
1347263|NCT02980718|Randomized|Parallel Assignment||Treatment||Single||||||t
1347264|NCT02980705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347265|NCT02980692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347266|NCT02980679||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347267|NCT02980666||Single Group Assignment||Treatment||None (Open Label)||||||
1347268|NCT02980653||Single Group Assignment||Supportive Care||None (Open Label)||||||
1347269|NCT02980640|||Cohort||Prospective|||||||
1347270|NCT02980627||Single Group Assignment||Treatment||None (Open Label)||||||
1347271|NCT02980614||Single Group Assignment||Basic Science||None (Open Label)||||||
1347272|NCT02980601|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347273|NCT02980588||Single Group Assignment||Treatment||None (Open Label)||||||
1347274|NCT02980575|Randomized|Parallel Assignment||Treatment||Single||||||t
1347275|NCT02980562|Randomized|Parallel Assignment||||Single|||||t|
1347276|NCT02980549|||Cohort||Prospective|||||||
1347277|NCT02980536|||Cohort||Prospective|||||||
1347278|NCT02980523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347279|NCT02980510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347280|NCT02980497|Randomized|Parallel Assignment||Treatment||Single|||||t|
1347281|NCT02980484|Randomized|Crossover Assignment||Treatment||Quadruple||Randomized double-blind sham-controlled trial with an optional open-label crossover extension for subjects randomized to sham group.|t|t|t|t
1347282|NCT02980471|||Case-Only||Prospective|||||||
1347283|NCT02980458|Randomized|Crossover Assignment||||None (Open Label)||||||
1347284|NCT02980445|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347285|NCT02980432||Single Group Assignment||Basic Science||None (Open Label)||||||
1347286|NCT02980419||Single Group Assignment||Basic Science||None (Open Label)||||||
1347287|NCT02980406|Randomized|Crossover Assignment||||Single|||t|||
1347288|NCT02980393||Single Group Assignment||Supportive Care||None (Open Label)||||||
1347289|NCT02980380|||Case-Only||Retrospective|||||||
1347290|NCT02980367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347291|NCT02980354|||Case-Control||Prospective|||||||
1347598|NCT02976363|||Cohort||Prospective|||||||
1347292|NCT02980341|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347293|NCT02980328|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347294|NCT02980315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347295|NCT02980302|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1347296|NCT02980289|||Cohort||Prospective|||||||
1347297|NCT02980276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347298|NCT02980263||Single Group Assignment||Treatment||None (Open Label)||||||
1347299|NCT02980250|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1347300|NCT02980237|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1347301|NCT02980224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347302|NCT02980211||Single Group Assignment||Treatment||None (Open Label)||||||
1347303|NCT02980198|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347304|NCT02980185|||Cohort||Prospective|||||||
1347305|NCT02980172|||Cohort||Retrospective|||||||
1347306|NCT02980159|||Cohort||Retrospective|||||||
1347307|NCT02980146|||Cohort||Prospective|||||||
1347308|NCT02980133|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347309|NCT02980120|||Case-Control||Prospective|||||||
1347310|NCT02980107|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347311|NCT02980094|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1347312|NCT02980081|||Cohort||Retrospective|||||||
1347313|NCT02980068|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347314|NCT02980055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347315|NCT02980042|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347316|NCT02980029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347317|NCT02980016|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347318|NCT02980003|Randomized|Parallel Assignment||Prevention||Single|||t|||
1347319|NCT02979990|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1347320|NCT02979977||Single Group Assignment||Treatment||None (Open Label)||||||
1347321|NCT02979964|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1347322|NCT02979951|||Cohort||Prospective|||||||
1347323|NCT02979938|||Cohort||Prospective|||||||
1347324|NCT02979925|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347325|NCT02979912||Single Group Assignment||Treatment||None (Open Label)||||||
1347326|NCT02979899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347327|NCT02979886||Single Group Assignment||Screening||None (Open Label)||||||
1347328|NCT02979873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347329|NCT02979860|Randomized|Parallel Assignment||Prevention||Single||||||t
1347330|NCT02979847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347331|NCT02979834|||Cohort||Prospective|||||||
1347332|NCT02979821||Single Group Assignment||Treatment||None (Open Label)||||||
1347333|NCT02979808||Single Group Assignment||Other||None (Open Label)||||||
1347334|NCT02979795|||Case-Only||Prospective|||||||
1347335|NCT02979782|||Cohort||Prospective|||||||
1347336|NCT02979769|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347337|NCT02979756|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1347338|NCT02979743|Randomized|Parallel Assignment||Other||Single|||t|||
1347339|NCT02979730|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1347340|NCT02979717|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1347341|NCT02979704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347342|NCT02979691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347343|NCT02979678||Single Group Assignment||Health Services Research||None (Open Label)||||||
1347344|NCT02979665|||Cohort||Prospective|||||||
1347345|NCT02979652|||Cohort||Prospective|||||||
1347346|NCT02979639||Single Group Assignment||Prevention||None (Open Label)||||||
1347347|NCT02979626|||Case-Control||Prospective|||||||
1347348|NCT02979613|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347349|NCT02979600|||Case-Only||Retrospective|||||||
1347350|NCT02979587||Single Group Assignment||Treatment||None (Open Label)||||||
1347351|NCT02979574|Randomized|Parallel Assignment||Treatment||Single||||||t
1347352|NCT02979561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347353|NCT02979548|Randomized|Parallel Assignment||Prevention||Single||||||t
1347354|NCT02979535|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347355|NCT02979522||Single Group Assignment||Treatment||None (Open Label)||||||
1347356|NCT02979509|||Cohort||Prospective|||||||
1347357|NCT02979496|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1347358|NCT02979483||Single Group Assignment||Health Services Research||None (Open Label)||||||
1347359|NCT02979470|||Cohort||Prospective|||||||
1347360|NCT02979457|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1347361|NCT02979444|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1347362|NCT02979431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347363|NCT02979418|||Cohort||Prospective|||||||
1347364|NCT02979405|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1347365|NCT02979392||Single Group Assignment||Treatment||None (Open Label)||||||
1347366|NCT02979379|||Case-Control||Prospective|||||||
1347367|NCT02979366||Single Group Assignment||Treatment||None (Open Label)||||||
1347368|NCT02979353|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347369|NCT02979340|||Cohort||Prospective|||||||
1347370|NCT02979327|Randomized|Crossover Assignment||Other||Double|||t||t|
1347599|NCT02976350|||Cohort||Cross-Sectional|||||||
1347371|NCT02979314||Single Group Assignment||Basic Science||None (Open Label)||||||
1347372|NCT02979301||Single Group Assignment||Basic Science||None (Open Label)||||||
1347373|NCT02979288|Randomized|Parallel Assignment||Prevention||Single|||||t|
1347374|NCT02979275|||Case-Control||Prospective|||||||
1347375|NCT02979262|Randomized|Parallel Assignment||Treatment||Single||||||t
1347376|NCT02979249||Single Group Assignment||Treatment||None (Open Label)||||||
1347377|NCT02979236|||Cohort||Prospective|||||||
1347378|NCT02979223|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1347379|NCT02979210||Single Group Assignment||Basic Science||None (Open Label)||||||
1347380|NCT02979197|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1347381|NCT02979184||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347382|NCT02979171|Randomized|Crossover Assignment||Prevention||Single|||t|||
1347383|NCT02979158|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347384|NCT02979145|||Case-Only||Prospective|||||||
1347385|NCT02979132|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1347386|NCT02979119|||Cohort||Prospective|||||||
1347387|NCT02979106||Single Group Assignment||Basic Science||None (Open Label)||||||
1347388|NCT02979093|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1347389|NCT02979080||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347390|NCT02979067|Randomized|Parallel Assignment||Prevention||Single|||t|||
1347391|NCT02979054|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1347392|NCT02979041|Randomized|Parallel Assignment||Treatment||Single||||||t
1347393|NCT02979028|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1347394|NCT02979015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347395|NCT02979002|||Cohort||Prospective|||||||
1347396|NCT02978989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347397|NCT02978976|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1347398|NCT02978963||Single Group Assignment||Treatment||None (Open Label)||||||
1347399|NCT02978950|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1347400|NCT02978937|||Cohort||Retrospective|||||||
1347401|NCT02978924|Randomized|Crossover Assignment||Other||Double|||t|||t
1347402|NCT02978911||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347403|NCT02978898|||Cohort||Retrospective|||||||
1347404|NCT02978885|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1347405|NCT02978872|||Cohort||Prospective|||||||
1347406|NCT02978859||Single Group Assignment||Treatment||None (Open Label)||||||
1347407|NCT02978846|||Case-Only||Prospective|||||||
1347408|NCT02978833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347409|NCT02978820|Randomized|Parallel Assignment||Treatment||Single||||||t
1347410|NCT02978807|||Cohort||Prospective|||||||
1347411|NCT02978794|||Cohort||Prospective|||||||
1347412|NCT02978781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347413|NCT02978768|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1347414|NCT02978755|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"phase 1 escalation GM102 single agent~phase 1 escalation GM102 combined with paclitaxel and carboplatin~phase 1b: 3 parallel expansion cohorts at the recommended dose of GM102 single agent"||||
1347415|NCT02978742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347416|NCT02978729|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347417|NCT02978716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347418|NCT02978703|||Other||Prospective|||||||
1347419|NCT02978690||Single Group Assignment||Supportive Care||None (Open Label)||||||
1347420|NCT02978677|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347421|NCT02978664|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1347422|NCT02978651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347423|NCT02978638||Single Group Assignment||Treatment||None (Open Label)||||||
1347424|NCT02978625||Single Group Assignment||Treatment||None (Open Label)||||||
1347425|NCT02978612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347426|NCT02978599|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1347427|NCT02978586||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347428|NCT02978573||Single Group Assignment||Treatment||None (Open Label)||||||
1347429|NCT02978560|||Case-Control||Prospective|||||||
1347430|NCT02978547||Single Group Assignment||Treatment||None (Open Label)||||||
1347431|NCT02978534|||Cohort||Prospective|||||||
1347432|NCT02978521|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347433|NCT02978508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347434|NCT02978495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347435|NCT02978482|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347436|NCT02978469|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347437|NCT02978456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347438|NCT02978443|||Cohort||Prospective|||||||
1347439|NCT02978430|Non-Randomized|||Prevention||None (Open Label)||||||
1347440|NCT02978417|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1347441|NCT02978404||Single Group Assignment||Treatment||None (Open Label)||||||
1347442|NCT02978391|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347443|NCT02978378|||Cohort||Prospective|||||||
1347444|NCT02978365||Single Group Assignment||Screening||None (Open Label)||||||
1347445|NCT02978352|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1347446|NCT02978339||Single Group Assignment||Treatment||None (Open Label)||||||
1347447|NCT02978326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347448|NCT02978313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347449|NCT02978300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347450|NCT02978287|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1347451|NCT02978274|||Case-Control||Prospective|||||||
1347452|NCT02978261||Single Group Assignment||Treatment||None (Open Label)||||||
1347453|NCT02978248|||Cohort||Prospective|||||||
1347454|NCT02978235||Single Group Assignment||Treatment||None (Open Label)||||||
1347455|NCT02978222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347456|NCT02978209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347457|NCT02978196||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347458|NCT02978183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347459|NCT02978170||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347460|NCT02978157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347461|NCT02978144|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1347462|NCT02978131|||Case-Only||Retrospective|||||||
1347463|NCT02978118|||Cohort||Prospective|||||||
1347464|NCT02978105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347465|NCT02978092|||||Retrospective|||||||
1347466|NCT02978079||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347467|NCT02978066|||Cohort||Prospective|||||||
1347468|NCT02978053|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1347469|NCT02978040|Randomized|Parallel Assignment||Treatment||Single|The study is open label. Participant and Investigators will be not masked to randomly assigned treatments. An independent blinded committee will assess clinical adverse events.|||||t
1347470|NCT02978027|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1347471|NCT02978014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347472|NCT02978001|||Case-Control||Prospective|||||||
1347473|NCT02977988|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1347474|NCT02977975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347475|NCT02977962|Randomized|Factorial Assignment||Treatment||Single||||||t
1347476|NCT02977949|||Case-Only||Prospective|||||||
1347477|NCT02977936|||Cohort||Prospective|||||||
1347478|NCT02977923|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347479|NCT02977910|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347480|NCT02977897|||Cohort||Prospective|||||||
1347481|NCT02977884||Single Group Assignment||Treatment||None (Open Label)||||||
1347482|NCT02977871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347483|NCT02977858|||Case-Control||Prospective|||||||
1347484|NCT02977845|Randomized|Parallel Assignment||Supportive Care||Single|In the current study, based on nature of the intervention, blinding was not feasible with researcher, statistician, Qigong master who were responsible for recruitment of subject, randomization, deliver the intervention. However, the investigators who collect the outcome information were blinded to the allocation sequence.|The design of this study was a randomized controlled trial (RCT) with two parallel groups in a 1:1 allocation ratio, allocation concealment, and assessor blinding.||||t
1347485|NCT02977832|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||alpha-antagonist (alfuzosin 10 mg)+ Odyliresin (Iresine celosia) 2 ml, 20 drops once daily.||||
1347486|NCT02977819|Randomized|Parallel Assignment||Prevention||Single||||||t
1347487|NCT02977806|||Cohort||Prospective|||||||
1347488|NCT02977793|||Cohort||Prospective|||||||
1347489|NCT02977780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347490|NCT02977767||Single Group Assignment||Supportive Care||None (Open Label)||||||
1347491|NCT02977754|||Cohort||Prospective|||||||
1347492|NCT02977741|||Cohort||Prospective|||||||
1347493|NCT02977728|||Case-Control||Prospective|||||||
1347494|NCT02977715||Single Group Assignment||Prevention||None (Open Label)||||||
1347495|NCT02977702|||Case-Only||Retrospective|||||||
1347496|NCT02977689||Single Group Assignment||Treatment||None (Open Label)||||||
1347497|NCT02977676|||Cohort||Retrospective|||||||
1347498|NCT02977663||Single Group Assignment||Other||None (Open Label)||||||
1347499|NCT02977650|||Cohort||Prospective|||||||
1347500|NCT02977637||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347501|NCT02977624||Single Group Assignment||Treatment||None (Open Label)||||||
1347502|NCT02977611||Single Group Assignment||Treatment||None (Open Label)||||||
1347503|NCT02977598||||||||||||
1347504|NCT02977585|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347505|NCT02977572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347506|NCT02977559|Randomized|Crossover Assignment||Treatment||Single|||||t|
1347507|NCT02977546|||Cohort||Prospective|||||||
1347508|NCT02977533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347509|NCT02977520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347510|NCT02977507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347511|NCT02977494||Single Group Assignment||Treatment||None (Open Label)||||||
1347512|NCT02977481|||Other||Cross-Sectional|||||||
1347513|NCT02977468||Single Group Assignment||Treatment||None (Open Label)||||||
1347514|NCT02977455|||Case Control||Cross-Sectional|||||||
1347515|NCT02977442|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1347516|NCT02977429|Randomized|Parallel Assignment||Treatment||Single||||||t
1347517|NCT02977416|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1347518|NCT02977403|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1347519|NCT02977390||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347520|NCT02977377|Randomized|Crossover Assignment||Treatment||Single||||||t
1348271|NCT02967601|||Case-Only||Cross-Sectional|||||||
1347521|NCT02977364|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347522|NCT02977351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347523|NCT02977338|||Cohort||Retrospective|||||||
1347524|NCT02977325|||||Prospective|||||||
1347525|NCT02977312|||Cohort|||||||||
1347526|NCT02977299|Randomized|Parallel Assignment||Treatment||Single||||||t
1347527|NCT02977286|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1347528|NCT02977273|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1347529|NCT02977260|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1347530|NCT02977247|||Other||Prospective|||||||
1347531|NCT02977234||Single Group Assignment||Supportive Care||None (Open Label)||||||
1347532|NCT02977221|Randomized|Parallel Assignment||Treatment||Single||||||t
1347533|NCT02977208|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347534|NCT02977195||Single Group Assignment||Treatment||None (Open Label)||||||
1347535|NCT02977182|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347536|NCT02977169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347537|NCT02977156||Single Group Assignment||Treatment||None (Open Label)||||||
1347538|NCT02977143||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347539|NCT02977130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347540|NCT02977117|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1347541|NCT02977104|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||40 subjects with Atrial Fibrillation 10 subjects with Atrial Flutter 20 subjects with Sinus Rhythm||||
1347542|NCT02977091|||Cohort||Prospective|||||||
1347543|NCT02977078|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1347544|NCT02977065|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1347545|NCT02977052|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347546|NCT02977039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347547|NCT02977026|Randomized|Parallel Assignment||Other||Single|||t|||
1347548|NCT02977013|||Case-Only||Prospective|||||||
1347549|NCT02977000||Single Group Assignment||Treatment||None (Open Label)||||||
1347550|NCT02976987||Single Group Assignment||Treatment||None (Open Label)||||||
1347551|NCT02976974|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1347552|NCT02976961|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1347553|NCT02976948|||||Prospective|||||||
1347554|NCT02976935|||Cohort||Prospective|||||||
1347555|NCT02976922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347556|NCT02976909||Single Group Assignment||Treatment||None (Open Label)||||||
1347557|NCT02976896||Single Group Assignment||Treatment||None (Open Label)||||||
1347558|NCT02976883||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347559|NCT02976870||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347560|NCT02976857||Single Group Assignment||Treatment||None (Open Label)||||||
1347561|NCT02976844|||Case-Crossover||Prospective|||||||
1347562|NCT02976831|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347563|NCT02976818|||Case-Control||Cross-Sectional|||||||
1347564|NCT02976805|Randomized|Parallel Assignment||Treatment||Single|||||t|
1347565|NCT02976792|||Cohort||Prospective|||||||
1347566|NCT02976779|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1347567|NCT02976766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347568|NCT02976753|||Cohort||Prospective|||||||
1347569|NCT02976740||Single Group Assignment||Treatment||None (Open Label)||||||
1347570|NCT02976727|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1347571|NCT02976714||Single Group Assignment||Prevention||None (Open Label)||||||
1347572|NCT02976701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347573|NCT02976688||Single Group Assignment||Treatment||None (Open Label)||||||
1347574|NCT02976675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347575|NCT02976662|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347576|NCT02976649|||Cohort||Retrospective|||||||
1347577|NCT02976636|Randomized|Parallel Assignment||Treatment||Single|The assessors will not know which arm of the study each family is in.|||||t
1347578|NCT02976623|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1347579|NCT02976610|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1347580|NCT02976597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347581|NCT02976584|||Case-Only||Prospective|||||||
1347582|NCT02976571|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1347583|NCT02976558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347584|NCT02976545|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1347585|NCT02976532||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347586|NCT02976519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347587|NCT02976506|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347588|NCT02976493|||Case-Only||Prospective|||||||
1347589|NCT02976480|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1347590|NCT02976467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347591|NCT02976454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347592|NCT02976441||Single Group Assignment||Treatment||None (Open Label)||||||
1347593|NCT02976428|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347594|NCT02976415||Single Group Assignment||Treatment||None (Open Label)||||||
1347595|NCT02976402||Single Group Assignment||Treatment||None (Open Label)||||||
1347596|NCT02976389|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347597|NCT02976376|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347600|NCT02976337|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1347601|NCT02976324|Randomized|Parallel Assignment||Treatment||Single|||||t|
1347602|NCT02976311|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1347603|NCT02976298|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1347604|NCT02976285|||Cohort||Prospective|||||||
1347605|NCT02976272|||||Prospective|||||||
1347606|NCT02976259||Single Group Assignment||Treatment||None (Open Label)||||||
1347607|NCT02976246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347608|NCT02976233|||Cohort||Prospective|||||||
1347609|NCT02976220||Single Group Assignment||Other||None (Open Label)||||||
1347610|NCT02976207|||Cohort||Prospective|||||||
1347611|NCT02976194||Single Group Assignment||Basic Science||None (Open Label)||||||
1347612|NCT02976181|||Cohort||Prospective|||||||
1347613|NCT02976168|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1347614|NCT02976155|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Before-after study model||||
1347615|NCT02976142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347616|NCT02976129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347617|NCT02976116||Single Group Assignment||Treatment||None (Open Label)||||||
1347618|NCT02976103|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347619|NCT02976090|||Cohort||Retrospective|||||||
1347620|NCT02976077|Randomized|Parallel Assignment||Treatment||Single||||||t
1347621|NCT02976064|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1347622|NCT02976051||Single Group Assignment||Treatment||None (Open Label)||||||
1347623|NCT02976038||Single Group Assignment||Treatment||None (Open Label)||||||
1347624|NCT02976025|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347625|NCT02976012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347626|NCT02975999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347627|NCT02975986||Single Group Assignment||Basic Science||None (Open Label)||||||
1347628|NCT02975973|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347629|NCT02975960||Single Group Assignment||Treatment||None (Open Label)||||||
1347630|NCT02975947|Randomized|Parallel Assignment||Prevention||Single|||t|||
1347631|NCT02975934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347632|NCT02975921|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347633|NCT02975908|||Case-Only||Prospective|||||||
1347634|NCT02975895|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347635|NCT02975882||Single Group Assignment||Treatment||None (Open Label)||||||
1347636|NCT02975869|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347637|NCT02975856||Crossover Assignment||Basic Science||None (Open Label)||||||
1347638|NCT02975843||Single Group Assignment||Treatment||None (Open Label)||||||
1347639|NCT02975830|||Case-Only||Retrospective|||||||
1347640|NCT02975817|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1347641|NCT02975804|Randomized|Parallel Assignment||Treatment||Single||||||t
1347642|NCT02975791|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1347643|NCT02975778||Single Group Assignment||Prevention||None (Open Label)||||||
1347644|NCT02975765|Randomized|Parallel Assignment||Treatment||Single||||||t
1347645|NCT02975752|||Cohort||Retrospective|||||||
1347646|NCT02975739||Single Group Assignment||Treatment||None (Open Label)||||||
1347647|NCT02975726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347648|NCT02975713|||Case-Control||Prospective|||||||
1347649|NCT02975700||Single Group Assignment||Treatment||None (Open Label)||||||
1347650|NCT02975687||Single Group Assignment||Treatment||None (Open Label)||||||
1347651|NCT02975674|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347652|NCT02975661|||Cohort||Prospective|||||||
1347653|NCT02975648|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347654|NCT02975635|||Cohort||Prospective|||||||
1347655|NCT02975622|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347656|NCT02975609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347657|NCT02975596|||Ecologic or Community||Prospective|||||||
1347658|NCT02975583|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1347659|NCT02975570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347660|NCT02975557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347661|NCT02975544|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347662|NCT02975531|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1347663|NCT02975518|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1347664|NCT02975505|Randomized|Parallel Assignment||Treatment||Single||||||t
1347665|NCT02975492|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347666|NCT02975479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347667|NCT02975466|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347668|NCT02975453|||Cohort||Prospective|||||||
1347669|NCT02975440||Single Group Assignment||Basic Science||None (Open Label)||||||
1347670|NCT02975427|||Cohort||Prospective|||||||
1347671|NCT02975414|||Cohort||Prospective|||||||
1347672|NCT02975401|||Cohort||Prospective|||||||
1347673|NCT02975388|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1347674|NCT02975375|||Cohort||Retrospective|||||||
1347675|NCT02975362|Randomized|Parallel Assignment||Treatment||Single||||||t
1347676|NCT02975349|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1347677|NCT02975336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347678|NCT02975323||Single Group Assignment||Treatment||None (Open Label)||||||
1347679|NCT02975310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347680|NCT02975297|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347681|NCT02975284|||Cohort||Prospective|||||||
1347682|NCT02975271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347683|NCT02975258|||Cohort||Prospective|||||||
1347684|NCT02975245|||Cohort||Prospective|||||||
1347685|NCT02975232|Randomized|Parallel Assignment||Prevention||Single|||t|||
1347686|NCT02975219||Single Group Assignment||Treatment||None (Open Label)||||||
1347687|NCT02975206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347688|NCT02975193|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1347689|NCT02975180|Randomized|Parallel Assignment||Treatment||Single||||||t
1347690|NCT02975167|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1347691|NCT02975154|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1347692|NCT02975141|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1347693|NCT02975128||Single Group Assignment||Treatment||None (Open Label)||||||
1347694|NCT02975115|||Cohort|||||||||
1347695|NCT02975102|Randomized|Parallel Assignment||Treatment||Single|||||t|
1347696|NCT02975089|Randomized|Parallel Assignment||Treatment||Single||||t||
1347697|NCT02975076|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1347698|NCT02975063|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1347699|NCT02975050|||Cohort||Prospective|||||||
1347700|NCT02975037|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1347701|NCT02975024|||Cohort||Prospective|||||||
1347702|NCT02975011|||Case-Only||Prospective|||||||
1347703|NCT02974998|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347704|NCT02974985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347705|NCT02974972|||Cohort||Prospective|||||||
1347706|NCT02974959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347707|NCT02974946|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347708|NCT02974933||Single Group Assignment||Treatment||None (Open Label)||||||
1347709|NCT02974920|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347710|NCT02974907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347711|NCT02974894|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1347712|NCT02974881||Single Group Assignment||Treatment||None (Open Label)||||||
1347713|NCT02974868|Randomized|||Treatment||Triple||The first 24 weeks are parallel. The single-blind extension period will have a segment for non-responder and a withdrawal/retreatment segment for responder. The cross-over extension period is parallel for non-responders.|t||t|t
1347714|NCT02974855|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1347715|NCT02974842|||Case-Only||Prospective|||||||
1347716|NCT02974829|||Cohort||Prospective|||||||
1347717|NCT02974816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347718|NCT02974803||Single Group Assignment||Treatment||None (Open Label)||||||
1347719|NCT02974790|||Cohort||Prospective|||||||
1347720|NCT02974777|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347721|NCT02974764|||Cohort||Prospective|||||||
1347722|NCT02974751|||Case-Only||Prospective|||||||
1347723|NCT02974738|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347724|NCT02974725|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347725|NCT02974712|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1347726|NCT02974699|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1347727|NCT02974686|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347728|NCT02974673||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347729|NCT02974660|Randomized|Parallel Assignment||Prevention||Single|||t|||
1347730|NCT02974647|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347731|NCT02974634|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347732|NCT02974621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347733|NCT02974608|||Cohort||Cross-Sectional|||||||
1347734|NCT02974595|||Cohort||Prospective|||||||
1347735|NCT02974582|||Case-Control||Cross-Sectional|||||||
1347736|NCT02974569|||Case-Only||Prospective|||||||
1347737|NCT02974556|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1347738|NCT02974543|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1347739|NCT02974530|||Cohort||Prospective|||||||
1347740|NCT02974517|||Cohort||Prospective|||||||
1347741|NCT02974504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347742|NCT02974491||Single Group Assignment||Treatment||None (Open Label)||||||
1347743|NCT02974478|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1347744|NCT02974465|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347745|NCT02974452|||Ecologic or Community||Cross-Sectional|||||||
1347746|NCT02974439|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347747|NCT02974426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347748|NCT02974413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347749|NCT02974400|Randomized|Parallel Assignment||Treatment||Single||||||t
1347750|NCT02974387|Randomized|Parallel Assignment||Treatment||Single||||||t
1347751|NCT02974374|Randomized|||Treatment||Double|||t|t||
1347752|NCT02974361|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1347753|NCT02974348|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347754|NCT02974335|||Other||Other|||||||
1348496|NCT02964663|||Cohort||Prospective|||||||
1347755|NCT02974322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347756|NCT02974309|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1347757|NCT02974296|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347758|NCT02974283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347759|NCT02974270||Single Group Assignment||Treatment||None (Open Label)||||||
1347760|NCT02974257|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1347761|NCT02974244|||Cohort||Retrospective|||||||
1347762|NCT02974231|||Case-Only||Retrospective|||||||
1347763|NCT02974218|||Cohort||Prospective|||||||
1347764|NCT02974205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347765|NCT02974192|||Case Control||Prospective|||||||
1347766|NCT02974179|||Cohort||Prospective|||||||
1347767|NCT02974166|Randomized|Parallel Assignment||Treatment||Single|||||t|
1347768|NCT02974153|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1347769|NCT02974140|Randomized|Parallel Assignment||Treatment||Single||||||t
1347770|NCT02974127|||Cohort||Prospective|||||||
1347771|NCT02974114|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1347772|NCT02974101||Single Group Assignment||Treatment||None (Open Label)||||||
1347773|NCT02974088|Randomized|Parallel Assignment||Treatment||Single||||||t
1347774|NCT02974075||Single Group Assignment||Treatment||None (Open Label)||||||
1347775|NCT02974062|Randomized|Parallel Assignment||Basic Science||Single||||||t
1347776|NCT02974049|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347777|NCT02974036||Single Group Assignment||Treatment||None (Open Label)||||||
1347778|NCT02974023|||Other||Prospective|||||||
1347779|NCT02974010|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1347780|NCT02973997||Single Group Assignment||Treatment||None (Open Label)||||||
1347781|NCT02973984|||Cohort||Prospective|||||||
1347782|NCT02973971|||Cohort||Prospective|||||||
1347783|NCT02973958|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1347784|NCT02973945|Randomized|Parallel Assignment||Treatment||Single||||||t
1347785|NCT02973932||Single Group Assignment||Treatment||None (Open Label)||||||
1347786|NCT02973919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347787|NCT02973906|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347788|NCT02973893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347789|NCT02973880|Randomized|Parallel Assignment||Treatment||Triple|All daily study products will be manufactured in indistinguishable single dose plastic vials, labeled in accordance with hour of administration. In accordance with the double-blind design of the study, daily treatment for patients randomized to group A (NETILDEX™ ophthalmic gel), will be of 2 doses of active treatment and 2 doses of indistinguishable placebo. For blinding purposes, Group B (NETILDEX™ eye drops solution) medications labels will consist in an aluminum envelope for each dose of the daily treatment, containing indistinguishable plastic vials of NETILDEX™ eye drops solution. Tertiary packaging (patient's treatment supply) will be a carton box appropriately labeled, containing 16 secondary packages (aluminum envelopes - each envelope containing 5 vials for each treatment time dose), containing enough plastic vials to allow the patient to complete the whole study treatment.|Two treatment arms, test group versus active-comparator (control) group, treated in parallel.|t|t|t|
1347790|NCT02973867|||Cohort||Retrospective|||||||
1347791|NCT02973854|||Case-Only||Prospective|||||||
1347792|NCT02973841||Single Group Assignment||Treatment||None (Open Label)||||||
1347793|NCT02973828|||Case-Only||Prospective|||||||
1347794|NCT02973815|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347795|NCT02973802||Single Group Assignment||Treatment||None (Open Label)||||||
1347796|NCT02973789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347797|NCT02973776|Randomized|Single Group Assignment||Treatment||Single|||||t|
1347798|NCT02973763||Single Group Assignment||Treatment||None (Open Label)||||||
1347799|NCT02973750|||Cohort||Prospective|||||||
1347800|NCT02973737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347801|NCT02973724||Single Group Assignment||Treatment||None (Open Label)||||||
1347802|NCT02973711||Single Group Assignment||Treatment||None (Open Label)||||||
1347803|NCT02973698|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347804|NCT02973685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347805|NCT02973672||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347806|NCT02973659|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1347807|NCT02973646|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347808|NCT02973633|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1347809|NCT02973620||||||||||||
1347810|NCT02973607|||Cohort||Other|||||||
1347811|NCT02973594|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1347812|NCT02973581|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1347813|NCT02973568|||Cohort||Prospective|||||||
1347814|NCT02973555||Single Group Assignment||Treatment||None (Open Label)||||||
1347815|NCT02973542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347816|NCT02973529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347817|NCT02973516||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347818|NCT02973503||Single Group Assignment||Treatment||None (Open Label)||||||
1347819|NCT02973490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347820|NCT02973477|Randomized|Crossover Assignment||Treatment||Single|Randomization will be performed by the research Pharmacy. The study coordinator will not be blind to the randomization so that they can adequately discuss the medication with the participant. The study investigator will be blind to the randomization so as to not introduce bias in data qualification.||||t|
1347821|NCT02973464|||Cohort||Prospective|||||||
1347822|NCT02973451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347823|NCT02973438|Randomized|Crossover Assignment||Treatment||Single|||t|||
1347824|NCT02973425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347825|NCT02973412|||Case-Only||Cross-Sectional|||||||
1347826|NCT02973399||Single Group Assignment||Treatment||None (Open Label)||||||
1347827|NCT02973386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347828|NCT02973373|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1347829|NCT02973360|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1347830|NCT02973347|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1347831|NCT02973334|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1347832|NCT02973321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347833|NCT02973308|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1347834|NCT02973295|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347835|NCT02973282|||Cohort||Prospective|||||||
1347836|NCT02973269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347837|NCT02973256|||Case-Only||Prospective|||||||
1347838|NCT02973243|||Cohort||Prospective|||||||
1347839|NCT02973230||||||||||||
1347840|NCT02973217||Single Group Assignment||Treatment||None (Open Label)||||||
1347841|NCT02973204|||Cohort||Prospective|||||||
1347842|NCT02973191||Single Group Assignment||Treatment||None (Open Label)||||||
1347843|NCT02973178|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1347844|NCT02973152|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347845|NCT02973139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347846|NCT02973126||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347847|NCT02973113||Single Group Assignment||Treatment||None (Open Label)||||||
1347848|NCT02973100|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347849|NCT02973087||Single Group Assignment||Prevention||None (Open Label)||||||
1347850|NCT02973074||Single Group Assignment||Treatment||None (Open Label)||||||
1347851|NCT02973061|||Case Control||Prospective|||||||
1347852|NCT02973048|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347853|NCT02973035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347854|NCT02973022|||Case-Control||Prospective|||||||
1347855|NCT02973009|||Cohort||Prospective|||||||
1347856|NCT02972996|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347857|NCT02972983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347858|NCT02972970||Single Group Assignment||Other||None (Open Label)||||||
1347859|NCT02972957|Randomized|Parallel Assignment||Prevention||Single||||||t
1347860|NCT02972944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347861|NCT02972931|||Case-Control||Retrospective|||||||
1347862|NCT02972918||Single Group Assignment||Prevention||None (Open Label)||||||
1347863|NCT02972905|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347864|NCT02972892||||||||||||
1347865|NCT02972879|Randomized|Parallel Assignment||Treatment||Single||||||t
1347866|NCT02972866|Randomized|Parallel Assignment||Treatment||Single|||||t|
1347867|NCT02972853||Single Group Assignment||Basic Science||None (Open Label)||||||
1347868|NCT02972840|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347869|NCT02972827||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347870|NCT02972814|||Cohort||Prospective|||||||
1347871|NCT02972801||Single Group Assignment||Treatment||None (Open Label)||||||
1347872|NCT02972788|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347873|NCT02972775|||Cohort||Retrospective|||||||
1347874|NCT02972762|Randomized|Parallel Assignment||Prevention||Single|||t|||
1347875|NCT02972749|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1347876|NCT02972736|||Cohort||Retrospective|||||||
1347877|NCT02972723||Single Group Assignment||||None (Open Label)||||||
1347878|NCT02972710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347879|NCT02972697||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347880|NCT02972684|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1347881|NCT02972671|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347882|NCT02972658|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1347883|NCT02972645|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1347884|NCT02972632||Single Group Assignment||Treatment||None (Open Label)||||||
1347885|NCT02972619|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347886|NCT02972606|||Case-Only||Cross-Sectional|||||||
1347887|NCT02972593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347888|NCT02972580|||Cohort||Prospective|||||||
1347889|NCT02972567|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1347890|NCT02972554|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1347891|NCT02972541|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347892|NCT02972528|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1347893|NCT02972515||Single Group Assignment||Treatment||None (Open Label)||||||
1347894|NCT02972502|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347895|NCT02972489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347896|NCT02972476|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1347897|NCT02972463|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1347898|NCT02972450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347899|NCT02972437|||Cohort||Prospective|||||||
1347900|NCT02972424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347901|NCT02972411|Randomized|Parallel Assignment||Prevention||Single|||t|||
1347902|NCT02972398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347903|NCT02972385|||Cohort||Prospective|||||||
1347904|NCT02972372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347905|NCT02972359||Single Group Assignment||Treatment||None (Open Label)||||||
1347906|NCT02972346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347907|NCT02972333||Single Group Assignment||Treatment||None (Open Label)||||||
1347908|NCT02972320||Single Group Assignment||Treatment||None (Open Label)||||||
1347909|NCT02972307|||Case-Only||Cross-Sectional|||||||
1347910|NCT02972294|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1347911|NCT02972281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347912|NCT02972268|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1347913|NCT02972255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347914|NCT02972242|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1347915|NCT02972229|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1347916|NCT02972216|||Case Control||Retrospective|||||||
1347917|NCT02972203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347918|NCT02972190|Randomized|Parallel Assignment||Treatment||Single||||||t
1347919|NCT02972177|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347920|NCT02972164|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347921|NCT02972151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347922|NCT02972138|||Cohort||Retrospective|||||||
1347923|NCT02972125|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347924|NCT02972112|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1347925|NCT02972099|Randomized|Parallel Assignment||Other||Double|||t||t|
1347926|NCT02972086||Single Group Assignment||Supportive Care||None (Open Label)||||||
1347927|NCT02972073|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1347928|NCT02972060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347929|NCT02972047|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347930|NCT02972034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1347931|NCT02972021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347932|NCT02972008|||Cohort||Prospective|||||||
1347933|NCT02971995|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1347934|NCT02971982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347935|NCT02971969|||Cohort||Prospective|||||||
1347936|NCT02971956||Single Group Assignment||Treatment||None (Open Label)||||||
1347937|NCT02971943||Single Group Assignment||Treatment||None (Open Label)||||||
1347938|NCT02971930|||Other||Prospective|||||||
1347939|NCT02971917||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347940|NCT02971904|||Case-Only||Prospective|||||||
1347941|NCT02971891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347942|NCT02971878|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1347943|NCT02971865|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1347944|NCT02971852|||Cohort||Prospective|||||||
1347945|NCT02971839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347946|NCT02971826||Single Group Assignment||Other||None (Open Label)||||||
1347947|NCT02971813|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347948|NCT02971800||Single Group Assignment||Diagnostic||None (Open Label)||||||
1347949|NCT02971787||Single Group Assignment||Basic Science||None (Open Label)||||||
1347950|NCT02971774|||Other||Prospective|||||||
1347951|NCT02971761||Single Group Assignment||Treatment||None (Open Label)||||||
1347952|NCT02971748||Single Group Assignment||Treatment||None (Open Label)||||||
1347953|NCT02971735|Randomized|Parallel Assignment||Other||Single|||t|||
1347954|NCT02971722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347955|NCT02971709|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347956|NCT02971696|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347957|NCT02971683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1347958|NCT02971670|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1347959|NCT02971657|||Case-Only||Prospective|||||||
1347960|NCT02971644||Single Group Assignment||Treatment||None (Open Label)||||||
1347961|NCT02971631|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1347962|NCT02971618|||Case-Control||Retrospective|||||||
1347963|NCT02971605||Single Group Assignment||Basic Science||None (Open Label)||||||
1347964|NCT02971592|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1347965|NCT02971579|||Case-Only||Prospective|||||||
1347966|NCT02971566|||Case Control||Prospective|||||||
1347967|NCT02971553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347968|NCT02971540|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1347969|NCT02971527|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1347970|NCT02971514|Randomized|Crossover Assignment||Supportive Care||Triple||||t|t|t
1347971|NCT02971501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347972|NCT02971488|||Cohort||Prospective|||||||
1347973|NCT02971475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347974|NCT02971462|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1347975|NCT02971449|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347976|NCT02971436|Randomized|Crossover Assignment||Treatment||Single|||t|||
1347977|NCT02971423|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1347978|NCT02971410||Single Group Assignment||Treatment||None (Open Label)||||||
1347979|NCT02971397||Single Group Assignment||Treatment||None (Open Label)||||||
1347980|NCT02971384|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1347981|NCT02971371|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1347982|NCT02971358||Single Group Assignment||Treatment||None (Open Label)||||||
1347983|NCT02971345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347984|NCT02971332|||Case-Only||Prospective|||||||
1347985|NCT02971319|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1347986|NCT02971306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1347987|NCT02971293|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1347988|NCT02971280|||Cohort||Prospective|||||||
1347989|NCT02971267|||Cohort||Prospective|||||||
1347990|NCT02971254|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1347991|NCT02971241|Randomized|Parallel Assignment||Treatment||Single|||t|||
1347992|NCT02971228|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347993|NCT02971215|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1347994|NCT02971202|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1347995|NCT02971189||Single Group Assignment||Treatment||None (Open Label)||||||
1347996|NCT02971176|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1347997|NCT02971163|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1347998|NCT02971150|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1347999|NCT02971137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348000|NCT02971124|||Case-Control||Prospective|||||||
1348001|NCT02971111|||Cohort||Retrospective|||||||
1348002|NCT02971098||Single Group Assignment||Treatment||None (Open Label)||||||
1348003|NCT02971085|||Cohort||Prospective|||||||
1348004|NCT02971072||Single Group Assignment||Treatment||None (Open Label)||||||
1348005|NCT02971059|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1348006|NCT02971046||Single Group Assignment||Other||None (Open Label)||||||
1348007|NCT02971033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348008|NCT02971020|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1348009|NCT02971007|Randomized|Parallel Assignment||Treatment||Single||||||t
1348010|NCT02970994|||Cohort||Prospective|||||||
1348011|NCT02970981||Single Group Assignment||Treatment||None (Open Label)||||||
1348012|NCT02970968|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348013|NCT02970955|||Cohort||Prospective|||||||
1348014|NCT02970942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348015|NCT02970929||Single Group Assignment||Treatment||None (Open Label)||||||
1348016|NCT02970916||Single Group Assignment||Treatment||None (Open Label)||||||
1348017|NCT02970903|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1348018|NCT02970890|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348019|NCT02970877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348020|NCT02970864||Single Group Assignment||Treatment||None (Open Label)||||||
1348021|NCT02970851|||Cohort||Prospective|||||||
1348022|NCT02970838||Single Group Assignment||Treatment||None (Open Label)||||||
1348023|NCT02970825|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348024|NCT02970812|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348025|NCT02970799||||||||||||
1348026|NCT02970786||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348027|NCT02970773||Single Group Assignment||Other||None (Open Label)||||||
1348028|NCT02970760|||Cohort||Prospective|||||||
1348029|NCT02970747|||Case-Only||Prospective|||||||
1348030|NCT02970734|Randomized|Crossover Assignment||Treatment||Single|||||t|
1348031|NCT02970721|||Cohort||Retrospective|||||||
1348032|NCT02970708|Randomized|Parallel Assignment||Treatment||Single||||||t
1348033|NCT02970695|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348034|NCT02970682|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1348035|NCT02970669|Randomized|Parallel Assignment||Other||Double|||t||t|
1348036|NCT02970656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348037|NCT02970643||Single Group Assignment||Prevention||None (Open Label)||||||
1348038|NCT02970630||Single Group Assignment||Treatment||None (Open Label)||||||
1348039|NCT02970617|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348040|NCT02970604|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1348041|NCT02970591|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1348042|NCT02970578||Single Group Assignment||Treatment||None (Open Label)||||||
1348043|NCT02970565|Randomized|Parallel Assignment||Other||Double|||t||t|
1348044|NCT02970552|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1348045|NCT02970539||Single Group Assignment||Treatment||None (Open Label)||||||
1348046|NCT02970526|||Other||Retrospective|||||||
1348047|NCT02970513||Single Group Assignment||Screening||None (Open Label)||||||
1348048|NCT02970500|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348049|NCT02970487||Single Group Assignment||Treatment||None (Open Label)||||||
1348050|NCT02970474||Single Group Assignment||Treatment||None (Open Label)||||||
1348051|NCT02970461|Randomized|Parallel Assignment||Treatment||Single|||||t|
1348052|NCT02970448||Single Group Assignment||Treatment||None (Open Label)||||||
1348053|NCT02970435|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348054|NCT02970422|||Other||Cross-Sectional|||||||
1348055|NCT02970409|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348056|NCT02970396|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1348057|NCT02970383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348058|NCT02970370|||Cohort|||||||||
1348059|NCT02970357||Single Group Assignment||Supportive Care||None (Open Label)||||||
1348060|NCT02970344|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348061|NCT02970331||Single Group Assignment||Treatment||None (Open Label)||||||
1348062|NCT02970318|Randomized|Parallel Assignment||Treatment||Single||||||t
1348063|NCT02970305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348064|NCT02970292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348065|NCT02970279||Single Group Assignment||Treatment||None (Open Label)||||||
1348066|NCT02970266|||Cohort||Retrospective|||||||
1348067|NCT02970253|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348068|NCT02970240|||Case-Control||Prospective|||||||
1348069|NCT02970227|||Cohort||Prospective|||||||
1348070|NCT02970214|||Cohort||Prospective|||||||
1348071|NCT02970201|Randomized|Crossover Assignment||Treatment||Single||||t||
1348072|NCT02970188|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348073|NCT02970175|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1348074|NCT02970162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348075|NCT02970149|||Cohort||Prospective|||||||
1348076|NCT02970136|Randomized|Parallel Assignment||Screening||Single||||||t
1348077|NCT02970123|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348078|NCT02970110|||Case-Only||Prospective|||||||
1348079|NCT02970097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348080|NCT02970084|Randomized|Parallel Assignment||Prevention||Single|||||t|
1348081|NCT02970071|||Case-Only||Prospective|||||||
1348082|NCT02970058|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1348083|NCT02970045|||Case-Only||Prospective|||||||
1348084|NCT02970032|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348085|NCT02970019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348086|NCT02970006||Single Group Assignment||Other||None (Open Label)||||||
1348087|NCT02969993||Single Group Assignment||Prevention||None (Open Label)||||||
1348088|NCT02969980||Single Group Assignment||Treatment||None (Open Label)||||||
1348089|NCT02969967||Single Group Assignment||Treatment||None (Open Label)||||||
1348090|NCT02969954||Single Group Assignment||Health Services Research||None (Open Label)||||||
1348091|NCT02969941|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348092|NCT02969928|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348093|NCT02969915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348094|NCT02969902|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348095|NCT02969889|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1348096|NCT02969876||Single Group Assignment||Basic Science||None (Open Label)||||||
1348097|NCT02969863|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348098|NCT02969850|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1348099|NCT02969837|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||"All participants will receive E-KRd regimen (elotuzumab, carfilzomib, lenalidomide, and dexamethasone) for up to 12 Cycles.~After Cycle 12, participants that are MRD negative will move to E-Rd (elotuzumab, carfilzomib, lenalidomide, and dexamethasone) maintenance regimen and continue until disease progression. Participants that are MRD positive will continue to receive E-KRd regimen for an additional 6 cycles followed by E-Rd maintenance regimen and continue until disease progression"||||
1348100|NCT02969824|Randomized|Parallel Assignment||Treatment||Single||||t||
1348101|NCT02969811|||Cohort||Prospective|||||||
1348102|NCT02969798|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348103|NCT02969785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348104|NCT02969772|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1348105|NCT02969759|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1348106|NCT02969746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348107|NCT02969733|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348108|NCT02969720|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1348109|NCT02969707|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1348110|NCT02969694|||||Prospective|||||||
1348111|NCT02969681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348112|NCT02969668|||Cohort||Prospective|||||||
1348113|NCT02969655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348114|NCT02969642|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348115|NCT02969629|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1348116|NCT02969616|||Cohort||Prospective|||||||
1348117|NCT02969603|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1348118|NCT02969590|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1348119|NCT02969577|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348120|NCT02969564|||Case-Only||Prospective|||||||
1348121|NCT02969551|||Cohort||Prospective|||||||
1348122|NCT02969538|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348123|NCT02969525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348124|NCT02969512|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1348125|NCT02969499|||Case-Only||Prospective|||||||
1348126|NCT02969486|||Other||Prospective|||||||
1348127|NCT02969473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348128|NCT02969460||Single Group Assignment||Health Services Research||None (Open Label)||||||
1348954|NCT02958683|||Case-Control||Prospective|||||||
1348129|NCT02969447|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348130|NCT02969434||Single Group Assignment||Supportive Care||None (Open Label)||||||
1348131|NCT02969421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348132|NCT02969408||Single Group Assignment||Treatment||None (Open Label)||||||
1348133|NCT02969395|||Other||Prospective|||||||
1348134|NCT02969382|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348135|NCT02969369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348136|NCT02969356||Single Group Assignment||Treatment||None (Open Label)||||||
1348137|NCT02969343|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348138|NCT02969330|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1348139|NCT02969317||Single Group Assignment||Treatment||None (Open Label)||||||
1348140|NCT02969304|||Cohort||Retrospective|||||||
1348141|NCT02969291||Single Group Assignment||Treatment||None (Open Label)||||||
1348142|NCT02969278||Single Group Assignment||Treatment||None (Open Label)||||||
1348143|NCT02969265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348144|NCT02969252||Single Group Assignment||Other||None (Open Label)||||||
1348145|NCT02969239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348146|NCT02969226|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1348147|NCT02969213|||||Retrospective|||||||
1348148|NCT02969200|||Cohort||Retrospective|||||||
1348149|NCT02969187|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348150|NCT02969174||||||||||||
1348151|NCT02969161|||Cohort||Retrospective|||||||
1348152|NCT02969148|Randomized|Parallel Assignment||Treatment||Single|||||t|
1348153|NCT02969135|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1348154|NCT02969122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348155|NCT02969109|||||Prospective|||||||
1348156|NCT02969096||Single Group Assignment||Treatment||None (Open Label)||||||
1348157|NCT02969083|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1348158|NCT02969070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348159|NCT02969057|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1348160|NCT02969044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348161|NCT02969031|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348162|NCT02969018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348163|NCT02969005||Single Group Assignment||Treatment||None (Open Label)||||||
1348164|NCT02968992|Randomized|Parallel Assignment||Treatment||Triple|•Randomized: Participants are assigned to intervention groups by chance||t|t|t|
1348165|NCT02968979|||Cohort||Cross-Sectional|||||||
1348166|NCT02968966||Single Group Assignment||Treatment||None (Open Label)||Treatment A - if no positive response: Treatment B||||
1348167|NCT02968953||||||||||||
1348168|NCT02968940||Single Group Assignment||Treatment||None (Open Label)||||||
1348169|NCT02968927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348170|NCT02968914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348171|NCT02968901||Single Group Assignment||Treatment||None (Open Label)||||||
1348172|NCT02968888|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1348173|NCT02968875|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348174|NCT02968862|||Cohort||Prospective|||||||
1348175|NCT02968849|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348176|NCT02968836|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1348177|NCT02968823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348178|NCT02968810|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1348179|NCT02968797|||Case-Only||Retrospective|||||||
1348180|NCT02968784||Single Group Assignment||Treatment||None (Open Label)||||||
1348181|NCT02968771|||Case-Only||Prospective|||||||
1348182|NCT02968758||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348183|NCT02968745|||||Cross-Sectional|||||||
1348184|NCT02968732||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348185|NCT02968719|Randomized|Crossover Assignment||Treatment||None (Open Label)|Open Label|||||
1348186|NCT02968706|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348187|NCT02968693|||Case-Control||Retrospective|||||||
1348188|NCT02968680||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348189|NCT02968667|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1348190|NCT02968654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348191|NCT02968641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348192|NCT02968628|||Case-Control||Prospective|||||||
1348193|NCT02968615||Single Group Assignment||Treatment||None (Open Label)||||||
1348194|NCT02968602|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1348195|NCT02968589|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1348196|NCT02968576|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1348197|NCT02968563|Randomized|Parallel Assignment||Treatment||None (Open Label)|With Amendment 3, randomization will be discontinued. All subsequently enrolled participants will enter Arm B (tirabrutinib + idelalisib + obinutuzumab).|||||
1348198|NCT02968550|||Cohort||Prospective|||||||
1348199|NCT02968537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348200|NCT02968524|||Other||Prospective|||||||
1348201|NCT02968511||Single Group Assignment||Treatment||None (Open Label)||||||
1348202|NCT02968498|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1348203|NCT02968485||Single Group Assignment||Treatment||None (Open Label)||||||
1348204|NCT02968472||Single Group Assignment||Treatment||None (Open Label)||||||
1348205|NCT02968459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348206|NCT02968446|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1348207|NCT02968433||Single Group Assignment||Treatment||None (Open Label)||||||
1348208|NCT02968420|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348209|NCT02968407|||Other||Prospective|||||||
1348210|NCT02968394||Single Group Assignment||Treatment||None (Open Label)||||||
1348211|NCT02968381|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348212|NCT02968368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348213|NCT02968355|||Case-Only||Prospective|||||||
1348214|NCT02968342|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348215|NCT02968329|||Case-Control||Retrospective|||||||
1348216|NCT02968316|||Cohort||Prospective|||||||
1348217|NCT02968303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348218|NCT02968290|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1348219|NCT02968277|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348220|NCT02968264|||Cohort||Prospective|||||||
1348221|NCT02968251|Randomized|Parallel Assignment||Prevention||Single||||||t
1348222|NCT02968238|Randomized|Factorial Assignment||Treatment||Single||||t||
1348223|NCT02968225|Randomized|Parallel Assignment||Treatment||Double|Given the design of the study, parents and adolescents will know the condition to which they have been assigned. However, researchers involved in data collection will be blinded from condition assignment during the pre-intervention data collection session as these data will be collected prior to randomization. Also, the research team is not involved in the randomization process. The research team members who are involved in ensuring the fidelity of the intervention are not involved in data collection procedures. Although we will attempt to limit unblinding, it is not possible for researchers involved in data collection to be completely blinded to the assignment of participant condition at the post-intervention visit as we cannot prohibit participants from talking to researchers about their experience in the study. Importantly, the primary outcome measures are believed to be robust to investigator bias.|Participants randomized into intervention or waitlist control conditions|t||t|
1348224|NCT02968212|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348225|NCT02968199||Single Group Assignment||Health Services Research||None (Open Label)|The study was not a randomized controlled trial. Participants and outcome assessors were not blinded.|||||
1348226|NCT02968186|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348227|NCT02968173||Single Group Assignment||Treatment||None (Open Label)||||||
1348228|NCT02968160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348229|NCT02968147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348230|NCT02968134||Single Group Assignment||Basic Science||None (Open Label)||||||
1348231|NCT02968121|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348232|NCT02968108|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348233|NCT02968095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348234|NCT02968082|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348235|NCT02968069||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348236|NCT02968056|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348237|NCT02968043|Randomized|Parallel Assignment||Treatment||Single||||||t
1348238|NCT02968030||Single Group Assignment||Treatment||None (Open Label)||||||
1348239|NCT02968017|||Cohort||Prospective|||||||
1348240|NCT02968004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348241|NCT02967991|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1348242|NCT02967978|||Cohort||Prospective|||||||
1348243|NCT02967965|||Cohort||Prospective|||||||
1348244|NCT02967952|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348245|NCT02967939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348246|NCT02967926||Single Group Assignment||Treatment||None (Open Label)||||||
1348247|NCT02967913|Randomized|Parallel Assignment||Prevention||Single|||t|||
1348248|NCT02967900|||Cohort||Retrospective|||||||
1348249|NCT02967887||Single Group Assignment||Treatment||None (Open Label)||||||
1348250|NCT02967874|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348251|NCT02967861|Randomized|Parallel Assignment||Treatment||Single|||||t|
1348252|NCT02967848|||Cohort||Prospective|||||||
1348253|NCT02967835||Single Group Assignment||Treatment||None (Open Label)||||||
1348254|NCT02967822|||Cohort||Prospective|||||||
1348255|NCT02967809|||Case Control||Prospective|||||||
1348256|NCT02967796|||Case-Control||Prospective|||||||
1348257|NCT02967783|Randomized|Single Group Assignment||Device Feasibility||None (Open Label)|six vaccination teams will be randomly assigned to administer the three different ID fIPV administration technique the campaign days|||||
1348258|NCT02967770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348259|NCT02967757|||Cohort||Retrospective|||||||
1348260|NCT02967744||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348261|NCT02967731||Single Group Assignment||Treatment||None (Open Label)||||||
1348262|NCT02967718|||Cohort||Cross-Sectional|||||||
1348263|NCT02967705|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348264|NCT02967692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348265|NCT02967679||Single Group Assignment||Treatment||None (Open Label)||||||
1348266|NCT02967666||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348267|NCT02967653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348268|NCT02967640|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1348269|NCT02967627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348270|NCT02967614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348272|NCT02967588||Single Group Assignment||Treatment||None (Open Label)||||||
1348273|NCT02967575|||Cohort||Prospective|||||||
1348274|NCT02967562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348275|NCT02967549|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348276|NCT02967536|||Cohort||Prospective|||||||
1348277|NCT02967523|||Case-Only||Other|||||||
1348278|NCT02967510|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348279|NCT02967497|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348280|NCT02967484|Randomized|Parallel Assignment||Prevention||Single|||t|||
1348281|NCT02967471|||Cohort||Prospective|||||||
1348282|NCT02967458||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348283|NCT02967445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348284|NCT02967432|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348285|NCT02967419|||||Cross-Sectional|||||||
1348286|NCT02967406|Randomized|Parallel Assignment||Prevention||Single||||||t
1348287|NCT02967393|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1348288|NCT02967380||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348289|NCT02967367||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348290|NCT02967354|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1348291|NCT02967341||Single Group Assignment||Treatment||None (Open Label)||||||
1348292|NCT02967328|||Case-Only||Prospective|||||||
1348293|NCT02967315||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348294|NCT02967302|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348295|NCT02967289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348296|NCT02967276||Single Group Assignment||Treatment||None (Open Label)||||||
1348297|NCT02967263|||Cohort||Prospective|||||||
1348298|NCT02967250||Single Group Assignment||Treatment||None (Open Label)||||||
1348299|NCT02967237||Single Group Assignment||Treatment||None (Open Label)||||||
1348300|NCT02967224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348301|NCT02967211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348302|NCT02967198||Single Group Assignment||Treatment||None (Open Label)||||||
1348303|NCT02967185|Randomized|Parallel Assignment||Treatment||Single||||||t
1348304|NCT02967172|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348305|NCT02967159|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348306|NCT02967146|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1348307|NCT02967133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348308|NCT02967120|||Cohort||Prospective|||||||
1348309|NCT02967107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348310|NCT02967094|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1348311|NCT02967081|||Other||Prospective|||||||
1348312|NCT02967068|||Cohort||Other|||||||
1348313|NCT02967055|||Cohort||Prospective|||||||
1348314|NCT02967042||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348315|NCT02967029|Randomized|Parallel Assignment||Screening||Single|||t|||
1348316|NCT02967016|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1348317|NCT02966990||Single Group Assignment||Treatment||None (Open Label)||||||
1348318|NCT02966977|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1348319|NCT02966964|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348320|NCT02966951||Single Group Assignment||Treatment||None (Open Label)||||||
1348321|NCT02966938|||Case-Only||Retrospective|||||||
1348322|NCT02966925||Single Group Assignment||Treatment||None (Open Label)||||||
1348323|NCT02966912|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348324|NCT02966899||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348325|NCT02966886|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348326|NCT02966873|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348327|NCT02966860||Single Group Assignment||Basic Science||None (Open Label)||||||
1348328|NCT02966847||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348329|NCT02966834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348330|NCT02966821||Single Group Assignment||Treatment||None (Open Label)||||||
1348331|NCT02966808|||Cohort||Retrospective|||||||
1348332|NCT02966795|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1348333|NCT02966782|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348334|NCT02966769|||Other||Retrospective|||||||
1348335|NCT02966756||Single Group Assignment||Treatment||None (Open Label)||||||
1348336|NCT02966743|Randomized|Parallel Assignment||||Double|||||t|t
1348337|NCT02966730||Single Group Assignment||Treatment||None (Open Label)||||||
1348338|NCT02966717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348339|NCT02966704|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1348340|NCT02966691|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1348341|NCT02966678|||Cohort||Prospective|||||||
1348342|NCT02966665|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1348343|NCT02966652|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348344|NCT02966639|||Cohort||Prospective|||||||
1348345|NCT02966626|||Case-Only||Retrospective|||||||
1348346|NCT02966613|Randomized|Parallel Assignment||Treatment||Single||||||t
1348347|NCT02966600|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1348348|NCT02966587||Single Group Assignment||Treatment||None (Open Label)||||||
1348349|NCT02966574||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348350|NCT02966561|Randomized|Parallel Assignment||Treatment||Single||||||t
1348351|NCT02966548|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348352|NCT02966535|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1348353|NCT02966522||Single Group Assignment||Treatment||None (Open Label)||||||
1348354|NCT02966509|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1348355|NCT02966496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348356|NCT02966483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348357|NCT02966470|||Cohort||Prospective|||||||
1348358|NCT02966457|Randomized|Parallel Assignment||Prevention||Single||||||t
1348359|NCT02966444|Randomized|Crossover Assignment||Prevention||Single|||t|||
1348360|NCT02966431|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348361|NCT02966418|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1348362|NCT02966405|||Case-Only||Prospective|||||||
1348363|NCT02966392|Randomized|Parallel Assignment||Prevention||Single||||||t
1348364|NCT02966379||Single Group Assignment||Treatment||None (Open Label)||||||
1348365|NCT02966366||Single Group Assignment||Treatment||None (Open Label)||||||
1348366|NCT02966353|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1348367|NCT02966340|Randomized|Crossover Assignment||Screening||Triple|||t|t|t|
1348368|NCT02966327|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1348369|NCT02966314|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1348370|NCT02966301||Single Group Assignment||Treatment||None (Open Label)||||||
1348371|NCT02966288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348372|NCT02966275|Randomized|Crossover Assignment||Treatment||Quadruple|Glucagon and placebo were blinded by the research pharmacy. Subjects were given bags of blinded medication labeled with which day they were to be used, and then were asked to label the bags with which day the medication was actually used. The contents of the bags were verified with the research pharmacy's blinding key upon completion of the study.||t|t|t|t
1348373|NCT02966262|||Case-Only||Cross-Sectional|||||||
1348374|NCT02966249|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1348375|NCT02966236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348376|NCT02966223||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348377|NCT02966210||||||||||||
1348378|NCT02966197|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348379|NCT02966184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348380|NCT02966171||Single Group Assignment||Treatment||None (Open Label)||||||
1348381|NCT02966158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348382|NCT02966145|||Cohort||Prospective|||||||
1348383|NCT02966132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348384|NCT02966119|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348385|NCT02966106|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348386|NCT02966093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348387|NCT02966080|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348388|NCT02966067|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1348389|NCT02966054|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348390|NCT02966041|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348391|NCT02966028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348392|NCT02966015||Single Group Assignment||Supportive Care||None (Open Label)||||||
1348393|NCT02966002||Single Group Assignment||Treatment||None (Open Label)||||||
1348394|NCT02965989|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1348395|NCT02965976|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1348396|NCT02965963|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1348397|NCT02965950|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1348398|NCT02965937|Randomized|Parallel Assignment||Prevention||Single||||||t
1348399|NCT02965924||Single Group Assignment||Basic Science||None (Open Label)||||||
1348400|NCT02965911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348401|NCT02965898|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1348402|NCT02965885||Single Group Assignment||Treatment||None (Open Label)||||||
1348403|NCT02965872|||||Prospective|||||||
1348404|NCT02965859|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348405|NCT02965846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348406|NCT02965833|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1348407|NCT02965820|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1348408|NCT02965807||Single Group Assignment||Treatment||None (Open Label)||||||
1348409|NCT02965794|||Other||Retrospective|||||||
1348410|NCT02965781|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348411|NCT02965768|Randomized|Crossover Assignment||Other||Quadruple|Double-blind trial. An encrypted and password-protected database will contain (1) information about individual group assignment, and (2) blister pack codes (medication will be dispensed in blister packs by investigators based on these codes). An investigator not involved with data collection or participant interactions will randomly assign individuals to the treatment group and provide blister pack ID codes for each individual.||t|t|t|t
1348412|NCT02965755||Single Group Assignment||Treatment||None (Open Label)||||||
1348413|NCT02965742|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1348414|NCT02965729|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1348415|NCT02965716||Single Group Assignment||Treatment||None (Open Label)||||||
1348416|NCT02965703|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1348417|NCT02965690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348418|NCT02965677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348419|NCT02965664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348420|NCT02965651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348421|NCT02965638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348422|NCT02965625|||Cohort||Prospective|||||||
1348423|NCT02965612|Randomized|Crossover Assignment||Treatment||Single|||t|||
1348424|NCT02965599|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348425|NCT02965586|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1348426|NCT02965573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348427|NCT02965560|||Cohort||Prospective|||||||
1348428|NCT02965547||Single Group Assignment||||None (Open Label)||||||
1348429|NCT02965534|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1348430|NCT02965521|Randomized|Crossover Assignment||Other||None (Open Label)|Statistician who analyzes the data will be masked to intervention/control status.|||||
1348431|NCT02965508|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1348432|NCT02965495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348433|NCT02965482|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1348434|NCT02965469|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1348435|NCT02965456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348436|NCT02965443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348437|NCT02965430||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348438|NCT02965417||Single Group Assignment||Treatment||None (Open Label)||||||
1348439|NCT02965404|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1348440|NCT02965391|||Case-Only||Prospective|||||||
1348441|NCT02965378|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348442|NCT02965365|||Cohort||Prospective|||||||
1348443|NCT02965352||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348444|NCT02965339|||Cohort||Prospective|||||||
1348445|NCT02965326|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1348446|NCT02965313|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348447|NCT02965300|||Cohort||Prospective|||||||
1348448|NCT02965287|||Cohort||Prospective|||||||
1348449|NCT02965274|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348450|NCT02965261|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348451|NCT02965248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348452|NCT02965235|||Case Control||Prospective|||||||
1348453|NCT02965222|Randomized|Parallel Assignment||Treatment||Single|||||t|
1348454|NCT02965209||Single Group Assignment||Treatment||None (Open Label)||||||
1348455|NCT02965196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348456|NCT02965183||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348457|NCT02965170|||Cohort||Prospective|||||||
1348458|NCT02965157||Single Group Assignment||Treatment||None (Open Label)||||||
1348459|NCT02965144|||Cohort||Prospective|||||||
1348460|NCT02965131|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1348461|NCT02965118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348462|NCT02965105|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1348463|NCT02965092||Single Group Assignment||Treatment||None (Open Label)||||||
1348464|NCT02965079|||Cohort||Prospective|||||||
1348465|NCT02965066|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1348466|NCT02965053|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1348467|NCT02965040|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348468|NCT02965027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348469|NCT02965014|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348470|NCT02965001||Single Group Assignment||Other||None (Open Label)||||||
1348471|NCT02964988||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348472|NCT02964975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348473|NCT02964962||Single Group Assignment||Treatment||None (Open Label)||||||
1348474|NCT02964949|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1348475|NCT02964936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348476|NCT02964923|||||Prospective|||||||
1348477|NCT02964910|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348478|NCT02964897|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348479|NCT02964884|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348480|NCT02964871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348481|NCT02964858|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348482|NCT02964845|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348483|NCT02964832|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1348484|NCT02964819|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348485|NCT02964806|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1348486|NCT02964793|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1348487|NCT02964780|||Case Control||Prospective|||||||
1348488|NCT02964767|||Cohort||Prospective|||||||
1348489|NCT02964754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348490|NCT02964741|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348491|NCT02964728|Randomized|Crossover Assignment||Treatment||Single|||t|||
1348492|NCT02964715||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1348493|NCT02964702||Single Group Assignment||Treatment||None (Open Label)||||||
1348494|NCT02964689||Single Group Assignment||Treatment||None (Open Label)||||||
1348495|NCT02964676|Randomized|Parallel Assignment||Treatment||Single|||||t|
1348497|NCT02964650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348498|NCT02964637|||Cohort||Cross-Sectional|||||||
1348499|NCT02964624||Single Group Assignment||Treatment||None (Open Label)||||||
1348500|NCT02964611|||Cohort||Cross-Sectional|||||||
1348501|NCT02964598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348502|NCT02964585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348503|NCT02964572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348504|NCT02964559||Single Group Assignment||Treatment||None (Open Label)||||||
1348505|NCT02964546|||||Prospective|||||||
1348506|NCT02964533|Randomized|Parallel Assignment||Treatment||Single||||||t
1348507|NCT02964520|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348508|NCT02964507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348509|NCT02964494|||Other||Other|||||||
1348510|NCT02964481|||Case-Control||Prospective|||||||
1348511|NCT02964468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348512|NCT02964455||Single Group Assignment||Treatment||None (Open Label)||||||
1348513|NCT02964442|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1348514|NCT02964429||Single Group Assignment||Basic Science||None (Open Label)||||||
1348515|NCT02964416|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348516|NCT02964403|Randomized|Parallel Assignment||Treatment||Single|||||t|
1348517|NCT02964390||Single Group Assignment||Treatment||None (Open Label)||||||
1348518|NCT02964377||Single Group Assignment||Treatment||None (Open Label)||||||
1348519|NCT02964364|||Case-Only||Cross-Sectional|||||||
1348520|NCT02964351|||Cohort||Prospective|||||||
1348521|NCT02964338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348522|NCT02964325|Randomized|Parallel Assignment||Supportive Care||Double|Though this is not a blinded study, treatment assignment is obtained through electronic system and should not be shared those performing the primary outcome assessment or assessors of adverse events.||||t|t
1348523|NCT02964312||Single Group Assignment||Treatment||None (Open Label)||||||
1348524|NCT02964299|||Case Control||Prospective|||||||
1348525|NCT02964286|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1348526|NCT02964273|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348527|NCT02964260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348528|NCT02964247|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348529|NCT02964234|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1348530|NCT02964221|||Cohort||Prospective|||||||
1348531|NCT02964208|||Cohort||Prospective|||||||
1348532|NCT02964195|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348533|NCT02964182|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1348534|NCT02964169|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1348535|NCT02964156|Randomized|Crossover Assignment||Treatment||Single||||||t
1348536|NCT02964143|Randomized|Parallel Assignment||Treatment||Double|"All patients will undergo blood collection, whatever treatment they will receive. The day of each treatment session, a specially trained staff member, who won't be otherwise related to the study, will perform blood withdrawal and prepare the treatment according to the randomization code in a separate -but neighboring- room. This staff member will then deliver the treatment to the ward where the clinician will inject it into the patient's knee. To preserve patient's blindness, a screen will be placed in order to prevent him/her from seeing the whole procedure (from blood withdrawal to treatment injection).~Evaluation of primary and secondary endpoints will be performed by a blinded assessor who will not know which treatment (PRP/HA combination, HA alone, or PRP alone) was given to the patient. The blinded assessor will not perform any other study-related procedure."||t|||t
1348537|NCT02964130||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348538|NCT02964117|||Cohort||Prospective|||||||
1348539|NCT02964104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348540|NCT02964091||Single Group Assignment||Treatment||None (Open Label)||||||
1348541|NCT02964078||Single Group Assignment||Treatment||None (Open Label)||||||
1348542|NCT02964065|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1348543|NCT02964052|||Cohort||Prospective|||||||
1348544|NCT02964039|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348545|NCT02964026|||Cohort||Retrospective|||||||
1348546|NCT02964013|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348547|NCT02964000|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1348548|NCT02963987|Randomized|Crossover Assignment||Prevention||Single|||t|||
1348549|NCT02963974||Single Group Assignment||Treatment||None (Open Label)||||||
1348550|NCT02963961|Randomized|Parallel Assignment||Prevention||Single|||||t|
1348551|NCT02963948|||Other||Prospective|||||||
1348552|NCT02963935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348553|NCT02963922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348554|NCT02963909|Randomized|Sequential Assignment||Prevention||Double|||t||t|
1348555|NCT02963896||Single Group Assignment||Supportive Care||None (Open Label)||||||
1348556|NCT02963883|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348557|NCT02963870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348558|NCT02963857|||Cohort||Prospective|||||||
1348559|NCT02963844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348560|NCT02963831|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348561|NCT02963818|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1348562|NCT02963805|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1348563|NCT02963792|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348564|NCT02963779|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1348565|NCT02963766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348566|NCT02963753|||Case-Control||Retrospective|||||||
1348567|NCT02963740||Single Group Assignment||Prevention||None (Open Label)||||||
1348568|NCT02963727||Single Group Assignment||Treatment||None (Open Label)||||||
1348569|NCT02963714|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348570|NCT02963701|Randomized|Parallel Assignment||Treatment||||||||
1348571|NCT02963688|||Case-Only||Retrospective|||||||
1348572|NCT02963675|||Cohort||Retrospective|||||||
1348573|NCT02963662|Non-Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1348574|NCT02963649|Randomized|Parallel Assignment||Treatment||Single||||||t
1348575|NCT02963636||Single Group Assignment||Health Services Research||None (Open Label)||||||
1348576|NCT02963623|||Other||Retrospective|||||||
1348577|NCT02963610||Single Group Assignment||Treatment||None (Open Label)||||||
1348578|NCT02963597|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348579|NCT02963584|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348580|NCT02963571||Single Group Assignment||Treatment||None (Open Label)||||||
1348581|NCT02963558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348582|NCT02963545|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348583|NCT02963532|||Cohort||Prospective|||||||
1348584|NCT02963519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348585|NCT02963506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348586|NCT02963493||Single Group Assignment||Treatment||None (Open Label)||||||
1348587|NCT02963480|||Cohort||Prospective|||||||
1348588|NCT02963467|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1348589|NCT02963454|Randomized|Parallel Assignment||Screening||Double|||||t|t
1348590|NCT02963441|||Case-Only||Cross-Sectional|||||||
1348591|NCT02963428|Randomized|Parallel Assignment||Prevention||Single||||||t
1348592|NCT02963415||Single Group Assignment||Prevention||None (Open Label)||||||
1348593|NCT02963402|||Cohort||Prospective|||||||
1348594|NCT02963389|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348595|NCT02963376|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348596|NCT02963363||Single Group Assignment||Supportive Care||None (Open Label)||||||
1348597|NCT02963350||||||||||||
1348598|NCT02963337|||Cohort||Prospective|||||||
1348599|NCT02963324||Single Group Assignment||Basic Science||None (Open Label)||||||
1348600|NCT02963311||Single Group Assignment||Treatment||None (Open Label)||||||
1348601|NCT02963298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348602|NCT02963285|||Cohort||Prospective|||||||
1348603|NCT02963272|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1348604|NCT02963259|||Cohort||Prospective|||||||
1348605|NCT02963246|Randomized|Parallel Assignment||Treatment||Single||||||t
1348606|NCT02963233|||Cohort||Prospective|||||||
1348607|NCT02963220||Single Group Assignment||Treatment||None (Open Label)||||||
1348608|NCT02963207|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1348609|NCT02963194|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1348610|NCT02963181|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348611|NCT02963168||Single Group Assignment||Treatment||None (Open Label)||||||
1348612|NCT02963155||Single Group Assignment||Basic Science||None (Open Label)||||||
1348613|NCT02963142|||Cohort||Prospective|||||||
1348614|NCT02963129|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348615|NCT02963116|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1348616|NCT02963103||Single Group Assignment||Treatment||None (Open Label)||||||
1348617|NCT02963090|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348618|NCT02963077|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348619|NCT02963064||Single Group Assignment||Treatment||None (Open Label)||||||
1348620|NCT02963051|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1348621|NCT02963038||Single Group Assignment||Treatment||None (Open Label)||||||
1348622|NCT02963025|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348623|NCT02963012|||Case-Only||Prospective|||||||
1348624|NCT02962999|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1348625|NCT02962986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348626|NCT02962973||Single Group Assignment||Treatment||None (Open Label)||||||
1348627|NCT02962960|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348628|NCT02962947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348629|NCT02962934|||Case-Only||Prospective|||||||
1348630|NCT02962921||Single Group Assignment||Treatment||None (Open Label)||||||
1348631|NCT02962908|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348632|NCT02962895|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348633|NCT02962882|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348634|NCT02962869||Single Group Assignment||Other||Single||||||
1348635|NCT02962856||Single Group Assignment||Other||None (Open Label)||||||
1348636|NCT02962843|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348637|NCT02962830||Single Group Assignment||Treatment||None (Open Label)||||||
1348638|NCT02962817|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1348639|NCT02962804||Single Group Assignment||Treatment||None (Open Label)||||||
1348640|NCT02962791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348641|NCT02962778|||Case-Only||Prospective|||||||
1348642|NCT02962765|||Cohort||Prospective|||||||
1348643|NCT02962752|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1348644|NCT02962739|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1348645|NCT02962726|||Case Control||Prospective|||||||
1348646|NCT02962713|Randomized|Parallel Assignment||Treatment||Single||||||t
1348647|NCT02962700|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1348648|NCT02962687|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348649|NCT02962674||Single Group Assignment||Treatment||None (Open Label)||||||
1348650|NCT02962661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348651|NCT02962648||Single Group Assignment||Treatment||None (Open Label)||||||
1348652|NCT02962635|||Cohort||Prospective|||||||
1348653|NCT02962622|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1348654|NCT02962609|Randomized|Parallel Assignment||Prevention||Single||||t||
1348655|NCT02962596|||Cohort||Prospective|||||||
1348656|NCT02962583|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348657|NCT02962570||Single Group Assignment||Supportive Care||None (Open Label)||||||
1348658|NCT02962557|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348659|NCT02962544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348660|NCT02962531|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1348661|NCT02962518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348662|NCT02962505|||Cohort||Prospective|||||||
1348663|NCT02962492|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1348664|NCT02962479|||Case Control||Cross-Sectional|||||||
1348665|NCT02962466|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1348666|NCT02962453|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1348667|NCT02962440||Single Group Assignment||Treatment||None (Open Label)||||||
1348668|NCT02962427|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1348669|NCT02962414||Single Group Assignment||Treatment||None (Open Label)||||||
1348670|NCT02962401||Single Group Assignment||Treatment||None (Open Label)||||||
1348671|NCT02962388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348672|NCT02962375|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1348673|NCT02962362|||||Prospective|||||||
1348674|NCT02962336|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348675|NCT02962323|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348676|NCT02962310|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348677|NCT02962297|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348678|NCT02962284||Single Group Assignment||Treatment||None (Open Label)||||||
1348679|NCT02962271|||Case Control||Cross-Sectional|||||||
1348680|NCT02962258|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348681|NCT02962245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348682|NCT02962232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348683|NCT02962219|Randomized|Parallel Assignment||Prevention||Single||||||t
1348684|NCT02962206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348685|NCT02962193|||Cohort||Prospective|||||||
1348686|NCT02962180||Single Group Assignment||Treatment||None (Open Label)||||||
1348687|NCT02962167|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348688|NCT02962154|||Cohort||Prospective|||||||
1348689|NCT02962141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348690|NCT02962128|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1348691|NCT02962115||Single Group Assignment||Screening||None (Open Label)||||||
1348692|NCT02962102|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348693|NCT02962089|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1348694|NCT02962076||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348695|NCT02962063||Single Group Assignment||Treatment||None (Open Label)||||||
1348696|NCT02962050|||Cohort||Prospective|||||||
1348697|NCT02962037|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348698|NCT02962024|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1348699|NCT02962011|Randomized|Parallel Assignment||Treatment||Single|unblinded|Knotless barbed suture vs conventional suture of uterine incision|t|||
1348700|NCT02961998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348701|NCT02961985|||Cohort||Prospective|||||||
1348702|NCT02961972|Randomized|Parallel Assignment||Treatment||Single|creatine or placebo supplementation|creatine or placebo supplementation|t|||
1348703|NCT02961959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348704|NCT02961946|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1348705|NCT02961933|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348706|NCT02961920|||Case-Control||Prospective|||||||
1348707|NCT02961907|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348708|NCT02961894||Single Group Assignment||Treatment||None (Open Label)||||||
1348709|NCT02961881||Single Group Assignment||Treatment||None (Open Label)||||||
1348710|NCT02961868||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348711|NCT02961855|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348712|NCT02961842|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348713|NCT02961829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348714|NCT02961816|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348715|NCT02961803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348716|NCT02961790|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1348717|NCT02961777|||Other||Cross-Sectional|||||||
1348718|NCT02961764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348719|NCT02961751||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348720|NCT02961738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348721|NCT02961725||Single Group Assignment||Treatment||None (Open Label)||||||
1348722|NCT02961712||Single Group Assignment||Treatment||None (Open Label)||||||
1348723|NCT02961699|Randomized|Parallel Assignment||Treatment||None (Open Label)||this study utilizes a medical device||||
1348724|NCT02961686|||Cohort||Prospective|||||||
1348725|NCT02961673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348726|NCT02961660|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1348727|NCT02961647|||Cohort||Retrospective|||||||
1348728|NCT02961634|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1348729|NCT02961621|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348730|NCT02961608||Single Group Assignment||Treatment||None (Open Label)||||||
1348731|NCT02961595|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348732|NCT02961582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348733|NCT02961569||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348734|NCT02961556||Single Group Assignment||Treatment||None (Open Label)||||||
1348735|NCT02961543|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348736|NCT02961530|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348737|NCT02961517|||Other||Cross-Sectional|||||||
1348738|NCT02961504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348739|NCT02961491||||||||||||
1348740|NCT02961478||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348741|NCT02961465|||Cohort||Prospective|||||||
1348742|NCT02961452|||Case-Only||Retrospective|||||||
1348743|NCT02961439|||Other||Prospective|||||||
1348744|NCT02961426|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348745|NCT02961413|||Cohort||Prospective|||||||
1348746|NCT02961400|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1348747|NCT02961387|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1348748|NCT02961374||Single Group Assignment||Prevention||None (Open Label)||||||
1348749|NCT02961361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348750|NCT02961348|Randomized|Parallel Assignment||Prevention||Single||||||t
1348751|NCT02961335||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348752|NCT02961322||Single Group Assignment||||None (Open Label)||||||
1348753|NCT02961309|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1348754|NCT02961296|||Case-Only||Cross-Sectional|||||||
1348755|NCT02961283|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348756|NCT02961270||Single Group Assignment||Treatment||None (Open Label)||||||
1348757|NCT02961257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348758|NCT02961244|Randomized|Parallel Assignment||Prevention||Single||||||t
1348759|NCT02961231|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348760|NCT02961218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348761|NCT02961205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348762|NCT02961192|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1348763|NCT02961179|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1348764|NCT02961166|||Cohort||Retrospective|||||||
1348765|NCT02961153|||Case-Only||Prospective|||||||
1348766|NCT02961140|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348767|NCT02961127|||||Prospective|||||||
1348768|NCT02961114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1348769|NCT02961101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348770|NCT02961088|||||Prospective|||||||
1348771|NCT02961075|Randomized|Parallel Assignment||Prevention||Single|||||t|
1348772|NCT02961062|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1348773|NCT02961049|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348774|NCT02961036|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1348775|NCT02961023|Randomized|Parallel Assignment||Treatment||Single||||||t
1348776|NCT02961010|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348777|NCT02960997|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1348778|NCT02960984|Randomized|Crossover Assignment||Treatment||Single||||||t
1348779|NCT02960971|||Cohort||Prospective|||||||
1348780|NCT02960958|||Cohort||Cross-Sectional|||||||
1348781|NCT02960945|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1348782|NCT02960932||Single Group Assignment||Other||None (Open Label)||||||
1348783|NCT02960919|||Cohort||Prospective|||||||
1348784|NCT02960906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348785|NCT02960893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348786|NCT02960880|||Cohort||Retrospective|||||||
1348787|NCT02960867|||Case-Only||Prospective|||||||
1348788|NCT02960854|Randomized|Parallel Assignment||Other||Double|||t||t|
1348789|NCT02960841|Randomized|Parallel Assignment||Treatment||Single||||||t
1348790|NCT02960828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348791|NCT02960815|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348792|NCT02960802|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1348793|NCT02960789||Single Group Assignment||Diagnostic||||||||
1348794|NCT02960776|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1348795|NCT02960763|Randomized|Parallel Assignment||Treatment||Single||||||t
1348796|NCT02960750|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348797|NCT02960737|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1348798|NCT02960724||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348799|NCT02960711|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1348800|NCT02960698|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1348801|NCT02960685|||Cohort||Prospective|||||||
1348802|NCT02960672|||Cohort||Prospective|||||||
1348803|NCT02960659|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1348804|NCT02960646||Single Group Assignment||Treatment||None (Open Label)||||||
1348805|NCT02960633|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348806|NCT02960620||||||||||||
1348807|NCT02960607||Single Group Assignment||Treatment||None (Open Label)||||||
1348808|NCT02960594|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1348809|NCT02960581|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1348810|NCT02960568|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348811|NCT02960555||Single Group Assignment||Treatment||None (Open Label)||||||
1348812|NCT02960542||Single Group Assignment||Prevention||None (Open Label)||||||
1348813|NCT02960529|||Case Control||Prospective|||||||
1348814|NCT02960516|||Cohort||Prospective|||||||
1348815|NCT02960503|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1348816|NCT02960490|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348817|NCT02960477|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1348818|NCT02960464|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1348819|NCT02960451|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348820|NCT02960438|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348821|NCT02960425|Randomized|Factorial Assignment||Other||Triple|||t||t|t
1348822|NCT02960412|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1348823|NCT02960399|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348824|NCT02960386||Single Group Assignment||Other||None (Open Label)||||||
1348825|NCT02960373|Randomized|Crossover Assignment||||Single|||||t|
1348826|NCT02960347||Single Group Assignment||Treatment||None (Open Label)||||||
1348827|NCT02960334|||Case-Only||Cross-Sectional|||||||
1348828|NCT02960321|||Cohort||Prospective|||||||
1348829|NCT02960308||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348830|NCT02960295||Single Group Assignment||Treatment||None (Open Label)||||||
1348831|NCT02960282|||Case-Only||Prospective|||||||
1348832|NCT02960269||Single Group Assignment||Health Services Research||None (Open Label)||||||
1348833|NCT02960256|||Cohort||Prospective|||||||
1348834|NCT02960243|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1348835|NCT02960230|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348836|NCT02960217|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1348837|NCT02960204|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1348838|NCT02960191|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1348839|NCT02960178|Randomized|Parallel Assignment||Treatment||Single||||||t
1348840|NCT02960165|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348841|NCT02960152|||Case-Control||Cross-Sectional|||||||
1348842|NCT02960139|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348843|NCT02960126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348844|NCT02960113|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348845|NCT02960100|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348846|NCT02960087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348847|NCT02960074||Single Group Assignment||Treatment||None (Open Label)||||||
1348848|NCT02960061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348849|NCT02960048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348850|NCT02960035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348851|NCT02960022|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348852|NCT02960009|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1348853|NCT02959996|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348854|NCT02959983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348855|NCT02959970||Single Group Assignment||Treatment||None (Open Label)||||||
1348856|NCT02959957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348857|NCT02959944|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348858|NCT02959931|Randomized|Crossover Assignment||Treatment||Single|||||t|
1348859|NCT02959918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348860|NCT02959905|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348861|NCT02959892||Single Group Assignment||Other||None (Open Label)||||||
1348862|NCT02959879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348863|NCT02959866||Single Group Assignment||Health Services Research||None (Open Label)||||||
1348864|NCT02959853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348865|NCT02959840|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348866|NCT02959827|||Cohort||Retrospective|||||||
1348867|NCT02959814|||Cohort||Prospective|||||||
1348868|NCT02959801||Single Group Assignment||Treatment||None (Open Label)||||||
1348869|NCT02959788|||Cohort||Prospective|||||||
1348870|NCT02959775|Randomized|Parallel Assignment||Prevention||Single||||||t
1348871|NCT02959762|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348872|NCT02959749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348873|NCT02959736|||Cohort||Prospective|||||||
1348874|NCT02959723|||Cohort||Prospective|||||||
1348875|NCT02959710|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1348876|NCT02959697|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1348877|NCT02959684|||Other||Prospective|||||||
1348878|NCT02959671||Single Group Assignment||Treatment||None (Open Label)||||||
1348879|NCT02959658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348880|NCT02959645|||Case-Only||Cross-Sectional|||||||
1348881|NCT02959632||Single Group Assignment||Supportive Care||None (Open Label)||||||
1348882|NCT02959619||Single Group Assignment||Treatment||None (Open Label)||||||
1348883|NCT02959606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348884|NCT02959593|Randomized|Single Group Assignment||Other||Single||||||t
1348885|NCT02959580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348886|NCT02959567||Single Group Assignment||Treatment||None (Open Label)||||||
1348887|NCT02959554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348888|NCT02959541|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1348889|NCT02959528|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348890|NCT02959515|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348891|NCT02959502|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1348892|NCT02959489|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1348893|NCT02959476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348894|NCT02959463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348895|NCT02959450|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348896|NCT02959437|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1348897|NCT02959424|||Cohort||Cross-Sectional|||||||
1348898|NCT02959411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348899|NCT02959398|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1348900|NCT02959385|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1348901|NCT02959372|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1348902|NCT02959359||Single Group Assignment||Prevention||None (Open Label)||||||
1348903|NCT02959346|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1348904|NCT02959333||Single Group Assignment||Treatment||None (Open Label)||||||
1348905|NCT02959320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348906|NCT02959307|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1348907|NCT02959294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348908|NCT02959281|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348909|NCT02959268||Single Group Assignment||Diagnostic||Double||||t||t
1348910|NCT02959255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348911|NCT02959242|||Cohort||Prospective|||||||
1348912|NCT02959229|Randomized|Parallel Assignment||Prevention||Single||||t||
1348913|NCT02959216|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1348914|NCT02959203|||Cohort||Prospective|||||||
1348915|NCT02959190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348916|NCT02959177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348917|NCT02959164||Single Group Assignment||Treatment||None (Open Label)||||||
1348918|NCT02959151||Single Group Assignment||Treatment||None (Open Label)||||||
1348919|NCT02959138|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348920|NCT02959125|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1348921|NCT02959112|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1348922|NCT02959099|||Case-Control||Retrospective|||||||
1348923|NCT02959086|||Cohort||Prospective|||||||
1348924|NCT02959073|||Case-Only||Prospective|||||||
1348925|NCT02959060||Single Group Assignment||Basic Science||None (Open Label)||||||
1348926|NCT02959047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348927|NCT02959034|||Case-Control||Prospective|||||||
1348928|NCT02959021|Randomized|Parallel Assignment||Treatment||Single||||||t
1348929|NCT02959008|||Cohort||Prospective|||||||
1348930|NCT02958995|||Cohort||Prospective|||||||
1348931|NCT02958982|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1348932|NCT02958969|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1348933|NCT02958956|||Cohort||Prospective|||||||
1348934|NCT02958943|Randomized|Parallel Assignment||Treatment||Single|||||t|
1348935|NCT02958930||Single Group Assignment||Treatment||None (Open Label)||||||
1348936|NCT02958917|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348937|NCT02958904|||||Cross-Sectional|||||||
1348938|NCT02958891|||Case-Crossover||Cross-Sectional|||||||
1348939|NCT02958878|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1348940|NCT02958865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1348941|NCT02958852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348942|NCT02958839|||Case Control||Prospective|||||||
1348943|NCT02958826|||Other||Prospective|||||||
1348944|NCT02958813|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348945|NCT02958800||Single Group Assignment||Supportive Care||None (Open Label)||||||
1348946|NCT02958787||Single Group Assignment||Treatment||None (Open Label)||||||
1348947|NCT02958774||Single Group Assignment||Treatment||None (Open Label)||||||
1348948|NCT02958761|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1348949|NCT02958748|||Cohort||Prospective|||||||
1348950|NCT02958735|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1348951|NCT02958722|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1348952|NCT02958709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348953|NCT02958696|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348955|NCT02958670||Single Group Assignment||Other||None (Open Label)||||||
1348956|NCT02958657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348957|NCT02958644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1348958|NCT02958631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348959|NCT02958618|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348960|NCT02958605|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1348961|NCT02958592|||Cohort||Prospective|||||||
1348962|NCT02958579|||Cohort||Prospective|||||||
1348963|NCT02958566|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1348964|NCT02958553||Sequential Assignment||Treatment||None (Open Label)||First the patient data is gathered with the subject's own passive prosthetic. Then switched over to the emPOWER Ankle. Third, the patient's prosthetic is switched back to test for carry-over benefits. Then they are put on the emPOWER for a final series of tests.||||
1348965|NCT02958540|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1348966|NCT02958527|||Case-Only||Prospective|||||||
1348967|NCT02958514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348968|NCT02958501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348969|NCT02958488||Single Group Assignment||Other||None (Open Label)||||||
1348970|NCT02958475|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1348971|NCT02958462||Single Group Assignment||Screening||None (Open Label)||||||
1348972|NCT02958449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348973|NCT02958436|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1348974|NCT02958423|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348975|NCT02958410||Single Group Assignment||Treatment||None (Open Label)||||||
1348976|NCT02958397||Single Group Assignment||Treatment||None (Open Label)||||||
1348977|NCT02958384||Single Group Assignment||Treatment||None (Open Label)||||||
1348978|NCT02958371||Single Group Assignment||||None (Open Label)||||||
1348979|NCT02958358||Single Group Assignment||||None (Open Label)||||||
1348980|NCT02958345|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1348981|NCT02958332||Single Group Assignment||Treatment||None (Open Label)||||||
1348982|NCT02958319|||Cohort||Prospective|||||||
1348983|NCT02958306|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1348984|NCT02958293|||Cohort||Retrospective|||||||
1348985|NCT02958280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348986|NCT02958267|Randomized|Parallel Assignment||Treatment||Single||||||t
1348987|NCT02958254|||||Cross-Sectional|||||||
1348988|NCT02958241||Single Group Assignment||Diagnostic||None (Open Label)||||||
1348989|NCT02958228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348990|NCT02958215|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1348991|NCT02958202|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348992|NCT02958189|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1348993|NCT02958176|Randomized|Parallel Assignment||Treatment||Single|||t|||
1348994|NCT02958163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348995|NCT02958150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348996|NCT02958137|||Cohort||Prospective|||||||
1348997|NCT02958124|||Case-Only||Prospective|||||||
1348998|NCT02958111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1348999|NCT02958098|||Cohort||Prospective|||||||
1349000|NCT02958085|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1349001|NCT02958072|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1349002|NCT02958059|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1349003|NCT02958046||Single Group Assignment||Treatment||None (Open Label)||||||
1349004|NCT02958033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349005|NCT02958020|||Cohort||Prospective|||||||
1349006|NCT02958007|Randomized|Parallel Assignment||Treatment||Single||||||t
1349007|NCT02957994||Single Group Assignment||Treatment||None (Open Label)||||||
1349008|NCT02957981|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349009|NCT02957968|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349010|NCT02957955|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1349011|NCT02957942|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1349012|NCT02957929|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1349013|NCT02957916|||Other||Other|||||||
1349014|NCT02957903|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1349015|NCT02957890|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1349016|NCT02957877|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349017|NCT02957864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349018|NCT02957851|Randomized|Parallel Assignment||Treatment||Single|||||t|
1349019|NCT02957838|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1349020|NCT02957825|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1349021|NCT02957812|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349022|NCT02957799|Randomized|Parallel Assignment||Prevention||Single||||||t
1349023|NCT02957786|Randomized|Parallel Assignment||Treatment||Single|||||t|
1349024|NCT02957773|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1349025|NCT02957760|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349026|NCT02957747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349027|NCT02957734||Single Group Assignment||Treatment||None (Open Label)||||||
1349028|NCT02957721|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349029|NCT02957708|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1349030|NCT02957695|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349031|NCT02957682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349032|NCT02957669|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349033|NCT02957656|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349034|NCT02957643|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1349035|NCT02957630|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349036|NCT02957617||Single Group Assignment||Treatment||None (Open Label)||||||
1349037|NCT02957604|||Cohort||Prospective|||||||
1349038|NCT02957591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349039|NCT02957578||Single Group Assignment||Treatment||None (Open Label)||||||
1349040|NCT02957565|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1349041|NCT02957552||Single Group Assignment||Treatment||None (Open Label)||||||
1349042|NCT02957539|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349043|NCT02957526|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349044|NCT02957513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349045|NCT02957500|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1349046|NCT02957487|||Cohort||Prospective|||||||
1349047|NCT02957474|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349048|NCT02957461|||Cohort||Prospective|||||||
1349049|NCT02957448||Single Group Assignment||Basic Science||None (Open Label)||||||
1349050|NCT02957435||Single Group Assignment||Other||None (Open Label)||||||
1349051|NCT02957422|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349052|NCT02957409|||Cohort||Prospective|||||||
1349053|NCT02957396|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1349054|NCT02957383|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1349055|NCT02957370|||Case-Control||Prospective|||||||
1349056|NCT02957357|||Other||Prospective|||||||
1349057|NCT02957344|||Ecologic or Community||Cross-Sectional|||||||
1349058|NCT02957331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349059|NCT02957318|Randomized|Crossover Assignment||Prevention||Single|||t|||
1349060|NCT02957305|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349061|NCT02957292|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349062|NCT02957279|||Cohort||Prospective|||||||
1349063|NCT02957266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349064|NCT02957253|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349065|NCT02957240|Randomized|Parallel Assignment||Prevention||Single||||||t
1349066|NCT02957227|||Case-Control||Prospective|||||||
1349067|NCT02957214||Single Group Assignment||Treatment||None (Open Label)||||||
1349068|NCT02957201||Single Group Assignment||||None (Open Label)||||||
1349069|NCT02957188|||Case-Crossover||Cross-Sectional|||||||
1349070|NCT02957175|||Cohort||Prospective|||||||
1349071|NCT02957162||Single Group Assignment||Prevention||None (Open Label)||||||
1349072|NCT02957149||Single Group Assignment||Treatment||None (Open Label)||||||
1349073|NCT02957136|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1349074|NCT02957123||Single Group Assignment||Treatment||None (Open Label)||||||
1349075|NCT02957110|||Other||Other|||||||
1349076|NCT02957097|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349077|NCT02957084|||Cohort||Prospective|||||||
1349078|NCT02957071||||||||||||
1349079|NCT02957058|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349080|NCT02957045||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349081|NCT02957032||Single Group Assignment||Treatment||None (Open Label)||||||
1349082|NCT02957019||Single Group Assignment||Treatment||None (Open Label)||||||
1349083|NCT02957006|||Case-Only||Prospective|||||||
1349084|NCT02956993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349085|NCT02956980|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1349086|NCT02956967|||Cohort||Prospective|||||||
1349087|NCT02956954|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1349088|NCT02956941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349089|NCT02956928||||||||||||
1349090|NCT02956915|||Cohort||Prospective|||||||
1349091|NCT02956902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349092|NCT02956889||Single Group Assignment||Treatment||None (Open Label)||||||
1349093|NCT02956876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349094|NCT02956863|Randomized|Parallel Assignment||Treatment||Single||||||t
1349095|NCT02956850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349096|NCT02956837|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1349097|NCT02956824||Single Group Assignment||||None (Open Label)||||||
1349098|NCT02956811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349099|NCT02956798||Single Group Assignment||Treatment||None (Open Label)||||||
1349100|NCT02956785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349101|NCT02956772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349102|NCT02956759|Randomized|Parallel Assignment||Treatment||Single||||||t
1349103|NCT02956746|Randomized|Parallel Assignment||Prevention||Single|||t|||
1349104|NCT02956733|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349105|NCT02956720||Single Group Assignment||Treatment||None (Open Label)||prospective, single arm||||
1349106|NCT02956707|||Cohort||Prospective|||||||
1349107|NCT02956694|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1349108|NCT02956681|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349109|NCT02956668|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349110|NCT02956655|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349111|NCT02956642|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349112|NCT02956629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349113|NCT02956616|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1349114|NCT02956603|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1349115|NCT02956590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349116|NCT02956577|||Cohort||Prospective|||||||
1349117|NCT02956564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349118|NCT02956551||Single Group Assignment||Treatment||None (Open Label)||||||
1349119|NCT02956538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349120|NCT02956525|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1349121|NCT02956512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349122|NCT02956499|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349123|NCT02956486|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349124|NCT02956473||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349125|NCT02956460|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1349126|NCT02956447|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349127|NCT02956434|Randomized|Parallel Assignment||Treatment||Single||||||t
1349128|NCT02956421|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349129|NCT02956408|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349130|NCT02956395|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1349131|NCT02956382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349132|NCT02956369|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1349133|NCT02956356|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1349134|NCT02956343|||Case-Control||Prospective|||||||
1349135|NCT02956330|||Cohort||Retrospective|||||||
1349136|NCT02956317|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1349137|NCT02956304|Randomized|Crossover Assignment||Other||Double|||t|||t
1349138|NCT02956291|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1349139|NCT02956278|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1349140|NCT02956265||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349141|NCT02956252|||Cohort||Retrospective|||||||
1349142|NCT02956239|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349143|NCT02956226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349144|NCT02956213|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1349145|NCT02956200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349146|NCT02956187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349147|NCT02956174|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1349148|NCT02956161|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1349149|NCT02956148||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349150|NCT02956135|||Case Control||Prospective|||||||
1349151|NCT02956122|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349152|NCT02956109|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1349153|NCT02956096|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1349154|NCT02956083|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349155|NCT02956070|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349156|NCT02956057|Randomized|Parallel Assignment||Treatment||Single||||||t
1349157|NCT02956044|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349158|NCT02956031|||Cohort||Cross-Sectional|||||||
1349159|NCT02956018|||Cohort||Prospective|||||||
1349160|NCT02956005||Single Group Assignment||Treatment||None (Open Label)||||||
1349161|NCT02955992|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349162|NCT02955979|||Cohort||Prospective|||||||
1349163|NCT02955966||Single Group Assignment||Other||None (Open Label)||||||
1349164|NCT02955953|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1349165|NCT02955940|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349166|NCT02955927|Randomized|Parallel Assignment||Treatment||Single||||||t
1349167|NCT02955914|||Other||Prospective|||||||
1349168|NCT02955901|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1349169|NCT02955888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349170|NCT02955875|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1349171|NCT02955862||Single Group Assignment||Screening||None (Open Label)||||||
1349172|NCT02955849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349173|NCT02955836|||Case-Only||Cross-Sectional|||||||
1349174|NCT02955823||Single Group Assignment||Treatment||None (Open Label)||||||
1349175|NCT02955810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349176|NCT02955797|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349177|NCT02955784||Single Group Assignment||Treatment||None (Open Label)||||||
1349178|NCT02955771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349179|NCT02955758||Single Group Assignment||Treatment||None (Open Label)||||||
1349180|NCT02955745|||Other||Prospective|||||||
1349181|NCT02955732||Single Group Assignment||Treatment||None (Open Label)||||||
1349182|NCT02955719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349183|NCT02955706|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349184|NCT02955693|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349185|NCT02955680|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1349186|NCT02955667|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1349187|NCT02955654|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349188|NCT02955641|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1349189|NCT02955628||Single Group Assignment||Treatment||None (Open Label)||||||
1349190|NCT02955615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349191|NCT02955602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349192|NCT02955589||Single Group Assignment||Treatment||None (Open Label)||||||
1349193|NCT02955576|Randomized|Parallel Assignment||Treatment||Single||||||t
1349194|NCT02955563|Randomized|Parallel Assignment||Other||Single||||||t
1349195|NCT02955550||Single Group Assignment||Treatment||None (Open Label)||||||
1349196|NCT02955537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349197|NCT02955524||Single Group Assignment||Prevention||None (Open Label)||||||
1349198|NCT02955511|Randomized|Factorial Assignment||Screening||Triple|||t|t||t
1349199|NCT02955498|Randomized|Crossover Assignment||||None (Open Label)||||||
1349200|NCT02955485|||Cohort||Prospective|||||||
1349201|NCT02955472|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1349202|NCT02955459|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1349203|NCT02955446||||||||||||
1349204|NCT02955433|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1349205|NCT02955420|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1349206|NCT02955407|||Case-Control||Cross-Sectional|||||||
1349207|NCT02955394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349208|NCT02955381|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349209|NCT02955368|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349210|NCT02955355||Single Group Assignment||Treatment||None (Open Label)||||||
1349211|NCT02955342|||Cohort||Prospective|||||||
1349212|NCT02955329|Randomized|Crossover Assignment||Other||Single|||t|||
1349213|NCT02955316|||Ecologic or Community||Cross-Sectional|||||||
1349214|NCT02955303||Single Group Assignment||Treatment||None (Open Label)||||||
1349215|NCT02955290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349216|NCT02955277|Randomized|Parallel Assignment||Treatment||Single||||||t
1349217|NCT02955264||Single Group Assignment||Treatment||None (Open Label)||||||
1349218|NCT02955251|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349219|NCT02955238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349220|NCT02955225|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349221|NCT02955212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349222|NCT02955199|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349223|NCT02955186|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1349224|NCT02955173|Non-Randomized|Parallel Assignment||Screening||Single||||||t
1349225|NCT02955160|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1349226|NCT02955147||Single Group Assignment||Treatment||None (Open Label)||||||
1349227|NCT02955134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349228|NCT02955121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349229|NCT02955108|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1349230|NCT02955095||Single Group Assignment||Treatment||None (Open Label)||||||
1349231|NCT02955082||Single Group Assignment||Treatment||None (Open Label)||||||
1349232|NCT02955069||Single Group Assignment||Treatment||None (Open Label)||||||
1349233|NCT02955056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349234|NCT02955043|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349235|NCT02955030|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349236|NCT02955017|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349237|NCT02955004|||Case-Control||Prospective|||||||
1349238|NCT02954991|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349239|NCT02954978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349240|NCT02954965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349241|NCT02954952|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1349242|NCT02954939|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1349243|NCT02954926|Randomized|Parallel Assignment||Prevention||Single|||||t|
1349244|NCT02954913||Single Group Assignment||Treatment||None (Open Label)||||||
1349245|NCT02954900||Single Group Assignment||Prevention||None (Open Label)||||||
1349246|NCT02954887||Single Group Assignment||Treatment||None (Open Label)|Open-label|||||
1349247|NCT02954874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349248|NCT02954861|||Cohort||Prospective|||||||
1349249|NCT02954848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349250|NCT02954835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349251|NCT02954822|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1349252|NCT02954809|Randomized|Parallel Assignment||||Single|||t|||
1349253|NCT02954796||Single Group Assignment||Treatment||None (Open Label)||||||
1349254|NCT02954783|Randomized|Factorial Assignment||Basic Science||Single||||||t
1349255|NCT02954770|||Cohort||Cross-Sectional|||||||
1349256|NCT02954757||Single Group Assignment||Treatment||None (Open Label)||||||
1349257|NCT02954744||Single Group Assignment||Treatment||None (Open Label)||||||
1349258|NCT02954731|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1349259|NCT02954718|Randomized|Parallel Assignment||Treatment||Single||||||t
1349260|NCT02954705|||Case Control||Prospective|||||||
1349261|NCT02954692||Single Group Assignment||Treatment||None (Open Label)||||||
1349262|NCT02954679|||Other||Prospective|||||||
1349263|NCT02954666|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349264|NCT02954653|Non-Randomized|||Treatment||None (Open Label)||||||
1349265|NCT02954640||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349266|NCT02954627|||Cohort||Prospective|||||||
1349267|NCT02954614|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349268|NCT02954601|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1349269|NCT02954588|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1349270|NCT02954575||Single Group Assignment||Treatment||None (Open Label)||||||
1349271|NCT02954562|||Case-Crossover||Prospective|||||||
1349272|NCT02954549|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1349273|NCT02954536||Single Group Assignment||Treatment||None (Open Label)||||||
1349274|NCT02954523||Single Group Assignment||Treatment||None (Open Label)||||||
1349275|NCT02954510||Single Group Assignment||Diagnostic||None (Open Label)|Experts evaluating ferumoxytol-enhanced magnetic resonance imaging will be masked to the results of other invasive and non-invasive cardiac testing|case control||||
1349276|NCT02954497||Single Group Assignment||Supportive Care||None (Open Label)||||||
1349277|NCT02954484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349278|NCT02954471|||Cohort||Retrospective|||||||
1349279|NCT02954458||Single Group Assignment||Treatment||None (Open Label)||||||
1349280|NCT02954445||Single Group Assignment||Treatment||None (Open Label)||||||
1349281|NCT02954432|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1349282|NCT02954419|||Cohort||Prospective|||||||
1349283|NCT02954406|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349284|NCT02954393|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1349285|NCT02954380||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349286|NCT02954367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349287|NCT02954354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349288|NCT02954341|||Cohort||Prospective|||||||
1349289|NCT02954328||Single Group Assignment||Prevention||None (Open Label)||||||
1349290|NCT02954315|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1349291|NCT02954302|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349292|NCT02954289||Single Group Assignment||Prevention||None (Open Label)||||||
1349293|NCT02954276|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349294|NCT02954263|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1349295|NCT02954250|Randomized|Parallel Assignment||Treatment||Single||||||t
1349296|NCT02954237|||Case-Only||Prospective|||||||
1349297|NCT02954224|Randomized|Parallel Assignment||Prevention||Single|||||t|
1349298|NCT02954211||Single Group Assignment||Treatment||None (Open Label)||||||
1349299|NCT02954198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349300|NCT02954185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349301|NCT02954172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349302|NCT02954159|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349303|NCT02954146|Randomized|Parallel Assignment||Treatment||Single||||||t
1349304|NCT02954133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349305|NCT02954120|||Case Control||Cross-Sectional|||||||
1349306|NCT02954107|||Case-Control||Prospective|||||||
1349307|NCT02954094|||Cohort||Prospective|||||||
1349308|NCT02954081|||Other||Prospective|||||||
1349309|NCT02954068|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1349310|NCT02954055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349311|NCT02954042|Randomized|Crossover Assignment||Treatment||Single|||t|||
1349312|NCT02954029|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349313|NCT02954016||Single Group Assignment||Treatment||None (Open Label)||||||
1349314|NCT02954003||Single Group Assignment||Treatment||None (Open Label)||||||
1349315|NCT02953990||Single Group Assignment||Other||None (Open Label)||||||
1349316|NCT02953977|Randomized|Parallel Assignment||Prevention||Single||||||t
1349317|NCT02953964|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349318|NCT02953951|||Cohort||Prospective|||||||
1349319|NCT02953938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349320|NCT02953925|||Other||Cross-Sectional|||||||
1349321|NCT02953912|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349322|NCT02953899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349323|NCT02953886||Single Group Assignment||Treatment||None (Open Label)||||||
1349324|NCT02953873||Single Group Assignment||Treatment||None (Open Label)||||||
1349325|NCT02953860||Single Group Assignment||Treatment||None (Open Label)||||||
1349326|NCT02953847|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1349327|NCT02953834|Randomized|Parallel Assignment||Other||Double|||t||t|
1349328|NCT02953821|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349329|NCT02953808|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349330|NCT02953782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349331|NCT02953769|||Cohort||Prospective|||||||
1349332|NCT02953756|||Case-Only||Prospective|||||||
1349333|NCT02953743|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349334|NCT02953730||Single Group Assignment||Treatment||None (Open Label)||||||
1349335|NCT02953717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349336|NCT02953704|||Cohort||Prospective|||||||
1349337|NCT02953691|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349338|NCT02953678||Single Group Assignment||Treatment||None (Open Label)||||||
1349339|NCT02953665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349340|NCT02953652||Single Group Assignment||Treatment||None (Open Label)||||||
1349341|NCT02953639|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349342|NCT02953626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349343|NCT02953613||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349344|NCT02953600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349345|NCT02953587|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1349346|NCT02953574|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349347|NCT02953561||Single Group Assignment||Treatment||None (Open Label)||||||
1349348|NCT02953548||Single Group Assignment||Treatment||None (Open Label)|Open-label|||||
1349349|NCT02953535|Randomized|Crossover Assignment||||None (Open Label)||||||
1349350|NCT02953522|Randomized|Parallel Assignment||Prevention||Single|||||t|
1349351|NCT02953509|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349352|NCT02953496||Single Group Assignment||Treatment||None (Open Label)||||||
1349353|NCT02953483|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349354|NCT02953470|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1349355|NCT02953457||Single Group Assignment||Treatment||None (Open Label)||||||
1349356|NCT02953444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349357|NCT02953431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349358|NCT02953418||Single Group Assignment||Treatment||None (Open Label)||||||
1349359|NCT02953405|||Cohort||Prospective|||||||
1349360|NCT02953392|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349361|NCT02953379|Randomized|Parallel Assignment||Treatment||Single|||||t|
1349362|NCT02953366|Randomized|Parallel Assignment||Treatment||Single|||||t|
1349363|NCT02953353|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349364|NCT02953340|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349365|NCT02953327|Randomized|Parallel Assignment||Basic Science||Single||||t||
1349366|NCT02953314|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349367|NCT02953301|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1349368|NCT02953288|||Case-Crossover||Cross-Sectional|||||||
1349369|NCT02953275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349370|NCT02953262|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1349371|NCT02953249|||Case Control||Prospective|||||||
1349372|NCT02953236|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1349373|NCT02953223|||Cohort||Prospective|||||||
1349374|NCT02953210|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349375|NCT02953197||Single Group Assignment||Treatment||None (Open Label)||||||
1349376|NCT02953184|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349377|NCT02953171|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1349378|NCT02953158|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1349379|NCT02953145|Randomized|Parallel Assignment||Treatment||Single||||||t
1349380|NCT02953132|Randomized|Parallel Assignment||Other||Double||||||
1349381|NCT02953119|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349382|NCT02953106|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1349383|NCT02953093|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1349384|NCT02953080|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1349385|NCT02953067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349386|NCT02953054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349387|NCT02953041|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1349388|NCT02953028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349389|NCT02953015|Randomized|Parallel Assignment||Treatment||Single||||||t
1349390|NCT02953002|||Cohort||Prospective|||||||
1349391|NCT02952989|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349392|NCT02952976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349393|NCT02952963|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349394|NCT02952950|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1349395|NCT02952937|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1349396|NCT02952924|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349397|NCT02952911|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1349398|NCT02952898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349399|NCT02952885||Single Group Assignment||Treatment||None (Open Label)||||||
1349400|NCT02952872|Randomized|Factorial Assignment||Treatment||Single|||t|||
1349401|NCT02952859|||Cohort||Prospective|||||||
1349402|NCT02952846|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349403|NCT02952833|Randomized|Sequential Assignment||Prevention||Double|||t||t|
1349404|NCT02952820|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349405|NCT02952807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349406|NCT02952794|||Cohort||Prospective|||||||
1349407|NCT02952781|||Case-Only||Prospective|||||||
1349408|NCT02952768||Single Group Assignment||Other||None (Open Label)||||||
1349409|NCT02952755|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349410|NCT02952742|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1349411|NCT02952729||Single Group Assignment||Treatment||None (Open Label)||||||
1349412|NCT02952716|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1349413|NCT02952703|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349414|NCT02952690|Randomized|Parallel Assignment||Other||Single|||t|||
1349415|NCT02952677|Randomized|Parallel Assignment||Treatment||Single||||||t
1349416|NCT02952664||Single Group Assignment||Prevention||None (Open Label)||||||
1349417|NCT02952651||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349418|NCT02952638|||Cohort||Prospective|||||||
1349419|NCT02952625||Single Group Assignment||||None (Open Label)||||||
1349420|NCT02952612|||Case-Only||Prospective|||||||
1349421|NCT02952599|||Cohort||Prospective|||||||
1349422|NCT02952586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349423|NCT02952573|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349424|NCT02952560|||Other||Prospective|||||||
1349425|NCT02952547|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349426|NCT02952534||Single Group Assignment||Treatment||None (Open Label)||||||
1349427|NCT02952521|||Cohort||Prospective|||||||
1349428|NCT02952508||Single Group Assignment||Treatment||None (Open Label)||||||
1349429|NCT02952495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349430|NCT02952482|||Cohort||Prospective|||||||
1349431|NCT02952469||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349432|NCT02952456|||Other||Prospective|||||||
1349433|NCT02952443|||Cohort||Cross-Sectional|||||||
1349434|NCT02952430|||Cohort||Prospective|||||||
1349435|NCT02952417|||Cohort||Prospective|||||||
1349436|NCT02952404|||Cohort||Retrospective|||||||
1349437|NCT02952391|||Case Control||Cross-Sectional|||||||
1349438|NCT02952378|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349439|NCT02952365||Single Group Assignment||Prevention||None (Open Label)||||||
1349440|NCT02952352|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349441|NCT02952339|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349442|NCT02952326|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349443|NCT02952313||Single Group Assignment||Treatment||None (Open Label)||||||
1349444|NCT02952300|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349445|NCT02952287||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349446|NCT02952274|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1349447|NCT02952261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349448|NCT02952248||Single Group Assignment||Treatment||None (Open Label)||||||
1349449|NCT02952235|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1349450|NCT02952222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349451|NCT02952209|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349452|NCT02952196|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349453|NCT02952183||Single Group Assignment||||None (Open Label)||||||
1349454|NCT02952170||Single Group Assignment||Prevention||None (Open Label)||||||
1349455|NCT02952157|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1349456|NCT02952144|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349457|NCT02952131|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1349458|NCT02952118||Single Group Assignment||Prevention||None (Open Label)||||||
1349459|NCT02952105|||Case-Only||Prospective|||||||
1349460|NCT02952092|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349461|NCT02952079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349462|NCT02952066||Single Group Assignment||Basic Science||None (Open Label)||||||
1349463|NCT02952053|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1349464|NCT02952040|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1349465|NCT02952027|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1349466|NCT02952014|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1349467|NCT02952001|||Cohort||Prospective|||||||
1349468|NCT02951988|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1349469|NCT02951975|||Cohort||Prospective|||||||
1349470|NCT02951962|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349471|NCT02951949|||Cohort||Cross-Sectional|||||||
1349472|NCT02951936|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349473|NCT02951923|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1349474|NCT02951910||Single Group Assignment||Treatment||None (Open Label)||||||
1349475|NCT02951897|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349476|NCT02951884|Randomized|Parallel Assignment||Treatment||Single|This study uses a single blind masking scheme|Participants will be randomized to receive aspiration of the joint alone, receive aspiration of the knee joint and an injection of 20cc bupivacaine 0.5% with 1:200,000 epinephrine, or receive no injection or aspiration therapy|t|||
1349477|NCT02951871|||||Retrospective|||||||
1349478|NCT02951858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349479|NCT02951845|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349480|NCT02951832|||Cohort||Prospective|||||||
1349481|NCT02951819||Single Group Assignment||Treatment||None (Open Label)||||||
1349482|NCT02951806|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1349483|NCT02951793|||Cohort||Prospective|||||||
1349484|NCT02951780|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1349485|NCT02951767||Single Group Assignment||Treatment||None (Open Label)||||||
1349486|NCT02951754||Single Group Assignment||Treatment||None (Open Label)||||||
1349487|NCT02951741|||Case-Only||Prospective|||||||
1349488|NCT02951728||Single Group Assignment||Treatment||None (Open Label)||||||
1349489|NCT02951715||Single Group Assignment||Treatment||None (Open Label)||||||
1351159|NCT02929953|||Cohort||Cross-Sectional|||||||
1349490|NCT02951702|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349491|NCT02951689|Randomized|Parallel Assignment||Other||Double|||t||t|
1349492|NCT02951676|||Case-Control||Prospective|||||||
1349493|NCT02951663|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1349494|NCT02951650||Single Group Assignment||Treatment||None (Open Label)||||||
1349495|NCT02951637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349496|NCT02951624|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1349497|NCT02951611|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349498|NCT02951598|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1349499|NCT02951585|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349500|NCT02951572||Single Group Assignment||Treatment||None (Open Label)||||||
1349501|NCT02951559||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349502|NCT02951546|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1349503|NCT02951533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349504|NCT02951520||Single Group Assignment||Treatment||None (Open Label)||||||
1349505|NCT02951507|Randomized|Parallel Assignment||||Double|||t||t|
1349506|NCT02951494|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349507|NCT02951481|||Cohort||Other|||||||
1349508|NCT02951468|||Case-Only||Retrospective|||||||
1349509|NCT02951455|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1349510|NCT02951442||Single Group Assignment||Other||None (Open Label)||||||
1349511|NCT02951429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349512|NCT02951416|||Cohort||Cross-Sectional|||||||
1349513|NCT02951403|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349514|NCT02951390|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1349515|NCT02951377|Randomized|Parallel Assignment||Treatment||Single||||||t
1349516|NCT02951364|||Cohort||Prospective|||||||
1349517|NCT02951351|Randomized|Parallel Assignment||Other||Single|||t|||
1349518|NCT02951338|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1349519|NCT02951325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349520|NCT02951312|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1349521|NCT02951299|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349522|NCT02951286|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1349523|NCT02951273|||Cohort||Prospective|||||||
1349524|NCT02951260|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1349525|NCT02951247||Single Group Assignment||Other||Single|||t|||
1349526|NCT02951234|Randomized|Parallel Assignment||Treatment||Single||||||t
1349527|NCT02951221|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1349528|NCT02951208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349529|NCT02951195|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349530|NCT02951182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349531|NCT02951169|||Cohort||Prospective|||||||
1349532|NCT02951156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349533|NCT02951143|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1349534|NCT02951130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349535|NCT02951117|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349536|NCT02951104||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349537|NCT02951091|||Other||Prospective|||||||
1349538|NCT02951078|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1349539|NCT02951065|Randomized|Parallel Assignment||Prevention||Single||||||t
1349540|NCT02951052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349541|NCT02951039|||Cohort||Prospective|||||||
1349542|NCT02951026|||Cohort||Prospective|||||||
1349543|NCT02951013|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349544|NCT02951000|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349545|NCT02950987||Single Group Assignment||Screening||None (Open Label)||||||
1349546|NCT02950974|Randomized|Crossover Assignment||Treatment||Single||||||t
1349547|NCT02950961||Single Group Assignment||Health Services Research||None (Open Label)||||||
1349548|NCT02950948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349549|NCT02950935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349550|NCT02950922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349551|NCT02950909|Randomized|Parallel Assignment||Treatment||Single||||||t
1349552|NCT02950896|||Other||Prospective|||||||
1349553|NCT02950883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349554|NCT02950870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349555|NCT02950857|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349556|NCT02950844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349557|NCT02950831||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349558|NCT02950818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349559|NCT02950805|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1349560|NCT02950792||Single Group Assignment||Treatment||None (Open Label)||||||
1349561|NCT02950779|||Cohort||Prospective|||||||
1349562|NCT02950766||Single Group Assignment||Treatment||None (Open Label)||||||
1349563|NCT02950753|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1349564|NCT02950740|||Case-Crossover||Cross-Sectional|||||||
1349565|NCT02950727|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349566|NCT02950714|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1349567|NCT02950701|||Cohort||Prospective|||||||
1349568|NCT02950688|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349569|NCT02950675|||Case-Control||Prospective|||||||
1349570|NCT02950662|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349571|NCT02950649|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1349572|NCT02950636||Single Group Assignment||Prevention||None (Open Label)||||||
1349573|NCT02950623|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1349574|NCT02950610|||Cohort||Prospective|||||||
1349575|NCT02950597|||Cohort||Prospective|||||||
1349576|NCT02950584|Randomized|Crossover Assignment||||Double|||||t|t
1349577|NCT02950571|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349578|NCT02950558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349579|NCT02950545||Single Group Assignment||Treatment||None (Open Label)||||||
1349580|NCT02950532|||Cohort||Retrospective|||||||
1349581|NCT02950519|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1349582|NCT02950506|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1349583|NCT02950493||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349584|NCT02950480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349585|NCT02950467||Single Group Assignment||Treatment||None (Open Label)||||||
1349586|NCT02950454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349587|NCT02950441|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1349588|NCT02950428||Single Group Assignment||Treatment||None (Open Label)||||||
1349589|NCT02950415|Randomized|Factorial Assignment||Other||Single|||||t|
1349590|NCT02950402|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1349591|NCT02950389|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1349592|NCT02950376|||Case-Only||Cross-Sectional|||||||
1349593|NCT02950363|||Other||Other|||||||
1349594|NCT02950350|||Case Control||Prospective|||||||
1349595|NCT02950337|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349596|NCT02950324|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349597|NCT02950311|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349598|NCT02950298|||Other||Prospective|||||||
1349599|NCT02950285|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349600|NCT02950272|||Cohort||Prospective|||||||
1349601|NCT02950259|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349602|NCT02950246|Randomized|Parallel Assignment||Screening||Single||||||t
1349603|NCT02950233|Randomized|Factorial Assignment||Treatment||Quadruple|Patients, health care providers, data collectors, outcome adjudicators, and Investigators (e.g., Steering Committee Members) will all be blind to treatment allocation.|We will randomize patients in a 1:1:1:1 fashion to receive; 1) NMDA active + dexamethasone placebo, 2) dexamethasone active + NMDA placebo, 3) NMDA active + dexamethasone active, and 4) NMDA placebo + dexamethasone placebo.|t|t|t|t
1349604|NCT02950220||Single Group Assignment||Treatment||None (Open Label)||||||
1349605|NCT02950207|||Cohort||Prospective|||||||
1349606|NCT02950194|||Case-Control||Prospective|||||||
1349607|NCT02950181||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349608|NCT02950168|||Cohort||Prospective|||||||
1349609|NCT02950155|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1349610|NCT02950142|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1349611|NCT02950129||Single Group Assignment||Health Services Research||None (Open Label)||||||
1349612|NCT02950116|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1349613|NCT02950103||Single Group Assignment||Treatment||None (Open Label)||||||
1349614|NCT02950090|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349615|NCT02950077||Single Group Assignment||Treatment||None (Open Label)||||||
1349616|NCT02950064||Single Group Assignment||Treatment||None (Open Label)||||||
1349617|NCT02950051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349618|NCT02950038||Single Group Assignment||Treatment||None (Open Label)||||||
1349619|NCT02950025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349620|NCT02950012|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1349621|NCT02949999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349622|NCT02949986||Single Group Assignment||Treatment||None (Open Label)||||||
1349623|NCT02949973||Single Group Assignment||Treatment||None (Open Label)||||||
1349624|NCT02949960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349625|NCT02949947|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349626|NCT02949934|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349627|NCT02949921|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349628|NCT02949908|||Cohort||Prospective|||||||
1349629|NCT02949895|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349630|NCT02949882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349631|NCT02949869||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349632|NCT02949856|Randomized|Factorial Assignment||Prevention||Single|||t|||
1349633|NCT02949843|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349634|NCT02949830||Single Group Assignment||Treatment||None (Open Label)||||||
1349635|NCT02949817|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349636|NCT02949804|||Ecologic or Community||Retrospective|||||||
1349637|NCT02949791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349638|NCT02949778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349639|NCT02949765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349640|NCT02949752||Single Group Assignment||Treatment||None (Open Label)||||||
1349641|NCT02949739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349642|NCT02949726||Single Group Assignment||Basic Science||None (Open Label)||||||
1349643|NCT02949713|Randomized|Parallel Assignment||||None (Open Label)||||||
1349644|NCT02949700||Single Group Assignment||Treatment||None (Open Label)||||||
1349645|NCT02949687||Single Group Assignment||Treatment||None (Open Label)||||||
1349646|NCT02949674|Randomized|Parallel Assignment||Prevention||Single|||t|||
1349647|NCT02949661|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1349648|NCT02949648|||Cohort||Prospective|||||||
1349649|NCT02949635|||Cohort||Prospective|||||||
1349650|NCT02949622|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349651|NCT02949609|Randomized|Parallel Assignment||Treatment||Single||||||t
1349652|NCT02949596|||Cohort||Prospective|||||||
1349653|NCT02949583|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1349654|NCT02949570||Single Group Assignment||Treatment||None (Open Label)||||||
1349655|NCT02949557|Randomized|Parallel Assignment||Treatment||Single|||||t|
1349656|NCT02949544||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1349657|NCT02949531|Randomized|Crossover Assignment||Treatment||Single|||t|||
1349658|NCT02949518|Randomized|Parallel Assignment||Other||Double|||t|||t
1349659|NCT02949505||Single Group Assignment||Treatment||None (Open Label)||||||
1349660|NCT02949492||Single Group Assignment||Treatment||None (Open Label)||||||
1349661|NCT02949479||Single Group Assignment||Health Services Research||None (Open Label)||||||
1349662|NCT02949466|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349663|NCT02949453||Single Group Assignment||Prevention||None (Open Label)||||||
1349664|NCT02949440|Randomized|Parallel Assignment||Treatment||Single||||||t
1349665|NCT02949427|||Cohort||Prospective|||||||
1349666|NCT02949414||Single Group Assignment||Treatment||None (Open Label)||||||
1349667|NCT02949401||||||||||||
1349668|NCT02949388|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349669|NCT02949375|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1349670|NCT02949362||Single Group Assignment||Treatment||None (Open Label)||||||
1349671|NCT02949349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349672|NCT02949336|||Case Control||Prospective|||||||
1349673|NCT02949323|||Case Control||Prospective|||||||
1349674|NCT02949310|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1349675|NCT02949297||Single Group Assignment||Treatment||None (Open Label)||||||
1349676|NCT02949284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349677|NCT02949271|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1349678|NCT02949258||Single Group Assignment||Treatment||None (Open Label)||||||
1349679|NCT02949245|||Case-Only||Prospective|||||||
1349680|NCT02949232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349681|NCT02949219||Single Group Assignment||Treatment||None (Open Label)||||||
1349682|NCT02949206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349683|NCT02949193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349684|NCT02949180|||Case-Control||Prospective|||||||
1349685|NCT02949167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349686|NCT02949154|||Cohort||Retrospective|||||||
1349687|NCT02949141||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349688|NCT02949128||Single Group Assignment||Treatment||None (Open Label)||||||
1349689|NCT02949115|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1349690|NCT02949102|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1349691|NCT02949089||Single Group Assignment||Treatment||None (Open Label)||||||
1349692|NCT02949076||Single Group Assignment||Basic Science||None (Open Label)||||||
1349693|NCT02949063|||Case-Only||Prospective|||||||
1349694|NCT02949050|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349695|NCT02949037|Randomized|Parallel Assignment||Other||Single|||t|||
1349696|NCT02949024|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349697|NCT02949011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349698|NCT02948998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349699|NCT02948985|||Case-Only||Prospective|||||||
1349700|NCT02948972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349701|NCT02948959|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349702|NCT02948946|||Cohort||Prospective|||||||
1349703|NCT02948933|||Cohort||Prospective|||||||
1349704|NCT02948920|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349705|NCT02948907||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349706|NCT02948894|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1349707|NCT02948881|Randomized|Parallel Assignment||Treatment||Double||||||
1349708|NCT02948855|||Case-Only||Prospective|||||||
1349709|NCT02948842||Single Group Assignment||Treatment||None (Open Label)||||||
1349710|NCT02948829||Single Group Assignment||Treatment||None (Open Label)||||||
1349711|NCT02948816|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1349712|NCT02948803|Randomized|Parallel Assignment||Prevention||None (Open Label)||pre, post, follow up measurements with an intervention and control group||||
1349713|NCT02948790|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1349714|NCT02948777||Single Group Assignment||Treatment||None (Open Label)||||||
1349715|NCT02948764||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349716|NCT02948751||||||||||||
1349717|NCT02948738|Randomized|Parallel Assignment||Prevention||Single||||||t
1349718|NCT02948725|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1349719|NCT02948712||Single Group Assignment||Supportive Care||None (Open Label)||||||
1349720|NCT02948699|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349721|NCT02948686|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349722|NCT02948673|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1349723|NCT02948660|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1349724|NCT02948647|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349725|NCT02948634|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349726|NCT02948621|||Case-Only||Prospective|||||||
1349727|NCT02948608|||Cohort||Prospective|||||||
1349728|NCT02948595|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1349729|NCT02948582|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1349730|NCT02948569||Single Group Assignment||Treatment||None (Open Label)|There is only one treatment arm in this study and the subjects are all aware that they are on active treatment. The outcomes assessor will be masked as to which data are from the baseline visit and which are from the follow-up visit. In other words, data will be analyzed in the lab in a blinded fashion as to whether the samples are from before or after treatment.|||||
1349731|NCT02948556|||Case Control||Prospective|||||||
1349732|NCT02948543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349733|NCT02948530|||Case-Crossover||Prospective|||||||
1349734|NCT02948517|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349735|NCT02948504|||Cohort||Prospective|||||||
1349736|NCT02948491|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1349737|NCT02948478|||Case-Control||Prospective|||||||
1349738|NCT02948465|||Case-Only||Prospective|||||||
1349739|NCT02948452|||Case-Control||Prospective|||||||
1349740|NCT02948439|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1349741|NCT02948426|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1349742|NCT02948413|||Case-Control||Cross-Sectional|||||||
1349743|NCT02948400|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349744|NCT02948387|||||Retrospective|||||||
1349745|NCT02948374|||Cohort||Prospective|||||||
1349746|NCT02948361||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349747|NCT02948348||Single Group Assignment||Treatment||None (Open Label)||||||
1349748|NCT02948335|||Cohort||Prospective|||||||
1349749|NCT02948322|Non-Randomized|Parallel Assignment||||Single||||||t
1349750|NCT02948309|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349751|NCT02948296|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1349752|NCT02948283||Single Group Assignment||Treatment||None (Open Label)||||||
1349753|NCT02948270|||Case Control||Prospective|||||||
1349754|NCT02948257|||Cohort||Prospective|||||||
1349755|NCT02948244|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1349756|NCT02948231||Single Group Assignment||Treatment||None (Open Label)||||||
1349757|NCT02948218|Randomized|Parallel Assignment||Treatment||Single||||||t
1349758|NCT02948205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349759|NCT02948192|||Cohort||Prospective|||||||
1349760|NCT02948179|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349761|NCT02948166|Randomized|Single Group Assignment||Treatment||Single|||t|||
1349762|NCT02948153|||Cohort||Cross-Sectional|||||||
1349763|NCT02948140||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349764|NCT02948127|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349765|NCT02948114|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1349766|NCT02948101||Single Group Assignment||Treatment||None (Open Label)||||||
1349767|NCT02948088|||Cohort||Prospective|||||||
1349768|NCT02948075||Single Group Assignment||Treatment||None (Open Label)||||||
1349769|NCT02948062|||Cohort||Prospective|||||||
1349770|NCT02948049|||Other||Prospective|||||||
1349771|NCT02948036||Single Group Assignment||Treatment||None (Open Label)||||||
1349772|NCT02948023|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349773|NCT02948010|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1349774|NCT02947997||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1349775|NCT02947984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349776|NCT02947971||Single Group Assignment||Other||None (Open Label)||||||
1349777|NCT02947958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349778|NCT02947945||Single Group Assignment||Treatment||None (Open Label)||||||
1349779|NCT02947932|Randomized|Parallel Assignment||Treatment||Single|||||t|
1349780|NCT02947919|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1349781|NCT02947906|||||Prospective|||||||
1349782|NCT02947893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349783|NCT02947880|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349784|NCT02947867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349785|NCT02947854|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349786|NCT02947841|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1349787|NCT02947828|||Case-Control||Cross-Sectional|||||||
1349788|NCT02947815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349789|NCT02947802|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1349790|NCT02947789|||Cohort||Retrospective|||||||
1349791|NCT02947776|Randomized|Parallel Assignment||Treatment||Single||||||t
1349792|NCT02947763|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349793|NCT02947750|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1349794|NCT02947737|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349795|NCT02947724|Randomized|Parallel Assignment||Prevention||Single|||t|||
1349796|NCT02947711||Single Group Assignment||Treatment||None (Open Label)||||||
1349797|NCT02947698|||Case Control||Retrospective|||||||
1349798|NCT02947685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349799|NCT02947672|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349800|NCT02947659|||Cohort||Prospective|||||||
1349801|NCT02947646|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||||||
1349802|NCT02947633|Randomized|Parallel Assignment||Prevention||Single||||||t
1349803|NCT02947620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349804|NCT02947607|||Cohort||Prospective|||||||
1349805|NCT02947594|||Cohort||Prospective|||||||
1349806|NCT02947581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349807|NCT02947568|||Case-Only||Cross-Sectional|||||||
1349808|NCT02947555|||Case-Control||Cross-Sectional|||||||
1349809|NCT02947542|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1349810|NCT02947529|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1349811|NCT02947516|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1349812|NCT02947503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349813|NCT02947490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349814|NCT02947477|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349815|NCT02947464|Randomized|Parallel Assignment||Treatment||Single||||||t
1349816|NCT02947451|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1349817|NCT02947438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349818|NCT02947425|||Cohort||Prospective|||||||
1349819|NCT02947412|||Case-Only||Retrospective|||||||
1349820|NCT02947399||Single Group Assignment||Other||None (Open Label)||||||
1349821|NCT02947386||Single Group Assignment||Treatment||None (Open Label)||||||
1349822|NCT02947373||Single Group Assignment||Other||None (Open Label)||||||
1349823|NCT02947360||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349824|NCT02947347|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349825|NCT02947334|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1349826|NCT02947321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349827|NCT02947308|||Case-Control||Prospective|||||||
1349828|NCT02947295|||Ecologic or Community||Prospective|||||||
1349829|NCT02947282|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349830|NCT02947269|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349831|NCT02947256|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349832|NCT02947243|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349833|NCT02947230|Randomized|Parallel Assignment||Other||Single|||||t|
1349834|NCT02947217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349835|NCT02947204|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1349836|NCT02947191||Single Group Assignment||Treatment||None (Open Label)||||||
1349837|NCT02947178|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1349838|NCT02947165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349839|NCT02947152|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349840|NCT02947139|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1349841|NCT02947126|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1349842|NCT02947113||Single Group Assignment||Treatment||None (Open Label)||||||
1349843|NCT02947100||Single Group Assignment||Treatment||None (Open Label)||||||
1349844|NCT02947087|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1349845|NCT02947074|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1349846|NCT02947061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349847|NCT02947048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349848|NCT02947035|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349849|NCT02947022||Single Group Assignment||Treatment||None (Open Label)||||||
1349850|NCT02947009|Non-Randomized|Factorial Assignment||Diagnostic||Single||||||t
1349851|NCT02946996||Single Group Assignment||Treatment||None (Open Label)||||||
1349852|NCT02946983|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1349853|NCT02946970|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1349854|NCT02946957|Randomized|Parallel Assignment||Treatment||Single||||||t
1349855|NCT02946944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349856|NCT02946931|||Cohort||Retrospective|||||||
1349857|NCT02946918|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349858|NCT02946905|||Cohort||Other|||||||
1349859|NCT02946892|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1349860|NCT02946879|||Cohort||Prospective|||||||
1349861|NCT02946866|||Cohort||Prospective|||||||
1349862|NCT02946853|Randomized|Parallel Assignment||Treatment||Single||||||t
1349863|NCT02946840|||Cohort||Prospective|||||||
1349864|NCT02946827|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349865|NCT02946814|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1349866|NCT02946801|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1349867|NCT02946788|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349868|NCT02946775|||Ecologic or Community||Prospective|||||||
1349869|NCT02946762||Single Group Assignment||Health Services Research||None (Open Label)||||||
1349870|NCT02946749|||Cohort||Prospective|||||||
1349871|NCT02946736|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1349872|NCT02946723|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349873|NCT02946710|||Other||Retrospective|||||||
1349874|NCT02946697|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1349875|NCT02946684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349876|NCT02946671|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349877|NCT02946658|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1349878|NCT02946645|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1349879|NCT02946632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349880|NCT02946619|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1349881|NCT02946606|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1349882|NCT02946593|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349883|NCT02946580|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1349884|NCT02946567|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1349885|NCT02946554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349886|NCT02946541|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349887|NCT02946528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349888|NCT02946515|Randomized|Parallel Assignment||Prevention||Single||||||t
1349889|NCT02946502||Single Group Assignment||Supportive Care||None (Open Label)||||||
1349890|NCT02946489||Single Group Assignment||Treatment||Single|Single-blind trial, with participants given the impression they may get any of several medications.||t|||
1349891|NCT02946476|||Ecologic or Community||Prospective|||||||
1349892|NCT02946463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349893|NCT02946450|||Case-Only||Prospective|||||||
1349894|NCT02946437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349895|NCT02946424|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1349896|NCT02946411|||Case-Only||Prospective|||||||
1349897|NCT02946398|||Cohort||Prospective|||||||
1349898|NCT02946385|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349899|NCT02946372||Single Group Assignment||Treatment||None (Open Label)||||||
1349900|NCT02946359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349901|NCT02946346||Single Group Assignment||Basic Science||None (Open Label)||||||
1349902|NCT02946333|||Cohort||Prospective|||||||
1349903|NCT02946320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349904|NCT02946307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349905|NCT02946294|Randomized|Parallel Assignment||Treatment||Single||||||t
1349906|NCT02946281|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349907|NCT02946268|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349908|NCT02946255|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1349909|NCT02946242||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349910|NCT02946229||Single Group Assignment||Device Feasibility||None (Open Label)||The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome. All eligible adults (aged 18 or older) will contribute case data from a convenience sample of maintenance hemodialysis population available at the study site and consistent with feasibility assessment of the technology. A relatively large feasibility population is used due to the need to test feasibility of multiple features across variations within this population.||||
1349911|NCT02946216|||Case-Only||Prospective|||||||
1349912|NCT02946203|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1349913|NCT02946190|Randomized|Parallel Assignment||Prevention||Single||||||t
1349914|NCT02946177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349915|NCT02946164|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349916|NCT02946151||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349917|NCT02946138||Single Group Assignment||Treatment||None (Open Label)||||||
1349918|NCT02946125|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1349919|NCT02946112|||Case Control|||||||||
1349920|NCT02946099|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1349921|NCT02946086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349922|NCT02946073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349923|NCT02946060|Randomized|Parallel Assignment||Other||Single||||||t
1349924|NCT02946047||Single Group Assignment||Treatment||None (Open Label)||||||
1349925|NCT02946034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1349926|NCT02946021|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1349927|NCT02946008||Single Group Assignment||Treatment||None (Open Label)||||||
1349928|NCT02945995|||Cohort||Retrospective|||||||
1349929|NCT02945982|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349930|NCT02945969|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349931|NCT02945956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349932|NCT02945943|Randomized|Parallel Assignment||Treatment||Single||||||t
1349933|NCT02945930|||Cohort||Prospective|||||||
1349934|NCT02945917|||Cohort||Prospective|||||||
1349935|NCT02945904|||Cohort||Prospective|||||||
1349936|NCT02945891||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349937|NCT02945878|||Cohort||Prospective|||||||
1349938|NCT02945865|Randomized|Parallel Assignment||Treatment||Single|||t|||
1349939|NCT02945852||Single Group Assignment||Treatment||None (Open Label)||||||
1349940|NCT02945839|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349941|NCT02945826||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349942|NCT02945813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349943|NCT02945800||Single Group Assignment||Treatment||None (Open Label)||||||
1349944|NCT02945787|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351160|NCT02929940|||Cohort||Prospective|||||||
1349945|NCT02945774||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349946|NCT02945761|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1349947|NCT02945748|||Case Control||Prospective|||||||
1349948|NCT02945735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349949|NCT02945722|Randomized|Parallel Assignment||Prevention||Single|All infections will be reviewed by a Clinical Adjudication Comitee|||||t
1349950|NCT02945709|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1349951|NCT02945696|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1349952|NCT02945683|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1349953|NCT02945670|||Cohort||Cross-Sectional|||||||
1349954|NCT02945657||Single Group Assignment||Treatment||None (Open Label)||||||
1349955|NCT02945644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349956|NCT02945631||Single Group Assignment||Treatment||None (Open Label)||||||
1349957|NCT02945618|Randomized|Parallel Assignment||Treatment||Single||||||t
1349958|NCT02945605|Randomized|Parallel Assignment||Treatment||Single|||||t|
1349959|NCT02945592|Randomized|Crossover Assignment||Treatment||Single|||t|||
1349960|NCT02945579||Single Group Assignment||Treatment||None (Open Label)||||||
1349961|NCT02945566|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1349962|NCT02945553|Randomized|Parallel Assignment||Prevention||Single||||||t
1349963|NCT02945540|||Cohort||Prospective|||||||
1349964|NCT02945527|Randomized|Parallel Assignment||Treatment||Single||||||t
1349965|NCT02945514|||Cohort||Prospective|||||||
1349966|NCT02945501|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1349967|NCT02945488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349968|NCT02945475|||Cohort||Prospective|||||||
1349969|NCT02945462||Single Group Assignment||Treatment||None (Open Label)||||||
1349970|NCT02945449||Single Group Assignment||Treatment||None (Open Label)||||||
1349971|NCT02945436|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1349972|NCT02945423|||Case-Only||Cross-Sectional|||||||
1349973|NCT02945410|Randomized|Crossover Assignment||Prevention||Single|||t|||
1349974|NCT02945397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349975|NCT02945384|Randomized|Parallel Assignment||Prevention||Single||||||t
1349976|NCT02945371|Randomized|Parallel Assignment||Prevention||Single|||t|||
1349977|NCT02945358|||Cohort||Cross-Sectional|||||||
1349978|NCT02945345|||Cohort||Prospective|||||||
1349979|NCT02945332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349980|NCT02945319|||Cohort||Retrospective|||||||
1349981|NCT02945306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349982|NCT02945293||Single Group Assignment||Basic Science||None (Open Label)||||||
1349983|NCT02945280||Single Group Assignment||Treatment||None (Open Label)||||||
1349984|NCT02945267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1349985|NCT02945254|Randomized|Crossover Assignment||Treatment||Single||||||t
1349986|NCT02945241|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1349987|NCT02945228|||Cohort||Prospective|||||||
1349988|NCT02945215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1349989|NCT02945202||Single Group Assignment||Treatment||None (Open Label)||||||
1349990|NCT02945189|||Case-Only||Prospective|||||||
1349991|NCT02945176||Single Group Assignment||Diagnostic||None (Open Label)||||||
1349992|NCT02945163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1349993|NCT02945150||Single Group Assignment||Prevention||None (Open Label)||||||
1349994|NCT02945137|||Case-Only||Retrospective|||||||
1349995|NCT02945124|Randomized|Parallel Assignment||Treatment||Single||||||t
1349996|NCT02945111|Randomized|Parallel Assignment||||None (Open Label)||||||
1349997|NCT02945098|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1349998|NCT02945085|Randomized|Parallel Assignment||Treatment||Single||||||t
1349999|NCT02945072|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1350000|NCT02945059||Single Group Assignment||Treatment||None (Open Label)||||||
1350001|NCT02945046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350002|NCT02945033|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350003|NCT02945020||Single Group Assignment||Other||None (Open Label)||||||
1350004|NCT02945007|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350005|NCT02944994|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1350006|NCT02944981|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350007|NCT02944968||Single Group Assignment||Treatment||None (Open Label)||||||
1350008|NCT02944955||Single Group Assignment||Treatment||None (Open Label)||||||
1350009|NCT02944942|||Cohort||Retrospective|||||||
1350010|NCT02944929|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1350011|NCT02944916||Single Group Assignment||Supportive Care||None (Open Label)||||||
1350012|NCT02944903|||Other||Prospective|||||||
1350013|NCT02944890|Randomized|Parallel Assignment||Treatment||Single||||||t
1350014|NCT02944877|Randomized|Parallel Assignment||Prevention||Single|||t|||
1350015|NCT02944864||Single Group Assignment||Treatment||None (Open Label)||||||
1350016|NCT02944851|||Cohort||Prospective|||||||
1350017|NCT02944838|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350018|NCT02944825|Randomized|Parallel Assignment||Prevention||Single|||||t|
1350019|NCT02944812||Single Group Assignment||Treatment||None (Open Label)||||||
1350020|NCT02944799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350021|NCT02944786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350022|NCT02944773|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1350023|NCT02944760|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350024|NCT02944747|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||4 parallel arm superiority community based randomized control trial||||
1350025|NCT02944734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350026|NCT02944721|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350027|NCT02944708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350028|NCT02944695|||||Prospective|||||||
1350029|NCT02944682|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350030|NCT02944669|||Case-Only||Prospective|||||||
1350031|NCT02944656|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350032|NCT02944643||Single Group Assignment||Treatment||None (Open Label)||||||
1350033|NCT02944630|Randomized|Parallel Assignment||Treatment||Single||||||t
1350034|NCT02944617|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350035|NCT02944604||Single Group Assignment||Treatment||None (Open Label)||||||
1350036|NCT02944591|||Case-Only||Other|||||||
1350037|NCT02944578|Randomized|Parallel Assignment||Treatment||Single||||||t
1350038|NCT02944565||Single Group Assignment||Treatment||None (Open Label)||||||
1350039|NCT02944552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350040|NCT02944539|||Case Control||Retrospective|||||||
1350041|NCT02944526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350042|NCT02944513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350043|NCT02944500|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1350044|NCT02944487|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1350045|NCT02944474|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1350046|NCT02944461||Single Group Assignment||Treatment||None (Open Label)||||||
1350047|NCT02944448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350048|NCT02944435|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350049|NCT02944422|||||Cross-Sectional|||||||
1350050|NCT02944409|||Cohort||Prospective|||||||
1350051|NCT02944396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350052|NCT02944383|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350053|NCT02944370||Single Group Assignment||Treatment||None (Open Label)||||||
1350054|NCT02944357||Single Group Assignment||Treatment||None (Open Label)||||||
1350055|NCT02944344|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350056|NCT02944331|||Cohort||Prospective|||||||
1350057|NCT02944318|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350058|NCT02944305|||Cohort||Retrospective|||||||
1350059|NCT02944292||Single Group Assignment||Treatment||None (Open Label)||||||
1350060|NCT02944279|||Cohort||Prospective|||||||
1350061|NCT02944266|||||Prospective|||||||
1350062|NCT02944253|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350063|NCT02944227||Single Group Assignment||Treatment||None (Open Label)||||||
1350064|NCT02944214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350065|NCT02944201||Single Group Assignment||Treatment||None (Open Label)||||||
1350066|NCT02944188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350067|NCT02944175|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1350068|NCT02944162||Single Group Assignment||Treatment||None (Open Label)||||||
1350069|NCT02944149|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350070|NCT02944136|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1350071|NCT02944123|Randomized|Parallel Assignment||Treatment||Single|Open-labeled|||||t
1350072|NCT02944110|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1350073|NCT02944097|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1350074|NCT02944084|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1350075|NCT02944071||Single Group Assignment||Treatment||None (Open Label)||||||
1350076|NCT02944058|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350077|NCT02944045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350078|NCT02944032|Randomized|Parallel Assignment||Treatment||Single||||||t
1350079|NCT02944019|||Cohort||Prospective|||||||
1350080|NCT02944006|||Case-Only||Prospective|||||||
1350081|NCT02943993|||Cohort||Prospective|||||||
1350082|NCT02943980|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350083|NCT02943967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350084|NCT02943954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350085|NCT02943941|||Cohort||Prospective|||||||
1350086|NCT02943928|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1350087|NCT02943915|Randomized|Parallel Assignment||Treatment||Single||||||t
1350088|NCT02943902|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350089|NCT02943889|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350090|NCT02943876|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1350091|NCT02943863|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350092|NCT02943850||Single Group Assignment||Treatment||None (Open Label)||||||
1350093|NCT02943837|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1350094|NCT02943824|Randomized|Parallel Assignment||Other||Single||||||t
1350095|NCT02943811|||Case Control||Retrospective|||||||
1350096|NCT02943798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350097|NCT02943785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350098|NCT02943772|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1350099|NCT02943759|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350100|NCT02943746|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1350101|NCT02943733||Single Group Assignment||Treatment||None (Open Label)||||||
1350102|NCT02943720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350103|NCT02943707|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350104|NCT02943694||Single Group Assignment||Treatment||None (Open Label)||||||
1350105|NCT02943681|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350106|NCT02943668||Single Group Assignment||Treatment||None (Open Label)||||||
1350107|NCT02943655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350108|NCT02943642|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350109|NCT02943629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350110|NCT02943616||Single Group Assignment||Treatment||None (Open Label)||||||
1350111|NCT02943603||Single Group Assignment||Treatment||None (Open Label)||||||
1350112|NCT02943590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350113|NCT02943577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350114|NCT02943564|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350115|NCT02943551|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1350116|NCT02943538|Randomized|Parallel Assignment||||None (Open Label)||||||
1350117|NCT02943525|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350118|NCT02943512|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1350119|NCT02943499|Randomized|Parallel Assignment||Other||Single|||t|||
1350120|NCT02943486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350121|NCT02943473||Single Group Assignment||Treatment||None (Open Label)||||||
1350122|NCT02943460|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350123|NCT02943447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350124|NCT02943434|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1350125|NCT02943421|||Cohort||Prospective|||||||
1350126|NCT02943408|Randomized|Parallel Assignment||Treatment||Single|Outcomes assessors will be blind to participant intervention assignment.|||||t
1350127|NCT02943395|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350128|NCT02943382||Single Group Assignment||Treatment||None (Open Label)||||||
1350129|NCT02943369|Randomized|Parallel Assignment||Treatment||Single||||||t
1350130|NCT02943356||Single Group Assignment||Supportive Care||None (Open Label)||||||
1350131|NCT02943343|||Other||Prospective|||||||
1350132|NCT02943330|||Case-Only||Prospective|||||||
1350133|NCT02943317|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350134|NCT02943304|||Cohort||Prospective|||||||
1350135|NCT02943291|Randomized|Parallel Assignment||Treatment||Single||||||t
1350136|NCT02943278|Randomized|Parallel Assignment||Treatment||Single||||||t
1350137|NCT02943265||Single Group Assignment||Health Services Research||None (Open Label)||||||
1350138|NCT02943252||Single Group Assignment||Treatment||None (Open Label)||||||
1350139|NCT02943239|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1350140|NCT02943226|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1350141|NCT02943213|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1350142|NCT02943200|||||Cross-Sectional|||||||
1350143|NCT02943187||Single Group Assignment||Treatment||None (Open Label)||||||
1350144|NCT02943174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350145|NCT02943161||Single Group Assignment||Treatment||None (Open Label)||||||
1350146|NCT02943148|||Other||Cross-Sectional|||||||
1350147|NCT02943135|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1350148|NCT02943122|||Cohort||Prospective|||||||
1350149|NCT02943109|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1350150|NCT02943096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350151|NCT02943083|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1350152|NCT02943070||Single Group Assignment||Treatment||None (Open Label)||||||
1350153|NCT02943057||Single Group Assignment||Treatment||None (Open Label)||||||
1350154|NCT02943044|||Cohort||Prospective|||||||
1350155|NCT02943031||Single Group Assignment||Treatment||None (Open Label)||||||
1350156|NCT02943018|||||Prospective|||||||
1350157|NCT02943005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350158|NCT02942992|Randomized|Parallel Assignment||Treatment||Single||||||t
1350159|NCT02942979|||Case-Control||Prospective|||||||
1350160|NCT02942966||Single Group Assignment||Treatment||None (Open Label)||||||
1350161|NCT02942953|||Case-Only||Cross-Sectional|||||||
1350162|NCT02942940|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350163|NCT02942927|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1350164|NCT02942914|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1350165|NCT02942901|||Cohort||Prospective|||||||
1350166|NCT02942888|Randomized|Factorial Assignment||Basic Science||Triple|||t|t|t|
1350167|NCT02942875|Randomized|Parallel Assignment||Treatment||Single||||||t
1350168|NCT02942862|||Cohort||Retrospective|||||||
1350169|NCT02942849|||Cohort||Prospective|||||||
1350170|NCT02942836|||Cohort||Retrospective|||||||
1350171|NCT02942823|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350172|NCT02942810||Single Group Assignment||Other||None (Open Label)||||||
1350173|NCT02942797|||Cohort||Prospective|||||||
1350174|NCT02942784|||Cohort||Retrospective|||||||
1350175|NCT02942771|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350176|NCT02942758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350177|NCT02942745|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350178|NCT02942732|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350179|NCT02942719|||Cohort||Prospective|||||||
1350180|NCT02942706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350181|NCT02942693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350182|NCT02942680|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350183|NCT02942667|||Other||Prospective|||||||
1350184|NCT02942654|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1350185|NCT02942641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350186|NCT02942628|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1350187|NCT02942615|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1350188|NCT02942602|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1350189|NCT02942589|Randomized|Crossover Assignment||Prevention||Single|||t|||
1350190|NCT02942576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350191|NCT02942563||Single Group Assignment||Treatment||None (Open Label)||||||
1350192|NCT02942550|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350193|NCT02942537|Randomized|Parallel Assignment||Treatment||Single||||||t
1350194|NCT02942524||Single Group Assignment||Supportive Care||None (Open Label)||||||
1350195|NCT02942511|||Cohort||Prospective|||||||
1350196|NCT02942498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350197|NCT02942485|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350198|NCT02942472|||Case-Only||Prospective|||||||
1350199|NCT02942459|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350200|NCT02942446||Single Group Assignment||Other||None (Open Label)||||||
1350201|NCT02942433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350202|NCT02942420|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|The study is unmasked, i.e., is open label.|Dosing will occur sequentially from low to high dose: The 600 mg bucillamine dose group (Arm A) will enroll first, then after safety is assured, the 900 mg bucillamine dose group will enroll.||||
1350203|NCT02942407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350204|NCT02942394|||Other||Prospective|||||||
1350205|NCT02942381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350206|NCT02942368||Single Group Assignment||Treatment||None (Open Label)|Outcomes assessors are blinded and unaware of the specifics of the study (although only a single arm, blinded raters do not know this).|||||
1350207|NCT02942355|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350208|NCT02942342||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350209|NCT02942329||Single Group Assignment||Treatment||None (Open Label)||||||
1350210|NCT02942316||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350211|NCT02942303|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1350212|NCT02942290||Single Group Assignment||Treatment||None (Open Label)||||||
1350213|NCT02942277|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1350214|NCT02942264|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1350215|NCT02942251|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350216|NCT02942238|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350217|NCT02942225|||Case-Control||Cross-Sectional|||||||
1350218|NCT02942212|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350219|NCT02942199||Single Group Assignment||Treatment||None (Open Label)||||||
1350220|NCT02942173|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350221|NCT02942160||Single Group Assignment||Treatment||None (Open Label)||||||
1350222|NCT02942147|Randomized|Parallel Assignment||Treatment||Single||||||t
1350223|NCT02942134|||Case-Only||Prospective|||||||
1350224|NCT02942121||Single Group Assignment||Prevention||None (Open Label)||||||
1350225|NCT02942108|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1350226|NCT02942095|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350227|NCT02942082|Randomized|Parallel Assignment||||Double|||t|||t
1350228|NCT02942069|||Case-Only||Cross-Sectional|||||||
1350229|NCT02942056|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1350230|NCT02942043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350231|NCT02942030|||Cohort||Cross-Sectional|||||||
1350232|NCT02942017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350233|NCT02942004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350234|NCT02941991|||Cohort||Prospective|||||||
1350235|NCT02941978|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350236|NCT02941965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350237|NCT02941952||||||||||||
1350238|NCT02941939|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350239|NCT02941926||Single Group Assignment||Treatment||None (Open Label)||||||
1350240|NCT02941913|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350241|NCT02941900|||Cohort||Prospective|||||||
1350242|NCT02941887|||Case-Only||Cross-Sectional|||||||
1350243|NCT02941874|||Cohort||Prospective|||||||
1350244|NCT02941861|||Cohort||Retrospective|||||||
1350245|NCT02941848|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350246|NCT02941835||Single Group Assignment||Treatment||None (Open Label)||||||
1350247|NCT02941822||Single Group Assignment||Prevention||None (Open Label)||||||
1350248|NCT02941809|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1350249|NCT02941796|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350250|NCT02941783|||Cohort||Prospective|||||||
1350251|NCT02941770|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351237|NCT02928926|||Case-Control||Prospective|||||||
1350252|NCT02941757|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1350253|NCT02941744||Single Group Assignment||Prevention||None (Open Label)||||||
1350254|NCT02941731|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350255|NCT02941718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350256|NCT02941705|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350257|NCT02941692|Randomized|Parallel Assignment||Other||Double|||t||t|
1350258|NCT02941679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350259|NCT02941666|||Case-Control||Prospective|||||||
1350260|NCT02941653|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350261|NCT02941640|Randomized|Parallel Assignment||Treatment||Single|The study included 120 patients randomly divided into four groups with 30 patients in each. The study was not blinded. The nurse designated for participation in this study allocated the patients randomly into four groups by selecting a sealed opaque envelope from a box and opening it in the operating theatre. A card inside the envelope contained name of the treatment. All the envelopes were prepared in advance in a ratio of 1:4, shuffled well, and placed in the box by the same nurse.||t|||
1350262|NCT02941627||Single Group Assignment||Treatment||None (Open Label)||||||
1350263|NCT02941614|||Other||Prospective|||||||
1350264|NCT02941601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350265|NCT02941588|||Cohort||Retrospective|||||||
1350266|NCT02941575|Randomized|Parallel Assignment||Treatment||Double||||t||t
1350267|NCT02941562|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350268|NCT02941549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350269|NCT02941536||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350270|NCT02941523|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1350271|NCT02941510|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1350272|NCT02941497|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1350273|NCT02941484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350274|NCT02941471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350275|NCT02941458|||Other||Prospective|||||||
1350276|NCT02941445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350277|NCT02941432||Single Group Assignment||Treatment||None (Open Label)||||||
1350278|NCT02941419||Single Group Assignment||Treatment||None (Open Label)||||||
1350279|NCT02941406|||Cohort||Prospective|||||||
1350280|NCT02941393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350281|NCT02941380|||Cohort||Prospective|||||||
1350282|NCT02941367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350283|NCT02941354||Single Group Assignment||Treatment||None (Open Label)||||||
1350284|NCT02941341|||Cohort||Prospective|||||||
1350285|NCT02941328|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1350286|NCT02941315|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1350287|NCT02941302||Single Group Assignment||Treatment||None (Open Label)||||||
1350288|NCT02941289|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1350289|NCT02941276|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350290|NCT02941263|||Cohort||Prospective|||||||
1350291|NCT02941250||Single Group Assignment||Treatment||None (Open Label)||||||
1350292|NCT02941237|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1350293|NCT02941224||Single Group Assignment||Treatment||None (Open Label)||||||
1350294|NCT02941211||Single Group Assignment||Treatment||None (Open Label)||||||
1350295|NCT02941198|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350296|NCT02941185|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350297|NCT02941172|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1350298|NCT02941159|Randomized|Parallel Assignment||Treatment||Single|||||t|
1350299|NCT02941146||Single Group Assignment||Other||None (Open Label)||||||
1350300|NCT02941133|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1350301|NCT02941120|||Case-Only||Retrospective|||||||
1350302|NCT02941107|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350303|NCT02941094|Randomized|Parallel Assignment||Prevention||Single|||t|||
1350304|NCT02941081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350305|NCT02941068|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350306|NCT02941055|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1350307|NCT02941042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350308|NCT02941029|||Cohort||Prospective|||||||
1350309|NCT02941016||Single Group Assignment||||None (Open Label)||||||
1350310|NCT02941003|Randomized|Factorial Assignment||Diagnostic||Single|||t|||
1350311|NCT02940990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350312|NCT02940977|||Case-Only||Prospective|||||||
1350313|NCT02940964|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1350314|NCT02940951|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1350315|NCT02940938||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350316|NCT02940925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350317|NCT02940912|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1350318|NCT02940899|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350319|NCT02940886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350320|NCT02940873|Randomized|Parallel Assignment||Treatment||Single||||||t
1350321|NCT02940860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350322|NCT02940847|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1350323|NCT02940834|||Case Control||Prospective|||||||
1350324|NCT02940821|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1350325|NCT02940808|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1350326|NCT02940795|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1350327|NCT02940782|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350328|NCT02940769|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1350329|NCT02940756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350330|NCT02940743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350331|NCT02940730|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1350332|NCT02940717|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350333|NCT02940704|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350334|NCT02940691||Single Group Assignment||Treatment||None (Open Label)||||||
1350335|NCT02940678|||Cohort||Retrospective|||||||
1350336|NCT02940665|||Cohort||Prospective|||||||
1350337|NCT02940652|||Cohort||Prospective|||||||
1350338|NCT02940639|||Cohort||Prospective|||||||
1350339|NCT02940626|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350340|NCT02940613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350341|NCT02940600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350342|NCT02940587|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350343|NCT02940574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350344|NCT02940561|Randomized|Crossover Assignment||||None (Open Label)||||||
1350345|NCT02940548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350346|NCT02940535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350347|NCT02940522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350348|NCT02940509|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350349|NCT02940496||Single Group Assignment||Treatment||None (Open Label)||||||
1350350|NCT02940483||Single Group Assignment||Treatment||None (Open Label)||||||
1350351|NCT02940470|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350352|NCT02940457|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350353|NCT02940444|Randomized|Parallel Assignment||Prevention||Single|||t|||
1350354|NCT02940431|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1350355|NCT02940418|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350356|NCT02940405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350357|NCT02940392||Single Group Assignment||Treatment||None (Open Label)||||||
1350358|NCT02940379|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350359|NCT02940366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350360|NCT02940353||Single Group Assignment||Treatment||None (Open Label)||||||
1350361|NCT02940340|||Cohort||Prospective|||||||
1350362|NCT02940327|||Case-Control||Prospective|||||||
1350363|NCT02940314|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350364|NCT02940301||Single Group Assignment||Treatment||None (Open Label)||||||
1350365|NCT02940288|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1350366|NCT02940275|||Case Control||Cross-Sectional|||||||
1350367|NCT02940262||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350368|NCT02940249|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1350369|NCT02940236|||Case-Only||Prospective|||||||
1350370|NCT02940223|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1350371|NCT02940210|Randomized|Parallel Assignment||Prevention||Single|||t|||
1350372|NCT02940197|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350373|NCT02940184|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1350374|NCT02940171|||Case-Only||Prospective|||||||
1350375|NCT02940158|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1350376|NCT02940145|Randomized|Factorial Assignment||Treatment||Single|||t|||
1350377|NCT02940132||Single Group Assignment||Treatment||None (Open Label)||||||
1350378|NCT02940119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350379|NCT02940106|Randomized|Crossover Assignment||Other||Single|||t|||
1350380|NCT02940093|||Cohort||Prospective|||||||
1350381|NCT02940080|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1350382|NCT02940067|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350383|NCT02940054|||||Prospective|||||||
1350384|NCT02940041|||||Prospective|||||||
1350385|NCT02940028|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1350386|NCT02940015|||Other||Cross-Sectional|||||||
1350387|NCT02940002|Randomized|Parallel Assignment||Other||Double|||t||t|
1350388|NCT02939989|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350389|NCT02939976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350390|NCT02939963|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350391|NCT02939950|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1350392|NCT02939937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350393|NCT02939924||Single Group Assignment||Treatment||None (Open Label)||||||
1350394|NCT02939911|||Cohort||Prospective|||||||
1350395|NCT02939898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350396|NCT02939885|||Cohort||Prospective|||||||
1350397|NCT02939872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350398|NCT02939859|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350399|NCT02939846||Single Group Assignment||Treatment||None (Open Label)||||||
1350400|NCT02939833|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350401|NCT02939820||||||||||||
1350402|NCT02939807||Single Group Assignment||Treatment||None (Open Label)||||||
1350403|NCT02939794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350404|NCT02939781|||Cohort||Prospective|||||||
1350405|NCT02939768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350406|NCT02939755|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1350407|NCT02939742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350408|NCT02939729|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1350409|NCT02939716|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1350410|NCT02939703|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1350411|NCT02939690|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1350412|NCT02939677|Randomized|Parallel Assignment||Prevention||Single|||||t|
1350413|NCT02939664|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350414|NCT02939651||Single Group Assignment||Treatment||None (Open Label)||||||
1350415|NCT02939638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350416|NCT02939625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350417|NCT02939612|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350418|NCT02939599||Single Group Assignment||Treatment||None (Open Label)||||||
1350419|NCT02939586|Randomized|Crossover Assignment||Treatment||None (Open Label)||eligible participants from stage 1 screening will be invited to participate in stage 2 RCT. participants will be randomly assigned to either HD or HDF for 2 months, 1 month wash-our period and cross-over to the other treatment for another 2 months. The total trial period will be 5 months.||||
1350420|NCT02939573|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350421|NCT02939560||Single Group Assignment||Treatment||None (Open Label)||||||
1350422|NCT02939547|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1350423|NCT02939534|||Case-Control||Cross-Sectional|||||||
1350424|NCT02939521||Single Group Assignment||Treatment||None (Open Label)||||||
1350425|NCT02939508|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350426|NCT02939495||Single Group Assignment||Treatment||None (Open Label)||||||
1350427|NCT02939482|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350428|NCT02939469||Single Group Assignment||||None (Open Label)||||||
1350429|NCT02939456||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350430|NCT02939443||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350431|NCT02939430|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1350432|NCT02939417|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350433|NCT02939404|||Cohort||Other|||||||
1350434|NCT02939391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350435|NCT02939378|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350436|NCT02939365||Single Group Assignment||Treatment||None (Open Label)||||||
1350437|NCT02939352|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1350438|NCT02939339|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350439|NCT02939326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350440|NCT02939313|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1350441|NCT02939300||Single Group Assignment||Treatment||None (Open Label)||||||
1350442|NCT02939287|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350443|NCT02939274||Single Group Assignment||Treatment||None (Open Label)||||||
1350444|NCT02939261|Randomized|Parallel Assignment||Prevention||Single||||||t
1350445|NCT02939248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350446|NCT02939235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350447|NCT02939222||Single Group Assignment||Treatment||None (Open Label)||||||
1350448|NCT02939209|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350449|NCT02939196|||Case-Control||Prospective|||||||
1350450|NCT02939183|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350451|NCT02939170|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350452|NCT02939157|||Case-Only||Cross-Sectional|||||||
1350453|NCT02939144||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350454|NCT02939131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350455|NCT02939118|||Cohort||Prospective|||||||
1350456|NCT02939105||Single Group Assignment||Other||None (Open Label)||||||
1350457|NCT02939092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350458|NCT02939079|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350459|NCT02939066|||Cohort||Prospective|||||||
1350460|NCT02939053|||Cohort||Prospective|||||||
1350461|NCT02939040|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350462|NCT02939027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350463|NCT02939014||Single Group Assignment||Treatment||None (Open Label)||||||
1350464|NCT02939001||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350465|NCT02938988|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350466|NCT02938975|Randomized|Parallel Assignment||Prevention||Quadruple|Placebo||t|t|t|t
1350467|NCT02938962|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1350468|NCT02938949|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350469|NCT02938936|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350470|NCT02938923|Randomized|Parallel Assignment||Treatment||Quadruple|Participants, investigators, and study staff conducting the interventions will be aware of the exercise group assignment. A Blinded Outcomes Assessor will be masked to study group assignment. Only the study pharmacist, an unblinded study physician, and Data Coordinating Center staff will be unblinded to gel treatment assignment.||t|t|t|t
1350471|NCT02938910|||Case Control||Cross-Sectional|||||||
1350472|NCT02938897|Randomized|Parallel Assignment||Treatment||Single||||||t
1350473|NCT02938884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350474|NCT02938871|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1350475|NCT02938858|||Case Control||Prospective|||||||
1350476|NCT02938845|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1350477|NCT02938832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350478|NCT02938819|Randomized|Parallel Assignment||Treatment||Single||||||t
1350479|NCT02938806|||Cohort||Cross-Sectional|||||||
1350480|NCT02938793||Single Group Assignment||Treatment||None (Open Label)||||||
1350481|NCT02938780|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1350482|NCT02938767|||Case Control||Prospective|||||||
1350483|NCT02938754|Randomized|Parallel Assignment||Treatment||Single|||||t|
1350484|NCT02938741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350485|NCT02938728|||Cohort||Prospective|||||||
1350486|NCT02938715|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350487|NCT02938702|||Cohort||Prospective|||||||
1350488|NCT02938689|Randomized|Parallel Assignment||Treatment||Single||||||t
1350489|NCT02938676|||||Prospective|||||||
1350490|NCT02938663|||Ecologic or Community||Cross-Sectional|||||||
1350491|NCT02938650||Single Group Assignment||Treatment||None (Open Label)||15 healthy controls will participate in the study Another set of healthy controls (n=20) will be recruited so that they participate in blood draws.||||
1350492|NCT02938637||||||||||||
1350493|NCT02938624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350494|NCT02938611|||Ecologic or Community||Prospective|||||||
1350495|NCT02938598|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1350496|NCT02938585|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350497|NCT02938572|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1350498|NCT02938559|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350499|NCT02938546|Non-Randomized|Factorial Assignment||Diagnostic||Double|||t|||t
1350500|NCT02938533|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350501|NCT02938520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350502|NCT02938507|Randomized|Crossover Assignment||Treatment||Single|||t|||
1350503|NCT02938494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350504|NCT02938481|||Cohort||Prospective|||||||
1350505|NCT02938468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350506|NCT02938455|||Case-Only||Prospective|||||||
1350507|NCT02938442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350508|NCT02938429|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1350509|NCT02938416|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350510|NCT02938403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350511|NCT02938390|||Case-Only||Prospective|||||||
1350512|NCT02938377|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1350513|NCT02938364|Randomized|Parallel Assignment||Prevention||Single||||||t
1350514|NCT02938351||Single Group Assignment||Supportive Care||None (Open Label)||Patient and caregiver will receive an IPAD with Vidyo software to complete the treatment sessions||||
1350515|NCT02938338|||Case-Only||Prospective|||||||
1350516|NCT02938325|||Case Control||Prospective|||||||
1350517|NCT02938312|Randomized|Parallel Assignment||Prevention||Single|||t|||
1350518|NCT02938299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350519|NCT02938286|Randomized|Factorial Assignment||Treatment||Single|||t|||
1350520|NCT02938273||Single Group Assignment||Treatment||None (Open Label)||||||
1350521|NCT02938260|||Cohort||Retrospective|||||||
1350522|NCT02938247||Single Group Assignment||Supportive Care||None (Open Label)||||||
1350523|NCT02938234||Single Group Assignment||Supportive Care||None (Open Label)||||||
1350524|NCT02938221||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350525|NCT02938208||Single Group Assignment||Treatment||None (Open Label)||||||
1350526|NCT02938195||Single Group Assignment||Treatment||None (Open Label)||||||
1350527|NCT02938182||Single Group Assignment||Treatment||None (Open Label)||||||
1350528|NCT02938169|Randomized|Parallel Assignment||Treatment||Single||||||t
1350529|NCT02938156|||Cohort||Prospective|||||||
1350530|NCT02938143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350531|NCT02938130||Single Group Assignment||Treatment||None (Open Label)||||||
1350532|NCT02938117|Randomized|Parallel Assignment||||Single|||t|||
1350533|NCT02938104|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350534|NCT02938091|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1350535|NCT02938078|Randomized|Single Group Assignment||Treatment||Single|||||t|
1350536|NCT02938065|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1350537|NCT02938052||Single Group Assignment||Treatment||None (Open Label)||||||
1350538|NCT02938039|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350539|NCT02938026|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350540|NCT02938013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350541|NCT02938000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350542|NCT02937987|||Cohort||Prospective|||||||
1350543|NCT02937974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350544|NCT02937961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350545|NCT02937948||Single Group Assignment||Other||None (Open Label)||||||
1350546|NCT02937935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350547|NCT02937922|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1351238|NCT02928913|||Cohort||Cross-Sectional|||||||
1350548|NCT02937909|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350549|NCT02937896|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350550|NCT02937883|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350551|NCT02937870|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1350552|NCT02937857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350553|NCT02937844||Single Group Assignment||Treatment||None (Open Label)||||||
1350554|NCT02937831|||Cohort||Retrospective|||||||
1350555|NCT02937818|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350556|NCT02937805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350557|NCT02937792|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350558|NCT02937779||Single Group Assignment||Prevention||None (Open Label)||||||
1350559|NCT02937766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350560|NCT02937740||Single Group Assignment||Treatment||None (Open Label)||||||
1350561|NCT02937727||Single Group Assignment||Treatment||None (Open Label)||||||
1350562|NCT02937714|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350563|NCT02937701|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350564|NCT02937688|||Cohort||Prospective|||||||
1350565|NCT02937675|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350566|NCT02937662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350567|NCT02937649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350568|NCT02937636|Randomized|Parallel Assignment||Treatment||Single|||||t|
1350569|NCT02937623|Randomized|Parallel Assignment||Treatment||Single||||||t
1350570|NCT02937610|||Cohort||Prospective|||||||
1350571|NCT02937597|Randomized|Parallel Assignment||Other||Double|||t|||t
1350572|NCT02937584|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1350573|NCT02937571||Single Group Assignment||Treatment||None (Open Label)||||||
1350574|NCT02937558|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350575|NCT02937545|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350576|NCT02937532|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1350577|NCT02937519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350578|NCT02937506|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1350579|NCT02937493|||Cohort||Prospective|||||||
1350580|NCT02937480|Randomized|Parallel Assignment||Treatment||Single||||||t
1350581|NCT02937467||||||||||||
1350582|NCT02937454|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350583|NCT02937441|||Cohort||Prospective|||||||
1350584|NCT02937428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350585|NCT02937415|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1350586|NCT02937402||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350587|NCT02937389|||Cohort||Prospective|||||||
1350588|NCT02937376|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1350589|NCT02937363|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1350590|NCT02937350||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350591|NCT02937337|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1350592|NCT02937324|Randomized|Crossover Assignment||Other||Single||||||t
1350593|NCT02937311|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1350594|NCT02937298|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1350595|NCT02937285|Randomized|Parallel Assignment||Treatment||Single||||||t
1350596|NCT02937272|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350597|NCT02937259||Single Group Assignment||Treatment||None (Open Label)||||||
1350598|NCT02937246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350599|NCT02937233|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350600|NCT02937220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350601|NCT02937207|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1350602|NCT02937194|Randomized|Parallel Assignment||Prevention||Single||||||t
1350603|NCT02937181||Single Group Assignment||Treatment||None (Open Label)||||||
1350604|NCT02937168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350605|NCT02937155|||Cohort||Prospective|||||||
1350606|NCT02937142|Randomized|Parallel Assignment||Treatment||Single||||||t
1350607|NCT02937129|||Cohort||Retrospective|||||||
1350608|NCT02937116|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350609|NCT02937103||Single Group Assignment||Treatment||None (Open Label)||||||
1350610|NCT02937090|||Case-Control||Cross-Sectional|||||||
1350611|NCT02937077|||Case-Only||Prospective|||||||
1350612|NCT02937064|||Case-Control||Cross-Sectional|||||||
1350613|NCT02937051|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1350614|NCT02937038|||Family-Based||Cross-Sectional|||||||
1350615|NCT02937025||Single Group Assignment||Treatment||None (Open Label)||||||
1350616|NCT02937012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350617|NCT02936999||Single Group Assignment||Treatment||None (Open Label)||||||
1350618|NCT02936986|||Cohort||Prospective|||||||
1350619|NCT02936973|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1350620|NCT02936960|||Cohort||Prospective|||||||
1350621|NCT02936947|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350622|NCT02936934|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350623|NCT02936921|||Cohort||Prospective|||||||
1350624|NCT02936908|||Cohort||Retrospective|||||||
1350625|NCT02936895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350626|NCT02936882||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350627|NCT02936869|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350628|NCT02936856|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1350629|NCT02936843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350630|NCT02936830|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1350631|NCT02936817||Single Group Assignment||Treatment||None (Open Label)||||||
1350632|NCT02936804||Single Group Assignment||Treatment||None (Open Label)||||||
1350633|NCT02936791|||Cohort||Prospective|||||||
1350634|NCT02936778|||Case-Control||Prospective|||||||
1350635|NCT02936765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350636|NCT02936752||Single Group Assignment||Treatment||None (Open Label)||||||
1350637|NCT02936739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350638|NCT02936726|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350639|NCT02936713|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350640|NCT02936700|Randomized|Parallel Assignment||||Single|||||t|
1350641|NCT02936687|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1350642|NCT02936674|Randomized|Crossover Assignment||Other||Double|||t||t|
1350643|NCT02936661|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350644|NCT02936648||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350645|NCT02936635||Single Group Assignment||Treatment||None (Open Label)||||||
1350646|NCT02936622|Randomized|Parallel Assignment||Treatment||Single||||||t
1350647|NCT02936609|||Case-Control||Prospective|||||||
1350648|NCT02936596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350649|NCT02936583||Single Group Assignment||Prevention||None (Open Label)||||||
1350650|NCT02936570||Single Group Assignment||Prevention||None (Open Label)||||||
1350651|NCT02936557||Single Group Assignment||Prevention||None (Open Label)||||||
1350652|NCT02936544||Single Group Assignment||Prevention||None (Open Label)||||||
1350653|NCT02936531|||Case-Only||Cross-Sectional|||||||
1350654|NCT02936518||Single Group Assignment||Treatment||None (Open Label)||||||
1350655|NCT02936505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350656|NCT02936492|Randomized|Parallel Assignment||Other||Double|||t||t|
1350657|NCT02936479||Single Group Assignment||Treatment||None (Open Label)||||||
1350658|NCT02936466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350659|NCT02936453||Single Group Assignment||Treatment||None (Open Label)||||||
1350660|NCT02936440|||Cohort||Prospective|||||||
1350661|NCT02936427|Randomized|Parallel Assignment||Prevention||Single|||t|||
1350662|NCT02936414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350663|NCT02936401|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350664|NCT02936388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350665|NCT02936375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350666|NCT02936362|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1350667|NCT02936349|||Other||Prospective|||||||
1350668|NCT02936336|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1350669|NCT02936323||Single Group Assignment||Treatment||None (Open Label)||||||
1350670|NCT02936310||Single Group Assignment||Prevention||None (Open Label)||||||
1350671|NCT02936297|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1350672|NCT02936284|Randomized|Parallel Assignment||Treatment||Single||||||t
1350673|NCT02936271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350674|NCT02936258|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350675|NCT02936245|||Cohort||Prospective|||||||
1350676|NCT02936232|||Cohort||Prospective|||||||
1350677|NCT02936219|||Cohort||Prospective|||||||
1350678|NCT02936206|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350679|NCT02936193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350680|NCT02936180|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350681|NCT02936167|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1350682|NCT02936154|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1350683|NCT02936141||Single Group Assignment||Supportive Care||None (Open Label)||||||
1350684|NCT02936128|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350685|NCT02936115|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350686|NCT02936102|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350687|NCT02936089||Single Group Assignment||Treatment||None (Open Label)||||||
1350688|NCT02936076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350689|NCT02936063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350690|NCT02936050||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350691|NCT02936037|Randomized|Parallel Assignment||Treatment||Quadruple||"Randomized double blind placebo-controlled for at least 15 months but not longer than 27 months study drug administration per patient.~The blinded placebo-controlled phase will end when the last patient randomized has completed the Month 15 evaluation (visit 7). Patients who have completed 15 months will be kept on blinded study drug for a maximum of 27 months or until the last study patient completes the Month 15 evaluation, whichever comes first."|t|t|t|t
1350692|NCT02936024|Randomized|Parallel Assignment||Treatment||Single||||||t
1350693|NCT02936011||Single Group Assignment||Treatment||None (Open Label)||||||
1350694|NCT02935998||Single Group Assignment||Treatment||None (Open Label)||||||
1350695|NCT02935985|||Case-Only||Prospective|||||||
1350696|NCT02935972|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350697|NCT02935959|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351549|NCT02924844|||Case Control||Prospective|||||||
1350698|NCT02935946|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350699|NCT02935933|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350700|NCT02935920|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350701|NCT02935907||Single Group Assignment||Treatment||None (Open Label)||||||
1350702|NCT02935894||Single Group Assignment||Basic Science||None (Open Label)||||||
1350703|NCT02935881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350704|NCT02935868|||Case Control||Cross-Sectional|||||||
1350705|NCT02935855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350706|NCT02935842|Randomized|Parallel Assignment||Treatment||Single|||||t|
1350707|NCT02935829|Randomized|Crossover Assignment||Other||Single|||||t|
1350708|NCT02935816|||Case-Only||Prospective|||||||
1350709|NCT02935803|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350710|NCT02935790||Single Group Assignment||Treatment||None (Open Label)||||||
1350711|NCT02935777|Randomized|Crossover Assignment||Health Services Research||Triple|||t||t|t
1350712|NCT02935764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350713|NCT02935751|||Cohort||Prospective|||||||
1350714|NCT02935738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350715|NCT02935725|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1350716|NCT02935712|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350717|NCT02935699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350718|NCT02935686|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1350719|NCT02935673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350720|NCT02935660||Single Group Assignment||Treatment||None (Open Label)||||||
1350721|NCT02935647||Single Group Assignment||Treatment||None (Open Label)||||||
1350722|NCT02935634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350723|NCT02935621|Randomized|Parallel Assignment||Treatment||Single||||||t
1350724|NCT02935608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350725|NCT02935595||Single Group Assignment||Treatment||None (Open Label)||Open-label||||
1350726|NCT02935582|||Cohort||Prospective|||||||
1350727|NCT02935569||Single Group Assignment||Supportive Care||None (Open Label)||||||
1350728|NCT02935556|||Case-Control||Prospective|||||||
1350729|NCT02935543||Single Group Assignment||Treatment||None (Open Label)||||||
1350730|NCT02935530|Randomized|Parallel Assignment||Treatment||||||||
1350731|NCT02935517|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350732|NCT02935504|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1350733|NCT02935491|||Cohort||Retrospective|||||||
1350734|NCT02935478||Single Group Assignment||Treatment||None (Open Label)||||||
1350735|NCT02935465|Randomized|Parallel Assignment||Treatment||Single||||||t
1350736|NCT02935452|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1350737|NCT02935439|Randomized|Parallel Assignment||||None (Open Label)||||||
1350738|NCT02935426|Randomized|Parallel Assignment||Treatment||Single||||||t
1350739|NCT02935413|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350740|NCT02935400|||Other||Prospective|||||||
1350741|NCT02935387|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350742|NCT02935374|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350743|NCT02935361||Single Group Assignment||Treatment||None (Open Label)||||||
1350744|NCT02935348|||Case-Only||Prospective|||||||
1350745|NCT02935335|||Cohort||Prospective|||||||
1350746|NCT02935322|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1350747|NCT02935309||Single Group Assignment||Treatment||None (Open Label)||||||
1350748|NCT02935296|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350749|NCT02935283|||Cohort||Prospective|||||||
1350750|NCT02935270|||Other||Cross-Sectional|||||||
1350751|NCT02935257||Single Group Assignment||Treatment||None (Open Label)||||||
1350752|NCT02935244|||Cohort||Prospective|||||||
1350753|NCT02935231|Randomized|Parallel Assignment||Treatment||Single||||||t
1350754|NCT02935218||Single Group Assignment||Supportive Care||None (Open Label)||||||
1350755|NCT02935205||Single Group Assignment||Treatment||None (Open Label)||||||
1350756|NCT02935192|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1350757|NCT02935179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350758|NCT02935166|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1350759|NCT02935153||Single Group Assignment||Treatment||None (Open Label)||||||
1350760|NCT02935140|||Cohort||Prospective|||||||
1350761|NCT02935127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350762|NCT02935114|Randomized|Parallel Assignment||Treatment||Single|||||t|
1350763|NCT02935101|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1350764|NCT02935088|||Case-Only||Prospective|||||||
1350765|NCT02935075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350766|NCT02935062|Randomized|Parallel Assignment||Treatment||Single||||||t
1350767|NCT02935049|||Cohort||Prospective|||||||
1350768|NCT02935036|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350769|NCT02935023||Single Group Assignment||Treatment||None (Open Label)||||||
1350770|NCT02935010|Randomized|Parallel Assignment||Treatment||Single||||||t
1350771|NCT02934997|||Cohort||Prospective|||||||
1350772|NCT02934984|||Cohort||Prospective|||||||
1350773|NCT02934971|||Cohort||Prospective|||||||
1350774|NCT02934958|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1350775|NCT02934945|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351780|NCT02921815|||Case-Only||Prospective|||||||
1350776|NCT02934932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350777|NCT02934919||Single Group Assignment||Treatment||None (Open Label)||||||
1350778|NCT02934906|||Cohort||Prospective|||||||
1350779|NCT02934893|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350780|NCT02934880|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350781|NCT02934867|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350782|NCT02934854|||Cohort||Prospective|||||||
1350783|NCT02934841|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350784|NCT02934828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350785|NCT02934815|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350786|NCT02934802|||Cohort||Prospective|||||||
1350787|NCT02934789|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1350788|NCT02934776||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350789|NCT02934763|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350790|NCT02934750|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1350791|NCT02934737|||Cohort||Retrospective|||||||
1350792|NCT02934724|||Cohort||Cross-Sectional|||||||
1350793|NCT02934711|||Other||Prospective|||||||
1350794|NCT02934698||Single Group Assignment||Treatment||None (Open Label)||||||
1350795|NCT02934685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350796|NCT02934672|||Other||Cross-Sectional|||||||
1350797|NCT02934659||Single Group Assignment||Treatment||None (Open Label)||||||
1350798|NCT02934646||Single Group Assignment||Treatment||None (Open Label)||||||
1350799|NCT02934633|Randomized|Parallel Assignment||||None (Open Label)||||||
1350800|NCT02934620|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350801|NCT02934607|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1350802|NCT02934594|||Case-Only|||||||||
1350803|NCT02934581|||Cohort||Prospective|||||||
1350804|NCT02934568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350805|NCT02934555|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1350806|NCT02934542|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350807|NCT02934529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350808|NCT02934516|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350809|NCT02934503||Single Group Assignment||Treatment||None (Open Label)||||||
1350810|NCT02934490||Single Group Assignment||Treatment||None (Open Label)||||||
1350811|NCT02934477|||Cohort||Prospective|||||||
1350812|NCT02934464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350813|NCT02934451|||Cohort||Prospective|||||||
1350814|NCT02934438|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1350815|NCT02934425|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1350816|NCT02934412|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1350817|NCT02934399|||Case-Control||Prospective|||||||
1350818|NCT02934386||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350819|NCT02934373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350820|NCT02934360|||Cohort||Prospective|||||||
1350821|NCT02934347|||Case-Control||Prospective|||||||
1350822|NCT02934334|||Case-Only||Prospective|||||||
1350823|NCT02934321|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1350824|NCT02934308||Single Group Assignment||Other||None (Open Label)||||||
1350825|NCT02934295||Single Group Assignment||Prevention||None (Open Label)||||||
1350826|NCT02934282||||||||||||
1350827|NCT02934269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350828|NCT02934256||Single Group Assignment||Treatment||None (Open Label)||||||
1350829|NCT02934243|||Case-Only||Prospective|||||||
1350830|NCT02934230|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1350831|NCT02934217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350832|NCT02934204||Single Group Assignment||Treatment||None (Open Label)||||||
1350833|NCT02934191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350834|NCT02934178|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350835|NCT02934165|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350836|NCT02934152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350837|NCT02934139|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1350838|NCT02934126|||Case-Only||Retrospective|||||||
1350839|NCT02934113|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350840|NCT02934100|Randomized|Factorial Assignment||Treatment||Single|||t|||
1350841|NCT02934087|Randomized|Crossover Assignment||||None (Open Label)||||||
1350842|NCT02934074|||||Prospective|||||||
1350843|NCT02934061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350844|NCT02934048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350845|NCT02934035|||||Prospective|||||||
1350846|NCT02934022||Single Group Assignment||Treatment||None (Open Label)||||||
1350847|NCT02934009|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1350848|NCT02933996|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350849|NCT02933983|||Case Control||Prospective|||||||
1350850|NCT02933970|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1350851|NCT02933957|||Ecologic or Community||Cross-Sectional|||||||
1350852|NCT02933944||Single Group Assignment||Treatment||None (Open Label)||||||
1350853|NCT02933931|||Cohort||Prospective|||||||
1350854|NCT02933918||Single Group Assignment||Treatment||None (Open Label)||||||
1350855|NCT02933905|||Cohort||Prospective|||||||
1350856|NCT02933892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350857|NCT02933879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350858|NCT02933866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350859|NCT02933853|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1350860|NCT02933840|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350861|NCT02933827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350862|NCT02933814|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350863|NCT02933801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350864|NCT02933788|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350865|NCT02933775||Single Group Assignment||Treatment||None (Open Label)||||||
1350866|NCT02933762|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350867|NCT02933749|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1350868|NCT02933736||Single Group Assignment||Treatment||None (Open Label)||||||
1350869|NCT02933723|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1350870|NCT02933710|||Other||Prospective|||||||
1350871|NCT02933697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350872|NCT02933684|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350873|NCT02933671|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1350874|NCT02933658|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350875|NCT02933645|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1350876|NCT02933632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350877|NCT02933619|||Other||Retrospective|||||||
1350878|NCT02933606|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind||t|t|t|t
1350879|NCT02933593|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1350880|NCT02933580|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350881|NCT02933567||Single Group Assignment||Treatment||None (Open Label)||||||
1350882|NCT02933554||Single Group Assignment||Treatment||None (Open Label)||||||
1350883|NCT02933541|||Case-Only||Prospective|||||||
1350884|NCT02933528||Single Group Assignment||Treatment||None (Open Label)||||||
1350885|NCT02933515||Single Group Assignment||Treatment||None (Open Label)||||||
1350886|NCT02933502||Single Group Assignment||Treatment||None (Open Label)||||||
1350887|NCT02933489|Randomized|Parallel Assignment||Screening||Single||||||t
1350888|NCT02933476||Single Group Assignment||Treatment||None (Open Label)||||||
1350889|NCT02933463|Randomized|Parallel Assignment||Prevention||Single||||||t
1350890|NCT02933450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350891|NCT02933437||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350892|NCT02933424|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1350893|NCT02933411|||Other||Prospective|||||||
1350894|NCT02933398|Randomized|Parallel Assignment||Treatment||Single|||t|||
1350895|NCT02933385|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350896|NCT02933372|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1350897|NCT02933359|||Other||Prospective|||||||
1350898|NCT02933346|||Cohort||Retrospective|||||||
1350899|NCT02933333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350900|NCT02933320|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350901|NCT02933307|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350902|NCT02933294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350903|NCT02933281|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350904|NCT02933268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350905|NCT02933255|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350906|NCT02933242||Single Group Assignment||Treatment||None (Open Label)||||||
1350907|NCT02933229||Single Group Assignment||Prevention||None (Open Label)||||||
1350908|NCT02933216|||Cohort||Prospective|||||||
1350909|NCT02933203|||Cohort||Prospective|||||||
1350910|NCT02933190|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1350911|NCT02933177|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350912|NCT02933164||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350913|NCT02933151|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350914|NCT02933138|||Cohort||Prospective|||||||
1350915|NCT02933125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350916|NCT02933112||Single Group Assignment||Other||None (Open Label)||||||
1350917|NCT02933099|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350918|NCT02933086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350919|NCT02933073||Single Group Assignment||Treatment||None (Open Label)||||||
1350920|NCT02933060|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350921|NCT02933047|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350922|NCT02933034||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350923|NCT02933021|||Cohort||Prospective|||||||
1350924|NCT02933008|Randomized|Parallel Assignment||Prevention||Single|||t|||
1350925|NCT02932995|||Cohort||Prospective|||||||
1350926|NCT02932982|||Other||Prospective|||||||
1350927|NCT02932969|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1350928|NCT02932956||Single Group Assignment||Treatment||None (Open Label)||||||
1350929|NCT02932943|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350930|NCT02932930|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350931|NCT02932917||Single Group Assignment||Treatment||None (Open Label)||||||
1350932|NCT02932904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350933|NCT02932891||Single Group Assignment||Treatment||None (Open Label)||||||
1350934|NCT02932878||Single Group Assignment||Treatment||None (Open Label)||||||
1350935|NCT02932865|||Case-Control||Prospective|||||||
1350936|NCT02932852|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350937|NCT02932839||Single Group Assignment||Basic Science||None (Open Label)||||||
1350938|NCT02932826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350939|NCT02932813|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350940|NCT02932800|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1350941|NCT02932787|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350942|NCT02932774|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350943|NCT02932761|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1350944|NCT02932748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350945|NCT02932735|||Cohort||Prospective|||||||
1350946|NCT02932722|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1350947|NCT02932709|||Cohort||Prospective|||||||
1350948|NCT02932696|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1350949|NCT02932683|Randomized|Parallel Assignment||||None (Open Label)||||||
1350950|NCT02932670|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1350951|NCT02932657|||Cohort||Prospective|||||||
1350952|NCT02932644|||Cohort||Prospective|||||||
1350953|NCT02932631|Randomized|Parallel Assignment||Treatment||Single|||||t|
1350954|NCT02932618|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350955|NCT02932605|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1350956|NCT02932592||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350957|NCT02932579|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1350958|NCT02932566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350959|NCT02932553||Single Group Assignment||Treatment||None (Open Label)||||||
1350960|NCT02932540|||Case-Control||Prospective|||||||
1350961|NCT02932527|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1350962|NCT02932514||Single Group Assignment||Diagnostic||None (Open Label)||||||
1350963|NCT02932501|||Case-Only||Prospective|||||||
1350964|NCT02932488||Single Group Assignment||Basic Science||None (Open Label)||||||
1350965|NCT02932475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350966|NCT02932462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350967|NCT02932449|||Cohort||Other|||||||
1350968|NCT02932436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350969|NCT02932423|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1350970|NCT02932410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350971|NCT02932397|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1350972|NCT02932384|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1350973|NCT02932371||Single Group Assignment||||None (Open Label)||||||
1350974|NCT02932358|Randomized|Crossover Assignment||Prevention||None (Open Label)||The following interventions will be evaluated in the present study: restrictive family visitation model (intermittent visits according to local ICU regulation) and flexible family visitation model (12 consecutive hours per day). The unit of of concealed randomization is the ICU to minimize the risk of contamination, given that we intend to apply the intervention to the whole ICU multidisciplinary team. We will randomize ICUs to either an RFVM or to an FFVM as the initial intervention (T1). After enrollment of 25 ICU patients, there will be a 30-day period without recruitment to avoid contamination bias. After this period, each ICU will be assigned to an intervention contrary to that which initially receive (T2) until the enrollment of more 25 ICU patients.||||
1350975|NCT02932345|||Case-Control||Retrospective|||||||
1350976|NCT02932332|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1350977|NCT02932319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350978|NCT02932306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350979|NCT02932293|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1350980|NCT02932280||Single Group Assignment||Treatment||None (Open Label)||||||
1350981|NCT02932267||Single Group Assignment||Treatment||None (Open Label)||||||
1350982|NCT02932254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1350983|NCT02932241|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1350984|NCT02932228|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1350985|NCT02932215||Single Group Assignment||Treatment||None (Open Label)||||||
1350986|NCT02932202|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are randomized to either a medical student assisted program comprising nutritional counselling and web based nutrition tracking methods (i.e., longitudinal nutritional counseling program) or routine follow-up with their primary healthcare specialist (standard of care) using a 1:1 random numbers block allocation||||
1350987|NCT02932189|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1350988|NCT02932176|||Cohort||Prospective|||||||
1350989|NCT02932163|||Cohort||Prospective|||||||
1350990|NCT02932150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1350991|NCT02932137|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1350992|NCT02932124|||Cohort||Prospective|||||||
1350993|NCT02932111|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1350994|NCT02932098|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1350995|NCT02932085|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1350996|NCT02932072|||Case-Only||Prospective|||||||
1350997|NCT02932059|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1350998|NCT02932046|||Case-Only||Prospective|||||||
1350999|NCT02932033|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1351000|NCT02932020|Randomized|Single Group Assignment||Treatment||Single|||t|||
1351001|NCT02932007||Single Group Assignment||Treatment||None (Open Label)||||||
1351002|NCT02931994|Randomized|Crossover Assignment||Prevention||Single||||||t
1351003|NCT02931981|||Case Control||Retrospective|||||||
1351004|NCT02931968|||Cohort||Retrospective|||||||
1351005|NCT02931955|||Cohort||Prospective|||||||
1351006|NCT02931942|||Cohort||Prospective|||||||
1351007|NCT02931929||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351008|NCT02931916|||Case-Control||Cross-Sectional|||||||
1351009|NCT02931903|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1351010|NCT02931890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351011|NCT02931877|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351012|NCT02931864|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351013|NCT02931851|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351014|NCT02931838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351015|NCT02931825|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1351016|NCT02931812|||Cohort||Prospective|||||||
1351017|NCT02931799|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351018|NCT02931786|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1351019|NCT02931773|||Case Control||Prospective|||||||
1351020|NCT02931760|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351021|NCT02931747|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351022|NCT02931734|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351023|NCT02931721|||Case-Only||Prospective|||||||
1351024|NCT02931708||Single Group Assignment||Treatment||None (Open Label)||||||
1351025|NCT02931695|Non-Randomized|Single Group Assignment||Screening||Single||||||t
1351026|NCT02931682|||Cohort||Prospective|||||||
1351027|NCT02931669|||Other||Prospective|||||||
1351028|NCT02931656|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351029|NCT02931643|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1351030|NCT02931630|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1351031|NCT02931617|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351032|NCT02931604||Single Group Assignment||Treatment||None (Open Label)||||||
1351033|NCT02931591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351034|NCT02931578|Randomized|Crossover Assignment||Other||Single|||t|||
1351035|NCT02931565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351036|NCT02931552|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1351037|NCT02931539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351038|NCT02931526|||Case Control||Prospective|||||||
1351039|NCT02931513|||Cohort||Prospective|||||||
1351040|NCT02931500|||Cohort||Retrospective|||||||
1351041|NCT02931487|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1351042|NCT02931474|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1351043|NCT02931461||||||||||||
1351044|NCT02931448|||Case-Only||Prospective|||||||
1351045|NCT02931435|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351046|NCT02931422|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1351047|NCT02931409|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351048|NCT02931396|Randomized|Parallel Assignment||Treatment||Single||||||t
1351049|NCT02931383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351050|NCT02931370|||Cohort||Prospective|||||||
1351051|NCT02931357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351052|NCT02931344||Single Group Assignment||Treatment||None (Open Label)||||||
1351053|NCT02931331|||Cohort||Prospective|||||||
1351054|NCT02931318||Single Group Assignment||Health Services Research||None (Open Label)||||||
1351055|NCT02931305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351056|NCT02931292|||Cohort||Prospective|||||||
1351057|NCT02931279|||Cohort||Prospective|||||||
1351058|NCT02931266|||Cohort||Prospective|||||||
1351059|NCT02931253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351060|NCT02931240|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351061|NCT02931227|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1351062|NCT02931214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351063|NCT02931201||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351064|NCT02931188|||Cohort||Cross-Sectional|||||||
1351065|NCT02931175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351066|NCT02931162|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1351067|NCT02931149||Single Group Assignment||Prevention||None (Open Label)||||||
1351068|NCT02931136|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351069|NCT02931123|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351070|NCT02931110||Single Group Assignment||Treatment||None (Open Label)||||||
1351071|NCT02931097|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1351072|NCT02931084|||Cohort||Prospective|||||||
1351073|NCT02931071||Single Group Assignment||Treatment||None (Open Label)||||||
1351074|NCT02931058|Randomized|Parallel Assignment||Treatment||Single||||||t
1351075|NCT02931045|Randomized|Parallel Assignment||Basic Science||Triple||||t|t|t
1351076|NCT02931032||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351077|NCT02931019|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1351078|NCT02931006|Randomized|Parallel Assignment||||None (Open Label)||||||
1351079|NCT02930993||Single Group Assignment||Treatment||None (Open Label)||||||
1351080|NCT02930980||Single Group Assignment||Health Services Research||None (Open Label)||||||
1351081|NCT02930967||Single Group Assignment||Treatment||None (Open Label)||||||
1351082|NCT02930954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351083|NCT02930941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351084|NCT02930928|||Cohort||Prospective|||||||
1351085|NCT02930915|||Cohort||Cross-Sectional|||||||
1351086|NCT02930902|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351087|NCT02930889||Single Group Assignment||Treatment||None (Open Label)||||||
1351088|NCT02930876|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1351089|NCT02930863|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351090|NCT02930850||||||||||||
1351091|NCT02930837||Single Group Assignment||Treatment||None (Open Label)||||||
1351092|NCT02930824|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1351093|NCT02930811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351094|NCT02930798||Single Group Assignment||Prevention||None (Open Label)||||||
1351095|NCT02930785||Single Group Assignment||Prevention||None (Open Label)||||||
1351096|NCT02930772||Single Group Assignment||Prevention||None (Open Label)||||||
1351097|NCT02930759||Single Group Assignment||Prevention||None (Open Label)||||||
1351098|NCT02930746||Single Group Assignment||Prevention||None (Open Label)||||||
1351099|NCT02930733|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351100|NCT02930720|||Cohort||Cross-Sectional|||||||
1351101|NCT02930707|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1351102|NCT02930694|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351103|NCT02930681|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1351104|NCT02930668|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1351105|NCT02930655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351106|NCT02930642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351107|NCT02930629|||Cohort||Prospective|||||||
1351108|NCT02930616|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1351109|NCT02930603|||Cohort||Prospective|||||||
1351110|NCT02930590|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1351111|NCT02930577|||||Retrospective|||||||
1351112|NCT02930564||Single Group Assignment||Other||None (Open Label)||||||
1351113|NCT02930551|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1351114|NCT02930538|||Cohort||Prospective|||||||
1351115|NCT02930525|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351116|NCT02930512|||||Cross-Sectional|||||||
1351117|NCT02930499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351118|NCT02930486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351119|NCT02930473|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351120|NCT02930460|||Cohort||Prospective|||||||
1351121|NCT02930447|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1351122|NCT02930434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351123|NCT02930421|Randomized|Parallel Assignment||Treatment||Single||||||t
1351124|NCT02930408||||||||||||
1351125|NCT02930395|||||Cross-Sectional|||||||
1351126|NCT02930382||Parallel Assignment||Diagnostic||None (Open Label)||||||
1351127|NCT02930369|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351128|NCT02930356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351129|NCT02930343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351130|NCT02930330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351131|NCT02930317|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351132|NCT02930304|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351133|NCT02930291|||Cohort||Prospective|||||||
1351134|NCT02930278|||Cohort||Prospective|||||||
1351135|NCT02930265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351136|NCT02930252|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1351137|NCT02930239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351138|NCT02930226|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351139|NCT02930213|||Case-Only||Prospective|||||||
1351140|NCT02930200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351141|NCT02930187|||Cohort||Prospective|||||||
1351142|NCT02930174||Single Group Assignment||Other||None (Open Label)||||||
1351143|NCT02930161|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351144|NCT02930148|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351145|NCT02930135|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1351146|NCT02930122|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351147|NCT02930109||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1351148|NCT02930096|||Case-Control||Prospective|||||||
1351149|NCT02930083|||Case-Only||Retrospective|||||||
1351150|NCT02930070|||Cohort||Prospective|||||||
1351151|NCT02930057|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1351152|NCT02930044|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351153|NCT02930031|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1351154|NCT02930018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351155|NCT02930005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351156|NCT02929992|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351157|NCT02929979|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1351158|NCT02929966|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351161|NCT02929927|Randomized|Parallel Assignment||Treatment||Single||||||t
1351162|NCT02929914|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351163|NCT02929901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351164|NCT02929888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351165|NCT02929875|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351166|NCT02929862||Single Group Assignment||Treatment||None (Open Label)||||||
1351167|NCT02929849|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1351168|NCT02929836|Randomized|Parallel Assignment||Treatment||Single||||||t
1351169|NCT02929823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351170|NCT02929810|Randomized|Parallel Assignment||Treatment||Single|||||t|
1351171|NCT02929797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351172|NCT02929784|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351173|NCT02929771|Randomized|Crossover Assignment||Treatment||Single||||||t
1351174|NCT02929758|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1351175|NCT02929745|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1351176|NCT02929732|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1351177|NCT02929719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351178|NCT02929706|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1351179|NCT02929693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351180|NCT02929667|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1351181|NCT02929654|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1351182|NCT02929641|||Cohort||Prospective|||||||
1351183|NCT02929628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351184|NCT02929615||Single Group Assignment||Treatment||None (Open Label)||||||
1351185|NCT02929602|||Case-Only||Prospective|||||||
1351186|NCT02929589|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351187|NCT02929576|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351188|NCT02929563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351189|NCT02929550|||Cohort|||||||||
1351190|NCT02929537|||Other||Prospective|||||||
1351191|NCT02929524|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351192|NCT02929511|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351193|NCT02929498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351194|NCT02929485|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1351195|NCT02929472|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351196|NCT02929459|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351197|NCT02929446|Randomized|Parallel Assignment||Treatment||Single|||||t|
1351198|NCT02929433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351199|NCT02929420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351200|NCT02929407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351201|NCT02929394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351202|NCT02929381|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1351203|NCT02929368|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1351204|NCT02929355|||Cohort||Prospective|||||||
1351205|NCT02929342|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1351206|NCT02929329|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351207|NCT02929316||Single Group Assignment||Treatment||None (Open Label)||||||
1351208|NCT02929303||||||||||||
1351209|NCT02929290||Single Group Assignment||Treatment||None (Open Label)||||||
1351210|NCT02929277||Single Group Assignment||Prevention||None (Open Label)||||||
1351211|NCT02929264|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1351212|NCT02929251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351213|NCT02929238|Randomized|Parallel Assignment||Treatment||Single||||||t
1351214|NCT02929225|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351215|NCT02929212|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1351216|NCT02929199|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351217|NCT02929186|Randomized|Parallel Assignment||Screening||Single|||||t|
1351218|NCT02929173|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351219|NCT02929160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351220|NCT02929147|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351221|NCT02929134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351222|NCT02929121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351223|NCT02929108|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351224|NCT02929095|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1351225|NCT02929082|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1351226|NCT02929069|Randomized|Parallel Assignment||Prevention||Single||||||t
1351227|NCT02929056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351228|NCT02929043|||Cohort||Prospective|||||||
1351229|NCT02929030|||Case-Only||Prospective|||||||
1351230|NCT02929017|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1351231|NCT02929004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351232|NCT02928991|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351233|NCT02928978|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1351234|NCT02928965|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351235|NCT02928952|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351236|NCT02928939|||Other||Retrospective|||||||
1351239|NCT02928900|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1351240|NCT02928887|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1351241|NCT02928874|Randomized|Crossover Assignment||Prevention||Single|||t|||
1351242|NCT02928861||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351243|NCT02928848|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1351244|NCT02928835|Randomized|Parallel Assignment||Prevention||Single||||||t
1351245|NCT02928822|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351246|NCT02928809|Randomized|Factorial Assignment||Prevention||Single|||t|||
1351247|NCT02928796|||Cohort||Prospective|||||||
1351248|NCT02928783|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351249|NCT02928770||Single Group Assignment||Treatment||None (Open Label)||||||
1351250|NCT02928757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351251|NCT02928744||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351252|NCT02928731|||Cohort||Cross-Sectional|||||||
1351253|NCT02928718|||Cohort||Prospective|||||||
1351254|NCT02928705|||Case Control||Retrospective|||||||
1351255|NCT02928692|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351256|NCT02928679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351257|NCT02928666|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1351258|NCT02928653|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1351259|NCT02928640||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351260|NCT02928627|||Other||Prospective|||||||
1351261|NCT02928614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351262|NCT02928601|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1351263|NCT02928575||Single Group Assignment||Treatment||None (Open Label)||||||
1351264|NCT02928562|Non-Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1351265|NCT02928549|||Cohort||Prospective|||||||
1351266|NCT02928536|||Other||Cross-Sectional|||||||
1351267|NCT02928523||Single Group Assignment||Treatment||None (Open Label)||||||
1351268|NCT02928510||Single Group Assignment||Basic Science||None (Open Label)||||||
1351269|NCT02928497|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351270|NCT02928484|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1351271|NCT02928471|||Cohort||Prospective|||||||
1351272|NCT02928458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351273|NCT02928445|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351274|NCT02928432||Single Group Assignment||Treatment||None (Open Label)||One-arm prospective||||
1351275|NCT02928419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351276|NCT02928406||Single Group Assignment||Treatment||None (Open Label)||||||
1351277|NCT02928393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351278|NCT02928380|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1351279|NCT02928367|||Case-Control||Prospective|||||||
1351280|NCT02928354|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1351281|NCT02928341|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1351282|NCT02928328|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1351283|NCT02928315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351284|NCT02928302|Randomized|Parallel Assignment||Screening||Single||||||t
1351285|NCT02928289|Randomized|Parallel Assignment||Treatment||Single||||||t
1351286|NCT02928276||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351287|NCT02928263|||Cohort||Retrospective|||||||
1351288|NCT02928250|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351289|NCT02928237|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351290|NCT02928224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351291|NCT02928211||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351292|NCT02928198|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351293|NCT02928185|||Cohort||Prospective|||||||
1351294|NCT02928172||Single Group Assignment||Screening||None (Open Label)||||||
1351295|NCT02928159||Single Group Assignment||||None (Open Label)||||||
1351296|NCT02928146|Randomized|Single Group Assignment||Treatment||Single|||t|||
1351297|NCT02928133|||Cohort||Prospective|||||||
1351298|NCT02928120|||Case Control||Prospective|||||||
1351299|NCT02928107|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1351300|NCT02928094|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1351301|NCT02928081|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1351302|NCT02928068||Single Group Assignment||Supportive Care||None (Open Label)||||||
1351303|NCT02928055|Randomized|Parallel Assignment||Treatment||Single||||||t
1351304|NCT02928042|||Cohort||Prospective|||||||
1351305|NCT02928029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351306|NCT02928016|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1351307|NCT02928003||Single Group Assignment||Other||None (Open Label)||||||
1351308|NCT02927990|||Cohort||Prospective|||||||
1351309|NCT02927977|Randomized|Parallel Assignment||Treatment||Single||||||t
1351310|NCT02927964||Single Group Assignment||Treatment||None (Open Label)||||||
1351311|NCT02927951|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1351312|NCT02927938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351313|NCT02927925||Single Group Assignment||Treatment||None (Open Label)||||||
1351314|NCT02927912||Single Group Assignment||Treatment||None (Open Label)||||||
1351315|NCT02927899||Single Group Assignment||Prevention||None (Open Label)||||||
1351316|NCT02927886|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351317|NCT02927873|Randomized|Parallel Assignment||Prevention||Quadruple|Observer blind||t|t|t|t
1351318|NCT02927860|||Case-Only||Prospective|||||||
1351319|NCT02927847|Randomized|Parallel Assignment||Basic Science||Single||||||t
1351320|NCT02927834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351321|NCT02927821|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351322|NCT02927808|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351323|NCT02927795|||Other||Prospective|||||||
1351324|NCT02927782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351325|NCT02927769|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351326|NCT02927756|||Cohort||Retrospective|||||||
1351327|NCT02927743|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351328|NCT02927730|||Case Control||Cross-Sectional|||||||
1351329|NCT02927717|||Cohort||Retrospective|||||||
1351330|NCT02927704|||Case Control||Cross-Sectional|||||||
1351331|NCT02927691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351332|NCT02927678|||Cohort||Prospective|||||||
1351333|NCT02927665|||Case-Only||Prospective|||||||
1351334|NCT02927652|||Cohort||Other|||||||
1351335|NCT02927639|Randomized|Parallel Assignment||Other||Single||||||t
1351336|NCT02927626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351337|NCT02927613|||Case-Only||Prospective|||||||
1351338|NCT02927600|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1351339|NCT02927587|Randomized|Parallel Assignment||Prevention||Single|||t|||
1351340|NCT02927574|||Other||Other|||||||
1351341|NCT02927561|||||Retrospective|||||||
1351342|NCT02927548|||Cohort||Retrospective|||||||
1351343|NCT02927535|||Cohort||Prospective|||||||
1351344|NCT02927522|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351345|NCT02927509|||Cohort||Prospective|||||||
1351346|NCT02927496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351347|NCT02927483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351348|NCT02927470||Single Group Assignment||Treatment||None (Open Label)||||||
1351349|NCT02927457|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351350|NCT02927444|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1351351|NCT02927431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351352|NCT02927418|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1351353|NCT02927405|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1351354|NCT02927392|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1351355|NCT02927379|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1351356|NCT02927366||Parallel Assignment||Treatment||Double|||t||t|
1351357|NCT02927353|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351358|NCT02927340||Single Group Assignment||Treatment||None (Open Label)||||||
1351359|NCT02927327|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351360|NCT02927314|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351361|NCT02927301||Single Group Assignment||Treatment||None (Open Label)||||||
1351362|NCT02927288|||Cohort||Prospective|||||||
1351363|NCT02927275|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1351364|NCT02927262|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351365|NCT02927249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351366|NCT02927236|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351367|NCT02927223|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1351368|NCT02927210|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1351369|NCT02927197|Randomized|Parallel Assignment||Treatment||Single||||||t
1351370|NCT02927184|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1351371|NCT02927171|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1351372|NCT02927158|||Cohort||Prospective|||||||
1351373|NCT02927145|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351374|NCT02927132|Randomized|Factorial Assignment||Prevention||Single|||t|||
1351375|NCT02927119|||||Retrospective|||||||
1351376|NCT02927106||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351377|NCT02927093|||Case-Control||Retrospective|||||||
1351378|NCT02927080|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351379|NCT02927067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351380|NCT02927054|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351381|NCT02927041|||Cohort||Cross-Sectional|||||||
1351382|NCT02927028||Single Group Assignment||Basic Science||None (Open Label)||||||
1351383|NCT02927015|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1351384|NCT02927002|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1351385|NCT02926989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351386|NCT02926976|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351387|NCT02926963||Single Group Assignment||Basic Science||None (Open Label)||||||
1351388|NCT02926950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351389|NCT02926937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351390|NCT02926924|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351391|NCT02926911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351392|NCT02926898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351393|NCT02926885|Randomized|Parallel Assignment||||None (Open Label)||||||
1351394|NCT02926872|||Other||Other|||||||
1351395|NCT02926859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351781|NCT02921802|||Case-Only||Prospective|||||||
1351396|NCT02926846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351397|NCT02926833||Single Group Assignment||Treatment||None (Open Label)||||||
1351398|NCT02926820||Single Group Assignment||Treatment||None (Open Label)||||||
1351399|NCT02926807|||Cohort||Prospective|||||||
1351400|NCT02926794|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1351401|NCT02926781|Randomized|Parallel Assignment||Screening||Double|||t|||t
1351402|NCT02926768|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1351403|NCT02926755||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351404|NCT02926742|||Cohort||Prospective|||||||
1351405|NCT02926729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351406|NCT02926716|||Case-Only||Prospective|||||||
1351407|NCT02926703|||Cohort||Prospective|||||||
1351408|NCT02926690||Single Group Assignment||Treatment||None (Open Label)||||||
1351409|NCT02926677|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1351410|NCT02926664|||Cohort||Prospective|||||||
1351411|NCT02926651|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351412|NCT02926638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351413|NCT02926625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351414|NCT02926612|||Cohort||Prospective|||||||
1351415|NCT02926599|Randomized|Parallel Assignment||Other||Double|||||t|t
1351416|NCT02926586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351417|NCT02926573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351418|NCT02926560|||Case-Only||Cross-Sectional|||||||
1351419|NCT02926547|||Other||Cross-Sectional|||||||
1351420|NCT02926534|||Case-Control||Cross-Sectional|||||||
1351421|NCT02926521|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351422|NCT02926508|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1351423|NCT02926495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351424|NCT02926482|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351425|NCT02926469|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1351426|NCT02926456|||Cohort||Prospective|||||||
1351427|NCT02926443|Randomized|Parallel Assignment||Treatment||Single|||||t|
1351428|NCT02926430|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1351429|NCT02926417|||Cohort||Prospective|||||||
1351430|NCT02926404|||Cohort||Prospective|||||||
1351431|NCT02926391|||Cohort||Prospective|||||||
1351432|NCT02926378||Single Group Assignment||Supportive Care||None (Open Label)||||||
1351433|NCT02926365||Single Group Assignment||Treatment||None (Open Label)||||||
1351434|NCT02926352|Randomized|Factorial Assignment||Treatment||Single|||t|||
1351435|NCT02926339|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1351436|NCT02926326||Single Group Assignment||Treatment||None (Open Label)||||||
1351437|NCT02926313|Randomized|Parallel Assignment||Treatment||Single||||||t
1351438|NCT02926300|||Cohort||Prospective|||||||
1351439|NCT02926287||Single Group Assignment||Health Services Research||None (Open Label)||||||
1351440|NCT02926274|||Cohort||Prospective|||||||
1351441|NCT02926261|||Cohort||Cross-Sectional|||||||
1351442|NCT02926248|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351443|NCT02926235|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351444|NCT02926222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351445|NCT02926209|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1351446|NCT02926196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351447|NCT02926183||Single Group Assignment||Treatment||None (Open Label)||||||
1351448|NCT02926170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351449|NCT02926157|Randomized|Parallel Assignment||Treatment||Single||||||t
1351450|NCT02926144|Randomized|Parallel Assignment||Other||Single||||||t
1351451|NCT02926131|||Case-Only||Prospective|||||||
1351452|NCT02926118|Randomized|Crossover Assignment||Basic Science||Single||||||t
1351453|NCT02926105|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1351454|NCT02926092|||Cohort||Prospective|||||||
1351455|NCT02926079|||Cohort||Cross-Sectional|||||||
1351456|NCT02926066||Single Group Assignment||Treatment||None (Open Label)||||||
1351457|NCT02926053||Single Group Assignment||Treatment||None (Open Label)||||||
1351458|NCT02926040|||Cohort||Prospective|||||||
1351459|NCT02926027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351460|NCT02926014|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1351461|NCT02926001|||||Retrospective|||||||
1351462|NCT02925988||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351463|NCT02925975|Randomized|Parallel Assignment||Prevention||Single||||||t
1351464|NCT02925962|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1351465|NCT02925949|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1351466|NCT02925936|Randomized|Parallel Assignment||||None (Open Label)||||||
1351467|NCT02925923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351468|NCT02925910|Randomized|Crossover Assignment||Treatment||Single|||t|||
1351469|NCT02925897|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1351470|NCT02925884|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1351471|NCT02925871|||Cohort||Prospective|||||||
1351472|NCT02925858|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351473|NCT02925845|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351474|NCT02925832|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1351475|NCT02925819|||Cohort||Prospective|||||||
1351476|NCT02925806|||Cohort||Retrospective|||||||
1351477|NCT02925793|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351478|NCT02925780|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351479|NCT02925767|Randomized|Parallel Assignment||Treatment||Single||||||t
1351480|NCT02925754|||||Cross-Sectional|||||||
1351481|NCT02925741|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1351482|NCT02925728|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351483|NCT02925715|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1351484|NCT02925702|||Cohort||Prospective|||||||
1351485|NCT02925676||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351486|NCT02925663||Single Group Assignment||Treatment||None (Open Label)||Patients are receiving an executive functioning intervention in an open trial design-pre-post||||
1351487|NCT02925650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351488|NCT02925637|Randomized|Parallel Assignment||Treatment||Single||||||t
1351489|NCT02925624||Single Group Assignment||Treatment||None (Open Label)||||||
1351490|NCT02925611|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1351491|NCT02925598|Randomized|Crossover Assignment||Other||Single||||t||
1351492|NCT02925585|||Case-Control||Prospective|||||||
1351493|NCT02925572|Randomized|Parallel Assignment||Other||Single|||t|||
1351494|NCT02925559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351495|NCT02925546|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1351496|NCT02925533||Single Group Assignment||Treatment||None (Open Label)||||||
1351497|NCT02925520||||||||||||
1351498|NCT02925507|||Case-Control||Prospective|||||||
1351499|NCT02925494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351500|NCT02925481|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351501|NCT02925468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351502|NCT02925455|Randomized|Parallel Assignment||Treatment||Single||||||t
1351503|NCT02925442|Randomized|Parallel Assignment||Treatment||Triple||Genicular radiofrequency ablation performed prior to total knee arthroplasty for pain management|t|t|t|
1351504|NCT02925429|||Cohort||Prospective|||||||
1351505|NCT02925416|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1351506|NCT02925403|Randomized|Parallel Assignment||Prevention||Single|||t|||
1351507|NCT02925390|||Cohort||Prospective|||||||
1351508|NCT02925377|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351509|NCT02925364|||Cohort||Cross-Sectional|||||||
1351510|NCT02925351||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351511|NCT02925338|||Cohort||Prospective|||||||
1351512|NCT02925325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351513|NCT02925312|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351514|NCT02925299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351515|NCT02925286|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351516|NCT02925273||Single Group Assignment||Health Services Research||None (Open Label)||||||
1351517|NCT02925260|||Case-Only||Cross-Sectional|||||||
1351518|NCT02925247||Single Group Assignment||||None (Open Label)||||||
1351519|NCT02925234|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351520|NCT02925221|||Cohort||Prospective|||||||
1351521|NCT02925208|||||Retrospective|||||||
1351522|NCT02925195|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1351523|NCT02925182|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1351524|NCT02925169|||Cohort||Retrospective|||||||
1351525|NCT02925156|||Cohort||Prospective|||||||
1351526|NCT02925143||Single Group Assignment||Health Services Research||None (Open Label)||||||
1351527|NCT02925130|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1351528|NCT02925117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351529|NCT02925104||Single Group Assignment||Treatment||None (Open Label)||||||
1351530|NCT02925091|||Cohort||Prospective|||||||
1351531|NCT02925078|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351532|NCT02925065|Randomized|Parallel Assignment||Treatment||Single||Participants will be randomly assigned to early-start or late start guitar groups. Following baseline assessment week, the early-start group will receive twice-weekly non traditional guitar instruction for 6 weeks. The late-start guitar group will receive same intervention after the early-start group complete their 6 week instruction. Study assessments will be conducted during week 7 and week 14. Follow up assessment will be conducted in week 20.|||t|
1351533|NCT02925052|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351534|NCT02925039|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Pilot Randomised controlled trial||||
1351535|NCT02925026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351536|NCT02925013|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1351537|NCT02925000||Single Group Assignment||Treatment||None (Open Label)||||||
1351538|NCT02924987||Single Group Assignment||Treatment||None (Open Label)||||||
1351539|NCT02924974|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1351540|NCT02924961|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351541|NCT02924948|Randomized|Parallel Assignment||Prevention||Single|||t|||
1351542|NCT02924935||Single Group Assignment||Treatment||None (Open Label)||||||
1351543|NCT02924922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351544|NCT02924909||Single Group Assignment||Treatment||None (Open Label)||||||
1351545|NCT02924896|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1351546|NCT02924883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351547|NCT02924870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351548|NCT02924857|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351550|NCT02924831|Randomized|Parallel Assignment||Treatment||Single||||||t
1351551|NCT02924818|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1351552|NCT02924805|||Case Control||Retrospective|||||||
1351553|NCT02924792|||Case-Control||Prospective|||||||
1351554|NCT02924779|||Case-Only||Retrospective|||||||
1351555|NCT02924766||Single Group Assignment||Treatment||None (Open Label)||||||
1351556|NCT02924753||Single Group Assignment||Treatment||None (Open Label)||||||
1351557|NCT02924740|Randomized|Parallel Assignment||Treatment||Single||||||t
1351558|NCT02924727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351559|NCT02924714||Single Group Assignment||Other||None (Open Label)||||||
1351560|NCT02924701|||Cohort||Prospective|||||||
1351561|NCT02924688|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1351562|NCT02924675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351563|NCT02924662|||Case-Crossover||Prospective|||||||
1351564|NCT02924649|Randomized|Parallel Assignment||Treatment||Single||||||t
1351565|NCT02924636|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351566|NCT02924623|||Case-Only||Cross-Sectional|||||||
1351567|NCT02924597|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1351568|NCT02924584|||Cohort||Retrospective|||||||
1351569|NCT02924571|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1351570|NCT02924558|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1351571|NCT02924545|||Case-Only||Cross-Sectional|||||||
1351572|NCT02924532|||Cohort||Retrospective|||||||
1351573|NCT02924519|||Cohort||Prospective|||||||
1351574|NCT02924506|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351575|NCT02924493|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351576|NCT02924480|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1351577|NCT02924467|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1351578|NCT02924454|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1351579|NCT02924441|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1351580|NCT02924428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351581|NCT02924415|Randomized|Parallel Assignment||Treatment||Single||||t||
1351582|NCT02924402|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This study will enroll two parallel disease groups: patients with non-CLL B cell malignancies and patients with CLL/SLL/Ricter's Transformation.||||
1351583|NCT02924389|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1351584|NCT02924376|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351585|NCT02924363||Single Group Assignment||Diagnostic||None (Open Label)||Participants undergoing cardiac magnetic imaging resonance scanning with an FDA cleared MRI and with or without an FDA approved contrast dye.||||
1351586|NCT02924350|Randomized|Parallel Assignment||Treatment||Single||||||t
1351587|NCT02924337|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1351588|NCT02924324|Randomized|Crossover Assignment||Treatment||Single|||t|||
1351589|NCT02924311|||Cohort||Prospective|||||||
1351590|NCT02924298|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351591|NCT02924285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351592|NCT02924272||Single Group Assignment||Treatment||None (Open Label)||||||
1351593|NCT02924259||Single Group Assignment||Treatment||None (Open Label)||||||
1351594|NCT02924246|Randomized|Parallel Assignment||Prevention||Single|||||t|
1351595|NCT02924233|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1351596|NCT02924220|||Case-Control||Retrospective|||||||
1351597|NCT02924207||Single Group Assignment||Treatment||None (Open Label)||||||
1351598|NCT02924194|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1351599|NCT02924181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351600|NCT02924168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351601|NCT02924155|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1351602|NCT02924142|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351603|NCT02924129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351604|NCT02924116||Single Group Assignment||Treatment||None (Open Label)||||||
1351605|NCT02924103|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1351606|NCT02924090|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351607|NCT02924077|||Cohort||Prospective|||||||
1351608|NCT02924064||Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351609|NCT02924051|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1351610|NCT02924038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351611|NCT02924025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351612|NCT02924012|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1351613|NCT02923999|Randomized|Parallel Assignment||Prevention||Single|||t|||
1351614|NCT02923986|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351615|NCT02923973|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351616|NCT02923960|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1351617|NCT02923947|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351618|NCT02923934||Single Group Assignment||Treatment||None (Open Label)|This is an open label study, all patients receive the same treatment as per the protocol.|||||
1351619|NCT02923921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351620|NCT02923908|||Cohort||Prospective|||||||
1351621|NCT02923895|Randomized|Parallel Assignment||Treatment||Single|||||t|
1351622|NCT02923882|Randomized|Parallel Assignment||Prevention||Single|||||t|
1351623|NCT02923869|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1351624|NCT02923856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351625|NCT02923843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351626|NCT02923830|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351627|NCT02923817||Single Group Assignment||Treatment||None (Open Label)||||||
1351628|NCT02923804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351629|NCT02923791|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351630|NCT02923778||Single Group Assignment||Treatment||None (Open Label)||||||
1351631|NCT02923765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351632|NCT02923752|||Other||Prospective|||||||
1351633|NCT02923739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351634|NCT02923726|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1351635|NCT02923700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351636|NCT02923687|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351637|NCT02923674|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1351638|NCT02923661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351639|NCT02923648|||Cohort||Cross-Sectional|||||||
1351640|NCT02923635|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351641|NCT02923622|||Cohort||Prospective|||||||
1351642|NCT02923609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351643|NCT02923596|||Cohort||Retrospective|||||||
1351644|NCT02923583|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1351645|NCT02923570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351646|NCT02923557|Randomized|Single Group Assignment||Prevention||Single||||||t
1351647|NCT02923544||Single Group Assignment||Treatment||None (Open Label)||||||
1351648|NCT02923531||Single Group Assignment||Treatment||None (Open Label)||||||
1351649|NCT02923518|||Case-Control||Prospective|||||||
1351650|NCT02923505|||Cohort||Retrospective|||||||
1351651|NCT02923492|Randomized|Parallel Assignment||Treatment||Single||||||t
1351652|NCT02923479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351653|NCT02923466|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351654|NCT02923453|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1351655|NCT02923440||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351656|NCT02923427|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1351657|NCT02923414|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351658|NCT02923401|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351659|NCT02923388|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351660|NCT02923375|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1351661|NCT02923362|||Cohort||Prospective|||||||
1351662|NCT02923349||Single Group Assignment||Treatment||None (Open Label)||||||
1351663|NCT02923336||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351664|NCT02923323|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1351665|NCT02923310|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1351666|NCT02923297||Single Group Assignment||Basic Science||None (Open Label)||||||
1351667|NCT02923284|||Case-Control||Prospective|||||||
1351668|NCT02923271|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1351669|NCT02923258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351670|NCT02923245|Randomized|Parallel Assignment||Other||Single|||t|||
1351671|NCT02923232||Sequential Assignment||Treatment||None (Open Label)||||||
1351672|NCT02923219||Single Group Assignment||Treatment||None (Open Label)||||||
1351673|NCT02923206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1351674|NCT02923193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351675|NCT02923180||Single Group Assignment||Treatment||None (Open Label)||||||
1351676|NCT02923167||Single Group Assignment||Treatment||None (Open Label)||||||
1351677|NCT02923154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351678|NCT02923141|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351679|NCT02923128|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351680|NCT02923115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351681|NCT02923102|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351682|NCT02923089|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1351683|NCT02923076||Single Group Assignment||Treatment||None (Open Label)||||||
1351684|NCT02923063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351685|NCT02923050|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351686|NCT02923037||Single Group Assignment||Supportive Care||None (Open Label)||||||
1351687|NCT02923024|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1351688|NCT02923011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351689|NCT02922998|||Cohort||Prospective|||||||
1351690|NCT02922985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351691|NCT02922972||Single Group Assignment||Treatment||None (Open Label)||||||
1351692|NCT02922959|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351693|NCT02922946|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351694|NCT02922933|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351695|NCT02922920|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1351696|NCT02922907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351697|NCT02922894|Randomized|Crossover Assignment||Other||Single|||t|||
1351698|NCT02922881||Single Group Assignment||Treatment||None (Open Label)||||||
1351699|NCT02922868|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1351700|NCT02922855|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1351701|NCT02922842|Randomized|Parallel Assignment||Device Feasibility||Single|||t|||
1351702|NCT02922829|||Cohort||Prospective|||||||
1351703|NCT02922816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351704|NCT02922803|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351705|NCT02922790|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351706|NCT02922777||Single Group Assignment||Treatment||None (Open Label)||||||
1351707|NCT02922764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351708|NCT02922751|||Case-Only||Cross-Sectional|||||||
1351709|NCT02922738|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1351710|NCT02922725|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351711|NCT02922712||Single Group Assignment||Treatment||None (Open Label)||||||
1351712|NCT02922699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351713|NCT02922686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351714|NCT02922673|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1351715|NCT02922660|Randomized|Parallel Assignment||Other||Single||||||t
1351716|NCT02922647|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351717|NCT02922634|||Other||Prospective|||||||
1351718|NCT02922621||||||||||||
1351719|NCT02922608|||Cohort||Prospective|||||||
1351720|NCT02922595|Randomized|Parallel Assignment||||Single|||t|||
1351721|NCT02922582|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351722|NCT02922569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351723|NCT02922556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351724|NCT02922543|||Case-Only||Prospective|||||||
1351725|NCT02922530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351726|NCT02922517|||Family-Based||Prospective|||||||
1351727|NCT02922504|Randomized|Parallel Assignment||Prevention||Single|||||t|
1351728|NCT02922491|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1351729|NCT02922478|||Cohort||Prospective|||||||
1351730|NCT02922465||Single Group Assignment||||None (Open Label)||||||
1351731|NCT02922452||Single Group Assignment||Basic Science||None (Open Label)||||||
1351732|NCT02922439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351733|NCT02922426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351734|NCT02922413|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351735|NCT02922400||Single Group Assignment||Supportive Care||None (Open Label)||||||
1351736|NCT02922387|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351737|NCT02922374||Single Group Assignment||Treatment||None (Open Label)||||||
1351738|NCT02922361|||Cohort||Retrospective|||||||
1351739|NCT02922348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351740|NCT02922335|Randomized|Parallel Assignment||Treatment||Single||||||t
1351741|NCT02922322|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1351742|NCT02922309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351743|NCT02922296|||Other||Prospective|||||||
1351744|NCT02922283||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351745|NCT02922270|||Ecologic or Community||Retrospective|||||||
1351746|NCT02922257|||Cohort||Prospective|||||||
1351747|NCT02922244|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1351748|NCT02922231|||Case-Only||Prospective|||||||
1351749|NCT02922218|||Cohort||Prospective|||||||
1351750|NCT02922205|||Cohort||Prospective|||||||
1351751|NCT02922192|||Cohort||Retrospective|||||||
1351752|NCT02922179|||Cohort||Retrospective|||||||
1351753|NCT02922166|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1351754|NCT02922153|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351755|NCT02922140|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351756|NCT02922127|Randomized|Parallel Assignment||Prevention||Single||||||t
1351757|NCT02922114||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351758|NCT02922101|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1351759|NCT02922088|||Other||Prospective|||||||
1351760|NCT02922075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351761|NCT02922062|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1351762|NCT02922049||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351763|NCT02922036|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351764|NCT02922023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351765|NCT02922010|||Other||Cross-Sectional|||||||
1351766|NCT02921997|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1351767|NCT02921984|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351768|NCT02921971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351769|NCT02921958|||Case-Only||Prospective|||||||
1351770|NCT02921945||Single Group Assignment||Treatment||None (Open Label)||||||
1351771|NCT02921932|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351772|NCT02921919||||Treatment||None (Open Label)||||||
1351773|NCT02921906|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1351774|NCT02921893|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351775|NCT02921880|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351776|NCT02921867|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1351777|NCT02921854||Single Group Assignment||Other||None (Open Label)||||||
1351778|NCT02921841|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351779|NCT02921828|||Case-Only||Prospective|||||||
1351782|NCT02921789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351783|NCT02921776|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351784|NCT02921763|||Cohort||Prospective|||||||
1351785|NCT02921750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351786|NCT02921737||Single Group Assignment||Treatment||None (Open Label)||||||
1351787|NCT02921724||Single Group Assignment||Health Services Research||None (Open Label)||||||
1351788|NCT02921711|||Cohort||Prospective|||||||
1351789|NCT02921698|||Cohort||Prospective|||||||
1351790|NCT02921685||Single Group Assignment||Treatment||None (Open Label)||||||
1351791|NCT02921672|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351792|NCT02921659|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1351793|NCT02921646||Single Group Assignment||Other||None (Open Label)||||||
1351794|NCT02921633|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351795|NCT02921620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351796|NCT02921607|||Cohort||Other|||||||
1351797|NCT02921594|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351798|NCT02921581|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1351799|NCT02921568||Single Group Assignment||Other||None (Open Label)||||||
1351800|NCT02921555|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1351801|NCT02921542|||Cohort||Prospective|||||||
1351802|NCT02921529|Randomized|Parallel Assignment||Treatment||Triple|Inventions were given by an investigator who is not involved in patient care. The anesthetists, surgeons,staff in the ward, the one who record the outcomes, and data analyzer were all blinded to the group allocation.|||t|t|t
1351803|NCT02921516|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1351804|NCT02921503||Single Group Assignment||Health Services Research||None (Open Label)||||||
1351805|NCT02921490||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351806|NCT02921477||Single Group Assignment||Treatment||None (Open Label)||||||
1351807|NCT02921464|||Cohort||Prospective|||||||
1351808|NCT02921451||Single Group Assignment||Treatment||None (Open Label)||||||
1351809|NCT02921438|||Cohort||Prospective|||||||
1351810|NCT02921425||Single Group Assignment||Health Services Research||None (Open Label)||||||
1351811|NCT02921412|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1351812|NCT02921399|||Case Control||Prospective|||||||
1351813|NCT02921386|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||Open-label, randomized, 5-period crossover food effect study||||
1351814|NCT02921373|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1351815|NCT02921360|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1351816|NCT02921347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351817|NCT02921334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351818|NCT02921321|||Cohort||Prospective|||||||
1351819|NCT02921308|||Other||Cross-Sectional|||||||
1351820|NCT02921295|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1351821|NCT02921282|||Other||Prospective|||||||
1351822|NCT02921269||Single Group Assignment||Treatment||None (Open Label)||||||
1351823|NCT02921256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351824|NCT02921243|||Case-Only||Prospective|||||||
1351825|NCT02921230|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351826|NCT02921217|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351827|NCT02921204|||Cohort||Cross-Sectional|||||||
1351828|NCT02921191|||Cohort||Retrospective|||||||
1351829|NCT02921178|||Cohort||Retrospective|||||||
1351830|NCT02921165|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351831|NCT02921152||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351832|NCT02921139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351833|NCT02921126|||Cohort||Retrospective|||||||
1351834|NCT02921113|||Cohort||Prospective|||||||
1351835|NCT02921100|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1351836|NCT02921087|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1351837|NCT02921074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351838|NCT02921061||Single Group Assignment||Treatment||None (Open Label)||||||
1351839|NCT02921048|||Cohort||Prospective|||||||
1351840|NCT02921035|||Cohort||Prospective|||||||
1351841|NCT02921022|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351842|NCT02921009||Single Group Assignment||Treatment||None (Open Label)||||||
1351843|NCT02920996|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351844|NCT02920983|Randomized|Crossover Assignment||Treatment||Single|||t|||
1351845|NCT02920970|Randomized|Crossover Assignment||Treatment||Single|||t|||
1351846|NCT02920957|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1351847|NCT02920944|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1351848|NCT02920931|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1351849|NCT02920918|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351850|NCT02920905|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1351851|NCT02920892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351852|NCT02920879|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351853|NCT02920866|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351854|NCT02920853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351855|NCT02920840|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1351856|NCT02920827|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1351857|NCT02920814||Single Group Assignment||Treatment||None (Open Label)||||||
1351858|NCT02920801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351859|NCT02920788|Randomized|Parallel Assignment||Treatment||Single||||||t
1351860|NCT02920775|||Case Control||Retrospective|||||||
1351861|NCT02920762|||Cohort||Retrospective|||||||
1351862|NCT02920749|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351863|NCT02920736|||Cohort||Prospective|||||||
1351864|NCT02920723|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351865|NCT02920710||Single Group Assignment||Treatment||None (Open Label)||||||
1351866|NCT02920697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1351867|NCT02920684|Randomized|Crossover Assignment||Treatment||Single|||t|||
1351868|NCT02920671|||Case-Control||Cross-Sectional|||||||
1351869|NCT02920658|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351870|NCT02920645|||Case-Only||Retrospective|||||||
1351871|NCT02920632|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351872|NCT02920619|||Case-Only||Cross-Sectional|||||||
1351873|NCT02920606|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351874|NCT02920593|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351875|NCT02920580|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1351876|NCT02920567|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351877|NCT02920554|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351878|NCT02920541||Single Group Assignment||Treatment||None (Open Label)||||||
1351879|NCT02920528|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351880|NCT02920515|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351881|NCT02920502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351882|NCT02920489|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351883|NCT02920476||Single Group Assignment||Treatment||None (Open Label)||||||
1351884|NCT02920463|||Cohort||Prospective|||||||
1351885|NCT02920450||Single Group Assignment||Treatment||None (Open Label)||||||
1351886|NCT02920437|Randomized|Parallel Assignment||Treatment||Single||||||t
1351887|NCT02920424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351888|NCT02920411||Single Group Assignment||Treatment||None (Open Label)||||||
1351889|NCT02920398|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1351890|NCT02920385||Single Group Assignment||Treatment||None (Open Label)||||||
1351891|NCT02920372||Single Group Assignment||Basic Science||None (Open Label)||||||
1351892|NCT02920359||Single Group Assignment||Basic Science||None (Open Label)||||||
1351893|NCT02920346|||Case-Only||Prospective|||||||
1351894|NCT02920333|Randomized|Parallel Assignment||Treatment||Single||||||t
1351895|NCT02920320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351896|NCT02920307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351897|NCT02920294|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1351898|NCT02920281||||||||||||
1351899|NCT02920268|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1351900|NCT02920255|||Cohort||Prospective|||||||
1351901|NCT02920242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351902|NCT02920229||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351903|NCT02920216||Single Group Assignment||Other||None (Open Label)||||||
1351904|NCT02920203|||Family-Based||Prospective|||||||
1351905|NCT02920190||Single Group Assignment||Treatment||None (Open Label)||||||
1351906|NCT02920177|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351907|NCT02920164|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1351908|NCT02920151|Randomized|Parallel Assignment||Treatment||Single||||||t
1351909|NCT02920138|||Case Control||Prospective|||||||
1351910|NCT02920125|Randomized|Parallel Assignment||Treatment||Triple|"For subjects/patients -Control and Trial medication are packaged in same looking blister / alu alu strips.~For Investigator and Outcome Assessor: no information on patient allocation (trial or Control group)"|Double Blind, Placebo controlled, two arm, on patients of vascular disease / atherosclerosis. Intervention is given in addition to ongoing conventional therapy.|t||t|t
1351911|NCT02920112||Single Group Assignment||Treatment||None (Open Label)||||||
1351912|NCT02920099|||Case-Only||Prospective|||||||
1351913|NCT02920086|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351914|NCT02920073|||Case Control||Prospective|||||||
1351915|NCT02920060|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1351916|NCT02920047|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1351917|NCT02920034|Randomized|Parallel Assignment||Treatment||Single|||t|||
1351918|NCT02920021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351919|NCT02920008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351920|NCT02919995|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1351921|NCT02919982|||Cohort||Prospective|||||||
1351922|NCT02919969||Single Group Assignment||Treatment||None (Open Label)||||||
1351923|NCT02919956|||Cohort||Cross-Sectional|||||||
1351924|NCT02919943|||Cohort||Prospective|||||||
1351925|NCT02919930|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1351995|NCT02919020|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1351996|NCT02919007||Single Group Assignment||Treatment||None (Open Label)||||||
1351997|NCT02918994||Single Group Assignment||Treatment||None (Open Label)||||||
1351998|NCT02918981|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1351999|NCT02918968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352000|NCT02918955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352001|NCT02918942||||||||||||
1352002|NCT02918929|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351926|NCT02919917|Randomized|Parallel Assignment||Treatment||Single|Therapists administering rehabilitation will be blinded to the randomization of patients enrolled in the study.|Newly injured individuals with SCI will be eligible to participate if they demonstrate hypotension (systolic blood pressure </= 110 mmHg in males or </= 100 mmHg in females) upon admission to acute in-patient rehabilitation at Mount Sinai Medical Center, New York, NY. Eligible participants will be randomized to usual care (administered anti-hypotensive therapy only if they demonstrate symptoms of hypotension: dizziness, lightheadedness, nausea, blurred vision, syncope) or treatment of hypotension based on a systolic blood pressure below the hypotensive threshold. Time spent in active rehabilitation program will be compared between the usual care and treatment groups.||t||
1351927|NCT02919904|||Cohort||Prospective|||||||
1351928|NCT02919891|||Other||Retrospective|||||||
1351929|NCT02919878||Single Group Assignment||Treatment||None (Open Label)||||||
1351930|NCT02919865||Single Group Assignment||Treatment||None (Open Label)||||||
1351931|NCT02919852||Single Group Assignment||Treatment||None (Open Label)||||||
1351932|NCT02919839|||Case-Only||Prospective|||||||
1351933|NCT02919826|Randomized|Parallel Assignment||Treatment||Single||||||t
1351934|NCT02919813|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1351935|NCT02919800|Randomized|Parallel Assignment||Other||Single|||t|||
1351936|NCT02919787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351937|NCT02919774|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1351938|NCT02919761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351939|NCT02919748|Randomized|Parallel Assignment||Prevention||Single||||||t
1351940|NCT02919735|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1351941|NCT02919722||Single Group Assignment||Treatment||None (Open Label)||||||
1351942|NCT02919709||Single Group Assignment||Prevention||None (Open Label)||||||
1351943|NCT02919696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351944|NCT02919683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351945|NCT02919670|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1351946|NCT02919657|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1351947|NCT02919644||Single Group Assignment||Treatment||None (Open Label)||||||
1351948|NCT02919631|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1351949|NCT02919618||Single Group Assignment||Treatment||None (Open Label)||||||
1351950|NCT02919605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351951|NCT02919592|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351952|NCT02919579|Randomized|Crossover Assignment||Treatment||Single|||t|||
1351953|NCT02919566||||||||||||
1351954|NCT02919553|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1351955|NCT02919540|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1351956|NCT02919527|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1351957|NCT02919514|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1351958|NCT02919501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351959|NCT02919488|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1351960|NCT02919475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351961|NCT02919462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351962|NCT02919449||Single Group Assignment||Treatment||None (Open Label)||||||
1351963|NCT02919436|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1351964|NCT02919423|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1351965|NCT02919410||||Prevention||||||||
1351966|NCT02919397|Randomized|Parallel Assignment||Prevention||Single||||||t
1351967|NCT02919384|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1351968|NCT02919371||Single Group Assignment||Treatment||None (Open Label)||||||
1351969|NCT02919358|Randomized|Parallel Assignment||Basic Science||Single||||||t
1351970|NCT02919345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351971|NCT02919332|||Cohort||Prospective|||||||
1351972|NCT02919319|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1351973|NCT02919306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1351974|NCT02919293|Randomized|Parallel Assignment||Prevention||Single|||t|||
1351975|NCT02919280|||Cohort||Prospective|||||||
1351976|NCT02919267|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1351977|NCT02919254|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1351978|NCT02919241|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351979|NCT02919228|Randomized|Crossover Assignment||Basic Science||Single||||||t
1351980|NCT02919215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1351981|NCT02919202|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1351982|NCT02919189|Randomized|Crossover Assignment||Basic Science||Single||||||t
1351983|NCT02919176|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1351984|NCT02919163|Randomized|Crossover Assignment||Basic Science||Single||||||t
1351985|NCT02919150|||Case-Only||Cross-Sectional|||||||
1351986|NCT02919137|Randomized|Crossover Assignment||Basic Science||Single||||||t
1351987|NCT02919124||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351988|NCT02919111||Single Group Assignment||Diagnostic||None (Open Label)||||||
1351989|NCT02919098|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1351990|NCT02919085||Single Group Assignment||Treatment||None (Open Label)||||||
1351991|NCT02919072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1351992|NCT02919059|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1351993|NCT02919046||Single Group Assignment||Treatment||None (Open Label)||||||
1351994|NCT02919033|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352382|NCT02913989|||||Cross-Sectional|||||||
1352003|NCT02918916|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352004|NCT02918903|Randomized|Parallel Assignment||Treatment||Single||||||t
1352005|NCT02918890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352006|NCT02918877|Randomized|Parallel Assignment||Prevention||Single||||||t
1352007|NCT02918864|Randomized|Parallel Assignment||Treatment||Single||||||t
1352008|NCT02918851|Randomized|Parallel Assignment||Other||Single|||t|||
1352009|NCT02918838|Randomized|Parallel Assignment||Treatment||Single||||||t
1352010|NCT02918825|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352011|NCT02918812|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1352012|NCT02918799||Single Group Assignment||Prevention||None (Open Label)||Intervention will be evaluated with community cohort and use of pre- post-intervention analysis plan||||
1352013|NCT02918786|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352014|NCT02918773|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352015|NCT02918760|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352016|NCT02918747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352017|NCT02918734|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352018|NCT02918721|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352019|NCT02918708|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352020|NCT02918695|||Cohort||Prospective|||||||
1352021|NCT02918682|Randomized|Parallel Assignment||Treatment||Single||||t||
1352022|NCT02918669||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352023|NCT02918656|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1352024|NCT02918643|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1352025|NCT02918630|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352026|NCT02918617|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352027|NCT02918604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352028|NCT02918591||Single Group Assignment||Treatment||None (Open Label)||||||
1352029|NCT02918578|Randomized|Parallel Assignment||Prevention||Single||||||t
1352030|NCT02918565|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1352031|NCT02918552|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352032|NCT02918539|||Other||Prospective|||||||
1352033|NCT02918526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352034|NCT02918513||Single Group Assignment||Treatment||None (Open Label)||||||
1352035|NCT02918500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352036|NCT02918487|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1352037|NCT02918474|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352038|NCT02918461||Single Group Assignment||Supportive Care||None (Open Label)||||||
1352039|NCT02918448|Randomized|Factorial Assignment||Treatment||Single|||t|||
1352040|NCT02918435|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1352041|NCT02918422|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1352042|NCT02918409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352043|NCT02918396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352044|NCT02918383||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352045|NCT02918370|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352046|NCT02918357||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352047|NCT02918344|||Cohort||Prospective|||||||
1352048|NCT02918331||Single Group Assignment||Treatment||None (Open Label)||||||
1352049|NCT02918318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352050|NCT02918305|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352051|NCT02918292||Single Group Assignment||Treatment||None (Open Label)||||||
1352052|NCT02918279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352053|NCT02918266|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1352054|NCT02918253|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1352055|NCT02918240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352056|NCT02918227||Single Group Assignment||Other||None (Open Label)||||||
1352057|NCT02918214|||Cohort||Prospective|||||||
1352058|NCT02918201|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1352059|NCT02918188||Single Group Assignment||Treatment||None (Open Label)||||||
1352060|NCT02918175|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352061|NCT02918162||Single Group Assignment||Treatment||None (Open Label)||||||
1352062|NCT02918149|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352063|NCT02918136|Randomized|Parallel Assignment||Treatment||Single||||||t
1352064|NCT02918123||Single Group Assignment||Treatment||None (Open Label)||||||
1352065|NCT02918110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352066|NCT02918097||Single Group Assignment||Treatment||None (Open Label)||||||
1352067|NCT02918084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352068|NCT02918071||Single Group Assignment||Treatment||None (Open Label)||||||
1352069|NCT02918058|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1352070|NCT02918045|Randomized|Crossover Assignment||Treatment||Single|||t|||
1352071|NCT02918032|||Cohort||Other|||||||
1352072|NCT02918019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352073|NCT02918006|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1352074|NCT02917993||Single Group Assignment||Treatment||None (Open Label)||||||
1352075|NCT02917980|||Cohort||Prospective|||||||
1352076|NCT02917967||Single Group Assignment||Treatment||None (Open Label)||||||
1352077|NCT02917954|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||Stepped-wedge randomized trial. Group 1: 3 month control period followed by a 12 month intervention period. Group 2: 6 month control period followed by a 9 month intervention period.||||
1352078|NCT02917941||Single Group Assignment||Treatment||None (Open Label)||||||
1352079|NCT02917928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352080|NCT02917915|Randomized|Parallel Assignment||Treatment||Single||||||t
1352081|NCT02917902|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1352082|NCT02917889|Randomized|Crossover Assignment||||Single|||t|||
1352083|NCT02917876|||Cohort||Prospective|||||||
1352084|NCT02917863|Randomized|Crossover Assignment||||None (Open Label)||||||
1352085|NCT02917850|Randomized|Parallel Assignment||Treatment||Single||||||t
1352086|NCT02917837|Randomized|Factorial Assignment||Health Services Research||Quadruple|||t|t|t|t
1352087|NCT02917824|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352088|NCT02917811|||Cohort||Prospective|||||||
1352089|NCT02917798|||Cohort||Prospective|||||||
1352090|NCT02917785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352091|NCT02917772||Single Group Assignment||Treatment||None (Open Label)||||||
1352092|NCT02917759|||Cohort||Prospective|||||||
1352093|NCT02917746|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352094|NCT02917733||Single Group Assignment||Basic Science||None (Open Label)||||||
1352095|NCT02917720||Single Group Assignment||Treatment||None (Open Label)||||||
1352096|NCT02917707|||Case Control||Retrospective|||||||
1352097|NCT02917694|||Cohort||Prospective|||||||
1352098|NCT02917681||Single Group Assignment||Treatment||None (Open Label)||||||
1352099|NCT02917668|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1352100|NCT02917655|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1352101|NCT02917642|Randomized|Factorial Assignment||Treatment||Single||||||t
1352102|NCT02917629|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352103|NCT02917616|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1352104|NCT02917603|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352105|NCT02917590|Randomized|Crossover Assignment||Treatment||Single||||||t
1352106|NCT02917577|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1352107|NCT02917564|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352108|NCT02917551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352109|NCT02917538|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1352110|NCT02917525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352111|NCT02917512|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352112|NCT02917499|Randomized|Parallel Assignment||Treatment||Single|||||t|
1352113|NCT02917486|||Case Control||Prospective|||||||
1352114|NCT02917473|Randomized|Parallel Assignment||Screening||Single|||t|||
1352115|NCT02917460||Single Group Assignment||Health Services Research||None (Open Label)||||||
1352116|NCT02917447|Randomized|Parallel Assignment||Treatment||Single||||||t
1352117|NCT02917434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1352118|NCT02917421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352119|NCT02917408|||Cohort||Retrospective|||||||
1352120|NCT02917395||Single Group Assignment||||None (Open Label)||||||
1352121|NCT02917382|||Cohort||Prospective|||||||
1352122|NCT02917369|||Case Control||Retrospective|||||||
1352123|NCT02917356|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352124|NCT02917343||Single Group Assignment||Treatment||None (Open Label)||||||
1352125|NCT02917330|Randomized|Parallel Assignment||Treatment||Single||||||t
1352126|NCT02917317|||Cohort||Prospective|||||||
1352127|NCT02917304||Single Group Assignment||Prevention||None (Open Label)||||||
1352128|NCT02917291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352129|NCT02917278|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352130|NCT02917265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352131|NCT02917252|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1352132|NCT02917239|||Cohort||Cross-Sectional|||||||
1352133|NCT02917226||||||||||||
1352134|NCT02917213|||Cohort||Prospective|||||||
1352135|NCT02917200|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352136|NCT02917187|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1352137|NCT02917174|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1352138|NCT02917161||Single Group Assignment||Treatment||None (Open Label)||||||
1352139|NCT02917148|||Case-Control||Prospective|||||||
1352140|NCT02917135|||Case-Only|||||||||
1352141|NCT02917122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352142|NCT02917109||Single Group Assignment||Treatment||None (Open Label)||||||
1352143|NCT02917096||Single Group Assignment||Supportive Care||None (Open Label)||||||
1352144|NCT02917083||Single Group Assignment||Treatment||None (Open Label)||||||
1352145|NCT02917070|||Case Control||Cross-Sectional|||||||
1352146|NCT02917057|||Cohort||Retrospective|||||||
1352147|NCT02917044|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352148|NCT02917031|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352149|NCT02917018|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1352150|NCT02917005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352151|NCT02916992|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1352152|NCT02916979||Single Group Assignment||Treatment||None (Open Label)||||||
1352153|NCT02916966|||Case-Control||Prospective|||||||
1352154|NCT02916953||||||||||||
1352155|NCT02916940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352156|NCT02916927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352157|NCT02916914|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352158|NCT02916901|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1352159|NCT02916888|||Cohort||Prospective|||||||
1352160|NCT02916875|||Other||Prospective|||||||
1352161|NCT02916862|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1352162|NCT02916849|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1352163|NCT02916836|||Cohort||Prospective|||||||
1352164|NCT02916823||||||||||||
1352165|NCT02916810|Randomized|Parallel Assignment||Other||Double|||t|||t
1352166|NCT02916797|Randomized|Parallel Assignment||Treatment||Single||||||t
1352167|NCT02916784|||Case-Crossover||Cross-Sectional|||||||
1352168|NCT02916771||Single Group Assignment||Treatment||None (Open Label)||||||
1352169|NCT02916758||Single Group Assignment||Prevention||None (Open Label)||||||
1352170|NCT02916745||Single Group Assignment||Treatment||None (Open Label)||||||
1352171|NCT02916732|||Cohort||Prospective|||||||
1352172|NCT02916719||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352173|NCT02916706||Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352174|NCT02916693||Single Group Assignment||Treatment||None (Open Label)||||||
1352175|NCT02916680||Single Group Assignment||Treatment||None (Open Label)||||||
1352176|NCT02916667|Randomized|Parallel Assignment||Prevention||Single|||t|||
1352177|NCT02916654|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352178|NCT02916641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352179|NCT02916628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352180|NCT02916615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352181|NCT02916602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352182|NCT02916589|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1352183|NCT02916576||||||||||||
1352184|NCT02916563||||||||||||
1352185|NCT02916550||Single Group Assignment||Treatment||None (Open Label)||||||
1352186|NCT02916537|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1352187|NCT02916524|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352188|NCT02916511||Single Group Assignment||Treatment||None (Open Label)||||||
1352189|NCT02916498|Randomized|Crossover Assignment||Other||Double|||t|||t
1352190|NCT02916485||Single Group Assignment||Treatment||None (Open Label)||||||
1352191|NCT02916472|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352192|NCT02916459|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1352193|NCT02916446|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352194|NCT02916433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352195|NCT02916420||Single Group Assignment||Treatment||None (Open Label)||||||
1352196|NCT02916407|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1352197|NCT02916394|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1352198|NCT02916381|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352199|NCT02916368|||Case Control||Prospective|||||||
1352200|NCT02916355|Randomized|Crossover Assignment||Other||Double|||t||t|
1352201|NCT02916342|Randomized|Parallel Assignment||Other||Single||||||t
1352202|NCT02916329|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1352203|NCT02916316|||Cohort||Prospective|||||||
1352204|NCT02916303|||Case-Only||Retrospective|||||||
1352205|NCT02916290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352206|NCT02916277|||Cohort||Prospective|||||||
1352207|NCT02916264|Randomized|Parallel Assignment||Prevention||Single|||t|||
1352208|NCT02916251|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1352209|NCT02916238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352210|NCT02916225|Randomized|Parallel Assignment||Treatment||Single||||||t
1352211|NCT02916212|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1352212|NCT02916199|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352213|NCT02916186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352214|NCT02916173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352215|NCT02916160||Single Group Assignment||Other||None (Open Label)||||||
1352216|NCT02916147|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1352217|NCT02916134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352218|NCT02916121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352219|NCT02916108|||Case Control||Prospective|||||||
1352220|NCT02916095||Single Group Assignment||Treatment||None (Open Label)||||||
1352221|NCT02916082|||Case-Only||Prospective|||||||
1352222|NCT02916069|Randomized|Parallel Assignment||Screening||Triple|||t|t||t
1352223|NCT02916056||Single Group Assignment||Treatment||None (Open Label)||||||
1352224|NCT02916043|||Cohort||Retrospective|||||||
1352225|NCT02916030|||Case-Control||Prospective|||||||
1352226|NCT02916017|||Cohort||Prospective|||||||
1352227|NCT02916004||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352228|NCT02915991|||Case-Only||Prospective|||||||
1352229|NCT02915978|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352230|NCT02915965||Single Group Assignment||Treatment||None (Open Label)||||||
1352231|NCT02915952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352232|NCT02915939|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1352233|NCT02915926|Randomized|Parallel Assignment||Treatment||Single||||||t
1352234|NCT02915913|Randomized|Factorial Assignment||Prevention||Single|||||t|
1352235|NCT02915900|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1352236|NCT02915887||Single Group Assignment||Treatment||None (Open Label)||||||
1352237|NCT02915874|Randomized|Parallel Assignment||Treatment||Single||||||t
1352238|NCT02915861|||Case-Control||Prospective|||||||
1352239|NCT02915848|||Cohort||Prospective|||||||
1352240|NCT02915835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352241|NCT02915822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352242|NCT02915809|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1352243|NCT02915796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352244|NCT02915783||Single Group Assignment||Treatment||None (Open Label)||||||
1352245|NCT02915770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352246|NCT02915757||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352247|NCT02915744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352248|NCT02915731|||Cohort||Prospective|||||||
1352249|NCT02915718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352250|NCT02915705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352251|NCT02915692|||Cohort||Retrospective|||||||
1352252|NCT02915679||Single Group Assignment||||None (Open Label)||||||
1352253|NCT02915666||Single Group Assignment||Treatment||None (Open Label)||||||
1352254|NCT02915653|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1352255|NCT02915640|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352256|NCT02915627|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352257|NCT02915614|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1352258|NCT02915601|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352259|NCT02915588|Randomized|Parallel Assignment||Treatment||Single||||||t
1352260|NCT02915575|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1352261|NCT02915562|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1352262|NCT02915549|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352263|NCT02915536|||||Cross-Sectional|||||||
1352264|NCT02915523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352265|NCT02915510||Single Group Assignment||Supportive Care||None (Open Label)||||||
1352266|NCT02915497|Randomized|Parallel Assignment||Prevention||Single|||t|||
1352267|NCT02915484|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1352268|NCT02915471|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1352269|NCT02915458|||Case-Control||Prospective|||||||
1352270|NCT02915445||Single Group Assignment||Treatment||None (Open Label)||||||
1352271|NCT02915432|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1352272|NCT02915419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352273|NCT02915406||||||||||||
1352274|NCT02915393|||Case Control||Cross-Sectional|||||||
1352275|NCT02915380|||Cohort||Prospective|||||||
1352276|NCT02915367|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352277|NCT02915354||Single Group Assignment||Prevention||None (Open Label)||||||
1352278|NCT02915341|||Other||Other|||||||
1352279|NCT02915328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352280|NCT02915315|||Case-Only||Prospective|||||||
1352281|NCT02915302|Randomized|Parallel Assignment||Prevention||Single||||||t
1352282|NCT02915289|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352283|NCT02915276|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1352284|NCT02915263|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352285|NCT02915250|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1352286|NCT02915237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352287|NCT02915224|||Case-Only||Prospective|||||||
1352288|NCT02915211||Single Group Assignment||Treatment||None (Open Label)||||||
1352289|NCT02915198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352290|NCT02915185|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352291|NCT02915172||Single Group Assignment||Treatment||None (Open Label)||||||
1352292|NCT02915159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352293|NCT02915146|Randomized|Parallel Assignment||Treatment||Single||||||t
1352294|NCT02915133|||Case-Only||Prospective|||||||
1352295|NCT02915120|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1352296|NCT02915107|Randomized|Parallel Assignment||Treatment||Single||||||t
1352297|NCT02915094|||Cohort||Prospective|||||||
1352298|NCT02915081|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1352299|NCT02915068|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1352300|NCT02915055|||Case-Control||Prospective|||||||
1352301|NCT02915042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352302|NCT02915029|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1352303|NCT02915016|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1352304|NCT02915003|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1352305|NCT02914990||Single Group Assignment||Treatment||None (Open Label)||||||
1352306|NCT02914977||Single Group Assignment||Treatment||None (Open Label)||||||
1352307|NCT02914964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352308|NCT02914951||Single Group Assignment||Treatment||None (Open Label)||||||
1352383|NCT02913976|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352384|NCT02913963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352385|NCT02913950|||Other||Other|||||||
1352386|NCT02913937|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352309|NCT02914938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a two-arm, Phase 1b, open-label, dose escalation study of ME-401 alone and an open label study of ME-401 in combination with rituximab in patients with relapsed/refractory B-cell malignancies. The two arms of the study will be conducted in parallel, with subject allocation to ME-401 alone or ME-401 plus rituximab based on disease type and availability of an open enrollment slot.||||
1352310|NCT02914925||Single Group Assignment||Treatment||None (Open Label)||||||
1352311|NCT02914912|||Cohort||Prospective|||||||
1352312|NCT02914899|||Cohort||Prospective|||||||
1352313|NCT02914886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352314|NCT02914873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352315|NCT02914860|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352316|NCT02914847|Randomized|Parallel Assignment||Treatment||Single||||||t
1352317|NCT02914834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352318|NCT02914821|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1352319|NCT02914808|||Other||Prospective|||||||
1352320|NCT02914795|||Case Control||Prospective|||||||
1352321|NCT02914782|||Cohort||Prospective|||||||
1352322|NCT02914769|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352323|NCT02914756|||Cohort||Prospective|||||||
1352324|NCT02914743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352325|NCT02914730|||Cohort||Cross-Sectional|||||||
1352326|NCT02914717|||Cohort||Retrospective|||||||
1352327|NCT02914704||Single Group Assignment||Treatment||None (Open Label)||||||
1352328|NCT02914691|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1352329|NCT02914678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352330|NCT02914665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352331|NCT02914652|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1352332|NCT02914639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352333|NCT02914626|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352334|NCT02914613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352335|NCT02914600|Non-Randomized|Parallel Assignment||Treatment||Double|Only 3 arms are blinded in this study.||t||t|
1352336|NCT02914587|Randomized|Crossover Assignment||Treatment||Single||||||t
1352337|NCT02914574||Single Group Assignment||Treatment||None (Open Label)||||||
1352338|NCT02914561|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352339|NCT02914548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352340|NCT02914535|Non-Randomized|Parallel Assignment||Treatment||Double|Only 3 arms are blinded in this study.||t||t|
1352341|NCT02914522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352342|NCT02914509|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352343|NCT02914496|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352344|NCT02914483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352345|NCT02914470||Single Group Assignment||Treatment||None (Open Label)||||||
1352346|NCT02914457|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1352347|NCT02914444|||Cohort||Prospective|||||||
1352348|NCT02914431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352349|NCT02914418|Randomized|Crossover Assignment||Treatment||Single|||t|||
1352350|NCT02914405||Single Group Assignment||Treatment||None (Open Label)||||||
1352351|NCT02914392|||Case-Control||Cross-Sectional|||||||
1352352|NCT02914379||Single Group Assignment||Basic Science||None (Open Label)||||||
1352353|NCT02914366|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352354|NCT02914353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352355|NCT02914340||Single Group Assignment||Treatment||None (Open Label)||||||
1352356|NCT02914327||Single Group Assignment||Treatment||None (Open Label)||||||
1352357|NCT02914314||Single Group Assignment||Treatment||None (Open Label)||||||
1352358|NCT02914301|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352359|NCT02914288|||Cohort||Prospective|||||||
1352360|NCT02914275|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1352361|NCT02914262|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352362|NCT02914249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352363|NCT02914236||Single Group Assignment||Treatment||None (Open Label)||||||
1352364|NCT02914223|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1352365|NCT02914210|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352366|NCT02914197|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1352367|NCT02914184|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1352368|NCT02914171|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352369|NCT02914158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352370|NCT02914145||Single Group Assignment||Treatment||None (Open Label)||||||
1352371|NCT02914132||Single Group Assignment||Treatment||None (Open Label)||||||
1352372|NCT02914119|||Other||Cross-Sectional|||||||
1352373|NCT02914106|||Case Control||Prospective|||||||
1352374|NCT02914093||Single Group Assignment||Treatment||None (Open Label)||||||
1352375|NCT02914080|||Other||Prospective|||||||
1352376|NCT02914067|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352377|NCT02914054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352378|NCT02914041|||Other||Cross-Sectional|||||||
1352379|NCT02914028|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1352380|NCT02914015|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1352381|NCT02914002|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352387|NCT02913924|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352388|NCT02913911|Randomized|Parallel Assignment||Other||Single||||||t
1352389|NCT02913898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352390|NCT02913885|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352391|NCT02913872|||Other||Prospective|||||||
1352392|NCT02913859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352393|NCT02913846|||Cohort||Prospective|||||||
1352394|NCT02913833|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352395|NCT02913820|||Cohort||Retrospective|||||||
1352396|NCT02913807|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352397|NCT02913794|||Other||Cross-Sectional|||||||
1352398|NCT02913781||Single Group Assignment||Treatment||None (Open Label)||||||
1352399|NCT02913768|Randomized|Parallel Assignment||Prevention||Double||||t||t
1352400|NCT02913755|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1352401|NCT02913742||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352402|NCT02913729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352403|NCT02913716||Single Group Assignment||Other||None (Open Label)||||||
1352404|NCT02913703|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1352405|NCT02913690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352406|NCT02913677|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352407|NCT02913664|Randomized|Factorial Assignment||Prevention||Single||||||t
1352408|NCT02913651|||Cohort||Retrospective|||||||
1352409|NCT02913638|||Other||Cross-Sectional|||||||
1352410|NCT02913625|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1352411|NCT02913612|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352412|NCT02913573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352413|NCT02913560||||||||||||
1352414|NCT02913547||Single Group Assignment||Treatment||None (Open Label)||||||
1352415|NCT02913534|||Case-Only||Retrospective|||||||
1352416|NCT02913521|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1352417|NCT02913508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352418|NCT02913495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352419|NCT02913482|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1352420|NCT02913469|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352421|NCT02913456|||Cohort||Prospective|||||||
1352422|NCT02913443|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1352423|NCT02913430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352424|NCT02913417||Single Group Assignment||Treatment||None (Open Label)||||||
1352425|NCT02913404|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1352426|NCT02913391|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352427|NCT02913378|Randomized|Parallel Assignment||Treatment||Single||||||t
1352428|NCT02913365|||Cohort||Retrospective|||||||
1352429|NCT02913352|Randomized|Parallel Assignment||Treatment||Single||||||t
1352430|NCT02913339|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1352431|NCT02913326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352432|NCT02913313|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352433|NCT02913300|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1352434|NCT02913287|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1352435|NCT02913274|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352436|NCT02913261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352437|NCT02913248||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352438|NCT02913235||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352439|NCT02913222|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1352440|NCT02913209|||Cohort||Cross-Sectional|||||||
1352441|NCT02913196||Single Group Assignment||Treatment||None (Open Label)||||||
1352442|NCT02913183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352443|NCT02913170|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1352444|NCT02913157||Single Group Assignment||Treatment||None (Open Label)||||||
1352445|NCT02913144|||Cohort||Prospective|||||||
1352446|NCT02913131|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1352447|NCT02913118|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1352448|NCT02913105|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352449|NCT02913092|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1352450|NCT02913079|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1352451|NCT02913066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352452|NCT02913053|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352453|NCT02913040|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352454|NCT02913027|Randomized|Parallel Assignment||Prevention||Single||||||t
1352455|NCT02913014|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352456|NCT02913001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352457|NCT02912988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352458|NCT02912975|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1352459|NCT02912962|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352460|NCT02912949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352461|NCT02912936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352462|NCT02912923|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1352463|NCT02912910|||Case-Only||Prospective|||||||
1352464|NCT02912897||Single Group Assignment||Treatment||None (Open Label)||||||
1352465|NCT02912884|||Cohort||Prospective|||||||
1352466|NCT02912871||Single Group Assignment||Treatment||None (Open Label)||||||
1352467|NCT02912858||Single Group Assignment||Other||None (Open Label)||||||
1352468|NCT02912845||Single Group Assignment||Treatment||None (Open Label)||||||
1352469|NCT02912832||Single Group Assignment||Diagnostic||Double|||||t|t
1352470|NCT02912819|||Case-Only||Prospective|||||||
1352471|NCT02912806|||Cohort||Prospective|||||||
1352472|NCT02912793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352473|NCT02912780|||||Prospective|||||||
1352474|NCT02912767|||Cohort||Retrospective|||||||
1352475|NCT02912754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352476|NCT02912741|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352477|NCT02912728|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1352478|NCT02912715||Single Group Assignment||Treatment||None (Open Label)||||||
1352479|NCT02912702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352480|NCT02912689|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352481|NCT02912676||Single Group Assignment||Treatment||None (Open Label)||||||
1352482|NCT02912663|Randomized|Parallel Assignment||Treatment||Single||||||t
1352483|NCT02912650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352484|NCT02912637|||Other||Cross-Sectional|||||||
1352485|NCT02912624|||Cohort||Prospective|||||||
1352486|NCT02912611||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352487|NCT02912598|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352488|NCT02912585|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1352489|NCT02912572|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352490|NCT02912559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352491|NCT02912546|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1352492|NCT02912533||||||||||||
1352493|NCT02912520|||Cohort||Prospective|||||||
1352494|NCT02912507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352495|NCT02912494||||||||||||
1352496|NCT02912481|Randomized|Parallel Assignment||Other||Single||||||t
1352497|NCT02912468|Randomized|Parallel Assignment||Treatment||Single||||t||
1352498|NCT02912455|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352499|NCT02912442|||Cohort||Prospective|||||||
1352500|NCT02912429|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352501|NCT02912416|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1352502|NCT02912403|||Case-Only||Prospective|||||||
1352503|NCT02912390|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352504|NCT02912377|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1352505|NCT02912364|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1352506|NCT02912351|||Cohort||Retrospective|||||||
1352507|NCT02912338|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1352508|NCT02912325||Single Group Assignment||Other||None (Open Label)||||||
1352509|NCT02912312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352510|NCT02912299|||Case-Control||Prospective|||||||
1352511|NCT02912286|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352512|NCT02912273|||Cohort||Prospective|||||||
1352513|NCT02912260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352514|NCT02912247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352515|NCT02912234||Single Group Assignment||Basic Science||None (Open Label)||||||
1352516|NCT02912221|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1352517|NCT02912208|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352518|NCT02912195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352519|NCT02912182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352520|NCT02912169||Single Group Assignment||Treatment||None (Open Label)||||||
1352521|NCT02912156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352522|NCT02912143|||Cohort||Prospective|||||||
1352523|NCT02912130|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1352524|NCT02912117|||Case-Only||Prospective|||||||
1352525|NCT02912104||Single Group Assignment||Treatment||None (Open Label)||||||
1352526|NCT02912078|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352527|NCT02912065|||||Retrospective|||||||
1352528|NCT02912052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352529|NCT02912039|||Case-Only||Prospective|||||||
1352530|NCT02912026|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352531|NCT02912013||Single Group Assignment||Treatment||None (Open Label)||||||
1352532|NCT02912000|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352533|NCT02911987|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1352534|NCT02911974|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1352535|NCT02911961|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1352536|NCT02911948|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352537|NCT02911935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352538|NCT02911922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352539|NCT02911909|Randomized|Parallel Assignment||Treatment||Single||||||t
1352540|NCT02911896|||Cohort||Prospective|||||||
1352541|NCT02911883|||Cohort||Prospective|||||||
1352542|NCT02911870|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1352543|NCT02911857||Single Group Assignment||Treatment||None (Open Label)||||||
1352544|NCT02911844||Single Group Assignment||Treatment||None (Open Label)||||||
1352545|NCT02911831|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1352546|NCT02911818|Randomized|Parallel Assignment||Treatment||None (Open Label)|In the 12 week extension study, participants who are eligible will continue to take liraglutide 3.0 mg in an open fashion. Participants will be randomly assigned in a double-blind fashion to placebo or phentermine.|||||
1352547|NCT02911805|Randomized|Parallel Assignment||Basic Science||Single||||||t
1352548|NCT02911792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352549|NCT02911779||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352550|NCT02911766|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1352551|NCT02911753|Randomized|Parallel Assignment||Treatment||Single||||||t
1352552|NCT02911740|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1352553|NCT02911727|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352554|NCT02911714|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1352555|NCT02911701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352556|NCT02911688|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1352557|NCT02911675|||Cohort||Prospective|||||||
1352558|NCT02911662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352559|NCT02911649|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352560|NCT02911636||Single Group Assignment||Treatment||None (Open Label)||||||
1352561|NCT02911623||Single Group Assignment||Treatment||None (Open Label)||||||
1352562|NCT02911610|Randomized|Parallel Assignment||Treatment||Single||||||t
1352563|NCT02911597|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1352564|NCT02911584|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352565|NCT02911571||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352566|NCT02911558|||Cohort||Retrospective|||||||
1352567|NCT02911545|||Cohort||Prospective|||||||
1352568|NCT02911532||Single Group Assignment||Treatment||None (Open Label)||||||
1352569|NCT02911519|Randomized|Parallel Assignment||Treatment||Single||||||t
1352570|NCT02911506|||Case-Control||Prospective|||||||
1352571|NCT02911493|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1352572|NCT02911480|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1352573|NCT02911467||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352574|NCT02911454||Single Group Assignment||Other||None (Open Label)||||||
1352575|NCT02911441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352576|NCT02911428|||Cohort||Prospective|||||||
1352577|NCT02911415|||Cohort||Prospective|||||||
1352578|NCT02911402|||Cohort||Prospective|||||||
1352579|NCT02911389||||||||||||
1352580|NCT02911376||||||||||||
1352581|NCT02911363|Randomized|Parallel Assignment||Screening||Single||||t||
1352582|NCT02911350||Single Group Assignment||Treatment||None (Open Label)||||||
1352583|NCT02911337||Single Group Assignment||Treatment||None (Open Label)||||||
1352584|NCT02911324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352585|NCT02911311|Randomized|Parallel Assignment||Treatment||Single||||||t
1352586|NCT02911298|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1352587|NCT02911285|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352588|NCT02911272|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1352589|NCT02911259|Randomized|Parallel Assignment||Treatment||Single||||t||
1352590|NCT02911246|||Cohort||Prospective|||||||
1352591|NCT02911233|||||Prospective|||||||
1352592|NCT02911220||Single Group Assignment||||None (Open Label)||||||
1352593|NCT02911207|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1352594|NCT02911194|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1352595|NCT02911181|||Cohort||Prospective|||||||
1352596|NCT02911168|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1352597|NCT02911155|||Cohort||Prospective|||||||
1352598|NCT02911142||Sequential Assignment||Treatment||None (Open Label)||||||
1352599|NCT02911129|||Case-Crossover||Cross-Sectional|||||||
1352600|NCT02911116||Single Group Assignment||Treatment||None (Open Label)||||||
1352601|NCT02911103||Single Group Assignment||Treatment||None (Open Label)||||||
1352602|NCT02911090|||Cohort||Prospective|||||||
1352603|NCT02911077|||Other||Prospective|||||||
1352604|NCT02911064|||Cohort||Prospective|||||||
1352605|NCT02911051||Single Group Assignment||Supportive Care||None (Open Label)||||||
1352606|NCT02911038|||Cohort||Prospective|||||||
1352607|NCT02911025|||Cohort||Prospective|||||||
1352608|NCT02911012|||Cohort||Retrospective|||||||
1352609|NCT02910999|||Cohort||Prospective|||||||
1352610|NCT02910986|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1352611|NCT02910973|Randomized|Single Group Assignment||Other||Single|||t|||
1352612|NCT02910960|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1352613|NCT02910947|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1352614|NCT02910934|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1352615|NCT02910921|||Cohort||Prospective|||||||
1352616|NCT02910908|||Cohort||Prospective|||||||
1352617|NCT02910895||Single Group Assignment||Basic Science||None (Open Label)||||||
1352618|NCT02910882||Single Group Assignment||Treatment||None (Open Label)||||||
1352619|NCT02910869|||Case Control||Retrospective|||||||
1352620|NCT02910856|||Cohort||Prospective|||||||
1352621|NCT02910843||Single Group Assignment||Treatment||None (Open Label)||||||
1352622|NCT02910830|||Cohort||Prospective|||||||
1352623|NCT02910817|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1352624|NCT02910804||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352625|NCT02910791|||Case Control||Prospective|||||||
1352626|NCT02910778|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352627|NCT02910765|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1352628|NCT02910752||Single Group Assignment||Treatment||None (Open Label)||||||
1352629|NCT02910739|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352630|NCT02910726||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352631|NCT02910713||||||||||||
1352632|NCT02910700|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352633|NCT02910687|||Cohort||Retrospective|||||||
1352634|NCT02910674||||||||||||
1352635|NCT02910661|||Cohort||Cross-Sectional|||||||
1352636|NCT02910648|Randomized|Single Group Assignment||Treatment||Triple|We have adopted a randomized placebo control experimental design which requires the subjects to be blind to the subject's group assignment to minimize expectancy effects and the testing technician to be partially blind (blind to the sound cue group assignment and not blind to the go/no-go task) to minimize technician bias that could comprise the causal conclusions from being drawn.||t|t|t|
1352637|NCT02910635|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1352638|NCT02910622|||Cohort||Prospective|||||||
1352639|NCT02910609|||Cohort||Prospective|||||||
1352640|NCT02910596|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352641|NCT02910583|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352642|NCT02910570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352643|NCT02910557|||Cohort||Prospective|||||||
1352644|NCT02910544|||Cohort||Prospective|||||||
1352645|NCT02910531|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1352646|NCT02910518|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1352647|NCT02910505||Single Group Assignment||Treatment||None (Open Label)||||||
1352648|NCT02910492||Single Group Assignment||Treatment||None (Open Label)||||||
1352649|NCT02910479||Single Group Assignment||Basic Science||None (Open Label)||||||
1352650|NCT02910466||Single Group Assignment||Treatment||None (Open Label)||||||
1352651|NCT02910453|||Case Control||Prospective|||||||
1352652|NCT02910440||||Treatment||||||||
1352653|NCT02910427|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1352654|NCT02910414|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352655|NCT02910401|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352656|NCT02910388|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352657|NCT02910375|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1352658|NCT02910362|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1352659|NCT02910349|||Cohort||Prospective|||||||
1352660|NCT02910336|||Case-Control||Cross-Sectional|||||||
1352661|NCT02910323|||Cohort||Prospective|||||||
1352662|NCT02910310|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1352663|NCT02910297|||Case-Crossover||Prospective|||||||
1352664|NCT02910284|||Cohort||Prospective|||||||
1352665|NCT02910271|||Cohort||Cross-Sectional|||||||
1352666|NCT02910258|||Cohort||Prospective|||||||
1352667|NCT02910245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352668|NCT02910232|||Cohort||Cross-Sectional|||||||
1352669|NCT02910219|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352670|NCT02910206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352671|NCT02910193|||Cohort||Cross-Sectional|||||||
1352672|NCT02910180|||||Prospective|||||||
1352673|NCT02910167|||Cohort||Prospective|||||||
1352674|NCT02910154|Randomized|Parallel Assignment||Prevention||Single||||||t
1352675|NCT02910141|||Cohort||Retrospective|||||||
1352676|NCT02910128|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352677|NCT02910115|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352678|NCT02910102|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1352679|NCT02910089|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352680|NCT02910076|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352681|NCT02910063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352682|NCT02910050||Single Group Assignment||Treatment||None (Open Label)||||||
1352683|NCT02910037||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352684|NCT02910024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352685|NCT02910011||Single Group Assignment||Treatment||None (Open Label)||||||
1352686|NCT02909998|||Case Control||Prospective|||||||
1352687|NCT02909985|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1352688|NCT02909972|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352689|NCT02909959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352690|NCT02909946|Randomized|Parallel Assignment||Prevention||Single||||||t
1352691|NCT02909933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352692|NCT02909920|Randomized|Parallel Assignment||Treatment||Single||||||t
1352693|NCT02909907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352694|NCT02909894|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1352695|NCT02909881||Single Group Assignment||Basic Science||None (Open Label)||||||
1352696|NCT02909868||Single Group Assignment||Basic Science||None (Open Label)||||||
1352697|NCT02909855|||Cohort||Prospective|||||||
1352698|NCT02909842|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1352699|NCT02909829|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1352700|NCT02909816|||Cohort||Prospective|||||||
1352701|NCT02909803|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1352702|NCT02909790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352703|NCT02909777||Single Group Assignment||Treatment||None (Open Label)||||||
1352704|NCT02909764|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1352705|NCT02909751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352706|NCT02909738|||Cohort||Prospective|||||||
1352707|NCT02909725|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352708|NCT02909712|Randomized|Parallel Assignment||Basic Science||Single||||||t
1352709|NCT02909699|||Other||Prospective|||||||
1352710|NCT02909686|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1352711|NCT02909673|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352712|NCT02909660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352713|NCT02909647|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352714|NCT02909634|||Cohort||Prospective|||||||
1352715|NCT02909621|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1352716|NCT02909608|||Case-Control||Prospective|||||||
1352717|NCT02909595|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352718|NCT02909582|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352719|NCT02909569||Single Group Assignment||Treatment||None (Open Label)||||||
1352720|NCT02909556||Single Group Assignment||Treatment||None (Open Label)||||||
1352721|NCT02909543|||Cohort||Retrospective|||||||
1352722|NCT02909530|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1352723|NCT02909517|||Cohort||Prospective|||||||
1352724|NCT02909504||Single Group Assignment||Basic Science||None (Open Label)||||||
1352725|NCT02909491|||Case-Control||Cross-Sectional|||||||
1352726|NCT02909478|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352727|NCT02909465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352728|NCT02909452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352729|NCT02909439|Randomized|Parallel Assignment||Treatment||Single||||||t
1352730|NCT02909426|||Cohort||Prospective|||||||
1352731|NCT02909413|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1352732|NCT02909400|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1352733|NCT02909387|Randomized|Crossover Assignment||Treatment||Single||||||t
1352734|NCT02909374||Single Group Assignment||Prevention||None (Open Label)||||||
1352735|NCT02909361|||Case-Only||Prospective|||||||
1352736|NCT02909348|||Cohort||Prospective|||||||
1352737|NCT02909335|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352738|NCT02909322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352739|NCT02909309||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352740|NCT02909296|||Cohort||Retrospective|||||||
1352741|NCT02909283|||Case-Only||Prospective|||||||
1352742|NCT02909270|Randomized|Parallel Assignment||Prevention||Single|||t|||
1352743|NCT02909257|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1352744|NCT02909244|||Other||Prospective|||||||
1352745|NCT02909231|||Cohort||Prospective|||||||
1352746|NCT02909218|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1352747|NCT02909205|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352748|NCT02909192|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352749|NCT02909179|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352750|NCT02909166|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1352751|NCT02909153|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1352752|NCT02909140|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352753|NCT02909127|||Cohort||Prospective|||||||
1352754|NCT02909114||Single Group Assignment||Treatment||None (Open Label)||||||
1352755|NCT02909101|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352756|NCT02909088|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352757|NCT02909075|||Cohort||Prospective|||||||
1352758|NCT02909062|||Cohort||Prospective|||||||
1352759|NCT02909049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352760|NCT02909036||Single Group Assignment||Treatment||None (Open Label)||||||
1352761|NCT02909023|||Cohort||Prospective|||||||
1352762|NCT02909010|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352763|NCT02908997|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352764|NCT02908984|Randomized|Crossover Assignment||Treatment||Single||||||t
1352765|NCT02908971|||Case Control||Prospective|||||||
1352766|NCT02908958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352767|NCT02908945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352768|NCT02908932|Randomized|Parallel Assignment||Other||Double|||t||t|
1352769|NCT02908919|Randomized|Parallel Assignment||Treatment||Single|||||t|
1352770|NCT02908906||Single Group Assignment||Treatment||None (Open Label)||||||
1352771|NCT02908893|Randomized|Parallel Assignment||Prevention||Single|||t|||
1352772|NCT02908880||Single Group Assignment||Other||None (Open Label)||||||
1352773|NCT02908867|||||Cross-Sectional|||||||
1352774|NCT02908854||Single Group Assignment||Other||None (Open Label)||||||
1352775|NCT02908841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352776|NCT02908828|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352777|NCT02908815|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1352778|NCT02908802|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352779|NCT02908789||Single Group Assignment||Treatment||None (Open Label)||||||
1352780|NCT02908776|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1352781|NCT02908763|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352782|NCT02908750||Single Group Assignment||Treatment||None (Open Label)||||||
1352783|NCT02908737||Single Group Assignment||Treatment||None (Open Label)||||||
1352784|NCT02908724|||Cohort||Retrospective|||||||
1352785|NCT02908711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352786|NCT02908698|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1352787|NCT02908685|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1352788|NCT02908672|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352789|NCT02908659|||Cohort||Prospective|||||||
1352790|NCT02908646|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352791|NCT02908633|Randomized|Parallel Assignment||Treatment||Single|||||t|
1352792|NCT02908620|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1352793|NCT02908607||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352794|NCT02908594|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1352795|NCT02908581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352796|NCT02908568|Randomized|Parallel Assignment||Treatment||Single|||||t|
1352797|NCT02908555|||Case-Only||Cross-Sectional|||||||
1352798|NCT02908542|||Cohort|||||||||
1352799|NCT02908529|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1352800|NCT02908516|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1352801|NCT02908503|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1352802|NCT02908490|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1352803|NCT02908477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352804|NCT02908464|Randomized|Parallel Assignment||Prevention||Single||||||t
1352805|NCT02908451||Single Group Assignment||Treatment||None (Open Label)||||||
1352806|NCT02908438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352807|NCT02908425||Single Group Assignment||Other||None (Open Label)||||||
1352808|NCT02908412|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1352809|NCT02908399||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352810|NCT02908386|||Cohort||Retrospective|||||||
1352811|NCT02908373|||Case Control||Prospective|||||||
1352812|NCT02908360|||Case-Only||Prospective|||||||
1352813|NCT02908347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352814|NCT02908334|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1352815|NCT02908321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352816|NCT02908308|Randomized|Parallel Assignment||Treatment||Triple|The clinical team responsible for the participant (physicians, nurses and others) and involved with direct patient care will not be blinded to allocation group due to the inherent difficulty in blinding the intervention and as temperature is a vital sign required for clinical care. Measures will be taken to ensure that the information about allocation will not disseminate beyond the immediate group of caregivers responsible for patient care. A blinded physician will evaluate the patient at 96 hours after randomisation and make a statement on neurological prognosis.||t||t|t
1352817|NCT02908295|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1352818|NCT02908282|Randomized|Parallel Assignment||Treatment||Single||||||t
1352819|NCT02908269|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352820|NCT02908256|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1352821|NCT02908243|||Cohort|||||||||
1352822|NCT02908230|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352823|NCT02908217|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1352824|NCT02908204|||Cohort||Retrospective|||||||
1352825|NCT02908191|Randomized|Parallel Assignment||Treatment||Single|||||t|
1352826|NCT02908178|||Cohort||Retrospective|||||||
1352827|NCT02908165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352828|NCT02908152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352829|NCT02908139|||Cohort||Prospective|||||||
1352830|NCT02908126|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352831|NCT02908113|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352832|NCT02908100|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352833|NCT02908087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352834|NCT02908074|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352835|NCT02908061|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352836|NCT02908048|||Case-Control||Prospective|||||||
1352837|NCT02908035|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352838|NCT02908022|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1352839|NCT02908009|||Case-Control||Prospective|||||||
1352840|NCT02907996|||Ecologic or Community||Prospective|||||||
1352841|NCT02907983|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1352842|NCT02907970|||Cohort||Cross-Sectional|||||||
1352843|NCT02907957|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1352844|NCT02907944|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1352845|NCT02907931||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352846|NCT02907918||Single Group Assignment||Treatment||None (Open Label)||||||
1352847|NCT02907905||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352848|NCT02907892|Randomized|Parallel Assignment||Other||Single||||||t
1352849|NCT02907879|||Cohort||Prospective|||||||
1352850|NCT02907866|||Case-Only||Cross-Sectional|||||||
1352851|NCT02907853||Single Group Assignment||Treatment||None (Open Label)||||||
1352852|NCT02907840||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352853|NCT02907827|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1352854|NCT02907814|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353171|NCT02903693|||||Cross-Sectional|||||||
1352855|NCT02907801||Single Group Assignment||Treatment||None (Open Label)||||||
1352856|NCT02907788|||Cohort||Prospective|||||||
1352857|NCT02907775|Randomized|Crossover Assignment||Treatment||Single|||||t|
1352858|NCT02907762|||Cohort||Prospective|||||||
1352859|NCT02907749|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352860|NCT02907736|||Other||Cross-Sectional|||||||
1352861|NCT02907723||Single Group Assignment||Other||None (Open Label)||||||
1352862|NCT02907710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352863|NCT02907697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352864|NCT02907684|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1352865|NCT02907671|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352866|NCT02907658|Randomized|Parallel Assignment||Prevention||Single||||||t
1352867|NCT02907645|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1352868|NCT02907632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352869|NCT02907619||||Treatment||None (Open Label)||||||
1352870|NCT02907606|||Case-Only||Prospective|||||||
1352871|NCT02907593|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1352872|NCT02907580|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1352873|NCT02907567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352874|NCT02907554|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352875|NCT02907541|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352876|NCT02907528|Randomized|Parallel Assignment||Treatment||Single||||||t
1352877|NCT02907515|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352878|NCT02907502|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1352879|NCT02907489|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1352880|NCT02907476|Randomized|Parallel Assignment||Treatment||Single||||||t
1352881|NCT02907463|||Other||Other|||||||
1352882|NCT02907450||Single Group Assignment||Treatment||None (Open Label)||||||
1352883|NCT02907437|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352884|NCT02907424|Randomized|Factorial Assignment||Treatment||Single|||||t|
1352885|NCT02907411||Single Group Assignment||Treatment||None (Open Label)||||||
1352886|NCT02907398|||Cohort||Other|||||||
1352887|NCT02907385|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352888|NCT02907372||Single Group Assignment||Diagnostic||None (Open Label)||||||
1352889|NCT02907359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352890|NCT02907346||Single Group Assignment||Treatment||None (Open Label)||||||
1352891|NCT02907333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352892|NCT02907320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352893|NCT02907307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352894|NCT02907294|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352895|NCT02907281|||Other||Prospective|||||||
1352896|NCT02907268|Randomized|Crossover Assignment||Treatment||Single|||t|||
1352897|NCT02907255|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1352898|NCT02907242|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352899|NCT02907229||Single Group Assignment||Treatment||None (Open Label)||||||
1352900|NCT02907216|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352901|NCT02907203||||||||||||
1352902|NCT02907190|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1352903|NCT02907177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352904|NCT02907164|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1352905|NCT02907151|||Cohort||Prospective|||||||
1352906|NCT02907138|Randomized|Parallel Assignment||Treatment||Single||||||t
1352907|NCT02907125|Randomized|Parallel Assignment||Other||Single||||||t
1352908|NCT02907112|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1352909|NCT02907099||Single Group Assignment||Treatment||None (Open Label)||||||
1352910|NCT02907086|||Case-Control||Prospective|||||||
1352911|NCT02907073|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1352912|NCT02907060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352913|NCT02907047||Parallel Assignment||||||||||
1352914|NCT02907034|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1352915|NCT02907021||Single Group Assignment||Treatment||None (Open Label)||||||
1352916|NCT02907008|||Case Control||Prospective|||||||
1352917|NCT02906995|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1352918|NCT02906982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352919|NCT02906969|Randomized|Parallel Assignment||||Single|||||t|
1352920|NCT02906956||Single Group Assignment||Treatment||None (Open Label)||||||
1352921|NCT02906943|||Cohort||Prospective|||||||
1352922|NCT02906930|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352923|NCT02906917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352924|NCT02906904|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1352925|NCT02906891||Single Group Assignment||Prevention||None (Open Label)||||||
1352926|NCT02906878|||Case-Only||Prospective|||||||
1352927|NCT02906865|||Cohort||Prospective|||||||
1352928|NCT02906852|||Cohort||Prospective|||||||
1352929|NCT02906839|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352930|NCT02906826|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1352931|NCT02906813|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1352932|NCT02906800||Single Group Assignment||Treatment||None (Open Label)||||||
1352933|NCT02906787|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352934|NCT02906774|||Cohort||Prospective|||||||
1352935|NCT02906761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352936|NCT02906748|Randomized|Parallel Assignment||Prevention||Single||||||t
1352937|NCT02906735|||Cohort||Prospective|||||||
1352938|NCT02906722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352939|NCT02906709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1352940|NCT02906696||Single Group Assignment||Treatment||None (Open Label)||||||
1352941|NCT02906683|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1352942|NCT02906670|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352943|NCT02906657|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1352944|NCT02906644|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1352945|NCT02906631|||Cohort||Prospective|||||||
1352946|NCT02906618|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1352947|NCT02906605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352948|NCT02906592|||Case-Control||Other|||||||
1352949|NCT02906579|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1352950|NCT02906566|Randomized|Parallel Assignment||Other||Double|||t||t|
1352951|NCT02906553|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1352952|NCT02906540|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352953|NCT02906527|||Cohort||Retrospective|||||||
1352954|NCT02906514|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1352955|NCT02906501|||Case Control||Prospective|||||||
1352956|NCT02906488|||Cohort||Prospective|||||||
1352957|NCT02906475|Randomized|Parallel Assignment||Prevention||Single|||||t|
1352958|NCT02906462|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1352959|NCT02906449|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352960|NCT02906436||Single Group Assignment||Treatment||None (Open Label)||||||
1352961|NCT02906423|||Ecologic or Community||Retrospective|||||||
1352962|NCT02906410|Randomized|Parallel Assignment||Other||Single|||t|||
1352963|NCT02906397||Single Group Assignment||Treatment||None (Open Label)||||||
1352964|NCT02906384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352965|NCT02906371|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352966|NCT02906358|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1352967|NCT02906345|Randomized|Parallel Assignment||Treatment||Single|||t|||
1352968|NCT02906332||Single Group Assignment||Treatment||None (Open Label)||||||
1352969|NCT02906319|||Case-Only||Cross-Sectional|||||||
1352970|NCT02906306|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1352971|NCT02906293|||Case-Only||Prospective|||||||
1352972|NCT02906280|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1352973|NCT02906267|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1352974|NCT02906254|||Cohort||Prospective|||||||
1352975|NCT02906241|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1352976|NCT02906228|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1352977|NCT02906215||Single Group Assignment||Health Services Research||None (Open Label)||||||
1352978|NCT02906202||Single Group Assignment||Treatment||None (Open Label)||||||
1352979|NCT02906189|||Cohort||Prospective|||||||
1352980|NCT02906176|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1352981|NCT02906163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352982|NCT02906150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352983|NCT02906137|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1352984|NCT02906124|||Other||Prospective|||||||
1352985|NCT02906111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352986|NCT02906098|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352987|NCT02906085|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1352988|NCT02906072|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1352989|NCT02906059||Single Group Assignment||Treatment||None (Open Label)||||||
1352990|NCT02906046|Randomized|Crossover Assignment||Treatment||Single|||||t|
1352991|NCT02906033|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1352992|NCT02906020|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1352993|NCT02906007||Single Group Assignment||Treatment||None (Open Label)||||||
1352994|NCT02905994||Single Group Assignment||Treatment||None (Open Label)||||||
1352995|NCT02905981|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1352996|NCT02905968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352997|NCT02905955||Single Group Assignment||Prevention||None (Open Label)||||||
1352998|NCT02905942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1352999|NCT02905929|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1353000|NCT02905916||Single Group Assignment||Prevention||None (Open Label)||||||
1353001|NCT02905903||Single Group Assignment||Other||None (Open Label)||||||
1353002|NCT02905890|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353003|NCT02905877|||Case-Control||Other|||||||
1353004|NCT02905864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353005|NCT02905851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353006|NCT02905838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353007|NCT02905825||Single Group Assignment||Diagnostic||None (Open Label)|The investigator and treating physician will remain blinded to the breath test results until the end of the study. There is only one arm.|A 13C labeled substrate is used as part of a combination product; a diagnostic breath test.||||
1353008|NCT02905812|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1353009|NCT02905799|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1353010|NCT02905786|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1353011|NCT02905773|Randomized|Parallel Assignment||||Double|||t||t|
1353012|NCT02905760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353013|NCT02905747||Single Group Assignment||Treatment||None (Open Label)||||||
1353014|NCT02905734|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353015|NCT02905721||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353016|NCT02905708|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353017|NCT02905695|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353018|NCT02905682|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353019|NCT02905669||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353020|NCT02905656|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1353021|NCT02905643|||Cohort||Prospective|||||||
1353022|NCT02905630|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353023|NCT02905617|||Cohort||Prospective|||||||
1353024|NCT02905604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353025|NCT02905591||Single Group Assignment||Treatment||None (Open Label)||||||
1353026|NCT02905578|Randomized|Parallel Assignment||Treatment||Single||||||t
1353027|NCT02905565|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1353028|NCT02905552|||Case Control||Prospective|||||||
1353029|NCT02905539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353030|NCT02905526|Randomized|Parallel Assignment||Prevention||Single||||||t
1353031|NCT02905513|Randomized|Parallel Assignment||Prevention||Single||||||t
1353032|NCT02905500|||Ecologic or Community||Cross-Sectional|||||||
1353033|NCT02905487|||Cohort||Cross-Sectional|||||||
1353034|NCT02905474|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1353035|NCT02905461|Randomized|Parallel Assignment||Prevention||Single||||||t
1353036|NCT02905448||Single Group Assignment||Prevention||None (Open Label)||||||
1353037|NCT02905435||Single Group Assignment||Treatment||None (Open Label)||||||
1353038|NCT02905422|Randomized|Crossover Assignment||Treatment||Single|||||t|
1353039|NCT02905409|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353040|NCT02905396||Single Group Assignment||Treatment||None (Open Label)||||||
1353041|NCT02905383|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1353042|NCT02905370|Randomized|Parallel Assignment||Treatment||Single||||||t
1353043|NCT02905357|||Cohort||Prospective|||||||
1353044|NCT02905344|||||Prospective|||||||
1353045|NCT02905331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353046|NCT02905318||Single Group Assignment||Treatment||None (Open Label)||||||
1353047|NCT02905305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353048|NCT02905292|||||Prospective|||||||
1353049|NCT02905279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353050|NCT02905266|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353051|NCT02905253|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1353052|NCT02905240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353053|NCT02905227|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353054|NCT02905214|||Cohort||Prospective|||||||
1353055|NCT02905201|||Cohort||Prospective|||||||
1353056|NCT02905188||Single Group Assignment||Treatment||None (Open Label)||||||
1353057|NCT02905175|||Cohort||Prospective|||||||
1353058|NCT02905162|||Cohort||Prospective|||||||
1353059|NCT02905149|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1353060|NCT02905136|||Cohort||Prospective|||||||
1353061|NCT02905123|Randomized|Parallel Assignment||Other||Single|||t|||
1353062|NCT02905110||Single Group Assignment||Treatment||None (Open Label)||||||
1353063|NCT02905097|||Cohort||Prospective|||||||
1353064|NCT02905084|||Cohort||Prospective|||||||
1353065|NCT02905071|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1353066|NCT02905058|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1353067|NCT02905045|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1353068|NCT02905032|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1353069|NCT02905019|Randomized|Parallel Assignment||Prevention||Single||||||t
1353070|NCT02905006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353071|NCT02904993|Randomized|Parallel Assignment||||None (Open Label)||||||
1353072|NCT02904980|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353073|NCT02904967|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353074|NCT02904954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353075|NCT02904941|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1353076|NCT02904928|||Cohort||Prospective|||||||
1353077|NCT02904915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353078|NCT02904902||Single Group Assignment||Treatment||None (Open Label)||||||
1353079|NCT02904889|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353080|NCT02904876||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353081|NCT02904863||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353082|NCT02904850|||Case-Only||Prospective|||||||
1353083|NCT02904837|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1353084|NCT02904824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353085|NCT02904811|Randomized|Parallel Assignment||Prevention||Single|||t|||
1353086|NCT02904798||Single Group Assignment||Prevention||None (Open Label)||||||
1353087|NCT02904785|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1353088|NCT02904772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353089|NCT02904759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353090|NCT02904746|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1353091|NCT02904733||Single Group Assignment||Health Services Research||None (Open Label)||||||
1353092|NCT02904720|||Cohort||Cross-Sectional|||||||
1353093|NCT02904707|||Cohort||Prospective|||||||
1353094|NCT02904694|||Case-Only||Prospective|||||||
1353095|NCT02904681|||Cohort||Retrospective|||||||
1353096|NCT02904668|Randomized|Parallel Assignment||Treatment||Single||||||t
1353097|NCT02904655|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353098|NCT02904642|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1353099|NCT02904629|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353100|NCT02904616||Single Group Assignment||Health Services Research||None (Open Label)||||||
1353101|NCT02904603|||Case-Only||Prospective|||||||
1353102|NCT02904590|||Cohort||Prospective|||||||
1353103|NCT02904577|||Cohort||Prospective|||||||
1353104|NCT02904564|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353105|NCT02904551|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1353106|NCT02904538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353107|NCT02904525||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353108|NCT02904512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353109|NCT02904499|||Cohort||Retrospective|||||||
1353110|NCT02904486|Randomized|Parallel Assignment||Prevention||Single|||t|||
1353111|NCT02904473|Randomized|Parallel Assignment||Other||Single|||t|||
1353112|NCT02904460|||Cohort||Retrospective|||||||
1353113|NCT02904447|||Case-Control||Cross-Sectional|||||||
1353114|NCT02904434|||Cohort||Prospective|||||||
1353115|NCT02904421|||Cohort||Other|||||||
1353116|NCT02904408|Randomized|Parallel Assignment||Treatment||Single||||||t
1353117|NCT02904395|||||Cross-Sectional|||||||
1353118|NCT02904382||||||||||||
1353119|NCT02904369|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1353120|NCT02904356||Single Group Assignment||Other||None (Open Label)||||||
1353121|NCT02904343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353122|NCT02904330||Single Group Assignment||Treatment||None (Open Label)||||||
1353123|NCT02904317|||Case Control|||||||||
1353124|NCT02904304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353125|NCT02904291|||Case-Only||Prospective|||||||
1353126|NCT02904278|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353127|NCT02904265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353128|NCT02904252|||Cohort||Cross-Sectional|||||||
1353129|NCT02904239|||Cohort||Prospective|||||||
1353130|NCT02904226|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353131|NCT02904213||Single Group Assignment||Prevention||None (Open Label)||||||
1353132|NCT02904200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353133|NCT02904187|Randomized|Parallel Assignment||||None (Open Label)||||||
1353134|NCT02904174||Single Group Assignment||Prevention||None (Open Label)||||||
1353135|NCT02904161|||Cohort||Prospective|||||||
1353136|NCT02904148||Single Group Assignment||Supportive Care||None (Open Label)||||||
1353137|NCT02904135|||Cohort||Prospective|||||||
1353138|NCT02904122|||||Prospective|||||||
1353139|NCT02904109|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1353140|NCT02904096|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353141|NCT02904083|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1353142|NCT02904070||Single Group Assignment||||None (Open Label)||||||
1353143|NCT02904057|Randomized|Parallel Assignment||Treatment||Single||||||t
1353144|NCT02904044|||Case Control||Prospective|||||||
1353145|NCT02904031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353146|NCT02904018|||||Prospective|||||||
1353147|NCT02904005||Single Group Assignment||Screening||None (Open Label)||||||
1353148|NCT02903992||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353149|NCT02903979|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353150|NCT02903966|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353151|NCT02903953|||Cohort||Prospective|||||||
1353152|NCT02903940||Single Group Assignment||Treatment||None (Open Label)||||||
1353153|NCT02903927|Randomized|Parallel Assignment||Treatment||||||||
1353154|NCT02903914|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1353155|NCT02903901|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1353156|NCT02903888|||Cohort||Cross-Sectional|||||||
1353157|NCT02903875|||Cohort||Prospective|||||||
1353158|NCT02903862||Parallel Assignment||Supportive Care||None (Open Label)||||||
1353159|NCT02903849|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1353160|NCT02903836|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1353161|NCT02903823||Single Group Assignment||Basic Science||None (Open Label)||||||
1353162|NCT02903810||Single Group Assignment||Treatment||None (Open Label)||||||
1353163|NCT02903797|||Case Control||Retrospective|||||||
1353164|NCT02903784|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1353165|NCT02903771||Single Group Assignment||Treatment||None (Open Label)||||||
1353166|NCT02903758|||||Cross-Sectional|||||||
1353167|NCT02903745|||||Cross-Sectional|||||||
1353168|NCT02903732|||||Cross-Sectional|||||||
1353169|NCT02903719|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1353170|NCT02903706|||Case-Crossover||Cross-Sectional|||||||
1353172|NCT02903680|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1353173|NCT02903667|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353174|NCT02903654|||||Cross-Sectional|||||||
1353175|NCT02903641|Randomized|Factorial Assignment||Prevention||||||||
1353176|NCT02903628||Single Group Assignment||Prevention||None (Open Label)||||||
1353177|NCT02903615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353178|NCT02903602|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1353179|NCT02903589|||||Cross-Sectional|||||||
1353180|NCT02903576|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353181|NCT02903563|||||Cross-Sectional|||||||
1353182|NCT02903550|||Other||Prospective|||||||
1353183|NCT02903537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353184|NCT02903524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353185|NCT02903511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353186|NCT02903498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353187|NCT02903485|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1353188|NCT02903472|||Cohort||Prospective|||||||
1353189|NCT02903459|||Case-Only||Retrospective|||||||
1353190|NCT02903446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353191|NCT02903433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353192|NCT02903420||Single Group Assignment||Treatment||None (Open Label)||||||
1353193|NCT02903407|Randomized|Parallel Assignment||Treatment||Single||||||t
1353194|NCT02903394||Single Group Assignment||Basic Science||None (Open Label)||||||
1353195|NCT02903381||Single Group Assignment||Treatment||None (Open Label)||||||
1353196|NCT02903368|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353197|NCT02903355|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1353198|NCT02903342|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1353199|NCT02903329|Randomized|Parallel Assignment||Treatment||Single||||||t
1353200|NCT02903316|||Case-Only||Prospective|||||||
1353201|NCT02903303||Single Group Assignment||Treatment||None (Open Label)||||||
1353202|NCT02903290||Single Group Assignment||Treatment||None (Open Label)||||||
1353203|NCT02903277|||Cohort||Prospective|||||||
1353204|NCT02903264|||Case Control||Cross-Sectional|||||||
1353205|NCT02903251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353206|NCT02903238||Single Group Assignment||Basic Science||Single|||t|||
1353207|NCT02903225|Randomized|Parallel Assignment||Treatment||Single||||||t
1353208|NCT02903212||Single Group Assignment||Treatment||None (Open Label)||||||
1353209|NCT02903199|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1353210|NCT02903186|Randomized|Parallel Assignment||Prevention||Single||||||t
1353211|NCT02903173|||Cohort||Prospective|||||||
1353212|NCT02903160||Single Group Assignment||Treatment||None (Open Label)||||||
1353213|NCT02903147|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353214|NCT02903134|||Cohort||Prospective|||||||
1353215|NCT02903121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353216|NCT02903108|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353217|NCT02903095|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1353218|NCT02903082|||Case-Control||Prospective|||||||
1353219|NCT02903069|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1353220|NCT02903056|||Case Control||Cross-Sectional|||||||
1353221|NCT02903043|||Cohort||Prospective|||||||
1353222|NCT02903030|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1353223|NCT02903017|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1353224|NCT02903004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353225|NCT02902991|||Cohort||Prospective|||||||
1353226|NCT02902978|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1353227|NCT02902965||Single Group Assignment||Treatment||None (Open Label)||||||
1353228|NCT02902952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353229|NCT02902939|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1353230|NCT02902926|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353231|NCT02902913|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1353232|NCT02902900|||Cohort||Retrospective|||||||
1353233|NCT02902887|Randomized|Parallel Assignment||Treatment||Single||||||t
1353234|NCT02902874||Single Group Assignment||Basic Science||None (Open Label)||||||
1353235|NCT02902861|Randomized|Parallel Assignment||||Double|||t||t|
1353236|NCT02902848|||Cohort||Prospective|||||||
1353237|NCT02902835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353238|NCT02902822|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353239|NCT02902809||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1353240|NCT02902796|Randomized|Crossover Assignment||Treatment||Single|||t|||
1353241|NCT02902783|||Cohort||Prospective|||||||
1353242|NCT02902770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353243|NCT02902757||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353244|NCT02902744||Single Group Assignment||Treatment||None (Open Label)||||||
1353245|NCT02902731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353246|NCT02902718||Single Group Assignment||Treatment||None (Open Label)||||||
1353247|NCT02902705|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1353248|NCT02902692|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1353249|NCT02902679||Single Group Assignment||Treatment||None (Open Label)||||||
1353250|NCT02902666|Randomized|Crossover Assignment||||None (Open Label)||||||
1353251|NCT02902653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353252|NCT02902640|||Cohort||Prospective|||||||
1353253|NCT02902627||Single Group Assignment||Other||None (Open Label)||||||
1353254|NCT02902614|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1353255|NCT02902601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353256|NCT02902588|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1353257|NCT02902575||Single Group Assignment||Treatment||None (Open Label)||||||
1353258|NCT02902562||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353259|NCT02902549|||Cohort||Prospective|||||||
1353260|NCT02902536|||Other||Other|||||||
1353261|NCT02902523|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353262|NCT02902510|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353263|NCT02902497|||||Prospective|||||||
1353264|NCT02902484||Single Group Assignment||Treatment||None (Open Label)||||||
1353265|NCT02902471||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353266|NCT02902458|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353267|NCT02902445|||Case Control||Prospective|||||||
1353268|NCT02902432|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1353269|NCT02902419|Randomized|Parallel Assignment||Prevention||Single||||t||
1353270|NCT02902406|||Case-Control||Prospective|||||||
1353271|NCT02902393|||Case-Only||Prospective|||||||
1353272|NCT02902380|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1353273|NCT02902367|Randomized|Parallel Assignment||Treatment||Single||||||t
1353274|NCT02902354||Single Group Assignment||Screening||None (Open Label)||||||
1353275|NCT02902341|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1353276|NCT02902328|||Cohort||Prospective|||||||
1353277|NCT02902315|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1353278|NCT02902302|Randomized|Crossover Assignment||||None (Open Label)||||||
1353279|NCT02902289|Randomized|Crossover Assignment||||None (Open Label)||||||
1353280|NCT02902276|||Case-Only||Prospective|||||||
1353281|NCT02902263|||Case-Only||Retrospective|||||||
1353282|NCT02902250|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353283|NCT02902237||Single Group Assignment||Treatment||None (Open Label)||||||
1353284|NCT02902224|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1353285|NCT02902211|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353286|NCT02902198|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1353287|NCT02902185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353288|NCT02902172|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1353289|NCT02902159|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1353290|NCT02902146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353291|NCT02902133||Single Group Assignment||Treatment||None (Open Label)||||||
1353292|NCT02902120|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353293|NCT02902107||Single Group Assignment||Treatment||None (Open Label)||||||
1353294|NCT02902094|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353295|NCT02902081|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1353296|NCT02902068|||Cohort||Prospective|||||||
1353297|NCT02902055|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1353298|NCT02902042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353299|NCT02902029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353300|NCT02902016||Single Group Assignment||Basic Science||None (Open Label)||||||
1353301|NCT02902003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353302|NCT02901990|||Cohort||Prospective|||||||
1353303|NCT02901977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353304|NCT02901964|Randomized|Parallel Assignment||Treatment||Single|||||t|
1353305|NCT02901951||Single Group Assignment||Prevention||None (Open Label)||||||
1353306|NCT02901938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353307|NCT02901925||Single Group Assignment||Basic Science||None (Open Label)|open label|Pilot feasibility study||||
1353308|NCT02901912|||Cohort|||||||||
1353309|NCT02901899||Single Group Assignment||Treatment||None (Open Label)||||||
1353310|NCT02901886|Randomized|Parallel Assignment||Prevention||Single||||||t
1353311|NCT02901873|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353312|NCT02901860|||Case Control||Cross-Sectional|||||||
1353313|NCT02901847||Single Group Assignment||Supportive Care||None (Open Label)||||||
1353314|NCT02901834|||Other||Prospective|||||||
1353315|NCT02901821|||Case-Control||Prospective|||||||
1353316|NCT02901808|||Cohort||Retrospective|||||||
1353317|NCT02901795|||Case-Control||Prospective|||||||
1353318|NCT02901782||Single Group Assignment||Treatment||None (Open Label)||||||
1353319|NCT02901769|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1353320|NCT02901756|||Case-Only||Prospective|||||||
1353321|NCT02901743|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353322|NCT02901730|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353323|NCT02901717|Randomized|Parallel Assignment||Treatment||Single||||||t
1353324|NCT02901704|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353325|NCT02901691|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353326|NCT02901678|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353327|NCT02901665|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353328|NCT02901652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353488|NCT02899559|Randomized|Parallel Assignment||Other||Single|||t|||
1353329|NCT02901639|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1353330|NCT02901626|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study is an unblinded randomized controlled trial. Participants will receive usual care (vaginal progesterone if they meet criteria per local standard of care) or an Arabin cervical pessary (plus progesterone if the local usual care is to receive vaginal progesterone for a short cervix).||||
1353331|NCT02901613|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353332|NCT02901600|||Case Control||Retrospective|||||||
1353333|NCT02901587|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353334|NCT02901574|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1353335|NCT02901561|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1353336|NCT02901548||Single Group Assignment||Treatment||None (Open Label)||||||
1353337|NCT02901535|Randomized|Parallel Assignment||Treatment||Single|||||t|
1353338|NCT02901522|Randomized|Single Group Assignment||Treatment||Single|||||t|
1353339|NCT02901509|||Cohort||Prospective|||||||
1353340|NCT02901496|Randomized|Parallel Assignment||Other||Single|||||t|
1353341|NCT02901483||Single Group Assignment||Treatment||None (Open Label)||||||
1353342|NCT02901470|||Cohort||Prospective|||||||
1353343|NCT02901457|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1353344|NCT02901444|||Cohort||Prospective|||||||
1353345|NCT02901431|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353346|NCT02901418|||Case Control||Prospective|||||||
1353347|NCT02901405|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353348|NCT02901392|||Cohort||Prospective|||||||
1353349|NCT02901379|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1353350|NCT02901366||Single Group Assignment||Basic Science||None (Open Label)||||||
1353351|NCT02901353|||Other||Prospective|||||||
1353352|NCT02901340|||Case Control||Prospective|||||||
1353353|NCT02901327|Randomized|Parallel Assignment||Treatment||Single||||||t
1353354|NCT02901314|Randomized|Parallel Assignment||Supportive Care||Single||usual care education versus education with a pre-recorded card with heart failure instructions|||t|
1353355|NCT02901301||Single Group Assignment||Treatment||None (Open Label)||||||
1353356|NCT02901288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353357|NCT02901275||Single Group Assignment||Basic Science||Triple|||t||t|t
1353358|NCT02901262|||Cohort||Prospective|||||||
1353359|NCT02901249||Single Group Assignment||Treatment||None (Open Label)||||||
1353360|NCT02901236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353361|NCT02901223|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353362|NCT02901210||Single Group Assignment||Treatment||None (Open Label)||||||
1353363|NCT02901197|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1353364|NCT02901184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353365|NCT02901171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353366|NCT02901158|||Cohort||Prospective|||||||
1353367|NCT02901145||Single Group Assignment||Treatment||None (Open Label)||||||
1353368|NCT02901132|||Cohort||Prospective|||||||
1353369|NCT02901119|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1353370|NCT02901106||Single Group Assignment||Treatment||None (Open Label)||||||
1353371|NCT02901093|||Other||Prospective|||||||
1353372|NCT02901080||Single Group Assignment||Treatment||None (Open Label)||||||
1353373|NCT02901067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353374|NCT02901054||Single Group Assignment||Other||None (Open Label)||||||
1353375|NCT02901041|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1353376|NCT02901028|Randomized|Crossover Assignment||||None (Open Label)||||||
1353377|NCT02901015|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353378|NCT02901002|||Case-Control||Prospective|||||||
1353379|NCT02900989|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1353380|NCT02900976|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353381|NCT02900963||Single Group Assignment||Other||None (Open Label)||||||
1353382|NCT02900950|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1353383|NCT02900937||Single Group Assignment||Treatment||None (Open Label)||||||
1353384|NCT02900924|||Cohort||Prospective|||||||
1353385|NCT02900911|Randomized|Parallel Assignment||Prevention||Single||||||t
1353386|NCT02900898|Randomized|Parallel Assignment||Treatment||Single|||||t|
1353387|NCT02900885|||Case-Only||Retrospective|||||||
1353388|NCT02900872|||Case-Only||Retrospective|||||||
1353389|NCT02900859|||Case-Only||Retrospective|||||||
1353390|NCT02900846|||Case-Only||Retrospective|||||||
1353391|NCT02900833|||Other||Cross-Sectional|||||||
1353392|NCT02900820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353393|NCT02900807|||Cohort||Prospective|||||||
1353394|NCT02900794|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353395|NCT02900781|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1353396|NCT02900768|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353397|NCT02900755||Single Group Assignment||||None (Open Label)||||||
1353398|NCT02900742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353399|NCT02900729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353400|NCT02900716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353401|NCT02900703|||Cohort||Prospective|||||||
1353402|NCT02900690|||Other||Retrospective|||||||
1353403|NCT02900677|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1353404|NCT02900664|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353405|NCT02900651|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1353406|NCT02900638|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353407|NCT02900625|||Cohort||Other|||||||
1353408|NCT02900612|Randomized|Parallel Assignment||Treatment||Single||||||t
1353409|NCT02900599|||Cohort||Prospective|||||||
1353410|NCT02900586|||Cohort||Prospective|||||||
1353411|NCT02900573|||Cohort||Prospective|||||||
1353412|NCT02900560|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353413|NCT02900547|||||Prospective|||||||
1353414|NCT02900534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353415|NCT02900521|||Cohort||Prospective|||||||
1353416|NCT02900508|Randomized|Parallel Assignment||Treatment||Single||||||t
1353417|NCT02900495|Randomized|Parallel Assignment||Treatment||Single||||||t
1353418|NCT02900482|||Case-Control||Prospective|||||||
1353419|NCT02900469||Single Group Assignment||Treatment||None (Open Label)||||||
1353420|NCT02900456|||Cohort||Prospective|||||||
1353421|NCT02900443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353422|NCT02900430|||Cohort|||||||||
1353423|NCT02900417||Single Group Assignment||||None (Open Label)||||||
1353424|NCT02900404|||Cohort||Other|||||||
1353425|NCT02900391|||Cohort||Prospective|||||||
1353426|NCT02900378|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1353427|NCT02900365|Randomized|Parallel Assignment||Treatment||Single|||||t|
1353428|NCT02900352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353429|NCT02900339||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353430|NCT02900326|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353431|NCT02900313||Single Group Assignment||Supportive Care||None (Open Label)||||||
1353432|NCT02900300|||Cohort||Retrospective|||||||
1353433|NCT02900287|||Cohort||Retrospective|||||||
1353434|NCT02900274|||Cohort||Prospective|||||||
1353435|NCT02900261|||Other||Cross-Sectional|||||||
1353436|NCT02900248|||Cohort||Prospective|||||||
1353437|NCT02900235||Single Group Assignment||Other||None (Open Label)||||||
1353438|NCT02900222||Single Group Assignment||Treatment||None (Open Label)||||||
1353439|NCT02900209|||Cohort||Prospective|||||||
1353440|NCT02900196|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1353441|NCT02900183||Single Group Assignment||Treatment||None (Open Label)||||||
1353442|NCT02900170|||Cohort||Prospective|||||||
1353443|NCT02900157||Single Group Assignment||Treatment||None (Open Label)||||||
1353444|NCT02900144|Randomized|Parallel Assignment||Treatment||Single||||||t
1353445|NCT02900131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353446|NCT02900118|||Cohort||Prospective|||||||
1353447|NCT02900105||Single Group Assignment||Treatment||None (Open Label)||||||
1353448|NCT02900092|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1353449|NCT02900079|||Cohort||Prospective|||||||
1353450|NCT02900066|||Cohort||Prospective|||||||
1353451|NCT02900053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353452|NCT02900040|||Cohort||Prospective|||||||
1353453|NCT02900027|Randomized|Parallel Assignment||Other||Double|||t||t|
1353454|NCT02900014||Single Group Assignment||Basic Science||None (Open Label)||||||
1353455|NCT02900001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353456|NCT02899988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353457|NCT02899975||Single Group Assignment||Prevention||None (Open Label)||||||
1353458|NCT02899962|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353459|NCT02899949|||Cohort||Retrospective|||||||
1353460|NCT02899936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353461|NCT02899923|||Case-Only||Cross-Sectional|||||||
1353462|NCT02899910|Randomized|Parallel Assignment||Treatment||Single||||||t
1353463|NCT02899897|||Cohort||Prospective|||||||
1353464|NCT02899884|||Cohort||Prospective|||||||
1353465|NCT02899871|||Case-Control||Prospective|||||||
1353466|NCT02899858||Single Group Assignment||Basic Science||None (Open Label)||||||
1353467|NCT02899845|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353468|NCT02899832|||Case-Only||Prospective|||||||
1353469|NCT02899819||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353470|NCT02899806|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1353471|NCT02899793||Single Group Assignment||Treatment||None (Open Label)||||||
1353472|NCT02899780||Single Group Assignment||Treatment||None (Open Label)||||||
1353473|NCT02899767|||Cohort||Retrospective|||||||
1353474|NCT02899754|Randomized|Parallel Assignment||Prevention||Single||||||t
1353475|NCT02899741||Single Group Assignment||Treatment||None (Open Label)||||||
1353476|NCT02899728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353477|NCT02899702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353478|NCT02899689|Randomized|Parallel Assignment||Treatment||Single||||||t
1353479|NCT02899676|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1353480|NCT02899663|||Case-Only||Retrospective|||||||
1353481|NCT02899650|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1353482|NCT02899637|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1353483|NCT02899624|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353484|NCT02899611||Single Group Assignment||Treatment||None (Open Label)||||||
1353485|NCT02899598||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353486|NCT02899585|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353487|NCT02899572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353489|NCT02899546|||Cohort||Prospective|||||||
1353490|NCT02899533|||Case-Only||Prospective|||||||
1353491|NCT02899520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353492|NCT02899507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353493|NCT02899494|Randomized|Parallel Assignment||||None (Open Label)||||||
1353494|NCT02899481|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353495|NCT02899468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353496|NCT02899455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353497|NCT02899442|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353498|NCT02899429|||Cohort||Prospective|||||||
1353499|NCT02899416|||Cohort||Cross-Sectional|||||||
1353500|NCT02899403||Single Group Assignment||Basic Science||None (Open Label)||||||
1353501|NCT02899390||Single Group Assignment||Prevention||None (Open Label)||||||
1353502|NCT02899377|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353503|NCT02899364|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1353504|NCT02899351|||Cohort||Prospective|||||||
1353505|NCT02899338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353506|NCT02899325|||Cohort||Prospective|||||||
1353507|NCT02899312|||Cohort||Prospective|||||||
1353508|NCT02899299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353509|NCT02899286||Single Group Assignment||Treatment||None (Open Label)||||||
1353510|NCT02899273|||Cohort||Prospective|||||||
1353511|NCT02899260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353512|NCT02899247|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353513|NCT02899234|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1353514|NCT02899221||Single Group Assignment||Treatment||None (Open Label)||||||
1353515|NCT02899208|||Cohort||Prospective|||||||
1353516|NCT02899195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Concurrent therapy with Durvalumab, Pemetrexed and Cisplatin (or Carboplatin) for up to 6 cycles followed by Maintenance Therapy with Durvalumab||||
1353517|NCT02899182|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1353518|NCT02899169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353519|NCT02899156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353520|NCT02899143|Randomized|Parallel Assignment||Treatment||Single||||t||
1353521|NCT02899130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353522|NCT02899117||Single Group Assignment||Supportive Care||None (Open Label)||||||
1353523|NCT02899104|||Case-Only||Retrospective|||||||
1353524|NCT02899091|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1353525|NCT02899078||Single Group Assignment||Treatment||None (Open Label)||||||
1353526|NCT02899065|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1353527|NCT02899052||Single Group Assignment||Treatment||None (Open Label)||||||
1353528|NCT02899039|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353529|NCT02899026|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353530|NCT02899013|||Cohort||Prospective|||||||
1353531|NCT02899000||Single Group Assignment||Treatment||None (Open Label)||||||
1353532|NCT02898987|||Cohort||Prospective|||||||
1353533|NCT02898974|||Case-Only||Prospective|||||||
1353534|NCT02898961||Single Group Assignment||Treatment||None (Open Label)||||||
1353535|NCT02898948|||Cohort||Prospective|||||||
1353536|NCT02898935|||Other||Cross-Sectional|||||||
1353537|NCT02898922|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353538|NCT02898909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353539|NCT02898896||Single Group Assignment||Prevention||None (Open Label)||||||
1353540|NCT02898883|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353541|NCT02898870|||Cohort||Retrospective|||||||
1353542|NCT02898857|||||Retrospective|||||||
1353543|NCT02898844|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1353544|NCT02898831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353545|NCT02898818|||Cohort||Other|||||||
1353546|NCT02898805|Randomized|Parallel Assignment||Prevention||Single||||||t
1353547|NCT02898792|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1353548|NCT02898779|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1353549|NCT02898766|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1353550|NCT02898753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353551|NCT02898740|Randomized|Parallel Assignment||Other||Single||||||t
1353552|NCT02898727||Single Group Assignment||Treatment||None (Open Label)||||||
1353553|NCT02898714|||Cohort||Prospective|||||||
1353554|NCT02898701|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1353555|NCT02898688|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1353556|NCT02898675|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1353557|NCT02898662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353558|NCT02898649||Single Group Assignment||Treatment||None (Open Label)||||||
1353559|NCT02898636|||||Prospective|||||||
1353560|NCT02898623|||Case Control||Prospective|||||||
1353561|NCT02898610|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1353562|NCT02898597|Randomized|Parallel Assignment||Treatment||Single||||||t
1353563|NCT02898584||Single Group Assignment||Treatment||None (Open Label)||||||
1353564|NCT02898571|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1353565|NCT02898558||Single Group Assignment||Treatment||None (Open Label)||||||
1353566|NCT02898545|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1353567|NCT02898532|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353568|NCT02898519|||Cohort||Prospective|||||||
1353569|NCT02898506|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1353570|NCT02898493|||Case-Only||Cross-Sectional|||||||
1353571|NCT02898480||Single Group Assignment||Basic Science||None (Open Label)||||||
1353572|NCT02898467|||Case Control||Prospective|||||||
1353573|NCT02898454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353574|NCT02898441|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1353575|NCT02898428|||Case-Control||Prospective|||||||
1353576|NCT02898415|||Cohort||Retrospective|||||||
1353577|NCT02898402|||Ecologic or Community||Prospective|||||||
1353578|NCT02898389|||Case-Control||Cross-Sectional|||||||
1353579|NCT02898376|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353580|NCT02898363|||Ecologic or Community||Prospective|||||||
1353581|NCT02898350|Randomized|Single Group Assignment||Treatment||Single||||||t
1353582|NCT02898337|||Cohort||Other|||||||
1353583|NCT02898324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353584|NCT02898311||Single Group Assignment||Treatment||||||||
1353585|NCT02898298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353586|NCT02898285|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1353587|NCT02898272|||Cohort||Cross-Sectional|||||||
1353588|NCT02898259||Single Group Assignment||Treatment||None (Open Label)||||||
1353589|NCT02898246|||Cohort||Cross-Sectional|||||||
1353590|NCT02898233|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353591|NCT02898220|||Cohort||Prospective|||||||
1353592|NCT02898207||Single Group Assignment||Treatment||None (Open Label)||||||
1353593|NCT02898194||Single Group Assignment||Health Services Research||None (Open Label)||||||
1353594|NCT02898181|Randomized|Parallel Assignment||Treatment||Single||||||t
1353595|NCT02898168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353596|NCT02898155|||Ecologic or Community||Cross-Sectional|||||||
1353597|NCT02898142|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353598|NCT02898129|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1353599|NCT02898116||Single Group Assignment||Treatment||None (Open Label)||||||
1353600|NCT02898103|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1353601|NCT02898090|||Cohort||Retrospective|||||||
1353602|NCT02898077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353603|NCT02898064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353604|NCT02898051|||Case-Control||Prospective|||||||
1353605|NCT02898038||Single Group Assignment||||None (Open Label)||||||
1353606|NCT02898025|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353607|NCT02898012||Single Group Assignment||Treatment||None (Open Label)||||||
1353608|NCT02897999|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353609|NCT02897986||Single Group Assignment||Treatment||None (Open Label)||||||
1353610|NCT02897973|||Case Control||Retrospective|||||||
1353611|NCT02897960|||Case-Control||Cross-Sectional|||||||
1353612|NCT02897947|||Cohort||Prospective|||||||
1353613|NCT02897934|||Cohort||Prospective|||||||
1353614|NCT02897921|||Case-Control||Cross-Sectional|||||||
1353615|NCT02897908|||Case-Only||Prospective|||||||
1353616|NCT02897895|Randomized|Parallel Assignment||Prevention||Single|||t|||
1353617|NCT02897882||Single Group Assignment||Other||None (Open Label)||||||
1353618|NCT02897869|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353619|NCT02897856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353620|NCT02897843|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1353621|NCT02897830||Single Group Assignment||Treatment||None (Open Label)||||||
1353622|NCT02897817|||Cohort||Prospective|||||||
1353623|NCT02897804|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1353624|NCT02897791|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353625|NCT02897778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353626|NCT02897765||Single Group Assignment||Treatment||None (Open Label)||||||
1353627|NCT02897752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353628|NCT02897739|||Case-Control||Prospective|||||||
1353629|NCT02897726|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1353630|NCT02897713|Randomized|Parallel Assignment||Treatment||Single||||||t
1353631|NCT02897700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353632|NCT02897687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353633|NCT02897674|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1353634|NCT02897661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353635|NCT02897648|||Cohort||Prospective|||||||
1353636|NCT02897635||Single Group Assignment||Supportive Care||None (Open Label)||||||
1353637|NCT02897622||Single Group Assignment||Treatment||None (Open Label)||||||
1353638|NCT02897609|||Cohort||Prospective|||||||
1353639|NCT02897596|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353640|NCT02897583|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353641|NCT02897570|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1353642|NCT02897557||Single Group Assignment||Treatment||None (Open Label)||||||
1353643|NCT02897544||Single Group Assignment||Supportive Care||None (Open Label)||||||
1353644|NCT02897531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353645|NCT02897518|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353646|NCT02897505||Single Group Assignment||Treatment||None (Open Label)||||||
1353647|NCT02897492|||Case-Only||Prospective|||||||
1353648|NCT02897479||Single Group Assignment||Treatment||None (Open Label)||||||
1353649|NCT02897466|Randomized|Parallel Assignment||Other||Single|||||t|
1353650|NCT02897453||Single Group Assignment||Treatment||None (Open Label)||||||
1353651|NCT02897440|||Cohort||Prospective|||||||
1353652|NCT02897427|||Cohort||Prospective|||||||
1353653|NCT02897414|||Ecologic or Community||Retrospective|||||||
1353654|NCT02897401|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353655|NCT02897388|Non-Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1353656|NCT02897375|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353657|NCT02897362|||Case-Control||Prospective|||||||
1353658|NCT02897349|Randomized|Parallel Assignment||Treatment||Double||||||
1353659|NCT02897336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353660|NCT02897323|||Cohort||Prospective|||||||
1353661|NCT02897310|||Cohort||Retrospective|||||||
1353662|NCT02897297|||Cohort||Cross-Sectional|||||||
1353663|NCT02897284|Randomized|Parallel Assignment||Prevention||Single||||||t
1353664|NCT02897271|||Case-Only||Retrospective|||||||
1353665|NCT02897258|||Cohort||Retrospective|||||||
1353666|NCT02897245|||Cohort||Retrospective|||||||
1353667|NCT02897232|||Ecologic or Community||Retrospective|||||||
1353668|NCT02897219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353669|NCT02897206|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1353670|NCT02897193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353671|NCT02897180|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1353672|NCT02897167|||Case-Control||Retrospective|||||||
1353673|NCT02897154|||Other||Prospective|||||||
1353674|NCT02897141|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1353675|NCT02897128|||Cohort||Prospective|||||||
1353676|NCT02897115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353677|NCT02897102|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353678|NCT02897089|Randomized|Parallel Assignment||Other||Single|||t|||
1353679|NCT02897076|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353680|NCT02897063|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1353681|NCT02897050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353682|NCT02897037|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353683|NCT02897024|Randomized|Parallel Assignment||Treatment||Single||||||t
1353684|NCT02897011|Randomized|Parallel Assignment||Treatment||Single||||||t
1353685|NCT02896998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353686|NCT02896985|||Cohort||Prospective|||||||
1353687|NCT02896972|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1353688|NCT02896959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353689|NCT02896946||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353690|NCT02896933|||||Cross-Sectional|||||||
1353691|NCT02896920|||Cohort||Prospective|||||||
1353692|NCT02896907||Single Group Assignment||Treatment||None (Open Label)||||||
1353693|NCT02896894|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1353694|NCT02896881|||Other||Cross-Sectional|||||||
1353695|NCT02896868|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1353696|NCT02896855|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353697|NCT02896842|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1353698|NCT02896829|||Other||Prospective|||||||
1353699|NCT02896816|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1353700|NCT02896803||Single Group Assignment||Treatment||None (Open Label)||||||
1353701|NCT02896790|||Case-Only||Prospective|||||||
1353702|NCT02896777|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1353703|NCT02896764||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353704|NCT02896751||Single Group Assignment||Treatment||None (Open Label)||||||
1353705|NCT02896738|||Other||Cross-Sectional|||||||
1353706|NCT02896725|Randomized|Parallel Assignment||Treatment||Single|Healing status for primary and secondary outcomes are adjudicated by blinded review of photographs of healed reference ulcer site or unhealed reference|Participants allocated to receive either keratin dressing or usual care dressing||||t
1353707|NCT02896712|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353708|NCT02896699|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1353709|NCT02896686|Randomized|Parallel Assignment||Prevention||Single|||t|||
1353710|NCT02896673||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353711|NCT02896660||Single Group Assignment||Basic Science||None (Open Label)||||||
1353712|NCT02896647|||Other||Cross-Sectional|||||||
1353713|NCT02896634|||Case Control||Cross-Sectional|||||||
1353714|NCT02896621|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353715|NCT02896608|||Other||Cross-Sectional|||||||
1353716|NCT02896595|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1353717|NCT02896582||Single Group Assignment||Treatment||None (Open Label)||||||
1353718|NCT02896569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353719|NCT02896556||Single Group Assignment||Other||None (Open Label)||||||
1353720|NCT02896543|||Case-Control||Prospective|||||||
1353721|NCT02896530|||Case-Only||Retrospective|||||||
1353722|NCT02896517|||Cohort||Retrospective|||||||
1353723|NCT02896504|||Cohort||Prospective|||||||
1353724|NCT02896491|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1353725|NCT02896478|||Cohort||Retrospective|||||||
1353726|NCT02896465|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1353727|NCT02896452|||Cohort||Prospective|||||||
1353728|NCT02896439||Single Group Assignment||Screening||None (Open Label)||||||
1353729|NCT02896426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353730|NCT02896413|Randomized|Parallel Assignment||||Triple|||t|t||t
1353731|NCT02896400|Randomized|Factorial Assignment||Treatment||Single|||||t|
1353732|NCT02896387|||Other||Cross-Sectional|||||||
1353733|NCT02896374|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353734|NCT02896361|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1353735|NCT02896348|Randomized|Parallel Assignment||Treatment||Single||||||t
1353736|NCT02896335||Single Group Assignment||Treatment||None (Open Label)||||||
1353737|NCT02896322||Single Group Assignment||Treatment||None (Open Label)||||||
1353738|NCT02896309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353739|NCT02896296||Single Group Assignment||Treatment||None (Open Label)||||||
1353740|NCT02896283|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1353741|NCT02896270||Single Group Assignment||Treatment||None (Open Label)||||||
1353742|NCT02896257|Randomized|Parallel Assignment||Other||Single||||||t
1353743|NCT02896244|||Cohort||Prospective|||||||
1353744|NCT02896231||Single Group Assignment||Treatment||None (Open Label)||||||
1353745|NCT02896218|||Cohort|||||||||
1353746|NCT02896205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353747|NCT02896192||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1353748|NCT02896179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353749|NCT02896166||Single Group Assignment||Treatment||None (Open Label)||||||
1353750|NCT02896153|||||Prospective|||||||
1353751|NCT02896140|||Cohort||Prospective|||||||
1353752|NCT02896127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353753|NCT02896114|||Cohort||Retrospective|||||||
1353754|NCT02896101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353755|NCT02896088|||||Prospective|||||||
1353756|NCT02896075|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1353757|NCT02896062|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1353758|NCT02896049|||Cohort||Prospective|||||||
1353759|NCT02896036|Randomized|Parallel Assignment||Other||Single|||t|||
1353760|NCT02896023|Non-Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1353761|NCT02896010|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353762|NCT02895997||Single Group Assignment||Health Services Research||None (Open Label)||||||
1353763|NCT02895984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353764|NCT02895971|||Cohort||Prospective|||||||
1353765|NCT02895958||Single Group Assignment||Treatment||None (Open Label)||||||
1353766|NCT02895945||Single Group Assignment||Treatment||None (Open Label)||||||
1353767|NCT02895932|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353768|NCT02895919|||Case-Only||Prospective|||||||
1353769|NCT02895906||Single Group Assignment||Treatment||None (Open Label)||||||
1353770|NCT02895893||Single Group Assignment||Treatment||None (Open Label)||||||
1353771|NCT02895880|||Case-Control||Prospective|||||||
1353772|NCT02895867|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1353773|NCT02895854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353774|NCT02895841|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353775|NCT02895828|Randomized|Parallel Assignment||Treatment||Single|||||t|
1353776|NCT02895815|Randomized|Parallel Assignment||Treatment||Single||||||t
1353777|NCT02895802|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1353778|NCT02895789|||Cohort||Prospective|||||||
1353779|NCT02895776|||Case-Control||Prospective|||||||
1353780|NCT02895763|||Cohort||Prospective|||||||
1353781|NCT02895750|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353782|NCT02895737|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1353783|NCT02895724|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353784|NCT02895711|||Other||Prospective|||||||
1353785|NCT02895698|Randomized|Parallel Assignment||Treatment||Single||||||t
1353786|NCT02895685|Randomized|Parallel Assignment||||Single||||||t
1353787|NCT02895672|||Cohort||Retrospective|||||||
1353788|NCT02895659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353789|NCT02895646|||Case-Control||Cross-Sectional|||||||
1353790|NCT02895633||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353791|NCT02895620||Single Group Assignment||||None (Open Label)||||||
1353792|NCT02895607|||Cohort||Prospective|||||||
1353793|NCT02895594|||Case-Only||Retrospective|||||||
1353794|NCT02895581|||Case-Only||Retrospective|||||||
1353795|NCT02895568|||Other||Cross-Sectional|||||||
1353796|NCT02895555|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1353797|NCT02895542|||Case-Only||Cross-Sectional|||||||
1353798|NCT02895529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353799|NCT02895516||Single Group Assignment||Treatment||None (Open Label)||||||
1353800|NCT02895503|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353801|NCT02895490|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353802|NCT02895477|Randomized|Parallel Assignment||Other||Single|||t|||
1353803|NCT02895464|Randomized|Parallel Assignment||Other||Single||||||t
1353804|NCT02895451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353805|NCT02895438|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1353806|NCT02895425|||Cohort||Prospective|||||||
1353807|NCT02895412||Single Group Assignment||Prevention||None (Open Label)||||||
1353808|NCT02895399|||||Prospective|||||||
1353809|NCT02895386|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353810|NCT02895373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353811|NCT02895360|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1353812|NCT02895347|Randomized|Parallel Assignment||Other||Single|||||t|
1353813|NCT02895334|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353814|NCT02895321||Single Group Assignment||Treatment||None (Open Label)||||||
1353815|NCT02895308|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1353816|NCT02895295|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1353817|NCT02895282|||Cohort||Prospective|||||||
1353818|NCT02895269|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1353819|NCT02895256|||Cohort||Retrospective|||||||
1353820|NCT02895243||Single Group Assignment||Prevention||None (Open Label)||||||
1353821|NCT02895230|||Cohort||Prospective|||||||
1353822|NCT02895217|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1353823|NCT02895204|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1353824|NCT02895191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353825|NCT02895178|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1353826|NCT02895165|||Cohort||Prospective|||||||
1353827|NCT02895152|Randomized|Parallel Assignment||||None (Open Label)||||||
1353828|NCT02895139|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1353829|NCT02895126|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353830|NCT02895113|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1353831|NCT02895100|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1353832|NCT02895087|||Cohort||Prospective|||||||
1353833|NCT02895074|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353834|NCT02895061|Randomized|Single Group Assignment||Treatment||Single|||||t|
1353835|NCT02895048|||Case Control||Prospective|||||||
1353836|NCT02895035|Randomized|Crossover Assignment||Other||Double|||t|||t
1353837|NCT02895022||Single Group Assignment||Treatment||None (Open Label)||||||
1353838|NCT02895009|Randomized|Parallel Assignment||Prevention||Single|||t|||
1353839|NCT02894996||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353840|NCT02894983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353841|NCT02894970|||Case Control||Prospective|||||||
1353842|NCT02894957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353843|NCT02894944||Single Group Assignment||Treatment||None (Open Label)||||||
1353844|NCT02894931|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1353845|NCT02894918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353846|NCT02894905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1353847|NCT02894892|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1353848|NCT02894879|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353849|NCT02894866|Randomized|Parallel Assignment||Treatment||Single||||||t
1353850|NCT02894853|||Other||Prospective|||||||
1353851|NCT02894840|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1353852|NCT02894827|||Case-Only||Retrospective|||||||
1353853|NCT02894814|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353854|NCT02894801|||Cohort||Retrospective|||||||
1353855|NCT02894788|||Case Control||Retrospective|||||||
1353856|NCT02894775|||Case Control||Retrospective|||||||
1353857|NCT02894762|||Case-Only||Prospective|||||||
1353858|NCT02894749|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1353859|NCT02894736||Single Group Assignment||Treatment||None (Open Label)||||||
1353860|NCT02894723|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353861|NCT02894710|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353862|NCT02894697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353863|NCT02894684|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353864|NCT02894671|||Cohort||Prospective|||||||
1353865|NCT02894658|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353866|NCT02894645|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353867|NCT02894632||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353868|NCT02894619|||Cohort||Prospective|||||||
1353869|NCT02894606|||Case Control||Prospective|||||||
1353870|NCT02894593|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1353871|NCT02894580|||Cohort||Retrospective|||||||
1353872|NCT02894567||Single Group Assignment||Basic Science||None (Open Label)||||||
1353873|NCT02894554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353874|NCT02894541|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353875|NCT02894528|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353876|NCT02894515|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353877|NCT02894502|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1353878|NCT02894489|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353879|NCT02894476|||Cohort||Prospective|||||||
1353880|NCT02894463|||Cohort||Prospective|||||||
1353881|NCT02894450|||Cohort||Prospective|||||||
1353882|NCT02894437|||Case-Control||Prospective|||||||
1353883|NCT02894424|||Other||Prospective|||||||
1353884|NCT02894411|||Other||Prospective|||||||
1353885|NCT02894398||Single Group Assignment||Treatment||None (Open Label)||||||
1353886|NCT02894385|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1353887|NCT02894372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353888|NCT02894359|||Other||Cross-Sectional|||||||
1353889|NCT02894346|||Case-Only||Cross-Sectional|||||||
1353890|NCT02894333|||Other||Cross-Sectional|||||||
1353891|NCT02894320|||Other||Cross-Sectional|||||||
1353892|NCT02894307||||||||||||
1353893|NCT02894294|||Ecologic or Community||Cross-Sectional|||||||
1353894|NCT02894281|||Other||Prospective|||||||
1353895|NCT02894268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353896|NCT02894255||Single Group Assignment||Treatment||None (Open Label)||||||
1353897|NCT02894242||Single Group Assignment||Treatment||None (Open Label)||||||
1353898|NCT02894229|Randomized|Parallel Assignment||Treatment||Single||||||t
1353899|NCT02894216|||Case-Only||Retrospective|||||||
1353900|NCT02894203|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1353901|NCT02894190|||Cohort||Prospective|||||||
1353902|NCT02894177||Single Group Assignment||Diagnostic||None (Open Label)|Care providers will be blinded of tcPCO2 measurements to avoid influencing extubation decisions.|tcPCO2 will be monitored in all patients performing SBTs. The difference between maximal and initial tcPCO2 (ΔtcPCO2) in patients succeeding extubation will be compared with ΔtcPCO2 in patients failing extubation.||||
1353903|NCT02894164|||Cohort||Prospective|||||||
1353904|NCT02894151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353905|NCT02894138|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353906|NCT02894125||||||||||||
1353907|NCT02894112|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1353908|NCT02894099|Randomized|Parallel Assignment||||None (Open Label)||||||
1353909|NCT02894086|||Cohort||Retrospective|||||||
1353910|NCT02894073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353911|NCT02894060||Single Group Assignment||Basic Science||None (Open Label)||||||
1353912|NCT02894047|||Case-Only||Prospective|||||||
1353913|NCT02894034|||Case-Only||Prospective|||||||
1353914|NCT02894021|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353915|NCT02894008|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353916|NCT02893995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353917|NCT02893982||Single Group Assignment||Treatment||None (Open Label)||||||
1353918|NCT02893969|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1353919|NCT02893956|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1353920|NCT02893943|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1353921|NCT02893930||Single Group Assignment||Treatment||None (Open Label)||||||
1353922|NCT02893917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353923|NCT02893904|Randomized|Parallel Assignment||Screening||Single|||t|||
1353924|NCT02893891|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353925|NCT02893878|||Other||Other|||||||
1353926|NCT02893865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353927|NCT02893852|Randomized|Parallel Assignment||Treatment||Single||||||t
1353928|NCT02893839||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353929|NCT02893826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353930|NCT02893813|||Cohort||Retrospective|||||||
1353931|NCT02893800|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1353932|NCT02893787|||||Prospective|||||||
1353933|NCT02893774||Single Group Assignment||||None (Open Label)||||||
1353934|NCT02893761|||Cohort||Prospective|||||||
1353935|NCT02893748|Randomized|Parallel Assignment||Treatment||Single|||||t|
1353936|NCT02893735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353937|NCT02893722|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1353938|NCT02893709||Single Group Assignment||Basic Science||None (Open Label)||||||
1353939|NCT02893696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353940|NCT02893683|||Other||Cross-Sectional|||||||
1353941|NCT02893670||Single Group Assignment||Treatment||None (Open Label)||||||
1353942|NCT02893657|||Cohort||Prospective|||||||
1353943|NCT02893644|||Other||Prospective|||||||
1353944|NCT02893631|||Case-Only||Cross-Sectional|||||||
1353945|NCT02893618|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353946|NCT02893605|||Case-Control||Retrospective|||||||
1353947|NCT02893592|||Cohort||Retrospective|||||||
1353948|NCT02893579|Randomized|Parallel Assignment||Treatment||Single|||t|||
1353949|NCT02893566||Single Group Assignment||Prevention||None (Open Label)||One group pretest-midtest-posttest design||||
1353950|NCT02893553|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353951|NCT02893540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353952|NCT02893527|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1353953|NCT02893514|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1353954|NCT02893501|||Case-Crossover||Prospective|||||||
1353955|NCT02893488|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1353956|NCT02893475|||Case-Only||Cross-Sectional|||||||
1353957|NCT02893462|||Cohort||Prospective|||||||
1353958|NCT02893449|Randomized|Parallel Assignment||||None (Open Label)||||||
1353959|NCT02893436|||Case-Only||Prospective|||||||
1353960|NCT02893423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353961|NCT02893410|||Cohort||Prospective|||||||
1353962|NCT02893397|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1353963|NCT02893384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1353964|NCT02893371|||Cohort||Retrospective|||||||
1353965|NCT02893358|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1353966|NCT02893345|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1353967|NCT02893332|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1353968|NCT02893319|Randomized|Parallel Assignment||Prevention||Single|||t|||
1353969|NCT02893306||Single Group Assignment||Treatment||None (Open Label)||||||
1353970|NCT02893293|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1353971|NCT02893280|||Cohort||Prospective|||||||
1353972|NCT02893267|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1353973|NCT02893254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1353974|NCT02893241|||Cohort||Prospective|||||||
1353975|NCT02893228|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1353976|NCT02893215|||Cohort||Prospective|||||||
1353977|NCT02893202|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1353978|NCT02893189||Single Group Assignment||Treatment||None (Open Label)||||||
1353979|NCT02893176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1353980|NCT02893163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353981|NCT02893150|Randomized|Parallel Assignment||Other||Single||||||t
1353982|NCT02893137||Single Group Assignment||Treatment||None (Open Label)||||||
1353983|NCT02893124|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353984|NCT02893111||Single Group Assignment||Treatment||None (Open Label)||||||
1353985|NCT02893098|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353986|NCT02893085|||Case Control||Retrospective|||||||
1353987|NCT02893072||Single Group Assignment||Treatment||None (Open Label)||||||
1353988|NCT02893059|||Cohort||Prospective|||||||
1353989|NCT02893046|||Cohort||Prospective|||||||
1353990|NCT02893033|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1353991|NCT02893020|||Cohort||Prospective|||||||
1353992|NCT02893007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353993|NCT02892994|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1353994|NCT02892981||Single Group Assignment||Diagnostic||None (Open Label)||||||
1353995|NCT02892968|Randomized|Crossover Assignment||Prevention||Single||||||t
1353996|NCT02892955||Single Group Assignment||Treatment||None (Open Label)||||||
1353997|NCT02892942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1353998|NCT02892929|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1353999|NCT02892916|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354000|NCT02892903|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354001|NCT02892890||Single Group Assignment||Prevention||None (Open Label)||||||
1354002|NCT02892877|||Cohort||Prospective|||||||
1354003|NCT02892864|Randomized|Parallel Assignment||Treatment||Single||||||t
1354004|NCT02892851||Single Group Assignment||Treatment||None (Open Label)||||||
1354005|NCT02892838|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354006|NCT02892825|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1354007|NCT02892812|Randomized|Parallel Assignment||Prevention||Single|||t|||
1354008|NCT02892799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354009|NCT02892786||Single Group Assignment||Basic Science||None (Open Label)||||||
1354010|NCT02892773|Randomized|Parallel Assignment||Prevention||Double|Participant and Care Provider will be masked from electrical impedance tomography distribution of ventilation recording during lung expansion therapy to reduce risk of performance bias.||t|t||
1354011|NCT02892760||Single Group Assignment||Treatment||None (Open Label)||||||
1354012|NCT02892747|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354013|NCT02892734||Single Group Assignment||Treatment||None (Open Label)||||||
1354014|NCT02892721|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354015|NCT02892708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354016|NCT02892695||Single Group Assignment||Treatment||None (Open Label)||||||
1354017|NCT02892682|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1354018|NCT02892669|||Case-Only||Prospective|||||||
1354019|NCT02892656|||Cohort||Prospective|||||||
1354020|NCT02892643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354021|NCT02892630|||Cohort||Prospective|||||||
1354022|NCT02892617|||Cohort||Prospective|||||||
1354023|NCT02892604||Single Group Assignment||Treatment||None (Open Label)||||||
1354024|NCT02892591|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1354025|NCT02892578||Single Group Assignment||Prevention||None (Open Label)||||||
1354026|NCT02892565|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1354027|NCT02892552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354028|NCT02892539|||Case-Only||Prospective|||||||
1354029|NCT02892526|||Case Control||Cross-Sectional|||||||
1354030|NCT02892513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354031|NCT02892500|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354032|NCT02892487|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354033|NCT02892474|||Case-Control||Prospective|||||||
1354034|NCT02892461|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1354035|NCT02892448|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354036|NCT02892435|Randomized|Parallel Assignment||Prevention||Single||||||t
1354037|NCT02892422||Single Group Assignment||Treatment||None (Open Label)||||||
1354038|NCT02892409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354039|NCT02892396|||Cohort||Prospective|||||||
1354040|NCT02892383|||Cohort||Prospective|||||||
1354041|NCT02892370|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354042|NCT02892357|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354043|NCT02892344|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1354044|NCT02892331|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354045|NCT02892318|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1354046|NCT02892305|||Cohort||Prospective|||||||
1354047|NCT02892292|||Cohort||Retrospective|||||||
1354048|NCT02892279||Single Group Assignment||Basic Science||None (Open Label)||||||
1354049|NCT02892266|||Cohort||Other|||||||
1354050|NCT02892253|Randomized|Parallel Assignment||Prevention||Single|||t|||
1354051|NCT02892240|||Cohort||Retrospective|||||||
1354052|NCT02892227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354053|NCT02892214|||Case-Only||Prospective|||||||
1354054|NCT02892201||Single Group Assignment||Treatment||None (Open Label)||||||
1354055|NCT02892188|||Cohort||Prospective|||||||
1354056|NCT02892175|||Cohort||Prospective|||||||
1354057|NCT02892162|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354058|NCT02892149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354059|NCT02892136|||Cohort||Prospective|||||||
1354060|NCT02892123||Single Group Assignment||Treatment||None (Open Label)||||||
1354061|NCT02892110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354062|NCT02892097|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1354063|NCT02892084|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354064|NCT02892071|Randomized|Parallel Assignment||Treatment||Single||||||t
1354065|NCT02892058|||Case-Only||Prospective|||||||
1354066|NCT02892045|||Case-Only||Prospective|||||||
1354067|NCT02892032|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354068|NCT02892019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354069|NCT02892006||Single Group Assignment||Other||None (Open Label)||||||
1354070|NCT02891993|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354071|NCT02891980|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1354072|NCT02891967|Randomized|Parallel Assignment||||Double|||t|||t
1354073|NCT02891954||Single Group Assignment||Basic Science||None (Open Label)||||||
1354074|NCT02891941|||Case Control||Prospective|||||||
1354075|NCT02891928|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354076|NCT02891915|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1354077|NCT02891902|||Cohort||Prospective|||||||
1354078|NCT02891889|||Cohort||Retrospective|||||||
1354079|NCT02891876|||Case-Only||Prospective|||||||
1354080|NCT02891863||Single Group Assignment||Treatment||None (Open Label)||||||
1354081|NCT02891850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354082|NCT02891837|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1354083|NCT02891824|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1354084|NCT02891811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354085|NCT02891798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354086|NCT02891785|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1354087|NCT02891772|||||Prospective|||||||
1354088|NCT02891759|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1354089|NCT02891746|||Cohort||Prospective|||||||
1354090|NCT02891733|||Cohort||Retrospective|||||||
1354091|NCT02891720|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1354092|NCT02891707|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354093|NCT02891694|||Other||Cross-Sectional|||||||
1354094|NCT02891681|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354095|NCT02891668|||Case-Control||Prospective|||||||
1354096|NCT02891655|||Other||Cross-Sectional|||||||
1354097|NCT02891642|||Case Control||Prospective|||||||
1354098|NCT02891629|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354099|NCT02891616||Single Group Assignment||Screening||None (Open Label)||||||
1354100|NCT02891603||Single Group Assignment||Prevention||None (Open Label)||||||
1354101|NCT02891590||Single Group Assignment||Treatment||None (Open Label)||||||
1354102|NCT02891577|||Case-Only||Prospective|||||||
1354103|NCT02891564|Randomized|Single Group Assignment||Treatment||None (Open Label)||Randomized Control Trial||||
1354104|NCT02891551|||Cohort||Prospective|||||||
1354105|NCT02891538|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354106|NCT02891525|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1354107|NCT02891512|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354108|NCT02891499|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1354109|NCT02891486|||Other||Prospective|||||||
1354110|NCT02891473|Randomized|Parallel Assignment||Treatment||Single|||||t|
1354111|NCT02891460|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354112|NCT02891447||Single Group Assignment||Treatment||None (Open Label)||||||
1354113|NCT02891434|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354114|NCT02891421|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354115|NCT02891408|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354116|NCT02891395||Single Group Assignment||Treatment||None (Open Label)||||||
1354117|NCT02891382|Randomized|Parallel Assignment||Treatment||Single|||||t|
1354118|NCT02891369|||Cohort||Retrospective|||||||
1354119|NCT02891356|||Cohort||Prospective|||||||
1354120|NCT02891343||Single Group Assignment||Other||None (Open Label)||||||
1354121|NCT02891330|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354122|NCT02891317|||Cohort||Prospective|||||||
1354123|NCT02891304|||Cohort||Prospective|||||||
1354124|NCT02891291||||||||||||
1354125|NCT02891278||Single Group Assignment||Treatment||None (Open Label)||||||
1354126|NCT02891265|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354127|NCT02891252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354128|NCT02891239||Single Group Assignment||Treatment||None (Open Label)||||||
1354129|NCT02891226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354130|NCT02891213|||||Retrospective|||||||
1354131|NCT02891200|Randomized|Parallel Assignment||Other||Single||||||t
1354132|NCT02891187|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354133|NCT02891174|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1354134|NCT02891161|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1354135|NCT02891148||Single Group Assignment||Treatment||None (Open Label)||||||
1354136|NCT02891135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354137|NCT02891122|||Cohort||Prospective|||||||
1354138|NCT02891109|||Case Control||Prospective|||||||
1354139|NCT02891096|||Cohort||Prospective|||||||
1354140|NCT02891083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354141|NCT02891070|Randomized|Parallel Assignment||Prevention||Single|||t|||
1354142|NCT02891057||Single Group Assignment||Treatment||None (Open Label)||||||
1354143|NCT02891044||Single Group Assignment||Prevention||None (Open Label)||||||
1354144|NCT02891031|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354145|NCT02891018|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354146|NCT02891005|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354147|NCT02890992|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354148|NCT02890979||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354149|NCT02890966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354150|NCT02890953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354151|NCT02890940||Single Group Assignment||Supportive Care||||||||
1354152|NCT02890927|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1354153|NCT02890914|Randomized|Parallel Assignment||||Single|||||t|
1354154|NCT02890901|||Cohort||Prospective|||||||
1354155|NCT02890888||Single Group Assignment||Treatment||None (Open Label)||||||
1354156|NCT02890875|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354157|NCT02890862|||Cohort||Prospective|||||||
1354158|NCT02890849||Single Group Assignment||Treatment||None (Open Label)||||||
1354159|NCT02890836|||Cohort||Prospective|||||||
1354160|NCT02890823|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354161|NCT02890810|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354162|NCT02890797||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354163|NCT02890784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354164|NCT02890771|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354165|NCT02890758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1354166|NCT02890745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354167|NCT02890732||Single Group Assignment||Treatment||None (Open Label)||||||
1354168|NCT02890719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354169|NCT02890706||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354170|NCT02890693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354171|NCT02890680|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354172|NCT02890667|||Cohort||Retrospective|||||||
1354173|NCT02890654|||Cohort||Prospective|||||||
1354174|NCT02890641|||Family-Based||Cross-Sectional|||||||
1354175|NCT02890628|||Other||Cross-Sectional|||||||
1354176|NCT02890615|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1354177|NCT02890602||Single Group Assignment||Supportive Care||None (Open Label)||||||
1354178|NCT02890589|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354179|NCT02890576|||Cohort||Prospective|||||||
1354180|NCT02890563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354181|NCT02890550|||Cohort||Prospective|||||||
1354182|NCT02890537|Randomized|Parallel Assignment||Treatment||Single||||||t
1354183|NCT02890524|Non-Randomized|Crossover Assignment||Prevention||Single|||t|||
1354184|NCT02890511||Single Group Assignment||Treatment||None (Open Label)||||||
1354185|NCT02890498|||Case Control||Retrospective|||||||
1354186|NCT02890485|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1354187|NCT02890472|||Cohort||Prospective|||||||
1354188|NCT02890459|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354189|NCT02890446|Randomized|Parallel Assignment||Treatment||Single||||||t
1354190|NCT02890433|||Cohort||Retrospective|||||||
1354191|NCT02890420|||Cohort||Prospective|||||||
1354192|NCT02890407|||Family-Based||Retrospective|||||||
1354193|NCT02890394|Randomized|Factorial Assignment||Treatment||Single||||||t
1354194|NCT02890381|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354195|NCT02890368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354196|NCT02890355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354197|NCT02890342|||Cohort||Prospective|||||||
1354198|NCT02890329|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354199|NCT02890316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354200|NCT02890303||Single Group Assignment||Treatment||None (Open Label)||||||
1354201|NCT02890290|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354202|NCT02890277||Single Group Assignment||Treatment||None (Open Label)||||||
1354203|NCT02890264|||Cohort||Cross-Sectional|||||||
1354204|NCT02890251|||Cohort||Cross-Sectional|||||||
1354205|NCT02890238|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354206|NCT02890225|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1354207|NCT02890212|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354208|NCT02890199|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354209|NCT02890186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354210|NCT02890173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354211|NCT02890160|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354212|NCT02890147|||Cohort||Prospective|||||||
1354213|NCT02890134|||Cohort||Prospective|||||||
1354214|NCT02890121|||Cohort||Prospective|||||||
1354215|NCT02890108|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1354216|NCT02890095|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354217|NCT02890082|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354218|NCT02890069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354219|NCT02890056|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354220|NCT02890043|Randomized|Parallel Assignment||Treatment||Single||||||t
1354221|NCT02890030|||Case-Control||Prospective|||||||
1354222|NCT02890017|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1354223|NCT02890004|||Cohort||Prospective|||||||
1354224|NCT02889991|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1354225|NCT02889978|||Cohort||Prospective|||||||
1354226|NCT02889965|||Cohort||Prospective|||||||
1354227|NCT02889952|||||Cross-Sectional|||||||
1354228|NCT02889939||Single Group Assignment||Treatment||None (Open Label)||A within-subject, repeated-measures design with pretest-posttest evaluation was utilised to assess outcomes after ETT. The intervention was preceded by a baseline period of usual care (UC) for 3 weeks, which also served as a control||||
1354229|NCT02889926|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354230|NCT02889913|||Cohort||Retrospective|||||||
1354231|NCT02889900||Single Group Assignment||Treatment||None (Open Label)||||||
1354232|NCT02889887|||Cohort||Prospective|||||||
1354233|NCT02889874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354234|NCT02889861||Single Group Assignment||Treatment||None (Open Label)||||||
1354235|NCT02889848|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1354236|NCT02889835|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354237|NCT02889822||Single Group Assignment||Treatment||None (Open Label)||||||
1354238|NCT02889809|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1354239|NCT02889796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354240|NCT02889783|||||Retrospective|||||||
1354241|NCT02889770|||Cohort||Prospective|||||||
1354242|NCT02889757|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1354243|NCT02889744|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354244|NCT02889731|||||Prospective|||||||
1354245|NCT02889718||Single Group Assignment||Treatment||None (Open Label)||||||
1354246|NCT02889705|||Cohort||Prospective|||||||
1354247|NCT02889692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354248|NCT02889679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354249|NCT02889666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354250|NCT02889653|||Cohort||Prospective|||||||
1354251|NCT02889640|Randomized|Parallel Assignment||Treatment||Single||||||t
1354252|NCT02889627|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354253|NCT02889614|||Cohort||Retrospective|||||||
1354254|NCT02889601|||Case-Control||Prospective|||||||
1354255|NCT02889588|||Other||Prospective|||||||
1354256|NCT02889575|||Cohort||Prospective|||||||
1354257|NCT02889562|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354258|NCT02889549|Randomized|Parallel Assignment||Prevention||Single||||||t
1354259|NCT02889536||||||||||||
1354260|NCT02889523||Single Group Assignment||Treatment||None (Open Label)||||||
1354261|NCT02889510|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1354262|NCT02889497|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1354263|NCT02889484|||Cohort||Prospective|||||||
1354264|NCT02889471|Randomized|Parallel Assignment||Other||Single|||t|||
1354265|NCT02889458|||Case-Control||Prospective|||||||
1354266|NCT02889445||||||||||||
1354267|NCT02889432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354268|NCT02889419||Single Group Assignment||Supportive Care||None (Open Label)||||||
1354269|NCT02889406|Randomized|Parallel Assignment||Treatment||Single|||||t|
1354270|NCT02889393|Randomized|Crossover Assignment||Treatment||Single||||||t
1354271|NCT02889380|||Other||Retrospective|||||||
1354272|NCT02889367|Randomized|Parallel Assignment||Other||Double|||t||t|
1354273|NCT02889354||Single Group Assignment||Treatment||||||||
1354274|NCT02889341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354275|NCT02889328||Single Group Assignment||Treatment||None (Open Label)||||||
1354276|NCT02889315|||Cohort||Prospective|||||||
1354277|NCT02889302|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354278|NCT02889289||Single Group Assignment||Treatment||None (Open Label)||||||
1354279|NCT02889276|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1354280|NCT02889263|||Cohort||Retrospective|||||||
1354281|NCT02889250||Single Group Assignment||Treatment||None (Open Label)||||||
1354282|NCT02889237|Randomized|Parallel Assignment||Other||Single|||||t|
1354283|NCT02889224|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1354284|NCT02889211|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1354285|NCT02889198|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354286|NCT02889185||Single Group Assignment||Other||None (Open Label)||||||
1354287|NCT02889172|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354288|NCT02889159|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1354289|NCT02889146|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1354290|NCT02889133|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1354291|NCT02889120|||Case-Only||Prospective|||||||
1354292|NCT02889107|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354293|NCT02889094|||Cohort||Other|||||||
1354294|NCT02889081|||Cohort||Prospective|||||||
1354295|NCT02889068|||Cohort||Cross-Sectional|||||||
1354296|NCT02889055|||Case-Only||Prospective|||||||
1354297|NCT02889042|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354298|NCT02889029||Single Group Assignment||Treatment||None (Open Label)||||||
1354299|NCT02889016|||Cohort||Prospective|||||||
1354300|NCT02889003||Single Group Assignment||Treatment||None (Open Label)||||||
1354301|NCT02888990||Single Group Assignment||Treatment||None (Open Label)||||||
1354302|NCT02888977|||Cohort||Prospective|||||||
1354303|NCT02888964||Single Group Assignment||Treatment||None (Open Label)||||||
1354304|NCT02888951|||Cohort||Prospective|||||||
1354305|NCT02888938|||Cohort||Cross-Sectional|||||||
1354306|NCT02888925|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1354307|NCT02888912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354308|NCT02888899||||Treatment||||||||
1354309|NCT02888886||Single Group Assignment||Prevention||None (Open Label)||||||
1354310|NCT02888873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354311|NCT02888860|||Cohort||Prospective|||||||
1354312|NCT02888847|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1354313|NCT02888834|||Cohort||Retrospective|||||||
1354314|NCT02888821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354315|NCT02888808|||Case Control||Prospective|||||||
1354316|NCT02888795||Single Group Assignment||Treatment||None (Open Label)||||||
1354317|NCT02888782|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1354318|NCT02888769|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1354319|NCT02888756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354320|NCT02888743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354321|NCT02888730|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1354322|NCT02888717||Single Group Assignment||||None (Open Label)||||||
1354323|NCT02888704||Single Group Assignment||Treatment||None (Open Label)||||||
1354324|NCT02888691|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354325|NCT02888678|Randomized|Factorial Assignment||Other||Double|||||t|t
1354326|NCT02888665||Single Group Assignment||Treatment||None (Open Label)||||||
1354327|NCT02888652|||Other||Prospective|||||||
1354328|NCT02888639|||Cohort||Prospective|||||||
1354329|NCT02888626||||||||||||
1354330|NCT02888613|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354331|NCT02888600|Randomized|Parallel Assignment||Basic Science||Single||||||t
1354332|NCT02888587|||Cohort||Prospective|||||||
1354333|NCT02888574|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1354334|NCT02888561|||Cohort||Prospective|||||||
1354335|NCT02888548|Randomized|Crossover Assignment||Treatment||Single|||||t|
1354336|NCT02888535|||Cohort||Prospective|||||||
1354337|NCT02888522|||Cohort||Prospective|||||||
1354338|NCT02888509|||Cohort||Cross-Sectional|||||||
1354339|NCT02888496|||Case Control||Prospective|||||||
1354340|NCT02888483|||Other||Cross-Sectional|||||||
1354341|NCT02888470|||Cohort||Prospective|||||||
1354342|NCT02888457|Non-Randomized|Parallel Assignment||||||||||
1354343|NCT02888444|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1354344|NCT02888431|||Cohort||Prospective|||||||
1354345|NCT02888418|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1354346|NCT02888405|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1354347|NCT02888392|Randomized|Crossover Assignment||Treatment||Single|||||t|
1354348|NCT02888379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354349|NCT02888366|||Other||Prospective|||||||
1354350|NCT02888353||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354351|NCT02888340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354352|NCT02888327|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354353|NCT02888314|||Cohort||Retrospective|||||||
1354354|NCT02888301||Single Group Assignment||Basic Science||None (Open Label)||||||
1354355|NCT02888288|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1354356|NCT02888275|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1354357|NCT02888262|||Cohort||Prospective|||||||
1354358|NCT02888249|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1354359|NCT02888236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354360|NCT02888223|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354361|NCT02888210||Single Group Assignment||Treatment||None (Open Label)||||||
1354362|NCT02888197|||Cohort||Prospective|||||||
1354363|NCT02888184|||Cohort||Retrospective|||||||
1354364|NCT02888171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354365|NCT02888158|Randomized|Parallel Assignment||||None (Open Label)||||||
1354366|NCT02888145|||Cohort|||||||||
1354367|NCT02888132||Single Group Assignment||Treatment||None (Open Label)||||||
1354368|NCT02888119|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354369|NCT02888106|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multicenter, Open-label, Randomized, Comparative, parallel-arm phase II study||||
1354370|NCT02888093|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354371|NCT02888080|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1354372|NCT02888067|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1354373|NCT02888054|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354374|NCT02888041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354375|NCT02888028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354376|NCT02888015||Single Group Assignment||Treatment||None (Open Label)||||||
1354377|NCT02888002|Randomized|Parallel Assignment||Treatment||Single||||||t
1354378|NCT02887989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354379|NCT02887976||Single Group Assignment||Treatment||None (Open Label)||||||
1354380|NCT02887963|||Other||Cross-Sectional|||||||
1354381|NCT02887950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354382|NCT02887937|||Case-Control||Cross-Sectional|||||||
1354383|NCT02887924|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354384|NCT02887911|||Case-Control||Prospective|||||||
1354385|NCT02887898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354386|NCT02887885|||Case-Only||Prospective|||||||
1354387|NCT02887872||Single Group Assignment||Treatment||None (Open Label)||||||
1354388|NCT02887859||Single Group Assignment||Treatment||None (Open Label)||||||
1354389|NCT02887846|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354390|NCT02887833|||Cohort||Prospective|||||||
1354391|NCT02887820||Single Group Assignment||Supportive Care||None (Open Label)||||||
1354392|NCT02887807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354393|NCT02887794||Single Group Assignment||Basic Science||None (Open Label)||||||
1354394|NCT02887781|||Cohort||Prospective|||||||
1354395|NCT02887768||Single Group Assignment||Treatment||None (Open Label)||||||
1354396|NCT02887755||Single Group Assignment||Treatment||None (Open Label)||||||
1354397|NCT02887742|||Case-Crossover||Cross-Sectional|||||||
1354398|NCT02887729|||Cohort||Prospective|||||||
1354399|NCT02887716|||Cohort||Retrospective|||||||
1354400|NCT02887703|Randomized|Crossover Assignment||Treatment||Single||||||t
1354401|NCT02887690||Single Group Assignment||Treatment||None (Open Label)||||||
1354402|NCT02887677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354403|NCT02887664|||Case-Control||Cross-Sectional|||||||
1354404|NCT02887651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354405|NCT02887638|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1354406|NCT02887625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354407|NCT02887612|||Case-Only||Prospective|||||||
1354408|NCT02887599|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354409|NCT02887586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354410|NCT02887573|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1354411|NCT02887560||Single Group Assignment||Basic Science||None (Open Label)||||||
1354412|NCT02887547|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1354413|NCT02887534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354414|NCT02887521|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1354415|NCT02887508|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354416|NCT02887495|||Cohort||Prospective|||||||
1354417|NCT02887482|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354418|NCT02887469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354419|NCT02887456|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354420|NCT02887443||Single Group Assignment||Other||None (Open Label)||||||
1354421|NCT02887430|Randomized|Parallel Assignment||Screening||Single||||||t
1354422|NCT02887417|||Cohort||Prospective|||||||
1354423|NCT02887404|Randomized|Parallel Assignment||Treatment||Single||||||t
1354424|NCT02887391|||Cohort||Prospective|||||||
1354425|NCT02887378|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354426|NCT02887365|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1354427|NCT02887352|||Other||Cross-Sectional|||||||
1354428|NCT02887339|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354429|NCT02887326|||Case-Only||Retrospective|||||||
1354430|NCT02887313||Single Group Assignment||Treatment||None (Open Label)||||||
1354431|NCT02887300|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1354432|NCT02887287|||Case-Only||Prospective|||||||
1354433|NCT02887274|||Cohort||Prospective|||||||
1354434|NCT02887261|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354435|NCT02887248||Single Group Assignment||Treatment||None (Open Label)||||||
1354436|NCT02887235|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354437|NCT02887222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354438|NCT02887209||Single Group Assignment||Treatment||None (Open Label)||||||
1354439|NCT02887196|||Cohort||Prospective|||||||
1354440|NCT02887183||Single Group Assignment||Other||None (Open Label)||||||
1354441|NCT02887170|||Cohort||Retrospective|||||||
1354442|NCT02887157|||Cohort||Prospective|||||||
1354443|NCT02887144|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1354444|NCT02887131|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354445|NCT02887118|||Cohort||Prospective|||||||
1354446|NCT02887105|||Cohort||Prospective|||||||
1354447|NCT02887092|||Cohort||Prospective|||||||
1354448|NCT02887079|||Cohort||Prospective|||||||
1354449|NCT02887066|||Case-Only||Prospective|||||||
1354450|NCT02887053||Single Group Assignment||||None (Open Label)||||||
1354451|NCT02887040|Randomized|Parallel Assignment||Treatment||Single||||||t
1354452|NCT02887027|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354453|NCT02887014|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1354454|NCT02887001||Single Group Assignment||Health Services Research||None (Open Label)||||||
1354455|NCT02886988|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354456|NCT02886975||Single Group Assignment||Treatment||None (Open Label)||||||
1354457|NCT02886962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354458|NCT02886949|||Cohort||Prospective|||||||
1354459|NCT02886936||Single Group Assignment||Other||None (Open Label)||||||
1354460|NCT02886923||||||||||||
1354461|NCT02886910|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354462|NCT02886897||Single Group Assignment||Treatment||None (Open Label)||||||
1354463|NCT02886884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354464|NCT02886871|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354465|NCT02886858|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354466|NCT02886845|||Case Control||Prospective|||||||
1354467|NCT02886832||Single Group Assignment||Health Services Research||None (Open Label)||||||
1354468|NCT02886819||Single Group Assignment||Basic Science||None (Open Label)||||||
1354469|NCT02886806||Single Group Assignment||Treatment||None (Open Label)||||||
1354470|NCT02886793||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354471|NCT02886780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354472|NCT02886767|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354473|NCT02886754|Randomized|Parallel Assignment||Other||Double|Participants and outcome assessors were unaware of which intervention group subjects were allocated|The study design is a parallel group, double-blind, randomized trial|t|||t
1354474|NCT02886741|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1354475|NCT02886728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354476|NCT02886715|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354477|NCT02886702|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354478|NCT02886689|||Cohort||Prospective|||||||
1354479|NCT02886676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354480|NCT02886663|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1354481|NCT02886650||Single Group Assignment||Treatment||None (Open Label)||||||
1354482|NCT02886637|||Case-Only||Prospective|||||||
1354483|NCT02886624||Single Group Assignment||Treatment||None (Open Label)||||||
1354484|NCT02886611|||Other||Cross-Sectional|||||||
1354485|NCT02886598|||Case-Only||Prospective|||||||
1354486|NCT02886585|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354487|NCT02886572||Single Group Assignment||Treatment||None (Open Label)||||||
1354488|NCT02886559||Single Group Assignment||Treatment||None (Open Label)||||||
1354489|NCT02886546||Single Group Assignment||Screening||Single||||||t
1354490|NCT02886533|||Cohort||Prospective|||||||
1354491|NCT02886520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354492|NCT02886507|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1354493|NCT02886494|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1354494|NCT02886481|||Cohort||Prospective|||||||
1354495|NCT02886468||Single Group Assignment||||None (Open Label)||||||
1354496|NCT02886455||Single Group Assignment||Basic Science||None (Open Label)||||||
1354497|NCT02886442||Single Group Assignment||Basic Science||None (Open Label)||||||
1354498|NCT02886429|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354499|NCT02886416|||Cohort||Other|||||||
1354500|NCT02886403||Single Group Assignment||Basic Science||None (Open Label)||||||
1354501|NCT02886390|Randomized|Parallel Assignment||Treatment||Single||||||t
1354502|NCT02886377|||Case Control||Retrospective|||||||
1354503|NCT02886364||Single Group Assignment||Health Services Research||None (Open Label)||||||
1354504|NCT02886351||Single Group Assignment||Treatment||None (Open Label)||||||
1354505|NCT02886338||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354506|NCT02886325|Randomized|Parallel Assignment||||Single|||t|||
1354507|NCT02886312||||Supportive Care||||||||
1354508|NCT02886299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354509|NCT02886286|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1354510|NCT02886273|||Cohort||Prospective|||||||
1354511|NCT02886260|||Cohort||Prospective|||||||
1354512|NCT02886247|||Family-Based||Prospective|||||||
1354513|NCT02886234|Randomized|Parallel Assignment||Treatment||Single|||||t|
1354514|NCT02886221||Single Group Assignment||Treatment||None (Open Label)||||||
1354515|NCT02886208||Single Group Assignment||Prevention||None (Open Label)||||||
1354516|NCT02886195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354517|NCT02886182|||Case Control||Prospective|||||||
1354518|NCT02886169|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1354519|NCT02886156|Randomized|Parallel Assignment||Treatment||Single||||||t
1354520|NCT02886143|Randomized|Parallel Assignment||Treatment||Single||||||t
1354521|NCT02886130|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1354522|NCT02886117|||Case-Only||Prospective|||||||
1354523|NCT02886104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354524|NCT02886091|||Cohort||Prospective|||||||
1354525|NCT02886078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354526|NCT02886065|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354527|NCT02886052|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354528|NCT02886039||Single Group Assignment||||None (Open Label)||||||
1354529|NCT02886026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354530|NCT02886013|||Ecologic or Community||Prospective|||||||
1354531|NCT02885987|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1354532|NCT02885974||Single Group Assignment||Treatment||None (Open Label)||||||
1354533|NCT02885961||Single Group Assignment||Basic Science||None (Open Label)||||||
1354534|NCT02885948|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354535|NCT02885935|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1354536|NCT02885922|||Cohort||Prospective|||||||
1354537|NCT02885909|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354538|NCT02885896|||Case-Control||Prospective|||||||
1354539|NCT02885883|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354540|NCT02885870|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354541|NCT02885857||Single Group Assignment||Treatment||None (Open Label)||||||
1354542|NCT02885844|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1354543|NCT02885831|||Cohort||Prospective|||||||
1354544|NCT02885818|||Cohort||Prospective|||||||
1354545|NCT02885805||Single Group Assignment||Prevention||None (Open Label)||||||
1354546|NCT02885792|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354547|NCT02885779|||Cohort||Prospective|||||||
1354548|NCT02885766||Single Group Assignment||Treatment||None (Open Label)||||||
1354549|NCT02885753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354550|NCT02885740|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1354551|NCT02885727||Single Group Assignment||Treatment||None (Open Label)||||||
1354552|NCT02885714|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354553|NCT02885701|Randomized|Parallel Assignment||Treatment||Single||||||t
1354554|NCT02885688|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354555|NCT02885675|||Case Control||Prospective|||||||
1354556|NCT02885662||Single Group Assignment||Treatment||None (Open Label)||||||
1354557|NCT02885649||Single Group Assignment||Treatment||None (Open Label)||||||
1354558|NCT02885636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354559|NCT02885623|||Case-Only||Prospective|||||||
1354560|NCT02885610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354561|NCT02885597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354562|NCT02885584|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1354563|NCT02885571|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1354564|NCT02885558|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1354565|NCT02885545|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354566|NCT02885532|||Cohort||Prospective|||||||
1354567|NCT02885519|Randomized|Parallel Assignment||Other||Double|||||t|t
1354568|NCT02885506|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1354569|NCT02885493|||Cohort||Prospective|||||||
1354570|NCT02885480|||Cohort||Prospective|||||||
1354571|NCT02885467|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1354572|NCT02885454||Single Group Assignment||Other||None (Open Label)||||||
1354573|NCT02885441|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354574|NCT02885428|||Case-Only||Cross-Sectional|||||||
1354575|NCT02885415|||Cohort||Prospective|||||||
1354576|NCT02885402|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354577|NCT02885389|||Case-Only||Prospective|||||||
1354578|NCT02885376|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354579|NCT02885363|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354580|NCT02885350|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354581|NCT02885337|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1354582|NCT02885324||Single Group Assignment||Treatment||None (Open Label)||||||
1354583|NCT02885311|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1354584|NCT02885298|||Cohort||Prospective|||||||
1354585|NCT02885285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354586|NCT02885272||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354587|NCT02885259||Single Group Assignment||Treatment||None (Open Label)||||||
1354588|NCT02885246|||Other||Retrospective|||||||
1354589|NCT02885233|Randomized|Parallel Assignment||Treatment||Single||||||t
1354590|NCT02885220|Randomized|Parallel Assignment||||None (Open Label)||||||
1354591|NCT02885207||Single Group Assignment||Treatment||None (Open Label)||||||
1354592|NCT02885194||Single Group Assignment||Basic Science||None (Open Label)||||||
1354593|NCT02885181|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354594|NCT02885168|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354595|NCT02885155|||Cohort|||||||||
1354596|NCT02885142|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1354597|NCT02885129|||Cohort||Prospective|||||||
1354598|NCT02885116|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354599|NCT02885103|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354600|NCT02885090|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1354601|NCT02885077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354602|NCT02885064|||Cohort||Prospective|||||||
1354603|NCT02885051||Single Group Assignment||Other||None (Open Label)||||||
1354604|NCT02885038|||Cohort||Retrospective|||||||
1354605|NCT02885025|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354606|NCT02885012|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354607|NCT02884999|||Cohort||Retrospective|||||||
1354693|NCT02883881|||Cohort||Retrospective|||||||
1354608|NCT02884986|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354609|NCT02884973|||Cohort||Retrospective|||||||
1354610|NCT02884960|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354611|NCT02884947|||Cohort||Prospective|||||||
1354612|NCT02884934|||Cohort||Prospective|||||||
1354613|NCT02884921|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354614|NCT02884908|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1354615|NCT02884895|Randomized|Crossover Assignment||Treatment||Single|||||t|
1354616|NCT02884882|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354617|NCT02884869|Randomized|Crossover Assignment||Treatment||Single|||||t|
1354618|NCT02884856|||Cohort||Cross-Sectional|||||||
1354619|NCT02884843|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1354620|NCT02884830|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354621|NCT02884817|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354622|NCT02884804|||Cohort||Prospective|||||||
1354623|NCT02884791|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354624|NCT02884778||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354625|NCT02884765|||Case-Only||Prospective|||||||
1354626|NCT02884752|||Case-Only||Retrospective|||||||
1354627|NCT02884739|||Cohort||Prospective|||||||
1354628|NCT02884726||Single Group Assignment||Treatment||None (Open Label)||||||
1354629|NCT02884713||Single Group Assignment||Treatment||None (Open Label)||||||
1354630|NCT02884700|||Cohort||Retrospective|||||||
1354631|NCT02884687|||Cohort||Retrospective|||||||
1354632|NCT02884674|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354633|NCT02884661|||Cohort||Retrospective|||||||
1354634|NCT02884648||Single Group Assignment||Treatment||None (Open Label)||||||
1354635|NCT02884635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354636|NCT02884622||Single Group Assignment||Basic Science||None (Open Label)||||||
1354637|NCT02884609|||Cohort||Prospective|||||||
1354638|NCT02884596|||Other||Prospective|||||||
1354639|NCT02884583||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354640|NCT02884570|||Cohort||Retrospective|||||||
1354641|NCT02884557|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1354642|NCT02884544||Single Group Assignment||Treatment||None (Open Label)||||||
1354643|NCT02884531|Randomized|Parallel Assignment||Treatment||Single||||||t
1354644|NCT02884518|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354645|NCT02884505|||Other||Prospective|||||||
1354646|NCT02884492|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354647|NCT02884479||Single Group Assignment||Treatment||None (Open Label)||||||
1354648|NCT02884466|Randomized|Parallel Assignment||Other||Single|||||t|
1354649|NCT02884453||Single Group Assignment||Treatment||None (Open Label)||||||
1354650|NCT02884440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354651|NCT02884427|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1354652|NCT02884414||Single Group Assignment||Treatment||None (Open Label)||||||
1354653|NCT02884401||Single Group Assignment||Treatment||None (Open Label)||||||
1354654|NCT02884388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354655|NCT02884375|||Cohort||Prospective|||||||
1354656|NCT02884362|||||Prospective|||||||
1354657|NCT02884349||Single Group Assignment||Basic Science||None (Open Label)||||||
1354658|NCT02884336|||Case-Only||Prospective|||||||
1354659|NCT02884323||Single Group Assignment||Other||None (Open Label)||||||
1354660|NCT02884310|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1354661|NCT02884297||Single Group Assignment||||None (Open Label)||||||
1354662|NCT02884284|||||Prospective|||||||
1354663|NCT02884271|||Cohort||Prospective|||||||
1354664|NCT02884258|||Case-Control||Other|||||||
1354665|NCT02884245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354666|NCT02884232|||Cohort||Prospective|||||||
1354667|NCT02884219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354668|NCT02884206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354669|NCT02884193|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1354670|NCT02884180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354671|NCT02884167|||Case-Control||Cross-Sectional|||||||
1354672|NCT02884154||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354673|NCT02884141|||Cohort||Prospective|||||||
1354674|NCT02884128||Single Group Assignment||Treatment||None (Open Label)||||||
1354675|NCT02884115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354676|NCT02884102|||Other||Prospective|||||||
1354677|NCT02884089|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1354678|NCT02884076|||Cohort||Prospective|||||||
1354679|NCT02884063|||Cohort||Prospective|||||||
1354680|NCT02884050|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1354681|NCT02884037|||Cohort||Prospective|||||||
1354682|NCT02884024|||Case Control||Cross-Sectional|||||||
1354683|NCT02884011|||Cohort||Retrospective|||||||
1354684|NCT02883998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354685|NCT02883985||Single Group Assignment||Treatment||None (Open Label)||||||
1354686|NCT02883972|Randomized|Factorial Assignment||||None (Open Label)||||||
1354687|NCT02883959|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354688|NCT02883946|||Cohort||Retrospective|||||||
1354689|NCT02883933|||Case-Only||Prospective|||||||
1354690|NCT02883920|||Case-Only||Cross-Sectional|||||||
1354691|NCT02883907|||Case-Control||Prospective|||||||
1354692|NCT02883894|||Case-Only||Prospective|||||||
1354694|NCT02883868|||Cohort||Retrospective|||||||
1354695|NCT02883855|||Case-Only||Retrospective|||||||
1354696|NCT02883842|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1354697|NCT02883829|Randomized|Parallel Assignment||Prevention||Single|||||t|
1354698|NCT02883816||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354699|NCT02883803|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354700|NCT02883790|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1354701|NCT02883777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354702|NCT02883764|||Ecologic or Community||Cross-Sectional|||||||
1354703|NCT02883751|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354704|NCT02883738||Single Group Assignment||||None (Open Label)||||||
1354705|NCT02883725|||Cohort||Prospective|||||||
1354706|NCT02883712|||Cohort||Prospective|||||||
1354707|NCT02883699|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354708|NCT02883686|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1354709|NCT02883673||Single Group Assignment||Treatment||None (Open Label)||||||
1354710|NCT02883660|||Case-Control||Retrospective|||||||
1354711|NCT02883647|||Cohort||Prospective|||||||
1354712|NCT02883634|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354713|NCT02883621|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354714|NCT02883608|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1354715|NCT02883595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354716|NCT02883582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354717|NCT02883569|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1354718|NCT02883556||Single Group Assignment||Treatment||None (Open Label)||||||
1354719|NCT02883543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354720|NCT02883530|||Cohort||Prospective|||||||
1354721|NCT02883517|||Cohort||Prospective|||||||
1354722|NCT02883504||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354723|NCT02883491|||Other||Prospective|||||||
1354724|NCT02883478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354725|NCT02883465||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354726|NCT02883452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354727|NCT02883439|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1354728|NCT02883426|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354729|NCT02883413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354730|NCT02883400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354731|NCT02883387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354732|NCT02883374||Single Group Assignment||Treatment||None (Open Label)||||||
1354733|NCT02883361|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1354734|NCT02883348|||Cohort||Prospective|||||||
1354735|NCT02883335|||Cohort||Prospective|||||||
1354736|NCT02883322|||||Cross-Sectional|||||||
1354737|NCT02883309||||||||||||
1354738|NCT02883296||Single Group Assignment||Prevention||None (Open Label)||||||
1354739|NCT02883283|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354740|NCT02883270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354741|NCT02883257||Single Group Assignment||Treatment||None (Open Label)||||||
1354742|NCT02883244|Randomized|Parallel Assignment||Prevention||Single||||||t
1354743|NCT02883231|||Case-Only||Prospective|||||||
1354744|NCT02883218|||Other||Prospective|||||||
1354745|NCT02883205|||||Prospective|||||||
1354746|NCT02883192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354747|NCT02883179|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354748|NCT02883166|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354749|NCT02883153||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354750|NCT02883140|||Case-Only||Prospective|||||||
1354751|NCT02883127|||Case-Control||Prospective|||||||
1354752|NCT02883114|Randomized|||Basic Science||None (Open Label)||||||
1354753|NCT02883101|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354754|NCT02883088|||Cohort||Prospective|||||||
1354755|NCT02883075|Randomized|Parallel Assignment||Prevention||Single||||||t
1354756|NCT02883062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354757|NCT02883049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354758|NCT02883036|||Cohort||Prospective|||||||
1354759|NCT02883023|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354760|NCT02883010|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354761|NCT02882997|Randomized|Parallel Assignment||Treatment||Single||||||t
1354762|NCT02882984|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1354763|NCT02882971|||Other||Prospective|||||||
1354764|NCT02882958|||Cohort||Prospective|||||||
1354765|NCT02882945|||Case Control||Prospective|||||||
1354766|NCT02882932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354767|NCT02882919|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1354768|NCT02882906|||Cohort||Prospective|||||||
1354769|NCT02882893|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354770|NCT02882880|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1354771|NCT02882867|||Cohort||Prospective|||||||
1354772|NCT02882854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354773|NCT02882841||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354774|NCT02882828||Single Group Assignment||Treatment||None (Open Label)||||||
1354775|NCT02882815||Single Group Assignment||Treatment||None (Open Label)||||||
1354776|NCT02882802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354777|NCT02882789|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354778|NCT02882776|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1354779|NCT02882763|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1354780|NCT02882750|||Cohort||Prospective|||||||
1354781|NCT02882737|Randomized|Crossover Assignment||Prevention||Single|||t|||
1354782|NCT02882724|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1354783|NCT02882711||Single Group Assignment||Treatment||None (Open Label)||||||
1354784|NCT02882698|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354785|NCT02882685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354786|NCT02882672|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1354787|NCT02882659||Single Group Assignment||Treatment||None (Open Label)||||||
1354788|NCT02882646||Single Group Assignment||Treatment||None (Open Label)||||||
1354789|NCT02882633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354790|NCT02882620|Randomized|Parallel Assignment||Screening||Double|||t|||t
1354791|NCT02882607|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354792|NCT02882594|||Cohort||Prospective|||||||
1354793|NCT02882581||Single Group Assignment||Other||None (Open Label)||11C-metformin uptake in breast cancer. Single center, single dose, open-label.||||
1354794|NCT02882568||Single Group Assignment||Supportive Care||None (Open Label)||||||
1354795|NCT02882555|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1354796|NCT02882542|Randomized|Crossover Assignment||Basic Science||Single||||||t
1354797|NCT02882529|Randomized|Crossover Assignment||Basic Science||Single||||||t
1354798|NCT02882516|Randomized|Crossover Assignment||Basic Science||Single||||||t
1354799|NCT02882503||Single Group Assignment||Treatment||None (Open Label)||||||
1354800|NCT02882490|Randomized|Parallel Assignment||Treatment||Single||||||t
1354801|NCT02882477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354802|NCT02882464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354803|NCT02882451|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1354804|NCT02882438|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354805|NCT02882425|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1354806|NCT02882412|||Cohort||Prospective|||||||
1354807|NCT02882399||Single Group Assignment||Treatment||None (Open Label)||||||
1354808|NCT02882386|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1354809|NCT02882373|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354810|NCT02882360|Randomized|Factorial Assignment||Health Services Research||Triple|||t|t||t
1354811|NCT02882347||Single Group Assignment||Treatment||None (Open Label)||||||
1354812|NCT02882334|Randomized|Parallel Assignment||Other||Double|||||t|t
1354813|NCT02882321|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354814|NCT02882308|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1354815|NCT02882295|||Other||Cross-Sectional|||||||
1354816|NCT02882282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354817|NCT02882269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354818|NCT02882256|Randomized|Parallel Assignment||Treatment||Single||||||t
1354819|NCT02882243|||Cohort||Prospective|||||||
1354820|NCT02882230|||Cohort||Prospective|||||||
1354821|NCT02882217|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1354822|NCT02882204|||Cohort||Prospective|||||||
1354823|NCT02882191||Single Group Assignment||Treatment||None (Open Label)||||||
1354824|NCT02882178|||Case Control|||||||||
1354825|NCT02882165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354826|NCT02882152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354827|NCT02882139|||Case-Only||Other|||||||
1354828|NCT02882126||Single Group Assignment||Treatment||None (Open Label)||||||
1354829|NCT02882113|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354830|NCT02882100|Randomized|Parallel Assignment||Prevention||Single||||||t
1354831|NCT02882087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354832|NCT02882074|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1354833|NCT02882061|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1354834|NCT02882048|Randomized|Parallel Assignment||Treatment||Single||||||t
1354835|NCT02882035|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1354836|NCT02882022||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354837|NCT02882009||Single Group Assignment||Treatment||None (Open Label)||||||
1354838|NCT02881996|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354839|NCT02881983|||Case-Control||Prospective|||||||
1354840|NCT02881970||Single Group Assignment||Treatment||None (Open Label)||||||
1354841|NCT02881957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354842|NCT02881944|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354843|NCT02881931|||Other||Prospective|||||||
1354844|NCT02881918|||Case-Only||Prospective|||||||
1354845|NCT02881905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354846|NCT02881892|||Case-Only||Cross-Sectional|||||||
1354847|NCT02881879||Single Group Assignment||Treatment||None (Open Label)||||||
1354848|NCT02881866|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1354849|NCT02881853|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1354850|NCT02881840||Single Group Assignment||Treatment||None (Open Label)||||||
1354851|NCT02881827|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1354852|NCT02881814||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354853|NCT02881801|||Cohort||Prospective|||||||
1354854|NCT02881788|||Ecologic or Community||Prospective|||||||
1354855|NCT02881775|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1354856|NCT02881762|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354857|NCT02881749||Single Group Assignment||Treatment||None (Open Label)||||||
1354858|NCT02881736|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354859|NCT02881723|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1354860|NCT02881710|||Case-Only||Prospective|||||||
1354861|NCT02881697|||Other||Prospective|||||||
1354862|NCT02881684|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1354863|NCT02881671|||Family-Based||Prospective|||||||
1354864|NCT02881658|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354865|NCT02881645|Randomized|Parallel Assignment||Other||Single||||t||
1354866|NCT02881632|||Cohort||Prospective|||||||
1354867|NCT02881619|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1354868|NCT02881606|Randomized|Parallel Assignment||Treatment||Single||||||t
1354869|NCT02881593|||Cohort||Prospective|||||||
1354870|NCT02881580|||Cohort||Retrospective|||||||
1354871|NCT02881567||Single Group Assignment||Treatment||None (Open Label)||||||
1354872|NCT02881554||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354873|NCT02881541|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1354874|NCT02881528|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354875|NCT02881515|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1354876|NCT02881502|||Case Control||Prospective|||||||
1354877|NCT02881489||Single Group Assignment||Treatment||None (Open Label)||||||
1354878|NCT02881476||Single Group Assignment||Treatment||None (Open Label)||||||
1354879|NCT02881463||Single Group Assignment||Prevention||None (Open Label)||||||
1354880|NCT02881450|||Cohort||Cross-Sectional|||||||
1354881|NCT02881437||Single Group Assignment||Treatment||None (Open Label)||||||
1354882|NCT02881424|||Case-Control||Prospective|||||||
1354883|NCT02881411|Randomized|Parallel Assignment||Treatment||Single||||||t
1354884|NCT02881398|Randomized|Parallel Assignment||Diagnostic||Triple||||t|t|t
1354885|NCT02881385|||Case-Crossover||Prospective|||||||
1354886|NCT02881372||Single Group Assignment||Other||None (Open Label)||||||
1354887|NCT02881359|||Cohort||Other|||||||
1354888|NCT02881346|||Cohort||Prospective|||||||
1354889|NCT02881333|||Cohort||Prospective|||||||
1354890|NCT02881320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1354891|NCT02881307|Randomized|Parallel Assignment||Other||Triple|Ultrasonographer and joint assessor are blinded to the diet intervention and to each others assessments.|Randomized Controlled Clinical Trial||t|t|t
1354892|NCT02881294|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354893|NCT02881281|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1354894|NCT02881268|||Case-Control||Prospective|||||||
1354895|NCT02881255|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354896|NCT02881242||Single Group Assignment||Treatment||None (Open Label)||||||
1354897|NCT02881229|||Cohort||Other|||||||
1354898|NCT02881216|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354899|NCT02881203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354900|NCT02881190||Single Group Assignment||Treatment||None (Open Label)||||||
1354901|NCT02881177|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1354902|NCT02881164|Non-Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1354903|NCT02881151||Single Group Assignment||Treatment||None (Open Label)||||||
1354904|NCT02881138||Single Group Assignment||Treatment||None (Open Label)||||||
1354905|NCT02881125||Single Group Assignment||Treatment||None (Open Label)||||||
1354906|NCT02881112||Single Group Assignment||Treatment||None (Open Label)||||||
1354907|NCT02881099|||Cohort||Prospective|||||||
1354908|NCT02881086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354909|NCT02881073|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1354910|NCT02881060|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1354911|NCT02881047||Single Group Assignment||Supportive Care||||||||
1354912|NCT02881034|||Cohort||Retrospective|||||||
1354913|NCT02881021|Randomized|Parallel Assignment||Treatment||Single||||||t
1354914|NCT02881008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354915|NCT02880995|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354916|NCT02880982|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1354917|NCT02880969||Single Group Assignment||Health Services Research||None (Open Label)||||||
1354918|NCT02880956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354919|NCT02880943|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354920|NCT02880930||Single Group Assignment||Prevention||None (Open Label)||||||
1354921|NCT02880917|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1354922|NCT02880904|||Cohort||Other|||||||
1354923|NCT02880891|Randomized|Parallel Assignment||Treatment||Single||||t||
1354924|NCT02880878|Randomized|Parallel Assignment||Treatment||Single||||||t
1354925|NCT02880865|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354926|NCT02880852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1354927|NCT02880839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354928|NCT02880826|||Case-Only||Prospective|||||||
1354929|NCT02880813|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1354930|NCT02880800|Randomized|Parallel Assignment||Prevention||Single||||||t
1354931|NCT02880787|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1354932|NCT02880774|Randomized|Parallel Assignment||Treatment||Single|||||t|
1354933|NCT02880761|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354934|NCT02880748|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354935|NCT02880735||Single Group Assignment||Treatment||None (Open Label)||||||
1354936|NCT02880722|||Other||Prospective|||||||
1354937|NCT02880709|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1354938|NCT02880696|Randomized|Parallel Assignment||||None (Open Label)||||||
1354939|NCT02880683||Single Group Assignment||||None (Open Label)||||||
1354940|NCT02880670||Single Group Assignment||Treatment||None (Open Label)||||||
1354941|NCT02880657|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1354942|NCT02880644|||Cohort||Prospective|||||||
1354943|NCT02880631|||Cohort||Prospective|||||||
1354944|NCT02880618|||Cohort||Prospective|||||||
1354945|NCT02880605|||Cohort||Prospective|||||||
1354946|NCT02880592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354947|NCT02880579|||Case-Only||Prospective|||||||
1354948|NCT02880566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354949|NCT02880553|||Other||Cross-Sectional|||||||
1354950|NCT02880540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354951|NCT02880527|||Cohort||Prospective|||||||
1354952|NCT02880514|Randomized|Parallel Assignment||Treatment||Single|||t|||
1354953|NCT02880501||Single Group Assignment||Treatment||None (Open Label)||||||
1354954|NCT02880488|||||Cross-Sectional|||||||
1354955|NCT02880475|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1354956|NCT02880462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354957|NCT02880449|Randomized|Parallel Assignment||Prevention||Single||||||t
1354958|NCT02880436|||Cohort||Retrospective|||||||
1354959|NCT02880423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354960|NCT02880410||Single Group Assignment||Treatment||None (Open Label)||||||
1354961|NCT02880397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1354962|NCT02880384||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354963|NCT02880371|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1354964|NCT02880358|||Cohort||Prospective|||||||
1354965|NCT02880345||Parallel Assignment||Treatment||||||||
1354966|NCT02880332|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1354967|NCT02880319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1354968|NCT02880306|||Case Control||Retrospective|||||||
1354969|NCT02880293||Single Group Assignment||Treatment||None (Open Label)||||||
1354970|NCT02880280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354971|NCT02880267||Single Group Assignment||Other||None (Open Label)||||||
1354972|NCT02880254|Randomized|Parallel Assignment||||Single|||||t|
1354973|NCT02880241|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354974|NCT02880228||Single Group Assignment||Treatment||None (Open Label)||||||
1354975|NCT02880215|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1354976|NCT02880202||Single Group Assignment||Supportive Care||None (Open Label)||||||
1354977|NCT02880189||Single Group Assignment||Supportive Care||None (Open Label)||||||
1354978|NCT02880176|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1354979|NCT02880163|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1354980|NCT02880150|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1354981|NCT02880137||Single Group Assignment||Diagnostic||None (Open Label)||||||
1354982|NCT02880124|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1354983|NCT02880111|||Case-Control||Prospective|||||||
1354984|NCT02880098|||Cohort||Prospective|||||||
1354985|NCT02880085|||Case-Crossover||Prospective|||||||
1354986|NCT02880072|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354987|NCT02880059|||Case-Control||Prospective|||||||
1354988|NCT02880046|||Cohort||Cross-Sectional|||||||
1354989|NCT02880033|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1354990|NCT02880020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1354991|NCT02880007||Single Group Assignment||Treatment||None (Open Label)||||||
1354992|NCT02879994||Single Group Assignment||Treatment||None (Open Label)||||||
1354993|NCT02879981|||Cohort||Prospective|||||||
1354994|NCT02879968|||Case-Only||Cross-Sectional|||||||
1354995|NCT02879955|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1354996|NCT02879942|||Cohort||Prospective|||||||
1354997|NCT02879929|||Cohort||Prospective|||||||
1354998|NCT02879916|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1354999|NCT02879903|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1355000|NCT02879890|||Case-Only||Prospective|||||||
1355001|NCT02879877|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1355002|NCT02879864|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355003|NCT02879851|||||Prospective|||||||
1355004|NCT02879838|||Cohort||Prospective|||||||
1355005|NCT02879825|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355006|NCT02879812|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1355007|NCT02879799|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1355008|NCT02879786|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355009|NCT02879773|||Cohort||Prospective|||||||
1355010|NCT02879760||Single Group Assignment||Treatment||None (Open Label)||||||
1355011|NCT02879747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355012|NCT02879734|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1355013|NCT02879721|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1355014|NCT02879708|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1355015|NCT02879695||Single Group Assignment||Treatment||None (Open Label)||||||
1355016|NCT02879682|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1355017|NCT02879669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355018|NCT02879656|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1355019|NCT02879643||Single Group Assignment||Treatment||None (Open Label)||||||
1355020|NCT02879630|||Case-Control||Prospective|||||||
1355021|NCT02879617||Single Group Assignment||Treatment||None (Open Label)||||||
1355022|NCT02879604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355023|NCT02879591|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1355024|NCT02879578||Single Group Assignment||Treatment||None (Open Label)||||||
1355025|NCT02879565||Single Group Assignment||||None (Open Label)||||||
1355026|NCT02879552|||Case-Only||Prospective|||||||
1355027|NCT02879539||Single Group Assignment||Treatment||None (Open Label)||||||
1355028|NCT02879526||Single Group Assignment||Treatment||None (Open Label)||||||
1355029|NCT02879513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355030|NCT02879500|||||Prospective|||||||
1355031|NCT02879487|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355032|NCT02879474|||Cohort||Prospective|||||||
1355033|NCT02879461|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1355034|NCT02879448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355035|NCT02879435|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1355036|NCT02879422|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355037|NCT02879409|Randomized|Parallel Assignment||Other||None (Open Label)|This is an randomized open label clinical trial.|||||
1355038|NCT02879396||Single Group Assignment||Prevention||None (Open Label)||||||
1355039|NCT02879383|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1355040|NCT02879370||Single Group Assignment||Prevention||None (Open Label)||||||
1355041|NCT02879357|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1355042|NCT02879344||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355043|NCT02879331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355044|NCT02879318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355045|NCT02879305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355046|NCT02879292|||Case-Only||Retrospective|||||||
1355047|NCT02879279|Randomized|Parallel Assignment||Treatment||Single||||||t
1355048|NCT02879266|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355049|NCT02879253|||Case-Only||Retrospective|||||||
1355050|NCT02879240|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1355051|NCT02879227|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1355052|NCT02879214||Single Group Assignment||Treatment||None (Open Label)||||||
1355053|NCT02879201|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355054|NCT02879188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355055|NCT02879175|||Other||Prospective|||||||
1355056|NCT02879162||Single Group Assignment||Treatment||None (Open Label)||||||
1355057|NCT02879149|||Cohort||Prospective|||||||
1355058|NCT02879136|Randomized|Parallel Assignment||Treatment||Single|||||t|
1355059|NCT02879123|||Other||Prospective|||||||
1355060|NCT02879110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355061|NCT02879097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355062|NCT02879084|||Cohort||Prospective|||||||
1355063|NCT02879071|||Other||Prospective|||||||
1355064|NCT02879058|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355065|NCT02879045||Single Group Assignment||Prevention||None (Open Label)||||||
1355066|NCT02879032|||Other||Cross-Sectional|||||||
1355067|NCT02879019|Randomized|Parallel Assignment||Treatment||Single||||||t
1355068|NCT02879006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355069|NCT02878993|||Cohort||Prospective|||||||
1355070|NCT02878980||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355071|NCT02878967|||Other||Prospective|||||||
1355072|NCT02878954|Randomized|Parallel Assignment||Treatment||Single||||||t
1355073|NCT02878941||Single Group Assignment||Basic Science||None (Open Label)||||||
1355074|NCT02878928|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1355075|NCT02878915|Randomized|Parallel Assignment||Other||Single|||t|||
1355076|NCT02878902|||Cohort||Cross-Sectional|||||||
1355077|NCT02878889||Single Group Assignment||Treatment||None (Open Label)||||||
1355078|NCT02878876|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1355079|NCT02878863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355080|NCT02878850|Randomized|Parallel Assignment||Treatment||Single||||||t
1355081|NCT02878837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355082|NCT02878824|||Other||Cross-Sectional|||||||
1355083|NCT02878811|||Cohort||Prospective|||||||
1355084|NCT02878798|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355085|NCT02878785||Single Group Assignment||Treatment||None (Open Label)||||||
1355086|NCT02878772|Randomized|Parallel Assignment||Treatment||Single||||||t
1355087|NCT02878759||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355088|NCT02878746|Randomized|Parallel Assignment||Treatment||Single||||||t
1355089|NCT02878733|||Cohort||Retrospective|||||||
1355090|NCT02878720|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355091|NCT02878707|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1355092|NCT02878694||Single Group Assignment||Treatment||None (Open Label)||||||
1355093|NCT02878681|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355094|NCT02878668|||Case-Only||Prospective|||||||
1355095|NCT02878655|||Cohort||Prospective|||||||
1355096|NCT02878642|||Cohort||Prospective|||||||
1355097|NCT02878629|||Cohort||Prospective|||||||
1355098|NCT02878616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355099|NCT02878603||Single Group Assignment||Treatment||None (Open Label)||||||
1355100|NCT02878590||Single Group Assignment||Treatment||None (Open Label)||||||
1355101|NCT02878577|||Cohort||Prospective|||||||
1355102|NCT02878564||Single Group Assignment||Basic Science||None (Open Label)||||||
1355103|NCT02878551||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355104|NCT02878538|Non-Randomized|Crossover Assignment||Other||Single|||t|||
1355105|NCT02878525|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1355106|NCT02878512|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1355107|NCT02878499||Single Group Assignment||||None (Open Label)||||||
1355108|NCT02878486|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355109|NCT02878473||Single Group Assignment||Treatment||None (Open Label)||||||
1355110|NCT02878460|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355111|NCT02878447|Randomized|Parallel Assignment||Treatment||Single||||||t
1355112|NCT02878434|||Cohort||Prospective|||||||
1355113|NCT02878421|Randomized|Parallel Assignment||Other||Single|||t|||
1355114|NCT02878408|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355115|NCT02878395|||Cohort||Prospective|||||||
1355116|NCT02878382|Randomized|Parallel Assignment||Treatment||Single||||||t
1355117|NCT02878369|||Case-Only||Prospective|||||||
1355118|NCT02878356|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1355119|NCT02878343|Randomized|Factorial Assignment||Treatment||Single|||||t|
1355120|NCT02878330|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355121|NCT02878317|||Cohort||Prospective|||||||
1355122|NCT02878304|||Cohort||Prospective|||||||
1355123|NCT02878291|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355124|NCT02878278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355125|NCT02878265|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355126|NCT02878252|||Other||Cross-Sectional|||||||
1355127|NCT02878239|||Case Control||Prospective|||||||
1355128|NCT02878226|||Case-Only||Prospective|||||||
1355129|NCT02878213||Single Group Assignment||Treatment||None (Open Label)||||||
1355130|NCT02878200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355131|NCT02878187|||Case-Control||Prospective|||||||
1355132|NCT02878174|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355133|NCT02878161|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355134|NCT02878148||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355135|NCT02878135|Randomized|Parallel Assignment||Prevention||Single|||t|||
1355136|NCT02878122|||Cohort||Retrospective|||||||
1355137|NCT02878109|||Case-Only||Prospective|||||||
1355138|NCT02878096||Single Group Assignment||Basic Science||None (Open Label)||||||
1355139|NCT02878083||Single Group Assignment||Treatment||None (Open Label)||||||
1355140|NCT02878070|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1355141|NCT02878057||Single Group Assignment||Treatment||None (Open Label)||||||
1355142|NCT02878044||Single Group Assignment||Health Services Research||None (Open Label)||||||
1355143|NCT02878031||Single Group Assignment||Treatment||None (Open Label)||||||
1355144|NCT02878018|||Cohort||Prospective|||||||
1355145|NCT02878005|Randomized|Crossover Assignment||Treatment||Single|||||t|
1355146|NCT02877992|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1355147|NCT02877979|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1355148|NCT02877966|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1355149|NCT02877953|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355150|NCT02877940|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355151|NCT02877927|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1355152|NCT02877914|||Other||Retrospective|||||||
1355153|NCT02877901|Randomized|Crossover Assignment||Treatment||Single|||t|||
1355154|NCT02877888|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1355155|NCT02877875|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1355156|NCT02877862|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1355157|NCT02877849|||Case-Control||Other|||||||
1355158|NCT02877836|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355159|NCT02877823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355160|NCT02877810|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1355161|NCT02877797|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1355162|NCT02877784||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355163|NCT02877771||Single Group Assignment||||None (Open Label)||||||
1355164|NCT02877758|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1355165|NCT02877745|||Cohort||Prospective|||||||
1355166|NCT02877732|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355167|NCT02877719|||Cohort||Cross-Sectional|||||||
1355168|NCT02877706|||Cohort||Prospective|||||||
1355169|NCT02877693||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355170|NCT02877680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355171|NCT02877667||Single Group Assignment||Treatment||None (Open Label)||||||
1355172|NCT02877654||Single Group Assignment||Screening||None (Open Label)||||||
1355173|NCT02877641|Randomized|Parallel Assignment||Prevention||Double||||||
1355174|NCT02877628|||Case-Only||Prospective|||||||
1355175|NCT02877615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355176|NCT02877602|||Other||Other|||||||
1355177|NCT02877589|||Case-Only||Prospective|||||||
1355178|NCT02877576||Single Group Assignment||Basic Science||None (Open Label)||||||
1355179|NCT02877563|||Cohort||Prospective|||||||
1355180|NCT02877550||Single Group Assignment||Treatment||None (Open Label)||||||
1355181|NCT02877537|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355182|NCT02877524|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1355183|NCT02877511|Randomized|Parallel Assignment||Other||Single|||t|||
1355184|NCT02877498|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1355185|NCT02877485|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1355186|NCT02877472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355187|NCT02877459||Single Group Assignment||Treatment||None (Open Label)||||||
1355188|NCT02877446|||Case-Only||Prospective|||||||
1355189|NCT02877433|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355190|NCT02877420|Randomized|Parallel Assignment||Other||Double|||||t|t
1355191|NCT02877407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355192|NCT02877394|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355193|NCT02877381|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1355194|NCT02877368|||Case-Only||Retrospective|||||||
1355195|NCT02877355||Single Group Assignment||Treatment||None (Open Label)||||||
1355196|NCT02877342|||Cohort||Prospective|||||||
1355197|NCT02877329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355198|NCT02877316|Randomized|Parallel Assignment||Prevention||Single||||||t
1355199|NCT02877303||Single Group Assignment||Treatment||None (Open Label)||||||
1355200|NCT02877290|Randomized|Crossover Assignment||Treatment||Single||||||t
1355201|NCT02877277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355202|NCT02877264|Randomized|Crossover Assignment||||None (Open Label)||||||
1355203|NCT02877251|||Cohort||Other|||||||
1355204|NCT02877238|Randomized|Parallel Assignment||Prevention||Single|||t|||
1355205|NCT02877225|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355206|NCT02877212||Single Group Assignment||Treatment||None (Open Label)||||||
1355207|NCT02877199|||Cohort||Retrospective|||||||
1355208|NCT02877186|Randomized|Parallel Assignment||||Single||||||t
1355209|NCT02877173|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355210|NCT02877160|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355211|NCT02877147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355212|NCT02877134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355213|NCT02877121|||Cohort|||||||||
1355214|NCT02877108|||Cohort||Prospective|||||||
1355215|NCT02877095||Single Group Assignment||Treatment||None (Open Label)||||||
1355216|NCT02877082||Single Group Assignment||Prevention||None (Open Label)||||||
1355217|NCT02877069||Single Group Assignment||Treatment||None (Open Label)||||||
1355218|NCT02877056|||Cohort||Prospective|||||||
1355219|NCT02877043|||Cohort||Retrospective|||||||
1355220|NCT02877030|Randomized|Crossover Assignment||Treatment||Single|||||t|
1355221|NCT02877017|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||pre-post intervention study||||
1355222|NCT02877004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355223|NCT02876991||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355224|NCT02876978||Single Group Assignment||Treatment||None (Open Label)||||||
1355225|NCT02876965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355226|NCT02876952|Randomized|Parallel Assignment||Treatment||Single|||||t|
1355227|NCT02876939|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355228|NCT02876926|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355229|NCT02876913|||Cohort||Prospective|||||||
1355230|NCT02876900|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1355231|NCT02876887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355232|NCT02876874|||||Prospective|||||||
1355233|NCT02876861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355234|NCT02876848|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1355235|NCT02876835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355236|NCT02876822||Single Group Assignment||Treatment||None (Open Label)||||||
1355237|NCT02876809|||Cohort||Cross-Sectional|||||||
1355238|NCT02876796|Randomized|Crossover Assignment||||Double|||t||t|
1355239|NCT02876783|||Case-Only||Prospective|||||||
1355240|NCT02876770|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355241|NCT02876757|||Cohort||Retrospective|||||||
1355242|NCT02876744|||Other||Cross-Sectional|||||||
1355243|NCT02876731||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355244|NCT02876718|||Cohort||Prospective|||||||
1355245|NCT02876705||Single Group Assignment||Health Services Research||None (Open Label)||||||
1355246|NCT02876692|||Cohort||Prospective|||||||
1355247|NCT02876679|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355248|NCT02876666|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1355249|NCT02876653|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355250|NCT02876640||Single Group Assignment||Prevention||None (Open Label)||||||
1355251|NCT02876627||Single Group Assignment||Treatment||None (Open Label)||||||
1355252|NCT02876614|||Cohort||Retrospective|||||||
1355253|NCT02876601|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1355254|NCT02876588|Randomized|Factorial Assignment||||Single|||||t|
1355255|NCT02876575||Single Group Assignment||Treatment||None (Open Label)||||||
1355256|NCT02876562|Randomized|Parallel Assignment||Treatment||Single||||||t
1355257|NCT02876549|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355258|NCT02876536|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355259|NCT02876523|||Cohort||Prospective|||||||
1355260|NCT02876510||Single Group Assignment||Treatment||None (Open Label)||||||
1355261|NCT02876497||Single Group Assignment||||None (Open Label)||||||
1355262|NCT02876484|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355263|NCT02876471|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355264|NCT02876458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355265|NCT02876445||Single Group Assignment||||None (Open Label)||||||
1355266|NCT02876432|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1355267|NCT02876419|||Cohort||Other|||||||
1355268|NCT02876406|||Cohort||Prospective|||||||
1355269|NCT02876393|||Case Control||Prospective|||||||
1355270|NCT02876380|||Cohort||Other|||||||
1355271|NCT02876367|||Cohort||Prospective|||||||
1355272|NCT02876354||Single Group Assignment||Treatment||None (Open Label)||||||
1355273|NCT02876341|||Cohort||Retrospective|||||||
1355274|NCT02876328|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355275|NCT02876315|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355276|NCT02876302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355277|NCT02876289|||Cohort||Retrospective|||||||
1355278|NCT02876276|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1355279|NCT02876263|||Cohort||Prospective|||||||
1355280|NCT02876250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355281|NCT02876237||Single Group Assignment||Other||None (Open Label)||||||
1355282|NCT02876224|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1355283|NCT02876211|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355284|NCT02876198|||Cohort||Prospective|||||||
1355285|NCT02876185|||Cohort||Prospective|||||||
1355286|NCT02876172||Single Group Assignment||Treatment||None (Open Label)||||||
1355287|NCT02876159|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355288|NCT02876146||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355289|NCT02876133|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355290|NCT02876120||Single Group Assignment||Treatment||Single|||||t|
1355291|NCT02876107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355292|NCT02876094||Single Group Assignment||Treatment||None (Open Label)||||||
1355293|NCT02876081||Single Group Assignment||Treatment||None (Open Label)||||||
1355294|NCT02876055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355295|NCT02876042|||Cohort||Prospective|||||||
1355296|NCT02876029|Randomized|Crossover Assignment||Prevention||Single|||t|||
1355297|NCT02876016||Single Group Assignment||Basic Science||None (Open Label)||||||
1355298|NCT02876003||Single Group Assignment||Treatment||None (Open Label)||||||
1355299|NCT02875990||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355300|NCT02875977|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|No masking is used in this study|Participants are randomized to standard counseling for pelvic floor physical therapy (PFPT) or to an experimental counseling group that comprises both standard counseling and a 4-minute PFPT educational video using a 1:1 allocation||||
1355301|NCT02875964||Single Group Assignment||Basic Science||None (Open Label)||||||
1355302|NCT02875951|||Cohort||Prospective|||||||
1355303|NCT02875938||Single Group Assignment||Treatment||None (Open Label)||||||
1355304|NCT02875925|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1355305|NCT02875912|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Prospective before and after intervention evaluation||||
1355306|NCT02875899|||Cohort||Prospective|||||||
1355307|NCT02875886|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355308|NCT02875873|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1355309|NCT02875860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355310|NCT02875847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355311|NCT02875834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355312|NCT02875821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355313|NCT02875808|||Cohort||Prospective|||||||
1355314|NCT02875795||Single Group Assignment||Prevention||None (Open Label)||||||
1355315|NCT02875782|Randomized|Parallel Assignment||Treatment||Single||||||t
1355316|NCT02875769|Randomized|Parallel Assignment||Prevention||Single||||t||
1355317|NCT02875756|Randomized|Parallel Assignment||Other||Single||||||t
1355318|NCT02875743||Single Group Assignment||Prevention||None (Open Label)||||||
1355319|NCT02875730||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355320|NCT02875717|||Cohort||Retrospective|||||||
1355321|NCT02875704|||Case-Control||Prospective|||||||
1355322|NCT02875691|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1355323|NCT02875678|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1355324|NCT02875665||Single Group Assignment||Other||None (Open Label)||The intervention is the using geko device||||
1355325|NCT02875652||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355326|NCT02875639|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1355327|NCT02875626||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355328|NCT02875613||Single Group Assignment||Treatment||None (Open Label)||||||
1355329|NCT02875600||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355330|NCT02875587|Randomized|Parallel Assignment||Prevention||Single||||||t
1355331|NCT02875574|||Cohort||Retrospective|||||||
1355332|NCT02875561|Randomized|Parallel Assignment||Treatment||Single||||||t
1355333|NCT02875548||Single Group Assignment||Treatment||None (Open Label)||||||
1355334|NCT02875535|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355335|NCT02875522|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1355336|NCT02875509|||Cohort||Prospective|||||||
1355337|NCT02875496|||Cohort||Prospective|||||||
1355338|NCT02875483|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355339|NCT02875470|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355340|NCT02875457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355341|NCT02875444|||Case-Only||Retrospective|||||||
1355342|NCT02875431|||Cohort||Prospective|||||||
1355343|NCT02875418||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355344|NCT02875405|Randomized|Parallel Assignment||Prevention||Single|||t|||
1355345|NCT02875392|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1355346|NCT02875379|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355347|NCT02875366|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1355348|NCT02875353|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355349|NCT02875340||Single Group Assignment||Treatment||None (Open Label)||||||
1355350|NCT02875327|||Cohort||Retrospective|||||||
1355351|NCT02875314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355352|NCT02875301|Randomized|Parallel Assignment||Basic Science||Double||Study participants will be randomly assigned to one of three exercise intervention arms.|||t|t
1355353|NCT02875288|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355354|NCT02875275|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1355355|NCT02875262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355356|NCT02875249|||||Prospective|||||||
1355357|NCT02875236|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1355358|NCT02875223||Single Group Assignment||Treatment||None (Open Label)||||||
1355359|NCT02875210||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355360|NCT02875197|||Case-Control||Cross-Sectional|||||||
1355361|NCT02875184|||Cohort||Prospective|||||||
1355362|NCT02875171|||Cohort||Prospective|||||||
1355363|NCT02875158|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1355364|NCT02875145|||Cohort||Retrospective|||||||
1355365|NCT02875132||Single Group Assignment||Treatment||None (Open Label)||||||
1355366|NCT02875119|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1355367|NCT02875106|||Cohort||Prospective|||||||
1355368|NCT02875093||Single Group Assignment||Treatment||None (Open Label)||||||
1355369|NCT02875080|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355370|NCT02875067||Single Group Assignment||Treatment||None (Open Label)||||||
1355371|NCT02875054|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355372|NCT02875041|Randomized|Parallel Assignment||Other||Double|||t||t|
1355373|NCT02875028|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1355374|NCT02875015|Randomized|Parallel Assignment||Prevention||Single|||t|||
1355375|NCT02875002||Single Group Assignment||Treatment||None (Open Label)||||||
1355376|NCT02874989||Single Group Assignment||Basic Science||None (Open Label)||||||
1355377|NCT02874976|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1355378|NCT02874963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355379|NCT02874950|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1355380|NCT02874937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355381|NCT02874924|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1355382|NCT02874911||Single Group Assignment||Treatment||None (Open Label)||||||
1355383|NCT02874898|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1355384|NCT02874885|||Case-Control||Prospective|||||||
1355385|NCT02874872|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355386|NCT02874859|||Case-Only||Retrospective|||||||
1355387|NCT02874846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355388|NCT02874833|Randomized|Parallel Assignment||Treatment||Single||||||t
1355389|NCT02874820||Single Group Assignment||Basic Science||None (Open Label)||||||
1355390|NCT02874807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355391|NCT02874794||Parallel Assignment||Treatment||Triple|||t|t|t|
1355392|NCT02874781|||Cohort||Cross-Sectional|||||||
1355393|NCT02874768|Randomized|Parallel Assignment||Basic Science||Single||||||t
1355394|NCT02874755|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1355395|NCT02874742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355396|NCT02874729||||||||||||
1355397|NCT02874716|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1355398|NCT02874703|||Case-Control||Cross-Sectional|||||||
1355399|NCT02874690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355400|NCT02874677|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1355401|NCT02874664||Single Group Assignment||Treatment||None (Open Label)||||||
1355402|NCT02874651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355403|NCT02874638|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1355404|NCT02874625|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1355405|NCT02874612|||Cohort||Prospective|||||||
1355406|NCT02874599||Single Group Assignment||Health Services Research||None (Open Label)||||||
1355407|NCT02874586||Single Group Assignment||Treatment||None (Open Label)||||||
1355408|NCT02874573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355409|NCT02874560|||Cohort||Prospective|||||||
1355410|NCT02874547|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355411|NCT02874534|Randomized|Parallel Assignment||Treatment||Single||||||t
1355412|NCT02874521|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1355413|NCT02874508|||Case-Only||Prospective|||||||
1355414|NCT02874495|||Case-Only||Prospective|||||||
1355415|NCT02874482|||Case-Control||Prospective|||||||
1355416|NCT02874469|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355417|NCT02874456||Single Group Assignment||Basic Science||None (Open Label)||||||
1355418|NCT02874443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355419|NCT02874430||Single Group Assignment||Treatment||None (Open Label)||||||
1355420|NCT02874417|Randomized|Parallel Assignment||Prevention||Single|||t|||
1355421|NCT02874404|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355422|NCT02874391|||Other||Prospective|||||||
1355423|NCT02874378|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1355424|NCT02874365|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355425|NCT02874352|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355426|NCT02874339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355427|NCT02874326||Single Group Assignment||Treatment||None (Open Label)||||||
1355428|NCT02874313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355429|NCT02874300|Randomized|Parallel Assignment||Treatment||Single||||||t
1355430|NCT02874287|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355431|NCT02874274|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355432|NCT02874261||Single Group Assignment||Treatment||None (Open Label)||||||
1355433|NCT02874248|Randomized|Parallel Assignment||Other||Double|||t||t|
1355434|NCT02874235|Randomized|Parallel Assignment||Treatment||Single|External psychologist performs primary outcome measurement not knowing participants treatment|||||t
1355435|NCT02874222|||Cohort||Prospective|||||||
1355436|NCT02874209|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355437|NCT02874196||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355438|NCT02874183|Randomized|Parallel Assignment||Other||Single||||||t
1355439|NCT02874170|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355440|NCT02874157|||Cohort||Prospective|||||||
1355441|NCT02874144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355442|NCT02874131|Randomized|Parallel Assignment||Treatment||Single||||||t
1355443|NCT02874118||Single Group Assignment||Prevention||None (Open Label)||||||
1355444|NCT02874105|Randomized|Parallel Assignment||Treatment||Single||||||t
1355445|NCT02874092|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355446|NCT02874079|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355447|NCT02874066||Single Group Assignment||Treatment||None (Open Label)||||||
1355448|NCT02874053|||Other||Cross-Sectional|||||||
1355449|NCT02874040||Single Group Assignment||Treatment||None (Open Label)||||||
1355450|NCT02874027|||Case Control|||||||||
1355451|NCT02874014||Single Group Assignment||Treatment||None (Open Label)||||||
1355452|NCT02874001|||||Prospective|||||||
1355453|NCT02873988|||Case Control||Cross-Sectional|||||||
1355454|NCT02873975|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1355455|NCT02873962||Single Group Assignment||Treatment||None (Open Label)||||||
1355456|NCT02873949|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355457|NCT02873936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355458|NCT02873923|||Cohort||Retrospective|||||||
1355459|NCT02873910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355460|NCT02873897|Randomized|Crossover Assignment||||None (Open Label)||||||
1355461|NCT02873884|||Cohort||Prospective|||||||
1355462|NCT02873871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355463|NCT02873858|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1355464|NCT02873845|||||Prospective|||||||
1355465|NCT02873832|||||Retrospective|||||||
1355466|NCT02873819|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355467|NCT02873806||Single Group Assignment||Treatment||None (Open Label)||||||
1355468|NCT02873793|||Cohort||Prospective|||||||
1355469|NCT02873780|||Cohort||Prospective|||||||
1355470|NCT02873767|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1355471|NCT02873754||Single Group Assignment||Treatment||None (Open Label)||||||
1355472|NCT02873741||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355473|NCT02873728|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1355542|NCT02872831|Randomized|Parallel Assignment||Treatment||Single|||||t|
1355543|NCT02872818|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1355544|NCT02872805|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355545|NCT02872792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355546|NCT02872779||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355474|NCT02873715|Randomized|Parallel Assignment||Treatment||Double|"Assessor will be blinded to the families group assignment. Coaches will be back up assessor. Coach 1 will be an assessor for families assigned to Coach 2, Coach 2 will collect measures for families assigned to Coach 3, and Coach 3 will collect measures for families assigned to Coach 1. Thus, coaches will not collect height and weight measures for families from their caseload.~Although not possible to guarantee that coaches are blind to condition for families that are not in their caseload due to the families not being blinded, use of a standard protocol (see Appendix C) ensures objective and reliable measurement of the primary outcome. Assessors will be blind to prior heights/weights, further protecting against assessment bias."||||t|t
1355475|NCT02873702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355476|NCT02873689|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355477|NCT02873676|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1355478|NCT02873663|Non-Randomized|Factorial Assignment||Diagnostic||Single|||||t|
1355479|NCT02873650|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||open-label, parallel group||||
1355480|NCT02873637|Randomized|Parallel Assignment||Other||Single|||t|||
1355481|NCT02873624|||Cohort||Prospective|||||||
1355482|NCT02873611||Single Group Assignment||Basic Science||None (Open Label)||||||
1355483|NCT02873598||Single Group Assignment||Treatment||None (Open Label)||||||
1355484|NCT02873585||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355485|NCT02873572|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1355486|NCT02873559|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1355487|NCT02873546|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1355488|NCT02873533||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355489|NCT02873520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355490|NCT02873507||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355491|NCT02873494|||Cohort||Prospective|||||||
1355492|NCT02873481|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355493|NCT02873468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355494|NCT02873455||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355495|NCT02873442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355496|NCT02873429|||Ecologic or Community||Prospective|||||||
1355497|NCT02873416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355498|NCT02873403|Randomized|Crossover Assignment||Treatment||Single|||t|||
1355499|NCT02873390||Single Group Assignment||Treatment||None (Open Label)||||||
1355500|NCT02873377|Randomized|Parallel Assignment||Treatment||None (Open Label)||Study arms will be conducted simultaneously.||||
1355501|NCT02873364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355502|NCT02873351|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355503|NCT02873338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355504|NCT02873325|||Cohort||Other|||||||
1355505|NCT02873312|Randomized|Parallel Assignment||Treatment||Triple|The implanting investigator, the study subjects, and the individuals who assess the outcome measures for each subject will be blinded to the subjects' randomization groups. Each study site's programmers will be unblinded to the randomization assignment and will receive each subject's randomization assignment. The programmers will then set the stimulation parameters and train the subjects on device use.||t|t|t|
1355506|NCT02873299|Randomized|Parallel Assignment||Treatment||Single||||||t
1355507|NCT02873286|Randomized|Parallel Assignment||Other||Single|||t|||
1355508|NCT02873273||Single Group Assignment||Treatment||None (Open Label)||||||
1355509|NCT02873260|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355510|NCT02873247|||Cohort||Prospective|||||||
1355511|NCT02873234|||Cohort||Prospective|||||||
1355512|NCT02873221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355513|NCT02873208||Single Group Assignment||Treatment||None (Open Label)||||||
1355514|NCT02873195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355515|NCT02873182||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355516|NCT02873169|||Cohort||Retrospective|||||||
1355517|NCT02873156|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1355518|NCT02873143|||Cohort||Prospective|||||||
1355519|NCT02873130|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355520|NCT02873117|||Cohort||Retrospective|||||||
1355521|NCT02873104|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355522|NCT02873091|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355523|NCT02873078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355524|NCT02873065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355525|NCT02873052|||Case-Only||Prospective|||||||
1355526|NCT02873039|||Cohort||Prospective|||||||
1355527|NCT02873026|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355528|NCT02873013|||Cohort||Prospective|||||||
1355529|NCT02873000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355530|NCT02872987|||Other||Prospective|||||||
1355531|NCT02872974|||Cohort||Prospective|||||||
1355532|NCT02872961|||Case-Control||Cross-Sectional|||||||
1355533|NCT02872948|||Cohort||Prospective|||||||
1355534|NCT02872935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355535|NCT02872922|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1355536|NCT02872909|Randomized|Parallel Assignment||Treatment||Single||||||t
1355537|NCT02872896|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355538|NCT02872883|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1355539|NCT02872870|||Case Control||Prospective|||||||
1355540|NCT02872857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355541|NCT02872844||||||||||||
1355547|NCT02872766||Single Group Assignment||Treatment||None (Open Label)||||||
1355548|NCT02872753|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355549|NCT02872740|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355550|NCT02872727|||Cohort||Cross-Sectional|||||||
1355551|NCT02872714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355552|NCT02872701||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355553|NCT02872688||Single Group Assignment||Basic Science||None (Open Label)||||||
1355554|NCT02872675|Non-Randomized|Crossover Assignment||Treatment||Quadruple|"Only the company providing the nutritional supplements (HOST Therabiomics) will be aware of the supplement blinding protocol.~Upon trial completion (e.g. the final visit of the final participant), the chief investigator will contact HOST Therabiomics to obtain information on the supplement blinding protocol. Should any participants, care providers, investigators, or outcome assessors become aware of the blinding protocol during the trial they will be informed not to disclose this information to any other relevant personnel. Participants who become aware of the blinding protocol during participation would be withdrawn from the trial."|"Participants will be administered a prebiotic (galactooligosaccharide; HOST-DM059), and a taste/appearance matched placebo (Maltodextrin) in a, double-blind, placebo-controlled, crossover design.~The nutritional intervention will be completed over a twelve week period, consisting of two, four-week supplementation phases separated by a four-week wash out period. Participants will be randomly allocated one of the nutritional supplements during phase one (labelled as either 'L', or 'X'), and asked to consume one powdered sachet every morning (3.6g). Participants will then complete a four week wash out period, before being assigned the remaining nutritional supplement during phase two. Sachets can be reconstituted in tea/coffee/fruit juice, or sprinkled over cereal etc."|t|t|t|t
1355555|NCT02872662|||Cohort||Prospective|||||||
1355556|NCT02872649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355557|NCT02872636||Single Group Assignment||Basic Science||None (Open Label)||||||
1355558|NCT02872623||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355559|NCT02872610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355560|NCT02872597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355561|NCT02872584|||Case-Only||Prospective|||||||
1355562|NCT02872571||Single Group Assignment||Prevention||None (Open Label)||||||
1355563|NCT02872558|Randomized|Parallel Assignment||Treatment||Single|||||t|
1355564|NCT02872545|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1355565|NCT02872532||Single Group Assignment||Treatment||None (Open Label)||||||
1355566|NCT02872519||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355567|NCT02872506|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355568|NCT02872493|||Cohort||Prospective|||||||
1355569|NCT02872480|Randomized|Parallel Assignment||Treatment||Single||||||t
1355570|NCT02872467|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1355571|NCT02872454||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355572|NCT02872441||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355573|NCT02872428|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1355574|NCT02872415|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1355575|NCT02872402|Randomized|Parallel Assignment||Prevention||Single|||||t|
1355576|NCT02872389|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1355577|NCT02872376|||Cohort||Prospective|||||||
1355578|NCT02872363|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1355579|NCT02872350||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355580|NCT02872337|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355581|NCT02872324||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355582|NCT02872311|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355583|NCT02872298||Single Group Assignment||Treatment||None (Open Label)||||||
1355584|NCT02872285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355585|NCT02872272||Single Group Assignment||Treatment||None (Open Label)||||||
1355586|NCT02872259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355587|NCT02872246||Single Group Assignment||Prevention||None (Open Label)||||||
1355588|NCT02872233||Single Group Assignment||Prevention||None (Open Label)||||||
1355589|NCT02872220||Single Group Assignment||Other||Single|||t|||
1355590|NCT02872207|Randomized|Parallel Assignment||Other||Single|||t|||
1355591|NCT02872194|Randomized|Single Group Assignment||Other||Single|||t|||
1355592|NCT02872181|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1355593|NCT02872168|||Case-Only||Prospective|||||||
1355594|NCT02872155|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355595|NCT02872142||Single Group Assignment||Treatment||None (Open Label)||||||
1355596|NCT02872129|||Cohort||Prospective|||||||
1355597|NCT02872116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355598|NCT02872103|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1355599|NCT02872090|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1355600|NCT02872077|Randomized|Parallel Assignment||Treatment||Single||||t||
1355601|NCT02872064||Single Group Assignment||Treatment||None (Open Label)||||||
1355602|NCT02872051|Randomized|Parallel Assignment||Other||Double|||||t|t
1355603|NCT02872038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355604|NCT02872025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355605|NCT02872012||||||||||||
1355606|NCT02871999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355607|NCT02871986|||Cohort||Prospective|||||||
1355608|NCT02871973|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1355609|NCT02871960|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355610|NCT02871947|||Cohort||Prospective|||||||
1355611|NCT02871934|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1355612|NCT02871921|Randomized|Parallel Assignment||Prevention||Single||||||t
1355613|NCT02871908|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355614|NCT02871895|||Cohort||Prospective|||||||
1355615|NCT02871882|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1355616|NCT02871869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355617|NCT02871856||Single Group Assignment||Screening||None (Open Label)||||||
1355618|NCT02871843||Single Group Assignment||Treatment||None (Open Label)||3+3 Dose Escalation||||
1355619|NCT02871830|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355620|NCT02871817|||Other||Prospective|||||||
1355621|NCT02871804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355622|NCT02871791||Single Group Assignment||Treatment||None (Open Label)||||||
1355623|NCT02871778|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1355624|NCT02871765|Randomized|Parallel Assignment||||Single|||t|||
1355625|NCT02871752|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1355626|NCT02871739|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1355627|NCT02871726||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355628|NCT02871713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355629|NCT02871700|Randomized|Parallel Assignment||Treatment||Single||||||t
1355630|NCT02871687|Randomized|Parallel Assignment||Other||Double|||t||t|
1355631|NCT02871674|Randomized|Parallel Assignment||Treatment||Single|||||t|
1355632|NCT02871661|Randomized|Parallel Assignment||Treatment||Single|||||t|
1355633|NCT02871648|Randomized|Crossover Assignment||Other||Double|||t||t|
1355634|NCT02871635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355635|NCT02871622|||Cohort||Prospective|||||||
1355636|NCT02871609|||Cohort||Prospective|||||||
1355637|NCT02871596|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1355638|NCT02871583|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1355639|NCT02871570|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355640|NCT02871557|||Cohort||Prospective|||||||
1355641|NCT02871544|Non-Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1355642|NCT02871531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355643|NCT02871518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355644|NCT02871505|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355645|NCT02871492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355646|NCT02871479|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355647|NCT02871466||Single Group Assignment||Treatment||None (Open Label)||||||
1355648|NCT02871453|Randomized|Parallel Assignment||Treatment||Single||||||t
1355649|NCT02871440|Randomized|Crossover Assignment||Treatment||Single|||||t|
1355650|NCT02871427||Single Group Assignment||Treatment||None (Open Label)||||||
1355651|NCT02871414|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355652|NCT02871401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355653|NCT02871388|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1355654|NCT02871375|Randomized|Crossover Assignment||Treatment||Single||||||t
1355655|NCT02871362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355656|NCT02871349|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1355657|NCT02871336|||Cohort||Prospective|||||||
1355658|NCT02871323||Single Group Assignment||Treatment||None (Open Label)||||||
1355659|NCT02871310|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1355660|NCT02871297||Single Group Assignment||Treatment||None (Open Label)||||||
1355661|NCT02871284|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355662|NCT02871271||Single Group Assignment||Treatment||None (Open Label)||||||
1355663|NCT02871258||Single Group Assignment||Treatment||None (Open Label)||||||
1355664|NCT02871245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355665|NCT02871232|||Cohort|||||||||
1355666|NCT02871219||Single Group Assignment||Treatment||None (Open Label)||||||
1355667|NCT02871206|Randomized|Parallel Assignment||||||||||
1355668|NCT02871193|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1355669|NCT02871180|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1355670|NCT02871167||Single Group Assignment||Prevention||None (Open Label)||||||
1355671|NCT02871154||Single Group Assignment||Treatment||None (Open Label)||||||
1355672|NCT02871141|||Cohort||Prospective|||||||
1355673|NCT02871128|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1355674|NCT02871115|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355675|NCT02871102||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355676|NCT02871089|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355677|NCT02871076|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355678|NCT02871063|||Cohort||Prospective|||||||
1355679|NCT02871050|||Cohort||Other|||||||
1355680|NCT02871037|Randomized|||Basic Science||Double|||t||t|
1355681|NCT02871024||Single Group Assignment||Treatment||None (Open Label)||||||
1355682|NCT02871011|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1355683|NCT02870998|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355684|NCT02870985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355685|NCT02870972|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1355686|NCT02870959||||||||||||
1355687|NCT02870946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355688|NCT02870933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355689|NCT02870920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355690|NCT02870907|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355691|NCT02870894|||||Cross-Sectional|||||||
1355692|NCT02870881||||||||||||
1355693|NCT02870868|Randomized|Parallel Assignment||Treatment||Single||||||t
1355694|NCT02870855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355695|NCT02870842|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1355696|NCT02870829|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1355697|NCT02870816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355698|NCT02870803|||Cohort||Prospective|||||||
1355699|NCT02870790||Single Group Assignment||Prevention||None (Open Label)||||||
1355700|NCT02870777||Single Group Assignment||Treatment||None (Open Label)||||||
1355701|NCT02870764|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1355702|NCT02870751||Single Group Assignment||Prevention||None (Open Label)||||||
1355703|NCT02870738|Randomized|Parallel Assignment||Treatment||Single||||||t
1355704|NCT02870725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355705|NCT02870712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355706|NCT02870699|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1355707|NCT02870686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355708|NCT02870673|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355709|NCT02870660|||Cohort||Prospective|||||||
1355710|NCT02870647||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355711|NCT02870634||Single Group Assignment||Treatment||None (Open Label)||||||
1355712|NCT02870621|||Cohort||Prospective|||||||
1355713|NCT02870608|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355714|NCT02870595|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355715|NCT02870582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355716|NCT02870569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355717|NCT02870556|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1355718|NCT02870543|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1355719|NCT02870530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355720|NCT02870517|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355721|NCT02870504|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355722|NCT02870491|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1355723|NCT02870478|Randomized|Crossover Assignment||Other||Single|||t|||
1355724|NCT02870465|||Cohort||Prospective|||||||
1355725|NCT02870452|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1355726|NCT02870439|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1355727|NCT02870426|||Other||Other|||||||
1355728|NCT02870413|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1355729|NCT02870400|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1355730|NCT02870387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355731|NCT02870374|||Case-Only||Prospective|||||||
1355732|NCT02870361|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1355733|NCT02870348||Single Group Assignment||Treatment||None (Open Label)||||||
1355734|NCT02870335|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1355735|NCT02870322|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355736|NCT02870309||Single Group Assignment||Treatment||None (Open Label)||||||
1355737|NCT02870296|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1355738|NCT02870283|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1355739|NCT02870270|||Cohort||Prospective|||||||
1355740|NCT02870257|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355741|NCT02870244||Single Group Assignment||Treatment||None (Open Label)||||||
1355742|NCT02870231|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355743|NCT02870218|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1355744|NCT02870205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355745|NCT02870192||Single Group Assignment||Prevention||None (Open Label)||||||
1355746|NCT02870179|||Case-Only||Prospective|||||||
1355747|NCT02870166|||Family-Based||Prospective|||||||
1355748|NCT02870153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355749|NCT02870140|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355750|NCT02870127|||Family-Based||Prospective|||||||
1355751|NCT02870114|||Cohort||Cross-Sectional|||||||
1355752|NCT02870101|Non-Randomized|Parallel Assignment||Other||None (Open Label)|All information collected anonymously.|||||
1355753|NCT02870088|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1355754|NCT02870075|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1355755|NCT02870062|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1355756|NCT02870049|Randomized|Factorial Assignment||Screening||Single|||t|||
1355757|NCT02870036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355758|NCT02870023|Randomized|Factorial Assignment||Treatment||Single|||||t|
1355759|NCT02870010||Single Group Assignment||Treatment||None (Open Label)||||||
1355760|NCT02869997||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355761|NCT02869984|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1355762|NCT02869971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355763|NCT02869958|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355764|NCT02869945|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1355765|NCT02869932||Single Group Assignment||||None (Open Label)||||||
1355766|NCT02869919|||Case-Control||Prospective|||||||
1355767|NCT02869906|||Cohort||Prospective|||||||
1355768|NCT02869893||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355769|NCT02869880|Randomized|Parallel Assignment||Other||Single|||t|||
1355770|NCT02869867|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355771|NCT02869854|Randomized|Parallel Assignment||Prevention||Single|||||t|
1355772|NCT02869841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355773|NCT02869828|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1355774|NCT02869815|||Cohort||Prospective|||||||
1355775|NCT02869802|||Cohort||Prospective|||||||
1355776|NCT02869789||Single Group Assignment||Treatment||None (Open Label)||||||
1355777|NCT02869776|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355778|NCT02869763|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1355779|NCT02869750|||Cohort||Prospective|||||||
1355780|NCT02869737|||||Prospective|||||||
1355781|NCT02869724|Randomized|Parallel Assignment||||None (Open Label)||||||
1355782|NCT02869711|||||Prospective|||||||
1355783|NCT02869698||Single Group Assignment||Prevention||None (Open Label)||||||
1355784|NCT02869685||Single Group Assignment||Treatment||None (Open Label)||||||
1355785|NCT02869672|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1355786|NCT02869659|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355787|NCT02869646|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355788|NCT02869633||Single Group Assignment||Treatment||None (Open Label)||||||
1355789|NCT02869620|||Cohort||Prospective|||||||
1355790|NCT02869607|||Cohort||Prospective|||||||
1355791|NCT02869594|||Cohort||Prospective|||||||
1355792|NCT02869581|||Cohort||Prospective|||||||
1355793|NCT02869568|||Cohort||Prospective|||||||
1355794|NCT02869555|||Cohort||Prospective|||||||
1355795|NCT02869542|||Cohort||Prospective|||||||
1355796|NCT02869529|||Cohort||Prospective|||||||
1355797|NCT02869516|||Cohort||Prospective|||||||
1355798|NCT02869503|||Cohort||Prospective|||||||
1355799|NCT02869490|||Cohort||Prospective|||||||
1355800|NCT02869477|||Cohort||Prospective|||||||
1355801|NCT02869464|||Cohort||Prospective|||||||
1355802|NCT02869451||Single Group Assignment||Treatment||None (Open Label)||||||
1355803|NCT02869438|Randomized|Parallel Assignment||Other||Double|||t||t|
1355804|NCT02869425|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1355805|NCT02869412|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355806|NCT02869399|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355807|NCT02869386|Randomized|Parallel Assignment||Treatment||Single||||||t
1355808|NCT02869373|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1355809|NCT02869360|||Cohort||Prospective|||||||
1355810|NCT02869347|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355811|NCT02869334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355812|NCT02869321|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1355813|NCT02869308||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355814|NCT02869295||Single Group Assignment||Treatment||None (Open Label)||||||
1355815|NCT02869282|||Cohort||Prospective|||||||
1355816|NCT02869269|||Case-Only||Prospective|||||||
1355817|NCT02869256|||Cohort||Prospective|||||||
1355818|NCT02869243||Single Group Assignment||Treatment||None (Open Label)||||||
1355819|NCT02869230|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355820|NCT02869217||Single Group Assignment||Treatment||None (Open Label)||||||
1355821|NCT02869204|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355822|NCT02869191|||Other||Prospective|||||||
1355823|NCT02869178|||||Cross-Sectional|||||||
1355824|NCT02869165|Randomized|Parallel Assignment||Basic Science||Single||||||t
1355825|NCT02869152||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355826|NCT02869139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355827|NCT02869126||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355828|NCT02869113|Randomized|Single Group Assignment||Other||Single|||t|||
1355829|NCT02869100||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355830|NCT02869087||Single Group Assignment||Treatment||None (Open Label)||||||
1355831|NCT02869074|||Cohort||Cross-Sectional|||||||
1355832|NCT02869061||Single Group Assignment||Prevention||None (Open Label)||||||
1355833|NCT02869048|||Case-Control||Prospective|||||||
1355834|NCT02869035|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1355835|NCT02869022|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355836|NCT02869009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355837|NCT02868996|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355838|NCT02868983|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1355839|NCT02868970||Single Group Assignment||Health Services Research||None (Open Label)||||||
1355840|NCT02868957|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1355841|NCT02868944|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355842|NCT02868931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355843|NCT02868918|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1355844|NCT02868905|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355845|NCT02868892||Single Group Assignment||Treatment||None (Open Label)||||||
1355846|NCT02868879|||Case-Control||Cross-Sectional|||||||
1355847|NCT02868866|Randomized|Parallel Assignment||Prevention||Single||||||t
1355848|NCT02868853|Randomized|Parallel Assignment||Treatment||Single||||||t
1355849|NCT02868840|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1355850|NCT02868827|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355851|NCT02868814|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1355852|NCT02868801|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1355853|NCT02868788|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1355854|NCT02868775|||Cohort||Prospective|||||||
1355855|NCT02868762|||Cohort||Cross-Sectional|||||||
1355856|NCT02868749|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1355857|NCT02868736|||Cohort||Prospective|||||||
1355858|NCT02868723|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355859|NCT02868710|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1355860|NCT02868697|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355861|NCT02868684|||Cohort||Prospective|||||||
1355862|NCT02868671|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355863|NCT02868658||Single Group Assignment||Prevention||None (Open Label)||||||
1355864|NCT02868645|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355865|NCT02868632|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355866|NCT02868619|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355867|NCT02868606|||Cohort||Retrospective|||||||
1355868|NCT02868593||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355869|NCT02868580||Single Group Assignment||Treatment||None (Open Label)||Safety and Tolerability open label||||
1355870|NCT02868567||Single Group Assignment||Treatment||None (Open Label)||||||
1355871|NCT02868554|Randomized|Parallel Assignment||Treatment||Single|||||t|
1355872|NCT02868541|||Cohort||Prospective|||||||
1355873|NCT02868528|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1355874|NCT02868515||Single Group Assignment||Basic Science||None (Open Label)||||||
1355875|NCT02868502|||Case Control||Cross-Sectional|||||||
1355876|NCT02868489|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1355877|NCT02868476|||Cohort||Prospective|||||||
1355878|NCT02868463|||Case-Only||Cross-Sectional|||||||
1355879|NCT02868450||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355880|NCT02868437|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1355881|NCT02868424||Single Group Assignment||Treatment||None (Open Label)||||||
1355882|NCT02868411||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355883|NCT02868398|||Case-Control||Prospective|||||||
1355884|NCT02868385|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1355885|NCT02868372|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1355886|NCT02868359|||Cohort||Prospective|||||||
1355887|NCT02868346||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355888|NCT02868333|||Cohort||Prospective|||||||
1355889|NCT02868320|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1355890|NCT02868307||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355891|NCT02868294||Single Group Assignment||Treatment||None (Open Label)||||||
1355892|NCT02868281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355893|NCT02868268|||Cohort||Prospective|||||||
1355894|NCT02868255|||Cohort||Prospective|||||||
1355895|NCT02868242||Single Group Assignment||Treatment||None (Open Label)||||||
1355896|NCT02868229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355897|NCT02868216|Randomized|Parallel Assignment||Treatment||Single|Blinding occurs only in relation to the evaluator of endothelial function|One group receives training for anger management, with guidance on infarction and physiology of anger and another group, does not receive.||||t
1355898|NCT02868203|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355899|NCT02868190||Single Group Assignment||Treatment||None (Open Label)||||||
1355900|NCT02868177|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355901|NCT02868164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355902|NCT02868151|Randomized|Parallel Assignment||Prevention||Single|||t|||
1355903|NCT02868138|||Cohort||Prospective|||||||
1355904|NCT02868125|||Cohort||Prospective|||||||
1355905|NCT02868112|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355906|NCT02868099|Randomized|Parallel Assignment||Treatment||Double|Placebo-controlled, Double-blinded then Open-label|multi-center, Randomized, Placebo-controlled, Double-blinded then Open-label|t||t|
1355907|NCT02868086|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1355908|NCT02868073|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1355909|NCT02868060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355910|NCT02868047|||Case-Only||Prospective|||||||
1355911|NCT02868034|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1355912|NCT02868021|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1355913|NCT02868008||Single Group Assignment||Treatment||None (Open Label)||||||
1355914|NCT02867995|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1355915|NCT02867982|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355916|NCT02867969||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355917|NCT02867956||Single Group Assignment||Treatment||None (Open Label)||||||
1355918|NCT02867943|||Cohort||Prospective|||||||
1355919|NCT02867930|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1355920|NCT02867917|Randomized|Single Group Assignment||Other||Double|||t||t|
1355921|NCT02867904|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1355922|NCT02867891|||Cohort||Prospective|||||||
1355923|NCT02867878|Randomized|Parallel Assignment||Treatment||Single|||t|||
1355924|NCT02867865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355925|NCT02867852||Single Group Assignment||Treatment||None (Open Label)||||||
1355926|NCT02867839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355927|NCT02867826||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355928|NCT02867813||Single Group Assignment||Treatment||None (Open Label)||||||
1355929|NCT02867800||Single Group Assignment||Treatment||None (Open Label)||||||
1355930|NCT02867787||Single Group Assignment||Treatment||None (Open Label)||||||
1355931|NCT02867774||Single Group Assignment||Treatment||None (Open Label)||||||
1355932|NCT02867761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355933|NCT02867748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355934|NCT02867735||Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355935|NCT02867722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1355936|NCT02867709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355937|NCT02867696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355938|NCT02867683|Randomized|Parallel Assignment||Treatment||Single||||||t
1355939|NCT02867670|||Case-Only||Cross-Sectional|||||||
1355940|NCT02867657|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355941|NCT02867644|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1355942|NCT02867631|Randomized|Parallel Assignment||Prevention||Single||||||t
1355943|NCT02867618||Single Group Assignment||Treatment||None (Open Label)||||||
1355944|NCT02867605|||Case-Only||Prospective|||||||
1355945|NCT02867592||Single Group Assignment||Treatment||None (Open Label)||||||
1355946|NCT02867579|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1355947|NCT02867566|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355948|NCT02867553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355949|NCT02867540||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355950|NCT02867527|||Cohort||Prospective|||||||
1355951|NCT02867514|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1355952|NCT02867501|||Cohort||Cross-Sectional|||||||
1355953|NCT02867488||||||||||||
1355954|NCT02867475||Single Group Assignment||Supportive Care||None (Open Label)||||||
1355955|NCT02867462|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1355956|NCT02867449|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355957|NCT02867436|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1355958|NCT02867423||Single Group Assignment||Treatment||None (Open Label)||||||
1355959|NCT02867410|||||Retrospective|||||||
1355960|NCT02867397||Single Group Assignment||Treatment||None (Open Label)||||||
1355961|NCT02867384|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1355962|NCT02867371||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355963|NCT02867358|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1355964|NCT02867345|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355965|NCT02867332|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355966|NCT02867319|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1355967|NCT02867306||Single Group Assignment||Treatment||None (Open Label)||||||
1355968|NCT02867293|Randomized|Parallel Assignment||Prevention||Single|||t|||
1355969|NCT02867280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355970|NCT02867267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1355971|NCT02867254|||Case Control||Prospective|||||||
1355972|NCT02867241|Randomized|Parallel Assignment||Prevention||Single||||||t
1355973|NCT02867228||Single Group Assignment||Diagnostic||None (Open Label)||||||
1355974|NCT02867215|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1355975|NCT02867202|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1355976|NCT02867189|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1355977|NCT02867176|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1355978|NCT02867163|||Case-Only||Prospective|||||||
1355979|NCT02867150||Single Group Assignment||Treatment||None (Open Label)||||||
1355980|NCT02867137|||Cohort||Prospective|||||||
1355981|NCT02867124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355982|NCT02867111|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1355983|NCT02867098|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1355984|NCT02867085|||Cohort||Prospective|||||||
1355985|NCT02867072|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355986|NCT02867059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355987|NCT02867046|Randomized|Parallel Assignment||Other||Single|||t|||
1355988|NCT02867033||Single Group Assignment||Other||None (Open Label)||||||
1355989|NCT02867020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355990|NCT02867007||Single Group Assignment||Treatment||None (Open Label)||||||
1355991|NCT02866994|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1355992|NCT02866981||Single Group Assignment||Treatment||None (Open Label)||||||
1355993|NCT02866968||Single Group Assignment||Treatment||None (Open Label)||||||
1355994|NCT02866955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1355995|NCT02866942|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1355996|NCT02866929|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1355997|NCT02866916||Single Group Assignment||Treatment||None (Open Label)||||||
1355998|NCT02866903||Single Group Assignment||Treatment||None (Open Label)||||||
1355999|NCT02866890|Randomized|Single Group Assignment||Treatment||Single|||||t|
1356000|NCT02866877|||Cohort||Prospective|||||||
1356001|NCT02866864|||Ecologic or Community||Cross-Sectional|||||||
1356002|NCT02866851||Single Group Assignment||||None (Open Label)||||||
1356003|NCT02866838|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356004|NCT02866825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356005|NCT02866812||Single Group Assignment||Basic Science||None (Open Label)||||||
1356006|NCT02866799|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1356007|NCT02866786|Randomized|Parallel Assignment||Treatment||Single||||||t
1356008|NCT02866773|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356009|NCT02866760|||Case-Only||Cross-Sectional|||||||
1356010|NCT02866747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356011|NCT02866734|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1356012|NCT02866721||Single Group Assignment||Treatment||None (Open Label)||||||
1356013|NCT02866708|Randomized|Crossover Assignment||Treatment||Single|Two experienced outcome assessors/outcome adjudicators (certified wound nurse or physician or wound trained health care specialist) will assess the wound photographs using Photographic wound assessment tool (PWAT 0-24 score). At least one of the PWAT assessors will be blinded to the study group's assignments, and will not be involved in the study otherwise (intervention or in the standard wound care).|16 week crossover pilot study comparing intermittent negative pressure (40mmHg) applied to the lower leg and foot plus standard best practice wound care comapred to standard best practice wound care alone.||||t
1356014|NCT02866695||Single Group Assignment||Treatment||None (Open Label)||||||
1356015|NCT02866682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356016|NCT02866669|Randomized|Factorial Assignment||Treatment||Single||||||t
1356017|NCT02866656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356018|NCT02866643|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356019|NCT02866630|||Cohort||Prospective|||||||
1356020|NCT02866617|Randomized|Crossover Assignment||Other||Double|||t||t|
1356021|NCT02866604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356022|NCT02866591|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356023|NCT02866578|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356024|NCT02866565||Single Group Assignment||Treatment||None (Open Label)||||||
1356025|NCT02866552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356026|NCT02866539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356027|NCT02866526|||Other||Cross-Sectional|||||||
1356028|NCT02866513||Single Group Assignment||Other||None (Open Label)||||||
1356029|NCT02866500||Single Group Assignment||Prevention||None (Open Label)||||||
1356030|NCT02866487|||Other||Prospective|||||||
1356031|NCT02866474|Randomized|Factorial Assignment||||None (Open Label)||||||
1356032|NCT02866461|||Ecologic or Community||Prospective|||||||
1356033|NCT02866448|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1356034|NCT02866435|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1356035|NCT02866422|||||Cross-Sectional|||||||
1356036|NCT02866409|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1356037|NCT02866396|||Cohort||Prospective|||||||
1356038|NCT02866383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356039|NCT02866370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356040|NCT02866357|||Case-Only||Prospective|||||||
1356041|NCT02866344|Randomized|Parallel Assignment||Treatment||Single||||||t
1356042|NCT02866331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356043|NCT02866318|||Cohort||Retrospective|||||||
1356044|NCT02866305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356045|NCT02866292|||||Cross-Sectional|||||||
1356046|NCT02866279|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356047|NCT02866266|||Cohort||Retrospective|||||||
1356048|NCT02866253|Randomized|Parallel Assignment||Treatment||Single|||||t|
1356049|NCT02866240||Single Group Assignment||Treatment||None (Open Label)||||||
1356050|NCT02866227|Randomized|Parallel Assignment||Treatment||Single||||||t
1356051|NCT02866214|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1356052|NCT02866201||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356053|NCT02866188|||Case-Only||Prospective|||||||
1356054|NCT02866175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356055|NCT02866162|||Case Control||Prospective|||||||
1356056|NCT02866149|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356057|NCT02866136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356058|NCT02866123||Single Group Assignment||||None (Open Label)||||||
1356059|NCT02866110||Single Group Assignment||Basic Science||None (Open Label)||||||
1356060|NCT02866097|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1356061|NCT02866084||Single Group Assignment||Treatment||None (Open Label)||||||
1356062|NCT02866071|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356063|NCT02866058|||Cohort||Retrospective|||||||
1356064|NCT02866045|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1356065|NCT02866032||||||||||||
1356066|NCT02866019||Single Group Assignment||Treatment||None (Open Label)||||||
1356067|NCT02866006||Single Group Assignment||Treatment||None (Open Label)||||||
1356068|NCT02865993|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1356069|NCT02865980|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356070|NCT02865967|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1356071|NCT02865954|Randomized|Parallel Assignment||Treatment||Single|||||t|
1356072|NCT02865941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356073|NCT02865928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356074|NCT02865915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356075|NCT02865902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356076|NCT02865889|||Cohort||Prospective|||||||
1356077|NCT02865876|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1356078|NCT02865863|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1356079|NCT02865850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356080|NCT02865837||Single Group Assignment||Other||None (Open Label)||||||
1356081|NCT02865824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356082|NCT02865811||Single Group Assignment||Treatment||None (Open Label)||||||
1356083|NCT02865798|||Cohort||Prospective|||||||
1356084|NCT02865785|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356085|NCT02865772|||Cohort||Prospective|||||||
1356086|NCT02865759|Randomized|Parallel Assignment||Prevention||Single||||||t
1356087|NCT02865746|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1356088|NCT02865733|Randomized|Parallel Assignment||Prevention||Single|||t|||
1356089|NCT02865720|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356090|NCT02865707|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1356091|NCT02865694|||Cohort||Prospective|||||||
1356092|NCT02865681|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356093|NCT02865668|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1356094|NCT02865655|||Cohort||Prospective|||||||
1356095|NCT02865642|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1356096|NCT02865629||Single Group Assignment||Treatment||None (Open Label)||||||
1356097|NCT02865616||Single Group Assignment||Treatment||None (Open Label)||||||
1356098|NCT02865603|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356099|NCT02865590|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1356100|NCT02865577|||Other||Cross-Sectional|||||||
1356101|NCT02865564|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1356102|NCT02865551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356103|NCT02865538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356104|NCT02865525|||||Prospective|||||||
1356105|NCT02865512|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356106|NCT02865499||Single Group Assignment||Prevention||None (Open Label)||||||
1356107|NCT02865486|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1356108|NCT02865473|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356109|NCT02865460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356110|NCT02865447|||Cohort||Prospective|||||||
1356111|NCT02865434|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356112|NCT02865421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356113|NCT02865408|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356114|NCT02865395|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356115|NCT02865382|Randomized|Single Group Assignment||Prevention||Single|||t|||
1356116|NCT02865369|||Cohort||Prospective|||||||
1356117|NCT02865356|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356118|NCT02865343|Randomized|Parallel Assignment||Treatment||Quadruple|Investigators and technicians helping for performing the test and encouraging the patient will be blind. Only one investigator will monitor the ventilation during the test and won't be blind but won't be participating to any encouragement or data acquisition.||t|t|t|t
1356119|NCT02865330|||Cohort||Other|||||||
1356120|NCT02865317|||Cohort||Cross-Sectional|||||||
1356121|NCT02865304||Single Group Assignment||Treatment||None (Open Label)||||||
1356122|NCT02865291||Single Group Assignment||Other||None (Open Label)||||||
1356123|NCT02865278|Randomized|Crossover Assignment||Prevention||Single||||||t
1356124|NCT02865265|||||Retrospective|||||||
1356125|NCT02865252|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1356126|NCT02865239|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1356127|NCT02865226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356128|NCT02865213|Randomized|Parallel Assignment||Treatment||Single||||||t
1356129|NCT02865200|Randomized|Parallel Assignment||Treatment||Single|||||t|
1356130|NCT02865187|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356131|NCT02865174|Randomized|Parallel Assignment||Prevention||Single|||t|||
1356132|NCT02865161||||||||||||
1356133|NCT02865148|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1356134|NCT02865135||Single Group Assignment||Treatment||None (Open Label)||||||
1356135|NCT02865122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356136|NCT02865109||||||||||||
1356137|NCT02865096|||Ecologic or Community||Prospective|||||||
1356138|NCT02865083|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356139|NCT02865070|||Cohort||Prospective|||||||
1356140|NCT02865057|||Cohort||Prospective|||||||
1356141|NCT02865044|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1356142|NCT02865031||Single Group Assignment||Prevention||None (Open Label)||||||
1356143|NCT02865018||Single Group Assignment||Treatment||None (Open Label)||||||
1356144|NCT02865005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356145|NCT02864992||Single Group Assignment||Treatment||None (Open Label)||||||
1356146|NCT02864966||Single Group Assignment||||None (Open Label)||||||
1356147|NCT02864953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356148|NCT02864940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356149|NCT02864927|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356150|NCT02864914|||Cohort||Retrospective|||||||
1356151|NCT02864901|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1356152|NCT02864888|Randomized|Parallel Assignment||Other||Single||||||t
1356153|NCT02864875|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1356154|NCT02864862|Randomized|Parallel Assignment||Treatment||Single||||||t
1356155|NCT02864849||Single Group Assignment||Treatment||None (Open Label)||||||
1356156|NCT02864836|||Other||Prospective|||||||
1356157|NCT02864823||Single Group Assignment||Treatment||None (Open Label)||||||
1356158|NCT02864810||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356159|NCT02864797||Single Group Assignment||Supportive Care||None (Open Label)||||||
1356160|NCT02864784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356161|NCT02864771|||Cohort||Prospective|||||||
1356162|NCT02864758|||Cohort||Retrospective|||||||
1356163|NCT02864745|Randomized|Parallel Assignment||Treatment||Single||||||t
1356164|NCT02864732|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356165|NCT02864719||Single Group Assignment||Treatment||None (Open Label)||||||
1356166|NCT02864706||Single Group Assignment||Treatment||None (Open Label)||||||
1356167|NCT02864693|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356168|NCT02864680|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1356169|NCT02864667|||Case-Only||Retrospective|||||||
1356170|NCT02864654||Single Group Assignment||Treatment||None (Open Label)||||||
1356171|NCT02864641|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356172|NCT02864628|Randomized|Parallel Assignment||Prevention||Single|||t|||
1356173|NCT02864615||Single Group Assignment||Treatment||None (Open Label)||||||
1356174|NCT02864602|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356175|NCT02864589|Randomized|Parallel Assignment||Treatment||Single||||||t
1356176|NCT02864576|Randomized|Parallel Assignment||Treatment||Single|||||t|
1356177|NCT02864563||Single Group Assignment||Basic Science||None (Open Label)||||||
1356178|NCT02864550|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1356179|NCT02864537|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356180|NCT02864524|Randomized|Parallel Assignment||Treatment||Single||||||t
1356181|NCT02864511||Single Group Assignment||Treatment||None (Open Label)||||||
1356182|NCT02864498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356183|NCT02864485||Single Group Assignment||Treatment||None (Open Label)||||||
1356184|NCT02864472|Randomized|Single Group Assignment||||None (Open Label)||||||
1356185|NCT02864459||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356186|NCT02864446|||Cohort||Prospective|||||||
1356187|NCT02864433|||Case-Control||Prospective|||||||
1356188|NCT02864420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356189|NCT02864407|||Other||Prospective|||||||
1356190|NCT02864394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356191|NCT02864381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356192|NCT02864368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356193|NCT02864355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356194|NCT02864342|Randomized|Parallel Assignment||||None (Open Label)||||||
1356195|NCT02864329|||Cohort||Retrospective|||||||
1356196|NCT02864316|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356197|NCT02864303||Single Group Assignment||||None (Open Label)||||||
1356198|NCT02864290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1356199|NCT02864277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356200|NCT02864264|Randomized|Parallel Assignment||Screening||Double|||t||t|
1356201|NCT02864251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356202|NCT02864238|||Cohort||Retrospective|||||||
1356203|NCT02864225||Single Group Assignment||Diagnostic||Double||||t||t
1356204|NCT02864212|||Case-Only||Cross-Sectional|||||||
1356205|NCT02864199|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356206|NCT02864186|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356207|NCT02864173|||Cohort||Retrospective|||||||
1356208|NCT02864160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356209|NCT02864147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356210|NCT02864134|||Cohort||Prospective|||||||
1356211|NCT02864121||Single Group Assignment||Screening||None (Open Label)||||||
1356212|NCT02864108|||Cohort||Prospective|||||||
1356213|NCT02864095|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356214|NCT02864082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356215|NCT02864069|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1356216|NCT02864056|Randomized|Parallel Assignment||Prevention||Single||||||t
1356217|NCT02864043||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356218|NCT02864030||Single Group Assignment||Health Services Research||None (Open Label)||||||
1356219|NCT02864017|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1356220|NCT02864004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356221|NCT02863991||Single Group Assignment||Treatment||None (Open Label)||||||
1356222|NCT02863978||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356223|NCT02863965|||Cohort||Prospective|||||||
1356224|NCT02863952||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356225|NCT02863939||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356226|NCT02863926|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356227|NCT02863913|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356228|NCT02863900||Single Group Assignment||||None (Open Label)||||||
1356229|NCT02863887|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356230|NCT02863874|Randomized|Parallel Assignment||Prevention||Single|||t|||
1356231|NCT02863861|Randomized|Parallel Assignment||||Double|||t|t||
1356232|NCT02863848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356233|NCT02863835||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356234|NCT02863822|Randomized|Parallel Assignment||Treatment||Single|||||t|
1356235|NCT02863809|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1356236|NCT02863796||||||||||||
1356237|NCT02863783||Single Group Assignment||Treatment||None (Open Label)||||||
1356238|NCT02863770||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356239|NCT02863757|||Cohort||Retrospective|||||||
1356240|NCT02863744||Single Group Assignment||Treatment||None (Open Label)||||||
1356241|NCT02863731|Randomized|Crossover Assignment||||None (Open Label)||||||
1356242|NCT02863718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356243|NCT02863705|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1356244|NCT02863692|||Other||Prospective|||||||
1356245|NCT02863679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356246|NCT02863666|||Case-Only||Prospective|||||||
1356247|NCT02863653|||||Cross-Sectional|||||||
1356248|NCT02863640|||Cohort||Retrospective|||||||
1356249|NCT02863627||Single Group Assignment||Other||None (Open Label)||||||
1356250|NCT02863614|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1356251|NCT02863601|||Cohort||Prospective|||||||
1356252|NCT02863588||Single Group Assignment||Basic Science||None (Open Label)||||||
1356253|NCT02863575|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356254|NCT02863562|Randomized|Factorial Assignment||Treatment||Single|||t|||
1356255|NCT02863549||Single Group Assignment||Treatment||None (Open Label)||||||
1356256|NCT02863536||Single Group Assignment||Prevention||None (Open Label)||||||
1356257|NCT02863523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356258|NCT02863510||Single Group Assignment||Treatment||None (Open Label)||||||
1356259|NCT02863497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356260|NCT02863484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356261|NCT02863471||Single Group Assignment||Treatment||None (Open Label)||||||
1356262|NCT02863458|||Cohort||Other|||||||
1356263|NCT02863445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356264|NCT02863432||||||||||||
1356265|NCT02863419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356266|NCT02863406|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1356267|NCT02863393||Single Group Assignment||Treatment||None (Open Label)||||||
1356268|NCT02863380|Randomized|Crossover Assignment||Treatment||Single||||t||
1356269|NCT02863367||Single Group Assignment||Treatment||None (Open Label)||||||
1356270|NCT02863354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356271|NCT02863341|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1356272|NCT02863328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356273|NCT02863315|Randomized|Crossover Assignment||Treatment||Single|tsDCS|tsDCS|t|||
1356274|NCT02863302||Single Group Assignment||Supportive Care||None (Open Label)||||||
1356275|NCT02863289|||Cohort||Retrospective|||||||
1356276|NCT02863276|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356277|NCT02863263|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356278|NCT02863250|||Cohort||Prospective|||||||
1356279|NCT02863237|||Cohort||Prospective|||||||
1356280|NCT02863224|||Case-Control||Prospective|||||||
1356281|NCT02863211|||Cohort||Prospective|||||||
1356282|NCT02863198|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356283|NCT02863185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356284|NCT02863172|||Family-Based||Prospective|||||||
1356285|NCT02863159|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1356286|NCT02863146|||Case-Only||Prospective|||||||
1356287|NCT02863133||Single Group Assignment||Treatment||None (Open Label)||||||
1356288|NCT02863120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356289|NCT02863107|||Cohort||Prospective|||||||
1356290|NCT02863094|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356291|NCT02863081|||Cohort||Prospective|||||||
1356292|NCT02863068|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356293|NCT02863055|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356294|NCT02863042|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1356295|NCT02863029||Single Group Assignment||Basic Science||None (Open Label)||||||
1356296|NCT02863016|||Cohort||Prospective|||||||
1356297|NCT02863003|||Cohort|||||||||
1356298|NCT02862990|||Case-Only||Cross-Sectional|||||||
1356299|NCT02862977|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356300|NCT02862964|||Case-Only||Prospective|||||||
1356301|NCT02862951|||Cohort||Prospective|||||||
1356302|NCT02862938|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356303|NCT02862925|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1356304|NCT02862912|Randomized|Factorial Assignment||Other||Quadruple|||t|t|t|t
1356305|NCT02862899||Single Group Assignment||Other||None (Open Label)||||||
1356306|NCT02862886||Single Group Assignment||||None (Open Label)||||||
1356307|NCT02862873|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1356308|NCT02862860|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1356309|NCT02862847|||Case Control||Prospective|||||||
1356310|NCT02862834|||Case-Only||Prospective|||||||
1356311|NCT02862821|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1356312|NCT02862808|||Case-Only||Retrospective|||||||
1356313|NCT02862795||Single Group Assignment||Prevention||None (Open Label)||||||
1356314|NCT02862782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356315|NCT02862769|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1356316|NCT02862756||Single Group Assignment||Basic Science||None (Open Label)||||||
1356317|NCT02862743||Single Group Assignment||Basic Science||None (Open Label)||||||
1356318|NCT02862730|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356319|NCT02862717|||Cohort||Prospective|||||||
1356320|NCT02862704||Single Group Assignment||Treatment||None (Open Label)||||||
1356321|NCT02862691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356322|NCT02862678||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356323|NCT02862665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356324|NCT02862652||Single Group Assignment||Basic Science||None (Open Label)||||||
1356325|NCT02862639|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356326|NCT02862626|||Family-Based||Retrospective|||||||
1356327|NCT02862613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356328|NCT02862600||Single Group Assignment||Treatment||None (Open Label)||Open-label, 2 period, dose escalation study of perhexiline in symptomatic patients with hypertrophic cardiomyopathy||||
1356329|NCT02862587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356330|NCT02862574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356331|NCT02862561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356332|NCT02862548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356333|NCT02862535|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356334|NCT02862522|||Cohort||Prospective|||||||
1356335|NCT02862509|Randomized|Parallel Assignment||Treatment||Single||||||t
1356336|NCT02862496|||Case Control||Prospective|||||||
1356337|NCT02862483|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356338|NCT02862470|||Cohort||Prospective|||||||
1356339|NCT02862457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356340|NCT02862444|||||Prospective|||||||
1356341|NCT02862431|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356342|NCT02862418|||Case-Control||Prospective|||||||
1356343|NCT02862405|||Case Control||Cross-Sectional|||||||
1356344|NCT02862392|||Cohort||Prospective|||||||
1356345|NCT02862379||Single Group Assignment||Other||None (Open Label)||||||
1356346|NCT02862366|||Cohort||Prospective|||||||
1356347|NCT02862353|||Cohort||Prospective|||||||
1356348|NCT02862340||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356349|NCT02862327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356350|NCT02862314|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356351|NCT02862301|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356352|NCT02862288|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356353|NCT02862275||Single Group Assignment||Treatment||None (Open Label)||||||
1356354|NCT02862262|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|All eligible specimens (de-identified remnants) enrolled are tested using both the investigational device as well as the reference method.|"The study is comprised of three arms:~Arm 1: Blinded, Prospective Arm Primary arm comprised of prospectively collected, de-identified, left-over nasopharyngeal swab specimens.~Arm 2: Blinded, Pre-selected Arm Because both B. pertussis and B. parapertussis exhibited low prevalence rates in the prospective study cohort, the prospective sample set was supplemented with banked (pre-selected) positive specimens collected at selected sites.~Arm 3: Contrived Specimens Because the number of B. parapertussis positive clinical specimens tested in Arm 1 and Arm 2 of the study was insufficient for accurate estimate of positive percent agreement (PPA) for this target, fifty (50) contrived specimens spiked with relevant B. parapertussis strains at different levels were also prepared. The analyte concentrations covered clinically relevant titers."||||
1356355|NCT02862249|Randomized|Parallel Assignment||Other||Single|||t|||
1356356|NCT02862236|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1356357|NCT02862223||Single Group Assignment||Supportive Care||None (Open Label)||||||
1356358|NCT02862210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356359|NCT02862197|||Case-Only||Prospective|||||||
1356360|NCT02862184|||Cohort||Prospective|||||||
1356361|NCT02862171||Single Group Assignment||Prevention||None (Open Label)||||||
1356362|NCT02862158||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356363|NCT02862145||Single Group Assignment||Treatment||None (Open Label)||||||
1356364|NCT02862132||Single Group Assignment||Treatment||None (Open Label)||||||
1356365|NCT02862119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356366|NCT02862106|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356367|NCT02862093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356368|NCT02862080||||||||||||
1356369|NCT02862067|||Cohort||Prospective|||||||
1356370|NCT02862054||Single Group Assignment||Treatment||None (Open Label)||||||
1356371|NCT02862041|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1356372|NCT02862028||Single Group Assignment||Treatment||None (Open Label)||||||
1356373|NCT02862015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356374|NCT02862002|Randomized|Parallel Assignment||||None (Open Label)||||||
1356375|NCT02861989|||||Cross-Sectional|||||||
1356376|NCT02861976|||Cohort||Prospective|||||||
1356377|NCT02861963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356378|NCT02861950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356379|NCT02861937|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1356380|NCT02861924||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356381|NCT02861911|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1356382|NCT02861898||Single Group Assignment||Treatment||None (Open Label)||||||
1356383|NCT02861885|||Cohort||Prospective|||||||
1356384|NCT02861872|||Cohort||Prospective|||||||
1356385|NCT02861859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356386|NCT02861846||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356387|NCT02861833|||||Retrospective|||||||
1356388|NCT02861820|||Case-Control||Prospective|||||||
1356389|NCT02861807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356390|NCT02861794||Single Group Assignment||Treatment||None (Open Label)||||||
1356391|NCT02861781|||Cohort||Prospective|||||||
1356392|NCT02861768||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356393|NCT02861755|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1356394|NCT02861742||Single Group Assignment||Other||None (Open Label)||||||
1356395|NCT02861729|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1356396|NCT02861716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356397|NCT02861703||Single Group Assignment||Treatment||None (Open Label)||||||
1356398|NCT02861690||Single Group Assignment||Treatment||None (Open Label)||||||
1356399|NCT02861677|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1356400|NCT02861664|Randomized|Parallel Assignment||Treatment||Single||||||t
1356401|NCT02861651|||Cohort||Retrospective|||||||
1356402|NCT02861638|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1356403|NCT02861625|||Family-Based||Prospective|||||||
1356404|NCT02861612|||Cohort||Prospective|||||||
1356405|NCT02861599|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1356406|NCT02861586|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1356407|NCT02861573|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356408|NCT02861560||Single Group Assignment||Treatment||None (Open Label)||||||
1356409|NCT02861547|||Cohort||Retrospective|||||||
1356410|NCT02861534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356411|NCT02861521|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1356412|NCT02861508|Randomized|Parallel Assignment||Other||Single||||||t
1356413|NCT02861495||Single Group Assignment||Treatment||None (Open Label)||||||
1356414|NCT02861482||Single Group Assignment||Treatment||None (Open Label)||||||
1356415|NCT02861469|||||Prospective|||||||
1356416|NCT02861456|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1356417|NCT02861443|||||Cross-Sectional|||||||
1356418|NCT02861430|||Cohort||Prospective|||||||
1356419|NCT02861417|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356420|NCT02861404|||Case-Only||Prospective|||||||
1356421|NCT02861391||Single Group Assignment||Treatment||None (Open Label)||||||
1356422|NCT02861378|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356423|NCT02861365|||Cohort||Prospective|||||||
1356424|NCT02861352||Single Group Assignment||||None (Open Label)||||||
1356425|NCT02861339||Single Group Assignment||||None (Open Label)||||||
1356426|NCT02861326||Single Group Assignment||Treatment||None (Open Label)||||||
1356427|NCT02861313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356428|NCT02861300||Single Group Assignment||Treatment||None (Open Label)||||||
1356429|NCT02861287|||Case-Only||Retrospective|||||||
1356430|NCT02861274|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1356431|NCT02861261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356432|NCT02861248||Single Group Assignment||Treatment||None (Open Label)||||||
1356433|NCT02861235|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356434|NCT02861222||Single Group Assignment||Treatment||None (Open Label)||||||
1356435|NCT02861209|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356436|NCT02861196|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356437|NCT02861183|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1356438|NCT02861170|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1356439|NCT02861157|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356440|NCT02861144|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356441|NCT02861131|Randomized|Parallel Assignment||Prevention||Single||||||t
1356442|NCT02861118|||Cohort||Retrospective|||||||
1356443|NCT02861105|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356444|NCT02861092|||Cohort||Retrospective|||||||
1356445|NCT02861079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356446|NCT02861066||Single Group Assignment||Treatment||None (Open Label)||||||
1356447|NCT02861053|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356448|NCT02861040||Single Group Assignment||Treatment||None (Open Label)||||||
1356449|NCT02861027|Randomized|Parallel Assignment||Treatment||Single||||||t
1356450|NCT02861014||Single Group Assignment||Treatment||None (Open Label)||||||
1356451|NCT02861001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356452|NCT02860988||Single Group Assignment||Treatment||None (Open Label)||||||
1356453|NCT02860975||Single Group Assignment||Treatment||None (Open Label)||||||
1356454|NCT02860962|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356455|NCT02860949|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1356456|NCT02860936||Single Group Assignment||Treatment||None (Open Label)||||||
1356457|NCT02860923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356458|NCT02860910||Single Group Assignment||Treatment||None (Open Label)||||||
1356459|NCT02860897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356460|NCT02860884|||Cohort||Retrospective|||||||
1356461|NCT02860871|||Cohort||Prospective|||||||
1356462|NCT02860858||Single Group Assignment||Treatment||None (Open Label)||||||
1356463|NCT02860845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356464|NCT02860832|||||Cross-Sectional|||||||
1356465|NCT02860819||Single Group Assignment||Treatment||None (Open Label)||||||
1356466|NCT02860806|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356467|NCT02860793||Single Group Assignment||Basic Science||None (Open Label)||||||
1356468|NCT02860780|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356469|NCT02860767|||Case-Only||Prospective|||||||
1356470|NCT02860754||Single Group Assignment||Prevention||None (Open Label)||||||
1356471|NCT02860741|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1356472|NCT02860728||Single Group Assignment||Treatment||None (Open Label)||||||
1356473|NCT02860715|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1356474|NCT02860702|Randomized|Parallel Assignment||Prevention||Single|||||t|
1356475|NCT02860689|||||Cross-Sectional|||||||
1356476|NCT02860676||Single Group Assignment||Treatment||None (Open Label)||||||
1356477|NCT02860663|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1356478|NCT02860650|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1356479|NCT02860637|||||Cross-Sectional|||||||
1356480|NCT02860624|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356481|NCT02860611|||Case Control||Cross-Sectional|||||||
1356482|NCT02860598|||Cohort||Prospective|||||||
1356483|NCT02860585|||Cohort||Retrospective|||||||
1356484|NCT02860572|Randomized|Parallel Assignment||Treatment||Single||||||t
1356485|NCT02860559||Single Group Assignment||Treatment||None (Open Label)||||||
1356486|NCT02860546||Single Group Assignment||Treatment||None (Open Label)||||||
1356487|NCT02860533||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356488|NCT02860520|||Cohort||Prospective|||||||
1356489|NCT02860507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356490|NCT02860494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356491|NCT02860481|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356492|NCT02860468|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1356493|NCT02860455||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356494|NCT02860442|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356495|NCT02860429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356496|NCT02860416|||Other||Retrospective|||||||
1356497|NCT02860403|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356498|NCT02860390|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1356499|NCT02860377|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1356500|NCT02860364|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1356501|NCT02860351|||Case-Only||Prospective|||||||
1356502|NCT02860338|||Cohort||Retrospective|||||||
1356503|NCT02860325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356504|NCT02860312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356505|NCT02860299|Randomized|Parallel Assignment||||Double|||t||t|
1356506|NCT02860286||Single Group Assignment||Treatment||None (Open Label)||||||
1356507|NCT02860273|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356508|NCT02860260|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1356509|NCT02860247|||Other||Prospective|||||||
1356510|NCT02860234|||Cohort||Prospective|||||||
1356511|NCT02860221|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356512|NCT02860208|||Cohort||Prospective|||||||
1356513|NCT02860195||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356514|NCT02860182|||||Prospective|||||||
1356515|NCT02860169|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356516|NCT02860156|||Cohort||Cross-Sectional|||||||
1356517|NCT02860143|||Case-Only||Prospective|||||||
1356518|NCT02860130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356519|NCT02860117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356520|NCT02860104||Single Group Assignment||Treatment||None (Open Label)||||||
1356521|NCT02860091|||Cohort||Prospective|||||||
1356522|NCT02860078|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1356523|NCT02860065||Single Group Assignment||Treatment||None (Open Label)||||||
1356524|NCT02860052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356525|NCT02860039|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1356526|NCT02860026|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1356527|NCT02860013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356528|NCT02860000|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356529|NCT02859987|Randomized|Parallel Assignment||||None (Open Label)||||||
1356530|NCT02859974||Single Group Assignment||Treatment||None (Open Label)||||||
1356531|NCT02859961||Single Group Assignment||Treatment||None (Open Label)||||||
1356532|NCT02859948||Single Group Assignment||Treatment||None (Open Label)||||||
1356533|NCT02859935|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1356534|NCT02859922|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1356535|NCT02859909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356536|NCT02859896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356537|NCT02859883|||Cohort||Prospective|||||||
1356538|NCT02859870|||Cohort||Prospective|||||||
1356539|NCT02859857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1356540|NCT02859844|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356541|NCT02859831|||Case Control||Prospective|||||||
1356542|NCT02859818||Single Group Assignment||||None (Open Label)||||||
1356543|NCT02859805|||||Prospective|||||||
1356544|NCT02859792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356545|NCT02859779||Single Group Assignment||Other||None (Open Label)||||||
1356546|NCT02859766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356547|NCT02859753|Randomized|Parallel Assignment||||None (Open Label)||||||
1356548|NCT02859740|||Cohort||Prospective|||||||
1356549|NCT02859727||Single Group Assignment||Treatment||None (Open Label)||||||
1356550|NCT02859714|||Cohort||Retrospective|||||||
1356551|NCT02859701|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356552|NCT02859688|||Family-Based||Prospective|||||||
1356553|NCT02859675|||Case-Only||Prospective|||||||
1356554|NCT02859662|||Cohort||Prospective|||||||
1356555|NCT02859649||Single Group Assignment||Basic Science||None (Open Label)||||||
1356556|NCT02859636|||Cohort||Prospective|||||||
1356557|NCT02859623|||||Retrospective|||||||
1356558|NCT02859610|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356559|NCT02859597|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356560|NCT02859584|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356561|NCT02859571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356562|NCT02859558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356563|NCT02859545|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356564|NCT02859532||Single Group Assignment||Treatment||None (Open Label)||||||
1356565|NCT02859519|Randomized|||Treatment||||||||
1356566|NCT02859506|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1356567|NCT02859493|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1356568|NCT02859480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356569|NCT02859467|Randomized|Parallel Assignment||Treatment||Single||||||t
1356570|NCT02859454||Single Group Assignment||Treatment||None (Open Label)||||||
1356571|NCT02859441||Single Group Assignment||Treatment||None (Open Label)||||||
1356572|NCT02859428|||Cohort||Prospective|||||||
1356573|NCT02859415|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1356574|NCT02859402||Single Group Assignment||Treatment||None (Open Label)||||||
1356575|NCT02859389|||Cohort||Prospective|||||||
1356576|NCT02859376|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1356577|NCT02859363|||Cohort||Retrospective|||||||
1356578|NCT02859350|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1356579|NCT02859337|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356580|NCT02859324||Single Group Assignment||Treatment||None (Open Label)||||||
1356581|NCT02859311|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356582|NCT02859298|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356583|NCT02859285|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1356584|NCT02859272|||Cohort||Retrospective|||||||
1356585|NCT02859259|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356586|NCT02859246||Single Group Assignment||Treatment||None (Open Label)||||||
1356587|NCT02859233|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356588|NCT02859220|Randomized|Parallel Assignment||||None (Open Label)||||||
1356589|NCT02859207|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356590|NCT02859194||Single Group Assignment||Treatment||None (Open Label)||||||
1356591|NCT02859181||Single Group Assignment||Basic Science||None (Open Label)||||||
1356592|NCT02859168|Randomized|Crossover Assignment||Treatment||Single|||||t|
1356593|NCT02859155||Single Group Assignment||Treatment||None (Open Label)||||||
1356594|NCT02859142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356595|NCT02859129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356596|NCT02859116|||Other||Prospective|||||||
1356597|NCT02859103|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356598|NCT02859090||Single Group Assignment||||None (Open Label)||||||
1356599|NCT02859077||Single Group Assignment||Treatment||None (Open Label)||||||
1356600|NCT02859064||Single Group Assignment||Treatment||None (Open Label)||||||
1356601|NCT02859051|Non-Randomized|Parallel Assignment||Prevention||Double|||||t|t
1356602|NCT02859038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356603|NCT02859025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356604|NCT02859012|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356605|NCT02858999||Single Group Assignment||Treatment||None (Open Label)||||||
1356606|NCT02858986|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1356607|NCT02858973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356608|NCT02858960|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356609|NCT02858947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356610|NCT02858934||Single Group Assignment||Treatment||None (Open Label)||||||
1356611|NCT02858921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356612|NCT02858908|Non-Randomized|Sequential Assignment||Treatment||Single|||t|||
1356613|NCT02858895||Single Group Assignment||Treatment||None (Open Label)||||||
1356614|NCT02858882|||Cohort||Prospective|||||||
1356615|NCT02858869|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356616|NCT02858856|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1356617|NCT02858843||Single Group Assignment||Screening||None (Open Label)||||||
1356618|NCT02858830|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356619|NCT02858817|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1356620|NCT02858804|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356621|NCT02858791|||Case-Control||Prospective|||||||
1356622|NCT02858778|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1356623|NCT02858765|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356624|NCT02858752||Single Group Assignment||Basic Science||None (Open Label)||||||
1356625|NCT02858739|||Cohort||Prospective|||||||
1356626|NCT02858726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356627|NCT02858713|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356628|NCT02858700||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356629|NCT02858687||Single Group Assignment||Treatment||None (Open Label)||||||
1356630|NCT02858674|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1356631|NCT02858661||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356632|NCT02858648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356633|NCT02858635||Single Group Assignment||||None (Open Label)||||||
1356634|NCT02858622|Randomized|Parallel Assignment||||None (Open Label)||||||
1356635|NCT02858609||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356636|NCT02858596|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356637|NCT02858583|Randomized|Parallel Assignment||Treatment||Single||||||t
1356638|NCT02858570|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1356639|NCT02858557|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1356640|NCT02858544|||Cohort||Retrospective|||||||
1356641|NCT02858531|||Cohort||Prospective|||||||
1356642|NCT02858518|||Cohort||Prospective|||||||
1356643|NCT02858505|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356644|NCT02858492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356645|NCT02858479|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356646|NCT02858466|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356647|NCT02858453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356648|NCT02858440||Single Group Assignment||Prevention||None (Open Label)||||||
1356649|NCT02858427|Non-Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1356650|NCT02858414||Single Group Assignment||Basic Science||None (Open Label)||||||
1356651|NCT02858401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356652|NCT02858388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356653|NCT02858375|||Case-Only||Retrospective|||||||
1356654|NCT02858362||Single Group Assignment||Treatment||None (Open Label)||||||
1356655|NCT02858349||Single Group Assignment||Basic Science||None (Open Label)||||||
1356656|NCT02858336|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1356657|NCT02858323|||Cohort||Retrospective|||||||
1356658|NCT02858310|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1356659|NCT02858297|Randomized|Parallel Assignment||Treatment||Single||||||t
1356660|NCT02858284|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356661|NCT02858271||Single Group Assignment||Treatment||None (Open Label)||||||
1356662|NCT02858258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356663|NCT02858245|||Cohort||Prospective|||||||
1356664|NCT02858232||Single Group Assignment||Supportive Care||None (Open Label)||||||
1356665|NCT02858219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356666|NCT02858206|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356667|NCT02858193|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356668|NCT02858180|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356669|NCT02858167||Single Group Assignment||||None (Open Label)||||||
1356670|NCT02858154||Single Group Assignment||Treatment||None (Open Label)||||||
1356671|NCT02858141|||Cohort||Prospective|||||||
1356672|NCT02858128|||Case-Only||Prospective|||||||
1356673|NCT02858115|||||Retrospective|||||||
1356674|NCT02858102|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356675|NCT02858089||||||||||||
1356676|NCT02858076|Randomized|Parallel Assignment||Treatment||Single||||||t
1356677|NCT02858063|||Cohort||Prospective|||||||
1356678|NCT02858050|||Cohort||Prospective|||||||
1356679|NCT02858037||Single Group Assignment||Prevention||None (Open Label)||Participants will receive a silicone elastomer vaginal matrix ring containing 25 mg of dapivirine to be replaced each month for a total period of 12 months of use.||||
1356680|NCT02858024|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1356681|NCT02858011|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356682|NCT02857998||Single Group Assignment||Treatment||None (Open Label)||||||
1356683|NCT02857985||Single Group Assignment||Other||None (Open Label)||||||
1356684|NCT02857972||Single Group Assignment||Health Services Research||None (Open Label)||||||
1356685|NCT02857959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356686|NCT02857946|Randomized|Crossover Assignment||||None (Open Label)||||||
1356687|NCT02857933|Randomized|Parallel Assignment||Treatment||Single||||||t
1356688|NCT02857920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356689|NCT02857907|||Cohort||Prospective|||||||
1356690|NCT02857894|||Cohort||Prospective|||||||
1356691|NCT02857881||Single Group Assignment||Treatment||None (Open Label)||||||
1356692|NCT02857868||Single Group Assignment||Treatment||None (Open Label)||||||
1356693|NCT02857855|Randomized|Parallel Assignment||Prevention||Single|||t|||
1356694|NCT02857842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356695|NCT02857829|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1356696|NCT02857816||Single Group Assignment||Treatment||None (Open Label)||||||
1356697|NCT02857803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356698|NCT02857790|||Cohort||Prospective|||||||
1356699|NCT02857777|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356700|NCT02857764|||Cohort||Retrospective|||||||
1356701|NCT02857751|||Cohort||Prospective|||||||
1356702|NCT02857738||Single Group Assignment||Prevention||None (Open Label)||||||
1356703|NCT02857725||Single Group Assignment||Prevention||None (Open Label)||||||
1356704|NCT02857712||Single Group Assignment||Treatment||None (Open Label)||||||
1356705|NCT02857699|||Cohort||Prospective|||||||
1356706|NCT02857686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356707|NCT02857673|Randomized|Parallel Assignment||Prevention||Single||||||t
1356708|NCT02857660|Randomized|Parallel Assignment||Treatment||Single||||||t
1356709|NCT02857647|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356710|NCT02857634|||Case-Only||Cross-Sectional|||||||
1356711|NCT02857621|||Other||Cross-Sectional|||||||
1356712|NCT02857608||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356713|NCT02857595|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1356714|NCT02857582|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356715|NCT02857569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356716|NCT02857556|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1356717|NCT02857543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356718|NCT02857530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356719|NCT02857517||Single Group Assignment||Treatment||None (Open Label)||||||
1356720|NCT02857504|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356721|NCT02857491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356722|NCT02857478||Single Group Assignment||Prevention||Single|||t|||
1356723|NCT02857465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356724|NCT02857452|||Cohort||Prospective|||||||
1356725|NCT02857439|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356726|NCT02857426|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1356727|NCT02857413|||Cohort||Prospective|||||||
1356728|NCT02857400|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1356729|NCT02857387||Single Group Assignment||Basic Science||None (Open Label)||||||
1356730|NCT02857374||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356731|NCT02857361|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356732|NCT02857348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356733|NCT02857335||Single Group Assignment||||None (Open Label)||||||
1356734|NCT02857322||Single Group Assignment||||None (Open Label)||||||
1356735|NCT02857309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356736|NCT02857296|||||Prospective|||||||
1356737|NCT02857283|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1356738|NCT02857270|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356739|NCT02857257||Single Group Assignment||Treatment||None (Open Label)||||||
1356740|NCT02857244||Single Group Assignment||Treatment||None (Open Label)||||||
1356741|NCT02857231|||Cohort||Prospective|||||||
1356742|NCT02857218||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356743|NCT02857205||Single Group Assignment||Basic Science||None (Open Label)||||||
1356744|NCT02857192|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1356745|NCT02857179|||Cohort||Prospective|||||||
1356746|NCT02857166||Single Group Assignment||Treatment||None (Open Label)||||||
1356747|NCT02857153|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1356748|NCT02857127|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356749|NCT02857114||Single Group Assignment||||None (Open Label)||||||
1356750|NCT02857101|||Cohort||Prospective|||||||
1356751|NCT02857088|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356752|NCT02857075|||Case Control|||||||||
1356753|NCT02857062||Single Group Assignment||Treatment||None (Open Label)||Open label, in use tolerance study in babies and children.||||
1356754|NCT02857049||Single Group Assignment||||None (Open Label)||||||
1356755|NCT02857036|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1356756|NCT02857023|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356757|NCT02857010|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356758|NCT02856997||Single Group Assignment||Treatment||None (Open Label)||||||
1356759|NCT02856984|||Cohort||Prospective|||||||
1356760|NCT02856971|||Cohort||Retrospective|||||||
1356761|NCT02856958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356762|NCT02856945|||Cohort||Prospective|||||||
1356763|NCT02856932|Randomized|||Treatment||Double|||t|||t
1356764|NCT02856919||Single Group Assignment||Treatment||None (Open Label)||||||
1356765|NCT02856906||Single Group Assignment||Treatment||None (Open Label)||||||
1356766|NCT02856893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356767|NCT02856880|Randomized|Crossover Assignment||Basic Science||Single||||||t
1356768|NCT02856867|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1356769|NCT02856854|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1356770|NCT02856841|||Cohort||Prospective|||||||
1356771|NCT02856828|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356772|NCT02856815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356773|NCT02856802|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356774|NCT02856789|||Other||Prospective|||||||
1356775|NCT02856776|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1356776|NCT02856763|||Cohort||Prospective|||||||
1356777|NCT02856750|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356778|NCT02856737||Single Group Assignment||Other||None (Open Label)||||||
1356779|NCT02856724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356780|NCT02856711|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1356781|NCT02856698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356782|NCT02856685||Single Group Assignment||Treatment||None (Open Label)||||||
1356783|NCT02856672|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1356784|NCT02856659|||Cohort||Prospective|||||||
1356785|NCT02856646|||Case-Only||Prospective|||||||
1356786|NCT02856633|||Other||Prospective|||||||
1356787|NCT02856620|||Cohort||Prospective|||||||
1356788|NCT02856607|||||Prospective|||||||
1356789|NCT02856594|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356790|NCT02856581|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1356791|NCT02856568||Single Group Assignment||Treatment||None (Open Label)||||||
1356792|NCT02856555|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356793|NCT02856542|||Cohort||Prospective|||||||
1356794|NCT02856529|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356795|NCT02856516|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1356796|NCT02856503|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356797|NCT02856490||||||||||||
1356798|NCT02856477|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1356799|NCT02856464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356800|NCT02856451|||Case-Only||Retrospective|||||||
1356801|NCT02856438||||||||||||
1356802|NCT02856425|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356803|NCT02856412|Randomized|Parallel Assignment||Treatment||Single||||||t
1356804|NCT02856399|||Cohort||Prospective|||||||
1356805|NCT02856386||Single Group Assignment||Supportive Care||None (Open Label)||||||
1356806|NCT02856373|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356807|NCT02856360|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1356808|NCT02856347||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356809|NCT02856334|||Cohort||Cross-Sectional|||||||
1356810|NCT02856321|||Cohort||Retrospective|||||||
1356811|NCT02856308||Single Group Assignment||Other||None (Open Label)||||||
1356812|NCT02856295|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356813|NCT02856282|||Case-Only||Retrospective|||||||
1356814|NCT02856269|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356815|NCT02856256||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356816|NCT02856243|||Cohort||Prospective|||||||
1356817|NCT02856230||Single Group Assignment||Treatment||None (Open Label)||||||
1356818|NCT02856217|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1356819|NCT02856204|||Cohort||Prospective|||||||
1356820|NCT02856191||Single Group Assignment||||None (Open Label)||||||
1356821|NCT02856178||Single Group Assignment||Prevention||None (Open Label)||||||
1356822|NCT02856165|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356823|NCT02856152|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1356824|NCT02856139|||Case-Only||Prospective|||||||
1356825|NCT02856126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356826|NCT02856113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356827|NCT02856100|||Cohort||Prospective|||||||
1356828|NCT02856087|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1356829|NCT02856074||Single Group Assignment||Prevention||None (Open Label)||||||
1356830|NCT02856061|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356831|NCT02856048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356832|NCT02856035|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356833|NCT02856022|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356834|NCT02856009||Single Group Assignment||Other||None (Open Label)||||||
1356835|NCT02855996|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356836|NCT02855983|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356837|NCT02855970||Single Group Assignment||||None (Open Label)||||||
1356838|NCT02855957||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356839|NCT02855944|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356840|NCT02855931|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356841|NCT02855918||Single Group Assignment||||None (Open Label)||||||
1356842|NCT02855905||Single Group Assignment||Basic Science||None (Open Label)||||||
1356843|NCT02855892|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356844|NCT02855879|||Case-Only||Prospective|||||||
1356845|NCT02855866|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356846|NCT02855853|Randomized|Parallel Assignment||||None (Open Label)||||||
1356847|NCT02855840|||Other||Prospective|||||||
1356848|NCT02855827|||Cohort||Other|||||||
1356849|NCT02855814|||Cohort||Cross-Sectional|||||||
1356850|NCT02855801|Randomized|Parallel Assignment||Treatment||Single|||||t|
1356851|NCT02855788||Single Group Assignment||Treatment||None (Open Label)||||||
1357011|NCT02853708|||Cohort||Prospective|||||||
1356852|NCT02855775|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356853|NCT02855762||Single Group Assignment||Supportive Care||None (Open Label)||||||
1356854|NCT02855749|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356855|NCT02855736|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356856|NCT02855723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356857|NCT02855710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356858|NCT02855697||Single Group Assignment||Treatment||None (Open Label)||||||
1356859|NCT02855684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356860|NCT02855671|||Cohort||Prospective|||||||
1356861|NCT02855658|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1356862|NCT02855645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356863|NCT02855632|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1356864|NCT02855619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356865|NCT02855606|||Other||Prospective|||||||
1356866|NCT02855593|||Case-Only||Prospective|||||||
1356867|NCT02855580|||Cohort||Prospective|||||||
1356868|NCT02855567|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356869|NCT02855554||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356870|NCT02855541||Single Group Assignment||Basic Science||None (Open Label)||||||
1356871|NCT02855528||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356872|NCT02855515||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356873|NCT02855502|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1356874|NCT02855489|Randomized|Factorial Assignment||Prevention||Single|||t|||
1356875|NCT02855476|||Cohort||Prospective|||||||
1356876|NCT02855463|||Cohort||Prospective|||||||
1356877|NCT02855450|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1356878|NCT02855437|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1356879|NCT02855424|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1356880|NCT02855411|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356881|NCT02855398|||Other||Cross-Sectional|||||||
1356882|NCT02855385|||Cohort||Cross-Sectional|||||||
1356883|NCT02855372|||Cohort||Retrospective|||||||
1356884|NCT02855359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356885|NCT02855346|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1356886|NCT02855333|||||Retrospective|||||||
1356887|NCT02855320|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356888|NCT02855307|Randomized|Crossover Assignment||Treatment||Single|||t|||
1356889|NCT02855294|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356890|NCT02855281|||Case-Only||Prospective|||||||
1356891|NCT02855268|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1356892|NCT02855255|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1356893|NCT02855242|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356894|NCT02855229|||Cohort||Cross-Sectional|||||||
1356895|NCT02855216|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356896|NCT02855203||Single Group Assignment||Treatment||None (Open Label)||||||
1356897|NCT02855190||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356898|NCT02855177|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1356899|NCT02855164|Randomized|Parallel Assignment||Treatment||Triple||This study was extended based on safety and efficacy results in Part A and available long-term toxicology coverage; Part C is added exploring 48 weeks of treatment at higher doses with paired biopsies in F2/3 NASH patients..|t|t|t|
1356900|NCT02855151|||Cohort||Cross-Sectional|||||||
1356901|NCT02855138|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1356902|NCT02855125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356903|NCT02855112|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1356904|NCT02855099|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356905|NCT02855086|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1356906|NCT02855073|Randomized|Crossover Assignment||Treatment||Single|||t|||
1356907|NCT02855060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356908|NCT02855047|||Cohort||Prospective|||||||
1356909|NCT02855034||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356910|NCT02855021||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356911|NCT02855008|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356912|NCT02854995|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356913|NCT02854982|||Cohort||Other|||||||
1356914|NCT02854969|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1356915|NCT02854956|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1356916|NCT02854943|||Cohort||Retrospective|||||||
1356917|NCT02854930|||||Prospective|||||||
1356918|NCT02854917|||Case-Control||Retrospective|||||||
1356919|NCT02854904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1356920|NCT02854891|||Cohort||Prospective|||||||
1356921|NCT02854878||Single Group Assignment||Treatment||None (Open Label)||||||
1356922|NCT02854865|||Case-Only||Prospective|||||||
1356923|NCT02854852|||Case-Only||Prospective|||||||
1356924|NCT02854839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356925|NCT02854826|||Other||Prospective|||||||
1356926|NCT02854813|||Cohort||Prospective|||||||
1356927|NCT02854800||Single Group Assignment||Treatment||None (Open Label)||||||
1356928|NCT02854787|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1356929|NCT02854774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356930|NCT02854761|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356931|NCT02854748|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356932|NCT02854735|||Cohort||Prospective|||||||
1356933|NCT02854722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356934|NCT02854709|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356935|NCT02854696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356936|NCT02854683|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356937|NCT02854670||Single Group Assignment||Treatment||None (Open Label)||||||
1356938|NCT02854657|Randomized|Parallel Assignment||Prevention||Single|||||t|
1356939|NCT02854644|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356940|NCT02854631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356941|NCT02854618||Single Group Assignment||Basic Science||None (Open Label)||||||
1356942|NCT02854605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356943|NCT02854592|||Cohort||Prospective|||||||
1356944|NCT02854579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356945|NCT02854566|||Case-Only||Retrospective|||||||
1356946|NCT02854553|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1356947|NCT02854540||Single Group Assignment||Treatment||None (Open Label)||||||
1356948|NCT02854527|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1356949|NCT02854514|||Cohort||Prospective|||||||
1356950|NCT02854501|||Case Control||Prospective|||||||
1356951|NCT02854488|||Cohort||Other|||||||
1356952|NCT02854475||Single Group Assignment||||None (Open Label)||||||
1356953|NCT02854462|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1356954|NCT02854449|||Case-Only||Prospective|||||||
1356955|NCT02854436||Single Group Assignment||Treatment||None (Open Label)||||||
1356956|NCT02854423|||Case Control||Retrospective|||||||
1356957|NCT02854410|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1356958|NCT02854397|||Other||Prospective|||||||
1356959|NCT02854384|||Case Control||Cross-Sectional|||||||
1356960|NCT02854371||Single Group Assignment||Diagnostic||None (Open Label)||gadoxetic acid MRI and ICG R15 test||||
1356961|NCT02854358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356962|NCT02854345||Single Group Assignment||Diagnostic||None (Open Label)||||||
1356963|NCT02854332|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1356964|NCT02854319||Single Group Assignment||Treatment||None (Open Label)||||||
1356965|NCT02854306|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356966|NCT02854293|||||Prospective|||||||
1356967|NCT02854280|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1356968|NCT02854267|||Cohort||Prospective|||||||
1356969|NCT02854254|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1356970|NCT02854241||Single Group Assignment||Screening||None (Open Label)||||||
1356971|NCT02854228|||Cohort||Prospective|||||||
1356972|NCT02854215||Single Group Assignment||Health Services Research||None (Open Label)||||||
1356973|NCT02854202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356974|NCT02854189|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1356975|NCT02854176|Randomized|Crossover Assignment||Treatment||||||||
1356976|NCT02854163||Single Group Assignment||Basic Science||None (Open Label)||||||
1356977|NCT02854150|||Cohort||Retrospective|||||||
1356978|NCT02854137|Randomized|Parallel Assignment||Other||Double|||t||t|
1356979|NCT02854124|||Cohort||Retrospective|||||||
1356980|NCT02854111|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1356981|NCT02854098|||Other||Cross-Sectional|||||||
1356982|NCT02854085|Randomized|Parallel Assignment||Prevention||Single||||||t
1356983|NCT02854072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356984|NCT02854059||Single Group Assignment||Treatment||None (Open Label)||||||
1356985|NCT02854046|||Case Control||Retrospective|||||||
1356986|NCT02854033|||Cohort||Prospective|||||||
1356987|NCT02854020|||Cohort||Retrospective|||||||
1356988|NCT02854007|||Cohort||Prospective|||||||
1356989|NCT02853994|||Cohort||Prospective|||||||
1356990|NCT02853981|Randomized|Parallel Assignment||Treatment||Single||||||t
1356991|NCT02853968|||Cohort||Cross-Sectional|||||||
1356992|NCT02853955|||Cohort||Retrospective|||||||
1356993|NCT02853942|Randomized|Parallel Assignment||Treatment||Single|||t|||
1356994|NCT02853929|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356995|NCT02853916|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1356996|NCT02853903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1356997|NCT02853890|||||Prospective|||||||
1356998|NCT02853877|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1356999|NCT02853864|Randomized|Crossover Assignment||Treatment||Double||||t|t|
1357000|NCT02853851|||Cohort||Retrospective|||||||
1357001|NCT02853838|Randomized|Parallel Assignment||Treatment||Single||||||t
1357002|NCT02853825|Randomized|Parallel Assignment||Other||Single||||||t
1357003|NCT02853812||Single Group Assignment||Basic Science||None (Open Label)||||||
1357004|NCT02853799|Randomized|Crossover Assignment||||None (Open Label)||||||
1357005|NCT02853786|Randomized|Parallel Assignment||||None (Open Label)||||||
1357006|NCT02853773|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1357007|NCT02853760|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1357008|NCT02853747|||Cohort||Cross-Sectional|||||||
1357009|NCT02853734|Non-Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1357010|NCT02853721|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357013|NCT02853682|||Cohort||Prospective|||||||
1357014|NCT02853669|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1357015|NCT02853656|||Cohort||Prospective|||||||
1357016|NCT02853643|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1357017|NCT02853630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357018|NCT02853617|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1357019|NCT02853604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357020|NCT02853591|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1357021|NCT02853578||Single Group Assignment||Treatment||None (Open Label)||||||
1357022|NCT02853565||Single Group Assignment||Treatment||None (Open Label)||||||
1357023|NCT02853552||Single Group Assignment||Health Services Research||None (Open Label)||||||
1357024|NCT02853539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357025|NCT02853526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357026|NCT02853513|||Cohort||Prospective|||||||
1357027|NCT02853500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357028|NCT02853487|||Case-Control||Prospective|||||||
1357029|NCT02853474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357030|NCT02853461|||Cohort||Prospective|||||||
1357031|NCT02853448||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1357032|NCT02853435|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357033|NCT02853422|||Cohort||Cross-Sectional|||||||
1357034|NCT02853409|||Case-Control||Prospective|||||||
1357035|NCT02853396|Randomized|Parallel Assignment||Treatment||Single||||||t
1357036|NCT02853383|||Cohort|||||||||
1357037|NCT02853370||Single Group Assignment||Treatment||None (Open Label)||||||
1357038|NCT02853357|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1357039|NCT02853344|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357040|NCT02853331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357041|NCT02853318||Single Group Assignment||Treatment||None (Open Label)||||||
1357042|NCT02853305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357043|NCT02853292|||Cohort||Prospective|||||||
1357044|NCT02853279|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357045|NCT02853266|||Cohort||Prospective|||||||
1357046|NCT02853253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357047|NCT02853240||Single Group Assignment||Basic Science||None (Open Label)||||||
1357048|NCT02853227|||Cohort||Retrospective|||||||
1357049|NCT02853214||Single Group Assignment||Screening||None (Open Label)||||||
1357050|NCT02853201|||Cohort||Prospective|||||||
1357051|NCT02853188||Single Group Assignment||Prevention||None (Open Label)||||||
1357052|NCT02853175|||Case-Control||Prospective|||||||
1357053|NCT02853162||Single Group Assignment||Treatment||None (Open Label)||||||
1357054|NCT02853149|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1357055|NCT02853136|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357056|NCT02853123|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1357057|NCT02853110||Single Group Assignment||Treatment||None (Open Label)||||||
1357058|NCT02853097|||Cohort||Prospective|||||||
1357059|NCT02853084||Single Group Assignment||Treatment||None (Open Label)||||||
1357060|NCT02853071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357061|NCT02853058|Non-Randomized|Single Group Assignment||Treatment||Double|||t|||t
1357062|NCT02853045|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1357063|NCT02853032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357064|NCT02853019|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1357065|NCT02853006|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357066|NCT02852993|||Cohort||Retrospective|||||||
1357067|NCT02852980|||Cohort||Retrospective|||||||
1357068|NCT02852967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357069|NCT02852954|||Case-Control||Retrospective|||||||
1357070|NCT02852941|||Cohort||Cross-Sectional|||||||
1357071|NCT02852928|||Case-Only||Prospective|||||||
1357072|NCT02852915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357073|NCT02852902|||Cohort||Retrospective|||||||
1357074|NCT02852889|||Case Control||Prospective|||||||
1357075|NCT02852876|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1357076|NCT02852863||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357077|NCT02852850|||Cohort||Prospective|||||||
1357078|NCT02852837|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1357079|NCT02852824|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357080|NCT02852811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357081|NCT02852798|||Cohort||Prospective|||||||
1357082|NCT02852785|||Case-Control||Cross-Sectional|||||||
1357083|NCT02852772|||Case-Control||Prospective|||||||
1357084|NCT02852759|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357085|NCT02852746|||Case-Control||Cross-Sectional|||||||
1357086|NCT02852733|||Cohort|||||||||
1357087|NCT02852720||Single Group Assignment||Basic Science||None (Open Label)||||||
1357088|NCT02852707|||Case-Control||Cross-Sectional|||||||
1357089|NCT02852694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357090|NCT02852681|Randomized|Crossover Assignment||||None (Open Label)||||||
1357091|NCT02852668|Randomized|Parallel Assignment||Prevention||Single|||t|||
1357092|NCT02852655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357093|NCT02852642|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357094|NCT02852629|||Case-Only||Prospective|||||||
1357095|NCT02852616|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1357096|NCT02852603|||Cohort||Retrospective|||||||
1357097|NCT02852590|||Cohort||Prospective|||||||
1357098|NCT02852577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357099|NCT02852564||Single Group Assignment||Treatment||None (Open Label)||||||
1357100|NCT02852551|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1357101|NCT02852538||Single Group Assignment||Treatment||None (Open Label)||||||
1357102|NCT02852525||Single Group Assignment||Treatment||None (Open Label)||||||
1357103|NCT02852512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357104|NCT02852499|||Cohort||Prospective|||||||
1357105|NCT02852486||Single Group Assignment||Other||None (Open Label)||||||
1357106|NCT02852473||Single Group Assignment||Basic Science||None (Open Label)||||||
1357107|NCT02852460|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357108|NCT02852447|||Cohort||Prospective|||||||
1357109|NCT02852434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357110|NCT02852421|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1357111|NCT02852408|||Case Control||Prospective|||||||
1357112|NCT02852395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357113|NCT02852382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357114|NCT02852369||Single Group Assignment||Treatment||None (Open Label)||||||
1357115|NCT02852356|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357116|NCT02852343|||Cohort||Prospective|||||||
1357117|NCT02852330||Single Group Assignment||Basic Science||None (Open Label)||||||
1357118|NCT02852317|||Cohort||Prospective|||||||
1357119|NCT02852304|||Cohort||Prospective|||||||
1357120|NCT02852291|Randomized|Parallel Assignment||Prevention||Single||||||t
1357121|NCT02852278|||Cohort||Prospective|||||||
1357122|NCT02852265||Single Group Assignment||Prevention||None (Open Label)||||||
1357123|NCT02852252|||Cohort||Prospective|||||||
1357124|NCT02852239|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||parallel-group, open-label||||
1357125|NCT02852226||Single Group Assignment||Prevention||None (Open Label)||||||
1357126|NCT02852213||Single Group Assignment||Treatment||None (Open Label)||||||
1357127|NCT02852200|||Cohort||Other|||||||
1357128|NCT02852187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357129|NCT02852174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357130|NCT02852161|Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1357131|NCT02852148||Single Group Assignment||Treatment||None (Open Label)||||||
1357132|NCT02852135|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1357133|NCT02852122||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357134|NCT02852109|||Case Control||Cross-Sectional|||||||
1357135|NCT02852096|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1357136|NCT02852083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357137|NCT02852070|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1357138|NCT02852057||Single Group Assignment||Treatment||None (Open Label)||||||
1357139|NCT02852044|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1357140|NCT02852031|||Case-Only||Prospective|||||||
1357141|NCT02852018|||Other||Other|||||||
1357142|NCT02852005|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1357143|NCT02851992||Single Group Assignment||Treatment||None (Open Label)||||||
1357144|NCT02851979|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357145|NCT02851966||Single Group Assignment||Basic Science||None (Open Label)||||||
1357146|NCT02851953||Single Group Assignment||Treatment||None (Open Label)||||||
1357147|NCT02851940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357148|NCT02851927|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1357149|NCT02851914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357150|NCT02851901||Parallel Assignment||Prevention||Double||||||
1357151|NCT02851888|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1357152|NCT02851875|||Cohort||Prospective|||||||
1357153|NCT02851862|||Cohort||Prospective|||||||
1357154|NCT02851849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357155|NCT02851836||Single Group Assignment||||None (Open Label)||||||
1357156|NCT02851823|Randomized|Parallel Assignment||Treatment||Double||split-mouth||t||t
1357157|NCT02851810||Single Group Assignment||Basic Science||None (Open Label)||||||
1357158|NCT02851797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357159|NCT02851784|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357160|NCT02851771||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357161|NCT02851758||Single Group Assignment||Treatment||None (Open Label)||||||
1357162|NCT02851745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357163|NCT02851732|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1357164|NCT02851719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357165|NCT02851706|||Cohort||Prospective|||||||
1357166|NCT02851693||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357167|NCT02851680|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1357168|NCT02851667||Single Group Assignment||Prevention||None (Open Label)||||||
1357169|NCT02851654|||Case-Only||Prospective|||||||
1357170|NCT02851641|||Cohort||Prospective|||||||
1357171|NCT02851628|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357172|NCT02851615|Randomized|Parallel Assignment||Treatment||Single||||||t
1357173|NCT02851602|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1357174|NCT02851589||Single Group Assignment||Treatment||None (Open Label)||||||
1357175|NCT02851576||Single Group Assignment||Treatment||None (Open Label)||||||
1357176|NCT02851563|||Cohort||Prospective|||||||
1357177|NCT02851550|||Cohort||Prospective|||||||
1357178|NCT02851537|||Cohort||Retrospective|||||||
1357179|NCT02851524||Single Group Assignment||||None (Open Label)||||||
1357180|NCT02851511|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357181|NCT02851498|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1357182|NCT02851485|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357183|NCT02851472|Randomized|Parallel Assignment||Treatment||Triple|iNO vs nitrogen will be administered from tanks labeled with a code number that is known by the manufacturer and a campus safety officer but masked to investigators and to bedside personnel.|subjects are randomize into either of two groups: intervention or placebo|t|t|t|
1357184|NCT02851459|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1357185|NCT02851446|||Case Control||Prospective|||||||
1357186|NCT02851433|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357187|NCT02851420|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357188|NCT02851407|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357189|NCT02851394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357190|NCT02851381||Single Group Assignment||Treatment||None (Open Label)||||||
1357191|NCT02851368||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357192|NCT02851355|||Cohort||Retrospective|||||||
1357193|NCT02851342|||Cohort||Prospective|||||||
1357194|NCT02851329|||Cohort||Retrospective|||||||
1357195|NCT02851316|Randomized|Crossover Assignment||Treatment||Single|||||t|
1357196|NCT02851303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357197|NCT02851290|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1357198|NCT02851277|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357199|NCT02851264|||Cohort||Prospective|||||||
1357200|NCT02851251|||Cohort||Prospective|||||||
1357201|NCT02851238|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1357202|NCT02851225|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357203|NCT02851212|Randomized|Crossover Assignment||||None (Open Label)||||||
1357204|NCT02851199|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357205|NCT02851186|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1357206|NCT02851173|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357207|NCT02851160|||||Retrospective|||||||
1357208|NCT02851147|||Cohort||Prospective|||||||
1357209|NCT02851134|||Family-Based||Prospective|||||||
1357210|NCT02851121||Single Group Assignment||Basic Science||None (Open Label)||||||
1357211|NCT02851108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357212|NCT02851095|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1357213|NCT02851082||Single Group Assignment||Treatment||None (Open Label)||||||
1357214|NCT02851069|||Cohort||Prospective|||||||
1357215|NCT02851056||Single Group Assignment||Treatment||None (Open Label)||||||
1357216|NCT02851043|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357217|NCT02851030|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357218|NCT02851017|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357219|NCT02851004||Single Group Assignment||Treatment||None (Open Label)||||||
1357220|NCT02850991|Randomized|Parallel Assignment||Treatment||Single||High dose radiation plus chemotherapy of paclitaxel and carboplatin vs standard dose radiation plus chemotherapy of paclitaxel and carboplatin.|||t|
1357221|NCT02850978|||Cohort||Prospective|||||||
1357222|NCT02850965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357223|NCT02850952||Single Group Assignment||Health Services Research||None (Open Label)||||||
1357224|NCT02850939|Randomized|Parallel Assignment||Other||Double|||||t|t
1357225|NCT02850926|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357226|NCT02850913|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1357227|NCT02850900|Randomized|Parallel Assignment||Treatment||Single|||||t|
1357228|NCT02850887|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357229|NCT02850874|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357230|NCT02850861|Randomized|Single Group Assignment||Treatment||Single||||||t
1357231|NCT02850848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357232|NCT02850835|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1357233|NCT02850822|||Case-Control||Prospective|||||||
1357234|NCT02850809|||Cohort||Retrospective|||||||
1357235|NCT02850796|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1357236|NCT02850783||Single Group Assignment||||||||||
1357237|NCT02850770|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357238|NCT02850757|Randomized|Single Group Assignment||Treatment||Single|||t|||
1357239|NCT02850744||Single Group Assignment||Treatment||None (Open Label)||||||
1357240|NCT02850731|Randomized|Parallel Assignment||Prevention||Single||||||t
1357241|NCT02850718|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357242|NCT02850705|||Cohort||Prospective|||||||
1357243|NCT02850692|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357244|NCT02850679|||Cohort||Retrospective|||||||
1357245|NCT02850666||Single Group Assignment||Treatment||None (Open Label)||||||
1357246|NCT02850653|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357247|NCT02850640|||Cohort||Prospective|||||||
1357248|NCT02850627|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1357329|NCT02849574|||Cohort||Prospective|||||||
1357249|NCT02850614|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1357250|NCT02850601|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357251|NCT02850588|||Case-Control||Prospective|||||||
1357252|NCT02850575|||Case-Only||Prospective|||||||
1357253|NCT02850562|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357254|NCT02850549||Single Group Assignment||Treatment||None (Open Label)||||||
1357255|NCT02850536||Single Group Assignment||Treatment||None (Open Label)||||||
1357256|NCT02850523|Randomized|Parallel Assignment||Treatment||Single||||||t
1357257|NCT02850510|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357258|NCT02850497|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357259|NCT02850484|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357260|NCT02850471|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1357261|NCT02850458|||Cohort||Retrospective|||||||
1357262|NCT02850445|Randomized|Parallel Assignment||Treatment||Single||||||t
1357263|NCT02850432|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1357264|NCT02850419||Single Group Assignment||Treatment||None (Open Label)||||||
1357265|NCT02850406||Single Group Assignment||Treatment||None (Open Label)||||||
1357266|NCT02850393|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357267|NCT02850380||Single Group Assignment||||None (Open Label)||||||
1357268|NCT02850367|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1357269|NCT02850354||Single Group Assignment||||None (Open Label)||||||
1357270|NCT02850341|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357271|NCT02850328||Single Group Assignment||Other||None (Open Label)||||||
1357272|NCT02850315|||Cohort||Cross-Sectional|||||||
1357273|NCT02850302||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357274|NCT02850289|||Cohort||Prospective|||||||
1357275|NCT02850276||Single Group Assignment||Treatment||None (Open Label)||||||
1357276|NCT02850263|||Cohort||Prospective|||||||
1357277|NCT02850250|||Case-Only||Prospective|||||||
1357278|NCT02850237|||||Prospective|||||||
1357279|NCT02850224|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1357280|NCT02850211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357281|NCT02850198|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1357282|NCT02850185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357283|NCT02850172|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1357284|NCT02850159|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1357285|NCT02850146||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357286|NCT02850133||Single Group Assignment||Basic Science||None (Open Label)||||||
1357287|NCT02850120|||Cohort||Retrospective|||||||
1357288|NCT02850107||Single Group Assignment||Treatment||None (Open Label)||||||
1357289|NCT02850094||Single Group Assignment||Treatment||None (Open Label)||||||
1357290|NCT02850081|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1357291|NCT02850068||Single Group Assignment||Treatment||None (Open Label)||||||
1357292|NCT02850055|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1357293|NCT02850042|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1357294|NCT02850029|||Cohort||Prospective|||||||
1357295|NCT02850016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357296|NCT02850003||Single Group Assignment||Treatment||None (Open Label)||||||
1357297|NCT02849990||Single Group Assignment||Treatment||None (Open Label)||||||
1357298|NCT02849977|||Case-Only||Prospective|||||||
1357299|NCT02849964|||Ecologic or Community||Retrospective|||||||
1357300|NCT02849951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357301|NCT02849938|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1357302|NCT02849925|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357303|NCT02849912|||Cohort||Prospective|||||||
1357304|NCT02849899|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1357305|NCT02849886|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1357306|NCT02849873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357307|NCT02849860||Single Group Assignment||Treatment||None (Open Label)||||||
1357308|NCT02849847||||||||||||
1357309|NCT02849834|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1357310|NCT02849821||Single Group Assignment||||None (Open Label)||||||
1357311|NCT02849808|||Cohort||Prospective|||||||
1357312|NCT02849795||Single Group Assignment||Basic Science||None (Open Label)||||||
1357313|NCT02849782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1357314|NCT02849769|||Cohort||Prospective|||||||
1357315|NCT02849756|||Cohort||Prospective|||||||
1357316|NCT02849743|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1357317|NCT02849730|||Case Control||Retrospective|||||||
1357318|NCT02849717|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1357319|NCT02849704|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357320|NCT02849691|||Cohort||Retrospective|||||||
1357321|NCT02849678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357322|NCT02849665|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357323|NCT02849652|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1357324|NCT02849639|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1357325|NCT02849626||Single Group Assignment||Treatment||None (Open Label)||||||
1357326|NCT02849613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357327|NCT02849600|||Cohort||Retrospective|||||||
1357328|NCT02849587|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1357330|NCT02849561|Randomized|Factorial Assignment||||Double|||t||t|
1357331|NCT02849548|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1357332|NCT02849535|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357333|NCT02849522|||Cohort||Prospective|||||||
1357334|NCT02849509|||Cohort||Prospective|||||||
1357335|NCT02849496|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357336|NCT02849483|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1357337|NCT02849470|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357338|NCT02849457|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1357339|NCT02849444|||Cohort||Prospective|||||||
1357340|NCT02849431||Single Group Assignment||Treatment||None (Open Label)||||||
1357341|NCT02849418|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357342|NCT02849405|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357343|NCT02849392|Randomized|Crossover Assignment||||None (Open Label)||||||
1357344|NCT02849379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357345|NCT02849366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357346|NCT02849353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357347|NCT02849340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357348|NCT02849327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357349|NCT02849314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357350|NCT02849301|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357351|NCT02849288||Single Group Assignment||Treatment||None (Open Label)||||||
1357352|NCT02849275|Randomized|Crossover Assignment||Basic Science||Double||Participants will pass through 2 arms, control and probiotic, in a randomized, counter-balanced order.|t||t|
1357353|NCT02849262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357354|NCT02849249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357355|NCT02849236|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1357356|NCT02849223|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1357357|NCT02849210||Single Group Assignment||Treatment||None (Open Label)||||||
1357358|NCT02849197|||Cohort||Retrospective|||||||
1357359|NCT02849184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357360|NCT02849171||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357361|NCT02849158||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357362|NCT02849145||Single Group Assignment||Other||None (Open Label)||||||
1357363|NCT02849132||Single Group Assignment||Treatment||None (Open Label)||||||
1357364|NCT02849119|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1357365|NCT02849106||Single Group Assignment||Other||None (Open Label)||||||
1357366|NCT02849093|||Cohort||Cross-Sectional|||||||
1357367|NCT02849080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357368|NCT02849067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357369|NCT02849054|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357370|NCT02849041||Single Group Assignment||Screening||None (Open Label)||||||
1357371|NCT02849028|||Case Control|||||||||
1357372|NCT02849015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357373|NCT02849002||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357374|NCT02848989||Single Group Assignment||Supportive Care||None (Open Label)||||||
1357375|NCT02848976|||Cohort||Prospective|||||||
1357376|NCT02848963|Randomized|Crossover Assignment||Prevention||Single|||t|||
1357377|NCT02848950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357378|NCT02848937|||Case-Crossover||Prospective|||||||
1357379|NCT02848924|||Cohort||Retrospective|||||||
1357380|NCT02848911||Single Group Assignment||Treatment||None (Open Label)||||||
1357381|NCT02848898|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1357382|NCT02848885|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1357383|NCT02848872|||Cohort||Prospective|||||||
1357384|NCT02848859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357385|NCT02848846||Single Group Assignment||||None (Open Label)||||||
1357386|NCT02848833|||Cohort||Prospective|||||||
1357387|NCT02848820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357388|NCT02848807|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357389|NCT02848794||Single Group Assignment||Treatment||None (Open Label)||||||
1357390|NCT02848781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357391|NCT02848768|||Cohort||Retrospective|||||||
1357392|NCT02848755|||Cohort||Prospective|||||||
1357393|NCT02848742||Single Group Assignment||Treatment||None (Open Label)||||||
1357394|NCT02848729|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357395|NCT02848716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357396|NCT02848703||Single Group Assignment||Treatment||None (Open Label)||||||
1357397|NCT02848690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357398|NCT02848677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357399|NCT02848664||Single Group Assignment||Treatment||None (Open Label)||||||
1357400|NCT02848651||Single Group Assignment||Treatment||None (Open Label)||||||
1357401|NCT02848638|||Case-Only||Prospective|||||||
1357402|NCT02848625|Randomized|Crossover Assignment||||None (Open Label)||||||
1357403|NCT02848612|||Cohort||Retrospective|||||||
1357404|NCT02848599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357405|NCT02848586|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357406|NCT02848573|||Cohort||Retrospective|||||||
1357407|NCT02848560|||Case-Control||Prospective|||||||
1357408|NCT02848547|||Cohort||Cross-Sectional|||||||
1357409|NCT02848534|||Cohort||Retrospective|||||||
1357410|NCT02848521|||Cohort||Prospective|||||||
1357411|NCT02848508|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357412|NCT02848495|||Family-Based||Prospective|||||||
1357413|NCT02848482|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1357414|NCT02848469|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1357415|NCT02848456|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1357416|NCT02848443||Single Group Assignment||Treatment||None (Open Label)||||||
1357417|NCT02848430||Single Group Assignment||Basic Science||None (Open Label)||||||
1357418|NCT02848417|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1357419|NCT02848404||Single Group Assignment||Treatment||None (Open Label)||||||
1357420|NCT02848391|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357421|NCT02848378|||Case Control||Cross-Sectional|||||||
1357422|NCT02848365|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1357423|NCT02848352|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1357424|NCT02848339|||Cohort||Prospective|||||||
1357425|NCT02848326|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1357426|NCT02848313||Single Group Assignment||Treatment||None (Open Label)||||||
1357427|NCT02848300||Single Group Assignment||Basic Science||None (Open Label)||||||
1357428|NCT02848287|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1357429|NCT02848274|||Cohort||Prospective|||||||
1357430|NCT02848261|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1357431|NCT02848248||Single Group Assignment||Treatment||None (Open Label)||||||
1357432|NCT02848235|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1357433|NCT02848222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357434|NCT02848209|Non-Randomized|Factorial Assignment||Basic Science||Single||||||t
1357435|NCT02848196||Single Group Assignment||Treatment||None (Open Label)||||||
1357436|NCT02848183||Single Group Assignment||Treatment||||||||
1357437|NCT02848170|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357438|NCT02848157|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1357439|NCT02848144|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357440|NCT02848131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357441|NCT02848118|Randomized|Parallel Assignment||Prevention||Single|||t|||
1357442|NCT02848105||Single Group Assignment||Treatment||None (Open Label)||||||
1357443|NCT02848092|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1357444|NCT02848079||Single Group Assignment||Treatment||None (Open Label)||||||
1357445|NCT02848066|||Case Control||Prospective|||||||
1357446|NCT02848053|||Case Control||Prospective|||||||
1357447|NCT02848040||Single Group Assignment||Basic Science||None (Open Label)||||||
1357448|NCT02848027||Single Group Assignment||Treatment||None (Open Label)||||||
1357449|NCT02848014|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1357450|NCT02848001|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1357451|NCT02847988|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357452|NCT02847975||Single Group Assignment||Basic Science||None (Open Label)||||||
1357453|NCT02847962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357454|NCT02847949||Single Group Assignment||Treatment||None (Open Label)||||||
1357455|NCT02847936|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357456|NCT02847923||Single Group Assignment||Health Services Research||None (Open Label)||||||
1357457|NCT02847910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357458|NCT02847897||Single Group Assignment||Treatment||None (Open Label)||||||
1357459|NCT02847884|||Cohort||Prospective|||||||
1357460|NCT02847871|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357461|NCT02847858|Randomized|Parallel Assignment||Prevention||Single|||t|||
1357462|NCT02847845|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1357463|NCT02847832|||Cohort||Prospective|||||||
1357464|NCT02847819|||Case-Control||Prospective|||||||
1357465|NCT02847806|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1357466|NCT02847793|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1357467|NCT02847780|Non-Randomized|Parallel Assignment||Diagnostic||Single||||t||
1357468|NCT02847767||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357469|NCT02847754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357470|NCT02847741||Single Group Assignment||||None (Open Label)||||||
1357471|NCT02847728|||Other||Prospective|||||||
1357472|NCT02847715|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1357473|NCT02847702|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357474|NCT02847689|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1357475|NCT02847676||||||||||||
1357476|NCT02847663|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357477|NCT02847650|Randomized|||Treatment||Triple|||t|t|t|
1357478|NCT02847637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357479|NCT02847624|||Cohort||Prospective|||||||
1357480|NCT02847611|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1357481|NCT02847598|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357482|NCT02847585||Single Group Assignment||Basic Science||None (Open Label)||||||
1357483|NCT02847572||Single Group Assignment||Treatment||None (Open Label)||||||
1357484|NCT02847559||Single Group Assignment||Treatment||None (Open Label)||||||
1357485|NCT02847546|||Case-Only||Prospective|||||||
1357486|NCT02847533|Non-Randomized|Factorial Assignment||Screening||Single||||||t
1357487|NCT02847520|||Case-Only||Prospective|||||||
1357488|NCT02847507|||Ecologic or Community||Prospective|||||||
1357489|NCT02847494|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1357490|NCT02847481|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357491|NCT02847468||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357492|NCT02847455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357493|NCT02847442||Single Group Assignment||Treatment||None (Open Label)||||||
1357494|NCT02847429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357495|NCT02847416|Randomized|Crossover Assignment||Other||Single|||||t|
1357496|NCT02847403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357497|NCT02847390|||Cohort||Retrospective|||||||
1357498|NCT02847377||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357499|NCT02847364|Randomized|Parallel Assignment||Prevention||Single||||||t
1357500|NCT02847351|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1357501|NCT02847338|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357502|NCT02847325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357503|NCT02847312|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1357504|NCT02847299|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1357505|NCT02847286|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1357506|NCT02847273|||Case-Only||Prospective|||||||
1357507|NCT02847260||Single Group Assignment||Treatment||None (Open Label)||||||
1357508|NCT02847247||Single Group Assignment||Other||None (Open Label)||||||
1357509|NCT02847234|||Cohort||Retrospective|||||||
1357510|NCT02847221|||Cohort||Prospective|||||||
1357511|NCT02847208|||Cohort||Cross-Sectional|||||||
1357512|NCT02847195||Single Group Assignment||Other||None (Open Label)||||||
1357513|NCT02847182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357514|NCT02847169|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1357515|NCT02847156||Single Group Assignment||||None (Open Label)||||||
1357516|NCT02847143|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1357517|NCT02847130||||||||||||
1357518|NCT02847117||Single Group Assignment||Other||None (Open Label)||||||
1357519|NCT02847104|||||Prospective|||||||
1357520|NCT02847091||Single Group Assignment||Treatment||None (Open Label)||||||
1357521|NCT02847078|Randomized|Parallel Assignment||Prevention||Single|||t|||
1357522|NCT02847065|||||Retrospective|||||||
1357523|NCT02847052|||||Retrospective|||||||
1357524|NCT02847039|||Other||Prospective|||||||
1357525|NCT02847026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357526|NCT02847013|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1357527|NCT02847000||Single Group Assignment||Treatment||None (Open Label)||||||
1357528|NCT02846987||Single Group Assignment||Treatment||None (Open Label)||||||
1357529|NCT02846974|||Other||Prospective|||||||
1357530|NCT02846961|||Cohort||Prospective|||||||
1357531|NCT02846948|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357532|NCT02846935||Single Group Assignment||Treatment||None (Open Label)||||||
1357533|NCT02846922|||Cohort||Retrospective|||||||
1357534|NCT02846909|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357535|NCT02846896|||Other||Cross-Sectional|||||||
1357536|NCT02846883|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1357537|NCT02846870|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357538|NCT02846857|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357539|NCT02846844|||Cohort||Prospective|||||||
1357540|NCT02846831|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357541|NCT02846818|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357542|NCT02846805|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1357543|NCT02846792||Single Group Assignment||Treatment||None (Open Label)||||||
1357544|NCT02846779|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1357545|NCT02846766||Single Group Assignment||Treatment||None (Open Label)||||||
1357546|NCT02846753||Single Group Assignment||Treatment||None (Open Label)||||||
1357547|NCT02846740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357548|NCT02846727|||Case-Control||Prospective|||||||
1357549|NCT02846714||Single Group Assignment||Prevention||None (Open Label)||||||
1357550|NCT02846701||Single Group Assignment||||None (Open Label)||||||
1357551|NCT02846688|||Case-Only||Prospective|||||||
1357552|NCT02846675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357553|NCT02846662|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1357554|NCT02846649||Single Group Assignment||Supportive Care||None (Open Label)||||||
1357555|NCT02846636|||Case-Only||Prospective|||||||
1357556|NCT02846623|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357557|NCT02846610|||Cohort|||||||||
1357558|NCT02846597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357559|NCT02846584||Single Group Assignment||Treatment||None (Open Label)||||||
1357560|NCT02846571||Single Group Assignment||Treatment||None (Open Label)||||||
1357561|NCT02846558|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357562|NCT02846545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357563|NCT02846532|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357564|NCT02846519|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357565|NCT02846506|Randomized|Crossover Assignment||||None (Open Label)||||||
1357566|NCT02846493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357567|NCT02846480|Randomized|Crossover Assignment||Prevention||Single||||||t
1357568|NCT02846467|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1357569|NCT02846454|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1357570|NCT02846441|||Cohort||Retrospective|||||||
1357571|NCT02846428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357572|NCT02846415|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1357573|NCT02846402|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||1:1:1 cluster randomized controlled trial||||
1357574|NCT02846389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357575|NCT02846376|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be assigned to Groups A, and B in a 1:1 fashion. If the safety endpoint is met for each of these groups, enrollment to Group C will open. Each patient will be monitored for toxicities for at least 28 days before the next patient is added to the same cohort.||||
1357576|NCT02846363|||||Prospective|||||||
1357577|NCT02846350|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1357578|NCT02846337|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357579|NCT02846324|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1357580|NCT02846311|||Cohort||Prospective|||||||
1357581|NCT02846298|||Cohort||Prospective|||||||
1357582|NCT02846285|||Cohort||Prospective|||||||
1357583|NCT02846272||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357584|NCT02846259|||Cohort||Prospective|||||||
1357585|NCT02846246|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1357586|NCT02846233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357587|NCT02846220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357588|NCT02846207|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1357589|NCT02846194|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1357590|NCT02846181||Single Group Assignment||Basic Science||None (Open Label)||||||
1357591|NCT02846168|||Cohort||Prospective|||||||
1357592|NCT02846155|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1357593|NCT02846142|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1357594|NCT02846129|||Case-Only||Retrospective|||||||
1357595|NCT02846116|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1357596|NCT02846103||Single Group Assignment||Other||None (Open Label)||||||
1357597|NCT02846090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357598|NCT02846077|||Cohort||Prospective|||||||
1357599|NCT02846064||Single Group Assignment||Other||None (Open Label)||||||
1357600|NCT02846051|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1357601|NCT02846038|||Family-Based||Prospective|||||||
1357602|NCT02846025|Randomized|Factorial Assignment||Prevention||Single|||||t|
1357603|NCT02846012|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357604|NCT02845999||Single Group Assignment||Treatment||None (Open Label)||||||
1357605|NCT02845986||Single Group Assignment||Treatment||None (Open Label)||||||
1357606|NCT02845973|||Cohort||Cross-Sectional|||||||
1357607|NCT02845960|||Cohort||Prospective|||||||
1357608|NCT02845947|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357609|NCT02845934||Single Group Assignment||Health Services Research||None (Open Label)||||||
1357610|NCT02845921|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357611|NCT02845908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357612|NCT02845895|||Cohort||Prospective|||||||
1357613|NCT02845882|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1357614|NCT02845869|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1357615|NCT02845856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357616|NCT02845843|Randomized|Parallel Assignment||Treatment||Quadruple||This is a recursive two-stage group sequential multicenter placebo-controlled double-blind randomized controlled trial. The trial is initially designed to include 2 two-stage components. The first two-stage component is designed to adjust sample size and determine futility stopping, but not efficacy stopping (n=34). The second two-stage component is designed to determine efficacy stopping and possibly readjustment of sample size.|t|t|t|t
1357617|NCT02845830|||Case Control||Prospective|||||||
1357618|NCT02845817||Single Group Assignment||||None (Open Label)||||||
1357619|NCT02845804|||Case-Only||Prospective|||||||
1357620|NCT02845791|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357621|NCT02845778|Randomized|Crossover Assignment||||Triple|||t||t|t
1357622|NCT02845765|||Case-Control||Prospective|||||||
1357623|NCT02845752|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1357624|NCT02845739||Single Group Assignment||Basic Science||None (Open Label)||||||
1357625|NCT02845726|||Cohort||Prospective|||||||
1357626|NCT02845713|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1357627|NCT02845700|Randomized|Parallel Assignment||Treatment||Single||||||t
1357628|NCT02845687|||Cohort||Prospective|||||||
1357629|NCT02845674||Single Group Assignment||Treatment||None (Open Label)||||||
1357630|NCT02845661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357631|NCT02845648|||Cohort||Retrospective|||||||
1357632|NCT02845635|||Case-Control||Prospective|||||||
1357633|NCT02845622|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1357634|NCT02845609||Single Group Assignment||Treatment||None (Open Label)||||||
1357635|NCT02845596|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1357636|NCT02845583|||Cohort|||||||||
1357637|NCT02845570||Single Group Assignment||Other||None (Open Label)||||||
1357638|NCT02845557|||Case Control||Cross-Sectional|||||||
1357639|NCT02845544|Randomized|Parallel Assignment||Basic Science||Single||||||t
1357640|NCT02845531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357641|NCT02845518||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357642|NCT02845505|||Cohort||Retrospective|||||||
1357643|NCT02845492|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1357644|NCT02845479||Single Group Assignment||Treatment||None (Open Label)||||||
1357645|NCT02845466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357646|NCT02845453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357647|NCT02845440|Randomized|Parallel Assignment||Treatment||Single||||||t
1357648|NCT02845427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357649|NCT02845414||Single Group Assignment||Treatment||None (Open Label)||||||
1357650|NCT02845401|Non-Randomized|Parallel Assignment||Other||Single|||||t|
1357651|NCT02845388|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1357652|NCT02845375|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1357653|NCT02845362||Single Group Assignment||Screening||None (Open Label)||||||
1357654|NCT02845349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357655|NCT02845336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357656|NCT02845323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357657|NCT02845310|Randomized|Parallel Assignment||Prevention||Single|||t|||
1357658|NCT02845297|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357659|NCT02845284|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357660|NCT02845271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357661|NCT02845258|||Cohort||Prospective|||||||
1357662|NCT02845245|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1357663|NCT02845232|||Cohort||Retrospective|||||||
1357664|NCT02845219||Single Group Assignment||Treatment||None (Open Label)||||||
1357665|NCT02845206|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1357666|NCT02845193|Randomized|Parallel Assignment||Treatment||Single||||||t
1357667|NCT02845180|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1357668|NCT02845167|Randomized|Factorial Assignment||Treatment||Single||||t||
1357669|NCT02845154|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1357670|NCT02845141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357671|NCT02845128|||Cohort||Prospective|||||||
1357672|NCT02845115|Randomized|Parallel Assignment||Other||Double|||t|||t
1357673|NCT02845102||Single Group Assignment||Other||None (Open Label)||||||
1357674|NCT02845089|||Cohort||Retrospective|||||||
1357675|NCT02845076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357676|NCT02845063|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1357677|NCT02845050||Single Group Assignment||Treatment||None (Open Label)||||||
1357678|NCT02845037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357679|NCT02845024|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1357680|NCT02845011|Randomized|Parallel Assignment||Treatment||Triple|The clinical provider was not involved in the study. S(he) was not blind during the resuscitation as they could see device, and it was not considered ethical to employ a sham device.||t||t|t
1357681|NCT02844998|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1357682|NCT02844985|||Case-Control||Cross-Sectional|||||||
1357683|NCT02844972|||Cohort||Prospective|||||||
1357684|NCT02844959|||Cohort||Prospective|||||||
1357685|NCT02844946|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1357686|NCT02844933|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357687|NCT02844920|||Cohort||Prospective|||||||
1357688|NCT02844907|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1357689|NCT02844894|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1357690|NCT02844881||Single Group Assignment||Treatment||None (Open Label)||||||
1357691|NCT02844868|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1357692|NCT02844855|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1357693|NCT02844842|||Cohort||Prospective|||||||
1357694|NCT02844829||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357695|NCT02844816||Single Group Assignment||Treatment||None (Open Label)||||||
1357696|NCT02844803|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1357697|NCT02844790||Single Group Assignment||Treatment||None (Open Label)||||||
1357698|NCT02844777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357699|NCT02844764||Single Group Assignment||Treatment||None (Open Label)||||||
1357700|NCT02844751|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357701|NCT02844738||Single Group Assignment||Treatment||None (Open Label)||||||
1357702|NCT02844725|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1357703|NCT02844712||Single Group Assignment||Health Services Research||None (Open Label)||||||
1357704|NCT02844699|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1357705|NCT02844686||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357706|NCT02844673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357707|NCT02844660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357708|NCT02844647||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357709|NCT02844634|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357710|NCT02844621||Single Group Assignment||Basic Science||None (Open Label)||||||
1357711|NCT02844608||Single Group Assignment||Other||None (Open Label)||||||
1357712|NCT02844595|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357713|NCT02844582||Single Group Assignment||Treatment||None (Open Label)||||||
1357714|NCT02844569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357715|NCT02844556|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357716|NCT02844543||Single Group Assignment||Other||None (Open Label)||||||
1357717|NCT02844530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357718|NCT02844517||Single Group Assignment||Other||None (Open Label)||The objective of the study is for clinical staff to gain experience using the proposed artificial pancreas system named inControl and the inControl Cloud and assess 24/7 in-home usability prior to initiating a large randomized controlled trial. Study subjects will wear the study insulin pump and CGM for approximately 2-4 weeks.||||
1357719|NCT02844504|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357720|NCT02844491|||Cohort||Prospective|||||||
1357721|NCT02844478|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1357722|NCT02844465||Single Group Assignment||Treatment||None (Open Label)||||||
1357723|NCT02844452|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357724|NCT02844439||Single Group Assignment||Treatment||None (Open Label)||||||
1357725|NCT02844426|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357726|NCT02844413|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357727|NCT02844400|||Cohort||Prospective|||||||
1357728|NCT02844387|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1357729|NCT02844374||Single Group Assignment||||None (Open Label)||||||
1357730|NCT02844361|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357731|NCT02844348|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357732|NCT02844335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357733|NCT02844322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357734|NCT02844309||Single Group Assignment||Treatment||None (Open Label)||||||
1357735|NCT02844296|Randomized|Parallel Assignment||Prevention||Single||||||t
1357736|NCT02844283|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357737|NCT02844270||Single Group Assignment||Treatment||None (Open Label)||||||
1357738|NCT02844257|||Cohort||Retrospective|||||||
1357739|NCT02844244||Single Group Assignment||||None (Open Label)||||||
1357740|NCT02844231||Parallel Assignment||Basic Science||Single|||t|||
1357741|NCT02844218|||Cohort||Retrospective|||||||
1357742|NCT02844205|||Case-Only||Prospective|||||||
1357743|NCT02844192|||Case-Only||Retrospective|||||||
1357744|NCT02844179||Single Group Assignment||Basic Science||None (Open Label)||||||
1357745|NCT02844166|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357746|NCT02844153|||Cohort|||||||||
1357747|NCT02844140||Single Group Assignment||Other||None (Open Label)||||||
1357748|NCT02844127|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1357749|NCT02844114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357750|NCT02844101|Randomized|Parallel Assignment||||Single|||t|||
1357751|NCT02844088|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1357752|NCT02844075||Single Group Assignment||Treatment||None (Open Label)||||||
1357753|NCT02844062||Single Group Assignment||Treatment||None (Open Label)||||||
1357754|NCT02844049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357755|NCT02844036||Single Group Assignment||Treatment||None (Open Label)||||||
1357756|NCT02844023|Randomized|Parallel Assignment||||None (Open Label)||||||
1357757|NCT02844010|||Case-Only||Prospective|||||||
1357758|NCT02843997||Single Group Assignment||||None (Open Label)||||||
1357759|NCT02843984|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357760|NCT02843971||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357761|NCT02843958||Single Group Assignment||||None (Open Label)||||||
1357762|NCT02843945||Single Group Assignment||Treatment||None (Open Label)||Dose escalation Phase I followed by a feasibility trial in Phase II||||
1357763|NCT02843932||Single Group Assignment||Basic Science||None (Open Label)||||||
1357764|NCT02843919||Single Group Assignment||Basic Science||None (Open Label)||||||
1357765|NCT02843906|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1357766|NCT02843893||Single Group Assignment||||None (Open Label)||||||
1357767|NCT02843880|||Cohort||Prospective|||||||
1357768|NCT02843867|||Cohort||Prospective|||||||
1357769|NCT02843841|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357770|NCT02843828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357771|NCT02843815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357772|NCT02843802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357773|NCT02843789||Single Group Assignment||Treatment||None (Open Label)||||||
1357774|NCT02843776|||Cohort||Prospective|||||||
1357775|NCT02843763|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1357776|NCT02843750||Single Group Assignment||Prevention||None (Open Label)||||||
1357777|NCT02843737|||Case-Only||Prospective|||||||
1357778|NCT02843724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357779|NCT02843711|||Cohort||Retrospective|||||||
1357780|NCT02843698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357781|NCT02843685|||||Retrospective|||||||
1357782|NCT02843672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357783|NCT02843659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357784|NCT02843646|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357785|NCT02843633||Single Group Assignment||Treatment||None (Open Label)||||||
1357786|NCT02843620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357787|NCT02843607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357788|NCT02843594|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357789|NCT02843581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357790|NCT02843568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357791|NCT02843555|||Cohort||Prospective|||||||
1357792|NCT02843542|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357793|NCT02843529||Single Group Assignment||Diagnostic||None (Open Label)||Adults at high risk of developing ALZ within 18-48 months but are currently cognitively normal for their age sex matching group. Risk factors include parents with a history of ALZ, and/or positive APOE4 alleles.||||
1357794|NCT02843516|||Case Control||Retrospective|||||||
1357795|NCT02843503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357796|NCT02843490|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357797|NCT02843477|||Other||Prospective|||||||
1357798|NCT02843464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357799|NCT02843451|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1357800|NCT02843438||Single Group Assignment||Screening||None (Open Label)||||||
1357801|NCT02843425|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1357802|NCT02843412|||Cohort||Prospective|||||||
1357803|NCT02843399|||Cohort||Retrospective|||||||
1357804|NCT02843386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357805|NCT02843373|||Cohort||Prospective|||||||
1357806|NCT02843360|||Ecologic or Community||Cross-Sectional|||||||
1357807|NCT02843347|||Cohort||Prospective|||||||
1357808|NCT02843334|||Cohort||Cross-Sectional|||||||
1357809|NCT02843321||Single Group Assignment||Treatment||None (Open Label)||||||
1357810|NCT02843308|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1357811|NCT02843295||Single Group Assignment||||None (Open Label)||||||
1357812|NCT02843282||Single Group Assignment||Supportive Care||None (Open Label)||||||
1357813|NCT02843269|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1357814|NCT02843256|||Cohort||Prospective|||||||
1357815|NCT02843243|||Cohort||Prospective|||||||
1357816|NCT02843230|||Cohort||Prospective|||||||
1357817|NCT02843217||Crossover Assignment||Screening||||||||
1357818|NCT02843204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357819|NCT02843191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357820|NCT02843178|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1357821|NCT02843165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357822|NCT02843152|||Case Control||Prospective|||||||
1357823|NCT02843139|||Cohort||Cross-Sectional|||||||
1357824|NCT02843126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357825|NCT02843113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357826|NCT02843100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357827|NCT02843087|||Cohort||Prospective|||||||
1357828|NCT02843074||Single Group Assignment||Treatment||None (Open Label)||||||
1357829|NCT02843061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357830|NCT02843048|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357831|NCT02843035||Single Group Assignment||Treatment||None (Open Label)||||||
1357832|NCT02843022|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357833|NCT02843009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357834|NCT02842996|||||Prospective|||||||
1357835|NCT02842983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357836|NCT02842970||||||||||||
1357837|NCT02842957|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357838|NCT02842944|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357839|NCT02842931|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1357840|NCT02842918|Randomized|Parallel Assignment||Treatment||Single||||||t
1357841|NCT02842905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357842|NCT02842892||||Diagnostic||||||||
1357843|NCT02842879|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357844|NCT02842866|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1357845|NCT02842853|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1357846|NCT02842840|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1357847|NCT02842827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1357848|NCT02842814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357849|NCT02842801||Single Group Assignment||Treatment||None (Open Label)||||||
1357850|NCT02842788|||Cohort||Prospective|||||||
1357851|NCT02842775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357852|NCT02842762|Randomized|Crossover Assignment||Diagnostic||Double||Sequence of measurements, during sinus rhythm and during pacing is randomized.|t|||t
1357853|NCT02842749|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1357854|NCT02842736||Single Group Assignment||Treatment||None (Open Label)||||||
1357855|NCT02842723||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357856|NCT02842710||Single Group Assignment||Prevention||None (Open Label)||||||
1357857|NCT02842697||Single Group Assignment||Diagnostic||None (Open Label)||||||
1357858|NCT02842684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357859|NCT02842671|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357860|NCT02842658|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1357861|NCT02842645|||Cohort||Cross-Sectional|||||||
1357862|NCT02842632|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1357863|NCT02842619||Single Group Assignment||Treatment||None (Open Label)||||||
1357864|NCT02842606|Randomized|Crossover Assignment||Prevention||Single||||||t
1357865|NCT02842593|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357866|NCT02842580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357867|NCT02842567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357868|NCT02842554|Randomized|Crossover Assignment||||Double|||t||t|
1357869|NCT02842541|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357870|NCT02842528|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1357871|NCT02842515|||||Prospective|||||||
1357872|NCT02842502||Single Group Assignment||Basic Science||None (Open Label)||||||
1357873|NCT02842489|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357874|NCT02842476|||Case-Only||Cross-Sectional|||||||
1357875|NCT02842463|||Cohort||Prospective|||||||
1357876|NCT02842450|||Cohort||Prospective|||||||
1357877|NCT02842437|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1357878|NCT02842424||Single Group Assignment||Treatment||None (Open Label)||||||
1357879|NCT02842411|||Cohort||Prospective|||||||
1357880|NCT02842398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357881|NCT02842385|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357882|NCT02842372|||Case-Only||Prospective|||||||
1357883|NCT02842359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357884|NCT02842346|||||Prospective|||||||
1357885|NCT02842333||Single Group Assignment||Other||None (Open Label)||||||
1357886|NCT02842320||Single Group Assignment||Other||None (Open Label)||||||
1357887|NCT02842307|Randomized|Parallel Assignment||Treatment||Single||||||t
1357888|NCT02842294|||Cohort||Prospective|||||||
1357889|NCT02842281|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1357890|NCT02842268||Single Group Assignment||Other||None (Open Label)||||||
1357891|NCT02842255||Single Group Assignment||||None (Open Label)||||||
1357892|NCT02842242||Single Group Assignment||Treatment||None (Open Label)||||||
1357893|NCT02842229|||Case-Only||Retrospective|||||||
1357894|NCT02842216|||Case-Only||Retrospective|||||||
1357895|NCT02842203|||Case-Only||Prospective|||||||
1357896|NCT02842190|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357897|NCT02842177|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357898|NCT02842164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357899|NCT02842151||Single Group Assignment||Other||Single||||||t
1357900|NCT02842138||Single Group Assignment||Treatment||None (Open Label)||||||
1357901|NCT02842125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||3 Arms, no cross-over||||
1357902|NCT02842112|||Cohort||Retrospective|||||||
1357903|NCT02842099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357904|NCT02842086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357905|NCT02842073||Single Group Assignment||Treatment||None (Open Label)||||||
1357906|NCT02842060|Randomized|Parallel Assignment||Prevention||Single|||t|||
1357907|NCT02842047|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357908|NCT02842034|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1357909|NCT02842021|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1357910|NCT02842008|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357911|NCT02841995|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357912|NCT02841982|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1357913|NCT02841969|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1357914|NCT02841956|Randomized|Parallel Assignment||Screening||Single||||||t
1357915|NCT02841943|||Cohort||Prospective|||||||
1357916|NCT02841930|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1357917|NCT02841917|||Cohort||Prospective|||||||
1357918|NCT02841904|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1357919|NCT02841891|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357920|NCT02841878||Single Group Assignment||Basic Science||None (Open Label)||||||
1357921|NCT02841865|||Other||Cross-Sectional|||||||
1357922|NCT02841852|||||Prospective|||||||
1357923|NCT02841839||Single Group Assignment||Basic Science||None (Open Label)||||||
1357924|NCT02841826|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357925|NCT02841813|||Case Control||Retrospective|||||||
1357926|NCT02841800||Single Group Assignment||Treatment||None (Open Label)||||||
1357927|NCT02841787|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357928|NCT02841774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357929|NCT02841761|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1357930|NCT02841748|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1357931|NCT02841735|||Cohort||Prospective|||||||
1357932|NCT02841722||Single Group Assignment||Prevention||None (Open Label)||||||
1357933|NCT02841709|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1357934|NCT02841696|||Cohort|||||||||
1357935|NCT02841683|Randomized|Parallel Assignment||Prevention||Single||||||t
1357936|NCT02841670|||Cohort||Prospective|||||||
1357937|NCT02841657|||Other||Prospective|||||||
1357938|NCT02841644|||Cohort||Prospective|||||||
1357939|NCT02841631|||Cohort||Prospective|||||||
1357940|NCT02841618|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1357941|NCT02841605|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1357942|NCT02841592|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1357943|NCT02841579||Single Group Assignment||Treatment||None (Open Label)||||||
1357944|NCT02841566|||Cohort||Prospective|||||||
1357945|NCT02841553|||Cohort||Cross-Sectional|||||||
1357946|NCT02841540|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1357947|NCT02841527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357948|NCT02841514|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1357949|NCT02841501|||Case-Control||Prospective|||||||
1357950|NCT02841488|Randomized|Parallel Assignment||Treatment||Single||||||t
1357951|NCT02841475|||Cohort||Retrospective|||||||
1357952|NCT02841462||Single Group Assignment||Treatment||None (Open Label)||||||
1357953|NCT02841449|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1357954|NCT02841436||Single Group Assignment||Treatment||None (Open Label)||||||
1357955|NCT02841423|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1357956|NCT02841410||Single Group Assignment||Basic Science||None (Open Label)||||||
1357957|NCT02841397||||||||||||
1357958|NCT02841384|Randomized|Parallel Assignment||Treatment||Single|||t|||
1357959|NCT02841371|||Cohort||Prospective|||||||
1357960|NCT02841358||Single Group Assignment||||None (Open Label)||||||
1357961|NCT02841345|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1357962|NCT02841332||Single Group Assignment||Basic Science||None (Open Label)||||||
1357963|NCT02841319|Randomized|Parallel Assignment||Treatment||Single||||||t
1357964|NCT02841306|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357965|NCT02841293|||Other||Prospective|||||||
1357966|NCT02841280|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357967|NCT02841267|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357968|NCT02841254|||Other||Prospective|||||||
1357969|NCT02841241||Single Group Assignment||Treatment||None (Open Label)||||||
1357970|NCT02841228||Single Group Assignment||Treatment||None (Open Label)||||||
1357971|NCT02841215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357972|NCT02841202|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1357973|NCT02841189||Single Group Assignment||Other||None (Open Label)||||||
1357974|NCT02841176||Single Group Assignment||||None (Open Label)||||||
1357975|NCT02841163|||Case-Only||Retrospective|||||||
1357976|NCT02841150|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1357977|NCT02841137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357978|NCT02841124||Single Group Assignment||||None (Open Label)||||||
1357979|NCT02841111|||Case Control||Retrospective|||||||
1357980|NCT02841098|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1357981|NCT02841085|||Family-Based||Prospective|||||||
1357982|NCT02841072|||Case-Only||Retrospective|||||||
1357983|NCT02841059|||Case-Control||Prospective|||||||
1357984|NCT02841046|Randomized|Parallel Assignment||Treatment||Single||||||t
1357985|NCT02841033||Single Group Assignment||Treatment||None (Open Label)||||||
1357986|NCT02841020|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1357987|NCT02841007||Single Group Assignment||Other||None (Open Label)||||||
1357988|NCT02840994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357989|NCT02840981|||Cohort||Cross-Sectional|||||||
1357990|NCT02840968|||Cohort||Retrospective|||||||
1357991|NCT02840955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1357992|NCT02840942|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1357993|NCT02840929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357994|NCT02840916|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1357995|NCT02840903|||Cohort||Prospective|||||||
1357996|NCT02840890|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1357997|NCT02840877||Single Group Assignment||Supportive Care||None (Open Label)||||||
1357998|NCT02840864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1357999|NCT02840851|||Case-Control||Prospective|||||||
1358000|NCT02840825|||Case-Only||Cross-Sectional|||||||
1358001|NCT02840812|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358002|NCT02840799|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1358003|NCT02840786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358004|NCT02840773|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358005|NCT02840760|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358006|NCT02840747|||Other||Prospective|||||||
1358007|NCT02840734|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1358008|NCT02840721||||Treatment||None (Open Label)||||||
1358009|NCT02840708|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358010|NCT02840695|||Cohort||Prospective|||||||
1358011|NCT02840682|||Other||Retrospective|||||||
1358012|NCT02840669||Factorial Assignment||Diagnostic||None (Open Label)||||||
1358013|NCT02840656|||Ecologic or Community||Prospective|||||||
1358014|NCT02840643|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1358015|NCT02840630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358016|NCT02840617||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358017|NCT02840604|||Cohort||Prospective|||||||
1358018|NCT02840591|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358019|NCT02840578|||Cohort||Prospective|||||||
1358020|NCT02840565|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358021|NCT02840552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358022|NCT02840539||Single Group Assignment||Treatment||None (Open Label)||||||
1358023|NCT02840526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358024|NCT02840513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358025|NCT02840500|||Cohort||Prospective|||||||
1358026|NCT02840487|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358027|NCT02840474|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1358028|NCT02840461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358029|NCT02840448|||Case-Control||Prospective|||||||
1358030|NCT02840435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358031|NCT02840422|||||Prospective|||||||
1358032|NCT02840409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358033|NCT02840396|Randomized|Crossover Assignment||Other||Single|||t|||
1358034|NCT02840383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358035|NCT02840370|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1358036|NCT02840357|Randomized|Parallel Assignment||Basic Science||Single||||||t
1358037|NCT02840344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358038|NCT02840331||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358039|NCT02840318||Single Group Assignment||Supportive Care||None (Open Label)||||||
1358040|NCT02840305|Randomized|Parallel Assignment||||None (Open Label)||||||
1358041|NCT02840292|||Cohort||Prospective|||||||
1358042|NCT02840279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358043|NCT02840266|||Case-Only||Prospective|||||||
1358044|NCT02840253||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358045|NCT02840240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358046|NCT02840227|Randomized|Parallel Assignment||Treatment||Single||||||t
1358047|NCT02840214|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358048|NCT02840201|||Cohort||Prospective|||||||
1358049|NCT02840188|||Case-Control||Retrospective|||||||
1358050|NCT02840175|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1358051|NCT02840162|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1358052|NCT02840149||Single Group Assignment||Basic Science||None (Open Label)||||||
1358053|NCT02840136||Single Group Assignment||Basic Science||None (Open Label)||||||
1358054|NCT02840123||Single Group Assignment||Treatment||None (Open Label)||||||
1358055|NCT02840110|||Case-Only||Prospective|||||||
1358056|NCT02840097|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358057|NCT02840084||Single Group Assignment||Treatment||None (Open Label)||||||
1358058|NCT02840071||Single Group Assignment||Treatment||None (Open Label)||||||
1358059|NCT02840058||Single Group Assignment||Other||None (Open Label)||||||
1358060|NCT02840045|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358061|NCT02840032|||Case-Only||Prospective|||||||
1358062|NCT02840019|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358063|NCT02840006|Randomized|Parallel Assignment||||Double|||t||t|
1358064|NCT02839993|Randomized|Crossover Assignment||Treatment||Single|||t|||
1358065|NCT02839980|||Ecologic or Community||Prospective|||||||
1358066|NCT02839967|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358067|NCT02839954||Single Group Assignment||Treatment||None (Open Label)||||||
1358068|NCT02839941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358069|NCT02839928||Single Group Assignment||Treatment||None (Open Label)||||||
1358070|NCT02839915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358071|NCT02839902|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1358072|NCT02839889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358073|NCT02839876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358074|NCT02839863|||Cohort||Prospective|||||||
1358075|NCT02839850||Single Group Assignment||Treatment||None (Open Label)|An independent radiographic reviewer will be assessing all radiographs from the study.|||||
1358076|NCT02839837||Single Group Assignment||Other||None (Open Label)||||||
1358077|NCT02839824|||Cohort||Retrospective|||||||
1358078|NCT02839811||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358079|NCT02839798||Single Group Assignment||Treatment||None (Open Label)||Open label, unblinded treatment series, all participants receive active treatment with the investigational device (NeoSync sTMS), as adjunct to ongoing stable pharmacotherapy||||
1358080|NCT02839785|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1358081|NCT02839772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358082|NCT02839759|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1358083|NCT02839746|||Cohort||Prospective|||||||
1358084|NCT02839733|||Case-Control||Prospective|||||||
1358085|NCT02839720||Single Group Assignment||Treatment||None (Open Label)||||||
1358086|NCT02839707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358087|NCT02839694|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358088|NCT02839681|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1358089|NCT02839668|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1358090|NCT02839655||Single Group Assignment||Treatment||None (Open Label)||||||
1358091|NCT02839642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358092|NCT02839629|||Cohort||Retrospective|||||||
1358093|NCT02839616|||Cohort||Prospective|||||||
1358094|NCT02839603|||Cohort||Prospective|||||||
1358095|NCT02839590|||Cohort||Prospective|||||||
1358096|NCT02839577|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1358097|NCT02839564|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358098|NCT02839551||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358099|NCT02839538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358100|NCT02839525|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1358101|NCT02839512||Single Group Assignment||Treatment||None (Open Label)||||||
1358102|NCT02839499|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358103|NCT02839486|||Cohort||Prospective|||||||
1358104|NCT02839473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358105|NCT02839460|||Case-Control||Prospective|||||||
1358106|NCT02839447|||Cohort||Prospective|||||||
1358107|NCT02839434|||Cohort||Prospective|||||||
1358108|NCT02839421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358109|NCT02839408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358110|NCT02839395|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1358111|NCT02839382|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1358112|NCT02839369|||||Cross-Sectional|||||||
1358113|NCT02839356|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1358114|NCT02839343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358115|NCT02839330|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1358116|NCT02839317|||Case-Control||Prospective|||||||
1358117|NCT02839304||Single Group Assignment||Treatment||None (Open Label)||||||
1358118|NCT02839291||Single Group Assignment||||None (Open Label)||||||
1358119|NCT02839278||Single Group Assignment||Basic Science||None (Open Label)||||||
1358120|NCT02839265||Single Group Assignment||Treatment||None (Open Label)||||||
1358121|NCT02839252|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358122|NCT02839239|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358123|NCT02839226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358124|NCT02839213|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358125|NCT02839200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358126|NCT02839187|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358127|NCT02839174|||Cohort||Cross-Sectional|||||||
1358128|NCT02839161|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1358129|NCT02839148|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358130|NCT02839135|Randomized|Crossover Assignment||Other||Single||||||t
1358131|NCT02839122|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1358132|NCT02839109|||Cohort||Prospective|||||||
1358133|NCT02839096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358134|NCT02839083|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1358135|NCT02839070|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358136|NCT02839057|||Cohort||Prospective|||||||
1358137|NCT02839044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358138|NCT02839031|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358139|NCT02839018|||Other||Prospective|||||||
1358140|NCT02839005|Randomized|Parallel Assignment||||Single|||t|||
1358141|NCT02838992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358142|NCT02838979|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1358143|NCT02838966|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358144|NCT02838953|Non-Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1358145|NCT02838940||Single Group Assignment||Prevention||None (Open Label)||||||
1358146|NCT02838927|||Cohort||Prospective|||||||
1358147|NCT02838914|Randomized|Parallel Assignment||Treatment||Single||||||t
1358148|NCT02838901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358149|NCT02838888|||Cohort||Prospective|||||||
1358150|NCT02838875||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358151|NCT02838862|||||Retrospective|||||||
1358152|NCT02838849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358153|NCT02838836|||Cohort||Prospective|||||||
1358154|NCT02838823||Single Group Assignment||Treatment||None (Open Label)||||||
1358155|NCT02838810|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358156|NCT02838797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358157|NCT02838784|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358158|NCT02838771|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1358159|NCT02838758|Randomized|Crossover Assignment||Treatment||Single|||t|||
1358160|NCT02838745||Single Group Assignment||Other||None (Open Label)||||||
1358161|NCT02838732|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358162|NCT02838719|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1358163|NCT02838706|||Cohort||Prospective|||||||
1358164|NCT02838693|||Cohort||Prospective|||||||
1358165|NCT02838680||Single Group Assignment||Treatment||None (Open Label)||||||
1358166|NCT02838667|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358167|NCT02838654|||Cohort||Cross-Sectional|||||||
1358168|NCT02838641|||Case-Only||Prospective|||||||
1358169|NCT02838628||Single Group Assignment||Treatment||None (Open Label)||||||
1358170|NCT02838615|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358171|NCT02838602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358172|NCT02838589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358173|NCT02838576|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358174|NCT02838563|||Cohort||Prospective|||||||
1358175|NCT02838550|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358176|NCT02838537|||||Retrospective|||||||
1358177|NCT02838524|||Cohort||Prospective|||||||
1358178|NCT02838511|||Cohort||Prospective|||||||
1358179|NCT02838498|Randomized|Parallel Assignment||Treatment||Single||||||t
1358180|NCT02838485||Single Group Assignment||Basic Science||None (Open Label)||||||
1358181|NCT02838472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1358182|NCT02838459|||Cohort||Prospective|||||||
1358183|NCT02838446|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358184|NCT02838433||Single Group Assignment||||None (Open Label)||||||
1358185|NCT02838420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358186|NCT02838407||Single Group Assignment||||None (Open Label)||||||
1358187|NCT02838394|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358188|NCT02838381||Single Group Assignment||||None (Open Label)||||||
1358189|NCT02838368|||Case-Only||Prospective|||||||
1358190|NCT02838355|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358191|NCT02838342||Single Group Assignment||Other||None (Open Label)||||||
1358192|NCT02838329|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1358193|NCT02838316|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Phase I open label clinical trial||||
1358194|NCT02838303|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1358195|NCT02838290|Randomized|Parallel Assignment||Other||Single|||t|||
1358196|NCT02838277|||Cohort||Prospective|||||||
1358197|NCT02838264||||Basic Science||None (Open Label)||||||
1358198|NCT02838251|||Cohort||Prospective|||||||
1358199|NCT02838238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358200|NCT02838225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358201|NCT02838212|||Cohort||Retrospective|||||||
1358202|NCT02838199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358203|NCT02838186|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1358204|NCT02838173|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1358205|NCT02838160|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1358206|NCT02838147|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358207|NCT02838134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358208|NCT02838121|Randomized|Parallel Assignment||Treatment||Single||||||t
1358209|NCT02838108|||Cohort||Prospective|||||||
1358210|NCT02838095|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358211|NCT02838082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358212|NCT02838069|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358213|NCT02838056||Single Group Assignment||Other||None (Open Label)||||||
1358214|NCT02838043||Single Group Assignment||Treatment||None (Open Label)||||||
1358215|NCT02838030|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1358216|NCT02838017|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358217|NCT02838004||Single Group Assignment||Other||None (Open Label)||||||
1358218|NCT02837991||Single Group Assignment||Treatment||None (Open Label)||||||
1358219|NCT02837978|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358220|NCT02837965|||Cohort||Prospective|||||||
1358221|NCT02837952|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358222|NCT02837939|Randomized|Parallel Assignment||Prevention||Single|||||t|
1358223|NCT02837926||Single Group Assignment||Prevention||None (Open Label)||||||
1358224|NCT02837913|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1358225|NCT02837900|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358226|NCT02837887|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358227|NCT02837874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358228|NCT02837861|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358229|NCT02837848|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358230|NCT02837835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358231|NCT02837822|Randomized|Crossover Assignment||Other||Double|||||t|t
1358232|NCT02837809|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358233|NCT02837796|Randomized|Parallel Assignment||||None (Open Label)||||||
1358234|NCT02837783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358235|NCT02837770|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1358236|NCT02837757||Single Group Assignment||||None (Open Label)||||||
1358237|NCT02837744|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358238|NCT02837731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358239|NCT02837718||Sequential Assignment||Prevention||None (Open Label)||A total of 55 ASA I-II patients underwent hand surgery operation by administering USG guided-axillary brachial plexus blockage were included in the study. Ulnar, median and radial nerves were seen and the minimum effective LA volume was investigated starting with total 21 ml of %0.5 bupivacain. After accomplishing the blockage, volume was decreased by 0.5 for each nerves. Block administration time, block onset times, anesthesia times and time to first analgesic requirement were recorded.||||
1358240|NCT02837705|||Case-Control||Cross-Sectional|||||||
1358241|NCT02837692|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358242|NCT02837679|Randomized|Parallel Assignment||Treatment||Single||||||t
1358243|NCT02837666|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1358244|NCT02837653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358245|NCT02837640||Single Group Assignment||Treatment||None (Open Label)||||||
1358246|NCT02837627|||Cohort||Prospective|||||||
1358247|NCT02837614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358248|NCT02837601|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358249|NCT02837588|Randomized|Parallel Assignment||Treatment||Single||||t||
1358250|NCT02837575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358251|NCT02837562|||Case Control||Prospective|||||||
1358252|NCT02837549||Single Group Assignment||Treatment||None (Open Label)||||||
1358253|NCT02837536|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1358254|NCT02837523|||Cohort||Prospective|||||||
1358255|NCT02837510||Single Group Assignment||Treatment||None (Open Label)||||||
1358256|NCT02837497|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1358257|NCT02837484||Single Group Assignment||Treatment||None (Open Label)||||||
1358258|NCT02837471|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1358259|NCT02837458|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1358260|NCT02837445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358261|NCT02837432|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1358262|NCT02837419|||Cohort||Prospective|||||||
1358263|NCT02837406|||||Prospective|||||||
1358264|NCT02837393|||Cohort||Prospective|||||||
1358265|NCT02837380||Single Group Assignment||Treatment||None (Open Label)||||||
1358266|NCT02837367|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1358267|NCT02837354|||Cohort||Prospective|||||||
1358268|NCT02837341||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358269|NCT02837328|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1358270|NCT02837315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358271|NCT02837302|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358272|NCT02837289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358273|NCT02837276|||Cohort||Prospective|||||||
1358274|NCT02837263||Single Group Assignment||Treatment||None (Open Label)||||||
1358275|NCT02837250|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358276|NCT02837237||Single Group Assignment||Treatment||None (Open Label)||||||
1358277|NCT02837224|||Other||Retrospective|||||||
1358278|NCT02837211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358279|NCT02837198|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358280|NCT02837185|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358281|NCT02837172|||Case-Control||Other|||||||
1358282|NCT02837159|Randomized|Parallel Assignment||Treatment||Single||||||t
1358283|NCT02837146||Single Group Assignment||Treatment||None (Open Label)||||||
1358284|NCT02837133||Single Group Assignment||||None (Open Label)||||||
1358285|NCT02837120|||Case-Only||Retrospective|||||||
1358286|NCT02837107|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1358287|NCT02837094||Single Group Assignment||Prevention||None (Open Label)||||||
1358288|NCT02837081|Randomized|Parallel Assignment||||None (Open Label)||||||
1358289|NCT02837068|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358290|NCT02837055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358291|NCT02837042||Single Group Assignment||Treatment||None (Open Label)||||||
1358292|NCT02837029||Single Group Assignment||Treatment||None (Open Label)||||||
1358293|NCT02837016|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358294|NCT02837003|||Cohort||Prospective|||||||
1358295|NCT02836990|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358296|NCT02836977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358297|NCT02836964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358298|NCT02836951|||Case-Only||Retrospective|||||||
1358299|NCT02836938|||Case-Control||Prospective|||||||
1358300|NCT02836925||Single Group Assignment||Treatment||None (Open Label)||||||
1358301|NCT02836912|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1358302|NCT02836899|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1358303|NCT02836886|||Other||Prospective|||||||
1358304|NCT02836873|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358305|NCT02836860|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358306|NCT02836847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358307|NCT02836834|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358308|NCT02836821||Single Group Assignment||Treatment||None (Open Label)||||||
1358309|NCT02836808|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358310|NCT02836795||Single Group Assignment||Treatment||None (Open Label)||||||
1358311|NCT02836782|||Ecologic or Community||Prospective|||||||
1358312|NCT02836769||Single Group Assignment||Treatment||None (Open Label)||||||
1358313|NCT02836743|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358314|NCT02836730|||Cohort||Prospective|||||||
1358315|NCT02836717|||Cohort||Retrospective|||||||
1358316|NCT02836704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358317|NCT02836691|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358318|NCT02836678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358319|NCT02836665|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358320|NCT02836652|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358321|NCT02836639||Single Group Assignment||Treatment||None (Open Label)||||||
1358322|NCT02836626|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1358323|NCT02836613|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358324|NCT02836600||Single Group Assignment||Treatment||None (Open Label)||||||
1358325|NCT02836587|Randomized|Parallel Assignment||Prevention||Single|||||t|
1358326|NCT02836574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358327|NCT02836561|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358328|NCT02836548||Single Group Assignment||Treatment||None (Open Label)||||||
1358329|NCT02836535|||Case-Control||Prospective|||||||
1358330|NCT02836522|||Cohort||Prospective|||||||
1358331|NCT02836509|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1358332|NCT02836496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358648|NCT02832388|||Cohort||Prospective|||||||
1358333|NCT02836483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358334|NCT02836470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358335|NCT02836457|||Cohort||Prospective|||||||
1358336|NCT02836444|||Cohort||Prospective|||||||
1358337|NCT02836431|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358338|NCT02836418||Single Group Assignment||Treatment||None (Open Label)||||||
1358339|NCT02836405|||Cohort||Cross-Sectional|||||||
1358340|NCT02836392|||Case-Only||Prospective|||||||
1358341|NCT02836379|||Cohort||Prospective|||||||
1358342|NCT02836366|||Cohort||Prospective|||||||
1358343|NCT02836353|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358344|NCT02836340||Single Group Assignment||Treatment||None (Open Label)||||||
1358345|NCT02836327|||Case Control||Prospective|||||||
1358346|NCT02836314|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1358347|NCT02836301|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1358348|NCT02836288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358349|NCT02836275||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358350|NCT02836262||Single Group Assignment||Treatment||None (Open Label)||||||
1358351|NCT02836249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358352|NCT02836236|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358353|NCT02836223|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358354|NCT02836210|Randomized|Single Group Assignment||||Triple|||t|t||t
1358355|NCT02836197|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1358356|NCT02836184|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1358357|NCT02836171||Single Group Assignment||Treatment||None (Open Label)||||||
1358358|NCT02836158||Single Group Assignment||Treatment||None (Open Label)||||||
1358359|NCT02836145|||||Prospective|||||||
1358360|NCT02836132|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1358361|NCT02836119|||Cohort||Prospective|||||||
1358362|NCT02836106|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1358363|NCT02836093|||Cohort||Prospective|||||||
1358364|NCT02836080|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358365|NCT02836067|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358366|NCT02836054|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1358367|NCT02836041|||Cohort||Prospective|||||||
1358368|NCT02836028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358369|NCT02836015||Single Group Assignment||Treatment||None (Open Label)||||||
1358370|NCT02836002|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358371|NCT02835989|Randomized|Single Group Assignment||Prevention||Single|||t|||
1358372|NCT02835976||Single Group Assignment||Treatment||None (Open Label)||||||
1358373|NCT02835963|||Cohort||Prospective|||||||
1358374|NCT02835950||Single Group Assignment||Treatment||None (Open Label)||||||
1358375|NCT02835937|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1358376|NCT02835924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358377|NCT02835911|||Cohort||Prospective|||||||
1358378|NCT02835898|||||Prospective|||||||
1358379|NCT02835885|Randomized|Crossover Assignment||||Single|||t|||
1358380|NCT02835872|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1358381|NCT02835859||Single Group Assignment||Basic Science||None (Open Label)||||||
1358382|NCT02835846||Single Group Assignment||Treatment||None (Open Label)||||||
1358383|NCT02835833|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358384|NCT02835820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358385|NCT02835807|Randomized|Parallel Assignment||Prevention||Single||||||t
1358386|NCT02835794||Single Group Assignment||Treatment||None (Open Label)||||||
1358387|NCT02835781|||Cohort||Prospective|||||||
1358388|NCT02835768|Randomized|Parallel Assignment||Prevention||Single||||||t
1358389|NCT02835755|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358390|NCT02835742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358391|NCT02835729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358392|NCT02835716|||Case-Only||Prospective|||||||
1358393|NCT02835703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358394|NCT02835690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358395|NCT02835677||Single Group Assignment||Treatment||None (Open Label)||||||
1358396|NCT02835664|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1358397|NCT02835651|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1358398|NCT02835638|||Cohort||Prospective|||||||
1358399|NCT02835625|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358400|NCT02835612|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1358401|NCT02835599|||Cohort||Prospective|||||||
1358402|NCT02835586||Single Group Assignment||Treatment||None (Open Label)||||||
1358403|NCT02835573|||Case-Only||Prospective|||||||
1358404|NCT02835560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358405|NCT02835547|||Cohort||Prospective|||||||
1358406|NCT02835534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358407|NCT02835521|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358408|NCT02835508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358409|NCT02835495|Randomized|Parallel Assignment||Prevention||Single||||||t
1358410|NCT02835482|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358411|NCT02835469|||Case-Only||Prospective|||||||
1358412|NCT02835456|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358413|NCT02835443||Single Group Assignment||Treatment||None (Open Label)||||||
1358414|NCT02835430|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1358415|NCT02835417|||Cohort||Prospective|||||||
1358416|NCT02835404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358417|NCT02835391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358418|NCT02835378|||Cohort||Prospective|||||||
1358419|NCT02835365|||Cohort||Prospective|||||||
1358420|NCT02835352|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1358421|NCT02835339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358422|NCT02835326|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1358423|NCT02835313|Randomized|Factorial Assignment||Treatment||Single||||||t
1358424|NCT02835300|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358425|NCT02835287|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1358426|NCT02835274|Randomized|Crossover Assignment||Other||Double|||t|||t
1358427|NCT02835261|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1358428|NCT02835248|||Cohort||Prospective|||||||
1358429|NCT02835235|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1358430|NCT02835222||Single Group Assignment||Treatment||None (Open Label)||||||
1358431|NCT02835209|||Cohort||Prospective|||||||
1358432|NCT02835196||||||||||||
1358433|NCT02835183|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1358434|NCT02835170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358435|NCT02835157|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358436|NCT02835144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358437|NCT02835131||||||||||||
1358438|NCT02835118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358439|NCT02835105|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358440|NCT02835092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358441|NCT02835079||Single Group Assignment||Treatment||None (Open Label)||||||
1358442|NCT02835066|||Cohort||Prospective|||||||
1358443|NCT02835053|||Cohort||Retrospective|||||||
1358444|NCT02835040|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1358445|NCT02835027|||Cohort||Prospective|||||||
1358446|NCT02835014|||Cohort||Prospective|||||||
1358447|NCT02835001||Single Group Assignment||Treatment||None (Open Label)||||||
1358448|NCT02834988||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358449|NCT02834975||Single Group Assignment||Treatment||None (Open Label)||||||
1358450|NCT02834962|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1358451|NCT02834949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358452|NCT02834936||Single Group Assignment||Treatment||None (Open Label)||||||
1358453|NCT02834923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358454|NCT02834910|||Case Control||Prospective|||||||
1358455|NCT02834897||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358456|NCT02834884|||Cohort||Prospective|||||||
1358457|NCT02834871|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358458|NCT02834858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358459|NCT02834845|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1358460|NCT02834832|||Cohort||Prospective|||||||
1358461|NCT02834819|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358462|NCT02834806||Single Group Assignment||Treatment||None (Open Label)||||||
1358463|NCT02834793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358464|NCT02834780||Single Group Assignment||Treatment||None (Open Label)||||||
1358465|NCT02834767|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358466|NCT02834754|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358467|NCT02834741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358468|NCT02834728|||Cohort||Prospective|||||||
1358469|NCT02834715|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1358470|NCT02834702|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358471|NCT02834689|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1358472|NCT02834676|||||Retrospective|||||||
1358473|NCT02834663||Single Group Assignment||||None (Open Label)||||||
1358474|NCT02834650|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1358475|NCT02834637|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358476|NCT02834624|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358477|NCT02834611||Single Group Assignment||Treatment||None (Open Label)||||||
1358478|NCT02834598|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1358479|NCT02834585|||Cohort||Prospective|||||||
1358480|NCT02834572|Randomized|Parallel Assignment||Prevention||Single||||||t
1358481|NCT02834559|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1358482|NCT02834546|||Cohort||Prospective|||||||
1358483|NCT02834533|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358484|NCT02834520|||Case Control||Cross-Sectional|||||||
1358485|NCT02834507|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1358486|NCT02834494||Single Group Assignment||Other||None (Open Label)||||||
1358487|NCT02834481||Single Group Assignment||Supportive Care||None (Open Label)||||||
1358488|NCT02834468||Single Group Assignment||Treatment||None (Open Label)||||||
1358489|NCT02834455|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358490|NCT02834442|Randomized|Parallel Assignment||Treatment||Double||||||
1358491|NCT02834429|||Cohort||Prospective|||||||
1358492|NCT02834416|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1358493|NCT02834403||Single Group Assignment||Treatment||None (Open Label)||||||
1358494|NCT02834390||Single Group Assignment||Treatment||None (Open Label)||||||
1358495|NCT02834377|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358496|NCT02834364||Single Group Assignment||Treatment||None (Open Label)||||||
1358497|NCT02834351|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1358498|NCT02834338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358499|NCT02834325|||Cohort||Prospective|||||||
1358500|NCT02834312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358501|NCT02834299|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1358502|NCT02834286||Single Group Assignment||Treatment||None (Open Label)||||||
1358503|NCT02834273|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358504|NCT02834260||Single Group Assignment||Prevention||None (Open Label)||||||
1358505|NCT02834247|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358506|NCT02834234|||Cohort||Retrospective|||||||
1358507|NCT02834221|Randomized|Parallel Assignment||Prevention||Single||||||t
1358508|NCT02834208|Randomized|Parallel Assignment||||None (Open Label)||||||
1358509|NCT02834195|||||Cross-Sectional|||||||
1358510|NCT02834182|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1358511|NCT02834169|||Cohort||Other|||||||
1358512|NCT02834156|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1358513|NCT02834143|||Cohort||Prospective|||||||
1358514|NCT02834130||Single Group Assignment||Supportive Care||None (Open Label)||||||
1358515|NCT02834117|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1358516|NCT02834104||Single Group Assignment||Prevention||None (Open Label)||||||
1358517|NCT02834091|||Cohort||Prospective|||||||
1358518|NCT02834078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358519|NCT02834065|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358520|NCT02834052|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1358521|NCT02834039|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1358522|NCT02834026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358523|NCT02834013||Single Group Assignment||Treatment||None (Open Label)||||||
1358524|NCT02834000|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358525|NCT02833987|||Cohort||Retrospective|||||||
1358526|NCT02833974|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358527|NCT02833961|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358528|NCT02833948|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1358529|NCT02833935|Randomized|Parallel Assignment||Prevention||Single||||||t
1358530|NCT02833922|||Cohort||Prospective|||||||
1358531|NCT02833909|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358532|NCT02833896|||Cohort||Retrospective|||||||
1358533|NCT02833883||Single Group Assignment||Treatment||None (Open Label)||||||
1358534|NCT02833870|Randomized|Factorial Assignment||Supportive Care||Double||||t||t
1358535|NCT02833857||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358536|NCT02833844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358537|NCT02833831|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1358538|NCT02833818|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358539|NCT02833805||Single Group Assignment||Treatment||None (Open Label)||||||
1358540|NCT02833792|Randomized|Crossover Assignment||Treatment||Single|||t|||
1358541|NCT02833779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358542|NCT02833766||Single Group Assignment||Treatment||None (Open Label)||||||
1358543|NCT02833753||Sequential Assignment||Treatment||None (Open Label)||"There are three cohorts of patients:~Group #1 is at 25mg/m2 of IP oxaliplatin and has been completed. Group #2 is at 55mg/m2 of IP oxaliplatin and is near completion. Group #3 is at 85mg/m2 of IP oxaliplatin and we haven't started enrolling yet."||||
1358544|NCT02833740||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358545|NCT02833727|||Case-Control||Cross-Sectional|||||||
1358546|NCT02833714|||Cohort||Prospective|||||||
1358547|NCT02833701||Single Group Assignment||Treatment||None (Open Label)||||||
1358548|NCT02833688|Randomized|Parallel Assignment||Prevention||Single|||t|||
1358549|NCT02833675|||Case-Control||Prospective|||||||
1358550|NCT02833662||Single Group Assignment||Screening||None (Open Label)||||||
1358551|NCT02833649||Single Group Assignment||Treatment||None (Open Label)||||||
1358552|NCT02833636|||Case Control||Retrospective|||||||
1358553|NCT02833623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358554|NCT02833610||Single Group Assignment||Treatment||None (Open Label)||||||
1358555|NCT02833597|||Cohort||Retrospective|||||||
1358556|NCT02833584|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358557|NCT02833571||||||||||||
1358558|NCT02833558|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358559|NCT02833545|Non-Randomized|Sequential Assignment||Treatment||Double|the outcome assessor was not aware of the therapy administered|A sequential series of patients receiving steroid injections was compared to a sequential series of patients receiving ozone injections|||t|t
1358560|NCT02833532|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358561|NCT02833519|Randomized|Parallel Assignment||Prevention||Single||||||t
1358562|NCT02833506|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358563|NCT02833493|||Case-Only||Prospective|||||||
1358564|NCT02833480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358565|NCT02833467|||Case-Only||Prospective|||||||
1358566|NCT02833454|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1358567|NCT02833441|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1358568|NCT02833428||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358569|NCT02833415|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1358570|NCT02833402|||Cohort||Prospective|||||||
1358571|NCT02833389|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358572|NCT02833376|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1358573|NCT02833363|||Cohort||Prospective|||||||
1358574|NCT02833350|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358575|NCT02833337|||Cohort||Retrospective|||||||
1358576|NCT02833324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358577|NCT02833311|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1358578|NCT02833298|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358579|NCT02833285|||Case-Control||Cross-Sectional|||||||
1358580|NCT02833272||Single Group Assignment||Health Services Research||None (Open Label)||||||
1358581|NCT02833259|||Cohort||Retrospective|||||||
1358582|NCT02833246|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358583|NCT02833233||Single Group Assignment||Treatment||None (Open Label)||||||
1358584|NCT02833220|||Cohort||Prospective|||||||
1358585|NCT02833207|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1358586|NCT02833194|||Cohort||Prospective|||||||
1358587|NCT02833181|||Other||Cross-Sectional|||||||
1358588|NCT02833168|||Case Control||Prospective|||||||
1358589|NCT02833155||Single Group Assignment||Treatment||None (Open Label)||||||
1358590|NCT02833142|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1358591|NCT02833129|||Cohort||Retrospective|||||||
1358592|NCT02833116|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1358593|NCT02833103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358594|NCT02833090|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1358595|NCT02833077||||||||||||
1358596|NCT02833064|||Cohort||Prospective|||||||
1358597|NCT02833051|||||Cross-Sectional|||||||
1358598|NCT02833038|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1358599|NCT02833025|||Cohort||Prospective|||||||
1358600|NCT02833012|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1358601|NCT02832999|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358602|NCT02832986|||Cohort||Prospective|||||||
1358603|NCT02832973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358604|NCT02832960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358605|NCT02832947||Single Group Assignment||Prevention||None (Open Label)||||||
1358606|NCT02832934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358607|NCT02832921|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1358608|NCT02832908||Single Group Assignment||||None (Open Label)||||||
1358609|NCT02832895||Single Group Assignment||Other||None (Open Label)||||||
1358610|NCT02832882|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358611|NCT02832869|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358612|NCT02832856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358613|NCT02832843|||Case-Control||Cross-Sectional|||||||
1358614|NCT02832830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358615|NCT02832817|||Case-Crossover||Prospective|||||||
1358616|NCT02832804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358617|NCT02832791|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358618|NCT02832778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1358619|NCT02832765|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1358620|NCT02832752|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358621|NCT02832739||Single Group Assignment||Health Services Research||None (Open Label)||||||
1358622|NCT02832726|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358623|NCT02832713|Randomized|Parallel Assignment||Treatment||Single||||||t
1358624|NCT02832700|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358625|NCT02832687|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1358626|NCT02832674||Single Group Assignment||Treatment||None (Open Label)||||||
1358627|NCT02832661|||Cohort|||||||||
1358628|NCT02832648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358629|NCT02832635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358630|NCT02832622|||Cohort||Prospective|||||||
1358631|NCT02832609|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1358632|NCT02832596|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358633|NCT02832583||Single Group Assignment||Treatment||None (Open Label)||||||
1358634|NCT02832570|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1358635|NCT02832557|||Case Control||Cross-Sectional|||||||
1358636|NCT02832544|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358637|NCT02832531|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358638|NCT02832518|||Case-Only||Prospective|||||||
1358639|NCT02832505|||Cohort||Cross-Sectional|||||||
1358640|NCT02832492|||Cohort||Prospective|||||||
1358641|NCT02832479|||Cohort||Retrospective|||||||
1358642|NCT02832466|||Cohort||Prospective|||||||
1358643|NCT02832453|Randomized|Parallel Assignment||Treatment||Single||||||t
1358644|NCT02832440|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358645|NCT02832427|||Cohort||Prospective|||||||
1358646|NCT02832414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358647|NCT02832401|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1358649|NCT02832375|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1358650|NCT02832362|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1358651|NCT02832349|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358652|NCT02832336|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1358653|NCT02832323||Single Group Assignment||Other||None (Open Label)||||||
1358654|NCT02832310|||Case-Only||Prospective|||||||
1358655|NCT02832297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358656|NCT02832284||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358657|NCT02832271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358658|NCT02832258|||Case-Only||Prospective|||||||
1358659|NCT02832245|||Other||Prospective|||||||
1358660|NCT02832232|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1358661|NCT02832219|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1358662|NCT02832206|||Cohort||Prospective|||||||
1358663|NCT02832193|||Cohort||Prospective|||||||
1358664|NCT02832180|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358665|NCT02832167||Single Group Assignment||Treatment||None (Open Label)||||||
1358666|NCT02832154||Single Group Assignment||Supportive Care||None (Open Label)||||||
1358667|NCT02832141|||Case-Crossover||Prospective|||||||
1358668|NCT02832128|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1358669|NCT02832115|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1358670|NCT02832102|||Cohort|||||||||
1358671|NCT02832089||Single Group Assignment||Treatment||None (Open Label)||||||
1358672|NCT02832076|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358673|NCT02832063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358674|NCT02832050|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358675|NCT02832037|Randomized|Parallel Assignment||Treatment||Double||||||
1358676|NCT02832024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358677|NCT02832011|Randomized|Parallel Assignment||||Single|||||t|
1358678|NCT02831998|Randomized|Parallel Assignment||Prevention||Single||||||t
1358679|NCT02831985|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1358680|NCT02831972|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358681|NCT02831959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358682|NCT02831946|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1358683|NCT02831933||Single Group Assignment||Treatment||None (Open Label)||||||
1358684|NCT02831920||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358685|NCT02831907|||Cohort||Prospective|||||||
1358686|NCT02831894|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358687|NCT02831881|||Cohort||Prospective|||||||
1358688|NCT02831868||Single Group Assignment||Treatment||None (Open Label)||||||
1358689|NCT02831855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358690|NCT02831842|||Cohort||Prospective|||||||
1358691|NCT02831829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358692|NCT02831816|Randomized|Parallel Assignment||Prevention||Single||||||t
1358693|NCT02831803||Single Group Assignment||Other||None (Open Label)||||||
1358694|NCT02831790|Randomized|Parallel Assignment||Other||Single|||t|||
1358695|NCT02831777|||Cohort||Retrospective|||||||
1358696|NCT02831764|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358697|NCT02831751|Randomized|Parallel Assignment||Prevention||Single||||||t
1358698|NCT02831738|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1358699|NCT02831725|||Cohort||Prospective|||||||
1358700|NCT02831712||Single Group Assignment||Screening||None (Open Label)||||||
1358701|NCT02831699|||Cohort||Prospective|||||||
1358702|NCT02831686||Single Group Assignment||Treatment||None (Open Label)||||||
1358703|NCT02831673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358704|NCT02831660||Single Group Assignment||Treatment||None (Open Label)||||||
1358705|NCT02831647||Single Group Assignment||||None (Open Label)||||||
1358706|NCT02831634||Single Group Assignment||Other||None (Open Label)||||||
1358707|NCT02831621|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1358708|NCT02831608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358709|NCT02831595|||Cohort||Prospective|||||||
1358710|NCT02831582|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1358711|NCT02831569||Single Group Assignment||Treatment||None (Open Label)||||||
1358712|NCT02831556|||Cohort||Prospective|||||||
1358713|NCT02831543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358714|NCT02831530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358715|NCT02831517|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358716|NCT02831504|||Cohort||Prospective|||||||
1358717|NCT02831491||Single Group Assignment||Treatment||None (Open Label)||||||
1358718|NCT02831478|Randomized|Parallel Assignment||Other||Double|||t||t|
1358719|NCT02831465||Single Group Assignment||Basic Science||None (Open Label)||||||
1358720|NCT02831452|||||Prospective|||||||
1358721|NCT02831439|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1358722|NCT02831426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358723|NCT02831413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358724|NCT02831400||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358725|NCT02831387|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358726|NCT02831374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358727|NCT02831361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358728|NCT02831348|||Cohort||Cross-Sectional|||||||
1358729|NCT02831335|||Cohort||Cross-Sectional|||||||
1358730|NCT02831322|Non-Randomized|Parallel Assignment||Prevention||Single|||||t|
1358731|NCT02831309|Randomized|Crossover Assignment||Prevention||Single|||t|||
1358732|NCT02831296|||Case-Control||Prospective|||||||
1358733|NCT02831283|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358734|NCT02831270|||Cohort||Prospective|||||||
1358735|NCT02831257||Single Group Assignment||Treatment||None (Open Label)||||||
1358736|NCT02831244||Single Group Assignment||Treatment||None (Open Label)||||||
1358737|NCT02831231|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358738|NCT02831218|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1358739|NCT02831205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358740|NCT02831192||Single Group Assignment||Treatment||None (Open Label)||||||
1358741|NCT02831179||Single Group Assignment||Treatment||None (Open Label)||||||
1358742|NCT02831166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358743|NCT02831153|Non-Randomized|Single Group Assignment||Diagnostic||Triple||||t|t|t
1358744|NCT02831140|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358745|NCT02831127|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1358746|NCT02831114|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1358747|NCT02831101|Randomized|Single Group Assignment||Other||Double|||t||t|
1358748|NCT02831088|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358749|NCT02831075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358750|NCT02831062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358751|NCT02831049|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358752|NCT02831036|Randomized|Parallel Assignment||||None (Open Label)||||||
1358753|NCT02831023|Randomized|Parallel Assignment||Treatment||Single||||||t
1358754|NCT02831010|||Cohort||Prospective|||||||
1358755|NCT02830997|||Cohort||Prospective|||||||
1358756|NCT02830984|Randomized|Parallel Assignment||Prevention||Single|||||t|
1358757|NCT02830971||Single Group Assignment||Basic Science||None (Open Label)||||||
1358758|NCT02830958|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358759|NCT02830945|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Clinical Trial||||
1358760|NCT02830932|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1358761|NCT02830919|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358762|NCT02830906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358763|NCT02830893|Randomized|Parallel Assignment||Treatment||Single||||||t
1358764|NCT02830880||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358765|NCT02830867|||Cohort||Retrospective|||||||
1358766|NCT02830854||Single Group Assignment||Supportive Care||None (Open Label)||||||
1358767|NCT02830841|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358768|NCT02830828|||Cohort||Prospective|||||||
1358769|NCT02830815|||Case-Crossover||Prospective|||||||
1358770|NCT02830802|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358771|NCT02830789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358772|NCT02830776||Single Group Assignment||Treatment||None (Open Label)||||||
1358773|NCT02830763||Single Group Assignment||Treatment||None (Open Label)||||||
1358774|NCT02830750|||Other||Prospective|||||||
1358775|NCT02830737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358776|NCT02830724|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358777|NCT02830711|||Case Control||Prospective|||||||
1358778|NCT02830698|||Cohort||Prospective|||||||
1358779|NCT02830685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358780|NCT02830672|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358781|NCT02830659|||Case-Only|||||||||
1358782|NCT02830646||Single Group Assignment||||None (Open Label)||||||
1358783|NCT02830633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358784|NCT02830620|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358785|NCT02830607||Single Group Assignment||Health Services Research||None (Open Label)||||||
1358786|NCT02830594||Single Group Assignment||Treatment||None (Open Label)||||||
1358787|NCT02830568|||Cohort||Prospective|||||||
1358788|NCT02830542|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1358789|NCT02830529|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1358790|NCT02830516|||Case-Crossover||Prospective|||||||
1358791|NCT02830503|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358792|NCT02830490|||Cohort||Prospective|||||||
1358793|NCT02830477|||Other||Prospective|||||||
1358794|NCT02830464|||Cohort||Prospective|||||||
1358795|NCT02830451|||Case-Only||Prospective|||||||
1358796|NCT02830438||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358797|NCT02830425|||Cohort||Prospective|||||||
1358798|NCT02830412|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1358799|NCT02830399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358800|NCT02830386|||Case-Only||Prospective|||||||
1358801|NCT02830373|||Case-Only||Prospective|||||||
1358802|NCT02830360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358803|NCT02830347|||Cohort||Prospective|||||||
1358804|NCT02830334|||Cohort||Prospective|||||||
1358805|NCT02830321|||Case Control||Prospective|||||||
1358806|NCT02830308|||Cohort||Prospective|||||||
1358807|NCT02830295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358808|NCT02830282|||Cohort||Prospective|||||||
1358809|NCT02830269|||Other||Prospective|||||||
1358810|NCT02830256|||Other||Prospective|||||||
1358811|NCT02830243|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1358812|NCT02830230|Non-Randomized|Single Group Assignment||Screening||Single||||||t
1358813|NCT02830217|||Cohort||Prospective|||||||
1358814|NCT02830204||Single Group Assignment||Treatment||None (Open Label)||||||
1358815|NCT02830191|||Cohort||Prospective|||||||
1358816|NCT02830178|||Case Control||Prospective|||||||
1358817|NCT02830165||Single Group Assignment||Treatment||None (Open Label)||||||
1358818|NCT02830152|Randomized|Parallel Assignment||Prevention||Single||||||t
1358819|NCT02830139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358820|NCT02830126|Randomized|Parallel Assignment||Other||Single||||t||
1358821|NCT02830113||Single Group Assignment||Prevention||None (Open Label)||||||
1358822|NCT02830100||Single Group Assignment||Basic Science||None (Open Label)||||||
1358823|NCT02830087|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1358824|NCT02830074|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1358825|NCT02830061|||Case-Only||Cross-Sectional|||||||
1358826|NCT02830048||Single Group Assignment||Treatment||None (Open Label)||||||
1358827|NCT02830035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358828|NCT02830022|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358829|NCT02830009|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358830|NCT02829996|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358831|NCT02829983|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358832|NCT02829970|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358833|NCT02829957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358834|NCT02829944|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358835|NCT02829931||Single Group Assignment||Treatment||None (Open Label)||||||
1358836|NCT02829918||Single Group Assignment||Treatment||None (Open Label)||||||
1358837|NCT02829905|||Cohort||Prospective|||||||
1358838|NCT02829892||Single Group Assignment||Supportive Care||None (Open Label)||||||
1358839|NCT02829879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358840|NCT02829866|||Case-Only||Prospective|||||||
1358841|NCT02829853|||Cohort||Prospective|||||||
1358842|NCT02829840|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358843|NCT02829827||Single Group Assignment||Treatment||None (Open Label)||||||
1358844|NCT02829814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358845|NCT02829801|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1358846|NCT02829788|||Cohort||Prospective|||||||
1358847|NCT02829775||Single Group Assignment||Treatment||None (Open Label)||||||
1358848|NCT02829762|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358849|NCT02829749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358850|NCT02829736|Randomized|Parallel Assignment||Treatment||Double|Randomization occurs after ended surgery, thus masking allocation to the personnel and participant. After Randomization, there is no masking.||t|t||
1358851|NCT02829723|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358852|NCT02829710|||||Retrospective|||||||
1358853|NCT02829697|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358854|NCT02829684|||Cohort||Prospective|||||||
1358855|NCT02829671||Single Group Assignment||||None (Open Label)||||||
1358856|NCT02829658|||Cohort||Prospective|||||||
1358857|NCT02829645||Single Group Assignment||||None (Open Label)||||||
1358858|NCT02829632|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1358859|NCT02829619|||Cohort||Prospective|||||||
1358860|NCT02829606|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358861|NCT02829593|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358862|NCT02829580|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358863|NCT02829567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358864|NCT02829554|||Other||Cross-Sectional|||||||
1358865|NCT02829541|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358866|NCT02829528||Single Group Assignment||Treatment||None (Open Label)||||||
1358867|NCT02829515|||Cohort||Prospective|||||||
1358868|NCT02829502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358869|NCT02829489|||Cohort||Prospective|||||||
1358870|NCT02829476|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358871|NCT02829463|||Case-Control||Cross-Sectional|||||||
1358872|NCT02829450|||Cohort||Prospective|||||||
1358873|NCT02829437|||Cohort||Other|||||||
1358874|NCT02829424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358875|NCT02829411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358876|NCT02829398|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358877|NCT02829385||Single Group Assignment||Treatment||None (Open Label)||||||
1358878|NCT02829372||Single Group Assignment||Treatment||None (Open Label)||||||
1358879|NCT02829359|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358880|NCT02829346|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358881|NCT02829333|Randomized|Parallel Assignment||Prevention||Single|||t|||
1358882|NCT02829320||Single Group Assignment||Treatment||None (Open Label)||||||
1358883|NCT02829307||Single Group Assignment||Basic Science||None (Open Label)||||||
1358884|NCT02829294|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1358885|NCT02829281|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1358886|NCT02829268|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1358887|NCT02829255||Single Group Assignment||Prevention||None (Open Label)||||||
1358888|NCT02829242|||Case-Only||Prospective|||||||
1358889|NCT02829229|Randomized|Parallel Assignment||Treatment||Single||||||t
1358890|NCT02829216|||Cohort||Prospective|||||||
1358891|NCT02829203|||Case Control||Prospective|||||||
1358892|NCT02829190|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358893|NCT02829177|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1358894|NCT02829164|||Cohort||Retrospective|||||||
1358895|NCT02829151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358896|NCT02829138|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358897|NCT02829125|||Cohort||Prospective|||||||
1358898|NCT02829112|||Cohort||Retrospective|||||||
1358899|NCT02829099||Single Group Assignment||Treatment||None (Open Label)||||||
1358900|NCT02829086|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358901|NCT02829073|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358902|NCT02829060|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358903|NCT02829047||Single Group Assignment||Treatment||None (Open Label)||||||
1358904|NCT02829034|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358905|NCT02829021||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358906|NCT02829008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358907|NCT02828995|||Case-Only||Cross-Sectional|||||||
1358908|NCT02828982|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1358909|NCT02828969||Single Group Assignment||Supportive Care||None (Open Label)||||||
1358910|NCT02828956|||Case-Only||Prospective|||||||
1358911|NCT02828943|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1358912|NCT02828930||Single Group Assignment||Treatment||None (Open Label)||||||
1358913|NCT02828917||Single Group Assignment||Treatment||None (Open Label)||||||
1358914|NCT02828904|||Case-Control||Prospective|||||||
1358915|NCT02828891||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358916|NCT02828878||Single Group Assignment||Treatment||None (Open Label)||||||
1358917|NCT02828865||Single Group Assignment||Treatment||None (Open Label)||||||
1358918|NCT02828852|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1358919|NCT02828839||Single Group Assignment||Screening||None (Open Label)||||||
1358920|NCT02828826|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1358921|NCT02828813|||Ecologic or Community||Cross-Sectional|||||||
1358922|NCT02828800|||Case-Only||Prospective|||||||
1358923|NCT02828787|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1358924|NCT02828774|||Cohort||Prospective|||||||
1358925|NCT02828761|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1358926|NCT02828748|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1358927|NCT02828735||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358928|NCT02828722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358929|NCT02828709||Single Group Assignment||Treatment||None (Open Label)||||||
1358930|NCT02828696||Single Group Assignment||Treatment||None (Open Label)||||||
1358931|NCT02828683|Randomized|Parallel Assignment||Treatment||Single|||t|||
1358932|NCT02828670|||Case-Control||Prospective|||||||
1358933|NCT02828657|||Cohort||Prospective|||||||
1358934|NCT02828644|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1358935|NCT02828631|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358936|NCT02828618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358937|NCT02828605|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358938|NCT02828592||Single Group Assignment||Treatment||None (Open Label)||||||
1358939|NCT02828579|||Cohort||Prospective|||||||
1358940|NCT02828566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358941|NCT02828553|||Cohort||Prospective|||||||
1358942|NCT02828540|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1358943|NCT02828527|||Cohort||Prospective|||||||
1358944|NCT02828514|||Case-Only||Prospective|||||||
1358945|NCT02828501|Randomized|Factorial Assignment||Basic Science||Single|||||t|
1358946|NCT02828488|||Cohort||Retrospective|||||||
1358947|NCT02828475|||Cohort||Prospective|||||||
1358948|NCT02828462|||Case-Control||Prospective|||||||
1358949|NCT02828449||Single Group Assignment||Supportive Care||None (Open Label)||||||
1358950|NCT02828436|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1358951|NCT02828423|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358952|NCT02828410||Single Group Assignment||Treatment||None (Open Label)||||||
1358953|NCT02828397|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1358954|NCT02828384|Randomized|Parallel Assignment||Treatment||Single|||||t|
1358955|NCT02828371|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1358956|NCT02828358||Single Group Assignment||Treatment||None (Open Label)||||||
1358957|NCT02828345|||Cohort||Prospective|||||||
1358958|NCT02828332||Single Group Assignment||||None (Open Label)||||||
1358959|NCT02828319||Single Group Assignment||Treatment||None (Open Label)||||||
1358960|NCT02828306|||Case-Control||Prospective|||||||
1358961|NCT02828293|||Case Control||Prospective|||||||
1358962|NCT02828280|||Cohort||Prospective|||||||
1358963|NCT02828267|Randomized|Parallel Assignment||Prevention||Single|||t|||
1358964|NCT02828254|||Other||Prospective|||||||
1358965|NCT02828241|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1358966|NCT02828228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1358967|NCT02828215|||Cohort||Prospective|||||||
1358968|NCT02828202|||Cohort||Prospective|||||||
1358969|NCT02828189|Randomized|Parallel Assignment||Treatment||Single||||||t
1358970|NCT02828176||Single Group Assignment||Treatment||None (Open Label)||||||
1358971|NCT02828163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358972|NCT02828150||Single Group Assignment||Treatment||None (Open Label)||||||
1358973|NCT02828137|||Cohort||Retrospective|||||||
1358974|NCT02828124|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358975|NCT02828111|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358976|NCT02828098|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1358977|NCT02828085||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358978|NCT02828072|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1358979|NCT02828059|||Case-Only||Prospective|||||||
1358980|NCT02828046|Randomized|Parallel Assignment||Other||Double|||t||t|
1358981|NCT02828033||Single Group Assignment||Treatment||None (Open Label)||||||
1358982|NCT02828020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358983|NCT02828007||Single Group Assignment||Treatment||None (Open Label)||||||
1358984|NCT02827994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358985|NCT02827981|||Cohort||Retrospective|||||||
1358986|NCT02827968||Single Group Assignment||Treatment||None (Open Label)||||||
1358987|NCT02827955||Single Group Assignment||Treatment||None (Open Label)||||||
1358988|NCT02827942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1358989|NCT02827929||Single Group Assignment||Health Services Research||None (Open Label)||||||
1358990|NCT02827916||Single Group Assignment||Diagnostic||None (Open Label)||||||
1358991|NCT02827903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1358992|NCT02827890|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1358993|NCT02827877||Single Group Assignment||Treatment||None (Open Label)||||||
1358994|NCT02827864|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1358995|NCT02827851||Single Group Assignment||Treatment||None (Open Label)||||||
1358996|NCT02827838||Single Group Assignment||Treatment||None (Open Label)||||||
1358997|NCT02827825|||Cohort||Retrospective|||||||
1358998|NCT02827812|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1358999|NCT02827799|Randomized|Factorial Assignment||||None (Open Label)||||||
1359000|NCT02827786||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359001|NCT02827773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359002|NCT02827760|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1359003|NCT02827747|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1359004|NCT02827734|||Cohort||Prospective|||||||
1359005|NCT02827721|||Cohort||Prospective|||||||
1359006|NCT02827708|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359007|NCT02827695|Randomized|Parallel Assignment||Treatment||Single||||||t
1359008|NCT02827682|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1359009|NCT02827669|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359010|NCT02827656|Randomized|Parallel Assignment||Treatment||Single||||||t
1359011|NCT02827643|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1359012|NCT02827630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359013|NCT02827617|||Cohort||Prospective|||||||
1359014|NCT02827604|||Cohort||Prospective|||||||
1359015|NCT02827591|||Cohort||Prospective|||||||
1359016|NCT02827578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359017|NCT02827565||Single Group Assignment||Other||None (Open Label)||||||
1359018|NCT02827552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359019|NCT02827539|Randomized|Parallel Assignment||Other||Single|||t|||
1359020|NCT02827526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359021|NCT02827513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359022|NCT02827500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359023|NCT02827487|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359024|NCT02827474|||Other||Other|||||||
1359025|NCT02827461|||Cohort||Prospective|||||||
1359026|NCT02827448|||Cohort||Prospective|||||||
1359027|NCT02827435||Single Group Assignment||Basic Science||None (Open Label)||||||
1359028|NCT02827422|||Cohort||Prospective|||||||
1359029|NCT02827409|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359030|NCT02827396|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1359031|NCT02827383|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1359032|NCT02827370||Single Group Assignment||Treatment||None (Open Label)||||||
1359033|NCT02827357|||Cohort||Retrospective|||||||
1359034|NCT02827344|||Case-Only||Prospective|||||||
1359035|NCT02827331|||Cohort||Retrospective|||||||
1359036|NCT02827318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359037|NCT02827305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359038|NCT02827292|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1359039|NCT02827279|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359040|NCT02827266||Single Group Assignment||Treatment||None (Open Label)||||||
1359041|NCT02827253|||Cohort||Prospective|||||||
1359042|NCT02827240|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359043|NCT02827227|||Cohort||Prospective|||||||
1359044|NCT02827214|||Cohort||Prospective|||||||
1359045|NCT02827201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359046|NCT02827188|Randomized|Parallel Assignment||Treatment||Single||||||t
1359285|NCT02824081||Single Group Assignment||||None (Open Label)||||||
1359047|NCT02827175||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359048|NCT02827162|||Case-Control||Prospective|||||||
1359049|NCT02827149|||Cohort||Other|||||||
1359050|NCT02827136|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359051|NCT02827123|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359052|NCT02827110|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1359053|NCT02827097|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359054|NCT02827084|Randomized|Parallel Assignment||Treatment||Single||||||t
1359055|NCT02827071|||Case-Only||Prospective|||||||
1359056|NCT02827058|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359057|NCT02827045|||Case-Crossover||Cross-Sectional|||||||
1359058|NCT02827032||Single Group Assignment||Treatment||None (Open Label)||||||
1359059|NCT02827019|||Cohort||Retrospective|||||||
1359060|NCT02827006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359061|NCT02826993||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359062|NCT02826980|||Cohort||Prospective|||||||
1359063|NCT02826967||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359064|NCT02826954|||Case-Control||Cross-Sectional|||||||
1359065|NCT02826941|Randomized|Parallel Assignment||Treatment||Single||||||t
1359066|NCT02826928|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359067|NCT02826915|||Case-Only||Prospective|||||||
1359068|NCT02826902|Randomized|Parallel Assignment||Other||Double|||t|||t
1359069|NCT02826889||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359070|NCT02826876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359071|NCT02826863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359072|NCT02826850|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1359073|NCT02826837||Single Group Assignment||Treatment||None (Open Label)||||||
1359074|NCT02826824|||Cohort||Retrospective|||||||
1359075|NCT02826811|||Cohort|||||||||
1359076|NCT02826798|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359077|NCT02826785||Single Group Assignment||Treatment||None (Open Label)||||||
1359078|NCT02826772|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359079|NCT02826759|||Case Control||Prospective|||||||
1359080|NCT02826746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359081|NCT02826733|||Case-Only||Prospective|||||||
1359082|NCT02826720|||Case Control||Cross-Sectional|||||||
1359083|NCT02826707|Randomized|Parallel Assignment||Treatment||Single||||||t
1359084|NCT02826694|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359085|NCT02826681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359086|NCT02826668|Randomized|Parallel Assignment||Other||Single|||t|||
1359087|NCT02826655|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1359088|NCT02826642|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359089|NCT02826629|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359090|NCT02826616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359091|NCT02826603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359092|NCT02826590|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359093|NCT02826577|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1359094|NCT02826564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359095|NCT02826551|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359096|NCT02826538|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359097|NCT02826525|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359098|NCT02826512||Single Group Assignment||Treatment||None (Open Label)||||||
1359099|NCT02826499|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1359100|NCT02826486||Single Group Assignment||Treatment||None (Open Label)||||||
1359101|NCT02826473|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1359102|NCT02826460|||Cohort||Retrospective|||||||
1359103|NCT02826447|||Cohort||Prospective|||||||
1359104|NCT02826434||Single Group Assignment||Treatment||None (Open Label)||||||
1359105|NCT02826421|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359106|NCT02826408|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1359107|NCT02826395||||||||||||
1359108|NCT02826382|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359109|NCT02826369||Single Group Assignment||Other||None (Open Label)||||||
1359110|NCT02826356|||Cohort||Retrospective|||||||
1359111|NCT02826343||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359112|NCT02826330|||Family-Based||Cross-Sectional|||||||
1359113|NCT02826317|||Cohort||Prospective|||||||
1359114|NCT02826304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359115|NCT02826291|||Case-Only||Prospective|||||||
1359116|NCT02826278|||Cohort||Prospective|||||||
1359117|NCT02826265|||Cohort||Prospective|||||||
1359118|NCT02826252|||Case-Crossover||Other|||||||
1359119|NCT02826239|||Case-Crossover||Prospective|||||||
1359120|NCT02826226|||Case-Crossover||Prospective|||||||
1359121|NCT02826213|||Case-Control||Prospective|||||||
1359122|NCT02826200|Randomized|Parallel Assignment||Prevention||Single||||||t
1359123|NCT02826187|||Cohort||Prospective|||||||
1359124|NCT02826174|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359125|NCT02826161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359126|NCT02826148||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359127|NCT02826135||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359128|NCT02826122|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1359129|NCT02826109|Randomized|Parallel Assignment||Treatment||Single||||||t
1359130|NCT02826096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359131|NCT02826083|Randomized|Parallel Assignment||||Double|||t||t|
1359132|NCT02826070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1359133|NCT02826057|Randomized|Parallel Assignment||Basic Science||Single||||||t
1359134|NCT02826044|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1359135|NCT02826031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359136|NCT02826018|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359137|NCT02826005|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359138|NCT02825992||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359139|NCT02825979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359140|NCT02825966||Single Group Assignment||Basic Science||None (Open Label)||||||
1359141|NCT02825953|Randomized|Parallel Assignment||Treatment||Single|||||t|
1359142|NCT02825940|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359143|NCT02825927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359144|NCT02825914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359145|NCT02825901|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1359146|NCT02825888|||Cohort||Prospective|||||||
1359147|NCT02825875|||Cohort||Prospective|||||||
1359148|NCT02825862|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1359149|NCT02825849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359150|NCT02825836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1359151|NCT02825823|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1359152|NCT02825810|Randomized|Parallel Assignment||Treatment||Single|||||t|
1359153|NCT02825797|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1359154|NCT02825784||Single Group Assignment||Treatment||None (Open Label)||||||
1359155|NCT02825771|Randomized|Parallel Assignment||Treatment||Single||||||t
1359156|NCT02825758||Single Group Assignment||Treatment||None (Open Label)||||||
1359157|NCT02825745||Single Group Assignment||Other||None (Open Label)||||||
1359158|NCT02825732|||Cohort||Retrospective|||||||
1359159|NCT02825719|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1359160|NCT02825706|Randomized|Parallel Assignment||Treatment||Single||||||t
1359161|NCT02825693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359162|NCT02825680|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1359163|NCT02825667|Randomized|Parallel Assignment||Treatment||Single||||||t
1359164|NCT02825654|||Cohort||Cross-Sectional|||||||
1359165|NCT02825641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359166|NCT02825628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359167|NCT02825615|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359168|NCT02825602|||Other||Cross-Sectional|||||||
1359169|NCT02825589|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1359170|NCT02825576|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359171|NCT02825563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359172|NCT02825550||Single Group Assignment||Treatment||None (Open Label)||||||
1359173|NCT02825537|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1359174|NCT02825524||Single Group Assignment||Treatment||None (Open Label)||||||
1359175|NCT02825511|||Cohort||Prospective|||||||
1359176|NCT02825498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359177|NCT02825485|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1359178|NCT02825472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359179|NCT02825459|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1359180|NCT02825446|Randomized|Single Group Assignment||Treatment||Single|||t|||
1359181|NCT02825433|||Cohort||Prospective|||||||
1359182|NCT02825420|||Other||Prospective|||||||
1359183|NCT02825407||Single Group Assignment||||None (Open Label)||||||
1359184|NCT02825394|||Cohort||Prospective|||||||
1359185|NCT02825381|||Cohort||Retrospective|||||||
1359186|NCT02825368|Randomized|Parallel Assignment||||Double|||t||t|
1359187|NCT02825355|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359188|NCT02825342|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359189|NCT02825329||||||||||||
1359190|NCT02825316|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1359191|NCT02825303|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1359192|NCT02825290|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1359193|NCT02825277|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359194|NCT02825264|||Cohort||Other|||||||
1359195|NCT02825251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359196|NCT02825238|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359197|NCT02825225|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359198|NCT02825212||Single Group Assignment||Treatment||None (Open Label)||||||
1359199|NCT02825199|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1359200|NCT02825186|Randomized|Parallel Assignment||Treatment||Single|||||t|
1359201|NCT02825173||Single Group Assignment||Treatment||None (Open Label)||||||
1359202|NCT02825160|||Cohort||Prospective|||||||
1359203|NCT02825147||Single Group Assignment||Treatment||None (Open Label)||||||
1359204|NCT02825134|Randomized|Parallel Assignment||Treatment||Single||||||t
1359205|NCT02825121|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1359206|NCT02825108|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359207|NCT02825095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359208|NCT02825082|||Cohort||Other|||||||
1359209|NCT02825069|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359210|NCT02825056|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1359211|NCT02825043||Single Group Assignment||Treatment||None (Open Label)||||||
1359212|NCT02825030||Single Group Assignment||Treatment||None (Open Label)||||||
1359213|NCT02825017||Single Group Assignment||Treatment||None (Open Label)||||||
1359214|NCT02825004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359215|NCT02824991||Single Group Assignment||Basic Science||None (Open Label)||||||
1359216|NCT02824978|||Cohort||Prospective|||||||
1359217|NCT02824965|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359218|NCT02824952||Single Group Assignment||Treatment||None (Open Label)||||||
1359219|NCT02824939|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1359220|NCT02824926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359221|NCT02824913|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1359222|NCT02824900|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359223|NCT02824887|||Cohort||Prospective|||||||
1359224|NCT02824874|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359225|NCT02824861|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359226|NCT02824848|Randomized|Parallel Assignment||Treatment||Single||||||t
1359227|NCT02824835|||Case-Only||Prospective|||||||
1359228|NCT02824822|||Family-Based||Prospective|||||||
1359229|NCT02824809|||Case-Only||Cross-Sectional|||||||
1359230|NCT02824796|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359231|NCT02824783|||Cohort||Retrospective|||||||
1359232|NCT02824770|Randomized|Parallel Assignment||Treatment||Single||||||t
1359233|NCT02824757|||Cohort||Prospective|||||||
1359234|NCT02824744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359235|NCT02824731|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359236|NCT02824718|Randomized|Crossover Assignment||Treatment||Single|||||t|
1359237|NCT02824705|||Cohort||Prospective|||||||
1359238|NCT02824692|||Case-Only||Prospective|||||||
1359239|NCT02824679|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1359240|NCT02824666|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359241|NCT02824653||Single Group Assignment||Treatment||None (Open Label)||||||
1359242|NCT02824640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359243|NCT02824627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359244|NCT02824614|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1359245|NCT02824601|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1359246|NCT02824588|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359247|NCT02824575|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359248|NCT02824562|Randomized|Parallel Assignment||Other||Single||||||t
1359249|NCT02824549|||Cohort||Prospective|||||||
1359250|NCT02824536|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1359251|NCT02824523|||Other||Prospective|||||||
1359252|NCT02824510|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359253|NCT02824497|||Ecologic or Community||Retrospective|||||||
1359254|NCT02824484|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1359255|NCT02824471|||Case-Control||Prospective|||||||
1359256|NCT02824458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359257|NCT02824445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359258|NCT02824432|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1359259|NCT02824419|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359260|NCT02824406|||Case Control||Cross-Sectional|||||||
1359261|NCT02824393|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1359262|NCT02824380|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359263|NCT02824367|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1359264|NCT02824354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359265|NCT02824341|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1359266|NCT02824328|||Case-Only||Prospective|||||||
1359267|NCT02824315||Single Group Assignment||Treatment||None (Open Label)||||||
1359268|NCT02824302|||Cohort||Prospective|||||||
1359269|NCT02824289|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359270|NCT02824276|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1359271|NCT02824263|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1359272|NCT02824250|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1359273|NCT02824237||Single Group Assignment||Prevention||None (Open Label)||||||
1359274|NCT02824224|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1359275|NCT02824211||Single Group Assignment||Treatment||None (Open Label)||||||
1359276|NCT02824198|Randomized|Parallel Assignment||Prevention||Single||||||t
1359277|NCT02824185||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359278|NCT02824172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359279|NCT02824159|||Cohort||Prospective|||||||
1359280|NCT02824146|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359281|NCT02824133||Single Group Assignment||Treatment||None (Open Label)||||||
1359282|NCT02824120|Randomized|Parallel Assignment||Treatment||Single|||||t|
1359283|NCT02824107|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359284|NCT02824094||||||||||||
1359286|NCT02824068|||Case-Control||Retrospective|||||||
1359287|NCT02824055|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1359288|NCT02824042||Single Group Assignment||Treatment||None (Open Label)||||||
1359289|NCT02824029||Single Group Assignment||Treatment||None (Open Label)||||||
1359290|NCT02824016|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1359291|NCT02824003|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359292|NCT02823990||Single Group Assignment||Treatment||None (Open Label)||||||
1359293|NCT02823977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359294|NCT02823964||Single Group Assignment||Treatment||None (Open Label)||||||
1359295|NCT02823951|||Cohort||Retrospective|||||||
1359296|NCT02823938|||Cohort||Retrospective|||||||
1359297|NCT02823925|||Cohort||Retrospective|||||||
1359298|NCT02823912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359299|NCT02823899|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359300|NCT02823886||Single Group Assignment||Prevention||None (Open Label)||||||
1359301|NCT02823873|||Case Control||Cross-Sectional|||||||
1359302|NCT02823860||Single Group Assignment||Health Services Research||None (Open Label)||||||
1359303|NCT02823847||Single Group Assignment||Screening||None (Open Label)||||||
1359304|NCT02823834|||Cohort||Prospective|||||||
1359305|NCT02823821|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359306|NCT02823808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359307|NCT02823795|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359308|NCT02823782|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359309|NCT02823769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1359310|NCT02823756||Single Group Assignment||Treatment||None (Open Label)||||||
1359311|NCT02823743|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1359312|NCT02823730|||Other||Retrospective|||||||
1359313|NCT02823717|||Cohort||Prospective|||||||
1359314|NCT02823704|||Cohort||Prospective|||||||
1359315|NCT02823691||Single Group Assignment||Treatment||None (Open Label)||||||
1359316|NCT02823678|||Case-Only||Prospective|||||||
1359317|NCT02823665|Randomized|Crossover Assignment||Other||Single|||t|||
1359318|NCT02823652|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359319|NCT02823639|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1359320|NCT02823626||Single Group Assignment||Treatment||None (Open Label)||||||
1359321|NCT02823613|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)|open label|||||
1359322|NCT02823600||Single Group Assignment||Screening||None (Open Label)||||||
1359323|NCT02823587|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359324|NCT02823574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359325|NCT02823561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359326|NCT02823548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359327|NCT02823535|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1359328|NCT02823522|||Cohort||Prospective|||||||
1359329|NCT02823509||Single Group Assignment||Treatment||None (Open Label)||||||
1359330|NCT02823496||Single Group Assignment||||None (Open Label)||||||
1359331|NCT02823483||Single Group Assignment||||None (Open Label)||||||
1359332|NCT02823470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359333|NCT02823457||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1359334|NCT02823444|||Cohort||Prospective|||||||
1359335|NCT02823431|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1359336|NCT02823418|||Cohort||Prospective|||||||
1359337|NCT02823405||Single Group Assignment||Treatment||None (Open Label)||||||
1359338|NCT02823392|||Cohort||Prospective|||||||
1359339|NCT02823379|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359340|NCT02823366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359341|NCT02823353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359342|NCT02823340||Single Group Assignment||Treatment||None (Open Label)||||||
1359343|NCT02823327|||Case-Only||Retrospective|||||||
1359344|NCT02823314|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359345|NCT02823301|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359346|NCT02823288|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1359347|NCT02823275|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1359348|NCT02823262|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359349|NCT02823249|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1359350|NCT02823236|Randomized|Parallel Assignment||Treatment||Single||||||t
1359351|NCT02823223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359352|NCT02823210|||Cohort||Retrospective|||||||
1359353|NCT02823197|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1359354|NCT02823184|||Cohort||Retrospective|||||||
1359355|NCT02823171|Randomized|Crossover Assignment||||None (Open Label)||||||
1359356|NCT02823158|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359357|NCT02823145||Single Group Assignment||Treatment||None (Open Label)||||||
1359358|NCT02823132|||Case Control||Prospective|||||||
1359359|NCT02823119|Randomized|Parallel Assignment||Prevention||Single|||t|||
1359360|NCT02823106|Randomized|Parallel Assignment||Treatment||Single||||||t
1359361|NCT02823093|||Case-Control||Prospective|||||||
1359362|NCT02823080|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1359363|NCT02823067|||Cohort||Cross-Sectional|||||||
1359984|NCT02814929|||Cohort||Prospective|||||||
1359364|NCT02823054|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359365|NCT02823041|Randomized|Parallel Assignment||Treatment||Single||||||t
1359366|NCT02823028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359367|NCT02823015|||Cohort||Prospective|||||||
1359368|NCT02823002|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1359369|NCT02822989|Randomized|Single Group Assignment||Treatment||Single|||t|||
1359370|NCT02822976|||Cohort||Prospective|||||||
1359371|NCT02822963|||Cohort||Prospective|||||||
1359372|NCT02822950||Single Group Assignment||Basic Science||None (Open Label)||||||
1359373|NCT02822937|Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1359374|NCT02822924||Single Group Assignment||Treatment||None (Open Label)||||||
1359375|NCT02822911||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359376|NCT02822898|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1359377|NCT02822885||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359378|NCT02822872|||Cohort||Cross-Sectional|||||||
1359379|NCT02822859|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1359380|NCT02822846|||Case-Only||Prospective|||||||
1359381|NCT02822833||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359382|NCT02822820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359383|NCT02822807|Randomized|Parallel Assignment||||None (Open Label)||||||
1359384|NCT02822794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359385|NCT02822781|||Cohort||Prospective|||||||
1359386|NCT02822768|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359387|NCT02822755|Randomized|Parallel Assignment||Treatment||Single||||||t
1359388|NCT02822742||Single Group Assignment||Treatment||None (Open Label)||||||
1359389|NCT02822729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359390|NCT02822716||Single Group Assignment||Treatment||None (Open Label)||||||
1359391|NCT02822703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359392|NCT02822690|||Family-Based||Prospective|||||||
1359393|NCT02822677|||Other||Cross-Sectional|||||||
1359394|NCT02822664|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1359395|NCT02822651||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359396|NCT02822638|||Cohort||Prospective|||||||
1359397|NCT02822625|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359398|NCT02822612|||Case-Only||Cross-Sectional|||||||
1359399|NCT02822599|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1359400|NCT02822586|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359401|NCT02822573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359402|NCT02822560|Randomized|Single Group Assignment||Treatment||Single|||||t|
1359403|NCT02822547||Single Group Assignment||Treatment||None (Open Label)||||||
1359404|NCT02822534|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1359405|NCT02822521|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1359406|NCT02822508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359407|NCT02822495||||||||||||
1359408|NCT02822482||Single Group Assignment||Treatment||None (Open Label)||||||
1359409|NCT02822469|Randomized|Parallel Assignment||Treatment||Single||||||t
1359410|NCT02822456|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359411|NCT02822443|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359412|NCT02822430|||Cohort||Prospective|||||||
1359413|NCT02822417|||Other||Prospective|||||||
1359414|NCT02822404||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359415|NCT02822391|||Case Control||Cross-Sectional|||||||
1359416|NCT02822378|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359417|NCT02822365|||Case-Only||Cross-Sectional|||||||
1359418|NCT02822352|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359419|NCT02822339||Single Group Assignment||Treatment||None (Open Label)||||||
1359420|NCT02822326||Single Group Assignment||Treatment||None (Open Label)||||||
1359421|NCT02822313||Single Group Assignment||Treatment||None (Open Label)||||||
1359422|NCT02822300||Single Group Assignment||Treatment||None (Open Label)||||||
1359423|NCT02822287||Single Group Assignment||Treatment||None (Open Label)||||||
1359424|NCT02822274||Single Group Assignment||Treatment||None (Open Label)||||||
1359425|NCT02822261||Single Group Assignment||Treatment||None (Open Label)||||||
1359426|NCT02822248||Single Group Assignment||Treatment||None (Open Label)||||||
1359427|NCT02822235|||Cohort||Prospective|||||||
1359428|NCT02822222|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359429|NCT02822209|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359430|NCT02822196|Randomized|Parallel Assignment||Treatment||Single||||||t
1359431|NCT02822183||||||||||||
1359432|NCT02822170||Single Group Assignment||Treatment||None (Open Label)||||||
1359433|NCT02822157|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359434|NCT02822144|Randomized|Parallel Assignment||Treatment||Single||||||t
1359435|NCT02822131|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1359436|NCT02822118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359437|NCT02822105|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359438|NCT02822092|||Case-Only||Prospective|||||||
1359439|NCT02822066||Single Group Assignment||Treatment||None (Open Label)||||||
1359440|NCT02822053||Single Group Assignment||Treatment||None (Open Label)||||||
1359441|NCT02822040|||||Prospective|||||||
1359442|NCT02822027|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1359443|NCT02822014||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359444|NCT02822001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359445|NCT02821988|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1359446|NCT02821975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359447|NCT02821962|Randomized|Parallel Assignment||Prevention||Single||||||t
1359448|NCT02821949|||Cohort||Prospective|||||||
1359449|NCT02821936||Single Group Assignment||Other||None (Open Label)||||||
1359450|NCT02821923|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1359451|NCT02821910|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359452|NCT02821897|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359453|NCT02821884|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359454|NCT02821871|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359455|NCT02821858|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359456|NCT02821845|Randomized|Parallel Assignment||Treatment||Single||||||t
1359457|NCT02821832|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1359458|NCT02821819||Single Group Assignment||Treatment||None (Open Label)||||||
1359459|NCT02821806|||Cohort||Prospective|||||||
1359460|NCT02821793|||Cohort||Prospective|||||||
1359461|NCT02821780|||Cohort||Prospective|||||||
1359462|NCT02821767|||Cohort||Other|||||||
1359463|NCT02821754|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359464|NCT02821741|||Case-Crossover||Cross-Sectional|||||||
1359465|NCT02821728|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359466|NCT02821715|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1359467|NCT02821702|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359468|NCT02821689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359469|NCT02821676|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1359470|NCT02821663||Single Group Assignment||Treatment||None (Open Label)||||||
1359471|NCT02821650|Randomized|Parallel Assignment||Prevention||Single||||||t
1359472|NCT02821637||Single Group Assignment||Supportive Care||None (Open Label)||||||
1359473|NCT02821624|Randomized|Parallel Assignment||Other||Double|||t||t|
1359474|NCT02821611|Randomized|Parallel Assignment||Treatment||Single|||||t|
1359475|NCT02821598|Randomized|Crossover Assignment||Treatment||Single||||||t
1359476|NCT02821585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359477|NCT02821572|||Case-Control||Prospective|||||||
1359478|NCT02821559|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359479|NCT02821546|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1359480|NCT02821533||Single Group Assignment||Treatment||None (Open Label)||||||
1359481|NCT02821520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359482|NCT02821507||Single Group Assignment||Treatment||None (Open Label)||||||
1359483|NCT02821494||Single Group Assignment||||None (Open Label)||||||
1359484|NCT02821481|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1359485|NCT02821468|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359486|NCT02821455|||Cohort||Prospective|||||||
1359487|NCT02821442|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1359488|NCT02821429|||Cohort||Prospective|||||||
1359489|NCT02821416|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1359490|NCT02821403|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1359491|NCT02821390|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1359492|NCT02821377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359493|NCT02821364|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1359494|NCT02821351||Single Group Assignment||Treatment||None (Open Label)||||||
1359495|NCT02821338|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1359496|NCT02821325|||Cohort||Prospective|||||||
1359497|NCT02821312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359498|NCT02821299||Single Group Assignment||Treatment||None (Open Label)||||||
1359499|NCT02821286|||Cohort||Prospective|||||||
1359500|NCT02821273|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1359501|NCT02821260|||Cohort||Prospective|||||||
1359502|NCT02821247|||Cohort||Prospective|||||||
1359503|NCT02821234|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359504|NCT02821208|||Cohort||Prospective|||||||
1359505|NCT02821182||Single Group Assignment||Treatment||None (Open Label)||||||
1359506|NCT02821169|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1359507|NCT02821156|||||Prospective|||||||
1359508|NCT02821143|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359509|NCT02821130|||Case-Only||Prospective|||||||
1359510|NCT02821117||Single Group Assignment||Other||None (Open Label)||||||
1359511|NCT02821104|||Cohort||Prospective|||||||
1359512|NCT02821091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359513|NCT02821078||Single Group Assignment||Basic Science||None (Open Label)||||||
1359514|NCT02821065||Single Group Assignment||Supportive Care||None (Open Label)||||||
1359515|NCT02821052|||Cohort||Prospective|||||||
1359516|NCT02821039|||Cohort||Prospective|||||||
1359517|NCT02821026||Single Group Assignment||Treatment||None (Open Label)||||||
1359518|NCT02821013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359519|NCT02821000||Single Group Assignment||Treatment||None (Open Label)||||||
1359520|NCT02820987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359521|NCT02820974|||||Prospective|||||||
1359522|NCT02820961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359523|NCT02820948|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1359524|NCT02820935|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359525|NCT02820922|||||Retrospective|||||||
1359526|NCT02820909|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1359527|NCT02820896|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359528|NCT02820883|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359529|NCT02820870|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359530|NCT02820857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359531|NCT02820844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359532|NCT02820831|||Cohort||Prospective|||||||
1359533|NCT02820818|||Cohort||Cross-Sectional|||||||
1359534|NCT02820805|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1359535|NCT02820792|Randomized|Parallel Assignment||Treatment||Single||||t||
1359536|NCT02820779||Single Group Assignment||Treatment||None (Open Label)||||||
1359537|NCT02820766|||Cohort||Prospective|||||||
1359538|NCT02820753|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1359539|NCT02820740||Single Group Assignment||Treatment||None (Open Label)||||||
1359540|NCT02820727|||Case-Only||Prospective|||||||
1359541|NCT02820714||Single Group Assignment||Treatment||None (Open Label)||||||
1359542|NCT02820701|Randomized|Parallel Assignment||Treatment||Single||||||t
1359543|NCT02820688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359544|NCT02820675||Single Group Assignment||Health Services Research||None (Open Label)||||||
1359545|NCT02820662||Single Group Assignment||||None (Open Label)||||||
1359546|NCT02820649|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1359547|NCT02820636|Randomized|Parallel Assignment||Treatment||Single||||||t
1359548|NCT02820623|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359549|NCT02820610|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359550|NCT02820597||Single Group Assignment||Treatment||None (Open Label)||||||
1359551|NCT02820584||Single Group Assignment||Treatment||None (Open Label)||||||
1359552|NCT02820571|||Cohort||Prospective|||||||
1359553|NCT02820558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359554|NCT02820545|||Cohort||Prospective|||||||
1359555|NCT02820532||Single Group Assignment||Basic Science||None (Open Label)||||||
1359556|NCT02820519||Single Group Assignment||Treatment||None (Open Label)||||||
1359557|NCT02820506|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359558|NCT02820493||Single Group Assignment||Treatment||None (Open Label)||||||
1359559|NCT02820480||Single Group Assignment||Treatment||None (Open Label)||||||
1359560|NCT02820467||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359561|NCT02820454||Single Group Assignment||Treatment||None (Open Label)||||||
1359562|NCT02820441|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1359563|NCT02820428||Single Group Assignment||||None (Open Label)||||||
1359564|NCT02820415|||Cohort|||||||||
1359565|NCT02820402|||Cohort||Prospective|||||||
1359566|NCT02820389|||Cohort||Prospective|||||||
1359567|NCT02820376||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359568|NCT02820363|Randomized|Parallel Assignment||Treatment||Single||||||t
1359569|NCT02820350||Single Group Assignment||Treatment||None (Open Label)||||||
1359570|NCT02820337|||Case-Only||Prospective|||||||
1359571|NCT02820324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359572|NCT02820311|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1359573|NCT02820298|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359574|NCT02820285|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359575|NCT02820272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359576|NCT02820259|||Cohort||Prospective|||||||
1359577|NCT02820246|||Cohort||Cross-Sectional|||||||
1359578|NCT02820233|||Cohort||Prospective|||||||
1359579|NCT02820220|||||Prospective|||||||
1359580|NCT02820207|||Cohort||Prospective|||||||
1359581|NCT02820194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359582|NCT02820181|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359583|NCT02820168|||Cohort||Prospective|||||||
1359584|NCT02820155|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359585|NCT02820142|||Case-Only||Prospective|||||||
1359586|NCT02820129|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1359587|NCT02820116||Single Group Assignment||Treatment||None (Open Label)||||||
1359588|NCT02820103|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1359589|NCT02820090|||Case Control||Prospective|||||||
1359590|NCT02820077|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1359591|NCT02820064||Single Group Assignment||Basic Science||None (Open Label)||||||
1359592|NCT02820051|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1359593|NCT02820038|Randomized|Factorial Assignment||Other||Triple|||t||t|t
1359594|NCT02820025|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359595|NCT02820012||Single Group Assignment||Other||None (Open Label)||||||
1359596|NCT02819999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359597|NCT02819986||Single Group Assignment||Treatment||None (Open Label)||||||
1359598|NCT02819973|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359599|NCT02819960|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1359600|NCT02819947|||Cohort||Prospective|||||||
1359601|NCT02819934||Single Group Assignment||Basic Science||None (Open Label)||||||
1359602|NCT02819921|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359603|NCT02819908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359604|NCT02819895|Randomized|Parallel Assignment||Other||Single||||t||
1359605|NCT02819882|||Cohort||Prospective|||||||
1359606|NCT02819869|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359607|NCT02819856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359608|NCT02819843|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1359609|NCT02819830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359610|NCT02819817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359611|NCT02819804||Single Group Assignment||Treatment||None (Open Label)||||||
1359612|NCT02819791|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359613|NCT02819778|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359614|NCT02819765|||Case-Only||Prospective|||||||
1359615|NCT02819752|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1359616|NCT02819739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359617|NCT02819726|Randomized|Parallel Assignment||Treatment||Quadruple||"In Part A, patients are randomized in a 1:1:1 ratio to receive one course (baseline and Week 2) of SAIT101 (n=94) versus Rituxan® (n=94) versus MabThera® (n=94).~At Week 24, patients are evaluated for the second course (Week 24 and 26) of the infusion.~In Part B, eligible patients in the SAIT101 arm receive the second course of SAIT101 treatment. Eligible patients in the MabThera® arm receive the second course of MabThera® treatment. Eligible patients in the Rituxan® arm are randomized in a 1:1 ratio to receive SAIT101 or Rituxan® treatment. Patients are followed up for safety until Week 52."|t|t|t|t
1359618|NCT02819713|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1359619|NCT02819700|||Cohort||Prospective|||||||
1359620|NCT02819687|Non-Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1359621|NCT02819674|||Cohort||Prospective|||||||
1359622|NCT02819661|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359623|NCT02819648|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1359624|NCT02819635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359625|NCT02819622|||Case Control||Prospective|||||||
1359626|NCT02819609|||Cohort||Retrospective|||||||
1359627|NCT02819596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359628|NCT02819583||Single Group Assignment||Treatment||None (Open Label)||||||
1359629|NCT02819570|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359630|NCT02819557||Single Group Assignment||Treatment||None (Open Label)||||||
1359631|NCT02819544|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359632|NCT02819531|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359633|NCT02819518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359634|NCT02819505|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1359635|NCT02819492|||Cohort||Prospective|||||||
1359636|NCT02819479||Single Group Assignment||Treatment||None (Open Label)||||||
1359637|NCT02819466|||Cohort||Prospective|||||||
1359638|NCT02819453||Single Group Assignment||Treatment||None (Open Label)||||||
1359639|NCT02819440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1359640|NCT02819427|||Case-Only||Prospective|||||||
1359641|NCT02819414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359642|NCT02819401|||Cohort||Prospective|||||||
1359643|NCT02819388|Randomized|Parallel Assignment||Prevention||Single|||t|||
1359644|NCT02819375|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1359645|NCT02819362|||Cohort||Prospective|||||||
1359646|NCT02819349|Randomized|Parallel Assignment||Prevention||Single|||t|||
1359647|NCT02819336|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359648|NCT02819323|Randomized|Parallel Assignment||Treatment||Single||||||t
1359649|NCT02819310||Single Group Assignment||Treatment||None (Open Label)||||||
1359650|NCT02819297|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359651|NCT02819284|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359652|NCT02819271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359653|NCT02819258||Single Group Assignment||Treatment||None (Open Label)||||||
1359654|NCT02819245||Single Group Assignment||Treatment||None (Open Label)||||||
1359655|NCT02819232||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359656|NCT02819219|Randomized|Parallel Assignment||||Triple|||t||t|t
1359657|NCT02819206||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359658|NCT02819193|||Cohort||Prospective|||||||
1359659|NCT02819180|||Cohort||Prospective|||||||
1359660|NCT02819167||Single Group Assignment||Basic Science||None (Open Label)||||||
1359661|NCT02819154|||Cohort||Prospective|||||||
1359662|NCT02819141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359663|NCT02819128||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359664|NCT02819115|||Cohort||Prospective|||||||
1359665|NCT02819102||Single Group Assignment||Treatment||None (Open Label)||||||
1359666|NCT02819089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359667|NCT02819076|||Cohort||Prospective|||||||
1359668|NCT02819050|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359669|NCT02819037||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359670|NCT02819024||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359671|NCT02819011|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359672|NCT02818998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359673|NCT02818985|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359674|NCT02818972||Single Group Assignment||Treatment||None (Open Label)||||||
1359675|NCT02818959||Single Group Assignment||Treatment||None (Open Label)||||||
1359676|NCT02818946||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359677|NCT02818933|||||Prospective|||||||
1359678|NCT02818920||Single Group Assignment||Treatment||None (Open Label)||||||
1359679|NCT02818907||Single Group Assignment||Other||None (Open Label)||||||
1359680|NCT02818894|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1359681|NCT02818881|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1359682|NCT02818868|||Cohort||Prospective|||||||
1359683|NCT02818855|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1359684|NCT02818842|||Cohort||Prospective|||||||
1359685|NCT02818829|||Cohort||Prospective|||||||
1359686|NCT02818816|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359687|NCT02818803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359688|NCT02818790|Randomized|Parallel Assignment||Prevention||Single|||t|||
1359689|NCT02818777|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1359690|NCT02818764|||Case-Control||Prospective|||||||
1359691|NCT02818751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359692|NCT02818738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359693|NCT02818725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359694|NCT02818712|||Cohort||Prospective|||||||
1359695|NCT02818699|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1359696|NCT02818686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359697|NCT02818673||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359698|NCT02818660||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359699|NCT02818647|Randomized|Parallel Assignment||Treatment||Single||||||t
1359700|NCT02818634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359701|NCT02818621|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1359702|NCT02818608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359703|NCT02818595|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359704|NCT02818582|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1359705|NCT02818569|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1359706|NCT02818556|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1359707|NCT02818543|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1359708|NCT02818530||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359709|NCT02818517|||Other||Prospective|||||||
1359710|NCT02818504|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1359711|NCT02818491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359712|NCT02818478|Randomized|Parallel Assignment||Other||Double|||||t|t
1359713|NCT02818465||Single Group Assignment||Basic Science||None (Open Label)||||||
1359714|NCT02818452|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1359715|NCT02818439||Single Group Assignment||Other||None (Open Label)||||||
1359716|NCT02818426||Single Group Assignment||Treatment||None (Open Label)||||||
1359717|NCT02818413|||Cohort||Prospective|||||||
1359718|NCT02818400||Single Group Assignment||||None (Open Label)||||||
1359719|NCT02818387|Randomized|Parallel Assignment||||Double|||t|t||
1359720|NCT02818374||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359721|NCT02818361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359722|NCT02818348|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359723|NCT02818335|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1359724|NCT02818322|Randomized|Parallel Assignment||||None (Open Label)||||||
1359725|NCT02818309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359726|NCT02818296|Randomized|Parallel Assignment||Prevention||Single|||t|||
1359727|NCT02818283|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1359728|NCT02818270||Single Group Assignment||Health Services Research||None (Open Label)||||||
1359729|NCT02818257|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1359730|NCT02818244|Non-Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1359731|NCT02818231|||Case-Control||Prospective|||||||
1359732|NCT02818218|||Cohort||Prospective|||||||
1359733|NCT02818205|||Case Control||Prospective|||||||
1359734|NCT02818192|||Cohort||Prospective|||||||
1359735|NCT02818179||Single Group Assignment||||None (Open Label)||||||
1359736|NCT02818166|Randomized|Parallel Assignment||Treatment||Single||||t||
1359737|NCT02818153||Single Group Assignment||Prevention||None (Open Label)||||||
1359738|NCT02818140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359739|NCT02818127|Non-Randomized|Single Group Assignment||Diagnostic||Double|||||t|t
1359740|NCT02818114||Single Group Assignment||Treatment||None (Open Label)||Peer specialist led individual education and support for veterans receiving Prolonged Exposure Therapy||||
1359741|NCT02818101|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1359742|NCT02818088||Single Group Assignment||Treatment||None (Open Label)||||||
1359743|NCT02818075|Randomized|Parallel Assignment||Prevention||Single||||||t
1359744|NCT02818062|||Case Control||Prospective|||||||
1359745|NCT02818049||Single Group Assignment||Supportive Care||None (Open Label)||||||
1359746|NCT02818036|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1359747|NCT02818023||Single Group Assignment||Treatment||None (Open Label)||||||
1359748|NCT02818010|||Cohort||Prospective|||||||
1359749|NCT02817997|||Cohort||Other|||||||
1359750|NCT02817984||Single Group Assignment||Other||None (Open Label)||||||
1359751|NCT02817971|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359752|NCT02817958|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359753|NCT02817945||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359754|NCT02817932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359755|NCT02817919|||Cohort||Prospective|||||||
1359756|NCT02817906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359757|NCT02817893|||Cohort||Prospective|||||||
1359758|NCT02817880|Randomized|Parallel Assignment||Treatment||Single||||||t
1359759|NCT02817867|Randomized|Parallel Assignment||Treatment||Single|||||t|
1359760|NCT02817854|||Case-Only||Prospective|||||||
1359761|NCT02817841||Single Group Assignment||Prevention||None (Open Label)||||||
1359762|NCT02817828||Single Group Assignment||Prevention||None (Open Label)||||||
1359763|NCT02817815|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359764|NCT02817802|||Other||Prospective|||||||
1359765|NCT02817789|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359766|NCT02817776||Single Group Assignment||Treatment||None (Open Label)||||||
1359767|NCT02817763|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1359768|NCT02817750|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1359769|NCT02817737|||Cohort||Prospective|||||||
1359770|NCT02817724|Randomized|Parallel Assignment||Treatment||Single|||||t|
1359771|NCT02817711|||Cohort||Prospective|||||||
1359772|NCT02817698||Single Group Assignment||Other||None (Open Label)||||||
1359773|NCT02817685|||Cohort||Prospective|||||||
1359774|NCT02817672|Randomized|Factorial Assignment||Treatment||Single||||||t
1359775|NCT02817659||Single Group Assignment||Basic Science||None (Open Label)||||||
1359776|NCT02817646|||Case-Only||Retrospective|||||||
1359777|NCT02817633|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1359778|NCT02817620|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359779|NCT02817607||Single Group Assignment||Basic Science||None (Open Label)||||||
1359780|NCT02817594|||Cohort||Prospective|||||||
1359781|NCT02817581|||Cohort||Prospective|||||||
1359782|NCT02817568|||Case Control||Cross-Sectional|||||||
1359783|NCT02817555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359784|NCT02817542|||Cohort||Prospective|||||||
1359785|NCT02817529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359786|NCT02817516|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1359787|NCT02817503|Randomized|Parallel Assignment||Treatment||Single||||||t
1359788|NCT02817490|||Cohort||Prospective|||||||
1359789|NCT02817477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359790|NCT02817464|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1359791|NCT02817451|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359792|NCT02817438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359793|NCT02817425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359794|NCT02817412|Randomized|Parallel Assignment||Treatment||Single||||||t
1359795|NCT02817399|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1359796|NCT02817386|||Case-Only||Prospective|||||||
1359797|NCT02817373||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359798|NCT02817360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359799|NCT02817347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359800|NCT02817334||Single Group Assignment||Treatment||None (Open Label)||||||
1359801|NCT02817321|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1359802|NCT02817308|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359803|NCT02817295|||Cohort||Retrospective|||||||
1359804|NCT02817282||Single Group Assignment||Prevention||None (Open Label)||||||
1359805|NCT02817269|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1359806|NCT02817256|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359807|NCT02817243||Single Group Assignment||Treatment||None (Open Label)||||||
1359808|NCT02817230|||Case Control||Prospective|||||||
1359809|NCT02817217||Single Group Assignment||Treatment||None (Open Label)||||||
1359810|NCT02817204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359811|NCT02817191|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359812|NCT02817178||Single Group Assignment||Other||None (Open Label)||||||
1359813|NCT02817165|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359814|NCT02817152|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1359815|NCT02817139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359816|NCT02817126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359817|NCT02817113||Single Group Assignment||Treatment||None (Open Label)||||||
1359818|NCT02817100|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1359819|NCT02817087|Randomized|Parallel Assignment||Treatment||Triple|Double-blind, only the care provider is aware of active treatment assignment.|Active repetitive transcranial magnetic stimulation administered through cap worn by patient under healthcare provider.|t||t|t
1359820|NCT02817074|Randomized|Parallel Assignment||Prevention||Single||||||t
1359821|NCT02817061|Randomized|Parallel Assignment||Other||Single|||t|||
1359822|NCT02817048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359823|NCT02817035||Single Group Assignment||||None (Open Label)||||||
1359824|NCT02817022||Single Group Assignment||Supportive Care||None (Open Label)||||||
1359825|NCT02817009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359826|NCT02816996|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1359827|NCT02816983|||Case-Only||Prospective|||||||
1359828|NCT02816970|Randomized|Crossover Assignment||||None (Open Label)||||||
1359829|NCT02816957|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359830|NCT02816944||Single Group Assignment||Treatment||None (Open Label)||||||
1359831|NCT02816931|||Cohort||Prospective|||||||
1359832|NCT02816918|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1359833|NCT02816905|Randomized|Parallel Assignment||Treatment||Single|||||t|
1359834|NCT02816892|||Cohort||Prospective|||||||
1359835|NCT02816879||Single Group Assignment||Screening||None (Open Label)||||||
1359836|NCT02816866|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1359837|NCT02816853|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1359838|NCT02816840|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1359839|NCT02816827|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1359840|NCT02816814|Randomized|Parallel Assignment||||None (Open Label)||||||
1359841|NCT02816801|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1359842|NCT02816788||Single Group Assignment||Treatment||None (Open Label)|No masking.|Single group, within subjects comparison. Pre- and post-intervention comparisons.||||
1359843|NCT02816775|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1359844|NCT02816762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359845|NCT02816749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359846|NCT02816736|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1359847|NCT02816723|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359848|NCT02816710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359849|NCT02816697|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1359850|NCT02816684|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1359851|NCT02816671|||Case-Only||Prospective|||||||
1359852|NCT02816658|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359853|NCT02816645|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1359854|NCT02816632||Single Group Assignment||Basic Science||None (Open Label)||||||
1359855|NCT02816619|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359856|NCT02816606|||Cohort||Prospective|||||||
1359857|NCT02816593|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1359858|NCT02816580||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359859|NCT02816567|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1359860|NCT02816554|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1359861|NCT02816541|Randomized|Crossover Assignment||Treatment||Single||||||t
1359862|NCT02816528|||Cohort||Prospective|||||||
1359863|NCT02816515|||Case-Only||Prospective|||||||
1359864|NCT02816502|Randomized|Parallel Assignment||Treatment||Single|||||t|
1359865|NCT02816489|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1359866|NCT02816476||Single Group Assignment||Treatment||None (Open Label)||||||
1359867|NCT02816463|Randomized|Parallel Assignment||Other||Double|||t||t|
1359868|NCT02816450|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1359869|NCT02816437||Single Group Assignment||Treatment||None (Open Label)||||||
1359870|NCT02816424|Randomized|Parallel Assignment||Prevention||Double||||t||t
1359871|NCT02816411|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1359872|NCT02816398||Single Group Assignment||Treatment||None (Open Label)||||||
1359873|NCT02816385|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1359874|NCT02816372||Single Group Assignment||Treatment||None (Open Label)||||||
1359875|NCT02816359||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359876|NCT02816346|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359877|NCT02816333|||Cohort||Prospective|||||||
1359878|NCT02816320|||Cohort||Retrospective|||||||
1359879|NCT02816307||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359880|NCT02816294|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1359881|NCT02816281|||Case-Only||Retrospective|||||||
1359882|NCT02816268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359883|NCT02816255|Randomized|Parallel Assignment||Diagnostic||Single||Subjects will complete two week baseline with nasal mask then will complete two week treatment with full face either with new algorithm or old algorithm.|t|||
1359884|NCT02816242|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1359885|NCT02816229|Randomized|Parallel Assignment||Treatment||Single||||||t
1359886|NCT02816216||Single Group Assignment||Supportive Care||None (Open Label)||||||
1359887|NCT02816203||Single Group Assignment||Other||None (Open Label)||||||
1359888|NCT02816190|||Cohort||Prospective|||||||
1359889|NCT02816177|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359890|NCT02816164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359891|NCT02816151|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359892|NCT02816138||Single Group Assignment||Treatment||None (Open Label)||||||
1359893|NCT02816125|Randomized|Crossover Assignment||Prevention||Single||||||t
1359894|NCT02816112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359895|NCT02816099||Parallel Assignment||||None (Open Label)||||||
1359896|NCT02816086|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359897|NCT02816073|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359898|NCT02816060|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1359899|NCT02816047|||Cohort||Retrospective|||||||
1359900|NCT02816034|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1359901|NCT02816021|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359902|NCT02816008|Randomized|Parallel Assignment||Treatment||Single||||||t
1359903|NCT02815995|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359904|NCT02815982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359905|NCT02815969|||Cohort||Prospective|||||||
1359906|NCT02815956|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359907|NCT02815943|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359908|NCT02815930|||Cohort||Retrospective|||||||
1359909|NCT02815917|Non-Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1359910|NCT02815904|Randomized|Parallel Assignment||Treatment||Single|||t|||
1359911|NCT02815891|||Cohort||Other|||||||
1359912|NCT02815878|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359913|NCT02815865|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1359914|NCT02815852|||||Retrospective|||||||
1359915|NCT02815839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359916|NCT02815826|||Cohort||Prospective|||||||
1359917|NCT02815813|Randomized|Parallel Assignment||Treatment||Single||||||t
1359918|NCT02815800||Single Group Assignment||Other||None (Open Label)||||||
1359919|NCT02815787|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359920|NCT02815774|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359921|NCT02815761|||Cohort||Prospective|||||||
1359922|NCT02815748||Single Group Assignment||Treatment||None (Open Label)||||||
1359923|NCT02815735|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1359924|NCT02815722|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359925|NCT02815709|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359926|NCT02815696||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359927|NCT02815683|||Cohort||Prospective|||||||
1359928|NCT02815670||Single Group Assignment||Treatment||None (Open Label)||||||
1359929|NCT02815657|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359930|NCT02815644|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359931|NCT02815631|Non-Randomized|Parallel Assignment||Diagnostic||Triple||||t|t|t
1359932|NCT02815618|||Case-Only||Prospective|||||||
1359933|NCT02815605|||Cohort||Retrospective|||||||
1359934|NCT02815592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359935|NCT02815579|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1359936|NCT02815566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1359937|NCT02815553||Single Group Assignment||Treatment||None (Open Label)||||||
1359938|NCT02815540||Single Group Assignment||Diagnostic||None (Open Label)||||||
1359939|NCT02815527|||Cohort||Prospective|||||||
1359940|NCT02815514|||Case-Only||Prospective|||||||
1359941|NCT02815501|||Cohort||Prospective|||||||
1359942|NCT02815488|Randomized|||Treatment||Quadruple|||t|t|t|t
1359943|NCT02815475|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1359944|NCT02815462|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1359945|NCT02815449|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1359946|NCT02815436|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1359947|NCT02815423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359948|NCT02815410||Single Group Assignment||Treatment||None (Open Label)||||||
1359949|NCT02815397||Single Group Assignment||Treatment||None (Open Label)||||||
1359950|NCT02815384|||Cohort||Prospective|||||||
1359951|NCT02815371|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1359952|NCT02815358|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1359953|NCT02815345||Single Group Assignment||||None (Open Label)||||||
1359954|NCT02815332|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1359955|NCT02815319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359956|NCT02815306||Single Group Assignment||Treatment||None (Open Label)||||||
1359957|NCT02815293|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359958|NCT02815280|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359959|NCT02815267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359960|NCT02815254|Randomized|Parallel Assignment||Treatment||Single||||||t
1359961|NCT02815241||Single Group Assignment||Treatment||None (Open Label)||||||
1359962|NCT02815228||Single Group Assignment||Treatment||None (Open Label)||||||
1359963|NCT02815215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359964|NCT02815202||Single Group Assignment||Treatment||None (Open Label)||||||
1359965|NCT02815189|Randomized|Parallel Assignment||Treatment||Single||||||t
1359966|NCT02815176|||Case Control||Prospective|||||||
1359967|NCT02815163|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1359968|NCT02815150|Randomized|Parallel Assignment||Other||Single|||||t|
1359969|NCT02815137||Single Group Assignment||Other||None (Open Label)||||||
1359970|NCT02815124|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1359971|NCT02815111|||Cohort||Prospective|||||||
1359972|NCT02815085||Single Group Assignment||Supportive Care||None (Open Label)||||||
1359973|NCT02815072|||Case-Only||Prospective|||||||
1359974|NCT02815059||Single Group Assignment||Treatment||None (Open Label)||||||
1359975|NCT02815046|||Cohort||Prospective|||||||
1359976|NCT02815033||Single Group Assignment||Treatment||None (Open Label)||||||
1359977|NCT02815020||Single Group Assignment||Health Services Research||None (Open Label)||||||
1359978|NCT02815007||Single Group Assignment||Treatment||None (Open Label)||||||
1359979|NCT02814994|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1359980|NCT02814981|||Cohort||Prospective|||||||
1359981|NCT02814968||Single Group Assignment||Treatment||None (Open Label)||||||
1359982|NCT02814955|||Cohort||Prospective|||||||
1359983|NCT02814942|||Cohort||Prospective|||||||
1359985|NCT02814916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1359986|NCT02814903|||Cohort||Prospective|||||||
1359987|NCT02814890|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1359988|NCT02814877|||Ecologic or Community||Prospective|||||||
1359989|NCT02814864||Single Group Assignment||Treatment||None (Open Label)||||||
1359990|NCT02814851||Single Group Assignment||Prevention||None (Open Label)||||||
1359991|NCT02814838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1359992|NCT02814825|||Cohort||Prospective|||||||
1359993|NCT02814812||Single Group Assignment||||None (Open Label)||||||
1359994|NCT02814799|||||Prospective|||||||
1359995|NCT02814786|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1359996|NCT02814773|||Cohort||Prospective|||||||
1359997|NCT02814760|||||Prospective|||||||
1359998|NCT02814747||Parallel Assignment||||None (Open Label)||||||
1359999|NCT02814734|||Cohort||Prospective|||||||
1360000|NCT02814721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360001|NCT02814708|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1360002|NCT02814695|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360003|NCT02814682|||||Retrospective|||||||
1360004|NCT02814669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360005|NCT02814656|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360006|NCT02814643|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1360007|NCT02814630||Single Group Assignment||Other||None (Open Label)||||||
1360008|NCT02814617|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1360009|NCT02814604|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360010|NCT02814591|||Cohort|||||||||
1360011|NCT02814578|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1360012|NCT02814565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360013|NCT02814552|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1360014|NCT02814539|||Cohort||Prospective|||||||
1360015|NCT02814526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360016|NCT02814513||Single Group Assignment||Supportive Care||None (Open Label)||||||
1360017|NCT02814500|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1360018|NCT02814487|||Case-Only||Prospective|||||||
1360019|NCT02814474|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1360020|NCT02814461||Single Group Assignment||Treatment||None (Open Label)||||||
1360021|NCT02814448|Randomized|Parallel Assignment||Treatment||Single||||||t
1360022|NCT02814435|||Case-Control||Cross-Sectional|||||||
1360023|NCT02814422|||Case-Only||Prospective|||||||
1360024|NCT02814409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360025|NCT02814396|||Case-Only||Prospective|||||||
1360026|NCT02814383|||Cohort||Prospective|||||||
1360027|NCT02814357|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1360028|NCT02814344|||Cohort||Prospective|||||||
1360029|NCT02814331|||Case-Only||Prospective|||||||
1360030|NCT02814318|||Case-Control||Prospective|||||||
1360031|NCT02814305|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1360032|NCT02814292|||Cohort||Prospective|||||||
1360033|NCT02814279|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1360034|NCT02814266|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1360035|NCT02814253|||Cohort||Prospective|||||||
1360036|NCT02814240||Single Group Assignment||||None (Open Label)||||||
1360037|NCT02814227||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360038|NCT02814214|||Cohort||Prospective|||||||
1360039|NCT02814201|||Case Control||Prospective|||||||
1360040|NCT02814188|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1360041|NCT02814175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360042|NCT02814162|||Case-Only||Prospective|||||||
1360043|NCT02814149|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1360044|NCT02814136|Randomized|Parallel Assignment||Treatment||Single|||||t|
1360045|NCT02814123|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1360046|NCT02814110||Single Group Assignment||Treatment||None (Open Label)||||||
1360047|NCT02814097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360048|NCT02814084|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1360049|NCT02814071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360050|NCT02814058|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1360051|NCT02814045|||Cohort||Prospective|||||||
1360052|NCT02814032|||Cohort||Prospective|||||||
1360053|NCT02814019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360054|NCT02814006|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1360055|NCT02813993|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1360056|NCT02813980|||Cohort||Prospective|||||||
1360057|NCT02813967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360058|NCT02813954|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1360059|NCT02813941|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1360060|NCT02813928||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360061|NCT02813915|||Cohort||Prospective|||||||
1360062|NCT02813902|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1360063|NCT02813889||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360064|NCT02813876|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1360065|NCT02813863||Single Group Assignment||Treatment||None (Open Label)||||||
1360066|NCT02813850|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360067|NCT02813837||Single Group Assignment||Treatment||None (Open Label)||||||
1360068|NCT02813824|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360069|NCT02813811|||Cohort||Prospective|||||||
1360070|NCT02813798|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360071|NCT02813785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360072|NCT02813772|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360073|NCT02813759|Non-Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1360074|NCT02813746|||Cohort||Prospective|||||||
1360075|NCT02813733|||Cohort||Prospective|||||||
1360076|NCT02813720|||Cohort||Prospective|||||||
1360077|NCT02813707|||Case Control||Retrospective|||||||
1360078|NCT02813694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360079|NCT02813681|Randomized|Parallel Assignment||Prevention||Single|||t|||
1360080|NCT02813668||Single Group Assignment||Other||None (Open Label)||||||
1360081|NCT02813655|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1360082|NCT02813642||Single Group Assignment||Supportive Care||None (Open Label)||||||
1360083|NCT02813629|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1360084|NCT02813616|||Cohort||Prospective|||||||
1360085|NCT02813603|||Case-Control||Prospective|||||||
1360086|NCT02813590|||Cohort||Prospective|||||||
1360087|NCT02813577||Single Group Assignment||Treatment||None (Open Label)||||||
1360088|NCT02813564|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360089|NCT02813551|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360090|NCT02813538|||Case-Only||Prospective|||||||
1360091|NCT02813525|||Cohort||Prospective|||||||
1360092|NCT02813512||Single Group Assignment||Treatment||None (Open Label)||||||
1360093|NCT02813499|||Case-Only||Prospective|||||||
1360094|NCT02813486|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1360095|NCT02813473|||Case-Only||Cross-Sectional|||||||
1360096|NCT02813460|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1360097|NCT02813447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360098|NCT02813434||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360099|NCT02813421|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360100|NCT02813408|||Cohort||Prospective|||||||
1360101|NCT02813395|Randomized|Parallel Assignment||||Triple|||t||t|t
1360102|NCT02813382|||Cohort||Prospective|||||||
1360103|NCT02813369|||Cohort||Retrospective|||||||
1360104|NCT02813356|||Cohort||Retrospective|||||||
1360105|NCT02813343|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1360106|NCT02813330|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1360107|NCT02813317|||Cohort||Prospective|||||||
1360108|NCT02813304|Randomized|Parallel Assignment||Treatment||Single||||||t
1360109|NCT02813291|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1360110|NCT02813278|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360111|NCT02813265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360112|NCT02813252|||Cohort||Prospective|||||||
1360113|NCT02813239|||Case-Crossover||Retrospective|||||||
1360114|NCT02813226||Single Group Assignment||Other||None (Open Label)||||||
1360115|NCT02813213|Randomized|Parallel Assignment||Treatment||Double||Experimental intervention: skin micro grafts Comparative intervention: Meshed Split Thikness Skin Grafts|t||t|
1360116|NCT02813200|Randomized|Crossover Assignment||||None (Open Label)||||||
1360117|NCT02813187|||Case-Only||Prospective|||||||
1360118|NCT02813174||Single Group Assignment||Prevention||None (Open Label)||||||
1360119|NCT02813161|||Case-Only||Prospective|||||||
1360120|NCT02813148|||Cohort||Retrospective|||||||
1360121|NCT02813135|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360122|NCT02813122|||Cohort||Retrospective|||||||
1360123|NCT02813109|||Cohort||Prospective|||||||
1360124|NCT02813096|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1360125|NCT02813083|||Cohort||Prospective|||||||
1360126|NCT02813070|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1360127|NCT02813057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360128|NCT02813044|Randomized|Parallel Assignment||Other||Double|||t||t|
1360129|NCT02813031|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360130|NCT02813018|Randomized|Parallel Assignment||Other||Double|||t||t|
1360131|NCT02813005|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360132|NCT02812992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360133|NCT02812979|Randomized|Crossover Assignment||Treatment||Single|||t|||
1360134|NCT02812966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360135|NCT02812953|||Cohort||Prospective|||||||
1360136|NCT02812940||Single Group Assignment||Prevention||None (Open Label)||||||
1360137|NCT02812927|Randomized|Parallel Assignment||||None (Open Label)||||||
1360138|NCT02812914|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360139|NCT02812901|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360140|NCT02812888|||Case Control||Cross-Sectional|||||||
1360141|NCT02812875||Single Group Assignment||Treatment||None (Open Label)||||||
1360142|NCT02812862|||Case Control||Prospective|||||||
1360143|NCT02812849|||Cohort||Prospective|||||||
1360144|NCT02812836||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360145|NCT02812823||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360146|NCT02812810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360147|NCT02812797|||Cohort||Prospective|||||||
1360148|NCT02812784|||Cohort||Prospective|||||||
1360149|NCT02812771||Single Group Assignment||Treatment||None (Open Label)||||||
1360150|NCT02812758|||Cohort||Prospective|||||||
1360151|NCT02812745|||Cohort||Prospective|||||||
1360152|NCT02812732||Single Group Assignment||Health Services Research||None (Open Label)||||||
1360153|NCT02812719|Randomized|Parallel Assignment||Treatment||Single|||||t|
1360154|NCT02812706||Single Group Assignment||Treatment||None (Open Label)||||||
1360155|NCT02812693||Single Group Assignment||Treatment||None (Open Label)||||||
1360156|NCT02812680|||Case-Control||Prospective|||||||
1360157|NCT02812667||Single Group Assignment||Treatment||None (Open Label)||||||
1360158|NCT02812654||Single Group Assignment||Treatment||None (Open Label)||||||
1360159|NCT02812641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360160|NCT02812628|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1360161|NCT02812615||Single Group Assignment||Prevention||None (Open Label)||||||
1360162|NCT02812602|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1360163|NCT02812589||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360164|NCT02812576|||Case-Only||Prospective|||||||
1360165|NCT02812563|||Family-Based||Prospective|||||||
1360166|NCT02812550|Randomized|Parallel Assignment||Screening||Single|||t|||
1360167|NCT02812537|||Cohort||Prospective|||||||
1360168|NCT02812524||Single Group Assignment||Treatment||None (Open Label)||||||
1360169|NCT02812511||Single Group Assignment||Basic Science||None (Open Label)||||||
1360170|NCT02812498|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1360171|NCT02812472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360172|NCT02812459|Randomized|Parallel Assignment||Treatment||Single||||||t
1360173|NCT02812446|||Case Control||Retrospective|||||||
1360174|NCT02812433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360175|NCT02812420||Single Group Assignment||Treatment||None (Open Label)||||||
1360176|NCT02812407||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360177|NCT02812394||Single Group Assignment||Treatment||None (Open Label)||||||
1360178|NCT02812381|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360179|NCT02812368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360180|NCT02812355|Randomized|Parallel Assignment||Treatment||Single|||||t|
1360181|NCT02812342||Single Group Assignment||Treatment||None (Open Label)||||||
1360182|NCT02812329||Single Group Assignment||Prevention||None (Open Label)||||||
1360183|NCT02812316||Single Group Assignment||Other||None (Open Label)||||||
1360184|NCT02812303|||Cohort||Prospective|||||||
1360185|NCT02812290|||Cohort||Prospective|||||||
1360186|NCT02812277|||Cohort||Retrospective|||||||
1360187|NCT02812264|Randomized|Parallel Assignment||Treatment||Double|Participants will not know which arm they have been randomized to. Additionally, the investigators will be blinded to participant assignment. Randomization will be completed by the program manager.||t||t|
1360188|NCT02812251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360189|NCT02812238|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1360190|NCT02812225||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360191|NCT02812212||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360192|NCT02812199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360193|NCT02812186|Randomized|Crossover Assignment||Treatment||Single|||t|||
1360194|NCT02812173|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1360195|NCT02812160||||||||||||
1360196|NCT02812147|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1360197|NCT02812134|||Cohort||Prospective|||||||
1360198|NCT02812121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360199|NCT02812108|||Cohort||Prospective|||||||
1360200|NCT02812095|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1360201|NCT02812082||Single Group Assignment||Prevention||None (Open Label)||||||
1360202|NCT02812069||Single Group Assignment||Treatment||None (Open Label)||||||
1360203|NCT02812056||Single Group Assignment||Treatment||None (Open Label)||||||
1360204|NCT02812043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360205|NCT02812030|||Cohort||Prospective|||||||
1360206|NCT02812017|Randomized|Parallel Assignment||Other||Single|||t|||
1360207|NCT02812004|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1360208|NCT02811991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360209|NCT02811978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360210|NCT02811965|Randomized|Crossover Assignment||Basic Science||Single||Each research subject will have pressure mapping performed on his or her right foot in the 7 conditions described for each study arm to determine the contact forces experienced by the heel in each off-loading condition. Each intervention will be randomly applied.||||t
1360211|NCT02811952|||Case Control||Prospective|||||||
1360212|NCT02811939|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1360213|NCT02811926|||Other||Retrospective|||||||
1360214|NCT02811913||Single Group Assignment||Treatment||Double|||t|||t
1360215|NCT02811900|||Cohort||Prospective|||||||
1360216|NCT02811887|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1360217|NCT02811874|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1360218|NCT02811861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360219|NCT02811848|||Other||Prospective|||||||
1360220|NCT02811835|||Cohort||Prospective|||||||
1360221|NCT02811822|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360222|NCT02811809|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1360223|NCT02811796|||Cohort||Prospective|||||||
1360224|NCT02811783|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1360225|NCT02811770|||Cohort||Retrospective|||||||
1360226|NCT02811757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360227|NCT02811744|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1360228|NCT02811731|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1360229|NCT02811718|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360230|NCT02811705|||Cohort||Prospective|||||||
1360231|NCT02811692|||Other||Retrospective|||||||
1360232|NCT02811679||Single Group Assignment||Treatment||None (Open Label)||||||
1360233|NCT02811666||Single Group Assignment||Prevention||None (Open Label)||||||
1360234|NCT02811653|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360235|NCT02811640|||Case-Only||Cross-Sectional|||||||
1360236|NCT02811627||Single Group Assignment||Other||None (Open Label)||||||
1360237|NCT02811614|Randomized|Parallel Assignment||Treatment||Single||||||t
1360238|NCT02811601||Single Group Assignment||Treatment||None (Open Label)||||||
1360239|NCT02811588|||Cohort||Prospective|||||||
1360240|NCT02811575|||Case-Control||Prospective|||||||
1360241|NCT02811562|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360242|NCT02811549||Single Group Assignment||Treatment||None (Open Label)||||||
1360243|NCT02811536|||Cohort||Prospective|||||||
1360244|NCT02811523|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1360245|NCT02811510|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1360246|NCT02811497||Single Group Assignment||Treatment||None (Open Label)||||||
1360247|NCT02811484|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1360248|NCT02811458|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1360249|NCT02811445|||Case-Control||Cross-Sectional|||||||
1360250|NCT02811432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360251|NCT02811419|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1360252|NCT02811406|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360253|NCT02811393|||Case Control||Cross-Sectional|||||||
1360254|NCT02811380|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1360255|NCT02811367||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360256|NCT02811354||Single Group Assignment||Treatment||None (Open Label)||||||
1360257|NCT02811341|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1360258|NCT02811328||||||||||||
1360259|NCT02811315|||Other||Prospective|||||||
1360260|NCT02811302||Single Group Assignment||Screening||None (Open Label)||||||
1360261|NCT02811289|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360262|NCT02811276|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1360263|NCT02811263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360264|NCT02811250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1360265|NCT02811237|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360266|NCT02811224|||Case-Control||Prospective|||||||
1360267|NCT02811211|||Case-Only||Cross-Sectional|||||||
1360268|NCT02811198|||Cohort||Prospective|||||||
1360269|NCT02811185|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1360270|NCT02811172|||Cohort||Prospective|||||||
1360271|NCT02811159||Single Group Assignment||Treatment||None (Open Label)||||||
1360272|NCT02811146|Randomized|Parallel Assignment||Treatment||Single||||||t
1360273|NCT02811133||Single Group Assignment||Treatment||None (Open Label)||||||
1360274|NCT02811120|||Other||Other|||||||
1360275|NCT02811107|||Cohort||Prospective|||||||
1360276|NCT02811094||Single Group Assignment||Other||None (Open Label)||||||
1360277|NCT02811081|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1360278|NCT02811068|||Cohort||Other|||||||
1360279|NCT02811055|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1360280|NCT02811042|Randomized|Crossover Assignment||Treatment||Single|||t|||
1360281|NCT02811029||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360282|NCT02811016|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1360283|NCT02811003||Single Group Assignment||Treatment||None (Open Label)||||||
1360284|NCT02810990||Single Group Assignment||Treatment||None (Open Label)||||||
1360285|NCT02810977|||Other||Cross-Sectional|||||||
1360286|NCT02810964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360287|NCT02810951||Single Group Assignment||Treatment||None (Open Label)||||||
1360288|NCT02810938|||Case-Only||Prospective|||||||
1360289|NCT02810925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360290|NCT02810912|||Cohort||Prospective|||||||
1360291|NCT02810899|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360292|NCT02810886||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360293|NCT02810873|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1360294|NCT02810860||Single Group Assignment||||None (Open Label)||||||
1360295|NCT02810847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360296|NCT02810834|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360297|NCT02810821|||Cohort||Prospective|||||||
1360298|NCT02810808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360299|NCT02810795|||Cohort||Prospective|||||||
1360300|NCT02810782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360301|NCT02810769|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1360302|NCT02810756||Single Group Assignment||Treatment||None (Open Label)||||||
1360303|NCT02810743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360304|NCT02810730||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360305|NCT02810717|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1360306|NCT02810704|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360307|NCT02810691|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1360308|NCT02810678|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360309|NCT02810665|||Case-Only||Cross-Sectional|||||||
1360310|NCT02810652|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360311|NCT02810639|||Cohort||Prospective|||||||
1360312|NCT02810626|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1360313|NCT02810613|||Other||Other|||||||
1360314|NCT02810600|||Cohort||Prospective|||||||
1360315|NCT02810587|||Case-Only||Prospective|||||||
1360316|NCT02810574|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1360317|NCT02810561|||Cohort||Retrospective|||||||
1360318|NCT02810548|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1360319|NCT02810535|Randomized|Parallel Assignment||Other||Single||||||t
1360320|NCT02810522|Non-Randomized|||Diagnostic||None (Open Label)||||||
1360321|NCT02810509|||Cohort||Retrospective|||||||
1360322|NCT02810496||Single Group Assignment||Basic Science||None (Open Label)||||||
1360323|NCT02810483|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360324|NCT02810470|Randomized|Crossover Assignment||||None (Open Label)||||||
1360325|NCT02810457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360326|NCT02810444||Single Group Assignment||Treatment||None (Open Label)||||||
1360327|NCT02810418|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1360328|NCT02810405|||Cohort||Cross-Sectional|||||||
1360329|NCT02810392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360330|NCT02810379|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1360331|NCT02810366|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1360332|NCT02810353|Randomized|Parallel Assignment||Treatment||Single||||||t
1360333|NCT02810340|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360334|NCT02810327|||Case-Control||Cross-Sectional|||||||
1360335|NCT02810314|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360336|NCT02810301|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360337|NCT02810288|||||Cross-Sectional|||||||
1360338|NCT02810275|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1360339|NCT02810262|||Cohort||Prospective|||||||
1360340|NCT02810249|||Ecologic or Community||Prospective|||||||
1360341|NCT02810236|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1360342|NCT02810223||Single Group Assignment||Treatment||None (Open Label)||||||
1360343|NCT02810210|||Cohort||Prospective|||||||
1360344|NCT02810197|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360345|NCT02810184||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360346|NCT02810171|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1360347|NCT02810158|||Case-Only||Prospective|||||||
1360348|NCT02810145|||Cohort||Prospective|||||||
1360349|NCT02810132|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360350|NCT02810119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360351|NCT02810106|||Case-Only||Prospective|||||||
1360352|NCT02810093|||Cohort||Retrospective|||||||
1360353|NCT02810080||||||||||||
1360354|NCT02810067|Randomized|Parallel Assignment||Treatment||Single||||||t
1360355|NCT02810054|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1360356|NCT02810041|Randomized|Parallel Assignment||||Double|||t||t|
1360357|NCT02810028|Randomized|Parallel Assignment||Treatment||Single||||||t
1360358|NCT02810015||Single Group Assignment||Treatment||None (Open Label)||||||
1360359|NCT02810002|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360360|NCT02809989|||Cohort||Prospective|||||||
1360361|NCT02809976||Single Group Assignment||Treatment||None (Open Label)||||||
1360362|NCT02809963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360363|NCT02809950|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1360364|NCT02809937|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360365|NCT02809924|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360366|NCT02809911|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1360367|NCT02809898|||Case Control||Prospective|||||||
1360368|NCT02809885||Single Group Assignment||Screening||None (Open Label)||||||
1360369|NCT02809872|||Cohort||Retrospective|||||||
1360370|NCT02809859||Single Group Assignment||Treatment||None (Open Label)||||||
1360371|NCT02809846|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1360372|NCT02809833|||Cohort||Prospective|||||||
1360373|NCT02809820|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360374|NCT02809807|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1360375|NCT02809794||Single Group Assignment||Treatment||None (Open Label)||||||
1360376|NCT02809781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360377|NCT02809768|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360378|NCT02809755|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1360379|NCT02809742|||Cohort||Prospective|||||||
1360380|NCT02809729|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1360381|NCT02809716|||Case-Only||Prospective|||||||
1360382|NCT02809703|||Cohort||Other|||||||
1360383|NCT02809690||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360384|NCT02809677||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360385|NCT02809664|||Other||Retrospective|||||||
1360386|NCT02809651|Non-Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1360387|NCT02809638|||Cohort||Prospective|||||||
1360388|NCT02809625|||Case Control||Prospective|||||||
1360389|NCT02809612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360390|NCT02809599|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1360391|NCT02809586|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1360392|NCT02809573||Single Group Assignment||Treatment||None (Open Label)||||||
1360393|NCT02809560|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360394|NCT02809547|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1360395|NCT02809534||Single Group Assignment||Treatment||None (Open Label)||||||
1360396|NCT02809521||Single Group Assignment||Other||None (Open Label)||||||
1360397|NCT02809508|Randomized|Parallel Assignment||Prevention||Single||||||t
1360398|NCT02809495|||Case Control||Prospective|||||||
1360399|NCT02809482|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1360400|NCT02809469||Single Group Assignment||Prevention||None (Open Label)||||||
1360401|NCT02809456|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360402|NCT02809443|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360403|NCT02809430||Single Group Assignment||Treatment||None (Open Label)||||||
1360404|NCT02809417|||Cohort||Prospective|||||||
1360405|NCT02809404|||Case-Only||Prospective|||||||
1360406|NCT02809391|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1360407|NCT02809378|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1360408|NCT02809365|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360409|NCT02809352|||Cohort||Prospective|||||||
1360410|NCT02809339|||Cohort||Prospective|||||||
1360411|NCT02809326|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360412|NCT02809313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360413|NCT02809300||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360414|NCT02809287|||Cohort||Prospective|||||||
1360415|NCT02809274|||Cohort||Prospective|||||||
1360416|NCT02809261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360417|NCT02809248|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1360418|NCT02809235||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360419|NCT02809222|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1360420|NCT02809196|Randomized|Factorial Assignment||||None (Open Label)||||||
1360421|NCT02809183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360422|NCT02809170|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1360423|NCT02809157|||Cohort||Prospective|||||||
1360424|NCT02809144||Single Group Assignment||Treatment||None (Open Label)||||||
1360425|NCT02809131|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360426|NCT02809118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360427|NCT02809105|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360428|NCT02809092||Single Group Assignment||Treatment||None (Open Label)||||||
1360429|NCT02809079||Single Group Assignment||Treatment||None (Open Label)||||||
1360430|NCT02809066|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360431|NCT02809053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360432|NCT02809040|||Cohort||Prospective|||||||
1360433|NCT02809027|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360434|NCT02809014|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1360435|NCT02809001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360436|NCT02808988|Non-Randomized|Parallel Assignment||Screening||Single|||||t|
1360437|NCT02808975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360438|NCT02808962||Single Group Assignment||Treatment||None (Open Label)||||||
1360439|NCT02808949||Single Group Assignment||Prevention||None (Open Label)||||||
1360440|NCT02808936|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1360441|NCT02808923|Randomized|Parallel Assignment||Treatment||Single|||||t|
1360442|NCT02808910|Non-Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1360443|NCT02808897|Randomized|Parallel Assignment||Prevention||Single|||t|||
1360444|NCT02808884|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||Blood test screening for all who wish to participant. Additional screening test for those who test positive twice.||||
1360445|NCT02808871|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360446|NCT02808858|||Case-Only||Prospective|||||||
1360447|NCT02808845|||Cohort||Prospective|||||||
1360448|NCT02808832|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360449|NCT02808819|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360450|NCT02808806|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1360451|NCT02808793||Single Group Assignment||Treatment||None (Open Label)||||||
1360452|NCT02808780|||Cohort||Prospective|||||||
1360453|NCT02808767|Randomized|Parallel Assignment||Treatment||Single||||||t
1360454|NCT02808754|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1360455|NCT02808741|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1360456|NCT02808728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360457|NCT02808715|||Case Control||Prospective|||||||
1360458|NCT02808702||Single Group Assignment||Treatment||None (Open Label)||||||
1360459|NCT02808689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360460|NCT02808676|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1360461|NCT02808663||Single Group Assignment||Other||None (Open Label)||||||
1360462|NCT02808650||Single Group Assignment||Treatment||None (Open Label)||||||
1360463|NCT02808637|Randomized|||Prevention||Double|||t|||t
1360464|NCT02808624|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360465|NCT02808611|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1360466|NCT02808598|Randomized|Factorial Assignment||Health Services Research||Triple|||t||t|t
1360467|NCT02808585|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1360468|NCT02808572||Single Group Assignment||Supportive Care||None (Open Label)||||||
1360469|NCT02808559||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360470|NCT02808546|||Case Control||Retrospective|||||||
1360471|NCT02808533|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1360472|NCT02808520|||Cohort||Prospective|||||||
1360473|NCT02808507|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1360474|NCT02808494|||Case-Control||Prospective|||||||
1360475|NCT02808481|||Cohort||Retrospective|||||||
1360476|NCT02808468|Randomized|Parallel Assignment||Treatment||Single||||||t
1360477|NCT02808455|Randomized|Crossover Assignment||||None (Open Label)||||||
1360478|NCT02808442||Single Group Assignment||Treatment||None (Open Label)||||||
1360479|NCT02808429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360480|NCT02808416||Single Group Assignment||Treatment||None (Open Label)||||||
1360481|NCT02808403|||Cohort||Prospective|||||||
1360482|NCT02808390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360483|NCT02808377|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1360484|NCT02808364||Single Group Assignment||Treatment||None (Open Label)||||||
1360485|NCT02808351|Randomized|Parallel Assignment||Treatment||Single||||||t
1360486|NCT02808338||||||||||||
1360487|NCT02808325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360488|NCT02808312|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360489|NCT02808299|||Cohort||Prospective|||||||
1360490|NCT02808286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360491|NCT02808273|||Case-Control||Prospective|||||||
1360492|NCT02808260|||Cohort||Prospective|||||||
1360493|NCT02808247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360494|NCT02808234||Single Group Assignment||Treatment||None (Open Label)||||||
1360495|NCT02808221|||Cohort||Retrospective|||||||
1360496|NCT02808208|Randomized|Parallel Assignment||Treatment||Single|||||t|
1360497|NCT02808195|Randomized|Parallel Assignment||Treatment||Single||||||t
1360498|NCT02808182|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360499|NCT02808169|||Cohort||Prospective|||||||
1360500|NCT02808156|Randomized|Parallel Assignment||Treatment||Single||||||t
1360501|NCT02808143||Single Group Assignment||Treatment||None (Open Label)||||||
1360502|NCT02808130|||Case Control||Prospective|||||||
1360503|NCT02808117|||Case Control||Retrospective|||||||
1360504|NCT02808104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360505|NCT02808091|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360506|NCT02808078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360507|NCT02808065|||Cohort||Prospective|||||||
1360508|NCT02808052||Single Group Assignment||Treatment||None (Open Label)||||||
1360509|NCT02808039|||Cohort||Prospective|||||||
1360510|NCT02808026||Single Group Assignment||Treatment||None (Open Label)||||||
1360511|NCT02808013|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360512|NCT02808000|Randomized|Crossover Assignment||Prevention||Single||||||t
1360513|NCT02807987||Single Group Assignment||Treatment||None (Open Label)||||||
1360514|NCT02807974||Single Group Assignment||Treatment||None (Open Label)||||||
1360515|NCT02807961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360516|NCT02807948||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360517|NCT02807935||Single Group Assignment||Basic Science||None (Open Label)||||||
1360518|NCT02807922|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360519|NCT02807909|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1360520|NCT02807896|||Cohort||Retrospective|||||||
1360521|NCT02807883||Single Group Assignment||Treatment||None (Open Label)||||||
1360522|NCT02807870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360523|NCT02807857|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1360524|NCT02807844|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360525|NCT02807831|Randomized|Parallel Assignment||Treatment||Single||||||t
1360526|NCT02807818|Randomized|Parallel Assignment||Prevention||Single||||||t
1360527|NCT02807805||Single Group Assignment||Treatment||None (Open Label)||||||
1360528|NCT02807792||Single Group Assignment||Basic Science||None (Open Label)||||||
1360529|NCT02807779|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360530|NCT02807766|Randomized|Factorial Assignment||Basic Science||Triple|||t|t|t|
1360531|NCT02807753|||Cohort||Prospective|||||||
1360532|NCT02807740|Randomized|Parallel Assignment||Treatment||Single||||||t
1360533|NCT02807727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360534|NCT02807714|||Case-Only||Prospective|||||||
1360535|NCT02807701|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1360536|NCT02807688|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360537|NCT02807675|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1360538|NCT02807662|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1360539|NCT02807649|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1360540|NCT02807636|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360541|NCT02807623|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1360542|NCT02807610|Randomized|Parallel Assignment||Screening||Double|||||t|t
1360543|NCT02807597|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1360544|NCT02807584||Single Group Assignment||Treatment||None (Open Label)||||||
1360545|NCT02807571|||Cohort||Other|||||||
1360546|NCT02807558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360547|NCT02807545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360548|NCT02807532|||Case Control||Retrospective|||||||
1360549|NCT02807519|||Case-Control||Prospective|||||||
1360550|NCT02807506||Single Group Assignment||Supportive Care||None (Open Label)||||||
1360551|NCT02807493|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360552|NCT02807480|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360553|NCT02807467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360554|NCT02807454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360555|NCT02807441|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360556|NCT02807428|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360557|NCT02807415|||Case-Only||Prospective|||||||
1360558|NCT02807402|||Cohort||Prospective|||||||
1360559|NCT02807389||Single Group Assignment||Treatment||None (Open Label)||||||
1360560|NCT02807376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360561|NCT02807363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360562|NCT02807350|Randomized|Parallel Assignment||Treatment||Single||||||t
1360563|NCT02807337|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1360564|NCT02807324|||Cohort||Prospective|||||||
1360565|NCT02807311|||Cohort||Retrospective|||||||
1360566|NCT02807298|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1360567|NCT02807285||||||||||||
1360568|NCT02807272||Single Group Assignment||Treatment||None (Open Label)||||||
1360569|NCT02807259|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1360570|NCT02807246|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360571|NCT02807233|||Cohort||Cross-Sectional|||||||
1360572|NCT02807220||Single Group Assignment||Prevention||None (Open Label)||||||
1360573|NCT02807207|Randomized|Crossover Assignment||||Triple|||t|t|t|
1360574|NCT02807194|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360575|NCT02807181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360576|NCT02807168|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360577|NCT02807155|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1360578|NCT02807142||Single Group Assignment||Treatment||None (Open Label)||||||
1360579|NCT02807129||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360580|NCT02807116||Single Group Assignment||||None (Open Label)||||||
1360581|NCT02807103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360582|NCT02807090|Randomized|Parallel Assignment||Treatment||Single|||||t|
1360583|NCT02807077|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360584|NCT02807064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360585|NCT02807051||Single Group Assignment||||None (Open Label)||||||
1360586|NCT02807038||Single Group Assignment||Health Services Research||None (Open Label)||||||
1360587|NCT02807025|||Case-Control||Cross-Sectional|||||||
1360588|NCT02807012|Randomized|Parallel Assignment||Other||Single||||||t
1360589|NCT02806999|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1360590|NCT02806986||Single Group Assignment||Treatment||None (Open Label)||||||
1360591|NCT02806973|Randomized|Crossover Assignment||Basic Science||Single||||||t
1360592|NCT02806960|Randomized|Crossover Assignment||Basic Science||Single||||||t
1360593|NCT02806947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360594|NCT02806934|||Case-Only||Prospective|||||||
1360595|NCT02806921|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1360596|NCT02806908|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1360597|NCT02806895|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1360598|NCT02806882||Single Group Assignment||Treatment||None (Open Label)||||||
1360599|NCT02806869|Randomized|Parallel Assignment||Basic Science||None (Open Label)||"This is a parallel study design that allocated subjects into a fasted or fed group. Subject were asked to complete the same study procedures on two occasions.~Subjects assigned to the fasted or fed group were not crossed-over from one group to the other."||||
1360600|NCT02806856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360601|NCT02806843||Single Group Assignment||Other||None (Open Label)||||||
1360602|NCT02806830||Single Group Assignment||Supportive Care||None (Open Label)||||||
1360603|NCT02806817|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360604|NCT02806804|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1360605|NCT02806791|||Cohort||Retrospective|||||||
1360606|NCT02806778|||Other||Prospective|||||||
1360607|NCT02806765|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1360608|NCT02806752|Randomized|Parallel Assignment||Treatment||Single||||||t
1360609|NCT02806739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360610|NCT02806726||||||||||||
1360611|NCT02806713|Randomized|Parallel Assignment||Treatment||Single||||||t
1360612|NCT02806700|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1360613|NCT02806687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360614|NCT02806674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360615|NCT02806661|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360616|NCT02806648||Single Group Assignment||Treatment||None (Open Label)||||||
1360617|NCT02806635|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360618|NCT02806622|||Cohort||Cross-Sectional|||||||
1360619|NCT02806609|Randomized|Parallel Assignment||Treatment||Single|||||t|
1360620|NCT02806596||Single Group Assignment||||None (Open Label)||||||
1360621|NCT02806583|Randomized|Parallel Assignment||Treatment||Single||||||t
1360622|NCT02806570||Single Group Assignment||Treatment||None (Open Label)||||||
1360623|NCT02806557|||Cohort||Prospective|||||||
1360624|NCT02806544||Single Group Assignment||Treatment||None (Open Label)||||||
1360625|NCT02806531||Single Group Assignment||Prevention||None (Open Label)||||||
1360626|NCT02806518|||||Prospective|||||||
1360627|NCT02806505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360628|NCT02806492||Single Group Assignment||Basic Science||None (Open Label)||||||
1360629|NCT02806479|||Case-Control||Cross-Sectional|||||||
1360630|NCT02806466|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1360631|NCT02806453|Randomized|Crossover Assignment||Treatment||Single||||||t
1360632|NCT02806440|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1360633|NCT02806427|||Other||Prospective|||||||
1360634|NCT02806414||Single Group Assignment||Treatment||None (Open Label)||||||
1360635|NCT02806401|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1360636|NCT02806388|||Cohort||Retrospective|||||||
1360637|NCT02806375||Single Group Assignment||Treatment||None (Open Label)||||||
1360638|NCT02806362||Single Group Assignment||Treatment||None (Open Label)||||||
1360639|NCT02806349|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1360640|NCT02806336|Randomized|Parallel Assignment||Treatment||Single|Assessor blinded to group, statistical analyses blinded to group|Two group RCT||||t
1360641|NCT02806323||Single Group Assignment||Other||None (Open Label)||||||
1360642|NCT02806310|||Case-Only||Prospective|||||||
1360643|NCT02806297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360644|NCT02806284|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360645|NCT02806271|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360646|NCT02806258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360647|NCT02806245|Randomized|Parallel Assignment||Treatment||Single|||||t|
1360648|NCT02806232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360649|NCT02806219|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360650|NCT02806206|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1360651|NCT02806193|||||Retrospective|||||||
1360652|NCT02806180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360653|NCT02806167||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360654|NCT02806154|||Cohort||Prospective|||||||
1360655|NCT02806141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360656|NCT02806128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360657|NCT02806115||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360658|NCT02806102|||Cohort||Prospective|||||||
1360659|NCT02806089||Single Group Assignment||Supportive Care||None (Open Label)||||||
1360660|NCT02806076|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360661|NCT02806063||Single Group Assignment||Health Services Research||None (Open Label)||||||
1360662|NCT02806050||Single Group Assignment||Treatment||None (Open Label)||||||
1360663|NCT02806037|||Cohort||Prospective|||||||
1360664|NCT02806024|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1360665|NCT02806011|||Other||Prospective|||||||
1360666|NCT02805998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360667|NCT02805985||Single Group Assignment||Treatment||None (Open Label)||||||
1360668|NCT02805972|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1360669|NCT02805959||||||||||||
1360670|NCT02805946|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360671|NCT02805933||||||||||||
1360672|NCT02805920|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1360673|NCT02805907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360674|NCT02805894|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360675|NCT02805881||Single Group Assignment||Treatment||None (Open Label)||||||
1360676|NCT02805868||Single Group Assignment||Treatment||None (Open Label)||||||
1360677|NCT02805855|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360678|NCT02805842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360679|NCT02805829||Single Group Assignment||Treatment||None (Open Label)||||||
1360680|NCT02805816|||Cohort||Prospective|||||||
1360681|NCT02805803||Single Group Assignment||Health Services Research||None (Open Label)||||||
1360682|NCT02805790|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1360683|NCT02805777||||||||||||
1360684|NCT02805764||Single Group Assignment||Treatment||None (Open Label)||||||
1360685|NCT02805751|Randomized|Parallel Assignment||Treatment||Single||||||t
1360686|NCT02805738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360687|NCT02805725|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1360688|NCT02805712|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360689|NCT02805699|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360690|NCT02805686||Single Group Assignment||Screening||None (Open Label)||||||
1360691|NCT02805673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360692|NCT02805660||Single Group Assignment||Treatment||None (Open Label)||||||
1360693|NCT02805647|||Case Control||Prospective|||||||
1360694|NCT02805634|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1360695|NCT02805621|||Cohort||Retrospective|||||||
1360769|NCT02804659|||Case-Control||Prospective|||||||
1360696|NCT02805608||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360697|NCT02805595|Non-Randomized|Single Group Assignment||Treatment||Double|||t||t|
1360698|NCT02805582|Randomized|Parallel Assignment||Other||Single|||t|||
1360699|NCT02805569|Randomized|Parallel Assignment||Prevention||Single|||t|||
1360700|NCT02805556||Single Group Assignment||Treatment||None (Open Label)||||||
1360701|NCT02805543|||Case Control||Retrospective|||||||
1360702|NCT02805530||Single Group Assignment||Treatment||None (Open Label)||"First line systemic treatment Epidermal growth factor receptor (EGFR)-mutated with tyrosine kinase inhibitors (afatinib, erlotinib or gefitinib). Patients without driver mutation duplet of chemotherapy based on platin taking account histologic subtype (Carboplatin or Cisplatin plus pemetrexed for adenocarcinomas, gemcitabine for epidermoid or paclitaxel for both) at discretion of the treating physician.~Radical treatment to the primary and to the metastases will be with surgery, radiotherapy, chemoradiotherapy, stereotactic radiosurgery or radiofrequency ablation.~Radiation: radiation therapy Patients will receive dose and fraction regimen according to the metastatic site.~Chemoradiotherapy Chemoradiotherapy with duplet based on platins (Carboplatin or cisplatin plus pemetrexed or paclitaxel or etoposide or vinorelbine) or monotherapy with carboplatin."||||
1360703|NCT02805517||Single Group Assignment||Treatment||None (Open Label)||||||
1360704|NCT02805504|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360705|NCT02805491|||Case-Control||Prospective|||||||
1360706|NCT02805478|||Cohort||Prospective|||||||
1360707|NCT02805465|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1360708|NCT02805452|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360709|NCT02805439|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360710|NCT02805426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360711|NCT02805413||Single Group Assignment||||None (Open Label)||||||
1360712|NCT02805400||Single Group Assignment||||None (Open Label)||||||
1360713|NCT02805387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360714|NCT02805374|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1360715|NCT02805361|||Cohort||Prospective|||||||
1360716|NCT02805348|||Cohort||Prospective|||||||
1360717|NCT02805335|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360718|NCT02805322|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1360719|NCT02805309|Randomized|Parallel Assignment||Prevention||Single||||||t
1360720|NCT02805296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360721|NCT02805283|||Cohort||Cross-Sectional|||||||
1360722|NCT02805270|Randomized|Parallel Assignment||Prevention||Single||||||t
1360723|NCT02805257|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1360724|NCT02805244||Single Group Assignment||Basic Science||None (Open Label)||||||
1360725|NCT02805231|||Case Control||Retrospective|||||||
1360726|NCT02805218||Single Group Assignment||Prevention||None (Open Label)||||||
1360727|NCT02805205||Single Group Assignment||Prevention||None (Open Label)||||||
1360728|NCT02805192||Single Group Assignment||Other||None (Open Label)||||||
1360729|NCT02805179||Single Group Assignment||Treatment||None (Open Label)||||||
1360730|NCT02805166||Single Group Assignment||Prevention||None (Open Label)||||||
1360731|NCT02805153|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360732|NCT02805140|Randomized|Parallel Assignment||Prevention||Single||||||t
1360733|NCT02805127|||Case-Only||Prospective|||||||
1360734|NCT02805114|||Case-Only||Prospective|||||||
1360735|NCT02805101|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360736|NCT02805088|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1360737|NCT02805075||Single Group Assignment||Supportive Care||None (Open Label)||||||
1360738|NCT02805062|||Cohort||Prospective|||||||
1360739|NCT02805049||Single Group Assignment||Treatment||None (Open Label)||||||
1360740|NCT02805036|||Case-Control||Prospective|||||||
1360741|NCT02805023|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360742|NCT02805010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360743|NCT02804997|||Case-Crossover||Prospective|||||||
1360744|NCT02804984|||Case-Only||Prospective|||||||
1360745|NCT02804971|||Other||Prospective|||||||
1360746|NCT02804958|||Cohort||Retrospective|||||||
1360747|NCT02804945||Single Group Assignment||Treatment||None (Open Label)||||||
1360748|NCT02804932|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1360749|NCT02804919||Single Group Assignment||Treatment||None (Open Label)||||||
1360750|NCT02804906|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1360751|NCT02804893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360752|NCT02804880|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1360753|NCT02804867|||Case-Control||Cross-Sectional|||||||
1360754|NCT02804854||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360755|NCT02804841|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1360756|NCT02804828||||Other||||||||
1360757|NCT02804815|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1360758|NCT02804802|||Cohort||Prospective|||||||
1360759|NCT02804789|||Cohort||Prospective|||||||
1360760|NCT02804776||Single Group Assignment||Treatment||None (Open Label)||||||
1360761|NCT02804763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360762|NCT02804750||Single Group Assignment||Treatment||None (Open Label)||||||
1360763|NCT02804737|||Cohort||Prospective|||||||
1360764|NCT02804724|||||Retrospective|||||||
1360765|NCT02804711|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1360766|NCT02804698|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360767|NCT02804685|Randomized|Parallel Assignment||Prevention||Single|||||t|
1360768|NCT02804672|||Cohort||Prospective|||||||
1360770|NCT02804646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360771|NCT02804633|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1360772|NCT02804620|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360773|NCT02804607|||Cohort||Retrospective|||||||
1360774|NCT02804594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360775|NCT02804581||Single Group Assignment||Treatment||None (Open Label)||||||
1360776|NCT02804568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360777|NCT02804555|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1360778|NCT02804542|||Cohort||Other|||||||
1360779|NCT02804529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360780|NCT02804516|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360781|NCT02804503|Randomized|Parallel Assignment||Prevention||Single|||t|||
1360782|NCT02804490|Randomized|Parallel Assignment||Prevention||Single||||||t
1360783|NCT02804477|||Case-Only||Cross-Sectional|||||||
1360784|NCT02804464|||Case-Only||Prospective|||||||
1360785|NCT02804451|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1360786|NCT02804438|||Other||Prospective|||||||
1360787|NCT02804425|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1360788|NCT02804412|Randomized|Parallel Assignment||Treatment||Single||||||t
1360789|NCT02804399||Crossover Assignment||||None (Open Label)||||||
1360790|NCT02804386||Single Group Assignment||Treatment||None (Open Label)||||||
1360791|NCT02804373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360792|NCT02804360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1360793|NCT02804347|||Cohort||Prospective|||||||
1360794|NCT02804334|||Case-Control||Cross-Sectional|||||||
1360795|NCT02804321|||Cohort||Prospective|||||||
1360796|NCT02804308|Randomized|Factorial Assignment||Treatment||Single|||||t|
1360797|NCT02804295||Single Group Assignment||||None (Open Label)||||||
1360798|NCT02804282||Single Group Assignment||Treatment||None (Open Label)||||||
1360799|NCT02804269|||Cohort||Prospective|||||||
1360800|NCT02804256|||Case-Only||Prospective|||||||
1360801|NCT02804243|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360802|NCT02804230||Single Group Assignment||Treatment||None (Open Label)||||||
1360803|NCT02804217|||Cohort||Prospective|||||||
1360804|NCT02804204|||Case-Only||Prospective|||||||
1360805|NCT02804191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360806|NCT02804178||Single Group Assignment||Treatment||None (Open Label)||||||
1360807|NCT02804165||Single Group Assignment||Basic Science||None (Open Label)||||||
1360808|NCT02804152||Single Group Assignment||Treatment||None (Open Label)||||||
1360809|NCT02804139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360810|NCT02804126|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360811|NCT02804113||Single Group Assignment||Treatment||None (Open Label)||||||
1360812|NCT02804100|||Case-Only||Prospective|||||||
1360813|NCT02804087|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1360814|NCT02804074|Randomized|Parallel Assignment||Treatment||Single||||||t
1360815|NCT02804061|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360816|NCT02804048|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360817|NCT02804035||Single Group Assignment||Treatment||None (Open Label)||||||
1360818|NCT02804022||Single Group Assignment||Treatment||None (Open Label)||||||
1360819|NCT02804009|||Cohort||Prospective|||||||
1360820|NCT02803996|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1360821|NCT02803983|||Case-Control||Prospective|||||||
1360822|NCT02803970|||Cohort||Prospective|||||||
1360823|NCT02803957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360824|NCT02803944|||Cohort||Retrospective|||||||
1360825|NCT02803931|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1360826|NCT02803918|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360827|NCT02803905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360828|NCT02803892|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1360829|NCT02803879||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360830|NCT02803866|||Family-Based||Prospective|||||||
1360831|NCT02803853|Randomized|Factorial Assignment||Prevention||Single|||t|||
1360832|NCT02803840||Single Group Assignment||Treatment||None (Open Label)||||||
1360833|NCT02803827|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1360834|NCT02803814|Randomized|Parallel Assignment||Treatment||Single||||||t
1360835|NCT02803801||Single Group Assignment||Treatment||None (Open Label)||||||
1360836|NCT02803788|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360837|NCT02803775|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1360838|NCT02803762||Single Group Assignment||||None (Open Label)||||||
1360839|NCT02803749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360840|NCT02803736|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360841|NCT02803723|Randomized|Parallel Assignment||||None (Open Label)||||||
1360842|NCT02803710|||Case Control|||||||||
1360843|NCT02803697|||Cohort||Retrospective|||||||
1360844|NCT02803684||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360845|NCT02803671|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360846|NCT02803658|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360847|NCT02803645||Single Group Assignment||Basic Science||None (Open Label)||||||
1360848|NCT02803632||Single Group Assignment||Prevention||None (Open Label)||||||
1360849|NCT02803619|||Cohort||Prospective|||||||
1360850|NCT02803606|||Case-Only||Prospective|||||||
1360851|NCT02803593|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360852|NCT02803580|||Cohort||Prospective|||||||
1360853|NCT02803567|Randomized|Parallel Assignment||Prevention||Single|||t|||
1360854|NCT02803554||Single Group Assignment||Basic Science||None (Open Label)||||||
1360855|NCT02803541||Single Group Assignment||Supportive Care||None (Open Label)||||||
1360856|NCT02803528|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360857|NCT02803515|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360858|NCT02803502||Single Group Assignment||Prevention||None (Open Label)||||||
1360859|NCT02803489||Single Group Assignment||Prevention||None (Open Label)||||||
1360860|NCT02803476|||Case Control||Prospective|||||||
1360861|NCT02803463|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1360862|NCT02803450|Randomized|Single Group Assignment||Treatment||Single|||t|||
1360863|NCT02803437|||Cohort||Prospective|||||||
1360864|NCT02803424|Randomized|Parallel Assignment||||Double|||t|||t
1360865|NCT02803411|||Cohort||Prospective|||||||
1360866|NCT02803398||Single Group Assignment||Basic Science||None (Open Label)||||||
1360867|NCT02803385|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1360868|NCT02803372|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360869|NCT02803359|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1360870|NCT02803346|||Cohort||Prospective|||||||
1360871|NCT02803333|||Cohort||Prospective|||||||
1360872|NCT02803320|Randomized|Single Group Assignment||Other||Single|||t|||
1360873|NCT02803307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360874|NCT02803294||Single Group Assignment||Treatment||None (Open Label)||||||
1360875|NCT02803281|||Cohort||Prospective|||||||
1360876|NCT02803268|Randomized|Parallel Assignment||Other||Double|||t||t|
1360877|NCT02803255|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1360878|NCT02803242|||Cohort|||||||||
1360879|NCT02803229|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1360880|NCT02803216|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360881|NCT02803203||Single Group Assignment||Treatment||None (Open Label)||||||
1360882|NCT02803190|Randomized|Parallel Assignment||Prevention||Single||||||t
1360883|NCT02803177|Randomized|Parallel Assignment||Treatment||Single||||||t
1360884|NCT02803164||Single Group Assignment||Treatment||None (Open Label)||||||
1360885|NCT02803151||Single Group Assignment||Treatment||None (Open Label)||||||
1360886|NCT02803138|||Cohort||Prospective|||||||
1360887|NCT02803125|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360888|NCT02803112|||Case-Only||Retrospective|||||||
1360889|NCT02803099||Single Group Assignment||Treatment||None (Open Label)||||||
1360890|NCT02803086|||Cohort||Prospective|||||||
1360891|NCT02803073|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360892|NCT02803060||Single Group Assignment||Treatment||None (Open Label)||||||
1360893|NCT02803047||Single Group Assignment||Treatment||None (Open Label)||||||
1360894|NCT02803034||Single Group Assignment||Treatment||None (Open Label)||||||
1360895|NCT02803021||Single Group Assignment||Treatment||None (Open Label)||||||
1360896|NCT02803008||Single Group Assignment||Treatment||None (Open Label)||||||
1360897|NCT02802995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360898|NCT02802982|||Case-Only||Prospective|||||||
1360899|NCT02802969||Single Group Assignment||Treatment||None (Open Label)||||||
1360900|NCT02802956|Randomized|Parallel Assignment||Treatment||Single||||||t
1360901|NCT02802943|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"MRD-negative (MRD-) patients (flow cytometry based, CLL cells in peripheral blood and bone marrow <10-4 6-10 weeks after the end of first line treatment).~MRD-positive (MRD+) patients (flow cytometry based, CLL cells in peripheral blood or bone marrow ≥ 10-4 6-10 weeks after the end of first line treatment)"||||
1360902|NCT02802930||Single Group Assignment||Other||Single|||t|||
1360903|NCT02802917|Randomized|Parallel Assignment||Other||Single|||t|||
1360904|NCT02802904|Randomized|Crossover Assignment||||Single|||t|||
1360905|NCT02802891|||Case-Control||Prospective|||||||
1360906|NCT02802878|Randomized|Parallel Assignment||Treatment||Single||||||t
1360907|NCT02802865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360908|NCT02802852||Single Group Assignment||Treatment||None (Open Label)||||||
1360909|NCT02802839|Randomized|Parallel Assignment||||None (Open Label)||||||
1360910|NCT02802826|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1360911|NCT02802813|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360912|NCT02802800|Randomized|Parallel Assignment||Other||Single||||||t
1360913|NCT02802787||Single Group Assignment||Treatment||None (Open Label)||||||
1360914|NCT02802774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360915|NCT02802761|||Case-Only||Prospective|||||||
1360916|NCT02802748|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360917|NCT02802735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360918|NCT02802722|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1360919|NCT02802709|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1360920|NCT02802696|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360921|NCT02802683|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1360922|NCT02802670||Single Group Assignment||Basic Science||None (Open Label)||||||
1360923|NCT02802657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360924|NCT02802644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360925|NCT02802631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360926|NCT02802618|Randomized|Parallel Assignment||Treatment||Single||||t||
1360927|NCT02802605|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1360928|NCT02802592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360929|NCT02802579|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1360930|NCT02802566|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360931|NCT02802553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360932|NCT02802540|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360933|NCT02802527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360934|NCT02802514|Randomized|Crossover Assignment||Treatment||Single|||t|||
1360935|NCT02802501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360936|NCT02802488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360937|NCT02802475|||Cohort||Prospective|||||||
1360938|NCT02802462|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1360939|NCT02802449|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1360940|NCT02802436|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1360941|NCT02802423||Single Group Assignment||Treatment||None (Open Label)||||||
1360942|NCT02802410|Non-Randomized|Factorial Assignment||Treatment||Single||||||t
1360943|NCT02802397|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360944|NCT02802384|||Case-Control||Cross-Sectional|||||||
1360945|NCT02802371|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1360946|NCT02802358|||Cohort||Prospective|||||||
1360947|NCT02802345|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360948|NCT02802332|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1360949|NCT02802319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360950|NCT02802306||Single Group Assignment||Treatment||None (Open Label)||||||
1360951|NCT02802293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360952|NCT02802280||Single Group Assignment||||None (Open Label)||||||
1360953|NCT02802267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360954|NCT02802254|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1360955|NCT02802241|Randomized|Parallel Assignment||Treatment||||||||
1360956|NCT02802228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360957|NCT02802215|Randomized|Parallel Assignment||Prevention||Single|||t|||
1360958|NCT02802202|||||Prospective|||||||
1360959|NCT02802189|Randomized|Parallel Assignment||Treatment||Single||||||t
1360960|NCT02802176|Randomized|Parallel Assignment||Treatment||None (Open Label)||Arm 1: intra-vaginal culture using INVOcell device. Arm 2: Traditional IVF culture in an embryology laboratory||||
1360961|NCT02802163||Single Group Assignment||Treatment||None (Open Label)||||||
1360962|NCT02802150|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1360963|NCT02802137|Randomized|Crossover Assignment||Treatment||Single|||||t|
1360964|NCT02802124|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360965|NCT02802111|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1360966|NCT02802098||Single Group Assignment||Basic Science||None (Open Label)||||||
1360967|NCT02802085|||Cohort||Prospective|||||||
1360968|NCT02802072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1360969|NCT02802059|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1360970|NCT02802046|||Case Control||Retrospective|||||||
1360971|NCT02802033|||Case-Only||Prospective|||||||
1360972|NCT02802020||Single Group Assignment||Treatment||None (Open Label)||||||
1360973|NCT02802007||Single Group Assignment||Treatment||None (Open Label)||||||
1360974|NCT02801994||Single Group Assignment||Treatment||None (Open Label)||||||
1360975|NCT02801981|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1360976|NCT02801968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360977|NCT02801955|||Cohort||Prospective|||||||
1360978|NCT02801942|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1360979|NCT02801929||Single Group Assignment||Treatment||None (Open Label)||||||
1360980|NCT02801916||Single Group Assignment||Prevention||None (Open Label)||||||
1360981|NCT02801903||Single Group Assignment||Treatment||None (Open Label)||||||
1360982|NCT02801890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1360983|NCT02801877|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1360984|NCT02801864|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1360985|NCT02801851||Single Group Assignment||Screening||None (Open Label)||||||
1360986|NCT02801838||Single Group Assignment||Diagnostic||None (Open Label)||||||
1360987|NCT02801825|Randomized|Parallel Assignment||Treatment||Single|||t|||
1360988|NCT02801812|||Case-Control||Cross-Sectional|||||||
1360989|NCT02801799|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1360990|NCT02801786|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1360991|NCT02801773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1360992|NCT02801760|||Cohort||Retrospective|||||||
1360993|NCT02801747|Randomized|Factorial Assignment||Treatment||Single||||t||
1360994|NCT02801734|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1360995|NCT02801721|Randomized|Parallel Assignment||||None (Open Label)||||||
1360996|NCT02801708|||Case-Only||Prospective|||||||
1360997|NCT02801695|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1360998|NCT02801682|||Cohort||Prospective|||||||
1360999|NCT02801669|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1361000|NCT02801656|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361001|NCT02801643|||Cohort||Cross-Sectional|||||||
1361002|NCT02801630|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1361003|NCT02801617|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1361004|NCT02801604|||Case-Only||Prospective|||||||
1361005|NCT02801591|||Cohort||Prospective|||||||
1361006|NCT02801578||Single Group Assignment||Treatment||None (Open Label)||||||
1361007|NCT02801565||Single Group Assignment||Treatment||None (Open Label)||||||
1361008|NCT02801552|Randomized|Parallel Assignment||Treatment||Single||||||t
1361009|NCT02801539|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1361010|NCT02801526|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361011|NCT02801513|Randomized|Parallel Assignment||Basic Science||Single||||||t
1361012|NCT02801500|Randomized|Parallel Assignment||Treatment||Single||||||t
1361013|NCT02801487||Single Group Assignment||Treatment||None (Open Label)||||||
1361014|NCT02801474|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361015|NCT02801461|Randomized|Parallel Assignment||Treatment||Single|||||t|
1361016|NCT02801448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361017|NCT02801435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361018|NCT02801422|||Cohort||Prospective|||||||
1361019|NCT02801409|Randomized|Parallel Assignment||Prevention||Single||||||t
1361020|NCT02801396|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361021|NCT02801383|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361022|NCT02801370|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1361023|NCT02801357||Single Group Assignment||Treatment||None (Open Label)||||||
1361024|NCT02801344|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1361025|NCT02801331|Randomized|Parallel Assignment||Treatment||Single||||||t
1361026|NCT02801318||||||||||||
1361027|NCT02801305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361028|NCT02801292||Single Group Assignment||Treatment||None (Open Label)||||||
1361029|NCT02801279|Randomized|Parallel Assignment||Treatment||Single||||||t
1361030|NCT02801266|Randomized|Parallel Assignment||Prevention||Single|||t|||
1361031|NCT02801253|||Cohort||Prospective|||||||
1361032|NCT02801240||Single Group Assignment||Supportive Care||None (Open Label)||||||
1361033|NCT02801227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361034|NCT02801214|||Cohort||Cross-Sectional|||||||
1361035|NCT02801201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361036|NCT02801188|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1361037|NCT02801175|||Cohort||Prospective|||||||
1361038|NCT02801162|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361039|NCT02801149|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361040|NCT02801136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361041|NCT02801123|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361042|NCT02801110|||Cohort||Prospective|||||||
1361043|NCT02801097||Single Group Assignment||Treatment||None (Open Label)||||||
1361044|NCT02801084||Single Group Assignment||Other||None (Open Label)||||||
1361045|NCT02801071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361046|NCT02801058|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361047|NCT02801045||Single Group Assignment||Supportive Care||None (Open Label)||||||
1361048|NCT02801032|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1361049|NCT02801019|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1361050|NCT02801006|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361051|NCT02800980|||Cohort||Prospective|||||||
1361052|NCT02800967|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1361053|NCT02800954|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361054|NCT02800941|||Cohort||Prospective|||||||
1361055|NCT02800928|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1361056|NCT02800915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361057|NCT02800902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361058|NCT02800889||Single Group Assignment||Treatment||None (Open Label)||||||
1361059|NCT02800876|||Cohort||Retrospective|||||||
1361060|NCT02800863|||Cohort||Prospective|||||||
1361061|NCT02800850|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1361062|NCT02800837|||Case-Only||Prospective|||||||
1361063|NCT02800824|Randomized|Crossover Assignment||||None (Open Label)||||||
1361064|NCT02800811|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361065|NCT02800798|||||Cross-Sectional|||||||
1361066|NCT02800785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361067|NCT02800772|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1361068|NCT02800759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361069|NCT02800746|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361070|NCT02800733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361071|NCT02800720|Randomized|Parallel Assignment||Treatment||Single|||||t|
1361072|NCT02800707|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1361073|NCT02800694||Single Group Assignment||Treatment||None (Open Label)||||||
1361074|NCT02800681|||Case-Control||Cross-Sectional|||||||
1361075|NCT02800668|||Case-Only||Retrospective|||||||
1361076|NCT02800655||Single Group Assignment||Treatment||None (Open Label)||||||
1361077|NCT02800642||Single Group Assignment||Treatment||None (Open Label)||||||
1361078|NCT02800629|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, double blind clinical trial|t|t|t|t
1361079|NCT02800616|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1361080|NCT02800603|Randomized|Parallel Assignment||Prevention||Single||||||t
1361081|NCT02800590|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361082|NCT02800577||Single Group Assignment||Treatment||None (Open Label)||||||
1361083|NCT02800564|Randomized|Parallel Assignment||Prevention||Single|The study design and communities' status as active or passive are not discussed with the field staff.|||||t
1361084|NCT02800551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361085|NCT02800538|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1361086|NCT02800525|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361087|NCT02800512|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361088|NCT02800499|||Cohort||Prospective|||||||
1361089|NCT02800486||Single Group Assignment||Treatment||None (Open Label)||||||
1361090|NCT02800473||Single Group Assignment||Other||None (Open Label)||||||
1361091|NCT02800460||Single Group Assignment||Other||None (Open Label)||||||
1361092|NCT02800447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361093|NCT02800434||Single Group Assignment||Treatment||None (Open Label)||||||
1361094|NCT02800421|||Cohort|||||||||
1361095|NCT02800408|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1361096|NCT02800395||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361097|NCT02800382|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1361098|NCT02800369||Single Group Assignment||Treatment||None (Open Label)||||||
1361099|NCT02800356|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361100|NCT02800343|||Cohort||Prospective|||||||
1361101|NCT02800330|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361102|NCT02800317||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361103|NCT02800304|||Cohort||Prospective|||||||
1361104|NCT02800291|||||Prospective|||||||
1361105|NCT02800278|||Cohort||Prospective|||||||
1361106|NCT02800265||Single Group Assignment||Prevention||None (Open Label)||||||
1361107|NCT02800252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361108|NCT02800239||Single Group Assignment||Basic Science||None (Open Label)||||||
1361109|NCT02800226|Randomized|Parallel Assignment||Treatment||Single||||||t
1361110|NCT02800213|Randomized|Crossover Assignment||Treatment||Single||||||t
1361111|NCT02800200|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361112|NCT02800187|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361113|NCT02800174|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361114|NCT02800161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361115|NCT02800148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361116|NCT02800135||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361117|NCT02800122|||Cohort||Retrospective|||||||
1361118|NCT02800109|||Cohort||Prospective|||||||
1361119|NCT02800096|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1361120|NCT02800083|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361121|NCT02800070||Single Group Assignment||Treatment||None (Open Label)||||||
1361122|NCT02800057||||||||||||
1361123|NCT02800044||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361124|NCT02800031||Sequential Assignment||Diagnostic||None (Open Label)|"Level-II Transvaginal ultrasonography will be done by the principle investigator (who is unaware about the recognition pattern method) to confirm the presence of the ovarian mass and measure its size and to apply the IOTA simple rules on it (complimentary transabdominal ultrasound might be done for huge pelvi-abdominal masses originating from the ovary).~Level-III ultrasound will be done by expert ultrasound operator (who is blinded to the results of IOTA simple rules assessment of the examined mass) to classify the mass (either benign or malignant) using the pattern recognition method."|||||
1361125|NCT02800018|||Cohort||Retrospective|||||||
1361126|NCT02800005|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1361127|NCT02799992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361128|NCT02799979|||Case-Control||Prospective|||||||
1361129|NCT02799966|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361130|NCT02799953|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1361131|NCT02799940|||Cohort||Prospective|||||||
1361132|NCT02799927|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361133|NCT02799914|||Cohort||Prospective|||||||
1361134|NCT02799901||Single Group Assignment||Treatment||None (Open Label)||||||
1361135|NCT02799888||Single Group Assignment||Prevention||None (Open Label)||||||
1361136|NCT02799875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361137|NCT02799862|||Cohort||Prospective|||||||
1361138|NCT02799849|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361139|NCT02799836||Single Group Assignment||Treatment||None (Open Label)||||||
1361140|NCT02799823||Single Group Assignment||Treatment||None (Open Label)||||||
1361141|NCT02799810|||Cohort||Prospective|||||||
1361142|NCT02799797|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1361143|NCT02799784|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361144|NCT02799771|||Cohort||Prospective|||||||
1361145|NCT02799758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361146|NCT02799745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361147|NCT02799732|||Cohort||Prospective|||||||
1361148|NCT02799719|||Case-Crossover||Cross-Sectional|||||||
1361149|NCT02799706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361150|NCT02799693|||Cohort||Prospective|||||||
1361151|NCT02799680||Single Group Assignment||Treatment||None (Open Label)||||||
1361152|NCT02799667|Randomized|Parallel Assignment||Prevention||Single||||||t
1361153|NCT02799654|||Cohort||Prospective|||||||
1361154|NCT02799641|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1361155|NCT02799628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361156|NCT02799615|||Cohort||Prospective|||||||
1361157|NCT02799602|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361158|NCT02799589||Single Group Assignment||Treatment||None (Open Label)||||||
1361159|NCT02799576|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361160|NCT02799563|Randomized|Factorial Assignment||||None (Open Label)||||||
1361161|NCT02799550||Single Group Assignment||Treatment||None (Open Label)||||||
1361162|NCT02799537|Randomized|Single Group Assignment||||Double|||t||t|
1361163|NCT02799524|||Cohort||Prospective|||||||
1361164|NCT02799511||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361165|NCT02799498|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361166|NCT02799485||Single Group Assignment||Treatment||None (Open Label)||||||
1361167|NCT02799472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361168|NCT02799459|||Cohort||Prospective|||||||
1361169|NCT02799446|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361170|NCT02799433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361171|NCT02799420|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361172|NCT02799407|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361173|NCT02799394||Single Group Assignment||Treatment||None (Open Label)||||||
1361174|NCT02799381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361175|NCT02799368|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361176|NCT02799355|||||Retrospective|||||||
1361177|NCT02799342||||||||||||
1361178|NCT02799329||||||||||||
1361179|NCT02799316||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361180|NCT02799303|Randomized|Parallel Assignment||Screening||None (Open Label)||Intervention not a drug/biologic.||||
1361181|NCT02799290|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1361182|NCT02799277|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1361183|NCT02799264|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361184|NCT02799251|||Cohort||Prospective|||||||
1361185|NCT02799238|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|||||
1361186|NCT02799225|||Cohort||Prospective|||||||
1361187|NCT02799212|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1361188|NCT02799199|||Cohort||Retrospective|||||||
1361189|NCT02799186||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361190|NCT02799173||Single Group Assignment||Basic Science||None (Open Label)||||||
1361191|NCT02799160|||Cohort||Prospective|||||||
1361192|NCT02799147|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361193|NCT02799134|Randomized|Factorial Assignment||Basic Science||Triple|||t|t|t|
1361194|NCT02799121||Single Group Assignment||Treatment||None (Open Label)||||||
1361195|NCT02799108||Single Group Assignment||Basic Science||None (Open Label)||||||
1361196|NCT02799095|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361197|NCT02799082|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1361198|NCT02799069|Randomized|Parallel Assignment||Treatment||Single||||||t
1361199|NCT02799056|||Other||Prospective|||||||
1361200|NCT02799043|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361201|NCT02799030|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361202|NCT02799017|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1361203|NCT02799004|||Cohort||Prospective|||||||
1361204|NCT02798991|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361205|NCT02798978|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361206|NCT02798965|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361207|NCT02798952||Single Group Assignment||Prevention||None (Open Label)||||||
1361208|NCT02798939|||Cohort||Prospective|||||||
1361209|NCT02798926|||Case Control||Prospective|||||||
1361210|NCT02798913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361211|NCT02798900|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1361212|NCT02798887|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361213|NCT02798874|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1361214|NCT02798861||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361215|NCT02798848|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1361216|NCT02798835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361217|NCT02798822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361218|NCT02798809|||Cohort||Prospective|||||||
1361219|NCT02798796|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361220|NCT02798783|||Case-Only||Prospective|||||||
1361221|NCT02798770|||Cohort||Prospective|||||||
1361222|NCT02798757||Single Group Assignment||Treatment||None (Open Label)||||||
1361223|NCT02798744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361224|NCT02798731|||Cohort||Prospective|||||||
1361225|NCT02798718||Parallel Assignment||Prevention||None (Open Label)||||||
1361226|NCT02798705|||Cohort||Prospective|||||||
1361227|NCT02798692|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1361228|NCT02798679|||Cohort||Prospective|||||||
1361229|NCT02798666|Randomized|Parallel Assignment||Treatment||Single||||||t
1361230|NCT02798653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361231|NCT02798640|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1361232|NCT02798627|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361233|NCT02798614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361234|NCT02798601|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361235|NCT02798588||Single Group Assignment||Other||None (Open Label)||||||
1361236|NCT02798575|||Other||Prospective|||||||
1361237|NCT02798562||Single Group Assignment||Screening||None (Open Label)||||||
1361238|NCT02798549|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1361239|NCT02798536|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1361240|NCT02798523||Single Group Assignment||Basic Science||None (Open Label)||||||
1361241|NCT02798510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361242|NCT02798497|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361243|NCT02798484||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361244|NCT02798471|Randomized|Parallel Assignment||Treatment||Single||||||t
1361245|NCT02798458|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1361246|NCT02798445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361247|NCT02798432|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361248|NCT02798419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361249|NCT02798406||Single Group Assignment||Treatment||None (Open Label)||||||
1361250|NCT02798393|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361251|NCT02798380||Single Group Assignment||Treatment||None (Open Label)||||||
1361252|NCT02798367|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361253|NCT02798354|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1361254|NCT02798341|||Cohort||Prospective|||||||
1361255|NCT02798328|||Case-Only||Prospective|||||||
1361256|NCT02798315|||Cohort||Prospective|||||||
1361257|NCT02798302|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1361258|NCT02798289||Single Group Assignment||Supportive Care||None (Open Label)||||||
1361259|NCT02798276|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1361260|NCT02798263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361261|NCT02798250|Randomized|Crossover Assignment||Treatment||Single|||t|||
1361262|NCT02798237|Randomized|Parallel Assignment||Treatment||Single||||||t
1361263|NCT02798224|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1361264|NCT02798211|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361265|NCT02798198|||Case Control||Cross-Sectional|||||||
1361266|NCT02798185|||Cohort||Prospective|||||||
1361267|NCT02798172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361268|NCT02798159|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361269|NCT02798146||Single Group Assignment||Other||None (Open Label)||||||
1361270|NCT02798133|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361271|NCT02798120||Single Group Assignment||Treatment||None (Open Label)||||||
1361272|NCT02798107|||Other||Retrospective|||||||
1361273|NCT02798094|||Case-Control||Prospective|||||||
1361274|NCT02798081||Single Group Assignment||Prevention||None (Open Label)||||||
1361275|NCT02798068|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361276|NCT02798055|||Other||Prospective|||||||
1361277|NCT02798042|||Cohort||Prospective|||||||
1361278|NCT02798029||Single Group Assignment||Treatment||None (Open Label)||||||
1361279|NCT02798016|Randomized|Parallel Assignment||Treatment||Single||||||t
1361280|NCT02798003|||Cohort||Prospective|||||||
1361281|NCT02797990|||Cohort||Cross-Sectional|||||||
1361282|NCT02797977|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1361283|NCT02797964||Sequential Assignment||Treatment||None (Open Label)||||||
1361284|NCT02797951||Single Group Assignment||Treatment||None (Open Label)||||||
1361285|NCT02797938|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1361286|NCT02797925|||Case-Control||Prospective|||||||
1361287|NCT02797912|||Cohort||Cross-Sectional|||||||
1361288|NCT02797899|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1361289|NCT02797886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361290|NCT02797873|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1361291|NCT02797860|||Case-Control||Prospective|||||||
1361292|NCT02797847|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361293|NCT02797834|||Case-Only||Prospective|||||||
1361294|NCT02797821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361295|NCT02797808|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361296|NCT02797795||Single Group Assignment||Treatment||None (Open Label)||||||
1361297|NCT02797782|||Case-Only||Cross-Sectional|||||||
1361298|NCT02797769|||Cohort||Retrospective|||||||
1361299|NCT02797756|||Case-Control||Prospective|||||||
1361300|NCT02797743|||Family-Based||Prospective|||||||
1361301|NCT02797730|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361302|NCT02797717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361303|NCT02797704||Single Group Assignment||Treatment||None (Open Label)||||||
1361304|NCT02797691|Randomized|Parallel Assignment||Treatment||Single||||||t
1361305|NCT02797678||||||||||||
1361306|NCT02797665|Randomized|Parallel Assignment||Treatment||Single||||||t
1361307|NCT02797652|||Cohort||Prospective|||||||
1361308|NCT02797639|Randomized|Parallel Assignment||||None (Open Label)||||||
1361309|NCT02797626||Single Group Assignment||Treatment||None (Open Label)||||||
1361310|NCT02797613|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1361311|NCT02797600|||Case Control||Prospective|||||||
1361312|NCT02797587|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361313|NCT02797574|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361314|NCT02797561|||Cohort||Prospective|||||||
1361315|NCT02797548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361316|NCT02797535||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361317|NCT02797522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361318|NCT02797509|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1361319|NCT02797496|Randomized|Parallel Assignment||Treatment||Single|||||t|
1361320|NCT02797483|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1361321|NCT02797470||Single Group Assignment||Treatment||None (Open Label)||||||
1361322|NCT02797457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361323|NCT02797444|||Cohort||Prospective|||||||
1361324|NCT02797431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361325|NCT02797418|Randomized|Parallel Assignment||Treatment||Single||||||t
1361326|NCT02797405||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361327|NCT02797392||Single Group Assignment||Prevention||None (Open Label)||||||
1361328|NCT02797379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361329|NCT02797366||Single Group Assignment||Treatment||None (Open Label)||||||
1361330|NCT02797353|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1361331|NCT02797340||Single Group Assignment||Other||None (Open Label)||||||
1361332|NCT02797327|||Cohort||Prospective|||||||
1361333|NCT02797314|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361334|NCT02797301|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1361335|NCT02797288|||Case-Only||Prospective|||||||
1361336|NCT02797275|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1361337|NCT02797262|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361338|NCT02797249|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361339|NCT02797236|Randomized|Parallel Assignment||Prevention||Single|||t|||
1361340|NCT02797223|||Case-Only||Cross-Sectional|||||||
1361341|NCT02797210|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1361342|NCT02797197||Single Group Assignment||Other||None (Open Label)||||||
1361343|NCT02797184||Single Group Assignment||Treatment||None (Open Label)|Both the participant and the investigator will be masked to which KNO3 dose is administered at each visit. However, it is known at the outset that each patient will receive 10 mmol KNO3 during one visit and 20 mmol KNO3 at another visit, with the order randomly assigned.|Subjects will receive one drug dose on the first dose visit and the second drug dose on the second dose visit. The order of the two drug doses (10 and 20 mmol KNO3) will be randomized, so that some subjects will receive the lower dose first and others will receive the higher dose first||||
1361344|NCT02797171|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361345|NCT02797158||Single Group Assignment||Treatment||None (Open Label)||||||
1361346|NCT02797145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361347|NCT02797132||Single Group Assignment||Treatment||None (Open Label)||||||
1361348|NCT02797119|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1361349|NCT02797106|||||Cross-Sectional|||||||
1361350|NCT02797093|||Ecologic or Community||Prospective|||||||
1361351|NCT02797080||Single Group Assignment||Treatment||None (Open Label)||||||
1361352|NCT02797067|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1361353|NCT02797054|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1361354|NCT02797041|||Case-Only||Retrospective|||||||
1361355|NCT02797028|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1361356|NCT02797015|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361357|NCT02797002|||Case-Control||Cross-Sectional|||||||
1361358|NCT02796989|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1361359|NCT02796976|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1361360|NCT02796963|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1361361|NCT02796950|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1361362|NCT02796937||Single Group Assignment||Treatment||None (Open Label)||||||
1361363|NCT02796924||Single Group Assignment||Treatment||None (Open Label)||||||
1361364|NCT02796911|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361365|NCT02796898||Single Group Assignment||Treatment||None (Open Label)||||||
1361366|NCT02796885|||Case-Control||Cross-Sectional|||||||
1361367|NCT02796872|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1361368|NCT02796859|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361369|NCT02796846|||Cohort||Prospective|||||||
1361370|NCT02796833|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1361371|NCT02796820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361372|NCT02796807||Single Group Assignment||Basic Science||None (Open Label)||||||
1361373|NCT02796794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361374|NCT02796781||Single Group Assignment||Treatment||None (Open Label)||||||
1361375|NCT02796768|||Cohort||Prospective|||||||
1361376|NCT02796755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361377|NCT02796742|||Cohort||Prospective|||||||
1361378|NCT02796729||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361379|NCT02796716|||Other||Prospective|||||||
1361380|NCT02796703|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1361381|NCT02796690|||Cohort||Cross-Sectional|||||||
1361382|NCT02796677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361383|NCT02796664|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1361384|NCT02796651|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1361385|NCT02796638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361386|NCT02796625||Single Group Assignment||Basic Science||None (Open Label)||||||
1361387|NCT02796612|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361388|NCT02796599|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361389|NCT02796586|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1361390|NCT02796573|Randomized|Parallel Assignment||Treatment||Single|||||t|
1361391|NCT02796560|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361392|NCT02796547|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361393|NCT02796534|||Case-Only||Prospective|||||||
1361394|NCT02796521|Randomized|Crossover Assignment||Other||Single||||||t
1361395|NCT02796508|Randomized|Parallel Assignment||Prevention||Single|||t|||
1361396|NCT02796495||Single Group Assignment||Treatment||None (Open Label)||||||
1361397|NCT02796482||Single Group Assignment||||None (Open Label)||||||
1361398|NCT02796469||||||||||||
1361399|NCT02796456|||Case-Control||Prospective|||||||
1361400|NCT02796443|||Cohort||Retrospective|||||||
1361401|NCT02796430|||Cohort||Prospective|||||||
1361402|NCT02796417|Randomized|Parallel Assignment||Treatment||Single||||||t
1361403|NCT02796404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361404|NCT02796391|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1361405|NCT02796378|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1361406|NCT02796365|Randomized|Parallel Assignment||Prevention||Single||||||t
1361407|NCT02796352||Single Group Assignment||Treatment||None (Open Label)||||||
1361408|NCT02796339|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1361409|NCT02796326||Single Group Assignment||Treatment||None (Open Label)||||||
1361410|NCT02796313|Randomized|Parallel Assignment||Treatment||Single||||||t
1361411|NCT02796300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361412|NCT02796287||Single Group Assignment||Basic Science||None (Open Label)||||||
1361413|NCT02796274|||Case-Only||Retrospective|||||||
1361414|NCT02796261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361415|NCT02796248|||Cohort||Cross-Sectional|||||||
1361416|NCT02796235||Single Group Assignment||||None (Open Label)||||||
1361417|NCT02796222|||Cohort||Prospective|||||||
1361418|NCT02796209|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1361419|NCT02796196|||Cohort||Prospective|||||||
1361420|NCT02796183||Single Group Assignment||Treatment||None (Open Label)||||||
1361421|NCT02796170|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1361422|NCT02796157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361423|NCT02796144|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361424|NCT02796131|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1361425|NCT02796118|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1361426|NCT02796105|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361427|NCT02796092|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361428|NCT02796079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361429|NCT02796066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361430|NCT02796053|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361431|NCT02796040|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1361432|NCT02796027|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1361433|NCT02796014|||Case-Only||Prospective|||||||
1361434|NCT02796001|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1361435|NCT02795988|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label study|||||
1361436|NCT02795975|||Cohort||Cross-Sectional|||||||
1361437|NCT02795962|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1361438|NCT02795949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361439|NCT02795936|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361440|NCT02795910|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1361441|NCT02795897|||Cohort||Prospective|||||||
1361442|NCT02795884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361443|NCT02795871|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361444|NCT02795858||Single Group Assignment||Treatment||None (Open Label)||||||
1361445|NCT02795845|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361446|NCT02795832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361447|NCT02795819||Single Group Assignment||Treatment||None (Open Label)||||||
1361448|NCT02795806|||Other||Retrospective|||||||
1361449|NCT02795793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361450|NCT02795780||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361451|NCT02795767|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361452|NCT02795754|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1361453|NCT02795741||Single Group Assignment||Treatment||None (Open Label)||||||
1361454|NCT02795728|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1361455|NCT02795715|Randomized|Crossover Assignment||Treatment||Single|||t|||
1361456|NCT02795702|Randomized|Crossover Assignment||Treatment||Single|||t|||
1361457|NCT02795689||||||||||||
1361458|NCT02795676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361459|NCT02795663|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361460|NCT02795650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361461|NCT02795637||Single Group Assignment||Treatment||None (Open Label)||||||
1361462|NCT02795624|||Cohort||Prospective|||||||
1361463|NCT02795611|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1361464|NCT02795598|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361465|NCT02795585|||Cohort||Prospective|||||||
1361466|NCT02795572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361467|NCT02795559|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1361468|NCT02795546|Randomized|Parallel Assignment||Treatment||Single||||||t
1361469|NCT02795533|||Cohort||Retrospective|||||||
1361470|NCT02795520||Single Group Assignment||Treatment||None (Open Label)||||||
1361471|NCT02795507|Randomized|Parallel Assignment||Treatment||Single||||||t
1361472|NCT02795494|||Cohort||Prospective|||||||
1361473|NCT02795481|||Case-Control||Prospective|||||||
1361474|NCT02795468|Randomized|Parallel Assignment||Other||Single|||t|||
1361475|NCT02795455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361476|NCT02795442|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1361477|NCT02795429|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361478|NCT02795416||Single Group Assignment||Treatment||None (Open Label)||||||
1361479|NCT02795403|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1361480|NCT02795390|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361481|NCT02795377|||Cohort||Prospective|||||||
1361482|NCT02795364|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1361483|NCT02795351|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1361484|NCT02795338|||Cohort||Prospective|||||||
1361485|NCT02795325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361486|NCT02795312||Single Group Assignment||Health Services Research||None (Open Label)||||||
1361487|NCT02795299|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361488|NCT02795286|Randomized|Crossover Assignment||Treatment||Single|||t|||
1361489|NCT02795273|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361490|NCT02795260|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1361491|NCT02795247|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361492|NCT02795234|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361493|NCT02795221|||||Prospective|||||||
1361494|NCT02795208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361495|NCT02795195||Single Group Assignment||Treatment||None (Open Label)||||||
1361496|NCT02795182||Single Group Assignment||Treatment||None (Open Label)||||||
1361497|NCT02795156|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361498|NCT02795143|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361499|NCT02795130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361500|NCT02795117|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361501|NCT02795104|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1361502|NCT02795091|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1361503|NCT02795078|||Cohort||Prospective|||||||
1361504|NCT02795065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361505|NCT02795052|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361506|NCT02795039|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361507|NCT02795026|Randomized|Parallel Assignment||Treatment||None (Open Label)|It is difficult to mask the participants or care provider due to the nature of the therapy. The outcome questionnaires are filled in individually by the participants only.|||||
1361508|NCT02795013|||Case-Control||Prospective|||||||
1361509|NCT02795000|||Case-Control||Cross-Sectional|||||||
1361510|NCT02794987|||Case-Crossover||Prospective|||||||
1361511|NCT02794974|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361512|NCT02794961||Single Group Assignment||Treatment||None (Open Label)||||||
1361513|NCT02794948|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361514|NCT02794935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361515|NCT02794922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361516|NCT02794909|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361517|NCT02794896|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361518|NCT02794883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361519|NCT02794870|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1361520|NCT02794857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361521|NCT02794844||Single Group Assignment||Treatment||None (Open Label)||||||
1361522|NCT02794831|||Case Control||Prospective|||||||
1361523|NCT02794818|||Ecologic or Community||Prospective|||||||
1361524|NCT02794805|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1361525|NCT02794792|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361526|NCT02794779|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1361527|NCT02794766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361528|NCT02794753|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361529|NCT02794740|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361530|NCT02794727|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361531|NCT02794714|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361532|NCT02794701|||Other||Cross-Sectional|||||||
1361533|NCT02794688|||Cohort||Prospective|||||||
1361534|NCT02794675||Single Group Assignment||Treatment||None (Open Label)||||||
1361535|NCT02794662|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361536|NCT02794649|||Case-Control||Cross-Sectional|||||||
1361537|NCT02794636|||Cohort||Retrospective|||||||
1361538|NCT02794623||Single Group Assignment||Treatment||None (Open Label)||||||
1361539|NCT02794610||Single Group Assignment||Treatment||None (Open Label)||||||
1361540|NCT02794597|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361541|NCT02794584|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1361542|NCT02794571|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361543|NCT02794558||Single Group Assignment||Treatment||||||||
1361544|NCT02794545||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361545|NCT02794532|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361546|NCT02794519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361547|NCT02794506|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361548|NCT02794493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361549|NCT02794480|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361550|NCT02794467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361551|NCT02794454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361552|NCT02794441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361553|NCT02794428|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1361554|NCT02794415||Single Group Assignment||Other||None (Open Label)||||||
1361555|NCT02794402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361556|NCT02794389|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1361557|NCT02794376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361558|NCT02794363||Single Group Assignment||Treatment||None (Open Label)||||||
1361559|NCT02794350|||Cohort||Prospective|||||||
1361560|NCT02794337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361561|NCT02794324|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361562|NCT02794311||Single Group Assignment||Health Services Research||None (Open Label)||||||
1361563|NCT02794298|Randomized|Crossover Assignment||Treatment||Single|||t|||
1361564|NCT02794285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361565|NCT02794272|Randomized|Crossover Assignment||Treatment||Single|||t|||
1361566|NCT02794259|Randomized|Crossover Assignment||Treatment||Single|||t|||
1361567|NCT02794246||Single Group Assignment||Treatment||None (Open Label)||||||
1361568|NCT02794233||Single Group Assignment||Other||None (Open Label)||||||
1361569|NCT02794220|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1361570|NCT02794207|||Cohort||Prospective|||||||
1361571|NCT02794194|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1361572|NCT02794181|||Cohort||Prospective|||||||
1361573|NCT02794168|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361574|NCT02794155|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361575|NCT02794142||Single Group Assignment||Basic Science||None (Open Label)||||||
1361576|NCT02794129|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1361577|NCT02794116|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1361578|NCT02794103||Single Group Assignment||Treatment||None (Open Label)||||||
1361579|NCT02794090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361580|NCT02794077||Single Group Assignment||Treatment||None (Open Label)||||||
1361581|NCT02794064||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361582|NCT02794051||Single Group Assignment||Treatment||None (Open Label)||||||
1361583|NCT02794038|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1361584|NCT02794025|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361585|NCT02794012|||Case-Control||Cross-Sectional|||||||
1361586|NCT02793999|||Cohort||Prospective|||||||
1361587|NCT02793986|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1361588|NCT02793973|Randomized|Parallel Assignment||Treatment||Single|||||t|
1361589|NCT02793960||Single Group Assignment||Treatment||None (Open Label)||||||
1361590|NCT02793947|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1361591|NCT02793934|||Cohort||Cross-Sectional|||||||
1361592|NCT02793921|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1361593|NCT02793908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361594|NCT02793895|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361595|NCT02793882|||Case-Only||Prospective|||||||
1361596|NCT02793869|||Cohort||Prospective|||||||
1361597|NCT02793856|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361598|NCT02793843|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1361599|NCT02793830|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361600|NCT02793817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361601|NCT02793804|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361602|NCT02793791|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361603|NCT02793778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361604|NCT02793765||Single Group Assignment||Treatment||None (Open Label)||||||
1361605|NCT02793752|||Cohort||Prospective|||||||
1361606|NCT02793739||Single Group Assignment||Treatment||None (Open Label)||||||
1361607|NCT02793726|||Cohort||Retrospective|||||||
1361608|NCT02793713|||Cohort||Prospective|||||||
1361609|NCT02793700|||Other||Prospective|||||||
1361610|NCT02793687|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361611|NCT02793674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1361612|NCT02793661|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361613|NCT02793648|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1361614|NCT02793635||Single Group Assignment||Treatment||None (Open Label)||||||
1361615|NCT02793622|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1361616|NCT02793609|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1361617|NCT02793596||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361618|NCT02793583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361619|NCT02793570|||Cohort||Prospective|||||||
1361620|NCT02793557|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361621|NCT02793544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1361622|NCT02793531|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361623|NCT02793518||Parallel Assignment||||None (Open Label)||||||
1361624|NCT02793505|||Cohort||Prospective|||||||
1361625|NCT02793492||Single Group Assignment||Treatment||None (Open Label)||||||
1361626|NCT02793479|||Cohort||Prospective|||||||
1361627|NCT02793466||Single Group Assignment||Treatment||None (Open Label)||||||
1361628|NCT02793453|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1361629|NCT02793440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361630|NCT02793427|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361631|NCT02793414|||Cohort||Prospective|||||||
1361632|NCT02793401|Randomized|Parallel Assignment||Treatment||Single||||||t
1361633|NCT02793388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361634|NCT02793375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361635|NCT02793362|||Cohort||Prospective|||||||
1361636|NCT02793349||Single Group Assignment||Treatment||None (Open Label)||||||
1361637|NCT02793336|||Cohort||Prospective|||||||
1361638|NCT02793323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361639|NCT02793310|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361640|NCT02793297|Randomized|Crossover Assignment||||None (Open Label)||||||
1361641|NCT02793284||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361642|NCT02793271|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1361643|NCT02793258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361644|NCT02793245||Single Group Assignment||Other||None (Open Label)||||||
1361645|NCT02793232|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1361646|NCT02793219||Single Group Assignment||Treatment||None (Open Label)||||||
1361647|NCT02793206|||Cohort||Prospective|||||||
1361648|NCT02793193|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361649|NCT02793180|||Case-Only||Cross-Sectional|||||||
1361650|NCT02793167|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1361651|NCT02793154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361652|NCT02793141|||Cohort||Prospective|||||||
1361653|NCT02793128||Single Group Assignment||Treatment||None (Open Label)||||||
1361654|NCT02793115|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1361655|NCT02793102|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1361656|NCT02793089|||Cohort||Retrospective|||||||
1361657|NCT02793076||Single Group Assignment||Treatment||None (Open Label)||||||
1361658|NCT02793063|||Cohort||Prospective|||||||
1361659|NCT02793050|||Cohort||Retrospective|||||||
1361660|NCT02793037||Single Group Assignment||Treatment||None (Open Label)||||||
1361661|NCT02793024|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361662|NCT02793011|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361663|NCT02792998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361664|NCT02792985|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1361665|NCT02792972|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1361666|NCT02792959||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361667|NCT02792946|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361668|NCT02792933|Randomized|Parallel Assignment||||Double|||t||t|
1361669|NCT02792920||Single Group Assignment||Treatment||None (Open Label)||||||
1361670|NCT02792907|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361671|NCT02792894|Randomized|Parallel Assignment||Treatment||Single||||||t
1361672|NCT02792881||Single Group Assignment||Treatment||None (Open Label)||||||
1361673|NCT02792868|||Case-Only||Prospective|||||||
1361674|NCT02792855|Randomized|Factorial Assignment||Other||Double|||t|||t
1361675|NCT02792842|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1361676|NCT02792829|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361677|NCT02792816|||Cohort||Prospective|||||||
1361678|NCT02792803|Randomized|Crossover Assignment||Treatment||Single|||||t|
1361679|NCT02792790|||Cohort||Prospective|||||||
1361680|NCT02792777|||Other||Prospective|||||||
1361681|NCT02792764|||Cohort||Retrospective|||||||
1361682|NCT02792751|Randomized|Parallel Assignment||Other||Single||||||t
1361683|NCT02792738||Single Group Assignment||Basic Science||None (Open Label)||||||
1361684|NCT02792725||||||||||||
1361685|NCT02792712|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1361686|NCT02792699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361687|NCT02792686||Single Group Assignment||Treatment||None (Open Label)||||||
1361688|NCT02792673|Randomized|Parallel Assignment||||None (Open Label)||||||
1361689|NCT02792660||Single Group Assignment||Other||None (Open Label)||||||
1361690|NCT02792647|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361691|NCT02792634|||||Prospective|||||||
1361692|NCT02792621|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1361693|NCT02792608||Single Group Assignment||Treatment||None (Open Label)||||||
1361694|NCT02792595|Non-Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1361695|NCT02792582|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361696|NCT02792569|Randomized|Parallel Assignment||Treatment||Single|||||t|
1361697|NCT02792556|||Cohort||Prospective|||||||
1361698|NCT02792543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361699|NCT02792530||Single Group Assignment||Treatment||None (Open Label)||||||
1361700|NCT02792517||Single Group Assignment||Basic Science||None (Open Label)||||||
1361701|NCT02792504|||Cohort||Prospective|||||||
1361702|NCT02792491||Single Group Assignment||Treatment||None (Open Label)||||||
1361703|NCT02792478|||Other||Prospective|||||||
1361704|NCT02792465||Single Group Assignment||Treatment||None (Open Label)||||||
1361705|NCT02792452|||Cohort||Prospective|||||||
1361706|NCT02792439|||Ecologic or Community||Prospective|||||||
1361707|NCT02792426|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1361708|NCT02792413|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361709|NCT02792400|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1361710|NCT02792387|||Other||Retrospective|||||||
1361711|NCT02792374|||Case Control||Retrospective|||||||
1361712|NCT02792361|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361713|NCT02792348|||Cohort||Prospective|||||||
1361714|NCT02792335|||Cohort||Retrospective|||||||
1361715|NCT02792322||Single Group Assignment||Other||None (Open Label)||||||
1361716|NCT02792309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361717|NCT02792296|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361718|NCT02792283||Single Group Assignment||Screening||None (Open Label)||||||
1361719|NCT02792270|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361720|NCT02792257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361721|NCT02792244|||Cohort||Prospective|||||||
1361722|NCT02792231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361723|NCT02792218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361724|NCT02792205|||Cohort||Prospective|||||||
1361725|NCT02792192|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361726|NCT02792179|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1361727|NCT02792166|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361728|NCT02792153||Single Group Assignment||Treatment||None (Open Label)||||||
1361729|NCT02792140|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1361730|NCT02792127|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1361731|NCT02792114||Single Group Assignment||Treatment||None (Open Label)||||||
1361732|NCT02792088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361733|NCT02792075|||Cohort||Prospective|||||||
1361734|NCT02792062|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361735|NCT02792049|Randomized|Crossover Assignment||Treatment||Single|||||t|
1361736|NCT02792036||Single Group Assignment||Treatment||None (Open Label)||||||
1361737|NCT02792023|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361738|NCT02792010||Single Group Assignment||||None (Open Label)||||||
1361739|NCT02791997|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361740|NCT02791984||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361741|NCT02791971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361742|NCT02791958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361743|NCT02791945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361744|NCT02791932|Randomized|Parallel Assignment||Prevention||Single||||||t
1361745|NCT02791919||Single Group Assignment||Treatment||None (Open Label)||||||
1361746|NCT02791906|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361747|NCT02791893|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361748|NCT02791880|||Cohort||Prospective|||||||
1361749|NCT02791867|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1361750|NCT02791854|||Other||Prospective|||||||
1361751|NCT02791841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361752|NCT02791828|||Cohort||Prospective|||||||
1361753|NCT02791815|Randomized|Crossover Assignment||||None (Open Label)||||||
1361754|NCT02791802|||Cohort||Prospective|||||||
1361755|NCT02791789||Single Group Assignment||||None (Open Label)||||||
1361756|NCT02791776||Single Group Assignment||Other||None (Open Label)||||||
1361757|NCT02791763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361758|NCT02791750|||Cohort||Prospective|||||||
1361759|NCT02791737||Single Group Assignment||Supportive Care||None (Open Label)||||||
1361760|NCT02791724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361761|NCT02791711||Single Group Assignment||||None (Open Label)||||||
1361762|NCT02791698|||Cohort||Prospective|||||||
1361763|NCT02791685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361764|NCT02791672|||Cohort||Prospective|||||||
1361765|NCT02791659|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361766|NCT02791646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361767|NCT02791633|||Case-Only||Prospective|||||||
1361768|NCT02791620||Single Group Assignment||Treatment||None (Open Label)||||||
1361769|NCT02791607|||Cohort||Prospective|||||||
1361770|NCT02791594|||Cohort||Prospective|||||||
1361771|NCT02791581|||Cohort||Prospective|||||||
1361772|NCT02791568|||Case-Control||Prospective|||||||
1361773|NCT02791555|||Case-Control||Prospective|||||||
1361774|NCT02791542|||Case-Control||Cross-Sectional|||||||
1361775|NCT02791529|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361776|NCT02791516|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361777|NCT02791503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361778|NCT02791490|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361779|NCT02791477||Single Group Assignment||Treatment||None (Open Label)||||||
1361780|NCT02791464|Randomized|Crossover Assignment||Treatment||Single|||||t|
1361781|NCT02791451||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361782|NCT02791438|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1361783|NCT02791425||Single Group Assignment||Other||None (Open Label)||||||
1361784|NCT02791412|||Cohort||Retrospective|||||||
1361785|NCT02791399|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1361786|NCT02791386|||Cohort||Retrospective|||||||
1361787|NCT02791373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361788|NCT02791360||Single Group Assignment||Other||None (Open Label)||||||
1361789|NCT02791347|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361790|NCT02791334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361791|NCT02791321||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361792|NCT02791308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361793|NCT02791295|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361794|NCT02791282||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361795|NCT02791269|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361796|NCT02791256||Single Group Assignment||Treatment||None (Open Label)||||||
1361797|NCT02791243|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1361798|NCT02791230||Parallel Assignment||Treatment||None (Open Label)||||||
1361799|NCT02791217|||Cohort||Prospective|||||||
1361800|NCT02791204|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1361801|NCT02791191|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361802|NCT02791178|||Case-Only||Prospective|||||||
1361803|NCT02791165|||Case-Only||Prospective|||||||
1361804|NCT02791152|||Cohort||Prospective|||||||
1361805|NCT02791139|||Case Control||Prospective|||||||
1361806|NCT02791126|||Cohort||Prospective|||||||
1361807|NCT02791113|||Case-Only||Prospective|||||||
1361808|NCT02791100|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1361809|NCT02791087|||Case-Control||Cross-Sectional|||||||
1361810|NCT02791074|||Case-Control||Prospective|||||||
1361811|NCT02791061|||Case-Control||Prospective|||||||
1361812|NCT02791048|Randomized|Parallel Assignment||Treatment||Single|||||t|
1361813|NCT02791035||Single Group Assignment||Other||None (Open Label)||||||
1361814|NCT02791022|||Case-Only||Prospective|||||||
1361815|NCT02791009|||Case Control||Prospective|||||||
1361816|NCT02790996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361817|NCT02790983|||Case-Only||Prospective|||||||
1361818|NCT02790970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361819|NCT02790957|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361820|NCT02790944|||Cohort||Prospective|||||||
1361821|NCT02790931|Randomized|Parallel Assignment||Treatment||Single|||||t|
1361822|NCT02790918|||Case-Control||Prospective|||||||
1361823|NCT02790905|||Other||Cross-Sectional|||||||
1361824|NCT02790892||Single Group Assignment||Supportive Care||None (Open Label)||||||
1361825|NCT02790879|||Cohort||Prospective|||||||
1361826|NCT02790866|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1361827|NCT02790853||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361828|NCT02790840||Single Group Assignment||Treatment||None (Open Label)||||||
1361829|NCT02790827|Randomized|Parallel Assignment||Treatment||Single||||||t
1361830|NCT02790814|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1361831|NCT02790801|||Cohort||Prospective|||||||
1361832|NCT02790788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361833|NCT02790775|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1361834|NCT02790762||Single Group Assignment||Treatment||None (Open Label)||||||
1361835|NCT02790749|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361836|NCT02790736|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1361837|NCT02790723|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361838|NCT02790710|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1361839|NCT02790697|||Cohort||Prospective|||||||
1361840|NCT02790684||Single Group Assignment||Other||None (Open Label)||||||
1361841|NCT02790671||Single Group Assignment||Treatment||None (Open Label)||||||
1361842|NCT02790658||Single Group Assignment||||None (Open Label)||||||
1361843|NCT02790645|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1361844|NCT02790632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361845|NCT02790619|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1361846|NCT02790606||Single Group Assignment||Treatment||None (Open Label)||||||
1361847|NCT02790593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361848|NCT02790580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361849|NCT02790567|||||Prospective|||||||
1361850|NCT02790554|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1361851|NCT02790541|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1361852|NCT02790528|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361853|NCT02790515||Single Group Assignment||Treatment||None (Open Label)||||||
1361854|NCT02790502||Single Group Assignment||Other||None (Open Label)||||||
1361855|NCT02790489||Single Group Assignment||Treatment||None (Open Label)||||||
1361856|NCT02790476|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361857|NCT02790463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361858|NCT02790450||Single Group Assignment||Treatment||None (Open Label)||||||
1361859|NCT02790437||Single Group Assignment||Treatment||None (Open Label)||||||
1361860|NCT02790424||Single Group Assignment||Other||None (Open Label)||||||
1361861|NCT02790411||Single Group Assignment||Other||None (Open Label)||||||
1361862|NCT02790398|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361863|NCT02790385|Randomized|Parallel Assignment||Prevention||Single|||t|||
1361864|NCT02790372|Randomized|Parallel Assignment||Treatment||Single||||||t
1361865|NCT02790359|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1361866|NCT02790346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361867|NCT02790333|Randomized|Parallel Assignment||Prevention||Single|||t|||
1361868|NCT02790320|||||Retrospective|||||||
1361869|NCT02790307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361870|NCT02790294||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361871|NCT02790281|||Cohort||Prospective|||||||
1361872|NCT02790268|||Case-Only||Cross-Sectional|||||||
1361873|NCT02790255|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1361874|NCT02790242|||Cohort|||||||||
1361875|NCT02790229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361876|NCT02790216|||Case-Only||Prospective|||||||
1361877|NCT02790203|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1361878|NCT02790190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361879|NCT02790177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361880|NCT02790164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361881|NCT02790151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361882|NCT02790138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361883|NCT02790125|Randomized|Parallel Assignment||Screening||Double|||t||t|
1361884|NCT02790112|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1361885|NCT02790099|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1361886|NCT02790086|||Cohort||Prospective|||||||
1361887|NCT02790073||Single Group Assignment||Treatment||None (Open Label)||||||
1361888|NCT02790060|||Case-Only||Prospective|||||||
1361889|NCT02790047|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361890|NCT02790034|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361891|NCT02790021|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1361892|NCT02790008|||Cohort||Prospective|||||||
1361893|NCT02789995||Single Group Assignment||Basic Science||None (Open Label)||||||
1361894|NCT02789982|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361895|NCT02789969|Randomized|Parallel Assignment||Treatment||Single||||||t
1361896|NCT02789956|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361897|NCT02789943|||Cohort||Prospective|||||||
1361898|NCT02789930|||Case-Only||Prospective|||||||
1361899|NCT02789917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361900|NCT02789904|||Case-Only||Prospective|||||||
1361901|NCT02789891|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361902|NCT02789878|Randomized|Parallel Assignment||Treatment||Single||||||t
1361903|NCT02789865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361904|NCT02789852|Randomized|Parallel Assignment||Treatment||Single||||||t
1361905|NCT02789839||Single Group Assignment||Basic Science||None (Open Label)||||||
1361906|NCT02789826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361907|NCT02789813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361908|NCT02789800|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361909|NCT02789787|||Cohort||Prospective|||||||
1361910|NCT02789774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361911|NCT02789761|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1361912|NCT02789748|Randomized|Crossover Assignment||Treatment||Single|||t|||
1361913|NCT02789735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361914|NCT02789722|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1361915|NCT02789709|||Cohort||Prospective|||||||
1361916|NCT02789696||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361917|NCT02789683|Randomized|Crossover Assignment||||None (Open Label)||||||
1361918|NCT02789670|||Cohort||Prospective|||||||
1361919|NCT02789657|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1361920|NCT02789644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361921|NCT02789631|||Case-Control||Cross-Sectional|||||||
1361922|NCT02789618|Randomized|Parallel Assignment||Other||Double|||t|||t
1361923|NCT02789605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361924|NCT02789592|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1361925|NCT02789579|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1361926|NCT02789566||Single Group Assignment||||None (Open Label)||||||
1361927|NCT02789553|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1361928|NCT02789540|||Case-Only||Cross-Sectional|||||||
1361929|NCT02789527|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361930|NCT02789514|||Other||Cross-Sectional|||||||
1361931|NCT02789501|Randomized|Parallel Assignment||Prevention||Single|||t|||
1361932|NCT02789488||Single Group Assignment||Supportive Care||None (Open Label)||||||
1361933|NCT02789475|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361934|NCT02789462|||Case-Only||Other|||||||
1361935|NCT02789449|||Cohort||Prospective|||||||
1361936|NCT02789436|Randomized|Parallel Assignment||||Double|||t||t|
1361937|NCT02789423|Randomized|Parallel Assignment||Treatment||Single|||||t|
1361938|NCT02789410|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1361939|NCT02789397|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1361940|NCT02789384||Single Group Assignment||Other||None (Open Label)||||||
1361941|NCT02789371|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1361942|NCT02789358|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361943|NCT02789345|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361944|NCT02789332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361945|NCT02789319|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1361946|NCT02789306|||Case-Control||Cross-Sectional|||||||
1361947|NCT02789293||Single Group Assignment||Treatment||None (Open Label)||||||
1361948|NCT02789280|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361949|NCT02789267|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361950|NCT02789254||Single Group Assignment||Treatment||None (Open Label)||||||
1361951|NCT02789241|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1361952|NCT02789228||Single Group Assignment||Treatment||None (Open Label)||||||
1361953|NCT02789215|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1361954|NCT02789202|Randomized|Parallel Assignment||Treatment||Single||||||t
1361955|NCT02789189||Single Group Assignment||Treatment||None (Open Label)||||||
1361956|NCT02789176|||Cohort||Prospective|||||||
1361957|NCT02789163|||Case-Only||Prospective|||||||
1361958|NCT02789150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361959|NCT02789137|||Cohort||Prospective|||||||
1361960|NCT02789124||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361961|NCT02789111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361962|NCT02789098||Single Group Assignment||Other||None (Open Label)||||||
1361963|NCT02789085|Randomized|Parallel Assignment||Screening||Double|||t|||t
1361964|NCT02789072||Single Group Assignment||Basic Science||None (Open Label)||||||
1361965|NCT02789059||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361966|NCT02789046|||Cohort||Prospective|||||||
1361967|NCT02789033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361968|NCT02789020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361969|NCT02789007||Single Group Assignment||||None (Open Label)||||||
1361970|NCT02788994|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361971|NCT02788981|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1361972|NCT02788968|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1361973|NCT02788955|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361974|NCT02788942|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1361975|NCT02788929|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1361976|NCT02788916|||Cohort||Retrospective|||||||
1361977|NCT02788903|||Cohort||Other|||||||
1361978|NCT02788890|Non-Randomized|Crossover Assignment||Screening||Double|The care provider was not aware of study objectives. The outcomes assessor was not involved in the data collection.|||t||t
1361979|NCT02788877||Single Group Assignment||Treatment||None (Open Label)||||||
1361980|NCT02788864|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1361981|NCT02788851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361982|NCT02788838|||Cohort||Other|||||||
1361983|NCT02788825||Single Group Assignment||Diagnostic||None (Open Label)||||||
1361984|NCT02788812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361985|NCT02788799|||Case-Control||Other|||||||
1361986|NCT02788786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361987|NCT02788773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361988|NCT02788760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1361989|NCT02788747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1361990|NCT02788734|||Cohort||Prospective|||||||
1361991|NCT02788721|Randomized|Sequential Assignment||Basic Science||Quadruple|||t|t|t|t
1361992|NCT02788708||Single Group Assignment||Treatment||None (Open Label)||||||
1361993|NCT02788695|||Cohort||Prospective|||||||
1361994|NCT02788682|||Cohort||Prospective|||||||
1361995|NCT02788669|||Cohort||Retrospective|||||||
1361996|NCT02788656|Randomized|Parallel Assignment||Treatment||Single|||t|||
1361997|NCT02788643|||Cohort||Prospective|||||||
1361998|NCT02788630|Randomized|Parallel Assignment||Prevention||Single||||||t
1361999|NCT02788617|||Cohort||Prospective|||||||
1362000|NCT02788604|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1362001|NCT02788591|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1362002|NCT02788578|||Other||Retrospective|||||||
1362003|NCT02788565|||Cohort||Cross-Sectional|||||||
1362004|NCT02788552|Randomized|Parallel Assignment||Treatment||Single||||||t
1362005|NCT02788539|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1362006|NCT02788526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362007|NCT02788513|Randomized|Parallel Assignment||Treatment||Double||||||
1362008|NCT02788500|||Cohort||Prospective|||||||
1362009|NCT02788487|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362010|NCT02788474|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362011|NCT02788461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362012|NCT02788448||Single Group Assignment||Treatment||None (Open Label)||||||
1362013|NCT02788435|Randomized|Parallel Assignment||Treatment||Single||||||t
1362014|NCT02788422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362015|NCT02788409|||Cohort||Retrospective|||||||
1362016|NCT02788396|||Cohort||Prospective|||||||
1362017|NCT02788383|||Case-Only||Retrospective|||||||
1362018|NCT02788370|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1362019|NCT02788357|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362020|NCT02788344|||Cohort||Retrospective|||||||
1362021|NCT02788331|||Cohort||Retrospective|||||||
1362022|NCT02788318|||Cohort||Prospective|||||||
1362023|NCT02788305|||Cohort||Prospective|||||||
1362024|NCT02788292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362025|NCT02788279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362026|NCT02788266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362027|NCT02788253|||Cohort||Prospective|||||||
1362028|NCT02788240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362029|NCT02788227|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1362030|NCT02788214|||Case-Control||Cross-Sectional|||||||
1362031|NCT02788201||Single Group Assignment||Other||None (Open Label)||||||
1362032|NCT02788188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362033|NCT02788175|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1362034|NCT02788162||Single Group Assignment||Treatment||None (Open Label)||||||
1362035|NCT02788149|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1362036|NCT02788136|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1362037|NCT02788123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362038|NCT02788110|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362039|NCT02788097|Randomized|Parallel Assignment||||Single|||||t|
1362040|NCT02788084|||Case-Only||Prospective|||||||
1362041|NCT02788071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362042|NCT02788058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362043|NCT02788045|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1362044|NCT02788032||Single Group Assignment||||None (Open Label)||||||
1362045|NCT02788019|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362046|NCT02788006||Single Group Assignment||Treatment||None (Open Label)||||||
1362047|NCT02787993|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362048|NCT02787980|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362049|NCT02787967|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362050|NCT02787954|||Cohort||Prospective|||||||
1362051|NCT02787941|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1362052|NCT02787928||Single Group Assignment||Health Services Research||None (Open Label)||||||
1362053|NCT02787915||Single Group Assignment||Treatment||None (Open Label)||||||
1362054|NCT02787902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362055|NCT02787889|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1362056|NCT02787876||Single Group Assignment||Treatment||None (Open Label)||||||
1362057|NCT02787863|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362058|NCT02787850||Single Group Assignment||Other||None (Open Label)||||||
1362059|NCT02787837|||Cohort||Prospective|||||||
1362060|NCT02787824|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362061|NCT02787811|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362062|NCT02787798|Randomized|Parallel Assignment||Treatment||Single||||||t
1362063|NCT02787785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362064|NCT02787772|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362065|NCT02787759|Randomized|Parallel Assignment||Treatment||Single||||||t
1362066|NCT02787746||Single Group Assignment||Treatment||None (Open Label)||multi-center, single-arm, open labeling clinical trial||||
1362067|NCT02787733|Randomized|Parallel Assignment||||Double|||t||t|
1362068|NCT02787720|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1362069|NCT02787707|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1362070|NCT02787694||Single Group Assignment||Treatment||None (Open Label)||||||
1362071|NCT02787681||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362072|NCT02787668|Randomized|Parallel Assignment||Treatment||Single||||||t
1362073|NCT02787655|Randomized|Parallel Assignment||Prevention||Single||||||t
1362074|NCT02787642||Single Group Assignment||Treatment||None (Open Label)||||||
1362075|NCT02787629|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362076|NCT02787616|||Cohort||Prospective|||||||
1362077|NCT02787603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362078|NCT02787590|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1362079|NCT02787577|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362080|NCT02787564|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362081|NCT02787551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362082|NCT02787538|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1362083|NCT02787525|||Case Control||Retrospective|||||||
1362084|NCT02787512|Randomized|Crossover Assignment||Treatment||Single|||t|||
1362085|NCT02787499|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362086|NCT02787486|||Family-Based||Prospective|||||||
1362087|NCT02787473||Single Group Assignment||Treatment||None (Open Label)||||||
1362088|NCT02787460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362089|NCT02787447||Single Group Assignment||Treatment||None (Open Label)||||||
1362090|NCT02787434||Single Group Assignment||Screening||None (Open Label)||||||
1362091|NCT02787421||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362092|NCT02787408||Single Group Assignment||Treatment||None (Open Label)||||||
1362093|NCT02787395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362094|NCT02787382|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362095|NCT02787369|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362096|NCT02787356|Randomized|Parallel Assignment||Other||Double|||t||t|
1362097|NCT02787343||||||||||||
1362098|NCT02787330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362099|NCT02787317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362100|NCT02787304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362101|NCT02787291||Single Group Assignment||Treatment||None (Open Label)||||||
1362102|NCT02787278|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362103|NCT02787265|||Case-Only||Prospective|||||||
1362104|NCT02787252||Single Group Assignment||Treatment||None (Open Label)||||||
1362105|NCT02787239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362106|NCT02787226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362107|NCT02787213|||Cohort||Prospective|||||||
1362108|NCT02787200|||||Cross-Sectional|||||||
1362109|NCT02787187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362110|NCT02787174|Randomized|Parallel Assignment||Other||Single|||||t|
1362111|NCT02787161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362112|NCT02787148|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362113|NCT02787135|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362114|NCT02787122|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362115|NCT02787109|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1362116|NCT02787096||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362117|NCT02787083|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362118|NCT02787070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362119|NCT02787057|Randomized|Parallel Assignment||Treatment||Single||||||t
1362120|NCT02787044|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1362121|NCT02787031|||Cohort||Retrospective|||||||
1362122|NCT02787018|Randomized|Factorial Assignment||Supportive Care||Triple|||t||t|t
1362123|NCT02787005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362124|NCT02786992|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1362125|NCT02786979|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362126|NCT02786966||Single Group Assignment||Health Services Research||None (Open Label)||||||
1362127|NCT02786953|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1362128|NCT02786940|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362129|NCT02786927|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362130|NCT02786914|||Cohort||Prospective|||||||
1362131|NCT02786901|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362132|NCT02786888|||Cohort||Prospective|||||||
1362133|NCT02786875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362134|NCT02786862||Single Group Assignment||Other||None (Open Label)||||||
1362135|NCT02786849|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362136|NCT02786836||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362137|NCT02786823|Randomized|Factorial Assignment||Treatment||Double||||t||t
1362138|NCT02786810||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362139|NCT02786797|Randomized|Factorial Assignment||Treatment||Single|||||t|
1362140|NCT02786784||Single Group Assignment||Treatment||None (Open Label)||||||
1362141|NCT02786771|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362142|NCT02786758|||Cohort||Prospective|||||||
1362143|NCT02786732|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1362144|NCT02786719||Single Group Assignment||Treatment||None (Open Label)||||||
1362145|NCT02786706||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362146|NCT02786693|||Other||Prospective|||||||
1362147|NCT02786680|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1362148|NCT02786667|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1362149|NCT02786654|||Cohort||Prospective|||||||
1362150|NCT02786641|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1362151|NCT02786628|||Cohort||Prospective|||||||
1362152|NCT02786615|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1362153|NCT02786602|||Cohort||Retrospective|||||||
1362154|NCT02786589||Single Group Assignment||Treatment||None (Open Label)||||||
1362155|NCT02786576|||Cohort||Prospective|||||||
1362156|NCT02786563|||Cohort||Prospective|||||||
1362157|NCT02786550|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1362158|NCT02786537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362159|NCT02786524|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362160|NCT02786511|||Case-Only||Prospective|||||||
1362161|NCT02786498|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1362162|NCT02786485||Single Group Assignment||Treatment||None (Open Label)||||||
1362163|NCT02786472|Randomized|Parallel Assignment||Prevention||Single|||||t|
1362164|NCT02786459|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362165|NCT02786446|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1362166|NCT02786433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362167|NCT02786420|||Cohort||Prospective|||||||
1362168|NCT02786407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362169|NCT02786394||Single Group Assignment||Prevention||None (Open Label)||||||
1362170|NCT02786381|||||Cross-Sectional|||||||
1362171|NCT02786368|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362172|NCT02786355|Randomized|Crossover Assignment||Other||Double|||t|||t
1362173|NCT02786342|||Cohort||Prospective|||||||
1362174|NCT02786329|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1362175|NCT02786316|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362176|NCT02786303||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362177|NCT02786290||Single Group Assignment||Treatment||None (Open Label)||||||
1362178|NCT02786277|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1362179|NCT02786264|||Cohort||Retrospective|||||||
1362180|NCT02786251|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362181|NCT02786238|Randomized|Parallel Assignment||Treatment||Single||||||t
1362182|NCT02786225|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362183|NCT02786212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362184|NCT02786199|||Case-Only||Prospective|||||||
1362185|NCT02786186|||Cohort||Prospective|||||||
1362186|NCT02786173|||Cohort||Prospective|||||||
1362187|NCT02786160|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1362188|NCT02786147|||Cohort||Prospective|||||||
1362189|NCT02786134|Randomized|Parallel Assignment||Diagnostic||Double||The CIRT-CFR study is a sub-study based off the main CIRT trial.|t||t|
1362190|NCT02786121|||Cohort||Prospective|||||||
1362191|NCT02786108|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362192|NCT02786095|||Cohort||Prospective|||||||
1362193|NCT02786082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362194|NCT02786069||Single Group Assignment||Treatment||None (Open Label)||||||
1362195|NCT02786056||Single Group Assignment||Other||None (Open Label)||||||
1362196|NCT02786043||Single Group Assignment||Treatment||None (Open Label)||||||
1362197|NCT02786030|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362198|NCT02786017|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362199|NCT02786004|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362200|NCT02785991|||Case-Only||Prospective|||||||
1362201|NCT02785978|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362202|NCT02785965|Randomized|Parallel Assignment||Treatment||Single||||||t
1362203|NCT02785952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362204|NCT02785939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362205|NCT02785926|||Cohort||Prospective|||||||
1362206|NCT02785913|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362207|NCT02785900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362208|NCT02785887|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1362209|NCT02785874|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362210|NCT02785861|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362211|NCT02785848|||Cohort||Prospective|||||||
1362212|NCT02785835|||Cohort||Other|||||||
1362213|NCT02785822|Randomized|Parallel Assignment||Treatment||Single|||||t|
1362214|NCT02785809|||Cohort||Prospective|||||||
1362215|NCT02785796|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1362216|NCT02785783|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1362217|NCT02785770|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1362218|NCT02785757||Single Group Assignment||Other||None (Open Label)||||||
1362219|NCT02785744|||Other||Cross-Sectional|||||||
1362220|NCT02785731|||Cohort||Prospective|||||||
1362221|NCT02785718||Single Group Assignment||||None (Open Label)||||||
1362222|NCT02785705|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362223|NCT02785692|||Cohort||Retrospective|||||||
1362224|NCT02785679|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362225|NCT02785666||Single Group Assignment||Treatment||None (Open Label)||||||
1362226|NCT02785653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362227|NCT02785640|Randomized|Parallel Assignment||Prevention||Single||||||t
1362228|NCT02785627|||Case Control||Prospective|||||||
1362229|NCT02785614|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362230|NCT02785601|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362231|NCT02785588||Single Group Assignment||Other||None (Open Label)||||||
1362232|NCT02785575|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362233|NCT02785562||Single Group Assignment||||None (Open Label)||||||
1362234|NCT02785549|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362235|NCT02785536|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362236|NCT02785523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362237|NCT02785510|||Case-Only||Cross-Sectional|||||||
1362238|NCT02785497|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362239|NCT02785484|Randomized|Parallel Assignment||Prevention||Single|||t|||
1362240|NCT02785471|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362241|NCT02785458|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362242|NCT02785445||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362243|NCT02785432|Randomized|Parallel Assignment||Treatment||Single|||||t|
1362244|NCT02785419||Single Group Assignment||Treatment||None (Open Label)||||||
1362245|NCT02785406|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1362246|NCT02785393|Randomized|Crossover Assignment||||Double|||t|t||
1362247|NCT02785380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362248|NCT02785367||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362249|NCT02785354|||Cohort||Retrospective|||||||
1362250|NCT02785341|Randomized|Crossover Assignment||||None (Open Label)||||||
1362251|NCT02785328|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1362252|NCT02785315|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1362253|NCT02785302|||Cohort||Prospective|||||||
1362254|NCT02785289|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1362255|NCT02785276|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1362256|NCT02785263|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362257|NCT02785250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362258|NCT02785237|Randomized|Parallel Assignment||Treatment||Single||||||t
1362259|NCT02785224|||Other||Retrospective|||||||
1362260|NCT02785211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362261|NCT02785198|Randomized|Parallel Assignment||Prevention||Single||||||t
1362262|NCT02785185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362263|NCT02785172|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362264|NCT02785159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362265|NCT02785146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362266|NCT02785133||Single Group Assignment||Treatment||None (Open Label)||||||
1362267|NCT02785120|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362268|NCT02785107|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362269|NCT02785094|||Cohort||Prospective|||||||
1362270|NCT02785081|||Case-Only||Retrospective|||||||
1362271|NCT02785068||Single Group Assignment||Treatment||None (Open Label)||||||
1362272|NCT02785055|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362273|NCT02785042||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362274|NCT02785029||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362275|NCT02785016|||Cohort||Prospective|||||||
1362276|NCT02785003|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362277|NCT02784990||Single Group Assignment||||None (Open Label)||||||
1362278|NCT02784977|||Cohort||Prospective|||||||
1362279|NCT02784964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362280|NCT02784951|||Cohort||Prospective|||||||
1362281|NCT02784938|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362282|NCT02784925||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362283|NCT02784912|||Cohort||Prospective|||||||
1362284|NCT02784899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362285|NCT02784886|||Cohort||Prospective|||||||
1362286|NCT02784873|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1362287|NCT02784860|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1362288|NCT02784847||Single Group Assignment||Treatment||None (Open Label)||||||
1362289|NCT02784834||Single Group Assignment||Treatment||None (Open Label)||||||
1362290|NCT02784821|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362291|NCT02784808|||Case Control||Cross-Sectional|||||||
1362292|NCT02784795|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362293|NCT02784782|Randomized|Parallel Assignment||Treatment||Single||||||t
1362294|NCT02784769|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1362295|NCT02784756||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362296|NCT02784743||Single Group Assignment||Treatment||None (Open Label)||||||
1362297|NCT02784730|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362298|NCT02784717|||Case-Only||Prospective|||||||
1362299|NCT02784704|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1362300|NCT02784691||Single Group Assignment||Treatment||None (Open Label)||||||
1362301|NCT02784678|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362302|NCT02784665|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362303|NCT02784652||Single Group Assignment||Treatment||None (Open Label)||||||
1362304|NCT02784639||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362305|NCT02784626|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1362306|NCT02784613||Single Group Assignment||Treatment||None (Open Label)||||||
1362307|NCT02784600|||Cohort||Prospective|||||||
1362308|NCT02784587||Single Group Assignment||Prevention||None (Open Label)||||||
1362309|NCT02784574|||Other||Prospective|||||||
1362310|NCT02784561||Single Group Assignment||Treatment||None (Open Label)||||||
1362311|NCT02784548|Randomized|Single Group Assignment||Treatment||Single|||||t|
1362312|NCT02784535|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1362313|NCT02784522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362314|NCT02784509|||Cohort||Prospective|||||||
1362315|NCT02784496||Single Group Assignment||Treatment||None (Open Label)||||||
1362316|NCT02784483||Single Group Assignment||Treatment||None (Open Label)||||||
1362317|NCT02784470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362318|NCT02784457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362319|NCT02784444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362320|NCT02784431||||||||||||
1362321|NCT02784418|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362322|NCT02784405|||Cohort||Prospective|||||||
1362323|NCT02784392|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362324|NCT02784379|||Case Control||Prospective|||||||
1362325|NCT02784366|||Cohort||Prospective|||||||
1362326|NCT02784353|Randomized|Parallel Assignment||Supportive Care||Single|The result of allocation in control and intervention group would be blinded to primary and secondary outcomes assessor.|2 arm, parallel, randomized controlled study||||t
1362327|NCT02784340|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362328|NCT02784327||Single Group Assignment||Treatment||None (Open Label)||||||
1362329|NCT02784314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362330|NCT02784301|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362331|NCT02784288|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362332|NCT02784275|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1362333|NCT02784262||Single Group Assignment||Treatment||None (Open Label)||||||
1362334|NCT02784249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362335|NCT02784236||Single Group Assignment||Supportive Care||None (Open Label)||||||
1362336|NCT02784223||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362337|NCT02784210|Randomized|Parallel Assignment||Treatment||Single||||||t
1362338|NCT02784197||||||||||||
1362339|NCT02784184|||Cohort||Prospective|||||||
1362340|NCT02784171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362341|NCT02784158||||||||||||
1362342|NCT02784145|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362343|NCT02784132|Randomized|||Diagnostic||None (Open Label)||||||
1362344|NCT02784119|Randomized|Parallel Assignment||Other||Single|||t|||
1362345|NCT02784106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362346|NCT02784093|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362347|NCT02784080|||Cohort||Prospective|||||||
1362348|NCT02784067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362349|NCT02784054||Single Group Assignment||Treatment||None (Open Label)||||||
1362350|NCT02784041|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1362351|NCT02784028||Single Group Assignment||Treatment||None (Open Label)||||||
1362352|NCT02784015||Single Group Assignment||Treatment||None (Open Label)||||||
1362353|NCT02784002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362354|NCT02783989|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1362355|NCT02783976|||Ecologic or Community||Prospective|||||||
1362356|NCT02783963||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362357|NCT02783950|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362358|NCT02783937|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1362359|NCT02783924|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1362360|NCT02783911|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1362361|NCT02783898|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362362|NCT02783885|||Cohort||Prospective|||||||
1362363|NCT02783872|||Case-Control||Cross-Sectional|||||||
1362364|NCT02783859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362365|NCT02783846|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1362366|NCT02783833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1362367|NCT02783820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362368|NCT02783807|Randomized|Parallel Assignment||Screening||Single||||||t
1362369|NCT02783794|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1362370|NCT02783781|||Other||Prospective|||||||
1362371|NCT02783768|Randomized|Crossover Assignment||Other||Double|||t|||t
1362372|NCT02783755||Single Group Assignment||Treatment||None (Open Label)||||||
1362373|NCT02783742|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362374|NCT02783729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362375|NCT02783716|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362376|NCT02783703||Single Group Assignment||Other||None (Open Label)||||||
1362377|NCT02783690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362378|NCT02783677|||Case-Control||Prospective|||||||
1362379|NCT02783664|||Cohort||Prospective|||||||
1362380|NCT02783651|||Other||Retrospective|||||||
1362381|NCT02783638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362382|NCT02783625|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362383|NCT02783612|Randomized|Parallel Assignment||||Single|||t|||
1362384|NCT02783599|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1362385|NCT02783586|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1362386|NCT02783573|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362387|NCT02783560|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362388|NCT02783547||Single Group Assignment||Treatment||None (Open Label)||||||
1362389|NCT02783534|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1362390|NCT02783521|Randomized|Parallel Assignment||Treatment||Single||||||t
1362391|NCT02783508|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362392|NCT02783495||Single Group Assignment||Treatment||None (Open Label)||||||
1362393|NCT02783482||Single Group Assignment||Treatment||None (Open Label)||||||
1362394|NCT02783469|||Case-Control||Prospective|||||||
1362395|NCT02783456|Randomized|Crossover Assignment||Diagnostic||Single||||t||
1362396|NCT02783443|||Cohort||Prospective|||||||
1362397|NCT02783430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362398|NCT02783417|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Resistance Training with Blood Flow Restriction||||
1362399|NCT02783404|Randomized|Parallel Assignment||Prevention||Single|||t|||
1362400|NCT02783391||Single Group Assignment||Treatment||None (Open Label)||||||
1362401|NCT02783378||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362402|NCT02783365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362403|NCT02783352|Randomized|Parallel Assignment||Treatment||Single||||||t
1362404|NCT02783339|||Cohort||Prospective|||||||
1362405|NCT02783326|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362406|NCT02783313|Randomized|Parallel Assignment||Treatment||Single||||||t
1362407|NCT02783300|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362408|NCT02783287|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1362409|NCT02783274||Single Group Assignment||Treatment||None (Open Label)||||||
1362410|NCT02783261|||Cohort||Prospective|||||||
1362411|NCT02783248|||Cohort||Prospective|||||||
1362412|NCT02783235||Single Group Assignment||Prevention||None (Open Label)||||||
1362413|NCT02783222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362414|NCT02783209||Single Group Assignment||Other||None (Open Label)||||||
1362415|NCT02783196|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1362416|NCT02783183|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362417|NCT02783170|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362418|NCT02783157|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1362419|NCT02783144|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1362420|NCT02783131|Randomized|Parallel Assignment||||None (Open Label)||||||
1362421|NCT02783118|Randomized|Parallel Assignment||Prevention||Single|||||t|
1362422|NCT02783105|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1362423|NCT02783092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362424|NCT02783079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362425|NCT02783066||Single Group Assignment||Supportive Care||None (Open Label)||||||
1362426|NCT02783053|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1362427|NCT02783040|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362428|NCT02783027|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362429|NCT02783014|||Case-Control||Prospective|||||||
1362430|NCT02782988|||Case-Control||Cross-Sectional|||||||
1362431|NCT02782975|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1362432|NCT02782962|||Cohort||Prospective|||||||
1362433|NCT02782949|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1362434|NCT02782936|Randomized|Single Group Assignment||Health Services Research||Double|||t||t|
1362435|NCT02782923|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1362436|NCT02782910|Randomized|Parallel Assignment||Prevention||Single||||||t
1362437|NCT02782897|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1362438|NCT02782884|||Cohort||Prospective|||||||
1362439|NCT02782871|Randomized|Parallel Assignment||||Single|||t|||
1362440|NCT02782858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362441|NCT02782845||Single Group Assignment||Treatment||None (Open Label)||||||
1362442|NCT02782832|||Cohort||Retrospective|||||||
1362443|NCT02782819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362444|NCT02782806||||||||||||
1362445|NCT02782793|||Cohort||Prospective|||||||
1362446|NCT02782780|Randomized|Parallel Assignment||Treatment||Single|||||t|
1362447|NCT02782767|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362448|NCT02782754||Single Group Assignment||Treatment||None (Open Label)||||||
1362449|NCT02782741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362450|NCT02782728|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362451|NCT02782715||Single Group Assignment||Treatment||None (Open Label)||||||
1362452|NCT02782702||Single Group Assignment||Other||None (Open Label)||||||
1362453|NCT02782689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362454|NCT02782676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362455|NCT02782663|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362456|NCT02782650|||Cohort||Cross-Sectional|||||||
1362457|NCT02782637|||Cohort||Cross-Sectional|||||||
1362458|NCT02782624|Randomized|Crossover Assignment||||None (Open Label)||||||
1362459|NCT02782611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362460|NCT02782598||Single Group Assignment||Treatment||None (Open Label)||||||
1362461|NCT02782585|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362462|NCT02782572|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362463|NCT02782559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362464|NCT02782546|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362465|NCT02782533||Single Group Assignment||Treatment||None (Open Label)||||||
1362466|NCT02782520|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362467|NCT02782507|||Case-Only||Prospective|||||||
1362468|NCT02782494|||Cohort||Prospective|||||||
1362469|NCT02782481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362470|NCT02782468|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362471|NCT02782455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362472|NCT02782442|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1362473|NCT02782429|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1362474|NCT02782416|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1362475|NCT02782403|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362476|NCT02782390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362477|NCT02782377|||Cohort||Prospective|||||||
1362478|NCT02782364|||Cohort||Prospective|||||||
1362479|NCT02782351||Single Group Assignment||Treatment||None (Open Label)||||||
1362480|NCT02782338|||Case-Only||Prospective|||||||
1362481|NCT02782325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362482|NCT02782312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362483|NCT02782299|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362484|NCT02782286|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1362485|NCT02782273|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1362486|NCT02782260|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362487|NCT02782247|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1362488|NCT02782234|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362489|NCT02782221|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1362490|NCT02782208|Randomized|Factorial Assignment||Basic Science||Triple|||t|t|t|
1362491|NCT02782195||||||||||||
1362492|NCT02782182||Single Group Assignment||Treatment||None (Open Label)||||||
1362493|NCT02782169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362494|NCT02782156|||||Retrospective|||||||
1362495|NCT02782143|||Cohort||Prospective|||||||
1362496|NCT02782130|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362497|NCT02782117||||||||||||
1362498|NCT02782104||Single Group Assignment||Treatment||None (Open Label)||||||
1362499|NCT02782091|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362500|NCT02782078||Single Group Assignment||Treatment||None (Open Label)||||||
1362501|NCT02782065|||Cohort||Prospective|||||||
1362502|NCT02782052|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1362503|NCT02782039|||Cohort||Other|||||||
1362504|NCT02782026|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362505|NCT02782013|||Cohort||Prospective|||||||
1362506|NCT02782000|Randomized|Parallel Assignment||Health Services Research||Double||||t||t
1362507|NCT02781987|||Case Control|||||||||
1362508|NCT02781974|Randomized|Parallel Assignment||Treatment||Single||||||t
1362509|NCT02781961|||Case-Only||Prospective|||||||
1362510|NCT02781948|||Cohort||Prospective|||||||
1362511|NCT02781935|||Cohort||Prospective|||||||
1362512|NCT02781922|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362513|NCT02781909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362514|NCT02781896|Randomized|Parallel Assignment||Other||Single|||t|||
1362515|NCT02781883||Single Group Assignment||Treatment||None (Open Label)||||||
1362516|NCT02781870|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1362517|NCT02781857|||Case-Control||Prospective|||||||
1362518|NCT02781844|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362519|NCT02781831|Randomized|Parallel Assignment||Treatment||Single||||||t
1362520|NCT02781818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362521|NCT02781805||Single Group Assignment||Prevention||None (Open Label)||||||
1362522|NCT02781792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362523|NCT02781779|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362524|NCT02781766||Single Group Assignment||Other||None (Open Label)||||||
1362525|NCT02781753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362526|NCT02781740|Randomized|Parallel Assignment||Other||Double|||t|||t
1362527|NCT02781727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362528|NCT02781714|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362529|NCT02781701||Single Group Assignment||Treatment||None (Open Label)||||||
1362530|NCT02781688||Single Group Assignment||Treatment||None (Open Label)||||||
1362531|NCT02781675|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1362532|NCT02781662|Randomized|Parallel Assignment||Prevention||Single||||||t
1362533|NCT02781649|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362534|NCT02781636||Single Group Assignment||Treatment||None (Open Label)||||||
1362535|NCT02781623|||Case-Control||Prospective|||||||
1362536|NCT02781610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362537|NCT02781597|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362538|NCT02781584|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Cohorts 1-6 and 9 will be enrolled sequentially while Cohorts 7 and 8 will be randomized in parallel. Cohorts 10 and 11 will be randomized in parallel.||||
1362539|NCT02781571||Single Group Assignment||Treatment||None (Open Label)||||||
1362540|NCT02781558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362541|NCT02781545|||Cohort||Prospective|||||||
1362542|NCT02781532|||Cohort||Prospective|||||||
1362543|NCT02781519|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1362544|NCT02781506||Single Group Assignment||Treatment||None (Open Label)||||||
1362545|NCT02781493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362546|NCT02781480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||AAV2/5-OPTIRPE65||||
1362547|NCT02781467||Single Group Assignment||Treatment||None (Open Label)||||||
1362548|NCT02781454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362549|NCT02781441|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362550|NCT02781428|||Case-Control||Cross-Sectional|||||||
1362551|NCT02781415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362552|NCT02781402|Non-Randomized|Parallel Assignment||Treatment||Single|Assessor who measured pre and post outcomes was blended and did not know participants belonged to which group.|Same intervention (4 weeks of aerobic training) was given to 2 different groups (Normal BMI group & Overweight BMI group).||||t
1362553|NCT02781389|||Case-Control||Prospective|||||||
1362554|NCT02781376|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1362555|NCT02781363|Non-Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1362556|NCT02781350|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1362557|NCT02781337|||Cohort||Prospective|||||||
1362558|NCT02781324|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362559|NCT02781311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362560|NCT02781298|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1362561|NCT02781285|||Cohort||Prospective|||||||
1362562|NCT02781272|||Cohort||Prospective|||||||
1362563|NCT02781259||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362564|NCT02781246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362565|NCT02781233|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1362566|NCT02781220|||Case-Only||Prospective|||||||
1362567|NCT02781207|||Cohort||Prospective|||||||
1362568|NCT02781194|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1362569|NCT02781181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362570|NCT02781168|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1362571|NCT02781155||Single Group Assignment||Supportive Care||None (Open Label)||||||
1362572|NCT02781142|Randomized|Parallel Assignment||Treatment||Single||||||t
1362573|NCT02781129||Single Group Assignment||Other||None (Open Label)||||||
1362574|NCT02781116|||Cohort||Prospective|||||||
1362575|NCT02781103|Randomized|Factorial Assignment||Treatment||Single|||t|||
1362576|NCT02781090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362577|NCT02781077|||Case-Only||Prospective|||||||
1362578|NCT02781064|Randomized|Crossover Assignment||Other||Quadruple|Double Blinded IMP||t|t|t|t
1362579|NCT02781051||Single Group Assignment||Treatment||None (Open Label)||||||
1362580|NCT02781038|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1362581|NCT02781025|||Case-Only||Prospective|||||||
1362582|NCT02781012|||Cohort||Prospective|||||||
1362583|NCT02780999|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362584|NCT02780986|Non-Randomized|Parallel Assignment||Prevention||Single||||t||
1362585|NCT02780973|||Cohort||Prospective|||||||
1362586|NCT02780960||Single Group Assignment||Other||None (Open Label)||||||
1362587|NCT02780947|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362588|NCT02780934|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362589|NCT02780921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362590|NCT02780908|Randomized|Parallel Assignment||Prevention||Single|||||t|
1362591|NCT02780895||Single Group Assignment||Treatment||None (Open Label)||||||
1362592|NCT02780882||Single Group Assignment||Treatment||None (Open Label)||||||
1362593|NCT02780869|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362594|NCT02780856||Single Group Assignment||Other||None (Open Label)||||||
1362595|NCT02780843|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362596|NCT02780830||Single Group Assignment||Treatment||None (Open Label)||||||
1362597|NCT02780817|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362598|NCT02780804||Single Group Assignment||Treatment||None (Open Label)||||||
1362599|NCT02780791|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1362600|NCT02780778||Single Group Assignment||Screening||None (Open Label)||||||
1362601|NCT02780765|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362602|NCT02780752||Single Group Assignment||Treatment||None (Open Label)||||||
1362603|NCT02780739|Randomized|Parallel Assignment||||Double|||||t|t
1362604|NCT02780726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362605|NCT02780713||Single Group Assignment||Treatment||None (Open Label)||||||
1362606|NCT02780700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362607|NCT02780687||Single Group Assignment||Treatment||None (Open Label)||||||
1362608|NCT02780674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362609|NCT02780661|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1362610|NCT02780648||Single Group Assignment||Treatment||None (Open Label)||||||
1362611|NCT02780635|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1362612|NCT02780622|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1362613|NCT02780609||Single Group Assignment||Treatment||None (Open Label)||||||
1362614|NCT02780596|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1362615|NCT02780583|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362616|NCT02780570|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362617|NCT02780557|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1362618|NCT02780544|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1362619|NCT02780531|||Family-Based||Prospective|||||||
1362620|NCT02780518||Single Group Assignment||Treatment||None (Open Label)||||||
1362621|NCT02780505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362622|NCT02780492|||Cohort||Prospective|||||||
1362623|NCT02780479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362624|NCT02780466|||Cohort||Prospective|||||||
1362625|NCT02780453|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362626|NCT02780440|||Cohort||Prospective|||||||
1362627|NCT02780427|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1362628|NCT02780414|||Family-Based||Prospective|||||||
1362629|NCT02780401||Single Group Assignment||Prevention||None (Open Label)||||||
1362630|NCT02780388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362631|NCT02780375|||Cohort||Prospective|||||||
1362632|NCT02780362|Randomized|Crossover Assignment||||None (Open Label)||||||
1362633|NCT02780349||Single Group Assignment||Treatment||None (Open Label)||||||
1362634|NCT02780336|||Case-Control||Prospective|||||||
1362635|NCT02780323|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362636|NCT02780310||Single Group Assignment||Treatment||None (Open Label)||||||
1362637|NCT02780297|||Cohort||Prospective|||||||
1362638|NCT02780284||Single Group Assignment||Prevention||None (Open Label)||||||
1362639|NCT02780271|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1362640|NCT02780258|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1362641|NCT02780245|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1362642|NCT02780232|Randomized|Parallel Assignment||Prevention||Single||||||t
1362643|NCT02780219|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1362644|NCT02780206||Single Group Assignment||Supportive Care||None (Open Label)||||||
1362645|NCT02780193||||||||||||
1362646|NCT02780180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362647|NCT02780167|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1362648|NCT02780154|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1362649|NCT02780141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362650|NCT02780128|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362651|NCT02780115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362652|NCT02780102|Randomized|Parallel Assignment||Treatment||Single||||||t
1362653|NCT02780089|||Cohort||Other|||||||
1362654|NCT02780076|Randomized|Parallel Assignment||Treatment||Single||||||t
1362655|NCT02780063||Single Group Assignment||Screening||None (Open Label)||||||
1362656|NCT02780050|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362657|NCT02780037|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1362658|NCT02780024||Single Group Assignment||Treatment||None (Open Label)||||||
1362659|NCT02780011||Single Group Assignment||Treatment||None (Open Label)||||||
1362660|NCT02779998|Randomized|Parallel Assignment||Prevention||Single||||||t
1362661|NCT02779985|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1362662|NCT02779972|||Cohort||Retrospective|||||||
1362663|NCT02779959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362664|NCT02779946|||Cohort||Prospective|||||||
1362665|NCT02779933|||Cohort||Retrospective|||||||
1362666|NCT02779920||Single Group Assignment||Treatment||None (Open Label)||||||
1362667|NCT02779907|||Case-Only||Prospective|||||||
1362668|NCT02779894|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362669|NCT02779881|||Case-Crossover||Cross-Sectional|||||||
1362670|NCT02779868|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362671|NCT02779855||Single Group Assignment||Treatment||None (Open Label)||||||
1362672|NCT02779842||Single Group Assignment||Treatment||None (Open Label)||||||
1362673|NCT02779829||Single Group Assignment||Treatment||None (Open Label)||||||
1362674|NCT02779816||||||||||||
1362675|NCT02779803|||Cohort||Prospective|||||||
1362676|NCT02779790|||||Prospective|||||||
1362677|NCT02779777||Single Group Assignment||Treatment||None (Open Label)||||||
1362678|NCT02779764||Single Group Assignment||Treatment||None (Open Label)||||||
1362679|NCT02779751|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362680|NCT02779738|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1362681|NCT02779725|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1362682|NCT02779712|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362683|NCT02779699||Single Group Assignment||Treatment||None (Open Label)||||||
1362684|NCT02779686|||Case Control||Prospective|||||||
1362685|NCT02779673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362686|NCT02779660|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1362687|NCT02779647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362688|NCT02779634|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1362689|NCT02779621|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362690|NCT02779608||Single Group Assignment||Treatment||None (Open Label)||||||
1362691|NCT02779595|||Cohort||Prospective|||||||
1362692|NCT02779582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362693|NCT02779569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362694|NCT02779556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362695|NCT02779543|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1362696|NCT02779530|Randomized|Crossover Assignment||Screening||Double|||t||t|
1362697|NCT02779517||Single Group Assignment||Treatment||None (Open Label)||||||
1362698|NCT02779504|||Cohort||Retrospective|||||||
1362699|NCT02779491|Randomized|Parallel Assignment||Prevention||Single||||||t
1362700|NCT02779478|||Case-Control||Prospective|||||||
1362701|NCT02779465|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362702|NCT02779452|||Case Control||Retrospective|||||||
1362703|NCT02779439||Single Group Assignment||Treatment||None (Open Label)||||||
1362704|NCT02779426|Randomized|Parallel Assignment||Treatment||Single||||||t
1362705|NCT02779413|||Cohort||Prospective|||||||
1362706|NCT02779400||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362707|NCT02779387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362708|NCT02779374||Single Group Assignment||Treatment||None (Open Label)||||||
1362709|NCT02779361||Single Group Assignment||Basic Science||None (Open Label)||||||
1362710|NCT02779348|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362711|NCT02779335||Single Group Assignment||||None (Open Label)||||||
1362712|NCT02779322|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362713|NCT02779309|||Cohort||Retrospective|||||||
1362714|NCT02779296|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1362715|NCT02779283|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362716|NCT02779270|Randomized|Parallel Assignment||Other||Single|||t|||
1362717|NCT02779257||Single Group Assignment||Treatment||None (Open Label)||||||
1362718|NCT02779244|Randomized|Parallel Assignment||Treatment||Single||||t||
1362719|NCT02779231|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362720|NCT02779218|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1362721|NCT02779205|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1362722|NCT02779192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362723|NCT02779179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362724|NCT02779166|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362725|NCT02779153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362726|NCT02779140|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1362727|NCT02779127|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362728|NCT02779114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362729|NCT02779101||Single Group Assignment||Treatment||None (Open Label)||||||
1362730|NCT02779088|Randomized|Crossover Assignment||Other||Triple|Participants and investigator don't know which group participants are assined to in advance.|The investigators invited 60 persons with sarcopenia by telephone to attend the study and randomly assigned to group A and B (30 persons in each group). Group A first accepted exercise and nutrition intervention and then was given education course. Group B was the reverse order.|t|t|t|
1362731|NCT02779075|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362732|NCT02779062|||||Prospective|||||||
1362733|NCT02779049|||Cohort||Prospective|||||||
1362734|NCT02779036|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362735|NCT02779023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362736|NCT02779010|Randomized|Parallel Assignment||Prevention||Double||||t||t
1362737|NCT02778997|||Case-Only||Prospective|||||||
1362738|NCT02778984|Randomized|Parallel Assignment||||None (Open Label)||||||
1362739|NCT02778971|||Case-Only||Prospective|||||||
1362740|NCT02778958|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362741|NCT02778945|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1362742|NCT02778932|||||Prospective|||||||
1362743|NCT02778919||||||||||||
1362744|NCT02778906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362745|NCT02778893||Single Group Assignment||Treatment||||||||
1362746|NCT02778880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362747|NCT02778867|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362748|NCT02778854|||Cohort||Prospective|||||||
1362749|NCT02778841|Randomized|Parallel Assignment||Prevention||Single|||t|||
1362750|NCT02778828||Single Group Assignment||Other||None (Open Label)||||||
1362751|NCT02778815|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1362752|NCT02778802|||Cohort||Prospective|||||||
1362753|NCT02778789|||Case Control||Prospective|||||||
1362754|NCT02778776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362755|NCT02778763|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1362756|NCT02778750|||Cohort||Prospective|||||||
1362757|NCT02778737|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1362758|NCT02778724|||Cohort||Prospective|||||||
1362759|NCT02778711||Single Group Assignment||Treatment||None (Open Label)||||||
1362760|NCT02778698||||||||||||
1362761|NCT02778685||Single Group Assignment||Treatment||None (Open Label)||||||
1362762|NCT02778672|||Cohort||Prospective|||||||
1362763|NCT02778659|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1362764|NCT02778646|||Cohort||Cross-Sectional|||||||
1362765|NCT02778633|||Cohort||Prospective|||||||
1362766|NCT02778620|||Cohort||Prospective|||||||
1362767|NCT02778607|||Case Control||Prospective|||||||
1362768|NCT02778594|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1362769|NCT02778581|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1362770|NCT02778568|Randomized|Parallel Assignment||Treatment||Single||||||t
1362771|NCT02778555|||Cohort||Prospective|||||||
1362772|NCT02778542|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1362773|NCT02778529||Single Group Assignment||Basic Science||None (Open Label)||||||
1362774|NCT02778516|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1362775|NCT02778503|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362776|NCT02778490|||Cohort||Prospective|||||||
1362777|NCT02778477|Randomized|||Basic Science||Double|||t||t|
1362778|NCT02778464|||Cohort||Prospective|||||||
1362779|NCT02778451|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1362780|NCT02778438|||Case-Crossover||Prospective|||||||
1362781|NCT02778425|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362782|NCT02778412|||Cohort||Prospective|||||||
1362783|NCT02778399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362784|NCT02778386|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1362785|NCT02778373|Randomized|Crossover Assignment||||Triple|||t||t|t
1362786|NCT02778360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362787|NCT02778347|||Case-Only||Prospective|||||||
1362788|NCT02778334|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1362789|NCT02778321||Single Group Assignment||Screening||None (Open Label)||||||
1362790|NCT02778308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362791|NCT02778295|||Cohort||Prospective|||||||
1362792|NCT02778282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362793|NCT02778269||Single Group Assignment||Prevention||None (Open Label)||||||
1362794|NCT02778256|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362795|NCT02778243|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362796|NCT02778230|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1362797|NCT02778217|Randomized|Parallel Assignment||||Double|||||t|t
1362798|NCT02778204|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362799|NCT02778191|||Cohort||Retrospective|||||||
1362800|NCT02778178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362801|NCT02778165|Randomized|Parallel Assignment||||Single||||||t
1362802|NCT02778152||Single Group Assignment||Treatment||None (Open Label)||Laser hair removal||||
1362803|NCT02778139|||Case-Control||Cross-Sectional|||||||
1362804|NCT02778126|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1362805|NCT02778113|Randomized|Crossover Assignment||Basic Science||Single||||||t
1362806|NCT02778100|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1362807|NCT02778087|Randomized|Parallel Assignment||Treatment||Single||||||t
1362808|NCT02778074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362809|NCT02778061|||||Retrospective|||||||
1362810|NCT02778048|||Other||Retrospective|||||||
1362811|NCT02778035|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362812|NCT02778022|Randomized|Parallel Assignment||Treatment||Single|The study team member who will administer the follow-up study interviews will remain blinded to the group status throughout the duration of the study.|||||t
1362813|NCT02778009|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362814|NCT02777996|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1362815|NCT02777983|Randomized|Parallel Assignment||Treatment||Double||||t||t
1362816|NCT02777970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362817|NCT02777957|||Cohort||Prospective|||||||
1362818|NCT02777944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362819|NCT02777931|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362820|NCT02777918|Randomized|Parallel Assignment||Prevention||Single||||||t
1362821|NCT02777905|Randomized|Parallel Assignment||Treatment||Single||||||t
1362822|NCT02777892|||Case-Only||Retrospective|||||||
1362823|NCT02777879|||Cohort||Cross-Sectional|||||||
1362824|NCT02777866|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1362825|NCT02777853|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1362826|NCT02777840|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362827|NCT02777827|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1362828|NCT02777814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362829|NCT02777801|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362830|NCT02777788|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362831|NCT02777775|||Cohort||Prospective|||||||
1362832|NCT02777762|Randomized|Parallel Assignment||Treatment||Single||||||t
1362833|NCT02777749|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1362834|NCT02777736|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362835|NCT02777723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362836|NCT02777710||Single Group Assignment||Treatment||None (Open Label)||||||
1362837|NCT02777697|||||Prospective|||||||
1362838|NCT02777684|||||Cross-Sectional|||||||
1362839|NCT02777671|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362840|NCT02777658|||Cohort||Prospective|||||||
1362841|NCT02777645|||Case Control||Prospective|||||||
1362842|NCT02777632|||Cohort||Prospective|||||||
1362843|NCT02777619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362844|NCT02777606|Randomized|Parallel Assignment||Treatment||Single||||||t
1362845|NCT02777593|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362846|NCT02777580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362847|NCT02777567|||Case-Only||Prospective|||||||
1362848|NCT02777554|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362849|NCT02777541|Randomized|Parallel Assignment||||None (Open Label)||||||
1362850|NCT02777528|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362851|NCT02777515||Single Group Assignment||Other||None (Open Label)||||||
1362852|NCT02777502|||Case-Only||Prospective|||||||
1362853|NCT02777489||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362854|NCT02777476||Single Group Assignment||Treatment||None (Open Label)||||||
1362855|NCT02777463|||Cohort||Prospective|||||||
1362856|NCT02777450|||Cohort||Prospective|||||||
1362857|NCT02777437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362858|NCT02777424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362859|NCT02777411|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362860|NCT02777398|Randomized|Parallel Assignment||Treatment||Single|||||t|
1362861|NCT02777385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362862|NCT02777372||Single Group Assignment||Treatment||None (Open Label)||||||
1362863|NCT02777359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362864|NCT02777346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362865|NCT02777333|Randomized|Parallel Assignment||||Single||||||t
1362866|NCT02777320|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1362867|NCT02777307|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362868|NCT02777294|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362869|NCT02777281|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1362870|NCT02777268|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1362871|NCT02777255|||Case Control||Cross-Sectional|||||||
1362872|NCT02777242||Single Group Assignment||Treatment||None (Open Label)||||||
1363413|NCT02770183|||Cohort||Prospective|||||||
1362873|NCT02777229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362874|NCT02777216||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362875|NCT02777203||Single Group Assignment||Prevention||None (Open Label)||||||
1362876|NCT02777190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362877|NCT02777177|||Cohort||Prospective|||||||
1362878|NCT02777164||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362879|NCT02777151|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1362880|NCT02777138|||Other||Cross-Sectional|||||||
1362881|NCT02777125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362882|NCT02777112|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1362883|NCT02777099|Randomized|Parallel Assignment||Prevention||Single|||t|||
1362884|NCT02777086|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362885|NCT02777073|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1362886|NCT02777060|Randomized|Parallel Assignment||Treatment||Single||||||t
1362887|NCT02777047|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1362888|NCT02777034|Randomized|Parallel Assignment||||Single||||||t
1362889|NCT02777021|||Cohort||Prospective|||||||
1362890|NCT02777008|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1362891|NCT02776995||Single Group Assignment||||None (Open Label)||||||
1362892|NCT02776982||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362893|NCT02776969|||Cohort||Prospective|||||||
1362894|NCT02776956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362895|NCT02776943|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362896|NCT02776930|||Cohort||Prospective|||||||
1362897|NCT02776917||Single Group Assignment||Treatment||None (Open Label)||||||
1362898|NCT02776904|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1362899|NCT02776891||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362900|NCT02776878||Single Group Assignment||Treatment||None (Open Label)||||||
1362901|NCT02776865|Randomized|Parallel Assignment||Treatment||Single||||||t
1362902|NCT02776852||Single Group Assignment||Treatment||None (Open Label)||||||
1362903|NCT02776839||Single Group Assignment||Diagnostic||None (Open Label)||||||
1362904|NCT02776826|||Ecologic or Community||Other|||||||
1362905|NCT02776813||Single Group Assignment||Treatment||None (Open Label)||||||
1362906|NCT02776800|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1362907|NCT02776787|||Cohort||Prospective|||||||
1362908|NCT02776774|||Cohort||Prospective|||||||
1362909|NCT02776761|Randomized|Parallel Assignment||Prevention||Single|||t|||
1362910|NCT02776748||Single Group Assignment||Prevention||None (Open Label)||||||
1362911|NCT02776735||Single Group Assignment||Treatment||None (Open Label)||||||
1362912|NCT02776722|||Other||Prospective|||||||
1362913|NCT02776709|||Cohort||Prospective|||||||
1362914|NCT02776696|Randomized|Crossover Assignment||Treatment||None (Open Label)||segment 1 part 1 is a single arm study, segment 1 part 2 is a is a crossover study, segment 2 is a randomized crossover study , segment 3 is a parallel study and segment 4 is a single arm study||||
1362915|NCT02776683||Single Group Assignment||Treatment||None (Open Label)||||||
1362916|NCT02776670|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362917|NCT02776657|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362918|NCT02776644|||Cohort||Retrospective|||||||
1362919|NCT02776631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362920|NCT02776618|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1362921|NCT02776605||Single Group Assignment||Treatment||None (Open Label)||||||
1362922|NCT02776592|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1362923|NCT02776579|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1362924|NCT02776566|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362925|NCT02776553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362926|NCT02776540|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1362927|NCT02776527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362928|NCT02776514|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1362929|NCT02776501||Single Group Assignment||Treatment||None (Open Label)||||||
1362930|NCT02776488|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362931|NCT02776475||Single Group Assignment||Supportive Care||None (Open Label)||||||
1362932|NCT02776462|||Cohort||Prospective|||||||
1362933|NCT02776449|||Case-Only||Prospective|||||||
1362934|NCT02776436|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362935|NCT02776423|||Cohort||Prospective|||||||
1362936|NCT02776410|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1362937|NCT02776397|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1362938|NCT02776384|||Cohort||Prospective|||||||
1362939|NCT02776371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362940|NCT02776358|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1362941|NCT02776345|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362942|NCT02776332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362943|NCT02776319|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1362944|NCT02776306|Randomized|Crossover Assignment||Treatment||Single|||t|||
1362945|NCT02776293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362946|NCT02776280|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1362947|NCT02776267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362948|NCT02776254|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1362949|NCT02776241|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362950|NCT02776228|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1362951|NCT02776215||Single Group Assignment||Treatment||None (Open Label)||||||
1362952|NCT02776202||Single Group Assignment||Treatment||None (Open Label)||||||
1362953|NCT02776189|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362954|NCT02776176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362955|NCT02776163|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1362956|NCT02776150|||Case-Only||Prospective|||||||
1362957|NCT02776137||Single Group Assignment||Treatment||None (Open Label)||||||
1362958|NCT02776124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362959|NCT02776111|||Cohort||Prospective|||||||
1362960|NCT02776098|||Cohort||Prospective|||||||
1362961|NCT02776085|||||Prospective|||||||
1362962|NCT02776072|||Case-Control||Retrospective|||||||
1362963|NCT02776059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362964|NCT02776046|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1362965|NCT02776033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362966|NCT02776020|||Case-Only||Prospective|||||||
1362967|NCT02776007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362968|NCT02775994||Single Group Assignment||Treatment||None (Open Label)||||||
1362969|NCT02775981||Single Group Assignment||Treatment||None (Open Label)||||||
1362970|NCT02775968|||Cohort||Prospective|||||||
1362971|NCT02775955||Single Group Assignment||Treatment||None (Open Label)||||||
1362972|NCT02775942|Randomized|Parallel Assignment||Prevention||Single|||t|||
1362973|NCT02775929||Single Group Assignment||Prevention||None (Open Label)||||||
1362974|NCT02775916|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1362975|NCT02775903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362976|NCT02775890|||Case-Crossover||Prospective|||||||
1362977|NCT02775877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1362978|NCT02775864|||Cohort||Retrospective|||||||
1362979|NCT02775851|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362980|NCT02775838||||Diagnostic||||||||
1362981|NCT02775825|||Cohort||Retrospective|||||||
1362982|NCT02775812||Single Group Assignment||Treatment||None (Open Label)||||||
1362983|NCT02775799|||Cohort||Prospective|||||||
1362984|NCT02775786|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1362985|NCT02775773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362986|NCT02775760|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362987|NCT02775747|Randomized|Parallel Assignment||Treatment||Single||||||t
1362988|NCT02775734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1362989|NCT02775721|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1362990|NCT02775708||Single Group Assignment||Other||None (Open Label)||||||
1362991|NCT02775695||Single Group Assignment||Treatment||None (Open Label)||||||
1362992|NCT02775682|||Case-Control||Prospective|||||||
1362993|NCT02775669|||Cohort||Prospective|||||||
1362994|NCT02775656|||Cohort||Prospective|||||||
1362995|NCT02775643|||Cohort||Prospective|||||||
1362996|NCT02775630|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1362997|NCT02775617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1362998|NCT02775604|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1362999|NCT02775591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363000|NCT02775578|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363001|NCT02775565|||Other||Retrospective|||||||
1363002|NCT02775552|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363003|NCT02775539|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363004|NCT02775526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363005|NCT02775513|||Case Control||Cross-Sectional|||||||
1363006|NCT02775500|||Cohort||Prospective|||||||
1363007|NCT02775487|||Ecologic or Community||Prospective|||||||
1363008|NCT02775474|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1363009|NCT02775461|||Case-Only||Prospective|||||||
1363010|NCT02775448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363011|NCT02775435|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363012|NCT02775422||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363013|NCT02775409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363014|NCT02775396||Single Group Assignment||Basic Science||None (Open Label)||||||
1363015|NCT02775383|||Cohort||Prospective|||||||
1363016|NCT02775370||Single Group Assignment||Treatment||None (Open Label)||||||
1363017|NCT02775357|Randomized|Parallel Assignment||Prevention||Single||||||t
1363018|NCT02775344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363019|NCT02775331|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363020|NCT02775318||Single Group Assignment||Treatment||None (Open Label)||||||
1363021|NCT02775305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363022|NCT02775292||Single Group Assignment||Treatment||None (Open Label)||||||
1363023|NCT02775279|||Case Control||Cross-Sectional|||||||
1363024|NCT02775266|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1363025|NCT02775253||Single Group Assignment||Treatment||None (Open Label)||||||
1363026|NCT02775240|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363027|NCT02775227|Randomized|Parallel Assignment||Prevention||||||||
1363028|NCT02775214|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1363029|NCT02775201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363030|NCT02775188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363031|NCT02775175|Randomized|Parallel Assignment||Prevention||Single||||||t
1363032|NCT02775162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363033|NCT02775149|||Case-Only||Prospective|||||||
1363034|NCT02775136||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363035|NCT02775123|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1363036|NCT02775110|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1363037|NCT02775097|||Cohort||Prospective|||||||
1363038|NCT02775084|Randomized|Parallel Assignment||Other||Double|||t||t|
1363039|NCT02775071|||Case-Only||Prospective|||||||
1363040|NCT02775058|||Cohort||Prospective|||||||
1363041|NCT02775045|||Other||Prospective|||||||
1363042|NCT02775032||||Health Services Research||||||||
1363043|NCT02775019|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1363044|NCT02775006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363045|NCT02774993|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363046|NCT02774980|||Case-Only||Prospective|||||||
1363047|NCT02774967|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1363048|NCT02774954|Randomized|Parallel Assignment||Prevention||Single|The statistician who is conducting the data analysis will not know the content of the intervention assignment.|This study compares 2 active listening, information-motivation-behavior skills interventions aimed at improving health behaviors among very low-income, drug using participants.||||t
1363049|NCT02774941|||Cohort||Prospective|||||||
1363050|NCT02774928|||Cohort||Prospective|||||||
1363051|NCT02774915|||Cohort||Prospective|||||||
1363052|NCT02774902||Single Group Assignment||Treatment||None (Open Label)||||||
1363053|NCT02774889|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363054|NCT02774876|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363055|NCT02774863|||Case-Control||Prospective|||||||
1363056|NCT02774850|||Cohort||Other|||||||
1363057|NCT02774837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363058|NCT02774824|||Other||Other|||||||
1363059|NCT02774811|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1363060|NCT02774798|||Cohort||Prospective|||||||
1363061|NCT02774785|Randomized|Parallel Assignment||Other||Single||||||t
1363062|NCT02774772|||Cohort||Prospective|||||||
1363063|NCT02774759|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363064|NCT02774746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363065|NCT02774733|||Case-Only||Cross-Sectional|||||||
1363066|NCT02774720|Randomized|Parallel Assignment||Treatment||Single||||||t
1363067|NCT02774707|||||Cross-Sectional|||||||
1363068|NCT02774694|||Cohort||Prospective|||||||
1363069|NCT02774681||Single Group Assignment||Treatment||None (Open Label)||||||
1363070|NCT02774668|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363071|NCT02774655|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363072|NCT02774642|Randomized|Parallel Assignment||Treatment||Single||||||t
1363073|NCT02774629|||Cohort||Prospective|||||||
1363074|NCT02774616|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1363075|NCT02774603|Randomized|Parallel Assignment||Treatment||Single|||||t|
1363076|NCT02774590||Single Group Assignment||Treatment||None (Open Label)||||||
1363077|NCT02774577||Single Group Assignment||Health Services Research||None (Open Label)|similar procedures for variables, collected into similar device and positioning, using a sham device, patented, witch reproduce infra-physiologic vibrations and sound like an actual vibrating platform|acute wbv session, measuring ergospirometric variables during protocol and blood pressure, borg exertion, borg dyspnoea, blood lactate, heart rate and SpO2 before and after protocol.||||
1363078|NCT02774564|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1363079|NCT02774551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363080|NCT02774538||Single Group Assignment||Health Services Research||None (Open Label)||||||
1363081|NCT02774525|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1363082|NCT02774512||Single Group Assignment||Other||None (Open Label)||||||
1363083|NCT02774499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363084|NCT02774486||Single Group Assignment||Treatment||None (Open Label)||||||
1363085|NCT02774460|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1363086|NCT02774447|||Case-Only||Prospective|||||||
1363087|NCT02774434||Single Group Assignment||Screening||None (Open Label)||||||
1363088|NCT02774421|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363089|NCT02774408|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363090|NCT02774395|||Other||Prospective|||||||
1363091|NCT02774382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363092|NCT02774369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363093|NCT02774356|||Case Control||Cross-Sectional|||||||
1363094|NCT02774343|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363095|NCT02774330|||Other||Prospective|||||||
1363096|NCT02774317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363097|NCT02774304|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1363098|NCT02774291||Single Group Assignment||Treatment||None (Open Label)||||||
1363099|NCT02774278||Single Group Assignment||Treatment||None (Open Label)||||||
1363100|NCT02774265|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363101|NCT02774252||Single Group Assignment||Treatment||None (Open Label)||||||
1363102|NCT02774239||Single Group Assignment||Treatment||None (Open Label)||||||
1363103|NCT02774226|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363104|NCT02774213|||Case-Only||Prospective|||||||
1363105|NCT02774200||Single Group Assignment||Treatment||None (Open Label)||||||
1363106|NCT02774187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363107|NCT02774174|||Case-Control||Retrospective|||||||
1363108|NCT02774161||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363109|NCT02774148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363110|NCT02774135|||Cohort||Prospective|||||||
1363111|NCT02774122|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363112|NCT02774109|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363113|NCT02774096|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1363114|NCT02774083|Randomized|Parallel Assignment||Prevention||Single|||||t|
1363115|NCT02774070|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1363116|NCT02774057|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363117|NCT02774044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363118|NCT02774031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363119|NCT02774018||Single Group Assignment||Health Services Research||None (Open Label)||||||
1363120|NCT02774005||Single Group Assignment||Treatment||None (Open Label)||||||
1363121|NCT02773992|||Cohort||Prospective|||||||
1363122|NCT02773979|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1363123|NCT02773966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363124|NCT02773953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363125|NCT02773940||Single Group Assignment||Other||None (Open Label)||||||
1363126|NCT02773927|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363127|NCT02773914|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1363128|NCT02773901||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363129|NCT02773888||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363130|NCT02773875|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363131|NCT02773862||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363132|NCT02773849||Single Group Assignment||Treatment||None (Open Label)||||||
1363133|NCT02773836|||Cohort||Prospective|||||||
1363134|NCT02773823|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363135|NCT02773810||Single Group Assignment||Treatment||None (Open Label)||||||
1363136|NCT02773797|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1363137|NCT02773784|||Cohort||Prospective|||||||
1363138|NCT02773771|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1363139|NCT02773758|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1363140|NCT02773745|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1363141|NCT02773732||Single Group Assignment||Treatment||None (Open Label)||||||
1363142|NCT02773719|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363143|NCT02773706|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363144|NCT02773693|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363145|NCT02773680||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363146|NCT02773667|||Case-Only||Prospective|||||||
1363147|NCT02773654|||Cohort||Cross-Sectional|||||||
1363148|NCT02773641|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363149|NCT02773628|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363150|NCT02773615|||Cohort||Prospective|||||||
1363151|NCT02773602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363152|NCT02773589||Single Group Assignment||Treatment||None (Open Label)||||||
1363153|NCT02773576|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363154|NCT02773563|||Case-Control||Prospective|||||||
1363155|NCT02773550||Single Group Assignment||Treatment||None (Open Label)||||||
1363156|NCT02773537|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363157|NCT02773524|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363158|NCT02773511|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363159|NCT02773498|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1363160|NCT02773485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363161|NCT02773472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363162|NCT02773459|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363163|NCT02773446|Randomized|Parallel Assignment||Prevention||Single||||||t
1363164|NCT02773433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363165|NCT02773420||Single Group Assignment||Treatment||None (Open Label)||||||
1363166|NCT02773407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363167|NCT02773394|||Other||Retrospective|||||||
1363168|NCT02773381|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1363169|NCT02773368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363170|NCT02773355|||Cohort||Prospective|||||||
1363171|NCT02773342|||Cohort||Retrospective|||||||
1363172|NCT02773329|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1363173|NCT02773316|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363174|NCT02773303|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1363175|NCT02773290||Single Group Assignment||Treatment||None (Open Label)||||||
1363176|NCT02773277||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363177|NCT02773264|||Cohort||Prospective|||||||
1363178|NCT02773251|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363179|NCT02773238||Single Group Assignment||Treatment||None (Open Label)||||||
1363180|NCT02773225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363181|NCT02773212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363182|NCT02773199|||Cohort||Prospective|||||||
1363183|NCT02773186|||||Prospective|||||||
1363184|NCT02773173|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1363185|NCT02773160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363186|NCT02773147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363187|NCT02773134|Randomized|Parallel Assignment||Treatment||Single||||t||
1363188|NCT02773121|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363189|NCT02773108|||Cohort||Prospective|||||||
1363190|NCT02773095|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363191|NCT02773082||Single Group Assignment||Treatment||None (Open Label)||||||
1363192|NCT02773069||Single Group Assignment||Treatment||None (Open Label)||||||
1363193|NCT02773056|Randomized|Crossover Assignment||Other||Single||||||t
1363194|NCT02773043||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363195|NCT02773030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363196|NCT02773017|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363197|NCT02773004||Single Group Assignment||Other||None (Open Label)||||||
1363198|NCT02772991||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363199|NCT02772978||Single Group Assignment||Basic Science||Triple|||t||t|t
1363200|NCT02772965|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363201|NCT02772952|Randomized|Parallel Assignment||Treatment||Double||||t||t
1363202|NCT02772939||Single Group Assignment||Treatment||None (Open Label)||||||
1363203|NCT02772926|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1363204|NCT02772913|||Cohort||Retrospective|||||||
1363205|NCT02772900|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1363206|NCT02772887|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1363207|NCT02772874|||Case-Only||Cross-Sectional|||||||
1363208|NCT02772861|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1363209|NCT02772848|||Cohort||Prospective|||||||
1363210|NCT02772835|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363211|NCT02772822|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363212|NCT02772809||Single Group Assignment||Treatment||None (Open Label)||||||
1363213|NCT02772796||Single Group Assignment||Basic Science||None (Open Label)||||||
1363214|NCT02772783|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1363215|NCT02772770|||Cohort||Prospective|||||||
1363216|NCT02772757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363217|NCT02772744|||Cohort||Prospective|||||||
1363218|NCT02772731|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363219|NCT02772718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1363220|NCT02772705|||Case Control||Cross-Sectional|||||||
1363221|NCT02772692|Randomized|Parallel Assignment||Treatment||Single||||||t
1363222|NCT02772679||Single Group Assignment||Treatment||None (Open Label)||||||
1363223|NCT02772666|Non-Randomized|Single Group Assignment||Diagnostic||Double|||||t|t
1363224|NCT02772653|||Other||Prospective|||||||
1363225|NCT02772640|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363226|NCT02772627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363227|NCT02772614||Single Group Assignment||Treatment||None (Open Label)||||||
1363228|NCT02772601||Single Group Assignment||Treatment||None (Open Label)||||||
1363229|NCT02772588||Single Group Assignment||Treatment||None (Open Label)||||||
1363230|NCT02772575|||Cohort||Prospective|||||||
1363231|NCT02772562||Single Group Assignment||Treatment||None (Open Label)||||||
1363232|NCT02772549|||Cohort||Other|||||||
1363233|NCT02772536||Single Group Assignment||Basic Science||None (Open Label)||||||
1363234|NCT02772523||Single Group Assignment||Prevention||None (Open Label)||||||
1363235|NCT02772510|Randomized|Parallel Assignment||Treatment||Single||||||t
1363236|NCT02772497||Single Group Assignment||Treatment||None (Open Label)||||||
1363237|NCT02772484||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363238|NCT02772471||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363239|NCT02772458|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1363240|NCT02772445||Single Group Assignment||Supportive Care||None (Open Label)||||||
1363241|NCT02772432|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1363242|NCT02772419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363243|NCT02772406|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1363244|NCT02772380||Single Group Assignment||Device Feasibility||||Subjects who are undergoing a standard of care procedure will also undergo the ASD2 research procedure involving placing an investigational lead in the substernal space to gather electrograms during induced ventricular arrhythmias for future research/development.||||
1363245|NCT02772367|||Cohort||Prospective|||||||
1363246|NCT02772354|Randomized|Parallel Assignment||Treatment||Single||||||t
1363247|NCT02772341|Randomized|Parallel Assignment||||Triple|||t|t|t|
1363248|NCT02772328|Randomized|Parallel Assignment||Screening||Double|||||t|t
1363249|NCT02772315|||Cohort||Prospective|||||||
1363250|NCT02772302||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363251|NCT02772289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363252|NCT02772276|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363253|NCT02772263||Single Group Assignment||Prevention||None (Open Label)||||||
1363254|NCT02772250|Randomized|Parallel Assignment||Treatment||Single|||||t|
1363255|NCT02772237|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363256|NCT02772224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363257|NCT02772211|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363258|NCT02772198||Single Group Assignment||Treatment||None (Open Label)||||||
1363259|NCT02772185|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1363260|NCT02772172|Randomized|Parallel Assignment||Treatment||Single||||||t
1363261|NCT02772159||Single Group Assignment||Basic Science||None (Open Label)||||||
1363262|NCT02772146||Single Group Assignment||Supportive Care||None (Open Label)||||||
1363263|NCT02772133|||Case Control||Cross-Sectional|||||||
1363264|NCT02772120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363265|NCT02772107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363266|NCT02772094||Single Group Assignment||Treatment||None (Open Label)||||||
1363267|NCT02772081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363268|NCT02772068|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1363269|NCT02772055|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363270|NCT02772042|Randomized|Parallel Assignment||Treatment||Single||||||t
1363271|NCT02772029||Single Group Assignment||Treatment||None (Open Label)||||||
1363272|NCT02772016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363273|NCT02772003||Single Group Assignment||Prevention||Single||||||t
1363274|NCT02771990|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363275|NCT02771977|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363276|NCT02771964|||Cohort||Prospective|||||||
1363277|NCT02771951|Randomized|Factorial Assignment||Prevention||Single||||||t
1363278|NCT02771938||Single Group Assignment||Treatment||None (Open Label)||||||
1363279|NCT02771925|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363280|NCT02771912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363281|NCT02771899|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1363282|NCT02771886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363283|NCT02771873|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363284|NCT02771860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363285|NCT02771847|||Cohort||Prospective|||||||
1363286|NCT02771834|||Case Control||Prospective|||||||
1363287|NCT02771821|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363288|NCT02771808|||Case-Only||Prospective|||||||
1363289|NCT02771795|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363290|NCT02771782|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363291|NCT02771769|||Case-Only||Prospective|||||||
1363292|NCT02771756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363293|NCT02771743||Single Group Assignment||Treatment||None (Open Label)||||||
1363294|NCT02771730|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1363295|NCT02771717|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363296|NCT02771704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363297|NCT02771691|Randomized|Parallel Assignment||Treatment||Single||||||t
1363298|NCT02771678|||Cohort||Prospective|||||||
1363299|NCT02771665|||Case Control||Retrospective|||||||
1363300|NCT02771652|Randomized|Parallel Assignment||Treatment||Single||||||t
1363301|NCT02771639|||Cohort||Retrospective|||||||
1363302|NCT02771626|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1363303|NCT02771613|||Other||Prospective|||||||
1363304|NCT02771600|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363305|NCT02771587|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1363306|NCT02771574|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1363307|NCT02771561||Single Group Assignment||Treatment||None (Open Label)||||||
1363308|NCT02771548|||Cohort||Prospective|||||||
1363309|NCT02771535|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1363310|NCT02771522||Single Group Assignment||Other||None (Open Label)||||||
1363311|NCT02771509|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1363312|NCT02771496|||Cohort||Prospective|||||||
1363313|NCT02771483|||Cohort||Prospective|||||||
1363314|NCT02771470|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1363315|NCT02771457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363316|NCT02771444||Single Group Assignment||Diagnostic||None (Open Label)|This is an imaging study. All participants will be imaged using two modalities. All participant data will be deidentified.|||||
1363317|NCT02771431|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1363318|NCT02771418|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1363319|NCT02771405|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363320|NCT02771392|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1363321|NCT02771379|||Cohort||Prospective|||||||
1363322|NCT02771366|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1363323|NCT02771353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363324|NCT02771340|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363325|NCT02771327|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363326|NCT02771314||Single Group Assignment||||None (Open Label)||||||
1363327|NCT02771301||Single Group Assignment||Treatment||None (Open Label)||||||
1363328|NCT02771288||Single Group Assignment||Treatment||None (Open Label)||||||
1363329|NCT02771275||Single Group Assignment||Treatment||None (Open Label)||||||
1363330|NCT02771262|||Cohort||Prospective|||||||
1363331|NCT02771249||Single Group Assignment||Other||None (Open Label)||||||
1363332|NCT02771236|||Cohort||Prospective|||||||
1363333|NCT02771223|||Case-Only||Prospective|||||||
1363334|NCT02771210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363335|NCT02771197||Single Group Assignment||Treatment||None (Open Label)||||||
1363336|NCT02771184|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363337|NCT02771171|||Cohort||Retrospective|||||||
1363338|NCT02771158|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1363339|NCT02771145||Single Group Assignment||Supportive Care||None (Open Label)||||||
1363340|NCT02771132|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363341|NCT02771119||||||||||||
1363342|NCT02771106|||Case-Control||Prospective|||||||
1363343|NCT02771093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363344|NCT02771080|||Cohort||Retrospective|||||||
1363345|NCT02771067||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363346|NCT02771054||Single Group Assignment||Treatment||None (Open Label)||||||
1363347|NCT02771041|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1363348|NCT02771028|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363349|NCT02771015|Randomized|Parallel Assignment||||None (Open Label)||||||
1363350|NCT02771002|||Cohort||Prospective|||||||
1363351|NCT02770989||Single Group Assignment||Treatment||None (Open Label)||||||
1363352|NCT02770976||Single Group Assignment||Supportive Care||None (Open Label)||||||
1363353|NCT02770963|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363354|NCT02770950|Randomized|Parallel Assignment||Treatment||Single||||||t
1363355|NCT02770937|Randomized|Parallel Assignment||||Single||||||t
1363356|NCT02770924||Parallel Assignment||Treatment||None (Open Label)||||||
1363357|NCT02770911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363358|NCT02770898|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1363359|NCT02770885|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1363360|NCT02770872|||Case-Control||Cross-Sectional|||||||
1363361|NCT02770859|||Case-Only||Prospective|||||||
1363362|NCT02770846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363363|NCT02770833|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1363364|NCT02770820||Single Group Assignment||Treatment||None (Open Label)||||||
1363365|NCT02770807|Randomized|Parallel Assignment||Treatment||Triple|Double Blind ( Subject, Caregiver, Investigator)||t|t|t|
1363366|NCT02770794||Single Group Assignment||Treatment||None (Open Label)||||||
1363367|NCT02770781||Single Group Assignment||Supportive Care||None (Open Label)||||||
1363368|NCT02770768|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1363369|NCT02770755|||Case-Only||Prospective|||||||
1363370|NCT02770742|||Cohort||Prospective|||||||
1363371|NCT02770729|Randomized|Parallel Assignment||Prevention||Single|||t|||
1363372|NCT02770716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363373|NCT02770703|Randomized|Parallel Assignment||Treatment||Single||||||t
1363374|NCT02770690|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1363375|NCT02770677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363376|NCT02770664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363377|NCT02770651|||Case-Control||Prospective|||||||
1363378|NCT02770638|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1363379|NCT02770625||Single Group Assignment||Treatment||None (Open Label)||||||
1363380|NCT02770612||Single Group Assignment||Prevention||None (Open Label)||||||
1363381|NCT02770599|||Other||Retrospective|||||||
1363382|NCT02770586||Single Group Assignment||Basic Science||None (Open Label)||||||
1363383|NCT02770573||Single Group Assignment||Treatment||None (Open Label)||||||
1363384|NCT02770560|||Cohort||Retrospective|||||||
1363385|NCT02770547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363386|NCT02770534|||Case-Control||Prospective|||||||
1363387|NCT02770521|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1363388|NCT02770508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363389|NCT02770495||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363390|NCT02770482||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363391|NCT02770469|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1363392|NCT02770456|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1363393|NCT02770443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363394|NCT02770430|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363395|NCT02770417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363396|NCT02770404|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1363397|NCT02770391||Single Group Assignment||Treatment||None (Open Label)||||||
1363398|NCT02770378||Single Group Assignment||Treatment||None (Open Label)||||||
1363399|NCT02770365|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363400|NCT02770352|||Other||Prospective|||||||
1363401|NCT02770339|||Case-Only||Prospective|||||||
1363402|NCT02770326||Single Group Assignment||Treatment||None (Open Label)||||||
1363403|NCT02770313|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1363404|NCT02770300|Randomized|Parallel Assignment||Treatment||Double||||t||t
1363405|NCT02770287||Single Group Assignment||Treatment||None (Open Label)||||||
1363406|NCT02770274|Randomized|Parallel Assignment||Prevention||Single||||||t
1363407|NCT02770261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363408|NCT02770248|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363409|NCT02770235||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363410|NCT02770222|Randomized|Crossover Assignment||||None (Open Label)||||||
1363411|NCT02770209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363412|NCT02770196|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363414|NCT02770170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363415|NCT02770157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363416|NCT02770144|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363417|NCT02770131|||Other||Prospective|||||||
1363418|NCT02770118|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1363419|NCT02770105||Crossover Assignment||||Single|||t|||
1363420|NCT02770092|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363421|NCT02770079|||Case-Control||Prospective|||||||
1363422|NCT02770066|||Cohort||Prospective|||||||
1363423|NCT02770053|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363424|NCT02770040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363425|NCT02770027|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363426|NCT02770014||Single Group Assignment||Treatment||None (Open Label)||||||
1363427|NCT02770001|||Other||Other|||||||
1363428|NCT02769988|||Ecologic or Community||Prospective|||||||
1363429|NCT02769975|||Case-Only||Prospective|||||||
1363430|NCT02769962|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1363431|NCT02769949|||Other||Other|||||||
1363432|NCT02769936|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1363433|NCT02769923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363434|NCT02769910|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363435|NCT02769897|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363436|NCT02769884||Single Group Assignment||Treatment||None (Open Label)||Use the MMPPC system for 72 hours in a hotel setting||||
1363437|NCT02769871|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1363438|NCT02769858||Single Group Assignment||Treatment||None (Open Label)||||||
1363439|NCT02769845|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1363440|NCT02769832||Single Group Assignment||Treatment||None (Open Label)||||||
1363441|NCT02769819||Single Group Assignment||Other||None (Open Label)||||||
1363442|NCT02769806|||Case-Only||Prospective|||||||
1363443|NCT02769793|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363444|NCT02769780|||Case-Only||Prospective|||||||
1363445|NCT02769767|||Cohort||Retrospective|||||||
1363446|NCT02769754|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1363447|NCT02769741|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1363448|NCT02769728||Single Group Assignment||Treatment||None (Open Label)||||||
1363449|NCT02769715|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1363450|NCT02769702||Single Group Assignment||Treatment||None (Open Label)||||||
1363451|NCT02769689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363452|NCT02769676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363453|NCT02769663|||Case-Control||Prospective|||||||
1363454|NCT02769650|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1363455|NCT02769637|||Case-Crossover||Prospective|||||||
1363456|NCT02769624|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1363457|NCT02769611|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363458|NCT02769598|||Cohort||Prospective|||||||
1363459|NCT02769585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363460|NCT02769572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363461|NCT02769559|||Cohort||Retrospective|||||||
1363462|NCT02769546|||Cohort||Prospective|||||||
1363463|NCT02769533||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363464|NCT02769520|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363465|NCT02769507|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1363466|NCT02769494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363467|NCT02769481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363468|NCT02769468|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1363469|NCT02769455|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1363470|NCT02769442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363471|NCT02769429|||Cohort||Prospective|||||||
1363472|NCT02769416|||Cohort||Prospective|||||||
1363473|NCT02769403|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1363474|NCT02769390|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1363475|NCT02769377|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363476|NCT02769364|||Case-Only||Retrospective|||||||
1363477|NCT02769351|||Case-Only||Prospective|||||||
1363478|NCT02769338|Non-Randomized|Sequential Assignment||Health Services Research||None (Open Label)||Stepped-wedge||||
1363479|NCT02769325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363480|NCT02769312|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363481|NCT02769299|||Cohort||Prospective|||||||
1363482|NCT02769286|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363483|NCT02769273|||Case-Only||Prospective|||||||
1363484|NCT02769260|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1363485|NCT02769247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363486|NCT02769234|||Cohort||Prospective|||||||
1363487|NCT02769221|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363488|NCT02769208|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1363489|NCT02769195|||Cohort||Retrospective|||||||
1363490|NCT02769182|Randomized|Parallel Assignment||Treatment||Single|||||t|
1363491|NCT02769169|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363492|NCT02769156||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363493|NCT02769143|Randomized|Parallel Assignment||Treatment||Single||||||t
1363494|NCT02769130||Single Group Assignment||Treatment||None (Open Label)||||||
1363495|NCT02769117|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363496|NCT02769104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363497|NCT02769091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363498|NCT02769078|||Cohort||Retrospective|||||||
1363499|NCT02769065|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1363500|NCT02769052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363501|NCT02769039|||Cohort||Prospective|||||||
1363502|NCT02769026|||Cohort||Prospective|||||||
1363503|NCT02769013|||Case-Control||Prospective|||||||
1363504|NCT02769000||Single Group Assignment||Treatment||None (Open Label)||||||
1363505|NCT02768987|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1363506|NCT02768974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363507|NCT02768961||Single Group Assignment||Treatment||None (Open Label)||||||
1363508|NCT02768948|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363509|NCT02768935|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363510|NCT02768922|Randomized|Parallel Assignment||Treatment||Single||||||t
1363511|NCT02768909|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1363512|NCT02768896|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363513|NCT02768883|Randomized|Factorial Assignment||Prevention||Single||||||t
1363514|NCT02768870||Single Group Assignment||Treatment||None (Open Label)||||||
1363515|NCT02768857|Randomized|Parallel Assignment||Treatment||Single||||||t
1363516|NCT02768844||Single Group Assignment||Treatment||None (Open Label)||||||
1363517|NCT02768831||Single Group Assignment||Treatment||None (Open Label)||||||
1363518|NCT02768818|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1363519|NCT02768805|Randomized|Parallel Assignment||Prevention||Single||||||t
1363520|NCT02768792||Single Group Assignment||Treatment||None (Open Label)||||||
1363521|NCT02768779|||Cohort||Prospective|||||||
1363522|NCT02768766||Single Group Assignment||Treatment||None (Open Label)||||||
1363523|NCT02768753|||Case Control||Prospective|||||||
1363524|NCT02768740|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363525|NCT02768727||Single Group Assignment||Basic Science||None (Open Label)||||||
1363526|NCT02768714|Randomized|Parallel Assignment||Treatment||Single|||||t|
1363527|NCT02768701||Single Group Assignment||Treatment||None (Open Label)||||||
1363528|NCT02768688||Single Group Assignment||Basic Science||None (Open Label)||||||
1363529|NCT02768675||Single Group Assignment||Other||None (Open Label)||||||
1363530|NCT02768662||Single Group Assignment||Treatment||None (Open Label)||||||
1363531|NCT02768649|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363532|NCT02768636||Single Group Assignment||Basic Science||None (Open Label)||||||
1363533|NCT02768623|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363534|NCT02768610|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1363535|NCT02768597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363536|NCT02768584|||Case-Crossover||Prospective|||||||
1363537|NCT02768571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363538|NCT02768558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363539|NCT02768545||Single Group Assignment||Treatment||None (Open Label)||||||
1363540|NCT02768532||Single Group Assignment||Treatment||None (Open Label)||||||
1363541|NCT02768519|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1363542|NCT02768506|||Cohort||Prospective|||||||
1363543|NCT02768493|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1363544|NCT02768480|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363545|NCT02768467|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1363546|NCT02768454|||Case-Only||Retrospective|||||||
1363547|NCT02768441||Single Group Assignment||Treatment||None (Open Label)||||||
1363548|NCT02768428|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1363549|NCT02768415||Single Group Assignment||Treatment||None (Open Label)||||||
1363550|NCT02768402||Single Group Assignment||Treatment||None (Open Label)||||||
1363551|NCT02768389||Single Group Assignment||Treatment||None (Open Label)||||||
1363552|NCT02768376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363553|NCT02768363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363554|NCT02768350|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363555|NCT02768337|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1363556|NCT02768324|||Case-Control||Prospective|||||||
1363557|NCT02768311|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363558|NCT02768298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363559|NCT02768285|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363560|NCT02768272|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1363561|NCT02768259|||Cohort||Prospective|||||||
1363562|NCT02768246|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1363563|NCT02768233|Randomized|Parallel Assignment||Treatment||Single|||||t|
1363564|NCT02768220|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363565|NCT02768207||Single Group Assignment||Screening||None (Open Label)||||||
1363566|NCT02768194|Randomized|Crossover Assignment||Basic Science||Single||||||t
1363567|NCT02768181|Randomized|Factorial Assignment||Prevention||Single||||||t
1363568|NCT02768168|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1363569|NCT02768155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363570|NCT02768142|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363571|NCT02768129|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363572|NCT02768116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363573|NCT02768103||Single Group Assignment||Treatment||None (Open Label)||All participants complete 10 week task based training in home setting.||||
1363574|NCT02768090||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363575|NCT02768077|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363576|NCT02768064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363577|NCT02768051||Single Group Assignment||Treatment||None (Open Label)||||||
1363578|NCT02768038|||Cohort||Prospective|||||||
1363579|NCT02768025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363580|NCT02768012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363581|NCT02767999|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363582|NCT02767986|||Case-Only||Cross-Sectional|||||||
1363583|NCT02767973||Single Group Assignment||Screening||None (Open Label)||||||
1363584|NCT02767960|||Case-Control||Prospective|||||||
1363585|NCT02767947|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363586|NCT02767934||Single Group Assignment||Treatment||None (Open Label)||||||
1363587|NCT02767921||Single Group Assignment||Treatment||None (Open Label)||||||
1363588|NCT02767908|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363589|NCT02767895|Randomized|Parallel Assignment||Treatment||Single|||||t|
1363590|NCT02767882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363591|NCT02767869|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363592|NCT02767856|Randomized|Parallel Assignment||Treatment||Single||||||t
1363593|NCT02767843||Single Group Assignment||Treatment||None (Open Label)||||||
1363594|NCT02767830||Single Group Assignment||Prevention||None (Open Label)||||||
1363595|NCT02767817|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363596|NCT02767804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363597|NCT02767791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363598|NCT02767778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363599|NCT02767765||Single Group Assignment||Treatment||None (Open Label)||||||
1363600|NCT02767752|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363601|NCT02767739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363602|NCT02767726||Single Group Assignment||Screening||||||||
1363603|NCT02767713|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1363604|NCT02767700|||Cohort||Prospective|||||||
1363605|NCT02767687||Single Group Assignment||Supportive Care||None (Open Label)||||||
1363606|NCT02767674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363607|NCT02767661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363608|NCT02767648|||Cohort||Prospective|||||||
1363609|NCT02767635|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363610|NCT02767622|||Case Control||Prospective|||||||
1363611|NCT02767609||Single Group Assignment||Basic Science||None (Open Label)||||||
1363612|NCT02767596||Single Group Assignment||Treatment||None (Open Label)||||||
1363613|NCT02767583||Single Group Assignment||Screening||None (Open Label)||||||
1363614|NCT02767570|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363615|NCT02767557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363616|NCT02767544|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363617|NCT02767531|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363618|NCT02767518|Randomized|Parallel Assignment||Treatment||Single|||||t|
1363619|NCT02767505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363620|NCT02767492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363621|NCT02767479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363622|NCT02767466|||Case-Crossover||Prospective|||||||
1363623|NCT02767453|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363624|NCT02767440||Single Group Assignment||Treatment||None (Open Label)||||||
1363625|NCT02767427|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1363626|NCT02767414||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363627|NCT02767401|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363628|NCT02767388|||Cohort||Prospective|||||||
1363629|NCT02767375|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363630|NCT02767362||Single Group Assignment||Treatment||None (Open Label)||||||
1363631|NCT02767349||Single Group Assignment||Treatment||None (Open Label)||||||
1363632|NCT02767336||Single Group Assignment||||None (Open Label)||||||
1363633|NCT02767323|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1363634|NCT02767310|Randomized|Crossover Assignment||||None (Open Label)||||||
1363635|NCT02767297|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1363636|NCT02767284|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1363637|NCT02767271||Single Group Assignment||Treatment||None (Open Label)||||||
1363638|NCT02767258|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1363639|NCT02767245|Randomized|Parallel Assignment||Treatment||Single||||||t
1363640|NCT02767232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363641|NCT02767219|Randomized|Parallel Assignment||Treatment||Single||||||t
1363642|NCT02767206|||Other||Prospective|||||||
1363643|NCT02767193|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363644|NCT02767180|||Cohort||Other|||||||
1363645|NCT02767167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363646|NCT02767154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363647|NCT02767141|||Case-Only||Cross-Sectional|||||||
1363648|NCT02767128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363649|NCT02767115|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1363650|NCT02767102|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1363651|NCT02767089|Randomized|Crossover Assignment||||Single||||||
1363652|NCT02767076|Randomized|Parallel Assignment||||Single||||||t
1363653|NCT02767063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363654|NCT02767050|||Case Control||Cross-Sectional|||||||
1363655|NCT02767037|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1363656|NCT02767024|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363657|NCT02767011|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363658|NCT02766998||Single Group Assignment||Treatment||None (Open Label)||||||
1363659|NCT02766985|||Cohort||Prospective|||||||
1363660|NCT02766972||Single Group Assignment||Treatment||None (Open Label)||||||
1363661|NCT02766959|||Cohort||Prospective|||||||
1363662|NCT02766946|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1363663|NCT02766933|||Cohort||Prospective|||||||
1363664|NCT02766907|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1363665|NCT02766894|||Cohort||Prospective|||||||
1363666|NCT02766881|||Cohort||Prospective|||||||
1363667|NCT02766868||Single Group Assignment||Treatment||None (Open Label)||||||
1363668|NCT02766855||Single Group Assignment||Treatment||None (Open Label)||||||
1363669|NCT02766842|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1363670|NCT02766829|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363671|NCT02766816|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1363672|NCT02766803|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1363673|NCT02766790|Randomized|Parallel Assignment||||Double|||t||t|
1363674|NCT02766777||Single Group Assignment||Treatment||None (Open Label)||||||
1363675|NCT02766764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363676|NCT02766751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363677|NCT02766738|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1363678|NCT02766725|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363679|NCT02766712|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1363680|NCT02766699||Single Group Assignment||Treatment||None (Open Label)||||||
1363681|NCT02766686|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363682|NCT02766673|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1363683|NCT02766660|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1363684|NCT02766647|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1363685|NCT02766634|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1363686|NCT02766621|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1363687|NCT02766608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363688|NCT02766595||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363689|NCT02766582||Single Group Assignment||Treatment||None (Open Label)||||||
1363690|NCT02766569|||Cohort|||||||||
1363691|NCT02766556|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1363692|NCT02766543||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1363693|NCT02766530||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363694|NCT02766517||Single Group Assignment||Basic Science||None (Open Label)||||||
1363695|NCT02766504|||Cohort||Prospective|||||||
1363696|NCT02766491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363697|NCT02766478|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1363698|NCT02766465|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363699|NCT02766452|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1363700|NCT02766439|||Case-Only||Prospective|||||||
1363701|NCT02766426||Single Group Assignment||||None (Open Label)||||||
1363702|NCT02766400|Randomized|Parallel Assignment||Treatment||Single||||||t
1363703|NCT02766387||Single Group Assignment||Diagnostic||||||||
1363704|NCT02766374|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1363705|NCT02766361|Randomized|Parallel Assignment||Treatment||Single|||||t|
1363706|NCT02766348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363707|NCT02766335|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363708|NCT02766322|||Other||Other|||||||
1363709|NCT02766309|||||Cross-Sectional|||||||
1363710|NCT02766296|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363711|NCT02766283|||Cohort||Retrospective|||||||
1363712|NCT02766270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363713|NCT02766257||Single Group Assignment||||None (Open Label)||||||
1363714|NCT02766244||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363715|NCT02766231|||Cohort||Prospective|||||||
1363716|NCT02766218|||Cohort||Prospective|||||||
1363717|NCT02766205|||Cohort||Other|||||||
1363718|NCT02766192|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1363719|NCT02766179|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363720|NCT02766166|||Case-Control||Prospective|||||||
1363721|NCT02766153|||Other||Prospective|||||||
1363722|NCT02766140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363723|NCT02766127||Single Group Assignment||Treatment||None (Open Label)||||||
1363724|NCT02766114||Single Group Assignment||Treatment||None (Open Label)||||||
1363725|NCT02766101|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363726|NCT02766088||Single Group Assignment||Other||None (Open Label)||||||
1363727|NCT02766075|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1363728|NCT02766062|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1363729|NCT02766049|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363730|NCT02766036|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363731|NCT02766023|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1363732|NCT02766010||Single Group Assignment||Screening||None (Open Label)||||||
1363733|NCT02765997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363734|NCT02765984|||Case-Control||Prospective|||||||
1363735|NCT02765971|Randomized|Parallel Assignment||Prevention||Single||||||t
1363736|NCT02765958|||Case-Only||Prospective|||||||
1363737|NCT02765945||Single Group Assignment||Basic Science||None (Open Label)||||||
1363738|NCT02765932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363739|NCT02765919|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363740|NCT02765906|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1363741|NCT02765893|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363742|NCT02765880|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1363743|NCT02765867||Single Group Assignment||Treatment||None (Open Label)||||||
1363744|NCT02765854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363745|NCT02765841||Single Group Assignment||Treatment||None (Open Label)||||||
1363746|NCT02765828|||Case-Control||Cross-Sectional|||||||
1363747|NCT02765815|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363748|NCT02765802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363749|NCT02765789||Single Group Assignment||Treatment||None (Open Label)||||||
1363750|NCT02765776|||Cohort||Retrospective|||||||
1363751|NCT02765763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363752|NCT02765750|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1363753|NCT02765737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363754|NCT02765724|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1363755|NCT02765711|||Cohort||Prospective|||||||
1363756|NCT02765698|||Cohort||Prospective|||||||
1363757|NCT02765685|Randomized|Parallel Assignment||||None (Open Label)||||||
1363758|NCT02765672|Randomized|Parallel Assignment||Treatment||Single||||||t
1363759|NCT02765659|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363760|NCT02765646|||Cohort||Prospective|||||||
1363761|NCT02765633||Single Group Assignment||Prevention||None (Open Label)||||||
1363762|NCT02765620|||Case-Only||Prospective|||||||
1363763|NCT02765607|||Cohort||Prospective|||||||
1363764|NCT02765594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363765|NCT02765581|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1363766|NCT02765568|Randomized|Parallel Assignment||Other||Double|||||t|t
1363767|NCT02765555||Single Group Assignment||Treatment||None (Open Label)||||||
1363768|NCT02765542||Single Group Assignment||Health Services Research||None (Open Label)||||||
1363769|NCT02765529|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363770|NCT02765516|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1363771|NCT02765503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363772|NCT02765490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363773|NCT02765477|||Case Control||Retrospective|||||||
1363774|NCT02765464|||Cohort||Prospective|||||||
1363775|NCT02765451|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363776|NCT02765438||Single Group Assignment||Treatment||None (Open Label)||||||
1363777|NCT02765425|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363778|NCT02765412|||Case-Control||Prospective|||||||
1363779|NCT02765399|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363780|NCT02765386||Single Group Assignment||Treatment||None (Open Label)||||||
1363781|NCT02765373|||Cohort||Prospective|||||||
1363782|NCT02765360||Single Group Assignment||Treatment||None (Open Label)||||||
1363783|NCT02765347|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363784|NCT02765334||Single Group Assignment||Device Feasibility||None (Open Label)||Feasibility of nBETTER training (60 minutes) with conventional arm therapy (30minutes) for chronic stroke.||||
1363785|NCT02765321||Single Group Assignment||Prevention||None (Open Label)||||||
1363786|NCT02765308|||Case-Control||Prospective|||||||
1363787|NCT02765295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363788|NCT02765282|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1363789|NCT02765269|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363790|NCT02765256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363791|NCT02765243||Single Group Assignment||Treatment||None (Open Label)||||||
1363792|NCT02765230|||||Cross-Sectional|||||||
1363793|NCT02765217|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1363794|NCT02765204|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363795|NCT02765191||Single Group Assignment||Other||None (Open Label)||||||
1363796|NCT02765178|||Case-Control||Cross-Sectional|||||||
1363797|NCT02765165|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1363798|NCT02765152|Randomized|Parallel Assignment||Treatment||Single||||||t
1363799|NCT02765139|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363800|NCT02765126|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1364185|NCT02760095|||Case-Control||Prospective|||||||
1363801|NCT02765113|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363802|NCT02765100||Single Group Assignment||Other||None (Open Label)||||||
1363803|NCT02765087|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1363804|NCT02765074||Single Group Assignment||Treatment||None (Open Label)||||||
1363805|NCT02765061|||Case-Crossover||Retrospective|||||||
1363806|NCT02765048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363807|NCT02765035|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1363808|NCT02765022|Randomized|Parallel Assignment||Prevention||Single|||t|||
1363809|NCT02765009|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363810|NCT02764996||Single Group Assignment||Other||None (Open Label)||||||
1363811|NCT02764983|Randomized|Parallel Assignment||Treatment||Single||||||t
1363812|NCT02764970|||Cohort||Retrospective|||||||
1363813|NCT02764957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363814|NCT02764944||Single Group Assignment||Treatment||None (Open Label)||||||
1363815|NCT02764931|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1363816|NCT02764918|||Cohort||Prospective|||||||
1363817|NCT02764905|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363818|NCT02764892||Single Group Assignment||Basic Science||None (Open Label)||||||
1363819|NCT02764879|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363820|NCT02764866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363821|NCT02764853|Randomized|Parallel Assignment||Treatment||Single||||||t
1363822|NCT02764840|Randomized|Parallel Assignment||Other||Double|||||t|t
1363823|NCT02764827|||Case-Crossover||Cross-Sectional|||||||
1363824|NCT02764814|Randomized|Parallel Assignment||||None (Open Label)||||||
1363825|NCT02764801||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363826|NCT02764788|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363827|NCT02764775||Single Group Assignment||Treatment||None (Open Label)||Quasi-experimental, one-way repeated measures design||||
1363828|NCT02764762||Single Group Assignment||Treatment||None (Open Label)||||||
1363829|NCT02764749|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1363830|NCT02764736||Single Group Assignment||Treatment||None (Open Label)|Open label study|||||
1363831|NCT02764723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363832|NCT02764710|Randomized|Parallel Assignment||Prevention||Single||||||t
1363833|NCT02764697||Single Group Assignment||Treatment||None (Open Label)||||||
1363834|NCT02764684||Single Group Assignment||Prevention||None (Open Label)||||||
1363835|NCT02764671||Single Group Assignment||Prevention||None (Open Label)||||||
1363836|NCT02764658|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1363837|NCT02764645|Randomized|Parallel Assignment||Prevention||Single|||t|||
1363838|NCT02764632|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363839|NCT02764619|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363840|NCT02764606|||Cohort||Prospective|||||||
1363841|NCT02764593|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1363842|NCT02764580||||||||||||
1363843|NCT02764567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363844|NCT02764554|||Other||Prospective|||||||
1363845|NCT02764541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363846|NCT02764528|Randomized|Parallel Assignment||Prevention||Single|||t|||
1363847|NCT02764515|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363848|NCT02764502||Single Group Assignment||Health Services Research||None (Open Label)||||||
1363849|NCT02764489|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363850|NCT02764476|Randomized|Parallel Assignment||Treatment||Single||Single blinded randomized control trial for 8 weeks, then control group will be offered active treatment if desired.|t|||
1363851|NCT02764463||Single Group Assignment||Treatment||None (Open Label)||||||
1363852|NCT02764450|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1363853|NCT02764437||Single Group Assignment||Basic Science||None (Open Label)||||||
1363854|NCT02764424|||Cohort||Prospective|||||||
1363855|NCT02764411||Single Group Assignment||Treatment||None (Open Label)||||||
1363856|NCT02764398|||Case-Only||Prospective|||||||
1363857|NCT02764385|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363858|NCT02764372|Randomized|Parallel Assignment||Treatment||Single||||||t
1363859|NCT02764359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363860|NCT02764346|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363861|NCT02764333||Single Group Assignment||Treatment||None (Open Label)||||||
1363862|NCT02764320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363863|NCT02764307||Single Group Assignment||Health Services Research||None (Open Label)||||||
1363864|NCT02764294|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363865|NCT02764281||Single Group Assignment||Treatment||None (Open Label)||||||
1363866|NCT02764268||Single Group Assignment||Treatment||||||||
1363867|NCT02764255|||Case-Control||Prospective|||||||
1363868|NCT02764242||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363869|NCT02764229||Single Group Assignment||Treatment||None (Open Label)||||||
1363870|NCT02764216||Single Group Assignment||Treatment||None (Open Label)||||||
1363871|NCT02764203||Single Group Assignment||Basic Science||None (Open Label)||||||
1363872|NCT02764190|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1363873|NCT02764177|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1363874|NCT02764164||Single Group Assignment||Treatment||None (Open Label)||||||
1363875|NCT02764151||||Treatment||None (Open Label)||||||
1364186|NCT02760082||||||||||||
1363876|NCT02764138|Randomized|Parallel Assignment||Prevention||Single||||||t
1363877|NCT02764125|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1363878|NCT02764112|||||Prospective|||||||
1363879|NCT02764099|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363880|NCT02764086||Single Group Assignment||Treatment||None (Open Label)||||||
1363881|NCT02764073|||Cohort||Prospective|||||||
1363882|NCT02764060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363883|NCT02764047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363884|NCT02764034||||||||||||
1363885|NCT02764021|Randomized|Crossover Assignment||Treatment||None (Open Label)|Open Label|||||
1363886|NCT02764008|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363887|NCT02763995||Single Group Assignment||||None (Open Label)||||||
1363888|NCT02763982|||Case-Only||Cross-Sectional|||||||
1363889|NCT02763969|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1363890|NCT02763956|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1363891|NCT02763943||Single Group Assignment||Prevention||||||||
1363892|NCT02763930|Randomized|Crossover Assignment||Prevention||Single||||||t
1363893|NCT02763917|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1363894|NCT02763904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363895|NCT02763891|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1363896|NCT02763878|Randomized|Parallel Assignment||Prevention||Single|||||t|
1363897|NCT02763865|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363898|NCT02763852|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1363899|NCT02763839|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1363900|NCT02763826||Single Group Assignment||Treatment||None (Open Label)||||||
1363901|NCT02763813|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363902|NCT02763800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363903|NCT02763787|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363904|NCT02763774|Randomized|Parallel Assignment||Treatment||Single|||||t|
1363905|NCT02763761|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363906|NCT02763748|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363907|NCT02763735|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363908|NCT02763722||Single Group Assignment||Treatment||None (Open Label)||||||
1363909|NCT02763709|||Cohort||Prospective|||||||
1363910|NCT02763696|||Cohort||Cross-Sectional|||||||
1363911|NCT02763683|||Case-Control||Prospective|||||||
1363912|NCT02763670|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363913|NCT02763657||Single Group Assignment||Basic Science||None (Open Label)||||||
1363914|NCT02763644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363915|NCT02763631|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1363916|NCT02763618|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1363917|NCT02763605|||Cohort||Retrospective|||||||
1363918|NCT02763592|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363919|NCT02763579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363920|NCT02763566|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1363921|NCT02763553|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1363922|NCT02763540||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363923|NCT02763527|Randomized|Parallel Assignment||Treatment||Single||||||t
1363924|NCT02763514|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1363925|NCT02763501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363926|NCT02763488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363927|NCT02763475||Single Group Assignment||Treatment||None (Open Label)||||||
1363928|NCT02763462|||Case-Only||Prospective|||||||
1363929|NCT02763449|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1363930|NCT02763436|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363931|NCT02763423||Single Group Assignment||Treatment||None (Open Label)||||||
1363932|NCT02763410|||Case-Control||Prospective|||||||
1363933|NCT02763397|Randomized|Crossover Assignment||Treatment||Single|||t|||
1363934|NCT02763384||Single Group Assignment||Treatment||None (Open Label)||||||
1363935|NCT02763371|Randomized|Crossover Assignment||||None (Open Label)||||||
1363936|NCT02763358||Single Group Assignment||Other||None (Open Label)||||||
1363937|NCT02763345|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1363938|NCT02763332|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1363939|NCT02763319|Randomized|Parallel Assignment||Treatment||Single|Outcome assessor: blinding on treatment group|||||t
1363940|NCT02763306||Single Group Assignment||Treatment||None (Open Label)||||||
1363941|NCT02763293|Non-Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1363942|NCT02763280|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1363943|NCT02763267|||Cohort||Prospective|||||||
1363944|NCT02763254||Single Group Assignment||Treatment||None (Open Label)||||||
1363945|NCT02763241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363946|NCT02763228|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363947|NCT02763215|||Cohort||Prospective|||||||
1363948|NCT02763202|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1363949|NCT02763189|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363950|NCT02763176|||Other||Prospective|||||||
1363951|NCT02763163|||Cohort|||||||||
1363952|NCT02763150|Randomized|Parallel Assignment||Prevention||Single||||||t
1364480|NCT02756260||||||||||||
1363953|NCT02763137|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363954|NCT02763124||Single Group Assignment||Treatment||None (Open Label)||||||
1363955|NCT02763111|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363956|NCT02763098|Randomized|Parallel Assignment||||Triple|||t|t|t|
1363957|NCT02763085||Single Group Assignment||Treatment||None (Open Label)||||||
1363958|NCT02763072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363959|NCT02763059|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1363960|NCT02763046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363961|NCT02763033|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1363962|NCT02763020|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1363963|NCT02763007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363964|NCT02762994|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363965|NCT02762981||Single Group Assignment||Treatment||None (Open Label)||||||
1363966|NCT02762968|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1363967|NCT02762955|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363968|NCT02762942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363969|NCT02762929|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1363970|NCT02762916|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363971|NCT02762903|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1363972|NCT02762890|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1363973|NCT02762877|||||Prospective|||||||
1363974|NCT02762864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363975|NCT02762851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363976|NCT02762838|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363977|NCT02762825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363978|NCT02762812|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1363979|NCT02762799|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1363980|NCT02762786|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1363981|NCT02762773|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363982|NCT02762760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1363983|NCT02762747|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1363984|NCT02762734|Randomized|Parallel Assignment||Prevention||Single|||t|||
1363985|NCT02762721|||Case-Only||Cross-Sectional|||||||
1363986|NCT02762708|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1363987|NCT02762695|Randomized|Parallel Assignment||Treatment||Single||||||t
1363988|NCT02762682|||Case Control||Cross-Sectional|||||||
1363989|NCT02762669|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363990|NCT02762656|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1363991|NCT02762643|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1363992|NCT02762630|||Cohort||Cross-Sectional|||||||
1363993|NCT02762617|Randomized|Parallel Assignment||Prevention||Single|||t|||
1363994|NCT02762604|Randomized|Parallel Assignment||Treatment||Single|||t|||
1363995|NCT02762591||||||||||||
1363996|NCT02762578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1363997|NCT02762565||Single Group Assignment||Diagnostic||||||||
1363998|NCT02762552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1363999|NCT02762539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364000|NCT02762526|||Cohort||Prospective|||||||
1364001|NCT02762513||Single Group Assignment||Treatment||None (Open Label)||||||
1364002|NCT02762500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364003|NCT02762487||Single Group Assignment||Treatment||None (Open Label)||||||
1364004|NCT02762474||Single Group Assignment||Treatment||None (Open Label)||||||
1364005|NCT02762461|||Cohort||Prospective|||||||
1364006|NCT02762448|||Cohort||Prospective|||||||
1364007|NCT02762435|Randomized|Parallel Assignment||Treatment||Single||||||t
1364008|NCT02762422|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1364009|NCT02762409|||Cohort||Prospective|||||||
1364010|NCT02762396|||Case-Only||Prospective|||||||
1364011|NCT02762383||Single Group Assignment||Treatment||None (Open Label)||||||
1364012|NCT02762370|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364013|NCT02762357|||Cohort||Prospective|||||||
1364014|NCT02762344|||Cohort||Prospective|||||||
1364015|NCT02762331|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1364016|NCT02762318|||Family-Based||Prospective|||||||
1364017|NCT02762305||Single Group Assignment||Supportive Care||None (Open Label)||||||
1364018|NCT02762292||Single Group Assignment||Other||None (Open Label)||||||
1364019|NCT02762279||Single Group Assignment||Basic Science||None (Open Label)||||||
1364020|NCT02762266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364021|NCT02762253||Single Group Assignment||Treatment||None (Open Label)||||||
1364022|NCT02762240|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1364023|NCT02762227||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364024|NCT02762214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364025|NCT02762201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364026|NCT02762188||Single Group Assignment||Basic Science||None (Open Label)||||||
1364027|NCT02762175|||Cohort||Prospective|||||||
1364028|NCT02762162|||Cohort||Prospective|||||||
1364029|NCT02762149|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364030|NCT02762136|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364031|NCT02762123|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1364032|NCT02762097|Non-Randomized|Parallel Assignment||Treatment||Single||||t||
1364033|NCT02762084|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364034|NCT02762071|Randomized|Parallel Assignment||Treatment||Single||||||t
1364035|NCT02762058|Randomized|Parallel Assignment||Treatment||Double||||t||t
1364036|NCT02762045|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364037|NCT02762032|Randomized|Parallel Assignment||Other||Single||||||t
1364038|NCT02762019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364039|NCT02762006||Single Group Assignment||Treatment||None (Open Label)||||||
1364040|NCT02761993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364041|NCT02761980|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364042|NCT02761967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364043|NCT02761954|||Other||Prospective|||||||
1364044|NCT02761941|||Cohort|||||||||
1364045|NCT02761928|||Cohort||Prospective|||||||
1364046|NCT02761915|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1364047|NCT02761902|||Ecologic or Community|||||||||
1364048|NCT02761889||Single Group Assignment||Treatment||None (Open Label)||||||
1364049|NCT02761876|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364050|NCT02761863|||Other||Prospective|||||||
1364051|NCT02761850|||Cohort||Prospective|||||||
1364052|NCT02761837|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|This is a pragmatic controlled trial. Participants randomized to the intervention group will know when they receive the intervention, which will consist of an automated contact by IVR call/text, or email.|Participants were randomized to either 1) usual care or 2) IVR or 3) email. Those in the groups 2 or 3 will receive the intervention only if they smoke, underuse controller medication, or overuse rescue medication.||||
1364053|NCT02761824||Single Group Assignment||Treatment||None (Open Label)||||||
1364054|NCT02761811|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364055|NCT02761798|||Cohort||Prospective|||||||
1364056|NCT02761785|||Case-Control||Cross-Sectional|||||||
1364057|NCT02761772|||Cohort||Prospective|||||||
1364058|NCT02761759||||||||||||
1364059|NCT02761746|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364060|NCT02761733|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364061|NCT02761720|||Cohort||Prospective|||||||
1364062|NCT02761707|||Case-Control||Cross-Sectional|||||||
1364063|NCT02761694||Single Group Assignment||Treatment||None (Open Label)||||||
1364064|NCT02761681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364065|NCT02761668|Randomized|Parallel Assignment||Treatment||Single||||||t
1364066|NCT02761655|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1364067|NCT02761642||Single Group Assignment||Treatment||None (Open Label)||||||
1364068|NCT02761629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364069|NCT02761616|||Cohort||Retrospective|||||||
1364070|NCT02761603|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1364071|NCT02761590|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1364072|NCT02761577|Randomized|Parallel Assignment||Prevention||Single|||||t|
1364073|NCT02761564|Randomized|Parallel Assignment||Other||Single|||t|||
1364074|NCT02761551|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1364075|NCT02761538|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364076|NCT02761525|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1364077|NCT02761512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364078|NCT02761499|||Cohort||Prospective|||||||
1364079|NCT02761486|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1364080|NCT02761473|||Family-Based||Prospective|||||||
1364081|NCT02761460||Single Group Assignment||Treatment||None (Open Label)||||||
1364082|NCT02761447|Randomized|Parallel Assignment||Treatment||Single||||||t
1364083|NCT02761434|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1364084|NCT02761421|||Cohort||Prospective|||||||
1364085|NCT02761408|||Cohort||Prospective|||||||
1364086|NCT02761395|Randomized|Parallel Assignment||Treatment||Single||||||t
1364087|NCT02761382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364088|NCT02761369|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364089|NCT02761356|||Case-Only||Retrospective|||||||
1364090|NCT02761343||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364091|NCT02761330|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1364092|NCT02761317|Randomized|Parallel Assignment||Treatment||Single|||||t|
1364093|NCT02761304|Randomized|Parallel Assignment||Prevention||Single||||t||
1364094|NCT02761291||Single Group Assignment||Treatment||None (Open Label)||||||
1364095|NCT02761278|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364096|NCT02761265|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1364097|NCT02761252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364098|NCT02761239||Single Group Assignment||Basic Science||None (Open Label)||||||
1364099|NCT02761226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364100|NCT02761213|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1364101|NCT02761200|||Cohort||Prospective|||||||
1364102|NCT02761187|||Case-Only||Prospective|||||||
1364103|NCT02761174|Randomized|Parallel Assignment||Treatment||Single||||||t
1364104|NCT02761161|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1364105|NCT02761148|||Cohort||Prospective|||||||
1364106|NCT02761135|||Case-Control||Prospective|||||||
1364107|NCT02761122||Single Group Assignment||Basic Science||None (Open Label)||||||
1364108|NCT02761109|||Cohort||Prospective|||||||
1364109|NCT02761096|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364110|NCT02761083|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364111|NCT02761070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364112|NCT02761057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364113|NCT02761031|||Case-Only||Prospective|||||||
1364114|NCT02761018|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364115|NCT02761005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364116|NCT02760992|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364117|NCT02760979|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1364118|NCT02760966|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364119|NCT02760953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364120|NCT02760940||Single Group Assignment||Treatment||None (Open Label)||||||
1364121|NCT02760927||Single Group Assignment||Supportive Care||None (Open Label)||||||
1364122|NCT02760914|||Cohort||Prospective|||||||
1364123|NCT02760901|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364124|NCT02760888|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1364125|NCT02760875|||||Cross-Sectional|||||||
1364126|NCT02760862|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364127|NCT02760849|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364128|NCT02760836|||Case-Only||Prospective|||||||
1364129|NCT02760823|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364130|NCT02760810||Single Group Assignment||Treatment||None (Open Label)||||||
1364131|NCT02760797|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1364132|NCT02760784|||Case-Control||Cross-Sectional|||||||
1364133|NCT02760771|||Case-Control||Prospective|||||||
1364134|NCT02760758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364135|NCT02760745|||Case Control||Prospective|||||||
1364136|NCT02760732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364137|NCT02760719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364138|NCT02760706|||Case-Only||Prospective|||||||
1364139|NCT02760693|||Cohort||Prospective|||||||
1364140|NCT02760680|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1364141|NCT02760667||Single Group Assignment||Treatment||None (Open Label)||||||
1364142|NCT02760654|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1364143|NCT02760641|Randomized|Parallel Assignment||Treatment||Single|||||t|
1364144|NCT02760628|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364145|NCT02760615|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364146|NCT02760602|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364147|NCT02760589|||Cohort||Retrospective|||||||
1364148|NCT02760576||Single Group Assignment||Treatment||None (Open Label)||||||
1364149|NCT02760563||Single Group Assignment||Treatment||None (Open Label)||||||
1364150|NCT02760550|||Cohort||Retrospective|||||||
1364151|NCT02760537|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364152|NCT02760524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364153|NCT02760511|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1364154|NCT02760498|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364155|NCT02760485||Single Group Assignment||Treatment||None (Open Label)||||||
1364156|NCT02760472|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364157|NCT02760459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364158|NCT02760446||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364159|NCT02760433|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364160|NCT02760420|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364161|NCT02760407|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364162|NCT02760394|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364163|NCT02760381||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364164|NCT02760368|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364165|NCT02760355||Single Group Assignment||Basic Science||None (Open Label)||||||
1364166|NCT02760342||Single Group Assignment||Basic Science||None (Open Label)||||||
1364167|NCT02760329|||Cohort||Prospective|||||||
1364168|NCT02760316|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364169|NCT02760303|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1364170|NCT02760290|Randomized|Parallel Assignment||Prevention||Single||||||t
1364171|NCT02760277|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364172|NCT02760264|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364173|NCT02760251||Single Group Assignment||Treatment||None (Open Label)||||||
1364174|NCT02760238|||Cohort||Other|||||||
1364175|NCT02760225||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364176|NCT02760212|Randomized|Crossover Assignment||Treatment||Single|||t|||
1364177|NCT02760199||Single Group Assignment||Treatment||None (Open Label)||||||
1364178|NCT02760186||Single Group Assignment||Prevention||None (Open Label)||||||
1364179|NCT02760173||Single Group Assignment||Basic Science||None (Open Label)||||||
1364180|NCT02760160||Single Group Assignment||Treatment||None (Open Label)||||||
1364181|NCT02760147|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1364182|NCT02760134|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1364183|NCT02760121|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1364184|NCT02760108|||Family-Based||Cross-Sectional|||||||
1364187|NCT02760069|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364188|NCT02760056|Randomized|Sequential Assignment||Treatment||Quadruple|Double-blind, randomized, controlled|Dose escalation with monitoring for safety and tolerability, as well as reliability of VEP testing.|t|t|t|t
1364189|NCT02760043|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1364190|NCT02760030||Single Group Assignment||Treatment||None (Open Label)||||||
1364191|NCT02760017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364192|NCT02760004|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1364193|NCT02759991|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1364194|NCT02759978|||Cohort||Prospective|||||||
1364195|NCT02759965|||||Prospective|||||||
1364196|NCT02759952|||Cohort||Prospective|||||||
1364197|NCT02759939|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1364198|NCT02759926|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1364199|NCT02759913|||Cohort||Prospective|||||||
1364200|NCT02759900||Single Group Assignment||Treatment||None (Open Label)||||||
1364201|NCT02759887|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364202|NCT02759874|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1364203|NCT02759861||Single Group Assignment||Treatment||None (Open Label)||||||
1364204|NCT02759848|||Cohort||Prospective|||||||
1364205|NCT02759835|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364206|NCT02759822|||Cohort||Prospective|||||||
1364207|NCT02759809|||Cohort||Prospective|||||||
1364208|NCT02759796|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364209|NCT02759783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364210|NCT02759770||||||||||||
1364211|NCT02759757|Randomized|Parallel Assignment||Treatment||Single||||||t
1364212|NCT02759744||Single Group Assignment||Treatment||None (Open Label)||||||
1364213|NCT02759731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1364214|NCT02759718||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364215|NCT02759705|||Cohort||Prospective|||||||
1364216|NCT02759692|Randomized|Crossover Assignment||Treatment||Single|||t|||
1364217|NCT02759679|Non-Randomized|Parallel Assignment||Diagnostic||Triple||||t|t|t
1364218|NCT02759666||Single Group Assignment||Treatment||None (Open Label)||||||
1364219|NCT02759653|||Cohort||Prospective|||||||
1364220|NCT02759640||Single Group Assignment||Treatment||None (Open Label)||||||
1364221|NCT02759627|Randomized|Parallel Assignment||Treatment||Single||||||t
1364222|NCT02759614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364223|NCT02759601||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1364224|NCT02759588||Single Group Assignment||Treatment||None (Open Label)||||||
1364225|NCT02759575||Single Group Assignment||Treatment||None (Open Label)||||||
1364226|NCT02759562|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364227|NCT02759549|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364228|NCT02759536||Single Group Assignment||Treatment||None (Open Label)||||||
1364229|NCT02759523|||Cohort|||||||||
1364230|NCT02759510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364231|NCT02759497|||Case-Control||Cross-Sectional|||||||
1364232|NCT02759484|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1364233|NCT02759471||Single Group Assignment||||Single|||t|||
1364234|NCT02759458|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364235|NCT02759445|||Case-Only||Prospective|||||||
1364236|NCT02759432|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364237|NCT02759419||Single Group Assignment||Treatment||None (Open Label)||||||
1364238|NCT02759406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364239|NCT02759393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364240|NCT02759380|Randomized|Parallel Assignment||Prevention||Single||||||t
1364241|NCT02759367|Randomized|Parallel Assignment||Treatment||None (Open Label)|Treating physicians and participants were not blinded to randomization. Investigators performing randomization and analysis of dietary intake were blinded.|||||
1364242|NCT02759354|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364243|NCT02759341|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364244|NCT02759328|Randomized|Parallel Assignment||Treatment||Single||||||t
1364245|NCT02759315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364246|NCT02759302|||Case-Only||Prospective|||||||
1364247|NCT02759289|||Case-Crossover||Prospective|||||||
1364248|NCT02759276|||||Cross-Sectional|||||||
1364249|NCT02759263|Randomized|Parallel Assignment||Other||Single||||||t
1364250|NCT02759250|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364251|NCT02759237|||Other||Prospective|||||||
1364252|NCT02759224|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364253|NCT02759211|Randomized|Parallel Assignment||Treatment||Single||||||t
1364254|NCT02759198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364255|NCT02759185|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1364256|NCT02759172|Randomized|Parallel Assignment||Treatment||Single||||||t
1364257|NCT02759159|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1364258|NCT02759146|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1364259|NCT02759133|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364260|NCT02759120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364261|NCT02759107|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1364262|NCT02759094||Single Group Assignment||Treatment||None (Open Label)||||||
1364263|NCT02759081|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1364264|NCT02759068|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364265|NCT02759055|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364266|NCT02759042||||||||||||
1364267|NCT02759029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364268|NCT02759016||Single Group Assignment||Treatment||None (Open Label)||||||
1364269|NCT02759003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364270|NCT02758990|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364271|NCT02758977|Randomized|Parallel Assignment||Treatment||Single||||||t
1364272|NCT02758964|||Cohort||Prospective|||||||
1364273|NCT02758951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364274|NCT02758938|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1364275|NCT02758925||Single Group Assignment||Treatment||None (Open Label)||||||
1364276|NCT02758912|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1364277|NCT02758899|||Cohort||Prospective|||||||
1364278|NCT02758886|Randomized|Parallel Assignment||Prevention||Single|||t|||
1364279|NCT02758873|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364280|NCT02758860|||Cohort||Prospective|||||||
1364281|NCT02758847||Single Group Assignment||Treatment||None (Open Label)||||||
1364282|NCT02758834|||Cohort||Prospective|||||||
1364283|NCT02758821|Randomized|Parallel Assignment||Other||Double|||t||t|
1364284|NCT02758808|||Cohort||Prospective|||||||
1364285|NCT02758795|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1364286|NCT02758782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364287|NCT02758769|||Case-Only||Prospective|||||||
1364288|NCT02758756|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364289|NCT02758743|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1364290|NCT02758730|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364291|NCT02758717||Single Group Assignment||Treatment||None (Open Label)||||||
1364292|NCT02758704|Randomized|Crossover Assignment||Other||Single|||t|||
1364293|NCT02758691|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1364294|NCT02758678|||Cohort||Prospective|||||||
1364295|NCT02758665||Single Group Assignment||Treatment||None (Open Label)||||||
1364296|NCT02758652|||Case-Only||Prospective|||||||
1364297|NCT02758639|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364298|NCT02758626|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1364299|NCT02758613|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1364300|NCT02758600|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1364301|NCT02758587|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364302|NCT02758574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364303|NCT02758561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364304|NCT02758548||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364305|NCT02758535|Randomized|Parallel Assignment||||Single|||t|||
1364306|NCT02758522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364307|NCT02758509|||Cohort||Prospective|||||||
1364308|NCT02758496|||Cohort||Retrospective|||||||
1364309|NCT02758483|Non-Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1364310|NCT02758470|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1364311|NCT02758457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364312|NCT02758444|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1364313|NCT02758431|Randomized|Parallel Assignment||Other||Double|||t||t|
1364314|NCT02758418|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364315|NCT02758405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364316|NCT02758392|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364317|NCT02758379||Single Group Assignment||Treatment||None (Open Label)||||||
1364318|NCT02758366||Single Group Assignment||Treatment||None (Open Label)||||||
1364319|NCT02758353||Single Group Assignment||Health Services Research||None (Open Label)||||||
1364320|NCT02758340|Randomized|Parallel Assignment||||None (Open Label)||||||
1364321|NCT02758327||Single Group Assignment||Treatment||None (Open Label)||||||
1364322|NCT02758314|||Case Control||Prospective|||||||
1364323|NCT02758301|||Cohort||Prospective|||||||
1364324|NCT02758288|||Other||Prospective|||||||
1364325|NCT02758275|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1364326|NCT02758262|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1364327|NCT02758249|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1364328|NCT02758236|||Cohort||Prospective|||||||
1364329|NCT02758223||Single Group Assignment||Treatment||None (Open Label)||||||
1364330|NCT02758210||Single Group Assignment||Other||None (Open Label)||||||
1364331|NCT02758197|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1364332|NCT02758184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364333|NCT02758171|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364334|NCT02758158||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364335|NCT02758145|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364336|NCT02758132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364337|NCT02758119|Randomized|Parallel Assignment||Other||Single||||||t
1364338|NCT02758106|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1364339|NCT02758093|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364340|NCT02758080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364341|NCT02758067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364342|NCT02758054|Randomized|Parallel Assignment||Screening||Single|||||t|
1364343|NCT02758041||Single Group Assignment||Treatment||None (Open Label)||||||
1364344|NCT02758028||Single Group Assignment||Health Services Research||None (Open Label)||||||
1364345|NCT02758015|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1364346|NCT02758002||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364347|NCT02757989|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364348|NCT02757976|Randomized|Parallel Assignment||Treatment||None (Open Label)||This trial will compare two management strategies for patients with Heart Failure, left ventricular systolic dysfunction, and intermediate prolonged QRS duration (120-149ms). The control group is conventional Cardiac Resynchronization Therapy (CRT). The experimental group is LV endocardial CRT.||||
1364349|NCT02757963||Single Group Assignment||Screening||None (Open Label)||||||
1364350|NCT02757950|||Cohort||Prospective|||||||
1364351|NCT02757937|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364352|NCT02757924||Single Group Assignment||Other||None (Open Label)||||||
1364353|NCT02757911||Single Group Assignment||Treatment||None (Open Label)||||||
1364354|NCT02757898||Single Group Assignment||Basic Science||None (Open Label)||||||
1364355|NCT02757885|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1364356|NCT02757872|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1364357|NCT02757859|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1364358|NCT02757846|||Cohort||Retrospective|||||||
1364359|NCT02757833|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1364360|NCT02757820|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1364361|NCT02757807||Single Group Assignment||Treatment||None (Open Label)||||||
1364362|NCT02757794|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364363|NCT02757781|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1364364|NCT02757768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364365|NCT02757755|Randomized|||||Double|||t||t|
1364366|NCT02757742|||Cohort||Prospective|||||||
1364367|NCT02757729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364368|NCT02757716|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364369|NCT02757703|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364370|NCT02757690|Randomized|Parallel Assignment||||Single|||||t|
1364371|NCT02757677|||Cohort||Prospective|||||||
1364372|NCT02757664|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364373|NCT02757651|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1364374|NCT02757638|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364375|NCT02757625||Single Group Assignment||Treatment||None (Open Label)||||||
1364376|NCT02757612|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1364377|NCT02757599|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364378|NCT02757586|||Case-Crossover||Cross-Sectional|||||||
1364379|NCT02757573||Single Group Assignment||Treatment||None (Open Label)||||||
1364380|NCT02757560|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1364381|NCT02757547|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1364382|NCT02757534||Single Group Assignment||Treatment||None (Open Label)||||||
1364383|NCT02757521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364384|NCT02757508|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1364385|NCT02757495|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1364386|NCT02757482|Randomized|Parallel Assignment||||None (Open Label)||||||
1364387|NCT02757469||Single Group Assignment||Treatment||None (Open Label)||||||
1364388|NCT02757456|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364389|NCT02757443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364390|NCT02757430|||Cohort||Prospective|||||||
1364391|NCT02757417|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364392|NCT02757404|Randomized|Parallel Assignment||Treatment||Single||||||t
1364393|NCT02757391||Single Group Assignment||Treatment||None (Open Label)||||||
1364394|NCT02757378|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364395|NCT02757365|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364396|NCT02757352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364397|NCT02757339|||Case-Control||Cross-Sectional|||||||
1364398|NCT02757326||Single Group Assignment||Treatment||None (Open Label)||||||
1364399|NCT02757313|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1364400|NCT02757300|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364401|NCT02757287||Single Group Assignment||Treatment||None (Open Label)||||||
1364402|NCT02757274|||Cohort||Prospective|||||||
1364403|NCT02757261|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1364404|NCT02757248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1364405|NCT02757235|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364406|NCT02757222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364407|NCT02757209|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1364408|NCT02757196|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364409|NCT02757183|||Case-Only||Prospective|||||||
1364410|NCT02757170|Non-Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1364411|NCT02757157|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364412|NCT02757144|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1364413|NCT02757131|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1364414|NCT02757118|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364415|NCT02757105|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364416|NCT02757092|Randomized|Parallel Assignment||Prevention||Single|||t|||
1364417|NCT02757079||Single Group Assignment||Treatment||None (Open Label)||||||
1364418|NCT02757066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364419|NCT02757053|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1364420|NCT02757040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364421|NCT02757027|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364422|NCT02757014||Single Group Assignment||Treatment||None (Open Label)||||||
1364423|NCT02757001|||Cohort||Prospective|||||||
1364424|NCT02756988||Single Group Assignment||Treatment||None (Open Label)||||||
1364425|NCT02756975|Randomized|Parallel Assignment||||Single|||t|||
1364426|NCT02756962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364427|NCT02756949|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364428|NCT02756936|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1364429|NCT02756923|||Cohort||Prospective|||||||
1364430|NCT02756910|||Cohort||Prospective|||||||
1364431|NCT02756897||Single Group Assignment||Treatment||None (Open Label)||||||
1364432|NCT02756884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364433|NCT02756871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364434|NCT02756858||Single Group Assignment||Treatment||None (Open Label)||||||
1364435|NCT02756845||Single Group Assignment||Treatment||None (Open Label)||"Approximately 18 treated pediatric subjects are expected to be enrolled into 2 cohorts stratified by age (permissible based on the incidence of DLTs, a minimum of 6 subjects/cohort and a minimum of 18 subjects total).~Cohort A1 (12 to . 21 years of age)~Cohort B1 (2 to < 12 years of age) Initially, 3 subjects 12 to . 21 years of age are to be enrolled and treated at 100% of the recommended adult dose regimen of talimogene laherparepvec (cohort A1). dose level review team (DLRT) will review the safety data of the first 3 subjects in the olderage cohort A1 to decide if the younger age cohort B1 can be opened for enrollment. If a DLT occurs in the first 3 DLT-evaluable subjects in the older age cohort (A1 or A2), the younger age cohort will not open until a DLT rate < 33% is observed with at least 6 DLT-evaluable subjects in the older age cohort (A1 or A2)."||||
1364436|NCT02756832|||Cohort||Prospective|||||||
1364437|NCT02756819|||Cohort||Prospective|||||||
1364438|NCT02756806||Single Group Assignment||Treatment||None (Open Label)||||||
1364439|NCT02756793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364440|NCT02756780|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1364441|NCT02756767|||Cohort||Prospective|||||||
1364442|NCT02756754||Single Group Assignment||Other||None (Open Label)||||||
1364443|NCT02756741|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1364444|NCT02756728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364445|NCT02756715|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1364446|NCT02756702|||Cohort||Prospective|||||||
1364447|NCT02756689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364448|NCT02756676||Single Group Assignment||Treatment||None (Open Label)||||||
1364449|NCT02756663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364450|NCT02756650||Single Group Assignment||Treatment||None (Open Label)||||||
1364451|NCT02756637|||Other||Retrospective|||||||
1364452|NCT02756624|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364453|NCT02756611||Single Group Assignment||Treatment||None (Open Label)||||||
1364454|NCT02756598|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1364455|NCT02756585||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364456|NCT02756572||Single Group Assignment||Treatment||None (Open Label)||||||
1364457|NCT02756559|||Case Control||Prospective|||||||
1364458|NCT02756546|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364459|NCT02756533|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1364460|NCT02756520|||Cohort||Prospective|||||||
1364461|NCT02756507|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1364462|NCT02756494|||Case Control||Cross-Sectional|||||||
1364463|NCT02756481|||Case-Only||Retrospective|||||||
1364464|NCT02756468|||Case-Only||Prospective|||||||
1364465|NCT02756455|||Case-Only||Prospective|||||||
1364466|NCT02756442||Parallel Assignment||Prevention||None (Open Label)||||||
1364467|NCT02756429|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1364468|NCT02756416||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364469|NCT02756403|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1364470|NCT02756390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1364471|NCT02756377|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364472|NCT02756364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364473|NCT02756351|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1364474|NCT02756338|||Case-Only||Prospective|||||||
1364475|NCT02756325||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364476|NCT02756312|Randomized|Parallel Assignment||Treatment||Triple|The anesthesiologist know the grouping .The subjects and the outcome assesor trained for telephone visit were blinded to the grouping|This is a single centre, randomized, parallel group controlled clinical trial in patients with primary HGG. All eligible patients will be 1:1 randomized to the TIVA or INHA group. The object of the trail is to evaluate the effect of propofol or sevoflurane on the prognosis of HGG patients after craniotomy.|t||t|t
1364477|NCT02756299|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364478|NCT02756286|||Case-Control||Cross-Sectional|||||||
1364479|NCT02756273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364481|NCT02756247||Single Group Assignment||Treatment||None (Open Label)||||||
1364482|NCT02756234|||Cohort||Prospective|||||||
1364483|NCT02756221|Randomized|Parallel Assignment||Other||Double|||t||t|
1364484|NCT02756208|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1364485|NCT02756195|||Cohort||Prospective|||||||
1364486|NCT02756182||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364487|NCT02756169|Randomized|Single Group Assignment||Treatment||Single|||||t|
1364488|NCT02756156|||Case-Only||Retrospective|||||||
1364489|NCT02756143|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364490|NCT02756130||Single Group Assignment||Treatment||None (Open Label)||||||
1364491|NCT02756117||Single Group Assignment||Basic Science||None (Open Label)||||||
1364492|NCT02756104|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364493|NCT02756091|||Other||Prospective|||||||
1364494|NCT02756078|Randomized|Crossover Assignment||Treatment||Single|||t|||
1364495|NCT02756065|||Case Control||Prospective|||||||
1364496|NCT02756052|Randomized|Parallel Assignment||Other||Double|||t|||t
1364497|NCT02756039|||Cohort||Prospective|||||||
1364498|NCT02756026||Single Group Assignment||Basic Science||None (Open Label)||||||
1364499|NCT02756013||Single Group Assignment||Treatment||None (Open Label)||||||
1364500|NCT02756000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364501|NCT02755987||||||||||||
1364502|NCT02755974|||Cohort||Prospective|||||||
1364503|NCT02755961|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364504|NCT02755948|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1364505|NCT02755935||Single Group Assignment||Treatment||None (Open Label)||||||
1364506|NCT02755922|Randomized|Parallel Assignment||Treatment||Single||||||t
1364507|NCT02755909||Single Group Assignment||Supportive Care||None (Open Label)||||||
1364508|NCT02755896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364509|NCT02755883|Randomized|Parallel Assignment||Prevention||Single||||||t
1364510|NCT02755870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364511|NCT02755857||Single Group Assignment||Prevention||None (Open Label)||||||
1364512|NCT02755844||Single Group Assignment||Treatment||None (Open Label)||||||
1364513|NCT02755831|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1364514|NCT02755818|||Cohort||Cross-Sectional|||||||
1364515|NCT02755805|Randomized|Parallel Assignment||Treatment||Single||||||t
1364516|NCT02755792|Randomized|Parallel Assignment||Treatment||Single||||||t
1364517|NCT02755779|||Cohort||Prospective|||||||
1364518|NCT02755766|||Cohort||Prospective|||||||
1364519|NCT02755753|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364520|NCT02755740||Single Group Assignment||Health Services Research||None (Open Label)||||||
1364521|NCT02755727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364522|NCT02755714|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364523|NCT02755701|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364524|NCT02755688|Randomized|Parallel Assignment||Treatment||Single||||||t
1364525|NCT02755675||Single Group Assignment||||None (Open Label)||||||
1364526|NCT02755662|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364527|NCT02755649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364528|NCT02755636|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364529|NCT02755623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364530|NCT02755610|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1364531|NCT02755597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364532|NCT02755584|||Cohort||Prospective|||||||
1364533|NCT02755558|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1364534|NCT02755545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364535|NCT02755532|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1364536|NCT02755519|||Case Control||Prospective|||||||
1364537|NCT02755506||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364538|NCT02755493||Single Group Assignment||Basic Science||None (Open Label)||||||
1364539|NCT02755480||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364540|NCT02755467||Single Group Assignment||Treatment||None (Open Label)||||||
1364541|NCT02755454||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364542|NCT02755441|||Cohort||Prospective|||||||
1364543|NCT02755428||Single Group Assignment||Other||None (Open Label)|Open Label|||||
1364544|NCT02755415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364545|NCT02755402||Single Group Assignment||Health Services Research||None (Open Label)||||||
1364546|NCT02755389|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364547|NCT02755376|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364548|NCT02755363|Randomized|Crossover Assignment||Treatment||Single|||t|||
1364549|NCT02755350||Single Group Assignment||Prevention||None (Open Label)||||||
1364550|NCT02755337|||||Retrospective|||||||
1364551|NCT02755324||Single Group Assignment||Other||None (Open Label)||||||
1364552|NCT02755311|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364553|NCT02755298|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1364554|NCT02755285||||||||||||
1364555|NCT02755272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364556|NCT02755259|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1364557|NCT02755246|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364558|NCT02755233|||Case-Only||Prospective|||||||
1364559|NCT02755220||Single Group Assignment||Treatment||None (Open Label)||||||
1364560|NCT02755207|||Other||Prospective|||||||
1364561|NCT02755194|||Other||Cross-Sectional|||||||
1364562|NCT02755181|||Cohort||Prospective|||||||
1364563|NCT02755168|Randomized|Parallel Assignment||Prevention||Single|||t|||
1364564|NCT02755155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364565|NCT02755142|Randomized|Parallel Assignment||||Double||||||
1364566|NCT02755129||Single Group Assignment||Other||None (Open Label)||||||
1364567|NCT02755116|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1364568|NCT02755103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364569|NCT02755090|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1364570|NCT02755077|Randomized|Crossover Assignment||||None (Open Label)||||||
1364571|NCT02755064|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1364572|NCT02755051||Single Group Assignment||Treatment||None (Open Label)||||||
1364573|NCT02755038|||Cohort||Cross-Sectional|||||||
1364574|NCT02755025|||Cohort||Prospective|||||||
1364575|NCT02755012|||Cohort||Prospective|||||||
1364576|NCT02754999||Single Group Assignment||Treatment||None (Open Label)||||||
1364577|NCT02754986||Single Group Assignment||Treatment||Single|||t|||
1364578|NCT02754973|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1364579|NCT02754960|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364580|NCT02754947|||Cohort||Retrospective|||||||
1364581|NCT02754934|||||Cross-Sectional|||||||
1364582|NCT02754921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364583|NCT02754908|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1364584|NCT02754895|Randomized|Factorial Assignment||Treatment||Single||||||t
1364585|NCT02754882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364586|NCT02754869|||Case-Only|||||||||
1364587|NCT02754856||Single Group Assignment||Treatment||None (Open Label)||||||
1364588|NCT02754843|Randomized|Crossover Assignment||||Single|||t|||
1364589|NCT02754830|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1364590|NCT02754817|||Cohort||Retrospective|||||||
1364591|NCT02754804|||Cohort||Prospective|||||||
1364592|NCT02754791|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1364593|NCT02754778|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364594|NCT02754765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364595|NCT02754752|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1364596|NCT02754739|Randomized|Crossover Assignment||Treatment||None (Open Label)|This study was initially designed as a single center, double-blind, placebo-controlled, 2-group factorial randomized trial (placebo or pravastatin 40mg once daily for 24 weeks). Subjects were randomly assigned, in a 1:1 ratio, to receive pravastatin in a blinded fashion at a dose of 40 mg once daily or placebo. However, because of the problem of expiration date of the placebo drug, the study was converted to an open-label trial, and subjects without any medications were enrolled in an open-label control group in contrast to the pravastatin group. Therefore, the study cohort comprised the pravastatin group, placebo group, and the open-label control group. The placebo group and the open-label control group were classified as the control group.|||||
1364597|NCT02754726||Single Group Assignment||Treatment||None (Open Label)||||||
1364598|NCT02754713|||Cohort||Prospective|||||||
1364599|NCT02754700|Randomized|Parallel Assignment||Prevention||Single||||||t
1364600|NCT02754687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364601|NCT02754674|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364602|NCT02754661|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364603|NCT02754648|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364604|NCT02754635|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364605|NCT02754622|||Cohort||Prospective|||||||
1364606|NCT02754609|Randomized|Parallel Assignment||Treatment||Quadruple|Re-identifiable IP containers|Placebo, 20 hookworm L3 or 40 hookworm L3|t|t|t|t
1364607|NCT02754596|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364608|NCT02754583|Randomized|Parallel Assignment||Prevention||Single||||||t
1364609|NCT02754570||Single Group Assignment||Treatment||None (Open Label)||||||
1364610|NCT02754557|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1364611|NCT02754544|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364612|NCT02754531||Single Group Assignment||Supportive Care||None (Open Label)||||||
1364613|NCT02754518||Single Group Assignment||Treatment||None (Open Label)||||||
1364614|NCT02754505|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364615|NCT02754492|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364616|NCT02754479||Single Group Assignment||Treatment||None (Open Label)||||||
1364617|NCT02754466|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364618|NCT02754453||Single Group Assignment||Treatment||None (Open Label)||||||
1364619|NCT02754440|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364620|NCT02754427|Randomized|Parallel Assignment||Treatment||Single||||||t
1364621|NCT02754414||Single Group Assignment||Basic Science||None (Open Label)||||||
1364622|NCT02754401|Non-Randomized|Parallel Assignment||Screening||Double|||t||t|
1364623|NCT02754388|||Case-Only|||||||||
1364624|NCT02754375||Single Group Assignment||Basic Science||None (Open Label)||||||
1364625|NCT02754362|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364626|NCT02754349||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364627|NCT02754336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364628|NCT02754323||Single Group Assignment||||None (Open Label)||||||
1364629|NCT02754310|Randomized|Parallel Assignment||||Single||||||t
1364630|NCT02754297||Single Group Assignment||Treatment||None (Open Label)||||||
1365319|NCT02745301|||Cohort||Prospective|||||||
1364631|NCT02754284|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364632|NCT02754271|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1364633|NCT02754258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364634|NCT02754245|||Cohort||Prospective|||||||
1364635|NCT02754232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364636|NCT02754219||Single Group Assignment||Treatment||None (Open Label)||||||
1364637|NCT02754206|||Case-Control||Prospective|||||||
1364638|NCT02754193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364639|NCT02754180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364640|NCT02754167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364641|NCT02754154|||Cohort||Retrospective|||||||
1364642|NCT02754141|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364643|NCT02754128|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1364644|NCT02754115|||Cohort||Prospective|||||||
1364645|NCT02754102||Single Group Assignment||Other||Single|||t|||
1364646|NCT02754089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364647|NCT02754076||Single Group Assignment||Treatment||None (Open Label)||||||
1364648|NCT02754063|Randomized|Parallel Assignment||Treatment||Single||||||t
1364649|NCT02754050||Single Group Assignment||Treatment||None (Open Label)||||||
1364650|NCT02754037|||Case-Only||Prospective|||||||
1364651|NCT02754024|||Cohort||Prospective|||||||
1364652|NCT02754011||Single Group Assignment||Treatment||None (Open Label)||||||
1364653|NCT02753998|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364654|NCT02753985|||Cohort||Prospective|||||||
1364655|NCT02753972|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1364656|NCT02753959|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1364657|NCT02753946|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364658|NCT02753933|||Cohort||Prospective|||||||
1364659|NCT02753920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364660|NCT02753907|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364661|NCT02753894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364662|NCT02753881|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364663|NCT02753868|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1364664|NCT02753855||Single Group Assignment||||None (Open Label)||||||
1364665|NCT02753842|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1364666|NCT02753829|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364667|NCT02753816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364668|NCT02753803|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1364669|NCT02753790||Single Group Assignment||Treatment||None (Open Label)||||||
1364670|NCT02753777|||Case-Only||Prospective|||||||
1364671|NCT02753764|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1364672|NCT02753751|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1364673|NCT02753738|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1364674|NCT02753725|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1364675|NCT02753712|Randomized|Parallel Assignment||Treatment||Single||||||t
1364676|NCT02753699|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1364677|NCT02753686|||Cohort||Prospective|||||||
1364678|NCT02753673|||Cohort||Prospective|||||||
1364679|NCT02753660|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364680|NCT02753647||Single Group Assignment||Treatment||None (Open Label)||||||
1364681|NCT02753634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364682|NCT02753621|Randomized|Crossover Assignment||Treatment||Single||||||t
1364683|NCT02753608|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364684|NCT02753595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364685|NCT02753582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364686|NCT02753569|||Cohort||Prospective|||||||
1364687|NCT02753556|||Other||Cross-Sectional|||||||
1364688|NCT02753543||Single Group Assignment||Treatment||None (Open Label)||||||
1364689|NCT02753530|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364690|NCT02753517||Single Group Assignment||Screening||None (Open Label)||||||
1364691|NCT02753504|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364692|NCT02753491|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1364693|NCT02753478||Single Group Assignment||Treatment||None (Open Label)||||||
1364694|NCT02753465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364695|NCT02753452|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364696|NCT02753439||Single Group Assignment||Supportive Care||None (Open Label)||||||
1364697|NCT02753426|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1364698|NCT02753413|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1364699|NCT02753400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364700|NCT02753387|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364701|NCT02753374|||Cohort||Prospective|||||||
1364702|NCT02753361|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1364703|NCT02753348|||Cohort||Prospective|||||||
1364704|NCT02753335|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364705|NCT02753322|Randomized|Parallel Assignment||Treatment||Single||||||t
1364706|NCT02753309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364707|NCT02753296|||Cohort||Prospective|||||||
1364708|NCT02753283|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364709|NCT02753270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364710|NCT02753257|||Cohort||Prospective|||||||
1364711|NCT02753244|Randomized|Parallel Assignment||Treatment||Single||||||t
1364712|NCT02753231|Randomized|Factorial Assignment||Prevention||Single|||||t|
1364713|NCT02753218||Single Group Assignment||Other||None (Open Label)||||||
1364714|NCT02753205|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1364715|NCT02753192||Single Group Assignment||||None (Open Label)||||||
1364716|NCT02753179||Single Group Assignment||Basic Science||None (Open Label)||||||
1364717|NCT02753166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364718|NCT02753153|Randomized|Parallel Assignment||Treatment||Single|||||t|
1364719|NCT02753140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364720|NCT02753127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364721|NCT02753114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364722|NCT02753101||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364723|NCT02753088|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364724|NCT02753075|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364725|NCT02753062||Single Group Assignment||Treatment||None (Open Label)||||||
1364726|NCT02753049||Single Group Assignment||Other||None (Open Label)||||||
1364727|NCT02753036|||Cohort||Prospective|||||||
1364728|NCT02753023|||Cohort||Prospective|||||||
1364729|NCT02753010|||Cohort||Prospective|||||||
1364730|NCT02752997|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1364731|NCT02752984|||Cohort||Prospective|||||||
1364732|NCT02752971|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1364733|NCT02752958||Single Group Assignment||Other||Single|||||t|
1364734|NCT02752945|Randomized|Parallel Assignment||Other||Single||||||t
1364735|NCT02752932|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364736|NCT02752919|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1364737|NCT02752906|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1364738|NCT02752893|||Cohort||Prospective|||||||
1364739|NCT02752880|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364740|NCT02752867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364741|NCT02752854|||Case Control||Cross-Sectional|||||||
1364742|NCT02752841||Single Group Assignment||Treatment||None (Open Label)||||||
1364743|NCT02752828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364744|NCT02752815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364745|NCT02752802|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364746|NCT02752789|||Cohort||Prospective|||||||
1364747|NCT02752776||Single Group Assignment||Treatment||None (Open Label)||||||
1364748|NCT02752763|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1364749|NCT02752750|||Cohort||Prospective|||||||
1364750|NCT02752737|||Cohort||Prospective|||||||
1364751|NCT02752724|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364752|NCT02752711|||Cohort||Prospective|||||||
1364753|NCT02752698|||Cohort||Retrospective|||||||
1364754|NCT02752685|||Cohort||Prospective|||||||
1364755|NCT02752672|||Other||Prospective|||||||
1364756|NCT02752659|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364757|NCT02752646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364758|NCT02752633||Single Group Assignment||Treatment||None (Open Label)||||||
1364759|NCT02752620|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1364760|NCT02752607|||Cohort||Prospective|||||||
1364761|NCT02752594|Randomized|Parallel Assignment||Prevention||Single|||t|||
1364762|NCT02752581|Randomized|Single Group Assignment||Treatment||Triple||||t|t|t
1364763|NCT02752568|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1364764|NCT02752555|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364765|NCT02752542|Randomized|Parallel Assignment||Treatment||Single||||||t
1364766|NCT02752529|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364767|NCT02752516||Single Group Assignment||Treatment||None (Open Label)||||||
1364768|NCT02752503||Single Group Assignment||Treatment||None (Open Label)||||||
1364769|NCT02752490|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364770|NCT02752477|Randomized|Parallel Assignment||Treatment||Single||||||t
1364771|NCT02752464|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364772|NCT02752451|Randomized|Parallel Assignment||||Single||||||t
1364773|NCT02752438|||Cohort||Prospective|||||||
1364774|NCT02752425|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364775|NCT02752412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364776|NCT02752399|||Cohort||Cross-Sectional|||||||
1364777|NCT02752386|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364778|NCT02752373|||Other||Prospective|||||||
1364779|NCT02752360|Randomized|Single Group Assignment||Treatment||Single||||||t
1364780|NCT02752347|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1364781|NCT02752334|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1364782|NCT02752321|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364783|NCT02752308|Randomized|Parallel Assignment||Prevention||Single||||||t
1364784|NCT02752295|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364785|NCT02752282|Randomized|Parallel Assignment||Other||Single|||t|||
1364786|NCT02752269|||Other||Cross-Sectional|||||||
1364787|NCT02752256|||Cohort||Prospective|||||||
1364788|NCT02752243||Single Group Assignment||Treatment||None (Open Label)||||||
1364789|NCT02752230|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364790|NCT02752217|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364791|NCT02752204|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364792|NCT02752191|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364793|NCT02752178|||Case-Control||Prospective|||||||
1364794|NCT02752165|Randomized|Parallel Assignment||Treatment||Single||||||t
1364795|NCT02752152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364796|NCT02752139|||Case-Control||Prospective|||||||
1364797|NCT02752126|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364798|NCT02752113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364799|NCT02752100|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364800|NCT02752087|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1364801|NCT02752074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364802|NCT02752061|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1364803|NCT02752048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364804|NCT02752035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364805|NCT02752022|||Cohort||Prospective|||||||
1364806|NCT02752009||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364807|NCT02751996|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364808|NCT02751983|Randomized|Parallel Assignment||Treatment||Single||||||t
1364809|NCT02751970|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1364810|NCT02751957||Single Group Assignment||Treatment||None (Open Label)||||||
1364811|NCT02751944|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1364812|NCT02751931||Single Group Assignment||Treatment||None (Open Label)||||||
1364813|NCT02751918||Single Group Assignment||Treatment||None (Open Label)||||||
1364814|NCT02751905||Single Group Assignment||Treatment||None (Open Label)||||||
1364815|NCT02751892|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1364816|NCT02751879|||Cohort||Retrospective|||||||
1364817|NCT02751866|Randomized|Parallel Assignment||Prevention||Double|There is no blind in the dietary intervention given that participants are aware of the nature of the foods they consume. However, each dietary approach is described as healthy. In the berry supplementation studies, there is double blinding using berry fruit and placebo powders that are packaged with a code.|Intervention with carbohydrate restriction designed to produce adaptation to ketone metabolism OR intervention with berry fruit powder supplementation.|t||t|
1364818|NCT02751853|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364819|NCT02751840|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1364820|NCT02751827|||Cohort||Prospective|||||||
1364821|NCT02751814|||Case-Only||Prospective|||||||
1364822|NCT02751801|||Case-Only||Retrospective|||||||
1364823|NCT02751788|||Case-Only||Prospective|||||||
1364824|NCT02751775|||Case-Only||Prospective|||||||
1364825|NCT02751762|||Cohort||Prospective|||||||
1364826|NCT02751749||Single Group Assignment||Treatment||None (Open Label)||||||
1364827|NCT02751736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364828|NCT02751723|||Other||Prospective|||||||
1364829|NCT02751710|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364830|NCT02751684|||Other||Other|||||||
1364831|NCT02751671|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1364832|NCT02751658||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364833|NCT02751645|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364834|NCT02751632|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364835|NCT02751619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364836|NCT02751606||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364837|NCT02751593||Single Group Assignment||Treatment||None (Open Label)||||||
1364838|NCT02751580||Single Group Assignment||Health Services Research||None (Open Label)||||||
1364839|NCT02751567||Single Group Assignment||||Single|||t|||
1364840|NCT02751541||Single Group Assignment||Treatment||None (Open Label)||||||
1364841|NCT02751528||Single Group Assignment||Treatment||None (Open Label)||||||
1364842|NCT02751515||Single Group Assignment||||None (Open Label)||||||
1364843|NCT02751502|Randomized|Parallel Assignment||Treatment||Single||||||t
1364844|NCT02751489||Single Group Assignment||||None (Open Label)||||||
1364845|NCT02751476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364846|NCT02751463||Single Group Assignment||Other||None (Open Label)||||||
1364847|NCT02751450|Randomized|Parallel Assignment||Treatment||Single|||||t|
1364848|NCT02751437|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364849|NCT02751424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364850|NCT02751411|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized between two treatment arms||||
1364851|NCT02751398|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364852|NCT02751385||Single Group Assignment||Other||None (Open Label)||||||
1364853|NCT02751372||Single Group Assignment||Other||None (Open Label)||||||
1364854|NCT02751359|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1364855|NCT02751346|||Other||Other|||||||
1364856|NCT02751333|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364857|NCT02751320|Randomized|Crossover Assignment||Basic Science||Single||||||t
1364858|NCT02751307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364859|NCT02751294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364860|NCT02751281|Randomized|Parallel Assignment||Treatment||Single||||||t
1364861|NCT02751268|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1364862|NCT02751255||Single Group Assignment||Treatment||None (Open Label)||||||
1364863|NCT02751242|||Cohort||Prospective|||||||
1364864|NCT02751229|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364865|NCT02751216||Single Group Assignment||Treatment||None (Open Label)||||||
1364866|NCT02751203|Randomized|Parallel Assignment||Other||Single|||t|||
1364867|NCT02751190|||Cohort||Prospective|||||||
1364868|NCT02751177||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364869|NCT02751164|||Cohort||Retrospective|||||||
1364870|NCT02751151||Single Group Assignment||Treatment||None (Open Label)||||||
1364871|NCT02751138|||Cohort||Prospective|||||||
1364872|NCT02751125||Single Group Assignment||Treatment||None (Open Label)||||||
1364873|NCT02751112||Single Group Assignment||Prevention||None (Open Label)||||||
1364874|NCT02751099|||Cohort||Prospective|||||||
1364875|NCT02751086|||Cohort||Prospective|||||||
1364876|NCT02751073|||Cohort||Prospective|||||||
1364877|NCT02751060|||Cohort||Prospective|||||||
1364878|NCT02751047|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1364879|NCT02751034|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1364880|NCT02751021||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364881|NCT02751008|||Ecologic or Community||Prospective|||||||
1364882|NCT02750995||Single Group Assignment||Treatment||None (Open Label)||||||
1364883|NCT02750982||Single Group Assignment||Health Services Research||None (Open Label)||||||
1364884|NCT02750969|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1364885|NCT02750956|||Cohort||Prospective|||||||
1364886|NCT02750943|Randomized|Parallel Assignment||Treatment||Single|||||t|
1364887|NCT02750930||Single Group Assignment||Treatment||None (Open Label)||||||
1364888|NCT02750917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364889|NCT02750904|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364890|NCT02750891||Single Group Assignment||Treatment||None (Open Label)||||||
1364891|NCT02750878|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364892|NCT02750865|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364893|NCT02750852|||Cohort||Cross-Sectional|||||||
1364894|NCT02750839|||Cohort||Retrospective|||||||
1364895|NCT02750826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364896|NCT02750813|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1364897|NCT02750800|||Cohort||Prospective|||||||
1364898|NCT02750787||Single Group Assignment||Other||None (Open Label)||||||
1364899|NCT02750774|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364900|NCT02750761|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364901|NCT02750748|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1364902|NCT02750735|||Case-Only|||||||||
1364903|NCT02750722|Randomized|Crossover Assignment||Treatment||Single||||||t
1364904|NCT02750709|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1364905|NCT02750696|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364906|NCT02750683|||Cohort||Prospective|||||||
1364907|NCT02750670||Single Group Assignment||Treatment||None (Open Label)||||||
1364908|NCT02750657|||Cohort||Prospective|||||||
1364909|NCT02750644|||Case Control||Prospective|||||||
1364910|NCT02750631||Single Group Assignment||Treatment||None (Open Label)|All patients and staff know what the treatment is.|"All patients receive Chronotherapy, which consists of a night of no sleep (Wake Therapy) followed by bright lights at their desired sleep time and two nights of Sleep Phase Advance (i.e., sleeping 6 hours earlier than desired for 1 night and 3 hours earlier for the next night, then desired sleep time)."||||
1364911|NCT02750618||Single Group Assignment||Treatment||None (Open Label)||||||
1364912|NCT02750605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364913|NCT02750592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1364914|NCT02750579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364915|NCT02750566|Randomized|Parallel Assignment||Treatment||Single||||||t
1364916|NCT02750553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364917|NCT02750540|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1364918|NCT02750527|||Ecologic or Community||Prospective|||||||
1364919|NCT02750514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364920|NCT02750501||Single Group Assignment||Treatment||None (Open Label)||||||
1364921|NCT02750488||Single Group Assignment||Other||Single|||t|||
1364922|NCT02750475||Single Group Assignment||Other||None (Open Label)||||||
1364923|NCT02750462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364924|NCT02750449||Single Group Assignment||Other||Single|||t|||
1364925|NCT02750436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364926|NCT02750423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364927|NCT02750410|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364928|NCT02750397|||Cohort||Prospective|||||||
1364929|NCT02750384|Randomized|Parallel Assignment||||None (Open Label)||||||
1364930|NCT02750371||Single Group Assignment||Basic Science||None (Open Label)||||||
1364931|NCT02750358||Single Group Assignment||Treatment||None (Open Label)||||||
1364932|NCT02750345|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1364933|NCT02750332|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1364934|NCT02750319|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364935|NCT02750306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364936|NCT02750293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364937|NCT02750280|Randomized|Parallel Assignment||Treatment||Single||||||t
1364938|NCT02750267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364939|NCT02750254||Single Group Assignment||Treatment||None (Open Label)||||||
1364940|NCT02750241|Randomized|Parallel Assignment||Other||Single||||||t
1364941|NCT02750228|||Cohort||Prospective|||||||
1364942|NCT02750215||Single Group Assignment||Treatment||None (Open Label)||||||
1364943|NCT02750202|Randomized|Parallel Assignment||Prevention||Single|||t|||
1364944|NCT02750189|||Other||Retrospective|||||||
1364945|NCT02750176||Single Group Assignment||Treatment||None (Open Label)||||||
1364946|NCT02750163|||Case-Only||Prospective|||||||
1364947|NCT02750150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364948|NCT02750137|||Case-Only|||||||||
1364949|NCT02750124|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1364950|NCT02750111|||Cohort||Prospective|||||||
1364951|NCT02750098||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364952|NCT02750085|||Case-Only||Prospective|||||||
1364953|NCT02750072|Randomized|Parallel Assignment||Treatment||Single||||||t
1364954|NCT02750059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364955|NCT02750046|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1364956|NCT02750033|||Case-Only||Prospective|||||||
1364957|NCT02750020|||Cohort||Cross-Sectional|||||||
1364958|NCT02750007||Single Group Assignment||Treatment||None (Open Label)||||||
1364959|NCT02749994|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1364960|NCT02749981|||Other||Prospective|||||||
1364961|NCT02749968|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1364962|NCT02749955|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1364963|NCT02749942|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1364964|NCT02749929|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1364965|NCT02749916|||Case-Control||Prospective|||||||
1364966|NCT02749903||Single Group Assignment||Treatment||None (Open Label)||||||
1364967|NCT02749890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364968|NCT02749877|Randomized|Parallel Assignment||Treatment||Single||||||t
1364969|NCT02749864|||Other||Cross-Sectional|||||||
1364970|NCT02749851|||Cohort||Prospective|||||||
1364971|NCT02749838|||Case-Only||Prospective|||||||
1364972|NCT02749825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364973|NCT02749812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364974|NCT02749799||Single Group Assignment||Treatment||None (Open Label)||||||
1364975|NCT02749786||Single Group Assignment||Diagnostic||None (Open Label)||||||
1364976|NCT02749773|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1364977|NCT02749760||Single Group Assignment||Screening||None (Open Label)||||||
1364978|NCT02749747|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1364979|NCT02749734||Single Group Assignment||Treatment||None (Open Label)||||||
1364980|NCT02749721||Single Group Assignment||Other||None (Open Label)||||||
1364981|NCT02749708||Single Group Assignment||Treatment||None (Open Label)||||||
1364982|NCT02749695|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364983|NCT02749682|||Case Control||Prospective|||||||
1364984|NCT02749669|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1364985|NCT02749656|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364986|NCT02749643||Single Group Assignment||Treatment||None (Open Label)||||||
1364987|NCT02749630|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1364988|NCT02749617||Single Group Assignment||Prevention||None (Open Label)||||||
1364989|NCT02749604|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1364990|NCT02749591|Randomized|Parallel Assignment||Treatment||Single||||||t
1364991|NCT02749578||Single Group Assignment||Treatment||None (Open Label)||||||
1364992|NCT02749565|||Case-Control||Prospective|||||||
1364993|NCT02749552||Single Group Assignment||Treatment||None (Open Label)||||||
1364994|NCT02749539|Randomized|Parallel Assignment||Treatment||Single|||t|||
1364995|NCT02749526||Single Group Assignment||Treatment||None (Open Label)||||||
1364996|NCT02749513||Single Group Assignment||Other||None (Open Label)||||||
1364997|NCT02749500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1364998|NCT02749487|||Cohort||Retrospective|||||||
1364999|NCT02749474|||Cohort||Prospective|||||||
1365000|NCT02749461|||Cohort||Prospective|||||||
1365001|NCT02749448||Single Group Assignment||Treatment||None (Open Label)||||||
1365002|NCT02749435|||Other||Other|||||||
1365003|NCT02749422|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1365004|NCT02749409|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365005|NCT02749396|||Cohort||Retrospective|||||||
1365006|NCT02749383|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365007|NCT02749370||Single Group Assignment||Treatment||None (Open Label)||||||
1365008|NCT02749357|Randomized|Parallel Assignment||Treatment||Single||||||t
1365009|NCT02749344||Single Group Assignment||Treatment||None (Open Label)||||||
1365010|NCT02749331||Single Group Assignment||Treatment||None (Open Label)||||||
1365011|NCT02749318|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1365012|NCT02749305|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365013|NCT02749292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365014|NCT02749279|||Cohort||Prospective|||||||
1365015|NCT02749266|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365016|NCT02749253||Single Group Assignment||Treatment||None (Open Label)||||||
1365017|NCT02749240||Single Group Assignment||Other||None (Open Label)||||||
1365391|NCT02744365|||Other||Prospective|||||||
1365018|NCT02749227||Single Group Assignment||Treatment||None (Open Label)||||||
1365019|NCT02749214|||Case-Control||Prospective|||||||
1365020|NCT02749201||Single Group Assignment||Basic Science||None (Open Label)||||||
1365021|NCT02749188||Single Group Assignment||Other||None (Open Label)||||||
1365022|NCT02749175|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1365023|NCT02749162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365024|NCT02749149|||Cohort||Prospective|||||||
1365025|NCT02749136||Single Group Assignment||Treatment||None (Open Label)||||||
1365026|NCT02749123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365027|NCT02749110|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365028|NCT02749097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365029|NCT02749084||Single Group Assignment||Treatment||None (Open Label)||||||
1365030|NCT02749071|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1365031|NCT02749058|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365032|NCT02749045||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365033|NCT02749032|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1365034|NCT02749019||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365035|NCT02749006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365036|NCT02748993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365037|NCT02748980|||Cohort||Prospective|||||||
1365038|NCT02748967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365039|NCT02748954|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365040|NCT02748941||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365041|NCT02748928||Single Group Assignment||Treatment||None (Open Label)||||||
1365042|NCT02748915|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365043|NCT02748902||Single Group Assignment||Treatment||None (Open Label)||||||
1365044|NCT02748889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365045|NCT02748876|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1365046|NCT02748863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365047|NCT02748850|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365048|NCT02748837|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365049|NCT02748824|||Other||Cross-Sectional|||||||
1365050|NCT02748811|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365051|NCT02748798|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365052|NCT02748785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365053|NCT02748772|Randomized|Single Group Assignment||Treatment||Single|||t|||
1365054|NCT02748759|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365055|NCT02748746|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1365056|NCT02748733|Randomized|Crossover Assignment||Treatment||Single||||||t
1365057|NCT02748720|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365058|NCT02748707|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1365059|NCT02748694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365060|NCT02748681|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365061|NCT02748668|||Case-Control||Prospective|||||||
1365062|NCT02748655|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1365063|NCT02748642|Randomized|Sequential Assignment||Treatment||Single|||||t|
1365064|NCT02748629|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365065|NCT02748616||Single Group Assignment||Treatment||None (Open Label)||||||
1365066|NCT02748603|||Cohort||Retrospective|||||||
1365067|NCT02748590||Single Group Assignment||Treatment||None (Open Label)||||||
1365068|NCT02748577|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1365069|NCT02748564||Single Group Assignment||Treatment||None (Open Label)||||||
1365070|NCT02748551|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365071|NCT02748538|||Case-Control||Prospective|||||||
1365072|NCT02748525||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365073|NCT02748512||Single Group Assignment||Treatment||None (Open Label)||||||
1365074|NCT02748499|Randomized|Parallel Assignment||Prevention||Single||||||t
1365075|NCT02748486|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365076|NCT02748473|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365077|NCT02748460|||Case-Only||Prospective|||||||
1365078|NCT02748447|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1365079|NCT02748434|Randomized|Crossover Assignment||Other||Single||||||t
1365080|NCT02748421|Randomized|Parallel Assignment||||None (Open Label)||||||
1365081|NCT02748408|||Cohort||Prospective|||||||
1365082|NCT02748395|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1365083|NCT02748382|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365084|NCT02748369|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365085|NCT02748356||Single Group Assignment||Prevention||None (Open Label)||||||
1365086|NCT02748343|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365087|NCT02748330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365088|NCT02748317||Single Group Assignment||Prevention||None (Open Label)||||||
1365089|NCT02748304|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365090|NCT02748291|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365091|NCT02748278|||Ecologic or Community||Prospective|||||||
1365092|NCT02748265|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365093|NCT02748252|||Cohort||Prospective|||||||
1365094|NCT02748239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365095|NCT02748226|||Cohort||Other|||||||
1365096|NCT02748213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365097|NCT02748200|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365098|NCT02748187||Single Group Assignment||Treatment||None (Open Label)||||||
1365099|NCT02748174|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1365100|NCT02748161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365101|NCT02748148||Single Group Assignment||Health Services Research||None (Open Label)||||||
1365102|NCT02748135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1365103|NCT02748122||Single Group Assignment||Treatment||None (Open Label)||||||
1365104|NCT02748109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365105|NCT02748096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365106|NCT02748083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365107|NCT02748070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365108|NCT02748057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365109|NCT02748044||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365110|NCT02748031||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365111|NCT02748018|Randomized|Parallel Assignment||Treatment||None (Open Label)||There will be three cohorts sequentially enrolled for the study. Cohort 1: Continuous Subcutaneous Insulin Infusion (CSII cohort): randomized to HCL (treatment arm) or CSII (Control arm) Cohort 2: Multiple Daily Injections (MDI cohort): randomized to HCL (treatment arm) or MDI (Control arm) Cohort 3: Sensor-Augmented Pump therapy (SAP cohort): randomized to HCL (treatment arm) or SAP (Control arm)||||
1365112|NCT02748005||Single Group Assignment||Supportive Care||None (Open Label)||||||
1365113|NCT02747992|||Cohort||Retrospective|||||||
1365114|NCT02747979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365115|NCT02747966|||Cohort||Cross-Sectional|||||||
1365116|NCT02747953||Single Group Assignment||Treatment||None (Open Label)||||||
1365117|NCT02747940|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365118|NCT02747927|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1365119|NCT02747914|Randomized|Parallel Assignment||Treatment||Single||||||t
1365120|NCT02747901|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1365121|NCT02747888|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1365122|NCT02747875|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365123|NCT02747862|||Cohort||Retrospective|||||||
1365124|NCT02747849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365125|NCT02747836|||Case-Control||Prospective|||||||
1365126|NCT02747823|Randomized|Parallel Assignment||||Triple|||t||t|t
1365127|NCT02747810||Single Group Assignment||Treatment||None (Open Label)||||||
1365128|NCT02747797||Single Group Assignment||Treatment||None (Open Label)||||||
1365129|NCT02747784|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365130|NCT02747771|||Case-Only||Prospective|||||||
1365131|NCT02747758|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365132|NCT02747745|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1365133|NCT02747732||Single Group Assignment||Treatment||None (Open Label)||||||
1365134|NCT02747719||Single Group Assignment||Basic Science||None (Open Label)||||||
1365135|NCT02747706|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365136|NCT02747680|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365137|NCT02747667|||Cohort||Retrospective|||||||
1365138|NCT02747654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365139|NCT02747641||Single Group Assignment||Treatment||None (Open Label)||||||
1365140|NCT02747628|Randomized|Parallel Assignment||||Triple|||t|t|t|
1365141|NCT02747615|Randomized|Parallel Assignment||||Single|||t|||
1365142|NCT02747602|Randomized|Crossover Assignment||||None (Open Label)||||||
1365143|NCT02747589||Single Group Assignment||Basic Science||None (Open Label)||||||
1365144|NCT02747576|||Case-Control||Prospective|||||||
1365145|NCT02747563|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365146|NCT02747550|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365147|NCT02747537||Single Group Assignment||Treatment||None (Open Label)||||||
1365148|NCT02747524|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365149|NCT02747511|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365150|NCT02747498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365151|NCT02747485||Single Group Assignment||Prevention||None (Open Label)||||||
1365152|NCT02747472|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1365153|NCT02747459||Single Group Assignment||Supportive Care||None (Open Label)||||||
1365154|NCT02747446|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1365155|NCT02747433|Randomized|Factorial Assignment||Treatment||Single||||||t
1365156|NCT02747420|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365157|NCT02747407|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1365158|NCT02747394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365159|NCT02747381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365160|NCT02747368||Single Group Assignment||Screening||None (Open Label)||||||
1365161|NCT02747355|||Other||Retrospective|||||||
1365162|NCT02747342||Single Group Assignment||Treatment||None (Open Label)||||||
1365163|NCT02747329|Randomized|Parallel Assignment||Treatment||Single||||||t
1365164|NCT02747316|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366167|NCT02734277|||Cohort||Prospective|||||||
1365165|NCT02747303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365166|NCT02747290||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365167|NCT02747277|||Other||Cross-Sectional|||||||
1365168|NCT02747264|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365169|NCT02747251|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365170|NCT02747238|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365171|NCT02747225|||Case-Only||Cross-Sectional|||||||
1365172|NCT02747212|||Case-Only||Cross-Sectional|||||||
1365173|NCT02747199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1365174|NCT02747186|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1365175|NCT02747173|||Cohort||Prospective|||||||
1365176|NCT02747160||Single Group Assignment||Supportive Care||None (Open Label)||||||
1365177|NCT02747147|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365178|NCT02747134|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365179|NCT02747121|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||The intervention will be rolled out sequentially during 12 months to 24 hospitals, with six clusters of four geographically close hospitals. We collect data before and after the inspections.||||
1365180|NCT02747108|Randomized|Parallel Assignment||Prevention||Single|||||t|
1365181|NCT02747095||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365182|NCT02747082|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365183|NCT02747069|||Other||Prospective|||||||
1365184|NCT02747056|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365185|NCT02747043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365186|NCT02747030||Single Group Assignment||Treatment||None (Open Label)||||||
1365187|NCT02747017|||Cohort||Prospective|||||||
1365188|NCT02747004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365189|NCT02746991|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365190|NCT02746978|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365191|NCT02746965|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365192|NCT02746952||Single Group Assignment||Treatment||None (Open Label)||||||
1365193|NCT02746939|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1365194|NCT02746926|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1365195|NCT02746913|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365196|NCT02746900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365197|NCT02746887|||Case Control||Prospective|||||||
1365198|NCT02746874|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365199|NCT02746861|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365200|NCT02746848||Single Group Assignment||Treatment||None (Open Label)||||||
1365201|NCT02746835||Single Group Assignment||Prevention||None (Open Label)||||||
1365202|NCT02746822|||Case-Only||Prospective|||||||
1365203|NCT02746809||Single Group Assignment||Treatment||None (Open Label)||||||
1365204|NCT02746796|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365205|NCT02746783|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365206|NCT02746770|Randomized|Parallel Assignment||Treatment||Single||||||t
1365207|NCT02746757|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1365208|NCT02746744|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365209|NCT02746731|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1365210|NCT02746718||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365211|NCT02746705|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1365212|NCT02746692|Randomized|Parallel Assignment||Treatment||Single||||||t
1365213|NCT02746679|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1365214|NCT02746666|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365215|NCT02746653||Single Group Assignment||Treatment||None (Open Label)||||||
1365216|NCT02746640|||Case-Only||Prospective|||||||
1365217|NCT02746627|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1365218|NCT02746614|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365219|NCT02746601||Single Group Assignment||Screening||None (Open Label)||||||
1365220|NCT02746588|||Cohort||Prospective|||||||
1365221|NCT02746575||Single Group Assignment||Prevention||None (Open Label)||||||
1365222|NCT02746562|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365223|NCT02746549|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1365224|NCT02746536|Randomized|Crossover Assignment||Other||Single|||||t|
1365225|NCT02746523|||Case-Control||Other|||||||
1365226|NCT02746510||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365227|NCT02746497|Randomized|Crossover Assignment||Treatment||Single||||||t
1365228|NCT02746484|Randomized|Parallel Assignment||Treatment||Single||||||t
1365229|NCT02746471|||Cohort||Prospective|||||||
1365230|NCT02746458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365231|NCT02746445|||Cohort||Prospective|||||||
1365232|NCT02746432|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1365233|NCT02746419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365234|NCT02746406||Single Group Assignment||||None (Open Label)||||||
1365235|NCT02746393|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1365236|NCT02746380|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365237|NCT02746367|||Cohort||Prospective|||||||
1365238|NCT02746354|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1365239|NCT02746341|||Cohort||Prospective|||||||
1365240|NCT02746328||Single Group Assignment||Treatment||None (Open Label)||||||
1365241|NCT02746315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365242|NCT02746302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365243|NCT02746289||||||||||||
1365244|NCT02746276||Single Group Assignment||Treatment||None (Open Label)||Sparse sample pharmacokinetics study||||
1365245|NCT02746263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365246|NCT02746250|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365247|NCT02746237|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365248|NCT02746224|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365249|NCT02746211|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1365250|NCT02746198|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1365251|NCT02746185|Randomized|Parallel Assignment||Treatment||Single||||||t
1365252|NCT02746172|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365253|NCT02746159|||Case-Only||Prospective|||||||
1365254|NCT02746146||Single Group Assignment||Screening||None (Open Label)||||||
1365255|NCT02746133|||Cohort||Prospective|||||||
1365256|NCT02746120||||||||||||
1365257|NCT02746107|Randomized|Factorial Assignment||||None (Open Label)||||||
1365258|NCT02746094||Single Group Assignment||Treatment||None (Open Label)||||||
1365259|NCT02746081||Single Group Assignment||Treatment||None (Open Label)||||||
1365260|NCT02746068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365261|NCT02746055|||||Cross-Sectional|||||||
1365262|NCT02746042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365263|NCT02746029|||Cohort||Prospective|||||||
1365264|NCT02746016||Single Group Assignment||Other||None (Open Label)||||||
1365265|NCT02746003|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1365266|NCT02745990||Single Group Assignment||Prevention||None (Open Label)||||||
1365267|NCT02745977|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1365268|NCT02745964|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1365269|NCT02745951|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365270|NCT02745938|||Case-Control||Cross-Sectional|||||||
1365271|NCT02745925|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365272|NCT02745912||Single Group Assignment||Basic Science||None (Open Label)||||||
1365273|NCT02745899|Randomized|Parallel Assignment||Screening||Single|||||t|
1365274|NCT02745886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365275|NCT02745873|Randomized|Parallel Assignment||Prevention||Single||||||t
1365276|NCT02745860|Randomized|Crossover Assignment||||None (Open Label)||||||
1365277|NCT02745847||Single Group Assignment||Treatment||None (Open Label)||||||
1365278|NCT02745834|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365279|NCT02745821||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365280|NCT02745808|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365281|NCT02745795|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365282|NCT02745782|||||Prospective|||||||
1365283|NCT02745769|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365284|NCT02745756||Single Group Assignment||Treatment||None (Open Label)||||||
1365285|NCT02745743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1365286|NCT02745730|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1365287|NCT02745717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365288|NCT02745704|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365289|NCT02745691|||Cohort||Prospective|||||||
1365290|NCT02745678||Single Group Assignment||Treatment||None (Open Label)||||||
1365291|NCT02745665|||Cohort||Other|||||||
1365292|NCT02745652|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365293|NCT02745639||Single Group Assignment||Treatment||None (Open Label)||||||
1365294|NCT02745626|Randomized|Parallel Assignment||Treatment||Single||||||t
1365295|NCT02745613|Non-Randomized|Parallel Assignment||Health Services Research||Double||||t||t
1365296|NCT02745600||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365297|NCT02745587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365298|NCT02745574|Randomized|Factorial Assignment||Supportive Care||Triple|||t|t||t
1365299|NCT02745561||Single Group Assignment||Treatment||None (Open Label)||||||
1365300|NCT02745548|||Case-Only||Prospective|||||||
1365301|NCT02745535||Single Group Assignment||Treatment||None (Open Label)||||||
1365302|NCT02745522|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1365303|NCT02745509|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365304|NCT02745496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365305|NCT02745483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1365306|NCT02745470|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1365307|NCT02745457|||Cohort||Prospective|||||||
1365308|NCT02745444|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365309|NCT02745431|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1365310|NCT02745418|||Other||Cross-Sectional|||||||
1365311|NCT02745405|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365312|NCT02745392|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1365313|NCT02745379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365314|NCT02745366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365315|NCT02745353|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365316|NCT02745340|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1365317|NCT02745327|||Cohort||Prospective|||||||
1365318|NCT02745314|||Cohort||Prospective|||||||
1365320|NCT02745288|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1365321|NCT02745275|Randomized|Crossover Assignment||Prevention||Single||||||t
1365322|NCT02745262|||Cohort||Retrospective|||||||
1365323|NCT02745249|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1365324|NCT02745236|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1365325|NCT02745223|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1365326|NCT02745210||Single Group Assignment||Basic Science||None (Open Label)||||||
1365327|NCT02745197|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1365328|NCT02745184||Single Group Assignment||Treatment||None (Open Label)||||||
1365329|NCT02745171|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365330|NCT02745158|||Cohort||Prospective|||||||
1365331|NCT02745145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365332|NCT02745132||Single Group Assignment||||None (Open Label)||||||
1365333|NCT02745119|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365334|NCT02745106|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365335|NCT02745093|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365336|NCT02745080|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365337|NCT02745067||Single Group Assignment||Treatment||None (Open Label)||||||
1365338|NCT02745054|||Case-Only||Prospective|||||||
1365339|NCT02745041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365340|NCT02745028||Single Group Assignment||Treatment||None (Open Label)||||||
1365341|NCT02745015|Randomized|Parallel Assignment||Treatment||Single||||||t
1365342|NCT02745002||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365343|NCT02744989|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365344|NCT02744976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365345|NCT02744963|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1365346|NCT02744950|Randomized|Parallel Assignment||Treatment||Single||||||t
1365347|NCT02744937|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1365348|NCT02744924||Single Group Assignment||Other||None (Open Label)||||||
1365349|NCT02744911|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1365350|NCT02744898||Single Group Assignment||Treatment||None (Open Label)||||||
1365351|NCT02744885|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1365352|NCT02744872|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1365353|NCT02744859|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365354|NCT02744846|||Cohort||Retrospective|||||||
1365355|NCT02744833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365356|NCT02744820|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365357|NCT02744807|||Cohort||Prospective|||||||
1365358|NCT02744794||Single Group Assignment||Treatment||None (Open Label)||||||
1365359|NCT02744781||Single Group Assignment||Supportive Care||None (Open Label)||||||
1365360|NCT02744768||Single Group Assignment||Treatment||None (Open Label)||||||
1365361|NCT02744755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365362|NCT02744742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365363|NCT02744729||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365364|NCT02744716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365365|NCT02744703|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365366|NCT02744690|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365367|NCT02744677||Single Group Assignment||Treatment||None (Open Label)||||||
1365368|NCT02744664||Single Group Assignment||Treatment||None (Open Label)||||||
1365369|NCT02744651|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365370|NCT02744638|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1365371|NCT02744625|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1365372|NCT02744612||Single Group Assignment||Treatment||None (Open Label)||||||
1365373|NCT02744599|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365374|NCT02744586|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1365375|NCT02744573|||Case Control||Prospective|||||||
1365376|NCT02744560||Single Group Assignment||Supportive Care||None (Open Label)||||||
1365377|NCT02744547|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1365378|NCT02744534|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365379|NCT02744521|Randomized|Parallel Assignment||Diagnostic||||||||
1365380|NCT02744508|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1365381|NCT02744495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365382|NCT02744482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365383|NCT02744469|||Cohort||Prospective|||||||
1365384|NCT02744456||Single Group Assignment||Treatment||None (Open Label)||||||
1365385|NCT02744443|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1365386|NCT02744430|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1365387|NCT02744417||Single Group Assignment||Treatment||None (Open Label)|The outcome assessor was blind to smoking status. Before each follow-up periodontal examination (3, 6 and 12 months), the following procedures were performed by a periodontist: (1) removal of all tobacco stains from subject's teeth and/or dental polishing, with a standardized duration of up to 30 min., (2) 0.12% chlorohexidine rinse (1min.) aimed to hide any possible cigarette odour exhaled from the oral cavity. After these procedures, the examiner entered the examination room fully equipped (including a mask), in order to avoid noticing the smoking status by odour|||||
1365388|NCT02744404|||Cohort||Retrospective|||||||
1365389|NCT02744391||Single Group Assignment||Treatment||None (Open Label)||||||
1365390|NCT02744378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365392|NCT02744352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365393|NCT02744339|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365394|NCT02744326|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1365395|NCT02744313|||Case-Only||Prospective|||||||
1365396|NCT02744300|Randomized|Parallel Assignment||Prevention||Single|||||t|
1365397|NCT02744287|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1365398|NCT02744274|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1365399|NCT02744261|||Other||Other|||||||
1365400|NCT02744248|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1365401|NCT02744235||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365402|NCT02744222|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1365403|NCT02744209|||||Prospective|||||||
1365404|NCT02744196|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1365405|NCT02744183|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365406|NCT02744170|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1365407|NCT02744157||Single Group Assignment||Health Services Research||None (Open Label)||||||
1365408|NCT02744144|||Cohort||Other|||||||
1365409|NCT02744131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365410|NCT02744118|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1365411|NCT02744105|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1365412|NCT02744092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365413|NCT02744079|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365414|NCT02744066||Single Group Assignment||Other||None (Open Label)||||||
1365415|NCT02744053||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365416|NCT02744040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365417|NCT02744027||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365418|NCT02744014|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365419|NCT02744001||Single Group Assignment||Other||None (Open Label)||||||
1365420|NCT02743988|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365421|NCT02743975||Single Group Assignment||Diagnostic||None (Open Label)||phase I/II safety and dose-finding study||||
1365422|NCT02743962|Randomized|Parallel Assignment||Treatment||None (Open Label)|Unblinded|||||
1365423|NCT02743949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365424|NCT02743936|Randomized|Crossover Assignment||Treatment||Single|||||t|
1365425|NCT02743923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365426|NCT02743910|||Cohort||Prospective|||||||
1365427|NCT02743897||Single Group Assignment||Treatment||None (Open Label)||||||
1365428|NCT02743884|Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||Cross-over.||||
1365429|NCT02743871|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1365430|NCT02743858|||Cohort||Prospective|||||||
1365431|NCT02743845|||Family-Based||Prospective|||||||
1365432|NCT02743832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365433|NCT02743819|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365434|NCT02743806||Single Group Assignment||Treatment||None (Open Label)||||||
1365435|NCT02743793|||Cohort||Prospective|||||||
1365436|NCT02743780|Randomized|Parallel Assignment||Other||Double|||t||t|
1365437|NCT02743767|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365438|NCT02743754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365439|NCT02743741||Single Group Assignment||Treatment||None (Open Label)||||||
1365440|NCT02743728||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365441|NCT02743715|Randomized|Parallel Assignment||Treatment||Quadruple|all study staff were blind to the participant's condition; only the neuromodulation staff, external to the study team, were aware of the participant's treatment group|randomized, sham-controlled trial|t|t|t|t
1365442|NCT02743702|Randomized|Parallel Assignment||Treatment||Single||||||t
1365443|NCT02743689|||Cohort||Prospective|||||||
1365444|NCT02743676|||Case-Only||Retrospective|||||||
1365445|NCT02743663|||Cohort||Prospective|||||||
1365446|NCT02743650||Single Group Assignment||Other||None (Open Label)||||||
1365447|NCT02743637||Single Group Assignment||Treatment||None (Open Label)||||||
1365448|NCT02743624||Single Group Assignment||||None (Open Label)||||||
1365449|NCT02743611|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1365450|NCT02743598||Single Group Assignment||Treatment||None (Open Label)||||||
1365451|NCT02743585|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1365452|NCT02743572|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1365453|NCT02743559|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1365454|NCT02743546|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365455|NCT02743533|||Cohort||Prospective|||||||
1365456|NCT02743520||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365457|NCT02743507|||Case-Only||Retrospective|||||||
1365458|NCT02743494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365459|NCT02743481|||Cohort||Prospective|||||||
1365460|NCT02743468|||Cohort||Cross-Sectional|||||||
1365461|NCT02743455|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1365462|NCT02743442||Single Group Assignment||Treatment||None (Open Label)||||||
1365463|NCT02743429||Single Group Assignment||Treatment||None (Open Label)||||||
1365464|NCT02743416|||Cohort||Prospective|||||||
1365465|NCT02743403|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1365466|NCT02743390|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1365467|NCT02743377||Parallel Assignment||Diagnostic||None (Open Label)||||||
1365468|NCT02743364|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1365469|NCT02743351|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1365470|NCT02743338|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365471|NCT02743325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365472|NCT02743312|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1365473|NCT02743299||Single Group Assignment||Treatment||None (Open Label)||||||
1365474|NCT02743286|Randomized|Crossover Assignment||||None (Open Label)||||||
1365475|NCT02743273|||Case-Control||Prospective|||||||
1365476|NCT02743260|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1365477|NCT02743247||Single Group Assignment||||None (Open Label)||||||
1365478|NCT02743234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365479|NCT02743221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365480|NCT02743208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365481|NCT02743195||Single Group Assignment||||None (Open Label)||||||
1365482|NCT02743182|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365483|NCT02743169|||Cohort||Retrospective|||||||
1365484|NCT02743156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365485|NCT02743143|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365486|NCT02743130|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1365487|NCT02743117|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1365488|NCT02743104|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365489|NCT02743091|||Case-Only||Retrospective|||||||
1365490|NCT02743078||Single Group Assignment||Treatment||None (Open Label)||||||
1365491|NCT02743065|||Cohort||Prospective|||||||
1365492|NCT02743052|||Cohort||Prospective|||||||
1365493|NCT02743039|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365494|NCT02743026||Single Group Assignment||Prevention||None (Open Label)||||||
1365495|NCT02743013|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365496|NCT02743000|||Ecologic or Community||Cross-Sectional|||||||
1365497|NCT02742987|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365498|NCT02742974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365499|NCT02742961|||Cohort||Retrospective|||||||
1365500|NCT02742948|Randomized|Parallel Assignment||Prevention||Single||||||t
1365501|NCT02742935||Single Group Assignment||Treatment||None (Open Label)||||||
1365502|NCT02742922|Randomized|Parallel Assignment||Prevention||Single||||||t
1365503|NCT02742909|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1365504|NCT02742896|||Cohort||Prospective|||||||
1365505|NCT02742883||Single Group Assignment||Treatment||None (Open Label)||||||
1365506|NCT02742870|||Case-Only||Retrospective|||||||
1365507|NCT02742857||Single Group Assignment||Other||None (Open Label)||||||
1365508|NCT02742844||Single Group Assignment||Treatment||None (Open Label)||||||
1365509|NCT02742831|Randomized|Parallel Assignment||Other||Single||||||t
1365510|NCT02742818|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365511|NCT02742805|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1365512|NCT02742792|Randomized|Parallel Assignment||Treatment||Single||||||t
1365513|NCT02742779|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1365514|NCT02742766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365515|NCT02742753|||Other||Retrospective|||||||
1365516|NCT02742740|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365517|NCT02742727||Single Group Assignment||Treatment||None (Open Label)||||||
1365518|NCT02742714||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365519|NCT02742701|||Cohort||Prospective|||||||
1365520|NCT02742688|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1365521|NCT02742675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365522|NCT02742662|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365523|NCT02742649|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1365524|NCT02742636|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365525|NCT02742623|||Cohort||Prospective|||||||
1365526|NCT02742610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365527|NCT02742597|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365528|NCT02742584|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365529|NCT02742571|||||Prospective|||||||
1365530|NCT02742558|Randomized|Parallel Assignment||Prevention||Single|||||t|
1365531|NCT02742545|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1365532|NCT02742532|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1365533|NCT02742519|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1365534|NCT02742506|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365535|NCT02742493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365536|NCT02742480|||Case-Control||Prospective|||||||
1365537|NCT02742467|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365538|NCT02742454|Randomized|Parallel Assignment||Prevention||Single||||||t
1365539|NCT02742441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365540|NCT02742428|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365541|NCT02742415||Single Group Assignment||Supportive Care||None (Open Label)||||||
1365542|NCT02742402|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365543|NCT02742389|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365544|NCT02742376|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365545|NCT02742363|||Case-Only||Prospective|||||||
1365546|NCT02742350|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365547|NCT02742337|||Case Control||Cross-Sectional|||||||
1365548|NCT02742324||Single Group Assignment||Treatment||None (Open Label)||||||
1365549|NCT02742311|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365550|NCT02742298|Non-Randomized|Parallel Assignment||Device Feasibility||Single|||||t|
1365551|NCT02742285||Single Group Assignment||Other||None (Open Label)||||||
1365552|NCT02742272|||Cohort||Prospective|||||||
1365553|NCT02742259|||Cohort||Prospective|||||||
1365554|NCT02742246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365555|NCT02742233|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1365556|NCT02742220|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365557|NCT02742207|||Cohort||Prospective|||||||
1365558|NCT02742194|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365559|NCT02742181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365560|NCT02742168||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365561|NCT02742155|Randomized|Parallel Assignment||Treatment||Single||||||t
1365562|NCT02742142|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1365563|NCT02742129|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1365564|NCT02742116|||Cohort||Prospective|||||||
1365565|NCT02742103|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1365566|NCT02742090||Single Group Assignment||Treatment||None (Open Label)||||||
1365567|NCT02742077||Single Group Assignment||Treatment||None (Open Label)||||||
1365568|NCT02742064|||Case-Control||Prospective|||||||
1365569|NCT02742051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365570|NCT02742038|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1365571|NCT02742025|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1365572|NCT02742012|||Cohort||Prospective|||||||
1365573|NCT02741999|||Other||Prospective|||||||
1365574|NCT02741986|||Other||Prospective|||||||
1365575|NCT02741973|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365576|NCT02741960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365577|NCT02741947|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1365578|NCT02741934|||Case-Control||Prospective|||||||
1365579|NCT02741921|Randomized|Crossover Assignment||Treatment||Single|||t|||
1365580|NCT02741908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365581|NCT02741895|||Cohort||Prospective|||||||
1365582|NCT02741882|||Case-Control||Retrospective|||||||
1365583|NCT02741869||Single Group Assignment||Treatment||None (Open Label)||||||
1365584|NCT02741856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365585|NCT02741843||||Health Services Research||||||||
1365586|NCT02741830|||Cohort||Cross-Sectional|||||||
1365587|NCT02741817|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1365588|NCT02741804|Randomized|Parallel Assignment||Prevention||Single|||t|||
1365589|NCT02741791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365590|NCT02741778|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365591|NCT02741765|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1365592|NCT02741752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365593|NCT02741739|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365594|NCT02741726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365595|NCT02741713|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365596|NCT02741700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365597|NCT02741687|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1365598|NCT02741674|||Cohort||Retrospective|||||||
1365599|NCT02741661|||Case Control||Retrospective|||||||
1365600|NCT02741648|||Case-Control||Prospective|||||||
1365601|NCT02741635||||||||||||
1365602|NCT02741622||Single Group Assignment||Treatment||None (Open Label)||||||
1365603|NCT02741609||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365604|NCT02741596|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1365605|NCT02741583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365606|NCT02741570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365607|NCT02741557|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365608|NCT02741544|||Case-Only||Prospective|||||||
1365609|NCT02741531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365610|NCT02741518|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1365611|NCT02741505||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365612|NCT02741492|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1365613|NCT02741479|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1365614|NCT02741466||Single Group Assignment||Treatment||None (Open Label)||||||
1365615|NCT02741453|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365616|NCT02741440|||Cohort||Other|||||||
1365617|NCT02741427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365618|NCT02741414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365619|NCT02741401|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365620|NCT02741388||Single Group Assignment||Treatment||None (Open Label)||||||
1365621|NCT02741375|||Case Control||Prospective|||||||
1365622|NCT02741362||Single Group Assignment||Treatment||None (Open Label)||||||
1365623|NCT02741349|||Cohort||Prospective|||||||
1365624|NCT02741336|Randomized|Parallel Assignment||Treatment||Single||||||t
1365625|NCT02741323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365626|NCT02741310|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365627|NCT02741297||Single Group Assignment||Treatment||None (Open Label)||||||
1365628|NCT02741284|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365629|NCT02741271|Randomized|Parallel Assignment||Treatment||Triple|1:1 randomization to double-blinded MF/F 100/10 mg BID and MF 100 mg BID||t|t|t|
1365630|NCT02741258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365631|NCT02741245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365632|NCT02741232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365633|NCT02741219|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1365634|NCT02741206|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1365635|NCT02741193||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365636|NCT02741180|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365637|NCT02741167|||Cohort||Prospective|||||||
1365638|NCT02741154|Randomized|Parallel Assignment||Treatment||Single||||||t
1365639|NCT02741141|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1365640|NCT02741128|Randomized|Parallel Assignment||Prevention||Single||||||t
1365641|NCT02741115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365642|NCT02741102||Single Group Assignment||Treatment||None (Open Label)||||||
1365643|NCT02741089|||Cohort||Prospective|||||||
1365644|NCT02741076|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1365645|NCT02741063|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1365646|NCT02741050|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365647|NCT02741037|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1365648|NCT02741024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365649|NCT02741011||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365650|NCT02740998|||Cohort||Prospective|||||||
1365651|NCT02740985|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365652|NCT02740972|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365653|NCT02740959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365654|NCT02740946||Single Group Assignment||Treatment||None (Open Label)||||||
1365655|NCT02740933||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365656|NCT02740920||Single Group Assignment||Treatment||None (Open Label)||||||
1365657|NCT02740907|||Case-Only||Retrospective|||||||
1365658|NCT02740894|||Case-Only||Retrospective|||||||
1365659|NCT02740881|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1365660|NCT02740868|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365661|NCT02740855|||Other||Prospective|||||||
1365662|NCT02740842|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1365663|NCT02740829|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365664|NCT02740816|||Cohort||Cross-Sectional|||||||
1365665|NCT02740803|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1365666|NCT02740790|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1365667|NCT02740777|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365668|NCT02740764|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365669|NCT02740751|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1365670|NCT02740738||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365671|NCT02740725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365672|NCT02740712||Single Group Assignment||Other||None (Open Label)|Open Label|||||
1365673|NCT02740699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365674|NCT02740686|||Cohort||Prospective|||||||
1365675|NCT02740673||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365676|NCT02740660|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1365677|NCT02740647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365678|NCT02740634|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1365679|NCT02740621|||Case-Control||Prospective|||||||
1365680|NCT02740608||Single Group Assignment||Treatment||None (Open Label)||||||
1365681|NCT02740595|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1365682|NCT02740582|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1365683|NCT02740569|||Cohort||Cross-Sectional|||||||
1365684|NCT02740556|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1365685|NCT02740543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365686|NCT02740530|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1365687|NCT02740517|||Case-Only||Retrospective|||||||
1365688|NCT02740504|||Case-Only||Cross-Sectional|||||||
1365689|NCT02740491|||Case-Only||Prospective|||||||
1365690|NCT02740478|||Case-Only||Cross-Sectional|||||||
1365691|NCT02740465||Single Group Assignment||Supportive Care||None (Open Label)||||||
1365692|NCT02740452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365693|NCT02740439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365694|NCT02740426|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1365695|NCT02740413|||Cohort||Retrospective|||||||
1365696|NCT02740400|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365697|NCT02740387||Single Group Assignment||Treatment||None (Open Label)||||||
1365698|NCT02740374|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365699|NCT02740361|Randomized|Parallel Assignment||Treatment||Single||||||t
1365700|NCT02740348|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1365701|NCT02740335|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1365702|NCT02740322||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365703|NCT02740309|Randomized|Parallel Assignment||Treatment||Single||||t||
1365704|NCT02740296|||Case-Control||Cross-Sectional|||||||
1365705|NCT02740283||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365706|NCT02740270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1365707|NCT02740257|||Cohort||Prospective|||||||
1365708|NCT02740244|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1365709|NCT02740231|Randomized|Single Group Assignment||Treatment||Double|Double-blind||t||t|
1365710|NCT02740218|||Cohort||Retrospective|||||||
1365711|NCT02740205|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1365712|NCT02740192|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365713|NCT02740179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365714|NCT02740166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365715|NCT02740153|||Cohort||Prospective|||||||
1365716|NCT02740140|||Cohort||Prospective|||||||
1365717|NCT02740127|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1365718|NCT02740114|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365719|NCT02740101|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1365720|NCT02740088|||Cohort||Prospective|||||||
1365721|NCT02740075|||Cohort||Prospective|||||||
1365722|NCT02740062|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365723|NCT02740049||Single Group Assignment||Basic Science||None (Open Label)||||||
1365724|NCT02740036||||||||||||
1365725|NCT02740023|Randomized|Crossover Assignment||Treatment||Single|||t|||
1365726|NCT02740010|||Cohort||Retrospective|||||||
1365727|NCT02739997||Single Group Assignment||Treatment||None (Open Label)||||||
1365728|NCT02739984|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1365729|NCT02739971|Randomized|Parallel Assignment||Treatment||Single||||||t
1365730|NCT02739958|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1365731|NCT02739945|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365732|NCT02739932|||Cohort||Prospective|||||||
1365733|NCT02739919|||Case-Only||Prospective|||||||
1365734|NCT02739906|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1365735|NCT02739893|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1365736|NCT02739880||Single Group Assignment||Treatment||None (Open Label)||||||
1365737|NCT02739867|||Cohort||Prospective|||||||
1365738|NCT02739854|||Cohort||Prospective|||||||
1365739|NCT02739841|Randomized|Crossover Assignment||Treatment||Single|||t|||
1365740|NCT02739828|||Cohort||Prospective|||||||
1365741|NCT02739815|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1365742|NCT02739802||Single Group Assignment||Treatment||None (Open Label)||||||
1365743|NCT02739789|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1365744|NCT02739776|||Cohort||Prospective|||||||
1365745|NCT02739763||Single Group Assignment||Basic Science||None (Open Label)||||||
1365746|NCT02739750|||Cohort||Prospective|||||||
1365747|NCT02739737|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1365748|NCT02739724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365749|NCT02739711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365750|NCT02739698|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365751|NCT02739685|Randomized|Parallel Assignment||Treatment||Single||||||t
1365752|NCT02739672|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365753|NCT02739659||Single Group Assignment||Treatment||None (Open Label)||||||
1365754|NCT02739646|Non-Randomized|Parallel Assignment||Other||Single||||||t
1365755|NCT02739633||Single Group Assignment||Treatment||None (Open Label)||||||
1365756|NCT02739620|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1365757|NCT02739607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365758|NCT02739594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365759|NCT02739581|Randomized|Parallel Assignment||Treatment||||||||
1365760|NCT02739568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365761|NCT02739555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365762|NCT02739542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365763|NCT02739529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1365764|NCT02739516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365765|NCT02739503|||Cohort||Prospective|||||||
1365766|NCT02739490|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1365767|NCT02739477||Single Group Assignment||Treatment||None (Open Label)||||||
1365768|NCT02739464|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365769|NCT02739451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365770|NCT02739438|||Cohort||Prospective|||||||
1365771|NCT02739425||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365772|NCT02739412||Single Group Assignment||Basic Science||None (Open Label)||||||
1365773|NCT02739399||Single Group Assignment||Treatment||None (Open Label)||||||
1365774|NCT02739386|||Cohort||Retrospective|||||||
1365775|NCT02739373|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1365776|NCT02739360||Single Group Assignment||Treatment||None (Open Label)||||||
1365777|NCT02739347|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1365778|NCT02739334|Randomized|Parallel Assignment||Treatment||Single||||||t
1365779|NCT02739321|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1365780|NCT02739308|Randomized|Parallel Assignment||Prevention||Single||||||t
1365781|NCT02739295|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365782|NCT02739282|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1365783|NCT02739269|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1365784|NCT02739256|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1365785|NCT02739243|Randomized|Parallel Assignment||Treatment||Single||||||t
1365786|NCT02739230||Parallel Assignment||Treatment||Double|||t|t||
1365787|NCT02739217||Single Group Assignment||Treatment||None (Open Label)||||||
1365788|NCT02739204||Single Group Assignment||Prevention||None (Open Label)||||||
1365789|NCT02739191||Single Group Assignment||Prevention||None (Open Label)||||||
1365790|NCT02739178|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1365791|NCT02739165|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1365792|NCT02739152|||Case-Only||Prospective|||||||
1365793|NCT02739139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365794|NCT02739126|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1365795|NCT02739113||Single Group Assignment||Treatment||None (Open Label)||||||
1365796|NCT02739100|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365797|NCT02739087||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365798|NCT02739074|||Cohort||Prospective|||||||
1365799|NCT02739061|Randomized|Parallel Assignment||Treatment||Single|||||t|
1365800|NCT02739048|||Cohort||Prospective|||||||
1365801|NCT02739035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365802|NCT02739022||Single Group Assignment||Prevention||None (Open Label)||||||
1365803|NCT02739009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365804|NCT02738996|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365805|NCT02738983||Single Group Assignment||Treatment||None (Open Label)||||||
1365806|NCT02738970|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365807|NCT02738957|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1365808|NCT02738944|Randomized|Parallel Assignment||Treatment||Single||||||t
1365809|NCT02738931|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365810|NCT02738918||Single Group Assignment||Treatment||None (Open Label)||||||
1365811|NCT02738905||Single Group Assignment||Treatment||None (Open Label)||||||
1365812|NCT02738892|||Cohort||Prospective|||||||
1365813|NCT02738879|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365814|NCT02738866||Single Group Assignment||Treatment||None (Open Label)||||||
1365815|NCT02738853||Single Group Assignment||Treatment||None (Open Label)||||||
1365816|NCT02738840|||Other||Prospective|||||||
1365817|NCT02738827||Single Group Assignment||Treatment||None (Open Label)||||||
1365818|NCT02738814|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1365819|NCT02738801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365820|NCT02738788|||Cohort||Prospective|||||||
1365821|NCT02738775|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1365822|NCT02738762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365823|NCT02738749||Single Group Assignment||Other||None (Open Label)||||||
1365824|NCT02738736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365825|NCT02738723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365826|NCT02738710|Randomized|Parallel Assignment||Treatment||Single||||||t
1365827|NCT02738697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365828|NCT02738684|||Case-Only||Prospective|||||||
1365829|NCT02738671|||Cohort||Cross-Sectional|||||||
1365830|NCT02738658|Randomized|Parallel Assignment||Other||Single|||t|||
1365831|NCT02738645|||Cohort||Other|||||||
1365832|NCT02738632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365833|NCT02738619|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365834|NCT02738606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365835|NCT02738593|||Cohort||Prospective|||||||
1365836|NCT02738580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365837|NCT02738567|||Cohort||Prospective|||||||
1365838|NCT02738554||Single Group Assignment||Other||None (Open Label)||||||
1365839|NCT02738541|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365840|NCT02738528|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365841|NCT02738515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365842|NCT02738502||Single Group Assignment||Treatment||None (Open Label)||||||
1365843|NCT02738489||Single Group Assignment||Treatment||None (Open Label)||||||
1365844|NCT02738476|||Cohort||Prospective|||||||
1365845|NCT02738463|||Case Control||Prospective|||||||
1365846|NCT02738450|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1365847|NCT02738437|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1365848|NCT02738424|||Cohort||Prospective|||||||
1365849|NCT02738411|||Cohort||Prospective|||||||
1365850|NCT02738398||Single Group Assignment||Treatment||||||||
1365851|NCT02738385|Randomized|Parallel Assignment||Prevention||Single|||||t|
1365852|NCT02738372|||Cohort||Prospective|||||||
1365853|NCT02738359|||Cohort||Prospective|||||||
1365854|NCT02738346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365855|NCT02738333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365856|NCT02738320|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1365857|NCT02738307||Single Group Assignment||Prevention||None (Open Label)||||||
1365858|NCT02738294||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365859|NCT02738281|||Cohort||Prospective|||||||
1365860|NCT02738268|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1365861|NCT02738255|Randomized|Crossover Assignment||Treatment||Single||||||t
1365862|NCT02738242||Single Group Assignment||Treatment||None (Open Label)||||||
1365863|NCT02738229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365864|NCT02738216|Randomized|Parallel Assignment||Treatment||Single||||||t
1365865|NCT02738203|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365866|NCT02738190|Randomized|Parallel Assignment||Prevention||Single|||t|||
1365867|NCT02738177|Randomized|||Treatment||Single|||t|||
1365868|NCT02738164|||Cohort||Prospective|||||||
1365869|NCT02738151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365870|NCT02738138|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365871|NCT02738125|||Cohort||Prospective|||||||
1365872|NCT02738112|||Cohort||Prospective|||||||
1365873|NCT02738099|||Cohort||Prospective|||||||
1365874|NCT02738086|Randomized|Crossover Assignment||Treatment||Single||||||t
1365875|NCT02738073||||||||||||
1365876|NCT02738060||Single Group Assignment||Treatment||None (Open Label)||||||
1365877|NCT02738047|||Other||Other|||||||
1365878|NCT02738034|Randomized|Parallel Assignment||Other||Single||||||t
1365879|NCT02738021||Single Group Assignment||Treatment||None (Open Label)||||||
1365880|NCT02738008||Single Group Assignment||Treatment||None (Open Label)||||||
1365881|NCT02737995||Single Group Assignment||Treatment||None (Open Label)||||||
1365882|NCT02737982|||Cohort||Prospective|||||||
1365883|NCT02737969||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365884|NCT02737956|||Case-Only|||||||||
1365885|NCT02737943|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365886|NCT02737930|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365887|NCT02737917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365888|NCT02737904|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1365889|NCT02737891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365890|NCT02737878|Randomized|Factorial Assignment||Treatment||Single||||||t
1365891|NCT02737865||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365892|NCT02737852||Single Group Assignment||Other||None (Open Label)|The new personal lubricant was used by all participants|||||
1365893|NCT02737839||Single Group Assignment||Supportive Care||None (Open Label)||||||
1365894|NCT02737826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365895|NCT02737813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365896|NCT02737800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365897|NCT02737787||Single Group Assignment||Treatment||None (Open Label)||||||
1365898|NCT02737774||Single Group Assignment||Treatment||None (Open Label)||||||
1365899|NCT02737761||Single Group Assignment||Treatment||None (Open Label)||||||
1365900|NCT02737748|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1365901|NCT02737735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365902|NCT02737722|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1365903|NCT02737709||Single Group Assignment||Treatment||None (Open Label)||||||
1365904|NCT02737696|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365905|NCT02737683|||Other||Other|||||||
1365906|NCT02737670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365907|NCT02737657|||Cohort||Prospective|||||||
1365908|NCT02737644|||Case-Control||Prospective|||||||
1365909|NCT02737631||Single Group Assignment||Screening||None (Open Label)|All participants receive the same interventions|||||
1365910|NCT02737618||Single Group Assignment||Screening||None (Open Label)||||||
1365911|NCT02737605|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1365912|NCT02737592||Single Group Assignment||Other||Triple|||t||t|t
1365913|NCT02737579||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365914|NCT02737566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365915|NCT02737553|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1365916|NCT02737540|||Case-Control||Prospective|||||||
1365917|NCT02737527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365918|NCT02737514|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1365919|NCT02737501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365920|NCT02737488|Randomized|Parallel Assignment||Treatment||Single||||||t
1365921|NCT02737475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365922|NCT02737462||Single Group Assignment||Treatment||None (Open Label)||||||
1365923|NCT02737449|||Cohort||Prospective|||||||
1365924|NCT02737436|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1365925|NCT02737423||Single Group Assignment||Supportive Care||None (Open Label)||||||
1365926|NCT02737410|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1365927|NCT02737397|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1365928|NCT02737384||Single Group Assignment||Treatment||None (Open Label)||||||
1365929|NCT02737371|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1365930|NCT02737358|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1365931|NCT02737345|||Cohort||Prospective|||||||
1365932|NCT02737332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365933|NCT02737319|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365934|NCT02737306||Single Group Assignment||Treatment||None (Open Label)||||||
1365935|NCT02737293|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1365936|NCT02737280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365937|NCT02737267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365938|NCT02737254|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1365939|NCT02737241|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365940|NCT02737228||Single Group Assignment||Treatment||None (Open Label)||||||
1365941|NCT02737215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365942|NCT02737202||Single Group Assignment||Treatment||None (Open Label)||||||
1365943|NCT02737189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365944|NCT02737176|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365945|NCT02737163|||Cohort||Prospective|||||||
1365946|NCT02737150|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1365947|NCT02737137|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1365948|NCT02737124|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1365949|NCT02737111||Single Group Assignment||||None (Open Label)||||||
1365950|NCT02737098|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1365951|NCT02737085||Single Group Assignment||Treatment||None (Open Label)||||||
1365952|NCT02737072|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365953|NCT02737059|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1365954|NCT02737046||Single Group Assignment||Treatment||None (Open Label)||||||
1365955|NCT02737033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365956|NCT02737020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365957|NCT02737007||Single Group Assignment||Treatment||None (Open Label)||||||
1365958|NCT02736994|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t||t
1365959|NCT02736981|Randomized|Parallel Assignment||Treatment||Single||||||t
1365960|NCT02736968|Randomized|Parallel Assignment||Treatment||Single||||||t
1365961|NCT02736955||Single Group Assignment||Treatment||None (Open Label)||||||
1365962|NCT02736942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365963|NCT02736929|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1365964|NCT02736916|Randomized|Parallel Assignment||Treatment||Single|||t|||
1365965|NCT02736903|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1365966|NCT02736890|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1365967|NCT02736877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365968|NCT02736864|||Other||Cross-Sectional|||||||
1365969|NCT02736851|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1365970|NCT02736838||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365971|NCT02736825|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1365972|NCT02736812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365973|NCT02736799|Randomized|Parallel Assignment||||Triple|||t|t|t|
1365974|NCT02736786|||Cohort||Prospective|||||||
1365975|NCT02736773|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1365976|NCT02736760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365977|NCT02736747|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1365978|NCT02736734||Single Group Assignment||||None (Open Label)||||||
1365979|NCT02736721||Single Group Assignment||Treatment||None (Open Label)||||||
1365980|NCT02736708|||Cohort||Prospective|||||||
1365981|NCT02736695||Single Group Assignment||Diagnostic||None (Open Label)||||||
1365982|NCT02736682|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1365983|NCT02736669|Randomized|Parallel Assignment||Treatment||Single||||||t
1365984|NCT02736656||Single Group Assignment||Treatment||None (Open Label)||||||
1365985|NCT02736643|||Case-Only|||||||||
1365986|NCT02736630|||||Prospective|||||||
1365987|NCT02736617||Single Group Assignment||Treatment||None (Open Label)||||||
1365988|NCT02736604|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1365989|NCT02736591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365990|NCT02736578|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1365991|NCT02736565||Single Group Assignment||Treatment||None (Open Label)||||||
1365992|NCT02736552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365993|NCT02736539|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1365994|NCT02736526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365995|NCT02736513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1365996|NCT02736500|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1365997|NCT02736487|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1365998|NCT02736474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1365999|NCT02736461|||Case-Control||Retrospective|||||||
1366000|NCT02736448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366001|NCT02736435|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366002|NCT02736422||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366003|NCT02736409|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366004|NCT02736396|||Case Control||Prospective|||||||
1366005|NCT02736383|||Cohort||Retrospective|||||||
1366006|NCT02736370|||Cohort||Prospective|||||||
1366007|NCT02736357|||Cohort||Prospective|||||||
1366008|NCT02736344||Single Group Assignment||Treatment||None (Open Label)||||||
1366009|NCT02736331|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1366010|NCT02736318||Single Group Assignment||Treatment||None (Open Label)||||||
1366011|NCT02736305||Single Group Assignment||Treatment||None (Open Label)||||||
1366012|NCT02736292||Single Group Assignment||Other||None (Open Label)||||||
1366013|NCT02736279|||Cohort||Prospective|||||||
1366014|NCT02736266||Single Group Assignment||Treatment||None (Open Label)||||||
1366015|NCT02736253|||Cohort||Prospective|||||||
1366016|NCT02736240|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1366168|NCT02734264|||Cohort||Prospective|||||||
1366017|NCT02736227||Single Group Assignment||Treatment||None (Open Label)||||||
1366018|NCT02736214|Randomized|Parallel Assignment||Prevention||Single|The randomization was blind to the participants, but they were made aware of their allocation during the intervention||t|||
1366019|NCT02736201|Randomized|Parallel Assignment||Treatment||Single||||||t
1366020|NCT02736188||Single Group Assignment||Treatment||None (Open Label)||||||
1366021|NCT02736175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366022|NCT02736162|||Cohort||Retrospective|||||||
1366023|NCT02736149||Single Group Assignment||Treatment||None (Open Label)||||||
1366024|NCT02736136|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366025|NCT02736123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366026|NCT02736110|||Case-Only||Prospective|||||||
1366027|NCT02736097|||Cohort||Prospective|||||||
1366028|NCT02736084||Single Group Assignment||Treatment||None (Open Label)||||||
1366029|NCT02736071|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366030|NCT02736058||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366031|NCT02736045|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366032|NCT02736032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366033|NCT02736019|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366034|NCT02736006||Single Group Assignment||Basic Science||None (Open Label)||||||
1366035|NCT02735993|||Case-Only||Prospective|||||||
1366036|NCT02735980|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366037|NCT02735967|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1366038|NCT02735954|||Cohort||Cross-Sectional|||||||
1366039|NCT02735941|||Cohort||Prospective|||||||
1366040|NCT02735928||Single Group Assignment||Treatment||None (Open Label)||||||
1366041|NCT02735915||Single Group Assignment||Prevention||None (Open Label)||||||
1366042|NCT02735902|Randomized|Parallel Assignment||Treatment||Single||||||t
1366043|NCT02735889|Randomized|Crossover Assignment||||Single|||t|||
1366044|NCT02735876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366045|NCT02735863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366046|NCT02735850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366047|NCT02735837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366048|NCT02735824|||Case-Only||Prospective|||||||
1366049|NCT02735811|||Cohort||Retrospective|||||||
1366050|NCT02735798||Single Group Assignment||Treatment||None (Open Label)||||||
1366051|NCT02735785|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366052|NCT02735772||Single Group Assignment||Treatment||None (Open Label)||||||
1366053|NCT02735759|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1366054|NCT02735746||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366055|NCT02735733|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366056|NCT02735720|||Cohort||Prospective|||||||
1366057|NCT02735707|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1366058|NCT02735694|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1366059|NCT02735681|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366060|NCT02735668|Randomized|Parallel Assignment||Treatment||Single||||||t
1366061|NCT02735655|||Cohort||Prospective|||||||
1366062|NCT02735642|Randomized|Sequential Assignment||Supportive Care||Single|We utilized an approach called permuted blocks randomization for participant assignment to the SMART trial linkage to care intervention.|Adaptive linkage to care interventions for newly diagnosed HIV-positive participants. Total N recruited will depend on HIV prevalence found in the study.|t|||
1366063|NCT02735629|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1366064|NCT02735616|||Case Control||Prospective|||||||
1366065|NCT02735603|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1366066|NCT02735590|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1366067|NCT02735577||Single Group Assignment||Basic Science||None (Open Label)||||||
1366068|NCT02735564|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366069|NCT02735551|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1366070|NCT02735538|||Case Control||Prospective|||||||
1366071|NCT02735525||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366072|NCT02735512|||Case-Control||Prospective|||||||
1366073|NCT02735499||Single Group Assignment||Treatment||None (Open Label)||||||
1366074|NCT02735486|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1366075|NCT02735473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366076|NCT02735460||Single Group Assignment||Treatment||None (Open Label)||||||
1366077|NCT02735447|||Case-Only||Cross-Sectional|||||||
1366078|NCT02735434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366079|NCT02735421|Randomized|Single Group Assignment||Prevention||Single|||||t|
1366080|NCT02735408|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1366081|NCT02735395|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366082|NCT02735382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366083|NCT02735369|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366084|NCT02735356||Single Group Assignment||Treatment||None (Open Label)||||||
1366085|NCT02735343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366086|NCT02735330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366087|NCT02735317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366088|NCT02735304|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1366089|NCT02735291||Single Group Assignment||Treatment||None (Open Label)||||||
1366090|NCT02735278|||Cohort||Cross-Sectional|||||||
1366091|NCT02735265|Randomized|Parallel Assignment||Treatment||Single||||||t
1366092|NCT02735252|||Cohort||Prospective|||||||
1366093|NCT02735239|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366094|NCT02735226|||Cohort||Prospective|||||||
1366095|NCT02735213|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366096|NCT02735200|Randomized|Parallel Assignment||Treatment||Double||assignment|t||t|
1366097|NCT02735187|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366098|NCT02735174||Single Group Assignment||Treatment||None (Open Label)||||||
1366099|NCT02735161||Single Group Assignment||Other||None (Open Label)||||||
1366100|NCT02735148|Randomized|Parallel Assignment||Treatment||Single||||||t
1366101|NCT02735135|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1366102|NCT02735122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366103|NCT02735109||Single Group Assignment||Screening||None (Open Label)||||||
1366104|NCT02735096||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366105|NCT02735083||Single Group Assignment||Other||None (Open Label)||||||
1366106|NCT02735070|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366107|NCT02735057||Single Group Assignment||Treatment||None (Open Label)||||||
1366108|NCT02735044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366109|NCT02735031|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1366110|NCT02735018|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1366111|NCT02735005||Single Group Assignment||Health Services Research||None (Open Label)||||||
1366112|NCT02734992|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1366113|NCT02734979||Single Group Assignment||Treatment||None (Open Label)||||||
1366114|NCT02734966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366115|NCT02734953||Single Group Assignment||Treatment||None (Open Label)||||||
1366116|NCT02734940|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1366117|NCT02734927|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366118|NCT02734914|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366119|NCT02734901|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1366120|NCT02734888|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366121|NCT02734875|Randomized|Crossover Assignment||||None (Open Label)||||||
1366122|NCT02734862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366123|NCT02734849|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366124|NCT02734836||Single Group Assignment||Other||None (Open Label)||||||
1366125|NCT02734823|||Case-Only||Prospective|||||||
1366126|NCT02734810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366127|NCT02734797|||Cohort||Prospective|||||||
1366128|NCT02734784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366129|NCT02734771||Single Group Assignment||Treatment||None (Open Label)||||||
1366130|NCT02734758|||Cohort||Prospective|||||||
1366131|NCT02734745||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366132|NCT02734732|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366133|NCT02734719||Single Group Assignment||Treatment||None (Open Label)||||||
1366134|NCT02734706|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366135|NCT02734693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366136|NCT02734680|Randomized|Parallel Assignment||Treatment||Single||||||t
1366137|NCT02734667|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1366138|NCT02734654|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1366139|NCT02734641|||Cohort||Prospective|||||||
1366140|NCT02734628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366141|NCT02734615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366142|NCT02734602|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366143|NCT02734589|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366144|NCT02734576||Single Group Assignment||Treatment||None (Open Label)||||||
1366145|NCT02734563|||Case-Control||Prospective|||||||
1366146|NCT02734550|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||investigator-initiated prospective, multicenter, randomized, open, and parallel group study||||
1366147|NCT02734537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366148|NCT02734524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366149|NCT02734511||Single Group Assignment||Treatment||None (Open Label)||||||
1366150|NCT02734498|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366151|NCT02734485|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1366152|NCT02734472|||Cohort||Prospective|||||||
1366153|NCT02734459|Randomized|Crossover Assignment||||None (Open Label)||||||
1366154|NCT02734446|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366155|NCT02734433||Single Group Assignment||Treatment||None (Open Label)||||||
1366156|NCT02734420|Randomized|Parallel Assignment||Treatment||Double||||t||t
1366157|NCT02734407||Single Group Assignment||Treatment||None (Open Label)||||||
1366158|NCT02734394||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366159|NCT02734381|||Cohort||Retrospective|||||||
1366160|NCT02734368|||Case Control||Prospective|||||||
1366161|NCT02734355|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366162|NCT02734342||Single Group Assignment||Treatment||None (Open Label)||||||
1366163|NCT02734329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366164|NCT02734316|||Cohort||Cross-Sectional|||||||
1366165|NCT02734303|||Ecologic or Community||Retrospective|||||||
1366166|NCT02734290|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366169|NCT02734251|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1366170|NCT02734238|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366171|NCT02734225|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366172|NCT02734212|Randomized|Parallel Assignment||Treatment||Single|Assessors were blind with regards to participants condition|||||t
1366173|NCT02734199|||Cohort||Prospective|||||||
1366174|NCT02734186||Single Group Assignment||Basic Science||None (Open Label)||||||
1366175|NCT02734173|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366176|NCT02734160||Single Group Assignment||Treatment||None (Open Label)||||||
1366177|NCT02734147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366178|NCT02734134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366179|NCT02734121|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366180|NCT02734108||Single Group Assignment||Treatment||None (Open Label)||||||
1366181|NCT02734095||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366182|NCT02734082|||Cohort||Retrospective|||||||
1366183|NCT02734069|||Cohort||Prospective|||||||
1366184|NCT02734056|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking was possible.|||||
1366185|NCT02734043|||Case-Only||Retrospective|||||||
1366186|NCT02734030|||Other||Cross-Sectional|||||||
1366187|NCT02734017|Randomized|Parallel Assignment||||None (Open Label)||||||
1366188|NCT02734004||Single Group Assignment||Treatment||None (Open Label)||||||
1366189|NCT02733991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366190|NCT02733978|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366191|NCT02733965|Randomized|Parallel Assignment||||None (Open Label)||||||
1366192|NCT02733952|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366193|NCT02733939|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366194|NCT02733926|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366195|NCT02733913|||Cohort||Prospective|||||||
1366196|NCT02733900|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366197|NCT02733887||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366198|NCT02733874|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366199|NCT02733861|||Cohort||Prospective|||||||
1366200|NCT02733848|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1366201|NCT02733835||Single Group Assignment||Treatment||None (Open Label)||||||
1366202|NCT02733822|Randomized|Crossover Assignment||||None (Open Label)||||||
1366203|NCT02733809||Single Group Assignment||Basic Science||None (Open Label)||||||
1366204|NCT02733796|||Case-Only||Prospective|||||||
1366205|NCT02733783||Single Group Assignment||Basic Science||None (Open Label)||||||
1366206|NCT02733770|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366207|NCT02733757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366208|NCT02733744||Single Group Assignment||Treatment||None (Open Label)||||||
1366209|NCT02733731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366210|NCT02733718|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1366211|NCT02733705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366212|NCT02733692|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366213|NCT02733679|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366214|NCT02733666|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366215|NCT02733653||Single Group Assignment||Treatment||None (Open Label)||||||
1366216|NCT02733640|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1366217|NCT02733627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366218|NCT02733614|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1366219|NCT02733601|||Cohort||Prospective|||||||
1366220|NCT02733588||Single Group Assignment||Treatment||None (Open Label)||||||
1366221|NCT02733575||Single Group Assignment||Treatment||None (Open Label)||||||
1366222|NCT02733562|||Cohort||Retrospective|||||||
1366223|NCT02733549|||Case Control||Prospective|||||||
1366224|NCT02733536|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366225|NCT02733523|Randomized|Parallel Assignment||Other||Single|||||t|
1366226|NCT02733510|||Cohort||Prospective|||||||
1366227|NCT02733497|Randomized|Parallel Assignment||Treatment||Single||||||t
1366228|NCT02733484|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366229|NCT02733471|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1366230|NCT02733458||Single Group Assignment||Treatment||None (Open Label)||||||
1366231|NCT02733445|||Cohort||Retrospective|||||||
1366232|NCT02733432|Randomized|Parallel Assignment||Treatment||None (Open Label)|Sponsor blinded|||||
1366233|NCT02733419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366234|NCT02733406|Randomized|Parallel Assignment||Other||Single|||t|||
1366235|NCT02733393||Single Group Assignment||Treatment||None (Open Label)||||||
1366236|NCT02733380||Single Group Assignment||Treatment||None (Open Label)||||||
1366237|NCT02733367||Single Group Assignment||Treatment||None (Open Label)||||||
1366238|NCT02733354|||Cohort||Prospective|||||||
1366239|NCT02733341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366240|NCT02733328|||Cohort||Cross-Sectional|||||||
1366241|NCT02733315||Single Group Assignment||Health Services Research||None (Open Label)||||||
1366242|NCT02733302||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366243|NCT02733289|||Cohort||Prospective|||||||
1366244|NCT02733276|Randomized|Crossover Assignment||Treatment||Single|||t|||
1366245|NCT02733263|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1366246|NCT02733250||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1366247|NCT02733237|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1366248|NCT02733224|||Case-Only||Prospective|||||||
1366249|NCT02733211|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366250|NCT02733198|Randomized|Single Group Assignment||Treatment||Single||||||t
1366251|NCT02733185|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1366252|NCT02733172|||Cohort||Prospective|||||||
1366253|NCT02733159||Single Group Assignment||Treatment||None (Open Label)||||||
1366254|NCT02733146|||Cohort||Prospective|||||||
1366255|NCT02733133|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366256|NCT02733120|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1366257|NCT02733107||Single Group Assignment||Treatment||None (Open Label)||||||
1366258|NCT02733094||Single Group Assignment||Treatment||None (Open Label)||||||
1366259|NCT02733081|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366260|NCT02733068|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366261|NCT02733055||Single Group Assignment||Basic Science||None (Open Label)||||||
1366262|NCT02733042|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366263|NCT02733029|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366264|NCT02733016|||Cohort||Prospective|||||||
1366265|NCT02733003||Single Group Assignment||Health Services Research||None (Open Label)||||||
1366266|NCT02732990|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1366267|NCT02732977||Single Group Assignment||||None (Open Label)||||||
1366268|NCT02732964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366269|NCT02732951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366270|NCT02732938||||Treatment||None (Open Label)||||||
1366271|NCT02732925|Randomized|Crossover Assignment||Treatment||Single|||t|||
1366272|NCT02732912|Randomized|Parallel Assignment||Treatment||Single||Randomised, investigator-blinded, parallel group design|||t|
1366273|NCT02732899|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366274|NCT02732886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366275|NCT02732873||Single Group Assignment||Treatment||None (Open Label)||||||
1366276|NCT02732860|||Cohort||Prospective|||||||
1366277|NCT02732847|Randomized|Single Group Assignment||||None (Open Label)||||||
1366278|NCT02732834|||Cohort||Cross-Sectional|||||||
1366279|NCT02732821|||Cohort||Prospective|||||||
1366280|NCT02732808||Single Group Assignment||Treatment||None (Open Label)||||||
1366281|NCT02732795|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366282|NCT02732782|Randomized|Parallel Assignment||Treatment||Single||||||t
1366283|NCT02732769|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366284|NCT02732756|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1366285|NCT02732743||Single Group Assignment||Screening||None (Open Label)||||||
1366286|NCT02732730|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366287|NCT02732717|||Cohort||Prospective|||||||
1366288|NCT02732704||Single Group Assignment||Treatment||None (Open Label)||||||
1366289|NCT02732691||Single Group Assignment||Treatment||None (Open Label)||||||
1366290|NCT02732678|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1366291|NCT02732665|||Cohort||Prospective|||||||
1366292|NCT02732652|||Cohort||Prospective|||||||
1366293|NCT02732639||Single Group Assignment||Treatment||None (Open Label)||||||
1366294|NCT02732626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366295|NCT02732613|Randomized|Parallel Assignment||||Double|||t||t|
1366296|NCT02732600|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366297|NCT02732587||Single Group Assignment||Treatment||None (Open Label)||||||
1366298|NCT02732574|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1366299|NCT02732561|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366300|NCT02732548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366301|NCT02732535|||Case Control||Prospective|||||||
1366302|NCT02732522|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366303|NCT02732509|||Cohort||Cross-Sectional|||||||
1366304|NCT02732496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366305|NCT02732483||Single Group Assignment||Treatment||None (Open Label)||||||
1366306|NCT02732470||Single Group Assignment||Prevention||None (Open Label)||||||
1366307|NCT02732457|||Cohort||Prospective|||||||
1366308|NCT02732444|||Other||Prospective|||||||
1366309|NCT02732431||Single Group Assignment||Other||None (Open Label)||||||
1366310|NCT02732418|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366311|NCT02732405||Single Group Assignment||Treatment||None (Open Label)||||||
1366312|NCT02732392||Single Group Assignment||Prevention||None (Open Label)||||||
1366313|NCT02732379|Randomized|Parallel Assignment||Treatment||Single||||||t
1366314|NCT02732366|Randomized|Parallel Assignment||Treatment||Single||||||t
1366315|NCT02732353|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1366316|NCT02732340||Single Group Assignment||Treatment||None (Open Label)||||||
1366317|NCT02732327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366318|NCT02732314|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366319|NCT02732301|||Cohort||Prospective|||||||
1366320|NCT02732288|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1366321|NCT02732275||Single Group Assignment||Treatment||None (Open Label)||||||
1366322|NCT02732262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366323|NCT02732249|Randomized|Parallel Assignment||Treatment||Single||||||t
1366324|NCT02732236|||Cohort||Prospective|||||||
1366325|NCT02732223|Randomized|Crossover Assignment||||Single|||t|||
1366326|NCT02732210|||Cohort||Prospective|||||||
1366327|NCT02732197|||Cohort||Retrospective|||||||
1366328|NCT02732184||Single Group Assignment||Treatment||None (Open Label)||||||
1366329|NCT02732171||Single Group Assignment||Screening||||||||
1366330|NCT02732158||Single Group Assignment||Other||None (Open Label)||||||
1366331|NCT02732145|||Case Control||Prospective|||||||
1366332|NCT02732132|Randomized|Parallel Assignment||||Single|||||t|
1366333|NCT02732119|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366334|NCT02732106|||||Prospective|||||||
1366335|NCT02732093|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1366336|NCT02732080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366337|NCT02732067|||||Prospective|||||||
1366338|NCT02732054|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366339|NCT02732041|||Cohort||Prospective|||||||
1366340|NCT02732015|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366341|NCT02732002||Single Group Assignment||Treatment||Single|||t|||
1366342|NCT02731989|||Case-Control||Prospective|||||||
1366343|NCT02731976||Single Group Assignment||Basic Science||None (Open Label)||||||
1366344|NCT02731963|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366345|NCT02731950|Randomized|Parallel Assignment||Other||Double|||t|||t
1366346|NCT02731937||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366347|NCT02731924|||Cohort||Prospective|||||||
1366348|NCT02731911|||Cohort||Prospective|||||||
1366349|NCT02731898|||Cohort||Prospective|||||||
1366350|NCT02731885|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366351|NCT02731872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366352|NCT02731859|||Cohort||Prospective|||||||
1366353|NCT02731846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366354|NCT02731833|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366355|NCT02731820|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1366356|NCT02731807|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1366357|NCT02731794|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366358|NCT02731781|||Cohort||Prospective|||||||
1366359|NCT02731768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366360|NCT02731755|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1366361|NCT02731742|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366362|NCT02731729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366363|NCT02731716|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1366364|NCT02731703|||Cohort||Prospective|||||||
1366365|NCT02731690||Single Group Assignment||Treatment||None (Open Label)||||||
1366366|NCT02731677|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366367|NCT02731664|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1366368|NCT02731651|Randomized|Parallel Assignment||Screening||Single|||||t|
1366369|NCT02731638|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366370|NCT02731625|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366371|NCT02731612|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366372|NCT02731599||Single Group Assignment||Treatment||None (Open Label)||||||
1366373|NCT02731586||Single Group Assignment||Other||None (Open Label)||||||
1366374|NCT02731573|Randomized|Parallel Assignment||Prevention||Single||"Phase Ib/II, Prospective, Multicenter, Two part study; Part 1 Open Label, Single arm & Part 2 Randomized, Single-blinded, D-PLEX Concomitantly with Standard Of Care vs. Standard of Care alone.~Study population include subjects above the age of 18 years, that undergoing cardiac surgery through mid-sternotomy, including patients with high risk of infection, such as diabetes (Insulin and/or non-insulin dependent), patients with Peripheral Vascular Disease (PVD), Chronic Obstructive Pulmonary Disease (COPD), heavy smokers, Bilateral Mammary artery harvesting, and subjects administered chronic steroid treatment.~Subjects who meet the eligibility criteria and provide signed informed consent, will be enrolled into the study and will be treated with D-PLEX concomitantly with standard of care (part 1) or randomized 2:1 to D-PLEX concomitantly with standard of care vs. standard of care only (part 2)."|t|||
1366375|NCT02731560||Single Group Assignment||Treatment||None (Open Label)||||||
1366376|NCT02731547|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366377|NCT02731534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366378|NCT02731521|||Case-Only||Prospective|||||||
1366379|NCT02731508|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366380|NCT02731495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366381|NCT02731482|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366382|NCT02731469|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366383|NCT02731456||Single Group Assignment||Prevention||None (Open Label)||||||
1366384|NCT02731443|||Cohort||Prospective|||||||
1366385|NCT02731430|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1366386|NCT02731417|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366387|NCT02731404|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1366388|NCT02731391|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366389|NCT02731378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366390|NCT02731365||Single Group Assignment||Treatment||None (Open Label)||||||
1366391|NCT02731352||Single Group Assignment||Treatment||None (Open Label)||||||
1366392|NCT02731339|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1366393|NCT02731326|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1366394|NCT02731313|||Case-Only||Cross-Sectional|||||||
1366395|NCT02731300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366396|NCT02731287|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366397|NCT02731274|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366398|NCT02731261|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366399|NCT02731248|||||Prospective|||||||
1366400|NCT02731235|Randomized|Parallel Assignment||Prevention||Single||||||t
1366401|NCT02731222|||Other||Cross-Sectional|||||||
1366402|NCT02731209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366403|NCT02731196|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366404|NCT02731183||Single Group Assignment||Treatment||None (Open Label)||||||
1366405|NCT02731170||Single Group Assignment||Treatment||None (Open Label)||||||
1366406|NCT02731157|Non-Randomized|Crossover Assignment||Other||Single||||||t
1366407|NCT02731144|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366408|NCT02731131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366409|NCT02731118|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1366410|NCT02731105|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366411|NCT02731092|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366412|NCT02731079|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366413|NCT02731066|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366414|NCT02731053|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1366415|NCT02731040|||Case-Control||Other|||||||
1366416|NCT02731027|||Cohort||Prospective|||||||
1366417|NCT02731014|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366418|NCT02731001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366419|NCT02730988|Randomized|Parallel Assignment||Prevention||Single||||||t
1366420|NCT02730975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366421|NCT02730962|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366422|NCT02730949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366423|NCT02730936||Single Group Assignment||Treatment||None (Open Label)||||||
1366424|NCT02730923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366425|NCT02730910|Randomized|Crossover Assignment||Basic Science||Single||||||t
1366426|NCT02730897|||Cohort|||||||||
1366427|NCT02730884||Single Group Assignment||Treatment||None (Open Label)||||||
1366428|NCT02730871|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366429|NCT02730858|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366430|NCT02730845|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1366431|NCT02730832||Single Group Assignment||||None (Open Label)||||||
1366432|NCT02730819||Single Group Assignment||Treatment||None (Open Label)||||||
1366433|NCT02730806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366434|NCT02730793|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366435|NCT02730780|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1366436|NCT02730767|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366437|NCT02730754|||Cohort||Retrospective|||||||
1366438|NCT02730741|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366439|NCT02730728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366440|NCT02730715|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366441|NCT02730702|||Cohort||Prospective|||||||
1366442|NCT02730689|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1366443|NCT02730676|||Cohort||Cross-Sectional|||||||
1366444|NCT02730663||Single Group Assignment||Treatment||None (Open Label)||||||
1366445|NCT02730650||Single Group Assignment||Other||None (Open Label)||||||
1366446|NCT02730637|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366447|NCT02730624||Single Group Assignment||Treatment||None (Open Label)||||||
1366448|NCT02730611|||Cohort||Prospective|||||||
1366449|NCT02730598|Randomized|Parallel Assignment||Treatment||Single||||||t
1366450|NCT02730585|||Case-Only||Prospective|||||||
1366451|NCT02730572|||Cohort||Retrospective|||||||
1366452|NCT02730559|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366453|NCT02730546||Single Group Assignment||Treatment||None (Open Label)||||||
1366454|NCT02730533|Randomized|Parallel Assignment||Prevention||Single||||||t
1366455|NCT02730520|||Case-Only||Retrospective|||||||
1366456|NCT02730507|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366457|NCT02730494|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366458|NCT02730481||Single Group Assignment||Treatment||None (Open Label)||||||
1366459|NCT02730468|||Case-Only||Prospective|||||||
1366460|NCT02730455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366461|NCT02730442||Single Group Assignment||Treatment||None (Open Label)||||||
1366462|NCT02730429|Randomized|Parallel Assignment||Treatment||Double||randomized, double-blind, placebo-controlled|t||t|
1366463|NCT02730416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366464|NCT02730403|||Other||Prospective|||||||
1366465|NCT02730390|||Cohort||Prospective|||||||
1366466|NCT02730377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366467|NCT02730364|Randomized|Parallel Assignment||Treatment||None (Open Label)|This was an open label study.|||||
1366468|NCT02730351|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1366469|NCT02730338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366470|NCT02730325|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1366471|NCT02730312||Single Group Assignment||Treatment||None (Open Label)||||||
1368239|NCT02707289|||Other||Retrospective|||||||
1366472|NCT02730299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366473|NCT02730286|||||Cross-Sectional|||||||
1366474|NCT02730273||Single Group Assignment||Treatment||None (Open Label)||||||
1366475|NCT02730260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366476|NCT02730247||Single Group Assignment||Treatment||None (Open Label)||||||
1366477|NCT02730234||Single Group Assignment||Treatment||None (Open Label)||||||
1366478|NCT02730221|||Cohort||Prospective|||||||
1366479|NCT02730208|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366480|NCT02730195||Single Group Assignment||Treatment||None (Open Label)||||||
1366481|NCT02730182||Single Group Assignment||Prevention||None (Open Label)||||||
1366482|NCT02730169|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366483|NCT02730156||Single Group Assignment||Prevention||None (Open Label)||||||
1366484|NCT02730143||Single Group Assignment||Prevention||None (Open Label)||||||
1366485|NCT02730130||Single Group Assignment||Treatment||None (Open Label)||||||
1366486|NCT02730117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366487|NCT02730104|||Cohort||Prospective|||||||
1366488|NCT02730091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366489|NCT02730078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366490|NCT02730065|Randomized|Parallel Assignment||Prevention||Single||||||t
1366491|NCT02730052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366492|NCT02730039|||Cohort||Prospective|||||||
1366493|NCT02730026|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1366494|NCT02730013|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366495|NCT02730000|Randomized|Parallel Assignment||Treatment||Single||||||t
1366496|NCT02729987|Randomized|Parallel Assignment||Prevention||Single|||||t|
1366497|NCT02729974|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366498|NCT02729961||Single Group Assignment||Treatment||None (Open Label)||||||
1366499|NCT02729948||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1366500|NCT02729935|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1366501|NCT02729922|||Cohort||Prospective|||||||
1366502|NCT02729909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366503|NCT02729896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366504|NCT02729883||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366505|NCT02729870|||Cohort||Prospective|||||||
1366506|NCT02729857|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1366507|NCT02729844|||Cohort||Prospective|||||||
1366508|NCT02729831|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1366509|NCT02729818|||Other||Prospective|||||||
1366510|NCT02729805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366511|NCT02729792|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366512|NCT02729779|Randomized|Parallel Assignment||Treatment||Single||||||t
1366513|NCT02729766|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1366514|NCT02729753|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1366515|NCT02729740||Single Group Assignment||Treatment||None (Open Label)||||||
1366516|NCT02729727||Single Group Assignment||Basic Science||None (Open Label)||||||
1366517|NCT02729714|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1366518|NCT02729701||Single Group Assignment||Prevention||None (Open Label)||||||
1366519|NCT02729688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366520|NCT02729675|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1366521|NCT02729662||Single Group Assignment||Treatment||None (Open Label)||||||
1366522|NCT02729649|Randomized|Parallel Assignment||Treatment||Single||||||t
1366523|NCT02729636|Randomized|Parallel Assignment||Treatment||Single||||||t
1366524|NCT02729623|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366525|NCT02729610|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366526|NCT02729597|||Cohort||Prospective|||||||
1366527|NCT02729584|||Cohort||Prospective|||||||
1366528|NCT02729571|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366529|NCT02729558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366530|NCT02729545|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366531|NCT02729532|||Cohort||Prospective|||||||
1366532|NCT02729519|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366533|NCT02729506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366534|NCT02729493||Single Group Assignment||Treatment||None (Open Label)||||||
1366535|NCT02729480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366536|NCT02729467|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366537|NCT02729454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366538|NCT02729441|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366539|NCT02729428|||Case-Control||Prospective|||||||
1366540|NCT02729415||Single Group Assignment||Treatment||None (Open Label)||||||
1366541|NCT02729402||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366542|NCT02729389|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366543|NCT02729376||Single Group Assignment||Basic Science||None (Open Label)||||||
1366544|NCT02729363|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366545|NCT02729350|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366546|NCT02729337|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366547|NCT02729324|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366548|NCT02729311|Randomized|Parallel Assignment||Treatment||Single||||||t
1366549|NCT02729298|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366550|NCT02729285|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1366551|NCT02729272|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366552|NCT02729259|Randomized|Parallel Assignment||Other||Single||||t||
1366553|NCT02729246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366554|NCT02729233||Single Group Assignment||Other||None (Open Label)||||||
1366555|NCT02729220|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366556|NCT02729207||||||||||||
1366557|NCT02729194||Single Group Assignment||Treatment||None (Open Label)||||||
1366558|NCT02729181|||Cohort||Retrospective|||||||
1366559|NCT02729168||Single Group Assignment||Prevention||None (Open Label)||||||
1366560|NCT02729155|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1366561|NCT02729142||Single Group Assignment||Other||None (Open Label)||||||
1366562|NCT02729129|Randomized|Crossover Assignment||||Triple|||t||t|t
1366563|NCT02729116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366564|NCT02729103|||Cohort||Retrospective|||||||
1366565|NCT02729090|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366566|NCT02729077|||Cohort||Prospective|||||||
1366567|NCT02729064|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1366568|NCT02729051|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366569|NCT02729038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366570|NCT02729025|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366571|NCT02729012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366572|NCT02728999|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366573|NCT02728986|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1366574|NCT02728973|||Case Control||Prospective|||||||
1366575|NCT02728960|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1366576|NCT02728947|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366577|NCT02728934|||Cohort||Prospective|||||||
1366578|NCT02728921|Randomized|Parallel Assignment||Treatment||Single||||||t
1366579|NCT02728908||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366580|NCT02728895|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366581|NCT02728882||Single Group Assignment||Treatment||None (Open Label)||||||
1366582|NCT02728869|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366583|NCT02728856|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1366584|NCT02728843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366585|NCT02728830||Single Group Assignment||Treatment||None (Open Label)||||||
1366586|NCT02728817|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366587|NCT02728804|||Cohort||Prospective|||||||
1366588|NCT02728791|||Cohort||Prospective|||||||
1366589|NCT02728778|Randomized|Parallel Assignment||Treatment||Single||||||t
1366590|NCT02728765|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366591|NCT02728752|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366592|NCT02728739||Single Group Assignment||Treatment||None (Open Label)||||||
1366593|NCT02728726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366594|NCT02728713|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366595|NCT02728700||Single Group Assignment||Prevention||None (Open Label)||||||
1366596|NCT02728687|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1366597|NCT02728674|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1366598|NCT02728661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366599|NCT02728648||Single Group Assignment||Treatment||None (Open Label)||||||
1366600|NCT02728635|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1366601|NCT02728622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366602|NCT02728609|||Cohort||Prospective|||||||
1366603|NCT02728596|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1366604|NCT02728583|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1366605|NCT02728570|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1366606|NCT02728557|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366607|NCT02728544|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1366608|NCT02728531||Single Group Assignment||Treatment||None (Open Label)||||||
1366609|NCT02728518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366610|NCT02728505|Randomized|Crossover Assignment||Treatment||None (Open Label)|Open Label|||||
1366611|NCT02728492|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366612|NCT02728479|||Cohort||Prospective|||||||
1366613|NCT02728466|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1366614|NCT02728453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366615|NCT02728440|||Case Control||Prospective|||||||
1366616|NCT02728427|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366617|NCT02728414|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366618|NCT02728401|||Cohort||Prospective|||||||
1366619|NCT02728388||Single Group Assignment||Treatment||None (Open Label)||||||
1366620|NCT02728375|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366621|NCT02728362|||Cohort||Prospective|||||||
1366622|NCT02728349||Single Group Assignment||Treatment||None (Open Label)||||||
1366623|NCT02728336|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366624|NCT02728323|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1366625|NCT02728310|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1366626|NCT02728297||Single Group Assignment||Treatment||None (Open Label)||||||
1366627|NCT02728284|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366628|NCT02728271||Single Group Assignment||Treatment||None (Open Label)||||||
1366629|NCT02728258||Single Group Assignment||Treatment||None (Open Label)||||||
1366630|NCT02728245|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366631|NCT02728232|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366632|NCT02728219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366633|NCT02728206||Single Group Assignment||Treatment||None (Open Label)||||||
1366634|NCT02728193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366635|NCT02728180|Randomized|Parallel Assignment||Treatment||Single||||||t
1366636|NCT02728167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366637|NCT02728154|||Cohort||Prospective|||||||
1366638|NCT02728141|Randomized|Factorial Assignment||||Quadruple|||t|t|t|t
1366639|NCT02728128|||Cohort||Prospective|||||||
1366640|NCT02728115|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366641|NCT02728102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366642|NCT02728089||Single Group Assignment||Treatment||None (Open Label)||||||
1366643|NCT02728076||Single Group Assignment||Treatment||None (Open Label)||||||
1366644|NCT02728063||Single Group Assignment||Treatment||None (Open Label)||||||
1366645|NCT02728050||Single Group Assignment||Treatment||None (Open Label)||||||
1366646|NCT02728037|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366647|NCT02728024|||Cohort||Prospective|||||||
1366648|NCT02728011|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366649|NCT02727998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366650|NCT02727985|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1366651|NCT02727972|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366652|NCT02727959|||Cohort||Prospective|||||||
1366653|NCT02727946||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366654|NCT02727933|||Case-Only||Prospective|||||||
1366655|NCT02727920|Randomized|Crossover Assignment||Other||Double|||t||t|
1366656|NCT02727907|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1366657|NCT02727894|||Cohort||Prospective|||||||
1366658|NCT02727881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366659|NCT02727868|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366660|NCT02727855|||Cohort||Prospective|||||||
1366661|NCT02727842||Single Group Assignment||Treatment||None (Open Label)||||||
1366662|NCT02727829|||Other||Prospective|||||||
1366663|NCT02727816|Randomized|Parallel Assignment||Other||Double|||t||t|
1366664|NCT02727803|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366665|NCT02727790|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366666|NCT02727777|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366667|NCT02727764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366668|NCT02727751||Single Group Assignment||Treatment||None (Open Label)||||||
1366669|NCT02727738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366670|NCT02727725||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366671|NCT02727712|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366672|NCT02727699|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366673|NCT02727686||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366674|NCT02727673|||Cohort||Prospective|||||||
1366675|NCT02727660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366676|NCT02727647|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366677|NCT02727634||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366678|NCT02727621|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366679|NCT02727608||Single Group Assignment||Prevention||None (Open Label)||||||
1366680|NCT02727595||Single Group Assignment||Treatment||None (Open Label)||||||
1366681|NCT02727582|||Cohort||Retrospective|||||||
1366682|NCT02727569|||Cohort||Prospective|||||||
1366683|NCT02727556|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366684|NCT02727543|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1366685|NCT02727530|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1366686|NCT02727517|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1366687|NCT02727504|||Cohort||Prospective|||||||
1366688|NCT02727491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366689|NCT02727478|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366690|NCT02727465|||Cohort||Other|||||||
1366691|NCT02727452|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1366692|NCT02727439|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366693|NCT02727426|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1366694|NCT02727413|||Case Control||Cross-Sectional|||||||
1366695|NCT02727400|||Case-Control||Prospective|||||||
1366696|NCT02727387||Single Group Assignment||Treatment||None (Open Label)||||||
1366697|NCT02727374|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366698|NCT02727361||Single Group Assignment||Health Services Research||None (Open Label)||||||
1366699|NCT02727348|Randomized|Parallel Assignment||Treatment||Single||||t||
1366700|NCT02727335|||Cohort||Retrospective|||||||
1366701|NCT02727322|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366702|NCT02727309||Single Group Assignment||Treatment||None (Open Label)||||||
1366703|NCT02727296|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366704|NCT02727283|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1366705|NCT02727270|||Case-Control||Cross-Sectional|||||||
1366706|NCT02727257|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366707|NCT02727244|||Case-Only||Prospective|||||||
1366708|NCT02727231|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366709|NCT02727218|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366710|NCT02727205||Single Group Assignment||Treatment||Single||||||t
1366711|NCT02727192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366712|NCT02727179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366713|NCT02727166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366714|NCT02727153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366715|NCT02727140|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1366716|NCT02727127|||Cohort||Prospective|||||||
1366717|NCT02727114|||Cohort||Cross-Sectional|||||||
1366718|NCT02727101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366719|NCT02727088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366720|NCT02727075|||Cohort||Prospective|||||||
1366721|NCT02727062||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366722|NCT02727049|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366723|NCT02727036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366724|NCT02727023||Single Group Assignment||Treatment||None (Open Label)||||||
1366725|NCT02727010|||Case-Control||Prospective|||||||
1366726|NCT02726997||Single Group Assignment||Treatment||None (Open Label)||||||
1366727|NCT02726984|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366728|NCT02726971|Randomized|Parallel Assignment||Prevention||Single|||||t|
1366729|NCT02726958|||Cohort||Retrospective|||||||
1366730|NCT02726945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366731|NCT02726932|||Cohort||Prospective|||||||
1366732|NCT02726919||Single Group Assignment||Treatment||None (Open Label)||||||
1366733|NCT02726906|Randomized|Parallel Assignment||Treatment||Single||||||t
1366734|NCT02726893|||Cohort||Prospective|||||||
1366735|NCT02726880|Randomized|Parallel Assignment||Treatment||Single||||||t
1366736|NCT02726867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366737|NCT02726854||Single Group Assignment||Treatment||None (Open Label)||||||
1366738|NCT02726841|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1366739|NCT02726828|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1366740|NCT02726815|||Cohort||Prospective|||||||
1366741|NCT02726802|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1366742|NCT02726789|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366743|NCT02726776|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1366744|NCT02726763||Single Group Assignment||Treatment||None (Open Label)||||||
1366745|NCT02726750|||Cohort||Prospective|||||||
1366746|NCT02726737|Randomized|Parallel Assignment||||Double|||t||t|
1366747|NCT02726724|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1366748|NCT02726711|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1366749|NCT02726698|||Cohort||Prospective|||||||
1366750|NCT02726685|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1366751|NCT02726672|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366752|NCT02726659|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366753|NCT02726646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366754|NCT02726633|||Case-Only||Prospective|||||||
1366755|NCT02726620|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1366756|NCT02726607|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366757|NCT02726594|||Case Control||Prospective|||||||
1366758|NCT02726581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366759|NCT02726568||Single Group Assignment||Treatment||None (Open Label)||||||
1366760|NCT02726555|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366761|NCT02726542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366762|NCT02726529|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366763|NCT02726516|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1366764|NCT02726503||Single Group Assignment||Treatment||None (Open Label)||||||
1366765|NCT02726490|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366766|NCT02726477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366767|NCT02726464|||Case-Control||Prospective|||||||
1366768|NCT02726451|Randomized|Parallel Assignment||Other||Single|||||t|
1366769|NCT02726438|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366770|NCT02726425|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366771|NCT02726412|||Cohort||Prospective|||||||
1366772|NCT02726399||Single Group Assignment||Treatment||None (Open Label)||||||
1366773|NCT02726386|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366774|NCT02726373|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366775|NCT02726360|||Case-Control||Cross-Sectional|||||||
1366776|NCT02726347|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1366777|NCT02726334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366778|NCT02726321|||Cohort||Cross-Sectional|||||||
1366779|NCT02726308|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1366780|NCT02726295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366781|NCT02726282|||Other||Prospective|||||||
1366782|NCT02726269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366783|NCT02726256|||Cohort||Prospective|||||||
1366784|NCT02726243|||Case-Control||Prospective|||||||
1366785|NCT02726230|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1366786|NCT02726217|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1366787|NCT02726204|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1366788|NCT02726191|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1366789|NCT02726178|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1366790|NCT02726152|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366791|NCT02726139|||Case-Only||Cross-Sectional|||||||
1366792|NCT02726126|||Case Control||Prospective|||||||
1366793|NCT02726113|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1366794|NCT02726100|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1366795|NCT02726087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366796|NCT02726074||Single Group Assignment||Treatment||None (Open Label)||||||
1366797|NCT02726061||Single Group Assignment||Treatment||None (Open Label)||||||
1366798|NCT02726048||Single Group Assignment||Treatment||None (Open Label)||||||
1366799|NCT02726035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366800|NCT02726022|||Cohort||Prospective|||||||
1366801|NCT02726009||Single Group Assignment||Treatment||None (Open Label)||||||
1366802|NCT02725996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366803|NCT02725983|Randomized|Parallel Assignment||Prevention||Single||||t||
1366804|NCT02725970|||Family-Based||Cross-Sectional|||||||
1366805|NCT02725957|Randomized|Parallel Assignment||||Triple|||t||t|t
1366806|NCT02725944|||Cohort||Prospective|||||||
1366807|NCT02725931||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366808|NCT02725918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366809|NCT02725905|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366810|NCT02725892|||Cohort||Prospective|||||||
1366811|NCT02725879|||||Prospective|||||||
1366812|NCT02725866|||Cohort||Prospective|||||||
1366813|NCT02725853|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366814|NCT02725840|||Cohort||Prospective|||||||
1366815|NCT02725827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366816|NCT02725814||Single Group Assignment||Supportive Care||None (Open Label)||||||
1366817|NCT02725801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366818|NCT02725788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366819|NCT02725775|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1366820|NCT02725762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366821|NCT02725749|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366822|NCT02725736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366823|NCT02725723||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366824|NCT02725710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366825|NCT02725697|||Case-Only||Prospective|||||||
1366826|NCT02725684|||Cohort||Prospective|||||||
1366827|NCT02725671||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366828|NCT02725658||Single Group Assignment||Health Services Research||None (Open Label)||||||
1366829|NCT02725645||Single Group Assignment||Basic Science||None (Open Label)||||||
1366830|NCT02725632|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366831|NCT02725619|Randomized|Parallel Assignment||Treatment||Single||||||t
1366832|NCT02725606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366833|NCT02725593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366834|NCT02725580||Single Group Assignment||Treatment||None (Open Label)||||||
1366835|NCT02725567|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366836|NCT02725554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366837|NCT02725541||Single Group Assignment||Treatment||None (Open Label)||||||
1366838|NCT02725528|Randomized|Parallel Assignment||Treatment||Single||||||t
1366839|NCT02725515|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1366840|NCT02725502|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366841|NCT02725489|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366842|NCT02725476||Single Group Assignment||Treatment||None (Open Label)||||||
1366843|NCT02725463||Single Group Assignment||Treatment||None (Open Label)||||||
1366844|NCT02725450||Single Group Assignment||Treatment||None (Open Label)||||||
1366845|NCT02725437|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1366846|NCT02725424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366847|NCT02725411|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366848|NCT02725398|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1366849|NCT02725385|||Case-Control||Prospective|||||||
1366850|NCT02725372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366851|NCT02725359|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1366852|NCT02725346|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366853|NCT02725333||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366854|NCT02725320|||Cohort||Prospective|||||||
1366855|NCT02725307|||Case-Only||Prospective|||||||
1366856|NCT02725294|||Cohort||Prospective|||||||
1366857|NCT02725281|Randomized|Parallel Assignment||||None (Open Label)||||||
1366858|NCT02725268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366859|NCT02725255|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366860|NCT02725242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366861|NCT02725229|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1366862|NCT02725203|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366863|NCT02725190|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1366864|NCT02725177||Single Group Assignment||Treatment||None (Open Label)||||||
1366865|NCT02725164|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366866|NCT02725151|||Cohort||Prospective|||||||
1366867|NCT02725138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366868|NCT02725125||Single Group Assignment||Treatment||None (Open Label)||||||
1366869|NCT02725112|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1366870|NCT02725099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366871|NCT02725086|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366872|NCT02725073||Single Group Assignment||Treatment||None (Open Label)||||||
1366873|NCT02725060||Single Group Assignment||Other||None (Open Label)||||||
1366874|NCT02725047|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1366875|NCT02725034|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1366876|NCT02725021|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366877|NCT02725008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366878|NCT02724995|||Cohort||Prospective|||||||
1366879|NCT02724982|||||Cross-Sectional|||||||
1366880|NCT02724969|Randomized|Parallel Assignment||Prevention||Double|Lactation consultant providing assistance has no knowledge of group assignment. Statistician completing final analysis of data will be blinded to group assignment.|||t||t
1366881|NCT02724956|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1366882|NCT02724943|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366883|NCT02724930|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1366884|NCT02724917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366885|NCT02724904||Single Group Assignment||Treatment||None (Open Label)||||||
1366886|NCT02724891|||Case-Crossover||Prospective|||||||
1366887|NCT02724878||Single Group Assignment||Treatment||None (Open Label)||||||
1366888|NCT02724865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366889|NCT02724852|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366890|NCT02724839||Single Group Assignment||Prevention||None (Open Label)||||||
1366891|NCT02724826|Randomized|Parallel Assignment||Treatment||Single||||||t
1366892|NCT02724813|Randomized|Parallel Assignment||Treatment||Single||||||t
1366893|NCT02724800|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366894|NCT02724787||Single Group Assignment||Treatment||None (Open Label)||||||
1366895|NCT02724774|Randomized|Parallel Assignment||Prevention||Single||||||t
1366896|NCT02724761|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1366897|NCT02724748|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1366898|NCT02724735|||Cohort||Prospective|||||||
1366899|NCT02724722|Randomized|Parallel Assignment||Prevention||Single||||||t
1366900|NCT02724709|||Case-Only||Prospective|||||||
1366901|NCT02724696|||Cohort||Prospective|||||||
1366902|NCT02724683|||Cohort||Prospective|||||||
1366903|NCT02724670||Single Group Assignment||Treatment||None (Open Label)||||||
1366904|NCT02724657|Randomized|Parallel Assignment||Treatment||Single||||||t
1366905|NCT02724644|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1366906|NCT02724631||Single Group Assignment||Treatment||None (Open Label)||||||
1366907|NCT02724618|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1366908|NCT02724605|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1366909|NCT02724592|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366910|NCT02724579||Single Group Assignment||Treatment||None (Open Label)||||||
1366911|NCT02724566|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1366912|NCT02724553|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366913|NCT02724540|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366914|NCT02724527|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1366915|NCT02724514|||Cohort||Prospective|||||||
1366916|NCT02724501|||Cohort||Prospective|||||||
1366917|NCT02724488|||Cohort||Prospective|||||||
1366918|NCT02724475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366919|NCT02724462|Randomized|Parallel Assignment||Treatment||Single|||||t|
1366920|NCT02724449||Single Group Assignment||Prevention||None (Open Label)||||||
1366921|NCT02724436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366922|NCT02724423||Single Group Assignment||Treatment||None (Open Label)|open-label|||||
1366923|NCT02724410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366924|NCT02724397|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1366925|NCT02724384|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366926|NCT02724371|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366927|NCT02724358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366928|NCT02724345|||Cohort||Prospective|||||||
1366929|NCT02724332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366930|NCT02724319|||Cohort||Prospective|||||||
1366931|NCT02724306|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366932|NCT02724293|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1366933|NCT02724280|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1366934|NCT02724267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368392|NCT02705287|||Case-Control||Prospective|||||||
1366935|NCT02724254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1366936|NCT02724241|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1366937|NCT02724228||Single Group Assignment||Treatment||None (Open Label)||||||
1366938|NCT02724215|||Case-Control||Prospective|||||||
1366939|NCT02724202||Single Group Assignment||Treatment||None (Open Label)||||||
1366940|NCT02724189|||Case-Crossover||Prospective|||||||
1366941|NCT02724176||Single Group Assignment||Treatment||None (Open Label)||||||
1366942|NCT02724163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366943|NCT02724150|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1366944|NCT02724137|Randomized|Parallel Assignment||Treatment||Single||||||t
1366945|NCT02724124|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1366946|NCT02724111|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1366947|NCT02724098|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366948|NCT02724085|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1366949|NCT02724072||Single Group Assignment||Treatment||None (Open Label)||||||
1366950|NCT02724059||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366951|NCT02724046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366952|NCT02724033|Randomized|Parallel Assignment||Prevention||Single|||t|||
1366953|NCT02724020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366954|NCT02724007|||Cohort||Retrospective|||||||
1366955|NCT02723994||Single Group Assignment||Treatment||None (Open Label)||||||
1366956|NCT02723981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366957|NCT02723968||Single Group Assignment||Screening||None (Open Label)||||||
1366958|NCT02723955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1366959|NCT02723942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366960|NCT02723929|Randomized|Parallel Assignment||Treatment||Triple||tDCS and tUS|t||t|t
1366961|NCT02723916|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1366962|NCT02723903|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366963|NCT02723890||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366964|NCT02723877||Single Group Assignment||Treatment||None (Open Label)||||||
1366965|NCT02723864||Single Group Assignment||Treatment||None (Open Label)||||||
1366966|NCT02723851|||Case Control||Prospective|||||||
1366967|NCT02723838||Single Group Assignment||Treatment||None (Open Label)||||||
1366968|NCT02723825|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1366969|NCT02723812||Single Group Assignment||Prevention||None (Open Label)||||||
1366970|NCT02723799|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1366971|NCT02723786||Single Group Assignment||Treatment||None (Open Label)||||||
1366972|NCT02723773|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1366973|NCT02723760||Single Group Assignment||Diagnostic||None (Open Label)||||||
1366974|NCT02723747|||Case-Only||Prospective|||||||
1366975|NCT02723734|||Cohort||Prospective|||||||
1366976|NCT02723721||Single Group Assignment||Treatment||None (Open Label)||||||
1366977|NCT02723708||Single Group Assignment||Other||None (Open Label)||||||
1366978|NCT02723695|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1366979|NCT02723682|||||Cross-Sectional|||||||
1366980|NCT02723669|Randomized|Crossover Assignment||||None (Open Label)||||||
1366981|NCT02723656|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1366982|NCT02723643|||Case-Only||Prospective|||||||
1366983|NCT02723630|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1366984|NCT02723617|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1366985|NCT02723604||Single Group Assignment||Prevention||None (Open Label)||||||
1366986|NCT02723591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366987|NCT02723578||Single Group Assignment||Treatment||None (Open Label)||||||
1366988|NCT02723565|||Cohort||Prospective|||||||
1366989|NCT02723552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1366990|NCT02723539|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1366991|NCT02723526|||||Prospective|||||||
1366992|NCT02723513||Single Group Assignment||Basic Science||None (Open Label)||||||
1366993|NCT02723500||Single Group Assignment||Basic Science||None (Open Label)||||||
1366994|NCT02723487|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1366995|NCT02723474||Single Group Assignment||Basic Science||None (Open Label)||||||
1366996|NCT02723461|Randomized|Parallel Assignment||Treatment||Single|||t|||
1366997|NCT02723448||Single Group Assignment||Treatment||None (Open Label)||||||
1366998|NCT02723435||Single Group Assignment||Treatment||None (Open Label)||||||
1366999|NCT02723422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367000|NCT02723409|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1367001|NCT02723396|||Ecologic or Community||Prospective|||||||
1367002|NCT02723383|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367003|NCT02723370|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367004|NCT02723357|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367005|NCT02723344|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1367006|NCT02723331|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367007|NCT02723318|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367008|NCT02723305|||Case-Only||Cross-Sectional|||||||
1367009|NCT02723292|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367010|NCT02723279|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1367011|NCT02723266|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367012|NCT02723253||Single Group Assignment||Treatment||None (Open Label)||||||
1367013|NCT02723240|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367014|NCT02723227|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367015|NCT02723214|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1367016|NCT02723201|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1367017|NCT02723188|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1367018|NCT02723175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367019|NCT02723162|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1367020|NCT02723149|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1367021|NCT02723136|Randomized|Parallel Assignment||||Double|||||t|t
1367022|NCT02723123|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1367023|NCT02723110|||Case Control||Prospective|||||||
1367024|NCT02723097||Single Group Assignment||Supportive Care||None (Open Label)||||||
1367025|NCT02723084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367026|NCT02723071|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367027|NCT02723058|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1367028|NCT02723045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367029|NCT02723032||Single Group Assignment||||None (Open Label)||||||
1367030|NCT02723019|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1367031|NCT02723006|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1367032|NCT02722993|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367033|NCT02722980|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367034|NCT02722967||Single Group Assignment||Treatment||None (Open Label)||||||
1367035|NCT02722954||Single Group Assignment||Treatment||None (Open Label)||||||
1367036|NCT02722941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367037|NCT02722928|Randomized|Parallel Assignment||Other||Single||||||t
1367038|NCT02722915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367039|NCT02722902|Randomized|Crossover Assignment||Prevention||Single|||t|||
1367040|NCT02722889|||Cohort||Retrospective|||||||
1367041|NCT02722876|Randomized|Factorial Assignment||Treatment||Single|||t|||
1367042|NCT02722863|||Case-Only||Prospective|||||||
1367043|NCT02722850|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367044|NCT02722837||Single Group Assignment||Treatment||None (Open Label)||||||
1367045|NCT02722824|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1367046|NCT02722811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367047|NCT02722798||Single Group Assignment||Treatment||None (Open Label)||||||
1367048|NCT02722785|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367049|NCT02722772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367050|NCT02722759||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367051|NCT02722746|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1367052|NCT02722733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367053|NCT02722720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367054|NCT02722707||||||||||||
1367055|NCT02722694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367056|NCT02722681|||Cohort||Prospective|||||||
1367057|NCT02722668|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367058|NCT02722655|||Cohort||Prospective|||||||
1367059|NCT02722642||Single Group Assignment||Treatment||None (Open Label)||||||
1367060|NCT02722629||Single Group Assignment||Screening||None (Open Label)||||||
1367061|NCT02722616|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1367062|NCT02722603|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367063|NCT02722590|||Other||Prospective|||||||
1367064|NCT02722577|||Cohort||Prospective|||||||
1367065|NCT02722564||Single Group Assignment||Basic Science||Single||||||
1367066|NCT02722551||Single Group Assignment||Treatment||None (Open Label)||||||
1367067|NCT02722538|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1367068|NCT02722525||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367069|NCT02722512|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367070|NCT02722499|Randomized|Parallel Assignment||Treatment||Single|||||t|
1367071|NCT02722486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367072|NCT02722473|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1367073|NCT02722460|||Case-Only||Prospective|||||||
1367074|NCT02722447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367075|NCT02722434|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367076|NCT02722421||Single Group Assignment||Treatment||None (Open Label)||||||
1367077|NCT02722408|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1367078|NCT02722395|||Cohort||Prospective|||||||
1367079|NCT02722382|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1367080|NCT02722369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367081|NCT02722356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367082|NCT02722343|Randomized|Parallel Assignment||||None (Open Label)||||||
1367083|NCT02722330||Single Group Assignment||Other||None (Open Label)||||||
1367084|NCT02722317|||||Retrospective|||||||
1367085|NCT02722304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367086|NCT02722291||Single Group Assignment||Basic Science||None (Open Label)||||||
1367087|NCT02722278|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1367088|NCT02722265||Single Group Assignment||Treatment||None (Open Label)||||||
1367089|NCT02722252|||Case-Only||Prospective|||||||
1367090|NCT02722239|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367091|NCT02722226|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1367092|NCT02722213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367093|NCT02722200|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1367094|NCT02722187|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367095|NCT02722174|||Cohort||Prospective|||||||
1367096|NCT02722161||Single Group Assignment||Treatment||None (Open Label)||||||
1367097|NCT02722148||Single Group Assignment||Treatment||None (Open Label)||||||
1367098|NCT02722135||Single Group Assignment||Treatment||None (Open Label)||||||
1367099|NCT02722122||Single Group Assignment||Treatment||None (Open Label)||||||
1367100|NCT02722109|||Other||Other|||||||
1367101|NCT02722096|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367102|NCT02722083|Randomized|Crossover Assignment||Treatment||Single|||t|||
1367103|NCT02722070|||Cohort||Cross-Sectional|||||||
1367104|NCT02722057|||Cohort||Other|||||||
1367105|NCT02722044||Single Group Assignment||Treatment||None (Open Label)||||||
1367106|NCT02722031|||Cohort||Prospective|||||||
1367107|NCT02722018|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367108|NCT02722005|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367109|NCT02721992|||Cohort||Cross-Sectional|||||||
1367110|NCT02721979||Single Group Assignment||Treatment||None (Open Label)||||||
1367111|NCT02721966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367112|NCT02721953|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367113|NCT02721940|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367114|NCT02721927|||Case-Only||Retrospective|||||||
1367115|NCT02721914|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1367116|NCT02721901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367117|NCT02721888||Single Group Assignment||Treatment||None (Open Label)||||||
1367118|NCT02721875|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367119|NCT02721862|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367120|NCT02721849|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1367121|NCT02721836|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1367122|NCT02721823|Randomized|Parallel Assignment||Treatment||Single||||||t
1367123|NCT02721810|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1367124|NCT02721797|||Case-Control||Prospective|||||||
1367125|NCT02721784||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367126|NCT02721771|||Cohort||Prospective|||||||
1367127|NCT02721758|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367128|NCT02721745|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1367129|NCT02721732||Single Group Assignment||Treatment||None (Open Label)||||||
1367130|NCT02721719|||Case-Control||Prospective|||||||
1367131|NCT02721706|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1367132|NCT02721693||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367133|NCT02721680|Randomized|Parallel Assignment||Other||Double|||t|||t
1367134|NCT02721667|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367135|NCT02721654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367136|NCT02721641||Single Group Assignment||Treatment||None (Open Label)||||||
1367137|NCT02721628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367138|NCT02721615|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1367139|NCT02721602|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367140|NCT02721589||Single Group Assignment||Other||None (Open Label)||||||
1367141|NCT02721576||Single Group Assignment||Treatment||None (Open Label)||||||
1367142|NCT02721563|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367143|NCT02721550||Single Group Assignment||Treatment||None (Open Label)||||||
1367144|NCT02721537|Randomized|Parallel Assignment||Screening||Double|||t||t|
1367145|NCT02721524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367146|NCT02721511||Single Group Assignment||Treatment||None (Open Label)||||||
1367147|NCT02721498|Randomized|Crossover Assignment||Other||Single|||||t|
1367148|NCT02721485|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1367149|NCT02721472||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367150|NCT02721459||Single Group Assignment||Treatment||None (Open Label)||||||
1367151|NCT02721446|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367152|NCT02721433|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1367153|NCT02721420|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1367154|NCT02721407||Single Group Assignment||Treatment||None (Open Label)||||||
1367155|NCT02721394|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367156|NCT02721381|Randomized|Parallel Assignment||Treatment||Single||||||t
1367157|NCT02721368|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367158|NCT02721355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367159|NCT02721342|||Cohort||Prospective|||||||
1367160|NCT02721329|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1367161|NCT02721316|Randomized|Parallel Assignment||Prevention||Single|||t|||
1367162|NCT02721303|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1367163|NCT02721290|Randomized|Parallel Assignment||Treatment||Single|||||t|
1367164|NCT02721277||Single Group Assignment||Supportive Care||None (Open Label)||||||
1367165|NCT02721264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367166|NCT02721251|Randomized|Parallel Assignment||Treatment||Single||||||t
1367167|NCT02721238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367168|NCT02721225|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367169|NCT02721212|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1367170|NCT02721199|||Cohort||Prospective|||||||
1367171|NCT02721186|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367172|NCT02721173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367173|NCT02721160|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367174|NCT02721147|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367175|NCT02721134||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367176|NCT02721121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367177|NCT02721108|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1367178|NCT02721095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367179|NCT02721082|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367180|NCT02721069||Single Group Assignment||Treatment||None (Open Label)||||||
1367181|NCT02721056||Single Group Assignment||Treatment||None (Open Label)||||||
1367182|NCT02721043||Single Group Assignment||Treatment||None (Open Label)||||||
1367183|NCT02721030|||Cohort||Prospective|||||||
1367184|NCT02721017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367185|NCT02721004|||Case-Only||Cross-Sectional|||||||
1367186|NCT02720991||Single Group Assignment||Treatment||None (Open Label)||||||
1367187|NCT02720978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367188|NCT02720965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367189|NCT02720952||Single Group Assignment||Treatment||None (Open Label)||||||
1367190|NCT02720939|||Case Control||Cross-Sectional|||||||
1367191|NCT02720926||Single Group Assignment||Treatment||None (Open Label)||||||
1367192|NCT02720913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367193|NCT02720900|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1367194|NCT02720887|||Cohort||Prospective|||||||
1367195|NCT02720874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367196|NCT02720861|||Cohort||Cross-Sectional|||||||
1367197|NCT02720848|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1367198|NCT02720822|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367199|NCT02720809|||Cohort||Cross-Sectional|||||||
1367200|NCT02720796||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367201|NCT02720783|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1367202|NCT02720770||Single Group Assignment||Treatment||None (Open Label)||||||
1367203|NCT02720757|||Cohort||Prospective|||||||
1367204|NCT02720744|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367205|NCT02720731|||Ecologic or Community||Prospective|||||||
1367206|NCT02720718|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367207|NCT02720705|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367208|NCT02720692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367209|NCT02720679|||Cohort||Prospective|||||||
1367210|NCT02720666|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367211|NCT02720653|||Cohort||Prospective|||||||
1367212|NCT02720640||Single Group Assignment||Treatment||None (Open Label)||||||
1367213|NCT02720627||Single Group Assignment||Treatment||None (Open Label)||||||
1367214|NCT02720614||Single Group Assignment||Treatment||None (Open Label)||||||
1367215|NCT02720601||Single Group Assignment||Treatment||None (Open Label)||||||
1367216|NCT02720588|||Case Control||Cross-Sectional|||||||
1367217|NCT02720575|Randomized|Single Group Assignment||Basic Science||Single||||t||
1367218|NCT02720562|||Case Control||Cross-Sectional|||||||
1367219|NCT02720549|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1367220|NCT02720536||Single Group Assignment||Other||None (Open Label)||||||
1367221|NCT02720523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367222|NCT02720510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367223|NCT02720497|Randomized|Parallel Assignment||Treatment||Single||||||t
1367224|NCT02720484||Single Group Assignment||Treatment||None (Open Label)||||||
1367225|NCT02720471|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367226|NCT02720458|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367227|NCT02720445|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367228|NCT02720432|Randomized|Parallel Assignment||Treatment||Single||||||t
1367229|NCT02720419|||Cohort||Prospective|||||||
1367230|NCT02720406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367231|NCT02720393|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1367232|NCT02720380|Randomized|Parallel Assignment||Treatment||Single||||||t
1367233|NCT02720367|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1367234|NCT02720354||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367235|NCT02720341||Single Group Assignment||Treatment||None (Open Label)||||||
1367236|NCT02720328||Single Group Assignment||Health Services Research||None (Open Label)||||||
1367237|NCT02720315|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367238|NCT02720302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367239|NCT02720289|Randomized|Parallel Assignment||||Single||||||t
1367240|NCT02720276||Single Group Assignment||Treatment||None (Open Label)||||||
1367241|NCT02720263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367242|NCT02720250|Randomized|Parallel Assignment||||Double|||t||t|
1367243|NCT02720237|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1367244|NCT02720224||Single Group Assignment||Other||None (Open Label)||||||
1367245|NCT02720211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367246|NCT02720198|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1367247|NCT02720185||Single Group Assignment||Basic Science||None (Open Label)||||||
1367248|NCT02720172|Randomized|Parallel Assignment||Treatment||Single||||||t
1367249|NCT02720159||Single Group Assignment||Treatment||None (Open Label)||||||
1367250|NCT02720146|||||Prospective|||||||
1367251|NCT02720133|||Cohort||Prospective|||||||
1367252|NCT02720120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367253|NCT02720107|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1367254|NCT02720094|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367255|NCT02720081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367256|NCT02720068|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367257|NCT02720055|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367258|NCT02720042||Single Group Assignment||Treatment||None (Open Label)||||||
1367259|NCT02720029||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367260|NCT02720016|Randomized|Parallel Assignment||Treatment||Single|Study assessors are kept blind to the couple's randomly assigned treatment condition.|||||t
1367261|NCT02720003||Single Group Assignment||Treatment||None (Open Label)||||||
1367262|NCT02719990|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367263|NCT02719977||Single Group Assignment||Treatment||None (Open Label)||||||
1367264|NCT02719964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367265|NCT02719951|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1367266|NCT02719938|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1367267|NCT02719925|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367268|NCT02719912||Single Group Assignment||Treatment||None (Open Label)||||||
1367269|NCT02719899|||Cohort||Prospective|||||||
1367270|NCT02719886|Randomized|Parallel Assignment||||None (Open Label)||||||
1367271|NCT02719873|||Case-Control||Prospective|||||||
1367272|NCT02719860|Randomized|Parallel Assignment||Prevention||Double||||||
1367273|NCT02719847||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367274|NCT02719834|||Cohort||Prospective|||||||
1367275|NCT02719821||Single Group Assignment||Supportive Care||None (Open Label)||||||
1367276|NCT02719808|||Cohort||Prospective|||||||
1367277|NCT02719795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367278|NCT02719782||Single Group Assignment||Treatment||None (Open Label)||||||
1367279|NCT02719769|||Other||Prospective|||||||
1367280|NCT02719756|Randomized|Parallel Assignment||||None (Open Label)||||||
1367281|NCT02719743|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367282|NCT02719730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367283|NCT02719717||Single Group Assignment||Treatment||None (Open Label)||||||
1367284|NCT02719704|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367285|NCT02719691|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367286|NCT02719678|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1367287|NCT02719665|Randomized|Parallel Assignment||Other||Double|||t||t|
1367288|NCT02719652|||Cohort||Prospective|||||||
1367289|NCT02719639|||Other||Prospective|||||||
1367290|NCT02719626|||Case-Only||Cross-Sectional|||||||
1367291|NCT02719613||Single Group Assignment||Supportive Care||None (Open Label)||||||
1367292|NCT02719600|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367293|NCT02719587|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367294|NCT02719574|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367295|NCT02719561||Single Group Assignment||Treatment||None (Open Label)||||||
1367296|NCT02719548|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1367297|NCT02719535||Single Group Assignment||Treatment||None (Open Label)||||||
1367298|NCT02719522|||Cohort||Prospective|||||||
1367299|NCT02719509|||Cohort||Prospective|||||||
1367300|NCT02719496||Single Group Assignment||Treatment||None (Open Label)||||||
1367301|NCT02719483|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1367302|NCT02719470|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1367303|NCT02719457|Randomized|Crossover Assignment||||None (Open Label)||||||
1367304|NCT02719444||||||||||||
1367305|NCT02719431||Single Group Assignment||||None (Open Label)||||||
1367306|NCT02719418|||Cohort||Prospective|||||||
1367307|NCT02719405|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1367308|NCT02719392|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367309|NCT02719379|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1367310|NCT02719366||||||||||||
1367311|NCT02719353||||||||||||
1367312|NCT02719340|||Case-Only||Retrospective|||||||
1367313|NCT02719327|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367314|NCT02719314|||Cohort||Prospective|||||||
1367315|NCT02719301|||Cohort||Retrospective|||||||
1367316|NCT02719288|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367317|NCT02719275|||Cohort||Retrospective|||||||
1367318|NCT02719262||Single Group Assignment||Prevention||None (Open Label)|Blinded by lab. persons who analyzed biomarkers|Install local ventilation or not||||
1367319|NCT02719249|||Cohort||Prospective|||||||
1367320|NCT02719236|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1367321|NCT02719223|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1367322|NCT02719210|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367323|NCT02719197|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1367324|NCT02719184|||Cohort||Prospective|||||||
1367325|NCT02719171|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367326|NCT02719158|Randomized|Parallel Assignment||Treatment||Single||||t||
1367327|NCT02719145|||Case-Control||Cross-Sectional|||||||
1367328|NCT02719132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367329|NCT02719119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367330|NCT02719106|||Cohort||Prospective|||||||
1367331|NCT02719093||Single Group Assignment||Treatment||None (Open Label)||||||
1367332|NCT02719080|||Cohort||Prospective|||||||
1367333|NCT02719067|||Case Control||Cross-Sectional|||||||
1367334|NCT02719054|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367335|NCT02719041|||Case-Only||Retrospective|||||||
1367336|NCT02719028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367337|NCT02719015||Single Group Assignment||Treatment||None (Open Label)||||||
1367338|NCT02719002||Single Group Assignment||Screening||None (Open Label)||||||
1367339|NCT02718989|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1367340|NCT02718976|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1367341|NCT02718963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367342|NCT02718950||Single Group Assignment||Treatment||None (Open Label)||||||
1367343|NCT02718937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367344|NCT02718924|||Cohort||Prospective|||||||
1367345|NCT02718911|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367346|NCT02718898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367347|NCT02718885|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1367348|NCT02718872||Single Group Assignment||Health Services Research||None (Open Label)||||||
1367349|NCT02718859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367350|NCT02718846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367351|NCT02718833||Single Group Assignment||Treatment||None (Open Label)||||||
1367352|NCT02718820||Single Group Assignment||Treatment||None (Open Label)||||||
1367353|NCT02718807|||Cohort||Prospective|||||||
1367354|NCT02718794|Randomized|Crossover Assignment||Health Services Research||Triple|||t||t|t
1367355|NCT02718781|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367356|NCT02718768|||Other||Prospective|||||||
1367357|NCT02718755||Single Group Assignment||Treatment||None (Open Label)||||||
1367358|NCT02718742||Single Group Assignment||Treatment||None (Open Label)||||||
1367359|NCT02718729||Single Group Assignment||||None (Open Label)||||||
1367360|NCT02718716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367361|NCT02718703||Single Group Assignment||||None (Open Label)||||||
1367362|NCT02718690|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1367363|NCT02718677|||Other||Other|||||||
1367364|NCT02718664|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367365|NCT02718651|||Cohort||Prospective|||||||
1367366|NCT02718638||Single Group Assignment||Treatment||None (Open Label)||||||
1367367|NCT02718625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367368|NCT02718612|||Case-Crossover||Cross-Sectional|||||||
1367369|NCT02718599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367370|NCT02718586|||Case-Crossover||Cross-Sectional|||||||
1367371|NCT02718573|||Case-Only||Prospective|||||||
1367372|NCT02718560|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1367373|NCT02718547||Single Group Assignment||Treatment||None (Open Label)||||||
1367374|NCT02718534|||Cohort||Prospective|||||||
1367375|NCT02718521|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1367376|NCT02718508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367377|NCT02718495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367378|NCT02718482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367379|NCT02718469|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1367380|NCT02718456|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367381|NCT02718443||Single Group Assignment||Treatment||None (Open Label)||||||
1367382|NCT02718430||Single Group Assignment||Treatment||None (Open Label)||||||
1367383|NCT02718417|Randomized|||Treatment||None (Open Label)||||||
1367384|NCT02718404||Single Group Assignment||Treatment||None (Open Label)||||||
1367385|NCT02718391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367386|NCT02718378|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1367387|NCT02718365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367388|NCT02718352|||Case-Only||Prospective|||||||
1367389|NCT02718339|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1367390|NCT02718326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367391|NCT02718313|||Case-Only||Prospective|||||||
1367392|NCT02718300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367393|NCT02718287|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1367394|NCT02718274|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1367395|NCT02718261|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1367396|NCT02718248||Single Group Assignment||Treatment||None (Open Label)||||||
1367397|NCT02718235|||Cohort||Prospective|||||||
1368532|NCT02703467|||Cohort||Prospective|||||||
1367398|NCT02718222|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1367399|NCT02718209||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367400|NCT02718196||Single Group Assignment||Supportive Care||None (Open Label)||||||
1367401|NCT02718183|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1367402|NCT02718170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367403|NCT02718157||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367404|NCT02718144||Single Group Assignment||Other||None (Open Label)||||||
1367405|NCT02718131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367406|NCT02718118|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367407|NCT02718105|||Other||Prospective|||||||
1367408|NCT02718092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367409|NCT02718079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367410|NCT02718066||Single Group Assignment||Treatment||None (Open Label)||||||
1367411|NCT02718053|||||Prospective|||||||
1367412|NCT02718040||Single Group Assignment||Treatment||None (Open Label)||||||
1367413|NCT02718027|||Cohort||Prospective|||||||
1367414|NCT02718014|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367415|NCT02718001||Single Group Assignment||Treatment||None (Open Label)||||||
1367416|NCT02717988|Randomized|Parallel Assignment||Other||Double|||t||t|
1367417|NCT02717975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367418|NCT02717962||Single Group Assignment||Treatment||None (Open Label)||||||
1367419|NCT02717949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367420|NCT02717936||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367421|NCT02717923||Single Group Assignment||Treatment||None (Open Label)||||||
1367422|NCT02717910|Randomized|Parallel Assignment||Prevention||Single|||t|||
1367423|NCT02717897|||Cohort||Cross-Sectional|||||||
1367424|NCT02717884||Single Group Assignment||Treatment||None (Open Label)||||||
1367425|NCT02717871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367426|NCT02717858|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367427|NCT02717845|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1367428|NCT02717832||Single Group Assignment||Basic Science||None (Open Label)||||||
1367429|NCT02717819|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1367430|NCT02717806|Randomized|Parallel Assignment||Prevention||Single||||||t
1367431|NCT02717793|Randomized|Crossover Assignment||||Single||||||t
1367432|NCT02717780|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1367433|NCT02717767|||Other||Prospective|||||||
1367434|NCT02717754|Randomized|Parallel Assignment||||Double|||t||t|
1367435|NCT02717741||Single Group Assignment||||None (Open Label)||||||
1367436|NCT02717728|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1367437|NCT02717715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367438|NCT02717702|||Cohort||Prospective|||||||
1367439|NCT02717689|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367440|NCT02717676|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367441|NCT02717663|Randomized|Factorial Assignment||Treatment||Single|||t|||
1367442|NCT02717650|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1367443|NCT02717637|||Cohort||Prospective|||||||
1367444|NCT02717624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367445|NCT02717611||Single Group Assignment||Treatment||None (Open Label)||||||
1367446|NCT02717598|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367447|NCT02717585|Randomized|Parallel Assignment||Treatment||Single|||||t|
1367448|NCT02717572||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367449|NCT02717559|||Cohort||Prospective|||||||
1367450|NCT02717546|||Other||Prospective|||||||
1367451|NCT02717533|||Case-Only||Prospective|||||||
1367452|NCT02717520|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367453|NCT02717507|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1367454|NCT02717494|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367455|NCT02717481|||Case-Only||Prospective|||||||
1367456|NCT02717468||Single Group Assignment||||None (Open Label)||||||
1367457|NCT02717455|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1367458|NCT02717442|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1367459|NCT02717429|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367460|NCT02717416|Randomized|Parallel Assignment||Treatment||None (Open Label)||After randomization, patients in both group will undergo endoscopic hemostasis with epinephrine injection therapy. In the study group, Endo-clot will be applied after epinephrine injection therapy. In the control group, hemoclip will be applied after epinephrine injection therapy. The efficacy of Endo-Clot and hemoclip will be compared.||||
1367461|NCT02717403|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367462|NCT02717390|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367463|NCT02717377|Randomized|Crossover Assignment||Prevention||Single|||t|||
1367464|NCT02717364|||Cohort||Prospective|||||||
1367465|NCT02717351||Single Group Assignment||Treatment||None (Open Label)||||||
1367466|NCT02717338|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1367467|NCT02717325||Single Group Assignment||Treatment||None (Open Label)||||||
1367468|NCT02717312|||Cohort||Prospective|||||||
1367469|NCT02717299|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367470|NCT02717286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367471|NCT02717273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368611|NCT02702440|||||Prospective|||||||
1367472|NCT02717260|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367473|NCT02717247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367474|NCT02717234|Randomized|Crossover Assignment||||Single|||t|||
1367475|NCT02717221|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1367476|NCT02717208|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367477|NCT02717195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367478|NCT02717182|||Other||Cross-Sectional|||||||
1367479|NCT02717169||Single Group Assignment||Prevention||None (Open Label)||||||
1367480|NCT02717156||Single Group Assignment||Treatment||None (Open Label)||||||
1367481|NCT02717143|||Cohort||Prospective|||||||
1367482|NCT02717130||Single Group Assignment||Treatment||None (Open Label)||||||
1367483|NCT02717117||Single Group Assignment||Basic Science||None (Open Label)||||||
1367484|NCT02717104|||Cohort||Prospective|||||||
1367485|NCT02717091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367486|NCT02717078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367487|NCT02717065||Single Group Assignment||Other||None (Open Label)||||||
1367488|NCT02717052|Randomized|Parallel Assignment||Treatment||Quadruple||Pilot I and Pilot III not randomised|t|t|t|t
1367489|NCT02717039|||Cohort||Cross-Sectional|||||||
1367490|NCT02717026|||Case-Control||Prospective|||||||
1367491|NCT02717013|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1367492|NCT02717000|||Cohort||Prospective|||||||
1367493|NCT02716987|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1367494|NCT02716974||Single Group Assignment||Treatment||None (Open Label)||||||
1367495|NCT02716961|Randomized|Parallel Assignment||Treatment||Single|||||t|
1367496|NCT02716948||Single Group Assignment||Treatment||None (Open Label)||||||
1367497|NCT02716935|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1367498|NCT02716922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367499|NCT02716909|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367500|NCT02716896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367501|NCT02716883|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367502|NCT02716870||||||||||||
1367503|NCT02716857|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1367504|NCT02716844|Randomized|Parallel Assignment||Treatment||Single||||||t
1367505|NCT02716831|Randomized|Parallel Assignment||Treatment||Single||||||t
1367506|NCT02716818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367507|NCT02716805|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367508|NCT02716792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367509|NCT02716779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367510|NCT02716766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367511|NCT02716753|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367512|NCT02716740|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1367513|NCT02716727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367514|NCT02716714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367515|NCT02716701|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1367516|NCT02716688||Single Group Assignment||Treatment||None (Open Label)||||||
1367517|NCT02716675|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367518|NCT02716662||Single Group Assignment||Treatment||None (Open Label)||||||
1367519|NCT02716649|||Cohort||Retrospective|||||||
1367520|NCT02716636|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367521|NCT02716623||Single Group Assignment||Prevention||None (Open Label)||||||
1367522|NCT02716610|Randomized|Crossover Assignment||||None (Open Label)||||||
1367523|NCT02716597|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1367524|NCT02716584|Randomized|Parallel Assignment||Treatment||Single||||||t
1367525|NCT02716571||Single Group Assignment||Basic Science||None (Open Label)||||||
1367526|NCT02716558|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1367527|NCT02716545||Single Group Assignment||Treatment||None (Open Label)||||||
1367528|NCT02716532||Single Group Assignment||Other||None (Open Label)||||||
1367529|NCT02716519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367530|NCT02716506|||Cohort||Prospective|||||||
1367531|NCT02716493||Single Group Assignment||||None (Open Label)||||||
1367532|NCT02716480|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367533|NCT02716467|Randomized|Parallel Assignment||Other||Double|||t||t|
1367534|NCT02716454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367535|NCT02716441|||Cohort||Prospective|||||||
1367536|NCT02716428|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1367537|NCT02716415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367538|NCT02716402||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367539|NCT02716389|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1367540|NCT02716376|Randomized|Parallel Assignment||Prevention||Single||||||t
1367541|NCT02716363||Single Group Assignment||Treatment||None (Open Label)||||||
1367542|NCT02716350|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1367543|NCT02716337||Single Group Assignment||Supportive Care||None (Open Label)||||||
1367544|NCT02716324|Randomized|Parallel Assignment||Treatment||Single||||||t
1367545|NCT02716311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367546|NCT02716298|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1367547|NCT02716285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368924|NCT02698345|||Case-Only||Prospective|||||||
1367548|NCT02716272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367549|NCT02716259|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1367550|NCT02716246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1367551|NCT02716233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367552|NCT02716220||Single Group Assignment||Treatment||None (Open Label)||||||
1367553|NCT02716207||Single Group Assignment||Treatment||None (Open Label)||||||
1367554|NCT02716194|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367555|NCT02716181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367556|NCT02716168|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1367557|NCT02716155||||||||||||
1367558|NCT02716142|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367559|NCT02716129|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1367560|NCT02716116|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1367561|NCT02716103|||Cohort||Prospective|||||||
1367562|NCT02716090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367563|NCT02716077||Single Group Assignment||Other||||||||
1367564|NCT02716064||Single Group Assignment||Prevention||None (Open Label)||||||
1367565|NCT02716051|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1367566|NCT02716038||Single Group Assignment||Treatment||None (Open Label)||||||
1367567|NCT02716025|||Case Control||Prospective|||||||
1367568|NCT02716012||Single Group Assignment||Treatment||None (Open Label)||||||
1367569|NCT02715999|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1367570|NCT02715986||Single Group Assignment||Basic Science||None (Open Label)||||||
1367571|NCT02715973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367572|NCT02715960||Single Group Assignment||Treatment||None (Open Label)||||||
1367573|NCT02715947||Single Group Assignment||Treatment||None (Open Label)||||||
1367574|NCT02715934|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367575|NCT02715921||Single Group Assignment||||None (Open Label)||||||
1367576|NCT02715908||Single Group Assignment||Treatment||None (Open Label)||||||
1367577|NCT02715895|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1367578|NCT02715882|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367579|NCT02715869|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1367580|NCT02715856|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367581|NCT02715843||||||||||||
1367582|NCT02715830|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367583|NCT02715817|Randomized|Parallel Assignment||Treatment||Single||||||t
1367584|NCT02715804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367585|NCT02715791|Randomized|Parallel Assignment||Other||Single||||||t
1367586|NCT02715778|||Family-Based||Cross-Sectional|||||||
1367587|NCT02715765|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1367588|NCT02715752|||Cohort||Retrospective|||||||
1367589|NCT02715739|||Cohort||Retrospective|||||||
1367590|NCT02715726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367591|NCT02715713|||Case Control||Prospective|||||||
1367592|NCT02715700||Single Group Assignment||Treatment||None (Open Label)||||||
1367593|NCT02715687|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367594|NCT02715674|Randomized|Parallel Assignment||||Double|||t||t|
1367595|NCT02715661|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1367596|NCT02715648|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1367597|NCT02715635|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367598|NCT02715622|||Cohort||Prospective|||||||
1367599|NCT02715609||Single Group Assignment||Treatment||None (Open Label)||||||
1367600|NCT02715596|Randomized|Parallel Assignment||Supportive Care||Triple|Placebo (EPA)|eicosapentanoic acid (EPA) versus placebo|t|t|t|
1367601|NCT02715583||Single Group Assignment||Treatment||||||||
1367602|NCT02715570|Randomized|Crossover Assignment||Treatment||Single|||t|||
1367603|NCT02715557|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367604|NCT02715544|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367605|NCT02715531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367606|NCT02715518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367607|NCT02715505||Single Group Assignment||Treatment||None (Open Label)||||||
1367608|NCT02715492|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367609|NCT02715479|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1367610|NCT02715466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367611|NCT02715453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367612|NCT02715440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367613|NCT02715427|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367614|NCT02715414|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1367615|NCT02715401|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367616|NCT02715388||Single Group Assignment||Treatment||None (Open Label)||||||
1367617|NCT02715375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367618|NCT02715362||Single Group Assignment||Treatment||None (Open Label)||||||
1367619|NCT02715349|Randomized|Parallel Assignment||Treatment||Single||||||t
1367620|NCT02715336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367621|NCT02715323|||Cohort||Cross-Sectional|||||||
1367622|NCT02715310|||Case-Only||Retrospective|||||||
1367623|NCT02715297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367624|NCT02715284||Single Group Assignment||Treatment||None (Open Label)||||||
1367625|NCT02715271|||Cohort||Other|||||||
1367626|NCT02715258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367627|NCT02715245|Non-Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1367628|NCT02715232|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1367629|NCT02715219|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1367630|NCT02715206|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367631|NCT02715193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367632|NCT02715180||Single Group Assignment||Treatment||None (Open Label)||||||
1367633|NCT02715167|Randomized|Parallel Assignment||Treatment||Single||||||t
1367634|NCT02715154|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367635|NCT02715141|||Cohort||Prospective|||||||
1367636|NCT02715128|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1367637|NCT02715115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367638|NCT02715102|||Cohort||Prospective|||||||
1367639|NCT02715089|||Cohort||Prospective|||||||
1367640|NCT02715076|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1367641|NCT02715063|Randomized|Factorial Assignment||Prevention||Single|||||t|
1367642|NCT02715050|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1367643|NCT02715037|||Case Control||Prospective|||||||
1367644|NCT02715024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367645|NCT02715011|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1367646|NCT02714998|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367647|NCT02714985|||Cohort||Prospective|||||||
1367648|NCT02714972|Randomized|Parallel Assignment||Prevention||Triple|Subjects are randomized on a per-night level for when the PHHM will be active or not.||t|t|t|
1367649|NCT02714959||Single Group Assignment||Treatment||None (Open Label)||||||
1367650|NCT02714946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367651|NCT02714933||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367652|NCT02714920||Single Group Assignment||Screening||None (Open Label)||||||
1367653|NCT02714907|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1367654|NCT02714894|||Case-Control||Prospective|||||||
1367655|NCT02714881||Single Group Assignment||Prevention||None (Open Label)||||||
1367656|NCT02714868|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1367657|NCT02714855|||Cohort||Cross-Sectional|||||||
1367658|NCT02714842|Randomized|Crossover Assignment||||None (Open Label)||||||
1367659|NCT02714829|Randomized|Parallel Assignment||Treatment||Single||||||t
1367660|NCT02714816|||Cohort||Prospective|||||||
1367661|NCT02714803|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1367662|NCT02714790|||Cohort||Retrospective|||||||
1367663|NCT02714777|||Cohort||Prospective|||||||
1367664|NCT02714764|||Case-Only||Prospective|||||||
1367665|NCT02714751|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1367666|NCT02714738|Randomized|Parallel Assignment||Treatment||Single|||||t|
1367667|NCT02714725|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1367668|NCT02714712|||Case-Control||Retrospective|||||||
1367669|NCT02714699|Randomized|Parallel Assignment||Prevention||Single|||t|||
1367670|NCT02714686|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367671|NCT02714673|||Cohort||Prospective|||||||
1367672|NCT02714660|||Case-Only||Cross-Sectional|||||||
1367673|NCT02714647|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1367674|NCT02714634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367675|NCT02714621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1367676|NCT02714608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367677|NCT02714595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367678|NCT02714582|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367679|NCT02714569|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1367680|NCT02714556|||Cohort||Prospective|||||||
1367681|NCT02714543|Randomized|Parallel Assignment||Treatment||Single|||||t|
1367682|NCT02714530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367683|NCT02714517|Randomized|Parallel Assignment||Treatment||Single||||||t
1367684|NCT02714504|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367685|NCT02714491|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1367686|NCT02714478|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367687|NCT02714465||Single Group Assignment||Treatment||None (Open Label)||||||
1367688|NCT02714452|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367689|NCT02714439||Single Group Assignment||Prevention||None (Open Label)||||||
1367690|NCT02714426|Randomized|Parallel Assignment||Basic Science||Single||||||t
1367691|NCT02714413|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1367692|NCT02714400|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1367693|NCT02714387|||Cohort||Prospective|||||||
1367694|NCT02714374||Single Group Assignment||Treatment||None (Open Label)||||||
1367695|NCT02714361|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1367696|NCT02714348|||Cohort||Prospective|||||||
1367697|NCT02714335|||Case-Only||Retrospective|||||||
1367698|NCT02714322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367699|NCT02714309|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1367700|NCT02714296|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367701|NCT02714283|||Cohort||Retrospective|||||||
1367702|NCT02714270|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1367703|NCT02714257|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367704|NCT02714244||Single Group Assignment||Other||None (Open Label)||||||
1367705|NCT02714231|Randomized|Parallel Assignment||Prevention||Single|||t|||
1367706|NCT02714218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367707|NCT02714205|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1367708|NCT02714192|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1367709|NCT02714179|Randomized|Parallel Assignment||||Triple||||t|t|t
1367710|NCT02714166|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1367711|NCT02714153||Single Group Assignment||Supportive Care||None (Open Label)||||||
1367712|NCT02714140|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1367713|NCT02714127|||Case-Control||Prospective|||||||
1367714|NCT02714114|||Case-Control||Prospective|||||||
1367715|NCT02714101||Single Group Assignment||Treatment||None (Open Label)||||||
1367716|NCT02714088|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367717|NCT02714075||Single Group Assignment||Health Services Research||None (Open Label)||||||
1367718|NCT02714062|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367719|NCT02714049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367720|NCT02714036||Single Group Assignment||Treatment||None (Open Label)||||||
1367721|NCT02714023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367722|NCT02714010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367723|NCT02713997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367724|NCT02713984||Single Group Assignment||Treatment||None (Open Label)||||||
1367725|NCT02713971|Randomized|Parallel Assignment||Treatment||Single||||||t
1367726|NCT02713958|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1367727|NCT02713945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367728|NCT02713932|||Cohort||Prospective|||||||
1367729|NCT02713919|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1367730|NCT02713906||Single Group Assignment||Treatment||None (Open Label)||||||
1367731|NCT02713893|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1367732|NCT02713880|||Cohort||Prospective|||||||
1367733|NCT02713867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367734|NCT02713854||Single Group Assignment||Diagnostic||None (Open Label)||||||
1367735|NCT02713841|Randomized|Crossover Assignment||||None (Open Label)||||||
1367736|NCT02713828|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367737|NCT02713815|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367738|NCT02713802|Randomized|Crossover Assignment||||None (Open Label)||||||
1367739|NCT02713789|Randomized|Parallel Assignment||||Double|||t||t|
1367740|NCT02713776|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367741|NCT02713763||Single Group Assignment||Treatment||None (Open Label)||||||
1367742|NCT02713750|||Cohort||Prospective|||||||
1367743|NCT02713737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367744|NCT02713724|Randomized|Parallel Assignment||||None (Open Label)||||||
1367745|NCT02713711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367746|NCT02713698|||Other||Prospective|||||||
1367747|NCT02713685|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1367748|NCT02713672|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1367749|NCT02713659|Randomized|Parallel Assignment||Treatment||Single||||||t
1367750|NCT02713646|||Case-Only||Prospective|||||||
1367751|NCT02713633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367752|NCT02713620|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367753|NCT02713607|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1367754|NCT02713594|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1367755|NCT02713581|||Case-Control||Cross-Sectional|||||||
1367756|NCT02713568|Non-Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1367757|NCT02713555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367758|NCT02713542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367759|NCT02713529||Single Group Assignment||Treatment||None (Open Label)||||||
1367760|NCT02713516||Single Group Assignment||Other||None (Open Label)||||||
1367761|NCT02713503|||Cohort||Prospective|||||||
1367762|NCT02713490|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367763|NCT02713477|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367764|NCT02713464|Randomized|Parallel Assignment||Prevention||Single||||||t
1367765|NCT02713451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367766|NCT02713438|Randomized|Parallel Assignment||Prevention||Single|||t|||
1367767|NCT02713425||Single Group Assignment||Treatment||None (Open Label)||||||
1367768|NCT02713412|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1367769|NCT02713399|||Cohort||Prospective|||||||
1367770|NCT02713386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367771|NCT02713373||Single Group Assignment||Treatment||None (Open Label)||||||
1367772|NCT02713360|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1367773|NCT02713347|Randomized|Parallel Assignment||Health Services Research||Double|Statistician|Parallel|||t|t
1367774|NCT02713334|||Cohort||Prospective|||||||
1367775|NCT02713321|||Cohort||Retrospective|||||||
1367776|NCT02713308|||Cohort||Prospective|||||||
1367777|NCT02713295|||Cohort||Prospective|||||||
1367778|NCT02713282||Single Group Assignment||Treatment||None (Open Label)||||||
1367779|NCT02713269||Single Group Assignment||Treatment||None (Open Label)||||||
1367780|NCT02713256||Single Group Assignment||Treatment||None (Open Label)||||||
1367781|NCT02713243|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1367782|NCT02713230|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367783|NCT02713217|||Other||Prospective|||||||
1367784|NCT02713204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367785|NCT02713191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367786|NCT02713178|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367787|NCT02713165||Single Group Assignment||Other||None (Open Label)||||||
1367788|NCT02713152|||Case-Control||Prospective|||||||
1367789|NCT02713139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367790|NCT02713126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367791|NCT02713113|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1367792|NCT02713100|||Other||Prospective|||||||
1367793|NCT02713087|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367794|NCT02713074|Randomized|Parallel Assignment||Prevention||Single|||t|||
1367795|NCT02713061||Single Group Assignment||Treatment||None (Open Label)||||||
1367796|NCT02713048|||Case-Only||Prospective|||||||
1367797|NCT02713035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367798|NCT02713022|||Cohort||Prospective|||||||
1367799|NCT02713009|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1367800|NCT02712996|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1367801|NCT02712983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367802|NCT02712970|||Case-Only||Retrospective|||||||
1367803|NCT02712957|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1367804|NCT02712944|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367805|NCT02712931||||||||||||
1367806|NCT02712918|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367807|NCT02712905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1367808|NCT02712892|||Family-Based||Prospective|||||||
1367809|NCT02712879|||Cohort||Prospective|||||||
1367810|NCT02712866|||Case-Only||Prospective|||||||
1367811|NCT02712853|||Case-Control||Cross-Sectional|||||||
1367812|NCT02712840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367813|NCT02712827|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367814|NCT02712814|||Cohort||Prospective|||||||
1367815|NCT02712801|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367816|NCT02712788|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367817|NCT02712775|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367818|NCT02712762|||Cohort||Cross-Sectional|||||||
1367819|NCT02712749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367820|NCT02712736||Single Group Assignment||Other||None (Open Label)||||||
1367821|NCT02712723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367822|NCT02712710|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367823|NCT02712697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367824|NCT02712684|||Cohort||Prospective|||||||
1367825|NCT02712671|||Cohort||Prospective|||||||
1367826|NCT02712658|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1367827|NCT02712645|||Cohort||Prospective|||||||
1367828|NCT02712632|||Cohort||Prospective|||||||
1367829|NCT02712619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367830|NCT02712606|||Cohort||Prospective|||||||
1367831|NCT02712593|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1367832|NCT02712580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367833|NCT02712567||||||||||||
1367834|NCT02712554|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1367835|NCT02712541|||Cohort||Prospective|||||||
1367836|NCT02712528|Randomized|Parallel Assignment||Treatment||Single||||||t
1367837|NCT02712515|||Cohort||Cross-Sectional|||||||
1367838|NCT02712502|||Case Control||Prospective|||||||
1367839|NCT02712489|||||Prospective|||||||
1367840|NCT02712476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367841|NCT02712463|||||Retrospective|||||||
1367842|NCT02712450|||Other||Prospective|||||||
1367843|NCT02712437||Single Group Assignment||Treatment||None (Open Label)||||||
1367844|NCT02712424|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367845|NCT02712411|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367846|NCT02712398||Single Group Assignment||Treatment||None (Open Label)||||||
1367847|NCT02712385|Randomized|Parallel Assignment||Prevention||Single||The intervention groups will be getting access to a home-based rehabilitation, 'The Healthy Brain Rehabilitation Manual', telephone follow-up with either a GP or stroke nurse and a pedometer.||||t
1367848|NCT02712372|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1367849|NCT02712359||Single Group Assignment||Other||None (Open Label)||||||
1367850|NCT02712346|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367851|NCT02712333|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1367852|NCT02712320||Single Group Assignment||Treatment||None (Open Label)||||||
1367853|NCT02712307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367854|NCT02712294|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1367855|NCT02712281|Randomized|Parallel Assignment||Treatment||Single||||||t
1367856|NCT02712268||Single Group Assignment||Treatment||None (Open Label)||||||
1367857|NCT02712255|Randomized|Parallel Assignment||Prevention||Single|||t|||
1367858|NCT02712242|Randomized|Parallel Assignment||Treatment||Single|||||t|
1367859|NCT02712229|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1367860|NCT02712216||Single Group Assignment||Basic Science||None (Open Label)||||||
1367861|NCT02712203|||Cohort||Retrospective|||||||
1367862|NCT02712190|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1367863|NCT02712177|||||Retrospective|||||||
1367864|NCT02712164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367865|NCT02712151|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1367866|NCT02712138|||Cohort||Prospective|||||||
1367867|NCT02712125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367868|NCT02712112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367869|NCT02712099|||Cohort||Prospective|||||||
1367870|NCT02712086|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367871|NCT02712073|||Cohort||Prospective|||||||
1367872|NCT02712060|||Case-Control||Prospective|||||||
1367873|NCT02712047|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1367874|NCT02712034|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1367875|NCT02712021|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367876|NCT02712008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367877|NCT02711995|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367878|NCT02711982|Randomized|Parallel Assignment||Treatment||Single||||||t
1367879|NCT02711969||Single Group Assignment||Treatment||None (Open Label)||||||
1367880|NCT02711956||Single Group Assignment||Treatment||None (Open Label)||||||
1367881|NCT02711943|||Cohort||Prospective|||||||
1367882|NCT02711930|||Cohort||Prospective|||||||
1367883|NCT02711917|Randomized|Parallel Assignment||||None (Open Label)||||||
1367884|NCT02711904|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367885|NCT02711891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367886|NCT02711878|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367887|NCT02711865|||Case Control||Prospective|||||||
1367888|NCT02711852||Single Group Assignment||Treatment||None (Open Label)||||||
1367889|NCT02711839|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1367890|NCT02711826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367891|NCT02711813|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367892|NCT02711800||Single Group Assignment||Treatment||None (Open Label)||||||
1367893|NCT02711787|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367894|NCT02711774|||Case-Crossover||Prospective|||||||
1367895|NCT02711761|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1367896|NCT02711748|Randomized|Crossover Assignment||Treatment||Single|||t|||
1367897|NCT02711735|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1367898|NCT02711722|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1367899|NCT02711709||Single Group Assignment||Basic Science||None (Open Label)||||||
1367900|NCT02711696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367901|NCT02711683|||Cohort||Prospective|||||||
1367902|NCT02711670||Single Group Assignment||Prevention||None (Open Label)||||||
1367903|NCT02711657||Single Group Assignment||Basic Science||None (Open Label)||||||
1367904|NCT02711644|Randomized|Parallel Assignment||Prevention||Single|||t|||
1367905|NCT02711631|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1367906|NCT02711618||Single Group Assignment||Treatment||None (Open Label)||||||
1367907|NCT02711605|Randomized|Parallel Assignment||Treatment||Single||||||t
1367908|NCT02711592||Single Group Assignment||Treatment||None (Open Label)||||||
1367909|NCT02711579|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1367910|NCT02711566|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367911|NCT02711553|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367912|NCT02711540|||Cohort||Retrospective|||||||
1367913|NCT02711527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367914|NCT02711514|||Other||Retrospective|||||||
1367915|NCT02711501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367916|NCT02711488|Randomized|Parallel Assignment||Prevention||Single||||||t
1367917|NCT02711475|||Cohort||Prospective|||||||
1367918|NCT02711462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367919|NCT02711449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367920|NCT02711436|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1367921|NCT02711423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1367922|NCT02711410|||Cohort||Prospective|||||||
1367923|NCT02711397|||Case Control||Prospective|||||||
1367924|NCT02711384|||Other||Prospective|||||||
1367925|NCT02711371|||Cohort||Cross-Sectional|||||||
1367926|NCT02711358|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1367927|NCT02711345|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367928|NCT02711332|||Case-Only|||||||||
1367929|NCT02711319|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367930|NCT02711306|Randomized|Crossover Assignment||Prevention||Single|||t|||
1367931|NCT02711293|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1367932|NCT02711280|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1367933|NCT02711267|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1367934|NCT02711254||Single Group Assignment||Treatment||None (Open Label)||||||
1367935|NCT02711241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367936|NCT02711228||Single Group Assignment||Prevention||None (Open Label)||||||
1367937|NCT02711215|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1367938|NCT02711202|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1367939|NCT02711189|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1367940|NCT02711176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367941|NCT02711163|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1367942|NCT02711150|Non-Randomized|Single Group Assignment||Screening||Single||||||t
1367943|NCT02711137|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1367944|NCT02711124|||Cohort||Prospective|||||||
1367945|NCT02711111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367946|NCT02711098|Randomized|Parallel Assignment||Treatment||Single||||||t
1367947|NCT02711085|||Cohort||Prospective|||||||
1367948|NCT02711072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1367949|NCT02711059|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1367950|NCT02711046||Single Group Assignment||Treatment||None (Open Label)||||||
1367951|NCT02711033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367952|NCT02711020|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367953|NCT02711007||Single Group Assignment||Treatment||None (Open Label)||||||
1367954|NCT02710994|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367955|NCT02710981|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367956|NCT02710968||Single Group Assignment||Treatment||None (Open Label)||||||
1367957|NCT02710955||Single Group Assignment||Treatment||None (Open Label)||||||
1367958|NCT02710942|Randomized|Parallel Assignment||Treatment||Single|||||t|
1367959|NCT02710929|||Case Control||Cross-Sectional|||||||
1367960|NCT02710916|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1367961|NCT02710903|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1367962|NCT02710890||Single Group Assignment||Treatment||None (Open Label)||||||
1367963|NCT02710877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367964|NCT02710864|||Other||Cross-Sectional|||||||
1367965|NCT02710851|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1367966|NCT02710838|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1367967|NCT02710825|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367968|NCT02710812|||Cohort||Prospective|||||||
1367969|NCT02710799|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1367970|NCT02710786|||Cohort||Prospective|||||||
1367971|NCT02710773|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1367972|NCT02710760|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1367973|NCT02710747|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1367974|NCT02710734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1367975|NCT02710721|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1367976|NCT02710708||Single Group Assignment||Treatment||None (Open Label)||||||
1367977|NCT02710695|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1367978|NCT02710682|Randomized|Parallel Assignment||Treatment||Single||||||t
1367979|NCT02710669|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1367980|NCT02710656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367981|NCT02710643|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367982|NCT02710630|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1367983|NCT02710617||||||||||||
1367984|NCT02710604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367985|NCT02710591||Single Group Assignment||Treatment||None (Open Label)||||||
1367986|NCT02710578|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1367987|NCT02710565||Single Group Assignment||Basic Science||None (Open Label)||||||
1367988|NCT02710552|Randomized|Parallel Assignment||Treatment||Single|||t|||
1367989|NCT02710539|Randomized|Single Group Assignment||Treatment||Single|||t|||
1367990|NCT02710526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1367991|NCT02710513||Single Group Assignment||Basic Science||None (Open Label)||||||
1367992|NCT02710500|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1367993|NCT02710487|Non-Randomized|Crossover Assignment||Other||Triple|The sleep technician in charge to apply the study intervention was the only person to be aware of the sleep phase the patient was awaken from.|Awakening from NREM vs. REM sleep.|t||t|t
1367994|NCT02710474|Randomized|Parallel Assignment||Other||Single||||||t
1367995|NCT02710461||Single Group Assignment||Basic Science||None (Open Label)||||||
1367996|NCT02710448||Single Group Assignment||Treatment||None (Open Label)||||||
1367997|NCT02710435|||Other||Other|||||||
1367998|NCT02710422|Randomized|Parallel Assignment||Treatment||Single|Participants will not know their treatment arm assignment until after robotic assisted radical prostatectomy (RARP) surgery.||t|||
1367999|NCT02710409|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1368000|NCT02710396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368001|NCT02710383|||Cohort||Prospective|||||||
1368002|NCT02710370|||Cohort||Prospective|||||||
1368003|NCT02710357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368004|NCT02710344|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1368005|NCT02710331|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1368006|NCT02710318|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1368007|NCT02710305|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1368008|NCT02710292|Randomized|Crossover Assignment||Treatment||Single|||t|||
1368009|NCT02710279||Single Group Assignment||||None (Open Label)||||||
1368010|NCT02710266|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1368011|NCT02710253||Single Group Assignment||Treatment||None (Open Label)||||||
1368012|NCT02710240||||Diagnostic||||||||
1368013|NCT02710227|||Case-Control||Cross-Sectional|||||||
1368014|NCT02710214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368015|NCT02710201|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1368016|NCT02710188|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368017|NCT02710175|||Case Control||Prospective|||||||
1368018|NCT02710162||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368019|NCT02710149||Single Group Assignment||Treatment||None (Open Label)||||||
1368020|NCT02710136||Single Group Assignment||Treatment||None (Open Label)||||||
1368021|NCT02710123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368022|NCT02710110|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368023|NCT02710097|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1368024|NCT02710084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368025|NCT02710071|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1368026|NCT02710058|||Cohort||Prospective|||||||
1368027|NCT02710045|Randomized|Parallel Assignment||Basic Science||Single||||||t
1368028|NCT02710032|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368029|NCT02710019|Randomized|Parallel Assignment||||Single|||||t|
1368030|NCT02710006||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368031|NCT02709993||Single Group Assignment||Treatment||None (Open Label)||||||
1368032|NCT02709980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368033|NCT02709967|Randomized|Parallel Assignment||Prevention||Single||||||t
1368034|NCT02709954|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1368035|NCT02709941|Randomized|Parallel Assignment||Treatment||Double||the subjects were randomly allocated to either the sham training group or the inspiratory muscle training group using randomization lists for 4 strata (male/female X young/old)|t||t|
1368036|NCT02709928|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1368037|NCT02709915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368038|NCT02709902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368039|NCT02709889||Single Group Assignment||Treatment||None (Open Label)||||||
1368040|NCT02709876||Single Group Assignment||Treatment||None (Open Label)||||||
1368041|NCT02709863|Randomized|Parallel Assignment||||Double|||t||t|
1368042|NCT02709850|Randomized|Parallel Assignment||Other||Double|||t||t|
1368043|NCT02709837|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1368044|NCT02709824|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1368045|NCT02709811||Single Group Assignment||Treatment||None (Open Label)||||||
1368046|NCT02709798|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368047|NCT02709785|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368048|NCT02709772|Randomized|Parallel Assignment||Treatment||Single||||||t
1368049|NCT02709759|Randomized|Factorial Assignment||Treatment||Single||||||t
1368050|NCT02709746|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368051|NCT02709733||Single Group Assignment||Treatment||None (Open Label)||||||
1368052|NCT02709720||Single Group Assignment||Treatment||None (Open Label)||||||
1368053|NCT02709707|||Case-Only||Prospective|||||||
1368054|NCT02709694|||Cohort||Cross-Sectional|||||||
1368055|NCT02709681|||Cohort||Retrospective|||||||
1368056|NCT02709668|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1368057|NCT02709655|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368058|NCT02709642|Randomized|Parallel Assignment||Prevention||Single||||||t
1368059|NCT02709629|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1368060|NCT02709616||Single Group Assignment||Treatment||None (Open Label)||||||
1368061|NCT02709603|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368062|NCT02709590|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1368063|NCT02709577|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368064|NCT02709564|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1368065|NCT02709551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368066|NCT02709538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368067|NCT02709525|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1368068|NCT02709512|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368069|NCT02709499|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368070|NCT02709486|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368071|NCT02709473|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1368072|NCT02709460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368073|NCT02709447|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368074|NCT02709434|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368075|NCT02709421|||||Retrospective|||||||
1368076|NCT02709408|||Cohort||Prospective|||||||
1368077|NCT02709395||Single Group Assignment||||None (Open Label)||||||
1368078|NCT02709382||Single Group Assignment||||None (Open Label)||||||
1368079|NCT02709369||Single Group Assignment||Treatment||None (Open Label)||||||
1368080|NCT02709356|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368081|NCT02709343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368082|NCT02709330|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368083|NCT02709317|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368084|NCT02709304|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1368085|NCT02709291|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1368086|NCT02709278|Randomized|Parallel Assignment||Other||Double|||t|||t
1368087|NCT02709265|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1368088|NCT02709252||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368089|NCT02709239|Randomized|Parallel Assignment||Other||Double|||t||t|
1368090|NCT02709226||Sequential Assignment||Treatment||None (Open Label)||||||
1368091|NCT02709213|||Cohort||Prospective|||||||
1368092|NCT02709200|||Case-Only||Prospective|||||||
1368093|NCT02709187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368094|NCT02709174|||Cohort||Prospective|||||||
1368095|NCT02709161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368096|NCT02709148||Single Group Assignment||Basic Science||None (Open Label)||||||
1368097|NCT02709135|||Cohort||Prospective|||||||
1368098|NCT02709122|Randomized|Crossover Assignment||Treatment||Single|||t|||
1368099|NCT02709109|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1368100|NCT02709096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368101|NCT02709083||Single Group Assignment||Treatment||None (Open Label)||||||
1368102|NCT02709070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368103|NCT02709057|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1368104|NCT02709044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368105|NCT02709031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368106|NCT02709018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368107|NCT02709005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368108|NCT02708992||Single Group Assignment||Treatment||None (Open Label)||||||
1368109|NCT02708979|Randomized|Crossover Assignment||Basic Science||Single||||||t
1368110|NCT02708966|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368111|NCT02708953|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368112|NCT02708940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368113|NCT02708927|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1368114|NCT02708914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368115|NCT02708901|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized double blind study of dietary supplement compared to placebo|t|t|t|t
1368116|NCT02708888|Randomized|Parallel Assignment||Treatment||Single||||||t
1368117|NCT02708875|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1368118|NCT02708862|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368119|NCT02708849|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1368120|NCT02708836|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1368121|NCT02708823|||Cohort||Prospective|||||||
1368122|NCT02708810||Single Group Assignment||Treatment||None (Open Label)||||||
1368123|NCT02708797|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1368124|NCT02708784|||||Cross-Sectional|||||||
1368125|NCT02708771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368126|NCT02708758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368127|NCT02708745|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1368128|NCT02708732|||Cohort||Cross-Sectional|||||||
1368129|NCT02708719||Single Group Assignment||Treatment||None (Open Label)||||||
1368130|NCT02708706|Randomized|Parallel Assignment||Treatment||Single||||||t
1368131|NCT02708693|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368132|NCT02708680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368133|NCT02708667|||Case-Only||Retrospective|||||||
1368134|NCT02708654|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1368135|NCT02708641||Single Group Assignment||Treatment||None (Open Label)||||||
1368136|NCT02708628|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368137|NCT02708615|Randomized|Parallel Assignment||Other||Single|||t|||
1368138|NCT02708602|||Cohort||Retrospective|||||||
1368139|NCT02708589|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1368140|NCT02708576|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1368141|NCT02708563|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368142|NCT02708550|Randomized|Parallel Assignment||Prevention||Single||||||t
1368143|NCT02708537|||Case-Only||Prospective|||||||
1368144|NCT02708524|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368145|NCT02708511||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368146|NCT02708498|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1368147|NCT02708485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368148|NCT02708472||Single Group Assignment||Treatment||None (Open Label)||||||
1368149|NCT02708459|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1368150|NCT02708446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368151|NCT02708433|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1368152|NCT02708420|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368153|NCT02708407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368154|NCT02708394|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1368155|NCT02708381|||Case-Only||Prospective|||||||
1368156|NCT02708368|||Case Control||Prospective|||||||
1368157|NCT02708355|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1368158|NCT02708342|||Other||Retrospective|||||||
1368159|NCT02708329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368160|NCT02708316|||Case-Control||Prospective|||||||
1368161|NCT02708303|||Case-Only||Prospective|||||||
1368162|NCT02708290|||Cohort||Prospective|||||||
1368163|NCT02708277|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368164|NCT02708264|Randomized|Parallel Assignment||Treatment||Single|outcomes assessor and data analyst|||||t
1368165|NCT02708251|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368166|NCT02708238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368167|NCT02708225|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1368168|NCT02708212|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1368169|NCT02708199|||Cohort||Prospective|||||||
1368170|NCT02708186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368171|NCT02708173|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1368172|NCT02708160|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1368173|NCT02708147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368174|NCT02708134|||Cohort||Prospective|||||||
1368175|NCT02708121|Randomized|Parallel Assignment||Other||Single|Staff recruiting participants and doing outcomes assessment will remain blinded to treatment assignment|||||t
1368176|NCT02708108||Single Group Assignment||Treatment||None (Open Label)||||||
1368177|NCT02708095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368178|NCT02708082|||Cohort||Prospective|||||||
1368179|NCT02708069|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368180|NCT02708056||Single Group Assignment||Treatment||None (Open Label)||||||
1368181|NCT02708043||Single Group Assignment||Health Services Research||None (Open Label)||||||
1368182|NCT02708030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368183|NCT02708017|Randomized|Parallel Assignment||||Triple|||t|t||t
1368184|NCT02708004|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1368185|NCT02707991|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1368186|NCT02707978||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368187|NCT02707965|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1368188|NCT02707952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368189|NCT02707939|||Cohort||Prospective|||||||
1368190|NCT02707926|||Cohort||Prospective|||||||
1368191|NCT02707913|Randomized|Crossover Assignment||||None (Open Label)||||||
1368192|NCT02707900||Single Group Assignment||Treatment||None (Open Label)||||||
1368193|NCT02707887|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368194|NCT02707874|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368195|NCT02707861|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368196|NCT02707848|||Ecologic or Community||Cross-Sectional|||||||
1368197|NCT02707835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368198|NCT02707822|||Case-Only|||||||||
1368199|NCT02707809|Randomized|Parallel Assignment||Basic Science||Single||||||t
1368200|NCT02707796||Single Group Assignment||Screening||None (Open Label)||||||
1368201|NCT02707783|||Cohort||Prospective|||||||
1368202|NCT02707770|Randomized|Parallel Assignment||Treatment||Single||||||t
1368203|NCT02707757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368204|NCT02707744|||Cohort||Prospective|||||||
1368205|NCT02707731||Single Group Assignment||Health Services Research||None (Open Label)||||||
1368206|NCT02707718|||Cohort||Prospective|||||||
1368207|NCT02707705|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1368208|NCT02707692|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1368209|NCT02707679|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368210|NCT02707666||Single Group Assignment||Treatment||None (Open Label)||||||
1368211|NCT02707653||Single Group Assignment||Treatment||None (Open Label)||||||
1368212|NCT02707640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368213|NCT02707627|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1368214|NCT02707614|||Cohort||Prospective|||||||
1368215|NCT02707601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368216|NCT02707588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368217|NCT02707575||Single Group Assignment||Treatment||None (Open Label)||||||
1368218|NCT02707562||Single Group Assignment||Treatment||None (Open Label)||||||
1368219|NCT02707549|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368220|NCT02707536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368221|NCT02707523|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1368222|NCT02707510|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368223|NCT02707497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368224|NCT02707484|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368225|NCT02707471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368226|NCT02707458||Single Group Assignment||Prevention||None (Open Label)||||||
1368227|NCT02707445||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368228|NCT02707432|Randomized|Parallel Assignment||Prevention||Single|||t|||
1368229|NCT02707419|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368230|NCT02707406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368231|NCT02707393||Single Group Assignment||Treatment||None (Open Label)||||||
1368232|NCT02707380|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368233|NCT02707367|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1368234|NCT02707354||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368235|NCT02707341|||Cohort||Prospective|||||||
1368236|NCT02707328||Single Group Assignment||Treatment||None (Open Label)||||||
1368237|NCT02707315||Single Group Assignment||Treatment||None (Open Label)||||||
1368238|NCT02707302|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368240|NCT02707276|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368241|NCT02707263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368242|NCT02707250|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1368243|NCT02707237|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1368244|NCT02707224|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368245|NCT02707211||Single Group Assignment||Treatment||None (Open Label)||||||
1368246|NCT02707198|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1368247|NCT02707185|Randomized|Parallel Assignment||||None (Open Label)||||||
1368248|NCT02707172|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1368249|NCT02707159||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368250|NCT02707146|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1368251|NCT02707133|||Cohort||Prospective|||||||
1368252|NCT02707120|Randomized|Parallel Assignment||Treatment||Single|||||t|
1368253|NCT02707107|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1368254|NCT02707094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368255|NCT02707081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368256|NCT02707068|Randomized|Parallel Assignment||Treatment||Single||||||t
1368257|NCT02707055|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1368258|NCT02707042|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1368259|NCT02707029|||Cohort||Prospective|||||||
1368260|NCT02707016|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1368261|NCT02707003|||Cohort||Prospective|||||||
1368262|NCT02706990|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1368263|NCT02706977|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368264|NCT02706964||Single Group Assignment||Basic Science||None (Open Label)||||||
1368265|NCT02706951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368266|NCT02706938|Randomized|Crossover Assignment||Treatment||Single||||||t
1368267|NCT02706925|Randomized|Parallel Assignment||Treatment||Single||||||
1368268|NCT02706912||Single Group Assignment||Treatment||None (Open Label)||||||
1368269|NCT02706899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368270|NCT02706886|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368271|NCT02706873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368272|NCT02706860|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368273|NCT02706847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368274|NCT02706834|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1368275|NCT02706821|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1368276|NCT02706808|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1368277|NCT02706795|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368278|NCT02706782||Single Group Assignment||Treatment||None (Open Label)||||||
1368279|NCT02706769|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1368280|NCT02706756|Randomized|Parallel Assignment||Treatment||Single||||||t
1368281|NCT02706743|||Cohort||Prospective|||||||
1368282|NCT02706730||Single Group Assignment||Treatment||None (Open Label)||||||
1368283|NCT02706717|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1368284|NCT02706704|Randomized|Parallel Assignment||Treatment||Single||||||t
1368285|NCT02706691||Single Group Assignment||Treatment||None (Open Label)||||||
1368286|NCT02706678||Single Group Assignment||Treatment||None (Open Label)||||||
1368287|NCT02706665|||Cohort||Prospective|||||||
1368288|NCT02706652|||Cohort||Prospective|||||||
1368289|NCT02706639|||Case-Control||Prospective|||||||
1368290|NCT02706626||Single Group Assignment||Treatment||None (Open Label)||||||
1368291|NCT02706613|Randomized|Parallel Assignment||Treatment||Single||||||t
1368292|NCT02706600|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1368293|NCT02706587|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1368294|NCT02706574|||Cohort||Prospective|||||||
1368295|NCT02706561|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368296|NCT02706548|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368297|NCT02706535|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368298|NCT02706522|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368299|NCT02706509|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1368300|NCT02706496|||Cohort||Prospective|||||||
1368301|NCT02706483||Single Group Assignment||Treatment||None (Open Label)||||||
1368302|NCT02706470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368303|NCT02706457|||Cohort||Retrospective|||||||
1368304|NCT02706444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368305|NCT02706431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368306|NCT02706418||Single Group Assignment||Treatment||None (Open Label)||||||
1368307|NCT02706405|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368308|NCT02706392||Single Group Assignment||Treatment||None (Open Label)||||||
1368309|NCT02706379||Single Group Assignment||Treatment||None (Open Label)||||||
1368310|NCT02706353||Single Group Assignment||Treatment||None (Open Label)||||||
1368311|NCT02706340|||Cohort||Prospective|||||||
1368312|NCT02706327|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368313|NCT02706314|||Case-Control||Prospective|||||||
1368314|NCT02706301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368315|NCT02706288||Single Group Assignment||Other||None (Open Label)||||||
1368316|NCT02706275|Randomized|Parallel Assignment||Treatment||Single||||||t
1368317|NCT02706262|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1368318|NCT02706249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368319|NCT02706236|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1368320|NCT02706223|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1368321|NCT02706210|||Case-Control||Prospective|||||||
1368322|NCT02706197|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||There are two parallel arms of the study; however, the first 6 patients must be in the arm whose tumor will receive no therapy prior to surgical resection. If there are no safety issues, then both arms are open.||||
1368323|NCT02706184|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368324|NCT02706171|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368325|NCT02706158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368326|NCT02706145|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368327|NCT02706132||Single Group Assignment||Prevention||None (Open Label)||||||
1368328|NCT02706119|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1368329|NCT02706106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368330|NCT02706093|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368331|NCT02706080|||Other||Prospective|||||||
1368332|NCT02706067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368333|NCT02706054|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1368334|NCT02706041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368335|NCT02706028|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368336|NCT02706015|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368337|NCT02706002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368338|NCT02705989|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368339|NCT02705976|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1368340|NCT02705963||Single Group Assignment||Treatment||None (Open Label)||||||
1368341|NCT02705950|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368342|NCT02705937|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368343|NCT02705924|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368344|NCT02705911|Randomized|Parallel Assignment||Treatment||Single||||||t
1368345|NCT02705898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368346|NCT02705885|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1368347|NCT02705872|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368348|NCT02705859||Single Group Assignment||Treatment||None (Open Label)||||||
1368349|NCT02705846|||Case-Control||Prospective|||||||
1368350|NCT02705833|||Cohort||Retrospective|||||||
1368351|NCT02705820||Single Group Assignment||Treatment||None (Open Label)||||||
1368352|NCT02705807||Single Group Assignment||Treatment||None (Open Label)||||||
1368353|NCT02705794|||Case-Crossover||Prospective|||||||
1368354|NCT02705781||Single Group Assignment||Prevention||None (Open Label)||||||
1368355|NCT02705768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368356|NCT02705755|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368357|NCT02705742||Single Group Assignment||Treatment||None (Open Label)||||||
1368358|NCT02705729|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368359|NCT02705716|Randomized|Parallel Assignment||Treatment||Single|||||t|
1368360|NCT02705703||Single Group Assignment||Treatment||None (Open Label)||||||
1368361|NCT02705690|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1368362|NCT02705677|||Cohort||Prospective|||||||
1368363|NCT02705664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368364|NCT02705651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368365|NCT02705638||Single Group Assignment||Treatment||None (Open Label)||||||
1368366|NCT02705625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368367|NCT02705612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368368|NCT02705599|||Cohort||Prospective|||||||
1368369|NCT02705586||Single Group Assignment||Supportive Care||None (Open Label)||||||
1368370|NCT02705573|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1368371|NCT02705560|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1368372|NCT02705547||Single Group Assignment||Treatment||None (Open Label)||||||
1368373|NCT02705534||Single Group Assignment||Treatment||None (Open Label)||||||
1368374|NCT02705521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368375|NCT02705508||Single Group Assignment||Treatment||None (Open Label)||||||
1368376|NCT02705495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368377|NCT02705482|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368378|NCT02705469||Single Group Assignment||Treatment||None (Open Label)||||||
1368379|NCT02705456|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368380|NCT02705443|||Cohort||Prospective|||||||
1368381|NCT02705430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368382|NCT02705417|||Cohort||Retrospective|||||||
1368383|NCT02705404|||Case-Only||Prospective|||||||
1368384|NCT02705391|||Case-Only||Prospective|||||||
1368385|NCT02705378|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368386|NCT02705365|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368387|NCT02705352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368388|NCT02705339||Single Group Assignment||Treatment||None (Open Label)||||||
1368389|NCT02705326||Single Group Assignment||Treatment||None (Open Label)||||||
1368390|NCT02705313||||||||||||
1368391|NCT02705300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368393|NCT02705274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368394|NCT02705261||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1368395|NCT02705248|||Case Control||Cross-Sectional|||||||
1368396|NCT02705235|||Cohort||Cross-Sectional|||||||
1368397|NCT02705222|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1368398|NCT02705209|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368399|NCT02705196||Single Group Assignment||Treatment||None (Open Label)||||||
1368400|NCT02705183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368401|NCT02705170|||Cohort||Prospective|||||||
1368402|NCT02705157|||Cohort||Prospective|||||||
1368403|NCT02705144|||Cohort||Prospective|||||||
1368404|NCT02705131|Randomized|Parallel Assignment||Treatment||Single||||||t
1368405|NCT02705118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368406|NCT02705105||Single Group Assignment||Treatment||None (Open Label)||||||
1368407|NCT02705092|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1368408|NCT02705079|||Case Control||Retrospective|||||||
1368409|NCT02705066|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1368410|NCT02705053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368411|NCT02705040|||Cohort||Prospective|||||||
1368412|NCT02705027|Randomized|Parallel Assignment||||None (Open Label)||||||
1368413|NCT02705014||Single Group Assignment||Treatment||None (Open Label)||||||
1368414|NCT02705001|||||Retrospective|||||||
1368415|NCT02704988|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1368416|NCT02704975|Randomized|Factorial Assignment||Treatment||Single||||||t
1368417|NCT02704962|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368418|NCT02704949|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368419|NCT02704936|||Cohort||Prospective|||||||
1368420|NCT02704923|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368421|NCT02704910|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1368422|NCT02704897|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1368423|NCT02704884|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368424|NCT02704871|||Other||Prospective|||||||
1368425|NCT02704858||Single Group Assignment||Treatment||None (Open Label)||||||
1368426|NCT02704845|||Case Control||Cross-Sectional|||||||
1368427|NCT02704832|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1368428|NCT02704819|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1368429|NCT02704806|||Case Control||Prospective|||||||
1368430|NCT02704793|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1368431|NCT02704780|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368432|NCT02704767|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368433|NCT02704754|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368434|NCT02704741||Single Group Assignment||Treatment||None (Open Label)||||||
1368435|NCT02704728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368436|NCT02704715||Single Group Assignment||||None (Open Label)||||||
1368437|NCT02704702|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1368438|NCT02704689||Single Group Assignment||Treatment||None (Open Label)||||||
1368439|NCT02704676|||Case-Crossover||Cross-Sectional|||||||
1368440|NCT02704663|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368441|NCT02704650|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1368442|NCT02704637||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368443|NCT02704624|Randomized|Parallel Assignment||Treatment||Quadruple|Only the pharmacist responsible for confection of the tablets will know who will receive vitamin d or placebo, according to a list of randimization generated in the computer by the statistician. The list will be kept with the pharmacist throughout the intervention.|A double-blind, randomized, placebo-controlled study will be performed. After the evaluation of serum vitamin D levels, patients with vitamin D below 30ng/mL will be randomized into two groups. One group will receive supplementation with cholecalciferol (vitamin D3) tablets and the other group will receive placebo. Those will be provided at no cost to the patients. The dosage of 1.500-2.000 IU (International Units) vitamin D/day is recommended in order to meet the need of vitamin D above 30ng/mL in adults. However, a dose at least 2 to 3 times higher is recommended for CD patients due to malabsorption, significant loss of adipose tissue and use of glucocorticoids. Thus, the dose of 50,000IU/week will be administered in a single dose. The patients drawn to the placebo group will receive inert content tablets without therapeutic effect. After the study completion, these control patients will receive complete treatment for hypovitaminosis D.|t|t|t|t
1368444|NCT02704611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368445|NCT02704598|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1368446|NCT02704585|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1368447|NCT02704572|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368448|NCT02704559|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368449|NCT02704546|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1368450|NCT02704533|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368451|NCT02704520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368452|NCT02704507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368453|NCT02704494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368454|NCT02704481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368455|NCT02704468|||||Cross-Sectional|||||||
1368456|NCT02704455|||Cohort||Prospective|||||||
1368457|NCT02704442|||Cohort||Cross-Sectional|||||||
1368458|NCT02704429||Single Group Assignment||Treatment||None (Open Label)|Open Label|Part A with 12 weeks treatment and 12 weeks follow-up. Part B with 24 weeks treatment and 4 weeks follow-up.||||
1368459|NCT02704416|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368460|NCT02704403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368461|NCT02704390||Single Group Assignment||Treatment||None (Open Label)||||||
1368462|NCT02704377||Single Group Assignment||Supportive Care||None (Open Label)||||||
1368463|NCT02704364|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368464|NCT02704351|||Cohort||Retrospective|||||||
1368465|NCT02704338||Single Group Assignment||Treatment||None (Open Label)||||||
1368466|NCT02704325|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a dose escalation trial that will begin with the minimal efficacious dose as determined by preclinical studies and approved by the FDA. During the course of the trial, if safety is shown the dose will be escalated according to the clinical protocol.||||
1368467|NCT02704312||Single Group Assignment||Other||None (Open Label)||||||
1368468|NCT02704299||Single Group Assignment||Treatment||None (Open Label)||||||
1368469|NCT02704286|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368470|NCT02704273|||Cohort||Prospective|||||||
1368471|NCT02704260||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368472|NCT02704247||Single Group Assignment||Basic Science||None (Open Label)||||||
1368473|NCT02704234|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1368474|NCT02704221|Randomized|Parallel Assignment||Prevention||Single|||||t|
1368475|NCT02704208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368476|NCT02704195|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1368477|NCT02704182|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368478|NCT02704169||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368479|NCT02704156||Single Group Assignment||Treatment||None (Open Label)||||||
1368480|NCT02704143||Single Group Assignment||Treatment||None (Open Label)||||||
1368481|NCT02704130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368482|NCT02704117||Single Group Assignment||Basic Science||None (Open Label)||||||
1368483|NCT02704104|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1368484|NCT02704091|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368485|NCT02704078|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1368486|NCT02704065|||Case-Control||Retrospective|||||||
1368487|NCT02704052|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368488|NCT02704039|||Ecologic or Community||Prospective|||||||
1368489|NCT02704026|||Cohort||Prospective|||||||
1368490|NCT02704013||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368491|NCT02704000|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1368492|NCT02703987|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1368493|NCT02703974|Randomized|Parallel Assignment||||None (Open Label)||||||
1368494|NCT02703961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368495|NCT02703948||Single Group Assignment||Treatment||None (Open Label)||||||
1368496|NCT02703935|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1368497|NCT02703922||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368498|NCT02703909|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1368499|NCT02703896|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1368500|NCT02703883||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368501|NCT02703870|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368502|NCT02703857||Single Group Assignment||Other||None (Open Label)||||||
1368503|NCT02703844|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1368504|NCT02703831|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1368505|NCT02703818||Single Group Assignment||Treatment||None (Open Label)||||||
1368506|NCT02703805|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1368507|NCT02703792|||Other||Other|||||||
1368508|NCT02703779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368509|NCT02703766|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1368510|NCT02703753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368511|NCT02703740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368512|NCT02703727|||||Prospective|||||||
1368513|NCT02703714||Single Group Assignment||Treatment||None (Open Label)||||||
1368514|NCT02703701|||Case-Control||Prospective|||||||
1368515|NCT02703688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368516|NCT02703675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368517|NCT02703662|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368518|NCT02703649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368519|NCT02703636||Single Group Assignment||Treatment||None (Open Label)||||||
1368520|NCT02703623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368521|NCT02703610|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1368522|NCT02703597|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368523|NCT02703584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368524|NCT02703571|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368525|NCT02703558|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1368526|NCT02703545|||Case-Control||Prospective|||||||
1368527|NCT02703532|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1368528|NCT02703519|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1368529|NCT02703506|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368530|NCT02703493||Single Group Assignment||Treatment||None (Open Label)||Dose escalation of radiation therapy for high risk oropharyngeal cancer||||
1368531|NCT02703480|Randomized|Crossover Assignment||Treatment||Single|||t|||
1368533|NCT02703454|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1368534|NCT02703441|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368535|NCT02703428|||Cohort||Prospective|||||||
1368536|NCT02703415|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1368537|NCT02703402|Randomized|Parallel Assignment||Treatment||Single|||||t|
1368538|NCT02703389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368539|NCT02703376||Single Group Assignment||Prevention||None (Open Label)||||||
1368540|NCT02703363|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1368541|NCT02703350|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1368542|NCT02703337|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1368543|NCT02703324|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1368544|NCT02703311||Single Group Assignment||Treatment||None (Open Label)||||||
1368545|NCT02703298||Single Group Assignment||Treatment||None (Open Label)||||||
1368546|NCT02703285||Single Group Assignment||Treatment||None (Open Label)||||||
1368547|NCT02703272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368548|NCT02703259|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1368549|NCT02703246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368550|NCT02703233|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1368551|NCT02703220|Randomized|Crossover Assignment||Other||Single|||t|||
1368552|NCT02703207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368553|NCT02703194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368554|NCT02703181|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1368555|NCT02703168|||||Prospective|||||||
1368556|NCT02703155||Single Group Assignment||Screening||None (Open Label)||||||
1368557|NCT02703142|||Cohort||Prospective|||||||
1368558|NCT02703129||Single Group Assignment||Treatment||None (Open Label)||||||
1368559|NCT02703116|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368560|NCT02703103|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368561|NCT02703090|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1368562|NCT02703077|Randomized|Parallel Assignment||Treatment||Single||||||t
1368563|NCT02703064||Single Group Assignment||Supportive Care||None (Open Label)||open level||||
1368564|NCT02703051|Randomized|Single Group Assignment||Other||Single|||t|||
1368565|NCT02703038|||Cohort||Prospective|||||||
1368566|NCT02703025||Single Group Assignment||Supportive Care||None (Open Label)||open level||||
1368567|NCT02703012||Single Group Assignment||Treatment||None (Open Label)||||||
1368568|NCT02702999|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1368569|NCT02702986||Single Group Assignment||Treatment||None (Open Label)||||||
1368570|NCT02702973|||Case-Crossover|||||||||
1368571|NCT02702960||Single Group Assignment||Treatment||None (Open Label)||||||
1368572|NCT02702947||Single Group Assignment||||None (Open Label)||||||
1368573|NCT02702934|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1368574|NCT02702921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368575|NCT02702908|||Cohort||Retrospective|||||||
1368576|NCT02702895|||Cohort||Retrospective|||||||
1368577|NCT02702882||Single Group Assignment||Supportive Care||None (Open Label)||open level||||
1368578|NCT02702869|||Cohort||Prospective|||||||
1368579|NCT02702856|||Cohort||Prospective|||||||
1368580|NCT02702843|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1368581|NCT02702830|||Case-Control||Prospective|||||||
1368582|NCT02702817|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368583|NCT02702804||Single Group Assignment||Treatment||None (Open Label)||||||
1368584|NCT02702791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368585|NCT02702778|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368586|NCT02702765||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368587|NCT02702752|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1368588|NCT02702739|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368589|NCT02702726|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1368590|NCT02702713|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1368591|NCT02702700||Single Group Assignment||Treatment||None (Open Label)||||||
1368592|NCT02702687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368593|NCT02702674|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1368594|NCT02702661|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1368595|NCT02702648|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1368596|NCT02702635||Single Group Assignment||Basic Science||None (Open Label)||||||
1368597|NCT02702622||||||||||||
1368598|NCT02702609|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368599|NCT02702596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368600|NCT02702583|||Case Control||Prospective|||||||
1368601|NCT02702570||Single Group Assignment||Prevention||None (Open Label)||||||
1368602|NCT02702557||Single Group Assignment||||None (Open Label)||||||
1368603|NCT02702544|Randomized|Crossover Assignment||Treatment||Single|||t|||
1368604|NCT02702531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368605|NCT02702518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368606|NCT02702505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368607|NCT02702492|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368608|NCT02702479||||||||||||
1368609|NCT02702466|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368610|NCT02702453||Single Group Assignment||Supportive Care||None (Open Label)||||||
1368612|NCT02702427||Single Group Assignment||Treatment||None (Open Label)||||||
1368613|NCT02702414|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368614|NCT02702401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368615|NCT02702388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368616|NCT02702375|||Cohort||Prospective|||||||
1368617|NCT02702362|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1368618|NCT02702349||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368619|NCT02702336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368620|NCT02702323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368621|NCT02702310|||Cohort||Prospective|||||||
1368622|NCT02702297|||Cohort||Prospective|||||||
1368623|NCT02702284|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1368624|NCT02702271||Single Group Assignment||Prevention||None (Open Label)||||||
1368625|NCT02702258||Single Group Assignment||Treatment||None (Open Label)||||||
1368626|NCT02702245|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1368627|NCT02702232|||Case-Control||Prospective|||||||
1368628|NCT02702219|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368629|NCT02702206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368630|NCT02702193|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368631|NCT02702180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368632|NCT02702167|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1368633|NCT02702154|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1368634|NCT02702141||Single Group Assignment||Treatment||None (Open Label)||||||
1368635|NCT02702128|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368636|NCT02702115|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368637|NCT02702102||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368638|NCT02702089|||Cohort||Prospective|||||||
1368639|NCT02702076|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368640|NCT02702063|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1368641|NCT02702050|Randomized|Parallel Assignment||Treatment||Single||||||t
1368642|NCT02702037|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1368643|NCT02702024||||||||||||
1368644|NCT02702011|Randomized|Parallel Assignment||Treatment||Double||||||
1368645|NCT02701998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368646|NCT02701985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368647|NCT02701972||Single Group Assignment||Treatment||None (Open Label)||||||
1368648|NCT02701959|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1368649|NCT02701946|Randomized|Parallel Assignment||Treatment||Single||||||t
1368650|NCT02701933|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1368651|NCT02701920|||Cohort||Prospective|||||||
1368652|NCT02701907|Non-Randomized|Parallel Assignment||Other||Single|||||t|
1368653|NCT02701894|||||Retrospective|||||||
1368654|NCT02701881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368655|NCT02701868|||Cohort||Cross-Sectional|||||||
1368656|NCT02701855|||Case-Only||Prospective|||||||
1368657|NCT02701842|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1368658|NCT02701829|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368659|NCT02701816|||Case-Only||Prospective|||||||
1368660|NCT02701803|||Case-Only||Prospective|||||||
1368661|NCT02701777|Randomized|Crossover Assignment||Treatment||Single|participants will not know if they receive real or sham stimulation|Magnetic Stimulation and electrical stimulation|t|||
1368662|NCT02701764|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368663|NCT02701751||Single Group Assignment||Basic Science||None (Open Label)||||||
1368664|NCT02701738||Single Group Assignment||Basic Science||None (Open Label)||||||
1368665|NCT02701725|||Case Control||Prospective|||||||
1368666|NCT02701712||Single Group Assignment||Treatment||None (Open Label)||||||
1368667|NCT02701699||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368668|NCT02701686|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368669|NCT02701673||Single Group Assignment||Treatment||None (Open Label)||||||
1368670|NCT02701660||Single Group Assignment||Health Services Research||None (Open Label)||||||
1368671|NCT02701647|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368672|NCT02701634|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368673|NCT02701621|Randomized|Parallel Assignment||Treatment||Single|||||t|
1368674|NCT02701608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368675|NCT02701595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368676|NCT02701582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368677|NCT02701569|Randomized|Parallel Assignment||Treatment||Single||||||t
1368678|NCT02701556|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368679|NCT02701543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368680|NCT02701530|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368681|NCT02701517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368682|NCT02701504|||Cohort||Prospective|||||||
1368683|NCT02701491|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1368684|NCT02701478||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368685|NCT02701465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368686|NCT02701452||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368687|NCT02701439|||||Cross-Sectional|||||||
1368688|NCT02701426|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1368689|NCT02701413|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368690|NCT02701400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368691|NCT02701387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368692|NCT02701374|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368693|NCT02701361|Randomized|Parallel Assignment||Treatment||Single||||||t
1368694|NCT02701348||Single Group Assignment||Basic Science||None (Open Label)||||||
1368695|NCT02701335|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368696|NCT02701322|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368697|NCT02701309|||Cohort||Prospective|||||||
1368698|NCT02701296|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1368699|NCT02701283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368700|NCT02701270|Randomized|Crossover Assignment||||Single|||t|||
1368701|NCT02701257|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368702|NCT02701244|||Cohort||Prospective|||||||
1368703|NCT02701231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368704|NCT02701218|Randomized|Parallel Assignment||Treatment||Single||||||t
1368705|NCT02701205|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368706|NCT02701192|||Case-Only||Prospective|||||||
1368707|NCT02701179|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1368708|NCT02701166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368709|NCT02701153||Single Group Assignment||Treatment||None (Open Label)||||||
1368710|NCT02701140|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368711|NCT02701127|Randomized|Parallel Assignment||Other||Double|||t|t||
1368712|NCT02701114|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368713|NCT02701101|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1368714|NCT02701088||Single Group Assignment||Treatment||None (Open Label)||||||
1368715|NCT02701075|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368716|NCT02701062|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1368717|NCT02701049||Single Group Assignment||Health Services Research||None (Open Label)||||||
1368718|NCT02701036|||Cohort||Prospective|||||||
1368719|NCT02701023||||||||||||
1368720|NCT02701010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368721|NCT02700997||Single Group Assignment||Basic Science||None (Open Label)||||||
1368722|NCT02700984|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1368723|NCT02700971||Single Group Assignment||Basic Science||None (Open Label)||||||
1368724|NCT02700958|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1368725|NCT02700945|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Subjects will be randomized 1:1 to the continuous monitoring arm or the control arm. Subjects randomized to the continuous monitoring arm will have a Reveal LINQ ICM inserted within 10 days of the qualifying stroke and undergo continuous remote monitoring. Subjects randomized to the control arm will be followed per site specific standard of care.||||
1368726|NCT02700932||Single Group Assignment||Treatment||None (Open Label)||||||
1368727|NCT02700919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368728|NCT02700906|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368729|NCT02700893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368730|NCT02700880|||Cohort||Prospective|||||||
1368731|NCT02700867|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368732|NCT02700854||Single Group Assignment||Treatment||None (Open Label)||||||
1368733|NCT02700841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368734|NCT02700828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368735|NCT02700815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368736|NCT02700802|Randomized|Parallel Assignment||Other||Single|||t|||
1368737|NCT02700789|||Cohort||Prospective|||||||
1368738|NCT02700776|||Cohort||Prospective|||||||
1368739|NCT02700763||Single Group Assignment||Other||None (Open Label)||||||
1368740|NCT02700750||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368741|NCT02700737|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1368742|NCT02700724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368743|NCT02700711|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1368744|NCT02700698|||Cohort||Cross-Sectional|||||||
1368745|NCT02700685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368746|NCT02700672|||||Cross-Sectional|||||||
1368747|NCT02700659|||Cohort||Prospective|||||||
1368748|NCT02700646|Randomized|Parallel Assignment||Other||Single|||t|||
1368749|NCT02700633|||Cohort||Retrospective|||||||
1368750|NCT02700620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368751|NCT02700607|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368752|NCT02700594|Randomized|Parallel Assignment||Treatment||Single||||||t
1368753|NCT02700581|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1368754|NCT02700568||Single Group Assignment||Treatment||None (Open Label)||||||
1368755|NCT02700555|||Cohort||Prospective|||||||
1368756|NCT02700542|Randomized|Parallel Assignment||Prevention||Single|||||t|
1368757|NCT02700529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368758|NCT02700516|||Case Control||Retrospective|||||||
1368759|NCT02700503||Single Group Assignment||Prevention||None (Open Label)||||||
1368760|NCT02700490|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1368761|NCT02700477|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1368762|NCT02700464|Non-Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1368763|NCT02700451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368764|NCT02700438|Randomized|Parallel Assignment||Treatment||Single||||||t
1368765|NCT02700425|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368766|NCT02700412||Single Group Assignment||Treatment||None (Open Label)||||||
1368767|NCT02700399|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368768|NCT02700386||Single Group Assignment||Treatment||None (Open Label)||||||
1368769|NCT02700373|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368770|NCT02700360|Randomized|Crossover Assignment||||None (Open Label)||||||
1368771|NCT02700347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368772|NCT02700334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368773|NCT02700321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368774|NCT02700308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368775|NCT02700295|||Cohort||Prospective|||||||
1368776|NCT02700282|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1368777|NCT02700269|||Case-Only||Prospective|||||||
1368778|NCT02700256|||Cohort||Prospective|||||||
1368779|NCT02700243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368780|NCT02700230||Single Group Assignment||Treatment||None (Open Label)||||||
1368781|NCT02700217|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368782|NCT02700204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368783|NCT02700191|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1368784|NCT02700178||Single Group Assignment||Basic Science||None (Open Label)||||||
1368785|NCT02700165||Single Group Assignment||Other||None (Open Label)||||||
1368786|NCT02700152||Single Group Assignment||Treatment||None (Open Label)||||||
1368787|NCT02700139|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1368788|NCT02700126|||Cohort||Prospective|||||||
1368789|NCT02700113|||Case-Only||Cross-Sectional|||||||
1368790|NCT02700100||Single Group Assignment||Treatment||None (Open Label)||||||
1368791|NCT02700087|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368792|NCT02700074|||Case-Control||Cross-Sectional|||||||
1368793|NCT02700061|Randomized|Parallel Assignment||Treatment||Single|||||t|
1368794|NCT02700048|Randomized|Crossover Assignment||Prevention||Single|||t|||
1368795|NCT02700035|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368796|NCT02700022||Single Group Assignment||Treatment||None (Open Label)||||||
1368797|NCT02700009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368798|NCT02699996|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368799|NCT02699983|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368800|NCT02699970|||Case-Only||Cross-Sectional|||||||
1368801|NCT02699957|||Cohort||Prospective|||||||
1368802|NCT02699944||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368803|NCT02699931|Randomized|Parallel Assignment||Prevention||Single||||||t
1368804|NCT02699918||Single Group Assignment||Screening||None (Open Label)||||||
1368805|NCT02699905|||Cohort||Prospective|||||||
1368806|NCT02699892|||Cohort||Prospective|||||||
1368807|NCT02699879|||Cohort||Prospective|||||||
1368808|NCT02699866||Single Group Assignment||Other||None (Open Label)||||||
1368809|NCT02699853|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368810|NCT02699840|||Cohort||Prospective|||||||
1368811|NCT02699827|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1368812|NCT02699814||Single Group Assignment||Health Services Research||None (Open Label)||||||
1368813|NCT02699801|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368814|NCT02699788||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368815|NCT02699775|||Other||Prospective|||||||
1368816|NCT02699762|Randomized|Parallel Assignment||Other||Double||||t|t|
1368817|NCT02699749||Single Group Assignment||Other||None (Open Label)||||||
1368818|NCT02699736|||Cohort||Prospective|||||||
1368819|NCT02699723||Single Group Assignment||Treatment||None (Open Label)||||||
1368820|NCT02699710|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1368821|NCT02699697|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368822|NCT02699684|Randomized|Crossover Assignment||Other||Double|||t||t|
1368823|NCT02699671|||Cohort||Prospective|||||||
1368824|NCT02699658||Single Group Assignment||||None (Open Label)||||||
1368825|NCT02699645|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368826|NCT02699632|||Ecologic or Community||Retrospective|||||||
1368827|NCT02699619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368828|NCT02699606||Single Group Assignment||Treatment||None (Open Label)||||||
1368829|NCT02699593|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1368830|NCT02699580|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1368831|NCT02699567|||Case Control||Prospective|||||||
1368832|NCT02699554|||Cohort||Prospective|||||||
1368833|NCT02699541|Randomized|Parallel Assignment||Treatment||Single||||||t
1368834|NCT02699528|||Cohort||Prospective|||||||
1368835|NCT02699515||Single Group Assignment||Treatment||None (Open Label)||||||
1368836|NCT02699502||Single Group Assignment||Treatment||None (Open Label)||||||
1368837|NCT02699489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368838|NCT02699476|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1368839|NCT02699463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368840|NCT02699450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368841|NCT02699437|||Cohort||Cross-Sectional|||||||
1368842|NCT02699424||Single Group Assignment||Treatment||None (Open Label)||||||
1368843|NCT02699411|Randomized|Parallel Assignment||Treatment||Single|||||t|
1368844|NCT02699398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368845|NCT02699385|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368846|NCT02699372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1368847|NCT02699359||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368848|NCT02699346||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368849|NCT02699333|||Case-Control||Prospective|||||||
1368850|NCT02699320|||Case Control||Retrospective|||||||
1368851|NCT02699307||Single Group Assignment||Treatment||None (Open Label)||||||
1368852|NCT02699294|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368853|NCT02699281|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1368854|NCT02699268|||Cohort||Prospective|||||||
1368855|NCT02699255|||Cohort||Retrospective|||||||
1368856|NCT02699242|Randomized|Parallel Assignment||Other||Double|||t|||t
1368857|NCT02699229|||Cohort||Prospective|||||||
1368858|NCT02699216|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1368859|NCT02699203|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1368860|NCT02699190|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1368861|NCT02699177|||Cohort||Prospective|||||||
1368862|NCT02699164|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368863|NCT02699151|||Cohort||Prospective|||||||
1368864|NCT02699138|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1368865|NCT02699125|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1368866|NCT02699112|||Cohort||Prospective|||||||
1368867|NCT02699099|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368868|NCT02699086|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368869|NCT02699073||Single Group Assignment||Treatment||None (Open Label)||||||
1368870|NCT02699060||Single Group Assignment||||None (Open Label)||||||
1368871|NCT02699047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368872|NCT02699034||Single Group Assignment||Treatment||None (Open Label)||||||
1368873|NCT02699021||||||||||||
1368874|NCT02699008|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368875|NCT02698995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368876|NCT02698982|Randomized|Parallel Assignment||Prevention||Single|||t|||
1368877|NCT02698969|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1368878|NCT02698956|||Cohort||Prospective|||||||
1368879|NCT02698943|||Cohort||Prospective|||||||
1368880|NCT02698930|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1368881|NCT02698917|Randomized|Factorial Assignment||Treatment||Single|The physician determining neurological outcome at six months after cardiac arrest is blinded to the study group allocations|||||t
1368882|NCT02698904|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368883|NCT02698891||Single Group Assignment||Treatment||None (Open Label)||||||
1368884|NCT02698878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368885|NCT02698865||||||||||||
1368886|NCT02698852||Single Group Assignment||Treatment||None (Open Label)||||||
1368887|NCT02698839|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368888|NCT02698826||Single Group Assignment||Treatment||None (Open Label)||||||
1368889|NCT02698813|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1368890|NCT02698800|Randomized|Crossover Assignment||Treatment||Single|||t|||
1368891|NCT02698787||||||||||||
1368892|NCT02698761|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1368893|NCT02698748|Randomized|Parallel Assignment||Prevention||Single|||t|||
1368894|NCT02698735|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368895|NCT02698722|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1368896|NCT02698709|||Case Control||Retrospective|||||||
1368897|NCT02698696|Randomized|Parallel Assignment||Other||Double|||t|||t
1368898|NCT02698683|||Cohort||Prospective|||||||
1368899|NCT02698670|||Case-Only||Prospective|||||||
1368900|NCT02698657|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1368901|NCT02698644||Single Group Assignment||Basic Science||None (Open Label)||||||
1368902|NCT02698631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368903|NCT02698618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368904|NCT02698605||Single Group Assignment||||None (Open Label)||||||
1368905|NCT02698592|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368906|NCT02698579|||Case-Only||Prospective|||||||
1368907|NCT02698566||Single Group Assignment||Other||None (Open Label)||||||
1368908|NCT02698553||Single Group Assignment||Treatment||None (Open Label)||||||
1368909|NCT02698540|||Cohort||Prospective|||||||
1368910|NCT02698527|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1368911|NCT02698514|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1368912|NCT02698501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368913|NCT02698488|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1368914|NCT02698475||Single Group Assignment||Treatment||None (Open Label)||||||
1368915|NCT02698462||Single Group Assignment||Screening||None (Open Label)||||||
1368916|NCT02698449|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1368917|NCT02698436|Randomized|Parallel Assignment||Treatment||Single|||||t|
1368918|NCT02698423|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1368919|NCT02698410||Single Group Assignment||Treatment||None (Open Label)||||||
1368920|NCT02698397||||||||||||
1368921|NCT02698384|||Cohort||Prospective|||||||
1368922|NCT02698371|Randomized|Factorial Assignment||Other||Triple|||t|t||t
1368923|NCT02698358|||Case-Only||Prospective|||||||
1368925|NCT02698332|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1368926|NCT02698319|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1368927|NCT02698306|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368928|NCT02698293|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1368929|NCT02698280||Single Group Assignment||Treatment||None (Open Label)||||||
1368930|NCT02698267||Single Group Assignment||Treatment||None (Open Label)||||||
1368931|NCT02698254|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368932|NCT02698241|||Cohort||Prospective|||||||
1368933|NCT02698228|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1368934|NCT02698215|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1368935|NCT02698202|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1368936|NCT02698189|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368937|NCT02698176|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368938|NCT02698163|Randomized|Parallel Assignment||Treatment||Single|||t|||
1368939|NCT02698150|||Cohort||Prospective|||||||
1368940|NCT02698137|||Cohort||Cross-Sectional|||||||
1368941|NCT02698124|||Ecologic or Community||Prospective|||||||
1368942|NCT02698111||Single Group Assignment||Treatment||None (Open Label)||||||
1368943|NCT02698098|||Cohort||Prospective|||||||
1368944|NCT02698085|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1368945|NCT02698072|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1368946|NCT02698059|Randomized|Crossover Assignment||Treatment||Single||||||t
1368947|NCT02698046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368948|NCT02698033|Non-Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1368949|NCT02698020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368950|NCT02698007|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1368951|NCT02697994|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368952|NCT02697981|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368953|NCT02697968||Single Group Assignment||Treatment||None (Open Label)||||||
1368954|NCT02697955|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1368955|NCT02697942|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368956|NCT02697929|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1368957|NCT02697916|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368958|NCT02697903|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1368959|NCT02697890|Randomized|Parallel Assignment||Prevention||Single|||t|||
1368960|NCT02697877|||Cohort||Prospective|||||||
1368961|NCT02697864|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1368962|NCT02697851|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1368963|NCT02697838||Single Group Assignment||Treatment||None (Open Label)||||||
1368964|NCT02697825||Single Group Assignment||Diagnostic||None (Open Label)||||||
1368965|NCT02697812|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1368966|NCT02697799|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1368967|NCT02697786|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368968|NCT02697773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1368969|NCT02697760|||Case-Only||Prospective|||||||
1368970|NCT02697747|||Cohort||Prospective|||||||
1368971|NCT02697734|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1368972|NCT02697721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368973|NCT02697708|Randomized|Crossover Assignment||Prevention||None (Open Label)||Participants will receive a controlled diet containing 2340 mg potassium.(K) During the 4 - 16 day phases they will receive an additional 0 mg K, 1000 mg K from potatoes, 1000 mg K from French Fries, and 1000 mg K from supplement in randomized order. Blood pressure will be measured every other day during the intervention. There will be a 2 week washout phase during each phase.||||
1368974|NCT02697695|||Other||Retrospective|||||||
1368975|NCT02697682||Single Group Assignment||Treatment||None (Open Label)||||||
1368976|NCT02697669|||Case-Only||Prospective|||||||
1368977|NCT02697656|Randomized|Parallel Assignment||Treatment||Single||||||t
1368978|NCT02697643|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1368979|NCT02697630||Single Group Assignment||Treatment||None (Open Label)||||||
1368980|NCT02697617|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1368981|NCT02697604||||||||||||
1368982|NCT02697591||Single Group Assignment||Treatment||None (Open Label)||||||
1368983|NCT02697578|||Cohort||Prospective|||||||
1368984|NCT02697565|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368985|NCT02697552||Single Group Assignment||Treatment||None (Open Label)||||||
1368986|NCT02697539|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1368987|NCT02697526|Randomized|Parallel Assignment||||None (Open Label)||||||
1368988|NCT02697513|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1368989|NCT02697500|||Cohort||Cross-Sectional|||||||
1368990|NCT02697487|||Cohort||Prospective|||||||
1368991|NCT02697474|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368992|NCT02697461|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1368993|NCT02697448|Randomized|Parallel Assignment||Treatment||Single||||||t
1368994|NCT02697435|Randomized|Parallel Assignment||Treatment||Single|"Research Coordinators who perform the data measure portion of the baseline are masked from knowing which group (usual care or patient care) the participant ends up in. This is also true of monthly follow-up calls."||||t|
1369071|NCT02696434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369072|NCT02696421|||Case-Only||Prospective|||||||
1368995|NCT02697422|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|N/A; No masking will occur in this clinical trial.|Parallel: Participants are assigned to one of two groups--the control or intervention group- in parallel for the duration of the study.||||
1368996|NCT02697409|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1368997|NCT02697396|||Ecologic or Community||Prospective|||||||
1368998|NCT02697383||Single Group Assignment||Treatment||None (Open Label)||||||
1368999|NCT02697370||Single Group Assignment||Treatment||None (Open Label)||||||
1369000|NCT02697357|||Cohort||Prospective|||||||
1369001|NCT02697344||Single Group Assignment||Treatment||None (Open Label)||||||
1369002|NCT02697331|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369003|NCT02697318|Randomized|Parallel Assignment||Other||Single|||||t|
1369004|NCT02697305|Non-Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1369005|NCT02697292|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1369006|NCT02697279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369007|NCT02697266|||Cohort||Prospective|||||||
1369008|NCT02697253|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1369009|NCT02697240||Single Group Assignment||Treatment||None (Open Label)||||||
1369010|NCT02697227|Randomized|Parallel Assignment||Prevention||Single|||t|||
1369011|NCT02697214|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1369012|NCT02697201|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1369013|NCT02697188|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369014|NCT02697175|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1369015|NCT02697162|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369016|NCT02697149|||Cohort||Retrospective|||||||
1369017|NCT02697136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369018|NCT02697123|||Cohort||Prospective|||||||
1369019|NCT02697110|Randomized|Parallel Assignment||||Single|||t|||
1369020|NCT02697097|||Case Control||Prospective|||||||
1369021|NCT02697084|||Cohort||Prospective|||||||
1369022|NCT02697071|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1369023|NCT02697058|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1369024|NCT02697045||Single Group Assignment||Treatment||None (Open Label)||||||
1369025|NCT02697032||Single Group Assignment||Treatment||None (Open Label)||||||
1369026|NCT02697019||Single Group Assignment||Treatment||None (Open Label)||||||
1369027|NCT02697006|||Case-Only||Prospective|||||||
1369028|NCT02696993|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369029|NCT02696980|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369030|NCT02696967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369031|NCT02696954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369032|NCT02696941|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369033|NCT02696928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369034|NCT02696915|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1369035|NCT02696902|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369036|NCT02696889||Single Group Assignment||Treatment||None (Open Label)||||||
1369037|NCT02696876|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1369038|NCT02696863|||Other||Prospective|||||||
1369039|NCT02696850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369040|NCT02696837|Randomized|Parallel Assignment||||Single||||||t
1369041|NCT02696824|Randomized|Parallel Assignment||Treatment||Single||||||t
1369042|NCT02696811|Randomized|Parallel Assignment||Prevention||Single|||||t|
1369043|NCT02696798|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369044|NCT02696785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369045|NCT02696772|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1369046|NCT02696759||Single Group Assignment||Basic Science||None (Open Label)||||||
1369047|NCT02696746|||Cohort||Cross-Sectional|||||||
1369048|NCT02696733||Single Group Assignment||Treatment||None (Open Label)||||||
1369049|NCT02696720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369050|NCT02696707|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369051|NCT02696694|||Cohort||Prospective|||||||
1369052|NCT02696681||Single Group Assignment||Treatment||None (Open Label)||||||
1369053|NCT02696668|Randomized|Parallel Assignment||Treatment||Single||||||t
1369054|NCT02696655||Single Group Assignment||Supportive Care||None (Open Label)||||||
1369055|NCT02696642|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369056|NCT02696629|||Cohort||Other|||||||
1369057|NCT02696616|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369058|NCT02696603|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369059|NCT02696590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369060|NCT02696577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369061|NCT02696564|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1369062|NCT02696551|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369063|NCT02696538||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369064|NCT02696525|||Case-Only||Prospective|||||||
1369065|NCT02696512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369066|NCT02696499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369067|NCT02696486||Single Group Assignment||Treatment||None (Open Label)||||||
1369068|NCT02696473|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1369069|NCT02696460|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369070|NCT02696447|||Cohort||Prospective|||||||
1369073|NCT02696408|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1369074|NCT02696395|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369075|NCT02696382|Randomized|Parallel Assignment||Treatment||Single||||||t
1369076|NCT02696369|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1369077|NCT02696356|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369078|NCT02696343|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1369079|NCT02696330|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369080|NCT02696317|Randomized|Crossover Assignment||Other||Single|||||t|
1369081|NCT02696304|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369082|NCT02696291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369083|NCT02696278|Randomized|Parallel Assignment||Other||Single|||t|||
1369084|NCT02696265|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1369085|NCT02696252|||Cohort||Prospective|||||||
1369086|NCT02696239|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369087|NCT02696226|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1369088|NCT02696213|Randomized|Crossover Assignment||||Single|||||t|
1369089|NCT02696200|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369090|NCT02696187|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369091|NCT02696174|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369092|NCT02696161|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369093|NCT02696148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369094|NCT02696135|||Cohort||Prospective|||||||
1369095|NCT02696122|Randomized|Parallel Assignment||Treatment||Single||||||t
1369096|NCT02696109|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multimodal psychosocial intervention||||
1369097|NCT02696096||Single Group Assignment||Other||None (Open Label)||||||
1369098|NCT02696083||Single Group Assignment||Treatment||None (Open Label)||||||
1369099|NCT02696070|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1369100|NCT02696057|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1369101|NCT02696044|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1369102|NCT02696031|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369103|NCT02696018|||Cohort||Prospective|||||||
1369104|NCT02696005|||Cohort||Prospective|||||||
1369105|NCT02695992|Randomized|Parallel Assignment||Treatment||Single|||||t|
1369106|NCT02695979|||Cohort||Prospective|||||||
1369107|NCT02695966|||Case-Only||Prospective|||||||
1369108|NCT02695953|||Case-Only||Prospective|||||||
1369109|NCT02695940|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369110|NCT02695927|Randomized|Parallel Assignment||Treatment||Single||1/2 patients receive visual stimulation with rehabilitation glasses. 1/2 patients receive control stimulation with rehabilitation glasses.|t|||
1369111|NCT02695914|||Cohort||Retrospective|||||||
1369112|NCT02695901|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1369113|NCT02695888|Randomized|Parallel Assignment||Prevention||Single||||||t
1369114|NCT02695875|Randomized|Parallel Assignment||Treatment||Single||||||t
1369115|NCT02695862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369116|NCT02695849|||Cohort||Cross-Sectional|||||||
1369117|NCT02695836|Randomized|Parallel Assignment||Health Services Research||Double|Participants and outcome assessors are blinded to study arm assignment||t|||t
1369118|NCT02695823||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369119|NCT02695810|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369120|NCT02695797|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369121|NCT02695784|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369122|NCT02695771|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369123|NCT02695758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369124|NCT02695745|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1369125|NCT02695732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369126|NCT02695719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369127|NCT02695706||Single Group Assignment||Supportive Care||None (Open Label)||||||
1369128|NCT02695693|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1369129|NCT02695680|||Cohort||Prospective|||||||
1369130|NCT02695667|||Case-Control||Cross-Sectional|||||||
1369131|NCT02695654|||Cohort||Prospective|||||||
1369132|NCT02695641|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1369133|NCT02695628||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369134|NCT02695615|||Case Control||Prospective|||||||
1369135|NCT02695602|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369136|NCT02695576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369137|NCT02695563|Randomized|Parallel Assignment||Treatment||Single|||||t|
1369138|NCT02695550||Single Group Assignment||Treatment||None (Open Label)||||||
1369139|NCT02695537||Single Group Assignment||Treatment||None (Open Label)||||||
1369140|NCT02695524|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1369141|NCT02695511|Randomized|Parallel Assignment||Prevention||Single|||||t|
1369142|NCT02695498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369143|NCT02695485||Single Group Assignment||Treatment||None (Open Label)||||||
1369144|NCT02695472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369145|NCT02695459||Single Group Assignment||Treatment||None (Open Label)||||||
1369146|NCT02695446||Single Group Assignment||Treatment||None (Open Label)||||||
1369147|NCT02695433|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1369148|NCT02695420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369149|NCT02695407|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369150|NCT02695394|||Cohort||Prospective|||||||
1369151|NCT02695381|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1369152|NCT02695368|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1369153|NCT02695355||Single Group Assignment||Treatment||None (Open Label)||||||
1369154|NCT02695342||Single Group Assignment||Treatment||None (Open Label)||||||
1369155|NCT02695329|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1369156|NCT02695316|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369157|NCT02695303||Single Group Assignment||Treatment||None (Open Label)||||||
1369158|NCT02695290||Single Group Assignment||Treatment||None (Open Label)||||||
1369159|NCT02695277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369160|NCT02695264||Single Group Assignment||Screening||None (Open Label)||||||
1369161|NCT02695251|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1369162|NCT02695238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369163|NCT02695225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369164|NCT02695212||Single Group Assignment||Other||None (Open Label)||||||
1369165|NCT02695199|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1369166|NCT02695186|||Case Control||Prospective|||||||
1369167|NCT02695173|||Cohort||Retrospective|||||||
1369168|NCT02695160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1369169|NCT02695147|||Cohort||Retrospective|||||||
1369170|NCT02695134|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1369171|NCT02695121|||Cohort||Retrospective|||||||
1369172|NCT02695108|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369173|NCT02695095|||Cohort||Retrospective|||||||
1369174|NCT02695082|||Cohort||Retrospective|||||||
1369175|NCT02695069||Single Group Assignment||Prevention||None (Open Label)||||||
1369176|NCT02695043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1369177|NCT02695030||||||||||||
1369178|NCT02695017|Randomized|Crossover Assignment||Basic Science||Single||||||t
1369179|NCT02695004|Randomized|Parallel Assignment||||Double|||t||t|
1369180|NCT02694991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369181|NCT02694978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369182|NCT02694965|||Case-Only||Prospective|||||||
1369183|NCT02694952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369184|NCT02694939|Randomized|Single Group Assignment||Treatment||Single||||||t
1369185|NCT02694926||Single Group Assignment||Prevention||None (Open Label)||||||
1369186|NCT02694913|||Other||Prospective|||||||
1369187|NCT02694900|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369188|NCT02694887|||Cohort||Prospective|||||||
1369189|NCT02694874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369190|NCT02694861|||Cohort||Prospective|||||||
1369191|NCT02694848|Randomized|Parallel Assignment||Treatment||Single|||||t|
1369192|NCT02694835||||||||||||
1369193|NCT02694822||Single Group Assignment||Treatment||None (Open Label)||||||
1369194|NCT02694809|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369195|NCT02694796|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1369196|NCT02694783||Single Group Assignment||Treatment||None (Open Label)||||||
1369197|NCT02694770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369198|NCT02694757||Single Group Assignment||Treatment||None (Open Label)||||||
1369199|NCT02694744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369200|NCT02694731||Single Group Assignment||Treatment||None (Open Label)||||||
1369201|NCT02694718||Single Group Assignment||Treatment||None (Open Label)||||||
1369202|NCT02694705|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1369203|NCT02694692|||Case-Control||Prospective|||||||
1369204|NCT02694679|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1369205|NCT02694666|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1369206|NCT02694653|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1369207|NCT02694640|Randomized|Parallel Assignment||Treatment||Single||||||t
1369208|NCT02694627|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369209|NCT02694614||Single Group Assignment||Treatment||None (Open Label)||||||
1369210|NCT02694601||Single Group Assignment||Basic Science||None (Open Label)||||||
1369211|NCT02694588|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1369212|NCT02694575|||Case-Control||Cross-Sectional|||||||
1369213|NCT02694562||Single Group Assignment||Treatment||None (Open Label)||||||
1369214|NCT02694549||Single Group Assignment||Other||||||||
1369215|NCT02694536||Single Group Assignment||Treatment||None (Open Label)||||||
1369216|NCT02694523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369217|NCT02694510|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1369218|NCT02694497|||Cohort||Prospective|||||||
1369219|NCT02694484||Single Group Assignment||Basic Science||None (Open Label)||||||
1369220|NCT02694471|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369221|NCT02694458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369222|NCT02694445|||Case-Only||Cross-Sectional|||||||
1369223|NCT02694432|Randomized|Parallel Assignment||Treatment||Single||||||t
1369224|NCT02694419|||Case-Control||Prospective|||||||
1369225|NCT02694406|||Case-Only||Prospective|||||||
1369226|NCT02694393||Single Group Assignment||Treatment||None (Open Label)||||||
1369227|NCT02694380|||Other||Other|||||||
1369228|NCT02694367|||Case Control||Prospective|||||||
1369229|NCT02694354|Randomized|Parallel Assignment||Treatment||Single||||||
1369230|NCT02694341|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369231|NCT02694328|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369232|NCT02694315|||Cohort||Prospective|||||||
1369233|NCT02694302|Randomized|Parallel Assignment||Treatment||Single||||||t
1369234|NCT02694289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369235|NCT02694276||Single Group Assignment||Treatment||None (Open Label)||||||
1369236|NCT02694263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369237|NCT02694250||Single Group Assignment||Treatment||None (Open Label)||||||
1369238|NCT02694237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369239|NCT02694224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369240|NCT02694211|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369241|NCT02694198|||Case-Only||Prospective|||||||
1369242|NCT02694185|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1369243|NCT02694172|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369244|NCT02694159|||Case-Only||Retrospective|||||||
1369245|NCT02694146|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369246|NCT02694133||Single Group Assignment||Treatment||None (Open Label)||||||
1369247|NCT02694120|||Cohort||Prospective|||||||
1369248|NCT02694107|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369249|NCT02694094|||Case-Control||Prospective|||||||
1369250|NCT02694081|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369251|NCT02694068|||Cohort||Other|||||||
1369252|NCT02694055|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369253|NCT02694042|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369254|NCT02694029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369255|NCT02694016|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1369256|NCT02694003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369257|NCT02693990|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369258|NCT02693977|||Cohort||Prospective|||||||
1369259|NCT02693964|||Case-Control||Prospective|||||||
1369260|NCT02693951|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369261|NCT02693938|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1369262|NCT02693925|||Cohort||Cross-Sectional|||||||
1369263|NCT02693912|||Case Control||Prospective|||||||
1369264|NCT02693899|||Cohort||Prospective|||||||
1369265|NCT02693886|||Case-Only|||||||||
1369266|NCT02693873||Single Group Assignment||Treatment||None (Open Label)||GLA:DCanada Program - Education and targeted, personalized exercise for people with hip and/or knee osteoarthritis||||
1369267|NCT02693860||Single Group Assignment||Treatment||None (Open Label)||||||
1369268|NCT02693847|||Cohort||Prospective|||||||
1369269|NCT02693834||Single Group Assignment||Treatment||None (Open Label)||||||
1369270|NCT02693821|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369271|NCT02693808|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369272|NCT02693795|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1369273|NCT02693782|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1369274|NCT02693769|Randomized|Crossover Assignment||Treatment||Single|||||t|
1369275|NCT02693756|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369276|NCT02693743|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1369277|NCT02693730|||Case-Control||Cross-Sectional|||||||
1369278|NCT02693717|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369279|NCT02693704|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369280|NCT02693691||Single Group Assignment||Treatment||None (Open Label)||||||
1369281|NCT02693678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369282|NCT02693665|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1369283|NCT02693652|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369284|NCT02693639|||Cohort||Prospective|||||||
1369285|NCT02693626|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1369286|NCT02693613|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369287|NCT02693600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369288|NCT02693587|||Cohort||Prospective|||||||
1369289|NCT02693574|Randomized|Parallel Assignment||Treatment||Single||||||t
1369290|NCT02693561|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369291|NCT02693548|||Cohort||Prospective|||||||
1369292|NCT02693535|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1369293|NCT02693522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369294|NCT02693509|||Cohort||Other|||||||
1369295|NCT02693496|||Cohort||Prospective|||||||
1369296|NCT02693483|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369297|NCT02693470||Single Group Assignment||Treatment||None (Open Label)||||||
1369298|NCT02693457|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369299|NCT02693444|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1369300|NCT02693431|||Cohort||Prospective|||||||
1369301|NCT02693418|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369302|NCT02693405|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1369303|NCT02693392|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369304|NCT02693379||Single Group Assignment||Prevention||None (Open Label)||||||
1369305|NCT02693366||Single Group Assignment||Treatment||None (Open Label)||||||
1369306|NCT02693353|||Cohort||Prospective|||||||
1369307|NCT02693340|||Cohort||Prospective|||||||
1369308|NCT02693327|||Case-Control||Prospective|||||||
1369309|NCT02693314|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1369310|NCT02693301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369311|NCT02693288|Randomized|Parallel Assignment||Treatment||Single||||||t
1369312|NCT02693275||Single Group Assignment||Basic Science||None (Open Label)|Open Label|||||
1369313|NCT02693262|Randomized|Crossover Assignment||Treatment||Single|||t|||
1369314|NCT02693249|||Case-Only||Prospective|||||||
1369315|NCT02693236||Single Group Assignment||Treatment||None (Open Label)||||||
1369316|NCT02693223|||Cohort||Other|||||||
1369317|NCT02693210|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1369318|NCT02693197|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369319|NCT02693184|||Case-Crossover||Prospective|||||||
1369320|NCT02693171|||Cohort||Prospective|||||||
1369321|NCT02693158|||Case-Only||Prospective|||||||
1369322|NCT02693145|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1369323|NCT02693132|Randomized|Parallel Assignment||Treatment||Single||||||t
1369324|NCT02693119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369325|NCT02693106||Single Group Assignment||Basic Science||None (Open Label)||||||
1369326|NCT02693093|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1369327|NCT02693080||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369328|NCT02693067||Single Group Assignment||Treatment||None (Open Label)||||||
1369329|NCT02693054||Single Group Assignment||Other||None (Open Label)||||||
1369330|NCT02693041|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369331|NCT02693028|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1369332|NCT02693015|||Cohort||Prospective|||||||
1369333|NCT02693002|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1369334|NCT02692989|||Cohort||Retrospective|||||||
1369335|NCT02692976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369336|NCT02692963|Randomized|Parallel Assignment||Basic Science||Single||||||t
1369337|NCT02692950||Single Group Assignment||Health Services Research||None (Open Label)||||||
1369338|NCT02692937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369339|NCT02692924|||Other||Retrospective|||||||
1369340|NCT02692911|||Cohort||Prospective|||||||
1369341|NCT02692898|||Cohort||Retrospective|||||||
1369342|NCT02692885|||Cohort||Cross-Sectional|||||||
1369343|NCT02692872|||Other||Other|||||||
1369344|NCT02692859|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1369345|NCT02692846|||Case-Control||Prospective|||||||
1369346|NCT02692833|||Cohort||Prospective|||||||
1369347|NCT02692820|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369348|NCT02692807|Randomized|Parallel Assignment||Treatment||Double|"This is only for the RCT Study - the double-blinded study. The HARP study consists of only a prospective longitudial study With same outcome measure and follow-ups; hence, given 3 arms. The below Allocation and Number of Subjects is ONLY for the RCT part of the study"|The RCT part of the HIPARTI Study has 2 arms, but there is also a prospective longitudinal study of those who are either not willing to participate in the RCT, or where the study takes part in collaborating countries were there is ONLY the prospective longitudial ongoing (Australia). This part of the study is the HARP study. The HIPARTI consists on one RCT trial eith two parallel arms, and one prospective cohort, the HARP study.|t|||t
1369349|NCT02692794|||Cohort||Prospective|||||||
1369350|NCT02692781|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369351|NCT02692768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369352|NCT02692755||Single Group Assignment||Treatment||None (Open Label)||||||
1369353|NCT02692742|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1369354|NCT02692729|Randomized|Parallel Assignment||Treatment||Single||||||t
1369355|NCT02692716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369356|NCT02692703||Single Group Assignment||Treatment||None (Open Label)||||||
1369357|NCT02692690||Single Group Assignment||Basic Science||None (Open Label)||||||
1369358|NCT02692677||Single Group Assignment||Basic Science||None (Open Label)||||||
1369359|NCT02692664|||Other||Prospective|||||||
1369360|NCT02692651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369361|NCT02692638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369362|NCT02692625|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369363|NCT02692612|||Cohort||Cross-Sectional|||||||
1369364|NCT02692599|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1369365|NCT02692586||Single Group Assignment||Treatment||None (Open Label)||||||
1369366|NCT02692573|Randomized|Parallel Assignment||Prevention||Single||||||t
1369367|NCT02692560|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1369368|NCT02692547||Single Group Assignment||Treatment||None (Open Label)||||||
1369369|NCT02692534|||Cohort||Prospective|||||||
1369370|NCT02692521|||Case-Only||Prospective|||||||
1369371|NCT02692508|||Case-Control||Prospective|||||||
1369372|NCT02692495|||Cohort||Retrospective|||||||
1369373|NCT02692482|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369374|NCT02692469|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369375|NCT02692456|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1369376|NCT02692443|||Cohort||Prospective|||||||
1369377|NCT02692430|||Cohort||Retrospective|||||||
1369378|NCT02692417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369379|NCT02692404|||Cohort||Prospective|||||||
1369380|NCT02692391|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369381|NCT02692378|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369382|NCT02692365|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369383|NCT02692352|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1369384|NCT02692339|||Cohort||Prospective|||||||
1369385|NCT02692326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369386|NCT02692313|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369387|NCT02692300|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369388|NCT02692287||Single Group Assignment||Device Feasibility||None (Open Label)||If the device is not of the correct size, then the device is changed and the recruitment process is repeated until the correct size is obtained.||||
1369389|NCT02692274|||||Cross-Sectional|||||||
1369390|NCT02692261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369391|NCT02692248||Single Group Assignment||Treatment||None (Open Label)||||||
1369392|NCT02692235|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369393|NCT02692222|||||Prospective|||||||
1369394|NCT02692209|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1369395|NCT02692196|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1369396|NCT02692183|||Case-Only||Prospective|||||||
1369397|NCT02692170|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369398|NCT02692157|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1369399|NCT02692144|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1369400|NCT02692131|||Cohort||Prospective|||||||
1369401|NCT02692118|||Case-Only||Prospective|||||||
1369402|NCT02692105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369403|NCT02692092|||Case-Only||Prospective|||||||
1369404|NCT02692079|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369405|NCT02692066|||Case-Control||Prospective|||||||
1369406|NCT02692053|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369407|NCT02692040|Randomized|Single Group Assignment||Treatment||Single|||t|||
1369408|NCT02692027|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369409|NCT02692014|||Case Control||Retrospective|||||||
1369410|NCT02692001|Randomized|Crossover Assignment||Prevention||Single|||t|||
1369411|NCT02691988|Randomized|Parallel Assignment||Treatment||Single||||||t
1369412|NCT02691975||Single Group Assignment||Treatment||None (Open Label)||||||
1369413|NCT02691962||Single Group Assignment||Treatment||None (Open Label)||||||
1369414|NCT02691949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369415|NCT02691936|Randomized|Parallel Assignment||Treatment||Single||||||t
1369416|NCT02691923|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369417|NCT02691910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369418|NCT02691897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369419|NCT02691884|||Cohort||Prospective|||||||
1369420|NCT02691871||Single Group Assignment||Treatment||None (Open Label)||||||
1369421|NCT02691858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369422|NCT02691845|Randomized|Parallel Assignment||Treatment||Single||||||t
1369423|NCT02691832||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369424|NCT02691819|||Case-Only||Prospective|||||||
1369425|NCT02691806||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369426|NCT02691793||Single Group Assignment||Treatment||None (Open Label)||||||
1369427|NCT02691780||Single Group Assignment||Treatment||None (Open Label)||||||
1369428|NCT02691767||Single Group Assignment||Treatment||None (Open Label)||||||
1369429|NCT02691754|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369430|NCT02691741||||||||||||
1369431|NCT02691728||Single Group Assignment||Treatment||None (Open Label)||||||
1369432|NCT02691715|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369433|NCT02691702|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1369434|NCT02691689||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369435|NCT02691676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369436|NCT02691663|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1369437|NCT02691650|||Case-Control||Prospective|||||||
1369438|NCT02691637|||Case-Control||Prospective|||||||
1369439|NCT02691624|||Cohort||Prospective|||||||
1369440|NCT02691611|||Case-Control||Prospective|||||||
1369441|NCT02691598|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369442|NCT02691585|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369443|NCT02691572|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1369444|NCT02691559|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1369445|NCT02691546|||Cohort||Prospective|||||||
1369446|NCT02691533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369447|NCT02691520|||Cohort||Retrospective|||||||
1369448|NCT02691507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369449|NCT02691494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369450|NCT02691481|Randomized|Crossover Assignment||||None (Open Label)||||||
1369451|NCT02691468|Randomized|Parallel Assignment||Prevention||Single|||t|||
1369452|NCT02691455|Randomized|Parallel Assignment||Treatment||Single||||||t
1369453|NCT02691442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369454|NCT02691429|Randomized|Parallel Assignment||Other||Double|||t||t|
1369455|NCT02691416|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1369456|NCT02691403|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1369457|NCT02691390|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369458|NCT02691377|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1369459|NCT02691364|||Case Control||Prospective|||||||
1369460|NCT02691351|||Cohort||Prospective|||||||
1369461|NCT02691338|||Cohort||Prospective|||||||
1369462|NCT02691325|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1369463|NCT02691312|||Case-Only||Cross-Sectional|||||||
1369464|NCT02691299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369465|NCT02691286|||Case Control||Prospective|||||||
1369466|NCT02691273||Single Group Assignment||Treatment||None (Open Label)||||||
1369467|NCT02691260|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1369468|NCT02691247|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1369469|NCT02691234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369470|NCT02691221||Single Group Assignment||Prevention||None (Open Label)||||||
1369471|NCT02691208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369472|NCT02691195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369473|NCT02691182||Single Group Assignment||Treatment||None (Open Label)||||||
1369474|NCT02691169||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369475|NCT02691156|||Cohort||Prospective|||||||
1369476|NCT02691143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369477|NCT02691130|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369478|NCT02691117||Single Group Assignment||Treatment||None (Open Label)||||||
1369479|NCT02691104|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1369480|NCT02691078||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369481|NCT02691065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369482|NCT02691052|||Cohort||Other|||||||
1369483|NCT02691039|||Family-Based||Other|||||||
1369484|NCT02691026||Single Group Assignment||Treatment||None (Open Label)||||||
1369485|NCT02691013|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1369486|NCT02691000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369487|NCT02690987|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1369488|NCT02690974||Single Group Assignment||Supportive Care||None (Open Label)||||||
1369489|NCT02690961|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1369490|NCT02690948|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369491|NCT02690935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369492|NCT02690922||Single Group Assignment||Treatment||None (Open Label)||||||
1369493|NCT02690909||Single Group Assignment||Treatment||None (Open Label)||||||
1369494|NCT02690896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369495|NCT02690883|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369496|NCT02690870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369497|NCT02690857|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1369498|NCT02690844|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369499|NCT02690831|Randomized|Parallel Assignment||Treatment||Single||||||t
1369500|NCT02690818|Randomized|Parallel Assignment||Prevention||Single|||||t|
1369501|NCT02690805|||Case-Only||Prospective|||||||
1369502|NCT02690792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369503|NCT02690779|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1369504|NCT02690766||Single Group Assignment||||None (Open Label)||||||
1369505|NCT02690753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369506|NCT02690740||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369507|NCT02690727|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369508|NCT02690714||Single Group Assignment||Treatment||None (Open Label)||||||
1369509|NCT02690701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369510|NCT02690688|||Cohort||Prospective|||||||
1369511|NCT02690675|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1369512|NCT02690662||Single Group Assignment||Treatment||None (Open Label)||||||
1369513|NCT02690649|Randomized|Parallel Assignment||||None (Open Label)||||||
1369514|NCT02690636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369515|NCT02690623|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369516|NCT02690610||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369517|NCT02690597||Single Group Assignment||Health Services Research||None (Open Label)||||||
1369518|NCT02690584||Single Group Assignment||Treatment||None (Open Label)||||||
1369519|NCT02690571|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1369520|NCT02690558||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1369521|NCT02690545||Single Group Assignment||Treatment||None (Open Label)||||||
1369522|NCT02690532|||Case-Control||Prospective|||||||
1369523|NCT02690519||Single Group Assignment||Treatment||None (Open Label)||||||
1369524|NCT02690506|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1369525|NCT02690493|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369526|NCT02690480|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1369527|NCT02690467|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369528|NCT02690454|||Cohort||Prospective|||||||
1369529|NCT02690441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369530|NCT02690428||Single Group Assignment||Treatment||None (Open Label)||||||
1369531|NCT02690415|||Case-Control||Prospective|||||||
1369532|NCT02690402||Single Group Assignment||Prevention||None (Open Label)||||||
1369533|NCT02690389|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1369534|NCT02690376||Single Group Assignment||Treatment||None (Open Label)||||||
1369535|NCT02690350|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Single arm, three cohorts||||
1369536|NCT02690337||Single Group Assignment||Treatment||None (Open Label)||||||
1369537|NCT02690324|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369538|NCT02690311|Randomized|Crossover Assignment||Screening||Quadruple|||t|t|t|t
1369539|NCT02690298|||Cohort||Prospective|||||||
1369540|NCT02690285|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1369541|NCT02690272||Single Group Assignment||Supportive Care||None (Open Label)||||||
1369542|NCT02690259||Single Group Assignment||Treatment||None (Open Label)||||||
1369543|NCT02690246|||Cohort||Prospective|||||||
1369544|NCT02690233|||Cohort||Prospective|||||||
1369545|NCT02690220||Single Group Assignment||Treatment||None (Open Label)||||||
1369546|NCT02690207||Single Group Assignment||Prevention||None (Open Label)||||||
1369547|NCT02690194|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369548|NCT02690181|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369549|NCT02690168|||Case-Only||Prospective|||||||
1369550|NCT02690155|||Cohort||Retrospective|||||||
1369551|NCT02690142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369552|NCT02690129|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369553|NCT02690116|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1369554|NCT02690103|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1369555|NCT02690090|||Case-Only||Prospective|||||||
1369556|NCT02690077|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1369557|NCT02690064|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1369558|NCT02690051||Single Group Assignment||Treatment||None (Open Label)||||||
1369559|NCT02690038|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1369560|NCT02690025|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1369561|NCT02690012|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369562|NCT02689999||Single Group Assignment||Treatment||None (Open Label)||||||
1369563|NCT02689986||Single Group Assignment||Treatment||None (Open Label)||||||
1369564|NCT02689973|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369565|NCT02689960|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1369566|NCT02689947||Single Group Assignment||Treatment||None (Open Label)||||||
1369567|NCT02689934|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind (subjects, investigators)||t|t|t|t
1369568|NCT02689921||Single Group Assignment||Treatment||None (Open Label)||||||
1369569|NCT02689908||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369570|NCT02689895|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369571|NCT02689882||Single Group Assignment||Other||None (Open Label)||||||
1369572|NCT02689869||Single Group Assignment||Treatment||None (Open Label)||||||
1369573|NCT02689856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369574|NCT02689843|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1369575|NCT02689830||Single Group Assignment||Treatment||None (Open Label)||||||
1369576|NCT02689817||Single Group Assignment||Diagnostic||None (Open Label)|The investigator and outcomes assessors will be masked to the pressure data during the operating room and follow-up.|||||
1369577|NCT02689804|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1369578|NCT02689791|Randomized|Crossover Assignment||||Single|||t|||
1369579|NCT02689778|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369580|NCT02689765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369581|NCT02689752||Single Group Assignment||||None (Open Label)||||||
1369582|NCT02689739|||Case Control||Prospective|||||||
1369583|NCT02689726||Single Group Assignment||Treatment||None (Open Label)||||||
1369584|NCT02689713|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1369585|NCT02689700|||Cohort||Prospective|||||||
1369586|NCT02689687||Single Group Assignment||||None (Open Label)||||||
1369587|NCT02689661|||Cohort||Prospective|||||||
1369588|NCT02689648|||Cohort||Prospective|||||||
1369589|NCT02689635|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369590|NCT02689622||Single Group Assignment||Other||None (Open Label)||||||
1369591|NCT02689609|||Cohort||Prospective|||||||
1369592|NCT02689596||||Basic Science||||||||
1369593|NCT02689583|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369594|NCT02689570|||Cohort||Cross-Sectional|||||||
1369595|NCT02689557||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369596|NCT02689544|Randomized|Parallel Assignment||Prevention||Single||||||t
1369597|NCT02689531|||Cohort||Prospective|||||||
1369598|NCT02689518||Single Group Assignment||Treatment||None (Open Label)||||||
1369599|NCT02689505||Single Group Assignment||Treatment||None (Open Label)||||||
1369600|NCT02689492|||Cohort||Prospective|||||||
1369601|NCT02689479|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1369602|NCT02689466|||Case-Control||Cross-Sectional|||||||
1369603|NCT02689453||Sequential Assignment||Treatment||None (Open Label)||||||
1369604|NCT02689440||Single Group Assignment||Treatment||None (Open Label)||||||
1369605|NCT02689427||Single Group Assignment||Treatment||None (Open Label)||||||
1369606|NCT02689414|Randomized|Parallel Assignment||Prevention||Double|Patient, patient's physician, surgeon, anaesthesiologist and everyone else in the surgical team were blinded to study intervention. Blinding was attained with manometer's scale covered. Second arterial stiffness measurement was carried out by a study member who did not know the patient's group affiliation.||t|t||
1369607|NCT02689401||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369608|NCT02689388|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1369609|NCT02689375||Single Group Assignment||Supportive Care||None (Open Label)||||||
1369610|NCT02689362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369611|NCT02689349||Single Group Assignment||Treatment||None (Open Label)||||||
1369612|NCT02689336||Single Group Assignment||Treatment||None (Open Label)||||||
1369613|NCT02689323||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1369614|NCT02689310|Randomized|Parallel Assignment||Treatment||Single||||t||
1369615|NCT02689297|Randomized|Parallel Assignment||Prevention||Single|||||t|
1369616|NCT02689284|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369617|NCT02689271|||Cohort||Prospective|||||||
1369618|NCT02689258|Randomized|Parallel Assignment||Other||Double|||t|||t
1369619|NCT02689245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369620|NCT02689232|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369621|NCT02689219|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369622|NCT02689206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369623|NCT02689193|||Case-Control||Prospective|||||||
1369624|NCT02689180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369625|NCT02689167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369626|NCT02689154||Single Group Assignment||Treatment||None (Open Label)||||||
1369627|NCT02689141||Single Group Assignment||Treatment||None (Open Label)||||||
1369628|NCT02689128|||Cohort||Prospective|||||||
1369629|NCT02689115|||Case-Only||Cross-Sectional|||||||
1369630|NCT02689102|||Case-Only||Cross-Sectional|||||||
1369631|NCT02689089||Single Group Assignment||Prevention||None (Open Label)||||||
1369632|NCT02689076|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1369633|NCT02689063|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369634|NCT02689050|||Case-Only||Cross-Sectional|||||||
1369635|NCT02689037|Randomized|Parallel Assignment||Treatment||Single||||||t
1369636|NCT02689024|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369637|NCT02689011|Randomized|Parallel Assignment||||None (Open Label)||||||
1369638|NCT02688998|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369639|NCT02688985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369640|NCT02688972|Randomized|Parallel Assignment||Prevention||Single||||||t
1369641|NCT02688959|Randomized|Parallel Assignment||Treatment||Single||||||t
1369642|NCT02688946|||Cohort||Prospective|||||||
1369643|NCT02688933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369644|NCT02688920|||Case-Control||Cross-Sectional|||||||
1369645|NCT02688907||Single Group Assignment||Treatment||None (Open Label)||||||
1369646|NCT02688894|||Other||Prospective|||||||
1369647|NCT02688881||Single Group Assignment||Treatment||None (Open Label)||||||
1369648|NCT02688868||Single Group Assignment||Treatment||None (Open Label)||||||
1369649|NCT02688855|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1369650|NCT02688842||Single Group Assignment||Treatment||None (Open Label)||all patients implanted Firehawk stent of new specification (38mm long)||||
1369651|NCT02688829||Single Group Assignment||Treatment||None (Open Label)||||||
1369652|NCT02688816|||Cohort||Cross-Sectional|||||||
1369653|NCT02688803|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1369654|NCT02688790|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369655|NCT02688777|Randomized|Parallel Assignment||Treatment||Single||||||t
1369656|NCT02688764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369657|NCT02688751|||Other||Prospective|||||||
1369658|NCT02688738||Parallel Assignment||Prevention||||||||
1369659|NCT02688725||Single Group Assignment||Screening||None (Open Label)||||||
1369660|NCT02688712||Single Group Assignment||Treatment||None (Open Label)||||||
1369661|NCT02688699|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1369662|NCT02688686||Single Group Assignment||Treatment||None (Open Label)||||||
1369663|NCT02688673||Single Group Assignment||Treatment||None (Open Label)||||||
1369664|NCT02688660|||Other||Other|||||||
1369665|NCT02688647|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1369666|NCT02688634|||Cohort||Prospective|||||||
1369667|NCT02688621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369668|NCT02688608||Single Group Assignment||Treatment||None (Open Label)||||||
1369669|NCT02688595|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1369670|NCT02688582||Single Group Assignment||Treatment||None (Open Label)||||||
1369671|NCT02688569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369672|NCT02688556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369673|NCT02688543||Single Group Assignment||Treatment||None (Open Label)||||||
1369674|NCT02688530|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1369675|NCT02688517||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369676|NCT02688504|||Cohort||Cross-Sectional|||||||
1369677|NCT02688491|Randomized|Parallel Assignment||||None (Open Label)||||||
1369678|NCT02688478|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1369679|NCT02688465||Single Group Assignment||Treatment||None (Open Label)||||||
1369680|NCT02688452|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1369681|NCT02688439|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369682|NCT02688426|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1369683|NCT02688413|Randomized|Parallel Assignment||Treatment||Single||||||t
1369684|NCT02688400|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1369685|NCT02688387|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369686|NCT02688374|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1369687|NCT02688361|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1369688|NCT02688348||Single Group Assignment||Health Services Research||None (Open Label)||||||
1369689|NCT02688335||Single Group Assignment||Treatment||None (Open Label)||||||
1369690|NCT02688322||Single Group Assignment||Other||None (Open Label)||||||
1369691|NCT02688309|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369692|NCT02688296|||Cohort||Other|||||||
1369693|NCT02688283|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1369694|NCT02688270|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1369695|NCT02688257|||Cohort||Prospective|||||||
1369696|NCT02688244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369697|NCT02688231|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1369698|NCT02688218|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369699|NCT02688205|||Case Control||Cross-Sectional|||||||
1369700|NCT02688192|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369701|NCT02688179|||Cohort||Prospective|||||||
1369702|NCT02688166|||Case-Control||Prospective|||||||
1369703|NCT02688153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369704|NCT02688140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369705|NCT02688127|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1369706|NCT02688114||Single Group Assignment||Basic Science||None (Open Label)||||||
1369707|NCT02688101||Single Group Assignment||Treatment||None (Open Label)||||||
1369708|NCT02688088|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1369709|NCT02688075|||Cohort||Prospective|||||||
1369710|NCT02688062|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1369711|NCT02688049|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1369712|NCT02688036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369713|NCT02688023||Single Group Assignment||Treatment||None (Open Label)||||||
1369714|NCT02688010|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1369715|NCT02687997|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1369716|NCT02687984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369717|NCT02687971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369718|NCT02687958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369719|NCT02687945||||Supportive Care||||||||
1369720|NCT02687932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369721|NCT02687919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369722|NCT02687906||Single Group Assignment||Treatment||None (Open Label)||||||
1369723|NCT02687893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369724|NCT02687880|||Cohort||Prospective|||||||
1369725|NCT02687867|||Cohort||Retrospective|||||||
1369726|NCT02687854|||Cohort||Retrospective|||||||
1369727|NCT02687841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369728|NCT02687828|||Case-Only||Prospective|||||||
1369729|NCT02687815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369730|NCT02687802|||Cohort||Prospective|||||||
1369731|NCT02687789|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1369732|NCT02687776|||Cohort||Prospective|||||||
1369733|NCT02687763||Single Group Assignment||Other||None (Open Label)||||||
1369734|NCT02687750||Single Group Assignment||Basic Science||None (Open Label)||||||
1369735|NCT02687737||Single Group Assignment||Treatment||None (Open Label)||||||
1369736|NCT02687724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369737|NCT02687711|||Cohort||Prospective|||||||
1369738|NCT02687698|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369739|NCT02687685|Randomized|Parallel Assignment||Prevention||Single||||||t
1369740|NCT02687672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369741|NCT02687659||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369742|NCT02687646||Single Group Assignment||Treatment||None (Open Label)||||||
1369743|NCT02687633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369744|NCT02687620|||Cohort||Prospective|||||||
1369745|NCT02687607|||Case-Only||Prospective|||||||
1369746|NCT02687594|||Cohort||Prospective|||||||
1369747|NCT02687581|Randomized|Parallel Assignment||Treatment||Single||||||t
1369748|NCT02687568|||Case Control||Prospective|||||||
1369749|NCT02687555|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1369750|NCT02687542|Randomized|||Treatment||Triple|||t|t|t|
1369751|NCT02687529|||Case-Control||Prospective|||||||
1369752|NCT02687516|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369753|NCT02687503||Single Group Assignment||Prevention||None (Open Label)||||||
1369754|NCT02687490||Single Group Assignment||Treatment||None (Open Label)||||||
1369755|NCT02687477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369756|NCT02687464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369757|NCT02687451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369758|NCT02687438||Single Group Assignment||Treatment||None (Open Label)||||||
1369759|NCT02687425||Single Group Assignment||Treatment||None (Open Label)||||||
1369760|NCT02687412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369761|NCT02687399|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369762|NCT02687386||Single Group Assignment||Treatment||None (Open Label)||||||
1369763|NCT02687373|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369764|NCT02687360|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1369765|NCT02687347|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1369766|NCT02687334|||Cohort||Prospective|||||||
1369767|NCT02687321|||Cohort||Prospective|||||||
1369768|NCT02687308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369769|NCT02687295|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1369770|NCT02687282|||Cohort||Cross-Sectional|||||||
1369771|NCT02687269|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1369772|NCT02687256|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1369773|NCT02687243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369774|NCT02687230|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1369775|NCT02687217|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369776|NCT02687204|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369777|NCT02687191|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369778|NCT02687178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369779|NCT02687165|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1369780|NCT02687152||Single Group Assignment||Basic Science||None (Open Label)||||||
1369781|NCT02687139||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369782|NCT02687126||Single Group Assignment||Supportive Care||None (Open Label)||||||
1369783|NCT02687113||Single Group Assignment||Treatment||None (Open Label)||||||
1369784|NCT02687100|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369785|NCT02687087|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1369786|NCT02687074||Single Group Assignment||Treatment||None (Open Label)||||||
1369787|NCT02687061|||Cohort|||||||||
1369788|NCT02687048|Randomized|Parallel Assignment||Treatment||Single||||||t
1369789|NCT02687035||Single Group Assignment||Treatment||None (Open Label)||||||
1369790|NCT02687022|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1369791|NCT02687009||Single Group Assignment||Other||None (Open Label)||||||
1369792|NCT02686996|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369793|NCT02686983|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1369794|NCT02686970|||||Prospective|||||||
1369795|NCT02686957|||Cohort||Retrospective|||||||
1369796|NCT02686944||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1369797|NCT02686931|||Cohort||Prospective|||||||
1369798|NCT02686918||Single Group Assignment||Supportive Care||None (Open Label)||||||
1369799|NCT02686905|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369800|NCT02686892|||Cohort||Other|||||||
1369801|NCT02686879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369802|NCT02686866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369803|NCT02686853||Single Group Assignment||Treatment||None (Open Label)||||||
1369804|NCT02686840|Randomized|Parallel Assignment||Treatment||Single||||||t
1369805|NCT02686827|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1369806|NCT02686814||Single Group Assignment||Treatment||None (Open Label)||||||
1369807|NCT02686801|||Cohort||Prospective|||||||
1369808|NCT02686788||Single Group Assignment||Treatment||None (Open Label)||||||
1369809|NCT02686775|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1369810|NCT02686762|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1369811|NCT02686749|Randomized|Parallel Assignment||Treatment||None (Open Label)||Study randomizes subjects to already FDA approved treatment modalities. Approved anti-arrhythmic medications or AF ablation. There are no investigational drug or devices used.||||
1369812|NCT02686736|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369813|NCT02686723|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369814|NCT02686710|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369815|NCT02686697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369816|NCT02686684|||Case Control|||||||||
1369817|NCT02686671|||Cohort||Prospective|||||||
1369818|NCT02686658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369819|NCT02686645||Single Group Assignment||Treatment||None (Open Label)||||||
1369820|NCT02686632|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1369821|NCT02686619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369822|NCT02686606|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369823|NCT02686593||Single Group Assignment||Treatment||None (Open Label)||||||
1369824|NCT02686580||Single Group Assignment||Treatment||None (Open Label)||||||
1369825|NCT02686567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369826|NCT02686554|||Cohort||Retrospective|||||||
1369827|NCT02686541||||||||||||
1369828|NCT02686528|Randomized|Parallel Assignment||Treatment||Single||||||t
1369829|NCT02686515|Randomized|Parallel Assignment||Treatment||Single||||||t
1369830|NCT02686502|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369831|NCT02686489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369832|NCT02686476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369833|NCT02686463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369834|NCT02686450||||||||||||
1369835|NCT02686437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369836|NCT02686424|||Cohort||Retrospective|||||||
1369837|NCT02686411|||Cohort||Prospective|||||||
1369838|NCT02686398|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369839|NCT02686385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369840|NCT02686372||Single Group Assignment||Prevention||None (Open Label)||||||
1369841|NCT02686359|Non-Randomized|Parallel Assignment||Diagnostic||Single||||t||
1369842|NCT02686346||Single Group Assignment||Treatment||None (Open Label)||||||
1369843|NCT02686333|Randomized|Parallel Assignment||Treatment||Single||||||t
1369844|NCT02686320|||Case-Control||Cross-Sectional|||||||
1369845|NCT02686307|||||Prospective|||||||
1369846|NCT02686294|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369847|NCT02686281|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1369848|NCT02686268|||Case-Only||Prospective|||||||
1369849|NCT02686255|||Case-Only||Prospective|||||||
1369850|NCT02686242|||Cohort||Retrospective|||||||
1369851|NCT02686229|||Cohort||Prospective|||||||
1369852|NCT02686216||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369853|NCT02686203||Single Group Assignment||Supportive Care||None (Open Label)||||||
1369854|NCT02686190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369855|NCT02686177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369856|NCT02686164||Single Group Assignment||Treatment||None (Open Label)||||||
1369857|NCT02686151|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369858|NCT02686138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369859|NCT02686125|||Cohort||Prospective|||||||
1369860|NCT02686112|||||Retrospective|||||||
1369861|NCT02686099|Randomized|Parallel Assignment||Treatment||Single|participants are blinded to treatment choice until completion of the study.|Comparison of intervention using sternal closure with 360 plating system, to closure of the sternum using wire cerclage|t|||
1369862|NCT02686086|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369863|NCT02686073|||Cohort||Prospective|||||||
1369864|NCT02686060|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369865|NCT02686047|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1369866|NCT02686034|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369867|NCT02686021|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1369868|NCT02686008|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369869|NCT02685995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369870|NCT02685982||Single Group Assignment||Treatment||None (Open Label)||||||
1369871|NCT02685969|||Case-Crossover||Cross-Sectional|||||||
1369872|NCT02685956|||Other||Prospective|||||||
1369873|NCT02685943|Randomized|Parallel Assignment||Treatment||Single||||||t
1369874|NCT02685930|||Case-Control||Prospective|||||||
1369875|NCT02685917|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369876|NCT02685904|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369877|NCT02685891|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1369878|NCT02685878|||Other||Prospective|||||||
1369879|NCT02685865|Randomized|Parallel Assignment||Treatment||Single||||||t
1369880|NCT02685852|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1369881|NCT02685839|Randomized|Parallel Assignment||Treatment||Single|||||t|
1369882|NCT02685826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369883|NCT02685813|||Cohort||Cross-Sectional|||||||
1369884|NCT02685800|||Cohort||Prospective|||||||
1369885|NCT02685787|Randomized|Parallel Assignment||Treatment||Single||||||t
1369886|NCT02685774|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369887|NCT02685761|Randomized|Parallel Assignment||Prevention||Single|||t|||
1369888|NCT02685748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369889|NCT02685735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369890|NCT02685722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369891|NCT02685709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369892|NCT02685696|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369893|NCT02685683||Single Group Assignment||Treatment||None (Open Label)||||||
1369894|NCT02685670||Single Group Assignment||Treatment||None (Open Label)||||||
1369895|NCT02685657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369896|NCT02685644|||Cohort||Prospective|||||||
1369897|NCT02685631|||Cohort||Prospective|||||||
1369898|NCT02685618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369899|NCT02685605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369900|NCT02685592||Single Group Assignment||Treatment||None (Open Label)||||||
1369901|NCT02685579|||Cohort||Prospective|||||||
1369902|NCT02685566|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1369903|NCT02685553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369904|NCT02685540|||||Retrospective|||||||
1369905|NCT02685527|||Cohort||Cross-Sectional|||||||
1369906|NCT02685514||Single Group Assignment||Treatment||None (Open Label)||||||
1369907|NCT02685501|||Cohort||Prospective|||||||
1369908|NCT02685488|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369909|NCT02685475|||Cohort||Prospective|||||||
1369910|NCT02685462|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369911|NCT02685449|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1369912|NCT02685436||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369913|NCT02685423|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369914|NCT02685410||Single Group Assignment||Prevention||None (Open Label)||||||
1369915|NCT02685397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369916|NCT02685384|||Case-Control||Prospective|||||||
1369917|NCT02685371|||Case-Only||Prospective|||||||
1369983|NCT02684513|Randomized|Factorial Assignment||Health Services Research||Triple|||t|t|t|
1369984|NCT02684500|||Case-Only||Prospective|||||||
1369918|NCT02685358|Randomized|Parallel Assignment||Health Services Research||Single|The CAPS-5 will be administered via phone by a central assessor, blind to condition, at baseline and post-treatment and will be the primary measure of change in PTSD symptom severity.|Clinician-Supported PTSD Coach (CS PTSD Coach) consists of four 20-30 minute sessions focused on instructions for using the PTSD Coach app, setting symptom reductions goals, and assigning specific PTSD Coach activities (i.e., assessments, management strategies, psycho-educational readings) for completion between sessions. PC-MHI providers deliver CS PTSD Coach using a treatment manual, which was developed and piloted by the PIs. Session 1 will be face-to-face and sessions 2-4 may be face-to-face or by phone, depending on patient preference. To help participants overcome treatment barriers psycho-education about treatment options are provided and active problems solving is encouraged. Specific next steps for treatment or self-management are developed collaboratively, typically in session 4. After session 4, Participants are encouraged to continue using PTSD Coach and have access to the research version of the app until the 24-week follow-up.||||t
1369919|NCT02685345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369920|NCT02685332||Sequential Assignment||Treatment||None (Open Label)||||||
1369921|NCT02685319||Single Group Assignment||Other||None (Open Label)||||||
1369922|NCT02685306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369923|NCT02685293|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1369924|NCT02685280||Single Group Assignment||Treatment||None (Open Label)||||||
1369925|NCT02685267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369926|NCT02685254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369927|NCT02685241|||Case-Only||Prospective|||||||
1369928|NCT02685228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369929|NCT02685215|||Case-Control||Retrospective|||||||
1369930|NCT02685202||Single Group Assignment||Treatment||None (Open Label)||||||
1369931|NCT02685189|||Cohort||Prospective|||||||
1369932|NCT02685176|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1369933|NCT02685163|Randomized|Crossover Assignment||Treatment||Single|||t|||
1369934|NCT02685150|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369935|NCT02685137|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369936|NCT02685124|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369937|NCT02685111|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369938|NCT02685098|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369939|NCT02685085|Randomized|Parallel Assignment||||None (Open Label)||||||
1369940|NCT02685072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369941|NCT02685059|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369942|NCT02685046||Single Group Assignment||Treatment||None (Open Label)||||||
1369943|NCT02685033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369944|NCT02685020|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1369945|NCT02685007|||Cohort||Prospective|||||||
1369946|NCT02684994||Single Group Assignment||Treatment||None (Open Label)||||||
1369947|NCT02684981|||Cohort||Prospective|||||||
1369948|NCT02684968|Randomized|Parallel Assignment||Treatment||Quadruple||local anesthetic continuous infusion (QL block + IV PCA group) or normal saline continuous infusion (IV PCA group).|t|t|t|t
1369949|NCT02684955|||Cohort||Prospective|||||||
1369950|NCT02684942|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1369951|NCT02684929|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1369952|NCT02684916|Randomized|Parallel Assignment||Treatment||Single|||t|||
1369953|NCT02684903|Randomized|Parallel Assignment||Treatment||Single||||||t
1369954|NCT02684890|||Case Control||Prospective|||||||
1369955|NCT02684877|||Cohort||Prospective|||||||
1369956|NCT02684864|||Cohort||Prospective|||||||
1369957|NCT02684851|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369958|NCT02684838|||Cohort||Prospective|||||||
1369959|NCT02684825|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1369960|NCT02684812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369961|NCT02684799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369962|NCT02684786|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369963|NCT02684773|||Cohort||Prospective|||||||
1369964|NCT02684760|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1369965|NCT02684747|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1369966|NCT02684734|||Other||Cross-Sectional|||||||
1369967|NCT02684721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369968|NCT02684708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369969|NCT02684695|||Cohort||Prospective|||||||
1369970|NCT02684682|Randomized|Parallel Assignment||||Single|||||t|
1369971|NCT02684669|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1369972|NCT02684656|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1369973|NCT02684643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369974|NCT02684630|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1369975|NCT02684617||Single Group Assignment||Treatment||None (Open Label)||||||
1369976|NCT02684604|||Case Control||Cross-Sectional|||||||
1369977|NCT02684591|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1369978|NCT02684578|Randomized|Parallel Assignment||Treatment||Single||||||t
1369979|NCT02684565|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369980|NCT02684552|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1369981|NCT02684539||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369982|NCT02684526|Non-Randomized|Single Group Assignment||Basic Science||Single||||||t
1370820|NCT02673606||||||||||||
1369985|NCT02684487|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369986|NCT02684474||||||||||||
1369987|NCT02684461|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1369988|NCT02684448|||Cohort||Retrospective|||||||
1369989|NCT02684435||Single Group Assignment||Diagnostic||None (Open Label)||||||
1369990|NCT02684422|||Cohort||Prospective|||||||
1369991|NCT02684409||Single Group Assignment||Treatment||None (Open Label)||||||
1369992|NCT02684396|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1369993|NCT02684383|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1369994|NCT02684370|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1369995|NCT02684357|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1369996|NCT02684344|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1369997|NCT02684331|||Cohort||Cross-Sectional|||||||
1369998|NCT02684318|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1369999|NCT02684305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370000|NCT02684292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370001|NCT02684279||Single Group Assignment||Treatment||None (Open Label)|open-label|||||
1370002|NCT02684266||Single Group Assignment||Treatment||None (Open Label)||||||
1370003|NCT02684253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370004|NCT02684240|Randomized|Parallel Assignment||Treatment||Single||||||t
1370005|NCT02684227|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370006|NCT02684214|Randomized|Parallel Assignment||Treatment||Single||||||t
1370007|NCT02684201||Single Group Assignment||Treatment||None (Open Label)||||||
1370008|NCT02684188|Non-Randomized|Parallel Assignment||Supportive Care||Single||Patients were recruited from those admitted from one of four rural counties. In the initial phase, all patients enrolled from any county were assigned to a baseline condition. After enrollment stabilized, patients from one county were enrolled in the intervention while patients from the other three counties remained in baseline. Subsequently the intervention was introduced to the other counties sequentially while others remained in baseline. A return to baseline conditions followed a period after the intervention had been introduced in all counties.|t|||
1370009|NCT02684175|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1370010|NCT02684162|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370011|NCT02684149|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1370012|NCT02684136|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1370013|NCT02684123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370014|NCT02684110||||||||||||
1370015|NCT02684097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370016|NCT02684084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370017|NCT02684071||Single Group Assignment||Treatment||None (Open Label)||||||
1370018|NCT02684058|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370019|NCT02684045|||Cohort||Retrospective|||||||
1370020|NCT02684032|Non-Randomized|||Treatment||None (Open Label)||||||
1370021|NCT02684019|Randomized|Parallel Assignment||||Triple|||t|t||t
1370022|NCT02684006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370023|NCT02683993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370024|NCT02683980||Single Group Assignment||Treatment||None (Open Label)||||||
1370025|NCT02683967|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1370026|NCT02683954|||Case Control||Cross-Sectional|||||||
1370027|NCT02683941|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370028|NCT02683928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370029|NCT02683915|||Case-Control||Prospective|||||||
1370030|NCT02683902|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370031|NCT02683889||Single Group Assignment||Prevention||None (Open Label)||||||
1370032|NCT02683876|||Case-Control||Prospective|||||||
1370033|NCT02683863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370034|NCT02683850||Single Group Assignment||Supportive Care||None (Open Label)||||||
1370035|NCT02683837|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370036|NCT02683824|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1370037|NCT02683811|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370038|NCT02683798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370039|NCT02683785|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370040|NCT02683772|Randomized|Crossover Assignment||Treatment||Single|Patients were masked to the mode of treatment. The Core Lab was masked to the mode of treatment for all patients.||t|||
1370041|NCT02683759|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370042|NCT02683746|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370043|NCT02683733|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370044|NCT02683720|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1370045|NCT02683707|Randomized|Parallel Assignment||Treatment||Single||||||t
1370046|NCT02683694||Single Group Assignment||Treatment||None (Open Label)||||||
1370047|NCT02683681|||Cohort||Prospective|||||||
1370048|NCT02683668|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370049|NCT02683655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370050|NCT02683642|||Other||Prospective|||||||
1370051|NCT02683629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370052|NCT02683616|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370053|NCT02683603|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370054|NCT02683590||Single Group Assignment||Other||None (Open Label)||||||
1370055|NCT02683577||Single Group Assignment||Basic Science||None (Open Label)||||||
1370056|NCT02683564|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370057|NCT02683551|||Case Control||Cross-Sectional|||||||
1370058|NCT02683538||Single Group Assignment||Treatment||None (Open Label)||||||
1370059|NCT02683525||Single Group Assignment||Treatment||None (Open Label)||||||
1370060|NCT02683512|||Cohort||Other|||||||
1370061|NCT02683499|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1370062|NCT02683486|Randomized|Crossover Assignment||Treatment||Single|||t|||
1370063|NCT02683473|||Cohort||Cross-Sectional|||||||
1370064|NCT02683460|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370065|NCT02683447|||Cohort||Prospective|||||||
1370066|NCT02683434|Randomized|Parallel Assignment||Prevention||Single|||||t|
1370067|NCT02683421|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1370068|NCT02683408|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1370069|NCT02683395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370070|NCT02683382|Randomized|Parallel Assignment||Treatment||Single||||||t
1370071|NCT02683369||Single Group Assignment||Treatment||None (Open Label)||||||
1370072|NCT02683356|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1370073|NCT02683343|||Case-Control||Cross-Sectional|||||||
1370074|NCT02683330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370075|NCT02683317|Randomized|Parallel Assignment||Prevention||Triple||Regarding the Study phase, the intervention was a nutraceutical, docosahexaenoic acid, derived from omega 3 fatty acid family.|t|t||t
1370076|NCT02683304||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370077|NCT02683291|Randomized|Parallel Assignment||Treatment||Single||||||t
1370078|NCT02683278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370079|NCT02683265|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1370080|NCT02683252|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1370081|NCT02683239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370082|NCT02683226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370083|NCT02683213|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370084|NCT02683200||Single Group Assignment||Treatment||None (Open Label)||||||
1370085|NCT02683187|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1370086|NCT02683174||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370087|NCT02683161||Single Group Assignment||Treatment||None (Open Label)||||||
1370088|NCT02683148|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370089|NCT02683135|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1370090|NCT02683122|||Cohort||Prospective|||||||
1370091|NCT02683109|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370092|NCT02683096|||Other||Prospective|||||||
1370093|NCT02683083||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370094|NCT02683070|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1370095|NCT02683057|||Cohort||Prospective|||||||
1370096|NCT02683044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370097|NCT02683031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370098|NCT02683018|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1370099|NCT02683005||Single Group Assignment||Treatment||None (Open Label)||||||
1370100|NCT02682992||Single Group Assignment||Prevention||None (Open Label)||||||
1370101|NCT02682979|||Other||Retrospective|||||||
1370102|NCT02682966|||Cohort||Prospective|||||||
1370103|NCT02682953||Single Group Assignment||Treatment||None (Open Label)||||||
1370104|NCT02682940||Single Group Assignment||Treatment||None (Open Label)||||||
1370105|NCT02682927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370106|NCT02682914|||Cohort||Prospective|||||||
1370107|NCT02682901|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370108|NCT02682888|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1370109|NCT02682875|||Case-Only||Prospective|||||||
1370110|NCT02682862|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370111|NCT02682849|||Case Control|||||||||
1370112|NCT02682836||Single Group Assignment||Supportive Care||None (Open Label)||||||
1370113|NCT02682823|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1370114|NCT02682810|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1370115|NCT02682797|||Cohort||Prospective|||||||
1370116|NCT02682784|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1370117|NCT02682771|Randomized|Factorial Assignment||Treatment||Triple||||t|t|t
1370118|NCT02682758|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370119|NCT02682745|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370120|NCT02682732||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370121|NCT02682719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370122|NCT02682706|||Cohort||Prospective|||||||
1370123|NCT02682693|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1370124|NCT02682680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370125|NCT02682667|||Cohort||Prospective|||||||
1370126|NCT02682654||Single Group Assignment||Supportive Care||Single|||t|||
1370127|NCT02682641||Single Group Assignment||Treatment||None (Open Label)||||||
1370128|NCT02682628||Single Group Assignment||Treatment||None (Open Label)||||||
1370129|NCT02682615|||Other||Prospective|||||||
1370130|NCT02682602|||Cohort||Cross-Sectional|||||||
1370131|NCT02682589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370132|NCT02682576||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370133|NCT02682563|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1370134|NCT02682550|||Cohort||Prospective|||||||
1370135|NCT02682537|||Other||Prospective|||||||
1370136|NCT02682524|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370137|NCT02682511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370138|NCT02682498|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1370139|NCT02682485|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1370140|NCT02682472||Single Group Assignment||Supportive Care||None (Open Label)||||||
1370141|NCT02682459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370142|NCT02682446|||Cohort||Prospective|||||||
1370143|NCT02682433|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1370144|NCT02682420||Single Group Assignment||Treatment||None (Open Label)||||||
1370145|NCT02682407|Randomized|Parallel Assignment||Treatment||Quadruple||Cohort 2 and 3 will be randomized in a 1:1 fashion during the first 12 weeks of treatment.|t|t|t|t
1370146|NCT02682394|||Cohort||Prospective|||||||
1370147|NCT02682381|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1370148|NCT02682368|||Cohort||Prospective|||||||
1370149|NCT02682355|||Cohort||Prospective|||||||
1370150|NCT02682342|||Case-Only||Prospective|||||||
1370151|NCT02682329|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370152|NCT02682316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370153|NCT02682303|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370154|NCT02682290||Single Group Assignment||Other||None (Open Label)||||||
1370155|NCT02682277|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370156|NCT02682264||Single Group Assignment||Treatment||None (Open Label)||||||
1370157|NCT02682251||Single Group Assignment||||None (Open Label)||||||
1370158|NCT02682238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370159|NCT02682225|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1370160|NCT02682212|Randomized|Parallel Assignment||Treatment||Single||||||t
1370161|NCT02682199|||Cohort||Prospective|||||||
1370162|NCT02682186|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1370163|NCT02682173|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1370164|NCT02682160||Single Group Assignment||Supportive Care||None (Open Label)||||||
1370165|NCT02682147|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1370166|NCT02682134|Non-Randomized|Single Group Assignment||Prevention||Single|||t|||
1370167|NCT02682121|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1370168|NCT02682108||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370169|NCT02682095|||Cohort||Cross-Sectional|||||||
1370170|NCT02682082|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1370171|NCT02682069||Single Group Assignment||Screening||Single||||||t
1370172|NCT02682056||Single Group Assignment||Supportive Care||None (Open Label)||||||
1370173|NCT02682043||Single Group Assignment||||None (Open Label)||||||
1370174|NCT02682030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370175|NCT02682017|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1370176|NCT02682004|||Case Control||Prospective|||||||
1370177|NCT02681991||Single Group Assignment||Treatment||None (Open Label)||||||
1370178|NCT02681978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370179|NCT02681965|Randomized|Parallel Assignment||Treatment||Single||||||t
1370180|NCT02681952|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1370181|NCT02681939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370182|NCT02681926|||Cohort||Prospective|||||||
1370183|NCT02681913|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1370184|NCT02681900|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1370185|NCT02681887|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1370186|NCT02681874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370187|NCT02681861|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1370188|NCT02681848|||Cohort||Prospective|||||||
1370189|NCT02681835|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370190|NCT02681822|||Ecologic or Community||Cross-Sectional|||||||
1370191|NCT02681809|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370192|NCT02681796|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1370193|NCT02681783|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370194|NCT02681770|||Case-Only||Cross-Sectional|||||||
1370195|NCT02681757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370196|NCT02681744|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1370197|NCT02681731|||Cohort||Retrospective|||||||
1370198|NCT02681718|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370199|NCT02681705||Single Group Assignment||Treatment||None (Open Label)||||||
1370200|NCT02681692|Randomized|Parallel Assignment||Screening||Single|||t|||
1370201|NCT02681679|Randomized|Parallel Assignment||Treatment||Single||||||t
1370202|NCT02681666|Randomized|Parallel Assignment||Treatment||Single|||||t|
1370203|NCT02681653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370204|NCT02681640||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370205|NCT02681627|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1370206|NCT02681614||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370207|NCT02681601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370208|NCT02681588|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1370209|NCT02681575||Single Group Assignment||Treatment||None (Open Label)||||||
1370210|NCT02681562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370211|NCT02681549||Single Group Assignment||Treatment||None (Open Label)||||||
1370212|NCT02681536|Randomized|Parallel Assignment||||None (Open Label)||||||
1370213|NCT02681523||Single Group Assignment||Treatment||None (Open Label)||||||
1370214|NCT02681510||Single Group Assignment||Treatment||None (Open Label)||||||
1370215|NCT02681497|||Cohort||Retrospective|||||||
1370216|NCT02681484|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1370217|NCT02681471|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370218|NCT02681458|||Case Control||Prospective|||||||
1370219|NCT02681445|||Cohort||Prospective|||||||
1370220|NCT02681432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370221|NCT02681419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370222|NCT02681406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370223|NCT02681393|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1370224|NCT02681380|Randomized|Parallel Assignment||||Single||||||t
1370225|NCT02681367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370226|NCT02681354|Randomized|Parallel Assignment||||Single|||||t|
1370227|NCT02681341|||Case-Only||Prospective|||||||
1370228|NCT02681328|||Cohort||Prospective|||||||
1370229|NCT02681315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370230|NCT02681302||Single Group Assignment||Treatment||None (Open Label)||||||
1370231|NCT02681289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370232|NCT02681276|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370233|NCT02681263||Single Group Assignment||Treatment||None (Open Label)||||||
1370234|NCT02681250|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370235|NCT02681237||Single Group Assignment||Treatment||None (Open Label)||||||
1370236|NCT02681224|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370237|NCT02681211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370238|NCT02681198||Single Group Assignment||Treatment||None (Open Label)||||||
1370239|NCT02681185|Randomized|Parallel Assignment||Treatment||None (Open Label)||Experimental vs. Standard of Care||||
1370240|NCT02681172||Single Group Assignment||Health Services Research||None (Open Label)||||||
1370241|NCT02681159|||Cohort||Prospective|||||||
1370242|NCT02681146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370243|NCT02681133|||||Cross-Sectional|||||||
1370244|NCT02681120|||Case-Control||Prospective|||||||
1370245|NCT02681107||Single Group Assignment||Treatment||None (Open Label)||Phase 2 - Irradiation||||
1370246|NCT02681094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370247|NCT02681081|Randomized|Parallel Assignment||Basic Science||Single||||||t
1370248|NCT02681068|||Case-Only||Retrospective|||||||
1370249|NCT02681055||Single Group Assignment||Treatment||None (Open Label)||||||
1370250|NCT02681042||Single Group Assignment||Prevention||None (Open Label)||||||
1370251|NCT02681029|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370252|NCT02681016|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370253|NCT02680990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370254|NCT02680977|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1370255|NCT02680964||||||||||||
1370256|NCT02680951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370257|NCT02680938|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1370258|NCT02680925|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1370259|NCT02680912|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370260|NCT02680899||Single Group Assignment||Other||None (Open Label)||||||
1370261|NCT02680886|||Cohort||Prospective|||||||
1370262|NCT02680873||Single Group Assignment||Treatment||None (Open Label)||||||
1370263|NCT02680860||||||||||||
1370264|NCT02680847||||Treatment||None (Open Label)||||||
1370265|NCT02680834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370266|NCT02680821|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1370267|NCT02680808||Single Group Assignment||Treatment||None (Open Label)||||||
1370268|NCT02680795|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370269|NCT02680782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370270|NCT02680769|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370271|NCT02680756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370272|NCT02680743||Single Group Assignment||Screening||None (Open Label)||||||
1370273|NCT02680730|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1370274|NCT02680717|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370275|NCT02680704||Single Group Assignment||Other||None (Open Label)||||||
1370276|NCT02680691|Randomized|Parallel Assignment||Treatment||Single||||||t
1370277|NCT02680678|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1370278|NCT02680665|||Cohort||Prospective|||||||
1370279|NCT02680652|||Case Control||Prospective|||||||
1370280|NCT02680639|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1370281|NCT02680626|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370282|NCT02680613|Randomized|Parallel Assignment||Screening||Double|The participants were not aware of which group they were randomized to. The care provider providing the screening service was not aware of the group of the participant.||t|t||
1370283|NCT02680600||Single Group Assignment||Treatment||None (Open Label)||||||
1370284|NCT02680587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370285|NCT02680574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370286|NCT02680561|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1370287|NCT02680548|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370288|NCT02680535||Single Group Assignment||Treatment||None (Open Label)||||||
1370289|NCT02680522|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1370290|NCT02680509||Single Group Assignment||Treatment||None (Open Label)||||||
1370291|NCT02680496|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1370292|NCT02680483|||Case-Only||Prospective|||||||
1370293|NCT02680470||Single Group Assignment||Health Services Research||None (Open Label)||||||
1370294|NCT02680457|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1370295|NCT02680444|Randomized|Parallel Assignment||||Single|||t|||
1370296|NCT02680431|||Case Control||Prospective|||||||
1370297|NCT02680418|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1370298|NCT02680405|||Cohort||Prospective|||||||
1370299|NCT02680392|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1370300|NCT02680379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370301|NCT02680366|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370302|NCT02680353|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370303|NCT02680340|||Cohort||Retrospective|||||||
1370304|NCT02680327|||Cohort||Prospective|||||||
1370305|NCT02680314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370306|NCT02680301|Randomized|Parallel Assignment||Treatment||Single|||||t|
1370307|NCT02680288|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1370308|NCT02680275||Single Group Assignment||Treatment||None (Open Label)||||||
1370309|NCT02680262|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370310|NCT02680249|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1370311|NCT02680236|||Case-Control||Prospective|||||||
1370312|NCT02680223|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1370313|NCT02680210||Single Group Assignment||Treatment||None (Open Label)||||||
1370314|NCT02680197|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1370315|NCT02680184|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1370316|NCT02680171|Randomized|Parallel Assignment||Treatment||Single||||||t
1370317|NCT02680158|Randomized|Crossover Assignment||Supportive Care||Single||Three way cross-over study with 6 sequences.|||t|
1370318|NCT02680145||Single Group Assignment||Treatment||None (Open Label)||||||
1370319|NCT02680132|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370320|NCT02680119|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370321|NCT02680106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370322|NCT02680093|||Cohort||Prospective|||||||
1370323|NCT02680080|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1370324|NCT02680067|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Healthy individuals and subjects that have rheumatoid arthritis may participate in the developmental arm. Healthy individuals may participate in the clearance arm. There will be no randomization.||||
1370325|NCT02680054|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370326|NCT02680041||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370327|NCT02680028|Randomized|Parallel Assignment||Treatment||Single||||||t
1370328|NCT02680015|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370329|NCT02680002|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1370330|NCT02679989|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370331|NCT02679976||Single Group Assignment||Treatment||None (Open Label)||||||
1370332|NCT02679963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370333|NCT02679950|||Case-Only||Prospective|||||||
1370334|NCT02679937|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370335|NCT02679924|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370336|NCT02679911|Randomized|Parallel Assignment||Treatment||Single||Intra-individual study|||t|
1370337|NCT02679898|Randomized|Parallel Assignment||Basic Science||Single||||||t
1370338|NCT02679885|||Cohort||Cross-Sectional|||||||
1370339|NCT02679872||||||||||||
1370340|NCT02679859|Randomized|Single Group Assignment||Prevention||Single||||||t
1370341|NCT02679846|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370342|NCT02679833|Randomized|Parallel Assignment||Prevention||Single|||t|||
1370343|NCT02679820|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370344|NCT02679807|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1370345|NCT02679794|Randomized|Crossover Assignment||Other||Single|||||t|
1370346|NCT02679781|Randomized|Crossover Assignment||Treatment||Single||||||t
1370347|NCT02679768|Randomized|Parallel Assignment||Treatment||Single||||||t
1370348|NCT02679755|Non-Randomized|||Treatment||None (Open Label)||||||
1370349|NCT02679742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370350|NCT02679729|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1370351|NCT02679716||Single Group Assignment||Screening||None (Open Label)||||||
1370352|NCT02679703|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370353|NCT02679690||Single Group Assignment||Prevention||None (Open Label)||||||
1370354|NCT02679677|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370355|NCT02679664|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370356|NCT02679651|||Cohort||Prospective|||||||
1370357|NCT02679638|||Case-Only||Cross-Sectional|||||||
1370358|NCT02679625|||||Cross-Sectional|||||||
1370359|NCT02679599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370360|NCT02679586||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370361|NCT02679573|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370362|NCT02679560|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370363|NCT02679547|||Case Control||Cross-Sectional|||||||
1370364|NCT02679534|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370365|NCT02679521|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370366|NCT02679508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370367|NCT02679495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370368|NCT02679482|||Case Control||Prospective|||||||
1370369|NCT02679469||Single Group Assignment||Treatment||None (Open Label)||||||
1370370|NCT02679456|Randomized|Parallel Assignment||Treatment||Single|||||t|
1370371|NCT02679443|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370372|NCT02679430||Single Group Assignment||Treatment||None (Open Label)||||||
1370373|NCT02679417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370374|NCT02679404|||Cohort||Prospective|||||||
1370375|NCT02679391|||Cohort||Retrospective|||||||
1370376|NCT02679378|||Cohort||Prospective|||||||
1370377|NCT02679365|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1370378|NCT02679352||Single Group Assignment||Treatment||None (Open Label)||||||
1370379|NCT02679339|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370380|NCT02679326|Randomized|Single Group Assignment||Treatment||Double||Double blinded RCT|t|||t
1370381|NCT02679313||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370382|NCT02679300|Randomized|Parallel Assignment||||None (Open Label)||||||
1370383|NCT02679287|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370384|NCT02679274|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1370385|NCT02679261|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370386|NCT02679248|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1370387|NCT02679235||Single Group Assignment||Treatment||None (Open Label)||The participant will receive THN treatment.||||
1370388|NCT02679222||Single Group Assignment||Basic Science||None (Open Label)||||||
1370389|NCT02679209|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1370390|NCT02679196||Single Group Assignment||Treatment||None (Open Label)||||||
1370391|NCT02679183|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1370392|NCT02679170|||Cohort||Other|||||||
1370393|NCT02679157|||Cohort||Prospective|||||||
1370394|NCT02679144||Single Group Assignment||Prevention||None (Open Label)||||||
1370395|NCT02679131|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370396|NCT02679118||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1370397|NCT02679105|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370398|NCT02679092|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370399|NCT02679079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370400|NCT02679066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370401|NCT02679053|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370402|NCT02679040||Single Group Assignment||Treatment||None (Open Label)||||||
1370403|NCT02679027|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1370404|NCT02679014|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370405|NCT02679001|||Other||Cross-Sectional|||||||
1370406|NCT02678988|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370407|NCT02678975|Randomized|Parallel Assignment||Treatment||Single||||||t
1370408|NCT02678962|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1370409|NCT02678949|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1370410|NCT02678936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370411|NCT02678923|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370412|NCT02678910||Single Group Assignment||Other||None (Open Label)||||||
1370413|NCT02678897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370414|NCT02678884||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370415|NCT02678871||Single Group Assignment||Treatment||None (Open Label)||||||
1370416|NCT02678858|Randomized|Parallel Assignment||Treatment||Single||||||t
1370417|NCT02678845|Randomized|Parallel Assignment||Treatment||Single|||||t|
1370418|NCT02678832|||||Cross-Sectional|||||||
1370419|NCT02678819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370420|NCT02678806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370421|NCT02678793||Single Group Assignment||Treatment||None (Open Label)||||||
1370422|NCT02678780|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370423|NCT02678767|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1370424|NCT02678754||||||||||||
1370425|NCT02678741|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370426|NCT02678728|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1370427|NCT02678715|Randomized|Single Group Assignment||Prevention||Single||||||t
1370428|NCT02678702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370429|NCT02678689||Single Group Assignment||Treatment||None (Open Label)||||||
1370430|NCT02678676|||Cohort||Prospective|||||||
1370431|NCT02678663|Randomized|Parallel Assignment||Treatment||Single||||||t
1370432|NCT02678650|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1370433|NCT02678637|||Case-Only||Cross-Sectional|||||||
1370434|NCT02678624|Randomized|Parallel Assignment||Treatment||Single|||||t|
1370435|NCT02678611|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1370436|NCT02678598|||Cohort||Retrospective|||||||
1370437|NCT02678585|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1370438|NCT02678572||Single Group Assignment||Treatment||None (Open Label)||This is a multi-center, single-arm, open-label study to evaluate the efficacy and safety of Melphalan/HDS in patients with hepatic dominant metastatic ocular melanoma. The study will be conducted at approximately 40 centers in the United States and Europe.||||
1370439|NCT02678559|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1370440|NCT02678546|||||Cross-Sectional|||||||
1370441|NCT02678533||Single Group Assignment||Treatment||None (Open Label)||||||
1370442|NCT02678520|Randomized|Parallel Assignment||||None (Open Label)||||||
1370443|NCT02678507|||Case-Only||Prospective|||||||
1370444|NCT02678494||Single Group Assignment||Treatment||None (Open Label)||||||
1370445|NCT02678481|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1370446|NCT02678468|||Case-Control||Cross-Sectional|||||||
1370447|NCT02678455|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1370448|NCT02678442|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1370449|NCT02678429|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1370450|NCT02678416|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1370451|NCT02678403|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370452|NCT02678390|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1370453|NCT02678377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370454|NCT02678364|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1370455|NCT02678351||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370456|NCT02678338||Single Group Assignment||Treatment||None (Open Label)||||||
1370457|NCT02678325|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1370458|NCT02678312|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370459|NCT02678299||Single Group Assignment||Treatment||None (Open Label)||||||
1370460|NCT02678286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370461|NCT02678273|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1370462|NCT02678260|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370463|NCT02678247|Randomized|Crossover Assignment||Treatment||Single||||||t
1370464|NCT02678234|Randomized|Parallel Assignment||Treatment||None (Open Label)|This was an open label study.|||||
1370465|NCT02678221|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370466|NCT02678208|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1370467|NCT02678195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370468|NCT02678182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370469|NCT02678169|||Cohort||Prospective|||||||
1370470|NCT02678156|||Cohort||Prospective|||||||
1370471|NCT02678143||Single Group Assignment||Treatment||None (Open Label)||||||
1370472|NCT02678130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370473|NCT02678117|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1370474|NCT02678104|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370475|NCT02678091||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370476|NCT02678078|||Cohort||Prospective|||||||
1370477|NCT02678065||Single Group Assignment||Treatment||None (Open Label)||||||
1370478|NCT02678052|||Cohort||Prospective|||||||
1370479|NCT02678039|Randomized|Parallel Assignment||Treatment||Single||||t||
1370480|NCT02678026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370481|NCT02678013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370482|NCT02678000|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370483|NCT02677987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370484|NCT02677974|||Cohort||Prospective|||||||
1370485|NCT02677961|||Cohort||Prospective|||||||
1370486|NCT02677948||Single Group Assignment||Treatment||None (Open Label)||||||
1370487|NCT02677935||Single Group Assignment||Treatment||None (Open Label)||||||
1370488|NCT02677922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370489|NCT02677909|||Cohort||Prospective|||||||
1370490|NCT02677896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370491|NCT02677883|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1370492|NCT02677870|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1370493|NCT02677857|Randomized|Parallel Assignment||Treatment||Double|Blinded||||t|t
1370494|NCT02677844|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1370495|NCT02677831|||Cohort||Prospective|||||||
1370496|NCT02677818|||Cohort||Prospective|||||||
1370497|NCT02677805|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370498|NCT02677792||Single Group Assignment||Treatment||None (Open Label)||||||
1370499|NCT02677779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370500|NCT02677766|Randomized|Parallel Assignment||Treatment||Single||||||t
1370501|NCT02677753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370502|NCT02677740|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1370503|NCT02677727|||Cohort||Prospective|||||||
1370504|NCT02677714||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370505|NCT02677701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370506|NCT02677688||Single Group Assignment||Treatment||None (Open Label)||||||
1370507|NCT02677675|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1370508|NCT02677662|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1370509|NCT02677649|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1370510|NCT02677636|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370511|NCT02677623|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1370512|NCT02677610|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370513|NCT02677597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370514|NCT02677584|Randomized|Parallel Assignment||Treatment||Single|||||t|
1370515|NCT02677571|Randomized|Parallel Assignment||Treatment||Single||||||t
1370516|NCT02677558|||Case Control|||||||||
1370517|NCT02677545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370518|NCT02677532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370519|NCT02677519|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370520|NCT02677506|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370521|NCT02677493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370522|NCT02677480|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1370523|NCT02677467|||Cohort||Prospective|||||||
1370524|NCT02677454||Single Group Assignment||Treatment||None (Open Label)||||||
1370525|NCT02677441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370526|NCT02677428|Randomized|Parallel Assignment||Treatment||Single||||||t
1370527|NCT02677415|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1370528|NCT02677402|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1370529|NCT02677389|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1370530|NCT02677376|||Case-Only||Prospective|||||||
1370531|NCT02677363||Single Group Assignment||Health Services Research||None (Open Label)||||||
1370532|NCT02677350||Single Group Assignment||Treatment||None (Open Label)||||||
1370533|NCT02677337|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370534|NCT02677324||Single Group Assignment||Treatment||None (Open Label)||||||
1370535|NCT02677311|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1370536|NCT02677298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370537|NCT02677285|||Case-Only||Other|||||||
1370538|NCT02677272|||Case-Only||Retrospective|||||||
1370539|NCT02677259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370540|NCT02677246||Single Group Assignment||Prevention||None (Open Label)||||||
1370541|NCT02677233|||Case Control||Retrospective|||||||
1370542|NCT02677220||Single Group Assignment||Treatment||None (Open Label)||||||
1370543|NCT02677207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370544|NCT02677194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370545|NCT02677181|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370546|NCT02677168||Single Group Assignment||Treatment||None (Open Label)||||||
1370547|NCT02677155||Single Group Assignment||Treatment||None (Open Label)||||||
1370548|NCT02677142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370549|NCT02677129|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1370550|NCT02677116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370551|NCT02677103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370552|NCT02677090|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1370553|NCT02677077|||Cohort||Retrospective|||||||
1370554|NCT02677064|||Cohort||Prospective|||||||
1370555|NCT02677051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370556|NCT02677038||Single Group Assignment||Treatment||None (Open Label)||||||
1370557|NCT02677025|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370558|NCT02677012||||||||||||
1370559|NCT02676999|||Case-Only|||||||||
1370560|NCT02676986|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1370561|NCT02676973|Randomized|Factorial Assignment||Treatment||Single||||||t
1370562|NCT02676960|||Case-Control||Prospective|||||||
1370563|NCT02676947||Single Group Assignment||Treatment||None (Open Label)||||||
1370564|NCT02676934|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1370565|NCT02676921||||||||||||
1370566|NCT02676908|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1370567|NCT02676895|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1370568|NCT02676882||Single Group Assignment||Prevention||None (Open Label)||||||
1370569|NCT02676869||Sequential Assignment||Treatment||None (Open Label)||Study is an open label, dose finding study consisting of 2 parts. In part A, the dose is escalated following the protocol-defined safety observation period of the previous cohort. Patients will receive 9 cycles Pembrolizumab in combination with IMP321. In part B, the dose was defined based on the dose escalation. The treatment duration will be expanded to 19 cycles in the combined treatment.||||
1370570|NCT02676856|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370571|NCT02676843||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370572|NCT02676830||Single Group Assignment||Basic Science||None (Open Label)||||||
1370573|NCT02676817|||Case Control||Prospective|||||||
1370574|NCT02676804||Single Group Assignment||Supportive Care||None (Open Label)||||||
1370575|NCT02676791|Randomized|Parallel Assignment||Prevention||Single|||t|||
1370576|NCT02676778||Single Group Assignment||Treatment||None (Open Label)||||||
1370577|NCT02676765|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1370578|NCT02676752|||Case-Only||Cross-Sectional|||||||
1370579|NCT02676739|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1370580|NCT02676726|Randomized|Parallel Assignment||Treatment||Single||||||t
1370581|NCT02676713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370582|NCT02676700|Randomized|Parallel Assignment||Treatment||Single|||||t|
1370583|NCT02676687|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1370584|NCT02676674||Single Group Assignment||Treatment||None (Open Label)||||||
1370585|NCT02676661|||Cohort||Prospective|||||||
1370586|NCT02676648|Randomized|Factorial Assignment||Treatment||Single||||||t
1370587|NCT02676635|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370588|NCT02676622||Single Group Assignment||Treatment||None (Open Label)||||||
1370589|NCT02676609|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1370590|NCT02676596|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1370591|NCT02676583|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1370592|NCT02676570|||Case-Only||Retrospective|||||||
1370593|NCT02676557|||Cohort||Prospective|||||||
1370594|NCT02676544||Single Group Assignment||Treatment||None (Open Label)||||||
1370595|NCT02676531|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370596|NCT02676518|||Case-Only||Cross-Sectional|||||||
1370597|NCT02676505|||Case Control||Prospective|||||||
1370598|NCT02676492|||Case-Control||Cross-Sectional|||||||
1370599|NCT02676479||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370600|NCT02676466|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1370601|NCT02676453|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1370602|NCT02676440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370603|NCT02676427|||Cohort||Prospective|||||||
1370604|NCT02676414|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370605|NCT02676401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370606|NCT02676388|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370607|NCT02676375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370608|NCT02676362|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1370609|NCT02676349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370610|NCT02676336|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1370611|NCT02676323||Single Group Assignment||Treatment||None (Open Label)||||||
1370612|NCT02676310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370613|NCT02676297|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1370614|NCT02676284||Single Group Assignment||Treatment||None (Open Label)||||||
1370615|NCT02676271|||Cohort||Retrospective|||||||
1370616|NCT02676258|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1370617|NCT02676245|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1370618|NCT02676232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370619|NCT02676219|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1370620|NCT02676206|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1370621|NCT02676193|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1370622|NCT02676180|||Case-Crossover||Cross-Sectional|||||||
1370623|NCT02676167||Single Group Assignment||Health Services Research||None (Open Label)||||||
1370624|NCT02676154||Single Group Assignment||Treatment||None (Open Label)||||||
1370625|NCT02676141|||Cohort||Prospective|||||||
1370626|NCT02676128|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370627|NCT02676115|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370628|NCT02676102|Randomized|Parallel Assignment||Other||Single|||t|||
1370629|NCT02676089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370630|NCT02676076|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370631|NCT02676063|||Cohort||Prospective|||||||
1370632|NCT02676050||Single Group Assignment||Other||None (Open Label)||||||
1370633|NCT02676037|||Other||Cross-Sectional|||||||
1370634|NCT02676024|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1370635|NCT02676011|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1370636|NCT02675998|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370637|NCT02675985||Single Group Assignment||Treatment||None (Open Label)||||||
1370638|NCT02675972|||Case-Control||Prospective|||||||
1370639|NCT02675959||Single Group Assignment||Treatment||None (Open Label)||||||
1370640|NCT02675946|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370641|NCT02675933|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1370642|NCT02675920|||Cohort||Prospective|||||||
1370643|NCT02675907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370644|NCT02675894|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1370645|NCT02675881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370646|NCT02675868|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1370647|NCT02675855|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370648|NCT02675842|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370649|NCT02675829|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370650|NCT02675816||Single Group Assignment||Treatment||None (Open Label)||||||
1370651|NCT02675803|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370652|NCT02675790|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1370653|NCT02675777|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1370654|NCT02675764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370655|NCT02675751||Single Group Assignment||Treatment||None (Open Label)||||||
1370656|NCT02675738|||Cohort||Prospective|||||||
1370657|NCT02675725|||Case-Control||Prospective|||||||
1370658|NCT02675712|||Case-Only||Prospective|||||||
1370659|NCT02675699|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1370660|NCT02675686|||Cohort||Prospective|||||||
1370661|NCT02675673|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1370662|NCT02675660|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1370663|NCT02675647|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370664|NCT02675634|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1370665|NCT02675621|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1370666|NCT02675608|||Case Control||Retrospective|||||||
1370667|NCT02675595|||Case-Only||Cross-Sectional|||||||
1370668|NCT02675582|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1370669|NCT02675569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370670|NCT02675556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370671|NCT02675543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370672|NCT02675530||Single Group Assignment||||None (Open Label)||||||
1370673|NCT02675517|||Cohort||Prospective|||||||
1370674|NCT02675504|||||Prospective|||||||
1370675|NCT02675491||Single Group Assignment||Treatment||None (Open Label)||||||
1370676|NCT02675478||Single Group Assignment||Treatment||None (Open Label)||||||
1370677|NCT02675465|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370678|NCT02675452|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370679|NCT02675439|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370680|NCT02675426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370681|NCT02675413||Single Group Assignment||Basic Science||None (Open Label)||||||
1370682|NCT02675400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370683|NCT02675387|Randomized|Crossover Assignment||Treatment||Single|||t|||
1370684|NCT02675374|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1370685|NCT02675361|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1370686|NCT02675348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370687|NCT02675335|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370688|NCT02675322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370689|NCT02675309||Single Group Assignment||||None (Open Label)||||||
1370690|NCT02675296|||Cohort||Retrospective|||||||
1370691|NCT02675283||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370692|NCT02675270|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1370693|NCT02675257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370694|NCT02675244|Randomized|Parallel Assignment||Treatment||Single||||||t
1370695|NCT02675231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370696|NCT02675218|||Cohort||Prospective|||||||
1370697|NCT02675205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370698|NCT02675192|||Cohort||Prospective|||||||
1370699|NCT02675179||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370700|NCT02675166|||Cohort||Prospective|||||||
1370701|NCT02675153||Single Group Assignment||Treatment||None (Open Label)||||||
1370702|NCT02675140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370703|NCT02675127|Randomized|Crossover Assignment||||None (Open Label)||||||
1370704|NCT02675114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370705|NCT02675101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370706|NCT02675088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370707|NCT02675075|||Cohort||Prospective|||||||
1370708|NCT02675062|||Case-Only||Prospective|||||||
1370709|NCT02675049|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370710|NCT02675036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370711|NCT02675023|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370712|NCT02675010||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370713|NCT02674997|||Cohort||Prospective|||||||
1370714|NCT02674984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370715|NCT02674971|Randomized|Parallel Assignment||Treatment||Single||||||t
1370716|NCT02674958|Randomized|Parallel Assignment||Basic Science||Single||||||t
1370717|NCT02674945||Single Group Assignment||Health Services Research||None (Open Label)||||||
1370718|NCT02674932|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1370719|NCT02674919|Randomized|Parallel Assignment||Other||Single||||||t
1370720|NCT02674906|Randomized|Parallel Assignment||Other||Single|||t|||
1370721|NCT02674893||Parallel Assignment||||||||||
1370722|NCT02674880|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370723|NCT02674867|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1370724|NCT02674854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370725|NCT02674841|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370726|NCT02674828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370727|NCT02674815||Single Group Assignment||Treatment||None (Open Label)||||||
1370728|NCT02674802||||||||||||
1370729|NCT02674789|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1370730|NCT02674776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370731|NCT02674763|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370732|NCT02674750||Single Group Assignment||Treatment||None (Open Label)||||||
1370733|NCT02674737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370734|NCT02674724|Randomized|Parallel Assignment||Treatment||Single|||||t|
1370735|NCT02674711|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1370736|NCT02674698|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1370737|NCT02674685|||Cohort||Prospective|||||||
1370738|NCT02674672||Single Group Assignment||Treatment||None (Open Label)||||||
1370739|NCT02674659|Randomized|Parallel Assignment||Prevention||Single|||t|||
1370740|NCT02674646|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1370821|NCT02673593|Randomized|Parallel Assignment||||Triple|||t||t|t
1370741|NCT02674633|Randomized|Parallel Assignment||Treatment||Quadruple||Minimum number of subjects = 300, Anticipated number of subjects = 330, Maximum number of subjects = 1,000|t|t|t|t
1370742|NCT02674620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370743|NCT02674607|Randomized|Parallel Assignment||Prevention||Double||||t||t
1370744|NCT02674594|||Cohort||Retrospective|||||||
1370745|NCT02674581|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370746|NCT02674568||Single Group Assignment||Treatment||None (Open Label)||||||
1370747|NCT02674555||Single Group Assignment||Treatment||None (Open Label)||||||
1370748|NCT02674542|||Cohort||Prospective|||||||
1370749|NCT02674529|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370750|NCT02674516|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1370751|NCT02674503|Randomized|Parallel Assignment||Treatment||Single||||||t
1370752|NCT02674490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370753|NCT02674477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370754|NCT02674464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370755|NCT02674451|Randomized|Parallel Assignment||Prevention||Single||||||t
1370756|NCT02674438|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1370757|NCT02674425|||Case-Only|||||||||
1370758|NCT02674412|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1370759|NCT02674399|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370760|NCT02674386||Single Group Assignment||Other||None (Open Label)||||||
1370761|NCT02674373|||Cohort||Prospective|||||||
1370762|NCT02674360|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370763|NCT02674347|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1370764|NCT02674334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370765|NCT02674321||Single Group Assignment||Treatment||None (Open Label)||||||
1370766|NCT02674308|||Cohort||Prospective|||||||
1370767|NCT02674295|Randomized|Single Group Assignment||||None (Open Label)||||||
1370768|NCT02674282|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370769|NCT02674269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370770|NCT02674256|Randomized|Crossover Assignment||||Single|||t|||
1370771|NCT02674243|Randomized|Parallel Assignment||Treatment||Single||||||t
1370772|NCT02674230|||Cohort||Prospective|||||||
1370773|NCT02674217||Single Group Assignment||Treatment||None (Open Label)||||||
1370774|NCT02674204|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370775|NCT02674191|Randomized|Parallel Assignment||Treatment||Single||||||t
1370776|NCT02674178|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1370777|NCT02674165|Randomized|Parallel Assignment||Treatment||Single||||t||
1370778|NCT02674152||Single Group Assignment||Treatment||None (Open Label)||||||
1370779|NCT02674139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370780|NCT02674126|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1370781|NCT02674113|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1370782|NCT02674100|||Cohort||Prospective|||||||
1370783|NCT02674087|||Cohort||Prospective|||||||
1370784|NCT02674074||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370785|NCT02674061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370786|NCT02674048|||||Prospective|||||||
1370787|NCT02674035|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1370788|NCT02674022|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370789|NCT02674009|||Cohort||Prospective|||||||
1370790|NCT02673996|||Case-Control||Cross-Sectional|||||||
1370791|NCT02673983||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370792|NCT02673970|||Cohort||Prospective|||||||
1370793|NCT02673957|||Cohort||Cross-Sectional|||||||
1370794|NCT02673944||Single Group Assignment||||None (Open Label)||||||
1370795|NCT02673931|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1370796|NCT02673918||Single Group Assignment||Treatment||None (Open Label)||||||
1370797|NCT02673905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370798|NCT02673892|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1370799|NCT02673879|Randomized|Parallel Assignment||Treatment||Single||||||t
1370800|NCT02673866|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370801|NCT02673853|||Case-Only||Prospective|||||||
1370802|NCT02673840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370803|NCT02673827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370804|NCT02673814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370805|NCT02673801|||Cohort||Prospective|||||||
1370806|NCT02673788|||Case-Only||Prospective|||||||
1370807|NCT02673775|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1370808|NCT02673762|||Other||Prospective|||||||
1370809|NCT02673749|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370810|NCT02673736||Single Group Assignment||Treatment||None (Open Label)||||||
1370811|NCT02673723|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1370812|NCT02673710|||Cohort||Other|||||||
1370813|NCT02673697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370814|NCT02673684|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370815|NCT02673671|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1370816|NCT02673658|Randomized|Parallel Assignment||Treatment||Single||||||t
1370817|NCT02673645|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370818|NCT02673632|||Cohort||Prospective|||||||
1370819|NCT02673619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370822|NCT02673580|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370823|NCT02673567|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1370824|NCT02673554|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370825|NCT02673541|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370826|NCT02673528|||Case Control||Retrospective|||||||
1370827|NCT02673515|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1370828|NCT02673502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370829|NCT02673489||Single Group Assignment||Treatment||None (Open Label)||||||
1370830|NCT02673476|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370831|NCT02673463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370832|NCT02673450|||Cohort||Prospective|||||||
1370833|NCT02673437|||Cohort||Prospective|||||||
1370834|NCT02673424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370835|NCT02673411|||Case-Only||Cross-Sectional|||||||
1370836|NCT02673398||Single Group Assignment||Treatment||None (Open Label)||||||
1370837|NCT02673385|||Case Control||Prospective|||||||
1370838|NCT02673372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370839|NCT02673359|Randomized|Parallel Assignment||Prevention||Single||||||t
1370840|NCT02673346|||Cohort||Cross-Sectional|||||||
1370841|NCT02673333||Single Group Assignment||Treatment||None (Open Label)||||||
1370842|NCT02673320|Randomized|Parallel Assignment||||None (Open Label)||||||
1370843|NCT02673307|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1370844|NCT02673294|Randomized|Parallel Assignment||Treatment||Single||||||t
1370845|NCT02673281|Randomized|Crossover Assignment||Other||Double|||t||t|
1370846|NCT02673268||Single Group Assignment||Treatment||None (Open Label)||||||
1370847|NCT02673255|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1370848|NCT02673242|Randomized|Parallel Assignment||Treatment||Single||||||t
1370849|NCT02673229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370850|NCT02673216|||Cohort||Prospective|||||||
1370851|NCT02673203|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1370852|NCT02673177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370853|NCT02673164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370854|NCT02673151||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370855|NCT02673138|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370856|NCT02673125||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370857|NCT02673112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370858|NCT02673099||Single Group Assignment||Treatment||None (Open Label)||||||
1370859|NCT02673086|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1370860|NCT02673073|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370861|NCT02673060||Single Group Assignment||Treatment||None (Open Label)||||||
1370862|NCT02673047|||Case-Only||Prospective|||||||
1370863|NCT02673034|||Cohort||Prospective|||||||
1370864|NCT02673021||Single Group Assignment||Treatment||None (Open Label)||||||
1370865|NCT02673008||Single Group Assignment||Prevention||None (Open Label)||||||
1370866|NCT02672995||Single Group Assignment||Treatment||None (Open Label)||||||
1370867|NCT02672982|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1370868|NCT02672969|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370869|NCT02672956|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370870|NCT02672943|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370871|NCT02672930|||Cohort||Prospective|||||||
1370872|NCT02672917|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370873|NCT02672904|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1370874|NCT02672891||Single Group Assignment||Treatment||None (Open Label)||||||
1370875|NCT02672878||Single Group Assignment||Treatment||Single||||||t
1370876|NCT02672865||Single Group Assignment||Treatment||None (Open Label)||||||
1370877|NCT02672852|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370878|NCT02672839|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370879|NCT02672826||Single Group Assignment||Other||None (Open Label)||||||
1370880|NCT02672813|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370881|NCT02672800|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1370882|NCT02672787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370883|NCT02672774|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1370884|NCT02672761|Randomized|Parallel Assignment||Treatment||Single||||||t
1370885|NCT02672748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370886|NCT02672735|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1370887|NCT02672722||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370888|NCT02672709||Single Group Assignment||||None (Open Label)||||||
1370889|NCT02672696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370890|NCT02672683|||Cohort||Prospective|||||||
1370891|NCT02672670|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1370892|NCT02672657|||Cohort||Prospective|||||||
1370893|NCT02672644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370894|NCT02672631|||Case Control||Cross-Sectional|||||||
1370895|NCT02672618|||||Cross-Sectional|||||||
1370896|NCT02672605|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1370897|NCT02672592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370898|NCT02672579|||Other||Prospective|||||||
1370899|NCT02672566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370900|NCT02672553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370901|NCT02672540|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370902|NCT02672527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370903|NCT02672514|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370904|NCT02672501||Single Group Assignment||Treatment||None (Open Label)||||||
1370905|NCT02672488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370906|NCT02672475||Single Group Assignment||Treatment||None (Open Label)||||||
1370907|NCT02672462||Single Group Assignment||Treatment||None (Open Label)||||||
1370908|NCT02672449||Single Group Assignment||Treatment||None (Open Label)||||||
1370909|NCT02672436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370910|NCT02672423|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1370911|NCT02672397|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1370912|NCT02672384||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370913|NCT02672371|Randomized|Crossover Assignment||Other||Single|||||t|
1370914|NCT02672358||Single Group Assignment||Treatment||None (Open Label)||||||
1370915|NCT02672345|||Case-Control||Prospective|||||||
1370916|NCT02672332|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370917|NCT02672319|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Comparison of clinical outcomes of a prospective study cohort to those in a historical control group||||
1370918|NCT02672306|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1370919|NCT02672293||Single Group Assignment||Other||None (Open Label)||||||
1370920|NCT02672280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370921|NCT02672267|Randomized|Parallel Assignment||Treatment||Single||||t||
1370922|NCT02672254|||Case Control||Cross-Sectional|||||||
1370923|NCT02672241||Single Group Assignment||Treatment||None (Open Label)||||||
1370924|NCT02672228||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370925|NCT02672215|Randomized|Factorial Assignment||Prevention||Single|||t|||
1370926|NCT02672202|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1370927|NCT02672189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370928|NCT02672176|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1370929|NCT02672163|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370930|NCT02672150|Randomized|Parallel Assignment||Health Services Research||Triple|Pairs of sites were optimally randomize based on 10,000 trials to the two conditions by the coordinating center. The assignment (to core or core+enhanced) was not revealed to the local research center or site until after completion of the core. Thus it is double blind.|Staff from 34 juvenile community supervision agencies were observed for a 6 month baseline period than trained over 4 months on using a behavioral health service cascade model to screen, identify, and refer youth to substance use treatment. Half the sites were randomized to 12 additional months of facilitation. Sites were then monitored for an additional 4 month maintenance phase.|t||t|t
1370931|NCT02672137|Randomized|Parallel Assignment||||None (Open Label)||||||
1370932|NCT02672124|||Cohort||Retrospective|||||||
1370933|NCT02672111|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370934|NCT02672098||Single Group Assignment||Treatment||None (Open Label)||||||
1370935|NCT02672085|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370936|NCT02672072|||Other||Prospective|||||||
1370937|NCT02672059|||Cohort||Cross-Sectional|||||||
1370938|NCT02672046|||Cohort||Prospective|||||||
1370939|NCT02672033||Single Group Assignment||Treatment||None (Open Label)||||||
1370940|NCT02672020||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370941|NCT02672007||Single Group Assignment||Diagnostic||||||||
1370942|NCT02671994|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370943|NCT02671968|Randomized|Parallel Assignment||||||||||
1370944|NCT02671955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1370945|NCT02671942|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1370946|NCT02671929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370947|NCT02671916||||||||||||
1370948|NCT02671903|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1370949|NCT02671890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1370950|NCT02671877|||Other||Prospective|||||||
1370951|NCT02671864|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1370952|NCT02671851|||Cohort||Retrospective|||||||
1370953|NCT02671838|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1370954|NCT02671825|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1370955|NCT02671812|||Cohort||Cross-Sectional|||||||
1370956|NCT02671799||Single Group Assignment||Treatment||None (Open Label)||||||
1370957|NCT02671786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370958|NCT02671773|||||Cross-Sectional|||||||
1370959|NCT02671760|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1370960|NCT02671747||Single Group Assignment||Other||None (Open Label)||||||
1370961|NCT02671734|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1370962|NCT02671721|Randomized|Parallel Assignment||Basic Science||Single||||||t
1370963|NCT02671708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370964|NCT02671695|Randomized|Parallel Assignment||Treatment||Double||||t||t
1370965|NCT02671682|||Cohort||Prospective|||||||
1370966|NCT02671669|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1370967|NCT02671656|||||Prospective|||||||
1370968|NCT02671643|||Cohort||Prospective|||||||
1370969|NCT02671630|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1370970|NCT02671617|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1370971|NCT02671604|||Case Control||Prospective|||||||
1370972|NCT02671591|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370973|NCT02671578||Single Group Assignment||Treatment||None (Open Label)||||||
1370974|NCT02671565|||Cohort||Retrospective|||||||
1370975|NCT02671552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1370976|NCT02671539||Single Group Assignment||Treatment||None (Open Label)||||||
1370977|NCT02671526||Single Group Assignment||Treatment||None (Open Label)||||||
1370978|NCT02671513||Single Group Assignment||Treatment||None (Open Label)||||||
1370979|NCT02671500||Single Group Assignment||Treatment||None (Open Label)||||||
1370980|NCT02671487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370981|NCT02671474||||Diagnostic||||||||
1370982|NCT02671461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1370983|NCT02671448|||Cohort||Prospective|||||||
1370984|NCT02671435|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370985|NCT02671422|||Cohort||Prospective|||||||
1370986|NCT02671409|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370987|NCT02671396|Randomized|Parallel Assignment||Treatment||Single|||t|||
1370988|NCT02671383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1370989|NCT02671370|||Other||Cross-Sectional|||||||
1370990|NCT02671357|||Cohort||Prospective|||||||
1370991|NCT02671344|||Case-Only||Retrospective|||||||
1370992|NCT02671331|||Case-Only||Prospective|||||||
1370993|NCT02671318|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370994|NCT02671305|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370995|NCT02671292|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1370996|NCT02671279||Single Group Assignment||Basic Science||None (Open Label)||||||
1370997|NCT02671266|Randomized|Crossover Assignment||Other||Double|||t||t|
1370998|NCT02671253|||Cohort||Prospective|||||||
1370999|NCT02671240|||Cohort||Retrospective|||||||
1371000|NCT02671227|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1371001|NCT02671214|Randomized|Crossover Assignment||||Double|||t||t|
1371002|NCT02671201|||Other||Prospective|||||||
1371003|NCT02671188|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371004|NCT02671175|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1371005|NCT02671162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371006|NCT02671149|Randomized|Parallel Assignment||Prevention||Single|||t|||
1371007|NCT02671136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371008|NCT02671123|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371009|NCT02671110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371010|NCT02671097||Single Group Assignment||||None (Open Label)||||||
1371011|NCT02671084|Randomized|Parallel Assignment||Treatment||Double||||t||t
1371012|NCT02671071|||Case-Only||Prospective|||||||
1371013|NCT02671058|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371014|NCT02671045|||Cohort||Prospective|||||||
1371015|NCT02671032||Single Group Assignment||Treatment||None (Open Label)||||||
1371016|NCT02671019|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371017|NCT02671006|||Case-Control||Prospective|||||||
1371018|NCT02670993|Randomized|Parallel Assignment||||None (Open Label)||||||
1371019|NCT02670980||Single Group Assignment||Treatment||None (Open Label)||||||
1371020|NCT02670967|||||Retrospective|||||||
1371021|NCT02670954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371022|NCT02670941|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1371023|NCT02670928|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371024|NCT02670915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371025|NCT02670902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371026|NCT02670889|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371027|NCT02670876||Single Group Assignment||Treatment||None (Open Label)||||||
1371028|NCT02670863|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1371029|NCT02670850|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1371030|NCT02670837|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371031|NCT02670824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371032|NCT02670811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371033|NCT02670798|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1371034|NCT02670785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371035|NCT02670772|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371036|NCT02670759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371037|NCT02670746|||Cohort||Prospective|||||||
1371038|NCT02670733|||Cohort||Prospective|||||||
1371039|NCT02670720||Single Group Assignment||Prevention||None (Open Label)||||||
1371040|NCT02670707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371041|NCT02670694|||Case Control||Prospective|||||||
1371042|NCT02670681|Randomized|Parallel Assignment||Treatment||Single||||||t
1371043|NCT02670668|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1371044|NCT02670655|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1371045|NCT02670642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371046|NCT02670629|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1371047|NCT02670616||Single Group Assignment||Treatment||None (Open Label)||||||
1371048|NCT02670603|Randomized|Parallel Assignment||Supportive Care||Single|This study is open-labeled study. But outcome would be assessed the statistician who did not involve this study with blind data.|||||t
1371049|NCT02670590||Single Group Assignment||Treatment||None (Open Label)||||||
1371050|NCT02670577|||Cohort||Prospective|||||||
1371051|NCT02670564|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1371052|NCT02670551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371053|NCT02670538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371054|NCT02670525|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371055|NCT02670512|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1371056|NCT02670499|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371057|NCT02670486|Randomized|Parallel Assignment||Basic Science||Single||||||t
1371058|NCT02670473|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1371059|NCT02670460||Single Group Assignment||||None (Open Label)||||||
1371060|NCT02670447|||Case-Only||Prospective|||||||
1371061|NCT02670434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371062|NCT02670421|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371063|NCT02670408|||Cohort||Prospective|||||||
1371064|NCT02670395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371065|NCT02670382|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1371066|NCT02670369||Single Group Assignment||Supportive Care||None (Open Label)||||||
1371067|NCT02670356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371068|NCT02670343||Single Group Assignment||Basic Science||None (Open Label)||||||
1371069|NCT02670330||Single Group Assignment||Treatment||None (Open Label)||||||
1371070|NCT02670317||Single Group Assignment||Treatment||None (Open Label)||||||
1371071|NCT02670304|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1371072|NCT02670291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371073|NCT02670278|||||Cross-Sectional|||||||
1371074|NCT02670265|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371075|NCT02670252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371076|NCT02670239|||Cohort||Prospective|||||||
1371077|NCT02670226|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371078|NCT02670213|||Cohort||Prospective|||||||
1371079|NCT02670200|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1371080|NCT02670187|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371081|NCT02670174|Randomized|Parallel Assignment||Treatment||Single||Subjects are randomly assigned in 3 parallel intervention groups. They cannot participate in 2 or more intervention groups.|||t|
1371082|NCT02670161|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371083|NCT02670148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371084|NCT02670135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371085|NCT02670122|||Cohort||Prospective|||||||
1371086|NCT02670109||Single Group Assignment||Treatment||None (Open Label)||||||
1371087|NCT02670096||Single Group Assignment||Treatment||None (Open Label)||||||
1371088|NCT02670083|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371089|NCT02670070|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371090|NCT02670057||Single Group Assignment||Treatment||None (Open Label)||||||
1371091|NCT02670044|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371092|NCT02670031|||Cohort||Prospective|||||||
1371093|NCT02670018|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371094|NCT02670005|||Cohort||Retrospective|||||||
1371095|NCT02669992|Randomized|Factorial Assignment||Prevention||Single|||t|||
1371096|NCT02669979|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1371097|NCT02669966||Single Group Assignment||Treatment||None (Open Label)||||||
1371098|NCT02669953|||Cohort||Prospective|||||||
1371099|NCT02669940|||Cohort||Prospective|||||||
1371100|NCT02669927|||Cohort||Prospective|||||||
1371101|NCT02669914|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371102|NCT02669901||Single Group Assignment||Prevention||None (Open Label)||||||
1371103|NCT02669888|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371104|NCT02669875|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371105|NCT02669862|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371106|NCT02669849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371107|NCT02669836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371108|NCT02669823|||Case-Only||Prospective|||||||
1371109|NCT02669810|Randomized|Parallel Assignment||Treatment||Single||||||t
1371110|NCT02669797|Randomized|Parallel Assignment||Treatment||Quadruple|Like most behavioral interventions, it is not possible to double blind this RCT because interventionists will be delivering the in-home visiting components to participants. However, the proposed study incorporates participant, study staff, physician, and investigator blinding as much as possible. The intervention will be administered by trained staff assigned to the intervention team, who will not be involved with evaluation team responsibilities/meetings. Evaluation team members will carry out all measurement home visits and will be blinded to participant study arm assignment. They will not be involved with intervention team responsibilities/meetings. Specific co-investigators are responsible for training and supervising staff within the intervention team versus the evaluation team in to order to blind as many co-investigators as possible. In addition, physicians who will be a part of carrying out the 5-2-1-0 obesity prevention messages in the primary care clinics will be blinded.|Three-arm, individual randomized controlled superiority trial.|t|t|t|t
1371111|NCT02669784|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371112|NCT02669771|||Cohort||Prospective|||||||
1371113|NCT02669758||Single Group Assignment||Treatment||None (Open Label)||||||
1371114|NCT02669745|||Other||Prospective|||||||
1371115|NCT02669732|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1371116|NCT02669719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371117|NCT02669706|||Cohort||Prospective|||||||
1371118|NCT02669693|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1371119|NCT02669680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371120|NCT02669667|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1371121|NCT02669654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371122|NCT02669641||Single Group Assignment||Treatment||None (Open Label)||||||
1371123|NCT02669628|||Cohort||Prospective|||||||
1371124|NCT02669615||Single Group Assignment||Treatment||None (Open Label)||||||
1371125|NCT02669602|||Cohort||Prospective|||||||
1371126|NCT02669589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371127|NCT02669576|Randomized|Parallel Assignment||Treatment||Single||||||t
1371128|NCT02669563|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1371129|NCT02669550|Randomized|Factorial Assignment||Other||Double|||t||t|
1371130|NCT02669537|Randomized|Parallel Assignment||||Single|||||t|
1371131|NCT02669524|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1371132|NCT02669511||Single Group Assignment||Treatment||None (Open Label)||||||
1371133|NCT02669498|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371134|NCT02669485||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371135|NCT02669472|Randomized|Parallel Assignment||Prevention||Single||||||t
1371136|NCT02669459|Randomized|Parallel Assignment||Treatment||Single|||||t|
1371137|NCT02669446|||Case-Only||Prospective|||||||
1371138|NCT02669433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371139|NCT02669420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371140|NCT02669407||Single Group Assignment||Treatment||None (Open Label)||||||
1371141|NCT02669394|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371142|NCT02669381||Single Group Assignment||Basic Science||None (Open Label)||||||
1371143|NCT02669368|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1371144|NCT02669355|||Case Control||Prospective|||||||
1371145|NCT02669342|Randomized|Parallel Assignment||Prevention||Single|Patients are not told which catheter is inserted at which time point until after they exit the study.||t|||
1371146|NCT02669329||Single Group Assignment||Other||None (Open Label)||||||
1371147|NCT02669316|||Cohort||Cross-Sectional|||||||
1371148|NCT02669303|Randomized|Parallel Assignment||Treatment||Single||||||t
1371149|NCT02669290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371150|NCT02669277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371151|NCT02669264||Single Group Assignment||Treatment||None (Open Label)||||||
1371152|NCT02669251||Single Group Assignment||Treatment||None (Open Label)||||||
1371153|NCT02669238|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371154|NCT02669225|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1371155|NCT02669212|||Case-Control||Cross-Sectional|||||||
1371156|NCT02669199||Single Group Assignment||Treatment||None (Open Label)||||||
1371157|NCT02669186|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371158|NCT02669173||Single Group Assignment||Treatment||None (Open Label)||||||
1371159|NCT02669160|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371160|NCT02669147|||Cohort||Prospective|||||||
1371161|NCT02669134|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1371162|NCT02669121|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1371163|NCT02669108||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371164|NCT02669095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371165|NCT02669082||Single Group Assignment||Treatment||None (Open Label)||||||
1371166|NCT02669069|Randomized|Parallel Assignment||Device Feasibility||Quadruple|||t|t|t|t
1371167|NCT02669056|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371168|NCT02669043||Single Group Assignment||Other||None (Open Label)||||||
1371169|NCT02669030|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371170|NCT02669017||Single Group Assignment||Treatment||None (Open Label)||||||
1371171|NCT02669004|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1371172|NCT02668991|||Cohort||Prospective|||||||
1371173|NCT02668978|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371174|NCT02668965|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1371175|NCT02668952|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371176|NCT02668926|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1371177|NCT02668913||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371178|NCT02668900|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1371179|NCT02668887|||Cohort||Prospective|||||||
1371180|NCT02668874|Randomized|Parallel Assignment||Health Services Research||Triple|It is a double blinded trial. participants and outcome assessors do not know the randomization. However, it was hard to blind the care provider.||t||t|t
1371181|NCT02668861|Randomized|Single Group Assignment||Treatment||Single||||||t
1371182|NCT02668848||Single Group Assignment||Treatment||None (Open Label)||||||
1371183|NCT02668835|||Cohort||Retrospective|||||||
1371184|NCT02668822|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371185|NCT02668809|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371186|NCT02668796|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371187|NCT02668783|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371188|NCT02668770|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371189|NCT02668757||Single Group Assignment||Prevention||None (Open Label)||||||
1371190|NCT02668744|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371191|NCT02668718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371192|NCT02668705|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1371193|NCT02668692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371194|NCT02668679|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1371195|NCT02668666|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open-Label|||||
1371196|NCT02668653|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371197|NCT02668640|||Case-Control||Prospective|||||||
1371198|NCT02668627|||Cohort||Prospective|||||||
1371199|NCT02668614||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371200|NCT02668601|||Case-Control||Retrospective|||||||
1371201|NCT02668588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371202|NCT02668575|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371203|NCT02668562|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1371204|NCT02668549|||Cohort||Retrospective|||||||
1371205|NCT02668536|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1371206|NCT02668523||Single Group Assignment||Treatment||None (Open Label)||||||
1371207|NCT02668510|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1371208|NCT02668497|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371209|NCT02668484|Randomized|Parallel Assignment||Treatment||Single||||||t
1371210|NCT02668471|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371211|NCT02668458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371212|NCT02668445|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371213|NCT02668432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371214|NCT02668419|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1371215|NCT02668406|||Case-Control||Prospective|||||||
1371216|NCT02668393|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371217|NCT02668380|||Case-Only||Prospective|||||||
1371218|NCT02668367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371219|NCT02668354|||Cohort||Retrospective|||||||
1371220|NCT02668341|||Case-Only||Cross-Sectional|||||||
1371221|NCT02668328||Single Group Assignment||||None (Open Label)||||||
1371222|NCT02668315|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1371223|NCT02668302|Randomized|Parallel Assignment||Treatment||Double|"Patients were wearing eye masked and noise-cancelling headsets during placement and follow-up endoscopies.~The primary outcome was assessed by an independent sinus surgeon based on a centralized, blinded video-endoscopy review."|Patients assigned to the treatment group underwent a bilateral in-office placement of a steroid-eluting sinus implant 7 days following ethmoidectomy in addition to post-op standard of care, including debridement, irrigation, and topical steroids. Patients randomized to the control group received same standard of care alone.|t|||t
1371224|NCT02668289||Single Group Assignment||Treatment||None (Open Label)||||||
1371225|NCT02668276|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371226|NCT02668263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371227|NCT02668250|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371228|NCT02668237|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371229|NCT02668224|Randomized|Parallel Assignment||||None (Open Label)||||||
1371230|NCT02668211||Single Group Assignment||Treatment||None (Open Label)||||||
1371231|NCT02668198|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371232|NCT02668185|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1371233|NCT02668172|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371234|NCT02668159|Randomized|Crossover Assignment||Prevention||Single|||t|||
1371235|NCT02668146|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371236|NCT02668133|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1371237|NCT02668120|||Case-Control||Prospective|||||||
1371238|NCT02668107|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371239|NCT02668094|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1371240|NCT02668081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371241|NCT02668068|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371242|NCT02668055||Single Group Assignment||Treatment||None (Open Label)||||||
1371243|NCT02668042||Single Group Assignment||Treatment||None (Open Label)||||||
1371244|NCT02668029|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1371245|NCT02668016|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1371246|NCT02668003|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371247|NCT02667990||Single Group Assignment||Basic Science||None (Open Label)||||||
1371248|NCT02667977|Randomized|Single Group Assignment||Prevention||Single||||t||
1371249|NCT02667964|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1371250|NCT02667951|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1371251|NCT02667938|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371252|NCT02667925||Single Group Assignment||Treatment||None (Open Label)||||||
1371253|NCT02667912|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371254|NCT02667899|Randomized|Parallel Assignment||Treatment||Single||||||t
1371255|NCT02667886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371256|NCT02667873||Single Group Assignment||Treatment||None (Open Label)||||||
1371257|NCT02667860|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371258|NCT02667847|||Cohort||Prospective|||||||
1371259|NCT02667834|Randomized|Parallel Assignment||Treatment||Single||||||t
1371405|NCT02665923|||Cohort||Prospective|||||||
1371260|NCT02667821||Single Group Assignment||Basic Science||None (Open Label)||||||
1371261|NCT02667808|||Case-Only||Cross-Sectional|||||||
1371262|NCT02667795|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371263|NCT02667782|Randomized|Parallel Assignment||Treatment||Double||||t||t
1371264|NCT02667769|Randomized|Crossover Assignment||||None (Open Label)||||||
1371265|NCT02667756|||Cohort||Prospective|||||||
1371266|NCT02667743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371267|NCT02667730|Randomized|Parallel Assignment||Treatment||Double|Patients are aware of their allocation. The treating physiotherapists will not be aware of allocation and patients are asked to not discuss their medication (allocation) with physiotherapists|||t||t
1371268|NCT02667717|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371269|NCT02667704|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371270|NCT02667691|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1371271|NCT02667678||Single Group Assignment||Other||None (Open Label)||||||
1371272|NCT02667665|||Other||Prospective|||||||
1371273|NCT02667652|Randomized|Parallel Assignment||Treatment||Single|||||t|
1371274|NCT02667639|Randomized|Parallel Assignment||Other||Double|||t||t|
1371275|NCT02667626|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1371276|NCT02667613|Randomized|Parallel Assignment||Treatment||Double||||t||t
1371277|NCT02667600|||Cohort||Prospective|||||||
1371278|NCT02667587|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371279|NCT02667574||Single Group Assignment||Treatment||None (Open Label)||||||
1371280|NCT02667561|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371281|NCT02667548|||Case-Only||Prospective|||||||
1371282|NCT02667535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371283|NCT02667522|Randomized|Parallel Assignment||Prevention||Single|||||t|
1371284|NCT02667509|||||Cross-Sectional|||||||
1371285|NCT02667496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371286|NCT02667483||Single Group Assignment||Treatment||None (Open Label)||||||
1371287|NCT02667470||Single Group Assignment||Treatment||None (Open Label)||||||
1371288|NCT02667457|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371289|NCT02667444|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371290|NCT02667431|||Cohort||Prospective|||||||
1371291|NCT02667418|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371292|NCT02667405|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1371293|NCT02667392|Randomized|Parallel Assignment||Treatment||Single||||||t
1371294|NCT02667379||Single Group Assignment||Basic Science||None (Open Label)||||||
1371295|NCT02667366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371296|NCT02667353||Single Group Assignment||Basic Science||None (Open Label)||||||
1371297|NCT02667340|Randomized|Crossover Assignment||||Double|||t||t|
1371298|NCT02667327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371299|NCT02667314|Randomized|Parallel Assignment||Prevention||Single|||||t|
1371300|NCT02667301||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371301|NCT02667288||Single Group Assignment||Treatment||None (Open Label)||||||
1371302|NCT02667275|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371303|NCT02667262|||Other||Retrospective|||||||
1371304|NCT02667249|||Case Control||Retrospective|||||||
1371305|NCT02667236|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371306|NCT02667223|Randomized|||Basic Science||None (Open Label)||||||
1371307|NCT02667210|||Other||Retrospective|||||||
1371308|NCT02667197|||Other||Retrospective|||||||
1371309|NCT02667184|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1371310|NCT02667171|Randomized|Parallel Assignment||Treatment||Double|"All assessors are blinded to group allocation and previous test results. Due to the nature of the study the patients cannot be blinded, but prior to the assessments they are reminded not to disclose their group allocation to the assessors. In case of failure keeping the outcome assessor blinded (that is, if a participant reveals his/her allocation) a second assessor will be available to step in and conduct the assessment on another day.~To avoid investigators (subconscious) bias the biostatistician who perform the data analyses and validate the results will be blinded to group allocation.~The research group will interpret the results, and the conclusion will be prepared in two versions before the allocation code is broken (one assuming that arm A is the intervention, and one assuming that arm B is the intervention)."|This study is a randomized controlled, assessor- and statistician blinded, superiority, multicentre trial with two parallel-groups. Online COPD Rehab versus Coventional COPD rehab|||t|t
1371311|NCT02667158|||Other||Retrospective|||||||
1371312|NCT02667145|Randomized|Parallel Assignment||Treatment||Single||||||t
1371313|NCT02667132|||Case-Control||Retrospective|||||||
1371314|NCT02667119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371315|NCT02667106||Single Group Assignment||Basic Science||None (Open Label)||||||
1371316|NCT02667093|||Case-Control||Prospective|||||||
1371317|NCT02667080|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1371318|NCT02667067|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371319|NCT02667054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371320|NCT02667041|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371321|NCT02667028|||Case-Only||Retrospective|||||||
1371322|NCT02667015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371323|NCT02667002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371324|NCT02666989|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371325|NCT02666976||Single Group Assignment||Treatment||None (Open Label)||||||
1371326|NCT02666963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371327|NCT02666950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371328|NCT02666937|||Cohort||Other|||||||
1371329|NCT02666924|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371330|NCT02666911|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1371331|NCT02666898||Single Group Assignment||Treatment||None (Open Label)||||||
1371332|NCT02666885||Single Group Assignment||Treatment||None (Open Label)||||||
1371333|NCT02666872|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371334|NCT02666859|Randomized|Single Group Assignment||Treatment||None (Open Label)||Virtual Reality Job Training||||
1371335|NCT02666846|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1371336|NCT02666833|||Case-Only|||||||||
1371337|NCT02666820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371338|NCT02666807|Randomized|Parallel Assignment||||Triple|||t|t|t|
1371339|NCT02666794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371340|NCT02666781|||Cohort||Prospective|||||||
1371341|NCT02666768||Single Group Assignment||Treatment||None (Open Label)||||||
1371342|NCT02666755|||Case-Only||Prospective|||||||
1371343|NCT02666742|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371344|NCT02666729|||Case-Only||Prospective|||||||
1371345|NCT02666716|||Case-Only||Prospective|||||||
1371346|NCT02666703|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371347|NCT02666690||Single Group Assignment||||None (Open Label)||||||
1371348|NCT02666677|||||Prospective|||||||
1371349|NCT02666664|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371350|NCT02666651|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1371351|NCT02666638|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371352|NCT02666625|||Cohort||Prospective|||||||
1371353|NCT02666612||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371354|NCT02666599||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371355|NCT02666586|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1371356|NCT02666573|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1371357|NCT02666560|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1371358|NCT02666547||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371359|NCT02666534|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1371360|NCT02666521|||Other||Other|||||||
1371361|NCT02666508|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371362|NCT02666495||Single Group Assignment||Treatment||None (Open Label)||||||
1371363|NCT02666482||Single Group Assignment||Treatment||None (Open Label)||||||
1371364|NCT02666469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371365|NCT02666456|||Cohort||Prospective|||||||
1371366|NCT02666443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371367|NCT02666430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371368|NCT02666417|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1371369|NCT02666404||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371370|NCT02666391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371371|NCT02666378||Single Group Assignment||Screening||None (Open Label)||||||
1371372|NCT02666365|Randomized|Single Group Assignment||Prevention||Single|||t|||
1371373|NCT02666352|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371374|NCT02666339|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371375|NCT02666326|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1371376|NCT02666313||Single Group Assignment||Treatment||None (Open Label)||||||
1371377|NCT02666300|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1371378|NCT02666287|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371379|NCT02666274|||Case Control||Prospective|||||||
1371380|NCT02666261|||Cohort||Prospective|||||||
1371381|NCT02666248|||Cohort||Prospective|||||||
1371382|NCT02666235|Randomized|Parallel Assignment||Diagnostic||Triple||||t|t|t
1371383|NCT02666222|||Cohort||Prospective|||||||
1371384|NCT02666209||||||||||||
1371385|NCT02666196|Randomized|Single Group Assignment||||Single|||t|||
1371386|NCT02666183|Randomized|Parallel Assignment||Supportive Care||Single|Study personnel administering questionnaire and follow-up questions with participants will be blinded to the arm assignment of the participant|||t||
1371387|NCT02666170||Single Group Assignment||Treatment||None (Open Label)||||||
1371388|NCT02666157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371389|NCT02666144|||Case Control||Prospective|||||||
1371390|NCT02666131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371391|NCT02666118|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1371392|NCT02666105||Single Group Assignment||Treatment||None (Open Label)||||||
1371393|NCT02666092|||Case Control||Retrospective|||||||
1371394|NCT02666079||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371395|NCT02666066|||Cohort||Retrospective|||||||
1371396|NCT02666053|Randomized|Crossover Assignment||Other||||||||
1371397|NCT02666040|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1371398|NCT02666027|Randomized|Parallel Assignment||Other||Single|||t|||
1371399|NCT02666014|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1371400|NCT02666001|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1371401|NCT02665988|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371402|NCT02665975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371403|NCT02665962||Single Group Assignment||Other||||||||
1371404|NCT02665936|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1371406|NCT02665910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371407|NCT02665897|||Case-Control||Prospective|||||||
1371408|NCT02665884|||Cohort||Prospective|||||||
1371409|NCT02665871|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1371410|NCT02665858|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1371411|NCT02665845|Randomized|Parallel Assignment||Treatment||Single|||||t|
1371412|NCT02665832|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1371413|NCT02665819|||Case-Only||Prospective|||||||
1371414|NCT02665806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371415|NCT02665793|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1371416|NCT02665780||Single Group Assignment||Treatment||None (Open Label)||||||
1371417|NCT02665767|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1371418|NCT02665754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371419|NCT02665741|Randomized|Parallel Assignment||Prevention||Single|||t|||
1371420|NCT02665728||Single Group Assignment||Treatment||None (Open Label)||||||
1371421|NCT02665715|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1371422|NCT02665702||Single Group Assignment||Treatment||None (Open Label)||||||
1371423|NCT02665689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371424|NCT02665676|||Cohort||Retrospective|||||||
1371425|NCT02665663|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1371426|NCT02665650||Single Group Assignment||Treatment||None (Open Label)||||||
1371427|NCT02665637|Randomized|Parallel Assignment||||Double|||t||t|
1371428|NCT02665624|Randomized|Parallel Assignment||||Single|||||t|
1371429|NCT02665611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371430|NCT02665598|||Cohort||Retrospective|||||||
1371431|NCT02665585|Randomized|Parallel Assignment||Treatment||Single||||||t
1371432|NCT02665572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371433|NCT02665559|||Case-Only||Cross-Sectional|||||||
1371434|NCT02665546|||Other||Cross-Sectional|||||||
1371435|NCT02665533|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1371436|NCT02665520|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371437|NCT02665507|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1371438|NCT02665494|||Cohort||Prospective|||||||
1371439|NCT02665481|Randomized|Factorial Assignment||Treatment||Single||||||t
1371440|NCT02665468|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1371441|NCT02665455||Single Group Assignment||Other||None (Open Label)||||||
1371442|NCT02665442|Randomized|Parallel Assignment||Prevention||Single|||t|||
1371443|NCT02665429|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371444|NCT02665416|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371445|NCT02665403|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371446|NCT02665390||Single Group Assignment||Treatment||None (Open Label)||||||
1371447|NCT02665377|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1371448|NCT02665364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371449|NCT02665351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371450|NCT02665338|Randomized|Crossover Assignment||Other||Single|||t|||
1371451|NCT02665325|||Cohort||Prospective|||||||
1371452|NCT02665312|||Cohort||Prospective|||||||
1371453|NCT02665299|||Cohort||Prospective|||||||
1371454|NCT02665286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371455|NCT02665273|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1371456|NCT02665260|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371457|NCT02665247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371458|NCT02665234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371459|NCT02665221|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1371460|NCT02665208|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1371461|NCT02665195|||Cohort||Prospective|||||||
1371462|NCT02665182|Randomized|Parallel Assignment||Treatment||Single|||||t|
1371463|NCT02665169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371464|NCT02665156||Single Group Assignment||Treatment||None (Open Label)||||||
1371465|NCT02665143|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371466|NCT02665130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371467|NCT02665117|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1371468|NCT02665104|||Cohort||Prospective|||||||
1371469|NCT02665091||Single Group Assignment||Prevention||None (Open Label)||||||
1371470|NCT02665078|||Other||Prospective|||||||
1371471|NCT02665065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371472|NCT02665052|Randomized|Crossover Assignment||Treatment||Single|Blinded evaluator|||||t
1371473|NCT02665039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371474|NCT02665026||Single Group Assignment||Treatment||None (Open Label)||||||
1371475|NCT02665013|Randomized|Parallel Assignment||Prevention||Single||||||t
1371476|NCT02665000|Randomized|Parallel Assignment||||Single|||t|||
1371477|NCT02664987|||Case-Only||Cross-Sectional|||||||
1371478|NCT02664974|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371479|NCT02664961||Single Group Assignment||Treatment||None (Open Label)||||||
1371480|NCT02664948|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371481|NCT02664935|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371482|NCT02664922|Randomized|Parallel Assignment||Other||Single||||t||
1371483|NCT02664909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371484|NCT02664896|||Case Control||Cross-Sectional|||||||
1371485|NCT02664883|||Case-Control||Prospective|||||||
1371486|NCT02664870|||Cohort||Prospective|||||||
1371487|NCT02664857|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1371488|NCT02664844||Single Group Assignment||Treatment||None (Open Label)||||||
1371489|NCT02664831|||Cohort||Prospective|||||||
1371490|NCT02664818|||Cohort||Prospective|||||||
1371491|NCT02664805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371492|NCT02664792||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371493|NCT02664779|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371494|NCT02664766|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371495|NCT02664753|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371496|NCT02664740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371497|NCT02664727|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371498|NCT02664714|Randomized|Parallel Assignment||Treatment||Single|||||t|
1371499|NCT02664701|Randomized|Parallel Assignment||Treatment||Single||||||t
1371500|NCT02664688|Randomized|Parallel Assignment||Treatment||Single||||||t
1371501|NCT02664675|||Case Control||Cross-Sectional|||||||
1371502|NCT02664662|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1371503|NCT02664649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371504|NCT02664636||Single Group Assignment||Treatment||None (Open Label)||||||
1371505|NCT02664623|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1371506|NCT02664610|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371507|NCT02664597|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371508|NCT02664584|||Cohort||Cross-Sectional|||||||
1371509|NCT02664571|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1371510|NCT02664558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371511|NCT02664545|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371512|NCT02664532|Randomized|Parallel Assignment||||None (Open Label)||||||
1371513|NCT02664519|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1371514|NCT02664506||Single Group Assignment||Treatment||None (Open Label)||||||
1371515|NCT02664493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371516|NCT02664480|||Case Control||Prospective|||||||
1371517|NCT02664467|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1371518|NCT02664454|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371519|NCT02664441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371520|NCT02664428|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1371521|NCT02664415|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371522|NCT02664402|||Case-Only||Cross-Sectional|||||||
1371523|NCT02664389|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371524|NCT02664376|||Cohort||Prospective|||||||
1371525|NCT02664363||Single Group Assignment||Treatment||None (Open Label)||||||
1371526|NCT02664350|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371527|NCT02664337|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371528|NCT02664324|||Cohort||Prospective|||||||
1371529|NCT02664311|Randomized|Single Group Assignment||Treatment||Single|||t|||
1371530|NCT02664298|||Cohort||Prospective|||||||
1371531|NCT02664285|Randomized|Parallel Assignment||Prevention||Single|||||t|
1371532|NCT02664272|||Other||Prospective|||||||
1371533|NCT02664259|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371534|NCT02664246|||Cohort||Retrospective|||||||
1371535|NCT02664233|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371536|NCT02664220|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371537|NCT02664207||Single Group Assignment||Treatment||None (Open Label)||||||
1371538|NCT02664194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371539|NCT02664181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371540|NCT02664168|Randomized|Parallel Assignment||Prevention||||||||
1371541|NCT02664155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371542|NCT02664142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371543|NCT02664129|Randomized|Parallel Assignment||Treatment||Single||||||t
1371544|NCT02664116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371545|NCT02664103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371546|NCT02664090|||Cohort||Prospective|||||||
1371547|NCT02664077|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371548|NCT02664064|Non-Randomized|Parallel Assignment||Prevention||Single|||||t|
1371549|NCT02664051|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1371550|NCT02664038|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1371551|NCT02664025|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371552|NCT02664012|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1371553|NCT02663999|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371554|NCT02663986||Single Group Assignment||Supportive Care||None (Open Label)||||||
1371555|NCT02663973|||Case-Only||Prospective|||||||
1371556|NCT02663960|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371557|NCT02663947|||Case-Only||Prospective|||||||
1371558|NCT02663934|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371559|NCT02663921||Single Group Assignment||Other||None (Open Label)||||||
1371560|NCT02663908|Randomized|Parallel Assignment||Treatment||Single||||||t
1371561|NCT02663895||Single Group Assignment||Treatment||None (Open Label)||||||
1371562|NCT02663882|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371563|NCT02663869|||Case-Control||Retrospective|||||||
1371564|NCT02663856|||Case-Only||Prospective|||||||
1371565|NCT02663843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371566|NCT02663830|Randomized|Crossover Assignment||Treatment||Single|||t|||
1371567|NCT02663817|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1371568|NCT02663804|Randomized|Parallel Assignment||Treatment||Single||||t||
1371569|NCT02663791|||Cohort||Prospective|||||||
1371570|NCT02663778|Randomized|Parallel Assignment||Treatment||Single||||||t
1371571|NCT02663765|||Cohort||Cross-Sectional|||||||
1371572|NCT02663752||Single Group Assignment||Basic Science||None (Open Label)||||||
1371573|NCT02663739|||Case-Only||Prospective|||||||
1371574|NCT02663726|Randomized|Parallel Assignment||Treatment||Single||||||t
1371575|NCT02663713|Randomized|Crossover Assignment||Treatment||Single||||||t
1371576|NCT02663700|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1371577|NCT02663687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371578|NCT02663674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371579|NCT02663661|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371580|NCT02663648|||Case Control||Prospective|||||||
1371581|NCT02663635||Single Group Assignment||||None (Open Label)||||||
1371582|NCT02663622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371583|NCT02663609|||Case-Only||Retrospective|||||||
1371584|NCT02663596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1371585|NCT02663583|||Cohort||Prospective|||||||
1371586|NCT02663570||Single Group Assignment||Treatment||None (Open Label)||||||
1371587|NCT02663557|||Cohort||Prospective|||||||
1371588|NCT02663544|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371589|NCT02663531|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1371590|NCT02663518|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1371591|NCT02663505|||Cohort||Prospective|||||||
1371592|NCT02663492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371593|NCT02663479|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1371594|NCT02663466|||Case Control||Retrospective|||||||
1371595|NCT02663453|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371596|NCT02663440||Single Group Assignment||Treatment||None (Open Label)||||||
1371597|NCT02663427|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371598|NCT02663414||Single Group Assignment||Treatment||None (Open Label)||||||
1371599|NCT02663401|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371600|NCT02663388|||Cohort||Prospective|||||||
1371601|NCT02663375|||Case-Only||Prospective|||||||
1371602|NCT02663362|||Cohort||Cross-Sectional|||||||
1371603|NCT02663349||Single Group Assignment||Treatment||Single||||||t
1371604|NCT02663336|||Cohort||Prospective|||||||
1371605|NCT02663323||Single Group Assignment||Treatment||None (Open Label)||Single intervention with MeRes100 Device||||
1371606|NCT02663310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371607|NCT02663297||Single Group Assignment||Treatment||None (Open Label)||||||
1371608|NCT02663284||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371609|NCT02663271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1371610|NCT02663258||Single Group Assignment||Treatment||None (Open Label)||||||
1371611|NCT02663245|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371612|NCT02663232|||Cohort||Cross-Sectional|||||||
1371613|NCT02663219|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371614|NCT02663206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371615|NCT02663193|||Cohort||Prospective|||||||
1371616|NCT02663180|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371617|NCT02663167||Single Group Assignment||Treatment||None (Open Label)||||||
1371618|NCT02663154|Randomized|Parallel Assignment||Prevention||Single|||||t|
1371619|NCT02663141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371620|NCT02663128|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1371621|NCT02663115|||Cohort||Prospective|||||||
1371622|NCT02663102|||Other||Prospective|||||||
1371623|NCT02663089||Single Group Assignment||Treatment||None (Open Label)||||||
1371624|NCT02663076|||Cohort||Prospective|||||||
1371625|NCT02663063|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1371626|NCT02663050|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371627|NCT02663037|||Cohort||Prospective|||||||
1371628|NCT02663024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371629|NCT02663011|||Case-Only||Retrospective|||||||
1371630|NCT02662998|||Cohort||Prospective|||||||
1371631|NCT02662985|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371632|NCT02662972||Single Group Assignment||Treatment||None (Open Label)||||||
1371633|NCT02662959||Single Group Assignment||Treatment||None (Open Label)||||||
1371634|NCT02662946|Randomized|Parallel Assignment||Prevention||Single|||t|||
1371635|NCT02662933||Single Group Assignment||Supportive Care||None (Open Label)||||||
1371636|NCT02662920|||Cohort||Retrospective|||||||
1371637|NCT02662907|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371638|NCT02662894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371639|NCT02662881|||Cohort||Prospective|||||||
1371640|NCT02662868|||Case-Only||Retrospective|||||||
1371641|NCT02662855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371642|NCT02662842|||Case-Crossover||Prospective|||||||
1371643|NCT02662829|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371644|NCT02662816||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371645|NCT02662803|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1371646|NCT02662790||Single Group Assignment||Treatment||None (Open Label)||||||
1371647|NCT02662777|||Cohort||Prospective|||||||
1371648|NCT02662764||Single Group Assignment||Treatment||None (Open Label)||||||
1371649|NCT02662751|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1371650|NCT02662738|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1371651|NCT02662725||Single Group Assignment||Treatment||None (Open Label)||||||
1371652|NCT02662712|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1371653|NCT02662699|||Other||Retrospective|||||||
1371654|NCT02662686|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1371655|NCT02662673||Single Group Assignment||Treatment||None (Open Label)||||||
1371656|NCT02662660|Randomized|Parallel Assignment||Treatment||Single||||||t
1371657|NCT02662647|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371658|NCT02662634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371659|NCT02662621|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1371660|NCT02662608||Single Group Assignment||Treatment||None (Open Label)||||||
1371661|NCT02662595|Randomized|Parallel Assignment||Health Services Research||Double||||t|t|
1371662|NCT02662582|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1371663|NCT02662569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371664|NCT02662556||Single Group Assignment||Treatment||None (Open Label)||||||
1371665|NCT02662543|||Cohort||Prospective|||||||
1371666|NCT02662530|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371667|NCT02662517|||Cohort||Prospective|||||||
1371668|NCT02662504||Single Group Assignment||Treatment||None (Open Label)||||||
1371669|NCT02662491|Randomized|Factorial Assignment||Treatment||Quadruple|Double blind|Calcium 600mg, vitamin D 2000IU, both or placebo|t|t|t|t
1371670|NCT02662478|||Cohort||Prospective|||||||
1371671|NCT02662465|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371672|NCT02662452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371673|NCT02662439|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371674|NCT02662426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371675|NCT02662413|||Cohort||Prospective|||||||
1371676|NCT02662400||Single Group Assignment||Treatment||None (Open Label)||||||
1371677|NCT02662387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371678|NCT02662374|Randomized|Parallel Assignment||Prevention||Single|||t|||
1371679|NCT02662361|||Cohort||Retrospective|||||||
1371680|NCT02662348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1371681|NCT02662335|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371682|NCT02662322|Randomized|Parallel Assignment||Other||Single|||t|||
1371683|NCT02662309||Single Group Assignment||Treatment||None (Open Label)||||||
1371684|NCT02662296||Single Group Assignment||Treatment||None (Open Label)||||||
1371685|NCT02662283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371686|NCT02662270|||Case-Control||Cross-Sectional|||||||
1371687|NCT02662257|Randomized|Parallel Assignment||Prevention||Single||||||t
1371688|NCT02662244||Single Group Assignment||Treatment||None (Open Label)||||||
1371689|NCT02662231|||Ecologic or Community||Prospective|||||||
1371690|NCT02662218|||Cohort||Prospective|||||||
1371691|NCT02662205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371692|NCT02662192|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371693|NCT02662179|||Other||Prospective|||||||
1371694|NCT02662166||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371695|NCT02662153|||Cohort||Retrospective|||||||
1371696|NCT02662140||Single Group Assignment||Supportive Care||None (Open Label)||||||
1371697|NCT02662127||Single Group Assignment||Basic Science||None (Open Label)||||||
1371698|NCT02662114|||Cohort||Retrospective|||||||
1371699|NCT02662101||Single Group Assignment||Basic Science||None (Open Label)||||||
1371700|NCT02662088|||Cohort||Cross-Sectional|||||||
1371701|NCT02662075||Single Group Assignment||Other||None (Open Label)||||||
1371702|NCT02662062||Single Group Assignment||Treatment||None (Open Label)||||||
1371703|NCT02662049||||||||||||
1371704|NCT02662036|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1371705|NCT02662023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371706|NCT02662010|||Case-Control||Cross-Sectional|||||||
1371707|NCT02661997|Randomized|Parallel Assignment||Treatment||Single||||||t
1371708|NCT02661984|||Cohort||Prospective|||||||
1371709|NCT02661971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371710|NCT02661958|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371711|NCT02661945|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371712|NCT02661932||Single Group Assignment||Prevention||None (Open Label)||||||
1371713|NCT02661919||Single Group Assignment||Prevention||None (Open Label)||||||
1371714|NCT02661906|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371715|NCT02661893||Single Group Assignment||Treatment||None (Open Label)||||||
1371716|NCT02661880||Single Group Assignment||Supportive Care||None (Open Label)||||||
1371717|NCT02661867|||Cohort||Prospective|||||||
1371718|NCT02661854|Randomized|Parallel Assignment||Screening||Double|||t||t|
1371719|NCT02661841|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372329|NCT02653859|||Cohort||Prospective|||||||
1371720|NCT02661828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371721|NCT02661815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371722|NCT02661802||Single Group Assignment||Supportive Care||None (Open Label)||||||
1371723|NCT02661789|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1371724|NCT02661776|||Cohort||Prospective|||||||
1371725|NCT02661763|||Ecologic or Community||Cross-Sectional|||||||
1371726|NCT02661750|||Case-Only||Prospective|||||||
1371727|NCT02661737|||||Prospective|||||||
1371728|NCT02661724|Randomized|Parallel Assignment||Treatment||Single||||||t
1371729|NCT02661711||Single Group Assignment||Treatment||None (Open Label)||||||
1371730|NCT02661698|Randomized|Crossover Assignment||||Triple|||t||t|t
1371731|NCT02661685||Single Group Assignment||Treatment||None (Open Label)||||||
1371732|NCT02661672||Single Group Assignment||Treatment||None (Open Label)||||||
1371733|NCT02661659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371734|NCT02661646|||Cohort||Prospective|||||||
1371735|NCT02661633|||Cohort||Prospective|||||||
1371736|NCT02661620|||Case-Only||Retrospective|||||||
1371737|NCT02661607||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371738|NCT02661594|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1371739|NCT02661581|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371740|NCT02661568|||Cohort||Retrospective|||||||
1371741|NCT02661555|Randomized|Crossover Assignment||Treatment||Single||||||t
1371742|NCT02661542|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1371743|NCT02661529|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1371744|NCT02661516|||Cohort||Retrospective|||||||
1371745|NCT02661503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371746|NCT02661490|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1371747|NCT02661477|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1371748|NCT02661464||Single Group Assignment||Prevention||None (Open Label)||||||
1371749|NCT02661451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371750|NCT02661438||Single Group Assignment||Other||None (Open Label)||||||
1371751|NCT02661425|||Case Control||Retrospective|||||||
1371752|NCT02661412|||Cohort||Retrospective|||||||
1371753|NCT02661399|||Other||Other|||||||
1371754|NCT02661386||Single Group Assignment||Supportive Care||None (Open Label)||||||
1371755|NCT02661373||Single Group Assignment||Other||None (Open Label)||||||
1371756|NCT02661360|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1371757|NCT02661347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371758|NCT02661334|Randomized|Parallel Assignment||Other||Double|||t||t|
1371759|NCT02661321|||Cohort||Prospective|||||||
1371760|NCT02661308|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1371761|NCT02661295||Single Group Assignment||||None (Open Label)||||||
1371762|NCT02661282|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371763|NCT02661269|||Cohort||Prospective|||||||
1371764|NCT02661256|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1371765|NCT02661243|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371766|NCT02661230||Single Group Assignment||Treatment||None (Open Label)||||||
1371767|NCT02661217|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1371768|NCT02661204|||Cohort||Prospective|||||||
1371769|NCT02661191||Single Group Assignment||Treatment||None (Open Label)||||||
1371770|NCT02661178|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1371771|NCT02661165|||Cohort||Retrospective|||||||
1371772|NCT02661152|Randomized|Parallel Assignment||||Single||||t||
1371773|NCT02661139|||Cohort||Prospective|||||||
1371774|NCT02661126|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371775|NCT02661100||Single Group Assignment||Treatment||None (Open Label)||||||
1371776|NCT02661087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371777|NCT02661074|||Case Control||Prospective|||||||
1371778|NCT02661061|Randomized|Parallel Assignment||Other||Quadruple|Masking took place by sealed envelope random allocation and double blinding of participants and raters was assessed throughout. The anaesthesiologist administering infusions was aware of the allocation.|A randomised, double-blind, placebo-controlled study designed to assess feasibility of recruitment, randomisation and retention.|t|t|t|t
1371779|NCT02661048||Single Group Assignment||Treatment||None (Open Label)||||||
1371780|NCT02661035||Single Group Assignment||Treatment||None (Open Label)||||||
1371781|NCT02661022||Single Group Assignment||Treatment||None (Open Label)||||||
1371782|NCT02661009|||Cohort||Retrospective|||||||
1371783|NCT02660996|||Cohort||Prospective|||||||
1371784|NCT02660983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371785|NCT02660970|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371786|NCT02660957|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371787|NCT02660944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371788|NCT02660931|Randomized|Parallel Assignment||Screening||Double|||t|t||
1371789|NCT02660918|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371790|NCT02660905||Single Group Assignment||Treatment||None (Open Label)||||||
1371791|NCT02660892||Single Group Assignment||Basic Science||None (Open Label)||||||
1371792|NCT02660879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371793|NCT02660866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371794|NCT02660853|||Cohort||Prospective|||||||
1371795|NCT02660840|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371796|NCT02660827||Single Group Assignment||Treatment||None (Open Label)||||||
1371797|NCT02660814|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371798|NCT02660801|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1371799|NCT02660788|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1371800|NCT02660775|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1371801|NCT02660762||Single Group Assignment||Treatment||None (Open Label)||||||
1371802|NCT02660749|||Case Control||Prospective|||||||
1371803|NCT02660736|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1371804|NCT02660723||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371805|NCT02660710||Single Group Assignment||Treatment||None (Open Label)||||||
1371806|NCT02660697|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371807|NCT02660684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1371808|NCT02660671|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1371809|NCT02660658||Single Group Assignment||Prevention||None (Open Label)||||||
1371810|NCT02660645|||Case-Only||Prospective|||||||
1371811|NCT02660632|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1371812|NCT02660619|||||Cross-Sectional|||||||
1371813|NCT02660606|||Case-Only||Prospective|||||||
1371814|NCT02660593||Single Group Assignment||Treatment||None (Open Label)||||||
1371815|NCT02660580|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371816|NCT02660567|Randomized|Parallel Assignment||Prevention||Single|||t|||
1371817|NCT02660554|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371818|NCT02660541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371819|NCT02660528||Single Group Assignment||Treatment||None (Open Label)||||||
1371820|NCT02660515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371821|NCT02660502|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1371822|NCT02660489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371823|NCT02660476|||Cohort||Cross-Sectional|||||||
1371824|NCT02660463|||Case Control||Prospective|||||||
1371825|NCT02660450|Randomized|Parallel Assignment||||None (Open Label)||||||
1371826|NCT02660437|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1371827|NCT02660424|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1371828|NCT02660411|Randomized|Parallel Assignment||Prevention||Single||||||t
1371829|NCT02660398|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371830|NCT02660385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371831|NCT02660372|Randomized|Parallel Assignment||Treatment||Single|||||t|
1371832|NCT02660359|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371833|NCT02660346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371834|NCT02660333|Randomized|Parallel Assignment||Treatment||Quadruple|Study participants and researchers were masked over consumption and distribution of supplementation, respectively. Laboratory technicians who performed the blood collection were also masked as to the distribution of supplementation. Supplements and placebo were pre-packaged by the supplier in opaque and closed sachets with randomization codes, being identical in physical appearance, taste and color. Supplement identification codes were only disclosed by the supplier after statistical analysis of study data.||t|t|t|t
1371835|NCT02660320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371836|NCT02660307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371837|NCT02660294|Randomized|Parallel Assignment||Treatment||Single||||||t
1371838|NCT02660281|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371839|NCT02660268|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371840|NCT02660255||||||||||||
1371841|NCT02660242|Randomized|Crossover Assignment||Prevention||Single|||t|||
1371842|NCT02660229|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371843|NCT02660216|||Cohort||Prospective|||||||
1371844|NCT02660203|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371845|NCT02660190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371846|NCT02660177||Single Group Assignment||Other||None (Open Label)||||||
1371847|NCT02660164|||Case-Control||Prospective|||||||
1371848|NCT02660151|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371849|NCT02660138|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371850|NCT02660125|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1371851|NCT02660112||Single Group Assignment||Treatment||None (Open Label)||||||
1371852|NCT02660099||Single Group Assignment||Treatment||None (Open Label)||||||
1371853|NCT02660086|Randomized|Parallel Assignment||Prevention||Single||||||t
1371854|NCT02660073|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371855|NCT02660060|Randomized|Crossover Assignment||||None (Open Label)||||||
1371856|NCT02660047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371857|NCT02660034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1371858|NCT02660021|||Cohort||Prospective|||||||
1371859|NCT02660008|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1371860|NCT02659995|||Cohort||Prospective|||||||
1371861|NCT02659982|||Cohort||Retrospective|||||||
1371862|NCT02659956|||Cohort||Prospective|||||||
1371863|NCT02659943|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1371864|NCT02659930|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371865|NCT02659917|Randomized|Parallel Assignment||Prevention||Single|||||t|
1371866|NCT02659904|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371867|NCT02659891|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1371868|NCT02659878|||Case-Only||Prospective|||||||
1371869|NCT02659865|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1371870|NCT02659852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371871|NCT02659839|||Cohort||Prospective|||||||
1371872|NCT02659826|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1371873|NCT02659813|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1371874|NCT02659800|Randomized|Parallel Assignment||Supportive Care||Double|participant is blinded and randomized in the second part of study.|Dose Escalation - 3 levels - Group A Dexamethasone less/equal 0.75mg/day; Group B Dexamethasone greater/equal 4mg/day. At MTD Group A - w/Dexamethasone randomized Arm 1 placebo and Arm 2 MTD; Group B MTD w/out Dexamethasone single arm|t|t||
1371875|NCT02659787|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1371876|NCT02659774|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1371877|NCT02659761||Single Group Assignment||Treatment||None (Open Label)||||||
1371878|NCT02659748|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1371879|NCT02659735|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371880|NCT02659722|||Case-Only||Prospective|||||||
1371881|NCT02659709||Single Group Assignment||Health Services Research||None (Open Label)||||||
1371882|NCT02659696|||Cohort||Prospective|||||||
1371883|NCT02659683|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371884|NCT02659657||Single Group Assignment||Prevention||None (Open Label)||||||
1371885|NCT02659644||Single Group Assignment||Diagnostic||None (Open Label)||||||
1371886|NCT02659631||||Treatment||None (Open Label)||||||
1371887|NCT02659618|||Cohort||Prospective|||||||
1371888|NCT02659605|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1371889|NCT02659592||Single Group Assignment||Treatment||None (Open Label)||||||
1371890|NCT02659579|Randomized|Parallel Assignment||Other||Single||||||t
1371891|NCT02659566|||Cohort||Prospective|||||||
1371892|NCT02659553|||Cohort||Retrospective|||||||
1371893|NCT02659540|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371894|NCT02659527|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1371895|NCT02659514||Single Group Assignment||Treatment||None (Open Label)||||||
1371896|NCT02659501|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371897|NCT02659488||Single Group Assignment||||None (Open Label)||||||
1371898|NCT02659475||Single Group Assignment||Treatment||None (Open Label)||||||
1371899|NCT02659462|||Cohort||Prospective|||||||
1371900|NCT02659449|||Case-Crossover||Prospective|||||||
1371901|NCT02659436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371902|NCT02659423|||Other||Prospective|||||||
1371903|NCT02659410||Single Group Assignment||Prevention||None (Open Label)||||||
1371904|NCT02659397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371905|NCT02659384|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371906|NCT02659371||Single Group Assignment||Treatment||None (Open Label)||||||
1371907|NCT02659358|||Cohort||Prospective|||||||
1371908|NCT02659345||Single Group Assignment||Supportive Care||None (Open Label)||||||
1371909|NCT02659332||Single Group Assignment||Treatment||None (Open Label)||||||
1371910|NCT02659319|Randomized|Factorial Assignment||Prevention||Single||||||t
1371911|NCT02659306||Single Group Assignment||Treatment||None (Open Label)||||||
1371912|NCT02659293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371913|NCT02659280|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1371914|NCT02659267|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1371915|NCT02659254||Single Group Assignment||Treatment||None (Open Label)||||||
1371916|NCT02659241||Single Group Assignment||Treatment||None (Open Label)||||||
1371917|NCT02659228|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1371918|NCT02659215|Randomized|Parallel Assignment||Treatment||Single||||||t
1371919|NCT02659202||Single Group Assignment||Basic Science||None (Open Label)||||||
1371920|NCT02659189|||Cohort||Prospective|||||||
1371921|NCT02659176|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1371922|NCT02659163|Randomized|Parallel Assignment||Prevention||Single|||t|||
1371923|NCT02659150||Single Group Assignment||Treatment||None (Open Label)||||||
1371924|NCT02659137|||||Prospective|||||||
1371925|NCT02659124||Single Group Assignment||Supportive Care||None (Open Label)||||||
1371926|NCT02659111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371927|NCT02659098||Single Group Assignment||Treatment||None (Open Label)||||||
1371928|NCT02659085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371929|NCT02659072|||Ecologic or Community||Prospective|||||||
1371930|NCT02659059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371931|NCT02659046|||Case-Control||Retrospective|||||||
1371932|NCT02659033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371933|NCT02659020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371934|NCT02659007||Single Group Assignment||Treatment||None (Open Label)||||||
1371935|NCT02658994|Randomized|Parallel Assignment||Treatment||Single||||||t
1371936|NCT02658981|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371937|NCT02658968||Sequential Assignment||Treatment||None (Open Label)||||||
1371938|NCT02658955|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371939|NCT02658942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371940|NCT02658929||Single Group Assignment||Treatment||None (Open Label)||||||
1371941|NCT02658916|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371942|NCT02658903|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372330|NCT02653846|||Cohort||Prospective|||||||
1371943|NCT02658890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371944|NCT02658877|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371945|NCT02658864|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1371946|NCT02658851||Single Group Assignment||Prevention||None (Open Label)||||||
1371947|NCT02658838|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371948|NCT02658825|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1371949|NCT02658812||Single Group Assignment||Treatment||None (Open Label)||||||
1371950|NCT02658799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371951|NCT02658786|||Cohort||Prospective|||||||
1371952|NCT02658773|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1371953|NCT02658760|Randomized|Parallel Assignment||Treatment||Single||||||t
1371954|NCT02658747|||Cohort||Retrospective|||||||
1371955|NCT02658734||Single Group Assignment||Basic Science||None (Open Label)||||||
1371956|NCT02658721|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371957|NCT02658708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371958|NCT02658695|||Case Control||Prospective|||||||
1371959|NCT02658682|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1371960|NCT02658669|Randomized|Parallel Assignment||Treatment||Single||||||t
1371961|NCT02658656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371962|NCT02658643|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1371963|NCT02658630||Single Group Assignment||Treatment||None (Open Label)|The outcomes assessor is masked as to the prediction model and to particulars of performance during the intervention, but knows that there is a single group design.|||||
1371964|NCT02658617|||Cohort||Prospective|||||||
1371965|NCT02658604|||Cohort||Cross-Sectional|||||||
1371966|NCT02658591|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1371967|NCT02658578|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1371968|NCT02658565|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371969|NCT02658552||Single Group Assignment||Treatment||None (Open Label)||||||
1371970|NCT02658539|||Cohort||Cross-Sectional|||||||
1371971|NCT02658526|||Cohort||Prospective|||||||
1371972|NCT02658513|||Cohort||Prospective|||||||
1371973|NCT02658500|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1371974|NCT02658487||Single Group Assignment||Treatment||None (Open Label)||||||
1371975|NCT02658474|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1371976|NCT02658461|||Cohort||Prospective|||||||
1371977|NCT02658448||Single Group Assignment||Treatment||None (Open Label)||||||
1371978|NCT02658435|Randomized|Parallel Assignment||Treatment||Single|||t|||
1371979|NCT02658422|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1371980|NCT02658409|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1371981|NCT02658396||Single Group Assignment||Treatment||None (Open Label)||||||
1371982|NCT02658383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1371983|NCT02658370|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1371984|NCT02658357|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371985|NCT02658344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371986|NCT02658331|||Case-Only||Cross-Sectional|||||||
1371987|NCT02658318|||Case Control||Retrospective|||||||
1371988|NCT02658305|||Case Control||Retrospective|||||||
1371989|NCT02658292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1371990|NCT02658279||Single Group Assignment||Treatment||None (Open Label)||||||
1371991|NCT02658266|Randomized|Parallel Assignment||Treatment||Single||||||t
1371992|NCT02658253|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1371993|NCT02658240|Randomized|Parallel Assignment||Treatment||Single||||||t
1371994|NCT02658214|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1371995|NCT02658201||Single Group Assignment||Treatment||None (Open Label)||||||
1371996|NCT02658188||Single Group Assignment||Treatment||None (Open Label)||||||
1371997|NCT02658175||Single Group Assignment||Treatment||None (Open Label)||||||
1371998|NCT02658162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1371999|NCT02658149|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372000|NCT02658136||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372001|NCT02658123|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372002|NCT02658110|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1372003|NCT02658097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372004|NCT02658084|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1372005|NCT02658071|||Case-Only||Prospective|||||||
1372006|NCT02658058|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372007|NCT02658045|||Cohort||Prospective|||||||
1372008|NCT02658032|Randomized|Factorial Assignment||Prevention||Single|||t|||
1372009|NCT02658019||Single Group Assignment||Treatment||None (Open Label)||||||
1372010|NCT02658006|||Cohort||Prospective|||||||
1372011|NCT02657993|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1372012|NCT02657980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372013|NCT02657967|||Cohort||Prospective|||||||
1372014|NCT02657954|Randomized|Parallel Assignment||Treatment||Single||||||t
1372015|NCT02657941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372016|NCT02657928||Single Group Assignment||Treatment||None (Open Label)||||||
1372093|NCT02656927|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1372094|NCT02656914|Randomized|Parallel Assignment||Treatment||Double|Double blind study||t||t|
1372017|NCT02657915|Randomized|||||Triple|This was a follow-up study with no investigational product; however, the allocation method in RENEW was randomised-controlled and to maintain the blind from RENEW, the treatment disclosure for RENEW was not shared with study sites or participants until the end of this study.||t||t|t
1372018|NCT02657902|||Cohort||Retrospective|||||||
1372019|NCT02657889||Single Group Assignment||Treatment||None (Open Label)||||||
1372020|NCT02657876||Single Group Assignment||Treatment||None (Open Label)||||||
1372021|NCT02657863|||Cohort||Prospective|||||||
1372022|NCT02657850|||Cohort||Prospective|||||||
1372023|NCT02657837|||Cohort||Prospective|||||||
1372024|NCT02657824|||||Prospective|||||||
1372025|NCT02657811|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372026|NCT02657798|||Other||Cross-Sectional|||||||
1372027|NCT02657785||Single Group Assignment||Treatment||None (Open Label)||||||
1372028|NCT02657772|||Cohort||Prospective|||||||
1372029|NCT02657759|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1372030|NCT02657746|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1372031|NCT02657733||Single Group Assignment||||None (Open Label)||||||
1372032|NCT02657720||Single Group Assignment||||None (Open Label)||||||
1372033|NCT02657707||Single Group Assignment||Treatment||None (Open Label)||||||
1372034|NCT02657694|||Cohort||Prospective|||||||
1372035|NCT02657681|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372036|NCT02657668|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372037|NCT02657655||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372038|NCT02657642|||Cohort||Prospective|||||||
1372039|NCT02657629|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372040|NCT02657616|||Cohort||Retrospective|||||||
1372041|NCT02657603|Randomized|Parallel Assignment||Other||Double|||t|||t
1372042|NCT02657590|||Cohort||Prospective|||||||
1372043|NCT02657577|||Ecologic or Community||Other|||||||
1372044|NCT02657564||Single Group Assignment||Health Services Research||None (Open Label)||||||
1372045|NCT02657551||Single Group Assignment||Treatment||None (Open Label)||||||
1372046|NCT02657538|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1372047|NCT02657525|||Case-Only||Prospective|||||||
1372048|NCT02657512|Randomized|Factorial Assignment||||Single||||||t
1372049|NCT02657499|||Case-Control||Prospective|||||||
1372050|NCT02657486||Single Group Assignment||Treatment||None (Open Label)||||||
1372051|NCT02657473|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372052|NCT02657460|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372053|NCT02657447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372054|NCT02657434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372055|NCT02657421|||Cohort||Prospective|||||||
1372056|NCT02657408|Randomized|Parallel Assignment||Treatment||Double||||||
1372057|NCT02657395||Single Group Assignment||Treatment||None (Open Label)||Bovine collagen matrix -PriMatrix||||
1372058|NCT02657382|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372059|NCT02657369||Single Group Assignment||Treatment||None (Open Label)||||||
1372060|NCT02657356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372061|NCT02657343|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372062|NCT02657330||Single Group Assignment||Treatment||None (Open Label)||||||
1372063|NCT02657317|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1372064|NCT02657304|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372065|NCT02657291|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1372066|NCT02657278||Single Group Assignment||Screening||None (Open Label)||||||
1372067|NCT02657265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372068|NCT02657252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372069|NCT02657239||Single Group Assignment||Prevention||None (Open Label)||||||
1372070|NCT02657226|||Cohort||Retrospective|||||||
1372071|NCT02657213|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372072|NCT02657200||Single Group Assignment||Health Services Research||None (Open Label)||||||
1372073|NCT02657187|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1372074|NCT02657174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372075|NCT02657161|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372076|NCT02657148|||Case-Control||Prospective|||||||
1372077|NCT02657135||Single Group Assignment||Health Services Research||None (Open Label)||||||
1372078|NCT02657122|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1372079|NCT02657109|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372080|NCT02657096|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1372081|NCT02657083|Randomized|Crossover Assignment||Treatment||Single|||||t|
1372082|NCT02657070|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372083|NCT02657057|Randomized|Parallel Assignment||Treatment||Single||||||t
1372084|NCT02657044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372085|NCT02657031|Randomized|Parallel Assignment||Treatment||Double||Double-Blind Randomized Clinical Control Trial|t|t||
1372086|NCT02657018|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1372087|NCT02657005||Single Group Assignment||Treatment||None (Open Label)||||||
1372088|NCT02656992|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372089|NCT02656979|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1372090|NCT02656966|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372091|NCT02656953|Randomized|Parallel Assignment||Other||Single|||||t|
1372092|NCT02656940|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372095|NCT02656901|Randomized|Parallel Assignment||Screening||Double|||t|t||
1372096|NCT02656888|Randomized|Parallel Assignment||Treatment||Double|Double blind study||t||t|
1372097|NCT02656875||Single Group Assignment||Treatment||None (Open Label)||||||
1372098|NCT02656862|||Case-Only||Cross-Sectional|||||||
1372099|NCT02656849||Single Group Assignment||Treatment||None (Open Label)||||||
1372100|NCT02656836|||Case-Only||Prospective|||||||
1372101|NCT02656823||Single Group Assignment||Treatment||None (Open Label)||||||
1372102|NCT02656810|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1372103|NCT02656797|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372104|NCT02656784|Randomized|Parallel Assignment||Treatment||Single|||||t|
1372105|NCT02656771|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372106|NCT02656758|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1372107|NCT02656745||Single Group Assignment||Treatment||None (Open Label)||||||
1372108|NCT02656732|Randomized|Parallel Assignment||Treatment||Single||||||t
1372109|NCT02656719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372110|NCT02656706||Single Group Assignment||Treatment||None (Open Label)||||||
1372111|NCT02656693|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372112|NCT02656680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372113|NCT02656667|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372114|NCT02656654||Single Group Assignment||Treatment||None (Open Label)||||||
1372115|NCT02656641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372116|NCT02656628|||Cohort||Prospective|||||||
1372117|NCT02656615||Single Group Assignment||Treatment||None (Open Label)||||||
1372118|NCT02656602|Non-Randomized|Single Group Assignment||Health Services Research||Single||||t||
1372119|NCT02656589|||Cohort||Prospective|||||||
1372120|NCT02656576||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372121|NCT02656563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372122|NCT02656550||Single Group Assignment||Treatment||None (Open Label)||||||
1372123|NCT02656537||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372124|NCT02656524|||Cohort||Retrospective|||||||
1372125|NCT02656511||Single Group Assignment||Treatment||None (Open Label)||||||
1372126|NCT02656498|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1372127|NCT02656485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372128|NCT02656472|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1372129|NCT02656459|||Cohort||Prospective|||||||
1372130|NCT02656446|||Case-Only||Prospective|||||||
1372131|NCT02656433|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1372132|NCT02656420|Randomized|Parallel Assignment||Prevention||Single|||t|||
1372133|NCT02656407||Single Group Assignment||Health Services Research||None (Open Label)||||||
1372134|NCT02656394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372135|NCT02656381|||Cohort||Prospective|||||||
1372136|NCT02656368||Single Group Assignment||Treatment||None (Open Label)||||||
1372137|NCT02656355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372138|NCT02656342|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1372139|NCT02656329|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372140|NCT02656316|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372141|NCT02656303||Single Group Assignment||Treatment||None (Open Label)||||||
1372142|NCT02656290||Single Group Assignment||Treatment||None (Open Label)||||||
1372143|NCT02656277|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372144|NCT02656264|||Case-Only||Prospective|||||||
1372145|NCT02656251|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1372146|NCT02656238|||Cohort||Prospective|||||||
1372147|NCT02656225|Randomized|Parallel Assignment||Treatment||Single||||t||
1372148|NCT02656212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372149|NCT02656199|||Cohort||Prospective|||||||
1372150|NCT02656186||Single Group Assignment||Supportive Care||None (Open Label)||||||
1372151|NCT02656173|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372152|NCT02656160|Randomized|Crossover Assignment||Treatment||Single|||||t|
1372153|NCT02656147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372154|NCT02656134|||Cohort||Prospective|||||||
1372155|NCT02656121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372156|NCT02656108|Randomized|Parallel Assignment||Prevention||Single||||||t
1372157|NCT02656095|||Cohort||Prospective|||||||
1372158|NCT02656082||Single Group Assignment||Treatment||None (Open Label)||||||
1372159|NCT02656069|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1372160|NCT02656056|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372161|NCT02656043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372162|NCT02656030|Randomized|Parallel Assignment||Treatment||Single|||||t|
1372163|NCT02656017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372164|NCT02656004|Randomized|Crossover Assignment||||Single|||t|||
1372165|NCT02655991|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372166|NCT02655978|||Case-Control||Cross-Sectional|||||||
1372167|NCT02655965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372168|NCT02655952||Single Group Assignment||Treatment||None (Open Label)||||||
1372169|NCT02655939|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1372170|NCT02655926|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1372171|NCT02655913|Randomized|Parallel Assignment||Treatment||Single||||||t
1372172|NCT02655900|||Cohort||Prospective|||||||
1372174|NCT02655874|Randomized|Parallel Assignment||Prevention||Single||||||t
1372175|NCT02655861|||Case-Only||Prospective|||||||
1372176|NCT02655848|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372177|NCT02655835|Randomized|Parallel Assignment||Other||Single|||||t|
1372178|NCT02655822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372179|NCT02655809||Single Group Assignment||Basic Science||None (Open Label)||||||
1372180|NCT02655796|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1372181|NCT02655783|Randomized|Parallel Assignment||||Triple|||t|t|t|
1372182|NCT02655770|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372183|NCT02655757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372184|NCT02655744|||Cohort||Prospective|||||||
1372185|NCT02655731||Single Group Assignment||Treatment||None (Open Label)||||||
1372186|NCT02655718||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372187|NCT02655705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372188|NCT02655692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372189|NCT02655679|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1372190|NCT02655666|||Cohort||Prospective|||||||
1372191|NCT02655653|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1372192|NCT02655640|||Cohort||Prospective|||||||
1372193|NCT02655627|Randomized|Parallel Assignment||Treatment||Single||||||t
1372194|NCT02655614|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1372195|NCT02655601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372196|NCT02655588|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372197|NCT02655575|Randomized|Parallel Assignment||Treatment||Single||||||t
1372198|NCT02655562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372199|NCT02655549|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1372200|NCT02655536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372201|NCT02655523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372202|NCT02655510||Single Group Assignment||Treatment||None (Open Label)||||||
1372203|NCT02655497|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372204|NCT02655484||Single Group Assignment||||None (Open Label)||||||
1372205|NCT02655471||Single Group Assignment||Treatment||None (Open Label)||||||
1372206|NCT02655458||Single Group Assignment||Treatment||None (Open Label)||||||
1372207|NCT02655445|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1372208|NCT02655432|||Case-Only||Retrospective|||||||
1372209|NCT02655419|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372210|NCT02655406|Randomized|Parallel Assignment||Treatment||Single||||||t
1372211|NCT02655393|Randomized|Factorial Assignment||||Triple|||t||t|t
1372212|NCT02655380|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1372213|NCT02655367|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1372214|NCT02655354|Randomized|Parallel Assignment||Treatment||Single||||||t
1372215|NCT02655341|||Cohort||Prospective|||||||
1372216|NCT02655328||Single Group Assignment||Treatment||None (Open Label)||||||
1372217|NCT02655315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372218|NCT02655302|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372219|NCT02655289|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1372220|NCT02655276|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1372221|NCT02655263|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1372222|NCT02655250|||Cohort||Prospective|||||||
1372223|NCT02655237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372224|NCT02655224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372225|NCT02655211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372226|NCT02655198||Single Group Assignment||Treatment||None (Open Label)||||||
1372227|NCT02655185|||Cohort||Retrospective|||||||
1372228|NCT02655172|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372229|NCT02655159|||Case Control||Retrospective|||||||
1372230|NCT02655146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372231|NCT02655133|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372232|NCT02655120|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372233|NCT02655107|||Cohort||Prospective|||||||
1372234|NCT02655094|||Cohort||Retrospective|||||||
1372235|NCT02655081||Single Group Assignment||Basic Science||None (Open Label)||||||
1372236|NCT02655068|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1372237|NCT02655055|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1372238|NCT02655042|||Cohort||Prospective|||||||
1372239|NCT02655029|||Cohort||Prospective|||||||
1372240|NCT02655016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372241|NCT02655003|Randomized|Parallel Assignment||Treatment||Single||||||t
1372242|NCT02654990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372243|NCT02654977||Single Group Assignment||Treatment||None (Open Label)||||||
1372244|NCT02654964||Single Group Assignment||Treatment||None (Open Label)||||||
1372245|NCT02654951|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1372246|NCT02654938|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372247|NCT02654925|||Case-Control||Other|||||||
1372248|NCT02654912|Randomized|Parallel Assignment||Treatment||Single||||||t
1372249|NCT02654899|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1372250|NCT02654886||Single Group Assignment||Treatment||None (Open Label)||||||
1372251|NCT02654873|||Case-Only||Prospective|||||||
1372252|NCT02654860|Randomized|Parallel Assignment||Supportive Care||Double|Phase II only|4 arms for Phase II only|t||t|
1372253|NCT02654847|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372254|NCT02654834|||Case-Control||Prospective|||||||
1372255|NCT02654821||Single Group Assignment||Treatment||None (Open Label)||||||
1372256|NCT02654808|Randomized|Parallel Assignment||||None (Open Label)||||||
1372257|NCT02654795|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1372258|NCT02654782|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1372259|NCT02654769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372260|NCT02654756|||Cohort||Retrospective|||||||
1372261|NCT02654743||Single Group Assignment||||None (Open Label)||||||
1372262|NCT02654730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372263|NCT02654717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372264|NCT02654704|||Other||Prospective|||||||
1372265|NCT02654691|||Cohort||Prospective|||||||
1372266|NCT02654678||Single Group Assignment||Treatment||None (Open Label)||||||
1372267|NCT02654665|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372268|NCT02654652|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1372269|NCT02654639||Single Group Assignment||Treatment||None (Open Label)||||||
1372270|NCT02654626|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372271|NCT02654613|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372272|NCT02654600|||Cohort||Prospective|||||||
1372273|NCT02654587|Randomized|Parallel Assignment||Treatment||None (Open Label)||Step 1 primary objective: Overall Survival rate (approx. 100 patients) / Step 2 primary objective: Overall Survival (approx. 325 patients in total, number to be reassessed based on the step 1 results)||||
1372274|NCT02654574|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1372275|NCT02654561|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372276|NCT02654548|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1372277|NCT02654535|||||Prospective|||||||
1372278|NCT02654522|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372279|NCT02654509||Single Group Assignment||Prevention||None (Open Label)||||||
1372280|NCT02654496|||Case-Control||Cross-Sectional|||||||
1372281|NCT02654483|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1372282|NCT02654470|||Cohort||Prospective|||||||
1372283|NCT02654457|||Cohort||Retrospective|||||||
1372284|NCT02654444|||Cohort||Retrospective|||||||
1372285|NCT02654431|||Cohort||Retrospective|||||||
1372286|NCT02654418|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372287|NCT02654405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372288|NCT02654392|Randomized|Parallel Assignment||||Double|||t||t|
1372289|NCT02654379|||Cohort||Retrospective|||||||
1372290|NCT02654366||Single Group Assignment||Health Services Research||None (Open Label)||||||
1372291|NCT02654353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372292|NCT02654340|||Cohort||Prospective|||||||
1372293|NCT02654327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372294|NCT02654314|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1372295|NCT02654301|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1372296|NCT02654288|||Cohort||Prospective|||||||
1372297|NCT02654275|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372298|NCT02654262|||Cohort||Prospective|||||||
1372299|NCT02654249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372300|NCT02654236|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1372301|NCT02654223|Randomized|Parallel Assignment||Screening||Double|||t||t|
1372302|NCT02654210|||Cohort||Prospective|||||||
1372303|NCT02654197|||Cohort||Prospective|||||||
1372304|NCT02654184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372305|NCT02654171|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372306|NCT02654158|||Case-Only||Prospective|||||||
1372307|NCT02654145||Single Group Assignment||Treatment||None (Open Label)||||||
1372308|NCT02654132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372309|NCT02654119||Single Group Assignment||Treatment||None (Open Label)||||||
1372310|NCT02654106||Single Group Assignment||Treatment||None (Open Label)||||||
1372311|NCT02654093|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1372312|NCT02654080|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1372313|NCT02654067|||Cohort||Prospective|||||||
1372314|NCT02654054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372315|NCT02654041||Single Group Assignment||Supportive Care||None (Open Label)||||||
1372316|NCT02654028|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1372317|NCT02654015||Single Group Assignment||Treatment||None (Open Label)||||||
1372318|NCT02654002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372319|NCT02653989||Single Group Assignment||Treatment||None (Open Label)||||||
1372320|NCT02653976||Single Group Assignment||Treatment||None (Open Label)||||||
1372321|NCT02653963|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1372322|NCT02653950|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372323|NCT02653937||Single Group Assignment||Treatment||None (Open Label)||||||
1372324|NCT02653924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372325|NCT02653911|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372326|NCT02653898|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372327|NCT02653885|||Case-Crossover||Retrospective|||||||
1372328|NCT02653872|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372331|NCT02653833|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372332|NCT02653820||Single Group Assignment||Supportive Care||None (Open Label)||||||
1372333|NCT02653807|Randomized|Parallel Assignment||Treatment||Single||||||t
1372334|NCT02653794|||||Cross-Sectional|||||||
1372335|NCT02653781|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1372336|NCT02653768|Randomized|Parallel Assignment||Treatment||Single||||||t
1372337|NCT02653755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372338|NCT02653742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372339|NCT02653729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372340|NCT02653716|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1372341|NCT02653703|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1372342|NCT02653677|Randomized|Crossover Assignment||Prevention||Single||||||t
1372343|NCT02653664|Randomized|Parallel Assignment||Treatment||Single||||||t
1372344|NCT02653651|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1372345|NCT02653638||Single Group Assignment||Other||None (Open Label)||||||
1372346|NCT02653625||Single Group Assignment||Treatment||None (Open Label)||||||
1372347|NCT02653612||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372348|NCT02653599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372349|NCT02653586|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372350|NCT02653573||Single Group Assignment||Treatment||None (Open Label)||||||
1372351|NCT02653560|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1372352|NCT02653547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372353|NCT02653534|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372354|NCT02653521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372355|NCT02653508|Randomized|Parallel Assignment||||Single|||t|||
1372356|NCT02653495|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372357|NCT02653482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372358|NCT02653469|||Cohort||Prospective|||||||
1372359|NCT02653456||Single Group Assignment||Treatment||None (Open Label)||||||
1372360|NCT02653443|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1372361|NCT02653430||Single Group Assignment||Treatment||None (Open Label)||||||
1372362|NCT02653417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372363|NCT02653404|||Case-Only||Other|||||||
1372364|NCT02653391|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1372365|NCT02653378|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1372366|NCT02653365|||Cohort||Prospective|||||||
1372367|NCT02653352|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372368|NCT02653339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372369|NCT02653326|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1372370|NCT02653313||Single Group Assignment||Treatment||None (Open Label)||||||
1372371|NCT02653300||Single Group Assignment||Treatment||None (Open Label)||||||
1372372|NCT02653287|Randomized|Parallel Assignment||Treatment||Single||||||t
1372373|NCT02653274|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1372374|NCT02653261|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1372375|NCT02653248|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372376|NCT02653235|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1372377|NCT02653222||Single Group Assignment||Treatment||None (Open Label)||||||
1372378|NCT02653209|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1372379|NCT02653196||Single Group Assignment||Treatment||None (Open Label)||||||
1372380|NCT02653183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372381|NCT02653170|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372382|NCT02653157|||Cohort||Prospective|||||||
1372383|NCT02653144|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1372384|NCT02653131|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372385|NCT02653118|||Cohort||Prospective|||||||
1372386|NCT02653105||Single Group Assignment||Screening||None (Open Label)||||||
1372387|NCT02653092|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372388|NCT02653079|||Case-Only||Prospective|||||||
1372389|NCT02653066|Randomized|Parallel Assignment||Other||Single|||t|||
1372390|NCT02653040|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1372391|NCT02653027||Single Group Assignment||Screening||None (Open Label)||||||
1372392|NCT02653014|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372393|NCT02653001||Single Group Assignment||Basic Science||None (Open Label)||||||
1372394|NCT02652988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372395|NCT02652975|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372396|NCT02652962|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1372397|NCT02652949||Single Group Assignment||Treatment||None (Open Label)||||||
1372398|NCT02652936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372399|NCT02652923|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1372400|NCT02652910|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372401|NCT02652897|||Cohort||Prospective|||||||
1372402|NCT02652884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372403|NCT02652871||Single Group Assignment||Treatment||None (Open Label)||||||
1372404|NCT02652858||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372405|NCT02652845|Randomized|Parallel Assignment||Prevention||Single||||||t
1372406|NCT02652832|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1372407|NCT02652819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372408|NCT02652806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372409|NCT02652793||Single Group Assignment||Treatment||None (Open Label)||||||
1372410|NCT02652780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372411|NCT02652767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372412|NCT02652754||Single Group Assignment||Treatment||None (Open Label)||||||
1372413|NCT02652741||Single Group Assignment||Treatment||None (Open Label)||||||
1372414|NCT02652728||Single Group Assignment||Treatment||None (Open Label)||||||
1372415|NCT02652715||Single Group Assignment||Basic Science||None (Open Label)||||||
1372416|NCT02652702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372417|NCT02652689||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372418|NCT02652676||Single Group Assignment||Treatment||None (Open Label)||||||
1372419|NCT02652663|||Cohort||Retrospective|||||||
1372420|NCT02652650||Single Group Assignment||||None (Open Label)||||||
1372421|NCT02652637|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1372422|NCT02652624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372423|NCT02652611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372424|NCT02652598||Single Group Assignment||Treatment||None (Open Label)||||||
1372425|NCT02652585|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1372426|NCT02652572||Single Group Assignment||Treatment||None (Open Label)||||||
1372427|NCT02652559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372428|NCT02652546|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1372429|NCT02652533|||Cohort||Prospective|||||||
1372430|NCT02652520||Single Group Assignment||Other||None (Open Label)||||||
1372431|NCT02652507||Single Group Assignment||Other||None (Open Label)||||||
1372432|NCT02652494|||Cohort||Prospective|||||||
1372433|NCT02652481||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372434|NCT02652468||Single Group Assignment||Treatment||None (Open Label)||||||
1372435|NCT02652455||Single Group Assignment||Treatment||None (Open Label)||||||
1372436|NCT02652442|Randomized|Parallel Assignment||Treatment||Single||||||t
1372437|NCT02652429||Single Group Assignment||Treatment||None (Open Label)||Open Label Extension||||
1372438|NCT02652416|Randomized|Parallel Assignment||Treatment||Double||||||
1372439|NCT02652403|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372440|NCT02652390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372441|NCT02652377|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372442|NCT02652364|||Case-Only||Prospective|||||||
1372443|NCT02652351||Single Group Assignment||Treatment||None (Open Label)||||||
1372444|NCT02652338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372445|NCT02652325|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1372446|NCT02652312|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1372447|NCT02652299|||Case-Control||Prospective|||||||
1372448|NCT02652286||Single Group Assignment||Treatment||None (Open Label)||||||
1372449|NCT02652273||Single Group Assignment||Treatment||None (Open Label)||||||
1372450|NCT02652260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372451|NCT02652247|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1372452|NCT02652234||Single Group Assignment||Treatment||None (Open Label)||||||
1372453|NCT02652221||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372454|NCT02652208|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372455|NCT02652195|Randomized|Factorial Assignment||Basic Science||Triple|||t|t|t|
1372456|NCT02652182|||Case-Crossover||Retrospective|||||||
1372457|NCT02652169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372458|NCT02652156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372459|NCT02652143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372460|NCT02652130|||Case-Only||Prospective|||||||
1372461|NCT02652117|||Other||Retrospective|||||||
1372462|NCT02652104|||Case-Only|||||||||
1372463|NCT02652091|||Cohort||Prospective|||||||
1372464|NCT02652078|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372465|NCT02652065|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1372466|NCT02652052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372467|NCT02652039|||||Prospective|||||||
1372468|NCT02652026|Randomized|Parallel Assignment||Treatment||Single||||||t
1372469|NCT02652013|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1372470|NCT02652000|||||Retrospective|||||||
1372471|NCT02651987||Single Group Assignment||Treatment||None (Open Label)||||||
1372472|NCT02651974|Randomized|Factorial Assignment||Health Services Research||Double|||t||t|
1372473|NCT02651961|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372474|NCT02651948|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1372475|NCT02651935|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372476|NCT02651922|||Cohort||Prospective|||||||
1372477|NCT02651909|||Cohort||Prospective|||||||
1372478|NCT02651896|||Cohort||Prospective|||||||
1372479|NCT02651883|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1372480|NCT02651870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372481|NCT02651857||Single Group Assignment||Other||None (Open Label)||||||
1372482|NCT02651844||Single Group Assignment||Treatment||None (Open Label)||||||
1372483|NCT02651831|||Cohort||Prospective|||||||
1372484|NCT02651818|||Cohort||Prospective|||||||
1372485|NCT02651805|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1372486|NCT02651792|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1372487|NCT02651779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372488|NCT02651766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372489|NCT02651753|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1372490|NCT02651740||Single Group Assignment||Treatment||None (Open Label)||||||
1372491|NCT02651727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372492|NCT02651714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372493|NCT02651701|||Case-Control||Prospective|||||||
1372494|NCT02651688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372495|NCT02651675||Single Group Assignment||Treatment||None (Open Label)||||||
1372496|NCT02651662|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372497|NCT02651649|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372498|NCT02651636||Single Group Assignment||Treatment||None (Open Label)||||||
1372499|NCT02651623|Randomized|Crossover Assignment||||Double|||t||t|
1372500|NCT02651610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372501|NCT02651597|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1372502|NCT02651584|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372503|NCT02651571|||Cohort||Retrospective|||||||
1372504|NCT02651558|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1372505|NCT02651545|||Case-Control||Prospective|||||||
1372506|NCT02651532|||Case-Control||Cross-Sectional|||||||
1372507|NCT02651519|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372508|NCT02651506|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1372509|NCT02651493|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372510|NCT02651480|Randomized|Crossover Assignment||Supportive Care||Single||||t||
1372511|NCT02651467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372512|NCT02651454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372513|NCT02651441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372514|NCT02651428|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1372515|NCT02651415||Single Group Assignment||Treatment||None (Open Label)||||||
1372516|NCT02651402|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372517|NCT02651389|||Case-Control||Prospective|||||||
1372518|NCT02651376||Single Group Assignment||Treatment||None (Open Label)||||||
1372519|NCT02651363|||Cohort||Prospective|||||||
1372520|NCT02651350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372521|NCT02651337||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372522|NCT02651324|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372523|NCT02651311|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1372524|NCT02651298|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372525|NCT02651285|Randomized|Parallel Assignment||||Single|||t|||
1372526|NCT02651272||Single Group Assignment||Other||None (Open Label)|Study is Open Label|||||
1372527|NCT02651259|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372528|NCT02651246|||Cohort||Prospective|||||||
1372529|NCT02651233|||||Prospective|||||||
1372530|NCT02651220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372531|NCT02651207|||Other||Prospective|||||||
1372532|NCT02651194||Single Group Assignment||Treatment||None (Open Label)||||||
1372533|NCT02651181||Single Group Assignment||Treatment||None (Open Label)||||||
1372534|NCT02651168||Single Group Assignment||Treatment||None (Open Label)||||||
1372535|NCT02651155|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372536|NCT02651142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372537|NCT02651129|||Case-Only||Prospective|||||||
1372538|NCT02651116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372539|NCT02651103|||Cohort||Prospective|||||||
1372540|NCT02651090||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372541|NCT02651077|||Case Control||Prospective|||||||
1372542|NCT02651064|Randomized|Parallel Assignment||||None (Open Label)||||||
1372543|NCT02651051|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1372544|NCT02651038||Single Group Assignment||Treatment||None (Open Label)||||||
1372545|NCT02651025|Randomized|Parallel Assignment||Treatment||Single||||||t
1372546|NCT02650999|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372547|NCT02650986||Single Group Assignment||Treatment||None (Open Label)||||||
1372548|NCT02650973|Randomized|Crossover Assignment||||Single|||t|||
1372549|NCT02650960|||Cohort||Prospective|||||||
1372550|NCT02650947|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1372551|NCT02650934|||Cohort||Prospective|||||||
1372552|NCT02650921|Randomized|Parallel Assignment||Treatment||Single||||||t
1372553|NCT02650908|||||Retrospective|||||||
1372554|NCT02650895|Randomized|Parallel Assignment||||Double|||t||t|
1372555|NCT02650882|Randomized|Crossover Assignment||Treatment||Single|||t|||
1372556|NCT02650869|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372557|NCT02650856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372558|NCT02650843|||Cohort||Prospective|||||||
1372559|NCT02650830|||Cohort||Prospective|||||||
1372560|NCT02650817||Single Group Assignment||Treatment||None (Open Label)||||||
1372561|NCT02650804||Single Group Assignment||Treatment||None (Open Label)||||||
1372562|NCT02650791|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372563|NCT02650778|||Other||Prospective|||||||
1372564|NCT02650765|||Cohort||Prospective|||||||
1372565|NCT02650752||Single Group Assignment||Treatment||None (Open Label)||||||
1372566|NCT02650739|||Case Control||Retrospective|||||||
1372567|NCT02650726|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372568|NCT02650713|Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1372569|NCT02650700|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1372570|NCT02650687|||Cohort||Prospective|||||||
1372571|NCT02650674|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1372572|NCT02650661|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372573|NCT02650648||Single Group Assignment||Treatment||None (Open Label)||||||
1372574|NCT02650635||Single Group Assignment||Treatment||None (Open Label)||||||
1372575|NCT02650622|||Cohort||Prospective|||||||
1372576|NCT02650609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372577|NCT02650596|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1372578|NCT02650583||Single Group Assignment||Supportive Care||None (Open Label)||||||
1372579|NCT02650570|||Case-Control||Prospective|||||||
1372580|NCT02650557|||Case Control||Prospective|||||||
1372581|NCT02650544|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372582|NCT02650531|||Cohort||Prospective|||||||
1372583|NCT02650518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372584|NCT02650505|Randomized|Parallel Assignment||Other||Double|||t||t|
1372585|NCT02650492||Single Group Assignment||Treatment||None (Open Label)||||||
1372586|NCT02650479|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1372587|NCT02650466||Single Group Assignment||Treatment||None (Open Label)||||||
1372588|NCT02650453|||||Retrospective|||||||
1372589|NCT02650440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1372590|NCT02650427||Single Group Assignment||Treatment||None (Open Label)||||||
1372591|NCT02650414||Single Group Assignment||Treatment||None (Open Label)||||||
1372592|NCT02650401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372593|NCT02650388||Single Group Assignment||Treatment||None (Open Label)||||||
1372594|NCT02650375||Single Group Assignment||Treatment||None (Open Label)||||||
1372595|NCT02650362||Single Group Assignment||Treatment||None (Open Label)||||||
1372596|NCT02650349||Single Group Assignment||Treatment||None (Open Label)||||||
1372597|NCT02650336|||Case Control||Prospective|||||||
1372598|NCT02650323|||Cohort||Prospective|||||||
1372599|NCT02650310|Randomized|Parallel Assignment||||None (Open Label)||||||
1372600|NCT02650297|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372601|NCT02650284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372602|NCT02650271|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1372603|NCT02650258|||Cohort||Cross-Sectional|||||||
1372604|NCT02650245||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372605|NCT02650232|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372606|NCT02650219|||Case Control||Prospective|||||||
1372607|NCT02650206|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1372608|NCT02650193||Parallel Assignment||Other||None (Open Label)||||||
1372609|NCT02650180||Single Group Assignment||Supportive Care||None (Open Label)||||||
1372610|NCT02650167|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372611|NCT02650154|||Case Control||Prospective|||||||
1372612|NCT02650141|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372613|NCT02650128||Single Group Assignment||Treatment||None (Open Label)||||||
1372614|NCT02650115|||Cohort||Prospective|||||||
1372615|NCT02650102|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372616|NCT02650089|Randomized|Crossover Assignment||||None (Open Label)||||||
1372617|NCT02650076||||Treatment||||||||
1372618|NCT02650063||Single Group Assignment||Basic Science||None (Open Label)||||||
1372619|NCT02650050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372620|NCT02650037|||Cohort||Prospective|||||||
1372621|NCT02650024|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372622|NCT02650011|||Cohort||Prospective|||||||
1372623|NCT02649998|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372624|NCT02649985|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1372625|NCT02649972||Single Group Assignment||Treatment||None (Open Label)||||||
1372626|NCT02649959||Single Group Assignment||Treatment||None (Open Label)||||||
1372627|NCT02649946||||||||||||
1372628|NCT02649933|||Cohort||Prospective|||||||
1372629|NCT02649920|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372630|NCT02649907||Single Group Assignment||Treatment||None (Open Label)||||||
1372631|NCT02649894|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372632|NCT02649881|||Cohort||Prospective|||||||
1372633|NCT02649868||Single Group Assignment||Treatment||None (Open Label)||||||
1372634|NCT02649855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372635|NCT02649842|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1372636|NCT02649829||Single Group Assignment||Treatment||None (Open Label)||||||
1372637|NCT02649816|||Cohort||Retrospective|||||||
1372638|NCT02649803||Single Group Assignment||Health Services Research||None (Open Label)||||||
1372639|NCT02649790||Single Group Assignment||Treatment||None (Open Label)||||||
1372640|NCT02649777|||Case-Only||Prospective|||||||
1372641|NCT02649764||Single Group Assignment||Treatment||None (Open Label)||||||
1372642|NCT02649751|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372643|NCT02649738||Single Group Assignment||Treatment||None (Open Label)||||||
1372644|NCT02649725|||Ecologic or Community||Prospective|||||||
1372645|NCT02649712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372646|NCT02649699||Single Group Assignment||Treatment||None (Open Label)||||||
1372647|NCT02649686||Single Group Assignment||Other||None (Open Label)||||||
1372648|NCT02649673||Single Group Assignment||Treatment||None (Open Label)||||||
1372649|NCT02649660|||Cohort||Cross-Sectional|||||||
1372650|NCT02649647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372651|NCT02649634|Randomized|Parallel Assignment||Treatment||Single||||||t
1372652|NCT02649621||Single Group Assignment||Treatment||None (Open Label)||||||
1372653|NCT02649608||Single Group Assignment||Treatment||None (Open Label)||||||
1372654|NCT02649595|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372655|NCT02649582||Single Group Assignment||Treatment||None (Open Label)||||||
1372656|NCT02649569|||Cohort||Prospective|||||||
1372657|NCT02649556|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372658|NCT02649543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372659|NCT02649530||Single Group Assignment||Treatment||None (Open Label)||||||
1372660|NCT02649517||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372661|NCT02649504|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372662|NCT02649491|||Cohort||Prospective|||||||
1372663|NCT02649478|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372664|NCT02649465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372665|NCT02649452|Randomized|Parallel Assignment||Prevention||Single||||||t
1372666|NCT02649439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372667|NCT02649426|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1372668|NCT02649413||Single Group Assignment||Treatment||None (Open Label)||||||
1372669|NCT02649400|||Cohort||Cross-Sectional|||||||
1372670|NCT02649387||Single Group Assignment||Treatment||None (Open Label)||||||
1372671|NCT02649374|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372672|NCT02649361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372673|NCT02649348|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372674|NCT02649335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372675|NCT02649322|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1372676|NCT02649309|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1372677|NCT02649296|Randomized|Parallel Assignment||||Double|||t|||t
1372678|NCT02649283|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372679|NCT02649270|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372680|NCT02649257||Single Group Assignment||||None (Open Label)||||||
1372681|NCT02649244|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1372682|NCT02649231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372683|NCT02649218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372684|NCT02649205|||Cohort||Prospective|||||||
1372685|NCT02649192|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1372686|NCT02649179|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1372687|NCT02649166||Single Group Assignment||Treatment||None (Open Label)||||||
1372688|NCT02649153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372689|NCT02649140|Randomized|Parallel Assignment||||None (Open Label)||||||
1372690|NCT02649127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372691|NCT02649114|Randomized|Parallel Assignment||Treatment||Single||||||t
1372692|NCT02649101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372693|NCT02649088|||Cohort||Prospective|||||||
1372694|NCT02649075|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1372695|NCT02649062|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372696|NCT02649049|||Case Control||Cross-Sectional|||||||
1372697|NCT02649036|||Cohort||Retrospective|||||||
1372698|NCT02649023|||Cohort||Prospective|||||||
1372699|NCT02649010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372700|NCT02648997||Single Group Assignment||Treatment||None (Open Label)||||||
1372701|NCT02648984|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1372702|NCT02648971|Randomized|Parallel Assignment||Treatment||Single||||||t
1372703|NCT02648958|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1372704|NCT02648945|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372705|NCT02648932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372706|NCT02648919||Single Group Assignment||Treatment||None (Open Label)||||||
1372707|NCT02648906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372708|NCT02648893|Randomized|Parallel Assignment||Other||Double|||t||t|
1372709|NCT02648880|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372710|NCT02648867|Randomized|Parallel Assignment||Other||Single|||t|||
1372711|NCT02648854|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1372712|NCT02648841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372713|NCT02648828|||Cohort||Prospective|||||||
1372714|NCT02648815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372715|NCT02648802|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372716|NCT02648789|||Cohort||Prospective|||||||
1372717|NCT02648776|||Cohort||Prospective|||||||
1372718|NCT02648763|||Case-Only||Prospective|||||||
1372719|NCT02648750|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1372720|NCT02648737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372721|NCT02648724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372722|NCT02648711|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372723|NCT02648698|Randomized|Parallel Assignment||Treatment||Single|||||t|
1372724|NCT02648685|||Case-Control||Prospective|||||||
1372725|NCT02648672|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372726|NCT02648659|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1372727|NCT02648646||Single Group Assignment||Prevention||None (Open Label)||||||
1372728|NCT02648633||Single Group Assignment||Treatment||None (Open Label)||||||
1372729|NCT02648620||Single Group Assignment||Treatment||None (Open Label)||||||
1372730|NCT02648607||Single Group Assignment||Treatment||None (Open Label)||||||
1372731|NCT02648594||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372732|NCT02648581||Single Group Assignment||Treatment||None (Open Label)||||||
1372733|NCT02648568|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1372734|NCT02648555|Randomized|Parallel Assignment||Prevention||Single|||t|||
1372735|NCT02648542|Randomized|Crossover Assignment||Treatment||Single|||t|||
1372736|NCT02648529|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372737|NCT02648516||Single Group Assignment||Treatment||None (Open Label)||||||
1372738|NCT02648503|Randomized|Parallel Assignment||Treatment||Single||||||t
1372739|NCT02648490||Single Group Assignment||Treatment||None (Open Label)||||||
1372740|NCT02648477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372741|NCT02648464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372742|NCT02648451||Single Group Assignment||Treatment||None (Open Label)||||||
1372743|NCT02648438|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372744|NCT02648425|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372745|NCT02648412||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372746|NCT02648399|Randomized|Parallel Assignment||Treatment||Single|||||t|
1372747|NCT02648386|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372748|NCT02648373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372749|NCT02648360||Single Group Assignment||Supportive Care||None (Open Label)||||||
1372750|NCT02648347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372751|NCT02648334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372752|NCT02648321|Randomized|Parallel Assignment||Treatment||Single||||||t
1372753|NCT02648308|||Case-Only||Prospective|||||||
1372754|NCT02648295|||Case-Only||Prospective|||||||
1372755|NCT02648282||Single Group Assignment||Treatment||None (Open Label)||||||
1372756|NCT02648269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372757|NCT02648256||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372758|NCT02648243|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1372759|NCT02648230||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372760|NCT02648217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372761|NCT02648204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372762|NCT02648191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372763|NCT02648178|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1372764|NCT02648165|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1372765|NCT02648152|||Cohort||Prospective|||||||
1372766|NCT02648139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372767|NCT02648126||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372768|NCT02648113|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372769|NCT02648100|||Cohort||Retrospective|||||||
1372770|NCT02648087||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372771|NCT02648074|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372772|NCT02648061|||Cohort||Prospective|||||||
1372773|NCT02648048||Single Group Assignment||Treatment||None (Open Label)||||||
1372774|NCT02648035|||Cohort||Prospective|||||||
1372775|NCT02648022|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372776|NCT02648009|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372777|NCT02647996|||Case-Control||Prospective|||||||
1372778|NCT02647983||Single Group Assignment||Other||None (Open Label)||||||
1372779|NCT02647970|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372780|NCT02647957|Non-Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1372781|NCT02647944|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1372782|NCT02647931||Single Group Assignment||Treatment||None (Open Label)||||||
1372783|NCT02647918|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372784|NCT02647905||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372785|NCT02647892|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372786|NCT02647879|||Cohort||Prospective|||||||
1372787|NCT02647866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372788|NCT02647853|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1372789|NCT02647840||Single Group Assignment||Treatment||None (Open Label)||||||
1372790|NCT02647827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372791|NCT02647814|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372792|NCT02647801|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1372793|NCT02647788|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372794|NCT02647775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372795|NCT02647762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372796|NCT02647749|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372797|NCT02647736||Single Group Assignment||||None (Open Label)||||||
1372798|NCT02647723|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1372799|NCT02647710|Randomized|Parallel Assignment||Prevention||Single|||t|||
1372800|NCT02647697||Single Group Assignment||Basic Science||None (Open Label)||||||
1372801|NCT02647684||Single Group Assignment||Supportive Care||None (Open Label)||||||
1372802|NCT02647671|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1372803|NCT02647658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372804|NCT02647645|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372805|NCT02647632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372806|NCT02647619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372807|NCT02647606|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372808|NCT02647593|||Cohort||Prospective|||||||
1372809|NCT02647580|||Case-Only||Cross-Sectional|||||||
1372810|NCT02647567|Randomized|Parallel Assignment||||Double|||t||t|
1372811|NCT02647554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372812|NCT02647541|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372813|NCT02647528|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1372814|NCT02647515||Single Group Assignment||Treatment||None (Open Label)||||||
1372815|NCT02647502|Randomized|Parallel Assignment||Treatment||Single||||||t
1372816|NCT02647489|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1372817|NCT02647476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372818|NCT02647463|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1372819|NCT02647450|||Cohort||Retrospective|||||||
1372820|NCT02647437|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1372821|NCT02647424|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372822|NCT02647411|||||Retrospective|||||||
1372823|NCT02647398|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1372824|NCT02647385|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372825|NCT02647372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372826|NCT02647359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372827|NCT02647346||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372828|NCT02647333|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1372829|NCT02647320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372830|NCT02647307||Single Group Assignment||Basic Science||None (Open Label)||||||
1372831|NCT02647294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372832|NCT02647281|Randomized|Parallel Assignment||Other||Double|||t||t|
1372833|NCT02647268|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372834|NCT02647255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372835|NCT02647242||Single Group Assignment||Treatment||None (Open Label)||||||
1372836|NCT02647229|Randomized|Parallel Assignment||Treatment||Single|||||t|
1372837|NCT02647216|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372838|NCT02647203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372839|NCT02647190||Single Group Assignment||Treatment||None (Open Label)||||||
1372840|NCT02647177|||Case-Only||Cross-Sectional|||||||
1372841|NCT02647164|||Case-Only||Prospective|||||||
1372842|NCT02647151|Randomized|Crossover Assignment||Treatment||Single||||||t
1372843|NCT02647138||Single Group Assignment||Treatment||None (Open Label)||||||
1372844|NCT02647125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372845|NCT02647112|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1372846|NCT02647099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372847|NCT02647086|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1372848|NCT02647073||Single Group Assignment||Other||None (Open Label)||||||
1372849|NCT02647060|||Case-Control||Cross-Sectional|||||||
1372850|NCT02647047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372851|NCT02647034|||Cohort||Prospective|||||||
1372852|NCT02647021|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1372853|NCT02647008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372854|NCT02646995|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1372855|NCT02646982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372856|NCT02646969|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1372857|NCT02646956|||Cohort||Cross-Sectional|||||||
1372858|NCT02646943|||Cohort||Prospective|||||||
1372859|NCT02646930||Single Group Assignment||Diagnostic||Single||||||t
1372860|NCT02646917||Single Group Assignment||Treatment||None (Open Label)||||||
1372861|NCT02646904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372862|NCT02646891|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1372863|NCT02646878|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1372864|NCT02646865|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372865|NCT02646852||Single Group Assignment||Treatment||None (Open Label)||||||
1372866|NCT02646839||Single Group Assignment||Treatment||None (Open Label)||||||
1372867|NCT02646826|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372868|NCT02646813|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1372869|NCT02646800||Single Group Assignment||Treatment||None (Open Label)||||||
1372870|NCT02646787|Randomized|Factorial Assignment||Treatment||Single||||t||
1372871|NCT02646774||Single Group Assignment||Treatment||None (Open Label)||||||
1372872|NCT02646761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373028|NCT02644733|||Case-Control||Prospective|||||||
1372873|NCT02646748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372874|NCT02646735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372875|NCT02646722|||Case Control||Prospective|||||||
1372876|NCT02646709|Randomized|Parallel Assignment||||Triple||||t|t|t
1372877|NCT02646696|||Case Control||Prospective|||||||
1372878|NCT02646683|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372879|NCT02646670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372880|NCT02646657|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372881|NCT02646644|||Cohort||Retrospective|||||||
1372882|NCT02646631|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1372883|NCT02646618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372884|NCT02646605|||Case-Only||Cross-Sectional|||||||
1372885|NCT02646592||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372886|NCT02646579|Randomized|Parallel Assignment||Treatment||Single||||||t
1372887|NCT02646566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372888|NCT02646553|||Case-Only||Prospective|||||||
1372889|NCT02646540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372890|NCT02646527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372891|NCT02646514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372892|NCT02646501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372893|NCT02646488|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1372894|NCT02646475|Randomized|Crossover Assignment||Other||Double|||t||t|
1372895|NCT02646462|||Cohort||Prospective|||||||
1372896|NCT02646449|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1372897|NCT02646436|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372898|NCT02646423|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1372899|NCT02646410|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1372900|NCT02646397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372901|NCT02646384||Single Group Assignment||Treatment||None (Open Label)||||||
1372902|NCT02646371|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1372903|NCT02646358|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1372904|NCT02646345|||Case Control||Retrospective|||||||
1372905|NCT02646332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372906|NCT02646319||Single Group Assignment||Treatment||None (Open Label)||||||
1372907|NCT02646306|||Case Control||Retrospective|||||||
1372908|NCT02646293|||Cohort||Prospective|||||||
1372909|NCT02646280|Randomized|Parallel Assignment||Treatment||Single|||||t|
1372910|NCT02646267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372911|NCT02646254|Randomized|Parallel Assignment||Prevention||Single|||||t|
1372912|NCT02646241|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1372913|NCT02646228|||Cohort||Prospective|||||||
1372914|NCT02646215|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1372915|NCT02646202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372916|NCT02646189||Single Group Assignment||Treatment||None (Open Label)||||||
1372917|NCT02646176|||Cohort||Prospective|||||||
1372918|NCT02646163||Single Group Assignment||Treatment||None (Open Label)||||||
1372919|NCT02646150|||Cohort||Prospective|||||||
1372920|NCT02646137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372921|NCT02646124|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1372922|NCT02646111|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372923|NCT02646098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372924|NCT02646085||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372925|NCT02646072|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1372926|NCT02646059|Randomized|Parallel Assignment||Other||Single|||t|||
1372927|NCT02646046|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1372928|NCT02646033|||Cohort||Prospective|||||||
1372929|NCT02646020|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372930|NCT02646007||Single Group Assignment||Treatment||None (Open Label)||||||
1372931|NCT02645994|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1372932|NCT02645981|Randomized|Parallel Assignment||Treatment||None (Open Label)|open-label|||||
1372933|NCT02645968|||Cohort||Prospective|||||||
1372934|NCT02645955|||Cohort||Prospective|||||||
1372935|NCT02645942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372936|NCT02645929|||Cohort||Prospective|||||||
1372937|NCT02645916|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372938|NCT02645903|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1372939|NCT02645890|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1372940|NCT02645877|||Cohort||Retrospective|||||||
1372941|NCT02645864||Single Group Assignment||Treatment||None (Open Label)||||||
1372942|NCT02645851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372943|NCT02645838|Randomized|Parallel Assignment||||None (Open Label)||||||
1372944|NCT02645825|||Cohort||Prospective|||||||
1372945|NCT02645812|||Cohort||Prospective|||||||
1372946|NCT02645799|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1372947|NCT02645786|||Case Control||Prospective|||||||
1372948|NCT02645773|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1372949|NCT02645760|Randomized|Factorial Assignment||Treatment||Single||||||t
1372950|NCT02645747|||Other||Retrospective|||||||
1372951|NCT02645734|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372952|NCT02645721|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372953|NCT02645708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372954|NCT02645695|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1372955|NCT02645682|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372956|NCT02645669|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372957|NCT02645656||Single Group Assignment||Treatment||None (Open Label)||||||
1372958|NCT02645643|Randomized|Parallel Assignment||||Single|||t|||
1372959|NCT02645630|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372960|NCT02645617||Single Group Assignment||Prevention||None (Open Label)||||||
1372961|NCT02645604|||Case-Only||Cross-Sectional|||||||
1372962|NCT02645591|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372963|NCT02645578|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1372964|NCT02645565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372965|NCT02645552|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1372966|NCT02645539||Single Group Assignment||Treatment||None (Open Label)||||||
1372967|NCT02645526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372968|NCT02645513|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1372969|NCT02645500|Randomized|Parallel Assignment||Prevention||Single|||t|||
1372970|NCT02645487||Single Group Assignment||Treatment||None (Open Label)||||||
1372971|NCT02645474|Randomized|Parallel Assignment||Treatment||Single||||||t
1372972|NCT02645461|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1372973|NCT02645448|Randomized|Crossover Assignment||||Single|||t|||
1372974|NCT02645435|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372975|NCT02645422|||Family-Based||Cross-Sectional|||||||
1372976|NCT02645409|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372977|NCT02645396|||Cohort||Prospective|||||||
1372978|NCT02645383|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1372979|NCT02645370|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372980|NCT02645357|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1372981|NCT02645344|Randomized|Parallel Assignment||Treatment||Single||||||t
1372982|NCT02645331|Randomized|Parallel Assignment||Treatment||Single||||||t
1372983|NCT02645318|||Case-Only||Prospective|||||||
1372984|NCT02645305||Single Group Assignment||Treatment||None (Open Label)||||||
1372985|NCT02645292|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1372986|NCT02645279|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1372987|NCT02645266||Single Group Assignment||Treatment||None (Open Label)||||||
1372988|NCT02645253|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1372989|NCT02645240||Single Group Assignment||Diagnostic||None (Open Label)||||||
1372990|NCT02645227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1372991|NCT02645214|Randomized|Crossover Assignment||Prevention||Single|||t|||
1372992|NCT02645201|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1372993|NCT02645188|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372994|NCT02645175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1372995|NCT02645162|Randomized|Parallel Assignment||Prevention||Single||||||t
1372996|NCT02645149|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1372997|NCT02645136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1372998|NCT02645123|Randomized|Parallel Assignment||Treatment||Single|||t|||
1372999|NCT02645110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373000|NCT02645097|Randomized|Parallel Assignment||Treatment||Single||||||t
1373001|NCT02645084|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1373002|NCT02645071||Single Group Assignment||Prevention||None (Open Label)||||||
1373003|NCT02645058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373004|NCT02645045|||Case-Crossover||Cross-Sectional|||||||
1373005|NCT02645032|Randomized|Parallel Assignment||Prevention||Quadruple|Laboratory personnel who analyzes immunogenicity at sponsor is also blinded.||t|t|t|t
1373006|NCT02645019|||Cohort||Prospective|||||||
1373007|NCT02645006|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1373008|NCT02644993||Single Group Assignment||Treatment||None (Open Label)||||||
1373009|NCT02644980|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373010|NCT02644967|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373011|NCT02644954|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373012|NCT02644941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373013|NCT02644928|||Case-Only||Prospective|||||||
1373014|NCT02644915|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1373015|NCT02644902|Randomized|Parallel Assignment||Treatment||Single||||||t
1373016|NCT02644889|||Cohort||Retrospective|||||||
1373017|NCT02644876|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1373018|NCT02644863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373019|NCT02644850|||Case-Only||Prospective|||||||
1373020|NCT02644837|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373021|NCT02644824|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373022|NCT02644811|Randomized|Parallel Assignment||Treatment||Single||||||t
1373023|NCT02644798|||Cohort||Prospective|||||||
1373024|NCT02644785|||Cohort||Prospective|||||||
1373025|NCT02644772|||Cohort||Prospective|||||||
1373026|NCT02644759||Single Group Assignment||Treatment||None (Open Label)||||||
1373027|NCT02644746|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1373029|NCT02644720|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373030|NCT02644707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373031|NCT02644694||Single Group Assignment||Treatment||None (Open Label)||||||
1373032|NCT02644681|||Cohort||Prospective|||||||
1373033|NCT02644668|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373034|NCT02644655||Single Group Assignment||Treatment||None (Open Label)||||||
1373035|NCT02644642|Randomized|Parallel Assignment||Other||Single||||||t
1373036|NCT02644629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373037|NCT02644616|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373038|NCT02644603|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373039|NCT02644590||Single Group Assignment||Treatment||None (Open Label)||||||
1373040|NCT02644577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373041|NCT02644564|||Cohort||Prospective|||||||
1373042|NCT02644551|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373043|NCT02644538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373044|NCT02644525|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1373045|NCT02644499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373046|NCT02644486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373047|NCT02644473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373048|NCT02644460|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373049|NCT02644447|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373050|NCT02644434|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373051|NCT02644421|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1373052|NCT02644408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373053|NCT02644395|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373054|NCT02644382|||Other||Other|||||||
1373055|NCT02644369||Single Group Assignment||Treatment||None (Open Label)||||||
1373056|NCT02644356||Single Group Assignment||Other||None (Open Label)||||||
1373057|NCT02644343||||||||||||
1373058|NCT02644330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373059|NCT02644317|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1373060|NCT02644304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373061|NCT02644291||Single Group Assignment||Treatment||None (Open Label)||||||
1373062|NCT02644278||Single Group Assignment||Treatment||None (Open Label)||||||
1373063|NCT02644265|||Cohort||Prospective|||||||
1373064|NCT02644252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373065|NCT02644239|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1373066|NCT02644226|||Cohort||Retrospective|||||||
1373067|NCT02644213||Single Group Assignment||||None (Open Label)||||||
1373068|NCT02644200|Randomized|Parallel Assignment||Treatment||Single||||||t
1373069|NCT02644187|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373070|NCT02644174|||Cohort||Prospective|||||||
1373071|NCT02644161|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373072|NCT02644148|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373073|NCT02644135|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1373074|NCT02644122||Single Group Assignment||Treatment||None (Open Label)||||||
1373075|NCT02644109|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373076|NCT02644096|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1373077|NCT02644083|||Cohort||Prospective|||||||
1373078|NCT02644070|Randomized|Crossover Assignment||Treatment||Single||||||t
1373079|NCT02644057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373080|NCT02644044||Single Group Assignment||Treatment||None (Open Label)||||||
1373081|NCT02644031|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1373082|NCT02644018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373083|NCT02644005|||Cohort||Prospective|||||||
1373084|NCT02643992|||Cohort||Cross-Sectional|||||||
1373085|NCT02643979|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1373086|NCT02643966||Single Group Assignment||Screening||None (Open Label)||||||
1373087|NCT02643953|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1373088|NCT02643940|||Cohort||Prospective|||||||
1373089|NCT02643927|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1373090|NCT02643914||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373091|NCT02643901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373092|NCT02643888|||Cohort||Retrospective|||||||
1373093|NCT02643875|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1373094|NCT02643862|Randomized|Parallel Assignment||Treatment||Double||In a 3:1 ratio, 36* participants will receive Xolair for 16 weeks while 12* will receive corresponding placebo instead of Xolair. 12 controls will be enrolled who will receive no OIT and no Xolair. These 12 controls are not part of the randomization. The total number of participants randomized to the two arms is 48*.|t||t|
1373095|NCT02643849||Single Group Assignment||Treatment||None (Open Label)||||||
1373096|NCT02643836|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373097|NCT02643823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373098|NCT02643810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373099|NCT02643797|Randomized|Parallel Assignment||Treatment||Single||||||t
1373100|NCT02643784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373101|NCT02643771|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1373102|NCT02643758|Randomized|Parallel Assignment||Treatment||Single||||||t
1373103|NCT02643745|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373104|NCT02643732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373105|NCT02643719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373106|NCT02643706|||Case Control||Prospective|||||||
1373107|NCT02643693|Randomized|Single Group Assignment||||None (Open Label)||||||
1373108|NCT02643680|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373109|NCT02643667|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1373110|NCT02643654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373111|NCT02643641|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373112|NCT02643628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373113|NCT02643615|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373114|NCT02643602|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1373115|NCT02643589|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373116|NCT02643576|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1373117|NCT02643563|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1373118|NCT02643550|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1373119|NCT02643537|||Cohort||Retrospective|||||||
1373120|NCT02643524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373121|NCT02643511||Single Group Assignment||Treatment||None (Open Label)||||||
1373122|NCT02643498||Single Group Assignment||Treatment||None (Open Label)||||||
1373123|NCT02643485|||Case-Control||Prospective|||||||
1373124|NCT02643472|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373125|NCT02643459|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373126|NCT02643446|||Cohort||Prospective|||||||
1373127|NCT02643433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373128|NCT02643420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373129|NCT02643407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373130|NCT02643394|Randomized|Parallel Assignment||Treatment||Single||||||t
1373131|NCT02643381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373132|NCT02643368|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373133|NCT02643355|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1373134|NCT02643342|Randomized|Parallel Assignment||Treatment||Single||||||t
1373135|NCT02643329|Randomized|Crossover Assignment||||None (Open Label)||||||
1373136|NCT02643316|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1373137|NCT02643303|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373138|NCT02643290||Single Group Assignment||Treatment||None (Open Label)||||||
1373139|NCT02643277|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1373140|NCT02643264|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373141|NCT02643251|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373142|NCT02643238|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373143|NCT02643225|||Case Control||Prospective|||||||
1373144|NCT02643212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373145|NCT02643199|||Cohort||Prospective|||||||
1373146|NCT02643186|Randomized|Parallel Assignment||Prevention||Single|||t|||
1373147|NCT02643173|||Cohort||Retrospective|||||||
1373148|NCT02643160|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373149|NCT02643147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373150|NCT02643134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373151|NCT02643121|||Cohort||Prospective|||||||
1373152|NCT02643108|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373153|NCT02643095||Single Group Assignment||Other||None (Open Label)||||||
1373154|NCT02643082|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1373155|NCT02643069|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1373156|NCT02643056||Single Group Assignment||Treatment||None (Open Label)||||||
1373157|NCT02643043|||Case-Only||Prospective|||||||
1373158|NCT02643030|Randomized|Parallel Assignment||Prevention||Single||||||t
1373159|NCT02643017|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1373160|NCT02643004|Randomized|Crossover Assignment||Treatment||Single|||t|||
1373161|NCT02642991|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373162|NCT02642978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373163|NCT02642965||Single Group Assignment||Treatment||None (Open Label)||||||
1373164|NCT02642952|||Cohort||Prospective|||||||
1373165|NCT02642939||Single Group Assignment||Treatment||None (Open Label)||||||
1373166|NCT02642926|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373167|NCT02642913|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373168|NCT02642900|Randomized|Parallel Assignment||Treatment||Single||||||t
1373169|NCT02642887|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373170|NCT02642874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373171|NCT02642861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373172|NCT02642848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373173|NCT02642835|||Case-Only||Retrospective|||||||
1373174|NCT02642822|||Cohort||Prospective|||||||
1373175|NCT02642809||Single Group Assignment||Treatment||None (Open Label)||||||
1373176|NCT02642796|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1373177|NCT02642783|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1373178|NCT02642770|||Cohort||Prospective|||||||
1373179|NCT02642757|Randomized|Parallel Assignment||Prevention||Single||||||t
1374176|NCT02629744||Single Group Assignment||||None (Open Label)||||||
1373180|NCT02642744|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1373181|NCT02642731|||Cohort||Prospective|||||||
1373182|NCT02642718|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1373183|NCT02642705|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373184|NCT02642692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373185|NCT02642679||Single Group Assignment||Treatment||None (Open Label)||Opticell Ag dressing applied to STSG donor site||||
1373186|NCT02642666|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373187|NCT02642653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373188|NCT02642640|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1373189|NCT02642627||Single Group Assignment||Treatment||None (Open Label)||||||
1373190|NCT02642614|Randomized|Parallel Assignment||Treatment||Double||||||
1373191|NCT02642601|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373192|NCT02642588|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1373193|NCT02642575|||Cohort||Prospective|||||||
1373194|NCT02642562|Randomized|Parallel Assignment||Treatment||Single||||||t
1373195|NCT02642549|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373196|NCT02642536|Randomized|Parallel Assignment||Treatment||Triple|Masking was Double Blind||t||t|t
1373197|NCT02642523|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1373198|NCT02642510|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1373199|NCT02642497|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1373200|NCT02642484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373201|NCT02642471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373202|NCT02642458|||Cohort||Prospective|||||||
1373203|NCT02642445|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373204|NCT02642432||Single Group Assignment||Treatment||None (Open Label)||||||
1373205|NCT02642419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373206|NCT02642406|||Case-Only||Prospective|||||||
1373207|NCT02642393|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1373208|NCT02642380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373209|NCT02642367|Randomized|Parallel Assignment||Prevention||Single|||t|||
1373210|NCT02642354|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373211|NCT02642341|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373212|NCT02642328|Randomized|Parallel Assignment||||None (Open Label)||||||
1373213|NCT02642315||Single Group Assignment||Treatment||None (Open Label)||||||
1373214|NCT02642302|Randomized|Parallel Assignment||||Single|||t|||
1373215|NCT02642289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373216|NCT02642276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373217|NCT02642263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373218|NCT02642250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373219|NCT02642237|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373220|NCT02642224||Single Group Assignment||Prevention||None (Open Label)||||||
1373221|NCT02642211|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1373222|NCT02642198|||Case-Only|||||||||
1373223|NCT02642185|||Cohort||Prospective|||||||
1373224|NCT02642172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373225|NCT02642159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373226|NCT02642146|||Cohort||Prospective|||||||
1373227|NCT02642133||Single Group Assignment||Treatment||None (Open Label)||||||
1373228|NCT02642120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373229|NCT02642107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373230|NCT02642094||Single Group Assignment||Basic Science||None (Open Label)||||||
1373231|NCT02642081|||Case-Only||Retrospective|||||||
1373232|NCT02642068|||Case Control||Cross-Sectional|||||||
1373233|NCT02642055|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1373234|NCT02642042||Single Group Assignment||Treatment||None (Open Label)||||||
1373235|NCT02642029|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1373236|NCT02642016||Single Group Assignment||Treatment||None (Open Label)||||||
1373237|NCT02642003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373238|NCT02641990|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1373239|NCT02641977|||Cohort||Prospective|||||||
1373240|NCT02641964|||Case-Control||Retrospective|||||||
1373241|NCT02641951|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1373242|NCT02641938|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1373243|NCT02641925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373244|NCT02641912|Randomized|Parallel Assignment||Treatment||Single||||||t
1373245|NCT02641899||Single Group Assignment||Other||None (Open Label)||||||
1373246|NCT02641886|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1373247|NCT02641873||Single Group Assignment||Treatment||None (Open Label)||||||
1373248|NCT02641860|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373249|NCT02641847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373250|NCT02641834|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1373251|NCT02641821||Single Group Assignment||Treatment||None (Open Label)||||||
1373252|NCT02641808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373253|NCT02641795||Single Group Assignment||Treatment||None (Open Label)||||||
1373254|NCT02641782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373255|NCT02641769||Single Group Assignment||Treatment||None (Open Label)||||||
1373256|NCT02641756||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373257|NCT02641743|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1373258|NCT02641730|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373259|NCT02641717||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373260|NCT02641704|||Cohort||Prospective|||||||
1373261|NCT02641691||Single Group Assignment||Treatment||None (Open Label)||||||
1373262|NCT02641678|||Cohort||Prospective|||||||
1373263|NCT02641665|||Cohort||Prospective|||||||
1373264|NCT02641652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373265|NCT02641639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373266|NCT02641626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373267|NCT02641613|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373268|NCT02641600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373269|NCT02641587|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373270|NCT02641574|||||Retrospective|||||||
1373271|NCT02641561|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1373272|NCT02641548|Randomized|Parallel Assignment||Treatment||Single||||||t
1373273|NCT02641535||Single Group Assignment||||None (Open Label)||||||
1373274|NCT02641522||Single Group Assignment||Basic Science||None (Open Label)||||||
1373275|NCT02641509|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1373276|NCT02641496|Randomized|Parallel Assignment||Supportive Care||Single|The Outcomes Assessor will be masked so as to not influence the 12 month outcome variables.|||||t
1373277|NCT02641483||Single Group Assignment||Treatment||None (Open Label)||||||
1373278|NCT02641470|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373279|NCT02641457||Single Group Assignment||Treatment||None (Open Label)||||||
1373280|NCT02641444|||Cohort||Cross-Sectional|||||||
1373281|NCT02641431||Single Group Assignment||Treatment||None (Open Label)||||||
1373282|NCT02641418|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1373283|NCT02641405|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1373284|NCT02641392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373285|NCT02641379|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373286|NCT02641366|||Case-Control||Prospective|||||||
1373287|NCT02641353|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1373288|NCT02641340|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373289|NCT02641327|||Case Control||Retrospective|||||||
1373290|NCT02641314||Single Group Assignment||Treatment||None (Open Label)||||||
1373291|NCT02641301|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373292|NCT02641288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373293|NCT02641275|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373294|NCT02641262|||Cohort||Prospective|||||||
1373295|NCT02641249|Randomized|Sequential Assignment||Treatment||None (Open Label)|Open Label|"In the same subject there were 2 periods:~Arm 1. 'No intervention' period (no vibrations) - two 6 hour epochs - total of 12 hours of 'No intervention' Arm 2. Experimental period (with vibrations) - two 6 hour epochs - total of 12 hours of 'vibration intervention'~In the same subjects cardiorespiratory parameters - heart rate, respiratory rate and oxygen saturation were compared during the experimental period (vibration) and druing the no intervention period (no vibration)."||||
1373296|NCT02641236|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373297|NCT02641223|||Cohort||Prospective|||||||
1373298|NCT02641210|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373299|NCT02641197||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373300|NCT02641184|||Cohort||Prospective|||||||
1373301|NCT02641171|||Cohort||Cross-Sectional|||||||
1373302|NCT02641158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373303|NCT02641145|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1373304|NCT02641132|Randomized|Parallel Assignment||Prevention||Single|||t|||
1373305|NCT02641119|||Cohort||Retrospective|||||||
1373306|NCT02641106|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373307|NCT02641093||Single Group Assignment||Treatment||None (Open Label)||||||
1373308|NCT02641080|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373309|NCT02641067|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373310|NCT02641054|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1373311|NCT02641041|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1373312|NCT02641028|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373313|NCT02641015|||Cohort||Retrospective|||||||
1373314|NCT02641002||Single Group Assignment||Treatment||None (Open Label)||||||
1373315|NCT02640989|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1373316|NCT02640976|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1373317|NCT02640963|Randomized|Parallel Assignment||||None (Open Label)||||||
1373318|NCT02640950||Single Group Assignment||Treatment||None (Open Label)||||||
1373319|NCT02640937|||Case-Only||Prospective|||||||
1373320|NCT02640924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373321|NCT02640911|||Case-Only||Prospective|||||||
1373322|NCT02640898|Randomized|Parallel Assignment||Treatment||Single|open label||t|||
1373323|NCT02640885||Single Group Assignment||Treatment||None (Open Label)||||||
1373324|NCT02640872|||Cohort||Prospective|||||||
1373325|NCT02640859|||Cohort||Prospective|||||||
1373326|NCT02640846|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1373327|NCT02640833||Single Group Assignment||Treatment||None (Open Label)||||||
1373328|NCT02640820|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1373329|NCT02640807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373330|NCT02640794|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373331|NCT02640781|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373332|NCT02640768|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373333|NCT02640755|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373334|NCT02640742|||Case-Only||Cross-Sectional|||||||
1373335|NCT02640729|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1373336|NCT02640716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373337|NCT02640703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373338|NCT02640690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373339|NCT02640677|||Other||Prospective|||||||
1373340|NCT02640664|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373341|NCT02640651||Single Group Assignment||Treatment||None (Open Label)||||||
1373342|NCT02640638|Randomized|Parallel Assignment||Prevention||Single||||||t
1373343|NCT02640625||Single Group Assignment||Treatment||None (Open Label)||||||
1373344|NCT02640612||Single Group Assignment||Treatment||None (Open Label)||||||
1373345|NCT02640599|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373346|NCT02640586||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373347|NCT02640573||Single Group Assignment||Treatment||None (Open Label)||||||
1373348|NCT02640560|||Case Control||Retrospective|||||||
1373349|NCT02640547|||Cohort||Prospective|||||||
1373350|NCT02640534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373351|NCT02640521|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1373352|NCT02640508||Single Group Assignment||Treatment||None (Open Label)||||||
1373353|NCT02640495|||Case-Only||Prospective|||||||
1373354|NCT02640482|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373355|NCT02640469|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1373356|NCT02640456|||Case Control||Prospective|||||||
1373357|NCT02640443||Single Group Assignment||Treatment||Single||||||t
1373358|NCT02640430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373359|NCT02640417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373360|NCT02640404|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373361|NCT02640391|||Case-Only||Cross-Sectional|||||||
1373362|NCT02640378|||Case-Only||Cross-Sectional|||||||
1373363|NCT02640365||Single Group Assignment||Treatment||None (Open Label)||||||
1373364|NCT02640352|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1373365|NCT02640339|||Cohort||Prospective|||||||
1373366|NCT02640326|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373367|NCT02640313||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373368|NCT02640300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373369|NCT02640287|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373370|NCT02640274|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373371|NCT02640261|||Case Control||Prospective|||||||
1373372|NCT02640248|||Cohort||Prospective|||||||
1373373|NCT02640235|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1373374|NCT02640222|||Cohort||Retrospective|||||||
1373375|NCT02640209||Single Group Assignment||Treatment||None (Open Label)||||||
1373376|NCT02640196|Randomized|Crossover Assignment||||None (Open Label)||||||
1373377|NCT02640183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373378|NCT02640170|||Cohort||Prospective|||||||
1373379|NCT02640157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373380|NCT02640144|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373381|NCT02640131|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373382|NCT02640118|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1373383|NCT02640105|||Cohort||Prospective|||||||
1373384|NCT02640092||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373385|NCT02640079||Single Group Assignment||Treatment||None (Open Label)||||||
1373386|NCT02640066|Randomized|Parallel Assignment||Treatment||Single||||||t
1373387|NCT02640053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373388|NCT02640040||Single Group Assignment||Treatment||None (Open Label)||||||
1373389|NCT02640027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373390|NCT02640014|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373391|NCT02640001|||Cohort||Prospective|||||||
1373392|NCT02639988|||Cohort||Prospective|||||||
1373393|NCT02639975|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1373394|NCT02639962|||Case-Control||Prospective|||||||
1373395|NCT02639949|Randomized|Single Group Assignment||Treatment||||||||
1373396|NCT02639936|||Cohort||Prospective|||||||
1373397|NCT02639923|||Cohort||Prospective|||||||
1373398|NCT02639910||Single Group Assignment||Treatment||None (Open Label)||||||
1373399|NCT02639897|||Cohort||Prospective|||||||
1373400|NCT02639884||||||||||||
1373401|NCT02639871|||Other||Prospective|||||||
1373402|NCT02639858||Single Group Assignment||Treatment||None (Open Label)||||||
1373403|NCT02639845|||Cohort||Prospective|||||||
1373404|NCT02639832|||Cohort||Prospective|||||||
1373405|NCT02639819||Single Group Assignment||Treatment||None (Open Label)||||||
1373406|NCT02639806|||Cohort|||||||||
1373407|NCT02639793|Randomized|Parallel Assignment||Treatment||Single||||||t
1373408|NCT02639780|||Case-Control||Prospective|||||||
1373409|NCT02639767||Single Group Assignment||Treatment||None (Open Label)||||||
1373410|NCT02639754|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1373411|NCT02639741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373412|NCT02639728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373413|NCT02639715|||Cohort||Retrospective|||||||
1373414|NCT02639702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373415|NCT02639689||Single Group Assignment||Treatment||None (Open Label)||||||
1373416|NCT02639676|||Cohort||Prospective|||||||
1373417|NCT02639663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373418|NCT02639650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373419|NCT02639637|Randomized|Crossover Assignment||Basic Science||Quadruple||Crossover Arms 1 and 2, Crossover Arms 3 and 4|t|t|t|t
1373420|NCT02639624|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373421|NCT02639611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373422|NCT02639598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373423|NCT02639585||Single Group Assignment||Treatment||None (Open Label)||||||
1373424|NCT02639572|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373425|NCT02639559|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373426|NCT02639546|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1373427|NCT02639533|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1373428|NCT02639520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373429|NCT02639507|||Case-Only||Prospective|||||||
1373430|NCT02639494||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1373431|NCT02639481|Randomized|Parallel Assignment||Treatment||Single||||||t
1373432|NCT02639468||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373433|NCT02639455|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1373434|NCT02639442||Single Group Assignment||Treatment||None (Open Label)||||||
1373435|NCT02639429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373436|NCT02639416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373437|NCT02639403||Single Group Assignment||Treatment||None (Open Label)||||||
1373438|NCT02639390|Randomized|Parallel Assignment||Treatment||Single||||||t
1373439|NCT02639377|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373440|NCT02639364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373441|NCT02639351|Randomized|Parallel Assignment||Prevention||Single|||t|||
1373442|NCT02639338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373443|NCT02639325|||Cohort||Prospective|||||||
1373444|NCT02639312|||Case-Control||Other|||||||
1373445|NCT02639299|||Cohort||Cross-Sectional|||||||
1373446|NCT02639286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373447|NCT02639273|Randomized|Crossover Assignment||Other||Double|||t||t|
1373448|NCT02639260|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373449|NCT02639247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373450|NCT02639234||Single Group Assignment||Treatment||None (Open Label)||||||
1373451|NCT02639221|Randomized|Parallel Assignment||||Double|||t||t|
1373452|NCT02639208||Single Group Assignment||Supportive Care||None (Open Label)||||||
1373453|NCT02639195|||Case-Control||Prospective|||||||
1373454|NCT02639182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373455|NCT02639169|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373456|NCT02639156||Single Group Assignment||Treatment||None (Open Label)||||||
1373457|NCT02639143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373458|NCT02639130|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373459|NCT02639117||Single Group Assignment||Treatment||None (Open Label)||||||
1373460|NCT02639104|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1373461|NCT02639091||Single Group Assignment||Treatment||None (Open Label)||||||
1373462|NCT02639078|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1373463|NCT02639065||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1373464|NCT02639052|Randomized|Crossover Assignment||Treatment||Single|||t|||
1373465|NCT02639039|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373466|NCT02639026|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373467|NCT02639013||Single Group Assignment||Prevention||None (Open Label)||||||
1373468|NCT02639000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373469|NCT02638987|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1373470|NCT02638974|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373471|NCT02638961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373472|NCT02638948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373473|NCT02638935|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1373474|NCT02638922|||Case Control||Retrospective|||||||
1373475|NCT02638909||Single Group Assignment||Treatment||None (Open Label)||||||
1373476|NCT02638896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373477|NCT02638883||||||||||||
1373478|NCT02638870|||Case-Only||Prospective|||||||
1373479|NCT02638857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373480|NCT02638844|||Case-Only||Prospective|||||||
1373481|NCT02638831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373482|NCT02638818|||Cohort||Prospective|||||||
1373483|NCT02638805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373484|NCT02638792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373485|NCT02638779||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373486|NCT02638766||Single Group Assignment||Treatment||None (Open Label)||||||
1373487|NCT02638753|Randomized|Parallel Assignment||Treatment||Single||||||t
1373488|NCT02638740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373489|NCT02638727|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1373490|NCT02638714||Single Group Assignment||Treatment||None (Open Label)||||||
1373491|NCT02638701||Single Group Assignment||Treatment||None (Open Label)||||||
1373492|NCT02638688|||Case-Only||Cross-Sectional|||||||
1373493|NCT02638675|Randomized|Parallel Assignment||Prevention||Single|||||t|
1373494|NCT02638662|||Cohort||Prospective|||||||
1373495|NCT02638649|||Case-Only||Prospective|||||||
1373496|NCT02638636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373497|NCT02638623|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1373498|NCT02638610||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373499|NCT02638597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373500|NCT02638584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373501|NCT02638571|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373502|NCT02638558|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1373503|NCT02638545||Single Group Assignment||Treatment||None (Open Label)||||||
1373504|NCT02638532||Single Group Assignment||Treatment||None (Open Label)||||||
1373505|NCT02638519|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373506|NCT02638506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373507|NCT02638493|||Case-Control||Prospective|||||||
1373508|NCT02638480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373509|NCT02638467||Single Group Assignment||Treatment||None (Open Label)||||||
1373510|NCT02638454|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373511|NCT02638441|||Case Control||Cross-Sectional|||||||
1373512|NCT02638428||Single Group Assignment||Treatment||None (Open Label)||||||
1373513|NCT02638415|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373514|NCT02638402|||Case Control||Retrospective|||||||
1373515|NCT02638389||Single Group Assignment||Treatment||None (Open Label)||||||
1373516|NCT02638376|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373517|NCT02638363|||Case-Only||Prospective|||||||
1373518|NCT02638350||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373519|NCT02638337|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373520|NCT02638324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373521|NCT02638311|||||Prospective|||||||
1373522|NCT02638298|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373523|NCT02638285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373524|NCT02638272||Single Group Assignment||Treatment||None (Open Label)||||||
1373525|NCT02638259|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373526|NCT02638246|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373527|NCT02638233||Single Group Assignment||Treatment||None (Open Label)||||||
1373528|NCT02638220|||Cohort||Other|||||||
1373529|NCT02638207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373530|NCT02638194|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373531|NCT02638181||Single Group Assignment||Basic Science||None (Open Label)||||||
1373532|NCT02638168|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1373533|NCT02638155|||Case Control||Prospective|||||||
1373534|NCT02638142|||Case-Control||Prospective|||||||
1373535|NCT02638129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373536|NCT02638116||Single Group Assignment||Treatment||None (Open Label)||||||
1373537|NCT02638103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373538|NCT02638090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373539|NCT02638077|||Cohort||Prospective|||||||
1373540|NCT02638064||Single Group Assignment||Treatment||None (Open Label)||||||
1373541|NCT02638051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373542|NCT02638038|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind|A randomized double blind parallel group study with 3mg, 1mg or placebo|t|t|t|t
1373543|NCT02638025|||Case-Only||Prospective|||||||
1373544|NCT02638012|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373545|NCT02637999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373546|NCT02637986|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1373547|NCT02637973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373548|NCT02637960|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373549|NCT02637947|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373550|NCT02637934||Parallel Assignment||Treatment||||||||
1373551|NCT02637921|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1373552|NCT02637908|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373553|NCT02637895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373554|NCT02637882|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1373555|NCT02637869|||Case-Control||Prospective|||||||
1373556|NCT02637856||Single Group Assignment||Treatment||None (Open Label)||||||
1373557|NCT02637843|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1373558|NCT02637830|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373559|NCT02637817|||Cohort||Prospective|||||||
1373636|NCT02636816|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1373637|NCT02636803|Randomized|Factorial Assignment||Treatment||Single||||||t
1374333|NCT02627703|||||Prospective|||||||
1373560|NCT02637804|Randomized|Parallel Assignment||Other||None (Open Label)||Study participants will be allocated in to 2 parallel groups: Group 1: stenfilcon A and narafilcon A, and Group 2: stenfilcon A and delefilcon A. Each participant will be randomized to wear either lens pair in a bilateral design for 1 week, and then cross over to the alternative pair.||||
1373561|NCT02637791|Randomized|Parallel Assignment||Treatment||Single||||||t
1373562|NCT02637778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373563|NCT02637765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373564|NCT02637752|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373565|NCT02637739||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373566|NCT02637726|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1373567|NCT02637713|||Cohort||Prospective|||||||
1373568|NCT02637700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373569|NCT02637687||Single Group Assignment||Treatment||None (Open Label)||||||
1373570|NCT02637674||Single Group Assignment||Treatment||None (Open Label)||||||
1373571|NCT02637661|||Case Control||Cross-Sectional|||||||
1373572|NCT02637648|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373573|NCT02637635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373574|NCT02637622|||Case-Only||Cross-Sectional|||||||
1373575|NCT02637609|||Case-Only||Cross-Sectional|||||||
1373576|NCT02637596||Single Group Assignment||Treatment||None (Open Label)||||||
1373577|NCT02637583|Randomized|Parallel Assignment||Prevention||Single||||||t
1373578|NCT02637570|Randomized|Parallel Assignment||Other||Double|||t||t|
1373579|NCT02637557|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373580|NCT02637544|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373581|NCT02637531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1373582|NCT02637518|||Cohort||Prospective|||||||
1373583|NCT02637505|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373584|NCT02637492|||Cohort||Prospective|||||||
1373585|NCT02637479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373586|NCT02637466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373587|NCT02637453|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373588|NCT02637440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373589|NCT02637427|Randomized|Parallel Assignment||Treatment||Single||||||t
1373590|NCT02637414|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373591|NCT02637401|||Case-Only||Prospective|||||||
1373592|NCT02637388|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1373593|NCT02637375||Single Group Assignment||Treatment||None (Open Label)||||||
1373594|NCT02637362|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373595|NCT02637349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373596|NCT02637336|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373597|NCT02637323|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373598|NCT02637310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373599|NCT02637297|Randomized|Parallel Assignment||Supportive Care||Single||||||
1373600|NCT02637284|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1373601|NCT02637271|Randomized|Parallel Assignment||||None (Open Label)||||||
1373602|NCT02637258|||Cohort||Prospective|||||||
1373603|NCT02637245|||Cohort||Prospective|||||||
1373604|NCT02637232|||||Prospective|||||||
1373605|NCT02637219|||Cohort||Cross-Sectional|||||||
1373606|NCT02637206|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1373607|NCT02637193|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1373608|NCT02637180|||Cohort||Prospective|||||||
1373609|NCT02637167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373610|NCT02637154|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1373611|NCT02637141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373612|NCT02637128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373613|NCT02637115|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1373614|NCT02637102|||Cohort||Prospective|||||||
1373615|NCT02637089|||Case-Control||Prospective|||||||
1373616|NCT02637076|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||Participants will be recruited to fill 2 separate study groups: 1) participants with a diagnosis of narcolepsy with cataplexy; 2) healthy controls.||||
1373617|NCT02637063|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373618|NCT02637050|||Cohort||Prospective|||||||
1373619|NCT02637037|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1373620|NCT02637024|Randomized|Parallel Assignment||Treatment||Single||||||t
1373621|NCT02637011|||Cohort||Prospective|||||||
1373622|NCT02636998|||Cohort||Prospective|||||||
1373623|NCT02636985|||Case-Only||Retrospective|||||||
1373624|NCT02636972|||Cohort||Cross-Sectional|||||||
1373625|NCT02636959|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373626|NCT02636946|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373627|NCT02636933|||Case-Control||Prospective|||||||
1373628|NCT02636920|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373629|NCT02636907||Single Group Assignment||Treatment||None (Open Label)||||||
1373630|NCT02636894||Single Group Assignment||Treatment||None (Open Label)||||||
1373631|NCT02636881|Randomized|Parallel Assignment||Treatment||Single||||||t
1373632|NCT02636868|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1373633|NCT02636855|||Case-Only||Prospective|||||||
1373634|NCT02636842||Single Group Assignment||Treatment||None (Open Label)||||||
1373635|NCT02636829|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1373638|NCT02636790|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1373639|NCT02636777|||Other||Prospective|||||||
1373640|NCT02636764|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373641|NCT02636751|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373642|NCT02636738||Single Group Assignment||Treatment||None (Open Label)||||||
1373643|NCT02636725||Single Group Assignment||Treatment||None (Open Label)||||||
1373644|NCT02636712|||Case-Only||Prospective|||||||
1373645|NCT02636699|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373646|NCT02636686||||||||||||
1373647|NCT02636673|||Cohort||Retrospective|||||||
1373648|NCT02636660|||Cohort||Prospective|||||||
1373649|NCT02636647|Randomized|Parallel Assignment||||None (Open Label)||||||
1373650|NCT02636634||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373651|NCT02636621|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373652|NCT02636608|||Cohort||Prospective|||||||
1373653|NCT02636595||Single Group Assignment||Treatment||None (Open Label)||||||
1373654|NCT02636582|Randomized|Parallel Assignment||Prevention||Single|||t|||
1373655|NCT02636569|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1373656|NCT02636556||Single Group Assignment||Treatment||None (Open Label)||chemoradiation.VP-16+DDP scheme.||||
1373657|NCT02636543|||||Prospective|||||||
1373658|NCT02636530|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1373659|NCT02636517|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373660|NCT02636504|||Cohort||Prospective|||||||
1373661|NCT02636491|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373662|NCT02636478|||||Prospective|||||||
1373663|NCT02636465|||||Prospective|||||||
1373664|NCT02636452|||Other||Prospective|||||||
1373665|NCT02636439|Randomized|Parallel Assignment||Treatment||Single||||||t
1373666|NCT02636426||Single Group Assignment||Treatment||None (Open Label)||||||
1373667|NCT02636413|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1373668|NCT02636400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373669|NCT02636387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373670|NCT02636374||Single Group Assignment||Supportive Care||None (Open Label)||||||
1373671|NCT02636361|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1373672|NCT02636348|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1373673|NCT02636335|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373674|NCT02636322||Single Group Assignment||Treatment||None (Open Label)||||||
1373675|NCT02636309|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373676|NCT02636296|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373677|NCT02636283|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373678|NCT02636270||Single Group Assignment||Treatment||None (Open Label)||||||
1373679|NCT02636257|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373680|NCT02636244||Single Group Assignment||Treatment||None (Open Label)||||||
1373681|NCT02636231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373682|NCT02636218|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373683|NCT02636205||Single Group Assignment||Treatment||None (Open Label)||||||
1373684|NCT02636192|||Cohort||Retrospective|||||||
1373685|NCT02636179|||Case Control||Prospective|||||||
1373686|NCT02636166||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373687|NCT02636153|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1373688|NCT02636140||Single Group Assignment||Basic Science||Double|||t|||t
1373689|NCT02636127|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373690|NCT02636114|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1373691|NCT02636101|||Cohort||Prospective|||||||
1373692|NCT02636088||Single Group Assignment||Treatment||None (Open Label)||||||
1373693|NCT02636075|||Cohort||Prospective|||||||
1373694|NCT02636062|||Cohort||Prospective|||||||
1373695|NCT02636049|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373696|NCT02636036||Single Group Assignment||Treatment||None (Open Label)||||||
1373697|NCT02636023||Single Group Assignment||Supportive Care||None (Open Label)||||||
1373698|NCT02636010||Single Group Assignment||Treatment||None (Open Label)||||||
1373699|NCT02635997|||Cohort||Retrospective|||||||
1373700|NCT02635984|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1373701|NCT02635971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373702|NCT02635958|||Cohort||Other|||||||
1373703|NCT02635945|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373704|NCT02635932|Randomized|Parallel Assignment||Treatment||Single||||||t
1373705|NCT02635919|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373706|NCT02635906|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373707|NCT02635893|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1373708|NCT02635880||Single Group Assignment||Treatment||None (Open Label)||||||
1373709|NCT02635867|Randomized|Parallel Assignment||Other||Double|||t|||t
1373710|NCT02635854|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373711|NCT02635841||||||||||||
1373712|NCT02635828||Single Group Assignment||Prevention||None (Open Label)||||||
1373713|NCT02635815|||Cohort||Prospective|||||||
1373714|NCT02635802|Randomized|Parallel Assignment||Prevention||Single|||t|||
1373715|NCT02635789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373716|NCT02635776|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373717|NCT02635763|Randomized|Parallel Assignment||Treatment||Single||||||t
1373718|NCT02635750|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373719|NCT02635737||Single Group Assignment||Treatment||None (Open Label)||||||
1373720|NCT02635724||Single Group Assignment||Treatment||None (Open Label)||||||
1373721|NCT02635711|Randomized|Parallel Assignment||Treatment||Single||||||t
1373722|NCT02635698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373723|NCT02635685|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373724|NCT02635672||Single Group Assignment||Treatment||None (Open Label)||||||
1373725|NCT02635659|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1373726|NCT02635646|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1373727|NCT02635633||Single Group Assignment||Treatment||None (Open Label)||||||
1373728|NCT02635620|||Case-Control||Prospective|||||||
1373729|NCT02635607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373730|NCT02635594|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1373731|NCT02635581||Single Group Assignment||Treatment||None (Open Label)||||||
1373732|NCT02635568|||Cohort||Prospective|||||||
1373733|NCT02635555|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1373734|NCT02635542|Randomized|Parallel Assignment||Prevention||Triple|Open label drug administration. Outcomes assessor and care providers are otherwise masked.||t|t||t
1373735|NCT02635529|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373736|NCT02635516||Single Group Assignment||Treatment||None (Open Label)||||||
1373737|NCT02635503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373738|NCT02635490|||Case-Crossover||Prospective|||||||
1373739|NCT02635477|Randomized|Parallel Assignment||Prevention||Single||||||t
1373740|NCT02635464|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373741|NCT02635451|||Case Control||Cross-Sectional|||||||
1373742|NCT02635438|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373743|NCT02635425|Randomized|Parallel Assignment||Prevention||Single|||t|||
1373744|NCT02635412|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373745|NCT02635399|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373746|NCT02635386|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373747|NCT02635373|||||Prospective|||||||
1373748|NCT02635360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373749|NCT02635347||Single Group Assignment||Treatment||None (Open Label)||||||
1373750|NCT02635334|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373751|NCT02635321|||Case-Only||Cross-Sectional|||||||
1373752|NCT02635308||Single Group Assignment||Treatment||None (Open Label)||||||
1373753|NCT02635295|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373754|NCT02635282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373755|NCT02635269||Single Group Assignment||Basic Science||None (Open Label)||||||
1373756|NCT02635256||Single Group Assignment||Treatment||None (Open Label)||||||
1373757|NCT02635243|Randomized|Crossover Assignment||Basic Science||Double||||||
1373758|NCT02635230|||Cohort||Prospective|||||||
1373759|NCT02635217|Randomized|Parallel Assignment||Treatment||Single||||||t
1373760|NCT02635204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373761|NCT02635191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373762|NCT02635178|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373763|NCT02635165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373764|NCT02635152|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373765|NCT02635139|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1373766|NCT02635113||Single Group Assignment||Supportive Care||None (Open Label)||||||
1373767|NCT02635100||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373768|NCT02635087|||Cohort||Prospective|||||||
1373769|NCT02635074||Single Group Assignment||Treatment||None (Open Label)||||||
1373770|NCT02635061||Single Group Assignment||Treatment||None (Open Label)||||||
1373771|NCT02635048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373772|NCT02635035|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373773|NCT02635022|||Case-Only||Prospective|||||||
1373774|NCT02635009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373775|NCT02634996||||||||||||
1373776|NCT02634983|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373777|NCT02634970||Single Group Assignment||Treatment||None (Open Label)||||||
1373778|NCT02634957|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373779|NCT02634944|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1373780|NCT02634931||Single Group Assignment||Treatment||None (Open Label)||||||
1373781|NCT02634918|||Cohort||Prospective|||||||
1373782|NCT02634905|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1373783|NCT02634892|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373784|NCT02634879|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373785|NCT02634866|||Cohort||Prospective|||||||
1373786|NCT02634853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373787|NCT02634840||Single Group Assignment||Treatment||None (Open Label)||||||
1373788|NCT02634827||Single Group Assignment||Treatment||None (Open Label)||||||
1373789|NCT02634814|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373790|NCT02634801|Randomized|Parallel Assignment||Treatment||Single||||||t
1373791|NCT02634788|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373792|NCT02634775|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373793|NCT02634762|||Cohort||Prospective|||||||
1373794|NCT02634749|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1373795|NCT02634736|Randomized|Parallel Assignment||Treatment||Single||||||t
1373796|NCT02634723|||Cohort||Retrospective|||||||
1373797|NCT02634710||Single Group Assignment||Treatment||None (Open Label)||||||
1373798|NCT02634697|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373799|NCT02634684|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1373800|NCT02634671|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1373801|NCT02634658|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1373802|NCT02634645|||Cohort||Prospective|||||||
1373803|NCT02634632||Single Group Assignment||Health Services Research||None (Open Label)||||||
1373804|NCT02634619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373805|NCT02634606|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1373806|NCT02634593|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373807|NCT02634580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373808|NCT02634567|Randomized|Parallel Assignment||Treatment||Single||||||t
1373809|NCT02634554||||||||||||
1373810|NCT02634541|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373811|NCT02634528|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373812|NCT02634515|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373813|NCT02634502||Single Group Assignment||Treatment||None (Open Label)||||||
1373814|NCT02634489|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1373815|NCT02634476|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373816|NCT02634463||Single Group Assignment||Other||None (Open Label)||||||
1373817|NCT02634450|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1373818|NCT02634437|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373819|NCT02634424||Single Group Assignment||Supportive Care||None (Open Label)||||||
1373820|NCT02634411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373821|NCT02634398|||Cohort||Prospective|||||||
1373822|NCT02634385||Single Group Assignment||Treatment||None (Open Label)||||||
1373823|NCT02634372|Randomized|Parallel Assignment||Treatment||Single||||||t
1373824|NCT02634359|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1373825|NCT02634346|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373826|NCT02634333|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1373827|NCT02634320||Single Group Assignment||Treatment||None (Open Label)||||||
1373828|NCT02634307||Single Group Assignment||Treatment||None (Open Label)||||||
1373829|NCT02634294||Single Group Assignment||Treatment||None (Open Label)||||||
1373830|NCT02634281|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373831|NCT02634268|Randomized|Parallel Assignment||Treatment||Single||||||t
1373832|NCT02634255|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373833|NCT02634242|Randomized|Crossover Assignment||||Double|||t||t|
1373834|NCT02634229|||Family-Based||Prospective|||||||
1373835|NCT02634216||Single Group Assignment||Other||None (Open Label)||||||
1373836|NCT02634203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373837|NCT02634190|||Cohort||Other|||||||
1373838|NCT02634177|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373839|NCT02634164|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1373840|NCT02634151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373841|NCT02634138||Single Group Assignment||Treatment||None (Open Label)||||||
1373842|NCT02634125||||||||||||
1373843|NCT02634112|||Case-Only||Prospective|||||||
1373844|NCT02634099||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373845|NCT02634086|||Cohort||Retrospective|||||||
1373846|NCT02634073|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1373847|NCT02634060||Single Group Assignment||Diagnostic||None (Open Label)||||||
1373848|NCT02634047|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1373849|NCT02634034|Randomized|Crossover Assignment||||None (Open Label)||||||
1373850|NCT02634021|Randomized|Factorial Assignment||Treatment||Single|||t|||
1373851|NCT02634008|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373852|NCT02633995|||Case Control||Prospective|||||||
1373853|NCT02633982|||Cohort||Prospective|||||||
1373854|NCT02633969|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373855|NCT02633956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373856|NCT02633943|||Case-Only||Prospective|||||||
1373857|NCT02633930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373858|NCT02633917|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373859|NCT02633904|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373860|NCT02633891|Randomized|Parallel Assignment||Treatment||Single||||||t
1373861|NCT02633878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373862|NCT02633865|||||Cross-Sectional|||||||
1373863|NCT02633852||Single Group Assignment||Treatment||None (Open Label)||||||
1373864|NCT02633839|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373865|NCT02633826|||Cohort||Prospective|||||||
1373866|NCT02633813|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373867|NCT02633800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373868|NCT02633787||Single Group Assignment||Treatment||None (Open Label)||||||
1373869|NCT02633774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373870|NCT02633761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373871|NCT02633748|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1373872|NCT02633735|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1373873|NCT02633722|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1373874|NCT02633709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373875|NCT02633696|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373876|NCT02633683||Single Group Assignment||Treatment||None (Open Label)||||||
1373877|NCT02633670|Randomized|Factorial Assignment||Treatment||Single|||t|||
1373878|NCT02633657||Single Group Assignment||Treatment||None (Open Label)||||||
1373879|NCT02633644||Single Group Assignment||Treatment||None (Open Label)||||||
1373880|NCT02633631|||Cohort||Prospective|||||||
1373881|NCT02633618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373882|NCT02633605|||Cohort||Prospective|||||||
1373883|NCT02633592|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1373884|NCT02633579|Randomized|Crossover Assignment||||Single|||t|||
1373885|NCT02633566|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373886|NCT02633553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373887|NCT02633540||Single Group Assignment||Treatment||None (Open Label)||||||
1373888|NCT02633527|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373889|NCT02633514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373890|NCT02633501|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1373891|NCT02633488|Randomized|Crossover Assignment||Treatment||Single|||t|||
1373892|NCT02633475|||Case-Control||Cross-Sectional|||||||
1373893|NCT02633462|Randomized|Parallel Assignment||Treatment||Single||||||t
1373894|NCT02633449|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373895|NCT02633436|||Case-Only|||||||||
1373896|NCT02633423|Randomized|Parallel Assignment||Prevention||Single|||t|||
1373897|NCT02633410|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373898|NCT02633397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373899|NCT02633384|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1373900|NCT02633371||Single Group Assignment||Treatment||None (Open Label)||||||
1373901|NCT02633358||Single Group Assignment||Treatment||None (Open Label)||||||
1373902|NCT02633345|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1373903|NCT02633319|Randomized|Factorial Assignment||Prevention||Single||||||t
1373904|NCT02633306||Single Group Assignment||Treatment||None (Open Label)||This is a device study and therefore does not have a drug, biological/vaccine or combination product involved.||||
1373905|NCT02633293||Single Group Assignment||Treatment||None (Open Label)||||||
1373906|NCT02633280|||Case-Control||Prospective|||||||
1373907|NCT02633267|Randomized|Parallel Assignment||Treatment||Single||||||t
1373908|NCT02633254||Single Group Assignment||Treatment||None (Open Label)||||||
1373909|NCT02633241||Single Group Assignment||Health Services Research||None (Open Label)||||||
1373910|NCT02633228||Single Group Assignment||Treatment||None (Open Label)||||||
1373911|NCT02633215|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373912|NCT02633202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373913|NCT02633189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373914|NCT02633176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373915|NCT02633163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373916|NCT02633150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1373917|NCT02633137||Single Group Assignment||Treatment||None (Open Label)||||||
1373918|NCT02633124|Randomized|Crossover Assignment||Prevention||Single|||t|||
1373919|NCT02633111||Single Group Assignment||Diagnostic||Double|||t||t|
1373920|NCT02633098|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1373921|NCT02633085|||Cohort||Retrospective|||||||
1373922|NCT02633072||Single Group Assignment||Treatment||None (Open Label)||||||
1373923|NCT02633059||Single Group Assignment||Treatment||None (Open Label)||||||
1373924|NCT02633046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373925|NCT02633033|||Case-Only||Prospective|||||||
1373926|NCT02633020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373927|NCT02633007|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1373928|NCT02632994||||||||||||
1373929|NCT02632981|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1373930|NCT02632968|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373931|NCT02632955|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373932|NCT02632942|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373933|NCT02632929|||Cohort||Prospective|||||||
1373934|NCT02632916|Randomized|Parallel Assignment||Treatment||Single||||||t
1373935|NCT02632903||Single Group Assignment||Treatment||None (Open Label)||||||
1373936|NCT02632890|||Case-Only||Cross-Sectional|||||||
1373937|NCT02632877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373938|NCT02632864||Single Group Assignment||Treatment||None (Open Label)||||||
1373939|NCT02632851|||Case-Crossover||Prospective|||||||
1373940|NCT02632838|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373941|NCT02632825|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373942|NCT02632812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373943|NCT02632799|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1373944|NCT02632786|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373945|NCT02632773|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1373946|NCT02632760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373947|NCT02632747|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1373948|NCT02632734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1373949|NCT02632721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373950|NCT02632708|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373951|NCT02632695|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373952|NCT02632682|||Cohort||Prospective|||||||
1373953|NCT02632669||Single Group Assignment||Treatment||None (Open Label)||||||
1373954|NCT02632656|||Cohort||Prospective|||||||
1373955|NCT02632643||Single Group Assignment||Treatment||None (Open Label)||||||
1373956|NCT02632630|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1373957|NCT02632617|||Cohort||Prospective|||||||
1373958|NCT02632604|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1373959|NCT02632578|||Cohort||Prospective|||||||
1373960|NCT02632565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1373961|NCT02632552|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1373962|NCT02632539|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1373963|NCT02632526|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1373964|NCT02632513|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373965|NCT02632500|Randomized|Parallel Assignment||Treatment||Single|||t|||
1373966|NCT02632487|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1373967|NCT02632474||Single Group Assignment||Treatment||None (Open Label)||||||
1373968|NCT02632461|Randomized|Parallel Assignment||||Single||||||t
1373969|NCT02632448|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1373970|NCT02632435|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1373971|NCT02632422|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373972|NCT02632409|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1373973|NCT02632396||Single Group Assignment||Treatment||None (Open Label)||||||
1373974|NCT02632383|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1373975|NCT02632370|||Cohort||Prospective|||||||
1373976|NCT02632357|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1373977|NCT02632344||Single Group Assignment||Treatment||None (Open Label)||||||
1373978|NCT02632331|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1373979|NCT02632318|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1373980|NCT02632305||Single Group Assignment||Treatment||None (Open Label)||||||
1373981|NCT02632292|Randomized|Parallel Assignment||Treatment||Single||||||t
1373982|NCT02632279|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1373983|NCT02632266|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1373984|NCT02632253|Randomized|Parallel Assignment||Treatment||Single||||||t
1373985|NCT02632240|Randomized|Parallel Assignment||Treatment||Single|||||t|
1373986|NCT02632227|||Cohort||Prospective|||||||
1373987|NCT02632214|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1373988|NCT02632201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373989|NCT02632188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373990|NCT02632175||Single Group Assignment||Treatment||None (Open Label)||||||
1373991|NCT02632162|||Case Control||Prospective|||||||
1373992|NCT02632149||Single Group Assignment||Treatment||None (Open Label)||||||
1373993|NCT02632136|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1373994|NCT02632123|||Cohort||Prospective|||||||
1373995|NCT02632110|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373996|NCT02632097|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1373997|NCT02632084|||Case-Only||Prospective|||||||
1373998|NCT02632071|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1373999|NCT02632058|||Cohort||Retrospective|||||||
1374000|NCT02632045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374001|NCT02632032||Single Group Assignment||||None (Open Label)||||||
1374002|NCT02632019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374003|NCT02632006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374004|NCT02631993|||Cohort||Retrospective|||||||
1374005|NCT02631980|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1374006|NCT02631967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374007|NCT02631954|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374008|NCT02631941|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374009|NCT02631928|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1374010|NCT02631902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374011|NCT02631889|Randomized|Parallel Assignment||Treatment||Single||||||t
1374012|NCT02631876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374013|NCT02631863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374014|NCT02631850|Randomized|Parallel Assignment||Treatment||Single||||||t
1374015|NCT02631837|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374016|NCT02631824|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374017|NCT02631811|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1374018|NCT02631798||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374019|NCT02631785|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1374020|NCT02631772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374021|NCT02631759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374022|NCT02631746||Single Group Assignment||Treatment||None (Open Label)||||||
1374023|NCT02631733||Single Group Assignment||Treatment||None (Open Label)||||||
1374024|NCT02631720|||Cohort||Prospective|||||||
1374025|NCT02631707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374026|NCT02631694|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1374027|NCT02631681||Single Group Assignment||Treatment||None (Open Label)||||||
1374028|NCT02631668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374029|NCT02631655||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374030|NCT02631642|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1374031|NCT02631629|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374032|NCT02631616||Single Group Assignment||Treatment||None (Open Label)||||||
1374033|NCT02631603|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374034|NCT02631590||Single Group Assignment||Treatment||None (Open Label)||||||
1374035|NCT02631577||Single Group Assignment||Treatment||None (Open Label)||||||
1374036|NCT02631564|||Cohort||Prospective|||||||
1374037|NCT02631551|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374038|NCT02631538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374039|NCT02631525|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374040|NCT02631512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374041|NCT02631499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374042|NCT02631486|Randomized|Parallel Assignment||Treatment||Single||||||t
1374043|NCT02631473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374044|NCT02631460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374045|NCT02631447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374046|NCT02631434|Randomized|Parallel Assignment||Screening||Single||||||t
1374047|NCT02631421|||Cohort||Cross-Sectional|||||||
1374048|NCT02631408|Randomized|Parallel Assignment||Prevention||Single|||t|||
1374049|NCT02631395|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374050|NCT02631382|Randomized|Parallel Assignment||||Double|||||t|t
1374051|NCT02631369|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374052|NCT02631356|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1374053|NCT02631343|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374054|NCT02631330|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374055|NCT02631317|||Cohort||Prospective|||||||
1374056|NCT02631304|||Cohort||Prospective|||||||
1374057|NCT02631291|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1374058|NCT02631278||Single Group Assignment||||None (Open Label)||||||
1374059|NCT02631265|Randomized|Crossover Assignment||Treatment||Single|||t|||
1374060|NCT02631252||Single Group Assignment||Treatment||None (Open Label)||||||
1374061|NCT02631239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374062|NCT02631226|||Cohort||Prospective|||||||
1374063|NCT02631213||||||||||||
1374064|NCT02631200|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1374065|NCT02631187||Single Group Assignment||Other||None (Open Label)||||||
1374066|NCT02631174|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374067|NCT02631161|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374068|NCT02631148|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1374069|NCT02631135|Randomized|Crossover Assignment||Prevention||Single|||t|||
1374070|NCT02631122|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1374071|NCT02631109||Single Group Assignment||Treatment||None (Open Label)||||||
1374072|NCT02631096|Randomized|Parallel Assignment||Treatment||Single|Single Blind (Subject) in cohort 1-3, Open label in Cohort 4||t|||
1374073|NCT02631083|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1374074|NCT02631070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374075|NCT02631057|||Cohort||Retrospective|||||||
1374076|NCT02631044|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374077|NCT02631031|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374078|NCT02631018|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374079|NCT02631005||Single Group Assignment||Treatment||None (Open Label)||||||
1374080|NCT02630992||Single Group Assignment||Other||None (Open Label)||||||
1374081|NCT02630979|||Ecologic or Community||Prospective|||||||
1374082|NCT02630966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374083|NCT02630953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374084|NCT02630940|||Cohort||Cross-Sectional|||||||
1374085|NCT02630927|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1374086|NCT02630914||Single Group Assignment||Treatment||None (Open Label)||||||
1374087|NCT02630901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374088|NCT02630888|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374089|NCT02630875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374090|NCT02630862|Randomized|Parallel Assignment||||Single|||||t|
1374091|NCT02630849|Randomized|Parallel Assignment||Treatment||Single||||||t
1374092|NCT02630836|Randomized|Parallel Assignment||Treatment||Single||||||t
1374093|NCT02630823||Single Group Assignment||Treatment||None (Open Label)||||||
1374094|NCT02630810|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1374095|NCT02630797|Randomized|Crossover Assignment||Prevention||Single||This partially randomized crossover design model will include participants assigned first to a control baseline period followed by three intervention phases with a low, medium or high daily dose of blueberry products in a randomized order.||||t
1374096|NCT02630784|Randomized|Crossover Assignment||Treatment||Single|||t|||
1374097|NCT02630771|||Case-Control||Cross-Sectional|||||||
1374098|NCT02630758|Randomized|Parallel Assignment||Treatment||Single||||||t
1374099|NCT02630745|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1374100|NCT02630732|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1374101|NCT02630719|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374102|NCT02630706|Randomized|Parallel Assignment||Treatment||Double|Sponsor was masked.||t||t|
1374103|NCT02630693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374104|NCT02630680|||Cohort||Prospective|||||||
1374105|NCT02630667|Randomized|Parallel Assignment||||Triple|||t||t|t
1374106|NCT02630654|||Cohort||Prospective|||||||
1374107|NCT02630641|||Case-Only||Prospective|||||||
1374108|NCT02630628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374109|NCT02630615|||Case-Only||Prospective|||||||
1374110|NCT02630602|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374111|NCT02630589||Single Group Assignment||Treatment||None (Open Label)||||||
1374112|NCT02630576|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1374113|NCT02630563|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374114|NCT02630550|||Case-Only||Prospective|||||||
1374115|NCT02630537|||Cohort||Cross-Sectional|||||||
1374116|NCT02630524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374117|NCT02630511|Randomized|Factorial Assignment||Basic Science||Double|||t|||t
1374118|NCT02630498|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374119|NCT02630485|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1374120|NCT02630472|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1374121|NCT02630459|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1374122|NCT02630446|Non-Randomized|Parallel Assignment||Supportive Care||Single||||t||
1374123|NCT02630433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374124|NCT02630420||Single Group Assignment||Treatment||None (Open Label)||||||
1374125|NCT02630407|Randomized|Parallel Assignment||Treatment||Double||injection of saline VS injection of Hyaluronic acid|t|||t
1374126|NCT02630394||Single Group Assignment||Prevention||None (Open Label)||||||
1374127|NCT02630381|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374128|NCT02630368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374129|NCT02630355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374130|NCT02630342|Randomized|Parallel Assignment||||None (Open Label)||||||
1374131|NCT02630329|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374132|NCT02630316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374133|NCT02630303|Randomized|Parallel Assignment||Other||Single|||t|||
1374134|NCT02630290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374135|NCT02630277|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374136|NCT02630264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374137|NCT02630251||Single Group Assignment||Treatment||None (Open Label)||||||
1374138|NCT02630238|Randomized|Parallel Assignment||||Double|||t||t|
1374139|NCT02630225|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374140|NCT02630212|||Case Control||Prospective|||||||
1374141|NCT02630199||Single Group Assignment||Treatment||None (Open Label)||||||
1374142|NCT02630186||Single Group Assignment||Prevention||None (Open Label)||||||
1374143|NCT02630173|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374144|NCT02630160|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374145|NCT02630147|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374146|NCT02630134||Single Group Assignment||Other||None (Open Label)||||||
1374147|NCT02630121|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1374148|NCT02630108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374149|NCT02630095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374150|NCT02630082||Single Group Assignment||||None (Open Label)||||||
1374151|NCT02630069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374152|NCT02630056|||Case-Only||Prospective|||||||
1374153|NCT02630043||Single Group Assignment||Treatment||None (Open Label)||||||
1374154|NCT02630030||Single Group Assignment||Basic Science||None (Open Label)||||||
1374155|NCT02630017|Non-Randomized|Parallel Assignment||Other||Double|||t||t|
1374156|NCT02630004|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1374157|NCT02629991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374158|NCT02629978||Single Group Assignment||Treatment||None (Open Label)||||||
1374159|NCT02629965|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1374160|NCT02629952|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374161|NCT02629939|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1374162|NCT02629926|||Case-Only||Prospective|||||||
1374163|NCT02629913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374164|NCT02629900||Single Group Assignment||||None (Open Label)||||||
1374165|NCT02629887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374166|NCT02629874|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1374167|NCT02629861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374168|NCT02629848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374169|NCT02629835|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1374170|NCT02629822||Single Group Assignment||Treatment||None (Open Label)||||||
1374171|NCT02629809||Single Group Assignment||Treatment||None (Open Label)||||||
1374172|NCT02629796|||Case-Control||Prospective|||||||
1374173|NCT02629783|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1374174|NCT02629770|||Ecologic or Community||Cross-Sectional|||||||
1374175|NCT02629757||Single Group Assignment||Treatment||None (Open Label)||||||
1374177|NCT02629731|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1374178|NCT02629718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374179|NCT02629705|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1374180|NCT02629692|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Part A: 2 arms: Investigational agent arm and Placebo arm Part B and C: Single arm|Part A: Single ascending dose Part B: Multiple ascending dose safety and tolerability study in subjects with CML or Ph + ALL Part C: Efficacy and safety study in subjects with CML or Ph+ ALL||||
1374181|NCT02629679|||Cohort||Prospective|||||||
1374182|NCT02629666|Randomized|Parallel Assignment||Prevention||Single||||||t
1374183|NCT02629653||Single Group Assignment||Prevention||None (Open Label)||||||
1374184|NCT02629640|||Cohort||Prospective|||||||
1374185|NCT02629627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374186|NCT02629614|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374187|NCT02629601|Randomized|Parallel Assignment||Treatment||Single|||||t|
1374188|NCT02629588|||||Retrospective|||||||
1374189|NCT02629575|||Cohort||Prospective|||||||
1374190|NCT02629562|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1374191|NCT02629549||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374192|NCT02629536|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374193|NCT02629523||Single Group Assignment||Treatment||None (Open Label)||||||
1374194|NCT02629510|Randomized|Parallel Assignment||Prevention||Single||||||t
1374195|NCT02629497|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1374196|NCT02629484|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1374197|NCT02629471||Single Group Assignment||Basic Science||None (Open Label)||||||
1374198|NCT02629458||Single Group Assignment||Treatment||None (Open Label)||||||
1374199|NCT02629445|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1374200|NCT02629432|||Cohort||Prospective|||||||
1374201|NCT02629419||Single Group Assignment||Treatment||None (Open Label)||||||
1374202|NCT02629406|||Case-Control||Prospective|||||||
1374203|NCT02629393||Single Group Assignment||Treatment||None (Open Label)||||||
1374204|NCT02629380|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374205|NCT02629367|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1374206|NCT02629354|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374207|NCT02629341|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374208|NCT02629328||Single Group Assignment||Treatment||None (Open Label)||||||
1374209|NCT02629315|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1374210|NCT02629302|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374211|NCT02629289|Randomized|Crossover Assignment||||None (Open Label)||||||
1374212|NCT02629276|||Case-Only||Prospective|||||||
1374213|NCT02629263|||Other||Retrospective|||||||
1374214|NCT02629250|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1374215|NCT02629237|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1374216|NCT02629224|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374217|NCT02629211||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374218|NCT02629198|||Ecologic or Community||Cross-Sectional|||||||
1374219|NCT02629185|||Ecologic or Community||Cross-Sectional|||||||
1374220|NCT02629172|||Cohort||Prospective|||||||
1374221|NCT02629159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374222|NCT02629146|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1374223|NCT02629133|Randomized|Parallel Assignment||Treatment||Single||||||t
1374224|NCT02629120||Single Group Assignment||Treatment||None (Open Label)||||||
1374225|NCT02629107|||Cohort||Cross-Sectional|||||||
1374226|NCT02629094||Single Group Assignment||Treatment||None (Open Label)||||||
1374227|NCT02629081|||Case Control||Prospective|||||||
1374228|NCT02629068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374229|NCT02629055|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374230|NCT02629042|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1374231|NCT02629029||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374232|NCT02629016|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374233|NCT02629003|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1374234|NCT02628990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374235|NCT02628977|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374236|NCT02628964|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1374237|NCT02628951||Single Group Assignment||Treatment||None (Open Label)||||||
1374238|NCT02628938|Randomized|Parallel Assignment||Treatment||Single||||||t
1374239|NCT02628925|||Case Control||Cross-Sectional|||||||
1374240|NCT02628912|||Cohort||Prospective|||||||
1374241|NCT02628899|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374242|NCT02628886|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374243|NCT02628873|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1374244|NCT02628860||Single Group Assignment||Treatment||None (Open Label)||||||
1374245|NCT02628847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374246|NCT02628834|Non-Randomized|Crossover Assignment||Treatment||Double|||t|||t
1374247|NCT02628821|||Case-Only||Prospective|||||||
1374248|NCT02628808|||Case Control||Prospective|||||||
1374249|NCT02628795|Randomized|Parallel Assignment||Treatment||Single|||||t|
1374250|NCT02628782||Single Group Assignment||Treatment||None (Open Label)||||||
1374251|NCT02628769|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1374252|NCT02628756||Single Group Assignment||Treatment||None (Open Label)||||||
1374253|NCT02628743||Single Group Assignment||Treatment||None (Open Label)||||||
1374254|NCT02628730|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374255|NCT02628717|||Cohort||Prospective|||||||
1374256|NCT02628704|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374257|NCT02628691|||Cohort||Prospective|||||||
1374258|NCT02628678||Single Group Assignment||Basic Science||None (Open Label)||||||
1374259|NCT02628665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374260|NCT02628652|Randomized|Parallel Assignment||||Single|||t|||
1374261|NCT02628639||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374262|NCT02628626|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374263|NCT02628613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374264|NCT02628600||Single Group Assignment||Treatment||None (Open Label)||||||
1374265|NCT02628587|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1374266|NCT02628574|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374267|NCT02628561|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374268|NCT02628548|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1374269|NCT02628535||Single Group Assignment||Treatment||None (Open Label)||||||
1374270|NCT02628522||Single Group Assignment||Treatment||None (Open Label)||||||
1374271|NCT02628509|||Cohort||Prospective|||||||
1374272|NCT02628496||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374273|NCT02628483|Randomized|Parallel Assignment||||Triple|||t|t|t|
1374274|NCT02628470|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374275|NCT02628457|||Cohort||Retrospective|||||||
1374276|NCT02628444|Randomized|Parallel Assignment||Prevention||Single||||||t
1374277|NCT02628431|||Cohort||Prospective|||||||
1374278|NCT02628418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374279|NCT02628405||Single Group Assignment||Treatment||None (Open Label)||||||
1374280|NCT02628392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374281|NCT02628379|||Case-Only||Prospective|||||||
1374282|NCT02628366|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374283|NCT02628353|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1374284|NCT02628340|||||Cross-Sectional|||||||
1374285|NCT02628327|||Cohort||Prospective|||||||
1374286|NCT02628314|||Cohort||Prospective|||||||
1374287|NCT02628301|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1374288|NCT02628288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374289|NCT02628275|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374290|NCT02628262|||Case Control||Retrospective|||||||
1374291|NCT02628249|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1374292|NCT02628236||Single Group Assignment||Other||None (Open Label)||||||
1374293|NCT02628223|Randomized|Parallel Assignment||Treatment||Single|||||t|
1374294|NCT02628210||Single Group Assignment||Treatment||None (Open Label)||||||
1374295|NCT02628197|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374296|NCT02628184|||||Retrospective|||||||
1374297|NCT02628171|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1374298|NCT02628158|||Case Control||Retrospective|||||||
1374299|NCT02628145|Randomized|Parallel Assignment||||None (Open Label)||||||
1374300|NCT02628132||Single Group Assignment||Treatment||None (Open Label)||||||
1374301|NCT02628119|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1374302|NCT02628106||Single Group Assignment||Treatment||None (Open Label)||||||
1374303|NCT02628093|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374304|NCT02628080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374305|NCT02628067||Single Group Assignment||Treatment||None (Open Label)||||||
1374306|NCT02628054|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1374307|NCT02628041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374308|NCT02628028|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374309|NCT02628015|||Case Control||Cross-Sectional|||||||
1374310|NCT02628002|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1374311|NCT02627989|||Other||Prospective|||||||
1374312|NCT02627976||Single Group Assignment||Treatment||None (Open Label)||||||
1374313|NCT02627963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374314|NCT02627950|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374315|NCT02627937|||Case-Only||Retrospective|||||||
1374316|NCT02627924|||Case-Only||Prospective|||||||
1374317|NCT02627911|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374318|NCT02627898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374319|NCT02627885|Randomized|Parallel Assignment||Treatment||Single||||||t
1374320|NCT02627872|||Cohort||Cross-Sectional|||||||
1374321|NCT02627859||Single Group Assignment||Treatment||None (Open Label)||||||
1374322|NCT02627846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374323|NCT02627833|||Case Control||Prospective|||||||
1374324|NCT02627820||Single Group Assignment||Treatment||None (Open Label)||||||
1374325|NCT02627807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374326|NCT02627794||Single Group Assignment||Prevention||Single|||t|||
1374327|NCT02627781|||Cohort||Prospective|||||||
1374328|NCT02627768|||Cohort||Prospective|||||||
1374329|NCT02627755|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374330|NCT02627742||Single Group Assignment||Prevention||None (Open Label)||||||
1374331|NCT02627729|Randomized|Parallel Assignment||Treatment||Single||||t||
1374332|NCT02627716|Randomized|Parallel Assignment||Prevention||Single||||||t
1374334|NCT02627690|||Case-Control||Retrospective|||||||
1374335|NCT02627677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374336|NCT02627664|||Other||Prospective|||||||
1374337|NCT02627651|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374338|NCT02627638||Single Group Assignment||Supportive Care||None (Open Label)||||||
1374339|NCT02627625|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1374340|NCT02627612|Randomized|Parallel Assignment||Prevention||Single||||||t
1374341|NCT02627599|||Cohort||Prospective|||||||
1374342|NCT02627586|Randomized|Parallel Assignment||Treatment||Single||||||t
1374343|NCT02627573|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374344|NCT02627560|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374345|NCT02627547||Single Group Assignment||Basic Science||None (Open Label)||||||
1374346|NCT02627534|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374347|NCT02627521|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1374348|NCT02627508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374349|NCT02627495||Single Group Assignment||Treatment||None (Open Label)||||||
1374350|NCT02627482|||Cohort||Prospective|||||||
1374351|NCT02627469|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1374352|NCT02627456|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1374353|NCT02627443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374354|NCT02627430||Single Group Assignment||Treatment||None (Open Label)||||||
1374355|NCT02627417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374356|NCT02627404||Single Group Assignment||Basic Science||None (Open Label)||||||
1374357|NCT02627391|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374358|NCT02627378|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1374359|NCT02627365|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1374360|NCT02627352||Single Group Assignment||Treatment||None (Open Label)||Diode Laser Cyclophotocoagulation||||
1374361|NCT02627339|||Cohort||Prospective|||||||
1374362|NCT02627326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374363|NCT02627313||Single Group Assignment||Treatment||None (Open Label)||||||
1374364|NCT02627300||Single Group Assignment||Treatment||None (Open Label)||||||
1374365|NCT02627287|Randomized|Crossover Assignment||Other||Double|||t||t|
1374366|NCT02627274|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1374367|NCT02627261|||Cohort||Prospective|||||||
1374368|NCT02627248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374369|NCT02627235|Randomized|Parallel Assignment||Treatment||Single||||||t
1374370|NCT02627222|Randomized|Parallel Assignment||Prevention||Single||||||t
1374371|NCT02627209|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374372|NCT02627196|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1374373|NCT02627183|||Cohort||Prospective|||||||
1374374|NCT02627170|||Case-Only||Prospective|||||||
1374375|NCT02627157|||Case-Only||Prospective|||||||
1374376|NCT02627144|||Cohort||Cross-Sectional|||||||
1374377|NCT02627131||Single Group Assignment||Treatment||None (Open Label)||||||
1374378|NCT02627118||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374379|NCT02627105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374380|NCT02627092|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374381|NCT02627079|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374382|NCT02627066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374383|NCT02627053||Single Group Assignment||Treatment||None (Open Label)||||||
1374384|NCT02627040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374385|NCT02627027|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374386|NCT02627014|Randomized|Parallel Assignment||Treatment||Single|||||t|
1374387|NCT02627001|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374388|NCT02626988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374389|NCT02626975|||Cohort||Prospective|||||||
1374390|NCT02626962||Single Group Assignment||Treatment||None (Open Label)||||||
1374391|NCT02626949|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374392|NCT02626936|Randomized|Crossover Assignment||Treatment||Single|||t|||
1374393|NCT02626923|||Case-Only||Retrospective|||||||
1374394|NCT02626910|||Cohort||Prospective|||||||
1374395|NCT02626897|Randomized|Crossover Assignment||||None (Open Label)||||||
1374396|NCT02626884||Single Group Assignment||Treatment||None (Open Label)||||||
1374397|NCT02626871|||Cohort||Retrospective|||||||
1374398|NCT02626858||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374399|NCT02626845|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1374400|NCT02626832|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374401|NCT02626819|Randomized|Parallel Assignment||Health Services Research||Double|Blinded to intervention arm|Randomized Controlled Trial|t|||t
1374402|NCT02626806|||Cohort||Prospective|||||||
1374403|NCT02626793|||Cohort||Prospective|||||||
1374404|NCT02626780||Single Group Assignment||Treatment||None (Open Label)||||||
1374405|NCT02626767|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374406|NCT02626754||Single Group Assignment||Treatment||None (Open Label)||||||
1374407|NCT02626741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374408|NCT02626728|||Cohort||Prospective|||||||
1374409|NCT02626715|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374410|NCT02626702|||Other||Prospective|||||||
1374411|NCT02626689|||Cohort||Prospective|||||||
1374412|NCT02626676||Single Group Assignment||Health Services Research||None (Open Label)||||||
1374413|NCT02626663|||Cohort||Prospective|||||||
1374414|NCT02626650|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1374415|NCT02626637||Single Group Assignment||Health Services Research||None (Open Label)||||||
1374416|NCT02626624||||||||||||
1374417|NCT02626611|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374418|NCT02626598|||Case-Only||Prospective|||||||
1374419|NCT02626585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374420|NCT02626572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374421|NCT02626559|||Case-Only||Prospective|||||||
1374422|NCT02626546|||Cohort||Prospective|||||||
1374423|NCT02626533|||Cohort||Prospective|||||||
1374424|NCT02626520|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374425|NCT02626507||Single Group Assignment||Treatment||None (Open Label)||||||
1374426|NCT02626494|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1374427|NCT02626481||Single Group Assignment||Treatment||None (Open Label)||||||
1374428|NCT02626468|||Cohort||Prospective|||||||
1374429|NCT02626455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374430|NCT02626442|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374431|NCT02626429||Single Group Assignment||Basic Science||None (Open Label)||||||
1374432|NCT02626416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374433|NCT02626403|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1374434|NCT02626390|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374435|NCT02626377|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374436|NCT02626364||Single Group Assignment||Treatment||None (Open Label)||||||
1374437|NCT02626351|Randomized|Single Group Assignment||Health Services Research||Single|Masking was only until randomisation status identified at the start of each intervention step.|Stepped wedge trial: therefore all clusters receive intervention, in randomised sequence.||t||
1374438|NCT02626338|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374439|NCT02626325|||||Retrospective|||||||
1374440|NCT02626312|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374441|NCT02626299|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374442|NCT02626286||Single Group Assignment||Prevention||None (Open Label)||||||
1374443|NCT02626273|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1374444|NCT02626260||Single Group Assignment||Basic Science||None (Open Label)||||||
1374445|NCT02626247|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374446|NCT02626234||Single Group Assignment||Treatment||None (Open Label)||||||
1374447|NCT02626221|||Cohort||Prospective|||||||
1374448|NCT02626208|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374449|NCT02626195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374450|NCT02626182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374451|NCT02626169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374452|NCT02626156|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374453|NCT02626143|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1374454|NCT02626130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374455|NCT02626117|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374456|NCT02626104|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374457|NCT02626091||Single Group Assignment||Prevention||None (Open Label)||||||
1374458|NCT02626078|||Cohort||Prospective|||||||
1374459|NCT02626065|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374460|NCT02626052|||Cohort||Prospective|||||||
1374461|NCT02626039|||Case-Only||Retrospective|||||||
1374462|NCT02626026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374463|NCT02626013|||Cohort||Prospective|||||||
1374464|NCT02626000||Single Group Assignment||Other||None (Open Label)|For Phase 1b there are no 'maskings' as it's open-label.|||||
1374465|NCT02625987|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1374466|NCT02625974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374467|NCT02625961||Single Group Assignment||Treatment||None (Open Label)||||||
1374468|NCT02625948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374469|NCT02625935|||Cohort||Prospective|||||||
1374470|NCT02625922|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1374471|NCT02625909|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374472|NCT02625896|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1374473|NCT02625883|||Case-Only||Retrospective|||||||
1374474|NCT02625870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374475|NCT02625857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374476|NCT02625844|||Case Control||Prospective|||||||
1374477|NCT02625831|||Case-Control||Retrospective|||||||
1374478|NCT02625818|||Case-Only||Prospective|||||||
1374479|NCT02625805|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1374480|NCT02625792||Single Group Assignment||Prevention||None (Open Label)||||||
1374481|NCT02625779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374482|NCT02625766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374483|NCT02625753|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374484|NCT02625740|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374485|NCT02625727|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374486|NCT02625714|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374487|NCT02625701|Randomized|Parallel Assignment||Prevention||Single|||t|||
1374488|NCT02625688|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374489|NCT02625675|||Cohort||Prospective|||||||
1374490|NCT02625662|||Cohort||Prospective|||||||
1374491|NCT02625649|||Cohort||Cross-Sectional|||||||
1374492|NCT02625636|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1374493|NCT02625623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374494|NCT02625610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374495|NCT02625597||Single Group Assignment||Prevention||None (Open Label)||||||
1374496|NCT02625584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374497|NCT02625571||Single Group Assignment||Treatment||None (Open Label)||||||
1374498|NCT02625558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374499|NCT02625545||Single Group Assignment||Treatment||None (Open Label)||||||
1374500|NCT02625532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374501|NCT02625519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374502|NCT02625506|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1374503|NCT02625493|||Cohort||Prospective|||||||
1374504|NCT02625480||Single Group Assignment||Treatment||None (Open Label)||||||
1374505|NCT02625467|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374506|NCT02625454|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374507|NCT02625441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374508|NCT02625428|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1374509|NCT02625415|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1374510|NCT02625402|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1374511|NCT02625389||Single Group Assignment||Treatment||None (Open Label)||||||
1374512|NCT02625376|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1374513|NCT02625363|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1374514|NCT02625350|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1374515|NCT02625337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374516|NCT02625324||Single Group Assignment||Treatment||None (Open Label)||||||
1374517|NCT02625311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374518|NCT02625298|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1374519|NCT02625285|||Cohort||Prospective|||||||
1374520|NCT02625272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374521|NCT02625259|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374522|NCT02625246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374523|NCT02625233|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374524|NCT02625220||Single Group Assignment||Treatment||None (Open Label)||||||
1374525|NCT02625207|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374526|NCT02625194|Randomized|Parallel Assignment||Prevention||Single|||t|||
1374527|NCT02625181||Single Group Assignment||Prevention||None (Open Label)||||||
1374528|NCT02625168|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374529|NCT02625155|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374530|NCT02625142|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1374531|NCT02625129|||Cohort||Prospective|||||||
1374532|NCT02625116|||Cohort||Prospective|||||||
1374533|NCT02625103||Single Group Assignment||Health Services Research||None (Open Label)||||||
1374534|NCT02625090||Single Group Assignment||Treatment||None (Open Label)||||||
1374535|NCT02625077|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1374536|NCT02625064|||Cohort||Prospective|||||||
1374537|NCT02625051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374538|NCT02625038||Single Group Assignment||Treatment||None (Open Label)||||||
1374539|NCT02625025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374540|NCT02625012|||Case-Only||Prospective|||||||
1374541|NCT02624999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374542|NCT02624986|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374543|NCT02624973|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1374544|NCT02624960||Single Group Assignment||Treatment||None (Open Label)||||||
1374545|NCT02624947|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1374546|NCT02624934|||Case-Only||Prospective|||||||
1374547|NCT02624921|||Case-Crossover||Prospective|||||||
1374548|NCT02624908|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374549|NCT02624895|||Other||Prospective|||||||
1374550|NCT02624882|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1374551|NCT02624869||Single Group Assignment||Treatment||None (Open Label)||||||
1374552|NCT02624856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374553|NCT02624843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374554|NCT02624830||Single Group Assignment||Treatment||None (Open Label)||||||
1374555|NCT02624817||Single Group Assignment||Treatment||None (Open Label)||||||
1374556|NCT02624804||Single Group Assignment||Treatment||None (Open Label)||||||
1374557|NCT02624791|Randomized|Crossover Assignment||Treatment||Double|participants and research assistant blind to hypothesis||t||t|
1374558|NCT02624778|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1374559|NCT02624765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374632|NCT02623816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374633|NCT02623803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374634|NCT02623790|Randomized|Crossover Assignment||Treatment||Single|||||t|
1374635|NCT02623777|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1374636|NCT02623764|||Case-Only||Prospective|||||||
1374560|NCT02624752|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Patients will be randomized via REDCap (Research Electronic Data Capture), a secure, centralized web-based randomization module to:~Ensure Enlive (enhanced ONS) + standard menu; or~Standard of care (including standard menu and possibly ONS) Patients randomized will receive standard menu or standard menu plus enhanced oral nutritional supplements (ONS). Patients randomized to enhanced ONS, will receive one bottle of ONS Abbott Ensure Enlive (235 mL, 350 calories), or similar product, two times daily for 90 days."||||
1374561|NCT02624739||||||||||||
1374562|NCT02624726||Single Group Assignment||Treatment||None (Open Label)||||||
1374563|NCT02624713||Single Group Assignment||Treatment||None (Open Label)||||||
1374564|NCT02624700||Single Group Assignment||Treatment||None (Open Label)||||||
1374565|NCT02624687|Randomized|Parallel Assignment||Treatment||Single||||||t
1374566|NCT02624674||Single Group Assignment||Treatment||None (Open Label)||||||
1374567|NCT02624661||Single Group Assignment||Treatment||None (Open Label)||||||
1374568|NCT02624648|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374569|NCT02624635|Randomized|Parallel Assignment||Treatment||Single||||||t
1374570|NCT02624622|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374571|NCT02624609|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1374572|NCT02624596|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374573|NCT02624583|||Case-Only||Prospective|||||||
1374574|NCT02624570||||||||||||
1374575|NCT02624557|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1374576|NCT02624544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374577|NCT02624531||Single Group Assignment||Treatment||None (Open Label)||||||
1374578|NCT02624518||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374579|NCT02624505|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1374580|NCT02624492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374581|NCT02624479|Non-Randomized|Crossover Assignment||Other||Single|||t|||
1374582|NCT02624466|||Cohort||Prospective|||||||
1374583|NCT02624453|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1374584|NCT02624440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374585|NCT02624427|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374586|NCT02624414||Single Group Assignment||Supportive Care||None (Open Label)||||||
1374587|NCT02624401|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1374588|NCT02624388|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1374589|NCT02624375||Single Group Assignment||Basic Science||None (Open Label)||||||
1374590|NCT02624362|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1374591|NCT02624349|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374592|NCT02624336|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1374593|NCT02624323|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374594|NCT02624310|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1374595|NCT02624297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374596|NCT02624284|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1374597|NCT02624271||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374598|NCT02624258||Single Group Assignment||Treatment||None (Open Label)||||||
1374599|NCT02624245|Randomized|Parallel Assignment||Treatment||Single||||||t
1374600|NCT02624232|||Cohort||Prospective|||||||
1374601|NCT02624219|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1374602|NCT02624206|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1374603|NCT02624193|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1374604|NCT02624180|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1374605|NCT02624167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374606|NCT02624154|||Case-Only||Retrospective|||||||
1374607|NCT02624141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374608|NCT02624128||Single Group Assignment||Treatment||None (Open Label)||||||
1374609|NCT02624115|||Cohort||Prospective|||||||
1374610|NCT02624102|Randomized|Parallel Assignment||Treatment||Single|||||t|
1374611|NCT02624089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374612|NCT02624076|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374613|NCT02624063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374614|NCT02624050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374615|NCT02624037||Single Group Assignment||Treatment||None (Open Label)||||||
1374616|NCT02624024|||Case-Only||Prospective|||||||
1374617|NCT02624011||Single Group Assignment||Basic Science||None (Open Label)||||||
1374618|NCT02623998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374619|NCT02623985|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1374620|NCT02623972||Single Group Assignment||Treatment||None (Open Label)||||||
1374621|NCT02623959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374622|NCT02623946|||Cohort||Prospective|||||||
1374623|NCT02623933||Single Group Assignment||Treatment||None (Open Label)||||||
1374624|NCT02623920||Single Group Assignment||Treatment||None (Open Label)||||||
1374625|NCT02623907|||Cohort||Prospective|||||||
1374626|NCT02623894|||Case-Only||Cross-Sectional|||||||
1374627|NCT02623881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374628|NCT02623868|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374629|NCT02623855|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374630|NCT02623842||Single Group Assignment||Supportive Care||None (Open Label)||||||
1374631|NCT02623829|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374637|NCT02623751||Single Group Assignment||Treatment||None (Open Label)||||||
1374638|NCT02623738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374639|NCT02623725|Randomized|Parallel Assignment||Prevention||Single||||||t
1374640|NCT02623712|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374641|NCT02623699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374642|NCT02623686|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1374643|NCT02623673|||Case-Only||Retrospective|||||||
1374644|NCT02623660|Randomized|Parallel Assignment||Treatment||Single||||||t
1374645|NCT02623647||Single Group Assignment||Treatment||None (Open Label)||||||
1374646|NCT02623634|||Cohort||Prospective|||||||
1374647|NCT02623621|||Cohort||Prospective|||||||
1374648|NCT02623608|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1374649|NCT02623595||Single Group Assignment||Treatment||None (Open Label)||||||
1374650|NCT02623582|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374651|NCT02623569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374652|NCT02623556|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1374653|NCT02623543|Randomized|Parallel Assignment||Prevention||Single|||||t|
1374654|NCT02623530|Randomized|Parallel Assignment||||Single|||t|||
1374655|NCT02623517|||Cohort||Prospective|||||||
1374656|NCT02623504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374657|NCT02623491|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1374658|NCT02623478|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1374659|NCT02623465|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1374660|NCT02623452|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1374661|NCT02623439||Single Group Assignment||Treatment||None (Open Label)||||||
1374662|NCT02623426|Randomized|Parallel Assignment||Treatment||Single||||||t
1374663|NCT02623413|||Cohort||Prospective|||||||
1374664|NCT02623400|||Cohort||Prospective|||||||
1374665|NCT02623387|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1374666|NCT02623374|Randomized|Parallel Assignment||Treatment||Single||||||t
1374667|NCT02623361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374668|NCT02623348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374669|NCT02623335|Randomized|Crossover Assignment||Other||Single|||t|||
1374670|NCT02623322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374671|NCT02623309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374672|NCT02623296|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1374673|NCT02623283|||Cohort||Prospective|||||||
1374674|NCT02623270||Single Group Assignment||Supportive Care||None (Open Label)||||||
1374675|NCT02623257|||Case-Only||Prospective|||||||
1374676|NCT02623244|||Case-Control||Prospective|||||||
1374677|NCT02623231|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1374678|NCT02623218|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374679|NCT02623205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374680|NCT02623192|||Cohort||Cross-Sectional|||||||
1374681|NCT02623179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374682|NCT02623166|||Ecologic or Community||Cross-Sectional|||||||
1374683|NCT02623153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374684|NCT02623140|Randomized|Parallel Assignment||Treatment||Single||||||t
1374685|NCT02623127||Single Group Assignment||Treatment||None (Open Label)||||||
1374686|NCT02623114|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374687|NCT02623101|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374688|NCT02623088|||Cohort||Prospective|||||||
1374689|NCT02623075|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374690|NCT02623062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374691|NCT02623049|||Cohort||Cross-Sectional|||||||
1374692|NCT02623036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374693|NCT02623023|Randomized|Parallel Assignment||Prevention||Single|||||t|
1374694|NCT02623010||Single Group Assignment||Treatment||None (Open Label)||||||
1374695|NCT02622997|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1374696|NCT02622984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374697|NCT02622971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374698|NCT02622958|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1374699|NCT02622945|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1374700|NCT02622932||Single Group Assignment||Treatment||None (Open Label)||||||
1374701|NCT02622919||||||||||||
1374702|NCT02622906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374703|NCT02622893|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374704|NCT02622880|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374705|NCT02622867|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374706|NCT02622854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374707|NCT02622841||Single Group Assignment||Treatment||None (Open Label)||||||
1374708|NCT02622828||Single Group Assignment||Other||None (Open Label)||||||
1374709|NCT02622815|||Case-Control||Prospective|||||||
1374710|NCT02622802||Single Group Assignment||Basic Science||None (Open Label)||||||
1374711|NCT02622789|||Case Control||Prospective|||||||
1374712|NCT02622776||Single Group Assignment||Screening||None (Open Label)||||||
1374713|NCT02622763|Randomized|Parallel Assignment||Other||Single|||||t|
1374714|NCT02622750|Randomized|Parallel Assignment||Treatment||Single||||||t
1374715|NCT02622737|Randomized|Parallel Assignment||Treatment||Single||||||t
1374716|NCT02622724|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374717|NCT02622711|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374718|NCT02622698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374719|NCT02622685|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1374720|NCT02622672|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1374721|NCT02622659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374722|NCT02622646|||||Prospective|||||||
1374723|NCT02622633|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1374724|NCT02622620|||Cohort||Prospective|||||||
1374725|NCT02622607|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374726|NCT02622594|Randomized|Parallel Assignment||Treatment||Single|||||t|
1374727|NCT02622581|||Cohort||Prospective|||||||
1374728|NCT02622568|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374729|NCT02622555|||Case-Only||Prospective|||||||
1374730|NCT02622542|Randomized|Parallel Assignment||Treatment||Single|Participant and investigator/treating physician would be blinded until the day of treament initiation|||||t
1374731|NCT02622529|||Cohort||Prospective|||||||
1374732|NCT02622516|Randomized|Parallel Assignment||Treatment||Single|||||t|
1374733|NCT02622503|||Case-Only||Retrospective|||||||
1374734|NCT02622490|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1374735|NCT02622477|||Cohort||Cross-Sectional|||||||
1374736|NCT02622464||Single Group Assignment||Treatment||None (Open Label)||||||
1374737|NCT02622451|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374738|NCT02622438||Single Group Assignment||Supportive Care||None (Open Label)||||||
1374739|NCT02622425|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1374740|NCT02622412|Randomized|Parallel Assignment||Treatment||Single||||||t
1374741|NCT02622399|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374742|NCT02622386|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1374743|NCT02622373|||Case Control||Prospective|||||||
1374744|NCT02622360|||Case-Control||Retrospective|||||||
1374745|NCT02622347|||Other||Cross-Sectional|||||||
1374746|NCT02622334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374747|NCT02622321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374748|NCT02622308||Single Group Assignment||Treatment||None (Open Label)||||||
1374749|NCT02622295|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1374750|NCT02622282|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374751|NCT02622269|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1374752|NCT02622256|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374753|NCT02622243|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1374754|NCT02622230|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374755|NCT02622217|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1374756|NCT02622204|||Cohort||Prospective|||||||
1374757|NCT02622191|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374758|NCT02622178|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374759|NCT02622165|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374760|NCT02622152|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1374761|NCT02622139||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374762|NCT02622126|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374763|NCT02622113||Single Group Assignment||Treatment||None (Open Label)||||||
1374764|NCT02622100|||Cohort||Prospective|||||||
1374765|NCT02622087|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374766|NCT02622074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374767|NCT02622061|||Cohort||Prospective|||||||
1374768|NCT02622048||Single Group Assignment||Supportive Care||None (Open Label)||||||
1374769|NCT02622035|Randomized|Factorial Assignment||Basic Science||||||||
1374770|NCT02622022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374771|NCT02622009|||Case Control||Prospective|||||||
1374772|NCT02621996|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1374773|NCT02621983|Randomized|Parallel Assignment||Treatment||Single||||||t
1374774|NCT02621970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374775|NCT02621957||Single Group Assignment||Basic Science||None (Open Label)||||||
1374776|NCT02621944|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374777|NCT02621931|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374778|NCT02621918|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374779|NCT02621905|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1374780|NCT02621892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374781|NCT02621879||Single Group Assignment||Treatment||None (Open Label)||||||
1374782|NCT02621866|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1374783|NCT02621853||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374784|NCT02621840|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1374785|NCT02621827|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1374786|NCT02621814|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1374787|NCT02621801|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1374788|NCT02621788||Single Group Assignment||Treatment||None (Open Label)||||||
1374789|NCT02621775|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374790|NCT02621762|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1374791|NCT02621749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374792|NCT02621736|||Cohort||Prospective|||||||
1374793|NCT02621723|||Cohort||Prospective|||||||
1374794|NCT02621710|||Cohort||Prospective|||||||
1374795|NCT02621697|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374796|NCT02621684|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1374797|NCT02621671|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374798|NCT02621658|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1374799|NCT02621645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374800|NCT02621632||Single Group Assignment||Prevention||None (Open Label)||||||
1374801|NCT02621619|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374802|NCT02621606|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374803|NCT02621593||Single Group Assignment||Treatment||None (Open Label)||||||
1374804|NCT02621580|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374805|NCT02621567|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374806|NCT02621554|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1374807|NCT02621541||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374808|NCT02621528||Single Group Assignment||Treatment||None (Open Label)||||||
1374809|NCT02621515||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374810|NCT02621502|Randomized|Crossover Assignment||||Double|||t||t|
1374811|NCT02621489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374812|NCT02621476|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1374813|NCT02621463||Single Group Assignment||Supportive Care||None (Open Label)||||||
1374814|NCT02621450|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1374815|NCT02621437|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1374816|NCT02621424|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1374817|NCT02621411|||Cohort||Prospective|||||||
1374818|NCT02621398||Single Group Assignment||Treatment||None (Open Label)||||||
1374819|NCT02621385||Single Group Assignment||Treatment||None (Open Label)||||||
1374820|NCT02621372|||Case-Only||Other|||||||
1374821|NCT02621359||Single Group Assignment||Treatment||None (Open Label)||||||
1374822|NCT02621346|Randomized|Factorial Assignment||||Single|||t|||
1374823|NCT02621333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374824|NCT02621320|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1374825|NCT02621307|Randomized|Crossover Assignment||Prevention||Single|||t|||
1374826|NCT02621294||Single Group Assignment||||None (Open Label)||||||
1374827|NCT02621281|Randomized|Parallel Assignment||Other||Double|||t||t|
1374828|NCT02621268||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374829|NCT02621255|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1374830|NCT02621242||Single Group Assignment||Basic Science||None (Open Label)||||||
1374831|NCT02621216|||Cohort||Prospective|||||||
1374832|NCT02621203|||Cohort||Prospective|||||||
1374833|NCT02621190|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374834|NCT02621177|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374835|NCT02621164|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374836|NCT02621151||Single Group Assignment||Treatment||None (Open Label)||||||
1374837|NCT02621138|||Case Control||Cross-Sectional|||||||
1374838|NCT02621125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374839|NCT02621112|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1374840|NCT02621099|||Case-Only||Prospective|||||||
1374841|NCT02621086|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Ascending dose tolerability study||||
1374842|NCT02621073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374843|NCT02621060|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374844|NCT02621047|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374845|NCT02621034|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374846|NCT02621021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374847|NCT02621008||Single Group Assignment||Treatment||None (Open Label)||||||
1374848|NCT02620995|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1374849|NCT02620982||Single Group Assignment||Treatment||None (Open Label)||||||
1374850|NCT02620969|||Cohort||Cross-Sectional|||||||
1374851|NCT02620956|Randomized|Crossover Assignment||Treatment||Single|||t|||
1374852|NCT02620943|||Cohort||Prospective|||||||
1374853|NCT02620930|||Cohort||Prospective|||||||
1374854|NCT02620917|||Case-Only||Cross-Sectional|||||||
1374855|NCT02620904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374856|NCT02620891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374857|NCT02620878|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374858|NCT02620865||Single Group Assignment||Treatment||None (Open Label)||||||
1374859|NCT02620852|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1374860|NCT02620839|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1374861|NCT02620826|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1374862|NCT02620813|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1374863|NCT02620800||Single Group Assignment||Treatment||None (Open Label)||||||
1374864|NCT02620787|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374865|NCT02620774|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374866|NCT02620761|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1374867|NCT02620748|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374868|NCT02620735|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1374869|NCT02620722||Single Group Assignment||Other||None (Open Label)||||||
1374870|NCT02620709|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374871|NCT02620696|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374872|NCT02620683|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1374873|NCT02620670|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1374874|NCT02620657|||Other||Retrospective|||||||
1374875|NCT02620644|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374876|NCT02620631|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1374877|NCT02620618||Single Group Assignment||Treatment||None (Open Label)||||||
1374878|NCT02620605|Randomized|Parallel Assignment||Prevention||Single||||||t
1374879|NCT02620592|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1374880|NCT02620579|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374881|NCT02620566|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1374882|NCT02620553|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1374883|NCT02620540|||Case-Only||Prospective|||||||
1374884|NCT02620527|||Other||Other|||||||
1374885|NCT02620514|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1374886|NCT02620501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374887|NCT02620488|Non-Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1374888|NCT02620475|Randomized|Single Group Assignment||Prevention||Single||||||t
1374889|NCT02620462|Randomized|Parallel Assignment||Prevention||Single||||||t
1374890|NCT02620449||Single Group Assignment||Other||None (Open Label)||||||
1374891|NCT02620436|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1374892|NCT02620423||Single Group Assignment||Treatment||None (Open Label)||||||
1374893|NCT02620410||Single Group Assignment||Treatment||None (Open Label)||||||
1374894|NCT02620397|||||Prospective|||||||
1374895|NCT02620384|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1374896|NCT02620371|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1374897|NCT02620358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374898|NCT02620345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374899|NCT02620332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374900|NCT02620319||Single Group Assignment||Treatment||None (Open Label)||||||
1374901|NCT02620306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374902|NCT02620293||Single Group Assignment||||None (Open Label)||||||
1374903|NCT02620280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374904|NCT02620267||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1374905|NCT02620254|||Cohort||Prospective|||||||
1374906|NCT02620241||Single Group Assignment||Treatment||None (Open Label)||||||
1374907|NCT02620228||Single Group Assignment||Other||None (Open Label)||||||
1374908|NCT02620215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374909|NCT02620202|||Cohort||Cross-Sectional|||||||
1374910|NCT02620189|||Cohort||Prospective|||||||
1374911|NCT02620176|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1374912|NCT02620163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374913|NCT02620150|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374914|NCT02620137|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1374915|NCT02620124|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374916|NCT02620111|Randomized|Crossover Assignment||Treatment||Single|||t|||
1374917|NCT02620098|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374918|NCT02620085|||Cohort||Prospective|||||||
1374919|NCT02620072|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1374920|NCT02620059|Randomized|Parallel Assignment||Prevention||Single||||||t
1374921|NCT02620046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374922|NCT02620033|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1374923|NCT02620020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374924|NCT02620007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374925|NCT02619994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374926|NCT02619981|Non-Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1374927|NCT02619968|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374928|NCT02619955|||Cohort||Prospective|||||||
1374929|NCT02619942|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374930|NCT02619929|||Cohort||Prospective|||||||
1374931|NCT02619916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374932|NCT02619903|Randomized|Parallel Assignment||Prevention||Single||Test versus control for dental treatment in attenuating exacerbations in COPD.|t|||
1374933|NCT02619890|||Cohort||Prospective|||||||
1374934|NCT02619877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1374935|NCT02619864||Single Group Assignment||Treatment||None (Open Label)||||||
1374936|NCT02619851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374937|NCT02619838|||Case-Only||Prospective|||||||
1374938|NCT02619825|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1374939|NCT02619812|Randomized|Factorial Assignment||Supportive Care||Triple|||t|t|t|
1374940|NCT02619799|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1374941|NCT02619786||Single Group Assignment||Treatment||None (Open Label)||||||
1374942|NCT02619773|Randomized|Parallel Assignment||Prevention||Single|||t|||
1374943|NCT02619760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374944|NCT02619747|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1375560|NCT02611713|||Cohort||Prospective|||||||
1374945|NCT02619734||Single Group Assignment||Treatment||None (Open Label)||||||
1374946|NCT02619721|Randomized|Parallel Assignment||Treatment||Single||||||t
1374947|NCT02619708|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1374948|NCT02619695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1374949|NCT02619682||Single Group Assignment||Treatment||None (Open Label)||||||
1374950|NCT02619669||Single Group Assignment||Treatment||None (Open Label)||||||
1374951|NCT02619656|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1374952|NCT02619643|Randomized|Crossover Assignment||Other||Double|||t||t|
1374953|NCT02619630||Single Group Assignment||Treatment||None (Open Label)||||||
1374954|NCT02619617||Sequential Assignment||Treatment||Triple|||t|t|t|
1374955|NCT02619604||Single Group Assignment||Health Services Research||None (Open Label)||||||
1374956|NCT02619591|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1374957|NCT02619578|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1374958|NCT02619565||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374959|NCT02619552|||Cohort||Prospective|||||||
1374960|NCT02619539|||Cohort||Prospective|||||||
1374961|NCT02619526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374962|NCT02619513|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1374963|NCT02619500|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1374964|NCT02619487|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1374965|NCT02619474|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1374966|NCT02619461|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1374967|NCT02619448||Single Group Assignment||Treatment||None (Open Label)||||||
1374968|NCT02619435||Single Group Assignment||Treatment||None (Open Label)||||||
1374969|NCT02619422|Randomized|Parallel Assignment||Prevention||Single||||||t
1374970|NCT02619409|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1374971|NCT02619396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374972|NCT02619383||Single Group Assignment||Treatment||None (Open Label)||||||
1374973|NCT02619370|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1374974|NCT02619357|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1374975|NCT02619344|||Cohort||Prospective|||||||
1374976|NCT02619331||Single Group Assignment||Diagnostic||None (Open Label)||||||
1374977|NCT02619318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374978|NCT02619305|Randomized|Parallel Assignment||||None (Open Label)||||||
1374979|NCT02619292||Single Group Assignment||Treatment||None (Open Label)||||||
1374980|NCT02619279|Randomized|Parallel Assignment||||None (Open Label)||||||
1374981|NCT02619266|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1374982|NCT02619253|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1374983|NCT02619240|||Case-Only||Prospective|||||||
1374984|NCT02619227|Randomized|Parallel Assignment||||None (Open Label)||||||
1374985|NCT02619214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374986|NCT02619201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1374987|NCT02619188|||Cohort||Prospective|||||||
1374988|NCT02619175|Randomized|Parallel Assignment||Treatment||Single||||||t
1374989|NCT02619162||Single Group Assignment||Treatment||None (Open Label)||||||
1374990|NCT02619149|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1374991|NCT02619136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374992|NCT02619123|Randomized|Parallel Assignment||Screening||Single|||||t|
1374993|NCT02619110|Randomized|Parallel Assignment||||None (Open Label)||||||
1374994|NCT02619097|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374995|NCT02619084|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1374996|NCT02619071||Single Group Assignment||||None (Open Label)||||||
1374997|NCT02619058|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1374998|NCT02619045||Single Group Assignment||Health Services Research||None (Open Label)||||||
1374999|NCT02619032|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1375000|NCT02619019|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375001|NCT02619006|||Cohort||Prospective|||||||
1375002|NCT02618993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375003|NCT02618980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375004|NCT02618967|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1375005|NCT02618954||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375006|NCT02618941|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1375007|NCT02618928|||Cohort||Prospective|||||||
1375008|NCT02618915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375009|NCT02618902||Single Group Assignment||Treatment||None (Open Label)||||||
1375010|NCT02618889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375011|NCT02618876|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375012|NCT02618863|Randomized|Parallel Assignment||Prevention||Single|||t|||
1375013|NCT02618850||Single Group Assignment||Treatment||None (Open Label)||||||
1375014|NCT02618837|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375015|NCT02618824|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375016|NCT02618811|||Cohort||Prospective|||||||
1375017|NCT02618798|||Case-Only||Cross-Sectional|||||||
1375018|NCT02618785|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375019|NCT02618772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375020|NCT02618759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375021|NCT02618746|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1375022|NCT02618733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375023|NCT02618720|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1375024|NCT02618707|||Case-Only||Prospective|||||||
1375025|NCT02618694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375026|NCT02618681|||Cohort||Prospective|||||||
1375027|NCT02618668|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375028|NCT02618655|||Cohort||Prospective|||||||
1375029|NCT02618642|Randomized|Factorial Assignment||Basic Science||Single||||||t
1375030|NCT02618629||Single Group Assignment||Basic Science||None (Open Label)||||||
1375031|NCT02618616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375032|NCT02618603|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375033|NCT02618590|||Case-Only||Retrospective|||||||
1375034|NCT02618577|Randomized|Parallel Assignment||Prevention||Double||Phase 3b|t||t|
1375035|NCT02618564|Randomized|Parallel Assignment||Other||Double|||||t|t
1375036|NCT02618551||Single Group Assignment||Basic Science||None (Open Label)||||||
1375037|NCT02618538|||Other||Cross-Sectional|||||||
1375038|NCT02618525|Randomized|Parallel Assignment||Other||Single|||t|||
1375039|NCT02618512||Single Group Assignment||Treatment||None (Open Label)||||||
1375040|NCT02618499|Randomized|Parallel Assignment||||None (Open Label)||||||
1375041|NCT02618486|Randomized|Parallel Assignment||Treatment||Single||||t||
1375042|NCT02618473|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375043|NCT02618460||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375044|NCT02618447||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1375045|NCT02618434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375046|NCT02618421|||Cohort||Cross-Sectional|||||||
1375047|NCT02618408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375048|NCT02618395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375049|NCT02618382||Single Group Assignment||Treatment||None (Open Label)||||||
1375050|NCT02618369||Single Group Assignment||Treatment||None (Open Label)||||||
1375051|NCT02618356||Single Group Assignment||Treatment||None (Open Label)||||||
1375052|NCT02618343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375053|NCT02618330|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1375054|NCT02618317|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1375055|NCT02618304||Single Group Assignment||Treatment||None (Open Label)||||||
1375056|NCT02618291|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1375057|NCT02618278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375058|NCT02618265|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375059|NCT02618252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375060|NCT02618239||Single Group Assignment||Basic Science||None (Open Label)||||||
1375061|NCT02618226||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375062|NCT02618213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375063|NCT02618200||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375064|NCT02618187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375065|NCT02618174|Randomized|Parallel Assignment||||Single|||t|||
1375066|NCT02618161|Randomized|Parallel Assignment||Treatment||Single||||||t
1375067|NCT02618148|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1375068|NCT02618135|Randomized|Parallel Assignment||Treatment||Single||||||t
1375069|NCT02618122|||Cohort||Prospective|||||||
1375070|NCT02618109|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1375071|NCT02618096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375072|NCT02618083||Single Group Assignment||Other||None (Open Label)||||||
1375073|NCT02618070|Non-Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1375074|NCT02618057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375075|NCT02618044|||Cohort||Prospective|||||||
1375076|NCT02618031|||Cohort||Prospective|||||||
1375077|NCT02618018||Single Group Assignment||Treatment||None (Open Label)||||||
1375078|NCT02618005|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1375079|NCT02617992|||Cohort||Prospective|||||||
1375080|NCT02617979|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375081|NCT02617966|||Cohort||Prospective|||||||
1375082|NCT02617953|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1375083|NCT02617940|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1375084|NCT02617927|||Case Control||Prospective|||||||
1375085|NCT02617914|||Other||Prospective|||||||
1375086|NCT02617901||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375087|NCT02617888|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375088|NCT02617875|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1375089|NCT02617862||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375090|NCT02617849||Single Group Assignment||Treatment||None (Open Label)||||||
1375091|NCT02617823|Randomized|Parallel Assignment||Treatment||Single||||||t
1375092|NCT02617810||Single Group Assignment||Treatment||None (Open Label)||||||
1375093|NCT02617797|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375094|NCT02617784|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375095|NCT02617771|Randomized|Parallel Assignment||Prevention||Single||||||t
1375096|NCT02617758|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375097|NCT02617745||Single Group Assignment||Other||None (Open Label)||||||
1375098|NCT02617732|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1375099|NCT02617719|||Case-Only||Prospective|||||||
1375100|NCT02617706|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375101|NCT02617693|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375102|NCT02617680|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1375103|NCT02617667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375104|NCT02617654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375105|NCT02617641|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375106|NCT02617628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375107|NCT02617615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375108|NCT02617602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375109|NCT02617589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375110|NCT02617576|||Case-Only||Prospective|||||||
1375111|NCT02617563|||Cohort||Prospective|||||||
1375112|NCT02617550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375113|NCT02617537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375114|NCT02617524||Single Group Assignment||Treatment||None (Open Label)||||||
1375115|NCT02617511|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375116|NCT02617498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375117|NCT02617485|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375118|NCT02617472||Single Group Assignment||Treatment||None (Open Label)||||||
1375119|NCT02617459|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375120|NCT02617446|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375121|NCT02617433||Single Group Assignment||Supportive Care||None (Open Label)||||||
1375122|NCT02617420|||Case Control||Prospective|||||||
1375123|NCT02617407|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1375124|NCT02617394|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1375125|NCT02617381||Single Group Assignment||Other||None (Open Label)||||||
1375126|NCT02617368|||Case Control||Prospective|||||||
1375127|NCT02617355|Non-Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1375128|NCT02617342|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1375129|NCT02617329|Randomized|Parallel Assignment||||None (Open Label)||||||
1375130|NCT02617316|Randomized|Crossover Assignment||||None (Open Label)||||||
1375131|NCT02617303|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375132|NCT02617290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375133|NCT02617277|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375134|NCT02617264||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375135|NCT02617251|||Ecologic or Community||Retrospective|||||||
1375136|NCT02617238|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375137|NCT02617225|||Cohort||Cross-Sectional|||||||
1375138|NCT02617212|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375139|NCT02617199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375140|NCT02617186|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375141|NCT02617173||Single Group Assignment||Treatment||None (Open Label)||||||
1375142|NCT02617160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375143|NCT02617147|||Cohort||Prospective|||||||
1375144|NCT02617134||Single Group Assignment||Treatment||None (Open Label)||||||
1375145|NCT02617121|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1375146|NCT02617108|Randomized|Parallel Assignment||Prevention||Single|||t|||
1375147|NCT02617095|Randomized|Parallel Assignment||Treatment||Single|||||t|
1375148|NCT02617082|||Cohort||Prospective|||||||
1375149|NCT02617069|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375150|NCT02617056|||Ecologic or Community||Prospective|||||||
1375151|NCT02617043||Single Group Assignment||Treatment||None (Open Label)||||||
1375152|NCT02617030|||Other||Prospective|||||||
1375153|NCT02617017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375154|NCT02617004|||Cohort||Prospective|||||||
1375155|NCT02616991||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375156|NCT02616978|||Case-Only||Retrospective|||||||
1375157|NCT02616965||Single Group Assignment||Treatment||None (Open Label)||||||
1375158|NCT02616952|Randomized|Parallel Assignment||Treatment||Single||||||t
1375159|NCT02616939|||Case-Only||Prospective|||||||
1375160|NCT02616926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375161|NCT02616913|Randomized|Crossover Assignment||||Triple|||t||t|t
1375162|NCT02616900||Single Group Assignment||Supportive Care||None (Open Label)||||||
1375163|NCT02616887|||Cohort||Prospective|||||||
1375164|NCT02616874||Single Group Assignment||Treatment||None (Open Label)||||||
1375165|NCT02616861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375166|NCT02616848||Single Group Assignment||Treatment||None (Open Label)||||||
1375167|NCT02616835|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1375168|NCT02616822|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1375169|NCT02616809|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1375170|NCT02616796|Randomized|Factorial Assignment||Treatment||Single||||t||
1375171|NCT02616783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375172|NCT02616770|Randomized|Parallel Assignment||||Triple|||t|t||t
1375173|NCT02616757|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375174|NCT02616744|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375175|NCT02616731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375176|NCT02616718||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375177|NCT02616705|||Cohort||Prospective|||||||
1375178|NCT02616692|||Other||Prospective|||||||
1375179|NCT02616679|||Cohort||Cross-Sectional|||||||
1375180|NCT02616666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375181|NCT02616653|Non-Randomized|Crossover Assignment||Other||Double||||t|t|
1375182|NCT02616640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375183|NCT02616627|||Case-Only|||||||||
1375184|NCT02616614|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375185|NCT02616601|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375186|NCT02616588||Single Group Assignment||Health Services Research||None (Open Label)||||||
1375187|NCT02616575|||Case-Only||Prospective|||||||
1375188|NCT02616562|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375189|NCT02616549|Randomized|Parallel Assignment||Treatment||Single||||||t
1375190|NCT02616536|Randomized|Parallel Assignment||||Double|||t|||t
1375191|NCT02616523|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375192|NCT02616510|||Case-Control||Cross-Sectional|||||||
1375193|NCT02616497|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1375194|NCT02616484|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1375195|NCT02616471|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375196|NCT02616458|Randomized|Parallel Assignment||Prevention||Single||||||t
1375197|NCT02616445|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1375198|NCT02616432|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1375199|NCT02616419|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1375200|NCT02616406|||Cohort||Prospective|||||||
1375201|NCT02616393|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375202|NCT02616380|||Case-Control||Prospective|||||||
1375203|NCT02616367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375204|NCT02616354|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375205|NCT02616341|Randomized|Parallel Assignment||Treatment||Single||||||t
1375206|NCT02616328|||Cohort||Prospective|||||||
1375207|NCT02616315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375208|NCT02616302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375209|NCT02616289|Randomized|Parallel Assignment||Treatment||None (Open Label)||Clinical Trial in two treatment arms||||
1375210|NCT02616276|Randomized|Crossover Assignment||Other||Single||||||t
1375211|NCT02616263|Randomized|Parallel Assignment||Other||Single||||||t
1375212|NCT02616250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375213|NCT02616237|Randomized|Parallel Assignment||Treatment||Single||||||t
1375214|NCT02616224|||Case-Only||Prospective|||||||
1375215|NCT02616211|||Case-Only||Prospective|||||||
1375216|NCT02616198|Randomized|Crossover Assignment||Treatment||Single|||t|||
1375217|NCT02616185||Single Group Assignment||Treatment||None (Open Label)||||||
1375218|NCT02616172||Single Group Assignment||Treatment||None (Open Label)||||||
1375219|NCT02616159|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1375220|NCT02616146|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375221|NCT02616133|||Other||Prospective|||||||
1375222|NCT02616120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375223|NCT02616107|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1375224|NCT02616094|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375225|NCT02616081|||Other||Prospective|||||||
1375226|NCT02616068|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375227|NCT02616055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Extension Study||||
1375228|NCT02616042|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1375229|NCT02616029||Single Group Assignment||Treatment||None (Open Label)||||||
1375230|NCT02616016||Single Group Assignment||Treatment||None (Open Label)||||||
1375231|NCT02616003||Single Group Assignment||Other||None (Open Label)||||||
1375232|NCT02615990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375233|NCT02615977|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375234|NCT02615964|||Case-Only||Prospective|||||||
1375235|NCT02615951|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1375236|NCT02615938|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375237|NCT02615925||Single Group Assignment||Prevention||None (Open Label)||||||
1375238|NCT02615912||Single Group Assignment||Basic Science||None (Open Label)||||||
1375239|NCT02615899|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375240|NCT02615886|Randomized|Parallel Assignment||Other||Single|||||t|
1375241|NCT02615873||Single Group Assignment||Treatment||None (Open Label)||||||
1375242|NCT02615860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375243|NCT02615847||Single Group Assignment||Treatment||None (Open Label)||||||
1375244|NCT02615834|Randomized|Parallel Assignment||Prevention||Single|||t|||
1375245|NCT02615821|Randomized|Parallel Assignment||||Single|||t|||
1375246|NCT02615808|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1375247|NCT02615795|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375248|NCT02615782|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375249|NCT02615769|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375250|NCT02615756||Single Group Assignment||Basic Science||None (Open Label)||||||
1375251|NCT02615743|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1375252|NCT02615730||Single Group Assignment||Treatment||None (Open Label)||||||
1375253|NCT02615717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375254|NCT02615704|||Other||Other|||||||
1375255|NCT02615691||Single Group Assignment||Treatment||None (Open Label)||||||
1375256|NCT02615678||Single Group Assignment||Treatment||None (Open Label)||||||
1375257|NCT02615665|||Cohort||Retrospective|||||||
1375258|NCT02615652|||Ecologic or Community||Cross-Sectional|||||||
1375259|NCT02615639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375260|NCT02615626|||Cohort||Prospective|||||||
1375261|NCT02615613|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1375262|NCT02615600||Single Group Assignment||Treatment||None (Open Label)||||||
1375263|NCT02615587|||Cohort||Retrospective|||||||
1375264|NCT02615574||Single Group Assignment||Treatment||None (Open Label)||||||
1375265|NCT02615561|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375266|NCT02615548|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1375267|NCT02615535|Randomized|Parallel Assignment||Treatment||Single||||||t
1375268|NCT02615522|||Case-Only||Prospective|||||||
1375269|NCT02615509||||||||||||
1375270|NCT02615496|||Other||Cross-Sectional|||||||
1375271|NCT02615483|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375272|NCT02615470|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1375273|NCT02615457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375274|NCT02615444|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1375275|NCT02615431|||Cohort||Prospective|||||||
1375276|NCT02615418|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1375277|NCT02615405|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375278|NCT02615392|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375279|NCT02615379|Randomized|Parallel Assignment||Prevention||Single|The outcomes assessor will be given blinded data and pictures to enable unbiased assessment.|||||t
1375280|NCT02615366|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375281|NCT02615353|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375282|NCT02615340|Randomized|Parallel Assignment||Prevention||Quadruple|All study personnel, patients, and their families will remain blinded. Treatment allocation will only be known to the clinical trials pharmacist, who will perform subject randomization.||t|t|t|t
1375283|NCT02615327|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1375284|NCT02615314|||Case Control||Cross-Sectional|||||||
1375285|NCT02615301|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375286|NCT02615288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375287|NCT02615275||Single Group Assignment||Supportive Care||None (Open Label)||||||
1375288|NCT02615262|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375289|NCT02615249||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375290|NCT02615236|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1375291|NCT02615223|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375292|NCT02615210|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375293|NCT02615197|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1375294|NCT02615184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375295|NCT02615171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375296|NCT02615158|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1375297|NCT02615145|||Cohort||Prospective|||||||
1375298|NCT02615132|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1375299|NCT02615119|Non-Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1375300|NCT02615106||Single Group Assignment||Treatment||None (Open Label)||||||
1375301|NCT02615080|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375302|NCT02615067||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375303|NCT02615054|||Case-Crossover||Prospective|||||||
1375304|NCT02615041|Randomized|Parallel Assignment||||None (Open Label)||||||
1375305|NCT02615028||Single Group Assignment||||None (Open Label)||||||
1375306|NCT02615015|||Cohort||Cross-Sectional|||||||
1375307|NCT02615002|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375308|NCT02614989||Single Group Assignment||Treatment||None (Open Label)||||||
1375309|NCT02614976|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1375310|NCT02614963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375311|NCT02614950||Single Group Assignment||Treatment||None (Open Label)||||||
1375312|NCT02614937|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375313|NCT02614924|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375314|NCT02614911|||Cohort||Prospective|||||||
1375315|NCT02614898||Single Group Assignment||Other||None (Open Label)||||||
1375316|NCT02614885|||Cohort||Prospective|||||||
1375317|NCT02614872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375318|NCT02614859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375319|NCT02614846||Single Group Assignment||Treatment||None (Open Label)||||||
1375320|NCT02614833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375321|NCT02614820|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375322|NCT02614807||Single Group Assignment||Treatment||None (Open Label)||||||
1375323|NCT02614794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375324|NCT02614781|||Cohort||Prospective|||||||
1375325|NCT02614768||Single Group Assignment||Basic Science||None (Open Label)||||||
1375326|NCT02614755|||Cohort||Retrospective|||||||
1375327|NCT02614742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375328|NCT02614729|Randomized|Crossover Assignment||Prevention||Single|||t|||
1375329|NCT02614716|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1375330|NCT02614703|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1375331|NCT02614690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375332|NCT02614677|||Case-Only||Prospective|||||||
1375333|NCT02614664|||Cohort||Prospective|||||||
1375334|NCT02614651||Single Group Assignment||Basic Science||None (Open Label)||||||
1375335|NCT02614638|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1375336|NCT02614625|||Case-Only||Prospective|||||||
1375337|NCT02614612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375338|NCT02614599|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1375339|NCT02614586|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1375340|NCT02614573||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375341|NCT02614560|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375342|NCT02614547|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375343|NCT02614534||||||||||||
1375344|NCT02614521|||Other||Prospective|||||||
1375345|NCT02614508|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375346|NCT02614495||Single Group Assignment||Treatment||None (Open Label)||||||
1375347|NCT02614482||Single Group Assignment||Treatment||None (Open Label)||||||
1375348|NCT02614469|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375349|NCT02614456||Single Group Assignment||Treatment||None (Open Label)||||||
1375350|NCT02614443|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375351|NCT02614430|Randomized|Parallel Assignment||Prevention||Single|||||t|
1375352|NCT02614417|||Cohort||Cross-Sectional|||||||
1375353|NCT02614404||Single Group Assignment||Treatment||None (Open Label)||||||
1375354|NCT02614391|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375355|NCT02614378|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375356|NCT02614365|Randomized|Parallel Assignment||Prevention||Single||||||t
1375357|NCT02614352|Randomized|Crossover Assignment||||None (Open Label)||||||
1375358|NCT02614339|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375359|NCT02614326|Randomized|Parallel Assignment||Prevention||Single||||||t
1375360|NCT02614313|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1375361|NCT02614300|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1375362|NCT02614287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375363|NCT02614274||Single Group Assignment||Treatment||None (Open Label)||||||
1375364|NCT02614261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375365|NCT02614248|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375366|NCT02614235|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1375367|NCT02614222|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1375368|NCT02614209|||Cohort||Prospective|||||||
1375369|NCT02614196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375370|NCT02614183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375371|NCT02614170|||Cohort||Prospective|||||||
1375372|NCT02614157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375373|NCT02614144|||Cohort||Prospective|||||||
1375374|NCT02614131|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375375|NCT02614118|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375376|NCT02614105|Randomized|Parallel Assignment||Treatment||Single||||||t
1375377|NCT02614092||Single Group Assignment||Treatment||None (Open Label)||||||
1375378|NCT02614079||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375379|NCT02614066||Single Group Assignment||Treatment||None (Open Label)||||||
1375380|NCT02614053|||Cohort||Prospective|||||||
1375381|NCT02614040|Randomized|Parallel Assignment||Treatment||Single||||||t
1375382|NCT02614027|||Cohort||Cross-Sectional|||||||
1375383|NCT02614014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375384|NCT02614001|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1375385|NCT02613988||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375386|NCT02613975|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375387|NCT02613962||Single Group Assignment||Screening||None (Open Label)||||||
1375388|NCT02613949|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375389|NCT02613936|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1375390|NCT02613923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375391|NCT02613910||Single Group Assignment||Treatment||None (Open Label)||||||
1375392|NCT02613897|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375393|NCT02613884||Single Group Assignment||Treatment||None (Open Label)||||||
1375394|NCT02613871||Single Group Assignment||Treatment||None (Open Label)||||||
1375395|NCT02613858|||Cohort||Prospective|||||||
1375396|NCT02613845|||Cohort||Retrospective|||||||
1375397|NCT02613832|Randomized|Crossover Assignment||Treatment||Single|||t|||
1375398|NCT02613819||Single Group Assignment||Treatment||None (Open Label)||"Radiotherapy;~Fraction schedule 1: 26Gy in 1 fraction, for tumours < 4cm in size~Fraction schedule 2: 42Gy in 3 fractions, for tumours > 4cm in size"||||
1375399|NCT02613806|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375400|NCT02613793|||Case-Control||Prospective|||||||
1375401|NCT02613780|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375402|NCT02613767|||Cohort||Prospective|||||||
1375403|NCT02613754|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375404|NCT02613741|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375405|NCT02613728|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1375406|NCT02613715|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1375407|NCT02613702|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375408|NCT02613689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375409|NCT02613676|Randomized|Parallel Assignment||Screening||Single||||||t
1375410|NCT02613663|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375411|NCT02613650||Single Group Assignment||Treatment||None (Open Label)||||||
1375412|NCT02613637|||Other||Prospective|||||||
1375413|NCT02613624|||||Prospective|||||||
1375414|NCT02613611|||Case-Only||Prospective|||||||
1375415|NCT02613598||Single Group Assignment||Treatment||None (Open Label)||||||
1375416|NCT02613585|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1375417|NCT02613572|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375418|NCT02613559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375419|NCT02613546|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375420|NCT02613533||Single Group Assignment||Supportive Care||None (Open Label)||||||
1375421|NCT02613520|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375422|NCT02613507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375423|NCT02613494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375424|NCT02613481||Single Group Assignment||Other||None (Open Label)||||||
1375425|NCT02613468|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1375426|NCT02613455|Randomized|Parallel Assignment||Treatment||Single||||||t
1375427|NCT02613442|||Cohort||Cross-Sectional|||||||
1375428|NCT02613429|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1375429|NCT02613416||Single Group Assignment||Treatment||None (Open Label)||||||
1375430|NCT02613403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375431|NCT02613390||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375432|NCT02613377|||Cohort||Prospective|||||||
1375433|NCT02613364|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1375434|NCT02613351||Single Group Assignment||Treatment||None (Open Label)||||||
1375435|NCT02613338|||Case-Only||Cross-Sectional|||||||
1375436|NCT02613325||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375437|NCT02613312|||Case-Only||Prospective|||||||
1375438|NCT02613299|||Case-Only||Prospective|||||||
1375439|NCT02613286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375440|NCT02613273|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375441|NCT02613260|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375442|NCT02613247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375443|NCT02613234|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375444|NCT02613221||Single Group Assignment||Treatment||None (Open Label)||||||
1375445|NCT02613208|||Case-Control||Cross-Sectional|||||||
1375446|NCT02613195|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1375447|NCT02613182||Single Group Assignment||Treatment||None (Open Label)||||||
1375448|NCT02613169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375449|NCT02613156|||Cohort||Prospective|||||||
1375450|NCT02613143|||||Retrospective|||||||
1375451|NCT02613130|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375452|NCT02613117|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375453|NCT02613104|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375454|NCT02613091||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375455|NCT02613078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375456|NCT02613065|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1375457|NCT02613052|Randomized|Factorial Assignment||Diagnostic||Single||||||t
1375458|NCT02613039||Single Group Assignment||Treatment||None (Open Label)||||||
1375459|NCT02613026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375460|NCT02613013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375461|NCT02613000|||Cohort||Prospective|||||||
1375462|NCT02612987||Single Group Assignment||Treatment||None (Open Label)||||||
1375463|NCT02612974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375464|NCT02612961|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375465|NCT02612948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375466|NCT02612935|||Cohort||Retrospective|||||||
1375467|NCT02612922|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375468|NCT02612909|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1375469|NCT02612896|Non-Randomized|Parallel Assignment||Other||Single|||||t|
1375470|NCT02612883|||Other||Prospective|||||||
1375471|NCT02612870|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375472|NCT02612857|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375473|NCT02612844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375474|NCT02612831|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375475|NCT02612818|||Cohort||Prospective|||||||
1375476|NCT02612805|Randomized|Parallel Assignment||Treatment||Single||||||t
1375477|NCT02612792|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375478|NCT02612779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375479|NCT02612766||Single Group Assignment||Treatment||None (Open Label)||||||
1375480|NCT02612753|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1375481|NCT02612740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375482|NCT02612727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375483|NCT02612714||Single Group Assignment||||None (Open Label)||||||
1375484|NCT02612701|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1375485|NCT02612688|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1375486|NCT02612675|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1375487|NCT02612662|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1375488|NCT02612649|||Cohort||Prospective|||||||
1375489|NCT02612636|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375490|NCT02612623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375491|NCT02612610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375492|NCT02612597|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1375493|NCT02612584||Single Group Assignment||Treatment||None (Open Label)||||||
1375494|NCT02612571|||Cohort||Prospective|||||||
1375495|NCT02612558||Sequential Assignment||Treatment||None (Open Label)||||||
1375496|NCT02612545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375497|NCT02612532||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375498|NCT02612519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375499|NCT02612506|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375500|NCT02612493|||Case-Only||Retrospective|||||||
1375501|NCT02612480|Randomized|Parallel Assignment||Basic Science||Single||||||t
1375502|NCT02612467|Randomized|Parallel Assignment||Treatment||Single||||||t
1375503|NCT02612454||Single Group Assignment||Treatment||None (Open Label)||||||
1375504|NCT02612441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375505|NCT02612428|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375506|NCT02612415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375507|NCT02612402|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1375508|NCT02612389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375509|NCT02612376|||Case-Control||Prospective|||||||
1375510|NCT02612363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375511|NCT02612350|||Cohort||Prospective|||||||
1375512|NCT02612337|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375513|NCT02612324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375514|NCT02612311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375515|NCT02612298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375516|NCT02612285||Single Group Assignment||Treatment||None (Open Label)||||||
1375517|NCT02612272|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1375518|NCT02612259|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375519|NCT02612246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375520|NCT02612233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375521|NCT02612220|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375522|NCT02612207|||Cohort||Prospective|||||||
1375523|NCT02612194|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375524|NCT02612181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375525|NCT02612168||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375526|NCT02612155|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375527|NCT02612142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375528|NCT02612129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375529|NCT02612116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375530|NCT02612103|||Cohort||Prospective|||||||
1375531|NCT02612090|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1375532|NCT02612077|||Cohort||Prospective|||||||
1375533|NCT02612064|Randomized|Parallel Assignment||Treatment||Single|||||t|
1375534|NCT02612051|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1375535|NCT02612038|Randomized|Crossover Assignment||Treatment||Single|||t|||
1375536|NCT02612025|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375537|NCT02612012|||Cohort||Prospective|||||||
1375538|NCT02611999|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1375539|NCT02611986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375540|NCT02611973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375541|NCT02611960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375542|NCT02611947|||Case-Only||Prospective|||||||
1375543|NCT02611934|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1375544|NCT02611921|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1375545|NCT02611908||Single Group Assignment||Treatment||None (Open Label)||||||
1375546|NCT02611895||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375547|NCT02611882|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375548|NCT02611869|Randomized|Parallel Assignment||Treatment||Single||||||t
1375549|NCT02611856|||Cohort||Retrospective|||||||
1375550|NCT02611843|Randomized|Parallel Assignment||Treatment||Single||||||t
1375551|NCT02611830|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375552|NCT02611817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375553|NCT02611804|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1375554|NCT02611791|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375555|NCT02611778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375556|NCT02611765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375557|NCT02611752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375558|NCT02611739|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375559|NCT02611726|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1375561|NCT02611700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375562|NCT02611687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375563|NCT02611674|||Cohort||Prospective|||||||
1375564|NCT02611661|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375565|NCT02611648|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1375566|NCT02611635|||Other||Cross-Sectional|||||||
1375567|NCT02611622|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1375568|NCT02611609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375569|NCT02611596|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1375570|NCT02611583|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375571|NCT02611570|||Cohort||Prospective|||||||
1375572|NCT02611557||Single Group Assignment||Screening||None (Open Label)||||||
1375573|NCT02611544|Randomized|Factorial Assignment||Health Services Research||None (Open Label)|Participants were blinded to study hypotheses.|||||
1375574|NCT02611531|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1375575|NCT02611518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375576|NCT02611505|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375577|NCT02611492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375578|NCT02611479|||Cohort||Prospective|||||||
1375579|NCT02611466|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375580|NCT02611453||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375581|NCT02611440|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375582|NCT02611427|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1375583|NCT02611414|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375584|NCT02611401|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1375585|NCT02611388|Randomized|Parallel Assignment||||Triple|||t||t|t
1375586|NCT02611375|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375587|NCT02611362|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375588|NCT02611336||Single Group Assignment||Treatment||None (Open Label)||||||
1375589|NCT02611323|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375590|NCT02611310|||Cohort||Prospective|||||||
1375591|NCT02611297||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375592|NCT02611284|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1375593|NCT02611271|||Cohort||Prospective|||||||
1375594|NCT02611258||Single Group Assignment||Treatment||None (Open Label)||||||
1375595|NCT02611245||Single Group Assignment||Treatment||None (Open Label)||||||
1375596|NCT02611232|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375597|NCT02611219|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375598|NCT02611206||Single Group Assignment||Treatment||None (Open Label)||||||
1375599|NCT02611193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375600|NCT02611180|||Case-Only||Prospective|||||||
1375601|NCT02611167||Single Group Assignment||Treatment||None (Open Label)||||||
1375602|NCT02611154||Single Group Assignment||Basic Science||None (Open Label)||||||
1375603|NCT02611141|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1375604|NCT02611128|||Other||Cross-Sectional|||||||
1375605|NCT02611115|||Cohort||Prospective|||||||
1375606|NCT02611102|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375607|NCT02611089|||Case Control||Cross-Sectional|||||||
1375608|NCT02611076|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1375609|NCT02611063||Single Group Assignment||Treatment||None (Open Label)||||||
1375610|NCT02611050|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1375611|NCT02611037||Single Group Assignment||Treatment||None (Open Label)||||||
1375612|NCT02611024|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with selected advanced solid tumors will be divided into two groups: the PM01183 Escalation Group and the Irinotecan Escalation Group. Each group will have a different dose escalation scheme.||||
1375613|NCT02611011|||Other||Prospective|||||||
1375614|NCT02610985|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375615|NCT02610972|||Case-Control||Prospective|||||||
1375616|NCT02610959|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375617|NCT02610946|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375618|NCT02610933|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375619|NCT02610920||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375620|NCT02610907||Single Group Assignment||Basic Science||None (Open Label)||||||
1375621|NCT02610894|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1375622|NCT02610881|Randomized|Crossover Assignment||||None (Open Label)||||||
1375623|NCT02610868||Single Group Assignment||Treatment||None (Open Label)||||||
1375624|NCT02610855|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375625|NCT02610842||Single Group Assignment||Treatment||None (Open Label)||||||
1375626|NCT02610829||Single Group Assignment||Basic Science||None (Open Label)||||||
1375627|NCT02610816|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375628|NCT02610803|||Cohort||Retrospective|||||||
1375629|NCT02610790|||Cohort||Prospective|||||||
1375630|NCT02610777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375631|NCT02610764||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375632|NCT02610751|||Case-Control||Prospective|||||||
1375633|NCT02610738||Single Group Assignment||Supportive Care||None (Open Label)||||||
1375634|NCT02610725||Single Group Assignment||Other||None (Open Label)||||||
1375635|NCT02610712||Single Group Assignment||Treatment||None (Open Label)||||||
1375636|NCT02610699|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1375637|NCT02610686||Single Group Assignment||Treatment||None (Open Label)||||||
1375638|NCT02610673|||Cohort||Prospective|||||||
1375639|NCT02610660|||Cohort||Prospective|||||||
1375640|NCT02610647|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1375641|NCT02610634|||Case-Control||Cross-Sectional|||||||
1375642|NCT02610621||Single Group Assignment||Treatment||None (Open Label)||||||
1375643|NCT02610608|||Cohort||Prospective|||||||
1375644|NCT02610595||Single Group Assignment||Treatment||None (Open Label)||||||
1375645|NCT02610582||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1375646|NCT02610569|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1375647|NCT02610556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375648|NCT02610543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375649|NCT02610530|||Case Control||Retrospective|||||||
1375650|NCT02610517|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1375651|NCT02610504||Single Group Assignment||Treatment||None (Open Label)||||||
1375652|NCT02610491|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1375653|NCT02610465|||Case-Control||Prospective|||||||
1375654|NCT02610452||Single Group Assignment||Supportive Care||None (Open Label)||||||
1375655|NCT02610439||||||||||||
1375656|NCT02610426||||||||||||
1375657|NCT02610413||||||||||||
1375658|NCT02610400|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1375659|NCT02610387|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375660|NCT02610374|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1375661|NCT02610361||Single Group Assignment||Treatment||None (Open Label)||||||
1375662|NCT02610348|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1375663|NCT02610335|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375664|NCT02610322|Randomized|Parallel Assignment||Prevention||Single||||||t
1375665|NCT02610309|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375666|NCT02610296|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375667|NCT02610283|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375668|NCT02610270|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1375669|NCT02610257|Randomized|Parallel Assignment||Screening||Single||||||t
1375670|NCT02610244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375671|NCT02610231||Single Group Assignment||Treatment||None (Open Label)||||||
1375672|NCT02610218|||Cohort||Prospective|||||||
1375673|NCT02610205|||Cohort||Prospective|||||||
1375674|NCT02610192|||Other||Prospective|||||||
1375675|NCT02610179|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1375676|NCT02610166|Randomized|Parallel Assignment||Treatment||Single|||||t|
1375677|NCT02610153|||Cohort||Prospective|||||||
1375678|NCT02610140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375679|NCT02610127|||Cohort||Other|||||||
1375680|NCT02610114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375681|NCT02610101|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1375682|NCT02610088|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375683|NCT02610075||Single Group Assignment||Treatment||None (Open Label)||||||
1375684|NCT02610062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375685|NCT02610049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375686|NCT02610036|||Case Control||Prospective|||||||
1375687|NCT02610023|||Cohort||Prospective|||||||
1375688|NCT02610010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375689|NCT02609997|Randomized|Parallel Assignment||Treatment||Single||||||t
1375690|NCT02609984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375691|NCT02609971|Randomized|Parallel Assignment||Treatment||Single|||||t|
1375692|NCT02609958||Single Group Assignment||Treatment||None (Open Label)||||||
1375693|NCT02609945||Single Group Assignment||Treatment||None (Open Label)||||||
1375694|NCT02609932||Single Group Assignment||Basic Science||None (Open Label)||||||
1375695|NCT02609919|||Cohort||Prospective|||||||
1375696|NCT02609906|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375697|NCT02609893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375698|NCT02609880|Randomized|Parallel Assignment||Treatment||Single||||||t
1375699|NCT02609867||Single Group Assignment||Treatment||None (Open Label)||||||
1375700|NCT02609854|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375701|NCT02609841|||Cohort||Prospective|||||||
1375702|NCT02609828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375703|NCT02609815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375704|NCT02609802|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1375705|NCT02609789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375706|NCT02609776|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375707|NCT02609763|||Cohort||Cross-Sectional|||||||
1375708|NCT02609750|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375709|NCT02609737||Single Group Assignment||Treatment||None (Open Label)||||||
1375710|NCT02609724|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375711|NCT02609711|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375712|NCT02609698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375713|NCT02609685|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1375714|NCT02609672|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1375715|NCT02609659||Single Group Assignment||Treatment||None (Open Label)||||||
1375716|NCT02609646|||Case-Only||Prospective|||||||
1375717|NCT02609633|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375718|NCT02609620|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375719|NCT02609607|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375720|NCT02609594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375721|NCT02609581|||Other||Prospective|||||||
1375722|NCT02609568|||Case-Control||Prospective|||||||
1375723|NCT02609555||Single Group Assignment||Treatment||None (Open Label)||||||
1375724|NCT02609542|||Case-Control||Prospective|||||||
1375725|NCT02609529|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1375726|NCT02609516|||Cohort||Retrospective|||||||
1375727|NCT02609503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375728|NCT02609490|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375729|NCT02609477|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1375730|NCT02609464|Randomized|Parallel Assignment||||Single||||||t
1375731|NCT02609451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375732|NCT02609438|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375733|NCT02609425||Single Group Assignment||Treatment||None (Open Label)||||||
1375734|NCT02609412|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375735|NCT02609399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375736|NCT02609386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375737|NCT02609373||Single Group Assignment||Prevention||None (Open Label)||||||
1375738|NCT02609360|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1375739|NCT02609347|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375740|NCT02609334|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1375741|NCT02609321|Randomized|Parallel Assignment||Treatment||Single||||||t
1375742|NCT02609308|Randomized|Single Group Assignment||Treatment||Double|Application of autologous platelet-rich plasma|Use of platelet rich plasma in patients with ankle sprain|||t|t
1375743|NCT02609295|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1375744|NCT02609282|Randomized|Parallel Assignment||Basic Science||Single||||||t
1375745|NCT02609269|||Case-Only||Prospective|||||||
1375746|NCT02609256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375747|NCT02609243|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375748|NCT02609230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375749|NCT02609217|||Cohort||Prospective|||||||
1375750|NCT02609204||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375751|NCT02609191|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1375752|NCT02609178|Randomized|Crossover Assignment||Treatment||Single|||t|||
1375753|NCT02609165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375754|NCT02609152|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375755|NCT02609139|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1375756|NCT02609126|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375757|NCT02609113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375758|NCT02609100|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1375759|NCT02609087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375760|NCT02609074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375761|NCT02609061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375762|NCT02609048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375763|NCT02609035|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1375764|NCT02609022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375765|NCT02609009|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1375766|NCT02608996|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375767|NCT02608983|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1375768|NCT02608970|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375769|NCT02608957||Single Group Assignment||Treatment||None (Open Label)||||||
1375770|NCT02608944||Single Group Assignment||Health Services Research||None (Open Label)||||||
1375771|NCT02608931|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1375772|NCT02608918||Single Group Assignment||Other||None (Open Label)||||||
1375773|NCT02608905|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1375774|NCT02608892|Randomized|Parallel Assignment||Other||Single||||t||
1375775|NCT02608879|Randomized|Parallel Assignment||Treatment||Single||||||t
1375776|NCT02608866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375777|NCT02608853|||Cohort||Retrospective|||||||
1375778|NCT02608840|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1375779|NCT02608827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375780|NCT02608814||Single Group Assignment||Basic Science||||||||
1375781|NCT02608801|||Cohort||Prospective|||||||
1375782|NCT02608788|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1375783|NCT02608775|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1375784|NCT02608762|||Cohort||Prospective|||||||
1375785|NCT02608749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375786|NCT02608736|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1375787|NCT02608723|Randomized|Parallel Assignment||Treatment||Single||||||t
1375788|NCT02608710|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1375789|NCT02608697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375790|NCT02608684||Single Group Assignment||Treatment||None (Open Label)||||||
1375791|NCT02608671|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375792|NCT02608658||Single Group Assignment||Supportive Care||None (Open Label)||||||
1375793|NCT02608645|||||Prospective|||||||
1375794|NCT02608632|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1375795|NCT02608619|||Cohort||Prospective|||||||
1375796|NCT02608606|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375797|NCT02608593|||Case Control|||||||||
1375798|NCT02608580||Single Group Assignment||Other||None (Open Label)||||||
1375799|NCT02608567|||Other||Retrospective|||||||
1375800|NCT02608554|Randomized|Parallel Assignment||Treatment||Single||||||t
1375801|NCT02608541|||Cohort||Other|||||||
1375802|NCT02608528||Single Group Assignment||Basic Science||||||||
1375803|NCT02608515|||Other||Retrospective|||||||
1375804|NCT02608502|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1375805|NCT02608489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375806|NCT02608476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375807|NCT02608463|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375808|NCT02608450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375809|NCT02608437||Single Group Assignment||Treatment||None (Open Label)||||||
1375810|NCT02608424||Single Group Assignment||Supportive Care||None (Open Label)||||||
1375811|NCT02608411||Single Group Assignment||Treatment||None (Open Label)||||||
1375812|NCT02608398|||Cohort||Prospective|||||||
1375813|NCT02608385|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1375814|NCT02608372|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1375815|NCT02608359|||Cohort||Prospective|||||||
1375816|NCT02608346||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375817|NCT02608333|Randomized|Parallel Assignment||Treatment||Single||||||t
1375818|NCT02608320|Randomized|Crossover Assignment||Other||||||||
1375819|NCT02608307|||Cohort||Prospective|||||||
1375820|NCT02608294|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375821|NCT02608281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375822|NCT02608268|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375823|NCT02608255||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375824|NCT02608242|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375825|NCT02608229|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375826|NCT02608216||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375827|NCT02608203||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375828|NCT02608190|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375829|NCT02608177|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1375830|NCT02608164|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1375831|NCT02608151|Randomized|Parallel Assignment||||None (Open Label)||||||
1375832|NCT02608138|||||Cross-Sectional|||||||
1375833|NCT02608125||Single Group Assignment||Treatment||None (Open Label)||||||
1375834|NCT02608112|||Case-Only||Prospective|||||||
1375835|NCT02608099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375836|NCT02608086|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1375837|NCT02608073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375838|NCT02608060|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375839|NCT02608047|||Case Control||Retrospective|||||||
1375840|NCT02608034||Single Group Assignment||Treatment||None (Open Label)||||||
1375841|NCT02608021|||Case-Control||Cross-Sectional|||||||
1375842|NCT02608008|||Other||Prospective|||||||
1375843|NCT02607995|||Cohort||Prospective|||||||
1375844|NCT02607982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375845|NCT02607969|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375846|NCT02607956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375847|NCT02607943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375848|NCT02607930|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375849|NCT02607917|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375850|NCT02607904||Single Group Assignment||Treatment||None (Open Label)||||||
1375851|NCT02607891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375852|NCT02607878|||Cohort||Prospective|||||||
1375853|NCT02607865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375854|NCT02607852|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||Arm A: Patients 5-18 years old Arm B: Patients 0-4 years old||||
1375855|NCT02607839|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1375856|NCT02607826|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375857|NCT02607813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375858|NCT02607800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375859|NCT02607787|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1375860|NCT02607774|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1375861|NCT02607761|Randomized|Parallel Assignment||Prevention||Single|||t|||
1375862|NCT02607748||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375863|NCT02607735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375864|NCT02607722|||Cohort||Prospective|||||||
1375865|NCT02607709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375866|NCT02607696|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1375867|NCT02607683|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375868|NCT02607670|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1375869|NCT02607657|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1375870|NCT02607644|Randomized|Parallel Assignment||Treatment||Single|||||t|
1375871|NCT02607631||Single Group Assignment||Treatment||None (Open Label)||||||
1375872|NCT02607618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375873|NCT02607605|||Case-Only||Prospective|||||||
1375874|NCT02607592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375875|NCT02607579|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375876|NCT02607566|Randomized|Parallel Assignment||Treatment||Single||||||t
1375877|NCT02607553||Single Group Assignment||Treatment||None (Open Label)||||||
1375878|NCT02607540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375879|NCT02607527||Single Group Assignment||Treatment||None (Open Label)||||||
1375880|NCT02607514|Randomized|Crossover Assignment||Treatment||Single||||||t
1375881|NCT02607501||Single Group Assignment||Treatment||None (Open Label)||||||
1375882|NCT02607488|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375883|NCT02607475||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375884|NCT02607462|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1375885|NCT02607449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375886|NCT02607436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375887|NCT02607423||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375888|NCT02607410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375889|NCT02607397|||Cohort||Retrospective|||||||
1375890|NCT02607384||Single Group Assignment||Other||None (Open Label)||||||
1375891|NCT02607371|||Other||Prospective|||||||
1375892|NCT02607358|||Cohort|||||||||
1375893|NCT02607345|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1375894|NCT02607332||Single Group Assignment||Treatment||None (Open Label)||||||
1375895|NCT02607319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375896|NCT02607306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375897|NCT02607293|||Cohort||Cross-Sectional|||||||
1375898|NCT02607280||Single Group Assignment||Treatment||None (Open Label)||||||
1375899|NCT02607267|||Case-Only||Prospective|||||||
1375900|NCT02607254|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375901|NCT02607241|Randomized|Parallel Assignment||Treatment||Single||||||t
1375902|NCT02607228|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375903|NCT02607215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375904|NCT02607202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375905|NCT02607176||Single Group Assignment||Treatment||None (Open Label)||||||
1375906|NCT02607163|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375907|NCT02607150|||Cohort||Prospective|||||||
1375908|NCT02607137||Single Group Assignment||Prevention||None (Open Label)||||||
1375909|NCT02607124|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375910|NCT02607111||Single Group Assignment||Prevention||None (Open Label)||||||
1375911|NCT02607098|||Cohort||Prospective|||||||
1375912|NCT02607085|||Case-Only||Prospective|||||||
1375913|NCT02607072|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375914|NCT02607059|||Case-Only||Prospective|||||||
1375915|NCT02607046|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1375916|NCT02607033|Randomized|Parallel Assignment||Treatment||Single||||||t
1375917|NCT02607020|Randomized|Parallel Assignment||Treatment||Single||||||t
1375918|NCT02607007|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1375919|NCT02606994|Randomized|Parallel Assignment||Treatment||Single|||||t|
1375920|NCT02606981|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375921|NCT02606955||Single Group Assignment||Treatment||None (Open Label)||||||
1375922|NCT02606942|||Case Control||Cross-Sectional|||||||
1375923|NCT02606916||Single Group Assignment||Treatment||None (Open Label)||||||
1375924|NCT02606903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375925|NCT02606890|||Cohort||Retrospective|||||||
1375926|NCT02606877|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375927|NCT02606864|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375928|NCT02606851|||Case-Only||Prospective|||||||
1375929|NCT02606838||Single Group Assignment||Supportive Care||None (Open Label)||||||
1375930|NCT02606825|||Case-Only||Retrospective|||||||
1375931|NCT02606812|Randomized|Parallel Assignment||||Single|||||t|
1375932|NCT02606799|Randomized|Parallel Assignment||Treatment||Single|||t|||
1375933|NCT02606786||Single Group Assignment||Treatment||None (Open Label)||||||
1375934|NCT02606773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375935|NCT02606760|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1375936|NCT02606747|||Cohort||Prospective|||||||
1375937|NCT02606734||Single Group Assignment||Treatment||None (Open Label)||||||
1375938|NCT02606721|||Cohort||Cross-Sectional|||||||
1375939|NCT02606708||Single Group Assignment||Treatment||None (Open Label)||||||
1375940|NCT02606695|||Cohort||Prospective|||||||
1375941|NCT02606682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375942|NCT02606669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375943|NCT02606643|Randomized|Parallel Assignment||Other||Single||||||t
1375944|NCT02606630||Single Group Assignment||Treatment||None (Open Label)||||||
1375945|NCT02606617|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375946|NCT02606604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375947|NCT02606591||Single Group Assignment||Prevention||None (Open Label)||||||
1375948|NCT02606578|||Cohort||Prospective|||||||
1375949|NCT02606565|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375950|NCT02606552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375951|NCT02606539|Randomized|Parallel Assignment||Treatment||Single|||||t|
1375952|NCT02606526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375953|NCT02606513||Single Group Assignment||Diagnostic||||||||
1375954|NCT02606500|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375955|NCT02606487|||Case-Only||Prospective|||||||
1375956|NCT02606474|||Case Control||Prospective|||||||
1375957|NCT02606461|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1375958|NCT02606448|Randomized|Parallel Assignment||Treatment||Single||||||t
1375959|NCT02606435|Randomized|Parallel Assignment||Treatment||Single||||||t
1375960|NCT02606422|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1375961|NCT02606409|Randomized|Parallel Assignment||Treatment||Double||||t||t
1375962|NCT02606396|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1375963|NCT02606383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375964|NCT02606370|Randomized|Parallel Assignment||Treatment||Single||||||t
1375965|NCT02606357||Single Group Assignment||Treatment||None (Open Label)||||||
1375966|NCT02606344|Randomized|Parallel Assignment||Prevention||Single||||||t
1375967|NCT02606331|Randomized|Parallel Assignment||Treatment||Single||||||t
1375968|NCT02606318|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1375969|NCT02606305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375970|NCT02606292||Single Group Assignment||Diagnostic||None (Open Label)||||||
1375971|NCT02606279|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1375972|NCT02606266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375973|NCT02606253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375974|NCT02606240|||Cohort||Prospective|||||||
1375975|NCT02606227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375976|NCT02606214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1375977|NCT02606201||Single Group Assignment||Treatment||None (Open Label)||||||
1375978|NCT02606188|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1375979|NCT02606175||Single Group Assignment||Screening||None (Open Label)||||||
1375980|NCT02606162|||Cohort||Prospective|||||||
1375981|NCT02606149|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1375982|NCT02606136||Single Group Assignment||Treatment||None (Open Label)||||||
1375983|NCT02606123||Single Group Assignment||Treatment||None (Open Label)||||||
1375984|NCT02606110|||Case-Only||Prospective|||||||
1375985|NCT02606097||Single Group Assignment||Treatment||None (Open Label)||||||
1375986|NCT02606084|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375987|NCT02606071|||Cohort||Prospective|||||||
1375988|NCT02606058|Randomized|Parallel Assignment||Prevention||Single|||t|||
1375989|NCT02606045|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1375990|NCT02606032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1375991|NCT02606019|||Cohort||Prospective|||||||
1375992|NCT02606006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375993|NCT02605993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1375994|NCT02605980|||Cohort||Cross-Sectional|||||||
1375995|NCT02605967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375996|NCT02605954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1375997|NCT02605941|||Cohort||Prospective|||||||
1375998|NCT02605928||Single Group Assignment||Other||None (Open Label)||||||
1375999|NCT02605915|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376000|NCT02605902|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376001|NCT02605889|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1376002|NCT02605876|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1376003|NCT02605863|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376004|NCT02605850|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376005|NCT02605837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376006|NCT02605824|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1376007|NCT02605811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376008|NCT02605798|Randomized|Crossover Assignment||||None (Open Label)||||||
1376009|NCT02605785||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376010|NCT02605772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376011|NCT02605759||Single Group Assignment||Treatment||None (Open Label)||||||
1376012|NCT02605746|Randomized|Parallel Assignment||||None (Open Label)||||||
1376013|NCT02605733|||Cohort||Prospective|||||||
1376014|NCT02605720||Single Group Assignment||Treatment||None (Open Label)||||||
1376015|NCT02605707|Randomized|Parallel Assignment||Treatment||Single||||||t
1376016|NCT02605694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376017|NCT02605681|||Cohort||Prospective|||||||
1376018|NCT02605668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376019|NCT02605655|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376020|NCT02605642|||Cohort||Prospective|||||||
1376021|NCT02605629|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1376022|NCT02605616|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1376023|NCT02605603|||Cohort||Prospective|||||||
1376024|NCT02605590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376025|NCT02605577|Randomized|Parallel Assignment||Treatment||Double||||t||t
1376026|NCT02605564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376027|NCT02605551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376028|NCT02605538|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376029|NCT02605525|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376030|NCT02605512||Single Group Assignment||Screening||None (Open Label)||||||
1376031|NCT02605499|Randomized|Crossover Assignment||Prevention||None (Open Label)||Patient rooms are counted as enrolled since consent was waived and the number of participants is unknown. Total of 83 rooms.||||
1376032|NCT02605486||Single Group Assignment||Treatment||None (Open Label)||||||
1376033|NCT02605460||Single Group Assignment||Treatment||None (Open Label)||||||
1376034|NCT02605447||Single Group Assignment||Treatment||None (Open Label)||||||
1376035|NCT02605434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376036|NCT02605421||Single Group Assignment||Treatment||None (Open Label)||||||
1376037|NCT02605408|||Cohort||Prospective|||||||
1376038|NCT02605395|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1376039|NCT02605382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376040|NCT02605369|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376041|NCT02605356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376042|NCT02605343|||Case Control||Prospective|||||||
1376043|NCT02605330|||Cohort||Prospective|||||||
1376044|NCT02605317|||Case-Only||Retrospective|||||||
1376045|NCT02605304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376046|NCT02605291|Randomized|Crossover Assignment||Basic Science||Single||||||t
1376047|NCT02605278|Randomized|Parallel Assignment||Treatment||Single||||||t
1376048|NCT02605265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376049|NCT02605252||Single Group Assignment||Treatment||None (Open Label)||||||
1376050|NCT02605239||Single Group Assignment||Treatment||None (Open Label)||||||
1376051|NCT02605226|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376052|NCT02605213|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376053|NCT02605200||Single Group Assignment||Supportive Care||None (Open Label)||||||
1376054|NCT02605187|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376055|NCT02605174|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1376056|NCT02605161|||Case-Control||Prospective|||||||
1376057|NCT02605148|Randomized|Parallel Assignment||Prevention||Single||||||t
1376058|NCT02605135|||Cohort||Prospective|||||||
1376059|NCT02605122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376060|NCT02605109|||Case Control||Retrospective|||||||
1376061|NCT02605096|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1376062|NCT02605083||Single Group Assignment||Treatment||None (Open Label)||||||
1376063|NCT02605070|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376064|NCT02605057|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1376065|NCT02605044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376066|NCT02605005|||Case Control||Prospective|||||||
1376067|NCT02604992|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1376068|NCT02604979|||Other||Prospective|||||||
1376069|NCT02604966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376070|NCT02604953|||Cohort||Prospective|||||||
1376071|NCT02604940|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1376072|NCT02604927|Randomized|Parallel Assignment||||Triple|||t||t|t
1376073|NCT02604914|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376074|NCT02604901|Randomized|Factorial Assignment||||None (Open Label)||||||
1376075|NCT02604888||Single Group Assignment||Treatment||None (Open Label)||||||
1376076|NCT02604875|||||Prospective|||||||
1376077|NCT02604862||Single Group Assignment||Other||None (Open Label)||||||
1376078|NCT02604849|||Case Control||Retrospective|||||||
1376079|NCT02604836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376080|NCT02604823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376081|NCT02604810|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1376082|NCT02604797|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376083|NCT02604784|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Two parallel cohorts according to patients characteristics Patient with indication for systemic standard chemotherapy will be accrued in Cohort A (for a Phase II repeated single dose PIPAC).~Patient with no indication for sistemic standard chemotheralpy will be accrued in Cohort B ( for a Phase, single ascending dose PIPAC)"||||
1376084|NCT02604771|||Other||Cross-Sectional|||||||
1376085|NCT02604758|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376086|NCT02604745|||Cohort||Prospective|||||||
1376087|NCT02604732|Randomized|Parallel Assignment||||Double||||t||t
1376088|NCT02604719|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1376089|NCT02604706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376090|NCT02604693|||Cohort||Prospective|||||||
1376091|NCT02604680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376092|NCT02604667|||Other||Prospective|||||||
1376093|NCT02604654||Single Group Assignment||Treatment||None (Open Label)||||||
1376094|NCT02604641|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1376095|NCT02604628|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376096|NCT02604615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376097|NCT02604602|||Cohort||Prospective|||||||
1376098|NCT02604589|Randomized|Parallel Assignment||Treatment||Double||||t||t
1376099|NCT02604576|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1376100|NCT02604563|||Cohort||Prospective|||||||
1376101|NCT02604550|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376102|NCT02604537|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376103|NCT02604524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376104|NCT02604511||Single Group Assignment||Treatment||None (Open Label)||||||
1376105|NCT02604498|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1376106|NCT02604485||Single Group Assignment||Treatment||None (Open Label)||||||
1376107|NCT02604472|||Cohort||Retrospective|||||||
1376108|NCT02604459|Randomized|Parallel Assignment||Treatment||Double||||t||t
1376109|NCT02604446|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376110|NCT02604433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376111|NCT02604420|||Cohort||Prospective|||||||
1376112|NCT02604407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376113|NCT02604394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376114|NCT02604381|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1376115|NCT02604368|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1376116|NCT02604355|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1376117|NCT02604342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376118|NCT02604329||Single Group Assignment||Supportive Care||None (Open Label)||||||
1376119|NCT02604316|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1376120|NCT02604303|||Cohort||Prospective|||||||
1376121|NCT02604290|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376122|NCT02604277||Single Group Assignment||Treatment||None (Open Label)||||||
1376123|NCT02604264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376124|NCT02604251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376125|NCT02604238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376126|NCT02604225|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376127|NCT02604212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376128|NCT02604199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376129|NCT02604186|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1376130|NCT02604173|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1376131|NCT02604160|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1376132|NCT02604147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376133|NCT02604134|Randomized|Parallel Assignment||Treatment||Single|the radiographic progression of caries is assessed by a masked investigator|||||t
1376134|NCT02604121||Single Group Assignment||Screening||None (Open Label)||||||
1376135|NCT02604108|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376136|NCT02604095||Single Group Assignment||Treatment||None (Open Label)||||||
1376137|NCT02604082|Randomized|Crossover Assignment||Treatment||Single||||||t
1376138|NCT02604069||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376139|NCT02604056|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1376140|NCT02604043||Single Group Assignment||Other||None (Open Label)||||||
1376141|NCT02604030||Single Group Assignment||Treatment||None (Open Label)||||||
1376142|NCT02604017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376143|NCT02604004|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1376144|NCT02603991|||Cohort||Prospective|||||||
1376145|NCT02603978|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1376146|NCT02603965||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376147|NCT02603952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376148|NCT02603939|||Cohort||Prospective|||||||
1376149|NCT02603926||Single Group Assignment||Treatment||None (Open Label)||||||
1376150|NCT02603913|||Cohort||Prospective|||||||
1376151|NCT02603900|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1376152|NCT02603887||Single Group Assignment||Treatment||None (Open Label)||||||
1376153|NCT02603874|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376154|NCT02603861|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1376155|NCT02603848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376156|NCT02603835||Single Group Assignment||Treatment||None (Open Label)||||||
1376157|NCT02603822||Single Group Assignment||Basic Science||None (Open Label)|Open Label|||||
1376158|NCT02603809|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376159|NCT02603796|||Cohort||Prospective|||||||
1376160|NCT02603783|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1376161|NCT02603770|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376162|NCT02603757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376163|NCT02603744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376164|NCT02603731|||Cohort||Retrospective|||||||
1376165|NCT02603718|Randomized|Parallel Assignment||Treatment||Single||||||t
1376166|NCT02603705||Single Group Assignment||Treatment||None (Open Label)||||||
1376167|NCT02603692|||Cohort||Prospective|||||||
1376168|NCT02603679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376169|NCT02603666||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376170|NCT02603653|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1376171|NCT02603640||Single Group Assignment||Prevention||None (Open Label)||||||
1376172|NCT02603627|||Ecologic or Community||Cross-Sectional|||||||
1376173|NCT02603614|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1376174|NCT02603601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376175|NCT02603588|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376176|NCT02603575|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376177|NCT02603562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376178|NCT02603549|||Cohort||Prospective|||||||
1376179|NCT02603536||Single Group Assignment||Health Services Research||None (Open Label)||Repeated measures study. All participants acted as their own controls with data from year prior to intervention serving as control data and data from intervention year as intervention data.||||
1376180|NCT02603523|Randomized|Parallel Assignment||Treatment||Single||||||t
1376181|NCT02603510|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376182|NCT02603497|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376183|NCT02603471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376184|NCT02603458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376185|NCT02603445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376186|NCT02603432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376187|NCT02603419|Randomized|||Treatment||None (Open Label)||||||
1376188|NCT02603406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376189|NCT02603393|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376190|NCT02603380|||||Cross-Sectional|||||||
1376191|NCT02603367||Single Group Assignment||Supportive Care||None (Open Label)||||||
1376192|NCT02603354|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376193|NCT02603341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376194|NCT02603328|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376195|NCT02603315|||Cohort||Retrospective|||||||
1376196|NCT02603302||Single Group Assignment||Treatment||None (Open Label)||||||
1376197|NCT02603289|||Cohort||Prospective|||||||
1376198|NCT02603276|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376199|NCT02603263||||||||||||
1376200|NCT02603250|||Case-Only||Cross-Sectional|||||||
1376201|NCT02603237|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1376202|NCT02603224|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1376203|NCT02603211|||Case-Only||Retrospective|||||||
1376204|NCT02603198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376205|NCT02603185|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376206|NCT02603172|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376207|NCT02603159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376208|NCT02603146|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1376209|NCT02603133|Randomized|Sequential Assignment||Treatment||None (Open Label)||Participants are individually randomized to one of two cohorts. 1 cohort will serve as the waitlist control for Cohort 1 before starting their version of the intervention. Each cohort will experience slightly different versions of WISER, which only differ by the spacing of the intervention. Cohort 1 will receive a 10-day sequential (Seq) and a 10-day non-sequential (NSeq) rollout of the resilience tools. Seq will receive the tools on ten consecutive days. NSeq will receive messages daily with the exception of Thursdays, Fridays and Saturdays. Our tracking of attrition in the first study showed marked declines in participation on Thursdays, Fridays, and to some extent on Saturdays, but an increase on Sundays, hence this design to test a new way of counteracting attrition.||||
1376210|NCT02603120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376211|NCT02603107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376212|NCT02603094|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1376213|NCT02603081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376214|NCT02603068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376215|NCT02603055|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1376216|NCT02603042|||Cohort||Prospective|||||||
1376217|NCT02603029|Randomized|Parallel Assignment||||Single|||t|||
1376218|NCT02603016|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1376219|NCT02603003|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376220|NCT02602990|||Cohort||Prospective|||||||
1376221|NCT02602977|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376222|NCT02602964|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1376223|NCT02602951|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1376224|NCT02602938||Single Group Assignment||Basic Science||None (Open Label)||||||
1376225|NCT02602925|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized, controlled non-inferiority study||||
1376226|NCT02602912||Single Group Assignment||Other||None (Open Label)||||||
1376227|NCT02602899||Single Group Assignment||Treatment||None (Open Label)||||||
1376228|NCT02602886||Single Group Assignment||Treatment||None (Open Label)||||||
1376229|NCT02602873||||||||||||
1376230|NCT02602860|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1376231|NCT02602847|||||Prospective|||||||
1376232|NCT02602834|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1376233|NCT02602808|||Case Control||Prospective|||||||
1376234|NCT02602795|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376235|NCT02602782|||Case-Only||Prospective|||||||
1376236|NCT02602769|||Case-Control||Prospective|||||||
1376237|NCT02602756|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376238|NCT02602743|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376239|NCT02602730|Randomized|Parallel Assignment||||None (Open Label)||||||
1376240|NCT02602717||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376241|NCT02602704|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376242|NCT02602691|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1376397|NCT02600650|Randomized|Parallel Assignment||||Double|||t||t|
1376243|NCT02602678|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376244|NCT02602665|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376245|NCT02602652||Single Group Assignment||Prevention||None (Open Label)||||||
1376246|NCT02602639||Single Group Assignment||Prevention||None (Open Label)||||||
1376247|NCT02602626|||Ecologic or Community||Prospective|||||||
1376248|NCT02602613||Single Group Assignment||Treatment||None (Open Label)||||||
1376249|NCT02602600||Single Group Assignment||Treatment||None (Open Label)||||||
1376250|NCT02602587||Single Group Assignment||Basic Science||None (Open Label)||||||
1376251|NCT02602574|||Case-Control||Prospective|||||||
1376252|NCT02602561|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1376253|NCT02602548|||Cohort||Prospective|||||||
1376254|NCT02602535|Randomized|Parallel Assignment||Treatment||Single||||||t
1376255|NCT02602522|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1376256|NCT02602509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376257|NCT02602496|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376258|NCT02602483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376259|NCT02602470|||Cohort||Cross-Sectional|||||||
1376260|NCT02602457|Randomized|Parallel Assignment||Other||Double|||||t|t
1376261|NCT02602444|||Cohort||Prospective|||||||
1376262|NCT02602431|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376263|NCT02602418|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376264|NCT02602405|||Cohort||Retrospective|||||||
1376265|NCT02602392|Randomized|Parallel Assignment||||None (Open Label)||||||
1376266|NCT02602379|||Cohort||Prospective|||||||
1376267|NCT02602366|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1376268|NCT02602353|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376269|NCT02602340||Single Group Assignment||Basic Science||None (Open Label)||||||
1376270|NCT02602327||Single Group Assignment||Treatment||None (Open Label)||||||
1376271|NCT02602314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376272|NCT02602301|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1376273|NCT02602288|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1376274|NCT02602275|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1376275|NCT02602262|||Cohort||Prospective|||||||
1376276|NCT02602249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376277|NCT02602236||Single Group Assignment||Supportive Care||None (Open Label)||||||
1376278|NCT02602223|Randomized|Parallel Assignment||Treatment||Single||||||t
1376279|NCT02602210|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1376280|NCT02602197|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376281|NCT02602184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376282|NCT02602171|Randomized|Parallel Assignment||Other||Single|||t|||
1376283|NCT02602158|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1376284|NCT02602145|||Other||Prospective|||||||
1376285|NCT02602132|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1376286|NCT02602119||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376287|NCT02602106|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376288|NCT02602093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376289|NCT02602080|||Cohort||Prospective|||||||
1376290|NCT02602067||Single Group Assignment||Treatment||None (Open Label)||Tenatumomab infusion||||
1376291|NCT02602054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376292|NCT02602041|||Cohort||Prospective|||||||
1376293|NCT02602028|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376294|NCT02602002|Randomized|Crossover Assignment||||Double|||t|t||
1376295|NCT02601989|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1376296|NCT02601976||Single Group Assignment||Treatment||None (Open Label)||||||
1376297|NCT02601963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376298|NCT02601950||Single Group Assignment||Treatment||None (Open Label)||||||
1376299|NCT02601937||Single Group Assignment||Treatment||None (Open Label)||||||
1376300|NCT02601924|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1376301|NCT02601911|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376302|NCT02601898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376303|NCT02601885|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376304|NCT02601859||Single Group Assignment||Other||None (Open Label)||||||
1376305|NCT02601846|||Cohort||Prospective|||||||
1376306|NCT02601833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376307|NCT02601820|||Cohort||Prospective|||||||
1376308|NCT02601807|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1376309|NCT02601794|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376310|NCT02601781||Single Group Assignment||Treatment||None (Open Label)||||||
1376311|NCT02601768|||Cohort||Retrospective|||||||
1376312|NCT02601755|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376313|NCT02601742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376314|NCT02601729|||Cohort||Other|||||||
1376315|NCT02601716|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376316|NCT02601703|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376317|NCT02601690|||Ecologic or Community||Prospective|||||||
1376318|NCT02601677|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1376319|NCT02601664|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376320|NCT02601651|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376321|NCT02601638||Single Group Assignment||Supportive Care||None (Open Label)||||||
1376322|NCT02601625|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1376323|NCT02601612|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1376324|NCT02601599|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376325|NCT02601586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376326|NCT02601573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376327|NCT02601560|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1376328|NCT02601547||Single Group Assignment||||None (Open Label)||||||
1376329|NCT02601534|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376330|NCT02601521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376331|NCT02601508|Randomized|Parallel Assignment||Treatment||Single||||||t
1376332|NCT02601495|||Case-Only||Prospective|||||||
1376333|NCT02601482|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376334|NCT02601469||Single Group Assignment||Treatment||None (Open Label)||||||
1376335|NCT02601456|||Case-Only||Cross-Sectional|||||||
1376336|NCT02601443|Randomized|Parallel Assignment||Prevention||Single||||||t
1376337|NCT02601430||Single Group Assignment||Other||None (Open Label)||||||
1376338|NCT02601417|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376339|NCT02601404|||Other||Prospective|||||||
1376340|NCT02601391||Single Group Assignment||Treatment||None (Open Label)||||||
1376341|NCT02601378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376342|NCT02601365|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376343|NCT02601352|||Cohort||Prospective|||||||
1376344|NCT02601339|||Cohort||Prospective|||||||
1376345|NCT02601326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376346|NCT02601313||Single Group Assignment||Treatment||None (Open Label)||||||
1376347|NCT02601300||Single Group Assignment||Treatment||None (Open Label)||||||
1376348|NCT02601287|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376349|NCT02601274||Single Group Assignment||Treatment||None (Open Label)||||||
1376350|NCT02601261|||Case Control||Cross-Sectional|||||||
1376351|NCT02601248||Single Group Assignment||Treatment||None (Open Label)||||||
1376352|NCT02601235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376353|NCT02601222|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376354|NCT02601209|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376355|NCT02601196||Single Group Assignment||Treatment||None (Open Label)||||||
1376356|NCT02601183|||Case Control||Prospective|||||||
1376357|NCT02601170|Randomized|Parallel Assignment||Treatment||Single||||||t
1376358|NCT02601157|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1376359|NCT02601144|Non-Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1376360|NCT02601131|||Cohort||Prospective|||||||
1376361|NCT02601118|Randomized|Single Group Assignment||||Double|||t|||t
1376362|NCT02601105|Randomized|Parallel Assignment||||Triple|||t||t|t
1376363|NCT02601092|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376364|NCT02601079|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1376365|NCT02601066||Single Group Assignment||Prevention||None (Open Label)||||||
1376366|NCT02601053|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1376367|NCT02601040|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1376368|NCT02601027|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1376369|NCT02601014||Single Group Assignment||Treatment||None (Open Label)||||||
1376370|NCT02601001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376371|NCT02600988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376372|NCT02600975|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376373|NCT02600962|||Cohort||Prospective|||||||
1376374|NCT02600949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376375|NCT02600936|||Case-Only||Other|||||||
1376376|NCT02600923||Parallel Assignment||Treatment||None (Open Label)||||||
1376377|NCT02600910|||Cohort||Prospective|||||||
1376378|NCT02600897|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376379|NCT02600884|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376380|NCT02600871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376381|NCT02600858|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1376382|NCT02600845||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376383|NCT02600832|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376384|NCT02600819||Single Group Assignment||Treatment||None (Open Label)||||||
1376385|NCT02600806||Single Group Assignment||Treatment||None (Open Label)||||||
1376386|NCT02600793||Single Group Assignment||Treatment||None (Open Label)||||||
1376387|NCT02600780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376388|NCT02600767||Single Group Assignment||Treatment||None (Open Label)||Evaluation of the efficacy of artemether and lumefantrine for uncomplicated P. falciparum malaria.||||
1376389|NCT02600754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376390|NCT02600741|||Cohort||Prospective|||||||
1376391|NCT02600728|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376392|NCT02600715|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1376393|NCT02600702|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376394|NCT02600689|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1376395|NCT02600676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376396|NCT02600663|||Cohort||Prospective|||||||
1376398|NCT02600637|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376399|NCT02600624|||Case-Only||Cross-Sectional|||||||
1376400|NCT02600611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376401|NCT02600598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376402|NCT02600585|||Cohort||Retrospective|||||||
1376403|NCT02600572|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1376404|NCT02600559||Single Group Assignment||Treatment||None (Open Label)||||||
1376405|NCT02600546|||Case Control||Prospective|||||||
1376406|NCT02600533|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1376407|NCT02600520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376408|NCT02600507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376409|NCT02600494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376410|NCT02600481|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376411|NCT02600468|||Cohort||Prospective|||||||
1376412|NCT02600455|||Cohort||Prospective|||||||
1376413|NCT02600442|||Cohort|||||||||
1376414|NCT02600429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376415|NCT02600416||Single Group Assignment||Treatment||None (Open Label)||||||
1376416|NCT02600403|||Cohort||Prospective|||||||
1376417|NCT02600390|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376418|NCT02600377|||||Prospective|||||||
1376419|NCT02600364|||Cohort||Prospective|||||||
1376420|NCT02600351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376421|NCT02600338||||||||||||
1376422|NCT02600325||Single Group Assignment||Treatment||None (Open Label)||||||
1376423|NCT02600312|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1376424|NCT02600299|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1376425|NCT02600286|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1376426|NCT02600273|Randomized|Crossover Assignment||Other||Single|||t|||
1376427|NCT02600260|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376428|NCT02600247|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376429|NCT02600234|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1376430|NCT02600221|||Cohort||Cross-Sectional|||||||
1376431|NCT02600208||Single Group Assignment||Treatment||None (Open Label)||||||
1376432|NCT02600195|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1376433|NCT02600182|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376434|NCT02600169|||Cohort||Retrospective|||||||
1376435|NCT02600156||Single Group Assignment||Treatment||None (Open Label)||||||
1376436|NCT02600143|||Cohort||Prospective|||||||
1376437|NCT02600130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376438|NCT02600117||Single Group Assignment||Treatment||None (Open Label)||||||
1376439|NCT02600104||Single Group Assignment||Treatment||None (Open Label)||||||
1376440|NCT02600091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376441|NCT02600078|Randomized|Crossover Assignment||||Single|||t|||
1376442|NCT02600065|||Case-Only||Prospective|||||||
1376443|NCT02600052|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1376444|NCT02600039|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1376445|NCT02600026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376446|NCT02600013|||Cohort||Other|||||||
1376447|NCT02600000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376448|NCT02599987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376449|NCT02599974|||Cohort||Prospective|||||||
1376450|NCT02599961||Single Group Assignment||Treatment||None (Open Label)||||||
1376451|NCT02599948|||||Prospective|||||||
1376452|NCT02599935|Randomized|Parallel Assignment||Treatment||Single||||||t
1376453|NCT02599922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376454|NCT02599909|||Cohort||Prospective|||||||
1376455|NCT02599896|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376456|NCT02599883||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376457|NCT02599870|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1376458|NCT02599857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376459|NCT02599844|||Case-Control||Cross-Sectional|||||||
1376460|NCT02599831|Randomized|Parallel Assignment||Treatment||Single||||||t
1376461|NCT02599818|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1376462|NCT02599805|Randomized|Parallel Assignment||Treatment||Single||||||t
1376463|NCT02599792|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1376464|NCT02599779|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376465|NCT02599766|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376466|NCT02599753||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376467|NCT02599740|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1376468|NCT02599727|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1376469|NCT02599714|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376470|NCT02599701|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1376471|NCT02599688|||Cohort||Prospective|||||||
1376472|NCT02599675|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376473|NCT02599662|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376474|NCT02599649|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376475|NCT02599636|||Cohort||Prospective|||||||
1376476|NCT02599623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376477|NCT02599610|Randomized|Parallel Assignment||||Single||||||t
1376478|NCT02599597|Randomized|Parallel Assignment||Prevention||Single||||||t
1376479|NCT02599584|Randomized|Parallel Assignment||||Double|||||t|t
1376480|NCT02599571|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1376481|NCT02599558||Single Group Assignment||Supportive Care||None (Open Label)||||||
1376482|NCT02599545|||Case-Only||Prospective|||||||
1376483|NCT02599532|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1376484|NCT02599519||||||||||||
1376485|NCT02599506|||Cohort||Prospective|||||||
1376486|NCT02599493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376487|NCT02599480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376488|NCT02599467|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1376489|NCT02599454||Single Group Assignment||Treatment||None (Open Label)||||||
1376490|NCT02599441|||Case-Only||Cross-Sectional|||||||
1376491|NCT02599428|||Cohort||Prospective|||||||
1376492|NCT02599415||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376493|NCT02599402|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376494|NCT02599389|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1376495|NCT02599376|Non-Randomized|Parallel Assignment||Basic Science||Single||||t||
1376496|NCT02599363||Single Group Assignment||Treatment||||||||
1376497|NCT02599350|||Cohort||Prospective|||||||
1376498|NCT02599337|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1376499|NCT02599324|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376500|NCT02599311|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376501|NCT02599298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376502|NCT02599285|||Cohort||Prospective|||||||
1376503|NCT02599272|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1376504|NCT02599259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376505|NCT02599246|||Cohort||Prospective|||||||
1376506|NCT02599233|||Cohort||Prospective|||||||
1376507|NCT02599220|||Cohort||Prospective|||||||
1376508|NCT02599207|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376509|NCT02599194||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376510|NCT02599181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376511|NCT02599168|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1376512|NCT02599155|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1376513|NCT02599142|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single centre parallel group randomised controlled trial investigating the impact of using open-face thermoplastic immobilisation shells upon setup reproducibility in patients having cranial radiotherapy.||||
1376514|NCT02599129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376515|NCT02599116||Single Group Assignment||Other||None (Open Label)||||||
1376516|NCT02599103|Non-Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1376517|NCT02599090|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376518|NCT02599077|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376519|NCT02599064||Single Group Assignment||Treatment||None (Open Label)||||||
1376520|NCT02599051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376521|NCT02599038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376522|NCT02599025|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1376523|NCT02599012||Single Group Assignment||Treatment||None (Open Label)||||||
1376524|NCT02598999|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376525|NCT02598986|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1376526|NCT02598973|Randomized|Parallel Assignment||Treatment||Single||||||t
1376527|NCT02598960|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376528|NCT02598947|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376529|NCT02598934|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376530|NCT02598921|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1376531|NCT02598908|||Cohort||Other|||||||
1376532|NCT02598895||Single Group Assignment||Treatment||None (Open Label)||||||
1376533|NCT02598882|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376534|NCT02598869|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376535|NCT02598856|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1376536|NCT02598843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376537|NCT02598830|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376538|NCT02598817|||Cohort||Prospective|||||||
1376539|NCT02598804|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1376540|NCT02598791|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1376541|NCT02598778|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376542|NCT02598765|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376543|NCT02598752|||Cohort||Prospective|||||||
1376544|NCT02598739|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1376545|NCT02598726||Single Group Assignment||Supportive Care||None (Open Label)||||||
1376546|NCT02598713||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376547|NCT02598700|||Case-Only||Cross-Sectional|||||||
1376548|NCT02598687||Single Group Assignment||Treatment||None (Open Label)||||||
1376549|NCT02598674|||Case-Control||Cross-Sectional|||||||
1376550|NCT02598661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376551|NCT02598648|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1376552|NCT02598635|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377081|NCT02591758|||Cohort||Prospective|||||||
1376553|NCT02598622|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376554|NCT02598609|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1376555|NCT02598596|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1376556|NCT02598583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376557|NCT02598570||Single Group Assignment||Treatment||None (Open Label)||||||
1376558|NCT02598557|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1376559|NCT02598544|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1376560|NCT02598531|||Case-Control||Prospective|||||||
1376561|NCT02598518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376562|NCT02598505|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1376563|NCT02598492|||Cohort||Prospective|||||||
1376564|NCT02598479|||Case-Only||Prospective|||||||
1376565|NCT02598466|||Cohort||Retrospective|||||||
1376566|NCT02598453|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376567|NCT02598440|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376568|NCT02598427||Single Group Assignment||Treatment||None (Open Label)||||||
1376569|NCT02598414|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376570|NCT02598401|||Cohort||Prospective|||||||
1376571|NCT02598388|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1376572|NCT02598375|||Case Control||Prospective|||||||
1376573|NCT02598362|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376574|NCT02598349||Single Group Assignment||Treatment||None (Open Label)||||||
1376575|NCT02598336|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376576|NCT02598323||Single Group Assignment||Prevention||None (Open Label)||||||
1376577|NCT02598310||Single Group Assignment||Treatment||None (Open Label)||||||
1376578|NCT02598297|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1376579|NCT02598284|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1376580|NCT02598271|||Other||Prospective|||||||
1376581|NCT02598258||Single Group Assignment||Prevention||None (Open Label)||||||
1376582|NCT02598245|Randomized|Parallel Assignment||||None (Open Label)||||||
1376583|NCT02598232||Single Group Assignment||Treatment||None (Open Label)||||||
1376584|NCT02598219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376585|NCT02598206|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1376586|NCT02598193||Single Group Assignment||Treatment||None (Open Label)||||||
1376587|NCT02598180||Single Group Assignment||Treatment||None (Open Label)||||||
1376588|NCT02598167|||Case-Only||Cross-Sectional|||||||
1376589|NCT02598154|||Cohort||Prospective|||||||
1376590|NCT02598141||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376591|NCT02598128|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1376592|NCT02598115|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1376593|NCT02598102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376594|NCT02598089|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1376595|NCT02598076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376596|NCT02598063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376597|NCT02598050|||||Prospective|||||||
1376598|NCT02598037||Single Group Assignment||Health Services Research||None (Open Label)||||||
1376599|NCT02598024|Randomized|Parallel Assignment||Treatment||Single||||||t
1376600|NCT02598011|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376601|NCT02597998||Single Group Assignment||Treatment||None (Open Label)||||||
1376602|NCT02597985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376603|NCT02597972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376604|NCT02597959|||Cohort||Prospective|||||||
1376605|NCT02597946||Single Group Assignment||Treatment||None (Open Label)||||||
1376606|NCT02597933|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376607|NCT02597920|||Cohort||Prospective|||||||
1376608|NCT02597907|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1376609|NCT02597894||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376610|NCT02597881|||Cohort||Other|||||||
1376611|NCT02597868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376612|NCT02597855|||Cohort||Prospective|||||||
1376613|NCT02597842|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1376614|NCT02597829||Single Group Assignment||Treatment||None (Open Label)||||||
1376615|NCT02597816||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376616|NCT02597803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376617|NCT02597790|||Cohort||Prospective|||||||
1376618|NCT02597777|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1376619|NCT02597764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376620|NCT02597751|Randomized|Crossover Assignment||Treatment||Single||||||t
1376621|NCT02597738|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376622|NCT02597725|||Cohort||Prospective|||||||
1376623|NCT02597712|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376624|NCT02597699|Randomized|Parallel Assignment||||Single|||t|||
1376625|NCT02597686||Single Group Assignment||Treatment||None (Open Label)||||||
1376626|NCT02597673|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1376627|NCT02597660|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1376628|NCT02597647|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376629|NCT02597634|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1376630|NCT02597621|||Cohort||Prospective|||||||
1376631|NCT02597608|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1376632|NCT02597595|Randomized|Parallel Assignment||Prevention||Single||||t||
1376633|NCT02597582|Randomized|Parallel Assignment||||Single|||t|||
1376634|NCT02597569|||Cohort||Prospective|||||||
1376635|NCT02597556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376636|NCT02597543|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1376637|NCT02597530|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1376638|NCT02597517|||Case Control||Cross-Sectional|||||||
1376639|NCT02597504|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1376640|NCT02597491|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1376641|NCT02597478|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376642|NCT02597465|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376643|NCT02597452||Single Group Assignment||Screening||None (Open Label)||||||
1376644|NCT02597439|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1376645|NCT02597426|||Cohort||Cross-Sectional|||||||
1376646|NCT02597413|||Case Control||Prospective|||||||
1376647|NCT02597400||Single Group Assignment||Treatment||None (Open Label)||||||
1376648|NCT02597387||Single Group Assignment||Treatment||None (Open Label)||||||
1376649|NCT02597374||Single Group Assignment||Basic Science||None (Open Label)||||||
1376650|NCT02597361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376651|NCT02597348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376652|NCT02597335||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376653|NCT02597322||Single Group Assignment||Treatment||None (Open Label)||||||
1376654|NCT02597309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376655|NCT02597296||||||||||||
1376656|NCT02597283|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376657|NCT02597270|||Cohort||Retrospective|||||||
1376658|NCT02597257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376659|NCT02597244||Single Group Assignment||Treatment||None (Open Label)||||||
1376660|NCT02597231|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1376661|NCT02597218|||Cohort||Retrospective|||||||
1376662|NCT02597205||Single Group Assignment||Prevention||None (Open Label)||||||
1376663|NCT02597192|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376664|NCT02597179|||Cohort||Prospective|||||||
1376665|NCT02597166||Single Group Assignment||Treatment||None (Open Label)||||||
1376666|NCT02597153||Single Group Assignment||Treatment||None (Open Label)||||||
1376667|NCT02597140|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1376668|NCT02597127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376669|NCT02597114||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1376670|NCT02597101|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1376671|NCT02597088||||||||||||
1376672|NCT02597075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376673|NCT02597062||Single Group Assignment||Treatment||None (Open Label)||||||
1376674|NCT02597049|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376675|NCT02597036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376676|NCT02597023|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1376677|NCT02597010|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1376678|NCT02596997||||||||||||
1376679|NCT02596984||Single Group Assignment||Treatment||None (Open Label)||||||
1376680|NCT02596971|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376681|NCT02596958|||Case Control||Cross-Sectional|||||||
1376682|NCT02596945|||Cohort||Prospective|||||||
1376683|NCT02596932|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1376684|NCT02596919||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376685|NCT02596906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376686|NCT02596893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376687|NCT02596880||Single Group Assignment||Treatment||None (Open Label)||||||
1376688|NCT02596867||Single Group Assignment||Treatment||None (Open Label)||||||
1376689|NCT02596854||Single Group Assignment||Diagnostic||None (Open Label)|None used for this single group study.|A single group will be enrolled from the general imaging population using the scanner available at the investigational site (either 1.5T or 3.0T, based on site determination and not specified per protocol). All participants are assigned to a single group.||||
1376690|NCT02596841|||Case-Only||Retrospective|||||||
1376691|NCT02596828||Single Group Assignment||Treatment||None (Open Label)||||||
1376692|NCT02596815|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376693|NCT02596802||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1376694|NCT02596789||Single Group Assignment||Basic Science||None (Open Label)||||||
1376695|NCT02596776|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376696|NCT02596763||Single Group Assignment||Other||None (Open Label)||||||
1376697|NCT02596750|Randomized|Parallel Assignment||Prevention||Single||Each subject will serve as his or her own control. The right forearm and the left forearm will be randomized through a binary randomization to determine whether the right arm will receive microneedle treatment or sham microneedle treatment (roller with no microneedles). This randomization is developed through code in Excel that will result in binary result of either the value 0 or 1 for each subject. For those subjects assigned a binary code of 0, the right forearm will receive microneedle treatment and the left forearm will receive sham microneedle treatment. For those subjects assigned a binary code of 1, the left forearm will receive microneedle treatment and the right forearm will receive sham microneedle treatment.|t|||
1376698|NCT02596737||Single Group Assignment||||None (Open Label)||||||
1376699|NCT02596724|||Cohort||Prospective|||||||
1377082|NCT02591745|||Case-Only||Prospective|||||||
1376700|NCT02596711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376701|NCT02596698|||Case-Control||Prospective|||||||
1376702|NCT02596685|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376703|NCT02596672|Randomized|Parallel Assignment||Prevention||Single|||||t|
1376704|NCT02596659|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376705|NCT02596646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376706|NCT02596633|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376707|NCT02596620|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376708|NCT02596607|||Cohort||Prospective|||||||
1376709|NCT02596594|Non-Randomized|Parallel Assignment||Supportive Care||Single||Intraumbilical amino acid and glucose suplementation of human fetuses with a severe IUGR via a subcutaneously implanted port system|t|||
1376710|NCT02596581|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1376711|NCT02596568|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1376712|NCT02596555||Single Group Assignment||Treatment||None (Open Label)||||||
1376713|NCT02596542||Single Group Assignment||Treatment||None (Open Label)||||||
1376714|NCT02596529|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376715|NCT02596516|||Cohort||Prospective|||||||
1376716|NCT02596503||Single Group Assignment||Treatment||None (Open Label)||||||
1376717|NCT02596490|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376718|NCT02596477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376719|NCT02596464||||||||||||
1376720|NCT02596451|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376721|NCT02596438|||Ecologic or Community||Prospective|||||||
1376722|NCT02596425|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1376723|NCT02596412|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376724|NCT02596399|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376725|NCT02596386|||Case Control||Prospective|||||||
1376726|NCT02596373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376727|NCT02596360|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1376728|NCT02596347|||Case-Only||Cross-Sectional|||||||
1376729|NCT02596334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376730|NCT02596321|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1376731|NCT02596308|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1376732|NCT02596295|||Ecologic or Community||Prospective|||||||
1376733|NCT02596282|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1376734|NCT02596269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376735|NCT02596256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376736|NCT02596243|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376737|NCT02596230|||Cohort||Prospective|||||||
1376738|NCT02596217|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376739|NCT02596204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376740|NCT02596191|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1376741|NCT02596178||Single Group Assignment||Treatment||None (Open Label)||||||
1376742|NCT02596165||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376743|NCT02596152|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1376744|NCT02596139||||||||||||
1376745|NCT02596126|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376746|NCT02596113|||Case Control||Prospective|||||||
1376747|NCT02596100|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1376748|NCT02596087|Randomized|Parallel Assignment||||Single|||t|||
1376749|NCT02596074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376750|NCT02596061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376751|NCT02596048||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376752|NCT02596035||Single Group Assignment||Other||None (Open Label)||||||
1376753|NCT02596022|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1376754|NCT02596009|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376755|NCT02595996||Single Group Assignment||Treatment||None (Open Label)||||||
1376756|NCT02595983||Single Group Assignment||Treatment||None (Open Label)||||||
1376757|NCT02595970||Single Group Assignment||Treatment||None (Open Label)||||||
1376758|NCT02595957|||Cohort||Cross-Sectional|||||||
1376759|NCT02595944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376760|NCT02595931||Single Group Assignment||Treatment||None (Open Label)||||||
1376761|NCT02595918||Single Group Assignment||Treatment||None (Open Label)||||||
1376762|NCT02595905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376763|NCT02595892|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376764|NCT02595879||Single Group Assignment||Treatment||None (Open Label)||||||
1376765|NCT02595866||Single Group Assignment||Treatment||None (Open Label)||||||
1376766|NCT02595853|||Cohort||Prospective|||||||
1376767|NCT02595840||||||||||||
1376768|NCT02595827|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1376769|NCT02595814|||Other||Prospective|||||||
1376770|NCT02595801|||Cohort||Retrospective|||||||
1376771|NCT02595788|||Cohort||Prospective|||||||
1376772|NCT02595775|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1376773|NCT02595762|||Cohort||Prospective|||||||
1376774|NCT02595749|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1376775|NCT02595736|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1376776|NCT02595723|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1376777|NCT02595710|||Case-Only||Prospective|||||||
1376778|NCT02595697|Randomized|Single Group Assignment||Treatment||Single||||||t
1376779|NCT02595684|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376780|NCT02595671|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1376781|NCT02595658|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376782|NCT02595645||Single Group Assignment||Screening||None (Open Label)||||||
1376783|NCT02595632|||Case-Only||Prospective|||||||
1376784|NCT02595619||Single Group Assignment||Treatment||None (Open Label)||||||
1376785|NCT02595606|Randomized|Parallel Assignment||Treatment||Single||||||t
1376786|NCT02595593|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1376787|NCT02595580||Single Group Assignment||Treatment||None (Open Label)||||||
1376788|NCT02595567||Single Group Assignment||Treatment||None (Open Label)||||||
1376789|NCT02595554|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376790|NCT02595541|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376791|NCT02595528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376792|NCT02595515|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376793|NCT02595502|Randomized|Crossover Assignment||Treatment||Single|||t|||
1376794|NCT02595489||Single Group Assignment||Prevention||None (Open Label)||single-arm dose escalation||||
1376795|NCT02595476|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1376796|NCT02595463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376797|NCT02595450|||Cohort||Cross-Sectional|||||||
1376798|NCT02595437||Single Group Assignment||Treatment||None (Open Label)||||||
1376799|NCT02595424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376800|NCT02595411|||Other||Cross-Sectional|||||||
1376801|NCT02595398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376802|NCT02595385|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1376803|NCT02595372||Single Group Assignment||Treatment||None (Open Label)||||||
1376804|NCT02595359||Single Group Assignment||Prevention||None (Open Label)||||||
1376805|NCT02595346|Randomized|Parallel Assignment||Treatment||Single||||||t
1376806|NCT02595333|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376807|NCT02595320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376808|NCT02595307|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1376809|NCT02595294|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1376810|NCT02595281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376811|NCT02595268||Single Group Assignment||||None (Open Label)||||||
1376812|NCT02595255|||Case-Control||Prospective|||||||
1376813|NCT02595242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376814|NCT02595229|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376815|NCT02595216||Single Group Assignment||Treatment||None (Open Label)||||||
1376816|NCT02595203|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376817|NCT02595190|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376818|NCT02595177|Randomized|Parallel Assignment||Treatment||Single||||||t
1376819|NCT02595164|||Ecologic or Community||Retrospective|||||||
1376820|NCT02595151|||Case Control||Prospective|||||||
1376821|NCT02595138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376822|NCT02595125|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376823|NCT02595112||Single Group Assignment||Screening||None (Open Label)||||||
1376824|NCT02595099||Single Group Assignment||Treatment||None (Open Label)||||||
1376825|NCT02595086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376826|NCT02595073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376827|NCT02595060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376828|NCT02595047||Single Group Assignment||Treatment||None (Open Label)||||||
1376829|NCT02595034|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376830|NCT02595021|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376831|NCT02595008||Single Group Assignment||Treatment||None (Open Label)||||||
1376832|NCT02594995|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376833|NCT02594982||Single Group Assignment||Prevention||None (Open Label)||||||
1376834|NCT02594969|Randomized|Factorial Assignment||Treatment||Single|||t|||
1376835|NCT02594956|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376836|NCT02594943|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1376837|NCT02594930||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376838|NCT02594917|||Cohort||Prospective|||||||
1376839|NCT02594904|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376840|NCT02594891|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376841|NCT02594878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376842|NCT02594865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376843|NCT02594852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376844|NCT02594839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376845|NCT02594826|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1376846|NCT02594813|||Cohort||Prospective|||||||
1376847|NCT02594800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376848|NCT02594787|Randomized|Crossover Assignment||||Triple|||t||t|t
1376849|NCT02594774|Randomized|Parallel Assignment||Treatment||Single||||||t
1376850|NCT02594761|Randomized|Parallel Assignment||||Double|||t||t|
1376851|NCT02594748|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1376852|NCT02594735||Single Group Assignment||Treatment||None (Open Label)||||||
1377238|NCT02589717||||||||||||
1376853|NCT02594722||Single Group Assignment||Supportive Care||None (Open Label)||||||
1376854|NCT02594709||Single Group Assignment||Treatment||None (Open Label)||||||
1376855|NCT02594696||Single Group Assignment||Health Services Research||None (Open Label)||||||
1376856|NCT02594683|||Cohort||Prospective|||||||
1376857|NCT02594670|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376858|NCT02594657|Randomized|Single Group Assignment||||None (Open Label)||||||
1376859|NCT02594644|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376860|NCT02594631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376861|NCT02594618||||||||||||
1376862|NCT02594605|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1376863|NCT02594592|||Case-Crossover||Cross-Sectional|||||||
1376864|NCT02594579|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376865|NCT02594566||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376866|NCT02594553|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376867|NCT02594540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376868|NCT02594527||Single Group Assignment||Health Services Research||None (Open Label)||||||
1376869|NCT02594514|||Cohort||Retrospective|||||||
1376870|NCT02594501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376871|NCT02594488|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1376872|NCT02594475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376873|NCT02594462||Single Group Assignment||Treatment||None (Open Label)||||||
1376874|NCT02594449|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1376875|NCT02594436|||Cohort||Prospective|||||||
1376876|NCT02594423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376877|NCT02594410||Single Group Assignment||Treatment||None (Open Label)||||||
1376878|NCT02594397|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376879|NCT02594384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376880|NCT02594371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376881|NCT02594358|Randomized|Single Group Assignment||Treatment||Single||||||t
1376882|NCT02594345||Single Group Assignment||Basic Science||None (Open Label)||||||
1376883|NCT02594332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376884|NCT02594319|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376885|NCT02594306|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1376886|NCT02594293|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376887|NCT02594280|||Cohort||Prospective|||||||
1376888|NCT02594267||Single Group Assignment||Treatment||None (Open Label)||||||
1376889|NCT02594254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376890|NCT02594241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376891|NCT02594228|Randomized|Parallel Assignment||||None (Open Label)||||||
1376892|NCT02594215||Single Group Assignment||Other||None (Open Label)||||||
1376893|NCT02594202|||Case-Only||Prospective|||||||
1376894|NCT02594189||Single Group Assignment||Basic Science||None (Open Label)||||||
1376895|NCT02594176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376896|NCT02594163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376897|NCT02594150|Randomized|Parallel Assignment||Screening||Single|||||t|
1376898|NCT02594137|Randomized|Parallel Assignment||Treatment||Single||||||t
1376899|NCT02594124|Non-Randomized|Parallel Assignment||Treatment||Triple|"During the blinded loading period, the following participants will be masked:~Key site personnel (Investigator, Study Coordinator, and Outcomes Assessors)~Participant~The sponsor~After the loading period has been completed. Subsequent doses will be unblinded."||t||t|t
1376900|NCT02594111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376901|NCT02594098|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376902|NCT02594085|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1376903|NCT02594072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376904|NCT02594059||Single Group Assignment||Basic Science||None (Open Label)||||||
1376905|NCT02594046|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1376906|NCT02594033|Randomized|Crossover Assignment||Other||Single|||t|||
1376907|NCT02594020|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1376908|NCT02594007|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376909|NCT02593994|||Cohort||Prospective|||||||
1376910|NCT02593981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376911|NCT02593968|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376912|NCT02593955|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1376913|NCT02593942|Randomized|Parallel Assignment||Prevention||Single||||||t
1376914|NCT02593929||Single Group Assignment||Treatment||None (Open Label)||||||
1376915|NCT02593916|||Cohort||Prospective|||||||
1376916|NCT02593903|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376917|NCT02593890|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1376918|NCT02593877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376919|NCT02593864||Single Group Assignment||Basic Science||None (Open Label)||||||
1376920|NCT02593851|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376921|NCT02593838||Single Group Assignment||Diagnostic||None (Open Label)||||||
1376922|NCT02593825|Randomized|Parallel Assignment||Treatment||Single||||||t
1376923|NCT02593812|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1376924|NCT02593799|||Cohort||Cross-Sectional|||||||
1376925|NCT02593786|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376926|NCT02593773||Single Group Assignment||Treatment||None (Open Label)||||||
1376927|NCT02593760|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376928|NCT02593747|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376929|NCT02593734|Randomized|Parallel Assignment||Treatment||Single|||||t|
1376930|NCT02593721|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1376931|NCT02593708|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376932|NCT02593695|Randomized|Parallel Assignment||Treatment||Single||||||t
1376933|NCT02593682|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1376934|NCT02593669|Randomized|Parallel Assignment||Treatment||Single||||||t
1376935|NCT02593656|Randomized|Parallel Assignment||||None (Open Label)||||||
1376936|NCT02593643|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376937|NCT02593630||Single Group Assignment||Prevention||None (Open Label)||||||
1376938|NCT02593617|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1376939|NCT02593604|||Cohort||Retrospective|||||||
1376940|NCT02593591|||Other||Prospective|||||||
1376941|NCT02593578|||Other||Prospective|||||||
1376942|NCT02593565|||Cohort||Prospective|||||||
1376943|NCT02593552||Single Group Assignment||Prevention||None (Open Label)||||||
1376944|NCT02593539||Single Group Assignment||Treatment||None (Open Label)||||||
1376945|NCT02593526|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1376946|NCT02593513|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376947|NCT02593500|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1376948|NCT02593487|Randomized|Parallel Assignment||Prevention||Single|||t|||
1376949|NCT02593474||Single Group Assignment||Treatment||None (Open Label)||||||
1376950|NCT02593461|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376951|NCT02593448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376952|NCT02593435|||Family-Based||Cross-Sectional|||||||
1376953|NCT02593422|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1376954|NCT02593409||Single Group Assignment||Prevention||None (Open Label)||||||
1376955|NCT02593396|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1376956|NCT02593383|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376957|NCT02593370|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1376958|NCT02593357||Single Group Assignment||Basic Science||None (Open Label)||||||
1376959|NCT02593344||Single Group Assignment||Basic Science||None (Open Label)||||||
1376960|NCT02593331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376961|NCT02593318|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376962|NCT02593305|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1376963|NCT02593292|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1376964|NCT02593279|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1376965|NCT02593266|Randomized|Parallel Assignment||Prevention||Single||||||t
1376966|NCT02593253|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1376967|NCT02593240|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1376968|NCT02593227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376969|NCT02593214||Single Group Assignment||Prevention||None (Open Label)||||||
1376970|NCT02593201|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1376971|NCT02593188|||Cohort||Prospective|||||||
1376972|NCT02593175||Single Group Assignment||Treatment||None (Open Label)||||||
1376973|NCT02593162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376974|NCT02593149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376975|NCT02593136|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1376976|NCT02593123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376977|NCT02593110|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1376978|NCT02593097|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1376979|NCT02593084|Randomized|Parallel Assignment||Prevention||Single||||||t
1376980|NCT02593071|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1376981|NCT02593058|Randomized|Parallel Assignment||Treatment||Single||||||t
1376982|NCT02593045||Single Group Assignment||Treatment||None (Open Label)||||||
1376983|NCT02593032|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1376984|NCT02593019||Single Group Assignment||Treatment||None (Open Label)||||||
1376985|NCT02593006|||Cohort||Prospective|||||||
1376986|NCT02592993||Single Group Assignment||Treatment||None (Open Label)||||||
1376987|NCT02592980|Randomized|Parallel Assignment||Treatment||Single|||t|||
1376988|NCT02592967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1376989|NCT02592954|Non-Randomized|Single Group Assignment||Other||Single|||t|||
1376990|NCT02592941||||||||||||
1376991|NCT02592928|||Case-Only||Prospective|||||||
1376992|NCT02592915|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1376993|NCT02592902|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376994|NCT02592889|Randomized|Parallel Assignment||Treatment||Single||mitraclip versus control||||t
1376995|NCT02592876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1376996|NCT02592863|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1376997|NCT02592850|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1376998|NCT02592837|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1376999|NCT02592824|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377000|NCT02592811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377001|NCT02592798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377002|NCT02592785||Single Group Assignment||Treatment||None (Open Label)||||||
1377003|NCT02592772|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1377004|NCT02592759|Randomized|Parallel Assignment||Treatment||Single||||||t
1377005|NCT02592746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377006|NCT02592733|||Cohort||Prospective|||||||
1377007|NCT02592720|Randomized|Parallel Assignment||Treatment||Single||||||t
1377008|NCT02592707||Single Group Assignment||Treatment||None (Open Label)||||||
1377009|NCT02592694|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1377010|NCT02592681|Randomized|Factorial Assignment||Prevention||Single||||||t
1377011|NCT02592668||Single Group Assignment||Treatment||None (Open Label)||||||
1377012|NCT02592655|Randomized|Crossover Assignment||Treatment||Single||||||t
1377013|NCT02592642|Randomized|Parallel Assignment||Treatment||Single||||||t
1377014|NCT02592629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377015|NCT02592616|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377016|NCT02592603|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377017|NCT02592590|Randomized|Factorial Assignment||Prevention||Single|||t|||
1377018|NCT02592577||Single Group Assignment||Treatment||None (Open Label)||||||
1377019|NCT02592564||Single Group Assignment||Treatment||None (Open Label)||||||
1377020|NCT02592551|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1377021|NCT02592538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377022|NCT02592525|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1377023|NCT02592512|||Other||Prospective|||||||
1377024|NCT02592499|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1377025|NCT02592486|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377026|NCT02592473||Single Group Assignment||Treatment||None (Open Label)||||||
1377027|NCT02592460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377028|NCT02592447|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377029|NCT02592434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377030|NCT02592421|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377031|NCT02592408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377032|NCT02592395||Single Group Assignment||Treatment||None (Open Label)||||||
1377033|NCT02592382|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1377034|NCT02592369|||Cohort||Prospective|||||||
1377035|NCT02592356||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377036|NCT02592343||Single Group Assignment||Treatment||None (Open Label)||||||
1377037|NCT02592330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377038|NCT02592317||Single Group Assignment||Treatment||None (Open Label)||||||
1377039|NCT02592304||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377040|NCT02592291|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1377041|NCT02592278|Randomized|Parallel Assignment||Prevention||Single|||||t|
1377042|NCT02592265|||Case-Only||Prospective|||||||
1377043|NCT02592252|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377044|NCT02592239|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377045|NCT02592226|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377046|NCT02592213||Single Group Assignment||Treatment||None (Open Label)||||||
1377047|NCT02592200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377048|NCT02592187|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377049|NCT02592174||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377050|NCT02592161|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377051|NCT02592148|||Cohort||Cross-Sectional|||||||
1377052|NCT02592135|||Cohort||Prospective|||||||
1377053|NCT02592122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377054|NCT02592109|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377055|NCT02592096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377056|NCT02592083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377057|NCT02592070||Single Group Assignment||Treatment||None (Open Label)||||||
1377058|NCT02592057|||Cohort||Prospective|||||||
1377059|NCT02592044|Randomized|Parallel Assignment||Treatment||Single||||||t
1377060|NCT02592031|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377061|NCT02592018||Single Group Assignment||Basic Science||None (Open Label)||||||
1377062|NCT02592005|||Cohort||Prospective|||||||
1377063|NCT02591992|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377064|NCT02591979|||Other||Prospective|||||||
1377065|NCT02591966|||Other||Prospective|||||||
1377066|NCT02591953|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377067|NCT02591940|||||Prospective|||||||
1377068|NCT02591927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377069|NCT02591914||Single Group Assignment||Treatment||None (Open Label)||||||
1377070|NCT02591901|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377071|NCT02591888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377072|NCT02591875|||Cohort||Prospective|||||||
1377073|NCT02591862||Single Group Assignment||Treatment||None (Open Label)||||||
1377074|NCT02591849|Randomized|Crossover Assignment||||None (Open Label)||||||
1377075|NCT02591836|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1377076|NCT02591823|||Case Control||Prospective|||||||
1377077|NCT02591810|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377078|NCT02591797|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377079|NCT02591784||Single Group Assignment||Treatment||None (Open Label)||||||
1377080|NCT02591771||Single Group Assignment||Treatment||None (Open Label)||||||
1377083|NCT02591732|||Ecologic or Community||Retrospective|||||||
1377084|NCT02591719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377085|NCT02591706|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377086|NCT02591693|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377087|NCT02591680|Randomized|Parallel Assignment||Treatment||Single||||||t
1377088|NCT02591667||Single Group Assignment||Treatment||None (Open Label)||||||
1377089|NCT02591654||Single Group Assignment||Treatment||None (Open Label)||||||
1377090|NCT02591641|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1377091|NCT02591628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377092|NCT02591615|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377093|NCT02591602|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1377094|NCT02591589|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377095|NCT02591576|||Cohort||Retrospective|||||||
1377096|NCT02591563|||Cohort||Prospective|||||||
1377097|NCT02591550|||Case Control|||||||||
1377098|NCT02591537|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377099|NCT02591524||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377100|NCT02591511|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1377101|NCT02591498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377102|NCT02591485|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1377103|NCT02591472|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377104|NCT02591459||Single Group Assignment||||None (Open Label)||||||
1377105|NCT02591446|||Other||Cross-Sectional|||||||
1377106|NCT02591433||Single Group Assignment||Prevention||None (Open Label)||||||
1377107|NCT02591420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377108|NCT02591407|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377109|NCT02591394|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377110|NCT02591381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377111|NCT02591368|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377112|NCT02591355|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1377113|NCT02591342|||Cohort||Prospective|||||||
1377114|NCT02591329|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1377115|NCT02591316|||Case Control||Cross-Sectional|||||||
1377116|NCT02591303|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1377117|NCT02591290||Single Group Assignment||Prevention||None (Open Label)||||||
1377118|NCT02591277|||Ecologic or Community||Prospective|||||||
1377119|NCT02591264|||Case Control||Prospective|||||||
1377120|NCT02591251|Randomized|Parallel Assignment||Prevention||Single|||t|||
1377121|NCT02591238|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1377122|NCT02591225|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377123|NCT02591212|Randomized|Parallel Assignment||Prevention||Single|||||t|
1377124|NCT02591199|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377125|NCT02591186|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1377126|NCT02591173|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1377127|NCT02591160||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377128|NCT02591147|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1377129|NCT02591134|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1377130|NCT02591121|||Cohort||Prospective|||||||
1377131|NCT02591108|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1377132|NCT02591095||Single Group Assignment||Treatment||None (Open Label)||||||
1377133|NCT02591082|||Cohort||Prospective|||||||
1377134|NCT02591069||Single Group Assignment||||None (Open Label)||||||
1377135|NCT02591056||Single Group Assignment||Treatment||None (Open Label)||||||
1377136|NCT02591043||Single Group Assignment||Health Services Research||None (Open Label)||||||
1377137|NCT02591030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377138|NCT02591017|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1377139|NCT02591004|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377140|NCT02590991|||Case-Control||Prospective|||||||
1377141|NCT02590978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377142|NCT02590965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377143|NCT02590952||Single Group Assignment||Treatment||None (Open Label)||||||
1377144|NCT02590939|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377145|NCT02590926|||Cohort||Prospective|||||||
1377146|NCT02590913|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1377147|NCT02590900|||Cohort||Retrospective|||||||
1377148|NCT02590887||Single Group Assignment||||None (Open Label)||||||
1377149|NCT02590874|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1377150|NCT02590861||Single Group Assignment||Treatment||None (Open Label)||||||
1377151|NCT02590848|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377152|NCT02590835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377153|NCT02590822|Randomized|Parallel Assignment||Treatment||Single||||||t
1377154|NCT02590809|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377155|NCT02590796|||Other||Other|||||||
1377156|NCT02590783|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377157|NCT02590770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377158|NCT02590757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377159|NCT02590744|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377160|NCT02590731|||Cohort||Prospective|||||||
1377161|NCT02590718|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1377162|NCT02590705|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1377163|NCT02590692||Single Group Assignment||Other||None (Open Label)||||||
1377164|NCT02590679||Single Group Assignment||Treatment||None (Open Label)||||||
1377165|NCT02590666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377166|NCT02590653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377167|NCT02590640|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1377168|NCT02590627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377169|NCT02590614|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1377170|NCT02590601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377171|NCT02590588||Single Group Assignment||Treatment||None (Open Label)||||||
1377172|NCT02590575||Single Group Assignment||Treatment||None (Open Label)||||||
1377173|NCT02590562|||Case-Only||Cross-Sectional|||||||
1377174|NCT02590549||Single Group Assignment||Treatment||None (Open Label)||||||
1377175|NCT02590536|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377176|NCT02590523|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377177|NCT02590510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377178|NCT02590497||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377179|NCT02590484||||Treatment||||||||
1377180|NCT02590471|Randomized|Single Group Assignment||Treatment||Single|||t|||
1377181|NCT02590458||Single Group Assignment||Screening||None (Open Label)||||||
1377182|NCT02590445|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1377183|NCT02590432|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377184|NCT02590419|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377185|NCT02590406|Randomized|Parallel Assignment||Prevention||Single|||t|||
1377186|NCT02590393|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1377187|NCT02590380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377188|NCT02590367|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1377189|NCT02590354||Single Group Assignment||Other||None (Open Label)||||||
1377190|NCT02590341|||Cohort||Prospective|||||||
1377191|NCT02590328|||Cohort||Prospective|||||||
1377192|NCT02590315|Randomized|Parallel Assignment||Screening||Single|||t|||
1377193|NCT02590302||Single Group Assignment||Health Services Research||None (Open Label)||||||
1377194|NCT02590289|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377195|NCT02590276||Single Group Assignment||Prevention||None (Open Label)||||||
1377196|NCT02590263|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377197|NCT02590250|||Cohort||Prospective|||||||
1377198|NCT02590237|Randomized|Parallel Assignment||||None (Open Label)||||||
1377199|NCT02590224|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1377200|NCT02590211|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377201|NCT02590198|||Case-Control||Prospective|||||||
1377202|NCT02590185||Single Group Assignment||Treatment||None (Open Label)||||||
1377203|NCT02590172|||Cohort||Prospective|||||||
1377204|NCT02590159||Single Group Assignment||Treatment||None (Open Label)||||||
1377205|NCT02590146|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1377206|NCT02590133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377207|NCT02590120|Randomized|Crossover Assignment||Other||Single|||t|||
1377208|NCT02590107||Single Group Assignment||Supportive Care||None (Open Label)||||||
1377209|NCT02590094|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1377210|NCT02590081|Randomized|Parallel Assignment||||Double|||t||t|
1377211|NCT02590068|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1377212|NCT02590055||Single Group Assignment||Treatment||None (Open Label)||||||
1377213|NCT02590042||Single Group Assignment||Treatment||None (Open Label)||||||
1377214|NCT02590029|Randomized|Parallel Assignment||Treatment||Single||||||t
1377215|NCT02590016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377216|NCT02590003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377217|NCT02589990||Single Group Assignment||Screening||None (Open Label)||||||
1377218|NCT02589977|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1377219|NCT02589964|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1377220|NCT02589951|||||Retrospective|||||||
1377221|NCT02589938|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1377222|NCT02589925|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1377223|NCT02589912||||||||||||
1377224|NCT02589899|||||Prospective|||||||
1377225|NCT02589886|Randomized|Parallel Assignment||Treatment||Single||||||t
1377226|NCT02589873|Randomized|Parallel Assignment||Prevention||Single||||||t
1377227|NCT02589860|||Cohort||Prospective|||||||
1377228|NCT02589847||Single Group Assignment||Treatment||None (Open Label)||||||
1377229|NCT02589834|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377230|NCT02589821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377231|NCT02589808||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377232|NCT02589795|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1377233|NCT02589782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377234|NCT02589769|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377235|NCT02589756|Randomized|Parallel Assignment||Prevention||Single||||||t
1377236|NCT02589743|Randomized|Parallel Assignment||Prevention||Single|||t|||
1377237|NCT02589730|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1377239|NCT02589704|||Cohort||Prospective|||||||
1377240|NCT02589691|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377241|NCT02589678|Randomized|Crossover Assignment||Screening||Triple|||t|t|t|
1377242|NCT02589665|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377243|NCT02589652|||Cohort||Prospective|||||||
1377244|NCT02589639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377245|NCT02589626|Randomized|Parallel Assignment||Treatment||Double||||||
1377246|NCT02589613|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1377247|NCT02589600|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377248|NCT02589587|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1377249|NCT02589574|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1377250|NCT02589561|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1377251|NCT02589548|||Cohort||Prospective|||||||
1377252|NCT02589535|||Case-Control||Prospective|||||||
1377253|NCT02589522|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377254|NCT02589509|Randomized|Crossover Assignment||Treatment||Single||||||t
1377255|NCT02589496||Single Group Assignment||Treatment||None (Open Label)||||||
1377256|NCT02589483||Single Group Assignment||Prevention||None (Open Label)||||||
1377257|NCT02589470|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377258|NCT02589457|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377259|NCT02589444|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1377260|NCT02589431|||Case Control||Prospective|||||||
1377261|NCT02589418||Single Group Assignment||Treatment||Single|||t|||
1377262|NCT02589405||Single Group Assignment||||None (Open Label)||||||
1377263|NCT02589392|Randomized|Parallel Assignment||Prevention||Single|||||t|
1377264|NCT02589379|||Cohort||Prospective|||||||
1377265|NCT02589366||Single Group Assignment||Treatment||None (Open Label)||||||
1377266|NCT02589353||Single Group Assignment||Basic Science||None (Open Label)||||||
1377267|NCT02589340|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1377268|NCT02589327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377269|NCT02589314||Single Group Assignment||Treatment||None (Open Label)||||||
1377270|NCT02589301|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1377271|NCT02589288|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377272|NCT02589275||Single Group Assignment||Treatment||None (Open Label)||||||
1377273|NCT02589262||||Treatment||||||||
1377274|NCT02589249|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377275|NCT02589236|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377276|NCT02589223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377277|NCT02589210||Single Group Assignment||Treatment||None (Open Label)||||||
1377278|NCT02589197|||Case-Control||Prospective|||||||
1377279|NCT02589184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377280|NCT02589171|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377281|NCT02589158||Single Group Assignment||Treatment||None (Open Label)||||||
1377282|NCT02589145||Single Group Assignment||Treatment||None (Open Label)||||||
1377283|NCT02589132|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377284|NCT02589119||Single Group Assignment||Treatment||None (Open Label)||||||
1377285|NCT02589106||Single Group Assignment||Treatment||None (Open Label)||||||
1377286|NCT02589093||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377287|NCT02589080||Single Group Assignment||Treatment||None (Open Label)||||||
1377288|NCT02589067|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377289|NCT02589054|||Case-Control||Prospective|||||||
1377290|NCT02589041||Single Group Assignment||Treatment||None (Open Label)||||||
1377291|NCT02589028|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1377292|NCT02589015|||Case-Only||Prospective|||||||
1377293|NCT02589002|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1377294|NCT02588989|||Cohort||Prospective|||||||
1377295|NCT02588976||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377296|NCT02588963|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1377297|NCT02588950|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1377298|NCT02588937|Randomized|||Treatment||None (Open Label)||||||
1377299|NCT02588924|||Case Control||Retrospective|||||||
1377300|NCT02588911|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1377301|NCT02588898|||Case-Control||Cross-Sectional|||||||
1377302|NCT02588885||Single Group Assignment||Treatment||None (Open Label)||||||
1377303|NCT02588872|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377304|NCT02588859|||Other||Prospective|||||||
1377305|NCT02588846|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||All patients receive the intervention for comparison against retrospective matched cohort.||||
1377306|NCT02588833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377307|NCT02588820||Single Group Assignment||Treatment||None (Open Label)||||||
1377308|NCT02588807||Single Group Assignment||Treatment||None (Open Label)||||||
1377309|NCT02588794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377310|NCT02588781||Single Group Assignment||Treatment||None (Open Label)||||||
1377311|NCT02588768|Randomized|Crossover Assignment||Health Services Research||Triple|||t|t|t|
1377312|NCT02588755|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377313|NCT02588742|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1377314|NCT02588729|Randomized|Parallel Assignment||Prevention||Single||||||t
1377315|NCT02588716|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1377316|NCT02588703|Randomized|Parallel Assignment||Treatment||None (Open Label)||RCT||||
1377317|NCT02588690|||Ecologic or Community||Prospective|||||||
1377318|NCT02588677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377319|NCT02588664|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1377320|NCT02588651||Single Group Assignment||Treatment||None (Open Label)||||||
1377321|NCT02588638|||Other||Other|||||||
1377322|NCT02588625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377323|NCT02588612||Single Group Assignment||Treatment||None (Open Label)||||||
1377324|NCT02588599||Single Group Assignment||Treatment||None (Open Label)||||||
1377325|NCT02588586||Single Group Assignment||Treatment||None (Open Label)||||||
1377326|NCT02588573|Randomized|Single Group Assignment||||Double|||t||t|
1377327|NCT02588560|||Case-Only||Prospective|||||||
1377328|NCT02588547|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377329|NCT02588534|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377330|NCT02588521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377331|NCT02588508|Randomized|Parallel Assignment||Prevention||Single|||||t|
1377332|NCT02588495|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1377333|NCT02588482||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377334|NCT02588469|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377335|NCT02588456||Single Group Assignment||Treatment||None (Open Label)||||||
1377336|NCT02588443||Parallel Assignment||Treatment||||||||
1377337|NCT02588430|||Case-Only|||||||||
1377338|NCT02588417|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1377339|NCT02588404|||Case-Only||Prospective|||||||
1377340|NCT02588391|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1377341|NCT02588378|||Cohort||Prospective|||||||
1377342|NCT02588365|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1377343|NCT02588352||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377344|NCT02588339||Single Group Assignment||Prevention||None (Open Label)||||||
1377345|NCT02588326|Randomized|Crossover Assignment||Other||Double|||t|t||
1377346|NCT02588313|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1377347|NCT02588300||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377348|NCT02588287||Single Group Assignment||Other||None (Open Label)||||||
1377349|NCT02588274|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1377350|NCT02588261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377351|NCT02588248|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1377352|NCT02588235|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377353|NCT02588222|||Case Control||Prospective|||||||
1377354|NCT02588209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377355|NCT02588196||Single Group Assignment||Treatment||None (Open Label)||||||
1377356|NCT02588183||Single Group Assignment||Treatment||None (Open Label)||||||
1377357|NCT02588170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377358|NCT02588157|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1377359|NCT02588144|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1377360|NCT02588131||Single Group Assignment||Treatment||None (Open Label)||||||
1377361|NCT02588118|||Case-Control||Prospective|||||||
1377362|NCT02588105||Single Group Assignment||Treatment||None (Open Label)||||||
1377363|NCT02588092||Single Group Assignment||Treatment||None (Open Label)||||||
1377364|NCT02588079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377365|NCT02588066|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377366|NCT02588053|||Other||Prospective|||||||
1377367|NCT02588040|||Other||Prospective|||||||
1377368|NCT02588027|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1377369|NCT02588014|||Cohort||Prospective|||||||
1377370|NCT02588001||Single Group Assignment||Treatment||None (Open Label)||||||
1377371|NCT02587988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377372|NCT02587975||Single Group Assignment||Treatment||None (Open Label)||||||
1377373|NCT02587962||Single Group Assignment||Treatment||None (Open Label)||||||
1377374|NCT02587949|||Cohort||Retrospective|||||||
1377375|NCT02587936|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1377376|NCT02587923|||Case-Only||Retrospective|||||||
1377377|NCT02587910|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377378|NCT02587897|||Case-Control||Prospective|||||||
1377379|NCT02587884|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377380|NCT02587871||Single Group Assignment||Treatment||None (Open Label)||||||
1377381|NCT02587858|||Cohort||Other|||||||
1377382|NCT02587845|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1377383|NCT02587832|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377384|NCT02587819||Single Group Assignment||Treatment||None (Open Label)||||||
1377385|NCT02587806||Single Group Assignment||Treatment||None (Open Label)||||||
1377386|NCT02587793|||Case-Only||Prospective|||||||
1377387|NCT02587780|||Case Control||Cross-Sectional|||||||
1377388|NCT02587767|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1377389|NCT02587754|Randomized|Parallel Assignment||Treatment||Double||2 arm study comparing acupuncture with sham|t|||t
1377390|NCT02587741|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377391|NCT02587728|||Cohort||Prospective|||||||
1377392|NCT02587715||Single Group Assignment||Treatment||None (Open Label)||||||
1377393|NCT02587702|Randomized|Parallel Assignment||Basic Science||Double||||t|t|
1377394|NCT02587689||Single Group Assignment||Treatment||None (Open Label)||||||
1377395|NCT02587676||||||||||||
1377396|NCT02587663|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377397|NCT02587650|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377398|NCT02587637|||Cohort||Prospective|||||||
1377399|NCT02587624|||Cohort||Prospective|||||||
1377400|NCT02587611|Randomized|Crossover Assignment||Treatment||Single||||||t
1377401|NCT02587598|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377402|NCT02587585|Randomized|Parallel Assignment||Treatment||Double|The patients wear identical watches; one gives no feedback on activity levels and one gives feedback on a two-hourly basis, with progress against a target derived from activity 24 hours earlier.|A randomised, parallel group, single-blinded, attention and feedback controlled study|||t|t
1377403|NCT02587572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377404|NCT02587559|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377405|NCT02587546|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377406|NCT02587533|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1377407|NCT02587520|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377408|NCT02587507|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1377409|NCT02587494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377410|NCT02587481|||Case-Only||Prospective|||||||
1377411|NCT02587468||Single Group Assignment||Basic Science||None (Open Label)||||||
1377412|NCT02587455|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1377413|NCT02587442||Single Group Assignment||Prevention||None (Open Label)||||||
1377414|NCT02587429|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377415|NCT02587416|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1377416|NCT02587403|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1377417|NCT02587390|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1377418|NCT02587377||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377419|NCT02587364|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1377420|NCT02587351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377421|NCT02587338|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377422|NCT02587325||Single Group Assignment||Treatment||None (Open Label)||||||
1377423|NCT02587312|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1377424|NCT02587286|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377425|NCT02587273||Single Group Assignment||Supportive Care||None (Open Label)||||||
1377426|NCT02587260|Randomized|Crossover Assignment||Treatment||Single||Latin square design||||t
1377427|NCT02587247||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377428|NCT02587234|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1377429|NCT02587221|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377430|NCT02587208|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1377431|NCT02587195||Single Group Assignment||Treatment||None (Open Label)||||||
1377432|NCT02587182||Single Group Assignment||Treatment||None (Open Label)||||||
1377433|NCT02587169||Single Group Assignment||Treatment||None (Open Label)||||||
1377434|NCT02587156|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1377435|NCT02587143|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377436|NCT02587130||Single Group Assignment||Treatment||None (Open Label)||||||
1377437|NCT02587117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377438|NCT02587104||Single Group Assignment||Treatment||None (Open Label)||||||
1377439|NCT02587091|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1377440|NCT02587078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377441|NCT02587065||Single Group Assignment||Treatment||None (Open Label)||||||
1377442|NCT02587052|||Case Control||Retrospective|||||||
1377443|NCT02587039|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1377444|NCT02587026|||Cohort||Other|||||||
1377445|NCT02587013|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1377446|NCT02587000|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377447|NCT02586987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377448|NCT02586974|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1377449|NCT02586961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377450|NCT02586948||Single Group Assignment||Treatment||None (Open Label)||||||
1377451|NCT02586935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377452|NCT02586922|||Cohort||Prospective|||||||
1377453|NCT02586909||Single Group Assignment||Treatment||None (Open Label)||||||
1377454|NCT02586896|Randomized|Parallel Assignment||Treatment||Single||||||t
1377455|NCT02586883|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377456|NCT02586870||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377457|NCT02586857||Single Group Assignment||Treatment||None (Open Label)||||||
1377458|NCT02586844|||Cohort||Prospective|||||||
1377459|NCT02586831|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377460|NCT02586818|||Cohort||Prospective|||||||
1377461|NCT02586805|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377462|NCT02586792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377463|NCT02586779|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1377464|NCT02586766|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1377465|NCT02586753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377466|NCT02586740|||Cohort||Retrospective|||||||
1377467|NCT02586727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377468|NCT02586714|||Cohort||Prospective|||||||
1377469|NCT02586701|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377470|NCT02586688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377471|NCT02586675||Single Group Assignment||Treatment||None (Open Label)||||||
1377472|NCT02586662|||||Cross-Sectional|||||||
1377473|NCT02586649|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1377474|NCT02586636|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1377475|NCT02586623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377476|NCT02586610||Single Group Assignment||Treatment||None (Open Label)||||||
1377477|NCT02586597|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1377478|NCT02586584|||Case-Only||Prospective|||||||
1377479|NCT02586571|||Cohort||Prospective|||||||
1377480|NCT02586558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377481|NCT02586545|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1377482|NCT02586532|||Cohort||Prospective|||||||
1377483|NCT02586519|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377484|NCT02586506||Single Group Assignment||Other||None (Open Label)||||||
1377485|NCT02586493||Single Group Assignment||Other||None (Open Label)||||||
1377486|NCT02586480|||Cohort||Prospective|||||||
1377487|NCT02586467|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1377488|NCT02586454|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1377489|NCT02586441||Single Group Assignment||Supportive Care||None (Open Label)||||||
1377490|NCT02586428|||||Prospective|||||||
1377491|NCT02586415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377492|NCT02586402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377493|NCT02586389|||Case-Only||Prospective|||||||
1377494|NCT02586376|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1377495|NCT02586363|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1377496|NCT02586350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377497|NCT02586337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377498|NCT02586324|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1377499|NCT02586311|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377500|NCT02586298|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1377501|NCT02586285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377502|NCT02586272|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377503|NCT02586259|||Cohort||Prospective|||||||
1377504|NCT02586246|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377505|NCT02586233|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1377506|NCT02586220|||Cohort||Prospective|||||||
1377507|NCT02586207||Single Group Assignment||Treatment||None (Open Label)||||||
1377508|NCT02586194|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377509|NCT02586181|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1377510|NCT02586168|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1377511|NCT02586155|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1377512|NCT02586142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377513|NCT02586129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377514|NCT02586116|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377515|NCT02586103|||Cohort||Prospective|||||||
1377516|NCT02586090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377517|NCT02586077||Single Group Assignment||Treatment||None (Open Label)||||||
1377518|NCT02586064|Randomized|Parallel Assignment||Treatment||Single||||||t
1377519|NCT02586051|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377520|NCT02586038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377521|NCT02586025|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377522|NCT02586012|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377523|NCT02585999||Single Group Assignment||Other||None (Open Label)||||||
1377524|NCT02585986|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377525|NCT02585973||Single Group Assignment||Treatment||None (Open Label)||||||
1377526|NCT02585960|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377527|NCT02585947|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377528|NCT02585934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377529|NCT02585921|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1377530|NCT02585908|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377531|NCT02585895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377532|NCT02585882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377533|NCT02585869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377534|NCT02585856|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1377535|NCT02585843|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377536|NCT02585830|||Case-Only||Cross-Sectional|||||||
1377537|NCT02585817||Single Group Assignment||Other||None (Open Label)||||||
1377538|NCT02585804||Single Group Assignment||Treatment||None (Open Label)||||||
1377539|NCT02585791|Randomized|Single Group Assignment||Other||Single|||t|||
1377540|NCT02585778|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377541|NCT02585765|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377542|NCT02585752||Single Group Assignment||Other||None (Open Label)||||||
1377543|NCT02585739|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1377544|NCT02585726|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377545|NCT02585713|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377546|NCT02585700|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377547|NCT02585687||Single Group Assignment||Screening||None (Open Label)||||||
1377548|NCT02585674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377549|NCT02585661|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1377550|NCT02585648|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1377551|NCT02585635|||Other||Cross-Sectional|||||||
1377552|NCT02585622|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1377553|NCT02585609|||Cohort||Cross-Sectional|||||||
1377554|NCT02585596|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1377555|NCT02585583||Single Group Assignment||Treatment||None (Open Label)||||||
1377556|NCT02585570|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377557|NCT02585557|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1377558|NCT02585544||Single Group Assignment||Treatment||None (Open Label)||||||
1377559|NCT02585531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377560|NCT02585518|||Case-Only||Prospective|||||||
1377561|NCT02585505|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377562|NCT02585492|Randomized|Parallel Assignment||Prevention||Single||||||t
1377563|NCT02585479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377564|NCT02585466|||Case Control||Prospective|||||||
1377565|NCT02585453|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1377566|NCT02585440|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377567|NCT02585427|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1377568|NCT02585414|||Case-Control||Cross-Sectional|||||||
1377569|NCT02585401|||Other||Cross-Sectional|||||||
1377570|NCT02585388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377571|NCT02585375|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1377572|NCT02585362|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377573|NCT02585349|||Cohort||Prospective|||||||
1377574|NCT02585336|Randomized|Parallel Assignment||Treatment||Single||||||t
1377575|NCT02585323|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1377576|NCT02585310|||Cohort||Prospective|||||||
1377577|NCT02585297|||Cohort||Prospective|||||||
1377578|NCT02585284|||Case Control||Prospective|||||||
1377579|NCT02585271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377580|NCT02585258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377581|NCT02585245|||Cohort||Prospective|||||||
1377582|NCT02585232|Randomized|Parallel Assignment||Treatment||Single||||||t
1377583|NCT02585219|||Cohort||Prospective|||||||
1377584|NCT02585206|Randomized|Factorial Assignment||Treatment||Single||Phase I: full factorial design of four factors each with 2 levels (16 arms); Phase II: 2-arm randomized trial|t|||
1377585|NCT02585193||Single Group Assignment||Other||None (Open Label)||||||
1377586|NCT02585180|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1377587|NCT02585167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377588|NCT02585154||Single Group Assignment||||||||||
1377589|NCT02585141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377590|NCT02585128||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377591|NCT02585115|||Cohort||Prospective|||||||
1377592|NCT02585102|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1377593|NCT02585089|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1377594|NCT02585076|||Case-Only||Cross-Sectional|||||||
1377595|NCT02585063|||Cohort||Prospective|||||||
1377596|NCT02585050|||Case-Only||Retrospective|||||||
1377597|NCT02585037|Randomized|Parallel Assignment||||Double|||t||t|
1377598|NCT02585024|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1377599|NCT02585011|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377600|NCT02584998|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1377601|NCT02584985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377602|NCT02584972|||Case Control||Cross-Sectional|||||||
1377603|NCT02584959|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1377604|NCT02584946|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1377605|NCT02584933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377606|NCT02584920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377607|NCT02584907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377608|NCT02584894|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377609|NCT02584881|Non-Randomized|Single Group Assignment||Prevention||Single|||t|||
1377610|NCT02584868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377611|NCT02584855|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377612|NCT02584842|||Cohort||Retrospective|||||||
1377613|NCT02584829|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377614|NCT02584816|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377615|NCT02584803|||Case-Only||Cross-Sectional|||||||
1377616|NCT02584790||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377617|NCT02584777||Single Group Assignment||Treatment||None (Open Label)||||||
1377618|NCT02584764||Single Group Assignment||Treatment||None (Open Label)||||||
1377619|NCT02584751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377620|NCT02584738|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377621|NCT02584725|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377622|NCT02584712|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377623|NCT02584699||Single Group Assignment||Treatment||None (Open Label)||||||
1377624|NCT02584686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377625|NCT02584673|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377626|NCT02584660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377627|NCT02584647|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377628|NCT02584634|Non-Randomized|||Treatment||None (Open Label)||||||
1377629|NCT02584621|Randomized|Parallel Assignment||Prevention||Single|||t|||
1377630|NCT02584608||Single Group Assignment||Treatment||None (Open Label)||||||
1377631|NCT02584595|||Cohort||Prospective|||||||
1377632|NCT02584582|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377633|NCT02584569||Single Group Assignment||Treatment||None (Open Label)||||||
1377634|NCT02584556|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377635|NCT02584543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377636|NCT02584530|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377637|NCT02584517|||Cohort||Prospective|||||||
1377638|NCT02584504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377639|NCT02584491||Single Group Assignment||Treatment||None (Open Label)||||||
1377640|NCT02584478||Single Group Assignment||Treatment||None (Open Label)||||||
1377641|NCT02584465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377642|NCT02584452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377643|NCT02584439|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1377644|NCT02584426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377645|NCT02584413||Single Group Assignment||Screening||None (Open Label)||||||
1377646|NCT02584400||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377647|NCT02584387|Randomized|Parallel Assignment||Treatment||Single||||||t
1377648|NCT02584374|||Case Control||Prospective|||||||
1377649|NCT02584361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377650|NCT02584348||Single Group Assignment||||None (Open Label)||||||
1377651|NCT02584335|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1377652|NCT02584322||Single Group Assignment||Treatment||None (Open Label)||||||
1377653|NCT02584309|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377654|NCT02584296|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1377655|NCT02584283|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1377656|NCT02584270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377657|NCT02584257|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1377658|NCT02584244||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1377659|NCT02584231|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1377660|NCT02584218|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1377661|NCT02584205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377662|NCT02584192|Randomized|Parallel Assignment||Treatment||Single||||||t
1377663|NCT02584179||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377664|NCT02584166|||Cohort||Prospective|||||||
1377665|NCT02584153||Single Group Assignment||Prevention||None (Open Label)||||||
1377666|NCT02584140||Single Group Assignment||Prevention||None (Open Label)||All enrolled participants will receive daily oral emtricitabine/tenofovir disoproxil fumarate, adherence counseling, and daily text message reminders.||||
1377667|NCT02584127|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377668|NCT02584114|Randomized|Parallel Assignment||Treatment||Single||||||t
1377669|NCT02584101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377670|NCT02584088|||Case-Only||Prospective|||||||
1377671|NCT02584075||Single Group Assignment||Treatment||None (Open Label)||||||
1377672|NCT02584062|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377673|NCT02584049|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377674|NCT02584036|||Cohort||Prospective|||||||
1377675|NCT02584023|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1377676|NCT02584010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377677|NCT02583997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377678|NCT02583984|||Cohort||Prospective|||||||
1377679|NCT02583971|||Case Control||Prospective|||||||
1377680|NCT02583958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377681|NCT02583945||Single Group Assignment||Prevention||None (Open Label)||||||
1377682|NCT02583932|Randomized|Parallel Assignment||Supportive Care||Double|Investigators and care providers are masked as to group assignment|||t|t|
1377683|NCT02583919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377684|NCT02583906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377685|NCT02583893||Single Group Assignment||Basic Science||None (Open Label)||||||
1377686|NCT02583880|||||Retrospective|||||||
1377687|NCT02583867||Single Group Assignment||Treatment||None (Open Label)||||||
1377688|NCT02583854|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377689|NCT02583841|Randomized|Parallel Assignment||Prevention||Single|||t|||
1377690|NCT02583828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377691|NCT02583815|||Case-Control||Prospective|||||||
1377692|NCT02583802|Randomized|Crossover Assignment||Treatment||Single|||||t|
1377693|NCT02583789|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1377694|NCT02583776|Randomized|Parallel Assignment||||Single||||||t
1377695|NCT02583763|||Case-Control||Prospective|||||||
1377696|NCT02583750|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1377697|NCT02583737|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1377698|NCT02583711|||Cohort||Prospective|||||||
1377773|NCT02582736|||Cohort||Retrospective|||||||
1377699|NCT02583698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377700|NCT02583685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377701|NCT02583672||Single Group Assignment||Treatment||None (Open Label)||||||
1377702|NCT02583659|||Cohort||Prospective|||||||
1377703|NCT02583646|||Cohort||Cross-Sectional|||||||
1377704|NCT02583633|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1377705|NCT02583620|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1377706|NCT02583607||Single Group Assignment||Treatment||None (Open Label)||||||
1377707|NCT02583594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377708|NCT02583581||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377709|NCT02583568|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377710|NCT02583555|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377711|NCT02583542|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377712|NCT02583529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377713|NCT02583516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377714|NCT02583503|||Cohort||Prospective|||||||
1377715|NCT02583490|Randomized|Parallel Assignment||Treatment||Single||||||t
1377716|NCT02583477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377717|NCT02583464|Randomized|Crossover Assignment||||None (Open Label)||||||
1377718|NCT02583451|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1377719|NCT02583438||Single Group Assignment||Treatment||None (Open Label)||||||
1377720|NCT02583425||Single Group Assignment||Treatment||None (Open Label)||||||
1377721|NCT02583412|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1377722|NCT02583399||Single Group Assignment||Treatment||None (Open Label)||Multi-center, Open-label||||
1377723|NCT02583386|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377724|NCT02583373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377725|NCT02583360|Non-Randomized|Parallel Assignment||Treatment||Single||Feeding difficulties are complex conditions. Simple solitary therapies are not feasible. Therefore, to improve recruitment and compliance to feeding therapies (flow regulated or thickener use), we have now adopted Parent Preferred Therapy for the feeding modification.||||t
1377726|NCT02583347|||Cohort||Prospective|||||||
1377727|NCT02583334|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1377728|NCT02583321|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1377729|NCT02583308|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1377730|NCT02583295|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377731|NCT02583282|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1377732|NCT02583269||Single Group Assignment||Treatment||None (Open Label)||||||
1377733|NCT02583256|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377734|NCT02583243|||Cohort||Prospective|||||||
1377735|NCT02583230||Single Group Assignment||Other||None (Open Label)||||||
1377736|NCT02583217|||Case-Control||Prospective|||||||
1377737|NCT02583204|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377738|NCT02583191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377739|NCT02583178||Single Group Assignment||Treatment||None (Open Label)||||||
1377740|NCT02583165||Single Group Assignment||Treatment||None (Open Label)||||||
1377741|NCT02583152|||Cohort||Prospective|||||||
1377742|NCT02583139|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377743|NCT02583126|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377744|NCT02583113|||Cohort||Retrospective|||||||
1377745|NCT02583100|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1377746|NCT02583087|||Cohort||Prospective|||||||
1377747|NCT02583074|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1377748|NCT02583061|||Cohort||Prospective|||||||
1377749|NCT02583048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377750|NCT02583035||Single Group Assignment||Other||None (Open Label)||||||
1377751|NCT02583022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377752|NCT02583009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377753|NCT02582996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377754|NCT02582983||Single Group Assignment||Treatment||None (Open Label)||||||
1377755|NCT02582970||Single Group Assignment||Treatment||None (Open Label)||||||
1377756|NCT02582957|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377757|NCT02582944||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377758|NCT02582931||Single Group Assignment||Treatment||None (Open Label)||||||
1377759|NCT02582918|Randomized|Parallel Assignment||Screening||Double|||t|t||
1377760|NCT02582905|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377761|NCT02582892||Single Group Assignment||Treatment||None (Open Label)||||||
1377762|NCT02582879|||Cohort||Prospective|||||||
1377763|NCT02582866||Single Group Assignment||Treatment||None (Open Label)||||||
1377764|NCT02582853||||||||||||
1377765|NCT02582840|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1377766|NCT02582827||Single Group Assignment||Treatment||None (Open Label)||||||
1377767|NCT02582814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377768|NCT02582801|Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1377769|NCT02582788|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377770|NCT02582775|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377771|NCT02582762||Single Group Assignment||Treatment||None (Open Label)||||||
1377772|NCT02582749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377774|NCT02582723|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1377775|NCT02582710|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377776|NCT02582697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377777|NCT02582684||Single Group Assignment||Treatment||None (Open Label)||||||
1377778|NCT02582671|||Cohort||Prospective|||||||
1377779|NCT02582658|||Cohort||Prospective|||||||
1377780|NCT02582645|Randomized|Parallel Assignment||Treatment||Single||||||t
1377781|NCT02582632||Single Group Assignment||Treatment||None (Open Label)||||||
1377782|NCT02582619|||Cohort||Cross-Sectional|||||||
1377783|NCT02582606|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1377784|NCT02582593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377785|NCT02582580|Randomized|Parallel Assignment||Prevention||Single|||||t|
1377786|NCT02582567|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1377787|NCT02582554|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1377788|NCT02582541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377789|NCT02582528|Randomized|Parallel Assignment||Treatment||Single||||||t
1377790|NCT02582515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377791|NCT02582502|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1377792|NCT02582489|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1377793|NCT02582476|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1377794|NCT02582463|||Cohort||Prospective|||||||
1377795|NCT02582450|||Cohort||Prospective|||||||
1377796|NCT02582437|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377797|NCT02582424|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377798|NCT02582411|||Cohort||Cross-Sectional|||||||
1377799|NCT02582398|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1377800|NCT02582385|||||Retrospective|||||||
1377801|NCT02582372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377802|NCT02582359||Single Group Assignment||Treatment||None (Open Label)||||||
1377803|NCT02582346||Single Group Assignment||Prevention||None (Open Label)||||||
1377804|NCT02582333|||Cohort||Prospective|||||||
1377805|NCT02582320|||Cohort||Retrospective|||||||
1377806|NCT02582307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377807|NCT02582294|||Other||Retrospective|||||||
1377808|NCT02582281|Randomized|Parallel Assignment||||Single|||t|||
1377809|NCT02582268|Randomized|Parallel Assignment||||Single|||t|||
1377810|NCT02582255||Single Group Assignment||Prevention||None (Open Label)||||||
1377811|NCT02582242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377812|NCT02582229||Single Group Assignment||Treatment||None (Open Label)||||||
1377813|NCT02582216||Single Group Assignment||Treatment||None (Open Label)||||||
1377814|NCT02582203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377815|NCT02582190||Single Group Assignment||Treatment||None (Open Label)||||||
1377816|NCT02582177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377817|NCT02582164|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1377818|NCT02582151|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377819|NCT02582138|Randomized|Parallel Assignment||Prevention||Single||||||t
1377820|NCT02582125||Single Group Assignment||Treatment||None (Open Label)||||||
1377821|NCT02582112|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1377822|NCT02582099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377823|NCT02582086|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377824|NCT02582073|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377825|NCT02582060||Single Group Assignment||Other||None (Open Label)||||||
1377826|NCT02582047|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377827|NCT02582034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377828|NCT02582021|||Cohort||Prospective|||||||
1377829|NCT02582008|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377830|NCT02581995||Single Group Assignment||Treatment||None (Open Label)||||||
1377831|NCT02581982||Single Group Assignment||Treatment||None (Open Label)||||||
1377832|NCT02581969|||Cohort||Retrospective|||||||
1377833|NCT02581956|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377834|NCT02581943|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1377835|NCT02581930||Single Group Assignment||Treatment||None (Open Label)||||||
1377836|NCT02581917|||Cohort||Prospective|||||||
1377837|NCT02581904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377838|NCT02581891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377839|NCT02581878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377840|NCT02581865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377841|NCT02581852||Single Group Assignment||Supportive Care||None (Open Label)||||||
1377842|NCT02581839||Single Group Assignment||Treatment||None (Open Label)||||||
1377843|NCT02581826|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1377844|NCT02581813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377845|NCT02581800|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1377846|NCT02581787||Single Group Assignment||Treatment||None (Open Label)||||||
1377847|NCT02581774|||Case Control||Prospective|||||||
1377848|NCT02581761|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1377849|NCT02581748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377850|NCT02581735|||Cohort||Prospective|||||||
1377851|NCT02581722||Single Group Assignment||Prevention||None (Open Label)||||||
1377852|NCT02581709||Single Group Assignment||Supportive Care||None (Open Label)||||||
1377853|NCT02581696||Single Group Assignment||Other||None (Open Label)|Open Label|||||
1377854|NCT02581683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377855|NCT02581670||Single Group Assignment||Treatment||None (Open Label)||||||
1377856|NCT02581657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377857|NCT02581644|||Case-Only||Cross-Sectional|||||||
1377858|NCT02581631||Single Group Assignment||Treatment||None (Open Label)||||||
1377859|NCT02581618|Randomized|Parallel Assignment||Treatment||Single||||||t
1377860|NCT02581605|||Cohort||Prospective|||||||
1377861|NCT02581592|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1377862|NCT02581579|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1377863|NCT02581566|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377864|NCT02581553|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377865|NCT02581540|||Cohort||Prospective|||||||
1377866|NCT02581527|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377867|NCT02581514||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377868|NCT02581501||Single Group Assignment||Treatment||None (Open Label)||||||
1377869|NCT02581488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377870|NCT02581475|Randomized|Single Group Assignment||Prevention||Single|||t|||
1377871|NCT02581462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377872|NCT02581449|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377873|NCT02581436|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1377874|NCT02581423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377875|NCT02581410|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377876|NCT02581397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377877|NCT02581384||Single Group Assignment||Treatment||None (Open Label)||||||
1377878|NCT02581371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377879|NCT02581358||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377880|NCT02581345|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1377881|NCT02581332|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377882|NCT02581319||Single Group Assignment||Treatment||None (Open Label)||||||
1377883|NCT02581306||Single Group Assignment||Basic Science||None (Open Label)||||||
1377884|NCT02581293|Randomized|Crossover Assignment||Screening||Double|||t||t|
1377885|NCT02581280|||Cohort||Prospective|||||||
1377886|NCT02581267|||Cohort||Retrospective|||||||
1377887|NCT02581254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377888|NCT02581241|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377889|NCT02581228|||Cohort||Retrospective|||||||
1377890|NCT02581215|Randomized|Parallel Assignment||Treatment||Quadruple|Site pharmacy staff will be unblinded to the study treatment. Subjects, site investigators, site analysis teams, and other site personnel will be blinded to the study treatment.||t|t|t|t
1377891|NCT02581202|||Cohort||Prospective|||||||
1377892|NCT02581189|||Cohort||Prospective|||||||
1377893|NCT02581176||Single Group Assignment||Treatment||None (Open Label)||||||
1377894|NCT02581163|||Cohort||Prospective|||||||
1377895|NCT02581150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377896|NCT02581137||Single Group Assignment||Prevention||None (Open Label)||||||
1377897|NCT02581124||Single Group Assignment||Treatment||None (Open Label)||||||
1377898|NCT02581111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377899|NCT02581098|||Cohort||Prospective|||||||
1377900|NCT02581085|Randomized|Single Group Assignment||Other||Double|||t|t||
1377901|NCT02581072|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1377902|NCT02581059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377903|NCT02581046|Randomized|Parallel Assignment||Treatment||Single||||||t
1377904|NCT02581033||Single Group Assignment||Treatment||None (Open Label)||||||
1377905|NCT02581020|||Cohort||Other|||||||
1377906|NCT02581007||Single Group Assignment||Treatment||None (Open Label)||||||
1377907|NCT02580994|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377908|NCT02580981||Single Group Assignment||Treatment||None (Open Label)||||||
1377909|NCT02580968|Randomized|Parallel Assignment||Treatment||Single||||||t
1377910|NCT02580955||Single Group Assignment||Treatment||None (Open Label)||||||
1377911|NCT02580942|Randomized|Parallel Assignment||Treatment||Single||||||t
1377912|NCT02580929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377913|NCT02580916|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1377914|NCT02580903|||Cohort||Prospective|||||||
1377915|NCT02580890|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1377916|NCT02580877|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1377917|NCT02580864|||Other||Prospective|||||||
1377918|NCT02580851|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377919|NCT02580838|Randomized|Parallel Assignment||Treatment||Single||||||t
1377920|NCT02580825|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377921|NCT02580812|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377922|NCT02580799|||Case Control||Cross-Sectional|||||||
1377923|NCT02580786|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1377924|NCT02580773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377925|NCT02580760|||Case-Only||Cross-Sectional|||||||
1377926|NCT02580747||Single Group Assignment||Treatment||None (Open Label)||||||
1377927|NCT02580734|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1377928|NCT02580721|Randomized|Factorial Assignment||Screening||Single||||||t
1377929|NCT02580708||Single Group Assignment||Treatment||None (Open Label)||||||
1377930|NCT02580695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377931|NCT02580682|Randomized|Parallel Assignment||Treatment||Single|Since the treatments in this study are visualized, it is not feasible to blind the patients and therapists.Therefore, the outcome assessors will be blinded, they will not participate in the recruitment, study design and the treatment|||||t
1377932|NCT02580669|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1377933|NCT02580656||Single Group Assignment||Treatment||None (Open Label)||||||
1377934|NCT02580643|||Other||Prospective|||||||
1377935|NCT02580630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377936|NCT02580617||Single Group Assignment||Treatment||None (Open Label)||||||
1377937|NCT02580604|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1377938|NCT02580591|Randomized|Parallel Assignment||Treatment||Double||||||
1377939|NCT02580578|||Case-Only||Prospective|||||||
1377940|NCT02580565|||Case-Crossover||Prospective|||||||
1377941|NCT02580552|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377942|NCT02580539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1377943|NCT02580526|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1377944|NCT02580513|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1377945|NCT02580500|Randomized|Parallel Assignment||||None (Open Label)||||||
1377946|NCT02580487|||Cohort|||||||||
1377947|NCT02580474||Single Group Assignment||Treatment||None (Open Label)||||||
1377948|NCT02580461|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1377949|NCT02580448|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377950|NCT02580435|||Cohort||Prospective|||||||
1377951|NCT02580422|||Cohort||Prospective|||||||
1377952|NCT02580409||Single Group Assignment||Treatment||None (Open Label)||||||
1377953|NCT02580396||Single Group Assignment||Other||None (Open Label)||||||
1377954|NCT02580383|||Case Control||Retrospective|||||||
1377955|NCT02580370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377956|NCT02580357|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1377957|NCT02580344||Single Group Assignment||Treatment||None (Open Label)||||||
1377958|NCT02580331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1377959|NCT02580318||Single Group Assignment||Other||None (Open Label)||||||
1377960|NCT02580305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377961|NCT02580292|||Cohort||Prospective|||||||
1377962|NCT02580279|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377963|NCT02580266|||Cohort||Prospective|||||||
1377964|NCT02580253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377965|NCT02580240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377966|NCT02580227|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1377967|NCT02580214|Randomized|Parallel Assignment||Prevention||Single||||||t
1377968|NCT02580201||Single Group Assignment||Prevention||None (Open Label)||||||
1377969|NCT02580188|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1377970|NCT02580175|Randomized|Parallel Assignment||Prevention||Single|||t|||
1377971|NCT02580162|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377972|NCT02580149|Randomized|Parallel Assignment||Treatment||Single|||||t|
1377973|NCT02580136|||Cohort||Prospective|||||||
1377974|NCT02580123|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1377975|NCT02580110|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1377976|NCT02580097|||Case-Only||Prospective|||||||
1377977|NCT02580084|Randomized|Single Group Assignment||Treatment||Single|||t|||
1377978|NCT02580071|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1377979|NCT02580058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377980|NCT02580045|||Case-Only||Cross-Sectional|||||||
1377981|NCT02580032|||Cohort||Prospective|||||||
1377982|NCT02580019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377983|NCT02580006|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1377984|NCT02579993||Single Group Assignment||Treatment||None (Open Label)||||||
1377985|NCT02579980||Single Group Assignment||Diagnostic||None (Open Label)||||||
1377986|NCT02579967|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377987|NCT02579954|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377988|NCT02579941|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1377989|NCT02579928|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1377990|NCT02579915|Randomized|Parallel Assignment||Treatment||Single||||||t
1377991|NCT02579902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377992|NCT02579889|Randomized|Parallel Assignment||Treatment||Single|||t|||
1377993|NCT02579876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377994|NCT02579863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1377995|NCT02579850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1377996|NCT02579837|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1377997|NCT02579824||Single Group Assignment||Treatment||None (Open Label)||||||
1377998|NCT02579811||Single Group Assignment||Treatment||None (Open Label)||||||
1377999|NCT02579798|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1378000|NCT02579785|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1378001|NCT02579772|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1378002|NCT02579759|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378003|NCT02579746|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1378004|NCT02579733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378005|NCT02579720|||||Prospective|||||||
1378006|NCT02579707|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378007|NCT02579694|||Cohort||Retrospective|||||||
1378008|NCT02579681||Single Group Assignment||Treatment||None (Open Label)||||||
1378009|NCT02579668||Single Group Assignment||||None (Open Label)||||||
1378010|NCT02579655|Randomized|Factorial Assignment||Prevention||Single||||||t
1378011|NCT02579642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378012|NCT02579629|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1378013|NCT02579616||Single Group Assignment||Treatment||None (Open Label)||||||
1378014|NCT02579603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378015|NCT02579590|||Case-Only||Cross-Sectional|||||||
1378016|NCT02579577|||Cohort||Prospective|||||||
1378017|NCT02579564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378018|NCT02579551||Single Group Assignment||Treatment||None (Open Label)||||||
1378019|NCT02579538|||Cohort||Prospective|||||||
1378020|NCT02579525|Randomized|Parallel Assignment||Treatment||Single||||||t
1378021|NCT02579512|||Case-Only||Retrospective|||||||
1378022|NCT02579499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378023|NCT02579486||||||||||||
1378024|NCT02579473|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378025|NCT02579460||Single Group Assignment||Basic Science||None (Open Label)||||||
1378026|NCT02579434|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1378027|NCT02579421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378028|NCT02579408|||Cohort||Prospective|||||||
1378029|NCT02579395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378030|NCT02579382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378031|NCT02579369|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378032|NCT02579356|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378033|NCT02579343|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378034|NCT02579330|Randomized|Parallel Assignment||Treatment||Single||||||t
1378035|NCT02579317|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378036|NCT02579304|||Cohort||Prospective|||||||
1378037|NCT02579291|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1378038|NCT02579278|||Cohort||Prospective|||||||
1378039|NCT02579265|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1378040|NCT02579252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378041|NCT02579239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378042|NCT02579226|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378043|NCT02579213|||Case Control||Prospective|||||||
1378044|NCT02579200|Randomized|Parallel Assignment||Treatment||Single||||||t
1378045|NCT02579187|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1378046|NCT02579174|Randomized|Single Group Assignment||Treatment||Single|||t|||
1378047|NCT02579161|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1378048|NCT02579148|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378049|NCT02579135|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378050|NCT02579122|||Case-Only||Prospective|||||||
1378051|NCT02579109|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378052|NCT02579096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378053|NCT02579083|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378054|NCT02579070|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378055|NCT02579057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378056|NCT02579044||Single Group Assignment||Treatment||None (Open Label)||||||
1378057|NCT02579031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378058|NCT02579018|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1378059|NCT02579005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378060|NCT02578992|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378061|NCT02578979|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378062|NCT02578966|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378063|NCT02578953|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378064|NCT02578940||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378065|NCT02578927|Randomized|Parallel Assignment||||Double|||t||t|
1378066|NCT02578914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378067|NCT02578901|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378068|NCT02578888|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378069|NCT02578875|||Other||Prospective|||||||
1378070|NCT02578862|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1378071|NCT02578849|||Cohort||Cross-Sectional|||||||
1378072|NCT02578836||Single Group Assignment||Treatment||None (Open Label)||||||
1378073|NCT02578823|Randomized|Parallel Assignment||Treatment||Single||||||t
1378074|NCT02578810|||Case-Control||Prospective|||||||
1378075|NCT02578797||Single Group Assignment||Treatment||None (Open Label)||||||
1378076|NCT02578784|Randomized|Parallel Assignment||Treatment||Single||||||t
1378077|NCT02578771|Randomized|Parallel Assignment||Other||Double|||t|||t
1378078|NCT02578758|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378079|NCT02578745|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378080|NCT02578732||Single Group Assignment||Treatment||None (Open Label)||||||
1378081|NCT02578719|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1378082|NCT02578706|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1378083|NCT02578693|||Cohort||Other|||||||
1378084|NCT02578680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378085|NCT02578667|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1378086|NCT02578654||Single Group Assignment||Health Services Research||None (Open Label)||||||
1378087|NCT02578641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378088|NCT02578628|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1378089|NCT02578615|||Cohort||Prospective|||||||
1378090|NCT02578602||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378091|NCT02578589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378092|NCT02578576|||Case Control||Prospective|||||||
1378093|NCT02578563|||Case-Only||Prospective|||||||
1378094|NCT02578550|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378095|NCT02578537|Randomized|Parallel Assignment||Treatment||Single||||||t
1378096|NCT02578524|||Case Control||Retrospective|||||||
1378097|NCT02578511||Single Group Assignment||Treatment||None (Open Label)||||||
1378098|NCT02578498|Randomized|Crossover Assignment||||None (Open Label)||||||
1378099|NCT02578485|Randomized|Crossover Assignment||||None (Open Label)||||||
1378100|NCT02578472|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1378101|NCT02578459|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378102|NCT02578446|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378103|NCT02578433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378104|NCT02578420|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1378105|NCT02578407||Single Group Assignment||Treatment||None (Open Label)||||||
1378106|NCT02578394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378107|NCT02578381|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1378108|NCT02578368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378109|NCT02578355|||Cohort||Prospective|||||||
1378110|NCT02578342|||Case Control||Prospective|||||||
1378111|NCT02578329|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378112|NCT02578316||Single Group Assignment||Treatment||None (Open Label)||||||
1378113|NCT02578303|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378114|NCT02578290|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1378115|NCT02578277||Single Group Assignment||Other||None (Open Label)||||||
1378116|NCT02578264|||Case-Only||Prospective|||||||
1378117|NCT02578251|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378118|NCT02578238|||Case-Only||Prospective|||||||
1378119|NCT02578225|||Cohort||Prospective|||||||
1378120|NCT02578212|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1378121|NCT02578199||Single Group Assignment||Treatment||None (Open Label)||||||
1378122|NCT02578186|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1378123|NCT02578173|||Cohort||Prospective|||||||
1378124|NCT02578160|Randomized|Parallel Assignment||Treatment||Single|||||t|
1378125|NCT02578147|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378126|NCT02578134|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1378127|NCT02578121||Single Group Assignment||Treatment||None (Open Label)||||||
1378128|NCT02578108|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1378129|NCT02578095|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378130|NCT02578082|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378131|NCT02578069|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378132|NCT02578056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378133|NCT02578043|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378134|NCT02578030|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378135|NCT02578017|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1378136|NCT02578004|||Case Control||Retrospective|||||||
1378137|NCT02577991|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378138|NCT02577978|Randomized|Single Group Assignment||Treatment||Single|||t|||
1378139|NCT02577965|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1378140|NCT02577952|||Cohort||Cross-Sectional|||||||
1378141|NCT02577939||Single Group Assignment||Treatment||None (Open Label)||||||
1378142|NCT02577926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378143|NCT02577913|||Cohort||Prospective|||||||
1378144|NCT02577900|Randomized|Parallel Assignment||Treatment||Single||||||t
1378145|NCT02577887|||Cohort||Prospective|||||||
1378146|NCT02577874|||Cohort||Cross-Sectional|||||||
1378147|NCT02577861||Single Group Assignment||Treatment||None (Open Label)||||||
1378148|NCT02577848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378149|NCT02577835|||Cohort||Prospective|||||||
1378150|NCT02577822|Randomized|Single Group Assignment||Treatment||Single|||t|||
1378151|NCT02577809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378152|NCT02577796|||Cohort||Prospective|||||||
1378153|NCT02577783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378154|NCT02577770|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1378155|NCT02577757|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1378156|NCT02577744|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378157|NCT02577731|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378158|NCT02577718||Single Group Assignment||Prevention||None (Open Label)||||||
1378159|NCT02577705|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378160|NCT02577692|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1378161|NCT02577679|||Case Control||Cross-Sectional|||||||
1378162|NCT02577666|Randomized|Parallel Assignment||Treatment||Single||||||t
1378163|NCT02577653||Single Group Assignment||Basic Science||None (Open Label)||||||
1378164|NCT02577640|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378165|NCT02577627|||Cohort||Retrospective|||||||
1378166|NCT02577614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378167|NCT02577601|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1378168|NCT02577588||Single Group Assignment||Treatment||None (Open Label)||||||
1378169|NCT02577575|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1378170|NCT02577562||||||||||||
1378171|NCT02577549|Randomized|Parallel Assignment||Treatment||Single||||||t
1378172|NCT02577536|||Cohort||Prospective|||||||
1378173|NCT02577523|Randomized|Parallel Assignment||Treatment||Single||||||t
1378174|NCT02577510|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1378175|NCT02577497|Randomized|Crossover Assignment||Treatment||Single||||||t
1378176|NCT02577484|||Cohort||Prospective|||||||
1378177|NCT02577471|||Case Control||Prospective|||||||
1378178|NCT02577458||Single Group Assignment||Treatment||None (Open Label)||||||
1378179|NCT02577445|||Cohort||Other|||||||
1378180|NCT02577432|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378181|NCT02577419|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378182|NCT02577406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378183|NCT02577393|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378184|NCT02577380|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378185|NCT02577367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378186|NCT02577354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378187|NCT02577341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378188|NCT02577328|||Case-Only||Prospective|||||||
1378189|NCT02577315|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378190|NCT02577302|Randomized|Parallel Assignment||Treatment||None (Open Label)||Prospective, Randomized, Controlled, Non-Inferiority||||
1378191|NCT02577289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378192|NCT02577276||Single Group Assignment||Treatment||None (Open Label)||||||
1378193|NCT02577263|||Cohort||Prospective|||||||
1378194|NCT02577250||Single Group Assignment||Treatment||None (Open Label)||||||
1378195|NCT02577237|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378196|NCT02577224|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1378197|NCT02577211|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1378198|NCT02577198|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1378199|NCT02577185|Randomized|Parallel Assignment||Other||Single|||||t|
1378200|NCT02577172|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378201|NCT02577159||Single Group Assignment||Treatment||None (Open Label)||||||
1378202|NCT02577146||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378203|NCT02577133|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1378204|NCT02577120|||Cohort||Prospective|||||||
1378205|NCT02577107|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378206|NCT02577094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378207|NCT02577081||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378208|NCT02577068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378209|NCT02577055|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378210|NCT02577042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378211|NCT02577029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378212|NCT02577016|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378213|NCT02577003|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378214|NCT02576990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378215|NCT02576977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378216|NCT02576964|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378217|NCT02576951|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1378218|NCT02576938|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378219|NCT02576925|||Cohort||Prospective|||||||
1378220|NCT02576912|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1378221|NCT02576899|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378222|NCT02576886||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378223|NCT02576873|||Cohort||Retrospective|||||||
1378224|NCT02576860|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378225|NCT02576847||Single Group Assignment||Treatment||None (Open Label)||||||
1378226|NCT02576834|Randomized|Parallel Assignment||Treatment||Single||||||t
1378227|NCT02576821|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378228|NCT02576808|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378229|NCT02576795||Single Group Assignment||Treatment||None (Open Label)||||||
1378230|NCT02576782|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1378231|NCT02576769|||Case-Only||Prospective|||||||
1378232|NCT02576756|||Case Control||Retrospective|||||||
1378233|NCT02576743|||Case-Control||Prospective|||||||
1378234|NCT02576730|||Cohort||Retrospective|||||||
1378235|NCT02576717||Single Group Assignment||Treatment||None (Open Label)||||||
1378236|NCT02576704|||Cohort||Prospective|||||||
1378237|NCT02576691|||Case Control||Retrospective|||||||
1378238|NCT02576678||Single Group Assignment||Treatment||None (Open Label)||||||
1378239|NCT02576665||Single Group Assignment||Treatment||None (Open Label)||||||
1378240|NCT02576652||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378241|NCT02576639|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1378242|NCT02576626|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1378243|NCT02576613|Randomized|Parallel Assignment||Treatment||Single||||||t
1378244|NCT02576600|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378245|NCT02576587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378246|NCT02576574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378247|NCT02576561|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1378248|NCT02576548||Single Group Assignment||Treatment||None (Open Label)||||||
1378249|NCT02576535||Single Group Assignment||Treatment||None (Open Label)||||||
1378250|NCT02576522||Single Group Assignment||Treatment||None (Open Label)||||||
1378251|NCT02576509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378252|NCT02576496||Single Group Assignment||Treatment||None (Open Label)||||||
1378253|NCT02576483|||Cohort||Prospective|||||||
1378254|NCT02576470|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1378255|NCT02576457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378256|NCT02576444|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378257|NCT02576431|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378258|NCT02576418||Single Group Assignment||Treatment||None (Open Label)||||||
1378259|NCT02576405|||Cohort||Prospective|||||||
1378260|NCT02576392|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1378261|NCT02576379|||Cohort||Prospective|||||||
1378262|NCT02576366|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1378263|NCT02576353|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378264|NCT02576340|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1378265|NCT02576327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378266|NCT02576314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378267|NCT02576301|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378268|NCT02576288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378269|NCT02576275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378270|NCT02576262|||Other||Prospective|||||||
1378271|NCT02576249|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378272|NCT02576236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378273|NCT02576223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378274|NCT02576210||||||||||||
1378275|NCT02576197|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1378276|NCT02576184|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1378277|NCT02576171||Single Group Assignment||Treatment||None (Open Label)||||||
1378278|NCT02576158|||Other||Prospective|||||||
1378279|NCT02576145|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378280|NCT02576132|||Cohort||Retrospective|||||||
1378281|NCT02576119|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1378282|NCT02576106||Single Group Assignment||Treatment||None (Open Label)||||||
1378283|NCT02576093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378284|NCT02576080|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378285|NCT02576067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378286|NCT02576054||Single Group Assignment||Prevention||None (Open Label)||||||
1378287|NCT02576041||Single Group Assignment||Supportive Care||None (Open Label)||||||
1378288|NCT02576028|Randomized|Parallel Assignment||Treatment||Single|||||t|
1378289|NCT02576015|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1378290|NCT02576002|||Cohort||Retrospective|||||||
1378291|NCT02575989|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378292|NCT02575976|Randomized|Parallel Assignment||Treatment||Single||||||t
1378293|NCT02575963||Single Group Assignment||Treatment||None (Open Label)||||||
1378294|NCT02575950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378295|NCT02575937|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1378296|NCT02575924|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378297|NCT02575911||Single Group Assignment||Treatment||None (Open Label)||||||
1378298|NCT02575898||Single Group Assignment||Supportive Care||None (Open Label)||||||
1378299|NCT02575885|Randomized|Parallel Assignment||Prevention||Single|||t|||
1378300|NCT02575872|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1378301|NCT02575859|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1378302|NCT02575846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378303|NCT02575833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378304|NCT02575820|||Cohort||Retrospective|||||||
1378305|NCT02575807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378306|NCT02575794||Single Group Assignment||Treatment||None (Open Label)||||||
1378307|NCT02575781|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378308|NCT02575768|||Case Control||Prospective|||||||
1378309|NCT02575755|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378310|NCT02575742|||Case Control||Prospective|||||||
1378311|NCT02575729|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378312|NCT02575716|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1378313|NCT02575703||Single Group Assignment||Basic Science||None (Open Label)||||||
1378314|NCT02575690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378315|NCT02575677|||Cohort||Prospective|||||||
1378316|NCT02575664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378317|NCT02575651||Single Group Assignment||Treatment||None (Open Label)||||||
1378318|NCT02575638||Single Group Assignment||Basic Science||None (Open Label)||||||
1378319|NCT02575625||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378320|NCT02575612||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378321|NCT02575599|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378322|NCT02575586|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1378323|NCT02575573|||Cohort||Retrospective|||||||
1378324|NCT02575560|||Case-Only||Prospective|||||||
1378325|NCT02575547|||Case-Only||Prospective|||||||
1378326|NCT02575534||Single Group Assignment||Treatment||None (Open Label)||||||
1378327|NCT02575521|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1378328|NCT02575508||Single Group Assignment||Treatment||None (Open Label)||||||
1378329|NCT02575495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378330|NCT02575482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378331|NCT02575469|||Cohort||Prospective|||||||
1378332|NCT02575456|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378333|NCT02575443|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378334|NCT02575430|||||Retrospective|||||||
1378335|NCT02575417|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1378336|NCT02575404|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378337|NCT02575391||Single Group Assignment||Treatment||None (Open Label)||||||
1378338|NCT02575378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378339|NCT02575365||Single Group Assignment||Treatment||None (Open Label)||||||
1378340|NCT02575352|||Other||Prospective|||||||
1378341|NCT02575339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378342|NCT02575326|Randomized|Parallel Assignment||Other||None (Open Label)|Physicians are randomized. Eligible youth that present to the participating physician assume the assignment of that physician|||||
1378343|NCT02575313||Single Group Assignment||Treatment||None (Open Label)||||||
1378344|NCT02575300||Single Group Assignment||Treatment||None (Open Label)||||||
1378345|NCT02575287|||Case Control||Cross-Sectional|||||||
1378346|NCT02575274|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1378347|NCT02575261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378348|NCT02575248|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378349|NCT02575235|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378350|NCT02575222||Single Group Assignment||Treatment||None (Open Label)||||||
1378351|NCT02575209|||Case-Control||Cross-Sectional|||||||
1378352|NCT02575196|||Cohort||Prospective|||||||
1378353|NCT02575183|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1378354|NCT02575170|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1378355|NCT02575157|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1378356|NCT02575144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378357|NCT02575131|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1378358|NCT02575118|||Cohort||Prospective|||||||
1378359|NCT02575105|||Case Control||Prospective|||||||
1378360|NCT02575092|Randomized|Parallel Assignment||Treatment||Single||||||t
1378361|NCT02575079||Single Group Assignment||Prevention||None (Open Label)||||||
1378362|NCT02575066||Single Group Assignment||Treatment||None (Open Label)||||||
1378363|NCT02575053|||Cohort||Prospective|||||||
1378364|NCT02575040||Single Group Assignment||Treatment||None (Open Label)||||||
1378365|NCT02575027||Single Group Assignment||Treatment||None (Open Label)||||||
1378366|NCT02575014|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378367|NCT02575001|||Case Control||Cross-Sectional|||||||
1378368|NCT02574988|||Cohort||Prospective|||||||
1378369|NCT02574975|Randomized|Parallel Assignment||||None (Open Label)||||||
1378370|NCT02574962||Single Group Assignment||Treatment||None (Open Label)||||||
1378371|NCT02574949|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1378372|NCT02574936||Single Group Assignment||Treatment||None (Open Label)||||||
1378373|NCT02574923||Single Group Assignment||Treatment||None (Open Label)||||||
1378374|NCT02574910|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1378375|NCT02574897|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1378376|NCT02574884|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378377|NCT02574871|||Case-Only||Cross-Sectional|||||||
1378378|NCT02574858||Single Group Assignment||Other||None (Open Label)||||||
1378379|NCT02574845|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378380|NCT02574832||Single Group Assignment||Prevention||None (Open Label)||||||
1378381|NCT02574819|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378382|NCT02574806|||Cohort||Prospective|||||||
1378383|NCT02574793|||Other||Prospective|||||||
1378384|NCT02574780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378385|NCT02574767|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1378386|NCT02574754||Single Group Assignment||Basic Science||None (Open Label)||||||
1378387|NCT02574741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378388|NCT02574728||Single Group Assignment||Treatment||None (Open Label)||||||
1378389|NCT02574715|||Cohort||Cross-Sectional|||||||
1379387|NCT02561715|||Case-Only||Prospective|||||||
1378390|NCT02574702|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378391|NCT02574689|Randomized|Parallel Assignment||Treatment||Single||||||t
1378392|NCT02574676|||Ecologic or Community||Prospective|||||||
1378393|NCT02574663|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378394|NCT02574650||Single Group Assignment||Treatment||None (Open Label)||||||
1378395|NCT02574637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378396|NCT02574624||Single Group Assignment||Health Services Research||None (Open Label)||||||
1378397|NCT02574611|Non-Randomized|Single Group Assignment||||Single|||t|||
1378398|NCT02574598|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378399|NCT02574585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378400|NCT02574572||Single Group Assignment||Treatment||None (Open Label)||||||
1378401|NCT02574559||Single Group Assignment||Supportive Care||None (Open Label)||||||
1378402|NCT02574546|||Cohort||Prospective|||||||
1378403|NCT02574533||Single Group Assignment||Treatment||None (Open Label)||||||
1378404|NCT02574520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378405|NCT02574507||Single Group Assignment||Treatment||None (Open Label)||||||
1378406|NCT02574494|||Cohort||Prospective|||||||
1378407|NCT02574481|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378408|NCT02574468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378409|NCT02574455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378410|NCT02574442|||Case-Only||Prospective|||||||
1378411|NCT02574429||Single Group Assignment||Treatment||None (Open Label)||||||
1378412|NCT02574416|||Case-Only||Other|||||||
1378413|NCT02574403||Single Group Assignment||Treatment||None (Open Label)||||||
1378414|NCT02574390|||Case-Only||Prospective|||||||
1378415|NCT02574377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378416|NCT02574364|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1378417|NCT02574351|||||Prospective|||||||
1378418|NCT02574338|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378419|NCT02574325|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378420|NCT02574312|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1378421|NCT02574299|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378422|NCT02574286||Single Group Assignment||Treatment||None (Open Label)||||||
1378423|NCT02574273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378424|NCT02574260||Single Group Assignment||Treatment||None (Open Label)||||||
1378425|NCT02574247|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378426|NCT02574234||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378427|NCT02574221|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1378428|NCT02574208|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378429|NCT02574195|||Case-Only||Cross-Sectional|||||||
1378430|NCT02574182|||Case Control||Prospective|||||||
1378431|NCT02574169|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378432|NCT02574156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378433|NCT02574143|||Case-Only||Prospective|||||||
1378434|NCT02574130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378435|NCT02574117||Single Group Assignment||Treatment||None (Open Label)||||||
1378436|NCT02574104|||Cohort||Prospective|||||||
1378437|NCT02574091|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378438|NCT02574078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378439|NCT02574065|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378440|NCT02574052||Single Group Assignment||Treatment||None (Open Label)||||||
1378441|NCT02574039|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378442|NCT02574026||Single Group Assignment||Other||None (Open Label)||||||
1378443|NCT02574013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378444|NCT02574000|||Cohort||Prospective|||||||
1378445|NCT02573987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378446|NCT02573974|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1378447|NCT02573961|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378448|NCT02573948|||Cohort||Prospective|||||||
1378449|NCT02573935|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378450|NCT02573922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378451|NCT02573909|Randomized|Parallel Assignment||Treatment||Double|similar syringes equal amount of drug||t||t|
1378452|NCT02573896||Single Group Assignment||Treatment||None (Open Label)||||||
1378453|NCT02573883|Randomized|Parallel Assignment||Treatment||Single||||||t
1378454|NCT02573870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378455|NCT02573857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378456|NCT02573844|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1378457|NCT02573831|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378458|NCT02573818|||Case-Only||Prospective|||||||
1378459|NCT02573805|||Case Control||Prospective|||||||
1378460|NCT02573792|||Cohort||Prospective|||||||
1378461|NCT02573779|||Cohort||Prospective|||||||
1378462|NCT02573766|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1378463|NCT02573753|Randomized|Crossover Assignment||Prevention||None (Open Label)||Crossover; Single group||||
1378464|NCT02573740|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378465|NCT02573727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378466|NCT02573714|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379692|NCT02557711|||Case-Only||Cross-Sectional|||||||
1378467|NCT02573701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378468|NCT02573688||Single Group Assignment||Treatment||None (Open Label)||||||
1378469|NCT02573675|||Cohort||Retrospective|||||||
1378470|NCT02573662|||Case Control||Prospective|||||||
1378471|NCT02573649|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1378472|NCT02573636|||Case-Only||Prospective|||||||
1378473|NCT02573623|||||Prospective|||||||
1378474|NCT02573610|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378475|NCT02573597|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1378476|NCT02573584|||Cohort||Prospective|||||||
1378477|NCT02573571|||Case-Only||Prospective|||||||
1378478|NCT02573558|||Cohort||Retrospective|||||||
1378479|NCT02573545|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378480|NCT02573532|||Cohort||Prospective|||||||
1378481|NCT02573519|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1378482|NCT02573506||Single Group Assignment||Treatment||None (Open Label)||||||
1378483|NCT02573493|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378484|NCT02573480||Single Group Assignment||Treatment||None (Open Label)||||||
1378485|NCT02573467|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378486|NCT02573454|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378487|NCT02573441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378488|NCT02573428|||Case-Control||Cross-Sectional|||||||
1378489|NCT02573415||Single Group Assignment||Treatment||None (Open Label)||||||
1378490|NCT02573402|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378491|NCT02573389|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378492|NCT02573376|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1378493|NCT02573363||Single Group Assignment||Treatment||None (Open Label)||||||
1378494|NCT02573350||Single Group Assignment||Treatment||None (Open Label)||||||
1378495|NCT02573337||Single Group Assignment||Treatment||None (Open Label)||||||
1378496|NCT02573324|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378497|NCT02573311||Single Group Assignment||Treatment||None (Open Label)||||||
1378498|NCT02573298|Randomized|Parallel Assignment||Treatment||Single||||||t
1378499|NCT02573285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378500|NCT02573272||||||||||||
1378501|NCT02573259|Non-Randomized|||Treatment||None (Open Label)||||||
1378502|NCT02573246|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1378503|NCT02573233|Randomized|Parallel Assignment||Treatment||Double||||||
1378504|NCT02573220||Single Group Assignment||Treatment||None (Open Label)||||||
1378505|NCT02573207|||Cohort||Prospective|||||||
1378506|NCT02573194|Randomized|Crossover Assignment||Prevention||Single|||t|||
1378507|NCT02573181|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1378508|NCT02573168|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1378509|NCT02573155|Randomized|Crossover Assignment||Treatment||Single|||t|||
1378510|NCT02573142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378511|NCT02573129|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1378512|NCT02573116|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378513|NCT02573103|||Cohort||Prospective|||||||
1378514|NCT02573090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378515|NCT02573077|||Cohort||Prospective|||||||
1378516|NCT02573064|||Cohort||Retrospective|||||||
1378517|NCT02573051|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378518|NCT02573038||Single Group Assignment||Treatment||None (Open Label)||||||
1378519|NCT02573025|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1378520|NCT02573012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378521|NCT02572999|||Cohort||Prospective|||||||
1378522|NCT02572986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378523|NCT02572973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378524|NCT02572960|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378525|NCT02572947||Single Group Assignment||Treatment||None (Open Label)||||||
1378526|NCT02572934|||Cohort||Cross-Sectional|||||||
1378527|NCT02572921|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1378528|NCT02572908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378529|NCT02572895|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378530|NCT02572882|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1378531|NCT02572869|||Cohort||Retrospective|||||||
1378532|NCT02572856||Single Group Assignment||Other||None (Open Label)||||||
1378533|NCT02572843||Single Group Assignment||Treatment||None (Open Label)||||||
1378534|NCT02572830|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378535|NCT02572817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378536|NCT02572804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378537|NCT02572791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378538|NCT02572778|||Cohort||Prospective|||||||
1378539|NCT02572765|||Cohort||Prospective|||||||
1378540|NCT02572752|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378541|NCT02572739|||Case-Only||Cross-Sectional|||||||
1378542|NCT02572726|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1378543|NCT02572713|||Cohort||Prospective|||||||
1378544|NCT02572700|||Cohort||Prospective|||||||
1378545|NCT02572687|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378546|NCT02572674||Single Group Assignment||Other||None (Open Label)||||||
1379856|NCT02555566||Single Group Assignment||||None (Open Label)||||||
1378547|NCT02572661||Single Group Assignment||Treatment||None (Open Label)||||||
1378548|NCT02572648|||Case-Control||Prospective|||||||
1378549|NCT02572635|Randomized|Parallel Assignment||Other||Double|||t||t|
1378550|NCT02572622|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378551|NCT02572609||Crossover Assignment||Treatment||None (Open Label)||||||
1378552|NCT02572596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378553|NCT02572583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378554|NCT02572570|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1378555|NCT02572557||Single Group Assignment||Treatment||None (Open Label)||||||
1378556|NCT02572544||Single Group Assignment||Basic Science||None (Open Label)||||||
1378557|NCT02572531|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1378558|NCT02572518|||Case Control||Prospective|||||||
1378559|NCT02572505||Single Group Assignment||Treatment||None (Open Label)||||||
1378560|NCT02572492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378561|NCT02572479|||Case-Only||Prospective|||||||
1378562|NCT02572466|||Cohort||Cross-Sectional|||||||
1378563|NCT02572453||Single Group Assignment||Treatment||None (Open Label)||||||
1378564|NCT02572440||||||||||||
1378565|NCT02572427|Randomized|Parallel Assignment||||None (Open Label)||||||
1378566|NCT02572414|Randomized|Parallel Assignment||Prevention||Single||||||t
1378567|NCT02572401|Randomized|Factorial Assignment||Prevention||Single||||||t
1378568|NCT02572388|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378569|NCT02572375|Randomized|Crossover Assignment||Treatment||Single|||t|||
1378570|NCT02572362|||||Retrospective|||||||
1378571|NCT02572349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378572|NCT02572336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378573|NCT02572323|Randomized|Crossover Assignment||Treatment||Single||||||t
1378574|NCT02572310||Single Group Assignment||Treatment||None (Open Label)||||||
1378575|NCT02572297|||Cohort||Prospective|||||||
1378576|NCT02572284||Single Group Assignment||Treatment||None (Open Label)||||||
1378577|NCT02572271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378578|NCT02572258|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378579|NCT02572245|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378580|NCT02572232||Single Group Assignment||Treatment||None (Open Label)||||||
1378581|NCT02572219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378582|NCT02572206||Single Group Assignment||Basic Science||None (Open Label)||||||
1378583|NCT02572193||Single Group Assignment||Treatment||None (Open Label)||||||
1378584|NCT02572180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378585|NCT02572167||Single Group Assignment||Treatment||None (Open Label)||||||
1378586|NCT02572154|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1378587|NCT02572141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378588|NCT02572128|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1378589|NCT02572115|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1378590|NCT02572102|Randomized|Crossover Assignment||||Double|||t||t|
1378591|NCT02572089|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378592|NCT02572076||Single Group Assignment||Screening||None (Open Label)||||||
1378593|NCT02572063|||Cohort||Prospective|||||||
1378594|NCT02572050||Single Group Assignment||Treatment||None (Open Label)||||||
1378595|NCT02572037|||Cohort||Prospective|||||||
1378596|NCT02572024|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1378597|NCT02572011|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1378598|NCT02571998|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378599|NCT02571985||||||||||||
1378600|NCT02571972||Single Group Assignment||Treatment||None (Open Label)||||||
1378601|NCT02571959||Single Group Assignment||Treatment||None (Open Label)||||||
1378602|NCT02571946||Single Group Assignment||Treatment||None (Open Label)||Proton beam radiotherapy||||
1378603|NCT02571933|||||Prospective|||||||
1378604|NCT02571920|||Cohort||Prospective|||||||
1378605|NCT02571907||Single Group Assignment||Treatment||None (Open Label)||||||
1378606|NCT02571894|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378607|NCT02571881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378608|NCT02571868|||Cohort||Prospective|||||||
1378609|NCT02571855|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1378610|NCT02571842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378611|NCT02571829||Single Group Assignment||Treatment||None (Open Label)||||||
1378612|NCT02571816|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378613|NCT02571803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378614|NCT02571790|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378615|NCT02571777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378616|NCT02571764||Single Group Assignment||Basic Science||None (Open Label)||||||
1378617|NCT02571751||Single Group Assignment||Treatment||None (Open Label)||||||
1378618|NCT02571738|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378619|NCT02571725||Single Group Assignment||Treatment||None (Open Label)||||||
1378620|NCT02571712||Single Group Assignment||Treatment||None (Open Label)||||||
1378621|NCT02571699|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1378622|NCT02571686|||||Prospective|||||||
1378623|NCT02571673|||Cohort||Prospective|||||||
1378624|NCT02571660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378625|NCT02571647|||Cohort||Prospective|||||||
1378626|NCT02571634||Single Group Assignment||Treatment||None (Open Label)||||||
1378627|NCT02571621|||Case-Only||Retrospective|||||||
1378628|NCT02571608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378629|NCT02571595|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1378630|NCT02571582|||||Retrospective|||||||
1378631|NCT02571569|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378632|NCT02571556||Single Group Assignment||Treatment||None (Open Label)||||||
1378633|NCT02571543|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1378634|NCT02571530||Single Group Assignment||Treatment||None (Open Label)||||||
1378635|NCT02571517|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378636|NCT02571504|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1378637|NCT02571491|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378638|NCT02571478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378639|NCT02571465|||Case-Only||Prospective|||||||
1378640|NCT02571452|Randomized|Parallel Assignment||Treatment||Single||||||t
1378641|NCT02571439|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378642|NCT02571426|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378643|NCT02571413|Randomized|Parallel Assignment||||None (Open Label)||||||
1378644|NCT02571400|||Cohort||Prospective|||||||
1378645|NCT02571387|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378646|NCT02571374|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1378647|NCT02571361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378648|NCT02571348|Randomized|Parallel Assignment||Treatment||Single||||||t
1378649|NCT02571335|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1378650|NCT02571322|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1378651|NCT02571309|Randomized|Crossover Assignment||Treatment||Single|||||t|
1378652|NCT02571296|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1378653|NCT02571283|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1378654|NCT02571270|Randomized|Parallel Assignment||Treatment||Single||||||t
1378655|NCT02571257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378656|NCT02571244|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378657|NCT02571231|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378658|NCT02571218|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378659|NCT02571205|||Case-Only||Prospective|||||||
1378660|NCT02571192||Single Group Assignment||Basic Science||None (Open Label)||||||
1378661|NCT02571179||Single Group Assignment||Treatment||None (Open Label)||Intranasal fentanyl||||
1378662|NCT02571166||Single Group Assignment||Treatment||None (Open Label)||||||
1378663|NCT02571153|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378664|NCT02571140|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378665|NCT02571127||Single Group Assignment||Treatment||None (Open Label)||||||
1378666|NCT02571114|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1378667|NCT02571101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378668|NCT02571088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378669|NCT02571075|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378670|NCT02571062|Randomized|Crossover Assignment||||None (Open Label)||||||
1378671|NCT02571049|Randomized|Crossover Assignment||Treatment||Double||DFN-11 injection and placebo injection administered in one treatment period and two DFN-11 injections administered in another treatment period|t||t|
1378672|NCT02571036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378673|NCT02571023|||Cohort||Prospective|||||||
1378674|NCT02571010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378675|NCT02570997|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1378676|NCT02570984|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378677|NCT02570971|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1378678|NCT02570958||Single Group Assignment||Treatment||None (Open Label)||||||
1378679|NCT02570945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378680|NCT02570932||Single Group Assignment||Treatment||None (Open Label)||||||
1378681|NCT02570919|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378682|NCT02570906|||Case-Only||Prospective|||||||
1378683|NCT02570893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378684|NCT02570880||Single Group Assignment||Basic Science||None (Open Label)||||||
1378685|NCT02570867|||Case Control||Retrospective|||||||
1378686|NCT02570854|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1378687|NCT02570841|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1378688|NCT02570828||Single Group Assignment||||None (Open Label)||||||
1378689|NCT02570815||Single Group Assignment||Treatment||None (Open Label)||||||
1378690|NCT02570802||Single Group Assignment||Basic Science||None (Open Label)||||||
1378691|NCT02570789||Single Group Assignment||Basic Science||None (Open Label)||||||
1378692|NCT02570776|||Cohort||Prospective|||||||
1378693|NCT02570763|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378694|NCT02570750|||Other||Prospective|||||||
1378695|NCT02570737|||Cohort||Prospective|||||||
1378696|NCT02570724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378697|NCT02570711|Randomized|Parallel Assignment||Treatment||Single||||||t
1378698|NCT02570698|||Cohort||Prospective|||||||
1378699|NCT02570685|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378700|NCT02570672|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378701|NCT02570659|Randomized|Single Group Assignment||Prevention||Single|||t|||
1378702|NCT02570646||Single Group Assignment||Treatment||None (Open Label)||||||
1378703|NCT02570633|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1378704|NCT02570620||Single Group Assignment||Prevention||None (Open Label)||||||
1378705|NCT02570607|||Other||Prospective|||||||
1378706|NCT02570594||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378707|NCT02570581|Non-Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1378708|NCT02570568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378709|NCT02570555|||Other||Other|||||||
1378710|NCT02570542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378711|NCT02570529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378712|NCT02570516|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1378713|NCT02570503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378714|NCT02570490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378715|NCT02570477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378716|NCT02570464|Randomized|Parallel Assignment||||None (Open Label)||||||
1378717|NCT02570451|||Cohort||Prospective|||||||
1378718|NCT02570438|||||Prospective|||||||
1378719|NCT02570425|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378720|NCT02570412||||||||||||
1378721|NCT02570399||Single Group Assignment||Treatment||None (Open Label)||||||
1378722|NCT02570386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378723|NCT02570373||Single Group Assignment||||None (Open Label)||||||
1378724|NCT02570360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378725|NCT02570347|Randomized|Parallel Assignment||Treatment||Single||||||t
1378726|NCT02570334|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1378727|NCT02570321|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1378728|NCT02570308|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378729|NCT02570295|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378730|NCT02570282|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1378731|NCT02570269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378732|NCT02570256|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1378733|NCT02570243|Randomized|Parallel Assignment||Treatment||Single||||||t
1378734|NCT02570230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378735|NCT02570217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378736|NCT02570204||Single Group Assignment||Health Services Research||None (Open Label)||||||
1378737|NCT02570191|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378738|NCT02570178|Randomized|Parallel Assignment||Prevention||Single|||||t|
1378739|NCT02570165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378740|NCT02570152||Single Group Assignment||Other||None (Open Label)||||||
1378741|NCT02570139|Randomized|Parallel Assignment||Treatment||Single||||||t
1378742|NCT02570126|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378743|NCT02570113||Single Group Assignment||Treatment||None (Open Label)||||||
1378744|NCT02570100||Single Group Assignment||Basic Science||None (Open Label)||||||
1378745|NCT02570087|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1378746|NCT02570074|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1378747|NCT02570061|Randomized|Parallel Assignment||||None (Open Label)||||||
1378748|NCT02570048|||Cohort||Retrospective|||||||
1378749|NCT02570035|||Cohort||Prospective|||||||
1378750|NCT02570022|Randomized|Parallel Assignment||Treatment||Single||||||t
1378751|NCT02570009|Randomized|Parallel Assignment||Treatment||Single||||||t
1378752|NCT02569996||Single Group Assignment||Treatment||None (Open Label)||||||
1378753|NCT02569983|||Cohort||Prospective|||||||
1378754|NCT02569970|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378755|NCT02569957|Randomized|Parallel Assignment||Treatment||Single||||||t
1378756|NCT02569944|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378757|NCT02569931|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378758|NCT02569918||Single Group Assignment||Treatment||None (Open Label)||||||
1378759|NCT02569905|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1378760|NCT02569892|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1378761|NCT02569879|||Ecologic or Community||Retrospective|||||||
1378762|NCT02569866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378763|NCT02569853|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378764|NCT02569840||Single Group Assignment||Other||None (Open Label)||||||
1378765|NCT02569827|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378766|NCT02569814|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378767|NCT02569801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378768|NCT02569788||Single Group Assignment||Treatment||None (Open Label)||||||
1378769|NCT02569775||Single Group Assignment||Treatment||None (Open Label)||||||
1378770|NCT02569762|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1378771|NCT02569749|||Cohort||Prospective|||||||
1378772|NCT02569736|||Cohort||Prospective|||||||
1378773|NCT02569723||Single Group Assignment||Treatment||None (Open Label)||||||
1378774|NCT02569710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378775|NCT02569697|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1378776|NCT02569684|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1378777|NCT02569671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378778|NCT02569658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378779|NCT02569645||Single Group Assignment||Treatment||None (Open Label)||||||
1378780|NCT02569632||Single Group Assignment||||None (Open Label)||||||
1378781|NCT02569619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378782|NCT02569606|||Cohort||Retrospective|||||||
1378783|NCT02569593||Single Group Assignment||Supportive Care||None (Open Label)||||||
1378784|NCT02569580||Single Group Assignment||Treatment||None (Open Label)||||||
1378785|NCT02569567|||Cohort||Prospective|||||||
1378786|NCT02569554||Crossover Assignment||Basic Science||None (Open Label)||||||
1378787|NCT02569541||Single Group Assignment||Treatment||None (Open Label)||||||
1378788|NCT02569528|||Other||Prospective|||||||
1378789|NCT02569515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378790|NCT02569502|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378791|NCT02569489||Single Group Assignment||Treatment||None (Open Label)||||||
1378792|NCT02569476||Single Group Assignment||Treatment||None (Open Label)||||||
1378793|NCT02569463||Single Group Assignment||Treatment||None (Open Label)||||||
1378794|NCT02569450|||Cohort||Prospective|||||||
1378795|NCT02569437|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378796|NCT02569424||Single Group Assignment||Prevention||None (Open Label)||||||
1378797|NCT02569411|Randomized|Parallel Assignment||Other||Single|||||t|
1378798|NCT02569398|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378799|NCT02569385|||Case-Only||Prospective|||||||
1378800|NCT02569372|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378801|NCT02569359|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378802|NCT02569346|Randomized|Crossover Assignment||||None (Open Label)||||||
1378803|NCT02569333|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1378804|NCT02569320||Single Group Assignment||Treatment||None (Open Label)||||||
1378805|NCT02569307|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1378806|NCT02569294|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1378807|NCT02569281|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378808|NCT02569268|||Cohort||Prospective|||||||
1378809|NCT02569255|||Cohort||Prospective|||||||
1378810|NCT02569242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378811|NCT02569229|||Cohort||Prospective|||||||
1378812|NCT02569216||Single Group Assignment||Prevention||None (Open Label)||||||
1378813|NCT02569203|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1378814|NCT02569190||Single Group Assignment||Treatment||None (Open Label)||||||
1378815|NCT02569177|||Cohort||Prospective|||||||
1378816|NCT02569164|||Case-Only||Prospective|||||||
1378817|NCT02569151|||Cohort||Prospective|||||||
1378818|NCT02569138|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1378819|NCT02569125||Single Group Assignment||Treatment||None (Open Label)||||||
1378820|NCT02569112|Non-Randomized|Single Group Assignment||Treatment||Double|Both investigator and independent reviewer to determine which side of the body the multi-polar radiofrequency, pulsed-electromagnetic fields and vacuum therapy was applied.|All participants to receive cryolipolysis treatment on one side of their body and cryolipolysis plus multipolar radiofrequency with varipulse technology treatment on the other side of their body.|||t|t
1378821|NCT02569099|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1378822|NCT02569086|||Case-Only||Prospective|||||||
1378823|NCT02569073|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1378824|NCT02569060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378825|NCT02569047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378826|NCT02569034|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1378827|NCT02569021|||Case-Only||Prospective|||||||
1378828|NCT02569008|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1378829|NCT02568995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378830|NCT02568982|||Cohort||Prospective|||||||
1378831|NCT02568969||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378832|NCT02568943||||||||||||
1378833|NCT02568930|||Other||Prospective|||||||
1378834|NCT02568917|Randomized|Parallel Assignment||Treatment||Single||||||t
1378835|NCT02568904|||Other||Prospective|||||||
1378836|NCT02568891|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378837|NCT02568878||Single Group Assignment||Treatment||None (Open Label)||||||
1378838|NCT02568865|||Cohort||Prospective|||||||
1378839|NCT02568852|Randomized|Parallel Assignment||||None (Open Label)||||||
1378840|NCT02568839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378841|NCT02568826||Single Group Assignment||Other||None (Open Label)||||||
1378842|NCT02568813||Single Group Assignment||Supportive Care||None (Open Label)||||||
1378843|NCT02568800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378844|NCT02568787|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1378845|NCT02568774|Randomized|Parallel Assignment||Treatment||Single||||||t
1378846|NCT02568761|Randomized|Parallel Assignment||Treatment||Single||||||t
1378847|NCT02568748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|No Masking|||||
1378848|NCT02568735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378849|NCT02568722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378850|NCT02568709|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1378851|NCT02568696|||Case-Only||Prospective|||||||
1378852|NCT02568683|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378853|NCT02568670|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1378854|NCT02568657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378855|NCT02568644|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1378856|NCT02568631|Randomized|Parallel Assignment||Other||Single||||||t
1378857|NCT02568618|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1378858|NCT02568605|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378859|NCT02568592|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1378860|NCT02568579|||Cohort||Prospective|||||||
1378861|NCT02568566||Single Group Assignment||Prevention||None (Open Label)||||||
1378862|NCT02568553||Single Group Assignment||Treatment||None (Open Label)||||||
1378863|NCT02568540|||Cohort||Prospective|||||||
1378864|NCT02568527||Single Group Assignment||Treatment||None (Open Label)||||||
1378865|NCT02568514|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1378866|NCT02568501|Randomized|Parallel Assignment||Treatment||Single|||||t|
1378867|NCT02568488||Single Group Assignment||Treatment||None (Open Label)||||||
1378868|NCT02568475|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378869|NCT02568462||Single Group Assignment||Treatment||None (Open Label)||||||
1378870|NCT02568449||Single Group Assignment||Treatment||None (Open Label)||||||
1378871|NCT02568436|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378872|NCT02568423|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1378873|NCT02568410|||Cohort||Prospective|||||||
1378874|NCT02568397|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1378875|NCT02568384||Single Group Assignment||Supportive Care||None (Open Label)||||||
1378876|NCT02568371|||Cohort||Prospective|||||||
1378877|NCT02568358|||Cohort||Prospective|||||||
1378878|NCT02568345||Single Group Assignment||Treatment||None (Open Label)||||||
1378879|NCT02568332||Single Group Assignment||Prevention||None (Open Label)||||||
1378880|NCT02568319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378881|NCT02568306|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1378882|NCT02568293|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1378883|NCT02568280|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1378884|NCT02568267|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378885|NCT02568254|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1378886|NCT02568241||Single Group Assignment||Prevention||None (Open Label)||||||
1378887|NCT02568228|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1378888|NCT02568215|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378889|NCT02568202|||Cohort||Prospective|||||||
1378890|NCT02568189|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378891|NCT02568176|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378892|NCT02568163||Single Group Assignment||Prevention||None (Open Label)||||||
1378893|NCT02568150||Single Group Assignment||Treatment||None (Open Label)||||||
1378894|NCT02568137|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1378895|NCT02568124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378896|NCT02568111|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1378897|NCT02568098|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378898|NCT02568085|Randomized|Parallel Assignment||Prevention||Single|||||t|
1378899|NCT02568072|||Cohort||Prospective|||||||
1378900|NCT02568059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378901|NCT02568046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378902|NCT02568033||Single Group Assignment||Treatment||None (Open Label)||||||
1378903|NCT02568020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1378904|NCT02568007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378905|NCT02567994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378906|NCT02567981|Randomized|Parallel Assignment||Treatment||Single||||||t
1378907|NCT02567968|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1378908|NCT02567955|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1378909|NCT02567942|Randomized|Factorial Assignment||Basic Science||Single|||||t|
1378910|NCT02567929|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1378911|NCT02567916|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378912|NCT02567903|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1378913|NCT02567890|Randomized|Parallel Assignment||Prevention||Single||||||t
1378914|NCT02567877|||Cohort||Prospective|||||||
1378915|NCT02567864|Randomized|Parallel Assignment||Prevention||Single||||||t
1378916|NCT02567851||Single Group Assignment||Treatment||None (Open Label)||||||
1378917|NCT02567838|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1378918|NCT02567825|Randomized|Parallel Assignment||Treatment||None (Open Label)|Subjects in the randomization phase of the study will be randomized to either medical management or tube surgery. No masking will occur.|||||
1378919|NCT02567812|||Cohort||Prospective|||||||
1378920|NCT02567799||Single Group Assignment||Prevention||None (Open Label)||||||
1378921|NCT02567786|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378922|NCT02567773|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378923|NCT02567760|Randomized|Crossover Assignment||||Double|||t|||t
1378924|NCT02567747|||Other||Retrospective|||||||
1378925|NCT02567734||Single Group Assignment||Treatment||None (Open Label)||||||
1378926|NCT02567721||||||||||||
1378927|NCT02567708|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1378928|NCT02567695|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378929|NCT02567682||Single Group Assignment||Treatment||None (Open Label)||||||
1378930|NCT02567669|||Cohort||Prospective|||||||
1378931|NCT02567656||Single Group Assignment||Treatment||None (Open Label)||||||
1378932|NCT02567643||Single Group Assignment||Treatment||None (Open Label)||||||
1378933|NCT02567630|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1378934|NCT02567617|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1378935|NCT02567604|||||Prospective|||||||
1378936|NCT02567591|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378937|NCT02567578|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378938|NCT02567565|||Case-Only||Prospective|||||||
1378939|NCT02567552|Randomized|Parallel Assignment||Treatment||Single|Masked samples for histological evaluation and assessment of gene expression|Parallel Assignment||||t
1378940|NCT02567539||Single Group Assignment||Treatment||None (Open Label)||||||
1378941|NCT02567526|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1378942|NCT02567513|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1378943|NCT02567500|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378944|NCT02567487|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1378945|NCT02567474|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1378946|NCT02567461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378947|NCT02567448|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1378948|NCT02567435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378949|NCT02567422||Single Group Assignment||Treatment||None (Open Label)||||||
1378950|NCT02567409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378951|NCT02567396||Single Group Assignment||Treatment||None (Open Label)||||||
1378952|NCT02567383||Single Group Assignment||Treatment||None (Open Label)||||||
1378953|NCT02567370|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1378954|NCT02567357|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1378955|NCT02567344|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1378956|NCT02567331|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1378957|NCT02567318||Single Group Assignment||Basic Science||Single||||||t
1378958|NCT02567305|||Cohort||Prospective|||||||
1378959|NCT02567292|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1378960|NCT02567279|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1378961|NCT02567266|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1378962|NCT02567253|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378963|NCT02567240|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1378964|NCT02567227|Randomized|Parallel Assignment||Treatment||Single|||t|||
1378965|NCT02567214|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1378966|NCT02567201|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378967|NCT02567188|||Case Control||Cross-Sectional|||||||
1378968|NCT02567175||||||||||||
1378969|NCT02567162|||Cohort||Prospective|||||||
1378970|NCT02567149||Single Group Assignment||Treatment||None (Open Label)||||||
1378971|NCT02567136|||Case-Control||Prospective|||||||
1378972|NCT02567123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378973|NCT02567110|||Cohort||Cross-Sectional|||||||
1378974|NCT02567097|Randomized|Parallel Assignment||Prevention||Single|||||t|
1378975|NCT02567084||Single Group Assignment||Treatment||None (Open Label)||||||
1378976|NCT02567071|Randomized|Parallel Assignment||||Single|||t|||
1378977|NCT02567058||Single Group Assignment||Prevention||None (Open Label)||||||
1378978|NCT02567045|Randomized|Parallel Assignment||Screening||None (Open Label)|Participants were randomized to either colonoscopy or faecal occult blood test|||||
1378979|NCT02567032|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1378980|NCT02567019|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1378981|NCT02567006|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1378982|NCT02566993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378983|NCT02566980|||Cohort||Prospective|||||||
1378984|NCT02566967||Single Group Assignment||Treatment||None (Open Label)||||||
1378985|NCT02566954||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378986|NCT02566941|Randomized|Parallel Assignment||Prevention||Single|||||t|
1378987|NCT02566928|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1378988|NCT02566915|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t||t
1378989|NCT02566902|Randomized|Parallel Assignment||Treatment||Single|||||t|
1378990|NCT02566889|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378991|NCT02566876|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1378992|NCT02566863||Single Group Assignment||Diagnostic||None (Open Label)||||||
1378993|NCT02566850||Single Group Assignment||Supportive Care||None (Open Label)||||||
1378994|NCT02566837|Randomized|Parallel Assignment||Treatment||Single||||||t
1378995|NCT02566824|Randomized|Parallel Assignment||Treatment||Single||||||t
1378996|NCT02566811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1378997|NCT02566798|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1378998|NCT02566785|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1378999|NCT02566772||Single Group Assignment||Treatment||None (Open Label)||||||
1379000|NCT02566759|Randomized|Parallel Assignment||Other||Double|||t||t|
1379001|NCT02566746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379002|NCT02566733|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379003|NCT02566720||Single Group Assignment||||None (Open Label)||||||
1379004|NCT02566707||Single Group Assignment||Treatment||None (Open Label)||||||
1379005|NCT02566694|||Case-Control||Retrospective|||||||
1379006|NCT02566681||Single Group Assignment||Treatment||None (Open Label)||||||
1379007|NCT02566668|||Case-Control||Prospective|||||||
1379008|NCT02566655||Single Group Assignment||Treatment||None (Open Label)||||||
1379009|NCT02566642|||Case-Only||Prospective|||||||
1379010|NCT02566629|||Case Control||Prospective|||||||
1379011|NCT02566616|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379012|NCT02566603||Single Group Assignment||Treatment||None (Open Label)||||||
1379013|NCT02566590|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379014|NCT02566577|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1379015|NCT02566564||Single Group Assignment||Supportive Care||None (Open Label)||||||
1379016|NCT02566551|Randomized|Parallel Assignment||Treatment||Single||||||t
1379017|NCT02566538|||Cohort||Prospective|||||||
1379018|NCT02566525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379019|NCT02566512|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1379020|NCT02566499||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379021|NCT02566486|Randomized|Single Group Assignment||Treatment||Single|||t|||
1379022|NCT02566473|||Cohort||Prospective|||||||
1379023|NCT02566460|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1379024|NCT02566447|||Other||Prospective|||||||
1379025|NCT02566434||Single Group Assignment||Other||None (Open Label)||||||
1379026|NCT02566421||Single Group Assignment||Treatment||None (Open Label)||||||
1379027|NCT02566408||Single Group Assignment||Supportive Care||None (Open Label)||||||
1379028|NCT02566395||Single Group Assignment||Treatment||None (Open Label)||||||
1379029|NCT02566382||Single Group Assignment||Treatment||None (Open Label)||||||
1379030|NCT02566369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379031|NCT02566356|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1379032|NCT02566343|||Case Control||Prospective|||||||
1379033|NCT02566330|||Cohort||Prospective|||||||
1379034|NCT02566317|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379035|NCT02566304||Single Group Assignment||Treatment||None (Open Label)||||||
1379036|NCT02566291|||Ecologic or Community||Prospective|||||||
1379037|NCT02566278||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379038|NCT02566265|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1379039|NCT02566252|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379040|NCT02566239|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379041|NCT02566226|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1379042|NCT02566213||Single Group Assignment||Basic Science||None (Open Label)||||||
1379043|NCT02566200|||Cohort||Prospective|||||||
1379044|NCT02566187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379045|NCT02566174|||Cohort||Prospective|||||||
1379046|NCT02566161|||Family-Based||Cross-Sectional|||||||
1379047|NCT02566148|||Case-Only||Retrospective|||||||
1379048|NCT02566135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379049|NCT02566122|||Cohort||Other|||||||
1379050|NCT02566109||Single Group Assignment||Other||None (Open Label)||||||
1379051|NCT02566096|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1379052|NCT02566083|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379053|NCT02566070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379054|NCT02566057|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379055|NCT02566044||Crossover Assignment||Treatment||Double|||t||t|
1379056|NCT02566031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379057|NCT02566018|||Cohort||Other|||||||
1379058|NCT02566005|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379059|NCT02565992||Single Group Assignment||Treatment||None (Open Label)||||||
1379060|NCT02565979|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379061|NCT02565966|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1379062|NCT02565953|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379063|NCT02565940|||Case-Only||Prospective|||||||
1379064|NCT02565927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379065|NCT02565914|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379066|NCT02565901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379067|NCT02565888|Randomized|Crossover Assignment||||None (Open Label)||||||
1379068|NCT02565875|Randomized|Parallel Assignment||||Single|||t|||
1379069|NCT02565862|Randomized|Crossover Assignment||||None (Open Label)||||||
1379070|NCT02565849|||Case Control||Cross-Sectional|||||||
1379071|NCT02565836|||Cohort||Retrospective|||||||
1379072|NCT02565823||Single Group Assignment||Basic Science||None (Open Label)||||||
1379073|NCT02565810||Single Group Assignment||Other||None (Open Label)||||||
1379074|NCT02565797|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1379075|NCT02565784||Single Group Assignment||Treatment||None (Open Label)||||||
1379076|NCT02565771|||Cohort||Prospective|||||||
1379077|NCT02565758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379078|NCT02565745|Randomized|Parallel Assignment||Prevention||Double|Outcome assessors unaware of the treatment allocation will be sent photographs of the target skin areas with suspected PUs.||||t|t
1379079|NCT02565732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379080|NCT02565719|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379081|NCT02565706|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1379082|NCT02565693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379083|NCT02565680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379084|NCT02565667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379085|NCT02565654|||Case Control||Prospective|||||||
1379086|NCT02565641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379087|NCT02565628|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1379088|NCT02565615|||Cohort||Prospective|||||||
1379089|NCT02565602||Single Group Assignment||Basic Science||None (Open Label)||||||
1379090|NCT02565589|||Case-Control||Cross-Sectional|||||||
1379091|NCT02565576|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379092|NCT02565563|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1379093|NCT02565550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379094|NCT02565537|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379095|NCT02565524||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379096|NCT02565511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379097|NCT02565498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379098|NCT02565485|Randomized|Parallel Assignment||Prevention||Single||||||t
1379099|NCT02565472|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1379100|NCT02565459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379101|NCT02565446||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379102|NCT02565433||Single Group Assignment||Other||None (Open Label)||||||
1379103|NCT02565420|Non-Randomized|Sequential Assignment||Other||None (Open Label)||Alternating intervention||||
1379104|NCT02565407|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379105|NCT02565394|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379106|NCT02565381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379107|NCT02565368|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379108|NCT02565355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379109|NCT02565342||Single Group Assignment||Treatment||None (Open Label)||||||
1379110|NCT02565329|||Cohort||Retrospective|||||||
1379111|NCT02565316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379112|NCT02565303|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379113|NCT02565290|Randomized|Single Group Assignment||||Triple|||t||t|t
1379114|NCT02565277|Randomized|Crossover Assignment||Other||Double|||t||t|
1379115|NCT02565264||Single Group Assignment||Treatment||None (Open Label)||||||
1379116|NCT02565251|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379117|NCT02565238|||Case-Only||Prospective|||||||
1379118|NCT02565225|||||Prospective|||||||
1379119|NCT02565212|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379120|NCT02565199|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379121|NCT02565186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379122|NCT02565173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379123|NCT02565160|||Case-Only||Prospective|||||||
1379124|NCT02565147|Randomized|Parallel Assignment||Treatment||Single|The primary endpoint was evaluated by a core lab totally blinded to clinical information and the treatment groups.|||||t
1379125|NCT02565134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379126|NCT02565121||Single Group Assignment||Treatment||None (Open Label)||||||
1379127|NCT02565108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379128|NCT02565095||Single Group Assignment||Basic Science||None (Open Label)||||||
1379129|NCT02565082|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1379130|NCT02565069||Single Group Assignment||Treatment||None (Open Label)||||||
1379131|NCT02565056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379132|NCT02565043|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379133|NCT02565030|||Cohort||Retrospective|||||||
1379134|NCT02565017|||Cohort||Prospective|||||||
1379135|NCT02565004|||Family-Based||Cross-Sectional|||||||
1379136|NCT02564991|||Case-Control||Prospective|||||||
1379137|NCT02564978||Single Group Assignment||Treatment||None (Open Label)||||||
1379138|NCT02564965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379139|NCT02564952||Single Group Assignment||Other||None (Open Label)||||||
1379140|NCT02564939|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379141|NCT02564926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379142|NCT02564913|||Case Control||Prospective|||||||
1379143|NCT02564900|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379144|NCT02564887|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379145|NCT02564874|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379146|NCT02564861|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1379147|NCT02564848||Single Group Assignment||Treatment||None (Open Label)||||||
1379148|NCT02564835|Randomized|Parallel Assignment||Supportive Care||Single|Research assistants at Time 2 and 3 are blinded to which arm the participant is in.|||||t
1379149|NCT02564822|||Other||Cross-Sectional|||||||
1379150|NCT02564809|Randomized|Parallel Assignment||Prevention||Single||||||t
1379151|NCT02564796|Randomized|Parallel Assignment||Treatment||Single||||||t
1379152|NCT02564783|||Cohort||Prospective|||||||
1379153|NCT02564770|||Case-Only||Retrospective|||||||
1379154|NCT02564757|||Cohort||Retrospective|||||||
1379155|NCT02564744||Single Group Assignment||Treatment||None (Open Label)||||||
1379156|NCT02564731|||Cohort||Prospective|||||||
1379157|NCT02564718||Single Group Assignment||Other||None (Open Label)||||||
1379158|NCT02564705|||Cohort||Prospective|||||||
1379159|NCT02564692|||Cohort||Prospective|||||||
1379160|NCT02564679|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379161|NCT02564666|Randomized|Parallel Assignment||||None (Open Label)||||||
1379162|NCT02564653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379163|NCT02564640|Randomized|Parallel Assignment||Prevention||Single||||||t
1379164|NCT02564627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379165|NCT02564614||Single Group Assignment||Treatment||None (Open Label)||||||
1379166|NCT02564601|Randomized|Parallel Assignment||||Single||||||t
1379167|NCT02564588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379168|NCT02564575|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379169|NCT02564562||Single Group Assignment||Basic Science||None (Open Label)||||||
1379170|NCT02564549|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1379171|NCT02564536||Single Group Assignment||Treatment||None (Open Label)||||||
1379172|NCT02564523|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1379173|NCT02564497|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379174|NCT02564484|||Case-Control||Prospective|||||||
1379175|NCT02564471|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379176|NCT02564458|Randomized|Parallel Assignment||Treatment||Single||||||t
1379177|NCT02564445|Randomized|Parallel Assignment||Treatment||Single|||||t|
1379178|NCT02564432|||Cohort||Prospective|||||||
1379179|NCT02564419||Single Group Assignment||Health Services Research||None (Open Label)||||||
1379180|NCT02564406||Single Group Assignment||Treatment||None (Open Label)||||||
1379181|NCT02564393|||Case Control||Prospective|||||||
1379182|NCT02564380|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379183|NCT02564367||Single Group Assignment||Treatment||None (Open Label)||||||
1379184|NCT02564354|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1379185|NCT02564341|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1379186|NCT02564328|Randomized|Parallel Assignment||Treatment||Single||||||t
1379187|NCT02564315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379188|NCT02564302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379189|NCT02564289|||Case Control||Cross-Sectional|||||||
1379190|NCT02564276|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1379191|NCT02564263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379192|NCT02564250|||Cohort||Prospective|||||||
1379193|NCT02564237|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1379194|NCT02564224||||||||||||
1379195|NCT02564211||Single Group Assignment||Treatment||None (Open Label)||||||
1379196|NCT02564198||Single Group Assignment||Treatment||None (Open Label)||||||
1379197|NCT02564185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379198|NCT02564172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379199|NCT02564159||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379200|NCT02564146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379201|NCT02564133||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379202|NCT02564120|||Cohort||Prospective|||||||
1379203|NCT02564107|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379204|NCT02564094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379205|NCT02564081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379206|NCT02564068|Randomized|Crossover Assignment||Other||Triple|All members of the research team except the IP dispensing staff will be blinded for the duration of the research study. Once all the subjects have finished in the research study, and all data is data-locked, the outcomes assessor will then unblind the research data for the statistical analysis.||t|t|t|
1379207|NCT02564055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379208|NCT02564042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379209|NCT02564029|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1379210|NCT02564016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379211|NCT02564003|||Case Control||Prospective|||||||
1379212|NCT02563990|Randomized|Parallel Assignment||Prevention||Single|||t|||
1379213|NCT02563977|||||Prospective|||||||
1379214|NCT02563964|||Case-Control||Prospective|||||||
1379215|NCT02563951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379216|NCT02563938|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1379217|NCT02563925||Single Group Assignment||Treatment||None (Open Label)||||||
1379218|NCT02563912|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379219|NCT02563899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379220|NCT02563886|Randomized|Crossover Assignment||Treatment||Single||||||t
1379221|NCT02563873|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1379222|NCT02563860||Single Group Assignment||Treatment||None (Open Label)||||||
1379223|NCT02563847|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1379224|NCT02563834|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1379225|NCT02563821|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379226|NCT02563808|Randomized|Single Group Assignment||||None (Open Label)||||||
1379227|NCT02563795|||Case Control||Prospective|||||||
1379228|NCT02563782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379229|NCT02563769|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1379230|NCT02563756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379231|NCT02563743|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1379232|NCT02563730||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379233|NCT02563717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379234|NCT02563704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379235|NCT02563691||Single Group Assignment||Treatment||None (Open Label)||||||
1379236|NCT02563678|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379237|NCT02563665|||Cohort||Prospective|||||||
1379238|NCT02563652|||Cohort||Prospective|||||||
1379239|NCT02563639|||Case-Only||Prospective|||||||
1379240|NCT02563626|||Cohort||Prospective|||||||
1379241|NCT02563613|Randomized|Crossover Assignment||Prevention||Single|||t|||
1379242|NCT02563600|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1379243|NCT02563587|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379244|NCT02563574|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379245|NCT02563561|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379246|NCT02563548||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1379247|NCT02563535|Randomized|Parallel Assignment||Treatment||Single||||||t
1379248|NCT02563522|Randomized|Parallel Assignment||Treatment||Triple||Active: VM202 + standard of care - 200 subjects Control: Placebo (VM202 vehicle) + standard of care - 100 subjects|t|t|t|
1379249|NCT02563509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379250|NCT02563496||Single Group Assignment||Treatment||None (Open Label)||||||
1379251|NCT02563483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379252|NCT02563470|||Cohort||Retrospective|||||||
1379253|NCT02563457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379254|NCT02563444||Single Group Assignment||||None (Open Label)||||||
1379255|NCT02563431|Randomized|Parallel Assignment||Prevention||Single||||||t
1379256|NCT02563418||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379257|NCT02563405|Randomized|Crossover Assignment||Treatment||Single||||||t
1379258|NCT02563392|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379259|NCT02563379|||Cohort||Cross-Sectional|||||||
1379260|NCT02563366|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379261|NCT02563353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379262|NCT02563340|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1379263|NCT02563327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379264|NCT02563314|Randomized|Parallel Assignment||Other||Single|||||t|
1379265|NCT02563301|Randomized|Crossover Assignment||Treatment||Single|||t|||
1379266|NCT02563288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379267|NCT02563275||Single Group Assignment||Basic Science||None (Open Label)||||||
1379268|NCT02563262||Single Group Assignment||Basic Science||None (Open Label)||||||
1379269|NCT02563249||Single Group Assignment||Basic Science||None (Open Label)||||||
1379270|NCT02563236||Single Group Assignment||Basic Science||None (Open Label)||||||
1379271|NCT02563223||Single Group Assignment||Basic Science||None (Open Label)||||||
1379272|NCT02563210||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379273|NCT02563197||Single Group Assignment||Treatment||None (Open Label)||||||
1379274|NCT02563184|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379275|NCT02563171|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1379276|NCT02563158|Randomized|Parallel Assignment||Treatment||Single||||||t
1379277|NCT02563145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379278|NCT02563132|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1379279|NCT02563119|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379280|NCT02563106|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1379281|NCT02563093|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379282|NCT02563080|||Case-Only||Prospective|||||||
1379283|NCT02563067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379284|NCT02563054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379285|NCT02563041|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379286|NCT02563028||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379287|NCT02563015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379288|NCT02563002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379289|NCT02562989|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1379290|NCT02562976|||Case Control||Prospective|||||||
1379291|NCT02562963||Single Group Assignment||Treatment||None (Open Label)||||||
1379292|NCT02562950|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379293|NCT02562937|Randomized|Parallel Assignment||Prevention||Single|||t|||
1379294|NCT02562924|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1379295|NCT02562911|||Cohort||Prospective|||||||
1379296|NCT02562898|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379297|NCT02562885||Single Group Assignment||Basic Science||None (Open Label)||||||
1379298|NCT02562872|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379299|NCT02562859|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379300|NCT02562846|||Cohort||Prospective|||||||
1379301|NCT02562833|Randomized|Parallel Assignment||Treatment||Single|||||t|
1379302|NCT02562820|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1379303|NCT02562807|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1379304|NCT02562794|Randomized|Parallel Assignment||Prevention||Single||||||t
1379305|NCT02562781|Randomized|Parallel Assignment||Other||Single|||t|||
1379306|NCT02562768|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1379307|NCT02562755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379308|NCT02562742|||Ecologic or Community||Prospective|||||||
1379309|NCT02562729||Single Group Assignment||Treatment||None (Open Label)||||||
1379310|NCT02562716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379311|NCT02562703|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1379312|NCT02562690|||Cohort||Prospective|||||||
1379313|NCT02562677||Single Group Assignment||Treatment||None (Open Label)||||||
1379314|NCT02562664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379315|NCT02562651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379316|NCT02562638|Randomized|Parallel Assignment||Treatment||Single|||||t|
1379317|NCT02562625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379318|NCT02562612||Single Group Assignment||Treatment||None (Open Label)||||||
1379319|NCT02562599||Single Group Assignment||Treatment||None (Open Label)||||||
1379320|NCT02562586|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1379321|NCT02562573||Single Group Assignment||Treatment||None (Open Label)||||||
1379322|NCT02562560||||Diagnostic||||||||
1379323|NCT02562547|||Case Control||Retrospective|||||||
1379324|NCT02562534|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1379325|NCT02562521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379326|NCT02562508|Randomized|Parallel Assignment||Prevention||Single||||||t
1379327|NCT02562495||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379328|NCT02562482|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1379329|NCT02562469||Single Group Assignment||Treatment||None (Open Label)||||||
1379330|NCT02562456|Randomized|Parallel Assignment||Treatment||Single||||||t
1379331|NCT02562443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379332|NCT02562430|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379333|NCT02562417|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379334|NCT02562404|||Cohort||Prospective|||||||
1379335|NCT02562391|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379336|NCT02562378||Single Group Assignment||Treatment||None (Open Label)||||||
1379337|NCT02562365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379338|NCT02562352|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1379339|NCT02562339|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379340|NCT02562326|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1379341|NCT02562313|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1379342|NCT02562300|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379343|NCT02562287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379344|NCT02562274|Randomized|Parallel Assignment||||Double|||t||t|
1379345|NCT02562261|||Cohort||Prospective|||||||
1379346|NCT02562248|Randomized|Parallel Assignment||Screening||Single||||t||
1379347|NCT02562235||Single Group Assignment||Treatment||None (Open Label)||||||
1379348|NCT02562222|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1379349|NCT02562209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379350|NCT02562196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379351|NCT02562183||Single Group Assignment||Treatment||None (Open Label)||||||
1379352|NCT02562170|Randomized|Parallel Assignment||||None (Open Label)||||||
1379353|NCT02562157||Single Group Assignment||Treatment||None (Open Label)||||||
1379354|NCT02562144|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1379355|NCT02562131|||Case-Only||Prospective|||||||
1379356|NCT02562118||Single Group Assignment||Treatment||None (Open Label)||||||
1379357|NCT02562105|||Cohort||Prospective|||||||
1379358|NCT02562092|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1379359|NCT02562079|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379360|NCT02562066|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1379361|NCT02562053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379362|NCT02562040|Randomized|Parallel Assignment||Treatment||Single||||||t
1379363|NCT02562027||Single Group Assignment||Health Services Research||None (Open Label)||||||
1379364|NCT02562014|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1379365|NCT02562001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379366|NCT02561988||Single Group Assignment||Treatment||None (Open Label)||||||
1379367|NCT02561975||Single Group Assignment||Other||None (Open Label)||||||
1379368|NCT02561962||Single Group Assignment||Treatment||None (Open Label)||||||
1379369|NCT02561949|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1379370|NCT02561936|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379371|NCT02561923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379372|NCT02561910|||Cohort||Prospective|||||||
1379373|NCT02561897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379374|NCT02561884|Randomized|Crossover Assignment||||None (Open Label)||||||
1379375|NCT02561871|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1379376|NCT02561858||Single Group Assignment||Other||None (Open Label)||||||
1379377|NCT02561845|||Case-Only||Retrospective|||||||
1379378|NCT02561832||Single Group Assignment||Treatment||None (Open Label)||||||
1379379|NCT02561819|||Cohort||Prospective|||||||
1379380|NCT02561806|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379381|NCT02561793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379382|NCT02561780|Randomized|Parallel Assignment||||Single|||t|||
1379383|NCT02561767|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379384|NCT02561754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379385|NCT02561741||Single Group Assignment||||None (Open Label)||||||
1379386|NCT02561728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379388|NCT02561702|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1379389|NCT02561689|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379390|NCT02561676|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379391|NCT02561663|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1379392|NCT02561650||Single Group Assignment||||None (Open Label)||||||
1379393|NCT02561637|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379394|NCT02561624|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1379395|NCT02561611|Randomized|Parallel Assignment||Prevention||Single||||||t
1379396|NCT02561598|||Case-Control||Retrospective|||||||
1379397|NCT02561585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379398|NCT02561572|Randomized|Parallel Assignment||Treatment||Single||||||t
1379399|NCT02561559|||Cohort||Prospective|||||||
1379400|NCT02561546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379401|NCT02561533||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379402|NCT02561520||Single Group Assignment||Treatment||None (Open Label)||||||
1379403|NCT02561507|||Cohort||Prospective|||||||
1379404|NCT02561494|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1379405|NCT02561481|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1379406|NCT02561468|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1379407|NCT02561455||Single Group Assignment||Treatment||None (Open Label)||||||
1379408|NCT02561442|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1379409|NCT02561429||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379410|NCT02561416|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1379411|NCT02561403|Randomized|Parallel Assignment||||Single||||||t
1379412|NCT02561390|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1379413|NCT02561377|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379414|NCT02561364|||Case-Only||Prospective|||||||
1379415|NCT02561351|||Cohort||Prospective|||||||
1379416|NCT02561338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379417|NCT02561325|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1379418|NCT02561312|||Case-Crossover||Prospective|||||||
1379419|NCT02561299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379420|NCT02561286|Randomized|Parallel Assignment||Prevention||Single||||||t
1379421|NCT02561273||Single Group Assignment||Treatment||None (Open Label)||||||
1379422|NCT02561260|||Case Control||Prospective|||||||
1379423|NCT02561247||Single Group Assignment||Treatment||None (Open Label)||||||
1379424|NCT02561234||Single Group Assignment||Treatment||None (Open Label)||||||
1379425|NCT02561221|Randomized|Parallel Assignment||Treatment||Single||||||t
1379426|NCT02561208|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379427|NCT02561195|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1379428|NCT02561182|||Cohort||Prospective|||||||
1379429|NCT02561169|Randomized|Parallel Assignment||||Triple|||t|t|t|
1379430|NCT02561156|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1379431|NCT02561143|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1379432|NCT02561130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379433|NCT02561117|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1379434|NCT02561104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379435|NCT02561091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379436|NCT02561078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379437|NCT02561065|Randomized|Parallel Assignment||Prevention||Single||||||t
1379438|NCT02561052||||||||||||
1379439|NCT02561039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379440|NCT02561026|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379441|NCT02561013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379442|NCT02561000|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379443|NCT02560974||Parallel Assignment||Treatment||None (Open Label)||||||
1379444|NCT02560961|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1379445|NCT02560948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379446|NCT02560935|Randomized|Single Group Assignment||Prevention||Double|||||t|t
1379447|NCT02560922|Randomized|Parallel Assignment||Treatment||Single||||||t
1379448|NCT02560909|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379449|NCT02560896|||Family-Based||Prospective|||||||
1379450|NCT02560883|||Cohort||Prospective|||||||
1379451|NCT02560870|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379452|NCT02560857|||Cohort||Prospective|||||||
1379453|NCT02560844|||Cohort||Prospective|||||||
1379454|NCT02560831|Randomized|Parallel Assignment||Treatment||Single|||||t|
1379455|NCT02560818|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1379456|NCT02560805|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1379457|NCT02560792|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1379458|NCT02560779||Single Group Assignment||Treatment||None (Open Label)||||||
1379459|NCT02560766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379460|NCT02560753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379461|NCT02560740|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1379462|NCT02560727|||Cohort||Prospective|||||||
1379463|NCT02560714|||Cohort||Prospective|||||||
1379464|NCT02560701|||Cohort||Retrospective|||||||
1379465|NCT02560688|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1379466|NCT02560675|||Cohort||Prospective|||||||
1379467|NCT02560662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379468|NCT02560649|Randomized|||Treatment||None (Open Label)||||||
1379469|NCT02560636|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379470|NCT02560623|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1379471|NCT02560610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379472|NCT02560597||Single Group Assignment||Treatment||None (Open Label)||||||
1379473|NCT02560584||Single Group Assignment||Diagnostic||None (Open Label)||"This is a prospective, open, comparative, within-patient controlled Phase 3 multicenter study in patients with bladder cancer. There is a maximum of three study visits for an enrolled patient:~Visit 1: Screening visit Visit 2: Surveillance cystoscopy in white light (WL) followed by blue light (BL) Visit 3: Operating room (OR) cystoscopy in WL followed by BL for patients with suspicion of recurrence after surveillance cystoscopy.~Cystoscopy in WL followed by BL is performed in all patients after Cysview instillation. Only patients with suspicious lesions at Visit 2 continue to a second cystoscopy in WL followed by BL at Visit 3."||||
1379474|NCT02560571||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379475|NCT02560558|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379476|NCT02560545|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1379477|NCT02560532||Single Group Assignment||Treatment||None (Open Label)||||||
1379478|NCT02560519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379479|NCT02560506||Single Group Assignment||Treatment||None (Open Label)||||||
1379480|NCT02560493|Randomized|Parallel Assignment||Prevention||Single||||||t
1379481|NCT02560480|||Case-Control||Prospective|||||||
1379482|NCT02560467||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379483|NCT02560454|Randomized|Parallel Assignment||Treatment||Single||||||t
1379484|NCT02560441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379485|NCT02560428|||Case-Only||Cross-Sectional|||||||
1379486|NCT02560415|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379487|NCT02560402|||Cohort||Prospective|||||||
1379488|NCT02560389|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1379489|NCT02560376||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379490|NCT02560363|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1379491|NCT02560350|||Cohort||Prospective|||||||
1379492|NCT02560337|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379493|NCT02560324|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1379494|NCT02560311|||Cohort||Retrospective|||||||
1379495|NCT02560298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379496|NCT02560285|||Cohort||Prospective|||||||
1379497|NCT02560272|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379498|NCT02560259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379499|NCT02560246|||Case-Control||Prospective|||||||
1379500|NCT02560233|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1379501|NCT02560220||Single Group Assignment||Prevention||None (Open Label)||||||
1379502|NCT02560207|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379503|NCT02560194|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1379504|NCT02560181||Single Group Assignment||Treatment||None (Open Label)||||||
1379505|NCT02560168||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1379506|NCT02560155|Randomized|Parallel Assignment||Prevention||Single||||||t
1379507|NCT02560142|||Cohort||Prospective|||||||
1379508|NCT02560129|||Cohort||Prospective|||||||
1379509|NCT02560116|||Cohort||Prospective|||||||
1379510|NCT02560103|||Case-Only||Prospective|||||||
1379511|NCT02560090|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1379512|NCT02560077|Randomized|Parallel Assignment||||Double|||t||t|
1379513|NCT02560064|||Cohort||Prospective|||||||
1379514|NCT02560051|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379515|NCT02560038||Single Group Assignment||Treatment||None (Open Label)||||||
1379516|NCT02560025||Single Group Assignment||Treatment||None (Open Label)||||||
1379517|NCT02560012||Single Group Assignment||Treatment||None (Open Label)||||||
1379518|NCT02559999||Single Group Assignment||Basic Science||None (Open Label)||||||
1379519|NCT02559986|||Cohort||Cross-Sectional|||||||
1379520|NCT02559973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379521|NCT02559960|||Cohort||Prospective|||||||
1379522|NCT02559934||Single Group Assignment||Treatment||None (Open Label)||||||
1379523|NCT02559921|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1379524|NCT02559908|Randomized|Parallel Assignment||Treatment||Single||||||t
1379525|NCT02559895|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379526|NCT02559882|||Cohort||Prospective|||||||
1379527|NCT02559869|||Case-Control||Prospective|||||||
1379528|NCT02559856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379529|NCT02559843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379530|NCT02559830||Single Group Assignment||Treatment||None (Open Label)||||||
1379531|NCT02559817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379532|NCT02559804|||Cohort||Prospective|||||||
1379533|NCT02559791||Single Group Assignment||Treatment||Single|||t|||
1379534|NCT02559778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379535|NCT02559765|||Cohort||Cross-Sectional|||||||
1379536|NCT02559752|||Case-Only||Prospective|||||||
1379537|NCT02559739|||Cohort||Prospective|||||||
1379538|NCT02559726|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379539|NCT02559713||Single Group Assignment||Treatment||None (Open Label)||||||
1380013|NCT02553512|||Cohort||Prospective|||||||
1379540|NCT02559700||Single Group Assignment||Prevention||None (Open Label)||||||
1379541|NCT02559687||Single Group Assignment||Treatment||None (Open Label)||||||
1379542|NCT02559674||Single Group Assignment||Treatment||None (Open Label)||||||
1379543|NCT02559661|||Other||Prospective|||||||
1379544|NCT02559648|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379545|NCT02559635|Randomized|Parallel Assignment||Treatment||Single||||||t
1379546|NCT02559622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379547|NCT02559609|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1379548|NCT02559596|||Case-Control||Retrospective|||||||
1379549|NCT02559583|||Case Control||Retrospective|||||||
1379550|NCT02559570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379551|NCT02559557||Single Group Assignment||Supportive Care||None (Open Label)||||||
1379552|NCT02559531||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379553|NCT02559518|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1379554|NCT02559505|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379555|NCT02559492|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379556|NCT02559479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379557|NCT02559466|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379558|NCT02559453|Randomized|Parallel Assignment||Treatment||Single||||t||
1379559|NCT02559440|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379560|NCT02559427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379561|NCT02559414|Randomized|Parallel Assignment||Prevention||Single||||||t
1379562|NCT02559401|||Cohort||Prospective|||||||
1379563|NCT02559388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379564|NCT02559375|||Cohort||Prospective|||||||
1379565|NCT02559362|||Cohort||Prospective|||||||
1379566|NCT02559349|||Cohort||Prospective|||||||
1379567|NCT02559336|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1379568|NCT02559323|||Cohort||Prospective|||||||
1379569|NCT02559310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379570|NCT02559297|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379571|NCT02559284|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379572|NCT02559271|||||Prospective|||||||
1379573|NCT02559258|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1379574|NCT02559245|Randomized|Parallel Assignment||Treatment||Single|||||t|
1379575|NCT02559232|||Cohort||Cross-Sectional|||||||
1379576|NCT02559219|||Cohort||Prospective|||||||
1379577|NCT02559206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379578|NCT02559193|||Case-Only||Other|||||||
1379579|NCT02559180||Single Group Assignment||Treatment||None (Open Label)||||||
1379580|NCT02559167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379581|NCT02559154|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379582|NCT02559141|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379583|NCT02559128|||Other||Cross-Sectional|||||||
1379584|NCT02559115||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379585|NCT02559102|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379586|NCT02559089|||Case Control||Prospective|||||||
1379587|NCT02559076|Randomized|Parallel Assignment||Prevention||Single|||||t|
1379588|NCT02559063|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1379589|NCT02559050|||Case-Only||Retrospective|||||||
1379590|NCT02559037|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379591|NCT02559024|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379592|NCT02559011|||Cohort||Prospective|||||||
1379593|NCT02558998||Single Group Assignment||Supportive Care||None (Open Label)||||||
1379594|NCT02558985|||Case-Only||Prospective|||||||
1379595|NCT02558972|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1379596|NCT02558959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379597|NCT02558946|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379598|NCT02558933||Single Group Assignment||Treatment||None (Open Label)||||||
1379599|NCT02558920|||Cohort||Prospective|||||||
1379600|NCT02558907|||Cohort||Prospective|||||||
1379601|NCT02558894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379602|NCT02558881|||Case Control||Prospective|||||||
1379603|NCT02558868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379604|NCT02558855|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1379605|NCT02558842|Randomized|Parallel Assignment||||None (Open Label)||||||
1379606|NCT02558829|Randomized|Crossover Assignment||Diagnostic||None (Open Label)|This was an open label trial. No masking with regard to the Growth Hormone Stimulation Tests (GHSTs) performed was done. However, Data Review Committee/Sponsor/Project Management was masked towards the Growth Hormone (GH) values as results fo both tests. GH values were provided to the investigator only after both GHSTs had been performed, to avoid bias.|||||
1379607|NCT02558816||Single Group Assignment||Treatment||None (Open Label)||||||
1379608|NCT02558803|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1379609|NCT02558790||Single Group Assignment||Treatment||None (Open Label)||||||
1379610|NCT02558777|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1379611|NCT02558764|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1379612|NCT02558751|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379613|NCT02558738|||Case-Crossover||Prospective|||||||
1379614|NCT02558725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379615|NCT02558712||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379616|NCT02558699|Randomized|Parallel Assignment||Treatment||Single|||||t|
1379617|NCT02558686|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1379618|NCT02558673|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1379619|NCT02558660||Single Group Assignment||||None (Open Label)||||||
1379620|NCT02558647|Randomized|Parallel Assignment||Treatment||Double|Study participants are randomized to CBT-I or a potential active comparator (PE). Follow-up data is primarily self-report; data on sick leave etc is objective data obtained form national registers, with investigators are blinded to participant identity.|This is a parallel-group superiority RCT comparing internet-delivered CBT-I (a Norwegian language version of SHUTi) with online patient education about sleep (PE).|t||t|
1379621|NCT02558634|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1379622|NCT02558621||Single Group Assignment||Treatment||None (Open Label)||||||
1379623|NCT02558608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379624|NCT02558595|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1379625|NCT02558582|Randomized|Parallel Assignment||Treatment||Single||||||t
1379626|NCT02558569|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1379627|NCT02558556|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1379628|NCT02558543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379629|NCT02558530||Single Group Assignment||Treatment||None (Open Label)||||||
1379630|NCT02558517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379631|NCT02558504|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379632|NCT02558491|Randomized|Crossover Assignment||Treatment||Single|||t|||
1379633|NCT02558478|||Family-Based|||||||||
1379634|NCT02558465|||Cohort||Prospective|||||||
1379635|NCT02558452|||Cohort||Prospective|||||||
1379636|NCT02558439|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379637|NCT02558426|||Cohort||Prospective|||||||
1379638|NCT02558413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379639|NCT02558400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379640|NCT02558387||Single Group Assignment||Treatment||None (Open Label)||||||
1379641|NCT02558374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379642|NCT02558361||Single Group Assignment||Treatment||None (Open Label)||||||
1379643|NCT02558348||Single Group Assignment||Treatment||None (Open Label)||||||
1379644|NCT02558335|||Cohort||Prospective|||||||
1379645|NCT02558322|||Other||Cross-Sectional|||||||
1379646|NCT02558309|||Case-Only||Prospective|||||||
1379647|NCT02558296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379648|NCT02558283|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1379649|NCT02558270|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1379650|NCT02558257|||Cohort||Prospective|||||||
1379651|NCT02558244|||Cohort||Retrospective|||||||
1379652|NCT02558231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379653|NCT02558218|Randomized|Parallel Assignment||Prevention||Single||||||t
1379654|NCT02558205|||Cohort||Prospective|||||||
1379655|NCT02558192|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1379656|NCT02558179|||Cohort||Prospective|||||||
1379657|NCT02558166|||Cohort||Prospective|||||||
1379658|NCT02558153|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379659|NCT02558140|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379660|NCT02558127|||Case Control||Cross-Sectional|||||||
1379661|NCT02558114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379662|NCT02558101|Randomized|Parallel Assignment||Screening||Single||||||t
1379663|NCT02558088||Single Group Assignment||Basic Science||None (Open Label)||||||
1379664|NCT02558075||Single Group Assignment||Supportive Care||None (Open Label)||||||
1379665|NCT02558062||Single Group Assignment||Other||None (Open Label)||||||
1379666|NCT02558049||Single Group Assignment||Other||None (Open Label)||||||
1379667|NCT02558036|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379668|NCT02558023|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379669|NCT02558010|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1379670|NCT02557997|||Cohort||Prospective|||||||
1379671|NCT02557984|Randomized|Parallel Assignment||||Double|||t||t|
1379672|NCT02557971|||Cohort||Retrospective|||||||
1379673|NCT02557958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379674|NCT02557945|Randomized|Parallel Assignment||||Double|||t||t|
1379675|NCT02557932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379676|NCT02557919|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379677|NCT02557906|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379678|NCT02557893|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1379679|NCT02557880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379680|NCT02557867|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1379681|NCT02557854||Single Group Assignment||Treatment||None (Open Label)||||||
1379682|NCT02557841|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1379683|NCT02557828|Randomized|Single Group Assignment||Other||Single||||||t
1379684|NCT02557815|Randomized|Parallel Assignment||||Single|||t|||
1379685|NCT02557802|Randomized|Crossover Assignment||||None (Open Label)||||||
1379686|NCT02557789|Randomized|Crossover Assignment||||None (Open Label)||||||
1379687|NCT02557776||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379688|NCT02557763||Single Group Assignment||Treatment||Single||||||t
1379689|NCT02557750|||Cohort||Retrospective|||||||
1379690|NCT02557737|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379691|NCT02557724|||Case-Control||Prospective|||||||
1379693|NCT02557698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379694|NCT02557685||Single Group Assignment||Treatment||None (Open Label)||||||
1379695|NCT02557672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379696|NCT02557659||||||||||||
1379697|NCT02557646|||Cohort||Prospective|||||||
1379698|NCT02557633|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379699|NCT02557620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379700|NCT02557607||Single Group Assignment||||None (Open Label)||||||
1379701|NCT02557594|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379702|NCT02557581|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1379703|NCT02557568|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1379704|NCT02557555|||Case-Control||Prospective|||||||
1379705|NCT02557542|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1379706|NCT02557529|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1379707|NCT02557516||Single Group Assignment||Treatment||None (Open Label)||||||
1379708|NCT02557503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379709|NCT02557490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379710|NCT02557477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379711|NCT02557464|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1379712|NCT02557451|Randomized|Parallel Assignment||||None (Open Label)||||||
1379713|NCT02557438|||Cohort||Prospective|||||||
1379714|NCT02557425|||Cohort||Prospective|||||||
1379715|NCT02557412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379716|NCT02557399|Randomized|Parallel Assignment||Treatment||Single|||||t|
1379717|NCT02557386|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379718|NCT02557373|Randomized|Parallel Assignment||Other||Single|||||t|
1379719|NCT02557360||Single Group Assignment||Treatment||None (Open Label)||||||
1379720|NCT02557347||Single Group Assignment||Treatment||None (Open Label)||||||
1379721|NCT02557334|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1379722|NCT02557321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379723|NCT02557308|||Cohort||Prospective|||||||
1379724|NCT02557295|||Cohort||Prospective|||||||
1379725|NCT02557282|||Case-Only||Retrospective|||||||
1379726|NCT02557269|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379727|NCT02557256|||Cohort||Retrospective|||||||
1379728|NCT02557243|||Cohort||Retrospective|||||||
1379729|NCT02557230|||Cohort||Retrospective|||||||
1379730|NCT02557217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379731|NCT02557204|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1379732|NCT02557191|||Cohort||Prospective|||||||
1379733|NCT02557178|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1379734|NCT02557165|||Case-Crossover||Prospective|||||||
1379735|NCT02557152|||Case-Only||Other|||||||
1379736|NCT02557139|Randomized|Crossover Assignment||||None (Open Label)||||||
1379737|NCT02557126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379738|NCT02557113|Randomized|Parallel Assignment||Treatment||Single||||||t
1379739|NCT02557100|Randomized|Parallel Assignment||Basic Science||Single||||||t
1379740|NCT02557087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379741|NCT02557074|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379742|NCT02557061||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379743|NCT02557048|||Cohort||Retrospective|||||||
1379744|NCT02557035|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379745|NCT02557022|||||Prospective|||||||
1379746|NCT02557009|||Cohort||Prospective|||||||
1379747|NCT02556996|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379748|NCT02556983|||Other||Prospective|||||||
1379749|NCT02556970|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1379750|NCT02556957|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1379751|NCT02556944||Single Group Assignment||Treatment||None (Open Label)||||||
1379752|NCT02556931|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379753|NCT02556918|Randomized|Parallel Assignment||Prevention||Single|||t|||
1379754|NCT02556905|||Case-Only||Prospective|||||||
1379755|NCT02556892||Single Group Assignment||Treatment||None (Open Label)||||||
1379756|NCT02556879||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379757|NCT02556866|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379758|NCT02556853|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1379759|NCT02556840|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379760|NCT02556827|||Case Control||Cross-Sectional|||||||
1379761|NCT02556814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379762|NCT02556801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379763|NCT02556788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379764|NCT02556775|||Cohort||Prospective|||||||
1379765|NCT02556762|Randomized|Parallel Assignment||Treatment||Single||||||t
1379766|NCT02556749|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1379767|NCT02556736||Single Group Assignment||Treatment||None (Open Label)||||||
1379768|NCT02556723||Single Group Assignment||Treatment||None (Open Label)||||||
1379769|NCT02556710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379770|NCT02556697|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1379771|NCT02556684|||Cohort||Prospective|||||||
1379772|NCT02556671|||Cohort||Prospective|||||||
1379773|NCT02556658|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1379774|NCT02556645|Randomized|Parallel Assignment||Treatment||Single||||||t
1379775|NCT02556632|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1379776|NCT02556619|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379777|NCT02556606|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379778|NCT02556593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379779|NCT02556580|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379780|NCT02556567||Single Group Assignment||Other||None (Open Label)||||||
1379781|NCT02556554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379782|NCT02556541||Crossover Assignment||Supportive Care||||||||
1379783|NCT02556528||Single Group Assignment||||None (Open Label)||||||
1379784|NCT02556515|Randomized|Parallel Assignment||Treatment||Single||||||t
1379785|NCT02556502||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379786|NCT02556489|||Cohort||Prospective|||||||
1379787|NCT02556476|||Cohort||Prospective|||||||
1379788|NCT02556463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379789|NCT02556450|Randomized|Parallel Assignment||Other||Single||||||t
1379790|NCT02556437|Randomized|Crossover Assignment||Treatment||Single||||||t
1379791|NCT02556424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379792|NCT02556411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379793|NCT02556398||Single Group Assignment||Supportive Care||None (Open Label)||||||
1379794|NCT02556385|Non-Randomized|Parallel Assignment||Treatment||Double|||t|t||
1379795|NCT02556372||Single Group Assignment||Treatment||None (Open Label)||||||
1379796|NCT02556359|||Case-Only||Prospective|||||||
1379797|NCT02556346|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379798|NCT02556333||Single Group Assignment||Treatment||None (Open Label)||||||
1379799|NCT02556320||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379800|NCT02556307|||Case-Only||Prospective|||||||
1379801|NCT02556294|Randomized|Parallel Assignment||Prevention||Single||||||t
1379802|NCT02556281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379803|NCT02556268|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379804|NCT02556255||Single Group Assignment||Treatment||None (Open Label)||||||
1379805|NCT02556242|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379806|NCT02556229||Single Group Assignment||Treatment||None (Open Label)||||||
1379807|NCT02556216|||Cohort||Cross-Sectional|||||||
1379808|NCT02556203|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379809|NCT02556190|||Cohort||Prospective|||||||
1379810|NCT02556177|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379811|NCT02556164|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379812|NCT02556151|Randomized|Factorial Assignment||Treatment||Single||||||t
1379813|NCT02556138||Single Group Assignment||Supportive Care||None (Open Label)||||||
1379814|NCT02556125|||Case-Only||Prospective|||||||
1379815|NCT02556112|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379816|NCT02556099||Single Group Assignment||Treatment||None (Open Label)||||||
1379817|NCT02556086||Single Group Assignment||Treatment||None (Open Label)||||||
1379818|NCT02556073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379819|NCT02556060|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379820|NCT02556047||Single Group Assignment||||Single|||||t|
1379821|NCT02556034|||Case-Only||Prospective|||||||
1379822|NCT02556021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379823|NCT02556008||||||||||||
1379824|NCT02555995||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379825|NCT02555982|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379826|NCT02555969|||Other||Prospective|||||||
1379827|NCT02555956|||Case-Only||Prospective|||||||
1379828|NCT02555943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379829|NCT02555930|||Cohort||Cross-Sectional|||||||
1379830|NCT02555917|Randomized|Parallel Assignment||||Double|||t|||t
1379831|NCT02555904|||Cohort||Prospective|||||||
1379832|NCT02555891|||||Retrospective|||||||
1379833|NCT02555878|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1379834|NCT02555865|||Case-Only||Cross-Sectional|||||||
1379835|NCT02555852|||Cohort||Retrospective|||||||
1379836|NCT02555839|||Cohort||Cross-Sectional|||||||
1379837|NCT02555813|||Cohort||Cross-Sectional|||||||
1379838|NCT02555800|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1379839|NCT02555787|||Cohort||Prospective|||||||
1379840|NCT02555774|Randomized|Parallel Assignment||Treatment||Single||||||t
1379841|NCT02555761|||Cohort||Prospective|||||||
1379842|NCT02555748|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1379843|NCT02555735|||Cohort||Prospective|||||||
1379844|NCT02555722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379845|NCT02555709|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1379846|NCT02555696|||Cohort||Cross-Sectional|||||||
1379847|NCT02555683|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379848|NCT02555670|||Case-Only||Prospective|||||||
1379849|NCT02555657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379850|NCT02555644|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379851|NCT02555631||Single Group Assignment||Prevention||None (Open Label)||||||
1379852|NCT02555618|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1379853|NCT02555605|||Case-Only||Retrospective|||||||
1379854|NCT02555592|||Cohort||Prospective|||||||
1379855|NCT02555579||Single Group Assignment||Treatment||None (Open Label)||||||
1379857|NCT02555553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379858|NCT02555540|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1379859|NCT02555527|||Cohort||Retrospective|||||||
1379860|NCT02555514|||Case-Crossover||Prospective|||||||
1379861|NCT02555501|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379862|NCT02555488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379863|NCT02555475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379864|NCT02555462|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1379865|NCT02555449||Single Group Assignment||Basic Science||None (Open Label)||||||
1379866|NCT02555423||||Supportive Care||||||||
1379867|NCT02555410|||Cohort||Prospective|||||||
1379868|NCT02555397||Single Group Assignment||Treatment||None (Open Label)||||||
1379869|NCT02555384|Randomized|Parallel Assignment||Treatment||Single||||||t
1379870|NCT02555371|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379871|NCT02555358|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1379872|NCT02555345|||Case Control||Cross-Sectional|||||||
1379873|NCT02555332|||Cohort||Prospective|||||||
1379874|NCT02555319||Single Group Assignment||Treatment||None (Open Label)||||||
1379875|NCT02555306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379876|NCT02555293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379877|NCT02555280|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379878|NCT02555267|||Cohort||Prospective|||||||
1379879|NCT02555254|Randomized|Parallel Assignment||Treatment||Single||||||t
1379880|NCT02555241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379881|NCT02555228|Randomized|Parallel Assignment||||Single|||||t|
1379882|NCT02555215||Single Group Assignment||Treatment||None (Open Label)||||||
1379883|NCT02555202|||Cohort||Prospective|||||||
1379884|NCT02555189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379885|NCT02555176||Single Group Assignment||Basic Science||None (Open Label)||||||
1379886|NCT02555163|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379887|NCT02555150|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1379888|NCT02555137|||Cohort||Prospective|||||||
1379889|NCT02555124|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1379890|NCT02555111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379891|NCT02555098||||||||||||
1379892|NCT02555085|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379893|NCT02555072||Single Group Assignment||Prevention||None (Open Label)||||||
1379894|NCT02555059|||Cohort||Prospective|||||||
1379895|NCT02555046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379896|NCT02555033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379897|NCT02555020|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1379898|NCT02555007||Single Group Assignment||Treatment||None (Open Label)||||||
1379899|NCT02554994|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1379900|NCT02554981||Single Group Assignment||Treatment||None (Open Label)||||||
1379901|NCT02554968|||Other||Cross-Sectional|||||||
1379902|NCT02554955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379903|NCT02554942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379904|NCT02554929|Randomized|Parallel Assignment||Treatment||Single||||||t
1379905|NCT02554916|||Cohort||Prospective|||||||
1379906|NCT02554903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379907|NCT02554890|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1379908|NCT02554877|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379909|NCT02554864|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1379910|NCT02554851|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1379911|NCT02554838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379912|NCT02554825|Randomized|Parallel Assignment||Prevention||||||||
1379913|NCT02554812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379914|NCT02554799|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379915|NCT02554786|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379916|NCT02554773||Single Group Assignment||Treatment||None (Open Label)||||||
1379917|NCT02554760||Single Group Assignment||Other||None (Open Label)||||||
1379918|NCT02554747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379919|NCT02554734|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379920|NCT02554721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379921|NCT02554708|||Cohort||Prospective|||||||
1379922|NCT02554695|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1379923|NCT02554682|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1379924|NCT02554669|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1379925|NCT02554656|||Cohort||Prospective|||||||
1379926|NCT02554643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379927|NCT02554630|||Case-Control||Prospective|||||||
1379928|NCT02554617|||Case-Only||Cross-Sectional|||||||
1379929|NCT02554604|||Cohort||Prospective|||||||
1379930|NCT02554591|||Cohort||Retrospective|||||||
1379931|NCT02554578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379932|NCT02554565||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379933|NCT02554552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379934|NCT02554539|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379935|NCT02554526||||||||||||
1379936|NCT02554513|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379937|NCT02554500|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1379938|NCT02554487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379939|NCT02554474|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1379940|NCT02554461|||Cohort||Prospective|||||||
1379941|NCT02554448||Single Group Assignment||Screening||None (Open Label)||||||
1379942|NCT02554435|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379943|NCT02554422||Single Group Assignment||Basic Science||None (Open Label)||||||
1379944|NCT02554409|||Cohort||Prospective|||||||
1379945|NCT02554396|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379946|NCT02554383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379947|NCT02554370|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1379948|NCT02554357|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1379949|NCT02554344||Single Group Assignment||Treatment||None (Open Label)||||||
1379950|NCT02554331|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1379951|NCT02554318|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379952|NCT02554305|Randomized|Parallel Assignment||||Single||||||t
1379953|NCT02554292|||Cohort||Prospective|||||||
1379954|NCT02554279|Randomized|Parallel Assignment||Treatment||Single||||||t
1379955|NCT02554266|||Other||Prospective|||||||
1379956|NCT02554253|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1379957|NCT02554240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379958|NCT02554227|||Other||Prospective|||||||
1379959|NCT02554214||Single Group Assignment||Prevention||None (Open Label)||||||
1379960|NCT02554201|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1379961|NCT02554188|Randomized|Parallel Assignment||Basic Science||Single||||||t
1379962|NCT02554175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379963|NCT02554162|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1379964|NCT02554149|||Cohort||Prospective|||||||
1379965|NCT02554136|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1379966|NCT02554123|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1379967|NCT02554110|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1379968|NCT02554097|||Cohort||Prospective|||||||
1379969|NCT02554084|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1379970|NCT02554071||Single Group Assignment||Supportive Care||None (Open Label)||||||
1379971|NCT02554058||Single Group Assignment||Treatment||None (Open Label)||||||
1379972|NCT02554045|Randomized|Parallel Assignment||Treatment||Single|||t|||
1379973|NCT02554032|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379974|NCT02554019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379975|NCT02554006|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379976|NCT02553993|Randomized|Parallel Assignment||Treatment||Single||||||t
1379977|NCT02553980|Randomized|Parallel Assignment||Prevention||Single|||t|||
1379978|NCT02553967|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1379979|NCT02553954||Single Group Assignment||||None (Open Label)||||||
1379980|NCT02553941||Single Group Assignment||Treatment||None (Open Label)||||||
1379981|NCT02553928|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379982|NCT02553915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1379983|NCT02553902|Randomized|Parallel Assignment||Treatment||Single||||||t
1379984|NCT02553889|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1379985|NCT02553876|||Cohort||Prospective|||||||
1379986|NCT02553863|Randomized|Parallel Assignment||Treatment||Single||||||t
1379987|NCT02553850|||Cohort||Prospective|||||||
1379988|NCT02553837||Single Group Assignment||Prevention||None (Open Label)||||||
1379989|NCT02553824|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1379990|NCT02553811||Single Group Assignment||Diagnostic||None (Open Label)||||||
1379991|NCT02553798||Single Group Assignment||Treatment||None (Open Label)||||||
1379992|NCT02553785||Single Group Assignment||Treatment||None (Open Label)||||||
1379993|NCT02553772|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1379994|NCT02553759|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1379995|NCT02553746|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1379996|NCT02553733|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1379997|NCT02553720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1379998|NCT02553707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1379999|NCT02553694|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1380000|NCT02553681|Randomized|Single Group Assignment||Other||Double|||t||t|
1380001|NCT02553668||Single Group Assignment||Basic Science||None (Open Label)||||||
1380002|NCT02553655|Randomized|Parallel Assignment||Other||Single|||t|||
1380003|NCT02553642||Single Group Assignment||Treatment||None (Open Label)||||||
1380004|NCT02553629|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380005|NCT02553616||Single Group Assignment||Prevention||None (Open Label)||||||
1380006|NCT02553603|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380007|NCT02553590|||||Prospective|||||||
1380008|NCT02553577|||Other||Prospective|||||||
1380009|NCT02553564|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380010|NCT02553551|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380011|NCT02553538|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1380012|NCT02553525|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1380014|NCT02553499|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380015|NCT02553486|||||Prospective|||||||
1380016|NCT02553473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380017|NCT02553460||Single Group Assignment||Treatment||None (Open Label)||||||
1380018|NCT02553447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380019|NCT02553434|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380020|NCT02553421|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380021|NCT02553408||Single Group Assignment||Treatment||None (Open Label)||||||
1380022|NCT02553395||||||||||||
1380023|NCT02553382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380024|NCT02553369|||Cohort||Prospective|||||||
1380025|NCT02553356|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380026|NCT02553343|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380027|NCT02553330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380028|NCT02553317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380029|NCT02553304|||Cohort||Prospective|||||||
1380030|NCT02553291|Randomized|Parallel Assignment||Treatment||Single||||||t
1380031|NCT02553278|Randomized|Parallel Assignment||Treatment||Single||||||t
1380032|NCT02553265|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380033|NCT02553252|Randomized|Parallel Assignment||Treatment||Single||||||t
1380034|NCT02553239||Single Group Assignment||Treatment||None (Open Label)||||||
1380035|NCT02553226|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380036|NCT02553213|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1380037|NCT02553200|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380038|NCT02553187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380039|NCT02553174|||Cohort||Prospective|||||||
1380040|NCT02553161|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380041|NCT02553148|||||Retrospective|||||||
1380042|NCT02553135||Single Group Assignment||Treatment||None (Open Label)||||||
1380043|NCT02553122|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380044|NCT02553109|||Cohort||Prospective|||||||
1380045|NCT02553096|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||2-block randomised trial||||
1380046|NCT02553083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380047|NCT02553070|||Ecologic or Community||Prospective|||||||
1380048|NCT02553057|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380049|NCT02553044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380050|NCT02553031|||Case-Only||Prospective|||||||
1380051|NCT02553018|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1380052|NCT02553005|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380053|NCT02552992|Randomized|Parallel Assignment||Treatment||Single||||||t
1380054|NCT02552979|||||Prospective|||||||
1380055|NCT02552966||Single Group Assignment||Treatment||None (Open Label)||||||
1380056|NCT02552953||Single Group Assignment||Treatment||None (Open Label)||||||
1380057|NCT02552940|||Case-Control||Prospective|||||||
1380058|NCT02552927|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1380059|NCT02552914|||Cohort||Prospective|||||||
1380060|NCT02552901|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1380061|NCT02552888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380062|NCT02552875|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1380063|NCT02552862|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380064|NCT02552849|||Cohort||Prospective|||||||
1380065|NCT02552836|Randomized|Parallel Assignment||Treatment||Single||||||t
1380066|NCT02552823|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380067|NCT02552810|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1380068|NCT02552797|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380069|NCT02552784||Single Group Assignment||||None (Open Label)||||||
1380070|NCT02552771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380071|NCT02552758|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1380072|NCT02552745|||Cohort||Prospective|||||||
1380073|NCT02552732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380074|NCT02552719|||Other||Other|||||||
1380075|NCT02552706|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1380076|NCT02552693|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1380077|NCT02552680|Randomized|Parallel Assignment||Prevention||Single||||||t
1380078|NCT02552667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380079|NCT02552654|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1380080|NCT02552641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380081|NCT02552628|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1380082|NCT02552615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380083|NCT02552602|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1380084|NCT02552589|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380085|NCT02552576||Single Group Assignment||Treatment||None (Open Label)||||||
1380086|NCT02552563|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380087|NCT02552550|||Cohort||Prospective|||||||
1380088|NCT02552537|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1380089|NCT02552524|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1380090|NCT02552511|||Case-Control||Retrospective|||||||
1380091|NCT02552498|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1380093|NCT02552472|||Cohort||Prospective|||||||
1380094|NCT02552459|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380095|NCT02552446|||||Prospective|||||||
1380096|NCT02552433|||Cohort||Prospective|||||||
1380097|NCT02552420|||Cohort|||||||||
1380098|NCT02552407|||Other||Retrospective|||||||
1380099|NCT02552394||Single Group Assignment||Treatment||None (Open Label)||||||
1380100|NCT02552381|||Cohort||Prospective|||||||
1380101|NCT02552368||Single Group Assignment||Treatment||None (Open Label)||||||
1380102|NCT02552355|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1380103|NCT02552342|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380104|NCT02552329|Randomized|Parallel Assignment||Treatment||Single||||||t
1380105|NCT02552316||Single Group Assignment||Other||None (Open Label)||||||
1380106|NCT02552303|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1380107|NCT02552290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380108|NCT02552277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380109|NCT02552264|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1380110|NCT02552251|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1380111|NCT02552238||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380112|NCT02552225|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380113|NCT02552212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380114|NCT02552199|||Cohort||Prospective|||||||
1380115|NCT02552186|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380116|NCT02552173|||Cohort||Prospective|||||||
1380117|NCT02552160|||Case-Control||Other|||||||
1380118|NCT02552147|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380119|NCT02552134|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380120|NCT02552121||Single Group Assignment||Treatment||None (Open Label)||||||
1380121|NCT02552108|Randomized|Parallel Assignment||Treatment||Single||||||t
1380122|NCT02552095||Single Group Assignment||Treatment||None (Open Label)||||||
1380123|NCT02552082|||Cohort||Retrospective|||||||
1380124|NCT02552069|||Cohort||Prospective|||||||
1380125|NCT02552056|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1380126|NCT02552043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380127|NCT02552030||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380128|NCT02552017|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380129|NCT02552004||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380130|NCT02551991||Single Group Assignment||Treatment||None (Open Label)||||||
1380131|NCT02551978|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380132|NCT02551965||Single Group Assignment||Prevention||None (Open Label)||||||
1380133|NCT02551952|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1380134|NCT02551939||Single Group Assignment||Health Services Research||Quadruple|||t|t|t|t
1380135|NCT02551926|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1380136|NCT02551913|Randomized|Parallel Assignment||Prevention||Single||||||t
1380137|NCT02551900|Randomized|Parallel Assignment||Treatment||Single||||||t
1380138|NCT02551887|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1380139|NCT02551874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380140|NCT02551861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380141|NCT02551848||Single Group Assignment||Treatment||None (Open Label)||||||
1380142|NCT02551835|||||Prospective|||||||
1380143|NCT02551822|Randomized|Crossover Assignment||Treatment||Single|||t|||
1380144|NCT02551809|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380145|NCT02551796|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380146|NCT02551783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380147|NCT02551770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380148|NCT02551757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380149|NCT02551744|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380150|NCT02551731||Single Group Assignment||Treatment||None (Open Label)||||||
1380151|NCT02551718||Single Group Assignment||Treatment||None (Open Label)||||||
1380152|NCT02551705|Non-Randomized|Crossover Assignment||Basic Science||Single|||||t|
1380153|NCT02551692|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1380154|NCT02551679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380155|NCT02551666|Randomized|Parallel Assignment||Prevention||Single||||||t
1380156|NCT02551653||Single Group Assignment||Other||None (Open Label)||||||
1380157|NCT02551640|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1380158|NCT02551627|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1380159|NCT02551614|Randomized|Parallel Assignment||Other||Single|||t|||
1380160|NCT02551601|||Case-Only||Prospective|||||||
1380161|NCT02551588|||Case Control||Prospective|||||||
1380162|NCT02551575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380163|NCT02551562|Randomized|Parallel Assignment||||None (Open Label)||||||
1380164|NCT02551549|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1380165|NCT02551536|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380166|NCT02551523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380167|NCT02551510|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380168|NCT02551497|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1380169|NCT02551484||||||||||||
1380170|NCT02551471|||Cohort||Prospective|||||||
1380171|NCT02551458||||||||||||
1380172|NCT02551445||Single Group Assignment||Treatment||None (Open Label)||||||
1380173|NCT02551432||Single Group Assignment||Treatment||None (Open Label)||||||
1380174|NCT02551419|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1380175|NCT02551406|||Cohort||Retrospective|||||||
1380176|NCT02551393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380177|NCT02551380|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380178|NCT02551367|Randomized|Parallel Assignment||Treatment||Single|||||t|
1380179|NCT02551354||Single Group Assignment||Prevention||None (Open Label)||||||
1380180|NCT02551341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380181|NCT02551328|||Case Control||Prospective|||||||
1380182|NCT02551315|||Cohort||Prospective|||||||
1380183|NCT02551302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380184|NCT02551289|||Cohort||Prospective|||||||
1380185|NCT02551276|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1380186|NCT02551263|||Cohort||Prospective|||||||
1380187|NCT02551250|||Case-Only||Prospective|||||||
1380188|NCT02551237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380189|NCT02551224|Randomized|Crossover Assignment||Other||None (Open Label)||open-label, cross-over study comparing the preference on the feedback mechanisms of dose delivery confirmation with the Breezhaler® device compared to the Ellipta® device||||
1380190|NCT02551211||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380191|NCT02551198|Randomized|Parallel Assignment||Treatment||Single|||||t|
1380192|NCT02551185||Single Group Assignment||Treatment||None (Open Label)||||||
1380193|NCT02551172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380194|NCT02551159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380195|NCT02551146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380196|NCT02551133|Randomized|Parallel Assignment||Treatment||Double||||t||t
1380197|NCT02551120|||Cohort||Prospective|||||||
1380198|NCT02551107|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380199|NCT02551094|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380200|NCT02551081|||Cohort||Prospective|||||||
1380201|NCT02551068|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380202|NCT02551055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380203|NCT02551042|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380204|NCT02551029|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1380205|NCT02551016|||Cohort||Prospective|||||||
1380206|NCT02551003|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380207|NCT02550990|Randomized|Parallel Assignment||Treatment||Single||||||t
1380208|NCT02550977||Single Group Assignment||Prevention||None (Open Label)||||||
1380209|NCT02550964|||Cohort||Prospective|||||||
1380210|NCT02550951|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1380211|NCT02550938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380212|NCT02550925|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380213|NCT02550912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380214|NCT02550899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380215|NCT02550886|||Cohort||Prospective|||||||
1380216|NCT02550873|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380217|NCT02550860|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380218|NCT02550847|||Case-Only||Prospective|||||||
1380219|NCT02550834|Randomized|Crossover Assignment||Treatment||Single||||||t
1380220|NCT02550821|||Case-Control||Prospective|||||||
1380221|NCT02550808|||Cohort||Prospective|||||||
1380222|NCT02550795|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380223|NCT02550782|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1380224|NCT02550769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380225|NCT02550756|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380226|NCT02550743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380227|NCT02550730|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1380228|NCT02550717|||Cohort||Retrospective|||||||
1380229|NCT02550704||Single Group Assignment||Screening||None (Open Label)||||||
1380230|NCT02550691|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380231|NCT02550678|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380232|NCT02550665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380233|NCT02550652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380234|NCT02550639|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1380235|NCT02550626|||Case Control||Prospective|||||||
1380236|NCT02550613|||Case-Only||Prospective|||||||
1380237|NCT02550600|Randomized|Parallel Assignment||Treatment||Single||||||t
1380238|NCT02550587|||Cohort||Retrospective|||||||
1380239|NCT02550574|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380240|NCT02550561||Single Group Assignment||Treatment||None (Open Label)||||||
1380241|NCT02550548|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1380242|NCT02550535||Single Group Assignment||Treatment||None (Open Label)||||||
1380243|NCT02550522||Single Group Assignment||Treatment||None (Open Label)||||||
1380244|NCT02550509||Single Group Assignment||Basic Science||None (Open Label)||||||
1380245|NCT02550496||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380246|NCT02550483|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1380247|NCT02550470|Randomized|Parallel Assignment||||Double|||t|t||
1380248|NCT02550457|Randomized|Parallel Assignment||Treatment||Single||||||t
1380249|NCT02550444|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1380250|NCT02550431|||Other||Cross-Sectional|||||||
1380251|NCT02550418||Single Group Assignment||Treatment||None (Open Label)||||||
1380252|NCT02550405|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1380253|NCT02550392|Randomized|Parallel Assignment||Treatment||Single||||||t
1380254|NCT02550379|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380255|NCT02550366||Single Group Assignment||Basic Science||None (Open Label)||||||
1380256|NCT02550353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380257|NCT02550340|||Cohort||Prospective|||||||
1380258|NCT02550327||Single Group Assignment||Treatment||None (Open Label)||||||
1380259|NCT02550314||Single Group Assignment||Treatment||None (Open Label)||||||
1380260|NCT02550301|||Case-Only||Prospective|||||||
1380261|NCT02550288|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380262|NCT02550275|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380263|NCT02550262|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1380264|NCT02550249||Single Group Assignment||Treatment||None (Open Label)||||||
1380265|NCT02550236|||Cohort||Prospective|||||||
1380266|NCT02550223|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1380267|NCT02550210||Single Group Assignment||Treatment||None (Open Label)||||||
1380268|NCT02550197|Randomized|Parallel Assignment||Prevention||Single||||||t
1380269|NCT02550184|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1380270|NCT02550171|||Cohort||Prospective|||||||
1380271|NCT02550158|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1380272|NCT02550145|Randomized|Crossover Assignment||Treatment||Single|||t|||
1380273|NCT02550132||Single Group Assignment||Basic Science||None (Open Label)||||||
1380274|NCT02550119|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380275|NCT02550106||Single Group Assignment||Treatment||None (Open Label)||||||
1380276|NCT02550093|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1380277|NCT02550080|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1380278|NCT02550067|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1380279|NCT02550054|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1380280|NCT02550041||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380281|NCT02550028|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380282|NCT02550015|Randomized|Parallel Assignment||Treatment||Single||||||t
1380283|NCT02550002|||Cohort||Prospective|||||||
1380284|NCT02549989||Single Group Assignment||Treatment||None (Open Label)||||||
1380285|NCT02549976||Single Group Assignment||Treatment||None (Open Label)||||||
1380286|NCT02549963|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380287|NCT02549950|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1380288|NCT02549937||Single Group Assignment||Treatment||None (Open Label)||||||
1380289|NCT02549924|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380290|NCT02549911||Single Group Assignment||Treatment||None (Open Label)||||||
1380291|NCT02549898|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1380292|NCT02549885|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1380293|NCT02549872|||Cohort||Retrospective|||||||
1380294|NCT02549859|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380295|NCT02549846|Randomized|Parallel Assignment||Treatment||Single||||||t
1380296|NCT02549833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380297|NCT02549820||Single Group Assignment||Treatment||None (Open Label)||||||
1380298|NCT02549807|||Cohort||Prospective|||||||
1380299|NCT02549794|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1380300|NCT02549781|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1380301|NCT02549768|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380302|NCT02549755||Single Group Assignment||Basic Science||None (Open Label)||||||
1380303|NCT02549742||Single Group Assignment||Treatment||None (Open Label)||||||
1380304|NCT02549729|Randomized|Parallel Assignment||Treatment||Single|||||t|
1380305|NCT02549716|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380306|NCT02549703|||Cohort||Prospective|||||||
1380307|NCT02549690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380308|NCT02549677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380309|NCT02549664|||Cohort||Prospective|||||||
1380310|NCT02549651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380311|NCT02549638|||Case-Only||Prospective|||||||
1380312|NCT02549625||Single Group Assignment||Treatment||None (Open Label)||||||
1380313|NCT02549612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380314|NCT02549599|Randomized|Parallel Assignment||Prevention||Single|||t|||
1380315|NCT02549586||Single Group Assignment||Treatment||None (Open Label)||||||
1380316|NCT02549573|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380317|NCT02549560|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1380318|NCT02549547||Single Group Assignment||Treatment||None (Open Label)||||||
1380319|NCT02549534|||Cohort||Prospective|||||||
1380320|NCT02549521|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1380321|NCT02549508|Randomized|Crossover Assignment||Treatment||Single|||t|||
1380322|NCT02549495|||Other||Prospective|||||||
1380323|NCT02549482||Single Group Assignment||||None (Open Label)||||||
1380324|NCT02549469|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380325|NCT02549456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380326|NCT02549443|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1380644|NCT02545309|||Case-Control||Cross-Sectional|||||||
1380327|NCT02549430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380328|NCT02549417||Single Group Assignment||Treatment||None (Open Label)||||||
1380329|NCT02549404||Single Group Assignment||Treatment||None (Open Label)||||||
1380330|NCT02549391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380331|NCT02549378||Single Group Assignment||Basic Science||None (Open Label)||||||
1380332|NCT02549365|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380333|NCT02549352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380334|NCT02549339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380335|NCT02549326|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1380336|NCT02549313|||Cohort||Prospective|||||||
1380337|NCT02549300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380338|NCT02549287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380339|NCT02549274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380340|NCT02549261|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380341|NCT02549248|||Cohort||Prospective|||||||
1380342|NCT02549235|||Cohort||Prospective|||||||
1380343|NCT02549222|||Other||Prospective|||||||
1380344|NCT02549209||Single Group Assignment||Treatment||None (Open Label)|Open-Label|||||
1380345|NCT02549196|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1380346|NCT02549183|Randomized|Crossover Assignment||Treatment||Single|||t|||
1380347|NCT02549170|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380348|NCT02549157|||Cohort||Prospective|||||||
1380349|NCT02549144||Single Group Assignment||Prevention||None (Open Label)||||||
1380350|NCT02549131|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1380351|NCT02549118|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380352|NCT02549105|Randomized|Parallel Assignment||Treatment||Single|||||t|
1380353|NCT02549092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380354|NCT02549079|||Cohort||Prospective|||||||
1380355|NCT02549066||Single Group Assignment||Prevention||None (Open Label)||||||
1380356|NCT02549053|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1380357|NCT02549040||Single Group Assignment||Treatment||None (Open Label)||||||
1380358|NCT02549027|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1380359|NCT02549014|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380360|NCT02549001|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380361|NCT02548988|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380362|NCT02548975|||Cohort||Retrospective|||||||
1380363|NCT02548962|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380364|NCT02548949|||Case-Only||Prospective|||||||
1380365|NCT02548936|Randomized|Parallel Assignment||Prevention||Single||||||t
1380366|NCT02548923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380367|NCT02548910|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1380368|NCT02548897||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1380369|NCT02548884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380370|NCT02548871|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380371|NCT02548858|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380372|NCT02548845|||Cohort||Retrospective|||||||
1380373|NCT02548832|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380374|NCT02548819|||Case-Only||Prospective|||||||
1380375|NCT02548806|Randomized|Crossover Assignment||Treatment||Single||||||t
1380376|NCT02548793|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380377|NCT02548780||Single Group Assignment||Treatment||None (Open Label)||||||
1380378|NCT02548767|Randomized|Factorial Assignment||Basic Science||Double|||t|t||
1380379|NCT02548754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380380|NCT02548741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380381|NCT02548728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380382|NCT02548715|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380383|NCT02548702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380384|NCT02548689|||Case-Control||Cross-Sectional|||||||
1380385|NCT02548676|||Cohort||Prospective|||||||
1380386|NCT02548663|Randomized|Parallel Assignment||Treatment||Single||||||t
1380387|NCT02548650|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380388|NCT02548637||Single Group Assignment||Treatment||None (Open Label)||||||
1380389|NCT02548624|||Case-Only||Prospective|||||||
1380390|NCT02548611|Randomized|Parallel Assignment||Treatment||Single||||||t
1380391|NCT02548598|||Cohort||Cross-Sectional|||||||
1380392|NCT02548585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380393|NCT02548572|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380394|NCT02548559||Single Group Assignment||Basic Science||None (Open Label)||||||
1380395|NCT02548546|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380396|NCT02548533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380397|NCT02548520|||Cohort||Prospective|||||||
1380398|NCT02548507|||Ecologic or Community||Cross-Sectional|||||||
1380399|NCT02548494|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380400|NCT02548481|||Case-Only||Prospective|||||||
1380401|NCT02548468||Single Group Assignment||Treatment||None (Open Label)||||||
1380402|NCT02548455||Single Group Assignment||Treatment||None (Open Label)||||||
1380403|NCT02548442|||Cohort||Prospective|||||||
1380404|NCT02548429||||||||||||
1380405|NCT02548416|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1380406|NCT02548403|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1380407|NCT02548390||Single Group Assignment||Treatment||None (Open Label)||||||
1380408|NCT02548377|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380409|NCT02548364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380410|NCT02548351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380411|NCT02548338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380412|NCT02548325|||Cohort||Retrospective|||||||
1380413|NCT02548312|Randomized|Parallel Assignment||Other||Double|||t|||t
1380414|NCT02548299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380415|NCT02548286|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380416|NCT02548273|||Case Control||Prospective|||||||
1380417|NCT02548260|Randomized|Parallel Assignment||Treatment||Single||||||t
1380418|NCT02548247|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380419|NCT02548234|Randomized|Parallel Assignment||Treatment||Single||||||t
1380420|NCT02548221|||Cohort||Prospective|||||||
1380421|NCT02548208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380422|NCT02548195|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380423|NCT02548182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380424|NCT02548169|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380425|NCT02548156|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1380426|NCT02548143||Single Group Assignment||Treatment||None (Open Label)||||||
1380427|NCT02548130|||Cohort||Retrospective|||||||
1380428|NCT02548117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380429|NCT02548104|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1380430|NCT02548091|Randomized|Parallel Assignment||Prevention||Single|||t|||
1380431|NCT02548078|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1380432|NCT02548065|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380433|NCT02548052|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1380434|NCT02548039|||Cohort||Prospective|||||||
1380435|NCT02548026|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1380436|NCT02548013|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380437|NCT02548000|Randomized|Parallel Assignment||Other||Single||||||t
1380438|NCT02547987||Single Group Assignment||Treatment||None (Open Label)||||||
1380439|NCT02547974|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1380440|NCT02547961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380441|NCT02547948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380442|NCT02547935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380443|NCT02547922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380444|NCT02547909||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380445|NCT02547896|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1380446|NCT02547883|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1380447|NCT02547870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380448|NCT02547857|||Cohort||Prospective|||||||
1380449|NCT02547844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380450|NCT02547831|||Case-Only||Prospective|||||||
1380451|NCT02547818|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1380452|NCT02547805|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380453|NCT02547792|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1380454|NCT02547779|Randomized|Crossover Assignment||Treatment||Single||||||t
1380455|NCT02547766||Single Group Assignment||Other||None (Open Label)||||||
1380456|NCT02547753|||Cohort||Prospective|||||||
1380457|NCT02547740|||Case-Control||Prospective|||||||
1380458|NCT02547727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380459|NCT02547714|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380460|NCT02547701||Single Group Assignment||Treatment||None (Open Label)||||||
1380461|NCT02547688||Single Group Assignment||Other||None (Open Label)||||||
1380462|NCT02547675||||||||||||
1380463|NCT02547662||Single Group Assignment||Treatment||None (Open Label)||||||
1380464|NCT02547649|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1380465|NCT02547636|||Case-Only||Prospective|||||||
1380466|NCT02547623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380467|NCT02547610|||Case-Only||Prospective|||||||
1380468|NCT02547597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380469|NCT02547584|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1380470|NCT02547571|Randomized|Parallel Assignment||Treatment||Single|||||t|
1380471|NCT02547558||Single Group Assignment||Treatment||None (Open Label)||||||
1380472|NCT02547545|||Cohort||Prospective|||||||
1380473|NCT02547532|||Cohort||Cross-Sectional|||||||
1380474|NCT02547519|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1380475|NCT02547506|||Case-Control||Cross-Sectional|||||||
1380476|NCT02547493|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380477|NCT02547480||Single Group Assignment||Treatment||None (Open Label)||||||
1380478|NCT02547467|||Cohort||Prospective|||||||
1380479|NCT02547454|||Case-Only||Prospective|||||||
1380480|NCT02547441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380481|NCT02547428|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1380482|NCT02547415|||Cohort||Prospective|||||||
1380483|NCT02547402||Single Group Assignment||Treatment||None (Open Label)||||||
1380484|NCT02547389|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1380485|NCT02547376|||Case-Only||Prospective|||||||
1380486|NCT02547363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380487|NCT02547350|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380488|NCT02547337|||Case Control||Cross-Sectional|||||||
1380489|NCT02547324|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1380490|NCT02547311|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1380491|NCT02547298||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380492|NCT02547285|||Cohort||Prospective|||||||
1380493|NCT02547272|||Cohort||Prospective|||||||
1380494|NCT02547259|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380495|NCT02547246|Randomized|Parallel Assignment||||Single|||t|||
1380496|NCT02547233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380497|NCT02547220|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380498|NCT02547207|||Cohort||Prospective|||||||
1380499|NCT02547194|||||Prospective|||||||
1380500|NCT02547181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380501|NCT02547168||Single Group Assignment||Screening||None (Open Label)||||||
1380502|NCT02547155|Randomized|Parallel Assignment||Prevention||Single|||t|||
1380503|NCT02547142||Single Group Assignment||Supportive Care||None (Open Label)||||||
1380504|NCT02547129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380505|NCT02547116|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380506|NCT02547103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380507|NCT02547090|||Case Control||Prospective|||||||
1380508|NCT02547077|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380509|NCT02547064|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380510|NCT02547051||Single Group Assignment||Treatment||None (Open Label)||||||
1380511|NCT02547038|Randomized|Parallel Assignment||Treatment||Single|||||t|
1380512|NCT02547025|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380513|NCT02547012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380514|NCT02546999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380515|NCT02546986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380516|NCT02546973|||Cohort||Cross-Sectional|||||||
1380517|NCT02546960|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380518|NCT02546947|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1380519|NCT02546934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380520|NCT02546921||||Treatment||||||||
1380521|NCT02546908|||Cohort||Prospective|||||||
1380522|NCT02546895|||Cohort||Prospective|||||||
1380523|NCT02546882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380524|NCT02546869|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380525|NCT02546856|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1380526|NCT02546843|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380527|NCT02546830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380528|NCT02546817|||Case-Only||Prospective|||||||
1380529|NCT02546804|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1380530|NCT02546791|||Cohort||Retrospective|||||||
1380531|NCT02546778||Single Group Assignment||Treatment||None (Open Label)||||||
1380532|NCT02546765|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1380533|NCT02546752|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1380534|NCT02546739|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380535|NCT02546726|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1380536|NCT02546713|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380537|NCT02546700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380538|NCT02546687|||Cohort||Prospective|||||||
1380539|NCT02546674||Single Group Assignment||Treatment||None (Open Label)||||||
1380540|NCT02546661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380541|NCT02546648|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1380542|NCT02546635|Randomized|Crossover Assignment||||Double|||t||t|
1380543|NCT02546622|||Cohort||Other|||||||
1380544|NCT02546609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380545|NCT02546596||Single Group Assignment||Treatment||None (Open Label)||||||
1380546|NCT02546583|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380547|NCT02546570|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380548|NCT02546557|||Cohort||Prospective|||||||
1380549|NCT02546544||Single Group Assignment||Treatment||None (Open Label)||||||
1380550|NCT02546531|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380551|NCT02546518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380552|NCT02546505|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1380553|NCT02546492||Single Group Assignment||Treatment||None (Open Label)||||||
1380554|NCT02546479|||Cohort||Prospective|||||||
1380555|NCT02546466|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380556|NCT02546453||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380557|NCT02546440||Single Group Assignment||Treatment||None (Open Label)||||||
1380558|NCT02546427||Single Group Assignment||Treatment||None (Open Label)||||||
1380559|NCT02546414|||Case Control||Retrospective|||||||
1380560|NCT02546401|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380561|NCT02546388||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380562|NCT02546375|||Case-Only||Retrospective|||||||
1380563|NCT02546362||Single Group Assignment||Treatment||None (Open Label)||||||
1380564|NCT02546349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380565|NCT02546336||Single Group Assignment||Treatment||None (Open Label)||||||
1380566|NCT02546323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380567|NCT02546310|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1380568|NCT02546297|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380569|NCT02546284||Single Group Assignment||Treatment||None (Open Label)||||||
1380570|NCT02546271||Single Group Assignment||Prevention||None (Open Label)||||||
1380571|NCT02546258||Single Group Assignment||Treatment||None (Open Label)||||||
1380572|NCT02546245|Randomized|Parallel Assignment||||None (Open Label)||||||
1380573|NCT02546232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380574|NCT02546219|||Other||Prospective|||||||
1380575|NCT02546206|Randomized|Parallel Assignment||Prevention||Single|||||t|
1380576|NCT02546193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380577|NCT02546180|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380578|NCT02546167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380579|NCT02546154|||Cohort||Prospective|||||||
1380580|NCT02546141|Randomized|Crossover Assignment||Basic Science||Single||||||t
1380581|NCT02546128|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1380582|NCT02546115|Randomized|Parallel Assignment||Treatment||Single|||||t|
1380583|NCT02546102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380584|NCT02546089|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380585|NCT02546076|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1380586|NCT02546063|Randomized|Crossover Assignment||||None (Open Label)||||||
1380587|NCT02546050||Single Group Assignment||Basic Science||None (Open Label)||||||
1380588|NCT02546037|||Case-Crossover||Prospective|||||||
1380589|NCT02546024|||Cohort||Prospective|||||||
1380590|NCT02546011|||Cohort||Prospective|||||||
1380591|NCT02545998|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1380592|NCT02545985||Single Group Assignment||Treatment||None (Open Label)||||||
1380593|NCT02545972||Single Group Assignment||Treatment||None (Open Label)||||||
1380594|NCT02545959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380595|NCT02545946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380596|NCT02545933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380597|NCT02545920|||Case-Only||Prospective|||||||
1380598|NCT02545907||Single Group Assignment||Treatment||None (Open Label)||||||
1380599|NCT02545894|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380600|NCT02545881|||Case-Only||Prospective|||||||
1380601|NCT02545868|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380602|NCT02545855|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380603|NCT02545842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380604|NCT02545829|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380605|NCT02545816||Single Group Assignment||Supportive Care||None (Open Label)||||||
1380606|NCT02545803||Single Group Assignment||Other||None (Open Label)||||||
1380607|NCT02545790|||Case-Control||Prospective|||||||
1380608|NCT02545777|Randomized|Parallel Assignment||Treatment||Single||||||t
1380609|NCT02545764|Randomized|Parallel Assignment||Treatment||Single||||||t
1380610|NCT02545751||Single Group Assignment||Treatment||None (Open Label)||||||
1380611|NCT02545738|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380612|NCT02545725|||Cohort||Retrospective|||||||
1380613|NCT02545712|||Case-Control||Retrospective|||||||
1380614|NCT02545699|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380615|NCT02545686||Single Group Assignment||Health Services Research||None (Open Label)||||||
1380616|NCT02545673|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1380617|NCT02545660|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380618|NCT02545647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380619|NCT02545634|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1380620|NCT02545621|||||Cross-Sectional|||||||
1380621|NCT02545608|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1380622|NCT02545595||||||||||||
1380623|NCT02545582|||Cohort||Prospective|||||||
1380624|NCT02545569|Randomized|Crossover Assignment||||Single|||t|||
1380625|NCT02545556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380626|NCT02545543|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380627|NCT02545530|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380628|NCT02545517||Single Group Assignment||Prevention||None (Open Label)||||||
1380629|NCT02545504|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380630|NCT02545491|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1380631|NCT02545478|||Cohort||Prospective|||||||
1380632|NCT02545465|||Cohort||Retrospective|||||||
1380633|NCT02545452|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380634|NCT02545439||Single Group Assignment||Treatment||None (Open Label)||||||
1380635|NCT02545426|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1380636|NCT02545413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380637|NCT02545400|||Cohort||Retrospective|||||||
1380638|NCT02545387|||Cohort||Retrospective|||||||
1380639|NCT02545374|Randomized|Parallel Assignment||||None (Open Label)||||||
1380640|NCT02545361||Single Group Assignment||Treatment||None (Open Label)||||||
1380641|NCT02545348|||Case-Only||Prospective|||||||
1380642|NCT02545335|||Cohort||Prospective|||||||
1380643|NCT02545322||Single Group Assignment||Treatment||None (Open Label)||||||
1380645|NCT02545296||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380646|NCT02545283|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380647|NCT02545270|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1380648|NCT02545257|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1380649|NCT02545244|Randomized|Parallel Assignment||Treatment||Single|||||t|
1380650|NCT02545231|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380651|NCT02545218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380652|NCT02545205|Randomized|Parallel Assignment||Treatment||Single||||||t
1380653|NCT02545192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380654|NCT02545179|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1380655|NCT02545166|||Case-Control||Prospective|||||||
1380656|NCT02545153|Randomized|Parallel Assignment||Treatment||Single||||||t
1380657|NCT02545140|||Cohort||Cross-Sectional|||||||
1380658|NCT02545127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380659|NCT02545114||Single Group Assignment||Treatment||None (Open Label)||||||
1380660|NCT02545101|||Cohort||Retrospective|||||||
1380661|NCT02545088|Randomized|Parallel Assignment||Treatment||Single||||||t
1380662|NCT02545075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380663|NCT02545062|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1380664|NCT02545049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380665|NCT02545036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380666|NCT02545023|||Case-Only||Prospective|||||||
1380667|NCT02545010||Single Group Assignment||Treatment||None (Open Label)||||||
1380668|NCT02544997||Single Group Assignment||Treatment||None (Open Label)||||||
1380669|NCT02544984|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1380670|NCT02544971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380671|NCT02544958||Single Group Assignment||Treatment||None (Open Label)||||||
1380672|NCT02544945|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380673|NCT02544932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380674|NCT02544919|Randomized|Parallel Assignment||Prevention||Single||||||t
1380675|NCT02544906|Randomized|Parallel Assignment||Prevention||Single|||t|||
1380676|NCT02544893|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1380677|NCT02544880|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380678|NCT02544867|Randomized|Parallel Assignment||Prevention||Single||||||t
1380679|NCT02544854|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1380680|NCT02544841|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380681|NCT02544828|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380682|NCT02544815|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1380683|NCT02544802||Single Group Assignment||Treatment||None (Open Label)||||||
1380684|NCT02544789||Single Group Assignment||Treatment||None (Open Label)||||||
1380685|NCT02544776|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1380686|NCT02544763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380687|NCT02544750||Single Group Assignment||Treatment||None (Open Label)||||||
1380688|NCT02544737||Single Group Assignment||Treatment||None (Open Label)||||||
1380689|NCT02544724||Single Group Assignment||Treatment||None (Open Label)||||||
1380690|NCT02544711|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380691|NCT02544698|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1380692|NCT02544685|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380693|NCT02544672||Single Group Assignment||||None (Open Label)||||||
1380694|NCT02544659||Single Group Assignment||Treatment||None (Open Label)||||||
1380695|NCT02544646||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380696|NCT02544633|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380697|NCT02544620|||Cohort||Prospective|||||||
1380698|NCT02544607||Single Group Assignment||Other||None (Open Label)||||||
1380699|NCT02544594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380700|NCT02544581|||Ecologic or Community||Retrospective|||||||
1380701|NCT02544568|Randomized|Crossover Assignment||||None (Open Label)||||||
1380702|NCT02544555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380703|NCT02544542|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380704|NCT02544529|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1380705|NCT02544516|Randomized|Parallel Assignment||||None (Open Label)||||||
1380706|NCT02544503|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380707|NCT02544490|||Cohort||Prospective|||||||
1380708|NCT02544477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380709|NCT02544464|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380710|NCT02544451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380711|NCT02544438||Single Group Assignment||Treatment||None (Open Label)||||||
1380712|NCT02544425||Single Group Assignment||Treatment||None (Open Label)||||||
1380713|NCT02544412|Randomized|Parallel Assignment||Prevention||Single||||||t
1380714|NCT02544399|||Cohort||Prospective|||||||
1380715|NCT02544386|||Cohort||Prospective|||||||
1380716|NCT02544373|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1380717|NCT02544360|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380718|NCT02544347|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1380719|NCT02544334|||Case-Control||Cross-Sectional|||||||
1380720|NCT02544321|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1380721|NCT02544308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380722|NCT02544295|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1380723|NCT02544282|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1380724|NCT02544269|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1380725|NCT02544256|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1380726|NCT02544243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380727|NCT02544230|||Cohort||Retrospective|||||||
1380728|NCT02544217|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1380729|NCT02544204|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380730|NCT02544191||Single Group Assignment||Treatment||None (Open Label)||||||
1380731|NCT02544178|||Cohort||Prospective|||||||
1380732|NCT02544165|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380733|NCT02544152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380734|NCT02544139|||Case-Only||Prospective|||||||
1380735|NCT02544126|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380736|NCT02544113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380737|NCT02544100|||Case-Only||Retrospective|||||||
1380738|NCT02544087|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1380739|NCT02544074|||Other||Prospective|||||||
1380740|NCT02544061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380741|NCT02544048|||Cohort||Prospective|||||||
1380742|NCT02544035|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1380743|NCT02544022|||Case-Only||Prospective|||||||
1380744|NCT02544009|||Cohort||Prospective|||||||
1380745|NCT02543996|||Case-Only||Cross-Sectional|||||||
1380746|NCT02543983||Single Group Assignment||Basic Science||None (Open Label)||||||
1380747|NCT02543970|||Case-Only||Prospective|||||||
1380748|NCT02543957|||Cohort||Prospective|||||||
1380749|NCT02543944|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380750|NCT02543931|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380751|NCT02543918|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1380752|NCT02543905|||Cohort||Prospective|||||||
1380753|NCT02543892|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380754|NCT02543879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380755|NCT02543866||Single Group Assignment||Other||None (Open Label)||||||
1380756|NCT02543853|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380757|NCT02543840|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380758|NCT02543827|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1380759|NCT02543814||||||||||||
1380760|NCT02543801|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1380761|NCT02543788|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1380762|NCT02543775||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380763|NCT02543762|||Cohort||Prospective|||||||
1380764|NCT02543749||Single Group Assignment||Treatment||None (Open Label)||||||
1380765|NCT02543736||Single Group Assignment||Screening||None (Open Label)||||||
1380766|NCT02543723|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1380767|NCT02543710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380768|NCT02543697||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380769|NCT02543684|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1380770|NCT02543671|Randomized|Parallel Assignment||Prevention||Single|||t|||
1380771|NCT02543658|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380772|NCT02543645||Single Group Assignment||Treatment||None (Open Label)||||||
1380773|NCT02543632|||Case-Control||Prospective|||||||
1380774|NCT02543619|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1380775|NCT02543606|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1380776|NCT02543593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380777|NCT02543580|Randomized|Parallel Assignment||Prevention||Triple|For all patients, electrodes were placed at the bilateral PC6 and RN17 and connected to the Hwato Electric Acupuncture Treatment Instrument. No patients in the study had previous experience of undergoing transcutaneous electrical stimulation treatment. Patients were told that they might or might not feel the electrical stimulation. Interventions were performed by a designated investigator who was not involved in the anaesthesia or the follow-up. The stimulator was placed in an opaque box to blind the surgical team and the anaesthetists to the group allocation.|||t|t|t
1380778|NCT02543567|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1380779|NCT02543554|||Other||Other|||||||
1380780|NCT02543541|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380781|NCT02543528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380782|NCT02543515|||Cohort||Prospective|||||||
1380783|NCT02543502|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1380784|NCT02543489||Single Group Assignment||Treatment||None (Open Label)||||||
1380785|NCT02543476|||Case-Only||Retrospective|||||||
1380786|NCT02543463|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380787|NCT02543450|Randomized|Parallel Assignment||Treatment||Single||||||t
1380788|NCT02543437||Single Group Assignment||Treatment||None (Open Label)||||||
1380789|NCT02543424|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380790|NCT02543411|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380791|NCT02543398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380792|NCT02543385|Randomized|Parallel Assignment||||Triple|||t||t|t
1380793|NCT02543372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380794|NCT02543359|Randomized|Parallel Assignment||Treatment||Single||||||t
1380795|NCT02543346|Randomized|Crossover Assignment||||Double|||t||t|
1380796|NCT02543333|||Cohort||Prospective|||||||
1380797|NCT02543320||Single Group Assignment||Treatment||None (Open Label)||||||
1380798|NCT02543307|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380799|NCT02543294|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380800|NCT02543281|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380801|NCT02543268|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1380802|NCT02543255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380803|NCT02543242||Single Group Assignment||Treatment||None (Open Label)||||||
1380804|NCT02543229|Randomized|Parallel Assignment||Treatment||Single||||||t
1380805|NCT02543216|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380806|NCT02543203|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1380807|NCT02543190|Randomized|Parallel Assignment||Prevention||Double|Care provider did not know study assignment. Reviewer for primary outcomes did not know study assignment|||t||t
1380808|NCT02543177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380809|NCT02543164|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1380810|NCT02543151||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380811|NCT02543138||Single Group Assignment||||Single|||t|||
1380812|NCT02543125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380813|NCT02543099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380814|NCT02543086||Single Group Assignment||Treatment||None (Open Label)||||||
1380815|NCT02543073|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380816|NCT02543060|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1380817|NCT02543047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380818|NCT02543034|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380819|NCT02543021|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1380820|NCT02543008|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1380821|NCT02542995|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1380822|NCT02542982|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1380823|NCT02542969||Single Group Assignment||Treatment||None (Open Label)||||||
1380824|NCT02542956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380825|NCT02542943|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380826|NCT02542930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380827|NCT02542917|||Cohort||Prospective|||||||
1380828|NCT02542904|Randomized|Single Group Assignment||Prevention||Single|||t|||
1380829|NCT02542891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380830|NCT02542878|Randomized|Parallel Assignment||Prevention||Single||||||t
1380831|NCT02542865|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380832|NCT02542852||Single Group Assignment||Treatment||None (Open Label)||||||
1380833|NCT02542839|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1380834|NCT02542826||Single Group Assignment||Treatment||None (Open Label)||||||
1380835|NCT02542813|Randomized|Factorial Assignment||Treatment||Single|||t|||
1380836|NCT02542800||Single Group Assignment||Basic Science||None (Open Label)||||||
1380837|NCT02542787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380838|NCT02542774|||Cohort||Retrospective|||||||
1380839|NCT02542761|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||This was a repeated measures cross-over trial whereby only the prosthetic foot was changed. Each subject was tested using their current carbon-fiber prosthetic foot (CFPF), and the fiberglass prosthetic foot (FPF). Half of the subjects began the study on the CFPF while the other half began on the FPF. Each subject was given an acclimation period of 4 weeks before testing.||||
1380840|NCT02542748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380841|NCT02542735|||Cohort||Prospective|||||||
1380842|NCT02542722|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380843|NCT02542709|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1380844|NCT02542696||Single Group Assignment||Treatment||None (Open Label)||||||
1380845|NCT02542683|||Cohort||Prospective|||||||
1380846|NCT02542670|||Case-Control||Retrospective|||||||
1380847|NCT02542657||Single Group Assignment||Treatment||None (Open Label)||||||
1380848|NCT02542644||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380849|NCT02542631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380850|NCT02542618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380851|NCT02542605|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1380852|NCT02542592|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1380853|NCT02542579|||Case-Only||Prospective|||||||
1380854|NCT02542566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380855|NCT02542553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380856|NCT02542540|Randomized|Parallel Assignment||||None (Open Label)||||||
1380857|NCT02542527||Single Group Assignment||||None (Open Label)||||||
1380858|NCT02542514||Single Group Assignment||Treatment||None (Open Label)||||||
1380859|NCT02542501|||Case-Only||Prospective|||||||
1380860|NCT02542488|||Cohort||Prospective|||||||
1380861|NCT02542475||Single Group Assignment||Treatment||None (Open Label)||||||
1380862|NCT02542462|Randomized|Parallel Assignment||Other||Double||||t||t
1380863|NCT02542449|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380864|NCT02542436|||Cohort||Retrospective|||||||
1380865|NCT02542423||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380866|NCT02542410|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380867|NCT02542397||Single Group Assignment||Supportive Care||None (Open Label)||Pharmacogenomic testing||||
1380868|NCT02542384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1380869|NCT02542371|||Case-Control||Cross-Sectional|||||||
1380870|NCT02542345||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380871|NCT02542332|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1380872|NCT02542319|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1380873|NCT02542306|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380874|NCT02542293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380875|NCT02542280|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380876|NCT02542267||Single Group Assignment||Treatment||None (Open Label)||||||
1380877|NCT02542254|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1380878|NCT02542241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380879|NCT02542228|||Cohort||Prospective|||||||
1380880|NCT02542215|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380881|NCT02542202||Single Group Assignment||Treatment||None (Open Label)||||||
1380882|NCT02542189|||||Retrospective|||||||
1380883|NCT02542176|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1380884|NCT02542163|||Cohort||Prospective|||||||
1380885|NCT02542150|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1380886|NCT02542137|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1380887|NCT02542124||Single Group Assignment||Treatment||None (Open Label)||||||
1380888|NCT02542111||Single Group Assignment||Treatment||None (Open Label)||||||
1380889|NCT02542098||Single Group Assignment||Treatment||None (Open Label)||||||
1380890|NCT02542085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380891|NCT02542072|Randomized|Crossover Assignment||Other||Single|||t|||
1380892|NCT02542059|||Case-Control||Prospective|||||||
1380893|NCT02542046|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1380894|NCT02542033|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1380895|NCT02542020|||Cohort||Prospective|||||||
1380896|NCT02542007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380897|NCT02541994||Single Group Assignment||Screening||None (Open Label)||||||
1380898|NCT02541981|||Case-Only||Retrospective|||||||
1380899|NCT02541968|Randomized|Crossover Assignment||Treatment||Single||||||t
1380900|NCT02541955|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1380901|NCT02541942||Single Group Assignment||Other||None (Open Label)||||||
1380902|NCT02541929|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1380903|NCT02541916||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380904|NCT02541903||Single Group Assignment||Treatment||None (Open Label)||||||
1380905|NCT02541890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380906|NCT02541877|Randomized|Parallel Assignment||Treatment||Single||||||t
1380907|NCT02541864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380908|NCT02541851|||Cohort||Retrospective|||||||
1380909|NCT02541838||Single Group Assignment||Treatment||None (Open Label)||||||
1380910|NCT02541825|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380911|NCT02541812|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380912|NCT02541799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380913|NCT02541786|Randomized|Parallel Assignment||Treatment||Single|||||t|
1380914|NCT02541773|||Cohort||Prospective|||||||
1380915|NCT02541760|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1380916|NCT02541747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380917|NCT02541734|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1380918|NCT02541721||Single Group Assignment||Treatment||None (Open Label)||||||
1380919|NCT02541708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380920|NCT02541695|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1380921|NCT02541682|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1380922|NCT02541669|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1380923|NCT02541656||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380924|NCT02541643||||||||||||
1380925|NCT02541630||Single Group Assignment||Treatment||None (Open Label)||||||
1380926|NCT02541617|Randomized|Parallel Assignment||Treatment||Single||||||t
1380927|NCT02541604||Single Group Assignment||Treatment||None (Open Label)||||||
1380928|NCT02541591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380929|NCT02541578|||Cohort||Prospective|||||||
1380930|NCT02541565||Single Group Assignment||Treatment||None (Open Label)||||||
1380931|NCT02541552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380932|NCT02541539|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1380933|NCT02541526|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1380934|NCT02541513||Single Group Assignment||Treatment||None (Open Label)||||||
1380935|NCT02541500||Single Group Assignment||Treatment||None (Open Label)||||||
1380936|NCT02541487|||Cohort||Prospective|||||||
1380937|NCT02541474|Non-Randomized|Parallel Assignment||Health Services Research||Double|"This is a registry based study design. The Primary outcome is extracted from routine data recorded by clinical and administrative personell who are unaware of study allocation in the electronic health care record.~The questionnaire outcome data can not be masked as the patient and study personell will be aware of treatment allocation group. To avoid preferential recording of these outcomes, study personell assist in data collection in either treatment or control groups - never both, so that they could not compare or favor one group above the other."|Treatment patients|||t|t
1380938|NCT02541461|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380939|NCT02541448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380940|NCT02541435|||Cohort||Prospective|||||||
1380941|NCT02541422|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1380942|NCT02541409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380943|NCT02541396|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380944|NCT02541383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380945|NCT02541370||Single Group Assignment||Treatment||None (Open Label)||||||
1380946|NCT02541357|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1380947|NCT02541344|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1380948|NCT02541331|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1380949|NCT02541318|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380950|NCT02541305|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380951|NCT02541292|||Cohort||Prospective|||||||
1380952|NCT02541279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380953|NCT02541266|||Cohort||Prospective|||||||
1380954|NCT02541253|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1380955|NCT02541240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380956|NCT02541227|||Cohort||Prospective|||||||
1380957|NCT02541214||||||||||||
1380958|NCT02541201|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1380959|NCT02541188|||Cohort||Prospective|||||||
1380960|NCT02541175|||Case-Only||Cross-Sectional|||||||
1380961|NCT02541162|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1380962|NCT02541149|||Case Control||Prospective|||||||
1380963|NCT02541136|Randomized|Parallel Assignment||Basic Science||Single||||||t
1380964|NCT02541123|||Cohort||Prospective|||||||
1380965|NCT02541110|||Case Control||Prospective|||||||
1380966|NCT02541097|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1380967|NCT02541084|||Cohort||Prospective|||||||
1380968|NCT02541071|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1380969|NCT02541058|||Case Control||Prospective|||||||
1380970|NCT02541045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380971|NCT02541032|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1380972|NCT02541019|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1380973|NCT02541006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380974|NCT02540993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380975|NCT02540967|||Other||Prospective|||||||
1380976|NCT02540954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380977|NCT02540941||||||||||||
1380978|NCT02540928|Randomized|Parallel Assignment||Treatment||Double||||||
1380979|NCT02540915|||Other||Other|||||||
1380980|NCT02540902||Single Group Assignment||Diagnostic||None (Open Label)||||||
1380981|NCT02540889|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1380982|NCT02540876||Single Group Assignment||Treatment||None (Open Label)||||||
1380983|NCT02540863|Randomized|Parallel Assignment||Treatment||Single||||||t
1380984|NCT02540850|||Cohort||Prospective|||||||
1380985|NCT02540837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1380986|NCT02540824||Single Group Assignment||Treatment||None (Open Label)||||||
1380987|NCT02540811||Single Group Assignment||Treatment||None (Open Label)||||||
1380988|NCT02540798|||Cohort||Prospective|||||||
1380989|NCT02540785|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380990|NCT02540772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380991|NCT02540759|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1380992|NCT02540746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380993|NCT02540733|||Cohort||Prospective|||||||
1380994|NCT02540720|Randomized|Parallel Assignment||Treatment||Single|||t|||
1380995|NCT02540707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1380996|NCT02540694|Randomized|Factorial Assignment||Diagnostic||Single||||||t
1380997|NCT02540681|||Cohort||Prospective|||||||
1380998|NCT02540668|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1380999|NCT02540655|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381000|NCT02540642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381001|NCT02540629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381002|NCT02540616|Randomized|Crossover Assignment||Treatment||Single||Participants will be randomized to a real vs a sham stimulation arm. The sham arm will be offered real treatment after unblinding.|t|||
1381003|NCT02540603||Single Group Assignment||Treatment||None (Open Label)||||||
1381004|NCT02540590|||Cohort||Prospective|||||||
1381005|NCT02540577||||||||||||
1381006|NCT02540564||||||||||||
1381007|NCT02540551||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381008|NCT02540538|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381009|NCT02540525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381010|NCT02540512|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1381011|NCT02540499||Single Group Assignment||Treatment||None (Open Label)||||||
1381012|NCT02540486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381013|NCT02540473|Randomized|Parallel Assignment||Prevention||Single||||||t
1381014|NCT02540460|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1381015|NCT02540447|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1381016|NCT02540434|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1381017|NCT02540421|||Case Control||Retrospective|||||||
1381018|NCT02540408|||Case Control||Prospective|||||||
1381019|NCT02540395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381020|NCT02540382|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1381021|NCT02540369|||Cohort||Prospective|||||||
1381022|NCT02540356|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381023|NCT02540343||||||||||||
1381024|NCT02540330|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381025|NCT02540317|Randomized|Parallel Assignment||Treatment||||||||
1381026|NCT02540304|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1381027|NCT02540291||Single Group Assignment||Treatment||None (Open Label)||||||
1381028|NCT02540278|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381029|NCT02540265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381030|NCT02540252|||Cohort||Prospective|||||||
1381031|NCT02540239|Randomized|Parallel Assignment||Screening||Single|||||t|
1381032|NCT02540226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381033|NCT02540213|||Cohort||Prospective|||||||
1381034|NCT02540200|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1381035|NCT02540187|||Cohort||Prospective|||||||
1381036|NCT02540174|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1381037|NCT02540161|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381038|NCT02540148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381039|NCT02540135|Randomized|Parallel Assignment||Other||Single|||t|||
1381040|NCT02540122|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381041|NCT02540109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381042|NCT02540096|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1381043|NCT02540083|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1381044|NCT02540070|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381045|NCT02540057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381046|NCT02540044|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1381047|NCT02540031|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1381048|NCT02540018|Randomized|Single Group Assignment||Treatment||Single|||t|||
1381049|NCT02540005|||Cohort||Prospective|||||||
1381050|NCT02539992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381051|NCT02539979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381052|NCT02539966|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1381053|NCT02539953||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381054|NCT02539940|||Cohort||Prospective|||||||
1381055|NCT02539927|||Cohort||Other|||||||
1381056|NCT02539914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381057|NCT02539901|||Cohort||Prospective|||||||
1381058|NCT02539875|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1381059|NCT02539862|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381060|NCT02539849||Single Group Assignment||Other||None (Open Label)||||||
1381061|NCT02539836|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381062|NCT02539823|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1381063|NCT02539810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381064|NCT02539797|Randomized|Crossover Assignment||Treatment||Single|||t|||
1381065|NCT02539784||Single Group Assignment||Treatment||None (Open Label)||||||
1381066|NCT02539771|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381067|NCT02539758||Single Group Assignment||Treatment||None (Open Label)||||||
1381068|NCT02539745|||Case Control||Prospective|||||||
1381069|NCT02539732|||Cohort||Prospective|||||||
1381070|NCT02539719|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1381071|NCT02539706|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1381072|NCT02539693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381073|NCT02539680|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381074|NCT02539654||Single Group Assignment||Other||None (Open Label)||||||
1381075|NCT02539641|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381076|NCT02539628|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1381077|NCT02539615|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1381078|NCT02539602|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1381079|NCT02539589|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381080|NCT02539576||Single Group Assignment||Treatment||None (Open Label)||||||
1381081|NCT02539563|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1381082|NCT02539550|Randomized|||Treatment||Double|||t||t|
1381083|NCT02539537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381084|NCT02539524|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1381085|NCT02539511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381086|NCT02539498|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381087|NCT02539485|Randomized|Single Group Assignment||Prevention||Single||||||t
1381088|NCT02539472||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381089|NCT02539459||Single Group Assignment||Treatment||None (Open Label)||||||
1381090|NCT02539446|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1381091|NCT02539433||Single Group Assignment||Diagnostic||Single|||||t|
1381092|NCT02539420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381093|NCT02539407|||Cohort||Prospective|||||||
1381094|NCT02539394|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1381095|NCT02539381|Randomized|Parallel Assignment||Screening||Double|||||t|t
1381096|NCT02539368|||Cohort||Prospective|||||||
1381097|NCT02539355|Randomized|Parallel Assignment||Prevention||Single|||t|||
1381098|NCT02539342|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381099|NCT02539329|||Case-Control||Prospective|||||||
1381100|NCT02539316|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381101|NCT02539303||Single Group Assignment||Treatment||None (Open Label)||||||
1381102|NCT02539290|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381103|NCT02539277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381104|NCT02539264|||Cohort||Retrospective|||||||
1381105|NCT02539251|||Other||Cross-Sectional|||||||
1381106|NCT02539238|Randomized|Parallel Assignment||||None (Open Label)||||||
1381107|NCT02539225|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381108|NCT02539212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381109|NCT02539199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381110|NCT02539186|Randomized|Parallel Assignment||Treatment||Single|||||t|
1381111|NCT02539173||Single Group Assignment||Supportive Care||None (Open Label)||||||
1381112|NCT02539160|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381113|NCT02539147|||Other||Other|||||||
1381114|NCT02539134|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1381115|NCT02539121|Randomized|Parallel Assignment||Prevention||Single|||t|||
1381116|NCT02539108|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381117|NCT02539095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381118|NCT02539082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381119|NCT02539069||Single Group Assignment||Treatment||None (Open Label)||||||
1381120|NCT02539056||Single Group Assignment||Treatment||None (Open Label)||||||
1381121|NCT02539043|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1381122|NCT02539030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381123|NCT02539017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381124|NCT02539004|||Case-Only||Prospective|||||||
1381125|NCT02538991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381126|NCT02538978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381127|NCT02538965||Single Group Assignment||Treatment||None (Open Label)||||||
1381128|NCT02538952|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1381129|NCT02538939||Single Group Assignment||Treatment||None (Open Label)||||||
1381130|NCT02538926||Single Group Assignment||Treatment||None (Open Label)||||||
1381131|NCT02538913|Randomized|Parallel Assignment||Prevention||Single|||||t|
1381132|NCT02538900|Randomized|Parallel Assignment||Treatment||Single||||||t
1381133|NCT02538887|||Case-Only||Prospective|||||||
1381134|NCT02538874|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1381135|NCT02538861|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381136|NCT02538848|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1381137|NCT02538835|Randomized|Parallel Assignment||Treatment||Single||||||t
1381138|NCT02538822||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381139|NCT02538809|||Case-Control||Cross-Sectional|||||||
1381140|NCT02538796|Randomized|Parallel Assignment||||None (Open Label)||||||
1381141|NCT02538783|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1381142|NCT02538770|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381143|NCT02538744|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381144|NCT02538731|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381145|NCT02538718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381146|NCT02538705||Single Group Assignment||Treatment||None (Open Label)||||||
1381147|NCT02538692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381148|NCT02538679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381149|NCT02538666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381150|NCT02538653|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381151|NCT02538640|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1381152|NCT02538627|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381153|NCT02538614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381154|NCT02538601|Randomized|Parallel Assignment||Treatment||Single||||||t
1381155|NCT02538588|Randomized|Crossover Assignment||Treatment||Single||||||t
1381156|NCT02538575||Single Group Assignment||Other||None (Open Label)||||||
1381157|NCT02538562|||Cohort||Prospective|||||||
1381158|NCT02538549|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1381159|NCT02538536||Single Group Assignment||Treatment||None (Open Label)||||||
1381160|NCT02538523||||||||||||
1381161|NCT02538510||Single Group Assignment||Treatment||None (Open Label)||||||
1381162|NCT02538497|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381163|NCT02538484|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381164|NCT02538471||Single Group Assignment||Treatment||None (Open Label)||||||
1381165|NCT02538458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381166|NCT02538445|Randomized|Parallel Assignment||||None (Open Label)||||||
1381167|NCT02538432|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1381168|NCT02538419|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381169|NCT02538406|||Cohort||Prospective|||||||
1381170|NCT02538393|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1381245|NCT02537418||Single Group Assignment||Other||None (Open Label)||||||
1381171|NCT02538380||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381172|NCT02538367|Randomized|Parallel Assignment||||Double|||t||t|
1381173|NCT02538354|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1381174|NCT02538341|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381175|NCT02538328|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1381176|NCT02538315|||Case-Control||Prospective|||||||
1381177|NCT02538302|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1381178|NCT02538289|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1381179|NCT02538276|||Cohort||Prospective|||||||
1381180|NCT02538263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381181|NCT02538250||Single Group Assignment||||None (Open Label)||||||
1381182|NCT02538237|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381183|NCT02538224|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381184|NCT02538211|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381185|NCT02538198||Single Group Assignment||Treatment||None (Open Label)||||||
1381186|NCT02538185|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381187|NCT02538172|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381188|NCT02538159|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1381189|NCT02538146||Single Group Assignment||Supportive Care||None (Open Label)||||||
1381190|NCT02538133||Single Group Assignment||Diagnostic||Double|||t||t|
1381191|NCT02538120|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381192|NCT02538107|||Cohort||Prospective|||||||
1381193|NCT02538094|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1381194|NCT02538081|Randomized|Parallel Assignment||Treatment||Double||||||
1381195|NCT02538068|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381196|NCT02538055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381197|NCT02538042|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381198|NCT02538029|Randomized|Parallel Assignment||Treatment||Single||||||t
1381199|NCT02538016||Single Group Assignment||Treatment||None (Open Label)||||||
1381200|NCT02538003|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381201|NCT02537990|||Cohort||Prospective|||||||
1381202|NCT02537977||Single Group Assignment||Treatment||None (Open Label)||||||
1381203|NCT02537964|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1381204|NCT02537951|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381205|NCT02537938|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381206|NCT02537925|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381207|NCT02537912|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1381208|NCT02537899||Single Group Assignment||Treatment||None (Open Label)||||||
1381209|NCT02537886|||Other||Other|||||||
1381210|NCT02537873|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1381211|NCT02537860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381212|NCT02537847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381213|NCT02537834||Single Group Assignment||Treatment||None (Open Label)||||||
1381214|NCT02537821|||Cohort||Prospective|||||||
1381215|NCT02537808|||Case-Only||Prospective|||||||
1381216|NCT02537795|||||Prospective|||||||
1381217|NCT02537782||||||||||||
1381218|NCT02537769|Randomized|Parallel Assignment||Treatment||Single||||||t
1381219|NCT02537756|Randomized|Factorial Assignment||Prevention||Single||||t||
1381220|NCT02537743|||Cohort||Prospective|||||||
1381221|NCT02537730|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381222|NCT02537717||||||||||||
1381223|NCT02537704||Single Group Assignment||Treatment||None (Open Label)||||||
1381224|NCT02537691||Single Group Assignment||Health Services Research||None (Open Label)||||||
1381225|NCT02537678|Randomized|Parallel Assignment||Treatment||Single||||||t
1381226|NCT02537665|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1381227|NCT02537652|||Cohort||Cross-Sectional|||||||
1381228|NCT02537639|||Cohort||Prospective|||||||
1381229|NCT02537626|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381230|NCT02537613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381231|NCT02537600||Single Group Assignment||Treatment||None (Open Label)||||||
1381232|NCT02537587|Randomized|Crossover Assignment||Prevention||Single||||t||
1381233|NCT02537574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381234|NCT02537561|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381235|NCT02537548||Single Group Assignment||Treatment||None (Open Label)||||||
1381236|NCT02537535|||Other||Prospective|||||||
1381237|NCT02537522|Randomized|Crossover Assignment||Other||Double|||t||t|
1381238|NCT02537509|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381239|NCT02537496|Randomized|Parallel Assignment||Treatment||Quadruple|Active placebo coil will be used as a Sham condition. This coil effectively mimics the real stimulation producing somatic sensation and sound (contraction of scalp muscles) with minimal direct brain effects. Same stimulation parameters and site as active condition will be used.|Participants will be assigned randomly to a 4-week repetitive course of either rTMS or control intervention (Sham rTMS) that is similar to rTMS but does not produce the same amount of brain stimulation.|t|t|t|t
1381240|NCT02537483|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1381241|NCT02537470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381242|NCT02537457|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381243|NCT02537444|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1381244|NCT02537431||Single Group Assignment||Treatment||None (Open Label)||||||
1381246|NCT02537405|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381247|NCT02537392|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381248|NCT02537379|||Ecologic or Community||Prospective|||||||
1381249|NCT02537366|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1381250|NCT02537353|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1381251|NCT02537340|||Cohort||Prospective|||||||
1381252|NCT02537327|||Case-Only||Cross-Sectional|||||||
1381253|NCT02537314|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1381254|NCT02537301|||||Retrospective|||||||
1381255|NCT02537288|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1381256|NCT02537275||Single Group Assignment||||None (Open Label)||||||
1381257|NCT02537262|Randomized|Parallel Assignment||Treatment||Single||||t||
1381258|NCT02537249|Randomized|Parallel Assignment||||Double|||t||t|
1381259|NCT02537236|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381260|NCT02537223||Single Group Assignment||Treatment||None (Open Label)||||||
1381261|NCT02537210|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1381262|NCT02537197||Single Group Assignment||Treatment||None (Open Label)||||||
1381263|NCT02537184|Randomized|Parallel Assignment||Prevention||Single|||||t|
1381264|NCT02537171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381265|NCT02537158|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381266|NCT02537145|||Case-Control||Cross-Sectional|||||||
1381267|NCT02537132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381268|NCT02537119|Randomized|Crossover Assignment||Treatment||Single|||t|||
1381269|NCT02537106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381270|NCT02537093|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1381271|NCT02537080|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381272|NCT02537067||Single Group Assignment||Treatment||None (Open Label)||||||
1381273|NCT02537054||Single Group Assignment||Treatment||None (Open Label)||||||
1381274|NCT02537041|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381275|NCT02537028|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381276|NCT02537015||Single Group Assignment||Treatment||None (Open Label)||||||
1381277|NCT02537002|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1381278|NCT02536989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381279|NCT02536976|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381280|NCT02536963|Non-Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1381281|NCT02536950|Non-Randomized|Sequential Assignment||Device Feasibility||Single|||t|||
1381282|NCT02536937|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381283|NCT02536924|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1381284|NCT02536911|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381285|NCT02536898|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1381286|NCT02536885|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381287|NCT02536872|||Cohort||Prospective|||||||
1381288|NCT02536859|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1381289|NCT02536846||Single Group Assignment||Basic Science||None (Open Label)||||||
1381290|NCT02536833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381291|NCT02536820|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1381292|NCT02536807|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1381293|NCT02536794||Single Group Assignment||Treatment||None (Open Label)||||||
1381294|NCT02536781|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381295|NCT02536768|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1381296|NCT02536755||Single Group Assignment||Treatment||None (Open Label)||||||
1381297|NCT02536742||Single Group Assignment||Treatment||None (Open Label)||||||
1381298|NCT02536729|||Cohort||Prospective|||||||
1381299|NCT02536716|Randomized|Parallel Assignment||Treatment||Single||||||t
1381300|NCT02536703||Single Group Assignment||Treatment||None (Open Label)||||||
1381301|NCT02536690|Randomized|Parallel Assignment||||Double|||t|t||
1381302|NCT02536677|||Cohort||Prospective|||||||
1381303|NCT02536664|||Cohort||Prospective|||||||
1381304|NCT02536651|||Cohort||Cross-Sectional|||||||
1381305|NCT02536638|||Case Control||Prospective|||||||
1381306|NCT02536625|||Case-Control||Prospective|||||||
1381307|NCT02536612|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381308|NCT02536599|||Cohort||Prospective|||||||
1381309|NCT02536586||Single Group Assignment||Treatment||None (Open Label)||||||
1381310|NCT02536573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381311|NCT02536560|||Cohort||Prospective|||||||
1381312|NCT02536547|||Cohort||Prospective|||||||
1381313|NCT02536534|||Other||Prospective|||||||
1381314|NCT02536521|||Cohort||Prospective|||||||
1381315|NCT02536508|Randomized|Parallel Assignment||Treatment||Double|Double-Blind||t||t|
1381316|NCT02536495||Single Group Assignment||Treatment||None (Open Label)||||||
1381317|NCT02536482||Single Group Assignment||Treatment||None (Open Label)||||||
1381318|NCT02536469||Single Group Assignment||Treatment||None (Open Label)||||||
1381319|NCT02536456|||||Prospective|||||||
1381320|NCT02536443|||Cohort||Prospective|||||||
1381321|NCT02536430|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381322|NCT02536417|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381323|NCT02536404|Randomized|Parallel Assignment||Treatment||||||||
1381324|NCT02536391|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381325|NCT02536378|||Case-Only||Prospective|||||||
1381326|NCT02536365|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1381327|NCT02536352|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1381328|NCT02536339||Single Group Assignment||Treatment||None (Open Label)||||||
1381329|NCT02536326||Single Group Assignment||Treatment||None (Open Label)||||||
1381330|NCT02536313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381331|NCT02536300|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381332|NCT02536287|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381333|NCT02536274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381334|NCT02536261|||Case-Only||Prospective|||||||
1381335|NCT02536248|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1381336|NCT02536235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381337|NCT02536222|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1381338|NCT02536209|Randomized|Crossover Assignment||||Double||||||
1381339|NCT02536196|Randomized|Parallel Assignment||Prevention||Single||||||t
1381340|NCT02536183|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1381341|NCT02536170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381342|NCT02536157|Randomized|Parallel Assignment||Treatment||Single||||||t
1381343|NCT02536144|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1381344|NCT02536131||Single Group Assignment||Basic Science||None (Open Label)||||||
1381345|NCT02536118|||Cohort||Prospective|||||||
1381346|NCT02536105|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1381347|NCT02536092||Single Group Assignment||Treatment||None (Open Label)||||||
1381348|NCT02536079|||Cohort||Prospective|||||||
1381349|NCT02536066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381350|NCT02536053|||Cohort||Prospective|||||||
1381351|NCT02536040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381352|NCT02536027||Single Group Assignment||Treatment||Single|||||t|
1381353|NCT02536014|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381354|NCT02536001|Randomized|Parallel Assignment||Treatment||Single||||||t
1381355|NCT02535988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1381356|NCT02535975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381357|NCT02535962|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381358|NCT02535949|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1381359|NCT02535936||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381360|NCT02535923|Randomized|Parallel Assignment||Treatment||Single||||||t
1381361|NCT02535910|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1381362|NCT02535897|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1381363|NCT02535884|Randomized|Parallel Assignment||Treatment||Quadruple||During the first 3 month the one group will be stimulated (pallidal DBS), thereafter 12 weeks open follow up, where patients in both groups are stimulated.|t|t|t|t
1381364|NCT02535871|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1381365|NCT02535858|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381366|NCT02535845|Randomized|Parallel Assignment||Prevention||Single||||t||
1381367|NCT02535832|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381368|NCT02535819|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381369|NCT02535806||Single Group Assignment||Treatment||None (Open Label)||||||
1381370|NCT02535793||Single Group Assignment||Prevention||None (Open Label)||||||
1381371|NCT02535780|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1381372|NCT02535767|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1381373|NCT02535754|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381374|NCT02535741||Single Group Assignment||Treatment||None (Open Label)||||||
1381375|NCT02535728|||Cohort||Prospective|||||||
1381376|NCT02535715||Single Group Assignment||Treatment||None (Open Label)||||||
1381377|NCT02535702|||Case-Control||Prospective|||||||
1381378|NCT02535689|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1381379|NCT02535676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381380|NCT02535663|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1381381|NCT02535650||Single Group Assignment||Treatment||None (Open Label)||||||
1381382|NCT02535637|||Cohort||Prospective|||||||
1381383|NCT02535624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381384|NCT02535611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381385|NCT02535598|Randomized|Factorial Assignment||||Single|||t|||
1381386|NCT02535585|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1381387|NCT02535572|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1381388|NCT02535559|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1381389|NCT02535546|||Cohort||Prospective|||||||
1381390|NCT02535533||Single Group Assignment||Treatment||None (Open Label)||||||
1381391|NCT02535520|||Case-Only||Prospective|||||||
1381392|NCT02535507||Single Group Assignment||Treatment||None (Open Label)||||||
1381393|NCT02535494|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1381394|NCT02535481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381395|NCT02535468|||Cohort||Prospective|||||||
1381396|NCT02535455||Single Group Assignment||Treatment||None (Open Label)||||||
1381397|NCT02535442|||Case-Crossover||Prospective|||||||
1381398|NCT02535429|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1381399|NCT02535416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1381400|NCT02535403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381401|NCT02535390|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1381402|NCT02535377|||Cohort||Prospective|||||||
1381403|NCT02535364||Single Group Assignment||Treatment||None (Open Label)||||||
1381404|NCT02535351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381405|NCT02535338||Single Group Assignment||Treatment||None (Open Label)||||||
1381406|NCT02535325||Single Group Assignment||Treatment||None (Open Label)||||||
1381407|NCT02535312|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381408|NCT02535299||Single Group Assignment||Treatment||None (Open Label)||||||
1381409|NCT02535286||Single Group Assignment||Treatment||None (Open Label)||||||
1381410|NCT02535273|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1381411|NCT02535260|||Cohort||Prospective|||||||
1381412|NCT02535247||Single Group Assignment||Treatment||None (Open Label)||||||
1381413|NCT02535234||||||||||||
1381414|NCT02535221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381415|NCT02535208|Randomized|Parallel Assignment||Other||Single|||t|||
1381416|NCT02535195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381417|NCT02535182|||Case-Control||Prospective|||||||
1381418|NCT02535169|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1381419|NCT02535156|Non-Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1381420|NCT02535143|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1381421|NCT02535130|Randomized|Crossover Assignment||Treatment||Single||||||t
1381422|NCT02535117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381423|NCT02535104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381424|NCT02535091||Single Group Assignment||Treatment||None (Open Label)||||||
1381425|NCT02535078|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381426|NCT02535065||Single Group Assignment||Treatment||None (Open Label)||||||
1381427|NCT02535052|||Case Control||Prospective|||||||
1381428|NCT02535039|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381429|NCT02535026|||Case-Only||Prospective|||||||
1381430|NCT02535013|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381431|NCT02535000|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1381432|NCT02534987|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1381433|NCT02534974|Randomized|Parallel Assignment||Prevention||||||||
1381434|NCT02534961|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381435|NCT02534948|Randomized|Parallel Assignment||Treatment||Single||||||t
1381436|NCT02534935|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1381437|NCT02534922||Single Group Assignment||Treatment||None (Open Label)||||||
1381438|NCT02534909||Single Group Assignment||Treatment||None (Open Label)||||||
1381439|NCT02534896|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381440|NCT02534883|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381441|NCT02534870||Single Group Assignment||Treatment||None (Open Label)||||||
1381442|NCT02534857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381443|NCT02534844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381444|NCT02534831||Single Group Assignment||Treatment||Single||||||t
1381445|NCT02534818|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1381446|NCT02534805|||Cohort||Prospective|||||||
1381447|NCT02534792|||Cohort||Retrospective|||||||
1381448|NCT02534779||Single Group Assignment||||None (Open Label)||||||
1381449|NCT02534766|||Cohort||Retrospective|||||||
1381450|NCT02534753||Single Group Assignment||Treatment||None (Open Label)||||||
1381451|NCT02534740|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1381452|NCT02534727|||Cohort||Prospective|||||||
1381453|NCT02534714|||Cohort||Other|||||||
1381454|NCT02534701|||Cohort||Prospective|||||||
1381455|NCT02534688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381456|NCT02534675|||Other||Prospective|||||||
1381457|NCT02534662||Single Group Assignment||Treatment||None (Open Label)||||||
1381458|NCT02534649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381459|NCT02534636|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1381460|NCT02534623|Randomized|Parallel Assignment||Treatment||Single||||||t
1381461|NCT02534610|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1381462|NCT02534597|Randomized|Crossover Assignment||Other||Single||||||t
1381463|NCT02534584|||Cohort||Prospective|||||||
1381464|NCT02534571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381465|NCT02534558|Randomized|Parallel Assignment||Diagnostic||Triple|Double-blind||t||t|t
1381466|NCT02534545|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381467|NCT02534532|||||Cross-Sectional|||||||
1381468|NCT02534519|||Case Control|||||||||
1381469|NCT02534506||Single Group Assignment||Treatment||None (Open Label)||||||
1381470|NCT02534493||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1381471|NCT02534480|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381472|NCT02534467|Randomized|Crossover Assignment||Treatment||Single||||||t
1381473|NCT02534454|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1381474|NCT02534441||Single Group Assignment||Prevention||Double|||t||t|
1381475|NCT02534428|Randomized|Crossover Assignment||Treatment||Single||||||t
1381476|NCT02534415|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381477|NCT02534402|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381478|NCT02534389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381479|NCT02534376||Single Group Assignment||Treatment||None (Open Label)||||||
1381480|NCT02534363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381481|NCT02534350|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381482|NCT02534337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381483|NCT02534324|||Cohort||Prospective|||||||
1381484|NCT02534311|||Case-Control||Prospective|||||||
1381485|NCT02534298|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1381486|NCT02534285|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1381487|NCT02534272|||Cohort||Prospective|||||||
1381488|NCT02534259|||Case-Only||Prospective|||||||
1381489|NCT02534246|Randomized|Crossover Assignment||Diagnostic||Single||||t||
1381490|NCT02534233||Single Group Assignment||Treatment||None (Open Label)||||||
1381491|NCT02534220|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1381492|NCT02534207||Single Group Assignment||Basic Science||None (Open Label)||||||
1381493|NCT02534194|||Cohort||Prospective|||||||
1381494|NCT02534181|Randomized|Parallel Assignment||Treatment||Single||||||t
1381495|NCT02534168||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381496|NCT02534155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381497|NCT02534142|||Case-Control||Prospective|||||||
1381498|NCT02534129||Single Group Assignment||Prevention||None (Open Label)||||||
1381499|NCT02534116|Randomized|Parallel Assignment||Treatment||Single||||||t
1381500|NCT02534103|||Case-Only||Prospective|||||||
1381501|NCT02534090|||Case Control||Prospective|||||||
1381502|NCT02534077||Single Group Assignment||Treatment||None (Open Label)||||||
1381503|NCT02534064|Randomized|Parallel Assignment||||None (Open Label)||||||
1381504|NCT02534051|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1381505|NCT02534038|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1381506|NCT02534025|Randomized|Parallel Assignment||Prevention||Single|||t|||
1381507|NCT02534012|Randomized|Parallel Assignment||Other||Single||||||t
1381508|NCT02533999|Randomized|Parallel Assignment||Treatment||Single||||t||
1381509|NCT02533986|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1381510|NCT02533973|Randomized|Parallel Assignment||Treatment||Single|||||t|
1381511|NCT02533960|||Cohort||Prospective|||||||
1381512|NCT02533947|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381513|NCT02533934||Single Group Assignment||Treatment||None (Open Label)||||||
1381514|NCT02533921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381515|NCT02533908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381516|NCT02533895|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381517|NCT02533882|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1381518|NCT02533869||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381519|NCT02533856|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381520|NCT02533843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381521|NCT02533830|Randomized|Parallel Assignment||Treatment||Single||||t||
1381522|NCT02533817|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1381523|NCT02533804|||Other||Prospective|||||||
1381524|NCT02533791|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1381525|NCT02533778||Single Group Assignment||Treatment||None (Open Label)||with control group||||
1381526|NCT02533765||Single Group Assignment||Treatment||None (Open Label)||||||
1381527|NCT02533752|||Cohort||Prospective|||||||
1381528|NCT02533739|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381529|NCT02533726|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381530|NCT02533713|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381531|NCT02533700|Randomized|Parallel Assignment||Treatment||Single|||||t|
1381532|NCT02533687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381533|NCT02533674||Single Group Assignment||Other||None (Open Label)||||||
1381534|NCT02533661|Randomized|Parallel Assignment||Prevention||Single||||||t
1381535|NCT02533648|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1381536|NCT02533635|Randomized|Crossover Assignment||Treatment||Single|||||t|
1381537|NCT02533622|||Cohort||Prospective|||||||
1381538|NCT02533609|||Cohort||Prospective|||||||
1381539|NCT02533596|||Cohort||Prospective|||||||
1381540|NCT02533583|||Case-Crossover||Prospective|||||||
1381541|NCT02533570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381542|NCT02533557|Randomized|Parallel Assignment||||Double|||t||t|
1381543|NCT02533544|||Cohort||Other|||||||
1381544|NCT02533531||Single Group Assignment||Other||None (Open Label)||||||
1381545|NCT02533518||Single Group Assignment||Screening||None (Open Label)||||||
1381546|NCT02533505|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1381547|NCT02533492|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381548|NCT02533479||Single Group Assignment||Basic Science||None (Open Label)||||||
1381549|NCT02533466|Randomized|Parallel Assignment||Basic Science||Single||||||t
1381550|NCT02533453||Single Group Assignment||Treatment||None (Open Label)||||||
1381551|NCT02533440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381552|NCT02533427||Single Group Assignment||Treatment||None (Open Label)||||||
1381553|NCT02533414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381554|NCT02533401||Single Group Assignment||Treatment||None (Open Label)||||||
1381555|NCT02533388|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1381556|NCT02533375||Single Group Assignment||Treatment||None (Open Label)||||||
1381557|NCT02533362||Single Group Assignment||Treatment||None (Open Label)||||||
1381558|NCT02533349|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381946|NCT02528279||Single Group Assignment||Other||None (Open Label)||||||
1381559|NCT02533336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381560|NCT02533323||Single Group Assignment||Treatment||None (Open Label)||||||
1381561|NCT02533310|Randomized|Parallel Assignment||Treatment||Single||||||t
1381562|NCT02533297|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1381563|NCT02533284|Randomized|Parallel Assignment||Prevention||Single|||t|||
1381564|NCT02533271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381565|NCT02533258|||Case-Only||Retrospective|||||||
1381566|NCT02533245|Non-Randomized|Parallel Assignment||||Single||||||t
1381567|NCT02533232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381568|NCT02533219||||||||||||
1381569|NCT02533206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381570|NCT02533193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381571|NCT02533180||Single Group Assignment||Treatment||None (Open Label)||||||
1381572|NCT02533167||Single Group Assignment||Health Services Research||None (Open Label)||||||
1381573|NCT02533154|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1381574|NCT02533141|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1381575|NCT02533128|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381576|NCT02533115||||||||||||
1381577|NCT02533102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381578|NCT02533089|Randomized|Parallel Assignment||Health Services Research||||||||
1381579|NCT02533076|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381580|NCT02533063|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381581|NCT02533050|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1381582|NCT02533037|Randomized|Parallel Assignment||Treatment||Single||||||t
1381583|NCT02533024||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381584|NCT02533011|||Cohort||Prospective|||||||
1381585|NCT02532998|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1381586|NCT02532985|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1381587|NCT02532972||Single Group Assignment||Treatment||None (Open Label)||||||
1381588|NCT02532959|||Case-Only||Prospective|||||||
1381589|NCT02532946|Randomized|Parallel Assignment||Prevention||Single|||||t|
1381590|NCT02532933|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381591|NCT02532920|||Ecologic or Community||Retrospective|||||||
1381592|NCT02532907|||Cohort||Prospective|||||||
1381593|NCT02532894|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1381594|NCT02532881|Randomized|Parallel Assignment||Treatment||Single||||t||
1381595|NCT02532868||Single Group Assignment||Treatment||None (Open Label)||||||
1381596|NCT02532855|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381597|NCT02532842|||Cohort||Retrospective|||||||
1381598|NCT02532829|||Cohort||Prospective|||||||
1381599|NCT02532816|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1381600|NCT02532803||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381601|NCT02532790|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381602|NCT02532777|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381603|NCT02532764|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1381604|NCT02532751|||Cohort||Prospective|||||||
1381605|NCT02532738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381606|NCT02532725|||Case Control||Prospective|||||||
1381607|NCT02532712|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381608|NCT02532699|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1381609|NCT02532686|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381610|NCT02532673|||Cohort||Retrospective|||||||
1381611|NCT02532660|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381612|NCT02532647|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1381613|NCT02532634|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1381614|NCT02532621|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381615|NCT02532608||Single Group Assignment||Basic Science||None (Open Label)||||||
1381616|NCT02532595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381617|NCT02532582|||Cohort||Prospective|||||||
1381618|NCT02532569||Single Group Assignment||Prevention||None (Open Label)|Open Label|||||
1381619|NCT02532556|Non-Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1381620|NCT02532543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381621|NCT02532530||Single Group Assignment||Screening||None (Open Label)||||||
1381622|NCT02532517||Single Group Assignment||Treatment||None (Open Label)||||||
1381623|NCT02532504|Randomized|Parallel Assignment||||Single||||||t
1381624|NCT02532491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381625|NCT02532478|||Cohort||Retrospective|||||||
1381626|NCT02532465|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381627|NCT02532452||Single Group Assignment||Treatment||None (Open Label)||||||
1381628|NCT02532439|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381629|NCT02532426|||Case-Control||Prospective|||||||
1381630|NCT02532413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381631|NCT02532400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381632|NCT02532387|||Case-Only||Prospective|||||||
1381633|NCT02532374||Single Group Assignment||Other||None (Open Label)||||||
1381634|NCT02532361|||Cohort||Retrospective|||||||
1381635|NCT02532348|||Cohort||Prospective|||||||
1381636|NCT02532335|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1381637|NCT02532322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381638|NCT02532309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381639|NCT02532296|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1381640|NCT02532283|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381641|NCT02532270|Randomized|Parallel Assignment||Prevention||Single||||||t
1381642|NCT02532257||Single Group Assignment||Treatment||None (Open Label)||||||
1381643|NCT02532244|||Case-Only||Prospective|||||||
1381644|NCT02532231||Single Group Assignment||Treatment||None (Open Label)||||||
1381645|NCT02532218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381646|NCT02532192||Single Group Assignment||Treatment||None (Open Label)||||||
1381647|NCT02532179||Single Group Assignment||Treatment||None (Open Label)||||||
1381648|NCT02532166||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381649|NCT02532153||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381650|NCT02532140|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1381651|NCT02532127||Single Group Assignment||Health Services Research||None (Open Label)||||||
1381652|NCT02532114||Single Group Assignment||Treatment||None (Open Label)||||||
1381653|NCT02532101||Single Group Assignment||Supportive Care||None (Open Label)||||||
1381654|NCT02532088|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1381655|NCT02532075|Randomized|Factorial Assignment||||None (Open Label)||||||
1381656|NCT02532062|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1381657|NCT02532049|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381658|NCT02532036|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1381659|NCT02532023|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1381660|NCT02532010|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381661|NCT02531997|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381662|NCT02531984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381663|NCT02531971|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1381664|NCT02531958|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1381665|NCT02531945||Single Group Assignment||Basic Science||None (Open Label)||||||
1381666|NCT02531932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381667|NCT02531919||Single Group Assignment||Treatment||None (Open Label)||||||
1381668|NCT02531906|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381669|NCT02531893|||Case-Control||Prospective|||||||
1381670|NCT02531880||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381671|NCT02531867||Single Group Assignment||Treatment||None (Open Label)||||||
1381672|NCT02531854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381673|NCT02531841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381674|NCT02531828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381675|NCT02531815|Randomized|||Basic Science||Triple|||t|t|t|
1381676|NCT02531802|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381677|NCT02531789|||Cohort||Prospective|||||||
1381678|NCT02531776||Single Group Assignment||Basic Science||Single|||t|||
1381679|NCT02531763|Randomized|Parallel Assignment||Treatment||Single|||||t|
1381680|NCT02531750|||Cohort||Prospective|||||||
1381681|NCT02531737||Single Group Assignment||Treatment||None (Open Label)||||||
1381682|NCT02531724|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381683|NCT02531711|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381684|NCT02531698|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1381685|NCT02531685|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1381686|NCT02531672||||||||||||
1381687|NCT02531646|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1381688|NCT02531633|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381689|NCT02531620|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381690|NCT02531607|||Case-Control||Prospective|||||||
1381691|NCT02531594|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381692|NCT02531581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381693|NCT02531568||Crossover Assignment||Screening||None (Open Label)||||||
1381694|NCT02531555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381695|NCT02531542||Single Group Assignment||Diagnostic||Single||||t||
1381696|NCT02531529|Randomized|Parallel Assignment||Prevention||Single|||t|||
1381697|NCT02531516|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381698|NCT02531503|||Cohort||Prospective|||||||
1381699|NCT02531490|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381700|NCT02531477||Single Group Assignment||Prevention||None (Open Label)||||||
1381701|NCT02531464|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381702|NCT02531451|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1381703|NCT02531438|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381704|NCT02531425||Single Group Assignment||Treatment||None (Open Label)||||||
1381705|NCT02531412|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381706|NCT02531399||Single Group Assignment||Basic Science||None (Open Label)||||||
1381707|NCT02531386||||||||||||
1381708|NCT02531373|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1381709|NCT02531360||Single Group Assignment||||None (Open Label)||||||
1381710|NCT02531347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381711|NCT02531334|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1381712|NCT02531321|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381713|NCT02531308||Single Group Assignment||Treatment||None (Open Label)||||||
1381714|NCT02531295|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1381715|NCT02531282|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381716|NCT02531269|||Cohort||Retrospective|||||||
1381717|NCT02531256||Single Group Assignment||Treatment||None (Open Label)||||||
1381718|NCT02531243||Single Group Assignment||Treatment||None (Open Label)||||||
1381719|NCT02531230|||Cohort||Prospective|||||||
1381720|NCT02531217||Single Group Assignment||Treatment||None (Open Label)||||||
1381721|NCT02531204|Randomized|Crossover Assignment||||None (Open Label)||||||
1381722|NCT02531191|Randomized|Crossover Assignment||||None (Open Label)||||||
1381723|NCT02531178|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1381724|NCT02531165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381725|NCT02531152|Randomized|Parallel Assignment||Treatment||Single||||||t
1381726|NCT02531139|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1381727|NCT02531126||Single Group Assignment||Treatment||None (Open Label)||||||
1381728|NCT02531113||Single Group Assignment||Treatment||None (Open Label)||||||
1381729|NCT02531100|Randomized|Parallel Assignment||Prevention||Single|||t|||
1381730|NCT02531087|||Cohort||Prospective|||||||
1381731|NCT02531074|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381732|NCT02531061|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381733|NCT02531048||Single Group Assignment||||None (Open Label)||||||
1381734|NCT02531035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381735|NCT02531022|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1381736|NCT02531009|||Cohort||Prospective|||||||
1381737|NCT02530996|||Case-Only||Prospective|||||||
1381738|NCT02530983|||Case-Only||Prospective|||||||
1381739|NCT02530970|||Case-Only||Prospective|||||||
1381740|NCT02530957|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1381741|NCT02530944|||Cohort||Prospective|||||||
1381742|NCT02530931||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381743|NCT02530918|Randomized|Parallel Assignment||Treatment||None (Open Label)||Sequential Assignment with 3 cohorts in Part 1, Parallel Assignment with 3 arms in Part 2, and Parallel Assignment with 2 arms in Part 3||||
1381744|NCT02530905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381745|NCT02530892|||Cohort||Prospective|||||||
1381746|NCT02530879|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1381747|NCT02530866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381748|NCT02530853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381749|NCT02530840|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1381750|NCT02530827|||Case Control||Cross-Sectional|||||||
1381751|NCT02530814|||Case Control||Prospective|||||||
1381752|NCT02530801||Single Group Assignment||Treatment||None (Open Label)||||||
1381753|NCT02530788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381754|NCT02530775|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381755|NCT02530762|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1381756|NCT02530749|||Cohort||Prospective|||||||
1381757|NCT02530736|||Cohort||Prospective|||||||
1381758|NCT02530723|Randomized|Parallel Assignment||Prevention||Single|Functional testers are masked to what group the participants are in (control, Exercise Group I, II, or III). All testers are masked during baseline testing.|||||t
1381759|NCT02530710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381760|NCT02530697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381761|NCT02530684|||Case-Crossover||Prospective|||||||
1381762|NCT02530671|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1381763|NCT02530658|||Cohort||Prospective|||||||
1381764|NCT02530645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381765|NCT02530632|Randomized|Parallel Assignment||||None (Open Label)||||||
1381766|NCT02530619||Single Group Assignment||Treatment||None (Open Label)||||||
1381767|NCT02530606||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381768|NCT02530593|||Cohort||Prospective|||||||
1381769|NCT02530580|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1381770|NCT02530567||Single Group Assignment||Basic Science||None (Open Label)||||||
1381771|NCT02530554|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1381772|NCT02530541|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1381773|NCT02530528|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1381774|NCT02530515||Single Group Assignment||Treatment||None (Open Label)||||||
1381775|NCT02530502||Single Group Assignment||Treatment||None (Open Label)||||||
1381776|NCT02530489||Single Group Assignment||Treatment||None (Open Label)||||||
1381777|NCT02530476|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381778|NCT02530463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381779|NCT02530450|||Case-Crossover||Prospective|||||||
1381780|NCT02530437|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381781|NCT02530424||Single Group Assignment||Other||None (Open Label)||||||
1381782|NCT02530411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381783|NCT02530398|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1381784|NCT02530385|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381785|NCT02530372||Single Group Assignment||Supportive Care||None (Open Label)||||||
1381786|NCT02530359|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381787|NCT02530346|Randomized|Parallel Assignment||Treatment||Single|||||t|
1381788|NCT02530333|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381789|NCT02530320||Single Group Assignment||Treatment||None (Open Label)||||||
1381790|NCT02530307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381791|NCT02530294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381792|NCT02530281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381793|NCT02530268|||Cohort||Prospective|||||||
1381794|NCT02530255|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381795|NCT02530242|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381796|NCT02530229|||Cohort||Prospective|||||||
1381797|NCT02530216|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1381798|NCT02530203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381799|NCT02530190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381800|NCT02530177|||Case-Control||Retrospective|||||||
1381801|NCT02530164|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381802|NCT02530151|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1381803|NCT02530138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381804|NCT02530125||Single Group Assignment||Treatment||None (Open Label)||||||
1381805|NCT02530112|||Cohort||Prospective|||||||
1381806|NCT02530099|Randomized|Factorial Assignment||||None (Open Label)||||||
1381807|NCT02530086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381808|NCT02530073||Single Group Assignment||Treatment||None (Open Label)||||||
1381809|NCT02530060||Single Group Assignment||Treatment||None (Open Label)||||||
1381810|NCT02530047||Single Group Assignment||Treatment||None (Open Label)||||||
1381811|NCT02530034||Single Group Assignment||Treatment||None (Open Label)||||||
1381812|NCT02530021|||Case-Only||Prospective|||||||
1381813|NCT02530008|||Cohort||Prospective|||||||
1381814|NCT02529995|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1381815|NCT02529982|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381816|NCT02529969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381817|NCT02529956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381818|NCT02529943|||Cohort||Prospective|||||||
1381819|NCT02529930|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381820|NCT02529917|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1381821|NCT02529904||Single Group Assignment||Prevention||None (Open Label)||||||
1381822|NCT02529891|||Case-Control||Prospective|||||||
1381823|NCT02529878||Single Group Assignment||Treatment||None (Open Label)||||||
1381824|NCT02529865||Single Group Assignment||Treatment||None (Open Label)||||||
1381825|NCT02529852||Single Group Assignment||Treatment||None (Open Label)||||||
1381826|NCT02529839||Single Group Assignment||Treatment||None (Open Label)||||||
1381827|NCT02529826||Single Group Assignment||Supportive Care||None (Open Label)||||||
1381828|NCT02529813||Single Group Assignment||Treatment||None (Open Label)||||||
1381829|NCT02529800|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381830|NCT02529787|Randomized|Crossover Assignment||||None (Open Label)||||||
1381831|NCT02529774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381832|NCT02529761|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381833|NCT02529748||Single Group Assignment||Basic Science||None (Open Label)||||||
1381834|NCT02529735|||||Prospective|||||||
1381835|NCT02529722|||Cohort||Cross-Sectional|||||||
1381836|NCT02529709|Randomized|Crossover Assignment||Treatment||Single|||t|||
1381837|NCT02529696|||Cohort||Prospective|||||||
1381838|NCT02529683||Single Group Assignment||||None (Open Label)||||||
1381839|NCT02529670|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1381840|NCT02529657|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1381841|NCT02529644|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1381842|NCT02529631|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1381843|NCT02529618|||Case Control||Prospective|||||||
1381844|NCT02529605|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1381845|NCT02529592|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1381846|NCT02529579|Randomized|Parallel Assignment||Treatment||Single||||||t
1381847|NCT02529566|||Cohort||Prospective|||||||
1381848|NCT02529553||Single Group Assignment||Treatment||None (Open Label)||||||
1381849|NCT02529540|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||This is a randomized non-inferiority trial, and the margin of the non-inferiority is 20%.||||
1381850|NCT02529527|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1381851|NCT02529514|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381852|NCT02529501|||Cohort||Cross-Sectional|||||||
1381853|NCT02529488||Single Group Assignment||Treatment||None (Open Label)||||||
1381854|NCT02529475||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381855|NCT02529462|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1381856|NCT02529449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381857|NCT02529436|||||Prospective|||||||
1381858|NCT02529423|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1381859|NCT02529410|Randomized|Parallel Assignment||Treatment||Single||||||t
1381860|NCT02529397|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381861|NCT02529384|||||Prospective|||||||
1381862|NCT02529371||Single Group Assignment||Supportive Care||None (Open Label)||||||
1381863|NCT02529358|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1381864|NCT02529345||Single Group Assignment||Treatment||None (Open Label)||||||
1381865|NCT02529332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381866|NCT02529319|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381867|NCT02529306|||Other||Prospective|||||||
1381868|NCT02529293|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1381869|NCT02529280|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1381870|NCT02529267|||Cohort||Prospective|||||||
1381871|NCT02529254|Randomized|Parallel Assignment||||Single||||||t
1381872|NCT02529241|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381873|NCT02529228|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1381874|NCT02529215|Randomized|Parallel Assignment||||Single||||||t
1381875|NCT02529202||Single Group Assignment||Treatment||None (Open Label)||||||
1381876|NCT02529189|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381877|NCT02529176|Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1381878|NCT02529163|Randomized|Factorial Assignment||Treatment||Single||||||t
1381879|NCT02529150|Randomized|Single Group Assignment||Supportive Care||||||||
1381880|NCT02529137|||Case-Only||Cross-Sectional|||||||
1381881|NCT02529124|Randomized|Factorial Assignment||Prevention||Single|||t|||
1381882|NCT02529111||Single Group Assignment||Health Services Research||None (Open Label)||||||
1381883|NCT02529098|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1381884|NCT02529085|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1381885|NCT02529072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381886|NCT02529059||Single Group Assignment||Treatment||None (Open Label)||||||
1381887|NCT02529046|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381888|NCT02529033|||||Prospective|||||||
1381889|NCT02529020|Non-Randomized|Single Group Assignment||Basic Science||Single|||||t|
1381890|NCT02529007|Randomized|Parallel Assignment||Screening||Single|||t|||
1381891|NCT02528994|Randomized|Parallel Assignment||||None (Open Label)||||||
1381892|NCT02528981|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1381893|NCT02528968||Single Group Assignment||Other||None (Open Label)||||||
1381894|NCT02528955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1381895|NCT02528942||Single Group Assignment||Treatment||None (Open Label)||||||
1381896|NCT02528929|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1381897|NCT02528916|||Case-Only||Prospective|||||||
1381898|NCT02528903|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1381899|NCT02528890|||Cohort||Prospective|||||||
1381900|NCT02528877||Single Group Assignment||Supportive Care||None (Open Label)||||||
1381901|NCT02528864|||Case Control||Prospective|||||||
1381902|NCT02528851|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1381903|NCT02528838|||Cohort||Prospective|||||||
1381904|NCT02528825||Single Group Assignment||Supportive Care||Double|||t||t|
1381905|NCT02528812|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1381906|NCT02528799|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1381907|NCT02528786||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381908|NCT02528773|||Cohort||Prospective|||||||
1381909|NCT02528760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381910|NCT02528747|||Cohort||Prospective|||||||
1381911|NCT02528734|||Cohort||Prospective|||||||
1381912|NCT02528721|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1381913|NCT02528708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381914|NCT02528695|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381915|NCT02528682||Single Group Assignment||Treatment||None (Open Label)||||||
1381916|NCT02528669|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1381917|NCT02528656|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381918|NCT02528643|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381919|NCT02528630|Randomized|Parallel Assignment||Treatment||Single||||||t
1381920|NCT02528617||Single Group Assignment||Treatment||None (Open Label)||||||
1381921|NCT02528604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381922|NCT02528591||Single Group Assignment||Diagnostic||None (Open Label)||||||
1381923|NCT02528578||Single Group Assignment||Other||None (Open Label)||||||
1381924|NCT02528565|||Cohort||Prospective|||||||
1381925|NCT02528552|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1381926|NCT02528539||Single Group Assignment||Prevention||None (Open Label)||||||
1381927|NCT02528526||Single Group Assignment||Treatment||None (Open Label)||||||
1381928|NCT02528513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381929|NCT02528500||Single Group Assignment||Treatment||None (Open Label)||||||
1381930|NCT02528487|||Case Control||Prospective|||||||
1381931|NCT02528474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381932|NCT02528461|||Cohort||Prospective|||||||
1381933|NCT02528448|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1381934|NCT02528435|||Cohort||Cross-Sectional|||||||
1381935|NCT02528422|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1381936|NCT02528409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381937|NCT02528396|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1381938|NCT02528383||Single Group Assignment||Prevention||None (Open Label)||||||
1381939|NCT02528370|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381940|NCT02528357|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381941|NCT02528344||Single Group Assignment||Treatment||None (Open Label)||||||
1381942|NCT02528331||Single Group Assignment||||None (Open Label)||||||
1381943|NCT02528318|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1381944|NCT02528305||Single Group Assignment||Treatment||None (Open Label)|No Masking, this was not possible with this study design.|||||
1381945|NCT02528292|||Cohort||Prospective|||||||
1381947|NCT02528266||Single Group Assignment||Treatment||None (Open Label)||||||
1381948|NCT02528253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381949|NCT02528240|Randomized|Factorial Assignment||Treatment||Single||||||t
1381950|NCT02528227|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1381951|NCT02528214|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1381952|NCT02528201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381953|NCT02528188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1381954|NCT02528175||Single Group Assignment||Treatment||None (Open Label)||||||
1381955|NCT02528162|||Cohort||Prospective|||||||
1381956|NCT02528149|||Cohort||Prospective|||||||
1381957|NCT02528136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1381958|NCT02528123||Single Group Assignment||Treatment||None (Open Label)||||||
1381959|NCT02528110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381960|NCT02528097|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1381961|NCT02528084|Randomized|Parallel Assignment||Treatment||Single||||||t
1381962|NCT02528071|||Cohort||Prospective|||||||
1381963|NCT02528058|||Case-Only||Retrospective|||||||
1381964|NCT02528045|||Case-Only||Retrospective|||||||
1381965|NCT02528032||Single Group Assignment||Other||None (Open Label)||||||
1381966|NCT02528019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381967|NCT02528006||Single Group Assignment||Screening||None (Open Label)||||||
1381968|NCT02527993|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1381969|NCT02527980|||Ecologic or Community||Prospective|||||||
1381970|NCT02527967|||Cohort||Prospective|||||||
1381971|NCT02527954|||Cohort||Prospective|||||||
1381972|NCT02527941||Single Group Assignment||Basic Science||None (Open Label)||||||
1381973|NCT02527928|||||Cross-Sectional|||||||
1381974|NCT02527915|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1381975|NCT02527902|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1381976|NCT02527889|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1381977|NCT02527876|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1381978|NCT02527863|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1381979|NCT02527850|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1381980|NCT02527837|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1381981|NCT02527824||Single Group Assignment||Treatment||None (Open Label)||||||
1381982|NCT02527811|Randomized|Parallel Assignment||Treatment||Single|||t|||
1381983|NCT02527798|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1381984|NCT02527785||Single Group Assignment||Treatment||None (Open Label)||||||
1381985|NCT02527772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381986|NCT02527759|||Cohort||Prospective|||||||
1381987|NCT02527746|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381988|NCT02527733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381989|NCT02527720||Single Group Assignment||Treatment||None (Open Label)||||||
1381990|NCT02527707||Single Group Assignment||Treatment||None (Open Label)||||||
1381991|NCT02527694|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381992|NCT02527681||Single Group Assignment||Treatment||None (Open Label)||||||
1381993|NCT02527668|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1381994|NCT02527655|Randomized|Parallel Assignment||Treatment||Single||||||t
1381995|NCT02527642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1381996|NCT02527629|||Other||Prospective|||||||
1381997|NCT02527616|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1381998|NCT02527603|Randomized|Parallel Assignment||Treatment||Single||||||t
1381999|NCT02527590|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1382000|NCT02527577|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382001|NCT02527564|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382002|NCT02527551||Single Group Assignment||Treatment||None (Open Label)||||||
1382003|NCT02527538|||Cohort||Prospective|||||||
1382004|NCT02527525|Randomized|Parallel Assignment||Treatment||Single||||||t
1382005|NCT02527512|Randomized|Parallel Assignment||Prevention||Single|||t|||
1382006|NCT02527499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382007|NCT02527486|||Cohort||Prospective|||||||
1382008|NCT02527473|Randomized|Parallel Assignment||||Single||||||t
1382009|NCT02527460||Single Group Assignment||Other||None (Open Label)||||||
1382010|NCT02527447|||Cohort||Prospective|||||||
1382011|NCT02527434||Single Group Assignment||Treatment||None (Open Label)||||||
1382012|NCT02527421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382013|NCT02527408|||||Prospective|||||||
1382014|NCT02527395||Single Group Assignment||Basic Science||Single||||||t
1382015|NCT02527382|Randomized|Parallel Assignment||||Double|||t|t||
1382016|NCT02527369||Single Group Assignment||Treatment||None (Open Label)||||||
1382017|NCT02527356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382018|NCT02527343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382019|NCT02527330|||Case-Only||Prospective|||||||
1382020|NCT02527317|||Cohort||Prospective|||||||
1382021|NCT02527304||Single Group Assignment||Treatment||None (Open Label)||||||
1382022|NCT02527291|||Case Control||Prospective|||||||
1382023|NCT02527278|||Cohort||Retrospective|||||||
1382024|NCT02527265||Single Group Assignment||Treatment||None (Open Label)||||||
1382025|NCT02527252|Randomized|Parallel Assignment||Treatment||Single||||||t
1382026|NCT02527239|||||Prospective|||||||
1382027|NCT02527226|Randomized|Parallel Assignment||Treatment||Single||||||t
1382028|NCT02527213|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1382029|NCT02527200|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382030|NCT02527187||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382031|NCT02527174||Single Group Assignment||Treatment||None (Open Label)||||||
1382032|NCT02527161||Single Group Assignment||Treatment||None (Open Label)||||||
1382033|NCT02527148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382034|NCT02527135|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382035|NCT02527122||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382036|NCT02527109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382037|NCT02527096||Single Group Assignment||Treatment||None (Open Label)||||||
1382038|NCT02527083|Randomized|Parallel Assignment||Prevention||Single|||t|||
1382039|NCT02527070|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1382040|NCT02527057|||Cohort||Prospective|||||||
1382041|NCT02527044||Single Group Assignment||Treatment||Quadruple|FFR values are collected by a member of the research staff. The treating physicians (interventional cardiologist and cardiac surgeon), the patient, and the outcome assessor (interventional cardiologist and cardiac surgeon) will be blinded to the pre-operative FFR values.||t|t|t|t
1382042|NCT02527031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382043|NCT02527018|||Case-Only||Prospective|||||||
1382044|NCT02527005|Randomized|Parallel Assignment||Prevention||Single||||||t
1382045|NCT02526992||Single Group Assignment||||None (Open Label)||||||
1382046|NCT02526979||Single Group Assignment||Basic Science||None (Open Label)||||||
1382047|NCT02526966||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382048|NCT02526953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382049|NCT02526940|||Cohort||Prospective|||||||
1382050|NCT02526927|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1382051|NCT02526914|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1382052|NCT02526901|||Cohort||Prospective|||||||
1382053|NCT02526888|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1382054|NCT02526875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382055|NCT02526862|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382056|NCT02526849|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382057|NCT02526836|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382058|NCT02526823|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382059|NCT02526810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382060|NCT02526797|||Case-Only||Retrospective|||||||
1382061|NCT02526784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382062|NCT02526771|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382063|NCT02526758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382064|NCT02526745|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382065|NCT02526732||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382066|NCT02526719|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382067|NCT02526706||Single Group Assignment||||None (Open Label)||||||
1382068|NCT02526693|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382069|NCT02526680||Single Group Assignment||Other||None (Open Label)||||||
1382070|NCT02526667|Randomized|Parallel Assignment||Prevention||Single||||||t
1382071|NCT02526654|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382072|NCT02526641|||Cohort||Prospective|||||||
1382073|NCT02526628|||Case-Control||Other|||||||
1382074|NCT02526615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382075|NCT02526602|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382076|NCT02526589|||Cohort||Prospective|||||||
1382077|NCT02526576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382078|NCT02526563|||Cohort||Prospective|||||||
1382079|NCT02526550||Single Group Assignment||Prevention||None (Open Label)||||||
1382080|NCT02526537|||Case-Control||Prospective|||||||
1382081|NCT02526524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382082|NCT02526511||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382083|NCT02526498||Single Group Assignment||Treatment||None (Open Label)||||||
1382084|NCT02526485|||Cohort||Cross-Sectional|||||||
1382085|NCT02526472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382086|NCT02526459|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382087|NCT02526446|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1382088|NCT02526433|||Case-Only||Cross-Sectional|||||||
1382089|NCT02526420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382090|NCT02526407|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382091|NCT02526394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382092|NCT02526381|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1382093|NCT02526368||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382094|NCT02526355|Randomized|Parallel Assignment||Treatment||Single||||||t
1382095|NCT02526342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382096|NCT02526329||Single Group Assignment||Treatment||None (Open Label)||||||
1382097|NCT02526316||Single Group Assignment||Treatment||None (Open Label)||||||
1382098|NCT02526303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382099|NCT02526290||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382100|NCT02526277|Randomized|Factorial Assignment||Treatment||Single|||||t|
1382101|NCT02526264|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382102|NCT02526251|||Cohort||Prospective|||||||
1382103|NCT02526238|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382104|NCT02526225|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382105|NCT02526212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382106|NCT02526199|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382107|NCT02526186|Randomized|Parallel Assignment||Treatment||Single|||||t|
1382108|NCT02526173|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382109|NCT02526160|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1382110|NCT02526147|Randomized|Parallel Assignment||||None (Open Label)||||||
1382111|NCT02526134||Single Group Assignment||Treatment||None (Open Label)||||||
1382112|NCT02526121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382113|NCT02526108||Single Group Assignment||Prevention||None (Open Label)||||||
1382114|NCT02526095|||Cohort||Prospective|||||||
1382115|NCT02526082|||Cohort||Prospective|||||||
1382116|NCT02526069||Single Group Assignment||||None (Open Label)||||||
1382117|NCT02526056|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382118|NCT02526043|Randomized|Parallel Assignment||Treatment||Single|||||t|
1382119|NCT02526030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382120|NCT02526017|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382121|NCT02526004|Randomized|Parallel Assignment||Treatment||||||||
1382122|NCT02525991||Single Group Assignment||Treatment||None (Open Label)||Intervention: treatment with Loxapine staccato- just one treatment arm - outside the hospital setting.||||
1382123|NCT02525978|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1382124|NCT02525965|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382125|NCT02525952|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382126|NCT02525939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382127|NCT02525926|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382128|NCT02525913||Single Group Assignment||Basic Science||None (Open Label)||||||
1382129|NCT02525900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382130|NCT02525887|||Case-Only||Retrospective|||||||
1382131|NCT02525874||Single Group Assignment||Treatment||None (Open Label)||||||
1382132|NCT02525861|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1382133|NCT02525848|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1382134|NCT02525835|Randomized|Crossover Assignment||Treatment||Single||||||t
1382135|NCT02525822|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382136|NCT02525809|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382137|NCT02525796|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382138|NCT02525783||||||||||||
1382139|NCT02525770|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382140|NCT02525757|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382141|NCT02525744|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1382142|NCT02525731|||Cohort||Prospective|||||||
1382143|NCT02525718|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382144|NCT02525705||Single Group Assignment||Prevention||None (Open Label)||||||
1382145|NCT02525692|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382146|NCT02525679|Randomized|Parallel Assignment||Treatment||Single||||||
1382147|NCT02525666|||Cohort||Prospective|||||||
1382148|NCT02525653||Single Group Assignment||Treatment||None (Open Label)||||||
1382149|NCT02525640|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382150|NCT02525627|Randomized|Parallel Assignment||Treatment||Single||||||t
1382151|NCT02525614|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382152|NCT02525601|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382153|NCT02525588|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382154|NCT02525575||Single Group Assignment||Treatment||None (Open Label)||||||
1382155|NCT02525562|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382156|NCT02525549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382157|NCT02525536|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382158|NCT02525523|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382159|NCT02525510|Randomized|Parallel Assignment||Prevention||Triple||"Enrolled donors will be divided into two populations based on local Organ Procurement Organization criteria:Pump Eligible and Not Pump Eligible.~Pump Eligible will include three arms. Not Pump Eligible will include two arms."|t||t|t
1382160|NCT02525497|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382161|NCT02525484|Randomized|Crossover Assignment||||None (Open Label)||||||
1382162|NCT02525471||Single Group Assignment||Treatment||None (Open Label)||||||
1382163|NCT02525458|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t||t
1382164|NCT02525445|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382165|NCT02525432|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1382166|NCT02525419|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1382167|NCT02525406|||Other||Retrospective|||||||
1382168|NCT02525393|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1382169|NCT02525380||Single Group Assignment||Treatment||None (Open Label)||||||
1382170|NCT02525367|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382171|NCT02525354|||Cohort||Cross-Sectional|||||||
1382172|NCT02525341|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1382173|NCT02525328|||Family-Based||Prospective|||||||
1382174|NCT02525315||Single Group Assignment||Treatment||None (Open Label)||||||
1382175|NCT02525302|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382176|NCT02525289|Randomized|Single Group Assignment||Treatment||Single|||t|||
1382177|NCT02525276|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382178|NCT02525263||Single Group Assignment||Treatment||None (Open Label)||||||
1382179|NCT02525250||Single Group Assignment||||None (Open Label)||||||
1382180|NCT02525237||Single Group Assignment||Treatment||None (Open Label)||||||
1382181|NCT02525224||Single Group Assignment||Other||None (Open Label)||||||
1382182|NCT02525211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382183|NCT02525198|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382184|NCT02525185|||Cohort||Prospective|||||||
1382185|NCT02525172||Single Group Assignment||Treatment||None (Open Label)||||||
1382186|NCT02525159|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382187|NCT02525146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382188|NCT02525133|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382189|NCT02525120|Randomized|Parallel Assignment||Treatment||Single||||||t
1382190|NCT02525107|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382191|NCT02525094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382192|NCT02525081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382193|NCT02525068|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382194|NCT02525055|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1382195|NCT02525042|||Family-Based||Retrospective|||||||
1382196|NCT02525029|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1382197|NCT02525016||Single Group Assignment||Basic Science||None (Open Label)||||||
1382198|NCT02525003|Randomized|Parallel Assignment||Prevention||Single|||t|||
1382199|NCT02524990||Single Group Assignment||Health Services Research||None (Open Label)||||||
1382200|NCT02524977|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382201|NCT02524964|Randomized|Parallel Assignment||Prevention||Single||||||t
1382202|NCT02524951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382203|NCT02524938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382204|NCT02524925|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382205|NCT02524912|||Cohort|||||||||
1382206|NCT02524899|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1382207|NCT02524886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382208|NCT02524873|||Cohort||Retrospective|||||||
1382209|NCT02524860||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382210|NCT02524847||Single Group Assignment||Treatment||None (Open Label)||||||
1382211|NCT02524834||Single Group Assignment||Treatment||None (Open Label)||||||
1382212|NCT02524821|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1382213|NCT02524808|||Case-Only||Prospective|||||||
1382214|NCT02524795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382215|NCT02524782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382216|NCT02524769||Single Group Assignment||Treatment||None (Open Label)||||||
1382217|NCT02524756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382218|NCT02524743|Randomized|Crossover Assignment||Treatment||Double||||t||t
1382219|NCT02524730||Single Group Assignment||Treatment||None (Open Label)||||||
1382220|NCT02524717||Single Group Assignment||Treatment||None (Open Label)||||||
1382221|NCT02524704|||Case-Only||Cross-Sectional|||||||
1382222|NCT02524691|||Cohort||Prospective|||||||
1382223|NCT02524678|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382224|NCT02524665|Randomized|Crossover Assignment||Treatment||Single||||||t
1382225|NCT02524652|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1382226|NCT02524639||Single Group Assignment||Treatment||None (Open Label)||||||
1382227|NCT02524626|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382228|NCT02524613|||Case-Only||Prospective|||||||
1382229|NCT02524600||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382230|NCT02524587|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382231|NCT02524574||Single Group Assignment||Treatment||None (Open Label)||||||
1382232|NCT02524561|Randomized|Parallel Assignment||Other||Double|||t||t|
1382233|NCT02524548|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382234|NCT02524535||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382235|NCT02524522|Randomized|Parallel Assignment||||Single|||t|||
1382236|NCT02524509|||Case-Only||Prospective|||||||
1382237|NCT02524496|||Cohort||Prospective|||||||
1382238|NCT02524483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382239|NCT02524470||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382240|NCT02524457|||Case Control||Cross-Sectional|||||||
1382241|NCT02524444|Randomized|Parallel Assignment||Prevention||Single||||||t
1382242|NCT02524431|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382243|NCT02524418||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382244|NCT02524405|||Cohort||Cross-Sectional|||||||
1382245|NCT02524392|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382246|NCT02524379||Single Group Assignment||Treatment||None (Open Label)||||||
1382247|NCT02524366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382248|NCT02524353||Single Group Assignment||Treatment||None (Open Label)||||||
1382249|NCT02524340|||Cohort||Retrospective|||||||
1382250|NCT02524327|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1382251|NCT02524301|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382252|NCT02524288||Single Group Assignment||Prevention||None (Open Label)||||||
1382253|NCT02524275||Single Group Assignment||Treatment||None (Open Label)||||||
1382254|NCT02524262|Randomized|Crossover Assignment||Prevention||Single|||t|||
1382255|NCT02524249|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1382256|NCT02524236|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1382257|NCT02524223||Single Group Assignment||Screening||None (Open Label)||||||
1382258|NCT02524210|Randomized|Factorial Assignment||||Single||||||t
1382259|NCT02524197|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382260|NCT02524184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382261|NCT02524171|Randomized|Parallel Assignment||Treatment||Single|Research Assistants conducting the 6- and 12- month outcome assessments are blinded to condition assignment.|||||t
1382262|NCT02524158|Randomized|Parallel Assignment||Treatment||Single||||||t
1382263|NCT02524145|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382264|NCT02524132||Single Group Assignment||||None (Open Label)||||||
1382265|NCT02524119||Single Group Assignment||Treatment||None (Open Label)||||||
1382266|NCT02524106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382267|NCT02524093|Randomized|Parallel Assignment||Treatment||Single||||||t
1382268|NCT02524080|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382269|NCT02524067||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382270|NCT02524054|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1382271|NCT02524041||Single Group Assignment||Basic Science||None (Open Label)||||||
1382272|NCT02524028|||Case Control||Prospective|||||||
1382273|NCT02524015|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382274|NCT02524002|Randomized|Single Group Assignment||Prevention||Single||||||t
1382275|NCT02523989|||Case Control||Cross-Sectional|||||||
1382276|NCT02523976||Single Group Assignment||Treatment||None (Open Label)||||||
1382277|NCT02523963|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382278|NCT02523950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382279|NCT02523937|||Cohort||Prospective|||||||
1382280|NCT02523924||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382281|NCT02523911|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1382282|NCT02523898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382283|NCT02523885|||Cohort||Prospective|||||||
1382284|NCT02523872|||Cohort||Prospective|||||||
1382285|NCT02523859|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382286|NCT02523846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382287|NCT02523833||Single Group Assignment||Other||None (Open Label)||||||
1382288|NCT02523820|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1382289|NCT02523807|||Other||Prospective|||||||
1382290|NCT02523794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382291|NCT02523781|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382292|NCT02523768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382293|NCT02523755|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382294|NCT02523742|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1382295|NCT02523729|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382296|NCT02523716|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1382297|NCT02523703|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382298|NCT02523690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382299|NCT02523677|||Cohort||Prospective|||||||
1382300|NCT02523664|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1382301|NCT02523651|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382302|NCT02523638||Single Group Assignment||Treatment||None (Open Label)||||||
1382303|NCT02523625|||Cohort||Prospective|||||||
1382304|NCT02523612||Single Group Assignment||Other||None (Open Label)||||||
1382305|NCT02523599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382306|NCT02523586|||Case-Crossover||Prospective|||||||
1382307|NCT02523573|||Case-Only||Prospective|||||||
1382308|NCT02523560|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1382309|NCT02523547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382310|NCT02523534||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382311|NCT02523521|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1382312|NCT02523508|Randomized|Parallel Assignment||Prevention||Single|||||t|
1382313|NCT02523495|||Cohort||Prospective|||||||
1382314|NCT02523482|||Cohort||Cross-Sectional|||||||
1382315|NCT02523469|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382316|NCT02523456|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382317|NCT02523443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382318|NCT02523430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382319|NCT02523417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382320|NCT02523404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382321|NCT02523391|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382322|NCT02523378|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382323|NCT02523365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382397|NCT02522403|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382398|NCT02522390|||Cohort||Prospective|||||||
1382399|NCT02522377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382400|NCT02522364|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382324|NCT02523352||Sequential Assignment||Treatment||None (Open Label)||29 patients will be enrolled in this study. The study is divided in two phases: the first phase will evaluate the PEEP in 12 consecutive obese subjects using Trans-thoracic echocardiography (TTE) and Electrical Impedance Tomography (EIT). The second phase will evaluate the PEEP in the other 12 consecutive obese subjects and 5 healthy volunteers using Magnetic Resonance Imaging (MRI).||||
1382325|NCT02523339|||Cohort||Prospective|||||||
1382326|NCT02523326|||||Prospective|||||||
1382327|NCT02523313|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1382328|NCT02523300|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382329|NCT02523287|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1382330|NCT02523274|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382331|NCT02523261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382332|NCT02523248|Randomized|Parallel Assignment||Treatment||Single||||||t
1382333|NCT02523235|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382334|NCT02523222|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382335|NCT02523209|||Cohort||Prospective|||||||
1382336|NCT02523196|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1382337|NCT02523183|||Cohort||Prospective|||||||
1382338|NCT02523170||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382339|NCT02523157|Randomized|Single Group Assignment||||Single|||t|||
1382340|NCT02523144|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382341|NCT02523131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382342|NCT02523118|||Case-Only||Other|||||||
1382343|NCT02523105|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382344|NCT02523092||Single Group Assignment||Treatment||None (Open Label)||||||
1382345|NCT02523079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382346|NCT02523066|||Case-Only||Prospective|||||||
1382347|NCT02523053|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382348|NCT02523040||Single Group Assignment||Treatment||None (Open Label)||||||
1382349|NCT02523027|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1382350|NCT02523014|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382351|NCT02523001|||Cohort||Prospective|||||||
1382352|NCT02522988|Randomized|Crossover Assignment||Treatment||Single|||||t|
1382353|NCT02522975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382354|NCT02522962|Randomized|Parallel Assignment||Treatment||Single||||||t
1382355|NCT02522949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382356|NCT02522936|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1382357|NCT02522923|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1382358|NCT02522910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382359|NCT02522897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382360|NCT02522884||Single Group Assignment||Treatment||None (Open Label)||||||
1382361|NCT02522871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382362|NCT02522858|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1382363|NCT02522845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382364|NCT02522832|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1382365|NCT02522819||Single Group Assignment||Prevention||None (Open Label)||||||
1382366|NCT02522806|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1382367|NCT02522793|||Cohort||Prospective|||||||
1382368|NCT02522780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382369|NCT02522767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382370|NCT02522754|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382371|NCT02522741||Single Group Assignment||Prevention||None (Open Label)||||||
1382372|NCT02522728|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382373|NCT02522715||Single Group Assignment||Treatment||None (Open Label)||||||
1382374|NCT02522702|||Cohort||Prospective|||||||
1382375|NCT02522689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382376|NCT02522676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382377|NCT02522663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382378|NCT02522650|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382379|NCT02522637|Randomized|Parallel Assignment||Treatment||Single||||||t
1382380|NCT02522624|Randomized|Parallel Assignment||Prevention||Single|||t|||
1382381|NCT02522611||Single Group Assignment||Treatment||None (Open Label)||||||
1382382|NCT02522598|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382383|NCT02522585|||Cohort||Prospective|||||||
1382384|NCT02522572|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1382385|NCT02522559||Single Group Assignment||Other||None (Open Label)||||||
1382386|NCT02522546|||Cohort||Prospective|||||||
1382387|NCT02522533||Single Group Assignment||Treatment||None (Open Label)||||||
1382388|NCT02522520|Randomized|Parallel Assignment||Other||Single|Primary outcome (VO2 peak) Physiological tests assessors blinded|||||t
1382389|NCT02522507|Randomized|Parallel Assignment||Treatment||Single||||||t
1382390|NCT02522494|Randomized|Parallel Assignment||Health Services Research||Double||||t||t
1382391|NCT02522481||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382392|NCT02522468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382393|NCT02522455||Single Group Assignment||Treatment||None (Open Label)||||||
1382394|NCT02522442|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1382395|NCT02522429||Single Group Assignment||Treatment||None (Open Label)||||||
1382396|NCT02522416|||Cohort||Cross-Sectional|||||||
1382401|NCT02522351|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1382402|NCT02522338||Single Group Assignment||||None (Open Label)||||||
1382403|NCT02522325|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1382404|NCT02522312|||Cohort||Retrospective|||||||
1382405|NCT02522299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382406|NCT02522286|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1382407|NCT02522273|||Cohort||Prospective|||||||
1382408|NCT02522260|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382409|NCT02522247|Randomized|Parallel Assignment||Treatment||Single||||||t
1382410|NCT02522234|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382411|NCT02522221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382412|NCT02522208|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382413|NCT02522195|||Case-Crossover||Cross-Sectional|||||||
1382414|NCT02522182|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382415|NCT02522169|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382416|NCT02522156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382417|NCT02522143|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382418|NCT02522130|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382419|NCT02522117|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382420|NCT02522104|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1382421|NCT02522091|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382422|NCT02522078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382423|NCT02522065|||Case-Control||Prospective|||||||
1382424|NCT02522052|Randomized|Crossover Assignment||Treatment||Double||||t||t
1382425|NCT02522039|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1382426|NCT02522026|||Cohort||Prospective|||||||
1382427|NCT02522013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382428|NCT02522000|||Cohort||Prospective|||||||
1382429|NCT02521987|Randomized|Parallel Assignment||Prevention||Single|||t|||
1382430|NCT02521974||Single Group Assignment||Prevention||None (Open Label)||||||
1382431|NCT02521961|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382432|NCT02521948||Single Group Assignment||Treatment||None (Open Label)||||||
1382433|NCT02521935|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382434|NCT02521922||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382435|NCT02521909|||Case-Only||Prospective|||||||
1382436|NCT02521896||Single Group Assignment||Treatment||None (Open Label)||||||
1382437|NCT02521883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382438|NCT02521870|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382439|NCT02521857||Single Group Assignment||Treatment||None (Open Label)||||||
1382440|NCT02521844||Single Group Assignment||Treatment||None (Open Label)||||||
1382441|NCT02521831|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382442|NCT02521818|Randomized|Parallel Assignment||Treatment||Single||||||t
1382443|NCT02521805|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1382444|NCT02521792||Single Group Assignment||Treatment||None (Open Label)||||||
1382445|NCT02521779|Randomized|Crossover Assignment||Treatment||Single|||t|||
1382446|NCT02521766||||||||||||
1382447|NCT02521753|Randomized|Parallel Assignment||Treatment||None (Open Label)|The study is open label. No blindness for participant or investigator is used|||||
1382448|NCT02521740|||Case Control||Prospective|||||||
1382449|NCT02521727|||Cohort||Prospective|||||||
1382450|NCT02521714|Randomized|Crossover Assignment||||None (Open Label)||||||
1382451|NCT02521701||Single Group Assignment||Treatment||None (Open Label)||||||
1382452|NCT02521688|||Case Control||Retrospective|||||||
1382453|NCT02521675|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1382454|NCT02521662|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382455|NCT02521649|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382456|NCT02521636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382457|NCT02521623|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382458|NCT02521610|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1382459|NCT02521597|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1382460|NCT02521584|||Cohort||Retrospective|||||||
1382461|NCT02521571|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382462|NCT02521558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382463|NCT02521545||Single Group Assignment||Treatment||None (Open Label)||||||
1382464|NCT02521532|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1382465|NCT02521519|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1382466|NCT02521506|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382467|NCT02521493|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382468|NCT02521480|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382469|NCT02521467|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1382470|NCT02521454|Randomized|Parallel Assignment||Prevention||Single||||||t
1382471|NCT02521441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382472|NCT02521428|||Cohort||Retrospective|||||||
1382473|NCT02521415|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382474|NCT02521402||Single Group Assignment||Treatment||None (Open Label)||||||
1382475|NCT02521389|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1382476|NCT02521376|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382477|NCT02521363|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382478|NCT02521350|||Cohort||Prospective|||||||
1382479|NCT02521337|||Cohort||Prospective|||||||
1382480|NCT02521324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382481|NCT02521311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382482|NCT02521298|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382483|NCT02521285|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382484|NCT02521272||Single Group Assignment||Basic Science||Double|||t||t|
1382485|NCT02521259|||Case-Only||Prospective|||||||
1382486|NCT02521246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382487|NCT02521233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382488|NCT02521220|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1382489|NCT02521207|Randomized|Parallel Assignment||Prevention||Single||||||t
1382490|NCT02521194|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382491|NCT02521181|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1382492|NCT02521168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382493|NCT02521155|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382494|NCT02521142|||Cohort||Prospective|||||||
1382495|NCT02521129||Single Group Assignment||Treatment||None (Open Label)||||||
1382496|NCT02521116||Single Group Assignment||Other||None (Open Label)||||||
1382497|NCT02521103||Single Group Assignment||Treatment||None (Open Label)||||||
1382498|NCT02521090||Single Group Assignment||Treatment||None (Open Label)||||||
1382499|NCT02521077|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1382500|NCT02521064|||Case-Control||Prospective|||||||
1382501|NCT02521051||Single Group Assignment||Treatment||None (Open Label)||||||
1382502|NCT02521038|||Cohort||Prospective|||||||
1382503|NCT02521025|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382504|NCT02521012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382505|NCT02520999|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1382506|NCT02520986|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382507|NCT02520973|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382508|NCT02520960|||Cohort||Prospective|||||||
1382509|NCT02520947|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382510|NCT02520934|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382511|NCT02520921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382512|NCT02520908|||Cohort||Prospective|||||||
1382513|NCT02520895|||Cohort||Prospective|||||||
1382514|NCT02520882||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382515|NCT02520869|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382516|NCT02520856|||Case-Only||Prospective|||||||
1382517|NCT02520843||Single Group Assignment||Treatment||None (Open Label)||||||
1382518|NCT02520830|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382519|NCT02520817|||Case-Only||Prospective|||||||
1382520|NCT02520804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382521|NCT02520791||Single Group Assignment||Treatment||None (Open Label)||||||
1382522|NCT02520778||Single Group Assignment||Treatment||None (Open Label)||||||
1382523|NCT02520765|||Cohort||Prospective|||||||
1382524|NCT02520752||Single Group Assignment||Treatment||None (Open Label)||||||
1382525|NCT02520739|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1382526|NCT02520726|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1382527|NCT02520713||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382528|NCT02520700||Single Group Assignment||Treatment||Single||||||t
1382529|NCT02520687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382530|NCT02520674||Single Group Assignment||Diagnostic||Single|||||t|
1382531|NCT02520661|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382532|NCT02520648|Randomized|Factorial Assignment||Treatment||Single||||||t
1382533|NCT02520635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382534|NCT02520622|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382535|NCT02520609|||Case-Control||Cross-Sectional|||||||
1382536|NCT02520596||Single Group Assignment||Treatment||None (Open Label)||||||
1382537|NCT02520583|Randomized|Crossover Assignment||||Triple|||t||t|t
1382538|NCT02520570|||Other||Prospective|||||||
1382539|NCT02520557|||Case-Control||Retrospective|||||||
1382540|NCT02520544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382541|NCT02520531|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382542|NCT02520518|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1382543|NCT02520505|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382544|NCT02520492||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382545|NCT02520479||Single Group Assignment||Treatment||None (Open Label)||||||
1382546|NCT02520466|Randomized|Parallel Assignment||Other||Double|||t||t|
1382547|NCT02520453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382548|NCT02520440|||Cohort||Prospective|||||||
1382549|NCT02520427||Single Group Assignment||Treatment||None (Open Label)||||||
1382550|NCT02520414||Single Group Assignment||Treatment||None (Open Label)||||||
1382551|NCT02520401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382552|NCT02520388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382553|NCT02520375|Randomized|||||Double||||||
1382554|NCT02520362|||Other||Prospective|||||||
1382555|NCT02520349|||Cohort||Prospective|||||||
1382556|NCT02520336|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1382557|NCT02520323|||Cohort||Prospective|||||||
1382558|NCT02520310||Single Group Assignment||Treatment||None (Open Label)||||||
1382559|NCT02520297||Single Group Assignment||Treatment||None (Open Label)||||||
1382560|NCT02520284|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382561|NCT02520271|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382562|NCT02520258|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1382563|NCT02520245||Single Group Assignment||Treatment||None (Open Label)||||||
1382564|NCT02520232|Randomized|Parallel Assignment||Prevention||Single||||||t
1382565|NCT02520219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382566|NCT02520206||||||||||||
1382567|NCT02520193|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382568|NCT02520180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382569|NCT02520167|Randomized|Parallel Assignment||Prevention||Single||||||t
1382570|NCT02520154||Single Group Assignment||Treatment||None (Open Label)||||||
1382571|NCT02520141||Single Group Assignment||Treatment||None (Open Label)||||||
1382572|NCT02520128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382573|NCT02520115|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382574|NCT02520102||Single Group Assignment||Treatment||None (Open Label)||||||
1382575|NCT02520089|Randomized|Parallel Assignment||Treatment||Single|||||t|
1382576|NCT02520076||Single Group Assignment||Treatment||None (Open Label)||||||
1382577|NCT02520063|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382578|NCT02520050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382579|NCT02520037|||Case-Only||Prospective|||||||
1382580|NCT02520024|Randomized|Single Group Assignment||||None (Open Label)||||||
1382581|NCT02520011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382582|NCT02519998|||Cohort||Prospective|||||||
1382583|NCT02519985||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382584|NCT02519972||Single Group Assignment||Screening||None (Open Label)||||||
1382585|NCT02519946||Single Group Assignment||Prevention||None (Open Label)||||||
1382586|NCT02519933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382587|NCT02519920|Randomized|Parallel Assignment||Screening||Double|||||t|t
1382588|NCT02519907||Single Group Assignment||Treatment||None (Open Label)||||||
1382589|NCT02519894|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382590|NCT02519881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382591|NCT02519868||Single Group Assignment||Treatment||None (Open Label)||||||
1382592|NCT02519855|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382593|NCT02519842|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1382594|NCT02519829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382595|NCT02519816||Single Group Assignment||Basic Science||None (Open Label)||||||
1382596|NCT02519803|||Cohort||Prospective|||||||
1382597|NCT02519790|||Cohort||Prospective|||||||
1382598|NCT02519777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382599|NCT02519764|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1382600|NCT02519751||Single Group Assignment||Basic Science||None (Open Label)||||||
1382601|NCT02519738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382602|NCT02519725|Randomized|Parallel Assignment||Prevention||Single|the psychologist is blind for the study for assessing outcome measures|||||t
1382603|NCT02519712||Single Group Assignment||Treatment||None (Open Label)||||||
1382604|NCT02519699||Single Group Assignment||Treatment||None (Open Label)||||||
1382605|NCT02519686|||Case Control||Prospective|||||||
1382606|NCT02519673|||Cohort||Prospective|||||||
1382607|NCT02519660|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382608|NCT02519647|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382609|NCT02519634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382610|NCT02519621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382611|NCT02519608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382612|NCT02519595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382613|NCT02519582||Single Group Assignment||Treatment||None (Open Label)||||||
1382614|NCT02519569||Single Group Assignment||Treatment||None (Open Label)||||||
1382615|NCT02519556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382616|NCT02519543|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382617|NCT02519530|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1382618|NCT02519517||Single Group Assignment||Screening||None (Open Label)||||||
1382619|NCT02519504|||Case-Control||Prospective|||||||
1382620|NCT02519491|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1382621|NCT02519478|Randomized|Parallel Assignment||Prevention||Single|||||t|
1382622|NCT02519465|Randomized|Crossover Assignment||Treatment||Single||||||t
1382623|NCT02519452|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382624|NCT02519439||Single Group Assignment||Treatment||None (Open Label)||||||
1382625|NCT02519426|||Cohort||Prospective|||||||
1382626|NCT02519413|||Cohort||Retrospective|||||||
1382627|NCT02519400||Single Group Assignment||||None (Open Label)||||||
1382628|NCT02519387||Single Group Assignment||Treatment||None (Open Label)||||||
1382629|NCT02519374|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1382630|NCT02519361|||Cohort||Prospective|||||||
1382631|NCT02519348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382632|NCT02519335||Single Group Assignment||Treatment||None (Open Label)||||||
1382633|NCT02519322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382634|NCT02519309|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"open label, non-randomized, before-and-after study of patients with type 2 diabetes who self-select the intervention (with education delivered via onsite group classes or web-based, self-selected by participant) or usual care~single arm, before-and-after study of patients with prediabetes who self-select to receive the intervention (no comparison group)"||||
1382635|NCT02519296|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382636|NCT02519283|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1382637|NCT02519270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382638|NCT02519257|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382639|NCT02519244||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382640|NCT02519231|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382641|NCT02519218|||Cohort||Other|||||||
1382642|NCT02519205|||Cohort||Prospective|||||||
1382643|NCT02519192|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1382644|NCT02519179||Single Group Assignment||Basic Science||None (Open Label)||This is a within-subject study; mothers are observed during both feeding conditions.||||
1382645|NCT02519166||Single Group Assignment||||None (Open Label)||||||
1382646|NCT02519153|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382647|NCT02519140||Single Group Assignment||Treatment||None (Open Label)||||||
1382648|NCT02519127|Randomized|Parallel Assignment||Basic Science||Single||||||t
1382649|NCT02519114||Single Group Assignment||Treatment||None (Open Label)||||||
1382650|NCT02519101|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1382651|NCT02519088|||||Retrospective|||||||
1382652|NCT02519075|||||Prospective|||||||
1382653|NCT02519062|||Cohort||Retrospective|||||||
1382654|NCT02519049|||||Prospective|||||||
1382655|NCT02519036|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382656|NCT02519023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382657|NCT02519010|Randomized|Crossover Assignment||||None (Open Label)||||||
1382658|NCT02518997||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382659|NCT02518984|||Cohort||Prospective|||||||
1382660|NCT02518971|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382661|NCT02518958||Single Group Assignment||Treatment||None (Open Label)||||||
1382662|NCT02518945|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382663|NCT02518932|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1382664|NCT02518919|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1382665|NCT02518906|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1382666|NCT02518893|||Case-Only||Cross-Sectional|||||||
1382667|NCT02518880||Single Group Assignment||Basic Science||None (Open Label)||||||
1382668|NCT02518867|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382669|NCT02518854|||Cohort||Cross-Sectional|||||||
1382670|NCT02518841|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382671|NCT02518828|Randomized|Parallel Assignment||Treatment||Single||||||t
1382672|NCT02518815|Randomized|Parallel Assignment||Prevention||Single||||||t
1382673|NCT02518802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382674|NCT02518789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382675|NCT02518776||Single Group Assignment||Basic Science||None (Open Label)||||||
1382676|NCT02518763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382677|NCT02518750||Single Group Assignment||Treatment||None (Open Label)||||||
1382678|NCT02518737|||Case Control||Cross-Sectional|||||||
1382679|NCT02518724|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1382680|NCT02518711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382681|NCT02518698|||Cohort||Retrospective|||||||
1382682|NCT02518685|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382683|NCT02518672|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382684|NCT02518659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382685|NCT02518646|||Cohort||Prospective|||||||
1382686|NCT02518633|||Case-Control||Prospective|||||||
1382687|NCT02518620||Single Group Assignment||Treatment||None (Open Label)||||||
1382688|NCT02518607|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1382689|NCT02518594|Randomized|Parallel Assignment||Treatment||Double|Participants and care providers will be blinded to active study drug vs. placebo.|Women will be randomly assigned to study drug (200 mg micronized progesterone daily), placebo study drug appearing identical to progesterone capsule, or Arabin pessary.|t|t||
1382690|NCT02518581||Single Group Assignment||Basic Science||None (Open Label)||||||
1382691|NCT02518568||Single Group Assignment||Treatment||None (Open Label)||||||
1382692|NCT02518555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382693|NCT02518542|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382694|NCT02518529||Single Group Assignment||Treatment||None (Open Label)||||||
1382695|NCT02518516|||Cohort||Retrospective|||||||
1382696|NCT02518503|||Cohort||Retrospective|||||||
1382697|NCT02518490||||||||||||
1382698|NCT02518477|Randomized|Parallel Assignment||Prevention||Single||||||t
1382699|NCT02518464||Single Group Assignment||Treatment||None (Open Label)||||||
1382700|NCT02518451|Randomized|Crossover Assignment||Treatment||Single|||||t|
1382701|NCT02518438|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1382702|NCT02518425|||Cohort||Retrospective|||||||
1382703|NCT02518412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382704|NCT02518399|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382705|NCT02518386|||Cohort||Prospective|||||||
1382706|NCT02518373||Single Group Assignment||Treatment||None (Open Label)||||||
1382707|NCT02518360|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382708|NCT02518347|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1382709|NCT02518334||Single Group Assignment||Basic Science||None (Open Label)||||||
1382710|NCT02518321|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1382711|NCT02518308|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1382712|NCT02518295|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1382713|NCT02518282|||Cohort||Prospective|||||||
1382714|NCT02518269|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382715|NCT02518256||Single Group Assignment||Prevention||None (Open Label)||||||
1382716|NCT02518243||Single Group Assignment||Prevention||None (Open Label)||||||
1382717|NCT02518230|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382718|NCT02518217|Randomized|Parallel Assignment||Treatment||Single|||||t|
1382719|NCT02518204|Randomized|Parallel Assignment||Other||Single|||t|||
1382720|NCT02518191|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382721|NCT02518178|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382722|NCT02518165|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1382723|NCT02518152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382724|NCT02518139|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382725|NCT02518126|||Case Control||Prospective|||||||
1382726|NCT02518113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382727|NCT02518100|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1382728|NCT02518087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382729|NCT02518074||Single Group Assignment||Basic Science||None (Open Label)||||||
1382730|NCT02518061|||Cohort||Retrospective|||||||
1382731|NCT02518048|Randomized|Single Group Assignment||Treatment||Single|||||t|
1382732|NCT02518035|Randomized|Parallel Assignment||Treatment||Single||||||t
1382733|NCT02518022|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382734|NCT02518009|||Cohort||Prospective|||||||
1382735|NCT02517996|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382736|NCT02517983|||||Cross-Sectional|||||||
1382737|NCT02517970||Single Group Assignment||Basic Science||None (Open Label)||||||
1382738|NCT02517957|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1382739|NCT02517944|||Case Control||Prospective|||||||
1382740|NCT02517931|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1382741|NCT02517918||Single Group Assignment||Treatment||None (Open Label)||||||
1382742|NCT02517905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382743|NCT02517892||Single Group Assignment||Other||None (Open Label)||||||
1382744|NCT02517879|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382745|NCT02517866||Single Group Assignment||Treatment||None (Open Label)||||||
1382746|NCT02517853|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1382747|NCT02517840|||Cohort||Prospective|||||||
1382748|NCT02517827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382749|NCT02517814||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382750|NCT02517801|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382751|NCT02517788|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1382752|NCT02517775|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382753|NCT02517762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382754|NCT02517749|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382755|NCT02517736||Single Group Assignment||Treatment||None (Open Label)||||||
1382756|NCT02517723|Randomized|Factorial Assignment||Treatment||Single||||||t
1382757|NCT02517710|Randomized|Single Group Assignment||Treatment||Single|||||t|
1382758|NCT02517697|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382759|NCT02517684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382760|NCT02517671||Single Group Assignment||Treatment||None (Open Label)||||||
1382761|NCT02517658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382762|NCT02517645||||||||||||
1382763|NCT02517632|Randomized|Parallel Assignment||Treatment||Single||The intervention group performed exercise sessions, pharmaceutical and nutritional counceling. The control group had only pharmaceutical and nutritional counceling.||||t
1382764|NCT02517619|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382765|NCT02517606|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382766|NCT02517593||Single Group Assignment||Prevention||None (Open Label)||||||
1382767|NCT02517580||Single Group Assignment||Treatment||None (Open Label)||||||
1382768|NCT02517567|Randomized|Crossover Assignment||Treatment||Single|||||t|
1382769|NCT02517554|||Cohort||Prospective|||||||
1382770|NCT02517541||Single Group Assignment||Basic Science||None (Open Label)||||||
1382771|NCT02517528||Single Group Assignment||Treatment||None (Open Label)||||||
1382772|NCT02517515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382773|NCT02517502|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1382774|NCT02517489|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382775|NCT02517476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382776|NCT02517463|||Cohort||Prospective|||||||
1382777|NCT02517450|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1382778|NCT02517437|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382779|NCT02517424|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1382780|NCT02517411|Randomized|Single Group Assignment||Treatment||Single|||||t|
1382781|NCT02517398||Single Group Assignment||Treatment||None (Open Label)||||||
1382782|NCT02517385||Single Group Assignment||Treatment||None (Open Label)||||||
1382783|NCT02517372|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1382784|NCT02517359|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382785|NCT02517346|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382786|NCT02517333||Single Group Assignment||Health Services Research||None (Open Label)||||||
1382787|NCT02517320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382788|NCT02517307|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1382789|NCT02517294|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1382790|NCT02517281||Single Group Assignment||Other||None (Open Label)||||||
1382791|NCT02517268|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382792|NCT02517255||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382793|NCT02517242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382794|NCT02517229||Single Group Assignment||Basic Science||None (Open Label)||||||
1382795|NCT02517216||Single Group Assignment||Basic Science||None (Open Label)||||||
1382796|NCT02517190||Single Group Assignment||Basic Science||None (Open Label)||||||
1382797|NCT02517177||Single Group Assignment||Basic Science||None (Open Label)||||||
1382798|NCT02517164|||Cohort||Prospective|||||||
1382799|NCT02517151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382800|NCT02517138||Single Group Assignment||Basic Science||None (Open Label)||||||
1382801|NCT02517125||Single Group Assignment||Treatment||None (Open Label)||||||
1382802|NCT02517112||Single Group Assignment||Basic Science||None (Open Label)||||||
1382803|NCT02517099|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382804|NCT02517086|Randomized|Crossover Assignment||||Single|||||t|
1382805|NCT02517073|||Case-Only||Cross-Sectional|||||||
1382806|NCT02517060|||Cohort||Prospective|||||||
1382807|NCT02517047||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382808|NCT02517034|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382809|NCT02517021|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1382810|NCT02517008|Randomized|Parallel Assignment||||None (Open Label)||||||
1382811|NCT02516995||Single Group Assignment||||None (Open Label)||||||
1382812|NCT02516982|||Other||Prospective|||||||
1382813|NCT02516969||Single Group Assignment||Treatment||None (Open Label)||||||
1382814|NCT02516956|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1382815|NCT02516943|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382816|NCT02516930|Randomized|Parallel Assignment||||None (Open Label)||||||
1382817|NCT02516917||Single Group Assignment||Treatment||None (Open Label)||||||
1382818|NCT02516904|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1382819|NCT02516891|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1382820|NCT02516878|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382821|NCT02516865|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1382822|NCT02516852|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382823|NCT02516839|Randomized|Parallel Assignment||Treatment||Single||||||t
1382824|NCT02516826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382825|NCT02516813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382826|NCT02516800|||Other||Cross-Sectional|||||||
1382827|NCT02516787||Single Group Assignment||Basic Science||None (Open Label)||||||
1382828|NCT02516774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382829|NCT02516761|Randomized|Factorial Assignment||Treatment||Single||||||t
1382830|NCT02516748|||Cohort||Prospective|||||||
1382831|NCT02516735|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1382832|NCT02516722||Single Group Assignment||Treatment||None (Open Label)||||||
1382833|NCT02516709|||Cohort||Prospective|||||||
1382834|NCT02516696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382835|NCT02516683|||Case Control||Prospective|||||||
1382836|NCT02516670|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382837|NCT02516657|||Case-Only|||||||||
1382838|NCT02516644|Randomized|Parallel Assignment||Treatment||Single||||||t
1382839|NCT02516631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382840|NCT02516618|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1382841|NCT02516605|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382842|NCT02516592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382843|NCT02516579|||Cohort||Prospective|||||||
1382844|NCT02516566|Randomized|Parallel Assignment||||Triple|||t||t|t
1382845|NCT02516553|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382846|NCT02516540|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382847|NCT02516527|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382848|NCT02516514|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1382849|NCT02516501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382850|NCT02516488|||Other||Prospective|||||||
1382851|NCT02516475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382852|NCT02516462||Single Group Assignment||Treatment||None (Open Label)||||||
1382853|NCT02516449|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1382854|NCT02516436|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382855|NCT02516423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382856|NCT02516410|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382857|NCT02516397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382858|NCT02516384||Single Group Assignment||Treatment||None (Open Label)||||||
1382859|NCT02516371||Single Group Assignment||Basic Science||None (Open Label)||||||
1382860|NCT02516358|||Cohort||Prospective|||||||
1382861|NCT02516345|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1382862|NCT02516332|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1382863|NCT02516319|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1382864|NCT02516306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382865|NCT02516293||Single Group Assignment||Treatment||None (Open Label)||||||
1382866|NCT02516280|Randomized|Parallel Assignment||Treatment||Single||||||t
1382867|NCT02516267|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1382868|NCT02516254|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1382869|NCT02516241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382870|NCT02516228||Single Group Assignment||Treatment||None (Open Label)||||||
1382871|NCT02516215|||Cohort||Cross-Sectional|||||||
1382872|NCT02516202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382873|NCT02516189|Randomized|Parallel Assignment||Basic Science||Single||||t||
1382874|NCT02516176||Single Group Assignment||Treatment||None (Open Label)||||||
1382875|NCT02516163||Single Group Assignment||Treatment||None (Open Label)||||||
1382876|NCT02516150|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382877|NCT02516137|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382878|NCT02516124|||Cohort||Prospective|||||||
1382879|NCT02516111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382880|NCT02516098|Randomized|Crossover Assignment||Treatment||Double||||||
1382881|NCT02516085||Single Group Assignment||Treatment||None (Open Label)||||||
1382882|NCT02516072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382883|NCT02516059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382884|NCT02516046||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382885|NCT02516033|||Case-Only||Prospective|||||||
1382886|NCT02516020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382887|NCT02515994|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382888|NCT02515981|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1382889|NCT02515968|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1382890|NCT02515955|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382891|NCT02515942|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382892|NCT02515929|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1382893|NCT02515916|||Cohort||Prospective|||||||
1382894|NCT02515903|Randomized|Parallel Assignment||Treatment||Single||||||t
1382895|NCT02515890|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1382896|NCT02515877||Single Group Assignment||Treatment||None (Open Label)||||||
1382897|NCT02515864|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1382898|NCT02515851|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382899|NCT02515838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382900|NCT02515825|||Cohort||Prospective|||||||
1382901|NCT02515812|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1382902|NCT02515799|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1382903|NCT02515786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382904|NCT02515773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382905|NCT02515760|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1382906|NCT02515747|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382907|NCT02515734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382908|NCT02515721|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1382909|NCT02515708|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1382910|NCT02515695|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1382911|NCT02515682|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1382912|NCT02515669|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1382913|NCT02515656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382914|NCT02515643|||Cohort||Prospective|||||||
1382915|NCT02515630||Single Group Assignment||Treatment||None (Open Label)||||||
1382916|NCT02515617|Randomized|Crossover Assignment||Prevention||Single||||||t
1382917|NCT02515604|Randomized|Parallel Assignment||Treatment||Single||||||t
1382918|NCT02515591|||Cohort||Prospective|||||||
1382919|NCT02515578|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382920|NCT02515565|Randomized|Single Group Assignment||Treatment||Single|||||t|
1382921|NCT02515552||Single Group Assignment||||None (Open Label)||||||
1382922|NCT02515539||Single Group Assignment||Treatment||None (Open Label)||||||
1382923|NCT02515526|Randomized|Crossover Assignment||||None (Open Label)||||||
1382924|NCT02515513|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382925|NCT02515500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382926|NCT02515487||Single Group Assignment||Supportive Care||None (Open Label)||||||
1382927|NCT02515474|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382928|NCT02515461||Single Group Assignment||Treatment||None (Open Label)||||||
1382929|NCT02515448||Single Group Assignment||Treatment||None (Open Label)||||||
1382930|NCT02515435||Single Group Assignment||Treatment||None (Open Label)||||||
1382931|NCT02515422|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1382932|NCT02515409|||Cohort||Prospective|||||||
1382933|NCT02515396|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1382934|NCT02515383|||Cohort||Prospective|||||||
1382935|NCT02515370|Randomized|Parallel Assignment||||None (Open Label)||||||
1382936|NCT02515357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382937|NCT02515344|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382938|NCT02515331|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382939|NCT02515318|Randomized|Single Group Assignment||Treatment||Single|||||t|
1382940|NCT02515305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382941|NCT02515292|||Case Control||Prospective|||||||
1382942|NCT02515279|||Cohort||Prospective|||||||
1382943|NCT02515266|||Cohort||Retrospective|||||||
1382944|NCT02515253|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382945|NCT02515240|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382946|NCT02515227||Single Group Assignment||Treatment||None (Open Label)||||||
1382947|NCT02515214|||Cohort||Prospective|||||||
1382948|NCT02515201|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382949|NCT02515188|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1382950|NCT02515175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382951|NCT02515162|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382952|NCT02515149|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1382953|NCT02515136|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382954|NCT02515123|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1382955|NCT02515110||Single Group Assignment||Treatment||None (Open Label)||||||
1382956|NCT02515097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382957|NCT02515084||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382958|NCT02515071|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1382959|NCT02515058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382960|NCT02515045|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382961|NCT02515032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382962|NCT02515019|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1382963|NCT02515006|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1382964|NCT02514993|||Case Control||Retrospective|||||||
1382965|NCT02514980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382966|NCT02514967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382967|NCT02514954|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1382968|NCT02514941|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1382969|NCT02514928|Randomized|Parallel Assignment||Treatment||Single|||t|||
1382970|NCT02514915||Single Group Assignment||Treatment||None (Open Label)||||||
1382971|NCT02514902||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1382972|NCT02514889|Randomized|Parallel Assignment||Treatment||Single||||||t
1382973|NCT02514876||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1382974|NCT02514863|||Cohort||Prospective|||||||
1382975|NCT02514850|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1382976|NCT02514837||Single Group Assignment||Diagnostic||None (Open Label)||||||
1382977|NCT02514824||Single Group Assignment||Treatment||None (Open Label)||||||
1382978|NCT02514811|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1382979|NCT02514798|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1382980|NCT02514772|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1382981|NCT02514759|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1382982|NCT02514746||Single Group Assignment||Prevention||None (Open Label)||||||
1382983|NCT02514733|||Cohort||Retrospective|||||||
1382984|NCT02514720|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1382985|NCT02514707|||Cohort||Prospective|||||||
1382986|NCT02514694|Randomized|Parallel Assignment||Other||Single|||||t|
1382987|NCT02514681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382988|NCT02514668||Single Group Assignment||Treatment||None (Open Label)||||||
1382989|NCT02514655|Randomized|Parallel Assignment||Prevention||Single|||t|||
1382990|NCT02514642|Randomized|Crossover Assignment||Treatment||Single|||||t|
1382991|NCT02514629|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382992|NCT02514616|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1382993|NCT02514603||Single Group Assignment||Treatment||None (Open Label)||||||
1382994|NCT02514590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382995|NCT02514577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1382996|NCT02514564|||Cohort||Prospective|||||||
1382997|NCT02514551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1382998|NCT02514538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1382999|NCT02514525||Single Group Assignment||Treatment||None (Open Label)||||||
1383000|NCT02514512|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383001|NCT02514499||Single Group Assignment||Screening||||||||
1383002|NCT02514486|||Cohort||Prospective|||||||
1383003|NCT02514473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383004|NCT02514460|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383005|NCT02514447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383006|NCT02514434|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1383007|NCT02514421||Single Group Assignment||Treatment||None (Open Label)||||||
1383008|NCT02514408|||Case-Only||Prospective|||||||
1383009|NCT02514395|||||Cross-Sectional|||||||
1383010|NCT02514382||Single Group Assignment||Treatment||None (Open Label)||||||
1383011|NCT02514369|||Cohort||Cross-Sectional|||||||
1383012|NCT02514356|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383013|NCT02514343|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383014|NCT02514330|Randomized|Single Group Assignment||||None (Open Label)||||||
1383015|NCT02514317||Single Group Assignment||Treatment||None (Open Label)||||||
1383016|NCT02514304|||Case-Control||Prospective|||||||
1383017|NCT02514291|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383018|NCT02514278|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383019|NCT02514265|||Cohort||Prospective|||||||
1383020|NCT02514252||Single Group Assignment||Treatment||None (Open Label)||||||
1383021|NCT02514239||Single Group Assignment||Treatment||None (Open Label)||||||
1383022|NCT02514226|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383023|NCT02514213|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383024|NCT02514200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383025|NCT02514187|Non-Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1383026|NCT02514174||Single Group Assignment||Treatment||None (Open Label)||||||
1383027|NCT02514161|Randomized|Parallel Assignment||Treatment||Single||||||t
1383028|NCT02514148|Randomized|Parallel Assignment||Treatment||Single||||||t
1383029|NCT02514135|||Cohort||Prospective|||||||
1383030|NCT02514122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383031|NCT02514109|||Case Control||Prospective|||||||
1383032|NCT02514083||Single Group Assignment||Treatment||None (Open Label)||||||
1383033|NCT02514070|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1383034|NCT02514057|||Cohort||Prospective|||||||
1383035|NCT02514044|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1383036|NCT02514031||Single Group Assignment||Other||None (Open Label)||||||
1383037|NCT02514018|Randomized|Parallel Assignment||||None (Open Label)||||||
1383038|NCT02514005|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1383039|NCT02513992||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383040|NCT02513979|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1383041|NCT02513966|||Other||Retrospective|||||||
1383042|NCT02513953||Single Group Assignment||Treatment||None (Open Label)||||||
1383043|NCT02513940|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1383044|NCT02513927|Randomized|Crossover Assignment||Treatment||Single||||||t
1383045|NCT02513914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383046|NCT02513901||Single Group Assignment||Treatment||None (Open Label)||||||
1383047|NCT02513888|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1383048|NCT02513875|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1383049|NCT02513862|Randomized|Parallel Assignment||Prevention||Single|||t|||
1383050|NCT02513849||Single Group Assignment||Basic Science||None (Open Label)||||||
1383051|NCT02513836|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1383052|NCT02513823||Single Group Assignment||Prevention||None (Open Label)||||||
1383053|NCT02513810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383054|NCT02513797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383055|NCT02513784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383056|NCT02513771|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383057|NCT02513758|||Cohort||Prospective|||||||
1383058|NCT02513745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383059|NCT02513732|||Cohort||Retrospective|||||||
1383060|NCT02513719|||Cohort||Prospective|||||||
1383061|NCT02513693|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1383062|NCT02513680|Randomized|Parallel Assignment||Treatment||Single||||||t
1383063|NCT02513667|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383064|NCT02513654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383065|NCT02513641||Single Group Assignment||Treatment||None (Open Label)||||||
1383066|NCT02513628|||Cohort||Prospective|||||||
1383067|NCT02513615|||Cohort||Prospective|||||||
1383068|NCT02513602|||Case Control||Prospective|||||||
1383069|NCT02513589||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383070|NCT02513576||Single Group Assignment||Treatment||None (Open Label)||||||
1383071|NCT02513563||Single Group Assignment||Treatment||None (Open Label)||||||
1383072|NCT02513550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383073|NCT02513537|||Cohort||Prospective|||||||
1383074|NCT02513524|||Cohort||Prospective|||||||
1383075|NCT02513511||Single Group Assignment||Supportive Care||None (Open Label)||||||
1383076|NCT02513498||Single Group Assignment||Treatment||None (Open Label)||||||
1383077|NCT02513485|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1383078|NCT02513472||Single Group Assignment||Treatment||None (Open Label)||||||
1383079|NCT02513459||Single Group Assignment||Treatment||None (Open Label)||||||
1383080|NCT02513446|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383081|NCT02513433|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1383082|NCT02513420|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1383083|NCT02513407|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383084|NCT02513394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383085|NCT02513381|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1383086|NCT02513368|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1383087|NCT02513355|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383088|NCT02513342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383089|NCT02513329|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1383090|NCT02513316|||Cohort||Prospective|||||||
1383091|NCT02513303|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1383092|NCT02513290|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383093|NCT02513277|||Cohort||Cross-Sectional|||||||
1383094|NCT02513264|||Cohort||Prospective|||||||
1383095|NCT02513251|||||Prospective|||||||
1383096|NCT02513238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383097|NCT02513225|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383098|NCT02513212|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383099|NCT02513199|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383100|NCT02513186||Single Group Assignment||Treatment||None (Open Label)||||||
1383101|NCT02513173|||Case Control||Prospective|||||||
1383102|NCT02513160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383103|NCT02513147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383104|NCT02513134|||||Prospective|||||||
1383105|NCT02513121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383106|NCT02513108|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1383107|NCT02513095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383108|NCT02513082|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383109|NCT02513069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383110|NCT02513056|||Case-Control||Prospective|||||||
1383111|NCT02513043|||Case-Only||Prospective|||||||
1383112|NCT02513030|||Cohort||Prospective|||||||
1383113|NCT02513017|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1383114|NCT02513004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383115|NCT02512991|||Cohort||Prospective|||||||
1383116|NCT02512978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383117|NCT02512965|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1383118|NCT02512952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383119|NCT02512939||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383120|NCT02512926||Single Group Assignment||Treatment||None (Open Label)||||||
1383121|NCT02512913|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1383122|NCT02512900||Single Group Assignment||Other||None (Open Label)||||||
1383123|NCT02512887|Randomized|Parallel Assignment||Treatment||Single||||||t
1383124|NCT02512874||Single Group Assignment||Other||None (Open Label)||||||
1383125|NCT02512861|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383126|NCT02512848||||||||||||
1383127|NCT02512835|||Ecologic or Community||Other|||||||
1383128|NCT02512822||Single Group Assignment||Treatment||Single||||||t
1383129|NCT02512809|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383130|NCT02512796|||Case Control||Prospective|||||||
1383131|NCT02512783|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383132|NCT02512770|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1383133|NCT02512757|||Case-Control||Prospective|||||||
1383134|NCT02512744|Randomized|Parallel Assignment||Treatment||Single||||||t
1383135|NCT02512731|Randomized|Single Group Assignment||Prevention||Single||||||t
1383136|NCT02512718|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383137|NCT02512705|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383138|NCT02512692||Single Group Assignment||Treatment||None (Open Label)||||||
1383139|NCT02512679|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383140|NCT02512666||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1383141|NCT02512653||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383142|NCT02512640|Randomized|Parallel Assignment||Prevention||Single|||t|||
1383143|NCT02512627|Randomized|Parallel Assignment||Treatment||Single||||||t
1383144|NCT02512614|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383145|NCT02512601||Single Group Assignment||Other||None (Open Label)||||||
1383146|NCT02512588|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1383147|NCT02512575|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1383148|NCT02512562|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383149|NCT02512549|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383150|NCT02512536||Single Group Assignment||Treatment||None (Open Label)||||||
1383151|NCT02512523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383152|NCT02512510|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383153|NCT02512497||Single Group Assignment||Treatment||None (Open Label)||||||
1383154|NCT02512484|||Cohort||Prospective|||||||
1383155|NCT02512471|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383156|NCT02512458||Single Group Assignment||Treatment||None (Open Label)||||||
1383157|NCT02512445|Randomized|Parallel Assignment||Treatment||Single||||||t
1383158|NCT02512432||Single Group Assignment||Treatment||None (Open Label)||||||
1383159|NCT02512419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383160|NCT02512406|||Case-Control||Cross-Sectional|||||||
1383161|NCT02512393|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383162|NCT02512380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383163|NCT02512367|Randomized|Parallel Assignment||||None (Open Label)||||||
1383164|NCT02512354||||||||||||
1383165|NCT02512341|||Cohort||Cross-Sectional|||||||
1383166|NCT02512328|Non-Randomized|Parallel Assignment||Prevention||Single||||t||
1383167|NCT02512315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383168|NCT02512302|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383169|NCT02512289|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1383170|NCT02512276|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1383171|NCT02512263|Randomized|Parallel Assignment||Treatment||Single||||||t
1383172|NCT02512250|||Cohort||Prospective|||||||
1383173|NCT02512237|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383174|NCT02512224|||||Retrospective|||||||
1383175|NCT02512211|||Cohort||Prospective|||||||
1383176|NCT02512198|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1383177|NCT02512185|||Cohort||Prospective|||||||
1383178|NCT02512172|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383179|NCT02512159|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1383180|NCT02512146|||Case Control||Prospective|||||||
1383181|NCT02512133|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383182|NCT02512120|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383183|NCT02512107|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1383184|NCT02512094|||Case-Only||Cross-Sectional|||||||
1383185|NCT02512081||||||||||||
1383186|NCT02512068|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383187|NCT02512055||Single Group Assignment||Treatment||Single|||||t|
1383188|NCT02512042|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1383189|NCT02512029|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1383190|NCT02512016||Single Group Assignment||Other||None (Open Label)||||||
1383191|NCT02512003||Single Group Assignment||Treatment||None (Open Label)||||||
1383192|NCT02511990|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383193|NCT02511977|||Case-Only||Retrospective|||||||
1383194|NCT02511964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383195|NCT02511951|Randomized|Single Group Assignment||Treatment||Single|||t|||
1383196|NCT02511938|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1383197|NCT02511925|||Case-Crossover||Prospective|||||||
1383198|NCT02511912||Single Group Assignment||Treatment||None (Open Label)||||||
1383199|NCT02511899|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1383200|NCT02511886|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383201|NCT02511873|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383202|NCT02511860|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1383203|NCT02511847||Single Group Assignment||Treatment||None (Open Label)||||||
1383204|NCT02511834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383205|NCT02511821||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1383206|NCT02511808|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1383207|NCT02511795|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383208|NCT02511782|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1383209|NCT02511769|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383210|NCT02511756||Single Group Assignment||Diagnostic||Single||||||t
1383211|NCT02511743|||||Prospective|||||||
1383212|NCT02511730|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1383213|NCT02511717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383214|NCT02511704|Randomized|Crossover Assignment||||None (Open Label)||||||
1383215|NCT02511691||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383216|NCT02511678||Single Group Assignment||Treatment||None (Open Label)||||||
1383217|NCT02511665|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1383218|NCT02511652|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1383219|NCT02511639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383220|NCT02511626|||Case-Control||Cross-Sectional|||||||
1383221|NCT02511613|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383222|NCT02511600|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383223|NCT02511587|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383224|NCT02511574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383225|NCT02511561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383226|NCT02511548|Randomized|Parallel Assignment||Prevention||Single||||t||
1383227|NCT02511535|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383228|NCT02511522|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383229|NCT02511509|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383230|NCT02511496|||||Prospective|||||||
1383231|NCT02511483|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383232|NCT02511470|Randomized|Crossover Assignment||||Single|||t|||
1383233|NCT02511457|||Case-Only||Prospective|||||||
1383234|NCT02511444||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383235|NCT02511431|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383236|NCT02511418||||Treatment||||||||
1383237|NCT02511405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383238|NCT02511392|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383239|NCT02511379||Single Group Assignment||Treatment||None (Open Label)||||||
1383240|NCT02511366|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1383241|NCT02511353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383242|NCT02511340||Single Group Assignment||Treatment||None (Open Label)||||||
1383243|NCT02511327|||Case Control||Prospective|||||||
1383244|NCT02511314|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1383245|NCT02511301||Single Group Assignment||Screening||None (Open Label)||||||
1383246|NCT02511288|||Cohort||Prospective|||||||
1383247|NCT02511275||Single Group Assignment||Other||None (Open Label)||||||
1383248|NCT02511262|||Cohort||Prospective|||||||
1383249|NCT02511249|||Cohort||Prospective|||||||
1383250|NCT02511236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383251|NCT02511223||Single Group Assignment||Treatment||None (Open Label)||||||
1383252|NCT02511210|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1383253|NCT02511197||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383254|NCT02511184||||Treatment||None (Open Label)||||||
1383255|NCT02511171|Randomized|Parallel Assignment||Treatment||Single||||t||
1383256|NCT02511158|||Cohort||Prospective|||||||
1383257|NCT02511145|Randomized|Single Group Assignment||||None (Open Label)||||||
1383258|NCT02511132||Single Group Assignment||Treatment||None (Open Label)||||||
1383259|NCT02511119|||Cohort||Prospective|||||||
1383260|NCT02511106|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383261|NCT02511093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383262|NCT02511080|Randomized|Parallel Assignment||Prevention||Single|||t|||
1383263|NCT02511067|Randomized|Factorial Assignment||Treatment||Single|||||t|
1383264|NCT02511054|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383265|NCT02511041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383266|NCT02511028||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383267|NCT02511015|||Case-Control||Cross-Sectional|||||||
1383268|NCT02511002|||Cohort||Prospective|||||||
1383269|NCT02510989|||Family-Based||Other|||||||
1383270|NCT02510976|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1383271|NCT02510963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383272|NCT02510950||Single Group Assignment||Treatment||None (Open Label)||||||
1383273|NCT02510937|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383274|NCT02510924|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383275|NCT02510911|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383276|NCT02510898||Single Group Assignment||Treatment||None (Open Label)||||||
1383277|NCT02510885||Single Group Assignment||Other||None (Open Label)||||||
1383278|NCT02510872|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1383279|NCT02510859|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383280|NCT02510846|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383281|NCT02510833|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383282|NCT02510820|Randomized|Crossover Assignment||Other||Single|||t|||
1383283|NCT02510807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383284|NCT02510794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383285|NCT02510781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383286|NCT02510768|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383287|NCT02510755|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1383288|NCT02510742|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1383289|NCT02510729|Randomized|Crossover Assignment||Other||Double|||t||t|
1383290|NCT02510716|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383291|NCT02510703|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1383292|NCT02510690|||Cohort||Retrospective|||||||
1383293|NCT02510677||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383294|NCT02510664||Single Group Assignment||Other||None (Open Label)||||||
1383295|NCT02510651||Single Group Assignment||Treatment||None (Open Label)||||||
1383296|NCT02510638|||Cohort||Retrospective|||||||
1383297|NCT02510625|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383298|NCT02510612|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383299|NCT02510599||Single Group Assignment||Treatment||None (Open Label)||||||
1383300|NCT02510586|Randomized|Crossover Assignment||||Double|||t|||t
1383301|NCT02510573|||Case-Only||Prospective|||||||
1383302|NCT02510560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383303|NCT02510547|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383304|NCT02510534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383305|NCT02510521|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383306|NCT02510508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383307|NCT02510495|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383308|NCT02510482|||Other||Prospective|||||||
1383309|NCT02510469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383310|NCT02510456||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383311|NCT02510443|||Cohort||Prospective|||||||
1383312|NCT02510430|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383313|NCT02510417||Single Group Assignment||Treatment||None (Open Label)||||||
1383314|NCT02510404||Single Group Assignment||Treatment||None (Open Label)||||||
1383315|NCT02510391||Single Group Assignment||Treatment||None (Open Label)||||||
1383316|NCT02510378||Single Group Assignment||Treatment||None (Open Label)||||||
1383317|NCT02510365||Single Group Assignment||Treatment||None (Open Label)||||||
1383318|NCT02510352|||Cohort||Prospective|||||||
1383319|NCT02510339|||Cohort||Prospective|||||||
1383320|NCT02510326|||Cohort||Cross-Sectional|||||||
1383391|NCT02509403||Single Group Assignment||Other||None (Open Label)||||||
1383392|NCT02509390||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383393|NCT02509377||Single Group Assignment||Treatment||None (Open Label)||||||
1383321|NCT02510313|Randomized|Parallel Assignment||Prevention||Single|Our study works with Laterite to oversee data collection in the field. Laterite enumerators are blind to study condition and therefore do not know which study arm, apart from their VUP status (class or expanded), participants have been randomized into.|"The proposed study design consists of a four-arm cluster randomized control trial (CRT), which will span approximately 52 cells in 3 districts of Rwanda to compare outcomes among VUP eligible households with at least one child 6-36 months in the following study arms:~Classic VUP public works (control)~Expanded VUP public works (control)~Combined Classic VUP public works with Sugira Muryango (treatment)~Combined Expanded VUP public works with Sugira Muryango (treatment)"||||t
1383322|NCT02510300|||Cohort||Prospective|||||||
1383323|NCT02510287|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1383324|NCT02510274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383325|NCT02510261||Single Group Assignment||Treatment||None (Open Label)||||||
1383326|NCT02510248|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1383327|NCT02510235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383328|NCT02510222|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383329|NCT02510209|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383330|NCT02510196|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1383331|NCT02510183|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1383332|NCT02510170|||Other||Cross-Sectional|||||||
1383333|NCT02510157|Randomized|Parallel Assignment||||Double||||t|t|
1383334|NCT02510144|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1383335|NCT02510131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383336|NCT02510118|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383337|NCT02510105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383338|NCT02510092|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1383339|NCT02510079||||||||||||
1383340|NCT02510066|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383341|NCT02510053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383342|NCT02510040|||Cohort||Prospective|||||||
1383343|NCT02510027|||Cohort||Prospective|||||||
1383344|NCT02510014|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383345|NCT02510001|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1383346|NCT02509988|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1383347|NCT02509975||Single Group Assignment||Treatment||None (Open Label)||||||
1383348|NCT02509962||Single Group Assignment||Basic Science||None (Open Label)||||||
1383349|NCT02509949|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1383350|NCT02509936|Randomized|Parallel Assignment||Treatment||Single||||||t
1383351|NCT02509923|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383352|NCT02509910|||Cohort||Retrospective|||||||
1383353|NCT02509897|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1383354|NCT02509884|||||Retrospective|||||||
1383355|NCT02509871||Single Group Assignment||Basic Science||None (Open Label)||||||
1383356|NCT02509858|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383357|NCT02509845|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383358|NCT02509832|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1383359|NCT02509819||Single Group Assignment||Treatment||None (Open Label)||||||
1383360|NCT02509806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383361|NCT02509793||Single Group Assignment||Treatment||None (Open Label)||||||
1383362|NCT02509780||Single Group Assignment||Basic Science||None (Open Label)||||||
1383363|NCT02509767|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1383364|NCT02509754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383365|NCT02509741|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383366|NCT02509728|Randomized|Parallel Assignment||Prevention||Single||||||t
1383367|NCT02509715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383368|NCT02509702|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1383369|NCT02509689||Single Group Assignment||Treatment||None (Open Label)||||||
1383370|NCT02509676|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1383371|NCT02509663|Randomized|Parallel Assignment||Other||Single|||||t|
1383372|NCT02509650|||Cohort||Prospective|||||||
1383373|NCT02509637|Randomized|Parallel Assignment||Treatment||Single|||||t|
1383374|NCT02509624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383375|NCT02509611|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1383376|NCT02509598||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383377|NCT02509585||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383378|NCT02509572|Randomized|Parallel Assignment||Screening||Single|||t|||
1383379|NCT02509559|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1383380|NCT02509546||Single Group Assignment||Treatment||None (Open Label)||||||
1383381|NCT02509533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383382|NCT02509520|Randomized|Parallel Assignment||Treatment||Single||||||t
1383383|NCT02509507|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1383384|NCT02509494|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1383385|NCT02509481|Randomized|Parallel Assignment||Treatment||Single||||||t
1383386|NCT02509468|Randomized|Crossover Assignment||Treatment||Single||||||t
1383387|NCT02509455|||Cohort||Prospective|||||||
1383388|NCT02509442||Single Group Assignment||Supportive Care||None (Open Label)||||||
1383389|NCT02509429|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383390|NCT02509416|||Cohort||Prospective|||||||
1383394|NCT02509364|||Case Control||Retrospective|||||||
1383395|NCT02509351|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383396|NCT02509338||Single Group Assignment||Treatment||None (Open Label)||||||
1383397|NCT02509325|||Cohort||Prospective|||||||
1383398|NCT02509312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383399|NCT02509299|Randomized|Parallel Assignment||Treatment||Single|||||t|
1383400|NCT02509286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383401|NCT02509273|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383402|NCT02509260|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383403|NCT02509247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383404|NCT02509234|||Case-Only||Retrospective|||||||
1383405|NCT02509221|||Cohort||Prospective|||||||
1383406|NCT02509208||Single Group Assignment||Supportive Care||None (Open Label)||||||
1383407|NCT02509195||Single Group Assignment||Treatment||None (Open Label)||||||
1383408|NCT02509182|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1383409|NCT02509169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383410|NCT02509156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383411|NCT02509143|Randomized|Parallel Assignment||Treatment||Single||||||t
1383412|NCT02509130|||Cohort||Retrospective|||||||
1383413|NCT02509117|Randomized|||Basic Science||Triple|||t|t|t|
1383414|NCT02509104|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383415|NCT02509091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383416|NCT02509078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383417|NCT02509065|Randomized|Crossover Assignment||Treatment||None (Open Label)|Some of the study arms are double blinded: the 110 mg/dl and 130 mg/dl set point configurations of the bionic pancreas are double blinded, so neither the patient nor the study team know if they are using the bihormonal bionic pancreas or insulin only bionic pancreas|||||
1383418|NCT02509052||Single Group Assignment||Treatment||None (Open Label)||||||
1383419|NCT02509039||Single Group Assignment||Treatment||None (Open Label)||||||
1383420|NCT02509026||Single Group Assignment||Treatment||None (Open Label)||||||
1383421|NCT02509013|||Cohort||Prospective|||||||
1383422|NCT02509000|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1383423|NCT02508987|||||Cross-Sectional|||||||
1383424|NCT02508974|||Cohort||Prospective|||||||
1383425|NCT02508961|Randomized|Parallel Assignment||Treatment||Single||||||t
1383426|NCT02508948|||Cohort||Prospective|||||||
1383427|NCT02508935||Single Group Assignment||Treatment||None (Open Label)||||||
1383428|NCT02508922|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1383429|NCT02508909||Single Group Assignment||Treatment||None (Open Label)||||||
1383430|NCT02508896|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383431|NCT02508883|||Cohort||Prospective|||||||
1383432|NCT02508870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383433|NCT02508857|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383434|NCT02508844|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383435|NCT02508831||Single Group Assignment||Treatment||None (Open Label)||||||
1383436|NCT02508818||Single Group Assignment||Basic Science||None (Open Label)||||||
1383437|NCT02508805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383438|NCT02508792|Randomized|Crossover Assignment||||Double|||t||t|
1383439|NCT02508779|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383440|NCT02508766|Randomized|Factorial Assignment||Treatment||Single||||||t
1383441|NCT02508753|Randomized|Crossover Assignment||Other||Double|||t||t|
1383442|NCT02508740|Randomized|Parallel Assignment||||None (Open Label)||||||
1383443|NCT02508727|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1383444|NCT02508714|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383445|NCT02508701|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1383446|NCT02508688||Single Group Assignment||Treatment||None (Open Label)||||||
1383447|NCT02508675|||Cohort||Prospective|||||||
1383448|NCT02508662|||Cohort||Prospective|||||||
1383449|NCT02508649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383450|NCT02508636||Single Group Assignment||Treatment||None (Open Label)||||||
1383451|NCT02508623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383452|NCT02508610|||Case-Only||Prospective|||||||
1383453|NCT02508597||Single Group Assignment||Health Services Research||None (Open Label)||||||
1383454|NCT02508584||Single Group Assignment||Treatment||None (Open Label)||||||
1383455|NCT02508571|Randomized|Factorial Assignment||Supportive Care||Triple|||t|t||t
1383456|NCT02508558||Single Group Assignment||Basic Science||None (Open Label)||||||
1383457|NCT02508545||Single Group Assignment||Basic Science||None (Open Label)||||||
1383458|NCT02508532||Single Group Assignment||Treatment||None (Open Label)||||||
1383459|NCT02508519|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383460|NCT02508506||Single Group Assignment||Treatment||None (Open Label)||||||
1383461|NCT02508493|||Case Control||Cross-Sectional|||||||
1383462|NCT02508480|Randomized|Parallel Assignment||Other||Single||||||t
1383463|NCT02508467||Single Group Assignment||Treatment||None (Open Label)||||||
1383464|NCT02508454|||Cohort||Prospective|||||||
1383465|NCT02508441||Single Group Assignment||Treatment||None (Open Label)||||||
1383466|NCT02508428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383467|NCT02508415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383468|NCT02508402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383852|NCT02503384|||Cohort||Retrospective|||||||
1383469|NCT02508389|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1383470|NCT02508376|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1383471|NCT02508363|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1383472|NCT02508350||Single Group Assignment||||None (Open Label)||||||
1383473|NCT02508337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383474|NCT02508324||Single Group Assignment||Treatment||None (Open Label)||||||
1383475|NCT02508311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383476|NCT02508298|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1383477|NCT02508272|||Cohort||Prospective|||||||
1383478|NCT02508259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383479|NCT02508246||Single Group Assignment||Treatment||None (Open Label)||||||
1383480|NCT02508233|||Cohort||Prospective|||||||
1383481|NCT02508220|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1383482|NCT02508207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383483|NCT02508194|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1383484|NCT02508181|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1383485|NCT02508168|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383486|NCT02508155|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1383487|NCT02508142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383488|NCT02508129|Randomized|Parallel Assignment||Treatment||Single|||||t|
1383489|NCT02508116|Randomized|Parallel Assignment||Other||None (Open Label)||Patients undergoing PCI are randomized to genotype guided antiplatelet therapy vs. usual care.||||
1383490|NCT02508103|Randomized|Crossover Assignment||Treatment||Single|||t|||
1383491|NCT02508090|||Cohort||Prospective|||||||
1383492|NCT02508077||Single Group Assignment||Treatment||None (Open Label)||||||
1383493|NCT02508064|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1383494|NCT02508051|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1383495|NCT02508038||Single Group Assignment||Treatment||None (Open Label)||||||
1383496|NCT02508025|||Cohort||Retrospective|||||||
1383497|NCT02508012|Randomized|Parallel Assignment||||None (Open Label)||||||
1383498|NCT02507999|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1383499|NCT02507986|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1383500|NCT02507973|||Case-Crossover||Prospective|||||||
1383501|NCT02507960||Single Group Assignment||Treatment||None (Open Label)||||||
1383502|NCT02507947|||Case-Only||Prospective|||||||
1383503|NCT02507934|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383504|NCT02507921|||Cohort||Cross-Sectional|||||||
1383505|NCT02507908|||Other||Prospective|||||||
1383506|NCT02507895||Single Group Assignment||Treatment||None (Open Label)||||||
1383507|NCT02507882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383508|NCT02507869|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383509|NCT02507856|||Cohort||Prospective|||||||
1383510|NCT02507843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383511|NCT02507830|||Cohort||Prospective|||||||
1383512|NCT02507817|||Case Control||Prospective|||||||
1383513|NCT02507804|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383514|NCT02507791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383515|NCT02507778||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383516|NCT02507765||Single Group Assignment||Treatment||None (Open Label)||||||
1383517|NCT02507752|||Cohort||Prospective|||||||
1383518|NCT02507739|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1383519|NCT02507726||Single Group Assignment||Treatment||None (Open Label)||||||
1383520|NCT02507713|||Case Control||Retrospective|||||||
1383521|NCT02507700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383522|NCT02507687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383523|NCT02507674|||Cohort||Prospective|||||||
1383524|NCT02507661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383525|NCT02507648|Randomized|Crossover Assignment||||None (Open Label)||||||
1383526|NCT02507635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383527|NCT02507622||Single Group Assignment||Basic Science||None (Open Label)||||||
1383528|NCT02507609|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1383529|NCT02507596|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383530|NCT02507583||Single Group Assignment||Treatment||None (Open Label)||||||
1383531|NCT02507570||Single Group Assignment||Treatment||None (Open Label)||||||
1383532|NCT02507557|||||Retrospective|||||||
1383533|NCT02507544||Single Group Assignment||Treatment||None (Open Label)||||||
1383534|NCT02507531||||||||||||
1383535|NCT02507518||Single Group Assignment||Other||None (Open Label)||||||
1383536|NCT02507505|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1383537|NCT02507492||Single Group Assignment||Treatment||None (Open Label)||||||
1383538|NCT02507479||Single Group Assignment||Treatment||None (Open Label)||||||
1383539|NCT02507466|Randomized|Parallel Assignment||Treatment||Single||3 arm RCT - high intensity variable, high intensity forward, low intensity variable||||t
1383540|NCT02507453||Single Group Assignment||Basic Science||None (Open Label)||||||
1383541|NCT02507440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383542|NCT02507427||Single Group Assignment||Treatment||None (Open Label)||||||
1383543|NCT02507414||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383544|NCT02507401|||Cohort||Prospective|||||||
1383545|NCT02507388|Randomized|Parallel Assignment||Other||Double|||t||t|
1383546|NCT02507375|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383547|NCT02507362|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383548|NCT02507349|Randomized|Parallel Assignment||Treatment||Single||||||t
1383549|NCT02507336|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383550|NCT02507323|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1383551|NCT02507310|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1383552|NCT02507297|Randomized|Parallel Assignment||Treatment||Single||||||t
1383553|NCT02507284|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1383554|NCT02507271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383555|NCT02507258|||Cohort||Prospective|||||||
1383556|NCT02507245|||Case-Only||Prospective|||||||
1383557|NCT02507232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383558|NCT02507219|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1383559|NCT02507206|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1383560|NCT02507193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383561|NCT02507180|||Cohort||Prospective|||||||
1383562|NCT02507167|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1383563|NCT02507154||Single Group Assignment||Treatment||None (Open Label)||||||
1383564|NCT02507141|||Cohort||Prospective|||||||
1383565|NCT02507128|Randomized|Parallel Assignment||Treatment||Double||||||
1383566|NCT02507115|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383567|NCT02507102||Single Group Assignment||Treatment||None (Open Label)||||||
1383568|NCT02507089|Randomized|Single Group Assignment||Treatment||Single|||t|||
1383569|NCT02507076||Single Group Assignment||Treatment||None (Open Label)||||||
1383570|NCT02507063|||Case-Only||Prospective|||||||
1383571|NCT02507050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383572|NCT02507037|Randomized|Parallel Assignment||Screening||Single|||||t|
1383573|NCT02507024|||Other||Prospective|||||||
1383574|NCT02507011|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1383575|NCT02506998||Single Group Assignment||Treatment||None (Open Label)||||||
1383576|NCT02506985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383577|NCT02506972|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1383578|NCT02506959||Single Group Assignment||Treatment||None (Open Label)||||||
1383579|NCT02506946|||Case Control||Cross-Sectional|||||||
1383580|NCT02506933|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1383581|NCT02506920|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1383582|NCT02506907|||Cohort||Prospective|||||||
1383583|NCT02506894|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1383584|NCT02506881|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1383585|NCT02506868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383586|NCT02506855|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1383587|NCT02506842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383588|NCT02506829|Randomized|Parallel Assignment||Prevention||Single||||||t
1383589|NCT02506816|||Case-Only||Prospective|||||||
1383590|NCT02506803||Single Group Assignment||Treatment||None (Open Label)||||||
1383591|NCT02506790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383592|NCT02506777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383593|NCT02506751||Single Group Assignment||Treatment||None (Open Label)||||||
1383594|NCT02506738|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383595|NCT02506725|Randomized|Parallel Assignment||Prevention||Single|statistician and qualitative researchers|||||t
1383596|NCT02506712|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1383597|NCT02506699|||Cohort||Prospective|||||||
1383598|NCT02506686||Single Group Assignment||Treatment||None (Open Label)||||||
1383599|NCT02506673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383600|NCT02506660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383601|NCT02506647|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1383602|NCT02506634|||Cohort||Prospective|||||||
1383603|NCT02506621||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383604|NCT02506608||Single Group Assignment||Treatment||None (Open Label)||||||
1383605|NCT02506595|Randomized|Crossover Assignment||Treatment||Single||||||t
1383606|NCT02506582|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383607|NCT02506569|||Case-Only||Prospective|||||||
1383608|NCT02506556||Single Group Assignment||Treatment||None (Open Label)||||||
1383609|NCT02506543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383610|NCT02506530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383611|NCT02506517||Single Group Assignment||Treatment||None (Open Label)||||||
1383612|NCT02506504|Randomized|Parallel Assignment||Other||Single|||t|||
1383613|NCT02506491|Randomized|Parallel Assignment||Treatment||Single||||||t
1383614|NCT02506478|||||Cross-Sectional|||||||
1383615|NCT02506465|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383616|NCT02506452|Randomized|Parallel Assignment||Treatment||Single|Blinded wound core lab|||||t
1383617|NCT02506439|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1383618|NCT02506426|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383619|NCT02506413||Single Group Assignment||Health Services Research||None (Open Label)||||||
1383620|NCT02506400||||||||||||
1383621|NCT02506387|||Cohort||Prospective|||||||
1383622|NCT02506374|||Cohort|||||||||
1383623|NCT02506361|||Case Control||Prospective|||||||
1383624|NCT02506348||Single Group Assignment||||Single|||t|||
1383625|NCT02506335||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383626|NCT02506322|Randomized|Parallel Assignment||Treatment||Single||||||t
1383627|NCT02506309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383628|NCT02506296||Single Group Assignment||||None (Open Label)||||||
1383629|NCT02506283|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383630|NCT02506270|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383631|NCT02506257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383632|NCT02506244|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383633|NCT02506231|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383634|NCT02506218|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383635|NCT02506205||Single Group Assignment||Treatment||Single||||||t
1383636|NCT02506192|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383637|NCT02506179|||Cohort||Prospective|||||||
1383638|NCT02506166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383639|NCT02506153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383640|NCT02506140|Randomized|Parallel Assignment||Treatment||Single||||||t
1383641|NCT02506127|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1383642|NCT02506114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383643|NCT02506101|Randomized|Single Group Assignment||Treatment||Single||||||t
1383644|NCT02506088|Randomized|Parallel Assignment||Prevention||Single||||||t
1383645|NCT02506075|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1383646|NCT02506062|Randomized|Crossover Assignment||Treatment||Single|||t|||
1383647|NCT02506049||Single Group Assignment||Treatment||None (Open Label)||||||
1383648|NCT02506036|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383649|NCT02506023|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1383650|NCT02506010|||Cohort||Prospective|||||||
1383651|NCT02505997||Single Group Assignment||Basic Science||None (Open Label)||||||
1383652|NCT02505984|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383653|NCT02505971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383654|NCT02505958|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1383655|NCT02505945|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383656|NCT02505932|||Case Control||Prospective|||||||
1383657|NCT02505919|Randomized|Parallel Assignment||Treatment||Triple|All study subjects are blinded to the assigned treatment until study exit. One of the investigational site teams is blinded to the randomization assignment as well.||t|t|t|
1383658|NCT02505906|||Cohort||Prospective|||||||
1383659|NCT02505893||Single Group Assignment||Treatment||None (Open Label)||||||
1383660|NCT02505880|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1383661|NCT02505867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383662|NCT02505854|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383663|NCT02505841|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1383664|NCT02505828|Non-Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1383665|NCT02505815|||Cohort||Prospective|||||||
1383666|NCT02505802|Randomized|Parallel Assignment||Treatment||Single||||||t
1383667|NCT02505789|||Cohort||Prospective|||||||
1383668|NCT02505776|||Cohort||Prospective|||||||
1383669|NCT02505763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383670|NCT02505750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383671|NCT02505737|Randomized|Parallel Assignment||Treatment||Single||||||t
1383672|NCT02505724|Randomized|Parallel Assignment||||Single||||||t
1383673|NCT02505711|Randomized|Parallel Assignment||Prevention||Single||||||t
1383674|NCT02505698|||Case-Control||Prospective|||||||
1383675|NCT02505685|||Case Control||Prospective|||||||
1383676|NCT02505672|||Cohort||Prospective|||||||
1383677|NCT02505659|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383678|NCT02505646|||Cohort||Prospective|||||||
1383679|NCT02505633|Randomized|Parallel Assignment||||Double|||t||t|
1383680|NCT02505620|||Cohort||Prospective|||||||
1383681|NCT02505607|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383682|NCT02505594|||Other||Prospective|||||||
1383683|NCT02505581|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383684|NCT02505568||Single Group Assignment||Treatment||None (Open Label)||||||
1383685|NCT02505555|||||Prospective|||||||
1383686|NCT02505542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383687|NCT02505529|Randomized|Parallel Assignment||Basic Science||Single||||||t
1383688|NCT02505516|Randomized|Single Group Assignment||Screening||Single|||t|||
1383689|NCT02505503|Randomized|Crossover Assignment||Treatment||Single||||||t
1383690|NCT02505490|Randomized|Factorial Assignment||Other||Single|||t|||
1383691|NCT02505477|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383692|NCT02505464|||Case-Only||Prospective|||||||
1383693|NCT02505451|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1383694|NCT02505438|Randomized|Parallel Assignment||Prevention||Single|||||t|
1383695|NCT02505425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383696|NCT02505412|||Cohort||Cross-Sectional|||||||
1383697|NCT02505399|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1383698|NCT02505386|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1383699|NCT02505373|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383700|NCT02505360||Single Group Assignment||Supportive Care||None (Open Label)||||||
1383701|NCT02505347|Randomized|Parallel Assignment||Treatment||Single||||||t
1383702|NCT02505334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383703|NCT02505321|Non-Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1383704|NCT02505308|Non-Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1383705|NCT02505295|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383706|NCT02505282|||Case Control||Cross-Sectional|||||||
1383707|NCT02505269||Single Group Assignment||Treatment||None (Open Label)||||||
1383708|NCT02505256|||Case-Only||Prospective|||||||
1383709|NCT02505243|||Cohort|||||||||
1383710|NCT02505230|Randomized|Single Group Assignment||Other||Single|||t|||
1383711|NCT02505217|||Cohort||Prospective|||||||
1383712|NCT02505204|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1383713|NCT02505191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383714|NCT02505178||Single Group Assignment||Treatment||None (Open Label)||||||
1383715|NCT02505165|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383716|NCT02505152||Single Group Assignment||Treatment||None (Open Label)||||||
1383717|NCT02505139|||Cohort||Prospective|||||||
1383718|NCT02505126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383719|NCT02505113|||Case Control||Prospective|||||||
1383720|NCT02505100|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383721|NCT02505087|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1383722|NCT02505074|||Cohort||Retrospective|||||||
1383723|NCT02505061|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1383724|NCT02505048||Single Group Assignment||Treatment||None (Open Label)||||||
1383725|NCT02505035|Randomized|Crossover Assignment||Health Services Research||Double|||t|||t
1383726|NCT02505022|||Other||Prospective|||||||
1383727|NCT02505009|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1383728|NCT02504996|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383729|NCT02504983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383730|NCT02504970|||Cohort|||||||||
1383731|NCT02504957||Single Group Assignment||Treatment||None (Open Label)||||||
1383732|NCT02504944||Single Group Assignment||Treatment||None (Open Label)||||||
1383733|NCT02504931|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383734|NCT02504918|||Cohort||Prospective|||||||
1383735|NCT02504905|||Cohort||Prospective|||||||
1383736|NCT02504892|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383737|NCT02504879|||Cohort||Prospective|||||||
1383738|NCT02504866|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383739|NCT02504853|||Case-Control||Prospective|||||||
1383740|NCT02504840|||Other||Prospective|||||||
1383741|NCT02504827||Single Group Assignment||Other||None (Open Label)||||||
1383742|NCT02504814||Single Group Assignment||Treatment||None (Open Label)||||||
1383743|NCT02504801|Randomized|Parallel Assignment||Prevention||Single|||t|||
1383744|NCT02504788||Single Group Assignment||Treatment||None (Open Label)||||||
1383745|NCT02504775|Randomized|Crossover Assignment||Other||Single|||t|||
1383746|NCT02504762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383747|NCT02504749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383748|NCT02504736|||Cohort||Prospective|||||||
1383749|NCT02504723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383750|NCT02504710|Randomized|Parallel Assignment||Treatment||Single||||||t
1383751|NCT02504697|||Cohort||Prospective|||||||
1383752|NCT02504684|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383753|NCT02504671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383754|NCT02504658|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383755|NCT02504645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383756|NCT02504632|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1383757|NCT02504619||Single Group Assignment||Treatment||None (Open Label)||||||
1383758|NCT02504606|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383759|NCT02504593||Single Group Assignment||||||||||
1383760|NCT02504580|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1383761|NCT02504567|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1383762|NCT02504554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383763|NCT02504541||Single Group Assignment||Treatment||None (Open Label)||||||
1383764|NCT02504528|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1383765|NCT02504515|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1383766|NCT02504502|Randomized|Parallel Assignment||Health Services Research||Single|participants do not know whether they are in the intervention (enhanced report) or control (routine clinical care with delayed access to the enhanced report) arm|"intervention = routine clinical care for return of results per whole genome sequencing study with enhanced genetic test results report developed through phase 1 and 2 of this study.~Control with delayed intervention = routine clinical care for return of results per whole genome sequencing study with crossover to receipt of enhanced report upon completion of baseline and 3 month post-baseline followup surveys. Participants in this arm will complete a third survey at 3 months post receipt of enhanced report"|t|||
1383767|NCT02504489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383768|NCT02504476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383769|NCT02504463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383770|NCT02504450|||Case-Only||Retrospective|||||||
1383771|NCT02504437|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383772|NCT02504424||Single Group Assignment||Treatment||None (Open Label)||||||
1383773|NCT02504411|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1383774|NCT02504398|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1383775|NCT02504385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383776|NCT02504372|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1383777|NCT02504359||Single Group Assignment||Treatment||None (Open Label)||||||
1383778|NCT02504346||Single Group Assignment||Treatment||None (Open Label)||||||
1383779|NCT02504333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383780|NCT02504320|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1383781|NCT02504307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383782|NCT02504294|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1383783|NCT02504281|||Case Control||Prospective|||||||
1383784|NCT02504268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383785|NCT02504255|||Cohort||Prospective|||||||
1383786|NCT02504242|Randomized|Parallel Assignment||Treatment||Single||||||t
1383787|NCT02504229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383788|NCT02504216|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383789|NCT02504203|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383790|NCT02504190|||Cohort||Prospective|||||||
1383791|NCT02504177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383792|NCT02504164|Randomized|Parallel Assignment||||Double|||t|||t
1383793|NCT02504151|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1383794|NCT02504138|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383795|NCT02504125|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1383796|NCT02504112|||Cohort||Cross-Sectional|||||||
1383797|NCT02504099||Single Group Assignment||Treatment||None (Open Label)||||||
1383798|NCT02504086||Single Group Assignment||Treatment||None (Open Label)||||||
1383799|NCT02504073|||Other||Other|||||||
1383800|NCT02504060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383801|NCT02504047||Single Group Assignment||Treatment||None (Open Label)||||||
1383802|NCT02504034||Single Group Assignment||Treatment||None (Open Label)||||||
1383803|NCT02504021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383804|NCT02504008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383805|NCT02503995|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1383806|NCT02503982||Single Group Assignment||Prevention||None (Open Label)||||||
1383807|NCT02503969|||Case Control||Cross-Sectional|||||||
1383808|NCT02503956|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383809|NCT02503943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383810|NCT02503930|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383811|NCT02503917|||Cohort||Prospective|||||||
1383812|NCT02503904|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383813|NCT02503891||Single Group Assignment||Treatment||None (Open Label)||||||
1383814|NCT02503878|||Cohort||Prospective|||||||
1383815|NCT02503865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383816|NCT02503852|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383817|NCT02503839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383818|NCT02503826|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1383819|NCT02503813||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383820|NCT02503800|||Cohort||Prospective|||||||
1383821|NCT02503787||Single Group Assignment||Treatment||None (Open Label)||||||
1383822|NCT02503774|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383823|NCT02503761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383824|NCT02503748||Single Group Assignment||Health Services Research||None (Open Label)||||||
1383825|NCT02503735||Single Group Assignment||Treatment||None (Open Label)||||||
1383826|NCT02503722||Single Group Assignment||Treatment||None (Open Label)||||||
1383827|NCT02503709||Single Group Assignment||Treatment||None (Open Label)||||||
1383828|NCT02503696|||Case-Only||Prospective|||||||
1383829|NCT02503683|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383830|NCT02503670|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383831|NCT02503657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383832|NCT02503644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383833|NCT02503631|||Case-Only||Prospective|||||||
1383834|NCT02503618|||Cohort||Prospective|||||||
1383835|NCT02503605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383836|NCT02503592|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1383837|NCT02503579|Randomized|Parallel Assignment||Basic Science||Single||||||t
1383838|NCT02503566||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383839|NCT02503553|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1383840|NCT02503540||Single Group Assignment||Treatment||None (Open Label)||||||
1383841|NCT02503527|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1383842|NCT02503514|||Cohort||Prospective|||||||
1383843|NCT02503501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383844|NCT02503488|Randomized|Parallel Assignment||Treatment||Single||||||t
1383845|NCT02503475|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383846|NCT02503462||Single Group Assignment||Treatment||None (Open Label)||||||
1383847|NCT02503449|||Cohort||Prospective|||||||
1383848|NCT02503436|||Cohort||Prospective|||||||
1383849|NCT02503423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1383850|NCT02503410|Randomized|Parallel Assignment||Treatment||Single|Assessor is blinded to treatment assignment.|||||t
1383851|NCT02503397|||Cohort||Prospective|||||||
1383853|NCT02503371|||Cohort||Prospective|||||||
1383854|NCT02503358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383855|NCT02503345|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1383856|NCT02503332|Randomized|Single Group Assignment||Treatment||Single|||t|||
1383857|NCT02503319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383858|NCT02503306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383859|NCT02503293|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383860|NCT02503280|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383861|NCT02503267|||Case-Only||Cross-Sectional|||||||
1383862|NCT02503254|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1383863|NCT02503241|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Physiologic crossover study. There is no randomization. All participants will receive the same interventions in the same order.||||
1383864|NCT02503228||Single Group Assignment||Other||None (Open Label)||||||
1383865|NCT02503215||Single Group Assignment||Treatment||None (Open Label)||||||
1383866|NCT02503202|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1383867|NCT02503189||||||||||||
1383868|NCT02503176||||||||||||
1383869|NCT02503163||||||||||||
1383870|NCT02503150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383871|NCT02503137|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1383872|NCT02503124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383873|NCT02503111|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1383874|NCT02503098|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383875|NCT02503085|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1383876|NCT02503072|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1383877|NCT02503059|||Case-Only||Retrospective|||||||
1383878|NCT02503046|||Case Control||Retrospective|||||||
1383879|NCT02503033||Single Group Assignment||Treatment||None (Open Label)||||||
1383880|NCT02503020|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1383881|NCT02503007|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1383882|NCT02502994||Single Group Assignment||Treatment||None (Open Label)||||||
1383883|NCT02502981||Single Group Assignment||Treatment||None (Open Label)||||||
1383884|NCT02502968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383885|NCT02502955|||Case-Only||Prospective|||||||
1383886|NCT02502942|Randomized|Factorial Assignment||Treatment||Single|||t|||
1383887|NCT02502929|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383888|NCT02502916|||Cohort||Prospective|||||||
1383889|NCT02502903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383890|NCT02502890|||Case-Control||Prospective|||||||
1383891|NCT02502877|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1383892|NCT02502864||Single Group Assignment||Treatment||None (Open Label)||||||
1383893|NCT02502851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383894|NCT02502838|||Cohort||Prospective|||||||
1383895|NCT02502825|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1383896|NCT02502812|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1383897|NCT02502799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383898|NCT02502786||Single Group Assignment||Treatment||None (Open Label)||||||
1383899|NCT02502773|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383900|NCT02502760|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1383901|NCT02502747|Randomized|Parallel Assignment||Treatment||Single||||||t
1383902|NCT02502734|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1383903|NCT02502721|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383904|NCT02502708|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383905|NCT02502695|||Cohort||Prospective|||||||
1383906|NCT02502682|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383907|NCT02502669|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1383908|NCT02502656|||Cohort||Prospective|||||||
1383909|NCT02502643|Randomized|Parallel Assignment||Treatment||Single||||||t
1383910|NCT02502630||Single Group Assignment||Treatment||None (Open Label)||||||
1383911|NCT02502617|||Case-Only||Prospective|||||||
1383912|NCT02502604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383913|NCT02502591|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1383914|NCT02502578||Single Group Assignment||Treatment||None (Open Label)||||||
1383915|NCT02502565|||Cohort||Prospective|||||||
1383916|NCT02502552|||Cohort||Prospective|||||||
1383917|NCT02502539||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383918|NCT02502526|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383919|NCT02502513|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383920|NCT02502500|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1383921|NCT02502487|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1383922|NCT02502474||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383923|NCT02502461|Randomized|Parallel Assignment||Prevention||Single|||t|||
1383924|NCT02502448|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1383925|NCT02502435|||Case-Control||Prospective|||||||
1383926|NCT02502422||Single Group Assignment||Screening||None (Open Label)||||||
1383927|NCT02502409|||Other||Prospective|||||||
1383928|NCT02502396|||Cohort||Retrospective|||||||
1383929|NCT02502383|Randomized|Parallel Assignment||Prevention||Single|||t|||
1383930|NCT02502370|Randomized|Parallel Assignment||||None (Open Label)||||||
1383931|NCT02502357|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1383932|NCT02502344|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1383933|NCT02502331|Randomized|Parallel Assignment||Prevention||Single|||t|||
1383934|NCT02502318|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1383935|NCT02502305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383936|NCT02502292||Single Group Assignment||Prevention||None (Open Label)||||||
1383937|NCT02502279|Randomized|Parallel Assignment||Treatment||Double||||t||t
1383938|NCT02502266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383939|NCT02502253|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383940|NCT02502240|||Case-Only||Other|||||||
1383941|NCT02502227|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1383942|NCT02502214|||Other||Prospective|||||||
1383943|NCT02502201|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1383944|NCT02502188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383945|NCT02502175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383946|NCT02502162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383947|NCT02502149|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1383948|NCT02502136|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1383949|NCT02502123|||Cohort||Prospective|||||||
1383950|NCT02502110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383951|NCT02502097|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1383952|NCT02502084||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383953|NCT02502071||Single Group Assignment||Treatment||None (Open Label)||||||
1383954|NCT02502058|||Case-Only||Prospective|||||||
1383955|NCT02502045|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1383956|NCT02502032|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1383957|NCT02502019||Single Group Assignment||Treatment||None (Open Label)||||||
1383958|NCT02502006|Randomized|Crossover Assignment||Other||Double|||t||t|
1383959|NCT02501993|||Cohort||Prospective|||||||
1383960|NCT02501980|||Cohort||Prospective|||||||
1383961|NCT02501967|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1383962|NCT02501954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383963|NCT02501941|Randomized|Crossover Assignment||Treatment||Single||||||t
1383964|NCT02501928|Non-Randomized|||Treatment||None (Open Label)||||||
1383965|NCT02501915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383966|NCT02501902||||Treatment||None (Open Label)||||||
1383967|NCT02501889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383968|NCT02501876|||Case-Control||Other|||||||
1383969|NCT02501863|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1383970|NCT02501850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383971|NCT02501837|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1383972|NCT02501824|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383973|NCT02501811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383974|NCT02501798|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1383975|NCT02501785|||Cohort||Prospective|||||||
1383976|NCT02501772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1383977|NCT02501759||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383978|NCT02501746|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1383979|NCT02501733||Single Group Assignment||Treatment||None (Open Label)||||||
1383980|NCT02501720|Randomized|Parallel Assignment||Treatment||Single||||||t
1383981|NCT02501707|||Cohort||Prospective|||||||
1383982|NCT02501694|||Cohort||Prospective|||||||
1383983|NCT02501681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383984|NCT02501668|||Case Control||Retrospective|||||||
1383985|NCT02501655|Randomized|Crossover Assignment||Treatment||Single||||||t
1383986|NCT02501642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383987|NCT02501629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1383988|NCT02501616|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1383989|NCT02501603||Single Group Assignment||Treatment||None (Open Label)||||||
1383990|NCT02501590|||Case-Control||Cross-Sectional|||||||
1383991|NCT02501577|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1383992|NCT02501564|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1383993|NCT02501551||Single Group Assignment||Treatment||None (Open Label)||||||
1383994|NCT02501538||Single Group Assignment||Treatment||None (Open Label)||||||
1383995|NCT02501525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1383996|NCT02501512|||Case-Only||Prospective|||||||
1383997|NCT02501499|||Case-Only||Retrospective|||||||
1383998|NCT02501486||Single Group Assignment||Diagnostic||None (Open Label)||||||
1383999|NCT02501473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384000|NCT02501460|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1384001|NCT02501447|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384002|NCT02501434|Randomized|Parallel Assignment||Treatment||Single||||||t
1384003|NCT02501421|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1384004|NCT02501408|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384005|NCT02501395|||Case-Control||Cross-Sectional|||||||
1384006|NCT02501382|||Cohort||Prospective|||||||
1384007|NCT02501369||Single Group Assignment||Supportive Care||None (Open Label)||||||
1384008|NCT02501356|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1384009|NCT02501343|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1384010|NCT02501330|||Case-Only||Prospective|||||||
1384011|NCT02501317|Randomized|Parallel Assignment||Treatment||Single||||||t
1384012|NCT02501304||Single Group Assignment||Treatment||None (Open Label)||||||
1384013|NCT02501291||Single Group Assignment||Treatment||None (Open Label)||||||
1384014|NCT02501278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384015|NCT02501265|Randomized|Parallel Assignment||Treatment||Quadruple||The study (N=300) is a double-blinded randomized placebo-controlled trial designed to compare biochemically-confirmed abstinence rates in smokers randomized to Varenicline Adaptive Protocol vs. Varenicline (N=150) and for comparison, Nicotine Patch Adaptive Protocol vs. Nicotine Patch (N=150).|t|t|t|t
1384016|NCT02501252|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1384017|NCT02501239|Randomized|Parallel Assignment||Treatment||Single||||||t
1384018|NCT02501226|Randomized|Parallel Assignment||Treatment||Single||||||t
1384019|NCT02501213|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384020|NCT02501200|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384021|NCT02501187|Randomized|Parallel Assignment||Treatment||Single||||||t
1384022|NCT02501174|||Case-Only|||||||||
1384023|NCT02501161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384024|NCT02501148|||Cohort||Prospective|||||||
1384025|NCT02501135|||Cohort||Retrospective|||||||
1384026|NCT02501122|||Cohort||Retrospective|||||||
1384027|NCT02501109|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384028|NCT02501096||Single Group Assignment||Treatment||None (Open Label)||||||
1384029|NCT02501083|||Case-Only||Retrospective|||||||
1384030|NCT02501070|||Cohort||Retrospective|||||||
1384031|NCT02501057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384032|NCT02501044|||Cohort||Retrospective|||||||
1384033|NCT02501031|Randomized|Parallel Assignment||Prevention||Single||||||t
1384034|NCT02501018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384035|NCT02501005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384036|NCT02500992|||Case Control||Prospective|||||||
1384037|NCT02500979|Randomized|Crossover Assignment||Treatment||Single|||t|||
1384038|NCT02500966|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384039|NCT02500953|Randomized|Single Group Assignment||||Triple|||t|t|t|
1384040|NCT02500940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384041|NCT02500927||Single Group Assignment||Treatment||None (Open Label)||||||
1384042|NCT02500914||Single Group Assignment||Treatment||None (Open Label)||||||
1384043|NCT02500901||Single Group Assignment||Treatment||None (Open Label)||||||
1384044|NCT02500888||Single Group Assignment||Treatment||None (Open Label)||||||
1384045|NCT02500875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384046|NCT02500862|||Other||Other|||||||
1384047|NCT02500849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384048|NCT02500836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384049|NCT02500823|||Case Control||Retrospective|||||||
1384050|NCT02500810|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384051|NCT02500797|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384052|NCT02500784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384053|NCT02500771||Single Group Assignment||Treatment||None (Open Label)||||||
1384054|NCT02500758|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1384055|NCT02500745|||||Cross-Sectional|||||||
1384056|NCT02500732|Randomized|Parallel Assignment||Treatment||Quadruple|Study drug was encapsulated in opaque capsules by study personnel not involved in the day to day operations of the study.||t|t|t|t
1384057|NCT02500719|||Other||Cross-Sectional|||||||
1384058|NCT02500706|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384059|NCT02500693||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384060|NCT02500680|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1384061|NCT02500667||Single Group Assignment||Basic Science||None (Open Label)||||||
1384062|NCT02500654|Randomized|Parallel Assignment||Treatment||Single||||||t
1384063|NCT02500641|Randomized|Parallel Assignment||Treatment||Single||||||t
1384064|NCT02500628|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1384065|NCT02500615|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1384066|NCT02500602|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1384067|NCT02500589|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1384068|NCT02500576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384069|NCT02500563|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1384070|NCT02500550||Single Group Assignment||Prevention||None (Open Label)||||||
1384071|NCT02500537|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384072|NCT02500524|Randomized|Parallel Assignment||Treatment||Single||||||t
1384073|NCT02500511|||Case Control||Retrospective|||||||
1384074|NCT02500498|||Cohort||Retrospective|||||||
1384075|NCT02500485||Single Group Assignment||Treatment||None (Open Label)||||||
1384076|NCT02500472||Single Group Assignment||Basic Science||None (Open Label)||||||
1384077|NCT02500459||Single Group Assignment||Treatment||None (Open Label)||||||
1384078|NCT02500446|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384079|NCT02500433|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384080|NCT02500420||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384081|NCT02500407|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1384082|NCT02500394|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384157|NCT02499419|||Case Control||Prospective|||||||
1384083|NCT02500381|Randomized|Parallel Assignment||Treatment||Quadruple|Part 1 is double-blind and randomized; Part 2 is open-label.||t|t|t|t
1384084|NCT02500368|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1384085|NCT02500355|Randomized|Crossover Assignment||Treatment||Single|||t|||
1384086|NCT02500342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384087|NCT02500329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384088|NCT02500316||Single Group Assignment||Treatment||None (Open Label)||||||
1384089|NCT02500303|||Cohort||Prospective|||||||
1384090|NCT02500290|||Cohort||Prospective|||||||
1384091|NCT02500277|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1384092|NCT02500264|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384093|NCT02500251|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384094|NCT02500238|||Ecologic or Community||Cross-Sectional|||||||
1384095|NCT02500225|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1384096|NCT02500212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384097|NCT02500199||Single Group Assignment||Treatment||None (Open Label)||||||
1384098|NCT02500186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384099|NCT02500173|||Other||Prospective|||||||
1384100|NCT02500160|Randomized|Parallel Assignment||Treatment||Single||||||t
1384101|NCT02500147|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384102|NCT02500134|||Case-Only||Cross-Sectional|||||||
1384103|NCT02500121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384104|NCT02500108|||Cohort||Retrospective|||||||
1384105|NCT02500095|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1384106|NCT02500082||||||||||||
1384107|NCT02500069|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1384108|NCT02500056|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384109|NCT02500043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384110|NCT02500030|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384111|NCT02500017|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384112|NCT02500004|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1384113|NCT02499991|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384114|NCT02499978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384115|NCT02499965|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1384116|NCT02499952||Single Group Assignment||Treatment||None (Open Label)||||||
1384117|NCT02499939|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1384118|NCT02499926||Single Group Assignment||Basic Science||None (Open Label)||||||
1384119|NCT02499913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384120|NCT02499900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384121|NCT02499887|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1384122|NCT02499874||Single Group Assignment||Treatment||None (Open Label)||||||
1384123|NCT02499861||Single Group Assignment||Treatment||None (Open Label)||||||
1384124|NCT02499848||Single Group Assignment||Treatment||None (Open Label)||||||
1384125|NCT02499835|Randomized|Parallel Assignment||Treatment||None (Open Label)||Once at least 12 subjects per arm are accrued to Arms 1 and 2, and Arm 3 is open to accrual, accrual will occur only to Arm 3 (other arms will be closed). Extended treatment Arm 4 will open only when Arm 3 has met accrual.||||
1384126|NCT02499822|Randomized|Parallel Assignment||Treatment||Single||||||t
1384127|NCT02499809|Randomized|Crossover Assignment||Basic Science||Single||||||t
1384128|NCT02499796||Single Group Assignment||Other||None (Open Label)||||||
1384129|NCT02499783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384130|NCT02499770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384131|NCT02499757|Non-Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1384132|NCT02499744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384133|NCT02499731|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384134|NCT02499718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384135|NCT02499705|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1384136|NCT02499692||Single Group Assignment||Treatment||None (Open Label)||||||
1384137|NCT02499679|||Case-Only||Prospective|||||||
1384138|NCT02499666|||Cohort||Prospective|||||||
1384139|NCT02499653|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384140|NCT02499640|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384141|NCT02499627||Single Group Assignment||Treatment||None (Open Label)||||||
1384142|NCT02499614|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384143|NCT02499601||Single Group Assignment||Treatment||None (Open Label)||||||
1384144|NCT02499588|||Cohort||Prospective|||||||
1384145|NCT02499575|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1384146|NCT02499562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384147|NCT02499549|Randomized|Parallel Assignment||Treatment||Single||||||t
1384148|NCT02499536||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384149|NCT02499523|Randomized|Parallel Assignment||Treatment||Single||||||t
1384150|NCT02499510||Single Group Assignment||Treatment||None (Open Label)||||||
1384151|NCT02499497|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1384152|NCT02499484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384153|NCT02499471|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1384154|NCT02499458|||Cohort||Prospective|||||||
1384155|NCT02499445|Randomized|Parallel Assignment||Treatment||Single||||||t
1384156|NCT02499432|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1384158|NCT02499406||Single Group Assignment||Treatment||None (Open Label)||||||
1384159|NCT02499393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384160|NCT02499380|||Cohort||Prospective|||||||
1384161|NCT02499367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384162|NCT02499354|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384163|NCT02499341|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384164|NCT02499328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384165|NCT02499315|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384166|NCT02499302|Randomized|Parallel Assignment||Treatment||Single||||||t
1384167|NCT02499289|||Cohort||Prospective|||||||
1384168|NCT02499276||Single Group Assignment||Treatment||None (Open Label)||||||
1384169|NCT02499263|||Case-Only||Prospective|||||||
1384170|NCT02499250|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384171|NCT02499237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384172|NCT02499224||Single Group Assignment||Treatment||None (Open Label)||||||
1384173|NCT02499211|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1384174|NCT02499198|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1384175|NCT02499185|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1384176|NCT02499172|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384177|NCT02499159|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384178|NCT02499146||||Other||None (Open Label)||||||
1384179|NCT02499133|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1384180|NCT02499120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384181|NCT02499107|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1384182|NCT02499094|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1384183|NCT02499081||Single Group Assignment||Treatment||None (Open Label)||||||
1384184|NCT02499068|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384185|NCT02499055|Randomized|Parallel Assignment||Treatment||Single||||||t
1384186|NCT02499042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384187|NCT02499029|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1384188|NCT02499016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384189|NCT02499003||Single Group Assignment||Treatment||None (Open Label)||||||
1384190|NCT02498990||Single Group Assignment||Treatment||None (Open Label)||||||
1384191|NCT02498977|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1384192|NCT02498964|||Other||Prospective|||||||
1384193|NCT02498951|Randomized|Parallel Assignment||Treatment||Single||||||t
1384194|NCT02498938|||Case Control||Retrospective|||||||
1384195|NCT02498925||Single Group Assignment||Treatment||None (Open Label)||||||
1384196|NCT02498912||Single Group Assignment||Treatment||None (Open Label)||||||
1384197|NCT02498899|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1384198|NCT02498886|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1384199|NCT02498873|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384200|NCT02498860||Single Group Assignment||Treatment||None (Open Label)||||||
1384201|NCT02498847|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1384202|NCT02498834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384203|NCT02498821|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1384204|NCT02498808|||Case-Control||Prospective|||||||
1384205|NCT02498795|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384206|NCT02498782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384207|NCT02498769|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1384208|NCT02498756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384209|NCT02498743|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1384210|NCT02498730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384211|NCT02498717|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384212|NCT02498704|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384213|NCT02498691|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1384214|NCT02498678|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384215|NCT02498665|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384216|NCT02498652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384217|NCT02498639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384218|NCT02498626|||Case-Only||Prospective|||||||
1384219|NCT02498613||Single Group Assignment||Treatment||None (Open Label)||||||
1384220|NCT02498600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384221|NCT02498587|||Cohort||Prospective|||||||
1384222|NCT02498574|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1384223|NCT02498561|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1384224|NCT02498548|Randomized|Parallel Assignment||Treatment||Single||||||t
1384225|NCT02498535|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384226|NCT02498522|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384227|NCT02498509|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384228|NCT02498496|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1384229|NCT02498483|Randomized|Single Group Assignment||Treatment||Double||||t||t
1384230|NCT02498470|||Cohort||Prospective|||||||
1384231|NCT02498457|Randomized|Parallel Assignment||Prevention||Single|||t|||
1384232|NCT02498444|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385610|NCT02480452|||Cohort|||||||||
1384233|NCT02498431|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1384234|NCT02498418|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384235|NCT02498405|||Case-Only||Prospective|||||||
1384236|NCT02498392|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384237|NCT02498379||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384238|NCT02498366||Single Group Assignment||Basic Science||None (Open Label)||||||
1384239|NCT02498353|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384240|NCT02498340||Single Group Assignment||Treatment||None (Open Label)||||||
1384241|NCT02498327|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1384242|NCT02498314|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384243|NCT02498301|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1384244|NCT02498288||Single Group Assignment||Treatment||None (Open Label)||||||
1384245|NCT02498275|||Case Control||Cross-Sectional|||||||
1384246|NCT02498262||Single Group Assignment||Other||None (Open Label)||||||
1384247|NCT02498249|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1384248|NCT02498236|Randomized|Crossover Assignment||Other||Triple|||t|t||t
1384249|NCT02498223||Single Group Assignment||Prevention||None (Open Label)||||||
1384250|NCT02498210||Single Group Assignment||Treatment||None (Open Label)||||||
1384251|NCT02498197|Randomized|Parallel Assignment||Prevention||Single||||||t
1384252|NCT02498184|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1384253|NCT02498171|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1384254|NCT02498158|||Cohort||Prospective|||||||
1384255|NCT02498145|Randomized|Parallel Assignment||Other||Double|||t||t|
1384256|NCT02498132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384257|NCT02498119|||||Prospective|||||||
1384258|NCT02498106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384259|NCT02498093|Randomized|Parallel Assignment||Treatment||Single||||t||
1384260|NCT02498080|Randomized|Parallel Assignment||Treatment||Single||||||t
1384261|NCT02498067||Single Group Assignment||Prevention||None (Open Label)||||||
1384262|NCT02498054||Single Group Assignment||Basic Science||None (Open Label)||||||
1384263|NCT02498041|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1384264|NCT02498028|||Case-Only||Prospective|||||||
1384265|NCT02498015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384266|NCT02498002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384267|NCT02497989|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1384268|NCT02497976|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384269|NCT02497963|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384270|NCT02497950|||Other||Prospective|||||||
1384271|NCT02497937|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1384272|NCT02497924||Single Group Assignment||Other||None (Open Label)||||||
1384273|NCT02497911|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384274|NCT02497898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384275|NCT02497885|||Cohort||Prospective|||||||
1384276|NCT02497872|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384277|NCT02497859|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384278|NCT02497846||Single Group Assignment||Treatment||None (Open Label)||||||
1384279|NCT02497833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384280|NCT02497820|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1384281|NCT02497807|||Case Control||Cross-Sectional|||||||
1384282|NCT02497794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384283|NCT02497781|Randomized|Parallel Assignment||Treatment||Single||||||t
1384284|NCT02497768||Single Group Assignment||||None (Open Label)||||||
1384285|NCT02497755||Single Group Assignment||Treatment||None (Open Label)||||||
1384286|NCT02497742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384287|NCT02497729|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384288|NCT02497716||Single Group Assignment||Other||None (Open Label)||||||
1384289|NCT02497703||Single Group Assignment||Treatment||None (Open Label)||||||
1384290|NCT02497690|Non-Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1384291|NCT02497677|Randomized|Parallel Assignment||Prevention||Single||||||t
1384292|NCT02497664||Single Group Assignment||Prevention||None (Open Label)||||||
1384293|NCT02497651|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1384294|NCT02497638|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384295|NCT02497625|Randomized|Parallel Assignment||Treatment||Single||||||t
1384296|NCT02497612|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384297|NCT02497599||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384298|NCT02497586||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384299|NCT02497573|||Cohort||Prospective|||||||
1384300|NCT02497560|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1384301|NCT02497547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384302|NCT02497534|||Case-Control||Cross-Sectional|||||||
1384303|NCT02497521|||Case-Only||Prospective|||||||
1384304|NCT02497508||Single Group Assignment||Treatment||None (Open Label)||||||
1384305|NCT02497495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384306|NCT02497469|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384307|NCT02497456|Randomized|Parallel Assignment||||None (Open Label)||||||
1384308|NCT02497443|Randomized|Parallel Assignment||Treatment||Single|Masking was specified as Opel Label study in old format||||t|
1384309|NCT02497430|||Case-Only||Prospective|||||||
1384310|NCT02497417|||Case-Only||Prospective|||||||
1384311|NCT02497404||Single Group Assignment||Treatment||None (Open Label)||||||
1384312|NCT02497391|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1384313|NCT02497378||Single Group Assignment||Treatment||None (Open Label)||||||
1384314|NCT02497365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384315|NCT02497352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384316|NCT02497339|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1384317|NCT02497326|Randomized|Parallel Assignment||Treatment||Single||||||t
1384318|NCT02497313|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1384319|NCT02497300|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1384320|NCT02497287||Single Group Assignment||Treatment||None (Open Label)||||||
1384321|NCT02497274|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1384322|NCT02497261|||Cohort||Prospective|||||||
1384323|NCT02497248|||Cohort||Prospective|||||||
1384324|NCT02497235||Single Group Assignment||Other||None (Open Label)||||||
1384325|NCT02497222|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1384326|NCT02497209|||Cohort|||||||||
1384327|NCT02497196|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1384328|NCT02497183||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384329|NCT02497170||Single Group Assignment||Supportive Care||None (Open Label)||||||
1384330|NCT02497157||Single Group Assignment||Treatment||None (Open Label)||||||
1384331|NCT02497144|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1384332|NCT02497131||Single Group Assignment||Treatment||None (Open Label)||||||
1384333|NCT02497118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384334|NCT02497105|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384335|NCT02497092|Randomized|Parallel Assignment||||Single|||t|||
1384336|NCT02497079|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1384337|NCT02497066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384338|NCT02497053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384339|NCT02497040|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1384340|NCT02497027|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1384341|NCT02497014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384342|NCT02497001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384343|NCT02496988|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1384344|NCT02496975|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384345|NCT02496962|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384346|NCT02496949||Single Group Assignment||Treatment||None (Open Label)||||||
1384347|NCT02496936|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1384348|NCT02496923|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384349|NCT02496910|Randomized|Crossover Assignment||||None (Open Label)||||||
1384350|NCT02496897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384351|NCT02496884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384352|NCT02496871|Randomized|Parallel Assignment||Treatment||Single||||||t
1384353|NCT02496858|||Case-Crossover||Cross-Sectional|||||||
1384354|NCT02496845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384355|NCT02496832||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384356|NCT02496819|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1384357|NCT02496806||Single Group Assignment||Basic Science||None (Open Label)||||||
1384358|NCT02496793|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1384359|NCT02496780|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384360|NCT02496767|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384361|NCT02496754|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384362|NCT02496741||Single Group Assignment||Treatment||None (Open Label)||||||
1384363|NCT02496728|Randomized|Parallel Assignment||Prevention||Single||||||t
1384364|NCT02496715|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384365|NCT02496702|Randomized|Parallel Assignment||Prevention||Single||||||t
1384366|NCT02496689||||||||||||
1384367|NCT02496676|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1384368|NCT02496663||Single Group Assignment||Treatment||None (Open Label)||||||
1384369|NCT02496650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384370|NCT02496637|Randomized|Parallel Assignment||Prevention||Single||||||t
1384371|NCT02496624||Single Group Assignment||Other||None (Open Label)||||||
1384372|NCT02496611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384373|NCT02496598||Single Group Assignment||Treatment||None (Open Label)||||||
1384374|NCT02496585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384375|NCT02496572|||Cohort||Prospective|||||||
1384376|NCT02496559|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1384377|NCT02496546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384378|NCT02496533|Randomized|Parallel Assignment||Prevention||Single|||t|||
1384379|NCT02496520||Single Group Assignment||Treatment||None (Open Label)||||||
1384380|NCT02496507|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1384381|NCT02496494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384382|NCT02496481|Randomized|Factorial Assignment||Prevention||Single||||||t
1384383|NCT02496468|||Cohort||Prospective|||||||
1384384|NCT02496455|||Cohort||Prospective|||||||
1384385|NCT02496442|Randomized|Parallel Assignment||||None (Open Label)||||||
1384386|NCT02496429||Single Group Assignment||Supportive Care||None (Open Label)||||||
1384387|NCT02496416|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1384388|NCT02496403|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1384389|NCT02496390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384390|NCT02496377|Randomized|Parallel Assignment||||Single|||||t|
1384391|NCT02496364|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1384392|NCT02496351|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1384393|NCT02496338|Randomized|Parallel Assignment||||Single|||t|||
1384394|NCT02496325||Single Group Assignment||||None (Open Label)||||||
1384395|NCT02496312||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384396|NCT02496299|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1384397|NCT02496286||Single Group Assignment||Treatment||||||||
1384398|NCT02496273||Single Group Assignment||Treatment||None (Open Label)||||||
1384399|NCT02496260|||Case-Only||Prospective|||||||
1384400|NCT02496247|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384401|NCT02496234|||Cohort||Prospective|||||||
1384402|NCT02496221|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1384403|NCT02496208|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384404|NCT02496182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384405|NCT02496169|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384406|NCT02496156|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||2 group (Usual Clinical Practice or Shared Medical Decision Making X 5 time points (0, 3, 6, 9 and 12 months) repeated measures randomized treatments design.||||
1384407|NCT02496143|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1384408|NCT02496130|||Cohort||Prospective|||||||
1384409|NCT02496117|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384410|NCT02496104|||Cohort||Prospective|||||||
1384411|NCT02496091|||Cohort||Cross-Sectional|||||||
1384412|NCT02496078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384413|NCT02496065||Single Group Assignment||Other||None (Open Label)||||||
1384414|NCT02496052|Randomized|Parallel Assignment||Prevention||Single|||t|||
1384415|NCT02496039||Single Group Assignment||Other||None (Open Label)||||||
1384416|NCT02496026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384417|NCT02496013||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384418|NCT02496000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384419|NCT02495987|||||Prospective|||||||
1384420|NCT02495974|||Case-Only||Prospective|||||||
1384421|NCT02495961|||Cohort||Prospective|||||||
1384422|NCT02495948|Randomized|Crossover Assignment||||Single|||t|||
1384423|NCT02495935|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384424|NCT02495922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384425|NCT02495909|||Cohort||Prospective|||||||
1384426|NCT02495896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384427|NCT02495883|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1384428|NCT02495870|Randomized|Crossover Assignment||Prevention||Single|||t|||
1384429|NCT02495857|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384430|NCT02495844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384431|NCT02495831|Randomized|Crossover Assignment||||None (Open Label)||||||
1384432|NCT02495818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384433|NCT02495805|Randomized|Parallel Assignment||Treatment||Single||||||t
1384434|NCT02495792|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1384435|NCT02495779||Single Group Assignment||Prevention||None (Open Label)||||||
1384436|NCT02495766|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1384437|NCT02495753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384438|NCT02495740|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384439|NCT02495727|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1384440|NCT02495714|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384441|NCT02495701|||Cohort||Prospective|||||||
1384442|NCT02495688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384443|NCT02495675|Randomized|Crossover Assignment||Treatment||Single|||t|||
1384444|NCT02495662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384445|NCT02495649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384446|NCT02495636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384447|NCT02495623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384448|NCT02495610||Single Group Assignment||Basic Science||None (Open Label)||||||
1384449|NCT02495597|||Case Control||Prospective|||||||
1384450|NCT02495584|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1384451|NCT02495571|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1384452|NCT02495558||Single Group Assignment||||None (Open Label)||||||
1384453|NCT02495545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384454|NCT02495532|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1384455|NCT02495519||Single Group Assignment||Treatment||None (Open Label)||||||
1384456|NCT02495506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384457|NCT02495493||Single Group Assignment||Treatment||None (Open Label)||||||
1384458|NCT02495480|Randomized|Parallel Assignment||Screening||Single|||t|||
1384459|NCT02495467|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1384460|NCT02495454||Single Group Assignment||Treatment||None (Open Label)||||||
1384461|NCT02495441|||Case-Only||Prospective|||||||
1384462|NCT02495428|Randomized|Parallel Assignment||Treatment||Single|||||t|
1384463|NCT02495415||Single Group Assignment||Treatment||None (Open Label)||||||
1384464|NCT02495402|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1384465|NCT02495389||Single Group Assignment||Treatment||None (Open Label)||||||
1384466|NCT02495376|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384467|NCT02495363|||Case-Only||Prospective|||||||
1384468|NCT02495350|||Other||Prospective|||||||
1384469|NCT02495337|||Cohort||Prospective|||||||
1384470|NCT02495324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384471|NCT02495311|||Case-Control||Prospective|||||||
1384472|NCT02495298|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384473|NCT02495285|||Cohort||Prospective|||||||
1384474|NCT02495272|Randomized|Parallel Assignment||Prevention||Single|||||t|
1384475|NCT02495259|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1384476|NCT02495246|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384477|NCT02495233|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384478|NCT02495220|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1384479|NCT02495207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384480|NCT02495194|Randomized|Parallel Assignment||||Single||||||t
1384481|NCT02495181|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384482|NCT02495168|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384483|NCT02495155|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384484|NCT02495142|||Cohort||Prospective|||||||
1384485|NCT02495129|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384486|NCT02495116||||||||||||
1384487|NCT02495103|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1384488|NCT02495090||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384489|NCT02495077|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384490|NCT02495064|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1384491|NCT02495051|||Cohort||Prospective|||||||
1384492|NCT02495038|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384493|NCT02495025|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Participants were randomized individually at the time of enrollment, to receive either telephone-based developmental screening and care coordination, through 2-1-1 Los Angeles, in addition to usual care, or usual care alone. Primary outcomes were measured at 6 months after enrollment.||||
1384494|NCT02495012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384495|NCT02494999|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1384496|NCT02494986||Single Group Assignment||Treatment||None (Open Label)||||||
1384497|NCT02494973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384498|NCT02494960|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1384499|NCT02494947|Randomized|Parallel Assignment||Treatment||Single||||||t
1384500|NCT02494934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384501|NCT02494921|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384502|NCT02494908|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1384503|NCT02494895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384504|NCT02494882||Single Group Assignment||Treatment||None (Open Label)||||||
1384505|NCT02494869|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384506|NCT02494856|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1384507|NCT02494843|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1384508|NCT02494830|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384509|NCT02494817|Randomized|Parallel Assignment||Prevention||Single|||t|||
1384510|NCT02494804|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1384511|NCT02494791||Single Group Assignment||Screening||None (Open Label)||||||
1384512|NCT02494778||Single Group Assignment||Treatment||None (Open Label)||||||
1384513|NCT02494765|Randomized|Parallel Assignment||||Single|||t|||
1384514|NCT02494752|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1384515|NCT02494739|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1384516|NCT02494726|||Case Control||Prospective|||||||
1384517|NCT02494713||Single Group Assignment||Treatment||None (Open Label)||||||
1384518|NCT02494700||Single Group Assignment||Treatment||None (Open Label)||||||
1384519|NCT02494687||||||||||||
1384520|NCT02494674||Single Group Assignment||Treatment||None (Open Label)||||||
1384521|NCT02494661|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384522|NCT02494648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384523|NCT02494635|||Case-Only||Prospective|||||||
1384524|NCT02494622|||||Retrospective|||||||
1384525|NCT02494609|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384526|NCT02494596|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384527|NCT02494583|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384528|NCT02494570||Single Group Assignment||Treatment||None (Open Label)||||||
1384529|NCT02494557|||Case-Control||Prospective|||||||
1384530|NCT02494544|Non-Randomized|Sequential Assignment||Basic Science||Single|Site staff that is performing functional testing on subject is blinded to what implant the patient has.|||||t
1384531|NCT02494531||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384532|NCT02494518|Randomized|Parallel Assignment||Treatment||Single||||||t
1384533|NCT02494505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384534|NCT02494492||Single Group Assignment||Treatment||None (Open Label)||||||
1384535|NCT02494479|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384536|NCT02494466|Randomized|Crossover Assignment||Prevention||Single||||||t
1384537|NCT02494453||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384538|NCT02494440|||Cohort||Prospective|||||||
1384539|NCT02494427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384540|NCT02494414|||Cohort||Prospective|||||||
1384541|NCT02494401|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1384542|NCT02494388|||Cohort||Other|||||||
1384543|NCT02494375||Single Group Assignment||Basic Science||None (Open Label)||||||
1384544|NCT02494362||Single Group Assignment||Treatment||None (Open Label)||||||
1384545|NCT02494349|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384546|NCT02494336|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1384547|NCT02494323||Single Group Assignment||Treatment||None (Open Label)||||||
1384548|NCT02494310|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384549|NCT02494297|||||Cross-Sectional|||||||
1384550|NCT02494284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384551|NCT02494271|||Case Control||Retrospective|||||||
1384552|NCT02494258||Single Group Assignment||Treatment||None (Open Label)||||||
1384553|NCT02494245|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1384554|NCT02494232|||Cohort||Prospective|||||||
1384555|NCT02494219||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384556|NCT02494206||Single Group Assignment||Treatment||None (Open Label)||||||
1384557|NCT02494193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384558|NCT02494180|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1384559|NCT02494167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384560|NCT02494154|Randomized|Crossover Assignment||Treatment||Single|||t|||
1384561|NCT02494141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384562|NCT02494128|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1384563|NCT02494115||Single Group Assignment||Treatment||None (Open Label)||||||
1384564|NCT02494102|Randomized|Parallel Assignment||Treatment||Double|Computer generated randomization list, subject, clinical team and research team blinded to intervention|double blind randomized placebo controlled trial|t||t|
1384565|NCT02494089|||Case-Only||Prospective|||||||
1384566|NCT02494076|Randomized|Parallel Assignment||Treatment||Single||||||t
1384567|NCT02494063|||Cohort||Prospective|||||||
1384568|NCT02494050|Randomized|Parallel Assignment||Treatment||Single||||||t
1384569|NCT02494037|||Case-Only||Prospective|||||||
1384570|NCT02494024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384571|NCT02494011|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384572|NCT02493998|||Case-Only||Prospective|||||||
1384573|NCT02493985|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1384574|NCT02493972||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384575|NCT02493959||Single Group Assignment||Basic Science||Single|||t|||
1384576|NCT02493946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384577|NCT02493933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384578|NCT02493920|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384579|NCT02493907|||Cohort||Prospective|||||||
1384580|NCT02493894|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1384581|NCT02493881|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1384582|NCT02493868|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384583|NCT02493855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384584|NCT02493842||Single Group Assignment||Treatment||None (Open Label)||||||
1384585|NCT02493829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384586|NCT02493816||Single Group Assignment||Treatment||None (Open Label)||||||
1384587|NCT02493803|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1384588|NCT02493790|||Cohort||Prospective|||||||
1384589|NCT02493777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384590|NCT02493764|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384591|NCT02493751||||Treatment||None (Open Label)||||||
1384592|NCT02493738|Randomized|Crossover Assignment||||None (Open Label)||||||
1384593|NCT02493725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384594|NCT02493712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384595|NCT02493699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384596|NCT02493686|||Cohort||Retrospective|||||||
1384597|NCT02493673|Randomized|Parallel Assignment||Other||Double|||t|||t
1384598|NCT02493660|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384599|NCT02493647|Randomized|Parallel Assignment||Prevention||Single|||t|||
1384600|NCT02493634||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384601|NCT02493621|||Case Control||Retrospective|||||||
1384602|NCT02493608|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384603|NCT02493595|||Cohort||Prospective|||||||
1384604|NCT02493582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384605|NCT02493569|||Ecologic or Community||Retrospective|||||||
1384606|NCT02493556|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384607|NCT02493543|||Cohort||Prospective|||||||
1384608|NCT02493530||Single Group Assignment||Treatment||None (Open Label)||||||
1384609|NCT02493517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384610|NCT02493504|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384611|NCT02493491|||Cohort||Prospective|||||||
1384612|NCT02493478|||Case-Only||Prospective|||||||
1384613|NCT02493465||Single Group Assignment||||None (Open Label)||||||
1384614|NCT02493452|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384615|NCT02493439|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384616|NCT02493426|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1384617|NCT02493413|||Case Control||Prospective|||||||
1384618|NCT02493400|||Case-Control||Retrospective|||||||
1384619|NCT02493387|Randomized|Parallel Assignment||Treatment||Single|||||t|
1384620|NCT02493374|||Cohort||Prospective|||||||
1384621|NCT02493361||Single Group Assignment||Treatment||None (Open Label)||||||
1384622|NCT02493348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384623|NCT02493335|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384624|NCT02493322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384625|NCT02493309|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1384626|NCT02493296|||Cohort||Prospective|||||||
1384627|NCT02493283|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1384628|NCT02493270||Single Group Assignment||Treatment||None (Open Label)||||||
1384629|NCT02493257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384630|NCT02493244|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1384631|NCT02493231|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1384632|NCT02493218|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1384633|NCT02493205|||Case-Only||Prospective|||||||
1384634|NCT02493192|Randomized|Parallel Assignment||Treatment||Single||||t||
1384635|NCT02493179|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384636|NCT02493166|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1384637|NCT02493153|||Cohort||Prospective|||||||
1384638|NCT02493140|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1384639|NCT02493127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384640|NCT02493114|||Cohort||Prospective|||||||
1384641|NCT02493101|||Case Control||Cross-Sectional|||||||
1384642|NCT02493088|||Case-Only||Prospective|||||||
1384643|NCT02493075|Randomized|Parallel Assignment||Screening||Single|||||t|
1384644|NCT02493062||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384645|NCT02493049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384646|NCT02493036||Single Group Assignment||Treatment||None (Open Label)||Subjects from the study SB-2-010-001 (NCT02495623) were given either SYN-010 21 mg, SYN-010 42 mg, or Placebo. The subjects were offered the opportunity to roll over into SB-2-010-002 and receive SYN-010 42 mg. Some of the analyses were done from day one of SYN-010-001.||||
1384647|NCT02493023||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384648|NCT02493010|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384649|NCT02492997|Randomized|Parallel Assignment||Treatment||Single||||||t
1384650|NCT02492984||Single Group Assignment||Treatment||None (Open Label)||||||
1384651|NCT02492971|||Other||Cross-Sectional|||||||
1384652|NCT02492958|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1384653|NCT02492945|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384654|NCT02492932||Single Group Assignment||Supportive Care||Single||||||t
1384655|NCT02492919|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384656|NCT02492906|||Case Control||Cross-Sectional|||||||
1384657|NCT02492893|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384658|NCT02492880||Single Group Assignment||Basic Science||None (Open Label)||||||
1384659|NCT02492867||Single Group Assignment||Treatment||None (Open Label)||||||
1384660|NCT02492854|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384661|NCT02492841|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1384662|NCT02492828|||Cohort||Retrospective|||||||
1384663|NCT02492815|||Cohort||Retrospective|||||||
1384664|NCT02492802|||Cohort||Prospective|||||||
1384665|NCT02492789||Single Group Assignment||Treatment||None (Open Label)||||||
1384666|NCT02492776||Single Group Assignment||Treatment||None (Open Label)||||||
1384667|NCT02492763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384668|NCT02492750|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384669|NCT02492737||Single Group Assignment||Treatment||None (Open Label)||||||
1384670|NCT02492724|||Case-Only||Prospective|||||||
1384671|NCT02492711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384672|NCT02492698|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1384673|NCT02492685||Single Group Assignment||Treatment||None (Open Label)||||||
1384674|NCT02492672|||Other||Prospective|||||||
1384675|NCT02492659|Randomized|Single Group Assignment||Treatment||Single|||||t|
1384676|NCT02492646|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1384677|NCT02492633|Randomized|Parallel Assignment||Prevention||Single|||t|||
1384678|NCT02492620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384679|NCT02492607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384680|NCT02492594|||Case-Only||Prospective|||||||
1384681|NCT02492581|||Cohort||Prospective|||||||
1384682|NCT02492568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384683|NCT02492555|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1384684|NCT02492542|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384685|NCT02492529|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1384686|NCT02492516||Single Group Assignment||Treatment||None (Open Label)||||||
1384687|NCT02492503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384688|NCT02492490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384689|NCT02492477|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1384690|NCT02492464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384691|NCT02492451|Randomized|Parallel Assignment||Treatment||Single||||||t
1384692|NCT02492438|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384693|NCT02492425|||Cohort||Prospective|||||||
1384694|NCT02492412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384695|NCT02492399|Randomized|Crossover Assignment||Treatment||Single|||t|||
1384696|NCT02492386||Single Group Assignment||Treatment||None (Open Label)||||||
1384697|NCT02492373|Randomized|Parallel Assignment||Treatment||Single|||||t|
1384698|NCT02492360|||Case-Control||Prospective|||||||
1384699|NCT02492347|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1384700|NCT02492334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384701|NCT02492321|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384702|NCT02492308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384703|NCT02492295||Single Group Assignment||Treatment||None (Open Label)||||||
1384704|NCT02492282|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384705|NCT02492269|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1384706|NCT02492256|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384707|NCT02492243||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384708|NCT02492230|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384709|NCT02492217||Single Group Assignment||Treatment||None (Open Label)||||||
1384710|NCT02492204|||Cohort||Prospective|||||||
1384711|NCT02492191|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1384712|NCT02492178|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1384713|NCT02492165|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384714|NCT02492152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384715|NCT02492139||Crossover Assignment||Supportive Care||None (Open Label)||||||
1384716|NCT02492126|||Case-Only||Prospective|||||||
1384717|NCT02492113||Single Group Assignment||Treatment||None (Open Label)||||||
1384718|NCT02492100||Single Group Assignment||Supportive Care||None (Open Label)||||||
1384719|NCT02492087|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1384720|NCT02492074|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1384721|NCT02492061|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384722|NCT02492048|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384723|NCT02492035|Randomized|Factorial Assignment||Treatment||Single|||||t|
1384724|NCT02492022|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1384725|NCT02492009|Randomized|Parallel Assignment||Other||Single||||||t
1384726|NCT02491996||Single Group Assignment||Treatment||None (Open Label)||||||
1384727|NCT02491983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384728|NCT02491970|Randomized|Parallel Assignment||Treatment||Single||||||t
1384729|NCT02491957||Single Group Assignment||Supportive Care||None (Open Label)||||||
1384730|NCT02491944||Single Group Assignment||Treatment||None (Open Label)||||||
1384731|NCT02491931|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384732|NCT02491918|Randomized|Parallel Assignment||Prevention||Single|||t|||
1384733|NCT02491905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384734|NCT02491892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384735|NCT02491879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384736|NCT02491866||Single Group Assignment||Other||None (Open Label)||||||
1384737|NCT02491853|||Cohort||Prospective|||||||
1384738|NCT02491840||Single Group Assignment||Basic Science||None (Open Label)||||||
1384739|NCT02491827|||Cohort||Prospective|||||||
1384740|NCT02491814|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1384741|NCT02491801|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1384742|NCT02491788|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384743|NCT02491775|||Cohort||Other|||||||
1384744|NCT02491762|||Cohort||Prospective|||||||
1384745|NCT02491749|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384746|NCT02491736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384747|NCT02491723||Single Group Assignment||Treatment||None (Open Label)||||||
1384748|NCT02491710|Randomized|Parallel Assignment||Other||Single||||||t
1384749|NCT02491697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384750|NCT02491684|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1384751|NCT02491671|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384752|NCT02491658||Single Group Assignment||Treatment||None (Open Label)||||||
1384753|NCT02491645|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384754|NCT02491632|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1384755|NCT02491619||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384756|NCT02491606|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384757|NCT02491593|||Case-Control||Prospective|||||||
1384758|NCT02491580|||Case Control||Retrospective|||||||
1384759|NCT02491567|||Case Control||Cross-Sectional|||||||
1384760|NCT02491554|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1384761|NCT02491541|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1384762|NCT02491528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384763|NCT02491515|||Case-Only||Prospective|||||||
1384764|NCT02491502||Single Group Assignment||Treatment||None (Open Label)||||||
1384765|NCT02491489|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1384766|NCT02491476||Single Group Assignment||Basic Science||None (Open Label)||||||
1384767|NCT02491463|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1384768|NCT02491450|Randomized|Crossover Assignment||||None (Open Label)||||||
1384769|NCT02491437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384770|NCT02491424||Single Group Assignment||Treatment||None (Open Label)||||||
1384771|NCT02491411||Single Group Assignment||Treatment||None (Open Label)||||||
1384772|NCT02491398|||Cohort||Cross-Sectional|||||||
1384773|NCT02491385|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1384774|NCT02491372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384775|NCT02491359||Single Group Assignment||Treatment||None (Open Label)||||||
1384776|NCT02491346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384777|NCT02491333|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384778|NCT02491320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384779|NCT02491307|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384780|NCT02491294|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1384781|NCT02491281|Randomized|Single Group Assignment||Other||Triple|||t||t|t
1384782|NCT02491268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384783|NCT02491255||Single Group Assignment||Treatment||None (Open Label)||||||
1384784|NCT02491242|||Cohort||Prospective|||||||
1384785|NCT02491229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384786|NCT02491216|Randomized|Parallel Assignment||Treatment||Single||||||t
1384787|NCT02491203|Randomized|Parallel Assignment||Treatment||Single||||||t
1384788|NCT02491190|Randomized|Single Group Assignment||Health Services Research||Single|||||t|
1384789|NCT02491177|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1384790|NCT02491164||Single Group Assignment||Other||None (Open Label)||||||
1384791|NCT02491151|||Cohort||Prospective|||||||
1384792|NCT02491138|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384793|NCT02491125|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1384794|NCT02491099||Single Group Assignment||Treatment||None (Open Label)||||||
1384795|NCT02491086|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384796|NCT02491073|||Case-Control||Prospective|||||||
1384797|NCT02491060|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1384798|NCT02491047|Randomized|Parallel Assignment||Prevention||Single||"Subjects will be randomized into either Study investigational arm or Study control arm, using a 1:1 ratio. Randomization will be stratified by Gustilo classification (I and II; IIIA ; IIIB).~In the study treatment arm patients will receive BonyPid-1000 in addition to the standard of care treatment. in the control arm patients will receive the standard of care treatment alone."|t|||
1384799|NCT02491034||Single Group Assignment||Health Services Research||None (Open Label)||||||
1384800|NCT02491021|Randomized|Parallel Assignment||Treatment||Single||||||t
1384801|NCT02491008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384802|NCT02490995|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1384803|NCT02490982|||Cohort||Prospective|||||||
1384804|NCT02490969|||Case-Only||Prospective|||||||
1384805|NCT02490956||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384806|NCT02490943|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1384807|NCT02490930||Single Group Assignment||Other||None (Open Label)||||||
1384808|NCT02490917|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1384809|NCT02490904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384810|NCT02490891||Single Group Assignment||Other||None (Open Label)||||||
1384811|NCT02490878|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1384812|NCT02490865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384813|NCT02490852|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1384814|NCT02490839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384815|NCT02490826|Randomized|Parallel Assignment||Other||Single|||t|||
1384816|NCT02490813|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1384817|NCT02490800||Single Group Assignment||Treatment||None (Open Label)||||||
1384818|NCT02490787|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1384819|NCT02490774|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384820|NCT02490761|||Cohort||Prospective|||||||
1384821|NCT02490748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384822|NCT02490735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384823|NCT02490722|Randomized|Parallel Assignment||Treatment||Single|||||t|
1384824|NCT02490709||Single Group Assignment||Treatment||None (Open Label)||||||
1384825|NCT02490696|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1384826|NCT02490683|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1384827|NCT02490670|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1384828|NCT02490657|Randomized|Single Group Assignment||||Double|||t||t|
1384829|NCT02490644|||Case-Only||Prospective|||||||
1384830|NCT02490631|Randomized|Parallel Assignment||Prevention||Single||||||t
1384831|NCT02490618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384832|NCT02490605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384833|NCT02490592|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384834|NCT02490579|||Cohort||Prospective|||||||
1384835|NCT02490566||Single Group Assignment||Supportive Care||None (Open Label)||||||
1384836|NCT02490553|||||Cross-Sectional|||||||
1384837|NCT02490540|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384838|NCT02490527|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384839|NCT02490514|||Cohort|||||||||
1384840|NCT02490501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384841|NCT02490488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384842|NCT02490475|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384843|NCT02490462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384844|NCT02490449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384845|NCT02490436|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1384846|NCT02490423|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384847|NCT02490410|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1384848|NCT02490397|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384849|NCT02490384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384850|NCT02490371|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384851|NCT02490358|||||Cross-Sectional|||||||
1384852|NCT02490345|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384853|NCT02490332|Randomized|Parallel Assignment||Prevention||Single||||||t
1384854|NCT02490319|||Cohort||Prospective|||||||
1384855|NCT02490306|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1384856|NCT02490293|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384857|NCT02490280||Single Group Assignment||||None (Open Label)||||||
1384858|NCT02490267|||Case Control||Prospective|||||||
1384859|NCT02490254|||||Prospective|||||||
1384860|NCT02490241|||Cohort||Prospective|||||||
1384861|NCT02490228||Single Group Assignment||Treatment||None (Open Label)||||||
1384862|NCT02490215|||Cohort||Prospective|||||||
1384863|NCT02490202|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384864|NCT02490189|Randomized|Parallel Assignment||Treatment||Single||||||t
1384865|NCT02490176|Randomized|Parallel Assignment||Treatment||Double||||||
1384866|NCT02490163|Randomized|Crossover Assignment||||None (Open Label)||||||
1384867|NCT02490150|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384868|NCT02490137|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1384869|NCT02490124|||Cohort||Prospective|||||||
1384870|NCT02490111|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1384871|NCT02490098|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384872|NCT02490085|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384873|NCT02490072|Randomized|Single Group Assignment||||Double|||t||t|
1384874|NCT02490059|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1384875|NCT02490046|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1384876|NCT02490033|Randomized|Parallel Assignment||||None (Open Label)||||||
1384877|NCT02490020|Randomized|Parallel Assignment||Prevention||Single|||t|||
1384878|NCT02490007|||Case-Control||Retrospective|||||||
1384879|NCT02489994||Single Group Assignment||Treatment||None (Open Label)||||||
1384880|NCT02489981|||Cohort||Prospective|||||||
1384881|NCT02489968|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384882|NCT02489955||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384883|NCT02489942|||Cohort||Prospective|||||||
1384884|NCT02489929||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384885|NCT02489916||Single Group Assignment||Treatment||None (Open Label)||||||
1384886|NCT02489903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384887|NCT02489890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384888|NCT02489877|||Case Control||Prospective|||||||
1384889|NCT02489864|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384890|NCT02489851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384891|NCT02489838|||Cohort||Prospective|||||||
1384892|NCT02489825|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1384893|NCT02489812|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384894|NCT02489799|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1384895|NCT02489786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384896|NCT02489773|||||Prospective|||||||
1384897|NCT02489760|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384898|NCT02489747|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1384899|NCT02489734|Randomized|Parallel Assignment||Prevention||Single||||||t
1384900|NCT02489721|||Cohort||Prospective|||||||
1384901|NCT02489708||Single Group Assignment||Health Services Research||None (Open Label)||||||
1384902|NCT02489695||Single Group Assignment||Treatment||None (Open Label)||||||
1384903|NCT02489682|Randomized|Parallel Assignment||||Double|||t||t|
1384904|NCT02489669|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1384905|NCT02489656|Randomized|Parallel Assignment||Treatment||Single|||t|||
1384906|NCT02489643|Randomized|Parallel Assignment||Treatment||Single||||||t
1384907|NCT02489630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384908|NCT02489617||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384909|NCT02489604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384910|NCT02489591|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1384911|NCT02489578|||Cohort||Retrospective|||||||
1384912|NCT02489565|Randomized|Parallel Assignment||||None (Open Label)||||||
1384913|NCT02489539|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384914|NCT02489526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384915|NCT02489513||Single Group Assignment||||None (Open Label)||||||
1384916|NCT02489500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384917|NCT02489487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384918|NCT02489474|||Cohort||Prospective|||||||
1384919|NCT02489461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384920|NCT02489448||Single Group Assignment||Treatment||None (Open Label)||||||
1384921|NCT02489435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384922|NCT02489422|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384923|NCT02489409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384924|NCT02489396|||Other||Prospective|||||||
1384925|NCT02489383|Randomized|Parallel Assignment||Treatment||Single||||||t
1384926|NCT02489370|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384927|NCT02489357||Single Group Assignment||Treatment||None (Open Label)||||||
1384928|NCT02489344||Single Group Assignment||Treatment||None (Open Label)||||||
1384929|NCT02489331|||Case-Only||Prospective|||||||
1384930|NCT02489318|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384931|NCT02489305|||Cohort||Prospective|||||||
1384932|NCT02489292||Single Group Assignment||Treatment||None (Open Label)||||||
1384933|NCT02489279|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384934|NCT02489266||Single Group Assignment||Treatment||None (Open Label)||||||
1384935|NCT02489253|||Case Control||Prospective|||||||
1384936|NCT02489240|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1384937|NCT02489227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384938|NCT02489214||Single Group Assignment||Treatment||None (Open Label)||||||
1384939|NCT02489201||Single Group Assignment||Treatment||None (Open Label)||||||
1384940|NCT02489188|||Cohort||Prospective|||||||
1384941|NCT02489175|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384942|NCT02489162|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1384943|NCT02489149|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1384944|NCT02489136|Randomized|Single Group Assignment||Other||Double|||t|||t
1384945|NCT02489123||Single Group Assignment||Treatment||None (Open Label)||||||
1384946|NCT02489110|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1384947|NCT02489097|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1384948|NCT02489084|||Cohort||Prospective|||||||
1384949|NCT02489071|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1384950|NCT02489058|||Cohort||Other|||||||
1384951|NCT02489045||Single Group Assignment||Diagnostic||None (Open Label)||||||
1384952|NCT02489032|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1384953|NCT02489019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384954|NCT02489006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384955|NCT02488993|||Case-Only||Other|||||||
1384956|NCT02488980|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384957|NCT02488967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384958|NCT02488954||Single Group Assignment||Treatment||None (Open Label)||||||
1384959|NCT02488941|||||Prospective|||||||
1384960|NCT02488928|||Cohort||Prospective|||||||
1384961|NCT02488915||Single Group Assignment||Treatment||None (Open Label)||||||
1384962|NCT02488902|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1384963|NCT02488889|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1384964|NCT02488876|||Cohort||Prospective|||||||
1384965|NCT02488863|||Case-Control||Prospective|||||||
1384966|NCT02488850|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1384967|NCT02488837|||Cohort||Prospective|||||||
1384968|NCT02488824|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1384969|NCT02488798|||Cohort||Prospective|||||||
1384970|NCT02488785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384971|NCT02488772|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1384972|NCT02488759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384973|NCT02488746|||Case-Only||Prospective|||||||
1384974|NCT02488733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384975|NCT02488720|||Cohort||Prospective|||||||
1384976|NCT02488707|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1384977|NCT02488694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384978|NCT02488681||Single Group Assignment||Treatment||None (Open Label)||||||
1384979|NCT02488668||Single Group Assignment||Treatment||None (Open Label)||||||
1384980|NCT02488655||Single Group Assignment||Treatment||None (Open Label)||||||
1384981|NCT02488642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384982|NCT02488629||Single Group Assignment||Treatment||None (Open Label)||||||
1384983|NCT02488616|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384984|NCT02488603|Randomized|Parallel Assignment||||Single|||t|||
1384985|NCT02488590|||Cohort||Prospective|||||||
1384986|NCT02488577|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1384987|NCT02488564||Single Group Assignment||Treatment||None (Open Label)||||||
1384988|NCT02488551|Randomized|Parallel Assignment||Treatment||Single|||||t|
1384989|NCT02488538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384990|NCT02488525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1384991|NCT02488512||Single Group Assignment||Treatment||None (Open Label)||||||
1384992|NCT02488499|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1384993|NCT02488486||Single Group Assignment||Treatment||None (Open Label)||||||
1384994|NCT02488473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1384995|NCT02488460|Randomized|Factorial Assignment||Prevention||Single|||t|||
1384996|NCT02488447|||Case-Crossover||Prospective|||||||
1384997|NCT02488434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1384998|NCT02488421|||Cohort||Retrospective|||||||
1384999|NCT02488408|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1385000|NCT02488395|||Case Control||Prospective|||||||
1385001|NCT02488382||Single Group Assignment||Treatment||None (Open Label)||||||
1385002|NCT02488369||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385003|NCT02488356|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385004|NCT02488343|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385005|NCT02488330||Single Group Assignment||Treatment||None (Open Label)||||||
1385006|NCT02488317|Randomized|Parallel Assignment||Other||||||||
1385007|NCT02488304||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385008|NCT02488291|Randomized|Parallel Assignment||Treatment||Single|||||t|
1385009|NCT02488278||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385010|NCT02488265|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385011|NCT02488252|Randomized|Parallel Assignment||Treatment||Single||||||t
1385012|NCT02488239|||Case-Only||Prospective|||||||
1385013|NCT02488226|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1385014|NCT02488213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385015|NCT02488200|||Cohort||Prospective|||||||
1385016|NCT02488187|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385017|NCT02488174|Randomized|Single Group Assignment||Prevention||Single|||t|||
1385018|NCT02488161|||Cohort||Prospective|||||||
1385019|NCT02488148|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385020|NCT02488135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385021|NCT02488122|Randomized|Parallel Assignment||||Single||||||t
1385022|NCT02488109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385023|NCT02488096|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385024|NCT02488083||Single Group Assignment||Treatment||None (Open Label)||||||
1385025|NCT02488070||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385026|NCT02488057|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385027|NCT02488044||Single Group Assignment||Treatment||None (Open Label)||||||
1385028|NCT02488031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385029|NCT02488018||Single Group Assignment||Supportive Care||None (Open Label)||||||
1385030|NCT02488005||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385031|NCT02487992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385032|NCT02487979||Single Group Assignment||Treatment||None (Open Label)||||||
1385033|NCT02487966|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1385034|NCT02487953|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1385035|NCT02487940|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385036|NCT02487927|||Cohort||Prospective|||||||
1385037|NCT02487914|Non-Randomized|Single Group Assignment||Treatment||Double|||t||t|
1385038|NCT02487901|Randomized|Parallel Assignment||Treatment||Double|ultrasonic bone osteotome||t|||t
1385039|NCT02487888|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385040|NCT02487875|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385041|NCT02487862|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1385042|NCT02487849||Single Group Assignment||Treatment||None (Open Label)||||||
1385043|NCT02487836||Single Group Assignment||Treatment||None (Open Label)||||||
1385044|NCT02487823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385045|NCT02487810|Randomized|Parallel Assignment||||Single|||t|||
1385046|NCT02487797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385047|NCT02487784|Randomized|Parallel Assignment||Treatment||Single||||||t
1385048|NCT02487771|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385049|NCT02487758|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385050|NCT02487745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385051|NCT02487732|Randomized|Crossover Assignment||||None (Open Label)||||||
1385052|NCT02487719|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1385053|NCT02487706||Single Group Assignment||Basic Science||None (Open Label)||||||
1385054|NCT02487693|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385055|NCT02487680|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1385056|NCT02487667|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385057|NCT02487654|Randomized|Parallel Assignment||Treatment||Single||||||t
1385058|NCT02487641|||Case Control||Prospective|||||||
1385059|NCT02487628|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385060|NCT02487615|||Cohort||Cross-Sectional|||||||
1385061|NCT02487602|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1385062|NCT02487589|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385063|NCT02487576|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1385064|NCT02487563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385065|NCT02487550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385066|NCT02487537|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1385067|NCT02487524|Non-Randomized|Parallel Assignment||Other||Single|||||t|
1385068|NCT02487511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385069|NCT02487498|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1385070|NCT02487485|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1385071|NCT02487472|||Cohort||Prospective|||||||
1385072|NCT02487459||Single Group Assignment||Treatment||None (Open Label)||||||
1385073|NCT02487446|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1385074|NCT02487433|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1385075|NCT02487420|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385076|NCT02487407|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1385077|NCT02487394|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385078|NCT02487381|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1385079|NCT02487368||Single Group Assignment||Treatment||None (Open Label)||||||
1385080|NCT02487355|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1385081|NCT02487342|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385082|NCT02487329|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385083|NCT02487316||Single Group Assignment||Treatment||None (Open Label)||||||
1385084|NCT02487303|Randomized|Parallel Assignment||Treatment||Single|||||t|
1385085|NCT02487290||Single Group Assignment||Device Feasibility||None (Open Label)||This is a feasibility study, where initially 5 patients are to be treated.||||
1385086|NCT02487277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385087|NCT02487264|||Case-Only||Retrospective|||||||
1385088|NCT02487251|Randomized|Factorial Assignment||Prevention||Single||||||t
1385089|NCT02487238|Randomized|Parallel Assignment||Treatment||Single|Patients will not be aware of which type of enema they have been randomized to receive (fecal microbial enema, or normal saline enema). Patients who were randomized to the normal saline enema will still be eligible to receive the fecal microbial enema when they finish the trial; these patients will know what they are receiving and no longer need masking.|Patients will be randomized to receive either the fecal microbial enema containing healthy donor stool OR the normal saline enema placebo. Patients who receive the normal saline enema placebo may be eligible to still receive the fecal microbial enema when they finish the trial.|t|||
1385090|NCT02487225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385091|NCT02487212|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1385092|NCT02487199|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385093|NCT02487186|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385094|NCT02487173||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385095|NCT02487160|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385096|NCT02487147|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385097|NCT02487134|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1385098|NCT02487121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385099|NCT02487108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385100|NCT02487095|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1385101|NCT02487082|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1385102|NCT02487069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385103|NCT02487056|||Cohort||Prospective|||||||
1385104|NCT02487043|Randomized|Parallel Assignment||Prevention||Single||||||t
1385105|NCT02487030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385106|NCT02487017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385107|NCT02487004|||Cohort||Prospective|||||||
1385108|NCT02486991|Randomized|Parallel Assignment||Treatment||Single||||||t
1385109|NCT02486978|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1385110|NCT02486965|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1385111|NCT02486952|||Case-Only||Prospective|||||||
1385112|NCT02486939||Single Group Assignment||Treatment||None (Open Label)||||||
1385113|NCT02486926|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1385114|NCT02486913|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385115|NCT02486900|Randomized|Parallel Assignment||Treatment||Single||||||t
1385116|NCT02486887|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385117|NCT02486874||Single Group Assignment||Treatment||None (Open Label)||||||
1385118|NCT02486861|||Cohort|||||||||
1385119|NCT02486848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385120|NCT02486835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385121|NCT02486822|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385122|NCT02486809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385123|NCT02486796|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385124|NCT02486783|||Cohort||Prospective|||||||
1385125|NCT02486770|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385126|NCT02486757||Single Group Assignment||Basic Science||None (Open Label)||||||
1385127|NCT02486744|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385128|NCT02486731|||Case Control||Cross-Sectional|||||||
1385129|NCT02486718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385130|NCT02486705|Randomized|Parallel Assignment||||None (Open Label)||||||
1385131|NCT02486692|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385132|NCT02486679|Randomized|Parallel Assignment||Treatment||Single||||||t
1385133|NCT02486666|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385134|NCT02486653|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1385135|NCT02486640|||Cohort||Prospective|||||||
1385136|NCT02486627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385137|NCT02486614|||Cohort||Prospective|||||||
1385138|NCT02486601||Single Group Assignment||Treatment||None (Open Label)||||||
1385139|NCT02486588|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385140|NCT02486575|Randomized|Parallel Assignment||||None (Open Label)||||||
1385141|NCT02486562|||Cohort||Other|||||||
1385142|NCT02486549|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1385143|NCT02486536|Randomized|Parallel Assignment||Other||Single||||||t
1385144|NCT02486523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385145|NCT02486510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385146|NCT02486497|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385147|NCT02486484||Single Group Assignment||Treatment||None (Open Label)||||||
1385148|NCT02486471|Randomized|Parallel Assignment||||Single|||t|||
1385149|NCT02486458|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1385150|NCT02486445||Single Group Assignment||Treatment||None (Open Label)||||||
1385151|NCT02486432||Single Group Assignment||||None (Open Label)||||||
1385152|NCT02486419|||Cohort||Cross-Sectional|||||||
1385153|NCT02486406|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385154|NCT02486393|||Cohort||Prospective|||||||
1385155|NCT02486380||Single Group Assignment||Treatment||None (Open Label)||||||
1385156|NCT02486367|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385157|NCT02486354||Single Group Assignment||Treatment||None (Open Label)||||||
1385158|NCT02486341|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385159|NCT02486328|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1385160|NCT02486315|||Cohort||Prospective|||||||
1385161|NCT02486302|||Cohort||Prospective|||||||
1385162|NCT02486289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385163|NCT02486276|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1385164|NCT02486263|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385165|NCT02486250|||Cohort||Prospective|||||||
1385166|NCT02486237|||Cohort||Retrospective|||||||
1385167|NCT02486224|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1385168|NCT02486211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385169|NCT02486198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385170|NCT02486185||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385171|NCT02486172||Single Group Assignment||Health Services Research||None (Open Label)||||||
1385172|NCT02486159||Single Group Assignment||Basic Science||None (Open Label)||||||
1385173|NCT02486146|||Other||Prospective|||||||
1385174|NCT02486133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385175|NCT02486120|||Case-Only||Cross-Sectional|||||||
1385176|NCT02486107|||Cohort||Prospective|||||||
1385177|NCT02486094|||Cohort||Retrospective|||||||
1385178|NCT02486081|||Case-Control||Cross-Sectional|||||||
1385179|NCT02486068|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385180|NCT02486055|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385181|NCT02486042|Randomized|Parallel Assignment||Prevention||Single|||||t|
1385182|NCT02486016|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1385183|NCT02486003|||Case-Control||Prospective|||||||
1385184|NCT02485990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385185|NCT02485977|||Other||Cross-Sectional|||||||
1385186|NCT02485964||Single Group Assignment||Other||None (Open Label)||||||
1385187|NCT02485951|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385188|NCT02485938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385189|NCT02485925||Single Group Assignment||Treatment||None (Open Label)||||||
1385190|NCT02485912|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385191|NCT02485899||Single Group Assignment||Treatment||None (Open Label)||||||
1385192|NCT02485886||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385193|NCT02485873|||Cohort||Retrospective|||||||
1385194|NCT02485860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385195|NCT02485847|||Cohort||Prospective|||||||
1385196|NCT02485834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385197|NCT02485821|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385198|NCT02485808|||Cohort||Prospective|||||||
1385199|NCT02485795|||Cohort||Prospective|||||||
1385200|NCT02485782|||Cohort||Cross-Sectional|||||||
1385201|NCT02485769|Randomized|||Treatment||Triple|||t|t|t|
1385202|NCT02485756|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385203|NCT02485743|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1385204|NCT02485730|||Cohort||Prospective|||||||
1385205|NCT02485717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385206|NCT02485704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385207|NCT02485691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385208|NCT02485678|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385209|NCT02485665|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385210|NCT02485652||Single Group Assignment||Treatment||None (Open Label)||||||
1385211|NCT02485639||Single Group Assignment||Prevention||None (Open Label)||||||
1385212|NCT02485626|||Cohort||Cross-Sectional|||||||
1385213|NCT02485613|||Case-Only||Retrospective|||||||
1385214|NCT02485600|||Cohort||Prospective|||||||
1385215|NCT02485587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385216|NCT02485574||Single Group Assignment||Treatment||None (Open Label)||||||
1385217|NCT02485561|Randomized|Parallel Assignment||Prevention||Single|||t|||
1385218|NCT02485548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385219|NCT02485535||Single Group Assignment||Treatment||None (Open Label)||||||
1385220|NCT02485522|||Case-Control||Cross-Sectional|||||||
1385221|NCT02485509|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385222|NCT02485496|||Cohort||Prospective|||||||
1385223|NCT02485483|||||Prospective|||||||
1385224|NCT02485470|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385225|NCT02485457|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1385226|NCT02485444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385227|NCT02485431|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1385228|NCT02485418||Single Group Assignment||Treatment||None (Open Label)||||||
1385229|NCT02485405|||Cohort||Other|||||||
1385230|NCT02485392|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385231|NCT02485379||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385232|NCT02485366||Single Group Assignment||Basic Science||None (Open Label)||||||
1385233|NCT02485353||Single Group Assignment||Treatment||None (Open Label)||||||
1385234|NCT02485340|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1385235|NCT02485327||Single Group Assignment||Treatment||None (Open Label)||||||
1385236|NCT02485314|||Family-Based||Prospective|||||||
1385237|NCT02485301|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1385238|NCT02485288|||Cohort||Prospective|||||||
1385239|NCT02485275|||Cohort||Prospective|||||||
1385240|NCT02485262|||Cohort||Prospective|||||||
1385241|NCT02485249||Single Group Assignment||Treatment||None (Open Label)||||||
1385242|NCT02485236|Randomized|Parallel Assignment||Treatment||Single||||||t
1385243|NCT02485223|||Cohort||Prospective|||||||
1385244|NCT02485210|Randomized|Parallel Assignment||Treatment||Single||||||t
1385245|NCT02485197|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1385246|NCT02485184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385247|NCT02485171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385248|NCT02485158|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1385249|NCT02485145|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1385250|NCT02485132|||Cohort||Prospective|||||||
1385251|NCT02485119||Single Group Assignment||Treatment||None (Open Label)||||||
1385252|NCT02485106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385253|NCT02485093|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385254|NCT02485080||Single Group Assignment||Treatment||None (Open Label)||||||
1385255|NCT02485067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385256|NCT02485054|||Case-Only||Prospective|||||||
1385257|NCT02485041|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1385258|NCT02485028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1385259|NCT02485015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385260|NCT02485002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385261|NCT02484989|||||Prospective|||||||
1385262|NCT02484976||Single Group Assignment||Basic Science||None (Open Label)||||||
1385263|NCT02484963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385264|NCT02484950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385265|NCT02484937|Randomized|Parallel Assignment||Treatment||Single||||||t
1385266|NCT02484924|||Cohort||Retrospective|||||||
1385267|NCT02484911|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385268|NCT02484898|||Cohort||Prospective|||||||
1385269|NCT02484885||Single Group Assignment||Basic Science||None (Open Label)||||||
1385270|NCT02484872|||Cohort||Prospective|||||||
1385271|NCT02484859|Randomized|Parallel Assignment||||Double|||t|||t
1385272|NCT02484846|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1385273|NCT02484833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385274|NCT02484820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385275|NCT02484807|||Cohort||Prospective|||||||
1385276|NCT02484794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385277|NCT02484781|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1385278|NCT02484768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385279|NCT02484755||Single Group Assignment||Treatment||None (Open Label)||||||
1385280|NCT02484742|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1385281|NCT02484729|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1385282|NCT02484716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385283|NCT02484703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385284|NCT02484690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385285|NCT02484677||Single Group Assignment||Treatment||None (Open Label)||||||
1385286|NCT02484664||Single Group Assignment||Treatment||None (Open Label)||||||
1385287|NCT02484651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385288|NCT02484638|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385289|NCT02484625|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1385290|NCT02484612|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1385291|NCT02484599|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385292|NCT02484586|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1385293|NCT02484573||Single Group Assignment||Treatment||None (Open Label)||||||
1385294|NCT02484560|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385295|NCT02484547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385296|NCT02484534|||Cohort||Prospective|||||||
1385297|NCT02484521|Non-Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1385298|NCT02484508|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385299|NCT02484495|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385300|NCT02484482|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1385301|NCT02484469|Randomized|Parallel Assignment||||None (Open Label)||||||
1385302|NCT02484456|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1385303|NCT02484443||Single Group Assignment||Treatment||None (Open Label)||||||
1385304|NCT02484430||Single Group Assignment||Treatment||None (Open Label)||||||
1385305|NCT02484417|Randomized|Parallel Assignment||Other||Double|||t||t|
1385306|NCT02484404|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385307|NCT02484391||Single Group Assignment||Treatment||None (Open Label)||||||
1385308|NCT02484378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385309|NCT02484365|||Cohort||Prospective|||||||
1385310|NCT02484352|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1385311|NCT02484339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385312|NCT02484326|||Cohort||Prospective|||||||
1385313|NCT02484313|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1385314|NCT02484300|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1385315|NCT02484287|Randomized|Single Group Assignment||Other||Triple|||t|t|t|
1385316|NCT02484274||Single Group Assignment||Prevention||None (Open Label)||||||
1385317|NCT02484261|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1385318|NCT02484248|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1385319|NCT02484235|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1385320|NCT02484222|||Cohort||Prospective|||||||
1385321|NCT02484209|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385322|NCT02484196|||Cohort||Prospective|||||||
1385323|NCT02484183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385324|NCT02484170|Randomized|Crossover Assignment||Treatment||Quadruple||1 week observation, one week cream A assigned, 3 day crossover, one week of cream B assigned. After the crossover study, 3 months of mannitol cream assigned.|t|t|t|t
1385325|NCT02484157||Single Group Assignment||Diagnostic||Single|||t|||
1385326|NCT02484144|||||Prospective|||||||
1385327|NCT02484131|Randomized|Parallel Assignment||Prevention||Single|data analyst||||t|
1385328|NCT02484118|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1385329|NCT02484105|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1385330|NCT02484092||Sequential Assignment||Treatment||None (Open Label)||||||
1385331|NCT02484079|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385332|NCT02484066|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385333|NCT02484053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385334|NCT02484040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385335|NCT02484027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385336|NCT02484014|Randomized|Parallel Assignment||||Single||||||t
1385337|NCT02484001|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385338|NCT02483988||||||||||||
1385339|NCT02483975|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385340|NCT02483962|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385341|NCT02483949|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385342|NCT02483936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385343|NCT02483923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385344|NCT02483910|Randomized|Parallel Assignment||Treatment||Single||||||t
1385345|NCT02483897|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1385346|NCT02483884|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385347|NCT02483871||Single Group Assignment||Treatment||None (Open Label)||||||
1385348|NCT02483858||Single Group Assignment||Treatment||None (Open Label)||||||
1385349|NCT02483845||Single Group Assignment||Treatment||None (Open Label)||||||
1385350|NCT02483832|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385351|NCT02483819|||Cohort||Prospective|||||||
1385352|NCT02483806|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1385353|NCT02483793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385354|NCT02483780|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385355|NCT02483767|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385356|NCT02483754|||Other||Cross-Sectional|||||||
1385357|NCT02483741|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385358|NCT02483728|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1385359|NCT02483715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385360|NCT02483702|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385361|NCT02483689|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385362|NCT02483676|Randomized|Parallel Assignment||Treatment||Single||||||t
1385363|NCT02483663|||Family-Based||Prospective|||||||
1385364|NCT02483650|||Other||Prospective|||||||
1385365|NCT02483637||Single Group Assignment||Treatment||None (Open Label)||RejuvenAir||||
1385366|NCT02483624|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385367|NCT02483611|Randomized|Parallel Assignment||||Triple|||t|t|t|
1385368|NCT02483598|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1385369|NCT02483585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385370|NCT02483572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385371|NCT02483559|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1385372|NCT02483546|Randomized|Parallel Assignment||||None (Open Label)||||||
1385373|NCT02483533|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1385374|NCT02483520|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1385375|NCT02483507|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385376|NCT02483494|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385377|NCT02483481|||Cohort||Prospective|||||||
1385378|NCT02483468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385379|NCT02483455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385380|NCT02483442|||Cohort||Prospective|||||||
1385381|NCT02483429|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1385382|NCT02483416|||Other||Prospective|||||||
1385383|NCT02483403||Single Group Assignment||Basic Science||None (Open Label)||||||
1385384|NCT02483390|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1385385|NCT02483377|||Case-Only||Prospective|||||||
1385386|NCT02483364||Single Group Assignment||Treatment||None (Open Label)||Cell therapy||||
1385387|NCT02483351|Randomized|Parallel Assignment||Treatment||Single||||||t
1385388|NCT02483338||Single Group Assignment||Supportive Care||None (Open Label)||||||
1385389|NCT02483325||Single Group Assignment||Treatment||None (Open Label)||||||
1385390|NCT02483312||Single Group Assignment||Treatment||None (Open Label)||||||
1385391|NCT02483299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385392|NCT02483286|Randomized|Parallel Assignment||Prevention||Single||||||t
1385393|NCT02483273|||Case Control||Prospective|||||||
1385394|NCT02483260||Single Group Assignment||Treatment||None (Open Label)||||||
1385395|NCT02483247|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385396|NCT02483234||Single Group Assignment||||None (Open Label)||||||
1385397|NCT02483221|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385398|NCT02483208|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1385399|NCT02483195|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1385400|NCT02483182|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385401|NCT02483169|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1385402|NCT02483156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385403|NCT02483143|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1385404|NCT02483130|||Case-Only||Prospective|||||||
1385405|NCT02483117|||Cohort||Prospective|||||||
1385406|NCT02483104||Single Group Assignment||Treatment||None (Open Label)||||||
1385407|NCT02483091|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1385408|NCT02483078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385409|NCT02483065|||Cohort||Prospective|||||||
1385410|NCT02483052||Single Group Assignment||Other||None (Open Label)||RejuvenAir||||
1385411|NCT02483039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385412|NCT02483026|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1385413|NCT02483013|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1385414|NCT02483000||Single Group Assignment||Treatment||None (Open Label)||||||
1385415|NCT02482987|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385416|NCT02482974|||Cohort||Prospective|||||||
1385417|NCT02482961|||Cohort||Prospective|||||||
1385418|NCT02482948|Randomized|Parallel Assignment||Treatment||Single|||||t|
1385419|NCT02482935|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1385420|NCT02482922||Single Group Assignment||Other||None (Open Label)||||||
1385421|NCT02482909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385422|NCT02482896|||Family-Based||Cross-Sectional|||||||
1385423|NCT02482883|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1385424|NCT02482870|Randomized|Crossover Assignment||Other||Double|||||t|t
1385425|NCT02482857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385426|NCT02482844|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1385427|NCT02482831|||Cohort||Prospective|||||||
1385428|NCT02482818|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1385429|NCT02482805|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385430|NCT02482792|Randomized|Parallel Assignment||Treatment||Single||||||t
1385431|NCT02482779|||Other||Prospective|||||||
1385432|NCT02482766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385433|NCT02482753|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385434|NCT02482740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385435|NCT02482727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385436|NCT02482714|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385437|NCT02482701|||Case-Only||Prospective|||||||
1385438|NCT02482688|Randomized|Parallel Assignment||Treatment||Single||||||t
1385439|NCT02482675|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1385440|NCT02482662|||Cohort||Prospective|||||||
1385441|NCT02482649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385442|NCT02482636|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385443|NCT02482623|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1385444|NCT02482610|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1385445|NCT02482597|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1385446|NCT02482584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385447|NCT02482571||Single Group Assignment||Basic Science||None (Open Label)||||||
1385448|NCT02482558|Randomized|Crossover Assignment||Basic Science||Single||||||t
1385449|NCT02482545|Randomized|Parallel Assignment||||None (Open Label)||||||
1385450|NCT02482532||Single Group Assignment||Treatment||None (Open Label)||||||
1385451|NCT02482519||Single Group Assignment||Other||None (Open Label)||||||
1385452|NCT02482506|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1385453|NCT02482493|Randomized|Parallel Assignment||Treatment||Single||||||t
1385454|NCT02482480|Randomized|Parallel Assignment||Treatment||Single||||||t
1385455|NCT02482467|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1385456|NCT02482454|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1385457|NCT02482441|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385458|NCT02482428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385459|NCT02482415|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385460|NCT02482402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385461|NCT02482389||Single Group Assignment||Treatment||None (Open Label)||||||
1385462|NCT02482376||Single Group Assignment||Treatment||None (Open Label)||||||
1385463|NCT02482363|Non-Randomized|Crossover Assignment||Basic Science||Single|||||t|
1385464|NCT02482350||Single Group Assignment||Treatment||None (Open Label)||||||
1385465|NCT02482337||Single Group Assignment||Other||None (Open Label)||||||
1385466|NCT02482324|Randomized|Crossover Assignment||||None (Open Label)||||||
1385467|NCT02482311||Single Group Assignment||Treatment||None (Open Label)||||||
1385468|NCT02482298|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1385469|NCT02482285|||Cohort||Prospective|||||||
1385470|NCT02482272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385471|NCT02482259|||Cohort||Prospective|||||||
1385472|NCT02482246|||Case-Only||Prospective|||||||
1385473|NCT02482233|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1385474|NCT02482220|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385475|NCT02482207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385476|NCT02482194||Single Group Assignment||Treatment||None (Open Label)||||||
1385477|NCT02482181|||Case-Only||Prospective|||||||
1385478|NCT02482168|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1385479|NCT02482155||Single Group Assignment||||None (Open Label)||||||
1385480|NCT02482142|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1385481|NCT02482129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385482|NCT02482116|||Cohort||Prospective|||||||
1385483|NCT02482103|||Cohort||Prospective|||||||
1385484|NCT02482090||Single Group Assignment||Treatment||None (Open Label)||||||
1385485|NCT02482077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385486|NCT02482064|Randomized|Crossover Assignment||Treatment||Single|||t|||
1385487|NCT02482051|||Other||Prospective|||||||
1385488|NCT02482038||Single Group Assignment||Other||None (Open Label)||||||
1385489|NCT02482025|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385490|NCT02482012|||Cohort||Prospective|||||||
1385491|NCT02481999|||Cohort||Prospective|||||||
1385492|NCT02481986|Randomized|Parallel Assignment||Treatment||Single||||||t
1385493|NCT02481973||Single Group Assignment||Treatment||None (Open Label)||||||
1385494|NCT02481960||Single Group Assignment||Treatment||None (Open Label)||||||
1385495|NCT02481947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385496|NCT02481934||Single Group Assignment||Treatment||None (Open Label)||||||
1385497|NCT02481921|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants are assigned to either usual care group or the MEDIC-HF group in parallel for the duration of the study.||||
1385498|NCT02481908|||Cohort||Prospective|||||||
1385499|NCT02481895|Randomized|Parallel Assignment||Treatment||Single|||||t|
1385500|NCT02481882|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385501|NCT02481869|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385502|NCT02481856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385503|NCT02481843|||Case Control||Prospective|||||||
1385504|NCT02481830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385505|NCT02481817|||Cohort||Prospective|||||||
1385506|NCT02481804||Single Group Assignment||Treatment||None (Open Label)||||||
1385507|NCT02481791||Single Group Assignment||Supportive Care||None (Open Label)||||||
1385508|NCT02481778|||Cohort||Prospective|||||||
1385509|NCT02481765||Single Group Assignment||||None (Open Label)||||||
1385510|NCT02481752|Randomized|Parallel Assignment||||Single|||t|||
1385511|NCT02481739|||||Retrospective|||||||
1385512|NCT02481726||Parallel Assignment||Diagnostic||None (Open Label)||||||
1385513|NCT02481713|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385514|NCT02481700|||Cohort||Prospective|||||||
1385515|NCT02481687|||Cohort||Prospective|||||||
1385516|NCT02481674|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385517|NCT02481661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385518|NCT02481648|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385519|NCT02481635||Single Group Assignment||Treatment||None (Open Label)||||||
1385520|NCT02481622|||Other||Retrospective|||||||
1385521|NCT02481609||Single Group Assignment||Treatment||None (Open Label)||||||
1385522|NCT02481596|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1385523|NCT02481583|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385524|NCT02481570||Single Group Assignment||Supportive Care||None (Open Label)||||||
1385525|NCT02481557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385526|NCT02481544|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1385527|NCT02481531|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1385528|NCT02481518|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1385529|NCT02481505|Randomized|Parallel Assignment||||Single|||||t|
1385530|NCT02481492|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1385531|NCT02481479||Single Group Assignment||Treatment||None (Open Label)||||||
1386619|NCT02467309|||Case-Only||Prospective|||||||
1385532|NCT02481466|Randomized|Factorial Assignment||Treatment||Double||This is a 2 x 2 factorial design|||t|t
1385533|NCT02481453|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385534|NCT02481440|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1385535|NCT02481427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385536|NCT02481414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385537|NCT02481401|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385538|NCT02481388|||||Cross-Sectional|||||||
1385539|NCT02481375|Randomized|Factorial Assignment||Diagnostic||Quadruple|||t|t|t|t
1385540|NCT02481362|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1385541|NCT02481349|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385542|NCT02481336|||Cohort||Prospective|||||||
1385543|NCT02481323|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1385544|NCT02481310||Single Group Assignment||Treatment||None (Open Label)||||||
1385545|NCT02481297|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385546|NCT02481284|||||Prospective|||||||
1385547|NCT02481271|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1385548|NCT02481258|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1385549|NCT02481245||Single Group Assignment||Treatment||None (Open Label)||||||
1385550|NCT02481232|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1385551|NCT02481219|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385552|NCT02481206|Randomized|Parallel Assignment||Treatment||Single||||||t
1385553|NCT02481193|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1385554|NCT02481180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385555|NCT02481167|||Cohort||Cross-Sectional|||||||
1385556|NCT02481154||Single Group Assignment||Treatment||None (Open Label)||||||
1385557|NCT02481141|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385558|NCT02481128|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385559|NCT02481115|||Cohort||Prospective|||||||
1385560|NCT02481102|||Cohort||Prospective|||||||
1385561|NCT02481089|||Cohort||Prospective|||||||
1385562|NCT02481076|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385563|NCT02481063|Non-Randomized|Parallel Assignment||Screening||Single||||||t
1385564|NCT02481050||Single Group Assignment||Treatment||None (Open Label)||||||
1385565|NCT02481037|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385566|NCT02481024|||Other||Cross-Sectional|||||||
1385567|NCT02481011|||Case-Only||Retrospective|||||||
1385568|NCT02480998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385569|NCT02480985||Single Group Assignment||Other||None (Open Label)||||||
1385570|NCT02480972||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385571|NCT02480959|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385572|NCT02480946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385573|NCT02480933|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1385574|NCT02480920|||Cohort||Retrospective|||||||
1385575|NCT02480907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385576|NCT02480894||Single Group Assignment||Treatment||None (Open Label)||||||
1385577|NCT02480881||Single Group Assignment||Treatment||None (Open Label)||||||
1385578|NCT02480868||Single Group Assignment||Treatment||None (Open Label)||||||
1385579|NCT02480855|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1385580|NCT02480842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385581|NCT02480829||Single Group Assignment||Treatment||None (Open Label)||||||
1385582|NCT02480816|Randomized|Crossover Assignment||Prevention||Single||||||t
1385583|NCT02480803|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385584|NCT02480790|||Cohort||Prospective|||||||
1385585|NCT02480777||||||||||||
1385586|NCT02480764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385587|NCT02480751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385588|NCT02480738|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385589|NCT02480725|||Cohort||Prospective|||||||
1385590|NCT02480712||Single Group Assignment||Treatment||None (Open Label)||||||
1385591|NCT02480699||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385592|NCT02480686||Single Group Assignment||Treatment||None (Open Label)||||||
1385593|NCT02480673|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385594|NCT02480660|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1385595|NCT02480647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385596|NCT02480634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385597|NCT02480621|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385598|NCT02480608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385599|NCT02480595|||Cohort||Prospective|||||||
1385600|NCT02480582|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1385601|NCT02480569|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1385602|NCT02480556|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385603|NCT02480543|Randomized|Parallel Assignment||Prevention||Double||||t||t
1385604|NCT02480530|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1385605|NCT02480517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385606|NCT02480504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385607|NCT02480491|||Cohort|||||||||
1385608|NCT02480478|||Case Control||Cross-Sectional|||||||
1385609|NCT02480465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385611|NCT02480439|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1385612|NCT02480426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385613|NCT02480413|||Case-Only||Prospective|||||||
1385614|NCT02480400|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1385615|NCT02480387|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385616|NCT02480374||Single Group Assignment||Treatment||None (Open Label)||||||
1385617|NCT02480361|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385618|NCT02480348||Single Group Assignment||Treatment||None (Open Label)||||||
1385619|NCT02480335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385620|NCT02480322|||Case Control||Retrospective|||||||
1385621|NCT02480296|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385622|NCT02480283|||Cohort||Retrospective|||||||
1385623|NCT02480270|||Case-Only||Prospective|||||||
1385624|NCT02480257||Single Group Assignment||Treatment||None (Open Label)||||||
1385625|NCT02480244|Randomized|Parallel Assignment||Prevention||Single||||||t
1385626|NCT02480231|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385627|NCT02480218|||Cohort||Prospective|||||||
1385628|NCT02480205||Single Group Assignment||Treatment||None (Open Label)||||||
1385629|NCT02480192|Randomized|Parallel Assignment||Treatment||Single||||||t
1385630|NCT02480179||Single Group Assignment||Treatment||None (Open Label)||||||
1385631|NCT02480166|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385632|NCT02480153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385633|NCT02480140|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1385634|NCT02480127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385635|NCT02480114|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385636|NCT02480101|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1385637|NCT02480088|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1385638|NCT02480075|||Cohort||Prospective|||||||
1385639|NCT02480062|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1385640|NCT02480049|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1385641|NCT02480036||Single Group Assignment||Treatment||None (Open Label)||||||
1385642|NCT02480023||Single Group Assignment||Screening||None (Open Label)||||||
1385643|NCT02480010|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385644|NCT02479997|Randomized|Parallel Assignment||||Single|||||t|
1385645|NCT02479984||Single Group Assignment||Treatment||None (Open Label)||||||
1385646|NCT02479971|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1385647|NCT02479958|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385648|NCT02479945||Single Group Assignment||||||||||
1385649|NCT02479932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385650|NCT02479919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385651|NCT02479906|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1385652|NCT02479893|||Case Control||Prospective|||||||
1385653|NCT02479880|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385654|NCT02479867|Randomized|Crossover Assignment||||None (Open Label)||||||
1385655|NCT02479854|Randomized|Crossover Assignment||||None (Open Label)||||||
1385656|NCT02479841|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385657|NCT02479828|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1385658|NCT02479815||Single Group Assignment||Prevention||None (Open Label)||||||
1385659|NCT02479802||Single Group Assignment||Treatment||None (Open Label)||||||
1385660|NCT02479789|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1385661|NCT02479776|Randomized|Crossover Assignment||Treatment||Single||||||t
1385662|NCT02479763|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385663|NCT02479750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385664|NCT02479737|||Cohort||Prospective|||||||
1385665|NCT02479724|||Cohort||Retrospective|||||||
1385666|NCT02479711|Randomized|Parallel Assignment||Treatment||Single|||||t|
1385667|NCT02479698||Single Group Assignment||Treatment||None (Open Label)||||||
1385668|NCT02479685|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1385669|NCT02479672|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1385670|NCT02479659|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385671|NCT02479646|Randomized|Crossover Assignment||Health Services Research||Triple|||t|t||t
1385672|NCT02479633|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1385673|NCT02479620|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385674|NCT02479607|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1385675|NCT02479594|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385676|NCT02479581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385677|NCT02479568|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1385678|NCT02479555|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385679|NCT02479542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385680|NCT02479529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385681|NCT02479516|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1385682|NCT02479503||||||||||||
1385683|NCT02479490||Single Group Assignment||Treatment||None (Open Label)||||||
1385684|NCT02479477||Single Group Assignment||Treatment||Double|||||t|t
1385685|NCT02479464|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1385686|NCT02479451||Single Group Assignment||Treatment||None (Open Label)||||||
1385687|NCT02479438|||Cohort||Prospective|||||||
1385688|NCT02479425|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385689|NCT02479412|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1385690|NCT02479399|||Case-Control||Prospective|||||||
1385691|NCT02479386||Single Group Assignment||Other||None (Open Label)||||||
1385692|NCT02479373|Non-Randomized|Parallel Assignment||Supportive Care||||Control and participant groups.||||
1385693|NCT02479360|||Cohort||Prospective|||||||
1385694|NCT02479347|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1385695|NCT02479334|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1385696|NCT02479321|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385697|NCT02479308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385698|NCT02479295|Randomized|Parallel Assignment||Treatment||None (Open Label)||straight versus coiled Tenckhoff catheters||||
1385699|NCT02479282|Randomized|Parallel Assignment||Screening||Single|||t|||
1385700|NCT02479269|Randomized|Parallel Assignment||Prevention||Single||||||t
1385701|NCT02479256|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1385702|NCT02479243|||Case-Control||Prospective|||||||
1385703|NCT02479230||Single Group Assignment||Treatment||None (Open Label)||||||
1385704|NCT02479217|||Case-Control||Prospective|||||||
1385705|NCT02479204|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385706|NCT02479191|||Cohort||Prospective|||||||
1385707|NCT02479178||Single Group Assignment||Treatment||None (Open Label)||||||
1385708|NCT02479165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385709|NCT02479152|Randomized|Parallel Assignment||Treatment||Single||||||t
1385710|NCT02479139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385711|NCT02479126|||Cohort||Retrospective|||||||
1385712|NCT02479113|||Cohort||Prospective|||||||
1385713|NCT02479100|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385714|NCT02479087||Single Group Assignment||Treatment||None (Open Label)||||||
1385715|NCT02479074|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1385716|NCT02479061|||Other||Cross-Sectional|||||||
1385717|NCT02479048|Randomized|Crossover Assignment||Other||Single|||t|||
1385718|NCT02479035|Randomized|Crossover Assignment||Other||Single|||t|||
1385719|NCT02479022|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1385720|NCT02479009||Single Group Assignment||Treatment||None (Open Label)||||||
1385721|NCT02478996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385722|NCT02478983|Randomized|Parallel Assignment||Device Feasibility||Single|||t|||
1385723|NCT02478970|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385724|NCT02478957|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1385725|NCT02478944||Single Group Assignment||Screening||None (Open Label)||||||
1385726|NCT02478931|||Cohort||Other|||||||
1385727|NCT02478918|Randomized|Parallel Assignment||Other||Single||||||t
1385728|NCT02478905|||Cohort||Prospective|||||||
1385729|NCT02478892|||Cohort||Prospective|||||||
1385730|NCT02478879|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1385731|NCT02478866||Single Group Assignment||Treatment||None (Open Label)||||||
1385732|NCT02478853|||Ecologic or Community||Prospective|||||||
1385733|NCT02478840||Single Group Assignment||Treatment||None (Open Label)||||||
1385734|NCT02478827|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1385735|NCT02478814||Single Group Assignment||Basic Science||None (Open Label)||||||
1385736|NCT02478801||Single Group Assignment||Basic Science||None (Open Label)||||||
1385737|NCT02478788|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1385738|NCT02478775||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385739|NCT02478762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385740|NCT02478749|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1385741|NCT02478736|||Case-Control||Prospective|||||||
1385742|NCT02478723|||Case-Only||Prospective|||||||
1385743|NCT02478710|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385744|NCT02478697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385745|NCT02478684|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385746|NCT02478671||Single Group Assignment||Basic Science||None (Open Label)||||||
1385747|NCT02478658|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385748|NCT02478645|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1385749|NCT02478632|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385750|NCT02478619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385751|NCT02478606|Randomized|Parallel Assignment||Basic Science||Single||||||t
1385752|NCT02478593|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1385753|NCT02478580|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1385754|NCT02478567|Randomized|Crossover Assignment||Treatment||Single|||||t|
1385755|NCT02478554|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1385756|NCT02478541|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1385757|NCT02478528||Single Group Assignment||Prevention||None (Open Label)||||||
1385758|NCT02478515||Single Group Assignment||Treatment||None (Open Label)||||||
1385759|NCT02478502||Single Group Assignment||Treatment||None (Open Label)||||||
1385760|NCT02478489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385761|NCT02478476|||Cohort||Prospective|||||||
1385762|NCT02478463||Single Group Assignment||Treatment||None (Open Label)||||||
1385763|NCT02478450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385764|NCT02478437|Randomized|Single Group Assignment||Treatment||Single|||t|||
1385765|NCT02478424||Single Group Assignment||Prevention||None (Open Label)||||||
1385766|NCT02478411|Randomized|Parallel Assignment||Treatment||Single||||||t
1385767|NCT02478398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385768|NCT02478385|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1385769|NCT02478372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385770|NCT02478359|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1385771|NCT02478346||Single Group Assignment||Treatment||None (Open Label)||||||
1385772|NCT02478333|Randomized|Parallel Assignment||||Double|||t||t|
1385773|NCT02478320||Single Group Assignment||Treatment||None (Open Label)||||||
1385774|NCT02478307|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385775|NCT02478294|||Cohort||Prospective|||||||
1385776|NCT02478281||Single Group Assignment||Treatment||None (Open Label)||||||
1385777|NCT02478268|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385778|NCT02478255|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385779|NCT02478242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385780|NCT02478229||Single Group Assignment||Treatment||None (Open Label)||||||
1385781|NCT02478216|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1385782|NCT02478203|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1385783|NCT02478190|Randomized|Parallel Assignment||Treatment||Single||||||t
1385784|NCT02478177|||Cohort||Prospective|||||||
1385785|NCT02478164||Single Group Assignment||Treatment||None (Open Label)||||||
1385786|NCT02478151||Single Group Assignment||Other||None (Open Label)||||||
1385787|NCT02478138||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385788|NCT02478125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385789|NCT02478112||Single Group Assignment||Treatment||None (Open Label)||||||
1385790|NCT02478099||Single Group Assignment||Treatment||None (Open Label)||||||
1385791|NCT02478086|Randomized|Parallel Assignment||Prevention||Single|||||t|
1385792|NCT02478073|||Case-Only||Prospective|||||||
1385793|NCT02478060|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385794|NCT02478047|Randomized|Parallel Assignment||Treatment||Single||||||t
1385795|NCT02478034|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1385796|NCT02478021|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1385797|NCT02478008||Single Group Assignment||Treatment||None (Open Label)||||||
1385798|NCT02477995|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1385799|NCT02477982|||Cohort||Prospective|||||||
1385800|NCT02477969|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385801|NCT02477956|Randomized|Parallel Assignment||Treatment||Single|||||t|
1385802|NCT02477943|||Cohort||Prospective|||||||
1385803|NCT02477930|||Other||Prospective|||||||
1385804|NCT02477917||Single Group Assignment||Treatment||None (Open Label)||||||
1385805|NCT02477904|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385806|NCT02477891||||||||||||
1385807|NCT02477878||Single Group Assignment||Treatment||None (Open Label)||||||
1385808|NCT02477865|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385809|NCT02477852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385810|NCT02477839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385811|NCT02477826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385812|NCT02477813||Single Group Assignment||Treatment||None (Open Label)||||||
1385813|NCT02477800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385814|NCT02477787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385815|NCT02477774|Randomized|Parallel Assignment||Prevention||Single|||||t|
1385816|NCT02477761|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1385817|NCT02477748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385818|NCT02477735|||Case Control||Prospective|||||||
1385819|NCT02477722|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385820|NCT02477709||Single Group Assignment||Treatment||None (Open Label)||||||
1385821|NCT02477696|Randomized|Parallel Assignment||Treatment||Single||||||t
1385822|NCT02477683|||Case-Only||Prospective|||||||
1385823|NCT02477670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385824|NCT02477657|||Cohort||Prospective|||||||
1385825|NCT02477644|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385826|NCT02477631||Single Group Assignment||Treatment||None (Open Label)||||||
1385827|NCT02477618|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385828|NCT02477605|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385829|NCT02477592|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385830|NCT02477579||Single Group Assignment||Treatment||None (Open Label)||||||
1385831|NCT02477566|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385832|NCT02477553|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1385833|NCT02477540||Single Group Assignment||Treatment||None (Open Label)||||||
1385834|NCT02477527||Single Group Assignment||Treatment||None (Open Label)||||||
1385835|NCT02477514||Single Group Assignment||Treatment||None (Open Label)||||||
1385836|NCT02477501|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1385837|NCT02477488||Single Group Assignment||Prevention||None (Open Label)||||||
1385838|NCT02477475|||Cohort||Prospective|||||||
1385839|NCT02477462|||Case-Control||Prospective|||||||
1385840|NCT02477449|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385841|NCT02477436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385842|NCT02477423|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1385843|NCT02477410|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1385844|NCT02477397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385845|NCT02477384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385846|NCT02477371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385847|NCT02477358|Randomized|Parallel Assignment||Treatment||Single|||||t|
1385848|NCT02477345||||||||||||
1385849|NCT02477332|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1385850|NCT02477319|||Other||Prospective|||||||
1385851|NCT02477306|Randomized|Crossover Assignment||||None (Open Label)||||||
1385852|NCT02477293||Single Group Assignment||Treatment||None (Open Label)||||||
1385853|NCT02477280|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1385854|NCT02477267|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1385855|NCT02477254|||Case Control||Prospective|||||||
1385856|NCT02477241||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385857|NCT02477228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385858|NCT02477215||Single Group Assignment||Treatment||None (Open Label)||||||
1385859|NCT02477202||Single Group Assignment||Treatment||None (Open Label)||||||
1385860|NCT02477189|||Case-Only||Retrospective|||||||
1385861|NCT02477176|||Case-Control||Prospective|||||||
1385862|NCT02477163|||Case-Only||Prospective|||||||
1385863|NCT02477150|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1385864|NCT02477137|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1385865|NCT02477124|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385866|NCT02477111|||Cohort||Prospective|||||||
1385867|NCT02477098|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385868|NCT02477085|||Cohort||Prospective|||||||
1385869|NCT02477072|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1385870|NCT02477059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385871|NCT02477046|Randomized|Parallel Assignment||Prevention||Single||||||t
1385872|NCT02477033|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1385873|NCT02477020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385874|NCT02477007|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1385875|NCT02476994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385876|NCT02476981|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385877|NCT02476968||Single Group Assignment||Other||None (Open Label)||||||
1385878|NCT02476955||Single Group Assignment||Treatment||None (Open Label)||||||
1385879|NCT02476942|||Cohort||Cross-Sectional|||||||
1385880|NCT02476929|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1385881|NCT02476916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385882|NCT02476903||||||||||||
1385883|NCT02476890|Randomized|Crossover Assignment||Treatment||Triple||Chronic cough and healthy participants were randomly assigned to receive gefapixant and placebo in one of two treatment sequences: Sequence A (placebo in treatment period 1, then gefapixant in treatment period 2) or Sequence B (gefapixant in treatment period 1, then placebo in treatment period 2). There was at least a 48-hour washout between the treatment periods. Daytime cough monitoring was performed in chronic cough participants only.|t||t|t
1385884|NCT02476877|||Cohort||Prospective|||||||
1385885|NCT02476864|Randomized|Crossover Assignment||||None (Open Label)||||||
1385886|NCT02476851||Single Group Assignment||||None (Open Label)||||||
1385887|NCT02476838||Single Group Assignment||Other||None (Open Label)||||||
1385888|NCT02476825|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385889|NCT02476812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385890|NCT02476799|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385891|NCT02476786||Single Group Assignment||Treatment||None (Open Label)||||||
1385892|NCT02476773|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1385893|NCT02476760|||Cohort||Retrospective|||||||
1385894|NCT02476747|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385895|NCT02476734|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385896|NCT02476721|||Cohort||Retrospective|||||||
1385897|NCT02476708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385898|NCT02476695|||Cohort||Prospective|||||||
1385899|NCT02476682|||Cohort||Prospective|||||||
1385900|NCT02476669|||Cohort||Prospective|||||||
1385901|NCT02476656|||Cohort||Prospective|||||||
1385902|NCT02476643|||Cohort||Prospective|||||||
1385903|NCT02476630|||Case-Only||Prospective|||||||
1385904|NCT02476617||Single Group Assignment||Treatment||None (Open Label)||||||
1385905|NCT02476604|Randomized|Parallel Assignment||Prevention||Single|||t|||
1385906|NCT02476591|||Cohort||Prospective|||||||
1385907|NCT02476578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385908|NCT02476565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385909|NCT02476552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385910|NCT02476539||Single Group Assignment||Treatment||None (Open Label)||||||
1385911|NCT02476526|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385912|NCT02476513|||Cohort||Prospective|||||||
1385913|NCT02476500|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1385914|NCT02476487||Single Group Assignment||Diagnostic||None (Open Label)||||||
1385915|NCT02476474|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385916|NCT02476461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385917|NCT02476448|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1385918|NCT02476435|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1385919|NCT02476422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385920|NCT02476409|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385921|NCT02476396|||Case-Control||Prospective|||||||
1385922|NCT02476383|Randomized|Parallel Assignment||Treatment||Single|||t|||
1385923|NCT02476370|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1385924|NCT02476357|Randomized|Parallel Assignment||Prevention||Single|||t|||
1385925|NCT02476344||Single Group Assignment||Prevention||None (Open Label)||||||
1385926|NCT02476331|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1385927|NCT02476318||Single Group Assignment||Treatment||None (Open Label)||||||
1385928|NCT02476305||Single Group Assignment||Treatment||None (Open Label)||||||
1385929|NCT02476292|||||Prospective|||||||
1385930|NCT02476279|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1385931|NCT02476266|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1385932|NCT02476253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385933|NCT02476240|Randomized|Parallel Assignment||Treatment||Single||||||t
1385934|NCT02476227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385935|NCT02476214|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1385936|NCT02476201||Single Group Assignment||Treatment||None (Open Label)||||||
1385937|NCT02476188|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385938|NCT02476175||Single Group Assignment||Treatment||None (Open Label)||||||
1385939|NCT02476162|||Cohort||Prospective|||||||
1385940|NCT02476149|||Cohort||Prospective|||||||
1385941|NCT02476136||||||||||||
1385942|NCT02476123||Single Group Assignment||Treatment||None (Open Label)||||||
1385943|NCT02476110|||Cohort||Prospective|||||||
1385944|NCT02476097|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1385945|NCT02476084|||Case-Control||Prospective|||||||
1385946|NCT02476071|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385947|NCT02476058|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1385948|NCT02476045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385949|NCT02476032|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385950|NCT02476019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385951|NCT02476006||Single Group Assignment||Treatment||None (Open Label)||||||
1385952|NCT02475993|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1385953|NCT02475980|||Cohort||Prospective|||||||
1385954|NCT02475967|Randomized|Parallel Assignment||Prevention||Single||||||t
1385955|NCT02475954|Randomized|Parallel Assignment||Treatment||Single||||||t
1385956|NCT02475941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385957|NCT02475928|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385958|NCT02475915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385959|NCT02475902|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1385960|NCT02475889|||Case Control||Retrospective|||||||
1385961|NCT02475876|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1385962|NCT02475863|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1385963|NCT02475850|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1385964|NCT02475837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1385965|NCT02475824|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1385966|NCT02475811|||Cohort||Prospective|||||||
1385967|NCT02475798||||||||||||
1385968|NCT02475785|Randomized|Parallel Assignment||Treatment||Single||||||t
1385969|NCT02475772||Single Group Assignment||Treatment||None (Open Label)||||||
1385970|NCT02475759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385971|NCT02475746||Single Group Assignment||Treatment||None (Open Label)||||||
1385972|NCT02475733|Randomized|Parallel Assignment||Treatment||Single||||||t
1385973|NCT02475720|||Cohort||Retrospective|||||||
1385974|NCT02475707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1385975|NCT02475694|||Cohort||Prospective|||||||
1385976|NCT02475681|Randomized|Parallel Assignment||Treatment||Single||||||t
1385977|NCT02475668|||Cohort||Prospective|||||||
1385978|NCT02475655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385979|NCT02475642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385980|NCT02475629||Single Group Assignment||Treatment||None (Open Label)||||||
1385981|NCT02475616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1385982|NCT02475603|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1385983|NCT02475590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385984|NCT02475577|Randomized|Parallel Assignment||Prevention||Single|||t|||
1385985|NCT02475564|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1385986|NCT02475551||Single Group Assignment||Treatment||None (Open Label)||||||
1385987|NCT02475538|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1385988|NCT02475525|Randomized|Parallel Assignment||Prevention||Single||||||t
1385989|NCT02475512|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1385990|NCT02475499|||Cohort||Retrospective|||||||
1385991|NCT02475486|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385992|NCT02475473|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385993|NCT02475460||Single Group Assignment||Supportive Care||None (Open Label)||||||
1385994|NCT02475447|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1385995|NCT02475434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1385996|NCT02475421|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1385997|NCT02475408||Single Group Assignment||Basic Science||None (Open Label)||||||
1385998|NCT02475395|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1385999|NCT02475382||||||||||||
1386000|NCT02475369|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386001|NCT02475356|||Cohort||Prospective|||||||
1386002|NCT02475343|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1386003|NCT02475330|Randomized|Single Group Assignment||Supportive Care||||||||
1386004|NCT02475317|Randomized|Parallel Assignment||||Double|||t||t|
1386005|NCT02475304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386006|NCT02475291|||Case-Only||Prospective|||||||
1386007|NCT02475278||Single Group Assignment||Other||None (Open Label)||||||
1386008|NCT02475265||Single Group Assignment||Treatment||None (Open Label)||||||
1386009|NCT02475252|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386010|NCT02475239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386011|NCT02475226|||Case-Crossover||Retrospective|||||||
1386012|NCT02475213||Single Group Assignment||Treatment||None (Open Label)||||||
1386013|NCT02475200|||Case-Only||Prospective|||||||
1386014|NCT02475187|||Case-Only||Prospective|||||||
1386015|NCT02475174|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1386016|NCT02475161||Single Group Assignment||Treatment||None (Open Label)||||||
1386017|NCT02475148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386018|NCT02475135|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386019|NCT02475122||Single Group Assignment||||None (Open Label)||||||
1386020|NCT02475109||Single Group Assignment||Treatment||None (Open Label)||||||
1386021|NCT02475096||Single Group Assignment||Treatment||None (Open Label)||||||
1386022|NCT02475083|Randomized|Parallel Assignment||Treatment||Single|||||t|
1386023|NCT02475070|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386024|NCT02475057|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1386025|NCT02475044|Randomized|Parallel Assignment||||None (Open Label)||||||
1386026|NCT02475031|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386027|NCT02475018|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386028|NCT02475005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386029|NCT02474992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386030|NCT02474979|Randomized|Parallel Assignment||Prevention||Single||||||t
1386031|NCT02474966|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1386032|NCT02474953|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1386033|NCT02474940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386034|NCT02474927||Single Group Assignment||Treatment||None (Open Label)||||||
1386035|NCT02474914|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1386036|NCT02474901|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Open label|||||
1386037|NCT02474888|||Cohort||Prospective|||||||
1386038|NCT02474875|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386039|NCT02474862|Randomized|Parallel Assignment||Treatment||Single||||||t
1386040|NCT02474849|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386041|NCT02474836|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1386042|NCT02474823||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386043|NCT02474810|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386044|NCT02474797||Single Group Assignment||Screening||None (Open Label)||||||
1386045|NCT02474784||||||||||||
1386046|NCT02474771||||||||||||
1386047|NCT02474758||||||||||||
1386048|NCT02474745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386049|NCT02474732||Single Group Assignment||Other||None (Open Label)||||||
1386050|NCT02474719|Randomized|Crossover Assignment||||None (Open Label)||||||
1386051|NCT02474706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386052|NCT02474693|||||Cross-Sectional|||||||
1386053|NCT02474680|||Cohort||Other|||||||
1386054|NCT02474667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386055|NCT02474654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386056|NCT02474641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386057|NCT02474628|Randomized|Crossover Assignment||||Triple|||t||t|t
1386058|NCT02474615|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386059|NCT02474602|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1386060|NCT02474589|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386061|NCT02474576||Single Group Assignment||Treatment||None (Open Label)||||||
1386062|NCT02474563|||Cohort||Prospective|||||||
1386063|NCT02474550|||Cohort||Prospective|||||||
1386064|NCT02474537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386065|NCT02474524|Randomized|Parallel Assignment||Treatment||Single||||||t
1386066|NCT02474511|||Cohort||Prospective|||||||
1386067|NCT02474498|Randomized|Parallel Assignment||Treatment||Single|||||t|
1386068|NCT02474485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386069|NCT02474459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386070|NCT02474446||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386071|NCT02474433|Randomized|Parallel Assignment||Prevention||Single||||t||
1386072|NCT02474420|Randomized|Parallel Assignment||Treatment||Single||||||t
1386073|NCT02474407|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386074|NCT02474394|Randomized|Parallel Assignment||Screening||Double|||t|||t
1386075|NCT02474381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386076|NCT02474368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386077|NCT02474355||Single Group Assignment||Treatment||None (Open Label)||||||
1386078|NCT02474342||Single Group Assignment||Treatment||None (Open Label)||||||
1386079|NCT02474329|||Cohort||Prospective|||||||
1386080|NCT02474316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386081|NCT02474303||Single Group Assignment||Prevention||None (Open Label)||Single Group Assignment||||
1386082|NCT02474290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386083|NCT02474277||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386084|NCT02474264|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1386085|NCT02474251|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)|Mechanistic or physiologic study in humans.|||||
1386086|NCT02474238|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386087|NCT02474225|||Cohort||Prospective|||||||
1386088|NCT02474212|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386089|NCT02474199||Single Group Assignment||Treatment||None (Open Label)||||||
1386090|NCT02474186||Single Group Assignment||Treatment||None (Open Label)||||||
1386091|NCT02474173||Single Group Assignment||Treatment||None (Open Label)||||||
1386092|NCT02474160||||||||||||
1386093|NCT02474147|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1386094|NCT02474134|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386095|NCT02474121||||||||||||
1386096|NCT02474108|Randomized|Single Group Assignment||Prevention||Single|||t|||
1386097|NCT02474095|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386098|NCT02474082|Randomized|Parallel Assignment||Treatment||Single||||||t
1386099|NCT02474069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386100|NCT02474056|||||Prospective|||||||
1386101|NCT02474043|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1386102|NCT02474030|||Case-Only||Prospective|||||||
1386103|NCT02474017||Single Group Assignment||Treatment||None (Open Label)||||||
1386104|NCT02474004|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1386105|NCT02473991|||Cohort||Prospective|||||||
1386106|NCT02473978|||Case-Crossover||Cross-Sectional|||||||
1386107|NCT02473965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386108|NCT02473952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386109|NCT02473939|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386110|NCT02473926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386111|NCT02473913|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1386112|NCT02473900|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386113|NCT02473887||Single Group Assignment||Treatment||None (Open Label)||||||
1386114|NCT02473874|||Case-Control||Prospective|||||||
1386115|NCT02473861|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1386116|NCT02473848||Single Group Assignment||Treatment||None (Open Label)||||||
1386117|NCT02473835||Single Group Assignment||Basic Science||None (Open Label)||||||
1386118|NCT02473822|||||Retrospective|||||||
1386119|NCT02473809|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386120|NCT02473796|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1386121|NCT02473783||Single Group Assignment||Other||None (Open Label)||||||
1386122|NCT02473770|||Cohort||Other|||||||
1386123|NCT02473757|||Cohort||Prospective|||||||
1386124|NCT02473744||Single Group Assignment||Supportive Care||None (Open Label)||||||
1386125|NCT02473731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386126|NCT02473718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386127|NCT02473705|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1386128|NCT02473692|||Other||Prospective|||||||
1386129|NCT02473679|||Cohort|||||||||
1386130|NCT02473666|||Other||Retrospective|||||||
1386131|NCT02473653||||||||||||
1386132|NCT02473640||Single Group Assignment||Treatment||None (Open Label)||||||
1386133|NCT02473627|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386134|NCT02473614|Randomized|Crossover Assignment||Treatment||Single||||||t
1386135|NCT02473601|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386136|NCT02473588||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386137|NCT02473575|Randomized|Crossover Assignment||||Triple|||t||t|t
1386138|NCT02473562|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386139|NCT02473549||Single Group Assignment||Treatment||None (Open Label)||||||
1386140|NCT02473536||Single Group Assignment||Treatment||None (Open Label)||||||
1386141|NCT02473523||Single Group Assignment||Supportive Care||None (Open Label)||||||
1386142|NCT02473510|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386143|NCT02473497||||||||||||
1386144|NCT02473484|||Cohort||Prospective|||||||
1386145|NCT02473471|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1386146|NCT02473458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386147|NCT02473445||Single Group Assignment||Treatment||None (Open Label)||Open-label extension study||||
1386148|NCT02473432|Randomized|Parallel Assignment||Treatment||Single||||||t
1386149|NCT02473419|||Other||Prospective|||||||
1386150|NCT02473406|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386151|NCT02473393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386152|NCT02473380||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386153|NCT02473367||Single Group Assignment||Treatment||None (Open Label)||||||
1386154|NCT02473354||Single Group Assignment||Health Services Research||None (Open Label)||||||
1386155|NCT02473341|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386156|NCT02473328||Single Group Assignment||Treatment||None (Open Label)||||||
1386157|NCT02473315|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386158|NCT02473302|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1386159|NCT02473289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386160|NCT02473276|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386161|NCT02473263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386162|NCT02473250||Single Group Assignment||Basic Science||None (Open Label)||||||
1386163|NCT02473237|Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1386164|NCT02473224|Randomized|Sequential Assignment||Other||Double|||t||t|
1386165|NCT02473211||Single Group Assignment||Treatment||None (Open Label)||||||
1386166|NCT02473198|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386167|NCT02473185|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1386168|NCT02473172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386169|NCT02473159||Single Group Assignment||Treatment||None (Open Label)||||||
1386170|NCT02473146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386171|NCT02473133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386172|NCT02473120||Single Group Assignment||Other||None (Open Label)||||||
1386173|NCT02473107|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1386174|NCT02473094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386175|NCT02473081|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1386176|NCT02473068|Randomized|Crossover Assignment||Treatment||Single|||t|||
1386177|NCT02473055|Randomized|Parallel Assignment||Treatment||Single||||||t
1386178|NCT02473042|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1386179|NCT02473029|||Case-Only||Cross-Sectional|||||||
1386180|NCT02473016||Crossover Assignment||Treatment||Single|||t|||
1386181|NCT02473003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386182|NCT02472990|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1386183|NCT02472977|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1386184|NCT02472964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386185|NCT02472951|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386186|NCT02472938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386187|NCT02472925|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1386188|NCT02472912|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1386189|NCT02472899|||Case Control|||||||||
1386190|NCT02472886|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386191|NCT02472873|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386192|NCT02472860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386193|NCT02472847|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1386194|NCT02472834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386195|NCT02472821|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386196|NCT02472808|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1386197|NCT02472795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386198|NCT02472782|||Cohort||Prospective|||||||
1386199|NCT02472769|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386200|NCT02472756|||Cohort||Prospective|||||||
1386201|NCT02472743||Single Group Assignment||Treatment||None (Open Label)||||||
1386202|NCT02472730|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1386203|NCT02472717|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1386204|NCT02472704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386205|NCT02472691||Single Group Assignment||Treatment||None (Open Label)||||||
1386206|NCT02472678|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386207|NCT02472665||Single Group Assignment||Treatment||None (Open Label)||||||
1386208|NCT02472652||Single Group Assignment||Treatment||None (Open Label)||||||
1386209|NCT02472639|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1386210|NCT02472626||Single Group Assignment||Treatment||None (Open Label)||||||
1386211|NCT02472613|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386212|NCT02472600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386213|NCT02472587|||Ecologic or Community||Retrospective|||||||
1386214|NCT02472574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386215|NCT02472561|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386216|NCT02472548|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1386217|NCT02472535||Single Group Assignment||Treatment||None (Open Label)||||||
1386218|NCT02472522|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1386219|NCT02472509||Single Group Assignment||Prevention||None (Open Label)||||||
1386220|NCT02472496|||Cohort||Retrospective|||||||
1386221|NCT02472483|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386222|NCT02472470||Single Group Assignment||Treatment||None (Open Label)||||||
1386223|NCT02472457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386224|NCT02472444|||Cohort||Prospective|||||||
1386225|NCT02472431||Single Group Assignment||Treatment||None (Open Label)||||||
1386226|NCT02472418|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386227|NCT02472405|Randomized|Crossover Assignment||Treatment||Single||Each participant scar was randomized to the 3 treatment arms.||||t
1386228|NCT02472392|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386229|NCT02472379|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1386230|NCT02472366|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386231|NCT02472353|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386232|NCT02472340|||Cohort||Cross-Sectional|||||||
1386233|NCT02472327|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1386234|NCT02472314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386235|NCT02472301|Randomized|Parallel Assignment||Treatment||Single|||||t|
1386236|NCT02472288|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386237|NCT02472275||Single Group Assignment||Treatment||None (Open Label)||||||
1386238|NCT02472262|Randomized|Parallel Assignment||Treatment||Single|||||t|
1386239|NCT02472249||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386240|NCT02472236||Single Group Assignment||Other||None (Open Label)||||||
1386241|NCT02472223|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386242|NCT02472210|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386243|NCT02472197|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386244|NCT02472184|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1386245|NCT02472171|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1386246|NCT02472158|Randomized|Parallel Assignment||Prevention||Single||||||t
1386247|NCT02472145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386248|NCT02472132|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1386249|NCT02472119|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386250|NCT02472106|||Case-Only||Prospective|||||||
1386251|NCT02472093|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386252|NCT02472080||Single Group Assignment||Treatment||None (Open Label)||||||
1386253|NCT02472067|Randomized|Parallel Assignment||Prevention||Single|||t|||
1386254|NCT02472054||Single Group Assignment||Treatment||None (Open Label)||||||
1386255|NCT02472041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386256|NCT02472028|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386257|NCT02472015|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386258|NCT02472002||Single Group Assignment||Treatment||None (Open Label)||||||
1386259|NCT02471989|Randomized|Parallel Assignment||||None (Open Label)||||||
1386260|NCT02471976|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386261|NCT02471963|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386262|NCT02471950|||Cohort||Prospective|||||||
1386263|NCT02471937||Single Group Assignment||Screening||None (Open Label)||||||
1386264|NCT02471924||Single Group Assignment||Prevention||None (Open Label)||||||
1386265|NCT02471911||Single Group Assignment||Treatment||None (Open Label)||||||
1386266|NCT02471898|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386267|NCT02471885|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1386268|NCT02471872|Randomized|Parallel Assignment||Prevention||Single|||t|||
1386269|NCT02471859|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1386270|NCT02471846|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386271|NCT02471833|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1386272|NCT02471820||Single Group Assignment||Treatment||None (Open Label)||||||
1386273|NCT02471807||Single Group Assignment||Treatment||None (Open Label)||||||
1386274|NCT02471794|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386275|NCT02471781||||||||||||
1386276|NCT02471768|||Cohort||Prospective|||||||
1386277|NCT02471755|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386278|NCT02471742|||Cohort||Prospective|||||||
1386279|NCT02471729||Single Group Assignment||Treatment||None (Open Label)||||||
1386280|NCT02471716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386281|NCT02471703|||Case-Only||Prospective|||||||
1386282|NCT02471690|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1386283|NCT02471677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386284|NCT02471664||Single Group Assignment||Treatment||None (Open Label)||||||
1386285|NCT02471651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386286|NCT02471638||Single Group Assignment||Treatment||None (Open Label)||||||
1386287|NCT02471625|||Case Control||Cross-Sectional|||||||
1386288|NCT02471612|||Cohort||Retrospective|||||||
1386289|NCT02471599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386290|NCT02471586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386291|NCT02471573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386292|NCT02471560|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1386293|NCT02471547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386294|NCT02471534||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386295|NCT02471521|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1386296|NCT02471508||Single Group Assignment||Treatment||None (Open Label)||||||
1386297|NCT02471495||Single Group Assignment||Treatment||None (Open Label)||||||
1386298|NCT02471482|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1386299|NCT02471469|||Cohort||Prospective|||||||
1386300|NCT02471456|||Case-Control||Prospective|||||||
1386301|NCT02471443|||Cohort||Prospective|||||||
1386302|NCT02471430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386303|NCT02471417|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1386304|NCT02471404|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386305|NCT02471391||Single Group Assignment||Treatment||None (Open Label)||||||
1386306|NCT02471378|||Cohort||Cross-Sectional|||||||
1386307|NCT02471365|||Cohort||Prospective|||||||
1386308|NCT02471352|||Cohort||Prospective|||||||
1386309|NCT02471339|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386310|NCT02471326||Single Group Assignment||Treatment||None (Open Label)||||||
1386311|NCT02471313||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386312|NCT02471300|||Case-Only||Prospective|||||||
1386313|NCT02471287|||Cohort||Cross-Sectional|||||||
1386314|NCT02471274|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386315|NCT02471261|||Case-Only||Prospective|||||||
1386316|NCT02471248|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1386317|NCT02471235|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1386318|NCT02471222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386319|NCT02471209|||Case-Only||Prospective|||||||
1386320|NCT02471196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386321|NCT02471183||Single Group Assignment||Treatment||None (Open Label)||||||
1386322|NCT02471170|||Cohort||Prospective|||||||
1386323|NCT02471157|||Case Control||Prospective|||||||
1386324|NCT02471144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386325|NCT02471131||Single Group Assignment||Treatment||None (Open Label)||||||
1386326|NCT02471118|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1386327|NCT02471105|Randomized|Crossover Assignment||Treatment||Single|||||t|
1386328|NCT02471092|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1386329|NCT02471079|||Cohort||Retrospective|||||||
1386330|NCT02471066|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1386331|NCT02471053||Single Group Assignment||Treatment||None (Open Label)||||||
1386332|NCT02471040|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1386333|NCT02471027|||Case Control|||||||||
1386334|NCT02471014|||Cohort||Prospective|||||||
1386335|NCT02471001|||Cohort||Cross-Sectional|||||||
1386336|NCT02470988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386337|NCT02470975|||Family-Based||Prospective|||||||
1386338|NCT02470962|||Cohort||Prospective|||||||
1386339|NCT02470949|Randomized|Crossover Assignment||||Single|||t|||
1386340|NCT02470936|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386341|NCT02470923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386342|NCT02470910||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386343|NCT02470897|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386344|NCT02470884||Single Group Assignment||Treatment||None (Open Label)||||||
1386345|NCT02470871|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1386346|NCT02470858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386347|NCT02470845|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386348|NCT02470832|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386349|NCT02470819||Single Group Assignment||Treatment||None (Open Label)||||||
1386350|NCT02470806|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1386351|NCT02470793|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386352|NCT02470780|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386353|NCT02470767|||Cohort||Cross-Sectional|||||||
1386354|NCT02470754|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386355|NCT02470741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386356|NCT02470728|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1386357|NCT02470715|||Other||Other|||||||
1386358|NCT02470702|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1386359|NCT02470689|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1386360|NCT02470676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386361|NCT02470663|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1386362|NCT02470650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386363|NCT02470637|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386364|NCT02470624|||Cohort||Prospective|||||||
1386365|NCT02470611|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386366|NCT02470598|||Cohort||Prospective|||||||
1386367|NCT02470585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386368|NCT02470572|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1386369|NCT02470559||Single Group Assignment||Treatment||None (Open Label)||||||
1386370|NCT02470546|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386371|NCT02470533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386372|NCT02470520|||Cohort||Prospective|||||||
1386373|NCT02470507|||Case-Control||Prospective|||||||
1386374|NCT02470494||Single Group Assignment||Treatment||None (Open Label)||||||
1386375|NCT02470481|||Case-Only||Prospective|||||||
1386376|NCT02470468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386377|NCT02470455|||Cohort||Prospective|||||||
1386378|NCT02470442|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1386379|NCT02470429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386380|NCT02470416|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1386381|NCT02470403|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1386382|NCT02470390|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1386383|NCT02470377||Single Group Assignment||Treatment||None (Open Label)||||||
1386384|NCT02470364|||Cohort||Prospective|||||||
1386385|NCT02470351|||Cohort||Prospective|||||||
1386386|NCT02470338|Randomized|Parallel Assignment||Other||Single||||||t
1386387|NCT02470325|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386388|NCT02470312|||Cohort||Prospective|||||||
1386922|NCT02463370|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1386389|NCT02470299|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1386390|NCT02470286|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1386391|NCT02470273|||Cohort||Cross-Sectional|||||||
1386392|NCT02470260|||Cohort||Prospective|||||||
1386393|NCT02470247|Randomized|Parallel Assignment||Prevention||Single|||t|||
1386394|NCT02470234||Single Group Assignment||Treatment||None (Open Label)||||||
1386395|NCT02470221|||Cohort||Prospective|||||||
1386396|NCT02470208|||Other||Prospective|||||||
1386397|NCT02470195|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1386398|NCT02470182|||Case-Only||Cross-Sectional|||||||
1386399|NCT02470169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386400|NCT02470156|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1386401|NCT02470143|||Other||Prospective|||||||
1386402|NCT02470130|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1386403|NCT02470117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386404|NCT02470104|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386405|NCT02470091||Single Group Assignment||Treatment||None (Open Label)||||||
1386406|NCT02470078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386407|NCT02470065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386408|NCT02470052||Single Group Assignment||Treatment||None (Open Label)||||||
1386409|NCT02470039|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386410|NCT02470026|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1386411|NCT02470013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386412|NCT02470000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386413|NCT02469987|Randomized|Parallel Assignment||||Double|||t||t|
1386414|NCT02469974||Single Group Assignment||Treatment||None (Open Label)||||||
1386415|NCT02469961|Randomized|Parallel Assignment||||None (Open Label)||||||
1386416|NCT02469948|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386417|NCT02469935|||||Prospective|||||||
1386418|NCT02469922||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386419|NCT02469909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386420|NCT02469896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386421|NCT02469883||Single Group Assignment||Treatment||None (Open Label)||||||
1386422|NCT02469870||Single Group Assignment||Supportive Care||None (Open Label)||||||
1386423|NCT02469857|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1386424|NCT02469844|||Case-Only||Prospective|||||||
1386425|NCT02469831|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1386426|NCT02469818|||Case-Only||Prospective|||||||
1386427|NCT02469805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386428|NCT02469792||Single Group Assignment||Treatment||None (Open Label)||||||
1386429|NCT02469779|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386430|NCT02469766|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386431|NCT02469753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386432|NCT02469740|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386433|NCT02469727|Randomized|Parallel Assignment||Treatment||Single|||||t|
1386434|NCT02469714|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386435|NCT02469701||Single Group Assignment||Treatment||None (Open Label)||||||
1386436|NCT02469688|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386437|NCT02469675||Single Group Assignment||Basic Science||None (Open Label)||||||
1386438|NCT02469662|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386439|NCT02469649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386440|NCT02469636||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386441|NCT02469623||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386442|NCT02469610|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386443|NCT02469597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386444|NCT02469584||Single Group Assignment||Treatment||None (Open Label)||||||
1386445|NCT02469571|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386446|NCT02469558|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386447|NCT02469545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386448|NCT02469532|||Case-Only||Prospective|||||||
1386449|NCT02469519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386450|NCT02469506|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386451|NCT02469493|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1386452|NCT02469480|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386453|NCT02469467||Single Group Assignment||Treatment||None (Open Label)||||||
1386454|NCT02469454|Randomized|Parallel Assignment||||Single||||||t
1386455|NCT02469441|||Case-Control||Prospective|||||||
1386456|NCT02469428|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1386457|NCT02469415||Single Group Assignment||Treatment||None (Open Label)||||||
1386458|NCT02469402|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386459|NCT02469389|Randomized|Parallel Assignment||Treatment||Single||||||t
1386460|NCT02469376||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386461|NCT02469363|Randomized|Parallel Assignment||Screening||Single|||||t|
1386462|NCT02469350||Single Group Assignment||Other||None (Open Label)||||||
1386463|NCT02469337|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1386464|NCT02469324|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1386465|NCT02469311|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386466|NCT02469298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386467|NCT02469285|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1386468|NCT02469272||Single Group Assignment||Treatment||None (Open Label)||||||
1386469|NCT02469259|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386470|NCT02469246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386471|NCT02469233|Randomized|Crossover Assignment||Treatment||Single||||||t
1386472|NCT02469220|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1386473|NCT02469207|||Cohort||Prospective|||||||
1386474|NCT02469194|||Cohort||Prospective|||||||
1386475|NCT02469181|||Case-Only||Prospective|||||||
1386476|NCT02469168|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386477|NCT02469155|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386478|NCT02469142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386479|NCT02469129|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1386480|NCT02469116||Single Group Assignment||Treatment||None (Open Label)||||||
1386481|NCT02469103||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386482|NCT02469090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386483|NCT02469077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386484|NCT02469064|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1386485|NCT02469051||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386486|NCT02469038|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1386487|NCT02469025|Randomized|Parallel Assignment||Treatment||Single|||||t|
1386488|NCT02469012||Single Group Assignment||Screening||None (Open Label)||||||
1386489|NCT02468999|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1386490|NCT02468986|||Case Control||Cross-Sectional|||||||
1386491|NCT02468973||Single Group Assignment||Prevention||None (Open Label)||||||
1386492|NCT02468960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386493|NCT02468947|||Cohort||Prospective|||||||
1386494|NCT02468934||Single Group Assignment||Treatment||None (Open Label)||||||
1386495|NCT02468921|||Cohort||Prospective|||||||
1386496|NCT02468908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386497|NCT02468895|||Cohort||Prospective|||||||
1386498|NCT02468882|Randomized|Parallel Assignment||||Double||||t||t
1386499|NCT02468869|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1386500|NCT02468856|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1386501|NCT02468843|||Case-Only||Prospective|||||||
1386502|NCT02468830||Single Group Assignment||Treatment||None (Open Label)||||||
1386503|NCT02468817|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1386504|NCT02468804|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1386505|NCT02468791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386506|NCT02468778|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386507|NCT02468765|||Case Control||Cross-Sectional|||||||
1386508|NCT02468752|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1386509|NCT02468739|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1386510|NCT02468726|Randomized|Crossover Assignment||Screening||Double|||t|t||
1386511|NCT02468713|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386512|NCT02468700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386513|NCT02468687||Single Group Assignment||Treatment||None (Open Label)||||||
1386514|NCT02468674|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1386515|NCT02468661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386516|NCT02468648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386517|NCT02468635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386518|NCT02468622|||Case-Only||Prospective|||||||
1386519|NCT02468609||Single Group Assignment||Diagnostic||Single|||||t|
1386520|NCT02468596||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386521|NCT02468583|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386522|NCT02468570|||Cohort||Prospective|||||||
1386523|NCT02468557|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386524|NCT02468544||Single Group Assignment||Supportive Care||None (Open Label)||||||
1386525|NCT02468531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386526|NCT02468518|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386527|NCT02468505|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1386528|NCT02468492|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1386529|NCT02468479|||Cohort||Prospective|||||||
1386530|NCT02468466|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386531|NCT02468453|Randomized|Single Group Assignment||Treatment||Single||||||t
1386532|NCT02468440|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386533|NCT02468427|Randomized|Parallel Assignment||||Single||||||t
1386534|NCT02468414||Single Group Assignment||Treatment||None (Open Label)||||||
1386535|NCT02468401||Single Group Assignment||Prevention||None (Open Label)||||||
1386536|NCT02468388|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1386537|NCT02468375||Single Group Assignment||Treatment||None (Open Label)||||||
1386538|NCT02468362|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386539|NCT02468349|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1386540|NCT02468336|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1386541|NCT02468323|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386542|NCT02468310|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1386543|NCT02468297|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386544|NCT02468284||Single Group Assignment||Basic Science||None (Open Label)||||||
1386545|NCT02468271|||Cohort||Prospective|||||||
1386546|NCT02468258|Randomized|Parallel Assignment||||Single|||t|||
1386547|NCT02468245|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386548|NCT02468232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386549|NCT02468219|Randomized|Parallel Assignment||Treatment||Single|||||t|
1386550|NCT02468206|Randomized|Parallel Assignment||Treatment||Single||||||t
1386551|NCT02468193||Single Group Assignment||Treatment||None (Open Label)||||||
1386552|NCT02468180|Randomized|Parallel Assignment||Treatment||Single||||||t
1386553|NCT02468167|Randomized|Parallel Assignment||Treatment||Single||||||t
1386554|NCT02468154|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386555|NCT02468141|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1386556|NCT02468128|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386557|NCT02468115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386558|NCT02468102|||Cohort||Prospective|||||||
1386559|NCT02468089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386560|NCT02468076||Single Group Assignment||Treatment||None (Open Label)||||||
1386561|NCT02468063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386562|NCT02468050|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1386563|NCT02468037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386564|NCT02468024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386565|NCT02468011||Single Group Assignment||Basic Science||None (Open Label)||||||
1386566|NCT02467998|||Case-Control||Prospective|||||||
1386567|NCT02467985|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386568|NCT02467972|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1386569|NCT02467959|||Cohort||Prospective|||||||
1386570|NCT02467946||Single Group Assignment||Treatment||None (Open Label)||||||
1386571|NCT02467933|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1386572|NCT02467920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386573|NCT02467907||Single Group Assignment||Treatment||None (Open Label)||||||
1386574|NCT02467894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386575|NCT02467881|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386576|NCT02467868|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1386577|NCT02467855|||Cohort||Prospective|||||||
1386578|NCT02467842|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386579|NCT02467829|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386580|NCT02467816|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386581|NCT02467803|Randomized|Crossover Assignment||Treatment||Single||||||t
1386582|NCT02467790|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386583|NCT02467777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386584|NCT02467764|||||Retrospective|||||||
1386585|NCT02467751|||Case-Crossover||Cross-Sectional|||||||
1386586|NCT02467738||Single Group Assignment||Treatment||None (Open Label)||||||
1386587|NCT02467725|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1386588|NCT02467712|||||Retrospective|||||||
1386589|NCT02467699|||Other||Retrospective|||||||
1386590|NCT02467686|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386591|NCT02467673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386592|NCT02467660|Randomized|Factorial Assignment||Health Services Research||Double|||||t|t
1386593|NCT02467647|Randomized|Crossover Assignment||Treatment||Single|||t|||
1386594|NCT02467634||Single Group Assignment||Treatment||None (Open Label)||||||
1386595|NCT02467621|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386596|NCT02467608|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386597|NCT02467595|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1386598|NCT02467582|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386599|NCT02467569||Single Group Assignment||Treatment||None (Open Label)||||||
1386600|NCT02467556||Single Group Assignment||Treatment||None (Open Label)||||||
1386601|NCT02467543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386602|NCT02467530|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386603|NCT02467517|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386604|NCT02467504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386605|NCT02467491||Single Group Assignment||||None (Open Label)||||||
1386606|NCT02467478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386607|NCT02467465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386608|NCT02467452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386609|NCT02467439|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386610|NCT02467426|||Case Control||Prospective|||||||
1386611|NCT02467413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386612|NCT02467400|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1386613|NCT02467387|Randomized|Crossover Assignment||Treatment||Single|||t|||
1386614|NCT02467374|Randomized|Parallel Assignment||Treatment||Single||||||t
1386615|NCT02467361|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386616|NCT02467348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386617|NCT02467335|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1386618|NCT02467322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386620|NCT02467296|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1386621|NCT02467283|||Case-Control||Cross-Sectional|||||||
1386622|NCT02467270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386623|NCT02467257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386624|NCT02467244|||Cohort||Prospective|||||||
1386625|NCT02467231|||Cohort||Prospective|||||||
1386626|NCT02467218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386627|NCT02467205|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1386628|NCT02467192||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386629|NCT02467179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386630|NCT02467166||Single Group Assignment||Prevention||None (Open Label)||||||
1386631|NCT02467153|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1386632|NCT02467140|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386633|NCT02467127|Randomized|Parallel Assignment||Treatment||Single|||||t|
1386634|NCT02467114||Single Group Assignment||Basic Science||Single|||t|||
1386635|NCT02467101||Single Group Assignment||Treatment||Triple|||t||t|t
1386636|NCT02467088||Single Group Assignment||Treatment||None (Open Label)||||||
1386637|NCT02467075|Randomized|Parallel Assignment||Other||Double|||t||t|
1386638|NCT02467062|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1386639|NCT02467049|Randomized|Parallel Assignment||Treatment||Single||||||t
1386640|NCT02467036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386641|NCT02467023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386642|NCT02467010||Single Group Assignment||Treatment||None (Open Label)||||||
1386643|NCT02466997|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386644|NCT02466984|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386645|NCT02466971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386646|NCT02466958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386647|NCT02466945||Single Group Assignment||Treatment||None (Open Label)||||||
1386648|NCT02466932|||||Cross-Sectional|||||||
1386649|NCT02466919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386650|NCT02466906|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386651|NCT02466893||Single Group Assignment||Treatment||None (Open Label)||||||
1386652|NCT02466880|Randomized|Parallel Assignment||Treatment||Single||||||t
1386653|NCT02466867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386654|NCT02466854|||Cohort||Retrospective|||||||
1386655|NCT02466841|||Cohort||Prospective|||||||
1386656|NCT02466828||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386657|NCT02466815|Randomized|Crossover Assignment||||None (Open Label)||||||
1386658|NCT02466802||Single Group Assignment||Treatment||None (Open Label)||||||
1386659|NCT02466789|||Ecologic or Community||Prospective|||||||
1386660|NCT02466776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386661|NCT02466763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386662|NCT02466750|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386663|NCT02466737|Randomized|Parallel Assignment||Treatment||||||||
1386664|NCT02466724|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1386665|NCT02466711|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1386666|NCT02466698|Randomized|Parallel Assignment||Treatment||Single||||||t
1386667|NCT02466685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386668|NCT02466672|||Cohort||Prospective|||||||
1386669|NCT02466659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386670|NCT02466646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386671|NCT02466633||Single Group Assignment||Health Services Research||None (Open Label)||||||
1386672|NCT02466620|||||Cross-Sectional|||||||
1386673|NCT02466607|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1386674|NCT02466594||Single Group Assignment||Supportive Care||None (Open Label)||||||
1386675|NCT02466581|Randomized|Parallel Assignment||Treatment||Single||||||t
1386676|NCT02466568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386677|NCT02466555||Single Group Assignment||Treatment||None (Open Label)||||||
1386678|NCT02466542|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1386679|NCT02466529|||Case-Only||Retrospective|||||||
1386680|NCT02466516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386681|NCT02466503|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386682|NCT02466490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386683|NCT02466477|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386684|NCT02466464|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386685|NCT02466451|||Case-Only||Prospective|||||||
1386686|NCT02466438||Single Group Assignment||Treatment||None (Open Label)||||||
1386687|NCT02466425|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386688|NCT02466412|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1386689|NCT02466399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386690|NCT02466386|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386691|NCT02466373|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386692|NCT02466360|||||Cross-Sectional|||||||
1386693|NCT02466347|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386694|NCT02466334|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1386695|NCT02466321||Single Group Assignment||Treatment||None (Open Label)||||||
1386696|NCT02466308||Single Group Assignment||Treatment||None (Open Label)||||||
1386697|NCT02466295|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1386698|NCT02466282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386699|NCT02466269|||Case-Only||Retrospective|||||||
1386700|NCT02466256|Randomized|Single Group Assignment||Treatment||Single|||t|||
1386701|NCT02466243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386702|NCT02466230||Single Group Assignment||Treatment||None (Open Label)||||||
1386703|NCT02466217|||Case Control||Cross-Sectional|||||||
1386704|NCT02466204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386705|NCT02466191|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386706|NCT02466178|||Cohort||Prospective|||||||
1386707|NCT02466165|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386708|NCT02466152|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386709|NCT02466139|||Cohort||Prospective|||||||
1386710|NCT02466126|Randomized|Parallel Assignment||Treatment||Single||||||t
1386711|NCT02466113|Randomized|Parallel Assignment||||None (Open Label)||||||
1386712|NCT02466100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386713|NCT02466087|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386714|NCT02466074|Randomized|Parallel Assignment||Treatment||Triple||Two phase design: phase 1, patients randomized to ACZ or placebo and followed for 24 weeks; phase 2, patients that received placebo in phase 1 switch to ACZ (delayed-start group) and patients that received ACZ in phase 1 continue on ACZ (ACZ-ACZ group)|t||t|t
1386715|NCT02466061|Randomized|Single Group Assignment||||None (Open Label)||||||
1386716|NCT02466048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386717|NCT02466035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386718|NCT02466022|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386719|NCT02466009||Single Group Assignment||Treatment||None (Open Label)||||||
1386720|NCT02465996|Randomized|Parallel Assignment||||None (Open Label)||||||
1386721|NCT02465983||Single Group Assignment||Treatment||None (Open Label)||||||
1386722|NCT02465970|Randomized|Crossover Assignment||Treatment||Single|||t|||
1386723|NCT02465957||Single Group Assignment||Treatment||None (Open Label)||||||
1386724|NCT02465944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386725|NCT02465931|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1386726|NCT02465918|Randomized|Crossover Assignment||Treatment||Single|||t|||
1386727|NCT02465905|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1386728|NCT02465892|Randomized|Parallel Assignment||Supportive Care||||||||
1386729|NCT02465879||Single Group Assignment||||None (Open Label)||||||
1386730|NCT02465866|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386731|NCT02465853|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386732|NCT02465840|Non-Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1386733|NCT02465827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386734|NCT02465814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386735|NCT02465801|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386736|NCT02465788||Single Group Assignment||Treatment||None (Open Label)||||||
1386737|NCT02465775||Single Group Assignment||Treatment||None (Open Label)||||||
1386738|NCT02465762||Single Group Assignment||Treatment||None (Open Label)||||||
1386739|NCT02465749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386740|NCT02465736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386741|NCT02465723||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386742|NCT02465710|||Case-Only||Retrospective|||||||
1386743|NCT02465697|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1386744|NCT02465684|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1386745|NCT02465671|||Case-Only||Prospective|||||||
1386746|NCT02465658|||Case-Only||Retrospective|||||||
1386747|NCT02465645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386748|NCT02465632|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386749|NCT02465619|||Case-Only||Prospective|||||||
1386750|NCT02465606|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386751|NCT02465593||Single Group Assignment||Treatment||None (Open Label)||||||
1386752|NCT02465580|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386753|NCT02465567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386754|NCT02465554|||Cohort||Prospective|||||||
1386755|NCT02465541|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1386756|NCT02465528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386757|NCT02465515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386758|NCT02465502||Single Group Assignment||Treatment||None (Open Label)||||||
1386759|NCT02465489|Randomized|Crossover Assignment||||None (Open Label)||||||
1386760|NCT02465476|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386761|NCT02465463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386762|NCT02465450|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1386763|NCT02465437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386764|NCT02465424|||Case-Only||Other|||||||
1386765|NCT02465411||Single Group Assignment||Treatment||None (Open Label)||||||
1386766|NCT02465398||Single Group Assignment||Treatment||None (Open Label)||||||
1386767|NCT02465385||Single Group Assignment||Treatment||Single||||||t
1386768|NCT02465372|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386769|NCT02465359||Single Group Assignment||Other||None (Open Label)||||||
1386770|NCT02465346|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1386771|NCT02465333|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386772|NCT02465320|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1386773|NCT02465307|||Case-Control||Prospective|||||||
1386774|NCT02465294|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1386775|NCT02465281|||Case-Only||Prospective|||||||
1386776|NCT02465268|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386777|NCT02465255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386778|NCT02465242|||Cohort||Prospective|||||||
1386779|NCT02465229||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386780|NCT02465216|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1386781|NCT02465203|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1386782|NCT02465190|||Case Control||Prospective|||||||
1386783|NCT02465177|||Cohort||Prospective|||||||
1386784|NCT02465164|Randomized|Single Group Assignment||||None (Open Label)||||||
1386785|NCT02465151|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1386786|NCT02465138|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1386787|NCT02465125|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386788|NCT02465112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386789|NCT02465099|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386790|NCT02465086|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386791|NCT02465073|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1386792|NCT02465060|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386793|NCT02465047|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386794|NCT02465034|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386795|NCT02465021|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386796|NCT02465008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386797|NCT02464995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386798|NCT02464982|||Cohort||Prospective|||||||
1386799|NCT02464969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386800|NCT02464956|||Cohort||Prospective|||||||
1386801|NCT02464943||||||||||||
1386802|NCT02464930|||Case Control||Prospective|||||||
1386803|NCT02464917|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1386804|NCT02464904|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386805|NCT02464891||Single Group Assignment||Treatment||None (Open Label)||||||
1386806|NCT02464878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386807|NCT02464865|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1386808|NCT02464852||Single Group Assignment||Supportive Care||None (Open Label)||||||
1386809|NCT02464839|||Cohort||Prospective|||||||
1386810|NCT02464826||Single Group Assignment||Treatment||None (Open Label)||||||
1386811|NCT02464813|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1386812|NCT02464800|||Case Control||Retrospective|||||||
1386813|NCT02464787||Single Group Assignment||Other||None (Open Label)||||||
1386814|NCT02464774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386815|NCT02464761||Single Group Assignment||Treatment||None (Open Label)||||||
1386816|NCT02464748|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386817|NCT02464735|||Cohort||Prospective|||||||
1386818|NCT02464722|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1386819|NCT02464709||Single Group Assignment||Treatment||Double|||t|||t
1386820|NCT02464696|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386821|NCT02464683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386822|NCT02464670|Randomized|Sequential Assignment||Prevention||Double|In Part II only (Groups 3A and 3B), the current strength of the device will be masked from the study team administering the procedure and participant. All IP assignments will be open label and unmasked.||t||t|
1386823|NCT02464657||Single Group Assignment||Treatment||None (Open Label)||||||
1386824|NCT02464644|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1386825|NCT02464631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386826|NCT02464618|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1386827|NCT02464605||Single Group Assignment||Treatment||None (Open Label)||||||
1386828|NCT02464592|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1386829|NCT02464579|||Cohort||Prospective|||||||
1386830|NCT02464566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386831|NCT02464553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386832|NCT02464540|Randomized|Parallel Assignment||Treatment||Single||||||t
1386833|NCT02464527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386834|NCT02464514|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1386835|NCT02464501||Single Group Assignment||Treatment||None (Open Label)||||||
1386836|NCT02464488|||Case-Only||Prospective|||||||
1386837|NCT02464475|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386838|NCT02464462|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386839|NCT02464449|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1386840|NCT02464436||Single Group Assignment||Treatment||None (Open Label)||||||
1386841|NCT02464423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386842|NCT02464410|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386843|NCT02464397|Randomized|Parallel Assignment||Treatment||Single||||||t
1386844|NCT02464384||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386845|NCT02464371|||Case-Control||Prospective|||||||
1386846|NCT02464358|Randomized|Parallel Assignment||Prevention||Single|||t|||
1386847|NCT02464345|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386848|NCT02464332||Single Group Assignment||||None (Open Label)||||||
1386849|NCT02464319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386850|NCT02464306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386851|NCT02464293||Single Group Assignment||Treatment||None (Open Label)||||||
1386852|NCT02464280|||Case-Only||Prospective|||||||
1386853|NCT02464267|||Other||Other|||||||
1386854|NCT02464254|Randomized|Parallel Assignment||Prevention||Single||||||t
1386855|NCT02464241|||Cohort||Prospective|||||||
1386856|NCT02464228||Single Group Assignment||Treatment||None (Open Label)||||||
1386857|NCT02464215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386858|NCT02464202||Single Group Assignment||Treatment||None (Open Label)||||||
1386859|NCT02464189|||Case-Only||Prospective|||||||
1386860|NCT02464176|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1386861|NCT02464163|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386862|NCT02464150||Single Group Assignment||Basic Science||None (Open Label)||||||
1386863|NCT02464137||Single Group Assignment||Treatment||None (Open Label)||||||
1386864|NCT02464124|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386865|NCT02464111|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1386866|NCT02464098|||Cohort||Prospective|||||||
1386867|NCT02464085|||Cohort||Prospective|||||||
1386868|NCT02464072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386869|NCT02464059||Single Group Assignment||Basic Science||None (Open Label)||||||
1386870|NCT02464046|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386871|NCT02464033||Single Group Assignment||Treatment||None (Open Label)||||||
1386872|NCT02464020|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1386873|NCT02464007||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1386874|NCT02463994||Single Group Assignment||Treatment||None (Open Label)||||||
1386875|NCT02463981|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1386876|NCT02463968|||Cohort||Cross-Sectional|||||||
1386877|NCT02463955||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386878|NCT02463942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386879|NCT02463929|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386880|NCT02463916|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386881|NCT02463903|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386882|NCT02463890|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386883|NCT02463877|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1386884|NCT02463864|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386885|NCT02463851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386886|NCT02463838|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1386887|NCT02463825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386888|NCT02463812|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386889|NCT02463799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386890|NCT02463786|||Cohort||Other|||||||
1386891|NCT02463773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386892|NCT02463760|||Other||Prospective|||||||
1386893|NCT02463747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386894|NCT02463734|||||Cross-Sectional|||||||
1386895|NCT02463721||Single Group Assignment||Diagnostic||None (Open Label)||||||
1386896|NCT02463708|||Case-Only||Prospective|||||||
1386897|NCT02463695|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1386898|NCT02463682|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386899|NCT02463669|||Cohort||Prospective|||||||
1386900|NCT02463656|||Case-Only||Cross-Sectional|||||||
1386901|NCT02463643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386902|NCT02463630||Single Group Assignment||Treatment||Single||||||t
1386903|NCT02463617||Single Group Assignment||Other||None (Open Label)||||||
1386904|NCT02463604|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1386905|NCT02463591|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1386906|NCT02463578|||||Prospective|||||||
1386907|NCT02463565|||Cohort||Cross-Sectional|||||||
1386908|NCT02463552|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1386909|NCT02463539|||||Prospective|||||||
1386910|NCT02463526|Randomized|Crossover Assignment||Treatment||Single|||||t|
1386911|NCT02463513|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1386912|NCT02463500|||Case-Only||Prospective|||||||
1386913|NCT02463487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386914|NCT02463474||Single Group Assignment||Supportive Care||None (Open Label)||||||
1386915|NCT02463461|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1386916|NCT02463448||Single Group Assignment||Treatment||None (Open Label)||||||
1386917|NCT02463435|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386918|NCT02463422|||Cohort||Prospective|||||||
1386919|NCT02463409||Single Group Assignment||Treatment||None (Open Label)||||||
1386920|NCT02463396|Randomized|Parallel Assignment||Treatment||Single||||||t
1386921|NCT02463383|Randomized|Crossover Assignment||Basic Science||Quadruple||Participants are randomized to an ibuprofen or placebo pill in the first period and are then provided with placebo or ibuprofen pills, respectively, in the second period in a crossover fashion. Alcohol (0.4g/kg bw) is provided as a challenge 30min after the pill has been swallowed.|t|t|t|t
1386923|NCT02463357|Non-Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1386924|NCT02463344|||Cohort||Prospective|||||||
1386925|NCT02463331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386926|NCT02463318|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1386927|NCT02463305|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1386928|NCT02463292|||Case Control||Cross-Sectional|||||||
1386929|NCT02463279||Single Group Assignment||Treatment||None (Open Label)||||||
1386930|NCT02463266|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1386931|NCT02463253|||Case Control||Prospective|||||||
1386932|NCT02463227||Single Group Assignment||Treatment||None (Open Label)||||||
1386933|NCT02463214|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386934|NCT02463201|||Cohort||Prospective|||||||
1386935|NCT02463188|Randomized|Parallel Assignment||Prevention||Single||||||t
1386936|NCT02463175|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386937|NCT02463162|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1386938|NCT02463149|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386939|NCT02463136||Single Group Assignment||Basic Science||None (Open Label)||||||
1386940|NCT02463123|||Cohort||Prospective|||||||
1386941|NCT02463110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386942|NCT02463097||Single Group Assignment||Treatment||None (Open Label)||||||
1386943|NCT02463084|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1386944|NCT02463071|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386945|NCT02463058||Single Group Assignment||Prevention||None (Open Label)||||||
1386946|NCT02463045|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1386947|NCT02463032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386948|NCT02463019|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386949|NCT02463006|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386950|NCT02462993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386951|NCT02462967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386952|NCT02462954|Randomized|Parallel Assignment||Prevention||Single||||||t
1386953|NCT02462941||Single Group Assignment||Treatment||None (Open Label)||||||
1386954|NCT02462928|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1386955|NCT02462915|Randomized|Parallel Assignment||Treatment||Single||||||t
1386956|NCT02462902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386957|NCT02462889|Randomized|Parallel Assignment||Prevention||Single|||t|||
1386958|NCT02462876|||Cohort||Retrospective|||||||
1386959|NCT02462863||Single Group Assignment||Treatment||None (Open Label)||||||
1386960|NCT02462850||Single Group Assignment||Treatment||None (Open Label)||||||
1386961|NCT02462837|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386962|NCT02462824|Randomized|Parallel Assignment||Treatment||Single||||||t
1386963|NCT02462811|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1386964|NCT02462798|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1386965|NCT02462785|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386966|NCT02462772|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1386967|NCT02462759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1386968|NCT02462746|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1386969|NCT02462733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386970|NCT02462720|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386971|NCT02462707||Parallel Assignment||Treatment||None (Open Label)||||||
1386972|NCT02462694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386973|NCT02462681|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386974|NCT02462668|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386975|NCT02462655|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1386976|NCT02462642|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1386977|NCT02462629||Single Group Assignment||Other||None (Open Label)||||||
1386978|NCT02462616|||Ecologic or Community||Cross-Sectional|||||||
1386979|NCT02462603||Single Group Assignment||Treatment||None (Open Label)||||||
1386980|NCT02462590|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1386981|NCT02462577|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1386982|NCT02462564|||Case-Only||Prospective|||||||
1386983|NCT02462551||Single Group Assignment||Treatment||None (Open Label)||||||
1386984|NCT02462538||Single Group Assignment||Treatment||None (Open Label)||||||
1386985|NCT02462525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1386986|NCT02462512|||Cohort||Prospective|||||||
1386987|NCT02462499||Single Group Assignment||Treatment||None (Open Label)||||||
1386988|NCT02462486|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1386989|NCT02462473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386990|NCT02462460|||Cohort||Prospective|||||||
1386991|NCT02462447|||Other||Prospective|||||||
1386992|NCT02462434|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1386993|NCT02462421|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1386994|NCT02462408|Randomized|Parallel Assignment||||None (Open Label)||||||
1386995|NCT02462395||Single Group Assignment||Treatment||None (Open Label)||||||
1386996|NCT02462382|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1386997|NCT02462369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1386998|NCT02462356|Randomized|Parallel Assignment||Treatment||Single|||t|||
1386999|NCT02462343|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1387000|NCT02462330|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387001|NCT02462317|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1387002|NCT02462304|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387003|NCT02462291|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1387004|NCT02462278||Single Group Assignment||Other||None (Open Label)||||||
1387005|NCT02462265||Single Group Assignment||Treatment||None (Open Label)||||||
1387006|NCT02462252||Single Group Assignment||Treatment||None (Open Label)||||||
1387007|NCT02462239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387008|NCT02462226|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1387009|NCT02462213|||Other||Prospective|||||||
1387010|NCT02462200|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387011|NCT02462187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387012|NCT02462174|Randomized|Parallel Assignment||Treatment||Double||||t||t
1387013|NCT02462161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387014|NCT02462148|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387015|NCT02462135|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1387016|NCT02462122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387017|NCT02462109||Single Group Assignment||Supportive Care||None (Open Label)||||||
1387018|NCT02462096||Single Group Assignment||Treatment||None (Open Label)||||||
1387019|NCT02462083||Single Group Assignment||Treatment||None (Open Label)||||||
1387020|NCT02462070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387021|NCT02462057|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1387022|NCT02462044|Randomized|Single Group Assignment||Diagnostic||Double||||t||t
1387023|NCT02462031|Randomized|Parallel Assignment||||Double|||t||t|
1387024|NCT02462018||Single Group Assignment||Treatment||None (Open Label)||||||
1387025|NCT02462005|||Other||Prospective|||||||
1387026|NCT02461992||||Basic Science||None (Open Label)||||||
1387027|NCT02461979|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1387028|NCT02461966|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|No Masking|||||
1387029|NCT02461953|Randomized|Factorial Assignment||Treatment||Single||||||t
1387030|NCT02461940|Randomized|Parallel Assignment||Prevention||Single||||t||
1387031|NCT02461927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387032|NCT02461914||Single Group Assignment||Other||None (Open Label)||||||
1387033|NCT02461901|||Case-Control||Prospective|||||||
1387034|NCT02461888|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387035|NCT02461875|Randomized|Parallel Assignment||Treatment||Single||||||t
1387036|NCT02461862|||Case-Only||Retrospective|||||||
1387037|NCT02461849||Single Group Assignment||Treatment||None (Open Label)||||||
1387038|NCT02461836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387039|NCT02461823|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387040|NCT02461810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387041|NCT02461797|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1387042|NCT02461784|||Case Control||Prospective|||||||
1387043|NCT02461771|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387044|NCT02461758|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387045|NCT02461745|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387046|NCT02461732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387047|NCT02461719|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387048|NCT02461706||||||||||||
1387049|NCT02461693|Randomized|Parallel Assignment||Other||Double|Participants, study personnel interacting with participants, and investigators were blinded. Only the study statistician knew treatment assignments.||t||t|
1387050|NCT02461680|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387051|NCT02461667|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387052|NCT02461654|||Cohort||Prospective|||||||
1387053|NCT02461641|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387054|NCT02461628|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1387055|NCT02461615|||Other||Prospective|||||||
1387056|NCT02461602|||Cohort||Prospective|||||||
1387057|NCT02461589|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387058|NCT02461576|||Other||Cross-Sectional|||||||
1387059|NCT02461563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387060|NCT02461550||Single Group Assignment||Treatment||None (Open Label)||||||
1387061|NCT02461537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387062|NCT02461524||Single Group Assignment||Treatment||None (Open Label)||||||
1387063|NCT02461511|||Cohort||Prospective|||||||
1387064|NCT02461498|||Cohort||Prospective|||||||
1387065|NCT02461485|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1387066|NCT02461472|||Ecologic or Community||Cross-Sectional|||||||
1387067|NCT02461459|||Cohort||Prospective|||||||
1387068|NCT02461446|||Cohort||Prospective|||||||
1387069|NCT02461433|Randomized|Parallel Assignment||Treatment||Single||||t||
1387070|NCT02461420|||Cohort||Prospective|||||||
1387071|NCT02461407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387072|NCT02461394||||||||||||
1387073|NCT02461381|||Ecologic or Community||Cross-Sectional|||||||
1387074|NCT02461368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387075|NCT02461355|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1387076|NCT02461342|||Ecologic or Community||Cross-Sectional|||||||
1387077|NCT02461329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387078|NCT02461316|||Case-Only||Prospective|||||||
1387079|NCT02461303|||Case-Only||Other|||||||
1387080|NCT02461290|||Case Control||Retrospective|||||||
1387081|NCT02461277|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1387082|NCT02461264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387083|NCT02461251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387084|NCT02461238|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387085|NCT02461225||||||||||||
1387086|NCT02461212|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387087|NCT02461199|||Case-Only||Prospective|||||||
1387088|NCT02461186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387089|NCT02461173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387090|NCT02461160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387091|NCT02461147|||Cohort||Prospective|||||||
1387092|NCT02461134||Single Group Assignment||Treatment||None (Open Label)||||||
1387093|NCT02461121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387094|NCT02461108|Randomized|Factorial Assignment||||Double|||t||t|
1387095|NCT02461095|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387096|NCT02461082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387097|NCT02461069|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1387098|NCT02461056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387099|NCT02461043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387100|NCT02461030|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387101|NCT02461017|||Cohort||Prospective|||||||
1387102|NCT02461004|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387103|NCT02460991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387104|NCT02460978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387105|NCT02460965|||||Cross-Sectional|||||||
1387106|NCT02460952|||Case Control||Retrospective|||||||
1387107|NCT02460939|||Case-Only||Retrospective|||||||
1387108|NCT02460926|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1387109|NCT02460913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387110|NCT02460900|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1387111|NCT02460887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387112|NCT02460874|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387113|NCT02460861|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1387114|NCT02460848|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387115|NCT02460835||Single Group Assignment||Treatment||None (Open Label)||||||
1387116|NCT02460822||Single Group Assignment||Supportive Care||None (Open Label)||||||
1387117|NCT02460809|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1387118|NCT02460796|||Cohort||Prospective|||||||
1387119|NCT02460783|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387120|NCT02460770||Single Group Assignment||Treatment||None (Open Label)||||||
1387121|NCT02460757|||Cohort||Prospective|||||||
1387122|NCT02460744||Single Group Assignment||Treatment||None (Open Label)||||||
1387123|NCT02460731||Single Group Assignment||Treatment||None (Open Label)||||||
1387124|NCT02460718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387125|NCT02460705||Single Group Assignment||Treatment||None (Open Label)||||||
1387126|NCT02460692|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387127|NCT02460679||Single Group Assignment||Treatment||None (Open Label)||||||
1387128|NCT02460666|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1387129|NCT02460653|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387130|NCT02460640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387131|NCT02460627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387132|NCT02460614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387133|NCT02460601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387134|NCT02460588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387135|NCT02460575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387136|NCT02460562|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1387137|NCT02460549||Single Group Assignment||Supportive Care||None (Open Label)||||||
1387138|NCT02460536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387139|NCT02460523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387140|NCT02460510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387141|NCT02460497||Single Group Assignment||Treatment||None (Open Label)||||||
1387142|NCT02460484||Single Group Assignment||Treatment||None (Open Label)||||||
1387143|NCT02460471||Single Group Assignment||Treatment||None (Open Label)||||||
1387144|NCT02460458|||Cohort|||||||||
1387145|NCT02460445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387146|NCT02460432|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387147|NCT02460419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387148|NCT02460406|Randomized|Parallel Assignment||Treatment||Single||||||t
1387149|NCT02460393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387150|NCT02460380|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387151|NCT02460367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387152|NCT02460354||Single Group Assignment||Treatment||None (Open Label)||||||
1387153|NCT02460341|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1387154|NCT02460328|||Case-Only|||||||||
1387155|NCT02460315|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387156|NCT02460302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387157|NCT02460289||Single Group Assignment||Treatment||None (Open Label)||||||
1387158|NCT02460276||Single Group Assignment||Treatment||None (Open Label)||||||
1387159|NCT02460263|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387160|NCT02460250||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387161|NCT02460237|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1387162|NCT02460224|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387163|NCT02460211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387164|NCT02460198|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387165|NCT02460185|Randomized|Parallel Assignment||||None (Open Label)||||||
1387166|NCT02460172|Randomized|Single Group Assignment||Treatment||Single||||||t
1387167|NCT02460159|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387168|NCT02460146|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1387169|NCT02460133||Single Group Assignment||Treatment||None (Open Label)||||||
1387170|NCT02460120||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387171|NCT02460107|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387172|NCT02460094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387173|NCT02460081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387174|NCT02460068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387175|NCT02460055|Randomized|Parallel Assignment||Prevention||Single|||t|||
1387176|NCT02460042|||Cohort||Prospective|||||||
1387177|NCT02460029|||Cohort||Prospective|||||||
1387178|NCT02460016||Single Group Assignment||Treatment||None (Open Label)||||||
1387179|NCT02460003|Randomized|Parallel Assignment||Treatment||Single||||||t
1387180|NCT02459990|||Case Control||Retrospective|||||||
1387181|NCT02459977|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387182|NCT02459964|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387183|NCT02459951|||Case-Only||Prospective|||||||
1387184|NCT02459938|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387185|NCT02459925|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387186|NCT02459912||Single Group Assignment||Treatment||None (Open Label)||||||
1387187|NCT02459899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387188|NCT02459886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387189|NCT02459873|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1387190|NCT02459860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387191|NCT02459847|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387192|NCT02459834|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1387193|NCT02459821|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1387194|NCT02459808|||Cohort||Cross-Sectional|||||||
1387195|NCT02459795|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387196|NCT02459782||Single Group Assignment||||None (Open Label)||||||
1387197|NCT02459769|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1387198|NCT02459756|Randomized|Crossover Assignment||||Triple|||t||t|t
1387199|NCT02459743|||Cohort||Prospective|||||||
1387200|NCT02459730|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387201|NCT02459717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387202|NCT02459704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387203|NCT02459691|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1387204|NCT02459678|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1387205|NCT02459665|Randomized|Parallel Assignment||Prevention||Single||||||t
1387206|NCT02459652||Single Group Assignment||Treatment||None (Open Label)||||||
1387207|NCT02459639|||Cohort||Prospective|||||||
1387208|NCT02459626|||Case-Control||Prospective|||||||
1387209|NCT02459613||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387210|NCT02459600||Single Group Assignment||Prevention||None (Open Label)||||||
1387211|NCT02459587|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1387212|NCT02459574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387213|NCT02459561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387214|NCT02459548|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1387215|NCT02459535|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387216|NCT02459522|||Ecologic or Community||Cross-Sectional|||||||
1387217|NCT02459509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387218|NCT02459496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387219|NCT02459483|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387220|NCT02459470||Single Group Assignment||Diagnostic||Single||||||t
1387221|NCT02459457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387222|NCT02459444|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1387223|NCT02459431|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1387224|NCT02459418|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1387225|NCT02459405||Single Group Assignment||Supportive Care||None (Open Label)||||||
1387226|NCT02459392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387227|NCT02459379|||Case-Only||Prospective|||||||
1387228|NCT02459366|||Case Control||Cross-Sectional|||||||
1387229|NCT02459353|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387230|NCT02459340|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1387231|NCT02459327|Randomized|Parallel Assignment||Prevention||Single||||||t
1387232|NCT02459314|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387233|NCT02459301||Single Group Assignment||Other||None (Open Label)||||||
1387234|NCT02459288|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387235|NCT02459275|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387236|NCT02459262|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1387237|NCT02459249|Randomized|Single Group Assignment||Treatment||Single|||t|||
1387238|NCT02459236|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387239|NCT02459223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387240|NCT02459210|Randomized|Parallel Assignment||Treatment||Single||||||t
1387241|NCT02459197|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1387242|NCT02459184|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1387243|NCT02459171|||Cohort||Prospective|||||||
1387244|NCT02459158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387245|NCT02459145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387246|NCT02459132|Randomized|Parallel Assignment||Treatment||Single||||||t
1387247|NCT02459119||Single Group Assignment||Treatment||None (Open Label)||||||
1387248|NCT02459106|||Case-Control||Prospective|||||||
1387249|NCT02459093|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387250|NCT02459080|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387251|NCT02459067||Single Group Assignment||Treatment||None (Open Label)||||||
1387252|NCT02459054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387253|NCT02459041|||Cohort||Prospective|||||||
1387254|NCT02459028|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387255|NCT02459015|Randomized|Parallel Assignment||Treatment||Single||||||t
1387256|NCT02459002|||Cohort||Prospective|||||||
1387257|NCT02458989|Randomized|Parallel Assignment||||Single|||t|||
1387258|NCT02458976||Single Group Assignment||Prevention||None (Open Label)||||||
1387259|NCT02458963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387260|NCT02458950|||Cohort||Retrospective|||||||
1387261|NCT02458937|||Cohort||Prospective|||||||
1387262|NCT02458924|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1387263|NCT02458911|||Cohort||Prospective|||||||
1387264|NCT02458898|Randomized|Parallel Assignment||||None (Open Label)||||||
1387265|NCT02458885|||Cohort||Prospective|||||||
1387266|NCT02458872|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1387267|NCT02458859|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387268|NCT02458846|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1387269|NCT02458833|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387270|NCT02458820|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387271|NCT02458807|||Cohort||Prospective|||||||
1387272|NCT02458794|Randomized|Crossover Assignment||Treatment||Single||||t||
1387273|NCT02458781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387274|NCT02458768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387275|NCT02458755||Single Group Assignment||Treatment||None (Open Label)||||||
1387276|NCT02458742|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1387277|NCT02458729|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387278|NCT02458716||Single Group Assignment||Treatment||None (Open Label)||||||
1387279|NCT02458703|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387280|NCT02458690|Randomized|Parallel Assignment||Prevention||Single||||||t
1387281|NCT02458677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387282|NCT02458664|||Cohort|||||||||
1387283|NCT02458651|||Cohort||Prospective|||||||
1387284|NCT02458638||Single Group Assignment||Treatment||None (Open Label)||||||
1387285|NCT02458625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387286|NCT02458612|Randomized|Parallel Assignment||Treatment||Single||||||t
1387287|NCT02458599|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1387288|NCT02458586|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1387289|NCT02458573|Randomized|Parallel Assignment||Other||Single||||||t
1387290|NCT02458560||Single Group Assignment||Treatment||None (Open Label)||||||
1387291|NCT02458547|Randomized|Parallel Assignment||||None (Open Label)||||||
1387292|NCT02458534|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387293|NCT02458521|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387294|NCT02458508|||Case-Only||Retrospective|||||||
1387295|NCT02458495|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1387296|NCT02458482|Randomized|Parallel Assignment||Treatment||Single||||||t
1387297|NCT02458469|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1387298|NCT02458456|Randomized|Factorial Assignment||Treatment||Single|||t|||
1387299|NCT02458443|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1387300|NCT02458430|||Cohort||Prospective|||||||
1387301|NCT02458417|Randomized|Parallel Assignment||Treatment||Single||||||t
1387302|NCT02458404|||Cohort||Prospective|||||||
1387303|NCT02458391|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1387304|NCT02458378||||||||||||
1387305|NCT02458365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387306|NCT02458352|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1387307|NCT02458339||Single Group Assignment||Treatment||None (Open Label)||||||
1387308|NCT02458326|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1387309|NCT02458313|Randomized|Parallel Assignment||Other||Double|||t|||t
1387310|NCT02458300|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1387311|NCT02458287|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387312|NCT02458274|||Case-Control||Prospective|||||||
1387313|NCT02458261|||Other||Prospective|||||||
1387314|NCT02458248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387315|NCT02458235||Single Group Assignment||Treatment||None (Open Label)||||||
1387316|NCT02458222|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387317|NCT02458209|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1387318|NCT02458196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387319|NCT02458183|Randomized|Parallel Assignment||Prevention||None (Open Label)|Open Label|||||
1387320|NCT02458170|||Cohort||Retrospective|||||||
1387321|NCT02458157|Randomized|Parallel Assignment||Treatment||Single||||||t
1387322|NCT02458144|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1387323|NCT02458131|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387324|NCT02458118||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387325|NCT02458105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387326|NCT02458092|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1387327|NCT02458079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387328|NCT02458066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387329|NCT02458053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387330|NCT02458040|||||Prospective|||||||
1387331|NCT02458027|Randomized|Crossover Assignment||Treatment||Single|||t|||
1387332|NCT02458014||Single Group Assignment||Treatment||None (Open Label)||||||
1387333|NCT02458001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387334|NCT02457988|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387335|NCT02457975||||||||||||
1387336|NCT02457962|||Other||Prospective|||||||
1387337|NCT02457949|Randomized|Parallel Assignment||Other||Single|||||t|
1387338|NCT02457936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387339|NCT02457923|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1387340|NCT02457910|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387341|NCT02457897|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387342|NCT02457884|Randomized|Factorial Assignment||Other||Single||||||t
1387343|NCT02457871|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387344|NCT02457858||Single Group Assignment||Treatment||None (Open Label)||||||
1387345|NCT02457845||Single Group Assignment||Treatment||None (Open Label)||||||
1387346|NCT02457832|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387347|NCT02457819||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1387348|NCT02457806|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1387349|NCT02457793|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387350|NCT02457780|Randomized|Parallel Assignment||Treatment||Single||||||t
1387351|NCT02457767|||Cohort||Prospective|||||||
1387352|NCT02457754|||Cohort||Cross-Sectional|||||||
1387353|NCT02457741|||Cohort||Prospective|||||||
1387354|NCT02457728||Single Group Assignment||Treatment||None (Open Label)||||||
1387355|NCT02457715|||Cohort||Prospective|||||||
1387356|NCT02457702||Single Group Assignment||Basic Science||None (Open Label)||||||
1387357|NCT02457689|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1387358|NCT02457676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387359|NCT02457663|||Ecologic or Community||Prospective|||||||
1387360|NCT02457650||Single Group Assignment||Treatment||None (Open Label)||||||
1387361|NCT02457637|||Cohort||Prospective|||||||
1387362|NCT02457624|||Cohort||Prospective|||||||
1387363|NCT02457611||Single Group Assignment||Treatment||None (Open Label)||||||
1387364|NCT02457598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387365|NCT02457585||Single Group Assignment||Treatment||None (Open Label)||||||
1387366|NCT02457572|||Cohort||Prospective|||||||
1387367|NCT02457559||Single Group Assignment||Treatment||None (Open Label)||||||
1387368|NCT02457546|Randomized|Parallel Assignment||Prevention||Single|||t|||
1387369|NCT02457533|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387370|NCT02457520||Single Group Assignment||Treatment||None (Open Label)||||||
1387371|NCT02457507|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1387372|NCT02457494|||Cohort||Prospective|||||||
1387373|NCT02457481||Single Group Assignment||Treatment||None (Open Label)||||||
1387374|NCT02457468|||Cohort||Prospective|||||||
1387375|NCT02457455|||||Retrospective|||||||
1387376|NCT02457442|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1387377|NCT02457429||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387378|NCT02457416|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387379|NCT02457403|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1387380|NCT02457390||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387381|NCT02457377||Single Group Assignment||Treatment||None (Open Label)||||||
1387382|NCT02457364|||Cohort||Prospective|||||||
1387383|NCT02457351||Single Group Assignment||||None (Open Label)||||||
1387384|NCT02457338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387385|NCT02457325|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1387386|NCT02457312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387387|NCT02457299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387388|NCT02457286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387389|NCT02457273||Single Group Assignment||Treatment||None (Open Label)||||||
1387390|NCT02457260|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Healthy Controls vs Heart Failure with reduced Ejection Fraction (HFrEF) vs Heart Failure with preserved Ejection Fraction (HFpEF) on four weeks of nitrite treatment tid.||||
1387391|NCT02457247|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387392|NCT02457234|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1387393|NCT02457221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387394|NCT02457208||Single Group Assignment||Treatment||None (Open Label)||||||
1387395|NCT02457195||Single Group Assignment||Treatment||None (Open Label)||||||
1387396|NCT02457182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387397|NCT02457169|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1387398|NCT02457156|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1387399|NCT02457143|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1387400|NCT02457130|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387401|NCT02457117|||Other||Other|||||||
1387402|NCT02457104|||Cohort||Prospective|||||||
1387403|NCT02457091|Randomized|Parallel Assignment||Treatment||Single|||||t|
1387404|NCT02457078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387405|NCT02457065|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1387406|NCT02457052|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1387407|NCT02457039|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1387408|NCT02457026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387409|NCT02457013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387410|NCT02457000|||Cohort||Other|||||||
1387411|NCT02456987|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1387412|NCT02456974|||Other||Prospective|||||||
1387413|NCT02456961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387414|NCT02456948|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387415|NCT02456935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387416|NCT02456922||Single Group Assignment||Other||None (Open Label)||||||
1387417|NCT02456909|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387418|NCT02456896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387419|NCT02456883||Single Group Assignment||Treatment||None (Open Label)||||||
1387420|NCT02456870|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1387421|NCT02456857||Single Group Assignment||Treatment||None (Open Label)||||||
1387422|NCT02456844|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1387423|NCT02456831|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1387424|NCT02456818|||Cohort||Prospective|||||||
1387425|NCT02456805|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1387426|NCT02456792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387427|NCT02456779|||Case-Control||Prospective|||||||
1387428|NCT02456766|||Cohort||Cross-Sectional|||||||
1387429|NCT02456753|||Case-Only||Cross-Sectional|||||||
1387430|NCT02456740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387431|NCT02456727|Randomized|Parallel Assignment||Treatment||Single||||||t
1387432|NCT02456714||Single Group Assignment||Treatment||None (Open Label)||||||
1387433|NCT02456701||Single Group Assignment||Treatment||None (Open Label)||||||
1387434|NCT02456688|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387435|NCT02456675|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387436|NCT02456662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387437|NCT02456649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387438|NCT02456636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387439|NCT02456623|Randomized|Parallel Assignment||Treatment||Single||||||t
1387440|NCT02456610||Single Group Assignment||Treatment||None (Open Label)||||||
1387441|NCT02456597|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1387442|NCT02456584|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387443|NCT02456571|||Cohort||Prospective|||||||
1387444|NCT02456558|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387445|NCT02456545|||Cohort||Prospective|||||||
1387446|NCT02456532|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387447|NCT02456519|||Cohort||Prospective|||||||
1387448|NCT02456506|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387449|NCT02456493|||Cohort||Prospective|||||||
1387450|NCT02456480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387451|NCT02456467|||Cohort||Prospective|||||||
1387452|NCT02456454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387453|NCT02456441|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1387454|NCT02456428|||Cohort||Retrospective|||||||
1387455|NCT02456415||Single Group Assignment||Treatment||None (Open Label)||||||
1387456|NCT02456402|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387457|NCT02456389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387458|NCT02456376|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387459|NCT02456363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387460|NCT02456350||Single Group Assignment||Treatment||None (Open Label)||||||
1387461|NCT02456337|Randomized|Parallel Assignment||Treatment||Single||||||t
1387462|NCT02456324|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387539|NCT02455310|||Other||Retrospective|||||||
1387463|NCT02456311||Single Group Assignment||Treatment||None (Open Label)||||||
1387464|NCT02456298|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1387465|NCT02456285|||Cohort||Prospective|||||||
1387466|NCT02456272||Single Group Assignment||Treatment||None (Open Label)||||||
1387467|NCT02456259|||Case Control||Prospective|||||||
1387468|NCT02456246||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387469|NCT02456233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387470|NCT02456220|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387471|NCT02456207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387472|NCT02456194||Single Group Assignment||Treatment||None (Open Label)||||||
1387473|NCT02456181||Single Group Assignment||||None (Open Label)||||||
1387474|NCT02456168|||Cohort||Cross-Sectional|||||||
1387475|NCT02456155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387476|NCT02456142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387477|NCT02456129||Single Group Assignment||||None (Open Label)||||||
1387478|NCT02456116|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387479|NCT02456103||Single Group Assignment||Treatment||None (Open Label)||||||
1387480|NCT02456090|||Cohort||Prospective|||||||
1387481|NCT02456077|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1387482|NCT02456064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387483|NCT02456051|||Cohort||Prospective|||||||
1387484|NCT02456038||Single Group Assignment||Treatment||None (Open Label)||||||
1387485|NCT02456025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387486|NCT02456012|Randomized|Parallel Assignment||Prevention||Single|||t|||
1387487|NCT02455999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387488|NCT02455986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387489|NCT02455973|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387490|NCT02455960|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1387491|NCT02455947|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387492|NCT02455934|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1387493|NCT02455921|Randomized|Parallel Assignment||Screening||Single|||||t|
1387494|NCT02455908||Single Group Assignment||Treatment||None (Open Label)||||||
1387495|NCT02455895|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1387496|NCT02455882|||Cohort||Prospective|||||||
1387497|NCT02455869|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1387498|NCT02455856||Single Group Assignment||Treatment||None (Open Label)||||||
1387499|NCT02455843|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients were divided into two groups: The microwave ablation plus chemotherapy group and the chemotherapy group.The former will be treated with microwave, followed by chemotherapy.The latter will be treated with chemotherapy alone.||||
1387500|NCT02455830|||Case Control||Prospective|||||||
1387501|NCT02455817|||Case-Only||Retrospective|||||||
1387502|NCT02455804||Single Group Assignment||Treatment||None (Open Label)||||||
1387503|NCT02455791||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387504|NCT02455778|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1387505|NCT02455765|Randomized|Crossover Assignment||||None (Open Label)||||||
1387506|NCT02455752||Single Group Assignment||Treatment||None (Open Label)||||||
1387507|NCT02455739|Randomized|Parallel Assignment||Treatment||Single||||t||
1387508|NCT02455726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387509|NCT02455713|||Case-Crossover||Prospective|||||||
1387510|NCT02455700|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1387511|NCT02455687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387512|NCT02455674|||Cohort||Cross-Sectional|||||||
1387513|NCT02455661|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387514|NCT02455648|Randomized|Single Group Assignment||Treatment||None (Open Label)||Single assignment||||
1387515|NCT02455635|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387516|NCT02455622||Single Group Assignment||Treatment||None (Open Label)||||||
1387517|NCT02455609|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387518|NCT02455596||Single Group Assignment||Treatment||None (Open Label)||||||
1387519|NCT02455583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387520|NCT02455570|||Cohort||Prospective|||||||
1387521|NCT02455557||Single Group Assignment||Treatment||None (Open Label)||||||
1387522|NCT02455544|||Cohort||Prospective|||||||
1387523|NCT02455531|||Cohort||Prospective|||||||
1387524|NCT02455518|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387525|NCT02455505|||Cohort||Prospective|||||||
1387526|NCT02455492|||Cohort||Retrospective|||||||
1387527|NCT02455479|Randomized|Sequential Assignment||Treatment||Triple|||t||t|t
1387528|NCT02455466|||Case-Only||Prospective|||||||
1387529|NCT02455453||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387530|NCT02455440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387531|NCT02455427|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1387532|NCT02455414|||Cohort||Prospective|||||||
1387533|NCT02455401|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1387534|NCT02455388|Randomized|Crossover Assignment||Prevention||Single||Study 1: Crossover design Study 2: Cross-sectional design|t|||
1387535|NCT02455375|||Case-Control||Prospective|||||||
1387536|NCT02455362|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1387537|NCT02455336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387538|NCT02455323|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1387540|NCT02455297||Single Group Assignment||Treatment||None (Open Label)||||||
1387541|NCT02455284||Single Group Assignment||Basic Science||None (Open Label)||||||
1387542|NCT02455271|||Cohort||Prospective|||||||
1387543|NCT02455258|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387544|NCT02455245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387545|NCT02455232||Single Group Assignment||Prevention||None (Open Label)||||||
1387546|NCT02455219|||Case-Only||Prospective|||||||
1387547|NCT02455206|Randomized|Parallel Assignment||Treatment||Single||||||t
1387548|NCT02455193|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1387549|NCT02455180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387550|NCT02455167||Single Group Assignment||Other||None (Open Label)||||||
1387551|NCT02455154|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387552|NCT02455141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387553|NCT02455128|Randomized|Parallel Assignment||Treatment||Single||||||t
1387554|NCT02455115|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387555|NCT02455102|Randomized|Parallel Assignment||Prevention||Single|||t|||
1387556|NCT02455089||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387557|NCT02455076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387558|NCT02455063||||||||||||
1387559|NCT02455050|Randomized|Crossover Assignment||Treatment||Single|||||t|
1387560|NCT02455037|Randomized|Parallel Assignment||||None (Open Label)||||||
1387561|NCT02455024|||Other||Prospective|||||||
1387562|NCT02455011|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387563|NCT02454998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387564|NCT02454972||Single Group Assignment||Treatment||None (Open Label)||||||
1387565|NCT02454959|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387566|NCT02454946|||Case Control||Retrospective|||||||
1387567|NCT02454933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387568|NCT02454920|||Other||Prospective|||||||
1387569|NCT02454907|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1387570|NCT02454894|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1387571|NCT02454881|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387572|NCT02454868||Single Group Assignment||Supportive Care||None (Open Label)||||||
1387573|NCT02454855|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1387574|NCT02454842||Single Group Assignment||Treatment||None (Open Label)||||||
1387575|NCT02454829|||Cohort||Prospective|||||||
1387576|NCT02454816|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387577|NCT02454803|||Cohort||Prospective|||||||
1387578|NCT02454790|||Cohort||Prospective|||||||
1387579|NCT02454777|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387580|NCT02454764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387581|NCT02454751||Single Group Assignment||Treatment||None (Open Label)||||||
1387582|NCT02454738||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387583|NCT02454725|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387584|NCT02454712|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387585|NCT02454699|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387586|NCT02454686|||Cohort||Prospective|||||||
1387587|NCT02454673|||Cohort||Retrospective|||||||
1387588|NCT02454660|Randomized|Parallel Assignment||Prevention||Single|||||t|
1387589|NCT02454647|||Cohort||Retrospective|||||||
1387590|NCT02454634||Single Group Assignment||Treatment||None (Open Label)||||||
1387591|NCT02454621|Randomized|Parallel Assignment||Prevention||Single|||||t|
1387592|NCT02454608|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387593|NCT02454595|||Cohort||Prospective|||||||
1387594|NCT02454582|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1387595|NCT02454569|||Cohort||Prospective|||||||
1387596|NCT02454556|Randomized|Parallel Assignment||Treatment||Single||||||t
1387597|NCT02454543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387598|NCT02454530|||Cohort||Prospective|||||||
1387599|NCT02454517|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387600|NCT02454504|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1387601|NCT02454491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387602|NCT02454478||Single Group Assignment||Treatment||None (Open Label)||||||
1387603|NCT02454465|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387604|NCT02454452|Randomized|Parallel Assignment||Treatment||Single||||||t
1387605|NCT02454439|Randomized|Parallel Assignment||||Double|||t||t|
1387606|NCT02454426||Single Group Assignment||Treatment||None (Open Label)||||||
1387607|NCT02454413|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1387608|NCT02454400|Randomized|Parallel Assignment||Treatment||Single|||||t|
1387609|NCT02454387|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1387610|NCT02454374|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387611|NCT02454361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387612|NCT02454348|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387613|NCT02454335|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387614|NCT02454322|||Cohort||Prospective|||||||
1387615|NCT02454309|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1387616|NCT02454296|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1387617|NCT02454283|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387618|NCT02454270|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387619|NCT02454257|||Cohort||Retrospective|||||||
1387620|NCT02454244|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1387621|NCT02454231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387622|NCT02454218|Randomized|Crossover Assignment||||Single|||t|||
1387623|NCT02454205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387624|NCT02454192|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387625|NCT02454179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387626|NCT02454166|||Case-Only||Prospective|||||||
1387627|NCT02454153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387628|NCT02454140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387629|NCT02454127|Randomized|Parallel Assignment||Treatment||Single||||||t
1387630|NCT02454114|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387631|NCT02454101|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1387632|NCT02454088|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387633|NCT02454075||Single Group Assignment||Treatment||None (Open Label)||||||
1387634|NCT02454062|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387635|NCT02454049|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1387636|NCT02454036||Single Group Assignment||Supportive Care||None (Open Label)||||||
1387637|NCT02454023|Randomized|Parallel Assignment||Screening||Single||||||t
1387638|NCT02454010|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387639|NCT02453997|||Cohort||Prospective|||||||
1387640|NCT02453984||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387641|NCT02453971|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387642|NCT02453958|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387643|NCT02453945|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387644|NCT02453932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387645|NCT02453919|||Cohort||Prospective|||||||
1387646|NCT02453906|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1387647|NCT02453893|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387648|NCT02453880||Single Group Assignment||Prevention||None (Open Label)||||||
1387649|NCT02453867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387650|NCT02453854|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387651|NCT02453841|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387652|NCT02453828|Randomized|Single Group Assignment||Supportive Care||Double|||t|||t
1387653|NCT02453815|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1387654|NCT02453802|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387655|NCT02453789|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1387656|NCT02453776|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387657|NCT02453763|||Cohort||Prospective|||||||
1387658|NCT02453750||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387659|NCT02453737|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387660|NCT02453724|||Cohort||Prospective|||||||
1387661|NCT02453711|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387662|NCT02453698|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1387663|NCT02453685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387664|NCT02453672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387665|NCT02453659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387666|NCT02453646||Single Group Assignment||Other||None (Open Label)||||||
1387667|NCT02453633|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1387668|NCT02453620||Single Group Assignment||Treatment||None (Open Label)||||||
1387669|NCT02453607|||Cohort||Prospective|||||||
1387670|NCT02453594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387671|NCT02453581|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387672|NCT02453555|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387673|NCT02453542|||Cohort||Prospective|||||||
1387674|NCT02453529||Single Group Assignment||||None (Open Label)||||||
1387675|NCT02453516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387676|NCT02453503|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387677|NCT02453490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387678|NCT02453477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387679|NCT02453464||Single Group Assignment||Treatment||None (Open Label)||||||
1387680|NCT02453451||Single Group Assignment||Basic Science||None (Open Label)||||||
1387681|NCT02453438|||Other||Other|||||||
1387682|NCT02453425|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1387683|NCT02453412|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387684|NCT02453399||Single Group Assignment||Treatment||Triple|||t||t|t
1387685|NCT02453386|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387686|NCT02453373|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1387687|NCT02453360|Randomized|Parallel Assignment||Other||Double|||t|||t
1387688|NCT02453347||Single Group Assignment||Treatment||None (Open Label)||||||
1387689|NCT02453334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387690|NCT02453321|Randomized|Parallel Assignment||Treatment||Single||||||t
1387691|NCT02453308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387692|NCT02453295|Randomized|Parallel Assignment||||Single|||t|||
1387693|NCT02453282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387694|NCT02453269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387695|NCT02453256|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387696|NCT02453243|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1387697|NCT02453230|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1387698|NCT02453217|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1387699|NCT02453204|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1387700|NCT02453191||Single Group Assignment||Treatment||None (Open Label)||||||
1387701|NCT02453178|Randomized|Parallel Assignment||Basic Science||Single||||||t
1387702|NCT02453165|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1387703|NCT02453152|||Cohort||Prospective|||||||
1387704|NCT02453139|Randomized|Parallel Assignment||Treatment||Single||||||t
1387705|NCT02453126|||Case-Control||Prospective|||||||
1387706|NCT02453113||Single Group Assignment||Other||None (Open Label)||||||
1387707|NCT02453100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387708|NCT02453087|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387709|NCT02453074|||||Prospective|||||||
1387710|NCT02453061|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387711|NCT02453048|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387712|NCT02453035|||Case-Only||Prospective|||||||
1387713|NCT02453022|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387714|NCT02453009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387715|NCT02452996|Randomized|||Treatment||Quadruple|||t|t|t|t
1387716|NCT02452983||Single Group Assignment||Treatment||None (Open Label)||||||
1387717|NCT02452970||Single Group Assignment||Treatment||None (Open Label)||||||
1387718|NCT02452957|||Cohort||Prospective|||||||
1387719|NCT02452944|Randomized|Parallel Assignment||||Double|||t||t|
1387720|NCT02452931||Single Group Assignment||Treatment||None (Open Label)||||||
1387721|NCT02452918||Single Group Assignment||Treatment||None (Open Label)||||||
1387722|NCT02452905|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387723|NCT02452892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387724|NCT02452879|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1387725|NCT02452866||Single Group Assignment||Treatment||None (Open Label)||||||
1387726|NCT02452853||Single Group Assignment||Treatment||None (Open Label)||||||
1387727|NCT02452840|||Cohort||Prospective|||||||
1387728|NCT02452827|||Case Control||Prospective|||||||
1387729|NCT02452814|||Case-Control||Cross-Sectional|||||||
1387730|NCT02452801||Single Group Assignment||Treatment||None (Open Label)||||||
1387731|NCT02452788|Randomized|Single Group Assignment||||Double|||t|||t
1387732|NCT02452775||||Treatment||None (Open Label)||||||
1387733|NCT02452762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387734|NCT02452749||Single Group Assignment||Other||None (Open Label)||||||
1387735|NCT02452736||Single Group Assignment||Treatment||None (Open Label)||||||
1387736|NCT02452723||Single Group Assignment||Treatment||None (Open Label)||||||
1387737|NCT02452710|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387738|NCT02452697|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387739|NCT02452684|||Cohort||Prospective|||||||
1387740|NCT02452671|||Case-Control||Prospective|||||||
1387741|NCT02452658||Single Group Assignment||Basic Science||None (Open Label)||||||
1387742|NCT02452645|Randomized|Parallel Assignment||Prevention||Single|||||t|
1387743|NCT02452632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387744|NCT02452619|||Cohort||Retrospective|||||||
1387745|NCT02452606||Single Group Assignment||Treatment||None (Open Label)||||||
1387746|NCT02452593|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387747|NCT02452580|||Cohort||Prospective|||||||
1387748|NCT02452567||Single Group Assignment||Other||None (Open Label)||||||
1387749|NCT02452554||Single Group Assignment||Treatment||None (Open Label)||||||
1387750|NCT02452541||Single Group Assignment||||None (Open Label)||||||
1387751|NCT02452528|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387752|NCT02452515|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1387753|NCT02452502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387754|NCT02452489|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387755|NCT02452476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387756|NCT02452463|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1387757|NCT02452450|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1387758|NCT02452437|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1387759|NCT02452424||Single Group Assignment||Treatment||None (Open Label)||||||
1387760|NCT02452411|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387761|NCT02452398||Single Group Assignment||Treatment||None (Open Label)||||||
1387762|NCT02452385||Single Group Assignment||Treatment||None (Open Label)||||||
1387763|NCT02452372|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387764|NCT02452359||Single Group Assignment||Treatment||None (Open Label)||||||
1387765|NCT02452346||Single Group Assignment||Treatment||None (Open Label)||||||
1387766|NCT02452333|Randomized|Parallel Assignment||||None (Open Label)||||||
1387767|NCT02452320|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387768|NCT02452307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387769|NCT02452294||Single Group Assignment||Treatment||None (Open Label)||||||
1387770|NCT02452281||Single Group Assignment||Treatment||None (Open Label)||||||
1387771|NCT02452268|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387772|NCT02452255|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387773|NCT02452242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387774|NCT02452229|||||Retrospective|||||||
1387775|NCT02452216||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387776|NCT02452203|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1387777|NCT02452190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387778|NCT02452177|Randomized|Crossover Assignment||Treatment||Single|||t|||
1387779|NCT02452164|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387780|NCT02452151|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1387781|NCT02452138|||Cohort||Prospective|||||||
1387782|NCT02452125||Single Group Assignment||Treatment||None (Open Label)||||||
1387783|NCT02452112|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387784|NCT02452099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387785|NCT02452086|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387786|NCT02452073|||Cohort||Retrospective|||||||
1387787|NCT02452060|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1387788|NCT02452047|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387789|NCT02452034|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387790|NCT02452021|||Case-Only||Prospective|||||||
1387791|NCT02452008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387792|NCT02451995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387793|NCT02451982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387794|NCT02451969|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1387795|NCT02451956||Single Group Assignment||Treatment||None (Open Label)||||||
1387796|NCT02451943|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387797|NCT02451930||Single Group Assignment||Treatment||None (Open Label)||||||
1387798|NCT02451917|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387799|NCT02451904|||Case-Control||Prospective|||||||
1387800|NCT02451891|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387801|NCT02451878|Randomized|Parallel Assignment||Prevention||Single||||||t
1387802|NCT02451865||Single Group Assignment||Treatment||None (Open Label)||||||
1387803|NCT02451852||||||||||||
1387804|NCT02451839|||Cohort||Prospective|||||||
1387805|NCT02451826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387806|NCT02451813||Single Group Assignment||||None (Open Label)||||||
1387807|NCT02451800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387808|NCT02451787|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1387809|NCT02451774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387810|NCT02451761|||Other||Prospective|||||||
1387811|NCT02451748|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||In this study we determined whether expression of IL-7 and IL-7R is modulated by anti-TNF treatment. For this purpose blood was obtained from RA patients prior to anti-TNF (Cimzia treatment; day 0) and after 3 months as well as 6 months of therapy. Transcription levels of IL-7 and IL-7R was examined from the peripheral blood obtained from day 0, 3 and 6 months of therapy. Results of this study will be reported in the MS in preparation.||||
1387812|NCT02451735|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1387813|NCT02451722|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1387814|NCT02451709|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1387815|NCT02451696|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387816|NCT02451683|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1387817|NCT02451670|Randomized|Parallel Assignment||Treatment||None (Open Label)||Clinics have been randomized into a treatment and a control arm.||||
1387818|NCT02451657|||Cohort||Prospective|||||||
1387819|NCT02451644||Single Group Assignment||Prevention||None (Open Label)||||||
1387820|NCT02451631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387821|NCT02451618|||Cohort||Prospective|||||||
1387822|NCT02451605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387823|NCT02451592|||Cohort||Retrospective|||||||
1387824|NCT02451579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387825|NCT02451566|||Cohort||Prospective|||||||
1387826|NCT02451553||Single Group Assignment||Treatment||None (Open Label)||||||
1387827|NCT02451540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387828|NCT02451527||Single Group Assignment||Treatment||None (Open Label)||||||
1387829|NCT02451514|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387830|NCT02451501|Randomized|Parallel Assignment||Treatment||Single||||||t
1387831|NCT02451488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387832|NCT02451475|Randomized|Parallel Assignment||Treatment||Single||||||t
1387833|NCT02451462|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1387834|NCT02451449|||Case-Only||Cross-Sectional|||||||
1387835|NCT02451436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387836|NCT02451423||Single Group Assignment||Treatment||None (Open Label)||||||
1387837|NCT02451410||Sequential Assignment||Prevention||None (Open Label)||||||
1387838|NCT02451397|||Ecologic or Community||Cross-Sectional|||||||
1387839|NCT02451384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387840|NCT02451371||Single Group Assignment||Treatment||None (Open Label)||||||
1387841|NCT02451358|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387842|NCT02451345||Single Group Assignment||Other||None (Open Label)||||||
1387843|NCT02451332||Single Group Assignment||Basic Science||None (Open Label)||||||
1387844|NCT02451319|Randomized|Single Group Assignment||Treatment||Single|||t|||
1387845|NCT02451306|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1387846|NCT02451293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387847|NCT02451280|Randomized|Parallel Assignment||Treatment||Single||||||t
1387848|NCT02451267|Randomized|Parallel Assignment||Treatment||Double||||t||t
1387849|NCT02451254|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387850|NCT02451241|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1387851|NCT02451228|||Case-Only||Prospective|||||||
1387852|NCT02451215||Single Group Assignment||Treatment||None (Open Label)||||||
1387853|NCT02451202|Randomized|Parallel Assignment||Treatment||Single||||||t
1387854|NCT02451189|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1387855|NCT02451176|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387856|NCT02451163|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387857|NCT02451150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1387858|NCT02451137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387859|NCT02451124||Single Group Assignment||Screening||None (Open Label)||||||
1387860|NCT02451111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387861|NCT02451098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387862|NCT02451085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387863|NCT02451072||Single Group Assignment||Basic Science||Double|||t||t|
1387864|NCT02451059|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1387865|NCT02451046|||Cohort||Prospective|||||||
1387866|NCT02451033|Randomized|Single Group Assignment||Treatment||Single||||||t
1387867|NCT02451020||Single Group Assignment||Basic Science||None (Open Label)||||||
1387868|NCT02451007||Single Group Assignment||||None (Open Label)||||||
1387869|NCT02450994|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387870|NCT02450981||Single Group Assignment||||None (Open Label)||||||
1387871|NCT02450968|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387872|NCT02450955|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1387873|NCT02450942||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387874|NCT02450929|||Other||Prospective|||||||
1387875|NCT02450916|||Case-Only||Cross-Sectional|||||||
1387876|NCT02450903||Single Group Assignment||Treatment||None (Open Label)||||||
1387877|NCT02450890|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1387878|NCT02450877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387879|NCT02450864|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1387880|NCT02450851|||Case-Only||Prospective|||||||
1387881|NCT02450838|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387882|NCT02450825|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387883|NCT02450812|||Cohort||Prospective|||||||
1387884|NCT02450799|Non-Randomized|Parallel Assignment||||Single||||||t
1387885|NCT02450786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387886|NCT02450773|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387887|NCT02450760|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1387888|NCT02450747||Single Group Assignment||Treatment||None (Open Label)||||||
1387889|NCT02450734|||Case-Only||Prospective|||||||
1387890|NCT02450721|||Cohort||Cross-Sectional|||||||
1387891|NCT02450708|||Cohort||Prospective|||||||
1387892|NCT02450695|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1387893|NCT02450682|Randomized|Parallel Assignment||||None (Open Label)||||||
1387894|NCT02450669|||Cohort||Prospective|||||||
1387895|NCT02450656|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1387896|NCT02450643|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1387897|NCT02450630|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1387898|NCT02450617|Randomized|Crossover Assignment||Treatment||Single||||||t
1387899|NCT02450604||Single Group Assignment||Diagnostic||None (Open Label)||||||
1387900|NCT02450591||Single Group Assignment||Treatment||None (Open Label)||||||
1387901|NCT02450578|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1387902|NCT02450565|||Case Control||Prospective|||||||
1387903|NCT02450552|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387904|NCT02450539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387905|NCT02450526|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1387906|NCT02450513|||Cohort||Prospective|||||||
1387907|NCT02450500||Single Group Assignment||Prevention||None (Open Label)||||||
1387908|NCT02450487||Single Group Assignment||Supportive Care||None (Open Label)||||||
1387909|NCT02450474|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387910|NCT02450461|||Case-Control||Prospective|||||||
1387911|NCT02450448|||Cohort||Prospective|||||||
1387912|NCT02450435|||Cohort||Retrospective|||||||
1387913|NCT02450422|||Cohort||Prospective|||||||
1387914|NCT02450409|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1387915|NCT02450396|||Cohort||Prospective|||||||
1387916|NCT02450383|Randomized|Parallel Assignment||Treatment||Single||||||t
1387917|NCT02450370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387918|NCT02450357|||Cohort||Prospective|||||||
1387919|NCT02450344|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1387920|NCT02450331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387921|NCT02450318||Single Group Assignment||Other||None (Open Label)||||||
1387922|NCT02450305|||Case-Control||Prospective|||||||
1387923|NCT02450292|||Case-Only||Prospective|||||||
1387924|NCT02450279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387925|NCT02450266|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1387926|NCT02450253|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1387927|NCT02450240|||Case-Control||Prospective|||||||
1387928|NCT02450227|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1387929|NCT02450214|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1387930|NCT02450201|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1387931|NCT02450188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387932|NCT02450175|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1387933|NCT02450162|||Case Control||Prospective|||||||
1387934|NCT02450149||Single Group Assignment||Treatment||None (Open Label)||||||
1387935|NCT02450136||Single Group Assignment||Treatment||None (Open Label)||||||
1387936|NCT02450123||Single Group Assignment||Treatment||None (Open Label)||||||
1387937|NCT02450110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387938|NCT02450097||Single Group Assignment||Other||None (Open Label)||||||
1387939|NCT02450084|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1387940|NCT02450071|||Cohort||Prospective|||||||
1387941|NCT02450058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387942|NCT02450045|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1387943|NCT02450032||Single Group Assignment||Treatment||None (Open Label)||||||
1387944|NCT02450019|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1387945|NCT02450006|||Ecologic or Community||Prospective|||||||
1387946|NCT02449993|||||Retrospective|||||||
1387947|NCT02449980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387948|NCT02449967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387949|NCT02449954|Randomized|Crossover Assignment||Diagnostic||Double|||||t|t
1387950|NCT02449941|||Case-Only||Prospective|||||||
1387951|NCT02449928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387952|NCT02449915|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1387953|NCT02449902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1387954|NCT02449889|Randomized|Parallel Assignment||Treatment||Single||||||t
1387955|NCT02449876||Single Group Assignment||Treatment||None (Open Label)||||||
1387956|NCT02449863|||Cohort||Prospective|||||||
1387957|NCT02449850|Randomized|Factorial Assignment||Prevention||Single|At all investigations, skin scoring is performed prior to any information from the study participants parents of intervention group. Also, no baths are allowed within 24 hours of investigation, to fascilitate blinding of the investigator to interventional allocation.|International, multi-center, prospective 2x2 factorially designed randomized controlled trial of primary prevention in children of enrolled mother-child pairs, with an additional exploratory aim|||t|
1387958|NCT02449837|||Cohort||Prospective|||||||
1387959|NCT02449824|||Cohort||Prospective|||||||
1387960|NCT02449811|||Other||Prospective|||||||
1387961|NCT02449798||Single Group Assignment||Treatment||None (Open Label)||||||
1387962|NCT02449785||Single Group Assignment||Supportive Care||None (Open Label)||||||
1387963|NCT02449772|||Cohort||Retrospective|||||||
1387964|NCT02449759|Randomized|Parallel Assignment||Treatment||Single|||||t|
1387965|NCT02449746|Randomized|Parallel Assignment||Other||None (Open Label)|open label|||||
1387966|NCT02449733|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1387967|NCT02449720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387968|NCT02449707|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1387969|NCT02449694||Single Group Assignment||Treatment||None (Open Label)||||||
1387970|NCT02449681||Single Group Assignment||Treatment||None (Open Label)||||||
1387971|NCT02449668|Randomized|Parallel Assignment||Treatment||Single|||t|||
1387972|NCT02449655|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387973|NCT02449642|||Cohort||Prospective|||||||
1387974|NCT02449629|||Cohort||Cross-Sectional|||||||
1387975|NCT02449616||Single Group Assignment||Treatment||None (Open Label)||||||
1387976|NCT02449603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387977|NCT02449590|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1387978|NCT02449577|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1387979|NCT02449564||Single Group Assignment||Treatment||None (Open Label)||||||
1387980|NCT02449551||Single Group Assignment||Treatment||None (Open Label)||||||
1387981|NCT02449538||Single Group Assignment||Treatment||None (Open Label)||||||
1387982|NCT02449525||Single Group Assignment||Treatment||None (Open Label)||||||
1387983|NCT02449512|||Cohort||Cross-Sectional|||||||
1387984|NCT02449499|||Case Control||Prospective|||||||
1387985|NCT02449486|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387986|NCT02449473|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1387987|NCT02449460|||Cohort||Cross-Sectional|||||||
1387988|NCT02449447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387989|NCT02449434|||Cohort||Retrospective|||||||
1387990|NCT02449421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387991|NCT02449408|||Cohort||Prospective|||||||
1387992|NCT02449395|||Case-Only||Cross-Sectional|||||||
1387993|NCT02449382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387994|NCT02449369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1387995|NCT02449356|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1387996|NCT02449343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1387997|NCT02449330|Randomized|Parallel Assignment||Treatment||Single||||||t
1387998|NCT02449317|Randomized|Parallel Assignment||Prevention||Single|||t|||
1387999|NCT02449304||Single Group Assignment||Treatment||None (Open Label)||||||
1388000|NCT02449291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388001|NCT02449278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388002|NCT02449265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388003|NCT02449252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388004|NCT02449239||Single Group Assignment||Treatment||None (Open Label)||||||
1388005|NCT02449226|||Cohort||Prospective|||||||
1388006|NCT02449213|||Cohort||Prospective|||||||
1388007|NCT02449200|Randomized|Parallel Assignment||Treatment||Single||||||t
1388008|NCT02449187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388009|NCT02449174|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388010|NCT02449161|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1388011|NCT02449148|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388012|NCT02449135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388013|NCT02449122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388014|NCT02449109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388015|NCT02449096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388016|NCT02449083|||Cohort||Prospective|||||||
1388017|NCT02449070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388018|NCT02449057|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1388019|NCT02449044||Single Group Assignment||Treatment||None (Open Label)||||||
1388020|NCT02449031|||Cohort||Prospective|||||||
1388021|NCT02449018|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388022|NCT02449005|Randomized|Parallel Assignment||Treatment||Quadruple|The participant, care provider, investigator/outcome assessor is not aware of the treatment modality||t|t|t|t
1388023|NCT02448992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388024|NCT02448979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388025|NCT02448966|||Case Control||Prospective|||||||
1388026|NCT02448953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388027|NCT02448940|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388028|NCT02448927|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388029|NCT02448914|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388030|NCT02448901|||Cohort||Prospective|||||||
1388031|NCT02448888|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388032|NCT02448875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388033|NCT02448862|||Case Control||Retrospective|||||||
1388034|NCT02448849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388035|NCT02448836|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1388036|NCT02448823|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388037|NCT02448810|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1388038|NCT02448797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388039|NCT02448784|||Cohort||Prospective|||||||
1388040|NCT02448771||Single Group Assignment||Treatment||None (Open Label)||||||
1388041|NCT02448758|||Cohort|||||||||
1388042|NCT02448745|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388043|NCT02448732||Single Group Assignment||Treatment||None (Open Label)||||||
1388044|NCT02448719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388045|NCT02448706|Randomized|Crossover Assignment||Health Services Research||Double|||t|||t
1388046|NCT02448693|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1388047|NCT02448680|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388048|NCT02448667|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1388049|NCT02448654|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1388050|NCT02448641|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388051|NCT02448628||Single Group Assignment||Treatment||None (Open Label)||||||
1388052|NCT02448615|||Cohort||Prospective|||||||
1388053|NCT02448602|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388054|NCT02448589||Single Group Assignment||Treatment||None (Open Label)||||||
1388055|NCT02448576|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388056|NCT02448563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388057|NCT02448550|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388058|NCT02448537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388059|NCT02448524|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388060|NCT02448511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388061|NCT02448498|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1388062|NCT02448485|||Cohort||Retrospective|||||||
1388063|NCT02448472|||Case-Only||Prospective|||||||
1388064|NCT02448459||Single Group Assignment||Treatment||None (Open Label)||||||
1388065|NCT02448446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388066|NCT02448433||Single Group Assignment||Treatment||None (Open Label)||||||
1388067|NCT02448420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388068|NCT02448407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388069|NCT02448394|Randomized|Parallel Assignment||Supportive Care||Single|Study investigators (except statistician and data manager) blinded to interim outcome results by study arm.|Randomized community trial|||t|
1388070|NCT02448381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388071|NCT02448368|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1388072|NCT02448355||Single Group Assignment||Basic Science||None (Open Label)||||||
1388073|NCT02448342|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388074|NCT02448329||Single Group Assignment||Treatment||None (Open Label)||||||
1388075|NCT02448316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388076|NCT02448303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388077|NCT02448290||Single Group Assignment||Treatment||None (Open Label)||||||
1388078|NCT02448277|Randomized|Parallel Assignment||Treatment||Single||||||t
1388079|NCT02448264|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388080|NCT02448251|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388081|NCT02448238||Single Group Assignment||Supportive Care||None (Open Label)||||||
1388082|NCT02448225||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388083|NCT02448212|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1388084|NCT02448199|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388085|NCT02448186|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388086|NCT02448173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388087|NCT02448160||Single Group Assignment||Treatment||None (Open Label)||||||
1388088|NCT02448147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388089|NCT02448134|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388090|NCT02448121||Single Group Assignment||Treatment||None (Open Label)||||||
1388091|NCT02448108|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1388092|NCT02448095|||Cohort||Retrospective|||||||
1388093|NCT02448082|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388094|NCT02448069||Single Group Assignment||Treatment||None (Open Label)||||||
1388095|NCT02448056|||Case-Only||Prospective|||||||
1388096|NCT02448043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388097|NCT02448030|Randomized|Crossover Assignment||Treatment||Single||||||t
1388098|NCT02448017|Randomized|Parallel Assignment||Treatment||Single||||||t
1388099|NCT02448004||Single Group Assignment||Treatment||None (Open Label)||||||
1388100|NCT02447991|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388101|NCT02447978||||||||||||
1388102|NCT02447965|Randomized|Parallel Assignment||Other||Double|||t|t||
1388103|NCT02447952||Single Group Assignment||Other||None (Open Label)||||||
1388104|NCT02447939||Single Group Assignment||Treatment||None (Open Label)||||||
1388105|NCT02447926||Single Group Assignment||||None (Open Label)||||||
1388106|NCT02447913|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388107|NCT02447900||Single Group Assignment||Treatment||None (Open Label)||||||
1388108|NCT02447887||Single Group Assignment||Treatment||None (Open Label)||||||
1388109|NCT02447874|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388110|NCT02447861|||Case-Control||Prospective|||||||
1388111|NCT02447848||Single Group Assignment||Treatment||None (Open Label)||||||
1388112|NCT02447835|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1388113|NCT02447822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388114|NCT02447809|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1388115|NCT02447796|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1388116|NCT02447783|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1388117|NCT02447770||Single Group Assignment||Basic Science||None (Open Label)||||||
1388118|NCT02447757|||Cohort||Retrospective|||||||
1388119|NCT02447744|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1388120|NCT02447731|||Cohort||Prospective|||||||
1388121|NCT02447718|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388122|NCT02447705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388123|NCT02447692|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388124|NCT02447679||Single Group Assignment||Prevention||None (Open Label)||||||
1388125|NCT02447666|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388126|NCT02447653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388127|NCT02447640|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1388128|NCT02447627|||Cohort||Prospective|||||||
1388129|NCT02447614|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1388130|NCT02447601||Single Group Assignment||Other||None (Open Label)||||||
1388131|NCT02447588|Randomized|Parallel Assignment||||None (Open Label)||||||
1388132|NCT02447575||Single Group Assignment||Health Services Research||None (Open Label)||||||
1388133|NCT02447562|Randomized|Parallel Assignment||||Single|||||t|
1388134|NCT02447549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388135|NCT02447536|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388136|NCT02447523|||Cohort||Prospective|||||||
1388137|NCT02447510|Randomized|Parallel Assignment||Treatment||Single||||||t
1388138|NCT02447497|Randomized|Parallel Assignment||Prevention||Single||||||t
1388139|NCT02447484|Randomized|Parallel Assignment||Prevention||Single||||||t
1388140|NCT02447471|||Cohort||Prospective|||||||
1388141|NCT02447458|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1388142|NCT02447445|||Case-Only||Other|||||||
1388143|NCT02447432|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1388144|NCT02447419||Single Group Assignment||Treatment||None (Open Label)||||||
1388145|NCT02447406||Single Group Assignment||Treatment||None (Open Label)||||||
1388146|NCT02447393|Randomized|Crossover Assignment||Prevention||Single|||t|||
1388147|NCT02447380||Single Group Assignment||Treatment||None (Open Label)||||||
1388148|NCT02447367|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388149|NCT02447341|||Case-Only||Retrospective|||||||
1388150|NCT02447328||Single Group Assignment||Other||None (Open Label)||||||
1388151|NCT02447315|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1388152|NCT02447302|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388153|NCT02447289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388154|NCT02447276|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388155|NCT02447263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388156|NCT02447250||Single Group Assignment||Diagnostic||Single|||||t|
1388157|NCT02447237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388158|NCT02447224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388159|NCT02447211|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1388160|NCT02447198|||Cohort||Prospective|||||||
1388161|NCT02447185|Randomized|Parallel Assignment||Prevention||Single|||t|||
1388162|NCT02447172|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1388163|NCT02447159|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388164|NCT02447146|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1388165|NCT02447133||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388166|NCT02447120||Single Group Assignment||Diagnostic||Single|||t|||
1388167|NCT02447107|||Cohort||Prospective|||||||
1388168|NCT02447094|||Cohort||Prospective|||||||
1388169|NCT02447081|||Other||Prospective|||||||
1388170|NCT02447068|Randomized|Single Group Assignment||Treatment||Single||||||t
1388171|NCT02447055||Single Group Assignment||Treatment||None (Open Label)||||||
1388172|NCT02447042|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1388173|NCT02447029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388174|NCT02447016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388175|NCT02447003||Single Group Assignment||Treatment||None (Open Label)||||||
1388176|NCT02446990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388177|NCT02446977|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388178|NCT02446964||Single Group Assignment||Treatment||None (Open Label)||||||
1388179|NCT02446951|||Cohort||Prospective|||||||
1388180|NCT02446938|||Case-Only||Prospective|||||||
1388181|NCT02446925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388182|NCT02446912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388183|NCT02446899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388184|NCT02446886|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388185|NCT02446873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388186|NCT02446860||Single Group Assignment||Treatment||None (Open Label)||||||
1388187|NCT02446847|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388188|NCT02446834|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)|Open Label|||||
1388189|NCT02446821||Single Group Assignment||Treatment||None (Open Label)||VeraCept intrauterine contraceptive device||||
1388190|NCT02446808||Single Group Assignment||Prevention||None (Open Label)||||||
1388191|NCT02446795|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388192|NCT02446782|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1388193|NCT02446769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388194|NCT02446756|Randomized|Parallel Assignment||Treatment||Single||||||t
1388195|NCT02446743|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388196|NCT02446730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388197|NCT02446717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388198|NCT02446704||Single Group Assignment||Treatment||None (Open Label)||||||
1388199|NCT02446691||Single Group Assignment||Prevention||None (Open Label)||||||
1388200|NCT02446678|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1388201|NCT02446665|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1388202|NCT02446652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388203|NCT02446639|||Case-Only||Prospective|||||||
1388204|NCT02446626||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388205|NCT02446613||Single Group Assignment||Treatment||Single|||t|||
1388206|NCT02446600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388207|NCT02446587|||Cohort||Prospective|||||||
1388208|NCT02446574||Single Group Assignment||Treatment||None (Open Label)||||||
1388209|NCT02446561|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1388210|NCT02446548|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1388211|NCT02446535||Single Group Assignment||Treatment||None (Open Label)||||||
1388212|NCT02446522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388213|NCT02446509|Randomized|Crossover Assignment||Treatment||Single||||||t
1388214|NCT02446496|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1388215|NCT02446483|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1388216|NCT02446470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388217|NCT02446457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388218|NCT02446444|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Stratification Factors:~Gleason score (<=7 versus 8-10),~Regional lymph nodes involvement (N0 versus N1)~Clinical T-stage (T2 and below versus T3 and above),~PSA (<20ng/mL versus ≥ 20ng/mL)~Study Site~Brachytherapy (yes versus no)~Pelvic Field (yes versus no)"||||
1388219|NCT02446431||Single Group Assignment||Prevention||None (Open Label)||||||
1388220|NCT02446418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388285|NCT02445573|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388286|NCT02445560|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1388221|NCT02446405|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Stratification factors:~High volume disease (yes versus no), characterised as:~4 or more bone metastases, one of which is outside the vertebral column and pelvis AND/OR~Visceral metastases (e.g. lung, pleura, liver, adrenal and others) Lymph node involvement or bladder invasion do NOT qualify as visceral disease.~Study site~Concomitant anti-resorptive therapy to delay skeletal related events when commencing ADT~Co-morbidities according to the Adult Co-morbidity Evaluation (ACE-27: 0-1 vs 2-3)~Early use of docetaxel defined as use of docetaxel in conjunction with initiation of ADT."||||
1388222|NCT02446392|||Cohort||Prospective|||||||
1388223|NCT02446379|||Other||Prospective|||||||
1388224|NCT02446366||Single Group Assignment||Treatment||None (Open Label)||||||
1388225|NCT02446353|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388226|NCT02446340|Randomized|Parallel Assignment||||Double|||t||t|
1388227|NCT02446327||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388228|NCT02446314|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1388229|NCT02446301|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388230|NCT02446288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388231|NCT02446275|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388232|NCT02446262|||Other||Prospective|||||||
1388233|NCT02446249||Single Group Assignment||Treatment||None (Open Label)||||||
1388234|NCT02446236||Single Group Assignment||Treatment||None (Open Label)||||||
1388235|NCT02446223||Single Group Assignment||Treatment||None (Open Label)||||||
1388236|NCT02446210|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1388237|NCT02446197|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1388238|NCT02446184|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This study is an un-blinded, non-randomized, single arm Phase 1 study. Fetal intervention is usually offered to patients carrying fetuses with isolated LUTO that meet the inclusion criteria. Once the patient elected to have fetal intervention, fetal cystoscopy will be offered as an experimental procedure as an option to fetal vesico-amniotic shunting.||||
1388239|NCT02446171|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1388240|NCT02446158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388241|NCT02446145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388242|NCT02446132|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388243|NCT02446119|||Cohort||Prospective|||||||
1388244|NCT02446106|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1388245|NCT02446093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388246|NCT02446080|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388247|NCT02446067|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388248|NCT02446054||Single Group Assignment||Supportive Care||None (Open Label)||||||
1388249|NCT02446041|||Cohort||Retrospective|||||||
1388250|NCT02446028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388251|NCT02446015|Randomized|Parallel Assignment||Treatment||Single|||||t|
1388252|NCT02446002||Single Group Assignment||Treatment||None (Open Label)||||||
1388253|NCT02445989|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388254|NCT02445976|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1388255|NCT02445963|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388256|NCT02445950|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1388257|NCT02445937|Randomized|Sequential Assignment||Supportive Care||Single||Stepped Wedge Design||||t
1388258|NCT02445924|||Case Control||Prospective|||||||
1388259|NCT02445911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388260|NCT02445898|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1388261|NCT02445885|Randomized|Parallel Assignment||Treatment||Single||||||t
1388262|NCT02445872|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388263|NCT02445859|Randomized|Parallel Assignment||Prevention||Single|||t|||
1388264|NCT02445846|||Case-Only||Cross-Sectional|||||||
1388265|NCT02445833||Single Group Assignment||Treatment||None (Open Label)||||||
1388266|NCT02445820|||Cohort||Retrospective|||||||
1388267|NCT02445807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388268|NCT02445794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388269|NCT02445781|Randomized|Crossover Assignment||Treatment||Single|||t|||
1388270|NCT02445768|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1388271|NCT02445755|||Cohort||Prospective|||||||
1388272|NCT02445742||Single Group Assignment||Treatment||None (Open Label)||||||
1388273|NCT02445729|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388274|NCT02445716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388275|NCT02445703|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1388276|NCT02445690|||Cohort||Prospective|||||||
1388277|NCT02445677|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388278|NCT02445664|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1388279|NCT02445651|Randomized|Factorial Assignment||Supportive Care||None (Open Label)|This is an Open Label study. Randomization will occur via a 2:1 ratio of the NAC group and the waitlist control groups using the method of random permuted blocks with random block sizes without stratification. 28 subjects in the NAC arm and 14 subjects have been enrolled in the standard of care arm.|||||
1388280|NCT02445638|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1388281|NCT02445625||Single Group Assignment||Treatment||None (Open Label)||||||
1388282|NCT02445612|||Cohort||Prospective|||||||
1388283|NCT02445599|Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1388284|NCT02445586||Single Group Assignment||Treatment||None (Open Label)||||||
1388287|NCT02445547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388288|NCT02445534|||Cohort||Prospective|||||||
1388289|NCT02445521|||Case Control||Cross-Sectional|||||||
1388290|NCT02445508|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1388291|NCT02445495|||||Retrospective|||||||
1388292|NCT02445482|||Cohort||Prospective|||||||
1388293|NCT02445469|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1388294|NCT02445456|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1388295|NCT02445443|||Case-Only||Prospective|||||||
1388296|NCT02445430|||Family-Based||Prospective|||||||
1388297|NCT02445417|||Cohort||Prospective|||||||
1388298|NCT02445404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388299|NCT02445391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388300|NCT02445378|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1388301|NCT02445365|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1388302|NCT02445352|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388303|NCT02445339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388304|NCT02445326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388305|NCT02445313|||Case-Control||Prospective|||||||
1388306|NCT02445300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388307|NCT02445287|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1388308|NCT02445274|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388309|NCT02445261|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1388310|NCT02445248||Single Group Assignment||Treatment||None (Open Label)||||||
1388311|NCT02445235|||Case-Only||Prospective|||||||
1388312|NCT02445222|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1388313|NCT02445209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388314|NCT02445196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388315|NCT02445183|||Case-Control||Other|||||||
1388316|NCT02445170|||||Cross-Sectional|||||||
1388317|NCT02445157|||Cohort||Prospective|||||||
1388318|NCT02445144|||Case-Control||Prospective|||||||
1388319|NCT02445131||Single Group Assignment||Treatment||None (Open Label)||||||
1388320|NCT02445118|||Cohort||Prospective|||||||
1388321|NCT02445105|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1388322|NCT02445092|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1388323|NCT02445079|||Cohort||Prospective|||||||
1388324|NCT02445066||Single Group Assignment||Other||None (Open Label)||||||
1388325|NCT02445053|||Cohort||Prospective|||||||
1388326|NCT02445040||Single Group Assignment||Treatment||None (Open Label)||||||
1388327|NCT02445027||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1388328|NCT02445014||Single Group Assignment||Other||None (Open Label)||||||
1388329|NCT02445001||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388330|NCT02444988|Randomized|Crossover Assignment||Treatment||Single||||||t
1388331|NCT02444975|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388332|NCT02444962||Single Group Assignment||Treatment||None (Open Label)||||||
1388333|NCT02444949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388334|NCT02444936|Randomized|Parallel Assignment||Basic Science||Single||||||t
1388335|NCT02444923|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388336|NCT02444910||Single Group Assignment||Treatment||None (Open Label)||||||
1388337|NCT02444897|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388338|NCT02444884|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388339|NCT02444871|||||Prospective|||||||
1388340|NCT02444858|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388341|NCT02444845|||Cohort||Cross-Sectional|||||||
1388342|NCT02444832|||Case-Only||Retrospective|||||||
1388343|NCT02444819||Single Group Assignment||Treatment||None (Open Label)||||||
1388344|NCT02444806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388345|NCT02444793||||Treatment||None (Open Label)||||||
1388346|NCT02444780|||Cohort||Prospective|||||||
1388347|NCT02444767||Single Group Assignment||Basic Science||None (Open Label)||||||
1388348|NCT02444754|||Cohort||Prospective|||||||
1388349|NCT02444741|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388350|NCT02444728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388351|NCT02444715|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388352|NCT02444702|||Cohort||Cross-Sectional|||||||
1388353|NCT02444689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388354|NCT02444676|||Cohort||Prospective|||||||
1388355|NCT02444663|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1388356|NCT02444650|||Cohort||Prospective|||||||
1388357|NCT02444637||Single Group Assignment||Treatment||None (Open Label)||||||
1388358|NCT02444624|||Case-Control||Prospective|||||||
1388359|NCT02444611|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1388360|NCT02444598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388361|NCT02444585|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1388362|NCT02444572|Randomized|Parallel Assignment||Prevention||Single||||||t
1388363|NCT02444559|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1388364|NCT02444546||Single Group Assignment||Treatment||None (Open Label)||||||
1388365|NCT02444533|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388439|NCT02443571|||Cohort||Retrospective|||||||
1388440|NCT02443558|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1388366|NCT02444520|Randomized|Crossover Assignment||Other||Single|Patients and GPs will not be blind to treatment allocation due to the nature of the trial (i.e. therapy trial). The trial team member responsible for treatment allocation will be unblind. All outcome data are based on self-report and will be collected either by post or email. The research assistant(s) responsible for contacting participants who have not returned or completed follow-up questionnaires will be unblind. Moreover, the Data Monitoring and Ethics Committee (DMEC), research workers and trial statisticians will remain blind to treatment allocation.|PRINCE Primary is a cluster randomised waiting list controlled trial to evaluate the acceptability and feasibility of an integrated approach to care in general practice for adults with PPS.||||t
1388367|NCT02444507|Randomized|Crossover Assignment||||Single|||t|||
1388368|NCT02444494|||Cohort||Prospective|||||||
1388369|NCT02444481||Single Group Assignment||Treatment||None (Open Label)||||||
1388370|NCT02444468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388371|NCT02444455||Single Group Assignment||Treatment||None (Open Label)||||||
1388372|NCT02444442|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388373|NCT02444429|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388374|NCT02444416|||Cohort||Prospective|||||||
1388375|NCT02444403||Single Group Assignment||Prevention||None (Open Label)||||||
1388376|NCT02444390||Single Group Assignment||Screening||None (Open Label)||||||
1388377|NCT02444377|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388378|NCT02444364||Single Group Assignment||Treatment||None (Open Label)||||||
1388379|NCT02444351|Randomized|Parallel Assignment||Treatment||Single||||||t
1388380|NCT02444338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388381|NCT02444325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388382|NCT02444312|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1388383|NCT02444299|||Cohort||Prospective|||||||
1388384|NCT02444286|||Cohort||Prospective|||||||
1388385|NCT02444273|Randomized|Parallel Assignment||Treatment||Single||||||t
1388386|NCT02444260|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388387|NCT02444247|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1388388|NCT02444234|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1388389|NCT02444221|||Cohort||Prospective|||||||
1388390|NCT02444208|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1388391|NCT02444195|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388392|NCT02444182|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1388393|NCT02444169|||Cohort||Retrospective|||||||
1388394|NCT02444156||Single Group Assignment||||None (Open Label)||||||
1388395|NCT02444143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388396|NCT02444130|||Cohort||Prospective|||||||
1388397|NCT02444117|||Cohort||Prospective|||||||
1388398|NCT02444104|||Case-Only||Prospective|||||||
1388399|NCT02444091||Single Group Assignment||Treatment||None (Open Label)||||||
1388400|NCT02444078|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388401|NCT02444065|Randomized|Parallel Assignment||Treatment||Single||||||t
1388402|NCT02444052|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388403|NCT02444039|||Cohort||Prospective|||||||
1388404|NCT02444026|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388405|NCT02444013|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1388406|NCT02444000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388407|NCT02443987|Randomized|Parallel Assignment||||Triple|||t|t|t|
1388408|NCT02443974|Randomized|Parallel Assignment||Treatment||Single||||||t
1388409|NCT02443961||Single Group Assignment||Other||None (Open Label)||||||
1388410|NCT02443948|||Cohort||Prospective|||||||
1388411|NCT02443935||Single Group Assignment||Treatment||None (Open Label)||||||
1388412|NCT02443922|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1388413|NCT02443909|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388414|NCT02443896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388415|NCT02443883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388416|NCT02443870|||Other||Retrospective|||||||
1388417|NCT02443857||Single Group Assignment||Supportive Care||None (Open Label)||||||
1388418|NCT02443844|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388419|NCT02443831||Single Group Assignment||Treatment||None (Open Label)||||||
1388420|NCT02443818||Single Group Assignment||Treatment||None (Open Label)||||||
1388421|NCT02443805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388422|NCT02443792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388423|NCT02443779|||Case-Only||Prospective|||||||
1388424|NCT02443766|||Other||Prospective|||||||
1388425|NCT02443753||Single Group Assignment||Treatment||None (Open Label)||||||
1388426|NCT02443740|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1388427|NCT02443727|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1388428|NCT02443714|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1388429|NCT02443701|Randomized|Parallel Assignment||||Double|||||t|t
1388430|NCT02443688|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388431|NCT02443675||||||||||||
1388432|NCT02443662|||Case-Only||Prospective|||||||
1388433|NCT02443649|Randomized|Parallel Assignment||Treatment||Single||||||t
1388434|NCT02443636|||Cohort||Prospective|||||||
1388435|NCT02443623||Single Group Assignment||Basic Science||None (Open Label)||||||
1388436|NCT02443610|||Cohort||Prospective|||||||
1388437|NCT02443597|||Case Control||Prospective|||||||
1388438|NCT02443584|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1388441|NCT02443545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388442|NCT02443532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388443|NCT02443519|Randomized|Parallel Assignment||Treatment||Single||||||t
1388444|NCT02443506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388445|NCT02443493|Randomized|Parallel Assignment||Prevention||Single|||t|||
1388446|NCT02443480|||Cohort||Prospective|||||||
1388447|NCT02443467|||Cohort||Prospective|||||||
1388448|NCT02443454|||Cohort||Cross-Sectional|||||||
1388449|NCT02443428|||Cohort||Prospective|||||||
1388450|NCT02443415|||Case-Control||Prospective|||||||
1388451|NCT02443402|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1388452|NCT02443389|||Cohort|||||||||
1388453|NCT02443376|||Cohort||Prospective|||||||
1388454|NCT02443363|||Cohort||Cross-Sectional|||||||
1388455|NCT02443350|||Cohort||Prospective|||||||
1388456|NCT02443337||Single Group Assignment||Treatment||None (Open Label)||||||
1388457|NCT02443324|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388458|NCT02443311|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388459|NCT02443298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388460|NCT02443285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388461|NCT02443272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388462|NCT02443259|||Cohort||Prospective|||||||
1388463|NCT02443246|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388464|NCT02443233|||Cohort||Prospective|||||||
1388465|NCT02443220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388466|NCT02443207|||Case-Only||Cross-Sectional|||||||
1388467|NCT02443194|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1388468|NCT02443181||Single Group Assignment||Basic Science||None (Open Label)||||||
1388469|NCT02443168|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1388470|NCT02443155|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388471|NCT02443142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388472|NCT02443129|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1388473|NCT02443116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388474|NCT02443103||Single Group Assignment||Treatment||None (Open Label)||||||
1388475|NCT02443090|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388476|NCT02443077|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1388477|NCT02443064||Single Group Assignment||Treatment||None (Open Label)||||||
1388478|NCT02443051|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1388479|NCT02443038|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1388480|NCT02443025|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388481|NCT02443012|Randomized|Parallel Assignment||Treatment||Single|||||t|
1388482|NCT02442999|Randomized|Parallel Assignment||Treatment||Single||||||t
1388483|NCT02442986|||Case-Control||Prospective|||||||
1388484|NCT02442973|||Cohort||Prospective|||||||
1388485|NCT02442960|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388486|NCT02442947||Single Group Assignment||Prevention||None (Open Label)||||||
1388487|NCT02442934|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1388488|NCT02442921|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388489|NCT02442908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388490|NCT02442895|||Cohort||Retrospective|||||||
1388491|NCT02442882|||Cohort||Prospective|||||||
1388492|NCT02442869|Randomized|Parallel Assignment||Treatment||Single|The Independent Evaluator was blind to condition assignment when conducting the assessments.|||||t
1388493|NCT02442856||Single Group Assignment||Other||None (Open Label)||||||
1388494|NCT02442843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388495|NCT02442830|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1388496|NCT02442817|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1388497|NCT02442804|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1388498|NCT02442791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388499|NCT02442778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388500|NCT02442765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388501|NCT02442752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388502|NCT02442739|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1388503|NCT02442726|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1388504|NCT02442713||Single Group Assignment||Treatment||None (Open Label)||||||
1388505|NCT02442700|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1388506|NCT02442687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388507|NCT02442674|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388508|NCT02442661|||Other||Prospective|||||||
1388509|NCT02442648|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1388510|NCT02442635|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388511|NCT02442622|Randomized|Parallel Assignment||Treatment||Single||||||t
1388512|NCT02442609|||Case-Only||Prospective|||||||
1388513|NCT02442596|||Cohort||Prospective|||||||
1388514|NCT02442583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388515|NCT02442570|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1388516|NCT02442557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388517|NCT02442544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388518|NCT02442531||Single Group Assignment||Treatment||None (Open Label)||||||
1388519|NCT02442518|||Case-Only||Prospective|||||||
1388520|NCT02442505|||Case-Only||Prospective|||||||
1388521|NCT02442492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388522|NCT02442479|Randomized|Parallel Assignment||Treatment||Single||||||t
1388523|NCT02442466|Randomized|Single Group Assignment||||Triple|||t|t|t|
1388524|NCT02442453|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388525|NCT02442440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388526|NCT02442427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388527|NCT02442414||Single Group Assignment||Treatment||None (Open Label)||||||
1388528|NCT02442401|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388529|NCT02442388|Randomized|Parallel Assignment||||Double|||t|||t
1388530|NCT02442375|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388531|NCT02442362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388532|NCT02442349||Single Group Assignment||Treatment||None (Open Label)||||||
1388533|NCT02442336||Single Group Assignment||Supportive Care||None (Open Label)||||||
1388534|NCT02442323|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388535|NCT02442310|Randomized|Crossover Assignment||||None (Open Label)||||||
1388536|NCT02442297||Single Group Assignment||Treatment||None (Open Label)||||||
1388537|NCT02442284||Single Group Assignment||Treatment||None (Open Label)||||||
1388538|NCT02442271||Single Group Assignment||Treatment||None (Open Label)||||||
1388539|NCT02442258|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1388540|NCT02442245|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1388541|NCT02442232|||Case Control||Prospective|||||||
1388542|NCT02442219|||Case-Control||Cross-Sectional|||||||
1388543|NCT02442206|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1388544|NCT02442193|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1388545|NCT02442180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388546|NCT02442167|||Cohort||Prospective|||||||
1388547|NCT02442154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388548|NCT02442141|||Cohort||Prospective|||||||
1388549|NCT02442128|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1388550|NCT02442115|||Cohort||Prospective|||||||
1388551|NCT02442102|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1388552|NCT02442089|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1388553|NCT02442076|||Case-Only||Prospective|||||||
1388554|NCT02442063||Single Group Assignment||||None (Open Label)||||||
1388555|NCT02442050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388556|NCT02442037|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388557|NCT02442024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388558|NCT02442011|||Case-Only||Prospective|||||||
1388559|NCT02441998|||Cohort||Prospective|||||||
1388560|NCT02441985|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1388561|NCT02441972||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388562|NCT02441959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388563|NCT02441946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388564|NCT02441933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388565|NCT02441920|||Cohort||Cross-Sectional|||||||
1388566|NCT02441907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388567|NCT02441894||Single Group Assignment||Treatment||None (Open Label)||||||
1388568|NCT02441881|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388569|NCT02441868||Single Group Assignment||Treatment||None (Open Label)||||||
1388570|NCT02441855|||Case Control||Prospective|||||||
1388571|NCT02441842|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1388572|NCT02441829|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388573|NCT02441816||Single Group Assignment||Treatment||None (Open Label)||||||
1388574|NCT02441803|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388575|NCT02441790|Randomized|Parallel Assignment||Treatment||Single||||t||
1388576|NCT02441777||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1388577|NCT02441764|||Other||Prospective|||||||
1388578|NCT02441751|||Cohort||Prospective|||||||
1388579|NCT02441738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388580|NCT02441725|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1388581|NCT02441712|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388582|NCT02441699|||Cohort||Prospective|||||||
1388583|NCT02441686||Single Group Assignment||Treatment||None (Open Label)||||||
1388584|NCT02441673|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1388585|NCT02441660|Randomized|Crossover Assignment||Treatment||Single|||t|||
1388586|NCT02441647||Single Group Assignment||||Single|||t|||
1388587|NCT02441634||||||||||||
1388588|NCT02441621|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1388589|NCT02441608||Single Group Assignment||||Single|||t|||
1388590|NCT02441595|Randomized|Parallel Assignment||Prevention||Single||||||t
1388591|NCT02441582|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1388592|NCT02441569|Randomized|Parallel Assignment||Treatment||Single||||||t
1388593|NCT02441556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388594|NCT02441543|||Cohort||Prospective|||||||
1388595|NCT02441530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388596|NCT02441517||Single Group Assignment||Treatment||None (Open Label)||||||
1388597|NCT02441504||Single Group Assignment||Prevention||None (Open Label)||||||
1389537|NCT02429245|||||Retrospective|||||||
1388598|NCT02441491||Single Group Assignment||Treatment||None (Open Label)||||||
1388599|NCT02441478|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1388600|NCT02441465||Single Group Assignment||Basic Science||None (Open Label)||||||
1388601|NCT02441452|Randomized|Parallel Assignment||||None (Open Label)||||||
1388602|NCT02441439|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388603|NCT02441426|||Cohort||Prospective|||||||
1388604|NCT02441413||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388605|NCT02441400|||Cohort||Prospective|||||||
1388606|NCT02441387|||Case-Only||Prospective|||||||
1388607|NCT02441374|Randomized|Crossover Assignment||Treatment||Single|||||t|
1388608|NCT02441361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388609|NCT02441348|||Other||Prospective|||||||
1388610|NCT02441335|||Case-Control||Prospective|||||||
1388611|NCT02441322||Single Group Assignment||Health Services Research||None (Open Label)||||||
1388612|NCT02441309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388613|NCT02441296|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1388614|NCT02441283||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388615|NCT02441270||Single Group Assignment||Treatment||None (Open Label)||||||
1388616|NCT02441257||Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1388617|NCT02441244|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388618|NCT02441231|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388619|NCT02441218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388620|NCT02441205||Single Group Assignment||Treatment||Single||||||t
1388621|NCT02441192|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1388622|NCT02441179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388623|NCT02441166||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388624|NCT02441153|||Case-Only||Prospective|||||||
1388625|NCT02441140||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388626|NCT02441127|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388627|NCT02441114||Single Group Assignment||Screening||None (Open Label)||||||
1388628|NCT02441101|Randomized|Crossover Assignment||Treatment||Single|||t|||
1388629|NCT02441088||Single Group Assignment||Treatment||None (Open Label)||||||
1388630|NCT02441075||Single Group Assignment||Treatment||None (Open Label)||||||
1388631|NCT02441062||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388632|NCT02441049|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388633|NCT02441036|Randomized|Parallel Assignment||Treatment||Single||||||t
1388634|NCT02441023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388635|NCT02441010|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388636|NCT02440997|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388637|NCT02440984||Single Group Assignment||Other||None (Open Label)||||||
1388638|NCT02440971|||Cohort||Prospective|||||||
1388639|NCT02440958||Single Group Assignment||Treatment||None (Open Label)||||||
1388640|NCT02440945||Single Group Assignment||Supportive Care||None (Open Label)||||||
1388641|NCT02440932|Randomized|Crossover Assignment||||Single|||t|||
1388642|NCT02440919|Randomized|Crossover Assignment||Treatment||Single|||t|||
1388643|NCT02440906|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388644|NCT02440893|||Cohort||Prospective|||||||
1388645|NCT02440880|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388646|NCT02440867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388647|NCT02440854|||Other||Prospective|||||||
1388648|NCT02440841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388649|NCT02440828|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388650|NCT02440815||Single Group Assignment||Basic Science||None (Open Label)||||||
1388651|NCT02440802|||Case-Only||Prospective|||||||
1388652|NCT02440789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388653|NCT02440776|||Case-Only||Prospective|||||||
1388654|NCT02440763|||Cohort||Prospective|||||||
1388655|NCT02440750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388656|NCT02440737||Single Group Assignment||Supportive Care||None (Open Label)||||||
1388657|NCT02440724||Single Group Assignment||Treatment||None (Open Label)||||||
1388658|NCT02440711|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388659|NCT02440698|||Cohort||Prospective|||||||
1388660|NCT02440685|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388661|NCT02440672||Single Group Assignment||Treatment||None (Open Label)||||||
1388662|NCT02440659|||Cohort||Prospective|||||||
1388663|NCT02440646|||Cohort||Prospective|||||||
1388664|NCT02440633||Single Group Assignment||Treatment||None (Open Label)||||||
1388665|NCT02440620|||Cohort||Prospective|||||||
1388666|NCT02440607|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388667|NCT02440594|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1388668|NCT02440581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388669|NCT02440568||Single Group Assignment||Treatment||None (Open Label)||||||
1388670|NCT02440555|||Cohort||Prospective|||||||
1388671|NCT02440542|||Cohort||Prospective|||||||
1388672|NCT02440529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388673|NCT02440516|Randomized|Crossover Assignment||Treatment||Single|||t|||
1388674|NCT02440503|||Cohort||Cross-Sectional|||||||
1388675|NCT02440490|Randomized|Parallel Assignment||Treatment||Single|||||t|
1388676|NCT02440477|||Cohort||Other|||||||
1388677|NCT02440464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388678|NCT02440451||Single Group Assignment||Treatment||None (Open Label)||||||
1388679|NCT02440438||Single Group Assignment||||None (Open Label)||||||
1388680|NCT02440425||Single Group Assignment||Treatment||None (Open Label)||||||
1388681|NCT02440412|Randomized|Crossover Assignment||Basic Science||Single||||||t
1388682|NCT02440399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388683|NCT02440386|Randomized|Single Group Assignment||Treatment||Single||||||t
1388684|NCT02440373|||Cohort||Prospective|||||||
1388685|NCT02440360|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1388686|NCT02440347|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1388687|NCT02440334||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388688|NCT02440321|Randomized|Parallel Assignment||Prevention||Single|||t|||
1388689|NCT02440308||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388690|NCT02440295|||Cohort||Prospective|||||||
1388691|NCT02440282|||Cohort||Retrospective|||||||
1388692|NCT02440269|||Cohort||Prospective|||||||
1388693|NCT02440256|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1388694|NCT02440243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388695|NCT02440230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388696|NCT02440217|||Case Control||Cross-Sectional|||||||
1388697|NCT02440204|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1388698|NCT02440191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388699|NCT02440178||Single Group Assignment||Prevention||None (Open Label)||||||
1388700|NCT02440165|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1388701|NCT02440152|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388702|NCT02440139|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1388703|NCT02440126|||Cohort||Other|||||||
1388704|NCT02440113|||Cohort||Retrospective|||||||
1388705|NCT02440100|Randomized|||Basic Science||Triple|||t||t|t
1388706|NCT02440087|||Cohort||Prospective|||||||
1388707|NCT02440074||Single Group Assignment||Treatment||None (Open Label)||||||
1388708|NCT02440061|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1388709|NCT02440048|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388710|NCT02440035|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1388711|NCT02440022|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388712|NCT02440009|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388713|NCT02439996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388714|NCT02439983|Randomized|Parallel Assignment||||Triple|||t|t|t|
1388715|NCT02439970|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1388716|NCT02439957|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1388717|NCT02439944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388718|NCT02439931||Single Group Assignment||Treatment||None (Open Label)||||||
1388719|NCT02439918|||||Cross-Sectional|||||||
1388720|NCT02439905|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1388721|NCT02439892|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388722|NCT02439879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388723|NCT02439866|Randomized|Parallel Assignment||Treatment||Single|||||t|
1388724|NCT02439853|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388725|NCT02439840|||||Prospective|||||||
1388726|NCT02439827|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388727|NCT02439814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388728|NCT02439801|||Case-Crossover||Prospective|||||||
1388729|NCT02439788||Single Group Assignment||Treatment||None (Open Label)||||||
1388730|NCT02439775|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388731|NCT02439762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388732|NCT02439749|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388733|NCT02439736|||Cohort||Prospective|||||||
1388734|NCT02439723||Single Group Assignment||Treatment||None (Open Label)||||||
1388735|NCT02439710||||||||||||
1388736|NCT02439697|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388737|NCT02439684|||Cohort||Cross-Sectional|||||||
1388738|NCT02439671|Randomized|Parallel Assignment||Treatment||Single||||||t
1388739|NCT02439658|||Case-Control||Prospective|||||||
1388740|NCT02439645|||Case-Only||Prospective|||||||
1388741|NCT02439632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388742|NCT02439619||Single Group Assignment||Health Services Research||None (Open Label)||||||
1388743|NCT02439606|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1388744|NCT02439593|Randomized|Parallel Assignment||Treatment||None (Open Label)||Hyperthermia with chemoradiotherapy vs. Chemoradiotherapy alone||||
1388745|NCT02439580|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1388746|NCT02439567||Single Group Assignment||Other||None (Open Label)||||||
1388747|NCT02439554|||Cohort||Prospective|||||||
1388748|NCT02439541|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388749|NCT02439528|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1388750|NCT02439515|Randomized|Parallel Assignment||Treatment||Single||||||t
1388751|NCT02439502||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388752|NCT02439489|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388753|NCT02439476|||Cohort||Prospective|||||||
1388754|NCT02439463|||Other||Cross-Sectional|||||||
1388755|NCT02439450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389684|NCT02427321|||Cohort||Prospective|||||||
1388756|NCT02439437|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388757|NCT02439424||Single Group Assignment||Health Services Research||None (Open Label)||||||
1388758|NCT02439411|||Cohort||Retrospective|||||||
1388759|NCT02439398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388760|NCT02439385||Single Group Assignment||Treatment||None (Open Label)||||||
1388761|NCT02439372|||Cohort||Prospective|||||||
1388762|NCT02439359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388763|NCT02439346|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1388764|NCT02439333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388765|NCT02439320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388766|NCT02439307|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388767|NCT02439294|Randomized|Parallel Assignment||||None (Open Label)||||||
1388768|NCT02439281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388769|NCT02439255|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388770|NCT02439242|||Cohort||Prospective|||||||
1388771|NCT02439229|||Cohort||Prospective|||||||
1388772|NCT02439216|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1388773|NCT02439203|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1388774|NCT02439190|Randomized|Parallel Assignment||||None (Open Label)||||||
1388775|NCT02439177|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1388776|NCT02439164|Non-Randomized|Parallel Assignment||Other||Single|||||t|
1388777|NCT02439151|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388778|NCT02439138||Single Group Assignment||Treatment||None (Open Label)||||||
1388779|NCT02439125|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1388780|NCT02439112|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1388781|NCT02439099|||Case-Control||Prospective|||||||
1388782|NCT02439086||Single Group Assignment||Diagnostic||Single||||||t
1388783|NCT02439073|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1388784|NCT02439060|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388785|NCT02439047||Single Group Assignment||Basic Science||None (Open Label)||||||
1388786|NCT02439034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388787|NCT02439021|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388788|NCT02439008||Single Group Assignment||Basic Science||None (Open Label)||||||
1388789|NCT02438995|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388790|NCT02438982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388791|NCT02438969|||Case-Control||Cross-Sectional|||||||
1388792|NCT02438956|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1388793|NCT02438943|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1388794|NCT02438930|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1388795|NCT02438917|||Case-Control||Prospective|||||||
1388796|NCT02438904||Single Group Assignment||Treatment||None (Open Label)||||||
1388797|NCT02438891||Single Group Assignment||Treatment||None (Open Label)||||||
1388798|NCT02438878|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388799|NCT02438865|Randomized|Parallel Assignment||Prevention||Single|||t|||
1388800|NCT02438852|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1388801|NCT02438839|||Case-Only||Prospective|||||||
1388802|NCT02438826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388803|NCT02438813|||Cohort||Prospective|||||||
1388804|NCT02438800|Randomized|Parallel Assignment||Prevention||Single||||t||
1388805|NCT02438787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388806|NCT02438774|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388807|NCT02438761||Single Group Assignment||Treatment||None (Open Label)||||||
1388808|NCT02438748|||Cohort||Prospective|||||||
1388809|NCT02438735|||Cohort||Prospective|||||||
1388810|NCT02438722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388811|NCT02438709||Single Group Assignment||Treatment||None (Open Label)||||||
1388812|NCT02438696|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388813|NCT02438683|Randomized|Crossover Assignment||Treatment||Double||||||
1388814|NCT02438670|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1388815|NCT02438657||Single Group Assignment||Treatment||None (Open Label)||||||
1388816|NCT02438644|||Cohort||Prospective|||||||
1388817|NCT02438631|||Cohort||Other|||||||
1388818|NCT02438618|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388819|NCT02438605|||Case Control||Prospective|||||||
1388820|NCT02438592|||Cohort||Other|||||||
1388821|NCT02438579|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1388822|NCT02438566|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1388823|NCT02438553|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388824|NCT02438540|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388825|NCT02438527|Randomized|Parallel Assignment||||Single|||||t|
1388826|NCT02438514|||Cohort||Prospective|||||||
1388827|NCT02438501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388828|NCT02438488|||Cohort||Prospective|||||||
1388829|NCT02438475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388830|NCT02438462|||Cohort||Prospective|||||||
1388831|NCT02438449|||Cohort||Prospective|||||||
1388832|NCT02438436|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1388833|NCT02438423|Randomized|Parallel Assignment||Prevention||Single|||||t|
1388834|NCT02438410|||Cohort||Prospective|||||||
1388835|NCT02438397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388836|NCT02438384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388837|NCT02438371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388838|NCT02438358||Single Group Assignment||Other||None (Open Label)||||||
1388839|NCT02438345|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388840|NCT02438332|||Cohort||Retrospective|||||||
1388841|NCT02438319|||Case-Crossover||Retrospective|||||||
1388842|NCT02438306|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388843|NCT02438293|||Cohort||Prospective|||||||
1388844|NCT02438280|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388845|NCT02438267|||Cohort||Prospective|||||||
1388846|NCT02438254|||Cohort||Cross-Sectional|||||||
1388847|NCT02438241|Randomized|Parallel Assignment||Treatment||Single||||||t
1388848|NCT02438228||Single Group Assignment||||None (Open Label)||||||
1388849|NCT02438215||Single Group Assignment||Treatment||None (Open Label)||||||
1388850|NCT02438202||Single Group Assignment||Treatment||None (Open Label)||||||
1388851|NCT02438189|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388852|NCT02438176|Randomized|Parallel Assignment||Treatment||Single|||||t|
1388853|NCT02438163|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1388854|NCT02438150|Randomized|Parallel Assignment||||Single|||||t|
1388855|NCT02438137|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388856|NCT02438124|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1388857|NCT02438111|||Cohort||Prospective|||||||
1388858|NCT02438098||Single Group Assignment||Prevention||None (Open Label)||||||
1388859|NCT02438085|||Cohort||Prospective|||||||
1388860|NCT02438072||Single Group Assignment||||None (Open Label)||||||
1388861|NCT02438059|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388862|NCT02438046|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388863|NCT02438033||Single Group Assignment||Treatment||None (Open Label)||||||
1388864|NCT02438020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388865|NCT02438007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388866|NCT02437994|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1388867|NCT02437981|||Cohort||Prospective|||||||
1388868|NCT02437968|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1388869|NCT02437955|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1388870|NCT02437942||Single Group Assignment||Treatment||None (Open Label)||||||
1388871|NCT02437929|||||Prospective|||||||
1388872|NCT02437916||Single Group Assignment||Treatment||None (Open Label)||||||
1388873|NCT02437903||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1388874|NCT02437890|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388875|NCT02437877|||Case Control||Cross-Sectional|||||||
1388876|NCT02437864|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1388877|NCT02437851||Single Group Assignment||Treatment||None (Open Label)||||||
1388878|NCT02437838|||Other||Prospective|||||||
1388879|NCT02437825|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388880|NCT02437812||Single Group Assignment||Treatment||None (Open Label)||||||
1388881|NCT02437799|||Cohort||Prospective|||||||
1388882|NCT02437786||Single Group Assignment||Other||None (Open Label)||||||
1388883|NCT02437773|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1388884|NCT02437760|||Case Control||Prospective|||||||
1388885|NCT02437747|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388886|NCT02437734||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388887|NCT02437721|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1388888|NCT02437708|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1388889|NCT02437695|||||Retrospective|||||||
1388890|NCT02437682|||Cohort||Cross-Sectional|||||||
1388891|NCT02437669||Single Group Assignment||Treatment||None (Open Label)||||||
1388892|NCT02437656||Single Group Assignment||Treatment||None (Open Label)||||||
1388893|NCT02437643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388894|NCT02437630|||Case-Control||Prospective|||||||
1388895|NCT02437617|||Cohort||Prospective|||||||
1388896|NCT02437604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388897|NCT02437591||Single Group Assignment||Treatment||None (Open Label)||||||
1388898|NCT02437578|||Cohort||Prospective|||||||
1388899|NCT02437565|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388900|NCT02437552|Randomized|Parallel Assignment||Treatment||Single||||||t
1388901|NCT02437539||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388902|NCT02437526||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388903|NCT02437513|||Case-Only||Prospective|||||||
1388904|NCT02437500||||||||||||
1388905|NCT02437487|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1388906|NCT02437474|||Cohort||Prospective|||||||
1388907|NCT02437461|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388908|NCT02437448|||Case-Control||Prospective|||||||
1388909|NCT02437435|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1388910|NCT02437422||Single Group Assignment||Treatment||None (Open Label)||||||
1388911|NCT02437409|||Cohort||Prospective|||||||
1388912|NCT02437396|||Case-Control||Prospective|||||||
1388913|NCT02437383|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388914|NCT02437370|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388915|NCT02437357|Randomized|Parallel Assignment||Treatment||Single||||||t
1388916|NCT02437344||Single Group Assignment||Treatment||None (Open Label)||||||
1388917|NCT02437331|||Case-Only||Prospective|||||||
1388918|NCT02437318|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1388919|NCT02437305|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388920|NCT02437292|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388921|NCT02437279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388922|NCT02437266|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1388923|NCT02437253|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1388924|NCT02437240|Randomized|Parallel Assignment||Treatment||Single||||||t
1388925|NCT02437227||Single Group Assignment||Treatment||None (Open Label)||||||
1388926|NCT02437214|Randomized|Single Group Assignment||Treatment||Single|||||t|
1388927|NCT02437201|Randomized|Parallel Assignment||Prevention||Single||||||t
1388928|NCT02437188|Randomized|Parallel Assignment||Prevention||Single||||||t
1388929|NCT02437175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388930|NCT02437162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388931|NCT02437149|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388932|NCT02437136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388933|NCT02437123|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388934|NCT02437110||Single Group Assignment||Treatment||None (Open Label)||||||
1388935|NCT02437097|Randomized|Parallel Assignment||Basic Science||Single||||||t
1388936|NCT02437084|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1388937|NCT02437071|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388938|NCT02437058|||Cohort||Prospective|||||||
1388939|NCT02437045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388940|NCT02437032|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388941|NCT02437019||||||||||||
1388942|NCT02437006|Randomized|Factorial Assignment||Treatment||Single||||||t
1388943|NCT02436993|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388944|NCT02436980|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1388945|NCT02436967|||Case-Only||Prospective|||||||
1388946|NCT02436954|Randomized|Parallel Assignment||Treatment||Single||||||t
1388947|NCT02436941|||Other||Prospective|||||||
1388948|NCT02436928|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388949|NCT02436915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388950|NCT02436902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388951|NCT02436889|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1388952|NCT02436876|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388953|NCT02436863|||Cohort||Prospective|||||||
1388954|NCT02436850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388955|NCT02436837|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388956|NCT02436824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388957|NCT02436811|Randomized|Parallel Assignment||Prevention||Single||||||t
1388958|NCT02436798|||Other||Prospective|||||||
1388959|NCT02436785|Randomized|Parallel Assignment||Treatment||Single|open label|||||t
1388960|NCT02436772|||Other||Prospective|||||||
1388961|NCT02436759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388962|NCT02436746|||Cohort||Cross-Sectional|||||||
1388963|NCT02436733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388964|NCT02436720|||Cohort||Prospective|||||||
1388965|NCT02436707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388966|NCT02436694|Randomized|Parallel Assignment||Treatment||Single|||t|||
1388967|NCT02436681||Single Group Assignment||Treatment||None (Open Label)||||||
1388968|NCT02436668|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388969|NCT02436655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388970|NCT02436642|||Case-Only||Prospective|||||||
1388971|NCT02436629|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1388972|NCT02436616|||Cohort||Prospective|||||||
1388973|NCT02436603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388974|NCT02436590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1388975|NCT02436577|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1388976|NCT02436564|||Case-Only||Prospective|||||||
1388977|NCT02436551|||Cohort||Prospective|||||||
1388978|NCT02436538|||Case-Only||Retrospective|||||||
1388979|NCT02436525|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1388980|NCT02436512||Single Group Assignment||Diagnostic||None (Open Label)||||||
1388981|NCT02436499||Single Group Assignment||Treatment||None (Open Label)||||||
1388982|NCT02436486|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1388983|NCT02436473|Randomized|Crossover Assignment||Treatment||Single||||||t
1388984|NCT02436460||Single Group Assignment||Treatment||None (Open Label)||||||
1388985|NCT02436447|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1388986|NCT02436434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1388987|NCT02436421|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1388988|NCT02436408||Single Group Assignment||Treatment||None (Open Label)||||||
1388989|NCT02436395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1388990|NCT02436382|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388991|NCT02436369|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388992|NCT02436356|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1388993|NCT02436343|||Cohort||Prospective|||||||
1388994|NCT02436330|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1388995|NCT02436317|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1388996|NCT02436304|Randomized|Parallel Assignment||Treatment||Single|||||t|
1388997|NCT02436291||Single Group Assignment||Treatment||None (Open Label)||||||
1388998|NCT02436278|||Cohort||Prospective|||||||
1388999|NCT02436265|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389000|NCT02436252||Single Group Assignment||Treatment||None (Open Label)||||||
1389001|NCT02436239||Single Group Assignment||Treatment||None (Open Label)||||||
1389002|NCT02436226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389003|NCT02436213|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1389004|NCT02436200||Single Group Assignment||Treatment||None (Open Label)||||||
1389005|NCT02436187|||Cohort||Prospective|||||||
1389006|NCT02436174|||Cohort||Prospective|||||||
1389007|NCT02436161|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1389008|NCT02436148|||Other||Cross-Sectional|||||||
1389009|NCT02436135||Single Group Assignment||Treatment||None (Open Label)||||||
1389010|NCT02436122|||Cohort||Prospective|||||||
1389011|NCT02436109|||Cohort||Prospective|||||||
1389012|NCT02436096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389013|NCT02436083|Randomized|Parallel Assignment||Prevention||Single|||t|||
1389014|NCT02436070|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1389015|NCT02436057|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1389016|NCT02436044||||||||||||
1389017|NCT02436031|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1389018|NCT02436018|Randomized|Parallel Assignment||Prevention||Single|||t|||
1389019|NCT02436005||||||||||||
1389020|NCT02435992|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389021|NCT02435979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389022|NCT02435966|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389023|NCT02435953|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389024|NCT02435940|||Other||Prospective|||||||
1389025|NCT02435927|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389026|NCT02435914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389027|NCT02435901||Single Group Assignment||Treatment||None (Open Label)||||||
1389028|NCT02435888|||Case-Only||Cross-Sectional|||||||
1389029|NCT02435875|||Cohort||Prospective|||||||
1389030|NCT02435862|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389031|NCT02435849||Single Group Assignment||Treatment||None (Open Label)||||||
1389032|NCT02435836||Single Group Assignment||Treatment||None (Open Label)||||||
1389033|NCT02435823||Single Group Assignment||Treatment||None (Open Label)||||||
1389034|NCT02435810|||Cohort||Prospective|||||||
1389035|NCT02435797|Randomized|Parallel Assignment||Prevention||Single|||t|||
1389036|NCT02435784|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389037|NCT02435771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389038|NCT02435758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389039|NCT02435745|||Case Control||Prospective|||||||
1389040|NCT02435732|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389041|NCT02435719|||Cohort||Prospective|||||||
1389042|NCT02435706|Randomized|Parallel Assignment||Treatment||Single||||||t
1389043|NCT02435693|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389044|NCT02435680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389045|NCT02435667|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389046|NCT02435654||Single Group Assignment||Treatment||None (Open Label)||||||
1389047|NCT02435641|||Cohort||Prospective|||||||
1389048|NCT02435628|||Cohort||Prospective|||||||
1389049|NCT02435615||Single Group Assignment||Diagnostic||||||||
1389050|NCT02435602|Randomized|Parallel Assignment||Screening||Single||||||t
1389051|NCT02435589|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389052|NCT02435576|||Cohort||Prospective|||||||
1389053|NCT02435563|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1389054|NCT02435550|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1389055|NCT02435537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389056|NCT02435524|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1389057|NCT02435511|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1389058|NCT02435498|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1389059|NCT02435485|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1389060|NCT02435472|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1389061|NCT02435459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389062|NCT02435446||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389063|NCT02435433|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389064|NCT02435420|||Cohort||Other|||||||
1389065|NCT02435407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389066|NCT02435394|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1389067|NCT02435381|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1389068|NCT02435368|||Case-Only||Cross-Sectional|||||||
1389069|NCT02435355|Randomized|Parallel Assignment||||None (Open Label)||||||
1389070|NCT02435342|Randomized|Parallel Assignment||||Double|||t||t|
1389071|NCT02435329|||||Prospective|||||||
1389072|NCT02435316|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1389073|NCT02435303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389074|NCT02435290|||Case-Only||Cross-Sectional|||||||
1389075|NCT02435277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389076|NCT02435264|Randomized|Parallel Assignment||||None (Open Label)||||||
1389077|NCT02435251|||Case-Only||Prospective|||||||
1389078|NCT02435238|||Other||Prospective|||||||
1389079|NCT02435225||Single Group Assignment||Treatment||None (Open Label)||||||
1389080|NCT02435212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389081|NCT02435199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389082|NCT02435186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389083|NCT02435173|Non-Randomized|Single Group Assignment||Treatment||Triple|Part I was a non-randomized, open-label study Part II is a randomized subject, investigator and sponsor-blinded, placebo controlled study|"Part I of the study was a non-randomized, open-label, within-patient up-titration study.~Part II is a randomized, subject, investigator and sponsor-blinded, placebo-controlled, fixed dose study"|t|t|t|
1389084|NCT02435160||Single Group Assignment||Treatment||None (Open Label)||||||
1389085|NCT02435147|||Cohort||Retrospective|||||||
1389086|NCT02435134|||Case-Crossover||Cross-Sectional|||||||
1389087|NCT02435121||Single Group Assignment||Treatment||None (Open Label)||||||
1389088|NCT02435108||Single Group Assignment||Treatment||None (Open Label)||||||
1389089|NCT02435095|Randomized|Parallel Assignment||Treatment||Single||||||t
1389090|NCT02435082|||Cohort||Prospective|||||||
1389091|NCT02435069|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1389092|NCT02435056|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389093|NCT02435043|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1389094|NCT02435030|||Case-Only||Prospective|||||||
1389095|NCT02435017|||Cohort||Cross-Sectional|||||||
1389096|NCT02435004||Single Group Assignment||Treatment||None (Open Label)||||||
1389097|NCT02434991||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389098|NCT02434978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389099|NCT02434965||Single Group Assignment||Treatment||None (Open Label)||||||
1389100|NCT02434952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389101|NCT02434939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389102|NCT02434926|||Case-Only||Retrospective|||||||
1389103|NCT02434913||||||||||||
1389104|NCT02434900|||Cohort||Prospective|||||||
1389105|NCT02434887||Single Group Assignment||||Single|||t|||
1389106|NCT02434874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389107|NCT02434861|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1389108|NCT02434848|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389109|NCT02434835||||||||||||
1389110|NCT02434822|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389111|NCT02434809||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389112|NCT02434796|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1389113|NCT02434783|||Case Control||Cross-Sectional|||||||
1389114|NCT02434770|Randomized|Parallel Assignment||Prevention||Single|||t|||
1389115|NCT02434757|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389116|NCT02434744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389117|NCT02434731|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389118|NCT02434718|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389119|NCT02434705|||Case-Control||Prospective|||||||
1389120|NCT02434692||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389121|NCT02434679|||Cohort||Prospective|||||||
1389122|NCT02434666||Single Group Assignment||Treatment||None (Open Label)||||||
1389123|NCT02434653|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1389124|NCT02434640|Randomized|Parallel Assignment||||Triple|||t|t|t|
1389125|NCT02434627||Single Group Assignment||Treatment||None (Open Label)||||||
1389126|NCT02434614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389127|NCT02434601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389128|NCT02434588||Single Group Assignment||Treatment||None (Open Label)||||||
1389129|NCT02434575|||Case-Control||Prospective|||||||
1389130|NCT02434562|||Cohort||Prospective|||||||
1389131|NCT02434549|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389132|NCT02434536|||Cohort||Prospective|||||||
1389133|NCT02434523|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389134|NCT02434510|||Cohort||Prospective|||||||
1389135|NCT02434497||Single Group Assignment||Treatment||None (Open Label)||||||
1389136|NCT02434484|||Other||Prospective|||||||
1389137|NCT02434471|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1389138|NCT02434458|||Cohort||Cross-Sectional|||||||
1389139|NCT02434445|||Cohort||Prospective|||||||
1389140|NCT02434432|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1389141|NCT02434419|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389142|NCT02434406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389143|NCT02434393|||Case-Control||Prospective|||||||
1389144|NCT02434380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389145|NCT02434367|Randomized|Factorial Assignment||Treatment||Single|||||t|
1389146|NCT02434354||Single Group Assignment||Treatment||||||||
1389147|NCT02434341|||Cohort||Prospective|||||||
1389148|NCT02434328|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389149|NCT02434315|Randomized|Parallel Assignment||||None (Open Label)||||||
1389150|NCT02434302|||Cohort||Cross-Sectional|||||||
1389151|NCT02434289||Single Group Assignment||Prevention||None (Open Label)||||||
1389152|NCT02434276|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1389153|NCT02434263||Single Group Assignment||Treatment||None (Open Label)||||||
1389154|NCT02434250||Single Group Assignment||Treatment||None (Open Label)||||||
1389155|NCT02434237|||Cohort||Prospective|||||||
1389156|NCT02434224|Randomized|Parallel Assignment||Treatment||Single||||||t
1389157|NCT02434211||Single Group Assignment||Prevention||None (Open Label)||||||
1389158|NCT02434198|||Cohort||Prospective|||||||
1389159|NCT02434185|||Other||Cross-Sectional|||||||
1389160|NCT02434172|||Cohort||Prospective|||||||
1389161|NCT02434159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389162|NCT02434146||Single Group Assignment||Supportive Care||None (Open Label)||||||
1389163|NCT02434133|||Other||Prospective|||||||
1389164|NCT02434120|||Case-Only||Cross-Sectional|||||||
1389165|NCT02434107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389166|NCT02434094|||Case Control||Prospective|||||||
1389167|NCT02434081||Single Group Assignment||Treatment||None (Open Label)||||||
1389168|NCT02434068|||Cohort||Prospective|||||||
1389169|NCT02434055|||Case-Only||Prospective|||||||
1389170|NCT02434042|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1389171|NCT02434029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389172|NCT02434016|||Cohort||Prospective|||||||
1389173|NCT02434003|||Cohort||Prospective|||||||
1389174|NCT02433990|||Ecologic or Community||Prospective|||||||
1389175|NCT02433977||Single Group Assignment||Treatment||None (Open Label)||||||
1389176|NCT02433964|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1389177|NCT02433951|||Case Control||Cross-Sectional|||||||
1389178|NCT02433938|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1389179|NCT02433925|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1389180|NCT02433912|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389181|NCT02433899|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1389182|NCT02433886||Single Group Assignment||Treatment||None (Open Label)||||||
1389183|NCT02433873|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1389184|NCT02433860||Single Group Assignment||Treatment||None (Open Label)||||||
1389185|NCT02433847||Single Group Assignment||Treatment||None (Open Label)||||||
1389186|NCT02433834|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1389187|NCT02433821|Randomized|Parallel Assignment||Treatment||Single||||||t
1389188|NCT02433808|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1389189|NCT02433795||Single Group Assignment||Treatment||None (Open Label)||||||
1389190|NCT02433782|Randomized|Parallel Assignment||Treatment||Single||||||t
1389191|NCT02433769|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1389192|NCT02433756|||Case-Only||Prospective|||||||
1389193|NCT02433743|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389194|NCT02433730|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1389195|NCT02433717||Single Group Assignment||Treatment||None (Open Label)||||||
1389196|NCT02433704|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389197|NCT02433691|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1389198|NCT02433678|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389199|NCT02433665|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1389200|NCT02433652|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389201|NCT02433639||Single Group Assignment||Treatment||None (Open Label)||||||
1389202|NCT02433626||Single Group Assignment||Treatment||None (Open Label)||||||
1389203|NCT02433613|||Cohort||Prospective|||||||
1389204|NCT02433600|Randomized|Parallel Assignment||||Triple|||t|t|t|
1389205|NCT02433587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389206|NCT02433574||Single Group Assignment||Treatment||None (Open Label)||||||
1389207|NCT02433561|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389208|NCT02433548|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1389209|NCT02433535|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1389210|NCT02433522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389211|NCT02433509||Single Group Assignment||Treatment||None (Open Label)||acute ischemic stroke||||
1389212|NCT02433496|||Case-Control||Prospective|||||||
1389213|NCT02433483||Single Group Assignment||Treatment||None (Open Label)||||||
1389214|NCT02433470|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389215|NCT02433457|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1389216|NCT02433444|||Case-Only||Prospective|||||||
1389217|NCT02433431|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1389218|NCT02433418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389219|NCT02433405|||Case Control||Cross-Sectional|||||||
1389220|NCT02433392||Single Group Assignment||Treatment||None (Open Label)||||||
1389221|NCT02433379||Single Group Assignment||Supportive Care||None (Open Label)||||||
1389222|NCT02433366|||Cohort||Cross-Sectional|||||||
1389223|NCT02433353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389224|NCT02433340||Single Group Assignment||Treatment||None (Open Label)||||||
1389225|NCT02433327|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389226|NCT02433314||||||||||||
1389227|NCT02433301|||||Prospective|||||||
1389228|NCT02433288|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389229|NCT02433275|||Case-Only||Prospective|||||||
1389230|NCT02433262|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1389231|NCT02433249|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1389232|NCT02433236|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389233|NCT02433223|||Case-Control||Retrospective|||||||
1389234|NCT02433210|Randomized|Crossover Assignment||Basic Science||None (Open Label)|Open Label|||||
1389235|NCT02433197|Randomized|Parallel Assignment||Treatment||Single|||||t|
1389236|NCT02433184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389237|NCT02433171|||Cohort||Prospective|||||||
1389238|NCT02433158|Non-Randomized|||Treatment||Quadruple|||t|t|t|t
1389239|NCT02433145|||Case Control||Prospective|||||||
1389240|NCT02433132||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389241|NCT02433119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389242|NCT02433106|Randomized|Parallel Assignment||Prevention||Single||||||t
1389243|NCT02433093|Randomized|Parallel Assignment||||Double|||t||t|
1389244|NCT02433080|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1389245|NCT02433067|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389246|NCT02433054|||Case-Only||Prospective|||||||
1389247|NCT02433041|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1389248|NCT02433028|||Cohort||Prospective|||||||
1389249|NCT02433015|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1389250|NCT02433002|||Cohort||Prospective|||||||
1389251|NCT02432989|Randomized|Parallel Assignment||Treatment||Single||||||t
1389252|NCT02432976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389253|NCT02432963||Single Group Assignment||Treatment||None (Open Label)||||||
1389254|NCT02432950||Single Group Assignment||Supportive Care||None (Open Label)||||||
1389255|NCT02432937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389256|NCT02432924|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389257|NCT02432911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389258|NCT02432898|||Cohort||Prospective|||||||
1389259|NCT02432885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389260|NCT02432872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389261|NCT02432859|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389262|NCT02432846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389263|NCT02432833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389264|NCT02432820|||Case-Only||Cross-Sectional|||||||
1389265|NCT02432807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389266|NCT02432794|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389267|NCT02432781|Randomized|Parallel Assignment||Prevention||Single||||||t
1389268|NCT02432768|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1389269|NCT02432755|Randomized|Parallel Assignment||Treatment||Single||||||t
1389270|NCT02432742|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389271|NCT02432729|||Other||Prospective|||||||
1389272|NCT02432716|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1389273|NCT02432703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389274|NCT02432690||Single Group Assignment||Treatment||None (Open Label)||||||
1389275|NCT02432677|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389276|NCT02432664|Randomized|Parallel Assignment||Other||Double|||t||t|
1389277|NCT02432651|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1389278|NCT02432638|||Case-Only||Prospective|||||||
1389279|NCT02432625|||Cohort||Prospective|||||||
1389280|NCT02432612||Single Group Assignment||Treatment||None (Open Label)||||||
1389281|NCT02432599||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389282|NCT02432586||Single Group Assignment||Supportive Care||None (Open Label)||||||
1389283|NCT02432573|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1389284|NCT02432560|||Cohort||Prospective|||||||
1389285|NCT02432547|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1389286|NCT02432534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389287|NCT02432521|||Ecologic or Community||Prospective|||||||
1389288|NCT02432508|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1389289|NCT02432495|||Cohort||Retrospective|||||||
1389290|NCT02432482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389291|NCT02432469|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1389292|NCT02432456|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389293|NCT02432443|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1389294|NCT02432430|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1389295|NCT02432417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389296|NCT02432404|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389297|NCT02432391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389298|NCT02432378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389299|NCT02432365||Single Group Assignment||Treatment||None (Open Label)||||||
1389300|NCT02432352|Randomized|Parallel Assignment||Prevention||Single||||||t
1389301|NCT02432339|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1389302|NCT02432326||Single Group Assignment||Treatment||None (Open Label)||||||
1389303|NCT02432313||Single Group Assignment||Basic Science||None (Open Label)||||||
1389304|NCT02432300||Single Group Assignment||Treatment||None (Open Label)||||||
1389305|NCT02432287|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1389306|NCT02432274|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389307|NCT02432261|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1389308|NCT02432248|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389309|NCT02432235||Single Group Assignment||Treatment||None (Open Label)||||||
1389310|NCT02432222|Randomized|Parallel Assignment||Treatment||Single||||||t
1389311|NCT02432209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389312|NCT02432196||Single Group Assignment||Treatment||None (Open Label)||||||
1389313|NCT02432183|||Cohort||Prospective|||||||
1389314|NCT02432170||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389315|NCT02432157|Randomized|Parallel Assignment||Prevention||Single||||||t
1389316|NCT02432144||Single Group Assignment||Treatment||None (Open Label)||||||
1389317|NCT02432131|||Cohort||Prospective|||||||
1389318|NCT02432118||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389319|NCT02432105|Randomized|Parallel Assignment||Treatment||Single|||||t|
1389320|NCT02432092|||Cohort||Prospective|||||||
1389321|NCT02432079|||Family-Based||Prospective|||||||
1389322|NCT02432066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389323|NCT02432053||Single Group Assignment||Treatment||None (Open Label)||||||
1389324|NCT02432040|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389325|NCT02432027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389326|NCT02432014|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389327|NCT02432001|||Cohort||Prospective|||||||
1389328|NCT02431988||Single Group Assignment||Treatment||None (Open Label)||||||
1389329|NCT02431975||Single Group Assignment||Treatment||None (Open Label)||||||
1389330|NCT02431962|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1389331|NCT02431949|||Cohort||Cross-Sectional|||||||
1389332|NCT02431936|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1389333|NCT02431923|||Cohort||Prospective|||||||
1389334|NCT02431910|Randomized|Parallel Assignment||Prevention||Single||||||t
1389335|NCT02431897|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389336|NCT02431884|||Case-Control||Prospective|||||||
1389337|NCT02431871|||Cohort||Cross-Sectional|||||||
1389338|NCT02431858|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389339|NCT02431845||Single Group Assignment||Treatment||None (Open Label)|Open label study|Open naturalistic treatment||||
1389340|NCT02431832||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389341|NCT02431819||Single Group Assignment||Supportive Care||None (Open Label)||||||
1389342|NCT02431806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389343|NCT02431793|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1389344|NCT02431780|Randomized|Parallel Assignment||Other||Single||||||t
1389345|NCT02431767|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389346|NCT02431754|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1389347|NCT02431741||Single Group Assignment||Treatment||None (Open Label)||||||
1389348|NCT02431728|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389349|NCT02431715||||||||||||
1389350|NCT02431702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389351|NCT02431689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389352|NCT02431676|Randomized|Parallel Assignment||Prevention||Single||||||t
1389353|NCT02431663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389354|NCT02431650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389355|NCT02431637||Single Group Assignment||Treatment||None (Open Label)||||||
1389356|NCT02431624|Randomized|Crossover Assignment||||None (Open Label)||||||
1389357|NCT02431611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389358|NCT02431598|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1389359|NCT02431585|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1389360|NCT02431572|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1389361|NCT02431559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389362|NCT02431546|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389363|NCT02431533|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389364|NCT02431520|Randomized|Parallel Assignment||||None (Open Label)||||||
1389365|NCT02431507||Single Group Assignment||Treatment||None (Open Label)||||||
1389366|NCT02431494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389367|NCT02431481|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389368|NCT02431468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389369|NCT02431455|Randomized|Parallel Assignment||Treatment||Single||||||t
1389370|NCT02431442|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389371|NCT02431429|||Case-Only||Prospective|||||||
1389372|NCT02431416|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1389373|NCT02431403|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389374|NCT02431390|Randomized|Parallel Assignment||Treatment||Single||||||t
1389375|NCT02431377||Single Group Assignment||||None (Open Label)||||||
1389376|NCT02431364|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1389377|NCT02431351||Single Group Assignment||Treatment||None (Open Label)||||||
1389378|NCT02431338|Randomized|Parallel Assignment||Treatment||Single||||||t
1389379|NCT02431325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389380|NCT02431312|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1389381|NCT02431299|||Cohort||Prospective|||||||
1389382|NCT02431286|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1389383|NCT02431273|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1389384|NCT02431260||Single Group Assignment||Treatment||None (Open Label)||||||
1389385|NCT02431247|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389386|NCT02431234|||Cohort||Prospective|||||||
1389387|NCT02431221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389388|NCT02431208|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389389|NCT02431195|||Cohort||Prospective|||||||
1389390|NCT02431182|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1389391|NCT02431169|||Case-Only||Prospective|||||||
1389392|NCT02431156|||Cohort||Retrospective|||||||
1389393|NCT02431143||Single Group Assignment||Treatment||None (Open Label)||||||
1389394|NCT02431130||||||||||||
1389395|NCT02431117|||Cohort||Prospective|||||||
1389396|NCT02431104||Single Group Assignment||Treatment||None (Open Label)||||||
1389397|NCT02431091|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1389398|NCT02431078|||Cohort||Prospective|||||||
1389399|NCT02431065|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389400|NCT02431052|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389401|NCT02431039|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389402|NCT02431026|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1389403|NCT02431013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389404|NCT02431000|||Cohort||Prospective|||||||
1389405|NCT02430987|||Case-Control||Cross-Sectional|||||||
1389406|NCT02430974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389407|NCT02430961|||Cohort||Prospective|||||||
1389408|NCT02430948|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1389409|NCT02430935|Randomized|Parallel Assignment||Treatment||Single||||||t
1389410|NCT02430922||Single Group Assignment||Treatment||None (Open Label)||||||
1389411|NCT02430909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389412|NCT02430896|||Case-Control||Prospective|||||||
1389413|NCT02430883|Randomized|Parallel Assignment||Screening||Single|||t|||
1389414|NCT02430870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389415|NCT02430857|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389416|NCT02430844|||Cohort||Prospective|||||||
1389417|NCT02430831|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389418|NCT02430818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389419|NCT02430805||Single Group Assignment||||None (Open Label)||||||
1389420|NCT02430792|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1389421|NCT02430779||Single Group Assignment||Treatment||None (Open Label)||||||
1389422|NCT02430766||Single Group Assignment||Treatment||None (Open Label)||||||
1389423|NCT02430753||Single Group Assignment||Treatment||None (Open Label)||||||
1389424|NCT02430740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389425|NCT02430714|||Other||Prospective|||||||
1389426|NCT02430701||Single Group Assignment||Treatment||None (Open Label)||||||
1389427|NCT02430688||Single Group Assignment||Treatment||None (Open Label)||||||
1389428|NCT02430675||Single Group Assignment||Treatment||None (Open Label)||||||
1389429|NCT02430662||Single Group Assignment||Treatment||None (Open Label)||||||
1389430|NCT02430649||Single Group Assignment||Treatment||None (Open Label)||||||
1389431|NCT02430636||Single Group Assignment||Treatment||None (Open Label)||||||
1389432|NCT02430623||Single Group Assignment||Treatment||None (Open Label)||||||
1389433|NCT02430610||Single Group Assignment||Treatment||None (Open Label)||||||
1389434|NCT02430597||Single Group Assignment||Treatment||None (Open Label)||||||
1389435|NCT02430584|||Family-Based||Prospective|||||||
1389436|NCT02430571|||Case-Only||Prospective|||||||
1389437|NCT02430558||Single Group Assignment||Treatment||None (Open Label)||||||
1389438|NCT02430545||Crossover Assignment||Basic Science||None (Open Label)||||||
1389439|NCT02430532|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389440|NCT02430519|Randomized|Parallel Assignment||Treatment||Double|The eligible samples were screened and randomly assigned by lottery method by investigator KRR into PRF (Group A) and GTR + Allograft (Group B). The treatment was performed by investigator SA who was blinded to the randomization process|Prospective, randomized, parallel arm, interventional trial|t||t|
1389441|NCT02430506|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389442|NCT02430493|||Cohort||Prospective|||||||
1389443|NCT02430480||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389444|NCT02430467|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389445|NCT02430454|Randomized|Parallel Assignment||||None (Open Label)||||||
1389446|NCT02430441||||||||||||
1389447|NCT02430428||Single Group Assignment||Treatment||None (Open Label)||||||
1389448|NCT02430415|Randomized|Crossover Assignment||||Double|||t|||t
1389449|NCT02430402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389450|NCT02430389|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1389451|NCT02430376|||Family-Based||Retrospective|||||||
1389452|NCT02430363|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389453|NCT02430350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389454|NCT02430337|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1389455|NCT02430324|||Case Control||Prospective|||||||
1389456|NCT02430311|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389457|NCT02430298|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389458|NCT02430285||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389459|NCT02430272|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389460|NCT02430259|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389461|NCT02430246|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389462|NCT02430233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389463|NCT02430207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389464|NCT02430194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389465|NCT02430181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389466|NCT02430168|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389467|NCT02430155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389468|NCT02430142|||Cohort||Prospective|||||||
1389469|NCT02430129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389470|NCT02430116|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1389471|NCT02430103|||Case Control||Prospective|||||||
1389472|NCT02430090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389473|NCT02430077|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1389474|NCT02430064||Single Group Assignment||Basic Science||None (Open Label)||||||
1389475|NCT02430051|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1389476|NCT02430038|||Cohort||Prospective|||||||
1389477|NCT02430025|||Cohort||Prospective|||||||
1389478|NCT02430012|Randomized|Parallel Assignment||Treatment||Single||||||t
1389479|NCT02429999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389480|NCT02429986||Single Group Assignment||Treatment||None (Open Label)||||||
1389481|NCT02429973|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389482|NCT02429960||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389483|NCT02429947|||Cohort||Cross-Sectional|||||||
1389484|NCT02429934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389485|NCT02429921|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389486|NCT02429908||Single Group Assignment||Treatment||None (Open Label)||||||
1389487|NCT02429895||Single Group Assignment||Treatment||None (Open Label)||||||
1389488|NCT02429882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389489|NCT02429869||Single Group Assignment||Basic Science||None (Open Label)||||||
1389490|NCT02429856|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389491|NCT02429843||Single Group Assignment||Treatment||None (Open Label)||||||
1389492|NCT02429830||Single Group Assignment||Treatment||None (Open Label)||||||
1389493|NCT02429817|Randomized|Crossover Assignment||||Double|||||t|t
1389494|NCT02429804||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389495|NCT02429791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389496|NCT02429778|Randomized|Parallel Assignment||Treatment||None (Open Label)||Behavioral Intervention (relaxation, breathing, activity engagement)||||
1389497|NCT02429765|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1389498|NCT02429752||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389499|NCT02429739|Randomized|Parallel Assignment||Treatment||Single||||||t
1389500|NCT02429726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389501|NCT02429713|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1389502|NCT02429700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389503|NCT02429687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389504|NCT02429674||Single Group Assignment||Treatment||None (Open Label)||||||
1389505|NCT02429661|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1389506|NCT02429648|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1389507|NCT02429635|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389508|NCT02429622|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1389509|NCT02429609|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1389510|NCT02429596|Randomized|Parallel Assignment||||None (Open Label)||||||
1389511|NCT02429583|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1389512|NCT02429570||Single Group Assignment||Treatment||None (Open Label)||||||
1389513|NCT02429557|Randomized|Crossover Assignment||Other||Single|||t|||
1389514|NCT02429544|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1389515|NCT02429531|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1389516|NCT02429518|||Case-Only||Prospective|||||||
1389517|NCT02429505|||Case-Only||Prospective|||||||
1389518|NCT02429492|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1389519|NCT02429479|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1389520|NCT02429466||Single Group Assignment||Treatment||None (Open Label)||||||
1389521|NCT02429453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389522|NCT02429440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389523|NCT02429427|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389524|NCT02429414|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389525|NCT02429401|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389526|NCT02429388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389527|NCT02429375||Single Group Assignment||Treatment||None (Open Label)||||||
1389528|NCT02429362|||Case-Only||Prospective|||||||
1389529|NCT02429349||Single Group Assignment||Treatment||None (Open Label)||||||
1389530|NCT02429336|||Case-Control||Prospective|||||||
1389531|NCT02429323|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1389532|NCT02429310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389533|NCT02429297|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1389534|NCT02429284|||Cohort||Prospective|||||||
1389535|NCT02429271|Randomized|Parallel Assignment||Treatment||Single||||||t
1389536|NCT02429258|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389538|NCT02429232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389539|NCT02429219|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389540|NCT02429206|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1389541|NCT02429193||Single Group Assignment||Treatment||None (Open Label)||||||
1389542|NCT02429180|Randomized|Parallel Assignment||Treatment||Single||||||t
1389543|NCT02429167||||||||||||
1389544|NCT02429154|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1389545|NCT02429141|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389546|NCT02429128|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1389547|NCT02429115|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389548|NCT02429102|Randomized|Parallel Assignment||||Double||||||
1389549|NCT02429089||Single Group Assignment||Treatment||None (Open Label)||||||
1389550|NCT02429076|Randomized|Single Group Assignment||Other||Double|||t||t|
1389551|NCT02429063|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389552|NCT02429050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389553|NCT02429037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389554|NCT02429024|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1389555|NCT02429011|||Case-Control||Prospective|||||||
1389556|NCT02428998|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1389557|NCT02428985|||Cohort||Prospective|||||||
1389558|NCT02428972|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1389559|NCT02428959||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389560|NCT02428946|Randomized|Crossover Assignment||||None (Open Label)||||||
1389561|NCT02428933||Single Group Assignment||||None (Open Label)||||||
1389562|NCT02428920|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389563|NCT02428907|||Other||Prospective|||||||
1389564|NCT02428894|||Cohort||Prospective|||||||
1389565|NCT02428881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389566|NCT02428868|Randomized|Parallel Assignment||Prevention||Single|||t|||
1389567|NCT02428855||Single Group Assignment||Treatment||None (Open Label)||||||
1389568|NCT02428842||Single Group Assignment||Basic Science||None (Open Label)||||||
1389569|NCT02428829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389570|NCT02428816|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1389571|NCT02428803|||Case-Crossover||Prospective|||||||
1389572|NCT02428790|||Cohort||Cross-Sectional|||||||
1389573|NCT02428777|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1389574|NCT02428764||Single Group Assignment||Treatment||None (Open Label)||||||
1389575|NCT02428751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389576|NCT02428738|||Case Control||Prospective|||||||
1389577|NCT02428725||Single Group Assignment||Prevention||None (Open Label)||||||
1389578|NCT02428712||Single Group Assignment||Treatment||None (Open Label)||||||
1389579|NCT02428699|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1389580|NCT02428686||Single Group Assignment||Treatment||None (Open Label)||||||
1389581|NCT02428673||Single Group Assignment||Treatment||None (Open Label)||||||
1389582|NCT02428660|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1389583|NCT02428647|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389584|NCT02428634|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389585|NCT02428621|Randomized|Parallel Assignment||Treatment||Single||||||t
1389586|NCT02428608||Single Group Assignment||Treatment||None (Open Label)|This is an open label safety study|||||
1389587|NCT02428595||Single Group Assignment||Treatment||None (Open Label)||||||
1389588|NCT02428582|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389589|NCT02428569|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1389590|NCT02428556|Randomized|Parallel Assignment||||Single|||||t|
1389591|NCT02428543||Single Group Assignment||Treatment||None (Open Label)||||||
1389592|NCT02428530|||Ecologic or Community||Cross-Sectional|||||||
1389593|NCT02428517|||Cohort||Prospective|||||||
1389594|NCT02428504|||||Prospective|||||||
1389595|NCT02428491||Single Group Assignment||Prevention||None (Open Label)||Participants in this trial were randomized in a 1:1 ratio in 2 cohorts. All participants in both cohorts received Sanofi Pasteur's DTaP-IPV-HB-PRP~T combined vaccine in a 3-dose Infant Series. Participants from Cohort 1 provided blood samples for immunogenicity assessment and were evaluated for safety and immunogenicity. Participants in Cohort 2 did not provide any blood samples for immunogenicity analysis and were evaluated for safety only.||||
1389596|NCT02428478|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1389597|NCT02428465|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1389598|NCT02428452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389599|NCT02428439|||Cohort||Prospective|||||||
1389600|NCT02428426|||Case Control||Prospective|||||||
1389601|NCT02428413|Randomized|Parallel Assignment||||None (Open Label)||||||
1389602|NCT02428400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389603|NCT02428387|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1389604|NCT02428374|Randomized|Parallel Assignment||Treatment||Single||||||t
1389605|NCT02428361||Single Group Assignment||Treatment||None (Open Label)||||||
1389606|NCT02428348||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389607|NCT02428335|||Cohort||Prospective|||||||
1389608|NCT02428322|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1389609|NCT02428309|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389610|NCT02428296||Single Group Assignment||Treatment||None (Open Label)||||||
1389611|NCT02428283|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1389612|NCT02428270||Single Group Assignment||Treatment||None (Open Label)||||||
1389613|NCT02428257|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1389614|NCT02428244|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1389615|NCT02428231|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389616|NCT02428218|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389617|NCT02428205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389618|NCT02428192|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389619|NCT02428179|||Case-Control||Prospective|||||||
1389620|NCT02428166|||Cohort||Retrospective|||||||
1389621|NCT02428153||Single Group Assignment||Screening||None (Open Label)||||||
1389622|NCT02428140|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1389623|NCT02428127|Randomized|Crossover Assignment||Other||Single|||||t|
1389624|NCT02428114|||Cohort||Other|||||||
1389625|NCT02428101|||Cohort||Prospective|||||||
1389626|NCT02428088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389627|NCT02428075|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389628|NCT02428062|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1389629|NCT02428049|||Case Control||Prospective|||||||
1389630|NCT02428036|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389631|NCT02428023|||Case Control||Cross-Sectional|||||||
1389632|NCT02428010||Single Group Assignment||Treatment||None (Open Label)||||||
1389633|NCT02427997|Randomized|Parallel Assignment||Treatment||Single||||||t
1389634|NCT02427984|||Cohort||Prospective|||||||
1389635|NCT02427971|||Cohort||Prospective|||||||
1389636|NCT02427958||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1389637|NCT02427945|Randomized|Parallel Assignment||Prevention||Single||||||t
1389638|NCT02427932|||Cohort||Prospective|||||||
1389639|NCT02427919|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389640|NCT02427906|||Cohort||Prospective|||||||
1389641|NCT02427893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389642|NCT02427880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389643|NCT02427867|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389644|NCT02427854|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1389645|NCT02427841||Single Group Assignment||Treatment||None (Open Label)||||||
1389646|NCT02427828|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389647|NCT02427802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389648|NCT02427789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389649|NCT02427776||Single Group Assignment||Treatment||None (Open Label)||||||
1389650|NCT02427763|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1389651|NCT02427750||Single Group Assignment||Prevention||None (Open Label)||||||
1389652|NCT02427737|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The original model was to have parallel randomized MRI sites. This was possible at one participating institution, The Ohio State Universty Medical Center (OSUMC). For the second institution (Duke University) staff cuts resulted in personnel cross-over between test and control sites making randomization impossible. Therefore a sequential model was used compared data from the pre- to post training period for the Duke sites. In total 12 MRI entities contributed, six at OSU, and six at Duke.||||
1389653|NCT02427724|Randomized|Parallel Assignment||Other||Double|||t||t|
1389654|NCT02427711|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1389655|NCT02427698|Randomized|Parallel Assignment||Treatment||Single||||||t
1389656|NCT02427685|||||Prospective|||||||
1389657|NCT02427672|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1389658|NCT02427659|Randomized|Parallel Assignment||Other||Single||||t||
1389659|NCT02427646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389660|NCT02427633|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389661|NCT02427620||Single Group Assignment||Treatment||None (Open Label)||||||
1389662|NCT02427607||Single Group Assignment||Treatment||None (Open Label)||||||
1389663|NCT02427594|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1389664|NCT02427581||Single Group Assignment||Treatment||None (Open Label)||||||
1389665|NCT02427568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389666|NCT02427555|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1389667|NCT02427542|Randomized|Parallel Assignment||Treatment||Single||||||t
1389668|NCT02427529|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1389669|NCT02427516|||Cohort||Retrospective|||||||
1389670|NCT02427503|||Cohort||Prospective|||||||
1389671|NCT02427490|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389672|NCT02427477|Randomized|Crossover Assignment||Treatment||Single|||t|||
1389673|NCT02427464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389674|NCT02427451||Single Group Assignment||Treatment||None (Open Label)||||||
1389675|NCT02427438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389676|NCT02427425|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389677|NCT02427412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389678|NCT02427399|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1389679|NCT02427386|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389680|NCT02427373|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1389681|NCT02427360|||Cohort||Retrospective|||||||
1389682|NCT02427347|Randomized|Parallel Assignment||Treatment||Single||||||t
1389683|NCT02427334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389685|NCT02427308|||Case-Only||Prospective|||||||
1389686|NCT02427295|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389687|NCT02427282|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389688|NCT02427269|||Cohort||Prospective|||||||
1389689|NCT02427256|||Cohort||Prospective|||||||
1389690|NCT02427243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389691|NCT02427230|Randomized|Parallel Assignment||Treatment||Single|||||t|
1389692|NCT02427217|||Cohort||Other|||||||
1389693|NCT02427204|||Case-Only||Prospective|||||||
1389694|NCT02427191|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389695|NCT02427178||Single Group Assignment||Treatment||None (Open Label)||||||
1389696|NCT02427165|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1389697|NCT02427152|||Case-Control||Cross-Sectional|||||||
1389698|NCT02427139||Single Group Assignment||Supportive Care||None (Open Label)||||||
1389699|NCT02427126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389700|NCT02427113|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1389701|NCT02427100|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389702|NCT02427087|Randomized|Parallel Assignment||Treatment||Double||||t||t
1389703|NCT02427074|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389704|NCT02427061|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389705|NCT02427048|Randomized|Single Group Assignment||Health Services Research||Single|||||t|
1389706|NCT02427035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389707|NCT02427022|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1389708|NCT02427009||Single Group Assignment||Prevention||None (Open Label)||||||
1389709|NCT02426996||Single Group Assignment||Prevention||None (Open Label)||||||
1389710|NCT02426983|Randomized|Crossover Assignment||||Double|||t||t|
1389711|NCT02426970|||Cohort||Prospective|||||||
1389712|NCT02426957|Randomized|Single Group Assignment||Treatment||Single||||||t
1389713|NCT02426944|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389714|NCT02426931|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389715|NCT02426918|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389716|NCT02426905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389717|NCT02426892||Single Group Assignment||Treatment||None (Open Label)||||||
1389718|NCT02426879||Single Group Assignment||Treatment||None (Open Label)||||||
1389719|NCT02426866|||Cohort||Retrospective|||||||
1389720|NCT02426853|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1389721|NCT02426840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389722|NCT02426827||Single Group Assignment||Treatment||None (Open Label)||||||
1389723|NCT02426814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389724|NCT02426801|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389725|NCT02426788|Randomized|Parallel Assignment||Treatment||Single||||||t
1389726|NCT02426775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389727|NCT02426762||Single Group Assignment||Prevention||None (Open Label)||||||
1389728|NCT02426749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389729|NCT02426736|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1389730|NCT02426723||Single Group Assignment||Treatment||None (Open Label)||||||
1389731|NCT02426710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389732|NCT02426697|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389733|NCT02426684||Single Group Assignment||Treatment||None (Open Label)||||||
1389734|NCT02426671||Single Group Assignment||Treatment||None (Open Label)||||||
1389735|NCT02426658||Single Group Assignment||Treatment||None (Open Label)||||||
1389736|NCT02426645|||Cohort||Prospective|||||||
1389737|NCT02426632|Randomized|Crossover Assignment||Other||Double|||t||t|
1389738|NCT02426619|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389739|NCT02426606|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1389740|NCT02426593|||Ecologic or Community||Prospective|||||||
1389741|NCT02426580|Randomized|Parallel Assignment||Prevention||Single||||||t
1389742|NCT02426567|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1389743|NCT02426554|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1389744|NCT02426541|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389745|NCT02426528|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1389746|NCT02426515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389747|NCT02426502||Single Group Assignment||Treatment||None (Open Label)||||||
1389748|NCT02426489|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1389749|NCT02426476|Randomized|Factorial Assignment||Treatment||Single||||||t
1389750|NCT02426463|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389751|NCT02426450|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389752|NCT02426437|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389753|NCT02426424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389754|NCT02426411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389755|NCT02426398|||Case-Control||Prospective|||||||
1389756|NCT02426385|||Case-Control||Prospective|||||||
1389757|NCT02426372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389758|NCT02426359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389759|NCT02426346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389760|NCT02426333|||Case-Only||Prospective|||||||
1389921|NCT02424227|||Case-Only||Prospective|||||||
1389761|NCT02426320|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1389762|NCT02426307|||Cohort||Retrospective|||||||
1389763|NCT02426294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389764|NCT02426281||Single Group Assignment||Treatment||None (Open Label)||||||
1389765|NCT02426268|||Cohort||Prospective|||||||
1389766|NCT02426255|||Cohort||Prospective|||||||
1389767|NCT02426242|||Cohort||Prospective|||||||
1389768|NCT02426229||Single Group Assignment||Treatment||None (Open Label)||||||
1389769|NCT02426216|||||Prospective|||||||
1389770|NCT02426203|||Case-Only||Prospective|||||||
1389771|NCT02426190|Randomized|Parallel Assignment||Treatment||Single|||||t|
1389772|NCT02426177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389773|NCT02426164|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389774|NCT02426151|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1389775|NCT02426138|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1389776|NCT02426125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389777|NCT02426112|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1389778|NCT02426099|Randomized|Parallel Assignment||Treatment||Single||||||t
1389779|NCT02426086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389780|NCT02426073|||Case-Control||Cross-Sectional|||||||
1389781|NCT02426060||Single Group Assignment||Treatment||None (Open Label)||||||
1389782|NCT02426047||Single Group Assignment||Treatment||None (Open Label)||||||
1389783|NCT02426034||Single Group Assignment||Treatment||None (Open Label)||||||
1389784|NCT02426021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389785|NCT02426008|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1389786|NCT02425995||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389787|NCT02425982|||Cohort||Prospective|||||||
1389788|NCT02425969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389789|NCT02425956||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389790|NCT02425943||Single Group Assignment||Treatment||None (Open Label)||||||
1389791|NCT02425930|||Cohort||Prospective|||||||
1389792|NCT02425917|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1389793|NCT02425904|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389794|NCT02425891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389795|NCT02425878|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389796|NCT02425865||Single Group Assignment||Treatment||None (Open Label)||||||
1389797|NCT02425852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389798|NCT02425839||Single Group Assignment||||None (Open Label)||||||
1389799|NCT02425826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389800|NCT02425813||Single Group Assignment||Treatment||None (Open Label)||||||
1389801|NCT02425800|||Cohort||Prospective|||||||
1389802|NCT02425787|||Cohort||Prospective|||||||
1389803|NCT02425774|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389804|NCT02425761|Randomized|Parallel Assignment||Treatment||Single||||||t
1389805|NCT02425748|Randomized|Single Group Assignment||Treatment||Single|||||t|
1389806|NCT02425735|Randomized|Single Group Assignment||Treatment||Single|||||t|
1389807|NCT02425722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389808|NCT02425709|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1389809|NCT02425696|||Cohort||Prospective|||||||
1389810|NCT02425683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389811|NCT02425670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389812|NCT02425657|||Cohort|||||||||
1389813|NCT02425644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389814|NCT02425631|||Cohort||Prospective|||||||
1389815|NCT02425605||Single Group Assignment||Treatment||None (Open Label)||||||
1389816|NCT02425592|||Cohort||Prospective|||||||
1389817|NCT02425579|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1389818|NCT02425566|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1389819|NCT02425553|||Case-Crossover||Prospective|||||||
1389820|NCT02425540|||Cohort||Prospective|||||||
1389821|NCT02425527|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1389822|NCT02425514|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389823|NCT02425501|||Cohort||Prospective|||||||
1389824|NCT02425488|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1389825|NCT02425475|||Cohort||Prospective|||||||
1389826|NCT02425462|||Cohort||Prospective|||||||
1389827|NCT02425449|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1389828|NCT02425436|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389829|NCT02425423||Single Group Assignment||Treatment||None (Open Label)||||||
1389830|NCT02425410|||Case-Only||Retrospective|||||||
1389831|NCT02425397|||Case Control||Retrospective|||||||
1389832|NCT02425384|Randomized|Parallel Assignment||||None (Open Label)||||||
1389833|NCT02425371|Randomized|Parallel Assignment||Treatment||Single||||||t
1389834|NCT02425358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389835|NCT02425345|Randomized|Parallel Assignment||Prevention||Single||||||t
1389836|NCT02425332||Single Group Assignment||Other||None (Open Label)||||||
1389837|NCT02425319|||Cohort||Prospective|||||||
1389838|NCT02425306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389839|NCT02425293|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389840|NCT02425280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389841|NCT02425267|Randomized|Parallel Assignment||Treatment||Single||||||t
1389842|NCT02425254|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1389843|NCT02425241|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389844|NCT02425228|||Case-Control||Prospective|||||||
1389845|NCT02425215|||Cohort||Prospective|||||||
1389846|NCT02425202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389847|NCT02425189|||Family-Based||Prospective|||||||
1389848|NCT02425176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389849|NCT02425163||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389850|NCT02425150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389851|NCT02425137||Single Group Assignment||Treatment||None (Open Label)||||||
1389852|NCT02425124|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1389853|NCT02425111||Single Group Assignment||Treatment||None (Open Label)||||||
1389854|NCT02425098|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389855|NCT02425085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389856|NCT02425072||Single Group Assignment||Treatment||None (Open Label)||||||
1389857|NCT02425059||Single Group Assignment||Treatment||None (Open Label)||||||
1389858|NCT02425046|Randomized|Parallel Assignment||Prevention||Single||||||t
1389859|NCT02425033||Single Group Assignment||Treatment||None (Open Label)||||||
1389860|NCT02425020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389861|NCT02425007|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389862|NCT02424994|||Cohort||Retrospective|||||||
1389863|NCT02424981|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389864|NCT02424968||Single Group Assignment||Treatment||None (Open Label)||||||
1389865|NCT02424955||Single Group Assignment||Other||None (Open Label)||||||
1389866|NCT02424942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389867|NCT02424929|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Randomized parallel assignment, unblinded|||||
1389868|NCT02424916||Single Group Assignment||Treatment||None (Open Label)||||||
1389869|NCT02424903|||Cohort||Prospective|||||||
1389870|NCT02424890||||||||||||
1389871|NCT02424877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389872|NCT02424864||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389873|NCT02424851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389874|NCT02424838|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1389875|NCT02424825|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389876|NCT02424812|Randomized|Parallel Assignment||Prevention||Single||||||t
1389877|NCT02424799|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1389878|NCT02424786|Randomized|Parallel Assignment||Treatment||Single|||t|||
1389879|NCT02424773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389880|NCT02424760|||Cohort||Prospective|||||||
1389881|NCT02424747|||Cohort||Prospective|||||||
1389882|NCT02424734||||Treatment||None (Open Label)||||||
1389883|NCT02424721|||Cohort||Prospective|||||||
1389884|NCT02424708|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1389885|NCT02424695||Single Group Assignment||Treatment||Single|||t|||
1389886|NCT02424682|||Case-Only||Prospective|||||||
1389887|NCT02424669|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1389888|NCT02424656|||Case-Control||Prospective|||||||
1389889|NCT02424643|Randomized|Parallel Assignment||||None (Open Label)||||||
1389890|NCT02424630|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1389891|NCT02424617|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1389892|NCT02424604|||Cohort||Retrospective|||||||
1389893|NCT02424591|Randomized|Parallel Assignment||Other||Single||||||t
1389894|NCT02424578|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389895|NCT02424565|Randomized|Crossover Assignment||Basic Science||Single||||||t
1389896|NCT02424552|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389897|NCT02424539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389898|NCT02424526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389899|NCT02424513||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389900|NCT02424500||||||||||||
1389901|NCT02424487|||Cohort||Prospective|||||||
1389902|NCT02424474||Single Group Assignment||Screening||None (Open Label)||||||
1389903|NCT02424461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389904|NCT02424448|||Cohort||Prospective|||||||
1389905|NCT02424435||Single Group Assignment||Treatment||None (Open Label)||||||
1389906|NCT02424422|||Cohort||Prospective|||||||
1389907|NCT02424409|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389908|NCT02424396|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389909|NCT02424383|||Cohort||Prospective|||||||
1389910|NCT02424370|||||Prospective|||||||
1389911|NCT02424357|Randomized|Parallel Assignment||Prevention||Triple|The surgeon will be unaware of the randomization until the end of the surgery. All microbiology personnel and patients will be unaware of the interventional group||t|t|t|
1389912|NCT02424344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389913|NCT02424331|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1389914|NCT02424318||Single Group Assignment||Treatment||None (Open Label)||||||
1389915|NCT02424305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389916|NCT02424292|||Case-Only||Prospective|||||||
1389917|NCT02424279|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389918|NCT02424266|||Case Control||Prospective|||||||
1389919|NCT02424253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389920|NCT02424240|||||Retrospective|||||||
1389922|NCT02424214|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1389923|NCT02424201|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1389924|NCT02424188|Randomized|Parallel Assignment||Treatment||Single||||||t
1389925|NCT02424175||Single Group Assignment||Treatment||None (Open Label)||||||
1389926|NCT02424162|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389927|NCT02424149|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1389928|NCT02424136||Single Group Assignment||Diagnostic||None (Open Label)||||||
1389929|NCT02424123|||Cohort||Prospective|||||||
1389930|NCT02424110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389931|NCT02424097|Randomized|Parallel Assignment||Prevention||Single|||||t|
1389932|NCT02424084|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1389933|NCT02424071|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1389934|NCT02424058|||Case Control|||||||||
1389935|NCT02424045||Single Group Assignment||Treatment||None (Open Label)||||||
1389936|NCT02424032|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1389937|NCT02424019||Single Group Assignment||Treatment||None (Open Label)||||||
1389938|NCT02424006|Randomized|Parallel Assignment||Treatment||None (Open Label)||RHCIII-MPC Biosynthetic Cornea||||
1389939|NCT02423993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389940|NCT02423980||Single Group Assignment||Treatment||None (Open Label)||||||
1389941|NCT02423967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389942|NCT02423954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389943|NCT02423941|Randomized|Parallel Assignment||Prevention||Single||||||t
1389944|NCT02423928||Single Group Assignment||Treatment||None (Open Label)||||||
1389945|NCT02423915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389946|NCT02423902||Single Group Assignment||Treatment||None (Open Label)||||||
1389947|NCT02423889||Single Group Assignment||Treatment||None (Open Label)||||||
1389948|NCT02423876|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1389949|NCT02423863||Single Group Assignment||Treatment||None (Open Label)||||||
1389950|NCT02423850|||Cohort||Prospective|||||||
1389951|NCT02423837||Single Group Assignment||Treatment||None (Open Label)||||||
1389952|NCT02423824|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389953|NCT02423811||Single Group Assignment||Treatment||None (Open Label)||||||
1389954|NCT02423798||Single Group Assignment||Treatment||None (Open Label)||||||
1389955|NCT02423785|||Cohort||Prospective|||||||
1389956|NCT02423772|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389957|NCT02423759|Randomized|Parallel Assignment||Prevention||Single|||t|||
1389958|NCT02423746|Randomized|Single Group Assignment||Other||Double|||t||t|
1389959|NCT02423733|Randomized|Parallel Assignment||Other||Single|||t|||
1389960|NCT02423720||Single Group Assignment||Supportive Care||None (Open Label)||||||
1389961|NCT02423707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389962|NCT02423694|Randomized|Parallel Assignment||Treatment||Single||||||t
1389963|NCT02423681|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1389964|NCT02423668|||Cohort||Retrospective|||||||
1389965|NCT02423655|Randomized|Parallel Assignment||Treatment||Single||||||t
1389966|NCT02423642|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389967|NCT02423629||Single Group Assignment||Treatment||None (Open Label)||||||
1389968|NCT02423616||Single Group Assignment||Screening||Single|||t|||
1389969|NCT02423603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389970|NCT02423590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389971|NCT02423577|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1389972|NCT02423564|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1389973|NCT02423551|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1389974|NCT02423538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389975|NCT02423525||Single Group Assignment||Treatment||None (Open Label)||||||
1389976|NCT02423512|||Cohort||Prospective|||||||
1389977|NCT02423499|||Cohort||Prospective|||||||
1389978|NCT02423486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389979|NCT02423473|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389980|NCT02423460||Single Group Assignment||Other||None (Open Label)||||||
1389981|NCT02423447|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1389982|NCT02423434|||Cohort||Prospective|||||||
1389983|NCT02423421|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389984|NCT02423408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1389985|NCT02423395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1389986|NCT02423382|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389987|NCT02423369||Single Group Assignment||Screening||None (Open Label)||||||
1389988|NCT02423356|||Cohort||Prospective|||||||
1389989|NCT02423343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1389990|NCT02423330||Single Group Assignment||Treatment||None (Open Label)||||||
1389991|NCT02423317|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1389992|NCT02423304|||Cohort||Cross-Sectional|||||||
1389993|NCT02423291||Single Group Assignment||Treatment||None (Open Label)||||||
1389994|NCT02423278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389995|NCT02423265|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1389996|NCT02423252|Randomized|Parallel Assignment||Treatment||Double||||t||t
1389997|NCT02423239|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389998|NCT02423226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1389999|NCT02423213|||Other||Prospective|||||||
1390000|NCT02423200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390001|NCT02423187|||Cohort||Prospective|||||||
1390002|NCT02423174|||Case-Only||Prospective|||||||
1390003|NCT02423161|||Other||Prospective|||||||
1390004|NCT02423148||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390005|NCT02423135|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1390006|NCT02423122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390007|NCT02423109|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1390008|NCT02423096|||Case Control||Prospective|||||||
1390009|NCT02423083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390010|NCT02423070|||Cohort||Prospective|||||||
1390011|NCT02423057||Single Group Assignment||Treatment||None (Open Label)||||||
1390012|NCT02423044|||Case-Control||Prospective|||||||
1390013|NCT02423031|||Cohort||Prospective|||||||
1390014|NCT02423018|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1390015|NCT02423005|Randomized|Parallel Assignment||Treatment||Single||||||t
1390016|NCT02422992|||Case Control||Cross-Sectional|||||||
1390017|NCT02422979||Single Group Assignment||Treatment||None (Open Label)||||||
1390018|NCT02422966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390019|NCT02422953|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390020|NCT02422940|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390021|NCT02422927|Randomized|Parallel Assignment||Treatment||Single||||||t
1390022|NCT02422914|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390023|NCT02422901|||Other||Prospective|||||||
1390024|NCT02422888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390025|NCT02422875|||Case-Control||Cross-Sectional|||||||
1390026|NCT02422862|Randomized|Parallel Assignment||Treatment||Single||||||t
1390027|NCT02422849|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390028|NCT02422836||Single Group Assignment||||Triple|||t|t|t|
1390029|NCT02422823|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390030|NCT02422810|||Case-Control||Cross-Sectional|||||||
1390031|NCT02422797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390032|NCT02422784|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390033|NCT02422771|Randomized|Parallel Assignment||Prevention||Single||||||t
1390034|NCT02422758|Randomized|Parallel Assignment||Prevention||Single|||t|||
1390035|NCT02422745|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1390036|NCT02422732|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1390037|NCT02422719||Single Group Assignment||Treatment||None (Open Label)||||||
1390038|NCT02422706|Randomized|Parallel Assignment||Treatment||Double|blinding was applied by using consecutively numbered envelopes that contained the treatment assignments||t|t||
1390039|NCT02422693|Randomized|Parallel Assignment||Treatment||Single||||||t
1390040|NCT02422680|||Case-Only||Prospective|||||||
1390041|NCT02422667|||Cohort||Other|||||||
1390042|NCT02422654|Randomized|Crossover Assignment||Treatment||Single|||t|||
1390043|NCT02422641||Single Group Assignment||Treatment||None (Open Label)||||||
1390044|NCT02422628|||Case-Crossover||Prospective|||||||
1390045|NCT02422615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390046|NCT02422602|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1390047|NCT02422589||Single Group Assignment||Other||None (Open Label)||||||
1390048|NCT02422576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390049|NCT02422563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390050|NCT02422550|||Cohort||Prospective|||||||
1390051|NCT02422537|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1390052|NCT02422524|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390053|NCT02422511|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1390054|NCT02422498||Single Group Assignment||Treatment||None (Open Label)||||||
1390055|NCT02422485||Single Group Assignment||Treatment||None (Open Label)||||||
1390056|NCT02422472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390057|NCT02422459|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390058|NCT02422446|Randomized|Parallel Assignment||Prevention||Single|||||t|
1390059|NCT02422433||Single Group Assignment||Screening||None (Open Label)||||||
1390060|NCT02422420|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390061|NCT02422407|||Cohort||Prospective|||||||
1390062|NCT02422394||Single Group Assignment||Treatment||None (Open Label)||||||
1390063|NCT02422381||Single Group Assignment||Treatment||None (Open Label)||||||
1390064|NCT02422368|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1390065|NCT02422355|||Case-Only||Prospective|||||||
1390066|NCT02422342|||Cohort||Prospective|||||||
1390067|NCT02422329|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390068|NCT02422316|||Cohort||Prospective|||||||
1390069|NCT02422303|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1390070|NCT02422290||Single Group Assignment||Treatment||None (Open Label)||||||
1390071|NCT02422277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390072|NCT02422264|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390073|NCT02422251|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1390074|NCT02422238|||Cohort||Prospective|||||||
1390075|NCT02422225|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390076|NCT02422212|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1390077|NCT02422199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390078|NCT02422186|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390079|NCT02422173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390080|NCT02422160|||Cohort||Prospective|||||||
1390081|NCT02422147|||Cohort||Prospective|||||||
1390082|NCT02422134|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390083|NCT02422121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390084|NCT02422108||Single Group Assignment||Treatment||None (Open Label)||||||
1390085|NCT02422095|||Cohort||Prospective|||||||
1390086|NCT02422082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390087|NCT02422069|||Cohort||Cross-Sectional|||||||
1390088|NCT02422056|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1390089|NCT02422043||Single Group Assignment||||None (Open Label)||||||
1390090|NCT02422030|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390091|NCT02422017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390092|NCT02422004|Randomized|Parallel Assignment||Treatment||Single||||||t
1390093|NCT02421991|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390094|NCT02421978|||Case-Control||Prospective|||||||
1390095|NCT02421965|Randomized|Parallel Assignment||Treatment||Single||||||t
1390096|NCT02421952|||Case-Only||Cross-Sectional|||||||
1390097|NCT02421939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390098|NCT02421926|||Cohort||Prospective|||||||
1390099|NCT02421913|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1390100|NCT02421900|||Case-Only||Prospective|||||||
1390101|NCT02421887|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390102|NCT02421874|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390103|NCT02421861|Randomized|Parallel Assignment||Treatment||Single||||||t
1390104|NCT02421848|||Cohort||Prospective|||||||
1390105|NCT02421835|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1390106|NCT02421822||Single Group Assignment||Prevention||None (Open Label)||||||
1390107|NCT02421809|||Case-Control||Prospective|||||||
1390108|NCT02421796|||Case-Control||Prospective|||||||
1390109|NCT02421783|||Case-Control||Prospective|||||||
1390110|NCT02421770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390111|NCT02421757|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390112|NCT02421744|Randomized|Parallel Assignment||Treatment||Single||||||t
1390113|NCT02421731|Randomized|Parallel Assignment||Treatment||Single||||||t
1390114|NCT02421718|||Cohort||Prospective|||||||
1390115|NCT02421705||Single Group Assignment||Basic Science||None (Open Label)||||||
1390116|NCT02421692|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1390117|NCT02421679||Single Group Assignment||Treatment||None (Open Label)||||||
1390118|NCT02421666|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1390119|NCT02421653|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1390120|NCT02421640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390121|NCT02421627|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1390122|NCT02421614|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1390123|NCT02421601||Single Group Assignment||Treatment||None (Open Label)||||||
1390124|NCT02421588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390125|NCT02421575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390126|NCT02421562||Single Group Assignment||||None (Open Label)||||||
1390127|NCT02421549|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1390128|NCT02421536||Single Group Assignment||Supportive Care||None (Open Label)||||||
1390129|NCT02421523|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390130|NCT02421510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390131|NCT02421497|||Cohort||Prospective|||||||
1390132|NCT02421484||Single Group Assignment||Treatment||None (Open Label)||||||
1390133|NCT02421471|||Cohort||Prospective|||||||
1390134|NCT02421458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390135|NCT02421445|||Cohort||Prospective|||||||
1390136|NCT02421432||Single Group Assignment||Treatment||None (Open Label)||||||
1390137|NCT02421419|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390138|NCT02421406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390139|NCT02421393|Randomized|Parallel Assignment||Treatment||Single||||||t
1390140|NCT02421380||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390141|NCT02421367|Randomized|Parallel Assignment||Prevention||Single|||||t|
1390142|NCT02421354||Single Group Assignment||Treatment||None (Open Label)||||||
1390143|NCT02421341|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1390144|NCT02421328|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390145|NCT02421315||Single Group Assignment||Other||None (Open Label)||||||
1390146|NCT02421302|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390147|NCT02421289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390148|NCT02421276|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390149|NCT02421263|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390150|NCT02421250|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390151|NCT02421237|Randomized|Parallel Assignment||Treatment||Single||||||t
1390152|NCT02421224|Randomized|Single Group Assignment||Treatment||Single||||||t
1390153|NCT02421211|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1390154|NCT02421198|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390155|NCT02421185||Single Group Assignment||Treatment||None (Open Label)||||||
1390156|NCT02421172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390157|NCT02421159||Single Group Assignment||Other||None (Open Label)||||||
1390158|NCT02421146|Randomized|Parallel Assignment||Other||Double|||t||t|
1390159|NCT02421133|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390160|NCT02421120||Single Group Assignment||Other||None (Open Label)||||||
1390161|NCT02421107||Single Group Assignment||||||||||
1390162|NCT02421094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390163|NCT02421081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390164|NCT02421068|||Cohort||Prospective|||||||
1390165|NCT02421055|||Cohort||Prospective|||||||
1390166|NCT02421042||Single Group Assignment||Treatment||None (Open Label)||||||
1390167|NCT02421029||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390168|NCT02421016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390169|NCT02421003||Single Group Assignment||Basic Science||None (Open Label)||||||
1390170|NCT02420990|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390171|NCT02420977||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390172|NCT02420964|Randomized|Parallel Assignment||||None (Open Label)||||||
1390173|NCT02420951|Randomized|Parallel Assignment||Treatment||None (Open Label)||We randomized 50 patients undergoing TKA at one institution into two groups. Group 1, 25 patients, received a postoperative intra-articular catheter in combination with injection of 30 ml of 0.5% Marcaine the day after surgery before removal. Group 2, 25 patients, received no pain catheter. Both groups received intraoperative pericapsular injection and postoperative pain medication. We measured pain scores using the Visual Analog Scale (VAS) and recorded narcotic medication consumption in morphine milligram equivalents (mgs).||||
1390174|NCT02420938||Single Group Assignment||Treatment||None (Open Label)||||||
1390175|NCT02420925||Single Group Assignment||Treatment||None (Open Label)||||||
1390176|NCT02420912|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390177|NCT02420899||Single Group Assignment||Prevention||None (Open Label)||||||
1390178|NCT02420886|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1390179|NCT02420873|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390180|NCT02420860||Single Group Assignment||Treatment||None (Open Label)||||||
1390181|NCT02420847||Single Group Assignment||Treatment||None (Open Label)||||||
1390182|NCT02420834|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1390183|NCT02420821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390184|NCT02420808|||Case-Only||Prospective|||||||
1390185|NCT02420795|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390186|NCT02420782|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1390187|NCT02420769|||Other||Prospective|||||||
1390188|NCT02420756|||Cohort||Prospective|||||||
1390189|NCT02420743|||Case-Only||Prospective|||||||
1390190|NCT02420730|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390191|NCT02420717|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390192|NCT02420704|||Cohort||Prospective|||||||
1390193|NCT02420691||Single Group Assignment||Treatment||None (Open Label)||||||
1390194|NCT02420678|||Cohort||Prospective|||||||
1390195|NCT02420665||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390196|NCT02420652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390197|NCT02420639||Single Group Assignment||Supportive Care||None (Open Label)||||||
1390198|NCT02420626|||Case Control||Prospective|||||||
1390199|NCT02420613|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390200|NCT02420600|||Cohort||Prospective|||||||
1390201|NCT02420587||Single Group Assignment||Treatment||None (Open Label)||||||
1390202|NCT02420574|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390203|NCT02420561|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390204|NCT02420548|Randomized|Parallel Assignment||Prevention||Single||||||t
1390205|NCT02420535|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1390206|NCT02420522|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1390207|NCT02420509|||Case-Control||Prospective|||||||
1390208|NCT02420496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390209|NCT02420483||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390210|NCT02420470|||Cohort||Prospective|||||||
1390211|NCT02420457|||Cohort||Prospective|||||||
1390212|NCT02420444|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1390213|NCT02420431|Randomized|Parallel Assignment||Treatment||Single|||||t|
1390214|NCT02420418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390215|NCT02420405|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1390216|NCT02420392|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1390217|NCT02420379|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1390218|NCT02420366|||Case-Only||Retrospective|||||||
1390219|NCT02420353|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390220|NCT02420340||Single Group Assignment||Health Services Research||None (Open Label)||||||
1390221|NCT02420327|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1390222|NCT02420314||Single Group Assignment||Treatment||None (Open Label)||||||
1390223|NCT02420301|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390224|NCT02420288|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1390225|NCT02420275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390696|NCT02414113|||Cohort||Prospective|||||||
1390226|NCT02420262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390227|NCT02420249|Randomized|Parallel Assignment||Treatment||Single||||||t
1390228|NCT02420236|Randomized|Parallel Assignment||Treatment||Single|||||t|
1390229|NCT02420223|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390230|NCT02420210||Single Group Assignment||Treatment||None (Open Label)||||||
1390231|NCT02420197|Randomized|Parallel Assignment||Treatment||Single|||||t|
1390232|NCT02420184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390233|NCT02420171|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390234|NCT02420158||Single Group Assignment||Treatment||None (Open Label)||||||
1390235|NCT02420145|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390236|NCT02420132|||Case-Control||Prospective|||||||
1390237|NCT02420119|||Cohort||Prospective|||||||
1390238|NCT02420106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390239|NCT02420093|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390240|NCT02420080|||Case Control||Retrospective|||||||
1390241|NCT02420067|||Cohort||Prospective|||||||
1390242|NCT02420054|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1390243|NCT02420041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390244|NCT02420028|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390245|NCT02420015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390246|NCT02420002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390247|NCT02419989|||Case-Only||Prospective|||||||
1390248|NCT02419976||Single Group Assignment||Screening||None (Open Label)||||||
1390249|NCT02419963|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1390250|NCT02419950|||Cohort|||||||||
1390251|NCT02419937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390252|NCT02419924||Single Group Assignment||Treatment||None (Open Label)||||||
1390253|NCT02419911|Randomized|Parallel Assignment||||None (Open Label)||||||
1390254|NCT02419898|||Cohort||Prospective|||||||
1390255|NCT02419885|||Case-Only||Retrospective|||||||
1390256|NCT02419872|||Cohort||Prospective|||||||
1390257|NCT02419859||Single Group Assignment||Treatment||None (Open Label)||||||
1390258|NCT02419846|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1390259|NCT02419833|Randomized|Parallel Assignment||Treatment||Single||||||t
1390260|NCT02419820|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1390261|NCT02419807||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390262|NCT02419794|||Cohort||Prospective|||||||
1390263|NCT02419781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390264|NCT02419768|Randomized|Crossover Assignment||||Single||||||t
1390265|NCT02419755|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390266|NCT02419742||Single Group Assignment||Treatment||None (Open Label)||||||
1390267|NCT02419729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390268|NCT02419716|||Other||Prospective|||||||
1390269|NCT02419703|||Cohort||Prospective|||||||
1390270|NCT02419690|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390271|NCT02419677|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390272|NCT02419664||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390273|NCT02419651|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1390274|NCT02419638|||Cohort||Prospective|||||||
1390275|NCT02419625||Single Group Assignment||Screening||None (Open Label)||||||
1390276|NCT02419612|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390277|NCT02419599|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1390278|NCT02419586|Randomized|Parallel Assignment||Prevention||Single|||t|||
1390279|NCT02419573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390280|NCT02419560||Single Group Assignment||Treatment||None (Open Label)||||||
1390281|NCT02419547||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390282|NCT02419534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390283|NCT02419521||Single Group Assignment||Treatment||None (Open Label)||||||
1390284|NCT02419508|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390285|NCT02419495|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390286|NCT02419482|Randomized|Parallel Assignment||Treatment||Single||||||t
1390287|NCT02419469||Single Group Assignment||Treatment||None (Open Label)||||||
1390288|NCT02419456|Randomized|Parallel Assignment||Prevention||Single|||t|||
1390289|NCT02419443|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390290|NCT02419430|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1390291|NCT02419417|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390292|NCT02419404|||Cohort||Prospective|||||||
1390293|NCT02419391|Randomized|Parallel Assignment||Prevention||Single|||t|||
1390294|NCT02419378||Single Group Assignment||Basic Science||None (Open Label)||||||
1390295|NCT02419365|||Cohort||Prospective|||||||
1390296|NCT02419352|Randomized|Parallel Assignment||Screening||Double|||t|||t
1390297|NCT02419339|||Cohort||Prospective|||||||
1390298|NCT02419326||Single Group Assignment||Treatment||None (Open Label)||||||
1390299|NCT02419313|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1390300|NCT02419300|||Case-Only||Prospective|||||||
1390301|NCT02419287||Single Group Assignment||Treatment||None (Open Label)||||||
1390302|NCT02419274|||Cohort||Prospective|||||||
1390303|NCT02419261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390304|NCT02419248|||||Prospective|||||||
1390305|NCT02419235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390306|NCT02419222||Single Group Assignment||Treatment||None (Open Label)||||||
1390307|NCT02419209||Single Group Assignment||Treatment||None (Open Label)||||||
1390308|NCT02419196|||Cohort||Prospective|||||||
1390309|NCT02419183|||Case-Crossover||Prospective|||||||
1390310|NCT02419170||Single Group Assignment||Treatment||None (Open Label)||||||
1390311|NCT02419157|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1390312|NCT02419144|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1390313|NCT02419131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390314|NCT02419118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390315|NCT02419105|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1390316|NCT02419092|||Case-Control||Prospective|||||||
1390317|NCT02419066|||Cohort||Other|||||||
1390318|NCT02419053|||Cohort||Retrospective|||||||
1390319|NCT02419040|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390320|NCT02419027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390321|NCT02419014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390322|NCT02419001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390323|NCT02418988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390324|NCT02418975|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1390325|NCT02418962|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1390326|NCT02418949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390327|NCT02418936|||Case-Only|||||||||
1390328|NCT02418923|||Cohort||Prospective|||||||
1390329|NCT02418910|||Cohort||Prospective|||||||
1390330|NCT02418897|||Case Control||Prospective|||||||
1390331|NCT02418884||Single Group Assignment||Prevention||None (Open Label)||||||
1390332|NCT02418871||Single Group Assignment||Treatment||None (Open Label)||||||
1390333|NCT02418858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390334|NCT02418845|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390335|NCT02418832||Single Group Assignment||Other||None (Open Label)||||||
1390336|NCT02418819|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1390337|NCT02418806|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390338|NCT02418793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390339|NCT02418780|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1390340|NCT02418767|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1390341|NCT02418754|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390342|NCT02418741||Single Group Assignment||||Single|||t|||
1390343|NCT02418728|||Cohort||Retrospective|||||||
1390344|NCT02418715|Randomized|Parallel Assignment||Treatment||Single||||||t
1390345|NCT02418702|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390346|NCT02418689||Single Group Assignment||Treatment||None (Open Label)||||||
1390347|NCT02418676|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1390348|NCT02418663||Single Group Assignment||Screening||Triple|||t|t||t
1390349|NCT02418650|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390350|NCT02418637||Single Group Assignment||Prevention||None (Open Label)||||||
1390351|NCT02418624||Single Group Assignment||Treatment||None (Open Label)||||||
1390352|NCT02418598|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390353|NCT02418585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390354|NCT02418572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390355|NCT02418559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390356|NCT02418546|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390357|NCT02418533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390358|NCT02418520|Randomized|Parallel Assignment||Prevention||Single|||t|||
1390359|NCT02418507|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1390360|NCT02418494|||Case-Only||Prospective|||||||
1390361|NCT02418481|Randomized|Single Group Assignment||Treatment||Single|||||t|
1390362|NCT02418468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390363|NCT02418455||Single Group Assignment||Treatment||None (Open Label)||||||
1390364|NCT02418442|||Cohort||Prospective|||||||
1390365|NCT02418429|Randomized|Single Group Assignment||Other||Single|||t|||
1390366|NCT02418416|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390367|NCT02418403|Randomized|Single Group Assignment||Health Services Research||Double||||t||t
1390368|NCT02418390|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390369|NCT02418377|||Cohort||Cross-Sectional|||||||
1390370|NCT02418364|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390371|NCT02418338|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1390372|NCT02418325||Single Group Assignment||Treatment||None (Open Label)||||||
1390373|NCT02418312|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1390374|NCT02418299||Single Group Assignment||Treatment||None (Open Label)||||||
1390375|NCT02418286|||Other||Prospective|||||||
1390376|NCT02418273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390377|NCT02418260|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390378|NCT02418247|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390379|NCT02418234|||Case-Only||Prospective|||||||
1390380|NCT02418221||Single Group Assignment||Diagnostic||Double|||t||t|
1390381|NCT02418208|||Other||Prospective|||||||
1390382|NCT02418195|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390697|NCT02414100|||Case-Only||Prospective|||||||
1390383|NCT02418182|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1390384|NCT02418169|||Case-Only||Prospective|||||||
1390385|NCT02418156|||Case-Only||Prospective|||||||
1390386|NCT02418143|||Case-Control||Prospective|||||||
1390387|NCT02418130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390388|NCT02418117||Single Group Assignment||||None (Open Label)||||||
1390389|NCT02418104|Randomized|Parallel Assignment||||Triple|||t|t|t|
1390390|NCT02418091|Non-Randomized|Single Group Assignment||Prevention||Single||||||t
1390391|NCT02418078|||Case Control||Retrospective|||||||
1390392|NCT02418065|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390393|NCT02418052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390394|NCT02418039|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390395|NCT02418026|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1390396|NCT02418013|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390397|NCT02418000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390398|NCT02417987|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1390399|NCT02417974|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1390400|NCT02417961||Single Group Assignment||Treatment||None (Open Label)||||||
1390401|NCT02417948|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390402|NCT02417935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390403|NCT02417922|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1390404|NCT02417909|||||Cross-Sectional|||||||
1390405|NCT02417896|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390406|NCT02417883||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390407|NCT02417870||Single Group Assignment||Treatment||None (Open Label)||||||
1390408|NCT02417857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390409|NCT02417844|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390410|NCT02417831|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390411|NCT02417818|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390412|NCT02417805|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1390413|NCT02417792|||Case Control||Prospective|||||||
1390414|NCT02417779|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1390415|NCT02417766|||Other||Prospective|||||||
1390416|NCT02417753||Single Group Assignment||Treatment||None (Open Label)||||||
1390417|NCT02417740|||Cohort||Prospective|||||||
1390418|NCT02417727|||Cohort||Prospective|||||||
1390419|NCT02417714|||Case-Only||Prospective|||||||
1390420|NCT02417701||Single Group Assignment||Treatment||None (Open Label)||||||
1390421|NCT02417688||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390422|NCT02417675|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390423|NCT02417662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390424|NCT02417649|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390425|NCT02417636|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390426|NCT02417623|Randomized|Parallel Assignment||Treatment||Single||||||t
1390427|NCT02417610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390428|NCT02417597|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390429|NCT02417584||Single Group Assignment||Treatment||None (Open Label)||||||
1390430|NCT02417571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390431|NCT02417558|Non-Randomized|Parallel Assignment||Prevention||Single|||||t|
1390432|NCT02417545|||Case Control||Prospective|||||||
1390433|NCT02417532||Single Group Assignment||Supportive Care||None (Open Label)||||||
1390434|NCT02417519|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1390435|NCT02417506|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390436|NCT02417493|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390437|NCT02417480|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1390438|NCT02417467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390439|NCT02417454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390440|NCT02417441|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1390441|NCT02417428|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390442|NCT02417415|Randomized|Crossover Assignment||Other||None (Open Label)||randomized, 2-arm crossover study (heat vs. sham)||||
1390443|NCT02417402|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1390444|NCT02417389||Single Group Assignment||Treatment||None (Open Label)||||||
1390445|NCT02417376|Randomized|Parallel Assignment||Treatment||Single||||||t
1390446|NCT02417363|||Case-Crossover||Cross-Sectional|||||||
1390447|NCT02417350|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1390448|NCT02417337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390449|NCT02417324|||Cohort||Prospective|||||||
1390450|NCT02417311|||Case-Control||Prospective|||||||
1390451|NCT02417298|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1390452|NCT02417285||Single Group Assignment||Treatment||None (Open Label)||||||
1390453|NCT02417272|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1390454|NCT02417259|||Cohort||Prospective|||||||
1390455|NCT02417246|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390456|NCT02417233|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390457|NCT02417220|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390458|NCT02417207|Randomized|Parallel Assignment||Treatment||Single|||||t|
1390459|NCT02417194|||Cohort||Prospective|||||||
1390460|NCT02417181|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390461|NCT02417168|||Cohort||Prospective|||||||
1390462|NCT02417155|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390463|NCT02417142|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1390464|NCT02417129|Randomized|Parallel Assignment||Treatment||Double||||||
1390465|NCT02417116|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390466|NCT02417103|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1390467|NCT02417090|||Case Control||Retrospective|||||||
1390468|NCT02417077|||Cohort||Retrospective|||||||
1390469|NCT02417064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390470|NCT02417051|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390471|NCT02417038|||Cohort||Prospective|||||||
1390472|NCT02417025|Randomized|Parallel Assignment||Treatment||Single||||||t
1390473|NCT02417012|Randomized|Parallel Assignment||Treatment||Single||||||t
1390474|NCT02416999||Single Group Assignment||Treatment||None (Open Label)||||||
1390475|NCT02416986||Single Group Assignment||Basic Science||None (Open Label)||||||
1390476|NCT02416973|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390477|NCT02416960|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1390478|NCT02416947|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1390479|NCT02416934|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1390480|NCT02416921|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390481|NCT02416908|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390482|NCT02416895|||Cohort||Prospective|||||||
1390483|NCT02416882|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1390484|NCT02416869|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1390485|NCT02416856|||Other||Prospective|||||||
1390486|NCT02416843|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390487|NCT02416830|||Cohort||Prospective|||||||
1390488|NCT02416817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390489|NCT02416804|Randomized|Parallel Assignment||Treatment||Single|||||t|
1390490|NCT02416791|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1390491|NCT02416778||Single Group Assignment||Treatment||None (Open Label)||||||
1390492|NCT02416765|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390493|NCT02416752|||Case Control||Prospective|||||||
1390494|NCT02416739|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390495|NCT02416726|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1390496|NCT02416713|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1390497|NCT02416700|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390498|NCT02416687|Randomized|Parallel Assignment||||Single||||||t
1390499|NCT02416674||Single Group Assignment||Treatment||None (Open Label)||||||
1390500|NCT02416661|||Cohort||Prospective|||||||
1390501|NCT02416648|Randomized|Factorial Assignment||Prevention||Single|||t|||
1390502|NCT02416635|||Cohort||Retrospective|||||||
1390503|NCT02416622|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390504|NCT02416609||Single Group Assignment||Treatment||None (Open Label)||||||
1390505|NCT02416596|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390506|NCT02416583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390507|NCT02416570|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1390508|NCT02416557|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1390509|NCT02416544|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390510|NCT02416531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390511|NCT02416518|||Case-Only||Prospective|||||||
1390512|NCT02416505|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390513|NCT02416492|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1390514|NCT02416479|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390515|NCT02416466||Single Group Assignment||Treatment||None (Open Label)||||||
1390516|NCT02416453|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390517|NCT02416440|||Ecologic or Community||Cross-Sectional|||||||
1390518|NCT02416427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390519|NCT02416414|||Case Control||Cross-Sectional|||||||
1390520|NCT02416401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390521|NCT02416388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390522|NCT02416375|||Cohort||Prospective|||||||
1390523|NCT02416362|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1390524|NCT02416349|Randomized|Crossover Assignment||Treatment||Single|||||t|
1390525|NCT02416336||Single Group Assignment||Treatment||None (Open Label)||||||
1390526|NCT02416323|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1390527|NCT02416310|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1390528|NCT02416297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390529|NCT02416284||Single Group Assignment||||Single|||t|||
1390530|NCT02416271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390531|NCT02416258|Randomized|Single Group Assignment||Treatment||Single|||||t|
1390532|NCT02416245|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1390533|NCT02416232||||||||||||
1390534|NCT02416219|||Case-Only||Prospective|||||||
1390535|NCT02416206||Single Group Assignment||Treatment||None (Open Label)||||||
1390536|NCT02416193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390537|NCT02416180||Single Group Assignment||Treatment||None (Open Label)||||||
1390538|NCT02416167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390539|NCT02416154|||Cohort||Cross-Sectional|||||||
1390540|NCT02416141|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390541|NCT02416128|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1390542|NCT02416115|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1390543|NCT02416102|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1390544|NCT02416089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390545|NCT02416076|Randomized|Parallel Assignment||Treatment||Single||||||t
1390546|NCT02416063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390547|NCT02416050|||||Prospective|||||||
1390548|NCT02416037|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390549|NCT02416024|||Cohort||Prospective|||||||
1390550|NCT02416011|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1390551|NCT02415998|||Cohort||Prospective|||||||
1390552|NCT02415985|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1390553|NCT02415972|||Cohort||Prospective|||||||
1390554|NCT02415959|Randomized|Parallel Assignment||||Triple|||t|t|t|
1390555|NCT02415946|Randomized|Parallel Assignment||Treatment||Single||||||t
1390556|NCT02415933|Randomized|Parallel Assignment||Prevention||Single||||||t
1390557|NCT02415920|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1390558|NCT02415907||Single Group Assignment||Treatment||None (Open Label)||||||
1390559|NCT02415894|||Cohort||Prospective|||||||
1390560|NCT02415881||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390561|NCT02415868|||Cohort||Prospective|||||||
1390562|NCT02415855|||Cohort||Prospective|||||||
1390563|NCT02415842|||Cohort||Retrospective|||||||
1390564|NCT02415829||Single Group Assignment||Treatment||None (Open Label)||||||
1390565|NCT02415816||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390566|NCT02415803|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1390567|NCT02415790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390568|NCT02415777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390569|NCT02415764||Single Group Assignment||Health Services Research||None (Open Label)||||||
1390570|NCT02415751|||Cohort||Prospective|||||||
1390571|NCT02415738|||Cohort||Prospective|||||||
1390572|NCT02415725||Single Group Assignment||Prevention||None (Open Label)||||||
1390573|NCT02415712|||Cohort||Prospective|||||||
1390574|NCT02415699|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390575|NCT02415686|||Case-Control||Prospective|||||||
1390576|NCT02415673|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390577|NCT02415660|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390578|NCT02415647|||Case-Control||Prospective|||||||
1390579|NCT02415634|Randomized|Parallel Assignment||Treatment||Single||||||t
1390580|NCT02415621||Single Group Assignment||Treatment||None (Open Label)||||||
1390581|NCT02415608|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390582|NCT02415595|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390583|NCT02415582|Randomized|Crossover Assignment||Treatment||Single||||||t
1390584|NCT02415569|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1390585|NCT02415556|Randomized|Parallel Assignment||Treatment||Quadruple||120 T2DM adults and 90 non-DM controls (as of 9/25/2017)|t|t|t|t
1390586|NCT02415543|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390587|NCT02415530|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1390588|NCT02415517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390589|NCT02415504|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390590|NCT02415491||Single Group Assignment||Basic Science||None (Open Label)||||||
1390591|NCT02415478|||||Prospective|||||||
1390592|NCT02415465|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390593|NCT02415452|||Cohort||Retrospective|||||||
1390594|NCT02415439|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1390595|NCT02415426|||Other||Prospective|||||||
1390596|NCT02415413||Single Group Assignment||Treatment||None (Open Label)||||||
1390597|NCT02415400|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1390598|NCT02415387|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1390599|NCT02415374|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1390600|NCT02415361|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390601|NCT02415348||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390602|NCT02415335|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1390603|NCT02415322|||Cohort||Prospective|||||||
1390604|NCT02415309|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1390605|NCT02415296||||||||||||
1390606|NCT02415283|||Cohort||Prospective|||||||
1390607|NCT02415270|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390608|NCT02415257|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390609|NCT02415244|||Cohort||Prospective|||||||
1390610|NCT02415231|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1390611|NCT02415218||Single Group Assignment||Treatment||None (Open Label)||||||
1390612|NCT02415205|||Cohort||Prospective|||||||
1390613|NCT02415192|||Cohort||Prospective|||||||
1390614|NCT02415179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390615|NCT02415166|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1390616|NCT02415153||Single Group Assignment||Treatment||None (Open Label)||||||
1390617|NCT02415140|||Case Control||Cross-Sectional|||||||
1390618|NCT02415127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390619|NCT02415114|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390620|NCT02415101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390621|NCT02415088|Randomized|Parallel Assignment||Treatment||Single||||||t
1390622|NCT02415075|||Cohort||Cross-Sectional|||||||
1390623|NCT02415062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390624|NCT02415049|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390625|NCT02415036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390626|NCT02415023||Single Group Assignment||Treatment||None (Open Label)||||||
1390627|NCT02415010|||Cohort||Prospective|||||||
1390628|NCT02414997|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390629|NCT02414984|||Cohort||Prospective|||||||
1390630|NCT02414971|||Cohort||Prospective|||||||
1390631|NCT02414958|Randomized|Parallel Assignment||Treatment||Double||||||
1390632|NCT02414945||Single Group Assignment||Treatment||None (Open Label)||||||
1390633|NCT02414932|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1390634|NCT02414919|||Cohort||Retrospective|||||||
1390635|NCT02414906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390636|NCT02414893|||Case Control||Prospective|||||||
1390637|NCT02414880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390638|NCT02414867|||Cohort||Prospective|||||||
1390639|NCT02414854|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390640|NCT02414841|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390641|NCT02414828|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1390642|NCT02414815||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390643|NCT02414802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390644|NCT02414789||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390645|NCT02414776||Single Group Assignment||Treatment||None (Open Label)||||||
1390646|NCT02414763|Randomized|Parallel Assignment||Treatment||Single||||||t
1390647|NCT02414750||Single Group Assignment||Other||None (Open Label)||||||
1390648|NCT02414737||Single Group Assignment||Treatment||None (Open Label)||||||
1390649|NCT02414724||Single Group Assignment||Treatment||None (Open Label)||||||
1390650|NCT02414711|Randomized|Single Group Assignment||||None (Open Label)||||||
1390651|NCT02414698|Randomized|Parallel Assignment||Treatment||Single||||||t
1390652|NCT02414685||Single Group Assignment||Treatment||None (Open Label)||||||
1390653|NCT02414672|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390654|NCT02414659|||Case Control||Retrospective|||||||
1390655|NCT02414646||Single Group Assignment||Treatment||None (Open Label)||||||
1390656|NCT02414633|||Cohort||Prospective|||||||
1390657|NCT02414620||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390658|NCT02414607|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390659|NCT02414594|Randomized|Single Group Assignment||Other||Double|||t||t|
1390660|NCT02414581|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390661|NCT02414568||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1390662|NCT02414555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390663|NCT02414542|||Case-Control||Prospective|||||||
1390664|NCT02414529|Randomized|Crossover Assignment||Treatment||Single|||t|||
1390665|NCT02414516||Single Group Assignment||Treatment||None (Open Label)||||||
1390666|NCT02414503|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1390667|NCT02414490|||Cohort||Prospective|||||||
1390668|NCT02414477||Single Group Assignment||Basic Science||None (Open Label)||||||
1390669|NCT02414464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390670|NCT02414451|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1390671|NCT02414438|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1390672|NCT02414425|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390673|NCT02414412|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1390674|NCT02414399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390675|NCT02414386|||Case-Control||Prospective|||||||
1390676|NCT02414373|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390677|NCT02414360|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1390678|NCT02414347||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390679|NCT02414334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390680|NCT02414321|||Cohort||Cross-Sectional|||||||
1390681|NCT02414308||Single Group Assignment||Treatment||None (Open Label)||||||
1390682|NCT02414295||Single Group Assignment||Treatment||Single|||||t|
1390683|NCT02414282||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390684|NCT02414269|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390685|NCT02414256|||Cohort||Prospective|||||||
1390686|NCT02414243|Randomized|Crossover Assignment||||Double|||t||t|
1390687|NCT02414230||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390688|NCT02414217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390689|NCT02414204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390690|NCT02414191|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1390691|NCT02414178||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390692|NCT02414165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390693|NCT02414152||Single Group Assignment||Treatment||None (Open Label)||||||
1390694|NCT02414139|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390695|NCT02414126|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1390698|NCT02414087|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1390699|NCT02414074|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1390700|NCT02414061|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1390701|NCT02414048||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390702|NCT02414035|||Cohort||Prospective|||||||
1390703|NCT02414022|||Other||Prospective|||||||
1390704|NCT02414009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390705|NCT02413996|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390706|NCT02413983|||Cohort||Prospective|||||||
1390707|NCT02413970||Single Group Assignment||Treatment||None (Open Label)||Inspire UAS||||
1390708|NCT02413957|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390709|NCT02413944||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390710|NCT02413931|||Cohort||Prospective|||||||
1390711|NCT02413918||Single Group Assignment||Treatment||None (Open Label)||||||
1390712|NCT02413905|||Case Control||Prospective|||||||
1390713|NCT02413892|||Cohort||Prospective|||||||
1390714|NCT02413879||Single Group Assignment||Prevention||None (Open Label)||||||
1390715|NCT02413866|Randomized|Parallel Assignment||||None (Open Label)||||||
1390716|NCT02413853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390717|NCT02413840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390718|NCT02413827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390719|NCT02413814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390720|NCT02413801|||Case-Control||Prospective|||||||
1390721|NCT02413788|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390722|NCT02413775|||Cohort||Prospective|||||||
1390723|NCT02413762|||Cohort||Cross-Sectional|||||||
1390724|NCT02413749|||Case-Control||Prospective|||||||
1390725|NCT02413736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390726|NCT02413723|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1390727|NCT02413710|Randomized|Parallel Assignment||Prevention||Single||||||t
1390728|NCT02413697|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390729|NCT02413684||Single Group Assignment||Supportive Care||None (Open Label)||||||
1390730|NCT02413671|Randomized|Crossover Assignment||Treatment||Single|||t|||
1390731|NCT02413658|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390732|NCT02413645|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390733|NCT02413632|Non-Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1390734|NCT02413619|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390735|NCT02413606|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1390736|NCT02413593||Single Group Assignment||Treatment||None (Open Label)||||||
1390737|NCT02413580||Single Group Assignment||Treatment||None (Open Label)||||||
1390738|NCT02413567||Single Group Assignment||Treatment||None (Open Label)||||||
1390739|NCT02413554|Randomized|Parallel Assignment||Prevention||Single||||||t
1390740|NCT02413541|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1390741|NCT02413528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390742|NCT02413515||Single Group Assignment||Treatment||None (Open Label)||||||
1390743|NCT02413502||Single Group Assignment||Basic Science||None (Open Label)||||||
1390744|NCT02413489||Single Group Assignment||Treatment||None (Open Label)||||||
1390745|NCT02413476|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390746|NCT02413463|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1390747|NCT02413450|||Family-Based||Prospective|||||||
1390748|NCT02413437|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1390749|NCT02413424|Randomized|Factorial Assignment||Basic Science||Double|||t|||t
1390750|NCT02413411|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1390751|NCT02413398|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390752|NCT02413385|Randomized|Parallel Assignment||Prevention||Single|||||t|
1390753|NCT02413372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390754|NCT02413359|||Case-Only||Cross-Sectional|||||||
1390755|NCT02413346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390756|NCT02413333|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1390757|NCT02413320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390758|NCT02413307|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390759|NCT02413294||Single Group Assignment||Prevention||None (Open Label)||||||
1390760|NCT02413281|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1390761|NCT02413268|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1390762|NCT02413255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390763|NCT02413242|||Cohort||Prospective|||||||
1390764|NCT02413229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390765|NCT02413216|Randomized|Parallel Assignment||Treatment||Single||||||t
1390766|NCT02413203|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1390767|NCT02413190|||Case-Only||Cross-Sectional|||||||
1390768|NCT02413177|Randomized|Parallel Assignment||Treatment||Single||||||t
1390769|NCT02413164|Randomized|Crossover Assignment||Treatment||Single|||||t|
1390770|NCT02413151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390771|NCT02413138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390772|NCT02413125|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390773|NCT02413112|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390774|NCT02413099|Randomized|Parallel Assignment||Treatment||Double||||||
1390775|NCT02413086|Randomized|Factorial Assignment||Treatment||Single||||||t
1390776|NCT02413073|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1390777|NCT02413060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390778|NCT02413047||Single Group Assignment||Treatment||None (Open Label)||||||
1390779|NCT02413034|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1390780|NCT02413021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390781|NCT02413008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390782|NCT02412995|Randomized|Crossover Assignment||Prevention||Single|||||t|
1390783|NCT02412982|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390784|NCT02412969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390785|NCT02412956|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390786|NCT02412943||Single Group Assignment||Basic Science||None (Open Label)||||||
1390787|NCT02412930|Randomized|Parallel Assignment||Treatment||Single||||||t
1390788|NCT02412917|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1390789|NCT02412904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390790|NCT02412891|Randomized|Parallel Assignment||Prevention||Single|||t|||
1390791|NCT02412878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390792|NCT02412865|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390793|NCT02412852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390794|NCT02412839|||Case-Only||Cross-Sectional|||||||
1390795|NCT02412826|||Case-Only||Prospective|||||||
1390796|NCT02412813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390797|NCT02412800|||Cohort||Retrospective|||||||
1390798|NCT02412787||Single Group Assignment||Treatment||None (Open Label)||||||
1390799|NCT02412774|Randomized|Parallel Assignment||Treatment||Single||||||t
1390800|NCT02412761|Randomized|Crossover Assignment||Treatment||Single||||||t
1390801|NCT02412748|Randomized|Parallel Assignment||Other||Single|||t|||
1390802|NCT02412735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390803|NCT02412722|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390804|NCT02412709|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1390805|NCT02412696|Randomized|Parallel Assignment||Other||Single||||||t
1390806|NCT02412683|||Cohort||Prospective|||||||
1390807|NCT02412670|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390808|NCT02412657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390809|NCT02412644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390810|NCT02412631|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390811|NCT02412618|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390812|NCT02412605|||Case Control||Retrospective|||||||
1390813|NCT02412592|||Cohort||Prospective|||||||
1390814|NCT02412579|||Cohort||Prospective|||||||
1390815|NCT02412566||||||||||||
1390816|NCT02412553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390817|NCT02412540|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390818|NCT02412527|||Case-Only||Prospective|||||||
1390819|NCT02412514|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390820|NCT02412501||Single Group Assignment||Treatment||None (Open Label)||||||
1390821|NCT02412488||Single Group Assignment||Health Services Research||None (Open Label)||||||
1390822|NCT02412475||Single Group Assignment||Treatment||None (Open Label)||||||
1390823|NCT02412462||Single Group Assignment||Treatment||None (Open Label)||||||
1390824|NCT02412449|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1390825|NCT02412436||Single Group Assignment||Treatment||None (Open Label)||||||
1390826|NCT02412423||Single Group Assignment||Prevention||None (Open Label)||||||
1390827|NCT02412410||Single Group Assignment||Health Services Research||None (Open Label)||||||
1390828|NCT02412397|||Cohort||Cross-Sectional|||||||
1390829|NCT02412384|||Cohort||Prospective|||||||
1390830|NCT02412371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390831|NCT02412358|Randomized|Crossover Assignment||Prevention||Single||||||t
1390832|NCT02412345|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1390833|NCT02412332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390834|NCT02412319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390835|NCT02412306||Single Group Assignment||Treatment||None (Open Label)||||||
1390836|NCT02412293|Randomized|Single Group Assignment||Prevention||Single|||t|||
1390837|NCT02412280|||||Retrospective|||||||
1390838|NCT02412267||Single Group Assignment||Treatment||None (Open Label)||||||
1390839|NCT02412254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390840|NCT02412241||Single Group Assignment||Supportive Care||None (Open Label)||||||
1390841|NCT02412228||Single Group Assignment||Treatment||None (Open Label)||||||
1390842|NCT02412215||Single Group Assignment||||None (Open Label)||||||
1390843|NCT02412202||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390844|NCT02412189|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390845|NCT02412176|Randomized|Parallel Assignment||Prevention||Single|||t|||
1390846|NCT02412163|||Case-Only||Prospective|||||||
1390847|NCT02412150|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1390848|NCT02412137|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1390849|NCT02412124||Single Group Assignment||Supportive Care||None (Open Label)||||||
1390850|NCT02412111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390851|NCT02412098|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391613|NCT02402127|Randomized|Crossover Assignment||||Single||||||t
1390852|NCT02412085||Single Group Assignment||Treatment||None (Open Label)||||||
1390853|NCT02412072|||Cohort||Prospective|||||||
1390854|NCT02412059|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1390855|NCT02412046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390856|NCT02412033|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1390857|NCT02412020|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1390858|NCT02412007|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1390859|NCT02411994|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390860|NCT02411981||Single Group Assignment||Treatment||None (Open Label)||||||
1390861|NCT02411968|||Cohort||Prospective|||||||
1390862|NCT02411955|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390863|NCT02411942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390864|NCT02411929||Single Group Assignment||Treatment||None (Open Label)||||||
1390865|NCT02411916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390866|NCT02411903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390867|NCT02411890|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1390868|NCT02411877|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390869|NCT02411864|||Cohort||Prospective|||||||
1390870|NCT02411851|Randomized|Parallel Assignment||Treatment||Single||||t||
1390871|NCT02411838|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1390872|NCT02411825|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1390873|NCT02411812|Randomized|Parallel Assignment||Treatment||Single||||||t
1390874|NCT02411799|||Other||Prospective|||||||
1390875|NCT02411786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390876|NCT02411773|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1390877|NCT02411760|||Case-Only||Prospective|||||||
1390878|NCT02411747|Randomized|Parallel Assignment||||Double|||t||t|
1390879|NCT02411734|||Cohort||Prospective|||||||
1390880|NCT02411721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390881|NCT02411708|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390882|NCT02411695|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390883|NCT02411682|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1390884|NCT02411669|||Other||Cross-Sectional|||||||
1390885|NCT02411656||Single Group Assignment||Treatment||None (Open Label)||||||
1390886|NCT02411643||Single Group Assignment||Basic Science||None (Open Label)||||||
1390887|NCT02411630|||Case-Only||Retrospective|||||||
1390888|NCT02411617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390889|NCT02411604||||||||||||
1390890|NCT02411591||Single Group Assignment||Treatment||None (Open Label)||||||
1390891|NCT02411578|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390892|NCT02411565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390893|NCT02411552|||Cohort||Prospective|||||||
1390894|NCT02411539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390895|NCT02411526|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390896|NCT02411513||Single Group Assignment||Treatment||None (Open Label)||||||
1390897|NCT02411500|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390898|NCT02411487|||Case-Only||Prospective|||||||
1390899|NCT02411474|||Case Control||Prospective|||||||
1390900|NCT02411461|||Case-Control||Cross-Sectional|||||||
1390901|NCT02411448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390902|NCT02411435||Single Group Assignment||||None (Open Label)||||||
1390903|NCT02411422|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1390904|NCT02411409|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390905|NCT02411396|||Cohort||Prospective|||||||
1390906|NCT02411383||Single Group Assignment||Treatment||None (Open Label)||||||
1390907|NCT02411370|||Case-Only||Prospective|||||||
1390908|NCT02411357|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1390909|NCT02411344||Single Group Assignment||Treatment||None (Open Label)||||||
1390910|NCT02411331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390911|NCT02411318|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1390912|NCT02411305|||Cohort||Prospective|||||||
1390913|NCT02411292||Single Group Assignment||Other||None (Open Label)||||||
1390914|NCT02411279|||Cohort||Prospective|||||||
1390915|NCT02411266|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390916|NCT02411253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390917|NCT02411240||Single Group Assignment||Basic Science||None (Open Label)||||||
1390918|NCT02411227|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390919|NCT02411214|||Cohort||Prospective|||||||
1390920|NCT02411201||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390921|NCT02411188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390922|NCT02411175||Single Group Assignment||Treatment||None (Open Label)||||||
1390923|NCT02411162|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1390924|NCT02411149|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1390925|NCT02411136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390926|NCT02411123|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1390927|NCT02411110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390928|NCT02411097||Single Group Assignment||Prevention||Double|||t|||t
1390929|NCT02411084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390930|NCT02411071|||Cohort||Retrospective|||||||
1390931|NCT02411058|Randomized|Parallel Assignment||||Single|||t|||
1390932|NCT02411045|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1390933|NCT02411032|Randomized|Factorial Assignment||Prevention||Single|||t|||
1390934|NCT02411019|||Cohort||Prospective|||||||
1390935|NCT02411006|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1390936|NCT02410993|||Cohort||Prospective|||||||
1390937|NCT02410980||Single Group Assignment||Treatment||None (Open Label)||||||
1390938|NCT02410967|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1390939|NCT02410954|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1390940|NCT02410941|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1390941|NCT02410928|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1390942|NCT02410915|Randomized|Parallel Assignment||Treatment||Single||||||t
1390943|NCT02410902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390944|NCT02410889|||Case-Only|||||||||
1390945|NCT02410876|||Case-Control||Prospective|||||||
1390946|NCT02410863|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390947|NCT02410850|||Cohort||Prospective|||||||
1390948|NCT02410837|||Cohort||Prospective|||||||
1390949|NCT02410824|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1390950|NCT02410811|||Cohort||Prospective|||||||
1390951|NCT02410798||Single Group Assignment||Treatment||None (Open Label)||||||
1390952|NCT02410785|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390953|NCT02410772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390954|NCT02410759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1390955|NCT02410746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390956|NCT02410733||Single Group Assignment||Treatment||None (Open Label)||||||
1390957|NCT02410720|Randomized|Parallel Assignment||Prevention||Single||||||t
1390958|NCT02410707||Single Group Assignment||Treatment||None (Open Label)||||||
1390959|NCT02410694||Single Group Assignment||Treatment||None (Open Label)||||||
1390960|NCT02410681|||Cohort||Prospective|||||||
1390961|NCT02410668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390962|NCT02410655|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1390963|NCT02410642|||Cohort||Prospective|||||||
1390964|NCT02410629|Randomized|Crossover Assignment||Treatment||Single||||||t
1390965|NCT02410616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390966|NCT02410603|||Case-Only||Prospective|||||||
1390967|NCT02410590|Randomized|Parallel Assignment||||Double|||t||t|
1390968|NCT02410577||Single Group Assignment||Diagnostic||None (Open Label)||||||
1390969|NCT02410564|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1390970|NCT02410551||Single Group Assignment||Treatment||None (Open Label)||||||
1390971|NCT02410538|||||Prospective|||||||
1390972|NCT02410525|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1390973|NCT02410512|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1390974|NCT02410499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390975|NCT02410486|||Cohort||Prospective|||||||
1390976|NCT02410473|||Cohort||Prospective|||||||
1390977|NCT02410460|Randomized|Parallel Assignment||||Triple|||t|t||t
1390978|NCT02410447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1390979|NCT02410434||Single Group Assignment||||None (Open Label)||||||
1390980|NCT02410421|Randomized|Crossover Assignment||Treatment||Single||||t||
1390981|NCT02410408|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1390982|NCT02410395|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1390983|NCT02410382|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390984|NCT02410369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390985|NCT02410356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390986|NCT02410343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1390987|NCT02410330|||Case Control||Prospective|||||||
1390988|NCT02410317|Randomized|Parallel Assignment||Treatment||Single|||t|||
1390989|NCT02410304|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1390990|NCT02410291|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1390991|NCT02410278|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1390992|NCT02410265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390993|NCT02410252||Single Group Assignment||Other||None (Open Label)||||||
1390994|NCT02410239||Single Group Assignment||Treatment||None (Open Label)||||||
1390995|NCT02410226|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1390996|NCT02410213||Sequential Assignment||Treatment||None (Open Label)||Eligible subjects were enrolled sequentially in Cohort 1 (FCM at 7.5 mg/kg with a maximum single dose of 750 mg) and Cohort 2 (FCM at 15 mg/kg with a maximum single dose of 750 mg). Enrollment in Cohort 2 was initiated only after all subjects in Cohort 1 completed 4 weeks of therapy and a Data and Safety Monitoring Board (DSMB) approved continuation.||||
1390997|NCT02410200||Single Group Assignment||Treatment||None (Open Label)||||||
1390998|NCT02410187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1390999|NCT02410174||Single Group Assignment||Treatment||None (Open Label)||||||
1391000|NCT02410161||Single Group Assignment||Basic Science||None (Open Label)||||||
1391001|NCT02410148|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1391002|NCT02410135|||Cohort||Prospective|||||||
1391003|NCT02410122|||Cohort||Prospective|||||||
1391004|NCT02410109|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391005|NCT02410096|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1391006|NCT02410083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391007|NCT02410070|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1391008|NCT02410057|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1391009|NCT02410044|||Cohort||Prospective|||||||
1391010|NCT02410031|||Other||Other|||||||
1391011|NCT02410018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391012|NCT02410005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391013|NCT02409992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391014|NCT02409979|Randomized|Parallel Assignment||||Double|||t||t|
1391015|NCT02409966|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391016|NCT02409953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391017|NCT02409940|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1391018|NCT02409927||Single Group Assignment||Basic Science||Single||Each participant underwent 7 metabolic day (1-day visit), each visit separate by a minimum of 3 day|t|||
1391019|NCT02409914|||Cohort||Cross-Sectional|||||||
1391020|NCT02409901|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391021|NCT02409888|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1391022|NCT02409875|||Cohort||Prospective|||||||
1391023|NCT02409862|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1391024|NCT02409849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391025|NCT02409836|Randomized|Crossover Assignment||||None (Open Label)||||||
1391026|NCT02409823|||Cohort||Retrospective|||||||
1391027|NCT02409810||Single Group Assignment||Supportive Care||None (Open Label)||||||
1391028|NCT02409797||Single Group Assignment||Basic Science||None (Open Label)||||||
1391029|NCT02409784|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1391030|NCT02409771||Single Group Assignment||Treatment||None (Open Label)||||||
1391031|NCT02409758|Randomized|Parallel Assignment||Treatment||Single||||||t
1391032|NCT02409745|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1391033|NCT02409732||Single Group Assignment||Treatment||None (Open Label)||||||
1391034|NCT02409719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391035|NCT02409706|||Cohort||Prospective|||||||
1391036|NCT02409693|||Cohort||Retrospective|||||||
1391037|NCT02409680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391038|NCT02409667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391039|NCT02409654|Randomized|Parallel Assignment||Screening||Single||||||t
1391040|NCT02409641||Single Group Assignment||Basic Science||Double|||t||t|
1391041|NCT02409628||Single Group Assignment||Treatment||None (Open Label)||||||
1391042|NCT02409615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391043|NCT02409602|||Case Control||Prospective|||||||
1391044|NCT02409589|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391045|NCT02409576||Single Group Assignment||Treatment||None (Open Label)||||||
1391046|NCT02409563|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391047|NCT02409550|||Case-Only||Prospective|||||||
1391048|NCT02409537|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1391049|NCT02409524||Single Group Assignment||Treatment||None (Open Label)||||||
1391050|NCT02409511|||Case-Only||Prospective|||||||
1391051|NCT02409498|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1391052|NCT02409485|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391053|NCT02409472|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1391054|NCT02409459|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391055|NCT02409446|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391056|NCT02409433|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391057|NCT02409420|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1391058|NCT02409407|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1391059|NCT02409394|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1391060|NCT02409381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391061|NCT02409368||Single Group Assignment||Other||None (Open Label)||||||
1391062|NCT02409355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391063|NCT02409342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391064|NCT02409329|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1391065|NCT02409316||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391066|NCT02409303|Randomized|Sequential Assignment||Health Services Research||None (Open Label)||||||
1391067|NCT02409290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391068|NCT02409277|Randomized|Parallel Assignment||Prevention||Single|||t|||
1391069|NCT02409264||Single Group Assignment||Treatment||None (Open Label)||||||
1391070|NCT02409251||Single Group Assignment||Health Services Research||None (Open Label)||||||
1391071|NCT02409238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391072|NCT02409225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391073|NCT02409212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391074|NCT02409199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391075|NCT02409186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391076|NCT02409173|Randomized|Parallel Assignment||Treatment||Single||||||t
1391077|NCT02409160|Randomized|Parallel Assignment||Treatment||Single||||||t
1391078|NCT02409147||Single Group Assignment||Treatment||None (Open Label)||||||
1391079|NCT02409134|||Cohort||Prospective|||||||
1391080|NCT02409121||Single Group Assignment||Supportive Care||None (Open Label)||||||
1391081|NCT02409108||Single Group Assignment||Treatment||None (Open Label)||||||
1391082|NCT02409095|Randomized|Parallel Assignment||Prevention||Single||||||t
1391083|NCT02409082|||Cohort||Prospective|||||||
1391084|NCT02409069|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1391085|NCT02409056|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1391086|NCT02409043|||Case-Control||Prospective|||||||
1391087|NCT02409030|||Other||Prospective|||||||
1391088|NCT02409017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391089|NCT02409004||Single Group Assignment||Treatment||None (Open Label)||||||
1391090|NCT02408991||Single Group Assignment||Treatment||None (Open Label)||||||
1391091|NCT02408978|Randomized|Parallel Assignment||||None (Open Label)||||||
1391092|NCT02408965|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1391093|NCT02408952|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1391094|NCT02408939|||Other||Retrospective|||||||
1391095|NCT02408926|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391096|NCT02408913|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391097|NCT02408900|||Cohort||Cross-Sectional|||||||
1391098|NCT02408887|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391099|NCT02408874|||Cohort||Prospective|||||||
1391100|NCT02408861||Single Group Assignment||Treatment||None (Open Label)||||||
1391101|NCT02408848|||Cohort||Prospective|||||||
1391102|NCT02408835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391103|NCT02408822|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391104|NCT02408809|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1391105|NCT02408796||Single Group Assignment||Treatment||None (Open Label)||||||
1391106|NCT02408783|||Case-Only||Cross-Sectional|||||||
1391107|NCT02408770||Single Group Assignment||Prevention||None (Open Label)||||||
1391108|NCT02408757|||Cohort||Prospective|||||||
1391109|NCT02408744||Single Group Assignment||Treatment||None (Open Label)||||||
1391110|NCT02408731|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1391111|NCT02408718|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1391112|NCT02408705|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1391113|NCT02408692|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1391114|NCT02408679|||Cohort||Prospective|||||||
1391115|NCT02408666||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391116|NCT02408653|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1391117|NCT02408640|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391118|NCT02408627|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1391119|NCT02408614|||Case-Crossover||Prospective|||||||
1391120|NCT02408601|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1391121|NCT02408588|||Cohort||Prospective|||||||
1391122|NCT02408575|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391123|NCT02408562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391124|NCT02408549||Single Group Assignment||Treatment||None (Open Label)||||||
1391125|NCT02408536|||Cohort||Retrospective|||||||
1391126|NCT02408523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391127|NCT02408510|||Case-Only||Cross-Sectional|||||||
1391128|NCT02408497|||Case-Only||Prospective|||||||
1391129|NCT02408484||Single Group Assignment||Treatment||None (Open Label)||||||
1391130|NCT02408471||Single Group Assignment||Treatment||None (Open Label)||||||
1391131|NCT02408458||Single Group Assignment||Treatment||None (Open Label)||||||
1391132|NCT02408445|Randomized|Parallel Assignment||Treatment||Single||||||t
1391133|NCT02408432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391134|NCT02408419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391135|NCT02408406|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391136|NCT02408393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391137|NCT02408380|||Cohort||Prospective|||||||
1391138|NCT02408367|||Case-Crossover||Prospective|||||||
1391139|NCT02408354|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1391140|NCT02408341|||Case-Only||Prospective|||||||
1391141|NCT02408328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391142|NCT02408315|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1391143|NCT02408302|Randomized|Parallel Assignment||||None (Open Label)||||||
1391144|NCT02408289|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1391145|NCT02408276|||Cohort||Prospective|||||||
1391146|NCT02408263|||Cohort||Prospective|||||||
1391147|NCT02408250|||||Prospective|||||||
1391148|NCT02408237|Randomized|Crossover Assignment||Device Feasibility||Triple|||t||t|t
1391149|NCT02408224|||Other||Prospective|||||||
1391150|NCT02408198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391151|NCT02408185|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391152|NCT02408172|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391153|NCT02408159|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1391154|NCT02408146|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1391155|NCT02408133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391156|NCT02408120|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391157|NCT02408107|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391158|NCT02408094|||Case-Control||Cross-Sectional|||||||
1391159|NCT02408081|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1391160|NCT02408068|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1391161|NCT02408055||Single Group Assignment||Treatment||None (Open Label)||||||
1391162|NCT02408042|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391163|NCT02408029|||Case-Only||Cross-Sectional|||||||
1391164|NCT02408016|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391165|NCT02408003|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391166|NCT02407990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391167|NCT02407977|||Case-Only||Prospective|||||||
1391168|NCT02407964|||||Retrospective|||||||
1391169|NCT02407951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391170|NCT02407938||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391171|NCT02407925|||Cohort||Prospective|||||||
1391172|NCT02407912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391173|NCT02407899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391174|NCT02407886|||Cohort||Prospective|||||||
1391175|NCT02407873|||Cohort||Prospective|||||||
1391176|NCT02407860|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391177|NCT02407847|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391178|NCT02407834|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1391179|NCT02407821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391180|NCT02407808|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1391181|NCT02407795|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1391182|NCT02407782|Randomized|Parallel Assignment||Treatment||Single|||||t|
1391183|NCT02407769|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391184|NCT02407756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391185|NCT02407743|||Cohort||Prospective|||||||
1391186|NCT02407730|||Cohort||Prospective|||||||
1391187|NCT02407717|||Cohort||Prospective|||||||
1391188|NCT02407704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391189|NCT02407691|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1391190|NCT02407678|Randomized|Single Group Assignment||Treatment||None (Open Label)|The study is designated as Open Label with no masking. However, in order to minimise bias evaluation of the treated eye and untreated fellow eye (control eye), the ophthalmic assessments (visual acuity, microperimetry, fundus autofluorescence, etc.) will be conducted by an appropriately qualified masked observer once the participant's treated eye has had time to heal after the surgical procedure and has regained its normal appearance and function.|||||
1391191|NCT02407665|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391192|NCT02407652|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1391193|NCT02407639|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1391194|NCT02407626|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391195|NCT02407613||Single Group Assignment||Treatment||None (Open Label)||||||
1391196|NCT02407600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391197|NCT02407587|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1391198|NCT02407574|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1391199|NCT02407561|||Cohort||Prospective|||||||
1391200|NCT02407548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391201|NCT02407535||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391202|NCT02407522|Randomized|Parallel Assignment||Treatment||Single||||||t
1391203|NCT02407509|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391204|NCT02407496|||Case Control||Cross-Sectional|||||||
1391205|NCT02407483|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1391206|NCT02407470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391207|NCT02407457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391208|NCT02407444|Randomized|Parallel Assignment||Treatment||Single||||||t
1391209|NCT02407431|||Cohort||Prospective|||||||
1391210|NCT02407418|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1391211|NCT02407405||Single Group Assignment||Treatment||None (Open Label)||||||
1391212|NCT02407392|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1391213|NCT02407379|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1391214|NCT02407366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391215|NCT02407353|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1391216|NCT02407340|Randomized|Parallel Assignment||Basic Science||Quadruple|Double blind, placebo controlled|Oxytocin vs. placebo|t|t|t|t
1391217|NCT02407327|||Cohort||Prospective|||||||
1391218|NCT02407314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391219|NCT02407301|||Cohort||Prospective|||||||
1391220|NCT02407288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391221|NCT02407275||Single Group Assignment||Screening||None (Open Label)||||||
1391222|NCT02407262|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1391223|NCT02407249|||Case-Only||Other|||||||
1391224|NCT02407236|Randomized|Parallel Assignment||||Double|||t||t|
1391225|NCT02407223|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391226|NCT02407210|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1391227|NCT02407197|||Cohort||Prospective|||||||
1391228|NCT02407184|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1391229|NCT02407171|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391230|NCT02407158|||Cohort||Prospective|||||||
1391231|NCT02407145|||Case-Only||Prospective|||||||
1391232|NCT02407132|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1391233|NCT02407119|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1391234|NCT02407106||Single Group Assignment||Prevention||None (Open Label)||||||
1392703|NCT02387944|||Cohort||Prospective|||||||
1391235|NCT02407093|Randomized|Parallel Assignment||Prevention||Single||||||t
1391236|NCT02407080||Single Group Assignment||Treatment||None (Open Label)||||||
1391237|NCT02407067|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1391238|NCT02407054|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391239|NCT02407041||Single Group Assignment||Treatment||None (Open Label)||||||
1391240|NCT02407028|Randomized|Factorial Assignment||Treatment||Single||||||t
1391241|NCT02407015|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1391242|NCT02407002|||Cohort||Prospective|||||||
1391243|NCT02406989|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391244|NCT02406976|Randomized|Parallel Assignment||Treatment||Single||||||t
1391245|NCT02406963|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391246|NCT02406950|Randomized|Crossover Assignment||Prevention||Single|||||t|
1391247|NCT02406937|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1391248|NCT02406924|Randomized|Parallel Assignment||Treatment||Single||||||t
1391249|NCT02406911|Randomized|Crossover Assignment||Treatment||Single|||||t|
1391250|NCT02406898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391251|NCT02406885|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1391252|NCT02406872|Randomized|Parallel Assignment||||Double|||t|||t
1391253|NCT02406859|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1391254|NCT02406846|||Cohort||Prospective|||||||
1391255|NCT02406833||Single Group Assignment||Treatment||None (Open Label)||||||
1391256|NCT02406820|||Cohort||Prospective|||||||
1391257|NCT02406807|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1391258|NCT02406794|Randomized|Parallel Assignment||Treatment||Single|||||t|
1391259|NCT02406781||Single Group Assignment||Treatment||None (Open Label)||||||
1391260|NCT02406768|||Case Control||Prospective|||||||
1391261|NCT02406755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391262|NCT02406742|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391263|NCT02406729|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1391264|NCT02406716|||Case Control||Prospective|||||||
1391265|NCT02406703|||Case-Control||Prospective|||||||
1391266|NCT02406690|||Case-Control||Prospective|||||||
1391267|NCT02406677|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391268|NCT02406664|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1391269|NCT02406651||Single Group Assignment||Treatment||None (Open Label)||||||
1391270|NCT02406638|||Case-Only||Cross-Sectional|||||||
1391271|NCT02406625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391272|NCT02406612||Single Group Assignment||Supportive Care||None (Open Label)||||||
1391273|NCT02406599|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1391274|NCT02406586|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1391275|NCT02406573|Randomized|Single Group Assignment||Treatment||Single||||||t
1391276|NCT02406560|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1391277|NCT02406547|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1391278|NCT02406534|||Cohort||Prospective|||||||
1391279|NCT02406521|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391280|NCT02406508||Single Group Assignment||Treatment||None (Open Label)||||||
1391281|NCT02406495||Single Group Assignment||||None (Open Label)||||||
1391282|NCT02406482|Randomized|Parallel Assignment||Prevention||Single||||||t
1391283|NCT02406469|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1391284|NCT02406456||Single Group Assignment||Treatment||None (Open Label)||||||
1391285|NCT02406443|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1391286|NCT02406430|||Case-Only||Retrospective|||||||
1391287|NCT02406417||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391288|NCT02406404|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391289|NCT02406391|||Case-Only||Cross-Sectional|||||||
1391290|NCT02406365||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391291|NCT02406352||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391292|NCT02406339|Randomized|Parallel Assignment||Treatment||Single|||||t|
1391293|NCT02406326|||Other||Prospective|||||||
1391294|NCT02406313|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391295|NCT02406300|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1391296|NCT02406287|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391297|NCT02406274||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391298|NCT02406261|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1391299|NCT02406248||Single Group Assignment||Treatment||None (Open Label)||||||
1391300|NCT02406235|||Cohort||Prospective|||||||
1391301|NCT02406222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391302|NCT02406209|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1391303|NCT02406183||Single Group Assignment||Treatment||None (Open Label)||||||
1391304|NCT02406170||Single Group Assignment||Treatment||None (Open Label)||||||
1391305|NCT02406157|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391306|NCT02406144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391307|NCT02406131|Randomized|Parallel Assignment||Treatment||Double||||t||t
1391308|NCT02406118||Single Group Assignment||Treatment||None (Open Label)||||||
1391309|NCT02406105||Single Group Assignment||Treatment||None (Open Label)||||||
1391310|NCT02406092||Single Group Assignment||Treatment||None (Open Label)||||||
1391311|NCT02406079||Single Group Assignment||Screening||None (Open Label)||||||
1391312|NCT02406066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391313|NCT02406053|||Case-Only||Prospective|||||||
1391314|NCT02406040|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1391315|NCT02406027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391316|NCT02406014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391317|NCT02406001|Randomized|Parallel Assignment||Treatment||Single||||||t
1391318|NCT02405988||Single Group Assignment||Basic Science||None (Open Label)||||||
1391319|NCT02405975|Randomized|Parallel Assignment||||Single|||||t|
1391320|NCT02405962|Randomized|Parallel Assignment||Treatment||Single||||||t
1391321|NCT02405949|||Case Control||Retrospective|||||||
1391322|NCT02405936|||Cohort||Prospective|||||||
1391323|NCT02405923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391324|NCT02405910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391325|NCT02405897|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1391326|NCT02405884||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391327|NCT02405871||||||||||||
1391328|NCT02405858||Single Group Assignment||Treatment||None (Open Label)||||||
1391329|NCT02405845||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391330|NCT02405832|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1391331|NCT02405819|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391332|NCT02405806|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1391333|NCT02405793|Randomized|Parallel Assignment||Treatment||Single|||||t|
1391334|NCT02405780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391335|NCT02405767||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391336|NCT02405754|||Case-Only||Retrospective|||||||
1391337|NCT02405741||Single Group Assignment||Treatment||None (Open Label)||||||
1391338|NCT02405728|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1391339|NCT02405715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391340|NCT02405702|||||Retrospective|||||||
1391341|NCT02405689|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1391342|NCT02405676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391343|NCT02405663|Randomized|Parallel Assignment||Other||Single||||||t
1391344|NCT02405650|||Cohort||Prospective|||||||
1391345|NCT02405637|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1391346|NCT02405624||Single Group Assignment||Treatment||None (Open Label)||||||
1391347|NCT02405611|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1391348|NCT02405598||Single Group Assignment||Treatment||None (Open Label)||||||
1391349|NCT02405585||Single Group Assignment||Treatment||None (Open Label)||||||
1391350|NCT02405572|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1391351|NCT02405559||Single Group Assignment||Basic Science||None (Open Label)||||||
1391352|NCT02405546|Randomized|Single Group Assignment||Diagnostic||Single||||t||
1391353|NCT02405533|Randomized|Parallel Assignment||Treatment||Quadruple||Randomized, double-blind, placebo control phase II study that patients receive either AHCC or placebo.|t|t|t|t
1391354|NCT02405520|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1391355|NCT02405507|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1391356|NCT02405494|Randomized|Parallel Assignment||Basic Science||Single||||||t
1391357|NCT02405481|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391358|NCT02405468|||Case Control||Prospective|||||||
1391359|NCT02405455|Randomized|Parallel Assignment||Treatment||None (Open Label)||Cervical pessary vs. Cervical cerclage||||
1391360|NCT02405442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391361|NCT02405429|||Cohort||Cross-Sectional|||||||
1391362|NCT02405416|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1391363|NCT02405403||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391364|NCT02405390|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391365|NCT02405377|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1391366|NCT02405364||Single Group Assignment||Treatment||None (Open Label)||||||
1391367|NCT02405351||Single Group Assignment||Treatment||None (Open Label)||||||
1391368|NCT02405338||Single Group Assignment||Treatment||None (Open Label)||||||
1391369|NCT02405325|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391370|NCT02405312||Single Group Assignment||Supportive Care||None (Open Label)||||||
1391371|NCT02405299|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391372|NCT02405286|||Cohort||Prospective|||||||
1391373|NCT02405273|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391374|NCT02405260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391375|NCT02405247|||Cohort||Prospective|||||||
1391376|NCT02405234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391377|NCT02405221|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391378|NCT02405208|||Cohort||Prospective|||||||
1391379|NCT02405195|||Cohort||Prospective|||||||
1391380|NCT02405182|||Case-Control||Prospective|||||||
1391381|NCT02405169|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391382|NCT02405156|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1391383|NCT02405143|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391384|NCT02405130|Randomized|Parallel Assignment||||None (Open Label)||||||
1391385|NCT02405117|Randomized|Parallel Assignment||Treatment||Single||||||t
1391386|NCT02405104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391387|NCT02405091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391388|NCT02405078||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391389|NCT02405065||Single Group Assignment||Treatment||None (Open Label)||||||
1391390|NCT02405052|||Cohort||Cross-Sectional|||||||
1391391|NCT02405039|Randomized|Parallel Assignment||||Triple|||t|t|t|
1391392|NCT02405026|||Cohort||Prospective|||||||
1391393|NCT02405013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391394|NCT02405000||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391395|NCT02404987|||Cohort||Prospective|||||||
1391396|NCT02404974||Single Group Assignment||Prevention||None (Open Label)||||||
1391397|NCT02404961|||Case Control||Cross-Sectional|||||||
1391398|NCT02404948|||Cohort||Prospective|||||||
1391399|NCT02404935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391400|NCT02404922|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1391401|NCT02404909|||Cohort||Retrospective|||||||
1391402|NCT02404896||Single Group Assignment||Treatment||None (Open Label)||||||
1391403|NCT02404883|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391404|NCT02404870|Randomized|Crossover Assignment||Other||Single|||t|||
1391405|NCT02404857||Single Group Assignment||Basic Science||None (Open Label)||||||
1391406|NCT02404844||Single Group Assignment||Treatment||None (Open Label)||||||
1391407|NCT02404831|Randomized|Parallel Assignment||Treatment||Single||||||t
1391408|NCT02404818|||Cohort||Prospective|||||||
1391409|NCT02404805|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1391410|NCT02404792|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1391411|NCT02404779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391412|NCT02404766|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1391413|NCT02404753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391414|NCT02404740|||Cohort||Prospective|||||||
1391415|NCT02404727|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391416|NCT02404714|||Case-Only||Cross-Sectional|||||||
1391417|NCT02404701|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1391418|NCT02404688|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1391419|NCT02404675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391420|NCT02404662|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1391421|NCT02404649|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391422|NCT02404636|||Cohort||Prospective|||||||
1391423|NCT02404623|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1391424|NCT02404610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391425|NCT02404597|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391426|NCT02404584|||Cohort||Prospective|||||||
1391427|NCT02404571||Single Group Assignment||Treatment||None (Open Label)||||||
1391428|NCT02404558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391429|NCT02404545|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391430|NCT02404532||Single Group Assignment||Treatment||None (Open Label)||||||
1391431|NCT02404519|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1391432|NCT02404506||Single Group Assignment||Treatment||None (Open Label)||||||
1391433|NCT02404493|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1391434|NCT02404480|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label, first-in-human, safety and pharmacokinetic (PK)||||
1391435|NCT02404467|||Other||Prospective|||||||
1391436|NCT02404454||Single Group Assignment||Prevention||None (Open Label)||||||
1391437|NCT02404441|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391438|NCT02404428|Randomized|Parallel Assignment||||Double|||t||t|
1391439|NCT02404415|||Cohort||Prospective|||||||
1391440|NCT02404402|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391441|NCT02404389|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391442|NCT02404376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391443|NCT02404363|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391444|NCT02404350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391445|NCT02404337|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1391446|NCT02404324||Single Group Assignment||Treatment||None (Open Label)||||||
1391447|NCT02404311|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1391448|NCT02404298||Single Group Assignment||Treatment||None (Open Label)||||||
1391449|NCT02404285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391450|NCT02404272|||Other||Prospective|||||||
1391451|NCT02404259|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1391452|NCT02404246|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391453|NCT02404233||Single Group Assignment||Treatment||None (Open Label)||||||
1391454|NCT02404220||Single Group Assignment||Treatment||None (Open Label)||||||
1391455|NCT02404207|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1391456|NCT02404194|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391457|NCT02404181|||Cohort||Prospective|||||||
1391458|NCT02404168|Non-Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1391459|NCT02404155||Single Group Assignment||Treatment||None (Open Label)||||||
1391460|NCT02404142|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1391461|NCT02404129|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1391462|NCT02404116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391463|NCT02404103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391464|NCT02404090|||Cohort||Prospective|||||||
1391465|NCT02404077|||Cohort||Retrospective|||||||
1393097|NCT02382822|||Cohort||Prospective|||||||
1391466|NCT02404064|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391467|NCT02404051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391468|NCT02404038|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1391469|NCT02404025||Single Group Assignment||Treatment||None (Open Label)||||||
1391470|NCT02404012|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391471|NCT02403999|Randomized|Parallel Assignment||Basic Science||Single||||||t
1391472|NCT02403986|Randomized|Parallel Assignment||Treatment||Single||||||t
1391473|NCT02403973|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391474|NCT02403960|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391475|NCT02403947|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1391476|NCT02403934|||Cohort||Prospective|||||||
1391477|NCT02403921|||||Prospective|||||||
1391478|NCT02403908|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391479|NCT02403895||Single Group Assignment||Treatment||None (Open Label)||||||
1391480|NCT02403882|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391481|NCT02403869|||Cohort||Prospective|||||||
1391482|NCT02403856|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391483|NCT02403843|||Cohort||Prospective|||||||
1391484|NCT02403830|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1391485|NCT02403817|Randomized|Single Group Assignment||Treatment||None (Open Label)||This project develops the intervention and includes a small clinical (behavioral) trial for ASD participants. A small number of ASD participants will be randomly assigned to intervention 'games' played by mouse response--the others to gaze-driven response.||||
1391486|NCT02403804||Single Group Assignment||Other||None (Open Label)||||||
1391487|NCT02403791|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1391488|NCT02403778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391489|NCT02403765|||Family-Based||Cross-Sectional|||||||
1391490|NCT02403752||Single Group Assignment||Treatment||None (Open Label)||||||
1391491|NCT02403739|||Cohort||Cross-Sectional|||||||
1391492|NCT02403726|||||Retrospective|||||||
1391493|NCT02403713|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1391494|NCT02403700|||Cohort||Prospective|||||||
1391495|NCT02403687|||Case-Only||Prospective|||||||
1391496|NCT02403674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391497|NCT02403661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391498|NCT02403648|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1391499|NCT02403635||Single Group Assignment||||None (Open Label)||||||
1391500|NCT02403622||Single Group Assignment||Treatment||None (Open Label)||||||
1391501|NCT02403609||Single Group Assignment||||None (Open Label)||||||
1391502|NCT02403596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391503|NCT02403583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391504|NCT02403570|||Case-Only||Prospective|||||||
1391505|NCT02403557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391506|NCT02403544||Single Group Assignment||Treatment||None (Open Label)||||||
1391507|NCT02403531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391508|NCT02403518|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391509|NCT02403505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391510|NCT02403492|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1391511|NCT02403479|Randomized|Crossover Assignment||Treatment||Single|||t|||
1391512|NCT02403466||Single Group Assignment||Health Services Research||Single||||||t
1391513|NCT02403453|||Cohort||Prospective|||||||
1391514|NCT02403440||Single Group Assignment||Treatment||None (Open Label)||||||
1391515|NCT02403427|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1391516|NCT02403414|||Cohort||Cross-Sectional|||||||
1391517|NCT02403401||Single Group Assignment||Prevention||None (Open Label)||||||
1391518|NCT02403388|||||Prospective|||||||
1391519|NCT02403375||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391520|NCT02403362|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1391521|NCT02403349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391522|NCT02403336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391523|NCT02403323|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391524|NCT02403310||Single Group Assignment||Treatment||None (Open Label)||||||
1391525|NCT02403297|||Case Control||Cross-Sectional|||||||
1391526|NCT02403284|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1391527|NCT02403271||Single Group Assignment||Treatment||None (Open Label)||||||
1391528|NCT02403258|Randomized|Parallel Assignment||Treatment||Single||||||t
1391529|NCT02403245|Randomized|Parallel Assignment||||Single|||t|||
1391530|NCT02403232|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391531|NCT02403219|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1391532|NCT02403206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391533|NCT02403193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391534|NCT02403180|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1391535|NCT02403167||||||||||||
1391536|NCT02403154|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391537|NCT02403141|||Other||Prospective|||||||
1391538|NCT02403128||Single Group Assignment||Treatment||None (Open Label)||||||
1391539|NCT02403115|||Cohort||Prospective|||||||
1391540|NCT02403102|||Cohort||Prospective|||||||
1391541|NCT02403089|||Other||Prospective|||||||
1391542|NCT02403076|||||Prospective|||||||
1393564|NCT02376738|||Case-Only||Prospective|||||||
1391543|NCT02403063|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1391544|NCT02403050|||Case Control|||||||||
1391545|NCT02403037|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1391546|NCT02403024|Randomized|Parallel Assignment||Treatment||Single||||||t
1391547|NCT02403011|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391548|NCT02402998||Single Group Assignment||Treatment||None (Open Label)||||||
1391549|NCT02402985|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1391550|NCT02402972|Randomized|Parallel Assignment||Treatment||Single||||||t
1391551|NCT02402959|||Cohort||Prospective|||||||
1391552|NCT02402946|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391553|NCT02402933||Single Group Assignment||Treatment||None (Open Label)||||||
1391554|NCT02402920|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391555|NCT02402907|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1391556|NCT02402894|||Cohort||Prospective|||||||
1391557|NCT02402881||Single Group Assignment||Treatment||None (Open Label)||||||
1391558|NCT02402868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391559|NCT02402855|Randomized|Parallel Assignment||||None (Open Label)||||||
1391560|NCT02402842||Single Group Assignment||Treatment||None (Open Label)||||||
1391561|NCT02402829|||Case-Only||Prospective|||||||
1391562|NCT02402816|Randomized|Parallel Assignment||||None (Open Label)||||||
1391563|NCT02402803|||Cohort||Prospective|||||||
1391564|NCT02402764||Single Group Assignment||Treatment||None (Open Label)||||||
1391565|NCT02402751||Single Group Assignment||||None (Open Label)||||||
1391566|NCT02402738|Randomized|Parallel Assignment||Treatment||Single||||||t
1391567|NCT02402725||Single Group Assignment||Treatment||None (Open Label)||||||
1391568|NCT02402712||Single Group Assignment||Treatment||None (Open Label)||||||
1391569|NCT02402699|||Case-Only||Prospective|||||||
1391570|NCT02402686|||Cohort||Prospective|||||||
1391571|NCT02402673||Single Group Assignment||Treatment||None (Open Label)||||||
1391572|NCT02402660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391573|NCT02402647|Randomized|Parallel Assignment||Treatment||Single||Cognitive rehabilitation and exposure/sorting therapy (CREST) versus Exposure therapy only||||t
1391574|NCT02402634|||Case Control||Prospective|||||||
1391575|NCT02402621|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391576|NCT02402608|Randomized|Parallel Assignment||||Double|||t||t|
1391577|NCT02402595|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1391578|NCT02402582|Randomized|Parallel Assignment||Supportive Care||Triple||"All patients had similar inpatient rehabilitation programs. Both groups exercised for 0-2h/day. Walking distance was measured using a Fitbit (Fitbit, San Francisco, USA). Routine care included education on smoking cessation and education on food selection.~FCEM: Daily exercise occurred between 8-10 AM and was supervised by designated family members. Investigators randomly attended sessions in an unannounced fashion. Physical therapy consultation was available on investigator request. Exercise data were independently collected from the patient and their designated family member on a weekly basis (κ statistic=0.9).~Control: Patients exercised daily, at any time. Sessions were supervised by family members. Investigators did not attend sessions. Exercise data were independently collected from the patient and their designated family member on a weekly basis (κ statistic=0.4)."|t||t|t
1391579|NCT02402569|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1391580|NCT02402556|Randomized|Parallel Assignment||||None (Open Label)||||||
1391581|NCT02402543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391582|NCT02402530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391583|NCT02402517|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1391584|NCT02402504|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1391585|NCT02402491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391586|NCT02402478|||Cohort||Prospective|||||||
1391587|NCT02402465|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1391588|NCT02402452|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391589|NCT02402439||Single Group Assignment||Treatment||None (Open Label)||||||
1391590|NCT02402426|||Cohort||Prospective|||||||
1391591|NCT02402413||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391592|NCT02402400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391593|NCT02402387|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1391594|NCT02402374|Randomized|Parallel Assignment||Treatment||Single||||||t
1391595|NCT02402361|||Cohort||Prospective|||||||
1391596|NCT02402348||Single Group Assignment||Basic Science||None (Open Label)||||||
1391597|NCT02402335|||Case Control||Prospective|||||||
1391598|NCT02402322|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391599|NCT02402309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391600|NCT02402296|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1391601|NCT02402283|Randomized|Crossover Assignment||||None (Open Label)||||||
1391602|NCT02402270|Randomized|Parallel Assignment||Other||Single|||||t|
1391603|NCT02402257|||Cohort||Other|||||||
1391604|NCT02402244||||||||||||
1391605|NCT02402231||Single Group Assignment||Treatment||None (Open Label)||||||
1391606|NCT02402218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391607|NCT02402205|Randomized|Parallel Assignment||||Double|||t|||t
1391608|NCT02402192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391609|NCT02402179||Single Group Assignment||Health Services Research||None (Open Label)||||||
1391610|NCT02402166||Single Group Assignment||Treatment||None (Open Label)||||||
1391611|NCT02402153||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1391612|NCT02402140|Randomized|Parallel Assignment||||None (Open Label)||||||
1391614|NCT02402114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391615|NCT02402101|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1391616|NCT02402088|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1391617|NCT02402075|||Case-Only||Prospective|||||||
1391618|NCT02402062||Single Group Assignment||Treatment||None (Open Label)||||||
1391619|NCT02402049|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1391620|NCT02402036||Single Group Assignment||Basic Science||None (Open Label)||||||
1391621|NCT02402023|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1391622|NCT02402010|Randomized|Parallel Assignment||Treatment||Single||||||t
1391623|NCT02401997|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391624|NCT02401984|||Cohort||Cross-Sectional|||||||
1391625|NCT02401971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391626|NCT02401958|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391627|NCT02401945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391628|NCT02401932|||Cohort||Retrospective|||||||
1391629|NCT02401919|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1391630|NCT02401906|||Cohort||Prospective|||||||
1391631|NCT02401893|||Cohort||Prospective|||||||
1391632|NCT02401880|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1391633|NCT02401867|||Other||Cross-Sectional|||||||
1391634|NCT02401854|||Cohort||Prospective|||||||
1391635|NCT02401841|||Case Control||Prospective|||||||
1391636|NCT02401828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391637|NCT02401815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391638|NCT02401802|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1391639|NCT02401789|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391640|NCT02401776|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1391641|NCT02401763|||||Retrospective|||||||
1391642|NCT02401750|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391643|NCT02401737|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1391644|NCT02401724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391645|NCT02401711|Randomized|Parallel Assignment||Other||Single|||t|||
1391646|NCT02401698|||Case-Only||Prospective|||||||
1391647|NCT02401685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391648|NCT02401672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391649|NCT02401659|||Cohort||Prospective|||||||
1391650|NCT02401646|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1391651|NCT02401633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391652|NCT02401620|||Cohort||Cross-Sectional|||||||
1391653|NCT02401607|||||Prospective|||||||
1391654|NCT02401594|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1391655|NCT02401581||Single Group Assignment||Prevention||None (Open Label)||||||
1391656|NCT02401568|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1391657|NCT02401555|||Case-Control||Prospective|||||||
1391658|NCT02401542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391659|NCT02401529|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1391660|NCT02401516|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391661|NCT02401503||Single Group Assignment||Treatment||None (Open Label)||||||
1391662|NCT02401490|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391663|NCT02401477||Single Group Assignment||Treatment||None (Open Label)||||||
1391664|NCT02401464|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1391665|NCT02401451||Single Group Assignment||Screening||None (Open Label)||||||
1391666|NCT02401438|||Cohort||Prospective|||||||
1391667|NCT02401425|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1391668|NCT02401412|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1391669|NCT02401399|Randomized|Parallel Assignment||Prevention||Single||||||t
1391670|NCT02401386|Randomized|Parallel Assignment||Treatment||Single||||||t
1391671|NCT02401373|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1391672|NCT02401360|Randomized|Parallel Assignment||Treatment||Single||||||t
1391673|NCT02401347|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391674|NCT02401334||Single Group Assignment||Treatment||None (Open Label)||||||
1391675|NCT02401321||Single Group Assignment||Supportive Care||None (Open Label)||||||
1391676|NCT02401308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391677|NCT02401295||Single Group Assignment||Treatment||None (Open Label)||||||
1391678|NCT02401282|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1391679|NCT02401269|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1391680|NCT02401256||Single Group Assignment||Treatment||None (Open Label)||||||
1391681|NCT02401243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391682|NCT02401230|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391683|NCT02401217|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1391684|NCT02401204|||Other||Prospective|||||||
1391685|NCT02401191||Single Group Assignment||Treatment||None (Open Label)||||||
1391686|NCT02401178|||Other||Prospective|||||||
1391687|NCT02401165||Single Group Assignment||Basic Science||Single|||t|||
1391688|NCT02401152|Randomized|Crossover Assignment||||Triple|||t||t|t
1391689|NCT02401139|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391690|NCT02401126|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1391691|NCT02401113|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1391692|NCT02401100|||Cohort||Prospective|||||||
1391693|NCT02401087|||Cohort||Prospective|||||||
1391694|NCT02401074||Single Group Assignment||Prevention||None (Open Label)||||||
1391695|NCT02401061||Single Group Assignment||Treatment||None (Open Label)||||||
1391696|NCT02401048|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1391697|NCT02401035||Single Group Assignment||Treatment||None (Open Label)||||||
1391698|NCT02401022|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1391699|NCT02401009|||Other||Other|||||||
1391700|NCT02400996|||Cohort||Prospective|||||||
1391701|NCT02400983|||Case-Only||Retrospective|||||||
1391702|NCT02400970||||||||||||
1391703|NCT02400957|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1391704|NCT02400944|||Cohort||Prospective|||||||
1391705|NCT02400931|Randomized|Parallel Assignment||Prevention||Single|||t|||
1391706|NCT02400918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391707|NCT02400905||Single Group Assignment||Treatment||None (Open Label)||||||
1391708|NCT02400892|||Cohort||Prospective|||||||
1391709|NCT02400879|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1391710|NCT02400866|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391711|NCT02400853|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1391712|NCT02400840|Non-Randomized|Parallel Assignment||Screening||Single||||||t
1391713|NCT02400827||||||||||||
1391714|NCT02400814|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391715|NCT02400801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391716|NCT02400788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391717|NCT02400775||Single Group Assignment||Treatment||None (Open Label)||||||
1391718|NCT02400762|||Cohort||Prospective|||||||
1391719|NCT02400749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391720|NCT02400736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391721|NCT02400723|Randomized|Parallel Assignment||Treatment||Single||||||t
1391722|NCT02400710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391723|NCT02400697|||Cohort||Prospective|||||||
1391724|NCT02400684|||Case-Only||Prospective|||||||
1391725|NCT02400671|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391726|NCT02400658||Single Group Assignment||Treatment||None (Open Label)||||||
1391727|NCT02400645|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1391728|NCT02400632||Single Group Assignment||Treatment||None (Open Label)||||||
1391729|NCT02400619|Randomized|Crossover Assignment||Treatment||Single||||||t
1391730|NCT02400606|Randomized|Parallel Assignment||||Single||||||t
1391731|NCT02400593|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1391732|NCT02400580|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1391733|NCT02400567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391734|NCT02400554|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1391735|NCT02400541|Randomized|Parallel Assignment||Treatment||Single||||t||
1391736|NCT02400528|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1391737|NCT02400515||Single Group Assignment||||None (Open Label)||||||
1391738|NCT02400502||Single Group Assignment||Treatment||None (Open Label)||||||
1391739|NCT02400489|||Case-Only|||||||||
1391740|NCT02400476|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391741|NCT02400463||Single Group Assignment||Treatment||None (Open Label)||||||
1391742|NCT02400450|Randomized|Parallel Assignment||Other||Double|||t||t|
1391743|NCT02400437||Single Group Assignment||Treatment||None (Open Label)||||||
1391744|NCT02400424||Single Group Assignment||Treatment||None (Open Label)||||||
1391745|NCT02400411|Randomized|Crossover Assignment||||Single||||||t
1391746|NCT02400398|||Cohort||Prospective|||||||
1391747|NCT02400385||Single Group Assignment||Treatment||None (Open Label)||||||
1391748|NCT02400372|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391749|NCT02400359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391750|NCT02400346||Single Group Assignment||Treatment||None (Open Label)||||||
1391751|NCT02400333|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1391752|NCT02400320|Randomized|Parallel Assignment||Other||Single||||||t
1391753|NCT02400307|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391754|NCT02400294|||||Cross-Sectional|||||||
1391755|NCT02400281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391756|NCT02400268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391757|NCT02400255|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391758|NCT02400242||Single Group Assignment||Treatment||None (Open Label)||||||
1391759|NCT02400229|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1391760|NCT02400216|||Case-Only||Cross-Sectional|||||||
1391761|NCT02400203|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1391762|NCT02400190||Single Group Assignment||Treatment||None (Open Label)||||||
1391763|NCT02400177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391764|NCT02400164||Single Group Assignment||Treatment||None (Open Label)||||||
1391765|NCT02400151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391766|NCT02400138|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391767|NCT02400125|||Cohort||Prospective|||||||
1391768|NCT02400112|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391769|NCT02400099|Randomized|Parallel Assignment||Treatment||Single||||||t
1391770|NCT02400086|||Case-Only||Prospective|||||||
1391771|NCT02400073||Single Group Assignment||Treatment||None (Open Label)||||||
1391772|NCT02400060||Single Group Assignment||Supportive Care||None (Open Label)||||||
1391773|NCT02400047|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391774|NCT02400034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391775|NCT02400021|Randomized|Parallel Assignment||Treatment||Single||||||t
1391776|NCT02400008||Single Group Assignment||Treatment||None (Open Label)||||||
1391777|NCT02399995|||Cohort||Prospective|||||||
1391778|NCT02399982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391779|NCT02399969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391780|NCT02399956|||Case Control||Prospective|||||||
1391781|NCT02399943||Single Group Assignment||Treatment||None (Open Label)||||||
1391782|NCT02399930|||||Prospective|||||||
1391783|NCT02399917||Single Group Assignment||Treatment||None (Open Label)||||||
1391784|NCT02399904|Randomized|Single Group Assignment||Treatment||Single|||||t|
1391785|NCT02399891|||Cohort||Prospective|||||||
1391786|NCT02399878|||Cohort||Prospective|||||||
1391787|NCT02399865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391788|NCT02399852|||Other||Prospective|||||||
1391789|NCT02399839|||Other||Prospective|||||||
1391790|NCT02399826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391791|NCT02399813||Single Group Assignment||Treatment||None (Open Label)||||||
1391792|NCT02399800|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391793|NCT02399787|||Case-Control||Prospective|||||||
1391794|NCT02399774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391795|NCT02399761|||Cohort||Prospective|||||||
1391796|NCT02399748|||Case-Only||Prospective|||||||
1391797|NCT02399735|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391798|NCT02399722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391799|NCT02399709|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1391800|NCT02399696|Randomized|Parallel Assignment||Treatment||Single||||||t
1391801|NCT02399683|||Case-Only|||||||||
1391802|NCT02399670|||Cohort||Prospective|||||||
1391803|NCT02399657||Single Group Assignment||Treatment||None (Open Label)||||||
1391804|NCT02399644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391805|NCT02399631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391806|NCT02399618||Single Group Assignment||Treatment||None (Open Label)||||||
1391807|NCT02399605|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391808|NCT02399592||Single Group Assignment||Treatment||None (Open Label)||||||
1391809|NCT02399579||Single Group Assignment||||None (Open Label)||||||
1391810|NCT02399566|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1391811|NCT02399553|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391812|NCT02399540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391813|NCT02399527|||Cohort||Prospective|||||||
1391814|NCT02399514||Single Group Assignment||Basic Science||None (Open Label)||||||
1391815|NCT02399501||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391816|NCT02399488|||Case-Only||Prospective|||||||
1391817|NCT02399475|Randomized|Crossover Assignment||Other||Double|||t||t|
1391818|NCT02399462||Single Group Assignment||Treatment||None (Open Label)||||||
1391819|NCT02399449|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1391820|NCT02399436|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1391821|NCT02399423|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1391822|NCT02399410||Single Group Assignment||Treatment||None (Open Label)||||||
1391823|NCT02399397|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391824|NCT02399384|||Case Control||Cross-Sectional|||||||
1391825|NCT02399371||Single Group Assignment||Treatment||None (Open Label)||||||
1391826|NCT02399358|||Cohort||Prospective|||||||
1391827|NCT02399345||Single Group Assignment||Treatment||None (Open Label)||||||
1391828|NCT02399332|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391829|NCT02399319|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391830|NCT02399306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391831|NCT02399293|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391832|NCT02399280|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391833|NCT02399267|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1391834|NCT02399254|||Cohort||Prospective|||||||
1391835|NCT02399241||Single Group Assignment||Health Services Research||None (Open Label)||||||
1391836|NCT02399228||Single Group Assignment||Prevention||None (Open Label)||||||
1391837|NCT02399215||Single Group Assignment||Treatment||None (Open Label)||||||
1391838|NCT02399202||Single Group Assignment||Treatment||None (Open Label)||||||
1391839|NCT02399189||Single Group Assignment||Treatment||None (Open Label)||||||
1391840|NCT02399176||Single Group Assignment||Treatment||None (Open Label)||||||
1391841|NCT02399163|Randomized|Crossover Assignment||Treatment||Single||||||t
1391842|NCT02399150|||Cohort||Prospective|||||||
1391843|NCT02399137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391844|NCT02399124||Single Group Assignment||Treatment||None (Open Label)||||||
1391845|NCT02399111|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391846|NCT02399098|Randomized|Parallel Assignment||||Single|||t|||
1391847|NCT02399085||Single Group Assignment||Treatment||None (Open Label)||||||
1391848|NCT02399072||Single Group Assignment||Other||None (Open Label)||||||
1391849|NCT02399059|Randomized|Parallel Assignment||Prevention||Single||||||t
1391850|NCT02399046|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391851|NCT02399033|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391852|NCT02399020||Single Group Assignment||Treatment||None (Open Label)||||||
1391853|NCT02399007|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391854|NCT02398994|Randomized|Parallel Assignment||Treatment||Single||||||t
1391855|NCT02398981|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1391856|NCT02398968|Randomized|Parallel Assignment||Prevention||Single|||t|||
1391857|NCT02398955|||Case-Only||Prospective|||||||
1391858|NCT02398942|||Cohort||Prospective|||||||
1391859|NCT02398929||Single Group Assignment||Treatment||None (Open Label)||||||
1391860|NCT02398916|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391861|NCT02398903|||Cohort||Prospective|||||||
1391862|NCT02398890|||Cohort||Prospective|||||||
1391863|NCT02398877|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1391864|NCT02398864||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391865|NCT02398851|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391866|NCT02398838|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391867|NCT02398825||Single Group Assignment||Treatment||None (Open Label)||||||
1391868|NCT02398812|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391869|NCT02398799|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391870|NCT02398786|||Cohort||Prospective|||||||
1391871|NCT02398773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391872|NCT02398760||Single Group Assignment||Treatment||None (Open Label)||||||
1391873|NCT02398747||Single Group Assignment||Treatment||None (Open Label)||||||
1391874|NCT02398734|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1391875|NCT02398721|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391876|NCT02398708|||Case-Control||Cross-Sectional|||||||
1391877|NCT02398695|||Case-Control||Cross-Sectional|||||||
1391878|NCT02398682|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1391879|NCT02398669||Single Group Assignment||Treatment||None (Open Label)||||||
1391880|NCT02398656|Randomized|Parallel Assignment||Treatment||Single||||||t
1391881|NCT02398643|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391882|NCT02398630||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391883|NCT02398617||Single Group Assignment||Supportive Care||None (Open Label)||||||
1391884|NCT02398604|Randomized|Parallel Assignment||Treatment||None (Open Label)|HLHS patients which will be randomized to the treatment and control arms in a 1:1 ratio|20 patients and 10 patients will be controls with a total of 30 HLHS patients.||||
1391885|NCT02398591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391886|NCT02398578||Single Group Assignment||Other||None (Open Label)||||||
1391887|NCT02398565|||Cohort||Retrospective|||||||
1391888|NCT02398552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391889|NCT02398539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391890|NCT02398526|||Cohort||Prospective|||||||
1391891|NCT02398513||Single Group Assignment||Treatment||None (Open Label)||||||
1391892|NCT02398500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391893|NCT02398487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391894|NCT02398474|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391895|NCT02398461|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1391896|NCT02398448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391897|NCT02398435|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391898|NCT02398422|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1391899|NCT02398409|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1391900|NCT02398396||Single Group Assignment||Basic Science||None (Open Label)||||||
1391901|NCT02398383|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1391902|NCT02398370||Single Group Assignment||Treatment||None (Open Label)||||||
1391903|NCT02398357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391904|NCT02398344|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1391905|NCT02398331|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391906|NCT02398318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391907|NCT02398305|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1391908|NCT02398292|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391909|NCT02398279|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1391910|NCT02398266|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1391911|NCT02398253|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391912|NCT02398240|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391913|NCT02398227|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1391914|NCT02398214|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1391915|NCT02398201||Single Group Assignment||Other||None (Open Label)||||||
1391916|NCT02398188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391917|NCT02398175|||||Retrospective|||||||
1391918|NCT02398162|||Cohort||Prospective|||||||
1391919|NCT02398149|||Cohort||Cross-Sectional|||||||
1391920|NCT02398136|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391921|NCT02398123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391922|NCT02398110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391923|NCT02398097|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391924|NCT02398084||Single Group Assignment||||None (Open Label)||||||
1391925|NCT02398071|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1391926|NCT02398058||Single Group Assignment||Treatment||None (Open Label)||||||
1391927|NCT02398045||Single Group Assignment||Treatment||None (Open Label)||||||
1391928|NCT02398032|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1391929|NCT02398019|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391930|NCT02398006|Randomized|Single Group Assignment||Treatment||Single||||||t
1391931|NCT02397993|||Cohort||Prospective|||||||
1391932|NCT02397980|Randomized|Crossover Assignment||Supportive Care||Double|||||t|t
1391933|NCT02397967|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1391934|NCT02397954||Single Group Assignment||Treatment||None (Open Label)||||||
1391935|NCT02397941|||Cohort||Prospective|||||||
1391936|NCT02397928||Single Group Assignment||Treatment||None (Open Label)||||||
1391937|NCT02397915|Randomized|Crossover Assignment||Other||Double|||t||t|
1391938|NCT02397902|Randomized|Crossover Assignment||Treatment||Single|||||t|
1391939|NCT02397889|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391940|NCT02397876|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1391941|NCT02397863||||||||||||
1391942|NCT02397850||Single Group Assignment||Treatment||None (Open Label)||||||
1391943|NCT02397837|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391944|NCT02397824|||Cohort||Prospective|||||||
1391945|NCT02397811|Randomized|Crossover Assignment||||Double|||t||t|
1391946|NCT02397798|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1391947|NCT02397785|Randomized|Parallel Assignment||Treatment||Single|||t|||
1391948|NCT02397772|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391949|NCT02397759|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1391950|NCT02397746|||Cohort||Prospective|||||||
1391951|NCT02397733|Randomized|Parallel Assignment||Prevention||Single|||t|||
1391952|NCT02397720|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391953|NCT02397707|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391954|NCT02397694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391955|NCT02397681||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391956|NCT02397668||Single Group Assignment||Treatment||None (Open Label)||||||
1391957|NCT02397655|||Case-Only||Cross-Sectional|||||||
1391958|NCT02397642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391959|NCT02397629|||Cohort||Prospective|||||||
1391960|NCT02397616|||Cohort||Retrospective|||||||
1391961|NCT02397603|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1391962|NCT02397590|Randomized|Crossover Assignment||||None (Open Label)||||||
1391963|NCT02397577||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391964|NCT02397564||Single Group Assignment||Treatment||None (Open Label)||||||
1391965|NCT02397551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391966|NCT02397538|Randomized|Crossover Assignment||||None (Open Label)||||||
1391967|NCT02397525||Single Group Assignment||Treatment||None (Open Label)||||||
1391968|NCT02397512|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1391969|NCT02397499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391970|NCT02397486|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1391971|NCT02397473|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391972|NCT02397460|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1391973|NCT02397447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1391974|NCT02397434||Single Group Assignment||Treatment||None (Open Label)||||||
1391975|NCT02397421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1391976|NCT02397408||Single Group Assignment||Diagnostic||None (Open Label)||||||
1391977|NCT02397395||Single Group Assignment||Treatment||None (Open Label)||||||
1391978|NCT02397382||Single Group Assignment||Treatment||None (Open Label)||||||
1391979|NCT02397369|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1391980|NCT02397356|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1391981|NCT02397343|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1391982|NCT02397330|Randomized|Parallel Assignment||Treatment||Single||||||t
1391983|NCT02397317||Single Group Assignment||Treatment||None (Open Label)||||||
1391984|NCT02397304|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1391985|NCT02397291|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1391986|NCT02397278|Randomized|Parallel Assignment||Treatment||Single||||||t
1391987|NCT02397265|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1391988|NCT02397252|Randomized|Crossover Assignment||Screening||Double||||t||t
1391989|NCT02397239|||Cohort||Prospective|||||||
1391990|NCT02397226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391991|NCT02397213|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1391992|NCT02397200|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1391993|NCT02397187|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1391994|NCT02397174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1391995|NCT02397161|Randomized|Parallel Assignment||Treatment||Single||||||t
1391996|NCT02397148||Single Group Assignment||||None (Open Label)||||||
1391997|NCT02397135|||Case-Only||Retrospective|||||||
1391998|NCT02397122|Randomized|Parallel Assignment||Treatment||Single||||||t
1391999|NCT02397109|||Case-Only||Cross-Sectional|||||||
1392000|NCT02397096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392001|NCT02397083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392002|NCT02397070|Randomized|Parallel Assignment||Treatment||Single||||||t
1392003|NCT02397057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392004|NCT02397044|||Case Control||Prospective|||||||
1392005|NCT02397031|Randomized|Single Group Assignment||Treatment||Single|||t|||
1392006|NCT02397018||Single Group Assignment||Treatment||None (Open Label)||||||
1392007|NCT02397005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392008|NCT02396992||Single Group Assignment||Prevention||None (Open Label)||||||
1392009|NCT02396979|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1392010|NCT02396966|||Case-Control||Prospective|||||||
1392011|NCT02396953||Single Group Assignment||Treatment||None (Open Label)||||||
1392012|NCT02396940|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1392013|NCT02396927|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1392014|NCT02396914||||||||||||
1392015|NCT02396901|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392016|NCT02396888|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1392017|NCT02396875|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1392018|NCT02396862|||Cohort||Prospective|||||||
1392019|NCT02396849|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392020|NCT02396836|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1392021|NCT02396823|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1392022|NCT02396810|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1392023|NCT02396797|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392024|NCT02396784|||Cohort||Prospective|||||||
1392025|NCT02396771|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392026|NCT02396758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392027|NCT02396745||Single Group Assignment||Treatment||None (Open Label)||||||
1392028|NCT02396732|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392029|NCT02396719|||||Prospective|||||||
1392030|NCT02396706|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392031|NCT02396693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392032|NCT02396680|||Cohort||Prospective|||||||
1392033|NCT02396667|||Cohort||Prospective|||||||
1392034|NCT02396654|||Cohort||Prospective|||||||
1392035|NCT02396641||Single Group Assignment||Supportive Care||None (Open Label)||||||
1392036|NCT02396628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392037|NCT02396615|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1392038|NCT02396602|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392039|NCT02396589|Randomized|Parallel Assignment||Treatment||Single||||||t
1392040|NCT02396576|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1392041|NCT02396563|||Case Control||Prospective|||||||
1392042|NCT02396550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392043|NCT02396537|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1392044|NCT02396524|Randomized|Parallel Assignment||Prevention||Single|||||t|
1392045|NCT02396511||Single Group Assignment||Treatment||None (Open Label)||||||
1392046|NCT02396498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392047|NCT02396485|Randomized|Parallel Assignment||||None (Open Label)||||||
1392048|NCT02396472|Randomized|Single Group Assignment||Supportive Care||Double|||t|||t
1392049|NCT02396459||Single Group Assignment||Treatment||None (Open Label)||||||
1392050|NCT02396446|||Case-Only||Prospective|||||||
1392051|NCT02396433||Single Group Assignment||Treatment||None (Open Label)||||||
1392052|NCT02396420||Single Group Assignment||Treatment||None (Open Label)||||||
1392053|NCT02396407|Randomized|Parallel Assignment||Prevention||Single|||||t|
1392054|NCT02396394||Single Group Assignment||Treatment||None (Open Label)||||||
1392055|NCT02396381|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1392056|NCT02396368||Single Group Assignment||Treatment||None (Open Label)||||||
1392057|NCT02396355|||Other||Prospective|||||||
1392058|NCT02396342|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392059|NCT02396329|Randomized|Parallel Assignment||Prevention||Single|||t|||
1392060|NCT02396316|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392061|NCT02396303|Randomized|Single Group Assignment||||None (Open Label)||||||
1392062|NCT02396290|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1392063|NCT02396277|||Case-Only||Prospective|||||||
1392064|NCT02396264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392065|NCT02396251|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1392066|NCT02396238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392067|NCT02396225|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1392068|NCT02396212||Single Group Assignment||Treatment||None (Open Label)||||||
1392069|NCT02396199||Single Group Assignment||Treatment||None (Open Label)||||||
1392070|NCT02396186|||Cohort||Prospective|||||||
1392071|NCT02396173|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1392072|NCT02396160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392073|NCT02396147|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392074|NCT02396134|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1392075|NCT02396121||Single Group Assignment||Treatment||None (Open Label)||||||
1392076|NCT02396108||Single Group Assignment||Treatment||None (Open Label)||||||
1392077|NCT02396095|||Cohort||Prospective|||||||
1392078|NCT02396082|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1392079|NCT02396069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392080|NCT02396056|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392081|NCT02396043||Single Group Assignment||Treatment||None (Open Label)||||||
1392082|NCT02396030|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1392083|NCT02396017|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1392084|NCT02396004|||Cohort||Prospective|||||||
1392085|NCT02395991|||Other||Prospective|||||||
1392086|NCT02395978|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392087|NCT02395965|||Cohort||Prospective|||||||
1392088|NCT02395952|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392089|NCT02395939|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1392090|NCT02395926|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392091|NCT02395913|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392092|NCT02395900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392093|NCT02395887|||Cohort||Prospective|||||||
1392094|NCT02395874|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1392095|NCT02395861||Single Group Assignment||Basic Science||None (Open Label)||||||
1392096|NCT02395848||Single Group Assignment||Treatment||None (Open Label)||||||
1392097|NCT02395835|||Cohort||Prospective|||||||
1392098|NCT02395822||Single Group Assignment||Treatment||None (Open Label)||||||
1392099|NCT02395809|Randomized|Single Group Assignment||Treatment||Single|||||t|
1392100|NCT02395796||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392101|NCT02395783|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392102|NCT02395770||Single Group Assignment||Treatment||None (Open Label)||||||
1392103|NCT02395757||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392104|NCT02395744||Single Group Assignment||Treatment||None (Open Label)||||||
1392105|NCT02395731||Single Group Assignment||Health Services Research||None (Open Label)||||||
1392106|NCT02395718|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1392107|NCT02395705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392108|NCT02395692||Single Group Assignment||Treatment||None (Open Label)||||||
1392109|NCT02395679||Single Group Assignment||Treatment||None (Open Label)||||||
1392110|NCT02395666||Single Group Assignment||Prevention||None (Open Label)||||||
1392111|NCT02395653||Single Group Assignment||Supportive Care||None (Open Label)||||||
1392112|NCT02395640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392113|NCT02395627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392114|NCT02395614|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1392115|NCT02395601||Single Group Assignment||Treatment||None (Open Label)||||||
1392116|NCT02395588|||Cohort||Prospective|||||||
1392117|NCT02395575|||Cohort||Prospective|||||||
1392118|NCT02395562|||Cohort||Retrospective|||||||
1392119|NCT02395549|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392120|NCT02395536|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|The site of the Reveal LINQ insertion was randomized. Therefore it was not possible to blind the subject or the investigator.|||||
1392121|NCT02395523||Single Group Assignment||Treatment||None (Open Label)||||||
1392122|NCT02395510||Single Group Assignment||Treatment||None (Open Label)||||||
1392123|NCT02395497||Single Group Assignment||Treatment||None (Open Label)||||||
1392124|NCT02395484|||Ecologic or Community||Prospective|||||||
1392125|NCT02395471|||Cohort||Prospective|||||||
1392126|NCT02395458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392127|NCT02395445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392128|NCT02395432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392129|NCT02395419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392130|NCT02395406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392131|NCT02395393||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392132|NCT02395380||Single Group Assignment||Other||None (Open Label)||||||
1392133|NCT02395367|||Other||Prospective|||||||
1392134|NCT02395354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392135|NCT02395341|||Cohort||Prospective|||||||
1392136|NCT02395328|Randomized|Parallel Assignment||Treatment||Single||||||t
1392137|NCT02395315|||Cohort||Prospective|||||||
1392138|NCT02395302||Single Group Assignment||Treatment||None (Open Label)||||||
1392139|NCT02395289|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1392140|NCT02395276|Randomized|Parallel Assignment||Treatment||Single||||||t
1392141|NCT02395263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392142|NCT02395250||Single Group Assignment||Treatment||None (Open Label)||||||
1392143|NCT02395237|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392144|NCT02395224|||Cohort||Prospective|||||||
1392145|NCT02395211|Randomized|Parallel Assignment||Treatment||Single||||||t
1392146|NCT02395198|||Cohort||Cross-Sectional|||||||
1392147|NCT02395185|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1392148|NCT02395172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392149|NCT02395159|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392150|NCT02395146|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392151|NCT02395133|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392152|NCT02395120|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1392153|NCT02395107|||Cohort||Prospective|||||||
1392154|NCT02395094|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1392155|NCT02395081|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1392156|NCT02395068|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392157|NCT02395055|Randomized|Parallel Assignment||||Double|||t||t|
1392158|NCT02395042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392159|NCT02395029||Single Group Assignment||Treatment||None (Open Label)||||||
1392160|NCT02395016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392161|NCT02395003|||Cohort||Prospective|||||||
1392162|NCT02394990|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392163|NCT02394977|Randomized|Single Group Assignment||Supportive Care||Triple|||t||t|t
1392164|NCT02394964|||Case-Control||Prospective|||||||
1392165|NCT02394951|Randomized|Crossover Assignment||Other||Double|||t||t|
1392166|NCT02394938|Randomized|Parallel Assignment||Treatment||Single||||||t
1392167|NCT02394925||Single Group Assignment||Treatment||None (Open Label)||||||
1392168|NCT02394912||Single Group Assignment||Treatment||None (Open Label)||||||
1392169|NCT02394899|Randomized|Parallel Assignment||Prevention||Single||||||t
1392170|NCT02394886||Single Group Assignment||Treatment||None (Open Label)||||||
1392171|NCT02394873||Single Group Assignment||Treatment||None (Open Label)||||||
1392172|NCT02394860|||Cohort||Prospective|||||||
1392173|NCT02394847||Single Group Assignment||Screening||None (Open Label)||||||
1392174|NCT02394834|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1392175|NCT02394821|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1392176|NCT02394808|Randomized|Crossover Assignment||Treatment||Single|||t|||
1392177|NCT02394795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392178|NCT02394782|||Cohort||Prospective|||||||
1392179|NCT02394769|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1392180|NCT02394756|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392181|NCT02394743|||Case Control||Retrospective|||||||
1392182|NCT02394730|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392183|NCT02394717||Single Group Assignment||Prevention||None (Open Label)||||||
1392184|NCT02394704|Randomized|Single Group Assignment||Treatment||Single|||||t|
1392185|NCT02394691|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1392186|NCT02394678||Single Group Assignment||Treatment||None (Open Label)||||||
1392187|NCT02394665|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392188|NCT02394652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392189|NCT02394639|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1392190|NCT02394626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392191|NCT02394613||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392192|NCT02394600|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1392193|NCT02394587|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1392194|NCT02394574|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392195|NCT02394561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392196|NCT02394548||Single Group Assignment||Treatment||None (Open Label)||||||
1392197|NCT02394535||Single Group Assignment||Treatment||None (Open Label)||||||
1392198|NCT02394522|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1392199|NCT02394509|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1392200|NCT02394496|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1392201|NCT02394483|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392202|NCT02394470||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392203|NCT02394457|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1392204|NCT02394444|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1392205|NCT02394431|||Cohort||Prospective|||||||
1392206|NCT02394418|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392207|NCT02394405|||Cohort||Retrospective|||||||
1392208|NCT02394392|||||Prospective|||||||
1392209|NCT02394379|||Cohort||Prospective|||||||
1392210|NCT02394366|Randomized|Crossover Assignment||Supportive Care||Double|||||t|t
1392211|NCT02394353|Randomized|Parallel Assignment||Treatment||Single||||||t
1392212|NCT02394340||Single Group Assignment||Treatment||None (Open Label)||||||
1392213|NCT02394327|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1392214|NCT02394314|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1392215|NCT02394301|||Cohort||Prospective|||||||
1392216|NCT02394288|||Cohort||Prospective|||||||
1392217|NCT02394275||Single Group Assignment||Treatment||None (Open Label)||||||
1392218|NCT02394262||Single Group Assignment||Other||None (Open Label)||||||
1392219|NCT02394249|Randomized|Crossover Assignment||Prevention||Single||||||t
1392220|NCT02394236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392221|NCT02394223|||Case-Control||Prospective|||||||
1392222|NCT02394210|||Cohort||Prospective|||||||
1392223|NCT02394197|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392224|NCT02394184|||Cohort||Prospective|||||||
1392225|NCT02394171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392226|NCT02394158|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1392227|NCT02394145|Randomized|Parallel Assignment||Treatment||Single|||||t|
1392228|NCT02394132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392229|NCT02394119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392230|NCT02394106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392231|NCT02394093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392232|NCT02394080||Single Group Assignment||Treatment||None (Open Label)||||||
1392233|NCT02394067|||Cohort||Prospective|||||||
1392234|NCT02394054|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1392235|NCT02394041|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1392236|NCT02394028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392237|NCT02394015|||||Retrospective|||||||
1392238|NCT02394002|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1392239|NCT02393989||Single Group Assignment||Treatment||None (Open Label)||||||
1392240|NCT02393976|Randomized|Parallel Assignment||||None (Open Label)||||||
1392241|NCT02393963|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1392242|NCT02393950|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1392243|NCT02393937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392244|NCT02393924|||Cohort||Prospective|||||||
1392245|NCT02393911|Randomized|Parallel Assignment||||None (Open Label)||||||
1392246|NCT02393898|||Cohort||Prospective|||||||
1392247|NCT02393885||Single Group Assignment||Treatment||None (Open Label)||||||
1392248|NCT02393872|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392249|NCT02393859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392250|NCT02393846|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392251|NCT02393833|Randomized|Parallel Assignment||||None (Open Label)||||||
1392252|NCT02393820||Single Group Assignment||Treatment||None (Open Label)||||||
1392253|NCT02393807|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1392254|NCT02393794|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392255|NCT02393781|||Case-Only||Prospective|||||||
1392256|NCT02393768|||Case Control||Cross-Sectional|||||||
1392257|NCT02393755||Single Group Assignment||Treatment||None (Open Label)||||||
1392258|NCT02393742|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1392259|NCT02393729|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1392260|NCT02393716||Single Group Assignment||Treatment||None (Open Label)||||||
1392261|NCT02393703|||Cohort||Prospective|||||||
1392262|NCT02393690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392263|NCT02393677|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1392264|NCT02393664|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392265|NCT02393651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392266|NCT02393638|Randomized|Parallel Assignment||||Single|||||t|
1392267|NCT02393625|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392268|NCT02393612|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392269|NCT02393599|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1392270|NCT02393586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392271|NCT02393573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392272|NCT02393560|||Other||Prospective|||||||
1392273|NCT02393547||Single Group Assignment||Treatment||None (Open Label)||||||
1392274|NCT02393534|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1392275|NCT02393521|Randomized|Parallel Assignment||Treatment||Single||||||t
1392276|NCT02393508|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392277|NCT02393495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392278|NCT02393482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392279|NCT02393469|Non-Randomized|Factorial Assignment||Treatment||Single|||t|||
1392280|NCT02393456|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1392281|NCT02393443|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1392282|NCT02393430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392283|NCT02393417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392284|NCT02393404|Randomized|Parallel Assignment||Treatment||Single||||||t
1392285|NCT02393391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392286|NCT02393378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392287|NCT02393365||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392288|NCT02393352|Randomized|Single Group Assignment||Treatment||Single||||||t
1392289|NCT02393339|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1392290|NCT02393326|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392291|NCT02393313||Single Group Assignment||Treatment||None (Open Label)||||||
1392292|NCT02393300|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392293|NCT02393287|||Cohort|||||||||
1392294|NCT02393274|||Cohort||Prospective|||||||
1392295|NCT02393261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392296|NCT02393248||Single Group Assignment||Treatment||None (Open Label)||||||
1392297|NCT02393235|||Case Control||Prospective|||||||
1392298|NCT02393222|||Cohort||Prospective|||||||
1392299|NCT02393209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392300|NCT02393196|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1392301|NCT02393183|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1392302|NCT02393170|Randomized|Parallel Assignment||Treatment||Single||||||t
1392303|NCT02393157|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392304|NCT02393144|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1392305|NCT02393131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392306|NCT02393118||Single Group Assignment||Supportive Care||None (Open Label)||||||
1392307|NCT02393105|||||Cross-Sectional|||||||
1392308|NCT02393092|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392309|NCT02393079|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1392310|NCT02393066|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392311|NCT02393053|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392312|NCT02393040||Single Group Assignment||Treatment||Triple|||t||t|t
1392313|NCT02393027|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1392314|NCT02393014|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392315|NCT02393001|||Case-Control||Prospective|||||||
1392316|NCT02392988|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392317|NCT02392975||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392318|NCT02392962|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1392319|NCT02392949|Randomized|Parallel Assignment||Prevention||Single||||||t
1392320|NCT02392936|||Cohort||Prospective|||||||
1392321|NCT02392923|||Cohort||Prospective|||||||
1392322|NCT02392910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392323|NCT02392897|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1392324|NCT02392884|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392325|NCT02392871||Single Group Assignment||Treatment||None (Open Label)||||||
1392326|NCT02392858||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392327|NCT02392845||Single Group Assignment||Treatment||None (Open Label)||||||
1392328|NCT02392832|Randomized|Crossover Assignment||Other||Single|||t|||
1392329|NCT02392819|Randomized|Crossover Assignment||Prevention||Single|||t|||
1392330|NCT02392806|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392331|NCT02392793|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392332|NCT02392780||Single Group Assignment||Treatment||None (Open Label)||||||
1392333|NCT02392767|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1392334|NCT02392754|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1392335|NCT02392741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392336|NCT02392728|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1392337|NCT02392715|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392338|NCT02392702|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1392339|NCT02392689|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1392340|NCT02392676|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392341|NCT02392663|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1392342|NCT02392650|||Cohort||Other|||||||
1392343|NCT02392637||Single Group Assignment||Treatment||None (Open Label)||||||
1392344|NCT02392624|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392345|NCT02392611|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392346|NCT02392598|||Cohort||Prospective|||||||
1392347|NCT02392585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392348|NCT02392572|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392349|NCT02392559|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392350|NCT02392546|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1392351|NCT02392533|||Cohort||Retrospective|||||||
1392352|NCT02392520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392353|NCT02392507||Single Group Assignment||Treatment||None (Open Label)||||||
1392354|NCT02392494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392355|NCT02392481|||Cohort||Cross-Sectional|||||||
1392356|NCT02392468|Randomized|Parallel Assignment||Treatment||Double||||||
1392357|NCT02392455|||Cohort||Prospective|||||||
1392358|NCT02392442||Parallel Assignment||Basic Science||None (Open Label)||||||
1392359|NCT02392429||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392360|NCT02392416|||||Prospective|||||||
1392361|NCT02392403||Single Group Assignment||Treatment||None (Open Label)||||||
1392362|NCT02392390||Single Group Assignment||Treatment||None (Open Label)||||||
1392363|NCT02392377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392364|NCT02392364|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392365|NCT02392351|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392366|NCT02392338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392367|NCT02392325|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1392368|NCT02392312|||Case-Only||Prospective|||||||
1392369|NCT02392299|||Cohort||Prospective|||||||
1392370|NCT02392286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392371|NCT02392273|||Case-Only||Prospective|||||||
1392372|NCT02392260||Single Group Assignment||||None (Open Label)||||||
1392373|NCT02392247|||||Prospective|||||||
1392374|NCT02392234|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1392375|NCT02392221|||Cohort||Retrospective|||||||
1392376|NCT02392208|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1392377|NCT02392195|||Case-Only||Prospective|||||||
1392378|NCT02392182|||Case-Only||Prospective|||||||
1392379|NCT02392169|||Case-Only||Prospective|||||||
1392380|NCT02392156|||Cohort||Prospective|||||||
1392381|NCT02392143|Randomized|Parallel Assignment||Screening||Single||||||t
1392382|NCT02392130|Randomized|Parallel Assignment||Other||Single|||||t|
1392383|NCT02392117|||Cohort||Prospective|||||||
1392384|NCT02392104||Single Group Assignment||Treatment||None (Open Label)||||||
1392385|NCT02392091|||Cohort||Prospective|||||||
1392386|NCT02392078|||Cohort||Prospective|||||||
1392387|NCT02392065|||Cohort||Prospective|||||||
1392388|NCT02392052|Randomized|Parallel Assignment||Treatment||Single||||||t
1392389|NCT02392039|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1392390|NCT02392026||Single Group Assignment||Treatment||None (Open Label)||||||
1392391|NCT02392013|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392392|NCT02392000||Single Group Assignment||Treatment||None (Open Label)||||||
1393643|NCT02375711||Single Group Assignment||Other||None (Open Label)||||||
1392393|NCT02391987|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1392394|NCT02391974|Randomized|Parallel Assignment||Treatment||Single||||||t
1392395|NCT02391961|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1392396|NCT02391948|||Cohort||Prospective|||||||
1392397|NCT02391935|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392398|NCT02391922|Randomized|Factorial Assignment||Treatment||Single||||||t
1392399|NCT02391909|||Cohort||Prospective|||||||
1392400|NCT02391896|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1392401|NCT02391883|||Case Control||Retrospective|||||||
1392402|NCT02391870||Single Group Assignment||Prevention||None (Open Label)||||||
1392403|NCT02391857||Single Group Assignment||Treatment||None (Open Label)||||||
1392404|NCT02391844||Single Group Assignment||Treatment||None (Open Label)||||||
1392405|NCT02391831||Single Group Assignment||Basic Science||None (Open Label)||||||
1392406|NCT02391818|||Cohort||Prospective|||||||
1392407|NCT02391805|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392408|NCT02391792|||Cohort||Prospective|||||||
1392409|NCT02391779|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1392410|NCT02391766|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1392411|NCT02391753|||Cohort||Prospective|||||||
1392412|NCT02391740|||Case-Only||Prospective|||||||
1392413|NCT02391727||Single Group Assignment||Treatment||None (Open Label)||||||
1392414|NCT02391714|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392415|NCT02391701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392416|NCT02391688|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1392417|NCT02391675|||Cohort||Prospective|||||||
1392418|NCT02391662||Single Group Assignment||Treatment||None (Open Label)||||||
1392419|NCT02391649|Randomized|Parallel Assignment||Health Services Research||Single|Outcome assessors are blind to the group assignment and intervention undertaken and concealed to the participant list.|Repeated-measures, three-arm design||||t
1392420|NCT02391636|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1392421|NCT02391623|Randomized|||Basic Science||Triple|||t|t|t|
1392422|NCT02391610|||Cohort||Prospective|||||||
1392423|NCT02391584|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392424|NCT02391571|Randomized|Parallel Assignment||||Triple|||t||t|t
1392425|NCT02391558|||Other||Cross-Sectional|||||||
1392426|NCT02391545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392427|NCT02391532|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1392428|NCT02391519|||Case-Control||Prospective|||||||
1392429|NCT02391506||Single Group Assignment||Treatment||None (Open Label)||||||
1392430|NCT02391493|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1392431|NCT02391480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392432|NCT02391467|||Cohort||Prospective|||||||
1392433|NCT02391454|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1392434|NCT02391441|||Case-Control||Prospective|||||||
1392435|NCT02391428|Non-Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1392436|NCT02391415|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1392437|NCT02391402|Randomized|Parallel Assignment||Treatment||Single||||||t
1392438|NCT02391389||Single Group Assignment||Treatment||None (Open Label)||||||
1392439|NCT02391376|Randomized|Parallel Assignment||||Double|||t||t|
1392440|NCT02391363|Randomized|Parallel Assignment||Treatment||Single||||||t
1392441|NCT02391350|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1392442|NCT02391337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392443|NCT02391324|Randomized|Factorial Assignment||Treatment||Single||||||t
1392444|NCT02391311|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1392445|NCT02391298||Single Group Assignment||Treatment||None (Open Label)||||||
1392446|NCT02391285||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392447|NCT02391272||Single Group Assignment||Treatment||None (Open Label)||||||
1392448|NCT02391259|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1392449|NCT02391246|||Cohort||Retrospective|||||||
1392450|NCT02391233|Randomized|Parallel Assignment||Prevention||Single|||||t|
1392451|NCT02391220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392452|NCT02391207|||Cohort||Prospective|||||||
1392453|NCT02391194||Single Group Assignment||Treatment||None (Open Label)||||||
1392454|NCT02391181|Randomized|Crossover Assignment||||None (Open Label)||||||
1392455|NCT02391168|||Cohort||Prospective|||||||
1392456|NCT02391155|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1392457|NCT02391142|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1392458|NCT02391129|||Cohort||Retrospective|||||||
1392459|NCT02391116||Single Group Assignment||Treatment||None (Open Label)||||||
1392460|NCT02391103|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392461|NCT02391090|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1392462|NCT02391077|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392463|NCT02391064|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1392464|NCT02391051||Single Group Assignment||Treatment||None (Open Label)||||||
1392465|NCT02391038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392466|NCT02391025||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392467|NCT02391012||Single Group Assignment||Treatment||None (Open Label)||||||
1392468|NCT02390999|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1392469|NCT02390986||Single Group Assignment||Treatment||None (Open Label)||||||
1392470|NCT02390973|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392471|NCT02390960|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1392472|NCT02390947|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392473|NCT02390934||Single Group Assignment||Treatment||None (Open Label)||||||
1392474|NCT02390921|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392475|NCT02390908|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392476|NCT02390895|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392477|NCT02390882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392478|NCT02390869|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392479|NCT02390856|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392480|NCT02390843||Single Group Assignment||Treatment||None (Open Label)||||||
1392481|NCT02390830|Randomized|Parallel Assignment||Treatment||Single||||||t
1392482|NCT02390817|Randomized|Parallel Assignment||Screening||Single|||t|||
1392483|NCT02390804|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392484|NCT02390791|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1392485|NCT02390778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392486|NCT02390765|||Cohort||Prospective|||||||
1392487|NCT02390752|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1392488|NCT02390739||Single Group Assignment||Treatment||None (Open Label)||||||
1392489|NCT02390726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392490|NCT02390713||Single Group Assignment||Treatment||None (Open Label)||||||
1392491|NCT02390700|||Cohort||Prospective|||||||
1392492|NCT02390687|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392493|NCT02390674|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392494|NCT02390661|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392495|NCT02390648|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1392496|NCT02390635||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392497|NCT02390622||Single Group Assignment||Treatment||None (Open Label)||||||
1392498|NCT02390609|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392499|NCT02390596||Single Group Assignment||Treatment||None (Open Label)||||||
1392500|NCT02390583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392501|NCT02390570||Single Group Assignment||Health Services Research||None (Open Label)||||||
1392502|NCT02390557|Randomized|Parallel Assignment||Health Services Research||Double|Randomization was performed at the level of primary care practice. Providers and patients were unaware of assignment to study arms|control v Survey v YESHealth|t|t||
1392503|NCT02390544||Single Group Assignment||Basic Science||None (Open Label)||||||
1392504|NCT02390531||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1392505|NCT02390518||Single Group Assignment||Treatment||None (Open Label)||||||
1392506|NCT02390505|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1392507|NCT02390492|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1392508|NCT02390479|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1392509|NCT02390466||Single Group Assignment||Treatment||None (Open Label)||||||
1392510|NCT02390453|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1392511|NCT02390440||Single Group Assignment||Treatment||None (Open Label)||||||
1392512|NCT02390427|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392513|NCT02390414|||Cohort||Prospective|||||||
1392514|NCT02390401|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1392515|NCT02390388|Randomized|Parallel Assignment||Treatment||Single|||||t|
1392516|NCT02390375|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1392517|NCT02390362|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392518|NCT02390349|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392519|NCT02390336|Randomized|Parallel Assignment||Treatment||Single||||||t
1392520|NCT02390323||Single Group Assignment||Supportive Care||None (Open Label)||||||
1392521|NCT02390310|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392522|NCT02390297|||Other||Prospective|||||||
1392523|NCT02390284|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392524|NCT02390271||Single Group Assignment||Prevention||None (Open Label)||||||
1392525|NCT02390258|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1392526|NCT02390245|Randomized|Parallel Assignment||Other||Single|||t|||
1392527|NCT02390232|||Cohort||Prospective|||||||
1392528|NCT02390219||Single Group Assignment||Treatment||None (Open Label)||||||
1392529|NCT02390206|||Cohort||Prospective|||||||
1392530|NCT02390193||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392531|NCT02390180|||||Cross-Sectional|||||||
1392532|NCT02390167|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1392533|NCT02390154|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392534|NCT02390141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392535|NCT02390128|||Cohort||Prospective|||||||
1392536|NCT02390115|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1392537|NCT02390102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392538|NCT02390089|Non-Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1392539|NCT02390076|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392540|NCT02390063|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1392541|NCT02390050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392542|NCT02390037|||Cohort||Prospective|||||||
1392543|NCT02390024|||Cohort||Prospective|||||||
1392544|NCT02390011|||Cohort||Prospective|||||||
1392545|NCT02389998|Randomized|Crossover Assignment||Treatment||None (Open Label)|Open placebo. No masking|||||
1392546|NCT02389985||Single Group Assignment||Treatment||None (Open Label)||||||
1392547|NCT02389972|||Cohort||Prospective|||||||
1392548|NCT02389959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392549|NCT02389946|Randomized|Parallel Assignment||Treatment||Single||||||t
1392550|NCT02389933||||||||||||
1392551|NCT02389920||Single Group Assignment||Treatment||None (Open Label)||||||
1392552|NCT02389907|||Cohort||Prospective|||||||
1392553|NCT02389894|Randomized|Parallel Assignment||Prevention||Single||||||t
1392554|NCT02389881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392555|NCT02389868||Single Group Assignment||Basic Science||None (Open Label)||||||
1392556|NCT02389855|||Cohort||Retrospective|||||||
1392557|NCT02389842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392558|NCT02389829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392559|NCT02389816|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1392560|NCT02389803|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392561|NCT02389790||Single Group Assignment||Treatment||None (Open Label)||||||
1392562|NCT02389777|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1392563|NCT02389764||Single Group Assignment||Treatment||None (Open Label)||||||
1392564|NCT02389751||Single Group Assignment||Treatment||None (Open Label)||||||
1392565|NCT02389738||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392566|NCT02389725|Randomized|Parallel Assignment||Basic Science||Single||||t||
1392567|NCT02389712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392568|NCT02389699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392569|NCT02389686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392570|NCT02389673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392571|NCT02389660|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1392572|NCT02389647|||Cohort||Prospective|||||||
1392573|NCT02389634|||Cohort||Prospective|||||||
1392574|NCT02389621|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1392575|NCT02389608|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1392576|NCT02389595|||Cohort||Prospective|||||||
1392577|NCT02389582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392578|NCT02389569|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1392579|NCT02389556|||Cohort||Prospective|||||||
1392580|NCT02389543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392581|NCT02389530|||Cohort||Prospective|||||||
1392582|NCT02389517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392583|NCT02389504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392584|NCT02389491|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1392585|NCT02389478|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1392586|NCT02389465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392587|NCT02389452||Single Group Assignment||Treatment||None (Open Label)||||||
1392588|NCT02389439||Single Group Assignment||Treatment||None (Open Label)||||||
1392589|NCT02389426|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1392590|NCT02389413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392591|NCT02389400||Single Group Assignment||Treatment||None (Open Label)||||||
1392592|NCT02389387|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1392593|NCT02389374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392594|NCT02389361|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1392595|NCT02389348||Single Group Assignment||Treatment||None (Open Label)||||||
1392596|NCT02389335|||Cohort||Prospective|||||||
1392597|NCT02389322|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1392598|NCT02389309||Single Group Assignment||Treatment||None (Open Label)||||||
1392599|NCT02389296|||Cohort||Prospective|||||||
1392600|NCT02389283|||Cohort||Prospective|||||||
1392601|NCT02389270|||Case-Only||Cross-Sectional|||||||
1392602|NCT02389257|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1392603|NCT02389244|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392604|NCT02389231||Single Group Assignment||Treatment||None (Open Label)||||||
1392605|NCT02389218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392606|NCT02389205|Randomized|Parallel Assignment||Prevention||Single||||||t
1392607|NCT02389192||Single Group Assignment||Other||None (Open Label)||||||
1392608|NCT02389179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392609|NCT02389166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392610|NCT02389153|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1392611|NCT02389140|Randomized|Parallel Assignment||Other||Single|||t|||
1392612|NCT02389127|||Case-Control||Prospective|||||||
1392613|NCT02389114|Randomized|Crossover Assignment||||Single|||t|||
1392614|NCT02389101||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392615|NCT02389088|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1392616|NCT02389075|||Case-Control||Cross-Sectional|||||||
1392617|NCT02389062|Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1392618|NCT02389049|||Cohort||Cross-Sectional|||||||
1392619|NCT02389036|Randomized|Crossover Assignment||Prevention||Single||||||t
1392620|NCT02389023|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392621|NCT02389010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392622|NCT02388997|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1392623|NCT02388984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392624|NCT02388971|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392625|NCT02388958|||Case-Control||Prospective|||||||
1392626|NCT02388945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392627|NCT02388932||Single Group Assignment||Treatment||None (Open Label)||||||
1392628|NCT02388919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392629|NCT02388906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392630|NCT02388893|||Case-Only||Prospective|||||||
1392631|NCT02388880||Single Group Assignment||Treatment||None (Open Label)||||||
1392632|NCT02388867|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1392633|NCT02388854|||Case Control||Prospective|||||||
1392634|NCT02388841|||Case Control||Prospective|||||||
1392635|NCT02388828|||Cohort||Prospective|||||||
1392636|NCT02388815||Single Group Assignment||||None (Open Label)||||||
1392637|NCT02388802||Single Group Assignment||Treatment||None (Open Label)||||||
1392638|NCT02388789||Single Group Assignment||Basic Science||None (Open Label)||||||
1392639|NCT02388776||Single Group Assignment||Other||None (Open Label)||||||
1392640|NCT02388763|Randomized|Crossover Assignment||Treatment||Single||||||t
1392641|NCT02388750|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392642|NCT02388737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392643|NCT02388724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392644|NCT02388711|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1392645|NCT02388698||Single Group Assignment||Health Services Research||None (Open Label)||||||
1392646|NCT02388685|Randomized|Parallel Assignment||Treatment||Single||||||t
1392647|NCT02388672|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1392648|NCT02388659|||Case-Control||Prospective|||||||
1392649|NCT02388646|Randomized|Parallel Assignment||Treatment||Single||||||t
1392650|NCT02388633|||Cohort||Prospective|||||||
1392651|NCT02388620|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392652|NCT02388607|||Other||Prospective|||||||
1392653|NCT02388594|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392654|NCT02388581||Single Group Assignment||Treatment||None (Open Label)||||||
1392655|NCT02388568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392656|NCT02388555|||Cohort||Prospective|||||||
1392657|NCT02388542||Single Group Assignment||Prevention||None (Open Label)||||||
1392658|NCT02388529|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392659|NCT02388516|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1392660|NCT02388503|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1392661|NCT02388490||Single Group Assignment||Treatment||None (Open Label)||||||
1392662|NCT02388477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392663|NCT02388464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392664|NCT02388451||Single Group Assignment||Supportive Care||None (Open Label)||||||
1392665|NCT02388438||Single Group Assignment||Treatment||None (Open Label)||||||
1392666|NCT02388425||||||||||||
1392667|NCT02388412|||Case Control||Prospective|||||||
1392668|NCT02388399|||Case-Only||Prospective|||||||
1392669|NCT02388386||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392670|NCT02388373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392671|NCT02388360||Single Group Assignment||Treatment||None (Open Label)||||||
1392672|NCT02388347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392673|NCT02388334|||||Prospective|||||||
1392674|NCT02388321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392675|NCT02388308|||Cohort||Prospective|||||||
1392676|NCT02388295|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392677|NCT02388282|||Case-Only||Prospective|||||||
1392678|NCT02388269|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1392679|NCT02388256|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1392680|NCT02388243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392681|NCT02388230|||Cohort||Prospective|||||||
1392682|NCT02388217|||Cohort||Prospective|||||||
1392683|NCT02388204|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392684|NCT02388191|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1392685|NCT02388178|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1392686|NCT02388165|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1392687|NCT02388152|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392688|NCT02388139|||Cohort||Prospective|||||||
1392689|NCT02388126||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392690|NCT02388113|Randomized|Parallel Assignment||Treatment||Single||||||t
1392691|NCT02388100|||Cohort||Prospective|||||||
1392692|NCT02388087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392693|NCT02388074||Single Group Assignment||Diagnostic||Single|||||t|
1392694|NCT02388061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392695|NCT02388048||Single Group Assignment||Treatment||None (Open Label)||||||
1392696|NCT02388035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392697|NCT02388022|||Case-Only||Retrospective|||||||
1392698|NCT02388009|Randomized|Parallel Assignment||Prevention||Single|||t|||
1392699|NCT02387996||Single Group Assignment||Treatment||None (Open Label)||||||
1392700|NCT02387983||Single Group Assignment||Prevention||None (Open Label)||||||
1392701|NCT02387970|Randomized|Parallel Assignment||Treatment||Single||||||t
1392702|NCT02387957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392704|NCT02387931|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392705|NCT02387918|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1392706|NCT02387905|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1392707|NCT02387892|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1392708|NCT02387879|||Cohort||Prospective|||||||
1392709|NCT02387866|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1392710|NCT02387853||Single Group Assignment||Treatment||None (Open Label)||||||
1392711|NCT02387840|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1392712|NCT02387827|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392713|NCT02387814|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1392714|NCT02387801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392715|NCT02387788||Single Group Assignment||Treatment||None (Open Label)||||||
1392716|NCT02387775||Single Group Assignment||Treatment||None (Open Label)||||||
1392717|NCT02387762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392718|NCT02387749||Single Group Assignment||Treatment||None (Open Label)||||||
1392719|NCT02387736|Randomized|Parallel Assignment||Treatment||Single||||||t
1392720|NCT02387723||Single Group Assignment||Treatment||None (Open Label)||||||
1392721|NCT02387710|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1392722|NCT02387697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392723|NCT02387684|||Cohort||Prospective|||||||
1392724|NCT02387671||Single Group Assignment||Prevention||None (Open Label)||||||
1392725|NCT02387658|||Cohort||Prospective|||||||
1392726|NCT02387645||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392727|NCT02387632|||Cohort||Prospective|||||||
1392728|NCT02387619|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392729|NCT02387606|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392730|NCT02387593|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1392731|NCT02387580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392732|NCT02387567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392733|NCT02387554|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1392734|NCT02387541|||Case Control||Prospective|||||||
1392735|NCT02387528|Randomized|Parallel Assignment||Prevention||Single|||t|||
1392736|NCT02387515||Single Group Assignment||Other||None (Open Label)||||||
1392737|NCT02387502|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1392738|NCT02387489|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1392739|NCT02387476|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392740|NCT02387463|||Cohort||Prospective|||||||
1392741|NCT02387450|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1392742|NCT02387437|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392743|NCT02387424|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392744|NCT02387411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392745|NCT02387398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392746|NCT02387385|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392747|NCT02387372|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392748|NCT02387359|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392749|NCT02387346|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1392750|NCT02387333|Randomized|Parallel Assignment||Prevention||Single|||t|||
1392751|NCT02387320|Randomized|Parallel Assignment||||None (Open Label)||||||
1392752|NCT02387307||Single Group Assignment||Treatment||None (Open Label)||||||
1392753|NCT02387294||Single Group Assignment||Prevention||None (Open Label)||||||
1392754|NCT02387281|||Case-Control||Prospective|||||||
1392755|NCT02387268||Single Group Assignment||Screening||None (Open Label)||||||
1392756|NCT02387255|||Cohort||Prospective|||||||
1392757|NCT02387242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392758|NCT02387229|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1392759|NCT02387216|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392760|NCT02387203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392761|NCT02387190|Randomized|Parallel Assignment||Prevention||Single|||||t|
1392762|NCT02387177|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392763|NCT02387164|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1392764|NCT02387151||Single Group Assignment||Treatment||None (Open Label)||||||
1392765|NCT02387138||Single Group Assignment||Treatment||None (Open Label)||||||
1392766|NCT02387125|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1392767|NCT02387112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392768|NCT02387099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392769|NCT02387086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392770|NCT02387073|||Cohort||Cross-Sectional|||||||
1392771|NCT02387060|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392772|NCT02387047|||Case-Only||Cross-Sectional|||||||
1392773|NCT02387034|Randomized|Parallel Assignment||Treatment||Single||||||t
1392774|NCT02387021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392775|NCT02387008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392776|NCT02386995|||Cohort||Prospective|||||||
1392777|NCT02386982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392778|NCT02386969|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1392779|NCT02386956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392780|NCT02386943|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392781|NCT02386930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392782|NCT02386917|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1392783|NCT02386904||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392784|NCT02386891|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1392785|NCT02386878|Randomized|Factorial Assignment||Treatment||Single||||||t
1392786|NCT02386865|||||Retrospective|||||||
1392787|NCT02386852|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1392788|NCT02386839|||Cohort||Prospective|||||||
1392789|NCT02386826||Single Group Assignment||Treatment||None (Open Label)||||||
1392790|NCT02386813|||Cohort||Retrospective|||||||
1392791|NCT02386800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392792|NCT02386787||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392793|NCT02386774|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1392794|NCT02386761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392795|NCT02386748|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1392796|NCT02386735|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392797|NCT02386722|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1392798|NCT02386709||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392799|NCT02386696||Single Group Assignment||Diagnostic||Single|||||t|
1392800|NCT02386683|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1392801|NCT02386670|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1392802|NCT02386657|||Cohort||Prospective|||||||
1392803|NCT02386644||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392804|NCT02386631||Single Group Assignment||Basic Science||None (Open Label)||||||
1392805|NCT02386618||Single Group Assignment||Treatment||None (Open Label)||||||
1392806|NCT02386605|Randomized|Parallel Assignment||Treatment||Single||||||t
1392807|NCT02386592||Single Group Assignment||Prevention||None (Open Label)||||||
1392808|NCT02386579|||Case Control||Cross-Sectional|||||||
1392809|NCT02386566|||Cohort||Prospective|||||||
1392810|NCT02386553||Single Group Assignment||Prevention||None (Open Label)||||||
1392811|NCT02386540|Randomized|Parallel Assignment||Treatment||Single||||||t
1392812|NCT02386527|||Cohort||Prospective|||||||
1392813|NCT02386514|||Cohort||Prospective|||||||
1392814|NCT02386501||Single Group Assignment||Treatment||None (Open Label)||||||
1392815|NCT02386488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392816|NCT02386475|Randomized|Parallel Assignment||Treatment||Single||||||t
1392817|NCT02386462||Single Group Assignment||Treatment||None (Open Label)||||||
1392818|NCT02386449|Randomized|Parallel Assignment||||Single||||||t
1392819|NCT02386436|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392820|NCT02386423||Single Group Assignment||Treatment||None (Open Label)||||||
1392821|NCT02386410|Randomized|Parallel Assignment||Prevention||Single||||||t
1392822|NCT02386397||Single Group Assignment||Treatment||None (Open Label)||||||
1392823|NCT02386384|||Case-Control||Prospective|||||||
1392824|NCT02386371||Single Group Assignment||Treatment||None (Open Label)||||||
1392825|NCT02386358|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392826|NCT02386345|||Case-Only||Other|||||||
1392827|NCT02386332|||||Prospective|||||||
1392828|NCT02386319|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392829|NCT02386306|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1392830|NCT02386293|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1392831|NCT02386280|Randomized|Parallel Assignment||Prevention||Single|||t|||
1392832|NCT02386267||Single Group Assignment||Treatment||None (Open Label)||||||
1392833|NCT02386254|||Case-Only||Prospective|||||||
1392834|NCT02386241|||Family-Based||Prospective|||||||
1392835|NCT02386228|||||Prospective|||||||
1392836|NCT02386215|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1392837|NCT02386202|||||Prospective|||||||
1392838|NCT02386189|Randomized|Parallel Assignment||Health Services Research||Single|For one of the outcomes (laboratory duplication) the assessor is blind to group assignment.|||||t
1392839|NCT02386176|||Cohort||Prospective|||||||
1392840|NCT02386163|||Case-Only||Prospective|||||||
1392841|NCT02386150|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392842|NCT02386137||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392843|NCT02386124||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392844|NCT02386111||Single Group Assignment||Treatment||None (Open Label)||||||
1392845|NCT02386098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392846|NCT02386085|||Cohort||Prospective|||||||
1392847|NCT02386072|||Cohort||Prospective|||||||
1392848|NCT02386059|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1392849|NCT02386046|||Cohort||Prospective|||||||
1392850|NCT02386033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392851|NCT02386020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392852|NCT02386007|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392853|NCT02385994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392854|NCT02385981||Single Group Assignment||Prevention||None (Open Label)||||||
1392855|NCT02385968|||Cohort||Prospective|||||||
1392856|NCT02385955||Single Group Assignment||Treatment||None (Open Label)||||||
1392857|NCT02385942||Single Group Assignment||Health Services Research||None (Open Label)||||||
1392858|NCT02385929|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1392859|NCT02385916|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1392860|NCT02385903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392861|NCT02385890|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1392862|NCT02385877|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1392863|NCT02385864|||Cohort||Prospective|||||||
1392864|NCT02385851|Randomized|Crossover Assignment||||Triple|||t|t|t|
1392865|NCT02385838|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1392866|NCT02385825|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392867|NCT02385812|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1392868|NCT02385799|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392869|NCT02385786||Single Group Assignment||Treatment||None (Open Label)||||||
1392870|NCT02385773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392871|NCT02385760|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392872|NCT02385747||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392873|NCT02385734|Randomized|Single Group Assignment||Treatment||Single||||||t
1392874|NCT02385721|||Cohort||Prospective|||||||
1392875|NCT02385708|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392876|NCT02385695|||Case Control||Prospective|||||||
1392877|NCT02385682|||Cohort||Prospective|||||||
1392878|NCT02385669||Single Group Assignment||Treatment||None (Open Label)||||||
1392879|NCT02385656||Single Group Assignment||Treatment||None (Open Label)||||||
1392880|NCT02385643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392881|NCT02385630|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1392882|NCT02385617|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1392883|NCT02385604|||Cohort||Prospective|||||||
1392884|NCT02385591|Randomized|Parallel Assignment||Prevention||Single||||||t
1392885|NCT02385578|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1392886|NCT02385565|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392887|NCT02385552|||Cohort||Prospective|||||||
1392888|NCT02385539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392889|NCT02385526|||Cohort||Prospective|||||||
1392890|NCT02385513|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392891|NCT02385500|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1392892|NCT02385487|||Case Control||Prospective|||||||
1392893|NCT02385474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392894|NCT02385461|||Cohort||Prospective|||||||
1392895|NCT02385448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392896|NCT02385435|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392897|NCT02385422|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392898|NCT02385409|||Cohort||Prospective|||||||
1392899|NCT02385396||Parallel Assignment||Treatment||None (Open Label)||||||
1392900|NCT02385383|||Cohort||Prospective|||||||
1392901|NCT02385370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392902|NCT02385357|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1392903|NCT02385344|||Other||Prospective|||||||
1392904|NCT02385331|||Case-Only||Cross-Sectional|||||||
1392905|NCT02385318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392906|NCT02385305||Single Group Assignment||||None (Open Label)||||||
1392907|NCT02385292|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1392908|NCT02385279|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392909|NCT02385266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392910|NCT02385253|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1392911|NCT02385240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392912|NCT02385227|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1392913|NCT02385214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392914|NCT02385201||Single Group Assignment||Treatment||None (Open Label)||||||
1392915|NCT02385188||Single Group Assignment||Treatment||None (Open Label)||||||
1392916|NCT02385175|||Case-Control||Prospective|||||||
1392917|NCT02385162|||Cohort||Retrospective|||||||
1392918|NCT02385149|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1392919|NCT02385136|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392920|NCT02385123||Single Group Assignment||Prevention||None (Open Label)||||||
1392921|NCT02385110|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392922|NCT02385097|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1392923|NCT02385084|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1392924|NCT02385071|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1392925|NCT02385058|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1392926|NCT02385045|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1392927|NCT02385032|Randomized|Crossover Assignment||||None (Open Label)||||||
1392928|NCT02385019|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1392929|NCT02385006|Non-Randomized|Parallel Assignment||Screening||Double|||t|t||
1392930|NCT02384993|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392931|NCT02384980|Randomized|Parallel Assignment||Treatment||Single||||||t
1392932|NCT02384967||Single Group Assignment||Treatment||None (Open Label)||||||
1392933|NCT02384954||Single Group Assignment||Treatment||None (Open Label)||||||
1392934|NCT02384941|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392935|NCT02384928|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1392936|NCT02384915|Randomized|Parallel Assignment||Treatment||Single|||||t|
1392937|NCT02384902|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1392938|NCT02384889|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1392939|NCT02384876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392940|NCT02384863|||Cohort||Prospective|||||||
1392941|NCT02384850||Single Group Assignment||Treatment||None (Open Label)||||||
1392942|NCT02384837|||Cohort||Prospective|||||||
1392943|NCT02384824|||Cohort||Prospective|||||||
1392944|NCT02384811||Single Group Assignment||Treatment||None (Open Label)||||||
1392945|NCT02384798|Randomized|Single Group Assignment||Treatment||Single|||||t|
1392946|NCT02384785|||Cohort||Prospective|||||||
1392947|NCT02384772|||Cohort||Prospective|||||||
1392948|NCT02384759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392949|NCT02384746||Single Group Assignment||Treatment||None (Open Label)||||||
1392950|NCT02384733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392951|NCT02384720|||Case-Only|||||||||
1392952|NCT02384707||Single Group Assignment||||None (Open Label)||||||
1392953|NCT02384694||Single Group Assignment||Treatment||None (Open Label)||||||
1392954|NCT02384681|||Case Control||Prospective|||||||
1392955|NCT02384668|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1392956|NCT02384655||Single Group Assignment||Treatment||None (Open Label)||||||
1392957|NCT02384642|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392958|NCT02384629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392959|NCT02384616|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1392960|NCT02384603|Randomized|Parallel Assignment||Treatment||Single||||||t
1392961|NCT02384590|Randomized|Parallel Assignment||Treatment||Single||||||t
1392962|NCT02384577|||Cohort||Prospective|||||||
1392963|NCT02384564|Randomized|Parallel Assignment||||None (Open Label)||||||
1392964|NCT02384551|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392965|NCT02384538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392966|NCT02384525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392967|NCT02384512|||Cohort||Prospective|||||||
1392968|NCT02384499|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392969|NCT02384486|Randomized|Parallel Assignment||||Single|||||t|
1392970|NCT02384473||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392971|NCT02384460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392972|NCT02384447|||Case-Only||Prospective|||||||
1392973|NCT02384434||Single Group Assignment||Supportive Care||None (Open Label)||||||
1392974|NCT02384421||Single Group Assignment||Basic Science||None (Open Label)||||||
1392975|NCT02384408|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1392976|NCT02384395||Single Group Assignment||Treatment||None (Open Label)||||||
1392977|NCT02384382||Single Group Assignment||Treatment||None (Open Label)||||||
1392978|NCT02384369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392979|NCT02384356|||Cohort||Prospective|||||||
1392980|NCT02384343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1392981|NCT02384330|||Case-Only||Other|||||||
1392982|NCT02384317||Single Group Assignment||Treatment||None (Open Label)||||||
1392983|NCT02384304|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392984|NCT02384291|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392985|NCT02384278||Single Group Assignment||Treatment||None (Open Label)||||||
1392986|NCT02384265|Randomized|Parallel Assignment||Treatment||Single|||t|||
1392987|NCT02384252|||Case-Control||Cross-Sectional|||||||
1392988|NCT02384239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392989|NCT02384226|||Cohort||Prospective|||||||
1392990|NCT02384213|||Cohort||Retrospective|||||||
1392991|NCT02384200|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392992|NCT02384187|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1392993|NCT02384174|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1392994|NCT02384161|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1392995|NCT02384148|||Cohort||Cross-Sectional|||||||
1392996|NCT02384135||Single Group Assignment||Diagnostic||None (Open Label)||||||
1392997|NCT02384122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1392998|NCT02384109|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1392999|NCT02384096|Randomized|Crossover Assignment||Other||Single|||t|||
1393000|NCT02384083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393001|NCT02384070|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1393002|NCT02384057|Randomized|Parallel Assignment||Treatment||Single||||||t
1393003|NCT02384044|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393004|NCT02384031|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1393005|NCT02384018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393006|NCT02384005||Single Group Assignment||Screening||None (Open Label)||||||
1393007|NCT02383992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393008|NCT02383979|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393009|NCT02383966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393010|NCT02383953|||Family-Based||Cross-Sectional|||||||
1393011|NCT02383940|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393012|NCT02383927|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393013|NCT02383914|||Cohort||Prospective|||||||
1393014|NCT02383901|||Cohort||Retrospective|||||||
1393015|NCT02383888|Randomized|Parallel Assignment||Treatment||Double||||||
1393016|NCT02383875||Single Group Assignment||Prevention||None (Open Label)||||||
1393879|NCT02372643||Single Group Assignment||Other||None (Open Label)||||||
1393017|NCT02383862|Randomized|Parallel Assignment||Screening||Single||||||t
1393018|NCT02383849|||Cohort||Prospective|||||||
1393019|NCT02383836|||Case Control||Prospective|||||||
1393020|NCT02383823|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1393021|NCT02383810|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393022|NCT02383797||Single Group Assignment||Prevention||None (Open Label)||||||
1393023|NCT02383784|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393024|NCT02383771|Randomized|Parallel Assignment||Treatment||Single|||||t|
1393025|NCT02383758|Randomized|Parallel Assignment||Treatment||Single||||||t
1393026|NCT02383745|||Cohort||Prospective|||||||
1393027|NCT02383732|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393028|NCT02383719||Single Group Assignment||Supportive Care||None (Open Label)||||||
1393029|NCT02383706|||Cohort||Prospective|||||||
1393030|NCT02383693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393031|NCT02383680|||Cohort||Prospective|||||||
1393032|NCT02383667|||Cohort||Prospective|||||||
1393033|NCT02383654||Single Group Assignment||Treatment||None (Open Label)||||||
1393034|NCT02383641|||Cohort||Prospective|||||||
1393035|NCT02383628|||Case-Control||Prospective|||||||
1393036|NCT02383615|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1393037|NCT02383602|||Cohort||Prospective|||||||
1393038|NCT02383589|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393039|NCT02383576|||Cohort||Retrospective|||||||
1393040|NCT02383563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393041|NCT02383550|||Cohort||Prospective|||||||
1393042|NCT02383537|||Case Control||Prospective|||||||
1393043|NCT02383524|||Cohort||Prospective|||||||
1393044|NCT02383511|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1393045|NCT02383498|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1393046|NCT02383485|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393047|NCT02383472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393048|NCT02383459|||Cohort||Prospective|||||||
1393049|NCT02383446||Single Group Assignment||Treatment||None (Open Label)||||||
1393050|NCT02383433||Single Group Assignment||Treatment||None (Open Label)||||||
1393051|NCT02383420|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1393052|NCT02383407|Randomized|Single Group Assignment||Treatment||Single|||t|||
1393053|NCT02383394|||Cohort||Retrospective|||||||
1393054|NCT02383381|||Case Control||Prospective|||||||
1393055|NCT02383368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393056|NCT02383355|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393057|NCT02383342|||Case-Control||Prospective|||||||
1393058|NCT02383329|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393059|NCT02383316||Single Group Assignment||Basic Science||None (Open Label)||||||
1393060|NCT02383303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393061|NCT02383290||Single Group Assignment||Health Services Research||None (Open Label)||||||
1393062|NCT02383277|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1393063|NCT02383264|||Case Control||Prospective|||||||
1393064|NCT02383251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393065|NCT02383238|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1393066|NCT02383225|Randomized|Factorial Assignment||Prevention||Single|||t|||
1393067|NCT02383212|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393068|NCT02383199|||Case-Only||Retrospective|||||||
1393069|NCT02383186|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393070|NCT02383173|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393071|NCT02383160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393072|NCT02383147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393073|NCT02383134|||||Prospective|||||||
1393074|NCT02383121|||Cohort||Prospective|||||||
1393075|NCT02383108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393076|NCT02383095|Randomized|Parallel Assignment||Treatment||Single||||||t
1393077|NCT02383082||||||||||||
1393078|NCT02383069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393079|NCT02383056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393080|NCT02383043|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1393081|NCT02383030|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1393082|NCT02383017|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1393083|NCT02383004|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1393084|NCT02382991|Randomized|Crossover Assignment||||None (Open Label)||||||
1393085|NCT02382978||Single Group Assignment||Health Services Research||None (Open Label)||||||
1393086|NCT02382965||Single Group Assignment||Basic Science||None (Open Label)||||||
1393087|NCT02382952|Randomized|Parallel Assignment||||None (Open Label)||||||
1393088|NCT02382939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393089|NCT02382926||Single Group Assignment||Basic Science||None (Open Label)||||||
1393090|NCT02382913|Randomized|Parallel Assignment||||None (Open Label)||||||
1393091|NCT02382900|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393092|NCT02382887|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393093|NCT02382874||Single Group Assignment||Treatment||None (Open Label)||||||
1393094|NCT02382861|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393095|NCT02382848|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1393096|NCT02382835|||Case Control||Retrospective|||||||
1393098|NCT02382809|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393099|NCT02382796||||Treatment||None (Open Label)||||||
1393100|NCT02382783|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393101|NCT02382770|||Cohort||Prospective|||||||
1393102|NCT02382757|||Cohort||Prospective|||||||
1393103|NCT02382744|Randomized|Parallel Assignment||Treatment||Single||||||t
1393104|NCT02382731|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1393105|NCT02382718|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393106|NCT02382705|||Cohort||Prospective|||||||
1393107|NCT02382692|||Cohort||Prospective|||||||
1393108|NCT02382679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393109|NCT02382666|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1393110|NCT02382653|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1393111|NCT02382640|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393112|NCT02382627|||Cohort||Cross-Sectional|||||||
1393113|NCT02382614|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393114|NCT02382601|||Case-Control||Prospective|||||||
1393115|NCT02382588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393116|NCT02382575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393117|NCT02382562||Single Group Assignment||Treatment||None (Open Label)||||||
1393118|NCT02382549||Single Group Assignment||Treatment||None (Open Label)||||||
1393119|NCT02382536||||||||||||
1393120|NCT02382523|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393121|NCT02382510|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1393122|NCT02382497|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393123|NCT02382484||Single Group Assignment||Treatment||None (Open Label)||||||
1393124|NCT02382471|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393125|NCT02382458|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393126|NCT02382445|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1393127|NCT02382432|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1393128|NCT02382419|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1393129|NCT02382406|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393130|NCT02382393|Randomized|Crossover Assignment||||Double|||t||t|
1393131|NCT02382380|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1393132|NCT02382367||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393133|NCT02382354|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393134|NCT02382341|||Case-Only||Prospective|||||||
1393135|NCT02382328|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393136|NCT02382315|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393137|NCT02382302||Single Group Assignment||Health Services Research||None (Open Label)||||||
1393138|NCT02382289|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1393139|NCT02382276||Single Group Assignment||Treatment||None (Open Label)||||||
1393140|NCT02382263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393141|NCT02382250|||Cohort||Prospective|||||||
1393142|NCT02382237||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393143|NCT02382224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393144|NCT02382211|||||Prospective|||||||
1393145|NCT02382198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393146|NCT02382185|Randomized|Single Group Assignment||Treatment||Single||||||t
1393147|NCT02382172|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393148|NCT02382159|||Case Control||Retrospective|||||||
1393149|NCT02382146|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1393150|NCT02382133||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393151|NCT02382120|||Case-Only||Prospective|||||||
1393152|NCT02382107|||Case-Only||Cross-Sectional|||||||
1393153|NCT02382094|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393154|NCT02382081|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393155|NCT02382068||Single Group Assignment||Supportive Care||None (Open Label)||||||
1393156|NCT02382055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393157|NCT02382042||Parallel Assignment||Treatment||||||||
1393158|NCT02382029|Randomized|Parallel Assignment||Treatment||Single|||||t|
1393159|NCT02382016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393160|NCT02382003|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393161|NCT02381990|||Cohort||Prospective|||||||
1393162|NCT02381977|||||Cross-Sectional|||||||
1393163|NCT02381964|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1393164|NCT02381951||Single Group Assignment||Treatment||None (Open Label)||||||
1393165|NCT02381938|Randomized|Parallel Assignment||Prevention||Single||||||t
1393166|NCT02381925|||Cohort||Prospective|||||||
1393167|NCT02381912|||Case Control||Prospective|||||||
1393168|NCT02381899|||Cohort||Prospective|||||||
1393169|NCT02381886|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393170|NCT02381873|||Cohort||Prospective|||||||
1393171|NCT02381860|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1393172|NCT02381847|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393173|NCT02381834||Single Group Assignment||Treatment||None (Open Label)||||||
1393174|NCT02381821|||Cohort||Prospective|||||||
1393175|NCT02381808|||Case-Only||Prospective|||||||
1393176|NCT02381795||Single Group Assignment||Treatment||None (Open Label)||||||
1393177|NCT02381782|||Cohort||Prospective|||||||
1393178|NCT02381769||Single Group Assignment||Supportive Care||None (Open Label)||||||
1393179|NCT02381756|||Cohort||Prospective|||||||
1393180|NCT02381743|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393181|NCT02381730||Single Group Assignment||Treatment||None (Open Label)||||||
1393182|NCT02381717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393183|NCT02381704|||Ecologic or Community||Prospective|||||||
1393184|NCT02381691|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1393185|NCT02381678|||Case-Only||Retrospective|||||||
1393186|NCT02381665|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393187|NCT02381652||Single Group Assignment||Treatment||None (Open Label)||||||
1393188|NCT02381639|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393189|NCT02381626|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393190|NCT02381613|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1393191|NCT02381600||Single Group Assignment||Treatment||None (Open Label)||||||
1393192|NCT02381587|||Case-Only||Retrospective|||||||
1393193|NCT02381574|||||Prospective|||||||
1393194|NCT02381561||Single Group Assignment||Treatment||None (Open Label)||||||
1393195|NCT02381548||Single Group Assignment||Treatment||None (Open Label)||||||
1393196|NCT02381535||Single Group Assignment||Treatment||None (Open Label)||||||
1393197|NCT02381522|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1393198|NCT02381509|||Cohort||Prospective|||||||
1393199|NCT02381496|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1393200|NCT02381483|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1393201|NCT02381470|Randomized|Parallel Assignment||Treatment||Single||||||t
1393202|NCT02381457|||Cohort||Prospective|||||||
1393203|NCT02381444|||Case-Only||Prospective|||||||
1393204|NCT02381431||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393205|NCT02381418||Single Group Assignment||Prevention||None (Open Label)||||||
1393206|NCT02381405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393207|NCT02381392|Randomized|Parallel Assignment||Treatment||None (Open Label)||Intervention group using Accuvein, Control group standard care||||
1393208|NCT02381379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393209|NCT02381366||Single Group Assignment||Prevention||None (Open Label)||||||
1393210|NCT02381353|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1393211|NCT02381340|||Cohort||Prospective|||||||
1393212|NCT02381327|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393213|NCT02381314||Single Group Assignment||Treatment||None (Open Label)||||||
1393214|NCT02381301|||Cohort||Prospective|||||||
1393215|NCT02381288|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393216|NCT02381275|||Cohort||Prospective|||||||
1393217|NCT02381262|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393218|NCT02381249|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1393219|NCT02381236||Single Group Assignment||Treatment||None (Open Label)||||||
1393220|NCT02381223|||Cohort||Prospective|||||||
1393221|NCT02381210|||Case-Control||Prospective|||||||
1393222|NCT02381197|||Cohort||Prospective|||||||
1393223|NCT02381184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393224|NCT02381171|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1393225|NCT02381158||Single Group Assignment||Treatment||None (Open Label)||||||
1393226|NCT02381145|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393227|NCT02381132|Randomized|Parallel Assignment||||None (Open Label)||||||
1393228|NCT02381119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393229|NCT02381106|||Case-Only||Prospective|||||||
1393230|NCT02381093|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393231|NCT02381080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393232|NCT02381067||Single Group Assignment||Treatment||None (Open Label)||||||
1393233|NCT02381054|||Case-Only||Cross-Sectional|||||||
1393234|NCT02381041|||Cohort||Prospective|||||||
1393235|NCT02381028|Randomized|Single Group Assignment||Treatment||Single|||||t|
1393236|NCT02381015|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1393237|NCT02381002||Single Group Assignment||Health Services Research||None (Open Label)||||||
1393238|NCT02380989|Randomized|Parallel Assignment||Treatment||Single||||||t
1393239|NCT02380976|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393240|NCT02380963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393241|NCT02380950||Single Group Assignment||Basic Science||None (Open Label)||||||
1393242|NCT02380937||Single Group Assignment||Treatment||None (Open Label)||||||
1393243|NCT02380924|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393244|NCT02380911|Randomized|Parallel Assignment||Other||Single|||t|||
1393245|NCT02380898|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393246|NCT02380885|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1393247|NCT02380872|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1393248|NCT02380859|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393249|NCT02380846|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1393250|NCT02380833|Randomized|Factorial Assignment||||None (Open Label)||||||
1393251|NCT02380820|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1393252|NCT02380807|Randomized|Single Group Assignment||Treatment||Single||||||t
1393253|NCT02380794|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393254|NCT02380781|Randomized|Parallel Assignment||Other||Single|||t|||
1396661|NCT02336269|||Case-Only||Prospective|||||||
1393255|NCT02380768|Randomized|Parallel Assignment||||None (Open Label)||||||
1393256|NCT02380755|Randomized|Parallel Assignment||Treatment||Triple|randomized, double blinded, placebo-controlled, parallel group, single-center study|78 patients were randomized (1:1) to receive Clomiphene Citrate (CC) 50 mg during 12 weeks or placebo (PLB). MAIN OUTCOME MEASURES: flow-mediated dilatation of the brachial artery (FMDAB), circulating levels of sICAM-1, sVCAM-1, E-selectin and progenitor endothelial cells. Secondary endpoints: Body mass index (BMI), abdominal circumference (AC), glycaemia, total cholesterol, fractions and triglycerides, HOMA-IR index, bioelectrical impedance parameters, Adam questionnaire and hormonal parameters (total testosterone levels, SHBG, LH, FSH and Estradiol).|t|t|t|
1393257|NCT02380742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393258|NCT02380729|||Family-Based||Prospective|||||||
1393259|NCT02380716||||||||||||
1393260|NCT02380703|Randomized|Parallel Assignment||Prevention||Single||||||t
1393261|NCT02380690|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393262|NCT02380677||Single Group Assignment||Treatment||None (Open Label)||||||
1393263|NCT02380664|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393264|NCT02380651|||Cohort||Prospective|||||||
1393265|NCT02380638|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1393266|NCT02380625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393267|NCT02380612|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393268|NCT02380599||Single Group Assignment||Basic Science||Double|||t|||t
1393269|NCT02380586|||Case-Only||Prospective|||||||
1393270|NCT02380573|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1393271|NCT02380560|||Case-Control||Prospective|||||||
1393272|NCT02380547|||Cohort||Prospective|||||||
1393273|NCT02380534||Single Group Assignment||Treatment||None (Open Label)||||||
1393274|NCT02380521||Single Group Assignment||Treatment||None (Open Label)||||||
1393275|NCT02380508|Randomized|Parallel Assignment||||None (Open Label)||||||
1393276|NCT02380495|||Case-Control||Cross-Sectional|||||||
1393277|NCT02380482|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1393278|NCT02380469|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393279|NCT02380443|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393280|NCT02380430|||||Prospective|||||||
1393281|NCT02380417|||Cohort||Prospective|||||||
1393282|NCT02380404|||Cohort||Prospective|||||||
1393283|NCT02380391|||Case Control||Prospective|||||||
1393284|NCT02380378|||||Prospective|||||||
1393285|NCT02380365|||Cohort||Prospective|||||||
1393286|NCT02380352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393287|NCT02380339|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393288|NCT02380326|||Cohort||Prospective|||||||
1393289|NCT02380313|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393290|NCT02380300|||Cohort||Prospective|||||||
1393291|NCT02380287|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1393292|NCT02380274|||Cohort||Prospective|||||||
1393293|NCT02380261||Single Group Assignment||||Single|||t|||
1393294|NCT02380248||Single Group Assignment||Treatment||None (Open Label)||||||
1393295|NCT02380235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393296|NCT02380222|||Case-Only||Cross-Sectional|||||||
1393297|NCT02380209||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393298|NCT02380196|||Cohort||Prospective|||||||
1393299|NCT02380183|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393300|NCT02380170|||Case-Only||Prospective|||||||
1393301|NCT02380157|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1393302|NCT02380144|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1393303|NCT02380131||Single Group Assignment||Treatment||None (Open Label)||||||
1393304|NCT02380118|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393305|NCT02380105|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393306|NCT02380092|||Cohort||Prospective|||||||
1393307|NCT02380079|Randomized|Crossover Assignment||Treatment||Quadruple||2x2 crossover|t|t|t|t
1393308|NCT02380066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393309|NCT02380053|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393310|NCT02380040|||Case Control||Prospective|||||||
1393311|NCT02380027|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1393312|NCT02380014||||||||||||
1393313|NCT02380001|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393314|NCT02379988||Single Group Assignment||Treatment||None (Open Label)||||||
1393315|NCT02379975|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393316|NCT02379962|||Ecologic or Community||Cross-Sectional|||||||
1393317|NCT02379949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393318|NCT02379936|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1393319|NCT02379923||Single Group Assignment||Treatment||None (Open Label)||||||
1393320|NCT02379910|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1393321|NCT02379897|Randomized|Parallel Assignment||||Triple|||t||t|t
1393322|NCT02379884|||Cohort||Prospective|||||||
1393323|NCT02379871|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1393324|NCT02379858|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393325|NCT02379845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393326|NCT02379832|||Case-Control||Prospective|||||||
1393327|NCT02379819||Single Group Assignment||Treatment||None (Open Label)||||||
1393328|NCT02379806|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1393329|NCT02379793||Single Group Assignment||Treatment||None (Open Label)||||||
1393330|NCT02379780|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393331|NCT02379767|||Case Control||Prospective|||||||
1393332|NCT02379754|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393333|NCT02379741|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393334|NCT02379728|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393335|NCT02379715||Single Group Assignment||||Single|||||t|
1393336|NCT02379702|||||Prospective|||||||
1393337|NCT02379689|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1393338|NCT02379676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393339|NCT02379663|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393340|NCT02379650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393341|NCT02379637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393342|NCT02379624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393343|NCT02379611|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1393344|NCT02379598|||Cohort||Prospective|||||||
1393345|NCT02379585|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393346|NCT02379572|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1393347|NCT02379559|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1393348|NCT02379546|Randomized|Parallel Assignment||Prevention||Single|||t|||
1393349|NCT02379533|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1393350|NCT02379520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393351|NCT02379507||Single Group Assignment||Supportive Care||None (Open Label)||||||
1393352|NCT02379494|||Cohort||Prospective|||||||
1393353|NCT02379481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393354|NCT02379468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393355|NCT02379455|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1393356|NCT02379442||Single Group Assignment||Treatment||None (Open Label)||||||
1393357|NCT02379429|||Case-Control||Prospective|||||||
1393358|NCT02379416||Single Group Assignment||Treatment||None (Open Label)||||||
1393359|NCT02379403|||Case-Crossover||Prospective|||||||
1393360|NCT02379390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393361|NCT02379377||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393362|NCT02379364||Single Group Assignment||Treatment||None (Open Label)||||||
1393363|NCT02379351||Single Group Assignment||Supportive Care||None (Open Label)||||||
1393364|NCT02379338|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393365|NCT02379325|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1393366|NCT02379312|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1393367|NCT02379299|Randomized|Crossover Assignment||Treatment||Single|||t|||
1393368|NCT02379286|||Cohort||Prospective|||||||
1393369|NCT02379273||Single Group Assignment||Treatment||None (Open Label)||||||
1393370|NCT02379260|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1393371|NCT02379247|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393372|NCT02379234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393373|NCT02379221||Single Group Assignment||Treatment||None (Open Label)||||||
1393374|NCT02379208|||Cohort||Prospective|||||||
1393375|NCT02379195||Single Group Assignment||Treatment||None (Open Label)||||||
1393376|NCT02379182|Randomized|Parallel Assignment||Treatment||Single||||||t
1393377|NCT02379169|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393378|NCT02379156|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393379|NCT02379143|||||Cross-Sectional|||||||
1393380|NCT02379130|Randomized|Parallel Assignment||||Double|||t|||t
1393381|NCT02379117|||Cohort||Prospective|||||||
1393382|NCT02379104|||Cohort||Prospective|||||||
1393383|NCT02379091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393384|NCT02379078|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1393385|NCT02379065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393386|NCT02379052|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393387|NCT02379039|||Case-Only||Prospective|||||||
1393388|NCT02379026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393389|NCT02379013||Single Group Assignment||Basic Science||None (Open Label)||||||
1393390|NCT02379000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393391|NCT02378987|||Cohort||Prospective|||||||
1393392|NCT02378974|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393393|NCT02378961|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1393394|NCT02378948|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393395|NCT02378935|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1393396|NCT02378922||Single Group Assignment||Treatment||None (Open Label)||||||
1393397|NCT02378909|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1393398|NCT02378896||Single Group Assignment||Treatment||None (Open Label)||||||
1393399|NCT02378883||Single Group Assignment||Treatment||None (Open Label)||||||
1393400|NCT02378870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393401|NCT02378857|||Cohort||Cross-Sectional|||||||
1393402|NCT02378844|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1393403|NCT02378831|||Case-Only||Prospective|||||||
1393404|NCT02378818|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1393405|NCT02378805|||Cohort||Cross-Sectional|||||||
1393406|NCT02378792|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393407|NCT02378779|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1393408|NCT02378766|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393409|NCT02378753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393410|NCT02378740|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393411|NCT02378727|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1393412|NCT02378714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393413|NCT02378701|||Cohort||Prospective|||||||
1393414|NCT02378688|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393415|NCT02378675|||Cohort||Prospective|||||||
1393416|NCT02378662|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393417|NCT02378649|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393418|NCT02378636||Single Group Assignment||Treatment||None (Open Label)||||||
1393419|NCT02378623|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1393420|NCT02378610|||Cohort||Retrospective|||||||
1393421|NCT02378597|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393422|NCT02378584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393423|NCT02378571|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393424|NCT02378558||Single Group Assignment||Treatment||None (Open Label)||||||
1393425|NCT02378545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393426|NCT02378532||Single Group Assignment||Treatment||None (Open Label)||||||
1393427|NCT02378519|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393428|NCT02378506||Single Group Assignment||Treatment||None (Open Label)||||||
1393429|NCT02378493|||Case-Control||Prospective|||||||
1393430|NCT02378480|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393431|NCT02378467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393432|NCT02378454|||Cohort||Cross-Sectional|||||||
1393433|NCT02378441|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393434|NCT02378428||Single Group Assignment||Treatment||None (Open Label)||||||
1393435|NCT02378415|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393436|NCT02378402|||Case-Only||Prospective|||||||
1393437|NCT02378389||Single Group Assignment||Treatment||None (Open Label)||||||
1393438|NCT02378376|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1393439|NCT02378363|||||Prospective|||||||
1393440|NCT02378350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393441|NCT02378337|||Cohort||Other|||||||
1393442|NCT02378324|Randomized|Parallel Assignment||Screening||Single||||t||
1393443|NCT02378311|||Case Control||Prospective|||||||
1393444|NCT02378298|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1393445|NCT02378285|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393446|NCT02378272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393447|NCT02378259|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomisation between Roux-en-Y gastric bypass or Intensive Medical treatment||||
1393448|NCT02378246|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1393449|NCT02378233|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1393450|NCT02378220|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393451|NCT02378207|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393452|NCT02378194|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393453|NCT02378181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393454|NCT02378168|||||Retrospective|||||||
1393455|NCT02378155|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393456|NCT02378142||Single Group Assignment||Treatment||None (Open Label)||||||
1393457|NCT02378129|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393458|NCT02378116|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393459|NCT02378103|||Case Control||Retrospective|||||||
1393460|NCT02378090|||Case-Only||Prospective|||||||
1393461|NCT02378077|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393462|NCT02378064|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1393463|NCT02378051|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1393464|NCT02378038||Single Group Assignment||Treatment||None (Open Label)||||||
1393465|NCT02378025|Randomized|Parallel Assignment||Treatment||Single||||||t
1393466|NCT02378012|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393467|NCT02377999||Single Group Assignment||Treatment||None (Open Label)||||||
1393468|NCT02377986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393469|NCT02377973|||Cohort||Prospective|||||||
1393470|NCT02377960|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393471|NCT02377947||||||||||||
1393472|NCT02377934|||Case-Only||Prospective|||||||
1393473|NCT02377921|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393474|NCT02377908|||||Cross-Sectional|||||||
1393475|NCT02377895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393476|NCT02377882|||Case Control||Prospective|||||||
1393477|NCT02377869|||Cohort||Prospective|||||||
1393478|NCT02377856|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393479|NCT02377843|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393480|NCT02377830|Randomized|Parallel Assignment||Treatment||Single||||||t
1393481|NCT02377817|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1393482|NCT02377804|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1393483|NCT02377791|||Cohort||Retrospective|||||||
1393484|NCT02377778|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393485|NCT02377765|Randomized|Parallel Assignment||Treatment||Single||||||t
1393486|NCT02377752|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393487|NCT02377739||Single Group Assignment||Treatment||None (Open Label)||||||
1393488|NCT02377726|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393489|NCT02377713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393490|NCT02377700||Single Group Assignment||Treatment||None (Open Label)||||||
1393491|NCT02377687|||Cohort||Prospective|||||||
1393492|NCT02377674||Single Group Assignment||Treatment||None (Open Label)||||||
1393493|NCT02377661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393494|NCT02377648||Single Group Assignment||Treatment||None (Open Label)||||||
1393495|NCT02377635|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1393496|NCT02377622|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393497|NCT02377609|||Case-Only|||||||||
1393498|NCT02377596|||Case-Only||Cross-Sectional|||||||
1393499|NCT02377583|||Family-Based||Prospective|||||||
1393500|NCT02377570|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393501|NCT02377557|||Cohort||Prospective|||||||
1393502|NCT02377544|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1393503|NCT02377531|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393504|NCT02377518|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1393505|NCT02377505|Randomized|Crossover Assignment||Treatment||Single||||||t
1393506|NCT02377492|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1393507|NCT02377479|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393508|NCT02377466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393509|NCT02377453|||Cohort||Prospective|||||||
1393510|NCT02377440|||Cohort||Prospective|||||||
1393511|NCT02377427|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393512|NCT02377414|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393513|NCT02377401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393514|NCT02377388|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393515|NCT02377375|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393516|NCT02377362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393517|NCT02377349|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1393518|NCT02377336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393519|NCT02377323|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393520|NCT02377310|||Cohort||Prospective|||||||
1393521|NCT02377297|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393522|NCT02377284|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393523|NCT02377271|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393524|NCT02377258|||Cohort||Prospective|||||||
1393525|NCT02377245|||Cohort||Prospective|||||||
1393526|NCT02377232|Randomized|Single Group Assignment||Screening||Triple|||t|t|t|
1393527|NCT02377219||Single Group Assignment||Basic Science||None (Open Label)||||||
1393528|NCT02377206||Single Group Assignment||Basic Science||None (Open Label)||||||
1393529|NCT02377193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393530|NCT02377180|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1393531|NCT02377167|Randomized|Parallel Assignment||Treatment||Single||||||t
1393532|NCT02377154||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393533|NCT02377141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393534|NCT02377128|Randomized|Parallel Assignment||Treatment||Single||||||t
1393535|NCT02377115||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393536|NCT02377102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393537|NCT02377089|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393538|NCT02377076|Randomized|Crossover Assignment||Treatment||Single|||t|||
1393539|NCT02377063||Single Group Assignment||||None (Open Label)||||||
1393540|NCT02377050|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393541|NCT02377037|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1393542|NCT02377024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393543|NCT02377011|Randomized|Parallel Assignment||Treatment||Single|||||t|
1393544|NCT02376998||Single Group Assignment||Treatment||None (Open Label)||||||
1393545|NCT02376985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393546|NCT02376972|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393547|NCT02376959|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393548|NCT02376946|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1393549|NCT02376933||Single Group Assignment||Treatment||None (Open Label)||||||
1393550|NCT02376920|||Cohort||Prospective|||||||
1393551|NCT02376907|||Cohort||Retrospective|||||||
1393552|NCT02376894|||Other||Cross-Sectional|||||||
1393553|NCT02376881|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1393554|NCT02376868|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1393555|NCT02376855|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1393556|NCT02376842|Randomized|Parallel Assignment||||Single||||t||
1393557|NCT02376829||Single Group Assignment||Treatment||None (Open Label)||||||
1393558|NCT02376816|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1393559|NCT02376803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393560|NCT02376790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393561|NCT02376777|||Cohort||Prospective|||||||
1393562|NCT02376764|||Cohort||Prospective|||||||
1393563|NCT02376751||||||||||||
1393565|NCT02376725|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393566|NCT02376712|||Cohort||Prospective|||||||
1393567|NCT02376699|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393568|NCT02376686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393569|NCT02376673|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393570|NCT02376660|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1393571|NCT02376647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393572|NCT02376634|Randomized|Parallel Assignment||Treatment||Single||||||t
1393573|NCT02376621|Randomized|Single Group Assignment||||None (Open Label)||||||
1393574|NCT02376608|Randomized|Crossover Assignment||||None (Open Label)||||||
1393575|NCT02376595|||Case-Only||Prospective|||||||
1393576|NCT02376582|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1393577|NCT02376569|||Cohort||Prospective|||||||
1393578|NCT02376556|||Case Control||Prospective|||||||
1393579|NCT02376543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393580|NCT02376530|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1393581|NCT02376517|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1393582|NCT02376504|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393583|NCT02376491|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393584|NCT02376478|||Case Control||Prospective|||||||
1393585|NCT02376465|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393586|NCT02376452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393587|NCT02376439|||Cohort||Cross-Sectional|||||||
1393588|NCT02376426|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1393589|NCT02376413|||Cohort||Prospective|||||||
1393590|NCT02376400|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1393591|NCT02376387|||Cohort||Prospective|||||||
1393592|NCT02376374|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393593|NCT02376361|Randomized|Parallel Assignment||Screening||Single||||||t
1393594|NCT02376348|Randomized|Single Group Assignment||Health Services Research||Single||||t||
1393595|NCT02376335|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393596|NCT02376322||Single Group Assignment||Treatment||None (Open Label)||Radiotherapy||||
1393597|NCT02376309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393598|NCT02376296|||Cohort||Prospective|||||||
1393599|NCT02376283|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393600|NCT02376270|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393601|NCT02376257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393602|NCT02376244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393603|NCT02376231|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393604|NCT02376218||Single Group Assignment||Treatment||None (Open Label)||||||
1393605|NCT02376205|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1393606|NCT02376192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393607|NCT02376179|||Cohort||Prospective|||||||
1393608|NCT02376166||Single Group Assignment||Other||None (Open Label)||||||
1393609|NCT02376153|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393610|NCT02376140|||Cohort||Cross-Sectional|||||||
1393611|NCT02376127|||Cohort||Prospective|||||||
1393612|NCT02376114|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1393613|NCT02376101|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1393614|NCT02376088|||Cohort||Prospective|||||||
1393615|NCT02376075|Randomized|Parallel Assignment||||Double|||t|||t
1393616|NCT02376062||Single Group Assignment||Health Services Research||None (Open Label)||||||
1393617|NCT02376049|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1393618|NCT02376036|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1393619|NCT02376023|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1393620|NCT02376010|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1393621|NCT02375997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393622|NCT02375984||Single Group Assignment||Treatment||None (Open Label)||||||
1393623|NCT02375971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393624|NCT02375958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393625|NCT02375945|Randomized|Single Group Assignment||Treatment||Single|||t|||
1393626|NCT02375932|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1393627|NCT02375919|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1393628|NCT02375906|||Cohort||Cross-Sectional|||||||
1393629|NCT02375893|||Case Control||Prospective|||||||
1393630|NCT02375880|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393631|NCT02375867|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1393632|NCT02375854|||Cohort||Prospective|||||||
1393633|NCT02375841|||Cohort||Prospective|||||||
1393634|NCT02375828||Single Group Assignment||Treatment||None (Open Label)||||||
1393635|NCT02375815||Single Group Assignment||Health Services Research||None (Open Label)||||||
1393636|NCT02375802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393637|NCT02375789|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393638|NCT02375776|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393639|NCT02375763|Randomized|Parallel Assignment||Prevention||Single|||t|||
1393640|NCT02375750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393641|NCT02375737||Single Group Assignment||||None (Open Label)||||||
1393642|NCT02375724|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393644|NCT02375698|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1393645|NCT02375685||Single Group Assignment||Treatment||None (Open Label)||||||
1393646|NCT02375672||Single Group Assignment||Treatment||None (Open Label)||||||
1393647|NCT02375659|||Cohort||Prospective|||||||
1393648|NCT02375646|Randomized|Parallel Assignment||Prevention||Single||||t||
1393649|NCT02375633|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393650|NCT02375620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393651|NCT02375607||Single Group Assignment||Screening||None (Open Label)||||||
1393652|NCT02375594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393653|NCT02375581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393654|NCT02375568|||Case-Only||Prospective|||||||
1393655|NCT02375555||Single Group Assignment||Treatment||None (Open Label)||||||
1393656|NCT02375542|||Cohort||Prospective|||||||
1393657|NCT02375529|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393658|NCT02375516|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393659|NCT02375503|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393660|NCT02375490|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393661|NCT02375477||Single Group Assignment||Health Services Research||None (Open Label)||||||
1393662|NCT02375464||||||||||||
1393663|NCT02375451|||Cohort||Cross-Sectional|||||||
1393664|NCT02375438|||Cohort||Prospective|||||||
1393665|NCT02375425|||Case-Control||Cross-Sectional|||||||
1393666|NCT02375412|||Case-Only||Prospective|||||||
1393667|NCT02375399|||Case-Only||Prospective|||||||
1393668|NCT02375386|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393669|NCT02375373|||Cohort||Prospective|||||||
1393670|NCT02375360|||Case Control||Prospective|||||||
1393671|NCT02375347||Single Group Assignment||||None (Open Label)||||||
1393672|NCT02375334|||Cohort||Prospective|||||||
1393673|NCT02375321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393674|NCT02375308|Randomized|Parallel Assignment||Treatment||Single||||||t
1393675|NCT02375295|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393676|NCT02375282|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393677|NCT02375269|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1393678|NCT02375256|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393679|NCT02375243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393680|NCT02375230|Randomized|Single Group Assignment||Prevention||Double|||||t|t
1393681|NCT02375217|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393682|NCT02375204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393683|NCT02375191|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393684|NCT02375178|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393685|NCT02375165|||Case-Control||Cross-Sectional|||||||
1393686|NCT02375152||Single Group Assignment||Treatment||None (Open Label)||||||
1393687|NCT02375139|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393688|NCT02375126|||Cohort||Prospective|||||||
1393689|NCT02375113|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1393690|NCT02375100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393691|NCT02375087|||Cohort||Prospective|||||||
1393692|NCT02375074|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393693|NCT02375061|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393694|NCT02375048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393695|NCT02375035|||||Prospective|||||||
1393696|NCT02375022||Single Group Assignment||Treatment||None (Open Label)||||||
1393697|NCT02375009||Single Group Assignment||Treatment||None (Open Label)||||||
1393698|NCT02374996|||Cohort||Cross-Sectional|||||||
1393699|NCT02374983|||||Prospective|||||||
1393700|NCT02374970|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393701|NCT02374957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393702|NCT02374944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393703|NCT02374931||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393704|NCT02374918|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393705|NCT02374905|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393706|NCT02374892|Randomized|Parallel Assignment||Other||Single|||t|||
1393707|NCT02374879||Single Group Assignment||Other||None (Open Label)||||||
1393708|NCT02374866|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393709|NCT02374853|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1393710|NCT02374840|||Cohort|||||||||
1393711|NCT02374827|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393712|NCT02374814|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393713|NCT02374801||Single Group Assignment||Treatment||None (Open Label)||||||
1393714|NCT02374788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393715|NCT02374775|||Case-Control||Retrospective|||||||
1393716|NCT02374762|||Case-Only||Prospective|||||||
1393717|NCT02374749|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393718|NCT02374736||Single Group Assignment||Treatment||None (Open Label)||||||
1393719|NCT02374723|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393720|NCT02374710|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393721|NCT02374697|||Case Control||Prospective|||||||
1393722|NCT02374684|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393723|NCT02374671||Single Group Assignment||Treatment||None (Open Label)||||||
1393724|NCT02374658|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1393725|NCT02374645|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393726|NCT02374632|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1393727|NCT02374619|Randomized|Crossover Assignment||||Double|||t||t|
1393728|NCT02374606|||Cohort||Prospective|||||||
1393729|NCT02374593||Single Group Assignment||Treatment||None (Open Label)||||||
1393730|NCT02374580|||||Cross-Sectional|||||||
1393731|NCT02374567||Single Group Assignment||Treatment||None (Open Label)||||||
1393732|NCT02374554||Single Group Assignment||Supportive Care||Single||||||t
1393733|NCT02374541|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1393734|NCT02374528|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393735|NCT02374515|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1393736|NCT02374502|Randomized|Parallel Assignment||Treatment||Single||||||t
1393737|NCT02374489||Single Group Assignment||Treatment||None (Open Label)||||||
1393738|NCT02374476||Single Group Assignment||Treatment||None (Open Label)||||||
1393739|NCT02374463|Randomized|Parallel Assignment||Prevention||Single||||||t
1393740|NCT02374450||Single Group Assignment||Other||None (Open Label)||||||
1393741|NCT02374437|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1393742|NCT02374424||Single Group Assignment||Treatment||None (Open Label)||||||
1393743|NCT02374411|||Case-Only||Cross-Sectional|||||||
1393744|NCT02374398|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1393745|NCT02374385|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1393746|NCT02374372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393747|NCT02374359|||Cohort||Retrospective|||||||
1393748|NCT02374346|||Cohort||Prospective|||||||
1393749|NCT02374333||Single Group Assignment||Treatment||None (Open Label)||||||
1393750|NCT02374320||Single Group Assignment||Treatment||None (Open Label)||||||
1393751|NCT02374307|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1393752|NCT02374294|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393753|NCT02374281|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1393754|NCT02374268|Randomized|Parallel Assignment||Treatment||Single||||||t
1393755|NCT02374255|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393756|NCT02374242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393757|NCT02374229|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393758|NCT02374216||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393759|NCT02374203||Single Group Assignment||Supportive Care||None (Open Label)||Patients were randomized 1:1 to two tube feeding regimens: general formula and high protein formula (1.5~2.0 gm/kg BW).||||
1393760|NCT02374190|||Case-Only||Retrospective|||||||
1393761|NCT02374177|||||Retrospective|||||||
1393762|NCT02374164|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393763|NCT02374151|||Case-Only||Prospective|||||||
1393764|NCT02374138|Randomized|Parallel Assignment||Treatment||Single||||||t
1393765|NCT02374125|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393766|NCT02374112|Randomized|Parallel Assignment||Treatment||Double||Creatine|t|t||
1393767|NCT02374099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393768|NCT02374086||Single Group Assignment||Treatment||None (Open Label)||||||
1393769|NCT02374073|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393770|NCT02374060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393771|NCT02374047|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1393772|NCT02374034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393773|NCT02374021|Randomized|Parallel Assignment||Treatment||Single||||||t
1393774|NCT02374008|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393775|NCT02373995|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393776|NCT02373982|||Cohort||Retrospective|||||||
1393777|NCT02373969|||Case-Only||Prospective|||||||
1393778|NCT02373956|Randomized|Parallel Assignment||Treatment||Single||||||t
1393779|NCT02373943|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1393780|NCT02373930|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393781|NCT02373917|||Cohort||Prospective|||||||
1393782|NCT02373904||Single Group Assignment||Treatment||None (Open Label)||||||
1393783|NCT02373891|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393784|NCT02373878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393785|NCT02373865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393786|NCT02373852|||Cohort||Retrospective|||||||
1393787|NCT02373839|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393788|NCT02373826|||Cohort||Retrospective|||||||
1393789|NCT02373813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393790|NCT02373800|||Cohort||Prospective|||||||
1393791|NCT02373787|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1393792|NCT02373774|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1393793|NCT02373761|||Case-Only||Prospective|||||||
1393794|NCT02373748||Single Group Assignment||Treatment||None (Open Label)||||||
1393795|NCT02373735|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1393796|NCT02373722|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1393797|NCT02373709|||Case-Control||Retrospective|||||||
1393798|NCT02373696|||Cohort||Prospective|||||||
1393799|NCT02373683|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393800|NCT02373670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393801|NCT02373657|Randomized|Parallel Assignment||Prevention||Single||||||t
1393802|NCT02373644|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393803|NCT02373631|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393804|NCT02373618|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393805|NCT02373605|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393806|NCT02373592|Randomized|Parallel Assignment||Prevention||Single||||||t
1393807|NCT02373579|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393808|NCT02373566|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393809|NCT02373553|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1393810|NCT02373540|||Cohort||Prospective|||||||
1393811|NCT02373527|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1393812|NCT02373514|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393813|NCT02373501|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393814|NCT02373488|Randomized|Parallel Assignment||Treatment||Single||||||t
1393815|NCT02373475|Randomized|Parallel Assignment||Prevention||Single|||t|||
1393816|NCT02373462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393817|NCT02373449||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393818|NCT02373436|Randomized|Crossover Assignment||Treatment||Single|||||t|
1393819|NCT02373423|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1393820|NCT02373410|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1393821|NCT02373397|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1393822|NCT02373384||Single Group Assignment||Treatment||None (Open Label)||||||
1393823|NCT02373371|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1393824|NCT02373358||Single Group Assignment||Treatment||None (Open Label)||||||
1393825|NCT02373345|||||Prospective|||||||
1393826|NCT02373332|||Case-Control||Prospective|||||||
1393827|NCT02373319|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1393828|NCT02373306|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1393829|NCT02373293|||Cohort||Prospective|||||||
1393830|NCT02373280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients selected study||||
1393831|NCT02373267|||Cohort||Prospective|||||||
1393832|NCT02373254|Randomized|Parallel Assignment||Treatment||Single||||||t
1393833|NCT02373241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393834|NCT02373228||Single Group Assignment||Treatment||Double|||t||t|
1393835|NCT02373215|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393836|NCT02373202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393837|NCT02373189||Single Group Assignment||Basic Science||None (Open Label)||||||
1393838|NCT02373176||Single Group Assignment||||None (Open Label)||||||
1393839|NCT02373163|Randomized|Parallel Assignment||Treatment||Single||||||t
1393840|NCT02373150|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393841|NCT02373137|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393842|NCT02373124||Single Group Assignment||Treatment||None (Open Label)||||||
1393843|NCT02373111|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393844|NCT02373098||Single Group Assignment||Treatment||None (Open Label)||||||
1393845|NCT02373085|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393846|NCT02373072|Randomized|||Basic Science||Double|||t||t|
1393847|NCT02373059|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393848|NCT02373046|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393849|NCT02373033|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1393850|NCT02373020|||Cohort||Prospective|||||||
1393851|NCT02373007|Randomized|Parallel Assignment||Treatment||Single|||t|||
1393852|NCT02372994|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393853|NCT02372981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393854|NCT02372968|||Cohort||Prospective|||||||
1393855|NCT02372955|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393856|NCT02372942|Randomized|Parallel Assignment||Prevention||Single|||||t|
1393857|NCT02372929|||Case-Only||Prospective|||||||
1393858|NCT02372916|||Case Control||Prospective|||||||
1393859|NCT02372903||Single Group Assignment||Treatment||None (Open Label)||||||
1393860|NCT02372890|||Case-Only||Prospective|||||||
1393861|NCT02372877||Single Group Assignment||Treatment||None (Open Label)||||||
1393862|NCT02372864|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1393863|NCT02372851|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393864|NCT02372838|||||Cross-Sectional|||||||
1393865|NCT02372825|||||Cross-Sectional|||||||
1393866|NCT02372812|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1393867|NCT02372799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393868|NCT02372786|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1393869|NCT02372773|||Family-Based||Prospective|||||||
1393870|NCT02372760|Randomized|Parallel Assignment||||Double|||t|||t
1393871|NCT02372747|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1393872|NCT02372734|||Cohort||Cross-Sectional|||||||
1393873|NCT02372721|||Case Control||Cross-Sectional|||||||
1393874|NCT02372708|||Cohort||Prospective|||||||
1393875|NCT02372695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393876|NCT02372682|||Case-Control||Prospective|||||||
1393877|NCT02372669|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393878|NCT02372656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393880|NCT02372630|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393881|NCT02372617|||Cohort||Prospective|||||||
1393882|NCT02372604|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393883|NCT02372591|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1393884|NCT02372578|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393885|NCT02372565|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393886|NCT02372552||Single Group Assignment||Treatment||None (Open Label)||||||
1393887|NCT02372539|||Other||Prospective|||||||
1393888|NCT02372526|||Case-Control||Cross-Sectional|||||||
1393889|NCT02372513|||Cohort||Prospective|||||||
1393890|NCT02372500|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1393891|NCT02372487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393892|NCT02372474||Single Group Assignment||Treatment||None (Open Label)||||||
1393893|NCT02372461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393894|NCT02372448|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1393895|NCT02372435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393896|NCT02372422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393897|NCT02372409|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393898|NCT02372396|Randomized|Parallel Assignment||Treatment||Single||||||t
1393899|NCT02372383|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393900|NCT02372370||Single Group Assignment||Treatment||None (Open Label)||||||
1393901|NCT02372357||Single Group Assignment||Prevention||None (Open Label)||||||
1393902|NCT02372344|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1393903|NCT02372331|Randomized|Parallel Assignment||Treatment||Single|The evaluation and judgement for morbidity (primary endpoint) / mortality (secondary endpoint) was made by Morbidity and Mortality Committee in our division. Committee members were blinded about knowledge of the interventions assigned to individual participants.|Two study groups (Control (conventional) group and study (intervention) group) were randomly allocated and assigned to one of two groups in parallel for the whole duration of this study.||||t
1393904|NCT02372318|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1393905|NCT02372305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393906|NCT02372292|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1393907|NCT02372279|Randomized|Parallel Assignment||||Double|||t|t||
1393908|NCT02372266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393909|NCT02372253|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393910|NCT02372240||Single Group Assignment||Treatment||None (Open Label)||||||
1393911|NCT02372227||Single Group Assignment||Treatment||None (Open Label)||||||
1393912|NCT02372214|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393913|NCT02372201||Single Group Assignment||Basic Science||None (Open Label)||||||
1393914|NCT02372188|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1393915|NCT02372175|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1393916|NCT02372162|||Other||Prospective|||||||
1393917|NCT02372149|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1393918|NCT02372136|Randomized|Parallel Assignment||Treatment||Quadruple|Only the statistician and the formula technicians know the patients' allocation.||t|t|t|t
1393919|NCT02372123|Randomized|Single Group Assignment||Treatment||Single||||||t
1393920|NCT02372110|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1393921|NCT02372097|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393922|NCT02372084||Single Group Assignment||Treatment||None (Open Label)||||||
1393923|NCT02372071||Single Group Assignment||Screening||None (Open Label)||||||
1393924|NCT02372058||Single Group Assignment||Screening||None (Open Label)||||||
1393925|NCT02372032|Randomized|Parallel Assignment||Treatment||Single||||t||
1393926|NCT02372019|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393927|NCT02372006||Single Group Assignment||Treatment||None (Open Label)||||||
1393928|NCT02371993|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1393929|NCT02371980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393930|NCT02371967|||Cohort||Prospective|||||||
1393931|NCT02371954|Randomized|Parallel Assignment||Prevention||Single||||||t
1393932|NCT02371941|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1393933|NCT02371928|Randomized|Parallel Assignment||Treatment||Single|||||t|
1393934|NCT02371915|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393935|NCT02371902|Randomized|Parallel Assignment||Treatment||Single||||||t
1393936|NCT02371889|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1393937|NCT02371876||Single Group Assignment||Diagnostic||None (Open Label)||||||
1393938|NCT02371863|||||Cross-Sectional|||||||
1393939|NCT02371850||Single Group Assignment||Basic Science||None (Open Label)||Each subjects gets two procedure days with heating applied for one hour at hours 4 and hour 8 after the application of the Nicoderm CQ nicotine patch, then followed by two procedure days with heating applied for one hour at hours 4 and hour 8, after the application of the Aveva nicotine patch (total of four Procedure days)||||
1393940|NCT02371837|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1393941|NCT02371824|||Case-Only||Cross-Sectional|||||||
1393942|NCT02371811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393943|NCT02371798||Single Group Assignment||Diagnostic||Single||||||t
1393944|NCT02371785||Single Group Assignment||Treatment||None (Open Label)||||||
1393945|NCT02371772|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1393946|NCT02371759|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1393947|NCT02371746|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393948|NCT02371733|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1393949|NCT02371720|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1393950|NCT02371707|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393951|NCT02371694|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1393952|NCT02371681|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1393953|NCT02371668|Randomized|Parallel Assignment||Other||Double|||t||t|
1393954|NCT02371655|Randomized|Parallel Assignment||Diagnostic||Triple||||t|t|t
1393955|NCT02371642|||Cohort||Prospective|||||||
1393956|NCT02371629|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1393957|NCT02371616|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1393958|NCT02371603|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393959|NCT02371590||Single Group Assignment||Treatment||None (Open Label)||||||
1393960|NCT02371577||Single Group Assignment||Treatment||None (Open Label)||||||
1393961|NCT02371564|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393962|NCT02371551|||Case-Only||Prospective|||||||
1393963|NCT02371538||Single Group Assignment||Supportive Care||None (Open Label)||||||
1393964|NCT02371525|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393965|NCT02371512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393966|NCT02371499|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1393967|NCT02371486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393968|NCT02371473|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1393969|NCT02371460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1393970|NCT02371447||Single Group Assignment||Treatment||None (Open Label)||||||
1393971|NCT02371434||Single Group Assignment||Treatment||None (Open Label)||||||
1393972|NCT02371421||Single Group Assignment||Treatment||None (Open Label)||||||
1393973|NCT02371408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393974|NCT02371395|||Cohort||Cross-Sectional|||||||
1393975|NCT02371382|||Other||Prospective|||||||
1393976|NCT02371369|Randomized|Parallel Assignment||Treatment||Quadruple|Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) in Part 1, Open-label (no masking) in Part 2|Parallel assignment in Part 1, Single treatment in Part 2|t|t|t|t
1393977|NCT02371356|||Cohort||Prospective|||||||
1393978|NCT02371343|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1393979|NCT02371330|||Cohort||Prospective|||||||
1393980|NCT02371317|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1393981|NCT02371304|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1393982|NCT02371291|Randomized|Parallel Assignment||Treatment||Single||||||t
1393983|NCT02371278|Randomized|Parallel Assignment||Prevention||Single|||t|||
1393984|NCT02371265|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1393985|NCT02371252|Randomized|Parallel Assignment||Treatment||Single||||||t
1393986|NCT02371239|Randomized|Crossover Assignment||Treatment||Single||||||t
1393987|NCT02371226|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1393988|NCT02371213|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1393989|NCT02371200|||Cohort||Prospective|||||||
1393990|NCT02371187|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1393991|NCT02371174|||Cohort||Prospective|||||||
1393992|NCT02371161||Single Group Assignment||Treatment||None (Open Label)||||||
1393993|NCT02371148||Single Group Assignment||Treatment||None (Open Label)||||||
1393994|NCT02371135|||Cohort||Prospective|||||||
1393995|NCT02371122|Randomized|Crossover Assignment||Treatment||Single|||t|||
1393996|NCT02371109|||Cohort||Prospective|||||||
1393997|NCT02371096||||||||||||
1393998|NCT02371083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1393999|NCT02371070|||Cohort||Prospective|||||||
1394000|NCT02371057|||Case Control||Prospective|||||||
1394001|NCT02371044|||Cohort||Prospective|||||||
1394002|NCT02371031||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394003|NCT02371018|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1394004|NCT02371005|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1394005|NCT02370992|||Cohort||Prospective|||||||
1394006|NCT02370979||Single Group Assignment||Treatment||None (Open Label)||||||
1394007|NCT02370966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394008|NCT02370953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394009|NCT02370940|Randomized|Parallel Assignment||||None (Open Label)||||||
1394010|NCT02370927|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1394011|NCT02370914|Non-Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1394012|NCT02370901|Randomized|Parallel Assignment||Treatment||Single||||||t
1394013|NCT02370888||Single Group Assignment||Treatment||None (Open Label)||||||
1394014|NCT02370875|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1394015|NCT02370862||Single Group Assignment||Treatment||None (Open Label)||||||
1394016|NCT02370849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394017|NCT02370836|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1394018|NCT02370823|||Cohort||Prospective|||||||
1394019|NCT02370810|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394020|NCT02370797||Single Group Assignment||Treatment||None (Open Label)||||||
1394021|NCT02370784|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394022|NCT02370771||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394023|NCT02370758|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1394024|NCT02370745|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1394025|NCT02370732||Single Group Assignment||||None (Open Label)||||||
1394026|NCT02370719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394027|NCT02370706||Parallel Assignment||Health Services Research||None (Open Label)||||||
1394028|NCT02370693|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394029|NCT02370680|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1394030|NCT02370667|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1394031|NCT02370654|Randomized|Single Group Assignment||Other||Single||||||t
1394032|NCT02370641|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1394033|NCT02370628|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394034|NCT02370615|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394035|NCT02370602|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394036|NCT02370589|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1394037|NCT02370576|||Cohort||Prospective|||||||
1394038|NCT02370563||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394039|NCT02370550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394040|NCT02370537|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1394041|NCT02370524||Single Group Assignment||Other||None (Open Label)||||||
1394042|NCT02370511|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394043|NCT02370498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394044|NCT02370485|Randomized|Crossover Assignment||||None (Open Label)||||||
1394045|NCT02370472|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1394046|NCT02370459|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1394047|NCT02370446|||Case Control||Prospective|||||||
1394048|NCT02370433|Non-Randomized|Single Group Assignment||Treatment||Double|||||t|t
1394049|NCT02370420|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394050|NCT02370407|Randomized|Parallel Assignment||Other||Single||||||t
1394051|NCT02370394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394052|NCT02370381|||Cohort||Prospective|||||||
1394053|NCT02370368|Randomized|Parallel Assignment||||None (Open Label)||||||
1394054|NCT02370355|||Cohort||Other|||||||
1394055|NCT02370342||Single Group Assignment||Treatment||None (Open Label)||||||
1394056|NCT02370329||Single Group Assignment||Treatment||None (Open Label)||||||
1394057|NCT02370316|Randomized|Parallel Assignment||Treatment||Single||||||t
1394058|NCT02370303|||Case-Only||Prospective|||||||
1394059|NCT02370290|||Case-Only||Prospective|||||||
1394060|NCT02370277|||Case-Control||Prospective|||||||
1394061|NCT02370264||Single Group Assignment||Supportive Care||None (Open Label)||||||
1394062|NCT02370251||Single Group Assignment||Treatment||None (Open Label)||||||
1394063|NCT02370238|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394064|NCT02370225|Randomized|Parallel Assignment||Treatment||Single||||||t
1394065|NCT02370212|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1394066|NCT02370199||Single Group Assignment||Basic Science||None (Open Label)||||||
1394067|NCT02370186|||Other||Prospective|||||||
1394068|NCT02370173|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394069|NCT02370160||Single Group Assignment||Treatment||None (Open Label)||||||
1394070|NCT02370147|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1394071|NCT02370134|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394072|NCT02370121|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394073|NCT02370108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394074|NCT02370095|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1394075|NCT02370082||Single Group Assignment||Treatment||None (Open Label)||||||
1394076|NCT02370069|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1394077|NCT02370056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394078|NCT02370043|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1394079|NCT02370030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394080|NCT02370017||Single Group Assignment||Treatment||None (Open Label)||||||
1394081|NCT02370004||Single Group Assignment||Supportive Care||None (Open Label)||||||
1394082|NCT02369991|||||Cross-Sectional|||||||
1394083|NCT02369978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394084|NCT02369965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394085|NCT02369939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394086|NCT02369926|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1394087|NCT02369913|||Cohort||Prospective|||||||
1394088|NCT02369900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394089|NCT02369887|||Cohort||Cross-Sectional|||||||
1394090|NCT02369874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394091|NCT02369861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394092|NCT02369848||Single Group Assignment||Treatment||None (Open Label)||||||
1394093|NCT02369835|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1394094|NCT02369822|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1394095|NCT02369809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394096|NCT02369796|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394097|NCT02369783||Single Group Assignment||Screening||None (Open Label)||||||
1394098|NCT02369770|Randomized|Parallel Assignment||Treatment||Single||||||t
1394099|NCT02369757|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394100|NCT02369744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394101|NCT02369731|||Cohort||Prospective|||||||
1394102|NCT02369718|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394103|NCT02369705|||Case-Only||Prospective|||||||
1394104|NCT02369692|||Other||Prospective|||||||
1394105|NCT02369679|Randomized|Parallel Assignment||Treatment||Single|||||t|
1394106|NCT02369666|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1394107|NCT02369653|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394108|NCT02369640|Randomized|Parallel Assignment||||Single||||||t
1394109|NCT02369627|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1394110|NCT02369614|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1394111|NCT02369601|||Cohort||Prospective|||||||
1394112|NCT02369588|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1394113|NCT02369575|||Case-Only||Prospective|||||||
1394114|NCT02369562|||Cohort||Retrospective|||||||
1394115|NCT02369549|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1394116|NCT02369536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394117|NCT02369523|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1394118|NCT02369510|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1394119|NCT02369497|||Cohort||Prospective|||||||
1394120|NCT02369484||Single Group Assignment||Treatment||None (Open Label)||||||
1394121|NCT02369471|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394122|NCT02369458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394123|NCT02369445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394124|NCT02369432||Single Group Assignment||Other||None (Open Label)||||||
1394125|NCT02369419|||Cohort||Prospective|||||||
1394126|NCT02369406|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394127|NCT02369393|Randomized|Parallel Assignment||Treatment||Single|||||t|
1394128|NCT02369380||Single Group Assignment||Treatment||None (Open Label)||||||
1394129|NCT02369354|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1394130|NCT02369341|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394131|NCT02369328|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1394132|NCT02369315|Randomized|Single Group Assignment||Prevention||Single||||||t
1394133|NCT02369302|Randomized|Crossover Assignment||||None (Open Label)||||||
1394134|NCT02369289|||Cohort|||||||||
1394135|NCT02369276|||Cohort||Prospective|||||||
1394136|NCT02369263|||Cohort||Prospective|||||||
1394137|NCT02369250|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1394138|NCT02369237|||||Cross-Sectional|||||||
1394139|NCT02369224|||Case-Crossover||Cross-Sectional|||||||
1394140|NCT02369211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394141|NCT02369198||Single Group Assignment||Treatment||None (Open Label)||||||
1394142|NCT02369172|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1394143|NCT02369159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394144|NCT02369146|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394145|NCT02369133|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1394146|NCT02369120|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1394147|NCT02369107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394148|NCT02369094|Randomized|Parallel Assignment||Treatment||Single||||||t
1394149|NCT02369081|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1394150|NCT02369068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394151|NCT02369055|||Cohort||Prospective|||||||
1394152|NCT02369042|Non-Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1394153|NCT02369029||Single Group Assignment||Treatment||None (Open Label)||||||
1394154|NCT02369016||Single Group Assignment||Treatment||None (Open Label)||||||
1394155|NCT02369003||Single Group Assignment||Treatment||None (Open Label)||||||
1394156|NCT02368990|||Cohort||Prospective|||||||
1394157|NCT02368977||Single Group Assignment||Diagnostic||None (Open Label)|Open Label|||||
1394158|NCT02368964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394159|NCT02368951||Single Group Assignment||Treatment||None (Open Label)||||||
1394160|NCT02368938|||Ecologic or Community||Prospective|||||||
1394161|NCT02368925||Single Group Assignment||Treatment||None (Open Label)||||||
1394162|NCT02368912|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1394163|NCT02368899|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1394164|NCT02368886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394165|NCT02368873|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394166|NCT02368860||Single Group Assignment||Treatment||None (Open Label)||||||
1394167|NCT02368847||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394168|NCT02368834|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1394169|NCT02368821|||Case Control|||||||||
1394170|NCT02368808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394171|NCT02368795|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1394172|NCT02368782|||Cohort||Prospective|||||||
1394173|NCT02368769|||Case Control||Prospective|||||||
1394174|NCT02368756||Single Group Assignment||Treatment||None (Open Label)||Patients assigned to same treatment but treatment extended according to response to medication||||
1394175|NCT02368743|||Cohort||Prospective|||||||
1394176|NCT02368730|||Cohort||Prospective|||||||
1394177|NCT02368717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394178|NCT02368704|||Case Control||Cross-Sectional|||||||
1394179|NCT02368691||Single Group Assignment||Treatment||None (Open Label)||||||
1394180|NCT02368678|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1394181|NCT02368665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394182|NCT02368652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394183|NCT02368639||Single Group Assignment||Treatment||None (Open Label)||||||
1394184|NCT02368626||Single Group Assignment||Treatment||None (Open Label)||||||
1394185|NCT02368613|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394186|NCT02368600|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1394187|NCT02368587|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394188|NCT02368574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394189|NCT02368561||Single Group Assignment||Treatment||None (Open Label)||||||
1394190|NCT02368548|Randomized|Parallel Assignment||||None (Open Label)||||||
1394191|NCT02368535|||Cohort||Prospective|||||||
1394192|NCT02368522|||Cohort||Other|||||||
1394193|NCT02368509|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1394194|NCT02368496||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394195|NCT02368483||Single Group Assignment||Treatment||None (Open Label)||||||
1394196|NCT02368470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394197|NCT02368457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394198|NCT02368444||Single Group Assignment||Treatment||None (Open Label)||||||
1394199|NCT02368431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394200|NCT02368418|||Cohort||Prospective|||||||
1394201|NCT02368405|Randomized|Single Group Assignment||Treatment||Single||||||t
1394202|NCT02368392|||Cohort||Cross-Sectional|||||||
1394203|NCT02368379||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394204|NCT02368366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394205|NCT02368353|Randomized|Parallel Assignment||Treatment||Single||||||t
1394206|NCT02368340|||Cohort||Prospective|||||||
1394207|NCT02368327|Randomized|Parallel Assignment||Basic Science||Single||||||t
1394208|NCT02368314|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1394209|NCT02368301||||||||||||
1394210|NCT02368288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394211|NCT02368275|||Cohort||Prospective|||||||
1394212|NCT02368262|||Case Control||Cross-Sectional|||||||
1394213|NCT02368249|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1394214|NCT02368236|Randomized|Parallel Assignment||Screening||Double|||t|t||
1394215|NCT02368223||Single Group Assignment||Treatment||None (Open Label)||||||
1394216|NCT02368210|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394217|NCT02368197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394218|NCT02368184|||Cohort||Prospective|||||||
1394219|NCT02368171|||Case Control||Prospective|||||||
1394220|NCT02368158|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1394221|NCT02368145|||||Prospective|||||||
1394222|NCT02368132|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1394223|NCT02368119|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1394224|NCT02368106|||Cohort||Prospective|||||||
1394225|NCT02368093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394226|NCT02368080|||Cohort||Cross-Sectional|||||||
1394227|NCT02368067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394228|NCT02368054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394229|NCT02368041|||Case-Control||Prospective|||||||
1394230|NCT02368028|||Case Control||Cross-Sectional|||||||
1394231|NCT02368015||Single Group Assignment||||None (Open Label)||||||
1394232|NCT02368002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394233|NCT02367989|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1394234|NCT02367976|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394235|NCT02367963|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1394236|NCT02367950||Single Group Assignment||Treatment||None (Open Label)||||||
1394237|NCT02367937||Single Group Assignment||||None (Open Label)||||||
1394238|NCT02367924|||Other||Prospective|||||||
1394239|NCT02367911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394240|NCT02367898|Randomized|Parallel Assignment||||Single|||t|||
1394241|NCT02367885|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1394242|NCT02367872|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394243|NCT02367859||Single Group Assignment||Treatment||None (Open Label)||||||
1394244|NCT02367846|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1394245|NCT02367833|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1394246|NCT02367820||Single Group Assignment||Treatment||None (Open Label)||||||
1394247|NCT02367807|||Cohort||Prospective|||||||
1394248|NCT02367794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394249|NCT02367781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394250|NCT02367768|||Cohort||Prospective|||||||
1394251|NCT02367755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394252|NCT02367742|Randomized|Parallel Assignment||Treatment||Single||||||t
1394253|NCT02367729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394254|NCT02367716|||Case-Only||Cross-Sectional|||||||
1394255|NCT02367703|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394256|NCT02367690|Randomized|Parallel Assignment||Treatment||Single||||||t
1394257|NCT02367677|||Other||Prospective|||||||
1394258|NCT02367664|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1394259|NCT02367651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394260|NCT02367638|Randomized|Parallel Assignment||Prevention||Single|||t|||
1394261|NCT02367625|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394262|NCT02367612|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1394263|NCT02367599|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1394264|NCT02367573|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394265|NCT02367560|Randomized|Parallel Assignment||Treatment||Single||||||t
1394266|NCT02367547|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394267|NCT02367534||Single Group Assignment||Treatment||None (Open Label)||||||
1394268|NCT02367521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394269|NCT02367508||Single Group Assignment||Supportive Care||None (Open Label)||||||
1394270|NCT02367495||Single Group Assignment||Treatment||None (Open Label)||||||
1394271|NCT02367482|||Case-Control||Prospective|||||||
1394272|NCT02367469|||Case-Control||Prospective|||||||
1394273|NCT02367456|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394274|NCT02367443||Single Group Assignment||Treatment||None (Open Label)||||||
1394275|NCT02367430|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394276|NCT02367417|||Cohort||Prospective|||||||
1394277|NCT02367404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394278|NCT02367391|Randomized|Parallel Assignment||Treatment||Single|||||t|
1394279|NCT02367378|||Case-Control||Prospective|||||||
1394280|NCT02367365|||Cohort||Prospective|||||||
1394281|NCT02367352|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394282|NCT02367339|||||Prospective|||||||
1394283|NCT02367326|||Cohort||Prospective|||||||
1394284|NCT02367313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394285|NCT02367300|||Case-Only||Prospective|||||||
1394286|NCT02367287|||Other||Cross-Sectional|||||||
1394287|NCT02367274|||Case-Only||Prospective|||||||
1394288|NCT02367261||Single Group Assignment||Treatment||None (Open Label)||||||
1394289|NCT02367248|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394290|NCT02367235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394291|NCT02367222|||Cohort||Retrospective|||||||
1394292|NCT02367209|||Case-Control||Prospective|||||||
1394293|NCT02367196||Single Group Assignment||Treatment||None (Open Label)||||||
1394294|NCT02367183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394295|NCT02367170|Randomized|Parallel Assignment||Prevention||Single|||t|||
1394296|NCT02367157|Randomized|Parallel Assignment||Treatment||Single||||||t
1394297|NCT02367131|||Cohort||Prospective|||||||
1394298|NCT02367118|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394299|NCT02367105|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394300|NCT02367092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394301|NCT02367079|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1394302|NCT02367066|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1394303|NCT02367053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394304|NCT02367040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394305|NCT02367027|Randomized|Crossover Assignment||||None (Open Label)||||||
1394306|NCT02367014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394307|NCT02367001|Randomized|Parallel Assignment||Screening||Single|||t|||
1394308|NCT02366988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394309|NCT02366975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394310|NCT02366962|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1394311|NCT02366949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394312|NCT02366936||Single Group Assignment||Prevention||None (Open Label)||||||
1394313|NCT02366923|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1394314|NCT02366910|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1394315|NCT02366897||Single Group Assignment||||None (Open Label)||||||
1394316|NCT02366884|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394317|NCT02366871|Randomized|Parallel Assignment||Prevention||Single||||||t
1394318|NCT02366858|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1394319|NCT02366845|Randomized|Parallel Assignment||Treatment||Single||||t||
1394320|NCT02366832||Single Group Assignment||Supportive Care||None (Open Label)||||||
1394321|NCT02366819||Single Group Assignment||Treatment||None (Open Label)||||||
1394322|NCT02366806|||Case-Control||Prospective|||||||
1394323|NCT02366793|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394324|NCT02366780|Randomized|Parallel Assignment||||Single|||||t|
1394325|NCT02366767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394326|NCT02366754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394327|NCT02366741||Single Group Assignment||Prevention||None (Open Label)||||||
1394328|NCT02366728|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394329|NCT02366715||Single Group Assignment||Supportive Care||None (Open Label)||||||
1394330|NCT02366702|||Case-Crossover||Prospective|||||||
1394331|NCT02366689|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394332|NCT02366676||Single Group Assignment||Prevention||None (Open Label)||||||
1394333|NCT02366663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394334|NCT02366650|||Cohort||Prospective|||||||
1394335|NCT02366637|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1394336|NCT02366624|||Case Control||Prospective|||||||
1397127|NCT02330185||Single Group Assignment||Screening||Double|||t||t|
1394337|NCT02366611|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394338|NCT02366598|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1394339|NCT02366585||Single Group Assignment||Treatment||None (Open Label)||||||
1394340|NCT02366572|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1394341|NCT02366559|Randomized|Parallel Assignment||Treatment||Single||||||t
1394342|NCT02366546|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394343|NCT02366533|||Cohort||Prospective|||||||
1394344|NCT02366520|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1394345|NCT02366507|||Case Control||Prospective|||||||
1394346|NCT02366494|||Other||Prospective|||||||
1394347|NCT02366481|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1394348|NCT02366468|Randomized|Parallel Assignment||Treatment||Single||||||t
1394349|NCT02366455|||Cohort||Retrospective|||||||
1394350|NCT02366442|||Ecologic or Community||Prospective|||||||
1394351|NCT02366429|Randomized|Parallel Assignment||Treatment||Single||||||t
1394352|NCT02366416||Single Group Assignment||Treatment||None (Open Label)||||||
1394353|NCT02366403|Randomized|Parallel Assignment||Treatment||Single||||||t
1394354|NCT02366390|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394355|NCT02366377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394356|NCT02366364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394357|NCT02366351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394358|NCT02366338|||Cohort||Prospective|||||||
1394359|NCT02366325|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394360|NCT02366312||Single Group Assignment||Treatment||None (Open Label)||||||
1394361|NCT02366299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394362|NCT02366286|||||Prospective|||||||
1394363|NCT02366273|||Cohort||Retrospective|||||||
1394364|NCT02366247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394365|NCT02366234|||Cohort||Prospective|||||||
1394366|NCT02366221|||Cohort||Prospective|||||||
1394367|NCT02366208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394368|NCT02366195||Single Group Assignment||Treatment||None (Open Label)||||||
1394369|NCT02366182|||Cohort||Prospective|||||||
1394370|NCT02366169|||Cohort||Prospective|||||||
1394371|NCT02366156|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1394372|NCT02366143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394373|NCT02366130||Single Group Assignment||Treatment||None (Open Label)||||||
1394374|NCT02366117|Randomized|Parallel Assignment||||None (Open Label)||||||
1394375|NCT02366104|||Cohort||Prospective|||||||
1394376|NCT02366091|Randomized|Factorial Assignment||Other||Triple|||t|t|t|
1394377|NCT02366078||Single Group Assignment||Prevention||None (Open Label)||||||
1394378|NCT02366065||Single Group Assignment||Treatment||None (Open Label)||||||
1394379|NCT02366052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394380|NCT02366039|||Cohort||Prospective|||||||
1394381|NCT02366026|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394382|NCT02366013|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1394383|NCT02366000|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1394384|NCT02365987|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1394385|NCT02365974|Randomized|Single Group Assignment||Treatment||Single|||t|||
1394386|NCT02365961|Randomized|Parallel Assignment||Treatment||Single||||||t
1394387|NCT02365948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394388|NCT02365935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394389|NCT02365922|||Cohort||Prospective|||||||
1394390|NCT02365909|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394391|NCT02365896|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394392|NCT02365883|||Case-Only||Cross-Sectional|||||||
1394393|NCT02365870|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394394|NCT02365857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394395|NCT02365844|||Case-Only||Cross-Sectional|||||||
1394396|NCT02365831|||Cohort|||||||||
1394397|NCT02365818||Single Group Assignment||Treatment||None (Open Label)||||||
1394398|NCT02365805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394399|NCT02365792|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1394400|NCT02365779||Single Group Assignment||Screening||None (Open Label)||||||
1394401|NCT02365766|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394402|NCT02365753|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394403|NCT02365740|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394404|NCT02365727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394405|NCT02365714||Single Group Assignment||Treatment||None (Open Label)||||||
1394406|NCT02365701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394407|NCT02365688||Single Group Assignment||Other||None (Open Label)||||||
1394408|NCT02365675|Randomized|Parallel Assignment||Treatment||Single||||||t
1394409|NCT02365662||Single Group Assignment||Treatment||None (Open Label)||||||
1394410|NCT02365649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394411|NCT02365636|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394412|NCT02365623||Single Group Assignment||Treatment||None (Open Label)||||||
1394413|NCT02365610|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394414|NCT02365597||Single Group Assignment||Treatment||None (Open Label)||||||
1394415|NCT02365584|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394416|NCT02365571|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1394417|NCT02365558|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1394418|NCT02365545||||||||||||
1394419|NCT02365532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394420|NCT02365519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394421|NCT02365506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394422|NCT02365493|Randomized|Parallel Assignment||Treatment||Single||||||t
1394423|NCT02365480|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1394424|NCT02365467||Single Group Assignment||Treatment||None (Open Label)||||||
1394425|NCT02365454||Single Group Assignment||Treatment||None (Open Label)||||||
1394426|NCT02365441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394427|NCT02365428|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1394428|NCT02365415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394429|NCT02365402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394430|NCT02365389|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394431|NCT02365376|||Case-Only|||||||||
1394432|NCT02365363|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1394433|NCT02365350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394434|NCT02365337|||Cohort||Prospective|||||||
1394435|NCT02365324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394436|NCT02365311||Single Group Assignment||||None (Open Label)||||||
1394437|NCT02365298|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1394438|NCT02365285|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1394439|NCT02365272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394440|NCT02365259|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394441|NCT02365246||Single Group Assignment||Treatment||None (Open Label)||||||
1394442|NCT02365233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394443|NCT02365220|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1394444|NCT02365207||Single Group Assignment||Treatment||None (Open Label)||||||
1394445|NCT02365194|Randomized|Parallel Assignment||Treatment||Single||||||t
1394446|NCT02365181|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394447|NCT02365168|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1394448|NCT02365155|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1394449|NCT02365142|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1394450|NCT02365129|Randomized|Parallel Assignment||Prevention||Single||||||t
1394451|NCT02365116|Randomized|Parallel Assignment||Treatment||Single||||||t
1394452|NCT02365103|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1394453|NCT02365090|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1394454|NCT02365077|||Case Control||Prospective|||||||
1394455|NCT02365064|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394456|NCT02365051|Randomized|Parallel Assignment||Treatment||Single||||||t
1394457|NCT02365038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394458|NCT02365025|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1394459|NCT02365012|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1394460|NCT02364999|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394461|NCT02364986||Single Group Assignment||Treatment||None (Open Label)||||||
1394462|NCT02364973|||Case-Only||Prospective|||||||
1394463|NCT02364960|||Cohort||Prospective|||||||
1394464|NCT02364947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394465|NCT02364934|||Cohort||Prospective|||||||
1394466|NCT02364921|Randomized|Parallel Assignment||Treatment||Single|||||t|
1394467|NCT02364908||Single Group Assignment||Prevention||None (Open Label)||||||
1394468|NCT02364895|Randomized|Factorial Assignment||Screening||Single|||||t|
1394469|NCT02364882|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1394470|NCT02364869|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1394471|NCT02364856|||Other||Prospective|||||||
1394472|NCT02364843||Single Group Assignment||Basic Science||None (Open Label)||||||
1394473|NCT02364830|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394474|NCT02364817|||Cohort||Prospective|||||||
1394475|NCT02364804|||Case Control|||||||||
1394476|NCT02364791|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394477|NCT02364778|||Cohort||Prospective|||||||
1394478|NCT02364765||Single Group Assignment||Treatment||None (Open Label)||||||
1394479|NCT02364752|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1394480|NCT02364739|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394481|NCT02364726||Single Group Assignment||Treatment||None (Open Label)||||||
1394482|NCT02364713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394483|NCT02364700||Single Group Assignment||Other||None (Open Label)||||||
1394484|NCT02364687|||Case-Only||Cross-Sectional|||||||
1394485|NCT02364674||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394486|NCT02364661||Single Group Assignment||Basic Science||None (Open Label)||||||
1394487|NCT02364648|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394488|NCT02364635|Randomized|Parallel Assignment||||Double|||t||t|
1394489|NCT02364622|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394490|NCT02364609|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394491|NCT02364596||Single Group Assignment||Prevention||None (Open Label)||||||
1394492|NCT02364583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394493|NCT02364570|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1394494|NCT02364557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394495|NCT02364544||Single Group Assignment||Treatment||None (Open Label)||||||
1394496|NCT02364531|||Cohort||Prospective|||||||
1394497|NCT02364518||Single Group Assignment||Treatment||None (Open Label)||||||
1394498|NCT02364505|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1394499|NCT02364492||Single Group Assignment||Treatment||None (Open Label)||||||
1394500|NCT02364479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394501|NCT02364466|||Cohort||Prospective|||||||
1394502|NCT02364453|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1394503|NCT02364440||Single Group Assignment||Treatment||Single||||||t
1394504|NCT02364427|||Cohort||Prospective|||||||
1394505|NCT02364414||Single Group Assignment||Health Services Research||None (Open Label)||||||
1394506|NCT02364401|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394507|NCT02364388|||Case-Only||Prospective|||||||
1394508|NCT02364375||||||||||||
1394509|NCT02364362||Single Group Assignment||Treatment||None (Open Label)||||||
1394510|NCT02364349|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1394511|NCT02364336||Parallel Assignment||Treatment||None (Open Label)||||||
1394512|NCT02364323|Randomized|Parallel Assignment||Health Services Research||Double||||t||t
1394513|NCT02364310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394514|NCT02364297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394515|NCT02364284|||Cohort||Retrospective|||||||
1394516|NCT02364271|||Cohort||Prospective|||||||
1394517|NCT02364258|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1394518|NCT02364245|Randomized|Single Group Assignment||Treatment||Single||||||t
1394519|NCT02364232|Randomized|Crossover Assignment||Treatment||Single||||||t
1394520|NCT02364219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394521|NCT02364206||Single Group Assignment||Treatment||None (Open Label)||||||
1394522|NCT02364193||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394523|NCT02364180||Single Group Assignment||Supportive Care||None (Open Label)||All subjects taking Pyridostigmine for at least 6mo, except for myasthenia gravis patients, will be considered for the study.Those that participate will answer a few questions pertaining to their medical history and will then undergo electromyography (CMAP) measurement with repetitive stimulation at 2 sites (ulnar nerve at the wrist and the accessory nerve in the neck). The first and fifth stimuli are delivered 2 seconds apart. Eight percent or greater decrement in the CMAP response on repetitive stimulation will be considered positive.||||
1394524|NCT02364167|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394525|NCT02364154|||Case-Control||Prospective|||||||
1394526|NCT02364141|Randomized|Parallel Assignment||||Double|||t||t|
1394527|NCT02364128|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1394528|NCT02364115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394529|NCT02364102|||Cohort||Prospective|||||||
1394530|NCT02364089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394531|NCT02364076||Single Group Assignment||Treatment||None (Open Label)||||||
1394532|NCT02364063|Randomized|Parallel Assignment||Treatment||Single||||||t
1394533|NCT02364050|||Other||Prospective|||||||
1394534|NCT02364037|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)|Due to the controlled time-trend design and, therefore, the different time periods for enrollment and follow up for each group, we were unable to mask the research and clinical staff who administered surveys to the study group assignment when collecting data regarding the study outcomes.|We used a prospective, controlled time-trend study design, a non-randomized design where outcomes are compared before and after a change in the healthcare setting.||||
1394535|NCT02364024|||Cohort||Prospective|||||||
1394536|NCT02364011|||Cohort||Prospective|||||||
1394537|NCT02363998||Single Group Assignment||Treatment||None (Open Label)||||||
1394538|NCT02363985|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1394539|NCT02363972||Single Group Assignment||Treatment||None (Open Label)||||||
1394540|NCT02363959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394541|NCT02363946|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394542|NCT02363933||Single Group Assignment||Treatment||None (Open Label)||||||
1394543|NCT02363920|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394544|NCT02363907|||Cohort||Prospective|||||||
1394545|NCT02363894|||Cohort|||||||||
1394546|NCT02363868|||Cohort||Retrospective|||||||
1394547|NCT02363855||Single Group Assignment||Treatment||None (Open Label)||||||
1394548|NCT02363842|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394549|NCT02363829||Single Group Assignment||Treatment||||||||
1394550|NCT02363816|||Cohort||Cross-Sectional|||||||
1394551|NCT02363803|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1394552|NCT02363790|Randomized|Parallel Assignment||Treatment||Single||||||t
1394553|NCT02363777|Randomized|Parallel Assignment||Treatment||Single||||||t
1394554|NCT02363764|||Cohort||Prospective|||||||
1394555|NCT02363751||Single Group Assignment||Treatment||None (Open Label)||||||
1394556|NCT02363738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394557|NCT02363725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394558|NCT02363712|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394559|NCT02363699|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1394560|NCT02363686||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394561|NCT02363673||Single Group Assignment||Treatment||None (Open Label)||||||
1394562|NCT02363660|Randomized|Parallel Assignment||Prevention||Single|||||t|
1394563|NCT02363647||Single Group Assignment||Treatment||None (Open Label)||||||
1394564|NCT02363634|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1394565|NCT02363621|Randomized|Parallel Assignment||Treatment||Single||||||t
1394566|NCT02363608|||Cohort||Prospective|||||||
1394567|NCT02363595|||Cohort||Prospective|||||||
1394568|NCT02363582|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1394569|NCT02363569|||Cohort||Prospective|||||||
1394570|NCT02363556|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1394571|NCT02363543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394572|NCT02363530|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1394573|NCT02363517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394574|NCT02363504|||Case-Control||Other|||||||
1394575|NCT02363491||Single Group Assignment||Treatment||None (Open Label)||||||
1394576|NCT02363478||Single Group Assignment||Treatment||None (Open Label)||||||
1394577|NCT02363465|||Cohort||Cross-Sectional|||||||
1394578|NCT02363452||Single Group Assignment||Treatment||None (Open Label)||||||
1394579|NCT02363439||Single Group Assignment||Treatment||None (Open Label)||||||
1394580|NCT02363426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394581|NCT02363413|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394582|NCT02363400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394583|NCT02363387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394584|NCT02363374|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394585|NCT02363361||Single Group Assignment||Treatment||None (Open Label)||||||
1394586|NCT02363348|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1394587|NCT02363335|Randomized|Crossover Assignment||Other||Double|||t||t|
1394588|NCT02363322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394589|NCT02363309|||Case-Control||Prospective|||||||
1394590|NCT02363296|||Case-Only||Prospective|||||||
1394591|NCT02363283||Single Group Assignment||Treatment||None (Open Label)||||||
1394592|NCT02363270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394593|NCT02363257|||Ecologic or Community||Cross-Sectional|||||||
1394594|NCT02363244|||Other||Cross-Sectional|||||||
1394595|NCT02363231|||Cohort||Prospective|||||||
1394596|NCT02363218||Single Group Assignment||Treatment||None (Open Label)||||||
1394597|NCT02363205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394598|NCT02363192|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394599|NCT02363179|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1394600|NCT02363166|||Case-Only||Cross-Sectional|||||||
1394601|NCT02363153||Single Group Assignment||Treatment||None (Open Label)||||||
1394602|NCT02363140|Non-Randomized|Parallel Assignment||Treatment||||||||
1394603|NCT02363127|Randomized|Parallel Assignment||Treatment||Single|||||t|
1394604|NCT02363114|||Cohort||Prospective|||||||
1394605|NCT02363101|||||Cross-Sectional|||||||
1394606|NCT02363088|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1394607|NCT02363075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394608|NCT02363062|||Cohort||Cross-Sectional|||||||
1394609|NCT02363049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394610|NCT02363036|||Cohort||Prospective|||||||
1394611|NCT02363023|||Cohort||Prospective|||||||
1394612|NCT02363010|Randomized|Parallel Assignment||Treatment||Single||||||t
1394613|NCT02362997|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394614|NCT02362984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394615|NCT02362971|||Cohort||Prospective|||||||
1394616|NCT02362958||Single Group Assignment||Treatment||None (Open Label)||||||
1394617|NCT02362945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394618|NCT02362932|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1394619|NCT02362919|||Cohort||Prospective|||||||
1394620|NCT02362906|Randomized|Parallel Assignment||Treatment||Single||||||t
1394621|NCT02362893|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394622|NCT02362880|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1394623|NCT02362867||Single Group Assignment||Treatment||None (Open Label)||||||
1394624|NCT02362854|Randomized|Parallel Assignment||Treatment||Single||||||t
1394625|NCT02362841|||Cohort||Prospective|||||||
1394626|NCT02362828|||Cohort||Prospective|||||||
1394627|NCT02362815|Randomized|Parallel Assignment||Treatment||Single|||||t|
1394628|NCT02362802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394629|NCT02362789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394630|NCT02362776|||Case Control||Cross-Sectional|||||||
1394631|NCT02362763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394632|NCT02362750|||Cohort||Prospective|||||||
1394633|NCT02362737|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1394634|NCT02362724||||||||||||
1394635|NCT02362711|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394636|NCT02362698|Randomized|Parallel Assignment||Treatment||Single||||||t
1394637|NCT02362685|||Cohort||Prospective|||||||
1394638|NCT02362672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394639|NCT02362659|||Cohort||Prospective|||||||
1394640|NCT02362646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394641|NCT02362633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394642|NCT02362620|||Cohort||Prospective|||||||
1394643|NCT02362607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394644|NCT02362594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394645|NCT02362581||Single Group Assignment||Treatment||None (Open Label)||||||
1394646|NCT02362568||Single Group Assignment||Diagnostic||Triple|||t|t|t|
1394647|NCT02362555|||Case Control||Cross-Sectional|||||||
1394648|NCT02362542|Non-Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1394649|NCT02362529|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1394650|NCT02362516||Single Group Assignment||Treatment||None (Open Label)||||||
1394651|NCT02362503|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394652|NCT02362490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394653|NCT02362477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394654|NCT02362464||Single Group Assignment||Treatment||None (Open Label)||||||
1394655|NCT02362451|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394656|NCT02362438|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1394657|NCT02362425|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394658|NCT02362412|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1394659|NCT02362399|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394660|NCT02362386|||Case-Only||Prospective|||||||
1394661|NCT02362373||Single Group Assignment||||None (Open Label)||||||
1394662|NCT02362360|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1394663|NCT02362347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394664|NCT02362334|||||Prospective|||||||
1394665|NCT02362321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394666|NCT02362308|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1394667|NCT02362295|||||Prospective|||||||
1394668|NCT02362282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394669|NCT02362269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394670|NCT02362256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394671|NCT02362243|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394672|NCT02362230||Single Group Assignment||Treatment||None (Open Label)||||||
1394673|NCT02362217|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394674|NCT02362204|||Cohort||Prospective|||||||
1394675|NCT02362191|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1394676|NCT02362178|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394677|NCT02362165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394678|NCT02362152|||Cohort||Prospective|||||||
1394679|NCT02362139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394680|NCT02362126|||Cohort||Prospective|||||||
1394681|NCT02362113|||||Cross-Sectional|||||||
1394682|NCT02362100|Randomized|Parallel Assignment||Treatment||Single||||||t
1394683|NCT02362087|||Cohort||Prospective|||||||
1394684|NCT02362074|||Cohort||Prospective|||||||
1394685|NCT02362061|||Cohort||Prospective|||||||
1394686|NCT02362048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394687|NCT02362035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394688|NCT02362022|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1394689|NCT02362009|||Cohort||Prospective|||||||
1394690|NCT02361996|||Case-Only||Prospective|||||||
1394691|NCT02361983|||Cohort||Prospective|||||||
1394692|NCT02361970|||Case-Control||Prospective|||||||
1394693|NCT02361957|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1394694|NCT02361944|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1394695|NCT02361931|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1394696|NCT02361918|||Case Control||Prospective|||||||
1394697|NCT02361905|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1394698|NCT02361892||Single Group Assignment||Treatment||None (Open Label)||||||
1394699|NCT02361879|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1394700|NCT02361866|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1394701|NCT02361853|||Cohort||Prospective|||||||
1394702|NCT02361840|||Cohort||Prospective|||||||
1394703|NCT02361827|||Cohort||Prospective|||||||
1394704|NCT02361814||Single Group Assignment||Treatment||None (Open Label)||||||
1394705|NCT02361801|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394706|NCT02361788|||Cohort||Prospective|||||||
1394707|NCT02361775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394708|NCT02361762|Randomized|Parallel Assignment||Treatment||Single||||||t
1394709|NCT02361749|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1394710|NCT02361736|Randomized|Parallel Assignment||||Triple|||t|t|t|
1394711|NCT02361723||Single Group Assignment||Treatment||None (Open Label)||||||
1394712|NCT02361710|||Cohort||Prospective|||||||
1394713|NCT02361697||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394714|NCT02361684|Randomized|Parallel Assignment||Treatment||Single|||||t|
1394715|NCT02361671|||Cohort||Prospective|||||||
1394716|NCT02361658|||Cohort||Prospective|||||||
1394717|NCT02361645|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1394718|NCT02361632|Randomized|Parallel Assignment||Prevention||Single||||||t
1394719|NCT02361619||Single Group Assignment||Basic Science||None (Open Label)||||||
1394720|NCT02361606||Single Group Assignment||Supportive Care||None (Open Label)||||||
1394721|NCT02361593|Randomized|Parallel Assignment||Treatment||Single||||||t
1394722|NCT02361580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394723|NCT02361567|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1394724|NCT02361554||Single Group Assignment||Treatment||None (Open Label)||||||
1394725|NCT02361541|||Cohort||Cross-Sectional|||||||
1394726|NCT02361528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394727|NCT02361515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394728|NCT02361502|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394729|NCT02361489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394730|NCT02361476|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1394731|NCT02361463|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1394732|NCT02361450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394733|NCT02361437|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394734|NCT02361424|Non-Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1394735|NCT02361411|||Cohort||Prospective|||||||
1394736|NCT02361398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394737|NCT02361385|||Other||Prospective|||||||
1394738|NCT02361372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394739|NCT02361359|||Cohort||Prospective|||||||
1394740|NCT02361346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394741|NCT02361333|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394742|NCT02361320||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394743|NCT02361307|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1394744|NCT02361294|||Other||Prospective|||||||
1394745|NCT02361281|||Case Control||Retrospective|||||||
1394746|NCT02361268|Randomized|Parallel Assignment||Treatment||Single||||||t
1394747|NCT02361255|||Case-Control||Prospective|||||||
1394748|NCT02361242|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394749|NCT02361229|||Cohort||Prospective|||||||
1394750|NCT02361216|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394751|NCT02361203|Randomized|Parallel Assignment||||None (Open Label)||||||
1394752|NCT02361190|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1394753|NCT02361177|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1394754|NCT02361164|||Cohort||Prospective|||||||
1394755|NCT02361151|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394756|NCT02361138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394757|NCT02361125||Single Group Assignment||Treatment||None (Open Label)||||||
1394758|NCT02361112||Single Group Assignment||Treatment||None (Open Label)||||||
1394759|NCT02361099|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1394760|NCT02361086|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394761|NCT02361073|||Cohort||Prospective|||||||
1394762|NCT02361060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394763|NCT02361047|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394764|NCT02361034|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1394765|NCT02361021|||||Cross-Sectional|||||||
1394766|NCT02361008|Randomized|Parallel Assignment||Treatment||Single||||t||
1394767|NCT02360995|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394768|NCT02360982|||Cohort||Prospective|||||||
1394769|NCT02360969|||Case-Only||Prospective|||||||
1394770|NCT02360956|Randomized|Parallel Assignment||Treatment||Single||||||t
1394771|NCT02360943|||Cohort||Prospective|||||||
1394772|NCT02360930|||Cohort||Prospective|||||||
1394773|NCT02360917|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1394774|NCT02360904|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394775|NCT02360891|||Cohort||Prospective|||||||
1394776|NCT02360878|||Cohort||Prospective|||||||
1394777|NCT02360865|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1394778|NCT02360852||Single Group Assignment||Treatment||None (Open Label)||||||
1394779|NCT02360839|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1394780|NCT02360826|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1394781|NCT02360813|Randomized|Parallel Assignment||Treatment||Single||||||t
1394782|NCT02360800|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1394783|NCT02360787|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1394784|NCT02360774|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394785|NCT02360761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394786|NCT02360748||Single Group Assignment||Supportive Care||None (Open Label)||||||
1394787|NCT02360735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394788|NCT02360722|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394789|NCT02360709|||Cohort||Prospective|||||||
1394790|NCT02360696|||Cohort||Prospective|||||||
1394791|NCT02360683|||Cohort||Prospective|||||||
1394792|NCT02360670|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1394793|NCT02360657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394794|NCT02360644|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1394795|NCT02360631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394796|NCT02360618||Single Group Assignment||Treatment||None (Open Label)||||||
1394797|NCT02360605|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394798|NCT02360592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394799|NCT02360579|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394800|NCT02360566||Single Group Assignment||Treatment||None (Open Label)||||||
1394801|NCT02360553|Randomized|Parallel Assignment||Prevention||Single|||t|||
1394802|NCT02360540|||Cohort||Prospective|||||||
1394803|NCT02360527|||Case-Control||Cross-Sectional|||||||
1394804|NCT02360514|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1394805|NCT02360501||Single Group Assignment||Treatment||None (Open Label)||||||
1394806|NCT02360488|Randomized|Parallel Assignment||Treatment||Single||||||t
1394807|NCT02360475|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1394808|NCT02360462|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1394809|NCT02360449|Randomized|Parallel Assignment||Treatment||Single||||||t
1394810|NCT02360436|||Case-Only||Prospective|||||||
1394811|NCT02360423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394812|NCT02360410|Randomized|Parallel Assignment||Prevention||Single|||t|||
1394813|NCT02360397||Single Group Assignment||Treatment||None (Open Label)||||||
1394814|NCT02360384|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1394815|NCT02360371||Single Group Assignment||Basic Science||Double||||||
1394816|NCT02360358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394817|NCT02360345|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394818|NCT02360332|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394819|NCT02360319|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1394820|NCT02360306|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1394821|NCT02360293|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394822|NCT02360280|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394823|NCT02360267|||Family-Based||Other|||||||
1394824|NCT02360254|||Cohort||Prospective|||||||
1394825|NCT02360241||Single Group Assignment||||None (Open Label)||||||
1394826|NCT02360228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394827|NCT02360215|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394828|NCT02360202||Single Group Assignment||Prevention||None (Open Label)||||||
1394829|NCT02360189|||Other||Prospective|||||||
1394830|NCT02360176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394831|NCT02360163|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394832|NCT02360150||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394833|NCT02360137|||Cohort||Prospective|||||||
1394834|NCT02360124|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1394835|NCT02360111||Single Group Assignment||Treatment||None (Open Label)||||||
1394836|NCT02360098|||Cohort||Prospective|||||||
1394837|NCT02360085|||Cohort||Prospective|||||||
1394838|NCT02360072|||Case Control||Prospective|||||||
1394839|NCT02360059|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394840|NCT02360046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394841|NCT02360033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394842|NCT02360020||Single Group Assignment||Treatment||None (Open Label)||||||
1394843|NCT02360007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394844|NCT02359994|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394845|NCT02359981|Randomized|Parallel Assignment||Prevention||Single|||t|||
1394846|NCT02359968|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1394847|NCT02359955|Randomized|Crossover Assignment||Treatment||Single||||||t
1394848|NCT02359942|Randomized|Parallel Assignment||Diagnostic||||||||
1394849|NCT02359929|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394850|NCT02359916|||Ecologic or Community||Cross-Sectional|||||||
1394851|NCT02359903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394852|NCT02359890||Single Group Assignment||Treatment||None (Open Label)||||||
1394853|NCT02359877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394854|NCT02359864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Single group pilot study of radiation treatment. The two arms are sequential dose increase.||||
1394855|NCT02359851||Single Group Assignment||Treatment||None (Open Label)||||||
1394856|NCT02359838|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1394857|NCT02359825|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394858|NCT02359812|||Cohort||Prospective|||||||
1394859|NCT02359799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394860|NCT02359786|||||Retrospective|||||||
1394861|NCT02359773|||Case Control||Prospective|||||||
1394862|NCT02359760|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1394863|NCT02359747|||Cohort||Retrospective|||||||
1394864|NCT02359734|||||Prospective|||||||
1394865|NCT02359721|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1394866|NCT02359708|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1394867|NCT02359695||Single Group Assignment||Treatment||None (Open Label)||||||
1394868|NCT02359682|||Case-Only||Cross-Sectional|||||||
1394869|NCT02359669|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1394870|NCT02359656|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394871|NCT02359643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394872|NCT02359630|Randomized|Parallel Assignment||Treatment||Single|||||t|
1394873|NCT02359617||Single Group Assignment||Basic Science||None (Open Label)||||||
1394874|NCT02359604||Single Group Assignment||Basic Science||None (Open Label)||Longitudinal study||||
1394875|NCT02359591|||Case-Control||Cross-Sectional|||||||
1394876|NCT02359578||Single Group Assignment||Basic Science||None (Open Label)||||||
1394877|NCT02359565||Single Group Assignment||Treatment||None (Open Label)||||||
1394878|NCT02359552|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394879|NCT02359539|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1394880|NCT02359526||Single Group Assignment||Treatment||None (Open Label)||||||
1394881|NCT02359513||Single Group Assignment||Treatment||None (Open Label)||||||
1394882|NCT02359500||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394883|NCT02359487|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394884|NCT02359474|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394885|NCT02359461|Randomized|Single Group Assignment||Prevention||Single|||t|||
1394886|NCT02359448||Single Group Assignment||Treatment||None (Open Label)||||||
1394887|NCT02359435|Randomized|Parallel Assignment||Treatment||Single|||||t|
1394888|NCT02359422|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394889|NCT02359409|Randomized|Parallel Assignment||Treatment||Single|||t|||
1394890|NCT02359396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394891|NCT02359383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394892|NCT02359370|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1394893|NCT02359357|Randomized|Parallel Assignment||||Triple|||t||t|t
1394894|NCT02359344|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1394895|NCT02359331|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1394896|NCT02359318|Randomized|Parallel Assignment||Prevention||Single|||t|||
1394897|NCT02359305|||Case-Only||Retrospective|||||||
1394898|NCT02359292|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1394899|NCT02359279||Single Group Assignment||Diagnostic||None (Open Label)||||||
1394900|NCT02359266|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394901|NCT02359253|Randomized|Parallel Assignment||Treatment||Single||||||t
1394902|NCT02359240|||Case Control||Prospective|||||||
1394903|NCT02359227||Single Group Assignment||Treatment||None (Open Label)||||||
1394904|NCT02359214|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1394905|NCT02359201|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1394906|NCT02359188|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1394907|NCT02359175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394908|NCT02359162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394909|NCT02359149|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394910|NCT02359136|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1394911|NCT02359123||Single Group Assignment||Treatment||None (Open Label)||||||
1394912|NCT02359110|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1394913|NCT02359097||Single Group Assignment||Diagnostic||Single||||||t
1394914|NCT02359084|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1394915|NCT02359071|||Case Control||Cross-Sectional|||||||
1394916|NCT02359058|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1394917|NCT02359045|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1394918|NCT02359032|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1394919|NCT02359019||Single Group Assignment||Treatment||None (Open Label)||||||
1394920|NCT02359006|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1394921|NCT02358993|Randomized|Single Group Assignment||Prevention||Single|||t|||
1394922|NCT02358980|||||Prospective|||||||
1394923|NCT02358967|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1394924|NCT02358954|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1394925|NCT02358941|Randomized|Parallel Assignment||Treatment||Single||||t||
1394926|NCT02358928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394927|NCT02358915||Single Group Assignment||Other||None (Open Label)||||||
1394928|NCT02358902|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1394929|NCT02358889|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394930|NCT02358876|||Cohort||Prospective|||||||
1394931|NCT02358863||Single Group Assignment||Treatment||None (Open Label)||||||
1394932|NCT02358850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394933|NCT02358837|||Case-Control||Prospective|||||||
1394934|NCT02358824|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1394935|NCT02358811|||Cohort||Prospective|||||||
1394936|NCT02358798||Single Group Assignment||||None (Open Label)||||||
1394937|NCT02358785|||Cohort||Prospective|||||||
1394938|NCT02358772|||Cohort||Prospective|||||||
1394939|NCT02358759|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1394940|NCT02358746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394941|NCT02358733|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1394942|NCT02358720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394943|NCT02358707||Single Group Assignment||Treatment||None (Open Label)||||||
1394944|NCT02358694|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1394945|NCT02358681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394946|NCT02358668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394947|NCT02358655|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1394948|NCT02358642|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1394949|NCT02358629||Single Group Assignment||Treatment||None (Open Label)||||||
1394950|NCT02358616|||Cohort||Retrospective|||||||
1394951|NCT02358603|||Case-Only||Prospective|||||||
1394952|NCT02358590|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1394953|NCT02358577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394954|NCT02358564|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1394955|NCT02358551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394956|NCT02358538||Single Group Assignment||Prevention||None (Open Label)||||||
1394957|NCT02358525|||Case Control||Prospective|||||||
1397437|NCT02326129|||Case-Control||Prospective|||||||
1394958|NCT02358512|Randomized|Parallel Assignment||Treatment||Single||||||t
1394959|NCT02358499||Single Group Assignment||Other||None (Open Label)||||||
1394960|NCT02358486|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394961|NCT02358473||Single Group Assignment||Treatment||None (Open Label)||||||
1394962|NCT02358460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394963|NCT02358447|||Cohort||Prospective|||||||
1394964|NCT02358434|||Case-Control||Cross-Sectional|||||||
1394965|NCT02358421|||Case-Only||Prospective|||||||
1394966|NCT02358408||||||||||||
1394967|NCT02358395||Single Group Assignment||Treatment||None (Open Label)||||||
1394968|NCT02358382|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394969|NCT02358369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1394970|NCT02358356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394971|NCT02358343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394972|NCT02358330|||Other||Prospective|||||||
1394973|NCT02358317|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394974|NCT02358304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394975|NCT02358291|Randomized|Parallel Assignment||Treatment||Single||||||t
1394976|NCT02358278|||Cohort||Retrospective|||||||
1394977|NCT02358265|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1394978|NCT02358252|||Case Control||Cross-Sectional|||||||
1394979|NCT02358239||Single Group Assignment||Supportive Care||None (Open Label)||||||
1394980|NCT02358226|Randomized|Parallel Assignment||Prevention||Single||||||t
1394981|NCT02358213||Single Group Assignment||||Double|||t||t|
1394982|NCT02358200||Single Group Assignment||Treatment||None (Open Label)||||||
1394983|NCT02358187||Single Group Assignment||Treatment||None (Open Label)||||||
1394984|NCT02358174|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1394985|NCT02358161||Single Group Assignment||Treatment||None (Open Label)||||||
1394986|NCT02358148|||Cohort||Prospective|||||||
1394987|NCT02358135|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1394988|NCT02358122|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1394989|NCT02358109|Randomized|Single Group Assignment||Prevention||Single|||t|||
1394990|NCT02358096|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1394991|NCT02358083|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1394992|NCT02358070|||Case Control||Cross-Sectional|||||||
1394993|NCT02358057||Single Group Assignment||Treatment||None (Open Label)||||||
1394994|NCT02358044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394995|NCT02358031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1394996|NCT02358018||||||||||||
1394997|NCT02358005|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1394998|NCT02357992||Single Group Assignment||Treatment||None (Open Label)||||||
1394999|NCT02357979|Randomized|Parallel Assignment||Prevention||Single|||||t|
1395000|NCT02357966|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395001|NCT02357953|||Cohort||Prospective|||||||
1395002|NCT02357940|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395003|NCT02357927|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395004|NCT02357914|||Case-Only||Cross-Sectional|||||||
1395005|NCT02357901|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395006|NCT02357888|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1395007|NCT02357862|||Cohort||Prospective|||||||
1395008|NCT02357849|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1395009|NCT02357836||Single Group Assignment||Treatment||None (Open Label)||||||
1395010|NCT02357823|||Case-Only||Prospective|||||||
1395011|NCT02357810||Single Group Assignment||Treatment||None (Open Label)||||||
1395012|NCT02357797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395013|NCT02357784||Single Group Assignment||Basic Science||None (Open Label)||||||
1395014|NCT02357771|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395015|NCT02357758|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1395016|NCT02357745|||||Cross-Sectional|||||||
1395017|NCT02357732|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395018|NCT02357719||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395019|NCT02357706|Randomized|Crossover Assignment||Treatment||Single|||||t|
1395020|NCT02357693|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1395021|NCT02357680|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1395022|NCT02357667|||Case-Control||Prospective|||||||
1395023|NCT02357654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395024|NCT02357641|||||Prospective|||||||
1395025|NCT02357628|||Cohort||Prospective|||||||
1395026|NCT02357615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395027|NCT02357602|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1395028|NCT02357589|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395029|NCT02357576|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395030|NCT02357563|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1395031|NCT02357550|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1395032|NCT02357537|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1395033|NCT02357524||Single Group Assignment||||None (Open Label)||||||
1395034|NCT02357511||Single Group Assignment||Health Services Research||None (Open Label)||||||
1395035|NCT02357498|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395036|NCT02357485||Single Group Assignment||Treatment||None (Open Label)||||||
1395037|NCT02357472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395038|NCT02357459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395039|NCT02357433|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395040|NCT02357420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395041|NCT02357407|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1395042|NCT02357394||||||||||||
1395043|NCT02357381|||Cohort||Prospective|||||||
1395044|NCT02357368|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1395045|NCT02357355|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1395046|NCT02357342|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395047|NCT02357329|||Ecologic or Community||Cross-Sectional|||||||
1395048|NCT02357316|||Ecologic or Community||Cross-Sectional|||||||
1395049|NCT02357303|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1395050|NCT02357290||Single Group Assignment||Treatment||None (Open Label)||||||
1395051|NCT02357277|Randomized|Parallel Assignment||Other||Double|||t||t|
1395052|NCT02357264|||Cohort||Prospective|||||||
1395053|NCT02357251|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395054|NCT02357238|||Case-Control||Prospective|||||||
1395055|NCT02357225|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395056|NCT02357212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395057|NCT02357199|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1395058|NCT02357186|||Cohort||Prospective|||||||
1395059|NCT02357173|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395060|NCT02357160|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1395061|NCT02357147|Randomized|Parallel Assignment||Treatment||||||||
1395062|NCT02357134|Randomized|Factorial Assignment||Supportive Care||Double|||t||t|
1395063|NCT02357121||Single Group Assignment||Treatment||None (Open Label)||||||
1395064|NCT02357108|Randomized|Single Group Assignment||||Single|||t|||
1395065|NCT02357095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395066|NCT02357082|||Cohort||Prospective|||||||
1395067|NCT02357069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395068|NCT02357056|Randomized|Parallel Assignment||Other||Single||||||t
1395069|NCT02357043|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1395070|NCT02357030||Single Group Assignment||Treatment||None (Open Label)||||||
1395071|NCT02357017|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1395072|NCT02357004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395073|NCT02356991|Randomized|Parallel Assignment||Treatment||Double||||||
1395074|NCT02356978||Single Group Assignment||Treatment||None (Open Label)||||||
1395075|NCT02356965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395076|NCT02356952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395077|NCT02356939|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395078|NCT02356926|||Case-Crossover||Prospective|||||||
1395079|NCT02356913|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395080|NCT02356900|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395081|NCT02356887|||||Prospective|||||||
1395082|NCT02356874|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1395083|NCT02356861|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1395084|NCT02356848|Randomized|Parallel Assignment||Prevention||Single||||||t
1395085|NCT02356835|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395086|NCT02356822|||Cohort||Other|||||||
1395087|NCT02356809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395088|NCT02356796|Randomized|Parallel Assignment||Treatment||Single||||||t
1395089|NCT02356783|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395090|NCT02356770|Randomized|Parallel Assignment||Treatment||Single||||||t
1395091|NCT02356757|Randomized|Parallel Assignment||Prevention||Single||||||t
1395092|NCT02356744|||Case-Control||Prospective|||||||
1395093|NCT02356731|||||Prospective|||||||
1395094|NCT02356718|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395095|NCT02356705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395096|NCT02356692|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395097|NCT02356679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395098|NCT02356666|||Case-Only||Retrospective|||||||
1395099|NCT02356653||Single Group Assignment||Treatment||None (Open Label)||"Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs)~Processing of stem cells using the CliniMACs device to selectively deplete specific T cells to decrease risk of graft versus host disease when using donor stem cells which are not fully matched."||||
1395100|NCT02356640|Randomized|Parallel Assignment||Treatment||Single||||||t
1395101|NCT02356627|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1395102|NCT02356614|||Cohort||Prospective|||||||
1395103|NCT02356601|||Cohort||Prospective|||||||
1395104|NCT02356588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395105|NCT02356575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395106|NCT02356562||Single Group Assignment||Treatment||None (Open Label)||||||
1395107|NCT02356549|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1395108|NCT02356536||Single Group Assignment||Treatment||None (Open Label)||||||
1395109|NCT02356523|||Cohort||Prospective|||||||
1395110|NCT02356510|||Cohort||Retrospective|||||||
1395111|NCT02356497|||Cohort||Prospective|||||||
1395112|NCT02356484|||Cohort||Prospective|||||||
1395113|NCT02356471||Single Group Assignment||Supportive Care||None (Open Label)||||||
1395114|NCT02356458||Single Group Assignment||Treatment||None (Open Label)||||||
1395115|NCT02356445|||Cohort||Retrospective|||||||
1395116|NCT02356432|||Cohort||Prospective|||||||
1395117|NCT02356419|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395118|NCT02356406||Single Group Assignment||Supportive Care||None (Open Label)||||||
1395119|NCT02356393|||Case-Control||Prospective|||||||
1395120|NCT02356380||Single Group Assignment||Treatment||None (Open Label)||||||
1395121|NCT02356367|||Cohort||Prospective|||||||
1395122|NCT02356354||Single Group Assignment||||None (Open Label)||||||
1395123|NCT02356341|||Cohort||Prospective|||||||
1395124|NCT02356328|||Cohort||Prospective|||||||
1395125|NCT02356315|||Case Control||Cross-Sectional|||||||
1395126|NCT02356302|Randomized|Parallel Assignment||Prevention||Single|||t|||
1395127|NCT02356289|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395128|NCT02356276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395129|NCT02356263|||||Cross-Sectional|||||||
1395130|NCT02356250|||Case-Only||Prospective|||||||
1395131|NCT02356237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395132|NCT02356224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395133|NCT02356211|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395134|NCT02356198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395135|NCT02356185|||Case-Only||Cross-Sectional|||||||
1395136|NCT02356172|||Case-Control||Cross-Sectional|||||||
1395137|NCT02356159|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1395138|NCT02356146|||Cohort||Prospective|||||||
1395139|NCT02356133|||Cohort||Prospective|||||||
1395140|NCT02356120|||Cohort||Prospective|||||||
1395141|NCT02356107||Single Group Assignment||Treatment||None (Open Label)||||||
1395142|NCT02356094|||Case Control||Retrospective|||||||
1395143|NCT02356081|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395144|NCT02356068|||Cohort||Prospective|||||||
1395145|NCT02356055|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1395146|NCT02356042|||Case Control||Prospective|||||||
1395147|NCT02356029|||Cohort||Cross-Sectional|||||||
1395148|NCT02356016|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395149|NCT02356003||Single Group Assignment||Treatment||None (Open Label)||||||
1395150|NCT02355990||Single Group Assignment||Treatment||None (Open Label)||||||
1395151|NCT02355977|Randomized|Parallel Assignment||Treatment||Single||||||t
1395152|NCT02355964|Randomized|Parallel Assignment||Treatment||Single||||||t
1395153|NCT02355951||||Screening||||||||
1395154|NCT02355938|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395155|NCT02355925|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395156|NCT02355912||Single Group Assignment||Basic Science||None (Open Label)||||||
1395157|NCT02355899||Single Group Assignment||Treatment||None (Open Label)||||||
1395158|NCT02355886|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1395159|NCT02355873|Randomized|Crossover Assignment||Treatment||Double||||t|t|
1395160|NCT02355860|||Ecologic or Community||Cross-Sectional|||||||
1395161|NCT02355847||Single Group Assignment||||None (Open Label)||||||
1395162|NCT02355834|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395163|NCT02355821|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1395164|NCT02355808|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1395165|NCT02355795|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1395166|NCT02355782||||||||||||
1395167|NCT02355769|||Case-Control||Prospective|||||||
1395168|NCT02355756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395169|NCT02355743||Single Group Assignment||Prevention||None (Open Label)||||||
1395170|NCT02355730||Single Group Assignment||Diagnostic||Single|||t|||
1395171|NCT02355717|||Cohort||Prospective|||||||
1395172|NCT02355704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395173|NCT02355691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395174|NCT02355678|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395175|NCT02355665|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395176|NCT02355652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395177|NCT02355639|Randomized|Parallel Assignment||Other||Single|||||t|
1395178|NCT02355626|||Cohort||Prospective|||||||
1395179|NCT02355613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395180|NCT02355600|||Cohort||Prospective|||||||
1395181|NCT02355587|||Cohort||Prospective|||||||
1395182|NCT02355574|||Cohort||Prospective|||||||
1395183|NCT02355561|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395184|NCT02355548|||Cohort||Prospective|||||||
1395185|NCT02355535||Single Group Assignment||Treatment||None (Open Label)||||||
1395186|NCT02355522|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1395187|NCT02355509|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395188|NCT02355496|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1395189|NCT02355483||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395190|NCT02355470|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395191|NCT02355457|||Cohort||Prospective|||||||
1395192|NCT02355444|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1395193|NCT02355431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395194|NCT02355418|||Case-Control||Prospective|||||||
1395195|NCT02355405|||Case-Only||Prospective|||||||
1395196|NCT02355392|||Cohort||Cross-Sectional|||||||
1395197|NCT02355379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395198|NCT02355366|Randomized|Parallel Assignment||Prevention||Single||||||t
1395199|NCT02355353||Single Group Assignment||Basic Science||None (Open Label)||||||
1395200|NCT02355340||Single Group Assignment||Supportive Care||None (Open Label)||||||
1395201|NCT02355327|Randomized|Parallel Assignment||||Single||||||t
1395202|NCT02355314||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395203|NCT02355301|||Case-Control||Prospective|||||||
1395204|NCT02355288|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395205|NCT02355275||Single Group Assignment||Prevention||None (Open Label)||||||
1395206|NCT02355262|||Ecologic or Community||Prospective|||||||
1395207|NCT02355249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395208|NCT02355236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395209|NCT02355223||Single Group Assignment||Health Services Research||None (Open Label)||||||
1395210|NCT02355210|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395211|NCT02355197|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395212|NCT02355184||Single Group Assignment||Treatment||None (Open Label)||||||
1395213|NCT02355171|||Cohort||Other|||||||
1395214|NCT02355158||Single Group Assignment||Treatment||None (Open Label)||||||
1395215|NCT02355145|||Cohort||Prospective|||||||
1395216|NCT02355132|||Case Control||Retrospective|||||||
1395217|NCT02355119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395218|NCT02355106||Single Group Assignment||Treatment||None (Open Label)||||||
1395219|NCT02355093|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395220|NCT02355080|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395221|NCT02355067|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395222|NCT02355054||||||||||||
1395223|NCT02355041|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1395224|NCT02355028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395225|NCT02355015|||Cohort||Prospective|||||||
1395226|NCT02355002|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395227|NCT02354989|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1395228|NCT02354976|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395229|NCT02354963|Randomized|Parallel Assignment||Treatment||Single||||||t
1395230|NCT02354950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395231|NCT02354937|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1395232|NCT02354924|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1395233|NCT02354911|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1395234|NCT02354898||Single Group Assignment||Treatment||None (Open Label)||||||
1395235|NCT02354885||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395236|NCT02354872|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1395237|NCT02354859|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395238|NCT02354846|||Cohort||Prospective|||||||
1395239|NCT02354833|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395240|NCT02354820|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395241|NCT02354807||Single Group Assignment||Basic Science||None (Open Label)||||||
1395242|NCT02354794|Randomized|Crossover Assignment||||Triple|||t||t|t
1395243|NCT02354781||Single Group Assignment||Other||None (Open Label)||||||
1395244|NCT02354768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395245|NCT02354755|||Cohort||Prospective|||||||
1395246|NCT02354742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395247|NCT02354729|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395248|NCT02354716|||Case-Only||Prospective|||||||
1395249|NCT02354703|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1395250|NCT02354690||Single Group Assignment||Treatment||None (Open Label)||||||
1395251|NCT02354677||Single Group Assignment||Basic Science||None (Open Label)||||||
1395252|NCT02354664|||Case-Control||Prospective|||||||
1395253|NCT02354651|||Cohort||Prospective|||||||
1395254|NCT02354638|Randomized|Single Group Assignment||Screening||Single|||t|||
1395255|NCT02354625||Single Group Assignment||Treatment||None (Open Label)||||||
1395256|NCT02354612||Single Group Assignment||Treatment||None (Open Label)||||||
1395257|NCT02354599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395258|NCT02354586||Single Group Assignment||Treatment||None (Open Label)||||||
1395259|NCT02354573|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1395260|NCT02354560||Single Group Assignment||Treatment||None (Open Label)||||||
1395261|NCT02354547||Single Group Assignment||Treatment||None (Open Label)||||||
1395262|NCT02354534|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395263|NCT02354521|||Cohort||Prospective|||||||
1395264|NCT02354508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395265|NCT02354495||Single Group Assignment||Supportive Care||None (Open Label)||||||
1395266|NCT02354482|||Cohort||Prospective|||||||
1395267|NCT02354469|||Cohort||Prospective|||||||
1395268|NCT02354456|||Case-Only||Prospective|||||||
1395269|NCT02354443||Single Group Assignment||Treatment||None (Open Label)||||||
1395270|NCT02354430|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395271|NCT02354417||Single Group Assignment||Treatment||None (Open Label)||||||
1395272|NCT02354404|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395273|NCT02354391||Single Group Assignment||Treatment||None (Open Label)||||||
1395274|NCT02354378|||Cohort||Prospective|||||||
1395275|NCT02354365|||Cohort||Prospective|||||||
1395276|NCT02354352|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1395277|NCT02354339|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395278|NCT02354326|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1395279|NCT02354313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395280|NCT02354300|||Case-Only||Prospective|||||||
1395281|NCT02354287|||Cohort||Prospective|||||||
1395282|NCT02354274|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395283|NCT02354261||Single Group Assignment||Treatment||None (Open Label)||||||
1395284|NCT02354248|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1395285|NCT02354235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395286|NCT02354222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395287|NCT02354209|||Cohort||Other|||||||
1395288|NCT02354196|||Cohort||Other|||||||
1395289|NCT02354183|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395290|NCT02354170|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1395291|NCT02354157|||Cohort||Cross-Sectional|||||||
1395292|NCT02354144|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1395293|NCT02354131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395294|NCT02354118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395295|NCT02354105|||Cohort||Prospective|||||||
1395296|NCT02354092|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395297|NCT02354079||Single Group Assignment||||None (Open Label)||||||
1395298|NCT02354066|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1395299|NCT02354053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395300|NCT02354040|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1395301|NCT02354027||Single Group Assignment||Treatment||None (Open Label)||||||
1395302|NCT02354014||Single Group Assignment||Treatment||None (Open Label)||||||
1395303|NCT02354001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395304|NCT02353988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395305|NCT02353975|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395306|NCT02353962||Single Group Assignment||Other||None (Open Label)||||||
1395307|NCT02353949||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395308|NCT02353936||Single Group Assignment||Treatment||None (Open Label)||||||
1395309|NCT02353923||Single Group Assignment||Treatment||None (Open Label)||||||
1395310|NCT02353910|||Cohort||Prospective|||||||
1395311|NCT02353897|||Cohort||Prospective|||||||
1395312|NCT02353884|||Case Control||Prospective|||||||
1395313|NCT02353871|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395314|NCT02353858||Single Group Assignment||Treatment||None (Open Label)||||||
1395315|NCT02353845|||Case Control||Prospective|||||||
1395316|NCT02353832||Single Group Assignment||Treatment||None (Open Label)||||||
1395317|NCT02353819||Single Group Assignment||Treatment||None (Open Label)||||||
1395318|NCT02353806||Single Group Assignment||Treatment||None (Open Label)||||||
1395319|NCT02353793|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395320|NCT02353780|Randomized|Parallel Assignment||Basic Science||Single||||||t
1395321|NCT02353767|||Case Control||Cross-Sectional|||||||
1395322|NCT02353754|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395323|NCT02353741||Single Group Assignment||Treatment||None (Open Label)||||||
1395324|NCT02353728||Single Group Assignment||Basic Science||None (Open Label)||||||
1395325|NCT02353715|||Cohort||Prospective|||||||
1395326|NCT02353702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395327|NCT02353689|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1395328|NCT02353676|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1395329|NCT02353663|||Cohort||Cross-Sectional|||||||
1395330|NCT02353650|Randomized|||Treatment||Quadruple|||t|t|t|t
1395331|NCT02353637|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1395332|NCT02353624|||||Prospective|||||||
1395333|NCT02353611|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395334|NCT02353598|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395335|NCT02353585|||Cohort||Prospective|||||||
1395336|NCT02353572||Single Group Assignment||Treatment||None (Open Label)||||||
1395337|NCT02353559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395338|NCT02353546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395339|NCT02353533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395340|NCT02353520|||||Cross-Sectional|||||||
1395341|NCT02353507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395342|NCT02353494|||Cohort||Prospective|||||||
1395343|NCT02353481|||Cohort||Retrospective|||||||
1395344|NCT02353468||Single Group Assignment||Treatment||None (Open Label)||||||
1395345|NCT02353455|||Cohort||Prospective|||||||
1395346|NCT02353442|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395347|NCT02353429||Single Group Assignment||Treatment||None (Open Label)||||||
1395348|NCT02353416|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395349|NCT02353403|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1395350|NCT02353390|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1395351|NCT02353377||||||||||||
1395352|NCT02353364|Randomized|Parallel Assignment||Screening||Single|||t|||
1395353|NCT02353351|||Cohort||Prospective|||||||
1395354|NCT02353338|Randomized|Parallel Assignment||Treatment||Single||||||t
1395355|NCT02353325|Randomized|Crossover Assignment||Prevention||Single|||t|||
1395356|NCT02353312|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395357|NCT02353299|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1395358|NCT02353286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395359|NCT02353273||Single Group Assignment||Treatment||None (Open Label)||||||
1395360|NCT02353260|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395361|NCT02353247||Single Group Assignment||Treatment||None (Open Label)||||||
1395362|NCT02353234|Randomized|Crossover Assignment||Treatment||Single|||t|||
1395363|NCT02353221|||Cohort||Prospective|||||||
1395364|NCT02353208|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1395365|NCT02353195|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395366|NCT02353182||Single Group Assignment||Treatment||None (Open Label)||||||
1395367|NCT02353169|Randomized|Factorial Assignment||Basic Science||Single||||||t
1395368|NCT02353156|Randomized|Parallel Assignment||Treatment||Single|||||t|
1395369|NCT02353143||Single Group Assignment||Treatment||None (Open Label)||||||
1395370|NCT02353130|||Cohort||Prospective|||||||
1395371|NCT02353117|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395372|NCT02353104||Single Group Assignment||Supportive Care||None (Open Label)||||||
1395373|NCT02353091|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395374|NCT02353078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395375|NCT02353065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395376|NCT02353052|||Cohort||Prospective|||||||
1395377|NCT02353039|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395378|NCT02353026||Single Group Assignment||Treatment||None (Open Label)||||||
1395379|NCT02353013|Randomized|Parallel Assignment||Prevention||Single|||||t|
1395380|NCT02353000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395381|NCT02352987|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395382|NCT02352974||Single Group Assignment||Treatment||None (Open Label)||||||
1395383|NCT02352961|||||Cross-Sectional|||||||
1395384|NCT02352948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395385|NCT02352935||Single Group Assignment||Treatment||None (Open Label)||||||
1395386|NCT02352922|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395387|NCT02352909|Randomized|Parallel Assignment||Treatment||Single||||||t
1395388|NCT02352896||Single Group Assignment||Treatment||None (Open Label)||||||
1395389|NCT02352883|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1395390|NCT02352870|Randomized|Parallel Assignment||Other||Single||||||t
1395391|NCT02352857|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1395392|NCT02352844||Single Group Assignment||Treatment||None (Open Label)||||||
1395393|NCT02352831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395394|NCT02352818|||Cohort||Prospective|||||||
1395395|NCT02352805|||Other||Prospective|||||||
1395396|NCT02352792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395397|NCT02352779|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1395398|NCT02352766|||Case-Only||Cross-Sectional|||||||
1395399|NCT02352753||Single Group Assignment||Treatment||None (Open Label)||||||
1395400|NCT02352740|Randomized|Crossover Assignment||||Single|||t|||
1395401|NCT02352727|||Case Control||Cross-Sectional|||||||
1395402|NCT02352714|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1395403|NCT02352701|||Case Control||Prospective|||||||
1395404|NCT02352688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395405|NCT02352675|||Case-Control||Prospective|||||||
1395406|NCT02352662|||Cohort||Prospective|||||||
1395407|NCT02352649|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395408|NCT02352636|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1395409|NCT02352623|||Cohort||Prospective|||||||
1395410|NCT02352610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395411|NCT02352597|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395412|NCT02352584|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1395413|NCT02352571||Single Group Assignment||Treatment||None (Open Label)||||||
1395414|NCT02352558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395415|NCT02352545|Randomized|Single Group Assignment||Treatment||Single|||t|||
1395416|NCT02352532|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1395417|NCT02352519|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1395418|NCT02352506|||Cohort||Prospective|||||||
1395419|NCT02352493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395420|NCT02352480|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395421|NCT02352467|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395422|NCT02352454|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395423|NCT02352441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395424|NCT02352428|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1395425|NCT02352402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395426|NCT02352389|||Cohort||Prospective|||||||
1395427|NCT02352376|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395428|NCT02352363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395429|NCT02352350|||Other||Prospective|||||||
1395430|NCT02352337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395431|NCT02352324||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395432|NCT02352311|Randomized|Crossover Assignment||||None (Open Label)||||||
1395433|NCT02352298|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1395434|NCT02352285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395435|NCT02352272|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395436|NCT02352259||Single Group Assignment||Treatment||None (Open Label)||||||
1395437|NCT02352246|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1395438|NCT02352233|||Case-Only||Prospective|||||||
1395439|NCT02352220|||Case-Control||Cross-Sectional|||||||
1395440|NCT02352207|||Cohort||Prospective|||||||
1395441|NCT02352194|||Cohort|||||||||
1395442|NCT02352181|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395443|NCT02352168|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395444|NCT02352155|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395445|NCT02352142|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395446|NCT02352129|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1395447|NCT02352116|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1395448|NCT02352103|Randomized|Parallel Assignment||Treatment||Single||||||t
1395449|NCT02352090|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395450|NCT02352077||Single Group Assignment||Treatment||None (Open Label)||||||
1395451|NCT02352064||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395452|NCT02352051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395453|NCT02352038|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1395454|NCT02352025||Single Group Assignment||Treatment||None (Open Label)||||||
1395455|NCT02352012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395456|NCT02351999||Single Group Assignment||||None (Open Label)||||||
1395457|NCT02351986|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395458|NCT02351973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395459|NCT02351960|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395460|NCT02351947|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1395461|NCT02351934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395462|NCT02351921|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1395463|NCT02351908|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1395464|NCT02351895|||Cohort||Prospective|||||||
1395465|NCT02351882|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1395466|NCT02351869|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395467|NCT02351856||Single Group Assignment||Treatment||None (Open Label)||||||
1395468|NCT02351843|Randomized|Crossover Assignment||Device Feasibility||Triple|||t||t|t
1395469|NCT02351830||||||||||||
1395470|NCT02351817|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1395471|NCT02351804|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1395472|NCT02351791|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1395473|NCT02351778|||||Cross-Sectional|||||||
1395474|NCT02351765||Single Group Assignment||Treatment||None (Open Label)||||||
1395475|NCT02351752||Single Group Assignment||Treatment||None (Open Label)||||||
1395476|NCT02351739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395477|NCT02351726||Single Group Assignment||Treatment||None (Open Label)||||||
1395478|NCT02351713|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1395479|NCT02351700|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1395480|NCT02351687|Randomized|Parallel Assignment||Treatment||Single|||||t|
1395481|NCT02351674|||Cohort||Retrospective|||||||
1395482|NCT02351661|||Cohort||Prospective|||||||
1395483|NCT02351648|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1395484|NCT02351635|||Case-Control||Cross-Sectional|||||||
1395485|NCT02351622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395486|NCT02351609|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395487|NCT02351596|Randomized|Parallel Assignment||Treatment||Single||||||t
1395488|NCT02351583|||Case Control||Prospective|||||||
1395489|NCT02351570|||||Cross-Sectional|||||||
1395490|NCT02351557|||Cohort||Prospective|||||||
1395491|NCT02351544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395492|NCT02351531||Single Group Assignment||Treatment||None (Open Label)||||||
1395493|NCT02351518|||Cohort||Prospective|||||||
1395494|NCT02351505||Single Group Assignment||Treatment||None (Open Label)||||||
1395495|NCT02351492|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1395496|NCT02351479||Single Group Assignment||Supportive Care||None (Open Label)||||||
1395497|NCT02351466|||Cohort||Prospective|||||||
1395498|NCT02351453|||Cohort||Prospective|||||||
1395499|NCT02351440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395500|NCT02351427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395501|NCT02351414|||Cohort||Prospective|||||||
1395502|NCT02351401|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1395503|NCT02351388|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395504|NCT02351375|Randomized|Crossover Assignment||Basic Science||Single||||||t
1395505|NCT02351362|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1395506|NCT02351349|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395507|NCT02351336|||Cohort||Prospective|||||||
1395508|NCT02351323|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395509|NCT02351310|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395510|NCT02351297|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1395511|NCT02351284|||Cohort||Prospective|||||||
1395512|NCT02351271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395513|NCT02351258|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1395514|NCT02351245|||Cohort||Retrospective|||||||
1395515|NCT02351232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395516|NCT02351219||Single Group Assignment||Treatment||None (Open Label)||||||
1395517|NCT02351206|||Case-Control||Retrospective|||||||
1395518|NCT02351193|||Cohort||Prospective|||||||
1395519|NCT02351180|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1395520|NCT02351167|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1395521|NCT02351154||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395522|NCT02351141||Single Group Assignment||Basic Science||None (Open Label)||||||
1395523|NCT02351128||Single Group Assignment||Treatment||None (Open Label)||||||
1395524|NCT02351115|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1395525|NCT02351102|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1395526|NCT02351089|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1395527|NCT02351076|||Case-Only||Prospective|||||||
1395528|NCT02351063||Single Group Assignment||Treatment||None (Open Label)||||||
1395529|NCT02351050|Randomized|Parallel Assignment||Prevention||Single||||||t
1395530|NCT02351037|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395531|NCT02351024||||||||||||
1395532|NCT02351011|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1395533|NCT02350998||Single Group Assignment||Treatment||None (Open Label)||||||
1395534|NCT02350985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395535|NCT02350972||Single Group Assignment||Basic Science||None (Open Label)||||||
1395536|NCT02350959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395537|NCT02350946|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1395538|NCT02350933||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395539|NCT02350920|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1395540|NCT02350907|||||Cross-Sectional|||||||
1395541|NCT02350894|||Cohort||Prospective|||||||
1395542|NCT02350881|||Cohort|||||||||
1395543|NCT02350868||Single Group Assignment||Treatment||None (Open Label)||||||
1395544|NCT02350855|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395545|NCT02350842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395546|NCT02350829|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1395547|NCT02350816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395548|NCT02350803|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395549|NCT02350790|Randomized|Single Group Assignment||Treatment||Single||||||t
1395550|NCT02350777|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395551|NCT02350764||Single Group Assignment||Treatment||None (Open Label)||||||
1395552|NCT02350751|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395553|NCT02350738|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1395554|NCT02350725|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395555|NCT02350712|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395556|NCT02350699|||Cohort||Prospective|||||||
1395557|NCT02350686||Single Group Assignment||Treatment||None (Open Label)||||||
1395558|NCT02350673|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1395559|NCT02350660|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395560|NCT02350647|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395561|NCT02350634||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395562|NCT02350621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395563|NCT02350608|||Cohort||Prospective|||||||
1395564|NCT02350595|Randomized|Parallel Assignment||Treatment||Single||||||t
1395565|NCT02350582|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1395566|NCT02350569||Single Group Assignment||Treatment||None (Open Label)||||||
1395567|NCT02350556|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395568|NCT02350543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395569|NCT02350530|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395570|NCT02350517||Single Group Assignment||Treatment||None (Open Label)||||||
1395571|NCT02350504|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395572|NCT02350491|||Other||Prospective|||||||
1395573|NCT02350478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395574|NCT02350465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395575|NCT02350452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395576|NCT02350439||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395577|NCT02350426|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1395578|NCT02350413|||Case-Only||Prospective|||||||
1395579|NCT02350400||Single Group Assignment||Treatment||None (Open Label)||||||
1395580|NCT02350387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395581|NCT02350374||Single Group Assignment||Other||None (Open Label)||||||
1395582|NCT02350361|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395583|NCT02350348|||Cohort||Prospective|||||||
1395584|NCT02350335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395585|NCT02350322|Randomized|Parallel Assignment||||None (Open Label)||||||
1395586|NCT02350309|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1395587|NCT02350296|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1395588|NCT02350283|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395589|NCT02350270|||Case Control||Cross-Sectional|||||||
1395590|NCT02350257|Randomized|Parallel Assignment||Treatment||Single||||||t
1395591|NCT02350244|Randomized|Single Group Assignment||||None (Open Label)||||||
1395592|NCT02350231|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395593|NCT02350218|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395594|NCT02350205|Randomized|Crossover Assignment||Treatment||Single||||||t
1395595|NCT02350192|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1395596|NCT02350179|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1395597|NCT02350166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395598|NCT02350153|||Cohort||Retrospective|||||||
1395599|NCT02350140|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1395600|NCT02350127|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1395601|NCT02350114||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395602|NCT02350101|||||Retrospective|||||||
1395603|NCT02350088|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395604|NCT02350075|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395605|NCT02350062|||Cohort||Prospective|||||||
1395606|NCT02350049|||Case-Control||Retrospective|||||||
1395607|NCT02350036|||Case-Control||Prospective|||||||
1395608|NCT02350023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395609|NCT02350010|||Cohort||Prospective|||||||
1395610|NCT02349997|||Case-Only||Prospective|||||||
1395611|NCT02349971||Single Group Assignment||Treatment||None (Open Label)||||||
1395612|NCT02349958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395613|NCT02349945|Non-Randomized|Parallel Assignment||Treatment||Single||||t||
1395614|NCT02349932|||Ecologic or Community||Cross-Sectional|||||||
1395615|NCT02349919|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395616|NCT02349906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395617|NCT02349893||Single Group Assignment||Treatment||None (Open Label)||||||
1395618|NCT02349880|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1395619|NCT02349867||Single Group Assignment||Treatment||None (Open Label)||||||
1395620|NCT02349854|||Case-Control||Cross-Sectional|||||||
1395621|NCT02349841|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395622|NCT02349828|Randomized|Parallel Assignment||Treatment||Single||||||t
1395623|NCT02349815|||Cohort||Retrospective|||||||
1395624|NCT02349802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395625|NCT02349789|||Cohort||Cross-Sectional|||||||
1395626|NCT02349776||Single Group Assignment||Supportive Care||None (Open Label)||||||
1395627|NCT02349763|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1395628|NCT02349750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395629|NCT02349737|||Cohort||Cross-Sectional|||||||
1395630|NCT02349724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395631|NCT02349711|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1395632|NCT02349698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395633|NCT02349685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395634|NCT02349672|||Cohort||Prospective|||||||
1395635|NCT02349659|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395636|NCT02349646|||Cohort||Prospective|||||||
1395637|NCT02349633|Randomized|||Treatment||None (Open Label)||||||
1395638|NCT02349620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395639|NCT02349607|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1395640|NCT02349594|Randomized|Crossover Assignment||Treatment||Single||||||t
1395641|NCT02349581|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1395642|NCT02349568|||Cohort||Prospective|||||||
1395643|NCT02349555||Single Group Assignment||||None (Open Label)||||||
1395644|NCT02349542||Single Group Assignment||Health Services Research||None (Open Label)||||||
1395645|NCT02349529|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395646|NCT02349516|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395647|NCT02349503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395648|NCT02349490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395649|NCT02349477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395650|NCT02349464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395651|NCT02349451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395652|NCT02349438|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1395653|NCT02349425|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1395654|NCT02349412|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395655|NCT02349399|||Cohort||Retrospective|||||||
1395656|NCT02349386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395657|NCT02349373|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1395658|NCT02349360|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1395659|NCT02349347||Single Group Assignment||Treatment||None (Open Label)||||||
1395660|NCT02349334|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395661|NCT02349321|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395662|NCT02349308|||||Prospective|||||||
1395663|NCT02349295|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395664|NCT02349282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395665|NCT02349269||||||||||||
1395666|NCT02349256|||Case-Only||Cross-Sectional|||||||
1395667|NCT02349243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395668|NCT02349230|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395669|NCT02349217|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395670|NCT02349204|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1395671|NCT02349191||Single Group Assignment||Treatment||None (Open Label)||||||
1395672|NCT02349178||Single Group Assignment||Treatment||None (Open Label)||||||
1395673|NCT02349165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395674|NCT02349152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395675|NCT02349139||Sequential Assignment||Treatment||None (Open Label)||||||
1395676|NCT02349126||Single Group Assignment||Treatment||None (Open Label)||||||
1395677|NCT02349113||Single Group Assignment||Basic Science||None (Open Label)||||||
1395678|NCT02349100|||Case-Control||Prospective|||||||
1395679|NCT02349087|||Cohort||Prospective|||||||
1395680|NCT02349074||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395681|NCT02349061|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1395682|NCT02349048|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395683|NCT02349035||Single Group Assignment||Basic Science||None (Open Label)||||||
1395684|NCT02349022||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395685|NCT02349009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395686|NCT02348996|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395687|NCT02348983||Single Group Assignment||Treatment||None (Open Label)||||||
1395688|NCT02348970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395689|NCT02348957|||Other||Prospective|||||||
1395690|NCT02348944|||Cohort|||||||||
1395691|NCT02348931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395692|NCT02348918|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395693|NCT02348905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395694|NCT02348892|||||Prospective|||||||
1395695|NCT02348879|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1395696|NCT02348866|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1395697|NCT02348853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395698|NCT02348840|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1395699|NCT02348827|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1395700|NCT02348814|||Case-Control||Prospective|||||||
1395701|NCT02348801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395702|NCT02348788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395703|NCT02348775||Single Group Assignment||Basic Science||None (Open Label)||||||
1395704|NCT02348762||Single Group Assignment||Basic Science||None (Open Label)||||||
1395705|NCT02348749||Single Group Assignment||Diagnostic||None (Open Label)||For phase I, a single dose of 18F-MFBG will be injected intravenously in patients. For all patients, pharmacokinetics and bio distribution will be evaluated using non invasive PET scanning and blood assays at multiple time points post injection. In the expansion phase, a single dose of 18F-MFBG will be injected intravenously followed by a single time point imaging using PET MR scanner (PET/CT if scan cannot be performed on PET/MR for technical reasons).||||
1395706|NCT02348736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395707|NCT02348723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395708|NCT02348710|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1395709|NCT02348697|||Case-Only||Prospective|||||||
1395710|NCT02348684|||Case-Only||Prospective|||||||
1395711|NCT02348671|||Cohort||Prospective|||||||
1395712|NCT02348658|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395713|NCT02348645|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395714|NCT02348632||Single Group Assignment||Treatment||None (Open Label)||||||
1395715|NCT02348619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395716|NCT02348606|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395717|NCT02348593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395718|NCT02348580|Randomized|Parallel Assignment||||None (Open Label)||||||
1395719|NCT02348567|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1395720|NCT02348554|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1395721|NCT02348541||Single Group Assignment||Prevention||None (Open Label)||||||
1395722|NCT02348528||Single Group Assignment||Treatment||None (Open Label)||||||
1395723|NCT02348515|||Cohort||Prospective|||||||
1395724|NCT02348502|||Cohort||Prospective|||||||
1395725|NCT02348489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395726|NCT02348476|||Cohort||Retrospective|||||||
1395727|NCT02348463|||Cohort||Prospective|||||||
1395728|NCT02348450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395729|NCT02348437|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1395730|NCT02348424|Non-Randomized|Parallel Assignment||Treatment||||||||
1395731|NCT02348411||Single Group Assignment||Treatment||None (Open Label)||||||
1395732|NCT02348398||Single Group Assignment||Treatment||None (Open Label)||||||
1395733|NCT02348385|||Case-Control||Prospective|||||||
1395734|NCT02348372|Randomized|Crossover Assignment||Other||Single|||t|||
1395735|NCT02348359|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1395736|NCT02348346|||Ecologic or Community||Prospective|||||||
1395737|NCT02348333|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1395738|NCT02348320||Single Group Assignment||Treatment||None (Open Label)||||||
1395739|NCT02348307|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1395740|NCT02348294|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1395741|NCT02348281||Single Group Assignment||Treatment||None (Open Label)||||||
1395742|NCT02348268|Randomized|Parallel Assignment||Treatment||Single||||||t
1395743|NCT02348255||Single Group Assignment||Treatment||None (Open Label)||||||
1395744|NCT02348242|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395745|NCT02348229|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395746|NCT02348216||Single Group Assignment||Treatment||None (Open Label)||||||
1395747|NCT02348203|Randomized|Parallel Assignment||Prevention||Single|||t|||
1395748|NCT02348190|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1395749|NCT02348177||Single Group Assignment||Treatment||None (Open Label)||||||
1395750|NCT02348164|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1395751|NCT02348151|Randomized|Single Group Assignment||||None (Open Label)||||||
1395752|NCT02348138|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1395753|NCT02348125||Single Group Assignment||Treatment||None (Open Label)||||||
1395754|NCT02348112|||Cohort||Prospective|||||||
1395755|NCT02348099|||Case-Only||Prospective|||||||
1395756|NCT02348086|||Cohort||Prospective|||||||
1395757|NCT02348073|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395758|NCT02348060|||Cohort||Prospective|||||||
1395759|NCT02348047|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395760|NCT02348034|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395761|NCT02348021||Single Group Assignment||Treatment||None (Open Label)||||||
1395762|NCT02348008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395763|NCT02347995|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395764|NCT02347982|||Cohort||Cross-Sectional|||||||
1395765|NCT02347969||Single Group Assignment||||None (Open Label)||||||
1395766|NCT02347956||Single Group Assignment||Treatment||None (Open Label)||||||
1395767|NCT02347943|||Cohort||Prospective|||||||
1395768|NCT02347930|||Other||Prospective|||||||
1395769|NCT02347917||Single Group Assignment||Treatment||None (Open Label)||||||
1395770|NCT02347904||Single Group Assignment||Treatment||None (Open Label)||||||
1395771|NCT02347891|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1395772|NCT02347878|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1395773|NCT02347865|||Case-Only||Prospective|||||||
1395774|NCT02347852|||Cohort||Prospective|||||||
1395775|NCT02347839||Single Group Assignment||Treatment||None (Open Label)||||||
1395776|NCT02347826|||||Retrospective|||||||
1395777|NCT02347813|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1395778|NCT02347787|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1395779|NCT02347774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395780|NCT02347761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395781|NCT02347748|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1395782|NCT02347735|||Cohort||Prospective|||||||
1395783|NCT02347722|||Cohort||Other|||||||
1395784|NCT02347709|||Cohort||Prospective|||||||
1395785|NCT02347696|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395786|NCT02347683|||Cohort||Prospective|||||||
1395787|NCT02347670|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1395788|NCT02347657|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395789|NCT02347644|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1395790|NCT02347631|Randomized|Crossover Assignment||Basic Science||Single||||||t
1395791|NCT02347618||Single Group Assignment||Treatment||None (Open Label)||||||
1395792|NCT02347605|Randomized|Crossover Assignment||Other||Double|||t||t|
1395793|NCT02347592|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1395794|NCT02347579|||Case-Control||Prospective|||||||
1395795|NCT02347566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395796|NCT02347553|||Other||Prospective|||||||
1395797|NCT02347540|||Case-Control||Cross-Sectional|||||||
1395798|NCT02347527|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395799|NCT02347514|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1395800|NCT02347501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395801|NCT02347488||Single Group Assignment||Treatment||None (Open Label)||||||
1395802|NCT02347475|||Cohort||Prospective|||||||
1395803|NCT02347462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395804|NCT02347449||Single Group Assignment||||None (Open Label)||||||
1395805|NCT02347436|||Case-Control||Prospective|||||||
1395806|NCT02347423|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1395807|NCT02347410||Single Group Assignment||Treatment||None (Open Label)||||||
1395808|NCT02347397|Randomized|Parallel Assignment||Treatment||Single||||||t
1395809|NCT02347384|Randomized|Parallel Assignment||Treatment||Single||||||t
1395810|NCT02347371|||Cohort||Prospective|||||||
1395811|NCT02347358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395812|NCT02347345|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395813|NCT02347332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395814|NCT02347319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395815|NCT02347306|||||Retrospective|||||||
1395816|NCT02347293|Randomized|Crossover Assignment||Prevention||Single|||t|||
1395817|NCT02347280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395818|NCT02347267|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395819|NCT02347254||Single Group Assignment||Treatment||None (Open Label)||||||
1398044|NCT02318199|||Cohort||Prospective|||||||
1395820|NCT02347241|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1395821|NCT02347228||Single Group Assignment||Treatment||None (Open Label)||||||
1395822|NCT02347215||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395823|NCT02347202|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395824|NCT02347189||Single Group Assignment||Treatment||None (Open Label)||||||
1395825|NCT02347176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395826|NCT02347163||Single Group Assignment||Treatment||None (Open Label)||||||
1395827|NCT02347150|||Cohort||Prospective|||||||
1395828|NCT02347137|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1395829|NCT02347124|Randomized|Parallel Assignment||Treatment||Single||||||t
1395830|NCT02347111|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395831|NCT02347098|Randomized|Parallel Assignment||Prevention||Single||||||t
1395832|NCT02347085|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1395833|NCT02347072|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1395834|NCT02347059|Randomized|Parallel Assignment||Treatment||Single||||||t
1395835|NCT02347046|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1395836|NCT02347033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395837|NCT02347020|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1395838|NCT02347007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395839|NCT02346994|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1395840|NCT02346981|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395841|NCT02346968|||Cohort||Prospective|||||||
1395842|NCT02346955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395843|NCT02346942|||Cohort||Retrospective|||||||
1395844|NCT02346929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395845|NCT02346916||Single Group Assignment||||None (Open Label)||||||
1395846|NCT02346903||Single Group Assignment||||None (Open Label)||||||
1395847|NCT02346890|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395848|NCT02346877|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1395849|NCT02346864|Randomized|Parallel Assignment||Prevention||Single||||||t
1395850|NCT02346851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395851|NCT02346838|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1395852|NCT02346825|Randomized|Factorial Assignment||Treatment||Single||||||t
1395853|NCT02346812|Randomized|Crossover Assignment||||Single||||||t
1395854|NCT02346799|Randomized|Parallel Assignment||||Single|||t|||
1395855|NCT02346786|Randomized|Parallel Assignment||Prevention||Single||||||t
1395856|NCT02346773|Randomized|Parallel Assignment||||Triple|||t|t|t|
1395857|NCT02346760||Single Group Assignment||Other||None (Open Label)||||||
1395858|NCT02346747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395859|NCT02346734|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1395860|NCT02346721||Single Group Assignment||Treatment||None (Open Label)||||||
1395861|NCT02346708|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395862|NCT02346695|||Case Control||Cross-Sectional|||||||
1395863|NCT02346682|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1395864|NCT02346669|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395865|NCT02346656|||Cohort||Prospective|||||||
1395866|NCT02346643|||Cohort||Prospective|||||||
1395867|NCT02346630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395868|NCT02346617||Single Group Assignment||Treatment||None (Open Label)||||||
1395869|NCT02346604|||Case Control||Prospective|||||||
1395870|NCT02346591|Randomized|Parallel Assignment||||None (Open Label)||||||
1395871|NCT02346578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395872|NCT02346565|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1395873|NCT02346552|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1395874|NCT02346539|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1395875|NCT02346526||Single Group Assignment||Treatment||None (Open Label)||||||
1395876|NCT02346513|||Case Control||Prospective|||||||
1395877|NCT02346500||Single Group Assignment||Treatment||None (Open Label)||||||
1395878|NCT02346487||Single Group Assignment||Treatment||None (Open Label)||||||
1395879|NCT02346474|||Cohort||Cross-Sectional|||||||
1395880|NCT02346461|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1395881|NCT02346448|Randomized|Factorial Assignment||Treatment||Single|||t|||
1395882|NCT02346435|||Other||Prospective|||||||
1395883|NCT02346422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395884|NCT02346409|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1395885|NCT02346396||Single Group Assignment||Treatment||Single|||t|||
1395886|NCT02346383|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1395887|NCT02346370||Single Group Assignment||Treatment||None (Open Label)||||||
1395888|NCT02346357|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395889|NCT02346344|||Case-Crossover||Prospective|||||||
1395890|NCT02346331|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395891|NCT02346318|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395892|NCT02346305|||Cohort||Prospective|||||||
1395893|NCT02346292|||Case-Only||Retrospective|||||||
1395894|NCT02346279|||Cohort||Prospective|||||||
1395895|NCT02346266|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1395896|NCT02346253||Single Group Assignment||Treatment||None (Open Label)||||||
1398045|NCT02318186|||Cohort||Prospective|||||||
1395897|NCT02346240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395898|NCT02346227|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1395899|NCT02346214|||Other||Cross-Sectional|||||||
1395900|NCT02346201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395901|NCT02346188|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1395902|NCT02346175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395903|NCT02346162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395904|NCT02346149|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1395905|NCT02346136|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1395906|NCT02346123|||||Cross-Sectional|||||||
1395907|NCT02346110|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1395908|NCT02346097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395909|NCT02346084|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1395910|NCT02346071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395911|NCT02346058||Single Group Assignment||Treatment||None (Open Label)||||||
1395912|NCT02346045|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395913|NCT02346032||Single Group Assignment||Treatment||None (Open Label)||||||
1395914|NCT02346019||Single Group Assignment||Basic Science||None (Open Label)||||||
1395915|NCT02346006||Single Group Assignment||Prevention||None (Open Label)||||||
1395916|NCT02345993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395917|NCT02345980|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395918|NCT02345967||Single Group Assignment||Diagnostic||None (Open Label)||||||
1395919|NCT02345954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395920|NCT02345941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395921|NCT02345928|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1395922|NCT02345915||Single Group Assignment||Basic Science||None (Open Label)||||||
1395923|NCT02345902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395924|NCT02345889|Randomized|Parallel Assignment||Screening||Single|||t|||
1395925|NCT02345876|||Case-Control||Prospective|||||||
1395926|NCT02345863||Single Group Assignment||Treatment||None (Open Label)||||||
1395927|NCT02345850|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395928|NCT02345837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395929|NCT02345824||Single Group Assignment||Treatment||None (Open Label)||||||
1395930|NCT02345811||||||||||||
1395931|NCT02345798|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395932|NCT02345785|||Cohort||Prospective|||||||
1395933|NCT02345772||Single Group Assignment||Treatment||None (Open Label)||||||
1395934|NCT02345759|||Case-Control||Prospective|||||||
1395935|NCT02345746||Single Group Assignment||Treatment||None (Open Label)||||||
1395936|NCT02345733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395937|NCT02345720||Single Group Assignment||Basic Science||None (Open Label)||||||
1395938|NCT02345707|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395939|NCT02345694|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1395940|NCT02345681|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395941|NCT02345668|Randomized|Parallel Assignment||Treatment||Single|||t|||
1395942|NCT02345655|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395943|NCT02345642|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1395944|NCT02345629|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395945|NCT02345616|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1395946|NCT02345603|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395947|NCT02345590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395948|NCT02345577|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1395949|NCT02345564||Single Group Assignment||Treatment||None (Open Label)||||||
1395950|NCT02345551||Single Group Assignment||Prevention||None (Open Label)||||||
1395951|NCT02345538|||Cohort||Prospective|||||||
1395952|NCT02345525|Randomized|Parallel Assignment||Treatment||Single||||||t
1395953|NCT02345512||Single Group Assignment||Treatment||None (Open Label)||||||
1395954|NCT02345499|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1395955|NCT02345486|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395956|NCT02345473|||Cohort||Prospective|||||||
1395957|NCT02345460||Single Group Assignment||Treatment||None (Open Label)||||||
1395958|NCT02345447|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1395959|NCT02345434|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1395960|NCT02345421|||Case-Only|||||||||
1395961|NCT02345408||Single Group Assignment||Treatment||None (Open Label)||||||
1395962|NCT02345395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395963|NCT02345382|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395964|NCT02345369|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395965|NCT02345356|||Case-Control||Prospective|||||||
1395966|NCT02345343|||Cohort||Prospective|||||||
1395967|NCT02345330||Single Group Assignment||Treatment||None (Open Label)||||||
1395968|NCT02345317|||Cohort||Prospective|||||||
1395969|NCT02345304|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1395970|NCT02345291|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395971|NCT02345278|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1395972|NCT02345265||Single Group Assignment||Treatment||None (Open Label)||||||
1395973|NCT02345252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395974|NCT02345239||Single Group Assignment||Treatment||None (Open Label)||||||
1395975|NCT02345226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395976|NCT02345213|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395977|NCT02345200|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395978|NCT02345187|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1395979|NCT02345174||Single Group Assignment||Other||None (Open Label)||||||
1395980|NCT02345161|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1395981|NCT02345148|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395982|NCT02345135|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395983|NCT02345122|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1395984|NCT02345109|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1395985|NCT02345096|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1395986|NCT02345083|||Cohort||Prospective|||||||
1395987|NCT02345070|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1395988|NCT02345057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395989|NCT02345044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395990|NCT02345031|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1395991|NCT02345018|||Cohort||Prospective|||||||
1395992|NCT02345005|||Cohort||Prospective|||||||
1395993|NCT02344992|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1395994|NCT02344979|||Case Control||Prospective|||||||
1395995|NCT02344966|||Cohort|||||||||
1395996|NCT02344953|||Cohort|||||||||
1395997|NCT02344940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1395998|NCT02344927|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1395999|NCT02344914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396000|NCT02344901|||Cohort||Cross-Sectional|||||||
1396001|NCT02344888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396002|NCT02344875|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1396003|NCT02344862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396004|NCT02344849||Single Group Assignment||Treatment||None (Open Label)||||||
1396005|NCT02344836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396006|NCT02344823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396007|NCT02344810|Randomized|Parallel Assignment||Treatment||Double||||||
1396008|NCT02344797|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1396009|NCT02344784|||Case-Only||Cross-Sectional|||||||
1396010|NCT02344771|||Cohort||Prospective|||||||
1396011|NCT02344758|Randomized|Parallel Assignment||||||||||
1396012|NCT02344745|Randomized|Parallel Assignment||Treatment||Single||||t||
1396013|NCT02344732|Randomized|Parallel Assignment||Treatment||Single||||||t
1396014|NCT02344719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396015|NCT02344706|||Cohort||Prospective|||||||
1396016|NCT02344693|||Cohort||Prospective|||||||
1396017|NCT02344680|||Cohort||Prospective|||||||
1396018|NCT02344667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396019|NCT02344654|Randomized|Parallel Assignment||Prevention||Single|||t|||
1396020|NCT02344641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396021|NCT02344628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396022|NCT02344615|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1396023|NCT02344602||Single Group Assignment||Treatment||None (Open Label)||||||
1396024|NCT02344589|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1396025|NCT02344576|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396026|NCT02344563|Randomized|Crossover Assignment||||None (Open Label)||||||
1396027|NCT02344550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396028|NCT02344537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396029|NCT02344524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396030|NCT02344511|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396031|NCT02344498|||Cohort||Prospective|||||||
1396032|NCT02344485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396033|NCT02344472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396034|NCT02344459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396035|NCT02344446||Single Group Assignment||Treatment||None (Open Label)||||||
1396036|NCT02344433|Randomized|Parallel Assignment||Screening||Single|||t|||
1396037|NCT02344420||Single Group Assignment||Treatment||None (Open Label)||||||
1396038|NCT02344407|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1396039|NCT02344394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396040|NCT02344381|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1396041|NCT02344368|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1396042|NCT02344355||Single Group Assignment||Treatment||None (Open Label)||||||
1396043|NCT02344342|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1396044|NCT02344329|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1396045|NCT02344316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396046|NCT02344303|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1396047|NCT02344290|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396048|NCT02344277|||Cohort||Prospective|||||||
1396049|NCT02344264|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396050|NCT02344251|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396051|NCT02344238|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1396052|NCT02344225|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396053|NCT02344212||Single Group Assignment||Prevention||None (Open Label)||||||
1396054|NCT02344199|||||Prospective|||||||
1396055|NCT02344186|Randomized|Crossover Assignment||||Single|||t|||
1396056|NCT02344173|||Case-Only||Prospective|||||||
1396057|NCT02344160|||||Prospective|||||||
1396058|NCT02344134|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396059|NCT02344121|||Case-Control||Prospective|||||||
1396060|NCT02344108||Single Group Assignment||Treatment||None (Open Label)||||||
1396061|NCT02344095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396062|NCT02344082|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1396063|NCT02344069|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1396064|NCT02344056|Randomized|Crossover Assignment||||None (Open Label)||||||
1396065|NCT02344043|||Cohort||Prospective|||||||
1396066|NCT02344030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396067|NCT02344017|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396068|NCT02344004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396069|NCT02343991||Single Group Assignment||Treatment||None (Open Label)||||||
1396070|NCT02343978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396071|NCT02343965|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396072|NCT02343952||Single Group Assignment||Treatment||None (Open Label)||||||
1396073|NCT02343939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396074|NCT02343926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396075|NCT02343913||Single Group Assignment||Health Services Research||None (Open Label)||||||
1396076|NCT02343887|Randomized|Parallel Assignment||||None (Open Label)||||||
1396077|NCT02343874|||Cohort||Cross-Sectional|||||||
1396078|NCT02343861|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1396079|NCT02343848||Single Group Assignment||Prevention||None (Open Label)||||||
1396080|NCT02343835||Single Group Assignment||Treatment||None (Open Label)||||||
1396081|NCT02343822|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396082|NCT02343809|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1396083|NCT02343796||Single Group Assignment||Treatment||None (Open Label)||||||
1396084|NCT02343783||Single Group Assignment||Treatment||None (Open Label)||||||
1396085|NCT02343770|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1396086|NCT02343757||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396087|NCT02343744||Single Group Assignment||Treatment||None (Open Label)||||||
1396088|NCT02343731||Single Group Assignment||||None (Open Label)||||||
1396089|NCT02343718||Single Group Assignment||Treatment||None (Open Label)||||||
1396090|NCT02343705||Single Group Assignment||Treatment||None (Open Label)||||||
1396091|NCT02343692||Single Group Assignment||Treatment||None (Open Label)||||||
1396092|NCT02343679||Single Group Assignment||Treatment||None (Open Label)||||||
1396093|NCT02343666||Single Group Assignment||Treatment||None (Open Label)||||||
1396094|NCT02343653|Randomized|Parallel Assignment||Treatment||Single||||||t
1396095|NCT02343640|||Cohort||Prospective|||||||
1396096|NCT02343627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396097|NCT02343614||Single Group Assignment||Treatment||Single||||||t
1396098|NCT02343601|Randomized|Parallel Assignment||||Double|||t|||t
1396099|NCT02343588|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1396100|NCT02343575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396101|NCT02343562|Randomized|Parallel Assignment||Prevention||Triple|Probiotic Sachets|Probiotic Sachets|t|t||t
1396102|NCT02343549||Single Group Assignment||Treatment||None (Open Label)||||||
1396103|NCT02343536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396104|NCT02343523||||||||||||
1396105|NCT02343510|||Case-Control||Retrospective|||||||
1396106|NCT02343497|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1396107|NCT02343484|Randomized|Parallel Assignment||Treatment||Single||||||t
1396108|NCT02343471|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1396109|NCT02343458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396110|NCT02343445|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396111|NCT02343432|Randomized|Parallel Assignment||||Double|||t||t|
1396112|NCT02343419||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396113|NCT02343406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396114|NCT02343393|Randomized|Parallel Assignment||Treatment||Single||||||t
1396115|NCT02343380|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1396116|NCT02343367|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1396117|NCT02343354||Single Group Assignment||Prevention||None (Open Label)||||||
1396118|NCT02343341|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1396119|NCT02343328|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1396120|NCT02343315|Randomized|Parallel Assignment||Treatment||Single||||||t
1396121|NCT02343302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396122|NCT02343289||Single Group Assignment||Treatment||None (Open Label)||||||
1396123|NCT02343276|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396124|NCT02343263|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1396125|NCT02343250|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1396126|NCT02343237|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396127|NCT02343224||Single Group Assignment||Treatment||None (Open Label)||||||
1396128|NCT02343211||Single Group Assignment||Treatment||None (Open Label)||||||
1396129|NCT02343198|Randomized|Parallel Assignment||Prevention||Single|||t|||
1396130|NCT02343185|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396131|NCT02343172||Single Group Assignment||Treatment||None (Open Label)||||||
1396132|NCT02343159|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396133|NCT02343146|Randomized|Parallel Assignment||Other||Single|||t|||
1396134|NCT02343133|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396135|NCT02343120||Single Group Assignment||Treatment||None (Open Label)||||||
1396136|NCT02343107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396137|NCT02343094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396138|NCT02343081|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1396139|NCT02343068||||||||||||
1396140|NCT02343055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396141|NCT02343042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396142|NCT02343029|Randomized|Parallel Assignment||Prevention||Single||||||t
1396143|NCT02343016|||Cohort||Cross-Sectional|||||||
1396144|NCT02343003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396145|NCT02342990|Randomized|Parallel Assignment||Treatment||Single||||||t
1396146|NCT02342977|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1396147|NCT02342964||Single Group Assignment||Screening||None (Open Label)||||||
1396148|NCT02342951||Single Group Assignment||Screening||None (Open Label)||||||
1396149|NCT02342938|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1396150|NCT02342925|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1396151|NCT02342912|Randomized|Parallel Assignment||Treatment||Single||||||t
1396152|NCT02342899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396153|NCT02342886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396154|NCT02342873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396155|NCT02342860|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396156|NCT02342847|||Cohort||Prospective|||||||
1396157|NCT02342834|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1396158|NCT02342821|||Other||Cross-Sectional|||||||
1396159|NCT02342808|Randomized|Parallel Assignment||Treatment||||||||
1396160|NCT02342795|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1396161|NCT02342782||Single Group Assignment||Treatment||None (Open Label)||||||
1396162|NCT02342769|||Other||Prospective|||||||
1396163|NCT02342756|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1396164|NCT02342743||Single Group Assignment||Prevention||None (Open Label)||||||
1396165|NCT02342730||Single Group Assignment||Supportive Care||None (Open Label)||||||
1396166|NCT02342717|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396167|NCT02342704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396168|NCT02342691|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396169|NCT02342678|Randomized|Parallel Assignment||Treatment||Single||||||t
1396170|NCT02342665||Single Group Assignment||Treatment||None (Open Label)||||||
1396171|NCT02342652|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1396172|NCT02342639|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1396173|NCT02342626|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396174|NCT02342613||Single Group Assignment||Treatment||None (Open Label)||||||
1396175|NCT02342600||Single Group Assignment||Treatment||None (Open Label)||||||
1396176|NCT02342587||Single Group Assignment||Treatment||None (Open Label)||||||
1396177|NCT02342574|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396178|NCT02342561|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1396179|NCT02342548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396180|NCT02342535||Single Group Assignment||Prevention||None (Open Label)||||||
1396181|NCT02342522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396182|NCT02342509|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1396183|NCT02342496|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396184|NCT02342483|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1396185|NCT02342470|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396186|NCT02342457||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396187|NCT02342444|Randomized|Parallel Assignment||Prevention||Single|||t|||
1396188|NCT02342431|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396189|NCT02342418|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396190|NCT02342405|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1396191|NCT02342392|Randomized|Parallel Assignment||Treatment||Single||||||t
1396192|NCT02342379||Single Group Assignment||Treatment||None (Open Label)||||||
1396193|NCT02342366|Randomized|Crossover Assignment||||Double|||t||t|
1396194|NCT02342353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396195|NCT02342340|Randomized|Crossover Assignment||||Single|||||t|
1396196|NCT02342327|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1396197|NCT02342314|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1396198|NCT02342301|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396199|NCT02342288|Randomized|Parallel Assignment||||Single|||t|||
1396200|NCT02342275|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1396201|NCT02342262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396202|NCT02342249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396203|NCT02342236|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1396204|NCT02342223||Single Group Assignment||Treatment||None (Open Label)||||||
1396205|NCT02342210|Randomized|Parallel Assignment||Treatment||Single||||||t
1396206|NCT02342197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396207|NCT02342184||Single Group Assignment||Treatment||None (Open Label)||||||
1396208|NCT02342171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396209|NCT02342158||Single Group Assignment||||None (Open Label)||||||
1396210|NCT02342145|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396211|NCT02342132||Single Group Assignment||Treatment||Single||||||t
1396212|NCT02342119|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1396213|NCT02342106|||Case Control||Prospective|||||||
1396214|NCT02342093|Randomized|Parallel Assignment||||Single||||||t
1396215|NCT02342080||Single Group Assignment||Treatment||Single|||||t|
1396216|NCT02342067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396217|NCT02342054||Single Group Assignment||Treatment||None (Open Label)||||||
1396218|NCT02342041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396219|NCT02342028|||Case Control||Prospective|||||||
1396220|NCT02342015||Single Group Assignment||Basic Science||None (Open Label)||||||
1396221|NCT02342002|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396222|NCT02341989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396223|NCT02341976||Single Group Assignment||Health Services Research||None (Open Label)||||||
1396224|NCT02341963||Single Group Assignment||Treatment||None (Open Label)||||||
1396225|NCT02341950|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396226|NCT02341937|||Cohort||Prospective|||||||
1396227|NCT02341924|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1396228|NCT02341911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396229|NCT02341898|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1396230|NCT02341885|||Cohort||Prospective|||||||
1396231|NCT02341872|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396232|NCT02341859|Randomized|Crossover Assignment||Other||Double|||t||t|
1396233|NCT02341846||||||||||||
1396234|NCT02341833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396235|NCT02341820|||Cohort||Prospective|||||||
1396236|NCT02341807|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396237|NCT02341794||Single Group Assignment||Treatment||None (Open Label)||||||
1396238|NCT02341781|||Case-Only||Retrospective|||||||
1396239|NCT02341768|||Cohort||Prospective|||||||
1396240|NCT02341755|||Cohort||Prospective|||||||
1396241|NCT02341742|||Cohort||Cross-Sectional|||||||
1396242|NCT02341729||Single Group Assignment||Treatment||None (Open Label)||||||
1396243|NCT02341716|Randomized|Parallel Assignment||Treatment||Single||||||t
1396244|NCT02341703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396245|NCT02341690|Randomized|Parallel Assignment||Treatment||Single|||||t|
1396246|NCT02341677||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396247|NCT02341664|||Cohort||Cross-Sectional|||||||
1396248|NCT02341651|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396249|NCT02341638|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1396250|NCT02341625|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396251|NCT02341612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396252|NCT02341599|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1396253|NCT02341586|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396254|NCT02341573|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396255|NCT02341560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396256|NCT02341547|||Cohort||Prospective|||||||
1396257|NCT02341534|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1396258|NCT02341521||Single Group Assignment||||None (Open Label)||||||
1396259|NCT02341508|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1396260|NCT02341495||Single Group Assignment||Treatment||None (Open Label)||||||
1396261|NCT02341482|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1396262|NCT02341469|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1396263|NCT02341456|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396264|NCT02341443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396265|NCT02341430||Single Group Assignment||Treatment||Triple|||t|t||t
1396266|NCT02341417||Single Group Assignment||Treatment||None (Open Label)||||||
1396267|NCT02341404||Single Group Assignment||Treatment||None (Open Label)||||||
1396268|NCT02341391|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396269|NCT02341378|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396270|NCT02341365|||Cohort||Retrospective|||||||
1396271|NCT02341352|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1396272|NCT02341339||Single Group Assignment||Treatment||None (Open Label)||||||
1396273|NCT02341326|||Case-Control||Prospective|||||||
1396274|NCT02341313|||Cohort||Prospective|||||||
1396275|NCT02341300|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396276|NCT02341287|Randomized|Parallel Assignment||Prevention||Single|||t|||
1396277|NCT02341274|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1396278|NCT02341261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396279|NCT02341248|||Case-Control||Prospective|||||||
1396280|NCT02341235|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1396281|NCT02341222|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1396282|NCT02341209||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1396283|NCT02341196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396284|NCT02341183|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1396285|NCT02341170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396286|NCT02341157|||Cohort||Prospective|||||||
1396287|NCT02341144|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1396288|NCT02341131|Randomized|Parallel Assignment||Treatment||Single||||||t
1396289|NCT02341118|||Case-Only||Prospective|||||||
1396290|NCT02341105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396291|NCT02341092|||||Prospective|||||||
1396292|NCT02341079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396293|NCT02341066|||Cohort||Prospective|||||||
1396294|NCT02341053||Single Group Assignment||Treatment||None (Open Label)||||||
1396295|NCT02341040|||Cohort||Prospective|||||||
1396296|NCT02341027|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1396297|NCT02341014||Single Group Assignment||Treatment||None (Open Label)||||||
1396298|NCT02341001|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396299|NCT02340988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396300|NCT02340975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396301|NCT02340962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396302|NCT02340949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396303|NCT02340936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396304|NCT02340923|||Cohort||Cross-Sectional|||||||
1396305|NCT02340910|Randomized|Parallel Assignment||Treatment||Double|Masked allocation and intervention||||t|t
1396306|NCT02340897|||Case Control||Cross-Sectional|||||||
1396307|NCT02340884|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1396308|NCT02340871|||||Prospective|||||||
1396309|NCT02340858||Single Group Assignment||Treatment||None (Open Label)||||||
1396310|NCT02340845|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1396311|NCT02340832||||||||||||
1396312|NCT02340819||Single Group Assignment||Treatment||None (Open Label)||||||
1396313|NCT02340806|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396314|NCT02340793||Single Group Assignment||Treatment||None (Open Label)||||||
1396315|NCT02340780||Single Group Assignment||Treatment||None (Open Label)||||||
1396316|NCT02340767|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1396317|NCT02340754|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1396318|NCT02340741|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1396319|NCT02340728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396320|NCT02340715|||Case-Control||Prospective|||||||
1396321|NCT02340702|||Cohort||Prospective|||||||
1396322|NCT02340689|||Cohort||Retrospective|||||||
1396323|NCT02340676||Single Group Assignment||Treatment||None (Open Label)||||||
1396324|NCT02340663|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1396325|NCT02340650||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396326|NCT02340637|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396327|NCT02340624|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1396328|NCT02340611||Single Group Assignment||Treatment||None (Open Label)||||||
1396329|NCT02340598|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396330|NCT02340585||Single Group Assignment||Treatment||None (Open Label)||||||
1396331|NCT02340572|Randomized|Parallel Assignment||||Double|||t||t|
1396332|NCT02340559|Randomized|Parallel Assignment||Treatment||Single||||||t
1396333|NCT02340546|||Cohort||Prospective|||||||
1396334|NCT02340533||Single Group Assignment||Diagnostic||Single|||||t|
1396335|NCT02340520||Single Group Assignment||Treatment||None (Open Label)||||||
1396336|NCT02340507|Randomized|Crossover Assignment||||None (Open Label)||||||
1396337|NCT02340494|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396338|NCT02340481|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396339|NCT02340468|||Case-Control||Prospective|||||||
1396340|NCT02340455|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396341|NCT02340442|||Cohort||Prospective|||||||
1396342|NCT02340429|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1396343|NCT02340416|||Cohort||Prospective|||||||
1396344|NCT02340403|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1396345|NCT02340390|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396346|NCT02340377|||Case-Only||Prospective|||||||
1396347|NCT02340364|Randomized|Factorial Assignment||Prevention||Single||||||t
1396348|NCT02340351|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396349|NCT02340338|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396350|NCT02340325|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1396351|NCT02340312|||Cohort||Prospective|||||||
1396352|NCT02340299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396353|NCT02340286|||Cohort||Prospective|||||||
1396354|NCT02340273|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396355|NCT02340260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396356|NCT02340247|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1396357|NCT02340234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396358|NCT02340221|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396359|NCT02340208||Single Group Assignment||Treatment||None (Open Label)||||||
1396360|NCT02340195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396361|NCT02340182||Single Group Assignment||Basic Science||None (Open Label)||||||
1396362|NCT02340169||Single Group Assignment||Treatment||None (Open Label)||||||
1396363|NCT02340156||Single Group Assignment||Treatment||None (Open Label)||||||
1396364|NCT02340143|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1396365|NCT02340130|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396366|NCT02340117||Single Group Assignment||Treatment||None (Open Label)||||||
1396367|NCT02340104||Single Group Assignment||Basic Science||None (Open Label)||||||
1396368|NCT02340091|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396369|NCT02340078|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396370|NCT02340065|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1396371|NCT02340052|||Cohort||Prospective|||||||
1396372|NCT02340039|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1396373|NCT02340026|Randomized|Parallel Assignment||Treatment||Single||||||t
1396374|NCT02340013|Randomized|Parallel Assignment||Treatment||Single||||t||
1396375|NCT02340000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396376|NCT02339987|||Case-Only||Prospective|||||||
1396377|NCT02339974||Single Group Assignment||Treatment||None (Open Label)||||||
1396378|NCT02339961||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396379|NCT02339948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396380|NCT02339935|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396381|NCT02339922||Single Group Assignment||Treatment||None (Open Label)||||||
1396382|NCT02339909|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1396383|NCT02339896|||Case-Only||Prospective|||||||
1396384|NCT02339883|||Cohort||Cross-Sectional|||||||
1396385|NCT02339870|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396386|NCT02339857|||Cohort||Prospective|||||||
1396387|NCT02339844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396388|NCT02339831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396389|NCT02339818|||Other||Cross-Sectional|||||||
1396390|NCT02339805||Single Group Assignment||Other||None (Open Label)||||||
1396391|NCT02339792|Randomized|Parallel Assignment||Treatment||Single|||||t|
1396392|NCT02339779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396393|NCT02339766|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396394|NCT02339753||Single Group Assignment||Treatment||None (Open Label)||||||
1396395|NCT02339740||Single Group Assignment||Treatment||None (Open Label)||||||
1396396|NCT02339727|Randomized|Parallel Assignment||Screening||Single|||||t|
1396397|NCT02339714|Randomized|Parallel Assignment||Treatment||Single||||||t
1396398|NCT02339701|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396399|NCT02339688||Single Group Assignment||||None (Open Label)||||||
1396400|NCT02339675||Single Group Assignment||||None (Open Label)||||||
1396401|NCT02339662|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1396402|NCT02339649|Non-Randomized|Parallel Assignment||Other||Single||||||t
1396403|NCT02339636|||Case Control||Retrospective|||||||
1396404|NCT02339623|||Case-Only||Prospective|||||||
1396405|NCT02339610||Single Group Assignment||Treatment||None (Open Label)||||||
1396406|NCT02339597|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396407|NCT02339584|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1396408|NCT02339571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396409|NCT02339558||Single Group Assignment||Treatment||None (Open Label)||||||
1396410|NCT02339545||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396411|NCT02339532|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396412|NCT02339519|Randomized|Crossover Assignment||Prevention||Single|||||t|
1396413|NCT02339506|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1396414|NCT02339493|Randomized|Parallel Assignment||Prevention||Single|||t|||
1396415|NCT02339480|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1396416|NCT02339467|Randomized|Parallel Assignment||Treatment||Single||||||t
1396417|NCT02339454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396418|NCT02339441|||Cohort||Prospective|||||||
1396419|NCT02339428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396420|NCT02339415|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1396421|NCT02339402|||Cohort||Prospective|||||||
1396422|NCT02339389|||Cohort||Prospective|||||||
1396423|NCT02339376|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1396424|NCT02339363|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1396425|NCT02339350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396426|NCT02339337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396427|NCT02339324||Single Group Assignment||Treatment||None (Open Label)||PI will be leaving this institution and has elected to close this trial to accrual||||
1396428|NCT02339311|||Cohort||Prospective|||||||
1396429|NCT02339298|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1396430|NCT02339285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396431|NCT02339272|||Case Control||Prospective|||||||
1396432|NCT02339259|||Case Control||Prospective|||||||
1396433|NCT02339246|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1396434|NCT02339233||Single Group Assignment||Health Services Research||None (Open Label)||||||
1396435|NCT02339220|Randomized|Factorial Assignment||Treatment||Single||||||t
1396436|NCT02339207|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1396437|NCT02339194|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1396438|NCT02339168||Single Group Assignment||Treatment||None (Open Label)||||||
1396439|NCT02339155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396440|NCT02339142|Randomized|Parallel Assignment||Prevention||Single||||||t
1396441|NCT02339129|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396442|NCT02339116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396443|NCT02339103|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1396444|NCT02339090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396445|NCT02339077|||Ecologic or Community||Prospective|||||||
1396446|NCT02339064||Single Group Assignment||Treatment||None (Open Label)||||||
1396447|NCT02339051||Single Group Assignment||Treatment||None (Open Label)||||||
1396448|NCT02339038||Single Group Assignment||Treatment||None (Open Label)||||||
1396449|NCT02339025|||Other||Cross-Sectional|||||||
1396450|NCT02339012|||Cohort||Cross-Sectional|||||||
1396451|NCT02338999|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1396452|NCT02338986|||Cohort||Prospective|||||||
1396453|NCT02338973||Single Group Assignment||Treatment||None (Open Label)||||||
1396454|NCT02338960|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396455|NCT02338947|Randomized|Parallel Assignment||Treatment||Double|Treatment assignments will be performed in a blinded manner according to a blocked randomization scheme with a block size of ten, stratified according to the participating center.|Eligible patients will be randomly assigned to off-pump CABG or on-pump CABG procedure|t|||t
1396456|NCT02338934||Single Group Assignment||Treatment||None (Open Label)||||||
1396457|NCT02338921|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396458|NCT02338908|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396459|NCT02338895|||Cohort||Prospective|||||||
1396460|NCT02338882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396461|NCT02338869|Randomized|Parallel Assignment||Treatment||Single|||||t|
1396462|NCT02338856|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1396463|NCT02338843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396464|NCT02338830|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396465|NCT02338817|||Cohort||Prospective|||||||
1396466|NCT02338804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396467|NCT02338791||Single Group Assignment||Treatment||None (Open Label)||||||
1396468|NCT02338778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396469|NCT02338765|Randomized|Parallel Assignment||Prevention||Single|||t|||
1396470|NCT02338752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396471|NCT02338739|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396472|NCT02338726|||Cohort||Prospective|||||||
1396473|NCT02338713||Single Group Assignment||Basic Science||None (Open Label)||||||
1396474|NCT02338700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396475|NCT02338687|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396476|NCT02338674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396477|NCT02338661|||Cohort||Prospective|||||||
1396478|NCT02338648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396479|NCT02338635|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396480|NCT02338622|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396481|NCT02338609|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1396482|NCT02338596|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396483|NCT02338583|||Cohort||Prospective|||||||
1396484|NCT02338570||Single Group Assignment||Other||None (Open Label)||||||
1396485|NCT02338557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396486|NCT02338544|||Cohort||Prospective|||||||
1396487|NCT02338531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396488|NCT02338518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396489|NCT02338505||Single Group Assignment||Treatment||None (Open Label)||||||
1396490|NCT02338492||Single Group Assignment||Treatment||None (Open Label)||||||
1396491|NCT02338479|||Cohort||Prospective|||||||
1396492|NCT02338466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396493|NCT02338453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396494|NCT02338440||Single Group Assignment||Treatment||None (Open Label)||||||
1396495|NCT02338427||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396496|NCT02338414||Single Group Assignment||Treatment||None (Open Label)||||||
1396497|NCT02338401|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1396498|NCT02338388|Randomized|Parallel Assignment||Treatment||Single||||||t
1396499|NCT02338375|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396500|NCT02338362|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1396501|NCT02338349||Single Group Assignment||Treatment||None (Open Label)||||||
1396502|NCT02338336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396503|NCT02338323|Randomized|Parallel Assignment||Treatment||Single||||||t
1396504|NCT02338310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396505|NCT02338297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396506|NCT02338284|||Cohort||Prospective|||||||
1396507|NCT02338271||Single Group Assignment||Treatment||None (Open Label)||||||
1396508|NCT02338258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396509|NCT02338245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396510|NCT02338232||Single Group Assignment||Treatment||None (Open Label)||||||
1396511|NCT02338219|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1396512|NCT02338206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396513|NCT02338193|Randomized|Parallel Assignment||Treatment||Single|||||t|
1396514|NCT02338180|Randomized|Parallel Assignment||Prevention||Single|||||t|
1396515|NCT02338167|||Case-Only||Other|||||||
1396516|NCT02338154|||Case-Only||Prospective|||||||
1396517|NCT02338141|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1396518|NCT02338128|||Cohort||Prospective|||||||
1396519|NCT02338115|||Cohort||Prospective|||||||
1396520|NCT02338102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396521|NCT02338089|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396522|NCT02338076||Single Group Assignment||Basic Science||None (Open Label)||||||
1396523|NCT02338063|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396524|NCT02338050||Single Group Assignment||Treatment||None (Open Label)||||||
1396525|NCT02338037||Single Group Assignment||Treatment||None (Open Label)||||||
1396526|NCT02338024|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396527|NCT02338011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396528|NCT02337998||Single Group Assignment||Prevention||None (Open Label)||||||
1396529|NCT02337985||Single Group Assignment||Treatment||None (Open Label)||||||
1396530|NCT02337972||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396531|NCT02337959|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1396532|NCT02337946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396533|NCT02337933|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396534|NCT02337920|||Cohort||Prospective|||||||
1396535|NCT02337907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396536|NCT02337894|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1396537|NCT02337881|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396538|NCT02337868|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1396539|NCT02337855|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1396540|NCT02337842|Randomized|Parallel Assignment||||Double|||t||t|
1396541|NCT02337829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396542|NCT02337816|||Case-Control||Prospective|||||||
1396543|NCT02337803|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396544|NCT02337790|||Cohort||Retrospective|||||||
1396545|NCT02337777|||Cohort||Retrospective|||||||
1396546|NCT02337764||Single Group Assignment||Treatment||None (Open Label)||||||
1396547|NCT02337751||Single Group Assignment||Treatment||None (Open Label)||||||
1396548|NCT02337738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396549|NCT02337725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396550|NCT02337712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396551|NCT02337699|||Cohort||Prospective|||||||
1396552|NCT02337686||Single Group Assignment||Treatment||None (Open Label)||||||
1396553|NCT02337673|||||Prospective|||||||
1396554|NCT02337660|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1396555|NCT02337647||Single Group Assignment||Basic Science||None (Open Label)||||||
1396556|NCT02337634|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1396557|NCT02337621|||Cohort||Prospective|||||||
1396558|NCT02337608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396559|NCT02337595||Single Group Assignment||Prevention||None (Open Label)||||||
1396560|NCT02337582|Randomized|Parallel Assignment||Screening||Double|||||t|t
1396561|NCT02337569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396562|NCT02337556|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1396563|NCT02337543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396564|NCT02337530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396565|NCT02337517||Single Group Assignment||Treatment||None (Open Label)||||||
1396566|NCT02337504|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396567|NCT02337491|Randomized|Parallel Assignment||Treatment||None (Open Label)||There is a safety lead-in before the start of the randomized phase 2 study.||||
1396568|NCT02337478||Single Group Assignment||Treatment||None (Open Label)||||||
1396569|NCT02337465||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396570|NCT02337452|||Family-Based||Prospective|||||||
1396571|NCT02337439|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396572|NCT02337426||Single Group Assignment||Treatment||None (Open Label)||||||
1396573|NCT02337413|Randomized|Parallel Assignment||Treatment||Single|||||t|
1396574|NCT02337400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396575|NCT02337387|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1396576|NCT02337374|||Case-Only||Prospective|||||||
1396577|NCT02337361|Randomized|Parallel Assignment||Prevention||Single|||t|||
1396578|NCT02337348|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1396579|NCT02337335|||Case-Crossover||Prospective|||||||
1396580|NCT02337322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396581|NCT02337309||Single Group Assignment||Treatment||None (Open Label)||||||
1396582|NCT02337296|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396583|NCT02337283|Randomized|Single Group Assignment||Treatment||Double||||||
1396584|NCT02337270|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398046|NCT02318173|||Case-Only||Prospective|||||||
1396585|NCT02337257|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1396586|NCT02337244|||Cohort||Prospective|||||||
1396587|NCT02337231|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1396588|NCT02337218|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396589|NCT02337205||Single Group Assignment||Treatment||None (Open Label)||||||
1396590|NCT02337192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396591|NCT02337179||Single Group Assignment||Prevention||None (Open Label)||||||
1396592|NCT02337166|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1396593|NCT02337153|||Cohort||Prospective|||||||
1396594|NCT02337140|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396595|NCT02337127|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396596|NCT02337114|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396597|NCT02337101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396598|NCT02337088|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396599|NCT02337075|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||This study used a delayed control design||||
1396600|NCT02337062|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396601|NCT02337049|||||Retrospective|||||||
1396602|NCT02337036||Single Group Assignment||Treatment||None (Open Label)||||||
1396603|NCT02337023|||Case-Crossover||Cross-Sectional|||||||
1396604|NCT02337010|Randomized|Parallel Assignment||||None (Open Label)||||||
1396605|NCT02336997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396606|NCT02336984||Single Group Assignment||Treatment||None (Open Label)||||||
1396607|NCT02336971|Randomized|Parallel Assignment||Treatment||Single||||||t
1396608|NCT02336958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396609|NCT02336945|||Case-Only||Prospective|||||||
1396610|NCT02336932|||Cohort||Prospective|||||||
1396611|NCT02336919|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1396612|NCT02336906|Randomized|Parallel Assignment||Treatment||Single|||||t|
1396613|NCT02336893|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396614|NCT02336880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396615|NCT02336867|Randomized|Parallel Assignment||Treatment||Single|||||t|
1396616|NCT02336854|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1396617|NCT02336841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396618|NCT02336828|||Cohort||Prospective|||||||
1396619|NCT02336815||Single Group Assignment||Treatment||None (Open Label)||||||
1396620|NCT02336802|||Case Control||Cross-Sectional|||||||
1396621|NCT02336789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396622|NCT02336776|Randomized|Parallel Assignment||Treatment||Single||||||t
1396623|NCT02336763||Single Group Assignment||Prevention||None (Open Label)||||||
1396624|NCT02336750|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396625|NCT02336737||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396626|NCT02336724||Single Group Assignment||Treatment||None (Open Label)||||||
1396627|NCT02336711||Single Group Assignment||Treatment||None (Open Label)||||||
1396628|NCT02336698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396629|NCT02336685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396630|NCT02336672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396631|NCT02336659|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1396632|NCT02336646|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1396633|NCT02336633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396634|NCT02336620|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396635|NCT02336607|Randomized|Parallel Assignment||||None (Open Label)||||||
1396636|NCT02336594|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1396637|NCT02336581|Randomized|Parallel Assignment||Treatment||Single||||||t
1396638|NCT02336568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396639|NCT02336555|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1396640|NCT02336542|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1396641|NCT02336529|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1396642|NCT02336516|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396643|NCT02336503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396644|NCT02336490|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396645|NCT02336477|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1396646|NCT02336464|||Cohort||Prospective|||||||
1396647|NCT02336451||Single Group Assignment||Treatment||None (Open Label)||||||
1396648|NCT02336438|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1396649|NCT02336425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396650|NCT02336412|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396651|NCT02336399|||Cohort||Prospective|||||||
1396652|NCT02336386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396653|NCT02336373||Single Group Assignment||Treatment||None (Open Label)||||||
1396654|NCT02336360||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396655|NCT02336347|Randomized|Crossover Assignment||||Triple|||t||t|t
1396656|NCT02336334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396657|NCT02336321||Single Group Assignment||Supportive Care||None (Open Label)||||||
1396658|NCT02336308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396659|NCT02336295||Single Group Assignment||||None (Open Label)||||||
1396660|NCT02336282|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1396662|NCT02336256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396663|NCT02336243|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396664|NCT02336230||Single Group Assignment||Treatment||None (Open Label)||||||
1396665|NCT02336217|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396666|NCT02336204|||Cohort||Prospective|||||||
1396667|NCT02336191|||Cohort||Prospective|||||||
1396668|NCT02336178||||Treatment||None (Open Label)||||||
1396669|NCT02336165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396670|NCT02336152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396671|NCT02336139||Single Group Assignment||Treatment||None (Open Label)||||||
1396672|NCT02336126||Single Group Assignment||Treatment||None (Open Label)||||||
1396673|NCT02336113|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396674|NCT02336100|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1396675|NCT02336087||Single Group Assignment||Treatment||None (Open Label)||||||
1396676|NCT02336074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396677|NCT02336061|||Cohort||Prospective|||||||
1396678|NCT02336048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396679|NCT02336035|Randomized|Parallel Assignment||Treatment||Single||||||t
1396680|NCT02336022|||Cohort||Prospective|||||||
1396681|NCT02336009||Single Group Assignment||Treatment||None (Open Label)||||||
1396682|NCT02335996|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1396683|NCT02335983|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396684|NCT02335970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396685|NCT02335957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396686|NCT02335944||Single Group Assignment||Treatment||None (Open Label)||||||
1396687|NCT02335931|||Case Control||Cross-Sectional|||||||
1396688|NCT02335918||Single Group Assignment||Treatment||None (Open Label)||||||
1396689|NCT02335905||Single Group Assignment||Treatment||None (Open Label)||||||
1396690|NCT02335892|||Other||Prospective|||||||
1396691|NCT02335879||Single Group Assignment||Treatment||Double|||t||t|
1396692|NCT02335866|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396693|NCT02335853|||Case-Only||Cross-Sectional|||||||
1396694|NCT02335840|Randomized|Crossover Assignment||||Double|||t||t|
1396695|NCT02335827|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396696|NCT02335814||Single Group Assignment||Treatment||None (Open Label)||||||
1396697|NCT02335801|||Cohort||Prospective|||||||
1396698|NCT02335788||Single Group Assignment||Treatment||None (Open Label)||||||
1396699|NCT02335775|||Cohort||Prospective|||||||
1396700|NCT02335762|||Cohort||Prospective|||||||
1396701|NCT02335749||Single Group Assignment||Other||None (Open Label)||||||
1396702|NCT02335736|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396703|NCT02335723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396704|NCT02335710|||Cohort||Retrospective|||||||
1396705|NCT02335697|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396706|NCT02335684|Randomized|Crossover Assignment||||Double|||t||t|
1396707|NCT02335671||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396708|NCT02335658||Single Group Assignment||Treatment||None (Open Label)||||||
1396709|NCT02335645|||Case Control||Prospective|||||||
1396710|NCT02335632|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1396711|NCT02335619|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1396712|NCT02335606|||Case-Only||Prospective|||||||
1396713|NCT02335593|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396714|NCT02335580|||Cohort||Prospective|||||||
1396715|NCT02335567|||Case-Only||Cross-Sectional|||||||
1396716|NCT02335554|Randomized|Parallel Assignment||||None (Open Label)||||||
1396717|NCT02335528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396718|NCT02335515||Single Group Assignment||Basic Science||None (Open Label)||||||
1396719|NCT02335502|||Cohort||Prospective|||||||
1396720|NCT02335489|||Cohort||Prospective|||||||
1396721|NCT02335476||||||||||||
1396722|NCT02335463||||||||||||
1396723|NCT02335450||Single Group Assignment||Treatment||None (Open Label)||||||
1396724|NCT02335437|||Cohort||Prospective|||||||
1396725|NCT02335424||Single Group Assignment||Treatment||None (Open Label)||||||
1396726|NCT02335411|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396727|NCT02335398||Single Group Assignment||Treatment||None (Open Label)||||||
1396728|NCT02335385|Randomized|Single Group Assignment||Treatment||Single|||||t|
1396729|NCT02335372||Single Group Assignment||Prevention||None (Open Label)||||||
1396730|NCT02335359|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396731|NCT02335346||Single Group Assignment||Treatment||None (Open Label)||||||
1396732|NCT02335333|||Cohort||Prospective|||||||
1396733|NCT02335320|||||Cross-Sectional|||||||
1396734|NCT02335307|||Cohort||Prospective|||||||
1396735|NCT02335294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396736|NCT02335281|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396737|NCT02335268|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396738|NCT02335255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396739|NCT02335242|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1396740|NCT02335229|||Cohort||Prospective|||||||
1396741|NCT02335216|||Cohort||Prospective|||||||
1396742|NCT02335203|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1396743|NCT02335190||Single Group Assignment||Treatment||None (Open Label)||||||
1396744|NCT02335177|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396745|NCT02335164|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1396746|NCT02335151|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1396747|NCT02335138|Randomized|Parallel Assignment||Prevention||Single|||t|||
1396748|NCT02335125|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1396749|NCT02335112|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396750|NCT02335099|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396751|NCT02335086|||Cohort||Prospective|||||||
1396752|NCT02335073|||Cohort||Prospective|||||||
1396753|NCT02335060|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1396754|NCT02335047||Single Group Assignment||Prevention||None (Open Label)||||||
1396755|NCT02335034|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1396756|NCT02335021|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1396757|NCT02335008|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1396758|NCT02334995|||Case-Crossover||Prospective|||||||
1396759|NCT02334982|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1396760|NCT02334969|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1396761|NCT02334956|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1396762|NCT02334943|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1396763|NCT02334930|||Cohort||Prospective|||||||
1396764|NCT02334917||Single Group Assignment||Treatment||Single||||||t
1396765|NCT02334904|||Case Control||Prospective|||||||
1396766|NCT02334891|||Cohort||Prospective|||||||
1396767|NCT02334878|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396768|NCT02334865|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396769|NCT02334852|||Cohort||Prospective|||||||
1396770|NCT02334839|||Cohort||Prospective|||||||
1396771|NCT02334826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396772|NCT02334813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396773|NCT02334800|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1396774|NCT02334787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396775|NCT02334774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396776|NCT02334761|||Other||Prospective|||||||
1396777|NCT02334748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396778|NCT02334735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396779|NCT02334722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396780|NCT02334709||Single Group Assignment||Treatment||None (Open Label)||||||
1396781|NCT02334696|||Cohort||Prospective|||||||
1396782|NCT02334683|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1396783|NCT02334670|||Cohort||Prospective|||||||
1396784|NCT02334657|||Cohort||Prospective|||||||
1396785|NCT02334644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396786|NCT02334631|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1396787|NCT02334618|||Cohort||Prospective|||||||
1396788|NCT02334605|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1396789|NCT02334592|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1396790|NCT02334579||Single Group Assignment||Treatment||None (Open Label)||||||
1396791|NCT02334566|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1396792|NCT02334553|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1396793|NCT02334540||Single Group Assignment||||None (Open Label)||||||
1396794|NCT02334527||Single Group Assignment||Treatment||None (Open Label)||||||
1396795|NCT02334514|||Cohort||Prospective|||||||
1396796|NCT02334501||Single Group Assignment||||None (Open Label)||||||
1396797|NCT02334488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396798|NCT02334475|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1396799|NCT02334462|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1396800|NCT02334449||Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396801|NCT02334436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396802|NCT02334423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396803|NCT02334410|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396804|NCT02334397|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1396805|NCT02334384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396806|NCT02334371||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396807|NCT02334358|||||Prospective|||||||
1396808|NCT02334345|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396809|NCT02334332|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396810|NCT02334319||Single Group Assignment||Treatment||None (Open Label)||||||
1396811|NCT02334306|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396812|NCT02334293||Single Group Assignment||Treatment||None (Open Label)||||||
1396813|NCT02334280|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1396814|NCT02334267|Randomized|Crossover Assignment||Other||Double|||t|||t
1396815|NCT02334254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396816|NCT02334241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396817|NCT02334228|Randomized|Parallel Assignment||Prevention||Single||||||t
1396818|NCT02334215|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396819|NCT02334202|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396820|NCT02334189|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1396821|NCT02334176|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396822|NCT02334163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396823|NCT02334150|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396824|NCT02334137|||Cohort||Prospective|||||||
1396825|NCT02334124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396826|NCT02334111|Randomized|Parallel Assignment||Prevention||Single||||||t
1396827|NCT02334098|Randomized|Parallel Assignment||Prevention||Quadruple|all participants and research assistants are blind to condition for the two fruit juice groups|3 parallel groups: (1) omega-3 + fruit juice (2) fruit juice only (3) controls (no drink).|t|t|t|t
1396828|NCT02334085|||Cohort||Prospective|||||||
1396829|NCT02334072|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1396830|NCT02334059|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396831|NCT02334046|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1396832|NCT02334033|||Ecologic or Community||Cross-Sectional|||||||
1396833|NCT02334020|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1396834|NCT02334007|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396835|NCT02333994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396836|NCT02333981||Single Group Assignment||Treatment||None (Open Label)||||||
1396837|NCT02333968|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1396838|NCT02333955||Single Group Assignment||Treatment||None (Open Label)||||||
1396839|NCT02333942|||Cohort||Cross-Sectional|||||||
1396840|NCT02333929|||Cohort||Prospective|||||||
1396841|NCT02333916||Single Group Assignment||Basic Science||None (Open Label)||||||
1396842|NCT02333903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396843|NCT02333890|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396844|NCT02333877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396845|NCT02333864|||Case-Only||Prospective|||||||
1396846|NCT02333851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396847|NCT02333838||Single Group Assignment||Other||None (Open Label)||||||
1396848|NCT02333825|Randomized|Parallel Assignment||Treatment||||||||
1396849|NCT02333812|||Cohort||Cross-Sectional|||||||
1396850|NCT02333799||Single Group Assignment||Treatment||None (Open Label)||||||
1396851|NCT02333786|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1396852|NCT02333773|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396853|NCT02333760||Single Group Assignment||Other||None (Open Label)||||||
1396854|NCT02333747|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396855|NCT02333734|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1396856|NCT02333721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396857|NCT02333708|||Case-Control||Prospective|||||||
1396858|NCT02333695||Single Group Assignment||Treatment||None (Open Label)||||||
1396859|NCT02333682|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396860|NCT02333669|||Case Control||Prospective|||||||
1396861|NCT02333656|Randomized|Crossover Assignment||Health Services Research||Single|||||t|
1396862|NCT02333643|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1396863|NCT02333630|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396864|NCT02333617|Randomized|Parallel Assignment||Treatment||Single||||||t
1396865|NCT02333604|||Case-Only||Cross-Sectional|||||||
1396866|NCT02333591|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1396867|NCT02333578||Single Group Assignment||Treatment||None (Open Label)||||||
1396868|NCT02333565||Single Group Assignment||Treatment||None (Open Label)||||||
1396869|NCT02333552|||Cohort||Prospective|||||||
1396870|NCT02333539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396871|NCT02333526|||Case-Control||Prospective|||||||
1396872|NCT02333513||Single Group Assignment||Treatment||None (Open Label)||||||
1396873|NCT02333500|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1396874|NCT02333487|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396875|NCT02333474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396876|NCT02333461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396877|NCT02333448|||Case-Only||Prospective|||||||
1396878|NCT02333435|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396879|NCT02333422||Single Group Assignment||Treatment||None (Open Label)||||||
1396880|NCT02333409|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1396881|NCT02333396|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1396882|NCT02333383|||Case-Only||Prospective|||||||
1396883|NCT02333370|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396884|NCT02333357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396885|NCT02333344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396886|NCT02333331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396887|NCT02333318|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1396888|NCT02333305|Randomized|Parallel Assignment||Treatment||Quadruple|placebo|coenzyme Q10|t|t|t|t
1396889|NCT02333292|||Cohort||Prospective|||||||
1396890|NCT02333279|||Cohort||Prospective|||||||
1396891|NCT02333266|||Case-Only||Prospective|||||||
1396892|NCT02333253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396893|NCT02333240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396894|NCT02333227|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1396895|NCT02333214|Randomized|Parallel Assignment||Treatment||Single|||||t|
1396896|NCT02333201|||||Prospective|||||||
1396897|NCT02333188||Single Group Assignment||Treatment||None (Open Label)||||||
1396898|NCT02333175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396899|NCT02333162||Single Group Assignment||Treatment||None (Open Label)||||||
1396900|NCT02333149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396901|NCT02333136|||Case-Only||Prospective|||||||
1396902|NCT02333123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396903|NCT02333110||Single Group Assignment||Supportive Care||None (Open Label)||||||
1396904|NCT02333097|||Case-Only||Prospective|||||||
1396905|NCT02333084|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1396906|NCT02333071|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396907|NCT02333058||Single Group Assignment||Treatment||None (Open Label)||||||
1396908|NCT02333045|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396909|NCT02333032||Single Group Assignment||Supportive Care||None (Open Label)||randomised controlled study experimental group : training with slope N=15 control group training with no slope N=15||||
1396910|NCT02333019|Randomized|Parallel Assignment||||None (Open Label)||||||
1396911|NCT02333006||Single Group Assignment||Other||None (Open Label)||||||
1396912|NCT02332993|||Cohort||Prospective|||||||
1396913|NCT02332980||Single Group Assignment||Treatment||None (Open Label)||||||
1396914|NCT02332967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396915|NCT02332954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396916|NCT02332941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396917|NCT02332928|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1396918|NCT02332915|Randomized|Crossover Assignment||Treatment||Single||||||t
1396919|NCT02332902||Single Group Assignment||Treatment||None (Open Label)||||||
1396920|NCT02332889||Single Group Assignment||Treatment||None (Open Label)||||||
1396921|NCT02332876|Randomized|Parallel Assignment||Treatment||||||||
1396922|NCT02332863|Randomized|Parallel Assignment||Treatment||Single||||||t
1396923|NCT02332850||Single Group Assignment||Treatment||None (Open Label)||||||
1396924|NCT02332837|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1396925|NCT02332824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396926|NCT02332811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396927|NCT02332798|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1396928|NCT02332785|||Cohort||Retrospective|||||||
1396929|NCT02332772|||Cohort||Retrospective|||||||
1396930|NCT02332759||Single Group Assignment||Prevention||None (Open Label)||||||
1396931|NCT02332746|||Cohort||Prospective|||||||
1396932|NCT02332733|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1396933|NCT02332720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396934|NCT02332707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396935|NCT02332694||Single Group Assignment||Treatment||None (Open Label)||||||
1396936|NCT02332681|||Cohort||Prospective|||||||
1396937|NCT02332668|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396938|NCT02332655||Single Group Assignment||Treatment||None (Open Label)||||||
1396939|NCT02332642|||Case-Only||Other|||||||
1396940|NCT02332629|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1396941|NCT02332616|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1396942|NCT02332603|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1396943|NCT02332590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396944|NCT02332577|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396945|NCT02332564|||Cohort||Prospective|||||||
1396946|NCT02332551||Single Group Assignment||Treatment||None (Open Label)||||||
1396947|NCT02332538|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1396948|NCT02332525||Single Group Assignment||Treatment||None (Open Label)||||||
1396949|NCT02332512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396950|NCT02332499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396951|NCT02332486|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1396952|NCT02332473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396953|NCT02332460|||Cohort||Prospective|||||||
1396954|NCT02332447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396955|NCT02332434|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1396956|NCT02332421|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1396957|NCT02332408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396958|NCT02332395|||Case-Only||Prospective|||||||
1396959|NCT02332382|||Case-Only||Prospective|||||||
1396960|NCT02332369||Single Group Assignment||Treatment||None (Open Label)||||||
1396961|NCT02332356|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1396962|NCT02332343|||Case-Crossover||Cross-Sectional|||||||
1396963|NCT02332330||Single Group Assignment||Treatment||None (Open Label)||||||
1396964|NCT02332317|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1396965|NCT02332304||Single Group Assignment||Diagnostic||None (Open Label)||||||
1396966|NCT02332291|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1396967|NCT02332278|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396968|NCT02332265||||||||||||
1396969|NCT02332252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396970|NCT02332239|Randomized|Parallel Assignment||Prevention||Single||||||t
1396971|NCT02332226|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1396972|NCT02332213|||Cohort||Prospective|||||||
1396973|NCT02332200|||Cohort||Other|||||||
1396974|NCT02332187|Randomized|Parallel Assignment||Treatment||Single|||t|||
1396975|NCT02332174|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1396976|NCT02332161|||Cohort||Prospective|||||||
1396977|NCT02332148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1396978|NCT02332135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396979|NCT02332122|||Case Control||Prospective|||||||
1396980|NCT02332109|||||Prospective|||||||
1396981|NCT02332096|||Cohort||Prospective|||||||
1396982|NCT02332083|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1396983|NCT02332070|||Cohort||Retrospective|||||||
1396984|NCT02332057|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1396985|NCT02332044|Randomized|Crossover Assignment||||None (Open Label)||||||
1396986|NCT02332031|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1396987|NCT02332018|||Cohort||Other|||||||
1396988|NCT02332005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1396989|NCT02331992||Single Group Assignment||Supportive Care||None (Open Label)||||||
1396990|NCT02331979|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396991|NCT02331966|||Case-Only||Prospective|||||||
1396992|NCT02331953|||Case Control||Prospective|||||||
1396993|NCT02331940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396994|NCT02331927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1396995|NCT02331914|||Case-Only||Prospective|||||||
1396996|NCT02331901|||Case Control||Cross-Sectional|||||||
1396997|NCT02331888||Single Group Assignment||Diagnostic||Double||||t||t
1396998|NCT02331875||Single Group Assignment||Treatment||None (Open Label)||||||
1396999|NCT02331862|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397000|NCT02331849||Single Group Assignment||||None (Open Label)||||||
1397001|NCT02331836|Randomized|Factorial Assignment||Diagnostic||Single|||t|||
1397002|NCT02331823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397003|NCT02331810|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1397004|NCT02331797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397005|NCT02331784|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1397006|NCT02331771|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1397007|NCT02331758|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397008|NCT02331745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397009|NCT02331732|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397010|NCT02331719|||Case-Control||Other|||||||
1397011|NCT02331706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397012|NCT02331693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397013|NCT02331680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397014|NCT02331667|Randomized|Parallel Assignment||||None (Open Label)||||||
1397015|NCT02331654|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397016|NCT02331641|||Case Control||Retrospective|||||||
1397017|NCT02331628|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397018|NCT02331615|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397019|NCT02331602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397020|NCT02331589|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397021|NCT02331576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397022|NCT02331563|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1397023|NCT02331550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397024|NCT02331537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397025|NCT02331524|Randomized|Parallel Assignment||Treatment||Single||||||t
1397026|NCT02331511|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397027|NCT02331498||Single Group Assignment||Treatment||None (Open Label)||||||
1397028|NCT02331485|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397029|NCT02331472|||Cohort||Cross-Sectional|||||||
1397030|NCT02331459|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1397031|NCT02331446|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1397032|NCT02331433|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1397033|NCT02331420|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1397034|NCT02331407||Single Group Assignment||Treatment||None (Open Label)||||||
1397035|NCT02331394||Single Group Assignment||Other||None (Open Label)||This is a feasibility study designed to see if the main study can be done.||||
1397036|NCT02331381||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397037|NCT02331368||Single Group Assignment||Treatment||None (Open Label)||||||
1397038|NCT02331355|||Case-Only||Prospective|||||||
1397039|NCT02331342|||Cohort||Prospective|||||||
1397040|NCT02331329|||Cohort||Prospective|||||||
1397041|NCT02331316|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1397042|NCT02331303|||Cohort||Other|||||||
1397043|NCT02331290|||Cohort||Prospective|||||||
1397044|NCT02331277|Randomized|Single Group Assignment||Treatment||Double||||||
1397045|NCT02331264|||Case Control||Prospective|||||||
1397046|NCT02331251|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397047|NCT02331238|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397048|NCT02331225|||Cohort||Cross-Sectional|||||||
1397049|NCT02331212|||Case-Control||Prospective|||||||
1397050|NCT02331199||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397051|NCT02331186|||Case-Only||Prospective|||||||
1397052|NCT02331173|||Cohort||Prospective|||||||
1397053|NCT02331160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397054|NCT02331147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397055|NCT02331134||Single Group Assignment||Basic Science||None (Open Label)||||||
1397056|NCT02331121|Randomized|Parallel Assignment||||Single|||||t|
1397057|NCT02331108|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1397058|NCT02331095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397059|NCT02331082|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397060|NCT02331069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397061|NCT02331056|||Case Control||Prospective|||||||
1397062|NCT02331043|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1397063|NCT02331030|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1397064|NCT02331017||Single Group Assignment||Treatment||None (Open Label)||||||
1397065|NCT02331004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397066|NCT02330991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397067|NCT02330978||Single Group Assignment||Treatment||None (Open Label)||||||
1397068|NCT02330965|||Case-Control||Prospective|||||||
1397069|NCT02330952|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397070|NCT02330939|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1397071|NCT02330926|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397072|NCT02330913||Single Group Assignment||Treatment||None (Open Label)||||||
1397073|NCT02330900||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397074|NCT02330887|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397075|NCT02330874|||Cohort||Retrospective|||||||
1397076|NCT02330861||Single Group Assignment||Other||None (Open Label)||||||
1397077|NCT02330848|Randomized|Crossover Assignment||Prevention||Single|||||t|
1397078|NCT02330835|Randomized|Parallel Assignment||||None (Open Label)||||||
1397079|NCT02330822|Randomized|Single Group Assignment||Treatment||Single|||t|||
1397080|NCT02330809|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1397081|NCT02330796|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1397082|NCT02330783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397083|NCT02330770|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397084|NCT02330757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397085|NCT02330744|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397086|NCT02330731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397087|NCT02330718|||Cohort|||||||||
1397088|NCT02330705|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397089|NCT02330692|||Cohort||Prospective|||||||
1397090|NCT02330679||Single Group Assignment||Treatment||Single|||t|||
1397091|NCT02330666|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397092|NCT02330653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397093|NCT02330640|Randomized|Parallel Assignment||Treatment||Single||Single center prospective randomized controlled study|||t|
1397094|NCT02330627|Randomized|Parallel Assignment||Treatment||Single||||||t
1397095|NCT02330614|||Case Control||Prospective|||||||
1397096|NCT02330601|Randomized|Parallel Assignment||Prevention||Single|||t|||
1397097|NCT02330588|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1397098|NCT02330575|Randomized|Crossover Assignment||Treatment||Single||||||t
1397099|NCT02330562||Single Group Assignment||Treatment||None (Open Label)||||||
1397100|NCT02330549|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397101|NCT02330536|Randomized|Crossover Assignment||Prevention||Double||||t||t
1397102|NCT02330523|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397103|NCT02330510|||Cohort||Prospective|||||||
1397104|NCT02330497||Single Group Assignment||Treatment||None (Open Label)||||||
1397105|NCT02330484|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397106|NCT02330471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397107|NCT02330458|||Cohort||Prospective|||||||
1397108|NCT02330445|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two parts of recipients are assigned for this Phase I/II open label, single site study. Part A subjects are all who had RA while Part B subjects are healthy volunteers. All subject are allocated to the single treatment group at a fixed dose of 6.0μg/kg of IV PRTX-100.||||
1397109|NCT02330432|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1397110|NCT02330419|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1397111|NCT02330406|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1397112|NCT02330380|||Cohort||Prospective|||||||
1397113|NCT02330367||Single Group Assignment||Treatment||None (Open Label)||||||
1397114|NCT02330354|Randomized|Crossover Assignment||Prevention||Single||||||t
1397115|NCT02330341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397116|NCT02330328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397117|NCT02330315|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397118|NCT02330302|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397119|NCT02330289|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1397120|NCT02330276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397121|NCT02330263|Randomized|Parallel Assignment||Treatment||Single|||||t|
1397122|NCT02330250|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1397123|NCT02330237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397124|NCT02330224|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397125|NCT02330211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397126|NCT02330198|||Case-Only||Prospective|||||||
1397128|NCT02330172|Randomized|Parallel Assignment||Treatment||Single||||||t
1397129|NCT02330159|||Cohort||Prospective|||||||
1397130|NCT02330146|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397131|NCT02330133|Randomized|Parallel Assignment||||None (Open Label)||||||
1397132|NCT02330120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397133|NCT02330107|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397134|NCT02330094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1397135|NCT02330081||Single Group Assignment||Prevention||None (Open Label)||||||
1397136|NCT02330068|||Case-Control||Prospective|||||||
1397137|NCT02330055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397138|NCT02330042|||Case-Control||Prospective|||||||
1397139|NCT02330029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397140|NCT02330016||Single Group Assignment||Treatment||None (Open Label)||||||
1397141|NCT02330003|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397142|NCT02329990|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1397143|NCT02329977|||Case Control||Prospective|||||||
1397144|NCT02329964|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1397145|NCT02329951|||Cohort||Prospective|||||||
1397146|NCT02329938|Randomized|Single Group Assignment||Treatment||Single||||||t
1397147|NCT02329925||Single Group Assignment||Treatment||None (Open Label)||||||
1397148|NCT02329912|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397149|NCT02329899|||Cohort||Prospective|||||||
1397150|NCT02329886|||Cohort||Prospective|||||||
1397151|NCT02329873|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397152|NCT02329860|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1397153|NCT02329847|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397154|NCT02329834|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397155|NCT02329821|||Case Control||Prospective|||||||
1397156|NCT02329808|||Cohort||Prospective|||||||
1397157|NCT02329795|||Cohort||Prospective|||||||
1397158|NCT02329782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397159|NCT02329769|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397160|NCT02329756|Randomized|Parallel Assignment||Prevention||Quadruple|Study drug and placebo will be prepared by Investigational Pharmacy, and with similar appearing packaging and syringes. The Investigational Pharmacy will maintain the randomization table and allocation list. Participants, care providers, investigators and outcomes assessors will remain blinded until after data analysis completed, unless unblinding required in case of clinical emergency, per the unblinding procedures within the protocol.||t|t|t|t
1397161|NCT02329743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397162|NCT02329730|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397163|NCT02329717||Single Group Assignment||Treatment||None (Open Label)||||||
1397164|NCT02329704|||Case Control||Prospective|||||||
1397165|NCT02329691|||Case-Only||Prospective|||||||
1397166|NCT02329678|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1397167|NCT02329665||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397168|NCT02329652||Single Group Assignment||Treatment||None (Open Label)||||||
1397169|NCT02329639|||Cohort||Prospective|||||||
1397170|NCT02329626|||Cohort||Prospective|||||||
1397171|NCT02329613|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397172|NCT02329600|Randomized|Parallel Assignment||Treatment||Single||||||t
1397173|NCT02329587|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397174|NCT02329574|||Cohort||Prospective|||||||
1397175|NCT02329561|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1397176|NCT02329548||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397177|NCT02329535|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397178|NCT02329522|||Cohort||Prospective|||||||
1397179|NCT02329509|Randomized|Parallel Assignment||Treatment||Single||||t||
1397180|NCT02329496||Single Group Assignment||Treatment||None (Open Label)||||||
1397181|NCT02329483|||Cohort||Prospective|||||||
1397182|NCT02329470|Randomized|Parallel Assignment||Treatment||Single||||||t
1397183|NCT02329457|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1397184|NCT02329444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397185|NCT02329431|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1397186|NCT02329418|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1397187|NCT02329405|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1397188|NCT02329392|||Cohort||Prospective|||||||
1397189|NCT02329379|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397190|NCT02329366|||||Prospective|||||||
1397191|NCT02329353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397192|NCT02329340|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397193|NCT02329327|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1397194|NCT02329314|||Case-Only||Retrospective|||||||
1397195|NCT02329301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397196|NCT02329288|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397197|NCT02329275|||Case-Control||Prospective|||||||
1397198|NCT02329262|Randomized|Parallel Assignment||Prevention||Single||||||t
1397199|NCT02329249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397200|NCT02329236|||Cohort||Prospective|||||||
1397201|NCT02329223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397202|NCT02329210|||Cohort||Prospective|||||||
1397203|NCT02329197|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397204|NCT02329184||Single Group Assignment||Treatment||None (Open Label)||||||
1397205|NCT02329171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397206|NCT02329158|||Cohort||Retrospective|||||||
1397207|NCT02329145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397208|NCT02329132|||Case-Only||Prospective|||||||
1397209|NCT02329119|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1397210|NCT02329106||Single Group Assignment||Treatment||None (Open Label)||||||
1397211|NCT02329093|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1397212|NCT02329080||Single Group Assignment||Treatment||None (Open Label)||||||
1397213|NCT02329067|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1397214|NCT02329054||Single Group Assignment||Treatment||None (Open Label)||||||
1397215|NCT02329041|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397216|NCT02329028|||Cohort||Prospective|||||||
1397217|NCT02329015|Randomized|Parallel Assignment||Prevention||Single||||||t
1397218|NCT02329002|||Cohort||Prospective|||||||
1397219|NCT02328989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397220|NCT02328976|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1397221|NCT02328963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397222|NCT02328950|||Cohort||Prospective|||||||
1397223|NCT02328937|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1397224|NCT02328924|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397225|NCT02328911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397226|NCT02328898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397227|NCT02328885||Single Group Assignment||Treatment||None (Open Label)||||||
1397228|NCT02328872|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1397229|NCT02328859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397230|NCT02328846|||Cohort||Prospective|||||||
1397231|NCT02328833|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397232|NCT02328820||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397233|NCT02328807||Single Group Assignment||Treatment||None (Open Label)||||||
1397234|NCT02328794|Randomized|Parallel Assignment||Treatment||Single||||||t
1397235|NCT02328781||Single Group Assignment||Treatment||None (Open Label)||||||
1397236|NCT02328768||Single Group Assignment||Treatment||None (Open Label)||||||
1397237|NCT02328755||Single Group Assignment||Treatment||None (Open Label)||||||
1397238|NCT02328742|||Cohort||Prospective|||||||
1397239|NCT02328729|||Case-Only||Prospective|||||||
1397240|NCT02328716|Randomized|Parallel Assignment||Other||Single|||t|||
1397241|NCT02328703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397242|NCT02328690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397243|NCT02328677|||Cohort||Prospective|||||||
1397244|NCT02328664||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397245|NCT02328651|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397246|NCT02328638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397247|NCT02328625|||Case-Only||Prospective|||||||
1397248|NCT02328612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397249|NCT02328599|||Cohort||Prospective|||||||
1397250|NCT02328586||Single Group Assignment||Treatment||None (Open Label)||||||
1397251|NCT02328573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397252|NCT02328560|||Case Control||Prospective|||||||
1397253|NCT02328547|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1397254|NCT02328534|||Cohort||Retrospective|||||||
1397255|NCT02328521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397256|NCT02328508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397257|NCT02328495|Randomized|Parallel Assignment||Treatment||Single|||||t|
1397258|NCT02328482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397259|NCT02328469|||Case-Control||Prospective|||||||
1397260|NCT02328456|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397261|NCT02328443|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1397262|NCT02328430|||Cohort||Prospective|||||||
1397263|NCT02328417|||Cohort||Prospective|||||||
1397264|NCT02328404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397265|NCT02328391|||Cohort||Prospective|||||||
1397266|NCT02328378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397267|NCT02328365|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397268|NCT02328352|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1397269|NCT02328339|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1397270|NCT02328326|Randomized|Parallel Assignment||Treatment||Single|||||t|
1397271|NCT02328313||Single Group Assignment||Other||None (Open Label)||||||
1397272|NCT02328300|||Cohort||Prospective|||||||
1397273|NCT02328287||Single Group Assignment||Treatment||None (Open Label)||||||
1397274|NCT02328274|||Case-Only||Retrospective|||||||
1397275|NCT02328261||Single Group Assignment||Treatment||None (Open Label)||||||
1397276|NCT02328248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397277|NCT02328235||Single Group Assignment||Basic Science||None (Open Label)||||||
1397278|NCT02328222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397279|NCT02328209||Single Group Assignment||Treatment||None (Open Label)||||||
1397280|NCT02328196|||Cohort||Cross-Sectional|||||||
1397281|NCT02328183||Single Group Assignment||Treatment||None (Open Label)||||||
1397282|NCT02328170|||Cohort||Cross-Sectional|||||||
1397283|NCT02328157||Single Group Assignment||Treatment||None (Open Label)||||||
1397284|NCT02328144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397285|NCT02328131|||Case-Only||Prospective|||||||
1397286|NCT02328118|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397287|NCT02328105||Single Group Assignment||Treatment||None (Open Label)||||||
1397288|NCT02328092|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397289|NCT02328079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397290|NCT02328066||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397291|NCT02328053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397292|NCT02328040|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1397293|NCT02328027||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397294|NCT02328014|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397295|NCT02328001|Non-Randomized|Single Group Assignment||Other||Single||||t||
1397296|NCT02327988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397297|NCT02327975|Non-Randomized|Factorial Assignment||Basic Science||Single|||t|||
1397298|NCT02327962|||Cohort||Prospective|||||||
1397299|NCT02327949|Randomized|Parallel Assignment||Treatment||Single||||||t
1397300|NCT02327936|Randomized|Crossover Assignment||Treatment||Single|||||t|
1397301|NCT02327923|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1397302|NCT02327910|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1397303|NCT02327897|||Cohort||Prospective|||||||
1397304|NCT02327884|||Cohort||Prospective|||||||
1397305|NCT02327871||Single Group Assignment||Treatment||None (Open Label)||||||
1397306|NCT02327858|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1397307|NCT02327845|||Cohort||Prospective|||||||
1397308|NCT02327832|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397309|NCT02327819|Randomized|Parallel Assignment||||Double|||t||t|
1397310|NCT02327806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397311|NCT02327793|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397312|NCT02327780||Single Group Assignment||Supportive Care||None (Open Label)||||||
1397313|NCT02327767|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397314|NCT02327754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397315|NCT02327741|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1397316|NCT02327728|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397317|NCT02327715|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1397318|NCT02327702|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397319|NCT02327689|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397320|NCT02327676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397321|NCT02327663|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397322|NCT02327650|||Cohort||Retrospective|||||||
1397323|NCT02327637|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397324|NCT02327624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397325|NCT02327611|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1397326|NCT02327598||||||||||||
1397327|NCT02327585||Parallel Assignment||Treatment||Double|||t|t||
1397328|NCT02327572|||Cohort||Prospective|||||||
1397329|NCT02327559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397330|NCT02327546|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1397331|NCT02327533|||Case Control||Cross-Sectional|||||||
1397332|NCT02327520|||Case-Only||Retrospective|||||||
1397333|NCT02327507|||Cohort||Prospective|||||||
1397334|NCT02327494|||Cohort||Prospective|||||||
1397335|NCT02327481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397336|NCT02327455||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397337|NCT02327442|||||Prospective|||||||
1397338|NCT02327429||Single Group Assignment||Treatment||None (Open Label)||||||
1397339|NCT02327416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397340|NCT02327403|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397341|NCT02327390||Single Group Assignment||Treatment||None (Open Label)||||||
1397342|NCT02327377|Randomized|Parallel Assignment||Treatment||Single||||||t
1397343|NCT02327364|||Cohort||Prospective|||||||
1397344|NCT02327351||Single Group Assignment||Treatment||None (Open Label)||||||
1397345|NCT02327338|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1397346|NCT02327325|Randomized|Parallel Assignment||Treatment||Single||||||t
1397347|NCT02327312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397348|NCT02327299|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1397349|NCT02327286|Randomized|Parallel Assignment||Prevention||Single||||||t
1397350|NCT02327273|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1397351|NCT02327260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397352|NCT02327247|Randomized|Crossover Assignment||||None (Open Label)||||||
1397353|NCT02327234|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1397354|NCT02327221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397355|NCT02327208|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1397356|NCT02327195|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1397357|NCT02327182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397358|NCT02327169|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397359|NCT02327156|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1398047|NCT02318160|||Case Control||Prospective|||||||
1397360|NCT02327143|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1397361|NCT02327130||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397362|NCT02327117|Randomized|Parallel Assignment||Treatment||Double||||||
1397363|NCT02327104|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397364|NCT02327091|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397365|NCT02327078|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397366|NCT02327065|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1397367|NCT02327052|||||Cross-Sectional|||||||
1397368|NCT02327039|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397369|NCT02327026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397370|NCT02327013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397371|NCT02327000|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1397372|NCT02326987|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1397373|NCT02326974||Single Group Assignment||Treatment||None (Open Label)||||||
1397374|NCT02326961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397375|NCT02326948|||Case Control||Retrospective|||||||
1397376|NCT02326935||Single Group Assignment||Treatment||None (Open Label)||||||
1397377|NCT02326922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397378|NCT02326909||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397379|NCT02326896|||Cohort||Retrospective|||||||
1397380|NCT02326883|Randomized|Parallel Assignment||Prevention||Single||||||t
1397381|NCT02326870||Single Group Assignment||||None (Open Label)||||||
1397382|NCT02326857|||Cohort||Prospective|||||||
1397383|NCT02326844||Single Group Assignment||Treatment||None (Open Label)||||||
1397384|NCT02326818|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1397385|NCT02326805|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1397386|NCT02326792|Randomized|Parallel Assignment||Treatment||Single||||||t
1397387|NCT02326779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397388|NCT02326766|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1397389|NCT02326753|Non-Randomized|Crossover Assignment||Treatment||Double|||t|||t
1397390|NCT02326740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397391|NCT02326727|Randomized|Single Group Assignment||Treatment||Single|||||t|
1397392|NCT02326714|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397393|NCT02326701|||Cohort||Prospective|||||||
1397394|NCT02326688|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397395|NCT02326675|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397396|NCT02326662|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1397397|NCT02326649|||Cohort||Prospective|||||||
1397398|NCT02326636|||Cohort||Prospective|||||||
1397399|NCT02326623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397400|NCT02326610|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397401|NCT02326597|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1397402|NCT02326584|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397403|NCT02326571|||Cohort||Prospective|||||||
1397404|NCT02326558|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397405|NCT02326545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397406|NCT02326532|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1397407|NCT02326519||Single Group Assignment||Other||None (Open Label)||||||
1397408|NCT02326506||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397409|NCT02326493||Single Group Assignment||Treatment||None (Open Label)||||||
1397410|NCT02326480|||Case-Only||Prospective|||||||
1397411|NCT02326467||Single Group Assignment||Other||None (Open Label)||||||
1397412|NCT02326454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397413|NCT02326441||Single Group Assignment||Treatment||None (Open Label)||||||
1397414|NCT02326428|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1397415|NCT02326415|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1397416|NCT02326402|||Case-Only||Prospective|||||||
1397417|NCT02326389|Randomized|Parallel Assignment||Treatment||Single||||||t
1397418|NCT02326376|||Cohort||Prospective|||||||
1397419|NCT02326363|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|||||
1397420|NCT02326350|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397421|NCT02326337|Randomized|Parallel Assignment||Treatment||Quadruple||Group Sequential Design of a maximum of 220 subjects with two predetermined interim analyses at 73 and 146 subjects|t|t|t|t
1397422|NCT02326324|||Cohort||Prospective|||||||
1397423|NCT02326311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397424|NCT02326298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397425|NCT02326285||Single Group Assignment||Treatment||None (Open Label)||||||
1397426|NCT02326272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397427|NCT02326259|||Cohort||Prospective|||||||
1397428|NCT02326246||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397429|NCT02326233|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1397430|NCT02326220|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397431|NCT02326207|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1397432|NCT02326194|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1397433|NCT02326181|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397434|NCT02326168||Single Group Assignment||Treatment||None (Open Label)||||||
1397435|NCT02326155|||Cohort||Prospective|||||||
1397436|NCT02326142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397438|NCT02326116|Randomized|Parallel Assignment||Prevention||Single|||||t|
1397439|NCT02326103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397440|NCT02326090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397441|NCT02326077|||Cohort||Prospective|||||||
1397442|NCT02326064|||Cohort||Prospective|||||||
1397443|NCT02326051|Randomized|Parallel Assignment||Prevention||Single||||||t
1397444|NCT02326038|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1397445|NCT02326025|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||||||
1397446|NCT02326012||Single Group Assignment||Treatment||None (Open Label)||||||
1397447|NCT02325999|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397448|NCT02325986||Single Group Assignment||Treatment||None (Open Label)||||||
1397449|NCT02325973||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397450|NCT02325960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397451|NCT02325947|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1397452|NCT02325934|Randomized|Crossover Assignment||||None (Open Label)||||||
1397453|NCT02325921|||Cohort||Prospective|||||||
1397454|NCT02325908|||Case Control||Prospective|||||||
1397455|NCT02325895|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1397456|NCT02325882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397457|NCT02325869||Single Group Assignment||Treatment||None (Open Label)||||||
1397458|NCT02325856|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397459|NCT02325843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397460|NCT02325830|Randomized|Parallel Assignment||Treatment||Double||With crossover for sham procedure patients who are eligible at time of 12 month follow up.|t|||t
1397461|NCT02325817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397462|NCT02325804|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1397463|NCT02325791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397464|NCT02325778|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397465|NCT02325765|||Cohort||Retrospective|||||||
1397466|NCT02325752|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1397467|NCT02325739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397468|NCT02325726|||Cohort||Prospective|||||||
1397469|NCT02325713|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397470|NCT02325700|||Case Control||Prospective|||||||
1397471|NCT02325687|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397472|NCT02325674|||Cohort||Prospective|||||||
1397473|NCT02325661||Single Group Assignment||||None (Open Label)||||||
1397474|NCT02325648|||Case-Only||Prospective|||||||
1397475|NCT02325635|Randomized|Crossover Assignment||Health Services Research||Single|||||t|
1397476|NCT02325622|||Cohort||Prospective|||||||
1397477|NCT02325609||||||||||||
1397478|NCT02325596|||Case Control|||||||||
1397479|NCT02325583||Single Group Assignment||Supportive Care||None (Open Label)||||||
1397480|NCT02325570|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397481|NCT02325557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397482|NCT02325544|Randomized|Parallel Assignment||Treatment||Single||||||t
1397483|NCT02325531|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1397484|NCT02325518|Randomized|Parallel Assignment||||Double|||t||t|
1397485|NCT02325505|||Cohort||Prospective|||||||
1397486|NCT02325492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397487|NCT02325479|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1397488|NCT02325466|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1397489|NCT02325453|||Other||Retrospective|||||||
1397490|NCT02325440||Single Group Assignment||Treatment||None (Open Label)||||||
1397491|NCT02325427|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397492|NCT02325414|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1397493|NCT02325401||Single Group Assignment||Treatment||None (Open Label)||||||
1397494|NCT02325388|Randomized|Parallel Assignment||Prevention||Single|||||t|
1397495|NCT02325375||||||||||||
1397496|NCT02325362|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1397497|NCT02325349||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397498|NCT02325336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397499|NCT02325323|||Cohort||Prospective|||||||
1397500|NCT02325310||Single Group Assignment||Prevention||None (Open Label)||||||
1397501|NCT02325297|Randomized|Parallel Assignment||||None (Open Label)||||||
1397502|NCT02325284|||Case-Only||Prospective|||||||
1397503|NCT02325271|||Case-Control||Prospective|||||||
1397504|NCT02325258|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397505|NCT02325245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397506|NCT02325232||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397507|NCT02325219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397508|NCT02325206|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1397509|NCT02325193|||Cohort||Prospective|||||||
1397510|NCT02325180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397511|NCT02325167|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397512|NCT02325154|||Cohort||Prospective|||||||
1397513|NCT02325141|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397514|NCT02325128|Randomized|Single Group Assignment||Treatment||Single||||t||
1397515|NCT02325115|||Cohort||Prospective|||||||
1397516|NCT02325102|||Cohort||Cross-Sectional|||||||
1397517|NCT02325089|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1397518|NCT02325076||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397519|NCT02325063|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397520|NCT02325050|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1397521|NCT02325037|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397522|NCT02325024|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1397523|NCT02325011|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1397524|NCT02324998|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1397525|NCT02324985|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1397526|NCT02324972|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397527|NCT02324959|Randomized|Parallel Assignment||Treatment||Single||||||t
1397528|NCT02324946|||Cohort||Prospective|||||||
1397529|NCT02324933|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397530|NCT02324920|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397531|NCT02324907|||Case-Only||Prospective|||||||
1397532|NCT02324894||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397533|NCT02324881||Single Group Assignment||Health Services Research||None (Open Label)||||||
1397534|NCT02324868|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1397535|NCT02324855|Randomized|Parallel Assignment||Treatment||Single||||||t
1397536|NCT02324842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397537|NCT02324829|||Cohort||Cross-Sectional|||||||
1397538|NCT02324816||Single Group Assignment||Other||None (Open Label)||||||
1397539|NCT02324803||Single Group Assignment||Treatment||None (Open Label)||||||
1397540|NCT02324790||Single Group Assignment||Treatment||None (Open Label)|evaluator blind|||||
1397541|NCT02324777|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1397542|NCT02324764|Randomized|Parallel Assignment||Prevention||Single|||t|||
1397543|NCT02324751|Randomized|Parallel Assignment||Prevention||Single|||t|||
1397544|NCT02324738||Single Group Assignment||Treatment||None (Open Label)||||||
1397545|NCT02324725||Single Group Assignment||Treatment||None (Open Label)||||||
1397546|NCT02324712|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1397547|NCT02324699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397548|NCT02324686||Single Group Assignment||Treatment||None (Open Label)||||||
1397549|NCT02324673|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1397550|NCT02324660||Single Group Assignment||Screening||None (Open Label)||||||
1397551|NCT02324647|||Cohort||Prospective|||||||
1397552|NCT02324634|Randomized|Parallel Assignment||Treatment||None (Open Label)|As this is a feasibility RCT, the outcome assessor has not been masked to treatment but would be in a subsequent pilot and definitive trial.|||||
1397553|NCT02324621||Single Group Assignment||Treatment||None (Open Label)||||||
1397554|NCT02324608||Single Group Assignment||Treatment||None (Open Label)||||||
1397555|NCT02324595||Single Group Assignment||Treatment||None (Open Label)||||||
1397556|NCT02324582||Single Group Assignment||Treatment||None (Open Label)||||||
1397557|NCT02324569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397558|NCT02324556|||Case-Control||Prospective|||||||
1397559|NCT02324543||Single Group Assignment||Treatment||None (Open Label)||||||
1397560|NCT02324530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397561|NCT02324517|||Cohort||Prospective|||||||
1397562|NCT02324504||Single Group Assignment||Treatment||None (Open Label)||||||
1397563|NCT02324491|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397564|NCT02324478|||Cohort||Prospective|||||||
1397565|NCT02324465|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397566|NCT02324452|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397567|NCT02324439||Single Group Assignment||Prevention||None (Open Label)||||||
1397568|NCT02324426||Single Group Assignment||Treatment||None (Open Label)||||||
1397569|NCT02324413|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1397570|NCT02324400|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1397571|NCT02324387||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397572|NCT02324374||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1397573|NCT02324361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397574|NCT02324348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397575|NCT02324335|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1397576|NCT02324322||Single Group Assignment||Treatment||None (Open Label)||||||
1397577|NCT02324309|Randomized|Crossover Assignment||Treatment||Single|||t|||
1397578|NCT02324296|||Cohort||Retrospective|||||||
1397579|NCT02324283|Randomized|Parallel Assignment||Other||Single|||t|||
1397580|NCT02324270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397581|NCT02324257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397582|NCT02324244|||Cohort||Prospective|||||||
1397583|NCT02324231|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1397584|NCT02324218|||Cohort||Retrospective|||||||
1397585|NCT02324205|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1397586|NCT02324192|Randomized|Single Group Assignment||||Triple|||t||t|t
1397587|NCT02324179|||Case Control||Prospective|||||||
1397588|NCT02324166|Randomized|Parallel Assignment||||Single|||t|||
1397589|NCT02324153|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1397590|NCT02324140|||Cohort||Prospective|||||||
1397591|NCT02324127||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397592|NCT02324114||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397593|NCT02324101||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397594|NCT02324088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397595|NCT02324075|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397596|NCT02324062|||Cohort||Prospective|||||||
1397597|NCT02324049||Single Group Assignment||Treatment||None (Open Label)||||||
1397598|NCT02324036|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397599|NCT02324023||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397600|NCT02324010|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1397601|NCT02323997|||||Cross-Sectional|||||||
1397602|NCT02323984|||Cohort||Prospective|||||||
1397603|NCT02323971|||Case-Only||Prospective|||||||
1397604|NCT02323958|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1397605|NCT02323945|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1397606|NCT02323932|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1397607|NCT02323919|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1397608|NCT02323906||Single Group Assignment||Treatment||None (Open Label)||||||
1397609|NCT02323893||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397610|NCT02323880||Single Group Assignment||Treatment||None (Open Label)||||||
1397611|NCT02323867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||intervention with device: Alpha Beta T cell depletion||||
1397612|NCT02323854||Single Group Assignment||Supportive Care||None (Open Label)||||||
1397613|NCT02323841||Single Group Assignment||||None (Open Label)||||||
1397614|NCT02323828|Randomized|Single Group Assignment||Prevention||Single|||t|||
1397615|NCT02323815|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397616|NCT02323802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397617|NCT02323789||Single Group Assignment||Other||None (Open Label)||||||
1397618|NCT02323776|||Cohort||Retrospective|||||||
1397619|NCT02323763|||Case-Only||Cross-Sectional|||||||
1397620|NCT02323750|||Cohort||Prospective|||||||
1397621|NCT02323737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397622|NCT02323724|||Case-Only||Retrospective|||||||
1397623|NCT02323711|Randomized|Parallel Assignment||||None (Open Label)||||||
1397624|NCT02323698|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1397625|NCT02323685||Single Group Assignment||||None (Open Label)||||||
1397626|NCT02323672|||Case-Control||Cross-Sectional|||||||
1397627|NCT02323659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397628|NCT02323646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397629|NCT02323633|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397630|NCT02323620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397631|NCT02323607|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397632|NCT02323594|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1397633|NCT02323581||Single Group Assignment||Treatment||None (Open Label)||||||
1397634|NCT02323568||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397635|NCT02323555||Single Group Assignment||Other||None (Open Label)||||||
1397636|NCT02323542|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1397637|NCT02323529||Crossover Assignment||Treatment||None (Open Label)||||||
1397638|NCT02323516|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397639|NCT02323503|||Cohort||Prospective|||||||
1397640|NCT02323490|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397641|NCT02323477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397642|NCT02323464|||Case-Control||Prospective|||||||
1397643|NCT02323451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397644|NCT02323438|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1397645|NCT02323425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397646|NCT02323412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397647|NCT02323399||Single Group Assignment||Treatment||None (Open Label)||||||
1397648|NCT02323386||Single Group Assignment||Other||None (Open Label)||||||
1397649|NCT02323373|Randomized|Parallel Assignment||Prevention||Single|||t|||
1397650|NCT02323360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397651|NCT02323347|||Case-Crossover||Retrospective|||||||
1397652|NCT02323334|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1397653|NCT02323321||Single Group Assignment||Treatment||None (Open Label)||||||
1397654|NCT02323308|||||Prospective|||||||
1397655|NCT02323295|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1397656|NCT02323282||Single Group Assignment||||Single|||t|||
1397657|NCT02323269|||Cohort||Prospective|||||||
1397658|NCT02323256|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1397659|NCT02323243||Single Group Assignment||Treatment||None (Open Label)||||||
1397660|NCT02323230||Single Group Assignment||Treatment||None (Open Label)||||||
1397661|NCT02323217||Single Group Assignment||Basic Science||None (Open Label)||||||
1397662|NCT02323204|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397663|NCT02323191|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397664|NCT02323178||Single Group Assignment||Treatment||None (Open Label)||||||
1397665|NCT02323165|||Other||Prospective|||||||
1397666|NCT02323152|Randomized|Parallel Assignment||Prevention||Single||||||t
1397667|NCT02323139||Single Group Assignment||Treatment||None (Open Label)||||||
1397668|NCT02323126||Parallel Assignment||Treatment||None (Open Label)||||||
1398126|NCT02317120|||Other||Prospective|||||||
1397669|NCT02323113|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397670|NCT02323100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397671|NCT02323087|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397672|NCT02323074|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397673|NCT02323061|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397674|NCT02323048||Single Group Assignment||Basic Science||Double|||t||t|
1397675|NCT02323035||Single Group Assignment||Other||None (Open Label)||||||
1397676|NCT02323022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397677|NCT02323009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397678|NCT02322996|||Other||Other|||||||
1397679|NCT02322983|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1397680|NCT02322970|||Cohort||Prospective|||||||
1397681|NCT02322957|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397682|NCT02322944|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1397683|NCT02322931||Single Group Assignment||Supportive Care||None (Open Label)||||||
1397684|NCT02322918|||Cohort|||||||||
1397685|NCT02322905|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397686|NCT02322892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397687|NCT02322879|Randomized|Crossover Assignment||Prevention||Double||"Eligible subjects will then be randomized at a 1:1 ratio to receive either acetaminophen (APAP) or APAP + propylene glycol for 2 weeks (Treatment Period 1). At the end of the Treatment Period 1 subjects will enter the Wash-Out period for 2 weeks. Study subjects will then receive the alternative treatment for 2 weeks (Treatment Period 2). Overall, the maximum duration of treatment is approximately 6 weeks.~RESPONDERS: Subjects whose transaminase levels rise to 3 times normal or greater during either of the Treatment Periods will be deemed responders and the intervention will cease.~If subjects are in the Treatment Period 1, they will enter the washout period and continue to return daily to ensure that liver function tests decline. After the 2 week washout-period, responders will cross over to Treatment Period 2.~If subjects are in the Treatment Period 2 phase, they will continue to return to the CRC and have their transaminases checked until they return to normal."|||t|t
1397688|NCT02322866|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397689|NCT02322853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397690|NCT02322840||||||||||||
1397691|NCT02322827|||||Retrospective|||||||
1397692|NCT02322814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397693|NCT02322801|||Cohort||Prospective|||||||
1397694|NCT02322788|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1397695|NCT02322775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397696|NCT02322762|||Cohort||Prospective|||||||
1397697|NCT02322749|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1397698|NCT02322736|||Cohort||Prospective|||||||
1397699|NCT02322723|||Cohort||Prospective|||||||
1397700|NCT02322710|Randomized|Parallel Assignment||Treatment||Single||||||t
1397701|NCT02322697|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397702|NCT02322684|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1397703|NCT02322671|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397704|NCT02322658|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397705|NCT02322645|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397706|NCT02322632|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397707|NCT02322619|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397708|NCT02322606|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397709|NCT02322593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397710|NCT02322580|||Cohort||Prospective|||||||
1397711|NCT02322567|||||Prospective|||||||
1397712|NCT02322554|||Other||Prospective|||||||
1397713|NCT02322541||Single Group Assignment||Basic Science||None (Open Label)||||||
1397714|NCT02322528||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397715|NCT02322515|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397716|NCT02322502|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397717|NCT02322489|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1397718|NCT02322476|||Cohort||Prospective|||||||
1397719|NCT02322463|||Case Control||Retrospective|||||||
1397720|NCT02322450|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1397721|NCT02322437|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397722|NCT02322424|||Cohort||Prospective|||||||
1397723|NCT02322411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397724|NCT02322398|||Case Control||Retrospective|||||||
1397725|NCT02322385|||Cohort||Prospective|||||||
1397726|NCT02322372|Randomized|Crossover Assignment||Treatment||Single||||||t
1397727|NCT02322359|||Case-Crossover||Prospective|||||||
1397728|NCT02322346|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1397729|NCT02322333|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1397730|NCT02322320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397731|NCT02322307|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1397732|NCT02322294|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1397733|NCT02322281|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1397734|NCT02322268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397735|NCT02322255|||Case-Only||Prospective|||||||
1397736|NCT02322242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397737|NCT02322229||Single Group Assignment||Treatment||None (Open Label)||||||
1397738|NCT02322216|Randomized|Parallel Assignment||Treatment||Single|||||t|
1397739|NCT02322203||Single Group Assignment||Basic Science||None (Open Label)||||||
1397740|NCT02322190||Single Group Assignment||Treatment||None (Open Label)||||||
1397741|NCT02322177|||Cohort||Cross-Sectional|||||||
1397742|NCT02322164|||Cohort||Cross-Sectional|||||||
1397743|NCT02322151|||Case-Only||Retrospective|||||||
1397744|NCT02322138|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1397745|NCT02322125||Single Group Assignment||Treatment||None (Open Label)||||||
1397746|NCT02322112|Randomized|Parallel Assignment||Other||Single|||t|||
1397747|NCT02322099|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1397748|NCT02322086||Single Group Assignment||Treatment||None (Open Label)||||||
1397749|NCT02322073|||Cohort||Prospective|||||||
1397750|NCT02322060|||Case-Only||Prospective|||||||
1397751|NCT02322047|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397752|NCT02322034|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1397753|NCT02322021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397754|NCT02322008|||Case-Only||Retrospective|||||||
1397755|NCT02321995|||Cohort||Prospective|||||||
1397756|NCT02321982|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397757|NCT02321969|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397758|NCT02321956|Randomized|Parallel Assignment||Diagnostic||Quadruple|Sealed envelops were used. Ultrasonographers were masked with the group of patients. Participants were masked with the techniques of selecting endotracheal tubes. Care providers and outcome assessors were masked with the techniques of selecting. endotracheal tubes|randomized controlled trial|t|t|t|t
1397759|NCT02321943|||Cohort||Prospective|||||||
1397760|NCT02321930||Single Group Assignment||Treatment||None (Open Label)||||||
1397761|NCT02321917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397762|NCT02321904|||Case-Control||Prospective|||||||
1397763|NCT02321891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397764|NCT02321878|||Cohort||Prospective|||||||
1397765|NCT02321865||Single Group Assignment||Treatment||None (Open Label)||||||
1397766|NCT02321852|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1397767|NCT02321839||Single Group Assignment||Treatment||None (Open Label)||||||
1397768|NCT02321826|Randomized|Parallel Assignment||Treatment||Single||||||t
1397769|NCT02321813|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397770|NCT02321800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397771|NCT02321787|Randomized|Parallel Assignment||Treatment||Single||||||t
1397772|NCT02321774|||||Prospective|||||||
1397773|NCT02321761||Single Group Assignment||Treatment||None (Open Label)||||||
1397774|NCT02321748|Randomized|Crossover Assignment||||None (Open Label)||||||
1397775|NCT02321735||Single Group Assignment||||None (Open Label)||||||
1397776|NCT02321722|||Cohort||Prospective|||||||
1397777|NCT02321709|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1397778|NCT02321696|Randomized|Factorial Assignment||Treatment||Single||||||t
1397779|NCT02321683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397780|NCT02321670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397781|NCT02321657|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397782|NCT02321644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397783|NCT02321631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397784|NCT02321618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397785|NCT02321605|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397786|NCT02321592|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397787|NCT02321579|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1397788|NCT02321566||Single Group Assignment||Treatment||None (Open Label)||||||
1397789|NCT02321553|Randomized|Crossover Assignment||Treatment||Single|||||t|
1397790|NCT02321540||Single Group Assignment||Treatment||None (Open Label)||||||
1397791|NCT02321527||Single Group Assignment||Screening||None (Open Label)||||||
1397792|NCT02321514||Single Group Assignment||Treatment||None (Open Label)||||||
1397793|NCT02321501|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397794|NCT02321475|||Case-Only||Prospective|||||||
1397795|NCT02321462|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1397796|NCT02321449|||Case-Only||Prospective|||||||
1397797|NCT02321436|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397798|NCT02321423|||Case-Only||Cross-Sectional|||||||
1397799|NCT02321410||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397800|NCT02321397|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1397801|NCT02321384|Randomized|Parallel Assignment||Other||Double|||t||t|
1397802|NCT02321371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397803|NCT02321358|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1397804|NCT02321345||Single Group Assignment||Supportive Care||None (Open Label)||||||
1397805|NCT02321332|Randomized|Single Group Assignment||Treatment||Single|||||t|
1397806|NCT02321319||Single Group Assignment||Treatment||None (Open Label)||||||
1397807|NCT02321306||Single Group Assignment||Treatment||None (Open Label)||||||
1397808|NCT02321293||Single Group Assignment||||None (Open Label)||||||
1397809|NCT02321280||Single Group Assignment||Treatment||None (Open Label)||||||
1397810|NCT02321267||Single Group Assignment||Treatment||None (Open Label)||||||
1397811|NCT02321254||Single Group Assignment||Treatment||Single||||||t
1397812|NCT02321241|||Cohort||Other|||||||
1397813|NCT02321228|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397814|NCT02321215|Randomized|Parallel Assignment||||None (Open Label)||||||
1397815|NCT02321202|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1397816|NCT02321189|Randomized|Parallel Assignment||||Single|||t|||
1397817|NCT02321176||Single Group Assignment||||Single|||t|||
1397818|NCT02321163|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1397819|NCT02321150|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397820|NCT02321137|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1397821|NCT02321124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397822|NCT02321111|Randomized|Crossover Assignment||Treatment||Quadruple|Participant, Care Provider, Investigator, Outcomes Assessor||t|t|t|t
1397823|NCT02321098|Randomized|Parallel Assignment||Treatment||Single|"Only 12 first weeks of treatment with Loceryl NL and/or Loceryl alone were investigator masked and randomized.~15 months of treatment with Loceryl NL alone had an open study design"||||t|
1397824|NCT02321085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397825|NCT02321072|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397826|NCT02321059|||Case Control||Prospective|||||||
1397827|NCT02321046|||Case-Only||Prospective|||||||
1397828|NCT02321033|Randomized|Crossover Assignment||Prevention||Single|||t|||
1397829|NCT02321020|||Cohort||Prospective|||||||
1397830|NCT02321007|||Case-Control||Prospective|||||||
1397831|NCT02320994|||Case-Only||Cross-Sectional|||||||
1397832|NCT02320981|||Case-Only||Prospective|||||||
1397833|NCT02320968||Single Group Assignment||Treatment||None (Open Label)||||||
1397834|NCT02320955|||Case-Only||Prospective|||||||
1397835|NCT02320942||Single Group Assignment||Supportive Care||None (Open Label)||||||
1397836|NCT02320929|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1397837|NCT02320916|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1397838|NCT02320903||Single Group Assignment||Treatment||None (Open Label)||||||
1397839|NCT02320890|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397840|NCT02320877||Single Group Assignment||Treatment||None (Open Label)||||||
1397841|NCT02320864|||Cohort||Prospective|||||||
1397842|NCT02320851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397843|NCT02320838|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1397844|NCT02320825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397845|NCT02320812||Single Group Assignment||Treatment||None (Open Label)||||||
1397846|NCT02320799|Randomized|Parallel Assignment||Treatment||Single||||||t
1397847|NCT02320786|Randomized|Parallel Assignment||Treatment||Single||||||t
1397848|NCT02320773|||Other||Prospective|||||||
1397849|NCT02320760|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1397850|NCT02320747|Randomized|Parallel Assignment||||Double|||||t|t
1397851|NCT02320734|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1397852|NCT02320721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397853|NCT02320708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397854|NCT02320695|Randomized|Crossover Assignment||Treatment||Single|||t|||
1397855|NCT02320682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397856|NCT02320669|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1397857|NCT02320656||Single Group Assignment||Basic Science||None (Open Label)||||||
1397858|NCT02320643||Single Group Assignment||Treatment||None (Open Label)||||||
1397859|NCT02320630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397860|NCT02320617||Single Group Assignment||Diagnostic||None (Open Label)||||||
1397861|NCT02320604|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1397862|NCT02320591|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397863|NCT02320578|Randomized|Single Group Assignment||Treatment||Double||||t|t|
1397864|NCT02320565|Randomized|Single Group Assignment||Treatment||Double||||t|t|
1397865|NCT02320552|||Cohort||Prospective|||||||
1397866|NCT02320539|||Case Control||Prospective|||||||
1397867|NCT02320526|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1397868|NCT02320513|||Case Control||Prospective|||||||
1397869|NCT02320500|Randomized|Parallel Assignment||Treatment||Single||||||t
1397870|NCT02320487||Single Group Assignment||Treatment||None (Open Label)||||||
1397871|NCT02320474||Single Group Assignment||Treatment||None (Open Label)||||||
1397872|NCT02320461|||Cohort||Prospective|||||||
1397873|NCT02320448||Single Group Assignment||Treatment||None (Open Label)||||||
1397874|NCT02320435||Single Group Assignment||Treatment||None (Open Label)||||||
1397875|NCT02320422||Single Group Assignment||Treatment||None (Open Label)||||||
1397876|NCT02320409|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1397877|NCT02320396|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397878|NCT02320383||Single Group Assignment||Treatment||None (Open Label)||||||
1397879|NCT02320370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397880|NCT02320357||Single Group Assignment||Treatment||None (Open Label)||||||
1397881|NCT02320344||Single Group Assignment||Supportive Care||None (Open Label)||||||
1397882|NCT02320331||Single Group Assignment||Treatment||None (Open Label)||||||
1397883|NCT02320318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397884|NCT02320305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397885|NCT02320292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397886|NCT02320279|||Cohort||Prospective|||||||
1397887|NCT02320266|||Case-Control||Prospective|||||||
1397888|NCT02320253|Randomized|Parallel Assignment||Treatment||Single||||||t
1397889|NCT02320240|||Cohort||Retrospective|||||||
1397890|NCT02320227||Single Group Assignment||Other||None (Open Label)||||||
1397891|NCT02320214||Single Group Assignment||Screening||None (Open Label)||||||
1397892|NCT02320201||Single Group Assignment||Other||None (Open Label)||||||
1397893|NCT02320188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397894|NCT02320175|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1397895|NCT02320162|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1397896|NCT02320149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397897|NCT02320136|||Case Control||Prospective|||||||
1397898|NCT02320123||Single Group Assignment||Health Services Research||||||||
1397899|NCT02320110|||Cohort||Cross-Sectional|||||||
1397900|NCT02320097||Single Group Assignment||||None (Open Label)||||||
1397901|NCT02320084|||Cohort||Other|||||||
1397902|NCT02320071|||Case-Only||Prospective|||||||
1397903|NCT02320058||Single Group Assignment||Treatment||None (Open Label)||||||
1397904|NCT02320045|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397905|NCT02320032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397906|NCT02320019|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1397907|NCT02320006|Randomized|Parallel Assignment||Treatment||Single|||t|||
1397908|NCT02319993|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1397909|NCT02319980|Randomized|Parallel Assignment||Treatment||Single||||||t
1397910|NCT02319967|Randomized|Parallel Assignment||Treatment||Single||||||t
1397911|NCT02319954|Randomized|Single Group Assignment||Prevention||Single||||||t
1397912|NCT02319941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397913|NCT02319928|Randomized|Parallel Assignment||Prevention||Single|||||t|
1397914|NCT02319915|Randomized|Parallel Assignment||Other||Double|||t||t|
1397915|NCT02319902|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1397916|NCT02319889||Single Group Assignment||Treatment||None (Open Label)||||||
1397917|NCT02319876|||Case Control||Prospective|||||||
1397918|NCT02319863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397919|NCT02319850|||Cohort||Cross-Sectional|||||||
1397920|NCT02319837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397921|NCT02319824||Single Group Assignment||Treatment||None (Open Label)||||||
1397922|NCT02319811|||Case-Only||Prospective|||||||
1397923|NCT02319798|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1397924|NCT02319785|Randomized|Crossover Assignment||Treatment||Single||||||t
1397925|NCT02319772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397926|NCT02319759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397927|NCT02319746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397928|NCT02319733||Single Group Assignment||Prevention||None (Open Label)||||||
1397929|NCT02319720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397930|NCT02319707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397931|NCT02319694|||Other||Other|||||||
1397932|NCT02319681|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397933|NCT02319668|Randomized|Parallel Assignment||Prevention||Single|||||t|
1397934|NCT02319655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397935|NCT02319642||Single Group Assignment||Treatment||None (Open Label)||||||
1397936|NCT02319629|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1397937|NCT02319616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397938|NCT02319603|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397939|NCT02319590|||Cohort||Prospective|||||||
1397940|NCT02319577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397941|NCT02319564|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1397942|NCT02319538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397943|NCT02319525|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1397944|NCT02319512|Randomized|Single Group Assignment||Treatment||Single|||t|||
1397945|NCT02319499|Randomized|Parallel Assignment||||Triple|||t||t|t
1397946|NCT02319486||Single Group Assignment||Treatment||None (Open Label)||||||
1397947|NCT02319473|||Ecologic or Community||Prospective|||||||
1397948|NCT02319460|||Cohort||Other|||||||
1397949|NCT02319447|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1397950|NCT02319434|||Cohort||Prospective|||||||
1397951|NCT02319421||Single Group Assignment||Health Services Research||None (Open Label)||||||
1397952|NCT02319408|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1397953|NCT02319395|||Case-Control||Prospective|||||||
1397954|NCT02319382||Single Group Assignment||Basic Science||None (Open Label)||||||
1397955|NCT02319369|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Parts 1 and 1A are sequential, then Part 2 is parallel||||
1397956|NCT02319356|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1397957|NCT02319343|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1397958|NCT02319330|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1397959|NCT02319317|Randomized|Parallel Assignment||Prevention||Single||||||t
1397960|NCT02319304||Single Group Assignment||Treatment||None (Open Label)||||||
1397961|NCT02319291|||Cohort||Other|||||||
1397962|NCT02319278|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397963|NCT02319265|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1397964|NCT02319252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397965|NCT02319239|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397966|NCT02319226|||Cohort||Prospective|||||||
1397967|NCT02319213|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397968|NCT02319200|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1397969|NCT02319187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397970|NCT02319174||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1397971|NCT02319161|||Case Control||Retrospective|||||||
1397972|NCT02319148|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1397973|NCT02319135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397974|NCT02319122|Randomized|Parallel Assignment||Treatment||Single||||||t
1397975|NCT02319109|||||Prospective|||||||
1397976|NCT02319096||Single Group Assignment||Treatment||None (Open Label)||||||
1397977|NCT02319083|||Cohort||Prospective|||||||
1397978|NCT02319070|||Cohort||Prospective|||||||
1397979|NCT02319057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397980|NCT02319044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397981|NCT02319031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397982|NCT02319018||Single Group Assignment||Treatment||None (Open Label)||||||
1397983|NCT02319005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397984|NCT02318992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397985|NCT02318979|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1397986|NCT02318966|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1397987|NCT02318953|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1397988|NCT02318940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397989|NCT02318927||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1397990|NCT02318914||Single Group Assignment||Treatment||None (Open Label)||||||
1397991|NCT02318901|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397992|NCT02318888|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1397993|NCT02318875|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1397994|NCT02318862|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1397995|NCT02318849|Randomized|Parallel Assignment||Treatment||Single|||||t|
1397996|NCT02318836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1397997|NCT02318823|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1397998|NCT02318810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1397999|NCT02318797|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1398000|NCT02318784||Single Group Assignment||Treatment||None (Open Label)||||||
1398001|NCT02318771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398002|NCT02318758|Randomized|Crossover Assignment||||None (Open Label)||||||
1398003|NCT02318745|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398004|NCT02318732|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398005|NCT02318719|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1398006|NCT02318706|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1398007|NCT02318693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398008|NCT02318680|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398009|NCT02318667||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398010|NCT02318654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398011|NCT02318641|||Cohort||Prospective|||||||
1398012|NCT02318628|||Other||Prospective|||||||
1398013|NCT02318615|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1398014|NCT02318602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398015|NCT02318576|Randomized|Parallel Assignment||||None (Open Label)||||||
1398016|NCT02318563|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398017|NCT02318550|||Other||Prospective|||||||
1398018|NCT02318537|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398019|NCT02318524|||Cohort||Prospective|||||||
1398020|NCT02318511|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398021|NCT02318498|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1398022|NCT02318485||Single Group Assignment||Treatment||None (Open Label)||||||
1398023|NCT02318472|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1398024|NCT02318459|Randomized|Parallel Assignment||||None (Open Label)||||||
1398025|NCT02318446|Randomized|Parallel Assignment||Prevention||Single||||||t
1398026|NCT02318433|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1398027|NCT02318420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398028|NCT02318407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398029|NCT02318394||Single Group Assignment||Treatment||None (Open Label)||||||
1398030|NCT02318381|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398031|NCT02318368|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398032|NCT02318355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398033|NCT02318342||Single Group Assignment||Treatment||None (Open Label)||||||
1398034|NCT02318329|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398035|NCT02318316|||Case-Only||Prospective|||||||
1398036|NCT02318303|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398037|NCT02318290|||Cohort||Prospective|||||||
1398038|NCT02318277||Single Group Assignment||Treatment||None (Open Label)||||||
1398039|NCT02318264|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1398040|NCT02318251|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398041|NCT02318238|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1398042|NCT02318225|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398043|NCT02318212|||Case-Only||Prospective|||||||
1398048|NCT02318147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398049|NCT02318134|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398050|NCT02318121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398051|NCT02318108|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1398052|NCT02318095||Single Group Assignment||Treatment||None (Open Label)||||||
1398053|NCT02318082||Single Group Assignment||Treatment||None (Open Label)||||||
1398054|NCT02318069|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398055|NCT02318056|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1398056|NCT02318043|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1398057|NCT02318030|||Case-Only||Prospective|||||||
1398058|NCT02318017|Randomized|Crossover Assignment||||Double|||t||t|
1398059|NCT02318004||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398060|NCT02317991||Single Group Assignment||Treatment||None (Open Label)||||||
1398061|NCT02317978|||Cohort||Retrospective|||||||
1398062|NCT02317965|||Cohort||Prospective|||||||
1398063|NCT02317952|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1398064|NCT02317939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398065|NCT02317926|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1398066|NCT02317913|||Case-Only||Retrospective|||||||
1398067|NCT02317900|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398068|NCT02317887|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398069|NCT02317874|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398070|NCT02317861|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1398071|NCT02317848||Single Group Assignment||Screening||None (Open Label)||||||
1398072|NCT02317835||Single Group Assignment||||None (Open Label)||||||
1398073|NCT02317809|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398074|NCT02317796|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398075|NCT02317783||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398076|NCT02317770|Randomized|Parallel Assignment||Treatment||Single||||||t
1398077|NCT02317757|||Cohort||Prospective|||||||
1398078|NCT02317744|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398079|NCT02317731|Randomized|Parallel Assignment||||Single|||||t|
1398080|NCT02317718|||Cohort||Prospective|||||||
1398081|NCT02317705||Single Group Assignment||||None (Open Label)||||||
1398082|NCT02317692|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1398083|NCT02317679||Single Group Assignment||Treatment||None (Open Label)||||||
1398084|NCT02317666|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1398085|NCT02317653|||Cohort||Prospective|||||||
1398086|NCT02317640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398087|NCT02317627|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398088|NCT02317614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398089|NCT02317601|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1398090|NCT02317588|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1398091|NCT02317575|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1398092|NCT02317562||Single Group Assignment||Treatment||None (Open Label)||||||
1398093|NCT02317549|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398094|NCT02317536|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1398095|NCT02317523|Randomized|Parallel Assignment||Treatment||Single||||||t
1398096|NCT02317510|Randomized|Parallel Assignment||||None (Open Label)||||||
1398097|NCT02317497|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398098|NCT02317484|||Cohort||Prospective|||||||
1398099|NCT02317471|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398100|NCT02317458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398101|NCT02317445|||Case Control||Retrospective|||||||
1398102|NCT02317432|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398103|NCT02317419|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398104|NCT02317406|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398105|NCT02317393||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398106|NCT02317380|||Ecologic or Community||Cross-Sectional|||||||
1398107|NCT02317367|||Other||Cross-Sectional|||||||
1398108|NCT02317354|||Cohort||Prospective|||||||
1398109|NCT02317341|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1398110|NCT02317328|||Case-Control||Prospective|||||||
1398111|NCT02317315|||Cohort||Prospective|||||||
1398112|NCT02317302||Single Group Assignment||Screening||None (Open Label)||||||
1398113|NCT02317289||Single Group Assignment||Prevention||None (Open Label)||||||
1398114|NCT02317276||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1398115|NCT02317263|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1398116|NCT02317250|Randomized|Factorial Assignment||Diagnostic||Triple|||t|t||t
1398117|NCT02317237|Randomized|Parallel Assignment||Treatment||Single||||||t
1398118|NCT02317224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398119|NCT02317211|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1398120|NCT02317198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398121|NCT02317185|||Cohort||Prospective|||||||
1398122|NCT02317172||Single Group Assignment||Supportive Care||None (Open Label)||||||
1398123|NCT02317159||Single Group Assignment||Treatment||None (Open Label)||||||
1398124|NCT02317146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398125|NCT02317133|||Case-Control||Cross-Sectional|||||||
1398127|NCT02317107|||Cohort||Prospective|||||||
1398128|NCT02317094|Randomized|Parallel Assignment||Treatment||Single||||||t
1398129|NCT02317081||Single Group Assignment||Treatment||None (Open Label)||||||
1398130|NCT02317068|Randomized|Parallel Assignment||Prevention||Single|||t|||
1398131|NCT02317055|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1398132|NCT02317042|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1398133|NCT02317029|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1398134|NCT02317016||Single Group Assignment||Treatment||None (Open Label)||||||
1398135|NCT02317003|Randomized|Parallel Assignment||Prevention||Single||||||t
1398136|NCT02316990|||Case-Only||Retrospective|||||||
1398137|NCT02316977|||Cohort||Prospective|||||||
1398138|NCT02316964||Single Group Assignment||Treatment||None (Open Label)||||||
1398139|NCT02316951|||Case-Only||Prospective|||||||
1398140|NCT02316925|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1398141|NCT02316912|Randomized|Parallel Assignment||||Double|||t||t|
1398142|NCT02316899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398143|NCT02316886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398144|NCT02316873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398145|NCT02316860|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1398146|NCT02316847|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398147|NCT02316834||Single Group Assignment||Treatment||None (Open Label)||||||
1398148|NCT02316821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398149|NCT02316808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398150|NCT02316795||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398151|NCT02316782|||Cohort||Prospective|||||||
1398152|NCT02316769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398153|NCT02316756|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1398154|NCT02316743||Single Group Assignment||Treatment||None (Open Label)||||||
1398155|NCT02316730|Randomized|Crossover Assignment||||None (Open Label)||||||
1398156|NCT02316717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398157|NCT02316704|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398158|NCT02316691|||Cohort||Prospective|||||||
1398159|NCT02316678|||Cohort||Retrospective|||||||
1398160|NCT02316665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398161|NCT02316652|Randomized|Single Group Assignment||Treatment||Single|||||t|
1398162|NCT02316639|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398163|NCT02316626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398164|NCT02316613|||Cohort||Prospective|||||||
1398165|NCT02316600|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398166|NCT02316587|||Cohort||Prospective|||||||
1398167|NCT02316574||Single Group Assignment||Basic Science||None (Open Label)||||||
1398168|NCT02316561||Single Group Assignment||Treatment||None (Open Label)||||||
1398169|NCT02316548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398170|NCT02316535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398171|NCT02316522|||Cohort||Prospective|||||||
1398172|NCT02316509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398173|NCT02316496||Single Group Assignment||Treatment||None (Open Label)||||||
1398174|NCT02316483|||Cohort||Prospective|||||||
1398175|NCT02316470|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398176|NCT02316457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398177|NCT02316444|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1398178|NCT02316431|||Case-Only||Prospective|||||||
1398179|NCT02316418||Single Group Assignment||Supportive Care||None (Open Label)||||||
1398180|NCT02316405||Single Group Assignment||||None (Open Label)||||||
1398181|NCT02316392|||Case-Only||Prospective|||||||
1398182|NCT02316379||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398183|NCT02316366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398184|NCT02316353|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398185|NCT02316340|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398186|NCT02316327||Single Group Assignment||Treatment||None (Open Label)||||||
1398187|NCT02316314|||Case-Control||Cross-Sectional|||||||
1398188|NCT02316301|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398189|NCT02316288|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1398190|NCT02316275|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398191|NCT02316262||Single Group Assignment||Treatment||None (Open Label)||||||
1398192|NCT02316249|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1398193|NCT02316236|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1398194|NCT02316223|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398195|NCT02316210||Single Group Assignment||Basic Science||None (Open Label)||||||
1398196|NCT02316197||Single Group Assignment||Treatment||None (Open Label)||||||
1398197|NCT02316184|Randomized|Parallel Assignment||Prevention||Single||||||t
1398198|NCT02316171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398199|NCT02316158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398200|NCT02316145||Single Group Assignment||Treatment||None (Open Label)||||||
1398201|NCT02316132|Non-Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1398202|NCT02316119|||Case Control||Prospective|||||||
1398203|NCT02316106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398204|NCT02316093|||Case Control||Prospective|||||||
1398205|NCT02316080|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1398206|NCT02316067|Randomized|Parallel Assignment||Treatment||Single||||||t
1398207|NCT02316054|||Cohort||Prospective|||||||
1398208|NCT02316041||Single Group Assignment||Treatment||None (Open Label)||||||
1398209|NCT02316028||Single Group Assignment||Treatment||None (Open Label)||||||
1398210|NCT02316015|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1398211|NCT02316002||Single Group Assignment||Treatment||||||||
1398212|NCT02315989||Single Group Assignment||Treatment||None (Open Label)||||||
1398213|NCT02315976||Single Group Assignment||Treatment||None (Open Label)||||||
1398214|NCT02315963|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1398215|NCT02315950||Single Group Assignment||Other||None (Open Label)||||||
1398216|NCT02315937|||Case-Only||Prospective|||||||
1398217|NCT02315924|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398218|NCT02315911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398219|NCT02315898||Single Group Assignment||Treatment||None (Open Label)||||||
1398220|NCT02315885|||Case-Crossover||Prospective|||||||
1398221|NCT02315872|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398222|NCT02315859|||Case-Only||Prospective|||||||
1398223|NCT02315846|||Case-Control||Prospective|||||||
1398224|NCT02315833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398225|NCT02315820|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398226|NCT02315807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398227|NCT02315794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398228|NCT02315781|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1398229|NCT02315768||Single Group Assignment||Treatment||None (Open Label)||||||
1398230|NCT02315755|||Other||Prospective|||||||
1398231|NCT02315742||Single Group Assignment||Treatment||None (Open Label)||||||
1398232|NCT02315729|||Cohort||Prospective|||||||
1398233|NCT02315716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398234|NCT02315703|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1398235|NCT02315690|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398236|NCT02315677|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1398237|NCT02315664|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1398238|NCT02315651|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1398239|NCT02315638|||Case-Only||Prospective|||||||
1398240|NCT02315625|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398241|NCT02315612|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1398242|NCT02315599|||Cohort||Prospective|||||||
1398243|NCT02315586|||Case-Control||Cross-Sectional|||||||
1398244|NCT02315573|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1398245|NCT02315560||Single Group Assignment||Treatment||None (Open Label)||||||
1398246|NCT02315547||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398247|NCT02315534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398248|NCT02315521|||Cohort||Prospective|||||||
1398249|NCT02315508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398250|NCT02315495|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398251|NCT02315482|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1398252|NCT02315469||||||||||||
1398253|NCT02315456|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1398254|NCT02315443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398255|NCT02315430||Single Group Assignment||Treatment||None (Open Label)||||||
1398256|NCT02315417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398257|NCT02315404|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1398258|NCT02315391|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1398259|NCT02315378|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398260|NCT02315365|||Cohort||Prospective|||||||
1398261|NCT02315352|Randomized|Crossover Assignment||||None (Open Label)||||||
1398262|NCT02315339|||Cohort||Prospective|||||||
1398263|NCT02315326||Single Group Assignment||Treatment||None (Open Label)||||||
1398264|NCT02315313|||Case-Only||Retrospective|||||||
1398265|NCT02315300||Single Group Assignment||Prevention||None (Open Label)||||||
1398266|NCT02315287|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398267|NCT02315274||Single Group Assignment||Treatment||None (Open Label)||||||
1398268|NCT02315261|||Cohort||Prospective|||||||
1398269|NCT02315248|||Cohort||Prospective|||||||
1398270|NCT02315235|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398271|NCT02315222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398272|NCT02315209|||Cohort||Prospective|||||||
1398273|NCT02315196||Single Group Assignment||Treatment||None (Open Label)||||||
1398274|NCT02315183|||Cohort||Prospective|||||||
1398275|NCT02315170|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1398276|NCT02315157|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398277|NCT02315144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398278|NCT02315131|Randomized|Parallel Assignment||||Double|||t||t|
1398279|NCT02315118||Single Group Assignment||Treatment||None (Open Label)||||||
1398280|NCT02315105||Single Group Assignment||Treatment||None (Open Label)||||||
1398281|NCT02315092|||Case-Only||Prospective|||||||
1398282|NCT02315079|||Cohort||Prospective|||||||
1398283|NCT02315066|Non-Randomized|||Treatment||None (Open Label)|Open-label|||||
1398284|NCT02315053||Single Group Assignment||Treatment||None (Open Label)||||||
1398285|NCT02315040|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398286|NCT02315027||Single Group Assignment||Treatment||None (Open Label)||||||
1398287|NCT02315014|Randomized|Parallel Assignment||||None (Open Label)||||||
1398288|NCT02315001|Randomized|Crossover Assignment||||Triple|||t||t|t
1398289|NCT02314988|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398290|NCT02314975|Randomized|Parallel Assignment||Treatment||Single||||||t
1398291|NCT02314962|||Case-Only||Prospective|||||||
1398292|NCT02314949|||Cohort||Retrospective|||||||
1398293|NCT02314936|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1398294|NCT02314923|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398295|NCT02314910|||Case-Only||Prospective|||||||
1398296|NCT02314897|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398297|NCT02314884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398298|NCT02314871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398299|NCT02314858|Randomized|Parallel Assignment||Treatment||Single|||||t|
1398300|NCT02314845|Randomized|Parallel Assignment||Prevention||Single|||t|||
1398301|NCT02314832|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398302|NCT02314819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398303|NCT02314806|Randomized|Parallel Assignment||Prevention||Single|||t|||
1398304|NCT02314793|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1398305|NCT02314780|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398306|NCT02314767|Randomized|Parallel Assignment||Treatment||Single|||||t|
1398307|NCT02314754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398308|NCT02314741||Single Group Assignment||Treatment||None (Open Label)||||||
1398309|NCT02314728|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398310|NCT02314715|||Case Control||Cross-Sectional|||||||
1398311|NCT02314702|||Cohort||Prospective|||||||
1398312|NCT02314689||Single Group Assignment||Treatment||None (Open Label)||||||
1398313|NCT02314676||Single Group Assignment||Treatment||None (Open Label)||||||
1398314|NCT02314663|Randomized|Parallel Assignment||Treatment||Single||||||t
1398315|NCT02314650|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1398316|NCT02314637|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398317|NCT02314624|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1398318|NCT02314611|||Cohort||Prospective|||||||
1398319|NCT02314598|||Cohort||Prospective|||||||
1398320|NCT02314585|Randomized|Parallel Assignment||||Single||||||t
1398321|NCT02314572||Single Group Assignment||Treatment||None (Open Label)||||||
1398322|NCT02314559|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1398323|NCT02314546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398324|NCT02314533||Single Group Assignment||Treatment||None (Open Label)||||||
1398325|NCT02314520|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1398326|NCT02314507|Randomized|Crossover Assignment||Treatment||Single||||||t
1398327|NCT02314494|||||Prospective|||||||
1398328|NCT02314481|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398329|NCT02314468|Randomized|Parallel Assignment||Treatment||Single||||||t
1398330|NCT02314455||Single Group Assignment||Basic Science||None (Open Label)||||||
1398331|NCT02314442|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398332|NCT02314429||Single Group Assignment||||None (Open Label)||||||
1398333|NCT02314416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398334|NCT02314403||Single Group Assignment||Treatment||None (Open Label)||||||
1398335|NCT02314390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398336|NCT02314377||Single Group Assignment||Treatment||None (Open Label)||||||
1398337|NCT02314364||Single Group Assignment||Treatment||None (Open Label)||||||
1398338|NCT02314351|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1398339|NCT02314338||Single Group Assignment||Health Services Research||None (Open Label)||||||
1398340|NCT02314325|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1398341|NCT02314312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398342|NCT02314299|Non-Randomized|||Treatment||None (Open Label)||||||
1398343|NCT02314286|Randomized|Single Group Assignment||Treatment||Single|||t|||
1398344|NCT02314273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398345|NCT02314260|||Case-Only||Prospective|||||||
1398346|NCT02314247||Single Group Assignment||Treatment||None (Open Label)||||||
1398347|NCT02314234|||Case-Only||Retrospective|||||||
1398348|NCT02314221|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398349|NCT02314208|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398350|NCT02314195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398351|NCT02314182|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1398352|NCT02314169||Parallel Assignment||Treatment||None (Open Label)||||||
1398353|NCT02314156|Randomized|Parallel Assignment||Prevention||Single|||t|||
1398354|NCT02314143|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1398355|NCT02314130|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398356|NCT02314117|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398357|NCT02314104|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398358|NCT02314091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398359|NCT02314078|||Cohort||Retrospective|||||||
1398360|NCT02314065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398361|NCT02314052||Single Group Assignment||Treatment||None (Open Label)||||||
1398362|NCT02314039|||Cohort||Cross-Sectional|||||||
1398363|NCT02314026||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398364|NCT02314013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398365|NCT02314000|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398366|NCT02313987|||Case Control||Prospective|||||||
1398367|NCT02313974|||Cohort||Prospective|||||||
1398368|NCT02313961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398369|NCT02313935|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1398370|NCT02313922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398371|NCT02313909|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398372|NCT02313896|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398373|NCT02313883|Randomized|Parallel Assignment||Treatment||Single||||||t
1398374|NCT02313870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398375|NCT02313857||Single Group Assignment||Treatment||None (Open Label)||||||
1398376|NCT02313844||Single Group Assignment||Treatment||None (Open Label)||||||
1398377|NCT02313831|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1398378|NCT02313818||Single Group Assignment||Treatment||None (Open Label)||Variable length Cognitive Processing Therapy||||
1398379|NCT02313805|Randomized|Single Group Assignment||||None (Open Label)||||||
1398380|NCT02313792|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1398381|NCT02313779|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1398382|NCT02313766|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1398383|NCT02313753|Randomized|Parallel Assignment||Treatment||Single||||||t
1398384|NCT02313740|||Cohort||Prospective|||||||
1398385|NCT02313727|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1398386|NCT02313714|Randomized|Single Group Assignment||Treatment||Single|||t|||
1398387|NCT02313701|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1398388|NCT02313688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398389|NCT02313675|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1398390|NCT02313662|||Case-Only||Prospective|||||||
1398391|NCT02313649|||Case-Only||Cross-Sectional|||||||
1398392|NCT02313636|||Case-Only||Prospective|||||||
1398393|NCT02313623|||Cohort||Prospective|||||||
1398394|NCT02313610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398395|NCT02313597|Randomized|Parallel Assignment||Treatment||Single||||||t
1398396|NCT02313584|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398397|NCT02313571|||Cohort||Retrospective|||||||
1398398|NCT02313558|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1398399|NCT02313545||Single Group Assignment||Treatment||None (Open Label)||||||
1398400|NCT02313532|||Cohort||Retrospective|||||||
1398401|NCT02313519|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1398402|NCT02313506|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||This study used a delayed control design.||||
1398403|NCT02313493|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1398404|NCT02313480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398405|NCT02313467|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398406|NCT02313454||||||||||||
1398407|NCT02313441|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1398408|NCT02313428|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1398409|NCT02313415||Single Group Assignment||Treatment||None (Open Label)||treatment of infertility caused by recurrent intrauterine adhesions by collagen scaffold loaded with UC-MSCs||||
1398410|NCT02313402||Single Group Assignment||||None (Open Label)||||||
1398411|NCT02313389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398412|NCT02313376||Single Group Assignment||Basic Science||None (Open Label)||||||
1398413|NCT02313363||Single Group Assignment||||None (Open Label)||||||
1398414|NCT02313350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398415|NCT02313337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398416|NCT02313324|Randomized|Parallel Assignment||Treatment||Single||||||t
1398417|NCT02313311|||Cohort|||||||||
1398418|NCT02313298||Single Group Assignment||Treatment||None (Open Label)||||||
1398419|NCT02313285|||Cohort||Prospective|||||||
1398420|NCT02313272||Single Group Assignment||Treatment||None (Open Label)||||||
1398421|NCT02313259|||Other||Prospective|||||||
1398422|NCT02313246||Single Group Assignment||Treatment||None (Open Label)||||||
1398423|NCT02313233|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398424|NCT02313220|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398425|NCT02313207|Non-Randomized|Crossover Assignment||Treatment||Double|||t||t|
1398426|NCT02313194|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398427|NCT02313181|Randomized|Parallel Assignment||Prevention||Single||||||t
1398428|NCT02313168|||Case-Only||Prospective|||||||
1398429|NCT02313155|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398430|NCT02313142||Single Group Assignment||Basic Science||None (Open Label)||||||
1398431|NCT02313129|||Case-Control||Prospective|||||||
1398432|NCT02313116|||Cohort||Prospective|||||||
1398433|NCT02313103|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1398434|NCT02313090|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1398435|NCT02313077|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1398436|NCT02313064|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1398437|NCT02313051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398438|NCT02313038|||Cohort||Prospective|||||||
1398439|NCT02313025|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398440|NCT02313012||Single Group Assignment||Treatment||None (Open Label)||||||
1398441|NCT02312999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398442|NCT02312986||Single Group Assignment||Treatment||None (Open Label)||||||
1398443|NCT02312973|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1398444|NCT02312960||Single Group Assignment||Other||None (Open Label)||||||
1398445|NCT02312947|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1398446|NCT02312934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398447|NCT02312921|||Cohort||Prospective|||||||
1398448|NCT02312908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398449|NCT02312895|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1398450|NCT02312882||Single Group Assignment||Treatment||None (Open Label)||||||
1398451|NCT02312869|||Cohort||Prospective|||||||
1398452|NCT02312856||Single Group Assignment||Treatment||None (Open Label)||||||
1398453|NCT02312843|Randomized|Parallel Assignment||Prevention||Single||||||t
1398454|NCT02312830|||Cohort||Cross-Sectional|||||||
1398455|NCT02312817|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1398456|NCT02312804|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398457|NCT02312791|||Cohort||Prospective|||||||
1398458|NCT02312778|Randomized|Parallel Assignment||Treatment||Single|||||t|
1398459|NCT02312765||Single Group Assignment||Supportive Care||None (Open Label)||||||
1398460|NCT02312752||Single Group Assignment||Other||None (Open Label)||||||
1398461|NCT02312739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398462|NCT02312726|||Case-Only||Cross-Sectional|||||||
1398463|NCT02312713|Randomized|Parallel Assignment||Treatment||Single||||||t
1398464|NCT02312700|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1398465|NCT02312687||Single Group Assignment||Treatment||None (Open Label)||||||
1398466|NCT02312674|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398467|NCT02312661||Single Group Assignment||Treatment||None (Open Label)||||||
1398468|NCT02312648|Randomized|Parallel Assignment||Prevention||Single||||||t
1398469|NCT02312635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398470|NCT02312622||Single Group Assignment||Treatment||None (Open Label)||||||
1398471|NCT02312609|Randomized|Crossover Assignment||||None (Open Label)||||||
1398472|NCT02312596|Randomized|Parallel Assignment||Treatment||Single||||||t
1398473|NCT02312583|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398474|NCT02312570|Randomized|Parallel Assignment||Treatment||Single||||||t
1398475|NCT02312557||Single Group Assignment||Treatment||None (Open Label)||||||
1398476|NCT02312544|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398477|NCT02312531|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398478|NCT02312518|Randomized|Parallel Assignment||Treatment||Single||||||t
1398479|NCT02312505||Single Group Assignment||||None (Open Label)||||||
1398480|NCT02312492|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1398481|NCT02312479||Single Group Assignment||Treatment||None (Open Label)||||||
1398482|NCT02312466|||Other||Cross-Sectional|||||||
1398483|NCT02312453||Single Group Assignment||||None (Open Label)||||||
1398484|NCT02312440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398485|NCT02312427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398486|NCT02312414|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398487|NCT02312401||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398488|NCT02312388|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398489|NCT02312375|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398490|NCT02312362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398491|NCT02312349|||Ecologic or Community||Cross-Sectional|||||||
1398492|NCT02312336|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398493|NCT02312323||||||||||||
1398494|NCT02312310|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1398495|NCT02312297|Randomized|Crossover Assignment||||None (Open Label)||||||
1398496|NCT02312284|||Cohort||Retrospective|||||||
1398497|NCT02312271|||Cohort||Prospective|||||||
1398498|NCT02312258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398499|NCT02312245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398500|NCT02312232|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398501|NCT02312219|||Cohort||Prospective|||||||
1398502|NCT02312206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398503|NCT02312193|||Case-Control||Prospective|||||||
1398504|NCT02312180|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398505|NCT02312167||Single Group Assignment||Treatment||None (Open Label)||||||
1398506|NCT02312154|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1398507|NCT02312141||||||||||||
1398508|NCT02312128|Randomized|Parallel Assignment||Treatment||Single||||||t
1398509|NCT02312115|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398510|NCT02312102||Single Group Assignment||Treatment||None (Open Label)||||||
1398511|NCT02312089|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398512|NCT02312076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398513|NCT02312063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398514|NCT02312050|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1398515|NCT02312037||||||||||||
1398516|NCT02312024|||Case-Only||Prospective|||||||
1398596|NCT02310984|||Cohort||Cross-Sectional|||||||
1398517|NCT02312011|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398518|NCT02311998||Single Group Assignment||Treatment||None (Open Label)||||||
1398519|NCT02311985|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1398520|NCT02311972|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398521|NCT02311959||Single Group Assignment||Treatment||None (Open Label)||||||
1398522|NCT02311946|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1398523|NCT02311933|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398524|NCT02311920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398525|NCT02311907|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1398526|NCT02311894||Single Group Assignment||Treatment||None (Open Label)||||||
1398527|NCT02311881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398528|NCT02311868|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398529|NCT02311855||Single Group Assignment||Basic Science||None (Open Label)||||||
1398530|NCT02311842|||Case-Crossover||Prospective|||||||
1398531|NCT02311829|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398532|NCT02311816|||Case Control||Retrospective|||||||
1398533|NCT02311803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398534|NCT02311790|Randomized|Crossover Assignment||Other||Double|||t||t|
1398535|NCT02311777|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1398536|NCT02311764||Single Group Assignment||Treatment||None (Open Label)||||||
1398537|NCT02311751|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398538|NCT02311738|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1398539|NCT02311725|Randomized|Parallel Assignment||Treatment||Single||||||t
1398540|NCT02311712|Randomized|Parallel Assignment||Screening||Single||||||t
1398541|NCT02311699|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398542|NCT02311686|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1398543|NCT02311673|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1398544|NCT02311660||Single Group Assignment||Treatment||None (Open Label)||||||
1398545|NCT02311647|||Case Control||Prospective|||||||
1398546|NCT02311634|Randomized|Parallel Assignment||Treatment||Single||||||t
1398547|NCT02311621|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398548|NCT02311608|||Cohort||Prospective|||||||
1398549|NCT02311595||Single Group Assignment||Treatment||None (Open Label)||||||
1398550|NCT02311582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398551|NCT02311569||Single Group Assignment||Treatment||None (Open Label)||||||
1398552|NCT02311556||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398553|NCT02311543|Randomized|Parallel Assignment||Other||Single|||t|||
1398554|NCT02311530|Randomized|Crossover Assignment||||None (Open Label)||||||
1398555|NCT02311517|Randomized|Parallel Assignment||||Double|||t|t||
1398556|NCT02311504|||Cohort||Prospective|||||||
1398557|NCT02311491|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1398558|NCT02311478||Single Group Assignment||Supportive Care||None (Open Label)||||||
1398559|NCT02311465|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398560|NCT02311452|||Cohort||Retrospective|||||||
1398561|NCT02311439||Single Group Assignment||Treatment||None (Open Label)||||||
1398562|NCT02311426|||Cohort||Prospective|||||||
1398563|NCT02311413|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398564|NCT02311400|||Other||Prospective|||||||
1398565|NCT02311387|||Cohort||Prospective|||||||
1398566|NCT02311374|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1398567|NCT02311361|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1398568|NCT02311348|||Case-Control||Prospective|||||||
1398569|NCT02311335|||Family-Based||Prospective|||||||
1398570|NCT02311322|||Family-Based||Cross-Sectional|||||||
1398571|NCT02311309|||Cohort||Prospective|||||||
1398572|NCT02311296|||Case Control||Prospective|||||||
1398573|NCT02311283|||Cohort||Cross-Sectional|||||||
1398574|NCT02311270|||Cohort||Cross-Sectional|||||||
1398575|NCT02311257|||Cohort||Cross-Sectional|||||||
1398576|NCT02311244|||Cohort||Prospective|||||||
1398577|NCT02311231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398578|NCT02311218|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1398579|NCT02311205||Single Group Assignment||Treatment||None (Open Label)||||||
1398580|NCT02311192||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398581|NCT02311179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398582|NCT02311166|||Cohort||Prospective|||||||
1398583|NCT02311153|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398584|NCT02311140|||Cohort||Prospective|||||||
1398585|NCT02311127|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398586|NCT02311114|||Other||Other|||||||
1398587|NCT02311101|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398588|NCT02311088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398589|NCT02311075|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1398590|NCT02311062|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398591|NCT02311049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398592|NCT02311036|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1398593|NCT02311023||Single Group Assignment||Treatment||None (Open Label)||||||
1398594|NCT02311010|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398595|NCT02310997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398597|NCT02310971||Single Group Assignment||Treatment||None (Open Label)||||||
1398598|NCT02310958|||Cohort||Prospective|||||||
1398599|NCT02310945|||Cohort||Prospective|||||||
1398600|NCT02310932|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398601|NCT02310919|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398602|NCT02310906|Randomized|Parallel Assignment||Treatment||Quadruple|Masking Description: Part 1 is double-blind and randomized; Part 2 is open-label.||t|t|t|t
1398603|NCT02310893|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1398604|NCT02310880|||Case Control||Prospective|||||||
1398605|NCT02310867||Single Group Assignment||Treatment||None (Open Label)||||||
1398606|NCT02310854|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1398607|NCT02310841||Single Group Assignment||Basic Science||None (Open Label)||||||
1398608|NCT02310828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398609|NCT02310815|||Case-Only||Prospective|||||||
1398610|NCT02310802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398611|NCT02310789||Single Group Assignment||Basic Science||None (Open Label)||||||
1398612|NCT02310776||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398613|NCT02310763|Randomized|||Treatment||Quadruple|||t|t|t|t
1398614|NCT02310750|Randomized|Parallel Assignment||||Triple|||t||t|t
1398615|NCT02310737|Randomized|Parallel Assignment||||Double|||t||t|
1398616|NCT02310724|||Cohort||Prospective|||||||
1398617|NCT02310711|||Case-Only||Prospective|||||||
1398618|NCT02310698|||Cohort||Prospective|||||||
1398619|NCT02310685|Randomized|Parallel Assignment||Prevention||Single|||t|||
1398620|NCT02310672||Single Group Assignment||Treatment||None (Open Label)||||||
1398621|NCT02310659|||Cohort||Prospective|||||||
1398622|NCT02310646|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1398623|NCT02310633|Randomized|Crossover Assignment||Treatment||Single||||||t
1398624|NCT02310620||Single Group Assignment||Prevention||None (Open Label)||||||
1398625|NCT02310607|||||Prospective|||||||
1398626|NCT02310594|||Cohort||Prospective|||||||
1398627|NCT02310581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398628|NCT02310568|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398629|NCT02310555|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398630|NCT02310542|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398631|NCT02310529|Randomized|Parallel Assignment||Treatment||Single||||||t
1398632|NCT02310516|Randomized|Parallel Assignment||||None (Open Label)||||||
1398633|NCT02310503|||Cohort||Prospective|||||||
1398634|NCT02310490|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1398635|NCT02310477|||Cohort|||||||||
1398636|NCT02310464|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1398637|NCT02310451||Single Group Assignment||Screening||None (Open Label)||||||
1398638|NCT02310438|Randomized|Crossover Assignment||Treatment||Single||||||t
1398639|NCT02310425|Randomized|Parallel Assignment||Treatment||Single|||||t|
1398640|NCT02310412|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1398641|NCT02310399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398642|NCT02310386|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1398643|NCT02310373||Single Group Assignment||||None (Open Label)||||||
1398644|NCT02310360|||Cohort||Cross-Sectional|||||||
1398645|NCT02310347|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1398646|NCT02310334|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1398647|NCT02310321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398648|NCT02310308|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398649|NCT02310295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398650|NCT02310282|||Cohort||Prospective|||||||
1398651|NCT02310269|||Other||Prospective|||||||
1398652|NCT02310256|Randomized|Parallel Assignment||Treatment||Single||||||t
1398653|NCT02310243||Single Group Assignment||Treatment||None (Open Label)||||||
1398654|NCT02310230|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1398655|NCT02310217|||Other||Cross-Sectional|||||||
1398656|NCT02310204|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398657|NCT02310191|||Case-Only||Prospective|||||||
1398658|NCT02310178||Single Group Assignment||Basic Science||None (Open Label)||||||
1398659|NCT02310165|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398660|NCT02310152|Randomized|Parallel Assignment||Treatment||Single||||||t
1398661|NCT02310139|||Cohort||Prospective|||||||
1398662|NCT02310126|Randomized|Crossover Assignment||Other||Single|||t|||
1398663|NCT02310113|||Cohort||Prospective|||||||
1398664|NCT02310100||Single Group Assignment||Treatment||None (Open Label)||||||
1398665|NCT02310087|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398666|NCT02310074|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398667|NCT02310061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398668|NCT02310048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398669|NCT02310035|||Cohort||Prospective|||||||
1398670|NCT02310022|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398671|NCT02310009|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1398672|NCT02309996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398673|NCT02309983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398674|NCT02309970|||Cohort||Prospective|||||||
1398675|NCT02309957|||Case-Only||Prospective|||||||
1398676|NCT02309944|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398677|NCT02309931|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1398678|NCT02309918||Single Group Assignment||Treatment||None (Open Label)||||||
1398679|NCT02309905|||Case Control||Retrospective|||||||
1398680|NCT02309892||Single Group Assignment||Treatment||None (Open Label)||||||
1398681|NCT02309879|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398682|NCT02309866|||Case-Only||Cross-Sectional|||||||
1398683|NCT02309853|Randomized|Parallel Assignment||Treatment||Single||||||t
1398684|NCT02309840|Randomized|Factorial Assignment||||None (Open Label)||||||
1398685|NCT02309827|Randomized|||Treatment||Double|||t||t|
1398686|NCT02309814||Single Group Assignment||Basic Science||None (Open Label)||||||
1398687|NCT02309801|Randomized|Crossover Assignment||||None (Open Label)||||||
1398688|NCT02309788|||Cohort||Retrospective|||||||
1398689|NCT02309775|Randomized|Single Group Assignment||Treatment||Single|||t|||
1398690|NCT02309762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398691|NCT02309749|||Cohort||Prospective|||||||
1398692|NCT02309736|||Case-Only||Prospective|||||||
1398693|NCT02309723|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1398694|NCT02309710||Single Group Assignment||||None (Open Label)||||||
1398695|NCT02309697|||Cohort||Prospective|||||||
1398696|NCT02309684|||Case-Only||Prospective|||||||
1398697|NCT02309671|Randomized|Parallel Assignment||Treatment||Single||||||t
1398698|NCT02309658||Single Group Assignment||Treatment||None (Open Label)||||||
1398699|NCT02309645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398700|NCT02309632|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1398701|NCT02309619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398702|NCT02309606|||Case-Control||Cross-Sectional|||||||
1398703|NCT02309593|||Cohort||Prospective|||||||
1398704|NCT02309580||Single Group Assignment||Treatment||None (Open Label)||||||
1398705|NCT02309567|||Case Control||Prospective|||||||
1398706|NCT02309554|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1398707|NCT02309541|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1398708|NCT02309528||Single Group Assignment||||None (Open Label)||||||
1398709|NCT02309515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398710|NCT02309502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398711|NCT02309489|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1398712|NCT02309476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398713|NCT02309463|||Cohort||Prospective|||||||
1398714|NCT02309450||Single Group Assignment||Treatment||None (Open Label)||||||
1398715|NCT02309437|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398716|NCT02309424|Randomized|Crossover Assignment||||None (Open Label)||||||
1398717|NCT02309411||Single Group Assignment||Treatment||None (Open Label)||||||
1398718|NCT02309398|||Case-Control||Retrospective|||||||
1398719|NCT02309385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398720|NCT02309372|Randomized|Parallel Assignment||Treatment||Single||||||t
1398721|NCT02309359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398722|NCT02309346|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398723|NCT02309333|||Cohort||Prospective|||||||
1398724|NCT02309320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398725|NCT02309307||Single Group Assignment||Treatment||None (Open Label)||||||
1398726|NCT02309294||Single Group Assignment||||None (Open Label)||||||
1398727|NCT02309281||Single Group Assignment||Treatment||None (Open Label)||||||
1398728|NCT02309268|||Case-Only||Prospective|||||||
1398729|NCT02309255|||Cohort||Retrospective|||||||
1398730|NCT02309242||Single Group Assignment||Screening||None (Open Label)||||||
1398731|NCT02309229|||Cohort||Prospective|||||||
1398732|NCT02309216|||Cohort||Prospective|||||||
1398733|NCT02309203||Single Group Assignment||Treatment||None (Open Label)||||||
1398734|NCT02309190|||Cohort||Prospective|||||||
1398735|NCT02309177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398736|NCT02309164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398737|NCT02309151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398738|NCT02309138|Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1398739|NCT02309125|Randomized|Single Group Assignment||Supportive Care||Single||||t||
1398740|NCT02309112|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398741|NCT02309099||Single Group Assignment||Treatment||None (Open Label)||||||
1398742|NCT02309086||Single Group Assignment||Treatment||None (Open Label)||||||
1398743|NCT02309073|||Cohort||Prospective|||||||
1398744|NCT02309060||Single Group Assignment||Treatment||None (Open Label)||||||
1398745|NCT02309047|||Cohort||Cross-Sectional|||||||
1398746|NCT02309034|Randomized|Parallel Assignment||Treatment||Single||||||t
1398747|NCT02309021|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398748|NCT02309008|Randomized|Parallel Assignment||||Double|||t||t|
1398749|NCT02308995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398750|NCT02308982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398751|NCT02308969||Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1398752|NCT02308956|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1398753|NCT02308930|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1398754|NCT02308917|||Cohort||Prospective|||||||
1398755|NCT02308904|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1398756|NCT02308891|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1398757|NCT02308878|Randomized|Parallel Assignment||Treatment||Single||||||t
1398758|NCT02308865|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398759|NCT02308852|Randomized|Crossover Assignment||Treatment||Quadruple||tDCS real versus sham tDCS|t|t|t|t
1398760|NCT02308839|||Cohort||Prospective|||||||
1398761|NCT02308826|Randomized|Parallel Assignment||Treatment||Single||||||t
1398762|NCT02308813|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1398763|NCT02308800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398764|NCT02308787|||Case-Only||Retrospective|||||||
1398765|NCT02308774|||Cohort||Prospective|||||||
1398766|NCT02308761||Single Group Assignment||Treatment||None (Open Label)||||||
1398767|NCT02308748|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1398768|NCT02308735|||Case Control||Prospective|||||||
1398769|NCT02308722||Single Group Assignment||Treatment||None (Open Label)||||||
1398770|NCT02308709||Single Group Assignment||Treatment||None (Open Label)||||||
1398771|NCT02308696|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398772|NCT02308683||Single Group Assignment||Supportive Care||None (Open Label)||||||
1398773|NCT02308670|||Cohort||Prospective|||||||
1398774|NCT02308657|||Cohort||Prospective|||||||
1398775|NCT02308644|Randomized|Crossover Assignment||Treatment||Single|||||t|
1398776|NCT02308631||Single Group Assignment||Treatment||None (Open Label)||||||
1398777|NCT02308618|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398778|NCT02308605|||Case Control||Prospective|||||||
1398779|NCT02308592|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1398780|NCT02308579|||Case Control||Retrospective|||||||
1398781|NCT02308566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398782|NCT02308553|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1398783|NCT02308540|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398784|NCT02308527|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1398785|NCT02308514|Randomized|Parallel Assignment||Treatment||Single||||t||
1398786|NCT02308501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398787|NCT02308488||Single Group Assignment||Treatment||None (Open Label)||||||
1398788|NCT02308475||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398789|NCT02308462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398790|NCT02308449|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1398791|NCT02308436||Single Group Assignment||Prevention||None (Open Label)||||||
1398792|NCT02308423|||Cohort||Retrospective|||||||
1398793|NCT02308410|||Cohort||Prospective|||||||
1398794|NCT02308397|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1398795|NCT02308384|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1398796|NCT02308371|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1398797|NCT02308358|||Cohort||Prospective|||||||
1398798|NCT02308345||Single Group Assignment||Health Services Research||None (Open Label)||||||
1398799|NCT02308332|Randomized|Parallel Assignment||Treatment||Single||||||t
1398800|NCT02308319|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398801|NCT02308306|||Cohort||Prospective|||||||
1398802|NCT02308293|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1398803|NCT02308280||Single Group Assignment||Treatment||None (Open Label)||||||
1398804|NCT02308267|||Cohort||Prospective|||||||
1398805|NCT02308254|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1398806|NCT02308241||Single Group Assignment||Treatment||None (Open Label)||||||
1398807|NCT02308228|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1398808|NCT02308215|||Case-Only||Prospective|||||||
1398809|NCT02308202|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1398810|NCT02308189|Randomized|Parallel Assignment||Treatment||Single||||||t
1398811|NCT02308176|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1398812|NCT02308163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398813|NCT02308150|||Cohort||Prospective|||||||
1398814|NCT02308137||Single Group Assignment||Treatment||None (Open Label)||||||
1398815|NCT02308124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398816|NCT02308111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398817|NCT02308098|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1398818|NCT02308085||Single Group Assignment||Treatment||None (Open Label)||||||
1398819|NCT02308072||Single Group Assignment||Treatment||None (Open Label)||||||
1398820|NCT02308059|||||Cross-Sectional|||||||
1398821|NCT02308046|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398822|NCT02308033|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398823|NCT02308020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398824|NCT02308007|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398825|NCT02307994|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398826|NCT02307981|||Case Control||Prospective|||||||
1398827|NCT02307968|||Case Control||Prospective|||||||
1398828|NCT02307955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398829|NCT02307942|Randomized|Parallel Assignment||Treatment||Single||||||t
1398830|NCT02307929|||Cohort||Prospective|||||||
1398831|NCT02307916|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1398832|NCT02307903|||Cohort||Prospective|||||||
1398833|NCT02307890|||Cohort||Prospective|||||||
1398834|NCT02307877|||Case-Control||Prospective|||||||
1398835|NCT02307864|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1398836|NCT02307851|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1398837|NCT02307838||Single Group Assignment||Other||None (Open Label)||||||
1398838|NCT02307825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398839|NCT02307812||||||||||||
1398840|NCT02307799|||Cohort||Prospective|||||||
1398841|NCT02307786|||Cohort||Retrospective|||||||
1398842|NCT02307773|||Case Control||Retrospective|||||||
1398843|NCT02307760|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1398844|NCT02307747||Single Group Assignment||Prevention||None (Open Label)||||||
1398845|NCT02307734|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1398846|NCT02307721|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398847|NCT02307708|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1398848|NCT02307695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398849|NCT02307682|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1398850|NCT02307669|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1398851|NCT02307656||Single Group Assignment||Other||None (Open Label)||||||
1398852|NCT02307643|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398853|NCT02307630||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398854|NCT02307617|||Case-Control||Other|||||||
1398855|NCT02307604|||Cohort||Prospective|||||||
1398856|NCT02307591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398857|NCT02307578||||||||||||
1398858|NCT02307565|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1398859|NCT02307552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398860|NCT02307539||Single Group Assignment||Supportive Care||None (Open Label)||||||
1398861|NCT02307526||Single Group Assignment||Treatment||None (Open Label)||||||
1398862|NCT02307513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398863|NCT02307500||Single Group Assignment||Treatment||None (Open Label)||||||
1398864|NCT02307487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1398865|NCT02307474||Single Group Assignment||Treatment||None (Open Label)||||||
1398866|NCT02307461|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1398867|NCT02307448|Randomized|Parallel Assignment||Treatment||Single||||||t
1398868|NCT02307435||Single Group Assignment||Treatment||None (Open Label)||||||
1398869|NCT02307422|||Case-Control||Retrospective|||||||
1398870|NCT02307409|||Case-Control||Prospective|||||||
1398871|NCT02307396|Randomized|Parallel Assignment||Treatment||Single||||||t
1398872|NCT02307383||Single Group Assignment||Treatment||None (Open Label)||||||
1398873|NCT02307370||Single Group Assignment||Treatment||None (Open Label)||||||
1398874|NCT02307357|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1398875|NCT02307344|Randomized|Parallel Assignment||Treatment||Single|||||t|
1398876|NCT02307331|Randomized|Parallel Assignment||Treatment||Single|||t|||
1398877|NCT02307318||Single Group Assignment||Supportive Care||None (Open Label)||||||
1398878|NCT02307305|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1398879|NCT02307292|||Cohort||Prospective|||||||
1398880|NCT02307279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398881|NCT02307266|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1398882|NCT02307253||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398883|NCT02307240||Single Group Assignment||Treatment||None (Open Label)||||||
1398884|NCT02307227|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398885|NCT02307214|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1398886|NCT02307201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398887|NCT02307188||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398888|NCT02307175|||Case-Control||Prospective|||||||
1398889|NCT02307162|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1398890|NCT02307149||Single Group Assignment||Treatment||None (Open Label)||||||
1398891|NCT02307136|||Cohort||Retrospective|||||||
1398892|NCT02307123|||Cohort||Retrospective|||||||
1398893|NCT02307110||Single Group Assignment||Diagnostic||None (Open Label)||||||
1398894|NCT02307097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398895|NCT02307084|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398896|NCT02307071||Single Group Assignment||Treatment||None (Open Label)||||||
1398897|NCT02307058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398898|NCT02307045|Randomized|Parallel Assignment||Prevention||Single|||||t|
1398899|NCT02307032|||Cohort||Prospective|||||||
1398900|NCT02307019|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1398901|NCT02307006|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1398902|NCT02306993|||Case-Control||Prospective|||||||
1398903|NCT02306980|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1398904|NCT02306967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398905|NCT02306954|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398906|NCT02306941||Single Group Assignment||Treatment||None (Open Label)||||||
1398907|NCT02306928|||Case-Only||Prospective|||||||
1398908|NCT02306915|Randomized|Parallel Assignment||||Triple|||t||t|t
1398909|NCT02306902|Randomized|Crossover Assignment||||None (Open Label)||||||
1398910|NCT02306889|Randomized|Crossover Assignment||||None (Open Label)||||||
1398911|NCT02306876|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1398912|NCT02306863|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1398913|NCT02306850||Single Group Assignment||Treatment||None (Open Label)||||||
1398995|NCT02305771||Single Group Assignment||Other||None (Open Label)||||||
1398914|NCT02306837||Single Group Assignment||Treatment||None (Open Label)||||||
1398915|NCT02306824|||Cohort||Prospective|||||||
1398916|NCT02306811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398917|NCT02306798||Single Group Assignment||Basic Science||None (Open Label)||||||
1398918|NCT02306785|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1398919|NCT02306772|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1398920|NCT02306759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398921|NCT02306746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398922|NCT02306733|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398923|NCT02306720|||Case-Control||Prospective|||||||
1398924|NCT02306707|||Cohort||Prospective|||||||
1398925|NCT02306694||Single Group Assignment||Treatment||None (Open Label)||||||
1398926|NCT02306681|||Cohort||Prospective|||||||
1398927|NCT02306668|||Case Control||Prospective|||||||
1398928|NCT02306655|||Case-Only||Retrospective|||||||
1398929|NCT02306642|||Cohort||Retrospective|||||||
1398930|NCT02306629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398931|NCT02306616|||Case-Only||Retrospective|||||||
1398932|NCT02306603|||Cohort||Prospective|||||||
1398933|NCT02306590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398934|NCT02306577|||||Prospective|||||||
1398935|NCT02306564|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1398936|NCT02306551|||Case Control||Prospective|||||||
1398937|NCT02306538|||Cohort||Prospective|||||||
1398938|NCT02306525|||Cohort||Prospective|||||||
1398939|NCT02306512|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1398940|NCT02306499|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398941|NCT02306486|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398942|NCT02306473|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1398943|NCT02306460|||Case-Control||Prospective|||||||
1398944|NCT02306447||Single Group Assignment||Treatment||None (Open Label)||||||
1398945|NCT02306434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398946|NCT02306421|Randomized|Single Group Assignment||Treatment||Single|||t|||
1398947|NCT02306395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398948|NCT02306382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398949|NCT02306369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398950|NCT02306356||Single Group Assignment||Treatment||None (Open Label)||||||
1398951|NCT02306343|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398952|NCT02306330|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1398953|NCT02306317|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1398954|NCT02306304||Single Group Assignment||Screening||None (Open Label)||||||
1398955|NCT02306291|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1398956|NCT02306278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398957|NCT02306265|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1398958|NCT02306252|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1398959|NCT02306239|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1398960|NCT02306226|||Cohort||Prospective|||||||
1398961|NCT02306213|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398962|NCT02306200|||Case-Control||Prospective|||||||
1398963|NCT02306187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1398964|NCT02306174||Single Group Assignment||Treatment||None (Open Label)||||||
1398965|NCT02306161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398966|NCT02306148|Randomized|Parallel Assignment||Prevention||Single|||||t|
1398967|NCT02306135|||Case-Only||Prospective|||||||
1398968|NCT02306122|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1398969|NCT02306109|Randomized|Parallel Assignment||Treatment||Single|||||t|
1398970|NCT02306096|||Cohort||Prospective|||||||
1398971|NCT02306083|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1398972|NCT02306070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398973|NCT02306057|||Case-Only||Prospective|||||||
1398974|NCT02306044|||Cohort||Prospective|||||||
1398975|NCT02306031|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398976|NCT02306018|||Case-Only||Prospective|||||||
1398977|NCT02306005|||Case-Only||Prospective|||||||
1398978|NCT02305992|Randomized|Parallel Assignment||Treatment||Single||||||t
1398979|NCT02305979|||Cohort||Prospective|||||||
1398980|NCT02305966|Randomized|Parallel Assignment||Prevention||Single|||t|||
1398981|NCT02305953|||Cohort||Retrospective|||||||
1398982|NCT02305940|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398983|NCT02305927|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1398984|NCT02305914||||||||||||
1398985|NCT02305901||Single Group Assignment||Treatment||None (Open Label)||||||
1398986|NCT02305888|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398987|NCT02305875||Single Group Assignment||Basic Science||None (Open Label)||||||
1398988|NCT02305862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398989|NCT02305849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398990|NCT02305836|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1398991|NCT02305823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1398992|NCT02305810||Single Group Assignment||Basic Science||None (Open Label)||||||
1398993|NCT02305797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1398994|NCT02305784|||Cohort||Prospective|||||||
1398996|NCT02305758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1398997|NCT02305745|||Cohort||Prospective|||||||
1398998|NCT02305732|||Cohort||Prospective|||||||
1398999|NCT02305719|||Case-Only||Prospective|||||||
1399000|NCT02305706|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1399001|NCT02305693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399002|NCT02305680|||Cohort||Prospective|||||||
1399003|NCT02305667|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1399004|NCT02305654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399005|NCT02305641|||Cohort||Prospective|||||||
1399006|NCT02305628|||Cohort||Prospective|||||||
1399007|NCT02305615|||Cohort||Prospective|||||||
1399008|NCT02305602||Single Group Assignment||Treatment||None (Open Label)||||||
1399009|NCT02305589|||Cohort||Retrospective|||||||
1399010|NCT02305576|||Cohort||Prospective|||||||
1399011|NCT02305563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399012|NCT02305550||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1399013|NCT02305537|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1399014|NCT02305524|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399015|NCT02305511|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399016|NCT02305498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399017|NCT02305485|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399018|NCT02305472||Single Group Assignment||Treatment||None (Open Label)||||||
1399019|NCT02305459|||Other||Prospective|||||||
1399020|NCT02305446||Single Group Assignment||Prevention||None (Open Label)||||||
1399021|NCT02305433|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399022|NCT02305420|Randomized|Crossover Assignment||Treatment||Quadruple||Randomised control trial comparing EmbryoGen/ BlastGen media use with standard media in IVF|t|t|t|t
1399023|NCT02305407|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1399024|NCT02305394|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399025|NCT02305381|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399026|NCT02305368|||Cohort||Prospective|||||||
1399027|NCT02305355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399028|NCT02305342|||Case-Only||Cross-Sectional|||||||
1399029|NCT02305329|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399030|NCT02305316|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399031|NCT02305303|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399032|NCT02305290|||Cohort||Retrospective|||||||
1399033|NCT02305277|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399034|NCT02305264||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399035|NCT02305251|||Other||Prospective|||||||
1399036|NCT02305238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399037|NCT02305225|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1399038|NCT02305212|Randomized|Crossover Assignment||Treatment||Single||||||t
1399039|NCT02305199|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1399040|NCT02305186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399041|NCT02305173|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1399042|NCT02305160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399043|NCT02305147|||Cohort||Prospective|||||||
1399044|NCT02305134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399045|NCT02305121|||Case-Only||Prospective|||||||
1399046|NCT02305108|Randomized|Parallel Assignment||Treatment||Single||||||t
1399047|NCT02305095|||Cohort||Prospective|||||||
1399048|NCT02305082|||Case Control||Prospective|||||||
1399049|NCT02305069|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1399050|NCT02305056||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399051|NCT02305043|||Cohort||Prospective|||||||
1399052|NCT02305030|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399053|NCT02305017|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399054|NCT02305004|||Cohort||Prospective|||||||
1399055|NCT02304991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399056|NCT02304978|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1399057|NCT02304965||Single Group Assignment||Treatment||None (Open Label)||||||
1399058|NCT02304952|Randomized|Parallel Assignment||Treatment||Single|||||t|
1399059|NCT02304939|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399060|NCT02304926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399061|NCT02304913|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399062|NCT02304900|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399063|NCT02304887|||Case-Only||Retrospective|||||||
1399064|NCT02304874||Single Group Assignment||||None (Open Label)||||||
1399065|NCT02304861|Randomized|Parallel Assignment||||Single||||||t
1399066|NCT02304848||Single Group Assignment||Treatment||None (Open Label)||||||
1399067|NCT02304835|||Cohort||Prospective|||||||
1399068|NCT02304822|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1399069|NCT02304809||Single Group Assignment||Treatment||None (Open Label)||||||
1399070|NCT02304796|Randomized|Parallel Assignment||Treatment||Single||||||t
1399071|NCT02304783|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1399072|NCT02304770|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399073|NCT02304757|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399074|NCT02304744|||Cohort||Prospective|||||||
1399075|NCT02304731||Single Group Assignment||Health Services Research||None (Open Label)||||||
1399076|NCT02304718|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399077|NCT02304705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399078|NCT02304692|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399079|NCT02304679|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399080|NCT02304666|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1399081|NCT02304653|||Cohort||Prospective|||||||
1399082|NCT02304640|||Cohort||Prospective|||||||
1399083|NCT02304627|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399084|NCT02304614|||Cohort||Cross-Sectional|||||||
1399085|NCT02304601|||Cohort||Prospective|||||||
1399086|NCT02304588||Single Group Assignment||Treatment||None (Open Label)||||||
1399087|NCT02304575|||Case-Control||Prospective|||||||
1399088|NCT02304562||Single Group Assignment||Treatment||None (Open Label)||||||
1399089|NCT02304549|||Cohort||Prospective|||||||
1399090|NCT02304536|Randomized|Parallel Assignment||Treatment||Single||||t||
1399091|NCT02304523|Randomized|Parallel Assignment||Treatment||Single||||||t
1399092|NCT02304510|||Cohort||Cross-Sectional|||||||
1399093|NCT02304497|||Case Control||Prospective|||||||
1399094|NCT02304484||Single Group Assignment||Treatment||None (Open Label)||||||
1399095|NCT02304471|||Case Control||Prospective|||||||
1399096|NCT02304458||Single Group Assignment||Treatment||None (Open Label)||||||
1399097|NCT02304445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399098|NCT02304432|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1399099|NCT02304419||Single Group Assignment||Basic Science||None (Open Label)||||||
1399100|NCT02304406|||Other||Retrospective|||||||
1399101|NCT02304393|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1399102|NCT02304380|||Other||Other|||||||
1399103|NCT02304367||Single Group Assignment||Treatment||None (Open Label)||||||
1399104|NCT02304354||Single Group Assignment||Treatment||None (Open Label)||||||
1399105|NCT02304341|||Cohort||Prospective|||||||
1399106|NCT02304328|||Case-Control||Prospective|||||||
1399107|NCT02304315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399108|NCT02304302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399109|NCT02304289||Single Group Assignment||Treatment||None (Open Label)||||||
1399110|NCT02304276|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1399111|NCT02304263|||Cohort||Prospective|||||||
1399112|NCT02304250|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399113|NCT02304237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399114|NCT02304224|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1399115|NCT02304211|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1399116|NCT02304198||Single Group Assignment||Treatment||None (Open Label)||||||
1399117|NCT02304185|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1399118|NCT02304172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399119|NCT02304159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399120|NCT02304146|||Cohort||Prospective|||||||
1399121|NCT02304133|Randomized|Parallel Assignment||||Single||||||t
1399122|NCT02304120|Randomized|Parallel Assignment||Treatment||Single||||||t
1399123|NCT02304107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399124|NCT02304094|Randomized|Parallel Assignment||Treatment||Single||||||t
1399125|NCT02304081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399126|NCT02304068||||||||||||
1399127|NCT02304055|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399128|NCT02304042|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1399129|NCT02304029||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399130|NCT02304016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399131|NCT02304003|Randomized|Parallel Assignment||Treatment||Single||||||t
1399132|NCT02303990||||Treatment||||||||
1399133|NCT02303977||||Treatment||||||||
1399134|NCT02303964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399135|NCT02303951||Single Group Assignment||Treatment||None (Open Label)||||||
1399136|NCT02303938|Randomized|Single Group Assignment||Treatment||Single|||||t|
1399137|NCT02303925||Single Group Assignment||Treatment||None (Open Label)||||||
1399138|NCT02303912||Single Group Assignment||Treatment||None (Open Label)||||||
1399139|NCT02303899||Single Group Assignment||Treatment||None (Open Label)||||||
1399140|NCT02303886|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1399141|NCT02303873||Single Group Assignment||Treatment||None (Open Label)||||||
1399142|NCT02303860|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399143|NCT02303847|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399144|NCT02303834|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399145|NCT02303821|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399146|NCT02303808|Randomized|Crossover Assignment||Treatment||Single||||||t
1399147|NCT02303795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399148|NCT02303782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399149|NCT02303769|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399150|NCT02303756||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399151|NCT02303743|Randomized|Parallel Assignment||Prevention||Single||||t||
1399152|NCT02303730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399153|NCT02303717|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399154|NCT02303704|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399155|NCT02303691|Randomized|Parallel Assignment||Treatment||Double||Completer analyses focused on prediction of active ABM outcomes using neural measures. Control arm used for effect size comparisons.|t|||t
1399156|NCT02303678||Single Group Assignment||Treatment||None (Open Label)||||||
1399157|NCT02303665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399158|NCT02303652|||Cohort||Prospective|||||||
1399159|NCT02303639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399160|NCT02303626|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399161|NCT02303613|||Cohort||Prospective|||||||
1399162|NCT02303600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399163|NCT02303587|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399164|NCT02303574|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1399165|NCT02303561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399166|NCT02303548|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399167|NCT02303535|||Cohort||Prospective|||||||
1399168|NCT02303522|||Cohort||Retrospective|||||||
1399169|NCT02303509|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1399170|NCT02303496|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1399171|NCT02303483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399172|NCT02303470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399173|NCT02303457|Randomized|Factorial Assignment||Treatment||Single|||||t|
1399174|NCT02303444|||Cohort||Prospective|||||||
1399175|NCT02303431|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1399176|NCT02303418|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1399177|NCT02303405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399178|NCT02303392||Single Group Assignment||Treatment||None (Open Label)||||||
1399179|NCT02303379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399180|NCT02303366||Single Group Assignment||Treatment||None (Open Label)||||||
1399181|NCT02303353|||Cohort||Retrospective|||||||
1399182|NCT02303340|||||Prospective|||||||
1399183|NCT02303327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399184|NCT02303314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399185|NCT02303301|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1399186|NCT02303288|||Cohort||Prospective|||||||
1399187|NCT02303275||Single Group Assignment||Prevention||None (Open Label)||||||
1399188|NCT02303262||Single Group Assignment||Treatment||None (Open Label)||||||
1399189|NCT02303249|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399190|NCT02303236|||Cohort||Prospective|||||||
1399191|NCT02303223||Single Group Assignment||Health Services Research||None (Open Label)||||||
1399192|NCT02303210|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1399193|NCT02303197|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399194|NCT02303184|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1399195|NCT02303171|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399196|NCT02303158|||Cohort||Prospective|||||||
1399197|NCT02303145|||Case Control||Cross-Sectional|||||||
1399198|NCT02303132|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1399199|NCT02303119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399200|NCT02303106|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1399201|NCT02303093|||Cohort||Prospective|||||||
1399202|NCT02303080|Randomized|Crossover Assignment||||Triple|||t||t|t
1399203|NCT02303067|||Case-Only||Prospective|||||||
1399204|NCT02303054||Single Group Assignment||Treatment||None (Open Label)||||||
1399205|NCT02303041|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Cohort assignment based on disease status.||||
1399206|NCT02303028||Single Group Assignment||Treatment||None (Open Label)||||||
1399207|NCT02303015|||Cohort||Retrospective|||||||
1399208|NCT02303002|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399209|NCT02302989|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1399210|NCT02302976|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1399211|NCT02302963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399212|NCT02302950|||Other||Retrospective|||||||
1399213|NCT02302937|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1399214|NCT02302924|||Cohort||Prospective|||||||
1399215|NCT02302911|||Other||Prospective|||||||
1399216|NCT02302898|||Case-Control||Cross-Sectional|||||||
1399217|NCT02302885|||Cohort||Prospective|||||||
1399218|NCT02302872||Single Group Assignment||Treatment||None (Open Label)||||||
1399219|NCT02302859|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399220|NCT02302846||Single Group Assignment||Treatment||None (Open Label)||||||
1399221|NCT02302833||Single Group Assignment||Treatment||None (Open Label)||||||
1399222|NCT02302820|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1399223|NCT02302807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399224|NCT02302794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399225|NCT02302781|||Cohort||Prospective|||||||
1399226|NCT02302768|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399227|NCT02302755||Single Group Assignment||Treatment||None (Open Label)||||||
1399228|NCT02302742|||Cohort||Prospective|||||||
1399229|NCT02302729|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1399230|NCT02302716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399231|NCT02302703|Randomized|Crossover Assignment||Treatment||||||||
1399232|NCT02302690|||Cohort||Prospective|||||||
1399233|NCT02302677|||Cohort||Prospective|||||||
1399234|NCT02302664|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1399235|NCT02302651||Single Group Assignment||Treatment||None (Open Label)||||||
1399236|NCT02302638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399237|NCT02302625||Single Group Assignment||Treatment||None (Open Label)||||||
1399238|NCT02302612|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1399239|NCT02302599|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1399240|NCT02302586|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399241|NCT02302573||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399242|NCT02302560|||Cohort||Prospective|||||||
1399243|NCT02302547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399244|NCT02302534|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1399245|NCT02302521|||Case-Control||Prospective|||||||
1399246|NCT02302508|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1399247|NCT02302495||Single Group Assignment||Treatment||None (Open Label)||||||
1399248|NCT02302482||Single Group Assignment||Health Services Research||None (Open Label)||||||
1399249|NCT02302469||Single Group Assignment||Treatment||None (Open Label)||||||
1399250|NCT02302456|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399251|NCT02302443|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399252|NCT02302430|Randomized|Parallel Assignment||Other||Triple||SOLO arm and ECHO arm -- Acquainted, Unacquainted|t||t|t
1399253|NCT02302417||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399254|NCT02302404|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1399255|NCT02302391|||Cohort||Prospective|||||||
1399256|NCT02302378|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1399257|NCT02302365|||Case-Only||Retrospective|||||||
1399258|NCT02302352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399259|NCT02302339|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399260|NCT02302326|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399261|NCT02302313||Single Group Assignment||Supportive Care||Single|||t|||
1399262|NCT02302300|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399263|NCT02302287|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399264|NCT02302274||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399265|NCT02302261|||||Prospective|||||||
1399266|NCT02302248|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1399267|NCT02302235|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399268|NCT02302222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399269|NCT02302209|Randomized|Crossover Assignment||Other||Double|||t||t|
1399270|NCT02302196|||Case-Control||Prospective|||||||
1399271|NCT02302183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399272|NCT02302170|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1399273|NCT02302157||Single Group Assignment||Treatment||None (Open Label)||||||
1399274|NCT02302144|Randomized|Crossover Assignment||Treatment||Single||||||t
1399275|NCT02302131|||Case-Only||Other|||||||
1399276|NCT02302118|||Cohort||Retrospective|||||||
1399277|NCT02302105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399278|NCT02302092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399279|NCT02302079|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399280|NCT02302066|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1399281|NCT02302053|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399282|NCT02302040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399283|NCT02302027||Single Group Assignment||Treatment||None (Open Label)||||||
1399284|NCT02302014|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1399285|NCT02302001||Single Group Assignment||Treatment||Single|||t|||
1399286|NCT02301988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399287|NCT02301975|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399288|NCT02301962||Single Group Assignment||Treatment||None (Open Label)||||||
1399289|NCT02301949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399290|NCT02301936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399291|NCT02301923|||Cohort||Retrospective|||||||
1399292|NCT02301910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399293|NCT02301897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399294|NCT02301884||Single Group Assignment||Treatment||None (Open Label)||||||
1399295|NCT02301871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399296|NCT02301858||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399297|NCT02301845||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399298|NCT02301832|||Cohort||Prospective|||||||
1399299|NCT02301819|Randomized|Parallel Assignment||Treatment||Single||||||t
1399300|NCT02301806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399301|NCT02301793|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1399302|NCT02301780|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399303|NCT02301767|||Case-Control||Prospective|||||||
1399304|NCT02301754||Single Group Assignment||Treatment||None (Open Label)||||||
1399305|NCT02301741|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1399306|NCT02301728|||Case-Only||Prospective|||||||
1399307|NCT02301715|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1399308|NCT02301702|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1399309|NCT02301689|||Cohort||Prospective|||||||
1399310|NCT02301676|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1399311|NCT02301663|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1399312|NCT02301650|||Case Control||Prospective|||||||
1399313|NCT02301637|||||Prospective|||||||
1399314|NCT02301624||Single Group Assignment||Treatment||None (Open Label)||||||
1399315|NCT02301611|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1399316|NCT02301598||Single Group Assignment||Treatment||None (Open Label)||||||
1399317|NCT02301585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399318|NCT02301572|||Cohort||Retrospective|||||||
1399319|NCT02301559||Single Group Assignment||Treatment||None (Open Label)||||||
1399320|NCT02301546|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1399321|NCT02301533|Randomized|Parallel Assignment||Other||Single||||||t
1399322|NCT02301520|||Ecologic or Community||Cross-Sectional|||||||
1399323|NCT02301507||Single Group Assignment||Supportive Care||None (Open Label)||||||
1399324|NCT02301494|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1399325|NCT02301481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399326|NCT02301468|Randomized|Parallel Assignment||Treatment||Single|||||t|
1399327|NCT02301455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399328|NCT02301442|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1399329|NCT02301429||Single Group Assignment||Treatment||None (Open Label)||||||
1399330|NCT02301416||Single Group Assignment||Treatment||None (Open Label)||||||
1399331|NCT02301403|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399332|NCT02301390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399333|NCT02301377|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1399334|NCT02301364||Single Group Assignment||Treatment||None (Open Label)||||||
1399335|NCT02301351|Randomized|Factorial Assignment||Other||Single|||t|||
1399336|NCT02301338|||Cohort||Prospective|||||||
1399337|NCT02301325|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1399338|NCT02301312||Single Group Assignment||Treatment||None (Open Label)||||||
1399339|NCT02301299||Single Group Assignment||Health Services Research||None (Open Label)||||||
1399340|NCT02301286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399341|NCT02301273|Randomized|Parallel Assignment||Treatment||Single||||||t
1399342|NCT02301260|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399343|NCT02301247|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399344|NCT02301234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399345|NCT02301221||Single Group Assignment||Treatment||None (Open Label)||||||
1399346|NCT02301208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399347|NCT02301195|Randomized|Parallel Assignment||Other||Single||||||t
1399348|NCT02301182|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399349|NCT02301169|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1399350|NCT02301156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399351|NCT02301143||Single Group Assignment||Treatment||None (Open Label)||||||
1399352|NCT02301130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399353|NCT02301117|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399354|NCT02301104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399355|NCT02301091|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399356|NCT02301078|||Case Control||Prospective|||||||
1399357|NCT02301065|||Cohort||Prospective|||||||
1399358|NCT02301052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399359|NCT02301039|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399360|NCT02301026|||Cohort||Prospective|||||||
1399361|NCT02301013||Single Group Assignment||Treatment||None (Open Label)||||||
1399362|NCT02301000|Randomized|Parallel Assignment||Treatment||Single||||||t
1399363|NCT02300987|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1399364|NCT02300974||||||||||||
1399365|NCT02300961||Single Group Assignment||Supportive Care||None (Open Label)||||||
1399366|NCT02300948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399367|NCT02300935||Single Group Assignment||Treatment||None (Open Label)||||||
1399368|NCT02300922||Single Group Assignment||||None (Open Label)||||||
1399369|NCT02300909|Randomized|Parallel Assignment||Prevention||Single|||t|||
1399370|NCT02300896|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1399371|NCT02300883|||Case-Only||Prospective|||||||
1399372|NCT02300870|||Case-Control||Prospective|||||||
1399373|NCT02300857|Randomized|Parallel Assignment||Basic Science||Single||||||t
1399374|NCT02300844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399375|NCT02300831|||Cohort||Prospective|||||||
1399376|NCT02300818|Randomized|Single Group Assignment||Treatment||Single|||||t|
1399377|NCT02300805|||Case-Only||Prospective|||||||
1399378|NCT02300792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399379|NCT02300779|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1399380|NCT02300766|||Cohort||Prospective|||||||
1399381|NCT02300753||||||||||||
1399382|NCT02300740|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399383|NCT02300727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399384|NCT02300714|Randomized|Parallel Assignment||||Single|||t|||
1399385|NCT02300701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399386|NCT02300688|Randomized|Crossover Assignment||||None (Open Label)||||||
1399387|NCT02300675|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399388|NCT02300662|Randomized|Parallel Assignment||Treatment||Single||||||t
1399389|NCT02300649|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1399390|NCT02300636|Randomized|Parallel Assignment||Treatment||Single||||||t
1399391|NCT02300623|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399392|NCT02300610||Single Group Assignment||Treatment||None (Open Label)||||||
1399393|NCT02300597|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399394|NCT02300584|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1399395|NCT02300571|||Case-Only||Other|||||||
1399396|NCT02300558|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1399397|NCT02300545||Single Group Assignment||Treatment||None (Open Label)||||||
1399398|NCT02300532|||Cohort||Prospective|||||||
1399399|NCT02300519|||Cohort||Prospective|||||||
1399400|NCT02300506|||Cohort||Prospective|||||||
1399401|NCT02300493|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399402|NCT02300480|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399403|NCT02300467||Single Group Assignment||Treatment||None (Open Label)||||||
1399404|NCT02300454|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399405|NCT02300441|||Cohort||Prospective|||||||
1399406|NCT02300428|||Cohort||Retrospective|||||||
1399407|NCT02300415|||Case-Only||Prospective|||||||
1399408|NCT02300402|||Other||Prospective|||||||
1399409|NCT02300389|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399410|NCT02300376||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399411|NCT02300363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399412|NCT02300350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399413|NCT02300337||Single Group Assignment||Treatment||None (Open Label)||||||
1399414|NCT02300324|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1399415|NCT02300311|Randomized|Parallel Assignment||Treatment||Double||||||
1399416|NCT02300298||Single Group Assignment||Treatment||None (Open Label)||||||
1399417|NCT02300285|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1399418|NCT02300272|||Cohort||Prospective|||||||
1399419|NCT02300259|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1399420|NCT02300246|Randomized|Parallel Assignment||Prevention||Single|||t|||
1399421|NCT02300233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399422|NCT02300220|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399423|NCT02300207|Randomized|Parallel Assignment||Prevention||Single||||||t
1399424|NCT02300194|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399425|NCT02300181|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1399426|NCT02300168|||Case-Only||Prospective|||||||
1399427|NCT02300155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399428|NCT02300142|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1399429|NCT02300129|Randomized|Crossover Assignment||Treatment||Single|||||t|
1399430|NCT02300116|||||Prospective|||||||
1399431|NCT02300103||Single Group Assignment||Treatment||None (Open Label)||||||
1399432|NCT02300090|||Other||Other|||||||
1399433|NCT02300077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399434|NCT02300064|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1399435|NCT02300051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399436|NCT02300038|Randomized|Crossover Assignment||||Double|||t||t|
1399437|NCT02300025|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1399438|NCT02300012|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399439|NCT02299999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399440|NCT02299986|||Cohort||Prospective|||||||
1399441|NCT02299973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399442|NCT02299960|||Case Control||Prospective|||||||
1399443|NCT02299947|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399444|NCT02299934||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399445|NCT02299921|||Cohort||Prospective|||||||
1399446|NCT02299908|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399447|NCT02299895|||||Retrospective|||||||
1399448|NCT02299882|Randomized|Single Group Assignment||Prevention||Single|||t|||
1399449|NCT02299869|Randomized|Parallel Assignment||Other||Double|||t||t|
1399450|NCT02299856|||Case Control||Prospective|||||||
1399451|NCT02299843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399452|NCT02299830|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399453|NCT02299817|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1399454|NCT02299804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399455|NCT02299791|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1399456|NCT02299778||Single Group Assignment||Basic Science||None (Open Label)||||||
1399457|NCT02299765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399458|NCT02299752|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399459|NCT02299739|||Cohort||Retrospective|||||||
1399460|NCT02299726|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1399461|NCT02299713|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1399462|NCT02299700|||Cohort||Prospective|||||||
1399463|NCT02299687|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1399464|NCT02299674|||Case-Control||Prospective|||||||
1399465|NCT02299661|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1399466|NCT02299648||Single Group Assignment||Screening||None (Open Label)||||||
1399467|NCT02299635||||Treatment||None (Open Label)||||||
1399468|NCT02299622|||Cohort||Prospective|||||||
1399469|NCT02299609|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1399470|NCT02299596|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1399471|NCT02299583|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399472|NCT02299570|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1399473|NCT02299557|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1399474|NCT02299544||Single Group Assignment||Treatment||None (Open Label)||||||
1399475|NCT02299531|Randomized|Crossover Assignment||||None (Open Label)||||||
1399476|NCT02299518|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399477|NCT02299505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399478|NCT02299492|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1399479|NCT02299479||Single Group Assignment||Prevention||None (Open Label)||||||
1399480|NCT02299466|||Cohort||Prospective|||||||
1399481|NCT02299453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399482|NCT02299440|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399483|NCT02299427|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399484|NCT02299414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399485|NCT02299401|Randomized|Parallel Assignment||Treatment||Single|||||t|
1399486|NCT02299388|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399487|NCT02299375|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399488|NCT02299362|||Cohort||Prospective|||||||
1399489|NCT02299349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399490|NCT02299336||Single Group Assignment||Treatment||None (Open Label)||||||
1399491|NCT02299323|||Case-Only||Prospective|||||||
1399492|NCT02299310|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399493|NCT02299297||Single Group Assignment||Treatment||None (Open Label)||||||
1399494|NCT02299284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399495|NCT02299271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399496|NCT02299258|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399497|NCT02299245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399498|NCT02299232|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1399499|NCT02299219|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1399500|NCT02299206|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1399501|NCT02299193|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399502|NCT02299180|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1399503|NCT02299167|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1399504|NCT02299154|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1399505|NCT02299141||Single Group Assignment||Treatment||None (Open Label)||||||
1399506|NCT02299128|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1399507|NCT02299115|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399508|NCT02299102|Randomized|Parallel Assignment||Basic Science||Single||||||t
1399509|NCT02299089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399510|NCT02299076|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399511|NCT02299063|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399512|NCT02299050||Single Group Assignment||Treatment||None (Open Label)||||||
1399513|NCT02299037|||Cohort||Prospective|||||||
1399514|NCT02299024|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1399515|NCT02299011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399516|NCT02298998|||Cohort||Prospective|||||||
1399517|NCT02298985|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1399518|NCT02298972|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1399519|NCT02298959||Single Group Assignment||Treatment||None (Open Label)||||||
1399520|NCT02298946||Single Group Assignment||Treatment||None (Open Label)||||||
1399521|NCT02298933||Single Group Assignment||Treatment||None (Open Label)||||||
1399522|NCT02298920|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1399523|NCT02298907|||Case-Only||Prospective|||||||
1399524|NCT02298894|||Case-Only||Prospective|||||||
1399525|NCT02298881|||Case Control||Prospective|||||||
1399526|NCT02298868||Single Group Assignment||Treatment||None (Open Label)||||||
1399527|NCT02298855|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399528|NCT02298842|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1399529|NCT02298829|||Cohort||Prospective|||||||
1399530|NCT02298816|||Cohort||Prospective|||||||
1399531|NCT02298803||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399532|NCT02298790|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1399533|NCT02298777|||Case-Control||Prospective|||||||
1399534|NCT02298764|Randomized|Parallel Assignment||Treatment||Single||||||t
1399535|NCT02298751|Randomized|Parallel Assignment||Treatment||Single|||||t|
1399536|NCT02298738|||Case Control||Prospective|||||||
1399537|NCT02298725|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1399538|NCT02298712|||Cohort||Prospective|||||||
1399539|NCT02298699|||Cohort||Prospective|||||||
1399540|NCT02298686|||Cohort||Prospective|||||||
1399541|NCT02298673|||Cohort||Prospective|||||||
1399542|NCT02298660||Single Group Assignment||Prevention||None (Open Label)||||||
1399543|NCT02298647|||Cohort||Prospective|||||||
1399544|NCT02298634|||Cohort||Prospective|||||||
1399545|NCT02298621|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1399546|NCT02298608||Single Group Assignment||Treatment||None (Open Label)||||||
1399547|NCT02298595|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399548|NCT02298582||Single Group Assignment||Treatment||None (Open Label)||||||
1399549|NCT02298569|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1399550|NCT02298556|||Case-Only||Prospective|||||||
1399551|NCT02298543|||Cohort||Prospective|||||||
1399552|NCT02298530|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1399553|NCT02298517|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1399554|NCT02298504|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399555|NCT02298491||Single Group Assignment||Treatment||None (Open Label)||||||
1399556|NCT02298478|Randomized|Factorial Assignment||Treatment||Single|||||t|
1399557|NCT02298465|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1399558|NCT02298452||Single Group Assignment||||Single|||t|||
1399559|NCT02298439|||Cohort||Prospective|||||||
1399560|NCT02298426|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1399561|NCT02298413|||Cohort||Prospective|||||||
1399562|NCT02298400|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1399563|NCT02298387||Single Group Assignment||Treatment||None (Open Label)||||||
1399564|NCT02298374|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399565|NCT02298361|||||Prospective|||||||
1399566|NCT02298348||Single Group Assignment||Treatment||None (Open Label)||||||
1399567|NCT02298335||Single Group Assignment||Treatment||None (Open Label)||||||
1399568|NCT02298322||Single Group Assignment||||None (Open Label)||||||
1399569|NCT02298309|Randomized|Parallel Assignment||Other||Single|||t|||
1399570|NCT02298296|||Cohort||Prospective|||||||
1399571|NCT02298283||Single Group Assignment||Treatment||None (Open Label)||||||
1399572|NCT02298270|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1399573|NCT02298257||Single Group Assignment||Treatment||None (Open Label)||||||
1399574|NCT02298244|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399575|NCT02298231|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399576|NCT02298218|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399577|NCT02298205|Randomized|Parallel Assignment||Treatment||Single||||||t
1399578|NCT02298192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399579|NCT02298179|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399580|NCT02298166|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399581|NCT02298153||Single Group Assignment||Treatment||None (Open Label)||||||
1399582|NCT02298140||Single Group Assignment||Health Services Research||None (Open Label)||||||
1399583|NCT02298127|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1399584|NCT02298114|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1399585|NCT02298101|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1399586|NCT02298088|Randomized|Parallel Assignment||Treatment||None (Open Label)|Blinded adjudication|||||
1399587|NCT02298075|||Other||Retrospective|||||||
1399588|NCT02298062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399589|NCT02298049||Single Group Assignment||Basic Science||None (Open Label)||||||
1399590|NCT02298036|Randomized|Parallel Assignment||Treatment||Single|||||t|
1399591|NCT02298023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399592|NCT02298010|||||Retrospective|||||||
1399593|NCT02297997|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399594|NCT02297984|||Case-Only||Prospective|||||||
1399595|NCT02297971|||Case-Only||Prospective|||||||
1399596|NCT02297958|||Case-Only||Prospective|||||||
1399597|NCT02297945||Single Group Assignment||Treatment||None (Open Label)||||||
1399598|NCT02297932|Randomized|Parallel Assignment||Treatment||Single||||||t
1399599|NCT02297919|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399600|NCT02297906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399601|NCT02297893|Randomized|Parallel Assignment||Treatment||Single||||||t
1399602|NCT02297880|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1399603|NCT02297867||Single Group Assignment||Treatment||None (Open Label)||||||
1399604|NCT02297854|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399605|NCT02297841||Single Group Assignment||Screening||None (Open Label)||||||
1399606|NCT02297828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399607|NCT02297815|||Cohort||Prospective|||||||
1399608|NCT02297802||||||||||||
1399609|NCT02297789|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399610|NCT02297776|||Cohort||Prospective|||||||
1399611|NCT02297763|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1399612|NCT02297750|Randomized|Parallel Assignment||||None (Open Label)||||||
1399613|NCT02297737|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1399614|NCT02297724|||Case-Control||Cross-Sectional|||||||
1399615|NCT02297711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399616|NCT02297698|Randomized|Parallel Assignment||Prevention||Single|||t|||
1399617|NCT02297685|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399618|NCT02297672||Single Group Assignment||Treatment||None (Open Label)||||||
1399619|NCT02297659|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1399620|NCT02297646|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1399621|NCT02297633|||Case Control||Prospective|||||||
1399622|NCT02297620|||Case Control||Prospective|||||||
1399623|NCT02297607|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399624|NCT02297594|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399625|NCT02297581|||Cohort||Prospective|||||||
1399626|NCT02297568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399627|NCT02297555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399628|NCT02297542|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1399629|NCT02297529||||||||||||
1399630|NCT02297516|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399631|NCT02297503|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399632|NCT02297490|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1399633|NCT02297477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399634|NCT02297464|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1399635|NCT02297451|Randomized|Parallel Assignment||Prevention||Single|||t|||
1399636|NCT02297438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399637|NCT02297425||Single Group Assignment||Basic Science||None (Open Label)||||||
1399638|NCT02297412|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1399639|NCT02297399|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1399640|NCT02297386||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399641|NCT02297373|||Cohort||Prospective|||||||
1399642|NCT02297360|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399643|NCT02297347|||Case-Only||Prospective|||||||
1399644|NCT02297334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399645|NCT02297321||Single Group Assignment||Basic Science||None (Open Label)||||||
1399646|NCT02297308|||Case-Only||Retrospective|||||||
1399647|NCT02297295||Single Group Assignment||Supportive Care||None (Open Label)||||||
1399648|NCT02297282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399649|NCT02297269|||Cohort||Prospective|||||||
1399650|NCT02297256|Randomized|Parallel Assignment||Prevention||Single|||t|||
1399651|NCT02297243||Single Group Assignment||Treatment||None (Open Label)||||||
1399652|NCT02297230|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399653|NCT02297217||Single Group Assignment||Treatment||None (Open Label)||||||
1399654|NCT02297204||Single Group Assignment||Prevention||None (Open Label)||||||
1399655|NCT02297191||Single Group Assignment||Treatment||None (Open Label)||||||
1399656|NCT02297178|||Cohort||Prospective|||||||
1399657|NCT02297165|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1399658|NCT02297152||Single Group Assignment||Treatment||None (Open Label)||||||
1399659|NCT02297139||Single Group Assignment||Supportive Care||None (Open Label)||||||
1399660|NCT02297126|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1399661|NCT02297113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399662|NCT02297100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399663|NCT02297087||Single Group Assignment||Diagnostic||None (Open Label)||This study is testing the specimens for genomic results. There are no other interventions.||||
1399664|NCT02297074|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1399665|NCT02297061|||Cohort||Prospective|||||||
1399666|NCT02297048|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1399667|NCT02297035|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1399668|NCT02297022||Single Group Assignment||Treatment||None (Open Label)||||||
1399669|NCT02297009|||Cohort||Prospective|||||||
1399670|NCT02296996||Single Group Assignment||Treatment||None (Open Label)||||||
1399671|NCT02296983|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399672|NCT02296970|||Other||Prospective|||||||
1399673|NCT02296957|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1399674|NCT02296944|||Cohort||Retrospective|||||||
1399675|NCT02296931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399676|NCT02296918|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399677|NCT02296905|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1399678|NCT02296892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399679|NCT02296879||Single Group Assignment||Treatment||None (Open Label)||||||
1399680|NCT02296866|||Cohort||Prospective|||||||
1399681|NCT02296853|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399682|NCT02296840|Randomized|Parallel Assignment||Treatment||Single|||||t|
1399683|NCT02296814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399684|NCT02296801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399685|NCT02296788|Randomized|Parallel Assignment||Prevention||Single||||||t
1399686|NCT02296775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399687|NCT02296762|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399688|NCT02296749|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399689|NCT02296736|||Cohort||Retrospective|||||||
1399690|NCT02296723|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399691|NCT02296710||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399692|NCT02296697|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1399693|NCT02296684|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1399694|NCT02296671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399695|NCT02296658||Single Group Assignment||Treatment||None (Open Label)||||||
1399696|NCT02296645|Randomized|Parallel Assignment||||Double|||t|||t
1399697|NCT02296632|||Case-Only||Prospective|||||||
1399698|NCT02296619|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1399699|NCT02296606|||Cohort||Prospective|||||||
1399700|NCT02296593|||Cohort||Prospective|||||||
1399701|NCT02296580||Single Group Assignment||Treatment||None (Open Label)||||||
1399702|NCT02296567|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1399703|NCT02296554|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399704|NCT02296541|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399705|NCT02296528||Single Group Assignment||Treatment||None (Open Label)||||||
1399706|NCT02296515|||Case-Only||Prospective|||||||
1399707|NCT02296502|||Cohort||Prospective|||||||
1399708|NCT02296489|||Case Control||Prospective|||||||
1399709|NCT02296476|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399710|NCT02296463|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1399711|NCT02296450|||Case-Only||Prospective|||||||
1399712|NCT02296437||Single Group Assignment||Treatment||None (Open Label)||||||
1399713|NCT02296424|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399714|NCT02296411|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1399715|NCT02296398|||Case-Only||Retrospective|||||||
1399716|NCT02296385||Single Group Assignment||Basic Science||None (Open Label)||||||
1399717|NCT02296372|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1399718|NCT02296359|||Case Control||Prospective|||||||
1399719|NCT02296346|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399720|NCT02296333|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1399721|NCT02296320|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399722|NCT02296307|||Case-Only||Prospective|||||||
1399723|NCT02296294|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1399724|NCT02296281||Single Group Assignment||Treatment||None (Open Label)||||||
1399725|NCT02296268|||Cohort||Prospective|||||||
1399726|NCT02296255|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399727|NCT02296242||Single Group Assignment||Treatment||None (Open Label)||||||
1399728|NCT02296229||Single Group Assignment||Treatment||None (Open Label)||||||
1399729|NCT02296216|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1399730|NCT02296203||Single Group Assignment||Treatment||None (Open Label)||||||
1399731|NCT02296190|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399732|NCT02296177|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1399733|NCT02296164|||Cohort||Prospective|||||||
1399734|NCT02296151|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1399735|NCT02296138|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399736|NCT02296125|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399737|NCT02296112||Single Group Assignment||Treatment||None (Open Label)||||||
1399738|NCT02296099|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399739|NCT02296086|||Cohort||Prospective|||||||
1399740|NCT02296073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399741|NCT02296060||Single Group Assignment||||None (Open Label)||||||
1399742|NCT02296047|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1399743|NCT02296034|||Cohort||Prospective|||||||
1399744|NCT02296021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399745|NCT02296008|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1399746|NCT02295995|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399747|NCT02295982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399748|NCT02295969|||Cohort||Prospective|||||||
1399749|NCT02295956||Single Group Assignment||Supportive Care||None (Open Label)||||||
1399750|NCT02295943||Single Group Assignment||Treatment||None (Open Label)||||||
1399751|NCT02295930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399752|NCT02295917|||Cohort||Prospective|||||||
1399753|NCT02295904|||Cohort||Prospective|||||||
1399754|NCT02295891||Single Group Assignment||Treatment||None (Open Label)||||||
1399755|NCT02295878|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1399756|NCT02295865|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1399757|NCT02295852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399758|NCT02295839|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1399759|NCT02295826|Randomized|Parallel Assignment||Treatment||||||||
1399760|NCT02295813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399761|NCT02295800|||Cohort||Prospective|||||||
1399762|NCT02295787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399763|NCT02295774|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1399764|NCT02295761|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1399765|NCT02295748||Single Group Assignment||Treatment||None (Open Label)||||||
1399766|NCT02295735|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1399767|NCT02295722||Single Group Assignment||Treatment||None (Open Label)||||||
1399768|NCT02295709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399769|NCT02295696|Randomized|Single Group Assignment||||None (Open Label)||||||
1399770|NCT02295683|||||Prospective|||||||
1399771|NCT02295670|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399772|NCT02295657|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399773|NCT02295644|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399774|NCT02295631|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399775|NCT02295618|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399776|NCT02295605|Randomized|Parallel Assignment||Treatment||Single||||||t
1399777|NCT02295592|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399778|NCT02295579|||Case-Only||Prospective|||||||
1399779|NCT02295566|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399780|NCT02295553|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399781|NCT02295540||Single Group Assignment||Treatment||None (Open Label)||||||
1399782|NCT02295527|Randomized|Parallel Assignment||Treatment||Single||||||t
1399783|NCT02295514||Single Group Assignment||||None (Open Label)||||||
1399784|NCT02295501||Single Group Assignment||Treatment||None (Open Label)||||||
1399785|NCT02295488||Single Group Assignment||Prevention||None (Open Label)||||||
1399786|NCT02295475|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399787|NCT02295462|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1399788|NCT02295449||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399789|NCT02295436|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1399790|NCT02295423|||Cohort||Prospective|||||||
1399791|NCT02295410|||Cohort||Prospective|||||||
1399792|NCT02295397||Single Group Assignment||Other||Double|||t||t|
1399793|NCT02295384|||Cohort||Retrospective|||||||
1399794|NCT02295371|||Case-Only||Prospective|||||||
1399795|NCT02295358|||Cohort||Prospective|||||||
1399796|NCT02295345||Single Group Assignment||Treatment||None (Open Label)||||||
1399797|NCT02295332|Randomized|Crossover Assignment||||Double|||t||t|
1399798|NCT02295319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399799|NCT02295306|||Cohort||Prospective|||||||
1399800|NCT02295293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399801|NCT02295280|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399802|NCT02295267||Single Group Assignment||Diagnostic||Double|||t||t|
1399803|NCT02295254|||Cohort||Prospective|||||||
1399804|NCT02295241|||Case-Only||Prospective|||||||
1399805|NCT02295228|||Case-Only||Prospective|||||||
1399806|NCT02295215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399807|NCT02295202|Randomized|Parallel Assignment||Treatment||Single||||||t
1399808|NCT02295189|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399809|NCT02295176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399810|NCT02295163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399811|NCT02295150||Single Group Assignment||Prevention||None (Open Label)||||||
1399812|NCT02295137||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399813|NCT02295124|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1399814|NCT02295111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399815|NCT02295098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399816|NCT02295085|||Cohort||Prospective|||||||
1399817|NCT02295072|Randomized|Parallel Assignment||Treatment||Double||||t||t
1399818|NCT02295059|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399819|NCT02295046|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399820|NCT02295033||||Treatment||||||||
1399821|NCT02295020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399822|NCT02295007||Single Group Assignment||Health Services Research||None (Open Label)||||||
1399823|NCT02294994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399824|NCT02294981|Randomized|Parallel Assignment||Treatment||Single||||||t
1399825|NCT02294968|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399826|NCT02294955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399827|NCT02294942|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399828|NCT02294929||Single Group Assignment||Treatment||None (Open Label)||||||
1399829|NCT02294916|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399830|NCT02294903||Single Group Assignment||Treatment||None (Open Label)||||||
1399831|NCT02294890|||Cohort||Retrospective|||||||
1399832|NCT02294877|||Cohort||Prospective|||||||
1399833|NCT02294864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399834|NCT02294851|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1399835|NCT02294838||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399836|NCT02294825|||Cohort||Prospective|||||||
1399837|NCT02294812|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399838|NCT02294799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399839|NCT02294786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399840|NCT02294773|Randomized|Parallel Assignment||||None (Open Label)||||||
1399841|NCT02294760|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1399842|NCT02294747|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1399843|NCT02294734|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399844|NCT02294721|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399845|NCT02294708|Randomized|Parallel Assignment||Treatment||Single||||||t
1399846|NCT02294695|||Case Control||Prospective|||||||
1399847|NCT02294682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399848|NCT02294669||Single Group Assignment||Treatment||None (Open Label)||||||
1399849|NCT02294656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399850|NCT02294643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399851|NCT02294630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399852|NCT02294617|Randomized|Crossover Assignment||||None (Open Label)||||||
1399853|NCT02294604|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1399854|NCT02294591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399855|NCT02294578|||Case-Control||Prospective|||||||
1399856|NCT02294565||Single Group Assignment||||None (Open Label)||||||
1399857|NCT02294552|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399858|NCT02294539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399859|NCT02294526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399860|NCT02294513|||Case-Control||Prospective|||||||
1399861|NCT02294500|||Cohort||Prospective|||||||
1399862|NCT02294487|||Case-Control||Prospective|||||||
1399863|NCT02294474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399864|NCT02294461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399865|NCT02294448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399866|NCT02294435|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399867|NCT02294422|Randomized|Parallel Assignment||Prevention||Single|||t|||
1399868|NCT02294409|Randomized|Parallel Assignment||Treatment||Single||||||t
1399869|NCT02294396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399870|NCT02294383|||Case-Control||Cross-Sectional|||||||
1399871|NCT02294370|||Case-Only||Prospective|||||||
1399872|NCT02294357|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399873|NCT02294344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399874|NCT02294331|||Other||Prospective|||||||
1399875|NCT02294318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399876|NCT02294305|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399877|NCT02294292|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399878|NCT02294279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399879|NCT02294266|Randomized|Crossover Assignment||||Triple|||t||t|t
1399880|NCT02294253||Single Group Assignment||Treatment||None (Open Label)||||||
1399881|NCT02294240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399882|NCT02294227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399883|NCT02294214|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399884|NCT02294201|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399885|NCT02294188|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399886|NCT02294175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399887|NCT02294162|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1399888|NCT02294149|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1399889|NCT02294136|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1399890|NCT02294123|Randomized|Crossover Assignment||||Single|||t|||
1399891|NCT02294110|||Cohort||Prospective|||||||
1399892|NCT02294097|Randomized|Parallel Assignment||Prevention||Single||||||t
1399893|NCT02294084|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399894|NCT02294071|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399895|NCT02294058|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399896|NCT02294045|||Case-Only||Prospective|||||||
1399897|NCT02294032|||Case-Only||Prospective|||||||
1399898|NCT02294019||||||None (Open Label)||||||
1399899|NCT02294006||Single Group Assignment||Treatment||None (Open Label)||||||
1399900|NCT02293993|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1399901|NCT02293980|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399902|NCT02293967||Single Group Assignment||Treatment||None (Open Label)||||||
1399903|NCT02293954||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399904|NCT02293941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399905|NCT02293928|||Cohort||Prospective|||||||
1399906|NCT02293915|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399907|NCT02293902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399908|NCT02293889|Randomized|Factorial Assignment||Treatment||Single|||t|||
1399909|NCT02293876|Randomized|Factorial Assignment||Prevention||Single|||||t|
1399910|NCT02293863|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399911|NCT02293850||Single Group Assignment||Treatment||None (Open Label)||||||
1399912|NCT02293837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399913|NCT02293824|||Cohort||Prospective|||||||
1399914|NCT02293811||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399915|NCT02293798||Single Group Assignment||Treatment||None (Open Label)||||||
1399916|NCT02293785|||Cohort||Prospective|||||||
1399917|NCT02293772|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1399918|NCT02293759|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399919|NCT02293746||Single Group Assignment||Treatment||None (Open Label)||Inspire Upper Airway Stimulation System||||
1399920|NCT02293733|||||Retrospective|||||||
1399921|NCT02293720||Single Group Assignment||Treatment||None (Open Label)||||||
1399922|NCT02293707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399923|NCT02293694|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1399924|NCT02293681|||Cohort||Prospective|||||||
1399925|NCT02293668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399926|NCT02293655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399927|NCT02293642|||Cohort||Prospective|||||||
1399928|NCT02293629|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1399929|NCT02293616|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1399930|NCT02293603|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1399931|NCT02293590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399932|NCT02293577|||Cohort||Prospective|||||||
1399933|NCT02293564||Single Group Assignment||Treatment||None (Open Label)||||||
1399934|NCT02293551|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1399935|NCT02293538|Randomized|Parallel Assignment||||Double|||t||t|
1399936|NCT02293525|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1399937|NCT02293512|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399938|NCT02293499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399939|NCT02293486|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399940|NCT02293473|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1399941|NCT02293460||Single Group Assignment||Treatment||None (Open Label)||||||
1399942|NCT02293447|Randomized|Parallel Assignment||||Single|||t|||
1399943|NCT02293434|||Cohort||Prospective|||||||
1399944|NCT02293421||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399945|NCT02293408|||Case-Only||Prospective|||||||
1399946|NCT02293395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399947|NCT02293382|||Case-Only||Retrospective|||||||
1399948|NCT02293369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399949|NCT02293356||Single Group Assignment||Treatment||None (Open Label)||||||
1399950|NCT02293343|||Case-Control||Prospective|||||||
1399951|NCT02293330|Randomized|Parallel Assignment||||Triple|||t|t||t
1399952|NCT02293317|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1399953|NCT02293304|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1399954|NCT02293291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399955|NCT02293278|Randomized|Single Group Assignment||Prevention||Single|||||t|
1399956|NCT02293265||Single Group Assignment||||None (Open Label)||||||
1399957|NCT02293252|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1399958|NCT02293239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1399959|NCT02293226|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399960|NCT02293213|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1399961|NCT02293200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399962|NCT02293187|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1399963|NCT02293174|||Cohort||Prospective|||||||
1399964|NCT02293161|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399965|NCT02293148|Randomized|Crossover Assignment||Treatment||Single|||t|||
1399966|NCT02293135|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1399967|NCT02293122|||Cohort||Prospective|||||||
1399968|NCT02293109||Single Group Assignment||Treatment||None (Open Label)||||||
1399969|NCT02293096|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1399970|NCT02293083|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1399971|NCT02293070||Single Group Assignment||Treatment||None (Open Label)||||||
1399972|NCT02293057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399973|NCT02293044||Single Group Assignment||Treatment||None (Open Label)||||||
1399974|NCT02293031||Single Group Assignment||Treatment||None (Open Label)||||||
1399975|NCT02293018|Randomized|Parallel Assignment||||Single||||||t
1399976|NCT02293005||Single Group Assignment||Treatment||None (Open Label)||||||
1399977|NCT02292992||Single Group Assignment||Diagnostic||None (Open Label)||||||
1399978|NCT02292979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399979|NCT02292966||Single Group Assignment||Treatment||None (Open Label)||||||
1399980|NCT02292953|||Case-Only||Prospective|||||||
1399981|NCT02292940|||Cohort||Retrospective|||||||
1399982|NCT02292927|||Cohort||Prospective|||||||
1399983|NCT02292914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399984|NCT02292901|Randomized|Parallel Assignment||Treatment||Single|||t|||
1399985|NCT02292888|Randomized|Single Group Assignment||Screening||Double||||t||t
1399986|NCT02292875|||Cohort||Prospective|||||||
1399987|NCT02292862|||Case Control||Prospective|||||||
1399988|NCT02292849|Randomized|Parallel Assignment||Treatment||Single||||||t
1399989|NCT02292836|||||Prospective|||||||
1399990|NCT02292823|||Case-Only||Prospective|||||||
1399991|NCT02292810|Randomized|Crossover Assignment||||Double|||||t|t
1399992|NCT02292797|||||Prospective|||||||
1399993|NCT02292784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1399994|NCT02292771|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399995|NCT02292758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1399996|NCT02292745||Single Group Assignment||Treatment||None (Open Label)||||||
1399997|NCT02292732||Single Group Assignment||Treatment||None (Open Label)||||||
1399998|NCT02292719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1399999|NCT02292706|||Cohort||Prospective|||||||
1400000|NCT02292693|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400001|NCT02292680|||Cohort||Retrospective|||||||
1400002|NCT02292667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400003|NCT02292654||Single Group Assignment||Treatment||None (Open Label)||||||
1400004|NCT02292641||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400005|NCT02292628|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400006|NCT02292615|||Case-Only||Prospective|||||||
1400007|NCT02292602|Randomized|Single Group Assignment||Treatment||Single||||||t
1400008|NCT02292589|Randomized|Crossover Assignment||Other||Triple|||t|t||t
1400009|NCT02292576|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1400010|NCT02292563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400011|NCT02292550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400012|NCT02292537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400013|NCT02292524|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1400014|NCT02292511|Randomized|Parallel Assignment||Prevention||Single||||||t
1400015|NCT02292498||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1400016|NCT02292485|||Cohort||Prospective|||||||
1400017|NCT02292472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400018|NCT02292459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400019|NCT02292446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400020|NCT02292433|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1400021|NCT02292420|||Case-Only||Prospective|||||||
1400022|NCT02292407||Single Group Assignment||Treatment||None (Open Label)||||||
1400023|NCT02292394|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400024|NCT02292381|||Cohort||Prospective|||||||
1400025|NCT02292368|Randomized|Crossover Assignment||Prevention||Single|||t|||
1400026|NCT02292355|Randomized|Parallel Assignment||Treatment||Single||||||t
1400027|NCT02292342|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1400028|NCT02292329|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1400029|NCT02292316|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1400030|NCT02292303|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1400031|NCT02292290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400032|NCT02292277|||Case Control||Prospective|||||||
1400033|NCT02292264|||Cohort||Retrospective|||||||
1400034|NCT02292251|Randomized|Parallel Assignment||Treatment||Single||||||t
1400035|NCT02292238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400036|NCT02292225||Single Group Assignment||Treatment||None (Open Label)||||||
1400037|NCT02292212||Single Group Assignment||Treatment||None (Open Label)||||||
1400038|NCT02292199|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400039|NCT02292186||Single Group Assignment||Treatment||None (Open Label)||||||
1400040|NCT02292173||Single Group Assignment||Treatment||None (Open Label)||||||
1400041|NCT02292160|||Cohort||Prospective|||||||
1400042|NCT02292147|||Cohort||Prospective|||||||
1400043|NCT02292134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400044|NCT02292121|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1400045|NCT02292108|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400046|NCT02292095|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400047|NCT02292082|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1400048|NCT02292069|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400049|NCT02292056||Single Group Assignment||Prevention||None (Open Label)||||||
1400050|NCT02292043|||Case-Only||Prospective|||||||
1400051|NCT02292030|||Cohort||Prospective|||||||
1400052|NCT02292017||Single Group Assignment||Treatment||None (Open Label)||||||
1400053|NCT02292004|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1400054|NCT02291991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400055|NCT02291978||Single Group Assignment||Treatment||None (Open Label)||||||
1400056|NCT02291965|||Case-Only||Prospective|||||||
1400057|NCT02291952|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1400058|NCT02291939|||Case-Only||Prospective|||||||
1400059|NCT02291926||Single Group Assignment||Treatment||None (Open Label)||||||
1400060|NCT02291913||Single Group Assignment||Treatment||None (Open Label)||||||
1400061|NCT02291900|Randomized|Parallel Assignment||Treatment||Single|||||t|
1400062|NCT02291887|||Cohort||Retrospective|||||||
1400063|NCT02291874||Single Group Assignment||Treatment||None (Open Label)||||||
1400064|NCT02291861|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400065|NCT02291848|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400066|NCT02291835|||Cohort||Prospective|||||||
1400067|NCT02291822|||Case-Only||Retrospective|||||||
1400068|NCT02291809|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400069|NCT02291796|Randomized|Parallel Assignment||Treatment||Single|||||t|
1400070|NCT02291783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400071|NCT02291770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400072|NCT02291757|Randomized|Crossover Assignment||Supportive Care||Quadruple||Single-crossover at 4 weeks|t|t|t|t
1400073|NCT02291744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400074|NCT02291731||Single Group Assignment||Treatment||Single|||t|||
1400075|NCT02291718|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1400076|NCT02291705|Randomized|Parallel Assignment||Treatment||Single||||||t
1400077|NCT02291692|Randomized|Parallel Assignment||Treatment||Single||||||t
1400078|NCT02291679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400079|NCT02291666|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1400080|NCT02291653|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400081|NCT02291640|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400082|NCT02291627|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400083|NCT02291614||Single Group Assignment||Treatment||None (Open Label)||||||
1400084|NCT02291601|Randomized|Parallel Assignment||Prevention||Single||||||t
1400085|NCT02291588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400086|NCT02291575|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1400087|NCT02291562|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1400088|NCT02291549|Randomized|Parallel Assignment||Treatment||Double|Participants were blindfolded and earmuffed during the baseline procedure and follow-up endoscopic examinations. Implants were removed at Day 60 to allow blinded assessment of bilateral polyp grade at Day 90 by a centralized videoendoscopy review by a panel of 3 independent sinus surgeons.||t|||t
1400318|NCT02288533||Single Group Assignment||Other||None (Open Label)||||||
1400089|NCT02291536|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1400090|NCT02291523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400091|NCT02291510|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1400092|NCT02291497|||||Prospective|||||||
1400093|NCT02291484|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1400094|NCT02291471|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400095|NCT02291458|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1400096|NCT02291445|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1400097|NCT02291432||Single Group Assignment||Treatment||None (Open Label)||||||
1400098|NCT02291419|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400099|NCT02291406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400100|NCT02291393|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1400101|NCT02291380|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400102|NCT02291367|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400103|NCT02291354|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400104|NCT02291341|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400105|NCT02291328|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1400106|NCT02291315|||Case-Crossover||Prospective|||||||
1400107|NCT02291302|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1400108|NCT02291289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400109|NCT02291276|||Cohort||Prospective|||||||
1400110|NCT02291263|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400111|NCT02291250|Randomized|Crossover Assignment||Treatment||Single|||t|||
1400112|NCT02291237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400113|NCT02291224|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400114|NCT02291211||Single Group Assignment||Treatment||None (Open Label)||||||
1400115|NCT02291198||Single Group Assignment||Screening||None (Open Label)||||||
1400116|NCT02291185|||Case-Only||Prospective|||||||
1400117|NCT02291172|Randomized|Single Group Assignment||Treatment||Single||||||t
1400118|NCT02291159|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400119|NCT02291146|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400120|NCT02291133||Single Group Assignment||Treatment||None (Open Label)||||||
1400121|NCT02291120|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400122|NCT02291107|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1400123|NCT02291094|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400124|NCT02291081|||Cohort||Prospective|||||||
1400125|NCT02291068||Single Group Assignment||Treatment||None (Open Label)||||||
1400126|NCT02291055|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400127|NCT02291042|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1400128|NCT02291029|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400129|NCT02291016|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1400130|NCT02291003|||Other||Other|||||||
1400131|NCT02290990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400132|NCT02290977||Single Group Assignment||Treatment||None (Open Label)||||||
1400133|NCT02290964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400134|NCT02290951|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400135|NCT02290938|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400136|NCT02290925|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1400137|NCT02290912|Randomized|Parallel Assignment||Prevention||Single||||||t
1400138|NCT02290899|||Other||Other|||||||
1400139|NCT02290886|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1400140|NCT02290873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400141|NCT02290860||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400142|NCT02290847|Randomized|Parallel Assignment||Treatment||Single||||||t
1400143|NCT02290834|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1400144|NCT02290821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400145|NCT02290808|Randomized|Parallel Assignment||Prevention||Single|||t|||
1400146|NCT02290795|||Case Control||Prospective|||||||
1400147|NCT02290782||Single Group Assignment||Treatment||None (Open Label)||Single arm study: IORT +/- EBRT||||
1400148|NCT02290769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400149|NCT02290756|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400150|NCT02290743|Randomized|Parallel Assignment||Treatment||Single||||||t
1400151|NCT02290730|Randomized|Parallel Assignment||Treatment||Single||||||t
1400152|NCT02290717|Randomized|Parallel Assignment||Treatment||Single||||||t
1400153|NCT02290704|||Other||Prospective|||||||
1400154|NCT02290691|Randomized|Parallel Assignment||Prevention||Single||||||t
1400155|NCT02290678||Single Group Assignment||Treatment||None (Open Label)||||||
1400156|NCT02290665|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1400157|NCT02290652|||Cohort||Retrospective|||||||
1400158|NCT02290639|Randomized|Crossover Assignment||Treatment||Single||||||t
1400159|NCT02290626|Randomized|Crossover Assignment||Treatment||Single||||||t
1400160|NCT02290613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400161|NCT02290600|||Cohort||Prospective|||||||
1400162|NCT02290587|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1400163|NCT02290574||Single Group Assignment||Treatment||None (Open Label)||||||
1400164|NCT02290561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400165|NCT02290548|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1400166|NCT02290535|||Case Control||Prospective|||||||
1400167|NCT02290522||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400168|NCT02290509|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400169|NCT02290496|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1400170|NCT02290470|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400171|NCT02290457|Randomized|Parallel Assignment||Treatment||Single||||||t
1400172|NCT02290444|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400173|NCT02290431||Single Group Assignment||Treatment||None (Open Label)||||||
1400174|NCT02290418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400175|NCT02290405|||Cohort||Cross-Sectional|||||||
1400176|NCT02290392|||Case-Only||Other|||||||
1400177|NCT02290379|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1400178|NCT02290366||Single Group Assignment||Treatment||None (Open Label)||||||
1400179|NCT02290353|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1400180|NCT02290340|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400181|NCT02290327|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400182|NCT02290314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400183|NCT02290301|||Cohort||Prospective|||||||
1400184|NCT02290288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400185|NCT02290275|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400186|NCT02290262|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1400187|NCT02290249|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1400188|NCT02290236|||||Prospective|||||||
1400189|NCT02290223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400190|NCT02290210|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400191|NCT02290197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400192|NCT02290184|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1400193|NCT02290171|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400194|NCT02290158|Non-Randomized|Single Group Assignment||Treatment||Double|||t|||t
1400195|NCT02290145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400196|NCT02290132|||Case-Only||Prospective|||||||
1400197|NCT02290119|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1400198|NCT02290106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400199|NCT02290093|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1400200|NCT02290080|Randomized|Parallel Assignment||Treatment||Single||||||t
1400201|NCT02290067|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1400202|NCT02290054|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1400203|NCT02290041|Randomized|Parallel Assignment||Treatment||Triple||Phase 1: uncontrolled, single arm biosafety evaluation (n=5) Phase 2: placebo-controlled, randomized, evaluation (n=10)|t||t|t
1400204|NCT02290028||Single Group Assignment||Other||None (Open Label)||||||
1400205|NCT02290015|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400206|NCT02290002|Randomized|Parallel Assignment||Prevention||Single|||t|||
1400207|NCT02289989|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1400208|NCT02289976|Randomized|Parallel Assignment||Treatment||Single|||||t|
1400209|NCT02289963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400210|NCT02289950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400211|NCT02289937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400212|NCT02289924|||Cohort||Prospective|||||||
1400213|NCT02289911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400214|NCT02289898|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400215|NCT02289885|Randomized|Crossover Assignment||Treatment||Single|||t|||
1400216|NCT02289872|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400217|NCT02289859|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400218|NCT02289846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400219|NCT02289833||Single Group Assignment||Treatment||None (Open Label)||||||
1400220|NCT02289820|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1400221|NCT02289807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400222|NCT02289794|Randomized|Parallel Assignment||Prevention||Single|||t|||
1400223|NCT02289781|||Cohort||Prospective|||||||
1400224|NCT02289768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400225|NCT02289755||Single Group Assignment||Treatment||None (Open Label)||||||
1400226|NCT02289742|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1400227|NCT02289729|||Cohort||Prospective|||||||
1400228|NCT02289716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400229|NCT02289703|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400230|NCT02289690|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400231|NCT02289677|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400232|NCT02289664|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400233|NCT02289651|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400234|NCT02289638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400235|NCT02289625|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1400236|NCT02289612|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1400237|NCT02289599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400238|NCT02289586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400239|NCT02289573|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400240|NCT02289560||Single Group Assignment||Treatment||None (Open Label)||||||
1400241|NCT02289547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400242|NCT02289534||||||||||||
1400243|NCT02289521|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1400244|NCT02289508|||Cohort||Prospective|||||||
1400245|NCT02289495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400246|NCT02289482|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400247|NCT02289469|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1400248|NCT02289456||Single Group Assignment||Treatment||None (Open Label)||||||
1400249|NCT02289443|||Cohort||Prospective|||||||
1400250|NCT02289430|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400251|NCT02289417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400252|NCT02289404|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400253|NCT02289391|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1400254|NCT02289378||Single Group Assignment||Treatment||None (Open Label)||||||
1400255|NCT02289365|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1400256|NCT02289352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400257|NCT02289339|||Cohort||Other|||||||
1400258|NCT02289326|||Case-Only||Prospective|||||||
1400259|NCT02289313||Single Group Assignment||Prevention||None (Open Label)||||||
1400260|NCT02289300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400261|NCT02289287|Randomized|Parallel Assignment||Treatment||Single||||||t
1400262|NCT02289274|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400263|NCT02289261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400264|NCT02289248||Single Group Assignment||Treatment||None (Open Label)||||||
1400265|NCT02289235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400266|NCT02289222||Single Group Assignment||Treatment||None (Open Label)||||||
1400267|NCT02289209||Single Group Assignment||Treatment||None (Open Label)||||||
1400268|NCT02289196|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400269|NCT02289183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400270|NCT02289170|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1400271|NCT02289157|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Placebo Controlled Clinical Trial - Open Label||||
1400272|NCT02289144||Single Group Assignment||Treatment||None (Open Label)||||||
1400273|NCT02289131|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1400274|NCT02289118||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400275|NCT02289105|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1400276|NCT02289092|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1400277|NCT02289079|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1400278|NCT02289066|||Case-Only||Cross-Sectional|||||||
1400279|NCT02289053|||Case-Control||Prospective|||||||
1400280|NCT02289040|||Case-Control||Prospective|||||||
1400281|NCT02289027|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400282|NCT02289014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400283|NCT02289001|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1400284|NCT02288988||Single Group Assignment||Treatment||None (Open Label)||||||
1400285|NCT02288975|||Case-Control||Prospective|||||||
1400286|NCT02288962|Randomized|Parallel Assignment||Treatment||Single||||||t
1400287|NCT02288949|||Cohort||Prospective|||||||
1400288|NCT02288936||Single Group Assignment||Treatment||None (Open Label)||||||
1400289|NCT02288923|Randomized|Parallel Assignment||Treatment||Single||||||t
1400290|NCT02288910|||Case-Only||Prospective|||||||
1400291|NCT02288897|Randomized|Parallel Assignment||Treatment||Single|Blinded review by independent review committee (IRC) for primary and key secondary endpoints.|||||t
1400292|NCT02288884|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400293|NCT02288871|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1400294|NCT02288858|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1400295|NCT02288845||Single Group Assignment||Basic Science||None (Open Label)||||||
1400296|NCT02288832|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1400297|NCT02288819||Single Group Assignment||Treatment||None (Open Label)||||||
1400298|NCT02288793|||Cohort||Retrospective|||||||
1400299|NCT02288780|||Cohort||Prospective|||||||
1400300|NCT02288767|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1400301|NCT02288754|||Cohort||Prospective|||||||
1400302|NCT02288741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400303|NCT02288728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400304|NCT02288715|||Case-Control||Prospective|||||||
1400305|NCT02288702|||Other||Prospective|||||||
1400306|NCT02288689|||Cohort||Prospective|||||||
1400307|NCT02288676|||Case-Control||Cross-Sectional|||||||
1400308|NCT02288663||Single Group Assignment||||None (Open Label)||||||
1400309|NCT02288650|Randomized|Parallel Assignment||||None (Open Label)||||||
1400310|NCT02288637|Randomized|Factorial Assignment||Prevention||Single|||t|||
1400311|NCT02288624|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1400312|NCT02288611|Randomized|Crossover Assignment||||None (Open Label)||||||
1400313|NCT02288598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400314|NCT02288585|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1400315|NCT02288572|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1400316|NCT02288559|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400317|NCT02288546|||Case Control||Cross-Sectional|||||||
1400319|NCT02288520|||Cohort||Prospective|||||||
1400320|NCT02288507||Single Group Assignment||Treatment||None (Open Label)||||||
1400321|NCT02288494|||||Cross-Sectional|||||||
1400322|NCT02288481|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1400323|NCT02288468|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1400324|NCT02288455||Single Group Assignment||Treatment||None (Open Label)||||||
1400325|NCT02288442|Randomized|Parallel Assignment||Treatment||Single||||||t
1400326|NCT02288429|||Case-Only||Prospective|||||||
1400327|NCT02288416|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400328|NCT02288403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400329|NCT02288390|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400330|NCT02288377|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400331|NCT02288364|Randomized|Parallel Assignment||||Double|||t||t|
1400332|NCT02288351||Single Group Assignment||Basic Science||None (Open Label)||||||
1400333|NCT02288338|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400334|NCT02288325|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400335|NCT02288312|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400336|NCT02288299||Single Group Assignment||Treatment||None (Open Label)||||||
1400337|NCT02288286|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1400338|NCT02288273|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400339|NCT02288260|||Cohort||Cross-Sectional|||||||
1400340|NCT02288247|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400341|NCT02288234|||Case-Only||Retrospective|||||||
1400342|NCT02288221|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400343|NCT02288208|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400344|NCT02288195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400345|NCT02288182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400346|NCT02288169|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1400347|NCT02288156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400348|NCT02288143||Single Group Assignment||Treatment||None (Open Label)||||||
1400349|NCT02288130|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1400350|NCT02288117|||Cohort||Prospective|||||||
1400351|NCT02288104||Single Group Assignment||Treatment||None (Open Label)||||||
1400352|NCT02288091||Single Group Assignment||Treatment||None (Open Label)||||||
1400353|NCT02288078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400354|NCT02288065|||Cohort||Retrospective|||||||
1400355|NCT02288052|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400356|NCT02288039|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1400357|NCT02288026|||Cohort||Prospective|||||||
1400358|NCT02288013|Randomized|Single Group Assignment||Treatment||Single|||||t|
1400359|NCT02288000|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1400360|NCT02287987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400361|NCT02287974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400362|NCT02287961||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400363|NCT02287948|||Case Control||Cross-Sectional|||||||
1400364|NCT02287935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400365|NCT02287922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400366|NCT02287909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400367|NCT02287896||Single Group Assignment||Prevention||None (Open Label)||||||
1400368|NCT02287883|||Cohort||Prospective|||||||
1400369|NCT02287870|Randomized|Parallel Assignment||||Double|||t|||t
1400370|NCT02287857|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400371|NCT02287844|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1400372|NCT02287831||Single Group Assignment||Treatment||None (Open Label)||||||
1400373|NCT02287818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400374|NCT02287805|||Cohort||Prospective|||||||
1400375|NCT02287792||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400376|NCT02287779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400377|NCT02287766|||Case Control||Cross-Sectional|||||||
1400378|NCT02287753||Single Group Assignment||Supportive Care||None (Open Label)||||||
1400379|NCT02287740|Randomized|Parallel Assignment||Prevention||Single||||||t
1400380|NCT02287727||Single Group Assignment||Treatment||None (Open Label)||||||
1400381|NCT02287714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400382|NCT02287701||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400383|NCT02287688|||Cohort||Prospective|||||||
1400384|NCT02287675|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1400385|NCT02287662||Single Group Assignment||Treatment||None (Open Label)||||||
1400386|NCT02287649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400387|NCT02287636||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400388|NCT02287623|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1400389|NCT02287610|||Cohort||Prospective|||||||
1400390|NCT02287597|||Cohort||Prospective|||||||
1400391|NCT02287584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400392|NCT02287571|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400393|NCT02287558||Single Group Assignment||Treatment||None (Open Label)||||||
1400394|NCT02287545|||Case Control||Prospective|||||||
1400395|NCT02287532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400396|NCT02287519||Single Group Assignment||Supportive Care||None (Open Label)||||||
1400709|NCT02283450|||Case Control||Prospective|||||||
1400397|NCT02287506|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400398|NCT02287493|||Cohort||Prospective|||||||
1400399|NCT02287480|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400400|NCT02287467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400401|NCT02287454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400402|NCT02287441|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1400403|NCT02287428|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400404|NCT02287415||Single Group Assignment||Treatment||None (Open Label)||||||
1400405|NCT02287402||Single Group Assignment||Treatment||None (Open Label)||||||
1400406|NCT02287389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400407|NCT02287376||Single Group Assignment||Treatment||None (Open Label)||||||
1400408|NCT02287363|||Case Control||Prospective|||||||
1400409|NCT02287350||Single Group Assignment||Treatment||None (Open Label)||||||
1400410|NCT02287337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400411|NCT02287324|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1400412|NCT02287311|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400413|NCT02287298|||Case Control||Retrospective|||||||
1400414|NCT02287285||Single Group Assignment||Treatment||None (Open Label)||||||
1400415|NCT02287272|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400416|NCT02287259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400417|NCT02287246|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1400418|NCT02287233||Single Group Assignment||Treatment||None (Open Label)||||||
1400419|NCT02287220|||Cohort||Prospective|||||||
1400420|NCT02287207|Randomized|Crossover Assignment||Treatment||Single|||t|||
1400421|NCT02287194|||Cohort||Prospective|||||||
1400422|NCT02287181|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400423|NCT02287168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400424|NCT02287155||Single Group Assignment||Prevention||None (Open Label)||||||
1400425|NCT02287142|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1400426|NCT02287129|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400427|NCT02287116|Randomized|Parallel Assignment||Prevention||Single|||||t|
1400428|NCT02287103|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400429|NCT02287090|||Cohort||Prospective|||||||
1400430|NCT02287077|Randomized|Parallel Assignment||Prevention||Single|||t|||
1400431|NCT02287064||Single Group Assignment||Treatment||None (Open Label)||||||
1400432|NCT02287051|||Cohort||Prospective|||||||
1400433|NCT02287038|||Case-Crossover||Other|||||||
1400434|NCT02287025|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400435|NCT02287012|||Cohort||Retrospective|||||||
1400436|NCT02286999|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400437|NCT02286986||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1400438|NCT02286973|Randomized|Parallel Assignment||Prevention||Single|||t|||
1400439|NCT02286960|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400440|NCT02286947||Single Group Assignment||Treatment||None (Open Label)||||||
1400441|NCT02286934||Single Group Assignment||Treatment||None (Open Label)||||||
1400442|NCT02286921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400443|NCT02286908|||Other||Prospective|||||||
1400444|NCT02286895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400445|NCT02286882|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1400446|NCT02286869|Randomized|Crossover Assignment||Basic Science||Single||||||t
1400447|NCT02286856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400448|NCT02286843||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400449|NCT02286830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400450|NCT02286817|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1400451|NCT02286804||Single Group Assignment||Treatment||Single|Improvement of leg telangiectasia was determined by a masked, qualitative assessment of 2D photographs compared to baseline.|||||t
1400452|NCT02286791|Randomized|Parallel Assignment||Prevention||Single||||||t
1400453|NCT02286778|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400454|NCT02286765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400455|NCT02286752|Randomized|Parallel Assignment||Prevention||Single|||t|||
1400456|NCT02286739|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1400457|NCT02286726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400458|NCT02286713|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1400459|NCT02286700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400460|NCT02286687|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400461|NCT02286674|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400462|NCT02286661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400463|NCT02286648|Randomized|Parallel Assignment||Treatment||Single||||||t
1400464|NCT02286635|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400465|NCT02286622|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1400466|NCT02286609|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1400467|NCT02286596|||Case-Crossover||Retrospective|||||||
1400468|NCT02286583||Single Group Assignment||Screening||None (Open Label)||||||
1400469|NCT02286570|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1400470|NCT02286557|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1400471|NCT02286544|Randomized|Parallel Assignment||Treatment||Single||||||t
1400472|NCT02286531||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400473|NCT02286518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400474|NCT02286505|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1400475|NCT02286492||||||||||||
1400476|NCT02286479|Randomized|Parallel Assignment||Treatment||Single||||||t
1400477|NCT02286466|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1400478|NCT02286453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400479|NCT02286440|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1400480|NCT02286427|Randomized|Single Group Assignment||Treatment||Single||||||t
1400481|NCT02286414|||Cohort||Prospective|||||||
1400482|NCT02286401|||Cohort||Prospective|||||||
1400483|NCT02286388|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400484|NCT02286375|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1400485|NCT02286362|||Cohort||Prospective|||||||
1400486|NCT02286349|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1400487|NCT02286336|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400488|NCT02286323|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400489|NCT02286310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400490|NCT02286297|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400491|NCT02286284||Single Group Assignment||Treatment||None (Open Label)||||||
1400492|NCT02286271|||Cohort||Prospective|||||||
1400493|NCT02286258|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1400494|NCT02286245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400495|NCT02286232|Randomized|Parallel Assignment||Treatment||Single||||||t
1400496|NCT02286219||Single Group Assignment||Treatment||None (Open Label)||||||
1400497|NCT02286206||Single Group Assignment||Other||None (Open Label)||||||
1400498|NCT02286193|||Other||Prospective|||||||
1400499|NCT02286180|||Case-Only||Cross-Sectional|||||||
1400500|NCT02286167||Single Group Assignment||Other||None (Open Label)||||||
1400501|NCT02286154||Single Group Assignment||Treatment||None (Open Label)||||||
1400502|NCT02286141|||||Prospective|||||||
1400503|NCT02286128|||Case-Control||Cross-Sectional|||||||
1400504|NCT02286115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400505|NCT02286102|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400506|NCT02286089||Single Group Assignment||Treatment||None (Open Label)||||||
1400507|NCT02286076|||Case Control||Prospective|||||||
1400508|NCT02286063|Randomized|Crossover Assignment||Treatment||Single|||t|||
1400509|NCT02286050||Single Group Assignment||Supportive Care||None (Open Label)||||||
1400510|NCT02286037||||||||||||
1400511|NCT02286024|||Case-Only||Prospective|||||||
1400512|NCT02286011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400513|NCT02285998|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400514|NCT02285985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400515|NCT02285972|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1400516|NCT02285959||Single Group Assignment||Treatment||None (Open Label)||||||
1400517|NCT02285946|||Other||Prospective|||||||
1400518|NCT02285933|Randomized|Parallel Assignment||Treatment||Single||||||t
1400519|NCT02285920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400520|NCT02285907|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1400521|NCT02285894||Single Group Assignment||Treatment||None (Open Label)||||||
1400522|NCT02285881|Randomized|Parallel Assignment||Treatment||Single||||||t
1400523|NCT02285868|||Ecologic or Community||Other|||||||
1400524|NCT02285855|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400525|NCT02285842|||Cohort||Prospective|||||||
1400526|NCT02285829|||Cohort||Prospective|||||||
1400527|NCT02285816|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400528|NCT02285803|Randomized|Parallel Assignment||Treatment||Double||||||
1400529|NCT02285790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400530|NCT02285777|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400531|NCT02285764|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1400532|NCT02285751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400533|NCT02285738|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400534|NCT02285725||Single Group Assignment||Treatment||None (Open Label)||||||
1400535|NCT02285712|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400536|NCT02285699||Single Group Assignment||Other||None (Open Label)||||||
1400537|NCT02285686|||Cohort||Prospective|||||||
1400538|NCT02285673|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400539|NCT02285660||||||||||||
1400540|NCT02285647|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1400541|NCT02285634|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400542|NCT02285621|Randomized|Parallel Assignment||Treatment||Single||||t||
1400543|NCT02285608|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1400544|NCT02285595||Single Group Assignment||Other||None (Open Label)||||||
1400545|NCT02285582|||Case-Only||Other|||||||
1400546|NCT02285569|||Cohort||Prospective|||||||
1400547|NCT02285556|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1400548|NCT02285543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400549|NCT02285530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400550|NCT02285517|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400551|NCT02285504||Single Group Assignment||Treatment||None (Open Label)||||||
1400552|NCT02285491|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400553|NCT02285478|||Cohort||Prospective|||||||
1400554|NCT02285465|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1400555|NCT02285452|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1400556|NCT02285439|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400557|NCT02285426|||Cohort||Prospective|||||||
1400558|NCT02285413|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400559|NCT02285400|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400560|NCT02285387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400561|NCT02285374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400562|NCT02285361|||Cohort||Prospective|||||||
1400563|NCT02285348|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1400564|NCT02285335|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400565|NCT02285322|||Cohort||Prospective|||||||
1400566|NCT02285309|||Cohort||Prospective|||||||
1400567|NCT02285296|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1400568|NCT02285283|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400569|NCT02285270||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400570|NCT02285257|||Ecologic or Community||Prospective|||||||
1400571|NCT02285244||Single Group Assignment||Treatment||None (Open Label)||||||
1400572|NCT02285231|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400573|NCT02285218|||Cohort||Prospective|||||||
1400574|NCT02285205||Single Group Assignment||Treatment||None (Open Label)||||||
1400575|NCT02285192||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400576|NCT02285179|Randomized|Parallel Assignment||Treatment||Triple|double blinded study||t|t|t|
1400577|NCT02285166|||Cohort||Prospective|||||||
1400578|NCT02285153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400579|NCT02285140|Randomized|Factorial Assignment||Prevention||Single||||||t
1400580|NCT02285127|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400581|NCT02285114|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1400582|NCT02285101|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400583|NCT02285088|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400584|NCT02285075||Single Group Assignment||Treatment||None (Open Label)||||||
1400585|NCT02285062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400586|NCT02285049|||Case-Only||Prospective|||||||
1400587|NCT02285036|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1400588|NCT02285023|||Case-Only||Prospective|||||||
1400589|NCT02285010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400590|NCT02284997|Randomized|Parallel Assignment||Treatment||Single|||||t|
1400591|NCT02284984||Single Group Assignment||Treatment||None (Open Label)||||||
1400592|NCT02284971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400593|NCT02284958|Randomized|Parallel Assignment||Treatment||Single||||||t
1400594|NCT02284945||||||||||||
1400595|NCT02284932|||Cohort||Prospective|||||||
1400596|NCT02284919||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400597|NCT02284906|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400598|NCT02284893|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400599|NCT02284880|Randomized|Crossover Assignment||Treatment||Single|||||t|
1400600|NCT02284867|||Case Control||Cross-Sectional|||||||
1400601|NCT02284854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400602|NCT02284841|Randomized|Single Group Assignment||Prevention||Single||||||t
1400603|NCT02284828||Single Group Assignment||Treatment||Single|||t|||
1400604|NCT02284815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400605|NCT02284802||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400606|NCT02284789||Single Group Assignment||||None (Open Label)||||||
1400607|NCT02284776|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1400608|NCT02284763||Single Group Assignment||Prevention||None (Open Label)||||||
1400609|NCT02284750|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400610|NCT02284737|Randomized|Parallel Assignment||Treatment||Single|||||t|
1400611|NCT02284724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400612|NCT02284711|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400613|NCT02284698|||||Prospective|||||||
1400614|NCT02284685|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1400615|NCT02284672|Randomized|Parallel Assignment||||Double|||t||t|
1400616|NCT02284659|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400617|NCT02284646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400618|NCT02284633|||Cohort||Prospective|||||||
1400619|NCT02284620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400620|NCT02284607|Randomized|Parallel Assignment||Other||Double|||t||t|
1400621|NCT02284594|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1400622|NCT02284581|||Cohort|||||||||
1400623|NCT02284568|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400624|NCT02284555||Single Group Assignment||Treatment||None (Open Label)||||||
1400625|NCT02284542|||Case-Control||Prospective|||||||
1400626|NCT02284529||Single Group Assignment||Treatment||Single|||t|||
1400627|NCT02284516|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400628|NCT02284503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400629|NCT02284490||Single Group Assignment||Treatment||None (Open Label)||||||
1400630|NCT02284477|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1400631|NCT02284464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400632|NCT02284451|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1400633|NCT02284438||Single Group Assignment||Health Services Research||None (Open Label)||||||
1400634|NCT02284425|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1400635|NCT02284412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400636|NCT02284399|||Case-Control||Retrospective|||||||
1400637|NCT02284386||Single Group Assignment||Treatment||None (Open Label)||||||
1400638|NCT02284373|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400639|NCT02284360|Randomized|Parallel Assignment||||Double|||t||t|
1400640|NCT02284347||Single Group Assignment||Treatment||None (Open Label)||||||
1400641|NCT02284334|||Case-Crossover||Prospective|||||||
1400642|NCT02284321||||||||||||
1400643|NCT02284308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400644|NCT02284295|||Case Control||Cross-Sectional|||||||
1400645|NCT02284282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400646|NCT02284269||||||||||||
1400647|NCT02284256|Randomized|Single Group Assignment||Treatment||Single|||t|||
1400648|NCT02284243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400649|NCT02284230|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400650|NCT02284217||Single Group Assignment||Screening||None (Open Label)||||||
1400651|NCT02284204|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1400652|NCT02284191|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1400653|NCT02284178|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1400654|NCT02284165|||Cohort||Retrospective|||||||
1400655|NCT02284152||Crossover Assignment||Basic Science||None (Open Label)||||||
1400656|NCT02284139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400657|NCT02284126|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1400658|NCT02284113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400659|NCT02284100|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400660|NCT02284087|||Other||Prospective|||||||
1400661|NCT02284074||Single Group Assignment||Basic Science||Single|||t|||
1400662|NCT02284061|Randomized|Parallel Assignment||||None (Open Label)||||||
1400663|NCT02284048|Randomized|Parallel Assignment||Treatment||Single||||||t
1400664|NCT02284035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400665|NCT02284022|||Ecologic or Community||Prospective|||||||
1400666|NCT02284009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400667|NCT02283996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400668|NCT02283983|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400669|NCT02283970|||Cohort||Prospective|||||||
1400670|NCT02283957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400671|NCT02283944||Single Group Assignment||Treatment||None (Open Label)||||||
1400672|NCT02283931|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1400673|NCT02283918|||Cohort||Prospective|||||||
1400674|NCT02283905||Single Group Assignment||Treatment||None (Open Label)||||||
1400675|NCT02283892|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400676|NCT02283879||Single Group Assignment||Treatment||None (Open Label)||||||
1400677|NCT02283866|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1400678|NCT02283853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400679|NCT02283840|Randomized|Crossover Assignment||Treatment||Single|||||t|
1400680|NCT02283827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400681|NCT02283814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400682|NCT02283801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400683|NCT02283788|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400684|NCT02283775||Single Group Assignment||Treatment||None (Open Label)||||||
1400685|NCT02283762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400686|NCT02283749||Single Group Assignment||Treatment||None (Open Label)||||||
1400687|NCT02283736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400688|NCT02283723|Randomized|Crossover Assignment||Prevention||Single||||||t
1400689|NCT02283710|Randomized|Parallel Assignment||Treatment||Double||||t||t
1400690|NCT02283697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400691|NCT02283684|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400692|NCT02283671||Single Group Assignment||Treatment||None (Open Label)||||||
1400693|NCT02283658||Single Group Assignment||Treatment||None (Open Label)||||||
1400694|NCT02283645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400695|NCT02283632||Single Group Assignment||Treatment||None (Open Label)||||||
1400696|NCT02283619|||Cohort||Prospective|||||||
1400697|NCT02283606|||Cohort||Prospective|||||||
1400698|NCT02283593|||Ecologic or Community||Prospective|||||||
1400699|NCT02283580|Randomized|Parallel Assignment||Treatment||Single||||||t
1400700|NCT02283567|||Cohort||Prospective|||||||
1400701|NCT02283554|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400702|NCT02283541|Randomized|Parallel Assignment||Treatment||Single||||||t
1400703|NCT02283528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400704|NCT02283515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400705|NCT02283502||Single Group Assignment||Treatment||None (Open Label)||||||
1400706|NCT02283489|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400707|NCT02283476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400708|NCT02283463|Randomized|Parallel Assignment||Prevention||Single|||t|||
1400710|NCT02283437|Randomized|Parallel Assignment||Health Services Research||Single|Outcome assessors are blind to the group assignment and intervention received by the participants|Repeated-measures, three-arm design||||t
1400711|NCT02283424|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400712|NCT02283411||Single Group Assignment||Other||None (Open Label)||||||
1400713|NCT02283398|Randomized|Parallel Assignment||||Double|||t|||t
1400714|NCT02283385||Single Group Assignment||Health Services Research||None (Open Label)||||||
1400715|NCT02283372||Single Group Assignment||Treatment||None (Open Label)||||||
1400716|NCT02283359||Single Group Assignment||Treatment||None (Open Label)||||||
1400717|NCT02283346||Single Group Assignment||Treatment||None (Open Label)||||||
1400718|NCT02283333|Randomized|Parallel Assignment||Treatment||Single||||||t
1400719|NCT02283320||Single Group Assignment||Treatment||None (Open Label)||||||
1400720|NCT02283307||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400721|NCT02283294|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400722|NCT02283281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400723|NCT02283268||Single Group Assignment||Treatment||None (Open Label)||||||
1400724|NCT02283255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400725|NCT02283242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400726|NCT02283229|Randomized|Parallel Assignment||Prevention||Single|||||t|
1400727|NCT02283216||Single Group Assignment||Other||None (Open Label)||||||
1400728|NCT02283203|Randomized|Parallel Assignment||||Double|||t||t|
1400729|NCT02283190||Single Group Assignment||Other||None (Open Label)||||||
1400730|NCT02283177|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400731|NCT02283164|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1400732|NCT02283151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400733|NCT02283138|||Case-Only||Prospective|||||||
1400734|NCT02283125||||||||||||
1400735|NCT02283112|||Case-Only||Prospective|||||||
1400736|NCT02283099||Single Group Assignment||Treatment||None (Open Label)||||||
1400737|NCT02283086|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1400738|NCT02283073|||Case-Control||Prospective|||||||
1400739|NCT02283060|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400740|NCT02283047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400741|NCT02283034|Randomized|Crossover Assignment||Treatment||Single|||t|||
1400742|NCT02283021|||Cohort||Prospective|||||||
1400743|NCT02283008|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400744|NCT02282995|||Case-Control||Cross-Sectional|||||||
1400745|NCT02282982|||Cohort||Prospective|||||||
1400746|NCT02282969|||Cohort||Cross-Sectional|||||||
1400747|NCT02282956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400748|NCT02282943|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400749|NCT02282930||Single Group Assignment||Treatment||None (Open Label)||||||
1400750|NCT02282917||Single Group Assignment||Treatment||None (Open Label)||||||
1400751|NCT02282904||Single Group Assignment||Treatment||None (Open Label)||||||
1400752|NCT02282891|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1400753|NCT02282878|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1400754|NCT02282865|||Case Control||Prospective|||||||
1400755|NCT02282852|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1400756|NCT02282839|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1400757|NCT02282826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400758|NCT02282813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400759|NCT02282800|||Case Control||Cross-Sectional|||||||
1400760|NCT02282787|Randomized|Parallel Assignment||||Double|||t||t|
1400761|NCT02282774|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1400762|NCT02282761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400763|NCT02282748|||Cohort||Prospective|||||||
1400764|NCT02282735|||Cohort||Prospective|||||||
1400765|NCT02282722|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1400766|NCT02282709||Single Group Assignment||Basic Science||None (Open Label)||||||
1400767|NCT02282696||Single Group Assignment||Other||None (Open Label)||||||
1400768|NCT02282683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400769|NCT02282670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400770|NCT02282657||Single Group Assignment||Treatment||None (Open Label)||||||
1400771|NCT02282644||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400772|NCT02282631|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1400773|NCT02282618|||Cohort||Prospective|||||||
1400774|NCT02282605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400775|NCT02282592|||Case Control||Cross-Sectional|||||||
1400776|NCT02282579|||Case-Only||Retrospective|||||||
1400777|NCT02282566|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1400778|NCT02282553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400779|NCT02282540||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400780|NCT02282527|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1400781|NCT02282514||Single Group Assignment||Treatment||None (Open Label)||||||
1400782|NCT02282501|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1400783|NCT02282488|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1400784|NCT02282475|||Other||Prospective|||||||
1400785|NCT02282462|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1400786|NCT02282449|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400787|NCT02282436|||Cohort||Prospective|||||||
1400788|NCT02282423|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1400789|NCT02282410||Single Group Assignment||Treatment||None (Open Label)||||||
1400790|NCT02282397|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1400791|NCT02282384|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1400792|NCT02282371||Single Group Assignment||Treatment||None (Open Label)||||||
1400793|NCT02282358||Single Group Assignment||Treatment||None (Open Label)||||||
1400794|NCT02282345||Single Group Assignment||Treatment||None (Open Label)||||||
1400795|NCT02282332||Single Group Assignment||Prevention||None (Open Label)||||||
1400796|NCT02282319|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1400797|NCT02282306||Single Group Assignment||Prevention||None (Open Label)||||||
1400798|NCT02282293|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400799|NCT02282280|||Cohort||Prospective|||||||
1400800|NCT02282267||Single Group Assignment||Treatment||None (Open Label)||Iressa treatment oral daily||||
1400801|NCT02282254|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400802|NCT02282241|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400803|NCT02282228||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400804|NCT02282215|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400805|NCT02282202||Crossover Assignment||Treatment||None (Open Label)||||||
1400806|NCT02282189||Crossover Assignment||Treatment||None (Open Label)||||||
1400807|NCT02282176|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400808|NCT02282163||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400809|NCT02282150||Single Group Assignment||Treatment||None (Open Label)||Cross over||||
1400810|NCT02282137||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400811|NCT02282124|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400812|NCT02282111|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1400813|NCT02282098|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400814|NCT02282085|Randomized|Parallel Assignment||Treatment||Single||||||t
1400815|NCT02282072|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1400816|NCT02282059|||Other||Prospective|||||||
1400817|NCT02282046|||Cohort||Prospective|||||||
1400818|NCT02282033||Single Group Assignment||Treatment||None (Open Label)||||||
1400819|NCT02282020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400820|NCT02282007|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400821|NCT02281994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400822|NCT02281981|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1400823|NCT02281968|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1400824|NCT02281955||Single Group Assignment||Treatment||None (Open Label)||||||
1400825|NCT02281942|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1400826|NCT02281929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400827|NCT02281916||Single Group Assignment||Treatment||None (Open Label)||||||
1400828|NCT02281903|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400829|NCT02281890|||Cohort||Prospective|||||||
1400830|NCT02281877|Randomized|Parallel Assignment||Treatment||Single|||||t|
1400831|NCT02281864|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400832|NCT02281851|||Case Control|||||||||
1400833|NCT02281838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400834|NCT02281825|||Cohort||Cross-Sectional|||||||
1400835|NCT02281812|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400836|NCT02281799||Single Group Assignment||Treatment||None (Open Label)||||||
1400837|NCT02281786|Randomized|Parallel Assignment||||Double|||t||t|
1400838|NCT02281773|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400839|NCT02281760||Single Group Assignment||Treatment||None (Open Label)||||||
1400840|NCT02281747|||Cohort||Retrospective|||||||
1400841|NCT02281721|||Cohort||Prospective|||||||
1400842|NCT02281708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400843|NCT02281695|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1400844|NCT02281682|Randomized|Parallel Assignment||Treatment||Single|||||t|
1400845|NCT02281669|||Cohort||Prospective|||||||
1400846|NCT02281656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400847|NCT02281643|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1400848|NCT02281630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400849|NCT02281617|||Case-Only||Prospective|||||||
1400850|NCT02281604|||Cohort||Prospective|||||||
1400851|NCT02281591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400852|NCT02281578|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1400853|NCT02281565|||Cohort||Retrospective|||||||
1400854|NCT02281552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400855|NCT02281539||Single Group Assignment||Treatment||None (Open Label)||||||
1400856|NCT02281526||Parallel Assignment||Treatment||None (Open Label)||||||
1400857|NCT02281513||Single Group Assignment||Prevention||None (Open Label)||||||
1400858|NCT02281500||Single Group Assignment||Treatment||None (Open Label)||||||
1400859|NCT02281487|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400860|NCT02281474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400861|NCT02281461|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400862|NCT02281448|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400863|NCT02281435||Single Group Assignment||Prevention||None (Open Label)||||||
1400864|NCT02281422|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400865|NCT02281409||Single Group Assignment||Treatment||None (Open Label)||||||
1400866|NCT02281396|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1400867|NCT02281383||Single Group Assignment||Treatment||None (Open Label)||||||
1400868|NCT02281370|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1400869|NCT02281357|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400870|NCT02281344|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1400871|NCT02281331|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1400872|NCT02281318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400873|NCT02281305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400874|NCT02281292|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400875|NCT02281279||Single Group Assignment||Treatment||None (Open Label)||||||
1400876|NCT02281266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400877|NCT02281253|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1400878|NCT02281240|||||Prospective|||||||
1400879|NCT02281227|Randomized|Parallel Assignment||||Single|||t|||
1400880|NCT02281214||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400881|NCT02281201||Single Group Assignment||Treatment||None (Open Label)||||||
1400882|NCT02281188|||Cohort||Prospective|||||||
1400883|NCT02281175|Randomized|Parallel Assignment||Treatment||Single||||||t
1400884|NCT02281162|||Cohort||Cross-Sectional|||||||
1400885|NCT02281149|||Case-Only||Prospective|||||||
1400886|NCT02281136||Single Group Assignment||||None (Open Label)||||||
1400887|NCT02281123|||Cohort||Prospective|||||||
1400888|NCT02281110|||Cohort||Prospective|||||||
1400889|NCT02281097|Randomized|Crossover Assignment||Other||Double|||t|||t
1400890|NCT02281084||Single Group Assignment||Treatment||None (Open Label)||||||
1400891|NCT02281071|Randomized|Parallel Assignment||Treatment||Single|||||t|
1400892|NCT02281058||Single Group Assignment||Treatment||None (Open Label)||||||
1400893|NCT02281045|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400894|NCT02281032|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1400895|NCT02281019|||Case-Only||Prospective|||||||
1400896|NCT02281006|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1400897|NCT02280993||Single Group Assignment||Treatment||None (Open Label)||||||
1400898|NCT02280980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400899|NCT02280967|Randomized|Parallel Assignment||Prevention||None (Open Label)|Open label|||||
1400900|NCT02280954||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400901|NCT02280941||Single Group Assignment||Diagnostic||None (Open Label)||||||
1400902|NCT02280928|Randomized|Parallel Assignment||Treatment||Single||||||t
1400903|NCT02280915|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1400904|NCT02280902|||Cohort||Prospective|||||||
1400905|NCT02280889|||Cohort||Prospective|||||||
1400906|NCT02280876|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400907|NCT02280863|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1400908|NCT02280850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400909|NCT02280837|||Case-Only||Cross-Sectional|||||||
1400910|NCT02280824||Single Group Assignment||Treatment||None (Open Label)||||||
1400911|NCT02280811||Single Group Assignment||Treatment||None (Open Label)||||||
1400912|NCT02280798|||||Prospective|||||||
1400913|NCT02280785||Single Group Assignment||Treatment||None (Open Label)||||||
1400914|NCT02280772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400915|NCT02280759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400916|NCT02280746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400917|NCT02280733|||Other||Prospective|||||||
1400918|NCT02280720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400919|NCT02280707|Randomized|Parallel Assignment||Treatment||Single||||||t
1400920|NCT02280694||Single Group Assignment||Treatment||None (Open Label)||||||
1400921|NCT02280681|||Cohort||Cross-Sectional|||||||
1400922|NCT02280668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400923|NCT02280655|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400924|NCT02280642|||||Prospective|||||||
1400925|NCT02280629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400926|NCT02280616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400927|NCT02280603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400928|NCT02280590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400929|NCT02280577||||||||||||
1400930|NCT02280564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400931|NCT02280551|||Cohort||Prospective|||||||
1400932|NCT02280538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400933|NCT02280525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400934|NCT02280512|||Cohort||Prospective|||||||
1400935|NCT02280499|||Cohort||Prospective|||||||
1400936|NCT02280486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400937|NCT02280473|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400938|NCT02280460|||Case-Control||Other|||||||
1400939|NCT02280447|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1400940|NCT02280434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400941|NCT02280421|Randomized|Crossover Assignment||||None (Open Label)||||||
1400942|NCT02280408|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1400943|NCT02280395|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1400944|NCT02280382||Single Group Assignment||Supportive Care||None (Open Label)||||||
1400945|NCT02280369|||Cohort||Cross-Sectional|||||||
1400946|NCT02280356||Single Group Assignment||Treatment||None (Open Label)||||||
1400947|NCT02280343|||||Cross-Sectional|||||||
1400948|NCT02280330|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1400949|NCT02280317||Single Group Assignment||Treatment||None (Open Label)||||||
1400950|NCT02280304|Randomized|Parallel Assignment||Treatment||Single||||||t
1400951|NCT02280291|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1400952|NCT02280278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400953|NCT02280265||Single Group Assignment||Treatment||None (Open Label)||||||
1400954|NCT02280252||Single Group Assignment||Treatment||None (Open Label)||||||
1400955|NCT02280239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400956|NCT02280226||Single Group Assignment||Basic Science||None (Open Label)||||||
1400957|NCT02280213|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1400958|NCT02280200||Single Group Assignment||Treatment||None (Open Label)||||||
1400959|NCT02280187|||Cohort||Retrospective|||||||
1400960|NCT02280174|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1400961|NCT02280161|||Cohort||Prospective|||||||
1400962|NCT02280148||Single Group Assignment||Supportive Care||None (Open Label)||||||
1400963|NCT02280135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400964|NCT02280122|||Case Control||Cross-Sectional|||||||
1400965|NCT02280109|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1400966|NCT02280096|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1400967|NCT02280083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400968|NCT02280070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400969|NCT02280057|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1400970|NCT02280044|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400971|NCT02280031|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1400972|NCT02280018|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1400973|NCT02280005||Single Group Assignment||Treatment||None (Open Label)||||||
1400974|NCT02279992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400975|NCT02279979||Single Group Assignment||Treatment||None (Open Label)||||||
1400976|NCT02279966|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400977|NCT02279953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1400978|NCT02279940|||Cohort||Prospective|||||||
1400979|NCT02279927|Randomized|Parallel Assignment||Treatment||Single|||t|||
1400980|NCT02279914|Randomized|Parallel Assignment||Treatment||Single||||t||
1400981|NCT02279901|Randomized|Parallel Assignment||Health Services Research||Double||||t|t|
1400982|NCT02279888|||Cohort||Prospective|||||||
1400983|NCT02279875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400984|NCT02279862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400985|NCT02279849|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1400986|NCT02279836||Single Group Assignment||Screening||None (Open Label)||||||
1400987|NCT02279823|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1400988|NCT02279810|||Cohort||Retrospective|||||||
1400989|NCT02279797|||Cohort||Retrospective|||||||
1400990|NCT02279784|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1400991|NCT02279771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400992|NCT02279758||Single Group Assignment||Treatment||None (Open Label)||||||
1400993|NCT02279745||Single Group Assignment||Treatment||None (Open Label)||||||
1400994|NCT02279732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1400995|NCT02279719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1400996|NCT02279706|||Cohort||Prospective|||||||
1400997|NCT02279693|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1400998|NCT02279680|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1400999|NCT02279667|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401000|NCT02279654|||Cohort||Prospective|||||||
1401001|NCT02279641|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1401002|NCT02279628|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401003|NCT02279615|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1401004|NCT02279602||Single Group Assignment||Treatment||None (Open Label)||||||
1401005|NCT02279589|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401006|NCT02279576||Single Group Assignment||Treatment||None (Open Label)||||||
1401007|NCT02279563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401008|NCT02279550|||Cohort||Prospective|||||||
1401009|NCT02279537|||Cohort||Other|||||||
1401010|NCT02279524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401011|NCT02279511|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1401012|NCT02279498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401013|NCT02279485|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1401014|NCT02279472||Single Group Assignment||Treatment||None (Open Label)||||||
1401015|NCT02279459|||Cohort||Prospective|||||||
1401016|NCT02279446|||||Cross-Sectional|||||||
1401017|NCT02279433||Single Group Assignment||Treatment||None (Open Label)||||||
1401018|NCT02279420||Single Group Assignment||Treatment||None (Open Label)||||||
1401019|NCT02279407|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401020|NCT02279394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401021|NCT02279381|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401022|NCT02279368|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1401023|NCT02279355|||Case Control||Retrospective|||||||
1401024|NCT02279342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401025|NCT02279329||Single Group Assignment||Basic Science||None (Open Label)||||||
1401026|NCT02279316|Randomized|Parallel Assignment||Prevention||Single|||||t|
1401027|NCT02279303|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1401028|NCT02279290|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401029|NCT02279277|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401030|NCT02279264|||Cohort||Prospective|||||||
1401031|NCT02279251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401032|NCT02279238|||Case-Crossover||Prospective|||||||
1401033|NCT02279225|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1401034|NCT02279212|||Other||Prospective|||||||
1401035|NCT02279199|||Case-Control||Cross-Sectional|||||||
1401036|NCT02279186|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1401037|NCT02279173||Single Group Assignment||Treatment||None (Open Label)||||||
1401038|NCT02279160|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401039|NCT02279147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401040|NCT02279134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401041|NCT02279121|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401042|NCT02279108|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401043|NCT02279095|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401044|NCT02279082||Single Group Assignment||Treatment||None (Open Label)||||||
1401045|NCT02279069|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401046|NCT02279056|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401047|NCT02279043|Randomized|Parallel Assignment||||Single|||t|||
1401048|NCT02279030|||Case-Control||Retrospective|||||||
1401049|NCT02279017||Single Group Assignment||Basic Science||None (Open Label)||||||
1401050|NCT02279004|||Cohort||Prospective|||||||
1401051|NCT02278991|||Cohort||Prospective|||||||
1401052|NCT02278978|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401053|NCT02278965||Single Group Assignment||Treatment||None (Open Label)||||||
1401054|NCT02278952|||Cohort||Prospective|||||||
1401055|NCT02278939|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401056|NCT02278926|||Case Control||Retrospective|||||||
1401057|NCT02278913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401058|NCT02278900|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401059|NCT02278887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401060|NCT02278874|||Cohort||Prospective|||||||
1401061|NCT02278861|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401062|NCT02278848||Single Group Assignment||||None (Open Label)||||||
1401063|NCT02278835|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401064|NCT02278822|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1401065|NCT02278809|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401066|NCT02278796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401067|NCT02278783||Single Group Assignment||Treatment||None (Open Label)||||||
1401068|NCT02278770|||Cohort||Prospective|||||||
1401069|NCT02278757|Randomized|Single Group Assignment||Treatment||Single|||t|||
1401070|NCT02278744||Single Group Assignment||Treatment||None (Open Label)||||||
1401071|NCT02278731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401072|NCT02278718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401073|NCT02278705|||Case-Control||Retrospective|||||||
1401074|NCT02278692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401075|NCT02278679|||Cohort||Prospective|||||||
1401076|NCT02278666|||Cohort||Prospective|||||||
1401077|NCT02278653|||Cohort||Prospective|||||||
1401078|NCT02278640||Single Group Assignment||Treatment||None (Open Label)||||||
1401079|NCT02278627|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401080|NCT02278614|Randomized|Parallel Assignment||Treatment||Single|||||t|
1401081|NCT02278601|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1401082|NCT02278588|||Case Control||Prospective|||||||
1401083|NCT02278575||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401084|NCT02278562|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401085|NCT02278549|||Case Control||Cross-Sectional|||||||
1401086|NCT02278536|||Cohort||Prospective|||||||
1401087|NCT02278523|Randomized|Single Group Assignment||Treatment||Single|||t|||
1401088|NCT02278510||Single Group Assignment||Treatment||None (Open Label)||||||
1401089|NCT02278497||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401090|NCT02278484||Single Group Assignment||Treatment||None (Open Label)||||||
1401091|NCT02278471|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401092|NCT02278458||Single Group Assignment||Treatment||None (Open Label)||||||
1401093|NCT02278445||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401094|NCT02278432|||||Prospective|||||||
1401095|NCT02278419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401096|NCT02278406||Single Group Assignment||Basic Science||None (Open Label)||||||
1401097|NCT02278393|Randomized|Parallel Assignment||||Triple|||t||t|t
1401098|NCT02278380|Randomized|Single Group Assignment||||None (Open Label)||||||
1401099|NCT02278367||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401100|NCT02278354|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1402558|NCT02259387|||Case-Control||Prospective|||||||
1401101|NCT02278341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401102|NCT02278328|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1401103|NCT02278315||Single Group Assignment||Treatment||None (Open Label)||||||
1401104|NCT02278302|Randomized|Parallel Assignment||Treatment||Double||||||
1401105|NCT02278289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401106|NCT02278276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401107|NCT02278263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401108|NCT02278250|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401109|NCT02278237||Single Group Assignment||Health Services Research||None (Open Label)||||||
1401110|NCT02278224|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1401111|NCT02278211|||Cohort||Prospective|||||||
1401112|NCT02278198||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401113|NCT02278185|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401114|NCT02278172|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1401115|NCT02278159|||Cohort||Prospective|||||||
1401116|NCT02278146|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401117|NCT02278133||Single Group Assignment||Treatment||None (Open Label)||||||
1401118|NCT02278120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401119|NCT02278107|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1401120|NCT02278094|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401121|NCT02278081|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401122|NCT02278068||Single Group Assignment||Treatment||None (Open Label)||||||
1401123|NCT02278055||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401124|NCT02278042|Randomized|Parallel Assignment||Basic Science||Single||||||t
1401125|NCT02278029|||Case Control||Retrospective|||||||
1401126|NCT02278016|||Case-Only||Prospective|||||||
1401127|NCT02278003|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401128|NCT02277990|Randomized|Parallel Assignment||Prevention||Single|||t|||
1401129|NCT02277977||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401130|NCT02277964|||Cohort||Prospective|||||||
1401131|NCT02277951|||Cohort||Prospective|||||||
1401132|NCT02277938||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401133|NCT02277925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401134|NCT02277912|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1401135|NCT02277899|||Cohort||Prospective|||||||
1401136|NCT02277886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401137|NCT02277873|||Ecologic or Community||Retrospective|||||||
1401138|NCT02277860||Single Group Assignment||Treatment||None (Open Label)||||||
1401139|NCT02277847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401140|NCT02277834|||Cohort||Prospective|||||||
1401141|NCT02277821||Single Group Assignment||Treatment||None (Open Label)||||||
1401142|NCT02277808|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1401143|NCT02277795||Single Group Assignment||Health Services Research||None (Open Label)||||||
1401144|NCT02277782|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1401145|NCT02277769|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401146|NCT02277756|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401147|NCT02277743|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401148|NCT02277730|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401149|NCT02277717||Single Group Assignment||Treatment||None (Open Label)||||||
1401150|NCT02277704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401151|NCT02277691||Single Group Assignment||Treatment||None (Open Label)||||||
1401152|NCT02277678|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1401153|NCT02277665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401154|NCT02277652|Randomized|Crossover Assignment||Treatment||Single||||||t
1401155|NCT02277639|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Reduced intensity conditioning with chemotherapy followed by stem cell transplant using the CliniMACs device to deplete CD3+ CD19+ peripheral stem cells.||||
1401156|NCT02277626|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1401157|NCT02277613|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401158|NCT02277600|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401159|NCT02277587|Randomized|Parallel Assignment||Treatment||Single||||||t
1401160|NCT02277574|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1401161|NCT02277561||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401162|NCT02277548|Randomized|Parallel Assignment||Treatment||||||||
1401163|NCT02277535|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1401164|NCT02277522||Single Group Assignment||Treatment||None (Open Label)||||||
1401165|NCT02277509|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1401166|NCT02277496|Non-Randomized|Factorial Assignment||Other||None (Open Label)||During the 2014-2015 school year a 2-arm design was used to compare outcomes between intervention and comparison schools. Subsequent years utilized a single-arm design to analyse trends between and within intervention schools only.||||
1401167|NCT02277483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401168|NCT02277470|||Cohort||Prospective|||||||
1401169|NCT02277457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401170|NCT02277444||Single Group Assignment||Treatment||None (Open Label)||||||
1401171|NCT02277431|Randomized|Parallel Assignment||||Double|||t||t|
1401172|NCT02277418|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401173|NCT02277405|Randomized|Crossover Assignment||Treatment||Single||||||t
1401174|NCT02277392||Single Group Assignment||Treatment||||||||
1401175|NCT02277379|||Cohort||Prospective|||||||
1401176|NCT02277366|||Case Control||Prospective|||||||
1401177|NCT02277353|||Cohort||Prospective|||||||
1401178|NCT02277340||Single Group Assignment||Treatment||None (Open Label)||||||
1401179|NCT02277327|Randomized|Single Group Assignment||Health Services Research||Double|||t||t|
1401180|NCT02277314||Single Group Assignment||Treatment||None (Open Label)||||||
1401181|NCT02277301|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1401182|NCT02277288|Randomized|Single Group Assignment||Other||Single|||t|||
1401183|NCT02277275|Randomized|Parallel Assignment||Other||Single|||t|||
1401184|NCT02277262|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401185|NCT02277249|Randomized|Parallel Assignment||||None (Open Label)||||||
1401186|NCT02277236|||Cohort||Prospective|||||||
1401187|NCT02277223|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1401188|NCT02277210|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401189|NCT02277197||Single Group Assignment||Other||None (Open Label)||||||
1401190|NCT02277184||Single Group Assignment||Other||None (Open Label)||||||
1401191|NCT02277171||Single Group Assignment||Prevention||None (Open Label)||||||
1401192|NCT02277158||Single Group Assignment||Treatment||None (Open Label)||||||
1401193|NCT02277145||Single Group Assignment||Treatment||None (Open Label)||||||
1401194|NCT02277132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401195|NCT02277119|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1401196|NCT02277106|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1401197|NCT02277093||Single Group Assignment||Treatment||None (Open Label)||||||
1401198|NCT02277080|||Other||Prospective|||||||
1401199|NCT02277067|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1401200|NCT02277054||Single Group Assignment||Treatment||None (Open Label)||||||
1401201|NCT02277041|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1401202|NCT02277028|Randomized|Parallel Assignment||Treatment||Single||||||t
1401203|NCT02277015|Randomized|Crossover Assignment||Treatment||Single||||||t
1401204|NCT02277002|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1401205|NCT02276989||Single Group Assignment||Other||None (Open Label)||||||
1401206|NCT02276976|||Case Control||Prospective|||||||
1401207|NCT02276963||Single Group Assignment||Treatment||None (Open Label)||||||
1401208|NCT02276950|||Cohort||Prospective|||||||
1401209|NCT02276937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401210|NCT02276924||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401211|NCT02276911|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401212|NCT02276898|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1401213|NCT02276885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401214|NCT02276872|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401215|NCT02276859|Randomized|Crossover Assignment||Treatment||Single|||||t|
1401216|NCT02276846|||||Prospective|||||||
1401217|NCT02276833||Single Group Assignment||Treatment||None (Open Label)||||||
1401218|NCT02276820||Single Group Assignment||Treatment||None (Open Label)||||||
1401219|NCT02276807|Randomized|Parallel Assignment||Treatment||Single||||||t
1401220|NCT02276794|Randomized|Parallel Assignment||Treatment||Single||||||t
1401221|NCT02276781|||Cohort||Prospective|||||||
1401222|NCT02276768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401223|NCT02276755|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1401224|NCT02276742|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1401225|NCT02276729|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1401226|NCT02276716||Single Group Assignment||Treatment||None (Open Label)||||||
1401227|NCT02276703|||Other||Prospective|||||||
1401228|NCT02276690|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1401229|NCT02276677|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1401230|NCT02276664|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1401231|NCT02276651|||Case-Control||Prospective|||||||
1401232|NCT02276638|||Cohort||Prospective|||||||
1401233|NCT02276625|Randomized|Parallel Assignment||Prevention||Single||||||t
1401234|NCT02276612||Single Group Assignment||Treatment||None (Open Label)||||||
1401235|NCT02276599|||Case-Only||Prospective|||||||
1401236|NCT02276586|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401237|NCT02276573||Single Group Assignment||Basic Science||None (Open Label)||||||
1401238|NCT02276560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401239|NCT02276547||Single Group Assignment||Treatment||None (Open Label)||||||
1401240|NCT02276534|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401241|NCT02276521|||Cohort||Retrospective|||||||
1401242|NCT02276508||Single Group Assignment||||None (Open Label)||||||
1401243|NCT02276495|Randomized|Factorial Assignment||Supportive Care||Quadruple|||t|t|t|t
1401244|NCT02276482|Randomized|Parallel Assignment||Treatment||Single|||||t|
1401245|NCT02276469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401246|NCT02276456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401247|NCT02276443||Single Group Assignment||Treatment||None (Open Label)||||||
1401248|NCT02276430|||Cohort||Cross-Sectional|||||||
1401249|NCT02276417|||Cohort||Prospective|||||||
1401250|NCT02276404|Randomized|Parallel Assignment||Treatment||Single||||||t
1401251|NCT02276391|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401252|NCT02276378|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401253|NCT02276365|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401254|NCT02276352|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401255|NCT02276339||Single Group Assignment||Treatment||None (Open Label)||||||
1401256|NCT02276326||Single Group Assignment||Treatment||None (Open Label)||||||
1401257|NCT02276313|||Other||Prospective|||||||
1401258|NCT02276300||Single Group Assignment||Treatment||None (Open Label)||||||
1401259|NCT02276287|||Cohort||Cross-Sectional|||||||
1401260|NCT02276274|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1401261|NCT02276261|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401262|NCT02276248||Single Group Assignment||Treatment||None (Open Label)||||||
1401263|NCT02276235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401264|NCT02276222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401265|NCT02276209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401266|NCT02276196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401267|NCT02276183||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401268|NCT02276170|||Cohort||Prospective|||||||
1401269|NCT02276157|||Cohort||Retrospective|||||||
1401270|NCT02276144|||Cohort||Prospective|||||||
1401271|NCT02276131||Single Group Assignment||||None (Open Label)||||||
1401272|NCT02276118|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401273|NCT02276105|||Cohort||Prospective|||||||
1401274|NCT02276092|||Cohort||Prospective|||||||
1401275|NCT02276079|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401276|NCT02276066|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1401277|NCT02276053|||Cohort||Prospective|||||||
1401278|NCT02276040|||Case-Only||Prospective|||||||
1401279|NCT02276027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401280|NCT02276014|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1401281|NCT02276001|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1401282|NCT02275988|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1401283|NCT02275975|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1401284|NCT02275962|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1401285|NCT02275949|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1401286|NCT02275936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401287|NCT02275923||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401288|NCT02275910||Single Group Assignment||Treatment||None (Open Label)||||||
1401289|NCT02275897|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401290|NCT02275884|Randomized|Crossover Assignment||Basic Science||Single||||||t
1401291|NCT02275871||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401292|NCT02275858|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1401293|NCT02275845|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401294|NCT02275832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401295|NCT02275819|||Case-Control||Prospective|||||||
1401296|NCT02275806||Single Group Assignment||Treatment||None (Open Label)||||||
1401297|NCT02275793|||Cohort||Prospective|||||||
1401298|NCT02275780|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401299|NCT02275767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401300|NCT02275754|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1401301|NCT02275741|||Cohort||Prospective|||||||
1401302|NCT02275728|Randomized|Crossover Assignment||Treatment||Single|||||t|
1401303|NCT02275715|Randomized|Parallel Assignment||Treatment||Single||||||t
1401304|NCT02275702|Randomized|Parallel Assignment||||Triple|||t|t|t|
1401305|NCT02275689|Randomized|Parallel Assignment||Treatment||Single||||||t
1401306|NCT02275676|||Cohort||Prospective|||||||
1401307|NCT02275663||Single Group Assignment||Treatment||None (Open Label)||||||
1401308|NCT02275650|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401309|NCT02275637|||Cohort||Prospective|||||||
1401310|NCT02275624||||||||||||
1401311|NCT02275611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401312|NCT02275598||Single Group Assignment||Treatment||None (Open Label)||||||
1401313|NCT02275585|||Cohort||Prospective|||||||
1401314|NCT02275572|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401315|NCT02275559|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401316|NCT02275546|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401317|NCT02275533|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401318|NCT02275520|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401319|NCT02275507|||Case-Only||Prospective|||||||
1401320|NCT02275494|||Cohort||Prospective|||||||
1401321|NCT02275481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401322|NCT02275468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401323|NCT02275455|Non-Randomized|Parallel Assignment||Prevention||Double|||||t|t
1401324|NCT02275442||||||||||||
1401325|NCT02275429||Single Group Assignment||Basic Science||None (Open Label)||||||
1401326|NCT02275416||Single Group Assignment||Treatment||None (Open Label)||||||
1401327|NCT02275403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401328|NCT02275390|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1401329|NCT02275377|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1401330|NCT02275364|Randomized|Crossover Assignment||Basic Science||Single||||||t
1401331|NCT02275351|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401332|NCT02275338||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401333|NCT02275325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401334|NCT02275312|||Other||Prospective|||||||
1401335|NCT02275299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401336|NCT02275286||Single Group Assignment||Treatment||None (Open Label)||||||
1401337|NCT02275273|||Cohort||Prospective|||||||
1401338|NCT02275260||Single Group Assignment||Screening||None (Open Label)||||||
1401339|NCT02275247|Randomized|Parallel Assignment||Prevention||Single|||t|||
1401340|NCT02275234|||Other||Other|||||||
1401341|NCT02275221|||Other||Prospective|||||||
1401342|NCT02275208|||Case-Only||Prospective|||||||
1401343|NCT02275195|||Other||Prospective|||||||
1401344|NCT02275182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401345|NCT02275169|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401346|NCT02275156||Single Group Assignment||Treatment||None (Open Label)||||||
1401347|NCT02275143|||Cohort||Prospective|||||||
1401348|NCT02275130||Single Group Assignment||Treatment||None (Open Label)||||||
1401349|NCT02275117|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1401350|NCT02275104|||Cohort||Retrospective|||||||
1401351|NCT02275091|||Case-Control||Cross-Sectional|||||||
1401352|NCT02275078||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401353|NCT02275065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401354|NCT02275052|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1401355|NCT02275039||Single Group Assignment||Treatment||None (Open Label)||||||
1401356|NCT02275026||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401357|NCT02275013|||Cohort||Retrospective|||||||
1401358|NCT02275000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401359|NCT02274987||Single Group Assignment||Treatment||None (Open Label)||||||
1401360|NCT02274974|Randomized|Parallel Assignment||Screening||Double|||t|||t
1401361|NCT02274961|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401362|NCT02274948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401363|NCT02274935|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1401364|NCT02274922|||Cohort||Prospective|||||||
1401365|NCT02274909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401366|NCT02274896||Single Group Assignment||Treatment||None (Open Label)||||||
1401367|NCT02274883|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1401368|NCT02274870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401369|NCT02274857|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401370|NCT02274844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401371|NCT02274831|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1401372|NCT02274818|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401373|NCT02274805|||Cohort||Retrospective|||||||
1401374|NCT02274792||Single Group Assignment||Treatment||None (Open Label)||||||
1401375|NCT02274779||Single Group Assignment||Treatment||None (Open Label)||||||
1401376|NCT02274766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401377|NCT02274753|||Cohort||Prospective|||||||
1401378|NCT02274740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401379|NCT02274727|||Cohort||Prospective|||||||
1401380|NCT02274714|||Case-Control||Prospective|||||||
1401381|NCT02274701|Randomized|Parallel Assignment||Supportive Care||||||||
1401382|NCT02274688|Randomized|Parallel Assignment||Health Services Research||Single||Patient-centered care transition intervention||||t
1401383|NCT02274675||Single Group Assignment||Treatment||Single||||||t
1401384|NCT02274662||||||||||||
1401385|NCT02274649|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1401386|NCT02274636|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1401387|NCT02274623||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401388|NCT02274610|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401389|NCT02274597|||Cohort||Prospective|||||||
1401390|NCT02274584||Single Group Assignment||Treatment||None (Open Label)||||||
1401391|NCT02274571|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1401392|NCT02274558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401393|NCT02274545||Single Group Assignment||Prevention||None (Open Label)||||||
1401394|NCT02274532|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1401395|NCT02274519|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401396|NCT02274506||Single Group Assignment||Treatment||None (Open Label)||||||
1401397|NCT02274493||Single Group Assignment||Treatment||None (Open Label)||||||
1401398|NCT02274480|||Case-Control||Prospective|||||||
1401399|NCT02274467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401400|NCT02274454|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401401|NCT02274441|||Cohort||Retrospective|||||||
1401402|NCT02274428||Single Group Assignment||Treatment||None (Open Label)||||||
1401403|NCT02274415|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1401404|NCT02274402|||Cohort||Prospective|||||||
1401405|NCT02274389|||Cohort||Prospective|||||||
1401406|NCT02274376|||Cohort||Prospective|||||||
1401407|NCT02274363|||Cohort||Cross-Sectional|||||||
1401408|NCT02274350|||Cohort||Cross-Sectional|||||||
1401409|NCT02274337||Single Group Assignment||Treatment||None (Open Label)||||||
1401410|NCT02274324|Randomized|Crossover Assignment||Treatment||Single|||||t|
1401411|NCT02274311||Single Group Assignment||Treatment||None (Open Label)||||||
1401412|NCT02274298|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401413|NCT02274285|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1401414|NCT02274272|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401415|NCT02274259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401416|NCT02274246||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401417|NCT02274233|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401418|NCT02274220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401419|NCT02274207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401420|NCT02274194|Randomized|Crossover Assignment||Treatment||Single||||||t
1401421|NCT02274181||Single Group Assignment||Treatment||None (Open Label)||||||
1401422|NCT02274168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401423|NCT02274155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401424|NCT02274142|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1401425|NCT02274129||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401426|NCT02274116|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1401427|NCT02274103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401428|NCT02274090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401429|NCT02274077|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401430|NCT02274064|Randomized|Parallel Assignment||||Single|||t|||
1401431|NCT02274051||Single Group Assignment||Treatment||None (Open Label)||||||
1401432|NCT02274038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401433|NCT02274025|||Cohort||Prospective|||||||
1401434|NCT02274012||Single Group Assignment||Treatment||None (Open Label)||||||
1401435|NCT02273999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401436|NCT02273986|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1401437|NCT02273973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401438|NCT02273960|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401439|NCT02273947|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1401440|NCT02273934|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401441|NCT02273921||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401442|NCT02273908|||||Prospective|||||||
1401443|NCT02273895|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401444|NCT02273882|||Case-Only||Prospective|||||||
1401445|NCT02273869|||Cohort||Prospective|||||||
1401446|NCT02273856|||Cohort||Prospective|||||||
1401447|NCT02273843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401448|NCT02273830|Randomized|Crossover Assignment||Treatment||Single|||t|||
1401449|NCT02273817|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1401450|NCT02273804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401451|NCT02273791|||Cohort||Retrospective|||||||
1401452|NCT02273778||||||||||||
1401453|NCT02273765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401454|NCT02273752||Single Group Assignment||Treatment||None (Open Label)||||||
1401455|NCT02273739||Single Group Assignment||Treatment||None (Open Label)||||||
1401456|NCT02273726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401457|NCT02273713||Single Group Assignment||Treatment||None (Open Label)||||||
1401458|NCT02273700|||Cohort||Prospective|||||||
1401459|NCT02273687||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401460|NCT02273674|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401461|NCT02273661|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401462|NCT02273648|||Other||Prospective|||||||
1401463|NCT02273635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401464|NCT02273622|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1401465|NCT02273609|||Cohort||Retrospective|||||||
1401466|NCT02273596||Single Group Assignment||Treatment||None (Open Label)||||||
1401467|NCT02273583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401468|NCT02273570|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401469|NCT02273557|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401470|NCT02273544|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401471|NCT02273531|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401472|NCT02273518|Randomized|Crossover Assignment||Treatment||Double||||||
1401473|NCT02273505|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401474|NCT02273492|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401475|NCT02273479|Randomized|Parallel Assignment||Treatment||Double||||||
1401476|NCT02273466|Randomized|Crossover Assignment||Treatment||Single||||||
1401477|NCT02273453|Randomized|Crossover Assignment||Treatment||Double||||||
1401478|NCT02273440|Randomized|Crossover Assignment||Treatment||Double||||||
1401479|NCT02273427|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401480|NCT02273414|Randomized|Parallel Assignment||Treatment||Double||||||
1401481|NCT02273401|Randomized|Parallel Assignment||Treatment||Double||||||
1401482|NCT02273388||||Treatment||None (Open Label)||||||
1401483|NCT02273375|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401484|NCT02273362||Single Group Assignment||Prevention||None (Open Label)||||||
1401485|NCT02273349||Single Group Assignment||Treatment||None (Open Label)||||||
1401486|NCT02273336|||Case-Only||Prospective|||||||
1401487|NCT02273323|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1402715|NCT02257307|||Cohort||Prospective|||||||
1401488|NCT02273310|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401489|NCT02273297|||Cohort||Prospective|||||||
1401490|NCT02273284|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401491|NCT02273271||Single Group Assignment||Basic Science||None (Open Label)||||||
1401492|NCT02273258|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1401493|NCT02273245|||Cohort||Retrospective|||||||
1401494|NCT02273232|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1401495|NCT02273219||Single Group Assignment||Treatment||None (Open Label)||||||
1401496|NCT02273206|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401497|NCT02273193|||Case-Control||Prospective|||||||
1401498|NCT02273180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401499|NCT02273167|Randomized|Parallel Assignment||Screening||Single|||||t|
1401500|NCT02273154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401501|NCT02273141|Randomized|Parallel Assignment||Screening||Single|||||t|
1401502|NCT02273128|||Case Control||Retrospective|||||||
1401503|NCT02273115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401504|NCT02273102|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401505|NCT02273089|||Cohort||Prospective|||||||
1401506|NCT02273076|||Case-Control||Prospective|||||||
1401507|NCT02273063||Single Group Assignment||Treatment||None (Open Label)||||||
1401508|NCT02273050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401509|NCT02273037|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401510|NCT02273024|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401511|NCT02273011|||Case Control||Prospective|||||||
1401512|NCT02272998||Single Group Assignment||Treatment||None (Open Label)||||||
1401513|NCT02272985||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401514|NCT02272972|||Other||Other|||||||
1401515|NCT02272959|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1401516|NCT02272946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401517|NCT02272933||Single Group Assignment||Prevention||None (Open Label)||||||
1401518|NCT02272920|Randomized|Parallel Assignment||Treatment||Single||||||t
1401519|NCT02272907|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1401520|NCT02272894|||Cohort||Prospective|||||||
1401521|NCT02272881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401522|NCT02272868|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401523|NCT02272855||Single Group Assignment||Treatment||None (Open Label)||||||
1401524|NCT02272842|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1401525|NCT02272829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401526|NCT02272816||Single Group Assignment||Treatment||None (Open Label)||||||
1401527|NCT02272803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401528|NCT02272790|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401529|NCT02272777|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401530|NCT02272764|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1401531|NCT02272751|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401532|NCT02272738||Single Group Assignment||Treatment||None (Open Label)||||||
1401533|NCT02272725|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1401534|NCT02272712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401535|NCT02272699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401536|NCT02272686||Single Group Assignment||Treatment||None (Open Label)||||||
1401537|NCT02272673|||Case-Crossover||Prospective|||||||
1401538|NCT02272660|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401539|NCT02272647|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1401540|NCT02272634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401541|NCT02272621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401542|NCT02272608|||Case Control||Retrospective|||||||
1401543|NCT02272595|||Case-Control||Prospective|||||||
1401544|NCT02272582|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1401545|NCT02272569||Single Group Assignment||Treatment||None (Open Label)||||||
1401546|NCT02272556|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1401547|NCT02272543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401548|NCT02272530|||Cohort||Prospective|||||||
1401549|NCT02272517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401550|NCT02272504|||Case Control||Prospective|||||||
1401551|NCT02272491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401552|NCT02272478|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1401553|NCT02272465|||Cohort||Prospective|||||||
1401554|NCT02272452|||Cohort||Prospective|||||||
1401555|NCT02272439|||Cohort||Prospective|||||||
1401556|NCT02272426|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1401557|NCT02272413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401558|NCT02272400||Single Group Assignment||Treatment||None (Open Label)||||||
1401559|NCT02272387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401560|NCT02272374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401561|NCT02272361|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401562|NCT02272348|Randomized|Parallel Assignment||||None (Open Label)||||||
1401563|NCT02272335|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1401564|NCT02272322|||Case-Only||Prospective|||||||
1401565|NCT02272309|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1401566|NCT02272296|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401567|NCT02272283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401568|NCT02272270||Single Group Assignment||Treatment||None (Open Label)||||||
1401569|NCT02272257|Randomized|Factorial Assignment||Health Services Research||Double|||t|||t
1401570|NCT02272244|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401571|NCT02272231|||Cohort||Prospective|||||||
1401572|NCT02272218||Single Group Assignment||Treatment||None (Open Label)||||||
1401573|NCT02272205|||Cohort||Retrospective|||||||
1401574|NCT02272192|Randomized|Parallel Assignment||Treatment||Single||||||t
1401575|NCT02272179|Randomized|Parallel Assignment||Treatment||Single||||||t
1401576|NCT02272166|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1401577|NCT02272153|Randomized|Single Group Assignment||||Single|||t|||
1401578|NCT02272140|||Cohort||Prospective|||||||
1401579|NCT02272127||Single Group Assignment||Treatment||None (Open Label)||||||
1401580|NCT02272114||||||||||||
1401581|NCT02272101|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1401582|NCT02272088|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1401583|NCT02272075|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1401584|NCT02272062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401585|NCT02272049||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401586|NCT02272036|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1401587|NCT02272023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401588|NCT02272010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401589|NCT02271997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401590|NCT02271984|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401591|NCT02271971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401592|NCT02271958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401593|NCT02271945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401594|NCT02271932|||Case-Control||Prospective|||||||
1401595|NCT02271919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401596|NCT02271906||Single Group Assignment||Treatment||None (Open Label)||||||
1401597|NCT02271893|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401598|NCT02271880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401599|NCT02271867|Randomized|Parallel Assignment||||Triple|||t|t|t|
1401600|NCT02271854|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1401601|NCT02271841|||Cohort||Prospective|||||||
1401602|NCT02271828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401603|NCT02271815|||Case-Only||Prospective|||||||
1401604|NCT02271802|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1401605|NCT02271789|||Case-Only||Prospective|||||||
1401606|NCT02271776|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1401607|NCT02271763|Non-Randomized|Single Group Assignment||||Double||||t|t|
1401608|NCT02271750||||||||||||
1401609|NCT02271737|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401610|NCT02271724||||||||||||
1401611|NCT02271711||Single Group Assignment||Treatment||None (Open Label)||||||
1401612|NCT02271698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401613|NCT02271685|Randomized|Factorial Assignment||Screening||Single|||t|||
1401614|NCT02271672|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401615|NCT02271659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401616|NCT02271646||Single Group Assignment||Prevention||None (Open Label)||||||
1401617|NCT02271633|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1401618|NCT02271620||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401619|NCT02271607|Randomized|Crossover Assignment||Treatment||Single||||||t
1401620|NCT02271594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401621|NCT02271581|||Other||Prospective|||||||
1401622|NCT02271568|||Case Control||Prospective|||||||
1401623|NCT02271555|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1401624|NCT02271542|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1401625|NCT02271529||Single Group Assignment||Treatment||None (Open Label)||||||
1401626|NCT02271516||Single Group Assignment||Treatment||None (Open Label)||||||
1401627|NCT02271503|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1401628|NCT02271490|Randomized|Parallel Assignment||||None (Open Label)||||||
1401629|NCT02271477|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1401630|NCT02271464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401631|NCT02271451|Randomized|Parallel Assignment||Prevention||Single||||||t
1401632|NCT02271438|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1401633|NCT02271425|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1401634|NCT02271412|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1401635|NCT02271399|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1401636|NCT02271386|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401637|NCT02271373|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1401638|NCT02271360|Randomized|Parallel Assignment||Prevention||Single|||t|||
1401639|NCT02271347||Single Group Assignment||Treatment||None (Open Label)||||||
1401640|NCT02271334|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1401641|NCT02271321|Randomized|Parallel Assignment||||Single||||||t
1401642|NCT02271308|Randomized|Parallel Assignment||Basic Science||Single||||||t
1401643|NCT02271295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401644|NCT02271282|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1401645|NCT02271269|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401646|NCT02271256||Single Group Assignment||Treatment||None (Open Label)||||||
1401647|NCT02271243|||Cohort||Prospective|||||||
1401648|NCT02271230|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1401649|NCT02271217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401650|NCT02271204|||Cohort||Prospective|||||||
1401651|NCT02271191|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1401652|NCT02271178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401653|NCT02271165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401654|NCT02271152|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401655|NCT02271139||||||||||||
1401656|NCT02271126|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401657|NCT02271113|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1401658|NCT02271100|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1401659|NCT02271087||||||||||||
1401660|NCT02271074|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1401661|NCT02271061|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1401662|NCT02271048|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1401663|NCT02271035|Randomized|Crossover Assignment||Treatment||Single|||||t|
1401664|NCT02271022|||Cohort||Prospective|||||||
1401665|NCT02271009|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401666|NCT02270996|||Cohort||Prospective|||||||
1401667|NCT02270983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401668|NCT02270970|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401669|NCT02270957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401670|NCT02270944|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401671|NCT02270931|||Cohort||Prospective|||||||
1401672|NCT02270918|Randomized|Crossover Assignment||Treatment||Single||||||t
1401673|NCT02270905||Single Group Assignment||Treatment||None (Open Label)||||||
1401674|NCT02270892|Randomized|Parallel Assignment||Treatment||Single||||||t
1401675|NCT02270879|||Cohort||Retrospective|||||||
1401676|NCT02270866||Single Group Assignment||Treatment||None (Open Label)||||||
1401677|NCT02270853||Single Group Assignment||Screening||None (Open Label)||||||
1401678|NCT02270840|||Cohort||Prospective|||||||
1401679|NCT02270827|||Cohort||Prospective|||||||
1401680|NCT02270814||Single Group Assignment||Treatment||None (Open Label)||||||
1401681|NCT02270801||Single Group Assignment||Treatment||None (Open Label)||||||
1401682|NCT02270788||Single Group Assignment||Treatment||None (Open Label)||||||
1401683|NCT02270775|||||Prospective|||||||
1401684|NCT02270762|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401685|NCT02270749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401686|NCT02270736|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401687|NCT02270723|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1401688|NCT02270710|||Cohort||Retrospective|||||||
1401689|NCT02270697|||||Retrospective|||||||
1401690|NCT02270684|Randomized|Parallel Assignment||Treatment||Single||||||t
1401691|NCT02270671|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401692|NCT02270658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401693|NCT02270645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401694|NCT02270632|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401695|NCT02270619|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1401696|NCT02270606||Single Group Assignment||Treatment||None (Open Label)||||||
1401697|NCT02270593|||Case Control||Prospective|||||||
1401698|NCT02270580|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401699|NCT02270567|||Cohort||Prospective|||||||
1401700|NCT02270554||Single Group Assignment||Treatment||None (Open Label)||||||
1401701|NCT02270541|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1401702|NCT02270528|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1401703|NCT02270515||Single Group Assignment||Health Services Research||None (Open Label)||||||
1401704|NCT02270502|||Cohort||Prospective|||||||
1401705|NCT02270489|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401706|NCT02270476|||Cohort||Prospective|||||||
1401707|NCT02270463|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401708|NCT02270450|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401709|NCT02270437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401710|NCT02270424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401711|NCT02270411|||Cohort||Cross-Sectional|||||||
1401712|NCT02270398|Randomized|Parallel Assignment||Treatment||Single||||||t
1401713|NCT02270385|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401714|NCT02270372||Single Group Assignment||Treatment||None (Open Label)||||||
1401715|NCT02270359||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401716|NCT02270346|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1401717|NCT02270333|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1401718|NCT02270320|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1401719|NCT02270307||Single Group Assignment||Prevention||None (Open Label)||||||
1401720|NCT02270294|Randomized|Crossover Assignment||Treatment||Single||||||t
1401721|NCT02270281||Single Group Assignment||Treatment||None (Open Label)||||||
1401722|NCT02270268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401723|NCT02270255|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1401724|NCT02270242|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1401725|NCT02270229|||||Prospective|||||||
1401726|NCT02270216|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1401727|NCT02270203|||Cohort||Prospective|||||||
1401728|NCT02270190||Single Group Assignment||Treatment||None (Open Label)||||||
1401729|NCT02270177|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401730|NCT02270164|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1401731|NCT02270151|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1401732|NCT02270138|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1401733|NCT02270125|||Case-Control||Prospective|||||||
1401734|NCT02270112|||Case-Control||Prospective|||||||
1401735|NCT02270099|||Cohort||Prospective|||||||
1401736|NCT02270086|||Cohort||Prospective|||||||
1401737|NCT02270073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401738|NCT02270060|Randomized|Parallel Assignment||Treatment||Single||||||t
1401739|NCT02270047|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1401740|NCT02270034||Single Group Assignment||Treatment||None (Open Label)||||||
1401741|NCT02270021|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1401742|NCT02270008|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401743|NCT02269995|||Cohort||Prospective|||||||
1401744|NCT02269982|||Cohort||Prospective|||||||
1401745|NCT02269969||Single Group Assignment||Basic Science||None (Open Label)||||||
1401746|NCT02269956|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401747|NCT02269943||Single Group Assignment||Treatment||None (Open Label)||||||
1401748|NCT02269930|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401749|NCT02269917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401750|NCT02269904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401751|NCT02269891|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1401752|NCT02269878|||Cohort||Prospective|||||||
1401753|NCT02269865|||Case Control||Prospective|||||||
1401754|NCT02269852||Single Group Assignment||Prevention||None (Open Label)||||||
1401755|NCT02269839|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401756|NCT02269826|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401757|NCT02269813|||Case Control||Prospective|||||||
1401758|NCT02269800|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1401759|NCT02269787|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1401760|NCT02269774|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1401761|NCT02269761||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401762|NCT02269748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401763|NCT02269735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401764|NCT02269722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401765|NCT02269709||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401766|NCT02269696|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401767|NCT02269683|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1401768|NCT02269670||Single Group Assignment||Treatment||None (Open Label)||||||
1401769|NCT02269657|||Cohort||Prospective|||||||
1401770|NCT02269644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401771|NCT02269631|Randomized|Parallel Assignment||Prevention||Single|||||t|
1401772|NCT02269618|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401773|NCT02269605|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401774|NCT02269592|||Cohort||Prospective|||||||
1401775|NCT02269579||Single Group Assignment||Treatment||None (Open Label)||||||
1401776|NCT02269566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401777|NCT02269553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401778|NCT02269540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401779|NCT02269527||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401780|NCT02269514|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1401781|NCT02269501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401782|NCT02269488|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1401783|NCT02269475|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1401784|NCT02269462|||Cohort||Prospective|||||||
1401785|NCT02269449|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1401786|NCT02269436||Single Group Assignment||Treatment||None (Open Label)||||||
1401787|NCT02269423|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1401788|NCT02269410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401789|NCT02269397|||Cohort||Prospective|||||||
1401790|NCT02269384|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1401791|NCT02269371|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401792|NCT02269358||Single Group Assignment||Treatment||None (Open Label)||||||
1401793|NCT02269345|Randomized|Parallel Assignment||Other||Single|||t|||
1401794|NCT02269332|||Case Control||Prospective|||||||
1401795|NCT02269319|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401796|NCT02269306||Single Group Assignment||||None (Open Label)||||||
1401797|NCT02269293|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401798|NCT02269280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401799|NCT02269267||Single Group Assignment||Treatment||None (Open Label)||||||
1401800|NCT02269254|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401801|NCT02269241||Single Group Assignment||Treatment||None (Open Label)||||||
1401802|NCT02269228|Randomized|Parallel Assignment||Treatment||Double||||||
1401803|NCT02269215|Randomized|Parallel Assignment||Treatment||Single||||||
1401804|NCT02269202|Randomized|||Treatment||Single||||||
1401805|NCT02269189|Randomized|Parallel Assignment||Treatment||Double||||||
1401806|NCT02269176|Randomized|Parallel Assignment||Treatment||Double||||||
1401807|NCT02269163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401808|NCT02269150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401809|NCT02269137|||Cohort|||||||||
1401810|NCT02269124|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401811|NCT02269111||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401812|NCT02269098|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401813|NCT02269085||Single Group Assignment||Treatment||None (Open Label)||||||
1401814|NCT02269072|Randomized|Crossover Assignment||Other||Double|||t||t|
1401815|NCT02269059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401816|NCT02269046|Randomized|Parallel Assignment||Treatment||Single||||||t
1401817|NCT02269033|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401818|NCT02269020||Single Group Assignment||Treatment||None (Open Label)||||||
1401819|NCT02269007||Single Group Assignment||Prevention||None (Open Label)||||||
1401820|NCT02268994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401821|NCT02268981||Single Group Assignment||Treatment||None (Open Label)||||||
1401822|NCT02268968|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1401823|NCT02268955|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401824|NCT02268942||Single Group Assignment||Treatment||None (Open Label)||||||
1401825|NCT02268929|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401826|NCT02268916|Randomized|Parallel Assignment||Treatment||Single||||||t
1401827|NCT02268903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401828|NCT02268890||Single Group Assignment||Treatment||None (Open Label)||||||
1401829|NCT02268877|Randomized|Parallel Assignment||Health Services Research||None (Open Label)|Open Label|||||
1401830|NCT02268864||Single Group Assignment||Treatment||None (Open Label)||||||
1401831|NCT02268851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401832|NCT02268838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401833|NCT02268825||Single Group Assignment||Treatment||None (Open Label)||||||
1401834|NCT02268812|||Other||Other|||||||
1401835|NCT02268799|||Case-Only||Prospective|||||||
1401836|NCT02268786|Randomized|Parallel Assignment||Screening||Single|||t|||
1401837|NCT02268773|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401838|NCT02268760|Randomized|Parallel Assignment||Treatment||Double||||||
1401839|NCT02268747||Single Group Assignment||Treatment||None (Open Label)||||||
1401840|NCT02268734|||Case-Only||Retrospective|||||||
1401841|NCT02268721|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1401842|NCT02268708|||Cohort||Prospective|||||||
1401843|NCT02268695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401844|NCT02268682|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1401845|NCT02268669|Randomized|Parallel Assignment||Treatment||Single||||||t
1401846|NCT02268656|Non-Randomized|Factorial Assignment||||Single|||||t|
1401847|NCT02268643|||Cohort||Prospective|||||||
1401848|NCT02268630|||Case-Control||Cross-Sectional|||||||
1401849|NCT02268617||Single Group Assignment||Treatment||None (Open Label)||||||
1401850|NCT02268604|Randomized|Parallel Assignment||Treatment||Double||||||
1401851|NCT02268591|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1401852|NCT02268578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401853|NCT02268565|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1401854|NCT02268552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401855|NCT02268539|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1401856|NCT02268526|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1401857|NCT02268513|||Cohort||Prospective|||||||
1401858|NCT02268500|Randomized|Parallel Assignment||Prevention||Single||||||t
1401859|NCT02268487||Single Group Assignment||Treatment||None (Open Label)||||||
1401860|NCT02268474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401861|NCT02268461|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1401862|NCT02268448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401863|NCT02268435||Single Group Assignment||Treatment||None (Open Label)||||||
1401864|NCT02268422|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401865|NCT02268409||Single Group Assignment||Treatment||None (Open Label)||||||
1401866|NCT02268396||Single Group Assignment||Treatment||None (Open Label)||||||
1401867|NCT02268383||Single Group Assignment||Treatment||None (Open Label)||||||
1401868|NCT02268370||Single Group Assignment||Other||None (Open Label)||||||
1401869|NCT02268357|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401870|NCT02268344|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1401871|NCT02268331|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1401872|NCT02268318|Randomized|Parallel Assignment||||Triple|||t||t|t
1401873|NCT02268305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1401874|NCT02268292||Single Group Assignment||Treatment||None (Open Label)||||||
1401875|NCT02268279||Single Group Assignment||Treatment||None (Open Label)||||||
1401876|NCT02268266||Single Group Assignment||Treatment||None (Open Label)||||||
1401877|NCT02268253|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401878|NCT02268240|Randomized|Parallel Assignment||Treatment||Single||||||t
1401879|NCT02268227||||||||||||
1401880|NCT02268214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401881|NCT02268201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401882|NCT02268188||Single Group Assignment||Supportive Care||None (Open Label)||||||
1401883|NCT02268175|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401884|NCT02268162|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1401885|NCT02268149|Randomized|Crossover Assignment||Treatment||Double||||||
1401886|NCT02268136|Randomized|Parallel Assignment||Treatment||Single||||||
1401887|NCT02268123|||Other||Prospective|||||||
1401888|NCT02268110|Randomized|Parallel Assignment||Treatment||Single||||||t
1401889|NCT02268097|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401890|NCT02268084|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1401891|NCT02268071||Single Group Assignment||Treatment||None (Open Label)||||||
1401892|NCT02268058|Randomized|Parallel Assignment||||None (Open Label)||||||
1401893|NCT02268045|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401894|NCT02268032|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1401895|NCT02268019||Single Group Assignment||Treatment||None (Open Label)||||||
1401896|NCT02268006||Single Group Assignment||Treatment||None (Open Label)||||||
1401897|NCT02267993|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401898|NCT02267980|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1401899|NCT02267967||Single Group Assignment||Treatment||None (Open Label)||||||
1401900|NCT02267954||Single Group Assignment||Basic Science||None (Open Label)||||||
1401901|NCT02267941|||Case Control||Retrospective|||||||
1401902|NCT02267928|Randomized|Factorial Assignment||Screening||Single|||t|||
1401903|NCT02267915||Single Group Assignment||Treatment||None (Open Label)||||||
1401904|NCT02267902|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1401905|NCT02267889||Single Group Assignment||Treatment||None (Open Label)||||||
1401906|NCT02267876||Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1401907|NCT02267863||Sequential Assignment||Treatment||None (Open Label)||||||
1401908|NCT02267850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401909|NCT02267837|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401910|NCT02267824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401911|NCT02267811|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401912|NCT02267798|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401913|NCT02267785|Randomized|Parallel Assignment||Treatment||Single||||||t
1401914|NCT02267772|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1401915|NCT02267759|Randomized|Parallel Assignment||||Double|||t|||t
1401916|NCT02267746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401917|NCT02267733|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401918|NCT02267720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401919|NCT02267707|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401920|NCT02267694||Single Group Assignment||Treatment||None (Open Label)||||||
1401921|NCT02267681|Randomized|Parallel Assignment||||Single|||t|||
1401922|NCT02267668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401923|NCT02267655|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401924|NCT02267642||Single Group Assignment||Treatment||None (Open Label)||||||
1401925|NCT02267629||Single Group Assignment||Treatment||None (Open Label)||||||
1401926|NCT02267616|Randomized|Parallel Assignment||Prevention||None (Open Label)||This study will evaluate the use of the Etonogestrel Implant or hormonal intrauterine device (IUD) for contraception past the FDA approved duration. The Etonogestrel Implant is currently approved for 3 years of use, and the hormonal IUD is currently approved for 5 years.||||
1401927|NCT02267603||Single Group Assignment||Treatment||None (Open Label)||||||
1401928|NCT02267590|||||Prospective|||||||
1401929|NCT02267577|||Case-Only||Prospective|||||||
1401930|NCT02267564|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1401931|NCT02267551|Randomized|||Health Services Research||||||||
1401932|NCT02267538|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1401933|NCT02267525|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401934|NCT02267512|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401935|NCT02267499|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401936|NCT02267486|||||Prospective|||||||
1401937|NCT02267473|||Cohort||Prospective|||||||
1401938|NCT02267460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401939|NCT02267447|||Cohort||Prospective|||||||
1401940|NCT02267434|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401941|NCT02267421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401942|NCT02267408|Randomized|Parallel Assignment||Treatment||None (Open Label)||Dosing of warfarin according to the Fearon algorithm or routine during 6 months for patients with unstable INRs||||
1401943|NCT02267395|||Case Control||Retrospective|||||||
1401944|NCT02267382|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1401945|NCT02267369|Randomized|Parallel Assignment||Basic Science||Double||||t||t
1401946|NCT02267356|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1401947|NCT02267343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401948|NCT02267330|||Cohort||Prospective|||||||
1401949|NCT02267317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401950|NCT02267304||Single Group Assignment||||Triple|||t|t|t|
1401951|NCT02267291||Single Group Assignment||Basic Science||None (Open Label)||||||
1401952|NCT02267278||Single Group Assignment||Treatment||None (Open Label)||||||
1401953|NCT02267265|Randomized|Parallel Assignment||Other||Single|||t|||
1401954|NCT02267252|||Other||Prospective|||||||
1401955|NCT02267239|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1401956|NCT02267226||Single Group Assignment||Treatment||None (Open Label)||||||
1401957|NCT02267213||Single Group Assignment||Treatment||None (Open Label)||||||
1401958|NCT02267200|||Cohort||Prospective|||||||
1401959|NCT02267187||Single Group Assignment||Treatment||None (Open Label)||||||
1401960|NCT02267174||Single Group Assignment||Health Services Research||None (Open Label)||||||
1401961|NCT02267161||Single Group Assignment||Screening||None (Open Label)||||||
1401962|NCT02267148|||Case Control||Cross-Sectional|||||||
1401963|NCT02267135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401964|NCT02267122|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1401965|NCT02267109|Non-Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1401966|NCT02267096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401967|NCT02267083||Single Group Assignment||Treatment||None (Open Label)||||||
1401968|NCT02267070|Randomized|Parallel Assignment||Treatment||Single||||||t
1401969|NCT02267057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1401970|NCT02267044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401971|NCT02267031|Randomized|Parallel Assignment||Prevention||Single||||||t
1401972|NCT02267018|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401973|NCT02267005|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1401974|NCT02266992||Single Group Assignment||Basic Science||None (Open Label)||||||
1401975|NCT02266979|||||Prospective|||||||
1401976|NCT02266966|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1401977|NCT02266953|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401978|NCT02266940|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1401979|NCT02266927|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1401980|NCT02266914||Single Group Assignment||Diagnostic||None (Open Label)||||||
1401981|NCT02266901|||Cohort||Retrospective|||||||
1401982|NCT02266888|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1401983|NCT02266875|Randomized|Parallel Assignment||Treatment||Single|||t|||
1401984|NCT02266862|||Case-Only||Prospective|||||||
1401985|NCT02266849|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1401986|NCT02266836||Single Group Assignment||Treatment||None (Open Label)||||||
1401987|NCT02266823|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1401988|NCT02266810|Randomized|Parallel Assignment||Treatment||Double||Intra-patient control|t|||t
1401989|NCT02266797|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1401990|NCT02266784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401991|NCT02266771|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1401992|NCT02266758|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1401993|NCT02266745||Single Group Assignment||Treatment||None (Open Label)||||||
1401994|NCT02266732|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401995|NCT02266719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"The study is divided in two groups. as follows:~Patients with complex abdominal aortic aneurysms including, juxtarenal, suprarenal and type IV thoracoabdominal aneurysms will be enrolled in the fenestrated-CMD group.~Patients with type I-III throacoabdominal aneurysms will be enrolled in the type I-III TAAAs groups and will be eligible for custom-made/ off-the-shelf branched devices."||||
1401996|NCT02266706|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401997|NCT02266693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401998|NCT02266680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1401999|NCT02266667|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402000|NCT02266654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402001|NCT02266641|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1402002|NCT02266628|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1402003|NCT02266615|||Cohort||Prospective|||||||
1402004|NCT02266602||Single Group Assignment||Treatment||None (Open Label)||||||
1402005|NCT02266589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402006|NCT02266576|Randomized|Parallel Assignment||Prevention||Single||||||t
1402007|NCT02266563|||Case-Control||Cross-Sectional|||||||
1402008|NCT02266550||Single Group Assignment||Treatment||None (Open Label)||||||
1402009|NCT02266537|Randomized|Parallel Assignment||Treatment||Double||||||
1402010|NCT02266524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402011|NCT02266511|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402012|NCT02266498|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402013|NCT02266485|Randomized|Parallel Assignment||Treatment||Double||||||
1402014|NCT02266472|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402015|NCT02266459||Single Group Assignment||Diagnostic||None (Open Label)||||||
1402016|NCT02266446||Single Group Assignment||Treatment||None (Open Label)||Open trial||||
1402017|NCT02266433|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1402018|NCT02266420|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402019|NCT02266407|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402020|NCT02266394|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402021|NCT02266381|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402022|NCT02266368|Randomized|Parallel Assignment||Prevention||Single|||t|||
1402023|NCT02266355||Single Group Assignment||Supportive Care||None (Open Label)||||||
1402024|NCT02266342|||Cohort||Prospective|||||||
1402025|NCT02266329|Randomized|Parallel Assignment||Treatment||Triple||Randomized double blind placebo-controlled clinical trial with 2:1 chance of randomization to active drug.|t||t|t
1402026|NCT02266316|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1402027|NCT02266303|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1402028|NCT02266290|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402029|NCT02266277|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1402030|NCT02266264|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1402031|NCT02266251|||Case-Control||Retrospective|||||||
1402032|NCT02266238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402033|NCT02266225||Single Group Assignment||Treatment||None (Open Label)||||||
1402034|NCT02266212|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1402035|NCT02266199|||Cohort||Prospective|||||||
1402036|NCT02266186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402037|NCT02266173|||Cohort||Prospective|||||||
1402038|NCT02266160|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402039|NCT02266147||Single Group Assignment||Treatment||None (Open Label)||||||
1402040|NCT02266134|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402041|NCT02266121|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1402042|NCT02266108|Randomized|Parallel Assignment||Prevention||Single|||t|||
1402043|NCT02266095|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402044|NCT02266082|||Cohort||Prospective|||||||
1402045|NCT02266069|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1402046|NCT02266056|Randomized|Parallel Assignment||||Double|||||t|t
1402047|NCT02266043|||Cohort||Prospective|||||||
1402048|NCT02266030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402049|NCT02266017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402050|NCT02266004|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1402051|NCT02265991|||Cohort||Prospective|||||||
1402052|NCT02265978|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402053|NCT02265965|Randomized|Single Group Assignment||Treatment||Single||||t||
1402054|NCT02265952||Single Group Assignment||Treatment||None (Open Label)||||||
1402055|NCT02265939|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1402056|NCT02265926||Single Group Assignment||Diagnostic||None (Open Label)||||||
1402057|NCT02265913|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402058|NCT02265900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402059|NCT02265887|||Cohort||Prospective|||||||
1402060|NCT02265874|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1402061|NCT02265861|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1402062|NCT02265848|Randomized|Crossover Assignment||Treatment||Single|||t|||
1402063|NCT02265835|||Case Control||Retrospective|||||||
1402064|NCT02265822|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1402065|NCT02265809|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1402066|NCT02265796|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1402067|NCT02265783||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1402068|NCT02265770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402069|NCT02265757|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1402070|NCT02265744|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1402071|NCT02265731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402072|NCT02265718|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1402073|NCT02265705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402074|NCT02265679|Randomized|Parallel Assignment||Treatment||Double||||||
1402075|NCT02265666|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402076|NCT02265653|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402077|NCT02265640|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402078|NCT02265627|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402079|NCT02265614|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402080|NCT02265601|Randomized|Parallel Assignment||Other||Double|||||t|t
1402081|NCT02265588|Randomized|Parallel Assignment||Treatment||Single||||||t
1402082|NCT02265575||Single Group Assignment||Treatment||None (Open Label)||||||
1402083|NCT02265562|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1402084|NCT02265549|||Cohort||Retrospective|||||||
1402085|NCT02265536|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1402086|NCT02265523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402087|NCT02265510|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402088|NCT02265497|||Cohort||Prospective|||||||
1402089|NCT02265484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402090|NCT02265471|||Other||Cross-Sectional|||||||
1402091|NCT02265458|Randomized|Parallel Assignment||Treatment||Single|||||t|
1402092|NCT02265445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402093|NCT02265432|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402094|NCT02265419||Single Group Assignment||Treatment||None (Open Label)||||||
1402095|NCT02265406|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1402096|NCT02265393|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402097|NCT02265380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402098|NCT02265367|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1402099|NCT02265354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402100|NCT02265341||Single Group Assignment||Treatment||None (Open Label)||||||
1402101|NCT02265328||Single Group Assignment||Treatment||None (Open Label)||||||
1402102|NCT02265315|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1402103|NCT02265302|Randomized|Parallel Assignment||Treatment||Double||||||
1402104|NCT02265289||Single Group Assignment||Treatment||None (Open Label)||||||
1402105|NCT02265276|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402106|NCT02265263|||Cohort||Prospective|||||||
1402107|NCT02265250|||Cohort||Prospective|||||||
1402108|NCT02265237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402109|NCT02265224|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402110|NCT02265211||Single Group Assignment||Treatment||None (Open Label)||||||
1402111|NCT02265198|||Case-Control||Prospective|||||||
1402112|NCT02265185|||Cohort||Cross-Sectional|||||||
1402113|NCT02265172|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1402114|NCT02265159||Single Group Assignment||Treatment||None (Open Label)||||||
1402115|NCT02265146|||Cohort||Prospective|||||||
1402116|NCT02265133|||Case-Control||Prospective|||||||
1402117|NCT02265120||Single Group Assignment||Health Services Research||None (Open Label)||||||
1402118|NCT02265107||Single Group Assignment||Supportive Care||Single||||||t
1402119|NCT02265094|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1402120|NCT02265081|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1402121|NCT02265068|||Case-Only||Retrospective|||||||
1402122|NCT02265055|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1402123|NCT02265042||Single Group Assignment||Treatment||None (Open Label)||||||
1402124|NCT02265029|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402125|NCT02265016|||Cohort|||||||||
1402126|NCT02265003|||Cohort||Prospective|||||||
1402127|NCT02264990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402128|NCT02264977||Single Group Assignment||Treatment||None (Open Label)||||||
1402129|NCT02264964|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1402130|NCT02264951|Randomized|Crossover Assignment||Treatment||Single|||t|||
1402131|NCT02264938|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1402132|NCT02264925||Single Group Assignment||Treatment||None (Open Label)||||||
1402133|NCT02264912|||Cohort||Prospective|||||||
1402134|NCT02264899||Single Group Assignment||Other||None (Open Label)||||||
1402135|NCT02264886||Single Group Assignment||Treatment||None (Open Label)||||||
1402136|NCT02264873||Single Group Assignment||Treatment||None (Open Label)||||||
1402137|NCT02264860||Single Group Assignment||Other||None (Open Label)||||||
1402138|NCT02264847|Randomized|Parallel Assignment||Treatment||Single|||||t|
1402139|NCT02264834|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402140|NCT02264821|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402141|NCT02264808|||Cohort||Retrospective|||||||
1402142|NCT02264795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402143|NCT02264782|Randomized|Parallel Assignment||Screening||Double|||t||t|
1402144|NCT02264769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402145|NCT02264756|||Cohort||Prospective|||||||
1402146|NCT02264743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402147|NCT02264730||Single Group Assignment||Treatment||None (Open Label)||||||
1402148|NCT02264717|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1402149|NCT02264704|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402150|NCT02264691|||Cohort||Prospective|||||||
1402151|NCT02264678|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402152|NCT02264665|||Cohort||Other|||||||
1402153|NCT02264652||Single Group Assignment||Treatment||None (Open Label)||||||
1402154|NCT02264639|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402155|NCT02264626||Single Group Assignment||Treatment||None (Open Label)||||||
1402156|NCT02264613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402157|NCT02264600|||Case Control||Cross-Sectional|||||||
1402158|NCT02264587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402159|NCT02264574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402160|NCT02264561|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1402161|NCT02264548||Single Group Assignment||Treatment||None (Open Label)||||||
1402162|NCT02264535|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1402163|NCT02264522||Single Group Assignment||Prevention||None (Open Label)||||||
1402164|NCT02264509|||Cohort||Prospective|||||||
1402165|NCT02264496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402166|NCT02264483|||Case Control||Prospective|||||||
1402167|NCT02264470|||Cohort||Prospective|||||||
1402168|NCT02264457|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402169|NCT02264444||Single Group Assignment||Treatment||None (Open Label)||||||
1402170|NCT02264431|||Cohort||Prospective|||||||
1402171|NCT02264418|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1402172|NCT02264405|||Cohort||Prospective|||||||
1402173|NCT02264392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402174|NCT02264379|||Case-Control||Prospective|||||||
1402175|NCT02264366|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1402176|NCT02264353|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1402177|NCT02264340|Randomized|Parallel Assignment||Treatment||Single||||||t
1402178|NCT02264327|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1402179|NCT02264314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402180|NCT02264301|Randomized|Parallel Assignment||Treatment||Single||||||t
1402181|NCT02264288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402182|NCT02264275||Single Group Assignment||Supportive Care||None (Open Label)||||||
1402183|NCT02264262||Single Group Assignment||Other||None (Open Label)||||||
1402184|NCT02264249|||Cohort||Prospective|||||||
1402185|NCT02264236||Single Group Assignment||Treatment||None (Open Label)||||||
1402186|NCT02264223|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1402187|NCT02264210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402188|NCT02264197|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402189|NCT02264184|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402190|NCT02264171|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402191|NCT02264158|Randomized|Parallel Assignment||Treatment||Double||||||
1402192|NCT02264145|Randomized|Crossover Assignment||Treatment||Double||||||
1402193|NCT02264132|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402194|NCT02264119|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402195|NCT02264106|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402196|NCT02264093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402197|NCT02264080|Randomized|Parallel Assignment||Treatment||Double||||||
1402198|NCT02264067|Randomized|Parallel Assignment||Treatment||Double||||||
1402199|NCT02264054|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402200|NCT02264041|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402201|NCT02264028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402202|NCT02264015|Randomized|Parallel Assignment||Treatment||Double||||||
1402203|NCT02264002|Randomized|Parallel Assignment||Treatment||Double||||||
1402204|NCT02263989|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402205|NCT02263976|Randomized|Parallel Assignment||Treatment||Double||||||
1402206|NCT02263963|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402207|NCT02263950||Single Group Assignment||Treatment||None (Open Label)||||||
1402208|NCT02263937|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1402209|NCT02263924|Randomized|Parallel Assignment||Treatment||Quadruple||Patients will be randomized to receive either placebo or investigational drug (mixed tocotrienols dietary supplement) for 6 months.|t|t|t|t
1402210|NCT02263911|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1402211|NCT02263898||Single Group Assignment||Treatment||None (Open Label)||||||
1402212|NCT02263885||Single Group Assignment||Treatment||None (Open Label)||||||
1402213|NCT02263872|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402214|NCT02263859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402215|NCT02263846|||Case-Only||Prospective|||||||
1402216|NCT02263833|||Cohort||Prospective|||||||
1402217|NCT02263820|||Cohort||Prospective|||||||
1402218|NCT02263807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402219|NCT02263794|Randomized|Parallel Assignment||Treatment||Single||||||t
1402220|NCT02263781|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1402221|NCT02263768|Randomized|Parallel Assignment||Prevention||Single|||||t|
1402222|NCT02263755|||Cohort||Other|||||||
1402223|NCT02263742|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1402224|NCT02263729|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402225|NCT02263716|||Cohort||Prospective|||||||
1402226|NCT02263703||Single Group Assignment||Prevention||None (Open Label)||||||
1402227|NCT02263690|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1402228|NCT02263677||Single Group Assignment||Treatment||None (Open Label)||||||
1402229|NCT02263664|||||Prospective|||||||
1402230|NCT02263651|Randomized|Parallel Assignment||Prevention||Single||||||t
1402231|NCT02263638||Single Group Assignment||Treatment||None (Open Label)||||||
1402232|NCT02263625|||Cohort||Prospective|||||||
1402233|NCT02263612|||Cohort||Retrospective|||||||
1402234|NCT02263599|||Cohort||Prospective|||||||
1402235|NCT02263586|||Cohort||Retrospective|||||||
1402236|NCT02263573|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402237|NCT02263560|||Cohort||Other|||||||
1402238|NCT02263547||Single Group Assignment||||None (Open Label)||||||
1402239|NCT02263534|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402240|NCT02263521|||Cohort||Cross-Sectional|||||||
1402241|NCT02263508|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402242|NCT02263495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402243|NCT02263482|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402244|NCT02263469||||||||||||
1402245|NCT02263456||||Treatment||||||||
1402246|NCT02263443|Randomized|Factorial Assignment||Health Services Research||Single||||t||
1402247|NCT02263430|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402248|NCT02263417|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402249|NCT02263404||Single Group Assignment||Treatment||None (Open Label)||||||
1402250|NCT02263391|Randomized|Parallel Assignment||Prevention||Single|||t|||
1402251|NCT02263378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402252|NCT02263365|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402253|NCT02263352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402254|NCT02263339|Randomized|Parallel Assignment||Treatment||Single||||||t
1402255|NCT02263326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402256|NCT02263313|||Cohort||Retrospective|||||||
1402257|NCT02263300|||Case-Crossover||Prospective|||||||
1402258|NCT02263287|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402259|NCT02263274||Single Group Assignment||Basic Science||None (Open Label)||||||
1402260|NCT02263261||Single Group Assignment||Treatment||None (Open Label)||||||
1402261|NCT02263248|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402262|NCT02263235|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1402263|NCT02263222||Single Group Assignment||Treatment||None (Open Label)||||||
1402264|NCT02263209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402265|NCT02263196|Randomized|Parallel Assignment||Prevention||Single|||t|||
1402266|NCT02263183|Randomized|Crossover Assignment||Prevention||Single|||||t|
1402267|NCT02263170|||Case-Only||Cross-Sectional|||||||
1402268|NCT02263157|||Case Control||Prospective|||||||
1402269|NCT02263144|||Case-Only||Prospective|||||||
1402270|NCT02263131|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1402271|NCT02263118|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1402272|NCT02263105||Single Group Assignment||Treatment||None (Open Label)||||||
1402273|NCT02263092|Randomized|Crossover Assignment||||Double|||t|||t
1402274|NCT02263079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402275|NCT02263066|||Case-Only||Retrospective|||||||
1402276|NCT02263053|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402277|NCT02263040|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1402278|NCT02263027|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1402279|NCT02263014|||Cohort||Prospective|||||||
1402280|NCT02263001|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402281|NCT02262988|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402282|NCT02262975|||Case-Only||Prospective|||||||
1402283|NCT02262962|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1402284|NCT02262949||Single Group Assignment||Treatment||None (Open Label)||||||
1402285|NCT02262936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402286|NCT02262923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402287|NCT02262910||Single Group Assignment||Treatment||None (Open Label)||||||
1402288|NCT02262897||Single Group Assignment||Treatment||None (Open Label)||||||
1402289|NCT02262884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402290|NCT02262871|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402291|NCT02262858|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402292|NCT02262845|||Cohort||Prospective|||||||
1402293|NCT02262832||Single Group Assignment||Treatment||None (Open Label)||||||
1402294|NCT02262819||Single Group Assignment||Basic Science||None (Open Label)||||||
1402295|NCT02262806||Single Group Assignment||Treatment||None (Open Label)||||||
1402296|NCT02262793|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402297|NCT02262780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402298|NCT02262767|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1402299|NCT02262754|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402300|NCT02262741||Single Group Assignment||Treatment||None (Open Label)||||||
1402301|NCT02262728|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402302|NCT02262715|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1402303|NCT02262702|||Cohort||Retrospective|||||||
1402304|NCT02262689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402305|NCT02262676|||Cohort||Cross-Sectional|||||||
1402306|NCT02262663|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1402307|NCT02262650|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402308|NCT02262637|||Cohort||Prospective|||||||
1402309|NCT02262624|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402310|NCT02262611|||Cohort||Prospective|||||||
1402311|NCT02262598|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402312|NCT02262585|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402313|NCT02262572|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402314|NCT02262559|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402315|NCT02262546|Randomized|Crossover Assignment||Treatment||Double||||||
1402316|NCT02262533|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1402317|NCT02262520|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1402318|NCT02262507||Single Group Assignment||||None (Open Label)||||||
1402319|NCT02262494||Single Group Assignment||Diagnostic||None (Open Label)||||||
1402320|NCT02262481|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1402321|NCT02262468|||Cohort||Retrospective|||||||
1402322|NCT02262455|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402323|NCT02262442|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1402324|NCT02262429|||Cohort||Prospective|||||||
1402325|NCT02262416|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1402326|NCT02262403|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1402327|NCT02262390|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1402328|NCT02262377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402329|NCT02262364||Single Group Assignment||Treatment||None (Open Label)||||||
1402330|NCT02262351||Single Group Assignment||Screening||None (Open Label)||||||
1402331|NCT02262338||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1402332|NCT02262325||Single Group Assignment||Treatment||None (Open Label)||||||
1402333|NCT02262312|||Case-Only||Cross-Sectional|||||||
1402334|NCT02262299|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402335|NCT02262286|||Case-Control||Prospective|||||||
1402336|NCT02262273|||Cohort||Retrospective|||||||
1402337|NCT02262260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402338|NCT02262247|||Case-Only||Prospective|||||||
1402339|NCT02262234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402340|NCT02262221|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1402341|NCT02262208|Randomized|Crossover Assignment||Prevention||Single|||||t|
1402342|NCT02262195|||Cohort||Prospective|||||||
1402343|NCT02262182|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1402344|NCT02262169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402345|NCT02262156|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1402346|NCT02262143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402347|NCT02262130||Single Group Assignment||Treatment||None (Open Label)||||||
1402348|NCT02262117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402349|NCT02262104|Randomized|Parallel Assignment||Treatment||Single||||||t
1402350|NCT02262091|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1402351|NCT02262078|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1402352|NCT02262065|||Case-Control||Retrospective|||||||
1402353|NCT02262052||Single Group Assignment||Diagnostic||None (Open Label)||||||
1402354|NCT02262039|Randomized|Parallel Assignment||Prevention||Single|||t|||
1402355|NCT02262026|Randomized|Crossover Assignment||Treatment||Single|||t|||
1402356|NCT02262013|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402357|NCT02262000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402358|NCT02261987|Randomized|Crossover Assignment||Treatment||Single||||||t
1402359|NCT02261974|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402360|NCT02261961|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1402361|NCT02261948|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402362|NCT02261935|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1402363|NCT02261922|Randomized|Crossover Assignment||Treatment||Single|||||t|
1402364|NCT02261909|||Case Control||Prospective|||||||
1402365|NCT02261896|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1402366|NCT02261883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402367|NCT02261870||Single Group Assignment||Diagnostic||None (Open Label)||||||
1402368|NCT02261857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402369|NCT02261844|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1402370|NCT02261831|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1402371|NCT02261818||Single Group Assignment||Health Services Research||None (Open Label)||||||
1402372|NCT02261805|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1402373|NCT02261792|Randomized|Parallel Assignment||Treatment||Single|||||t|
1402374|NCT02261779||Single Group Assignment||Treatment||None (Open Label)||||||
1402375|NCT02261766||Single Group Assignment||Prevention||None (Open Label)||||||
1402376|NCT02261753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402377|NCT02261740||Single Group Assignment||Treatment||None (Open Label)||||||
1402378|NCT02261727|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402379|NCT02261714||Single Group Assignment||Treatment||None (Open Label)||||||
1402380|NCT02261701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402381|NCT02261688||Single Group Assignment||Basic Science||None (Open Label)||||||
1402382|NCT02261675|Randomized|Crossover Assignment||||Double|||||t|t
1402383|NCT02261662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402384|NCT02261649|||Case-Control||Prospective|||||||
1402385|NCT02261636|||Cohort||Prospective|||||||
1402386|NCT02261623|||Cohort||Prospective|||||||
1402387|NCT02261610|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1402388|NCT02261597||Single Group Assignment||Basic Science||None (Open Label)||||||
1402389|NCT02261584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402390|NCT02261571|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1402391|NCT02261558|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1402392|NCT02261545|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1402393|NCT02261532||Single Group Assignment||Treatment||None (Open Label)||||||
1402394|NCT02261519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402395|NCT02261506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402396|NCT02261493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402397|NCT02261480|||Case Control||Prospective|||||||
1402398|NCT02261467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402399|NCT02261454|Randomized|Parallel Assignment||Treatment||Single||||||t
1402400|NCT02261441|||Cohort||Prospective|||||||
1402401|NCT02261428|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1402402|NCT02261415|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402403|NCT02261402|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402404|NCT02261389|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1402405|NCT02261376|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1402406|NCT02261363|||Cohort||Prospective|||||||
1402407|NCT02261350|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1402408|NCT02261337|||Cohort||Prospective|||||||
1402409|NCT02261324|||Cohort||Prospective|||||||
1402410|NCT02261311|||Cohort||Prospective|||||||
1402411|NCT02261298|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402412|NCT02261285|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402413|NCT02261272|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402414|NCT02261259|Randomized|Crossover Assignment||Basic Science||Triple||||t|t|t
1402415|NCT02261246|Randomized|Crossover Assignment||Basic Science||Triple||||t|t|t
1402416|NCT02261233|Randomized|Crossover Assignment||Basic Science||Triple||||t|t|t
1402417|NCT02261220||Single Group Assignment||Treatment||None (Open Label)||||||
1402418|NCT02261207||Single Group Assignment||Treatment||None (Open Label)||||||
1402419|NCT02261194|Randomized|Parallel Assignment||Treatment||Single||||||t
1402420|NCT02261181||Single Group Assignment||Treatment||None (Open Label)||||||
1402421|NCT02261168||Single Group Assignment||Basic Science||None (Open Label)||||||
1402422|NCT02261155||Single Group Assignment||Basic Science||None (Open Label)||||||
1402423|NCT02261142|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1402424|NCT02261129|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402425|NCT02261116|Randomized|Crossover Assignment||Treatment||Single||||||
1402426|NCT02261103|Randomized|Crossover Assignment||Treatment||Double||||||
1402427|NCT02261090|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402428|NCT02261077|Randomized|Parallel Assignment||Treatment||Double||||||
1402429|NCT02261064|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402430|NCT02261051|||||Prospective|||||||
1402431|NCT02261038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1402432|NCT02261025|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402433|NCT02261012|||Case Control||Prospective|||||||
1402434|NCT02260999|||Case Control||Prospective|||||||
1402435|NCT02260986|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402436|NCT02260973|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1402437|NCT02260960|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1402438|NCT02260947|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1402439|NCT02260934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402440|NCT02260921|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402441|NCT02260908|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1402442|NCT02260895|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1402443|NCT02260882|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402444|NCT02260869|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1402445|NCT02260856|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1402446|NCT02260843|Randomized|Factorial Assignment||Treatment||Single|||t|||
1402447|NCT02260830|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402448|NCT02260817|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1402449|NCT02260804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402450|NCT02260791|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402451|NCT02260778|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402452|NCT02260765|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1402453|NCT02260752|||Cohort||Prospective|||||||
1402454|NCT02260739|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1402455|NCT02260726|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1402456|NCT02260713|Randomized|Parallel Assignment||Treatment||Single||||||t
1402457|NCT02260700|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402458|NCT02260687|||Cohort||Prospective|||||||
1402459|NCT02260674|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1402460|NCT02260661|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402461|NCT02260648|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402462|NCT02260635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402463|NCT02260622|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402464|NCT02260609||Single Group Assignment||Treatment||None (Open Label)||||||
1402465|NCT02260596|||Cohort||Retrospective|||||||
1402466|NCT02260583||Single Group Assignment||Treatment||None (Open Label)||||||
1402467|NCT02260570|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1402468|NCT02260557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402469|NCT02260544|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402470|NCT02260531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402471|NCT02260518|Randomized|Parallel Assignment||Prevention||Single||||||t
1402472|NCT02260505|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402473|NCT02260492|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1402474|NCT02260479|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1402475|NCT02260466||Single Group Assignment||Screening||None (Open Label)||||||
1402476|NCT02260453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402477|NCT02260440||Single Group Assignment||Treatment||None (Open Label)||||||
1402478|NCT02260427|Randomized|Parallel Assignment||||Double|||t|||t
1402479|NCT02260414|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1402480|NCT02260401|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1402481|NCT02260388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403247|NCT02250352|||Cohort||Prospective|||||||
1402482|NCT02260375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402483|NCT02260362|||Cohort||Prospective|||||||
1402484|NCT02260349||Single Group Assignment||Diagnostic||None (Open Label)||||||
1402485|NCT02260336|Randomized|Factorial Assignment||Treatment||Single||||||t
1402486|NCT02260323|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1402487|NCT02260310|Randomized|Parallel Assignment||Treatment||Single||||||t
1402488|NCT02260297|||Cohort||Prospective|||||||
1402489|NCT02260284|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402490|NCT02260271|||Case-Only||Retrospective|||||||
1402491|NCT02260258|Randomized|Parallel Assignment||Other||Single|||t|||
1402492|NCT02260245||Single Group Assignment||Other||None (Open Label)||||||
1402493|NCT02260232|Randomized|Parallel Assignment||||Single||||||t
1402494|NCT02260219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402495|NCT02260206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402496|NCT02260193|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402497|NCT02260180|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402498|NCT02260167||Single Group Assignment||Treatment||None (Open Label)||||||
1402499|NCT02260154|||Cohort||Prospective|||||||
1402500|NCT02260141||Single Group Assignment||Treatment||None (Open Label)||||||
1402501|NCT02260128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402502|NCT02260115|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1402503|NCT02260102|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402504|NCT02260089|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402505|NCT02260076|Randomized|Parallel Assignment||Treatment||Double||||||
1402506|NCT02260063|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402507|NCT02260050|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402508|NCT02260037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402509|NCT02260024|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402510|NCT02260011|Randomized|Crossover Assignment||Treatment||Double||||||
1402511|NCT02259998|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402512|NCT02259985|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402513|NCT02259972|Randomized|Parallel Assignment||Treatment||Double||||||
1402514|NCT02259959|Randomized|Parallel Assignment||Treatment||Double||||||
1402515|NCT02259946|Randomized|Parallel Assignment||Treatment||Double||||||
1402516|NCT02259933|Randomized|Parallel Assignment||Treatment||Double||||||
1402517|NCT02259920|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402518|NCT02259907|Randomized|Parallel Assignment||Treatment||Double||||||
1402519|NCT02259894|Randomized|Parallel Assignment||Treatment||Double||||||
1402520|NCT02259881|Randomized|Parallel Assignment||Treatment||Double||||||
1402521|NCT02259868|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402522|NCT02259855|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402523|NCT02259842|Randomized|Parallel Assignment||Treatment||Double||||||
1402524|NCT02259829|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402525|NCT02259816|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402526|NCT02259803|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402527|NCT02259790|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402528|NCT02259777|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402529|NCT02259764|Randomized|Parallel Assignment||Treatment||Double||||||
1402530|NCT02259751|Randomized|Parallel Assignment||Treatment||Double||||||
1402531|NCT02259738||Single Group Assignment||Treatment||Single|||t|||
1402532|NCT02259725||Single Group Assignment||Treatment||None (Open Label)||||||
1402533|NCT02259712|Randomized|Parallel Assignment||Treatment||Single||||||t
1402534|NCT02259699|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402535|NCT02259686|Randomized|Crossover Assignment||||None (Open Label)||||||
1402536|NCT02259673|Randomized|Parallel Assignment||Prevention||Single|||t|||
1402537|NCT02259660|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1402538|NCT02259647|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402539|NCT02259634|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402540|NCT02259621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402541|NCT02259608||Single Group Assignment||Basic Science||None (Open Label)||||||
1402542|NCT02259595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402543|NCT02259582|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402544|NCT02259569|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1402545|NCT02259556||Single Group Assignment||Treatment||None (Open Label)||||||
1402546|NCT02259543|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402547|NCT02259530||Single Group Assignment||Treatment||None (Open Label)||||||
1402548|NCT02259517|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402549|NCT02259504||Single Group Assignment||Treatment||Double||||||
1402550|NCT02259491|Randomized|Parallel Assignment||Treatment||Single||||||t
1402551|NCT02259478|||Case-Control||Prospective|||||||
1402552|NCT02259465|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1402553|NCT02259452|||Cohort||Prospective|||||||
1402554|NCT02259439|||Case-Only||Prospective|||||||
1402555|NCT02259426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402556|NCT02259413|Randomized|Parallel Assignment||Treatment||Single||||||t
1402557|NCT02259400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402559|NCT02259374|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402560|NCT02259361|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402561|NCT02259348||Single Group Assignment||Treatment||None (Open Label)||||||
1402562|NCT02259335||Single Group Assignment||Treatment||None (Open Label)||||||
1402563|NCT02259322|Randomized|Parallel Assignment||Treatment||Single||||||t
1402564|NCT02259309|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1402565|NCT02259296|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402566|NCT02259283||Single Group Assignment||Treatment||None (Open Label)||||||
1402567|NCT02259270|||Other||Retrospective|||||||
1402568|NCT02259257|||Case-Only||Prospective|||||||
1402569|NCT02259244|Randomized|Parallel Assignment||||Single||||||t
1402570|NCT02259231|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402571|NCT02259218|||Case-Control||Retrospective|||||||
1402572|NCT02259205|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1402573|NCT02259192||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1402574|NCT02259179|Randomized|Crossover Assignment||||None (Open Label)||||||
1402575|NCT02259166|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402576|NCT02259153|Randomized|Crossover Assignment||Treatment||Single|||t|||
1402577|NCT02259140|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1402578|NCT02259127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402579|NCT02259114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402580|NCT02259101|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402581|NCT02259088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402582|NCT02259075||Single Group Assignment||Treatment||None (Open Label)||||||
1402583|NCT02259062|Randomized|Parallel Assignment||Treatment||Single||||||t
1402584|NCT02259049|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1402585|NCT02259036||Single Group Assignment||Treatment||None (Open Label)||||||
1402586|NCT02259023|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1402587|NCT02259010|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1402588|NCT02258997|||Cohort||Cross-Sectional|||||||
1402589|NCT02258984|Randomized|Single Group Assignment||Treatment||Single||||t||
1402590|NCT02258971|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402591|NCT02258958|||Cohort||Prospective|||||||
1402592|NCT02258945|||Case Control||Cross-Sectional|||||||
1402593|NCT02258932|||Cohort||Prospective|||||||
1402594|NCT02258919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402595|NCT02258906|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1402596|NCT02258893|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1402597|NCT02258880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402598|NCT02258867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402599|NCT02258854||Single Group Assignment||Treatment||None (Open Label)||||||
1402600|NCT02258841|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1402601|NCT02258828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402602|NCT02258815||Single Group Assignment||Treatment||None (Open Label)||||||
1402603|NCT02258802|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402604|NCT02258789||Single Group Assignment||Treatment||None (Open Label)||||||
1402605|NCT02258776|Randomized|Single Group Assignment||Prevention||Single|||t|||
1402606|NCT02258763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402607|NCT02258750|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1402608|NCT02258737|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402609|NCT02258724|||Cohort||Prospective|||||||
1402610|NCT02258711|Randomized|Parallel Assignment||Treatment||Single||||t||
1402611|NCT02258698|||Cohort||Prospective|||||||
1402612|NCT02258685|||Cohort||Cross-Sectional|||||||
1402613|NCT02258672|Randomized|Parallel Assignment||Treatment||Single||||||t
1402614|NCT02258659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402615|NCT02258646|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1402616|NCT02258633|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402617|NCT02258620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402618|NCT02258607|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402619|NCT02258594|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1402620|NCT02258581|||Cohort||Prospective|||||||
1402621|NCT02258568|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1402622|NCT02258555||Single Group Assignment||Treatment||None (Open Label)||||||
1402623|NCT02258542|Randomized|Parallel Assignment||Other||Double|||t||t|
1402624|NCT02258529||Single Group Assignment||Treatment||None (Open Label)||||||
1402625|NCT02258516|Randomized|Parallel Assignment||||None (Open Label)||||||
1402626|NCT02258503|||||Cross-Sectional|||||||
1402627|NCT02258490||||||||||||
1402628|NCT02258477|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1402629|NCT02258464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402630|NCT02258451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402631|NCT02258438|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1402632|NCT02258425|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402633|NCT02258412|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1402634|NCT02258399|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1402635|NCT02258386|||||Prospective|||||||
1402636|NCT02258373|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402637|NCT02258360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402638|NCT02258347||Single Group Assignment||Treatment||None (Open Label)||||||
1402639|NCT02258334|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402640|NCT02258321|Randomized|Crossover Assignment||||None (Open Label)||||||
1402641|NCT02258308|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402642|NCT02258295|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402643|NCT02258282|Randomized|Parallel Assignment||Treatment||Single||||||t
1402644|NCT02258269|Randomized|Crossover Assignment||Treatment||Single||||||t
1402645|NCT02258256||Single Group Assignment||Device Feasibility||None (Open Label)||Pregnant women will have their blood pressure measured by both the experimental device (Sphygmo ) and the gold-standard, commercial device (GE Dinamap Procare).||||
1402646|NCT02258230|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402647|NCT02258217||Single Group Assignment||Other||None (Open Label)||||||
1402648|NCT02258204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402649|NCT02258191|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402650|NCT02258178|||Cohort||Other|||||||
1402651|NCT02258165|||Cohort||Prospective|||||||
1402652|NCT02258152|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402653|NCT02258139||||||||||||
1402654|NCT02258126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402655|NCT02258113||Single Group Assignment||Health Services Research||None (Open Label)||||||
1402656|NCT02258100|||Cohort||Retrospective|||||||
1402657|NCT02258087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402658|NCT02258074|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1402659|NCT02258061|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1402660|NCT02258048|||Case-Only||Prospective|||||||
1402661|NCT02258035|||Case-Only||Prospective|||||||
1402662|NCT02258022||Single Group Assignment||||None (Open Label)||||||
1402663|NCT02258009|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402664|NCT02257996|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402665|NCT02257983|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1402666|NCT02257970|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1402667|NCT02257957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402668|NCT02257944|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402669|NCT02257931|||Case-Control||Prospective|||||||
1402670|NCT02257918|Randomized|Parallel Assignment||Treatment||||||||
1402671|NCT02257905|||Cohort||Prospective|||||||
1402672|NCT02257892|||Family-Based||Prospective|||||||
1402673|NCT02257879|||Case-Crossover||Prospective|||||||
1402674|NCT02257866|||Cohort||Other|||||||
1402675|NCT02257853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402676|NCT02257827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402677|NCT02257814|Randomized|Parallel Assignment||||None (Open Label)||||||
1402678|NCT02257801|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1402679|NCT02257788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402680|NCT02257775|||Case-Only||Prospective|||||||
1402681|NCT02257762|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402682|NCT02257749|Randomized|Parallel Assignment||Treatment||Single||||||t
1402683|NCT02257736|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402684|NCT02257723|||Cohort||Prospective|||||||
1402685|NCT02257710|||Other||Prospective|||||||
1402686|NCT02257697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402687|NCT02257684||Single Group Assignment||Treatment||None (Open Label)||||||
1402688|NCT02257671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402689|NCT02257658|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402690|NCT02257645|||Cohort||Prospective|||||||
1402691|NCT02257632|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402692|NCT02257619||Single Group Assignment||Treatment||None (Open Label)||||||
1402693|NCT02257606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402694|NCT02257593|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1402695|NCT02257580|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1402696|NCT02257567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402697|NCT02257554|||Cohort||Prospective|||||||
1402698|NCT02257541||Single Group Assignment||Treatment||None (Open Label)||||||
1402699|NCT02257528||Single Group Assignment||Treatment||None (Open Label)||||||
1402700|NCT02257502||Single Group Assignment||Treatment||None (Open Label)||||||
1402701|NCT02257489|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1402702|NCT02257476||Single Group Assignment||Treatment||None (Open Label)||||||
1402703|NCT02257463|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402704|NCT02257450|||Ecologic or Community||Cross-Sectional|||||||
1402705|NCT02257437|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1402706|NCT02257424||||Treatment||||||||
1402707|NCT02257411||Single Group Assignment||||Triple|||t|t|t|
1402708|NCT02257398|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1402709|NCT02257385|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402710|NCT02257372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402711|NCT02257359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402712|NCT02257346|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402713|NCT02257333|||Case-Only||Prospective|||||||
1402714|NCT02257320||Single Group Assignment||Treatment||None (Open Label)||||||
1402716|NCT02257294|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402717|NCT02257281|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402718|NCT02257268|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1402719|NCT02257255|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1402720|NCT02257242||Single Group Assignment||Treatment||None (Open Label)||||||
1402721|NCT02257229|||Cohort||Prospective|||||||
1402722|NCT02257216|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1402723|NCT02257203|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402724|NCT02257190|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402725|NCT02257177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402726|NCT02257164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402727|NCT02257151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402728|NCT02257138||Single Group Assignment||Treatment||None (Open Label)||||||
1402729|NCT02257125|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402730|NCT02257112||Single Group Assignment||Basic Science||None (Open Label)||||||
1402731|NCT02257099|||Case-Only||Prospective|||||||
1402732|NCT02257073|Randomized|Parallel Assignment||Treatment||Single||||||t
1402733|NCT02257060||Single Group Assignment||Treatment||None (Open Label)||||||
1402734|NCT02257047|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1402735|NCT02257034|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1402736|NCT02257021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402737|NCT02257008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402738|NCT02256995|||Cohort||Prospective|||||||
1402739|NCT02256982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402740|NCT02256969|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402741|NCT02256956|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1402742|NCT02256943|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1402743|NCT02256930|Randomized|Single Group Assignment||||Double|||t|||t
1402744|NCT02256917||Single Group Assignment||Prevention||None (Open Label)||||||
1402745|NCT02256904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402746|NCT02256891|Randomized|Single Group Assignment||Treatment||Single|||t|||
1402747|NCT02256878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402748|NCT02256865|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1402749|NCT02256852||Single Group Assignment||Treatment||None (Open Label)||||||
1402750|NCT02256839|||Case-Control||Prospective|||||||
1402751|NCT02256826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402752|NCT02256813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402753|NCT02256800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402754|NCT02256787|Randomized|Parallel Assignment||Treatment||Double||||||
1402755|NCT02256774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402756|NCT02256761|Randomized|Parallel Assignment||Treatment||Double||||||
1402757|NCT02256748||Single Group Assignment||Treatment||None (Open Label)||||||
1402758|NCT02256735|Randomized|Parallel Assignment||Treatment||Double||||||
1402759|NCT02256722|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402760|NCT02256709|Randomized|Parallel Assignment||Treatment||Double||||||
1402761|NCT02256696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402762|NCT02256683|Randomized|Parallel Assignment||Treatment||Single||||||t
1402763|NCT02256670||Single Group Assignment||Supportive Care||None (Open Label)||||||
1402764|NCT02256657|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1402765|NCT02256644|||Case-Control||Other|||||||
1402766|NCT02256631|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402767|NCT02256618||Single Group Assignment||Treatment||None (Open Label)||||||
1402768|NCT02256605|||Cohort||Prospective|||||||
1402769|NCT02256592||Single Group Assignment||Treatment||None (Open Label)||||||
1402770|NCT02256579|||Cohort||Prospective|||||||
1402771|NCT02256566|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402772|NCT02256553||Single Group Assignment||Treatment||None (Open Label)||||||
1402773|NCT02256540|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1402774|NCT02256527|||Case-Only||Retrospective|||||||
1402775|NCT02256514||Single Group Assignment||Treatment||None (Open Label)||||||
1402776|NCT02256501|Randomized|Parallel Assignment||Treatment||Single|||||t|
1402777|NCT02256488|Randomized|Parallel Assignment||||Double|||t||t|
1402778|NCT02256475|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1402779|NCT02256462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402780|NCT02256449|||Cohort||Prospective|||||||
1402781|NCT02256436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402782|NCT02256423|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1402783|NCT02256410|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402784|NCT02256397|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402785|NCT02256384||Single Group Assignment||Diagnostic||None (Open Label)||||||
1402786|NCT02256371|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402787|NCT02256358|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1402788|NCT02256345|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402789|NCT02256332|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1402790|NCT02256319|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1402791|NCT02256306||Single Group Assignment||Treatment||None (Open Label)||||||
1402792|NCT02256293||Single Group Assignment||Treatment||None (Open Label)||||||
1402793|NCT02256280|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1402794|NCT02256267|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1402795|NCT02256254|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1402796|NCT02256241|||Cohort|||||||||
1402797|NCT02256228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402798|NCT02256215|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402799|NCT02256202|||Cohort||Prospective|||||||
1402800|NCT02256189|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1402801|NCT02256163|||Family-Based||Prospective|||||||
1402802|NCT02256150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402803|NCT02256137|||Cohort||Prospective|||||||
1402804|NCT02256124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402805|NCT02256111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402806|NCT02256098|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402807|NCT02256085|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1402808|NCT02256072|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1402809|NCT02256059|||Cohort||Prospective|||||||
1402810|NCT02256046||Single Group Assignment||Screening||None (Open Label)||||||
1402811|NCT02256033||Single Group Assignment||Basic Science||None (Open Label)||||||
1402812|NCT02256020|Randomized|Parallel Assignment||Basic Science||Single||||||t
1402813|NCT02256007|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Two treatment sessions during an inpatient rehabilitation stay. Part 1 is the screening (Montreal Cognitive Assessment and the Boston Diagnostic Aphasia Examination). Assessments will be given to make sure patient is eligible for the study. If eligible, will complete part 2-paper and pencil tasks and video game tests.||||
1402814|NCT02255994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402815|NCT02255981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402816|NCT02255968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402817|NCT02255955|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402818|NCT02255942||Single Group Assignment||Health Services Research||None (Open Label)||||||
1402819|NCT02255929||Single Group Assignment||Treatment||None (Open Label)||||||
1402820|NCT02255916|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1402821|NCT02255903|||Case-Control||Prospective|||||||
1402822|NCT02255890|||Cohort||Prospective|||||||
1402823|NCT02255877|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402824|NCT02255864||Single Group Assignment||Treatment||None (Open Label)||||||
1402825|NCT02255851|||Cohort||Prospective|||||||
1402826|NCT02255838|Randomized|Crossover Assignment||Diagnostic||None (Open Label)|A blinded investigator will view the bronchoscopy video and evaluate. The blinded investigator will use the same criteria the investigator who did the procedure used (Un-blinded) for the evaluation. Video will not indicate which scope was used and only indicate if it is the right or left lung they are viewing. Research coordinator will keep separate a file indicating which scope was used.|The disposable aScope III bronchoscope will be compared to the re-usable bronchoscope||||
1402827|NCT02255825|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1402828|NCT02255812|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1402829|NCT02255799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402830|NCT02255786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402831|NCT02255773|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402832|NCT02255760|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1402833|NCT02255747|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402834|NCT02255734|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402835|NCT02255721|Randomized|Parallel Assignment||Treatment||Single||||||t
1402836|NCT02255708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402837|NCT02255695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402838|NCT02255682|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1402839|NCT02255669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402840|NCT02255656||Single Group Assignment||Treatment||None (Open Label)||||||
1402841|NCT02255643|Randomized|Crossover Assignment||Treatment||Single|||t|||
1402842|NCT02255630|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1402843|NCT02255617||Single Group Assignment||Treatment||None (Open Label)||||||
1402844|NCT02255604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402845|NCT02255591|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1402846|NCT02255578|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402847|NCT02255565|Randomized|Parallel Assignment||Treatment||Single||||||t
1402848|NCT02255552|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402849|NCT02255539||||||||||||
1402850|NCT02255526|||Cohort||Prospective|||||||
1402851|NCT02255513|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402852|NCT02255500||Single Group Assignment||Treatment||None (Open Label)||||||
1402853|NCT02255487|Randomized|Parallel Assignment||Prevention||Single|||t|||
1402854|NCT02255474|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1402855|NCT02255461||Single Group Assignment||Treatment||None (Open Label)||||||
1402856|NCT02255448||Single Group Assignment||||Single|||||t|
1402857|NCT02255435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402858|NCT02255422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402859|NCT02255409|Randomized|Parallel Assignment||Prevention||Single|||t|||
1402860|NCT02255396|||||Cross-Sectional|||||||
1402861|NCT02255383||Single Group Assignment||Treatment||None (Open Label)||||||
1402862|NCT02255370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1402863|NCT02255357|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1402864|NCT02255344|||Cohort||Prospective|||||||
1402865|NCT02255331|||Cohort||Prospective|||||||
1402866|NCT02255318|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1402867|NCT02255305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402868|NCT02255292||Single Group Assignment||Treatment||None (Open Label)||||||
1402869|NCT02255279|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1402870|NCT02255266|||Cohort||Retrospective|||||||
1402871|NCT02255253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402872|NCT02255240||Single Group Assignment||Supportive Care||Single||||||t
1402873|NCT02255227|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402874|NCT02255214|||Cohort||Prospective|||||||
1402875|NCT02255201|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1402876|NCT02255188|||Cohort||Prospective|||||||
1402877|NCT02255175|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1402878|NCT02255162||Single Group Assignment||Treatment||None (Open Label)||||||
1402879|NCT02255149||Single Group Assignment||Treatment||None (Open Label)||||||
1402880|NCT02255136|Randomized|Parallel Assignment||Treatment||Single||Prospective, single-blind (subject), randomized, placebo-controlled, parallel group, interventional clinical trial|t|||
1402881|NCT02255123|||Case-Only||Retrospective|||||||
1402882|NCT02255110||Single Group Assignment||Treatment||None (Open Label)||||||
1402883|NCT02255097||Single Group Assignment||Treatment||None (Open Label)||||||
1402884|NCT02255084|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1402885|NCT02255071|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1402886|NCT02255058|||Cohort||Prospective|||||||
1402887|NCT02255045|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1402888|NCT02255032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402889|NCT02255019|||Case-Crossover||Prospective|||||||
1402890|NCT02255006|Randomized|Crossover Assignment||Treatment||Single|||t|||
1402891|NCT02254993|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402892|NCT02254980|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402893|NCT02254967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402894|NCT02254954||Single Group Assignment||Treatment||None (Open Label)||||||
1402895|NCT02254941|||Cohort||Prospective|||||||
1402896|NCT02254928|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402897|NCT02254915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402898|NCT02254902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402899|NCT02254889|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402900|NCT02254876|Randomized|Parallel Assignment||Treatment||Single|||||t|
1402901|NCT02254863||Single Group Assignment||Treatment||None (Open Label)||||||
1402902|NCT02254850|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1402903|NCT02254837||Single Group Assignment||Treatment||None (Open Label)||||||
1402904|NCT02254824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402905|NCT02254811|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402906|NCT02254798|||Cohort||Prospective|||||||
1402907|NCT02254785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402908|NCT02254772||Single Group Assignment||Treatment||None (Open Label)||||||
1402909|NCT02254759|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1402910|NCT02254746||Single Group Assignment||Treatment||None (Open Label)||||||
1402911|NCT02254733|Randomized|Parallel Assignment||Treatment||Single|||||t|
1402912|NCT02254720|Randomized|Parallel Assignment||Treatment||Single||||||
1402913|NCT02254707|Randomized|Parallel Assignment||Treatment||Double||||||
1402914|NCT02254694||Single Group Assignment||Prevention||None (Open Label)||||||
1402915|NCT02254681||Single Group Assignment||Treatment||None (Open Label)||||||
1402916|NCT02254668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402917|NCT02254655|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1402918|NCT02254642|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1402919|NCT02254629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402920|NCT02254616|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402921|NCT02254603|Randomized|Crossover Assignment||Basic Science||Single||||||t
1402922|NCT02254590||Single Group Assignment||Treatment||None (Open Label)||||||
1402923|NCT02254577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402924|NCT02254564|||Case-Control||Prospective|||||||
1402925|NCT02254551||Single Group Assignment||Treatment||None (Open Label)||||||
1402926|NCT02254538|Randomized|Parallel Assignment||Treatment||Double||||||
1402927|NCT02254525|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1402928|NCT02254499|||Cohort||Prospective|||||||
1402929|NCT02254486|Randomized|Parallel Assignment||Screening||Single|||||t|
1402930|NCT02254473|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402931|NCT02254460|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1402932|NCT02254447|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1402933|NCT02254434|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1402934|NCT02254421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402935|NCT02254408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402936|NCT02254395|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1402937|NCT02254382||Single Group Assignment||Treatment||None (Open Label)||||||
1402938|NCT02254369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402939|NCT02254356||Single Group Assignment||Treatment||None (Open Label)||||||
1402940|NCT02254343|Randomized|Parallel Assignment||Treatment||Single||||||t
1402941|NCT02254330|||Cohort||Cross-Sectional|||||||
1402942|NCT02254317|Randomized|Crossover Assignment||Other||Single|||t|||
1402943|NCT02254304|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402944|NCT02254291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402945|NCT02254278|Randomized|Parallel Assignment||Treatment||Single||||||
1402946|NCT02254265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402947|NCT02254252|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402948|NCT02254239||Single Group Assignment||Treatment||None (Open Label)||||||
1402949|NCT02254226|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402950|NCT02254213|||Cohort||Prospective|||||||
1402951|NCT02254200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402952|NCT02254187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402953|NCT02254174|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402954|NCT02254161|Randomized|Single Group Assignment||Treatment||Double||||||
1402955|NCT02254148||Single Group Assignment||Treatment||None (Open Label)||||||
1402956|NCT02254135|Randomized|Parallel Assignment||Treatment||Single||||||
1402957|NCT02254122|Randomized|Parallel Assignment||Treatment||Double||||||
1402958|NCT02254109|Randomized|Parallel Assignment||Treatment||Double||||||
1402959|NCT02254096|Randomized|Parallel Assignment||Treatment||Double||||||
1402960|NCT02254083|Randomized|Parallel Assignment||Treatment||Double||||||
1402961|NCT02254070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402962|NCT02254057|Randomized|Parallel Assignment||Treatment||Double||||||
1402963|NCT02254044||Single Group Assignment||Treatment||None (Open Label)||||||
1402964|NCT02254031||Single Group Assignment||Treatment||None (Open Label)||||||
1402965|NCT02254018||Single Group Assignment||Treatment||None (Open Label)||||||
1402966|NCT02254005||Single Group Assignment||Treatment||None (Open Label)||||||
1402967|NCT02253992||Single Group Assignment||Treatment||None (Open Label)||||||
1402968|NCT02253979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402969|NCT02253966|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1402970|NCT02253953|Randomized|Parallel Assignment||Treatment||Double||||||
1402971|NCT02253940|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402972|NCT02253927||Single Group Assignment||Treatment||None (Open Label)||||||
1402973|NCT02253914|Randomized|Parallel Assignment||Treatment||Double||||||
1402974|NCT02253901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1402975|NCT02253888|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1402976|NCT02253875||Single Group Assignment||Treatment||None (Open Label)||||||
1402977|NCT02253862||Single Group Assignment||Treatment||None (Open Label)||||||
1402978|NCT02253849||Single Group Assignment||Treatment||None (Open Label)||||||
1402979|NCT02253836||Single Group Assignment||Treatment||None (Open Label)||||||
1402980|NCT02253823|Randomized|Parallel Assignment||||None (Open Label)||||||
1402981|NCT02253810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1402982|NCT02253797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402983|NCT02253784|Randomized|Single Group Assignment||Treatment||Single|||||t|
1402984|NCT02253771|Randomized|Parallel Assignment||Treatment||Single|||t|||
1402985|NCT02253758||Single Group Assignment||Basic Science||None (Open Label)||||||
1402986|NCT02253745|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1402987|NCT02253732||Single Group Assignment||Prevention||None (Open Label)||||||
1402988|NCT02253719|||Cohort||Prospective|||||||
1402989|NCT02253706|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402990|NCT02253693|||Cohort||Prospective|||||||
1402991|NCT02253680|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402992|NCT02253667|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1402993|NCT02253654|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1402994|NCT02253641|Randomized|Parallel Assignment||Treatment||Single||||||t
1402995|NCT02253628|Randomized|Crossover Assignment||||Single|||t|||
1402996|NCT02253615|Randomized|Parallel Assignment||Treatment||Single||||||t
1402997|NCT02253602|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1402998|NCT02253589|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1402999|NCT02253576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403000|NCT02253563|Randomized|Parallel Assignment||Treatment||Single||||||t
1403001|NCT02253550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403002|NCT02253537|||Case-Only||Prospective|||||||
1403003|NCT02253524|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1403004|NCT02253511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403005|NCT02253498|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1403006|NCT02253485|||Case Control||Prospective|||||||
1403007|NCT02253472|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1403008|NCT02253459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403009|NCT02253446|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1403010|NCT02253433|Randomized|Parallel Assignment||Treatment||Single||||||t
1403011|NCT02253420|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1403012|NCT02253407|Randomized|Parallel Assignment||Prevention||Single||||||t
1403013|NCT02253394|Randomized|Crossover Assignment||Other||Double|||t|t||
1403014|NCT02253381|Randomized|Parallel Assignment||Prevention||Single||||||t
1403015|NCT02253368|Randomized|Parallel Assignment||Other||Single|||t|||
1403016|NCT02253355|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1403017|NCT02253342||Single Group Assignment||Basic Science||None (Open Label)||||||
1403018|NCT02253329|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403019|NCT02253316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403020|NCT02253303|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403021|NCT02253290|||Cohort|||||||||
1403022|NCT02253277||Single Group Assignment||Treatment||None (Open Label)||||||
1403023|NCT02253264||Single Group Assignment||Treatment||None (Open Label)||||||
1403024|NCT02253251|||Cohort||Prospective|||||||
1403025|NCT02253238|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403026|NCT02253225|||Case-Control||Cross-Sectional|||||||
1403027|NCT02253212||Single Group Assignment||Treatment||None (Open Label)||||||
1403028|NCT02253199|Non-Randomized|Parallel Assignment||||Double||||t|t|
1403029|NCT02253186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403030|NCT02253173|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1403031|NCT02253160|Randomized|Crossover Assignment||||None (Open Label)||||||
1403032|NCT02253147|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1403033|NCT02253134|||||Prospective|||||||
1403034|NCT02253121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403035|NCT02253108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403036|NCT02253095|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403037|NCT02253082|Randomized|Factorial Assignment||Treatment||Single||||||t
1403038|NCT02253069|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1403039|NCT02253056|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403040|NCT02253043||Single Group Assignment||Treatment||None (Open Label)||||||
1403041|NCT02253030|||Case-Control||Prospective|||||||
1403042|NCT02253017|||Cohort||Prospective|||||||
1403043|NCT02253004|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1403044|NCT02252991|Randomized|Parallel Assignment||||None (Open Label)||||||
1403045|NCT02252978|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1403046|NCT02252965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403047|NCT02252952|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1403048|NCT02252939||Single Group Assignment||Treatment||None (Open Label)||||||
1403049|NCT02252926|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1403050|NCT02252913||Single Group Assignment||||None (Open Label)||||||
1403051|NCT02252900||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403052|NCT02252887||Single Group Assignment||Treatment||None (Open Label)||||||
1403053|NCT02252874|Randomized|Parallel Assignment||Other||Single||||||t
1403054|NCT02252861|||Cohort||Prospective|||||||
1403055|NCT02252848|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403056|NCT02252835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403057|NCT02252822||Single Group Assignment||Treatment||None (Open Label)||||||
1403058|NCT02252809|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1403059|NCT02252796|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403060|NCT02252783||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403061|NCT02252770|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1403062|NCT02252757|||Cohort||Prospective|||||||
1403063|NCT02252744|||Case-Only||Prospective|||||||
1403064|NCT02252731||Single Group Assignment||Basic Science||None (Open Label)||||||
1403065|NCT02252718|||Case-Only||Cross-Sectional|||||||
1403066|NCT02252705|||Cohort||Prospective|||||||
1403067|NCT02252692|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403068|NCT02252679|||Case-Control||Prospective|||||||
1403069|NCT02252666||Single Group Assignment||Treatment||None (Open Label)||||||
1403070|NCT02252653|||Cohort||Prospective|||||||
1403071|NCT02252640|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403072|NCT02252627|||||Prospective|||||||
1403073|NCT02252614|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1403074|NCT02252601|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1403075|NCT02252588|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1403076|NCT02252575||Single Group Assignment||Treatment||None (Open Label)||||||
1403077|NCT02252562|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1403078|NCT02252549|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1403079|NCT02252536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403080|NCT02252523|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403081|NCT02252510|||||Prospective|||||||
1403082|NCT02252497|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403083|NCT02252484|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403084|NCT02252471||Single Group Assignment||Prevention||None (Open Label)||||||
1403085|NCT02252458|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1403086|NCT02252445|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1403087|NCT02252432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403088|NCT02252419|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1403089|NCT02252406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403090|NCT02252393|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1403091|NCT02252380||Single Group Assignment||Treatment||None (Open Label)||||||
1403092|NCT02252367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403093|NCT02252354|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1403094|NCT02252341|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403095|NCT02252328|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403096|NCT02252315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403097|NCT02252302|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1403098|NCT02252289|||Cohort||Prospective|||||||
1403099|NCT02252276|Randomized|Parallel Assignment||Treatment||Single|||||t|
1403100|NCT02252263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403101|NCT02252250|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403102|NCT02252237|||Cohort||Prospective|||||||
1403103|NCT02252224|||Case-Only||Prospective|||||||
1403104|NCT02252211||Single Group Assignment||Treatment||None (Open Label)||||||
1403105|NCT02252198|||Cohort||Prospective|||||||
1403106|NCT02252185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403107|NCT02252172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403108|NCT02252159|||Cohort||Prospective|||||||
1403109|NCT02252146||Single Group Assignment||Treatment||None (Open Label)||||||
1403110|NCT02252133|Randomized|Crossover Assignment||||None (Open Label)||||||
1403111|NCT02252120|Randomized|Parallel Assignment||Treatment||Single|||||t|
1403112|NCT02252107||Single Group Assignment||Treatment||None (Open Label)||||||
1403113|NCT02252094|Randomized|Parallel Assignment||Treatment||Single|Data analysis will be blinded.|||||t
1403114|NCT02252081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403115|NCT02252068|Randomized|Parallel Assignment||Treatment||Single||||||t
1403116|NCT02252055||Single Group Assignment||Treatment||None (Open Label)||||||
1403117|NCT02252042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403118|NCT02252029|||Cohort||Prospective|||||||
1403119|NCT02252016|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403120|NCT02252003||Single Group Assignment||Supportive Care||None (Open Label)||||||
1403121|NCT02251990|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403122|NCT02251977|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403123|NCT02251964||Single Group Assignment||Treatment||None (Open Label)||||||
1403124|NCT02251951||Single Group Assignment||Treatment||None (Open Label)||||||
1403125|NCT02251938||Single Group Assignment||Treatment||None (Open Label)||||||
1403126|NCT02251925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403127|NCT02251912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403128|NCT02251899|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1403129|NCT02251886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403130|NCT02251873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403131|NCT02251860|||Cohort||Prospective|||||||
1403132|NCT02251847|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403133|NCT02251834|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1403134|NCT02251821||Single Group Assignment||Treatment||None (Open Label)||||||
1403135|NCT02251808|||Cohort||Prospective|||||||
1403136|NCT02251795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403137|NCT02251782|||Case Control||Prospective|||||||
1403138|NCT02251769||Single Group Assignment||Treatment||None (Open Label)||||||
1403139|NCT02251756|Randomized|Parallel Assignment||Treatment||Single|||||t|
1403140|NCT02251743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403141|NCT02251730||Single Group Assignment||Treatment||None (Open Label)||||||
1403142|NCT02251717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403143|NCT02251704||Single Group Assignment||Other||None (Open Label)||||||
1403144|NCT02251691|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403145|NCT02251678||Single Group Assignment||Basic Science||None (Open Label)||||||
1403146|NCT02251665|||Case-Only||Prospective|||||||
1403147|NCT02251652|Randomized|Parallel Assignment||Treatment||Single||||||t
1403148|NCT02251639||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403149|NCT02251626|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1403150|NCT02251613|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1403151|NCT02251600||Single Group Assignment||Basic Science||None (Open Label)||||||
1403152|NCT02251587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403153|NCT02251574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403154|NCT02251561|Randomized|Single Group Assignment||||Double|||t||t|
1403155|NCT02251548||Single Group Assignment||Treatment||None (Open Label)||||||
1403156|NCT02251535|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1403157|NCT02251522|||Case-Control||Other|||||||
1403158|NCT02251509|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1403159|NCT02251496|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1403160|NCT02251483|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1403161|NCT02251470|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1403162|NCT02251457||Single Group Assignment||Treatment||None (Open Label)||||||
1403163|NCT02251444|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403164|NCT02251431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403165|NCT02251418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403166|NCT02251405|Randomized|Crossover Assignment||Prevention||Single||||||t
1403167|NCT02251392|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1403248|NCT02250339|||Cohort||Prospective|||||||
1403168|NCT02251379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403169|NCT02251366|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1403170|NCT02251353|||Cohort||Prospective|||||||
1403171|NCT02251340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403172|NCT02251327|||Cohort||Prospective|||||||
1403173|NCT02251314|||Other||Prospective|||||||
1403174|NCT02251301|Randomized|Parallel Assignment||Other||Double|||t||t|
1403175|NCT02251288|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1403176|NCT02251275||Single Group Assignment||Treatment||None (Open Label)||||||
1403177|NCT02251262||Single Group Assignment||Diagnostic||Single||||||t
1403178|NCT02251249|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1403179|NCT02251236|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403180|NCT02251223|Non-Randomized|Parallel Assignment||Treatment||||||||
1403181|NCT02251210|Randomized|Parallel Assignment||Treatment||Double||||||
1403182|NCT02251197|Randomized|Parallel Assignment||Treatment||Double||||||
1403183|NCT02251184|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403184|NCT02251171||Single Group Assignment||Treatment||None (Open Label)||||||
1403185|NCT02251158|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403186|NCT02251145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403187|NCT02251132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403188|NCT02251119||Parallel Assignment||Treatment||None (Open Label)||||||
1403189|NCT02251106|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1403190|NCT02251093|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1403191|NCT02251080|||Cohort||Prospective|||||||
1403192|NCT02251067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403193|NCT02251054|Randomized|Parallel Assignment||||Double|||t|||t
1403194|NCT02251041|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403195|NCT02251028|Randomized|Crossover Assignment||Prevention||Single||||||t
1403196|NCT02251015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403197|NCT02251002|||Case-Control||Prospective|||||||
1403198|NCT02250989|||Cohort||Prospective|||||||
1403199|NCT02250976|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1403200|NCT02250963|||Cohort||Prospective|||||||
1403201|NCT02250950|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1403202|NCT02250937|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403203|NCT02250924|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1403204|NCT02250911|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1403205|NCT02250898|Randomized|Parallel Assignment||Treatment||Single||||||t
1403206|NCT02250885||Single Group Assignment||Treatment||None (Open Label)||||||
1403207|NCT02250872|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1403208|NCT02250859||Single Group Assignment||Treatment||None (Open Label)||||||
1403209|NCT02250846|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403210|NCT02250833|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403211|NCT02250820|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1403212|NCT02250807||Single Group Assignment||Treatment||None (Open Label)||||||
1403213|NCT02250794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403214|NCT02250781||Single Group Assignment||Treatment||None (Open Label)||||||
1403215|NCT02250768||Single Group Assignment||Treatment||None (Open Label)||||||
1403216|NCT02250755||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403217|NCT02250742|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1403218|NCT02250729|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1403219|NCT02250716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403220|NCT02250703|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1403221|NCT02250690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403222|NCT02250677|||Case Control||Cross-Sectional|||||||
1403223|NCT02250664|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1403224|NCT02250651|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1403225|NCT02250638|||Cohort||Prospective|||||||
1403226|NCT02250625|||Cohort||Prospective|||||||
1403227|NCT02250612|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403228|NCT02250599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403229|NCT02250586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403230|NCT02250573||||Treatment||||||||
1403231|NCT02250560||||||||||||
1403232|NCT02250547|||Other||Prospective|||||||
1403233|NCT02250534|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1403234|NCT02250521||Single Group Assignment||Supportive Care||None (Open Label)||||||
1403235|NCT02250508||||Treatment||||||||
1403236|NCT02250495||Single Group Assignment||Treatment||None (Open Label)||||||
1403237|NCT02250482||||Treatment||||||||
1403238|NCT02250469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403239|NCT02250456|||Cohort||Prospective|||||||
1403240|NCT02250443||Single Group Assignment||Treatment||None (Open Label)||||||
1403241|NCT02250430||Single Group Assignment||Treatment||None (Open Label)||||||
1403242|NCT02250417|Randomized|Crossover Assignment||Treatment||Single||||||t
1403243|NCT02250404|||Case-Only||Cross-Sectional|||||||
1403244|NCT02250391|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403245|NCT02250378||Single Group Assignment||Treatment||None (Open Label)||||||
1403246|NCT02250365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403249|NCT02250326|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403250|NCT02250313|||Case-Control||Prospective|||||||
1403251|NCT02250300|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403252|NCT02250287|||Case Control||Retrospective|||||||
1403253|NCT02250274|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1403254|NCT02250261|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1403255|NCT02250248|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403256|NCT02250235|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1403257|NCT02250222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403258|NCT02250209||Single Group Assignment||Treatment||None (Open Label)||||||
1403259|NCT02250196|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1403260|NCT02250183||Single Group Assignment||Treatment||None (Open Label)||||||
1403261|NCT02250170||Single Group Assignment||Treatment||None (Open Label)||||||
1403262|NCT02250157|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403263|NCT02250144|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1403264|NCT02250131|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1403265|NCT02250118||Single Group Assignment||Treatment||None (Open Label)||||||
1403266|NCT02250105|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403267|NCT02250092|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403268|NCT02250079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403269|NCT02250066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403270|NCT02250053||||Treatment||||||||
1403271|NCT02250040|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403272|NCT02250027|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1403273|NCT02250014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403274|NCT02250001|||Case-Only||Other|||||||
1403275|NCT02249988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403276|NCT02249975||Single Group Assignment||Treatment||None (Open Label)||||||
1403277|NCT02249962|||Cohort||Prospective|||||||
1403278|NCT02249949||Single Group Assignment||Treatment||None (Open Label)||||||
1403279|NCT02249936|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1403280|NCT02249923|||Cohort||Prospective|||||||
1403281|NCT02249910|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403282|NCT02249897|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||Prescription of 6 g oral cholestiramine in 7 patients with type 2 DM, to study changes in neuroophtalmologic variables (electroretinogram and optic nerve conduction)||||
1403283|NCT02249884|Randomized|Parallel Assignment||||Double|||t|||t
1403284|NCT02249871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403285|NCT02249858|||Case-Only||Prospective|||||||
1403286|NCT02249845|||Cohort||Prospective|||||||
1403287|NCT02249832||Single Group Assignment||Treatment||None (Open Label)||||||
1403288|NCT02249819|Randomized|Crossover Assignment||Treatment||Quadruple|Sequence of stimulation conditions was randomized across subjects.|All participants received both stimulation conditions (active tDCS + computerized naming therapy and sham tDCS + computerized naming therapy), separated by a 1-week washout period.|t|t|t|t
1403289|NCT02249806|||Cohort||Prospective|||||||
1403290|NCT02249793|||Cohort||Prospective|||||||
1403291|NCT02249780|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403292|NCT02249767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403293|NCT02249754|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403294|NCT02249741||Single Group Assignment||Treatment||None (Open Label)||||||
1403295|NCT02249728|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1403296|NCT02249715||Single Group Assignment||Treatment||None (Open Label)||||||
1403297|NCT02249702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403298|NCT02249689||||||||||||
1403299|NCT02249676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403300|NCT02249663|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1403301|NCT02249650||Sequential Assignment||Treatment||None (Open Label)||||||
1403302|NCT02249637|||Case Control||Retrospective|||||||
1403303|NCT02249624|||Case-Only||Prospective|||||||
1403304|NCT02249611|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1403305|NCT02249598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403306|NCT02249585|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1403307|NCT02249572|Randomized|Parallel Assignment||Treatment||Double|Study investigator masked to whether patient has had radiosurgery og no active treatment. Scars due to radiosurgery frame hidden With surgical cap at all study consultations in all pts. Radiologist measuring tumor size masked as to treatment|Block randomization of 100 individuals to radiosurgery or expectative treatment of vestibular schwannoma.|||t|t
1403308|NCT02249559|||Case-Only||Prospective|||||||
1403309|NCT02249546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403310|NCT02249533|Randomized|Parallel Assignment||Prevention||Single|||t|||
1403311|NCT02249520|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1403312|NCT02249507|Randomized|Crossover Assignment||Treatment||Single||||||t
1403313|NCT02249494|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403314|NCT02249481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403315|NCT02249468|||Case-Control||Prospective|||||||
1403316|NCT02249455|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403317|NCT02249442|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403318|NCT02249429||Single Group Assignment||Treatment||None (Open Label)||||||
1403319|NCT02249416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403320|NCT02249403|Randomized|Parallel Assignment||Treatment||Double||||||
1403321|NCT02249390|||Ecologic or Community||Retrospective|||||||
1403322|NCT02249377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403323|NCT02249364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403324|NCT02249351|Randomized|Parallel Assignment||Treatment||Double||||||
1403325|NCT02249338|Randomized|Parallel Assignment||Treatment||Double||||||
1403326|NCT02249325|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403327|NCT02249312|Randomized|Parallel Assignment||Treatment||Double||||||
1403328|NCT02249299|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1403329|NCT02249286|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403330|NCT02249273|||Cohort||Prospective|||||||
1403331|NCT02249260||Single Group Assignment||Treatment||None (Open Label)||||||
1403332|NCT02249247|Randomized|Parallel Assignment||Treatment||Double||||||
1403333|NCT02249234|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403334|NCT02249221|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1403335|NCT02249208|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1403336|NCT02249195|||||Prospective|||||||
1403337|NCT02249182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403338|NCT02249169|||Case-Control||Prospective|||||||
1403339|NCT02249156|||Cohort||Retrospective|||||||
1403340|NCT02249143|Randomized|Parallel Assignment||Treatment||Single||||||t
1403341|NCT02249130||Single Group Assignment||Treatment||None (Open Label)||||||
1403342|NCT02249117|Randomized|Parallel Assignment||Treatment||Double||||||
1403343|NCT02249104||Single Group Assignment||Treatment||None (Open Label)||||||
1403344|NCT02249091||Single Group Assignment||Treatment||None (Open Label)||||||
1403345|NCT02249078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403346|NCT02249065||Single Group Assignment||Treatment||None (Open Label)||||||
1403347|NCT02249052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403348|NCT02249039||Single Group Assignment||Treatment||None (Open Label)||||||
1403349|NCT02249026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403350|NCT02249013||Single Group Assignment||Treatment||None (Open Label)||||||
1403351|NCT02249000||Single Group Assignment||Treatment||None (Open Label)||||||
1403352|NCT02248987|||Case Control||Cross-Sectional|||||||
1403353|NCT02248974|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1403354|NCT02248961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403355|NCT02248948|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403356|NCT02248935|||Cohort||Prospective|||||||
1403357|NCT02248922||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403358|NCT02248909|||Cohort||Prospective|||||||
1403359|NCT02248896|||Case Control||Retrospective|||||||
1403360|NCT02248883|Randomized|Crossover Assignment||Treatment||Double||||||
1403361|NCT02248870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403362|NCT02248857|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1403363|NCT02248844|||Case-Only||Prospective|||||||
1403364|NCT02248831||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403365|NCT02248818|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1403366|NCT02248805|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403367|NCT02248792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403368|NCT02248779|||Cohort||Cross-Sectional|||||||
1403369|NCT02248766||Single Group Assignment||||Single|||t|||
1403370|NCT02248753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403371|NCT02248740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403372|NCT02248727||Single Group Assignment||Treatment||Single|||t|||
1403373|NCT02248714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403374|NCT02248701|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1403375|NCT02248688||Single Group Assignment||Treatment||None (Open Label)||||||
1403376|NCT02248675|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1403377|NCT02248662|||Cohort||Retrospective|||||||
1403378|NCT02248649|Randomized|Parallel Assignment||Other||Single||||||t
1403379|NCT02248636|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1403380|NCT02248623|||Cohort||Prospective|||||||
1403381|NCT02248610|||Cohort||Prospective|||||||
1403382|NCT02248597||Single Group Assignment||Treatment||None (Open Label)||||||
1403383|NCT02248584|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1403384|NCT02248571|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1403385|NCT02248558|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1403386|NCT02248545|||Case Control||Retrospective|||||||
1403387|NCT02248532|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1403388|NCT02248519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403389|NCT02248506||Single Group Assignment||Health Services Research||None (Open Label)||||||
1403390|NCT02248493|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1403391|NCT02248480|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403392|NCT02248467|||Cohort||Prospective|||||||
1403393|NCT02248454||Single Group Assignment||Treatment||None (Open Label)||||||
1403394|NCT02248441||Single Group Assignment||Treatment||None (Open Label)||||||
1403395|NCT02248428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403396|NCT02248415|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1403397|NCT02248402|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403398|NCT02248389||Single Group Assignment||||None (Open Label)||||||
1403399|NCT02248376|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403400|NCT02248363|||Cohort||Prospective|||||||
1403401|NCT02248350|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1403402|NCT02248337|Randomized|Parallel Assignment||Treatment||Single|||||t|
1403403|NCT02248324|||Case Control||Prospective|||||||
1403404|NCT02248311|||Case-Control||Prospective|||||||
1403405|NCT02248298|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1403406|NCT02248285|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1403407|NCT02248272|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403408|NCT02248259|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403409|NCT02248246||Single Group Assignment||Treatment||None (Open Label)||||||
1403410|NCT02248233|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1403411|NCT02248220|||Cohort||Prospective|||||||
1403412|NCT02248207|||Cohort||Prospective|||||||
1403413|NCT02248194|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403414|NCT02248181|||Cohort||Prospective|||||||
1403415|NCT02248168|||Cohort||Prospective|||||||
1403416|NCT02248155|||Cohort||Prospective|||||||
1403417|NCT02248142|||Cohort||Prospective|||||||
1403418|NCT02248129|||Cohort||Prospective|||||||
1403419|NCT02248116||Single Group Assignment||Treatment||None (Open Label)||||||
1403420|NCT02248103|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403421|NCT02248090||Single Group Assignment||Treatment||None (Open Label)||||||
1403422|NCT02248077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403423|NCT02248064|Randomized|Crossover Assignment||||Double|||t||t|
1403424|NCT02248051||Single Group Assignment||Treatment||None (Open Label)||||||
1403425|NCT02248038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403426|NCT02248025|||Cohort||Prospective|||||||
1403427|NCT02248012||Single Group Assignment||Treatment||None (Open Label)||||||
1403428|NCT02247999|||Cohort||Cross-Sectional|||||||
1403429|NCT02247986|Randomized|Crossover Assignment||Other||Double|||t||t|
1403430|NCT02247973||Single Group Assignment||Treatment||None (Open Label)||||||
1403431|NCT02247960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403432|NCT02247947|||Cohort||Prospective|||||||
1403433|NCT02247934|||||Cross-Sectional|||||||
1403434|NCT02247921|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1403435|NCT02247908|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403436|NCT02247895|Randomized|Parallel Assignment||Treatment||Single|||||t|
1403437|NCT02247882|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1403438|NCT02247869||Single Group Assignment||Treatment||None (Open Label)||||||
1403439|NCT02247856|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403440|NCT02247843||Single Group Assignment||Treatment||None (Open Label)||||||
1403441|NCT02247830|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1403442|NCT02247817||Single Group Assignment||Treatment||None (Open Label)||||||
1403443|NCT02247804|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1403444|NCT02247791|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403445|NCT02247778|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403446|NCT02247765|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1403447|NCT02247752||Single Group Assignment||Prevention||None (Open Label)||||||
1403448|NCT02247739|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1403449|NCT02247726|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1403450|NCT02247713|||Cohort|||||||||
1403451|NCT02247700|||Cohort||Prospective|||||||
1403452|NCT02247687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403453|NCT02247674|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1403454|NCT02247661|||Cohort||Prospective|||||||
1403455|NCT02247648|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403456|NCT02247635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403457|NCT02247622|||Cohort||Prospective|||||||
1403458|NCT02247609||Single Group Assignment||Treatment||None (Open Label)||||||
1403459|NCT02247596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403460|NCT02247583|||Cohort||Prospective|||||||
1403461|NCT02247570||Single Group Assignment||Treatment||None (Open Label)||||||
1403462|NCT02247557|Randomized|Parallel Assignment||Treatment||Triple|All participants, investigators and care providers do not know which regimen is given to patients of the three arms.|This is a double-blind, randomized, placebo-controlled physician initiated study enrolled patients with refractory IC/BPS. Patients were assigned to intravesical instillation of lipotoxin (onabotulinumtoxinA 200 U with 80mg sphingomyelin), onabotulinumtoxinA 200 U in normal saline, or normal saline.|t|t|t|
1403463|NCT02247544||Single Group Assignment||Treatment||None (Open Label)||||||
1403464|NCT02247531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403465|NCT02247518|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403466|NCT02247505|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403467|NCT02247492|||Other||Prospective|||||||
1403468|NCT02247479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403469|NCT02247466|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1403470|NCT02247453||Single Group Assignment||Screening||None (Open Label)||||||
1403471|NCT02247440|||Cohort||Prospective|||||||
1403472|NCT02247427|Randomized|Parallel Assignment||||Single|||t|||
1403473|NCT02247414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403474|NCT02247401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403475|NCT02247388|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403476|NCT02247375|Randomized|Parallel Assignment||Treatment||Double||||||
1403477|NCT02247362|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1403478|NCT02247349|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403479|NCT02247336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403480|NCT02247323|||Case-Only||Retrospective|||||||
1403481|NCT02247310|||Cohort||Prospective|||||||
1403482|NCT02247297|||Cohort||Prospective|||||||
1403483|NCT02247284||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403484|NCT02247271||Single Group Assignment||Supportive Care||None (Open Label)||||||
1403485|NCT02247258|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403486|NCT02247245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403487|NCT02247232|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1403488|NCT02247219|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1403489|NCT02247206|Randomized|Parallel Assignment||Treatment||Single||||||t
1403490|NCT02247193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403491|NCT02247180|Randomized|Parallel Assignment||Treatment||Single||||||t
1403492|NCT02247167||Single Group Assignment||Basic Science||Single|||||t|
1403493|NCT02247154||||Treatment||||||||
1403494|NCT02247141||||||||||||
1403495|NCT02247128|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403496|NCT02247115|||Cohort||Prospective|||||||
1403497|NCT02247102|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1403498|NCT02247089|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1403499|NCT02247076|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1403500|NCT02247063|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403501|NCT02247050|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1403502|NCT02247037|||Case-Only||Prospective|||||||
1403503|NCT02247024|||Cohort||Prospective|||||||
1403504|NCT02247011|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1403505|NCT02246998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403506|NCT02246985|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1403507|NCT02246972|Randomized|Parallel Assignment||Treatment||Single||||||t
1403508|NCT02246959|Randomized|Parallel Assignment||Prevention||None (Open Label)||In a 4-arm, randomized controlled trial, we propose to evaluate the relative effectiveness and cost-effectiveness of improving cholesterol levels among participants who are at high risk of CVD and who have elevated LDL cholesterol levels by testing process versus outcomes financial incentives. Participants will use electronic pill bottles that continuously monitor statin adherence.||||
1403509|NCT02246946|Randomized|Parallel Assignment||Treatment||Single||||||t
1403510|NCT02246933|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403511|NCT02246920|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1403512|NCT02246907|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1403513|NCT02246894||||||||||||
1403514|NCT02246881||||Treatment||||||||
1403515|NCT02246868||||Treatment||||||||
1403516|NCT02246855||||Treatment||||||||
1403517|NCT02246842||||Treatment||||||||
1403518|NCT02246829||Single Group Assignment||Treatment||None (Open Label)||||||
1403519|NCT02246816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403520|NCT02246803|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403521|NCT02246790|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403522|NCT02246777||Single Group Assignment||Treatment||None (Open Label)||||||
1403523|NCT02246764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403524|NCT02246751||Single Group Assignment||Basic Science||None (Open Label)||||||
1403525|NCT02246738|||Cohort||Prospective|||||||
1403526|NCT02246725|||Other||Prospective|||||||
1403527|NCT02246712|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403528|NCT02246699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403529|NCT02246686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403530|NCT02246673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403531|NCT02246660|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403532|NCT02246647|||Case Control||Cross-Sectional|||||||
1403533|NCT02246634||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403534|NCT02246621|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1403535|NCT02246608|Randomized|Parallel Assignment||Treatment||Single||||||t
1403536|NCT02246595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403537|NCT02246582|Randomized|Parallel Assignment||||None (Open Label)||||||
1403538|NCT02246569|||||Prospective|||||||
1403539|NCT02246556|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1403540|NCT02246543|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1403541|NCT02246530|Randomized|Single Group Assignment||Treatment||Single||||||t
1403542|NCT02246517|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1403543|NCT02246504||Single Group Assignment||Treatment||None (Open Label)||||||
1403544|NCT02246491|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1403545|NCT02246478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403546|NCT02246465||Single Group Assignment||Treatment||None (Open Label)||||||
1403547|NCT02246452|||||Retrospective|||||||
1403548|NCT02246439|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403549|NCT02246426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403550|NCT02246413|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1403551|NCT02246400|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1403552|NCT02246387|||Cohort||Prospective|||||||
1403553|NCT02246374|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1403554|NCT02246361|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1403555|NCT02246348||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403556|NCT02246335|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403557|NCT02246322|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1403558|NCT02246309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403559|NCT02246296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403560|NCT02246283|||Cohort||Retrospective|||||||
1403561|NCT02246270|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1403562|NCT02246257|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403563|NCT02246244|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403564|NCT02246231|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1403565|NCT02246218||Single Group Assignment||Treatment||None (Open Label)||||||
1403566|NCT02246205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403567|NCT02246192|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1403568|NCT02246179|Randomized|Factorial Assignment||Treatment||Single|||t|||
1403569|NCT02246166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403570|NCT02246153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403571|NCT02246140|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1403572|NCT02246127|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403573|NCT02246114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403574|NCT02246101|||Case-Only||Cross-Sectional|||||||
1403575|NCT02246088|Randomized|Parallel Assignment||Treatment||Single||||||t
1403576|NCT02246075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403577|NCT02246062|Randomized|Parallel Assignment||||None (Open Label)||||||
1403578|NCT02246049||Single Group Assignment||Treatment||None (Open Label)||||||
1403579|NCT02246036||Single Group Assignment||Treatment||None (Open Label)||||||
1403580|NCT02246023|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403581|NCT02246010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403582|NCT02245997||Single Group Assignment||Treatment||None (Open Label)||||||
1403583|NCT02245984|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1403584|NCT02245971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403585|NCT02245958|||Cohort||Retrospective|||||||
1403586|NCT02245945|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1403587|NCT02245932|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1403588|NCT02245919||Single Group Assignment||Treatment||None (Open Label)||||||
1403589|NCT02245906|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1403590|NCT02245893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403591|NCT02245880|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1403592|NCT02245867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403593|NCT02245854||Single Group Assignment||Treatment||None (Open Label)||||||
1403594|NCT02245841||Single Group Assignment||Treatment||None (Open Label)||||||
1403595|NCT02245828|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1403596|NCT02245815|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1403597|NCT02245802|||Cohort||Prospective|||||||
1403598|NCT02245789|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403599|NCT02245776||Single Group Assignment||Treatment||None (Open Label)||||||
1403600|NCT02245763|||Cohort||Prospective|||||||
1403601|NCT02245750|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403602|NCT02245737|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403603|NCT02245724||Single Group Assignment||Treatment||None (Open Label)||||||
1403604|NCT02245711||Single Group Assignment||Treatment||None (Open Label)||||||
1403605|NCT02245698||Single Group Assignment||Treatment||None (Open Label)||||||
1403606|NCT02245685|||Cohort||Prospective|||||||
1403607|NCT02245672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403608|NCT02245659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403609|NCT02245646|||Case Control||Prospective|||||||
1403610|NCT02245633|||Cohort||Cross-Sectional|||||||
1403611|NCT02245620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403612|NCT02245607|Randomized|Parallel Assignment||Treatment||Single||||||t
1403613|NCT02245594|||Cohort||Prospective|||||||
1403614|NCT02245581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403615|NCT02245568||Single Group Assignment||Treatment||None (Open Label)||||||
1403616|NCT02245555|||Cohort||Prospective|||||||
1403617|NCT02245542|||Cohort||Prospective|||||||
1403618|NCT02245529|||Cohort||Prospective|||||||
1403619|NCT02245516|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403620|NCT02245503|||Cohort||Prospective|||||||
1403621|NCT02245490|Randomized|Parallel Assignment||Treatment||Double||||||
1403622|NCT02245477|||Case-Control||Prospective|||||||
1403623|NCT02245464|||Cohort||Prospective|||||||
1403624|NCT02245451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403625|NCT02245438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403626|NCT02245425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403627|NCT02245412|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1403628|NCT02245399|Randomized|Parallel Assignment||Treatment||Single|||||t|
1403629|NCT02245386|||||Cross-Sectional|||||||
1403630|NCT02245373|||Case Control||Prospective|||||||
1403631|NCT02245360|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403632|NCT02245347|||Case-Only||Prospective|||||||
1403633|NCT02245334|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403634|NCT02245321|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403635|NCT02245308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403636|NCT02245295|||Case Control||Retrospective|||||||
1403637|NCT02245282|||Cohort||Prospective|||||||
1403638|NCT02245269||Single Group Assignment||Treatment||None (Open Label)||||||
1403639|NCT02245256|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1403640|NCT02245243||Single Group Assignment||Treatment||None (Open Label)||||||
1403641|NCT02245230|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1403642|NCT02245217||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403643|NCT02245204||Single Group Assignment||Treatment||None (Open Label)||||||
1403644|NCT02245191|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1403645|NCT02245178|||Cohort||Prospective|||||||
1403646|NCT02245165|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1403647|NCT02245152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403648|NCT02245139|||Case-Only||Prospective|||||||
1403649|NCT02245126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403650|NCT02245113|Randomized|Crossover Assignment||||Single|||t|||
1403651|NCT02245100|||Case-Only||Prospective|||||||
1403652|NCT02245087|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403653|NCT02245074|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1403654|NCT02245061||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403655|NCT02245048|||Cohort||Prospective|||||||
1403656|NCT02245035|||Case-Only||Prospective|||||||
1403657|NCT02245022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403658|NCT02245009|||Cohort||Prospective|||||||
1403659|NCT02244996|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403660|NCT02244983|||Cohort||Prospective|||||||
1403661|NCT02244970|Randomized|Parallel Assignment||Treatment||Single||||||t
1403662|NCT02244957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403663|NCT02244944||Single Group Assignment||Treatment||None (Open Label)||||||
1403664|NCT02244931|Randomized|Crossover Assignment||||None (Open Label)||||||
1403665|NCT02244918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403666|NCT02244905|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1403667|NCT02244892|||Case Control||Cross-Sectional|||||||
1403668|NCT02244879|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403669|NCT02244866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403670|NCT02244853|||Cohort||Prospective|||||||
1403671|NCT02244840||Single Group Assignment||Treatment||None (Open Label)||||||
1403672|NCT02244827||Single Group Assignment||Basic Science||None (Open Label)||||||
1403673|NCT02244814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403674|NCT02244801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403675|NCT02244788||||||||||||
1403676|NCT02244775||||||||||||
1403677|NCT02244762|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1403678|NCT02244749|||Case-Only||Prospective|||||||
1403679|NCT02244736|||Case-Control||Cross-Sectional|||||||
1403680|NCT02244723|||Cohort||Prospective|||||||
1403681|NCT02244710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403682|NCT02244697|||Case-Crossover||Prospective|||||||
1403683|NCT02244684|||Cohort||Prospective|||||||
1403684|NCT02244671||Single Group Assignment||Treatment||None (Open Label)||||||
1403685|NCT02244658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403686|NCT02244645|Randomized|Parallel Assignment||||Single||||||t
1403687|NCT02244632|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403688|NCT02244619|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1403689|NCT02244606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403690|NCT02244593|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1403691|NCT02244580||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403692|NCT02244567|Randomized|Single Group Assignment||Treatment||Single|||t|||
1403693|NCT02244554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403694|NCT02244541|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403695|NCT02244528||Single Group Assignment||Treatment||None (Open Label)||||||
1403696|NCT02244515|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1403697|NCT02244502||Single Group Assignment||Treatment||None (Open Label)||||||
1403698|NCT02244489|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403699|NCT02244476|||Other||Other|||||||
1403700|NCT02244463||Single Group Assignment||Treatment||None (Open Label)||||||
1403701|NCT02244450|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1403702|NCT02244437|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1403703|NCT02244424|Randomized|Parallel Assignment||Prevention||Single|||t|||
1403704|NCT02244411|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403705|NCT02244398|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1403706|NCT02244385|||Cohort||Prospective|||||||
1403707|NCT02244372|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1403708|NCT02244359|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1403709|NCT02244346|||Cohort||Prospective|||||||
1403710|NCT02244333|||Cohort||Prospective|||||||
1403711|NCT02244320|||Cohort||Prospective|||||||
1403712|NCT02244307|||Cohort||Prospective|||||||
1403713|NCT02244294|Randomized|Parallel Assignment||Treatment||Double||||||
1403714|NCT02244281|Randomized|Parallel Assignment||Treatment||Double||||||
1403715|NCT02244268|||Cohort||Prospective|||||||
1403716|NCT02244255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403717|NCT02244242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403718|NCT02244229|Randomized|Parallel Assignment||Treatment||Double||||||
1403719|NCT02244216|||Cohort||Prospective|||||||
1403720|NCT02244203|Randomized|Single Group Assignment||Treatment||Double||||||
1403721|NCT02244190|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403722|NCT02244177|||Cohort||Prospective|||||||
1403723|NCT02244164|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403724|NCT02244151|Randomized|Parallel Assignment||Treatment||Single|||||t|
1403725|NCT02244138|||Case-Control||Prospective|||||||
1403726|NCT02244125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403727|NCT02244112|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403728|NCT02244099||Single Group Assignment||Health Services Research||None (Open Label)||||||
1403729|NCT02244086|Randomized|Single Group Assignment||Supportive Care||Double|||t|t||
1403730|NCT02244073|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403731|NCT02244060|Randomized|Parallel Assignment||||Single|||t|||
1403732|NCT02244047|Randomized|Parallel Assignment||Prevention||Single|||t|||
1403733|NCT02244034|||Case-Control||Retrospective|||||||
1403734|NCT02244021||Single Group Assignment||Treatment||None (Open Label)||||||
1403735|NCT02244008|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403736|NCT02243995||Single Group Assignment||Treatment||None (Open Label)||||||
1403737|NCT02243982||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403738|NCT02243969|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1403739|NCT02243956|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1403740|NCT02243943|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403741|NCT02243930|Randomized|Parallel Assignment||||Single|||t|||
1403742|NCT02243917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403743|NCT02243904|||Cohort||Prospective|||||||
1403744|NCT02243891|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403745|NCT02243878|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1403746|NCT02243865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403747|NCT02243852|||Case Control||Prospective|||||||
1403748|NCT02243839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403749|NCT02243826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403750|NCT02243813|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1403751|NCT02243800|Randomized|Parallel Assignment||||Double|||t||t|
1403752|NCT02243787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403753|NCT02243774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403754|NCT02243761||Single Group Assignment||Treatment||None (Open Label)||||||
1403755|NCT02243748|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1403756|NCT02243735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403757|NCT02243722|||Cohort||Cross-Sectional|||||||
1403758|NCT02243709|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1403759|NCT02243696|||Case-Only||Prospective|||||||
1403760|NCT02243683|Randomized|Crossover Assignment||||Double|||t||t|
1403761|NCT02243670||Single Group Assignment||Treatment||None (Open Label)||||||
1403762|NCT02243657|Randomized|Single Group Assignment||Basic Science||Triple|||t|t|t|
1403763|NCT02243644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403764|NCT02243631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403765|NCT02243618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403766|NCT02243605||Single Group Assignment||Treatment||None (Open Label)||||||
1403767|NCT02243592||||||||||||
1403768|NCT02243579||Single Group Assignment||Treatment||None (Open Label)||||||
1403769|NCT02243566|||Cohort||Prospective|||||||
1403770|NCT02243553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403771|NCT02243540|||Cohort||Retrospective|||||||
1403772|NCT02243527|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1403773|NCT02243514|||Case Control||Cross-Sectional|||||||
1403774|NCT02243501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403775|NCT02243488|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1403776|NCT02243475|||Cohort||Prospective|||||||
1403777|NCT02243462|Randomized|Parallel Assignment||Prevention||Single||||||t
1403778|NCT02243449|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1403779|NCT02243436||Single Group Assignment||Treatment||None (Open Label)||||||
1403780|NCT02243423|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1403781|NCT02243410|||Cohort||Prospective|||||||
1403782|NCT02243397|||Cohort||Prospective|||||||
1403783|NCT02243384|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1403784|NCT02243371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403785|NCT02243358||Single Group Assignment||Treatment||None (Open Label)||||||
1403786|NCT02243345|||Cohort||Retrospective|||||||
1403787|NCT02243332||Single Group Assignment||Treatment||None (Open Label)||||||
1403788|NCT02243319|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403789|NCT02243306|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1403790|NCT02243293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403791|NCT02243280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403792|NCT02243267|||Case-Control||Prospective|||||||
1403793|NCT02243254|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1403794|NCT02243241|Randomized|Parallel Assignment||||Triple|||t||t|t
1403795|NCT02243228||Single Group Assignment||Treatment||None (Open Label)||||||
1403796|NCT02243215|Randomized|Parallel Assignment||||None (Open Label)||||||
1403797|NCT02243202|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403798|NCT02243189|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403799|NCT02243176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403800|NCT02243163||Single Group Assignment||Basic Science||Single||||||t
1403801|NCT02243150|Randomized|Single Group Assignment||Other||Double|||t||t|
1403802|NCT02243137|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403803|NCT02243124|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403804|NCT02243111||Single Group Assignment||Diagnostic||Single||||||t
1403805|NCT02243098|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1403806|NCT02243085|||Cohort||Retrospective|||||||
1403807|NCT02243072|Randomized|Single Group Assignment||Treatment||Single||||||t
1403808|NCT02243059||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403809|NCT02243046|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403810|NCT02243033|||Cohort||Prospective|||||||
1403811|NCT02243020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403812|NCT02243007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403813|NCT02242994||Single Group Assignment||Basic Science||None (Open Label)||||||
1403814|NCT02242981||Single Group Assignment||Basic Science||None (Open Label)||||||
1403815|NCT02242968|||Cohort||Prospective|||||||
1403816|NCT02242955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403817|NCT02242942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403818|NCT02242929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403819|NCT02242916|||Cohort||Retrospective|||||||
1403820|NCT02242903|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1403821|NCT02242890||Single Group Assignment||||None (Open Label)||||||
1403822|NCT02242877|||Cohort||Prospective|||||||
1403823|NCT02242864|||Cohort||Prospective|||||||
1403824|NCT02242851|||Cohort||Prospective|||||||
1403825|NCT02242838|||Cohort||Prospective|||||||
1403826|NCT02242825|||Cohort||Prospective|||||||
1403827|NCT02242812|Randomized|Parallel Assignment||Treatment||Double||||||
1403828|NCT02242799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403829|NCT02242786||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403830|NCT02242773||Single Group Assignment||Treatment||None (Open Label)||||||
1403831|NCT02242760|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403832|NCT02242747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403833|NCT02242734|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1403834|NCT02242721|||Cohort||Prospective|||||||
1403835|NCT02242708|Randomized|Parallel Assignment||Basic Science||Single||||||t
1403836|NCT02242695|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403837|NCT02242682|Randomized|Parallel Assignment||||Single||||t||
1403838|NCT02242669|||Case-Control||Other|||||||
1403839|NCT02242656|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1403840|NCT02242643|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1403841|NCT02242630|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403842|NCT02242617|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403843|NCT02242604|||Case-Only||Prospective|||||||
1403844|NCT02242591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403845|NCT02242578|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1403846|NCT02242565|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403847|NCT02242552|||Case-Only||Prospective|||||||
1403848|NCT02242539|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403849|NCT02242526|Randomized|Parallel Assignment||Other||Single|||t|||
1403850|NCT02242513|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1403851|NCT02242500|Randomized|Parallel Assignment||Treatment||Single||||||t
1403852|NCT02242487|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403853|NCT02242474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403854|NCT02242461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403855|NCT02242448|||Cohort||Prospective|||||||
1403856|NCT02242435|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1403857|NCT02242422|||Cohort||Retrospective|||||||
1403858|NCT02242409||Single Group Assignment||Treatment||None (Open Label)||||||
1403859|NCT02242396|||Cohort||Prospective|||||||
1403860|NCT02242383|||Cohort||Prospective|||||||
1403861|NCT02242370|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403862|NCT02242357|||Cohort||Prospective|||||||
1403863|NCT02242344|Randomized|Parallel Assignment||Treatment||Double||||||
1403864|NCT02242331|||Cohort||Prospective|||||||
1403865|NCT02242318|Randomized|Parallel Assignment||Treatment||Double||||||
1403866|NCT02242305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403867|NCT02242292|Randomized|Parallel Assignment||Treatment||Double||||||
1403868|NCT02242279|Randomized|Crossover Assignment||Treatment||Double||||||
1403869|NCT02242266|Randomized|Crossover Assignment||Treatment||Double||||||
1403870|NCT02242253|Randomized|Crossover Assignment||Treatment||Double||||||
1403871|NCT02242240|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403872|NCT02242227|Randomized|Crossover Assignment||Treatment||Double||||||
1403873|NCT02242214|||Cohort||Prospective|||||||
1403874|NCT02242201|Randomized|Parallel Assignment||Treatment||Single||||||t
1403875|NCT02242188|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1403876|NCT02242175|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1403877|NCT02242162|||Case Control||Prospective|||||||
1403878|NCT02242149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403879|NCT02242136|Randomized|Single Group Assignment||Treatment||Single||||||t
1403880|NCT02242123|||Case-Control||Prospective|||||||
1403881|NCT02242110||Single Group Assignment||Treatment||None (Open Label)||||||
1403882|NCT02242097||Single Group Assignment||Treatment||None (Open Label)||||||
1403883|NCT02242084||Single Group Assignment||Treatment||None (Open Label)||||||
1403884|NCT02242071||Single Group Assignment||Treatment||None (Open Label)||||||
1403885|NCT02242058|||Case-Control||Prospective|||||||
1403886|NCT02242045||Single Group Assignment||Treatment||None (Open Label)||||||
1403887|NCT02242032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403888|NCT02242019||Single Group Assignment||Treatment||None (Open Label)||||||
1403889|NCT02242006|||Cohort||Prospective|||||||
1403890|NCT02241993|||Case-Only||Prospective|||||||
1403891|NCT02241980|||Cohort||Prospective|||||||
1403892|NCT02241967|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1403893|NCT02241954|||Cohort||Prospective|||||||
1403894|NCT02241941||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403895|NCT02241928||Single Group Assignment||Treatment||None (Open Label)||||||
1403896|NCT02241915|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403897|NCT02241902|||Cohort||Prospective|||||||
1403898|NCT02241889|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403899|NCT02241876|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1403900|NCT02241863|Randomized|Parallel Assignment||Treatment||Single||||||t
1403901|NCT02241850||Single Group Assignment||Health Services Research||None (Open Label)||||||
1403902|NCT02241837|||Case-Only||Prospective|||||||
1403903|NCT02241824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403904|NCT02241811|Randomized|Single Group Assignment||Treatment||Single|||||t|
1403905|NCT02241798|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1403906|NCT02241785||Single Group Assignment||Treatment||None (Open Label)||||||
1403907|NCT02241772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403908|NCT02241759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403909|NCT02241746|||||Cross-Sectional|||||||
1403910|NCT02241733|Randomized|Factorial Assignment||Treatment||Single||||||t
1403911|NCT02241720||Single Group Assignment||Treatment||None (Open Label)||||||
1403912|NCT02241707|||Case Control||Prospective|||||||
1403913|NCT02241694|||Cohort||Cross-Sectional|||||||
1403914|NCT02241681||Single Group Assignment||Basic Science||None (Open Label)||||||
1403915|NCT02241668||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403916|NCT02241655|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1403917|NCT02241642||Single Group Assignment||Treatment||None (Open Label)||||||
1403918|NCT02241629|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1403919|NCT02241616||Single Group Assignment||Treatment||None (Open Label)||||||
1403920|NCT02241603|Non-Randomized|Parallel Assignment||Other||Single|participants are expressly assigned to intervention groups through a non-random method based on metabolic testing|Participants are assigned to two groups in parallel for the duration of the study. There is a dietary weight loss intervention aiming for ~5-10% weight loss|t|||
1403921|NCT02241590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403922|NCT02241577|Randomized|Parallel Assignment||Treatment||Single||||||t
1403923|NCT02241564|||Case-Only||Prospective|||||||
1403924|NCT02241551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403925|NCT02241538|Randomized|Parallel Assignment||Treatment||Single||||||t
1403926|NCT02241525|||Case Control||Prospective|||||||
1403927|NCT02241512|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1403928|NCT02241499||Single Group Assignment||Treatment||None (Open Label)||||||
1403929|NCT02241486||Single Group Assignment||Treatment||None (Open Label)||||||
1403930|NCT02241473|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403931|NCT02241460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403932|NCT02241447|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1403933|NCT02241434||Single Group Assignment||Treatment||None (Open Label)||||||
1403934|NCT02241421|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1403935|NCT02241408|||Cohort||Prospective|||||||
1403936|NCT02241395||Single Group Assignment||Treatment||None (Open Label)||||||
1403937|NCT02241382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403938|NCT02241369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403939|NCT02241356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403940|NCT02241343|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1403941|NCT02241330|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1403942|NCT02241317|||Cohort||Prospective|||||||
1403943|NCT02241304|||Cohort||Prospective|||||||
1403944|NCT02241291|||Other||Prospective|||||||
1403945|NCT02241278|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1403946|NCT02241265||Single Group Assignment||Treatment||None (Open Label)||||||
1403947|NCT02241252||Single Group Assignment||Screening||None (Open Label)||||||
1403948|NCT02241239|||Cohort||Prospective|||||||
1403949|NCT02241226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403950|NCT02241213|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1403951|NCT02241200|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1403952|NCT02241187||Single Group Assignment||Treatment||None (Open Label)||||||
1403953|NCT02241174|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1403954|NCT02241161|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403955|NCT02241148|Randomized|Parallel Assignment||Treatment||Single|||t|||
1403956|NCT02241135|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403957|NCT02241122||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403958|NCT02241109||Single Group Assignment||Diagnostic||Triple|||t||t|t
1403959|NCT02241096||Single Group Assignment||Other||None (Open Label)||||||
1403960|NCT02241083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403961|NCT02241070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403962|NCT02241057|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1403963|NCT02241044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403964|NCT02241031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403965|NCT02241018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403966|NCT02241005|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1403967|NCT02240992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403968|NCT02240979|||||Prospective|||||||
1403969|NCT02240966|||Cohort||Cross-Sectional|||||||
1403970|NCT02240953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403971|NCT02240940||Single Group Assignment||Treatment||None (Open Label)||||||
1403972|NCT02240927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403973|NCT02240914|||Cohort||Prospective|||||||
1403974|NCT02240901|Randomized|Parallel Assignment||Treatment||Single|||||t|
1403975|NCT02240888|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403976|NCT02240875|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403977|NCT02240862|||Cohort||Prospective|||||||
1403978|NCT02240849|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1403979|NCT02240836|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1403980|NCT02240823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1403981|NCT02240810|||Cohort||Prospective|||||||
1403982|NCT02240797|||Case Control||Cross-Sectional|||||||
1403983|NCT02240784|||Cohort||Prospective|||||||
1403984|NCT02240771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403985|NCT02240758||Single Group Assignment||Diagnostic||None (Open Label)||||||
1403986|NCT02240745|||Case-Only||Cross-Sectional|||||||
1403987|NCT02240732|||Cohort||Prospective|||||||
1403988|NCT02240719||Single Group Assignment||Treatment||None (Open Label)||||||
1403989|NCT02240706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1403990|NCT02240693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403991|NCT02240680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1403992|NCT02240667|||Cohort||Prospective|||||||
1403993|NCT02240654|||Other||Cross-Sectional|||||||
1403994|NCT02240641|||Cohort||Prospective|||||||
1403995|NCT02240628|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1403996|NCT02240615||Single Group Assignment||Treatment||None (Open Label)||||||
1403997|NCT02240602|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403998|NCT02240589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1403999|NCT02240576|||Case Control||Retrospective|||||||
1404000|NCT02240563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404001|NCT02240550|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1404002|NCT02240537||Single Group Assignment||Treatment||None (Open Label)||||||
1404003|NCT02240524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404004|NCT02240511|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1404005|NCT02240498|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404006|NCT02240485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404007|NCT02240472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404008|NCT02240459|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1404009|NCT02240446|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404010|NCT02240433||Single Group Assignment||Treatment||None (Open Label)||||||
1404011|NCT02240420|Randomized|Parallel Assignment||||None (Open Label)||||||
1404012|NCT02240407|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404013|NCT02240394|||Cohort||Prospective|||||||
1404014|NCT02240381||Single Group Assignment||Supportive Care||None (Open Label)||||||
1404015|NCT02240368|||Cohort||Prospective|||||||
1404016|NCT02240355|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1404017|NCT02240342||Single Group Assignment||Treatment||None (Open Label)||||||
1404018|NCT02240329||Single Group Assignment||||None (Open Label)||||||
1404019|NCT02240316|||Cohort||Prospective|||||||
1404020|NCT02240303|||||Prospective|||||||
1404021|NCT02240290||Single Group Assignment||Basic Science||None (Open Label)||||||
1404022|NCT02240277|||Cohort||Prospective|||||||
1404023|NCT02240264|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1404024|NCT02240251|||Case-Only||Prospective|||||||
1404025|NCT02240238||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1404026|NCT02240225|||||Prospective|||||||
1404027|NCT02240212|Non-Randomized|||Treatment||None (Open Label)||||||
1404028|NCT02240199|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1404029|NCT02240186||Single Group Assignment||Treatment||None (Open Label)||||||
1404030|NCT02240173|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404031|NCT02240160|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1404032|NCT02240147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404033|NCT02240134|Randomized|Parallel Assignment||Prevention||Single|||t|||
1404034|NCT02240121|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1404035|NCT02240108|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1404036|NCT02240095|Randomized|Factorial Assignment||Other||Single|||||t|
1404037|NCT02240082|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404038|NCT02240069|Randomized|Parallel Assignment||Prevention||Single|||t|||
1404039|NCT02240056|||Cohort||Prospective|||||||
1404040|NCT02240043||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404041|NCT02240030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404042|NCT02240017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404043|NCT02240004|||Cohort||Cross-Sectional|||||||
1404044|NCT02239991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404045|NCT02239978|||Cohort||Cross-Sectional|||||||
1404046|NCT02239965|||Case-Only||Prospective|||||||
1404047|NCT02239952|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1404048|NCT02239939|Randomized|Parallel Assignment||Treatment||Single||||||t
1404049|NCT02239926|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404050|NCT02239913|Randomized|Factorial Assignment||Basic Science||Triple|||t|t||t
1404051|NCT02239900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404052|NCT02239887|||Cohort||Prospective|||||||
1404053|NCT02239874|Randomized|Factorial Assignment||||Triple|||t||t|t
1404054|NCT02239861||Single Group Assignment||Treatment||None (Open Label)||||||
1404055|NCT02239835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404056|NCT02239822|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404057|NCT02239809|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404058|NCT02239796|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404059|NCT02239783|||Cohort||Prospective|||||||
1404060|NCT02239770|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1404061|NCT02239757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404062|NCT02239744|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1404063|NCT02239731|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404064|NCT02239718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404065|NCT02239705|||Case Control||Prospective|||||||
1404066|NCT02239692|Randomized|Parallel Assignment||||Single||||||t
1404067|NCT02239679|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1404068|NCT02239666|||Other||Prospective|||||||
1404069|NCT02239653|Randomized|Parallel Assignment||Treatment||Single||||||t
1404070|NCT02239640|||Cohort||Prospective|||||||
1404071|NCT02239627|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404072|NCT02239614|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404073|NCT02239601||Single Group Assignment||Treatment||None (Open Label)||||||
1404074|NCT02239588|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1404075|NCT02239575|||Case-Only||Prospective|||||||
1404076|NCT02239562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404077|NCT02239549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404078|NCT02239536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404079|NCT02239523|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404080|NCT02239510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404081|NCT02239497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404082|NCT02239484|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404083|NCT02239458|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1404084|NCT02239445|Randomized|Parallel Assignment||||Double||||t|t|
1404085|NCT02239432|||Cohort||Prospective|||||||
1404086|NCT02239419|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1404087|NCT02239406|||Cohort||Prospective|||||||
1404088|NCT02239393|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1404089|NCT02239380||Parallel Assignment||Treatment||None (Open Label)||||||
1404090|NCT02239367||Single Group Assignment||Health Services Research||None (Open Label)||||||
1404091|NCT02239354|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1404092|NCT02239341|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404093|NCT02239328|||Cohort||Prospective|||||||
1404094|NCT02239315||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404095|NCT02239302|||Cohort||Prospective|||||||
1404096|NCT02239289||Single Group Assignment||Treatment||None (Open Label)||||||
1404097|NCT02239276||||||||||||
1404098|NCT02239263||||||||||||
1404099|NCT02239250|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404100|NCT02239237|||Cohort||Prospective|||||||
1404101|NCT02239224|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404102|NCT02239211||Single Group Assignment||Treatment||None (Open Label)||||||
1404103|NCT02239198|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1404104|NCT02239185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404105|NCT02239172|Non-Randomized|Single Group Assignment||Prevention||Single|||t|||
1404106|NCT02239159|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1404107|NCT02239146|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404108|NCT02239133||Single Group Assignment||Treatment||None (Open Label)||||||
1404109|NCT02239120|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1404110|NCT02239107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404111|NCT02239094||Single Group Assignment||Treatment||None (Open Label)||||||
1404112|NCT02239081|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1404113|NCT02239068|||Case-Only||Prospective|||||||
1404114|NCT02239055|||Case-Control||Retrospective|||||||
1404115|NCT02239042|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1404116|NCT02239029|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1404117|NCT02239016|||Cohort||Prospective|||||||
1404118|NCT02239003|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404119|NCT02238990|||Cohort||Prospective|||||||
1404120|NCT02238977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404121|NCT02238964|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1404122|NCT02238951|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1404123|NCT02238938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404124|NCT02238925||Single Group Assignment||Treatment||None (Open Label)||||||
1404125|NCT02238912||Single Group Assignment||Treatment||None (Open Label)||||||
1404126|NCT02238899|||||Cross-Sectional|||||||
1404127|NCT02238886|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404128|NCT02238873|Randomized|Parallel Assignment||Prevention||Single||||||t
1404129|NCT02238860|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404130|NCT02238847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404131|NCT02238834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404132|NCT02238821|||Other||Prospective|||||||
1404133|NCT02238808||Single Group Assignment||Treatment||None (Open Label)||||||
1404134|NCT02238795|||Case-Only||Prospective|||||||
1404135|NCT02238782||Single Group Assignment||Basic Science||None (Open Label)||||||
1404136|NCT02238769|||Case-Only||Prospective|||||||
1404137|NCT02238756|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1404138|NCT02238743|||Case-Only||Prospective|||||||
1404139|NCT02238730|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1404140|NCT02238717|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1404141|NCT02238704|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1404142|NCT02238691|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404143|NCT02238678|||Cohort||Prospective|||||||
1404144|NCT02238665|||||Prospective|||||||
1404145|NCT02238652|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1404146|NCT02238639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404147|NCT02238626|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404148|NCT02238613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404149|NCT02238587|Randomized|Crossover Assignment||||Double|||t|||t
1404150|NCT02238574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404151|NCT02238561|||Cohort||Prospective|||||||
1404152|NCT02238548|Randomized|Parallel Assignment||Prevention||Single|||||t|
1404153|NCT02238535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404154|NCT02238522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404155|NCT02238509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404156|NCT02238496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404157|NCT02238483|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404158|NCT02238470|||Cohort||Prospective|||||||
1404159|NCT02238457|Randomized|Single Group Assignment||Treatment||Single|||t|||
1404160|NCT02238444|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404161|NCT02238431|Randomized|Parallel Assignment||Treatment||Single|||||t|
1404162|NCT02238418||Single Group Assignment||Other||None (Open Label)||||||
1404163|NCT02238405|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404164|NCT02238392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404165|NCT02238379|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1404166|NCT02238366|||Cohort||Prospective|||||||
1404167|NCT02238353|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404168|NCT02238340|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404169|NCT02238327|||Cohort||Prospective|||||||
1404170|NCT02238314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404171|NCT02238301|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1404172|NCT02238288|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404173|NCT02238275|||Cohort||Prospective|||||||
1404174|NCT02238262|||Cohort||Prospective|||||||
1404175|NCT02238249|||Cohort||Prospective|||||||
1404176|NCT02238236|||Cohort||Prospective|||||||
1404177|NCT02238223|||Cohort||Prospective|||||||
1404178|NCT02238210|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404179|NCT02238197|||Cohort||Prospective|||||||
1404180|NCT02238184|||Cohort||Prospective|||||||
1404181|NCT02238171|||Cohort||Prospective|||||||
1404182|NCT02238158|||Cohort||Prospective|||||||
1404183|NCT02238145|||Cohort||Prospective|||||||
1404184|NCT02238132|||Cohort||Prospective|||||||
1404185|NCT02238119|Randomized|Crossover Assignment||Treatment||Double||||||
1404186|NCT02238106|Randomized|Crossover Assignment||Treatment||Double||||||
1404187|NCT02238093|||Case-Only||Retrospective|||||||
1404188|NCT02238080|||Cohort||Prospective|||||||
1404189|NCT02238067|||Cohort||Cross-Sectional|||||||
1404190|NCT02238054|||Cohort||Prospective|||||||
1404191|NCT02238041|||||Prospective|||||||
1404192|NCT02238028|Randomized|Crossover Assignment||Prevention||Single||||||t
1404193|NCT02238015|||Case Control||Prospective|||||||
1404194|NCT02238002|||Cohort||Prospective|||||||
1404195|NCT02237989|Randomized|Factorial Assignment||Treatment||Single||||||t
1404196|NCT02237976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404197|NCT02237963|||Cohort||Prospective|||||||
1404198|NCT02237950|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404199|NCT02237937|Randomized|Single Group Assignment||||Double|||||t|t
1404200|NCT02237924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404201|NCT02237911|Randomized|Parallel Assignment||Treatment||Single||||||t
1404202|NCT02237898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404203|NCT02237885||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1404204|NCT02237872|||Case-Only||Cross-Sectional|||||||
1404205|NCT02237859||Single Group Assignment||Prevention||Triple|||t|t|t|
1404206|NCT02237846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404207|NCT02237833|||Cohort||Prospective|||||||
1404208|NCT02237820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404209|NCT02237807|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404210|NCT02237794|||||Prospective|||||||
1404211|NCT02237781||Single Group Assignment||Treatment||None (Open Label)||||||
1404212|NCT02237768|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404213|NCT02237755|Randomized|Parallel Assignment||Treatment||Single||||||t
1404214|NCT02237742||Single Group Assignment||Basic Science||None (Open Label)||||||
1404215|NCT02237729|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1404216|NCT02237716|||Case Control||Prospective|||||||
1404217|NCT02237703|||Case-Control||Cross-Sectional|||||||
1404218|NCT02237690|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404219|NCT02237677|||Case Control||Cross-Sectional|||||||
1404220|NCT02237664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404221|NCT02237651|||Cohort||Prospective|||||||
1404222|NCT02237638||Single Group Assignment||Treatment||None (Open Label)||||||
1404223|NCT02237625|||Family-Based||Prospective|||||||
1404224|NCT02237612||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404225|NCT02237599|||Case-Only||Prospective|||||||
1404226|NCT02237586|Non-Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1404227|NCT02237573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404228|NCT02237560|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404229|NCT02237547||Single Group Assignment||Treatment||None (Open Label)||||||
1404230|NCT02237534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404231|NCT02237521|||Case-Control||Cross-Sectional|||||||
1404232|NCT02237508|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404233|NCT02237495|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1404234|NCT02237482|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404235|NCT02237469|||Case-Only||Retrospective|||||||
1404236|NCT02237456|||Cohort||Prospective|||||||
1404237|NCT02237443||Single Group Assignment||Treatment||None (Open Label)||||||
1404238|NCT02237430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404239|NCT02237417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404240|NCT02237404|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1404241|NCT02237391|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1404242|NCT02237378||Single Group Assignment||Basic Science||None (Open Label)||||||
1404243|NCT02237365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404244|NCT02237352|||Case-Control||Cross-Sectional|||||||
1404245|NCT02237339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404246|NCT02237326|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1404247|NCT02237313||Single Group Assignment||Other||None (Open Label)||||||
1404248|NCT02237300|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1404249|NCT02237287|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1404250|NCT02237274|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404251|NCT02237261||Single Group Assignment||Treatment||None (Open Label)||||||
1404252|NCT02237248|||Cohort||Prospective|||||||
1404253|NCT02237235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404254|NCT02237222|||Case-Only||Prospective|||||||
1404255|NCT02237209|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404256|NCT02237196|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404257|NCT02237183|Non-Randomized|Parallel Assignment||Prevention||Double|||t||t|
1404258|NCT02237170|||Cohort||Prospective|||||||
1404259|NCT02237157||Single Group Assignment||Other||None (Open Label)||||||
1404260|NCT02237144|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1404261|NCT02237131|Randomized|Parallel Assignment||||None (Open Label)||||||
1404262|NCT02237118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404263|NCT02237105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404264|NCT02237092||Single Group Assignment||Prevention||None (Open Label)||||||
1404265|NCT02237079|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1404266|NCT02237066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404267|NCT02237053|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1404268|NCT02237040||Single Group Assignment||Treatment||None (Open Label)||||||
1404269|NCT02237027|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1404270|NCT02237014|||Case-Only||Prospective|||||||
1404271|NCT02237001||Single Group Assignment||Treatment||None (Open Label)||||||
1404272|NCT02236988|Randomized|Crossover Assignment||Other||||||||
1404273|NCT02236975|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404274|NCT02236962|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1404275|NCT02236949|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1404276|NCT02236936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404277|NCT02236923|||Cohort||Retrospective|||||||
1404278|NCT02236910|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404279|NCT02236897||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404280|NCT02236884||Single Group Assignment||Treatment||None (Open Label)||||||
1404281|NCT02236871|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404282|NCT02236858|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1404283|NCT02236845|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1404284|NCT02236832|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1404285|NCT02236819|||Cohort||Prospective|||||||
1404286|NCT02236806|Randomized|Parallel Assignment||Prevention||Single|||t|||
1404287|NCT02236793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404288|NCT02236780|||Cohort||Retrospective|||||||
1404289|NCT02236767||Single Group Assignment||Treatment||None (Open Label)||||||
1404290|NCT02236754|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1404291|NCT02236741|||Cohort||Retrospective|||||||
1404292|NCT02236728|||Cohort||Prospective|||||||
1404293|NCT02236715|||Cohort||Prospective|||||||
1404294|NCT02236702|||Case Control||Cross-Sectional|||||||
1404295|NCT02236689|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1404296|NCT02236676||Single Group Assignment||Treatment||None (Open Label)||||||
1404297|NCT02236663|Randomized|Parallel Assignment||Other||Single|||t|||
1404298|NCT02236650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404299|NCT02236637|||Cohort||Prospective|||||||
1404300|NCT02236624||Single Group Assignment||Supportive Care||None (Open Label)||||||
1404301|NCT02236611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404302|NCT02236598|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404303|NCT02236585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404304|NCT02236572||Single Group Assignment||Treatment||None (Open Label)||||||
1404305|NCT02236559|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404306|NCT02236546||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404307|NCT02236533|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1404308|NCT02236520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404309|NCT02236507||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404310|NCT02236494|Randomized|Parallel Assignment||Treatment||Single||||||t
1404311|NCT02236481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404312|NCT02236468|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404313|NCT02236455|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1404314|NCT02236442|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404315|NCT02236429||Single Group Assignment||Treatment||None (Open Label)||||||
1404316|NCT02236416|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1404317|NCT02236403|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1404318|NCT02236390|Randomized|Parallel Assignment||Treatment||Single||||||t
1404319|NCT02236377|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1404320|NCT02236364||Single Group Assignment||Health Services Research||None (Open Label)||||||
1404321|NCT02236351|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404322|NCT02236338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404323|NCT02236325|Randomized|Parallel Assignment||Treatment||Single||||||t
1404324|NCT02236312|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404325|NCT02236299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404326|NCT02236286|Randomized|Crossover Assignment||Other||Single||||||t
1404327|NCT02236273|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1404328|NCT02236260|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404329|NCT02236247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404330|NCT02236234||Single Group Assignment||Prevention||None (Open Label)||||||
1404331|NCT02236221|||Cohort||Prospective|||||||
1404332|NCT02236208|||Cohort||Prospective|||||||
1404333|NCT02236195||Single Group Assignment||Treatment||None (Open Label)||||||
1404334|NCT02236182|Randomized|Parallel Assignment||Treatment||Double||||||
1404335|NCT02236169|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404336|NCT02236156|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404337|NCT02236143|||Case-Control||Prospective|||||||
1404338|NCT02236130|Randomized|Parallel Assignment||||Single||||||t
1404339|NCT02236117|Randomized|Parallel Assignment||Treatment||Single||||||t
1404340|NCT02236104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404341|NCT02236091|||Case-Only||Cross-Sectional|||||||
1404342|NCT02236078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404343|NCT02236065||Single Group Assignment||Treatment||None (Open Label)||||||
1404344|NCT02236052|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404345|NCT02236039|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1404346|NCT02236026|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1404347|NCT02236013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404348|NCT02236000||Single Group Assignment||Treatment||None (Open Label)||||||
1404349|NCT02235987||Single Group Assignment||Treatment||None (Open Label)||||||
1404350|NCT02235974|Randomized|Parallel Assignment||Treatment||Single||||||t
1404351|NCT02235961|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404352|NCT02235948||Single Group Assignment||Prevention||Double|||t||t|
1404353|NCT02235935|||Cohort||Prospective|||||||
1404354|NCT02235922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404355|NCT02235909|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1404356|NCT02235896||Single Group Assignment||Prevention||None (Open Label)||||||
1404357|NCT02235883|||Case-Only||Prospective|||||||
1404358|NCT02235870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404359|NCT02235857||Single Group Assignment||Treatment||None (Open Label)||Patients with focal segmental glomerulosclerosis treated by LIPOSORBER® LA-15 system||||
1404360|NCT02235844||Single Group Assignment||Treatment||None (Open Label)||||||
1404361|NCT02235831|Randomized|Crossover Assignment||Treatment||Single|||||t|
1404362|NCT02235818|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404363|NCT02235805|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1404364|NCT02235792||Single Group Assignment||Treatment||None (Open Label)||||||
1404365|NCT02235779||Single Group Assignment||Diagnostic||Single||||||t
1404366|NCT02235766|||Case-Only||Prospective|||||||
1404367|NCT02235753|Randomized|Parallel Assignment||Treatment||Single||||||t
1404368|NCT02235740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404369|NCT02235727|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1404370|NCT02235714|||Case Control||Prospective|||||||
1404371|NCT02235701||Single Group Assignment||Treatment||None (Open Label)||||||
1404372|NCT02235688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404373|NCT02235675||Single Group Assignment||Treatment||None (Open Label)||||||
1404374|NCT02235662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404375|NCT02235649|Randomized|Parallel Assignment||Treatment||Single||||||t
1404376|NCT02235636|||Case-Crossover||Prospective|||||||
1404377|NCT02235623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404378|NCT02235610|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1404379|NCT02235597|||Ecologic or Community||Prospective|||||||
1404380|NCT02235584||Single Group Assignment||Basic Science||None (Open Label)||||||
1404381|NCT02235571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404382|NCT02235558||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1404383|NCT02235545|||Case-Only||Prospective|||||||
1404384|NCT02235532|Randomized|Crossover Assignment||Prevention||Single|||||t|
1404385|NCT02235519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404386|NCT02235506|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1404387|NCT02235493|||||Retrospective|||||||
1404388|NCT02235480|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404389|NCT02235467|Randomized|Parallel Assignment||Treatment||Single||||||t
1404390|NCT02235454||Single Group Assignment||Supportive Care||None (Open Label)||||||
1404391|NCT02235441||Single Group Assignment||Supportive Care||None (Open Label)||||||
1404392|NCT02235428|Randomized|Parallel Assignment||Treatment||Double||||||
1404393|NCT02235415|||Cohort||Prospective|||||||
1404394|NCT02235402|Randomized|Parallel Assignment||Treatment||Double||||||
1404395|NCT02235389|||Case Control||Prospective|||||||
1404396|NCT02235376|||||Prospective|||||||
1404397|NCT02235363||Single Group Assignment||Treatment||None (Open Label)||369 consecutive patients underwent the suture suspension technique, so called thread lift, using 3-0 V-Loc 180 device for facial rejuvenation with (n=305) or without additional facial procedures (n=64). The follow-up period ranged from 22 months to 43 months postoperatively, with a mean of 34.3 months.||||
1404398|NCT02235350|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1404399|NCT02235337||Single Group Assignment||Treatment||None (Open Label)||||||
1404400|NCT02235324||Single Group Assignment||Treatment||None (Open Label)||||||
1404401|NCT02235311|Randomized|Parallel Assignment||Treatment||Single||||||t
1404402|NCT02235298|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1404403|NCT02235285||Single Group Assignment||Treatment||None (Open Label)||||||
1404404|NCT02235272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404405|NCT02235259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404406|NCT02235246|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404407|NCT02235233|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1404408|NCT02235220||Single Group Assignment||Treatment||None (Open Label)||||||
1404409|NCT02235207|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1404410|NCT02235194|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1404411|NCT02235181|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404412|NCT02235168|Randomized|Parallel Assignment||Basic Science||Single||||||t
1404413|NCT02235155|||Cohort||Prospective|||||||
1404414|NCT02235142||Single Group Assignment||Other||None (Open Label)||||||
1404415|NCT02235129||Single Group Assignment||Screening||Single||||||t
1404416|NCT02235116|||||Cross-Sectional|||||||
1404417|NCT02235103|||Cohort||Prospective|||||||
1404418|NCT02235090|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1404419|NCT02235077|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404420|NCT02235064|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404421|NCT02235051|Randomized|Parallel Assignment||Prevention||Single|||||t|
1404422|NCT02235038|Randomized|Parallel Assignment||Basic Science||Single||||||t
1404423|NCT02235025|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1404424|NCT02235012|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1404425|NCT02234999||Single Group Assignment||||||||||
1404426|NCT02234986||Single Group Assignment||Treatment||None (Open Label)||||||
1404427|NCT02234973|||Case-Only||Prospective|||||||
1404428|NCT02234960|||Cohort||Prospective|||||||
1404429|NCT02234947|||Cohort||Prospective|||||||
1404430|NCT02234934||Single Group Assignment||Treatment||None (Open Label)||||||
1404431|NCT02234921||Single Group Assignment||Treatment||None (Open Label)||||||
1404432|NCT02234908|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1404433|NCT02234895|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1404434|NCT02234882||Single Group Assignment||Other||None (Open Label)||||||
1404435|NCT02234869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404436|NCT02234856|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404437|NCT02234843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404438|NCT02234830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404439|NCT02234804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404440|NCT02234791|||Cohort||Prospective|||||||
1404441|NCT02234778||Single Group Assignment||Treatment||None (Open Label)||||||
1404442|NCT02234765|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1404443|NCT02234752||Single Group Assignment||Treatment||None (Open Label)||||||
1404444|NCT02234739||Single Group Assignment||Treatment||None (Open Label)||||||
1404445|NCT02234726|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1404446|NCT02234713|Randomized|Parallel Assignment||||Single||||||t
1404447|NCT02234700|||Case Control||Prospective|||||||
1404448|NCT02234687|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1404449|NCT02234674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404450|NCT02234661|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1404451|NCT02234648|Randomized|Crossover Assignment||Prevention||Single|||t|||
1404452|NCT02234635|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404453|NCT02234622|Randomized|Parallel Assignment||Treatment||Single||||||t
1404454|NCT02234609||Single Group Assignment||Treatment||Single||||||t
1404455|NCT02234596||Single Group Assignment||Treatment||None (Open Label)||||||
1404456|NCT02234583||Single Group Assignment||Treatment||None (Open Label)||||||
1404457|NCT02234570|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404458|NCT02234557||Single Group Assignment||Treatment||None (Open Label)||||||
1404459|NCT02234544|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1404460|NCT02234531|Randomized|Parallel Assignment||Treatment||Single||||||t
1404461|NCT02234518|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404462|NCT02234505||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404463|NCT02234492|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1404464|NCT02234479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404465|NCT02234466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404466|NCT02234453||Single Group Assignment||Health Services Research||None (Open Label)||||||
1404467|NCT02234440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404468|NCT02234427||Single Group Assignment||Basic Science||None (Open Label)||||||
1404469|NCT02234414|||Cohort||Prospective|||||||
1404470|NCT02234401|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404471|NCT02234388|||Cohort||Prospective|||||||
1404472|NCT02234375||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404473|NCT02234362||Single Group Assignment||Treatment||None (Open Label)||||||
1404474|NCT02234349|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1404475|NCT02234336|||Cohort||Prospective|||||||
1404476|NCT02234323||Single Group Assignment||Treatment||None (Open Label)||||||
1404477|NCT02234310||Single Group Assignment||Treatment||None (Open Label)||||||
1404478|NCT02234297||Single Group Assignment||||None (Open Label)||||||
1404479|NCT02234284|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1404480|NCT02234271|Randomized|Single Group Assignment||||None (Open Label)||||||
1404481|NCT02234258|Randomized|Single Group Assignment||Treatment||Single||||||t
1404482|NCT02234245|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1404483|NCT02234232|Randomized|Factorial Assignment||||Single||||||t
1404484|NCT02234219|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404485|NCT02234206||Single Group Assignment||Treatment||None (Open Label)||||||
1404486|NCT02234193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404487|NCT02234180|Randomized|Parallel Assignment||Treatment||Double||||||
1404488|NCT02234167||||Prevention||||||||
1404489|NCT02234154||Single Group Assignment||Treatment||None (Open Label)||||||
1404490|NCT02234141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404491|NCT02234128|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405416|NCT02222090|||Cohort||Prospective|||||||
1404492|NCT02234115||Single Group Assignment||Treatment||None (Open Label)||||||
1404493|NCT02234102|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404494|NCT02234089|||Cohort||Prospective|||||||
1404495|NCT02234076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404496|NCT02234063|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1404497|NCT02234050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404498|NCT02234037||Single Group Assignment||Treatment||None (Open Label)||||||
1404499|NCT02234024||Single Group Assignment||Treatment||None (Open Label)||||||
1404500|NCT02234011|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1404501|NCT02233998|Randomized|Parallel Assignment||||Single|||||t|
1404502|NCT02233985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404503|NCT02233972|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1404504|NCT02233959|||Cohort||Prospective|||||||
1404505|NCT02233946|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404506|NCT02233933|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1404507|NCT02233920|||Cohort||Prospective|||||||
1404508|NCT02233907|||Cohort||Prospective|||||||
1404509|NCT02233894|||Cohort||Prospective|||||||
1404510|NCT02233881|||Cohort||Prospective|||||||
1404511|NCT02233868|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1404512|NCT02233855|||Cohort||Prospective|||||||
1404513|NCT02233842|||Cohort||Cross-Sectional|||||||
1404514|NCT02233829|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1404515|NCT02233816|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404516|NCT02233803|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404517|NCT02233790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404518|NCT02233777|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404519|NCT02233764|Randomized|Parallel Assignment||Other||Double|||t||t|
1404520|NCT02233751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404521|NCT02233738|Randomized|Factorial Assignment||Treatment||Single||||||t
1404522|NCT02233725||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404523|NCT02233712|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404524|NCT02233699|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1404525|NCT02233686|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1404526|NCT02233673|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404527|NCT02233660|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1404528|NCT02233647|Non-Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1404529|NCT02233634|Non-Randomized|Factorial Assignment||Supportive Care||Single||||||t
1404530|NCT02233621||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404531|NCT02233608|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1404532|NCT02233595|||Cohort||Prospective|||||||
1404533|NCT02233582|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1404534|NCT02233569|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404535|NCT02233556||Single Group Assignment||||None (Open Label)||||||
1404536|NCT02233543|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1404537|NCT02233530||Single Group Assignment||Supportive Care||Single||||||t
1404538|NCT02233517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404539|NCT02233504||Single Group Assignment||Treatment||||||||
1404540|NCT02233491|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1404541|NCT02233478|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1404542|NCT02233465|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404543|NCT02233452|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1404544|NCT02233439|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1404545|NCT02233426|||Case Control||Retrospective|||||||
1404546|NCT02233413|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1404547|NCT02233400|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404548|NCT02233387||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404549|NCT02233374||Single Group Assignment||Other||None (Open Label)||||||
1404550|NCT02233361|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1404551|NCT02233348|||Case Control||Cross-Sectional|||||||
1404552|NCT02233335|||Case Control||Retrospective|||||||
1404553|NCT02233322||Single Group Assignment||Other||None (Open Label)||||||
1404554|NCT02233309|||Case-Only||Prospective|||||||
1404555|NCT02233296|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1404556|NCT02233283|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1404557|NCT02233270|||Cohort||Prospective|||||||
1404558|NCT02233257||||||||||||
1404559|NCT02233244||Single Group Assignment||Basic Science||None (Open Label)||||||
1404560|NCT02233231|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404561|NCT02233218|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1404562|NCT02233205||Single Group Assignment||Treatment||None (Open Label)||||||
1404563|NCT02233192|||Cohort||Prospective|||||||
1404564|NCT02233179|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404565|NCT02233166|||Cohort||Prospective|||||||
1404566|NCT02233153|||Other||Prospective|||||||
1404567|NCT02233140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404568|NCT02233127|||Cohort||Prospective|||||||
1404569|NCT02233114|Randomized|Parallel Assignment||Prevention||Single||||||t
1404570|NCT02233101|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405417|NCT02222077|||Cohort||Cross-Sectional|||||||
1404571|NCT02233088|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1404572|NCT02233075||Single Group Assignment||Treatment||None (Open Label)||||||
1404573|NCT02233062||Single Group Assignment||Treatment||None (Open Label)||||||
1404574|NCT02233049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404575|NCT02233036|||Cohort||Retrospective|||||||
1404576|NCT02233023|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404577|NCT02233010|||Case-Only||Prospective|||||||
1404578|NCT02232997|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1404579|NCT02232984|||Cohort||Prospective|||||||
1404580|NCT02232971|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1404581|NCT02232958||Single Group Assignment||Treatment||None (Open Label)||||||
1404582|NCT02232945|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1404583|NCT02232932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404584|NCT02232919||Single Group Assignment||Treatment||None (Open Label)||||||
1404585|NCT02232906||Single Group Assignment||Treatment||None (Open Label)||||||
1404586|NCT02232893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404587|NCT02232880|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404588|NCT02232867||Single Group Assignment||Treatment||None (Open Label)||||||
1404589|NCT02232854|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1404590|NCT02232841|||Case-Only||Cross-Sectional|||||||
1404591|NCT02232828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404592|NCT02232815|||Cohort||Prospective|||||||
1404593|NCT02232802|Randomized|Crossover Assignment||||None (Open Label)||||||
1404594|NCT02232789|Randomized|Crossover Assignment||||Double|||t||t|
1404595|NCT02232776||Single Group Assignment||Treatment||None (Open Label)||||||
1404596|NCT02232763|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1404597|NCT02232750|||Cohort||Prospective|||||||
1404598|NCT02232737|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1404599|NCT02232724||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404600|NCT02232711|||Case-Only||Prospective|||||||
1404601|NCT02232698|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1404602|NCT02232685||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404603|NCT02232672||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404604|NCT02232659|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404605|NCT02232646||Single Group Assignment||Treatment||None (Open Label)||||||
1404606|NCT02232633||Single Group Assignment||Treatment||None (Open Label)||||||
1404607|NCT02232620||Single Group Assignment||Treatment||None (Open Label)||||||
1404608|NCT02232607|Randomized|Parallel Assignment||Treatment||Double||||||
1404609|NCT02232594|||Cohort||Prospective|||||||
1404610|NCT02232581|Randomized|Parallel Assignment||Treatment||Double||||||
1404611|NCT02232568|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1404612|NCT02232555|Randomized|Parallel Assignment||Treatment||Double||||||
1404613|NCT02232542|Randomized|Parallel Assignment||Treatment||Double||||||
1404614|NCT02232529|Randomized|Crossover Assignment||Basic Science||||||||
1404615|NCT02232516||Single Group Assignment||Treatment||None (Open Label)||||||
1404616|NCT02232503|||||Cross-Sectional|||||||
1404617|NCT02232490|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404618|NCT02232477||Single Group Assignment||Treatment||None (Open Label)||||||
1404619|NCT02232464|||Case Control||Cross-Sectional|||||||
1404620|NCT02232451|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404621|NCT02232438||Single Group Assignment||Treatment||Single||||||t
1404622|NCT02232425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404623|NCT02232412|||Case-Only||Prospective|||||||
1404624|NCT02232399|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1404625|NCT02232386||Single Group Assignment||Treatment||None (Open Label)||||||
1404626|NCT02232373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404627|NCT02232360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404628|NCT02232347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404629|NCT02232334|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1404630|NCT02232321||Single Group Assignment||Other||None (Open Label)||||||
1404631|NCT02232308|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1404632|NCT02232295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404633|NCT02232282|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404634|NCT02232269|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404635|NCT02232256|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1404636|NCT02232243||Single Group Assignment||Treatment||None (Open Label)||||||
1404637|NCT02232230|||Cohort||Retrospective|||||||
1404638|NCT02232217|Randomized|Parallel Assignment||Treatment||Single||||||t
1404639|NCT02232204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404640|NCT02232191|Non-Randomized|Parallel Assignment||Prevention||Single|||||t|
1404641|NCT02232178|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1404642|NCT02232165|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1404643|NCT02232152||Single Group Assignment||Treatment||None (Open Label)||||||
1404644|NCT02232139|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1404645|NCT02232126|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1404646|NCT02232113||Single Group Assignment||Treatment||None (Open Label)||||||
1404647|NCT02232100|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404648|NCT02232087|Randomized|Crossover Assignment||Treatment||Single||||||t
1404649|NCT02232074|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1404650|NCT02232061||Single Group Assignment||Other||None (Open Label)||||||
1404651|NCT02232048|||Cohort||Prospective|||||||
1404652|NCT02232035|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1404653|NCT02232022||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404654|NCT02232009||Single Group Assignment||Other||None (Open Label)||||||
1404655|NCT02231996|||Cohort||Prospective|||||||
1404656|NCT02231983|||Cohort||Prospective|||||||
1404657|NCT02231970||Single Group Assignment||Treatment||None (Open Label)||||||
1404658|NCT02231957|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1404659|NCT02231944||||Treatment||||||||
1404660|NCT02231931|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404661|NCT02231918|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404662|NCT02231905||Single Group Assignment||Treatment||None (Open Label)||||||
1404663|NCT02231892||Single Group Assignment||Basic Science||Double|||t||t|
1404664|NCT02231879|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1404665|NCT02231866|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404666|NCT02231853|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1404667|NCT02231840|||Case-Control||Prospective|||||||
1404668|NCT02231827||Single Group Assignment||Basic Science||None (Open Label)||||||
1404669|NCT02231814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404670|NCT02231801|||Cohort||Prospective|||||||
1404671|NCT02231788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404672|NCT02231775||Single Group Assignment||Treatment||None (Open Label)||||||
1404673|NCT02231762||Single Group Assignment||Treatment||None (Open Label)||||||
1404674|NCT02231749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404675|NCT02231736|||Cohort||Cross-Sectional|||||||
1404676|NCT02231723|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404677|NCT02231710||Single Group Assignment||Treatment||None (Open Label)||||||
1404678|NCT02231697|||Other||Retrospective|||||||
1404679|NCT02231684|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1404680|NCT02231671|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1404681|NCT02231658|Randomized|Parallel Assignment||Treatment||Single|||||t|
1404682|NCT02231645|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1404683|NCT02231632|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1404684|NCT02231619|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404685|NCT02231606|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1404686|NCT02231593|||Cohort||Cross-Sectional|||||||
1404687|NCT02231580|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404688|NCT02231567|Randomized|Parallel Assignment||Treatment||Single|||||t|
1404689|NCT02231554|Randomized|Parallel Assignment||Treatment||Single|||||t|
1404690|NCT02231541|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1404691|NCT02231528|Randomized|Parallel Assignment||||Single|||t|||
1404692|NCT02231515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404693|NCT02231502|Randomized|Crossover Assignment||Basic Science||Single||||||t
1404694|NCT02231489|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404695|NCT02231463|||Case-Only||Prospective|||||||
1404696|NCT02231450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404697|NCT02231437|||Cohort||Prospective|||||||
1404698|NCT02231424|||Cohort||Prospective|||||||
1404699|NCT02231411|Randomized|Parallel Assignment||Prevention||Single||||t||
1404700|NCT02231398|||Cohort||Prospective|||||||
1404701|NCT02231385|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1404702|NCT02231372|||Cohort||Prospective|||||||
1404703|NCT02231359|||Cohort||Prospective|||||||
1404704|NCT02231346|||Cohort||Prospective|||||||
1404705|NCT02231333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404706|NCT02231320|||Cohort||Prospective|||||||
1404707|NCT02231307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404708|NCT02231294|||Cohort||Prospective|||||||
1404709|NCT02231281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404710|NCT02231268|||Cohort||Prospective|||||||
1404711|NCT02231255|||Cohort||Prospective|||||||
1404712|NCT02231242|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1404713|NCT02231229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404714|NCT02231216|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404715|NCT02231203|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1404716|NCT02231190|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404717|NCT02231177|Randomized|Crossover Assignment||Treatment||Double||||||
1404718|NCT02231164|Randomized|Parallel Assignment||Treatment||Double||||||
1404719|NCT02231151||Single Group Assignment||||Single|||||t|
1404720|NCT02231138||Single Group Assignment||Treatment||None (Open Label)||||||
1404721|NCT02231125|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1404722|NCT02231112||Single Group Assignment||Treatment||None (Open Label)||||||
1404723|NCT02231099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404724|NCT02231086|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404725|NCT02231073|Randomized|Crossover Assignment||Other||Single||||||t
1404726|NCT02231060|||Cohort||Prospective|||||||
1404727|NCT02231047|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1404728|NCT02231034||||||||||||
1404729|NCT02231021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404730|NCT02231008|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1404731|NCT02230995|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404732|NCT02230982||||||||||||
1404733|NCT02230969|||Cohort||Prospective|||||||
1404734|NCT02230956|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404735|NCT02230943|||Cohort||Prospective|||||||
1404736|NCT02230930|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404737|NCT02230917|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1404738|NCT02230904|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1404739|NCT02230891|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404740|NCT02230878|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1404741|NCT02230865|||Cohort||Prospective|||||||
1404742|NCT02230852|||Cohort||Prospective|||||||
1404743|NCT02230839|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1404744|NCT02230826|||Cohort||Prospective|||||||
1404745|NCT02230813|||Cohort||Prospective|||||||
1404746|NCT02230800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404747|NCT02230787|Randomized|Parallel Assignment||Treatment||Single||||||t
1404748|NCT02230774|||Cohort||Prospective|||||||
1404749|NCT02230761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404750|NCT02230748|||Case-Only||Prospective|||||||
1404751|NCT02230735|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1404752|NCT02230722|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404753|NCT02230709|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1404754|NCT02230696|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404755|NCT02230683|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404756|NCT02230670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404757|NCT02230657||||||||||||
1404758|NCT02230644|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1404759|NCT02230631|||Cohort||Prospective|||||||
1404760|NCT02230618|||Cohort||Prospective|||||||
1404761|NCT02230605|Randomized|Parallel Assignment||Prevention||Single|||||t|
1404762|NCT02230592|||||Prospective|||||||
1404763|NCT02230579|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1404764|NCT02230566|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1404765|NCT02230553||Single Group Assignment||Treatment||None (Open Label)||||||
1404766|NCT02230540|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1404767|NCT02230527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404768|NCT02230514|Randomized|Parallel Assignment||Treatment||Single|Radiologist will assess images in a blinded manner|||||t
1404769|NCT02230501|Randomized|Parallel Assignment||Supportive Care||Triple|For the second part of the study, i.e. the open-label registry, 4000 subjects are anicipated.|For the second part of the study, i.e. the open-label registry, there ist no randomization.||t|t|t
1404770|NCT02230488|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404771|NCT02230475|||Cohort|||||||||
1404772|NCT02230462|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404773|NCT02230449|||Cohort||Prospective|||||||
1404774|NCT02230436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404775|NCT02230423||Single Group Assignment||Prevention||None (Open Label)||||||
1404776|NCT02230410||Single Group Assignment||Treatment||None (Open Label)||||||
1404777|NCT02230397|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1404778|NCT02230384|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1404779|NCT02230371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404780|NCT02230358|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1404781|NCT02230345|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1404782|NCT02230332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404783|NCT02230319||Single Group Assignment||Supportive Care||None (Open Label)||||||
1404784|NCT02230306||Single Group Assignment||Treatment||None (Open Label)||||||
1404785|NCT02230293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404786|NCT02230280||Single Group Assignment||Health Services Research||None (Open Label)||||||
1404787|NCT02230267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404788|NCT02230254||||Treatment||None (Open Label)||||||
1404789|NCT02230241|||Cohort||Prospective|||||||
1404790|NCT02230228||Single Group Assignment||Basic Science||None (Open Label)||||||
1404791|NCT02230215|Randomized|Single Group Assignment||Treatment||Single|||t|||
1404792|NCT02230202|||Case-Control||Cross-Sectional|||||||
1404793|NCT02230189|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1404794|NCT02230176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404795|NCT02230163||Single Group Assignment||Treatment||None (Open Label)||||||
1404796|NCT02230150||Single Group Assignment||Prevention||None (Open Label)||||||
1404797|NCT02230137|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404798|NCT02230124||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404799|NCT02230111|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1404800|NCT02230098|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1404801|NCT02230085|||Cohort||Prospective|||||||
1404802|NCT02230072||Single Group Assignment||Treatment||None (Open Label)||||||
1404803|NCT02230059|||Cohort||Retrospective|||||||
1404804|NCT02230046|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404805|NCT02230033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404806|NCT02230020|||Case-Only||Prospective|||||||
1406489|NCT02208076|||Cohort||Other|||||||
1404807|NCT02230007|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404808|NCT02229994|||Cohort||Prospective|||||||
1404809|NCT02229981||Single Group Assignment||Treatment||None (Open Label)||||||
1404810|NCT02229968|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404811|NCT02229955|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404812|NCT02229942|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404813|NCT02229929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404814|NCT02229916|||Cohort||Prospective|||||||
1404815|NCT02229903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404816|NCT02229890|||Cohort||Prospective|||||||
1404817|NCT02229877||Single Group Assignment||Treatment||Single|||t|||
1404818|NCT02229864||Single Group Assignment||Treatment||None (Open Label)||||||
1404819|NCT02229851|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404820|NCT02229838|Randomized|Parallel Assignment||Treatment||Double||||||
1404821|NCT02229825|Randomized|Parallel Assignment||Treatment||Double||||||
1404822|NCT02229812|||Cohort||Retrospective|||||||
1404823|NCT02229799|||Cohort||Prospective|||||||
1404824|NCT02229786|Randomized|Parallel Assignment||Treatment||Double||||||
1404825|NCT02229773|Randomized|Parallel Assignment||Treatment||Double||||||
1404826|NCT02229760|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404827|NCT02229747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404828|NCT02229734||Single Group Assignment||Treatment||None (Open Label)||||||
1404829|NCT02229721|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1404830|NCT02229708|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404831|NCT02229695|||Cohort||Prospective|||||||
1404832|NCT02229682||Single Group Assignment||Treatment||None (Open Label)||||||
1404833|NCT02229669|Randomized|Crossover Assignment||Treatment||Single|||t|||
1404834|NCT02229656||Single Group Assignment||Treatment||None (Open Label)||||||
1404835|NCT02229643|||Case-Only||Prospective|||||||
1404836|NCT02229630||Single Group Assignment||Screening||None (Open Label)||||||
1404837|NCT02229617||Single Group Assignment||Treatment||None (Open Label)||||||
1404838|NCT02229604|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404839|NCT02229591|||Cohort||Prospective|||||||
1404840|NCT02229578|||Cohort||Prospective|||||||
1404841|NCT02229565|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1404842|NCT02229552|||||Cross-Sectional|||||||
1404843|NCT02229539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404844|NCT02229526|Randomized|Parallel Assignment||||Triple|||t|t|t|
1404845|NCT02229513|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404846|NCT02229500|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1404847|NCT02229487|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1404848|NCT02229474|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1404849|NCT02229461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404850|NCT02229448|||Case-Only||Retrospective|||||||
1404851|NCT02229435|||Cohort|||||||||
1404852|NCT02229422||Single Group Assignment||Treatment||None (Open Label)||||||
1404853|NCT02229409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404854|NCT02229396|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404855|NCT02229383|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404856|NCT02229370|||Cohort||Prospective|||||||
1404857|NCT02229357||Single Group Assignment||Prevention||None (Open Label)||||||
1404858|NCT02229344|||Cohort||Prospective|||||||
1404859|NCT02229331|||Cohort||Cross-Sectional|||||||
1404860|NCT02229318||Single Group Assignment||||None (Open Label)||||||
1404861|NCT02229305|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1404862|NCT02229292|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404863|NCT02229279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404864|NCT02229266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404865|NCT02229253|||Cohort||Prospective|||||||
1404866|NCT02229240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404867|NCT02229227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404868|NCT02229214|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404869|NCT02229201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404870|NCT02229188|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1404871|NCT02229175|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1404872|NCT02229162|||Other||Other|||||||
1404873|NCT02229149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404874|NCT02229136|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404875|NCT02229123||Single Group Assignment||Treatment||None (Open Label)||LEVNEONAT-1 is an open and sequential dose-finding study with 1 loading dose of 30, 40, 50 and 60 mg/kg and 8 quarter-loading maintenance doses for a 3-day treatment. The optimal dose will be the one estimated to be associated with a toxicity not exceeding 10% and an efficacy higher than 60%. Efficacy has been defined by a seizure burden reduction of 80% after the loading dose. A 2-patient cohort will be necessary at each dose level to consider an upper dose level assignment with a dynamic consideration of each participant data. The maximal sample size expected is 50 participants with a minimum of 24 patients or less in case of high rate of toxicity.||||
1404876|NCT02229110|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1404877|NCT02229097|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404878|NCT02229084|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404879|NCT02229071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404880|NCT02229058||Single Group Assignment||Treatment||None (Open Label)||||||
1404881|NCT02229045||Single Group Assignment||Treatment||None (Open Label)||||||
1404882|NCT02229032|||Cohort||Cross-Sectional|||||||
1404883|NCT02229019||Single Group Assignment||Health Services Research||None (Open Label)||||||
1404884|NCT02229006|||Case-Control||Prospective|||||||
1404885|NCT02228993|||Cohort||Prospective|||||||
1404886|NCT02228980|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404887|NCT02228967|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1404888|NCT02228954|||Cohort||Prospective|||||||
1404889|NCT02228941|||Cohort||Prospective|||||||
1404890|NCT02228928|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404891|NCT02228915|||Cohort||Prospective|||||||
1404892|NCT02228902|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1404893|NCT02228889|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404894|NCT02228876||||||||||||
1404895|NCT02228863|Randomized|Parallel Assignment||Treatment||Single||||||t
1404896|NCT02228850|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1404897|NCT02228837|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1404898|NCT02228824|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1404899|NCT02228811||Single Group Assignment||Treatment||None (Open Label)||||||
1404900|NCT02228798|||Cohort||Prospective|||||||
1404901|NCT02228785|Randomized|||Treatment||None (Open Label)||||||
1404902|NCT02228772||Single Group Assignment||Treatment||None (Open Label)||||||
1404903|NCT02228759||Single Group Assignment||Supportive Care||None (Open Label)||||||
1404904|NCT02228746|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404905|NCT02228733|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404906|NCT02228720||Single Group Assignment||Device Feasibility||None (Open Label)||Propel Nova Sinus Implant||||
1404907|NCT02228707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404908|NCT02228694|||Cohort|||||||||
1404909|NCT02228681|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1404910|NCT02228668|||Cohort||Other|||||||
1404911|NCT02228655||Single Group Assignment||Treatment||None (Open Label)||||||
1404912|NCT02228642|||Case-Control||Prospective|||||||
1404913|NCT02228629||Single Group Assignment||Basic Science||None (Open Label)||||||
1404914|NCT02228616||Single Group Assignment||Treatment||None (Open Label)||||||
1404915|NCT02228603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404916|NCT02228590||Single Group Assignment||Treatment||None (Open Label)||||||
1404917|NCT02228577|||Case-Only||Retrospective|||||||
1404918|NCT02228564||Single Group Assignment||Treatment||None (Open Label)||||||
1404919|NCT02228551||Single Group Assignment||Screening||None (Open Label)||||||
1404920|NCT02228538|||Cohort||Prospective|||||||
1404921|NCT02228525||Single Group Assignment||Treatment||None (Open Label)||||||
1404922|NCT02228512|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404923|NCT02228499|||Case-Control||Prospective|||||||
1404924|NCT02228486|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404925|NCT02228473|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1404926|NCT02228460||Single Group Assignment||Treatment||None (Open Label)||||||
1404927|NCT02228447|Randomized|Single Group Assignment||Prevention||Single|||t|||
1404928|NCT02228434|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1404929|NCT02228421|||Cohort||Prospective|||||||
1404930|NCT02228408|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1404931|NCT02228395|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1404932|NCT02228382||||Treatment||None (Open Label)||||||
1404933|NCT02228369|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404934|NCT02228356|||Cohort||Prospective|||||||
1404935|NCT02228343||Single Group Assignment||Treatment||None (Open Label)||||||
1404936|NCT02228330||Single Group Assignment||Treatment||Single|||||t|
1404937|NCT02228317||Single Group Assignment||Treatment||None (Open Label)||||||
1404938|NCT02228304|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1404939|NCT02228291|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1404940|NCT02228278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404941|NCT02228265|||Case-Only||Prospective|||||||
1404942|NCT02228252|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1404943|NCT02228239|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1404944|NCT02228226|||Case-Only||Prospective|||||||
1404945|NCT02228213|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404946|NCT02228200|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1404947|NCT02228187|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1404948|NCT02228174||Single Group Assignment||Treatment||None (Open Label)||||||
1404949|NCT02228161|Randomized|Parallel Assignment||Basic Science||Single||||||t
1404950|NCT02228148|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1404951|NCT02228135|||Cohort||Retrospective|||||||
1404952|NCT02228122||Single Group Assignment||Treatment||None (Open Label)||||||
1404953|NCT02228109|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1404954|NCT02228096||Single Group Assignment||Treatment||None (Open Label)||||||
1404955|NCT02228083|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1404956|NCT02228070||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404957|NCT02228057|||Cohort||Prospective|||||||
1404958|NCT02228044|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1404959|NCT02228031|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1404960|NCT02228018||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404961|NCT02228005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404962|NCT02227992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404963|NCT02227979|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1404964|NCT02227966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404965|NCT02227953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404966|NCT02227940|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404967|NCT02227927||||||||||||
1404968|NCT02227914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404969|NCT02227901||Single Group Assignment||Treatment||None (Open Label)||||||
1404970|NCT02227888||Single Group Assignment||Treatment||None (Open Label)||||||
1404971|NCT02227875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404972|NCT02227862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404973|NCT02227849||Single Group Assignment||Treatment||None (Open Label)||||||
1404974|NCT02227836||Single Group Assignment||Diagnostic||None (Open Label)||||||
1404975|NCT02227823|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1404976|NCT02227810|Randomized|Parallel Assignment||Treatment||Single|||t|||
1404977|NCT02227797||Single Group Assignment||Treatment||None (Open Label)||||||
1404978|NCT02227784|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404979|NCT02227771|||Cohort||Prospective|||||||
1404980|NCT02227758|||Case-Only||Prospective|||||||
1404981|NCT02227745|||Cohort||Prospective|||||||
1404982|NCT02227732||Single Group Assignment||Treatment||None (Open Label)||||||
1404983|NCT02227719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404984|NCT02227706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404985|NCT02227693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1404986|NCT02227680|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1404987|NCT02227667||Single Group Assignment||Treatment||None (Open Label)||||||
1404988|NCT02227654||Single Group Assignment||Treatment||None (Open Label)||||||
1404989|NCT02227641|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1404990|NCT02227628|Randomized|Parallel Assignment||Prevention||Single|||t|||
1404991|NCT02227615|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1404992|NCT02227602|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1404993|NCT02227589|Randomized|Parallel Assignment||Treatment||Single|Duke site has masked outcomes assessor; University of Connecticut site does not have masked outcomes assessor|||||t
1404994|NCT02227576||Single Group Assignment||Treatment||None (Open Label)||||||
1404995|NCT02227563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1404996|NCT02227550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1404997|NCT02227537|||Cohort||Prospective|||||||
1404998|NCT02227524|Randomized|Factorial Assignment||||None (Open Label)||||||
1404999|NCT02227511|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1405000|NCT02227498||Single Group Assignment||Treatment||None (Open Label)||||||
1405001|NCT02227485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405002|NCT02227472|||Cohort||Prospective|||||||
1405003|NCT02227459|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405004|NCT02227446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405005|NCT02227433||Single Group Assignment||Treatment||None (Open Label)||||||
1405006|NCT02227420||Single Group Assignment||||None (Open Label)||||||
1405007|NCT02227407||Single Group Assignment||Treatment||Single|||t|||
1405008|NCT02227394|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1405009|NCT02227381|||Cohort||Prospective|||||||
1405010|NCT02227368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405011|NCT02227355|||Cohort||Prospective|||||||
1405012|NCT02227342||Single Group Assignment||Treatment||None (Open Label)||||||
1405013|NCT02227329|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1405014|NCT02227316|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1405015|NCT02227303||Single Group Assignment||Treatment||None (Open Label)||||||
1405016|NCT02227290|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405017|NCT02227277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405018|NCT02227264||Single Group Assignment||Health Services Research||None (Open Label)||||||
1405019|NCT02227251||Single Group Assignment||Treatment||None (Open Label)||||||
1405020|NCT02227238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405021|NCT02227225|||Cohort||Prospective|||||||
1405022|NCT02227212||Single Group Assignment||Treatment||None (Open Label)||||||
1405023|NCT02227199||Single Group Assignment||Treatment||None (Open Label)||||||
1405024|NCT02227186|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1405025|NCT02227173|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1405026|NCT02227160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405027|NCT02227147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405028|NCT02227134|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1405029|NCT02227121||Single Group Assignment||Treatment||None (Open Label)||||||
1405030|NCT02227108||Single Group Assignment||Treatment||None (Open Label)||||||
1405031|NCT02227095|Randomized|Parallel Assignment||||Single||||||t
1405032|NCT02227082||Single Group Assignment||Treatment||None (Open Label)||||||
1405033|NCT02227069|Randomized|Single Group Assignment||||Double|||t|||t
1405034|NCT02227056|Randomized|Crossover Assignment||Treatment||Single||||||t
1405035|NCT02227043|||Cohort||Prospective|||||||
1405036|NCT02227030|Randomized|Crossover Assignment||Treatment||Double||||||
1405037|NCT02227017|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405038|NCT02227004|||Cohort||Prospective|||||||
1405039|NCT02226991||Single Group Assignment||Treatment||None (Open Label)||||||
1405040|NCT02226978||Crossover Assignment||Treatment||None (Open Label)||||||
1405041|NCT02226965||Single Group Assignment||Treatment||None (Open Label)||||||
1405042|NCT02226952|Randomized|Parallel Assignment||Treatment||Double||||||
1405043|NCT02226939|Randomized|Parallel Assignment||Treatment||Double||||||
1405044|NCT02226926|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405045|NCT02226913|Randomized|Single Group Assignment||||Double|||t||t|
1405046|NCT02226900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405047|NCT02226887|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1405048|NCT02226874|||Case-Control||Retrospective|||||||
1405049|NCT02226861||Single Group Assignment||Prevention||None (Open Label)||||||
1405050|NCT02226848|Randomized|Parallel Assignment||Treatment||||||||
1405051|NCT02226835|||Cohort||Cross-Sectional|||||||
1405052|NCT02226822|||Cohort||Prospective|||||||
1405053|NCT02226809|||Cohort||Cross-Sectional|||||||
1405054|NCT02226796|Randomized|Crossover Assignment||Treatment||Single|||||t|
1405055|NCT02226783|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1405056|NCT02226770||Single Group Assignment||Screening||None (Open Label)||||||
1405057|NCT02226757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405058|NCT02226744|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405059|NCT02226731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405060|NCT02226718|||Cohort||Prospective|||||||
1405061|NCT02226705||Single Group Assignment||Treatment||None (Open Label)||||||
1405062|NCT02226692|||Cohort||Prospective|||||||
1405063|NCT02226679||Single Group Assignment||Treatment||None (Open Label)||||||
1405064|NCT02226666|||Cohort||Prospective|||||||
1405065|NCT02226653|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1405066|NCT02226640|||Cohort||Prospective|||||||
1405067|NCT02226627|||Case-Only||Cross-Sectional|||||||
1405068|NCT02226614||Single Group Assignment||||None (Open Label)||||||
1405069|NCT02226601|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405070|NCT02226588|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405071|NCT02226575|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405072|NCT02226562|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405073|NCT02226549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405074|NCT02226536|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405075|NCT02226523|||Cohort||Prospective|||||||
1405076|NCT02226510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405077|NCT02226497|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1405078|NCT02226484||Single Group Assignment||Basic Science||None (Open Label)||||||
1405079|NCT02226471|||Case-Crossover||Cross-Sectional|||||||
1405080|NCT02226458||Single Group Assignment||Treatment||None (Open Label)||||||
1405081|NCT02226445|||Cohort||Prospective|||||||
1405082|NCT02226432|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1405083|NCT02226419||Single Group Assignment||Treatment||None (Open Label)||||||
1405084|NCT02226406|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405085|NCT02226393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405086|NCT02226380||Single Group Assignment||Treatment||None (Open Label)||||||
1405087|NCT02226367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405088|NCT02226354|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1405089|NCT02226341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405090|NCT02226328|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405091|NCT02226315|||Case-Only||Retrospective|||||||
1405092|NCT02226302|||Cohort||Prospective|||||||
1405093|NCT02226289||Single Group Assignment||Treatment||None (Open Label)||||||
1405094|NCT02226276||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405095|NCT02226263|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1405096|NCT02226250||Single Group Assignment||Other||None (Open Label)||||||
1405097|NCT02226237|Randomized|Parallel Assignment||Treatment||Single||||||t
1405098|NCT02226224|||Cohort||Prospective|||||||
1405099|NCT02226211|Randomized|Parallel Assignment||||Single||||||t
1405100|NCT02226198|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1405101|NCT02226185|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1405102|NCT02226172|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1405103|NCT02226159|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1405104|NCT02226146||Single Group Assignment||Treatment||None (Open Label)||||||
1405105|NCT02226133||Single Group Assignment||Prevention||None (Open Label)||||||
1405106|NCT02226120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405107|NCT02226107|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405108|NCT02226094|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405109|NCT02226081|||Case-Only||Cross-Sectional|||||||
1405110|NCT02226068|Randomized|Crossover Assignment||Treatment||||||||
1405111|NCT02226055|||Cohort||Retrospective|||||||
1405112|NCT02226042|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1405113|NCT02226029|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1405114|NCT02226016||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405115|NCT02226003|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405116|NCT02225990|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405117|NCT02225977|||Cohort||Prospective|||||||
1405118|NCT02225964|||Cohort||Prospective|||||||
1405119|NCT02225951|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1405120|NCT02225938|||Cohort||Cross-Sectional|||||||
1405121|NCT02225925||Single Group Assignment||Treatment||None (Open Label)||||||
1405122|NCT02225912||Crossover Assignment||||Triple|||t||t|t
1405123|NCT02225899|||Cohort||Prospective|||||||
1405124|NCT02225886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405125|NCT02225873|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405126|NCT02225860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405127|NCT02225847|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1405128|NCT02225834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405129|NCT02225821|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405130|NCT02225808|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405131|NCT02225795||Single Group Assignment||Treatment||None (Open Label)||||||
1405132|NCT02225782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405133|NCT02225769|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405134|NCT02225756|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405135|NCT02225743|||Case-Only||Prospective|||||||
1405136|NCT02225730|||Cohort||Prospective|||||||
1405137|NCT02225717|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1405138|NCT02225704||Single Group Assignment||Treatment||None (Open Label)||||||
1405139|NCT02225691|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405140|NCT02225678|||Case Control||Prospective|||||||
1405141|NCT02225665|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405142|NCT02225652||Single Group Assignment||Treatment||None (Open Label)||||||
1405143|NCT02225639|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1405144|NCT02225626|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405145|NCT02225613|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405146|NCT02225600|Randomized|Crossover Assignment||Other||Double|||t||t|
1405147|NCT02225587|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1405148|NCT02225574|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405149|NCT02225561|Randomized|Parallel Assignment||||None (Open Label)||||||
1405150|NCT02225548||Single Group Assignment||Treatment||None (Open Label)||||||
1405151|NCT02225535|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1405152|NCT02225522|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1405153|NCT02225509||Single Group Assignment||Diagnostic||Triple|||t||t|t
1405154|NCT02225496||Single Group Assignment||Treatment||None (Open Label)||||||
1405155|NCT02225483|||Case-Control||Prospective|||||||
1405156|NCT02225470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405157|NCT02225457|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1405158|NCT02225444|||Cohort||Prospective|||||||
1405159|NCT02225431|Randomized|Parallel Assignment||Prevention||Single|||||t|
1405160|NCT02225418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405161|NCT02225405||Single Group Assignment||Treatment||None (Open Label)||||||
1405162|NCT02225392|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1405163|NCT02225379||Single Group Assignment||Prevention||None (Open Label)||||||
1405164|NCT02225366||Single Group Assignment||Treatment||None (Open Label)||||||
1405165|NCT02225353|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405166|NCT02225340|||Case Control||Cross-Sectional|||||||
1405167|NCT02225327|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405168|NCT02225314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405169|NCT02225301||Single Group Assignment||Other||None (Open Label)||||||
1405170|NCT02225288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405171|NCT02225275||Single Group Assignment||Treatment||None (Open Label)||||||
1405172|NCT02225262||Single Group Assignment||Treatment||None (Open Label)||||||
1405173|NCT02225249|||Cohort||Prospective|||||||
1405174|NCT02225236|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405175|NCT02225223|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405176|NCT02225210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405177|NCT02225197||Single Group Assignment||Treatment||None (Open Label)||||||
1405178|NCT02225184|||Ecologic or Community||Other|||||||
1405179|NCT02225171|||Other||Cross-Sectional|||||||
1405180|NCT02225158|||Cohort||Prospective|||||||
1405181|NCT02225145|||Cohort||Prospective|||||||
1405182|NCT02225132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405183|NCT02225119|||Cohort||Cross-Sectional|||||||
1405184|NCT02225106|Non-Randomized|Single Group Assignment||Treatment||||||||
1405185|NCT02225093|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1405186|NCT02225080|||Case-Only||Retrospective|||||||
1405187|NCT02225067|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1405188|NCT02225054|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1405189|NCT02225041|||Case-Control||Cross-Sectional|||||||
1405190|NCT02225028|Randomized|Parallel Assignment||Treatment||Single||||||t
1405191|NCT02225015|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1405192|NCT02225002||||Treatment||||||||
1405193|NCT02224989||Single Group Assignment||Treatment||None (Open Label)||||||
1405194|NCT02224976||Single Group Assignment||Basic Science||None (Open Label)||||||
1405195|NCT02224963|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1405196|NCT02224950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405197|NCT02224937|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1405198|NCT02224924|Randomized|Parallel Assignment||Treatment||Single||||||t
1405199|NCT02224911|||Case-Only||Prospective|||||||
1405200|NCT02224898|||Case Control||Prospective|||||||
1405201|NCT02224885||Single Group Assignment||Treatment||None (Open Label)||||||
1405202|NCT02224872||Single Group Assignment||Treatment||None (Open Label)||||||
1405203|NCT02224859||Single Group Assignment||||None (Open Label)||||||
1405204|NCT02224846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405205|NCT02224833|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405206|NCT02224820||Single Group Assignment||Treatment||None (Open Label)||||||
1405207|NCT02224807|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1405208|NCT02224794|||Cohort||Prospective|||||||
1405209|NCT02224781|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405210|NCT02224768|||Cohort||Cross-Sectional|||||||
1405211|NCT02224755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405212|NCT02224742|Randomized|Parallel Assignment||Treatment||Single||||||t
1405213|NCT02224729||Single Group Assignment||Treatment||None (Open Label)||||||
1405214|NCT02224716|||Cohort|||||||||
1405215|NCT02224703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405216|NCT02224690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405217|NCT02224677|||Case Control||Prospective|||||||
1405218|NCT02224664|Non-Randomized|||Basic Science||None (Open Label)||||||
1405219|NCT02224651|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1405220|NCT02224638|Randomized|Parallel Assignment||Treatment||None (Open Label)||A single-center, randomized open-label study with multiple application treatment of necrotic sacral or buttocks pressure ulcers with either TheraHoney HD or SkinTegrity Hydrogel.||||
1405221|NCT02224625|Randomized|Parallel Assignment||Prevention||Single||||||t
1405222|NCT02224612|Randomized|Crossover Assignment||||None (Open Label)||||||
1405223|NCT02224599||Single Group Assignment||Treatment||None (Open Label)||||||
1405224|NCT02224586|||Case-Crossover||Prospective|||||||
1405225|NCT02224573||Single Group Assignment||Treatment||None (Open Label)||||||
1405226|NCT02224560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405227|NCT02224547||Single Group Assignment||Treatment||None (Open Label)||||||
1405228|NCT02224534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405229|NCT02224521|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1405230|NCT02224508|||Cohort||Cross-Sectional|||||||
1405231|NCT02224495|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405232|NCT02224482|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1405233|NCT02224469||Single Group Assignment||Supportive Care||None (Open Label)||||||
1405234|NCT02224456||Single Group Assignment||Treatment||None (Open Label)||||||
1405235|NCT02224443|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405236|NCT02224430|||Ecologic or Community||Other|||||||
1405237|NCT02224417|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1405238|NCT02224404||Single Group Assignment||Treatment||None (Open Label)||||||
1405239|NCT02224391|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405240|NCT02224378|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405241|NCT02224365|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405242|NCT02224352||Single Group Assignment||Other||None (Open Label)||||||
1405243|NCT02224339|||Cohort||Prospective|||||||
1405244|NCT02224326|||Cohort||Prospective|||||||
1405245|NCT02224313|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1405246|NCT02224300|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1405247|NCT02224287||Single Group Assignment||Treatment||None (Open Label)||||||
1405248|NCT02224274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405249|NCT02224261|Randomized|Parallel Assignment||Treatment||Single||||||t
1405250|NCT02224248|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405251|NCT02224235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405252|NCT02224222|||Cohort||Prospective|||||||
1405253|NCT02224209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405254|NCT02224196|Randomized|Crossover Assignment||Other||Single|||t|||
1405255|NCT02224183|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405256|NCT02224170|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405257|NCT02224157|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405258|NCT02224144|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405259|NCT02224131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405260|NCT02224118|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405261|NCT02224105|Randomized|Parallel Assignment||Treatment||Double||||||
1405262|NCT02224092|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1405263|NCT02224079|Randomized|Parallel Assignment||Treatment||Single||||||
1405264|NCT02224066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405265|NCT02224053||Single Group Assignment||Treatment||None (Open Label)||||||
1405266|NCT02224040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405267|NCT02224027|Non-Randomized|Factorial Assignment||Supportive Care||Single||||||t
1405268|NCT02224014|||Cohort||Prospective|||||||
1405269|NCT02224001||Single Group Assignment||Treatment||None (Open Label)||||||
1405270|NCT02223988||Single Group Assignment||Prevention||None (Open Label)||||||
1405271|NCT02223975|||Case-Only||Other|||||||
1405272|NCT02223962|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405273|NCT02223949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405274|NCT02223936|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1405275|NCT02223923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405276|NCT02223910|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1405277|NCT02223897|Randomized|Parallel Assignment||Prevention||Single|||t|||
1405278|NCT02223884||Single Group Assignment||Treatment||None (Open Label)||||||
1405279|NCT02223871||Single Group Assignment||Other||None (Open Label)||||||
1405280|NCT02223858|Randomized|Factorial Assignment||Health Services Research||Double|The statistician will seal PA and AC program workbooks in envelopes following the randomization scheme. To blind participants and staff during the baseline assessment, staff will take the next sealed envelope in the sequence to each baseline visit, to be opened after a patient has consented and completed the baseline assessment. The study staff that complete the baseline visits will be unblinded once a participant's envelope is opened; participants will not be told whether they are in the PA or AC program. Staff who conduct the weekly intervention calls in the 6 weeks following the baseline visit will also be unblinded. To maintain blinding for the collection of outcome measures, study staff members who did not complete the baseline visit or any weekly calls during the 6-week program period for a given participant will collect the 1, 3, and 6-month follow-up assessments.|Randomization will be at the patient level, stratified by study site and patient race, with a 1:1 allocation using random block sizes of 2, 4, 6, or 8.|t|||t
1405281|NCT02223845|Randomized|Parallel Assignment||Treatment||Single||||||t
1405282|NCT02223832||Single Group Assignment||||None (Open Label)||||||
1405283|NCT02223819||Single Group Assignment||Treatment||None (Open Label)||||||
1405284|NCT02223806|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405285|NCT02223793|Randomized|Parallel Assignment||Screening||Single|||t|||
1405286|NCT02223780|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405287|NCT02223767|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405288|NCT02223754|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405289|NCT02223741|||Cohort||Prospective|||||||
1405290|NCT02223728|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1405291|NCT02223715|||Case-Only||Prospective|||||||
1405292|NCT02223702|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1405293|NCT02223689|||Cohort||Prospective|||||||
1405294|NCT02223676|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1405295|NCT02223663||||||||||||
1405296|NCT02223650|Randomized|Parallel Assignment||Treatment||Single||||||t
1405297|NCT02223637|||Cohort||Prospective|||||||
1405298|NCT02223624|Randomized|Factorial Assignment||Treatment||Single||||||t
1405299|NCT02223611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405300|NCT02223598|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405301|NCT02223585||Crossover Assignment||Basic Science||None (Open Label)||||||
1405302|NCT02223572||Single Group Assignment||Prevention||None (Open Label)||||||
1405303|NCT02223559|||Cohort||Prospective|||||||
1405304|NCT02223546|||||Prospective|||||||
1405305|NCT02223533|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405306|NCT02223520|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1405307|NCT02223507|Randomized|Parallel Assignment||Treatment||Single||||||
1405308|NCT02223494||Single Group Assignment||Treatment||None (Open Label)||||||
1405309|NCT02223481|Randomized|Parallel Assignment||Treatment||Double||||||
1405310|NCT02223468|||Case-Control||Prospective|||||||
1405311|NCT02223455|Randomized|Factorial Assignment||Prevention||Single|||t|||
1405312|NCT02223442|||Cohort||Prospective|||||||
1405313|NCT02223429|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1405314|NCT02223416||||||||||||
1405315|NCT02223403|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1405316|NCT02223390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405317|NCT02223377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405318|NCT02223364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405319|NCT02223351|Randomized|Crossover Assignment||||None (Open Label)||||||
1405320|NCT02223338|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1405321|NCT02223325|||Case Control||Prospective|||||||
1405322|NCT02223312||Single Group Assignment||Treatment||None (Open Label)||||||
1405323|NCT02223299|Randomized|Single Group Assignment||||Single|||t|||
1405324|NCT02223286|||Case-Control||Retrospective|||||||
1405325|NCT02223273|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1405326|NCT02223260||Single Group Assignment||||None (Open Label)||||||
1405327|NCT02223247||Single Group Assignment||Treatment||None (Open Label)||||||
1405328|NCT02223234|Randomized|Parallel Assignment||Prevention||Single||||||t
1405329|NCT02223221|Randomized|Parallel Assignment||Treatment||Single||||t||
1405330|NCT02223208||Single Group Assignment||Treatment||None (Open Label)||||||
1405331|NCT02223195|||Cohort||Prospective|||||||
1405332|NCT02223182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405333|NCT02223169|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1405334|NCT02223156|||Case Control||Prospective|||||||
1405335|NCT02223143|||Case-Only||Prospective|||||||
1405336|NCT02223130|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405337|NCT02223117|Randomized|Single Group Assignment||Treatment||Single|||t|||
1405338|NCT02223104|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405339|NCT02223091|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1405340|NCT02223078|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405341|NCT02223065|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1405342|NCT02223052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405343|NCT02223039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405344|NCT02223026|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405345|NCT02223013|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405346|NCT02223000|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405347|NCT02222987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405348|NCT02222974|Randomized|Parallel Assignment||Treatment||Single||||||
1405349|NCT02222961|Randomized|Parallel Assignment||Treatment||Single||||||
1405350|NCT02222948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405351|NCT02222935|Randomized|Parallel Assignment||Treatment||Single||||||t
1405352|NCT02222922|Non-Randomized|||Treatment||None (Open Label)||||||
1405353|NCT02222909|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1405354|NCT02222896|Randomized|Parallel Assignment||Prevention||Single||||||t
1405355|NCT02222883|||Cohort||Prospective|||||||
1405356|NCT02222870|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405357|NCT02222857|||Case-Only||Retrospective|||||||
1405358|NCT02222844|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405359|NCT02222831|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1405360|NCT02222818|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405361|NCT02222805|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1405362|NCT02222792|||||Prospective|||||||
1405363|NCT02222779|||Ecologic or Community|||||||||
1405364|NCT02222766|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1405365|NCT02222753|||Cohort||Prospective|||||||
1405366|NCT02222740|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1405367|NCT02222727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405368|NCT02222714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405369|NCT02222701|||Cohort||Prospective|||||||
1405370|NCT02222688||Single Group Assignment||Treatment||None (Open Label)||||||
1405371|NCT02222675|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1405372|NCT02222662|Randomized|Parallel Assignment||Treatment||Single||||||t
1405373|NCT02222649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405374|NCT02222636|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405375|NCT02222623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405376|NCT02222610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405377|NCT02222597|||Cohort||Prospective|||||||
1405378|NCT02222584|||Case-Only||Prospective|||||||
1405379|NCT02222571|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405380|NCT02222558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405381|NCT02222545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405382|NCT02222532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405383|NCT02222519|||Case Control||Prospective|||||||
1405384|NCT02222506||Single Group Assignment||Treatment||None (Open Label)||||||
1405385|NCT02222493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405386|NCT02222480|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405387|NCT02222467||Single Group Assignment||Treatment||None (Open Label)||||||
1405388|NCT02222454||Single Group Assignment||Treatment||None (Open Label)||||||
1405389|NCT02222441|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1405390|NCT02222428|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405391|NCT02222415|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1405392|NCT02222402|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1405393|NCT02222389|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1405394|NCT02222376|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405395|NCT02222363||Single Group Assignment||Treatment||None (Open Label)||||||
1405396|NCT02222350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405397|NCT02222337|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405398|NCT02222324|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1405399|NCT02222311|||Case Control||Prospective|||||||
1405400|NCT02222298|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405401|NCT02222285|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1405402|NCT02222272|||Cohort||Prospective|||||||
1405403|NCT02222259|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1405404|NCT02222246|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405405|NCT02222233|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405406|NCT02222220|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405407|NCT02222207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405408|NCT02222194|||Cohort||Prospective|||||||
1405409|NCT02222181||Single Group Assignment||||None (Open Label)||||||
1405410|NCT02222168|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405411|NCT02222155|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405412|NCT02222142|||Case Control||Retrospective|||||||
1405413|NCT02222129|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405414|NCT02222116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405415|NCT02222103|||Other||Other|||||||
1405418|NCT02222064||Single Group Assignment||Supportive Care||None (Open Label)||||||
1405419|NCT02222051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405420|NCT02222038||Single Group Assignment||Basic Science||None (Open Label)||||||
1405421|NCT02222025|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405422|NCT02222012|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405423|NCT02221999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405424|NCT02221986|Randomized|Parallel Assignment||Treatment||Single||||||t
1405425|NCT02221973|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405426|NCT02221960|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405427|NCT02221947|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1405428|NCT02221934|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405429|NCT02221921||Single Group Assignment||Treatment||None (Open Label)||||||
1405430|NCT02221908|||Cohort||Prospective|||||||
1405431|NCT02221895|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405432|NCT02221882||Single Group Assignment||Treatment||None (Open Label)||||||
1405433|NCT02221869|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405434|NCT02221856|Randomized|Parallel Assignment||Treatment||Single||||||t
1405435|NCT02221843|||Cohort||Prospective|||||||
1405436|NCT02221830|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405437|NCT02221817|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405438|NCT02221804|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1405439|NCT02221791|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1405440|NCT02221778||Single Group Assignment||Treatment||None (Open Label)||||||
1405441|NCT02221765|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1405442|NCT02221752|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405443|NCT02221739||Single Group Assignment||Treatment||None (Open Label)||||||
1405444|NCT02221726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405445|NCT02221713|||Family-Based||Cross-Sectional|||||||
1405446|NCT02221700|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1405447|NCT02221687|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1405448|NCT02221674||Single Group Assignment||Treatment||None (Open Label)||||||
1405449|NCT02221661|||Case-Only||Cross-Sectional|||||||
1405450|NCT02221648|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405451|NCT02221635|||Case Control||Retrospective|||||||
1405452|NCT02221622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405453|NCT02221609|Randomized|Parallel Assignment||Treatment||Single||||||t
1405454|NCT02221596|Randomized|Factorial Assignment||Other||Quadruple|||t|t|t|t
1405455|NCT02221583|Randomized|Crossover Assignment||||Double|||t||t|
1405456|NCT02221570|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405457|NCT02221557||Single Group Assignment||Treatment||None (Open Label)||||||
1405458|NCT02221544|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1405459|NCT02221531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405460|NCT02221518||Single Group Assignment||Other||None (Open Label)||||||
1405461|NCT02221505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405462|NCT02221492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405463|NCT02221479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405464|NCT02221466|||Cohort||Prospective|||||||
1405465|NCT02221453|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1405466|NCT02221440|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1405467|NCT02221427|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1405468|NCT02221414|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405469|NCT02221401|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405470|NCT02221388|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405471|NCT02221375|Randomized|Parallel Assignment||Treatment||Double||||||
1405472|NCT02221362|||Case Control||Prospective|||||||
1405473|NCT02221349|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405474|NCT02221336|Randomized|Parallel Assignment||Treatment||Single||||||t
1405475|NCT02221323|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1405476|NCT02221310||Single Group Assignment||Treatment||None (Open Label)||||||
1405477|NCT02221297|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405478|NCT02221284|||Cohort||Prospective|||||||
1405479|NCT02221271||Single Group Assignment||Treatment||None (Open Label)||||||
1405480|NCT02221258||Single Group Assignment||Treatment||None (Open Label)||||||
1405481|NCT02221245|||Cohort||Prospective|||||||
1405482|NCT02221232|Randomized|Parallel Assignment||||None (Open Label)||||||
1405483|NCT02221219|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405484|NCT02221206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405485|NCT02221193||Crossover Assignment||Supportive Care||Single||||||t
1405486|NCT02221180|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405487|NCT02221167|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405488|NCT02221154|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1405489|NCT02221141|||Cohort||Other|||||||
1405490|NCT02221128|||Case-Only||Prospective|||||||
1405491|NCT02221115|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1405492|NCT02221102|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405493|NCT02221089|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1405494|NCT02221076||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405495|NCT02221063|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1405496|NCT02221050|||Cohort||Cross-Sectional|||||||
1405497|NCT02221037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405498|NCT02221024|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405499|NCT02221011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405500|NCT02220998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405501|NCT02220985|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405502|NCT02220972|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1405503|NCT02220959||Single Group Assignment||Diagnostic||Single||||||t
1405504|NCT02220946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405505|NCT02220933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405506|NCT02220920|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1405507|NCT02220907||Single Group Assignment||Treatment||None (Open Label)||||||
1405508|NCT02220894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405509|NCT02220881|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405510|NCT02220868||Single Group Assignment||Treatment||None (Open Label)||||||
1405511|NCT02220855||Single Group Assignment||Treatment||None (Open Label)||||||
1405512|NCT02220842|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405513|NCT02220829|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405514|NCT02220816|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405515|NCT02220803|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405516|NCT02220790|||Cohort||Prospective|||||||
1405517|NCT02220777|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1405518|NCT02220764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405519|NCT02220751|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1405520|NCT02220738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405521|NCT02220725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405522|NCT02220712||Single Group Assignment||||None (Open Label)||||||
1405523|NCT02220699|||Case-Only||Cross-Sectional|||||||
1405524|NCT02220686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405525|NCT02220673|Randomized|Crossover Assignment||Treatment||Double||||||
1405526|NCT02220660|Randomized|Crossover Assignment||Treatment||Single||||||
1405527|NCT02220647|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405528|NCT02220634||Single Group Assignment||Treatment||None (Open Label)||||||
1405529|NCT02220621|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1405530|NCT02220608|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405531|NCT02220595|Randomized|Parallel Assignment||Treatment||Single||||||t
1405532|NCT02220582|||Cohort||Prospective|||||||
1405533|NCT02220569|||Cohort||Prospective|||||||
1405534|NCT02220556|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1405535|NCT02220543|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1405536|NCT02220530|||Case Control||Prospective|||||||
1405537|NCT02220517|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405538|NCT02220504|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405539|NCT02220491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405540|NCT02220478|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405541|NCT02220465|Randomized|Parallel Assignment||Treatment||Single||||||t
1405542|NCT02220452|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1405543|NCT02220439|||Case Control||Prospective|||||||
1405544|NCT02220426||Single Group Assignment||Basic Science||None (Open Label)||||||
1405545|NCT02220413|||Cohort||Prospective|||||||
1405546|NCT02220400|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405547|NCT02220387|||Case Control||Cross-Sectional|||||||
1405548|NCT02220374||Single Group Assignment||Treatment||Single|||t|||
1405549|NCT02220361|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1405550|NCT02220348||Single Group Assignment||Other||None (Open Label)||||||
1405551|NCT02220335|Randomized|Parallel Assignment||Treatment||Single||||||t
1405552|NCT02220322|||Cohort||Prospective|||||||
1405553|NCT02220309|||Cohort||Prospective|||||||
1405554|NCT02220296|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405555|NCT02220283|||Cohort||Retrospective|||||||
1405556|NCT02220270|||Cohort||Prospective|||||||
1405557|NCT02220257|||Case-Only||Prospective|||||||
1405558|NCT02220244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405559|NCT02220231||Single Group Assignment||||None (Open Label)||||||
1405560|NCT02220218|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405561|NCT02220205|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1405562|NCT02220192||Single Group Assignment||Treatment||None (Open Label)||||||
1405563|NCT02220179|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1405564|NCT02220166||Single Group Assignment||Treatment||None (Open Label)||||||
1405565|NCT02220153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405566|NCT02220140|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1405567|NCT02220127|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405568|NCT02220114||Single Group Assignment||Treatment||None (Open Label)||||||
1405569|NCT02220101|||Case-Only||Prospective|||||||
1405570|NCT02220088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405571|NCT02220075|||||Prospective|||||||
1405572|NCT02220062|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405573|NCT02220049||Single Group Assignment||Treatment||None (Open Label)||||||
1405574|NCT02220036|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405575|NCT02220023||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405576|NCT02220010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405577|NCT02219997|Non-Randomized|Parallel Assignment||||Single|||t|||
1405578|NCT02219984|||Cohort||Prospective|||||||
1405579|NCT02219971|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405580|NCT02219958|||Cohort||Prospective|||||||
1405581|NCT02219945|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||"6 groups:~1) 20 TB patients 2) 20 non-TB patients (alternative diagnosis) 3) 20 patients with chest symptoms - non-TB 4) 7 MDR-TB patients 5) 20 healthy controls 6) 300 subjects suspected to have pulmonary tuberculosis - follow-up for 2.5 years"||||
1405582|NCT02219932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405583|NCT02219919|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1405584|NCT02219906|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1405585|NCT02219893||Single Group Assignment||Treatment||None (Open Label)||||||
1405586|NCT02219880|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405587|NCT02219867||Single Group Assignment||Treatment||None (Open Label)||||||
1405588|NCT02219854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405589|NCT02219841|||Case-Control||Prospective|||||||
1405590|NCT02219828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405591|NCT02219815|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1405592|NCT02219802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405593|NCT02219789||Single Group Assignment||Treatment||None (Open Label)||||||
1405594|NCT02219776|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1405595|NCT02219763|||Cohort||Prospective|||||||
1405596|NCT02219750|Randomized|Parallel Assignment||Treatment||Single||||t||
1405597|NCT02219737||Single Group Assignment||Treatment||None (Open Label)||||||
1405598|NCT02219724|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405599|NCT02219711||Single Group Assignment||Treatment||None (Open Label)||||||
1405600|NCT02219698||Single Group Assignment||Treatment||None (Open Label)||||||
1405601|NCT02219685|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405602|NCT02219672|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1405603|NCT02219659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405604|NCT02219646|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1405605|NCT02219633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405606|NCT02219620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405607|NCT02219607|||Cohort||Prospective|||||||
1405608|NCT02219594|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405609|NCT02219581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405610|NCT02219568||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405611|NCT02219555||Factorial Assignment||Diagnostic||Quadruple|||t|t|t|t
1405612|NCT02219542|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1405613|NCT02219529|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1405614|NCT02219516|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1405615|NCT02219503||Single Group Assignment||Treatment||None (Open Label)||||||
1405616|NCT02219490||Single Group Assignment||Treatment||None (Open Label)||||||
1405617|NCT02219477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405618|NCT02219464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405619|NCT02219451||Single Group Assignment||||Single|||t|||
1405620|NCT02219438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405621|NCT02219425||Single Group Assignment||Treatment||None (Open Label)||||||
1405622|NCT02219412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405623|NCT02219399|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1405624|NCT02219386|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405625|NCT02219373|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1405626|NCT02219360|||Case-Only||Prospective|||||||
1405627|NCT02219347||Single Group Assignment||Basic Science||None (Open Label)||||||
1405628|NCT02219334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405629|NCT02219321|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405630|NCT02219308|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405631|NCT02219295|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1405632|NCT02219282|Non-Randomized|Parallel Assignment||Screening||Double|||||t|t
1405633|NCT02219269|||Cohort||Prospective|||||||
1405634|NCT02219256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405635|NCT02219243|Randomized|Parallel Assignment||Treatment||Single||||||t
1405636|NCT02219230||Single Group Assignment||||Single|||t|||
1405637|NCT02219217||Single Group Assignment||||None (Open Label)||||||
1405638|NCT02219204|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405639|NCT02219191|Randomized|Parallel Assignment||Treatment||Single||||||t
1405640|NCT02219178||Single Group Assignment||Treatment||None (Open Label)||||||
1405641|NCT02219165|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1405642|NCT02219152|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1405643|NCT02219139||Single Group Assignment||||None (Open Label)||||||
1405644|NCT02219126|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1405645|NCT02219113||Single Group Assignment||Treatment||None (Open Label)||||||
1405646|NCT02219100|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1405647|NCT02219087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405648|NCT02219074|Randomized|Parallel Assignment||Treatment||Single||||||t
1405649|NCT02219061|||||Prospective|||||||
1405650|NCT02219048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405651|NCT02219035|||Cohort||Prospective|||||||
1405652|NCT02219022|Randomized|Parallel Assignment||Treatment||Single||||||t
1405653|NCT02219009||Single Group Assignment||Treatment||None (Open Label)||||||
1405654|NCT02218996|||Case-Control||Prospective|||||||
1405655|NCT02218983|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405656|NCT02218970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405657|NCT02218957|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405658|NCT02218944|Randomized|Parallel Assignment||Prevention||Single|||t|||
1405659|NCT02218931|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405660|NCT02218918|Randomized|Parallel Assignment||Treatment||Single||Treadmill training vs ground walk training||||t
1405661|NCT02218905||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405662|NCT02218892|||Cohort||Prospective|||||||
1405663|NCT02218879|||Cohort||Prospective|||||||
1405664|NCT02218866|||Case-Control||Prospective|||||||
1405665|NCT02218853|||Case-Control||Prospective|||||||
1405666|NCT02218840|||Cohort||Prospective|||||||
1405667|NCT02218827||Single Group Assignment||Treatment||None (Open Label)||||||
1405668|NCT02218814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405669|NCT02218801|||Cohort||Prospective|||||||
1405670|NCT02218788|||Cohort||Retrospective|||||||
1405671|NCT02218775||Single Group Assignment||Health Services Research||None (Open Label)||||||
1405672|NCT02218762|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1405673|NCT02218749|Randomized|Parallel Assignment||Health Services Research||Double||||t||t
1405674|NCT02218736|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1405675|NCT02218723|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405676|NCT02218710|||Case Control||Cross-Sectional|||||||
1405677|NCT02218697|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405678|NCT02218684|Randomized|Parallel Assignment||Treatment||Double||||||
1405679|NCT02218671||Crossover Assignment||Treatment||None (Open Label)||||||
1405680|NCT02218658|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405681|NCT02218645|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405682|NCT02218632|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405683|NCT02218619|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405684|NCT02218606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405685|NCT02218593||Single Group Assignment||||||||||
1405686|NCT02218580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405687|NCT02218567|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405688|NCT02218554|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405689|NCT02218541|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405690|NCT02218528|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1405691|NCT02218515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405692|NCT02218502|Non-Randomized|Single Group Assignment||Diagnostic||Single||||t||
1405693|NCT02218489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405694|NCT02218476|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1405695|NCT02218463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405696|NCT02218450||||||||||||
1405697|NCT02218437||Single Group Assignment||Treatment||None (Open Label)||||||
1405698|NCT02218424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405699|NCT02218411||Parallel Assignment||Treatment||Triple|||t||t|t
1405700|NCT02218398|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405701|NCT02218385|||||Prospective|||||||
1405702|NCT02218372|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405703|NCT02218359|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1405704|NCT02218346|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405705|NCT02218333|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405706|NCT02218320|||Other||Prospective|||||||
1405707|NCT02218307|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1405708|NCT02218294||Single Group Assignment||Treatment||None (Open Label)||||||
1405709|NCT02218281|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1405710|NCT02218268|||Cohort||Prospective|||||||
1405711|NCT02218255|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1405712|NCT02218242||Single Group Assignment||Treatment||None (Open Label)||||||
1405713|NCT02218229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405714|NCT02218216|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1405715|NCT02218203|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1405716|NCT02218190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405717|NCT02218177|||Case-Control||Prospective|||||||
1405718|NCT02218164||Single Group Assignment||Treatment||None (Open Label)||||||
1405719|NCT02218151|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405720|NCT02218138|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405721|NCT02218125|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405722|NCT02218112|||Cohort||Prospective|||||||
1405723|NCT02218099|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1405724|NCT02218086|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405725|NCT02218073|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405726|NCT02218060|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1405727|NCT02218047|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1405728|NCT02218034|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1405729|NCT02218021|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1405730|NCT02218008|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1405731|NCT02217995|Randomized|Factorial Assignment||Treatment||Single||||||t
1405732|NCT02217982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405733|NCT02217969|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1405734|NCT02217956||Single Group Assignment||Treatment||None (Open Label)||||||
1405735|NCT02217943|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405736|NCT02217930|Randomized|Crossover Assignment||||Triple|||t||t|t
1405737|NCT02217917|Randomized|||Basic Science||Double|||t||t|
1405738|NCT02217904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405739|NCT02217891|||Case-Crossover||Prospective|||||||
1405740|NCT02217878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405741|NCT02217865|||Cohort||Prospective|||||||
1405742|NCT02217852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405743|NCT02217839|Randomized|Single Group Assignment||Treatment||Single|||t|||
1405744|NCT02217826|Randomized|Crossover Assignment||Treatment||Single|||t|||
1405745|NCT02217813|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1405746|NCT02217800||Single Group Assignment||Treatment||None (Open Label)||||||
1405747|NCT02217787|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1405748|NCT02217774||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405749|NCT02217761|||Case-Only||Prospective|||||||
1405750|NCT02217748|Randomized|Parallel Assignment||||Double|||t|||t
1405751|NCT02217735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405752|NCT02217722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405753|NCT02217709||Single Group Assignment||Treatment||None (Open Label)||||||
1405754|NCT02217696|Randomized|Crossover Assignment||Basic Science||Single||||||t
1405755|NCT02217683|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1405756|NCT02217670|Randomized|Crossover Assignment||||None (Open Label)||||||
1405757|NCT02217657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405758|NCT02217644|Randomized|Parallel Assignment||Treatment||Single||||||
1405759|NCT02217631|Randomized|Parallel Assignment||Treatment||Double||||||
1405760|NCT02217618||Single Group Assignment||Basic Science||None (Open Label)||||||
1405761|NCT02217605||Single Group Assignment||Basic Science||None (Open Label)||||||
1405762|NCT02217592|||Case-Only||Prospective|||||||
1405763|NCT02217579|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1405764|NCT02217566||Single Group Assignment||Treatment||None (Open Label)||||||
1405765|NCT02217553||Single Group Assignment||Prevention||None (Open Label)||||||
1405766|NCT02217540|Randomized|Parallel Assignment||Treatment||Single||||||t
1405767|NCT02217527|Randomized|Crossover Assignment||Basic Science||Triple||Crossover of active JNJ vs. placebo for 2 weeks each, involving 1 week of dose run-up and 1 week of attempting to quit each day on that drug condition. A one-week washout separates these drug conditions, which are administered in counter-balanced order.|t||t|t
1405768|NCT02217514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405769|NCT02217501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405770|NCT02217488|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1405771|NCT02217475|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1405772|NCT02217462|||Cohort||Prospective|||||||
1405773|NCT02217449|||Cohort||Prospective|||||||
1405774|NCT02217436|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405775|NCT02217423|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1405776|NCT02217410|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1405777|NCT02217397||Single Group Assignment||Treatment||None (Open Label)||||||
1405778|NCT02217384|||Case-Control||Cross-Sectional|||||||
1405779|NCT02217371|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1405780|NCT02217358||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405781|NCT02217345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405782|NCT02217332||Single Group Assignment||Treatment||None (Open Label)||||||
1405783|NCT02217319|Randomized|Parallel Assignment||Prevention||Single|||t|||
1405784|NCT02217306|||Case Control||Prospective|||||||
1405785|NCT02217293|Randomized|Parallel Assignment||Treatment||Single||||||t
1405786|NCT02217280||Single Group Assignment||Health Services Research||None (Open Label)||||||
1405787|NCT02217267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405788|NCT02217254|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405789|NCT02217241|Randomized|Parallel Assignment||||Single||||||t
1405790|NCT02217228|Randomized|Parallel Assignment||Treatment||Single||||||t
1405791|NCT02217215|||Cohort||Retrospective|||||||
1405792|NCT02217202|||Cohort||Prospective|||||||
1405793|NCT02217189|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405794|NCT02217176|||Cohort||Cross-Sectional|||||||
1405795|NCT02217163||Single Group Assignment||Treatment||None (Open Label)||||||
1405796|NCT02217150|||Cohort||Prospective|||||||
1405797|NCT02217137|||Case Control||Cross-Sectional|||||||
1405798|NCT02217124|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1405799|NCT02217111||Single Group Assignment||Treatment||None (Open Label)||||||
1405800|NCT02217098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405801|NCT02217085|||Cohort||Prospective|||||||
1405802|NCT02217072|Randomized|Parallel Assignment||Treatment||Single||||||t
1405803|NCT02217059|||Cohort||Prospective|||||||
1405804|NCT02217046|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405805|NCT02217033|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1405806|NCT02217020||Single Group Assignment||Treatment||None (Open Label)||||||
1405807|NCT02217007||Single Group Assignment||Treatment||None (Open Label)||||||
1405808|NCT02216994||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405809|NCT02216981|Randomized|Parallel Assignment||Treatment||Single||||||t
1405810|NCT02216968|Randomized|Single Group Assignment||Other||Single|||t|||
1405811|NCT02216955|||Cohort||Prospective|||||||
1405812|NCT02216942|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405813|NCT02216929|||||Retrospective|||||||
1405814|NCT02216916|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405815|NCT02216903|||Cohort||Prospective|||||||
1405816|NCT02216890||Single Group Assignment||Treatment||None (Open Label)||||||
1405817|NCT02216877|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405818|NCT02216864|Randomized|Parallel Assignment||Treatment||Single||||||t
1405819|NCT02216851|Randomized|Parallel Assignment||Treatment||Single||||||t
1405820|NCT02216838|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1405821|NCT02216825|Randomized|Parallel Assignment||||Double|||t||t|
1405822|NCT02216812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405823|NCT02216799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405824|NCT02216786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405825|NCT02216773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405826|NCT02216760|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405827|NCT02216747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405828|NCT02216734|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1405829|NCT02216721|||Case Control||Prospective|||||||
1405830|NCT02216708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405831|NCT02216695|||Cohort||Retrospective|||||||
1405832|NCT02216682|||Case Control||Prospective|||||||
1405833|NCT02216669||Single Group Assignment||Treatment||None (Open Label)||||||
1405834|NCT02216656|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405835|NCT02216643|Randomized|Parallel Assignment||Treatment||Single||||||t
1405836|NCT02216630||Single Group Assignment||Treatment||None (Open Label)||||||
1405837|NCT02216617||Single Group Assignment||Treatment||None (Open Label)||||||
1405838|NCT02216604|Non-Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1405839|NCT02216591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405840|NCT02216578||Single Group Assignment||Treatment||None (Open Label)||||||
1405841|NCT02216565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405842|NCT02216552|Randomized|Parallel Assignment||Prevention||Quadruple||Resveratrol as ResVida (TM) compared to a placebo|t|t|t|t
1405843|NCT02216539|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405844|NCT02216526|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405845|NCT02216513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405846|NCT02216500||Single Group Assignment||Treatment||None (Open Label)||||||
1405847|NCT02216487||Single Group Assignment||Treatment||None (Open Label)||||||
1405848|NCT02216474|Randomized|Crossover Assignment||Other||Double|||t|||t
1405849|NCT02216461|Randomized|Parallel Assignment||Treatment||Double||||||
1405850|NCT02216448|Randomized|Parallel Assignment||Other||Single||||||t
1405851|NCT02216435|||Case-Only||Cross-Sectional|||||||
1405852|NCT02216422||Single Group Assignment||Treatment||None (Open Label)||||||
1405853|NCT02216409||Single Group Assignment||Treatment||None (Open Label)||||||
1405854|NCT02216396|||Cohort||Prospective|||||||
1405855|NCT02216383|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405856|NCT02216370|||Case Control||Prospective|||||||
1405857|NCT02216357|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405858|NCT02216344|||Case-Only|||||||||
1405859|NCT02216331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405860|NCT02216318|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1405861|NCT02216305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405862|NCT02216292|||Cohort||Prospective|||||||
1405863|NCT02216279|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1405864|NCT02216266|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1405865|NCT02216253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405866|NCT02216240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405867|NCT02216227||Single Group Assignment||Prevention||None (Open Label)||||||
1405868|NCT02216214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405869|NCT02216201|||Cohort||Prospective|||||||
1405870|NCT02216188|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405871|NCT02216175|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1405872|NCT02216162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405873|NCT02216149|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405874|NCT02216136|||Cohort||Prospective|||||||
1405875|NCT02216123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405876|NCT02216110|||Cohort||Retrospective|||||||
1405877|NCT02216097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405878|NCT02216084||Single Group Assignment||Treatment||None (Open Label)||||||
1405879|NCT02216071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405880|NCT02216058||Single Group Assignment||Treatment||None (Open Label)||||||
1405881|NCT02216045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405882|NCT02216032|Randomized|Parallel Assignment||Other||Single|||t|||
1405883|NCT02216019|||Cohort||Prospective|||||||
1405884|NCT02216006|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1405885|NCT02215993|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1405886|NCT02215980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405887|NCT02215967||Sequential Assignment||Treatment||None (Open Label)||||||
1405888|NCT02215954|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1405889|NCT02215941|Randomized|Parallel Assignment||||Triple|||t|t|t|
1405890|NCT02215928||||||||||||
1405891|NCT02215915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405892|NCT02215902||Single Group Assignment||Treatment||None (Open Label)||||||
1405893|NCT02215889||Single Group Assignment||Treatment||None (Open Label)||||||
1405894|NCT02215876||Single Group Assignment||Treatment||None (Open Label)||||||
1405895|NCT02215863|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405896|NCT02215850||Single Group Assignment||Treatment||None (Open Label)||||||
1405897|NCT02215837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405898|NCT02215824|Randomized|Parallel Assignment||Treatment||Double||||||
1405899|NCT02215811||Single Group Assignment||Treatment||None (Open Label)||||||
1405900|NCT02215798|||Cohort||Prospective|||||||
1405901|NCT02215785||Single Group Assignment||Prevention||None (Open Label)||||||
1405902|NCT02215772||Single Group Assignment||Treatment||None (Open Label)||||||
1405903|NCT02215759|Randomized|Parallel Assignment||Treatment||Double||||||
1405904|NCT02215746|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405905|NCT02215733|||Cohort||Retrospective|||||||
1405906|NCT02215720||Single Group Assignment||Treatment||None (Open Label)||||||
1405907|NCT02215707|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405908|NCT02215694|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1405909|NCT02215681|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405910|NCT02215668|Randomized|Parallel Assignment||Prevention||Single|||||t|
1405911|NCT02215655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405912|NCT02215642|||Cohort||Prospective|||||||
1405913|NCT02215629|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405914|NCT02215616|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405915|NCT02215603|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405916|NCT02215590||Single Group Assignment||Treatment||None (Open Label)||||||
1405917|NCT02215577|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405918|NCT02215564|||Cohort||Prospective|||||||
1405919|NCT02215551|||Cohort||Prospective|||||||
1405920|NCT02215538|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1405921|NCT02215525|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405922|NCT02215512||Single Group Assignment||Treatment||None (Open Label)||||||
1405923|NCT02215499|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1405924|NCT02215486|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1405925|NCT02215473|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1405926|NCT02215460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405927|NCT02215447||Single Group Assignment||Treatment||None (Open Label)||||||
1405928|NCT02215434|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1405929|NCT02215421|Randomized|Parallel Assignment||Prevention||Single||||||t
1405930|NCT02215408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405931|NCT02215395|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405932|NCT02215382|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1405933|NCT02215369||Single Group Assignment||Treatment||None (Open Label)||||||
1405934|NCT02215356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405935|NCT02215343|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1405936|NCT02215330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405937|NCT02215317|||Cohort||Prospective|||||||
1405938|NCT02215304|Randomized|Parallel Assignment||||Triple|||t|t|t|
1405939|NCT02215291|||Cohort||Prospective|||||||
1405940|NCT02215278|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1405941|NCT02215265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405942|NCT02215252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1405943|NCT02215239|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1405944|NCT02215226|||Case-Control||Prospective|||||||
1405945|NCT02215213|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1405946|NCT02215200|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1405947|NCT02215187|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405948|NCT02215174|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1405949|NCT02215161||Single Group Assignment||Treatment||None (Open Label)||||||
1405950|NCT02215148|||Cohort||Prospective|||||||
1405951|NCT02215135||Single Group Assignment||Treatment||None (Open Label)||||||
1405952|NCT02215122|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405953|NCT02215109|||Case-Only||Prospective|||||||
1405954|NCT02215096|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405955|NCT02215083||Single Group Assignment||Treatment||None (Open Label)||||||
1405956|NCT02215070|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405957|NCT02215057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1405958|NCT02215044||Single Group Assignment||Treatment||None (Open Label)||||||
1405959|NCT02215031|Randomized|Parallel Assignment||Treatment||Single||||||
1405960|NCT02215018|Randomized|Parallel Assignment||Treatment||Double||||||
1405961|NCT02215005|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405962|NCT02214992|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405963|NCT02214979|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405964|NCT02214966|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405965|NCT02214953|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1405966|NCT02214940|Randomized|Parallel Assignment||Treatment||Double||||||
1405967|NCT02214927|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405968|NCT02214914|Randomized|Parallel Assignment||Treatment||Double||||||
1405969|NCT02214901|Randomized|Parallel Assignment||Treatment||Double||||||
1405970|NCT02214888|Randomized|Parallel Assignment||Treatment||Double||||||
1405971|NCT02214875|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1405972|NCT02214862||Single Group Assignment||||None (Open Label)||||||
1405973|NCT02214849||Single Group Assignment||Health Services Research||None (Open Label)||||||
1405974|NCT02214836||Single Group Assignment||Diagnostic||None (Open Label)||||||
1405975|NCT02214823|Randomized|Parallel Assignment||Treatment||Single||||||t
1405976|NCT02214810|Randomized|Parallel Assignment||Treatment||Single|||t|||
1405977|NCT02214797|Randomized|Crossover Assignment||Treatment||Single|||t|||
1405978|NCT02214784|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1405979|NCT02214771|||Cohort||Prospective|||||||
1405980|NCT02214758|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1405981|NCT02214745|||Ecologic or Community||Retrospective|||||||
1405982|NCT02214732|Randomized|Parallel Assignment||Treatment||Single||||||t
1405983|NCT02214719||Single Group Assignment||Supportive Care||None (Open Label)||||||
1405984|NCT02214706|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1405985|NCT02214693|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1405986|NCT02214680||Single Group Assignment||||None (Open Label)||||||
1405987|NCT02214667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1405988|NCT02214654|||Case Control||Prospective|||||||
1405989|NCT02214641|Randomized|Parallel Assignment||Treatment||Single||||||t
1405990|NCT02214628||Single Group Assignment||Treatment||None (Open Label)||||||
1405991|NCT02214615|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1405992|NCT02214602|Randomized|Parallel Assignment||Prevention||Single|||t|||
1405993|NCT02214589|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1405994|NCT02214576|||Cohort||Prospective|||||||
1405995|NCT02214563|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1405996|NCT02214550|Randomized|Parallel Assignment||Treatment||Single|||||t|
1405997|NCT02214537||Single Group Assignment||Basic Science||None (Open Label)||||||
1405998|NCT02214524|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1405999|NCT02214511|||Cohort||Prospective|||||||
1406000|NCT02214498|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1406001|NCT02214485|Randomized|Single Group Assignment||||Single|||t|||
1406002|NCT02214472|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406003|NCT02214459||Single Group Assignment||Treatment||None (Open Label)||||||
1406004|NCT02214446|||Cohort||Prospective|||||||
1406005|NCT02214433|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1406006|NCT02214420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406007|NCT02214407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406008|NCT02214394||Single Group Assignment||Prevention||None (Open Label)||||||
1406009|NCT02214381|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406010|NCT02214368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406011|NCT02214342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406012|NCT02214329|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1406013|NCT02214316||Single Group Assignment||Treatment||None (Open Label)||||||
1406014|NCT02214303|||||Prospective|||||||
1406015|NCT02214290|Randomized|Crossover Assignment||||Double|||t|||t
1406016|NCT02214277|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1406017|NCT02214264|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1406018|NCT02214251||Single Group Assignment||Basic Science||None (Open Label)||||||
1406019|NCT02214238|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406020|NCT02214225|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406021|NCT02214212|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406022|NCT02214199|Randomized|Single Group Assignment||Treatment||Single|||t|||
1406023|NCT02214186|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406024|NCT02214173|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1406025|NCT02214160||Single Group Assignment||Treatment||None (Open Label)||||||
1406026|NCT02214147|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406027|NCT02214134|||Cohort||Prospective|||||||
1406028|NCT02214121|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406029|NCT02214108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406030|NCT02214095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406031|NCT02214082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406032|NCT02214069|||Cohort||Prospective|||||||
1406033|NCT02214056|||Cohort||Prospective|||||||
1406034|NCT02214043|||Cohort||Prospective|||||||
1406035|NCT02214030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406036|NCT02214017|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1406037|NCT02214004||Single Group Assignment||Treatment||None (Open Label)||||||
1406038|NCT02213991||Single Group Assignment||Treatment||None (Open Label)||Evaluate the safety of intraoperative radiotherapy using Intrabeam in Korean patients with early breast cancer.||||
1406039|NCT02213978|||Cohort||Prospective|||||||
1406040|NCT02213965|||Cohort||Prospective|||||||
1406041|NCT02213952|Randomized|Parallel Assignment||Treatment||Single||||||t
1406042|NCT02213939|||Case-Control||Prospective|||||||
1406043|NCT02213926||Single Group Assignment||Treatment||None (Open Label)||||||
1406044|NCT02213913||Single Group Assignment||Treatment||None (Open Label)||||||
1406045|NCT02213900|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406046|NCT02213887|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1406047|NCT02213874||Single Group Assignment||Other||None (Open Label)||||||
1406048|NCT02213861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406049|NCT02213848|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1406050|NCT02213835||Single Group Assignment||Treatment||None (Open Label)||||||
1406051|NCT02213822|||Case-Only||Prospective|||||||
1406052|NCT02213809|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1406053|NCT02213796||Single Group Assignment||||None (Open Label)||||||
1406054|NCT02213783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406055|NCT02213770|||Case-Crossover||Cross-Sectional|||||||
1406056|NCT02213757|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406057|NCT02213744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406058|NCT02213731||Single Group Assignment||Treatment||None (Open Label)||||||
1406059|NCT02213718|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1406060|NCT02213705||Single Group Assignment||Treatment||None (Open Label)||||||
1406061|NCT02213692|||Case Control||Prospective|||||||
1406062|NCT02213679|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1406063|NCT02213666|||Case-Only||Prospective|||||||
1406064|NCT02213653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406065|NCT02213640|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406066|NCT02213627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406067|NCT02213614|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406068|NCT02213601|Randomized|Parallel Assignment||Treatment||Single||||||t
1406069|NCT02213588|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406070|NCT02213575||Single Group Assignment||Treatment||None (Open Label)||||||
1406071|NCT02213562|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1406072|NCT02213549|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1406073|NCT02213536|||Case-Only||Prospective|||||||
1406074|NCT02213523|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1406075|NCT02213510|Randomized|Parallel Assignment||||None (Open Label)||||||
1406076|NCT02213497||||Diagnostic||||||||
1406077|NCT02213484|||Cohort||Prospective|||||||
1406078|NCT02213471|||Cohort||Prospective|||||||
1406079|NCT02213458|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1406080|NCT02213432|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406081|NCT02213419||Single Group Assignment||Treatment||None (Open Label)||||||
1406082|NCT02213406||Single Group Assignment||Basic Science||||||||
1406083|NCT02213393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406084|NCT02213380|Randomized|Parallel Assignment||Prevention||Single|Data collectors or outcome assessors, e.g. the medical staff who provide post-operative care in the ward and visit patients for preoperational assessment, hospital visits and subsequent follow-ups, will be blinded from group allocation throughout the study.|||||t
1406085|NCT02213367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406086|NCT02213354|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1406087|NCT02213341|||Case Control||Prospective|||||||
1406088|NCT02213328||Single Group Assignment||Prevention||None (Open Label)||||||
1406089|NCT02213315|Randomized|||Treatment||Double|||t||t|
1406090|NCT02213302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406091|NCT02213289|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406092|NCT02213276||Single Group Assignment||Basic Science||None (Open Label)||||||
1406093|NCT02213263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406094|NCT02213250||Single Group Assignment||Treatment||None (Open Label)||||||
1406095|NCT02213237|||Case-Only||Cross-Sectional|||||||
1406096|NCT02213224|Randomized|Parallel Assignment||Treatment||Single||||||t
1406097|NCT02213211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406098|NCT02213198|Randomized|Parallel Assignment||Other||Single||||||t
1406099|NCT02213185|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406100|NCT02213172|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1406101|NCT02213159|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406102|NCT02213146|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1406103|NCT02213133||Single Group Assignment||Treatment||None (Open Label)||||||
1406104|NCT02213120|||Cohort||Prospective|||||||
1406105|NCT02213107||Single Group Assignment||Treatment||None (Open Label)||||||
1406106|NCT02213094|Randomized|Single Group Assignment||Other||None (Open Label)||Phase 1 dose escalation study||||
1406107|NCT02213081||Single Group Assignment||Treatment||None (Open Label)||||||
1406108|NCT02213068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406109|NCT02213055|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406110|NCT02213042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406111|NCT02213029|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1406112|NCT02213016|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406113|NCT02213003||Single Group Assignment||Treatment||None (Open Label)||||||
1406114|NCT02212990|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406115|NCT02212977|Randomized|Parallel Assignment||Treatment||Single||||||t
1406116|NCT02212964|||Case-Only||Cross-Sectional|||||||
1406117|NCT02212951|Randomized|Crossover Assignment||Treatment||Single|||t|||
1406118|NCT02212938|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406119|NCT02212925|Randomized|Parallel Assignment||Treatment||Double||||||
1406120|NCT02212912|Randomized|Parallel Assignment||Treatment||Single||||||t
1406121|NCT02212899|||Case-Only||Prospective|||||||
1406122|NCT02212886|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406123|NCT02212873|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406124|NCT02212860||Single Group Assignment||Treatment||None (Open Label)||||||
1406125|NCT02212847||Single Group Assignment||Basic Science||None (Open Label)||||||
1406126|NCT02212834|||Cohort||Retrospective|||||||
1406127|NCT02212821|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1406128|NCT02212808|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1406129|NCT02212795|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1406130|NCT02212782|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1406131|NCT02212769|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1406132|NCT02212756|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1406133|NCT02212730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406134|NCT02212717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406135|NCT02212704||Single Group Assignment||Basic Science||None (Open Label)||||||
1406136|NCT02212691|||Other||Prospective|||||||
1406137|NCT02212678||Single Group Assignment||Treatment||None (Open Label)||||||
1406138|NCT02212665|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1406139|NCT02212652|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406140|NCT02212639||Single Group Assignment||Treatment||None (Open Label)||||||
1406141|NCT02212626||Single Group Assignment||Treatment||None (Open Label)||||||
1406142|NCT02212613||Single Group Assignment||Treatment||Single|||t|||
1406143|NCT02212600|||Cohort||Prospective|||||||
1406144|NCT02212587||Single Group Assignment||Treatment||None (Open Label)||||||
1406145|NCT02212574||Single Group Assignment||Treatment||None (Open Label)||||||
1406146|NCT02212561||Single Group Assignment||Treatment||None (Open Label)||||||
1406147|NCT02212548||Single Group Assignment||Treatment||None (Open Label)||||||
1406148|NCT02212535||Single Group Assignment||Treatment||None (Open Label)||||||
1406149|NCT02212522|||Case Control|||||||||
1406150|NCT02212509|||Cohort||Prospective|||||||
1406151|NCT02212496|||Cohort||Prospective|||||||
1406152|NCT02212483|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1406153|NCT02212470|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406154|NCT02212457|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1406155|NCT02212444|Randomized|Parallel Assignment||||Single||||||t
1406156|NCT02212431||Single Group Assignment||||None (Open Label)||||||
1406157|NCT02212418||Crossover Assignment||Treatment||Double|||||t|t
1406158|NCT02212405|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1406159|NCT02212392|Randomized|Parallel Assignment||Treatment||Single||||t||
1406160|NCT02212379||Single Group Assignment||Treatment||None (Open Label)||||||
1406161|NCT02212366|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406162|NCT02212353|||Cohort||Prospective|||||||
1406163|NCT02212340|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1406164|NCT02212327|||Case-Control||Prospective|||||||
1406165|NCT02212314|Randomized|Crossover Assignment||Treatment||Single||||||t
1406166|NCT02212301|Randomized|Crossover Assignment||Treatment||Single|||t|||
1406167|NCT02212288|||Case Control||Prospective|||||||
1406168|NCT02212275|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1406169|NCT02212262|||Case-Control||Prospective|||||||
1406170|NCT02212249|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1406171|NCT02212236|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1406172|NCT02212223|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1406173|NCT02212210|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406174|NCT02212197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406175|NCT02212184|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1406176|NCT02212171|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1406177|NCT02212158||Single Group Assignment||Treatment||None (Open Label)||||||
1406178|NCT02212145|||Ecologic or Community||Retrospective|||||||
1406179|NCT02212132|||||Prospective|||||||
1406180|NCT02212119|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1406181|NCT02212106|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1406182|NCT02212093|||||Retrospective|||||||
1406183|NCT02212080|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1406184|NCT02212067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406185|NCT02212054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406186|NCT02212041||Single Group Assignment||Other||None (Open Label)||||||
1406187|NCT02212028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406188|NCT02212015||Single Group Assignment||Treatment||None (Open Label)||||||
1406189|NCT02212002|||Case Control||Prospective|||||||
1406190|NCT02211989|Randomized|Parallel Assignment||Treatment||Double||||||
1406191|NCT02211976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406192|NCT02211963|Randomized|Parallel Assignment||Treatment||Double||||||
1406193|NCT02211950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406194|NCT02211937|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406195|NCT02211924|Randomized|Parallel Assignment||Treatment||Double||||||
1406196|NCT02211911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406197|NCT02211898||Single Group Assignment||Treatment||None (Open Label)||||||
1406198|NCT02211885||Single Group Assignment||Treatment||None (Open Label)||||||
1406199|NCT02211872|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406200|NCT02211859||Single Group Assignment||Treatment||None (Open Label)||||||
1406201|NCT02211846||Single Group Assignment||Basic Science||None (Open Label)||||||
1406202|NCT02211833||Single Group Assignment||Treatment||None (Open Label)||||||
1406203|NCT02211820|||Cohort||Prospective|||||||
1406204|NCT02211807|||Cohort||Retrospective|||||||
1406205|NCT02211794|||Cohort||Prospective|||||||
1406206|NCT02211781|||Ecologic or Community||Retrospective|||||||
1406207|NCT02211768|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1406208|NCT02211755||Single Group Assignment||Treatment||None (Open Label)||||||
1406209|NCT02211742|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1406210|NCT02211729|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406211|NCT02211716||Single Group Assignment||Treatment||None (Open Label)||||||
1406212|NCT02211703|||Cohort||Prospective|||||||
1406213|NCT02211690||Single Group Assignment||Prevention||None (Open Label)||||||
1406214|NCT02211677|||Cohort||Prospective|||||||
1406215|NCT02211664||Single Group Assignment||Treatment||None (Open Label)||||||
1406216|NCT02211651|||Case-Control||Cross-Sectional|||||||
1406217|NCT02211638|||Cohort||Prospective|||||||
1406218|NCT02211625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406219|NCT02211612|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1406220|NCT02211599|Randomized|Crossover Assignment||Other||Double|||t||t|
1406221|NCT02211573|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406222|NCT02211560|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1406223|NCT02211547|Randomized|Single Group Assignment||Treatment||Single|||t|||
1406224|NCT02211534|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406225|NCT02211521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406226|NCT02211508|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406227|NCT02211495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406228|NCT02211482||Single Group Assignment||Treatment||None (Open Label)||||||
1406229|NCT02211469|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406230|NCT02211456||Single Group Assignment||Basic Science||None (Open Label)||||||
1406231|NCT02211443|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406232|NCT02211430|Randomized|Parallel Assignment||Treatment||Single||||||t
1406233|NCT02211417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406234|NCT02211404|||Cohort||Prospective|||||||
1406235|NCT02211391|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1406236|NCT02211378|Randomized|Single Group Assignment||||None (Open Label)||||||
1406237|NCT02211365|||Cohort||Prospective|||||||
1406238|NCT02211352|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1406239|NCT02211339|Randomized|Parallel Assignment||Treatment||Single||||||t
1406240|NCT02211326|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406241|NCT02211313|Randomized|Parallel Assignment||Other||Single|||t|||
1406242|NCT02211300|Non-Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1406243|NCT02211287|Randomized|Parallel Assignment||Supportive Care||||||||
1406244|NCT02211274||Single Group Assignment||Health Services Research||None (Open Label)||||||
1406245|NCT02211261|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1406246|NCT02211248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406247|NCT02211235|||Case-Control||Prospective|||||||
1406248|NCT02211222||||||||||||
1406249|NCT02211209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406250|NCT02211196||Single Group Assignment||Health Services Research||None (Open Label)||||||
1406251|NCT02211183|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406252|NCT02211170|Randomized|Parallel Assignment||Treatment||Double||||||
1406253|NCT02211157|Randomized|Parallel Assignment||Treatment||Double||||||
1406254|NCT02211144|Randomized|Parallel Assignment||Treatment||Double||||||
1406255|NCT02211131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406256|NCT02211118||Single Group Assignment||Treatment||None (Open Label)||||||
1406257|NCT02211105|||Case-Control||Prospective|||||||
1406258|NCT02211092|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406259|NCT02211079||Single Group Assignment||Treatment||None (Open Label)||||||
1406260|NCT02211066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406261|NCT02211053|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1406262|NCT02211040|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406263|NCT02211027||Single Group Assignment||Treatment||None (Open Label)||||||
1406264|NCT02211014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406265|NCT02211001|Randomized|Factorial Assignment||Treatment||Single||||||t
1406266|NCT02210988||Single Group Assignment||Treatment||Single||||||t
1406267|NCT02210975|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406268|NCT02210962|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406269|NCT02210949||Single Group Assignment||Prevention||None (Open Label)||||||
1406270|NCT02210936||Single Group Assignment||Prevention||None (Open Label)||||||
1406271|NCT02210923|||Cohort||Prospective|||||||
1406272|NCT02210910|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406273|NCT02210897||||||||||||
1406274|NCT02210884|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1406275|NCT02210871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406276|NCT02210858||Single Group Assignment||Treatment||None (Open Label)||||||
1406277|NCT02210845|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406278|NCT02210832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406279|NCT02210819|||Cohort||Prospective|||||||
1406280|NCT02210806|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1406281|NCT02210793|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1406282|NCT02210780|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406283|NCT02210767|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1406284|NCT02210754|Randomized|Crossover Assignment||||Single|||t|||
1406285|NCT02210741|||Case-Only||Prospective|||||||
1406286|NCT02210728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406287|NCT02210715|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1406288|NCT02210702|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1406289|NCT02210689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406290|NCT02210676||Single Group Assignment||Health Services Research||None (Open Label)||||||
1406291|NCT02210663||Single Group Assignment||Treatment||None (Open Label)||||||
1406292|NCT02210650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406293|NCT02210637|||Cohort||Retrospective|||||||
1406294|NCT02210624||Single Group Assignment||Treatment||None (Open Label)||||||
1406295|NCT02210611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406296|NCT02210598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406297|NCT02210585|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406298|NCT02210572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406299|NCT02210559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406300|NCT02210546|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1406301|NCT02210520|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1406302|NCT02210507|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1406303|NCT02210494||Single Group Assignment||Treatment||None (Open Label)||||||
1406304|NCT02210481|||Cohort||Prospective|||||||
1406305|NCT02210468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406306|NCT02210455|Randomized|Parallel Assignment||Treatment||Single||||||t
1406307|NCT02210442|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1406308|NCT02210429|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1406309|NCT02210416|||Case Control||Retrospective|||||||
1406310|NCT02210403|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1406311|NCT02210390|Randomized|Parallel Assignment||Treatment||Single||||||t
1406312|NCT02210377|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406313|NCT02210364||Single Group Assignment||Treatment||None (Open Label)||||||
1406314|NCT02210351||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406315|NCT02210338|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406316|NCT02210325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406317|NCT02210312|||Cohort||Prospective|||||||
1406318|NCT02210299||Single Group Assignment||Basic Science||None (Open Label)||||||
1406319|NCT02210286||Single Group Assignment||Treatment||None (Open Label)||||||
1406320|NCT02210273|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1406321|NCT02210260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406322|NCT02210247|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406323|NCT02210234|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1406324|NCT02210221|||Cohort||Prospective|||||||
1406325|NCT02210208|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two Parts (part A and B) with one dressing device for the skin graft placed on a surgical burn wound and another dressing device placed on the donor site.||||
1406326|NCT02210195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406327|NCT02210182|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406328|NCT02210169|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406329|NCT02210156|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1406330|NCT02210143|||||Prospective|||||||
1406331|NCT02210130|||Case-Control||Cross-Sectional|||||||
1406332|NCT02210117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406333|NCT02210104||Single Group Assignment||Treatment||None (Open Label)||||||
1406334|NCT02210091|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406335|NCT02210078||Single Group Assignment||Treatment||None (Open Label)||||||
1406336|NCT02210065||Single Group Assignment||Treatment||None (Open Label)||||||
1406337|NCT02210052||Single Group Assignment||Screening||None (Open Label)||||||
1406338|NCT02210039||Single Group Assignment||Screening||None (Open Label)||||||
1406339|NCT02210026||Single Group Assignment||Basic Science||None (Open Label)||||||
1406340|NCT02210013|||Cohort||Prospective|||||||
1406341|NCT02210000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406342|NCT02209987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406343|NCT02209974|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406344|NCT02209961|||Cohort||Prospective|||||||
1406345|NCT02209948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406346|NCT02209935|Randomized|Parallel Assignment||Treatment||Double||||t||t
1406347|NCT02209922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406348|NCT02209909|Randomized|Parallel Assignment||||Double||||t||t
1406349|NCT02209896||Single Group Assignment||Treatment||None (Open Label)||||||
1406350|NCT02209883|||Cohort||Prospective|||||||
1406351|NCT02209870|||Cohort||Prospective|||||||
1406352|NCT02209857|||Case-Control||Prospective|||||||
1406353|NCT02209844|Randomized|Parallel Assignment||Treatment||Double||||||
1406354|NCT02209831|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406355|NCT02209818|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406356|NCT02209805|Randomized|Parallel Assignment||Treatment||Double||||||
1406357|NCT02209792|Randomized|Parallel Assignment||Treatment||Double||||||
1406358|NCT02209779|Randomized|Parallel Assignment||Treatment||Double||||||
1406359|NCT02209766|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1406360|NCT02209753|Randomized|Parallel Assignment||Treatment||Double||||||
1406361|NCT02209740|||Cohort||Prospective|||||||
1406362|NCT02209727||Single Group Assignment||Treatment||None (Open Label)||||||
1406363|NCT02209714|Randomized|Parallel Assignment||Treatment||Double||||||
1406364|NCT02209701||Single Group Assignment||Treatment||None (Open Label)||||||
1406365|NCT02209688|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406366|NCT02209675||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406367|NCT02209662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406368|NCT02209649|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406369|NCT02209636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406370|NCT02209623|||Other||Prospective|||||||
1406371|NCT02209610|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1406372|NCT02209597|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1406373|NCT02209584|||Cohort||Prospective|||||||
1406374|NCT02209571|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1406375|NCT02209558|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406376|NCT02209545|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406377|NCT02209532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406378|NCT02209519|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1406379|NCT02209506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406380|NCT02209493|Randomized|Crossover Assignment||Prevention||Single||||||t
1406381|NCT02209480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406382|NCT02209467|Randomized|Crossover Assignment||Treatment||Single|||||t|
1406383|NCT02209454|Randomized|Crossover Assignment||||None (Open Label)||||||
1406384|NCT02209441||||||||||||
1406385|NCT02209428|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406386|NCT02209415|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1406387|NCT02209402|Randomized|Parallel Assignment||Prevention||Single||||||t
1406388|NCT02209389|||Case Control||Cross-Sectional|||||||
1406389|NCT02209376||Single Group Assignment||Treatment||None (Open Label)||||||
1406390|NCT02209363|Randomized|Parallel Assignment||Treatment||Single||||||t
1406391|NCT02209350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406392|NCT02209337||Single Group Assignment||Treatment||None (Open Label)||||||
1406393|NCT02209324||Single Group Assignment||Treatment||None (Open Label)||||||
1406394|NCT02209311||Single Group Assignment||Treatment||None (Open Label)||||||
1406395|NCT02209298|||Cohort||Prospective|||||||
1406396|NCT02209285|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1406397|NCT02209272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406398|NCT02209259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406399|NCT02209246|Randomized|||Health Services Research||||||||
1406400|NCT02209233|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406401|NCT02209220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406402|NCT02209207|Randomized|Parallel Assignment||Treatment||Single||||||t
1406403|NCT02209194|||Cohort||Prospective|||||||
1406404|NCT02209181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406405|NCT02209168|||Cohort||Prospective|||||||
1406406|NCT02209155|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406407|NCT02209142|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1406408|NCT02209129|||Cohort||Prospective|||||||
1406409|NCT02209116|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1406410|NCT02209103|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1406411|NCT02209090|Randomized|Parallel Assignment||Treatment||Single||||||t
1406412|NCT02209077|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1406413|NCT02209064||Single Group Assignment||Supportive Care||None (Open Label)||||||
1406414|NCT02209051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406415|NCT02209038|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1406416|NCT02209025|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1406417|NCT02209012|||Case Control||Prospective|||||||
1406418|NCT02208999|||Cohort||Prospective|||||||
1406419|NCT02208986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406420|NCT02208973|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406421|NCT02208960|Randomized|Factorial Assignment||Prevention||Single||||||t
1406422|NCT02208947|Randomized|Parallel Assignment||Other||Single||||||t
1406423|NCT02208934|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406424|NCT02208921|||||Cross-Sectional|||||||
1406425|NCT02208908|||Cohort||Prospective|||||||
1406426|NCT02208895|||Case-Only||Prospective|||||||
1406427|NCT02208882|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1406428|NCT02208869|||Cohort||Prospective|||||||
1406429|NCT02208856|Randomized|Parallel Assignment||Treatment||Double||||||
1406430|NCT02208843||Single Group Assignment||Treatment||None (Open Label)||||||
1406431|NCT02208830|Randomized|Single Group Assignment||Treatment||Single|||||t|
1406432|NCT02208817|||Case Control||Prospective|||||||
1406433|NCT02208804|Randomized|Single Group Assignment||Treatment||Single||||||t
1406434|NCT02208791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406435|NCT02208778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406436|NCT02208765||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406437|NCT02208752|Randomized|Parallel Assignment||Treatment||Single||||||t
1406438|NCT02208739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406439|NCT02208726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406440|NCT02208713||Single Group Assignment||Treatment||None (Open Label)||||||
1406441|NCT02208700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406442|NCT02208687|Randomized|Parallel Assignment||Treatment||Single||||||t
1406443|NCT02208674|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1406444|NCT02208661|||Cohort||Prospective|||||||
1406445|NCT02208648|||Cohort||Retrospective|||||||
1406446|NCT02208635|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1406447|NCT02208622|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1406448|NCT02208609|Randomized|Crossover Assignment||||Single||||||t
1406449|NCT02208596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406450|NCT02208583|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1406451|NCT02208570|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1406452|NCT02208557|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1406453|NCT02208544|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1406454|NCT02208531|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1406455|NCT02208518|||Case-Only||Prospective|||||||
1406456|NCT02208505|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406457|NCT02208492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406458|NCT02208479|||Cohort||Prospective|||||||
1406459|NCT02208466|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406460|NCT02208453||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1406461|NCT02208440|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406462|NCT02208427|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406463|NCT02208414|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406464|NCT02208401|Randomized|Parallel Assignment||Treatment||Single||||t||
1406465|NCT02208388|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406466|NCT02208375|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406467|NCT02208362|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406468|NCT02208349|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406469|NCT02208336|||Case-Only||Prospective|||||||
1406470|NCT02208323||Single Group Assignment||Treatment||None (Open Label)||||||
1406471|NCT02208310|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1406472|NCT02208297|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406473|NCT02208284|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1406474|NCT02208271|||Cohort||Prospective|||||||
1406475|NCT02208258||Single Group Assignment||Supportive Care||None (Open Label)||||||
1406476|NCT02208245|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406477|NCT02208232||||||||||||
1406478|NCT02208219|Randomized|Parallel Assignment||Treatment||Single||||||t
1406479|NCT02208206|||Case-Control||Cross-Sectional|||||||
1406480|NCT02208193|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1406481|NCT02208180|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406482|NCT02208167|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406483|NCT02208154|Randomized|Crossover Assignment||Prevention||None (Open Label)||This study is a cluster-randomized multicenter study with crossover of interventions within study centers. The first study period is always the baseline period. After six months, the first intervention period (order is determined by randomization) is implemented, followed by the second and third intervention. The intervention periods are separated by a wash out period of one month.||||
1406484|NCT02208141|||Cohort||Cross-Sectional|||||||
1406485|NCT02208128||Single Group Assignment||Treatment||None (Open Label)||||||
1406486|NCT02208115|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1406487|NCT02208102|||Cohort||Prospective|||||||
1406488|NCT02208089||Single Group Assignment||Treatment||None (Open Label)||||||
1406490|NCT02208063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406491|NCT02208050|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1406492|NCT02208037|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406493|NCT02208024||Single Group Assignment||Treatment||None (Open Label)||||||
1406494|NCT02208011|||Cohort||Prospective|||||||
1406495|NCT02207998|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406496|NCT02207985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406497|NCT02207972|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1406498|NCT02207959||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406499|NCT02207946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406500|NCT02207933|Randomized|Parallel Assignment||Treatment||Single|||||t|
1406501|NCT02207920|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406502|NCT02207907|Randomized|Parallel Assignment||Treatment||Single|||||t|
1406503|NCT02207894|||Cohort||Prospective|||||||
1406504|NCT02207881|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406505|NCT02207868|||Cohort||Prospective|||||||
1406506|NCT02207855|||Cohort||Retrospective|||||||
1406507|NCT02207842|||Cohort||Prospective|||||||
1406508|NCT02207829|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406509|NCT02207816|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406510|NCT02207803|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1406511|NCT02207790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406512|NCT02207777|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1406513|NCT02207764|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406514|NCT02207751|||Cohort||Prospective|||||||
1406515|NCT02207738|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1406516|NCT02207725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406517|NCT02207712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406518|NCT02207699|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1406519|NCT02207686|||Cohort||Retrospective|||||||
1406520|NCT02207673|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406521|NCT02207660|||Cohort||Retrospective|||||||
1406522|NCT02207647|||Ecologic or Community||Prospective|||||||
1406523|NCT02207634|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1406524|NCT02207621|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406525|NCT02207608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406526|NCT02207595|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1406527|NCT02207582|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406528|NCT02207569||Single Group Assignment||Treatment||None (Open Label)||||||
1406529|NCT02207556||Single Group Assignment||Treatment||None (Open Label)||||||
1406530|NCT02207543||Single Group Assignment||Other||None (Open Label)||||||
1406531|NCT02207530||Single Group Assignment||Treatment||None (Open Label)||||||
1406532|NCT02207517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406533|NCT02207504||Single Group Assignment||Treatment||None (Open Label)||||||
1406534|NCT02207491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406535|NCT02207478|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1406536|NCT02207465||Single Group Assignment||Treatment||||||||
1406537|NCT02207452|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1406538|NCT02207439||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406539|NCT02207426|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406540|NCT02207413|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406541|NCT02207400|Randomized|Parallel Assignment||Treatment||Single|||||t|
1406542|NCT02207387|Randomized|Parallel Assignment||Treatment||Single||||||t
1406543|NCT02207374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406544|NCT02207361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406545|NCT02207348|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406546|NCT02207335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406547|NCT02207322|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406548|NCT02207309|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1406549|NCT02207296|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406550|NCT02207270|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Randomized clinical trail||||
1406551|NCT02207257|Randomized|Sequential Assignment||Other||Single|||t|||
1406552|NCT02207244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406553|NCT02207231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406554|NCT02207218|||Cohort||Prospective|||||||
1406555|NCT02207205||Single Group Assignment||Other||None (Open Label)||||||
1406556|NCT02207192|||Case-Crossover||Prospective|||||||
1406557|NCT02207179||Single Group Assignment||Treatment||None (Open Label)||||||
1406558|NCT02207166|||Case-Only||Prospective|||||||
1406559|NCT02207153|||Cohort||Prospective|||||||
1406560|NCT02207140|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1406561|NCT02207127|||Cohort||Prospective|||||||
1406562|NCT02207114|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1406563|NCT02207101|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1406564|NCT02207088||Single Group Assignment||Treatment||None (Open Label)||||||
1406565|NCT02207075|||Cohort||Prospective|||||||
1406566|NCT02207062||Single Group Assignment||Treatment||None (Open Label)||||||
1406872|NCT02203084|||Family-Based||Cross-Sectional|||||||
1406567|NCT02207049|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1406568|NCT02207036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406569|NCT02207023|Randomized|Parallel Assignment||Prevention||Single||||||t
1406570|NCT02207010||Single Group Assignment||||None (Open Label)||||||
1406571|NCT02206997|||Cohort||Prospective|||||||
1406572|NCT02206984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406573|NCT02206971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406574|NCT02206958|Randomized|Parallel Assignment||Prevention||Single||||||t
1406575|NCT02206945|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406576|NCT02206932||Single Group Assignment||Treatment||None (Open Label)||||||
1406577|NCT02206919|||Cohort||Prospective|||||||
1406578|NCT02206906|||Cohort||Prospective|||||||
1406579|NCT02206893|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406580|NCT02206880|||Other||Prospective|||||||
1406581|NCT02206867|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406582|NCT02206854||Single Group Assignment||||None (Open Label)||||||
1406583|NCT02206841|||Cohort||Prospective|||||||
1406584|NCT02206828|||Cohort||Prospective|||||||
1406585|NCT02206815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406586|NCT02206802|||Case-Control||Prospective|||||||
1406587|NCT02206789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406588|NCT02206776|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406589|NCT02206763||Single Group Assignment||Treatment||None (Open Label)||||||
1406590|NCT02206750|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1406591|NCT02206737||Crossover Assignment||Basic Science||None (Open Label)||||||
1406592|NCT02206724||Single Group Assignment||Treatment||None (Open Label)||||||
1406593|NCT02206711|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1406594|NCT02206698|||Cohort||Prospective|||||||
1406595|NCT02206685|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1406596|NCT02206672||Single Group Assignment||||None (Open Label)||||||
1406597|NCT02206659||Single Group Assignment||Treatment||None (Open Label)||||||
1406598|NCT02206646|||Cohort||Prospective|||||||
1406599|NCT02206633|||Case-Only||Cross-Sectional|||||||
1406600|NCT02206620|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1406601|NCT02206607|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1406602|NCT02206594||Single Group Assignment||Treatment||None (Open Label)||||||
1406603|NCT02206581|||Case-Only||Cross-Sectional|||||||
1406604|NCT02206568||Single Group Assignment||Basic Science||Triple|||t|t|t|
1406605|NCT02206555||Single Group Assignment||Prevention||None (Open Label)||||||
1406606|NCT02206542|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1406607|NCT02206529|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406608|NCT02206516||Single Group Assignment||Treatment||None (Open Label)||||||
1406609|NCT02206503||Single Group Assignment||Treatment||None (Open Label)||||||
1406610|NCT02206490|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1406611|NCT02206477|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406612|NCT02206464|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406613|NCT02206451|||Case-Only||Prospective|||||||
1406614|NCT02206438|Randomized|Parallel Assignment||||Double|||t|||t
1406615|NCT02206425|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406616|NCT02206412|||Case-Only||Prospective|||||||
1406617|NCT02206399|||Case-Only||Cross-Sectional|||||||
1406618|NCT02206386|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1406619|NCT02206373|||Cohort||Cross-Sectional|||||||
1406620|NCT02206360|||Other||Prospective|||||||
1406621|NCT02206347||Single Group Assignment||||None (Open Label)||||||
1406622|NCT02206334||Single Group Assignment||Treatment||None (Open Label)||||||
1406623|NCT02206321|||Cohort||Prospective|||||||
1406624|NCT02206308||Single Group Assignment||Treatment||None (Open Label)||||||
1406625|NCT02206295|Randomized|Crossover Assignment||||None (Open Label)||||||
1406626|NCT02206282|||Cohort||Prospective|||||||
1406627|NCT02206269|||Cohort||Prospective|||||||
1406628|NCT02206256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406629|NCT02206243|||Case-Only||Prospective|||||||
1406630|NCT02206230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406631|NCT02206217|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406632|NCT02206204|Randomized|Parallel Assignment||||Triple|||t||t|t
1406633|NCT02206191|||Case-Only||Cross-Sectional|||||||
1406634|NCT02206178|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1406635|NCT02206165|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1406636|NCT02206152|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1406637|NCT02206139|||Ecologic or Community||Cross-Sectional|||||||
1406638|NCT02206126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406639|NCT02206113|Randomized|Single Group Assignment||||None (Open Label)||||||
1406640|NCT02206100|Randomized|Sequential Assignment||Other||Single|||t|||
1406641|NCT02206087|Randomized|Sequential Assignment||Other||Single|||t|||
1406642|NCT02206074|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1406643|NCT02206061|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1406644|NCT02206048||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406645|NCT02206035||Single Group Assignment||Prevention||None (Open Label)||||||
1406646|NCT02206022|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1406647|NCT02206009||Single Group Assignment||Treatment||None (Open Label)||||||
1406648|NCT02205996|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1406649|NCT02205983|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1406650|NCT02205970|Randomized|Parallel Assignment||Treatment||Double|one arm study||t|||t
1406651|NCT02205957|||Cohort||Cross-Sectional|||||||
1406652|NCT02205944|Randomized|Parallel Assignment||Treatment||Double||||t||t
1406653|NCT02205931|Randomized|Parallel Assignment||Treatment||Single||||||t
1406654|NCT02205918|||Case-Only||Cross-Sectional|||||||
1406655|NCT02205905||Single Group Assignment||Basic Science||None (Open Label)||||||
1406656|NCT02205892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406657|NCT02205879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406658|NCT02205866|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1406659|NCT02205853|Non-Randomized|Parallel Assignment||Health Services Research||||||||
1406660|NCT02205840|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406661|NCT02205827||Single Group Assignment||||None (Open Label)||||||
1406662|NCT02205814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406663|NCT02205801|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1406664|NCT02205788|||Case Control||Prospective|||||||
1406665|NCT02205775|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406666|NCT02205762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406667|NCT02205749|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1406668|NCT02205736||Single Group Assignment||Health Services Research||None (Open Label)||||||
1406669|NCT02205723|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406670|NCT02205710|Randomized|Parallel Assignment||||Triple|||t||t|t
1406671|NCT02205697||Single Group Assignment||||None (Open Label)||||||
1406672|NCT02205684|Randomized|Parallel Assignment||Treatment||Single||||||t
1406673|NCT02205671||Single Group Assignment||Prevention||None (Open Label)||||||
1406674|NCT02205658|||Case Control||Cross-Sectional|||||||
1406675|NCT02205645||Single Group Assignment||Treatment||None (Open Label)||||||
1406676|NCT02205632|Non-Randomized|||||None (Open Label)||||||
1406677|NCT02205619|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1406678|NCT02205606|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406679|NCT02205593|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406680|NCT02205580|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406681|NCT02205567|||Case-Only||Prospective|||||||
1406682|NCT02205554|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1406683|NCT02205541|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406684|NCT02205528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406685|NCT02205515||Single Group Assignment||Treatment||None (Open Label)||||||
1406686|NCT02205502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406687|NCT02205489||Single Group Assignment||Treatment||None (Open Label)||||||
1406688|NCT02205476|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406689|NCT02205463||Single Group Assignment||Treatment||None (Open Label)||||||
1406690|NCT02205450|||Cohort||Prospective|||||||
1406691|NCT02205437|||Case-Control||Cross-Sectional|||||||
1406692|NCT02205424|||Case-Control||Prospective|||||||
1406693|NCT02205411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406694|NCT02205398||Single Group Assignment||Treatment||None (Open Label)||||||
1406695|NCT02205385|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406696|NCT02205372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406697|NCT02205359|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406698|NCT02205346|||Cohort||Prospective|||||||
1406699|NCT02205333|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406700|NCT02205320|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1406701|NCT02205307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406702|NCT02205294|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406703|NCT02205281|Randomized|Parallel Assignment||Prevention||Single||||||t
1406704|NCT02205268||Single Group Assignment||Treatment||None (Open Label)||||||
1406705|NCT02205255|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406706|NCT02205242|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406707|NCT02205229|||Cohort||Prospective|||||||
1406708|NCT02205216|Randomized|Parallel Assignment||||Triple|||t|t||t
1406709|NCT02205203|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1406710|NCT02205190|Randomized|Crossover Assignment||||None (Open Label)||||||
1406711|NCT02205177|Randomized|Parallel Assignment||Treatment||Single||||||t
1406712|NCT02205164|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406713|NCT02205151|Randomized|Crossover Assignment||||None (Open Label)||||||
1406714|NCT02205138||Single Group Assignment||Treatment||None (Open Label)||||||
1406715|NCT02205125|||Cohort||Prospective|||||||
1406716|NCT02205112|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406717|NCT02205099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406718|NCT02205086||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406719|NCT02205073|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1406720|NCT02205060|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406721|NCT02205047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406722|NCT02205034|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406723|NCT02205021|||Cohort||Retrospective|||||||
1406724|NCT02205008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406725|NCT02204995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406726|NCT02204982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406727|NCT02204969|Randomized|Single Group Assignment||Treatment||Single|||||t|
1406728|NCT02204956|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1406729|NCT02204943||Single Group Assignment||Basic Science||None (Open Label)||||||
1406730|NCT02204930||Single Group Assignment||Supportive Care||None (Open Label)||||||
1406731|NCT02204917||Single Group Assignment||Diagnostic||None (Open Label)||Comparative performance of contrast enhanced Voiding Urosonography (ceVUS) and Voiding Cystourethrography (VCUG) in the same participant and in the same session.||||
1406732|NCT02204904|||Cohort||Other|||||||
1406733|NCT02204891|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406734|NCT02204878|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1406735|NCT02204865|||Cohort||Prospective|||||||
1406736|NCT02204852|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1406737|NCT02204839||Single Group Assignment||Basic Science||None (Open Label)||||||
1406738|NCT02204826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406739|NCT02204813||Crossover Assignment||Basic Science||Single||Patients with prior RYGB surgery receive all interventions, each on a separate day.|t|||
1406740|NCT02204800|||Other||Prospective|||||||
1406741|NCT02204787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406742|NCT02204774|||Cohort||Prospective|||||||
1406743|NCT02204761||Single Group Assignment||Treatment||None (Open Label)||||||
1406744|NCT02204748|||Case-Only||Cross-Sectional|||||||
1406745|NCT02204735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406746|NCT02204722|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406747|NCT02204709|Randomized|Crossover Assignment||Other||Double|||t||t|
1406748|NCT02204696|||Cohort||Prospective|||||||
1406749|NCT02204683|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1406750|NCT02204670|||Cohort||Prospective|||||||
1406751|NCT02204657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406752|NCT02204644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406753|NCT02204631|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406754|NCT02204618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406755|NCT02204605|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1406756|NCT02204592|||||Cross-Sectional|||||||
1406757|NCT02204579||Single Group Assignment||Treatment||None (Open Label)||||||
1406758|NCT02204566||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406759|NCT02204553||||||||||||
1406760|NCT02204540|Randomized|Crossover Assignment||||None (Open Label)||||||
1406761|NCT02204527|Randomized|Parallel Assignment||Treatment||Double||"This study was a randomized, double-blind, placebo-controlled clinical trial on 40 outpatients with hypertension and type 2 diabetes were recruited.~Patients were allocated into two equal groups of 20 by computer-generated randomly permutated codes. the subjects were randomly assigned to 1 of 2 groups: Group 1 received a single dose (100.000 IU) of oral supplementation with cholecalciferol (vitamin D3). Group 2 received matching placebo capsules containing microcrystalline cellulose."|t||t|
1406762|NCT02204514|||Cohort||Retrospective|||||||
1406763|NCT02204501|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1406764|NCT02204488|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406765|NCT02204475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406766|NCT02204462||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406767|NCT02204449|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1406768|NCT02204436||Single Group Assignment||Treatment||None (Open Label)||||||
1406769|NCT02204423||Single Group Assignment||Prevention||None (Open Label)||||||
1406770|NCT02204410||Single Group Assignment||Treatment||None (Open Label)||||||
1406771|NCT02204397||Single Group Assignment||Treatment||None (Open Label)||||||
1406772|NCT02204384|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1406773|NCT02204371|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406774|NCT02204358||Single Group Assignment||Treatment||None (Open Label)||||||
1406775|NCT02204345||Single Group Assignment||Treatment||None (Open Label)||||||
1406776|NCT02204332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406777|NCT02204319||Single Group Assignment||Treatment||None (Open Label)||||||
1406778|NCT02204306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406779|NCT02204293|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406780|NCT02204280|||Case Control||Cross-Sectional|||||||
1406781|NCT02204267|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1406782|NCT02204254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406783|NCT02204241||Single Group Assignment||Treatment||None (Open Label)||||||
1406784|NCT02204228|||Cohort||Prospective|||||||
1406785|NCT02204215||Single Group Assignment||Treatment||None (Open Label)||||||
1406786|NCT02204202|||Cohort||Cross-Sectional|||||||
1406787|NCT02204189||Single Group Assignment||Treatment||Single|||t|||
1406788|NCT02204176|Randomized|Parallel Assignment||||None (Open Label)||||||
1406789|NCT02204163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406790|NCT02204150||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406791|NCT02204137|||Cohort||Prospective|||||||
1406792|NCT02204124|Randomized|Parallel Assignment||Treatment||Single|The participants will be blinded to the assigned operating technique.||t|||
1406793|NCT02204111|||Case-Control||Prospective|||||||
1406794|NCT02204098|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406795|NCT02204085|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406796|NCT02204072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406797|NCT02204059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406798|NCT02204046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406799|NCT02204033|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406800|NCT02204020||Single Group Assignment||Treatment||None (Open Label)||||||
1406801|NCT02204007|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406802|NCT02203994||Single Group Assignment||Treatment||None (Open Label)||||||
1406803|NCT02203981|||Cohort||Prospective|||||||
1406804|NCT02203968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406805|NCT02203955|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1406806|NCT02203942|||Case-Only|||||||||
1406807|NCT02203929|||Cohort||Prospective|||||||
1406808|NCT02203916|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406809|NCT02203903||Single Group Assignment||Treatment||None (Open Label)||||||
1406810|NCT02203890|||Cohort||Cross-Sectional|||||||
1406811|NCT02203877|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406812|NCT02203864||Parallel Assignment||Treatment||None (Open Label)||||||
1406813|NCT02203851||Single Group Assignment||Treatment||None (Open Label)||||||
1406814|NCT02203838||Single Group Assignment||Treatment||None (Open Label)||||||
1406815|NCT02203825||Single Group Assignment||Treatment||None (Open Label)||||||
1406816|NCT02203812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406817|NCT02203799||Single Group Assignment||Treatment||None (Open Label)||||||
1406818|NCT02203786|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1406819|NCT02203773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406820|NCT02203760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406821|NCT02203747|||Case Control||Prospective|||||||
1406822|NCT02203734|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1406823|NCT02203721|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1406824|NCT02203708|Randomized|Parallel Assignment||Prevention||Single||||||t
1406825|NCT02203695|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406826|NCT02203682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406827|NCT02203669|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406828|NCT02203656|Randomized|Factorial Assignment||Treatment||Single|||t|||
1406829|NCT02203643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406830|NCT02203630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406831|NCT02203617|Randomized|Single Group Assignment||Prevention||Double||||t||t
1406832|NCT02203604||Single Group Assignment||Treatment||None (Open Label)||||||
1406833|NCT02203591|Randomized|Parallel Assignment||Prevention||Single||||||t
1406834|NCT02203578||Single Group Assignment||Supportive Care||None (Open Label)||||||
1406835|NCT02203565||Single Group Assignment||Supportive Care||None (Open Label)||||||
1406836|NCT02203552|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1406837|NCT02203539|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1406838|NCT02203526||Sequential Assignment||Treatment||None (Open Label)||||||
1406839|NCT02203513||Single Group Assignment||Treatment||None (Open Label)||||||
1406840|NCT02203500|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406841|NCT02203487|Randomized|Parallel Assignment||Treatment||Double||||||
1406842|NCT02203474|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406843|NCT02203461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406844|NCT02203448|||Cohort||Prospective|||||||
1406845|NCT02203435|||||Retrospective|||||||
1406846|NCT02203422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406847|NCT02203409|||Cohort||Prospective|||||||
1406848|NCT02203396||Single Group Assignment||Treatment||None (Open Label)||||||
1406849|NCT02203383|||Case Control||Prospective|||||||
1406850|NCT02203370|||Case-Only||Prospective|||||||
1406851|NCT02203357|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406852|NCT02203344|||||Prospective|||||||
1406853|NCT02203331|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406854|NCT02203318|||Case Control||Prospective|||||||
1406855|NCT02203305|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406856|NCT02203292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406857|NCT02203279|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406858|NCT02203266|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1406859|NCT02203253|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1406860|NCT02203240|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1406861|NCT02203227|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406862|NCT02203214|||Case-Only||Prospective|||||||
1406863|NCT02203201|||Case-Control||Prospective|||||||
1406864|NCT02203188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406865|NCT02203175|Randomized|Single Group Assignment||Prevention||Double|||||t|t
1406866|NCT02203162||Single Group Assignment||Other||None (Open Label)||||||
1406867|NCT02203149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406868|NCT02203136|||Cohort||Prospective|||||||
1406869|NCT02203123||Single Group Assignment||Treatment||None (Open Label)||||||
1406870|NCT02203110|||Cohort||Prospective|||||||
1406871|NCT02203097||Single Group Assignment||Basic Science||None (Open Label)||||||
1406873|NCT02203071|||Cohort||Prospective|||||||
1406874|NCT02203058|Randomized|Crossover Assignment||||None (Open Label)||||||
1406875|NCT02203045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406876|NCT02203032|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1406877|NCT02203019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406878|NCT02203006||Single Group Assignment||Other||None (Open Label)||||||
1406879|NCT02202993||Single Group Assignment||Treatment||None (Open Label)||||||
1406880|NCT02202980|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406881|NCT02202967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406882|NCT02202954|Randomized|Parallel Assignment||Treatment||Single||||||t
1406883|NCT02202941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406884|NCT02202928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406885|NCT02202915||Single Group Assignment||Other||None (Open Label)||||||
1406886|NCT02202902|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1406887|NCT02202889||Single Group Assignment||Prevention||None (Open Label)||||||
1406888|NCT02202876|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406889|NCT02202863|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406890|NCT02202850|||Cohort||Prospective|||||||
1406891|NCT02202837|||Cohort||Prospective|||||||
1406892|NCT02202824|Randomized|Parallel Assignment||||Double|||t|||t
1406893|NCT02202811|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1406894|NCT02202798|||Cohort||Prospective|||||||
1406895|NCT02202785||Single Group Assignment||Treatment||None (Open Label)||||||
1406896|NCT02202772|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406897|NCT02202759||Single Group Assignment||Treatment||None (Open Label)||||||
1406898|NCT02202746|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406899|NCT02202733||Single Group Assignment||||None (Open Label)||||||
1406900|NCT02202720||Single Group Assignment||Treatment||None (Open Label)||||||
1406901|NCT02202707||Single Group Assignment||Treatment||None (Open Label)||||||
1406902|NCT02202694|Randomized|Parallel Assignment||Treatment||Single||||||t
1406903|NCT02202681||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406904|NCT02202668||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1406905|NCT02202655|||Case-Only||Prospective|||||||
1406906|NCT02202642||Single Group Assignment||Treatment||None (Open Label)||||||
1406907|NCT02202629|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1406908|NCT02202616||Single Group Assignment||Treatment||None (Open Label)||||||
1406909|NCT02202603|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1406910|NCT02202590||Single Group Assignment||Screening||None (Open Label)||||||
1406911|NCT02202577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406912|NCT02202564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406913|NCT02202551||Single Group Assignment||Treatment||None (Open Label)||||||
1406914|NCT02202538||Single Group Assignment||Treatment||None (Open Label)||||||
1406915|NCT02202525|||Cohort||Prospective|||||||
1406916|NCT02202512|Randomized|Parallel Assignment||Treatment||Single||||||
1406917|NCT02202499|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406918|NCT02202486|||Case Control||Cross-Sectional|||||||
1406919|NCT02202473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406920|NCT02202460|||Case Control||Prospective|||||||
1406921|NCT02202447||Single Group Assignment||Treatment||None (Open Label)||||||
1406922|NCT02202434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406923|NCT02202421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406924|NCT02202408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406925|NCT02202395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406926|NCT02202382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406927|NCT02202369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406928|NCT02202356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406929|NCT02202343|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1406930|NCT02202330|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1406931|NCT02202317||Single Group Assignment||Screening||None (Open Label)||||||
1406932|NCT02202304|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1406933|NCT02202291||Single Group Assignment||Other||None (Open Label)||||||
1406934|NCT02202278|||Case Control||Prospective|||||||
1406935|NCT02202265|Randomized|Parallel Assignment||Treatment||Single||||||t
1406936|NCT02202252|Randomized|Parallel Assignment||Treatment||Single||||||t
1406937|NCT02202239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406938|NCT02202226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406939|NCT02202213|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406940|NCT02202200||Single Group Assignment||Treatment||None (Open Label)||||||
1406941|NCT02202187|Randomized|Parallel Assignment||Other||Single|||t|||
1406942|NCT02202174|||Cohort||Prospective|||||||
1406943|NCT02202161|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406944|NCT02202148|||Cohort||Prospective|||||||
1406945|NCT02202135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406946|NCT02202122|||Cohort||Prospective|||||||
1406947|NCT02202109|Randomized|Parallel Assignment||Screening||Single||||||t
1406948|NCT02202096|Randomized|Parallel Assignment||||||||||
1406949|NCT02202083|Randomized|Single Group Assignment||||Double||||t|t|
1406950|NCT02202070|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1406951|NCT02202057|||Case Control||Prospective|||||||
1406952|NCT02202044||Single Group Assignment||Treatment||None (Open Label)||||||
1406953|NCT02202031|Randomized|Parallel Assignment||Treatment||Single||||||t
1406954|NCT02202018|Randomized|Parallel Assignment||Other||Single||||||t
1406955|NCT02202005|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1406956|NCT02201992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406957|NCT02201979|||Case-Only||Prospective|||||||
1406958|NCT02201966|||Cohort||Cross-Sectional|||||||
1406959|NCT02201953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406960|NCT02201940|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406961|NCT02201927|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1406962|NCT02201914|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406963|NCT02201901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406964|NCT02201888|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406965|NCT02201875|||Cohort|||||||||
1406966|NCT02201862|||Case Control||Prospective|||||||
1406967|NCT02201849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1406968|NCT02201836|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1406969|NCT02201823||Single Group Assignment||Treatment||None (Open Label)||||||
1406970|NCT02201810|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406971|NCT02201797||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406972|NCT02201784|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1406973|NCT02201771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406974|NCT02201758|Randomized|Parallel Assignment||Treatment||Double||Flaxseed Lignan-Enriched Complex (FLC) vs. placebo|t|t||
1406975|NCT02201732|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406976|NCT02201719|||Case-Control||Prospective|||||||
1406977|NCT02201706||Single Group Assignment||Treatment||None (Open Label)||||||
1406978|NCT02201693|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1406979|NCT02201680|||Cohort||Prospective|||||||
1406980|NCT02201667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406981|NCT02201654||Single Group Assignment||Diagnostic||None (Open Label)||||||
1406982|NCT02201641|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406983|NCT02201628||Single Group Assignment||Supportive Care||None (Open Label)||||||
1406984|NCT02201615|Randomized|Parallel Assignment||Prevention||Single||||t||
1406985|NCT02201602|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1406986|NCT02201589||Single Group Assignment||Treatment||None (Open Label)||||||
1406987|NCT02201576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406988|NCT02201563||Single Group Assignment||Treatment||None (Open Label)||||||
1406989|NCT02201550|||Case-Only||Prospective|||||||
1406990|NCT02201537||Single Group Assignment||Screening||None (Open Label)||||||
1406991|NCT02201524|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1406992|NCT02201511|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1406993|NCT02201498|Randomized|Parallel Assignment||Treatment||Single|||t|||
1406994|NCT02201485|Randomized|Parallel Assignment||Treatment||Single||||t||
1406995|NCT02201472||Single Group Assignment||Diagnostic||None (Open Label)||Magnetic resonance elastography on infants with suspected liver disease||||
1406996|NCT02201459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1406997|NCT02201446|||Case Control||Prospective|||||||
1406998|NCT02201433|||Cohort||Prospective|||||||
1406999|NCT02201420||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407000|NCT02201407|||Cohort||Prospective|||||||
1407001|NCT02201394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407002|NCT02201381||Single Group Assignment||Treatment||None (Open Label)||Matched historical control comparison||||
1407003|NCT02201368|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407004|NCT02201355||Single Group Assignment||Treatment||None (Open Label)||||||
1407005|NCT02201342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407006|NCT02201329||Single Group Assignment||Treatment||None (Open Label)||||||
1407007|NCT02201316|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407008|NCT02201303|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1407009|NCT02201290||Single Group Assignment||Treatment||None (Open Label)||||||
1407010|NCT02201277|Randomized|Parallel Assignment||Basic Science||Single||||||t
1407011|NCT02201264|||Other||Prospective|||||||
1407012|NCT02201251|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407013|NCT02201238|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1407014|NCT02201225|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1407015|NCT02201212||Single Group Assignment||Treatment||None (Open Label)||||||
1407016|NCT02201199|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1407017|NCT02201186||Single Group Assignment||Treatment||None (Open Label)||||||
1407018|NCT02201173||Single Group Assignment||Treatment||None (Open Label)||||||
1407019|NCT02201160|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407020|NCT02201147|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1407021|NCT02201134||Single Group Assignment||Treatment||None (Open Label)||||||
1407022|NCT02201121||Single Group Assignment||||Single|||t|||
1407023|NCT02201108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407024|NCT02201095|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1407025|NCT02201082|Randomized|Parallel Assignment||Treatment||Single||||||t
1407026|NCT02201069||Single Group Assignment||Health Services Research||None (Open Label)||||||
1407027|NCT02201056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407028|NCT02201043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407029|NCT02201030|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1407030|NCT02201017|||Cohort||Prospective|||||||
1407031|NCT02201004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407032|NCT02200991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407033|NCT02200978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407034|NCT02200965|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407035|NCT02200952|||||Prospective|||||||
1407036|NCT02200939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407037|NCT02200926|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407038|NCT02200913|Randomized|Parallel Assignment||Treatment||Single|||||t|
1407039|NCT02200900|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1407040|NCT02200887|||Case-Control||Cross-Sectional|||||||
1407041|NCT02200874|||Case Control||Prospective|||||||
1407042|NCT02200861|||||Retrospective|||||||
1407043|NCT02200848||Single Group Assignment||Treatment||None (Open Label)||||||
1407044|NCT02200835|||Cohort||Retrospective|||||||
1407045|NCT02200822|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1407046|NCT02200809||Single Group Assignment||Treatment||None (Open Label)||||||
1407047|NCT02200796|Randomized|Crossover Assignment||Prevention||Single|||t|||
1407048|NCT02200783|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407049|NCT02200770|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1407050|NCT02200757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407051|NCT02200744|||Cohort||Prospective|||||||
1407052|NCT02200731|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407053|NCT02200718|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407054|NCT02200705||Single Group Assignment||Treatment||None (Open Label)||||||
1407055|NCT02200692|||Cohort||Prospective|||||||
1407056|NCT02200679|||Other||Cross-Sectional|||||||
1407057|NCT02200666|||Cohort||Prospective|||||||
1407058|NCT02200653|Randomized|Parallel Assignment||Treatment||Double||||||
1407059|NCT02200640|Randomized|Parallel Assignment||Treatment||Double||||||
1407060|NCT02200627|||Cohort||Retrospective|||||||
1407061|NCT02200614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407062|NCT02200601||Single Group Assignment||Treatment||None (Open Label)||||||
1407063|NCT02200588|||Case-Control||Cross-Sectional|||||||
1407064|NCT02200575|||Cohort||Prospective|||||||
1407065|NCT02200562||Single Group Assignment||Treatment||None (Open Label)||||||
1407066|NCT02200549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407067|NCT02200536|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407068|NCT02200523|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1407069|NCT02200510|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407070|NCT02200484|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407071|NCT02200471||Single Group Assignment||Supportive Care||None (Open Label)||||||
1407072|NCT02200458||Single Group Assignment||Basic Science||None (Open Label)||||||
1407073|NCT02200445||Single Group Assignment||Treatment||None (Open Label)||||||
1407074|NCT02200432|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407075|NCT02200419||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407076|NCT02200406||Single Group Assignment||Treatment||None (Open Label)||||||
1407077|NCT02200393||Single Group Assignment||Treatment||None (Open Label)||||||
1407078|NCT02200380|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407079|NCT02200367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407080|NCT02200354||Single Group Assignment||Treatment||None (Open Label)||||||
1407081|NCT02200341|Randomized|Parallel Assignment||Basic Science||Single||||||t
1407082|NCT02200328|Randomized|Parallel Assignment||Prevention||Single||||t||
1407083|NCT02200315||Single Group Assignment||Treatment||None (Open Label)||||||
1407084|NCT02200302|||Cohort||Prospective|||||||
1407085|NCT02200289|||Cohort||Prospective|||||||
1407086|NCT02200276||Single Group Assignment||Prevention||None (Open Label)||||||
1407087|NCT02200263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407088|NCT02200250|||Cohort||Retrospective|||||||
1407089|NCT02200237|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1407090|NCT02200224|Randomized|Parallel Assignment||||None (Open Label)||||||
1407091|NCT02200211|Randomized|Parallel Assignment||Treatment||Single||||||t
1407092|NCT02200198|Randomized|Parallel Assignment||Prevention||Single||||||t
1407093|NCT02200185|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1407094|NCT02200172|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1407095|NCT02200159|||Cohort|||||||||
1407096|NCT02200146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407097|NCT02200133|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407098|NCT02200120|||Cohort||Prospective|||||||
1407099|NCT02200107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407100|NCT02200094|||Cohort||Prospective|||||||
1407101|NCT02200081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407102|NCT02200068|Randomized|Parallel Assignment||||Single|||t|||
1407103|NCT02200055||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407104|NCT02200042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407105|NCT02200029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407106|NCT02200016|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1407107|NCT02200003|Randomized|Single Group Assignment||Treatment||Triple||RCT of Attention Bias Modification|t||t|t
1407108|NCT02199990|||Case Control||Prospective|||||||
1407109|NCT02199977|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407110|NCT02199964|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1407111|NCT02199951|||Cohort||Prospective|||||||
1407112|NCT02199938|||Cohort||Prospective|||||||
1407113|NCT02199925||Single Group Assignment||Treatment||None (Open Label)||||||
1407114|NCT02199912||Single Group Assignment||Other||None (Open Label)||||||
1407115|NCT02199899|Randomized|Parallel Assignment||Treatment||Double||||||
1407116|NCT02199886||Single Group Assignment||Treatment||None (Open Label)||||||
1407117|NCT02199873|Randomized|Single Group Assignment||Treatment||Double||||||
1407118|NCT02199860|Randomized|Single Group Assignment||Treatment||Double||||||
1407119|NCT02199847|Randomized|Parallel Assignment||Treatment||Double||||||
1407120|NCT02199834|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1407121|NCT02199821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407122|NCT02199808|||Cohort||Cross-Sectional|||||||
1407123|NCT02199795|Randomized|Parallel Assignment||Treatment||Single||||||t
1407124|NCT02199782|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1407125|NCT02199769|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407126|NCT02199756|||Cohort||Prospective|||||||
1407127|NCT02199743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407128|NCT02199717|||Cohort||Prospective|||||||
1407129|NCT02199704||Single Group Assignment||||None (Open Label)||||||
1407130|NCT02199691|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407131|NCT02199678|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407132|NCT02199665||Single Group Assignment||Treatment||None (Open Label)||||||
1407133|NCT02199652|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407134|NCT02199639|||Cohort||Prospective|||||||
1407135|NCT02199626||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407136|NCT02199613||Single Group Assignment||Treatment||None (Open Label)||||||
1407137|NCT02199600||Single Group Assignment||Treatment||None (Open Label)||||||
1407138|NCT02199587|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1407139|NCT02199574||Single Group Assignment||Treatment||None (Open Label)||||||
1407140|NCT02199561||Single Group Assignment||Treatment||None (Open Label)||||||
1407141|NCT02199548|||Cohort||Prospective|||||||
1407142|NCT02199535|||||Prospective|||||||
1407143|NCT02199522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407144|NCT02199509|Randomized|Crossover Assignment||Other||Double|||t||t|
1407145|NCT02199496|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407146|NCT02199483|||Cohort||Prospective|||||||
1407147|NCT02199470|||Case Control||Prospective|||||||
1407148|NCT02199457||Single Group Assignment||Other||None (Open Label)||||||
1407149|NCT02199444|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407150|NCT02199431|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407151|NCT02199418||Single Group Assignment||Treatment||None (Open Label)||||||
1407152|NCT02199405|Randomized|Parallel Assignment||Treatment||Single||||||t
1407153|NCT02199392||Single Group Assignment||Treatment||None (Open Label)||||||
1407154|NCT02199379|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407155|NCT02199366|||Cohort||Prospective|||||||
1407156|NCT02199353|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407157|NCT02199340|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1407158|NCT02199327|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407159|NCT02199314|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1407160|NCT02199301||Single Group Assignment||Treatment||None (Open Label)||||||
1407161|NCT02199288|||Cohort||Prospective|||||||
1407162|NCT02199275|||Case-Only||Prospective|||||||
1407163|NCT02199262|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407164|NCT02199249|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407165|NCT02199236||Single Group Assignment||Treatment||None (Open Label)||||||
1407166|NCT02199223||Single Group Assignment||Treatment||None (Open Label)||||||
1407167|NCT02199210|Randomized|Parallel Assignment||||Double|||t|||t
1407168|NCT02199197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407169|NCT02199184|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407170|NCT02199171||Single Group Assignment||Treatment||None (Open Label)||||||
1407171|NCT02199158||Single Group Assignment||Treatment||Single||||||t
1407172|NCT02199145||Single Group Assignment||Basic Science||None (Open Label)||||||
1407173|NCT02199132|||Case-Only||Retrospective|||||||
1407174|NCT02199119|Randomized|Crossover Assignment||Prevention||Single|||t|||
1407175|NCT02199106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407176|NCT02199093|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1407177|NCT02199080||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407178|NCT02199067|||Case-Only||Prospective|||||||
1407179|NCT02199054|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1407180|NCT02199041||Single Group Assignment||Treatment||None (Open Label)||||||
1407181|NCT02199028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407182|NCT02199015||Single Group Assignment||Treatment||None (Open Label)||||||
1407183|NCT02199002|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1407184|NCT02198989|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407185|NCT02198976|||Cohort||Prospective|||||||
1407186|NCT02198963|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1407187|NCT02198950|||Cohort||Prospective|||||||
1407188|NCT02198937|||Case Control||Cross-Sectional|||||||
1407189|NCT02198924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407190|NCT02198911|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1407191|NCT02198898|Randomized|Parallel Assignment||Prevention||Single|||t|||
1407192|NCT02198885|||Case-Only||Prospective|||||||
1407193|NCT02198872|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1407194|NCT02198859||Single Group Assignment||Treatment||None (Open Label)||||||
1407195|NCT02198846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407196|NCT02198833|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1407197|NCT02198820|||Cohort||Prospective|||||||
1407198|NCT02198807||Single Group Assignment||Treatment||None (Open Label)||||||
1407199|NCT02198794|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1407200|NCT02198781|||Cohort||Prospective|||||||
1407201|NCT02198768|||Cohort||Prospective|||||||
1407202|NCT02198755|Non-Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1407203|NCT02198742|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1407204|NCT02198729|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407205|NCT02198716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407206|NCT02198703|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1407207|NCT02198690|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1407208|NCT02198677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407209|NCT02198664||Single Group Assignment||Treatment||None (Open Label)||||||
1407210|NCT02198651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407211|NCT02198638||Single Group Assignment||Prevention||None (Open Label)||||||
1407212|NCT02198625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407213|NCT02198612||Single Group Assignment||||None (Open Label)||||||
1407214|NCT02198599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407215|NCT02198586|||Cohort||Prospective|||||||
1407216|NCT02198573|||||Prospective|||||||
1407217|NCT02198560|||Cohort||Prospective|||||||
1407218|NCT02198547|Randomized|Single Group Assignment||||None (Open Label)||||||
1407219|NCT02198534|||Cohort||Prospective|||||||
1407220|NCT02198521|||Cohort||Prospective|||||||
1407221|NCT02198508|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407222|NCT02198495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407223|NCT02198482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407224|NCT02198469|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1407225|NCT02198456|||Cohort||Prospective|||||||
1407226|NCT02198443|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407227|NCT02198430|||Cohort||Prospective|||||||
1407228|NCT02198417||Single Group Assignment||Basic Science||None (Open Label)||||||
1407229|NCT02198404||Single Group Assignment||Treatment||None (Open Label)||||||
1407230|NCT02198391|||Cohort||Prospective|||||||
1407231|NCT02198378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407232|NCT02198365|||Case Control||Prospective|||||||
1407233|NCT02198352|Randomized|Parallel Assignment||Treatment||Double||||||
1407234|NCT02198339|Randomized|Parallel Assignment||Treatment||Double||||||
1407235|NCT02198326|Randomized|Parallel Assignment||Treatment||Double||||||
1407236|NCT02198313|Randomized|Parallel Assignment||Treatment||Double||||||
1407237|NCT02198300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407238|NCT02198287|Randomized|Parallel Assignment||Treatment||Double||||||
1407239|NCT02198274||Single Group Assignment||Treatment||None (Open Label)||||||
1407240|NCT02198261|||Case-Control||Prospective|||||||
1407241|NCT02198248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407242|NCT02198235|Randomized|Parallel Assignment||Other||Double|||t|||t
1407243|NCT02198209||Single Group Assignment||Basic Science||None (Open Label)||||||
1407244|NCT02198196|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407245|NCT02198183|||Cohort||Prospective|||||||
1407246|NCT02198170|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407247|NCT02198157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407248|NCT02198144||Single Group Assignment||Treatment||None (Open Label)||||||
1407249|NCT02198131||Single Group Assignment||Supportive Care||None (Open Label)||||||
1407250|NCT02198118|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407251|NCT02198105|||Cohort||Prospective|||||||
1407252|NCT02198092|||Case-Control||Prospective|||||||
1407253|NCT02198079|||Case-Only||Prospective|||||||
1407254|NCT02198066|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407255|NCT02198053|||Case Control||Prospective|||||||
1407256|NCT02198040|Randomized|Parallel Assignment||Treatment||Single||||||t
1407257|NCT02198027|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1407258|NCT02198014|Randomized|Parallel Assignment||Treatment||Single||||||t
1407259|NCT02198001|Randomized|Parallel Assignment||Prevention||Single||||||t
1407260|NCT02197988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407261|NCT02197975|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1407262|NCT02197962|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407263|NCT02197949|||Cohort||Prospective|||||||
1407264|NCT02197936|||Case-Control||Prospective|||||||
1407265|NCT02197923|||Case-Control||Prospective|||||||
1407266|NCT02197910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407267|NCT02197897||Single Group Assignment||Treatment||None (Open Label)||||||
1407268|NCT02197884|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407269|NCT02197871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407270|NCT02197858|||Case-Only||Prospective|||||||
1407271|NCT02197845|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1407272|NCT02197832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407273|NCT02197819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407274|NCT02197806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407275|NCT02197793|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1407276|NCT02197780|||Cohort||Prospective|||||||
1407277|NCT02197767||Single Group Assignment||Treatment||None (Open Label)||||||
1407278|NCT02197754||Parallel Assignment||Prevention||None (Open Label)||||||
1407279|NCT02197741|||Case-Crossover||Prospective|||||||
1407280|NCT02197728|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407281|NCT02197715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407282|NCT02197702|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1407283|NCT02197689|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1407284|NCT02197676||Single Group Assignment||Treatment||None (Open Label)||||||
1407285|NCT02197663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407286|NCT02197650||||||||||||
1407287|NCT02197637||Single Group Assignment||Treatment||None (Open Label)||||||
1407288|NCT02197624|||Case-Only||Prospective|||||||
1407289|NCT02197611|||Cohort||Cross-Sectional|||||||
1407290|NCT02197598||Single Group Assignment||Treatment||None (Open Label)||||||
1407291|NCT02197585|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407292|NCT02197572||Single Group Assignment||Treatment||None (Open Label)||||||
1407293|NCT02197559|||Cohort||Prospective|||||||
1407294|NCT02197546|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407295|NCT02197533|Randomized|Parallel Assignment||Treatment||Single||||||t
1407296|NCT02197520|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1407297|NCT02197507||Single Group Assignment||Supportive Care||None (Open Label)||||||
1407298|NCT02197494|Randomized|Crossover Assignment||||None (Open Label)||||||
1407299|NCT02197481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407300|NCT02197468|||Cohort||Prospective|||||||
1407301|NCT02197455||Single Group Assignment||Treatment||None (Open Label)||||||
1407302|NCT02197442|Randomized|Crossover Assignment||||None (Open Label)||||||
1407303|NCT02197429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407304|NCT02197416||Single Group Assignment||Prevention||None (Open Label)||||||
1407305|NCT02197403|Randomized|Parallel Assignment||Prevention||Single|||t|||
1407306|NCT02197390|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1407307|NCT02197377|Randomized|Parallel Assignment||Screening||Double|||||t|t
1407308|NCT02197364|||Cohort||Retrospective|||||||
1407309|NCT02197351||Single Group Assignment||Diagnostic||Single|||t|||
1407310|NCT02197338|Randomized|Factorial Assignment||Treatment||Single|||t|||
1407311|NCT02197325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407312|NCT02197312||Single Group Assignment||Treatment||None (Open Label)||||||
1407313|NCT02197299|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1407314|NCT02197286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407315|NCT02197273|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407316|NCT02197260|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1407317|NCT02197247||Single Group Assignment||Other||None (Open Label)||||||
1407318|NCT02197234||Single Group Assignment||Treatment||None (Open Label)||||||
1407319|NCT02197221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407320|NCT02197208|Randomized|Parallel Assignment||Treatment||Single||||||t
1407321|NCT02197195|Randomized|Crossover Assignment||Prevention||Single|||t|||
1407322|NCT02197182|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407323|NCT02197169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407324|NCT02197156|Randomized|Parallel Assignment||||Double|||t||t|
1407325|NCT02197143|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1407326|NCT02197130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407327|NCT02197117|Randomized|Parallel Assignment||Treatment||Single||||||t
1407328|NCT02197104||Single Group Assignment||Treatment||None (Open Label)||||||
1407329|NCT02197091|||Case-Only||Prospective|||||||
1407330|NCT02197078|||Cohort||Retrospective|||||||
1407331|NCT02197065|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1407332|NCT02197052|||Cohort||Cross-Sectional|||||||
1407333|NCT02197039|||Case Control||Prospective|||||||
1407334|NCT02197026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407335|NCT02197013|||Cohort||Prospective|||||||
1407336|NCT02197000||Single Group Assignment||Prevention||None (Open Label)||||||
1407337|NCT02196987|||Case Control||Prospective|||||||
1407338|NCT02196974||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407339|NCT02196961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407340|NCT02196948|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407341|NCT02196935|||Cohort||Prospective|||||||
1407342|NCT02196922|Randomized|Parallel Assignment||Prevention||None (Open Label)|Open label|||||
1407343|NCT02196909|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1407344|NCT02196896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407345|NCT02196883||Single Group Assignment||Diagnostic||Single||||||
1407346|NCT02196870|||Case Control||Prospective|||||||
1407347|NCT02196857||Single Group Assignment||Treatment||None (Open Label)||||||
1407348|NCT02196844|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407349|NCT02196831|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407350|NCT02196818|||Cohort||Prospective|||||||
1407351|NCT02196805|Randomized|Parallel Assignment||||None (Open Label)||||||
1407352|NCT02196792|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1407353|NCT02196779|||Case-Only||Prospective|||||||
1407354|NCT02196766|Randomized|Crossover Assignment||||Single|||t|||
1407355|NCT02196753|||Case Control||Prospective|||||||
1407356|NCT02196740|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407357|NCT02196727|||Cohort||Prospective|||||||
1407358|NCT02196714|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1407359|NCT02196701||Single Group Assignment||Treatment||None (Open Label)||||||
1407360|NCT02196688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407361|NCT02196675|||Cohort||Prospective|||||||
1407362|NCT02196662|Randomized|Crossover Assignment||||None (Open Label)||||||
1407363|NCT02196649|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407364|NCT02196636|Randomized|Parallel Assignment||||Double|||t||t|
1407365|NCT02196623|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407366|NCT02196610|||Case Control||Prospective|||||||
1407367|NCT02196597|||Cohort||Prospective|||||||
1407368|NCT02196584|||Case Control||Prospective|||||||
1407369|NCT02196571|Randomized|Parallel Assignment||Treatment||Single||||||t
1407370|NCT02196558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407371|NCT02196545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407372|NCT02196532|||Case Control||Retrospective|||||||
1407373|NCT02196519||Single Group Assignment||Treatment||None (Open Label)||||||
1407374|NCT02196506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407375|NCT02196493||Single Group Assignment||Treatment||None (Open Label)||||||
1407376|NCT02196480|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407377|NCT02196467|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1407378|NCT02196454|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1407379|NCT02196441|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1407380|NCT02196428||Single Group Assignment||Health Services Research||None (Open Label)||||||
1407381|NCT02196415|||Case-Only||Prospective|||||||
1407382|NCT02196402|||Cohort||Prospective|||||||
1407383|NCT02196389|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407384|NCT02196376|||Case-Only||Prospective|||||||
1407385|NCT02196363|||Cohort||Prospective|||||||
1407386|NCT02196350|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407387|NCT02196337|||||Cross-Sectional|||||||
1407388|NCT02196324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407389|NCT02196311|||Cohort||Prospective|||||||
1407390|NCT02196298|Randomized|Crossover Assignment||Treatment||Single||||||t
1407391|NCT02196285||Single Group Assignment||Prevention||None (Open Label)||||||
1407392|NCT02196272|Randomized|Parallel Assignment||Treatment||Single|||||t|
1407393|NCT02196259|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1407394|NCT02196246|||Case-Control||Prospective|||||||
1407395|NCT02196233|||Cohort||Prospective|||||||
1407396|NCT02196220|||Cohort||Prospective|||||||
1407397|NCT02196207||Single Group Assignment||Treatment||None (Open Label)||||||
1407398|NCT02196194|||Cohort||Retrospective|||||||
1407399|NCT02196181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407400|NCT02196168|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407401|NCT02196155|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407402|NCT02196142|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1407403|NCT02196129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407404|NCT02196116|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1407405|NCT02196103|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407406|NCT02196090||Single Group Assignment||Treatment||None (Open Label)||||||
1407407|NCT02196077|Randomized|Crossover Assignment||Treatment||Double|Double Blind||t||t|
1407408|NCT02196064|||Cohort||Retrospective|||||||
1407409|NCT02196051||Single Group Assignment||Basic Science||None (Open Label)||||||
1407410|NCT02196038|Randomized|Parallel Assignment||Treatment||Single||||||t
1407411|NCT02196025||Single Group Assignment||Treatment||None (Open Label)||||||
1407412|NCT02196012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407413|NCT02195999|||Cohort||Prospective|||||||
1407414|NCT02195986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407415|NCT02195973||Single Group Assignment||Treatment||None (Open Label)||||||
1407416|NCT02195960|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1407417|NCT02195947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407418|NCT02195934|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407419|NCT02195921|Randomized|Parallel Assignment||Treatment||Single||||||t
1407420|NCT02195908|Randomized|Parallel Assignment||Treatment||Single||||||t
1407421|NCT02195895||Single Group Assignment||Treatment||None (Open Label)||||||
1407422|NCT02195882||Single Group Assignment||Treatment||None (Open Label)||||||
1407423|NCT02195869|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407424|NCT02195856|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1407425|NCT02195843|Randomized|Parallel Assignment||||None (Open Label)||||||
1407426|NCT02195830||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407427|NCT02195817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407428|NCT02195804|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407429|NCT02195791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407430|NCT02195778|||||Cross-Sectional|||||||
1407431|NCT02195765|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1407432|NCT02195752|||Cohort||Prospective|||||||
1407433|NCT02195739|||Cohort||Retrospective|||||||
1407434|NCT02195726|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407435|NCT02195713|||Cohort||Prospective|||||||
1407436|NCT02195700|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1407437|NCT02195687|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1407438|NCT02195674|||Cohort||Prospective|||||||
1407439|NCT02195661|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1407440|NCT02195648|Randomized|Parallel Assignment||Treatment||Double|Outcome assessor will be blinded to group allocation. Additionally, analysis blinding will be performed to group allocation.||||t|t
1407441|NCT02195635|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407442|NCT02195622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407443|NCT02195609|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407444|NCT02195596|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1407445|NCT02195583|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1407446|NCT02195570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407447|NCT02195557|||Cohort||Prospective|||||||
1407448|NCT02195544|||Cohort||Prospective|||||||
1407449|NCT02195531|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407450|NCT02195518||Single Group Assignment||Treatment||None (Open Label)||||||
1407451|NCT02195505|||Cohort||Retrospective|||||||
1407452|NCT02195492|||Cohort||Retrospective|||||||
1407453|NCT02195479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407454|NCT02195466||Single Group Assignment||Treatment||None (Open Label)||||||
1407455|NCT02195453|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407456|NCT02195440||Single Group Assignment||Treatment||None (Open Label)||||||
1407457|NCT02195427|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407458|NCT02195414||Single Group Assignment||Treatment||None (Open Label)||||||
1407459|NCT02195401|||Cohort||Prospective|||||||
1407460|NCT02195388|||Cohort||Prospective|||||||
1407461|NCT02195375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407462|NCT02195362||||||||||||
1407463|NCT02195349|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1407464|NCT02195336||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407465|NCT02195323||Single Group Assignment||Treatment||None (Open Label)||||||
1407466|NCT02195310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407467|NCT02195297|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1407468|NCT02195284|Randomized|Crossover Assignment||||None (Open Label)||||||
1407469|NCT02195271|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1407470|NCT02195258|||Case-Only||Prospective|||||||
1407471|NCT02195245|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1407472|NCT02195232||Single Group Assignment||Treatment||None (Open Label)||||||
1407473|NCT02195219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407474|NCT02195206|||Case-Only||Cross-Sectional|||||||
1407475|NCT02195193|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1407476|NCT02195180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407477|NCT02195167||Single Group Assignment||Treatment||None (Open Label)||||||
1407478|NCT02195154||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407479|NCT02195141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407480|NCT02195128||||||||||||
1407481|NCT02195115|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407482|NCT02195102|||Cohort|||||||||
1407483|NCT02195089|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407484|NCT02195076|||Case Control||Prospective|||||||
1407485|NCT02195063|||Case-Only||Prospective|||||||
1407486|NCT02195050|||Cohort||Cross-Sectional|||||||
1407487|NCT02195037|||Cohort||Prospective|||||||
1407488|NCT02195024|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1407489|NCT02195011|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407490|NCT02194998|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407491|NCT02194985||Single Group Assignment||Treatment||None (Open Label)||||||
1407492|NCT02194972|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407493|NCT02194959|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407494|NCT02194946|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407495|NCT02194933|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1407496|NCT02194920|||Cohort||Prospective|||||||
1407497|NCT02194907|||Case-Control||Prospective|||||||
1407498|NCT02194894|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1407499|NCT02194881|||Cohort||Retrospective|||||||
1407500|NCT02194868|||Cohort||Prospective|||||||
1407501|NCT02194855|Randomized|Parallel Assignment||||Double|||t||t|
1407502|NCT02194842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407503|NCT02194829|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407504|NCT02194816|||Cohort||Prospective|||||||
1407505|NCT02194803|||Cohort||Prospective|||||||
1407506|NCT02194790|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407507|NCT02194777|Randomized|Single Group Assignment||Treatment||Double||||||
1407508|NCT02194764||Single Group Assignment||||Triple|||t|t|t|
1407509|NCT02194751||Single Group Assignment||Treatment||None (Open Label)||||||
1407510|NCT02194738|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1407511|NCT02194725|||Cohort||Cross-Sectional|||||||
1407512|NCT02194712|||Cohort||Prospective|||||||
1407513|NCT02194699|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407514|NCT02194686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407515|NCT02194673|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1407516|NCT02194660|||Case-Only||Prospective|||||||
1407517|NCT02194647|||Case-Only|||||||||
1407518|NCT02194634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407519|NCT02194621|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1407520|NCT02194608|Randomized|Parallel Assignment||||None (Open Label)||||||
1407521|NCT02194595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407522|NCT02194582|||Family-Based||Prospective|||||||
1407523|NCT02194569|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407524|NCT02194556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407525|NCT02194543|||Case Control||Prospective|||||||
1407526|NCT02194530|||Case-Control||Prospective|||||||
1407527|NCT02194517|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407528|NCT02194504|Randomized|Parallel Assignment||||None (Open Label)||||||
1407529|NCT02194491|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1407530|NCT02194478||Single Group Assignment||Treatment||None (Open Label)||||||
1407531|NCT02194465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407532|NCT02194452||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407533|NCT02194439|||Cohort||Prospective|||||||
1407534|NCT02194426||Single Group Assignment||Treatment||None (Open Label)||||||
1407535|NCT02194413|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407536|NCT02194400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407537|NCT02194387|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407538|NCT02194374||Single Group Assignment||Treatment||None (Open Label)||||||
1407539|NCT02194361|Randomized|Crossover Assignment||Treatment||Double||||||
1407540|NCT02194348|Randomized|Parallel Assignment||Treatment||Double||||||
1407541|NCT02194335|Randomized|Parallel Assignment||Treatment||Double||||||
1407542|NCT02194322|Randomized|Single Group Assignment||Treatment||Double||||||
1407543|NCT02194309|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407544|NCT02194296|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407545|NCT02194283|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1407546|NCT02194270|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407547|NCT02194257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407548|NCT02194244|Randomized|Crossover Assignment||||None (Open Label)||||||
1407549|NCT02194231||Single Group Assignment||Treatment||None (Open Label)||||||
1407550|NCT02194218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407551|NCT02194205|Randomized|Parallel Assignment||Treatment||Double||||||
1407552|NCT02194192|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1407553|NCT02194179|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407554|NCT02194166|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407555|NCT02194153|||Cohort||Prospective|||||||
1407556|NCT02194140||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407557|NCT02194127|Randomized|Parallel Assignment||Treatment||Double||||||
1407558|NCT02194114||Single Group Assignment||Supportive Care||None (Open Label)||||||
1407559|NCT02194101|||Cohort||Prospective|||||||
1407560|NCT02194088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407561|NCT02194075|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407562|NCT02194062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407563|NCT02194049||Single Group Assignment||Treatment||None (Open Label)||||||
1407564|NCT02194036|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407565|NCT02194023|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1407566|NCT02194010|||Cohort||Prospective|||||||
1407567|NCT02193997|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407568|NCT02193984|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407569|NCT02193971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407570|NCT02193958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407571|NCT02193945|||Case-Only||Retrospective|||||||
1407572|NCT02193932||Single Group Assignment||Health Services Research||None (Open Label)||||||
1407573|NCT02193919|||Cohort||Prospective|||||||
1407574|NCT02193906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407575|NCT02193893|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407576|NCT02193880||Single Group Assignment||Treatment||None (Open Label)||||||
1407577|NCT02193867||Single Group Assignment||Treatment||None (Open Label)||||||
1407578|NCT02193854||Single Group Assignment||Health Services Research||None (Open Label)||||||
1407579|NCT02193841|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407734|NCT02191813|Randomized|Parallel Assignment||Treatment||Double||||||
1407580|NCT02193828|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407581|NCT02193815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407582|NCT02193802||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407583|NCT02193789||Single Group Assignment||Treatment||None (Open Label)||||||
1407584|NCT02193776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407585|NCT02193763|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407586|NCT02193750|Randomized|Factorial Assignment||Other||Double|||t||t|
1407587|NCT02193737||||||||||||
1407588|NCT02193724|||Cohort||Prospective|||||||
1407589|NCT02193711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407590|NCT02193698||Single Group Assignment||Treatment||None (Open Label)||||||
1407591|NCT02193685|||Cohort||Prospective|||||||
1407592|NCT02193672||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407593|NCT02193659||Single Group Assignment||Prevention||Single|||||t|
1407594|NCT02193646|||Case-Only||Retrospective|||||||
1407595|NCT02193633|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407596|NCT02193620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407597|NCT02193607|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407598|NCT02193594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407599|NCT02193581|||Case-Only||Prospective|||||||
1407600|NCT02193568|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1407601|NCT02193555|Randomized|Crossover Assignment||||Single|||t|||
1407602|NCT02193542|||Cohort||Prospective|||||||
1407603|NCT02193529|||Case-Only||Retrospective|||||||
1407604|NCT02193516|||Case-Only||Cross-Sectional|||||||
1407605|NCT02193503||Single Group Assignment||Treatment||None (Open Label)||||||
1407606|NCT02193490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407607|NCT02193477|Randomized|Parallel Assignment||Prevention||Single|||t|||
1407608|NCT02193464|||Cohort||Prospective|||||||
1407609|NCT02193451|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1407610|NCT02193438|Randomized|Crossover Assignment||||Triple|||t||t|t
1407611|NCT02193425|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1407612|NCT02193412||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407613|NCT02193399|Randomized|Parallel Assignment||Treatment||Single||||||t
1407614|NCT02193386|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1407615|NCT02193373|Randomized|Factorial Assignment||Treatment||Single||||||t
1407616|NCT02193360||Single Group Assignment||Treatment||None (Open Label)||||||
1407617|NCT02193347||Single Group Assignment||Treatment||None (Open Label)||||||
1407618|NCT02193334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407619|NCT02193321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407620|NCT02193308|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407621|NCT02193295|Randomized|Single Group Assignment||Basic Science||Single|||||t|
1407622|NCT02193282|Randomized|Parallel Assignment||Treatment||None (Open Label)|As of June 15, 2017, sites will sign into RAVE to unblind any patients that had previously enrolled|||||
1407623|NCT02193269|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1407624|NCT02193256|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1407625|NCT02193243|||Cohort||Prospective|||||||
1407626|NCT02193230|||||Prospective|||||||
1407627|NCT02193217||||||||||||
1407628|NCT02193204|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1407629|NCT02193191||Single Group Assignment||Treatment||None (Open Label)||||||
1407630|NCT02193178||Single Group Assignment||Treatment||None (Open Label)||||||
1407631|NCT02193165|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1407632|NCT02193152||Single Group Assignment||Treatment||None (Open Label)||||||
1407633|NCT02193139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407634|NCT02193126||||Other||||||||
1407635|NCT02193113|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407636|NCT02193100|||Cohort||Prospective|||||||
1407637|NCT02193087|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1407638|NCT02193074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407639|NCT02193061|Randomized|Crossover Assignment||Prevention||Single|||t|||
1407640|NCT02193048|||Case-Only||Prospective|||||||
1407641|NCT02193035||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407642|NCT02193022|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407643|NCT02193009|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407644|NCT02192996||Single Group Assignment||||None (Open Label)||||||
1407645|NCT02192983|||Cohort||Prospective|||||||
1407646|NCT02192970|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1407647|NCT02192957||Single Group Assignment||Treatment||None (Open Label)||||||
1407648|NCT02192944|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407649|NCT02192931|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407650|NCT02192918|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407651|NCT02192905||Single Group Assignment||Treatment||None (Open Label)||||||
1407652|NCT02192892|Randomized|Crossover Assignment||||Triple|||t||t|t
1407653|NCT02192879|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407654|NCT02192866|||Case-Control||Other|||||||
1407655|NCT02192853|Randomized|Crossover Assignment||Treatment||Double|intervention was blinded for the participant and the investigator||t||t|
1407656|NCT02192840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407657|NCT02192827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407658|NCT02192814||Single Group Assignment||Treatment||None (Open Label)||||||
1407659|NCT02192801|||Cohort||Prospective|||||||
1407660|NCT02192788||Single Group Assignment||Treatment||None (Open Label)||||||
1407661|NCT02192775||Single Group Assignment||Treatment||None (Open Label)||||||
1407662|NCT02192762|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1407663|NCT02192749||Single Group Assignment||Treatment||None (Open Label)||||||
1407664|NCT02192736||Single Group Assignment||Treatment||None (Open Label)||||||
1407665|NCT02192723|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1407666|NCT02192710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407667|NCT02192697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407668|NCT02192684|Randomized|Parallel Assignment||Other||Single|||t|||
1407669|NCT02192671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407670|NCT02192658|||||Cross-Sectional|||||||
1407671|NCT02192645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407672|NCT02192632|Randomized|Parallel Assignment||Treatment||Single|||||t|
1407673|NCT02192619|||Other||Prospective|||||||
1407674|NCT02192606|Randomized|Parallel Assignment||Other||Single|||t|||
1407675|NCT02192593|Randomized|Single Group Assignment||Treatment||Single||||||t
1407676|NCT02192580|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1407677|NCT02192567||Single Group Assignment||Treatment||None (Open Label)||||||
1407678|NCT02192554|||Other||Prospective|||||||
1407679|NCT02192541||Single Group Assignment||Treatment||None (Open Label)||||||
1407680|NCT02192528|||Cohort||Prospective|||||||
1407681|NCT02192515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407682|NCT02192502|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1407683|NCT02192489|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1407684|NCT02192476|Randomized|Parallel Assignment||Treatment||Single||||||t
1407685|NCT02192463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407686|NCT02192450|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407687|NCT02192437|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1407688|NCT02192424|Randomized|Parallel Assignment||Treatment||Single||||||t
1407689|NCT02192411|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1407690|NCT02192398|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407691|NCT02192372|||Cohort||Prospective|||||||
1407692|NCT02192359||Single Group Assignment||Treatment||None (Open Label)||||||
1407693|NCT02192346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407694|NCT02192333|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407695|NCT02192320|Randomized|Parallel Assignment||Treatment||Single||||||t
1407696|NCT02192307|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407697|NCT02192294||Crossover Assignment||Basic Science||None (Open Label)||||||
1407698|NCT02192281|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1407699|NCT02192268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407700|NCT02192255|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407701|NCT02192242||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407702|NCT02192229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407703|NCT02192216||Single Group Assignment||Supportive Care||None (Open Label)||||||
1407704|NCT02192203|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1407705|NCT02192190|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407706|NCT02192177|||Case Control||Prospective|||||||
1407707|NCT02192164|||Other||Prospective|||||||
1407708|NCT02192151|||Case-Crossover||Prospective|||||||
1407709|NCT02192138||Single Group Assignment||Basic Science||None (Open Label)||||||
1407710|NCT02192125||Single Group Assignment||Treatment||None (Open Label)||||||
1407711|NCT02192112|||Cohort||Prospective|||||||
1407712|NCT02192099||Single Group Assignment||Treatment||None (Open Label)||||||
1407713|NCT02192086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407714|NCT02192073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407715|NCT02192060|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1407716|NCT02192047|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1407717|NCT02192034|Randomized|Crossover Assignment||Screening||Triple|||t||t|t
1407718|NCT02192021||Single Group Assignment||Treatment||None (Open Label)||||||
1407719|NCT02192008|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1407720|NCT02191995|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407721|NCT02191982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407722|NCT02191969|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1407723|NCT02191956|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407724|NCT02191943|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1407725|NCT02191930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407726|NCT02191917||Single Group Assignment||Basic Science||None (Open Label)||||||
1407727|NCT02191904|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1407728|NCT02191891||Single Group Assignment||Treatment||None (Open Label)||||||
1407729|NCT02191878||Single Group Assignment||Treatment||None (Open Label)||||||
1407730|NCT02191865|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407731|NCT02191852||Single Group Assignment||Treatment||None (Open Label)||||||
1407732|NCT02191839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407733|NCT02191826|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407735|NCT02191800||||||||||||
1407736|NCT02191787||Single Group Assignment||Treatment||None (Open Label)||||||
1407737|NCT02191774|||Cohort||Prospective|||||||
1407738|NCT02191761||Single Group Assignment||Treatment||None (Open Label)||||||
1407739|NCT02191748|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407740|NCT02191735|||Cohort||Retrospective|||||||
1407741|NCT02191722||Single Group Assignment||Supportive Care||None (Open Label)||||||
1407742|NCT02191709|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407743|NCT02191696|||Case-Only||Prospective|||||||
1407744|NCT02191683|||Other||Prospective|||||||
1407745|NCT02191670|||Cohort||Prospective|||||||
1407746|NCT02191657|Randomized|Parallel Assignment||||Triple|||t||t|t
1407747|NCT02191644|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1407748|NCT02191631|Randomized|Parallel Assignment||Treatment||Single||||||t
1407749|NCT02191618||Single Group Assignment||Treatment||None (Open Label)||||||
1407750|NCT02191605|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407751|NCT02191592|||Case-Only||Prospective|||||||
1407752|NCT02191579|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407753|NCT02191566||Single Group Assignment||Treatment||None (Open Label)||||||
1407754|NCT02191553|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1407755|NCT02191540||Single Group Assignment||Treatment||None (Open Label)||||||
1407756|NCT02191527|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1407757|NCT02191514|||Cohort||Retrospective|||||||
1407758|NCT02191501||Single Group Assignment||Treatment||None (Open Label)||||||
1407759|NCT02191488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407760|NCT02191475|Randomized|Parallel Assignment||Treatment||Single|||||t|
1407761|NCT02191462|Randomized|Crossover Assignment||||Triple|||t||t|t
1407762|NCT02191449|||Cohort||Retrospective|||||||
1407763|NCT02191436|||Cohort||Cross-Sectional|||||||
1407764|NCT02191423|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1407765|NCT02191410|Randomized|Parallel Assignment||Treatment||Single||||||t
1407766|NCT02191397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407767|NCT02191384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407768|NCT02191371|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407769|NCT02191358|||Other||Prospective|||||||
1407770|NCT02191345|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1407771|NCT02191332|||Cohort||Prospective|||||||
1407772|NCT02191319|||Cohort||Prospective|||||||
1407773|NCT02191306|||Cohort||Prospective|||||||
1407774|NCT02191293|||Cohort||Prospective|||||||
1407775|NCT02191280|Randomized|Parallel Assignment||Treatment||Double||||||
1407776|NCT02191267|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1407777|NCT02191254|Randomized|Parallel Assignment||Treatment||Double||||||
1407778|NCT02191241||Single Group Assignment||||None (Open Label)||||||
1407779|NCT02191228|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407780|NCT02191215|||Cohort||Prospective|||||||
1407781|NCT02191202|||Cohort||Prospective|||||||
1407782|NCT02191189|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407783|NCT02191176|Randomized|Parallel Assignment||Treatment||Double||||||
1407784|NCT02191163|Randomized|Crossover Assignment||Treatment||Double||||||
1407785|NCT02191150|||||Retrospective|||||||
1407786|NCT02191137||Single Group Assignment||Treatment||None (Open Label)||||||
1407787|NCT02191124|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1407788|NCT02191111|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407789|NCT02191098||Single Group Assignment||Treatment||None (Open Label)||||||
1407790|NCT02191085|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1407791|NCT02191072||Single Group Assignment||Treatment||None (Open Label)||||||
1407792|NCT02191059||Single Group Assignment||Treatment||None (Open Label)||||||
1407793|NCT02191046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407794|NCT02191033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407795|NCT02191020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407796|NCT02191007|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407797|NCT02190994|Randomized|Parallel Assignment||Treatment||Single||||||t
1407798|NCT02190981|||Cohort||Prospective|||||||
1407799|NCT02190968|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1407800|NCT02190955|||Cohort||Cross-Sectional|||||||
1407801|NCT02190942|||Cohort||Cross-Sectional|||||||
1407802|NCT02190929|||Cohort||Cross-Sectional|||||||
1407803|NCT02190916|||Cohort||Cross-Sectional|||||||
1407804|NCT02190903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407805|NCT02190890|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407806|NCT02190877|||Cohort||Retrospective|||||||
1407807|NCT02190864|||Cohort||Prospective|||||||
1407808|NCT02190851|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407809|NCT02190838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407810|NCT02190825||Single Group Assignment||Treatment||None (Open Label)||||||
1407811|NCT02190812|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1407812|NCT02190799||Single Group Assignment||Treatment||None (Open Label)||||||
1407813|NCT02190786||||||||||||
1407814|NCT02190773|||Case Control||Prospective|||||||
1407815|NCT02190760|Randomized|Single Group Assignment||Treatment||Single|||||t|
1407816|NCT02190747|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407817|NCT02190734||Single Group Assignment||Treatment||None (Open Label)||||||
1407818|NCT02190721||Single Group Assignment||Treatment||None (Open Label)||||||
1407819|NCT02190708||Single Group Assignment||Basic Science||None (Open Label)||||||
1407820|NCT02190695|Randomized|Parallel Assignment||Treatment||Single||||||t
1407821|NCT02190682|||Case-Only||Prospective|||||||
1407822|NCT02190669|||Cohort||Prospective|||||||
1407823|NCT02190656|||||Cross-Sectional|||||||
1407824|NCT02190643|Randomized|Parallel Assignment||Treatment||Single||||||t
1407825|NCT02190630|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407826|NCT02190617|Randomized|Factorial Assignment||||None (Open Label)||||||
1407827|NCT02190604|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407828|NCT02190591|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1407829|NCT02190578||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407830|NCT02190565|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1407831|NCT02190552|||Cohort||Prospective|||||||
1407832|NCT02190539||Single Group Assignment||Supportive Care||None (Open Label)||||||
1407833|NCT02190526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407834|NCT02190513|||Cohort||Retrospective|||||||
1407835|NCT02190500|||Cohort||Prospective|||||||
1407836|NCT02190487|||Cohort||Retrospective|||||||
1407837|NCT02190474||Single Group Assignment||Treatment||None (Open Label)||||||
1407838|NCT02190461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407839|NCT02190448|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1407840|NCT02190435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407841|NCT02190422|||Case Control||Prospective|||||||
1407842|NCT02190409||Single Group Assignment||Health Services Research||None (Open Label)||||||
1407843|NCT02190396|||Case Control||Prospective|||||||
1407844|NCT02190383||Single Group Assignment||Treatment||None (Open Label)||||||
1407845|NCT02190370||Single Group Assignment||Treatment||None (Open Label)||||||
1407846|NCT02190357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407847|NCT02190344||Single Group Assignment||Other||None (Open Label)||||||
1407848|NCT02190331|Randomized|Parallel Assignment||Treatment||Single|||||t|
1407849|NCT02190318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407850|NCT02190305||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407851|NCT02190292|||Other||Other|||||||
1407852|NCT02190279|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1407853|NCT02190266|||Cohort||Cross-Sectional|||||||
1407854|NCT02190253|||Case-Control||Prospective|||||||
1407855|NCT02190240|||Case-Only|||||||||
1407856|NCT02190227||Single Group Assignment||Diagnostic||None (Open Label)||||||
1407857|NCT02190214|||Ecologic or Community||Cross-Sectional|||||||
1407858|NCT02190201|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407859|NCT02190188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407860|NCT02190175|||Cohort||Prospective|||||||
1407861|NCT02190162|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1407862|NCT02190149|||Other||Prospective|||||||
1407863|NCT02190136|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407864|NCT02190123|||Case-Only||Retrospective|||||||
1407865|NCT02190110|||Cohort||Prospective|||||||
1407866|NCT02190097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407867|NCT02190084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407868|NCT02190071|||Cohort||Prospective|||||||
1407869|NCT02190058|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1407870|NCT02190045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407871|NCT02190032|Randomized|Parallel Assignment||||Single|||t|||
1407872|NCT02190019|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1407873|NCT02190006|||Cohort||Prospective|||||||
1407874|NCT02189993|||Cohort||Retrospective|||||||
1407875|NCT02189980|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1407876|NCT02189967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407877|NCT02189954|Randomized|Parallel Assignment||Screening||Double|||||t|t
1407878|NCT02189941|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407879|NCT02189928|Randomized|Parallel Assignment||Treatment||Single||||||t
1407880|NCT02189915||Single Group Assignment||Treatment||None (Open Label)||||||
1407881|NCT02189902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407882|NCT02189889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407883|NCT02189876|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407884|NCT02189863|Randomized|Crossover Assignment||||Single|||||t|
1407885|NCT02189850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407886|NCT02189837|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407887|NCT02189824|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407888|NCT02189811|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407889|NCT02189798|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The two main arms are conducted in parallel. The third arm is optional for subjects who complete either of the two main arms using the EAS sound processor.||||
1407890|NCT02189785|||Case-Only||Cross-Sectional|||||||
1407891|NCT02189772|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407892|NCT02189759|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407893|NCT02189746|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407894|NCT02189733|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407895|NCT02189720||||||||||||
1407896|NCT02189707|Randomized|Parallel Assignment||||Double|||t||t|
1407897|NCT02189694|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407898|NCT02189681|Randomized|Parallel Assignment||||Double|||t|||t
1407899|NCT02189668|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407900|NCT02189655|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1407901|NCT02189642|||Cohort||Prospective|||||||
1407902|NCT02189629||Single Group Assignment||Treatment||None (Open Label)||||||
1407903|NCT02189616|Randomized|Parallel Assignment||Treatment||Single||||||t
1407904|NCT02189603|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1407905|NCT02189590|Randomized|Parallel Assignment||||Single||||t||
1407906|NCT02189577|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1407907|NCT02189564|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1407908|NCT02189551|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1407909|NCT02189538|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1407910|NCT02189525|||Cohort||Prospective|||||||
1407911|NCT02189512|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1407912|NCT02189499||Single Group Assignment||Treatment||None (Open Label)||||||
1407913|NCT02189486|||Cohort||Prospective|||||||
1407914|NCT02189473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407915|NCT02189460|||Other||Prospective|||||||
1407916|NCT02189447||Single Group Assignment||Treatment||None (Open Label)||||||
1407917|NCT02189434|||Case-Only||Prospective|||||||
1407918|NCT02189421|Randomized|Parallel Assignment||||Single|||t|||
1407919|NCT02189408|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407920|NCT02189395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407921|NCT02189382|Randomized|Parallel Assignment||Treatment||Single|||t|||
1407922|NCT02189369|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1407923|NCT02189356|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407924|NCT02189343||Single Group Assignment||Other||None (Open Label)||||||
1407925|NCT02189330|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1407926|NCT02189317|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407927|NCT02189304|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1407928|NCT02189291|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407929|NCT02189278|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1407930|NCT02189265|||Ecologic or Community||Retrospective|||||||
1407931|NCT02189252|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1407932|NCT02189239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407933|NCT02189226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407934|NCT02189213|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1407935|NCT02189200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407936|NCT02189187|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1407937|NCT02189174||Single Group Assignment||Treatment||None (Open Label)||||||
1407938|NCT02189161||Single Group Assignment||Treatment||None (Open Label)||||||
1407939|NCT02189148|||Cohort||Prospective|||||||
1407940|NCT02189135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407941|NCT02189122|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1407942|NCT02189109||Single Group Assignment||Treatment||None (Open Label)||||||
1407943|NCT02189096|||Cohort||Prospective|||||||
1407944|NCT02189083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407945|NCT02189070|||Cohort||Prospective|||||||
1407946|NCT02189057|Randomized|Crossover Assignment||Treatment||Double|Subject and study staff will be blind to randomization.|Subjects will be randomized to either genotyping intervention or treatment as usual.|t||t|
1407947|NCT02189044||Single Group Assignment||||None (Open Label)||||||
1407948|NCT02189031|||Case-Only||Prospective|||||||
1407949|NCT02189018|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407950|NCT02189005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407951|NCT02188992|||Cohort||Prospective|||||||
1407952|NCT02188979|||Case-Only||Prospective|||||||
1407953|NCT02188966||Single Group Assignment||||None (Open Label)||||||
1407954|NCT02188953|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1407955|NCT02188940|Randomized|Parallel Assignment||Treatment||Single||||||t
1407956|NCT02188927|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1407957|NCT02188914|||Case-Control||Cross-Sectional|||||||
1407958|NCT02188901||Single Group Assignment||Screening||None (Open Label)||||||
1407959|NCT02188888|||Cohort||Prospective|||||||
1407960|NCT02188875|Randomized|Parallel Assignment||Prevention||Single|||||t|
1407961|NCT02188862|||Case Control||Retrospective|||||||
1407962|NCT02188849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407963|NCT02188836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407964|NCT02188823||Single Group Assignment||Treatment||Single||||||t
1407965|NCT02188810|Randomized|Parallel Assignment||Prevention||Single|||||t|
1407966|NCT02188797|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1407967|NCT02188784|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407968|NCT02188771||Single Group Assignment||Treatment||None (Open Label)||||||
1407969|NCT02188758|||Cohort||Prospective|||||||
1407970|NCT02188745||Single Group Assignment||Treatment||None (Open Label)||||||
1407971|NCT02188732|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1407972|NCT02188719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407973|NCT02188693|||Case Control||Prospective|||||||
1409598|NCT02167503|||Cohort|||||||||
1407974|NCT02188680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407975|NCT02188667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407976|NCT02188654|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407977|NCT02188641|Randomized|Parallel Assignment||Treatment||Single|||||t|
1407978|NCT02188628|Randomized|Parallel Assignment||Other||Single|Blinded therapist assessor to determine clinical outcomes at pre and post treatment and follow up.|H-Man training + conventional therapy vs equal amount of conventional therapy 1:1 allocation||||t
1407979|NCT02188615|Randomized|Parallel Assignment||Treatment||Single||||||t
1407980|NCT02188602|||Cohort||Retrospective|||||||
1407981|NCT02188589||Single Group Assignment||Treatment||None (Open Label)||||||
1407982|NCT02188576|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1407983|NCT02188563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407984|NCT02188550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1407985|NCT02188537||Single Group Assignment||Treatment||None (Open Label)||||||
1407986|NCT02188524|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1407987|NCT02188511|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1407988|NCT02188498|||Cohort||Cross-Sectional|||||||
1407989|NCT02188485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407990|NCT02188472|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1407991|NCT02188459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1407992|NCT02188446|Randomized|Single Group Assignment||Prevention||Single||||||t
1407993|NCT02188433|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1407994|NCT02188420|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1407995|NCT02188407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407996|NCT02188394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1407997|NCT02188381|||Cohort||Prospective|||||||
1407998|NCT02188368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1407999|NCT02188355|||Other||Prospective|||||||
1408000|NCT02188342||Single Group Assignment||Supportive Care||None (Open Label)||||||
1408001|NCT02188329|||Ecologic or Community||Cross-Sectional|||||||
1408002|NCT02188316|Randomized|Parallel Assignment||Treatment||Single|||||t|
1408003|NCT02188303|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1408004|NCT02188290|||Cohort||Retrospective|||||||
1408005|NCT02188277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408006|NCT02188264||Single Group Assignment||Treatment||None (Open Label)||||||
1408007|NCT02188251|Randomized|Parallel Assignment||||Triple|||t||t|t
1408008|NCT02188238|||Other||Other|||||||
1408009|NCT02188225|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408010|NCT02188212||Single Group Assignment||Treatment||None (Open Label)||||||
1408011|NCT02188199|||Cohort||Prospective|||||||
1408012|NCT02188186|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1408013|NCT02188173|||Cohort||Prospective|||||||
1408014|NCT02188160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408015|NCT02188147||Single Group Assignment||Basic Science||None (Open Label)||||||
1408016|NCT02188134|||||Cross-Sectional|||||||
1408017|NCT02188121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408018|NCT02188108||Single Group Assignment||||None (Open Label)||||||
1408019|NCT02188095|||Cohort||Prospective|||||||
1408020|NCT02188082|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408021|NCT02188069|||Cohort||Prospective|||||||
1408022|NCT02188056|||Cohort||Prospective|||||||
1408023|NCT02188043|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1408024|NCT02188030|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1408025|NCT02188017|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408026|NCT02188004|||Cohort||Prospective|||||||
1408027|NCT02187991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408028|NCT02187978|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408029|NCT02187965|||Case-Only||Cross-Sectional|||||||
1408030|NCT02187952|Randomized|Parallel Assignment||Treatment||Single||||||t
1408031|NCT02187939|Randomized|Parallel Assignment||Prevention||Single|||t|||
1408032|NCT02187926|||Cohort||Prospective|||||||
1408033|NCT02187913|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1408034|NCT02187900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408035|NCT02187887|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408036|NCT02187874|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408037|NCT02187861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408038|NCT02187848|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408039|NCT02187835|||Case Control||Retrospective|||||||
1408040|NCT02187822||Single Group Assignment||Treatment||None (Open Label)||||||
1408041|NCT02187809||Single Group Assignment||Treatment||None (Open Label)||||||
1408042|NCT02187796|||Case Control||Cross-Sectional|||||||
1408043|NCT02187783|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408044|NCT02187770|||Case-Only||Prospective|||||||
1408045|NCT02187757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408046|NCT02187744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408047|NCT02187731|||Other||Prospective|||||||
1408048|NCT02187718|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408049|NCT02187705|||Cohort||Prospective|||||||
1408050|NCT02187692|Randomized|Parallel Assignment||Treatment||Single||||||t
1408051|NCT02187679||Single Group Assignment||Treatment||None (Open Label)||||||
1408052|NCT02187666|||Cohort||Prospective|||||||
1408053|NCT02187653|||Cohort||Prospective|||||||
1408054|NCT02187640|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408055|NCT02187627|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1408056|NCT02187614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408057|NCT02187601|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1408058|NCT02187588|Randomized|Parallel Assignment||Treatment||Double||||||
1408059|NCT02187575|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408060|NCT02187562|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408061|NCT02187549|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408062|NCT02187536|Randomized|Crossover Assignment||Treatment||Double||||||
1408063|NCT02187523|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408064|NCT02187510|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408065|NCT02187497|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408066|NCT02187484||Single Group Assignment||Treatment||None (Open Label)||||||
1408067|NCT02187471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408068|NCT02187458||||||||||||
1408069|NCT02187445||Single Group Assignment||Prevention||None (Open Label)||||||
1408070|NCT02187432|||Cohort||Prospective|||||||
1408071|NCT02187419|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1408072|NCT02187406|Randomized|Crossover Assignment||||Single|||||t|
1408073|NCT02187393|||||Prospective|||||||
1408074|NCT02187380|||Case Control||Prospective|||||||
1408075|NCT02187367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408076|NCT02187354||||||||||||
1408077|NCT02187341|Randomized|Crossover Assignment||||Double|||t||t|
1408078|NCT02187328|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1408079|NCT02187315|Randomized|Parallel Assignment||Treatment||Single||||t||
1408080|NCT02187302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408081|NCT02187289|Randomized|Crossover Assignment||Treatment||Single||||||t
1408082|NCT02187276|||Case-Only||Prospective|||||||
1408083|NCT02187263|||Cohort||Prospective|||||||
1408084|NCT02187250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408085|NCT02187237|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1408086|NCT02187224|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1408087|NCT02187211|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1408088|NCT02187198|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408089|NCT02187185|Randomized|Parallel Assignment||Other||Single||||t||
1408090|NCT02187172|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1408091|NCT02187159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408092|NCT02187146|||Cohort||Prospective|||||||
1408093|NCT02187133||Single Group Assignment||Treatment||None (Open Label)||||||
1408094|NCT02187120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408095|NCT02187107||Single Group Assignment||Treatment||None (Open Label)||||||
1408096|NCT02187094|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1408097|NCT02187081|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1408098|NCT02187068|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1408099|NCT02187055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408100|NCT02187042|||Other||Prospective|||||||
1408101|NCT02187029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408102|NCT02187016|Randomized|Parallel Assignment||Treatment||Single||||||t
1408103|NCT02187003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408104|NCT02186990|Randomized|Parallel Assignment||Prevention||Single||||||t
1408105|NCT02186977|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408106|NCT02186964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408107|NCT02186951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408108|NCT02186938|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408109|NCT02186925|||Cohort||Prospective|||||||
1408110|NCT02186912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408111|NCT02186899|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1408112|NCT02186886||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408113|NCT02186873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408114|NCT02186860||Single Group Assignment||Treatment||None (Open Label)||||||
1408115|NCT02186847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408116|NCT02186834||Single Group Assignment||Treatment||None (Open Label)||||||
1408117|NCT02186821||Single Group Assignment||Treatment||None (Open Label)||||||
1408118|NCT02186808||Single Group Assignment||Treatment||None (Open Label)||||||
1408119|NCT02186795|||Case Control||Retrospective|||||||
1408120|NCT02186782|Randomized|Parallel Assignment||Treatment||Single||||||t
1408121|NCT02186769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408122|NCT02186756|Randomized|Parallel Assignment||Treatment||Single||||||t
1408123|NCT02186743|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408124|NCT02186730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408125|NCT02186717|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408126|NCT02186704|||Case-Control||Prospective|||||||
1408127|NCT02186691||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408128|NCT02186678||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408129|NCT02186665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408130|NCT02186652||Single Group Assignment||Basic Science||None (Open Label)||||||
1408131|NCT02186639|||Case-Control||Prospective|||||||
1408132|NCT02186626|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1408133|NCT02186613|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408134|NCT02186600|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized to 3 treatment groups: Calcium + vitamin D only; risedronate and calcium + vitamin D; bone building exercises and calcium + vitamin D||||
1408135|NCT02186587||Single Group Assignment||Treatment||None (Open Label)||||||
1408136|NCT02186574|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408137|NCT02186561||Single Group Assignment||Treatment||None (Open Label)||||||
1408138|NCT02186548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408139|NCT02186535|Randomized|Parallel Assignment||||None (Open Label)||||||
1408140|NCT02186522|||Cohort||Prospective|||||||
1408141|NCT02186509||Single Group Assignment||Treatment||None (Open Label)||||||
1408142|NCT02186496|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408143|NCT02186483|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408144|NCT02186470||Single Group Assignment||Treatment||None (Open Label)||||||
1408145|NCT02186457|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1408146|NCT02186444|||Cohort||Prospective|||||||
1408147|NCT02186431|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408148|NCT02186418||Single Group Assignment||Treatment||None (Open Label)||Gamma Globin Lentivirus Vector||||
1408149|NCT02186405||Single Group Assignment||Treatment||None (Open Label)||||||
1408150|NCT02186392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408151|NCT02186379|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408152|NCT02186366|Randomized|Parallel Assignment||Treatment||Single||||||t
1408153|NCT02186353|Randomized|Crossover Assignment||Treatment||Single||||||t
1408154|NCT02186340||Single Group Assignment||Treatment||Single||||||t
1408155|NCT02186327|Randomized|Parallel Assignment||||None (Open Label)||||||
1408156|NCT02186314|Randomized|Crossover Assignment||Treatment||Single|||t|||
1408157|NCT02186301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408158|NCT02186288|||||Cross-Sectional|||||||
1408159|NCT02186275|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408160|NCT02186262|||Case-Only||Prospective|||||||
1408161|NCT02186249||||||||||||
1408162|NCT02186236|||Cohort||Prospective|||||||
1408163|NCT02186223||Single Group Assignment||Prevention||None (Open Label)||||||
1408164|NCT02186210|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408165|NCT02186197|||Case-Only||Prospective|||||||
1408166|NCT02186184|Randomized|Crossover Assignment||Treatment||Single||||||t
1408167|NCT02186171|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408168|NCT02186158|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408169|NCT02186145|Randomized|Parallel Assignment||Treatment||Single|||||t|
1408170|NCT02186132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408171|NCT02186119|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408172|NCT02186106|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408173|NCT02186093|||Case-Only||Prospective|||||||
1408174|NCT02186080|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1408175|NCT02186067|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408176|NCT02186054||Single Group Assignment||Diagnostic||Single|||||t|
1408177|NCT02186041|||Cohort||Prospective|||||||
1408178|NCT02186028|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408179|NCT02186015||Single Group Assignment||Treatment||None (Open Label)||||||
1408180|NCT02186002|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1408181|NCT02185989|Randomized|Parallel Assignment||Prevention||Single||||||t
1408182|NCT02185976|Randomized|Single Group Assignment||||Single||||||t
1408183|NCT02185963||Single Group Assignment||Treatment||None (Open Label)||||||
1408184|NCT02185950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408185|NCT02185937|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1408186|NCT02185924|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1408187|NCT02185911|||Cohort|||||||||
1408188|NCT02185898|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1408189|NCT02185885|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1408190|NCT02185872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408191|NCT02185859|Randomized|Parallel Assignment||||Double|||t||t|
1408192|NCT02185846|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408193|NCT02185833|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408194|NCT02185820||Single Group Assignment||Treatment||None (Open Label)||||||
1408195|NCT02185807|Randomized|Parallel Assignment||Treatment||Single||||||t
1408196|NCT02185794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408197|NCT02185781||Single Group Assignment||Treatment||None (Open Label)||||||
1408198|NCT02185768||Single Group Assignment||Treatment||None (Open Label)||||||
1408199|NCT02185755|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408200|NCT02185742|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1408201|NCT02185729||Single Group Assignment||Basic Science||None (Open Label)||||||
1408202|NCT02185716|Randomized|Crossover Assignment||Treatment||Double||||t|t|
1408203|NCT02185703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408204|NCT02185690||Single Group Assignment||Treatment||None (Open Label)||||||
1408205|NCT02185677|||Case Control||Cross-Sectional|||||||
1408206|NCT02185664|Randomized|Parallel Assignment||||Single|||t|||
1408207|NCT02185651|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408208|NCT02185638|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1408209|NCT02185625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408210|NCT02185612|Randomized|Parallel Assignment||Prevention||Single|||||t|
1408211|NCT02185599|||Other||Other|||||||
1408212|NCT02185586|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408213|NCT02185573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408214|NCT02185560|||Cohort||Other|||||||
1408215|NCT02185547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408216|NCT02185534|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1408217|NCT02185521|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408218|NCT02185508|||Case-Only||Retrospective|||||||
1408219|NCT02185495||Single Group Assignment||Screening||None (Open Label)||||||
1408220|NCT02185482|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1408221|NCT02185469|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408222|NCT02185456|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1408223|NCT02185443||Single Group Assignment||Treatment||None (Open Label)||||||
1408224|NCT02185430|Randomized|Parallel Assignment||||Triple|||t|t|t|
1408225|NCT02185417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408226|NCT02185404||Single Group Assignment||Treatment||None (Open Label)||||||
1408227|NCT02185391|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1408228|NCT02185378|Non-Randomized|Parallel Assignment||||Triple|||t|t|t|
1408229|NCT02185365|||Cohort||Prospective|||||||
1408230|NCT02185352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408231|NCT02185339|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1408232|NCT02185326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408233|NCT02185313||Single Group Assignment||Basic Science||None (Open Label)||||||
1408234|NCT02185300|Randomized|Crossover Assignment||||None (Open Label)||||||
1408235|NCT02185287|||Case Control||Prospective|||||||
1408236|NCT02185274|||Cohort||Prospective|||||||
1408237|NCT02185261||Single Group Assignment||Treatment||None (Open Label)||||||
1408238|NCT02185248|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408239|NCT02185235|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408240|NCT02185222|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408241|NCT02185209|Randomized|Parallel Assignment||Treatment||Single||||||t
1408242|NCT02185196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408243|NCT02185183||Single Group Assignment||Treatment||Double|||t||t|
1408244|NCT02185170||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408245|NCT02185157|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1408246|NCT02185144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408247|NCT02185131|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408248|NCT02185118||Single Group Assignment||Treatment||None (Open Label)||||||
1408249|NCT02185105|Randomized|Parallel Assignment||Other||Single|||t|||
1408250|NCT02185092|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408251|NCT02185079|Randomized|Parallel Assignment||Other||Double|||||t|t
1408252|NCT02185066|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408253|NCT02185053||Single Group Assignment||Treatment||None (Open Label)||||||
1408254|NCT02185040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408255|NCT02185027|||Cohort||Prospective|||||||
1408256|NCT02185014||Single Group Assignment||Treatment||None (Open Label)||||||
1408257|NCT02185001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408258|NCT02184988||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1408259|NCT02184975|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408260|NCT02184962|||Case Control||Cross-Sectional|||||||
1408261|NCT02184949|||Cohort||Retrospective|||||||
1408262|NCT02184936|||Cohort||Prospective|||||||
1408263|NCT02184923||Single Group Assignment||Basic Science||None (Open Label)||||||
1408264|NCT02184910|||Cohort||Prospective|||||||
1408265|NCT02184897|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408266|NCT02184884|||Case Control||Prospective|||||||
1408267|NCT02184871|||Cohort||Prospective|||||||
1408268|NCT02184858||Single Group Assignment||Treatment||None (Open Label)||||||
1408269|NCT02184845||Single Group Assignment||Treatment||None (Open Label)||||||
1408270|NCT02184832|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1408271|NCT02184819|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1408272|NCT02184806|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408273|NCT02184793|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1408274|NCT02184780|||Cohort||Retrospective|||||||
1408275|NCT02184767||Single Group Assignment||||None (Open Label)||||||
1408276|NCT02184754|||Cohort||Prospective|||||||
1408277|NCT02184741|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408278|NCT02184728||Single Group Assignment||||None (Open Label)||||||
1408279|NCT02184715|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1408280|NCT02184702|||Case-Only||Prospective|||||||
1408281|NCT02184689||Single Group Assignment||Treatment||None (Open Label)||||||
1408282|NCT02184676||Single Group Assignment||Screening||None (Open Label)||||||
1408283|NCT02184663|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1408284|NCT02184650|||Cohort||Prospective|||||||
1408285|NCT02184637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408286|NCT02184624|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1408287|NCT02184611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408288|NCT02184598|Randomized|Parallel Assignment||Treatment||Single||||||t
1408289|NCT02184585|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1408290|NCT02184572|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1408291|NCT02184559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408292|NCT02184546|||Cohort||Prospective|||||||
1408293|NCT02184533||Single Group Assignment||Treatment||None (Open Label)||||||
1408294|NCT02184520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408295|NCT02184507|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1408296|NCT02184494|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408297|NCT02184481|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408298|NCT02184468||Single Group Assignment||||None (Open Label)||||||
1408299|NCT02184455||Single Group Assignment||Treatment||None (Open Label)||||||
1408300|NCT02184442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408301|NCT02184429|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1408302|NCT02184416|||Other||Other|||||||
1408303|NCT02184403|||Cohort||Prospective|||||||
1408304|NCT02184390|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408305|NCT02184377|||Case-Only||Prospective|||||||
1408306|NCT02184364|Randomized|Parallel Assignment||Treatment||Double||||||
1408307|NCT02184351|Randomized|Parallel Assignment||Treatment||Single||||||
1408308|NCT02184338|Randomized|Parallel Assignment||Treatment||Double||||||
1408309|NCT02184325|Randomized|Crossover Assignment||Treatment||Double||||||
1408310|NCT02184312|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408311|NCT02184299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408312|NCT02184286||Single Group Assignment||Treatment||None (Open Label)||||||
1408313|NCT02184273|Randomized|Parallel Assignment||Treatment||Double||||||
1408314|NCT02184260|Randomized|Parallel Assignment||Treatment||Double||||||
1408315|NCT02184247|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408316|NCT02184234||Single Group Assignment||Treatment||None (Open Label)||||||
1408317|NCT02184221|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408318|NCT02184208|||Cohort||Retrospective|||||||
1408319|NCT02184195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408320|NCT02184182||Single Group Assignment||Treatment||None (Open Label)||||||
1408321|NCT02184169|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408322|NCT02184156|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408323|NCT02184143|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408324|NCT02184130||Single Group Assignment||Basic Science||None (Open Label)||||||
1408325|NCT02184117|||Cohort||Prospective|||||||
1408326|NCT02184104|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1408327|NCT02184091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408328|NCT02184078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408329|NCT02184065|||Cohort||Prospective|||||||
1408330|NCT02184052|||Cohort||Prospective|||||||
1408331|NCT02184039|||Cohort||Prospective|||||||
1408332|NCT02184026||Single Group Assignment||Treatment||None (Open Label)||||||
1408333|NCT02184013||Single Group Assignment||Treatment||None (Open Label)||||||
1408334|NCT02184000|||Case-Only||Prospective|||||||
1408335|NCT02183987|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1408336|NCT02183974||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408337|NCT02183961||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408338|NCT02183948|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1408339|NCT02183935|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408340|NCT02183922|Randomized|Factorial Assignment||Treatment||Single|||t|||
1408341|NCT02183909||Single Group Assignment||Other||None (Open Label)||||||
1408342|NCT02183896|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408343|NCT02183883||Single Group Assignment||Treatment||None (Open Label)||||||
1408344|NCT02183870||Single Group Assignment||Treatment||None (Open Label)||||||
1408345|NCT02183857|Randomized|Parallel Assignment||Other||Single|||t|||
1408346|NCT02183844||Single Group Assignment||Health Services Research||None (Open Label)||||||
1408347|NCT02183831|||Case Control||Retrospective|||||||
1408348|NCT02183818|||Case-Control||Prospective|||||||
1408349|NCT02183805||Single Group Assignment||Treatment||None (Open Label)||||||
1408350|NCT02183792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408351|NCT02183779|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1408352|NCT02183766|Non-Randomized|Crossover Assignment||Treatment||Double|||t||t|
1408353|NCT02183753|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1408354|NCT02183740|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1408355|NCT02183727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408356|NCT02183714|Randomized|Parallel Assignment||Treatment||Double||||||
1408357|NCT02183701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408358|NCT02183688|Randomized|Parallel Assignment||Treatment||Double||||||
1408359|NCT02183675|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408360|NCT02183662|Randomized|Crossover Assignment||Treatment||Double||||||
1408361|NCT02183649|Randomized|Crossover Assignment||Treatment||Single|||t|||
1408362|NCT02183636|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408363|NCT02183623||Single Group Assignment||Treatment||None (Open Label)||||||
1408364|NCT02183610|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408365|NCT02183597|||Cohort||Retrospective|||||||
1408366|NCT02183584||Single Group Assignment||Treatment||None (Open Label)||||||
1408367|NCT02183571|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408368|NCT02183558|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408369|NCT02183545|Randomized|Parallel Assignment||Treatment||Double||||||
1408370|NCT02183532||Single Group Assignment||Treatment||None (Open Label)||||||
1408371|NCT02183519|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|1) baseline respiratory maneuvers for calibration of the Respitrace system with spirometry 2) sequential voluntary cough (no cueing), 3) reflex cough sensitivity testing to establish the lowest concentration of capsaicin that elicits a two cough response (C2) (no cueing), 4) randomized production of sequential voluntary cough (3x) or reflex cough induced with C2 (3x) with cueing to 'cough long and hard' and 5) flexible laryngoscopy to assess age-related changes to the larynx that may impact cough function.|Participants with Parkinson's Disease are evaluated in parallel against a control group of health older adults||||
1408372|NCT02183506|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408373|NCT02183493|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408374|NCT02183480|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408375|NCT02183467|Randomized|Crossover Assignment||Treatment||Double||||||
1408376|NCT02183454|||Cohort||Prospective|||||||
1408377|NCT02183441|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408378|NCT02183428|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408379|NCT02183415|Randomized|Parallel Assignment||Treatment||Double||||||
1408380|NCT02183402|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408381|NCT02183389|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408382|NCT02183376|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408383|NCT02183363|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408384|NCT02183350|Randomized|Single Group Assignment||Treatment||Double||||||
1408385|NCT02183337|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408386|NCT02183324|Randomized|Parallel Assignment||Treatment||Double||||||
1408387|NCT02183311|Randomized|Single Group Assignment||Treatment||Double||||||
1408388|NCT02183298|Randomized|Single Group Assignment||Treatment||Single||||||
1408389|NCT02183285|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1408390|NCT02183272|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408391|NCT02183259|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408392|NCT02183246|Randomized|Parallel Assignment||Treatment||Double||||||
1408393|NCT02183233|Randomized|Parallel Assignment||Treatment||Double||||||
1408394|NCT02183220|Randomized|Parallel Assignment||Treatment||Double||||||
1408395|NCT02183207||Single Group Assignment||Treatment||None (Open Label)||||||
1408396|NCT02183194||Single Group Assignment||Treatment||None (Open Label)||||||
1408397|NCT02183181|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408398|NCT02183168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408399|NCT02183155|Randomized|Parallel Assignment||Treatment||Double||||||
1408400|NCT02183142|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408401|NCT02183129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408402|NCT02183116||Single Group Assignment||Treatment||None (Open Label)||||||
1408403|NCT02183103|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408404|NCT02183090|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408405|NCT02183077|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408406|NCT02183064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408407|NCT02183051|Randomized|Parallel Assignment||Treatment||Double||||||
1408408|NCT02183038|Randomized|Parallel Assignment||Treatment||Double||||||
1408409|NCT02183025|Randomized|Parallel Assignment||Treatment||Double||||||
1408410|NCT02183012|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408411|NCT02182999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408412|NCT02182986|||Case-Control||Prospective|||||||
1408413|NCT02182973|||Case-Only||Prospective|||||||
1408414|NCT02182960|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408415|NCT02182947||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408416|NCT02182934|Randomized|Parallel Assignment||Treatment||Double||||||
1408417|NCT02182921|||Case Control||Prospective|||||||
1408418|NCT02182908||Single Group Assignment||Screening||None (Open Label)||||||
1408419|NCT02182895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408420|NCT02182882|Randomized|Parallel Assignment||Treatment||Double||||||
1408421|NCT02182869|Randomized|Crossover Assignment||Treatment||Double||||||
1408422|NCT02182856|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1408423|NCT02182843||Single Group Assignment||Treatment||None (Open Label)||||||
1408424|NCT02182830|Randomized|Parallel Assignment||Treatment||Double||||||
1408425|NCT02182817|||Cohort||Prospective|||||||
1408426|NCT02182804||Single Group Assignment||Diagnostic||Single|||||t|
1408427|NCT02182791|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408428|NCT02182778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408429|NCT02182765|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408430|NCT02182752|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408431|NCT02182739|||Cohort||Prospective|||||||
1408432|NCT02182726|||Cohort||Prospective|||||||
1408433|NCT02182713|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1408434|NCT02182700||Single Group Assignment||Treatment||None (Open Label)||||||
1408435|NCT02182687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408436|NCT02182674|Randomized|Crossover Assignment||Treatment||Double||||||
1408437|NCT02182661||Single Group Assignment||Treatment||None (Open Label)||||||
1408438|NCT02182648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408439|NCT02182635||Single Group Assignment||Treatment||None (Open Label)||||||
1408440|NCT02182622|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408441|NCT02182609||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408442|NCT02182596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408443|NCT02182583|Randomized|Parallel Assignment||Treatment||Double||||||
1408444|NCT02182570||Single Group Assignment||Treatment||None (Open Label)||||||
1408445|NCT02182557|Randomized|Parallel Assignment||Treatment||Double||||||
1408446|NCT02182544|Randomized|Parallel Assignment||Treatment||Double||||||
1408447|NCT02182531|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408448|NCT02182518|Randomized|Parallel Assignment||Treatment||Double||||||
1408449|NCT02182505|Randomized|Parallel Assignment||Treatment||Double||||||
1408450|NCT02182492|Randomized|Parallel Assignment||Treatment||Single||||||t
1408451|NCT02182479|Randomized|Parallel Assignment||Treatment||Double||||||
1408452|NCT02182466|||Cohort||Prospective|||||||
1408453|NCT02182453|Randomized|Parallel Assignment||Treatment||Double||||||
1408454|NCT02182440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408455|NCT02182427|||Case-Only||Prospective|||||||
1408456|NCT02182414|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408457|NCT02182401||Single Group Assignment||Treatment||None (Open Label)||||||
1408458|NCT02182388|Randomized|Parallel Assignment||Treatment||Double||||||
1408459|NCT02182375||Single Group Assignment||Treatment||None (Open Label)||||||
1408460|NCT02182362|Randomized|Parallel Assignment||Treatment||Double||||||
1408461|NCT02182349||Single Group Assignment||Treatment||None (Open Label)||||||
1408462|NCT02182336||Single Group Assignment||Treatment||None (Open Label)||||||
1408463|NCT02182323|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408464|NCT02182310|Randomized|Crossover Assignment||Treatment||Double||||||
1408465|NCT02182297|Randomized|Parallel Assignment||Treatment||Double||||||
1408466|NCT02182284|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408467|NCT02182271|Randomized|Parallel Assignment||Treatment||Double||||||
1408468|NCT02182258|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1408469|NCT02182245||Single Group Assignment||Treatment||None (Open Label)||||||
1408470|NCT02182232|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408471|NCT02182219||Single Group Assignment||Treatment||None (Open Label)||||||
1408472|NCT02182206||Single Group Assignment||Treatment||None (Open Label)||||||
1408473|NCT02182193|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408474|NCT02182180|||Case-Control||Prospective|||||||
1408475|NCT02182167|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1408476|NCT02182154||Single Group Assignment||Treatment||None (Open Label)||||||
1408477|NCT02182141||Single Group Assignment||Treatment||None (Open Label)||||||
1408478|NCT02182128||Single Group Assignment||Treatment||None (Open Label)||||||
1408479|NCT02182115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408480|NCT02182102||Single Group Assignment||Treatment||None (Open Label)||||||
1408481|NCT02182089|||Cohort||Prospective|||||||
1408482|NCT02182076|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408483|NCT02182063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408484|NCT02182050|Randomized|Parallel Assignment||Treatment||Double||||||
1408485|NCT02182037|Randomized|Parallel Assignment||Treatment||Double||||||
1408486|NCT02182024|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408487|NCT02182011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408488|NCT02181998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408489|NCT02181985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408490|NCT02181972|Randomized|Parallel Assignment||Treatment||Double||||||
1408491|NCT02181959|Randomized|Parallel Assignment||Treatment||Double||||||
1408492|NCT02181946||Single Group Assignment||Treatment||None (Open Label)||||||
1408493|NCT02181933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408494|NCT02181920|Randomized|Crossover Assignment||Treatment||Double||||||
1408495|NCT02181907|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408496|NCT02181894|||Cohort||Prospective|||||||
1408497|NCT02181881|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1408498|NCT02181868||||||||||||
1408499|NCT02181855||Single Group Assignment||||None (Open Label)||||||
1408500|NCT02181842|||Cohort||Prospective|||||||
1408501|NCT02181829||Single Group Assignment||Treatment||None (Open Label)||||||
1408502|NCT02181816|||Cohort||Prospective|||||||
1408503|NCT02181803|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408504|NCT02181790|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408505|NCT02181777|Randomized|Parallel Assignment||Treatment||Single||||||t
1408506|NCT02181764||Single Group Assignment||Treatment||None (Open Label)||||||
1408507|NCT02181751|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408508|NCT02181738||Single Group Assignment||Treatment||None (Open Label)||||||
1408509|NCT02181725|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1408510|NCT02181712||Single Group Assignment||Treatment||None (Open Label)||||||
1408511|NCT02181699||Single Group Assignment||Treatment||None (Open Label)||||||
1408512|NCT02181686|||Case-Only||Prospective|||||||
1408513|NCT02181673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408514|NCT02181660||Single Group Assignment||Treatment||None (Open Label)||||||
1408515|NCT02181647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408516|NCT02181634||Single Group Assignment||Treatment||None (Open Label)||||||
1408517|NCT02181621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408518|NCT02181608|||Case-Control||Cross-Sectional|||||||
1408519|NCT02181595||Single Group Assignment||Supportive Care||None (Open Label)||||||
1408520|NCT02181582|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1408521|NCT02181569|||Cohort||Prospective|||||||
1408522|NCT02181556||Single Group Assignment||Treatment||None (Open Label)||||||
1408523|NCT02181543|Randomized|Parallel Assignment||Prevention||Single|||||t|
1408524|NCT02181530|||Cohort||Retrospective|||||||
1408525|NCT02181517|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408526|NCT02181504|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408527|NCT02181491||Single Group Assignment||Other||None (Open Label)||||||
1408528|NCT02181478||Single Group Assignment||Treatment||None (Open Label)||||||
1408529|NCT02181465|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408530|NCT02181452|||Case-Only||Retrospective|||||||
1408531|NCT02181439|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408532|NCT02181426|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1408533|NCT02181413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408534|NCT02181400|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408535|NCT02181387|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1408536|NCT02181374|||Case Control||Prospective|||||||
1408537|NCT02181361|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408538|NCT02181348|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408539|NCT02181335|Randomized|Parallel Assignment||Treatment||Double||||||
1408540|NCT02181322|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408541|NCT02181309|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408542|NCT02181296|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408543|NCT02181283|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1408544|NCT02181270|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1408545|NCT02181257|||Cohort||Prospective|||||||
1408546|NCT02181244|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1408547|NCT02181231|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408548|NCT02181218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408549|NCT02181205|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1408550|NCT02181192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408551|NCT02181179|Randomized|Parallel Assignment||Basic Science||Single||||||t
1408552|NCT02181166|Randomized|Parallel Assignment||Treatment||Single||||||t
1408553|NCT02181153|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1408554|NCT02181140||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408555|NCT02181127|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1408556|NCT02181114|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1408557|NCT02181101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408558|NCT02181088|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408559|NCT02181075||Single Group Assignment||Treatment||None (Open Label)||||||
1408560|NCT02181062|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408561|NCT02181049|||Cohort||Other|||||||
1408562|NCT02181036||Single Group Assignment||Health Services Research||None (Open Label)||||||
1408563|NCT02181023|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1408564|NCT02181010|Randomized|Factorial Assignment||Prevention||Single|||t|||
1408565|NCT02180997|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408566|NCT02180984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408567|NCT02180971|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1408568|NCT02180958|||Cohort||Prospective|||||||
1408569|NCT02180945|||Cohort||Prospective|||||||
1408570|NCT02180932||Single Group Assignment||Basic Science||None (Open Label)||||||
1408571|NCT02180919|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1408572|NCT02180906|||Cohort||Prospective|||||||
1408573|NCT02180893|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408574|NCT02180880||Single Group Assignment||Treatment||None (Open Label)||||||
1408575|NCT02180867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408576|NCT02180854|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1408577|NCT02180841|Randomized|Crossover Assignment||||Triple|||t||t|t
1408578|NCT02180828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408579|NCT02180815|||Cohort||Prospective|||||||
1408580|NCT02180802|Randomized|Parallel Assignment||Prevention||Single||||||t
1408581|NCT02180789||Single Group Assignment||Treatment||None (Open Label)||||||
1408582|NCT02180776|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408583|NCT02180763||Single Group Assignment||Treatment||None (Open Label)||||||
1408584|NCT02180750|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1408585|NCT02180737||Single Group Assignment||Treatment||None (Open Label)||||||
1408586|NCT02180724||Single Group Assignment||Treatment||None (Open Label)||||||
1408587|NCT02180711|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408588|NCT02180698||Single Group Assignment||Treatment||None (Open Label)||||||
1408589|NCT02180685|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1408590|NCT02180672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408591|NCT02180659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408592|NCT02180646|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1408593|NCT02180633|||Case Control||Cross-Sectional|||||||
1408594|NCT02180620|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1408595|NCT02180607|||Case Control||Cross-Sectional|||||||
1408596|NCT02180581|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1408597|NCT02180568|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408598|NCT02180555|||Cohort||Prospective|||||||
1408599|NCT02180542|||Cohort||Prospective|||||||
1408600|NCT02180529|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408601|NCT02180516|||Cohort||Prospective|||||||
1408602|NCT02180503|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408603|NCT02180490|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408604|NCT02180477|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408605|NCT02180464|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1408606|NCT02180451|||Case-Only||Prospective|||||||
1408607|NCT02180438||Single Group Assignment||Treatment||None (Open Label)||||||
1408608|NCT02180425|||Case-Control||Prospective|||||||
1408609|NCT02180412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408610|NCT02180399|||Other||Other|||||||
1408611|NCT02180386||Single Group Assignment||||None (Open Label)||||||
1408612|NCT02180373|||Cohort||Prospective|||||||
1408613|NCT02180360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408614|NCT02180347|||Case-Crossover||Cross-Sectional|||||||
1408615|NCT02180334|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1408616|NCT02180321|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1408617|NCT02180308||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408618|NCT02180295|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1408619|NCT02180282||Single Group Assignment||Treatment||None (Open Label)||||||
1408620|NCT02180269|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408621|NCT02180256|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408622|NCT02180243|Randomized|Parallel Assignment||Treatment||Single|RBANS assessment is blinded|||||t
1408623|NCT02180230||Single Group Assignment||Treatment||None (Open Label)||||||
1408624|NCT02180217|Randomized|Sequential Assignment||Treatment||Quadruple||It is a double-blind, randomized withdrawal study of LCI699 following a 24 week, single-arm, open-label dose titration and treatment period.|t|t|t|t
1408625|NCT02180204|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408626|NCT02180191|||Case Control||Cross-Sectional|||||||
1408627|NCT02180178|||Cohort||Other|||||||
1408628|NCT02180165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408629|NCT02180152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408630|NCT02180139|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408631|NCT02180126|||Case-Only||Retrospective|||||||
1408632|NCT02180113||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408633|NCT02180100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408634|NCT02180087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408635|NCT02180074|||Case Control||Prospective|||||||
1408636|NCT02180061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408637|NCT02180048|Randomized|Crossover Assignment||Supportive Care||Double|||t|t||
1408638|NCT02180035|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1408639|NCT02180022|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1408640|NCT02180009|||Cohort||Prospective|||||||
1408641|NCT02179996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408642|NCT02179983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408643|NCT02179970||Single Group Assignment||Treatment||None (Open Label)||||||
1408644|NCT02179957|||Cohort||Retrospective|||||||
1408645|NCT02179944|||Cohort||Prospective|||||||
1408646|NCT02179931|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408647|NCT02179918||||Treatment||None (Open Label)||||||
1408648|NCT02179905|||Case Control|||||||||
1408649|NCT02179892|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1408650|NCT02179879|||Cohort||Prospective|||||||
1408651|NCT02179866|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1408652|NCT02179853||Single Group Assignment||Treatment||None (Open Label)||||||
1408653|NCT02179840|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408654|NCT02179827|||Case-Only||Retrospective|||||||
1408655|NCT02179814|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1408656|NCT02179801|||Cohort||Prospective|||||||
1408657|NCT02179788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408658|NCT02179775|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1408659|NCT02179762|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408660|NCT02179749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408661|NCT02179736||Single Group Assignment||Treatment||None (Open Label)||||||
1408662|NCT02179723|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1408663|NCT02179710|||Case-Only||Prospective|||||||
1408664|NCT02179697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408665|NCT02179684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408666|NCT02179671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408667|NCT02179658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408668|NCT02179645|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1408669|NCT02179632|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1408670|NCT02179619|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408671|NCT02179606|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408672|NCT02179593|Randomized|Parallel Assignment||||Single||||||t
1408673|NCT02179580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408674|NCT02179567||Single Group Assignment||Treatment||None (Open Label)||||||
1408675|NCT02179554|||Cohort||Prospective|||||||
1408676|NCT02179541|||Case Control||Prospective|||||||
1408677|NCT02179528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408678|NCT02179515||Single Group Assignment||Treatment||None (Open Label)||||||
1408679|NCT02179502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408680|NCT02179489|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1408681|NCT02179476||Single Group Assignment||Treatment||None (Open Label)||||||
1408682|NCT02179463|||Cohort||Prospective|||||||
1408683|NCT02179450|||Case Control||Prospective|||||||
1408684|NCT02179437|||||Retrospective|||||||
1408685|NCT02179424|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1408686|NCT02179411|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408687|NCT02179398|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408688|NCT02179385|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408689|NCT02179372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408690|NCT02179359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408691|NCT02179346|||Case-Only||Prospective|||||||
1408692|NCT02179333|||Cohort||Prospective|||||||
1408693|NCT02179320|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408694|NCT02179307||Single Group Assignment||Basic Science||None (Open Label)||||||
1408695|NCT02179294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408696|NCT02179281|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408697|NCT02179268|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1408698|NCT02179255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408699|NCT02179242|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408700|NCT02179229|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408701|NCT02179216|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1408702|NCT02179203|||Case-Only||Cross-Sectional|||||||
1408703|NCT02179190||Single Group Assignment||Treatment||None (Open Label)||||||
1408704|NCT02179177|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1408705|NCT02179151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408706|NCT02179138||Single Group Assignment||||None (Open Label)||||||
1408707|NCT02179125||Single Group Assignment||Treatment||None (Open Label)||||||
1408708|NCT02179112|||Ecologic or Community||Prospective|||||||
1408709|NCT02179099||Single Group Assignment||Treatment||None (Open Label)||||||
1408710|NCT02179086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408711|NCT02179073|||Cohort||Prospective|||||||
1408712|NCT02179060|||Case-Control||Prospective|||||||
1408713|NCT02179047|||Case-Control||Prospective|||||||
1408714|NCT02179034|Randomized|Crossover Assignment||Other||Double|||t|t||
1408715|NCT02179021|||Case-Only||Prospective|||||||
1408716|NCT02179008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408717|NCT02178995|Non-Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1408718|NCT02178982|||Cohort||Prospective|||||||
1408719|NCT02178969|||Cohort||Prospective|||||||
1408720|NCT02178956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408721|NCT02178943|||Case-Only||Prospective|||||||
1408722|NCT02178930|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408723|NCT02178917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408724|NCT02178904|||Case-Only||Cross-Sectional|||||||
1408725|NCT02178891||Single Group Assignment||Treatment||None (Open Label)||||||
1408726|NCT02178878|||Cohort||Prospective|||||||
1408727|NCT02178865|||Case-Only||Other|||||||
1408728|NCT02178852|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1408729|NCT02178839|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408730|NCT02178826|Randomized|Single Group Assignment||Treatment||Double||Rapid Maxillary Expansion|t|||t
1408731|NCT02178813||Single Group Assignment||Treatment||None (Open Label)||||||
1408732|NCT02178800|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1408733|NCT02178787|||Case-Control||Cross-Sectional|||||||
1408734|NCT02178774|||Case-Only||Prospective|||||||
1408735|NCT02178761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408736|NCT02178748|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408737|NCT02178735|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408738|NCT02178722|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408739|NCT02178709||Single Group Assignment||Treatment||None (Open Label)||||||
1408740|NCT02178696|Randomized|Crossover Assignment||Other||Single|||t|||
1408741|NCT02178683||Single Group Assignment||Treatment||None (Open Label)||||||
1408742|NCT02178670|Randomized|Parallel Assignment||Treatment||Single|||||t|
1408743|NCT02178657|Randomized|Parallel Assignment||Treatment||Single||||||t
1408744|NCT02178644||Single Group Assignment||Treatment||None (Open Label)||||||
1408745|NCT02178631|Randomized|Parallel Assignment||Treatment||Single||||||t
1408746|NCT02178618||||||||||||
1408747|NCT02178605|||Cohort||Prospective|||||||
1408748|NCT02178592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408749|NCT02178579|||Cohort||Prospective|||||||
1408750|NCT02178566|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408751|NCT02178553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408752|NCT02178540||Single Group Assignment||||None (Open Label)||||||
1408753|NCT02178527|Randomized|Parallel Assignment||Treatment||Single||||||t
1408754|NCT02178514|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1408755|NCT02178501|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1408756|NCT02178488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408757|NCT02178475|||Case-Only||Prospective|||||||
1408758|NCT02178462|||Case-Control||Prospective|||||||
1408759|NCT02178449|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408760|NCT02178436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408761|NCT02178423||Single Group Assignment||Diagnostic||Single||||||t
1408762|NCT02178410|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1408763|NCT02178397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408764|NCT02178384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408765|NCT02178371|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408766|NCT02178358|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408767|NCT02178345|||Cohort||Prospective|||||||
1408768|NCT02178332|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408769|NCT02178319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408770|NCT02178306||Single Group Assignment||Treatment||None (Open Label)||||||
1408771|NCT02178293|Randomized|Parallel Assignment||Treatment||Single||||||
1408772|NCT02178280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408773|NCT02178267||Single Group Assignment||Prevention||None (Open Label)||||||
1408774|NCT02178254|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408775|NCT02178241||Single Group Assignment||Treatment||None (Open Label)||||||
1408776|NCT02178228|||Cohort||Prospective|||||||
1408777|NCT02178215|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408778|NCT02178202||||||||||||
1408779|NCT02178189|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408780|NCT02178176|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1408781|NCT02178163||Single Group Assignment||Other||None (Open Label)||This study will assess the percentage of advanced NSCLC patients whose tumor samples can undergo genomic analysis and in whom therapy can begin based on the results of this analysis.||||
1408782|NCT02178150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408783|NCT02178137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408784|NCT02178124|Randomized|Single Group Assignment||Treatment||Single|||t|||
1408785|NCT02178111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408786|NCT02178098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408787|NCT02178085||Single Group Assignment||Basic Science||None (Open Label)||||||
1408788|NCT02178072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408789|NCT02178059|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1408790|NCT02178046|||Case-Only||Prospective|||||||
1408791|NCT02178033|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1408792|NCT02178020|||Case-Control||Prospective|||||||
1408793|NCT02177994|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408794|NCT02177981|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1408795|NCT02177968|||Case-Only||Cross-Sectional|||||||
1408796|NCT02177955|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1408797|NCT02177942|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1408798|NCT02177929||Single Group Assignment||Treatment||None (Open Label)||||||
1408799|NCT02177916|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1408800|NCT02177903|Randomized|Parallel Assignment||Prevention||Single||||||t
1408801|NCT02177890|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1408802|NCT02177877|||||Prospective|||||||
1408803|NCT02177864|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408804|NCT02177851|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1408805|NCT02177838||Single Group Assignment||Treatment||None (Open Label)||||||
1408806|NCT02177825||Single Group Assignment||Treatment||None (Open Label)||||||
1408807|NCT02177812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408808|NCT02177799|||||Prospective|||||||
1408809|NCT02177786|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408810|NCT02177773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408811|NCT02177760||Single Group Assignment||Prevention||None (Open Label)||||||
1408812|NCT02177747||Single Group Assignment||||||||||
1408813|NCT02177734|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1408814|NCT02177721||Single Group Assignment||Treatment||None (Open Label)||||||
1408815|NCT02177708|||Cohort||Prospective|||||||
1408816|NCT02177695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408817|NCT02177682||||Treatment||None (Open Label)||||||
1408818|NCT02177669|||Cohort||Prospective|||||||
1408819|NCT02177656|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1408820|NCT02177643|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408821|NCT02177630|||Cohort||Prospective|||||||
1408822|NCT02177617|Randomized|Parallel Assignment||Treatment||Single||||||t
1408823|NCT02177604|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408824|NCT02177591|||Cohort||Cross-Sectional|||||||
1408825|NCT02177578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408826|NCT02177565|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408827|NCT02177552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408828|NCT02177539|Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1408829|NCT02177526||Single Group Assignment||Diagnostic||Single|||||t|
1408830|NCT02177513|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1408831|NCT02177500|Randomized|Parallel Assignment||Treatment||Double||||||
1408832|NCT02177487||Single Group Assignment||Treatment||None (Open Label)||||||
1408833|NCT02177474|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408834|NCT02177461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408835|NCT02177448|Randomized|Parallel Assignment||Treatment||Double||||||
1408836|NCT02177435|Randomized|Parallel Assignment||Treatment||Double||||||
1408837|NCT02177422||Parallel Assignment||Treatment||None (Open Label)||||||
1408838|NCT02177409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408839|NCT02177396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408840|NCT02177383|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1408841|NCT02177370|Randomized|Crossover Assignment||Treatment||Double||||||
1408842|NCT02177357|Randomized|Parallel Assignment||Treatment||Double||||||
1408843|NCT02177344|Randomized|Parallel Assignment||Treatment||Double||||||
1408844|NCT02177331||Single Group Assignment||Treatment||None (Open Label)||||||
1408845|NCT02177318|||Cohort||Prospective|||||||
1408846|NCT02177305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1408847|NCT02177292||Single Group Assignment||Treatment||None (Open Label)||||||
1408848|NCT02177279|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1408849|NCT02177266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408850|NCT02177253|Randomized|Parallel Assignment||Treatment||Double||||||
1408851|NCT02177240|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1408852|NCT02177227|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1408853|NCT02177214|||Cohort||Prospective|||||||
1408854|NCT02177201|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1408855|NCT02177188||Single Group Assignment||Basic Science||None (Open Label)||||||
1408856|NCT02177175|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1408857|NCT02177162||Single Group Assignment||Health Services Research||None (Open Label)||||||
1408858|NCT02177149|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1408859|NCT02177136|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1408860|NCT02177123||Single Group Assignment||Treatment||None (Open Label)||||||
1408861|NCT02177110|||Cohort||Prospective|||||||
1408862|NCT02177097|||Cohort||Retrospective|||||||
1408863|NCT02177084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408864|NCT02177071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408865|NCT02177058|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1408866|NCT02177045||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408867|NCT02177032|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408868|NCT02177019||Single Group Assignment||Prevention||None (Open Label)||||||
1408869|NCT02177006|||Cohort||Prospective|||||||
1408870|NCT02176993|||Cohort||Prospective|||||||
1408871|NCT02176980|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1408872|NCT02176967|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408873|NCT02176954|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1408874|NCT02176941|||Case Control||Cross-Sectional|||||||
1408875|NCT02176928|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1408876|NCT02176915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408877|NCT02176902|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408878|NCT02176889|Randomized|Parallel Assignment||||Double|||t||t|
1408879|NCT02176876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408880|NCT02176863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408881|NCT02176850|||Cohort||Prospective|||||||
1408882|NCT02176837||Single Group Assignment||Treatment||None (Open Label)||||||
1408883|NCT02176824|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408884|NCT02176811|||Case Control||Cross-Sectional|||||||
1408885|NCT02176785|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1408886|NCT02176772|||Case-Crossover||Prospective|||||||
1408887|NCT02176759|Randomized|Crossover Assignment||Prevention||Single|||t|||
1408888|NCT02176746|Randomized|Parallel Assignment||Treatment||Single|||||t|
1408889|NCT02176733||Single Group Assignment||Treatment||None (Open Label)||||||
1408890|NCT02176720|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1408891|NCT02176707|||Cohort||Prospective|||||||
1408892|NCT02176694|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1408893|NCT02176681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408894|NCT02176668|Randomized|Parallel Assignment||||None (Open Label)||||||
1408895|NCT02176655|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1408896|NCT02176642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408897|NCT02176629|Randomized|Crossover Assignment||||None (Open Label)||||||
1408898|NCT02176616|Randomized|Parallel Assignment||Treatment||Single|||||t|
1408899|NCT02176603|||Case-Control||Cross-Sectional|||||||
1408900|NCT02176590|Randomized|Parallel Assignment||Prevention||Single||||||t
1408901|NCT02176577||Single Group Assignment||Treatment||None (Open Label)||||||
1408902|NCT02176564|||Cohort||Prospective|||||||
1408903|NCT02176551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408904|NCT02176538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408905|NCT02176525|Randomized|Parallel Assignment||Treatment||Double||||||
1408906|NCT02176512|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408907|NCT02176499|Randomized|Parallel Assignment||Treatment||Double||||||
1408908|NCT02176486|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408909|NCT02176473||Single Group Assignment||Treatment||None (Open Label)||||||
1408910|NCT02176460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408911|NCT02176434||Single Group Assignment||Treatment||None (Open Label)||||||
1408912|NCT02176421||Single Group Assignment||Treatment||None (Open Label)||||||
1408913|NCT02176408|Randomized|Parallel Assignment||Treatment||Single||||||t
1408914|NCT02176395|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1408915|NCT02176382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408916|NCT02176369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408917|NCT02176356||Single Group Assignment||Treatment||Single||||||t
1408918|NCT02176343||Single Group Assignment||Other||None (Open Label)||||||
1408919|NCT02176330|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1408920|NCT02176317||Single Group Assignment||Treatment||None (Open Label)||||||
1408921|NCT02176304|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408922|NCT02176291|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1408923|NCT02176278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408924|NCT02176265||Single Group Assignment||Treatment||None (Open Label)||||||
1408925|NCT02176252||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1408926|NCT02176239|||Cohort||Prospective|||||||
1408927|NCT02176226||Single Group Assignment||Treatment||None (Open Label)||||||
1408928|NCT02176213||Single Group Assignment||Treatment||None (Open Label)||||||
1408929|NCT02176200|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408930|NCT02176187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1408931|NCT02176174|||Cohort||Prospective|||||||
1408932|NCT02176161|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408933|NCT02176148|||Cohort||Prospective|||||||
1408934|NCT02176135||Single Group Assignment||Treatment||None (Open Label)||||||
1408935|NCT02176122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408936|NCT02176109|||Cohort||Prospective|||||||
1408937|NCT02176096||Single Group Assignment||Treatment||None (Open Label)||||||
1408938|NCT02176083|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408939|NCT02176070|||Cohort||Cross-Sectional|||||||
1408940|NCT02176057|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1408941|NCT02176044|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1408942|NCT02176031||Single Group Assignment||Treatment||None (Open Label)||||||
1408943|NCT02176018|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1408944|NCT02176005|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408945|NCT02175992|||Cohort||Prospective|||||||
1408946|NCT02175979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408947|NCT02175966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408948|NCT02175953|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408949|NCT02175940|||Case Control||Prospective|||||||
1408950|NCT02175927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408951|NCT02175914||Single Group Assignment||Treatment||None (Open Label)||||||
1408952|NCT02175901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408953|NCT02175888|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408954|NCT02175875|||Case-Only||Prospective|||||||
1408955|NCT02175862|||Cohort||Prospective|||||||
1408956|NCT02175849|||Cohort||Prospective|||||||
1408957|NCT02175836|||Cohort||Prospective|||||||
1408958|NCT02175823|||Ecologic or Community||Prospective|||||||
1408959|NCT02175810|||Cohort||Prospective|||||||
1408960|NCT02175797||Single Group Assignment||||None (Open Label)||||||
1408961|NCT02175784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1408962|NCT02175771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408963|NCT02175758|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408964|NCT02175745||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408965|NCT02175732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408966|NCT02175719|||Cohort||Prospective|||||||
1408967|NCT02175706|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408968|NCT02175693|||Cohort||Prospective|||||||
1408969|NCT02175680||Single Group Assignment||Treatment||None (Open Label)||||||
1408970|NCT02175667|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1408971|NCT02175654||Single Group Assignment||Treatment||None (Open Label)||||||
1408972|NCT02175641|Randomized|Parallel Assignment||Treatment||Single||||||t
1408973|NCT02175628||Single Group Assignment||Diagnostic||None (Open Label)||||||
1408974|NCT02175615|||Cohort||Prospective|||||||
1408975|NCT02175602|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1408976|NCT02175589|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408977|NCT02175576|Randomized|Parallel Assignment||Treatment||Single|||t|||
1408978|NCT02175563|Randomized|Parallel Assignment||Basic Science||Single||||||t
1408979|NCT02175550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408980|NCT02175537|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1408981|NCT02175524|||Case Control||Prospective|||||||
1408982|NCT02175511|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1408983|NCT02175498||Single Group Assignment||Treatment||None (Open Label)||||||
1408984|NCT02175485||Single Group Assignment||Treatment||None (Open Label)||||||
1408985|NCT02175472|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1408986|NCT02175459|||Cohort||Cross-Sectional|||||||
1408987|NCT02175446||Single Group Assignment||Treatment||None (Open Label)||||||
1408988|NCT02175433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408989|NCT02175420|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1408990|NCT02175407|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1408991|NCT02175394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408992|NCT02175381|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408993|NCT02175368||Single Group Assignment||Treatment||None (Open Label)||||||
1408994|NCT02175355|Randomized|Parallel Assignment||Treatment||Double||||||
1408995|NCT02175342|Randomized|Parallel Assignment||Treatment||Double||||||
1408996|NCT02175329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1408997|NCT02175316||Single Group Assignment||Prevention||None (Open Label)||||||
1408998|NCT02175303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1408999|NCT02175290|||Cohort||Prospective|||||||
1409000|NCT02175277||Single Group Assignment||Treatment||None (Open Label)||||||
1409001|NCT02175264|||Case-Only||Prospective|||||||
1409002|NCT02175251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409003|NCT02175238|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409004|NCT02175225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409005|NCT02175212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409006|NCT02175199|Randomized|Parallel Assignment||||Single|||t|||
1409007|NCT02175186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409008|NCT02175173|||Other||Retrospective|||||||
1409009|NCT02175160|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1409010|NCT02175147|||Cohort||Prospective|||||||
1409011|NCT02175134|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1409012|NCT02175121|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409013|NCT02175108|||Cohort||Cross-Sectional|||||||
1409014|NCT02175095||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409015|NCT02175082|Randomized|Parallel Assignment||Treatment||Single||||||t
1409016|NCT02175069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409017|NCT02175056|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409018|NCT02175043|Randomized|Parallel Assignment||Treatment||Single|||||t|
1409019|NCT02175030|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409020|NCT02175017||Single Group Assignment||Treatment||None (Open Label)||||||
1409021|NCT02175004||Single Group Assignment||Treatment||None (Open Label)||||||
1409022|NCT02174991|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1409023|NCT02174978|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409024|NCT02174965|Randomized|Parallel Assignment||Treatment||Single||||||t
1409025|NCT02174952|Randomized|Parallel Assignment||Treatment||Single||||||t
1409026|NCT02174939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409027|NCT02174926|Randomized|||||None (Open Label)||||||
1409028|NCT02174913|Randomized|Parallel Assignment||||Triple|||t|t||t
1409029|NCT02174900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409030|NCT02174887||Single Group Assignment||Treatment||None (Open Label)||||||
1409031|NCT02174874|||Cohort||Prospective|||||||
1409032|NCT02174861||Single Group Assignment||Treatment||None (Open Label)||||||
1409033|NCT02174848||Single Group Assignment||Treatment||None (Open Label)||||||
1409034|NCT02174835|Randomized|Crossover Assignment||||None (Open Label)||||||
1409035|NCT02174822|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1409036|NCT02174809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409037|NCT02174796|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409038|NCT02174783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409039|NCT02174770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409040|NCT02174757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409041|NCT02174744|||||Cross-Sectional|||||||
1409042|NCT02174731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409043|NCT02174718|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409044|NCT02174705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409045|NCT02174692|Randomized|Parallel Assignment||||None (Open Label)||||||
1409046|NCT02174679||||||||||||
1409047|NCT02174666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409048|NCT02174653|Randomized|Parallel Assignment||||Double|||t||t|
1409049|NCT02174640|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1409050|NCT02174627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409051|NCT02174614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409052|NCT02174601|||||Prospective|||||||
1409053|NCT02174588|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1409054|NCT02174575|Randomized|Parallel Assignment||Prevention||Single||||||t
1409055|NCT02174562|Randomized|Parallel Assignment||Prevention||Single||||||t
1409056|NCT02174549||Single Group Assignment||Treatment||None (Open Label)||Open label, dose escalation 3+3 design; 3 expansion cohorts: hepatocellular carcinoma, advanced solid tumors and neuroendocrine tumor.||||
1409057|NCT02174536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409058|NCT02174523|Randomized|Parallel Assignment||||Triple|||t|t|t|
1409059|NCT02174510|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1409060|NCT02174497|||Cohort||Prospective|||||||
1409061|NCT02174484|||Cohort||Prospective|||||||
1409062|NCT02174471|||Cohort||Prospective|||||||
1409063|NCT02174458|||Case Control||Prospective|||||||
1409064|NCT02174445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409065|NCT02174432|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409066|NCT02174419|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409067|NCT02174406|||Case-Only||Prospective|||||||
1409068|NCT02174393||Single Group Assignment||Treatment||None (Open Label)||||||
1409069|NCT02174380|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1409070|NCT02174367|||Cohort||Prospective|||||||
1409071|NCT02174354|||Cohort|||||||||
1409072|NCT02174341|||Case-Control||Other|||||||
1409073|NCT02174328|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1409074|NCT02174315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409075|NCT02174302|||||Prospective|||||||
1409076|NCT02174289|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1409077|NCT02174276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409078|NCT02174263||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409079|NCT02174250|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1409080|NCT02174237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409081|NCT02174224||Single Group Assignment||Health Services Research||None (Open Label)||||||
1409082|NCT02174211|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409083|NCT02174198|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409084|NCT02174185|||Cohort||Prospective|||||||
1409085|NCT02174172|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409086|NCT02174159|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409087|NCT02174146||Single Group Assignment||Diagnostic||Single||||||t
1409088|NCT02174133|||Cohort||Prospective|||||||
1409089|NCT02174120|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409090|NCT02174107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409091|NCT02174094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409092|NCT02174081|||Cohort|||||||||
1409093|NCT02174068||Single Group Assignment||Treatment||None (Open Label)||||||
1409094|NCT02174055|||Case-Only||Prospective|||||||
1409095|NCT02174042||Single Group Assignment||Treatment||None (Open Label)||||||
1409096|NCT02174029|||Cohort||Prospective|||||||
1409097|NCT02174016||Single Group Assignment||Other||None (Open Label)||Open label use of ketogenic diet in children with acute brain injury||||
1409098|NCT02174003|||||Prospective|||||||
1409099|NCT02173990||Single Group Assignment||Treatment||None (Open Label)||||||
1409100|NCT02173977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409101|NCT02173964|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1409102|NCT02173951|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409103|NCT02173938|||Cohort||Prospective|||||||
1409104|NCT02173925|||Case Control||Prospective|||||||
1409105|NCT02173912|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1409106|NCT02173899|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409107|NCT02173886|Randomized|Crossover Assignment||||None (Open Label)||||||
1409108|NCT02173873||Single Group Assignment||Treatment||None (Open Label)||||||
1409109|NCT02173860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409110|NCT02173847||Single Group Assignment||Treatment||None (Open Label)||||||
1409111|NCT02173834|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409112|NCT02173821||||||||||||
1409113|NCT02173808||Single Group Assignment||Prevention||None (Open Label)||||||
1409114|NCT02173795|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409115|NCT02173782|Randomized|Parallel Assignment||Treatment||Double||||||
1409116|NCT02173769|||Cohort||Prospective|||||||
1409117|NCT02173756|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409118|NCT02173743|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409119|NCT02173730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409120|NCT02173717||Single Group Assignment||Treatment||None (Open Label)||||||
1409121|NCT02173704|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409122|NCT02173691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409123|NCT02173678|Randomized|Crossover Assignment||Treatment||Double||||||
1409124|NCT02173665|Randomized|Single Group Assignment||Treatment||Double||||||
1409125|NCT02173652|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409126|NCT02173639|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409127|NCT02173626||Single Group Assignment||||None (Open Label)||||||
1409128|NCT02173613|Randomized|Parallel Assignment||||None (Open Label)||||||
1409129|NCT02173600|Randomized|Parallel Assignment||Prevention||Single|||||t|
1409130|NCT02173587|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1409131|NCT02173574|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409132|NCT02173561|Randomized|Parallel Assignment||Treatment||Single||||||t
1409133|NCT02173548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409134|NCT02173535|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1409135|NCT02173522|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409136|NCT02173509||Single Group Assignment||||None (Open Label)||||||
1409137|NCT02173496|||Case-Only||Prospective|||||||
1409138|NCT02173483|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1409139|NCT02173470|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1409140|NCT02173457|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409141|NCT02173444||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409142|NCT02173431|||Cohort||Prospective|||||||
1409143|NCT02173418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409144|NCT02173405|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1409145|NCT02173392|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409146|NCT02173379|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409147|NCT02173366||Single Group Assignment||Prevention||||||||
1409148|NCT02173353||Single Group Assignment||Other||None (Open Label)||||||
1409149|NCT02173340|||||Prospective|||||||
1409150|NCT02173327|Randomized|Parallel Assignment||Prevention||Single||||||t
1409151|NCT02173314|Randomized|||Treatment||||||||
1409152|NCT02173301|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409153|NCT02173288|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409154|NCT02173275|||Cohort||Prospective|||||||
1409155|NCT02173262|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409156|NCT02173249||Single Group Assignment||Treatment||None (Open Label)||||||
1409157|NCT02173236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409158|NCT02173223|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409159|NCT02173210|||Cohort||Prospective|||||||
1409160|NCT02173197|||Cohort||Prospective|||||||
1409161|NCT02173184|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409162|NCT02173171|||Cohort||Prospective|||||||
1409163|NCT02173158||Single Group Assignment||Treatment||None (Open Label)||||||
1409164|NCT02173145|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1409165|NCT02173132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409166|NCT02173119|||Cohort||Prospective|||||||
1409167|NCT02173106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409168|NCT02173093||Single Group Assignment||Treatment||None (Open Label)||||||
1409169|NCT02173080|||Cohort||Cross-Sectional|||||||
1409170|NCT02173067|||||Prospective|||||||
1409171|NCT02173054|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409172|NCT02173041|Randomized|Parallel Assignment||Treatment||Single||||||t
1409173|NCT02173028|||Case-Control||Prospective|||||||
1409174|NCT02173015|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409175|NCT02173002|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1409176|NCT02172989|||Case-Only||Prospective|||||||
1409177|NCT02172976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409178|NCT02172963|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409179|NCT02172950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409180|NCT02172937|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409181|NCT02172924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409182|NCT02172911||Single Group Assignment||Treatment||None (Open Label)||||||
1409183|NCT02172898|||Case-Control||Prospective|||||||
1409184|NCT02172885||Single Group Assignment||Treatment||None (Open Label)||||||
1409185|NCT02172872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409186|NCT02172859|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1409187|NCT02172846||Single Group Assignment||Treatment||None (Open Label)||||||
1409188|NCT02172833|||Case Control||Retrospective|||||||
1409189|NCT02172820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409190|NCT02172807|Randomized|Parallel Assignment||Treatment||Double||||||
1409191|NCT02172794|Randomized|Crossover Assignment||Treatment||Double||||||
1409192|NCT02172781|Randomized|Crossover Assignment||Treatment||Double||||||
1409193|NCT02172768|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1409194|NCT02172755|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409195|NCT02172742|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1409196|NCT02172729|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1409197|NCT02172716||Single Group Assignment||Treatment||None (Open Label)||||||
1409198|NCT02172703||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409199|NCT02172690||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409200|NCT02172677||Single Group Assignment||Basic Science||None (Open Label)||||||
1409201|NCT02172664|Randomized|Parallel Assignment||Treatment||Single||||||t
1409202|NCT02172651||Single Group Assignment||Basic Science||None (Open Label)||||||
1409203|NCT02172638|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409204|NCT02172625|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1409205|NCT02172612|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409206|NCT02172599|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1409207|NCT02172586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409208|NCT02172573|Randomized|Parallel Assignment||Treatment||Double||||||
1409209|NCT02172560|||Case-Only||Retrospective|||||||
1409210|NCT02172547|||Cohort||Prospective|||||||
1409211|NCT02172534|Randomized|Parallel Assignment||Treatment||Double||||||
1409212|NCT02172521|||Cohort||Prospective|||||||
1409213|NCT02172508|Randomized|Parallel Assignment||Treatment||Double||||||
1409214|NCT02172495|||Cohort||Prospective|||||||
1409215|NCT02172482|||Cohort||Prospective|||||||
1409216|NCT02172469|Randomized|Parallel Assignment||Treatment||Double||||||
1409217|NCT02172456||Single Group Assignment||Treatment||None (Open Label)||||||
1409218|NCT02172443|Randomized|Parallel Assignment||Treatment||Double||||||
1409219|NCT02172430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409220|NCT02172417|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409221|NCT02172404|Randomized|Single Group Assignment||Treatment||Single|||t|||
1409222|NCT02172391|Randomized|Parallel Assignment||Treatment||Double||||||
1409223|NCT02172378|Randomized|Parallel Assignment||Treatment||Double||||||
1409224|NCT02172365|||||Retrospective|||||||
1409225|NCT02172352|Randomized|Crossover Assignment||Treatment||Double||||||
1409226|NCT02172339||Parallel Assignment||Treatment||None (Open Label)||||||
1409227|NCT02172326||Single Group Assignment||Treatment||None (Open Label)||||||
1409228|NCT02172313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409229|NCT02172300|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409230|NCT02172287|Randomized|Parallel Assignment||Treatment||Double||||||
1409231|NCT02172274||Single Group Assignment||Treatment||None (Open Label)||||||
1409232|NCT02172261|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409233|NCT02172248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409234|NCT02172235|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409235|NCT02172222|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409236|NCT02172209|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409237|NCT02172196|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409238|NCT02172183|Randomized|Parallel Assignment||Treatment||Single|||||t|
1409239|NCT02172170|Randomized|Parallel Assignment||Treatment||Double||||||
1409240|NCT02172157|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409241|NCT02172144|Randomized|Crossover Assignment||Treatment||Double||||||
1409242|NCT02172131|Randomized|Parallel Assignment||Treatment||Single||||||
1409243|NCT02172118|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409244|NCT02172105|Randomized|Parallel Assignment||Treatment||Double||||||
1409245|NCT02172092||Single Group Assignment||Other||None (Open Label)||||||
1409246|NCT02172079|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409247|NCT02172066|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1409248|NCT02172053|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1409249|NCT02172040|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409250|NCT02172027|||Case-Only||Prospective|||||||
1409251|NCT02172014|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1409252|NCT02172001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409253|NCT02171988|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409254|NCT02171975|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409255|NCT02171962||Single Group Assignment||Treatment||None (Open Label)||||||
1409256|NCT02171949|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409257|NCT02171936||||||||||||
1409258|NCT02171923|||Case Control|||||||||
1409259|NCT02171910|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1409260|NCT02171897|Randomized|Parallel Assignment||||None (Open Label)||||||
1409261|NCT02171884|||Cohort||Prospective|||||||
1409262|NCT02171871||Single Group Assignment||Prevention||Single||||||t
1409263|NCT02171858|||Cohort||Prospective|||||||
1409264|NCT02171845|||Case-Only||Prospective|||||||
1409265|NCT02171832|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409266|NCT02171819|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1409267|NCT02171806|Randomized|Parallel Assignment||Treatment||Double||||||
1409268|NCT02171793|Randomized|Parallel Assignment||Treatment||Single||||||
1409269|NCT02171780|Randomized|Parallel Assignment||Treatment||Double||||||
1409270|NCT02171767||Single Group Assignment||Treatment||None (Open Label)||||||
1409271|NCT02171754|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409272|NCT02171741||Single Group Assignment||Treatment||None (Open Label)||||||
1409273|NCT02171728||Single Group Assignment||Treatment||None (Open Label)||||||
1409274|NCT02171715|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409275|NCT02171702|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409276|NCT02171689||Single Group Assignment||Treatment||None (Open Label)||||||
1409277|NCT02171676|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409278|NCT02171663||Single Group Assignment||Treatment||None (Open Label)||||||
1409279|NCT02171650||Single Group Assignment||Treatment||None (Open Label)||||||
1409280|NCT02171637||Single Group Assignment||Treatment||None (Open Label)||||||
1409281|NCT02171624|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409282|NCT02171611|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409283|NCT02171598|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409284|NCT02171585|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409285|NCT02171572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409286|NCT02171559|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409287|NCT02171546|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409288|NCT02171533|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409289|NCT02171520|Randomized|Crossover Assignment||Treatment||Double||||||
1409290|NCT02171507|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409291|NCT02171494|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409292|NCT02171481|Randomized|Crossover Assignment||Treatment||Double||||||
1409293|NCT02171468|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409294|NCT02171455|Randomized|Parallel Assignment||Treatment||Double||||||
1409295|NCT02171442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409296|NCT02171429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409297|NCT02171416|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409298|NCT02171403|||Case Control||Prospective|||||||
1409299|NCT02171390|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409300|NCT02171377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409301|NCT02171364|Randomized|Parallel Assignment||Treatment||Single|||||t|
1409302|NCT02171351|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1409303|NCT02171338|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1409304|NCT02171325||Single Group Assignment||Treatment||None (Open Label)||||||
1409305|NCT02171312|||Case Control||Prospective|||||||
1409306|NCT02171299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409307|NCT02171286|||Other||Other|||||||
1409308|NCT02171273|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1409309|NCT02171260||Single Group Assignment||Treatment||None (Open Label)||||||
1409310|NCT02171247|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1409311|NCT02171234|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409312|NCT02171221||Single Group Assignment||Treatment||None (Open Label)||||||
1409313|NCT02171208|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1409314|NCT02171195|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409315|NCT02171182|||Cohort||Prospective|||||||
1409316|NCT02171169|||Cohort||Retrospective|||||||
1409317|NCT02171156||||||||||||
1409318|NCT02171143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409319|NCT02171130||Single Group Assignment||Treatment||None (Open Label)||||||
1409320|NCT02171117|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409321|NCT02171104|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409322|NCT02171091|||Other||Prospective|||||||
1409323|NCT02171078|||Other||Other|||||||
1409324|NCT02171065|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1409325|NCT02171052|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409326|NCT02171039|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409327|NCT02171026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409328|NCT02171013|Randomized|Crossover Assignment||Treatment||Double||||||
1409329|NCT02171000||Single Group Assignment||Treatment||None (Open Label)||||||
1409330|NCT02170987|Randomized|Crossover Assignment||Treatment||Double||||||
1409331|NCT02170974|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409332|NCT02170961|||Cohort||Prospective|||||||
1409333|NCT02170948|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409334|NCT02170935||Single Group Assignment||Treatment||None (Open Label)||||||
1409335|NCT02170922|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409336|NCT02170909|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409337|NCT02170896|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409338|NCT02170883|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1409339|NCT02170870|Randomized|Single Group Assignment||Basic Science||Triple|||t|t|t|
1409340|NCT02170857|Randomized|Single Group Assignment||Treatment||Single|||t|||
1409341|NCT02170844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409342|NCT02170831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409343|NCT02170818|Randomized|Parallel Assignment||||Double|||t|||t
1409344|NCT02170805|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409345|NCT02170792|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409346|NCT02170779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409347|NCT02170766|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409348|NCT02170753|Randomized|Parallel Assignment||Treatment||Single||||||t
1409349|NCT02170740|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409350|NCT02170727||Single Group Assignment||Treatment||None (Open Label)||||||
1409351|NCT02170714|||Cohort||Prospective|||||||
1409352|NCT02170701||Single Group Assignment||Treatment||None (Open Label)||||||
1409353|NCT02170688|Randomized|Parallel Assignment||||Single|||t|||
1409354|NCT02170675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409355|NCT02170662|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1409356|NCT02170649||Single Group Assignment||Treatment||None (Open Label)||||||
1409357|NCT02170636|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409358|NCT02170623|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409359|NCT02170610|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409360|NCT02170597|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409361|NCT02170584|Randomized|Crossover Assignment||Treatment||Double||||||
1409362|NCT02170571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409363|NCT02170558|||Case-Only||Prospective|||||||
1409364|NCT02170545|||Case-Control||Prospective|||||||
1409678|NCT02166450|||Case Control||Prospective|||||||
1409365|NCT02170532|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409366|NCT02170519|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409367|NCT02170506||Single Group Assignment||||None (Open Label)||||||
1409368|NCT02170493|||Cohort||Prospective|||||||
1409369|NCT02170480|||Cohort||Prospective|||||||
1409370|NCT02170467|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1409371|NCT02170454|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1409372|NCT02170441|||Cohort||Prospective|||||||
1409373|NCT02170428|||Cohort||Prospective|||||||
1409374|NCT02170415|Randomized|Parallel Assignment||Prevention||Single|||t|||
1409375|NCT02170402|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1409376|NCT02170389||Single Group Assignment||Treatment||None (Open Label)||||||
1409377|NCT02170376|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409378|NCT02170363||Single Group Assignment||Treatment||None (Open Label)||||||
1409379|NCT02170350||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409380|NCT02170337|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1409381|NCT02170324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409382|NCT02170311|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409383|NCT02170298|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1409384|NCT02170285|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1409385|NCT02170272||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409386|NCT02170259|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1409387|NCT02170246|Randomized|Parallel Assignment||||Double|||||t|t
1409388|NCT02170233|||Cohort||Prospective|||||||
1409389|NCT02170220|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409390|NCT02170207|||Cohort||Prospective|||||||
1409391|NCT02170194|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1409392|NCT02170181|||Other||Prospective|||||||
1409393|NCT02170168|||Cohort||Prospective|||||||
1409394|NCT02170155|||Case-Control||Cross-Sectional|||||||
1409395|NCT02170142|||Cohort||Prospective|||||||
1409396|NCT02170129|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1409397|NCT02170116|Randomized|Parallel Assignment||Treatment||Double||||||
1409398|NCT02170103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409399|NCT02170090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409400|NCT02170077|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409401|NCT02170064||Parallel Assignment||Treatment||None (Open Label)||||||
1409402|NCT02170051|Randomized|Parallel Assignment||Treatment||Single||||||t
1409403|NCT02170038|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1409404|NCT02170025|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409405|NCT02170012|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1409406|NCT02169999|Randomized|Parallel Assignment||||Single|||t|||
1409407|NCT02169986|Randomized|Parallel Assignment||Treatment||Single|||||t|
1409408|NCT02169973|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409409|NCT02169960|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1409410|NCT02169947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409411|NCT02169934||Single Group Assignment||Treatment||None (Open Label)||||||
1409412|NCT02169921||Single Group Assignment||Treatment||None (Open Label)||||||
1409413|NCT02169908||Single Group Assignment||||None (Open Label)||||||
1409414|NCT02169895|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1409415|NCT02169882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409416|NCT02169869|Randomized|Parallel Assignment||Other||None (Open Label)||randomized-controlled trial||||
1409417|NCT02169856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409418|NCT02169843|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1409419|NCT02169830|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409420|NCT02169817||Single Group Assignment||Treatment||None (Open Label)||||||
1409421|NCT02169804|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409422|NCT02169791||Single Group Assignment||Prevention||None (Open Label)||||||
1409423|NCT02169778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409424|NCT02169765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409425|NCT02169752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409426|NCT02169739|Randomized|Parallel Assignment||Prevention||Single||||||t
1409427|NCT02169726|||Case-Control||Prospective|||||||
1409428|NCT02169713|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1409429|NCT02169700|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409430|NCT02169687||Single Group Assignment||Treatment||None (Open Label)||||||
1409431|NCT02169674|||Cohort||Prospective|||||||
1409432|NCT02169661||Single Group Assignment||Basic Science||Single|||||t|
1409433|NCT02169648||Single Group Assignment||Treatment||None (Open Label)||||||
1409434|NCT02169635||Single Group Assignment||Treatment||None (Open Label)||||||
1409435|NCT02169622|||Case-Only||Prospective|||||||
1409436|NCT02169609||Single Group Assignment||Treatment||None (Open Label)||||||
1409437|NCT02169596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409438|NCT02169583|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409439|NCT02169570|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1409440|NCT02169557||Single Group Assignment||Treatment||None (Open Label)||||||
1409441|NCT02169544|||Cohort||Retrospective|||||||
1409679|NCT02166437|||Case-Only||Prospective|||||||
1409442|NCT02169531||Single Group Assignment||Treatment||None (Open Label)||||||
1409443|NCT02169518|||Case-Only||Other|||||||
1409444|NCT02169505||Single Group Assignment||Treatment||None (Open Label)||||||
1409445|NCT02169492|||Other||Prospective|||||||
1409446|NCT02169479|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1409447|NCT02169466|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1409448|NCT02169453|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1409449|NCT02169440|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409450|NCT02169427||Single Group Assignment||Treatment||None (Open Label)||||||
1409451|NCT02169414|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409452|NCT02169401|||Cohort||Prospective|||||||
1409453|NCT02169388|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1409454|NCT02169375|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1409455|NCT02169362|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1409456|NCT02169349|||Case-Only||Prospective|||||||
1409457|NCT02169336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409458|NCT02169323||Single Group Assignment||Treatment||None (Open Label)||||||
1409459|NCT02169310|||Cohort||Prospective|||||||
1409460|NCT02169297|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1409461|NCT02169284|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409462|NCT02169271|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1409463|NCT02169258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409464|NCT02169245|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1409465|NCT02169232|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1409466|NCT02169219||Single Group Assignment||Treatment||None (Open Label)||||||
1409467|NCT02169206||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409468|NCT02169193||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409469|NCT02169180||Single Group Assignment||Treatment||None (Open Label)||||||
1409470|NCT02169167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409471|NCT02169154|Randomized|Single Group Assignment||Other||Single||||||t
1409472|NCT02169141|||||Prospective|||||||
1409473|NCT02169128|||Cohort||Prospective|||||||
1409474|NCT02169115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409475|NCT02169102|Randomized|Parallel Assignment||||Single|||t|||
1409476|NCT02169089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409477|NCT02169076|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1409478|NCT02169063||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409479|NCT02169050|||Case-Only||Cross-Sectional|||||||
1409480|NCT02169037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409481|NCT02169024||Single Group Assignment||Prevention||None (Open Label)||||||
1409482|NCT02169011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409483|NCT02168998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409484|NCT02168985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409485|NCT02168972||Single Group Assignment||Treatment||None (Open Label)||||||
1409486|NCT02168959|Randomized|Parallel Assignment||||None (Open Label)||||||
1409487|NCT02168946|Randomized|Parallel Assignment||Treatment||Single|Blinded adjudication committee|||||t
1409488|NCT02168933|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409489|NCT02168920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409490|NCT02168907||Single Group Assignment||Treatment||None (Open Label)||||||
1409491|NCT02168894|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1409492|NCT02168881|Randomized|Parallel Assignment||||None (Open Label)||||||
1409493|NCT02168868|||Case Control||Cross-Sectional|||||||
1409494|NCT02168855|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409495|NCT02168842|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409496|NCT02168829|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409497|NCT02168816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409498|NCT02168803|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1409499|NCT02168790||Single Group Assignment||Treatment||None (Open Label)||||||
1409500|NCT02168777|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409501|NCT02168764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409502|NCT02168751|Randomized|Parallel Assignment||Treatment||Single||||||t
1409503|NCT02168738|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1409504|NCT02168725||Single Group Assignment||Treatment||None (Open Label)||||||
1409505|NCT02168712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409506|NCT02168699||||||||||||
1409507|NCT02168686|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Open-label, multicenter, dose-escalation clinical study to assess the safety and treatment effect of ADVM-043 in subjects with Alpha-1 Antitrypsin Deficiency.||||
1409508|NCT02168673|||Cohort||Prospective|||||||
1409509|NCT02168660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409510|NCT02168647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409511|NCT02168634|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409512|NCT02168621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409513|NCT02168608|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1409514|NCT02168595|Randomized|Single Group Assignment||Other||Double|||t||t|
1409515|NCT02168582|||Case-Only||Prospective|||||||
1409516|NCT02168569|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409517|NCT02168556|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1409518|NCT02168543|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409519|NCT02168530|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409520|NCT02168517|||Case Control||Retrospective|||||||
1409521|NCT02168504|||Cohort||Cross-Sectional|||||||
1409522|NCT02168491||Single Group Assignment||Treatment||None (Open Label)||||||
1409523|NCT02168478||Single Group Assignment||Treatment||None (Open Label)||||||
1409524|NCT02168465||Single Group Assignment||Prevention||None (Open Label)||||||
1409525|NCT02168452|||Case-Only||Prospective|||||||
1409526|NCT02168439|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1409527|NCT02168426|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409528|NCT02168413|||Cohort||Prospective|||||||
1409529|NCT02168400|Randomized|Parallel Assignment||Prevention||Single|||t|||
1409530|NCT02168387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409531|NCT02168374|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409532|NCT02168361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409533|NCT02168348|||Case-Only||Prospective|||||||
1409534|NCT02168335|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409535|NCT02168322||Single Group Assignment||Treatment||Double|||t|||t
1409536|NCT02168309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409537|NCT02168296|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1409538|NCT02168283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409539|NCT02168270||Single Group Assignment||Treatment||None (Open Label)||||||
1409540|NCT02168257|Randomized|Crossover Assignment||Treatment||Single|||t|||
1409541|NCT02168244|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1409542|NCT02168231|||Cohort||Cross-Sectional|||||||
1409543|NCT02168218|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1409544|NCT02168205|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1409545|NCT02168192|Randomized|Parallel Assignment||||Double|||t||t|
1409546|NCT02168179||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409547|NCT02168166|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409548|NCT02168153|Randomized|Parallel Assignment||Treatment||Single|||||t|
1409549|NCT02168140||Single Group Assignment||Treatment||None (Open Label)||||||
1409550|NCT02168127||Single Group Assignment||Treatment||None (Open Label)||||||
1409551|NCT02168114|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1409552|NCT02168101||Single Group Assignment||Treatment||None (Open Label)||||||
1409553|NCT02168088|||Case-Only||Prospective|||||||
1409554|NCT02168075|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1409555|NCT02168062|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1409556|NCT02168049||Single Group Assignment||Other||None (Open Label)||||||
1409557|NCT02168036|||Case-Only||Cross-Sectional|||||||
1409558|NCT02168023|Randomized|Parallel Assignment||Prevention||Single|||t|||
1409559|NCT02168010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409560|NCT02167997|||Cohort||Prospective|||||||
1409561|NCT02167984|||Cohort||Retrospective|||||||
1409562|NCT02167971|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409563|NCT02167958||Single Group Assignment||Treatment||None (Open Label)||||||
1409564|NCT02167945||Single Group Assignment||Treatment||None (Open Label)||||||
1409565|NCT02167932|||Cohort||Prospective|||||||
1409566|NCT02167919||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1409567|NCT02167906|Non-Randomized|Parallel Assignment||Screening||Single||||||t
1409568|NCT02167893|||Cohort||Prospective|||||||
1409569|NCT02167880||||||||||||
1409570|NCT02167867|Randomized|Parallel Assignment||||None (Open Label)||||||
1409571|NCT02167854||Single Group Assignment||Treatment||None (Open Label)||||||
1409572|NCT02167841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409573|NCT02167828|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1409574|NCT02167815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409575|NCT02167802|||Cohort||Prospective|||||||
1409576|NCT02167789||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409577|NCT02167776|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1409578|NCT02167763|Randomized|Parallel Assignment||Prevention||Single|||t|||
1409579|NCT02167750|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1409580|NCT02167737|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409581|NCT02167724||Single Group Assignment||||None (Open Label)||||||
1409582|NCT02167711||Single Group Assignment||Treatment||None (Open Label)||||||
1409583|NCT02167698|Randomized|Parallel Assignment||Treatment||Single||||||t
1409584|NCT02167685|||Case-Only||Prospective|||||||
1409585|NCT02167672|||Other||Other|||||||
1409586|NCT02167659|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409587|NCT02167646||Single Group Assignment||Treatment||None (Open Label)||||||
1409588|NCT02167633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409589|NCT02167620|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1409590|NCT02167607|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1409591|NCT02167594|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1409592|NCT02167581|||Cohort|||||||||
1409593|NCT02167568|||Cohort||Prospective|||||||
1409594|NCT02167555|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1409595|NCT02167542|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409596|NCT02167529|||Cohort||Prospective|||||||
1409597|NCT02167516|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409599|NCT02167490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409600|NCT02167477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409601|NCT02167464|Randomized|Parallel Assignment||Treatment||Single|The PI was blinded to clinic and group assignment when he conducted the final statistical analysis.|||||t
1409602|NCT02167451||Single Group Assignment||Prevention||None (Open Label)||||||
1409603|NCT02167438|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1409604|NCT02167425|||Cohort||Prospective|||||||
1409605|NCT02167412|||Cohort||Prospective|||||||
1409606|NCT02167399|||Cohort||Cross-Sectional|||||||
1409607|NCT02167386|Randomized|Parallel Assignment||Prevention||None (Open Label)||combination drug and behavioral intervention||||
1409608|NCT02167373|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1409609|NCT02167360||||Treatment||||||||
1409610|NCT02167347|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1409611|NCT02167334|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409612|NCT02167321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409613|NCT02167308|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1409614|NCT02167295|||||Cross-Sectional|||||||
1409615|NCT02167269|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1409616|NCT02167256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409617|NCT02167243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409618|NCT02167230|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409619|NCT02167217||Single Group Assignment||Treatment||None (Open Label)||||||
1409620|NCT02167204||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409621|NCT02167191||Single Group Assignment||Basic Science||None (Open Label)||||||
1409622|NCT02167178|||||Prospective|||||||
1409623|NCT02167165|||Case Control||Prospective|||||||
1409624|NCT02167152|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1409625|NCT02167139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409626|NCT02167126|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1409627|NCT02167113|||Cohort||Prospective|||||||
1409628|NCT02167100|||||Retrospective|||||||
1409629|NCT02167087||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409630|NCT02167074|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1409631|NCT02167061|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409632|NCT02167048|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1409633|NCT02167035|Randomized|Parallel Assignment||Treatment||Single|||||t|
1409634|NCT02167022|Randomized|Crossover Assignment||Treatment||Single||||||t
1409635|NCT02167009||Single Group Assignment||Treatment||None (Open Label)||||||
1409636|NCT02166996|Randomized|Parallel Assignment||Treatment||Double||||t||t
1409637|NCT02166983|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409638|NCT02166970|Randomized|Parallel Assignment||Treatment||Single||||t||
1409639|NCT02166957|||Cohort||Retrospective|||||||
1409640|NCT02166944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409641|NCT02166931|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409642|NCT02166918|||||Cross-Sectional|||||||
1409643|NCT02166905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409644|NCT02166892|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409645|NCT02166879|||Cohort||Retrospective|||||||
1409646|NCT02166866|||Cohort||Prospective|||||||
1409647|NCT02166853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409648|NCT02166840|Randomized|Parallel Assignment||Prevention||Single|||t|||
1409649|NCT02166827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409650|NCT02166814|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409651|NCT02166801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409652|NCT02166788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409653|NCT02166775|||||Prospective|||||||
1409654|NCT02166762||Single Group Assignment||Treatment||None (Open Label)||||||
1409655|NCT02166749|||Cohort||Retrospective|||||||
1409656|NCT02166736|Randomized|Parallel Assignment||Treatment||Single||||||t
1409657|NCT02166723|||Case-Only||Cross-Sectional|||||||
1409658|NCT02166710|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409659|NCT02166697|||Cohort||Prospective|||||||
1409660|NCT02166684||Single Group Assignment||||None (Open Label)||||||
1409661|NCT02166671||Single Group Assignment||Prevention||None (Open Label)||||||
1409662|NCT02166658||Single Group Assignment||Treatment||None (Open Label)||||||
1409663|NCT02166645|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409664|NCT02166632|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409665|NCT02166619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409666|NCT02166606|||Cohort||Prospective|||||||
1409667|NCT02166593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409668|NCT02166580|||Case-Control||Prospective|||||||
1409669|NCT02166567|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409670|NCT02166554|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1409671|NCT02166541|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409672|NCT02166528|||Case Control||Prospective|||||||
1409673|NCT02166515|||Case Control||Prospective|||||||
1409674|NCT02166502|||Case-Only||Prospective|||||||
1409675|NCT02166489||Single Group Assignment||Treatment||None (Open Label)||||||
1409676|NCT02166476|Randomized|Parallel Assignment||Treatment||Triple|Double blind-double dummy||t||t|t
1409677|NCT02166463|Randomized|Parallel Assignment||Treatment||Single||||||t
1409680|NCT02166424|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409681|NCT02166411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409682|NCT02166398|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409683|NCT02166372|||Case-Only||Prospective|||||||
1409684|NCT02166359|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409685|NCT02166346|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1409686|NCT02166333|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1409687|NCT02166320|Randomized|Single Group Assignment||Treatment||Single|||t|||
1409688|NCT02166307|||Case-Only||Retrospective|||||||
1409689|NCT02166294|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409690|NCT02166281|||Case-Only||Prospective|||||||
1409691|NCT02166268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409692|NCT02166255||Single Group Assignment||Treatment||None (Open Label)||||||
1409693|NCT02166242||Single Group Assignment||Treatment||None (Open Label)||||||
1409694|NCT02166229||Single Group Assignment||Treatment||None (Open Label)||||||
1409695|NCT02166216|||Cohort||Prospective|||||||
1409696|NCT02166190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409697|NCT02166177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409698|NCT02166164||Single Group Assignment||Basic Science||None (Open Label)||||||
1409699|NCT02166151||Single Group Assignment||Treatment||None (Open Label)||||||
1409700|NCT02166138|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1409701|NCT02166125|||Case-Only||Prospective|||||||
1409702|NCT02166112|||Cohort||Cross-Sectional|||||||
1409703|NCT02166099|||Case-Only||Prospective|||||||
1409704|NCT02166086|||Case-Only||Prospective|||||||
1409705|NCT02166073||||||||||||
1409706|NCT02166060||Single Group Assignment||Treatment||None (Open Label)||||||
1409707|NCT02166047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409708|NCT02166034|Randomized|Parallel Assignment||||None (Open Label)||||||
1409709|NCT02166021|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409710|NCT02166008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409711|NCT02165995||Single Group Assignment||Treatment||None (Open Label)||||||
1409712|NCT02165982|||Case Control||Prospective|||||||
1409713|NCT02165969||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409714|NCT02165956|Randomized|Parallel Assignment||||Double|||t||t|
1409715|NCT02165943|||Case Control|||||||||
1409716|NCT02165930|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1409717|NCT02165917|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409718|NCT02165904||Single Group Assignment||Treatment||None (Open Label)||||||
1409719|NCT02165891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409720|NCT02165878|||Cohort||Prospective|||||||
1409721|NCT02165865||Single Group Assignment||Treatment||None (Open Label)||||||
1409722|NCT02165852|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409723|NCT02165839|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409724|NCT02165826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409725|NCT02165813|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409726|NCT02165800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409727|NCT02165787|||Other||Other|||||||
1409728|NCT02165774|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1409729|NCT02165761|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1409730|NCT02165748|||Cohort||Prospective|||||||
1409731|NCT02165735|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409732|NCT02165722|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409733|NCT02165709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409734|NCT02165696|Randomized|Parallel Assignment||Treatment||Single|||||t|
1409735|NCT02165683|||Case-Only||Prospective|||||||
1409736|NCT02165670|||Cohort||Prospective|||||||
1409737|NCT02165657||Single Group Assignment||Treatment||None (Open Label)||||||
1409738|NCT02165644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409739|NCT02165631|||Cohort||Prospective|||||||
1409740|NCT02165618|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1409741|NCT02165605|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1409742|NCT02165592|||Cohort||Cross-Sectional|||||||
1409743|NCT02165579|||Case-Only||Prospective|||||||
1409744|NCT02165566|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409745|NCT02165553|Randomized|Crossover Assignment||Prevention||Single|||t|||
1409746|NCT02165540|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409747|NCT02165527|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1409748|NCT02165514|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1409749|NCT02165501|||Cohort||Prospective|||||||
1409750|NCT02165488|||Cohort||Prospective|||||||
1409751|NCT02165475||||Treatment||||||||
1409752|NCT02165462|||Cohort||Prospective|||||||
1409753|NCT02165449||Single Group Assignment||Treatment||None (Open Label)||||||
1409754|NCT02165436|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409755|NCT02165423|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1409756|NCT02165410||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409757|NCT02165397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409758|NCT02165384||Single Group Assignment||Treatment||None (Open Label)||||||
1409759|NCT02165371|Randomized|Parallel Assignment||Prevention||Single||||||t
1409760|NCT02165358|||Case Control||Cross-Sectional|||||||
1409761|NCT02165345||Single Group Assignment||Treatment||None (Open Label)||||||
1409762|NCT02165332|Randomized|Crossover Assignment||||Double|||t||t|
1409763|NCT02165319|Randomized|Parallel Assignment||Prevention||Single|||t|||
1409764|NCT02165306|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1409765|NCT02165293|Randomized|Single Group Assignment||||None (Open Label)||||||
1409766|NCT02165280|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409767|NCT02165267|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1409768|NCT02165254|Randomized|Parallel Assignment||Treatment||Single||||||t
1409769|NCT02165241|||Case-Control||Prospective|||||||
1409770|NCT02165228|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409771|NCT02165215|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409772|NCT02165202|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1409773|NCT02165189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409774|NCT02165176|Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1409775|NCT02165163|Randomized|Parallel Assignment||Treatment||Single||||||t
1409776|NCT02165150|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409777|NCT02165137|||Cohort||Other|||||||
1409778|NCT02165124||Single Group Assignment||Treatment||None (Open Label)||||||
1409779|NCT02165111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409780|NCT02165098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409781|NCT02165085|||Case Control||Prospective|||||||
1409782|NCT02165072|||||Prospective|||||||
1409783|NCT02165059|||Case-Control||Prospective|||||||
1409784|NCT02165046|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409785|NCT02165033||Single Group Assignment||Treatment||None (Open Label)||||||
1409786|NCT02165020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409787|NCT02165007||Single Group Assignment||Treatment||None (Open Label)||||||
1409788|NCT02164994|||Cohort||Prospective|||||||
1409789|NCT02164981|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1409790|NCT02164968|||Cohort||Prospective|||||||
1409791|NCT02164955|||Cohort||Prospective|||||||
1409792|NCT02164942|||Cohort||Prospective|||||||
1409793|NCT02164929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409794|NCT02164916|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409795|NCT02164903|||Case-Control||Cross-Sectional|||||||
1409796|NCT02164890||Single Group Assignment||Other||None (Open Label)||||||
1409797|NCT02164877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409798|NCT02164864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409799|NCT02164851|||Case-Only||Prospective|||||||
1409800|NCT02164838||Single Group Assignment||Treatment||None (Open Label)||||||
1409801|NCT02164825|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409802|NCT02164812||Single Group Assignment||||None (Open Label)||||||
1409803|NCT02164799|||Cohort||Prospective|||||||
1409804|NCT02164786|||Cohort||Prospective|||||||
1409805|NCT02164773|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1409806|NCT02164760|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409807|NCT02164747|||Case Control||Prospective|||||||
1409808|NCT02164734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409809|NCT02164721||Single Group Assignment||Treatment||None (Open Label)||||||
1409810|NCT02164708||Single Group Assignment||Treatment||Single|||t|||
1409811|NCT02164695|Randomized|Parallel Assignment||Treatment||Single|CMR results will be interpreted by observers blinded to randomization|"Control group: PPCI only~Study group: PPCI + RIPC"||||t
1409812|NCT02164682|||Cohort||Retrospective|||||||
1409813|NCT02164669|||Cohort||Prospective|||||||
1409814|NCT02164656||Single Group Assignment||Treatment||None (Open Label)||||||
1409815|NCT02164643|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1409816|NCT02164630|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409817|NCT02164617|Randomized|Parallel Assignment||Prevention||Single||||||t
1409818|NCT02164604||Single Group Assignment||Treatment||None (Open Label)||||||
1409819|NCT02164591|||Case-Only||Prospective|||||||
1409820|NCT02164578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409821|NCT02164565|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409822|NCT02164552|||||Prospective|||||||
1409823|NCT02164539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409824|NCT02164526|||Cohort||Prospective|||||||
1409825|NCT02164513|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409826|NCT02164500||Single Group Assignment||Treatment||None (Open Label)||||||
1409827|NCT02164487|||Case Control||Prospective|||||||
1409828|NCT02164474|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409829|NCT02164461||Single Group Assignment||Treatment||None (Open Label)||||||
1409830|NCT02164448|Randomized|Parallel Assignment||||Triple|||t|t||t
1409831|NCT02164435||Single Group Assignment||Treatment||None (Open Label)||||||
1409832|NCT02164422|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409833|NCT02164409|||Cohort||Prospective|||||||
1409834|NCT02164396|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1409835|NCT02164383|Randomized|Parallel Assignment||Treatment||Single||||||t
1409836|NCT02164370|||Case Control||Prospective|||||||
1409837|NCT02164357|||Cohort||Prospective|||||||
1409838|NCT02164344||Single Group Assignment||Treatment||None (Open Label)||||||
1409839|NCT02164331|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1409840|NCT02164318|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1409841|NCT02164305|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409842|NCT02164292|||Cohort||Prospective|||||||
1409843|NCT02164279|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1409844|NCT02164266|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409845|NCT02164253||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409846|NCT02164240||Single Group Assignment||Treatment||None (Open Label)||||||
1409847|NCT02164227|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1409848|NCT02164214|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409849|NCT02164201|||Cohort||Prospective|||||||
1409850|NCT02164188|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1409851|NCT02164175|||Case-Only||Prospective|||||||
1409852|NCT02164162|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1409853|NCT02164149|||Case-Only||Prospective|||||||
1409854|NCT02164136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409855|NCT02164123|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1409856|NCT02164110|Randomized|Parallel Assignment||Prevention||Single|||t|||
1409857|NCT02164097||Single Group Assignment||Treatment||None (Open Label)||||||
1409858|NCT02164084|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1409859|NCT02164071|||Cohort||Prospective|||||||
1409860|NCT02164058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409861|NCT02164045|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1409862|NCT02164032|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1409863|NCT02164019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409864|NCT02164006||Single Group Assignment||Treatment||None (Open Label)||||||
1409865|NCT02163993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409866|NCT02163980|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1409867|NCT02163967||Single Group Assignment||Basic Science||Double|||t|||t
1409868|NCT02163954|Randomized|Crossover Assignment||Treatment||Single|||||t|
1409869|NCT02163941||Single Group Assignment||Basic Science||None (Open Label)||||||
1409870|NCT02163928|||Cohort||Prospective|||||||
1409871|NCT02163915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409872|NCT02163902|Non-Randomized|Parallel Assignment||||Double|||t||t|
1409873|NCT02163889|||Case-Only||Prospective|||||||
1409874|NCT02163876|Randomized|Parallel Assignment||Treatment||Single||||||t
1409875|NCT02163863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409876|NCT02163850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409877|NCT02163837||Single Group Assignment||Treatment||None (Open Label)||||||
1409878|NCT02163824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409879|NCT02163811|Randomized|Single Group Assignment||Treatment||Single||||||t
1409880|NCT02163798|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409881|NCT02163785|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1409882|NCT02163772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409883|NCT02163759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409884|NCT02163746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409885|NCT02163733|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1409886|NCT02163720|||Cohort||Prospective|||||||
1409887|NCT02163707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409888|NCT02163694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409889|NCT02163681||Single Group Assignment||Basic Science||None (Open Label)||||||
1409890|NCT02163668|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409891|NCT02163655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409892|NCT02163642|||Cohort||Prospective|||||||
1409893|NCT02163629|Randomized|Parallel Assignment||Prevention||Single||||||t
1409894|NCT02163616||Single Group Assignment||Treatment||None (Open Label)||||||
1409895|NCT02163603|||Case Control||Prospective|||||||
1409896|NCT02163590|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1409897|NCT02163577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409898|NCT02163564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409899|NCT02163551|||Case-Control||Cross-Sectional|||||||
1409900|NCT02163538|Randomized|Single Group Assignment||Other||Single|||t|||
1409901|NCT02163525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409902|NCT02163512|||Cohort||Prospective|||||||
1409903|NCT02163499||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409904|NCT02163486|Randomized|Parallel Assignment||Screening||Double|||||t|t
1409905|NCT02163473|||Case Control||Prospective|||||||
1409906|NCT02163460|Randomized|Parallel Assignment||Treatment||Single||||||t
1409907|NCT02163447|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1409908|NCT02163434|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409909|NCT02163421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409910|NCT02163408|||Cohort||Prospective|||||||
1409911|NCT02163395||Single Group Assignment||Other||None (Open Label)||||||
1409912|NCT02163382||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409913|NCT02163369||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409914|NCT02163356||Single Group Assignment||Treatment||None (Open Label)||||||
1409915|NCT02163343|||Cohort||Retrospective|||||||
1409916|NCT02163330|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409917|NCT02163317||Single Group Assignment||Treatment||None (Open Label)||||||
1409918|NCT02163304|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1409919|NCT02163291||Single Group Assignment||Treatment||None (Open Label)||||||
1409920|NCT02163278|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1409921|NCT02163265||Single Group Assignment||Treatment||None (Open Label)||||||
1409922|NCT02163252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409923|NCT02163239|||||Prospective|||||||
1409924|NCT02163226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409925|NCT02163213||Single Group Assignment||Supportive Care||None (Open Label)||||||
1409926|NCT02163200|||Case-Crossover||Prospective|||||||
1409927|NCT02163187|Randomized|Crossover Assignment||Treatment||Single|||t|||
1409928|NCT02163174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409929|NCT02163161|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1409930|NCT02163148|||Case-Only||Cross-Sectional|||||||
1409931|NCT02163122|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1409932|NCT02163109|||Cohort||Prospective|||||||
1409933|NCT02163096|||Case Control||Prospective|||||||
1409934|NCT02163083|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1409935|NCT02163070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409936|NCT02163057|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409937|NCT02163044|||Other||Prospective|||||||
1409938|NCT02163031|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409939|NCT02163018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409940|NCT02163005||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409941|NCT02162992|||Case Control||Prospective|||||||
1409942|NCT02162979|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1409943|NCT02162966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409944|NCT02162953|||Other||Prospective|||||||
1409945|NCT02162940|||Case Control||Prospective|||||||
1409946|NCT02162927|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1409947|NCT02162914|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409948|NCT02162901|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1409949|NCT02162888|Randomized|Crossover Assignment||||None (Open Label)||||||
1409950|NCT02162875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409951|NCT02162862|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1409952|NCT02162849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409953|NCT02162836||Single Group Assignment||Treatment||None (Open Label)||||||
1409954|NCT02162823|||Case-Control||Prospective|||||||
1409955|NCT02162810|Randomized|Factorial Assignment||Health Services Research||Double|||t||t|
1409956|NCT02162797|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409957|NCT02162784|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409958|NCT02162771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409959|NCT02162758|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409960|NCT02162745|Randomized|Parallel Assignment||Treatment||Single||||||t
1409961|NCT02162732||Single Group Assignment||Treatment||None (Open Label)||||||
1409962|NCT02162719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409963|NCT02162706|||Cohort|||||||||
1409964|NCT02162693|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409965|NCT02162680|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409966|NCT02162667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1409967|NCT02162654|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1409968|NCT02162641|||Cohort||Prospective|||||||
1409969|NCT02162628|||Cohort||Prospective|||||||
1409970|NCT02162615|||Cohort||Prospective|||||||
1409971|NCT02162602|||Cohort||Prospective|||||||
1409972|NCT02162589|||Cohort||Prospective|||||||
1409973|NCT02162576||Single Group Assignment||Treatment||None (Open Label)||||||
1409974|NCT02162563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409975|NCT02162550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1409976|NCT02162537|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1409977|NCT02162524|Randomized|Parallel Assignment||Treatment||Single|||t|||
1409978|NCT02162511|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409979|NCT02162498|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1409980|NCT02162485|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409981|NCT02162472|||Cohort||Prospective|||||||
1409982|NCT02162459|||Case Control||Prospective|||||||
1409983|NCT02162446||Single Group Assignment||Diagnostic||None (Open Label)||||||
1409984|NCT02162433|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1409985|NCT02162420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1409986|NCT02162407|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1409987|NCT02162394|||Cohort||Prospective|||||||
1409988|NCT02162381|Randomized|Parallel Assignment||Treatment||Single|||||t|
1409989|NCT02162368|||Case-Control||Retrospective|||||||
1409990|NCT02162355|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1409991|NCT02162342|||Case Control|||||||||
1409992|NCT02162329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1409993|NCT02162316|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1409994|NCT02162303|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1409995|NCT02162290|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1409996|NCT02162277|||Cohort||Prospective|||||||
1409997|NCT02162264|||Cohort||Prospective|||||||
1409998|NCT02162251|||Cohort||Prospective|||||||
1409999|NCT02162238|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1410000|NCT02162225||Single Group Assignment||Treatment||None (Open Label)||||||
1410001|NCT02162212|Randomized|Parallel Assignment||Treatment||Single||||||t
1410002|NCT02162199|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1410003|NCT02162186|||Cohort||Prospective|||||||
1410004|NCT02162173||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410005|NCT02162160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410006|NCT02162147|||Cohort||Prospective|||||||
1410007|NCT02162134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410008|NCT02162121|Randomized|Parallel Assignment||Treatment||Single|||||t|
1410009|NCT02162095|||Case Control||Retrospective|||||||
1410010|NCT02162082||Single Group Assignment||Treatment||None (Open Label)||||||
1410011|NCT02162069||Single Group Assignment||Treatment||None (Open Label)||TAVR||||
1410012|NCT02162056||Single Group Assignment||Treatment||None (Open Label)||||||
1410013|NCT02162043|||Other||Other|||||||
1410014|NCT02162030|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410015|NCT02162017|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410016|NCT02162004|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410017|NCT02161991|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1410018|NCT02161978|||Case-Only||Prospective|||||||
1410019|NCT02161965|Randomized|Parallel Assignment||Treatment||Single|||||t|
1410020|NCT02161952|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410021|NCT02161939||||||||||||
1410022|NCT02161926|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410023|NCT02161913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410024|NCT02161900|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410025|NCT02161887|||Ecologic or Community||Prospective|||||||
1410026|NCT02161874|Randomized|Parallel Assignment||Treatment||Single|||||t|
1410027|NCT02161861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410028|NCT02161848|||||Cross-Sectional|||||||
1410029|NCT02161835|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410030|NCT02161822||Single Group Assignment||Treatment||None (Open Label)||||||
1410031|NCT02161809|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1410032|NCT02161796|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1410033|NCT02161783|||||Prospective|||||||
1410034|NCT02161770|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1410035|NCT02161757|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410036|NCT02161744||Single Group Assignment||Treatment||None (Open Label)||Phase I open label study to assess safety and tolerability||||
1410037|NCT02161731|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1410038|NCT02161718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410039|NCT02161705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410040|NCT02161692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410041|NCT02161679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410042|NCT02161666|||Cohort||Prospective|||||||
1410043|NCT02161653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410044|NCT02161640|||Case-Control||Cross-Sectional|||||||
1410045|NCT02161627|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1410046|NCT02161614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410047|NCT02161601||Single Group Assignment||Prevention||None (Open Label)||||||
1410048|NCT02161588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410049|NCT02161575||Single Group Assignment||Treatment||None (Open Label)||||||
1410050|NCT02161562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410051|NCT02161549|||Cohort||Prospective|||||||
1410052|NCT02161536|Non-Randomized|Sequential Assignment||Screening||None (Open Label)||Bowel cleansing level was evaluated by using the Boston Bowel Preparation Score (BBPS) at baseline and after the use of the Motus Cleansing System.||||
1410053|NCT02161523|||Other||Prospective|||||||
1410054|NCT02161510|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410055|NCT02161497|||Case-Only||Prospective|||||||
1410056|NCT02161484|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1410057|NCT02161471|||Cohort||Prospective|||||||
1410058|NCT02161458|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1410059|NCT02161445|||Case-Control||Prospective|||||||
1410060|NCT02161432|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410061|NCT02161419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410062|NCT02161406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410063|NCT02161393|Randomized|Parallel Assignment||Treatment||Single||||||t
1410064|NCT02161380|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410065|NCT02161367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410066|NCT02161354|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1410067|NCT02161341|||Case-Control||Cross-Sectional|||||||
1410068|NCT02161328|||Case-Only||Prospective|||||||
1410069|NCT02161315|||Case Control||Prospective|||||||
1410070|NCT02161302|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410071|NCT02161289|||Cohort||Prospective|||||||
1410072|NCT02161276||Single Group Assignment||Treatment||Double|||t||t|
1410073|NCT02161263|||Cohort||Prospective|||||||
1410074|NCT02161250|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1410075|NCT02161237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410076|NCT02161224|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1410077|NCT02161211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410078|NCT02161198|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410079|NCT02161185||Single Group Assignment||Treatment||None (Open Label)||||||
1410080|NCT02161172|||Case-Only||Cross-Sectional|||||||
1410081|NCT02161159|||Cohort||Prospective|||||||
1410082|NCT02161146|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1410083|NCT02161133|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1410084|NCT02161120|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1410085|NCT02161107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410086|NCT02161094|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1410087|NCT02161081|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1410088|NCT02161068|||Other||Retrospective|||||||
1410089|NCT02161055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410090|NCT02161042|||Case-Crossover||Prospective|||||||
1410091|NCT02161029|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1410092|NCT02161016||Single Group Assignment||Treatment||None (Open Label)||||||
1410093|NCT02161003||Single Group Assignment||Treatment||None (Open Label)||||||
1410094|NCT02160990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410095|NCT02160977|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1410096|NCT02160964|||Cohort||Prospective|||||||
1410097|NCT02160951||Single Group Assignment||Treatment||None (Open Label)||||||
1410098|NCT02160938|||Cohort||Prospective|||||||
1410099|NCT02160925||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410100|NCT02160912|||Case-Crossover||Prospective|||||||
1410101|NCT02160899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410102|NCT02160886|Randomized|Parallel Assignment||Treatment||Single||||||t
1410103|NCT02160873|Randomized|Crossover Assignment||Other||Double|||t||t|
1410104|NCT02160860|||Ecologic or Community||Cross-Sectional|||||||
1410105|NCT02160847|Randomized|Parallel Assignment||Treatment||Single||||||t
1410106|NCT02160834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410107|NCT02160821|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1410108|NCT02160808|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1410109|NCT02160795|||Cohort||Retrospective|||||||
1410110|NCT02160782|Randomized|Parallel Assignment||Treatment||Triple||Open-label single arm study with a randomized placebo-controlled parallel group period|t|t|t|
1410111|NCT02160769|||Case-Control||Prospective|||||||
1410112|NCT02160756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410113|NCT02160743|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410114|NCT02160730||Single Group Assignment||Treatment||None (Open Label)||||||
1410115|NCT02160717|||Cohort||Cross-Sectional|||||||
1410116|NCT02160704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410117|NCT02160691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410118|NCT02160678|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410119|NCT02160665|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410120|NCT02160652|||Case-Only||Prospective|||||||
1410121|NCT02160639|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1410122|NCT02160626|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410123|NCT02160613||Single Group Assignment||Diagnostic||Single|||||t|
1410124|NCT02160600|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1410125|NCT02160587||Single Group Assignment||||Double|||t|||t
1410126|NCT02160574||Single Group Assignment||||Double|||t|||t
1410127|NCT02160561||Single Group Assignment||Supportive Care||None (Open Label)||||||
1410128|NCT02160548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410129|NCT02160535||Single Group Assignment||Treatment||None (Open Label)||||||
1410130|NCT02160522|||Cohort||Prospective|||||||
1410131|NCT02160509|||Cohort||Prospective|||||||
1410132|NCT02160496|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410133|NCT02160483||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410134|NCT02160470|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1410135|NCT02160457|Randomized|Parallel Assignment||Treatment||Single||||||t
1410136|NCT02160444||Single Group Assignment||Treatment||None (Open Label)||||||
1410137|NCT02160431||Single Group Assignment||Treatment||None (Open Label)||||||
1410138|NCT02160418|Randomized|Factorial Assignment||Other||Single|||||t|
1410139|NCT02160405|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410140|NCT02160392|||Case Control||Cross-Sectional|||||||
1410141|NCT02160379|||Case Control||Cross-Sectional|||||||
1410142|NCT02160366|||Cohort||Prospective|||||||
1410143|NCT02160353||Single Group Assignment||Treatment||None (Open Label)||||||
1410144|NCT02160340|||Case-Only||Prospective|||||||
1410145|NCT02160327|||||Prospective|||||||
1410146|NCT02160314|Randomized|Parallel Assignment||Treatment||Single||||||t
1410147|NCT02160301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410148|NCT02160288|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410149|NCT02160275|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410150|NCT02160262||Single Group Assignment||Treatment||None (Open Label)||||||
1410151|NCT02160249|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1410308|NCT02158208|||Cohort||Prospective|||||||
1410152|NCT02160236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410153|NCT02160223|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1410154|NCT02160210||Single Group Assignment||Diagnostic||Single|||t|||
1410155|NCT02160197|Randomized|Parallel Assignment||Treatment||Single||||||t
1410156|NCT02160184||Single Group Assignment||Treatment||||||||
1410157|NCT02160171|||Cohort||Prospective|||||||
1410158|NCT02160158|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1410159|NCT02160145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410160|NCT02160132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410161|NCT02160119|||Case Control||Prospective|||||||
1410162|NCT02160106||Single Group Assignment||Treatment||None (Open Label)||||||
1410163|NCT02160093|||Cohort||Prospective|||||||
1410164|NCT02160080||Single Group Assignment||Treatment||None (Open Label)||||||
1410165|NCT02160067|Randomized|Crossover Assignment||||None (Open Label)||||||
1410166|NCT02160054|||Case-Only||Prospective|||||||
1410167|NCT02160041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410168|NCT02160028|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1410169|NCT02160015||Single Group Assignment||Treatment||None (Open Label)||||||
1410170|NCT02160002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410171|NCT02159989||Single Group Assignment||Treatment||None (Open Label)||||||
1410172|NCT02159976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410173|NCT02159963|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410174|NCT02159950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410175|NCT02159937|||Case-Only||Prospective|||||||
1410176|NCT02159924|||Case-Only||Cross-Sectional|||||||
1410177|NCT02159911|||Case Control||Prospective|||||||
1410178|NCT02159898|Randomized|Parallel Assignment||Treatment||Single||||||t
1410179|NCT02159885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410180|NCT02159872||Single Group Assignment||Treatment||None (Open Label)||||||
1410181|NCT02159859||Single Group Assignment||Other||None (Open Label)||||||
1410182|NCT02159846|||Case Control||Prospective|||||||
1410183|NCT02159833||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410184|NCT02159820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410185|NCT02159807|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410186|NCT02159794||Single Group Assignment||Treatment||None (Open Label)||||||
1410187|NCT02159781|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1410188|NCT02159768||Single Group Assignment||Treatment||None (Open Label)||||||
1410189|NCT02159755||Single Group Assignment||Treatment||None (Open Label)||||||
1410190|NCT02159742|||Cohort||Prospective|||||||
1410191|NCT02159729|Non-Randomized|Parallel Assignment||||Double|||t||t|
1410192|NCT02159716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410193|NCT02159703||Single Group Assignment||Diagnostic||||||||
1410194|NCT02159690||Single Group Assignment||Treatment||None (Open Label)||||||
1410195|NCT02159677|||Case Control||Cross-Sectional|||||||
1410196|NCT02159664||Single Group Assignment||Treatment||None (Open Label)||||||
1410197|NCT02159651|||Case-Only||Prospective|||||||
1410198|NCT02159638||Single Group Assignment||Treatment||None (Open Label)||||||
1410199|NCT02159625||Single Group Assignment||Treatment||None (Open Label)||||||
1410200|NCT02159612|||Cohort||Prospective|||||||
1410201|NCT02159599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410202|NCT02159586|||Case-Only||Prospective|||||||
1410203|NCT02159573|||Cohort||Retrospective|||||||
1410204|NCT02159560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410205|NCT02159547|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1410206|NCT02159534|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410207|NCT02159521||Single Group Assignment||Treatment||None (Open Label)||||||
1410208|NCT02159508|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410209|NCT02159495||Single Group Assignment||Treatment||None (Open Label)||||||
1410210|NCT02159482||Single Group Assignment||Treatment||None (Open Label)||||||
1410211|NCT02159469||Single Group Assignment||Treatment||None (Open Label)||||||
1410212|NCT02159456|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410213|NCT02159443|||Cohort||Prospective|||||||
1410214|NCT02159430|||Cohort||Cross-Sectional|||||||
1410215|NCT02159417||Single Group Assignment||Supportive Care||None (Open Label)||||||
1410216|NCT02159404|||Case-Control||Prospective|||||||
1410217|NCT02159391|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410218|NCT02159378|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410219|NCT02159365||Single Group Assignment||Treatment||None (Open Label)||||||
1410220|NCT02159352|Randomized|Parallel Assignment||||None (Open Label)||||||
1410221|NCT02159339|||Cohort||Prospective|||||||
1410222|NCT02159326|Randomized|Crossover Assignment||||None (Open Label)||||||
1410223|NCT02159313|Randomized|Crossover Assignment||||None (Open Label)||||||
1410224|NCT02159300|||Case Control||Cross-Sectional|||||||
1410225|NCT02159287|Randomized|Parallel Assignment||Prevention||Single||||||t
1410226|NCT02159274|||Other||Prospective|||||||
1410227|NCT02159261|||Cohort||Prospective|||||||
1410228|NCT02159248||Single Group Assignment||Treatment||None (Open Label)||||||
1410229|NCT02159235|||||Retrospective|||||||
1410230|NCT02159222||Single Group Assignment||Treatment||None (Open Label)||||||
1410231|NCT02159209|||Cohort||Prospective|||||||
1410232|NCT02159196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410233|NCT02159183|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410234|NCT02159170||Single Group Assignment||Basic Science||None (Open Label)||||||
1410235|NCT02159157|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410236|NCT02159144||Single Group Assignment||||None (Open Label)||||||
1410237|NCT02159131||Single Group Assignment||||None (Open Label)||||||
1410238|NCT02159118|Randomized|Parallel Assignment||||Single||||||t
1410239|NCT02159105|||Cohort||Prospective|||||||
1410240|NCT02159092|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410241|NCT02159079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410242|NCT02159066|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410243|NCT02159053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410244|NCT02159040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410245|NCT02159027|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410246|NCT02159014|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1410247|NCT02159001|Randomized|Crossover Assignment||Treatment||Single|||||t|
1410248|NCT02158988|Randomized|Parallel Assignment||Treatment||None (Open Label)||intraperitoneal (in the abdominal cavity) chemoperfusion with Mitomycin C and Cisplatin||||
1410249|NCT02158975||Single Group Assignment||Treatment||None (Open Label)||||||
1410250|NCT02158962|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410251|NCT02158949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410252|NCT02158936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410253|NCT02158923|Randomized|Factorial Assignment||Prevention||Single|||t|||
1410254|NCT02158910|||Case-Only||Prospective|||||||
1410255|NCT02158897|Randomized|Crossover Assignment||Basic Science||Single||||||t
1410256|NCT02158884||Single Group Assignment||Treatment||None (Open Label)||||||
1410257|NCT02158871|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1410258|NCT02158858|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410259|NCT02158845|Randomized|Parallel Assignment||||None (Open Label)||||||
1410260|NCT02158832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410261|NCT02158819|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410262|NCT02158806|Randomized|Parallel Assignment||Treatment||Quadruple|Identical placebo with only difference being unique code on bottle containing product.||t|t|t|t
1410263|NCT02158793||Single Group Assignment||Treatment||None (Open Label)||||||
1410264|NCT02158780|Randomized|Parallel Assignment||Treatment||Single||||||t
1410265|NCT02158767||||||||||||
1410266|NCT02158754|||Case-Control||Retrospective|||||||
1410267|NCT02158741|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1410268|NCT02158728|||Cohort||Prospective|||||||
1410269|NCT02158715|||Cohort||Prospective|||||||
1410270|NCT02158702|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410271|NCT02158689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410272|NCT02158676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410273|NCT02158663|Randomized|Parallel Assignment||Treatment||Single||||||t
1410274|NCT02158650|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1410275|NCT02158637|||Case-Only||Prospective|||||||
1410276|NCT02158624||Single Group Assignment||Treatment||None (Open Label)||||||
1410277|NCT02158611||Single Group Assignment||Supportive Care||None (Open Label)||||||
1410278|NCT02158598|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410279|NCT02158585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410280|NCT02158572||Single Group Assignment||Treatment||None (Open Label)||||||
1410281|NCT02158559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410282|NCT02158546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410283|NCT02158533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410284|NCT02158520|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410285|NCT02158507||Single Group Assignment||Treatment||None (Open Label)||||||
1410286|NCT02158494|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410287|NCT02158481|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1410288|NCT02158468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410289|NCT02158455|Randomized|Parallel Assignment||Treatment||Single||||||t
1410290|NCT02158442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410291|NCT02158429|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1410292|NCT02158416|||Cohort||Prospective|||||||
1410293|NCT02158403||Single Group Assignment||Prevention||None (Open Label)||||||
1410294|NCT02158390|Randomized|Parallel Assignment||Treatment||Single||||||t
1410295|NCT02158377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410296|NCT02158364|||Cohort||Prospective|||||||
1410297|NCT02158351|||Case Control||Cross-Sectional|||||||
1410298|NCT02158338|||Case Control||Retrospective|||||||
1410299|NCT02158325|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410300|NCT02158312|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1410301|NCT02158299|Randomized|Parallel Assignment||Treatment||Single||||t||
1410302|NCT02158286|||Case-Only|||||||||
1410303|NCT02158273|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1410304|NCT02158260|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1410305|NCT02158247|||||Prospective|||||||
1410306|NCT02158234||Single Group Assignment||Treatment||None (Open Label)||||||
1410307|NCT02158221|Non-Randomized|Parallel Assignment||||Double|||t|||t
1410309|NCT02158195|||Case-Control||Prospective|||||||
1410310|NCT02158182|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1410311|NCT02158169|||Cohort||Prospective|||||||
1410312|NCT02158156||Single Group Assignment||Supportive Care||None (Open Label)||||||
1410313|NCT02158143||Single Group Assignment||Treatment||None (Open Label)||||||
1410314|NCT02158130|||Case Control||Cross-Sectional|||||||
1410315|NCT02158117||Single Group Assignment||Treatment||None (Open Label)||||||
1410316|NCT02158104|||Cohort||Prospective|||||||
1410317|NCT02158091||Single Group Assignment||Treatment||None (Open Label)||||||
1410318|NCT02158078|||Case-Only||Prospective|||||||
1410319|NCT02158065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410320|NCT02158052||Single Group Assignment||Treatment||None (Open Label)||||||
1410321|NCT02158039||Single Group Assignment||Treatment||None (Open Label)||||||
1410322|NCT02158026|||Cohort||Prospective|||||||
1410323|NCT02158013|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1410324|NCT02158000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410325|NCT02157987||Single Group Assignment||Treatment||Single||||t||
1410326|NCT02157974|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1410327|NCT02157961|||Cohort||Prospective|||||||
1410328|NCT02157948|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410329|NCT02157935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410330|NCT02157922|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1410331|NCT02157909|Randomized|Parallel Assignment||||Double|||t||t|
1410332|NCT02157896|||Case-Only||Prospective|||||||
1410333|NCT02157883||Single Group Assignment||Other||None (Open Label)||||||
1410334|NCT02157857|||Cohort||Retrospective|||||||
1410335|NCT02157844|||Cohort||Cross-Sectional|||||||
1410336|NCT02157831||Single Group Assignment||Treatment||||||||
1410337|NCT02157818|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1410338|NCT02157805|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1410339|NCT02157792|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410340|NCT02157779|Randomized|Parallel Assignment||Treatment||Single||||||t
1410341|NCT02157766|Randomized|Factorial Assignment||Basic Science||Single|||||t|
1410342|NCT02157753|||Cohort||Prospective|||||||
1410343|NCT02157740|||Case Control||Retrospective|||||||
1410344|NCT02157727|||Case Control||Prospective|||||||
1410345|NCT02157714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410346|NCT02157701|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1410347|NCT02157688|||Case Control||Prospective|||||||
1410348|NCT02157675|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1410349|NCT02157662|||Case-Control||Prospective|||||||
1410350|NCT02157649|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410351|NCT02157636||Single Group Assignment||Treatment||None (Open Label)||||||
1410352|NCT02157623|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410353|NCT02157610|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410354|NCT02157597|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1410355|NCT02157584|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410356|NCT02157571|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410357|NCT02157558||Single Group Assignment||Treatment||None (Open Label)||||||
1410358|NCT02157545|||Case Control||Prospective|||||||
1410359|NCT02157532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410360|NCT02157519|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1410361|NCT02157506|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410362|NCT02157493|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410363|NCT02157480|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410364|NCT02157467||Single Group Assignment||Basic Science||None (Open Label)||||||
1410365|NCT02157454|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410366|NCT02157441||Single Group Assignment||Treatment||None (Open Label)||||||
1410367|NCT02157428|Randomized|Parallel Assignment||||Double|||t||t|
1410368|NCT02157415||Single Group Assignment||Prevention||None (Open Label)||||||
1410369|NCT02157402|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410370|NCT02157389||Single Group Assignment||Basic Science||Single|||t|||
1410371|NCT02157376|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1410372|NCT02157363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410373|NCT02157350||Single Group Assignment||Treatment||None (Open Label)||||||
1410374|NCT02157337|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1410375|NCT02157324|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410376|NCT02157311||Single Group Assignment||Treatment||None (Open Label)||||||
1410377|NCT02157298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410378|NCT02157285|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1410379|NCT02157272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410380|NCT02157259|||Case-Only||Prospective|||||||
1410381|NCT02157246|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1410382|NCT02157233|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1410383|NCT02157220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410384|NCT02157207|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1410385|NCT02157194|||Case-Only||Prospective|||||||
1410386|NCT02157181||Single Group Assignment||Treatment||None (Open Label)||||||
1410469|NCT02156102|||Case-Only||Cross-Sectional|||||||
1410387|NCT02157168|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1410388|NCT02157155|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1410389|NCT02157142||Single Group Assignment||Treatment||None (Open Label)||||||
1410390|NCT02157129|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1410391|NCT02157116||Single Group Assignment||Treatment||None (Open Label)||||||
1410392|NCT02157103||Single Group Assignment||Treatment||None (Open Label)||||||
1410393|NCT02157090||||||||||||
1410394|NCT02157077||Single Group Assignment||Treatment||None (Open Label)||||||
1410395|NCT02157064|||Cohort||Prospective|||||||
1410396|NCT02157051||Single Group Assignment||Treatment||None (Open Label)||||||
1410397|NCT02157038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410398|NCT02157025|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1410399|NCT02157012||Single Group Assignment||Treatment||None (Open Label)||||||
1410400|NCT02156999||Single Group Assignment||Treatment||None (Open Label)||||||
1410401|NCT02156986|||||Cross-Sectional|||||||
1410402|NCT02156973|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1410403|NCT02156960||Crossover Assignment||Treatment||None (Open Label)||||||
1410404|NCT02156947|||Case Control||Prospective|||||||
1410405|NCT02156934||Single Group Assignment||Treatment||None (Open Label)||||||
1410406|NCT02156921|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1410407|NCT02156908|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410408|NCT02156895|||Case-Only||Prospective|||||||
1410409|NCT02156882|||Case-Only||Prospective|||||||
1410410|NCT02156869|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1410411|NCT02156856|||||Prospective|||||||
1410412|NCT02156843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410413|NCT02156830|||||Prospective|||||||
1410414|NCT02156817|||Cohort||Prospective|||||||
1410415|NCT02156804||Single Group Assignment||Treatment||None (Open Label)||||||
1410416|NCT02156791||Single Group Assignment||Treatment||None (Open Label)||||||
1410417|NCT02156778|Randomized|Parallel Assignment||Prevention||Single||||||t
1410418|NCT02156765|||||Prospective|||||||
1410419|NCT02156752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410420|NCT02156739||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410421|NCT02156726|||Cohort||Retrospective|||||||
1410422|NCT02156713||Single Group Assignment||Treatment||None (Open Label)||||||
1410423|NCT02156700|||Cohort||Cross-Sectional|||||||
1410424|NCT02156687|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410425|NCT02156674||Single Group Assignment||Treatment||None (Open Label)||||||
1410426|NCT02156661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410427|NCT02156648||Single Group Assignment||Other||None (Open Label)||||||
1410428|NCT02156635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410429|NCT02156622|||Cohort||Prospective|||||||
1410430|NCT02156609||Single Group Assignment||Treatment||None (Open Label)||||||
1410431|NCT02156596|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1410432|NCT02156583|||Cohort||Prospective|||||||
1410433|NCT02156570||Single Group Assignment||Treatment||None (Open Label)||||||
1410434|NCT02156557||Single Group Assignment||Screening||None (Open Label)||||||
1410435|NCT02156544|Randomized|||Treatment||Double|||t||t|
1410436|NCT02156531|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1410437|NCT02156518|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1410438|NCT02156505||Single Group Assignment||Treatment||None (Open Label)||||||
1410439|NCT02156492|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1410440|NCT02156479|||Cohort||Prospective|||||||
1410441|NCT02156466|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410442|NCT02156453|||Cohort||Prospective|||||||
1410443|NCT02156440|Randomized|Crossover Assignment||||Double|||t||t|
1410444|NCT02156427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410445|NCT02156414|||Cohort||Prospective|||||||
1410446|NCT02156401|||Cohort||Prospective|||||||
1410447|NCT02156388|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410448|NCT02156375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410449|NCT02156362||Single Group Assignment||Other||None (Open Label)||||||
1410450|NCT02156349|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1410451|NCT02156336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410452|NCT02156323|Randomized|Crossover Assignment||||None (Open Label)||||||
1410453|NCT02156310|||||Retrospective|||||||
1410454|NCT02156297|||Cohort||Prospective|||||||
1410455|NCT02156284||Single Group Assignment||||Single||||||t
1410456|NCT02156271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410457|NCT02156258|||Case Control||Prospective|||||||
1410458|NCT02156245|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1410459|NCT02156232|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410460|NCT02156219|||Cohort||Prospective|||||||
1410461|NCT02156206|||Case-Control||Cross-Sectional|||||||
1410462|NCT02156193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410463|NCT02156180|||Cohort||Prospective|||||||
1410464|NCT02156167||Single Group Assignment||Treatment||None (Open Label)||||||
1410465|NCT02156154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410466|NCT02156141|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410467|NCT02156128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410468|NCT02156115|||Family-Based||Prospective|||||||
1410782|NCT02152020|||||Prospective|||||||
1410470|NCT02156089|Randomized|Parallel Assignment||Other||||||||
1410471|NCT02156076|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1410472|NCT02156063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410473|NCT02156050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410474|NCT02156037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410475|NCT02156024|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410476|NCT02156011|||Case-Only||Cross-Sectional|||||||
1410477|NCT02155998|||Cohort||Prospective|||||||
1410478|NCT02155985|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1410479|NCT02155972|Randomized|Parallel Assignment||Treatment||Quadruple||Participants are randomized to receive either ALIGN (probiotic) or Placebo|t|t|t|t
1410480|NCT02155959|||Cohort||Prospective|||||||
1410481|NCT02155946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410482|NCT02155933|||Case-Control||Cross-Sectional|||||||
1410483|NCT02155920||Single Group Assignment||Treatment||None (Open Label)||||||
1410484|NCT02155907|||Case-Only||Prospective|||||||
1410485|NCT02155894|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1410486|NCT02155881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410487|NCT02155868|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410488|NCT02155855|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1410489|NCT02155842|Randomized|Parallel Assignment||Treatment||Single||||||t
1410490|NCT02155829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410491|NCT02155816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410492|NCT02155803||Single Group Assignment||Treatment||None (Open Label)||||||
1410493|NCT02155790||Single Group Assignment||Treatment||None (Open Label)||||||
1410494|NCT02155777|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1410495|NCT02155764|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1410496|NCT02155751|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1410497|NCT02155738|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410498|NCT02155725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410499|NCT02155712|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410500|NCT02155699|Randomized|Single Group Assignment||Prevention||Single||||||t
1410501|NCT02155686|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410502|NCT02155673|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410503|NCT02155660|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410504|NCT02155647||Single Group Assignment||Treatment||None (Open Label)||||||
1410505|NCT02155634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410506|NCT02155621||Single Group Assignment||||None (Open Label)||||||
1410507|NCT02155608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410508|NCT02155595|||Cohort||Prospective|||||||
1410509|NCT02155582|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1410510|NCT02155569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410511|NCT02155556|||Cohort||Prospective|||||||
1410512|NCT02155543|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1410513|NCT02155530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410514|NCT02155517||Single Group Assignment||Health Services Research||Double|||t||t|
1410515|NCT02155504|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1410516|NCT02155491|||Cohort||Prospective|||||||
1410517|NCT02155478|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1410518|NCT02155465||Single Group Assignment||Treatment||None (Open Label)||||||
1410519|NCT02155452|||Case Control|||||||||
1410520|NCT02155439|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410521|NCT02155426|||Case-Only||Prospective|||||||
1410522|NCT02155413|||||Retrospective|||||||
1410523|NCT02155400|Randomized|Parallel Assignment||Prevention||Single|||t|||
1410524|NCT02155387|||Case Control||Prospective|||||||
1410525|NCT02155374|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1410526|NCT02155361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410527|NCT02155348|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410528|NCT02155335|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410529|NCT02155322||Single Group Assignment||Treatment||None (Open Label)||||||
1410530|NCT02155309|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1410531|NCT02155296|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1410532|NCT02155283||Single Group Assignment||Treatment||None (Open Label)||||||
1410533|NCT02155270|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1410534|NCT02155257|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1410535|NCT02155244|||Cohort||Retrospective|||||||
1410536|NCT02155231|||Cohort||Prospective|||||||
1410537|NCT02155218|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1410538|NCT02155205|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1410539|NCT02155192|||Cohort||Retrospective|||||||
1410540|NCT02155179|||Cohort||Retrospective|||||||
1410541|NCT02155166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410542|NCT02155153|Randomized|Single Group Assignment||Treatment||Single||||||t
1410543|NCT02155140|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410544|NCT02155127|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410545|NCT02155114|||Cohort||Cross-Sectional|||||||
1410546|NCT02155101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410547|NCT02155088||Single Group Assignment||Treatment||None (Open Label)||||||
1410548|NCT02155075|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1410549|NCT02155062|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1410550|NCT02155049||Single Group Assignment||Treatment||None (Open Label)||||||
1410551|NCT02155036|Randomized|Parallel Assignment||Treatment||Single||||||t
1410552|NCT02155023||Single Group Assignment||Basic Science||None (Open Label)||||||
1410553|NCT02155010|Randomized|Parallel Assignment||||Double|||t||t|
1410554|NCT02154997|||Case Control||Prospective|||||||
1410555|NCT02154984||Single Group Assignment||Prevention||None (Open Label)||||||
1410556|NCT02154971|||Case-Control||Cross-Sectional|||||||
1410557|NCT02154958|||Cohort||Prospective|||||||
1410558|NCT02154945|||Case-Only||Prospective|||||||
1410559|NCT02154932|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1410560|NCT02154919|||Case Control||Prospective|||||||
1410561|NCT02154906|Randomized|Parallel Assignment||Treatment||Single||||||t
1410562|NCT02154893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410563|NCT02154880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410564|NCT02154867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410565|NCT02154854|Randomized|Parallel Assignment||Treatment||Single|||||t|
1410566|NCT02154841||Single Group Assignment||Supportive Care||Double|||t||t|
1410567|NCT02154828|||Cohort||Prospective|||||||
1410568|NCT02154815|||||Prospective|||||||
1410569|NCT02154802|Randomized|Factorial Assignment||||None (Open Label)||||||
1410570|NCT02154789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410571|NCT02154776||Single Group Assignment||Other||None (Open Label)||||||
1410572|NCT02154763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410573|NCT02154750|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410574|NCT02154737||Single Group Assignment||Treatment||None (Open Label)||||||
1410575|NCT02154724||Crossover Assignment||Treatment||Double|||t|||t
1410576|NCT02154711|||Case-Control||Cross-Sectional|||||||
1410577|NCT02154698|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1410578|NCT02154685|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410579|NCT02154672|||Cohort||Prospective|||||||
1410580|NCT02154659|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1410581|NCT02154646||Single Group Assignment||Treatment||None (Open Label)||||||
1410582|NCT02154633|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1410583|NCT02154620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410584|NCT02154607|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410585|NCT02154594|Randomized|Factorial Assignment||Supportive Care||Quadruple|||t|t|t|t
1410586|NCT02154581|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1410587|NCT02154568||Single Group Assignment||Basic Science||None (Open Label)||||||
1410588|NCT02154555|Randomized|Parallel Assignment||Treatment||Single|||||t|
1410589|NCT02154542|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410590|NCT02154529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410591|NCT02154516|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410592|NCT02154503||Single Group Assignment||Treatment||Single||||||t
1410593|NCT02154490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410594|NCT02154477||Single Group Assignment||Treatment||None (Open Label)||||||
1410595|NCT02154464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410596|NCT02154451||Single Group Assignment||Screening||Single|||||t|
1410597|NCT02154438|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410598|NCT02154425||Single Group Assignment||Other||None (Open Label)||||||
1410599|NCT02154412|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1410600|NCT02154399||Single Group Assignment||Treatment||None (Open Label)||||||
1410601|NCT02154386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410602|NCT02154360||Single Group Assignment||Treatment||None (Open Label)||||||
1410603|NCT02154347||||||||||||
1410604|NCT02154334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410605|NCT02154321|||Other||Cross-Sectional|||||||
1410606|NCT02154308||Single Group Assignment||Prevention||None (Open Label)||||||
1410607|NCT02154295|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1410608|NCT02154282||Single Group Assignment||Treatment||None (Open Label)||||||
1410609|NCT02154269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410610|NCT02154256|Randomized|Factorial Assignment||Prevention||Single|||t|||
1410611|NCT02154243|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410612|NCT02154230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410613|NCT02154217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410614|NCT02154204|||Cohort||Prospective|||||||
1410615|NCT02154191|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1410616|NCT02154178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410617|NCT02154165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410618|NCT02154152||Single Group Assignment||Treatment||None (Open Label)||||||
1410619|NCT02154139|||Cohort||Prospective|||||||
1410620|NCT02154126||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410621|NCT02154113|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1410622|NCT02154100|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410623|NCT02154087||Single Group Assignment||Treatment||None (Open Label)||||||
1410624|NCT02154074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410625|NCT02154061|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1410626|NCT02154048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410627|NCT02154035|||Case-Only||Other|||||||
1410628|NCT02154022|||Case-Only||Prospective|||||||
1410629|NCT02154009|||Case-Only||Other|||||||
1410630|NCT02153996|||Cohort||Prospective|||||||
1410631|NCT02153983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410632|NCT02153970|||||Prospective|||||||
1410633|NCT02153957|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410634|NCT02153944|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1410635|NCT02153931|||Cohort||Prospective|||||||
1410636|NCT02153918||Single Group Assignment||Treatment||None (Open Label)||||||
1410637|NCT02153905|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1410638|NCT02153892||Single Group Assignment||Treatment||None (Open Label)||||||
1410639|NCT02153879|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1410640|NCT02153866|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1410641|NCT02153853|||Cohort||Retrospective|||||||
1410642|NCT02153840|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410643|NCT02153827|Randomized|Parallel Assignment||Treatment||Single||||||t
1410644|NCT02153814|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410645|NCT02153801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410646|NCT02153788|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410647|NCT02153775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410648|NCT02153762|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410649|NCT02153749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410650|NCT02153736|Randomized|Parallel Assignment||Treatment||Single||||||t
1410651|NCT02153723||Single Group Assignment||Treatment||None (Open Label)||||||
1410652|NCT02153710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410653|NCT02153697||Single Group Assignment||Treatment||None (Open Label)||||||
1410654|NCT02153684|||Case-Control||Prospective|||||||
1410655|NCT02153671|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410656|NCT02153658|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410657|NCT02153645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410658|NCT02153632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410659|NCT02153619|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1410660|NCT02153606|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410661|NCT02153593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410662|NCT02153580|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410663|NCT02153567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410664|NCT02153554|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410665|NCT02153541|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1410666|NCT02153528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410667|NCT02153515||Single Group Assignment||Treatment||None (Open Label)||||||
1410668|NCT02153502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410669|NCT02153489|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1410670|NCT02153476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410671|NCT02153463|Randomized|Parallel Assignment||Treatment||Single||||||t
1410672|NCT02153450||Single Group Assignment||Treatment||None (Open Label)||||||
1410673|NCT02153437|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1410674|NCT02153424|||Case-Only||Prospective|||||||
1410675|NCT02153411|||Case-Only||Prospective|||||||
1410676|NCT02153398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410677|NCT02153385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410678|NCT02153372||Single Group Assignment||Treatment||None (Open Label)||||||
1410679|NCT02153359|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1410680|NCT02153346||Single Group Assignment||Other||None (Open Label)||||||
1410681|NCT02153333|||||Retrospective|||||||
1410682|NCT02153320|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410683|NCT02153307||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410684|NCT02153294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410685|NCT02153281||Single Group Assignment||Treatment||None (Open Label)||||||
1410686|NCT02153268||Single Group Assignment||Treatment||None (Open Label)||||||
1410687|NCT02153255|||Cohort||Prospective|||||||
1410688|NCT02153242|||Case-Only||Prospective|||||||
1410689|NCT02153229||Single Group Assignment||Treatment||||||||
1410690|NCT02153216|||Cohort||Cross-Sectional|||||||
1410691|NCT02153203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410692|NCT02153190|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410693|NCT02153177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410694|NCT02153164|||Cohort||Prospective|||||||
1410695|NCT02153151|||Cohort||Prospective|||||||
1410696|NCT02153138||Single Group Assignment||Health Services Research||None (Open Label)||||||
1410697|NCT02153125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410698|NCT02153112|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1410699|NCT02153099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410700|NCT02153086|||Cohort||Prospective|||||||
1410701|NCT02153073|||Cohort||Prospective|||||||
1410702|NCT02153060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410703|NCT02153047|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410704|NCT02153034|||Case-Control||Prospective|||||||
1410705|NCT02153021|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410706|NCT02153008|||Other||Prospective|||||||
1410707|NCT02152995||Single Group Assignment||Treatment||None (Open Label)||||||
1410708|NCT02152982|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410709|NCT02152969|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1410710|NCT02152956||Single Group Assignment||Treatment||None (Open Label)||||||
1410711|NCT02152943|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410712|NCT02152930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410713|NCT02152917|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410714|NCT02152904|||Cohort||Prospective|||||||
1410715|NCT02152891|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410716|NCT02152878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410717|NCT02152865|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410718|NCT02152852|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410719|NCT02152839|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410720|NCT02152826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410721|NCT02152813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410722|NCT02152800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410723|NCT02152787|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1410724|NCT02152774|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410725|NCT02152761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410726|NCT02152748|||Case-Only||Retrospective|||||||
1410727|NCT02152735|Randomized|Single Group Assignment||Treatment||Single|||t|||
1410728|NCT02152722|||Cohort||Cross-Sectional|||||||
1410729|NCT02152709|Randomized|Parallel Assignment||Prevention||Single|||t|||
1410730|NCT02152696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410731|NCT02152683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410732|NCT02152670|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1410733|NCT02152657||Single Group Assignment||Treatment||None (Open Label)||Tomography-guided mesenchymal stem cells injection.||||
1410734|NCT02152644|||Cohort||Cross-Sectional|||||||
1410735|NCT02152631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410736|NCT02152618||Single Group Assignment||Other||None (Open Label)||||||
1410737|NCT02152605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410738|NCT02152592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410739|NCT02152579||Single Group Assignment||Treatment||None (Open Label)||||||
1410740|NCT02152566||Single Group Assignment||Basic Science||None (Open Label)||||||
1410741|NCT02152553|Randomized|Crossover Assignment||Treatment||Single|||t|||
1410742|NCT02152540|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1410743|NCT02152527|||Case Control||Cross-Sectional|||||||
1410744|NCT02152514|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1410745|NCT02152501|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1410746|NCT02152488|||Case-Crossover||Prospective|||||||
1410747|NCT02152475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410748|NCT02152462|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1410749|NCT02152449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410750|NCT02152436|||Other||Prospective|||||||
1410751|NCT02152423|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410752|NCT02152410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410753|NCT02152397|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410754|NCT02152384|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1410755|NCT02152371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410756|NCT02152358|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410757|NCT02152345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410758|NCT02152332|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1410759|NCT02152319|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1410760|NCT02152306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410761|NCT02152293|||Cohort||Prospective|||||||
1410762|NCT02152280|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410763|NCT02152267|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1410764|NCT02152254|Randomized|Parallel Assignment||Treatment||Single|||||t|
1410765|NCT02152241|||||Cross-Sectional|||||||
1410766|NCT02152228||Single Group Assignment||Treatment||None (Open Label)||||||
1410767|NCT02152215|Randomized|Parallel Assignment||Treatment||Single||||||t
1410768|NCT02152202|Randomized|Single Group Assignment||Treatment||Single|||t|||
1410769|NCT02152189|||Case-Only||Cross-Sectional|||||||
1410770|NCT02152176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410771|NCT02152163|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1410772|NCT02152150|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1410773|NCT02152137||Single Group Assignment||Treatment||None (Open Label)||||||
1410774|NCT02152124|||Case Control||Prospective|||||||
1410775|NCT02152111|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410776|NCT02152098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410777|NCT02152085|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1410778|NCT02152072|||Cohort||Prospective|||||||
1410779|NCT02152059||Single Group Assignment||Treatment||None (Open Label)||||||
1410780|NCT02152046|||Case-Crossover||Prospective|||||||
1410781|NCT02152033|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410783|NCT02152007|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1410784|NCT02151994|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410785|NCT02151981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410786|NCT02151968|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1410787|NCT02151955||Single Group Assignment||Treatment||None (Open Label)||||||
1410788|NCT02151942|||Case Control||Prospective|||||||
1410789|NCT02151929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410790|NCT02151916|Randomized|Parallel Assignment||Prevention||Single||||||t
1410791|NCT02151903||Single Group Assignment||Treatment||None (Open Label)||||||
1410792|NCT02151890||Single Group Assignment||Treatment||None (Open Label)||||||
1410793|NCT02151877|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410794|NCT02151864||Single Group Assignment||Treatment||None (Open Label)||||||
1410795|NCT02151851|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410796|NCT02151838|||Cohort||Prospective|||||||
1410797|NCT02151825|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1410798|NCT02151812|Randomized|Parallel Assignment||Treatment||Single||||||t
1410799|NCT02151799||Single Group Assignment||Treatment||None (Open Label)||||||
1410800|NCT02151786|||Cohort||Prospective|||||||
1410801|NCT02151773|||Cohort||Prospective|||||||
1410802|NCT02151760||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410803|NCT02151747|||Case-Control||Prospective|||||||
1410804|NCT02151734|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410805|NCT02151721||Single Group Assignment||Treatment||None (Open Label)||||||
1410806|NCT02151708|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410807|NCT02151695|Randomized|Parallel Assignment||Treatment||||||||
1410808|NCT02151682|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1410809|NCT02151669|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410810|NCT02151656|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410811|NCT02151643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410812|NCT02151630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410813|NCT02151617|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1410814|NCT02151604||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410815|NCT02151591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410816|NCT02151578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410817|NCT02151565|Randomized|Crossover Assignment||Treatment||Single||||||t
1410818|NCT02151552||Single Group Assignment||Basic Science||None (Open Label)||||||
1410819|NCT02151539|||Case-Only||Prospective|||||||
1410820|NCT02151526||Single Group Assignment||Treatment||None (Open Label)||||||
1410821|NCT02151513|||Case-Only||Prospective|||||||
1410822|NCT02151500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410823|NCT02151487|Randomized|Parallel Assignment||Treatment||Single|||||t|
1410824|NCT02151474|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410825|NCT02151461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410826|NCT02151448||Single Group Assignment||Treatment||None (Open Label)||||||
1410827|NCT02151435|||Cohort||Prospective|||||||
1410828|NCT02151422||Single Group Assignment||Treatment||None (Open Label)||||||
1410829|NCT02151409|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410830|NCT02151396||Single Group Assignment||Basic Science||None (Open Label)||||||
1410831|NCT02151383||Single Group Assignment||Treatment||None (Open Label)||||||
1410832|NCT02151370|||Cohort||Prospective|||||||
1410833|NCT02151357||Single Group Assignment||Treatment||None (Open Label)||||||
1410834|NCT02151344|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1410835|NCT02151331|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1410836|NCT02151318|||Case-Only|||||||||
1410837|NCT02151305|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1410838|NCT02151279|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1410839|NCT02151266|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1410840|NCT02151253|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1410841|NCT02151240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410842|NCT02151227|||Cohort||Cross-Sectional|||||||
1410843|NCT02151214|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410844|NCT02151201|Randomized|Crossover Assignment||Prevention||Single||||t||
1410845|NCT02151188|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410846|NCT02151175||Single Group Assignment||Basic Science||None (Open Label)||||||
1410847|NCT02151162|Randomized|Factorial Assignment||Prevention||Single||||||t
1410848|NCT02151149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410849|NCT02151136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410850|NCT02151123|||Case-Only||Cross-Sectional|||||||
1410851|NCT02151110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410852|NCT02151097|||||Prospective|||||||
1410853|NCT02151084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410854|NCT02151071||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410855|NCT02151058|Randomized|Parallel Assignment||||Single|||||t|
1410856|NCT02151045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410857|NCT02151032|||Case-Control||Prospective|||||||
1410858|NCT02151019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410859|NCT02151006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410860|NCT02150993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410861|NCT02150980|||Cohort||Prospective|||||||
1410862|NCT02150967||Single Group Assignment||Treatment||None (Open Label)||||||
1410863|NCT02150954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410864|NCT02150941|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1410865|NCT02150928||Single Group Assignment||Treatment||None (Open Label)||||||
1410866|NCT02150915|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1410867|NCT02150902|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410868|NCT02150889|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410869|NCT02150876|||Case Control||Retrospective|||||||
1410870|NCT02150863|Randomized|||Treatment||Single||||||t
1410871|NCT02150850|||Case-Control||Prospective|||||||
1410872|NCT02150837|||Cohort||Retrospective|||||||
1410873|NCT02150824|Randomized|Parallel Assignment||Treatment||Double||||||
1410874|NCT02150811|||Cohort||Prospective|||||||
1410875|NCT02150798|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410876|NCT02150785||Single Group Assignment||Treatment||None (Open Label)||||||
1410877|NCT02150772||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410878|NCT02150759|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1410879|NCT02150746|||Case-Only||Prospective|||||||
1410880|NCT02150733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1410881|NCT02150720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410882|NCT02150707|||Cohort||Prospective|||||||
1410883|NCT02150694|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1410884|NCT02150681||Single Group Assignment||Treatment||None (Open Label)||||||
1410885|NCT02150668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410886|NCT02150655|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1410887|NCT02150642|||Cohort||Prospective|||||||
1410888|NCT02150629|||Cohort||Prospective|||||||
1410889|NCT02150616|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1410890|NCT02150603|||||Cross-Sectional|||||||
1410891|NCT02150590|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1410892|NCT02150577|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1410893|NCT02150564|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1410894|NCT02150551||Single Group Assignment||Treatment||None (Open Label)||||||
1410895|NCT02150538|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410896|NCT02150525|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1410897|NCT02150512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410898|NCT02150499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410899|NCT02150486|||Cohort||Prospective|||||||
1410900|NCT02150473|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410901|NCT02150460|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410902|NCT02150447|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1410903|NCT02150434|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1410904|NCT02150421|||Case Control||Prospective|||||||
1410905|NCT02150408||Single Group Assignment||Diagnostic||None (Open Label)||||||
1410906|NCT02150395|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1410907|NCT02150382|||Cohort||Prospective|||||||
1410908|NCT02150369|||Case-Only||Prospective|||||||
1410909|NCT02150356|Randomized|Crossover Assignment||Treatment||Single|||t|||
1410910|NCT02150343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410911|NCT02150330|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410912|NCT02150317|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410913|NCT02150304|||Case Control||Retrospective|||||||
1410914|NCT02150291|Randomized|Parallel Assignment||Prevention||Single|||t|||
1410915|NCT02150278||Single Group Assignment||Prevention||Single|||t|||
1410916|NCT02150265|Randomized|Parallel Assignment||Treatment||Single||||||t
1410917|NCT02150252|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1410918|NCT02150239|||Case-Only||Cross-Sectional|||||||
1410919|NCT02150226||Single Group Assignment||Treatment||None (Open Label)||||||
1410920|NCT02150213||Single Group Assignment||||None (Open Label)||||||
1410921|NCT02150200|Randomized|Parallel Assignment||||None (Open Label)||||||
1410922|NCT02150187|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1410923|NCT02150174|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1410924|NCT02150161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410925|NCT02150148|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1410926|NCT02150135||Single Group Assignment||Treatment||None (Open Label)||||||
1410927|NCT02150122|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1410928|NCT02150109|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1410929|NCT02150096|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1410930|NCT02150083|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1410931|NCT02150070|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1410932|NCT02150057|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1410933|NCT02150044||Single Group Assignment||Treatment||None (Open Label)||||||
1410934|NCT02150031|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1410935|NCT02150018|||||Cross-Sectional|||||||
1410936|NCT02150005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410937|NCT02149992||Single Group Assignment||Prevention||None (Open Label)||||||
1410938|NCT02149979||Single Group Assignment||Treatment||None (Open Label)||||||
1410939|NCT02149966|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410940|NCT02149953||Single Group Assignment||Basic Science||None (Open Label)||||||
1410941|NCT02149940|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1410942|NCT02149927||Single Group Assignment||Basic Science||None (Open Label)||||||
1410943|NCT02149914||Single Group Assignment||Screening||None (Open Label)||||||
1410944|NCT02149901|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1410945|NCT02149888||Single Group Assignment||Prevention||None (Open Label)||||||
1410946|NCT02149875|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1410947|NCT02149862|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1410948|NCT02149849|Randomized|Parallel Assignment||Prevention||Single|||t|||
1410949|NCT02149836||Single Group Assignment||Treatment||None (Open Label)||||||
1410950|NCT02149823|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1410951|NCT02149810|Randomized|Parallel Assignment||Treatment||Single||||||t
1410952|NCT02149797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410953|NCT02149784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410954|NCT02149771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410955|NCT02149758|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1410956|NCT02149745|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1410957|NCT02149732||||||||||||
1410958|NCT02149719|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1410959|NCT02149706|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410960|NCT02149693|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1410961|NCT02149680|||Case Control||Retrospective|||||||
1410962|NCT02149667|||Cohort||Prospective|||||||
1410963|NCT02149654|||Other||Prospective|||||||
1410964|NCT02149641|||Cohort||Prospective|||||||
1410965|NCT02149628|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1410966|NCT02149615|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410967|NCT02149602|||Cohort||Prospective|||||||
1410968|NCT02149589|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1410969|NCT02149576|Non-Randomized|Parallel Assignment||Screening||Single||||||t
1410970|NCT02149563|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410971|NCT02149550|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1410972|NCT02149537|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||Adult patients to start to receive fixed low dose hydroxyurea (10 mg/kg) per day for six months and then crossover to no hydroxyurea treatment for six months, or start with no hydroxyurea treatment for six months and then crossover to receive fixed low dose hydroxyurea (10 mg/kg) per day for six months.||||
1410973|NCT02149524|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410974|NCT02149511|||Cohort||Prospective|||||||
1410975|NCT02149498|||Case Control||Prospective|||||||
1410976|NCT02149485|||Cohort||Prospective|||||||
1410977|NCT02149472|||Cohort||Prospective|||||||
1410978|NCT02149459||Single Group Assignment||Treatment||None (Open Label)||||||
1410979|NCT02149446|Randomized|Parallel Assignment||Treatment||Single|||t|||
1410980|NCT02149433|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1410981|NCT02149420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410982|NCT02149407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1410983|NCT02149394|Randomized|Parallel Assignment||Treatment||Single||||||t
1410984|NCT02149381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410985|NCT02149355|||Case Control||Retrospective|||||||
1410986|NCT02149342|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1410987|NCT02149329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1410988|NCT02149316|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1410989|NCT02149303|||Cohort||Retrospective|||||||
1410990|NCT02149290|||Case-Only||Prospective|||||||
1410991|NCT02149277|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1410992|NCT02149264||Single Group Assignment||Treatment||None (Open Label)||||||
1410993|NCT02149251|||Case Control||Retrospective|||||||
1410994|NCT02149238|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1410995|NCT02149225||Single Group Assignment||Treatment||None (Open Label)||||||
1410996|NCT02149212|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1410997|NCT02149199|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1410998|NCT02149186||Single Group Assignment||Basic Science||None (Open Label)||||||
1410999|NCT02149173||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411000|NCT02149160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411001|NCT02149147|||Cohort||Prospective|||||||
1411002|NCT02149134||Single Group Assignment||Treatment||None (Open Label)||||||
1411003|NCT02149121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411004|NCT02149108|Randomized|Parallel Assignment||Treatment||Double||||||
1411005|NCT02149095||Single Group Assignment||Treatment||None (Open Label)||||||
1411006|NCT02149082|||Cohort||Prospective|||||||
1411007|NCT02149069|||||Prospective|||||||
1411008|NCT02149056|||Cohort||Prospective|||||||
1411009|NCT02149043|||Case-Control||Prospective|||||||
1411010|NCT02149030|Randomized|Parallel Assignment||Screening||Single|||t|||
1411011|NCT02149017||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411012|NCT02149004|||Cohort||Prospective|||||||
1411013|NCT02148991|||Other||Prospective|||||||
1411014|NCT02148978|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1411015|NCT02148965|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411016|NCT02148952|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1411017|NCT02148939|||Case Control||Prospective|||||||
1411018|NCT02148926|||Family-Based||Prospective|||||||
1411019|NCT02148913|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411020|NCT02148900|||Case Control||Prospective|||||||
1411021|NCT02148887|||Case-Control||Cross-Sectional|||||||
1411022|NCT02148874|||Case-Control||Prospective|||||||
1411023|NCT02148861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411024|NCT02148848|Randomized|Parallel Assignment||Treatment||Single||||||t
1411025|NCT02148835|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1411026|NCT02148822|||Cohort||Prospective|||||||
1411027|NCT02148809||Single Group Assignment||Prevention||None (Open Label)||||||
1411028|NCT02148796|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1411029|NCT02148783||Single Group Assignment||Treatment||None (Open Label)||||||
1411030|NCT02148770|Randomized|Parallel Assignment||Treatment||Single|||t|||
1411031|NCT02148757||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411032|NCT02148744|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1411033|NCT02148731|||Cohort||Prospective|||||||
1411034|NCT02148718||Single Group Assignment||Treatment||None (Open Label)||||||
1411035|NCT02148705|Randomized|Factorial Assignment||Treatment||Single||||||t
1411036|NCT02148692|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1411037|NCT02148679|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1411038|NCT02148666||||||||||||
1411039|NCT02148653|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411040|NCT02148640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411041|NCT02148627|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411042|NCT02148614|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411043|NCT02148601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411044|NCT02148588||Single Group Assignment||Other||None (Open Label)||||||
1411045|NCT02148575|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1411046|NCT02148562|||||Prospective|||||||
1411047|NCT02148549||Single Group Assignment||Treatment||None (Open Label)||||||
1411048|NCT02148536|||Case-Only||Prospective|||||||
1411049|NCT02148523|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411050|NCT02148510|Randomized|Parallel Assignment||Treatment||Single||||||t
1411051|NCT02148497|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1411052|NCT02148484|Randomized|Parallel Assignment||Treatment||Single||||||t
1411053|NCT02148471|||Cohort||Cross-Sectional|||||||
1411054|NCT02148458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411055|NCT02148445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411056|NCT02148432|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1411057|NCT02148419|||Case-Control||Prospective|||||||
1411058|NCT02148406|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1411059|NCT02148393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411060|NCT02148380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411061|NCT02148367|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411062|NCT02148354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411063|NCT02148341|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1411064|NCT02148328|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411065|NCT02148315|Randomized|Parallel Assignment||||None (Open Label)||||||
1411066|NCT02148302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411067|NCT02148289|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1411068|NCT02148276|||Case-Crossover||Prospective|||||||
1411069|NCT02148263|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411070|NCT02148250|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1411071|NCT02148237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411072|NCT02148224|||Cohort||Cross-Sectional|||||||
1411073|NCT02148211|||Cohort||Prospective|||||||
1411074|NCT02148198|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1411075|NCT02148185||Single Group Assignment||Treatment||None (Open Label)||||||
1411076|NCT02148172|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411077|NCT02148159|||Cohort||Prospective|||||||
1411078|NCT02148146||Single Group Assignment||Treatment||None (Open Label)||||||
1411079|NCT02148133||||Treatment||None (Open Label)||||||
1411080|NCT02148120|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411081|NCT02148107|Randomized|Parallel Assignment||Treatment||Double||||||
1411082|NCT02148094||Single Group Assignment||Prevention||None (Open Label)||||||
1411083|NCT02148081|||Cohort||Prospective|||||||
1411084|NCT02148068|||Case-Control||Prospective|||||||
1411085|NCT02148055||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411086|NCT02148042|||Case Control||Prospective|||||||
1411087|NCT02148029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411088|NCT02148016|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411089|NCT02148003|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411090|NCT02147990||Single Group Assignment||Treatment||None (Open Label)||||||
1411091|NCT02147977|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411092|NCT02147964|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411093|NCT02147951||||||||||||
1411094|NCT02147938|||Cohort||Prospective|||||||
1411095|NCT02147925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411096|NCT02147912|Randomized|Parallel Assignment||Treatment||Single||||||t
1411097|NCT02147899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411098|NCT02147886|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411099|NCT02147873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411100|NCT02147860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411101|NCT02147847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411102|NCT02147834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411103|NCT02147821|Randomized|Single Group Assignment||Treatment||Single||||||t
1411104|NCT02147808||Single Group Assignment||Treatment||None (Open Label)||||||
1411105|NCT02147795|||Cohort||Other|||||||
1411106|NCT02147782|||Case-Control||Prospective|||||||
1411107|NCT02147769|||Cohort||Prospective|||||||
1411108|NCT02147756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411109|NCT02147743|Randomized|Factorial Assignment||Treatment||Single||||||t
1411110|NCT02147730|||Cohort||Prospective|||||||
1411111|NCT02147717|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411112|NCT02147704|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411113|NCT02147691|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411114|NCT02147678|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411115|NCT02147665||Single Group Assignment||||None (Open Label)||||||
1411116|NCT02147652||Single Group Assignment||Treatment||None (Open Label)||||||
1411117|NCT02147639|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1411118|NCT02147626|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411119|NCT02147613|Randomized|Parallel Assignment||Treatment||Single||||||t
1411120|NCT02147600|||Cohort||Cross-Sectional|||||||
1411121|NCT02147587|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411122|NCT02147574||Single Group Assignment||Treatment||Single|||||t|
1411123|NCT02147561||Single Group Assignment||Treatment||None (Open Label)||||||
1411124|NCT02147548|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1411125|NCT02147535||Single Group Assignment||Basic Science||None (Open Label)||||||
1411126|NCT02147522|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1411127|NCT02147509||Single Group Assignment||Treatment||Single||||||t
1411128|NCT02147496|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1411129|NCT02147483|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411130|NCT02147470||Parallel Assignment||Diagnostic||None (Open Label)||||||
1411131|NCT02147457|||Case Control||Cross-Sectional|||||||
1411132|NCT02147444|||Cohort||Prospective|||||||
1411133|NCT02147431|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1411134|NCT02147418|||Case-Control||Prospective|||||||
1411135|NCT02147405|||Cohort||Prospective|||||||
1411136|NCT02147392||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411137|NCT02147379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411138|NCT02147366|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1411139|NCT02147353|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411140|NCT02147340|||Cohort||Prospective|||||||
1411141|NCT02147327|||Cohort||Prospective|||||||
1411142|NCT02147314|||Case-Only||Prospective|||||||
1411143|NCT02147301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411144|NCT02147288|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411145|NCT02147275|||Cohort||Prospective|||||||
1411146|NCT02147262|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411147|NCT02147249||Single Group Assignment||Basic Science||None (Open Label)||||||
1411148|NCT02147236|Randomized|Parallel Assignment||Treatment||Single||||||
1411149|NCT02147223|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1411150|NCT02147210|||Case-Control||Retrospective|||||||
1411151|NCT02147197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411152|NCT02147184|||Cohort||Prospective|||||||
1411153|NCT02147171|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411154|NCT02147158|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411155|NCT02147145|||Cohort||Prospective|||||||
1411156|NCT02147132|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1411157|NCT02147119|||Cohort||Prospective|||||||
1411158|NCT02147106|||Cohort||Prospective|||||||
1411159|NCT02147093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411160|NCT02147080|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1411161|NCT02147067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411162|NCT02147054|Randomized|Parallel Assignment||Treatment||Single||||||t
1411163|NCT02147041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411164|NCT02147028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411165|NCT02147015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411166|NCT02147002|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1411167|NCT02146989|||Cohort||Cross-Sectional|||||||
1411168|NCT02146976|Randomized|Parallel Assignment||Treatment||Single|||t|||
1411169|NCT02146963|||Cohort||Prospective|||||||
1411170|NCT02146950|||Cohort||Prospective|||||||
1411171|NCT02146937||Single Group Assignment||Treatment||None (Open Label)||||||
1411172|NCT02146924|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411173|NCT02146911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411174|NCT02146898|Randomized|Parallel Assignment||Treatment||Single||||||t
1411175|NCT02146885|||Case-Only||Cross-Sectional|||||||
1411176|NCT02146872|||Family-Based||Cross-Sectional|||||||
1411177|NCT02146859|||Cohort||Prospective|||||||
1411178|NCT02146846|||Ecologic or Community||Prospective|||||||
1411179|NCT02146833|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411180|NCT02146820|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1411181|NCT02146807|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1411182|NCT02146794||Single Group Assignment||Treatment||None (Open Label)||||||
1411183|NCT02146781|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411184|NCT02146768|||Cohort||Retrospective|||||||
1411185|NCT02146755|||Cohort||Retrospective|||||||
1411186|NCT02146742|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1411187|NCT02146729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411188|NCT02146716|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1411189|NCT02146703||Single Group Assignment||Treatment||None (Open Label)||||||
1411190|NCT02146690|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411191|NCT02146677|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411192|NCT02146664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411193|NCT02146651|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411194|NCT02146638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411195|NCT02146625|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1411196|NCT02146612|||||Prospective|||||||
1411197|NCT02146599|||Case-Only||Prospective|||||||
1411198|NCT02146586|||Cohort||Prospective|||||||
1411199|NCT02146573|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1411200|NCT02146560|||Cohort||Prospective|||||||
1411201|NCT02146547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411202|NCT02146534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411203|NCT02146521|||Other||Prospective|||||||
1411204|NCT02146508||Single Group Assignment||Treatment||None (Open Label)||||||
1411205|NCT02146495|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1411206|NCT02146482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411207|NCT02146469|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411208|NCT02146456|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1411209|NCT02146443|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1411210|NCT02146430|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411211|NCT02146417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411212|NCT02146404|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1411213|NCT02146391||Crossover Assignment||Treatment||None (Open Label)||||||
1411214|NCT02146378|||Case-Only||Other|||||||
1411215|NCT02146365|||Cohort||Prospective|||||||
1411216|NCT02146352||Single Group Assignment||Treatment||None (Open Label)||||||
1411217|NCT02146339|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1411218|NCT02146326|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411219|NCT02146313|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411220|NCT02146300||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411221|NCT02146287|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411222|NCT02146274|||Cohort||Prospective|||||||
1411223|NCT02146261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411224|NCT02146248||Single Group Assignment||Other||None (Open Label)||||||
1411225|NCT02146235|Randomized|Parallel Assignment||Treatment||Single||||||t
1411226|NCT02146222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411227|NCT02146209|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411228|NCT02146196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411229|NCT02146183|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411230|NCT02146170|||Cohort||Prospective|||||||
1411231|NCT02146157|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411232|NCT02146144|Randomized|Parallel Assignment||Treatment||Single|||t|||
1411233|NCT02146131|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1411234|NCT02146118||Single Group Assignment||Treatment||None (Open Label)||||||
1411235|NCT02146105||Single Group Assignment||Treatment||None (Open Label)||||||
1411236|NCT02146092|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1411237|NCT02146079|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411238|NCT02146066||||||||||||
1411239|NCT02146053|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1411240|NCT02146040|||Cohort||Retrospective|||||||
1411241|NCT02146027|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1411242|NCT02146014|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411243|NCT02146001|Randomized|Parallel Assignment||||Single||||||t
1411244|NCT02145988|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411245|NCT02145975|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411246|NCT02145962|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411247|NCT02145949|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411248|NCT02145936|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1411249|NCT02145923||Single Group Assignment||Prevention||None (Open Label)||||||
1411250|NCT02145910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411251|NCT02145897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411252|NCT02145884||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1411253|NCT02145871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411254|NCT02145858|||Cohort||Prospective|||||||
1411255|NCT02145845||Single Group Assignment||Treatment||None (Open Label)||||||
1411256|NCT02145832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411257|NCT02145819|Randomized|||Treatment||||||||
1411258|NCT02145806|||Cohort||Cross-Sectional|||||||
1411259|NCT02145793|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1411260|NCT02145780|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1411261|NCT02145767|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411262|NCT02145754|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1411263|NCT02145741||Single Group Assignment||Treatment||None (Open Label)||||||
1411264|NCT02145728|Randomized|Parallel Assignment||Treatment||Single||||||t
1411265|NCT02145715||Single Group Assignment||Treatment||None (Open Label)||||||
1411266|NCT02145702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411267|NCT02145689|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1411268|NCT02145676|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1411269|NCT02145663|||Case-Only||Prospective|||||||
1411270|NCT02145650|||Case-Only||Cross-Sectional|||||||
1411271|NCT02145637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411272|NCT02145624|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411273|NCT02145611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411274|NCT02145598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411275|NCT02145585|||Case-Only||Prospective|||||||
1411276|NCT02145572|||Other||Cross-Sectional|||||||
1411277|NCT02145559|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411278|NCT02145546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411279|NCT02145533|||Cohort||Prospective|||||||
1411280|NCT02145520|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1411281|NCT02145507|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1411282|NCT02145494||Single Group Assignment||Treatment||None (Open Label)||||||
1411283|NCT02145481|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1411284|NCT02145468|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1411285|NCT02145455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411286|NCT02145442||Single Group Assignment||Treatment||None (Open Label)||||||
1411287|NCT02145429|Randomized|Parallel Assignment||Prevention||Single||||||t
1411288|NCT02145416|||Cohort||Prospective|||||||
1411289|NCT02145403||Single Group Assignment||Treatment||None (Open Label)||||||
1411290|NCT02145390||Single Group Assignment||Treatment||None (Open Label)||||||
1411291|NCT02145377|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1411292|NCT02145364||Single Group Assignment||Treatment||Single||||||t
1411293|NCT02145351|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411294|NCT02145338|Randomized|Parallel Assignment||Prevention||Single||||||t
1411295|NCT02145325||Single Group Assignment||Treatment||None (Open Label)||||||
1411296|NCT02145312||Single Group Assignment||Treatment||None (Open Label)||||||
1411297|NCT02145299|Randomized|Parallel Assignment||Treatment||Single|||t|||
1411298|NCT02145286||Single Group Assignment||Treatment||None (Open Label)||||||
1411299|NCT02145273|Randomized|Parallel Assignment||Treatment||None (Open Label)||There are 3 conditions that will be followed for up to 2 years: control, intervention and comparison. Randomization is by site. Half the sites are control half are intervention. all possible subjects are screened for depression. if the subject is depressed they are invited in to control or intervention based on site, all non depressed subjects are invited into the comparison.||||
1411300|NCT02145260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411301|NCT02145247|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1411302|NCT02145234|Randomized|Single Group Assignment||Other||Double|||t||t|
1411303|NCT02145221|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1411304|NCT02145208||Single Group Assignment||Treatment||None (Open Label)||iTind||||
1411305|NCT02145195|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1411306|NCT02145182|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411307|NCT02145169||Single Group Assignment||Treatment||None (Open Label)||||||
1411308|NCT02145156|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1411309|NCT02145143||Single Group Assignment||Treatment||None (Open Label)||||||
1411310|NCT02145130|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411311|NCT02145117||Single Group Assignment||Treatment||None (Open Label)||||||
1411312|NCT02145104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411313|NCT02145091|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411314|NCT02145078||Single Group Assignment||Treatment||None (Open Label)||||||
1411315|NCT02145065|Randomized|Parallel Assignment||Treatment||Single|||t|||
1411316|NCT02145052|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411317|NCT02145039||Single Group Assignment||Treatment||None (Open Label)||||||
1411318|NCT02145026||Single Group Assignment||Treatment||None (Open Label)||||||
1411319|NCT02145013|||Cohort||Prospective|||||||
1411320|NCT02145000|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411321|NCT02144987||Single Group Assignment||Treatment||None (Open Label)||||||
1411322|NCT02144974|||Case-Only||Retrospective|||||||
1411323|NCT02144961|||Cohort||Prospective|||||||
1411324|NCT02144948||Single Group Assignment||Treatment||None (Open Label)||||||
1411325|NCT02144935|||Case-Only||Prospective|||||||
1411326|NCT02144922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411327|NCT02144909|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1411328|NCT02144896|Randomized|Single Group Assignment||Other||Single||||||t
1411329|NCT02144883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411330|NCT02144870|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1411331|NCT02144857|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411332|NCT02144844|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1411333|NCT02144831|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411334|NCT02144818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411335|NCT02144805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411336|NCT02144792|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1411337|NCT02144779|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1411338|NCT02144766|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411339|NCT02144753|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1411340|NCT02144740|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1411341|NCT02144727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411342|NCT02144714|Randomized|Parallel Assignment||Other||Single|||t|||
1411343|NCT02144701|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1411344|NCT02144688||Single Group Assignment||Treatment||None (Open Label)||||||
1411345|NCT02144675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411346|NCT02144662||Single Group Assignment||Treatment||None (Open Label)||||||
1411347|NCT02144649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411348|NCT02144636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411349|NCT02144623||Single Group Assignment||Treatment||None (Open Label)||||||
1411350|NCT02144610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411351|NCT02144597|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411352|NCT02144584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411353|NCT02144571|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1411354|NCT02144558||Single Group Assignment||Prevention||None (Open Label)||||||
1411355|NCT02144545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411356|NCT02144532||Single Group Assignment||Supportive Care||None (Open Label)||||||
1411357|NCT02144519|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1411358|NCT02144506|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411359|NCT02144493|||Case Control||Retrospective|||||||
1411360|NCT02144480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411361|NCT02144467|||Cohort||Cross-Sectional|||||||
1411362|NCT02144454|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1411363|NCT02144441||Single Group Assignment||Supportive Care||None (Open Label)||||||
1411364|NCT02144428|||Cohort||Prospective|||||||
1411365|NCT02144415|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1411366|NCT02144402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411367|NCT02144389|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1411368|NCT02144376|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1411369|NCT02144363|||Cohort||Prospective|||||||
1411370|NCT02144350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411371|NCT02144337|Randomized|Parallel Assignment||||None (Open Label)||||||
1411372|NCT02144324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411373|NCT02144311||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411374|NCT02144298|||Cohort||Prospective|||||||
1411375|NCT02144285|Randomized|Parallel Assignment||||Double|||t||t|
1411376|NCT02144272|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411377|NCT02144259|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411378|NCT02144246|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1411379|NCT02144233|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411380|NCT02144220||Single Group Assignment||Health Services Research||None (Open Label)||||||
1411381|NCT02144207|Randomized|Parallel Assignment||Other||Single|||t|||
1411382|NCT02144194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411383|NCT02144181|Randomized|Parallel Assignment||Treatment||Single||||||t
1411384|NCT02144168|Randomized|Parallel Assignment||Prevention||Single||||||t
1411385|NCT02144155|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1411386|NCT02144142||Single Group Assignment||Treatment||None (Open Label)||||||
1411387|NCT02144129|Randomized|Parallel Assignment||Treatment||Single||||||t
1411388|NCT02144116|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411389|NCT02144103||Single Group Assignment||Treatment||None (Open Label)||||||
1411390|NCT02144090||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411391|NCT02144077|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1411392|NCT02144064|Randomized|Single Group Assignment||Prevention||Single|||t|||
1411393|NCT02144051||Single Group Assignment||Treatment||None (Open Label)||||||
1411394|NCT02144038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411395|NCT02144025||Single Group Assignment||Prevention||None (Open Label)||||||
1411396|NCT02144012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411397|NCT02143999|||Cohort||Prospective|||||||
1411398|NCT02143986|||Cohort||Prospective|||||||
1411399|NCT02143973|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411400|NCT02143960|Randomized|Parallel Assignment||Treatment||Single||||||t
1411401|NCT02143947|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411402|NCT02143934|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1411403|NCT02143921|Non-Randomized|Parallel Assignment||Health Services Research||Single||||t||
1411404|NCT02143908|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411405|NCT02143882||Single Group Assignment||Treatment||None (Open Label)||||||
1411406|NCT02143869|||Cohort||Prospective|||||||
1411407|NCT02143856|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411408|NCT02143843||Single Group Assignment||Treatment||None (Open Label)||||||
1411409|NCT02143830|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411410|NCT02143817|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411411|NCT02143804||||||||||||
1411412|NCT02143791|||Case Control||Prospective|||||||
1411413|NCT02143778||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411414|NCT02143765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411415|NCT02143752|||Case-Only||Prospective|||||||
1411416|NCT02143739|||Other||Prospective|||||||
1411417|NCT02143726|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411418|NCT02143713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411419|NCT02143700|||Case-Crossover||Cross-Sectional|||||||
1411420|NCT02143687|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1411421|NCT02143674|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1411422|NCT02143661|||Cohort||Prospective|||||||
1411423|NCT02143648|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1411424|NCT02143635|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411425|NCT02143622|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411426|NCT02143609|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1411427|NCT02143596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411428|NCT02143583|||||Prospective|||||||
1411429|NCT02143570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411430|NCT02143557|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1411431|NCT02143544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411432|NCT02143531|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411433|NCT02143518|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411434|NCT02143505|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1411435|NCT02143492|||Case-Only||Prospective|||||||
1411436|NCT02143479|||Cohort||Prospective|||||||
1411437|NCT02143466|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411438|NCT02143453|Randomized|Parallel Assignment||||None (Open Label)||||||
1411439|NCT02143440||Single Group Assignment||Treatment||None (Open Label)||||||
1411440|NCT02143427|Randomized|Parallel Assignment||Treatment||Single|||t|||
1411441|NCT02143414|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411442|NCT02143401||Single Group Assignment||Treatment||None (Open Label)||||||
1411443|NCT02143388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411444|NCT02143375||Single Group Assignment||Treatment||None (Open Label)||||||
1411445|NCT02143362|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411446|NCT02143349|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1411447|NCT02143336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411448|NCT02143323|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411449|NCT02143310||Single Group Assignment||||None (Open Label)||||||
1411450|NCT02143297|||Case Control||Prospective|||||||
1411451|NCT02143284||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411452|NCT02143271||Single Group Assignment||Treatment||None (Open Label)||||||
1411453|NCT02143258||Single Group Assignment||Treatment||None (Open Label)||||||
1411454|NCT02143245||Single Group Assignment||Treatment||None (Open Label)||||||
1411455|NCT02143232||Single Group Assignment||Supportive Care||None (Open Label)||||||
1411456|NCT02143219||Single Group Assignment||Treatment||None (Open Label)||||||
1411457|NCT02143206|||Cohort||Prospective|||||||
1411458|NCT02143193|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411459|NCT02143180|||||Prospective|||||||
1411460|NCT02143167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411461|NCT02143154|||Cohort||Prospective|||||||
1411462|NCT02143141|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411463|NCT02143128|||Cohort||Prospective|||||||
1411464|NCT02143115|||Case-Only||Prospective|||||||
1411465|NCT02143102|||Cohort||Prospective|||||||
1411466|NCT02143089|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1411467|NCT02143076|||Cohort||Prospective|||||||
1411468|NCT02143063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411469|NCT02143050||Single Group Assignment||Treatment||None (Open Label)||||||
1411470|NCT02143037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411471|NCT02143024|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1411472|NCT02143011|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411473|NCT02142998|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1411474|NCT02142985||Single Group Assignment||Treatment||None (Open Label)||||||
1411475|NCT02142972|||Cohort||Prospective|||||||
1411476|NCT02142959|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1411477|NCT02142946|||Case-Control||Retrospective|||||||
1411478|NCT02142933||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411479|NCT02142920||Single Group Assignment||Basic Science||None (Open Label)||||||
1411480|NCT02142907|||Case Control||Prospective|||||||
1411481|NCT02142894|||Case-Only||Prospective|||||||
1411482|NCT02142881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411483|NCT02142868||||||||||||
1411484|NCT02142855|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411485|NCT02142842||Parallel Assignment||Treatment||Single|||||t|
1411486|NCT02142829|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411487|NCT02142816|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411488|NCT02142803||Single Group Assignment||Treatment||None (Open Label)||||||
1411489|NCT02142790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411490|NCT02142777||Single Group Assignment||Treatment||Single|||t|||
1411491|NCT02142764|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1411492|NCT02142751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411493|NCT02142738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411494|NCT02142725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411495|NCT02142712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411496|NCT02142699|Randomized|Parallel Assignment||||Single|||t|||
1411497|NCT02142686|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1411498|NCT02142673|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1411499|NCT02142660|||||Prospective|||||||
1411500|NCT02142647|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411501|NCT02142634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411502|NCT02142621|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411503|NCT02142608||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411504|NCT02142595|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1411505|NCT02142582|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1411506|NCT02142569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411507|NCT02142556||Single Group Assignment||Treatment||None (Open Label)||||||
1411508|NCT02142543|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1411509|NCT02142530||Single Group Assignment||Treatment||None (Open Label)||||||
1411510|NCT02142517|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411511|NCT02142504|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411512|NCT02142491|||Case Control||Prospective|||||||
1411513|NCT02142478|||Case Control||Prospective|||||||
1411514|NCT02142465||||||||||||
1411515|NCT02142452|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411516|NCT02142439|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411517|NCT02142426|||||Retrospective|||||||
1411518|NCT02142413|||Cohort||Prospective|||||||
1411519|NCT02142400|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1411520|NCT02142387||Single Group Assignment||Treatment||None (Open Label)||||||
1411521|NCT02142374||||||||||||
1411522|NCT02142361|Non-Randomized|Parallel Assignment||||Single|||t|||
1411523|NCT02142348|||Cohort||Prospective|||||||
1411524|NCT02142335||Single Group Assignment||Treatment||None (Open Label)||||||
1411525|NCT02142322||Single Group Assignment||Treatment||None (Open Label)||||||
1411526|NCT02142309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411527|NCT02142296||Single Group Assignment||Treatment||None (Open Label)||||||
1411528|NCT02142283|Randomized|Parallel Assignment||Treatment||Single||||||t
1411529|NCT02142270|||Cohort||Prospective|||||||
1411530|NCT02142257|||Cohort||Prospective|||||||
1411531|NCT02142244||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411532|NCT02142231|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1411533|NCT02142218||||||||||||
1411534|NCT02142205||Single Group Assignment||Treatment||None (Open Label)||||||
1411535|NCT02142192||Single Group Assignment||Treatment||None (Open Label)||||||
1411536|NCT02142179|Randomized|Parallel Assignment||Prevention||Single|||||t|
1411537|NCT02142166|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411538|NCT02142153|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411539|NCT02142140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411540|NCT02142127||Single Group Assignment||Treatment||None (Open Label)||||||
1411541|NCT02142114|Randomized|Single Group Assignment||Health Services Research||Double|||t|||t
1411542|NCT02142101|||Cohort||Cross-Sectional|||||||
1411543|NCT02142088||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411544|NCT02142075||||||||||||
1411545|NCT02142062|||Cohort||Prospective|||||||
1411546|NCT02142049|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411547|NCT02142036||Single Group Assignment||Treatment||None (Open Label)||||||
1411548|NCT02142023||||||||||||
1411549|NCT02142010||Single Group Assignment||Treatment||None (Open Label)||||||
1411550|NCT02141997|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411551|NCT02141984|||Case-Only||Prospective|||||||
1411552|NCT02141971|||Case-Control||Prospective|||||||
1411553|NCT02141958|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1411554|NCT02141945|||Case-Only||Prospective|||||||
1411555|NCT02141932||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411556|NCT02141919||Single Group Assignment||Treatment||None (Open Label)||||||
1411557|NCT02141906||Single Group Assignment||Treatment||None (Open Label)||||||
1411558|NCT02141893|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1411559|NCT02141880|||Cohort||Prospective|||||||
1411560|NCT02141867|||Cohort||Prospective|||||||
1411561|NCT02141854|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1411562|NCT02141841|||||Prospective|||||||
1411563|NCT02141828||Single Group Assignment||Treatment||None (Open Label)||||||
1411564|NCT02141815|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1412403|NCT02130843|||Case-Only||Retrospective|||||||
1411565|NCT02141802|Randomized|Parallel Assignment||Treatment||Single||||||t
1411566|NCT02141789||Single Group Assignment||Treatment||None (Open Label)||||||
1411567|NCT02141776|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1411568|NCT02141763|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1411569|NCT02141750|||Cohort||Prospective|||||||
1411570|NCT02141737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411571|NCT02141724|||Cohort||Retrospective|||||||
1411572|NCT02141711|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1411573|NCT02141698|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1411574|NCT02141685|||Cohort||Prospective|||||||
1411575|NCT02141672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411576|NCT02141659|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1411577|NCT02141646|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1411578|NCT02141633|Randomized|Parallel Assignment||||Double|||t|||t
1411579|NCT02141620|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1411580|NCT02141607|||Cohort||Prospective|||||||
1411581|NCT02141594|||Case Control||Prospective|||||||
1411582|NCT02141581|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411583|NCT02141568|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411584|NCT02141555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411585|NCT02141542||Single Group Assignment||Treatment||None (Open Label)||||||
1411586|NCT02141529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411587|NCT02141516|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411588|NCT02141503|||||Other|||||||
1411589|NCT02141490||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411590|NCT02141477||Single Group Assignment||Treatment||None (Open Label)||||||
1411591|NCT02141464|||Cohort||Prospective|||||||
1411592|NCT02141451||Single Group Assignment||Treatment||None (Open Label)||||||
1411593|NCT02141438|||Cohort||Prospective|||||||
1411594|NCT02141425|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411595|NCT02141412|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1411596|NCT02141399||Single Group Assignment||Treatment||None (Open Label)||||||
1411597|NCT02141386|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411598|NCT02141373|Randomized|Parallel Assignment||Prevention||Single|||t|||
1411599|NCT02141360|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1411600|NCT02141347|Non-Randomized|||Other||None (Open Label)||||||
1411601|NCT02141334||||||||||||
1411602|NCT02141321|Randomized|Parallel Assignment||||Double|||t||t|
1411603|NCT02141308|||Case-Control||Prospective|||||||
1411604|NCT02141295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411605|NCT02141282|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411606|NCT02141269|||Cohort||Prospective|||||||
1411607|NCT02141256||Single Group Assignment||Supportive Care||None (Open Label)||||||
1411608|NCT02141243|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1411609|NCT02141230||Single Group Assignment||||None (Open Label)||||||
1411610|NCT02141217|Randomized|Parallel Assignment||Treatment||Single||||||t
1411611|NCT02141204|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411612|NCT02141191|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411613|NCT02141178||||Treatment||||||||
1411614|NCT02141165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411615|NCT02141152|||||Prospective|||||||
1411616|NCT02141139|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411617|NCT02141126|Randomized|Parallel Assignment||Treatment||Single||||||t
1411618|NCT02141113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411619|NCT02141100||Single Group Assignment||Treatment||None (Open Label)||||||
1411620|NCT02141087||||||||||||
1411621|NCT02141074||Single Group Assignment||Treatment||None (Open Label)||||||
1411622|NCT02141061|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1411623|NCT02141048|Randomized|Parallel Assignment||Prevention||Single||||||t
1411624|NCT02141035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411625|NCT02141022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411626|NCT02141009|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1411627|NCT02140996||Single Group Assignment||Treatment||None (Open Label)||||||
1411628|NCT02140983|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1411629|NCT02140970|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411630|NCT02140957|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1411631|NCT02140944|||Cohort||Prospective|||||||
1411632|NCT02140931|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411633|NCT02140918|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1411634|NCT02140905|||Cohort||Retrospective|||||||
1411635|NCT02140892|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411636|NCT02140879|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411637|NCT02140866|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1411638|NCT02140853|||Case Control||Prospective|||||||
1411639|NCT02140840||Single Group Assignment||Treatment||None (Open Label)||||||
1411640|NCT02140827|Randomized|Parallel Assignment||Screening||Double|||||t|t
1411641|NCT02140814||Single Group Assignment||Treatment||None (Open Label)||||||
1411642|NCT02140801|Randomized|Parallel Assignment||Treatment||Single||||||t
1411643|NCT02140788|Randomized|Factorial Assignment||||None (Open Label)||||||
1411644|NCT02140775|Randomized|Parallel Assignment||Treatment||Single||||||t
1411645|NCT02140762|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411646|NCT02140749|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1411647|NCT02140736|||Cohort||Prospective|||||||
1411648|NCT02140723|||Cohort||Prospective|||||||
1411649|NCT02140710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411650|NCT02140697|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411651|NCT02140684|||Cohort||Retrospective|||||||
1411652|NCT02140671|||Cohort||Prospective|||||||
1411653|NCT02140658|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411654|NCT02140645|||Cohort||Retrospective|||||||
1411655|NCT02140632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411656|NCT02140619|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411657|NCT02140606|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411658|NCT02140593|Randomized|Parallel Assignment||Treatment||Single||||||t
1411659|NCT02140580|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1411660|NCT02140567|||Cohort||Prospective|||||||
1411661|NCT02140554|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411662|NCT02140541|||Cohort||Retrospective|||||||
1411663|NCT02140528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411664|NCT02140515|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411665|NCT02140502|||Cohort||Prospective|||||||
1411666|NCT02140489|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411667|NCT02140476|Randomized|Factorial Assignment||||Double|||t|||t
1411668|NCT02140463|||Other||Prospective|||||||
1411669|NCT02140450|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1411670|NCT02140437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411671|NCT02140424|||Case Control||Prospective|||||||
1411672|NCT02140411||Single Group Assignment||Treatment||None (Open Label)||||||
1411673|NCT02140398|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411674|NCT02140385|Randomized|Parallel Assignment||||None (Open Label)||||||
1411675|NCT02140372||Single Group Assignment||Treatment||None (Open Label)||||||
1411676|NCT02140359|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1411677|NCT02140346|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411678|NCT02140333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411679|NCT02140320|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411680|NCT02140307|Randomized|Factorial Assignment||Treatment||Single|||||t|
1411681|NCT02140294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411682|NCT02140281|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1411683|NCT02140268|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1411684|NCT02140255|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1411685|NCT02140242|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1411686|NCT02140229|Randomized|Parallel Assignment||Prevention||Single|||||t|
1411687|NCT02140216|||Cohort||Prospective|||||||
1411688|NCT02140203|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1411689|NCT02140177|||||Prospective|||||||
1411690|NCT02140164||Single Group Assignment||Treatment||None (Open Label)||||||
1411691|NCT02140151|Randomized|Parallel Assignment||Prevention||Single||||||t
1411692|NCT02140138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411693|NCT02140125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411694|NCT02140112|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411695|NCT02140099|Randomized|Parallel Assignment||Prevention||Single|||t|||
1411696|NCT02140086|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411697|NCT02140073|Randomized|Parallel Assignment||Treatment||Single||||||t
1411698|NCT02140060|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411699|NCT02140047|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411700|NCT02140034|Randomized|Parallel Assignment||Prevention||Single|||t|||
1411701|NCT02140021||Single Group Assignment||Screening||None (Open Label)||||||
1411702|NCT02140008|Randomized|Parallel Assignment||||Double|||t|||t
1411703|NCT02139995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411704|NCT02139982|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1411705|NCT02139969|||Cohort||Retrospective|||||||
1411706|NCT02139956|||Case Control||Cross-Sectional|||||||
1411707|NCT02139943|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411708|NCT02139930|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411709|NCT02139917|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1411710|NCT02139904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411711|NCT02139891|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1411712|NCT02139878|Randomized|Crossover Assignment||Other||Single|||t|||
1411713|NCT02139865|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1411714|NCT02139852|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411715|NCT02139839|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411716|NCT02139826|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411717|NCT02139813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411718|NCT02139800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411719|NCT02139787|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411720|NCT02139774|||Cohort||Prospective|||||||
1411721|NCT02139761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411722|NCT02139748|Randomized|Parallel Assignment||Treatment||Single||||||t
1411723|NCT02139735|Randomized|Crossover Assignment||Treatment||Single|||||t|
1411724|NCT02139722|Randomized|Parallel Assignment||Screening||Double|||||t|t
1411725|NCT02139709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411726|NCT02139696|||Cohort||Prospective|||||||
1411727|NCT02139683||Single Group Assignment||Treatment||None (Open Label)||||||
1411728|NCT02139670|||Cohort||Prospective|||||||
1411729|NCT02139657||Single Group Assignment||Treatment||None (Open Label)||||||
1411730|NCT02139644|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1411731|NCT02139631||Single Group Assignment||Basic Science||Double|||t||t|
1411732|NCT02139618|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411733|NCT02139605|Randomized|Parallel Assignment||Treatment||None (Open Label)||Gastrectomy with D2 or D3 lymphadenectomy||||
1411734|NCT02139592|||Cohort||Prospective|||||||
1411735|NCT02139579||Single Group Assignment||Treatment||None (Open Label)||||||
1411736|NCT02139566|Randomized|Parallel Assignment||||None (Open Label)||||||
1411737|NCT02139553||Single Group Assignment||Treatment||None (Open Label)||||||
1411738|NCT02139540|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411739|NCT02139527|||Case-Only||Prospective|||||||
1411740|NCT02139514|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411741|NCT02139501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411742|NCT02139488|||Other||Prospective|||||||
1411743|NCT02139475|||Cohort||Prospective|||||||
1411744|NCT02139462|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1411745|NCT02139449|||Cohort||Prospective|||||||
1411746|NCT02139436|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1411747|NCT02139423||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411748|NCT02139410|||Cohort||Prospective|||||||
1411749|NCT02139397||Single Group Assignment||Treatment||None (Open Label)||||||
1411750|NCT02139384|||Case-Only||Prospective|||||||
1411751|NCT02139371||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411752|NCT02139358||Single Group Assignment||Treatment||None (Open Label)||||||
1411753|NCT02139345|Randomized|Parallel Assignment||Treatment||Single|Investigator who assesses KSS score is blinded to the subject's treatment.|Subject was randomized to receive the treatment of investigational device or the comparator.||||t
1411754|NCT02139332|Randomized|Parallel Assignment||Other||Single||||||t
1411755|NCT02139319|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411756|NCT02139306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411757|NCT02139293||Single Group Assignment||Basic Science||None (Open Label)||||||
1411758|NCT02139280|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411759|NCT02139267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411760|NCT02139254|||Cohort||Prospective|||||||
1411761|NCT02139241|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411762|NCT02139228|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411763|NCT02139215|||Cohort||Prospective|||||||
1411764|NCT02139202||Single Group Assignment||Health Services Research||None (Open Label)||||||
1411765|NCT02139189||Single Group Assignment||Treatment||None (Open Label)||||||
1411766|NCT02139176|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1411767|NCT02139163|||Cohort||Prospective|||||||
1411768|NCT02139150||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411769|NCT02139137|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411770|NCT02139124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411771|NCT02139111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411772|NCT02139098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411773|NCT02139085|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411774|NCT02139072|||Case Control||Prospective|||||||
1411775|NCT02139059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411776|NCT02139046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411777|NCT02139033||Single Group Assignment||Treatment||None (Open Label)||||||
1411778|NCT02139020|||Cohort||Prospective|||||||
1411779|NCT02139007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411780|NCT02138994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411781|NCT02138981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411782|NCT02138968|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411783|NCT02138955||Single Group Assignment||Treatment||None (Open Label)||||||
1411784|NCT02138942||Single Group Assignment||Treatment||None (Open Label)||||||
1411785|NCT02138929||Single Group Assignment||Treatment||None (Open Label)||||||
1411786|NCT02138916|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1411787|NCT02138903|||Case Control||Cross-Sectional|||||||
1411788|NCT02138890|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411789|NCT02138877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411790|NCT02138864||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411791|NCT02138851|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411792|NCT02138838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411793|NCT02138825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411794|NCT02138812||Single Group Assignment||Treatment||None (Open Label)||||||
1411795|NCT02138799|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411796|NCT02138786||Single Group Assignment||Treatment||None (Open Label)||||||
1411797|NCT02138773|Randomized|Crossover Assignment||||None (Open Label)||||||
1411798|NCT02138760|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1411799|NCT02138747|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1411800|NCT02138734|Randomized|Parallel Assignment||Treatment||None (Open Label)||Single arm phase Ib; two-arm phase IIb, 1:1 randomization and stratification by bladder tumor disease stage.||||
1411801|NCT02138721|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411802|NCT02138708||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411803|NCT02138695|||Cohort||Prospective|||||||
1411804|NCT02138682|||Cohort||Prospective|||||||
1411805|NCT02138669||Single Group Assignment||Treatment||None (Open Label)||||||
1411806|NCT02138656|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1411807|NCT02138643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411808|NCT02138630|Randomized|Crossover Assignment||||Double|||t|||t
1411809|NCT02138617|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411810|NCT02138604|||Cohort||Prospective|||||||
1411811|NCT02138591|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411812|NCT02138578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411813|NCT02138565||Single Group Assignment||Basic Science||None (Open Label)||||||
1411814|NCT02138552|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411815|NCT02138539|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1411816|NCT02138526|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1411817|NCT02138513|Randomized|Single Group Assignment||Treatment||Single|||||t|
1411818|NCT02138500|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411819|NCT02138487|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1411820|NCT02138474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411821|NCT02138461|||Cohort||Retrospective|||||||
1411822|NCT02138448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411823|NCT02138435|||Cohort||Prospective|||||||
1411824|NCT02138422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411825|NCT02138409|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411826|NCT02138396|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1411827|NCT02138383||Single Group Assignment||Treatment||None (Open Label)||||||
1411828|NCT02138370|||Cohort||Retrospective|||||||
1411829|NCT02138357|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411830|NCT02138344|||Case-Control||Prospective|||||||
1411831|NCT02138331||Single Group Assignment||Treatment||None (Open Label)||||||
1411832|NCT02138318|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411833|NCT02138305||Single Group Assignment||Diagnostic||None (Open Label)||Controlled prospective observational study||||
1411834|NCT02138292||Single Group Assignment||Treatment||None (Open Label)||||||
1411835|NCT02138279|||Cohort||Prospective|||||||
1411836|NCT02138266|||Cohort||Prospective|||||||
1411837|NCT02138253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411838|NCT02138240||Single Group Assignment||Treatment||None (Open Label)||||||
1411839|NCT02138227|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1411840|NCT02138214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411841|NCT02138201|||||Prospective|||||||
1411842|NCT02138188|||Cohort||Prospective|||||||
1411843|NCT02138175|||Cohort||Prospective|||||||
1411844|NCT02138162|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411845|NCT02138149|||Case Control||Prospective|||||||
1411846|NCT02138136||Single Group Assignment||Treatment||None (Open Label)||||||
1411847|NCT02138123|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411848|NCT02138110||Single Group Assignment||Treatment||None (Open Label)||||||
1411849|NCT02138097|||Cohort||Retrospective|||||||
1411850|NCT02138084|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1411851|NCT02138071|||Cohort||Prospective|||||||
1411852|NCT02138058|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1411853|NCT02138045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411854|NCT02138032|Randomized|Parallel Assignment||Prevention||Single||||t||
1411855|NCT02138019||Single Group Assignment||Treatment||None (Open Label)||||||
1411856|NCT02138006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411857|NCT02137993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411858|NCT02137980|||Case-Only||Prospective|||||||
1411859|NCT02137967|Randomized|Parallel Assignment||Treatment||Single|||t|||
1411860|NCT02137954|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411861|NCT02137941|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1411862|NCT02137928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411863|NCT02137915|||Case-Only||Prospective|||||||
1411864|NCT02137902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411865|NCT02137889|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411866|NCT02137876|||Case-Only||Prospective|||||||
1411867|NCT02137863|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411868|NCT02137850||Single Group Assignment||Treatment||None (Open Label)||||||
1411869|NCT02137837|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1411870|NCT02137824||Single Group Assignment||Treatment||None (Open Label)||||||
1411871|NCT02137811|||Cohort||Prospective|||||||
1411872|NCT02137798|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411873|NCT02137785|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411874|NCT02137772|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411875|NCT02137759|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411876|NCT02137746||Single Group Assignment||Treatment||None (Open Label)||||||
1411877|NCT02137733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411878|NCT02137720|Randomized|Parallel Assignment||Treatment||Single||||||t
1411879|NCT02137707|||Case-Only||Prospective|||||||
1411880|NCT02137694||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411881|NCT02137681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411882|NCT02137668||Single Group Assignment||Treatment||None (Open Label)||||||
1411883|NCT02137655|||Cohort||Prospective|||||||
1411884|NCT02137642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411885|NCT02137629|||Case-Only||Prospective|||||||
1411886|NCT02137616|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411887|NCT02137603|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1411888|NCT02137590||Single Group Assignment||||None (Open Label)||||||
1411889|NCT02137577|Randomized|Parallel Assignment||Treatment||Single||||||t
1411890|NCT02137564||Single Group Assignment||Treatment||None (Open Label)||||||
1411891|NCT02137551|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1411892|NCT02137538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411893|NCT02137525|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411894|NCT02137512|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1411895|NCT02137499|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411896|NCT02137486|||Case-Control||Retrospective|||||||
1411897|NCT02137473|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1411898|NCT02137460|||Cohort||Prospective|||||||
1411899|NCT02137447||Single Group Assignment||Treatment||None (Open Label)||||||
1411900|NCT02137434|Randomized|Crossover Assignment||||Single|||t|||
1411901|NCT02137421|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1411902|NCT02137408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411903|NCT02137395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411904|NCT02137382|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1411905|NCT02137369|Randomized|Crossover Assignment||Treatment||Single||||||t
1411906|NCT02137356||Single Group Assignment||Treatment||None (Open Label)||||||
1411907|NCT02137343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1411908|NCT02137330|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411909|NCT02137317|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1411910|NCT02137304||Single Group Assignment||Treatment||None (Open Label)||||||
1411911|NCT02137291|||Other||Prospective|||||||
1411912|NCT02137278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411913|NCT02137265|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411914|NCT02137252|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1411915|NCT02137239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411916|NCT02137226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411917|NCT02137213|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1411918|NCT02137200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411919|NCT02137187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411920|NCT02137174|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1411921|NCT02137161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411922|NCT02137148|||Case-Only||Prospective|||||||
1411923|NCT02137135|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1411924|NCT02137122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411925|NCT02137109|||Case-Only|||||||||
1411926|NCT02137096|||Case-Only||Prospective|||||||
1411927|NCT02137083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411928|NCT02137070|||Case-Control||Prospective|||||||
1411929|NCT02137057|||Cohort||Prospective|||||||
1411930|NCT02137044|Randomized|Parallel Assignment||Treatment||Single||||||t
1411931|NCT02137031||||Treatment||||||||
1411932|NCT02137018|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1411933|NCT02137005|||Cohort||Prospective|||||||
1411934|NCT02136992|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411935|NCT02136979|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1411936|NCT02136966|Randomized|Parallel Assignment||Treatment||Single||||||t
1411937|NCT02136953|Randomized|Factorial Assignment||Treatment||Single||||||t
1411938|NCT02136940|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411939|NCT02136927|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411940|NCT02136914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411941|NCT02136901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411942|NCT02136888|Randomized|Parallel Assignment||||Triple|||t||t|t
1411943|NCT02136875||Single Group Assignment||Treatment||None (Open Label)||||||
1411944|NCT02136862|||Cohort||Prospective|||||||
1411945|NCT02136849|||Family-Based||Prospective|||||||
1411946|NCT02136836|||Case-Only||Retrospective|||||||
1411947|NCT02136823|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411948|NCT02136810|||Cohort||Prospective|||||||
1411949|NCT02136797||Single Group Assignment||Treatment||None (Open Label)||||||
1411950|NCT02136784|Randomized|Single Group Assignment||||Single|||t|||
1411951|NCT02136771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1411952|NCT02136758|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411953|NCT02136745|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411954|NCT02136732|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1411955|NCT02136719|Randomized|Parallel Assignment||Prevention||Single|||t|||
1411956|NCT02136706||Single Group Assignment||Diagnostic||None (Open Label)||||||
1411957|NCT02136693|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1411958|NCT02136680|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1411959|NCT02136667|||Cohort||Retrospective|||||||
1411960|NCT02136654|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1411961|NCT02136641|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1411962|NCT02136628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1411963|NCT02136615|||Cohort||Prospective|||||||
1411964|NCT02136602|||Case-Only||Prospective|||||||
1411965|NCT02136589|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1411966|NCT02136576|Randomized|Parallel Assignment||Treatment||Single|||||t|
1411967|NCT02136563|||Cohort||Prospective|||||||
1411968|NCT02136550||Single Group Assignment||Screening||None (Open Label)|Fluid analysis and other physical measurements|Subjects that entered in the Smoking Cessation Program at Institute Dante Pazzanese of Cardiology State of Sao Paulo||||
1411969|NCT02136537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411970|NCT02136524|Randomized|Crossover Assignment||||None (Open Label)||||||
1411971|NCT02136511||||||||||||
1411972|NCT02136498|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411973|NCT02136485|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1411974|NCT02136472|||Case Control||Cross-Sectional|||||||
1411975|NCT02136459|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1411976|NCT02136446|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411977|NCT02136433|Randomized|Parallel Assignment||Treatment||Single||||||t
1411978|NCT02136420|Randomized|Crossover Assignment||Basic Science||Double|Double masking applies to arms 9&10. Other arms use participant masking only.|"The design includes three separate studies:~Arm 9&10 follows a crossover design. These results were reported in Diaz-Artiles et al 2017.~Arms 1-4 are a separate study which follow a factorial design, with arm 2 serving as the placebo, arms 1 and 3 assessing the effects of two separate interventions and arm 4 assessing the effect of two combined interventions.~Arms 5-8 are a separate study which follow a factorial design, with arm 6 serving as the placebo, arms 5 and 7 assessing the effects of two separate interventions and arm 8 assessing the effect of two combined interventions."|t||t|
1411979|NCT02136407|||Cohort||Cross-Sectional|||||||
1411980|NCT02136394|||Cohort||Prospective|||||||
1411981|NCT02136381|Randomized|Parallel Assignment||||Single||||||t
1411982|NCT02136368|Randomized|Parallel Assignment||Prevention||Single||||||t
1411983|NCT02136355||Single Group Assignment||Treatment||None (Open Label)||||||
1411984|NCT02136342||Single Group Assignment||Treatment||None (Open Label)||||||
1411985|NCT02136329||Single Group Assignment||Prevention||None (Open Label)||||||
1411986|NCT02136316|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1411987|NCT02136303|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1411988|NCT02136290|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1411989|NCT02136277|||||Prospective|||||||
1411990|NCT02136264|Randomized|Crossover Assignment||Treatment||Single||||||t
1411991|NCT02136251|||Other||Prospective|||||||
1411992|NCT02136238|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1411993|NCT02136225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1411994|NCT02136212|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1411995|NCT02136199|Randomized|Parallel Assignment||||None (Open Label)||||||
1411996|NCT02136186|Randomized|Parallel Assignment||Prevention||Single|patients deidentified||t|||
1411997|NCT02136173||Single Group Assignment||Treatment||None (Open Label)||||||
1411998|NCT02136160||||Prevention||None (Open Label)||||||
1411999|NCT02136147|||Cohort||Prospective|||||||
1412000|NCT02136134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412001|NCT02136121||Single Group Assignment||||None (Open Label)||||||
1412002|NCT02136108|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1412003|NCT02136095||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412004|NCT02136082|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1412005|NCT02136069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412006|NCT02136056|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412007|NCT02136043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412008|NCT02136030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412009|NCT02136017|||Case-Only||Retrospective|||||||
1412010|NCT02136004||Single Group Assignment||Treatment||None (Open Label)||||||
1412011|NCT02135991|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1412012|NCT02135978|Randomized|Parallel Assignment||Prevention||Single||||||t
1412013|NCT02135965|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1412014|NCT02135952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412015|NCT02135939|Randomized|Parallel Assignment||Treatment||Single||||||t
1412016|NCT02135926|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412017|NCT02135913||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412018|NCT02135900||Single Group Assignment||Treatment||None (Open Label)||||||
1412019|NCT02135887|||Other||Prospective|||||||
1412020|NCT02135874||Single Group Assignment||Treatment||None (Open Label)||||||
1412021|NCT02135861|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1412022|NCT02135848|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1412023|NCT02135835|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412024|NCT02135822||Single Group Assignment||Treatment||None (Open Label)||||||
1412025|NCT02135809||Single Group Assignment||Treatment||None (Open Label)||||||
1412026|NCT02135796|||Cohort||Prospective|||||||
1412027|NCT02135783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412028|NCT02135770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412029|NCT02135757|||Cohort||Prospective|||||||
1412030|NCT02135744|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1412031|NCT02135731|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1412032|NCT02135718|||||Prospective|||||||
1412033|NCT02135705|||Cohort||Prospective|||||||
1412034|NCT02135692||Single Group Assignment||Treatment||None (Open Label)||||||
1412035|NCT02135679|||Cohort||Prospective|||||||
1412036|NCT02135666|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412037|NCT02135653|||Cohort||Prospective|||||||
1412038|NCT02135640|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412039|NCT02135627|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412040|NCT02135614|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412041|NCT02135601|Randomized|Parallel Assignment||Screening||Single|||t|||
1412042|NCT02135588||Single Group Assignment||Treatment||None (Open Label)||||||
1412043|NCT02135575|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412044|NCT02135562||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412045|NCT02135549|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1412046|NCT02135536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412047|NCT02135523||Single Group Assignment||Treatment||None (Open Label)||||||
1412048|NCT02135510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412049|NCT02135484||Single Group Assignment||Treatment||None (Open Label)||||||
1412050|NCT02135471|Randomized|Crossover Assignment||Treatment||Single||||||t
1412051|NCT02135458|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412052|NCT02135445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412053|NCT02135432|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1412054|NCT02135419|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412055|NCT02135406||Single Group Assignment||Treatment||None (Open Label)||||||
1412056|NCT02135393||Single Group Assignment||Basic Science||None (Open Label)||||||
1412057|NCT02135380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412058|NCT02135367|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412059|NCT02135354|Randomized|Parallel Assignment||Treatment||Triple|"The identity of the study drug will be concealed by the use of a format that is identical in packaging, labelling, schedule of administration and appearance.~Patients will be randomly assigned in a 1:1 ratio to receive either azithromycin or placebo, with a permuted block size of ten and sequential assignment, stratified by the center.~Randomization of the study drug is based on an online generated randomization schedule (http://www.randomization.com). Unique randomization codes are locally obtained through a secured Web-based program.~At all times, randomization codes are kept strictly confidential during the study, with the exception of an ad hoc independent safety committee adjudicating cardiovascular side effects and mortality after 300 patients.~Nevertheless, code breaks will be available at the site and un-blinding may occur in the case of an emergency which will require knowledge of the treatment assignment."||t|t|t|
1412060|NCT02135341|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking was designed in this study|Patients with urodynamically proven DHIC and age-matched controlled OAB patients with urodynamic DO selected from our previous clinical trials were compared for the treatment outcome of onabotulinumtoxinA injection||||
1412061|NCT02135328|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1412062|NCT02135315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412063|NCT02135302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412064|NCT02135289|||Case-Control||Prospective|||||||
1412065|NCT02135276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412066|NCT02135263|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412067|NCT02135250|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1412068|NCT02135237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412069|NCT02135224|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1412070|NCT02135211||Single Group Assignment||Treatment||None (Open Label)||||||
1412071|NCT02135198|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1412072|NCT02135185|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412073|NCT02135172|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1412074|NCT02135159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412075|NCT02135146|Randomized|Parallel Assignment||Treatment||Single||||||t
1412076|NCT02135133||Single Group Assignment||Treatment||None (Open Label)||||||
1412077|NCT02135120|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1412078|NCT02135107|Randomized|Parallel Assignment||Treatment||Double||||||
1412079|NCT02135094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412080|NCT02135081|||Cohort||Prospective|||||||
1412081|NCT02135068|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412082|NCT02135055|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412083|NCT02135042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412084|NCT02135029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412085|NCT02135016|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412086|NCT02135003||Single Group Assignment||Health Services Research||None (Open Label)||||||
1412087|NCT02134990||Single Group Assignment||Treatment||None (Open Label)||||||
1412088|NCT02134977|||Cohort||Prospective|||||||
1413331|NCT02118740|||Other||Prospective|||||||
1412089|NCT02134964|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1412090|NCT02134951|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412091|NCT02134938|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1412092|NCT02134925|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1412093|NCT02134912|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412094|NCT02134899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412095|NCT02134886||Single Group Assignment||Treatment||None (Open Label)||||||
1412096|NCT02134873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412097|NCT02134860|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412098|NCT02134847|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1412099|NCT02134834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412100|NCT02134821|||Cohort||Prospective|||||||
1412101|NCT02134808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412102|NCT02134795||Single Group Assignment||Treatment||None (Open Label)||||||
1412103|NCT02134782|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412104|NCT02134769|Randomized|Parallel Assignment||Prevention||Single|||t|||
1412105|NCT02134756|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1412106|NCT02134743|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1412107|NCT02134730|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412108|NCT02134717||Single Group Assignment||Basic Science||None (Open Label)||||||
1412109|NCT02134704|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412110|NCT02134691|Randomized|Parallel Assignment||Treatment||Single||||||t
1412111|NCT02134678|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412112|NCT02134665|||Case Control||Retrospective|||||||
1412113|NCT02134652|||||Prospective|||||||
1412114|NCT02134639|||Case-Only||Prospective|||||||
1412115|NCT02134626|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412116|NCT02134613||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412117|NCT02134600||Single Group Assignment||Supportive Care||Single|||t|||
1412118|NCT02134587||Single Group Assignment||||None (Open Label)||||||
1412119|NCT02134574|||Cohort||Prospective|||||||
1412120|NCT02134561||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412121|NCT02134548|||Case-Only|||||||||
1412122|NCT02134535|||Cohort||Cross-Sectional|||||||
1412123|NCT02134522||Single Group Assignment||Treatment||None (Open Label)||||||
1412124|NCT02134509|Randomized|Parallel Assignment||Treatment||Single||||||t
1412125|NCT02134496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412126|NCT02134483||Single Group Assignment||Treatment||None (Open Label)||||||
1412127|NCT02134470||Single Group Assignment||Treatment||Single||||||t
1412128|NCT02134457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412129|NCT02134444|Randomized|Parallel Assignment||Treatment||Single||||||t
1412130|NCT02134431|||Cohort||Cross-Sectional|||||||
1412131|NCT02134418|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412132|NCT02134405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412133|NCT02134392||Single Group Assignment||Treatment||None (Open Label)||||||
1412134|NCT02134379|||Case-Only||Prospective|||||||
1412135|NCT02134366|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1412136|NCT02134353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412137|NCT02134340||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412138|NCT02134327||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1412139|NCT02134314|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1412140|NCT02134301||Single Group Assignment||Treatment||None (Open Label)||||||
1412141|NCT02134288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412142|NCT02134275|Randomized|Parallel Assignment||Prevention||Single||||||t
1412143|NCT02134262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412144|NCT02134249|Randomized|Single Group Assignment||Prevention||Single|||t|||
1412145|NCT02134236||||||||||||
1412146|NCT02134223|Randomized|Crossover Assignment||||Single||||||t
1412147|NCT02134210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412148|NCT02134197||Single Group Assignment||Treatment||None (Open Label)||||||
1412149|NCT02134184|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412150|NCT02134171||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412151|NCT02134158|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1412152|NCT02134145|||Other||Prospective|||||||
1412153|NCT02134132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412154|NCT02134119|Randomized|Parallel Assignment||||Single|||t|||
1412155|NCT02134106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412156|NCT02134093|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1412157|NCT02134080|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1412158|NCT02134067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412159|NCT02134054|||Cohort||Prospective|||||||
1412160|NCT02134041|||Case Control||Retrospective|||||||
1412161|NCT02134028||Single Group Assignment||Treatment||None (Open Label)||||||
1412162|NCT02134015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412163|NCT02134002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412164|NCT02133989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412165|NCT02133976|Randomized|Parallel Assignment||Treatment||Single||||||t
1412166|NCT02133963|||Case Control||Prospective|||||||
1412167|NCT02133950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412168|NCT02133937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412169|NCT02133924||Single Group Assignment||Treatment||None (Open Label)||||||
1412170|NCT02133911|Randomized|Parallel Assignment||Treatment||Single||||||t
1412171|NCT02133898||Single Group Assignment||Other||None (Open Label)||||||
1412172|NCT02133885|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1412173|NCT02133872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412174|NCT02133859|||Cohort||Prospective|||||||
1412175|NCT02133846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412176|NCT02133833||Single Group Assignment||Treatment||Single||||||t
1412177|NCT02133820|Randomized|Crossover Assignment||||None (Open Label)||||||
1412178|NCT02133807|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1412179|NCT02133794||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412180|NCT02133781|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412181|NCT02133768|||Cohort||Prospective|||||||
1412182|NCT02133755||Single Group Assignment||||None (Open Label)||||||
1412183|NCT02133742||||Treatment||None (Open Label)||||||
1412184|NCT02133729||Single Group Assignment||Screening||None (Open Label)||||||
1412185|NCT02133716|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1412186|NCT02133703|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1412187|NCT02133690|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1412188|NCT02133677||Single Group Assignment||Treatment||None (Open Label)||||||
1412189|NCT02133664|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412190|NCT02133651|||Cohort||Prospective|||||||
1412191|NCT02133638|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412192|NCT02133625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412193|NCT02133612||Single Group Assignment||Treatment||None (Open Label)||||||
1412194|NCT02133599||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412195|NCT02133586|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1412196|NCT02133573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412197|NCT02133560||Single Group Assignment||Health Services Research||None (Open Label)||||||
1412198|NCT02133547|||Cohort||Prospective|||||||
1412199|NCT02133534||Single Group Assignment||Treatment||None (Open Label)||||||
1412200|NCT02133521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412201|NCT02133508|||Case-Only||Other|||||||
1412202|NCT02133495||Single Group Assignment||Treatment||None (Open Label)||||||
1412203|NCT02133482|Randomized|Parallel Assignment||Treatment||Single||||||
1412204|NCT02133469|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412205|NCT02133456|||Ecologic or Community|||||||||
1412206|NCT02133443|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412207|NCT02133430|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1412208|NCT02133417|||Case-Crossover||Prospective|||||||
1412209|NCT02133404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412210|NCT02133391|Randomized|Parallel Assignment||Prevention||Single|||t|||
1412211|NCT02133378|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1412212|NCT02133365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412213|NCT02133352||Single Group Assignment||Treatment||None (Open Label)||||||
1412214|NCT02133339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412215|NCT02133326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412216|NCT02133313|||Case-Only||Prospective|||||||
1412217|NCT02133300|Randomized|Single Group Assignment||Treatment||Single||||||t
1412218|NCT02133287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412219|NCT02133274|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1412220|NCT02133261|||Cohort||Prospective|||||||
1412221|NCT02133248|||||Prospective|||||||
1412222|NCT02133235|Randomized|Parallel Assignment||||Triple|||t|t||t
1412223|NCT02133222||Single Group Assignment||Screening||None (Open Label)||||||
1412224|NCT02133209|Randomized|Parallel Assignment||Treatment||Single||||||t
1412225|NCT02133196|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412226|NCT02133183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412227|NCT02133170|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412228|NCT02133157||Single Group Assignment||Treatment||None (Open Label)||||||
1412229|NCT02133144|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412230|NCT02133131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412231|NCT02133118|||Cohort||Prospective|||||||
1412232|NCT02133105|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412233|NCT02133092|||Case-Only||Prospective|||||||
1412234|NCT02133079||Single Group Assignment||Treatment||None (Open Label)||||||
1412235|NCT02133066|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412236|NCT02133053|||Case-Only||Prospective|||||||
1412237|NCT02133040|||Case-Only||Prospective|||||||
1412238|NCT02133027|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412239|NCT02133014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412240|NCT02133001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412241|NCT02132988||Single Group Assignment||Treatment||None (Open Label)||||||
1412242|NCT02132975|Randomized|Parallel Assignment||||None (Open Label)||||||
1412243|NCT02132962|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412244|NCT02132949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412245|NCT02132936|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412246|NCT02132923|||Case-Only||Prospective|||||||
1412247|NCT02132910|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1412248|NCT02132897|Randomized|Crossover Assignment||||Single|||||t|
1412249|NCT02132884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412250|NCT02132871|||Cohort||Prospective|||||||
1412251|NCT02132858|||Case-Only||Prospective|||||||
1412252|NCT02132845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412253|NCT02132832|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1412254|NCT02132819|Randomized|Parallel Assignment||Prevention||Single||||||t
1412255|NCT02132806|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1412256|NCT02132793|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412257|NCT02132780|||Other||Cross-Sectional|||||||
1412258|NCT02132767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412259|NCT02132754|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412260|NCT02132741|||Cohort||Prospective|||||||
1412261|NCT02132728|Randomized|Parallel Assignment||Prevention||Single|||||t|
1412262|NCT02132715|Randomized|Parallel Assignment||Treatment||Single||||||t
1412263|NCT02132702||Single Group Assignment||Treatment||None (Open Label)||||||
1412264|NCT02132689|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412265|NCT02132676|||Cohort||Retrospective|||||||
1412266|NCT02132663|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1412267|NCT02132650|Randomized|Parallel Assignment||Treatment||Single||||||t
1412268|NCT02132637|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1412269|NCT02132624||Single Group Assignment||Treatment||None (Open Label)||||||
1412270|NCT02132611||Single Group Assignment||Treatment||None (Open Label)||||||
1412271|NCT02132598||Single Group Assignment||Treatment||None (Open Label)||||||
1412272|NCT02132585|||Case Control||Cross-Sectional|||||||
1412273|NCT02132572|||Cohort||Retrospective|||||||
1412274|NCT02132559|||Cohort||Retrospective|||||||
1412275|NCT02132546|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1412276|NCT02132533|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412277|NCT02132520|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412278|NCT02132507|||Cohort||Prospective|||||||
1412279|NCT02132494|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412280|NCT02132481|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1412281|NCT02132468||Single Group Assignment||Treatment||None (Open Label)||||||
1412282|NCT02132455|Randomized|Parallel Assignment||Screening||Single|||t|||
1412283|NCT02132442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412284|NCT02132429|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1412285|NCT02132416|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412286|NCT02132403||Single Group Assignment||Treatment||None (Open Label)||||||
1412287|NCT02132390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412288|NCT02132364|Randomized|Parallel Assignment||Prevention||Single||||||t
1412289|NCT02132351|||Cohort||Prospective|||||||
1412290|NCT02132338||Single Group Assignment||Prevention||None (Open Label)||||||
1412291|NCT02132325||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412292|NCT02132312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412293|NCT02132299|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1412294|NCT02132286|Randomized|Parallel Assignment||||Triple|||t||t|t
1412295|NCT02132273|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1412296|NCT02132260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412297|NCT02132247||Single Group Assignment||Treatment||None (Open Label)||||||
1412298|NCT02132234|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1412299|NCT02132221|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412300|NCT02132208|||Cohort||Prospective|||||||
1412301|NCT02132195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412302|NCT02132182|||Cohort||Prospective|||||||
1412303|NCT02132169|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412304|NCT02132143|Randomized|Parallel Assignment||Treatment||Double||||t||t
1412305|NCT02132130|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412306|NCT02132117|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412307|NCT02132104|Randomized|Parallel Assignment||Prevention||Single|||t|||
1412308|NCT02132091|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1412309|NCT02132078|||||Retrospective|||||||
1412310|NCT02132065|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412311|NCT02132052|||Case-Only||Retrospective|||||||
1412312|NCT02132039|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1412313|NCT02132026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412314|NCT02132013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412315|NCT02132000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412316|NCT02131987|||Cohort||Retrospective|||||||
1412317|NCT02131974|||Case-Only||Prospective|||||||
1412318|NCT02131961||Single Group Assignment||Treatment||None (Open Label)||||||
1412319|NCT02131948|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1412320|NCT02131935|||Cohort||Prospective|||||||
1412321|NCT02131922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412322|NCT02131909|Randomized|Parallel Assignment||Other||Single|||||t|
1412323|NCT02131896|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412324|NCT02131883|Randomized|Parallel Assignment||Treatment||Single||||||t
1412325|NCT02131870||Crossover Assignment||Basic Science||||||||
1412326|NCT02131857|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1412327|NCT02131844|Randomized|Parallel Assignment||Treatment||Single||||||t
1412328|NCT02131831|||Case-Only||Prospective|||||||
1412329|NCT02131818|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1412330|NCT02131805||Single Group Assignment||Treatment||None (Open Label)||||||
1412331|NCT02131792||Single Group Assignment||Treatment||None (Open Label)||||||
1412332|NCT02131779|Randomized|Parallel Assignment||Screening||Single|||t|||
1412333|NCT02131766|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412334|NCT02131753||Single Group Assignment||Treatment||None (Open Label)||||||
1412335|NCT02131740|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1412336|NCT02131727|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412337|NCT02131714|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412338|NCT02131701|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412339|NCT02131688||Parallel Assignment||Treatment||None (Open Label)||||||
1412340|NCT02131675|||Cohort||Cross-Sectional|||||||
1412341|NCT02131662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412342|NCT02131649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412343|NCT02131636|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412344|NCT02131623|||Case-Only||Prospective|||||||
1412345|NCT02131610|||Case Control||Prospective|||||||
1412346|NCT02131597||Single Group Assignment||Treatment||None (Open Label)||||||
1412347|NCT02131584||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412348|NCT02131571|||Cohort||Prospective|||||||
1412349|NCT02131558||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412350|NCT02131545||Single Group Assignment||Other||None (Open Label)||||||
1412351|NCT02131532||Single Group Assignment||Treatment||None (Open Label)||||||
1412352|NCT02131519|||Case-Only||Retrospective|||||||
1412353|NCT02131506||Single Group Assignment||Treatment||None (Open Label)||||||
1412354|NCT02131493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412355|NCT02131480|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412356|NCT02131467||Single Group Assignment||Treatment||None (Open Label)||||||
1412357|NCT02131454|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412358|NCT02131441|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412359|NCT02131428|||Cohort||Prospective|||||||
1412360|NCT02131415|||Cohort||Prospective|||||||
1412361|NCT02131402|Randomized|Parallel Assignment||Other||Double|||t||t|
1412362|NCT02131389||Single Group Assignment||Treatment||None (Open Label)||||||
1412363|NCT02131376|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1412364|NCT02131363||Single Group Assignment||Treatment||None (Open Label)||||||
1412365|NCT02131350||Single Group Assignment||Treatment||None (Open Label)||||||
1412366|NCT02131337||Single Group Assignment||Basic Science||None (Open Label)||||||
1412367|NCT02131324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412368|NCT02131311||Single Group Assignment||Treatment||None (Open Label)||||||
1412369|NCT02131298||Crossover Assignment||Basic Science||None (Open Label)||||||
1412370|NCT02131285|Randomized|Parallel Assignment||Treatment||Single||||||t
1412371|NCT02131272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412372|NCT02131259|||Cohort||Prospective|||||||
1412373|NCT02131246|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412374|NCT02131233|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412375|NCT02131220|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412376|NCT02131207|||Cohort||Prospective|||||||
1412377|NCT02131194|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1412378|NCT02131181|||Cohort||Prospective|||||||
1412379|NCT02131168|||Cohort||Prospective|||||||
1412380|NCT02131155|Randomized|Parallel Assignment||Treatment||Double||||||
1412381|NCT02131142||Single Group Assignment||Treatment||None (Open Label)||||||
1412382|NCT02131129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412383|NCT02131116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412384|NCT02131103|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412385|NCT02131090|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1412386|NCT02131077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412387|NCT02131064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412388|NCT02131051|||Case-Only||Prospective|||||||
1412389|NCT02131038|||Case-Only||Prospective|||||||
1412390|NCT02131012||Single Group Assignment||Treatment||None (Open Label)||||||
1412391|NCT02130999|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412392|NCT02130986|Randomized|Parallel Assignment||Treatment||Single||||||t
1412393|NCT02130973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412394|NCT02130960|||||Prospective|||||||
1412395|NCT02130947|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412396|NCT02130934|||Case-Only||Prospective|||||||
1412397|NCT02130921|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412398|NCT02130908|Randomized|Parallel Assignment||Other||Single|||||t|
1412399|NCT02130895|Randomized|Parallel Assignment||Prevention||Single||||||t
1412400|NCT02130882|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1412401|NCT02130869|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412402|NCT02130856|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412404|NCT02130830|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1412405|NCT02130817||Single Group Assignment||Treatment||None (Open Label)||||||
1412406|NCT02130804|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1412407|NCT02130791|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412408|NCT02130778|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1412409|NCT02130765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412410|NCT02130752|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412411|NCT02130739|||Cohort||Prospective|||||||
1412412|NCT02130726|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412413|NCT02130713|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412414|NCT02130700|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412415|NCT02130687|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1412416|NCT02130674||Single Group Assignment||Treatment||None (Open Label)||||||
1412417|NCT02130661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412418|NCT02130648|||Case-Only||Prospective|||||||
1412419|NCT02130635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412420|NCT02130622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412421|NCT02130609||Single Group Assignment||Treatment||None (Open Label)||||||
1412422|NCT02130596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412423|NCT02130583|Randomized|Parallel Assignment||Treatment||Single||||||t
1412424|NCT02130570|Randomized|Single Group Assignment||||Single||||||t
1412425|NCT02130557|Randomized|||Treatment||None (Open Label)|NOTE: Value was Open Label in old format; This study has an open-label design. Although most efficacy studies have a double blind design, this is not feasible in this trial, due to the complexity of the dose reduction and dose escalation schemes with tablets of various sizes, dosage strengths, as well as the number of tablets that would be required daily. However, the opportunity for bias is mitigated by the use of objective outcome measures (MMR, CCyR, CHR). The Investigators will be instructed to ensure that laboratory/pathology personnel are blinded to treatment information. For these reasons, an open-label, randomized study is appropriate.|||||
1412426|NCT02130544|||Cohort||Retrospective|||||||
1412427|NCT02130531|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1412428|NCT02130518|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1412429|NCT02130505|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1412430|NCT02130492||Single Group Assignment||Treatment||None (Open Label)||||||
1412431|NCT02130479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412432|NCT02130466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412433|NCT02130453|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1412434|NCT02130440|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1412435|NCT02130427||||Diagnostic||||||||
1412436|NCT02130414|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412437|NCT02130401||Single Group Assignment||Treatment||None (Open Label)||||||
1412438|NCT02130388|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1412439|NCT02130375||Single Group Assignment||Treatment||None (Open Label)||||||
1412440|NCT02130362|||Cohort||Prospective|||||||
1412441|NCT02130349|||Cohort||Prospective|||||||
1412442|NCT02130336|Randomized|Factorial Assignment||Treatment||Single||||||t
1412443|NCT02130323|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412444|NCT02130310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412445|NCT02130297|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1412446|NCT02130284||Single Group Assignment||Treatment||None (Open Label)||||||
1412447|NCT02130271|||Case-Control||Prospective|||||||
1412448|NCT02130258|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1412449|NCT02130245|Randomized|Parallel Assignment||Treatment||Single||||||t
1412450|NCT02130232|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1412451|NCT02130219|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1412452|NCT02130206|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1412453|NCT02130193|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412454|NCT02130180|||Cohort||Cross-Sectional|||||||
1412455|NCT02130167|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412456|NCT02130154|||Case Control||Prospective|||||||
1412457|NCT02130141|Randomized|Crossover Assignment||||Single||||||t
1412458|NCT02130128||Single Group Assignment||||None (Open Label)||||||
1412459|NCT02130115||Single Group Assignment||||None (Open Label)||||||
1412460|NCT02130102|||Case-Only||Prospective|||||||
1412461|NCT02130089||Single Group Assignment||Treatment||None (Open Label)||||||
1412462|NCT02130076|||Case Control||Prospective|||||||
1412463|NCT02130063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412464|NCT02130050|||Case Control||Retrospective|||||||
1412465|NCT02130037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412466|NCT02130024|Randomized|Parallel Assignment||Treatment||Single||||||t
1412467|NCT02130011|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412468|NCT02129998|||Cohort||Prospective|||||||
1412469|NCT02129985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412470|NCT02129972||Single Group Assignment||Prevention||Single||||||t
1412471|NCT02129959|||Cohort||Prospective|||||||
1412472|NCT02129946|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1412473|NCT02129933||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412474|NCT02129920|||Cohort||Prospective|||||||
1412475|NCT02129907|||Case-Only||Prospective|||||||
1412476|NCT02129894|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412477|NCT02129881||Single Group Assignment||Treatment||None (Open Label)||||||
1412478|NCT02129868|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412479|NCT02129855|||Other||Cross-Sectional|||||||
1412480|NCT02129842|||Case-Only||Prospective|||||||
1412481|NCT02129829|||Cohort||Prospective|||||||
1412482|NCT02129816|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1412483|NCT02129803|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1412484|NCT02129790||Single Group Assignment||Treatment||None (Open Label)||||||
1412485|NCT02129777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412486|NCT02129764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412487|NCT02129751|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1412488|NCT02129738||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412489|NCT02129725|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1412490|NCT02129712|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412491|NCT02129699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412492|NCT02129686|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412493|NCT02129673|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412494|NCT02129660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412495|NCT02129647||Single Group Assignment||Treatment||None (Open Label)||||||
1412496|NCT02129634|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412497|NCT02129621||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412498|NCT02129608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412499|NCT02129595|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1412500|NCT02129582||Single Group Assignment||Treatment||None (Open Label)||||||
1412501|NCT02129569|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412502|NCT02129556||Single Group Assignment||Treatment||None (Open Label)||||||
1412503|NCT02129543|||Cohort||Prospective|||||||
1412504|NCT02129530|Randomized|Parallel Assignment||Prevention||Single||||||t
1412505|NCT02129517|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412506|NCT02129504|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412507|NCT02129491|||Case-Only||Prospective|||||||
1412508|NCT02129478||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412509|NCT02129465|||Cohort||Prospective|||||||
1412510|NCT02129452|||Case Control||Cross-Sectional|||||||
1412511|NCT02129439|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1412512|NCT02129426|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1412513|NCT02129413||Single Group Assignment||Treatment||None (Open Label)||||||
1412514|NCT02129400|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1412515|NCT02129387|||Case-Only||Prospective|||||||
1412516|NCT02129374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412517|NCT02129361|Randomized|Parallel Assignment||Treatment||Single||||||t
1412518|NCT02129348|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412519|NCT02129335|||Cohort||Prospective|||||||
1412520|NCT02129322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412521|NCT02129309|Randomized|Parallel Assignment||Prevention||Single|||t|||
1412522|NCT02129296|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1412523|NCT02129283|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1412524|NCT02129270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412525|NCT02129257||Single Group Assignment||Treatment||None (Open Label)||||||
1412526|NCT02129244|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412527|NCT02129231|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412528|NCT02129218|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412529|NCT02129205||||Treatment||None (Open Label)||||||
1412530|NCT02129192|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412531|NCT02129179||Single Group Assignment||Basic Science||None (Open Label)||||||
1412532|NCT02129166|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412533|NCT02129153|Randomized|Parallel Assignment||Prevention||Single|Participants in the study do not know if they are in the intervention group.||t|||
1412534|NCT02129140|||Cohort||Prospective|||||||
1412535|NCT02129127||Single Group Assignment||Treatment||None (Open Label)||||||
1412536|NCT02129114|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412537|NCT02129101||Single Group Assignment||Treatment||None (Open Label)||||||
1412538|NCT02129088|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412539|NCT02129075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412540|NCT02129062||Single Group Assignment||Treatment||None (Open Label)||||||
1412541|NCT02129049||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412542|NCT02129036|||Case-Only||Retrospective|||||||
1412543|NCT02129023|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1412544|NCT02129010|||Cohort||Prospective|||||||
1412545|NCT02128997|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412546|NCT02128984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412547|NCT02128971|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412548|NCT02128958|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412549|NCT02128945||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412550|NCT02128932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412551|NCT02128919|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413943|NCT02110758|||Cohort||Prospective|||||||
1412552|NCT02128906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412553|NCT02128893|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412554|NCT02128880|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412555|NCT02128867|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412556|NCT02128854|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412557|NCT02128841||Single Group Assignment||Treatment||None (Open Label)||||||
1412558|NCT02128828||Single Group Assignment||Treatment||None (Open Label)||||||
1412559|NCT02128815|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1412560|NCT02128802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412561|NCT02128789|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1412562|NCT02128776|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1412563|NCT02128763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412564|NCT02128750||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412565|NCT02128737|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412566|NCT02128724||Single Group Assignment||Treatment||None (Open Label)||||||
1412567|NCT02128711|||Cohort||Prospective|||||||
1412568|NCT02128698|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1412569|NCT02128685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412570|NCT02128672|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1412571|NCT02128659|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412572|NCT02128646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412573|NCT02128633|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412574|NCT02128620|Randomized|Parallel Assignment||||Single|||t|||
1412575|NCT02128607|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412576|NCT02128594||Single Group Assignment||Prevention||None (Open Label)||||||
1412577|NCT02128581|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412578|NCT02128568|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1412579|NCT02128555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412580|NCT02128542||Single Group Assignment||Treatment||None (Open Label)||||||
1412581|NCT02128529|||Cohort||Cross-Sectional|||||||
1412582|NCT02128516|Randomized|Parallel Assignment||||Triple|||t||t|t
1412583|NCT02128503||Single Group Assignment||Prevention||None (Open Label)||||||
1412584|NCT02128490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412585|NCT02128477|||Cohort||Prospective|||||||
1412586|NCT02128464|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1412587|NCT02128451|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1412588|NCT02128438|||||Retrospective|||||||
1412589|NCT02128425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412590|NCT02128412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412591|NCT02128399|||||Prospective|||||||
1412592|NCT02128386|||Cohort||Prospective|||||||
1412593|NCT02128373|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412594|NCT02128360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412595|NCT02128347||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412596|NCT02128334|||Cohort||Prospective|||||||
1412597|NCT02128321||Single Group Assignment||Basic Science||None (Open Label)||||||
1412598|NCT02128308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412599|NCT02128295|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412600|NCT02128282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412601|NCT02128269||Single Group Assignment||Treatment||None (Open Label)||||||
1412602|NCT02128256||Single Group Assignment||Treatment||None (Open Label)||||||
1412603|NCT02128243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412604|NCT02128230||Single Group Assignment||Prevention||None (Open Label)||||||
1412605|NCT02128217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412606|NCT02128204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412607|NCT02128191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412608|NCT02128178|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1412609|NCT02128165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412610|NCT02128152||Single Group Assignment||Treatment||None (Open Label)||||||
1412611|NCT02128139|||Case-Only||Prospective|||||||
1412612|NCT02128126||Single Group Assignment||Treatment||None (Open Label)||||||
1412613|NCT02128113|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1412614|NCT02128100||Single Group Assignment||Treatment||None (Open Label)||||||
1412615|NCT02128087|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1412616|NCT02128074||Single Group Assignment||Treatment||None (Open Label)||||||
1412617|NCT02128061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412618|NCT02128048|||||Prospective|||||||
1412619|NCT02128035|Randomized|Parallel Assignment||Prevention||Single||||||t
1412620|NCT02128022|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1412621|NCT02128009|||Case Control||Prospective|||||||
1412622|NCT02127996|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412623|NCT02127983|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1412624|NCT02127970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412625|NCT02127957|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1412626|NCT02127944|||Case-Control||Prospective|||||||
1414176|NCT02107677|||Case-Only||Retrospective|||||||
1412627|NCT02127931||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412628|NCT02127918|||Cohort||Prospective|||||||
1412629|NCT02127905||Single Group Assignment||Treatment||None (Open Label)||||||
1412630|NCT02127892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412631|NCT02127879|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1412632|NCT02127866|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1412633|NCT02127853|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412634|NCT02127840|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1412635|NCT02127827||Single Group Assignment||Treatment||None (Open Label)||||||
1412636|NCT02127814|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1412637|NCT02127801|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1412638|NCT02127788|||Cohort||Prospective|||||||
1412639|NCT02127775|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412640|NCT02127762|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412641|NCT02127749|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1412642|NCT02127736||||||||||||
1412643|NCT02127723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412644|NCT02127710||Single Group Assignment||Treatment||None (Open Label)||||||
1412645|NCT02127697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412646|NCT02127684|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412647|NCT02127671|Randomized|Parallel Assignment||Prevention||Single||||||t
1412648|NCT02127658|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1412649|NCT02127645||Single Group Assignment||Treatment||None (Open Label)||||||
1412650|NCT02127632|Randomized|Parallel Assignment||Screening||Double|||||t|t
1412651|NCT02127619||Single Group Assignment||Treatment||None (Open Label)||||||
1412652|NCT02127606||Single Group Assignment||Treatment||None (Open Label)||||||
1412653|NCT02127593|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412654|NCT02127580|||Case-Only||Prospective|||||||
1412655|NCT02127567|Randomized|Crossover Assignment||||Single||||||t
1412656|NCT02127554|||Cohort||Prospective|||||||
1412657|NCT02127541||Single Group Assignment||Diagnostic||Single||||||t
1412658|NCT02127528|||Cohort||Prospective|||||||
1412659|NCT02127515|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1412660|NCT02127502|||Cohort||Prospective|||||||
1412661|NCT02127489|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412662|NCT02127476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412663|NCT02127463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412664|NCT02127450|||Case Control||Prospective|||||||
1412665|NCT02127437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412666|NCT02127424|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1412667|NCT02127411|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1412668|NCT02127398||Single Group Assignment||Treatment||None (Open Label)||||||
1412669|NCT02127385|||Case-Only||Retrospective|||||||
1412670|NCT02127372||Single Group Assignment||Treatment||None (Open Label)||||||
1412671|NCT02127359|||Cohort||Prospective|||||||
1412672|NCT02127346|||Case Control||Cross-Sectional|||||||
1412673|NCT02127333|||Case Control||Cross-Sectional|||||||
1412674|NCT02127320|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412675|NCT02127307|||Cohort||Retrospective|||||||
1412676|NCT02127294|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1412677|NCT02127281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412678|NCT02127268|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412679|NCT02127255|Randomized|Crossover Assignment||Treatment||Single||||||t
1412680|NCT02127242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412681|NCT02127229|Non-Randomized|Single Group Assignment||Other||Single||||t||
1412682|NCT02127216|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1412683|NCT02127203|||Case Control||Cross-Sectional|||||||
1412684|NCT02127190|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1412685|NCT02127177|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412686|NCT02127164||Single Group Assignment||Treatment||None (Open Label)||||||
1412687|NCT02127151||Single Group Assignment||Treatment||None (Open Label)||||||
1412688|NCT02127138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412689|NCT02127125|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412690|NCT02127112|Randomized|Parallel Assignment||Treatment||Single||||||t
1412691|NCT02127099|||Cohort||Prospective|||||||
1412692|NCT02127086|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1412693|NCT02127073||Single Group Assignment||Basic Science||None (Open Label)||||||
1412694|NCT02127060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412695|NCT02127047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412696|NCT02127034|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412697|NCT02127021|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1412698|NCT02127008|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412699|NCT02126995|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412700|NCT02126982|||||Prospective|||||||
1412701|NCT02126969|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412702|NCT02126956||Single Group Assignment||||None (Open Label)||||||
1412703|NCT02126943|||Cohort||Prospective|||||||
1412704|NCT02126930|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412705|NCT02126917|Randomized|Crossover Assignment||||None (Open Label)||||||
1412706|NCT02126904|||Cohort||Retrospective|||||||
1412707|NCT02126891|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1412708|NCT02126878|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412709|NCT02126865|Randomized|Parallel Assignment||Treatment||Double||||||
1412710|NCT02126852|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1412711|NCT02126839|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412712|NCT02126826|Randomized|Parallel Assignment||Treatment||Double||||||
1412713|NCT02126813|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412714|NCT02126800|||||Prospective|||||||
1412715|NCT02126787|Randomized|Factorial Assignment||Treatment||Single||||||t
1412716|NCT02126774|||Cohort||Prospective|||||||
1412717|NCT02126761|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1412718|NCT02126748|Randomized|Parallel Assignment||Treatment||Single||||||t
1412719|NCT02126735|||Case Control||Cross-Sectional|||||||
1412720|NCT02126722|||Cohort||Prospective|||||||
1412721|NCT02126709|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412722|NCT02126696|||Cohort||Cross-Sectional|||||||
1412723|NCT02126683|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412724|NCT02126670|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412725|NCT02126657||Single Group Assignment||Treatment||None (Open Label)||||||
1412726|NCT02126644||Single Group Assignment||Treatment||None (Open Label)||||||
1412727|NCT02126631|||Case-Only||Prospective|||||||
1412728|NCT02126618|||Case-Only||Retrospective|||||||
1412729|NCT02126605|||Cohort||Prospective|||||||
1412730|NCT02126592|||Cohort||Prospective|||||||
1412731|NCT02126579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412732|NCT02126566||Single Group Assignment||Treatment||None (Open Label)||||||
1412733|NCT02126553||Single Group Assignment||Treatment||None (Open Label)||||||
1412734|NCT02126540||Single Group Assignment||Treatment||None (Open Label)||||||
1412735|NCT02126527||Single Group Assignment||Treatment||None (Open Label)||||||
1412736|NCT02126514|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1412737|NCT02126501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412738|NCT02126488|Randomized|Parallel Assignment||Prevention||Single|||t|||
1412739|NCT02126475|||Case Control||Prospective|||||||
1412740|NCT02126462|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1412741|NCT02126449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412742|NCT02126436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412743|NCT02126423|||||Prospective|||||||
1412744|NCT02126410|||Cohort||Retrospective|||||||
1412745|NCT02126397|Randomized|Factorial Assignment||Treatment||Single|||t|||
1412746|NCT02126384||Single Group Assignment||Basic Science||None (Open Label)||||||
1412747|NCT02126371||Single Group Assignment||||None (Open Label)||||||
1412748|NCT02126358|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412749|NCT02126345|||Cohort||Prospective|||||||
1412750|NCT02126332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412751|NCT02126319|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1412752|NCT02126306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412753|NCT02126293|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412754|NCT02126280|||Cohort||Cross-Sectional|||||||
1412755|NCT02126267|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412756|NCT02126254|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1412757|NCT02126241||Single Group Assignment||Treatment||None (Open Label)||||||
1412758|NCT02126228|||Case Control||Prospective|||||||
1412759|NCT02126215|||Case-Only||Prospective|||||||
1412760|NCT02126202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412761|NCT02126189|||Case Control|||||||||
1412762|NCT02126176|||Case-Only||Prospective|||||||
1412763|NCT02126163|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412764|NCT02126150|||Cohort||Prospective|||||||
1412765|NCT02126137||Single Group Assignment||Basic Science||None (Open Label)||||||
1412766|NCT02126124|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412767|NCT02126111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412768|NCT02126098|||Cohort||Prospective|||||||
1412769|NCT02126085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412770|NCT02126072|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1412771|NCT02126059|Randomized|Factorial Assignment||Supportive Care||Single||||t||
1412772|NCT02126046||Single Group Assignment||Treatment||None (Open Label)||||||
1412773|NCT02126033||Parallel Assignment||Basic Science||||||||
1412774|NCT02126020||Single Group Assignment||Prevention||None (Open Label)||||||
1412775|NCT02126007|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412776|NCT02125994|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1412777|NCT02125981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412778|NCT02125968|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412779|NCT02125955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412780|NCT02125942|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412781|NCT02125929|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1412782|NCT02125916|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412783|NCT02125903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412784|NCT02125890||Single Group Assignment||Treatment||None (Open Label)||||||
1412785|NCT02125877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412786|NCT02125864||Single Group Assignment||Basic Science||None (Open Label)||||||
1412787|NCT02125851|Randomized|Crossover Assignment||||Triple|||t||t|t
1412788|NCT02125838|Randomized|Parallel Assignment||Other||Double|||||t|t
1412789|NCT02125825|||Cohort||Cross-Sectional|||||||
1412790|NCT02125812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412791|NCT02125799||Single Group Assignment||Treatment||None (Open Label)||||||
1412792|NCT02125786|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412793|NCT02125773|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412794|NCT02125760|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412795|NCT02125747|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412796|NCT02125734||Crossover Assignment||Treatment||None (Open Label)||||||
1412797|NCT02125721||Single Group Assignment||Treatment||None (Open Label)||||||
1412798|NCT02125708||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412799|NCT02125695|||Cohort||Cross-Sectional|||||||
1412800|NCT02125682|Randomized|Crossover Assignment||Treatment||Single||||||t
1412801|NCT02125669|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412802|NCT02125656|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1412803|NCT02125643|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1412804|NCT02125630|||Cohort||Prospective|||||||
1412805|NCT02125617|||Cohort||Prospective|||||||
1412806|NCT02125604||Single Group Assignment||Treatment||None (Open Label)||||||
1412807|NCT02125591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412808|NCT02125578|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1412809|NCT02125565|Randomized|Parallel Assignment||Treatment||Single|||t|||
1412810|NCT02125552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412811|NCT02125539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412812|NCT02125526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412813|NCT02125513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412814|NCT02125500||Single Group Assignment||Treatment||None (Open Label)||||||
1412815|NCT02125487|Randomized|Parallel Assignment||||Single||||||t
1412816|NCT02125474||Single Group Assignment||Treatment||None (Open Label)||||||
1412817|NCT02125461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412818|NCT02125448|||Cohort||Prospective|||||||
1412819|NCT02125435|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1412820|NCT02125422||Single Group Assignment||Basic Science||None (Open Label)||||||
1412821|NCT02125409|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412822|NCT02125396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412823|NCT02125383|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1412824|NCT02125370|||||Cross-Sectional|||||||
1412825|NCT02125357|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1412826|NCT02125344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412827|NCT02125331|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1412828|NCT02125318||Single Group Assignment||Treatment||None (Open Label)||||||
1412829|NCT02125305||Single Group Assignment||Treatment||None (Open Label)||||||
1412830|NCT02125292|Randomized|Crossover Assignment||||None (Open Label)||||||
1412831|NCT02125279||Single Group Assignment||Treatment||None (Open Label)||||||
1412832|NCT02125266|Randomized|Parallel Assignment||Treatment||Single||||||t
1412833|NCT02125253|Randomized|Parallel Assignment||Treatment||Single|||||t|
1412834|NCT02125240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412835|NCT02125227|Randomized|Crossover Assignment||||None (Open Label)||||||
1412836|NCT02125214||Single Group Assignment||Basic Science||None (Open Label)||||||
1412837|NCT02125201|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1412838|NCT02125188|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1412839|NCT02125175||Single Group Assignment||Treatment||None (Open Label)||||||
1412840|NCT02125162|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1412841|NCT02125149|Randomized|Parallel Assignment||Prevention||Single|||||t|
1412842|NCT02125136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412843|NCT02125123|Randomized|Parallel Assignment||||None (Open Label)||||||
1412844|NCT02125110|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1412845|NCT02125097||Single Group Assignment||Treatment||None (Open Label)||||||
1412846|NCT02125084||Single Group Assignment||Treatment||None (Open Label)||||||
1412847|NCT02125071|||Case-Only||Prospective|||||||
1412848|NCT02125058|Randomized|Parallel Assignment||Treatment||Single||||||t
1412849|NCT02125045|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1412850|NCT02125032|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412851|NCT02125019|||Cohort||Prospective|||||||
1412852|NCT02125006|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1412853|NCT02124993|||||Prospective|||||||
1412854|NCT02124980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412855|NCT02124967||Single Group Assignment||Prevention||None (Open Label)||||||
1412856|NCT02124954|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1412857|NCT02124941|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1412858|NCT02124928|||Case-Only||Prospective|||||||
1412859|NCT02124915|||Case-Crossover||Prospective|||||||
1412860|NCT02124902||Parallel Assignment||Treatment||None (Open Label)||||||
1412861|NCT02124889|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1412862|NCT02124876|||Cohort||Prospective|||||||
1412863|NCT02124863||Single Group Assignment||Treatment||None (Open Label)||||||
1412864|NCT02124850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412865|NCT02124837|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1412866|NCT02124824|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1412867|NCT02124811|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412868|NCT02124798||Single Group Assignment||Other||None (Open Label)||||||
1412869|NCT02124785|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1412870|NCT02124772|Randomized|||Treatment||None (Open Label)||||||
1412871|NCT02124759|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1412872|NCT02124746|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412873|NCT02124733|Randomized|Parallel Assignment||Treatment||Single|Evaluator assesses photographs without prior knowledge of intervention|||||t
1412874|NCT02124720||Single Group Assignment||Treatment||None (Open Label)||||||
1412875|NCT02124707||Single Group Assignment||Treatment||None (Open Label)||||||
1412876|NCT02124694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412877|NCT02124681|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1412878|NCT02124668||Single Group Assignment||Treatment||None (Open Label)||||||
1412879|NCT02124655||Crossover Assignment||Prevention||Double|||||t|t
1412880|NCT02124642|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1412881|NCT02124616|||Case-Only||Prospective|||||||
1412882|NCT02124603|||Case-Only||Cross-Sectional|||||||
1412883|NCT02124590||Single Group Assignment||Treatment||None (Open Label)||||||
1412884|NCT02124577|||Case Control||Prospective|||||||
1412885|NCT02124564||Single Group Assignment||Treatment||None (Open Label)||||||
1412886|NCT02124551|||||Prospective|||||||
1412887|NCT02124538||||||||||||
1412888|NCT02124525|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412889|NCT02124512|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412890|NCT02124499|||Cohort||Prospective|||||||
1412891|NCT02124486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412892|NCT02124473|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412893|NCT02124460|Randomized|Parallel Assignment||Treatment||Single||||||t
1412894|NCT02124447|Randomized|Parallel Assignment||Screening||Single||||t||
1412895|NCT02124434|||Cohort||Prospective|||||||
1412896|NCT02124421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412897|NCT02124408|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1412898|NCT02124395|||Cohort||Prospective|||||||
1412899|NCT02124382|||Cohort||Retrospective|||||||
1412900|NCT02124369||Single Group Assignment||Treatment||None (Open Label)||||||
1412901|NCT02124356|||Cohort||Prospective|||||||
1412902|NCT02124343||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412903|NCT02124330|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1412904|NCT02124317||Single Group Assignment||Treatment||None (Open Label)||||||
1412905|NCT02124304|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412906|NCT02124291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412907|NCT02124278|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1412908|NCT02124265||Single Group Assignment||Treatment||None (Open Label)||||||
1412909|NCT02124252|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1412910|NCT02124239|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412911|NCT02124226|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1412912|NCT02124213|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412913|NCT02124200||Single Group Assignment||Treatment||None (Open Label)||||||
1412914|NCT02124187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412915|NCT02124174||Single Group Assignment||Treatment||None (Open Label)||||||
1412916|NCT02124161|Randomized|||Basic Science||Triple|||t|t|t|
1412917|NCT02124148|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412918|NCT02124135|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1412919|NCT02124122|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1412920|NCT02124109|||||Prospective|||||||
1412921|NCT02124096|||Cohort||Prospective|||||||
1412922|NCT02124083||Single Group Assignment||Treatment||None (Open Label)||||||
1412923|NCT02124070|Randomized|Crossover Assignment||Treatment||||||||
1412924|NCT02124057|||Case-Control||Cross-Sectional|||||||
1412925|NCT02124044|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412926|NCT02124031|||Case-Crossover||Cross-Sectional|||||||
1412927|NCT02124018|||Cohort||Prospective|||||||
1412928|NCT02124005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412929|NCT02123992|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412930|NCT02123979|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1412931|NCT02123966||Single Group Assignment||Supportive Care||None (Open Label)||||||
1412932|NCT02123953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412933|NCT02123940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412934|NCT02123927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412935|NCT02123914|Randomized|Factorial Assignment||Treatment||Single|||||t|
1412936|NCT02123901|Randomized|Parallel Assignment||Treatment||Single||||||t
1412937|NCT02123888||Single Group Assignment||||None (Open Label)||||||
1412938|NCT02123875|Randomized|Parallel Assignment||Treatment||Single||||||t
1412939|NCT02123862|||Cohort||Prospective|||||||
1412940|NCT02123849|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1412941|NCT02123836||Single Group Assignment||Treatment||None (Open Label)||||||
1412942|NCT02123823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412943|NCT02123810|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1412944|NCT02123797|||Case-Control||Prospective|||||||
1412945|NCT02123784|||Cohort||Prospective|||||||
1412946|NCT02123771|||Case-Only||Prospective|||||||
1412947|NCT02123758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1412948|NCT02123745||Single Group Assignment||Diagnostic||None (Open Label)||||||
1412949|NCT02123732|Randomized|Crossover Assignment||Treatment||Single|||t|||
1412950|NCT02123719|||Cohort||Retrospective|||||||
1412951|NCT02123693|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412952|NCT02123680|||||Prospective|||||||
1412953|NCT02123667|||Cohort||Prospective|||||||
1412954|NCT02123654|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412955|NCT02123641|Randomized|Parallel Assignment||Prevention||Single||||||t
1412956|NCT02123628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412957|NCT02123615|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412958|NCT02123602|Randomized|Parallel Assignment||Treatment||Single||||||t
1412959|NCT02123589|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412960|NCT02123576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412961|NCT02123563|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412962|NCT02123550|||Cohort||Prospective|||||||
1412963|NCT02123537||Single Group Assignment||Treatment||None (Open Label)||||||
1412964|NCT02123524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412965|NCT02123511|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1412966|NCT02123498||Single Group Assignment||Treatment||None (Open Label)||||||
1412967|NCT02123485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412968|NCT02123472|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412969|NCT02123459|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412970|NCT02123446|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1412971|NCT02123433||Single Group Assignment||Prevention||None (Open Label)||||||
1412972|NCT02123420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1412973|NCT02123407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412974|NCT02123394|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412975|NCT02123381||Single Group Assignment||Treatment||None (Open Label)||||||
1412976|NCT02123368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412977|NCT02123355|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1412978|NCT02123342|Randomized|Parallel Assignment||Prevention||Single|||t|||
1412979|NCT02123329|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1412980|NCT02123316|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412981|NCT02123303|||Cohort||Retrospective|||||||
1412982|NCT02123290|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412983|NCT02123277||Single Group Assignment||Treatment||None (Open Label)||||||
1412984|NCT02123264|Randomized|Parallel Assignment||Prevention||Single||||||t
1412985|NCT02123251|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1412986|NCT02123238|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1412987|NCT02123225|||Case-Only||Prospective|||||||
1412988|NCT02123212|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1412989|NCT02123199|||Cohort||Prospective|||||||
1412990|NCT02123186|||Cohort||Prospective|||||||
1412991|NCT02123173|||Cohort||Prospective|||||||
1412992|NCT02123160|Randomized|Parallel Assignment||Treatment||None (Open Label)||Psychotherapy-behavioral intervention||||
1412993|NCT02123147|||Cohort||Prospective|||||||
1412994|NCT02123134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1412995|NCT02123121|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1412996|NCT02123108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1412997|NCT02123082|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1412998|NCT02123069|||Case-Control||Cross-Sectional|||||||
1412999|NCT02123056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413000|NCT02123043|Randomized|Parallel Assignment||Treatment||Single||||||t
1413001|NCT02123030|||Other||Prospective|||||||
1413002|NCT02123017|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1413003|NCT02123004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413004|NCT02122991|||Case-Control||Cross-Sectional|||||||
1413005|NCT02122978|Randomized|Parallel Assignment||||None (Open Label)||||||
1413006|NCT02122965|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1413007|NCT02122952|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413008|NCT02122939|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1413009|NCT02122926|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1413010|NCT02122913||Single Group Assignment||Treatment||None (Open Label)||||||
1413011|NCT02122900|||Case-Only||Prospective|||||||
1413012|NCT02122887|Randomized|Parallel Assignment||||None (Open Label)||||||
1413013|NCT02122874|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413014|NCT02122861||Single Group Assignment||Treatment||None (Open Label)||||||
1413015|NCT02122848||Single Group Assignment||Treatment||Double|||t||t|
1413016|NCT02122835|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413017|NCT02122822||Single Group Assignment||Treatment||None (Open Label)||||||
1414177|NCT02107664|||Cohort||Prospective|||||||
1413018|NCT02122809||Single Group Assignment||Treatment||None (Open Label)||||||
1413019|NCT02122796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413020|NCT02122783|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1413021|NCT02122770|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413022|NCT02122757|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413023|NCT02122744|Randomized|Parallel Assignment||Prevention||Single|||t|||
1413024|NCT02122731||Single Group Assignment||Treatment||None (Open Label)||||||
1413025|NCT02122718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413026|NCT02122705|||Case-Only||Prospective|||||||
1413027|NCT02122692||Single Group Assignment||Treatment||None (Open Label)||||||
1413028|NCT02122679|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413029|NCT02122666|||Case-Control||Prospective|||||||
1413030|NCT02122653|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413031|NCT02122640|||||Prospective|||||||
1413032|NCT02122627|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413033|NCT02122614|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1413034|NCT02122601||Single Group Assignment||Treatment||None (Open Label)||||||
1413035|NCT02122588|||Cohort||Prospective|||||||
1413036|NCT02122575|||||Prospective|||||||
1413037|NCT02122562|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413038|NCT02122549||Single Group Assignment||Basic Science||None (Open Label)||||||
1413039|NCT02122536|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413040|NCT02122523|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413041|NCT02122510|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1413042|NCT02122497|||Cohort||Prospective|||||||
1413043|NCT02122484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413044|NCT02122471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413045|NCT02122458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413046|NCT02122445||Single Group Assignment||Treatment||None (Open Label)||||||
1413047|NCT02122432|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413048|NCT02122419|||||Retrospective|||||||
1413049|NCT02122406|||Cohort||Cross-Sectional|||||||
1413050|NCT02122393|Randomized|Parallel Assignment||Treatment||Single||||||t
1413051|NCT02122380|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1413052|NCT02122367||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413053|NCT02122354|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1413054|NCT02122341|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413055|NCT02122328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413056|NCT02122315|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413057|NCT02122302||Single Group Assignment||Health Services Research||None (Open Label)||||||
1413058|NCT02122289|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413059|NCT02122276||Single Group Assignment||Treatment||None (Open Label)||||||
1413060|NCT02122263|||||Prospective|||||||
1413061|NCT02122250|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1413062|NCT02122237||Single Group Assignment||Treatment||None (Open Label)||||||
1413063|NCT02122224|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1413064|NCT02122211||Single Group Assignment||Basic Science||None (Open Label)||||||
1413065|NCT02122198|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1413066|NCT02122185|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413067|NCT02122172||Single Group Assignment||Treatment||None (Open Label)||||||
1413068|NCT02122159||Single Group Assignment||Treatment||None (Open Label)||||||
1413069|NCT02122146||||Treatment||None (Open Label)||||||
1413070|NCT02122133|||Case Control||Prospective|||||||
1413071|NCT02122120|||Case Control||Prospective|||||||
1413072|NCT02122107|||Cohort||Prospective|||||||
1413073|NCT02122094||Single Group Assignment||Treatment||None (Open Label)||||||
1413074|NCT02122081||Single Group Assignment||Treatment||None (Open Label)||||||
1413075|NCT02122068|Randomized|Crossover Assignment||Treatment||Single||||||t
1413076|NCT02122055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413077|NCT02122042|Randomized|Crossover Assignment||Treatment||Single||||||t
1413078|NCT02122029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413079|NCT02122016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413080|NCT02122003||Single Group Assignment||Treatment||None (Open Label)||||||
1413081|NCT02121990||Single Group Assignment||Treatment||None (Open Label)||||||
1413082|NCT02121977|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413083|NCT02121964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413084|NCT02121951|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1413085|NCT02121938|||Cohort||Prospective|||||||
1413086|NCT02121925|||Cohort||Prospective|||||||
1413087|NCT02121912|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1413088|NCT02121899|||Cohort||Prospective|||||||
1413089|NCT02121886||Single Group Assignment||Treatment||None (Open Label)||||||
1413090|NCT02121873|||Cohort||Prospective|||||||
1413091|NCT02121860|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413092|NCT02121847||Single Group Assignment||Treatment||None (Open Label)||||||
1413093|NCT02121834|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1413094|NCT02121821|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413095|NCT02121808|Randomized|Crossover Assignment||Prevention||Single||||||t
1413096|NCT02121795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413097|NCT02121782|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413098|NCT02121769||||||||||||
1413099|NCT02121756|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1413100|NCT02121743|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413101|NCT02121730|||Cohort||Retrospective|||||||
1413102|NCT02121717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413103|NCT02121704|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413104|NCT02121691|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413105|NCT02121678|Randomized|Parallel Assignment||||None (Open Label)||||||
1413106|NCT02121665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413107|NCT02121652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413108|NCT02121639|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413109|NCT02121626|||Cohort||Prospective|||||||
1413110|NCT02121613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413111|NCT02121600|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413112|NCT02121587|||Cohort||Prospective|||||||
1413113|NCT02121574|||||Cross-Sectional|||||||
1413114|NCT02121561||Single Group Assignment||Treatment||None (Open Label)||||||
1413115|NCT02121548|Randomized|Parallel Assignment||Screening||Single||||||t
1413116|NCT02121535|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413117|NCT02121522||Single Group Assignment||Treatment||None (Open Label)||||||
1413118|NCT02121509|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413119|NCT02121496|Randomized|Parallel Assignment||Prevention||Single|||||t|
1413120|NCT02121483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413121|NCT02121470|||Cohort||Prospective|||||||
1413122|NCT02121457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413123|NCT02121444|||Cohort||Prospective|||||||
1413124|NCT02121431|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1413125|NCT02121418||Single Group Assignment||Treatment||None (Open Label)||||||
1413126|NCT02121405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413127|NCT02121392|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413128|NCT02121379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413129|NCT02121366||Single Group Assignment||Treatment||None (Open Label)||||||
1413130|NCT02121353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413131|NCT02121340|Randomized|Parallel Assignment||Treatment||Single||||||t
1413132|NCT02121327|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1413133|NCT02121314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413134|NCT02121301|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413135|NCT02121288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413136|NCT02121275|||Case-Only||Prospective|||||||
1413137|NCT02121262|Randomized|Parallel Assignment||Treatment||Single||||||t
1413138|NCT02121249|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413139|NCT02121236|||Case-Only||Cross-Sectional|||||||
1413140|NCT02121223|Randomized|Parallel Assignment||Treatment||Single||||||t
1413141|NCT02121210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413142|NCT02121197|||Cohort||Retrospective|||||||
1413143|NCT02121184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413144|NCT02121171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413145|NCT02121158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413146|NCT02121145|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413147|NCT02121132|||Cohort||Prospective|||||||
1413148|NCT02121119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413149|NCT02121106|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1413150|NCT02121093|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1413151|NCT02121080|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1413152|NCT02121067||Single Group Assignment||Prevention||None (Open Label)||||||
1413153|NCT02121054|||Cohort||Prospective|||||||
1413154|NCT02121041|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413155|NCT02121028|||Cohort||Prospective|||||||
1413156|NCT02121015|Randomized|Parallel Assignment||Prevention||Single||||||t
1413157|NCT02121002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413158|NCT02120989||Single Group Assignment||Treatment||None (Open Label)||||||
1413159|NCT02120976|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413160|NCT02120963|Randomized|Parallel Assignment||Treatment||Single||||||t
1413161|NCT02120950|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413162|NCT02120937||Single Group Assignment||Treatment||None (Open Label)||||||
1413163|NCT02120924|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413164|NCT02120911||Single Group Assignment||Treatment||None (Open Label)||||||
1413165|NCT02120898|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413166|NCT02120885|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1413167|NCT02120872|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413168|NCT02120859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413169|NCT02120846|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413170|NCT02120833|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1413171|NCT02120820|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1413172|NCT02120807||Single Group Assignment||Treatment||None (Open Label)||||||
1413173|NCT02120794||Single Group Assignment||Treatment||None (Open Label)||single group||||
1413174|NCT02120781|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413175|NCT02120768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413176|NCT02120755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413177|NCT02120742|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1413178|NCT02120729|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413179|NCT02120716|Randomized|Parallel Assignment||Prevention||Single|||||t|
1413180|NCT02120703|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1413181|NCT02120690|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413182|NCT02120677||Single Group Assignment||Treatment||None (Open Label)||||||
1413183|NCT02120664|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1413184|NCT02120651|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413185|NCT02120638|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413186|NCT02120625|||Cohort||Prospective|||||||
1413187|NCT02120612|||Cohort||Prospective|||||||
1413188|NCT02120599|Randomized|Parallel Assignment||Treatment||Single||||||t
1413189|NCT02120586|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413190|NCT02120573|Non-Randomized|Parallel Assignment||||Single|||||t|
1413191|NCT02120560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413192|NCT02120547|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1413193|NCT02120534|||Case-Only||Prospective|||||||
1413194|NCT02120521|||Case-Only||Prospective|||||||
1413195|NCT02120508|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1413196|NCT02120495||Single Group Assignment||Treatment||None (Open Label)||||||
1413197|NCT02120482||Single Group Assignment||Treatment||None (Open Label)||||||
1413198|NCT02120469||Single Group Assignment||Treatment||None (Open Label)||||||
1413199|NCT02120456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413200|NCT02120443||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413201|NCT02120430|Randomized|Parallel Assignment||||None (Open Label)||||||
1413202|NCT02120417|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413203|NCT02120404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413204|NCT02120391|Randomized|Parallel Assignment||Other||Single|||t|||
1413205|NCT02120378|||Cohort||Prospective|||||||
1413206|NCT02120365|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1413207|NCT02120352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413208|NCT02120339||Single Group Assignment||Treatment||None (Open Label)||||||
1413209|NCT02120326|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413210|NCT02120313|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1413211|NCT02120300|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413212|NCT02120287||Single Group Assignment||Treatment||None (Open Label)||||||
1413213|NCT02120274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413214|NCT02120261|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413215|NCT02120248|Randomized|Single Group Assignment||Prevention||||||||
1413216|NCT02120235|||Other||Other|||||||
1413217|NCT02120222||Single Group Assignment||Treatment||None (Open Label)||||||
1413218|NCT02120209|||Cohort||Prospective|||||||
1413219|NCT02120196|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413220|NCT02120183||Single Group Assignment||Supportive Care||None (Open Label)||||||
1413221|NCT02120170|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413222|NCT02120157|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413223|NCT02120144|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1413224|NCT02120131|||Case Control||Retrospective|||||||
1413225|NCT02120118||Single Group Assignment||Treatment||None (Open Label)||||||
1413226|NCT02120105|||Case-Only||Prospective|||||||
1413227|NCT02120092|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413228|NCT02120079|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413229|NCT02120066||Single Group Assignment||Treatment||None (Open Label)||||||
1413230|NCT02120053|Randomized|Parallel Assignment||Treatment||Single||||||t
1413231|NCT02120040||Single Group Assignment||||None (Open Label)||||||
1413232|NCT02120027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413233|NCT02120014|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1413234|NCT02120001|Randomized|Parallel Assignment||Prevention||Single||||||t
1413235|NCT02119988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413236|NCT02119975|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413237|NCT02119962||||Treatment||||||||
1413238|NCT02119949|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413239|NCT02119936||Single Group Assignment||Supportive Care||None (Open Label)||||||
1413240|NCT02119923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413241|NCT02119910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413242|NCT02119897||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1413243|NCT02119884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413244|NCT02119871|Randomized|Parallel Assignment||Prevention||Single|||t|||
1413245|NCT02119858||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413246|NCT02119845||Single Group Assignment||Treatment||None (Open Label)||||||
1413247|NCT02119832||Single Group Assignment||Treatment||None (Open Label)||||||
1413248|NCT02119819|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413249|NCT02119806|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1413250|NCT02119793||Single Group Assignment||Treatment||None (Open Label)||||||
1413251|NCT02119780|Randomized|Parallel Assignment||Treatment||Single||||||t
1413252|NCT02119767|||Cohort||Prospective|||||||
1413253|NCT02119754||Single Group Assignment||Treatment||None (Open Label)||||||
1413254|NCT02119741|||Case-Only||Prospective|||||||
1413255|NCT02119728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413256|NCT02119715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413257|NCT02119702|||Cohort||Prospective|||||||
1413258|NCT02119689|||Cohort||Prospective|||||||
1413259|NCT02119676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413260|NCT02119663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413261|NCT02119650|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413262|NCT02119637|||||Prospective|||||||
1413263|NCT02119624|||||Prospective|||||||
1413264|NCT02119611|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1413265|NCT02119598|||Cohort||Prospective|||||||
1413266|NCT02119585|||Case-Only||Prospective|||||||
1413267|NCT02119572|Randomized|Parallel Assignment||Supportive Care||||||||
1413268|NCT02119559||Single Group Assignment||||None (Open Label)||||||
1413269|NCT02119546|Randomized|Crossover Assignment||Treatment||Single||||||t
1413270|NCT02119533|||Other||Prospective|||||||
1413271|NCT02119520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413272|NCT02119507|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413273|NCT02119494|||Cohort||Cross-Sectional|||||||
1413274|NCT02119481|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1413275|NCT02119468||Single Group Assignment||Treatment||None (Open Label)||||||
1413276|NCT02119455|Randomized|Parallel Assignment||Treatment||Single||||||t
1413277|NCT02119442||Single Group Assignment||Treatment||None (Open Label)||||||
1413278|NCT02119429|Randomized|Parallel Assignment||Prevention||Single|||t|||
1413279|NCT02119416|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1413280|NCT02119403||Single Group Assignment||Supportive Care||None (Open Label)||||||
1413281|NCT02119390|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413282|NCT02119377|||Case-Only||Cross-Sectional|||||||
1413283|NCT02119364|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1413284|NCT02119351|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413285|NCT02119338||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413286|NCT02119325|Randomized|Crossover Assignment||||Double|||t||t|
1413287|NCT02119312|||Other||Prospective|||||||
1413288|NCT02119299||Single Group Assignment||Treatment||None (Open Label)||||||
1413289|NCT02119286|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413290|NCT02119273|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413291|NCT02119260|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1413292|NCT02119247|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413293|NCT02119234|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413294|NCT02119221||Single Group Assignment||Basic Science||None (Open Label)||||||
1413295|NCT02119208||Parallel Assignment||Prevention||Single|||t|||
1413296|NCT02119195|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413297|NCT02119182|||Cohort||Prospective|||||||
1413298|NCT02119169||Single Group Assignment||Treatment||None (Open Label)||||||
1413299|NCT02119156|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413300|NCT02119143|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1413301|NCT02119130|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413302|NCT02119117|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1413303|NCT02119104|||Case-Only||Prospective|||||||
1413304|NCT02119091|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1413305|NCT02119078|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1413306|NCT02119065|||Case-Only||Prospective|||||||
1413307|NCT02119052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413308|NCT02119039|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1413309|NCT02119026|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413310|NCT02119013|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413311|NCT02119000|Randomized|Crossover Assignment||Treatment||Single|||||t|
1413312|NCT02118987||Single Group Assignment||Treatment||None (Open Label)||||||
1413313|NCT02118974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413314|NCT02118961|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413315|NCT02118948|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413316|NCT02118935|Randomized|Parallel Assignment||||Triple|||t|t|t|
1413317|NCT02118922|||Cohort||Cross-Sectional|||||||
1413318|NCT02118909|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1413319|NCT02118896||Single Group Assignment||Treatment||None (Open Label)||||||
1413320|NCT02118883|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1413321|NCT02118870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413322|NCT02118857|||Cohort|||||||||
1413323|NCT02118844|Randomized|Factorial Assignment||Supportive Care||Double|||t|||t
1413324|NCT02118831|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1413325|NCT02118818|||Case-Control||Prospective|||||||
1413326|NCT02118805|||Other||Cross-Sectional|||||||
1413327|NCT02118792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413328|NCT02118779|Randomized|Parallel Assignment||Treatment||Single||||||t
1413329|NCT02118766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413330|NCT02118753|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413332|NCT02118727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413333|NCT02118714||Single Group Assignment||Other||None (Open Label)||||||
1413334|NCT02118701||Single Group Assignment||Supportive Care||None (Open Label)||||||
1413335|NCT02118688|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1413336|NCT02118675|||Other||Retrospective|||||||
1413337|NCT02118662|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1413338|NCT02118649||Single Group Assignment||Treatment||None (Open Label)||||||
1413339|NCT02118636|||Cohort||Prospective|||||||
1413340|NCT02118623|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1413341|NCT02118610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413342|NCT02118597|||Case-Only||Prospective|||||||
1413343|NCT02118584||Single Group Assignment||Treatment||None (Open Label)||||||
1413344|NCT02118571|||Case-Only||Cross-Sectional|||||||
1413345|NCT02118558|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413346|NCT02118545|||Cohort||Prospective|||||||
1413347|NCT02118532||Single Group Assignment||Treatment||None (Open Label)||||||
1413348|NCT02118519|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413349|NCT02118506|Randomized|Factorial Assignment||Treatment||Single|||||t|
1413350|NCT02118493||Single Group Assignment||Treatment||None (Open Label)||||||
1413351|NCT02118480|Randomized|Parallel Assignment||Treatment||Single||||||t
1413352|NCT02118467|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413353|NCT02118454|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413354|NCT02118441|Randomized|Parallel Assignment||Prevention||Single||||||t
1413355|NCT02118428|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413356|NCT02118415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413357|NCT02118402|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1413358|NCT02118389||Single Group Assignment||Treatment||None (Open Label)||||||
1413359|NCT02118376||Single Group Assignment||Treatment||None (Open Label)||||||
1413360|NCT02118363|||Case-Control||Prospective|||||||
1413361|NCT02118350|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413362|NCT02118337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413363|NCT02118324|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413364|NCT02118311|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1413365|NCT02118298|||Case Control||Prospective|||||||
1413366|NCT02118285||Single Group Assignment||Treatment||None (Open Label)||||||
1413367|NCT02118272||Single Group Assignment||Treatment||None (Open Label)||||||
1413368|NCT02118259||Single Group Assignment||Prevention||None (Open Label)||||||
1413369|NCT02118246|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413370|NCT02118233|||Cohort||Prospective|||||||
1413371|NCT02118220||Single Group Assignment||Screening||None (Open Label)||||||
1413372|NCT02118207|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1413373|NCT02118194|||Cohort||Prospective|||||||
1413374|NCT02118181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413375|NCT02118168|||Other||Prospective|||||||
1413376|NCT02118155|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413377|NCT02118142|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1413378|NCT02118129|Randomized|Parallel Assignment||Prevention||Single|||t|||
1413379|NCT02118116|Randomized|Parallel Assignment||||None (Open Label)||||||
1413380|NCT02118103|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413381|NCT02118090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413382|NCT02118077|Randomized|||Treatment||Quadruple|||t|t|t|t
1413383|NCT02118064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413384|NCT02118051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413385|NCT02118038|||Cohort||Prospective|||||||
1413386|NCT02118025|||Cohort||Prospective|||||||
1413387|NCT02118012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413388|NCT02117999|Randomized|Parallel Assignment||Treatment||None (Open Label)||Consecutive patients were randomized, using block randomization model, in one of the arm||||
1413389|NCT02117986|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413390|NCT02117973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413391|NCT02117960|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413392|NCT02117947|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1413393|NCT02117934|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413394|NCT02117921||Single Group Assignment||Treatment||None (Open Label)||||||
1413395|NCT02117908|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1413396|NCT02117895|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413397|NCT02117882|||Case Control||Prospective|||||||
1413398|NCT02117869|Randomized|Crossover Assignment||||Double|||t||t|
1413399|NCT02117856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413400|NCT02117843||Single Group Assignment||Treatment||None (Open Label)||||||
1413401|NCT02117830|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1413402|NCT02117817||Single Group Assignment||Treatment||None (Open Label)||||||
1413403|NCT02117804|||Case Control||Prospective|||||||
1413404|NCT02117791|||Cohort||Prospective|||||||
1413405|NCT02117778|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413406|NCT02117765||Single Group Assignment||Treatment||None (Open Label)||||||
1413407|NCT02117752|Randomized|Parallel Assignment||Treatment||Single||||||t
1413408|NCT02117739||Single Group Assignment||Treatment||Triple|||t||t|t
1414178|NCT02107651|||Case-Only|||||||||
1413409|NCT02117726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413410|NCT02117713||Single Group Assignment||Treatment||Double|||t||t|
1413411|NCT02117700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413412|NCT02117687|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413413|NCT02117674|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1413414|NCT02117661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413415|NCT02117648|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1413416|NCT02117635||Single Group Assignment||Treatment||None (Open Label)||||||
1413417|NCT02117622|||Cohort||Prospective|||||||
1413418|NCT02117609|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1413419|NCT02117596||Single Group Assignment||Prevention||None (Open Label)||||||
1413420|NCT02117583|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1413421|NCT02117570|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1413422|NCT02117557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413423|NCT02117544|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1413424|NCT02117518|||Cohort||Prospective|||||||
1413425|NCT02117505|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413426|NCT02117492|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413427|NCT02117479|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413428|NCT02117466|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413429|NCT02117453|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413430|NCT02117440|||Case-Only||Prospective|||||||
1413431|NCT02117427|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413432|NCT02117414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413433|NCT02117401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413434|NCT02117388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413435|NCT02117375|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1413436|NCT02117362|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413437|NCT02117349|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413438|NCT02117336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413439|NCT02117323|||Cohort||Prospective|||||||
1413440|NCT02117310||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413441|NCT02117297||Single Group Assignment||Treatment||None (Open Label)||||||
1413442|NCT02117284|||Cohort||Prospective|||||||
1413443|NCT02117271|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413444|NCT02117258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413445|NCT02117245|||Case-Only||Prospective|||||||
1413446|NCT02117232|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1413447|NCT02117219|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413448|NCT02117206|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1413449|NCT02117193|Randomized|Crossover Assignment||||Single||||||t
1413450|NCT02117180||Single Group Assignment||Treatment||None (Open Label)||||||
1413451|NCT02117167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413452|NCT02117154|||Case-Only||Cross-Sectional|||||||
1413453|NCT02117141|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1413454|NCT02117128|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1413455|NCT02117115||Single Group Assignment||Screening||None (Open Label)||||||
1413456|NCT02117102|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413457|NCT02117089||Single Group Assignment||Treatment||None (Open Label)||||||
1413458|NCT02117076|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413459|NCT02117063||Single Group Assignment||Treatment||None (Open Label)||||||
1413460|NCT02117050||Single Group Assignment||Treatment||None (Open Label)||||||
1413461|NCT02117037||Single Group Assignment||Other||None (Open Label)||||||
1413462|NCT02117024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413463|NCT02117011|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1413464|NCT02116998|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413465|NCT02116985|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1413466|NCT02116972|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413467|NCT02116959|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413468|NCT02116946|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1413469|NCT02116933|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413470|NCT02116920|||Case-Only||Prospective|||||||
1413471|NCT02116907||Single Group Assignment||Treatment||None (Open Label)||||||
1413472|NCT02116894||Single Group Assignment||Treatment||None (Open Label)||||||
1413473|NCT02116881|||Cohort||Prospective|||||||
1413474|NCT02116868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413475|NCT02116855||Single Group Assignment||Treatment||Single||||||t
1413476|NCT02116842|Randomized|Parallel Assignment||Treatment||Double||||t||t
1413477|NCT02116829|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1413478|NCT02116816||Single Group Assignment||Health Services Research||None (Open Label)||||||
1413479|NCT02116803|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413480|NCT02116790|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413481|NCT02116777||Single Group Assignment||Treatment||None (Open Label)||||||
1413482|NCT02116764|||Cohort||Prospective|||||||
1413483|NCT02116751|||Cohort||Retrospective|||||||
1413484|NCT02116738||Single Group Assignment||Treatment||None (Open Label)||||||
1414569|NCT02102529|||Cohort||Prospective|||||||
1413485|NCT02116725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413486|NCT02116712||Single Group Assignment||Treatment||None (Open Label)||||||
1413487|NCT02116699|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1413488|NCT02116686|||Cohort||Retrospective|||||||
1413489|NCT02116673|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1413490|NCT02116660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413491|NCT02116647|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1413492|NCT02116634||Single Group Assignment||Treatment||None (Open Label)||||||
1413493|NCT02116621|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1413494|NCT02116608|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413495|NCT02116595|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1413496|NCT02116582||Single Group Assignment||Treatment||None (Open Label)||||||
1413497|NCT02116569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413498|NCT02116556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413499|NCT02116543|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1413500|NCT02116530|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1413501|NCT02116517|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1413502|NCT02116504||Single Group Assignment||Health Services Research||None (Open Label)||||||
1413503|NCT02116491|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413504|NCT02116478||Single Group Assignment||Treatment||None (Open Label)||||||
1413505|NCT02116465|Randomized|Crossover Assignment||||None (Open Label)||||||
1413506|NCT02116452|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1413507|NCT02116439|||Ecologic or Community||Prospective|||||||
1413508|NCT02116426|||Cohort||Prospective|||||||
1413509|NCT02116413|||Cohort||Prospective|||||||
1413510|NCT02116400|||Cohort||Cross-Sectional|||||||
1413511|NCT02116387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413512|NCT02116374|||Cohort||Prospective|||||||
1413513|NCT02116361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413514|NCT02116348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413515|NCT02116335|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1413516|NCT02116322||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413517|NCT02116309|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413518|NCT02116296||||Prevention||||||||
1413519|NCT02116283||Single Group Assignment||Basic Science||None (Open Label)||||||
1413520|NCT02116270|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1413521|NCT02116257|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1413522|NCT02116244||Single Group Assignment||Treatment||None (Open Label)||||||
1413523|NCT02116231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413524|NCT02116218|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413525|NCT02116205|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1413526|NCT02116192|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413527|NCT02116179|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413528|NCT02116166|||Cohort||Cross-Sectional|||||||
1413529|NCT02116153|||Case-Only||Prospective|||||||
1413530|NCT02116140||Single Group Assignment||Basic Science||None (Open Label)||||||
1413531|NCT02116127|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413532|NCT02116114|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413533|NCT02116101|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1413534|NCT02116088|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1413535|NCT02116075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413536|NCT02116062|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413537|NCT02116049|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413538|NCT02116036||Single Group Assignment||Other||None (Open Label)||||||
1413539|NCT02116023|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1413540|NCT02116010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413541|NCT02115997||Single Group Assignment||Treatment||None (Open Label)||||||
1413542|NCT02115984|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413543|NCT02115971|Randomized|Parallel Assignment||Treatment||Single||||||t
1413544|NCT02115958|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413545|NCT02115945|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1413546|NCT02115932|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1413547|NCT02115919|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413548|NCT02115906|||Case Control||Prospective|||||||
1413549|NCT02115893|Randomized|Crossover Assignment||||Double|||t||t|
1413550|NCT02115880|Randomized|Parallel Assignment||Prevention||Single||||||t
1413551|NCT02115867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413552|NCT02115854|||Case-Only||Prospective|||||||
1413553|NCT02115841|Randomized|Crossover Assignment||||Single|||t|||
1413554|NCT02115828||Single Group Assignment||Treatment||None (Open Label)||||||
1413555|NCT02115815|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1413556|NCT02115802||Single Group Assignment||Basic Science||None (Open Label)||||||
1413557|NCT02115789|||Case Control||Retrospective|||||||
1413558|NCT02115776|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1413559|NCT02115763||Single Group Assignment||Basic Science||Single|||t|||
1413560|NCT02115750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413561|NCT02115737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413562|NCT02115724|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1413563|NCT02115711|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1413564|NCT02115698|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1413565|NCT02115685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413566|NCT02115672||Single Group Assignment||Treatment||None (Open Label)||||||
1413567|NCT02115659|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413568|NCT02115646||Single Group Assignment||Treatment||None (Open Label)||||||
1413569|NCT02115633|Randomized|Crossover Assignment||Treatment||Single||||||t
1413570|NCT02115620||Single Group Assignment||Health Services Research||None (Open Label)||||||
1413571|NCT02115607||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413572|NCT02115594|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413573|NCT02115581|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413574|NCT02115568|||Cohort||Prospective|||||||
1413575|NCT02115555|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1413576|NCT02115542||Single Group Assignment||Treatment||None (Open Label)||||||
1413577|NCT02115529|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413578|NCT02115516|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413579|NCT02115503|||Cohort||Prospective|||||||
1413580|NCT02115490|||Case Control||Prospective|||||||
1413581|NCT02115477|||Cohort||Prospective|||||||
1413582|NCT02115464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413583|NCT02115451|||Cohort||Prospective|||||||
1413584|NCT02115438|||Cohort||Prospective|||||||
1413585|NCT02115425|||Cohort||Retrospective|||||||
1413586|NCT02115412|||||Cross-Sectional|||||||
1413587|NCT02115399|||Cohort||Prospective|||||||
1413588|NCT02115386|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413589|NCT02115373||Single Group Assignment||Treatment||None (Open Label)||||||
1413590|NCT02115360|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1413591|NCT02115347|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413592|NCT02115334|Randomized|Parallel Assignment||Treatment||Double||||t||t
1413593|NCT02115321|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413594|NCT02115308||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413595|NCT02115295|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413596|NCT02115282|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413597|NCT02115269|||Other||Prospective|||||||
1413598|NCT02115256|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413599|NCT02115243||Single Group Assignment||Treatment||None (Open Label)||||||
1413600|NCT02115230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413601|NCT02115217||Crossover Assignment||Prevention||Triple|||t||t|t
1413602|NCT02115204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413603|NCT02115191|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1413604|NCT02115178|||Cohort||Prospective|||||||
1413605|NCT02115165||Single Group Assignment||Treatment||None (Open Label)||||||
1413606|NCT02115152|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1413607|NCT02115139||Single Group Assignment||Treatment||None (Open Label)||||||
1413608|NCT02115126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413609|NCT02115113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413610|NCT02115100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413611|NCT02115087|Randomized|Factorial Assignment||Treatment||Single|||t|||
1413612|NCT02115074||Single Group Assignment||Treatment||None (Open Label)||||||
1413613|NCT02115061|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413614|NCT02115048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413615|NCT02115035||Single Group Assignment||Treatment||None (Open Label)||||||
1413616|NCT02115022|||Case-Only||Prospective|||||||
1413617|NCT02115009|||Case Control||Prospective|||||||
1413618|NCT02114996|||Case Control||Prospective|||||||
1413619|NCT02114983|||Cohort||Prospective|||||||
1413620|NCT02114970|Randomized|Parallel Assignment||||Single||||||t
1413621|NCT02114957||Single Group Assignment||Basic Science||None (Open Label)||||||
1413622|NCT02114944|||Cohort||Prospective|||||||
1413623|NCT02114931||Single Group Assignment||Treatment||None (Open Label)||||||
1413624|NCT02114918|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1413625|NCT02114905||Single Group Assignment||Treatment||None (Open Label)||||||
1413626|NCT02114892|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413627|NCT02114879|Randomized|Parallel Assignment||Treatment||Single||||||t
1413628|NCT02114866|||Case-Only||Prospective|||||||
1413629|NCT02114853|||Cohort||Prospective|||||||
1413630|NCT02114840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413631|NCT02114827|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1413632|NCT02114814|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413633|NCT02114801|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1413634|NCT02114788|||Cohort||Prospective|||||||
1413635|NCT02114775|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1413636|NCT02114762||Single Group Assignment||Treatment||None (Open Label)||||||
1413637|NCT02114749||Single Group Assignment||Basic Science||None (Open Label)||||||
1413638|NCT02114736|Randomized|Parallel Assignment||Treatment||Single||||||t
1413639|NCT02114723|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1413640|NCT02114710|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413641|NCT02114697|Non-Randomized|Parallel Assignment||Treatment||Single||The protocol originally specified randomizing participants to a study arm, but the protocol was amended to clarify that a participant's cardiologist could change the treatment regimens that participants were assigned to so that no participant was restricted from statin therapy.|||t|
1413642|NCT02114684|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413643|NCT02114671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413644|NCT02114658||Single Group Assignment||Treatment||None (Open Label)||||||
1413645|NCT02114645|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1413646|NCT02114632|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1413647|NCT02114619|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1413648|NCT02114606||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1413649|NCT02114593|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413650|NCT02114580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413651|NCT02114567|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1413652|NCT02114554|||Case-Only||Retrospective|||||||
1413653|NCT02114541|||Other||Prospective|||||||
1413654|NCT02114528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413655|NCT02114515|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1413656|NCT02114502||Single Group Assignment||Treatment||None (Open Label)||||||
1413657|NCT02114489|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413658|NCT02114476|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1413659|NCT02114463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413660|NCT02114450|Randomized|Parallel Assignment||Basic Science||Single||||||t
1413661|NCT02114437|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1413662|NCT02114424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413663|NCT02114411|||Cohort||Prospective|||||||
1413664|NCT02114398|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1413665|NCT02114385|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413666|NCT02114372|||Ecologic or Community||Prospective|||||||
1413667|NCT02114359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413668|NCT02114346|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413669|NCT02114333|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1413670|NCT02114320|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413671|NCT02114307|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413672|NCT02114294|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1413673|NCT02114281|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413674|NCT02114268|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1413675|NCT02114255|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413676|NCT02114242|||Case Control||Prospective|||||||
1413677|NCT02114229|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413678|NCT02114216|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413679|NCT02114203|Randomized|||Basic Science||Triple|||t|t|t|
1413680|NCT02114190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413681|NCT02114177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413682|NCT02114164|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1413683|NCT02114151||Single Group Assignment||Treatment||None (Open Label)||||||
1413684|NCT02114138|||Cohort||Prospective|||||||
1413685|NCT02114125|Non-Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1413686|NCT02114112|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413687|NCT02114099||Single Group Assignment||Treatment||None (Open Label)||||||
1413688|NCT02114086|||Case-Control||Prospective|||||||
1413689|NCT02114073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413690|NCT02114060|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1413691|NCT02114047|||Other||Prospective|||||||
1413692|NCT02114034|||Cohort||Prospective|||||||
1413693|NCT02114021|Randomized|Parallel Assignment||Treatment||Single||||t||
1413694|NCT02114008|Randomized|Crossover Assignment||||Double|||t||t|
1413695|NCT02113995|Randomized|Parallel Assignment||||None (Open Label)||||||
1413696|NCT02113982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413697|NCT02113969||Single Group Assignment||Treatment||None (Open Label)||||||
1413698|NCT02113956|Randomized|Parallel Assignment||Prevention||Single|||t|||
1413699|NCT02113943||Crossover Assignment||||Triple|||t|t|t|
1413700|NCT02113930|||Cohort||Prospective|||||||
1413701|NCT02113917|||Cohort||Prospective|||||||
1413702|NCT02113904||Single Group Assignment||Treatment||None (Open Label)||||||
1413703|NCT02113891||Single Group Assignment||Treatment||None (Open Label)||||||
1413704|NCT02113878||Single Group Assignment||Treatment||None (Open Label)||||||
1413705|NCT02113865|||||Cross-Sectional|||||||
1413706|NCT02113852|||Other||Other|||||||
1413707|NCT02113839|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413708|NCT02113826||Single Group Assignment||Treatment||None (Open Label)||||||
1413709|NCT02113813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413710|NCT02113800||Single Group Assignment||Treatment||None (Open Label)||||||
1413711|NCT02113787|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413712|NCT02113774||||Treatment||||||||
1413713|NCT02113761|||Cohort||Prospective|||||||
1413714|NCT02113748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413715|NCT02113735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413716|NCT02113722|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413717|NCT02113709||Single Group Assignment||Treatment||None (Open Label)||||||
1413718|NCT02113696|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413719|NCT02113683|||Case-Only||Prospective|||||||
1413720|NCT02113670||Single Group Assignment||Other||None (Open Label)||||||
1413721|NCT02113657||Single Group Assignment||Treatment||None (Open Label)||||||
1413722|NCT02113644|||Other||Cross-Sectional|||||||
1413723|NCT02113631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413724|NCT02113618|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413725|NCT02113605||Single Group Assignment||Treatment||None (Open Label)||||||
1413726|NCT02113592|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1413727|NCT02113579|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413728|NCT02113566|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413729|NCT02113553||Single Group Assignment||Prevention||None (Open Label)||||||
1413730|NCT02113540|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1413731|NCT02113527|||Case Control||Prospective|||||||
1413732|NCT02113514|||Case Control||Prospective|||||||
1413733|NCT02113501|||Cohort||Prospective|||||||
1413734|NCT02113488|||Case Control||Retrospective|||||||
1413735|NCT02113475|||Cohort||Prospective|||||||
1413736|NCT02113462|||Cohort||Prospective|||||||
1413737|NCT02113449||Single Group Assignment||Treatment||None (Open Label)||||||
1413738|NCT02113436|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413739|NCT02113423||Single Group Assignment||Treatment||None (Open Label)||||||
1413740|NCT02113410|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1413741|NCT02113397|||Cohort||Prospective|||||||
1413742|NCT02113384|||Cohort||Prospective|||||||
1413743|NCT02113371|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413744|NCT02113358|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413745|NCT02113345||Single Group Assignment||Treatment||Single|||t|||
1413746|NCT02113332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413747|NCT02113319||Single Group Assignment||Supportive Care||None (Open Label)||||||
1413748|NCT02113306|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1413749|NCT02113293|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1413750|NCT02113280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413751|NCT02113267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413752|NCT02113254||Single Group Assignment||Basic Science||None (Open Label)||||||
1413753|NCT02113241|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413754|NCT02113228|||||Prospective|||||||
1413755|NCT02113215|||Cohort||Prospective|||||||
1413756|NCT02113202|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413757|NCT02113189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413758|NCT02113176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413759|NCT02113163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413760|NCT02113150|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413761|NCT02113137|Randomized|Parallel Assignment||Prevention||Single|||||t|
1413762|NCT02113124|||Case Control||Cross-Sectional|||||||
1413763|NCT02113111|||Cohort||Prospective|||||||
1413764|NCT02113098|Randomized|Parallel Assignment||Treatment||Single||||||t
1413765|NCT02113085||Single Group Assignment||Prevention||None (Open Label)||||||
1413766|NCT02113072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413767|NCT02113059|||Cohort||Prospective|||||||
1413768|NCT02113046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413769|NCT02113033||Single Group Assignment||Treatment||None (Open Label)||Equilia VNS device||||
1413770|NCT02113020|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1413771|NCT02113007||Single Group Assignment||Treatment||None (Open Label)||||||
1413772|NCT02112994||Single Group Assignment||Treatment||None (Open Label)||||||
1413773|NCT02112981|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|BioMime Sirolimus Eluting Stent system compared to the Abbott XIENCE family (V, Xpedition or Prime) of Everolimus Eluting Stent system||||
1413774|NCT02112968|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413775|NCT02112955|Randomized|Parallel Assignment||Treatment||Single||||||t
1413776|NCT02112942|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413777|NCT02112929||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413778|NCT02112916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413779|NCT02112903|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1413780|NCT02112890|||Case-Only||Cross-Sectional|||||||
1413781|NCT02112877||Single Group Assignment||Treatment||None (Open Label)||||||
1413782|NCT02112864|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413783|NCT02112851|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1413784|NCT02112838|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1413785|NCT02112825|Randomized|Parallel Assignment||Treatment||Single||||||t
1413786|NCT02112812||Single Group Assignment||Treatment||None (Open Label)||||||
1413787|NCT02112799|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1413788|NCT02112786|Randomized|Crossover Assignment||Treatment||Single|||t|||
1413789|NCT02112773|||Cohort||Cross-Sectional|||||||
1413790|NCT02112760||Single Group Assignment||Treatment||None (Open Label)||||||
1413791|NCT02112747|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1413792|NCT02112734|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413793|NCT02112721|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1413794|NCT02112708|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413795|NCT02112695|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413796|NCT02112682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413797|NCT02112669|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413798|NCT02112656|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413799|NCT02112643|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413800|NCT02112630|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413801|NCT02112617||Single Group Assignment||Treatment||None (Open Label)||||||
1413802|NCT02112604|||Cohort||Prospective|||||||
1413803|NCT02112591|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413804|NCT02112578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413805|NCT02112565||Single Group Assignment||Treatment||None (Open Label)||||||
1413806|NCT02112552||Single Group Assignment||Treatment||None (Open Label)||||||
1413807|NCT02112539|||Cohort||Prospective|||||||
1413808|NCT02112526||Single Group Assignment||Treatment||None (Open Label)||||||
1413809|NCT02112513|||Case-Only||Prospective|||||||
1413810|NCT02112500||Single Group Assignment||Treatment||None (Open Label)||||||
1413811|NCT02112487||Single Group Assignment||Treatment||None (Open Label)||||||
1413812|NCT02112474|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1413813|NCT02112461|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413814|NCT02112448|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1413815|NCT02112435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413816|NCT02112422|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1413817|NCT02112409|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413818|NCT02112396|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413819|NCT02112383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413820|NCT02112370|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413821|NCT02112357|||Cohort||Prospective|||||||
1413822|NCT02112344||Single Group Assignment||Treatment||None (Open Label)||||||
1413823|NCT02112331|Randomized|Parallel Assignment||||None (Open Label)||||||
1413824|NCT02112318|||Cohort||Prospective|||||||
1413825|NCT02112305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413826|NCT02112292|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1413827|NCT02112279||Single Group Assignment||Treatment||None (Open Label)||||||
1413828|NCT02112266|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1413829|NCT02112253|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1413830|NCT02112240||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413831|NCT02112227|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1413832|NCT02112214|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1413833|NCT02112201|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413834|NCT02112188|||Cohort||Prospective|||||||
1413835|NCT02112175||Single Group Assignment||Treatment||None (Open Label)||||||
1413836|NCT02112162||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413837|NCT02112149|Randomized|Parallel Assignment||Treatment||Single|||||t|
1413838|NCT02112136||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413839|NCT02112123|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1413840|NCT02112110||Single Group Assignment||||None (Open Label)||||||
1413841|NCT02112097|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413842|NCT02112084|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413843|NCT02112071|Randomized|Parallel Assignment||Treatment||Single||||||t
1413844|NCT02112058|Randomized|Parallel Assignment||||None (Open Label)||||||
1413845|NCT02112045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413846|NCT02112032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413847|NCT02112019|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1413848|NCT02112006|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1413849|NCT02111993|Randomized|Parallel Assignment||||None (Open Label)||||||
1413850|NCT02111980||Single Group Assignment||||None (Open Label)||||||
1413851|NCT02111967|||Case Control||Prospective|||||||
1413852|NCT02111954|||Case-Only||Prospective|||||||
1413853|NCT02111941||Single Group Assignment||Treatment||None (Open Label)||||||
1413854|NCT02111928|||Cohort||Prospective|||||||
1413855|NCT02111915|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1413856|NCT02111902|||Cohort||Prospective|||||||
1413857|NCT02111889||Single Group Assignment||Other||None (Open Label)||||||
1413858|NCT02111876|||Cohort||Prospective|||||||
1413859|NCT02111863||Single Group Assignment||Treatment||None (Open Label)||||||
1413860|NCT02111850|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413861|NCT02111837|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1413862|NCT02111824|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1413863|NCT02111811|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1413864|NCT02111798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413865|NCT02111785|Randomized|Parallel Assignment||Treatment||Single||||||t
1413866|NCT02111772|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1413867|NCT02111759|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1413941|NCT02110784||Single Group Assignment||Treatment||None (Open Label)||||||
1413942|NCT02110771|Randomized|Parallel Assignment||Treatment||Single||||||t
1413868|NCT02111746|Randomized|Parallel Assignment||Treatment||Double|Masking included all patients, who were blinded to the contents of the intraoperative injection, as well as partial blinding of the surgical team who were masked from the treatment allocation up until the time of injection following which the knowledge of drug was inevitable as Exparel® has a milky appearance as opposed to the colorless bupivacaine hydrochloride (standard) formulations.|Prospective, blinded, controlled randomized clinical trial with 2-armed parallel-group sequential design|t||t|
1413869|NCT02111733||Single Group Assignment||||None (Open Label)||||||
1413870|NCT02111720|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413871|NCT02111707|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413872|NCT02111694||Single Group Assignment||Prevention||None (Open Label)||||||
1413873|NCT02111681||Single Group Assignment||Treatment||None (Open Label)||||||
1413874|NCT02111668|||Case-Only||Other|||||||
1413875|NCT02111655|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1413876|NCT02111642|Randomized|Parallel Assignment||||None (Open Label)||||||
1413877|NCT02111629||Single Group Assignment||Treatment||None (Open Label)||||||
1413878|NCT02111616|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1413879|NCT02111603||Single Group Assignment||Treatment||None (Open Label)||||||
1413880|NCT02111590|||Cohort||Prospective|||||||
1413881|NCT02111577|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413882|NCT02111564|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1413883|NCT02111551|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1413884|NCT02111538|||Case-Only||Prospective|||||||
1413885|NCT02111525|||Cohort||Prospective|||||||
1413886|NCT02111512||Single Group Assignment||Treatment||None (Open Label)||||||
1413887|NCT02111499|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413888|NCT02111486|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1413889|NCT02111473||Single Group Assignment||Treatment||None (Open Label)||||||
1413890|NCT02111460|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413891|NCT02111447|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1413892|NCT02111434||Single Group Assignment||Screening||None (Open Label)||||||
1413893|NCT02111421|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413894|NCT02111408|||Cohort||Prospective|||||||
1413895|NCT02111382|Randomized|Crossover Assignment||Treatment||Single||||||t
1413896|NCT02111369||Single Group Assignment||Treatment||None (Open Label)||||||
1413897|NCT02111356||Single Group Assignment||Basic Science||None (Open Label)||||||
1413898|NCT02111343|Randomized|Parallel Assignment||Treatment||Single|||t|||
1413899|NCT02111330|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413900|NCT02111317||Single Group Assignment||Basic Science||None (Open Label)||||||
1413901|NCT02111304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413902|NCT02111291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413903|NCT02111278|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1413904|NCT02111265|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413905|NCT02111252||Single Group Assignment||Treatment||None (Open Label)||||||
1413906|NCT02111239|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413907|NCT02111226|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1413908|NCT02111213|Randomized|Parallel Assignment||Prevention||Single||||||t
1413909|NCT02111200|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1413910|NCT02111187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413911|NCT02111174|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1413912|NCT02111161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413913|NCT02111148|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1413914|NCT02111135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413915|NCT02111122|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1413916|NCT02111109|||Cohort||Prospective|||||||
1413917|NCT02111096|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1413918|NCT02111083|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1413919|NCT02111070|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1413920|NCT02111057|||Cohort||Prospective|||||||
1413921|NCT02111044|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413922|NCT02111031|||Case-Only||Prospective|||||||
1413923|NCT02111018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413924|NCT02111005|||Case Control||Cross-Sectional|||||||
1413925|NCT02110992||Single Group Assignment||Treatment||None (Open Label)||||||
1413926|NCT02110979|Randomized|Parallel Assignment||||None (Open Label)||||||
1413927|NCT02110966|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413928|NCT02110953||Single Group Assignment||Treatment||None (Open Label)||||||
1413929|NCT02110940|Randomized|Parallel Assignment||Treatment||Single||||||t
1413930|NCT02110927|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1413931|NCT02110914|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1413932|NCT02110901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413933|NCT02110888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413934|NCT02110875|||Case-Only||Cross-Sectional|||||||
1413935|NCT02110862|||Case-Only||Cross-Sectional|||||||
1413936|NCT02110849|||Case Control||Prospective|||||||
1413937|NCT02110836|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1413938|NCT02110823|||Cohort||Prospective|||||||
1413939|NCT02110810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413940|NCT02110797||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415969|NCT02084225|||||Prospective|||||||
1413944|NCT02110745|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1413945|NCT02110732|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1413946|NCT02110719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413947|NCT02110706|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1413948|NCT02110693||Single Group Assignment||Screening||None (Open Label)||This study examined the accuracy of a substance abuse screening test compared to gold standard measures Participants all received the experimental screening instrument (via self- and tablet computer administration. The order of administration was randomly selected in order to control for an order effect.||||
1413949|NCT02110680|Randomized|Factorial Assignment||Treatment||Single|||t|||
1413950|NCT02110667|||Cohort||Prospective|||||||
1413951|NCT02110654|Randomized|Parallel Assignment||Treatment||Single||||||t
1413952|NCT02110641|Randomized|Parallel Assignment||Treatment||Single||||||t
1413953|NCT02110628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413954|NCT02110615||Single Group Assignment||Prevention||None (Open Label)||||||
1413955|NCT02110602|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1413956|NCT02110589|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1413957|NCT02110576|||Cohort||Prospective|||||||
1413958|NCT02110563||Single Group Assignment||Treatment||None (Open Label)||||||
1413959|NCT02110550|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413960|NCT02110537|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413961|NCT02110524||Single Group Assignment||Treatment||None (Open Label)||||||
1413962|NCT02110511|Randomized|Crossover Assignment||||Double|||t||t|
1413963|NCT02110498|||Cohort||Prospective|||||||
1413964|NCT02110485|Randomized|Parallel Assignment||Treatment||Single||||t||
1413965|NCT02110472||Single Group Assignment||||None (Open Label)||||||
1413966|NCT02110459|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1413967|NCT02110446|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1413968|NCT02110433|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1413969|NCT02110420|Randomized|Single Group Assignment||||Double|||t||t|
1413970|NCT02110407|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1413971|NCT02110394|||Case-Only||Prospective|||||||
1413972|NCT02110381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413973|NCT02110368|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1413974|NCT02110355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413975|NCT02110342||Single Group Assignment||Basic Science||None (Open Label)||||||
1413976|NCT02110329||Single Group Assignment||||None (Open Label)||||||
1413977|NCT02110316||Single Group Assignment||||None (Open Label)||||||
1413978|NCT02110303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413979|NCT02110290|||Case-Only||Prospective|||||||
1413980|NCT02110277||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413981|NCT02110264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413982|NCT02110251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413983|NCT02110238|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1413984|NCT02110225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1413985|NCT02110212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413986|NCT02110186|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413987|NCT02110147||Single Group Assignment||Treatment||None (Open Label)||||||
1413988|NCT02110134||Crossover Assignment||Treatment||None (Open Label)||||||
1413989|NCT02110121|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413990|NCT02110108||Single Group Assignment||Treatment||None (Open Label)||||||
1413991|NCT02110095||Single Group Assignment||Treatment||None (Open Label)||||||
1413992|NCT02110082|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413993|NCT02110069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1413994|NCT02110056|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1413995|NCT02110043|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1413996|NCT02110030|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1413997|NCT02110017|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1413998|NCT02110004||Single Group Assignment||Diagnostic||None (Open Label)||||||
1413999|NCT02109991||Single Group Assignment||Treatment||None (Open Label)||||||
1414000|NCT02109978|||Cohort||Retrospective|||||||
1414001|NCT02109965|Randomized|Parallel Assignment||Basic Science||Single||||||t
1414002|NCT02109952|||Case-Only||Prospective|||||||
1414003|NCT02109939|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1414004|NCT02109926|||Case-Control||Retrospective|||||||
1414005|NCT02109913||Single Group Assignment||Other||None (Open Label)||||||
1414006|NCT02109900|||Case Control||Prospective|||||||
1414007|NCT02109887|||Cohort||Prospective|||||||
1414008|NCT02109874|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1414009|NCT02109861|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1414010|NCT02109848|||Cohort||Prospective|||||||
1414011|NCT02109835|||Cohort||Prospective|||||||
1414012|NCT02109822|||Cohort||Prospective|||||||
1414013|NCT02109809||Single Group Assignment||Supportive Care||None (Open Label)||||||
1414014|NCT02109796|Randomized|Crossover Assignment||Treatment||Single|||t|||
1414015|NCT02109783|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1414016|NCT02109770|||Cohort||Prospective|||||||
1414017|NCT02109757|Randomized|Parallel Assignment||Prevention||Single|||t|||
1414018|NCT02109744|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414019|NCT02109731||Single Group Assignment||Treatment||None (Open Label)||||||
1414020|NCT02109718|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414021|NCT02109705|||Case Control||Prospective|||||||
1414022|NCT02109692||Single Group Assignment||Health Services Research||None (Open Label)||||||
1414023|NCT02109679|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414024|NCT02109666|||Cohort||Prospective|||||||
1414025|NCT02109653|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414026|NCT02109640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414027|NCT02109627||Single Group Assignment||Treatment||None (Open Label)||||||
1414028|NCT02109614|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1414029|NCT02109601|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1414030|NCT02109588|Randomized|Parallel Assignment||Prevention||Single|||||t|
1414031|NCT02109575|||Cohort||Prospective|||||||
1414032|NCT02109562|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414033|NCT02109549|||Cohort||Retrospective|||||||
1414034|NCT02109536|||Other||Prospective|||||||
1414035|NCT02109523|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1414036|NCT02109510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414037|NCT02109497||Single Group Assignment||Basic Science||None (Open Label)||||||
1414038|NCT02109484|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414039|NCT02109471|||Cohort||Prospective|||||||
1414040|NCT02109458||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414041|NCT02109445|Randomized|||Treatment||None (Open Label)||||||
1414042|NCT02109432||Single Group Assignment||||None (Open Label)||||||
1414043|NCT02109419|||Case Control||Prospective|||||||
1414044|NCT02109406|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1414045|NCT02109393|Randomized|Parallel Assignment||Treatment||Single||||||t
1414046|NCT02109380||Single Group Assignment||Basic Science||None (Open Label)||||||
1414047|NCT02109367|||Cohort||Prospective|||||||
1414048|NCT02109354|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1414049|NCT02109341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414050|NCT02109328|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414051|NCT02109315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414052|NCT02109302||Single Group Assignment||Basic Science||||||||
1414053|NCT02109289||Single Group Assignment||Treatment||None (Open Label)||||||
1414054|NCT02109276|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414055|NCT02109263|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414056|NCT02109250|||Case-Only||Other|||||||
1414057|NCT02109237|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1414058|NCT02109224||Single Group Assignment||Treatment||None (Open Label)||||||
1414059|NCT02109211|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1414060|NCT02109198|Randomized|Parallel Assignment||||Single|||t|||
1414061|NCT02109185|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414062|NCT02109172|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1414063|NCT02109159|Randomized|Parallel Assignment||||Double|||||t|t
1414064|NCT02109146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414065|NCT02109133|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1414066|NCT02109120|||Cohort||Prospective|||||||
1414067|NCT02109107||Single Group Assignment||Treatment||None (Open Label)||||||
1414068|NCT02109094|||Case Control||Prospective|||||||
1414069|NCT02109081|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414070|NCT02109068|Randomized|Parallel Assignment||Treatment||Single||||||t
1414071|NCT02109055|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1414072|NCT02109042||Single Group Assignment||Basic Science||None (Open Label)||||||
1414073|NCT02109029|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1414074|NCT02109016||Single Group Assignment||Treatment||None (Open Label)||||||
1414075|NCT02109003|Randomized|Crossover Assignment||Prevention||Single||||||t
1414076|NCT02108990|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414077|NCT02108977|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1414078|NCT02108964|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414079|NCT02108951||Single Group Assignment||Treatment||None (Open Label)||||||
1414080|NCT02108938|||Case Control||Prospective|||||||
1414081|NCT02108925||Single Group Assignment||Treatment||Double|||t||t|
1414082|NCT02108912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414083|NCT02108899|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1414084|NCT02108886|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414085|NCT02108873|||Cohort||Retrospective|||||||
1414086|NCT02108860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414087|NCT02108847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414088|NCT02108834|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414089|NCT02108821||Single Group Assignment||Treatment||None (Open Label)||||||
1414090|NCT02108808|Randomized|Parallel Assignment||Treatment||Single|||||t|
1414091|NCT02108795|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1414092|NCT02108782||Single Group Assignment||Treatment||None (Open Label)||||||
1414093|NCT02108769|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414094|NCT02108756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414095|NCT02108743|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1414096|NCT02108730|||Cohort||Prospective|||||||
1414097|NCT02108717|Randomized|Crossover Assignment||Basic Science||Single||||||t
1414098|NCT02108704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414099|NCT02108691|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1414100|NCT02108678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414101|NCT02108665|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1414102|NCT02108652||Single Group Assignment||Treatment||None (Open Label)||||||
1414103|NCT02108639||Single Group Assignment||||None (Open Label)||||||
1414104|NCT02108626|Randomized|Crossover Assignment||Treatment||Single|||t|||
1414105|NCT02108613|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1414106|NCT02108600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414107|NCT02108587||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414108|NCT02108574|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1414109|NCT02108561|||Cohort||Prospective|||||||
1414110|NCT02108548|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1414111|NCT02108535|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414112|NCT02108522||Single Group Assignment||Treatment||None (Open Label)||||||
1414113|NCT02108509|||Case-Only||Prospective|||||||
1414114|NCT02108496||||||||||||
1414115|NCT02108483||Single Group Assignment||Treatment||Triple|||t||t|t
1414116|NCT02108470|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1414117|NCT02108457||||Treatment||||||||
1414118|NCT02108444|||Case Control||Retrospective|||||||
1414119|NCT02108431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414120|NCT02108418|Randomized|Crossover Assignment||||None (Open Label)||||||
1414121|NCT02108405|||Case-Only||Prospective|||||||
1414122|NCT02108392|||Other||Prospective|||||||
1414123|NCT02108379||Single Group Assignment||Treatment||None (Open Label)||||||
1414124|NCT02108366|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414125|NCT02108353|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1414126|NCT02108340||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414127|NCT02108327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414128|NCT02108314|Randomized|Parallel Assignment||Screening||Double|||t|||t
1414129|NCT02108301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414130|NCT02108288|Randomized|Parallel Assignment||||None (Open Label)||||||
1414131|NCT02108275||||||||||||
1414132|NCT02108262|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414133|NCT02108249|||Cohort||Other|||||||
1414134|NCT02108236|Randomized|Parallel Assignment||Treatment||Single||||||t
1414135|NCT02108223|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414136|NCT02108210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414137|NCT02108197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414138|NCT02108184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414139|NCT02108171|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414140|NCT02108158|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1414141|NCT02108145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414142|NCT02108132||Single Group Assignment||Treatment||None (Open Label)||||||
1414143|NCT02108119|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414144|NCT02108106|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414145|NCT02108093|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414146|NCT02108080|||||Other|||||||
1414147|NCT02108054|||||Other|||||||
1414148|NCT02108041|||Case-Control||Cross-Sectional|||||||
1414149|NCT02108028|||Cohort||Prospective|||||||
1414150|NCT02108015|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1414151|NCT02108002|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1414152|NCT02107989|||Case-Control||Prospective|||||||
1414153|NCT02107976|||||Prospective|||||||
1414154|NCT02107963|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1414155|NCT02107950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414156|NCT02107937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414157|NCT02107924|||Case Control||Prospective|||||||
1414158|NCT02107911|||Case-Crossover||Cross-Sectional|||||||
1414159|NCT02107898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414160|NCT02107885|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1414161|NCT02107872|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1414162|NCT02107859||Single Group Assignment||Treatment||None (Open Label)||||||
1414163|NCT02107846|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414164|NCT02107833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414165|NCT02107820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414166|NCT02107807|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1414167|NCT02107794|Randomized|Parallel Assignment||||None (Open Label)||||||
1414168|NCT02107781|||Cohort||Prospective|||||||
1414169|NCT02107768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414170|NCT02107755||Single Group Assignment||Treatment||None (Open Label)||||||
1414171|NCT02107742||Single Group Assignment||Treatment||None (Open Label)||||||
1414172|NCT02107729|Randomized|Crossover Assignment||Treatment||Single|||t|||
1414173|NCT02107716||Single Group Assignment||Treatment||Double|||t||t|
1414174|NCT02107703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414175|NCT02107690|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1415970|NCT02084212||||||||||||
1414179|NCT02107638|Randomized|Parallel Assignment||Treatment||Single||||||t
1414180|NCT02107625|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414181|NCT02107612|Randomized|Parallel Assignment||Treatment||Single||||||t
1414182|NCT02107599||Single Group Assignment||Diagnostic||Single||||||t
1414183|NCT02107586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414184|NCT02107573|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414185|NCT02107560|||Case Control||Prospective|||||||
1414186|NCT02107547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414187|NCT02107534|Randomized|Parallel Assignment||Treatment||Single||||||t
1414188|NCT02107521|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1414189|NCT02107508|||||Cross-Sectional|||||||
1414190|NCT02107495|||Cohort||Prospective|||||||
1414191|NCT02107482|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414192|NCT02107469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414193|NCT02107456||Single Group Assignment||Treatment||Single|||t|||
1414194|NCT02107443|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1414195|NCT02107430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414196|NCT02107417|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1414197|NCT02107404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414198|NCT02107391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414199|NCT02107378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414200|NCT02107365||Single Group Assignment||Treatment||None (Open Label)||||||
1414201|NCT02107352|||Cohort||Prospective|||||||
1414202|NCT02107339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414203|NCT02107326|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414204|NCT02107313|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1414205|NCT02107300|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1414206|NCT02107287||Single Group Assignment||Treatment||None (Open Label)||||||
1414207|NCT02107274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414208|NCT02107261|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1414209|NCT02107248|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1414210|NCT02107235||Single Group Assignment||Treatment||None (Open Label)||||||
1414211|NCT02107222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414212|NCT02107209|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414213|NCT02107196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414214|NCT02107183|Randomized|Parallel Assignment||Prevention||Single||||||t
1414215|NCT02107170|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1414216|NCT02107157||Single Group Assignment||Treatment||None (Open Label)||||||
1414217|NCT02107144|Randomized|Parallel Assignment||Treatment||Single||||t||
1414218|NCT02107131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414219|NCT02107118|Randomized|Crossover Assignment||Treatment||Single|||t|||
1414220|NCT02107105|||Cohort||Prospective|||||||
1414221|NCT02107092||Single Group Assignment||Supportive Care||None (Open Label)||||||
1414222|NCT02107079|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1414223|NCT02107066|Randomized|Parallel Assignment||Prevention||Single||||||t
1414224|NCT02107053|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1414225|NCT02107027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414226|NCT02107014||Single Group Assignment||Basic Science||Single|||t|||
1414227|NCT02107001|||Cohort||Prospective|||||||
1414228|NCT02106988||Single Group Assignment||Treatment||None (Open Label)||||||
1414229|NCT02106975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414230|NCT02106962|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414231|NCT02106949|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414232|NCT02106936|||Other||Prospective|||||||
1414233|NCT02106923|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414234|NCT02106910|||Cohort||Prospective|||||||
1414235|NCT02106897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414236|NCT02106884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414237|NCT02106871|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1414238|NCT02106858|||Cohort||Prospective|||||||
1414239|NCT02106845|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414240|NCT02106832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414241|NCT02106819|||Case-Control||Prospective|||||||
1414242|NCT02106806|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1414243|NCT02106793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414244|NCT02106780||Single Group Assignment||Basic Science||None (Open Label)||||||
1414245|NCT02106767|Randomized|Crossover Assignment||||None (Open Label)||||||
1414246|NCT02106754|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1414247|NCT02106741|Randomized|Parallel Assignment||Treatment||Single|||||t|
1414248|NCT02106728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414249|NCT02106715|Randomized|Parallel Assignment||Prevention||Single|||t|||
1414250|NCT02106702|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1414251|NCT02106689|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414252|NCT02106676|||Case Control||Prospective|||||||
1414253|NCT02106663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414254|NCT02106650||Single Group Assignment||Prevention||None (Open Label)||||||
1414255|NCT02106637|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414256|NCT02106624|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1414257|NCT02106611|||Cohort||Prospective|||||||
1414258|NCT02106598|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1414259|NCT02106585|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414260|NCT02106572|Randomized|Parallel Assignment||Treatment||Single|Blind Review in accordance with with ICH-Biostatistics Guideline ICH E9|||||t
1414261|NCT02106559||Single Group Assignment||Treatment||None (Open Label)||||||
1414262|NCT02106546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414263|NCT02106533|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414264|NCT02106520|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414265|NCT02106507||Single Group Assignment||Treatment||None (Open Label)||||||
1414266|NCT02106494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414267|NCT02106481|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1414268|NCT02106468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414269|NCT02106455|||Cohort||Prospective|||||||
1414270|NCT02106442|||Cohort||Prospective|||||||
1414271|NCT02106429|||Case-Only||Prospective|||||||
1414272|NCT02106416||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414273|NCT02106403|Randomized|Crossover Assignment||||Double|||t|||t
1414274|NCT02106390|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414275|NCT02106364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414276|NCT02106351|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414277|NCT02106338|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414278|NCT02106325|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414279|NCT02106312||Single Group Assignment||Treatment||None (Open Label)||||||
1414280|NCT02106299|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414281|NCT02106286|Non-Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1414282|NCT02106273|||Case-Only||Prospective|||||||
1414283|NCT02106260||Single Group Assignment||Treatment||None (Open Label)||||||
1414284|NCT02106247|Randomized|Single Group Assignment||Treatment||Double||||||
1414285|NCT02106234|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1414286|NCT02106221|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1414287|NCT02106208|Randomized|Crossover Assignment||Prevention||Single||||||t
1414288|NCT02106195||Single Group Assignment||Treatment||None (Open Label)||||||
1414289|NCT02106182||Single Group Assignment||Treatment||None (Open Label)||||||
1414290|NCT02106169|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1414291|NCT02106156|||Case-Only||Prospective|||||||
1414292|NCT02106143||Single Group Assignment||Device Feasibility||None (Open Label)||RejuvenAir||||
1414293|NCT02106130|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414294|NCT02106117|||Cohort||Prospective|||||||
1414295|NCT02106104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414296|NCT02106091||Single Group Assignment||Treatment||None (Open Label)||||||
1414297|NCT02106078|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1414298|NCT02106065|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1414299|NCT02106052|Randomized|Parallel Assignment||Treatment||Single||||||t
1414300|NCT02106039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414301|NCT02106026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414302|NCT02106013|||Case Control||Cross-Sectional|||||||
1414303|NCT02106000|||Cohort||Prospective|||||||
1414304|NCT02105987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414305|NCT02105974|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414306|NCT02105961|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414307|NCT02105948|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414308|NCT02105935|||Cohort||Prospective|||||||
1414309|NCT02105922|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1414310|NCT02105909|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1414311|NCT02105896|||||Prospective|||||||
1414312|NCT02105883|Randomized|Parallel Assignment||||Double|||t|||t
1414313|NCT02105870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414314|NCT02105857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414315|NCT02105844|||Cohort||Prospective|||||||
1414316|NCT02105831|||Case-Only||Prospective|||||||
1414317|NCT02105818|||Cohort||Cross-Sectional|||||||
1414318|NCT02105805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414319|NCT02105792|||Cohort||Prospective|||||||
1414320|NCT02105779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414321|NCT02105766|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414322|NCT02105753|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414323|NCT02105740|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1414324|NCT02105727||Single Group Assignment||Treatment||None (Open Label)||||||
1414325|NCT02105714|||Case Control||Prospective|||||||
1414326|NCT02105701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414327|NCT02105688|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414328|NCT02105675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414329|NCT02105662||Single Group Assignment||Treatment||None (Open Label)||||||
1414330|NCT02105649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414331|NCT02105636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414332|NCT02105623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414333|NCT02105610|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414334|NCT02105597|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1414335|NCT02105584||Single Group Assignment||Treatment||None (Open Label)||||||
1414336|NCT02105571|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414337|NCT02105558|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414338|NCT02105545||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414339|NCT02105532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414340|NCT02105519|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414341|NCT02105506||Single Group Assignment||Treatment||None (Open Label)||||||
1414342|NCT02105493|Randomized|Parallel Assignment||Prevention||Single|||||t|
1414343|NCT02105480|||Cohort||Cross-Sectional|||||||
1414344|NCT02105467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414345|NCT02105454||Single Group Assignment||Treatment||None (Open Label)||||||
1414346|NCT02105441|||Cohort||Prospective|||||||
1414347|NCT02105428|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414348|NCT02105415|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414349|NCT02105402|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1414350|NCT02105389||Single Group Assignment||Treatment||None (Open Label)||||||
1414351|NCT02105376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414352|NCT02105363|||Cohort||Prospective|||||||
1414353|NCT02105350||Single Group Assignment||Treatment||None (Open Label)||||||
1414354|NCT02105337|||Case-Only||Prospective|||||||
1414355|NCT02105324|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414356|NCT02105311|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414357|NCT02105298|||||Prospective|||||||
1414358|NCT02105285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414359|NCT02105272|Randomized|Parallel Assignment||Treatment||Single|||||t|
1414360|NCT02105259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414361|NCT02105246|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414362|NCT02105233||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414363|NCT02105220|||Case-Only||Prospective|||||||
1414364|NCT02105207|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1414365|NCT02105194||Single Group Assignment||Treatment||None (Open Label)||||||
1414366|NCT02105181||Single Group Assignment||Treatment||None (Open Label)||||||
1414367|NCT02105168||Single Group Assignment||Screening||None (Open Label)||||||
1414368|NCT02105155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414369|NCT02105142|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1414370|NCT02105129|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414371|NCT02105116||Single Group Assignment||Treatment||None (Open Label)||||||
1414372|NCT02105103||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414373|NCT02105090|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414374|NCT02105077|||Cohort||Prospective|||||||
1414375|NCT02105064|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1414376|NCT02105051|||Cohort||Prospective|||||||
1414377|NCT02105038|Randomized|Crossover Assignment||||None (Open Label)||||||
1414378|NCT02105025|||||Prospective|||||||
1414379|NCT02105012|Randomized|Crossover Assignment||Treatment||Double|Double Blind||t||t|
1414380|NCT02104999||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414381|NCT02104986|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414382|NCT02104973|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1414383|NCT02104960|||Cohort||Prospective|||||||
1414384|NCT02104947||Single Group Assignment||Treatment||None (Open Label)||||||
1414385|NCT02104934|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1414386|NCT02104921|||Case-Control||Prospective|||||||
1414387|NCT02104908|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414388|NCT02104895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414389|NCT02104882||Single Group Assignment||Treatment||None (Open Label)||||||
1414390|NCT02104869|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414391|NCT02104856|||Case-Only||Other|||||||
1414392|NCT02104843||Single Group Assignment||||None (Open Label)||||||
1414393|NCT02104830|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1414394|NCT02104817|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414395|NCT02104804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414396|NCT02104791|||Case Control||Retrospective|||||||
1414397|NCT02104778|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414398|NCT02104765|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1414399|NCT02104752|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414400|NCT02104739|Randomized|Crossover Assignment||Treatment||Quadruple|Placebo pills and placebo injections provided||t|t|t|t
1414401|NCT02104726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414402|NCT02104713||Single Group Assignment||Health Services Research||None (Open Label)||||||
1414403|NCT02104700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414404|NCT02104687|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414405|NCT02104674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414406|NCT02104661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414407|NCT02104648|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414408|NCT02104635|Randomized|Factorial Assignment||Basic Science||||||||
1414409|NCT02104622||Single Group Assignment||Treatment||None (Open Label)||||||
1414410|NCT02104609|||Cohort||Prospective|||||||
1414411|NCT02104596|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414412|NCT02104583|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414413|NCT02104570|Randomized|Crossover Assignment||Prevention||Single|||t|||
1414414|NCT02104557|||Other||Prospective|||||||
1414415|NCT02104544|||Cohort|||||||||
1414416|NCT02104531|||Case-Control||Cross-Sectional|||||||
1414417|NCT02104518|||Ecologic or Community||Prospective|||||||
1414418|NCT02104505|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1414419|NCT02104492|Randomized|Parallel Assignment||Treatment||Single|||||t|
1414420|NCT02104479|||Cohort||Prospective|||||||
1414421|NCT02104466|Randomized|Parallel Assignment||Treatment||Single||||||t
1414422|NCT02104453|Randomized|Crossover Assignment||Treatment||Single|||t|||
1414423|NCT02104440||Single Group Assignment||Treatment||None (Open Label)||||||
1414424|NCT02104427||Single Group Assignment||Treatment||None (Open Label)||||||
1414425|NCT02104414|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1414426|NCT02104401||Single Group Assignment||Treatment||None (Open Label)||||||
1414427|NCT02104388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414428|NCT02104375|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1414429|NCT02104362||Single Group Assignment||Treatment||None (Open Label)||||||
1414430|NCT02104349|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1414431|NCT02104336||Single Group Assignment||Treatment||None (Open Label)||||||
1414432|NCT02104323||Single Group Assignment||Treatment||None (Open Label)||||||
1414433|NCT02104310||Single Group Assignment||Treatment||None (Open Label)||||||
1414434|NCT02104297|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1414435|NCT02104284|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1414436|NCT02104271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414437|NCT02104258|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1414438|NCT02104245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414439|NCT02104232|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1414440|NCT02104219|||||Retrospective|||||||
1414441|NCT02104193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414442|NCT02104180|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414443|NCT02104167|||Cohort|||||||||
1414444|NCT02104154|||Cohort||Prospective|||||||
1414445|NCT02104141|||Cohort|||||||||
1414446|NCT02104128|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414447|NCT02104115|Randomized|Crossover Assignment||||None (Open Label)||||||
1414448|NCT02104102|Randomized|Parallel Assignment||||None (Open Label)||||||
1414449|NCT02104089|||Case-Only||Other|||||||
1414450|NCT02104076||Single Group Assignment||Supportive Care||None (Open Label)||||||
1414451|NCT02104063|||Cohort||Prospective|||||||
1414452|NCT02104050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414453|NCT02104037|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1414454|NCT02104024|||Cohort||Prospective|||||||
1414455|NCT02104011||Single Group Assignment||Treatment||None (Open Label)||||||
1414456|NCT02103998|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1414457|NCT02103985|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414458|NCT02103972|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414459|NCT02103959|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1414460|NCT02103946|Randomized|Parallel Assignment||Treatment||Single||||||t
1414461|NCT02103933|||Case-Only||Prospective|||||||
1414462|NCT02103920|||Cohort||Retrospective|||||||
1414463|NCT02103907|Randomized|Parallel Assignment||Treatment||Single||||||t
1414464|NCT02103894||Single Group Assignment||||None (Open Label)||||||
1414465|NCT02103881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414466|NCT02103868|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1414467|NCT02103855||Single Group Assignment||Treatment||None (Open Label)||||||
1414468|NCT02103842||Single Group Assignment||Treatment||None (Open Label)||||||
1414469|NCT02103829|Randomized|Factorial Assignment||||None (Open Label)||||||
1414470|NCT02103816||Single Group Assignment||Treatment||None (Open Label)||||||
1414471|NCT02103803|||Cohort||Prospective|||||||
1414472|NCT02103790||Single Group Assignment||Treatment||None (Open Label)||||||
1414473|NCT02103777|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414474|NCT02103764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414475|NCT02103751|||Case Control||Prospective|||||||
1414476|NCT02103738|||Other||Prospective|||||||
1414477|NCT02103725|Randomized|Parallel Assignment||||Double|||t||t|
1414478|NCT02103712|||Cohort||Prospective|||||||
1414479|NCT02103699|||Cohort||Prospective|||||||
1414480|NCT02103686|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414481|NCT02103673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414482|NCT02103660|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1414483|NCT02103647|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414484|NCT02103634||Single Group Assignment||Screening||None (Open Label)||||||
1414485|NCT02103621|Randomized|Parallel Assignment||Treatment||Single||||||t
1414486|NCT02103608||Single Group Assignment||Treatment||None (Open Label)||||||
1414487|NCT02103595|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1414488|NCT02103582|Randomized|Parallel Assignment||Other||Single|||t|||
1414489|NCT02103569||Single Group Assignment||||None (Open Label)||||||
1414490|NCT02103556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414491|NCT02103543|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414492|NCT02103530||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414493|NCT02103517|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414494|NCT02103504||Single Group Assignment||Treatment||None (Open Label)||||||
1414495|NCT02103491|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1414496|NCT02103478|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414497|NCT02103465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414498|NCT02103452|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1414499|NCT02103439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414500|NCT02103426|Randomized|Parallel Assignment||Prevention||Single|||t|||
1414501|NCT02103413|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414502|NCT02103400|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414503|NCT02103387|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1414504|NCT02103374|Randomized|Parallel Assignment||||Single|||t|||
1414505|NCT02103361|||Case-Only||Other|||||||
1414506|NCT02103348|||Cohort||Cross-Sectional|||||||
1414507|NCT02103335||Single Group Assignment||Treatment||None (Open Label)||||||
1414508|NCT02103322|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414509|NCT02103309|Randomized|Crossover Assignment||Treatment||Single|||t|||
1414510|NCT02103296|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414511|NCT02103283||Single Group Assignment||Treatment||None (Open Label)||||||
1414512|NCT02103270|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1414513|NCT02103257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414514|NCT02103244||Single Group Assignment||Treatment||None (Open Label)||||||
1414515|NCT02103231|||Case-Control||Prospective|||||||
1414516|NCT02103218|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414517|NCT02103205|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414518|NCT02103192|Randomized|Crossover Assignment||||Double|||t||t|
1414519|NCT02103179|||Case Control||Retrospective|||||||
1414520|NCT02103166|Randomized|Parallel Assignment||||Triple|||t|t|t|
1414521|NCT02103153||Single Group Assignment||Treatment||None (Open Label)||||||
1414522|NCT02103140|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1414523|NCT02103127||Single Group Assignment||Treatment||None (Open Label)||||||
1414524|NCT02103114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414525|NCT02103101||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414526|NCT02103088|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1414527|NCT02103075||Parallel Assignment||Treatment||Single|||t|||
1414528|NCT02103062||Single Group Assignment||Treatment||None (Open Label)||||||
1414529|NCT02103049||Single Group Assignment||Treatment||None (Open Label)||||||
1414530|NCT02103036|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414531|NCT02103023|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1414532|NCT02103010|||Case-Control||Prospective|||||||
1414533|NCT02102997|||Ecologic or Community||Prospective|||||||
1414534|NCT02102984|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414535|NCT02102971|||Cohort||Prospective|||||||
1414536|NCT02102958|Randomized|Parallel Assignment||Prevention||Single|||t|||
1414537|NCT02102945||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414538|NCT02102932|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414539|NCT02102919|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414540|NCT02102906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414541|NCT02102893|||Case-Only||Retrospective|||||||
1414542|NCT02102880||Single Group Assignment||Other||None (Open Label)||||||
1414543|NCT02102867|||Other||Other|||||||
1414544|NCT02102854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414545|NCT02102841|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414546|NCT02102828|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414547|NCT02102815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414548|NCT02102802|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1414549|NCT02102789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414550|NCT02102776|Randomized|Parallel Assignment||Treatment||Single||||||t
1414551|NCT02102763|||Cohort||Cross-Sectional|||||||
1414552|NCT02102750||Single Group Assignment||Treatment||None (Open Label)||||||
1414553|NCT02102737|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1414554|NCT02102724|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414555|NCT02102711|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414556|NCT02102698|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1414557|NCT02102685|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414558|NCT02102672|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1414559|NCT02102659|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414560|NCT02102646|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414561|NCT02102633|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1414562|NCT02102620|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1414563|NCT02102607||||||||||||
1414564|NCT02102594||Single Group Assignment||Treatment||None (Open Label)||||||
1414565|NCT02102581|||Case Control||Prospective|||||||
1414566|NCT02102568|||Cohort||Prospective|||||||
1414567|NCT02102555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414568|NCT02102542|||||Prospective|||||||
1414570|NCT02102516||Single Group Assignment||Treatment||None (Open Label)||||||
1414571|NCT02102503|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1414572|NCT02102490||Single Group Assignment||Treatment||None (Open Label)||||||
1414573|NCT02102477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414574|NCT02102464|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414575|NCT02102451|||Other||Cross-Sectional|||||||
1414576|NCT02102438||Single Group Assignment||Treatment||None (Open Label)||||||
1414577|NCT02102425|||Case-Crossover||Prospective|||||||
1414578|NCT02102412||Single Group Assignment||Screening||None (Open Label)||||||
1414579|NCT02102399|Randomized|Parallel Assignment||Prevention||Single||||||t
1414580|NCT02102386|||Case-Only||Prospective|||||||
1414581|NCT02102373|Randomized|Parallel Assignment||Treatment||Single|||||t|
1414582|NCT02102360|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1414583|NCT02102347|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414584|NCT02102334|||Cohort||Prospective|||||||
1414585|NCT02102321|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1414586|NCT02102308|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1414587|NCT02102295|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414588|NCT02102282|||Cohort||Prospective|||||||
1414589|NCT02102269|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1414590|NCT02102256||Single Group Assignment||Treatment||None (Open Label)||||||
1414591|NCT02102243|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1414592|NCT02102230|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414593|NCT02102217|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1414594|NCT02102204||Single Group Assignment||Treatment||None (Open Label)||||||
1414595|NCT02102191|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1414596|NCT02102178|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1414597|NCT02102165||Single Group Assignment||Screening||None (Open Label)||||||
1414598|NCT02102152|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414599|NCT02102139|Randomized|Single Group Assignment||Supportive Care||Triple||||t|t|t
1414600|NCT02102126|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414601|NCT02102113|Randomized|Crossover Assignment||Other||Double|||t|t||
1414602|NCT02102100|Randomized|Crossover Assignment||Other||Double|||t||t|
1414603|NCT02102087|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1414604|NCT02102074|||Cohort||Prospective|||||||
1414605|NCT02102061|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1414606|NCT02102048|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414607|NCT02102035||Single Group Assignment||Treatment||Single||||||t
1414608|NCT02102022||Single Group Assignment||Treatment||None (Open Label)||||||
1414609|NCT02102009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414610|NCT02101996|||Cohort||Prospective|||||||
1414611|NCT02101983|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414612|NCT02101970|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414613|NCT02101957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414614|NCT02101944||Single Group Assignment||Treatment||None (Open Label)||||||
1414615|NCT02101931||Single Group Assignment||Diagnostic||Single|||t|||
1414616|NCT02101918||Single Group Assignment||Treatment||None (Open Label)||||||
1414617|NCT02101905|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414618|NCT02101892|Randomized|Parallel Assignment||Other||Double|||t||t|
1414619|NCT02101879|||Cohort||Prospective|||||||
1414620|NCT02101866|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1414621|NCT02101853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414622|NCT02101840|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1414623|NCT02101827|||Cohort||Retrospective|||||||
1414624|NCT02101814||Single Group Assignment||Treatment||None (Open Label)||||||
1414625|NCT02101801|Randomized|Crossover Assignment||Other||Single|||t|||
1414626|NCT02101788|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414627|NCT02101775|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414628|NCT02101762|||Cohort||Prospective|||||||
1414629|NCT02101749|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414630|NCT02101736||Single Group Assignment||Treatment||None (Open Label)||||||
1414631|NCT02101723|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414632|NCT02101710|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414633|NCT02101697|Randomized|Parallel Assignment||Other||Single|||t|||
1414634|NCT02101684||Single Group Assignment||Treatment||None (Open Label)||||||
1414635|NCT02101671|||Case Control||Prospective|||||||
1414636|NCT02101658|||Cohort||Cross-Sectional|||||||
1414637|NCT02101645||Single Group Assignment||||None (Open Label)||||||
1414638|NCT02101632|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1414639|NCT02101619|||Case-Only||Prospective|||||||
1414640|NCT02101606||Single Group Assignment||Treatment||None (Open Label)||||||
1414641|NCT02101593||Single Group Assignment||Treatment||None (Open Label)||||||
1414642|NCT02101580||Single Group Assignment||Treatment||None (Open Label)||||||
1414643|NCT02101567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414644|NCT02101554||||Treatment||None (Open Label)||||||
1414645|NCT02101541||Single Group Assignment||Treatment||None (Open Label)||||||
1414646|NCT02101528|||Cohort||Cross-Sectional|||||||
1414647|NCT02101515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414648|NCT02101502|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1414649|NCT02101489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414650|NCT02101476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414651|NCT02101463||Single Group Assignment||Treatment||None (Open Label)||||||
1414652|NCT02101450|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414653|NCT02101437|||Case-Control||Prospective|||||||
1414654|NCT02101424|||Cohort||Prospective|||||||
1414655|NCT02101411|||Case-Control||Prospective|||||||
1414656|NCT02101398|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1414657|NCT02101385|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1414658|NCT02101372|Randomized|Parallel Assignment||Treatment||Single||||||t
1414659|NCT02101359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414660|NCT02101346|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1414661|NCT02101333||Single Group Assignment||Treatment||None (Open Label)||||||
1414662|NCT02101320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414663|NCT02101307|||Case-Control||Cross-Sectional|||||||
1414664|NCT02101294||Single Group Assignment||Prevention||None (Open Label)||||||
1414665|NCT02101281|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414666|NCT02101268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414667|NCT02101255|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414668|NCT02101242|||Cohort||Prospective|||||||
1414669|NCT02101229|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1414670|NCT02101216|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1414671|NCT02101203|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414672|NCT02101190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414673|NCT02101177|||Cohort|||||||||
1414674|NCT02101164|Randomized|Crossover Assignment||||None (Open Label)||||||
1414675|NCT02101151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414676|NCT02101138|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414677|NCT02101125||Parallel Assignment||||None (Open Label)||||||
1414678|NCT02101112|Randomized|Crossover Assignment||||None (Open Label)||||||
1414679|NCT02101099|||Case-Only||Prospective|||||||
1414680|NCT02101086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414681|NCT02101073|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414682|NCT02101060|Randomized|Parallel Assignment||Other||Single||||||t
1414683|NCT02101047|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414684|NCT02101034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414685|NCT02101021|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414686|NCT02101008||Single Group Assignment||Treatment||None (Open Label)||||||
1414687|NCT02100995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414688|NCT02100982|Randomized|Parallel Assignment||Other||Single|Participants in both arms use iPad to complete assessments, Customized Care (intervention arm) receives intervention on iPad, care as usual completes assessments only|Customized Care (intervention) vs. care as usual|t|||
1414689|NCT02100969||Single Group Assignment||Treatment||None (Open Label)||||||
1414690|NCT02100956|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1414691|NCT02100943|||Cohort||Prospective|||||||
1414692|NCT02100930||Single Group Assignment||Treatment||None (Open Label)||||||
1414693|NCT02100917|Randomized|Parallel Assignment||||Double|||t||t|
1414694|NCT02100904|||Cohort||Prospective|||||||
1414695|NCT02100891||Single Group Assignment||Treatment||None (Open Label)||||||
1414696|NCT02100878|||Case-Crossover||Cross-Sectional|||||||
1414697|NCT02100865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414698|NCT02100852||Single Group Assignment||Treatment||None (Open Label)||||||
1414699|NCT02100839|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1414700|NCT02100826|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1414701|NCT02100813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414702|NCT02100800|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1414703|NCT02100787||Single Group Assignment||Treatment||None (Open Label)||||||
1414704|NCT02100774||||||||||||
1414705|NCT02100761|||Case-Only||Prospective|||||||
1414706|NCT02100748|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414707|NCT02100735|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1414708|NCT02100722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414709|NCT02100709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414710|NCT02100696|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414711|NCT02100683|||Cohort||Prospective|||||||
1414712|NCT02100670|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414713|NCT02100657||Single Group Assignment||Other||None (Open Label)||||||
1414714|NCT02100644||Single Group Assignment||Treatment||None (Open Label)||||||
1414715|NCT02100631|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414716|NCT02100618|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414717|NCT02100605|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1414718|NCT02100592||Single Group Assignment||Treatment||None (Open Label)||||||
1414719|NCT02100579|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414720|NCT02100566|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1414721|NCT02100553|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414722|NCT02100540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414723|NCT02100527|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414724|NCT02100514|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414725|NCT02100501|||Case Control||Prospective|||||||
1414726|NCT02100488|Randomized|Crossover Assignment||Treatment||Single|||t|||
1414727|NCT02100475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414728|NCT02100462|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1414729|NCT02100449|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1414730|NCT02100436|Randomized|Parallel Assignment||Prevention||||||||
1414731|NCT02100423||Single Group Assignment||Treatment||None (Open Label)||||||
1414732|NCT02100410|Randomized|Crossover Assignment||||Single|||t|||
1414733|NCT02100397||Single Group Assignment||Basic Science||None (Open Label)||||||
1414734|NCT02100384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414735|NCT02100371||Single Group Assignment||Treatment||None (Open Label)||||||
1414736|NCT02100358|||Cohort||Prospective|||||||
1414737|NCT02100345|||Cohort||Prospective|||||||
1414738|NCT02100332|||Case-Only||Cross-Sectional|||||||
1414739|NCT02100319|||Cohort||Prospective|||||||
1414740|NCT02100306||Single Group Assignment||Basic Science||None (Open Label)||||||
1414741|NCT02100293|Randomized|Parallel Assignment||Treatment||Single||||||t
1414742|NCT02100280|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1414743|NCT02100267||||Diagnostic||||||||
1414744|NCT02100254|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414745|NCT02100241|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1414746|NCT02100228|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1414747|NCT02100215|Randomized|Parallel Assignment||||Triple|||t||t|t
1414748|NCT02100202|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1414749|NCT02100189||Single Group Assignment||Screening||None (Open Label)||||||
1414750|NCT02100176|||Cohort||Prospective|||||||
1414751|NCT02100163|Randomized|Factorial Assignment||Treatment||Single||||t||
1414752|NCT02100150|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414753|NCT02100137|||Cohort||Prospective|||||||
1414754|NCT02100124|Randomized|Parallel Assignment||Prevention||Single|||||t|
1414755|NCT02100111|||Case-Control||Retrospective|||||||
1414756|NCT02100098|||Cohort||Prospective|||||||
1414757|NCT02100085|||Cohort||Prospective|||||||
1414758|NCT02100072||Single Group Assignment||Treatment||None (Open Label)||||||
1414759|NCT02100059||Single Group Assignment||Treatment||None (Open Label)||||||
1414760|NCT02100046|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414761|NCT02100033||Single Group Assignment||Basic Science||None (Open Label)||||||
1414762|NCT02100020|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1414763|NCT02100007||Single Group Assignment||Treatment||None (Open Label)||||||
1414764|NCT02099994|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1414765|NCT02099981|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414766|NCT02099968|Randomized|Parallel Assignment||Treatment||Single||||||t
1414767|NCT02099955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414768|NCT02099942|||Case-Only||Prospective|||||||
1414769|NCT02099929|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1414770|NCT02099916|Randomized|Parallel Assignment||Treatment||Single||||||t
1414771|NCT02099903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414772|NCT02099890||Single Group Assignment||Treatment||None (Open Label)||||||
1414773|NCT02099877|||Other||Prospective|||||||
1414774|NCT02099864||Single Group Assignment||Treatment||None (Open Label)||||||
1414775|NCT02099851||Single Group Assignment||Treatment||None (Open Label)||||||
1414776|NCT02099838|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414777|NCT02099825|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414778|NCT02099812|||Cohort||Cross-Sectional|||||||
1414779|NCT02099799|Randomized|Parallel Assignment||Treatment||Single|Research assistant who assesses outcomes is blinded to randomization group.|||||t
1414780|NCT02099786|Randomized|Parallel Assignment||Prevention||Single|||t|||
1414781|NCT02099773|||Cohort||Cross-Sectional|||||||
1414782|NCT02099760|||Case-Only||Cross-Sectional|||||||
1414783|NCT02099747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414784|NCT02099734|||Other||Prospective|||||||
1414785|NCT02099721|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414786|NCT02099708|||Cohort||Prospective|||||||
1414787|NCT02099695|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414788|NCT02099682|||Cohort||Prospective|||||||
1414789|NCT02099669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414790|NCT02099656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414791|NCT02099643|||Cohort||Prospective|||||||
1414792|NCT02099630|||Cohort||Prospective|||||||
1414793|NCT02099617|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414794|NCT02099604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414795|NCT02099591|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414796|NCT02099578|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1414797|NCT02099565|||Cohort||Prospective|||||||
1414798|NCT02099552|||Cohort||Other|||||||
1414799|NCT02099539||Single Group Assignment||Treatment||None (Open Label)||||||
1414800|NCT02099526||||||||||||
1414801|NCT02099513||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1414802|NCT02099500||Single Group Assignment||Treatment||None (Open Label)||||||
1414803|NCT02099487||Single Group Assignment||Treatment||Single|||t|||
1414804|NCT02099474||Single Group Assignment||Treatment||None (Open Label)||||||
1414805|NCT02099461|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414806|NCT02099448|||Case-Only||Prospective|||||||
1414807|NCT02099435|||Cohort||Prospective|||||||
1414808|NCT02099422|||Case Control||Prospective|||||||
1414809|NCT02099409|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414810|NCT02099396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414811|NCT02099383|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414812|NCT02099370|||||Prospective|||||||
1414813|NCT02099357|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1414814|NCT02099344|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Randomized to either~Combination product- device/biologic Artegraft® or Gore® Propaten®."||||
1414815|NCT02099331|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1414816|NCT02099318|Randomized|Single Group Assignment||Other||Double|||t|||t
1414817|NCT02099305|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1414818|NCT02099292||Single Group Assignment||Treatment||None (Open Label)||||||
1414819|NCT02099279|||Cohort||Prospective|||||||
1414820|NCT02099266||Single Group Assignment||Treatment||None (Open Label)||||||
1414821|NCT02099253|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414822|NCT02099240|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414823|NCT02099227|||Cohort||Prospective|||||||
1414824|NCT02099214|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1414825|NCT02099201|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1414826|NCT02099188||Single Group Assignment||Treatment||None (Open Label)||||||
1414827|NCT02099175||Single Group Assignment||Treatment||None (Open Label)||||||
1414828|NCT02099162|||Case-Only||Prospective|||||||
1414829|NCT02099149|||Case Control||Prospective|||||||
1414830|NCT02099136|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1414831|NCT02099123|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414832|NCT02099110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414833|NCT02099097|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414834|NCT02099084|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1414835|NCT02099071|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1414836|NCT02099058|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414837|NCT02099045|||Cohort||Prospective|||||||
1414838|NCT02099032|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1414839|NCT02099019|||Case-Only||Cross-Sectional|||||||
1414840|NCT02099006|Non-Randomized|Crossover Assignment||Treatment||Double|||t||t|
1414841|NCT02098993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414842|NCT02098980|Randomized|Parallel Assignment||||Double|||t||t|
1414843|NCT02098967|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414844|NCT02098954||Single Group Assignment||Treatment||None (Open Label)||||||
1414845|NCT02098941|||Cohort||Retrospective|||||||
1414846|NCT02098928|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1414847|NCT02098915|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414848|NCT02098902|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414849|NCT02098889|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414850|NCT02098876|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414851|NCT02098863|||Cohort||Prospective|||||||
1414852|NCT02098850|||Cohort||Prospective|||||||
1414853|NCT02098837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414854|NCT02098824|Randomized|Crossover Assignment||||Triple|||t|t|t|
1414855|NCT02098811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414856|NCT02098798|||Cohort||Prospective|||||||
1414857|NCT02098785||Single Group Assignment||Basic Science||None (Open Label)||||||
1414858|NCT02098772|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1414859|NCT02098759|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1414860|NCT02098746|||Cohort||Prospective|||||||
1414861|NCT02098733|||Cohort||Prospective|||||||
1414862|NCT02098720||Single Group Assignment||Treatment||None (Open Label)||||||
1414863|NCT02098707|||Cohort||Prospective|||||||
1414864|NCT02098694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414865|NCT02098681|||Cohort||Prospective|||||||
1414866|NCT02098668|||||Prospective|||||||
1414867|NCT02098655|||Case Control||Cross-Sectional|||||||
1414868|NCT02098642|||Case Control||Cross-Sectional|||||||
1414869|NCT02098629|Randomized|Parallel Assignment||Treatment||Single|||||t|
1414870|NCT02098616|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414871|NCT02098603|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414872|NCT02098590|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414873|NCT02098577|||Cohort||Prospective|||||||
1414874|NCT02098564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414875|NCT02098551|||Case-Only||Prospective|||||||
1414876|NCT02098538||Single Group Assignment||Treatment||None (Open Label)||||||
1414877|NCT02098525|||Cohort||Retrospective|||||||
1414878|NCT02098512||Single Group Assignment||Treatment||None (Open Label)||||||
1414879|NCT02098499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414880|NCT02098486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414881|NCT02098473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414882|NCT02098460|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414883|NCT02098447||Single Group Assignment||Basic Science||None (Open Label)||||||
1414884|NCT02098434||Single Group Assignment||Other||None (Open Label)||||||
1414885|NCT02098421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414886|NCT02098408|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1414887|NCT02098395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414888|NCT02098382|||Cohort||Prospective|||||||
1414889|NCT02098369|Randomized|Parallel Assignment||Treatment||Single||||||t
1414890|NCT02098356||Single Group Assignment||Treatment||None (Open Label)||||||
1414891|NCT02098343|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1414892|NCT02098330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414893|NCT02098317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414894|NCT02098304||Single Group Assignment||||None (Open Label)||||||
1414895|NCT02098291||Single Group Assignment||Treatment||None (Open Label)||||||
1414896|NCT02098278|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1414897|NCT02098265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414898|NCT02098252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414899|NCT02098239|Non-Randomized|||Treatment||None (Open Label)||||||
1414900|NCT02098226|||||Prospective|||||||
1414901|NCT02098213|Randomized|Parallel Assignment||Other||None (Open Label)||"Taking into account the hypothesis of a proportion of patients with a DLQI≤10 (absence of repercussion or low impact of psoriasis on quality of life) of 25% at 4 months 1/2 in the arm immediate spa treatment versus 10% in the usual care group (late spa treatment), 113 patients per group is required, with an alpha 5% risk and a power of 80 %. Given the risk of potential patients lost to follow-up estimates of 15%, we plan to include 130 patients per randomisation group, so 260 patients in total.~According to the protocol submitted to authorities, given the uncertainties of necessary hypothesis, a re-evaluation of the number of subjects required after the first 100 inclusions is planned. This reassessment will be carried out without intermediate analysis but in view of the results observed for the primary endpoint in mean and standard deviation (event driven)."||||
1414902|NCT02098200||Single Group Assignment||Treatment||None (Open Label)||||||
1414903|NCT02098187|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414904|NCT02098174||Single Group Assignment||Basic Science||None (Open Label)||||||
1414905|NCT02098161||Single Group Assignment||Treatment||None (Open Label)||||||
1414906|NCT02098148|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1414907|NCT02098135||Single Group Assignment||Treatment||None (Open Label)||||||
1414908|NCT02098122|||Cohort||Prospective|||||||
1414909|NCT02098109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414910|NCT02098096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414911|NCT02098083|||||Prospective|||||||
1414912|NCT02098070|||Other||Prospective|||||||
1414913|NCT02098057|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1414914|NCT02098044|||Case-Control||Retrospective|||||||
1414915|NCT02098031|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414916|NCT02098018|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1414917|NCT02098005|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1414918|NCT02097992|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1414919|NCT02097979||||||||||||
1414920|NCT02097966||||||||||||
1414921|NCT02097953||Single Group Assignment||Treatment||None (Open Label)||||||
1414922|NCT02097940|Randomized|Crossover Assignment||Treatment||Single|||t|||
1414923|NCT02097927|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1414924|NCT02097914|Randomized|Parallel Assignment||Treatment||Single||||||t
1414925|NCT02097901|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1414926|NCT02097888|||Cohort||Cross-Sectional|||||||
1414927|NCT02097875||Single Group Assignment||Treatment||None (Open Label)||||||
1414928|NCT02097862||Single Group Assignment||Treatment||||||||
1414929|NCT02097849|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414930|NCT02097836||Single Group Assignment||Treatment||None (Open Label)|Gross Motor Function Measure Outcome was masked for temporal order and video scored by reviewers who were not involved in data collections or intervention.|||||
1414931|NCT02097823|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1414932|NCT02097810||Single Group Assignment||Treatment||None (Open Label)||||||
1414933|NCT02097797|Randomized|Parallel Assignment||Treatment||Single|||t|||
1414934|NCT02097784||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414935|NCT02097771|Randomized|||||||||||
1414936|NCT02097758||Single Group Assignment||Diagnostic||None (Open Label)||||||
1414937|NCT02097745||Single Group Assignment||Treatment||None (Open Label)||||||
1414938|NCT02097732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414939|NCT02097719|Randomized|Parallel Assignment||Treatment||Single|||||t|
1414940|NCT02097706|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414941|NCT02097693|||Cohort||Prospective|||||||
1414942|NCT02097680|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1414943|NCT02097667|||Cohort||Prospective|||||||
1414944|NCT02097654|||Case-Only||Prospective|||||||
1414945|NCT02097641|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1414946|NCT02097628|Randomized|Crossover Assignment||||Single|||t|||
1414947|NCT02097615|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1414948|NCT02097602|||||Prospective|||||||
1414949|NCT02097589|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1414950|NCT02097576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414951|NCT02097563|Randomized|Parallel Assignment||Treatment||Single||||||t
1414952|NCT02097550|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1414953|NCT02097537||Single Group Assignment||Prevention||None (Open Label)||||||
1414954|NCT02097524|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414955|NCT02097511|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414956|NCT02097498|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1414957|NCT02097485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1414958|NCT02097472|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1414959|NCT02097459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414960|NCT02097446|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1414961|NCT02097433||Single Group Assignment||||None (Open Label)||||||
1414962|NCT02097420||Single Group Assignment||Treatment||None (Open Label)||||||
1414963|NCT02097407|Randomized|Single Group Assignment||Supportive Care||Triple||||t|t|t
1414964|NCT02097394|Randomized|Parallel Assignment||Prevention||Single||||||t
1414965|NCT02097381||Single Group Assignment||Basic Science||None (Open Label)||||||
1414966|NCT02097368|||Other||Prospective|||||||
1414967|NCT02097355|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1414968|NCT02097342|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414969|NCT02097329|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1414970|NCT02097316|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1414971|NCT02097303||Single Group Assignment||Treatment||None (Open Label)||||||
1414972|NCT02097290||Single Group Assignment||Treatment||None (Open Label)||||||
1414973|NCT02097277|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414974|NCT02097264|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414975|NCT02097251||||||||||||
1414976|NCT02097238||Single Group Assignment||Treatment||None (Open Label)||||||
1414977|NCT02097225||Single Group Assignment||Treatment||None (Open Label)||||||
1414978|NCT02097212|||Cohort||Prospective|||||||
1414979|NCT02097199|||||Prospective|||||||
1414980|NCT02097186|Randomized|Parallel Assignment||Prevention||Single||||||t
1414981|NCT02097173|Randomized|Crossover Assignment||||None (Open Label)||||||
1414982|NCT02097160|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1414983|NCT02097147|Randomized|Parallel Assignment||||Triple|||t||t|t
1414984|NCT02097134||Single Group Assignment||Treatment||None (Open Label)||||||
1414985|NCT02097121|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1414986|NCT02097108||Single Group Assignment||Treatment||None (Open Label)||||||
1414987|NCT02097095|||Cohort||Other|||||||
1414988|NCT02097082||Single Group Assignment||Treatment||None (Open Label)||||||
1414989|NCT02097069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414990|NCT02097056||Single Group Assignment||Treatment||None (Open Label)||||||
1414991|NCT02097043|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1414992|NCT02097030|Randomized|Crossover Assignment||||Double|||t||t|
1414993|NCT02097017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1414994|NCT02097004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1414995|NCT02096991|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1414996|NCT02096978|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1414997|NCT02096965|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1414998|NCT02096952||Single Group Assignment||Treatment||None (Open Label)||||||
1414999|NCT02096939|||Case Control||Prospective|||||||
1415000|NCT02096926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415001|NCT02096913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415002|NCT02096900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415003|NCT02096887|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415004|NCT02096874||Single Group Assignment||Treatment||None (Open Label)||||||
1415005|NCT02096861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415006|NCT02096848|||Cohort||Prospective|||||||
1415007|NCT02096835|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1415008|NCT02096822|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415009|NCT02096809||Single Group Assignment||Treatment||None (Open Label)||||||
1415010|NCT02096796|||Cohort||Prospective|||||||
1415011|NCT02096783|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1415012|NCT02096757|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415013|NCT02096744|Randomized|Crossover Assignment||Treatment||Double||||||
1415014|NCT02096731|||Cohort||Retrospective|||||||
1415015|NCT02096718|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415016|NCT02096705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415017|NCT02096692|||Case-Only||Prospective|||||||
1415018|NCT02096679|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1415019|NCT02096666||Single Group Assignment||Treatment||None (Open Label)||||||
1415020|NCT02096653|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415021|NCT02096640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415022|NCT02096627|||Case-Control||Prospective|||||||
1415023|NCT02096614|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415024|NCT02096601||||||||||||
1415025|NCT02096588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415026|NCT02096575|Randomized|Parallel Assignment||||Double|||t||t|
1415027|NCT02096562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415028|NCT02096549|||Cohort||Prospective|||||||
1415029|NCT02096536||Single Group Assignment||Basic Science||None (Open Label)||||||
1415030|NCT02096523|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1415031|NCT02096510|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415032|NCT02096497|||Cohort||Retrospective|||||||
1415033|NCT02096484|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415034|NCT02096471||Single Group Assignment||Treatment||None (Open Label)||||||
1415035|NCT02096458||Single Group Assignment||Treatment||None (Open Label)||||||
1415036|NCT02096445|Randomized|Parallel Assignment||Treatment||Single||||||t
1415037|NCT02096432|Randomized|Parallel Assignment||Prevention||Single|||t|||
1415038|NCT02096419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415039|NCT02096406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415040|NCT02096393|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415041|NCT02096380|||Case-Only||Prospective|||||||
1415042|NCT02096367||Single Group Assignment||Treatment||None (Open Label)||||||
1415043|NCT02096354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415044|NCT02096341||Single Group Assignment||Treatment||None (Open Label)||||||
1415045|NCT02096328||Single Group Assignment||Treatment||None (Open Label)||||||
1415046|NCT02096315||Single Group Assignment||Treatment||None (Open Label)||||||
1415047|NCT02096302|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415048|NCT02096289||Single Group Assignment||Treatment||None (Open Label)||||||
1415049|NCT02096276|||Cohort||Prospective|||||||
1415050|NCT02096263|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415051|NCT02096250|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1415052|NCT02096237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415053|NCT02096224|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1415054|NCT02096211||Single Group Assignment||Treatment||None (Open Label)||||||
1415055|NCT02096198|||Cohort||Prospective|||||||
1415056|NCT02096185|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1415057|NCT02096172|||Cohort|||||||||
1415058|NCT02096159|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415059|NCT02096146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415060|NCT02096133|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1415061|NCT02096120|||Cohort||Prospective|||||||
1415062|NCT02096107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415063|NCT02096094|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415064|NCT02096081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415065|NCT02096068|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415066|NCT02096055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415067|NCT02096042|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415068|NCT02096029|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1415069|NCT02096016|||Cohort||Prospective|||||||
1415070|NCT02096003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415071|NCT02095990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415072|NCT02095977||Single Group Assignment||Screening||None (Open Label)||||||
1415073|NCT02095964|||Case-Crossover||Retrospective|||||||
1415074|NCT02095951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415075|NCT02095938||Single Group Assignment||Basic Science||None (Open Label)||||||
1415076|NCT02095925|||Cohort||Prospective|||||||
1415077|NCT02095912|||Case-Only||Retrospective|||||||
1415078|NCT02095899|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1415079|NCT02095886|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1415080|NCT02095873|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1415081|NCT02095860|Randomized|Crossover Assignment||||None (Open Label)||||||
1415082|NCT02095847||Single Group Assignment||Treatment||None (Open Label)||||||
1415083|NCT02095834||Single Group Assignment||Treatment||None (Open Label)||||||
1415084|NCT02095821|||Cohort||Prospective|||||||
1415085|NCT02095808||Single Group Assignment||Treatment||None (Open Label)||||||
1415086|NCT02095795|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1415087|NCT02095782||Single Group Assignment||Treatment||None (Open Label)||||||
1415088|NCT02095769|||Cohort|||||||||
1415089|NCT02095756||Single Group Assignment||Treatment||Double|||t||t|
1415090|NCT02095743|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415091|NCT02095730|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415092|NCT02095717|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415093|NCT02095704|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1415094|NCT02095691||Single Group Assignment||Treatment||None (Open Label)||||||
1415095|NCT02095678|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1415096|NCT02095665|Randomized|Parallel Assignment||Treatment||Single||||||t
1415097|NCT02095639|||Cohort||Prospective|||||||
1415098|NCT02095626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415099|NCT02095613|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415100|NCT02095600||Single Group Assignment||Treatment||None (Open Label)||||||
1415101|NCT02095587|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415102|NCT02095574||Single Group Assignment||Basic Science||None (Open Label)||||||
1415103|NCT02095561|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1415104|NCT02095548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415105|NCT02095535|||Case-Only||Cross-Sectional|||||||
1415106|NCT02095522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415107|NCT02095509|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415108|NCT02095496|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1415109|NCT02095470|Randomized|Parallel Assignment||Treatment||Single||||||t
1415110|NCT02095457|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415111|NCT02095444||Single Group Assignment||Treatment||None (Open Label)||||||
1415112|NCT02095431|||Cohort||Prospective|||||||
1415113|NCT02095418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415114|NCT02095405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415115|NCT02095392|Non-Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1415116|NCT02095379|||Case-Only||Retrospective|||||||
1415117|NCT02095366|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415118|NCT02095353|||Case-Crossover||Prospective|||||||
1415119|NCT02095340|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1415120|NCT02095327|||Cohort||Retrospective|||||||
1415121|NCT02095314||Single Group Assignment||Prevention||None (Open Label)||||||
1415122|NCT02095301|Randomized|Crossover Assignment||||Double|||t||t|
1415123|NCT02095288|||Other||Other|||||||
1415124|NCT02095275|||Cohort||Prospective|||||||
1415125|NCT02095262|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415126|NCT02095249||Single Group Assignment||Other||None (Open Label)||||||
1415127|NCT02095236||Single Group Assignment||Other||None (Open Label)||||||
1415128|NCT02095223|Randomized|Parallel Assignment||Treatment||Single||||||t
1415129|NCT02095210||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415130|NCT02095197|Randomized|Parallel Assignment||Treatment||Single||||||t
1415131|NCT02095184|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415132|NCT02095171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415133|NCT02095158||Single Group Assignment||Treatment||None (Open Label)||||||
1415134|NCT02095145|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1415135|NCT02095132||Single Group Assignment||Treatment||None (Open Label)||||||
1415136|NCT02095119||Single Group Assignment||Treatment||None (Open Label)||||||
1415137|NCT02095106|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415138|NCT02095093|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1415139|NCT02095080||Single Group Assignment||Basic Science||None (Open Label)||||||
1415140|NCT02095067|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415141|NCT02095054||Single Group Assignment||Treatment||None (Open Label)||||||
1415142|NCT02095041|||||Prospective|||||||
1415143|NCT02095028|Randomized|Parallel Assignment||Prevention||Single|||t|||
1415144|NCT02095015|||Other||Prospective|||||||
1415145|NCT02095002|||Case-Crossover||Prospective|||||||
1415146|NCT02094989|||||Prospective|||||||
1415147|NCT02094976|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415148|NCT02094963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415149|NCT02094950||Single Group Assignment||Supportive Care||||||||
1415150|NCT02094937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415151|NCT02094924|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415152|NCT02094911|Randomized|Parallel Assignment||Prevention||Single||||||t
1415153|NCT02094898||Single Group Assignment||Treatment||None (Open Label)||||||
1415154|NCT02094885|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415155|NCT02094872||Single Group Assignment||Treatment||None (Open Label)||||||
1415156|NCT02094859|||||Prospective|||||||
1415157|NCT02094846|Randomized|Parallel Assignment||Treatment||Single||||||t
1415158|NCT02094833|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415159|NCT02094820|||Cohort||Cross-Sectional|||||||
1415160|NCT02094807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415161|NCT02094794||Single Group Assignment||Treatment||None (Open Label)||||||
1415162|NCT02094781|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1415163|NCT02094768|Randomized|Crossover Assignment||Prevention||Single|||||t|
1415164|NCT02094755|||Cohort||Prospective|||||||
1415165|NCT02094742||Single Group Assignment||Screening||None (Open Label)||||||
1415166|NCT02094729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415167|NCT02094716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415168|NCT02094703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415169|NCT02094690|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1415170|NCT02094677|Randomized|Parallel Assignment||||Double|||t||t|
1415171|NCT02094664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415172|NCT02094651|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1415173|NCT02094638|||Cohort|||||||||
1415174|NCT02094625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415175|NCT02094612|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1415176|NCT02094599||Single Group Assignment||||Triple|||t||t|t
1415177|NCT02094586|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415178|NCT02094573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415179|NCT02094560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415180|NCT02094547|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1415181|NCT02094534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415182|NCT02094521|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415183|NCT02094508|||Case-Control||Prospective|||||||
1415184|NCT02094495|||Case-Only||Cross-Sectional|||||||
1415185|NCT02094482|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415186|NCT02094469||Single Group Assignment||Treatment||None (Open Label)||||||
1415187|NCT02094456||Single Group Assignment||Prevention||None (Open Label)||||||
1415188|NCT02094443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415189|NCT02094430||Single Group Assignment||Treatment||None (Open Label)||||||
1415190|NCT02094417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415191|NCT02094404|||||Prospective|||||||
1415192|NCT02094391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415193|NCT02094378|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1415194|NCT02094365|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415195|NCT02094352|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415196|NCT02094339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415197|NCT02094326|||Case-Only||Cross-Sectional|||||||
1415198|NCT02094313|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415199|NCT02094300||Single Group Assignment||Treatment||None (Open Label)||||||
1415200|NCT02094287|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415201|NCT02094274|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1415202|NCT02094261||Single Group Assignment||Treatment||None (Open Label)||||||
1415203|NCT02094248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415204|NCT02094235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415205|NCT02094222||||||||||||
1415206|NCT02094209|||Case-Only||Prospective|||||||
1415207|NCT02094196|||Cohort||Prospective|||||||
1415208|NCT02094183|Randomized|Parallel Assignment||Basic Science||Single||||||t
1415209|NCT02094170|||Case-Control||Cross-Sectional|||||||
1415210|NCT02094157|Randomized|Parallel Assignment||Treatment||Single||||||t
1415211|NCT02094144|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415212|NCT02094131|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1415213|NCT02094118|Randomized|Parallel Assignment||Prevention||Single||||||t
1415214|NCT02094105|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415215|NCT02094092|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415216|NCT02094079|||Cohort||Retrospective|||||||
1415217|NCT02094066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415218|NCT02094053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415219|NCT02094040|Randomized|Parallel Assignment||Prevention||Single|||||t|
1415220|NCT02094027|Randomized|Parallel Assignment||Treatment||Single||||||t
1415221|NCT02094014|||Case Control||Cross-Sectional|||||||
1415222|NCT02094001||Single Group Assignment||Other||None (Open Label)||||||
1415223|NCT02093988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415224|NCT02093975|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415225|NCT02093962|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415226|NCT02093949|||Cohort||Prospective|||||||
1415227|NCT02093936|||||Cross-Sectional|||||||
1415228|NCT02093923|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415229|NCT02093910|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1415230|NCT02093897||Single Group Assignment||Treatment||None (Open Label)||||||
1415231|NCT02093884|Randomized|Parallel Assignment||Prevention||Single|||t|||
1415232|NCT02093871||Single Group Assignment||Treatment||None (Open Label)||||||
1415233|NCT02093858|||Case-Only||Prospective|||||||
1415234|NCT02093845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415235|NCT02093832|||Case-Only||Retrospective|||||||
1415236|NCT02093819|Randomized|Parallel Assignment||Treatment||Single||||||
1415237|NCT02093806|||Case-Only||Retrospective|||||||
1415238|NCT02093793|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415239|NCT02093780|Randomized|Parallel Assignment||Prevention||Single|||t|||
1415240|NCT02093767|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1415241|NCT02093754||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415242|NCT02093741|||Case-Only||Prospective|||||||
1415243|NCT02093728|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415244|NCT02093715|||Cohort||Prospective|||||||
1415245|NCT02093702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415246|NCT02093689|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415247|NCT02093676||Single Group Assignment||Treatment||None (Open Label)||||||
1415248|NCT02093663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415249|NCT02093650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415250|NCT02093637|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415251|NCT02093611|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1415252|NCT02093598||Single Group Assignment||||None (Open Label)||||||
1415253|NCT02093585|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1415254|NCT02093572|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415255|NCT02093559|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415256|NCT02093546||||||||||||
1415257|NCT02093533||Single Group Assignment||Treatment||None (Open Label)||||||
1415258|NCT02093520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415259|NCT02093507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415260|NCT02093494|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1415261|NCT02093481|Randomized|Crossover Assignment||Prevention||Single|||t|||
1415262|NCT02093468|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415263|NCT02093455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415264|NCT02093442|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1415265|NCT02093429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415266|NCT02093416|||Cohort||Prospective|||||||
1415267|NCT02093403||Single Group Assignment||Treatment||None (Open Label)||||||
1415268|NCT02093390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415269|NCT02093377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415270|NCT02093364|||Case-Only||Prospective|||||||
1415271|NCT02093351|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415272|NCT02093338|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1415273|NCT02093325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415274|NCT02093312|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1415275|NCT02093299|||Cohort||Prospective|||||||
1415276|NCT02093286|||Case-Control||Prospective|||||||
1415277|NCT02093273|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1415278|NCT02093260||Single Group Assignment||Prevention||Single||||||t
1415279|NCT02093247|||Cohort||Prospective|||||||
1415280|NCT02093234|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415281|NCT02093221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415282|NCT02093195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415283|NCT02093182|||Case-Only||Retrospective|||||||
1415284|NCT02093169|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415285|NCT02093156|||||Prospective|||||||
1415286|NCT02093143|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1415287|NCT02093130|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415288|NCT02093117|Randomized|Crossover Assignment||Treatment||Single||||||t
1415289|NCT02093104|||Case-Only||Prospective|||||||
1415290|NCT02093091|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415291|NCT02093078|||Cohort||Prospective|||||||
1415292|NCT02093065|||Cohort||Prospective|||||||
1415293|NCT02093052|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415294|NCT02093039|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415295|NCT02093026||Single Group Assignment||Treatment||None (Open Label)||||||
1415296|NCT02093013|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415297|NCT02093000|||Case-Only||Prospective|||||||
1415298|NCT02092987|Randomized|Parallel Assignment||||Double|||||t|t
1415299|NCT02092974|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1415300|NCT02092961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415301|NCT02092948||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415302|NCT02092935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415303|NCT02092922||Single Group Assignment||Treatment||None (Open Label)||||||
1415304|NCT02092909||Single Group Assignment||Treatment||None (Open Label)||||||
1415305|NCT02092896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415306|NCT02092883||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415307|NCT02092870||Single Group Assignment||Treatment||None (Open Label)||||||
1415308|NCT02092857|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1415309|NCT02092844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415310|NCT02092831|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415311|NCT02092818|||Cohort||Prospective|||||||
1415312|NCT02092805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415313|NCT02092792||Parallel Assignment||Treatment||None (Open Label)||||||
1415314|NCT02092779|||Case-Crossover||Cross-Sectional|||||||
1415315|NCT02092766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415316|NCT02092753|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1415317|NCT02092740|||Cohort||Retrospective|||||||
1415318|NCT02092727|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415319|NCT02092714|||Cohort||Cross-Sectional|||||||
1415320|NCT02092701|Randomized|||Supportive Care||Triple|||t|t||t
1415321|NCT02092688|||Case-Control||Prospective|||||||
1415322|NCT02092675|||Case Control||Prospective|||||||
1415323|NCT02092662|||Cohort||Prospective|||||||
1415324|NCT02092649|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1415325|NCT02092636|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1415326|NCT02092623||Single Group Assignment||Treatment||None (Open Label)||||||
1415327|NCT02092610|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415328|NCT02092597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415329|NCT02092584|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1415330|NCT02092571|Randomized|Crossover Assignment||||None (Open Label)||||||
1415331|NCT02092558|||Case Control||Retrospective|||||||
1415332|NCT02092545||Single Group Assignment||Treatment||None (Open Label)||||||
1415333|NCT02092532||Single Group Assignment||Treatment||None (Open Label)||||||
1415334|NCT02092519|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1415335|NCT02092506|Randomized|Parallel Assignment||Treatment||Single||||||t
1415336|NCT02092493|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415337|NCT02092480|Randomized|Parallel Assignment||Other||Single||||||t
1415338|NCT02092467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415339|NCT02092454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415340|NCT02092441|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1415341|NCT02092428|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1415342|NCT02092415||Single Group Assignment||Treatment||None (Open Label)||||||
1415343|NCT02092402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415344|NCT02092389|||Cohort||Prospective|||||||
1415345|NCT02092376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415346|NCT02092363||Single Group Assignment||Treatment||None (Open Label)||||||
1415347|NCT02092350|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415348|NCT02092337||Single Group Assignment||Treatment||None (Open Label)||||||
1415349|NCT02092324||Single Group Assignment||Treatment||None (Open Label)||||||
1415350|NCT02092311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415351|NCT02092298||Single Group Assignment||Treatment||None (Open Label)||||||
1415352|NCT02092285||Single Group Assignment||Treatment||None (Open Label)||||||
1415353|NCT02092272|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1415354|NCT02092259|||Case-Only||Prospective|||||||
1415355|NCT02092246|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415356|NCT02092233|||Case-Only||Prospective|||||||
1415357|NCT02092220|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415358|NCT02092207|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415359|NCT02092194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415360|NCT02092181|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415361|NCT02092168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415362|NCT02092155|||Cohort||Prospective|||||||
1415363|NCT02092142||Single Group Assignment||Prevention||None (Open Label)||||||
1415364|NCT02092129|||Cohort||Retrospective|||||||
1415365|NCT02092116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415366|NCT02092103|Randomized|Parallel Assignment||Prevention||Single|||t|||
1415367|NCT02092090|Randomized|Parallel Assignment||Prevention||Single||||||t
1415368|NCT02092077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415369|NCT02092064|||Case Control||Cross-Sectional|||||||
1415370|NCT02092051|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415371|NCT02092038||Single Group Assignment||Treatment||None (Open Label)||||||
1415372|NCT02092025|||Cohort||Prospective|||||||
1415373|NCT02092012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415374|NCT02091999|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415375|NCT02091986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415376|NCT02091973|Randomized|Parallel Assignment||Treatment||Single||||||t
1415377|NCT02091960||Single Group Assignment||Treatment||None (Open Label)||||||
1415378|NCT02091947|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415379|NCT02091934|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415380|NCT02091921|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1415381|NCT02091908|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1415382|NCT02091895||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415383|NCT02091882||Single Group Assignment||Treatment||None (Open Label)||||||
1415384|NCT02091869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415385|NCT02091856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415386|NCT02091843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415387|NCT02091830|||Cohort||Retrospective|||||||
1415388|NCT02091817|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1415389|NCT02091804|Randomized|Parallel Assignment||Other||Single||||||t
1415390|NCT02091791|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1415391|NCT02091778||Single Group Assignment||Treatment||None (Open Label)||||||
1415392|NCT02091765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415393|NCT02091752||Single Group Assignment||Treatment||None (Open Label)||||||
1415394|NCT02091739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415395|NCT02091726||Single Group Assignment||Prevention||None (Open Label)||||||
1415396|NCT02091713|||Cohort||Prospective|||||||
1415397|NCT02091700|||Cohort||Prospective|||||||
1415398|NCT02091687|||Cohort|||||||||
1415399|NCT02091674||Single Group Assignment||Treatment||None (Open Label)||||||
1415400|NCT02091661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415401|NCT02091648|Randomized|Parallel Assignment||Treatment||Single||||||t
1415402|NCT02091635|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415403|NCT02091622|Randomized|Parallel Assignment||||None (Open Label)||||||
1415404|NCT02091609|Randomized|Parallel Assignment||Prevention||Single|||||t|
1415405|NCT02091596|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415406|NCT02091583|Randomized|Crossover Assignment||Treatment||Single|||t|||
1415407|NCT02091570|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1415408|NCT02091557|||Cohort||Prospective|||||||
1415409|NCT02091544|||Cohort||Prospective|||||||
1415410|NCT02091531||Single Group Assignment||Treatment||None (Open Label)||||||
1415411|NCT02091518||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415412|NCT02091505||Single Group Assignment||Treatment||None (Open Label)||||||
1415413|NCT02091492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415414|NCT02091479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415415|NCT02091466|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415416|NCT02091453|Randomized|Parallel Assignment||Treatment||Single||||||t
1415417|NCT02091440||Single Group Assignment||Treatment||None (Open Label)||||||
1415418|NCT02091427||||||||||||
1415419|NCT02091414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415420|NCT02091401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415421|NCT02091388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415422|NCT02091375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415423|NCT02091362|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1415424|NCT02091349|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1415425|NCT02091336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415426|NCT02091323|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1415427|NCT02091310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415428|NCT02091297|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1415429|NCT02091284|Randomized|Parallel Assignment||Treatment||Triple||Sham-controlled double-blind randomized trial|t|t||t
1415430|NCT02091271|||||Other|||||||
1415431|NCT02091258|||Case-Only||Prospective|||||||
1415432|NCT02091245||Single Group Assignment||Treatment||None (Open Label)||||||
1415433|NCT02091232|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415434|NCT02091219|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415435|NCT02091206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415436|NCT02091193|||Cohort||Prospective|||||||
1415437|NCT02091180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415438|NCT02091167|Randomized|Parallel Assignment||Treatment||Triple||Sham-controlled double-blind randomized clinical trial|t|t||t
1415439|NCT02091154|Randomized|Factorial Assignment||||Double|||t||t|
1415440|NCT02091141|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415441|NCT02091128|||Cohort||Cross-Sectional|||||||
1415442|NCT02091115|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1415443|NCT02091102||Single Group Assignment||Treatment||None (Open Label)||||||
1415444|NCT02091089||Single Group Assignment||Treatment||None (Open Label)||||||
1415445|NCT02091076|Randomized|Factorial Assignment||Treatment||Single|||t|||
1415446|NCT02091063|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1415447|NCT02091050||Single Group Assignment||Treatment||None (Open Label)||||||
1415448|NCT02091037|||Case-Only||Cross-Sectional|||||||
1415449|NCT02091024|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1415450|NCT02091011|||Cohort||Prospective|||||||
1415451|NCT02090998|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415452|NCT02090985||Single Group Assignment||Treatment||None (Open Label)||||||
1415453|NCT02090972|||Case Control||Prospective|||||||
1415454|NCT02090959||Single Group Assignment||Treatment||None (Open Label)||||||
1415455|NCT02090946|||Cohort||Cross-Sectional|||||||
1415456|NCT02090933||Single Group Assignment||Prevention||None (Open Label)||||||
1415457|NCT02090920|||Case-Only||Prospective|||||||
1415458|NCT02090907|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1415459|NCT02090894||Single Group Assignment||Basic Science||None (Open Label)||||||
1415460|NCT02090881||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415461|NCT02090868|||Cohort||Prospective|||||||
1415462|NCT02090855|||Cohort||Retrospective|||||||
1415463|NCT02090842|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1415464|NCT02090829|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415465|NCT02090816|||Cohort||Retrospective|||||||
1415466|NCT02090803|||Cohort||Prospective|||||||
1415467|NCT02090790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415468|NCT02090777||Single Group Assignment||Health Services Research||None (Open Label)||||||
1415469|NCT02090764|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415470|NCT02090751|||Case Control||Cross-Sectional|||||||
1415471|NCT02090738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415472|NCT02090725||Single Group Assignment||Treatment||None (Open Label)||||||
1415473|NCT02090712|||Cohort||Prospective|||||||
1415474|NCT02090699|||Case Control||Prospective|||||||
1415475|NCT02090686|Randomized|||Treatment||Single|||t|||
1415476|NCT02090673|||Case-Only||Prospective|||||||
1415477|NCT02090660||Single Group Assignment||Treatment||None (Open Label)||||||
1415478|NCT02090647|Randomized|Factorial Assignment||Treatment||Single|||||t|
1415479|NCT02090634|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415480|NCT02090621||Single Group Assignment||Treatment||None (Open Label)||||||
1415481|NCT02090608|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415482|NCT02090595|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415483|NCT02090582|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415484|NCT02090569||Single Group Assignment||Treatment||None (Open Label)||||||
1415485|NCT02090556|||Cohort||Prospective|||||||
1415486|NCT02090543|||Cohort||Prospective|||||||
1415487|NCT02090530|||Cohort||Prospective|||||||
1415488|NCT02090517|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1415489|NCT02090504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415490|NCT02090491|||Ecologic or Community||Prospective|||||||
1415491|NCT02090478|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415492|NCT02090465|||Cohort||Prospective|||||||
1415493|NCT02090452|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415494|NCT02090439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415495|NCT02090426|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415496|NCT02090413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415497|NCT02090400|Randomized|Parallel Assignment||||None (Open Label)||||||
1415498|NCT02090387|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1415499|NCT02090374|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1415500|NCT02090361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415501|NCT02090348||Single Group Assignment||Treatment||None (Open Label)||||||
1415502|NCT02090335|Randomized|Parallel Assignment||Prevention||Single||||||t
1415503|NCT02090322||Single Group Assignment||Treatment||Double|||t||t|
1415504|NCT02090309|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415505|NCT02090296|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415506|NCT02090283||Single Group Assignment||Treatment||None (Open Label)||||||
1415507|NCT02090270|||Cohort||Prospective|||||||
1415508|NCT02090257|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1415509|NCT02090244|Randomized|Parallel Assignment||Treatment||Single||||||t
1415510|NCT02090231|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415511|NCT02090218|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415512|NCT02090205|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415513|NCT02090192|Randomized|Parallel Assignment||Treatment||Single||||||t
1415514|NCT02090179|||Case-Only||Prospective|||||||
1415515|NCT02090166||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415516|NCT02090153||Single Group Assignment||Treatment||None (Open Label)||||||
1415517|NCT02090140|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415518|NCT02090127||||||||||||
1415519|NCT02090114||Single Group Assignment||Treatment||None (Open Label)||||||
1415520|NCT02090101||Single Group Assignment||Treatment||None (Open Label)||||||
1415521|NCT02090088|||Case Control||Prospective|||||||
1415522|NCT02090075|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1415523|NCT02090062|||Case-Only||Prospective|||||||
1415524|NCT02090049|Randomized|Crossover Assignment||Prevention||Single|||||t|
1415525|NCT02090036|Randomized|Parallel Assignment||Prevention||Single|||t|||
1415526|NCT02090023|||Cohort||Retrospective|||||||
1415527|NCT02090010|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1415528|NCT02089997|||Cohort||Prospective|||||||
1415529|NCT02089984||Single Group Assignment||||None (Open Label)||||||
1415530|NCT02089971|||Ecologic or Community||Prospective|||||||
1415531|NCT02089958|||Cohort||Prospective|||||||
1415532|NCT02089945|||Cohort||Prospective|||||||
1415533|NCT02089932|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1415534|NCT02089919|Randomized|Parallel Assignment||Treatment||Single|||||t|
1415535|NCT02089906|||||Prospective|||||||
1415536|NCT02089893|||Cohort||Cross-Sectional|||||||
1415537|NCT02089880|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1415538|NCT02089867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415539|NCT02089854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415540|NCT02089841||Single Group Assignment||Treatment||None (Open Label)||||||
1415541|NCT02089828|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415542|NCT02089815|Randomized|Parallel Assignment||Treatment||Single||||||t
1415543|NCT02089802||Single Group Assignment||Treatment||None (Open Label)||||||
1415544|NCT02089789|||Cohort||Prospective|||||||
1415545|NCT02089776|||||Prospective|||||||
1415546|NCT02089763||Single Group Assignment||Treatment||None (Open Label)||||||
1415547|NCT02089750|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1415548|NCT02089737|||Cohort||Prospective|||||||
1415549|NCT02089724|||Cohort||Prospective|||||||
1415550|NCT02089711|||Cohort||Prospective|||||||
1415551|NCT02089698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415552|NCT02089685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415553|NCT02089672|||Case-Only||Retrospective|||||||
1415554|NCT02089659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415555|NCT02089646||||||||||||
1415556|NCT02089633||Single Group Assignment||Treatment||None (Open Label)||||||
1415557|NCT02089620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415558|NCT02089607||Single Group Assignment||Treatment||None (Open Label)||||||
1415559|NCT02089594|Randomized|Crossover Assignment||Treatment||Single|Neuropsychological testers and neuropsychologist blinded to treatment group.|Randomized prospective controlled|||t|
1415560|NCT02089581|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415561|NCT02089568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415562|NCT02089555|||Case Control||Prospective|||||||
1415563|NCT02089542||Single Group Assignment||Treatment||None (Open Label)||||||
1415564|NCT02089529|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1415565|NCT02089516|||Case-Only||Cross-Sectional|||||||
1415566|NCT02089503|||Cohort||Retrospective|||||||
1415567|NCT02089490||Single Group Assignment||Treatment||None (Open Label)||||||
1415568|NCT02089477|Randomized|Parallel Assignment||Treatment||Single|||||t|
1415569|NCT02089464|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1415570|NCT02089451|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415571|NCT02089438|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415572|NCT02089425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415573|NCT02089412|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415574|NCT02089399|Randomized|Crossover Assignment||||None (Open Label)||||||
1415575|NCT02089386||Single Group Assignment||Prevention||None (Open Label)||||||
1415576|NCT02089373|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1415577|NCT02089360|||Cohort||Prospective|||||||
1415578|NCT02089347|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415579|NCT02089334||Single Group Assignment||Treatment||None (Open Label)||||||
1415580|NCT02089321|||Case Control||Cross-Sectional|||||||
1415581|NCT02089308|Randomized|Crossover Assignment||||None (Open Label)||||||
1415582|NCT02089295|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1415583|NCT02089282|||Case-Only||Prospective|||||||
1415584|NCT02089269|||Cohort||Prospective|||||||
1415585|NCT02089256||Single Group Assignment||Treatment||None (Open Label)||||||
1415586|NCT02089243|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415587|NCT02089230||Single Group Assignment||Treatment||None (Open Label)||||||
1415588|NCT02089217|Randomized|Parallel Assignment||Prevention||Single|CREST-2 is two parallel multi-center randomized, observer-blinded endpoint clinical trials.|CREST-2 is two parallel multi-center randomized, observer-blinded endpoint clinical trials.|||t|
1415589|NCT02089204|||Case Control||Prospective|||||||
1415590|NCT02089191|Randomized|Crossover Assignment||||Double|||t||t|
1415591|NCT02089178|Randomized|Parallel Assignment||||Double|||t||t|
1415592|NCT02089165|Randomized|Crossover Assignment||Treatment||Single||||||t
1415593|NCT02089152|Randomized|Single Group Assignment||Prevention||Single|||t|||
1415594|NCT02089139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415595|NCT02089126|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415596|NCT02089113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415597|NCT02089100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415598|NCT02089087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415599|NCT02089074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415600|NCT02089061|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1415601|NCT02089048||Single Group Assignment||Treatment||None (Open Label)||||||
1415602|NCT02089035|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1415603|NCT02089022||Single Group Assignment||Prevention||None (Open Label)||||||
1415604|NCT02089009|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1415605|NCT02088996|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415606|NCT02088983|Randomized|Crossover Assignment||||Double|||t||t|
1415607|NCT02088970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415608|NCT02088957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415609|NCT02088944|||Case Control||Prospective|||||||
1415610|NCT02088931||Single Group Assignment||Treatment||None (Open Label)||||||
1415611|NCT02088918|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415612|NCT02088905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415613|NCT02088892|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1415614|NCT02088879|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1415615|NCT02088866||Single Group Assignment||Treatment||None (Open Label)||||||
1415616|NCT02088853|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1415617|NCT02088840|||Case-Only||Prospective|||||||
1415618|NCT02088827|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415619|NCT02088814|Randomized|Parallel Assignment||Prevention||Single||||||t
1415620|NCT02088801|Randomized|Parallel Assignment||||Single|||t|||
1415621|NCT02088788|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415622|NCT02088775||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415623|NCT02088762|||Cohort||Retrospective|||||||
1415624|NCT02088749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415625|NCT02088736|Randomized|Crossover Assignment||Treatment||Single|||t|||
1415626|NCT02088723||Single Group Assignment||Treatment||None (Open Label)||||||
1415627|NCT02088710|||Cohort||Prospective|||||||
1415628|NCT02088697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415629|NCT02088684|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415630|NCT02088671||Single Group Assignment||||None (Open Label)||||||
1415631|NCT02088658|Randomized|Parallel Assignment||Treatment||Single|||||t|
1415632|NCT02088645||Single Group Assignment||Treatment||None (Open Label)||||||
1415633|NCT02088632|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415634|NCT02088619|Randomized|Parallel Assignment||Treatment||Single||||||t
1415635|NCT02088606||Single Group Assignment||Treatment||None (Open Label)||||||
1415636|NCT02088593|Randomized|Parallel Assignment||Prevention||Single|||t|||
1415637|NCT02088580||Single Group Assignment||Treatment||None (Open Label)||||||
1415638|NCT02088567|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415639|NCT02088554||Single Group Assignment||Treatment||None (Open Label)||||||
1415640|NCT02088541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415641|NCT02088528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415642|NCT02088515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415643|NCT02088502|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415644|NCT02088489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415645|NCT02088476|||Cohort||Retrospective|||||||
1415646|NCT02088463|Randomized|Factorial Assignment||Treatment||Single|||t|||
1415647|NCT02088450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415648|NCT02088437|Randomized|Parallel Assignment||Treatment||Double||||t||t
1415649|NCT02088424|||Case Control||Cross-Sectional|||||||
1415650|NCT02088411|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415651|NCT02088398|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1415652|NCT02088385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415653|NCT02088372|||Case-Only||Prospective|||||||
1415654|NCT02088359|||Cohort||Prospective|||||||
1415655|NCT02088346|||Cohort||Prospective|||||||
1415656|NCT02088333|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1415657|NCT02088320|||Cohort||Prospective|||||||
1415658|NCT02088307|Randomized|Parallel Assignment||||None (Open Label)||||||
1415659|NCT02088294|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415660|NCT02088281||Single Group Assignment||Treatment||None (Open Label)||||||
1415661|NCT02088268||Single Group Assignment||Treatment||None (Open Label)||||||
1415662|NCT02088255|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1415663|NCT02088242|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1415664|NCT02088229|||Case-Only||Prospective|||||||
1415665|NCT02088216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415666|NCT02088203|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1415667|NCT02088190|||Cohort||Prospective|||||||
1415668|NCT02088177||Single Group Assignment||Treatment||None (Open Label)||||||
1415669|NCT02088164|||Cohort||Retrospective|||||||
1415670|NCT02088151||Single Group Assignment||Treatment||None (Open Label)||||||
1415671|NCT02088138|Randomized|Single Group Assignment||Treatment||Single||||||t
1415672|NCT02088125|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1415673|NCT02088112|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415674|NCT02088099|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1415675|NCT02088086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415676|NCT02088073|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1415677|NCT02088060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415678|NCT02088047|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415679|NCT02088034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415680|NCT02088021||Single Group Assignment||Treatment||None (Open Label)||||||
1415681|NCT02088008|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415682|NCT02087995||Single Group Assignment||Other||None (Open Label)||||||
1415683|NCT02087982|||Cohort||Prospective|||||||
1415684|NCT02087969|Randomized|Parallel Assignment||Treatment||Single|||||t|
1415685|NCT02087956|Randomized|Parallel Assignment||Treatment||Single||||||t
1415686|NCT02087943|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1415687|NCT02087930||||||||||||
1415688|NCT02087917|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415689|NCT02087904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415690|NCT02087891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415691|NCT02087878|||Other||Other|||||||
1415692|NCT02087865|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1415693|NCT02087852|||Case-Control||Prospective|||||||
1415694|NCT02087826|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415695|NCT02087813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415696|NCT02087800|||Case-Crossover||Prospective|||||||
1415697|NCT02087787|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1415698|NCT02087774|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415699|NCT02087761|||Case-Only||Prospective|||||||
1415700|NCT02087748|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415701|NCT02087735|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1415702|NCT02087722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415703|NCT02087709||Single Group Assignment||Treatment||None (Open Label)||||||
1415704|NCT02087696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415705|NCT02087683|Non-Randomized|Parallel Assignment||Treatment||Double|||t|t||
1415706|NCT02087670|Randomized|Parallel Assignment||Treatment||Single||||||t
1415707|NCT02087657||Single Group Assignment||Treatment||None (Open Label)||||||
1415708|NCT02087644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415709|NCT02087631||Sequential Assignment||Treatment||None (Open Label)||||||
1415710|NCT02087618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415711|NCT02087605|||Cohort||Prospective|||||||
1415712|NCT02087592|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415713|NCT02087579|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415714|NCT02087566|Randomized|Parallel Assignment||||None (Open Label)||||||
1415715|NCT02087553|||Cohort||Prospective|||||||
1415716|NCT02087540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415717|NCT02087527|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415718|NCT02087514|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1415719|NCT02087501||Single Group Assignment||Treatment||None (Open Label)||||||
1415720|NCT02087488|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415721|NCT02087475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415722|NCT02087462|Randomized|Parallel Assignment||Treatment||Single||||||t
1415723|NCT02087449|||Case-Only||Prospective|||||||
1415724|NCT02087436|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415725|NCT02087423||Single Group Assignment||Treatment||None (Open Label)||||||
1415726|NCT02087410|||Case Control||Cross-Sectional|||||||
1415727|NCT02087397||Single Group Assignment||Treatment||None (Open Label)||||||
1415728|NCT02087384|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415729|NCT02087371|||Cohort||Prospective|||||||
1415730|NCT02087358|||Cohort||Prospective|||||||
1415731|NCT02087345|||Cohort||Prospective|||||||
1415732|NCT02087332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415733|NCT02087319||Single Group Assignment||Treatment||None (Open Label)||||||
1415734|NCT02087306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415735|NCT02087293|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415736|NCT02087280|||Cohort||Prospective|||||||
1415737|NCT02087267|||Cohort||Prospective|||||||
1415738|NCT02087241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415739|NCT02087228|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415740|NCT02087215|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415741|NCT02087202|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1415742|NCT02087189|||Case-Only||Prospective|||||||
1415743|NCT02087176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415744|NCT02087163||Single Group Assignment||Treatment||None (Open Label)||||||
1415745|NCT02087150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415746|NCT02087137|Randomized|Parallel Assignment||Treatment||Single||||||t
1415747|NCT02087124|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1415748|NCT02087111||Single Group Assignment||Treatment||None (Open Label)||||||
1415749|NCT02087098|||Cohort||Prospective|||||||
1415750|NCT02087085|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1415751|NCT02087072|||Cohort||Prospective|||||||
1415752|NCT02087059||Single Group Assignment||Treatment||None (Open Label)||||||
1415753|NCT02087046||Single Group Assignment||Treatment||Single||||||t
1415754|NCT02087033|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1415755|NCT02087020|||Cohort||Retrospective|||||||
1415756|NCT02087007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415757|NCT02086994|Randomized|Single Group Assignment||Prevention||Single|||t|||
1415758|NCT02086981|||Cohort||Prospective|||||||
1415759|NCT02086968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415760|NCT02086955|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415761|NCT02086942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415762|NCT02086929|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1415763|NCT02086916|||Cohort||Prospective|||||||
1415764|NCT02086903|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1415765|NCT02086890|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1415766|NCT02086877|||Cohort||Prospective|||||||
1415767|NCT02086864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415768|NCT02086851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415769|NCT02086838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415770|NCT02086825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415771|NCT02086812||||||||||||
1415772|NCT02086799|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415773|NCT02086786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415774|NCT02086773|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415775|NCT02086760||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415776|NCT02086747|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1415777|NCT02086734|||Cohort||Prospective|||||||
1415778|NCT02086721||Single Group Assignment||Treatment||None (Open Label)||||||
1415779|NCT02086708||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415780|NCT02086695|||Cohort||Prospective|||||||
1415781|NCT02086682|||Cohort||Prospective|||||||
1415782|NCT02086669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415783|NCT02086656||Single Group Assignment||Treatment||None (Open Label)||||||
1415784|NCT02086643||Single Group Assignment||Supportive Care||None (Open Label)||||||
1415785|NCT02086630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415786|NCT02086617||||Screening||||||||
1415787|NCT02086604|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415788|NCT02086591||Single Group Assignment||Treatment||None (Open Label)||||||
1415789|NCT02086578|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415790|NCT02086565|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1415791|NCT02086552||Single Group Assignment||Treatment||None (Open Label)||||||
1415792|NCT02086539|Randomized|Parallel Assignment||Other||Single|||||t|
1415793|NCT02086526|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415794|NCT02086513||Single Group Assignment||Treatment||None (Open Label)||||||
1415795|NCT02086500|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415796|NCT02086487||Single Group Assignment||Treatment||None (Open Label)||||||
1415797|NCT02086474|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1415798|NCT02086461|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415799|NCT02086448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415800|NCT02086435|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415801|NCT02086422||||Treatment||||||||
1415802|NCT02086409|Randomized|Parallel Assignment||Prevention||Single|||||t|
1415803|NCT02086396|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1415804|NCT02086383|||Cohort||Prospective|||||||
1415805|NCT02086370|Randomized|Parallel Assignment||Prevention||Single||||||t
1415806|NCT02086357|||Cohort||Prospective|||||||
1415807|NCT02086344|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415808|NCT02086331|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1415809|NCT02086318|||Cohort||Prospective|||||||
1415810|NCT02086305|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1415811|NCT02086292|Randomized|Crossover Assignment||Treatment||Single|||t|||
1415812|NCT02086279||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415813|NCT02086266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415814|NCT02086253|Randomized|Crossover Assignment||||None (Open Label)||||||
1415815|NCT02086240||Single Group Assignment||Basic Science||None (Open Label)||||||
1415816|NCT02086227|Randomized|Crossover Assignment||Treatment||Single|||t|||
1415817|NCT02086214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415818|NCT02086201|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415819|NCT02086188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1415820|NCT02086175||Single Group Assignment||Treatment||None (Open Label)||||||
1415821|NCT02086162|Randomized|Parallel Assignment||Treatment||Single||||||t
1415822|NCT02086149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415823|NCT02086136|||Cohort||Prospective|||||||
1415824|NCT02086123|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415825|NCT02086110|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1415826|NCT02086097|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1415827|NCT02086084|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415828|NCT02086071||Single Group Assignment||Basic Science||None (Open Label)||||||
1415829|NCT02086058|||||Prospective|||||||
1415830|NCT02086045||Single Group Assignment||Treatment||None (Open Label)||||||
1415831|NCT02086032|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415832|NCT02086019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415833|NCT02086006||Single Group Assignment||Treatment||None (Open Label)||||||
1415834|NCT02085993|||Case-Only||Prospective|||||||
1415835|NCT02085980||Single Group Assignment||Treatment||None (Open Label)||||||
1415836|NCT02085967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415837|NCT02085954|||Cohort||Retrospective|||||||
1415838|NCT02085941||Single Group Assignment||Treatment||None (Open Label)||||||
1415839|NCT02085928|||Case-Only||Prospective|||||||
1415840|NCT02085915||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415841|NCT02085902|Randomized|Parallel Assignment||||Single||||||t
1415842|NCT02085889|||Cohort||Prospective|||||||
1415843|NCT02085876|||Case-Only||Prospective|||||||
1415844|NCT02085863|Randomized|Crossover Assignment||||Double|||t||t|
1415845|NCT02085850|||Cohort||Cross-Sectional|||||||
1415846|NCT02085837|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415847|NCT02085824|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1415848|NCT02085811|||Cohort||Retrospective|||||||
1415849|NCT02085798|||Cohort||Prospective|||||||
1415850|NCT02085785|Randomized|Parallel Assignment||Treatment||Single||||||t
1415851|NCT02085772||||||||||||
1415852|NCT02085759|||Case Control||Prospective|||||||
1415853|NCT02085746|||||Prospective|||||||
1415854|NCT02085733|||Cohort||Prospective|||||||
1415855|NCT02085720||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415856|NCT02085707|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1415857|NCT02085694||Single Group Assignment||Prevention||None (Open Label)||||||
1415858|NCT02085681|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415859|NCT02085668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415860|NCT02085655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415861|NCT02085642|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1415862|NCT02085629||Single Group Assignment||Treatment||None (Open Label)||||||
1415863|NCT02085616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415864|NCT02085603|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1415865|NCT02085590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415866|NCT02085577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415867|NCT02085564|||Cohort||Prospective|||||||
1415868|NCT02085551||Single Group Assignment||Treatment||None (Open Label)||||||
1415869|NCT02085538|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415870|NCT02085525|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415871|NCT02085512|Randomized|Parallel Assignment||Prevention||Single||||||t
1415872|NCT02085499|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1415873|NCT02085486|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415874|NCT02085473|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1415875|NCT02085460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415876|NCT02085447||Single Group Assignment||Supportive Care||None (Open Label)||||||
1415877|NCT02085434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415878|NCT02085421|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415879|NCT02085408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415880|NCT02085395||Single Group Assignment||Treatment||None (Open Label)||||||
1415881|NCT02085382|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415882|NCT02085369|||Cohort||Prospective|||||||
1415883|NCT02085356|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1415884|NCT02085343|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1415885|NCT02085330|Randomized|Crossover Assignment||Treatment||Single||||||t
1415886|NCT02085317|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415887|NCT02085304|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415888|NCT02085291|Randomized|Parallel Assignment||Treatment||Single||||||t
1415889|NCT02085278||Single Group Assignment||Treatment||None (Open Label)||||||
1415890|NCT02085265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415891|NCT02085252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415892|NCT02085239|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1415893|NCT02085226|Randomized|Parallel Assignment||Treatment||Single||||||t
1415894|NCT02085213|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1415895|NCT02085200|Randomized|Parallel Assignment||Prevention||Single|||||t|
1415896|NCT02085187||Single Group Assignment||Treatment||None (Open Label)||||||
1415897|NCT02085174||||||||||||
1415898|NCT02085161|Randomized|Parallel Assignment||Treatment||Single||||||
1415899|NCT02085148|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1415900|NCT02085135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415901|NCT02085122|Randomized|Crossover Assignment||Treatment||Single|||||t|
1415902|NCT02085109|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1415903|NCT02085096|Randomized|Factorial Assignment||Supportive Care||Quadruple|||t|t|t|t
1415904|NCT02085083|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415905|NCT02085070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1415906|NCT02085057|||Case-Control||Cross-Sectional|||||||
1415907|NCT02085044|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1415908|NCT02085031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415909|NCT02085018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415910|NCT02085005||Single Group Assignment||Treatment||None (Open Label)||||||
1415911|NCT02084992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415912|NCT02084979|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415913|NCT02084966||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415914|NCT02084953|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1415915|NCT02084940|||Cohort||Prospective|||||||
1415916|NCT02084927|Randomized|Crossover Assignment||Treatment||Single||||||t
1415917|NCT02084914|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1415918|NCT02084901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415919|NCT02084888|||Cohort|||||||||
1415920|NCT02084875|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1415921|NCT02084862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415922|NCT02084849|||Cohort||Prospective|||||||
1415923|NCT02084836|||Cohort||Prospective|||||||
1415924|NCT02084823|Randomized|Parallel Assignment||Treatment||Single|||||t|
1415925|NCT02084810|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1415926|NCT02084797|Randomized|Crossover Assignment||||Double|||t||t|
1415927|NCT02084784||Single Group Assignment||Treatment||None (Open Label)||||||
1415928|NCT02084771|Randomized|Parallel Assignment||Prevention||Single||||||t
1415929|NCT02084758|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1415930|NCT02084745|Randomized|Parallel Assignment||Treatment||Single||||||t
1415931|NCT02084732||Single Group Assignment||Treatment||None (Open Label)||||||
1415932|NCT02084719|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1415933|NCT02084706|Randomized|Parallel Assignment||||Single|||t|||
1415934|NCT02084693|||Case-Only||Prospective|||||||
1415935|NCT02084680|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415936|NCT02084654|Randomized|Parallel Assignment||||Triple|||t|t|t|
1415937|NCT02084641|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1415938|NCT02084628||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415939|NCT02084615|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415940|NCT02084602||Single Group Assignment||Treatment||None (Open Label)||||||
1415941|NCT02084589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415942|NCT02084576|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1415943|NCT02084563|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415944|NCT02084550|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1415945|NCT02084537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415946|NCT02084524||Single Group Assignment||Screening||None (Open Label)||||||
1415947|NCT02084511|Randomized|Parallel Assignment||Treatment||Double||||||
1415948|NCT02084498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415949|NCT02084485|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1415950|NCT02084472|Randomized|Parallel Assignment||||Single|||||t|
1415951|NCT02084459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415952|NCT02084446|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1415953|NCT02084433|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1415954|NCT02084420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415955|NCT02084407|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1415956|NCT02084394|||Case Control||Cross-Sectional|||||||
1415957|NCT02084381|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415958|NCT02084368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415959|NCT02084355|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1415960|NCT02084342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415961|NCT02084329|Randomized|Crossover Assignment||Treatment||Single|||||t|
1415962|NCT02084316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415963|NCT02084303||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415964|NCT02084290|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1415965|NCT02084277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415966|NCT02084264|||Case-Control||Prospective|||||||
1415967|NCT02084251||Single Group Assignment||Treatment||Double|||t||t|
1415968|NCT02084238||Single Group Assignment||Treatment||None (Open Label)||||||
1415971|NCT02084199|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415972|NCT02084186|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1415973|NCT02084173|Randomized|Parallel Assignment||Treatment||Single|||||t|
1415974|NCT02084160|||Cohort||Retrospective|||||||
1415975|NCT02084147||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415976|NCT02084134|Randomized|Parallel Assignment||Treatment||Single|||t|||
1415977|NCT02084121||||||||||||
1415978|NCT02084108|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1415979|NCT02084095|||Case-Only||Prospective|||||||
1415980|NCT02084082|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415981|NCT02084069|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1415982|NCT02084056|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415983|NCT02084043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415984|NCT02084030|||Case Control||Prospective|||||||
1415985|NCT02084017|Randomized|Parallel Assignment||Prevention||Single||||||t
1415986|NCT02084004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415987|NCT02083991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1415988|NCT02083978|||Case Control||Cross-Sectional|||||||
1415989|NCT02083965|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1415990|NCT02083952|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1415991|NCT02083939|||Cohort||Prospective|||||||
1415992|NCT02083926|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1415993|NCT02083913||Single Group Assignment||Supportive Care||None (Open Label)||||||
1415994|NCT02083900|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1415995|NCT02083887|Randomized|Parallel Assignment||Prevention||Single||||||t
1415996|NCT02083874||Single Group Assignment||Treatment||None (Open Label)||||||
1415997|NCT02083861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1415998|NCT02083848||Single Group Assignment||Diagnostic||None (Open Label)||||||
1415999|NCT02083835|||Cohort||Prospective|||||||
1416000|NCT02083822||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416001|NCT02083809|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416002|NCT02083796|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416003|NCT02083783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416004|NCT02083770|Randomized|Factorial Assignment||Health Services Research||Quadruple|||t|t|t|t
1416005|NCT02083757|||||Prospective|||||||
1416006|NCT02083744|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1416007|NCT02083731||Single Group Assignment||Treatment||None (Open Label)||||||
1416008|NCT02083718||Single Group Assignment||Treatment||None (Open Label)||||||
1416009|NCT02083705|Randomized|Single Group Assignment||Treatment||Single||||||t
1416010|NCT02083692||Single Group Assignment||Basic Science||None (Open Label)||||||
1416011|NCT02083679|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416012|NCT02083666|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416013|NCT02083653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416014|NCT02083640|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1416015|NCT02083627|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1416016|NCT02083614|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416017|NCT02083601|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416018|NCT02083588||Single Group Assignment||Treatment||None (Open Label)||||||
1416019|NCT02083575|Randomized|Crossover Assignment||Treatment||Single|||t|||
1416020|NCT02083562|||Cohort||Prospective|||||||
1416021|NCT02083549|||Case-Only||Prospective|||||||
1416022|NCT02083536||Single Group Assignment||Treatment||None (Open Label)||||||
1416023|NCT02083523|Randomized|Parallel Assignment||Treatment||Single||||||t
1416024|NCT02083510||Single Group Assignment||Basic Science||None (Open Label)||||||
1416025|NCT02083497|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1416026|NCT02083484||||||||||||
1416027|NCT02083471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416028|NCT02083458||Single Group Assignment||Supportive Care||None (Open Label)||||||
1416029|NCT02083445|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416030|NCT02083432|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416031|NCT02083419|||Case-Only||Prospective|||||||
1416032|NCT02083406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416033|NCT02083393|||Cohort||Prospective|||||||
1416034|NCT02083380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416035|NCT02083367|||Case Control||Prospective|||||||
1416036|NCT02083354||||Treatment||None (Open Label)||||||
1416037|NCT02083341|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416038|NCT02083328|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1416039|NCT02083315|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1416040|NCT02083302|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416041|NCT02083289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416042|NCT02083276||Single Group Assignment||Treatment||None (Open Label)||||||
1416043|NCT02083263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416044|NCT02083250||Single Group Assignment||Treatment||None (Open Label)||||||
1416045|NCT02083237|Randomized|Parallel Assignment||Prevention||Single|||t|||
1416046|NCT02083224|||Cohort||Prospective|||||||
1416047|NCT02083211|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416048|NCT02083198|||Cohort||Retrospective|||||||
1416049|NCT02083185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416050|NCT02083172|||Cohort||Prospective|||||||
1416051|NCT02083159|||Cohort||Prospective|||||||
1416052|NCT02083146|||Case-Control||Cross-Sectional|||||||
1416053|NCT02083133|||Cohort||Retrospective|||||||
1416054|NCT02083120|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416055|NCT02083107|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1416056|NCT02083081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416057|NCT02083068|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1416058|NCT02083055|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416059|NCT02083042|||Cohort||Prospective|||||||
1416060|NCT02083029|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416061|NCT02083016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416062|NCT02083003|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416063|NCT02082990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416064|NCT02082977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416065|NCT02082964|Randomized|Parallel Assignment||||Single||||||t
1416066|NCT02082951|Randomized|Parallel Assignment||||Single||||||t
1416067|NCT02082938||Single Group Assignment||Treatment||Single|||t|||
1416068|NCT02082925||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416069|NCT02082912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416070|NCT02082899|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416071|NCT02082886|||Case-Only||Prospective|||||||
1416072|NCT02082873|||Cohort||Prospective|||||||
1416073|NCT02082860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416074|NCT02082847||||||||||||
1416075|NCT02082834|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1416076|NCT02082821|||Case-Control||Cross-Sectional|||||||
1416077|NCT02082808|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416078|NCT02082795|||Cohort||Prospective|||||||
1416079|NCT02082782||Single Group Assignment||Treatment||None (Open Label)||||||
1416080|NCT02082769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416081|NCT02082756|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416082|NCT02082743|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416083|NCT02082730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416084|NCT02082717|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1416085|NCT02082704|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1416086|NCT02082691||||||||||||
1416087|NCT02082678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416088|NCT02082665||Single Group Assignment||Treatment||None (Open Label)||||||
1416089|NCT02082652|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416090|NCT02082639|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416091|NCT02082626||Single Group Assignment||Treatment||None (Open Label)||||||
1416092|NCT02082613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416093|NCT02082600|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1416094|NCT02082587|||Cohort||Prospective|||||||
1416095|NCT02082574|||Case Control||Prospective|||||||
1416096|NCT02082561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416097|NCT02082548|Randomized|Parallel Assignment||Treatment||Single||||||t
1416098|NCT02082535|||Cohort||Prospective|||||||
1416099|NCT02082522|Randomized|Parallel Assignment||Treatment||Single||||||t
1416100|NCT02082509|||Case-Control||Prospective|||||||
1416101|NCT02082496|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416102|NCT02082483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416103|NCT02082470|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416104|NCT02082457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416105|NCT02082444|Randomized|Crossover Assignment||||None (Open Label)||||||
1416106|NCT02082431|||Cohort||Prospective|||||||
1416107|NCT02082418|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1416108|NCT02082405||Single Group Assignment||Treatment||None (Open Label)||||||
1416109|NCT02082392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416110|NCT02082379|Randomized|Parallel Assignment||||None (Open Label)||||||
1416111|NCT02082366|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1416112|NCT02082353|||Cohort||Other|||||||
1416113|NCT02082340|Randomized|Parallel Assignment||||None (Open Label)||||||
1416114|NCT02082327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416115|NCT02082314|||Cohort||Prospective|||||||
1416116|NCT02082301|||Cohort||Prospective|||||||
1416117|NCT02082288||Single Group Assignment||Supportive Care||None (Open Label)||||||
1416118|NCT02082275|Randomized|Parallel Assignment||||None (Open Label)||||||
1416119|NCT02082262||Single Group Assignment||Treatment||None (Open Label)||||||
1416120|NCT02082249||Single Group Assignment||Treatment||None (Open Label)||||||
1416121|NCT02082236|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1416122|NCT02082223||Single Group Assignment||Supportive Care||None (Open Label)||||||
1416123|NCT02082210|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416124|NCT02082197||Single Group Assignment||Treatment||None (Open Label)||||||
1416125|NCT02082184|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1416126|NCT02082171|Randomized|Parallel Assignment||Prevention||Single||||||t
1416745|NCT02074111|||Case-Control||Other|||||||
1416127|NCT02082158|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416128|NCT02082145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416129|NCT02082132|||Other||Cross-Sectional|||||||
1416130|NCT02082119||Single Group Assignment||Treatment||Single||||||t
1416131|NCT02082106|||Cohort||Cross-Sectional|||||||
1416132|NCT02082093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416133|NCT02082080|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416134|NCT02082067|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416135|NCT02082054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416136|NCT02082041|||Case-Only||Cross-Sectional|||||||
1416137|NCT02082028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416138|NCT02082015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416139|NCT02082002|||Case-Control||Prospective|||||||
1416140|NCT02081989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416141|NCT02081976|Randomized|Parallel Assignment||Prevention||Single||||||t
1416142|NCT02081963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416143|NCT02081950||Single Group Assignment||||None (Open Label)||||||
1416144|NCT02081937||Single Group Assignment||Treatment||None (Open Label)||||||
1416145|NCT02081924|Randomized|Parallel Assignment||||Single|||t|||
1416146|NCT02081911|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416147|NCT02081898|Randomized|Parallel Assignment||Basic Science||Single||||||t
1416148|NCT02081885|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416149|NCT02081872|||Cohort|||||||||
1416150|NCT02081859|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416151|NCT02081846|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1416152|NCT02081833|||Cohort||Prospective|||||||
1416153|NCT02081820|||Case-Only||Prospective|||||||
1416154|NCT02081807|||Cohort||Retrospective|||||||
1416155|NCT02081794|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416156|NCT02081781|||Cohort||Retrospective|||||||
1416157|NCT02081768||Single Group Assignment||Treatment||None (Open Label)||90Yttrium colloid||||
1416158|NCT02081755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416159|NCT02081742|||Cohort||Prospective|||||||
1416160|NCT02081729|||Cohort||Prospective|||||||
1416161|NCT02081716|||Cohort||Prospective|||||||
1416162|NCT02081703|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416163|NCT02081690||Single Group Assignment||Treatment||None (Open Label)||||||
1416164|NCT02081677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416165|NCT02081664||Single Group Assignment||Treatment||None (Open Label)||||||
1416166|NCT02081651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416167|NCT02081638|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416168|NCT02081625||Single Group Assignment||Treatment||None (Open Label)||||||
1416169|NCT02081612|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416170|NCT02081599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416171|NCT02081586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416172|NCT02081573||Single Group Assignment||Treatment||None (Open Label)||||||
1416173|NCT02081560||Single Group Assignment||Treatment||None (Open Label)||||||
1416174|NCT02081547|||Cohort||Prospective|||||||
1416175|NCT02081534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416176|NCT02081521|Randomized|Parallel Assignment||Prevention||Single||||||t
1416177|NCT02081508|Randomized|Crossover Assignment||Treatment||Single|||t|||
1416178|NCT02081495|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416179|NCT02081482||Single Group Assignment||Health Services Research||None (Open Label)||||||
1416180|NCT02081469|Randomized|Parallel Assignment||||None (Open Label)||||||
1416181|NCT02081456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416182|NCT02081443|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1416183|NCT02081430|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416184|NCT02081417|Randomized|Parallel Assignment||Treatment||Single|||||t|
1416185|NCT02081404|Randomized|Factorial Assignment||Diagnostic||Single|||t|||
1416186|NCT02081391|Randomized|Parallel Assignment||Treatment||Quadruple|All participants in the European (EU) Pediatric Committee (PDCO) set (which includes completed subjects aged 2 years or older in the US FDA set) will remain locked after the analysis for the first report. Participants under 2 years old in the US FDA set will remain blinded, as independent randomization lists are used for subjects aged less than 2 years old.||t|t|t|t
1416187|NCT02081378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416188|NCT02081365|Randomized|Parallel Assignment||Treatment||Single||||||t
1416189|NCT02081352|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416190|NCT02081339|||Cohort||Prospective|||||||
1416191|NCT02081326|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416192|NCT02081313|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1416193|NCT02081300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416194|NCT02081287|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416195|NCT02081274|||Cohort||Retrospective|||||||
1416196|NCT02081261|||Cohort||Retrospective|||||||
1416197|NCT02081248|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1416198|NCT02081235|||Cohort||Retrospective|||||||
1416199|NCT02081222|||Cohort||Retrospective|||||||
1416200|NCT02081209||Single Group Assignment||Other||None (Open Label)||||||
1416201|NCT02081196||Single Group Assignment||Other||None (Open Label)||||||
1416202|NCT02081183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416203|NCT02081170||Single Group Assignment||Treatment||None (Open Label)||||||
1416204|NCT02081157||Single Group Assignment||Treatment||None (Open Label)||||||
1416205|NCT02081144|Randomized|Parallel Assignment||Treatment||Single|||||t|
1416206|NCT02081131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416207|NCT02081118|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416208|NCT02081105|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1416209|NCT02081092|||Case-Only||Prospective|||||||
1416210|NCT02081079|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416211|NCT02081066||Single Group Assignment||Basic Science||None (Open Label)||||||
1416212|NCT02081053||Single Group Assignment||Treatment||None (Open Label)||||||
1416213|NCT02081040|||Cohort||Cross-Sectional|||||||
1416214|NCT02081027|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1416215|NCT02081014|Randomized|Crossover Assignment||Treatment||Single|||t|||
1416216|NCT02081001|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1416217|NCT02080988|||Cohort||Cross-Sectional|||||||
1416218|NCT02080975||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416219|NCT02080962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416220|NCT02080949||Single Group Assignment||Treatment||None (Open Label)||||||
1416221|NCT02080936|||Cohort||Retrospective|||||||
1416222|NCT02080923|Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a brief motivational interview-style intervention. Adolescents ages 15-19 years old who visit the emergency department and screen positive for physical or sexual dating abuse perpetration participate in a ~45 minute brief intervention and receive up to three booster calls in the subsequent 6 weeks.||||
1416223|NCT02080910|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1416224|NCT02080897|||Case-Control||Prospective|||||||
1416225|NCT02080884|||Case-Only||Prospective|||||||
1416226|NCT02080871||Single Group Assignment||Treatment||None (Open Label)||||||
1416227|NCT02080858|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416228|NCT02080845|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1416229|NCT02080832|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416230|NCT02080819|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416231|NCT02080806||Single Group Assignment||Treatment||None (Open Label)||||||
1416232|NCT02080793||||||||||||
1416233|NCT02080780||Single Group Assignment||Treatment||None (Open Label)||||||
1416234|NCT02080767||||||||||||
1416235|NCT02080754|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1416236|NCT02080741|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1416237|NCT02080728|Randomized|Parallel Assignment||||Double||||||
1416238|NCT02080715||Single Group Assignment||Treatment||Double|||t||t|
1416239|NCT02080702|||Cohort||Prospective|||||||
1416240|NCT02080689|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1416241|NCT02080676|||Cohort||Prospective|||||||
1416242|NCT02080663|||Cohort||Retrospective|||||||
1416243|NCT02080650|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1416244|NCT02080637|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1416245|NCT02080624||Single Group Assignment||||Quadruple|||t|t|t|t
1416246|NCT02080611|||Case-Only||Cross-Sectional|||||||
1416247|NCT02080598|Randomized|Crossover Assignment||||||||||
1416248|NCT02080585|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1416249|NCT02080572|||Case-Only||Cross-Sectional|||||||
1416250|NCT02080559|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416251|NCT02080546|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416252|NCT02080533||Single Group Assignment||Treatment||None (Open Label)||||||
1416253|NCT02080520|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416254|NCT02080507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416255|NCT02080494|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416256|NCT02080481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416257|NCT02080468|Randomized|Single Group Assignment||||None (Open Label)||||||
1416258|NCT02080455|Randomized|Single Group Assignment||||None (Open Label)||||||
1416259|NCT02080442|||Cohort||Cross-Sectional|||||||
1416260|NCT02080429|Randomized|Parallel Assignment||Treatment||Single|||||t|
1416261|NCT02080416||Single Group Assignment||Treatment||None (Open Label)||||||
1416262|NCT02080403|Randomized|Parallel Assignment||Treatment||Single||||||t
1416263|NCT02080390|||Cohort||Other|||||||
1416264|NCT02080377|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416265|NCT02080364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416266|NCT02080351|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416267|NCT02080338|Randomized|Parallel Assignment||Treatment||Single||||||t
1416268|NCT02080325|Randomized|Crossover Assignment||||None (Open Label)||||||
1416269|NCT02080312||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416270|NCT02080299|Randomized|Parallel Assignment||Treatment||Single|||||t|
1416271|NCT02080286|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1416272|NCT02080273|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416273|NCT02080260||Single Group Assignment||Treatment||None (Open Label)||||||
1416274|NCT02080247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416275|NCT02080234||Single Group Assignment||Treatment||None (Open Label)||||||
1416276|NCT02080221||Single Group Assignment||Treatment||None (Open Label)||||||
1416277|NCT02080208|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1416278|NCT02080195||Single Group Assignment||Treatment||None (Open Label)||||||
1416279|NCT02080182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416280|NCT02080169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416281|NCT02080156|Randomized|Parallel Assignment||Treatment||Single||||||t
1416282|NCT02080143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416283|NCT02080130|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1416284|NCT02080117|||Cohort||Retrospective|||||||
1416285|NCT02080104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416286|NCT02080091|||Cohort||Prospective|||||||
1416287|NCT02080078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416288|NCT02080065|||Cohort||Retrospective|||||||
1416289|NCT02080052||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416290|NCT02080039||Single Group Assignment||Treatment||None (Open Label)||||||
1416291|NCT02080026|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416292|NCT02080013|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416293|NCT02080000|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1416294|NCT02079987|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416295|NCT02079974||Single Group Assignment||Treatment||None (Open Label)||||||
1416296|NCT02079961|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416297|NCT02079948|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416298|NCT02079935|Randomized|Parallel Assignment||Treatment||Single|The one transferring results from lab's and questionaires to SPSS are blinded for group affiliation.|Comparing treatment of cognitive behavioural therapy, with treatment of physical exercise and dietary therapy. All participants randomized to either of the two treatment offers. Waitlist serves as control group.||||t
1416299|NCT02079922|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1416300|NCT02079909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416301|NCT02079896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416302|NCT02079883|||Case-Only||Prospective|||||||
1416303|NCT02079870|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1416304|NCT02079857|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416305|NCT02079844|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1416306|NCT02079831|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416307|NCT02079818||Single Group Assignment||Treatment||None (Open Label)||||||
1416308|NCT02079805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416309|NCT02079792|Randomized|Parallel Assignment||Treatment||Single||||||t
1416310|NCT02079779|Randomized|Parallel Assignment||Treatment||Single||||||t
1416311|NCT02079766|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1416312|NCT02079753|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1416313|NCT02079740||Single Group Assignment||Treatment||None (Open Label)||||||
1416314|NCT02079727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416315|NCT02079714|||Cohort||Prospective|||||||
1416316|NCT02079701|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416317|NCT02079688|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1416318|NCT02079675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416319|NCT02079662|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416320|NCT02079649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416321|NCT02079636|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416322|NCT02079623||Single Group Assignment||Treatment||None (Open Label)||||||
1416323|NCT02079610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416324|NCT02079597|||Case Control||Prospective|||||||
1416325|NCT02079584|||Cohort||Prospective|||||||
1416326|NCT02079571|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1416327|NCT02079558|Randomized|Parallel Assignment||Screening||Double|||t||t|
1416328|NCT02079545|Randomized|Parallel Assignment||||None (Open Label)||||||
1416329|NCT02079532||Single Group Assignment||Treatment||None (Open Label)||||||
1416330|NCT02079519||Single Group Assignment||Treatment||None (Open Label)||||||
1416331|NCT02079506|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416332|NCT02079493|||Cohort||Prospective|||||||
1416333|NCT02079480|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1416334|NCT02079467|Randomized|Parallel Assignment||Treatment||Single||||||t
1416335|NCT02079454|||Cohort||Prospective|||||||
1416336|NCT02079441|||Cohort||Prospective|||||||
1416337|NCT02079428|||Cohort||Prospective|||||||
1416338|NCT02079415|||Cohort||Prospective|||||||
1416339|NCT02079402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416340|NCT02079389|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1416341|NCT02079376|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1416342|NCT02079363|||Cohort||Prospective|||||||
1416343|NCT02079350|||Case Control||Prospective|||||||
1416344|NCT02079337|Randomized|Crossover Assignment||||Single||||||t
1416345|NCT02079324||Single Group Assignment||Treatment||None (Open Label)||||||
1416346|NCT02079311|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416347|NCT02079298|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416348|NCT02079285|||Cohort||Prospective|||||||
1416349|NCT02079272||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416350|NCT02079259|||Case-Only||Prospective|||||||
1416351|NCT02079246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416352|NCT02079233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416353|NCT02079220|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416354|NCT02079207|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416355|NCT02079194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416356|NCT02079181||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416357|NCT02079168|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416358|NCT02079155|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416359|NCT02079142|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1416360|NCT02079129|||Cohort||Prospective|||||||
1416361|NCT02079116|Randomized|Crossover Assignment||Basic Science||Single||||||t
1416362|NCT02079103|Randomized|Parallel Assignment||Treatment||Single||||||t
1416363|NCT02079090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416364|NCT02079077|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416365|NCT02079064|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416366|NCT02079051|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416367|NCT02079038|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416368|NCT02079025|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1416369|NCT02079012|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416370|NCT02078999|||Other||Prospective|||||||
1416371|NCT02078986|Randomized|Parallel Assignment||Treatment||Single||||||t
1416372|NCT02078973|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1416373|NCT02078960||Single Group Assignment||Other||None (Open Label)||||||
1416374|NCT02078947|Randomized|Parallel Assignment||Treatment||Single||||||t
1416375|NCT02078934||Single Group Assignment||Treatment||None (Open Label)||||||
1416376|NCT02078921|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1416377|NCT02078908|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1416378|NCT02078895|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416379|NCT02078882||Single Group Assignment||Treatment||None (Open Label)||||||
1416380|NCT02078869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416381|NCT02078856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416382|NCT02078843||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416383|NCT02078830|Randomized|Parallel Assignment||Prevention||Single|||||t|
1416384|NCT02078817||Single Group Assignment||Treatment||None (Open Label)||||||
1416385|NCT02078804|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1416386|NCT02078791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416387|NCT02078778||Single Group Assignment||Treatment||None (Open Label)||||||
1416388|NCT02078765|||Case Control||Cross-Sectional|||||||
1416389|NCT02078752||||Treatment||None (Open Label)||||||
1416390|NCT02078739|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1416391|NCT02078726|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1416392|NCT02078713|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1416393|NCT02078700||Single Group Assignment||Supportive Care||None (Open Label)||||||
1416394|NCT02078687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416395|NCT02078674|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1416396|NCT02078661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416397|NCT02078648||Single Group Assignment||Treatment||None (Open Label)||||||
1416398|NCT02078635|Randomized|Parallel Assignment||Treatment||Single|||||t|
1416399|NCT02078622|||Cohort||Prospective|||||||
1416400|NCT02078609|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416401|NCT02078596|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1416402|NCT02078583|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1416403|NCT02078570|||Case-Only||Prospective|||||||
1416404|NCT02078557||Single Group Assignment||Treatment||None (Open Label)||||||
1416405|NCT02078544|||Case-Only||Prospective|||||||
1416406|NCT02078531|||Case-Only||Prospective|||||||
1416407|NCT02078518|||Case-Only||Prospective|||||||
1416408|NCT02078505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416409|NCT02078492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416410|NCT02078479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416411|NCT02078466|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416412|NCT02078453|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1416413|NCT02078440||Single Group Assignment||Treatment||None (Open Label)||||||
1416414|NCT02078427|||Cohort||Prospective|||||||
1416415|NCT02078414|||Cohort||Prospective|||||||
1416416|NCT02078401|||Cohort||Prospective|||||||
1416417|NCT02078388|||Case-Only||Prospective|||||||
1416418|NCT02078375|Randomized|Parallel Assignment||Other||Double|||t||t|
1416419|NCT02078362|||||Prospective|||||||
1416420|NCT02078349||Single Group Assignment||Treatment||None (Open Label)||||||
1416421|NCT02078336|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1416422|NCT02078323|Randomized|Parallel Assignment||Other||Double|||t||t|
1416423|NCT02078310|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1416424|NCT02078297|||Cohort||Cross-Sectional|||||||
1416425|NCT02078284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416426|NCT02078271|Randomized|Parallel Assignment||||Single|||t|||
1416427|NCT02078258|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416428|NCT02078245|||Other||Prospective|||||||
1416429|NCT02078232|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1416430|NCT02078219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417062|NCT02069964|||Cohort||Prospective|||||||
1416431|NCT02078206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416432|NCT02078193||Single Group Assignment||Treatment||None (Open Label)||||||
1416433|NCT02078180|Randomized|Crossover Assignment||Basic Science||Single||||||t
1416434|NCT02078167|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1416435|NCT02078154|||Case-Only||Prospective|||||||
1416436|NCT02078141||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416437|NCT02078128|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1416438|NCT02078115|||Cohort||Prospective|||||||
1416439|NCT02078102||Single Group Assignment||Treatment||None (Open Label)||||||
1416440|NCT02078089||Single Group Assignment||Supportive Care||None (Open Label)||||||
1416441|NCT02078076||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416442|NCT02078063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416443|NCT02078050||Single Group Assignment||||None (Open Label)||||||
1416444|NCT02078037|Randomized|Parallel Assignment||Treatment||Single||||||t
1416445|NCT02078024|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1416446|NCT02078011||Single Group Assignment||Treatment||None (Open Label)||||||
1416447|NCT02077998||Single Group Assignment||Treatment||None (Open Label)||||||
1416448|NCT02077985|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416449|NCT02077972||Single Group Assignment||Treatment||None (Open Label)||||||
1416450|NCT02077959||Single Group Assignment||Treatment||None (Open Label)||||||
1416451|NCT02077946|||Cohort||Retrospective|||||||
1416452|NCT02077933|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416453|NCT02077920|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416454|NCT02077907|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416455|NCT02077894|||Case-Control||Prospective|||||||
1416456|NCT02077881||Single Group Assignment||Treatment||None (Open Label)||||||
1416457|NCT02077868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416458|NCT02077855|||Case-Control||Prospective|||||||
1416459|NCT02077842|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416460|NCT02077829||Single Group Assignment||Health Services Research||None (Open Label)||||||
1416461|NCT02077816|||||Prospective|||||||
1416462|NCT02077803|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416463|NCT02077790||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416464|NCT02077777|Randomized|Parallel Assignment||Treatment||Single||||||t
1416465|NCT02077764|||Case Control||Cross-Sectional|||||||
1416466|NCT02077751||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416467|NCT02077738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416468|NCT02077725|||Cohort||Prospective|||||||
1416469|NCT02077712|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1416470|NCT02077699||Single Group Assignment||Treatment||None (Open Label)||||||
1416471|NCT02077686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416472|NCT02077673|||Case-Only||Prospective|||||||
1416473|NCT02077660|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1416474|NCT02077647|||Case-Control||Prospective|||||||
1416475|NCT02077634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416476|NCT02077621|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416477|NCT02077608|||Cohort||Prospective|||||||
1416478|NCT02077595|Randomized|Crossover Assignment||Treatment||Single|||t|||
1416479|NCT02077582|||Cohort||Prospective|||||||
1416480|NCT02077569|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1416481|NCT02077556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416482|NCT02077543||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416483|NCT02077530|||Cohort||Prospective|||||||
1416484|NCT02077517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416485|NCT02077504||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416486|NCT02077491|Randomized|Parallel Assignment||Prevention||Single||||||t
1416487|NCT02077478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416488|NCT02077465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416489|NCT02077452|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1416490|NCT02077439|Randomized|Parallel Assignment||Treatment||Single||||||t
1416491|NCT02077426||Single Group Assignment||Treatment||None (Open Label)||||||
1416492|NCT02077413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416493|NCT02077400|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416494|NCT02077387|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416495|NCT02077374|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416496|NCT02077361||Single Group Assignment||Treatment||None (Open Label)||||||
1416497|NCT02077348|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1416498|NCT02077335||Single Group Assignment||Treatment||None (Open Label)||||||
1416499|NCT02077322|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416500|NCT02077309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416501|NCT02077296|||Cohort||Prospective|||||||
1416502|NCT02077283|||Cohort||Prospective|||||||
1416503|NCT02077270|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1416504|NCT02077257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416505|NCT02077244|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416506|NCT02077231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416507|NCT02077218||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416508|NCT02077205||Single Group Assignment||Treatment||None (Open Label)||||||
1416509|NCT02077192||Single Group Assignment||Treatment||None (Open Label)||||||
1416510|NCT02077179|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416511|NCT02077166|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416512|NCT02077153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416513|NCT02077140|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416514|NCT02077127|||Case Control||Cross-Sectional|||||||
1416515|NCT02077114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416516|NCT02077101|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1416517|NCT02077088|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416518|NCT02077075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416519|NCT02077062|||Case Control||Prospective|||||||
1416520|NCT02077049|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1416521|NCT02077036|Randomized|Parallel Assignment||||Double||||||
1416522|NCT02077023|||Cohort||Prospective|||||||
1416523|NCT02077010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416524|NCT02076997||Single Group Assignment||Treatment||None (Open Label)||||||
1416525|NCT02076984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416526|NCT02076971|||Case-Only||Prospective|||||||
1416527|NCT02076958|Randomized|Parallel Assignment||Screening||Single|||t|||
1416528|NCT02076945|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416529|NCT02076932|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416530|NCT02076919|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1416531|NCT02076906||Single Group Assignment||Treatment||None (Open Label)||||||
1416532|NCT02076893|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416533|NCT02076880|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1416534|NCT02076867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416535|NCT02076854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416536|NCT02076841|||Cohort||Prospective|||||||
1416537|NCT02076828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416538|NCT02076815|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416539|NCT02076802|||Cohort||Prospective|||||||
1416540|NCT02076789|||Cohort||Prospective|||||||
1416541|NCT02076776|Randomized|Parallel Assignment||Treatment||Single||||||t
1416542|NCT02076763|||Cohort||Prospective|||||||
1416543|NCT02076750|Randomized|Parallel Assignment||Treatment||Single|||||t|
1416544|NCT02076737||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416545|NCT02076724|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416546|NCT02076711|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1416547|NCT02076698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416548|NCT02076685||Single Group Assignment||Supportive Care||None (Open Label)||||||
1416549|NCT02076672||Single Group Assignment||Prevention||None (Open Label)||||||
1416550|NCT02076659||Single Group Assignment||Treatment||None (Open Label)||||||
1416551|NCT02076646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416552|NCT02076633||Single Group Assignment||Treatment||None (Open Label)||||||
1416553|NCT02076620||Single Group Assignment||Treatment||None (Open Label)||||||
1416554|NCT02076607|||||Retrospective|||||||
1416555|NCT02076594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416556|NCT02076581|||Case-Only||Cross-Sectional|||||||
1416557|NCT02076568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416558|NCT02076555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416559|NCT02076542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416560|NCT02076529|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1416561|NCT02076516||Single Group Assignment||Treatment||None (Open Label)||||||
1416562|NCT02076503||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416563|NCT02076490|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1416564|NCT02076477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416565|NCT02076464|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1416566|NCT02076451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416567|NCT02076438|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1416568|NCT02076425|Randomized|Crossover Assignment||Treatment||Single||||||t
1416569|NCT02076412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416570|NCT02076399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416571|NCT02076386|||Other||Prospective|||||||
1416572|NCT02076373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416573|NCT02076360|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1416574|NCT02076347|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1416575|NCT02076334|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1416576|NCT02076321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416577|NCT02076308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416578|NCT02076295|||Cohort||Cross-Sectional|||||||
1416579|NCT02076282|||||Cross-Sectional|||||||
1416580|NCT02076269||Single Group Assignment||||None (Open Label)||||||
1416581|NCT02076256|Randomized|Crossover Assignment||Prevention||Single|||||t|
1416582|NCT02076243||Single Group Assignment||Treatment||None (Open Label)||||||
1416583|NCT02076230|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416584|NCT02076217|||Cohort||Prospective|||||||
1416585|NCT02076204|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1416586|NCT02076191||Single Group Assignment||Treatment||None (Open Label)||||||
1416587|NCT02076178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416588|NCT02076165|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416589|NCT02076152|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1416590|NCT02076139|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1416591|NCT02076126|||Case Control||Retrospective|||||||
1416592|NCT02076113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416593|NCT02076100|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416594|NCT02076087|||Other||Cross-Sectional|||||||
1416595|NCT02076074||Single Group Assignment||Treatment||None (Open Label)||||||
1416596|NCT02076061|||Cohort||Prospective|||||||
1416597|NCT02076048|||Cohort||Prospective|||||||
1416598|NCT02076035|||Cohort||Prospective|||||||
1416599|NCT02076022|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416600|NCT02076009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416601|NCT02075996|||Cohort||Prospective|||||||
1416602|NCT02075983|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416603|NCT02075970|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1416604|NCT02075957|||Cohort||Prospective|||||||
1416605|NCT02075944|Randomized|Factorial Assignment||Supportive Care||Single|||||t|
1416606|NCT02075931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416607|NCT02075918|||Case-Only||Prospective|||||||
1416608|NCT02075905|||Cohort||Prospective|||||||
1416609|NCT02075892|Randomized|Parallel Assignment||||Double|||t||t|
1416610|NCT02075879|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1416611|NCT02075866|||Case Control||Prospective|||||||
1416612|NCT02075853|||Cohort||Prospective|||||||
1416613|NCT02075840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416614|NCT02075827|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416615|NCT02075801|||Case Control||Prospective|||||||
1416616|NCT02075788|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1416617|NCT02075775|||Cohort||Prospective|||||||
1416618|NCT02075762|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1416619|NCT02075749|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1416620|NCT02075736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416621|NCT02075723|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1416622|NCT02075710|Randomized|Factorial Assignment||Other||Double|||t|||t
1416623|NCT02075697|||Cohort||Prospective|||||||
1416624|NCT02075684||Single Group Assignment||Other||None (Open Label)||||||
1416625|NCT02075671|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1416626|NCT02075658|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1416627|NCT02075645||Single Group Assignment||||None (Open Label)||||||
1416628|NCT02075632||Single Group Assignment||Treatment||None (Open Label)||||||
1416629|NCT02075619|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416630|NCT02075606||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416631|NCT02075593||Single Group Assignment||Treatment||None (Open Label)||||||
1416632|NCT02075580|Randomized|Parallel Assignment||Treatment||Single||||||t
1416633|NCT02075567|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1416634|NCT02075554||Single Group Assignment||Treatment||None (Open Label)||Lumbar interbody cages||||
1416635|NCT02075541|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1416636|NCT02075528||Single Group Assignment||Treatment||None (Open Label)||||||
1416637|NCT02075515|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1416638|NCT02075502|Randomized|Parallel Assignment||Treatment||Single|||||t|
1416639|NCT02075489|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416640|NCT02075476|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416641|NCT02075463||Single Group Assignment||Treatment||None (Open Label)||||||
1416642|NCT02075450|Randomized|Factorial Assignment||||Single||||||t
1416643|NCT02075437||Single Group Assignment||Treatment||None (Open Label)||||||
1416644|NCT02075424||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416645|NCT02075411|Randomized|Parallel Assignment||Treatment||Single||||||t
1416646|NCT02075398|||Case-Only|||||||||
1416647|NCT02075385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416648|NCT02075372|||Case-Only||Prospective|||||||
1416649|NCT02075359|||Cohort||Cross-Sectional|||||||
1416650|NCT02075346|||Case-Only|||||||||
1416651|NCT02075333|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1416652|NCT02075320||Single Group Assignment||Screening||None (Open Label)||||||
1416653|NCT02075307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416654|NCT02075294|||Cohort||Retrospective|||||||
1416655|NCT02075281|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416656|NCT02075268||Single Group Assignment||||None (Open Label)||||||
1416657|NCT02075255|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416658|NCT02075242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416659|NCT02075229|||Case-Control||Prospective|||||||
1416660|NCT02075216||Single Group Assignment||Treatment||None (Open Label)||||||
1416661|NCT02075203|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416662|NCT02075190|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1416663|NCT02075177||||||||||||
1416664|NCT02075164|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416665|NCT02075151||Single Group Assignment||Treatment||None (Open Label)||||||
1416666|NCT02075138|||||Prospective|||||||
1416667|NCT02075125|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416668|NCT02075112||Single Group Assignment||Treatment||None (Open Label)||||||
1416669|NCT02075099|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1416670|NCT02075086||Single Group Assignment||Treatment||None (Open Label)||||||
1416671|NCT02075073|Randomized|Parallel Assignment||Other||Double|||t||t|
1416672|NCT02075060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416673|NCT02075047|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416674|NCT02075034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416675|NCT02075021||Single Group Assignment||Treatment||None (Open Label)||||||
1416676|NCT02075008||Single Group Assignment||Treatment||None (Open Label)||||||
1416677|NCT02074995|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416678|NCT02074982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416679|NCT02074969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416680|NCT02074956|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416681|NCT02074943||Single Group Assignment||Treatment||Double|||t|||t
1416682|NCT02074930||Single Group Assignment||Basic Science||None (Open Label)||||||
1416683|NCT02074917|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416684|NCT02074904|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416685|NCT02074891|||Cohort||Prospective|||||||
1416686|NCT02074878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416687|NCT02074865|||Cohort||Prospective|||||||
1416688|NCT02074852|||Case Control||Cross-Sectional|||||||
1416689|NCT02074839||Single Group Assignment||Treatment||None (Open Label)||||||
1416690|NCT02074826|||Cohort||Prospective|||||||
1416691|NCT02074813|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416692|NCT02074800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416693|NCT02074787|||Cohort||Prospective|||||||
1416694|NCT02074774|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1416695|NCT02074761|||Cohort||Prospective|||||||
1416696|NCT02074748|||Case-Control||Prospective|||||||
1416697|NCT02074735|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416698|NCT02074722|||Other||Prospective|||||||
1416699|NCT02074709|Randomized|Parallel Assignment||Prevention||Single||||||t
1416700|NCT02074696|||Cohort||Cross-Sectional|||||||
1416701|NCT02074683|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416702|NCT02074670||Single Group Assignment||Treatment||None (Open Label)||||||
1416703|NCT02074657||Single Group Assignment||Treatment||None (Open Label)||||||
1416704|NCT02074644|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416705|NCT02074631|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416706|NCT02074618||Single Group Assignment||Treatment||None (Open Label)||||||
1416707|NCT02074605|||Case Control||Prospective|||||||
1416708|NCT02074592|Randomized|Parallel Assignment||||Single||||||t
1416709|NCT02074579|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416710|NCT02074566|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416711|NCT02074553|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416712|NCT02074540|||Case-Only||Prospective|||||||
1416713|NCT02074527|||||Cross-Sectional|||||||
1416714|NCT02074514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416715|NCT02074501||Single Group Assignment||Supportive Care||Single||||t||
1416716|NCT02074488|Randomized|Parallel Assignment||Prevention||Single||||||t
1416717|NCT02074475|||Cohort||Prospective|||||||
1416718|NCT02074462|||Cohort||Prospective|||||||
1416719|NCT02074449|||Case-Only||Prospective|||||||
1416720|NCT02074436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416721|NCT02074423|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1416722|NCT02074410|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416723|NCT02074397|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416724|NCT02074384|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1416725|NCT02074371|||Case-Crossover||Prospective|||||||
1416726|NCT02074358|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1416727|NCT02074345||Single Group Assignment||Prevention||None (Open Label)||||||
1416728|NCT02074332|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1416729|NCT02074319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416730|NCT02074306|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1416731|NCT02074293|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416732|NCT02074280|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416733|NCT02074267|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416734|NCT02074254|||||Retrospective|||||||
1416735|NCT02074241|||Cohort||Prospective|||||||
1416736|NCT02074228||Single Group Assignment||Treatment||None (Open Label)||||||
1416737|NCT02074215|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1416738|NCT02074202|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1416739|NCT02074189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416740|NCT02074176|||Case Control||Prospective|||||||
1416741|NCT02074163|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416742|NCT02074150|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416743|NCT02074137||Single Group Assignment||Treatment||None (Open Label)||||||
1416744|NCT02074124|||Cohort||Prospective|||||||
1416746|NCT02074098|Randomized|Crossover Assignment||Basic Science||Single||||||t
1416747|NCT02074085|||Case-Only||Retrospective|||||||
1416748|NCT02074072|Randomized|Crossover Assignment||Basic Science||Single||||||t
1416749|NCT02074059|Randomized|Sequential Assignment||Treatment||None (Open Label)||Sequential escalating dosing groups, each group contained an active and control arm of equal size.||||
1416750|NCT02074046|Randomized|Parallel Assignment||Treatment||Single|||||t|
1416751|NCT02074033|||||Retrospective|||||||
1416752|NCT02074020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416753|NCT02074007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416754|NCT02073994||Single Group Assignment||Treatment||None (Open Label)||||||
1416755|NCT02073981|||Cohort||Prospective|||||||
1416756|NCT02073968||Single Group Assignment||Treatment||None (Open Label)||||||
1416757|NCT02073955|||||Cross-Sectional|||||||
1416758|NCT02073942|||Case-Only||Prospective|||||||
1416759|NCT02073929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416760|NCT02073916||Single Group Assignment||Treatment||None (Open Label)||||||
1416761|NCT02073903|||Cohort||Prospective|||||||
1416762|NCT02073890|||||Cross-Sectional|||||||
1416763|NCT02073877|||Case Control||Prospective|||||||
1416764|NCT02073864|||Cohort||Prospective|||||||
1416765|NCT02073851||Single Group Assignment||Treatment||None (Open Label)||||||
1416766|NCT02073838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416767|NCT02073825|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416768|NCT02073812||Single Group Assignment||Treatment||None (Open Label)||||||
1416769|NCT02073799|||Cohort||Retrospective|||||||
1416770|NCT02073786|Randomized|Parallel Assignment||Treatment||Single||||||t
1416771|NCT02073773|Randomized|Parallel Assignment||Treatment||Single||||||t
1416772|NCT02073760|||Other||Cross-Sectional|||||||
1416773|NCT02073747|Non-Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1416774|NCT02073734|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1416775|NCT02073721|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1416776|NCT02073708|||Case-Control||Prospective|||||||
1416777|NCT02073695|Randomized|Parallel Assignment||||None (Open Label)||||||
1416778|NCT02073682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416779|NCT02073669|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1416780|NCT02073656|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416781|NCT02073643|||Cohort||Prospective|||||||
1416782|NCT02073630|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1416783|NCT02073617||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416784|NCT02073604|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1416785|NCT02073591|||||Prospective|||||||
1416786|NCT02073578||Single Group Assignment||Treatment||None (Open Label)||||||
1416787|NCT02073565|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416788|NCT02073552|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1416789|NCT02073539|Randomized|Crossover Assignment||Basic Science||Single||||||t
1416790|NCT02073526|||Cohort||Prospective|||||||
1416791|NCT02073513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416792|NCT02073500|||Cohort||Prospective|||||||
1416793|NCT02073487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416794|NCT02073474|||Other||Prospective|||||||
1416795|NCT02073461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416796|NCT02073448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416797|NCT02073435|||Other||Other|||||||
1416798|NCT02073422|||Cohort||Prospective|||||||
1416799|NCT02073409|||Case-Only||Prospective|||||||
1416800|NCT02073396|||Case Control||Prospective|||||||
1416801|NCT02073383|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416802|NCT02073370|||Cohort||Prospective|||||||
1416803|NCT02073357|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416804|NCT02073344|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1416805|NCT02073331|||Cohort||Prospective|||||||
1416806|NCT02073318|Randomized|Parallel Assignment||Treatment||Single||||||t
1416807|NCT02073305|||Cohort||Prospective|||||||
1416808|NCT02073292|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416809|NCT02073279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416810|NCT02073266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416811|NCT02073253|Randomized|Crossover Assignment||Treatment||Single|||||t|
1416812|NCT02073240|||||Prospective|||||||
1416813|NCT02073227|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416814|NCT02073214|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1416815|NCT02073201|||Case-Control||Cross-Sectional|||||||
1416816|NCT02073188|Randomized|Parallel Assignment||||None (Open Label)||||||
1416817|NCT02073175|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416818|NCT02073162|Randomized|Parallel Assignment||Treatment||Single||||||t
1416819|NCT02073149|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416820|NCT02073136|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416821|NCT02073123|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1416822|NCT02073110|||Case-Only||Prospective|||||||
1416823|NCT02073097||Single Group Assignment||Treatment||None (Open Label)||||||
1416824|NCT02073084|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1416825|NCT02073071|||Cohort||Prospective|||||||
1416826|NCT02073058|||Cohort||Prospective|||||||
1417771|NCT02060682|||Case-Only||Prospective|||||||
1416827|NCT02073045||Single Group Assignment||Supportive Care||None (Open Label)||||||
1416828|NCT02073032|||Cohort||Prospective|||||||
1416829|NCT02073019|Randomized|Parallel Assignment||||Triple|||t||t|t
1416830|NCT02073006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416831|NCT02072993|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1416832|NCT02072980|Randomized|Crossover Assignment||||Single||||||t
1416833|NCT02072967|||Case-Only||Prospective|||||||
1416834|NCT02072954|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416835|NCT02072941|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1416836|NCT02072928|||Cohort||Other|||||||
1416837|NCT02072915|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1416838|NCT02072902|||Cohort||Other|||||||
1416839|NCT02072889||Single Group Assignment||Prevention||None (Open Label)||||||
1416840|NCT02072876||||||||||||
1416841|NCT02072863||Single Group Assignment||Treatment||None (Open Label)||||||
1416842|NCT02072850|||Cohort||Prospective|||||||
1416843|NCT02072837|||Case Control||Cross-Sectional|||||||
1416844|NCT02072824|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416845|NCT02072811|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416846|NCT02072798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416847|NCT02072785|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416848|NCT02072772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416849|NCT02072759|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1416850|NCT02072746|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416851|NCT02072733||Single Group Assignment||Other||None (Open Label)||||||
1416852|NCT02072720|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416853|NCT02072707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416854|NCT02072694|Randomized|Crossover Assignment||Basic Science||Single||||||t
1416855|NCT02072681|||Cohort||Prospective|||||||
1416856|NCT02072668|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1416857|NCT02072655|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1416858|NCT02072642|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416859|NCT02072629||Single Group Assignment||Health Services Research||None (Open Label)||||||
1416860|NCT02072616||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416861|NCT02072603|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416862|NCT02072590|||Cohort||Prospective|||||||
1416863|NCT02072577||Single Group Assignment||||None (Open Label)||||||
1416864|NCT02072564|||Case-Only||Prospective|||||||
1416865|NCT02072551|||||Prospective|||||||
1416866|NCT02072538|||Cohort||Prospective|||||||
1416867|NCT02072525|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416868|NCT02072512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416869|NCT02072499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416870|NCT02072486||Single Group Assignment||Treatment||None (Open Label)||||||
1416871|NCT02072473|||Cohort||Prospective|||||||
1416872|NCT02072460||Factorial Assignment||Supportive Care||None (Open Label)||||||
1416873|NCT02072447||Single Group Assignment||Basic Science||None (Open Label)||||||
1416874|NCT02072434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416875|NCT02072421||Single Group Assignment||Health Services Research||None (Open Label)||||||
1416876|NCT02072408||Single Group Assignment||Treatment||None (Open Label)||||||
1416877|NCT02072395||Single Group Assignment||Treatment||None (Open Label)||||||
1416878|NCT02072382|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1416879|NCT02072369|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1416880|NCT02072356||Single Group Assignment||Treatment||None (Open Label)||||||
1416881|NCT02072343|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1416882|NCT02072330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416883|NCT02072317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416884|NCT02072304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416885|NCT02072291|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1416886|NCT02072278|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1416887|NCT02072265|||Case Control||Prospective|||||||
1416888|NCT02072252|Randomized|Parallel Assignment||Treatment||Single||||||t
1416889|NCT02072239||Single Group Assignment||Treatment||None (Open Label)||||||
1416890|NCT02072226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416891|NCT02072213|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1416892|NCT02072200||Single Group Assignment||Treatment||None (Open Label)||||||
1416893|NCT02072187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416894|NCT02072174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416895|NCT02072161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416896|NCT02072148|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416897|NCT02072135||Single Group Assignment||Treatment||None (Open Label)||||||
1416898|NCT02072122|||Cohort||Prospective|||||||
1416899|NCT02072109|||Case-Crossover||Prospective|||||||
1416900|NCT02072096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416901|NCT02072083|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416902|NCT02072070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416903|NCT02072057||Single Group Assignment||Treatment||None (Open Label)||||||
1416904|NCT02072044||Single Group Assignment||Treatment||None (Open Label)||||||
1418159|NCT02055612|||Cohort||Cross-Sectional|||||||
1416905|NCT02072031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416906|NCT02072018|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1416907|NCT02072005|||Case-Only||Prospective|||||||
1416908|NCT02071979|Randomized|Single Group Assignment||Treatment||Single||||||t
1416909|NCT02071966|Randomized|Parallel Assignment||Treatment||Single|||||t|
1416910|NCT02071953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416911|NCT02071940||Single Group Assignment||Treatment||None (Open Label)||||||
1416912|NCT02071927|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416913|NCT02071914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416914|NCT02071901||Single Group Assignment||Supportive Care||None (Open Label)||||||
1416915|NCT02071888|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416916|NCT02071875|||Cohort||Prospective|||||||
1416917|NCT02071862|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416918|NCT02071849||Single Group Assignment||Treatment||None (Open Label)||||||
1416919|NCT02071836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416920|NCT02071823|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416921|NCT02071810|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416922|NCT02071797|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416923|NCT02071784|||Case Control|||||||||
1416924|NCT02071771|Randomized|Crossover Assignment||Treatment||Single|||||t|
1416925|NCT02071758|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416926|NCT02071745|||Cohort||Retrospective|||||||
1416927|NCT02071732|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1416928|NCT02071719|||Cohort||Prospective|||||||
1416929|NCT02071706||Single Group Assignment||||None (Open Label)||||||
1416930|NCT02071693|||Case-Only||Retrospective|||||||
1416931|NCT02071680||Single Group Assignment||Diagnostic||None (Open Label)||||||
1416932|NCT02071667|||Case-Only||Prospective|||||||
1416933|NCT02071654||Single Group Assignment||Treatment||None (Open Label)||||||
1416934|NCT02071641||Single Group Assignment||Treatment||None (Open Label)||||||
1416935|NCT02071628|||Cohort||Prospective|||||||
1416936|NCT02071615|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1416937|NCT02071602|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416938|NCT02071589|Randomized|Crossover Assignment||||None (Open Label)||||||
1416939|NCT02071576||Single Group Assignment||Treatment||None (Open Label)||||||
1416940|NCT02071563|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1416941|NCT02071550|||Case Control||Prospective|||||||
1416942|NCT02071537||Single Group Assignment||Treatment||None (Open Label)||||||
1416943|NCT02071524|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1416944|NCT02071511|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416945|NCT02071498|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1416946|NCT02071485|||Case-Only||Prospective|||||||
1416947|NCT02071472|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1416948|NCT02071459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416949|NCT02071446|||Case-Only||Cross-Sectional|||||||
1416950|NCT02071433|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1416951|NCT02071420|Randomized|Parallel Assignment||Prevention||Single||||||t
1416952|NCT02071407|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416953|NCT02071394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416954|NCT02071381||||||||||||
1416955|NCT02071368|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1416956|NCT02071355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416957|NCT02071342|||Cohort||Prospective|||||||
1416958|NCT02071329|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1416959|NCT02071316|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1416960|NCT02071303|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1416961|NCT02071290|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1416962|NCT02071277||Single Group Assignment||Treatment||None (Open Label)||||||
1416963|NCT02071264||Single Group Assignment||Prevention||None (Open Label)||||||
1416964|NCT02071251||Single Group Assignment||Treatment||None (Open Label)||||||
1416965|NCT02071238|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1416966|NCT02071225|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1416967|NCT02071212|Randomized|Parallel Assignment||Treatment||Single||||||t
1416968|NCT02071199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416969|NCT02071186|Randomized|Parallel Assignment||Treatment||Single||||||t
1416970|NCT02071173||Single Group Assignment||Treatment||None (Open Label)||||||
1416971|NCT02071160|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1416972|NCT02071147|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1416973|NCT02071134|||Cohort||Prospective|||||||
1416974|NCT02071121|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416975|NCT02071108||Single Group Assignment||Treatment||None (Open Label)||||||
1416976|NCT02071095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416977|NCT02071082|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416978|NCT02071069||Single Group Assignment||Treatment||None (Open Label)||||||
1416979|NCT02071056|||Case-Only||Prospective|||||||
1416980|NCT02071043||Single Group Assignment||Treatment||None (Open Label)||||||
1416981|NCT02071030|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1416982|NCT02071017|||Cohort||Prospective|||||||
1416983|NCT02071004|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1416984|NCT02070991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1416985|NCT02070978|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1416986|NCT02070965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416987|NCT02070952||Single Group Assignment||Treatment||None (Open Label)||||||
1416988|NCT02070939|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1416989|NCT02070926|||Cohort||Prospective|||||||
1416990|NCT02070913|||Case-Only||Prospective|||||||
1416991|NCT02070900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1416992|NCT02070887|||Case Control||Prospective|||||||
1416993|NCT02070874|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1416994|NCT02070861||Single Group Assignment||Basic Science||None (Open Label)||||||
1416995|NCT02070848|||Case-Only||Prospective|||||||
1416996|NCT02070835|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416997|NCT02070822|||Case-Only||Prospective|||||||
1416998|NCT02070809|Randomized|Parallel Assignment||Treatment||Single|||t|||
1416999|NCT02070796|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417000|NCT02070783|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1417001|NCT02070770|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417002|NCT02070757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417003|NCT02070744|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417004|NCT02070731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417005|NCT02070718|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417006|NCT02070705|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1417007|NCT02070692|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417008|NCT02070679|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1417009|NCT02070666|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417010|NCT02070653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417011|NCT02070640||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417012|NCT02070627||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417013|NCT02070614|||Cohort|||||||||
1417014|NCT02070601||||||||||||
1417015|NCT02070588|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1417016|NCT02070575|||Cohort||Retrospective|||||||
1417017|NCT02070562|||Ecologic or Community||Prospective|||||||
1417018|NCT02070549||Single Group Assignment||Treatment||None (Open Label)||||||
1417019|NCT02070536|||Cohort||Prospective|||||||
1417020|NCT02070523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417021|NCT02070510|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417022|NCT02070497|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1417023|NCT02070484|Randomized|Parallel Assignment||Treatment||Single|||t|||
1417024|NCT02070471|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417025|NCT02070458||Single Group Assignment||Treatment||None (Open Label)||||||
1417026|NCT02070445|||Cohort||Prospective|||||||
1417027|NCT02070432||Single Group Assignment||Treatment||None (Open Label)||||||
1417028|NCT02070419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417029|NCT02070406||Single Group Assignment||Treatment||None (Open Label)||||||
1417030|NCT02070393||Single Group Assignment||Treatment||Single|||||t|
1417031|NCT02070380|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1417032|NCT02070367|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1417033|NCT02070354|||Cohort||Prospective|||||||
1417034|NCT02070341|Randomized|Parallel Assignment||||Single||||||t
1417035|NCT02070328|||Case-Control||Prospective|||||||
1417036|NCT02070315|||Cohort||Prospective|||||||
1417037|NCT02070302|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417038|NCT02070289|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1417039|NCT02070276|Randomized|Parallel Assignment||Prevention||Single||||||t
1417040|NCT02070263|||Other||Prospective|||||||
1417041|NCT02070250||Single Group Assignment||Supportive Care||None (Open Label)||||||
1417042|NCT02070237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417043|NCT02070224||Single Group Assignment||Other||None (Open Label)||||||
1417044|NCT02070211|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417045|NCT02070198|Randomized|Parallel Assignment||Treatment||Single|||t|||
1417046|NCT02070185|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1417047|NCT02070172|||||Prospective|||||||
1417048|NCT02070159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417049|NCT02070146|||Cohort||Prospective|||||||
1417050|NCT02070133|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417051|NCT02070120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417052|NCT02070107||Single Group Assignment||Supportive Care||None (Open Label)||||||
1417053|NCT02070081|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417054|NCT02070068|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1417055|NCT02070055|||Case-Only||Cross-Sectional|||||||
1417056|NCT02070042|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417057|NCT02070029||Single Group Assignment||Treatment||None (Open Label)||||||
1417058|NCT02070016|Randomized|Crossover Assignment||Treatment||Single|||t|||
1417059|NCT02070003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417060|NCT02069990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417061|NCT02069977||Single Group Assignment||Treatment||None (Open Label)||||||
1417063|NCT02069951|Randomized|Parallel Assignment||||None (Open Label)||||||
1417064|NCT02069938|||Case-Only||Prospective|||||||
1417065|NCT02069925|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417066|NCT02069912||Single Group Assignment||Health Services Research||None (Open Label)||||||
1417067|NCT02069899||Single Group Assignment||Other||None (Open Label)||||||
1417068|NCT02069886|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1417069|NCT02069873|Randomized|Parallel Assignment||Treatment||Single||||||t
1417070|NCT02069860||Single Group Assignment||Treatment||None (Open Label)||||||
1417071|NCT02069847||Single Group Assignment||Treatment||None (Open Label)||||||
1417072|NCT02069834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417073|NCT02069821|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1417074|NCT02069808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417075|NCT02069795||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417076|NCT02069782||Single Group Assignment||Health Services Research||None (Open Label)||||||
1417077|NCT02069769||Single Group Assignment||Supportive Care||None (Open Label)||||||
1417078|NCT02069756|||Cohort||Prospective|||||||
1417079|NCT02069743|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417080|NCT02069730|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417081|NCT02069717|||Case-Only||Prospective|||||||
1417082|NCT02069704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417083|NCT02069691||Single Group Assignment||Treatment||None (Open Label)||||||
1417084|NCT02069678|||Cohort||Prospective|||||||
1417085|NCT02069665|Randomized|Parallel Assignment||Treatment||Single||||||t
1417086|NCT02069652||||||||||||
1417087|NCT02069639|||Case-Only||Retrospective|||||||
1417088|NCT02069626|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417089|NCT02069613|||Cohort||Prospective|||||||
1417090|NCT02069600|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1417091|NCT02069587|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417092|NCT02069574|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1417093|NCT02069561|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1417094|NCT02069548|||Case Control||Cross-Sectional|||||||
1417095|NCT02069535||Single Group Assignment||Treatment||None (Open Label)||||||
1417096|NCT02069522|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1417097|NCT02069509|||Cohort||Prospective|||||||
1417098|NCT02069496|||||Prospective|||||||
1417099|NCT02069483|Randomized|Parallel Assignment||||None (Open Label)||||||
1417100|NCT02069470|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1417101|NCT02069457|||Cohort||Prospective|||||||
1417102|NCT02069444|||Case Control||Prospective|||||||
1417103|NCT02069431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417104|NCT02069418||Single Group Assignment||||None (Open Label)||||||
1417105|NCT02069405|Randomized|Parallel Assignment||||Single||||||t
1417106|NCT02069392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417107|NCT02069379|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1417108|NCT02069366|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1417109|NCT02069353||Single Group Assignment||Treatment||None (Open Label)||||||
1417110|NCT02069340|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1417111|NCT02069327|||Case-Only||Prospective|||||||
1417112|NCT02069314|Randomized|Crossover Assignment||||Single|||t|||
1417113|NCT02069301|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417114|NCT02069288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417115|NCT02069275|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417116|NCT02069262|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1417117|NCT02069249|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417118|NCT02069236||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417119|NCT02069223|Randomized|Factorial Assignment||Treatment||Single|||t|||
1417120|NCT02069210|||Cohort||Prospective|||||||
1417121|NCT02069197|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1417122|NCT02069184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417123|NCT02069171|||Case-Only||Cross-Sectional|||||||
1417124|NCT02069158||Single Group Assignment||Treatment||None (Open Label)||||||
1417125|NCT02069145||Single Group Assignment||Treatment||None (Open Label)||||||
1417126|NCT02069132|||Cohort||Prospective|||||||
1417127|NCT02069119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417128|NCT02069106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417129|NCT02069093||Single Group Assignment||Prevention||None (Open Label)||||||
1417130|NCT02069080||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417131|NCT02069067|||Cohort||Prospective|||||||
1417132|NCT02069054|||Case Control||Prospective|||||||
1417133|NCT02069041||Single Group Assignment||Treatment||None (Open Label)||||||
1417134|NCT02069028||||||||||||
1417135|NCT02069015|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417136|NCT02069002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417137|NCT02068989|||Cohort||Prospective|||||||
1417138|NCT02068976|||Cohort||Prospective|||||||
1417139|NCT02068963|||Cohort||Prospective|||||||
1417140|NCT02068950||Single Group Assignment||||None (Open Label)||||||
1417141|NCT02068937|Randomized|Parallel Assignment||Treatment||Single||||||t
1417142|NCT02068924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417143|NCT02068911|||||Prospective|||||||
1417144|NCT02068898|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417145|NCT02068885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417146|NCT02068872||Single Group Assignment||Treatment||None (Open Label)||||||
1417147|NCT02068859|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417148|NCT02068846|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417149|NCT02068833|||Cohort||Prospective|||||||
1417150|NCT02068820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417151|NCT02068807|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1417152|NCT02068794||Single Group Assignment||Treatment||None (Open Label)||||||
1417153|NCT02068781|Randomized|Crossover Assignment||Other||Double|||t||t|
1417154|NCT02068768|||Cohort||Prospective|||||||
1417155|NCT02068755|||Cohort||Prospective|||||||
1417156|NCT02068742|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||First arm of the study considers patients from the operating room with general anesthesia; Second arm of the study considers patients from geriatric regular general ward, without any anesthesia.||||
1417157|NCT02068729|||Cohort||Prospective|||||||
1417158|NCT02068716|||Case-Only||Prospective|||||||
1417159|NCT02068703|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1417160|NCT02068690|Randomized|Crossover Assignment||Treatment||Single||||||
1417161|NCT02068677|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1417162|NCT02068664|||Cohort||Prospective|||||||
1417163|NCT02068651|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1417164|NCT02068638|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1417165|NCT02068625|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1417166|NCT02068612|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417167|NCT02068599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417168|NCT02068586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417169|NCT02068573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417170|NCT02068560||Single Group Assignment||Basic Science||None (Open Label)||||||
1417171|NCT02068547|Randomized|Parallel Assignment||Treatment||Single|||t|||
1417172|NCT02068534|||||Retrospective|||||||
1417173|NCT02068521|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417174|NCT02068508|||Cohort||Prospective|||||||
1417175|NCT02068495|||Cohort||Prospective|||||||
1417176|NCT02068482|Randomized|Parallel Assignment||Treatment||Single|||||t|
1417177|NCT02068469|||Cohort||Prospective|||||||
1417178|NCT02068456|||Other||Prospective|||||||
1417179|NCT02068443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417180|NCT02068430||Single Group Assignment||Treatment||None (Open Label)||||||
1417181|NCT02068417|Randomized|Parallel Assignment||Treatment||Single|||t|||
1417182|NCT02068404||Single Group Assignment||Treatment||None (Open Label)||||||
1417183|NCT02068391|Randomized|Crossover Assignment||Prevention||Single||||||t
1417184|NCT02068378||Single Group Assignment||Other||None (Open Label)||||||
1417185|NCT02068365||Single Group Assignment||Treatment||None (Open Label)||||||
1417186|NCT02068352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417187|NCT02068339|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417188|NCT02068326|Randomized|Parallel Assignment||Treatment||Single||||||t
1417189|NCT02068313|||Cohort||Prospective|||||||
1417190|NCT02068300|||Case-Only||Cross-Sectional|||||||
1417191|NCT02068287||Single Group Assignment||Treatment||None (Open Label)||||||
1417192|NCT02068274|||Cohort||Prospective|||||||
1417193|NCT02068261|Randomized|Parallel Assignment||Treatment||Single||||||t
1417194|NCT02068248|||||Retrospective|||||||
1417195|NCT02068235|Randomized|Crossover Assignment||||None (Open Label)||||||
1417196|NCT02068222||Single Group Assignment||Treatment||None (Open Label)||||||
1417197|NCT02068209|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1417198|NCT02068196||Single Group Assignment||Treatment||None (Open Label)||||||
1417199|NCT02068183|||Cohort||Cross-Sectional|||||||
1417200|NCT02068170|||Cohort||Prospective|||||||
1417201|NCT02068157||Single Group Assignment||Treatment||None (Open Label)||||||
1417202|NCT02068144|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1417203|NCT02068131||Single Group Assignment||Treatment||None (Open Label)||||||
1417204|NCT02068118|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417205|NCT02068105|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417206|NCT02068092||Single Group Assignment||Prevention||None (Open Label)||||||
1417207|NCT02068079||Single Group Assignment||Treatment||None (Open Label)||||||
1417208|NCT02068066|||Cohort||Cross-Sectional|||||||
1417209|NCT02068053||Single Group Assignment||||None (Open Label)||||||
1417210|NCT02068040|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417211|NCT02068027|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417212|NCT02068014|||Cohort||Prospective|||||||
1417213|NCT02068001|||Cohort||Prospective|||||||
1417214|NCT02067988||Single Group Assignment||Treatment||None (Open Label)||||||
1417215|NCT02067975|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417216|NCT02067962||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417217|NCT02067949|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1417218|NCT02067936|Randomized|Parallel Assignment||||Triple|||t|t|t|
1417219|NCT02067923|||Cohort||Prospective|||||||
1417220|NCT02067910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417221|NCT02067897|||Cohort||Prospective|||||||
1417222|NCT02067884||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417223|NCT02067871|Randomized|Parallel Assignment||Treatment||Single||||||t
1417224|NCT02067858||Single Group Assignment||Other||None (Open Label)||||||
1417225|NCT02067845||Single Group Assignment||Prevention||None (Open Label)||||||
1417226|NCT02067832|||Case-Control||Prospective|||||||
1417227|NCT02067819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417228|NCT02067806|||Cohort||Prospective|||||||
1417229|NCT02067793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417230|NCT02067780|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1417231|NCT02067767||Single Group Assignment||Treatment||None (Open Label)||||||
1417232|NCT02067754|||Other||Other|||||||
1417233|NCT02067741|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417234|NCT02067728|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417235|NCT02067715|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1417236|NCT02067702|||Case-Control||Prospective|||||||
1417237|NCT02067689|||Cohort||Prospective|||||||
1417238|NCT02067676|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417239|NCT02067663|||Cohort||Prospective|||||||
1417240|NCT02067650|||Other||Cross-Sectional|||||||
1417241|NCT02067637|||Case-Control||Prospective|||||||
1417242|NCT02067624|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417243|NCT02067611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417244|NCT02067598|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1417245|NCT02067585|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417246|NCT02067572|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1417247|NCT02067559|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417248|NCT02067546|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417249|NCT02067533||||||||||||
1417250|NCT02067520|Non-Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1417251|NCT02067507|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417252|NCT02067494|Randomized|Single Group Assignment||Treatment||Single|||t|||
1417253|NCT02067481||Single Group Assignment||Prevention||None (Open Label)||||||
1417254|NCT02067468|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1417255|NCT02067455||Single Group Assignment||||None (Open Label)||||||
1417256|NCT02067442|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1417257|NCT02067429|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1417258|NCT02067416|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417259|NCT02067403||Single Group Assignment||Treatment||None (Open Label)||||||
1417260|NCT02067390|||Cohort||Prospective|||||||
1417261|NCT02067377|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417262|NCT02067364||Single Group Assignment||||None (Open Label)||||||
1417263|NCT02067351||Single Group Assignment||Supportive Care||None (Open Label)||||||
1417264|NCT02067338|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1417265|NCT02067325|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1417266|NCT02067312|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1417267|NCT02067299|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417268|NCT02067286|||Cohort||Prospective|||||||
1417269|NCT02067273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417270|NCT02067260||Parallel Assignment||Treatment||||||||
1417271|NCT02067247||Single Group Assignment||Screening||None (Open Label)||||||
1417272|NCT02067234|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417273|NCT02067221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417274|NCT02067208|Randomized|Parallel Assignment||Treatment||Double||||t||t
1417275|NCT02067195|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1417276|NCT02067182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417277|NCT02067169|||Cohort||Prospective|||||||
1417278|NCT02067156||Single Group Assignment||Treatment||None (Open Label)||||||
1417279|NCT02067143||Single Group Assignment||Treatment||None (Open Label)||||||
1417280|NCT02067130||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417281|NCT02067117|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1417282|NCT02067104|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1417283|NCT02067091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417284|NCT02067078|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417285|NCT02067065|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1417286|NCT02067052|||Case-Control||Prospective|||||||
1417287|NCT02067039|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1417288|NCT02067026|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1417289|NCT02067013|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1417290|NCT02067000|||Cohort||Prospective|||||||
1417291|NCT02066987|Randomized|Parallel Assignment||Prevention||Single||||||t
1417292|NCT02066974|||Cohort||Prospective|||||||
1417293|NCT02066961|||Cohort||Prospective|||||||
1417294|NCT02066948|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1417295|NCT02066935|||||Cross-Sectional|||||||
1417296|NCT02066922|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1417297|NCT02066909|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1417298|NCT02066896|Randomized|Parallel Assignment||Treatment||Single||||||t
1417299|NCT02066870||Single Group Assignment||Treatment||None (Open Label)||||||
1417300|NCT02066857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417301|NCT02066844|Randomized|Parallel Assignment||Treatment||Single|||t|||
1417302|NCT02066831|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1417303|NCT02066818|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1417304|NCT02066805|||Cohort||Retrospective|||||||
1417305|NCT02066792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417306|NCT02066766|||Ecologic or Community||Cross-Sectional|||||||
1417307|NCT02066753|Randomized|Parallel Assignment||Treatment||Single||||||t
1417308|NCT02066740||Single Group Assignment||Treatment||None (Open Label)||||||
1417309|NCT02066727|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1417310|NCT02066714|||Case Control||Prospective|||||||
1417311|NCT02066701|||Case-Control||Prospective|||||||
1417312|NCT02066688|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1417313|NCT02066675||Single Group Assignment||Treatment||None (Open Label)||||||
1417314|NCT02066662|Randomized|Parallel Assignment||Basic Science||Single||||||t
1417315|NCT02066649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417316|NCT02066636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417317|NCT02066623|||Case-Only||Prospective|||||||
1417318|NCT02066610|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1417319|NCT02066597||Single Group Assignment||Treatment||None (Open Label)||||||
1417320|NCT02066584|||Cohort||Retrospective|||||||
1417321|NCT02066571|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1417322|NCT02066558|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1417323|NCT02066545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417324|NCT02066532||Single Group Assignment||Treatment||None (Open Label)||||||
1417325|NCT02066519|Randomized|Parallel Assignment||Treatment||Single||||||t
1417326|NCT02066506|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1417327|NCT02066493|||Cohort||Prospective|||||||
1417328|NCT02066480|||Cohort||Prospective|||||||
1417329|NCT02066467|||Cohort||Prospective|||||||
1417330|NCT02066454||Single Group Assignment||Treatment||None (Open Label)||||||
1417331|NCT02066441|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1417332|NCT02066428|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417333|NCT02066415|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1417334|NCT02066402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417335|NCT02066389|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417336|NCT02066363|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417337|NCT02066350||Single Group Assignment||Basic Science||None (Open Label)||||||
1417338|NCT02066337|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417339|NCT02066324||||||||||||
1417340|NCT02066311||Single Group Assignment||Treatment||None (Open Label)||||||
1417341|NCT02066298|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417342|NCT02066285||Single Group Assignment||Treatment||None (Open Label)||||||
1417343|NCT02066272|||Cohort||Prospective|||||||
1417344|NCT02066259|||Case Control||Cross-Sectional|||||||
1417345|NCT02066246|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417346|NCT02066233|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1417347|NCT02066220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417348|NCT02066207|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417349|NCT02066194|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417350|NCT02066181|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1417351|NCT02066155|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417352|NCT02066142|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1417353|NCT02066129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417354|NCT02066116|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1417355|NCT02066103||Single Group Assignment||Supportive Care||None (Open Label)||||||
1417356|NCT02066090|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1417357|NCT02066077|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417358|NCT02066064|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1417359|NCT02066051||Single Group Assignment||Treatment||None (Open Label)||||||
1417360|NCT02066038||Single Group Assignment||Treatment||None (Open Label)||||||
1417361|NCT02066025|||Case Control||Cross-Sectional|||||||
1417362|NCT02066012|||Case Control||Cross-Sectional|||||||
1417363|NCT02065999|||Cohort||Prospective|||||||
1417364|NCT02065986|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1417365|NCT02065973|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1417366|NCT02065960||Single Group Assignment||Treatment||None (Open Label)||||||
1417367|NCT02065947|Randomized|Parallel Assignment||Treatment||Single||||||t
1417368|NCT02065934|||||Prospective|||||||
1417369|NCT02065921|||Cohort||Cross-Sectional|||||||
1417370|NCT02065908|||Cohort||Prospective|||||||
1417371|NCT02065895|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Study subjects are studied under closed-loop control on three occasions: once with the glucose values used for control equal to blood glucose (NO error), once with values 33% higher than blood glucose (HIGH error), and once with values 20% lower than blood glucose (LOW error). The six different sequences of these three exposures then comprise the six arms of this crossover study.||||
1417372|NCT02065882||Single Group Assignment||Treatment||None (Open Label)||||||
1417373|NCT02065869||Single Group Assignment||Treatment||None (Open Label)||||||
1417374|NCT02065856||Single Group Assignment||||None (Open Label)||||||
1417375|NCT02065843|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417376|NCT02065830||Single Group Assignment||Treatment||None (Open Label)||||||
1417377|NCT02065817||Single Group Assignment||Basic Science||None (Open Label)||||||
1417378|NCT02065804|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417379|NCT02065791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417380|NCT02065778||Single Group Assignment||Treatment||None (Open Label)||||||
1417381|NCT02065765||||||||||||
1417382|NCT02065752|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417383|NCT02065739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417384|NCT02065726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417385|NCT02065713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417386|NCT02065700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417387|NCT02065687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417388|NCT02065674||||||||||||
1417389|NCT02065661|||Case-Only||Prospective|||||||
1417390|NCT02065648|||Case-Only||Prospective|||||||
1417391|NCT02065635|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1417392|NCT02065622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417393|NCT02065609|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1417394|NCT02065596||Single Group Assignment||Treatment||None (Open Label)||||||
1417395|NCT02065583|||Cohort||Prospective|||||||
1417396|NCT02065570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417397|NCT02065557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417398|NCT02065544||Single Group Assignment||Treatment||None (Open Label)||||||
1417399|NCT02065531|Randomized|Single Group Assignment||Treatment||Single|||t|||
1417400|NCT02065518|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1417401|NCT02065505|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1417402|NCT02065492|Randomized|Parallel Assignment||Prevention||Single||||||t
1417403|NCT02065479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417404|NCT02065466||Single Group Assignment||Treatment||None (Open Label)||||||
1417405|NCT02065453|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417406|NCT02065440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417407|NCT02065427|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1417408|NCT02065414|Randomized|Parallel Assignment||||Triple|||t||t|t
1417409|NCT02065401|Randomized|Crossover Assignment||||None (Open Label)||||||
1417410|NCT02065388|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1417411|NCT02065375|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417412|NCT02065362||Single Group Assignment||Treatment||None (Open Label)||||||
1417413|NCT02065349|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417414|NCT02065336|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417415|NCT02065323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417416|NCT02065310||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417417|NCT02065297|||||Prospective|||||||
1417418|NCT02065284|Randomized|Parallel Assignment||Treatment||Single||||||t
1417419|NCT02065271|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1417420|NCT02065258|Randomized|Parallel Assignment||Treatment||Single||||||t
1417421|NCT02065245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417422|NCT02065232|Randomized|Parallel Assignment||||Double|||t||t|
1417423|NCT02065219|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417424|NCT02065206|||Cohort||Prospective|||||||
1417425|NCT02065193|||Ecologic or Community||Prospective|||||||
1417426|NCT02065180|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417427|NCT02065167||Single Group Assignment||Treatment||None (Open Label)||||||
1417428|NCT02065154||Single Group Assignment||Prevention||None (Open Label)||||||
1417429|NCT02065141|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1417430|NCT02065128|||Case-Control||Prospective|||||||
1417431|NCT02065115|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417432|NCT02065102|||Case-Crossover||Prospective|||||||
1417433|NCT02065089||Single Group Assignment||Health Services Research||None (Open Label)||||||
1417434|NCT02065076|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417435|NCT02065063|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417436|NCT02065050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417437|NCT02065037|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1417438|NCT02065024|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1417439|NCT02065011||Single Group Assignment||Other||None (Open Label)||||||
1417440|NCT02064998|Randomized|Parallel Assignment||Prevention||Single|||||t|
1417441|NCT02064985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417442|NCT02064972|||Case-Only||Prospective|||||||
1417443|NCT02064959|Randomized|Parallel Assignment||Treatment||Single||||||t
1417444|NCT02064946|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1417445|NCT02064933|||Cohort||Other|||||||
1417446|NCT02064920|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1417447|NCT02064907|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417448|NCT02064894|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417449|NCT02064881|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417450|NCT02064868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417451|NCT02064855|||Cohort||Prospective|||||||
1417452|NCT02064842|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417453|NCT02064829|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417454|NCT02064816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417455|NCT02064803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417456|NCT02064790|||Cohort||Prospective|||||||
1417457|NCT02064777||Single Group Assignment||Treatment||None (Open Label)||||||
1417458|NCT02064764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417459|NCT02064751||Single Group Assignment||Treatment||None (Open Label)||||||
1417460|NCT02064738|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417461|NCT02064725||Single Group Assignment||Treatment||None (Open Label)||||||
1417462|NCT02064712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417463|NCT02064699|||Cohort||Prospective|||||||
1417464|NCT02064686||Single Group Assignment||Screening||Single|||||t|
1417465|NCT02064673|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1417466|NCT02064660||Single Group Assignment||Prevention||None (Open Label)||||||
1417467|NCT02064647|Non-Randomized|Crossover Assignment||Treatment||Single|||||t|
1417468|NCT02064634|||Cohort||Prospective|||||||
1417469|NCT02064621|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417470|NCT02064608||Single Group Assignment||Treatment||None (Open Label)||||||
1417471|NCT02064595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417472|NCT02064582||Single Group Assignment||Treatment||None (Open Label)||||||
1417473|NCT02064569||Single Group Assignment||Treatment||None (Open Label)||||||
1417474|NCT02064556|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417475|NCT02064543|||Cohort||Prospective|||||||
1417476|NCT02064530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417477|NCT02064517|Randomized|Parallel Assignment||Other||Single|||t|||
1417478|NCT02064504|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417479|NCT02064491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417480|NCT02064478|||Case-Control||Prospective|||||||
1417481|NCT02064465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417482|NCT02064452|Randomized|Parallel Assignment||Treatment||Single||||||t
1417483|NCT02064439|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417484|NCT02064426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417485|NCT02064413||Single Group Assignment||Prevention||None (Open Label)||||||
1417486|NCT02064400|||Case-Only||Cross-Sectional|||||||
1417487|NCT02064387|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417488|NCT02064374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417489|NCT02064361||Single Group Assignment||Basic Science||None (Open Label)||||||
1417490|NCT02064348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417491|NCT02064335|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1417492|NCT02064322|||Cohort||Prospective|||||||
1417493|NCT02064309||Single Group Assignment||Treatment||None (Open Label)||||||
1417494|NCT02064296|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1417495|NCT02064283||Single Group Assignment||||None (Open Label)||||||
1417496|NCT02064270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417497|NCT02064257|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1417498|NCT02064244|||||Prospective|||||||
1417499|NCT02064231|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1417500|NCT02064218|||Cohort||Prospective|||||||
1417501|NCT02064205|Randomized|Crossover Assignment||Health Services Research||Quadruple||Breakfast meal with or without polydextrose|t|t|t|t
1417502|NCT02064192|||Cohort||Prospective|||||||
1417503|NCT02064179|||Case-Only||Prospective|||||||
1417504|NCT02064166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417505|NCT02064153|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1417506|NCT02064140||Single Group Assignment||Prevention||None (Open Label)||||||
1417507|NCT02064127|||Cohort||Retrospective|||||||
1417508|NCT02064114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417509|NCT02064101|||Cohort||Prospective|||||||
1417510|NCT02064088|Randomized|Parallel Assignment||||Single|||t|||
1417511|NCT02064075|Randomized|Parallel Assignment||Treatment||Single|||t|||
1417512|NCT02064062||Single Group Assignment||Treatment||None (Open Label)||||||
1417513|NCT02064049||Single Group Assignment||Treatment||None (Open Label)||||||
1417514|NCT02064036||Single Group Assignment||Treatment||None (Open Label)||||||
1417515|NCT02064023|Randomized|Parallel Assignment||Treatment||Single||||||t
1417516|NCT02064010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417517|NCT02063997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417518|NCT02063984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417519|NCT02063971||Single Group Assignment||Treatment||Double|||t||t|
1417520|NCT02063958||Single Group Assignment||Treatment||None (Open Label)||||||
1417521|NCT02063945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417522|NCT02063932|||Case Control||Prospective|||||||
1417523|NCT02063919|||Case Control||Prospective|||||||
1417524|NCT02063906|||Other||Retrospective|||||||
1417525|NCT02063893|||Case Control||Prospective|||||||
1417526|NCT02063880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417527|NCT02063867|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1417528|NCT02063854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417529|NCT02063841|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1417530|NCT02063828|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417531|NCT02063815|Randomized|Parallel Assignment||Prevention||Single|||t|||
1417532|NCT02063802|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417533|NCT02063789||Single Group Assignment||Treatment||None (Open Label)||||||
1417534|NCT02063776|||Case-Control||Prospective|||||||
1417535|NCT02063763|||Case-Only||Retrospective|||||||
1417536|NCT02063750|Randomized|Parallel Assignment||Treatment||Single||||||t
1417537|NCT02063737|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417538|NCT02063724||Single Group Assignment||Prevention||None (Open Label)||||||
1417539|NCT02063711|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1417540|NCT02063698|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1417541|NCT02063685|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417542|NCT02063672|Randomized|Parallel Assignment||Treatment||Single||||||t
1417543|NCT02063659|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417544|NCT02063646|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417545|NCT02063633|||Case Control||Prospective|||||||
1417546|NCT02063620|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1417547|NCT02063607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417548|NCT02063594|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1417549|NCT02063581|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417550|NCT02063568|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1417551|NCT02063555|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417552|NCT02063542|||Case-Only||Prospective|||||||
1417553|NCT02063529|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417554|NCT02063516|Randomized|Parallel Assignment||||Single|||t|||
1417555|NCT02063503|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417556|NCT02063490|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417557|NCT02063477|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417558|NCT02063464|||Cohort||Cross-Sectional|||||||
1417559|NCT02063451|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1417560|NCT02063438|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1417561|NCT02063425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417562|NCT02063412|||Other||Cross-Sectional|||||||
1417563|NCT02063399|||Cohort||Prospective|||||||
1417564|NCT02063386|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1417565|NCT02063373||Single Group Assignment||Basic Science||None (Open Label)||||||
1417566|NCT02063360|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1417567|NCT02063347|||Cohort||Prospective|||||||
1417568|NCT02063334|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1417569|NCT02063321|||Cohort||Prospective|||||||
1417570|NCT02063308||Single Group Assignment||Basic Science||None (Open Label)||||||
1417571|NCT02063295|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417572|NCT02063282|||Cohort||Prospective|||||||
1417573|NCT02063269||Single Group Assignment||Basic Science||None (Open Label)||||||
1417574|NCT02063256|Randomized|Parallel Assignment||Treatment||Single||||||t
1417575|NCT02063243||Single Group Assignment||Treatment||None (Open Label)||||||
1417576|NCT02063230|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1417577|NCT02063217|Randomized|Parallel Assignment||Other||Single|||t|||
1417578|NCT02063204|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1417579|NCT02063191|||Cohort||Prospective|||||||
1417580|NCT02063178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417581|NCT02063165||Single Group Assignment||Treatment||None (Open Label)||||||
1417582|NCT02063152|||Cohort||Prospective|||||||
1417583|NCT02063139|Randomized|Crossover Assignment||Treatment||Single||||||t
1417584|NCT02063126|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417585|NCT02063113||Single Group Assignment||||None (Open Label)||||||
1417586|NCT02063100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417587|NCT02063087|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1417588|NCT02063074|||Cohort||Prospective|||||||
1417589|NCT02063061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417590|NCT02063048|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1417591|NCT02063035|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1417592|NCT02063022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417593|NCT02063009|||Cohort||Prospective|||||||
1417594|NCT02062996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417595|NCT02062983|||Cohort||Prospective|||||||
1417596|NCT02062970||Single Group Assignment||Basic Science||None (Open Label)||||||
1417597|NCT02062957|||Case Control||Prospective|||||||
1417598|NCT02062944||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417599|NCT02062931||Single Group Assignment||Treatment||None (Open Label)||||||
1417600|NCT02062918|Randomized|Parallel Assignment||Treatment||Single||||||t
1417601|NCT02062905|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417602|NCT02062892|Randomized|Crossover Assignment||||None (Open Label)||||||
1417603|NCT02062879|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417604|NCT02062866|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417605|NCT02062853|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1417606|NCT02062840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417607|NCT02062827||Single Group Assignment||Treatment||None (Open Label)||||||
1417608|NCT02062801|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417609|NCT02062788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417610|NCT02062775|Randomized|Parallel Assignment||Treatment||Single|||t|||
1417611|NCT02062762|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1417612|NCT02062749||Single Group Assignment||Treatment||None (Open Label)||||||
1417613|NCT02062736|||Cohort||Prospective|||||||
1417614|NCT02062723|||Cohort||Prospective|||||||
1417615|NCT02062710|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1417616|NCT02062697||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417617|NCT02062684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417618|NCT02062671|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417619|NCT02062658||Single Group Assignment||Treatment||None (Open Label)||||||
1417620|NCT02062645||Single Group Assignment||Treatment||None (Open Label)||||||
1417621|NCT02062632|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1417622|NCT02062619|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1417623|NCT02062606|||Cohort||Prospective|||||||
1417624|NCT02062593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417625|NCT02062580|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1417626|NCT02062567|||Cohort||Prospective|||||||
1417627|NCT02062554|||Cohort||Prospective|||||||
1417628|NCT02062541|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1417629|NCT02062528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417630|NCT02062515||Single Group Assignment||Treatment||None (Open Label)||||||
1417631|NCT02062502|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1417632|NCT02062489|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417633|NCT02062476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417634|NCT02062463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417635|NCT02062450|||Cohort||Retrospective|||||||
1417636|NCT02062437|||Cohort||Retrospective|||||||
1417637|NCT02062424|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417638|NCT02062411|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417639|NCT02062398||Single Group Assignment||Treatment||None (Open Label)||||||
1417640|NCT02062385|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1417641|NCT02062372||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417642|NCT02062359||Single Group Assignment||Treatment||None (Open Label)||||||
1417643|NCT02062346|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1417644|NCT02062333|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417645|NCT02062320|||Cohort||Retrospective|||||||
1417646|NCT02062307|||Case Control||Cross-Sectional|||||||
1417647|NCT02062294|||Cohort||Retrospective|||||||
1417648|NCT02062281|Randomized|Parallel Assignment||Prevention||Single|||t|||
1417649|NCT02062268|||Ecologic or Community||Cross-Sectional|||||||
1417650|NCT02062255|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1417651|NCT02062242|Randomized|Parallel Assignment||Treatment||Single|||||t|
1417652|NCT02062229|||Case Control||Cross-Sectional|||||||
1417653|NCT02062216|||Cohort||Prospective|||||||
1417654|NCT02062203|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1417655|NCT02062190|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417656|NCT02062177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417657|NCT02062164|||Case-Control||Prospective|||||||
1417658|NCT02062151||Single Group Assignment||||None (Open Label)||||||
1417659|NCT02062138|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1417660|NCT02062125|||Cohort||Prospective|||||||
1417661|NCT02062112|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1417662|NCT02062099||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417663|NCT02062086|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417664|NCT02062073|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417665|NCT02062060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417666|NCT02062047|Randomized|Parallel Assignment||Treatment||Single||||||t
1417667|NCT02062034|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417668|NCT02062021|||Cohort||Retrospective|||||||
1417669|NCT02062008||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417670|NCT02061995||Single Group Assignment||Treatment||None (Open Label)||||||
1417671|NCT02061982|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417672|NCT02061969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417673|NCT02061956|||Cohort||Prospective|||||||
1417674|NCT02061943|||Case-Only||Prospective|||||||
1417675|NCT02061930|||Cohort||Retrospective|||||||
1417676|NCT02061917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417677|NCT02061904|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1417678|NCT02061891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417679|NCT02061878|Randomized|Parallel Assignment||||Triple|||t||t|t
1417680|NCT02061865||Single Group Assignment||Treatment||None (Open Label)||||||
1417681|NCT02061852|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417682|NCT02061839|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1417683|NCT02061826|||Case Control|||||||||
1417684|NCT02061813|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417685|NCT02061800|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417686|NCT02061787|||Cohort||Prospective|||||||
1417687|NCT02061774|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417688|NCT02061761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417689|NCT02061748|||Other||Retrospective|||||||
1417690|NCT02061735|||Case Control||Prospective|||||||
1417691|NCT02061722||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417692|NCT02061709|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417693|NCT02061696|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1417694|NCT02061683||Single Group Assignment||Treatment||None (Open Label)||||||
1417695|NCT02061670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417696|NCT02061657|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1417697|NCT02061644||Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1417698|NCT02061631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417699|NCT02061618|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1417700|NCT02061605||Single Group Assignment||Treatment||None (Open Label)||||||
1417701|NCT02061592|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1417702|NCT02061579|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1417703|NCT02061566|||Cohort||Prospective|||||||
1417704|NCT02061553|Randomized|Parallel Assignment||Treatment||Single||||||t
1417705|NCT02061540||Single Group Assignment||Treatment||None (Open Label)||||||
1417706|NCT02061527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417707|NCT02061514|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1417708|NCT02061501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417709|NCT02061488|Randomized|Crossover Assignment||||None (Open Label)||||||
1417710|NCT02061475|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417711|NCT02061462|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1417712|NCT02061449|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417713|NCT02061436|||Cohort||Prospective|||||||
1417714|NCT02061423||Single Group Assignment||Prevention||None (Open Label)||||||
1417715|NCT02061410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417716|NCT02061397||Single Group Assignment||Treatment||None (Open Label)||||||
1417717|NCT02061384|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417718|NCT02061371|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1417719|NCT02061358|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417720|NCT02061345|||Case Control||Cross-Sectional|||||||
1417721|NCT02061332|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417722|NCT02061319|Randomized|Parallel Assignment||Treatment||Single||||||t
1417723|NCT02061306|||Cohort||Prospective|||||||
1417724|NCT02061293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417725|NCT02061280|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1417726|NCT02061267|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1417727|NCT02061254||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417728|NCT02061241|||Case-Only||Prospective|||||||
1417729|NCT02061228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417730|NCT02061215|||Case Control||Prospective|||||||
1417731|NCT02061202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417732|NCT02061189|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417733|NCT02061176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417734|NCT02061163||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417735|NCT02061150|||Cohort||Retrospective|||||||
1417736|NCT02061137||Single Group Assignment||Treatment||None (Open Label)||||||
1417737|NCT02061124|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1417738|NCT02061111|||Case-Control||Prospective|||||||
1417739|NCT02061098|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1417740|NCT02061085||Single Group Assignment||Treatment||None (Open Label)||||||
1417741|NCT02061072|||Other||Other|||||||
1417742|NCT02061059|Randomized|Parallel Assignment||||None (Open Label)||||||
1417743|NCT02061046|||Case-Only||Prospective|||||||
1417744|NCT02061033|||Case Control||Cross-Sectional|||||||
1417745|NCT02061020|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417746|NCT02061007||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417747|NCT02060994|||Cohort||Retrospective|||||||
1417748|NCT02060981|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1417749|NCT02060968|||Cohort||Prospective|||||||
1417750|NCT02060955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417751|NCT02060942|||Cohort||Prospective|||||||
1417752|NCT02060929|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417753|NCT02060916||Single Group Assignment||Treatment||Single|||t|||
1417754|NCT02060903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417755|NCT02060890|||Other||Prospective|||||||
1417756|NCT02060877|||Cohort||Prospective|||||||
1417757|NCT02060864|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1417758|NCT02060851|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417759|NCT02060838|||Case-Only||Prospective|||||||
1417760|NCT02060825|||Case-Only||Prospective|||||||
1417761|NCT02060812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417762|NCT02060799|||Cohort||Prospective|||||||
1417763|NCT02060786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417764|NCT02060773|||Cohort||Prospective|||||||
1417765|NCT02060760|||Cohort||Prospective|||||||
1417766|NCT02060747|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1417767|NCT02060734|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1417768|NCT02060721||Single Group Assignment||Treatment||None (Open Label)||||||
1417769|NCT02060708|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1417770|NCT02060695|||Case-Only||Prospective|||||||
1417772|NCT02060669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417773|NCT02060656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417774|NCT02060643|||Cohort||Cross-Sectional|||||||
1417775|NCT02060630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417776|NCT02060617|Randomized|Parallel Assignment||Treatment||Single|||t|||
1417777|NCT02060604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417778|NCT02060591||||||||||||
1417779|NCT02060578||Single Group Assignment||||None (Open Label)||||||
1417780|NCT02060565|||Cohort||Other|||||||
1417781|NCT02060552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417782|NCT02060539||Single Group Assignment||Treatment||None (Open Label)||||||
1417783|NCT02060526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417784|NCT02060513|||Case Control||Prospective|||||||
1417785|NCT02060500||Single Group Assignment||Treatment||None (Open Label)||||||
1417786|NCT02060487|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417787|NCT02060474||Single Group Assignment||Treatment||None (Open Label)||||||
1417788|NCT02060461|Randomized|Single Group Assignment||Treatment||None (Open Label)||Contralateral eye study||||
1417789|NCT02060448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417790|NCT02060435|||Case Control||Retrospective|||||||
1417791|NCT02060422|Randomized|Parallel Assignment||Treatment||Single||||||t
1417792|NCT02060409|||Case-Only||Retrospective|||||||
1417793|NCT02060396||Single Group Assignment||Prevention||None (Open Label)||||||
1417794|NCT02060383|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417795|NCT02060370||Single Group Assignment||Treatment||None (Open Label)||||||
1417796|NCT02060357|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1417797|NCT02060344|||Cohort||Prospective|||||||
1417798|NCT02060331|||Cohort||Prospective|||||||
1417799|NCT02060318|||Cohort||Prospective|||||||
1417800|NCT02060305||Single Group Assignment||Treatment||None (Open Label)||||||
1417801|NCT02060292|||Case-Control||Prospective|||||||
1417802|NCT02060279|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1417803|NCT02060266|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417804|NCT02060253||Single Group Assignment||Treatment||None (Open Label)||||||
1417805|NCT02060240|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1417806|NCT02060227|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1417807|NCT02060214|||Case-Control||Prospective|||||||
1417808|NCT02060201|Randomized|Crossover Assignment||||None (Open Label)||||||
1417809|NCT02060188|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417810|NCT02060175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417811|NCT02060162|||Cohort||Prospective|||||||
1417812|NCT02060149|Randomized|Single Group Assignment||Treatment||Single|||t|||
1417813|NCT02060136|||Case-Crossover||Prospective|||||||
1417814|NCT02060123|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1417815|NCT02060110|||||Prospective|||||||
1417816|NCT02060097|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417817|NCT02060084|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417818|NCT02060071|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1417819|NCT02060058|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417820|NCT02060045||Single Group Assignment||Prevention||None (Open Label)||||||
1417821|NCT02060032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417822|NCT02060019|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1417823|NCT02060006|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417824|NCT02059993|Randomized|Parallel Assignment||Treatment||Single|||||t|
1417825|NCT02059980|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1417826|NCT02059967||Single Group Assignment||Treatment||None (Open Label)||||||
1417827|NCT02059954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417828|NCT02059941|||Cohort||Prospective|||||||
1417829|NCT02059928||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417830|NCT02059915|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1417831|NCT02059902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417832|NCT02059889||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417833|NCT02059876||Single Group Assignment||Treatment||None (Open Label)||||||
1417834|NCT02059863|Randomized|Parallel Assignment||Prevention||Single||||||t
1417835|NCT02059850||Single Group Assignment||Treatment||None (Open Label)||||||
1417836|NCT02059837|||Case-Only||Retrospective|||||||
1417837|NCT02059824|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1417838|NCT02059811||Single Group Assignment||Treatment||None (Open Label)||||||
1417839|NCT02059798|||Cohort||Prospective|||||||
1417840|NCT02059785|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417841|NCT02059772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417842|NCT02059759|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417843|NCT02059746|||Cohort||Prospective|||||||
1417844|NCT02059733||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417845|NCT02059720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417846|NCT02059707||Single Group Assignment||Basic Science||None (Open Label)||||||
1417847|NCT02059694|Randomized|Single Group Assignment||Treatment||Single|||t|||
1417848|NCT02059681||Single Group Assignment||Treatment||None (Open Label)||||||
1417849|NCT02059668|||Cohort||Prospective|||||||
1418160|NCT02055599|||Cohort||Prospective|||||||
1417850|NCT02059655|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417851|NCT02059642|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417852|NCT02059629|||Case-Only||Prospective|||||||
1417853|NCT02059616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417854|NCT02059603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417855|NCT02059590||Single Group Assignment||||None (Open Label)||||||
1417856|NCT02059577|Randomized|Parallel Assignment||Treatment||Single||||||t
1417857|NCT02059564|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417858|NCT02059551||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417859|NCT02059538|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1417860|NCT02059525|||Case-Control||Prospective|||||||
1417861|NCT02059512|Randomized|Parallel Assignment||Treatment||Single|||||t|
1417862|NCT02059499|Randomized|Crossover Assignment||Treatment||Single||||||t
1417863|NCT02059486|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417864|NCT02059473|Randomized|Parallel Assignment||Treatment||Single||||||t
1417865|NCT02059460|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1417866|NCT02059447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417867|NCT02059434|Randomized|Crossover Assignment||Treatment||Single|||t|||
1417868|NCT02059421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417869|NCT02059408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417870|NCT02059395|Randomized|Parallel Assignment||Other||Single||||||t
1417871|NCT02059382|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417872|NCT02059369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417873|NCT02059356|||Cohort||Prospective|||||||
1417874|NCT02059343|||||Prospective|||||||
1417875|NCT02059330|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1417876|NCT02059317|||Case-Control||Prospective|||||||
1417877|NCT02059304||||Screening||||||||
1417878|NCT02059291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417879|NCT02059278|Randomized|Parallel Assignment||Treatment||Single||||||t
1417880|NCT02059265||Single Group Assignment||Treatment||None (Open Label)||||||
1417881|NCT02059252||Single Group Assignment||Treatment||None (Open Label)||||||
1417882|NCT02059239|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417883|NCT02059226|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1417884|NCT02059213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417885|NCT02059200|Randomized|Parallel Assignment||Treatment||Single||||||t
1417886|NCT02059187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417887|NCT02059174|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1417888|NCT02059161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417889|NCT02059148|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1417890|NCT02059135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417891|NCT02059122|||Case-Only||Other|||||||
1417892|NCT02059109|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1417893|NCT02059096|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417894|NCT02059083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417895|NCT02059070|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1417896|NCT02059057||Single Group Assignment||Treatment||None (Open Label)||||||
1417897|NCT02059044|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1417898|NCT02059031|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417899|NCT02059018|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1417900|NCT02059005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417901|NCT02058992|||Cohort||Prospective|||||||
1417902|NCT02058979|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417903|NCT02058966|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1417904|NCT02058953|||Cohort||Prospective|||||||
1417905|NCT02058940||Single Group Assignment||Treatment||None (Open Label)||||||
1417906|NCT02058927|||Cohort||Prospective|||||||
1417907|NCT02058914|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1417908|NCT02058901|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1417909|NCT02058888|||Other||Prospective|||||||
1417910|NCT02058875|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1417911|NCT02058862|||Cohort||Prospective|||||||
1417912|NCT02058849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417913|NCT02058836|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1417914|NCT02058823|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1417915|NCT02058810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417916|NCT02058797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417917|NCT02058784|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1417918|NCT02058771|||Cohort||Prospective|||||||
1417919|NCT02058758|||Cohort||Prospective|||||||
1417920|NCT02058745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417921|NCT02058732|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1417922|NCT02058719|||Cohort||Prospective|||||||
1417923|NCT02058706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417924|NCT02058693|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1417925|NCT02058680||Single Group Assignment||Treatment||None (Open Label)||||||
1417926|NCT02058667||Single Group Assignment||Treatment||None (Open Label)||||||
1418392|NCT02052544|||||Prospective|||||||
1417927|NCT02058654|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1417928|NCT02058641|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1417929|NCT02058628|Randomized|Parallel Assignment||Treatment||Single|||||t|
1417930|NCT02058615|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417931|NCT02058602||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417932|NCT02058589|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1417933|NCT02058576|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1417934|NCT02058563|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1417935|NCT02058550|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417936|NCT02058537||Single Group Assignment||Treatment||None (Open Label)||||||
1417937|NCT02058524||Single Group Assignment||Treatment||None (Open Label)||||||
1417938|NCT02058511||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417939|NCT02058498||Single Group Assignment||||None (Open Label)||||||
1417940|NCT02058485|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1417941|NCT02058472|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1417942|NCT02058459|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1417943|NCT02058446||Single Group Assignment||Treatment||None (Open Label)||||||
1417944|NCT02058433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417945|NCT02058420|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1417946|NCT02058407|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1417947|NCT02058394|||Cohort||Prospective|||||||
1417948|NCT02058381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417949|NCT02058368|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1417950|NCT02058355|Randomized|Factorial Assignment||Health Services Research||Single|||||t|
1417951|NCT02058342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417952|NCT02058329|Randomized|Parallel Assignment||Prevention||Single|||||t|
1417953|NCT02058316|||Cohort||Prospective|||||||
1417954|NCT02058303|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1417955|NCT02058290|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1417956|NCT02058277||Crossover Assignment||Basic Science||None (Open Label)||||||
1417957|NCT02058264|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1417958|NCT02058251|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1417959|NCT02058238|||Case-Control||Prospective|||||||
1417960|NCT02058225|||Cohort||Prospective|||||||
1417961|NCT02058212|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1417962|NCT02058199|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417963|NCT02058186|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1417964|NCT02058173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417965|NCT02058160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417966|NCT02058147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417967|NCT02058134|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417968|NCT02058121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417969|NCT02058108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417970|NCT02058095|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1417971|NCT02058082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417972|NCT02058069||Single Group Assignment||Treatment||None (Open Label)||||||
1417973|NCT02058056||Single Group Assignment||Treatment||None (Open Label)||||||
1417974|NCT02058043|||Other||Prospective|||||||
1417975|NCT02058030|Randomized|Parallel Assignment||||Single|||t|||
1417976|NCT02058017||Single Group Assignment||Treatment||None (Open Label)||||||
1417977|NCT02058004|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1417978|NCT02057991|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1417979|NCT02057978|||Case Control||Prospective|||||||
1417980|NCT02057965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417981|NCT02057952|Randomized|Parallel Assignment||Treatment||Single||||||t
1417982|NCT02057939||Single Group Assignment||Treatment||None (Open Label)||||||
1417983|NCT02057926|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1417984|NCT02057913||Single Group Assignment||Treatment||None (Open Label)||||||
1417985|NCT02057900||Single Group Assignment||Treatment||None (Open Label)||||||
1417986|NCT02057887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417987|NCT02057874||Single Group Assignment||Diagnostic||None (Open Label)||||||
1417988|NCT02057861|||Case Control||Prospective|||||||
1417989|NCT02057848|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1417990|NCT02057835|Randomized|Parallel Assignment||Treatment||Double||||||
1417991|NCT02057822|||||Prospective|||||||
1417992|NCT02057809|||Family-Based||Cross-Sectional|||||||
1417993|NCT02057796|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1417994|NCT02057783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1417995|NCT02057770|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1417996|NCT02057757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1417997|NCT02057744|||Case-Control||Prospective|||||||
1417998|NCT02057731|||Case Control||Cross-Sectional|||||||
1417999|NCT02057718||Single Group Assignment||Treatment||None (Open Label)||||||
1418000|NCT02057705|||Cohort||Prospective|||||||
1418001|NCT02057692|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418002|NCT02057679|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1418003|NCT02057666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418004|NCT02057653|||Cohort||Retrospective|||||||
1418005|NCT02057640||Single Group Assignment||Treatment||None (Open Label)||||||
1418006|NCT02057627|Randomized|Parallel Assignment||Treatment||Single||||||t
1418007|NCT02057601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418008|NCT02057588||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418009|NCT02057575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418010|NCT02057562|||Cohort||Prospective|||||||
1418011|NCT02057549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418012|NCT02057536|Randomized|Parallel Assignment||Treatment||Single||||||t
1418013|NCT02057523||Single Group Assignment||Treatment||None (Open Label)||||||
1418014|NCT02057510|||Cohort||Prospective|||||||
1418015|NCT02057497|||Cohort||Other|||||||
1418016|NCT02057484|||Cohort||Prospective|||||||
1418017|NCT02057471||Single Group Assignment||Treatment||None (Open Label)||||||
1418018|NCT02057458|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1418019|NCT02057445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418020|NCT02057432||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1418021|NCT02057419|||Other||Prospective|||||||
1418022|NCT02057406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418023|NCT02057393||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418024|NCT02057380|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418025|NCT02057367|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1418026|NCT02057354|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418027|NCT02057341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418028|NCT02057328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418029|NCT02057315|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1418030|NCT02057302|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1418031|NCT02057289||Single Group Assignment||Basic Science||None (Open Label)||||||
1418032|NCT02057276|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1418033|NCT02057263|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1418034|NCT02057250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418035|NCT02057237||Single Group Assignment||Treatment||None (Open Label)||||||
1418036|NCT02057224||Single Group Assignment||Treatment||None (Open Label)||||||
1418037|NCT02057211|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1418038|NCT02057198|||Cohort||Prospective|||||||
1418039|NCT02057185|||Cohort||Cross-Sectional|||||||
1418040|NCT02057172|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418041|NCT02057159|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1418042|NCT02057146||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418043|NCT02057133|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418044|NCT02057120|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1418045|NCT02057107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418046|NCT02057094|Randomized|Parallel Assignment||Other||Double|||t||t|
1418047|NCT02057081|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418048|NCT02057068|Randomized|Sequential Assignment||Supportive Care||None (Open Label)|This efficacy study was not blinded.|Randomization to an immediate intervention group or a no-contact wait list control group. Following post intervention assessments the wait-list control group received the intervention.||||
1418049|NCT02057055|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418050|NCT02057042|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1418051|NCT02057029||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418052|NCT02057016|||Cohort||Retrospective|||||||
1418053|NCT02057003|||Cohort||Prospective|||||||
1418054|NCT02056990|||Cohort||Prospective|||||||
1418055|NCT02056977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418056|NCT02056964|||Cohort||Prospective|||||||
1418057|NCT02056951|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418058|NCT02056938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418059|NCT02056925||Single Group Assignment||Other||None (Open Label)||||||
1418060|NCT02056912||Single Group Assignment||||None (Open Label)||||||
1418061|NCT02056899||Single Group Assignment||Prevention||None (Open Label)||||||
1418062|NCT02056886|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1418063|NCT02056873||Single Group Assignment||Treatment||None (Open Label)||||||
1418064|NCT02056860|||Case-Only||Prospective|||||||
1418065|NCT02056847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418066|NCT02056834|||Cohort||Prospective|||||||
1418067|NCT02056821|||Cohort||Prospective|||||||
1418068|NCT02056808||Single Group Assignment||Treatment||None (Open Label)||||||
1418069|NCT02056795|Randomized|Parallel Assignment||||Single|||t|||
1418070|NCT02056782||Single Group Assignment||Treatment||None (Open Label)||||||
1418071|NCT02056769||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418072|NCT02056756||Single Group Assignment||Treatment||None (Open Label)||||||
1418073|NCT02056743|Randomized|Parallel Assignment||||None (Open Label)||||||
1418074|NCT02056730||Single Group Assignment||Treatment||None (Open Label)||||||
1418075|NCT02056717|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418076|NCT02056704|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1418077|NCT02056691||Single Group Assignment||Prevention||None (Open Label)||||||
1418078|NCT02056678|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418079|NCT02056665|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1418080|NCT02056652|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418081|NCT02056639|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418082|NCT02056626|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418083|NCT02056613|||Cohort||Prospective|||||||
1418084|NCT02056600|Randomized|Crossover Assignment||||None (Open Label)||||||
1418085|NCT02056587||Single Group Assignment||Treatment||None (Open Label)||||||
1418086|NCT02056574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418087|NCT02056561|||Case Control||Prospective|||||||
1418088|NCT02056548|||Case Control||Prospective|||||||
1418089|NCT02056535|Randomized|Parallel Assignment||Treatment||Single||||||t
1418090|NCT02056522|||Case-Only||Prospective|||||||
1418091|NCT02056509|||Cohort||Prospective|||||||
1418092|NCT02056496||Crossover Assignment||Basic Science||Double|||t|t||
1418093|NCT02056483|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418094|NCT02056470||Single Group Assignment||Treatment||None (Open Label)||||||
1418095|NCT02056457|Randomized|Single Group Assignment||Treatment||||||||
1418096|NCT02056444|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418097|NCT02056431|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1418098|NCT02056418|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418099|NCT02056405|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1418100|NCT02056392|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1418101|NCT02056379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418102|NCT02056366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418103|NCT02056353|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418104|NCT02056340|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418105|NCT02056327|||Case-Only||Cross-Sectional|||||||
1418106|NCT02056314|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418107|NCT02056301|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418108|NCT02056288|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418109|NCT02056275|Randomized|Parallel Assignment||||None (Open Label)||||||
1418110|NCT02056262|||Cohort||Cross-Sectional|||||||
1418111|NCT02056249|||Case-Crossover||Prospective|||||||
1418112|NCT02056236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418113|NCT02056223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418114|NCT02056210|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418115|NCT02056197|Randomized|Factorial Assignment||Treatment||Single||||||t
1418116|NCT02056184|Randomized|Parallel Assignment||Treatment||Single|||||t|
1418117|NCT02056171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418118|NCT02056158|||Case-Control||Cross-Sectional|||||||
1418119|NCT02056145|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1418120|NCT02056132|||Cohort||Prospective|||||||
1418121|NCT02056119|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1418122|NCT02056106|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418123|NCT02056093||Single Group Assignment||Treatment||None (Open Label)||||||
1418124|NCT02056080|||Cohort||Retrospective|||||||
1418125|NCT02056067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418126|NCT02056054|||Cohort||Prospective|||||||
1418127|NCT02056041|||Cohort||Retrospective|||||||
1418128|NCT02056028|||Cohort||Prospective|||||||
1418129|NCT02056015||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418130|NCT02056002|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418131|NCT02055989|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418132|NCT02055976|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1418133|NCT02055963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418134|NCT02055950|||Case-Control||Prospective|||||||
1418135|NCT02055937||Single Group Assignment||Treatment||None (Open Label)||||||
1418136|NCT02055924||Single Group Assignment||Treatment||None (Open Label)||||||
1418137|NCT02055911||Single Group Assignment||Treatment||None (Open Label)||||||
1418138|NCT02055898||Crossover Assignment||||Triple|||t||t|t
1418139|NCT02055885|||Cohort||Retrospective|||||||
1418140|NCT02055872|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418141|NCT02055859|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418142|NCT02055846||Single Group Assignment||Basic Science||None (Open Label)||||||
1418143|NCT02055833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418144|NCT02055820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418145|NCT02055807|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418146|NCT02055794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418147|NCT02055781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418148|NCT02055755|||Cohort||Prospective|||||||
1418149|NCT02055742|||Cohort||Prospective|||||||
1418150|NCT02055729|||Cohort||Prospective|||||||
1418151|NCT02055716|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1418152|NCT02055703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418153|NCT02055690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418154|NCT02055677|||||Prospective|||||||
1418155|NCT02055664|Randomized|Parallel Assignment||||Double||||||
1418156|NCT02055651|||Ecologic or Community||Prospective|||||||
1418157|NCT02055638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418158|NCT02055625||Single Group Assignment||Treatment||None (Open Label)||||||
1418161|NCT02055586||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418162|NCT02055573|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1418163|NCT02055560|||Cohort||Retrospective|||||||
1418164|NCT02055547|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1418165|NCT02055534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418166|NCT02055521||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418167|NCT02055508|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418168|NCT02055495|||Cohort||Prospective|||||||
1418169|NCT02055482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418170|NCT02055469|||Cohort||Prospective|||||||
1418171|NCT02055456||Single Group Assignment||Treatment||None (Open Label)||||||
1418172|NCT02055443|||Case-Only||Prospective|||||||
1418173|NCT02055430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418174|NCT02055417|Randomized|Parallel Assignment||Treatment||Single||||||t
1418175|NCT02055404|Randomized|Parallel Assignment||||None (Open Label)||||||
1418176|NCT02055391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418177|NCT02055378|Randomized|Parallel Assignment||Treatment||Single||||t||
1418178|NCT02055365||Single Group Assignment||Basic Science||None (Open Label)||||||
1418179|NCT02055352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418180|NCT02055339|Randomized|Single Group Assignment||Treatment||Single||||||t
1418181|NCT02055326|Randomized|Parallel Assignment||||None (Open Label)||||||
1418182|NCT02055313|||Other||Retrospective|||||||
1418183|NCT02055300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418184|NCT02055287|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418185|NCT02055274|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418186|NCT02055261|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1418187|NCT02055248|||||Retrospective|||||||
1418188|NCT02055235|||||Prospective|||||||
1418189|NCT02055222|||Case-Control||Retrospective|||||||
1418190|NCT02055209|||Case-Only||Prospective|||||||
1418191|NCT02055196||Single Group Assignment||Treatment||None (Open Label)||||||
1418192|NCT02055183|||Case-Only||Prospective|||||||
1418193|NCT02055170||Single Group Assignment||Treatment||None (Open Label)||||||
1418194|NCT02055157|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1418195|NCT02055144|||Case-Only||Prospective|||||||
1418196|NCT02055131|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1418197|NCT02055118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418198|NCT02055105||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418199|NCT02055092|||Cohort||Prospective|||||||
1418200|NCT02055079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418201|NCT02055066|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418202|NCT02055053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418203|NCT02055027|||Cohort||Prospective|||||||
1418204|NCT02055014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418205|NCT02055001|||Cohort||Prospective|||||||
1418206|NCT02054988|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1418207|NCT02054975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418208|NCT02054962|||Cohort||Prospective|||||||
1418209|NCT02054949||Single Group Assignment||Treatment||None (Open Label)||||||
1418210|NCT02054936|Randomized|Parallel Assignment||Treatment||Single|||||t|
1418211|NCT02054923|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1418212|NCT02054910|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418213|NCT02054897|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418214|NCT02054884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418215|NCT02054871|Randomized|Single Group Assignment||Treatment||Single||||||t
1418216|NCT02054858|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1418217|NCT02054845|Randomized|Parallel Assignment||Treatment||Single||||||t
1418218|NCT02054832|||Cohort||Prospective|||||||
1418219|NCT02054819||Single Group Assignment||Treatment||None (Open Label)||||||
1418220|NCT02054806||Single Group Assignment||Treatment||None (Open Label)||||||
1418221|NCT02054793||Single Group Assignment||Treatment||None (Open Label)||||||
1418222|NCT02054780|Randomized|Parallel Assignment||Treatment||Single||||||t
1418223|NCT02054767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418224|NCT02054754|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1418225|NCT02054741|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418226|NCT02054728||Single Group Assignment||Basic Science||None (Open Label)||||||
1418227|NCT02054715|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1418228|NCT02054702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418229|NCT02054689||Single Group Assignment||Treatment||None (Open Label)||||||
1418230|NCT02054676||Single Group Assignment||Treatment||None (Open Label)||||||
1418231|NCT02054663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418232|NCT02054650|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418233|NCT02054637||Single Group Assignment||Treatment||None (Open Label)||||||
1418234|NCT02054624|Randomized|Parallel Assignment||Treatment||Single||||||t
1418235|NCT02054611|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1418236|NCT02054598|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1418237|NCT02054585|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418238|NCT02054572||Single Group Assignment||Basic Science||None (Open Label)||||||
1418239|NCT02054559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418240|NCT02054546|||Cohort||Prospective|||||||
1418241|NCT02054533|||Cohort||Prospective|||||||
1418242|NCT02054520|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418243|NCT02054507||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418244|NCT02054494|||Case Control||Prospective|||||||
1418245|NCT02054481|Randomized|Parallel Assignment||Treatment||Double||||||
1418246|NCT02054468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418247|NCT02054455|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1418248|NCT02054442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418249|NCT02054429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418250|NCT02054416|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1418251|NCT02054403|||Cohort||Cross-Sectional|||||||
1418252|NCT02054390|||Cohort||Prospective|||||||
1418253|NCT02054377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418254|NCT02054364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418255|NCT02054351||Single Group Assignment||Treatment||None (Open Label)||||||
1418256|NCT02054338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418257|NCT02054325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418258|NCT02054312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418259|NCT02054299||Single Group Assignment||Basic Science||None (Open Label)||||||
1418260|NCT02054286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418261|NCT02054273|||Cohort||Cross-Sectional|||||||
1418262|NCT02054260||||||||||||
1418263|NCT02054247|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1418264|NCT02054234|||Cohort||Cross-Sectional|||||||
1418265|NCT02054221|Randomized|Crossover Assignment||Treatment||Single|||t|||
1418266|NCT02054208|Randomized|Parallel Assignment||Treatment||Quadruple||Stage 1: 9 subjects (3 subjects for low dose and 6 subjects for high dose) Stage 2: 36 subjects ( 24 subjects for high dose and 12 subjects for placebo) A total of 45 subjects to be enrolled|t|t|t|t
1418267|NCT02054195|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1418268|NCT02054182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418269|NCT02054169|||||Cross-Sectional|||||||
1418270|NCT02054156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418271|NCT02054143||Single Group Assignment||Basic Science||None (Open Label)||||||
1418272|NCT02054130|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418273|NCT02054117|||Case-Only||Prospective|||||||
1418274|NCT02054104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418275|NCT02054091|Randomized|Parallel Assignment||Supportive Care||Single||Single group for first 12 infants RCT for next 40 infants||||t
1418276|NCT02054078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418277|NCT02054065|Randomized|Parallel Assignment||Prevention||Single||||||t
1418278|NCT02054052||Single Group Assignment||Treatment||None (Open Label)||||||
1418279|NCT02054039|Randomized|Parallel Assignment||Prevention||Single||||||t
1418280|NCT02054026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418281|NCT02054013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418282|NCT02054000|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418283|NCT02053987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418284|NCT02053974|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1418285|NCT02053961|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418286|NCT02053948|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418287|NCT02053935||Single Group Assignment||Treatment||None (Open Label)||||||
1418288|NCT02053922|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418289|NCT02053909|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418290|NCT02053896|||Case-Only||Prospective|||||||
1418291|NCT02053883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418292|NCT02053870|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1418293|NCT02053857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418294|NCT02053844|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1418295|NCT02053831|||Case-Only||Prospective|||||||
1418296|NCT02053818|Randomized|Parallel Assignment||Prevention||Single||||||t
1418297|NCT02053805||Single Group Assignment||Screening||None (Open Label)||||||
1418298|NCT02053792||Single Group Assignment||Treatment||None (Open Label)||||||
1418299|NCT02053779|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1418300|NCT02053766|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1418301|NCT02053753|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418302|NCT02053740|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418303|NCT02053727|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1418304|NCT02053714||Single Group Assignment||Health Services Research||None (Open Label)||||||
1418305|NCT02053701|||Other||Other|||||||
1418306|NCT02053688|Randomized|Crossover Assignment||Treatment||Single|||t|||
1418307|NCT02053675||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418308|NCT02053662|||Cohort||Prospective|||||||
1418309|NCT02053649|Randomized|Parallel Assignment||Treatment||Single||||||t
1418310|NCT02053636||Single Group Assignment||Treatment||None (Open Label)||||||
1418311|NCT02053623|||Cohort||Retrospective|||||||
1418312|NCT02053610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418313|NCT02053597||Single Group Assignment||Treatment||None (Open Label)||||||
1418314|NCT02053584||Single Group Assignment||||None (Open Label)||||||
1418315|NCT02053571||Single Group Assignment||Treatment||None (Open Label)||||||
1418316|NCT02053558|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1418317|NCT02053545||Single Group Assignment||Treatment||None (Open Label)||||||
1418318|NCT02053532|||Case Control||Cross-Sectional|||||||
1418319|NCT02053519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418320|NCT02053506|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1418321|NCT02053493|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1418322|NCT02053480|||Cohort||Prospective|||||||
1418323|NCT02053467|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1418324|NCT02053454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418325|NCT02053441|||Case Control||Prospective|||||||
1418326|NCT02053428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418327|NCT02053415|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1418328|NCT02053402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418329|NCT02053389|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1418330|NCT02053376||Single Group Assignment||Treatment||None (Open Label)||||||
1418331|NCT02053363|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418332|NCT02053350||Single Group Assignment||Treatment||None (Open Label)||||||
1418333|NCT02053337|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1418334|NCT02053324||Single Group Assignment||Treatment||None (Open Label)||3+3 dose escalation design||||
1418335|NCT02053311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418336|NCT02053298||Single Group Assignment||Basic Science||None (Open Label)||||||
1418337|NCT02053285|||Cohort||Prospective|||||||
1418338|NCT02053272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418339|NCT02053259|Randomized|Factorial Assignment||Prevention||Single|||t|||
1418340|NCT02053246||Single Group Assignment||Treatment||None (Open Label)||||||
1418341|NCT02053233|Randomized|Parallel Assignment||Treatment||Single||||||t
1418342|NCT02053220|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418343|NCT02053207||Single Group Assignment||Other||None (Open Label)||||||
1418344|NCT02053194|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1418345|NCT02053181||Single Group Assignment||||None (Open Label)||||||
1418346|NCT02053168||Single Group Assignment||Treatment||None (Open Label)||||||
1418347|NCT02053155||Single Group Assignment||Prevention||None (Open Label)||||||
1418348|NCT02053142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418349|NCT02053129|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1418350|NCT02053116|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1418351|NCT02053103|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1418352|NCT02053090|Randomized|Parallel Assignment||Treatment||Single||||||t
1418353|NCT02053077|||Case-Only||Prospective|||||||
1418354|NCT02053064||Single Group Assignment||Treatment||None (Open Label)||||||
1418355|NCT02053051|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1418356|NCT02053038|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1418357|NCT02053025|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1418358|NCT02053012|||Cohort||Prospective|||||||
1418359|NCT02052999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418360|NCT02052986|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1418361|NCT02052973||Single Group Assignment||Prevention||None (Open Label)||||||
1418362|NCT02052960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418363|NCT02052947||Single Group Assignment||Screening||None (Open Label)||||||
1418364|NCT02052934|Randomized|Parallel Assignment||Prevention||||||||
1418365|NCT02052921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418366|NCT02052908|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1418367|NCT02052895|||Cohort||Prospective|||||||
1418368|NCT02052882||Single Group Assignment||Treatment||None (Open Label)||||||
1418369|NCT02052869||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418370|NCT02052856|||Cohort||Retrospective|||||||
1418371|NCT02052843|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418372|NCT02052830|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418373|NCT02052817|Randomized|Parallel Assignment||Treatment||Single||||||t
1418374|NCT02052804|||Cohort||Prospective|||||||
1418375|NCT02052791||Single Group Assignment||Treatment||None (Open Label)||||||
1418376|NCT02052778||Single Group Assignment||Treatment||None (Open Label)||||||
1418377|NCT02052765||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418378|NCT02052752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418379|NCT02052739||Single Group Assignment||Treatment||None (Open Label)||||||
1418380|NCT02052726|Randomized|||Prevention||Triple|||t||t|t
1418381|NCT02052713|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1418382|NCT02052687|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1418383|NCT02052674|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418384|NCT02052661||Single Group Assignment||Prevention||None (Open Label)||||||
1418385|NCT02052648|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418386|NCT02052635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418387|NCT02052609|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418388|NCT02052596|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418389|NCT02052583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418390|NCT02052570|||||Retrospective|||||||
1418391|NCT02052557|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1418393|NCT02052531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418394|NCT02052518|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418395|NCT02052505|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1418396|NCT02052492|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418397|NCT02052479||||Diagnostic||||||||
1418398|NCT02052466|||Case-Only||Retrospective|||||||
1418399|NCT02052453|||Cohort||Prospective|||||||
1418400|NCT02052440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418401|NCT02052427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418402|NCT02052414||Single Group Assignment||Treatment||None (Open Label)||||||
1418403|NCT02052401|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1418404|NCT02052388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418405|NCT02052375|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1418406|NCT02052362|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1418407|NCT02052349||Single Group Assignment||||None (Open Label)||||||
1418408|NCT02052336|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1418409|NCT02052323||Single Group Assignment||Treatment||None (Open Label)||||||
1418410|NCT02052310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418411|NCT02052297|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1418412|NCT02052284|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1418413|NCT02052271||Single Group Assignment||||Triple|||t||t|t
1418414|NCT02052258||||||||||||
1418415|NCT02052245|||Cohort||Prospective|||||||
1418416|NCT02052232|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1418417|NCT02052219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418418|NCT02052206||Single Group Assignment||Treatment||None (Open Label)||||||
1418419|NCT02052193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418420|NCT02052180|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1418421|NCT02052167||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1418422|NCT02052154||Single Group Assignment||Prevention||None (Open Label)||||||
1418423|NCT02052141|Randomized|Crossover Assignment||Prevention||Single|||t|||
1418424|NCT02052128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418425|NCT02052115||Single Group Assignment||Supportive Care||None (Open Label)||||||
1418426|NCT02052102|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1418427|NCT02052089|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418428|NCT02052076|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1418429|NCT02052063||Single Group Assignment||Prevention||None (Open Label)||||||
1418430|NCT02052050|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1418431|NCT02052037|Randomized|Crossover Assignment||Prevention||Single|||||t|
1418432|NCT02052024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418433|NCT02052011|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418434|NCT02051998|||Cohort||Prospective|||||||
1418435|NCT02051985|Randomized|Parallel Assignment||Treatment||Single||||||t
1418436|NCT02051972|||Cohort||Prospective|||||||
1418437|NCT02051959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418438|NCT02051946|Randomized|Parallel Assignment||Other||Double|||t||t|
1418439|NCT02051933|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418440|NCT02051920|||||Prospective|||||||
1418441|NCT02051907|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418442|NCT02051894|||Cohort||Prospective|||||||
1418443|NCT02051881||Single Group Assignment||||None (Open Label)||||||
1418444|NCT02051868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418445|NCT02051855|||Cohort||Prospective|||||||
1418446|NCT02051842|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1418447|NCT02051829|||Cohort||Prospective|||||||
1418448|NCT02051816|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1418449|NCT02051803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418450|NCT02051790|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1418451|NCT02051777|Randomized|Parallel Assignment||||None (Open Label)||||||
1418452|NCT02051764||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418453|NCT02051751||Single Group Assignment||Treatment||None (Open Label)||||||
1418454|NCT02051738|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1418455|NCT02051725|Randomized|Parallel Assignment||Prevention||Single||||||t
1418456|NCT02051712|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418457|NCT02051699|||||Prospective|||||||
1418458|NCT02051686|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1418459|NCT02051673||||||||||||
1418460|NCT02051660|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418461|NCT02051647|||||Prospective|||||||
1418462|NCT02051634|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1418463|NCT02051621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418464|NCT02051608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418465|NCT02051595||Single Group Assignment||Basic Science||None (Open Label)||||||
1418466|NCT02051582|||Cohort||Prospective|||||||
1418467|NCT02051569|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1418468|NCT02051556|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1418469|NCT02051543||||||||||||
1418470|NCT02051530|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1418471|NCT02051517|||Cohort||Cross-Sectional|||||||
1418472|NCT02051504|||Case Control||Cross-Sectional|||||||
1418473|NCT02051491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418474|NCT02051478|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418475|NCT02051465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418476|NCT02051452|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1418477|NCT02051439||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418478|NCT02051426|Randomized|Crossover Assignment||||Triple|||t||t|t
1418479|NCT02051413||Single Group Assignment||Treatment||None (Open Label)||||||
1418480|NCT02051400|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1418481|NCT02051387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418482|NCT02051374|Randomized|Parallel Assignment||Treatment||Single||||||t
1418483|NCT02051361|||||Prospective|||||||
1418484|NCT02051348|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1418485|NCT02051335|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1418486|NCT02051322|Randomized|Parallel Assignment||Treatment||Single||||||t
1418487|NCT02051309|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418488|NCT02051296|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418489|NCT02051283|||||Retrospective|||||||
1418490|NCT02051270|||Case-Only||Cross-Sectional|||||||
1418491|NCT02051257|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418492|NCT02051244|||Case Control||Cross-Sectional|||||||
1418493|NCT02051231|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418494|NCT02051218|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418495|NCT02051205|||Cohort||Prospective|||||||
1418496|NCT02051192|Randomized|Parallel Assignment||Treatment||Single||||||t
1418497|NCT02051179|||Case Control||Prospective|||||||
1418498|NCT02051166|||Case-Crossover||Retrospective|||||||
1418499|NCT02051153|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1418500|NCT02051140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418501|NCT02051127|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1418502|NCT02051114|||Cohort||Prospective|||||||
1418503|NCT02051101||Single Group Assignment||Basic Science||None (Open Label)||||||
1418504|NCT02051088|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418505|NCT02051075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418506|NCT02051062||Single Group Assignment||Basic Science||None (Open Label)||||||
1418507|NCT02051049|||Cohort||Prospective|||||||
1418508|NCT02051036|Randomized|Parallel Assignment||Treatment||Single||||||t
1418509|NCT02051023|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418510|NCT02051010|||Case-Only||Prospective|||||||
1418511|NCT02050997|||Cohort||Prospective|||||||
1418512|NCT02050984|||Case-Only||Prospective|||||||
1418513|NCT02050971|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1418514|NCT02050958|Randomized|Parallel Assignment||Treatment||Single||||||t
1418515|NCT02050945|Randomized|Parallel Assignment||Basic Science||Single||||||t
1418516|NCT02050932||Single Group Assignment||Prevention||None (Open Label)||||||
1418517|NCT02050919||Single Group Assignment||Treatment||None (Open Label)||||||
1418518|NCT02050906|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1418519|NCT02050893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418520|NCT02050880|||Cohort||Prospective|||||||
1418521|NCT02050867|||||Prospective|||||||
1418522|NCT02050854|||Cohort||Cross-Sectional|||||||
1418523|NCT02050841||Single Group Assignment||Treatment||None (Open Label)||||||
1418524|NCT02050828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418525|NCT02050815||Single Group Assignment||Treatment||None (Open Label)||||||
1418526|NCT02050802|Randomized|Crossover Assignment||||Triple|||t||t|t
1418527|NCT02050789|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1418528|NCT02050776||Single Group Assignment||Treatment||None (Open Label)||||||
1418529|NCT02050763|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1418530|NCT02050750|||Cohort||Prospective|||||||
1418531|NCT02050737|||Cohort||Prospective|||||||
1418532|NCT02050724|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1418533|NCT02050711|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1418534|NCT02050698|Randomized|Parallel Assignment||Treatment||Single||||||t
1418535|NCT02050685|||Cohort||Prospective|||||||
1418536|NCT02050672|Randomized|Parallel Assignment||||Single||||||t
1418537|NCT02050659|||Cohort||Prospective|||||||
1418538|NCT02050646|Randomized|Crossover Assignment||Basic Science||Double||||t|t|
1418539|NCT02050633|||Cohort||Prospective|||||||
1418540|NCT02050620|||Case-Only||Prospective|||||||
1418541|NCT02050607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418542|NCT02050594|||Case-Only||Prospective|||||||
1418543|NCT02050581|||Case-Only||Cross-Sectional|||||||
1418544|NCT02050568|||Case-Only||Prospective|||||||
1418545|NCT02050555|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1418546|NCT02050542|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1418547|NCT02050529|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418548|NCT02050516|Randomized|Parallel Assignment||||Double|||t|||t
1418549|NCT02050503|||Cohort||Prospective|||||||
1418550|NCT02050490|||Case Control||Prospective|||||||
1418551|NCT02050477||Single Group Assignment||Treatment||None (Open Label)||||||
1418552|NCT02050464|||Case-Control||Prospective|||||||
1418553|NCT02050451|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418554|NCT02050438|||Case-Only||Prospective|||||||
1418555|NCT02050425|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1418556|NCT02050412||Single Group Assignment||Basic Science||None (Open Label)||||||
1418557|NCT02050399|Randomized|Factorial Assignment||Other||Single|||t|||
1418558|NCT02050386|||Cohort||Cross-Sectional|||||||
1418559|NCT02050373|Randomized|Parallel Assignment||Treatment||Single|||||t|
1418560|NCT02050360|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1418561|NCT02050347|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418562|NCT02050334|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1418563|NCT02050321||Single Group Assignment||Treatment||None (Open Label)||||||
1418564|NCT02050308|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418565|NCT02050295|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418566|NCT02050282|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1418567|NCT02050269||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418568|NCT02050256||Single Group Assignment||Supportive Care||None (Open Label)||||||
1418569|NCT02050243||Single Group Assignment||Treatment||None (Open Label)||||||
1418570|NCT02050230|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418571|NCT02050217||Single Group Assignment||Treatment||None (Open Label)||||||
1418572|NCT02050204|Randomized|Parallel Assignment||Other||Single|||||t|
1418573|NCT02050191||Single Group Assignment||Health Services Research||None (Open Label)||||||
1418574|NCT02050178||Single Group Assignment||Treatment||None (Open Label)||||||
1418575|NCT02050165|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418576|NCT02050152|Randomized|Parallel Assignment||||Double|||t|||t
1418577|NCT02050139|Randomized|Crossover Assignment||Supportive Care||Double|||t|t||
1418578|NCT02050126||Single Group Assignment||Treatment||None (Open Label)||||||
1418579|NCT02050113||Single Group Assignment||Treatment||None (Open Label)||||||
1418580|NCT02050100|||Cohort||Prospective|||||||
1418581|NCT02050087|Randomized|Parallel Assignment||Treatment||Single|||||t|
1418582|NCT02050074|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1418583|NCT02050061|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1418584|NCT02050048|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418585|NCT02050035|Randomized|Parallel Assignment||Basic Science||Single||||||t
1418586|NCT02050022|||Case-Control||Prospective|||||||
1418587|NCT02050009||Single Group Assignment||Treatment||None (Open Label)||||||
1418588|NCT02049996|||Cohort||Prospective|||||||
1418589|NCT02049983||Single Group Assignment||Treatment||None (Open Label)||||||
1418590|NCT02049970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418591|NCT02049957|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418592|NCT02049944||Single Group Assignment||Prevention||None (Open Label)||||||
1418593|NCT02049931|Randomized|Parallel Assignment||Treatment||Single||||||t
1418594|NCT02049918|||Case Control||Cross-Sectional|||||||
1418595|NCT02049905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418596|NCT02049892|||Cohort||Cross-Sectional|||||||
1418597|NCT02049879||Single Group Assignment||Treatment||None (Open Label)||||||
1418598|NCT02049866||Single Group Assignment||Prevention||None (Open Label)||||||
1418599|NCT02049853|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1418600|NCT02049840||Single Group Assignment||Treatment||None (Open Label)||||||
1418601|NCT02049827||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418602|NCT02049814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418603|NCT02049801||Single Group Assignment||Treatment||None (Open Label)||||||
1418604|NCT02049788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418605|NCT02049775||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418606|NCT02049762|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1418607|NCT02049749|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1418608|NCT02049736||Single Group Assignment||Treatment||None (Open Label)||||||
1418609|NCT02049723|||Case-Only||Prospective|||||||
1418610|NCT02049710|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1418611|NCT02049697||Single Group Assignment||Treatment||None (Open Label)||||||
1418612|NCT02049684|||||Prospective|||||||
1418613|NCT02049671|||Cohort||Prospective|||||||
1418614|NCT02049658|||Cohort||Prospective|||||||
1418615|NCT02049645|||Cohort||Prospective|||||||
1418616|NCT02049632||Single Group Assignment||Treatment||None (Open Label)||||||
1418617|NCT02049619|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418618|NCT02049606|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418619|NCT02049593|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418620|NCT02049580||Single Group Assignment||Treatment||None (Open Label)||||||
1418621|NCT02049567||Single Group Assignment||Treatment||None (Open Label)||||||
1418622|NCT02049554|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1418623|NCT02049541||Single Group Assignment||Treatment||None (Open Label)||||||
1418624|NCT02049528|Randomized|Crossover Assignment||||None (Open Label)||||||
1418625|NCT02049515|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418626|NCT02049502||Single Group Assignment||Treatment||None (Open Label)||||||
1418627|NCT02049489||Single Group Assignment||Treatment||None (Open Label)||||||
1418628|NCT02049476||Single Group Assignment||Treatment||None (Open Label)||||||
1418629|NCT02049463|||Cohort||Retrospective|||||||
1418630|NCT02049450||Single Group Assignment||Treatment||None (Open Label)||||||
1418631|NCT02049437|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1418632|NCT02049424|||Cohort||Retrospective|||||||
1418633|NCT02049411|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1418634|NCT02049398|||Cohort||Prospective|||||||
1418635|NCT02049385|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1418636|NCT02049372|||Cohort||Prospective|||||||
1418637|NCT02049359|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418638|NCT02049346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418639|NCT02049333|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418640|NCT02049320|||Case-Only||Retrospective|||||||
1418641|NCT02049307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418642|NCT02049294|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418643|NCT02049281||Single Group Assignment||Treatment||None (Open Label)||||||
1418644|NCT02049268|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1418645|NCT02049255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418646|NCT02049242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418647|NCT02049229|Randomized|Parallel Assignment||Treatment||Single||||||t
1418648|NCT02049216|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1418649|NCT02049203|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1418650|NCT02049190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418651|NCT02049177|||Case-Only|||||||||
1418652|NCT02049164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418653|NCT02049151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418654|NCT02049138||Single Group Assignment||Treatment||None (Open Label)||||||
1418655|NCT02049125|||||Prospective|||||||
1418656|NCT02049112|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1418657|NCT02049099|||||Retrospective|||||||
1418658|NCT02049086|Randomized|Single Group Assignment||Screening||Single||||||t
1418659|NCT02049073|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418660|NCT02049060||Single Group Assignment||Treatment||None (Open Label)||||||
1418661|NCT02049047||Single Group Assignment||Treatment||None (Open Label)||||||
1418662|NCT02049034|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1418663|NCT02049021|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1418664|NCT02049008|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1418665|NCT02048995|||Cohort||Prospective|||||||
1418666|NCT02048982|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1418667|NCT02048969|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1418668|NCT02048956|Randomized|Single Group Assignment||Treatment||Single|||t|||
1418669|NCT02048943||Single Group Assignment||Treatment||None (Open Label)||||||
1418670|NCT02048930|||Cohort||Retrospective|||||||
1418671|NCT02048917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418672|NCT02048904|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418673|NCT02048891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418674|NCT02048878|||Case Control||Prospective|||||||
1418675|NCT02048865|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418676|NCT02048852|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1418677|NCT02048839|||Cohort||Prospective|||||||
1418678|NCT02048826|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418679|NCT02048813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418680|NCT02048800|||Cohort||Prospective|||||||
1418681|NCT02048787|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1418682|NCT02048774|Randomized|Parallel Assignment||||Double|||t||t|
1418683|NCT02048761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418684|NCT02048748|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1418685|NCT02048722||Single Group Assignment||Treatment||None (Open Label)||||||
1418686|NCT02048709||Single Group Assignment||Treatment||None (Open Label)||||||
1418687|NCT02048696|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1418688|NCT02048683|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418689|NCT02048670||Single Group Assignment||Treatment||None (Open Label)||||||
1418690|NCT02048657|Randomized|Parallel Assignment||Treatment||Single||||||t
1418691|NCT02048644|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1418692|NCT02048631|||Cohort||Retrospective|||||||
1418693|NCT02048618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418694|NCT02048605|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1418695|NCT02048592|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1418696|NCT02048579|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1418697|NCT02048566|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1418698|NCT02048553|Randomized|Parallel Assignment||Treatment||Single||||||t
1418699|NCT02048540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418700|NCT02048527|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1418701|NCT02048514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418702|NCT02048501|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1418703|NCT02048488||Single Group Assignment||Treatment||None (Open Label)||||||
1418704|NCT02048475||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418705|NCT02048462|||Cohort||Prospective|||||||
1418706|NCT02048449|||||Prospective|||||||
1418707|NCT02048436|||||Prospective|||||||
1418708|NCT02048423||Single Group Assignment||Treatment||None (Open Label)||||||
1418709|NCT02048410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418710|NCT02048397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418711|NCT02048384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418712|NCT02048371|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1418713|NCT02048358||||||||||||
1418714|NCT02048345|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1418715|NCT02048332||Single Group Assignment||Treatment||None (Open Label)||||||
1418716|NCT02048319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418717|NCT02048306|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418718|NCT02048293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418719|NCT02048280||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418720|NCT02048267|||Cohort||Prospective|||||||
1418721|NCT02048254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418722|NCT02048241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418723|NCT02048228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418724|NCT02048215|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1418725|NCT02048202|||Family-Based||Prospective|||||||
1418726|NCT02048189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418727|NCT02048176|||Case Control||Prospective|||||||
1418728|NCT02048163|||Case-Crossover||Prospective|||||||
1418729|NCT02048150||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418730|NCT02048137|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418731|NCT02048124|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1418732|NCT02048111||Single Group Assignment||Supportive Care||None (Open Label)||||||
1418733|NCT02048098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418734|NCT02048085|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1418735|NCT02048072||Single Group Assignment||Basic Science||None (Open Label)||||||
1418736|NCT02048059||Single Group Assignment||Treatment||None (Open Label)||||||
1418737|NCT02048046|||Case Control||Prospective|||||||
1418738|NCT02048033|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418739|NCT02048020||Single Group Assignment||Treatment||None (Open Label)||||||
1418740|NCT02048007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418741|NCT02047994|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418742|NCT02047981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418743|NCT02047968|Randomized|Parallel Assignment||Treatment||Single|||||t|
1418744|NCT02047955|||Cohort||Prospective|||||||
1418745|NCT02047942|Randomized|Parallel Assignment||Treatment||Single||||||t
1418746|NCT02047929|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1418747|NCT02047916|||Cohort||Prospective|||||||
1418748|NCT02047903|||Other||Prospective|||||||
1418749|NCT02047890||Single Group Assignment||Treatment||None (Open Label)||||||
1418750|NCT02047877|||Cohort||Prospective|||||||
1418751|NCT02047864|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418752|NCT02047851|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1418753|NCT02047838|||Case Control||Retrospective|||||||
1418754|NCT02047825|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1418755|NCT02047812|||Ecologic or Community||Retrospective|||||||
1418756|NCT02047799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418757|NCT02047786|||Ecologic or Community||Retrospective|||||||
1418758|NCT02047773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418759|NCT02047760|||Case Control||Prospective|||||||
1418760|NCT02047747||Single Group Assignment||Treatment||None (Open Label)||||||
1418761|NCT02047734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418762|NCT02047721|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1418763|NCT02047708|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1418764|NCT02047695|||Case-Control||Cross-Sectional|||||||
1418765|NCT02047682|Randomized|Parallel Assignment||Basic Science||Single||||||t
1418766|NCT02047669|Randomized|Parallel Assignment||Treatment||Single||||||t
1418767|NCT02047656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418768|NCT02047643|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1418769|NCT02047630|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1418770|NCT02047617|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418771|NCT02047604|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1418772|NCT02047591|||Case-Only||Prospective|||||||
1418773|NCT02047578||Single Group Assignment||Treatment||None (Open Label)||||||
1418774|NCT02047565|Randomized|Crossover Assignment||Supportive Care||Double|||t|t||
1418775|NCT02047552|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418776|NCT02047539|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1418777|NCT02047526|||||Prospective|||||||
1418778|NCT02047513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418779|NCT02047500||Single Group Assignment||Treatment||None (Open Label)||||||
1418780|NCT02047487|||Case Control||Prospective|||||||
1418781|NCT02047474||Single Group Assignment||Treatment||None (Open Label)||||||
1418782|NCT02047461||Single Group Assignment||Treatment||None (Open Label)||||||
1418783|NCT02047448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418784|NCT02047435|Randomized|Parallel Assignment||Treatment||Single||||||t
1418785|NCT02047422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418786|NCT02047409|||Cohort||Prospective|||||||
1418787|NCT02047396|||Ecologic or Community||Prospective|||||||
1418788|NCT02047383|||Case-Only||Prospective|||||||
1418789|NCT02047370|Randomized|Single Group Assignment||Treatment||Single|||t|||
1418790|NCT02047357|Randomized|Parallel Assignment||Prevention||Single||||||t
1418791|NCT02047344||Single Group Assignment||Treatment||None (Open Label)||||||
1418792|NCT02047331|Randomized|Parallel Assignment||Treatment||Double||||t||t
1418793|NCT02047318||Single Group Assignment||Treatment||None (Open Label)||||||
1418794|NCT02047305||Single Group Assignment||Treatment||None (Open Label)||||||
1418795|NCT02047292|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418796|NCT02047279|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418797|NCT02047266|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418798|NCT02047253||Single Group Assignment||Treatment||None (Open Label)||||||
1418799|NCT02047240|||Cohort||Cross-Sectional|||||||
1418800|NCT02047227|Randomized|Parallel Assignment||Treatment||Single|||||t|
1418801|NCT02047214||Sequential Assignment||Treatment||None (Open Label)||||||
1418802|NCT02047201||Single Group Assignment||Treatment||None (Open Label)||||||
1418803|NCT02047188|||Case-Only||Prospective|||||||
1418804|NCT02047175|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1418805|NCT02047162|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1418806|NCT02047149||Single Group Assignment||Treatment||None (Open Label)||||||
1418807|NCT02047136|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418808|NCT02047123||Single Group Assignment||Prevention||Single|||||t|
1418809|NCT02047110|Randomized|Parallel Assignment||Treatment||Double||||||
1418810|NCT02047097|||Cohort||Prospective|||||||
1418811|NCT02047084|||Cohort||Prospective|||||||
1418812|NCT02047071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418813|NCT02047058|||Cohort||Prospective|||||||
1418814|NCT02047045|Randomized|Parallel Assignment||Treatment||Single||||||t
1418815|NCT02047032|Randomized|Parallel Assignment||Treatment||Single||||||t
1418816|NCT02047019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418817|NCT02047006||Single Group Assignment||Treatment||None (Open Label)||||||
1418818|NCT02046993|Randomized|Parallel Assignment||Treatment||Single||||||t
1418819|NCT02046980|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1418820|NCT02046967|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418821|NCT02046954|||Case Control||Retrospective|||||||
1418822|NCT02046941||Single Group Assignment||Basic Science||None (Open Label)||||||
1418823|NCT02046928||Single Group Assignment||Treatment||None (Open Label)||||||
1418824|NCT02046915||Single Group Assignment||Treatment||None (Open Label)||||||
1418825|NCT02046902|||Cohort||Cross-Sectional|||||||
1418826|NCT02046889|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1418827|NCT02046876||Single Group Assignment||Treatment||Double||||t||t
1418828|NCT02046863||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418829|NCT02046850|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1418830|NCT02046837|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1418831|NCT02046824|Randomized|Crossover Assignment||Diagnostic||Double|||t|t||
1418832|NCT02046811|Randomized|Parallel Assignment||Screening||Single|||t|||
1418833|NCT02046798||Single Group Assignment||Basic Science||None (Open Label)||||||
1418834|NCT02046785||Single Group Assignment||Diagnostic||Double|||t||t|
1418835|NCT02046772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418836|NCT02046759|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1418837|NCT02046746||Single Group Assignment||Treatment||None (Open Label)||||||
1418838|NCT02046733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418839|NCT02046720||Single Group Assignment||Screening||None (Open Label)||||||
1418840|NCT02046707|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1418841|NCT02046694||Single Group Assignment||Treatment||None (Open Label)||Pilot Study||||
1418842|NCT02046681|||Cohort||Prospective|||||||
1418843|NCT02046668|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1418844|NCT02046655|Randomized|Parallel Assignment||Treatment||Single||||||t
1418845|NCT02046642|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1418846|NCT02046629||Single Group Assignment||Basic Science||None (Open Label)||||||
1418847|NCT02046616||Single Group Assignment||Treatment||None (Open Label)||||||
1418848|NCT02046603|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418849|NCT02046590|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1418850|NCT02046577|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418851|NCT02046564|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418852|NCT02046551|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1418853|NCT02046538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418854|NCT02046525|Randomized|Parallel Assignment||Prevention||Single|||t|||
1418855|NCT02046512|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418856|NCT02046499|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1418857|NCT02046486|Randomized|Parallel Assignment||Treatment||Single||||||t
1418858|NCT02046473||Single Group Assignment||Health Services Research||None (Open Label)||||||
1418859|NCT02046460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418860|NCT02046447|||Case-Control||Prospective|||||||
1418861|NCT02046434|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418862|NCT02046421||Single Group Assignment||Treatment||None (Open Label)||||||
1418863|NCT02046408|Randomized|Single Group Assignment||Health Services Research||Single||||t||
1418864|NCT02046395||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418865|NCT02046382|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1418866|NCT02046369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418867|NCT02046356|||Case Control||Prospective|||||||
1418868|NCT02046343|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1418869|NCT02046330||Single Group Assignment||Treatment||None (Open Label)||||||
1418870|NCT02046317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418871|NCT02046304||Single Group Assignment||Treatment||None (Open Label)||||||
1418872|NCT02046291||Single Group Assignment||Supportive Care||None (Open Label)||||||
1418873|NCT02046278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418874|NCT02046265|Randomized|Parallel Assignment||Prevention||Single|||t|||
1418875|NCT02046239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418876|NCT02046226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418877|NCT02046213|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418878|NCT02046200|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1418879|NCT02046187||Single Group Assignment||Treatment||None (Open Label)||||||
1418880|NCT02046174|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418881|NCT02046161|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1418882|NCT02046148|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418883|NCT02046135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418884|NCT02046122||Single Group Assignment||Treatment||None (Open Label)||||||
1418885|NCT02046109|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1418886|NCT02046096|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418887|NCT02046083|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1418888|NCT02046070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418889|NCT02046057||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418890|NCT02046044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418891|NCT02046031||Single Group Assignment||Treatment||None (Open Label)||||||
1418892|NCT02046018|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1418893|NCT02046005|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1418894|NCT02045992|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1418895|NCT02045979|Randomized|Parallel Assignment||Treatment||Double||||||
1418896|NCT02045966||Single Group Assignment||||None (Open Label)||||||
1418897|NCT02045953|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1418898|NCT02045940|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1418899|NCT02045927|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418900|NCT02045914|Randomized|Parallel Assignment||||None (Open Label)||||||
1418901|NCT02045901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418902|NCT02045888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418903|NCT02045875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418904|NCT02045862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418905|NCT02045849|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1418906|NCT02045836|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418907|NCT02045823|||Cohort||Prospective|||||||
1418908|NCT02045810|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1418909|NCT02045797|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418910|NCT02045784|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1418911|NCT02045771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418912|NCT02045758|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1418913|NCT02045745||Single Group Assignment||Treatment||None (Open Label)||||||
1418914|NCT02045732|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1418915|NCT02045719||Single Group Assignment||Supportive Care||None (Open Label)||||||
1418916|NCT02045706|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418917|NCT02045693|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1418918|NCT02045680|||Case-Only||Prospective|||||||
1418919|NCT02045667|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1418920|NCT02045654|||Case-Only||Retrospective|||||||
1418921|NCT02045641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418922|NCT02045628|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418923|NCT02045615|||Case Control||Retrospective|||||||
1418924|NCT02045602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418925|NCT02045589||Single Group Assignment||Treatment||None (Open Label)||||||
1418926|NCT02045576|Randomized|Parallel Assignment||Treatment||Single||||||t
1418927|NCT02045563|||||Prospective|||||||
1418928|NCT02045550|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1418929|NCT02045537|||Case-Control||Retrospective|||||||
1418930|NCT02045524|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1418931|NCT02045511|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1418932|NCT02045498|Non-Randomized|Parallel Assignment||||Single||||t||
1418933|NCT02045485|||Case Control||Prospective|||||||
1418934|NCT02045472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418935|NCT02045459||Single Group Assignment||Other||None (Open Label)||||||
1418936|NCT02045446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418937|NCT02045433||Single Group Assignment||Treatment||None (Open Label)||||||
1418938|NCT02045420|||Case Control||Retrospective|||||||
1418939|NCT02045407|||Case Control||Prospective|||||||
1418940|NCT02045394|||Cohort||Prospective|||||||
1418941|NCT02045381||Single Group Assignment||Health Services Research||None (Open Label)||||||
1418942|NCT02045368||Single Group Assignment||Treatment||None (Open Label)||||||
1418943|NCT02045355|Randomized|Parallel Assignment||Prevention||Single||||||t
1418944|NCT02045342|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1418945|NCT02045329|||Case-Only||Prospective|||||||
1418946|NCT02045316|||Case Control||Prospective|||||||
1418947|NCT02045303||Single Group Assignment||Treatment||None (Open Label)||||||
1418948|NCT02045290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418949|NCT02045277|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1418950|NCT02045264||Single Group Assignment||Treatment||None (Open Label)||||||
1418951|NCT02045251||Single Group Assignment||Treatment||None (Open Label)||||||
1418952|NCT02045238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418953|NCT02045225||Single Group Assignment||Prevention||None (Open Label)||||||
1418954|NCT02045212|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1418955|NCT02045199|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1418956|NCT02045186||Single Group Assignment||Other||None (Open Label)||||||
1418957|NCT02045173||Single Group Assignment||Diagnostic||None (Open Label)||||||
1418958|NCT02045160|||Case-Only||Prospective|||||||
1418959|NCT02045147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418960|NCT02045134|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1418961|NCT02045121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418962|NCT02045108|Randomized|Factorial Assignment||Prevention||Triple|||t|t||t
1418963|NCT02045095||Single Group Assignment||Treatment||None (Open Label)||||||
1418964|NCT02045082|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1418965|NCT02045069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418966|NCT02045056|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1418967|NCT02045043|||Cohort||Prospective|||||||
1418968|NCT02045030||Single Group Assignment||Treatment||None (Open Label)||||||
1418969|NCT02045017||Single Group Assignment||Treatment||None (Open Label)||||||
1418970|NCT02045004|||Cohort||Prospective|||||||
1418971|NCT02044991|Randomized|Parallel Assignment||Treatment||Quadruple||Participants are assigned to receive either an injection of methylprednisolone acetate plus lidocaine or to receive an injection of saline with lidocaine using a randomized block design with a 1:1 allocation.|t|t|t|t
1418972|NCT02044978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1418973|NCT02044965|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1418974|NCT02044952||Single Group Assignment||Treatment||Single|||t|||
1418975|NCT02044939|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1418976|NCT02044926|||Cohort||Prospective|||||||
1418977|NCT02044913|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1418978|NCT02044900|||Case Control||Cross-Sectional|||||||
1418979|NCT02044887|Randomized|Parallel Assignment||Treatment||Single|||||t|
1418980|NCT02044874|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418981|NCT02044861||Single Group Assignment||Treatment||None (Open Label)||||||
1418982|NCT02044848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418983|NCT02044835|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418984|NCT02044822||Single Group Assignment||Treatment||None (Open Label)||||||
1418985|NCT02044809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1418986|NCT02044796||Single Group Assignment||Treatment||None (Open Label)||||||
1418987|NCT02044783|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1418988|NCT02044770|||||Prospective|||||||
1418989|NCT02044757||Single Group Assignment||Supportive Care||None (Open Label)||||||
1418990|NCT02044744|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418991|NCT02044731||Single Group Assignment||Treatment||None (Open Label)||||||
1418992|NCT02044718|||Case-Only||Retrospective|||||||
1418993|NCT02044705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1418994|NCT02044692|||Cohort||Prospective|||||||
1418995|NCT02044679|Randomized|Parallel Assignment||||None (Open Label)||||||
1418996|NCT02044666||Single Group Assignment||Treatment||None (Open Label)||||||
1418997|NCT02044653|Randomized|Parallel Assignment||Treatment||Single|||t|||
1418998|NCT02044640|||Case-Only||Retrospective|||||||
1418999|NCT02044627||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419000|NCT02044614|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1419001|NCT02044601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419002|NCT02044588|||Cohort||Prospective|||||||
1419003|NCT02044575|||Cohort||Prospective|||||||
1419004|NCT02044562|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419005|NCT02044549|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1419006|NCT02044536|||Case-Control||Retrospective|||||||
1419007|NCT02044523|||Case-Only||Cross-Sectional|||||||
1419008|NCT02044510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419009|NCT02044497||Single Group Assignment||Other||None (Open Label)||||||
1419010|NCT02044484|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419011|NCT02044471|Randomized|Crossover Assignment||Prevention||Single||||||t
1419012|NCT02044458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419013|NCT02044445|Randomized|Parallel Assignment||Treatment||Single||||||t
1419014|NCT02044432|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1419015|NCT02044419|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1419016|NCT02044406|Randomized|Single Group Assignment||Treatment||Single||||||
1419017|NCT02044393|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419018|NCT02044380||Single Group Assignment||Treatment||None (Open Label)||||||
1419019|NCT02044367|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419020|NCT02044354|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1419021|NCT02044341|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419022|NCT02044328||Single Group Assignment||Treatment||None (Open Label)||||||
1419023|NCT02044315|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1419024|NCT02044302|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419025|NCT02044289|||Case-Only||Prospective|||||||
1419026|NCT02044276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419027|NCT02044263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419028|NCT02044250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419029|NCT02044237|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419030|NCT02044224||Single Group Assignment||Treatment||None (Open Label)||||||
1419031|NCT02044211|Randomized|Parallel Assignment||Treatment||Single||"Blended intervention: Blended, centralized, nurse-provided, telephone-delivered collaborative care for both heart failure and depression;~Collaborative care for heart failure: Blended, centralized, nurse-provided, telephone-delivered collaborative care for heart failure alone~Usual Care: PCPs usual care for heart failure and depression; and~Non-Depressed comparison cohort (randomly sampled, not randomized)."||||t
1419032|NCT02044198|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1419033|NCT02044185|||Case Control||Prospective|||||||
1419034|NCT02044172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419035|NCT02044159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419036|NCT02044146|Randomized|Parallel Assignment||Treatment||Double||||t||t
1419037|NCT02044133|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419038|NCT02044120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419039|NCT02044107|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419040|NCT02044094||Single Group Assignment||Treatment||None (Open Label)|The investigational drug, RBP-6000, was administered unblinded. The hydromorphone challenges used to measure the effectiveness of RBP-6000 were known and randomized in blinded fashion only to determine the order in which they were administered, with participant and clinical staff blinded to the order of dosing.|All subjects were dispensed the same 300 mg dose of the investigational drug, RBP-6000. They were all also exposed to 0 mg, 6 mg, and 18 mg of hydromorphone for challenges sequentially in a randomized manner.||||
1419041|NCT02044081|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1419042|NCT02044068|||Cohort||Retrospective|||||||
1419043|NCT02044055|||Cohort||Retrospective|||||||
1419044|NCT02044042|||Cohort||Retrospective|||||||
1419045|NCT02044029|||Case Control||Prospective|||||||
1419046|NCT02044016|||Cohort||Prospective|||||||
1419047|NCT02044003||Single Group Assignment||Treatment||None (Open Label)||||||
1419048|NCT02043990||Single Group Assignment||Treatment||None (Open Label)||||||
1419049|NCT02043977||Single Group Assignment||Health Services Research||None (Open Label)||||||
1419050|NCT02043964||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419051|NCT02043951|||Cohort||Prospective|||||||
1419052|NCT02043938||Single Group Assignment||Other||None (Open Label)||||||
1419053|NCT02043925|||Cohort||Prospective|||||||
1419054|NCT02043912|||Cohort||Prospective|||||||
1419055|NCT02043899||||Treatment||||||||
1419056|NCT02043886|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1419057|NCT02043873|||Case Control||Retrospective|||||||
1419058|NCT02043860||Single Group Assignment||Treatment||None (Open Label)||||||
1419059|NCT02043847||Single Group Assignment||Treatment||None (Open Label)||||||
1419060|NCT02043834|Randomized|Parallel Assignment||Treatment||Single||||||t
1419061|NCT02043821|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419062|NCT02043808|||||Retrospective|||||||
1419063|NCT02043795||Single Group Assignment||Other||None (Open Label)||||||
1419064|NCT02043782|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1419065|NCT02043769|||Cohort||Prospective|||||||
1419066|NCT02043756|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419067|NCT02043743||Single Group Assignment||Treatment||None (Open Label)||||||
1419068|NCT02043730|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419069|NCT02043717|||Cohort||Prospective|||||||
1419070|NCT02043704|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1419071|NCT02043691|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419072|NCT02043678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419073|NCT02043665||Single Group Assignment||Treatment||None (Open Label)||||||
1419074|NCT02043652||Single Group Assignment||Treatment||None (Open Label)||||||
1419075|NCT02043639|||Case-Only||Prospective|||||||
1419076|NCT02043626|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1419077|NCT02043613|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1419078|NCT02043600|Randomized|Parallel Assignment||Treatment||Single||||||t
1419079|NCT02043587||Single Group Assignment||Treatment||None (Open Label)||||||
1419080|NCT02043574|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects are randomized to either stretching or treadmill training.||||
1419081|NCT02043561|Randomized|Crossover Assignment||Other||Single|||t|||
1419082|NCT02043548|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419083|NCT02043535||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419084|NCT02043522||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419085|NCT02043509|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1419086|NCT02043496|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1419087|NCT02043483|||Case Control||Prospective|||||||
1419088|NCT02043470|||Case-Only||Prospective|||||||
1419089|NCT02043457|||Cohort||Prospective|||||||
1419090|NCT02043444|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1419091|NCT02043431|||Cohort||Prospective|||||||
1419092|NCT02043418|||Cohort||Prospective|||||||
1419093|NCT02043405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419094|NCT02043392||Single Group Assignment||Treatment||None (Open Label)||||||
1419095|NCT02043379|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419096|NCT02043366|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1419097|NCT02043353|||Cohort||Retrospective|||||||
1419098|NCT02043340||Single Group Assignment||Treatment||Double|||t|t||
1419099|NCT02043327|||Case Control|||||||||
1419100|NCT02043314|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419101|NCT02043301|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1419102|NCT02043288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419103|NCT02043275|Randomized|Parallel Assignment||Treatment||Single||||||t
1419104|NCT02043262|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1419105|NCT02043249||Single Group Assignment||Prevention||Single|||t|||
1419106|NCT02043236|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419107|NCT02043223|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1419108|NCT02043210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419109|NCT02043197|||Cohort||Prospective|||||||
1419110|NCT02043184|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1419111|NCT02043171|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1419112|NCT02043158|||Cohort||Prospective|||||||
1419113|NCT02043145|||Cohort||Prospective|||||||
1419114|NCT02043132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419115|NCT02043119|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419116|NCT02043106|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419117|NCT02043093|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419118|NCT02043080|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1419119|NCT02043067|||Cohort||Prospective|||||||
1419120|NCT02043054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419121|NCT02043041|||||Cross-Sectional|||||||
1419122|NCT02043028|Randomized|Crossover Assignment||Basic Science||Single||||||t
1419123|NCT02043015||Single Group Assignment||Prevention||None (Open Label)||||||
1419124|NCT02043002||Single Group Assignment||Treatment||None (Open Label)||||||
1419125|NCT02042989||Single Group Assignment||Treatment||None (Open Label)||||||
1419126|NCT02042976|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1419127|NCT02042963|||Cohort||Prospective|||||||
1419128|NCT02042950||Single Group Assignment||Treatment||None (Open Label)||||||
1419129|NCT02042937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419130|NCT02042924||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419131|NCT02042911||Single Group Assignment||Treatment||None (Open Label)||||||
1419132|NCT02042898|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1419133|NCT02042885|Non-Randomized|||Treatment||None (Open Label)||||||
1419134|NCT02042872|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419135|NCT02042859||Single Group Assignment||Treatment||None (Open Label)||||||
1419136|NCT02042846||Single Group Assignment||Treatment||None (Open Label)||||||
1419137|NCT02042833|||Cohort||Prospective|||||||
1419138|NCT02042820|||Case-Control||Prospective|||||||
1419139|NCT02042807|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1419140|NCT02042794|||||Prospective|||||||
1419141|NCT02042781||Single Group Assignment||Treatment||None (Open Label)||||||
1419142|NCT02042768|||Cohort||Prospective|||||||
1419143|NCT02042755|||Case-Only||Prospective|||||||
1419144|NCT02042742|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1419145|NCT02042729|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419146|NCT02042716||Single Group Assignment||Prevention||None (Open Label)||||||
1419147|NCT02042703|||Case Control||Prospective|||||||
1419148|NCT02042690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419149|NCT02042677|||Cohort||Prospective|||||||
1419150|NCT02042664|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419151|NCT02042651|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419152|NCT02042638|||Case-Only||Prospective|||||||
1419153|NCT02042625||Single Group Assignment||||None (Open Label)||||||
1419154|NCT02042612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419155|NCT02042599|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419156|NCT02042586|||Case Control||Prospective|||||||
1419157|NCT02042573|Randomized|Parallel Assignment||||None (Open Label)||||||
1419158|NCT02042560|||Case-Control||Prospective|||||||
1419159|NCT02042547|||Case-Only||Prospective|||||||
1419160|NCT02042534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419161|NCT02042521|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1419162|NCT02042508||Single Group Assignment||||None (Open Label)||||||
1419163|NCT02042495||Single Group Assignment||Treatment||None (Open Label)||||||
1419164|NCT02042482||Single Group Assignment||Treatment||None (Open Label)||||||
1419165|NCT02042469|||Cohort||Cross-Sectional|||||||
1419166|NCT02042456|||Cohort||Prospective|||||||
1419167|NCT02042443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419168|NCT02042430||Single Group Assignment||Treatment||None (Open Label)||||||
1419169|NCT02042417||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419170|NCT02042404||Single Group Assignment||Treatment||None (Open Label)||||||
1419171|NCT02042391|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419172|NCT02042378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419173|NCT02042365||||||||||||
1419174|NCT02042352|||Cohort||Prospective|||||||
1419175|NCT02042339|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419176|NCT02042326||Single Group Assignment||Treatment||None (Open Label)||||||
1419177|NCT02042313|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1419178|NCT02042300|||Cohort||Prospective|||||||
1419179|NCT02042287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419180|NCT02042274||Single Group Assignment||Treatment||None (Open Label)||||||
1419181|NCT02042261|||Cohort||Prospective|||||||
1419182|NCT02042248|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419183|NCT02042235|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419184|NCT02042222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419185|NCT02042209|||Cohort||Prospective|||||||
1419186|NCT02042196|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1419187|NCT02042183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419188|NCT02042170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419189|NCT02042157|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419190|NCT02042144|||Cohort||Prospective|||||||
1419191|NCT02042131|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419192|NCT02042118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419193|NCT02042105|||Cohort||Prospective|||||||
1419194|NCT02042092|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1419195|NCT02042079||Single Group Assignment||Treatment||None (Open Label)||||||
1419196|NCT02042066||Single Group Assignment||Treatment||None (Open Label)||||||
1419197|NCT02042053||Single Group Assignment||Other||None (Open Label)||||||
1419198|NCT02042027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419199|NCT02042014||Single Group Assignment||Treatment||None (Open Label)||||||
1419200|NCT02042001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419201|NCT02041988|||Case Control|||||||||
1419202|NCT02041975|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1419203|NCT02041962|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1419204|NCT02041936||Single Group Assignment||Treatment||None (Open Label)||||||
1419205|NCT02041923|Randomized|Parallel Assignment||Treatment||Single||||||t
1419206|NCT02041910|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419207|NCT02041897||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419208|NCT02041884|Randomized|Parallel Assignment||Treatment||Single||||||t
1419209|NCT02041871|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419210|NCT02041858|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1419211|NCT02041845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419212|NCT02041832|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1419213|NCT02041819||Single Group Assignment||Treatment||None (Open Label)||||||
1419214|NCT02041806|||Cohort||Prospective|||||||
1419215|NCT02041793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419216|NCT02041780||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419217|NCT02041767|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419218|NCT02041754|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419219|NCT02041741|Randomized|Parallel Assignment||Treatment||Single|||||t|
1419220|NCT02041728|||Case Control||Cross-Sectional|||||||
1419221|NCT02041715|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419222|NCT02041702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419223|NCT02041689|||Case-Only||Prospective|||||||
1419224|NCT02041676|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1419225|NCT02041663||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419226|NCT02041650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419227|NCT02041637|||Cohort||Prospective|||||||
1419228|NCT02041624|||||Prospective|||||||
1419229|NCT02041611||Single Group Assignment||Other||None (Open Label)||||||
1419230|NCT02041598|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1419231|NCT02041585|||Cohort||Prospective|||||||
1419232|NCT02041572||Single Group Assignment||Treatment||None (Open Label)|The transition point from the assessment only version of the attention bias program to the retraining/ bias correction version was randomized at the participant level and occurred between weeks 4 and 7 of the 10-week study.|||||
1419233|NCT02041559|||Cohort||Retrospective|||||||
1419234|NCT02041546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419235|NCT02041533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419236|NCT02041520|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1419237|NCT02041507|Randomized|Parallel Assignment||||Double|||t||t|
1419238|NCT02041494|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419239|NCT02041481|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419240|NCT02041468|||Cohort||Prospective|||||||
1419241|NCT02041455|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419242|NCT02041442||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419243|NCT02041429||Single Group Assignment||Treatment||None (Open Label)||||||
1419244|NCT02041416|||Cohort||Prospective|||||||
1419245|NCT02041403|||Cohort||Prospective|||||||
1419246|NCT02041390|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1419247|NCT02041377||Single Group Assignment||Supportive Care||None (Open Label)||||||
1419248|NCT02041364|||Case Control||Prospective|||||||
1419249|NCT02041351||Single Group Assignment||Treatment||None (Open Label)||||||
1419250|NCT02041338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419251|NCT02041325|Randomized|Parallel Assignment||||Double|||t||t|
1419252|NCT02041312|||Case Control||Prospective|||||||
1419253|NCT02041299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419254|NCT02041286||Single Group Assignment||Supportive Care||None (Open Label)||||||
1419255|NCT02041273||Single Group Assignment||Basic Science||None (Open Label)||||||
1419256|NCT02041260||||Treatment||||||||
1419257|NCT02041247|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419258|NCT02041234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419259|NCT02041221|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419260|NCT02041208|||Case-Only||Retrospective|||||||
1419261|NCT02041195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419262|NCT02041182|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1419263|NCT02041169||Single Group Assignment||Supportive Care||None (Open Label)||||||
1419264|NCT02041156|Randomized|Parallel Assignment||Treatment||Single||||||t
1419265|NCT02041143|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1419266|NCT02041130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419267|NCT02041117||Single Group Assignment||Treatment||None (Open Label)||||||
1419268|NCT02041104|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419269|NCT02041091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419270|NCT02041078|Randomized|Single Group Assignment||Prevention||Single|||t|||
1419271|NCT02041065|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419272|NCT02041052|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419273|NCT02041039|||Case-Control||Cross-Sectional|||||||
1419274|NCT02041026||Single Group Assignment||Prevention||Single|||t|||
1419275|NCT02041013|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419276|NCT02041000||Single Group Assignment||Treatment||None (Open Label)||||||
1419277|NCT02040987|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1419278|NCT02040974|||Case Control||Cross-Sectional|||||||
1419279|NCT02040961||Single Group Assignment||||None (Open Label)||||||
1419280|NCT02040948||Single Group Assignment||Supportive Care||None (Open Label)||||||
1419281|NCT02040935||Single Group Assignment||Treatment||None (Open Label)||||||
1419282|NCT02040922|||Cohort||Prospective|||||||
1419283|NCT02040909||Single Group Assignment||Treatment||None (Open Label)||||||
1419284|NCT02040896|||Cohort||Prospective|||||||
1419285|NCT02040883|Randomized|Parallel Assignment||Treatment||Single||||||t
1419286|NCT02040870||Single Group Assignment||Treatment||None (Open Label)||||||
1419287|NCT02040857||Single Group Assignment||Treatment||None (Open Label)||||||
1419288|NCT02040844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419289|NCT02040831|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1419290|NCT02040818|Randomized|||||None (Open Label)||||||
1419291|NCT02040805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419292|NCT02040792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419293|NCT02040779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419294|NCT02040766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419295|NCT02040753|||Cohort||Retrospective|||||||
1419296|NCT02040740|||Cohort||Cross-Sectional|||||||
1419297|NCT02040727|Randomized|Single Group Assignment||||None (Open Label)||||||
1419298|NCT02040714|||Cohort||Prospective|||||||
1419299|NCT02040701|||Cohort||Prospective|||||||
1419300|NCT02040688|||Case Control||Prospective|||||||
1419301|NCT02040675|||Case-Only||Prospective|||||||
1419302|NCT02040662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419303|NCT02040649|Randomized|Parallel Assignment||Treatment||Single|||||t|
1419304|NCT02040636|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419305|NCT02040623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419306|NCT02040610|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419307|NCT02040597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419308|NCT02040584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419309|NCT02040571|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419310|NCT02040558||Single Group Assignment||Treatment||None (Open Label)||||||
1419311|NCT02040545|||Case-Only||Prospective|||||||
1419312|NCT02040532||Single Group Assignment||Treatment||None (Open Label)||||||
1419313|NCT02040519||Single Group Assignment||Treatment||None (Open Label)||||||
1419314|NCT02040506|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419315|NCT02040493||Single Group Assignment||Treatment||None (Open Label)||||||
1419316|NCT02040480|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419317|NCT02040467|||Other||Prospective|||||||
1419318|NCT02040454|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1419319|NCT02040441|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1419320|NCT02040428|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419321|NCT02040415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419322|NCT02040402|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419323|NCT02040389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419324|NCT02040376|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1419325|NCT02040363|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1419326|NCT02040350|Randomized|Factorial Assignment||Treatment||Triple||||t|t|t
1419327|NCT02040337|||Case-Control||Prospective|||||||
1419328|NCT02040324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419329|NCT02040311|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419330|NCT02040298|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1419331|NCT02040285|Randomized|Parallel Assignment||Treatment||Single||||||t
1419332|NCT02040272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419333|NCT02040259|||Cohort||Prospective|||||||
1419334|NCT02040246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419335|NCT02040233|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419336|NCT02040220|||Cohort||Prospective|||||||
1419337|NCT02040207||Single Group Assignment||Treatment||None (Open Label)||||||
1419338|NCT02040194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419339|NCT02040181|||||Retrospective|||||||
1419340|NCT02040168|||Case-Only||Prospective|||||||
1419341|NCT02040155||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1419342|NCT02040142||Single Group Assignment||Treatment||None (Open Label)||||||
1419343|NCT02040129||Single Group Assignment||Treatment||None (Open Label)||||||
1419344|NCT02040116||Single Group Assignment||Treatment||None (Open Label)||||||
1419345|NCT02040103|Randomized|Parallel Assignment||Treatment||Single||||||t
1419346|NCT02040090|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1419347|NCT02040077|Randomized|Parallel Assignment||Prevention||Single|||||t|
1419348|NCT02040064||Single Group Assignment||Treatment||None (Open Label)||||||
1419349|NCT02040051|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1419350|NCT02040038|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1419351|NCT02040025|||Case-Only||Prospective|||||||
1419352|NCT02040012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419353|NCT02039999|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1419354|NCT02039986|||Cohort||Prospective|||||||
1419355|NCT02039973|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1419356|NCT02039960|||Case-Only||Cross-Sectional|||||||
1419357|NCT02039947|Non-Randomized|||Treatment||None (Open Label)||||||
1419358|NCT02039934||Single Group Assignment||Basic Science||None (Open Label)||||||
1419359|NCT02039921|||||Retrospective|||||||
1419360|NCT02039908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419361|NCT02039895||Single Group Assignment||Treatment||None (Open Label)||||||
1419362|NCT02039882|||Case-Control||Prospective|||||||
1419363|NCT02039869|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1419364|NCT02039856|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419365|NCT02039843|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1419366|NCT02039830|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419367|NCT02039817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419368|NCT02039804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419369|NCT02039791||Single Group Assignment||Treatment||None (Open Label)||||||
1419370|NCT02039778||Single Group Assignment||Treatment||None (Open Label)||||||
1419371|NCT02039765||Single Group Assignment||Screening||None (Open Label)||||||
1419372|NCT02039752|||Cohort||Other|||||||
1419373|NCT02039739|||Cohort||Prospective|||||||
1419374|NCT02039726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419375|NCT02039713|||Cohort||Prospective|||||||
1419376|NCT02039700||Single Group Assignment||Basic Science||None (Open Label)||||||
1419377|NCT02039687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419378|NCT02039674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419379|NCT02039661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419380|NCT02039648|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1419381|NCT02039635|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1419382|NCT02039622|||Cohort|||||||||
1419383|NCT02039609|||Other||Cross-Sectional|||||||
1419384|NCT02039596|Randomized|Crossover Assignment||Basic Science||Single||||||t
1419385|NCT02039583|||Ecologic or Community|||||||||
1419386|NCT02039570|||Case-Only||Prospective|||||||
1419387|NCT02039557|||Cohort||Retrospective|||||||
1419388|NCT02039544|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419389|NCT02039531|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419390|NCT02039518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419391|NCT02039505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419392|NCT02039492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419393|NCT02039479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419394|NCT02039466|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1419395|NCT02039453|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1419396|NCT02039440||Single Group Assignment||||None (Open Label)||||||
1419397|NCT02039427|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1419398|NCT02039414|||Case Control||Cross-Sectional|||||||
1419399|NCT02039401||Single Group Assignment||Treatment||None (Open Label)||||||
1419400|NCT02039388||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419401|NCT02039375||Single Group Assignment||Health Services Research||None (Open Label)||Single arm study||||
1419402|NCT02039362||Single Group Assignment||Prevention||None (Open Label)||||||
1419403|NCT02039349|Randomized|Crossover Assignment||Treatment||||||||
1419404|NCT02039336||Single Group Assignment||Treatment||None (Open Label)||||||
1419405|NCT02039323||Single Group Assignment||Prevention||None (Open Label)||||||
1419406|NCT02039310|||Cohort||Prospective|||||||
1419407|NCT02039297||Single Group Assignment||Supportive Care||None (Open Label)||||||
1419408|NCT02039284|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1419409|NCT02039271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419410|NCT02039258|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419411|NCT02039245||Single Group Assignment||Treatment||None (Open Label)||||||
1419412|NCT02039232||Single Group Assignment||Treatment||None (Open Label)||||||
1419413|NCT02039219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419414|NCT02039206||Single Group Assignment||Treatment||None (Open Label)||||||
1419415|NCT02039193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419416|NCT02039180|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1419417|NCT02039167|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419418|NCT02039154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419419|NCT02039141|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419420|NCT02039128|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1419421|NCT02039115|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1419422|NCT02039102|||||Cross-Sectional|||||||
1419423|NCT02039089|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419424|NCT02039076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419425|NCT02039063|Non-Randomized|Parallel Assignment||Treatment||||||||
1419426|NCT02039050|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419427|NCT02039037|Randomized|Parallel Assignment||Treatment||Single||||||t
1419428|NCT02039024||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419429|NCT02039011|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419430|NCT02038998|Randomized|Parallel Assignment||Treatment||Single||||||t
1419431|NCT02038985||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419432|NCT02038972||Single Group Assignment||Treatment||None (Open Label)||||||
1419433|NCT02038959|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1419434|NCT02038946||Single Group Assignment||Treatment||None (Open Label)||||||
1419435|NCT02038933||Single Group Assignment||Treatment||None (Open Label)||||||
1419436|NCT02038920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419437|NCT02038907|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1419438|NCT02038894|Randomized|Parallel Assignment||Prevention||Single|||t|||
1419439|NCT02038881|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419440|NCT02038868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419441|NCT02038855|Randomized|Parallel Assignment||Treatment||Single||||||t
1419442|NCT02038842|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419443|NCT02038829|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1419444|NCT02038816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419445|NCT02038803|||Cohort||Prospective|||||||
1419446|NCT02038790|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419447|NCT02038777|Non-Randomized|||Treatment||None (Open Label)||MTD was determined in monotherapy cohort. Then two combination cohorts (Combination Cohorts 1 and 2) were added to evaluate the safety of glasdegib administered with chemotherapies. Another combination cohort (Combination Cohort 3) was added to evaluate the safety of glasdegib administered with Azacitidine. Then, Continuation Cohort which allows one Japanese patient enrolled from another trial in the same project was added.||||
1419448|NCT02038764|Randomized|||Basic Science||Double|||t||t|
1419449|NCT02038751|||Family-Based||Cross-Sectional|||||||
1419450|NCT02038738|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1419451|NCT02038725|||Cohort||Prospective|||||||
1419452|NCT02038712|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1419453|NCT02038699||Single Group Assignment||Treatment||None (Open Label)||||||
1419454|NCT02038686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419455|NCT02038673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419456|NCT02038660|||Cohort||Prospective|||||||
1419457|NCT02038647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419458|NCT02038634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419459|NCT02038621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419460|NCT02038608||Single Group Assignment||Basic Science||None (Open Label)||||||
1419461|NCT02038595||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419462|NCT02038582|Randomized|Parallel Assignment||||None (Open Label)||||||
1419463|NCT02038569||Single Group Assignment||Treatment||None (Open Label)||||||
1419464|NCT02038556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419465|NCT02038543||Single Group Assignment||Treatment||None (Open Label)||||||
1419466|NCT02038530|||Cohort||Prospective|||||||
1419467|NCT02038517|||Cohort||Prospective|||||||
1419468|NCT02038504|||Cohort||Prospective|||||||
1419469|NCT02038491|||Cohort||Prospective|||||||
1419470|NCT02038478||Single Group Assignment||Treatment||None (Open Label)||||||
1419471|NCT02038465|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1419472|NCT02038452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419473|NCT02038439|Randomized|Factorial Assignment||||Single|||||t|
1419474|NCT02038426|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419475|NCT02038413|||Cohort||Retrospective|||||||
1419476|NCT02038400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419477|NCT02038387||Single Group Assignment||Treatment||None (Open Label)||||||
1419478|NCT02038374|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1419479|NCT02038361||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419480|NCT02038348||Single Group Assignment||Prevention||None (Open Label)||||||
1419481|NCT02038335|||Cohort||Prospective|||||||
1419482|NCT02038322||Single Group Assignment||||None (Open Label)||||||
1419483|NCT02038309|||Cohort||Prospective|||||||
1419484|NCT02038296|Randomized|Factorial Assignment||Treatment||Single|||t|||
1419485|NCT02038283|||Cohort||Prospective|||||||
1419486|NCT02038270|||||Retrospective|||||||
1419487|NCT02038257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419488|NCT02038244||Single Group Assignment||Treatment||None (Open Label)||||||
1419489|NCT02038231|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419490|NCT02038218||Single Group Assignment||Treatment||None (Open Label)||||||
1419491|NCT02038205|||Case-Control||Prospective|||||||
1419492|NCT02038192|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1419493|NCT02038179|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1419494|NCT02038166|||Cohort||Prospective|||||||
1419495|NCT02038153||Single Group Assignment||Treatment||None (Open Label)||||||
1419496|NCT02038140||Single Group Assignment||Treatment||None (Open Label)||||||
1419497|NCT02038127|||Cohort||Prospective|||||||
1419498|NCT02038114||Single Group Assignment||Supportive Care||Single|||||t|
1419499|NCT02038101|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1419500|NCT02038088|||Cohort||Prospective|||||||
1419501|NCT02038075|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1419502|NCT02038062|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1419503|NCT02038049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419504|NCT02038036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419505|NCT02038023||Single Group Assignment||Treatment||None (Open Label)||||||
1419506|NCT02038010||Single Group Assignment||Treatment||None (Open Label)||||||
1419507|NCT02037997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419508|NCT02037984|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1419509|NCT02037971|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1419510|NCT02037958|Randomized|Parallel Assignment||||Single|||t|||
1419511|NCT02037945||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419512|NCT02037932||Single Group Assignment||Treatment||None (Open Label)||||||
1419513|NCT02037919|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419514|NCT02037906|Randomized|Single Group Assignment||Treatment||Single|||t|||
1419515|NCT02037893|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1419516|NCT02037880|||Cohort||Prospective|||||||
1419517|NCT02037867|||Cohort||Prospective|||||||
1419518|NCT02037854|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1419519|NCT02037841|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1419520|NCT02037828|||Other||Prospective|||||||
1419521|NCT02037815|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1419522|NCT02037802|Randomized|Parallel Assignment||||None (Open Label)||||||
1419523|NCT02037789|||Case Control||Retrospective|||||||
1419524|NCT02037776|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419525|NCT02037763|||Cohort||Prospective|||||||
1419526|NCT02037750|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419527|NCT02037737|||Other||Retrospective|||||||
1419528|NCT02037724|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1419529|NCT02037711|Randomized|Parallel Assignment||||Single||||t||
1419530|NCT02037698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419531|NCT02037685|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419532|NCT02037672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419533|NCT02037659|||Case-Only||Prospective|||||||
1419534|NCT02037646|Randomized|Parallel Assignment||Screening||Single||||||t
1419535|NCT02037633|Randomized|Parallel Assignment||Treatment||Single||||||t
1419536|NCT02037620||Single Group Assignment||Basic Science||None (Open Label)||||||
1419537|NCT02037607|||Cohort||Prospective|||||||
1419538|NCT02037594|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1419539|NCT02037581|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1419540|NCT02037568|Randomized|Parallel Assignment||Treatment||Single|||||t|
1419541|NCT02037555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419542|NCT02037542||Single Group Assignment||Prevention||None (Open Label)||||||
1419543|NCT02037529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419544|NCT02037516|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1419545|NCT02037503|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419546|NCT02037490|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419547|NCT02037477|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419548|NCT02037464||Single Group Assignment||Basic Science||None (Open Label)||||||
1419549|NCT02037451|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419550|NCT02037438|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419551|NCT02037425||Single Group Assignment||Treatment||None (Open Label)||||||
1419552|NCT02037412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419553|NCT02037399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419554|NCT02037386||Single Group Assignment||Treatment||None (Open Label)||||||
1419555|NCT02037373|||Cohort||Prospective|||||||
1419556|NCT02037360|Randomized|Parallel Assignment||Treatment||Single||||||t
1419557|NCT02037347||Single Group Assignment||Treatment||None (Open Label)||||||
1419558|NCT02037334|||Cohort||Prospective|||||||
1419559|NCT02037321|||||Prospective|||||||
1419560|NCT02037308|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1419561|NCT02037295|Randomized|Parallel Assignment||Prevention||||||||
1419562|NCT02037282|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1419563|NCT02037269|||||Prospective|||||||
1419564|NCT02037256||Single Group Assignment||Treatment||None (Open Label)||||||
1419565|NCT02037243|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419566|NCT02037230||Single Group Assignment||Treatment||None (Open Label)||||||
1419567|NCT02037217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419568|NCT02037204||Single Group Assignment||Treatment||None (Open Label)||||||
1419569|NCT02037191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419570|NCT02037178|||Cohort||Cross-Sectional|||||||
1419571|NCT02037165|Randomized|Crossover Assignment||Treatment||Single||||||
1419572|NCT02037152|Randomized|Parallel Assignment||Treatment||Single|||||t|
1419573|NCT02037139|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1419574|NCT02037126|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419575|NCT02037113|||Cohort||Prospective|||||||
1419576|NCT02037100|||Case Control||Prospective|||||||
1419577|NCT02037087|Randomized|Factorial Assignment||||Single|||t|||
1419578|NCT02037074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419579|NCT02037061|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419580|NCT02037048|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419581|NCT02037035|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1419582|NCT02037022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419583|NCT02037009|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1419584|NCT02036996|||Cohort||Retrospective|||||||
1419585|NCT02036983|Randomized|Single Group Assignment||Treatment||Single|||t|||
1419586|NCT02036970|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419587|NCT02036957|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1419588|NCT02036944|||Cohort|||||||||
1419589|NCT02036931|||Cohort||Retrospective|||||||
1419590|NCT02036918|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1419591|NCT02036905|Randomized|Parallel Assignment||Treatment||Double||||t||t
1419592|NCT02036892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419593|NCT02036879|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1419594|NCT02036866|Randomized|Parallel Assignment||Treatment||Single|||||t|
1419595|NCT02036853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419596|NCT02036840|||Case-Only||Retrospective|||||||
1419597|NCT02036827|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1419598|NCT02036814|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1419599|NCT02036801|||Cohort||Prospective|||||||
1419600|NCT02036788|||Cohort||Prospective|||||||
1419601|NCT02036775|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419602|NCT02036762|Randomized|Parallel Assignment||Treatment||Single||||||t
1419603|NCT02036749|Randomized|Parallel Assignment||||Triple|||t|t||t
1419604|NCT02036736|Randomized|Parallel Assignment||Treatment||Single||||||t
1419605|NCT02036723|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419606|NCT02036710|||Case Control||Prospective|||||||
1419607|NCT02036697|Randomized|Single Group Assignment||||Double|||t|||t
1419608|NCT02036684|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1419609|NCT02036671||Single Group Assignment||Treatment||None (Open Label)||||||
1419610|NCT02036658|Randomized|Single Group Assignment||Treatment||Double||To investigate treatment outcome and mediators of Cognitive-Behavioral Group Therapy (CBGT) vs. Mindfulness-Based Stress Reduction (MBSR) vs. Waitlist (WL) in patients with generalized social anxiety disorder (SAD), unmedicated patients with a primary diagnosis of Social Anxiety Disorder (SAD) will be randomized to CBGT vs. MBSR vs. WL and will complete assessments at baseline, post-treatment/WL, and at 1-year follow-up, including the Liebowitz Social Anxiety Scale - Self-Report (primary outcome; Liebowitz, 1987) as well as measures of treatment-related processes.|||t|t
1419611|NCT02036645|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1419612|NCT02036632|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1419613|NCT02036619|||Cohort||Prospective|||||||
1419614|NCT02036606|||Other||Other|||||||
1419615|NCT02036593|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1419616|NCT02036580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419617|NCT02036567|||Cohort||Prospective|||||||
1419618|NCT02036554|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419619|NCT02036541||Single Group Assignment||Treatment||None (Open Label)||||||
1419620|NCT02036528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419621|NCT02036515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419622|NCT02036502|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419623|NCT02036489|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419624|NCT02036476||Single Group Assignment||Treatment||None (Open Label)||||||
1419625|NCT02036463|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1419626|NCT02036450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419627|NCT02036437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419628|NCT02036424|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419629|NCT02036411|||Case-Only||Prospective|||||||
1419630|NCT02036398|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419631|NCT02036385||||||||||||
1419632|NCT02036372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419633|NCT02036359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419634|NCT02036346|Randomized|Parallel Assignment||Prevention||Single|||t|||
1419635|NCT02036333|||Case-Control||Prospective|||||||
1419636|NCT02036320|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419637|NCT02036307|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1419638|NCT02036294|Randomized|Parallel Assignment||Treatment||Single||||||t
1419639|NCT02036281||Single Group Assignment||Treatment||None (Open Label)||||||
1419640|NCT02036268|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1419641|NCT02036255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419642|NCT02036242|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1419643|NCT02036229|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419644|NCT02036216|||Case-Only||Retrospective|||||||
1419645|NCT02036203|Randomized|Parallel Assignment||Other||Single|||t|||
1419646|NCT02036190|||Cohort||Prospective|||||||
1419647|NCT02036177|Randomized|Parallel Assignment||Other||Single|||t|||
1419648|NCT02036164|Randomized|Parallel Assignment||Treatment||Single||||||t
1419649|NCT02036151|Randomized|Parallel Assignment||Prevention||Single||||||t
1419650|NCT02036138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419651|NCT02036125|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419652|NCT02036112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419653|NCT02036099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419654|NCT02036086||Single Group Assignment||Treatment||None (Open Label)||||||
1419655|NCT02036073||Parallel Assignment||Prevention||Single||||||t
1419656|NCT02036060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419657|NCT02036047|Randomized|Single Group Assignment||Treatment||Single||||||t
1419658|NCT02036034|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1419659|NCT02036021|||Cohort||Prospective|||||||
1419660|NCT02036008||Single Group Assignment||Diagnostic||Single||||||t
1419661|NCT02035995|||Case-Crossover||Prospective|||||||
1419662|NCT02035982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419663|NCT02035969|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1419664|NCT02035956||Single Group Assignment||Treatment||None (Open Label)||||||
1419665|NCT02035943|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1419666|NCT02035930||Single Group Assignment||Prevention||Double|||t||t|
1419667|NCT02035917||||Treatment||||||||
1419668|NCT02035904|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419669|NCT02035891|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419670|NCT02035878|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1419671|NCT02035865|||Cohort||Cross-Sectional|||||||
1419672|NCT02035852|||Cohort||Prospective|||||||
1419673|NCT02035839|Randomized|Parallel Assignment||Other||Single||||||t
1419674|NCT02035826|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1419675|NCT02035813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419676|NCT02035800||Single Group Assignment||Basic Science||None (Open Label)||||||
1419677|NCT02035787||Single Group Assignment||Treatment||None (Open Label)||||||
1419678|NCT02035774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419679|NCT02035761|||Case-Only||Cross-Sectional|||||||
1419680|NCT02035748||Single Group Assignment||Treatment||None (Open Label)||||||
1419681|NCT02035735||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419682|NCT02035722|Randomized|Parallel Assignment||Prevention||Single||||||t
1419683|NCT02035709|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419684|NCT02035696|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1419685|NCT02035683||Single Group Assignment||Treatment||None (Open Label)||||||
1419686|NCT02035670|||Cohort||Prospective|||||||
1419687|NCT02035657||Single Group Assignment||Treatment||None (Open Label)||||||
1419688|NCT02035644|Randomized|Parallel Assignment||Treatment||Double||||||
1419689|NCT02035631|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419690|NCT02035618|Randomized|Parallel Assignment||Treatment||Single||||||t
1419691|NCT02035605|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419692|NCT02035592|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1419693|NCT02035579|Randomized|Parallel Assignment||Treatment||Single||||||t
1419694|NCT02035566|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1419695|NCT02035553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419696|NCT02035540|||Other||Prospective|||||||
1419697|NCT02035527||Single Group Assignment||Treatment||None (Open Label)||||||
1419698|NCT02035514|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1419699|NCT02035501|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1419700|NCT02035488||Single Group Assignment||Treatment||None (Open Label)||||||
1419701|NCT02035475|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1419702|NCT02035449|||Cohort||Prospective|||||||
1419703|NCT02035436|Randomized|Parallel Assignment||Other||Single|||||t|
1419704|NCT02035423|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1419705|NCT02035410|Randomized|Parallel Assignment||Prevention||Single|||t|||
1419706|NCT02035397|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1419707|NCT02035384|||Cohort||Prospective|||||||
1419708|NCT02035371|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1419709|NCT02035358||Single Group Assignment||Treatment||None (Open Label)||||||
1419710|NCT02035345||Single Group Assignment||Supportive Care||None (Open Label)||||||
1419711|NCT02035332||Single Group Assignment||Treatment||None (Open Label)||||||
1419712|NCT02035319|||Case-Only||Prospective|||||||
1419713|NCT02035306||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419714|NCT02035293||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419715|NCT02035280|||Cohort||Prospective|||||||
1419716|NCT02035267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419717|NCT02035254|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419718|NCT02035241|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1419719|NCT02035228|Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1419720|NCT02035215|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419721|NCT02035202|Randomized|Parallel Assignment||Treatment||Single||||||t
1419722|NCT02035189|||Case Control||Prospective|||||||
1419723|NCT02035176|||Case Control||Prospective|||||||
1419724|NCT02035163|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419725|NCT02035150|Randomized|Parallel Assignment||||None (Open Label)||||||
1419726|NCT02035137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419727|NCT02035124||Single Group Assignment||Treatment||None (Open Label)||||||
1419728|NCT02035111|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419729|NCT02035098||Single Group Assignment||Supportive Care||None (Open Label)||||||
1419730|NCT02035085||Single Group Assignment||Treatment||None (Open Label)||||||
1419731|NCT02035072||Single Group Assignment||Treatment||None (Open Label)||||||
1419732|NCT02035059|||Cohort||Prospective|||||||
1419733|NCT02035046|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1419734|NCT02035033|||||Prospective|||||||
1419735|NCT02035020||Single Group Assignment||Treatment||None (Open Label)||||||
1419736|NCT02035007||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419737|NCT02034994|Randomized|Parallel Assignment||Prevention||Single||||||t
1419738|NCT02034981||Single Group Assignment||Treatment||None (Open Label)||||||
1419739|NCT02034968||Single Group Assignment||Treatment||None (Open Label)||||||
1419740|NCT02034955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419741|NCT02034942|Randomized|Parallel Assignment||Other||Single||||||t
1419742|NCT02034929|Randomized|Factorial Assignment||Diagnostic||Single|||t|||
1419743|NCT02034916||Parallel Assignment||Treatment||None (Open Label)||||||
1419744|NCT02034903|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419745|NCT02034890|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1419746|NCT02034877||||Prevention||None (Open Label)||||||
1419747|NCT02034864|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419748|NCT02034851|||Case Control||Prospective|||||||
1419749|NCT02034838||Single Group Assignment||Supportive Care||None (Open Label)||||||
1419750|NCT02034825|||Cohort||Retrospective|||||||
1419751|NCT02034812|||Cohort||Retrospective|||||||
1419752|NCT02034799|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419753|NCT02034786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419754|NCT02034773|Randomized|Single Group Assignment||||Double|||t||t|
1419755|NCT02034760|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1419756|NCT02034747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419757|NCT02034734||Single Group Assignment||Basic Science||None (Open Label)||||||
1419758|NCT02034721|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1419759|NCT02034708|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1419760|NCT02034695|||Cohort||Prospective|||||||
1419761|NCT02034682|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419762|NCT02034669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419763|NCT02034656|||Cohort||Retrospective|||||||
1419764|NCT02034643|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419765|NCT02034630||Single Group Assignment||Treatment||None (Open Label)||||||
1419766|NCT02034617|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1419767|NCT02034604|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419768|NCT02034591|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1419769|NCT02034578|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1419770|NCT02034565|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1419771|NCT02034552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419772|NCT02034539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419773|NCT02034526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419774|NCT02034513|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1419775|NCT02034500|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1419776|NCT02034487|||Case-Only||Retrospective|||||||
1419777|NCT02034474|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419778|NCT02034461|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1419779|NCT02034448|||Cohort||Prospective|||||||
1419780|NCT02034435|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1419781|NCT02034422|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1419782|NCT02034409|Randomized|Parallel Assignment||Treatment||Quadruple||Participants in this double-blind, randomized, sham-controlled trial will be randomly assigned to receive either sham or PLIUS device for 48 weeks.|t|t|t|t
1419783|NCT02034396||Single Group Assignment||Screening||None (Open Label)||||||
1419784|NCT02034383|Randomized|Crossover Assignment||||Single||||||t
1419785|NCT02034370|||Case Control||Prospective|||||||
1419786|NCT02034357||Single Group Assignment||||None (Open Label)||||||
1419787|NCT02034344|||Cohort||Prospective|||||||
1419788|NCT02034331|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1419789|NCT02034318|||Case-Only||Prospective|||||||
1419790|NCT02034305|||Cohort||Cross-Sectional|||||||
1419791|NCT02034292|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1419792|NCT02034279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419793|NCT02034266||Single Group Assignment||Prevention||None (Open Label)||open label study with no placebo.||||
1419794|NCT02034253|||Case-Control||Prospective|||||||
1419795|NCT02034240||||||||||||
1419796|NCT02034227|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419797|NCT02034214|Randomized|Parallel Assignment||Prevention||Single|||||t|
1419798|NCT02034201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419799|NCT02034188||Single Group Assignment||Treatment||None (Open Label)||||||
1419800|NCT02034175|||Case-Crossover||Prospective|||||||
1419801|NCT02034162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419802|NCT02034149|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419803|NCT02034136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419804|NCT02034123|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419805|NCT02034110||Parallel Assignment||Treatment||None (Open Label)||9 indications||||
1419806|NCT02034097|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419807|NCT02034084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419808|NCT02034071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419809|NCT02034058||Single Group Assignment||Prevention||None (Open Label)||||||
1419810|NCT02034045|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419811|NCT02034032|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419812|NCT02034019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419813|NCT02034006||Single Group Assignment||Treatment||None (Open Label)||||||
1419814|NCT02033993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419815|NCT02033980||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419816|NCT02033967|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1419817|NCT02033954|||Case-Only||Prospective|||||||
1419818|NCT02033941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419819|NCT02033928|||Case-Only||Prospective|||||||
1419820|NCT02033915|Randomized|Single Group Assignment||||None (Open Label)||||||
1419821|NCT02033902|||Cohort||Prospective|||||||
1419822|NCT02033889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419823|NCT02033876|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419824|NCT02033863|||Case-Only||Prospective|||||||
1419825|NCT02033850|Randomized|Parallel Assignment||Treatment||Single||||||t
1419826|NCT02033837|||Case-Only||Cross-Sectional|||||||
1419827|NCT02033824|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419828|NCT02033811|||Cohort||Prospective|||||||
1419829|NCT02033798||Single Group Assignment||Treatment||None (Open Label)||||||
1419830|NCT02033785|||Cohort||Prospective|||||||
1419831|NCT02033772|||Case-Only||Prospective|||||||
1419832|NCT02033759|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1419833|NCT02033746|Randomized|Crossover Assignment||Treatment||Single|||t|||
1419834|NCT02033733|||Cohort||Retrospective|||||||
1419835|NCT02033720|||Cohort||Retrospective|||||||
1419836|NCT02033707|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1419837|NCT02033694|||Case-Control||Prospective|||||||
1419838|NCT02033681|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419839|NCT02033668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419840|NCT02033655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419841|NCT02033642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419842|NCT02033629|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419843|NCT02033616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419844|NCT02033603|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1419845|NCT02033590||Single Group Assignment||Treatment||None (Open Label)||||||
1419846|NCT02033577|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1419847|NCT02033564|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419848|NCT02033551|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419849|NCT02033538||Single Group Assignment||Treatment||None (Open Label)||||||
1419850|NCT02033525|Randomized|Parallel Assignment||Treatment||Single||||||t
1419851|NCT02033512||Single Group Assignment||Treatment||None (Open Label)||||||
1419852|NCT02033499|Randomized|Parallel Assignment||Treatment||Single|The investigators including the bio-statistician were blind to the study assignment.||||t|
1419853|NCT02033486||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419854|NCT02033473|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1419855|NCT02033460|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419856|NCT02033447||Single Group Assignment||Other||None (Open Label)||||||
1419857|NCT02033434||Single Group Assignment||Treatment||None (Open Label)||||||
1419858|NCT02033421|||Case-Only||Prospective|||||||
1419859|NCT02033408|Randomized|Parallel Assignment||Treatment||Single|||||t|
1419860|NCT02033395|||Cohort||Prospective|||||||
1419861|NCT02033382|||Case-Control||Prospective|||||||
1419862|NCT02033369|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1419863|NCT02033356|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419864|NCT02033343||Single Group Assignment||Treatment||None (Open Label)||||||
1419865|NCT02033330|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1419866|NCT02033317||Single Group Assignment||Treatment||None (Open Label)||||||
1419867|NCT02033304|||Cohort||Prospective|||||||
1419868|NCT02033291|||Case-Only||Prospective|||||||
1419869|NCT02033278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419870|NCT02033265|||Case-Control||Prospective|||||||
1419871|NCT02033252|Randomized|Parallel Assignment||Treatment||Single||||||t
1419872|NCT02033239|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1419873|NCT02033226|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1419874|NCT02033213|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1419875|NCT02033200|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419876|NCT02033187|Randomized|Crossover Assignment||Prevention||Single|||||t|
1419877|NCT02033174|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1419878|NCT02033161||Single Group Assignment||Treatment||None (Open Label)||||||
1419879|NCT02033148||Single Group Assignment||Treatment||None (Open Label)||||||
1419880|NCT02033135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419881|NCT02033122|Randomized|Parallel Assignment||Treatment||Single|||||t|
1419882|NCT02033109|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1419883|NCT02033096|||Cohort||Prospective|||||||
1419884|NCT02033083|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1419885|NCT02033070|||Cohort||Prospective|||||||
1419886|NCT02033057|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1419887|NCT02033044|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1419888|NCT02033031|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419889|NCT02033018||Single Group Assignment||Treatment||None (Open Label)||||||
1419890|NCT02033005|||Cohort||Prospective|||||||
1419891|NCT02032979||Single Group Assignment||Basic Science||None (Open Label)||||||
1419892|NCT02032966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419893|NCT02032953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419894|NCT02032940|||Cohort||Prospective|||||||
1419895|NCT02032927|Randomized|Parallel Assignment||Treatment||Single||||||t
1419896|NCT02032914|||Case-Only||Cross-Sectional|||||||
1419897|NCT02032901|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419898|NCT02032888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419899|NCT02032875|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419900|NCT02032862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419901|NCT02032849|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1419902|NCT02032836|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419903|NCT02032823|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1419904|NCT02032810||Single Group Assignment||Treatment||None (Open Label)||||||
1419905|NCT02032797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419906|NCT02032784|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1419907|NCT02032771||Single Group Assignment||Treatment||None (Open Label)||||||
1419908|NCT02032758|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1419909|NCT02032745|||Other||Prospective|||||||
1419910|NCT02032732|||Cohort||Prospective|||||||
1419911|NCT02032719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419912|NCT02032706||Single Group Assignment||Treatment||None (Open Label)||||||
1419913|NCT02032693|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1419914|NCT02032680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419915|NCT02032667|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1419916|NCT02032654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419917|NCT02032641|Randomized|Parallel Assignment||Treatment||Single||||||t
1419918|NCT02032628|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419919|NCT02032615|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419920|NCT02032602|Randomized|Parallel Assignment||Treatment||Single||||||t
1419921|NCT02032589|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1419922|NCT02032576||Single Group Assignment||Treatment||None (Open Label)||||||
1419923|NCT02032563||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419924|NCT02032550|Randomized|Parallel Assignment||Treatment||Single|||||t|
1419925|NCT02032537|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1419926|NCT02032524||Single Group Assignment||Treatment||None (Open Label)||||||
1419927|NCT02032511|||Cohort||Prospective|||||||
1419928|NCT02032498||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419929|NCT02032485||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419930|NCT02032472|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1419931|NCT02032459|||Cohort||Prospective|||||||
1419932|NCT02032446||Single Group Assignment||Treatment||None (Open Label)||||||
1419933|NCT02032433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419934|NCT02032420|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1419935|NCT02032407||Single Group Assignment||Treatment||None (Open Label)||||||
1419936|NCT02032394|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1419937|NCT02032381||Single Group Assignment||Screening||None (Open Label)||||||
1419938|NCT02032368|Randomized|Parallel Assignment||Screening||Single|||||t|
1419939|NCT02032355|||Case-Only||Prospective|||||||
1419940|NCT02032342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419941|NCT02032329||Single Group Assignment||Treatment||None (Open Label)||||||
1419942|NCT02032316||Single Group Assignment||Treatment||None (Open Label)||||||
1419943|NCT02032303|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1419944|NCT02032290|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1419945|NCT02032277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419946|NCT02032264|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419947|NCT02032251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419948|NCT02032238|Randomized|Parallel Assignment||Treatment||None (Open Label)|no masking|||||
1419949|NCT02032225|||Case-Only||Prospective|||||||
1419950|NCT02032212|Randomized|Crossover Assignment||||None (Open Label)||||||
1419951|NCT02032199|||Cohort||Prospective|||||||
1419952|NCT02032186|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1419953|NCT02032173||Single Group Assignment||Treatment||None (Open Label)||||||
1419954|NCT02032160|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1419955|NCT02032147|||Cohort||Prospective|||||||
1419956|NCT02032134||Single Group Assignment||Treatment||None (Open Label)||||||
1419957|NCT02032121||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419958|NCT02032108||Single Group Assignment||Supportive Care||None (Open Label)||||||
1419959|NCT02032095||Single Group Assignment||Treatment||None (Open Label)||||||
1419960|NCT02032082|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1419961|NCT02032069|||Case-Only||Prospective|||||||
1419962|NCT02032056|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1419963|NCT02032043|||Ecologic or Community||Cross-Sectional|||||||
1419964|NCT02032030|||Other||Prospective|||||||
1419965|NCT02032017|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1419966|NCT02032004|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1419967|NCT02031991|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1419968|NCT02031978|||Cohort||Prospective|||||||
1419969|NCT02031965||Single Group Assignment||Treatment||None (Open Label)||||||
1419970|NCT02031952|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419971|NCT02031939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419972|NCT02031926||Single Group Assignment||Basic Science||None (Open Label)||||||
1419973|NCT02031913|||Cohort||Prospective|||||||
1419974|NCT02031900|||Case-Only||Prospective|||||||
1419975|NCT02031887|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1419976|NCT02031874|||Cohort||Prospective|||||||
1419977|NCT02031861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419978|NCT02031848|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1419979|NCT02031835||Single Group Assignment||Treatment||None (Open Label)||||||
1419980|NCT02031822|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419981|NCT02031809|||Cohort||Retrospective|||||||
1419982|NCT02031796||Single Group Assignment||Diagnostic||None (Open Label)||||||
1419983|NCT02031783|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1419984|NCT02031770|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1419985|NCT02031757|Randomized|Parallel Assignment||Treatment||Single||||||t
1419986|NCT02031744|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419987|NCT02031731|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419988|NCT02031718|Randomized|Parallel Assignment||Treatment||Single||||||t
1419989|NCT02031705|Randomized|Parallel Assignment||Treatment||Single|||t|||
1419990|NCT02031692|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1419991|NCT02031679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1419992|NCT02031666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419993|NCT02031653|||Cohort||Prospective|||||||
1419994|NCT02031640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1419995|NCT02031627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419996|NCT02031614||Single Group Assignment||Health Services Research||None (Open Label)||||||
1419997|NCT02031601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1419998|NCT02031588|||Cohort||Prospective|||||||
1419999|NCT02031575|Randomized|Parallel Assignment||||None (Open Label)||||||
1420000|NCT02031562|Randomized|Parallel Assignment||Treatment||Single||||||t
1420001|NCT02031549|||Cohort||Prospective|||||||
1420002|NCT02031536|Randomized|Parallel Assignment||Treatment||Double||||||
1420003|NCT02031523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420004|NCT02031510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420005|NCT02031497|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1420006|NCT02031484|||Case-Only||Prospective|||||||
1420007|NCT02031471||Single Group Assignment||Treatment||None (Open Label)||||||
1420008|NCT02031458||Single Group Assignment||Treatment||None (Open Label)||||||
1420009|NCT02031445|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420010|NCT02031432||Single Group Assignment||Treatment||None (Open Label)||||||
1420011|NCT02031419|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420012|NCT02031406|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420013|NCT02031393|||Case Control||Prospective|||||||
1420014|NCT02031380||Single Group Assignment||Supportive Care||None (Open Label)||||||
1420015|NCT02031367|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1420016|NCT02031354||Single Group Assignment||Treatment||None (Open Label)||||||
1420017|NCT02031341|||||Cross-Sectional|||||||
1420018|NCT02031328||Single Group Assignment||Treatment||None (Open Label)||||||
1420019|NCT02031315|||Cohort||Prospective|||||||
1420020|NCT02031302|||Cohort||Prospective|||||||
1420021|NCT02031289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420022|NCT02031276|Randomized|Parallel Assignment||Treatment||Double|Period 1 was blinded intravenous (IV) therapy, period 2 was open label IV therapy and period 3 was open label subcutaneous (SC) therapy.||t||t|
1420023|NCT02031263||Single Group Assignment||Treatment||None (Open Label)||||||
1420024|NCT02031250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420025|NCT02031237|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1420026|NCT02031224|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420027|NCT02031211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420028|NCT02031198||Single Group Assignment||Treatment||None (Open Label)||||||
1420029|NCT02031185|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420030|NCT02031172|||Case Control||Cross-Sectional|||||||
1420031|NCT02031159|||Case-Only||Prospective|||||||
1420032|NCT02031146|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1420033|NCT02031120|||Cohort||Prospective|||||||
1420034|NCT02031107|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1420035|NCT02031094|||Case Control||Prospective|||||||
1420036|NCT02031081|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1420037|NCT02031068|Randomized|Parallel Assignment||Treatment||Single||||||t
1420038|NCT02031055|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420039|NCT02031042|||||Prospective|||||||
1420040|NCT02031029|||Cohort||Prospective|||||||
1420041|NCT02031016|Randomized|Parallel Assignment||Prevention||Single|||t|||
1420042|NCT02031003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420043|NCT02030990|Randomized|Parallel Assignment||Prevention||Single||||t||
1420044|NCT02030977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420045|NCT02030964||Single Group Assignment||Treatment||None (Open Label)||||||
1420046|NCT02030951|||Cohort||Prospective|||||||
1420047|NCT02030938||Single Group Assignment||Treatment||None (Open Label)||||||
1420048|NCT02030925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420049|NCT02030912|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1420050|NCT02030899|Randomized|Parallel Assignment||Treatment||Double||ACDF with plate and autologous bone|t|||t
1420051|NCT02030886||Single Group Assignment||||None (Open Label)||||||
1420052|NCT02030873|Randomized|Crossover Assignment||||Single||||||t
1420053|NCT02030860|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420054|NCT02030847||Single Group Assignment||Treatment||None (Open Label)||||||
1420055|NCT02030834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420056|NCT02030821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420057|NCT02030808|Randomized|Parallel Assignment||Treatment||Single||||||t
1420058|NCT02030795|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420059|NCT02030782|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1420060|NCT02030769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420061|NCT02030756|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1420062|NCT02030743|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420063|NCT02030730|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420064|NCT02030717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420065|NCT02030704|||Cohort||Prospective|||||||
1420066|NCT02030691|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420067|NCT02030678||Single Group Assignment||Treatment||None (Open Label)||||||
1420068|NCT02030665|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1420069|NCT02030652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420070|NCT02030639||Single Group Assignment||Basic Science||None (Open Label)||||||
1420071|NCT02030626|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420072|NCT02030613||Single Group Assignment||Basic Science||None (Open Label)||||||
1420073|NCT02030600|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1420074|NCT02030587|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420075|NCT02030574||Single Group Assignment||Treatment||None (Open Label)||||||
1420076|NCT02030561||Single Group Assignment||Treatment||None (Open Label)||||||
1420077|NCT02030548|||Cohort||Prospective|||||||
1420078|NCT02030535|Randomized|Crossover Assignment||Treatment||Double||||||
1420079|NCT02030522||Single Group Assignment||Treatment||None (Open Label)||||||
1420080|NCT02030509|||Case-Only|||||||||
1420081|NCT02030496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420082|NCT02030483||Single Group Assignment||Treatment||None (Open Label)||||||
1420083|NCT02030470||Single Group Assignment||Treatment||Single|||t|||
1420084|NCT02030457|Randomized|Crossover Assignment||||None (Open Label)||||||
1420085|NCT02030444|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1420086|NCT02030431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420087|NCT02030418||Single Group Assignment||Treatment||None (Open Label)||||||
1420088|NCT02030405||Single Group Assignment||Treatment||None (Open Label)||||||
1420089|NCT02030392|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1420090|NCT02030379|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420091|NCT02030366|||Cohort||Prospective|||||||
1420092|NCT02030353|Randomized|Parallel Assignment||Prevention||Single||||||t
1420093|NCT02030340||||||||||||
1420094|NCT02030327|||Cohort||Prospective|||||||
1420095|NCT02030314||Single Group Assignment||Treatment||None (Open Label)||||||
1420096|NCT02030301|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420097|NCT02030288|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1420098|NCT02030275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420099|NCT02030262|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420100|NCT02030249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420101|NCT02030236||Single Group Assignment||Treatment||None (Open Label)||||||
1420102|NCT02030223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420103|NCT02030210|||||Prospective|||||||
1420104|NCT02030197|Randomized|Parallel Assignment||Treatment||Single||||||t
1420105|NCT02030184||Single Group Assignment||Treatment||None (Open Label)||||||
1420106|NCT02030171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420107|NCT02030158|||||Prospective|||||||
1420108|NCT02030145|Randomized|Crossover Assignment||Treatment||Single|||t|||
1420109|NCT02030132|Randomized|Parallel Assignment||Other||Single|||||t|
1420110|NCT02030119|Randomized|Parallel Assignment||Other||Single|||||t|
1420111|NCT02030106|||Cohort||Prospective|||||||
1420112|NCT02030093|||Cohort||Prospective|||||||
1420113|NCT02030080|Randomized|Parallel Assignment||Other||Single|||||t|
1420114|NCT02030067||Single Group Assignment||Treatment||None (Open Label)||||||
1420115|NCT02030054|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1420116|NCT02030041|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1420117|NCT02030028||Single Group Assignment||Treatment||None (Open Label)||||||
1420118|NCT02030015||Single Group Assignment||Treatment||None (Open Label)||||||
1420119|NCT02030002|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1420120|NCT02029989|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1420121|NCT02029976|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420122|NCT02029963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420123|NCT02029950||Single Group Assignment||Treatment||None (Open Label)||||||
1420124|NCT02029937|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1420125|NCT02029924|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1420126|NCT02029911||Single Group Assignment||Treatment||None (Open Label)||||||
1420127|NCT02029898|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1420128|NCT02029885|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420129|NCT02029872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420130|NCT02029859||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420131|NCT02029846|Randomized|Parallel Assignment||Treatment||Single||||||t
1420132|NCT02029833|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1420133|NCT02029820|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420134|NCT02029807|||Case-Only||Prospective|||||||
1420135|NCT02029794|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1420136|NCT02029781||Single Group Assignment||Treatment||None (Open Label)||||||
1420137|NCT02029768|||Case-Only||Prospective|||||||
1420138|NCT02029755|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1420139|NCT02029742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420140|NCT02029729||Single Group Assignment||Treatment||None (Open Label)||||||
1420141|NCT02029716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420142|NCT02029703|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1420143|NCT02029690||Single Group Assignment||Treatment||None (Open Label)||||||
1420144|NCT02029677|||Cohort||Prospective|||||||
1420145|NCT02029664||Single Group Assignment||Basic Science||Triple|||t||t|t
1420146|NCT02029651|Randomized|Parallel Assignment||Treatment||Single||||||t
1420147|NCT02029638||Single Group Assignment||Treatment||None (Open Label)||||||
1420148|NCT02029625|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1420149|NCT02029612|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1420150|NCT02029599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420151|NCT02029586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420152|NCT02029573||Single Group Assignment||Treatment||None (Open Label)||||||
1420153|NCT02029560|||Case-Only||Prospective|||||||
1420154|NCT02029547||Single Group Assignment||Diagnostic||Single||||||t
1420155|NCT02029534|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420156|NCT02029521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420157|NCT02029508|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420158|NCT02029495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420159|NCT02029482|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1420160|NCT02029469||Single Group Assignment||Treatment||None (Open Label)||||||
1420161|NCT02029456||Single Group Assignment||Treatment||None (Open Label)||||||
1420162|NCT02029443||Single Group Assignment||Treatment||None (Open Label)||||||
1420163|NCT02029430||Single Group Assignment||Treatment||None (Open Label)||||||
1420164|NCT02029417||Single Group Assignment||Treatment||None (Open Label)||||||
1420165|NCT02029404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420166|NCT02029391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420167|NCT02029378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420168|NCT02029365|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1420169|NCT02029352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420170|NCT02029339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420171|NCT02029326|||Cohort||Prospective|||||||
1420172|NCT02029313|Randomized|Crossover Assignment||||None (Open Label)||||||
1420173|NCT02029300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420174|NCT02029287|||Ecologic or Community||Prospective|||||||
1420175|NCT02029274|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420176|NCT02029261|||Cohort||Prospective|||||||
1420177|NCT02029248|||Case-Only||Cross-Sectional|||||||
1420178|NCT02029235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420179|NCT02029222|||Cohort||Retrospective|||||||
1420180|NCT02029209|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1420181|NCT02029196|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1420182|NCT02029183||Single Group Assignment||Treatment||None (Open Label)||||||
1420183|NCT02029170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420184|NCT02029157|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420185|NCT02029144|||||Prospective|||||||
1420186|NCT02029131|Randomized|Parallel Assignment||Prevention||Single||||||t
1420187|NCT02029118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420188|NCT02029105|||Case-Only||Retrospective|||||||
1420189|NCT02029092|||Other||Prospective|||||||
1420190|NCT02029079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420191|NCT02029066||Single Group Assignment||||None (Open Label)||||||
1420192|NCT02029053||Single Group Assignment||Supportive Care||None (Open Label)||||||
1420193|NCT02029040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420194|NCT02029027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420195|NCT02029014||Single Group Assignment||Treatment||None (Open Label)||||||
1420196|NCT02029001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420197|NCT02028988||Single Group Assignment||Treatment||None (Open Label)||||||
1420198|NCT02028975|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1420199|NCT02028962|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420200|NCT02028949|Non-Randomized|||||None (Open Label)||||||
1420201|NCT02028936|Randomized|Parallel Assignment||||Double||||||
1420202|NCT02028923|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1420203|NCT02028910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420204|NCT02028897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420205|NCT02028884|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420206|NCT02028871|Randomized|Crossover Assignment||Treatment||Single|||t|||
1420207|NCT02028858|||Case-Only||Prospective|||||||
1420208|NCT02028845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420209|NCT02028832|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420210|NCT02028819||||||||||||
1420211|NCT02028806||Single Group Assignment||Treatment||None (Open Label)||||||
1420212|NCT02028793|||Case-Only||Prospective|||||||
1420213|NCT02028780|Randomized|Parallel Assignment||Treatment||Double||||||
1420214|NCT02028767|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1420215|NCT02028754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420216|NCT02028741|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1420217|NCT02028728|||Other||Prospective|||||||
1420218|NCT02028715|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1420219|NCT02028702|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1420220|NCT02028689|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1420221|NCT02028676|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1420222|NCT02028663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420223|NCT02028650|||Cohort||Retrospective|||||||
1420224|NCT02028637||Single Group Assignment||Basic Science||None (Open Label)||||||
1420225|NCT02028624|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1420226|NCT02028611|||Case-Crossover||Cross-Sectional|||||||
1420227|NCT02028598|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420228|NCT02028585|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420229|NCT02028572|||Case-Only||Cross-Sectional|||||||
1420230|NCT02028559||Single Group Assignment||Treatment||None (Open Label)||||||
1420231|NCT02028546|Randomized|Crossover Assignment||Treatment||Single|||||t|
1420232|NCT02028533|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1420233|NCT02028507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420234|NCT02028494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420235|NCT02028481||Single Group Assignment||Treatment||None (Open Label)||||||
1420236|NCT02028468|Randomized|Parallel Assignment||Treatment||Single||||||t
1420237|NCT02028455|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420238|NCT02028442||Single Group Assignment||Treatment||None (Open Label)||||||
1420239|NCT02028429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420240|NCT02028416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420241|NCT02028403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420242|NCT02028390||Single Group Assignment||||None (Open Label)||||||
1420243|NCT02028377||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420244|NCT02028364||Single Group Assignment||Treatment||None (Open Label)||||||
1420245|NCT02028351|||Case-Only||Prospective|||||||
1420246|NCT02028338|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1420247|NCT02028325||Single Group Assignment||Treatment||None (Open Label)||||||
1420248|NCT02028312|Randomized|Parallel Assignment||Treatment||Single|||||t|
1420249|NCT02028299||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420250|NCT02028286||Single Group Assignment||Treatment||None (Open Label)||||||
1420251|NCT02028273|||Cohort||Cross-Sectional|||||||
1420252|NCT02028260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420253|NCT02028247|Randomized|Parallel Assignment||Treatment||Single||||||t
1420254|NCT02028234|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1420255|NCT02028221|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1420256|NCT02028208||Single Group Assignment||Diagnostic||Double|||t||t|
1420257|NCT02028195|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420258|NCT02028182||Single Group Assignment||Diagnostic||Double|||t||t|
1420259|NCT02028169|||Other||Prospective|||||||
1420260|NCT02028156||Single Group Assignment||||None (Open Label)||||||
1420261|NCT02028143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420262|NCT02028130||Single Group Assignment||Treatment||None (Open Label)||||||
1420263|NCT02028117||Single Group Assignment||Treatment||None (Open Label)||||||
1420264|NCT02028104||Single Group Assignment||Treatment||None (Open Label)||||||
1420265|NCT02028091|||Case Control||Prospective|||||||
1420266|NCT02028078||Single Group Assignment||Basic Science||None (Open Label)||||||
1420267|NCT02028065|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420268|NCT02028052|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1420269|NCT02028039||Single Group Assignment||Treatment||None (Open Label)||||||
1420270|NCT02028026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420271|NCT02028013|||Case Control||Prospective|||||||
1420272|NCT02028000|Randomized|Factorial Assignment||Supportive Care||Single|||||t|
1420273|NCT02027987|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420274|NCT02027974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420275|NCT02027961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420276|NCT02027948||Single Group Assignment||Other||None (Open Label)||||||
1420277|NCT02027935||Single Group Assignment||Treatment||None (Open Label)||||||
1420278|NCT02027922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420279|NCT02027909|||Case-Control||Prospective|||||||
1420280|NCT02027896|Randomized|Parallel Assignment||Treatment||Single||||||t
1420281|NCT02027883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420282|NCT02027870|||Case-Only||Prospective|||||||
1420283|NCT02027857|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1420284|NCT02027844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420285|NCT02027831||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420286|NCT02027818||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420287|NCT02027805||Single Group Assignment||Treatment||None (Open Label)||||||
1420288|NCT02027792|Randomized|Parallel Assignment||Treatment||Single||||||t
1420289|NCT02027779|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420290|NCT02027766|Randomized|Parallel Assignment||Basic Science||Single||||||t
1420291|NCT02027753||Single Group Assignment||Treatment||None (Open Label)||||||
1420292|NCT02027740||Single Group Assignment||Prevention||None (Open Label)||||||
1420293|NCT02027727|||Cohort||Prospective|||||||
1420294|NCT02027714|||||Cross-Sectional|||||||
1420295|NCT02027701||Single Group Assignment||Treatment||None (Open Label)||||||
1420296|NCT02027688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420297|NCT02027675|Randomized|Crossover Assignment||Treatment||Single|||||t|
1420298|NCT02027662|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1420299|NCT02027649|||Case-Control||Prospective|||||||
1420300|NCT02027636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420301|NCT02027623|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1420302|NCT02027610|||Cohort||Cross-Sectional|||||||
1420303|NCT02027597|Randomized|Parallel Assignment||Prevention||Single|||t|||
1420304|NCT02027584|||Cohort||Prospective|||||||
1420305|NCT02027571||Single Group Assignment||Prevention||None (Open Label)||||||
1420306|NCT02027558|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420307|NCT02027545|Randomized|Parallel Assignment||Health Services Research||Single||A cluster-randomized (by provider) pragmatic trial of the patient-centered intervention versus pragmatic control.|t|||
1420308|NCT02027532|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420309|NCT02027519|||||Cross-Sectional|||||||
1420310|NCT02027506|||Case-Crossover||Prospective|||||||
1420311|NCT02027493|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420312|NCT02027480|||||Prospective|||||||
1420313|NCT02027467|Randomized|Parallel Assignment||||Double|||t||t|
1420314|NCT02027454|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1420315|NCT02027441|||Cohort||Prospective|||||||
1420316|NCT02027428|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420317|NCT02027415|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1420318|NCT02027402|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420319|NCT02027389|||Other||Retrospective|||||||
1420320|NCT02027376||Single Group Assignment||Treatment||None (Open Label)||||||
1420321|NCT02027363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420322|NCT02027350||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420323|NCT02027337|Randomized|Parallel Assignment||Prevention||Single|||t|||
1420324|NCT02027324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420325|NCT02027311|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420326|NCT02027298||Single Group Assignment||Treatment||None (Open Label)||||||
1420327|NCT02027285|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1420328|NCT02027272|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420329|NCT02027259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420330|NCT02027246||Single Group Assignment||Treatment||None (Open Label)||||||
1420331|NCT02027233||Single Group Assignment||Prevention||None (Open Label)||||||
1420332|NCT02027220||Single Group Assignment||Treatment||None (Open Label)||||||
1420333|NCT02027207|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1420334|NCT02027194|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420335|NCT02027181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420336|NCT02027168|||Case-Only||Prospective|||||||
1420337|NCT02027155|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1420338|NCT02027142|||Case-Control||Cross-Sectional|||||||
1420339|NCT02027129||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420340|NCT02027116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420341|NCT02027103|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1420342|NCT02027090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420343|NCT02027077|Randomized|Parallel Assignment||Treatment||Single||||||t
1420344|NCT02027064||Single Group Assignment||Treatment||None (Open Label)||||||
1420345|NCT02027051|||Case-Only||Cross-Sectional|||||||
1420346|NCT02027038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420347|NCT02027025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420348|NCT02027012||Single Group Assignment||Treatment||None (Open Label)||||||
1420349|NCT02026999|||Case Control||Prospective|||||||
1420350|NCT02026986|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1420351|NCT02026973|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1420352|NCT02026960|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1420353|NCT02026947|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420354|NCT02026934||||||||||||
1420355|NCT02026921||Single Group Assignment||Treatment||None (Open Label)||||||
1420356|NCT02026908||Single Group Assignment||Treatment||None (Open Label)||||||
1420357|NCT02026895||Single Group Assignment||Basic Science||None (Open Label)||||||
1420358|NCT02026882||Single Group Assignment||Treatment||None (Open Label)||||||
1420359|NCT02026869|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1420360|NCT02026856|||Other||Prospective|||||||
1420361|NCT02026843|||Case Control||Prospective|||||||
1420362|NCT02026830|||Cohort||Prospective|||||||
1420363|NCT02026817|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420364|NCT02026804|||Cohort||Prospective|||||||
1420365|NCT02026791|Randomized|Parallel Assignment||||None (Open Label)||||||
1420366|NCT02026778|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1420367|NCT02026765|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420368|NCT02026752|||Cohort||Cross-Sectional|||||||
1420369|NCT02026739|Randomized|Factorial Assignment||Treatment||Single||||||t
1420370|NCT02026726|||Cohort||Prospective|||||||
1420371|NCT02026713|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1420372|NCT02026700||Single Group Assignment||Treatment||None (Open Label)||||||
1420373|NCT02026687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420374|NCT02026674||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420375|NCT02026661|||Case Control||Retrospective|||||||
1420376|NCT02026648|||Case-Only||Retrospective|||||||
1420377|NCT02026635|||Cohort||Prospective|||||||
1420378|NCT02026622||Single Group Assignment||Basic Science||None (Open Label)||||||
1420379|NCT02026609|||Cohort||Prospective|||||||
1420380|NCT02026596|||Cohort||Prospective|||||||
1420381|NCT02026583||Single Group Assignment||Treatment||None (Open Label)||||||
1420382|NCT02026570|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1420383|NCT02026557|||Cohort||Retrospective|||||||
1420384|NCT02026544||Single Group Assignment||Basic Science||None (Open Label)||||||
1420385|NCT02026531||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420386|NCT02026518|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1420387|NCT02026505|||Case-Only||Prospective|||||||
1420388|NCT02026492|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1420389|NCT02026479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420390|NCT02026466|||Cohort||Prospective|||||||
1420391|NCT02026453|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420392|NCT02026440|||Case Control||Prospective|||||||
1420393|NCT02026427|||Case Control||Prospective|||||||
1420394|NCT02026414||Single Group Assignment||Health Services Research||None (Open Label)||||||
1420395|NCT02026401|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1420396|NCT02026388|||Cohort||Prospective|||||||
1420397|NCT02026362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420398|NCT02026349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420399|NCT02026336||Single Group Assignment||Screening||None (Open Label)||||||
1420400|NCT02026323|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420401|NCT02026310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420480|NCT02025283|||Case Control||Retrospective|||||||
1420402|NCT02026297|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420403|NCT02026284|||Cohort||Prospective|||||||
1420404|NCT02026271||Single Group Assignment||Treatment||None (Open Label)||||||
1420405|NCT02026258|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1420406|NCT02026245|Non-Randomized|Crossover Assignment||Health Services Research||Single||||||t
1420407|NCT02026232|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1420408|NCT02026219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420409|NCT02026206|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420410|NCT02026193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420411|NCT02026180|Randomized|Parallel Assignment||Treatment||Single||||||t
1420412|NCT02026167|Randomized|Parallel Assignment||Treatment||Single||||||t
1420413|NCT02026154|||Case Control||Cross-Sectional|||||||
1420414|NCT02026141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420415|NCT02026128|||Case-Only||Prospective|||||||
1420416|NCT02026115|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1420417|NCT02026102|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420418|NCT02026089|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420419|NCT02026076||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420420|NCT02026063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420421|NCT02026050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420422|NCT02026037||Single Group Assignment||Prevention||None (Open Label)||||||
1420423|NCT02026024|||Case-Only||Cross-Sectional|||||||
1420424|NCT02026011|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1420425|NCT02025998|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1420426|NCT02025985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420427|NCT02025972||Single Group Assignment||Treatment||None (Open Label)||||||
1420428|NCT02025959||Single Group Assignment||Health Services Research||None (Open Label)||||||
1420429|NCT02025946|||Cohort||Prospective|||||||
1420430|NCT02025933|||Case Control||Prospective|||||||
1420431|NCT02025920|||Case-Control||Prospective|||||||
1420432|NCT02025907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420433|NCT02025894|||Cohort||Prospective|||||||
1420434|NCT02025881||Single Group Assignment||Treatment||None (Open Label)||||||
1420435|NCT02025868||Single Group Assignment||Treatment||None (Open Label)||||||
1420436|NCT02025855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420437|NCT02025842|||Cohort|||||||||
1420438|NCT02025829|||Case-Only||Prospective|||||||
1420439|NCT02025816|||Other||Other|||||||
1420440|NCT02025803||Single Group Assignment||Treatment||None (Open Label)||||||
1420441|NCT02025790|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420442|NCT02025777||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420443|NCT02025764|||Case-Only||Prospective|||||||
1420444|NCT02025751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420445|NCT02025738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420446|NCT02025725|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420447|NCT02025712||Single Group Assignment||Treatment||None (Open Label)||||||
1420448|NCT02025699|||Cohort||Prospective|||||||
1420449|NCT02025686|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1420450|NCT02025673|||Case Control||Cross-Sectional|||||||
1420451|NCT02025660|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1420452|NCT02025647|||Cohort||Prospective|||||||
1420453|NCT02025634|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1420454|NCT02025621|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420455|NCT02025608|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1420456|NCT02025595|||Other||Cross-Sectional|||||||
1420457|NCT02025582||Single Group Assignment||Treatment||None (Open Label)||||||
1420458|NCT02025569|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420459|NCT02025556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420460|NCT02025543|||Case-Control||Prospective|||||||
1420461|NCT02025530|||Case-Control||Prospective|||||||
1420462|NCT02025517|Randomized|Parallel Assignment||Treatment||Single|||||t|
1420463|NCT02025504|Randomized|Parallel Assignment||Prevention||Single||||t||
1420464|NCT02025491||Single Group Assignment||Treatment||None (Open Label)||||||
1420465|NCT02025478||Single Group Assignment||Supportive Care||None (Open Label)||||||
1420466|NCT02025465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420467|NCT02025452|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1420468|NCT02025439|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1420469|NCT02025426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420470|NCT02025413|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1420471|NCT02025400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420472|NCT02025387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420473|NCT02025374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420474|NCT02025361|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1420475|NCT02025348|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1420476|NCT02025335|||Cohort||Prospective|||||||
1420477|NCT02025322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420478|NCT02025309|Randomized|Parallel Assignment||Screening||Double||||t|t|
1420479|NCT02025296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420481|NCT02025270|Randomized|Single Group Assignment||Treatment||Single|||t|||
1420482|NCT02025257|Randomized|Parallel Assignment||Treatment||Single||||||t
1420483|NCT02025244|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1420484|NCT02025231||Single Group Assignment||Treatment||None (Open Label)||||||
1420485|NCT02025218||Single Group Assignment||Treatment||None (Open Label)||||||
1420486|NCT02025205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420487|NCT02025192|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420488|NCT02025179||Single Group Assignment||Treatment||None (Open Label)||||||
1420489|NCT02025166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420490|NCT02025153|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1420491|NCT02025140|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420492|NCT02025127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420493|NCT02025114||Single Group Assignment||Treatment||None (Open Label)||||||
1420494|NCT02025101|||Case-Only|||||||||
1420495|NCT02025088|Randomized|Parallel Assignment||Treatment||Single||||||t
1420496|NCT02025075|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1420497|NCT02025062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420498|NCT02025049|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420499|NCT02025036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420500|NCT02025023|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420501|NCT02025010||Single Group Assignment||Treatment||None (Open Label)||||||
1420502|NCT02024997||Single Group Assignment||Basic Science||None (Open Label)||||||
1420503|NCT02024984|Randomized|Crossover Assignment||Treatment||Single|||t|||
1420504|NCT02024971|||Cohort||Prospective|||||||
1420505|NCT02024958|||Cohort||Prospective|||||||
1420506|NCT02024945|||Cohort||Prospective|||||||
1420507|NCT02024932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420508|NCT02024919|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1420509|NCT02024906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420510|NCT02024893|||Cohort||Cross-Sectional|||||||
1420511|NCT02024880|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420512|NCT02024867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420513|NCT02024854|Randomized|Parallel Assignment||Treatment||Single||||||t
1420514|NCT02024841||Single Group Assignment||Treatment||None (Open Label)||||||
1420515|NCT02024828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420516|NCT02024815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420517|NCT02024802|||Cohort||Prospective|||||||
1420518|NCT02024789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420519|NCT02024776|Randomized|Parallel Assignment||Prevention||Single||||||t
1420520|NCT02024763|Randomized|Parallel Assignment||||None (Open Label)||||||
1420521|NCT02024750|Randomized|Parallel Assignment||Treatment||Single||||||t
1420522|NCT02024737|||Case-Only||Prospective|||||||
1420523|NCT02024724|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420524|NCT02024711|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420525|NCT02024698|Randomized|Crossover Assignment||Treatment||Single||||t||
1420526|NCT02024685|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1420527|NCT02024672|||Cohort||Prospective|||||||
1420528|NCT02024659|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420529|NCT02024646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420530|NCT02024633||Single Group Assignment||Treatment||None (Open Label)||||||
1420531|NCT02024620|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420532|NCT02024607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420533|NCT02024594|Randomized|Parallel Assignment||||None (Open Label)||||||
1420534|NCT02024581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420535|NCT02024568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420536|NCT02024555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420537|NCT02024542|||Case-Control||Prospective|||||||
1420538|NCT02024529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420539|NCT02024516||Single Group Assignment||Treatment||None (Open Label)||||||
1420540|NCT02024503|||Case Control||Prospective|||||||
1420541|NCT02024490|||Cohort||Prospective|||||||
1420542|NCT02024477|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420543|NCT02024464|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420544|NCT02024451|Randomized|Parallel Assignment||Treatment||Single||||||t
1420545|NCT02024438|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1420546|NCT02024425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420547|NCT02024412|Non-Randomized|Parallel Assignment||Prevention||Double|||t||t|
1420548|NCT02024399||Single Group Assignment||Treatment||Double|||||t|t
1420549|NCT02024386|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1420550|NCT02024373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420551|NCT02024360||Single Group Assignment||Prevention||None (Open Label)||||||
1420552|NCT02024347|||Case-Control||Prospective|||||||
1420553|NCT02024334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420554|NCT02024321|||Case Control||Prospective|||||||
1420555|NCT02024308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420556|NCT02024295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420557|NCT02024282|Randomized|Factorial Assignment||Diagnostic||Single|||t|||
1420558|NCT02024269||Single Group Assignment||Treatment||None (Open Label)||||||
1420559|NCT02024256|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1420560|NCT02024243|||Cohort||Prospective|||||||
1420561|NCT02024230|||Case-Control||Prospective|||||||
1420562|NCT02024217||Single Group Assignment||Treatment||None (Open Label)||||||
1420563|NCT02024204|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420564|NCT02024191|Randomized|Parallel Assignment||Prevention||Single|||t|||
1420565|NCT02024178||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420566|NCT02024165|||Case-Only||Prospective|||||||
1420567|NCT02024152|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1420568|NCT02024139|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1420569|NCT02024126|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420570|NCT02024113|||Case-Control||Prospective|||||||
1420571|NCT02024100|||||Prospective|||||||
1420572|NCT02024087||Single Group Assignment||Treatment||None (Open Label)||||||
1420573|NCT02024074||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420574|NCT02024061|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420575|NCT02024048|||Case Control||Prospective|||||||
1420576|NCT02024035|||Cohort||Prospective|||||||
1420577|NCT02024022|Randomized|Parallel Assignment||||Single||||||t
1420578|NCT02024009|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1420579|NCT02023996||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420580|NCT02023983|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1420581|NCT02023970|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420582|NCT02023957|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420583|NCT02023944|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1420584|NCT02023931||Single Group Assignment||Other||None (Open Label)||||||
1420585|NCT02023918||Single Group Assignment||Treatment||None (Open Label)||||||
1420586|NCT02023905|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420587|NCT02023892|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420588|NCT02023879|Randomized|Parallel Assignment||Treatment||Triple|Masking during the double-blind treatment period|A double-blind treatment period of 24 weeks (3 parallel arms) followed by an open-label extension period (single arm)|t|t|t|
1420589|NCT02023866||Single Group Assignment||Treatment||None (Open Label)||||||
1420590|NCT02023853||Single Group Assignment||Treatment||None (Open Label)||||||
1420591|NCT02023840|Randomized|Parallel Assignment||Treatment||Double||||t||t
1420592|NCT02023827|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420593|NCT02023814|||Cohort||Retrospective|||||||
1420594|NCT02023801||Single Group Assignment||Treatment||None (Open Label)||||||
1420595|NCT02023788|||Case-Only||Prospective|||||||
1420596|NCT02023775|||Cohort||Prospective|||||||
1420597|NCT02023762|||Cohort||Prospective|||||||
1420598|NCT02023749|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420599|NCT02023736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420600|NCT02023723|Randomized|Crossover Assignment||||Double|||t||t|
1420601|NCT02023710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420602|NCT02023697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420603|NCT02023684|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1420604|NCT02023671|||||Retrospective|||||||
1420605|NCT02023658|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420606|NCT02023645|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1420607|NCT02023632|Randomized|Parallel Assignment||Prevention||Single|||t|||
1420608|NCT02023619|||Case-Crossover||Retrospective|||||||
1420609|NCT02023606||Single Group Assignment||Treatment||None (Open Label)||||||
1420610|NCT02023593||Single Group Assignment||Treatment||None (Open Label)||||||
1420611|NCT02023580|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420612|NCT02023567|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1420613|NCT02023554|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1420614|NCT02023541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420615|NCT02023528|||Cohort||Prospective|||||||
1420616|NCT02023515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420617|NCT02023502|||Case Control||Prospective|||||||
1420618|NCT02023489|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1420619|NCT02023476|Randomized|Crossover Assignment||||None (Open Label)||||||
1420620|NCT02023463||Single Group Assignment||Treatment||None (Open Label)||||||
1420621|NCT02023450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420622|NCT02023437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420623|NCT02023424||Single Group Assignment||Treatment||None (Open Label)||||||
1420624|NCT02023411|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1420625|NCT02023398|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420626|NCT02023385|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420627|NCT02023372||Single Group Assignment||Treatment||None (Open Label)||||||
1420628|NCT02023359|||Cohort||Prospective|||||||
1420629|NCT02023346|||Cohort||Prospective|||||||
1420630|NCT02023333||Single Group Assignment||Treatment||None (Open Label)||||||
1420631|NCT02023320|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1420632|NCT02023307||Single Group Assignment||Treatment||None (Open Label)||||||
1420633|NCT02023294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420634|NCT02023281|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420635|NCT02023268|Randomized|Parallel Assignment||Treatment||Single|||||t|
1420636|NCT02023255|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420637|NCT02023242|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420638|NCT02023229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420639|NCT02023216|||Case-Only||Prospective|||||||
1420640|NCT02023203|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1420641|NCT02023190|||Cohort||Prospective|||||||
1420642|NCT02023177|||Cohort||Prospective|||||||
1420643|NCT02023164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420644|NCT02023151||Single Group Assignment||Treatment||None (Open Label)||||||
1420645|NCT02023138|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1420646|NCT02023125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420647|NCT02023112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420648|NCT02023099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420649|NCT02023086|||Case-Control||Prospective|||||||
1420650|NCT02023073|||Cohort||Prospective|||||||
1420651|NCT02023060|||Cohort||Prospective|||||||
1420652|NCT02023047|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420653|NCT02023034|Randomized|Parallel Assignment||Treatment||Single||||||t
1420654|NCT02023021||Single Group Assignment||Treatment||None (Open Label)||||||
1420655|NCT02023008||Single Group Assignment||Supportive Care||None (Open Label)||||||
1420656|NCT02022995|||Case Control||Retrospective|||||||
1420657|NCT02022982||Single Group Assignment||Treatment||None (Open Label)||||||
1420658|NCT02022969|||Cohort||Prospective|||||||
1420659|NCT02022956||Single Group Assignment||||None (Open Label)||||||
1420660|NCT02022943|||Other||Other|||||||
1420661|NCT02022930|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420662|NCT02022917||Single Group Assignment||Treatment||None (Open Label)||||||
1420663|NCT02022904||Single Group Assignment||||None (Open Label)||||||
1420664|NCT02022891|||Cohort||Retrospective|||||||
1420665|NCT02022878|||Cohort||Retrospective|||||||
1420666|NCT02022865|||Case Control||Prospective|||||||
1420667|NCT02022852|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420668|NCT02022839|||Cohort||Prospective|||||||
1420669|NCT02022826||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420670|NCT02022813|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1420671|NCT02022800||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420672|NCT02022787|||Case Control||Prospective|||||||
1420673|NCT02022774|||Case-Only||Prospective|||||||
1420674|NCT02022761|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1420675|NCT02022748|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420676|NCT02022735|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1420677|NCT02022722|Randomized|Parallel Assignment||Treatment||Single||||||t
1420678|NCT02022709|Randomized|Crossover Assignment||Treatment||Single||||||t
1420679|NCT02022696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420680|NCT02022683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420681|NCT02022670|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420682|NCT02022657|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1420683|NCT02022644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420684|NCT02022631|Randomized|Parallel Assignment||||Triple|||t||t|t
1420685|NCT02022618|||Cohort||Cross-Sectional|||||||
1420686|NCT02022605|Randomized|Parallel Assignment||||Single||||||t
1420687|NCT02022592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420688|NCT02022579||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420689|NCT02022566|||Case Control||Prospective|||||||
1420690|NCT02022553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420691|NCT02022540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420692|NCT02022527|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1420693|NCT02022514|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420694|NCT02022501|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420695|NCT02022488|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1420696|NCT02022475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420697|NCT02022462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420698|NCT02022449|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420699|NCT02022436|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1420700|NCT02022423|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1420701|NCT02022410|||Cohort||Prospective|||||||
1420702|NCT02022397|||Cohort||Prospective|||||||
1420703|NCT02022384|||Case-Only||Prospective|||||||
1420704|NCT02022371||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420705|NCT02022358|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420706|NCT02022345|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420707|NCT02022319||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420708|NCT02022306|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1420709|NCT02022293|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1420710|NCT02022280|Randomized|Crossover Assignment||||None (Open Label)||||||
1420711|NCT02022267|||Cohort||Retrospective|||||||
1420712|NCT02022254||Crossover Assignment||Treatment||None (Open Label)||||||
1420713|NCT02022241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420714|NCT02022228|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420715|NCT02022215|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420716|NCT02022202|||Case-Only||Prospective|||||||
1420717|NCT02022189|||Cohort||Retrospective|||||||
1420718|NCT02022176|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1420719|NCT02022163|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420720|NCT02022150|||Cohort||Prospective|||||||
1420721|NCT02022137|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1420722|NCT02022124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420723|NCT02022111|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1420724|NCT02022098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420725|NCT02022085||Single Group Assignment||Treatment||None (Open Label)||||||
1420726|NCT02022072||Single Group Assignment||Supportive Care||None (Open Label)||||||
1420727|NCT02022059|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420728|NCT02022046|||Cohort||Prospective|||||||
1420729|NCT02022033||Single Group Assignment||Treatment||None (Open Label)||||||
1420730|NCT02022020|||Cohort||Retrospective|||||||
1420731|NCT02022007|Randomized|Parallel Assignment||Treatment||Single|||||t|
1420732|NCT02021994|||||Prospective|||||||
1420733|NCT02021981|||||Retrospective|||||||
1420734|NCT02021968|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420735|NCT02021955|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1420736|NCT02021942||Single Group Assignment||Treatment||None (Open Label)||||||
1420737|NCT02021929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420738|NCT02021916|||Case-Only||Cross-Sectional|||||||
1420739|NCT02021903|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1420740|NCT02021890|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1420741|NCT02021877|||Cohort||Prospective|||||||
1420742|NCT02021864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420743|NCT02021851|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1420744|NCT02021838|||Cohort||Prospective|||||||
1420745|NCT02021825||Single Group Assignment||Treatment||None (Open Label)||||||
1420746|NCT02021812||Single Group Assignment||Treatment||None (Open Label)||||||
1420747|NCT02021799|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1420748|NCT02021786|Randomized|Parallel Assignment||Prevention||Single||||||t
1420749|NCT02021773|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420750|NCT02021760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420751|NCT02021747|||Cohort||Prospective|||||||
1420752|NCT02021734|||Family-Based||Prospective|||||||
1420753|NCT02021721|||Family-Based||Prospective|||||||
1420754|NCT02021708|||Cohort||Prospective|||||||
1420755|NCT02021695|||Cohort||Prospective|||||||
1420756|NCT02021682|||Case-Control||Cross-Sectional|||||||
1420757|NCT02021669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420758|NCT02021656||Single Group Assignment||Treatment||None (Open Label)||||||
1420759|NCT02021643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420760|NCT02021630|||Family-Based||Prospective|||||||
1420761|NCT02021617||Single Group Assignment||Health Services Research||None (Open Label)||||||
1420762|NCT02021604||Single Group Assignment||Diagnostic||Single||||||
1420763|NCT02021591|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1420764|NCT02021578|Randomized|Parallel Assignment||Prevention||Single||||||t
1420765|NCT02021565|Randomized|Parallel Assignment||Supportive Care||Single|The objective outcomes assessor did not know whether the participants were in the intervention or control group.|This study was a wait list control design. Participating couples were either assigned to the intervention group and received the full CG ASSIST program (assessment, observation, recommendations, equipment, modifications, and training) or were assigned to the delayed intervention control group (assessment and observation only). Then, as the intervention group was evaluated, the delayed intervention control group received the full CG ASSIST program. Both groups received 3-month follow-up observations and assessments. Results are reported for Baseline to T1 Intervention and Control.||||t
1420766|NCT02021552|||Cohort||Prospective|||||||
1420767|NCT02021539|||Cohort||Prospective|||||||
1420768|NCT02021526|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1420769|NCT02021513|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420770|NCT02021500|||||Prospective|||||||
1420771|NCT02021487|||Case-Control||Prospective|||||||
1420772|NCT02021474|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420773|NCT02021461|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1420774|NCT02021448||Single Group Assignment||Prevention||None (Open Label)||||||
1420775|NCT02021435|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420776|NCT02021422||Single Group Assignment||Treatment||None (Open Label)||||||
1420777|NCT02021409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420778|NCT02021396|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1420779|NCT02021383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420780|NCT02021370|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420781|NCT02021357|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1420782|NCT02021344|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420783|NCT02021331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420784|NCT02021318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420785|NCT02021305|||Case Control||Prospective|||||||
1420786|NCT02021292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420787|NCT02021279|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420788|NCT02021266||||||||||||
1420789|NCT02021253|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1420790|NCT02021240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420791|NCT02021227|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1420792|NCT02021214|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1420793|NCT02021201|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1420794|NCT02021188|||Case-Only||Prospective|||||||
1420795|NCT02021175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420796|NCT02021162|||Case-Control||Prospective|||||||
1420797|NCT02021149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420798|NCT02021136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420799|NCT02021123||Single Group Assignment||||None (Open Label)||||||
1420800|NCT02021110|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420801|NCT02021097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420802|NCT02021084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420803|NCT02021071|||Cohort||Prospective|||||||
1420804|NCT02021058|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420805|NCT02021045|||Case-Only||Prospective|||||||
1420806|NCT02021032||Single Group Assignment||Treatment||None (Open Label)||||||
1420807|NCT02021019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420808|NCT02021006|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420809|NCT02020993|||Case Control||Prospective|||||||
1420810|NCT02020980|||Cohort||Prospective|||||||
1420811|NCT02020967|||Cohort||Prospective|||||||
1420812|NCT02020954|||Cohort||Prospective|||||||
1420813|NCT02020941||Single Group Assignment||Treatment||None (Open Label)||||||
1420814|NCT02020928|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1420815|NCT02020915|||Case-Only||Retrospective|||||||
1420816|NCT02020902|||||Prospective|||||||
1420817|NCT02020889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420818|NCT02020876|||Cohort||Retrospective|||||||
1420819|NCT02020863||Single Group Assignment||Treatment||None (Open Label)||||||
1420820|NCT02020850|||Case-Only||Cross-Sectional|||||||
1420821|NCT02020837||Single Group Assignment||Treatment||None (Open Label)||A lymphatic diversion with lymphaticovenous microanastomosis will be performed.||||
1420822|NCT02020824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420823|NCT02020811||Single Group Assignment||||None (Open Label)||||||
1420824|NCT02020798|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1420825|NCT02020785|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1420826|NCT02020772|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1420827|NCT02020759|||Cohort||Prospective|||||||
1420828|NCT02020746|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420829|NCT02020733|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1420830|NCT02020720||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420831|NCT02020707||Single Group Assignment||Treatment||None (Open Label)||||||
1420832|NCT02020694|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1420833|NCT02020681|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420834|NCT02020668|Randomized|Parallel Assignment||Treatment||Single||||||t
1420835|NCT02020655|||||Prospective|||||||
1420836|NCT02020642|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1420837|NCT02020629||Single Group Assignment||Basic Science||None (Open Label)||||||
1420838|NCT02020616|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420839|NCT02020603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420840|NCT02020590||Single Group Assignment||Treatment||None (Open Label)||||||
1420841|NCT02020577||Single Group Assignment||Treatment||None (Open Label)||||||
1420842|NCT02020564||Crossover Assignment||Treatment||Single||||||t
1420843|NCT02020551|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1420844|NCT02020538|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420845|NCT02020525|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1420846|NCT02020512||Single Group Assignment||Treatment||None (Open Label)||||||
1420847|NCT02020499|||Cohort||Prospective|||||||
1420848|NCT02020486|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420849|NCT02020473|||Cohort||Retrospective|||||||
1420850|NCT02020460|Non-Randomized|Crossover Assignment||Device Feasibility||Single|||t|||
1420851|NCT02020447||||||||||||
1420852|NCT02020434||Single Group Assignment||Treatment||None (Open Label)||||||
1420853|NCT02020421|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420854|NCT02020408||Single Group Assignment||Basic Science||None (Open Label)||||||
1420855|NCT02020395|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1420856|NCT02020382|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1420857|NCT02020369|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420858|NCT02020356|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1420859|NCT02020343|||Case Control||Prospective|||||||
1420860|NCT02020330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420861|NCT02020317|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1420862|NCT02020304|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1420863|NCT02020291||Single Group Assignment||Treatment||None (Open Label)||||||
1420864|NCT02020278||Single Group Assignment||Treatment||None (Open Label)||||||
1420865|NCT02020265|Randomized|Parallel Assignment||Prevention||Single|||t|||
1420866|NCT02020252|||Other||Prospective|||||||
1420867|NCT02020239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420868|NCT02020226||Single Group Assignment||Treatment||None (Open Label)||||||
1420869|NCT02020213||Single Group Assignment||Treatment||None (Open Label)||||||
1420870|NCT02020200||Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1420871|NCT02020187|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1420872|NCT02020174|||Case-Control||Other|||||||
1420873|NCT02020161|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420874|NCT02020148|||Cohort||Prospective|||||||
1420875|NCT02020135||Single Group Assignment||Treatment||None (Open Label)||||||
1420876|NCT02020122|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1420877|NCT02020109|||Case-Only||Retrospective|||||||
1420878|NCT02020096|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420879|NCT02020083|||Cohort||Prospective|||||||
1420880|NCT02020070|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420881|NCT02020057|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420882|NCT02020044||Single Group Assignment||Treatment||None (Open Label)||||||
1420883|NCT02020031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420884|NCT02020018|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420885|NCT02020005|Randomized|Single Group Assignment||Prevention||Single|||t|||
1420886|NCT02019992|||Cohort||Prospective|||||||
1420887|NCT02019979||Single Group Assignment||Treatment||None (Open Label)||||||
1420888|NCT02019966|||Cohort||Prospective|||||||
1420889|NCT02019953|Randomized|Parallel Assignment||Other||Single|||||t|
1420890|NCT02019940||Single Group Assignment||Treatment||None (Open Label)||||||
1420891|NCT02019927|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1420892|NCT02019914|||Cohort||Prospective|||||||
1420893|NCT02019901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420894|NCT02019888|||Case-Control||Cross-Sectional|||||||
1420895|NCT02019875|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1420896|NCT02019862|||Cohort||Retrospective|||||||
1420897|NCT02019849|||Cohort||Prospective|||||||
1420898|NCT02019836|||Case Control||Prospective|||||||
1420899|NCT02019823|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1420900|NCT02019810|Randomized|Crossover Assignment||Treatment||Single|||t|||
1420901|NCT02019797|Randomized|Parallel Assignment||Treatment||Single||||||t
1420902|NCT02019784|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1420903|NCT02019771|||Case-Only||Cross-Sectional|||||||
1420904|NCT02019758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420905|NCT02019745|||Cohort||Prospective|||||||
1420906|NCT02019732|||||Retrospective|||||||
1420907|NCT02019719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420908|NCT02019706|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1420909|NCT02019693||Single Group Assignment||Treatment||None (Open Label)||||||
1420910|NCT02019680|||Case-Crossover||Prospective|||||||
1420911|NCT02019667|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1420912|NCT02019654|||Cohort||Prospective|||||||
1420913|NCT02019641|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1420914|NCT02019628|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1420915|NCT02019615|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1420916|NCT02019602||Single Group Assignment||Other||None (Open Label)||||||
1420917|NCT02019589|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1420918|NCT02019576||Single Group Assignment||Treatment||None (Open Label)||||||
1420919|NCT02019563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420920|NCT02019550|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420921|NCT02019537|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420922|NCT02019524|Randomized|Parallel Assignment||Prevention||Single|||t|||
1420923|NCT02019511|||Cohort||Prospective|||||||
1420924|NCT02019498|Randomized|Parallel Assignment||||None (Open Label)||||||
1420925|NCT02019485|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420926|NCT02019472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420927|NCT02019459|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1420928|NCT02019446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420929|NCT02019433|||Cohort||Prospective|||||||
1420930|NCT02019420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420931|NCT02019407|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420932|NCT02019394||Single Group Assignment||||None (Open Label)||||||
1420933|NCT02019381|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1420934|NCT02019368|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1420935|NCT02019355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420936|NCT02019342|||Cohort||Other|||||||
1420937|NCT02019329|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420938|NCT02019316|Randomized|Crossover Assignment||||Double|||t||t|
1420939|NCT02019303||Single Group Assignment||Diagnostic||||||||
1420940|NCT02019290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420941|NCT02019277||Single Group Assignment||Treatment||None (Open Label)||||||
1420942|NCT02019264|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420943|NCT02019251||Single Group Assignment||Diagnostic||None (Open Label)||||||
1420944|NCT02019238|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420945|NCT02019225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420946|NCT02019212|||Cohort||Other|||||||
1420947|NCT02019199|||Cohort||Prospective|||||||
1420948|NCT02019186||Single Group Assignment||Treatment||None (Open Label)||||||
1420949|NCT02019173||Single Group Assignment||Treatment||None (Open Label)||||||
1420950|NCT02019160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420951|NCT02019147|||Case-Control||Prospective|||||||
1420952|NCT02019134|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1420953|NCT02019121|||Cohort||Retrospective|||||||
1420954|NCT02019108|Randomized|Parallel Assignment||Treatment||Single||||||t
1420955|NCT02019095|||Cohort||Prospective|||||||
1420956|NCT02019082|Randomized|Parallel Assignment||Treatment||Single|||t|||
1420957|NCT02019069||Single Group Assignment||Treatment||None (Open Label)||||||
1420958|NCT02019056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420959|NCT02019043|Randomized|Crossover Assignment||Screening||None (Open Label)||Note: Although the trial period and recruitment is complete, data entry is ongoing. Completion of data entry is anticipated for August 2018.||||
1420960|NCT02019030|||Case-Only||Prospective|||||||
1420961|NCT02019017|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420962|NCT02019004|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420963|NCT02018991|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1420964|NCT02018978|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1420965|NCT02018965|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420966|NCT02018952||Single Group Assignment||||None (Open Label)||||||
1420967|NCT02018939|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420968|NCT02018926||Single Group Assignment||Treatment||None (Open Label)||||||
1420969|NCT02018913|||Cohort||Prospective|||||||
1420970|NCT02018900|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1420971|NCT02018887|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1420972|NCT02018874||Single Group Assignment||Treatment||None (Open Label)||||||
1420973|NCT02018861|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1420974|NCT02018848|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420975|NCT02018835|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1420976|NCT02018822||Single Group Assignment||Treatment||Double|||t||t|
1420977|NCT02018809|Randomized|Parallel Assignment||Treatment||Single|||||t|
1420978|NCT02018796|||Case-Only||Prospective|||||||
1420979|NCT02018783|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1420980|NCT02018770|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1420981|NCT02018757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1420982|NCT02018744|||Cohort||Prospective|||||||
1420983|NCT02018731|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1420984|NCT02018718||Single Group Assignment||Other||None (Open Label)||||||
1420985|NCT02018705|||Cohort||Retrospective|||||||
1420986|NCT02018692|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1420987|NCT02018679|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1420988|NCT02018666|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1420989|NCT02018653|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1420990|NCT02018640|||Cohort||Prospective|||||||
1420991|NCT02018627|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1420992|NCT02018614|||||Cross-Sectional|||||||
1420993|NCT02018601|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1420994|NCT02018588||Single Group Assignment||Health Services Research||None (Open Label)||||||
1420995|NCT02018575||Single Group Assignment||Health Services Research||None (Open Label)||||||
1420996|NCT02018562|Randomized|Parallel Assignment||Treatment||None (Open Label)|Unable to mask because patients and care providers were able to visualize the type of tracheostomy tub that was used.|||||
1420997|NCT02018549||Single Group Assignment||Other||None (Open Label)||||||
1420998|NCT02018536|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1420999|NCT02018523||Single Group Assignment||Treatment||None (Open Label)||||||
1421000|NCT02018510|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421001|NCT02018497|||Cohort||Prospective|||||||
1421002|NCT02018484||Single Group Assignment||Treatment||None (Open Label)||||||
1421003|NCT02018471||Single Group Assignment||Supportive Care||None (Open Label)||||||
1421004|NCT02018458|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421005|NCT02018445||Single Group Assignment||Treatment||None (Open Label)||||||
1421006|NCT02018432|Randomized|Parallel Assignment||Treatment||Single||||||t
1421007|NCT02018419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421008|NCT02018406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421009|NCT02018393|||Case Control||Cross-Sectional|||||||
1421010|NCT02018380||Single Group Assignment||Treatment||None (Open Label)||||||
1421011|NCT02018367|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1421012|NCT02018354|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1421013|NCT02018341|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1421014|NCT02018328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421015|NCT02018315||Single Group Assignment||Basic Science||None (Open Label)||||||
1421016|NCT02018302||||||||||||
1421017|NCT02018289|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1421018|NCT02018276|Randomized|Parallel Assignment||||Double|||t|||t
1421019|NCT02018263|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1421020|NCT02018250|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1421021|NCT02018237|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1421022|NCT02018224|Randomized|Parallel Assignment||Treatment||Single|||||t|
1421023|NCT02018211||Single Group Assignment||Basic Science||None (Open Label)||||||
1421024|NCT02018198|||Case-Only||Prospective|||||||
1421025|NCT02018185|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421026|NCT02018172|||Cohort||Prospective|||||||
1421027|NCT02018159|||Cohort||Prospective|||||||
1421028|NCT02018146|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1421029|NCT02018133|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1421030|NCT02018120|Randomized|Parallel Assignment||Treatment||Single||||||t
1421031|NCT02018107||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421032|NCT02018094|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1421033|NCT02018081||Single Group Assignment||Treatment||None (Open Label)||||||
1421034|NCT02018068|Randomized|Parallel Assignment||Other||Single|||||t|
1421035|NCT02018055|||Cohort||Prospective|||||||
1421036|NCT02018042||Single Group Assignment||Treatment||None (Open Label)||||||
1421037|NCT02018029||||||||||||
1421038|NCT02018016|||Ecologic or Community||Retrospective|||||||
1421039|NCT02018003|||Cohort||Prospective|||||||
1421040|NCT02017990|||Cohort||Prospective|||||||
1421041|NCT02017977|||Ecologic or Community||Retrospective|||||||
1421042|NCT02017964||Single Group Assignment||Treatment||None (Open Label)||||||
1421043|NCT02017951|||Ecologic or Community||Retrospective|||||||
1421044|NCT02017938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421045|NCT02017925|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421046|NCT02017912|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421047|NCT02017899|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1421048|NCT02017886|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1421049|NCT02017873|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1421050|NCT02017860||Single Group Assignment||Treatment||None (Open Label)||||||
1421051|NCT02017847|||||Cross-Sectional|||||||
1421052|NCT02017834|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421053|NCT02017821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421054|NCT02017808|||Cohort||Prospective|||||||
1421055|NCT02017795|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1421056|NCT02017782|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1421057|NCT02017769|||Case Control||Prospective|||||||
1421058|NCT02017756|||Case-Only||Cross-Sectional|||||||
1421059|NCT02017743|||Cohort||Prospective|||||||
1421060|NCT02017730|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1421061|NCT02017717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421062|NCT02017704|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421063|NCT02017691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421064|NCT02017678||Single Group Assignment||Treatment||None (Open Label)||||||
1421065|NCT02017665|||Cohort||Prospective|||||||
1421066|NCT02017652|||Cohort||Prospective|||||||
1421067|NCT02017639|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1421068|NCT02017626|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421069|NCT02017613||Single Group Assignment||Treatment||None (Open Label)||||||
1421070|NCT02017600||Single Group Assignment||Treatment||None (Open Label)||||||
1421071|NCT02017587|||Cohort||Prospective|||||||
1421072|NCT02017574|Randomized|Parallel Assignment||Basic Science||Single||||||t
1421073|NCT02017561|Randomized|Parallel Assignment||Treatment||Single||||||t
1421074|NCT02017548|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1421075|NCT02017535|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1421076|NCT02017522||Single Group Assignment||Basic Science||None (Open Label)||Subjects will have be injected 11C-PBR28, a compound used as a radiotracer. They will then have a PET CT scan.||||
1421077|NCT02017509|||Cohort||Prospective|||||||
1421078|NCT02017496|||Cohort||Prospective|||||||
1421079|NCT02017483|||Case Control|||||||||
1421080|NCT02017470|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1421081|NCT02017457||Single Group Assignment||Treatment||None (Open Label)||||||
1421082|NCT02017444|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421083|NCT02017431|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1421084|NCT02017418|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1421085|NCT02017405|Randomized|Crossover Assignment||||Triple|||t||t|t
1421086|NCT02017392|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421087|NCT02017379|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1421088|NCT02017366|Randomized|Parallel Assignment||Basic Science||Single||||||t
1421089|NCT02017353||Single Group Assignment||Treatment||None (Open Label)||||||
1421090|NCT02017340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421091|NCT02017327|Randomized|Parallel Assignment||Treatment||Single|||||t|
1421092|NCT02017314|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421093|NCT02017301|||Cohort||Prospective|||||||
1421094|NCT02017288|||Cohort||Other|||||||
1421095|NCT02017275|Randomized|Parallel Assignment||Treatment||Single||||||t
1421096|NCT02017262|Randomized|Parallel Assignment||Treatment||Single||||||t
1421097|NCT02017249|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1421098|NCT02017236|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1421099|NCT02017223||Single Group Assignment||Prevention||None (Open Label)||||||
1421100|NCT02017210||Single Group Assignment||Other||None (Open Label)||||||
1421101|NCT02017197|Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1421102|NCT02017184||Single Group Assignment||Basic Science||None (Open Label)||||||
1421103|NCT02017171|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1421104|NCT02017158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421105|NCT02017145|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1421106|NCT02017132|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1421107|NCT02017119|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421108|NCT02017106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421109|NCT02017093|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1421110|NCT02017080|||Case Control||Prospective|||||||
1421111|NCT02017067|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1421112|NCT02017054|||Cohort||Prospective|||||||
1421113|NCT02017041|||Cohort||Prospective|||||||
1421114|NCT02017028|||Cohort||Prospective|||||||
1421115|NCT02017015||Single Group Assignment||Treatment||None (Open Label)||||||
1421116|NCT02017002|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421117|NCT02016989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421118|NCT02016976|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421119|NCT02016963||Single Group Assignment||Treatment||None (Open Label)||||||
1421120|NCT02016950|||Cohort||Retrospective|||||||
1421121|NCT02016937|||Case Control||Prospective|||||||
1421122|NCT02016924|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421123|NCT02016911|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421124|NCT02016898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421125|NCT02016885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421126|NCT02016872||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421127|NCT02016859|||Case Control||Prospective|||||||
1421128|NCT02016846|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1421129|NCT02016833|||Case-Only||Cross-Sectional|||||||
1421130|NCT02016820|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1421131|NCT02016807|||Cohort||Prospective|||||||
1421132|NCT02016794|||Case-Only||Prospective|||||||
1421133|NCT02016781|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Two arms will enroll and have data collected on them simultaneously.||||
1421134|NCT02016768|||Cohort||Prospective|||||||
1421135|NCT02016755||Single Group Assignment||Treatment||None (Open Label)||||||
1421136|NCT02016742|Randomized|Crossover Assignment||||None (Open Label)||||||
1421137|NCT02016729|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421138|NCT02016716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421139|NCT02016703|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1421140|NCT02016690|||Cohort||Prospective|||||||
1421141|NCT02016677|||Cohort||Prospective|||||||
1421142|NCT02016664||Single Group Assignment||||None (Open Label)||||||
1421143|NCT02016651|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1421144|NCT02016638||Single Group Assignment||Screening||None (Open Label)||||||
1421145|NCT02016625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421146|NCT02016612|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421147|NCT02016599|||Cohort||Prospective|||||||
1421148|NCT02016586|Randomized|Parallel Assignment||||None (Open Label)||||||
1421149|NCT02016573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421150|NCT02016560|Non-Randomized|Sequential Assignment||Diagnostic||Single||All subjects in both the exploratory and confirmatory phases of the study, receive both AV-1451 and florbetapir scans, regardless of subgroup assignment.||||t
1421151|NCT02016547|Randomized|Parallel Assignment||Treatment||Single||||||t
1421152|NCT02016534||Single Group Assignment||Treatment||None (Open Label)||||||
1421153|NCT02016521|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1421154|NCT02016508||Single Group Assignment||Treatment||None (Open Label)||||||
1421155|NCT02016495||||||||||||
1421156|NCT02016482|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421157|NCT02016469|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421158|NCT02016456|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421159|NCT02016443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421160|NCT02016430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421161|NCT02016417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421162|NCT02016404|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1421163|NCT02016391||Single Group Assignment||Treatment||None (Open Label)||||||
1421164|NCT02016378|Randomized|Factorial Assignment||Treatment||Single|||t|||
1421165|NCT02016365||Single Group Assignment||Treatment||None (Open Label)||||||
1421166|NCT02016352|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1421167|NCT02016339|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421168|NCT02016326|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1421169|NCT02016313|Randomized|Crossover Assignment||Treatment||Single|||t|||
1421170|NCT02016300|Randomized|Parallel Assignment||Treatment||Single||||||t
1421171|NCT02016287|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421172|NCT02016274|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421173|NCT02016261||Single Group Assignment||Treatment||None (Open Label)||||||
1421174|NCT02016248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421175|NCT02016235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421176|NCT02016222||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421177|NCT02016209||Single Group Assignment||Treatment||None (Open Label)||||||
1421178|NCT02016196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421179|NCT02016183|||Cohort||Prospective|||||||
1421180|NCT02016170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421181|NCT02016157||Single Group Assignment||Treatment||Double||||t|t|
1421182|NCT02016144|||Case-Only||Prospective|||||||
1421183|NCT02016131|||Case Control||Prospective|||||||
1421184|NCT02016118|||Case Control||Retrospective|||||||
1421185|NCT02016105|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421186|NCT02016092|||Case Control||Cross-Sectional|||||||
1421187|NCT02016079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421188|NCT02016066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421189|NCT02016053|||Cohort||Prospective|||||||
1421190|NCT02016040||Single Group Assignment||Treatment||None (Open Label)||||||
1421191|NCT02016027||Single Group Assignment||Treatment||None (Open Label)||||||
1421192|NCT02016014|Randomized|Parallel Assignment||Prevention||Single|||||t|
1421193|NCT02016001|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1421194|NCT02015988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421195|NCT02015975|||Case-Only||Prospective|||||||
1421196|NCT02015962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421197|NCT02015949|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1421198|NCT02015936||Single Group Assignment||Supportive Care||None (Open Label)||||||
1421199|NCT02015923|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1421200|NCT02015910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421201|NCT02015897|Randomized|Parallel Assignment||Treatment||Single||||||t
1421202|NCT02015884|||||Prospective|||||||
1421203|NCT02015871||Single Group Assignment||Treatment||None (Open Label)||||||
1421204|NCT02015858|||Cohort||Prospective|||||||
1421205|NCT02015845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421206|NCT02015832|||Case-Only||Prospective|||||||
1421207|NCT02015819||Single Group Assignment||Treatment||None (Open Label)||||||
1421208|NCT02015806|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1421209|NCT02015793|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421210|NCT02015780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421211|NCT02015767|||Case-Only||Prospective|||||||
1421212|NCT02015754||Single Group Assignment||Treatment||None (Open Label)||||||
1421213|NCT02015741|||Cohort||Prospective|||||||
1421214|NCT02015728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421215|NCT02015715|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421216|NCT02015702|Randomized|Parallel Assignment||||None (Open Label)||||||
1421217|NCT02015689|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1421218|NCT02015676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421219|NCT02015663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421220|NCT02015650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421221|NCT02015637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421222|NCT02015624|||||Cross-Sectional|||||||
1421223|NCT02015611|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1421224|NCT02015598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421225|NCT02015585|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1421226|NCT02015572|Randomized|Parallel Assignment||Treatment||Single||||||t
1421227|NCT02015559|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421228|NCT02015546|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1421229|NCT02015533|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421230|NCT02015520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421231|NCT02015507|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421232|NCT02015494|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421233|NCT02015481||Single Group Assignment||Treatment||None (Open Label)||||||
1421234|NCT02015468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421235|NCT02015455|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1421236|NCT02015442|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1421237|NCT02015429|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1421238|NCT02015416||Sequential Assignment||Treatment||None (Open Label)||Phase 1, open label, multicenter ascending dose study.||||
1421239|NCT02015403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421240|NCT02015390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421241|NCT02015377|Randomized|Crossover Assignment||Prevention||Single|||t|||
1421242|NCT02015364|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1421243|NCT02015351||Single Group Assignment||Treatment||None (Open Label)||||||
1421244|NCT02015338|||Cohort||Prospective|||||||
1421245|NCT02015325|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421246|NCT02015312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421247|NCT02015299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421248|NCT02015286|||Cohort||Other|||||||
1421249|NCT02015273|||Cohort||Other|||||||
1421250|NCT02015260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421251|NCT02015247||Single Group Assignment||Treatment||None (Open Label)||||||
1421252|NCT02015234||Single Group Assignment||Treatment||None (Open Label)||||||
1421253|NCT02015221|Randomized|Parallel Assignment||||None (Open Label)||||||
1421254|NCT02015208||Single Group Assignment||Treatment||None (Open Label)||||||
1421255|NCT02015195|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1421256|NCT02015182|||Case-Only||Prospective|||||||
1421257|NCT02015169||Single Group Assignment||Treatment||None (Open Label)||||||
1421258|NCT02015156|Randomized|Parallel Assignment||||Triple|||t|t|t|
1421259|NCT02015143|||||Retrospective|||||||
1421260|NCT02015130|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421261|NCT02015117|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421262|NCT02015104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421263|NCT02015091|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421264|NCT02015078|||||Other|||||||
1421265|NCT02015065|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421266|NCT02015039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421267|NCT02015026|||Case-Only||Prospective|||||||
1421268|NCT02015013|||||Prospective|||||||
1421269|NCT02015000||Single Group Assignment||Treatment||None (Open Label)||||||
1421270|NCT02014987||Single Group Assignment||Prevention||None (Open Label)||||||
1421271|NCT02014974|||Cohort||Prospective|||||||
1421272|NCT02014961|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1421273|NCT02014948||Single Group Assignment||Treatment||None (Open Label)||||||
1421274|NCT02014935||Single Group Assignment||Treatment||None (Open Label)||||||
1421275|NCT02014922|Randomized|Parallel Assignment||Treatment||Single|||||t|
1421276|NCT02014909|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421277|NCT02014896|||Cohort||Prospective|||||||
1421278|NCT02014883||Single Group Assignment||Treatment||None (Open Label)||||||
1421279|NCT02014870|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1421280|NCT02014857|||Case Control||Prospective|||||||
1421281|NCT02014844||Single Group Assignment||Treatment||None (Open Label)||||||
1421282|NCT02014831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421283|NCT02014818|Non-Randomized|Parallel Assignment||Treatment||Single|All patients' information will be blinded to OCT image analyzers.|This study will comprise of 1 month follow-up and 3-month follow up arm, which enroll patients in a parallel manner.||||t
1421284|NCT02014805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421285|NCT02014792|||Case-Only||Cross-Sectional|||||||
1421286|NCT02014779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421287|NCT02014766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421288|NCT02014753|||Cohort||Prospective|||||||
1421289|NCT02014740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421290|NCT02014727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421291|NCT02014714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421292|NCT02014701||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421293|NCT02014688|||Cohort||Prospective|||||||
1421294|NCT02014675|||Case-Only||Prospective|||||||
1421295|NCT02014662||Single Group Assignment||Basic Science||None (Open Label)||||||
1421296|NCT02014649|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421297|NCT02014636|Randomized|||Treatment||None (Open Label)||||||
1421298|NCT02014623|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421299|NCT02014610|||Cohort||Prospective|||||||
1421300|NCT02014597|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1421301|NCT02014584|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421302|NCT02014571|Randomized|Single Group Assignment||Treatment||Single|||t|||
1421303|NCT02014558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421304|NCT02014545|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1421305|NCT02014532|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421306|NCT02014519||Single Group Assignment||Other||None (Open Label)||||||
1421307|NCT02014506||Single Group Assignment||Treatment||None (Open Label)||||||
1421308|NCT02014493|Randomized|Crossover Assignment||Treatment||Single|||||t|
1421309|NCT02014480|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1421310|NCT02014467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421311|NCT02014454||Single Group Assignment||Treatment||None (Open Label)||||||
1421312|NCT02014441||Single Group Assignment||Treatment||None (Open Label)||||||
1421313|NCT02014428||||||||||||
1421314|NCT02014415|||Cohort||Prospective|||||||
1421315|NCT02014402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421316|NCT02014389|||Case Control||Prospective|||||||
1421317|NCT02014376|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421318|NCT02014363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421319|NCT02014350|||Cohort||Cross-Sectional|||||||
1421320|NCT02014337||Single Group Assignment||Treatment||None (Open Label)||||||
1421321|NCT02014324|||Cohort||Prospective|||||||
1421322|NCT02014311|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1421323|NCT02014298|Randomized|Parallel Assignment||Treatment||Single||||||t
1421324|NCT02014285|||Cohort||Prospective|||||||
1421325|NCT02014272|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1421326|NCT02014259|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421327|NCT02014246|||Case-Control||Other|||||||
1421328|NCT02014233|Randomized|Parallel Assignment||||Double|||t||t|
1421329|NCT02014220||||Prevention||||||||
1421330|NCT02014207||||Prevention||||||||
1421331|NCT02014194|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421332|NCT02014181||Single Group Assignment||Prevention||None (Open Label)||||||
1421333|NCT02014168|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1421334|NCT02014155|Randomized|Factorial Assignment||Treatment||Single|||||t|
1421335|NCT02014142|Randomized|Parallel Assignment||Treatment||Single||||||t
1421336|NCT02014129||Single Group Assignment||Treatment||None (Open Label)||||||
1421337|NCT02014116||Single Group Assignment||Treatment||None (Open Label)||||||
1421338|NCT02014103|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421339|NCT02014090|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1421340|NCT02014077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421341|NCT02014064|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421342|NCT02014051||Single Group Assignment||Treatment||None (Open Label)||||||
1421343|NCT02014038|||Cohort||Prospective|||||||
1421344|NCT02014025|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1421345|NCT02014012|||Case-Only||Prospective|||||||
1421346|NCT02013999|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1421347|NCT02013986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421348|NCT02013973|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421349|NCT02013960|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1421350|NCT02013947|Randomized|Single Group Assignment||Prevention||Single|||||t|
1421351|NCT02013934|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1421352|NCT02013921|||Cohort||Prospective|||||||
1421353|NCT02013908|Randomized|Parallel Assignment||Treatment||Single||||||t
1421354|NCT02013895||||||||||||
1421355|NCT02013882|||Cohort||Prospective|||||||
1421356|NCT02013869|Randomized|Parallel Assignment||Basic Science||Single||We studied the time to reach a MAC value for two fifferent anaesthetic machines, Flow-i versus Aisys looking at the time to reach 1 MAC desflurane|||t|
1421357|NCT02013856|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1421358|NCT02013843||Single Group Assignment||Health Services Research||None (Open Label)||||||
1421359|NCT02013830|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421360|NCT02013817||Single Group Assignment||Treatment||None (Open Label)||||||
1421361|NCT02013804||Single Group Assignment||Treatment||None (Open Label)||||||
1421362|NCT02013791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421363|NCT02013778||||Treatment||||||||
1421364|NCT02013765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421365|NCT02013752|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421366|NCT02013739|||Cohort||Prospective|||||||
1421367|NCT02013726||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421368|NCT02013713|||Cohort||Prospective|||||||
1421369|NCT02013700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421370|NCT02013687|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421371|NCT02013674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421372|NCT02013661|||||Cross-Sectional|||||||
1421373|NCT02013648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421374|NCT02013635|||Case-Only||Prospective|||||||
1421375|NCT02013622||Single Group Assignment||Treatment||None (Open Label)||||||
1421376|NCT02013609||Single Group Assignment||Treatment||None (Open Label)||||||
1421377|NCT02013596|Randomized|Parallel Assignment||Treatment||Single||||||t
1421378|NCT02013583|||Case-Only||Other|||||||
1421379|NCT02013570|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421380|NCT02013557|Randomized|Parallel Assignment||Screening||Single|||t|||
1421381|NCT02013544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421382|NCT02013531||Single Group Assignment||Treatment||None (Open Label)||||||
1421383|NCT02013518|Randomized|Single Group Assignment||Treatment||Single||||||t
1421384|NCT02013505|Randomized|Parallel Assignment||||Single||||t||
1421385|NCT02013492||Single Group Assignment||Treatment||None (Open Label)||||||
1421386|NCT02013479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421387|NCT02013466|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1421388|NCT02013453|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421389|NCT02013427|Randomized|Parallel Assignment||Treatment||Single|||||t|
1421390|NCT02013414||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421391|NCT02013401|||Cohort||Cross-Sectional|||||||
1421392|NCT02013388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421393|NCT02013375||Single Group Assignment||Treatment||None (Open Label)||||||
1421394|NCT02013362||Single Group Assignment||Treatment||None (Open Label)||||||
1421395|NCT02013349||Single Group Assignment||Treatment||None (Open Label)||prospective, multi-center registry||||
1421396|NCT02013336||Single Group Assignment||Treatment||None (Open Label)||||||
1421397|NCT02013323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421398|NCT02013310|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421399|NCT02013297||Single Group Assignment||Treatment||None (Open Label)||||||
1421400|NCT02013284|||Cohort||Prospective|||||||
1421401|NCT02013271|||Cohort||Prospective|||||||
1421402|NCT02013258|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1421403|NCT02013245|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1421404|NCT02013232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421405|NCT02013219|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1421406|NCT02013206|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421407|NCT02013193|Randomized|Parallel Assignment||Treatment||Single||||||t
1421408|NCT02013180|||Case Control||Prospective|||||||
1421409|NCT02013167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421410|NCT02013154|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421411|NCT02013141||Single Group Assignment||Basic Science||None (Open Label)||||||
1421412|NCT02013128||Single Group Assignment||Treatment||None (Open Label)||||||
1421413|NCT02013115|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1421414|NCT02013102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421415|NCT02013089|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421416|NCT02013076|||Cohort||Prospective|||||||
1421417|NCT02013063|||Case-Only||Prospective|||||||
1421418|NCT02013050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421419|NCT02013037|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421420|NCT02013024|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421421|NCT02013011|Randomized|Parallel Assignment||Treatment||Single||||||t
1421422|NCT02012998||Single Group Assignment||Prevention||None (Open Label)||||||
1421423|NCT02012985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421424|NCT02012972|||Cohort||Prospective|||||||
1421425|NCT02012959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421426|NCT02012946|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421427|NCT02012933||||||||||||
1421428|NCT02012920|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421429|NCT02012894|||Cohort||Prospective|||||||
1421430|NCT02012881|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421431|NCT02012868|||Cohort||Prospective|||||||
1421432|NCT02012855|Randomized|Crossover Assignment||Basic Science||Single||||||t
1421433|NCT02012842|Randomized|Parallel Assignment||Prevention||Single|||||t|
1421434|NCT02012829|Randomized|Parallel Assignment||Prevention||Single|||t|||
1421435|NCT02012816||Single Group Assignment||||None (Open Label)||||||
1421436|NCT02012803|Randomized|Parallel Assignment||Treatment||Single|||||t|
1421437|NCT02012790|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1421438|NCT02012777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421439|NCT02012764|||Cohort||Prospective|||||||
1421440|NCT02012751||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421441|NCT02012738|Randomized|Parallel Assignment||Treatment||Single||||||t
1421442|NCT02012725|||Case-Control||Prospective|||||||
1421443|NCT02012712|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1421444|NCT02012699|||Cohort||Prospective|||||||
1421445|NCT02012686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421446|NCT02012673||Single Group Assignment||Treatment||None (Open Label)||||||
1421447|NCT02012660|||||Retrospective|||||||
1421448|NCT02012647|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1421449|NCT02012634|||Case Control||Prospective|||||||
1421450|NCT02012621|||Cohort||Prospective|||||||
1421451|NCT02012608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421452|NCT02012595|||Case Control||Cross-Sectional|||||||
1421453|NCT02012582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421454|NCT02012569|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421455|NCT02012556||Single Group Assignment||Treatment||None (Open Label)||||||
1421456|NCT02012543||Single Group Assignment||Treatment||None (Open Label)||||||
1421457|NCT02012530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421458|NCT02012517|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421459|NCT02012504|||Case Control||Retrospective|||||||
1421460|NCT02012491|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1421461|NCT02012478|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1421462|NCT02012465||Single Group Assignment||Treatment||None (Open Label)||||||
1421463|NCT02012452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421464|NCT02012439|Randomized|Parallel Assignment||Treatment||Single||||||t
1421465|NCT02012426|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1421466|NCT02012413|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421467|NCT02012400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421468|NCT02012387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421469|NCT02012374|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421470|NCT02012361|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1421471|NCT02012348|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421472|NCT02012335|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421473|NCT02012322|Randomized|Crossover Assignment||Treatment||Double||||||
1421474|NCT02012309|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421475|NCT02012296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421476|NCT02012283|Randomized|Crossover Assignment||Prevention||Single|||t|||
1421477|NCT02012270|||Case-Control||Prospective|||||||
1421478|NCT02012257|Randomized|Crossover Assignment||||Double|||t|||t
1421479|NCT02012244|Randomized|Parallel Assignment||Prevention||Single||||||t
1421480|NCT02012231||Single Group Assignment||Treatment||None (Open Label)||||||
1421481|NCT02012218||Single Group Assignment||Treatment||None (Open Label)||||||
1421482|NCT02012205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421483|NCT02012192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421484|NCT02012179|Randomized|Parallel Assignment||Treatment||Single||||||t
1421485|NCT02012166|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1421486|NCT02012153||Single Group Assignment||Treatment||None (Open Label)||||||
1421487|NCT02012140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421488|NCT02012127|||Cohort||Retrospective|||||||
1421489|NCT02012114||Single Group Assignment||||None (Open Label)||||||
1421490|NCT02012101|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421491|NCT02012088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421492|NCT02012075|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421493|NCT02012062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421494|NCT02012049|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421495|NCT02012036|||Case-Only||Prospective|||||||
1421496|NCT02012023|Randomized|Single Group Assignment||Treatment||Single|||t|||
1421497|NCT02012010|Randomized|Parallel Assignment||Prevention||Single|||t|||
1421498|NCT02011997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421499|NCT02011984|||Cohort||Prospective|||||||
1421500|NCT02011971|Randomized|Crossover Assignment||Treatment||Quadruple||Double-blind single dose crossover with 1-month follow-up open label in patients.|t|t|t|t
1421501|NCT02011958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421502|NCT02011945||Single Group Assignment||Treatment||None (Open Label)||||||
1421503|NCT02011932|||Cohort||Prospective|||||||
1421504|NCT02011919||Single Group Assignment||Treatment||None (Open Label)||||||
1421505|NCT02011906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421506|NCT02011893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421507|NCT02011880||||||||||||
1421508|NCT02011867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421509|NCT02011854|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421510|NCT02011841|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421511|NCT02011828|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1421512|NCT02011815|||Cohort||Prospective|||||||
1421513|NCT02011802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421514|NCT02011789|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1421515|NCT02011776|||Case Control||Prospective|||||||
1421516|NCT02011763||Single Group Assignment||Prevention||None (Open Label)||||||
1421517|NCT02011750|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421518|NCT02011737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421519|NCT02011724||Single Group Assignment||Supportive Care||None (Open Label)||||||
1421520|NCT02011711|||Cohort||Prospective|||||||
1421521|NCT02011698|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1421522|NCT02011685|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421523|NCT02011672|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1421524|NCT02011659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421525|NCT02011646|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1421526|NCT02011633|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421527|NCT02011620|Randomized|Parallel Assignment||Treatment||Single|||||t|
1421528|NCT02011607|||Case-Only||Prospective|||||||
1421529|NCT02011594|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421530|NCT02011581|||Case Control||Cross-Sectional|||||||
1421531|NCT02011568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421532|NCT02011542|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421533|NCT02011529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421534|NCT02011516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421535|NCT02011503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421536|NCT02011490|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421537|NCT02011477|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421538|NCT02011464|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421539|NCT02011451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421540|NCT02011438|Randomized|Parallel Assignment||Prevention||Single||||||t
1421541|NCT02011425|Randomized|Crossover Assignment||Other||Single||||||t
1421542|NCT02011412|||Case Control||Prospective|||||||
1421543|NCT02011399|||Cohort||Prospective|||||||
1421544|NCT02011386|||Cohort||Prospective|||||||
1421545|NCT02011373||Single Group Assignment||Treatment||None (Open Label)||||||
1421546|NCT02011360|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1421547|NCT02011347|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1421548|NCT02011334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421549|NCT02011321||Single Group Assignment||Treatment||None (Open Label)||||||
1421550|NCT02011308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421551|NCT02011295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421552|NCT02011282|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1421553|NCT02011269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421554|NCT02011256||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421555|NCT02011243|||Cohort||Prospective|||||||
1421556|NCT02011230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421557|NCT02011217|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1421558|NCT02011204|||Cohort||Prospective|||||||
1421559|NCT02011191|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421560|NCT02011178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421561|NCT02011165|||Case-Crossover||Prospective|||||||
1421562|NCT02011152|||Case Control||Prospective|||||||
1421563|NCT02011139|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1421564|NCT02011126||Single Group Assignment||Treatment||None (Open Label)||||||
1421565|NCT02011113||Single Group Assignment||Treatment||None (Open Label)||||||
1421566|NCT02011100|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1421567|NCT02011087||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421568|NCT02011074|||Cohort||Prospective|||||||
1421569|NCT02011061|||Cohort||Prospective|||||||
1421570|NCT02011048|||Case Control||Prospective|||||||
1421571|NCT02011035|||Cohort||Prospective|||||||
1421572|NCT02011022|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1421573|NCT02011009||Single Group Assignment||Prevention||None (Open Label)||||||
1421574|NCT02010996|Randomized|Parallel Assignment||Prevention||Single|||t|||
1421575|NCT02010983||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421576|NCT02010970|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1421577|NCT02010957||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421578|NCT02010944|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1421579|NCT02010931|||Cohort||Retrospective|||||||
1421580|NCT02010918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421581|NCT02010905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421582|NCT02010892|||Cohort||Prospective|||||||
1421583|NCT02010879|||Cohort||Prospective|||||||
1421584|NCT02010866||Single Group Assignment||Treatment||None (Open Label)||||||
1421585|NCT02010853|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1421586|NCT02010840|Randomized|Parallel Assignment||Prevention||Single||||||t
1421587|NCT02010827|||Case Control||Prospective|||||||
1421588|NCT02010814|||Other||Cross-Sectional|||||||
1421589|NCT02010801||Single Group Assignment||Treatment||None (Open Label)||||||
1421590|NCT02010788|||Cohort||Prospective|||||||
1421591|NCT02010775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421592|NCT02010762|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1421593|NCT02010749|||Cohort||Retrospective|||||||
1421594|NCT02010736||Single Group Assignment||Treatment||None (Open Label)||||||
1421595|NCT02010723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421596|NCT02010710|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1421597|NCT02010697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421598|NCT02010684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421599|NCT02010671|||Case-Only||Cross-Sectional|||||||
1421600|NCT02010658||Crossover Assignment||Other||||||||
1421601|NCT02010645||Single Group Assignment||Treatment||None (Open Label)||||||
1421602|NCT02010632|Randomized|Crossover Assignment||||Single|||t|||
1421603|NCT02010619|Randomized|Parallel Assignment||Treatment||Single||||||t
1421604|NCT02010606|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421605|NCT02010593|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1421606|NCT02010580|||Cohort||Prospective|||||||
1421607|NCT02010567|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421608|NCT02010554|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1421609|NCT02010541|||Case Control||Prospective|||||||
1421610|NCT02010528|||Case Control||Cross-Sectional|||||||
1421611|NCT02010515|||Case-Only||Prospective|||||||
1421612|NCT02010502|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1421613|NCT02010489|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1421614|NCT02010476|||Case Control||Cross-Sectional|||||||
1421615|NCT02010463||Single Group Assignment||Basic Science||None (Open Label)||||||
1421616|NCT02010450|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421617|NCT02010437|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1421618|NCT02010424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421619|NCT02010411||Single Group Assignment||Treatment||None (Open Label)||||||
1421620|NCT02010398|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1421621|NCT02010385|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1421622|NCT02010372|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1421623|NCT02010359|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421624|NCT02010346|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1421625|NCT02010333||Single Group Assignment||Treatment||None (Open Label)||||||
1421626|NCT02010320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421627|NCT02010307|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1421628|NCT02010294|||Case-Control||Prospective|||||||
1421629|NCT02010281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421630|NCT02010268||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421631|NCT02010255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421632|NCT02010242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421633|NCT02010229|||Cohort||Prospective|||||||
1421634|NCT02010216||Single Group Assignment||Treatment||None (Open Label)||||||
1421635|NCT02010203|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421636|NCT02010190|||Cohort||Prospective|||||||
1421637|NCT02010177|||Cohort||Prospective|||||||
1421638|NCT02010164|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421639|NCT02010151|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1421640|NCT02010138|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421641|NCT02010125|||Cohort||Prospective|||||||
1421642|NCT02010112||Single Group Assignment||Diagnostic||Single|||||t|
1421643|NCT02010099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421644|NCT02010086|Randomized|Parallel Assignment||Treatment||Single||||||t
1421645|NCT02010073|||Cohort||Prospective|||||||
1421646|NCT02010060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421647|NCT02010047||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421648|NCT02010034||Single Group Assignment||Supportive Care||None (Open Label)||||||
1421649|NCT02010021|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1421650|NCT02010008|Randomized|Parallel Assignment||Prevention||Single||||||t
1421651|NCT02009995|Randomized|Parallel Assignment||Treatment||Single||||||t
1421652|NCT02009982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421653|NCT02009969|||Cohort||Prospective|||||||
1421654|NCT02009956||Single Group Assignment||Treatment||None (Open Label)||||||
1421655|NCT02009943|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421656|NCT02009930|||Other||Cross-Sectional|||||||
1421657|NCT02009917|||Cohort||Prospective|||||||
1421658|NCT02009904|||Case Control||Prospective|||||||
1421659|NCT02009891|||Other||Prospective|||||||
1421660|NCT02009878|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1421661|NCT02009865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421662|NCT02009852|||Case-Only|||||||||
1421663|NCT02009839|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1421664|NCT02009826|||Case-Control||Prospective|||||||
1421665|NCT02009813||Single Group Assignment||Basic Science||None (Open Label)||||||
1421666|NCT02009800|Randomized|Parallel Assignment||Prevention||Single||||||t
1421667|NCT02009787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421668|NCT02009774|||Cohort||Prospective|||||||
1421669|NCT02009761||Single Group Assignment||Treatment||None (Open Label)||||||
1421670|NCT02009748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421671|NCT02009735||Single Group Assignment||Diagnostic||Double|||||t|t
1421672|NCT02009722|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421673|NCT02009709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421674|NCT02009696|||Case-Only||Prospective|||||||
1421675|NCT02009683|||Cohort||Prospective|||||||
1421676|NCT02009670|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1421677|NCT02009644||Single Group Assignment||Treatment||None (Open Label)||AAA Device||||
1421678|NCT02009631|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1421679|NCT02009618|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1421680|NCT02009605||Single Group Assignment||Treatment||None (Open Label)||||||
1421681|NCT02009592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421682|NCT02009579|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421683|NCT02009566||Single Group Assignment||Prevention||None (Open Label)||||||
1421684|NCT02009553|||Case Control||Prospective|||||||
1421685|NCT02009540|Randomized|Crossover Assignment||Treatment||Single|||t|||
1421686|NCT02009527|Randomized|Crossover Assignment||Basic Science||Single||||||t
1421687|NCT02009514||Single Group Assignment||Treatment||None (Open Label)||||||
1421688|NCT02009501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421689|NCT02009488|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1421690|NCT02009475|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1421691|NCT02009462||Single Group Assignment||Treatment||None (Open Label)||||||
1421692|NCT02009449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421693|NCT02009436||Single Group Assignment||Treatment||None (Open Label)||||||
1421694|NCT02009423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421695|NCT02009410|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421696|NCT02009397||Single Group Assignment||Treatment||None (Open Label)||||||
1421697|NCT02009384||Single Group Assignment||Treatment||None (Open Label)||||||
1421698|NCT02009371|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421699|NCT02009358||Single Group Assignment||Treatment||Single|||t|||
1421700|NCT02009345||||||||||||
1421701|NCT02009332||Single Group Assignment||Treatment||None (Open Label)||||||
1421702|NCT02009319|||Case-Only||Prospective|||||||
1421703|NCT02009306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421704|NCT02009293|||Cohort||Prospective|||||||
1421705|NCT02009280|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1421706|NCT02009267|||Cohort||Retrospective|||||||
1421707|NCT02009254||||Prevention||||||||
1421708|NCT02009241|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421709|NCT02009228|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421710|NCT02009215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421711|NCT02009202|Randomized|Parallel Assignment||Treatment||Single|||||t|
1421712|NCT02009189|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1421713|NCT02009176|Randomized|Parallel Assignment||Treatment||Single||||||t
1421714|NCT02009163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421715|NCT02009150|||Case-Only||Prospective|||||||
1421716|NCT02009137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421717|NCT02009124|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421718|NCT02009111|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421719|NCT02009098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421720|NCT02009085|||Case-Only||Retrospective|||||||
1421721|NCT02009072|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421722|NCT02009059|||Cohort||Prospective|||||||
1421723|NCT02009046|Randomized|Parallel Assignment||Prevention||Single|||t|||
1421724|NCT02009033|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1421725|NCT02009020|||||Prospective|||||||
1421726|NCT02009007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421727|NCT02008994||Single Group Assignment||Treatment||None (Open Label)||||||
1421728|NCT02008981|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1421729|NCT02008968|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421730|NCT02008955||Single Group Assignment||Health Services Research||None (Open Label)||||||
1421731|NCT02008942|Randomized|Crossover Assignment||Prevention||Single||||||t
1421732|NCT02008929||Single Group Assignment||Treatment||None (Open Label)||||||
1421733|NCT02008916|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421734|NCT02008903|||Other||Prospective|||||||
1421735|NCT02008890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421736|NCT02008877||Single Group Assignment||Treatment||None (Open Label)||||||
1421737|NCT02008864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421738|NCT02008851||Single Group Assignment||||None (Open Label)||||||
1421739|NCT02008838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421740|NCT02008825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421741|NCT02008812||Single Group Assignment||Diagnostic||Double|||||t|t
1421742|NCT02008799||Single Group Assignment||Treatment||Single|||||t|
1421743|NCT02008786|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1421744|NCT02008773|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421745|NCT02008760|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1421746|NCT02008747|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421747|NCT02008734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421748|NCT02008721|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421749|NCT02008708|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1421750|NCT02008695|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1421751|NCT02008682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421752|NCT02008669|||Case-Only||Prospective|||||||
1421753|NCT02008656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421754|NCT02008643|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1421755|NCT02008630|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421756|NCT02008617|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1421757|NCT02008604|||Case-Control||Prospective|||||||
1421758|NCT02008591|Randomized|Parallel Assignment||Treatment||Triple|Anesthesiologist performing technique and bedside nurse instructed not to reveal randomization arm to the patient or study co-investigator who was waiting outside the room, and notified only after completion of the neuraxial placement protocol.|Randomized controlled trial with computer generated (Microsoft Excel 2015) assignment placed in sealed envelopes.|t||t|t
1421759|NCT02008578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421760|NCT02008565|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1421761|NCT02008552||Single Group Assignment||Prevention||None (Open Label)||||||
1421762|NCT02008539||Single Group Assignment||Treatment||None (Open Label)||||||
1421763|NCT02008526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421764|NCT02008513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421765|NCT02008500|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421766|NCT02008487||Single Group Assignment||Supportive Care||None (Open Label)||||||
1421767|NCT02008474|Randomized|Parallel Assignment||Treatment||Single||||||t
1421768|NCT02008461|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421769|NCT02008448|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421770|NCT02008435|Randomized|Parallel Assignment||Prevention||Single|||t|||
1421771|NCT02008422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421772|NCT02008409||Single Group Assignment||Basic Science||None (Open Label)||||||
1421773|NCT02008396|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421774|NCT02008383|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421775|NCT02008370||Single Group Assignment||Treatment||None (Open Label)||||||
1421776|NCT02008357|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421777|NCT02008344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421778|NCT02008331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421779|NCT02008318|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421780|NCT02008305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421781|NCT02008292||Single Group Assignment||Other||None (Open Label)||||||
1421782|NCT02008279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421783|NCT02008266|||Case-Only||Cross-Sectional|||||||
1421784|NCT02008253|||Case-Only||Retrospective|||||||
1421785|NCT02008240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421786|NCT02008227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421787|NCT02008214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421788|NCT02008201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421789|NCT02008188|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421790|NCT02008175||Single Group Assignment||Treatment||None (Open Label)||||||
1421791|NCT02008162|||Cohort||Prospective|||||||
1421867|NCT02007161|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1421868|NCT02007148||Single Group Assignment||Treatment||None (Open Label)||||||
1421869|NCT02007135|||Cohort||Cross-Sectional|||||||
1421870|NCT02007122|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421792|NCT02008149|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Group assignment will be based on the preference of potential subjects. Subjects can either participate in the FES-rowing group or they can participate in the standard-of-care group. The standard-of-care group will not perform FES-rowing; they will only receive periodic bone density measurements over a 36-week period, with a total time commitment of approximately 10 hours. Subjects in the FES-rowing group will participate in rowing sessions requiring a 2 to 3 hour time commitment per week for the duration of the participation.||||
1421793|NCT02008136||Single Group Assignment||Treatment||None (Open Label)||||||
1421794|NCT02008123||Single Group Assignment||Treatment||None (Open Label)||||||
1421795|NCT02008110|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421796|NCT02008097|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1421797|NCT02008084|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421798|NCT02008071|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421799|NCT02008058|||Cohort||Prospective|||||||
1421800|NCT02008045|||Cohort||Prospective|||||||
1421801|NCT02008032||Single Group Assignment||Screening||None (Open Label)||||||
1421802|NCT02008019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421803|NCT02008006||Single Group Assignment||Treatment||None (Open Label)||||||
1421804|NCT02007993|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1421805|NCT02007980|||Case-Only||Prospective|||||||
1421806|NCT02007967|||Cohort||Prospective|||||||
1421807|NCT02007954||Single Group Assignment||Treatment||None (Open Label)||||||
1421808|NCT02007941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421809|NCT02007928||Single Group Assignment||Other||None (Open Label)||||||
1421810|NCT02007915||Single Group Assignment||Treatment||None (Open Label)||||||
1421811|NCT02007902|||Cohort||Prospective|||||||
1421812|NCT02007889|Randomized|Parallel Assignment||Prevention||Single|||t|||
1421813|NCT02007876|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421814|NCT02007863||Single Group Assignment||Treatment||None (Open Label)||||||
1421815|NCT02007850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421816|NCT02007837|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1421817|NCT02007824|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421818|NCT02007811||Single Group Assignment||Treatment||None (Open Label)||||||
1421819|NCT02007798|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1421820|NCT02007785||Single Group Assignment||Treatment||None (Open Label)||||||
1421821|NCT02007772|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421822|NCT02007759|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421823|NCT02007746|||Case-Control||Cross-Sectional|||||||
1421824|NCT02007733||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421825|NCT02007720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421826|NCT02007707|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421827|NCT02007694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421828|NCT02007681|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1421829|NCT02007668|Randomized|Parallel Assignment||Treatment||Single|||||t|
1421830|NCT02007655|||Case-Only||Prospective|||||||
1421831|NCT02007642|||Case-Only||Prospective|||||||
1421832|NCT02007629||Single Group Assignment||Treatment||None (Open Label)||||||
1421833|NCT02007616|Randomized|Parallel Assignment||Prevention||Single|||t|||
1421834|NCT02007603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421835|NCT02007590|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1421836|NCT02007577|Randomized|Parallel Assignment||||Single|||t|||
1421837|NCT02007564|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421838|NCT02007551||Parallel Assignment||||Single||||||t
1421839|NCT02007538|||Case-Control||Prospective|||||||
1421840|NCT02007525|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421841|NCT02007512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421842|NCT02007499|||Ecologic or Community||Retrospective|||||||
1421843|NCT02007486|||Case-Control||Prospective|||||||
1421844|NCT02007473|||Case-Only||Prospective|||||||
1421845|NCT02007460|Randomized|Single Group Assignment||Basic Science||Single||||||t
1421846|NCT02007447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421847|NCT02007434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421848|NCT02007421|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1421849|NCT02007408|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421850|NCT02007395|||Case-Only||Prospective|||||||
1421851|NCT02007369|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421852|NCT02007356||Single Group Assignment||Treatment||None (Open Label)||||||
1421853|NCT02007343|||||Prospective|||||||
1421854|NCT02007330|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1421855|NCT02007317||Single Group Assignment||Treatment||None (Open Label)||||||
1421856|NCT02007304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421857|NCT02007291|||Other||Prospective|||||||
1421858|NCT02007278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421859|NCT02007265|||Cohort||Prospective|||||||
1421860|NCT02007252|Randomized|Parallel Assignment||||Triple|||t||t|t
1421861|NCT02007239||Single Group Assignment||Treatment||None (Open Label)||||||
1421862|NCT02007226|||Case-Only||Prospective|||||||
1421863|NCT02007213|||Cohort||Prospective|||||||
1421864|NCT02007200||Single Group Assignment||Treatment||None (Open Label)||||||
1421865|NCT02007187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421866|NCT02007174|||Cohort||Prospective|||||||
1421871|NCT02007109|||Cohort||Prospective|||||||
1421872|NCT02007096|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1421873|NCT02007083|Randomized|Parallel Assignment||Treatment||Single||||||t
1421874|NCT02007070||Single Group Assignment||Treatment||None (Open Label)||||||
1421875|NCT02007057|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421876|NCT02007044|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421877|NCT02007031|||||Cross-Sectional|||||||
1421878|NCT02007018|Randomized|Parallel Assignment||Prevention||Single||||||t
1421879|NCT02007005||Single Group Assignment||Treatment||None (Open Label)||||||
1421880|NCT02006992|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1421881|NCT02006979|Randomized|Parallel Assignment||Prevention||Single||||||t
1421882|NCT02006966|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1421883|NCT02006953|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421884|NCT02006940||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421885|NCT02006927||Single Group Assignment||Treatment||None (Open Label)||||||
1421886|NCT02006914|||Case Control||Prospective|||||||
1421887|NCT02006901|||Cohort||Prospective|||||||
1421888|NCT02006888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421889|NCT02006875|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1421890|NCT02006862|||||Prospective|||||||
1421891|NCT02006849|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421892|NCT02006836|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421893|NCT02006823|||Cohort||Prospective|||||||
1421894|NCT02006810|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1421895|NCT02006797|Randomized|Crossover Assignment||||None (Open Label)||||||
1421896|NCT02006784|||Other||Prospective|||||||
1421897|NCT02006771|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1421898|NCT02006758|||Case-Only||Prospective|||||||
1421899|NCT02006745|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1421900|NCT02006732|Randomized|Parallel Assignment||Treatment||Double||||||
1421901|NCT02006719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421902|NCT02006706||Single Group Assignment||Treatment||None (Open Label)||||||
1421903|NCT02006693|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421904|NCT02006680|||Cohort||Prospective|||||||
1421905|NCT02006667|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421906|NCT02006654|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421907|NCT02006641|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421908|NCT02006628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421909|NCT02006615|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1421910|NCT02006602|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421911|NCT02006589|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1421912|NCT02006576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421913|NCT02006563|||Cohort||Prospective|||||||
1421914|NCT02006550|||Cohort||Prospective|||||||
1421915|NCT02006537|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421916|NCT02006524||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421917|NCT02006511|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421918|NCT02006498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421919|NCT02006485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421920|NCT02006472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421921|NCT02006459|||Case Control||Prospective|||||||
1421922|NCT02006446|||Cohort||Prospective|||||||
1421923|NCT02006433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421924|NCT02006420|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1421925|NCT02006407||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421926|NCT02006394|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1421927|NCT02006381|||Cohort||Cross-Sectional|||||||
1421928|NCT02006368||Single Group Assignment||Basic Science||None (Open Label)||||||
1421929|NCT02006355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421930|NCT02006342|Randomized|Single Group Assignment||Treatment||Single|||t|||
1421931|NCT02006329|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421932|NCT02006316|||Case-Only||Retrospective|||||||
1421933|NCT02006303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421934|NCT02006290|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1421935|NCT02006277||Crossover Assignment||Basic Science||None (Open Label)||||||
1421936|NCT02006264|Randomized|Parallel Assignment||Prevention||Single|||t|||
1421937|NCT02006251||||||||||||
1421938|NCT02006238|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1421939|NCT02006225||Single Group Assignment||Treatment||None (Open Label)||||||
1421940|NCT02006212||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421941|NCT02006199|Randomized|Crossover Assignment||Treatment||Single||||||t
1421942|NCT02006186|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421943|NCT02006173|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421944|NCT02006160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421945|NCT02006147|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421946|NCT02006134|||Cohort||Prospective|||||||
1421947|NCT02006121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421948|NCT02006108||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421949|NCT02006095|||Cohort||Prospective|||||||
1421950|NCT02006082|||Cohort||Retrospective|||||||
1421951|NCT02006069|Randomized|Parallel Assignment||Treatment||Single||||||t
1421952|NCT02006056|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421953|NCT02006043||Single Group Assignment||Treatment||None (Open Label)||||||
1421954|NCT02006030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421955|NCT02006017|Randomized|Parallel Assignment||Other||Single|||||t|
1421956|NCT02006004|||Case-Only||Retrospective|||||||
1421957|NCT02005991|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1421958|NCT02005978|||Case Control||Prospective|||||||
1421959|NCT02005965|||Cohort||Prospective|||||||
1421960|NCT02005952|||Cohort||Prospective|||||||
1421961|NCT02005939|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1421962|NCT02005926||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421963|NCT02005913|||Case-Only||Prospective|||||||
1421964|NCT02005900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421965|NCT02005887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421966|NCT02005874|||Case Control||Prospective|||||||
1421967|NCT02005861||Single Group Assignment||Treatment||None (Open Label)||||||
1421968|NCT02005848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421969|NCT02005835|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1421970|NCT02005822|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1421971|NCT02005809|Randomized|Parallel Assignment||Treatment||Single|||t|||
1421972|NCT02005796|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1421973|NCT02005783|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421974|NCT02005770|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1421975|NCT02005757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421976|NCT02005744|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1421977|NCT02005731|||Cohort||Prospective|||||||
1421978|NCT02005718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421979|NCT02005705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421980|NCT02005692||Single Group Assignment||Supportive Care||Single||||t||
1421981|NCT02005679||Single Group Assignment||Diagnostic||None (Open Label)||||||
1421982|NCT02005666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421983|NCT02005653|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1421984|NCT02005640|||||Retrospective|||||||
1421985|NCT02005627|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1421986|NCT02005614||Single Group Assignment||Treatment||None (Open Label)||||||
1421987|NCT02005601|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1421988|NCT02005588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421989|NCT02005575|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1421990|NCT02005562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421991|NCT02005549|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421992|NCT02005536||Single Group Assignment||Prevention||None (Open Label)||||||
1421993|NCT02005523|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1421994|NCT02005510|Randomized|Parallel Assignment||Screening||Single||Eligibility is assessed weekly over 2.5 years. Study participants are assigned to the control arm or to the intervention arm. After follow-up is complete, control arm participants are re-assessed for eligibility and re-randomization.|||t|
1421995|NCT02005497|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1421996|NCT02005484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1421997|NCT02005471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421998|NCT02005458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1421999|NCT02005445|Randomized|Parallel Assignment||Treatment||Single||||||t
1422000|NCT02005432|Randomized|Parallel Assignment||Treatment||Single||||||t
1422001|NCT02005419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422002|NCT02005406|||Case Control||Prospective|||||||
1422003|NCT02005393||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422004|NCT02005380|||Cohort||Cross-Sectional|||||||
1422005|NCT02005367|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422006|NCT02005354|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1422007|NCT02005341||||Treatment||||||||
1422008|NCT02005328|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1422009|NCT02005315|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422010|NCT02005302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422011|NCT02005289|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422012|NCT02005276|Randomized|Parallel Assignment||||Single|||t|||
1422013|NCT02005263||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422014|NCT02005250|||Cohort||Prospective|||||||
1422015|NCT02005237|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1422016|NCT02005224||Single Group Assignment||Prevention||None (Open Label)||||||
1422017|NCT02005211|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1422018|NCT02005198|||Cohort||Prospective|||||||
1422019|NCT02005185|||Other||Prospective|||||||
1422020|NCT02005172||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422021|NCT02005159|||Cohort||Prospective|||||||
1422022|NCT02005146|||Cohort||Retrospective|||||||
1422023|NCT02005133|||Other||Prospective|||||||
1422024|NCT02005120|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422025|NCT02005107|Randomized|Crossover Assignment||||None (Open Label)||||||
1422026|NCT02005094|||Cohort||Prospective|||||||
1422027|NCT02005081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422028|NCT02005068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422029|NCT02005055|||||Prospective|||||||
1422030|NCT02005042|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1422031|NCT02005029|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1422032|NCT02005016||Single Group Assignment||Treatment||None (Open Label)||||||
1422033|NCT02005003|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1422034|NCT02004990||Single Group Assignment||Basic Science||None (Open Label)||||||
1422035|NCT02004977|Randomized|Parallel Assignment||Treatment||Single||||||t
1422036|NCT02004964|||Other||Prospective|||||||
1422037|NCT02004951|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1422038|NCT02004938|||Cohort||Prospective|||||||
1422039|NCT02004925|||Case Control||Cross-Sectional|||||||
1422040|NCT02004912|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1422041|NCT02004899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422042|NCT02004886|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422043|NCT02004873||Single Group Assignment||Treatment||None (Open Label)||||||
1422044|NCT02004860|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422045|NCT02004847|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422046|NCT02004834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422047|NCT02004821||Single Group Assignment||Basic Science||None (Open Label)||||||
1422048|NCT02004808|||Cohort||Prospective|||||||
1422049|NCT02004795||Single Group Assignment||Treatment||None (Open Label)||||||
1422050|NCT02004782|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1422051|NCT02004769||Single Group Assignment||Treatment||None (Open Label)||||||
1422052|NCT02004756|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422053|NCT02004743|Randomized|Parallel Assignment||Prevention||Single|||t|||
1422054|NCT02004730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422055|NCT02004717||Single Group Assignment||Treatment||None (Open Label)||||||
1422056|NCT02004704||Single Group Assignment||Treatment||None (Open Label)||||||
1422057|NCT02004691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422058|NCT02004678|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1422059|NCT02004665|||Cohort||Prospective|||||||
1422060|NCT02004652|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1422061|NCT02004639|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1422062|NCT02004626|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422063|NCT02004613|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1422064|NCT02004600||Single Group Assignment||Treatment||None (Open Label)||||||
1422065|NCT02004587|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422066|NCT02004574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422067|NCT02004561|||Cohort||Prospective|||||||
1422068|NCT02004548||Single Group Assignment||Treatment||None (Open Label)||||||
1422069|NCT02004535||Single Group Assignment||Treatment||None (Open Label)||||||
1422070|NCT02004522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422071|NCT02004509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422072|NCT02004496|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1422073|NCT02004483||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422074|NCT02004470|Randomized|Parallel Assignment||Prevention||Single|||t|||
1422075|NCT02004457|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422076|NCT02004444|||Case Control||Cross-Sectional|||||||
1422077|NCT02004431|||Case Control||Prospective|||||||
1422078|NCT02004418||Single Group Assignment||Treatment||None (Open Label)||"Subjects will receive a fixed dose (400 MBq +/-10%) of 11C-Choline and PET/CT imaging with co-registration 3T MRI imaging prior to Enhanced EBRT and two further doses of 11C-Choline at two intervals (3 and 6 months) thereafter.~Subjects with suitable intraprostatic lesion delineation with 11C-Choline will proceed to Enhanced EBRT, consisting of a dose prescription of 78 Gy in 25 fractions to the intraprostatic lesions and 68 Gy in 25 fractions (simultaneously) to the prostate gland. Subjects without suitable intraprostatic lesion delineation will be treated with Cross Cancer Institute standard of care EBRT and undergo follow-up for biochemical recurrence per protocol to determine the prognostic value of the baseline PET findings"||||
1422079|NCT02004405|Randomized|Parallel Assignment||Treatment||Single||||||t
1422080|NCT02004392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422081|NCT02004379|||Cohort|||||||||
1422082|NCT02004366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422083|NCT02004353|||Cohort||Prospective|||||||
1422084|NCT02004340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422085|NCT02004327|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1422086|NCT02004314||Single Group Assignment||Treatment||None (Open Label)||||||
1422087|NCT02004301|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422088|NCT02004288|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1422089|NCT02004275|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422090|NCT02004262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422091|NCT02004249||||||||||||
1422092|NCT02004236|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422093|NCT02004223||Single Group Assignment||Treatment||None (Open Label)||||||
1422094|NCT02004210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422095|NCT02004197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422096|NCT02004184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422255|NCT02002117||||||||||||
1422097|NCT02004171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422098|NCT02004158||Single Group Assignment||Treatment||None (Open Label)||||||
1422099|NCT02004145|Randomized|Parallel Assignment||Treatment||Single||||||t
1422100|NCT02004132||Single Group Assignment||Basic Science||None (Open Label)||||||
1422101|NCT02004119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422102|NCT02004106|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422103|NCT02004093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422104|NCT02004080|||Cohort||Prospective|||||||
1422105|NCT02004067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422106|NCT02004054|||Case-Only||Cross-Sectional|||||||
1422107|NCT02004041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422108|NCT02004028||Single Group Assignment||Treatment||None (Open Label)||||||
1422109|NCT02004015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422110|NCT02004002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422111|NCT02003989|||Case Control||Prospective|||||||
1422112|NCT02003976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422113|NCT02003963|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1422114|NCT02003950|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1422115|NCT02003937||Single Group Assignment||Treatment||None (Open Label)||||||
1422116|NCT02003924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422117|NCT02003911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422118|NCT02003898||Single Group Assignment||Treatment||None (Open Label)||All subjects are assigned to treatment with the Medtronic 530G Insulin Pump||||
1422119|NCT02003885||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422120|NCT02003872||Single Group Assignment||Treatment||None (Open Label)||||||
1422121|NCT02003859|||Cohort||Prospective|||||||
1422122|NCT02003846|||||Prospective|||||||
1422123|NCT02003833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422124|NCT02003820|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1422125|NCT02003807|||Case Control||Retrospective|||||||
1422126|NCT02003794|Randomized|Parallel Assignment||Treatment||Single||||||t
1422127|NCT02003781|||Cohort||Prospective|||||||
1422128|NCT02003768|Randomized|Parallel Assignment||||Single|||t|||
1422129|NCT02003755||Single Group Assignment||Treatment||None (Open Label)||||||
1422130|NCT02003742|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422131|NCT02003729|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1422132|NCT02003716|||Ecologic or Community||Cross-Sectional|||||||
1422133|NCT02003703|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1422134|NCT02003690|Randomized|Parallel Assignment||Treatment||Single||||||t
1422135|NCT02003677|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1422136|NCT02003664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422137|NCT02003651|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1422138|NCT02003638|Randomized|Parallel Assignment||||Double|||t||t|
1422139|NCT02003625|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422140|NCT02003612|||Cohort||Retrospective|||||||
1422141|NCT02003599|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1422142|NCT02003586|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1422143|NCT02003573|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422144|NCT02003560||Single Group Assignment||Treatment||None (Open Label)||||||
1422145|NCT02003547|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1422146|NCT02003534||Single Group Assignment||Treatment||None (Open Label)||||||
1422147|NCT02003521|||Cohort||Prospective|||||||
1422148|NCT02003508|||Ecologic or Community||Prospective|||||||
1422149|NCT02003495|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1422150|NCT02003482|||Cohort||Prospective|||||||
1422151|NCT02003469||Single Group Assignment||Prevention||None (Open Label)||||||
1422152|NCT02003456||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422153|NCT02003443|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422154|NCT02003430|||Cohort||Prospective|||||||
1422155|NCT02003417|||Cohort||Prospective|||||||
1422156|NCT02003404|||Cohort||Prospective|||||||
1422157|NCT02003391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422158|NCT02003378|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1422159|NCT02003365|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422160|NCT02003352||Single Group Assignment||Treatment||None (Open Label)||||||
1422161|NCT02003339||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422162|NCT02003326||Single Group Assignment||Other||None (Open Label)||||||
1422163|NCT02003313|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1422164|NCT02003300|||||Prospective|||||||
1422165|NCT02003287|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1422166|NCT02003274|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1422167|NCT02003261|Randomized|Parallel Assignment||Treatment||Single||||||t
1422168|NCT02003248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422169|NCT02003235||Single Group Assignment||Treatment||None (Open Label)||||||
1422170|NCT02003222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422171|NCT02003209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422172|NCT02003196|||Cohort||Prospective|||||||
1422173|NCT02003183||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422174|NCT02003170|||Case-Control||Prospective|||||||
1422175|NCT02003157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422176|NCT02003144||Single Group Assignment||Treatment||None (Open Label)||||||
1422177|NCT02003131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422178|NCT02003118|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422179|NCT02003105||||||||||||
1422180|NCT02003092||Single Group Assignment||Treatment||None (Open Label)||||||
1422181|NCT02003079|||Cohort||Cross-Sectional|||||||
1422182|NCT02003066|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422183|NCT02003053|Randomized|Parallel Assignment||Other||Single|||t|||
1422184|NCT02003040|||Cohort||Prospective|||||||
1422185|NCT02003027|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422186|NCT02003014|||Cohort||Prospective|||||||
1422187|NCT02003001||Single Group Assignment||Treatment||None (Open Label)||||||
1422188|NCT02002988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422189|NCT02002975|||Cohort||Prospective|||||||
1422190|NCT02002962|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422191|NCT02002949|Randomized|Parallel Assignment||||None (Open Label)||||||
1422192|NCT02002936||Single Group Assignment||Treatment||None (Open Label)||||||
1422193|NCT02002923|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422194|NCT02002910|||Case-Only||Prospective|||||||
1422195|NCT02002897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422196|NCT02002884|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422197|NCT02002871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422198|NCT02002858|Randomized|Parallel Assignment||Treatment||Single||||||t
1422199|NCT02002845|||Cohort||Retrospective|||||||
1422200|NCT02002832|||Cohort||Prospective|||||||
1422201|NCT02002819|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1422202|NCT02002806|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1422203|NCT02002793|Randomized|Single Group Assignment||Treatment||Single|||t|||
1422204|NCT02002780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422205|NCT02002767|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422206|NCT02002754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422207|NCT02002741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422208|NCT02002728|||Case-Only||Prospective|||||||
1422209|NCT02002715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422210|NCT02002702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422211|NCT02002689||Single Group Assignment||Treatment||None (Open Label)||||||
1422212|NCT02002676|||Case-Only||Prospective|||||||
1422213|NCT02002663|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422214|NCT02002650|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1422215|NCT02002637||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1422216|NCT02002624|Randomized|Parallel Assignment||Treatment||Single||||||t
1422217|NCT02002611|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422218|NCT02002598||Single Group Assignment||Treatment||None (Open Label)||||||
1422219|NCT02002585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422220|NCT02002572||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422221|NCT02002559|||Cohort||Prospective|||||||
1422222|NCT02002546|||Case-Only||Prospective|||||||
1422223|NCT02002533|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422224|NCT02002520|||Case Control||Prospective|||||||
1422225|NCT02002507|||Cohort||Prospective|||||||
1422226|NCT02002494|||Cohort||Prospective|||||||
1422227|NCT02002481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422228|NCT02002468|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1422229|NCT02002455||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422230|NCT02002442|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422231|NCT02002429|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422232|NCT02002416|||Case Control||Retrospective|||||||
1422233|NCT02002403|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422234|NCT02002390|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422235|NCT02002377||Single Group Assignment||Treatment||None (Open Label)||||||
1422236|NCT02002364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422237|NCT02002351|||Cohort||Prospective|||||||
1422238|NCT02002338|||Case-Only||Cross-Sectional|||||||
1422239|NCT02002325|Randomized|Parallel Assignment||Treatment||Single||||||t
1422240|NCT02002312||Single Group Assignment||Treatment||None (Open Label)||||||
1422241|NCT02002299|||Case-Only||Prospective|||||||
1422242|NCT02002286|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422243|NCT02002273|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422244|NCT02002260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422245|NCT02002247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422246|NCT02002234|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422247|NCT02002221|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422248|NCT02002208|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422249|NCT02002195|||Cohort||Prospective|||||||
1422250|NCT02002182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422251|NCT02002169|Randomized|Parallel Assignment||Prevention||Single||||||t
1422252|NCT02002156|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422253|NCT02002143|Randomized|Parallel Assignment||Treatment||Single||||||t
1422254|NCT02002130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422257|NCT02002091|||Cohort||Prospective|||||||
1422258|NCT02002078|Randomized|Single Group Assignment||Prevention||Single||||t||
1422259|NCT02002065|||Cohort||Prospective|||||||
1422260|NCT02002052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422261|NCT02002039|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422262|NCT02002026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422263|NCT02002013|||Cohort||Cross-Sectional|||||||
1422264|NCT02002000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422265|NCT02001987||Single Group Assignment||Treatment||None (Open Label)||||||
1422266|NCT02001974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422267|NCT02001961|||Case Control||Cross-Sectional|||||||
1422268|NCT02001948|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422269|NCT02001935||Single Group Assignment||||None (Open Label)||||||
1422270|NCT02001922|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1422271|NCT02001909|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1422272|NCT02001896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422273|NCT02001883|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422274|NCT02001870|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422275|NCT02001857|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1422276|NCT02001844|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422277|NCT02001831|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1422278|NCT02001818||Single Group Assignment||Treatment||None (Open Label)||||||
1422279|NCT02001805|||Cohort||Cross-Sectional|||||||
1422280|NCT02001792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422281|NCT02001779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422282|NCT02001766|Randomized|Parallel Assignment||Prevention||Single|||t|||
1422283|NCT02001753|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1422284|NCT02001740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422285|NCT02001727|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422286|NCT02001714|Randomized|Parallel Assignment||Treatment||Double|The randomization schedule will be concealed so that investigators and staff at the sites will not be able to anticipate experimental group assignments. Evaluators at each site will be blind to group assignment throughout all assessments.||||t|t
1422287|NCT02001701||Single Group Assignment||Treatment||None (Open Label)||||||
1422288|NCT02001688|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422289|NCT02001675||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422290|NCT02001662|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1422291|NCT02001649|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1422292|NCT02001636|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1422293|NCT02001623||Single Group Assignment||Treatment||None (Open Label)||||||
1422294|NCT02001610|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1422295|NCT02001597|||Cohort||Prospective|||||||
1422296|NCT02001584||||||||||||
1422297|NCT02001571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422298|NCT02001558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422299|NCT02001545|||Cohort||Prospective|||||||
1422300|NCT02001532|||Case-Control||Prospective|||||||
1422301|NCT02001519||Single Group Assignment||Treatment||None (Open Label)||||||
1422302|NCT02001506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422303|NCT02001493|||Cohort||Prospective|||||||
1422304|NCT02001480||Single Group Assignment||Prevention||None (Open Label)||||||
1422305|NCT02001467|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1422306|NCT02001454|||Case-Only||Prospective|||||||
1422307|NCT02001441|||Cohort||Prospective|||||||
1422308|NCT02001428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422309|NCT02001415|Randomized|Parallel Assignment||Treatment||Single||||||t
1422310|NCT02001402|||Case Control||Cross-Sectional|||||||
1422311|NCT02001389|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1422312|NCT02001376|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1422313|NCT02001363|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1422314|NCT02001350|||Cohort||Cross-Sectional|||||||
1422315|NCT02001337|||Cohort||Prospective|||||||
1422316|NCT02001324|Randomized|Parallel Assignment||||None (Open Label)||||||
1422317|NCT02001311||Single Group Assignment||Prevention||None (Open Label)||||||
1422318|NCT02001298|Randomized|Parallel Assignment||||None (Open Label)||||||
1422319|NCT02001285|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422320|NCT02001272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422321|NCT02001259|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1422322|NCT02001246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422323|NCT02001233|||Case Control||Prospective|||||||
1422324|NCT02001220|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1422325|NCT02001207|||Cohort||Prospective|||||||
1422326|NCT02001194|Randomized|Parallel Assignment||||Single|||t|||
1422327|NCT02001181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422328|NCT02001168|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422329|NCT02001155|||Case Control||Prospective|||||||
1422330|NCT02001142|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1422331|NCT02001129|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1422332|NCT02001116|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1422333|NCT02001103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422334|NCT02001090|||Case-Only||Prospective|||||||
1422335|NCT02001077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422336|NCT02001064|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1422337|NCT02001051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422338|NCT02001038|||Case-Only|||||||||
1422339|NCT02001025|||Cohort||Prospective|||||||
1422340|NCT02001012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422341|NCT02000999|||Cohort||Retrospective|||||||
1422342|NCT02000986||Single Group Assignment||Supportive Care||None (Open Label)||||||
1422343|NCT02000973|Randomized|Parallel Assignment||Treatment||Single||||||t
1422344|NCT02000960||Single Group Assignment||Treatment||None (Open Label)||||||
1422345|NCT02000947|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422346|NCT02000934||Single Group Assignment||Treatment||None (Open Label)||||||
1422347|NCT02000921|Randomized|Parallel Assignment||Other||Double|||t||t|
1422348|NCT02000908|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1422349|NCT02000895|||Cohort||Cross-Sectional|||||||
1422350|NCT02000882||Single Group Assignment||Treatment||None (Open Label)||||||
1422351|NCT02000869|||Cohort||Prospective|||||||
1422352|NCT02000856|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1422353|NCT02000843||Single Group Assignment||Treatment||None (Open Label)||||||
1422354|NCT02000830|||Cohort||Prospective|||||||
1422355|NCT02000817|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422356|NCT02000804||Single Group Assignment||Treatment||None (Open Label)||||||
1422357|NCT02000791|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1422358|NCT02000778||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422359|NCT02000765|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422360|NCT02000752|Randomized|Parallel Assignment||Prevention||Single|||t|||
1422361|NCT02000739||Single Group Assignment||Treatment||None (Open Label)||||||
1422362|NCT02000726||Single Group Assignment||||Single|||t|||
1422363|NCT02000713|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1422364|NCT02000700|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422365|NCT02000687|||Other||Prospective|||||||
1422366|NCT02000674|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422367|NCT02000661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422368|NCT02000648|||Cohort||Prospective|||||||
1422369|NCT02000635|||Other||Prospective|||||||
1422370|NCT02000622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422371|NCT02000609|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1422372|NCT02000596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422373|NCT02000583|Randomized|Parallel Assignment||Prevention||Single||||||t
1422374|NCT02000570||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422375|NCT02000557|||Case-Only||Cross-Sectional|||||||
1422376|NCT02000544||Single Group Assignment||Treatment||None (Open Label)||||||
1422377|NCT02000531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422378|NCT02000518|||Cohort||Prospective|||||||
1422379|NCT02000505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422380|NCT02000492|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1422381|NCT02000479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422382|NCT02000466|||Cohort||Prospective|||||||
1422383|NCT02000453||Single Group Assignment||Treatment||None (Open Label)||||||
1422384|NCT02000440||Single Group Assignment||Treatment||None (Open Label)||||||
1422385|NCT02000427||Single Group Assignment||Treatment||None (Open Label)||||||
1422386|NCT02000414||Single Group Assignment||Treatment||None (Open Label)||dose-finding study||||
1422387|NCT02000401||Single Group Assignment||Treatment||None (Open Label)||||||
1422388|NCT02000388|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422389|NCT02000375||Single Group Assignment||Treatment||None (Open Label)||||||
1422390|NCT02000362||Single Group Assignment||Treatment||None (Open Label)||||||
1422391|NCT02000349|Randomized|Parallel Assignment||Screening||Single||||||t
1422392|NCT02000336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422393|NCT02000323|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1422394|NCT02000310|||Cohort||Prospective|||||||
1422395|NCT02000297|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422396|NCT02000284|||Case-Control||Prospective|||||||
1422397|NCT02000271|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422398|NCT02000258|Non-Randomized|Single Group Assignment||Treatment||Double|||||t|t
1422399|NCT02000245|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422400|NCT02000232|||Case-Only||Prospective|||||||
1422401|NCT02000219||Single Group Assignment||Treatment||None (Open Label)||||||
1422402|NCT02000206|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422403|NCT02000193||Single Group Assignment||Treatment||None (Open Label)||||||
1422404|NCT02000180|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1422405|NCT02000167|||Case Control||Prospective|||||||
1422406|NCT02000154||Single Group Assignment||Treatment||None (Open Label)||||||
1422407|NCT02000141|||Cohort||Prospective|||||||
1422408|NCT02000128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422409|NCT02000115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422410|NCT02000102|||Cohort||Retrospective|||||||
1422411|NCT02000089|||Cohort||Prospective|||||||
1422412|NCT02000076|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1422413|NCT02000063|||Cohort||Prospective|||||||
1422414|NCT02000050||Single Group Assignment||Treatment||None (Open Label)||||||
1422415|NCT02000037|Randomized|Parallel Assignment||||None (Open Label)||||||
1422416|NCT02000024|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422417|NCT02000011|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422418|NCT01999998|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422419|NCT01999985|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422420|NCT01999972|Non-Randomized|||Treatment||None (Open Label)||||||
1422421|NCT01999959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422422|NCT01999946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422423|NCT01999933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422424|NCT01999920|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422425|NCT01999907|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422426|NCT01999894||Single Group Assignment||Treatment||None (Open Label)||||||
1422427|NCT01999881|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422428|NCT01999868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422429|NCT01999855|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1422430|NCT01999842|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1422431|NCT01999829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422432|NCT01999816|Randomized|Parallel Assignment||Prevention||Single||||||t
1422433|NCT01999803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422434|NCT01999790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422435|NCT01999777|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422436|NCT01999764|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422437|NCT01999751|||Cohort||Prospective|||||||
1422438|NCT01999738|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422439|NCT01999725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422440|NCT01999712|||Case-Only||Prospective|||||||
1422441|NCT01999699||Single Group Assignment||Basic Science||None (Open Label)||||||
1422442|NCT01999686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422443|NCT01999673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422444|NCT01999660|||Case Control||Prospective|||||||
1422445|NCT01999647|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1422446|NCT01999634||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422447|NCT01999621|||Cohort||Prospective|||||||
1422448|NCT01999608|||||Prospective|||||||
1422449|NCT01999595|Randomized|Parallel Assignment||Treatment||Double|The group allocation for each participant was sealed in an envelope prepared by an investigator. Just before the start of the second visit, a second investigator opened the envelope to confirm the allocation of TENS groups for individual participants and applied the TENS. For better blinding, a third investigator assessed the blunt pressure pain threshold (BPPT) for the baseline value.|"One hundred eighty participants (equal number of females and males, Fig. 1) were randomly assigned into six groups with the following TENS characteristics. (1) Group 1:~control group, (2) group 2: sham group, (3) group 3: high frequency (80 pps)/large pad (5 cm x 10 cm) group, (4) group 4: low frequency (3 pps)/large pad (5 cm x 10 cm) group, (5) group 5: high frequency (80 pps)/small pad (5 cm x 2.5 cm) group, and (6) group 6: low frequency (3 pps)/small pad (5 cm x 2.5 cm) group."|t||t|
1422450|NCT01999582|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422451|NCT01999569|Randomized|Crossover Assignment||Diagnostic||Triple||||t|t|t
1422452|NCT01999556|||Other||Prospective|||||||
1422453|NCT01999543|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1422454|NCT01999530||Single Group Assignment||Basic Science||None (Open Label)||||||
1422455|NCT01999517|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1422456|NCT01999504|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1422457|NCT01999478|||Cohort||Prospective|||||||
1422458|NCT01999465|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1422459|NCT01999452|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422460|NCT01999439||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422461|NCT01999426|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1422462|NCT01999413||Single Group Assignment||Treatment||None (Open Label)||||||
1422463|NCT01999400|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1422464|NCT01999387|||Cohort||Cross-Sectional|||||||
1422465|NCT01999374|||Other||Prospective|||||||
1422466|NCT01999361||Single Group Assignment||Prevention||None (Open Label)||||||
1422467|NCT01999348|||Case-Only||Prospective|||||||
1422468|NCT01999335|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422469|NCT01999322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422470|NCT01999309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422471|NCT01999296|||Cohort||Prospective|||||||
1422472|NCT01999283|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422473|NCT01999270||Single Group Assignment||Treatment||None (Open Label)||||||
1422474|NCT01999257|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1422475|NCT01999244|Randomized|Parallel Assignment||Treatment||Single||||||t
1422476|NCT01999231|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1422477|NCT01999218|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422478|NCT01999205||Single Group Assignment||||None (Open Label)||||||
1422479|NCT01999192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422480|NCT01999179||Single Group Assignment||Health Services Research||None (Open Label)||||||
1422481|NCT01999166|||Family-Based||Cross-Sectional|||||||
1422482|NCT01999153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422483|NCT01999140|||Cohort||Prospective|||||||
1422484|NCT01999114|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422485|NCT01999101||Single Group Assignment||Treatment||None (Open Label)||||||
1422486|NCT01999088|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1422487|NCT01999075|Randomized|Parallel Assignment||Treatment||Single|||||t|
1422488|NCT01999062||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422489|NCT01999049|||Case-Only||Prospective|||||||
1422490|NCT01999036|||Cohort||Prospective|||||||
1422491|NCT01999023|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422492|NCT01999010|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422493|NCT01998997|Randomized|Parallel Assignment||Prevention||Single|||t|||
1422494|NCT01998984|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422495|NCT01998971|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422496|NCT01998958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422497|NCT01998945|Randomized|Parallel Assignment||Treatment||Single||||||t
1422498|NCT01998932|||Cohort||Prospective|||||||
1422499|NCT01998919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422500|NCT01998906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422501|NCT01998893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422502|NCT01998880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422503|NCT01998867|||Cohort||Prospective|||||||
1422504|NCT01998854|||Cohort||Prospective|||||||
1422505|NCT01998841|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422506|NCT01998828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422507|NCT01998815|||Cohort||Prospective|||||||
1422508|NCT01998802|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422509|NCT01998789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422510|NCT01998776|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1422511|NCT01998763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422512|NCT01998750|||Cohort||Prospective|||||||
1422513|NCT01998737|||Cohort||Cross-Sectional|||||||
1422514|NCT01998724|Randomized|Parallel Assignment||Other||Single||||||t
1422515|NCT01998711|Randomized|Parallel Assignment||||Single|||||t|
1422516|NCT01998698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422517|NCT01998685|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1422518|NCT01998672|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422519|NCT01998659|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422520|NCT01998646|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1422521|NCT01998633||Single Group Assignment||Treatment||None (Open Label)||||||
1422522|NCT01998620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422523|NCT01998607|||Other||Cross-Sectional|||||||
1422524|NCT01998594|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422525|NCT01998581|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422526|NCT01998568|||Case-Only||Cross-Sectional|||||||
1422527|NCT01998555|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422528|NCT01998542|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422529|NCT01998529||Single Group Assignment||Treatment||None (Open Label)||||||
1422530|NCT01998516|||Other||Cross-Sectional|||||||
1422531|NCT01998503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422532|NCT01998490|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422533|NCT01998477|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1422534|NCT01998464|||Case-Control||Prospective|||||||
1422535|NCT01998451|Randomized|Single Group Assignment||Prevention||Single|||t|||
1422536|NCT01998438|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422537|NCT01998425|||Cohort||Prospective|||||||
1422538|NCT01998412|||Case-Only||Prospective|||||||
1422539|NCT01998399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422540|NCT01998386|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422541|NCT01998373|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422542|NCT01998360|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422543|NCT01998347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422544|NCT01998334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422545|NCT01998321|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1422546|NCT01998308|||Ecologic or Community||Prospective|||||||
1422547|NCT01998295||Single Group Assignment||Treatment||None (Open Label)||||||
1422548|NCT01998282|||Cohort||Prospective|||||||
1422549|NCT01998269|||Cohort||Cross-Sectional|||||||
1422550|NCT01998256|Randomized|Crossover Assignment||Treatment||Single|||t|||
1422551|NCT01998243|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422552|NCT01998230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422553|NCT01998217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422554|NCT01998204|||Case Control||Prospective|||||||
1422555|NCT01998191|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1422556|NCT01998165||Single Group Assignment||Treatment||None (Open Label)||||||
1422557|NCT01998152|Randomized|Parallel Assignment||Treatment||Single||||t||
1422558|NCT01998139|||Cohort||Retrospective|||||||
1422559|NCT01998126|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422561|NCT01998100|Randomized|Parallel Assignment||Treatment||Single||||||t
1422562|NCT01998087|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1422563|NCT01998074||Single Group Assignment||Treatment||||||||
1422564|NCT01998061|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422565|NCT01998048|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422566|NCT01998035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422567|NCT01998022|||||Prospective|||||||
1422568|NCT01998009||Single Group Assignment||Screening||None (Open Label)||||||
1422569|NCT01997996|||Cohort||Prospective|||||||
1422570|NCT01997983||Single Group Assignment||Treatment||None (Open Label)||||||
1422571|NCT01997970|Randomized|Parallel Assignment||Treatment||Single||||||t
1422572|NCT01997957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422573|NCT01997944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422574|NCT01997931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422575|NCT01997918|||Cohort||Retrospective|||||||
1422576|NCT01997905||Single Group Assignment||Treatment||None (Open Label)||||||
1422577|NCT01997892|||Cohort|||||||||
1422578|NCT01997879||Single Group Assignment||Treatment||None (Open Label)||||||
1422579|NCT01997866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422580|NCT01997853|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422581|NCT01997840||Single Group Assignment||Treatment||None (Open Label)||||||
1422582|NCT01997827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422583|NCT01997814|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422584|NCT01997801|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1422585|NCT01997788|Randomized|Parallel Assignment||Treatment||Single||||||t
1422586|NCT01997775||Single Group Assignment||Treatment||None (Open Label)||||||
1422587|NCT01997762|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1422588|NCT01997749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422589|NCT01997736||Single Group Assignment||Treatment||None (Open Label)||||||
1422590|NCT01997723|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1422591|NCT01997710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422592|NCT01997697||Single Group Assignment||Basic Science||None (Open Label)||||||
1422593|NCT01997684|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422594|NCT01997671|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1422595|NCT01997658|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1422596|NCT01997645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422597|NCT01997632|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1422598|NCT01997619|||Case-Only||Retrospective|||||||
1422599|NCT01997606|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1422600|NCT01997593||Single Group Assignment||Treatment||Double|||||t|t
1422601|NCT01997580|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1422602|NCT01997567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422603|NCT01997554|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1422604|NCT01997541|||Case Control||Cross-Sectional|||||||
1422605|NCT01997528||Single Group Assignment||Treatment||None (Open Label)||||||
1422606|NCT01997515|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1422607|NCT01997502|||Cohort||Prospective|||||||
1422608|NCT01997489||Single Group Assignment||Treatment||None (Open Label)||||||
1422609|NCT01997476||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422610|NCT01997463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422611|NCT01997450|||Case-Control||Prospective|||||||
1422612|NCT01997437||Single Group Assignment||Treatment||None (Open Label)||||||
1422613|NCT01997424||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422614|NCT01997411|Randomized|Crossover Assignment||Treatment||Quadruple|IM and NG arms are open labeled. NG cohorts, 2mg and 3mg, are quadruple blinded.||t|t|t|t
1422615|NCT01997398|||Case-Only||Prospective|||||||
1422616|NCT01997385|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422617|NCT01997372|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422618|NCT01997359|||Case Control||Prospective|||||||
1422619|NCT01997346|||||Cross-Sectional|||||||
1422620|NCT01997333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422621|NCT01997320|Randomized|Parallel Assignment||Prevention||Single|||||t|
1422622|NCT01997307|||Case Control||Prospective|||||||
1422623|NCT01997294|Randomized|Parallel Assignment||Treatment||Single||||||t
1422624|NCT01997281|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1422625|NCT01997268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422626|NCT01997255||Single Group Assignment||Treatment||None (Open Label)||||||
1422627|NCT01997242|||Cohort||Prospective|||||||
1422628|NCT01997229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422629|NCT01997216|Randomized|Crossover Assignment||||Double|||t||t|
1422630|NCT01997203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422631|NCT01997190||Single Group Assignment||Treatment||None (Open Label)||||||
1422632|NCT01997177||||||||||||
1422633|NCT01997164|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1422634|NCT01997151|Randomized|Parallel Assignment||Prevention||Single|||t|||
1422635|NCT01997138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422636|NCT01997125||Single Group Assignment||Other||None (Open Label)||||||
1422637|NCT01997112|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1422638|NCT01997099|||Case-Only||Prospective|||||||
1422639|NCT01997086|Randomized|Parallel Assignment||Treatment||Single||||||t
1422640|NCT01997073|||Cohort||Prospective|||||||
1422641|NCT01997060||Single Group Assignment||Prevention||None (Open Label)||||||
1422642|NCT01997047|||Case-Only||Prospective|||||||
1422643|NCT01997034|||Case Control||Cross-Sectional|||||||
1422644|NCT01997021|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422645|NCT01997008|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1422646|NCT01996995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422647|NCT01996982||Single Group Assignment||Treatment||None (Open Label)||||||
1422648|NCT01996969||Single Group Assignment||Screening||None (Open Label)||||||
1422649|NCT01996956||Single Group Assignment||Diagnostic||Single||||||t
1422650|NCT01996943|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1422651|NCT01996930|Randomized|Parallel Assignment||Treatment||Single||||||t
1422652|NCT01996917|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422653|NCT01996904|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422654|NCT01996891|Randomized|Crossover Assignment||Treatment||Single||||||t
1422655|NCT01996878|||Case Control||Prospective|||||||
1422656|NCT01996865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422657|NCT01996852|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422658|NCT01996839|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422659|NCT01996826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422660|NCT01996813|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1422661|NCT01996800|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1422662|NCT01996787|Randomized|Parallel Assignment||||None (Open Label)||||||
1422663|NCT01996774|||Case Control||Cross-Sectional|||||||
1422664|NCT01996761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422665|NCT01996748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422666|NCT01996735|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1422667|NCT01996709|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1422668|NCT01996696|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422669|NCT01996683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422670|NCT01996670|||Cohort||Retrospective|||||||
1422671|NCT01996657|||Cohort||Prospective|||||||
1422672|NCT01996644|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422673|NCT01996631|||Cohort||Prospective|||||||
1422674|NCT01996618|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422675|NCT01996605|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1422676|NCT01996592|||Other||Prospective|||||||
1422677|NCT01996579|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1422678|NCT01996566|||Case-Crossover||Prospective|||||||
1422679|NCT01996553|||Cohort||Prospective|||||||
1422680|NCT01996540|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422681|NCT01996527||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422682|NCT01996514|Randomized|Crossover Assignment||Prevention||Single|||t|||
1422683|NCT01996501||||||||||||
1422684|NCT01996488||||||||||||
1422685|NCT01996475||||||||||||
1422686|NCT01996462||||||||||||
1422687|NCT01996449|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1422688|NCT01996436|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1422689|NCT01996423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422690|NCT01996410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422691|NCT01996397||Single Group Assignment||Basic Science||None (Open Label)||||||
1422692|NCT01996384|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422693|NCT01996371|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422694|NCT01996358|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422695|NCT01996345|Randomized|Parallel Assignment||Treatment||None (Open Label)|There is no masking in this study.|||||
1422696|NCT01996332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422697|NCT01996319|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1422698|NCT01996306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422699|NCT01996293|||Case-Only||Prospective|||||||
1422700|NCT01996280|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422701|NCT01996267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422702|NCT01996254|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422703|NCT01996241|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1422704|NCT01996228|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422705|NCT01996215|||Cohort||Prospective|||||||
1422706|NCT01996202|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422707|NCT01996189|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1422708|NCT01996176|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422709|NCT01996163|||Cohort||Retrospective|||||||
1422710|NCT01996150||Single Group Assignment||Treatment||None (Open Label)||||||
1422711|NCT01996137||Single Group Assignment||Treatment||None (Open Label)||1 hour of VASST II training, total 15 sessions over 5 weeks continuously||||
1422712|NCT01996124|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1422713|NCT01996111|Randomized|Factorial Assignment||Treatment||Single|||t|||
1422714|NCT01996098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422715|NCT01996085|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1422716|NCT01996072||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422717|NCT01996059|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422718|NCT01996046|||Case-Only||Prospective|||||||
1422719|NCT01996033|||Cohort||Prospective|||||||
1422720|NCT01996020|||Case-Only||Prospective|||||||
1422721|NCT01996007|||Ecologic or Community||Cross-Sectional|||||||
1422722|NCT01995994|||Case-Only||Prospective|||||||
1422723|NCT01995981|||Case-Only||Prospective|||||||
1422724|NCT01995968|||Case Control||Prospective|||||||
1422725|NCT01995955||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422726|NCT01995942|||Cohort||Prospective|||||||
1422727|NCT01995929|||Case Control||Prospective|||||||
1422728|NCT01995916|Randomized|Parallel Assignment||Treatment||Single|||||t|
1422729|NCT01995903|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1422730|NCT01995890|Randomized|Parallel Assignment||||Double|||||t|t
1422731|NCT01995877|||Case-Only||Prospective|||||||
1422732|NCT01995864|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1422733|NCT01995851|||Case Control||Prospective|||||||
1422734|NCT01995838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422735|NCT01995825|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1422736|NCT01995812|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422737|NCT01995799|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1422738|NCT01995786|Non-Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1422739|NCT01995773|||Cohort||Cross-Sectional|||||||
1422740|NCT01995760|||Cohort||Retrospective|||||||
1422741|NCT01995747|||Case-Only||Retrospective|||||||
1422742|NCT01995734||||||||||||
1422743|NCT01995721||Single Group Assignment||Treatment||None (Open Label)||||||
1422744|NCT01995708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422745|NCT01995695|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422746|NCT01995682|||||Cross-Sectional|||||||
1422747|NCT01995669|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422748|NCT01995656|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1422749|NCT01995643|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1422750|NCT01995630|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422751|NCT01995617|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1422752|NCT01995604|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1422753|NCT01995591|||Cohort||Prospective|||||||
1422754|NCT01995578||Single Group Assignment||Treatment||None (Open Label)||||||
1422755|NCT01995565|||||Prospective|||||||
1422756|NCT01995552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422757|NCT01995539||Single Group Assignment||Treatment||None (Open Label)||||||
1422758|NCT01995526||Single Group Assignment||Basic Science||None (Open Label)||||||
1422759|NCT01995513|Randomized|||Treatment||Quadruple|||t|t|t|t
1422760|NCT01995500|Randomized|Parallel Assignment||Treatment||Single||This is a Drug-Device combination Product|t|||
1422761|NCT01995487|Randomized|Parallel Assignment||Treatment||Single||This is a Drug-Device combination Product.|t|||
1422762|NCT01995474|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1422763|NCT01995461||Single Group Assignment||Supportive Care||None (Open Label)||||||
1422764|NCT01995448|||Cohort||Prospective|||||||
1422765|NCT01995435|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1422766|NCT01995422||Single Group Assignment||Health Services Research||None (Open Label)||||||
1422767|NCT01995409||||Prevention||||||||
1422768|NCT01995396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422769|NCT01995383|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1422770|NCT01995370|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422771|NCT01995357|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1422772|NCT01995344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422773|NCT01995331|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422774|NCT01995318|Randomized|Parallel Assignment||Treatment||Single||||||t
1422775|NCT01995305||||||||||||
1422776|NCT01995292|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1422777|NCT01995279|Randomized|Parallel Assignment||Treatment||Single|||||t|
1422778|NCT01995266||Single Group Assignment||Treatment||None (Open Label)||||||
1422779|NCT01995253|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422780|NCT01995240|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1422781|NCT01995227||Single Group Assignment||Treatment||None (Open Label)||||||
1422782|NCT01995214|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1422783|NCT01995201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422784|NCT01995188|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422785|NCT01995175||Single Group Assignment||Other||None (Open Label)||||||
1422786|NCT01995162||Single Group Assignment||Prevention||None (Open Label)||||||
1422787|NCT01995149||Single Group Assignment||Treatment||None (Open Label)||||||
1422788|NCT01995136||Single Group Assignment||Treatment||None (Open Label)||||||
1422789|NCT01995123|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1422790|NCT01995110|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1422791|NCT01995097|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422792|NCT01995084|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1422793|NCT01995071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422794|NCT01995058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422795|NCT01995045|Randomized|Parallel Assignment||Prevention||Single|||t|||
1422796|NCT01995032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422797|NCT01995019|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422798|NCT01995006|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1422799|NCT01994993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422800|NCT01994980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422801|NCT01994967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422802|NCT01994954|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1422803|NCT01994941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422804|NCT01994928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422805|NCT01994915|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422806|NCT01994902|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1422807|NCT01994889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422808|NCT01994876|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1422809|NCT01994863|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1422810|NCT01994850||||Treatment||||||||
1422811|NCT01994837||Single Group Assignment||Treatment||None (Open Label)||||||
1422812|NCT01994824||Single Group Assignment||Prevention||None (Open Label)||||||
1422813|NCT01994811|||Cohort||Prospective|||||||
1422814|NCT01994798|||Case-Only||Prospective|||||||
1422815|NCT01994785|Randomized|Parallel Assignment||Other||Double|||t|t||
1422816|NCT01994772|Randomized|Single Group Assignment||Treatment||Single||||||t
1422817|NCT01994759|Randomized|Parallel Assignment||Treatment||Single||||||t
1422818|NCT01994746|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422819|NCT01994733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422820|NCT01994720|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1422821|NCT01994707|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1422822|NCT01994694|||Case Control||Cross-Sectional|||||||
1422823|NCT01994681|||Case Control||Cross-Sectional|||||||
1422824|NCT01994668|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1422825|NCT01994655||Single Group Assignment||Health Services Research||Single|||t|||
1422826|NCT01994642|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422827|NCT01994629|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1422828|NCT01994616|||||Prospective|||||||
1422829|NCT01994603|Randomized|Parallel Assignment||Prevention||Single|||t|||
1422830|NCT01994590||Single Group Assignment||Treatment||None (Open Label)||||||
1422831|NCT01994577|||Cohort||Prospective|||||||
1422832|NCT01994564|||Cohort||Prospective|||||||
1422833|NCT01994538|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422834|NCT01994525|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422835|NCT01994512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422836|NCT01994499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422837|NCT01994486||Single Group Assignment||Treatment||None (Open Label)||||||
1422838|NCT01994473|Randomized|Single Group Assignment||Treatment||Single|||t|||
1422839|NCT01994460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422840|NCT01994447|Randomized|Parallel Assignment||||Single||||||t
1422841|NCT01994434||Single Group Assignment||Treatment||Single||||||t
1422842|NCT01994421|Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1422843|NCT01994408||Single Group Assignment||Other||None (Open Label)||default drug escalation||||
1422844|NCT01994395|Randomized|Parallel Assignment||Treatment||Single|A blinded research physical therapist will test the outcome measure at baseline, Mid Testing after Session 9 , at Post Testing after Session 18 and at 3 month follow up testing after Session 18.|The SMA group (task specific training) will be trained to simulate the demands of overground walking. The impairment based group will match the SMA group in intensity but will be focused on balance and other functional goals rather than explicitly on walking. The rationale of this study is to assess task specific training with SMA vs. impairment based training. To this end, we will use the Stride Management Assist device by Honda Corporation and compare it to impairment based physical therapy in outpatient sessions.||||t
1422845|NCT01994382||Single Group Assignment||Treatment||None (Open Label)||||||
1422846|NCT01994369||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422847|NCT01994356|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422848|NCT01994343|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422849|NCT01994330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422850|NCT01994317|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422851|NCT01994304|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422852|NCT01994291|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1422853|NCT01994278||Single Group Assignment||Prevention||Single|||||t|
1422854|NCT01994265|Randomized|Parallel Assignment||Prevention||Single||||||t
1422855|NCT01994252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422856|NCT01994239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422857|NCT01994226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422858|NCT01994213||Single Group Assignment||Treatment||None (Open Label)||||||
1422859|NCT01994200|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422860|NCT01994187|||Case-Only||Prospective|||||||
1422861|NCT01994174|||Cohort||Prospective|||||||
1422862|NCT01994161|||Cohort||Prospective|||||||
1422863|NCT01994148||Single Group Assignment||Treatment||None (Open Label)||||||
1422864|NCT01994135|Randomized|Crossover Assignment||Basic Science||Single||||||t
1422865|NCT01994122|||Case Control||Prospective|||||||
1422866|NCT01994109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422867|NCT01994096||Single Group Assignment||Treatment||None (Open Label)||||||
1422868|NCT01994083|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422869|NCT01994070|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1422870|NCT01994057|||Case-Only||Retrospective|||||||
1422871|NCT01994044||||Treatment||||||||
1422872|NCT01994031|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422873|NCT01994018|||Case Control|||||||||
1422874|NCT01994005|Randomized|Single Group Assignment||||Single|||t|||
1422875|NCT01993992|||Case-Only||Prospective|||||||
1422876|NCT01993979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422877|NCT01993966|||Case-Only||Cross-Sectional|||||||
1422878|NCT01993953|Randomized|Parallel Assignment||Treatment||Single||||||t
1422879|NCT01993940|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422880|NCT01993927|||Cohort||Prospective|||||||
1422881|NCT01993914|||Cohort||Cross-Sectional|||||||
1422882|NCT01993901|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1422883|NCT01993888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422884|NCT01993875|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422885|NCT01993862|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1422886|NCT01993849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422887|NCT01993836|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1422888|NCT01993823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422889|NCT01993810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422890|NCT01993797|||Cohort|||||||||
1422891|NCT01993784||Single Group Assignment||Treatment||None (Open Label)||||||
1422892|NCT01993771|||Cohort||Prospective|||||||
1422893|NCT01993758|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1422894|NCT01993745|||Case Control||Cross-Sectional|||||||
1422895|NCT01993732||Single Group Assignment||Prevention||None (Open Label)||||||
1422896|NCT01993719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422897|NCT01993706|Randomized|Parallel Assignment||Prevention||||||||
1422898|NCT01993693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422899|NCT01993680|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1422900|NCT01993667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422901|NCT01993654|||Cohort||Prospective|||||||
1422902|NCT01993641||Single Group Assignment||Treatment||None (Open Label)||||||
1422903|NCT01993628|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1422904|NCT01993615|Randomized|Parallel Assignment||Treatment||Single||||||t
1422905|NCT01993602|Randomized|Parallel Assignment||Treatment||Single||||||t
1422906|NCT01993589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422907|NCT01993576||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422908|NCT01993563|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422909|NCT01993550|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1422910|NCT01993537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422911|NCT01993524|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1422912|NCT01993511|||Cohort||Prospective|||||||
1422913|NCT01993498||Single Group Assignment||||None (Open Label)||||||
1422914|NCT01993485|||Cohort||Prospective|||||||
1422915|NCT01993472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422916|NCT01993459|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422917|NCT01993446|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422918|NCT01993433|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422919|NCT01993420|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1422920|NCT01993407|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422921|NCT01993394||Single Group Assignment||Basic Science||Single||||||t
1422922|NCT01993381|||Cohort||Prospective|||||||
1422923|NCT01993368|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1422924|NCT01993355|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1422925|NCT01993342|||Cohort||Retrospective|||||||
1422926|NCT01993329|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1422927|NCT01993316||Single Group Assignment||Treatment||None (Open Label)||||||
1422928|NCT01993303|||Case Control||Retrospective|||||||
1422929|NCT01993290|Randomized|Parallel Assignment||Treatment||Single||||||t
1422930|NCT01993277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422931|NCT01993264|||Cohort||Prospective|||||||
1422932|NCT01993251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422933|NCT01993238||Single Group Assignment||Treatment||None (Open Label)||||||
1422934|NCT01993225|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422935|NCT01993212|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1422936|NCT01993199||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422937|NCT01993186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422938|NCT01993173|Randomized|Parallel Assignment||Prevention||Single||||||t
1422939|NCT01993160||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422940|NCT01993147|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1422941|NCT01993134|Randomized|Parallel Assignment||Prevention||Single|||t|||
1422942|NCT01993121||Single Group Assignment||||None (Open Label)||||||
1422943|NCT01993108|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1422944|NCT01993095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422945|NCT01993082|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1422946|NCT01993069||Single Group Assignment||Treatment||None (Open Label)||||||
1422947|NCT01993056|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1422948|NCT01993043|||Other||Prospective|||||||
1422949|NCT01993030|Randomized|Parallel Assignment||Treatment||Single|||t|||
1422950|NCT01993017|Randomized|Parallel Assignment||Screening||Single||||||t
1422951|NCT01993004|||Case Control||Cross-Sectional|||||||
1422952|NCT01992991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422953|NCT01992978|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422954|NCT01992965|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1422955|NCT01992952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1422956|NCT01992939|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1422957|NCT01992926|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1422958|NCT01992913|Randomized|Parallel Assignment||Treatment||Single||||||t
1422959|NCT01992900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422960|NCT01992887|||Ecologic or Community||Prospective|||||||
1422961|NCT01992874|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1422962|NCT01992861||Single Group Assignment||Diagnostic||None (Open Label)||||||
1422963|NCT01992848||Single Group Assignment||Diagnostic||Single|||||t|
1422964|NCT01992835|Randomized|Crossover Assignment||||Single|||t|||
1422965|NCT01992822||Single Group Assignment||Other||None (Open Label)||||||
1422966|NCT01992809|Randomized|Single Group Assignment||Treatment||Double||||t||t
1422967|NCT01992796|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1422968|NCT01992783|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1422969|NCT01992770|Randomized|Parallel Assignment||Treatment||Single||||||t
1422970|NCT01992757|||Cohort||Prospective|||||||
1422971|NCT01992744|||Cohort||Prospective|||||||
1422972|NCT01992731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422973|NCT01992718|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1422974|NCT01992705||Single Group Assignment||Treatment||None (Open Label)||||||
1422975|NCT01992692|||Case Control||Prospective|||||||
1422976|NCT01992679|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1422977|NCT01992666||Single Group Assignment||Other||None (Open Label)||||||
1422978|NCT01992653|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422979|NCT01992640|||Cohort||Prospective|||||||
1422980|NCT01992627||Single Group Assignment||Treatment||None (Open Label)||||||
1422981|NCT01992614|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1422982|NCT01992601|Randomized|Crossover Assignment||||None (Open Label)||||||
1422983|NCT01992588|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1422984|NCT01992575|||Case-Control||Prospective|||||||
1422985|NCT01992562|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1422986|NCT01992549||Single Group Assignment||Treatment||None (Open Label)||||||
1422987|NCT01992536|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1422988|NCT01992523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1422989|NCT01992510|||Case Control||Prospective|||||||
1422990|NCT01992497|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1422991|NCT01992484|||Cohort||Prospective|||||||
1422992|NCT01992471|||Cohort||Prospective|||||||
1422993|NCT01992458|||||Retrospective|||||||
1422994|NCT01992445|||Case Control||Prospective|||||||
1422995|NCT01992432|||Cohort||Prospective|||||||
1422996|NCT01992419|||||Prospective|||||||
1422997|NCT01992406|||Cohort||Prospective|||||||
1422998|NCT01992393|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1422999|NCT01992380|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1423000|NCT01992367|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1423001|NCT01992354||Single Group Assignment||Other||None (Open Label)||||||
1423002|NCT01992341||Single Group Assignment||Treatment||None (Open Label)||||||
1423003|NCT01992328||Single Group Assignment||Treatment||None (Open Label)||||||
1423004|NCT01992315||Single Group Assignment||Treatment||None (Open Label)||||||
1423005|NCT01992302|||Cohort||Prospective|||||||
1423006|NCT01992289|||Other||Prospective|||||||
1423007|NCT01992276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423008|NCT01992263|Randomized|Parallel Assignment||Other||Double|||t|||t
1423009|NCT01992250|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423010|NCT01992237|||Case-Only||Prospective|||||||
1423011|NCT01992224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423012|NCT01992211|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||6 x 3||||
1423013|NCT01992198|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423014|NCT01992185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423015|NCT01992172|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423016|NCT01992159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423017|NCT01992146|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1423018|NCT01992133|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423019|NCT01992120|Randomized|Parallel Assignment||||Single|||t|||
1423020|NCT01992107|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1423021|NCT01992094|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423022|NCT01992081|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423023|NCT01992068|||Case-Only||Prospective|||||||
1423177|NCT01990040|||Other||Prospective|||||||
1423024|NCT01992055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423025|NCT01992042||Single Group Assignment||Treatment||None (Open Label)||||||
1423026|NCT01992029|||Cohort||Prospective|||||||
1423027|NCT01992016|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1423028|NCT01992003|||Cohort||Prospective|||||||
1423029|NCT01991990|Randomized|Parallel Assignment||||Single|||t|||
1423030|NCT01991977||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423031|NCT01991964|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1423032|NCT01991951|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423033|NCT01991938||Single Group Assignment||Treatment||None (Open Label)||||||
1423034|NCT01991925|||||Prospective|||||||
1423035|NCT01991912||Single Group Assignment||Treatment||Double|||t|||t
1423036|NCT01991899|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1423037|NCT01991886||Single Group Assignment||Supportive Care||None (Open Label)||||||
1423038|NCT01991873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423039|NCT01991860|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423040|NCT01991847||Single Group Assignment||Other||None (Open Label)||||||
1423041|NCT01991834|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1423042|NCT01991821|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423043|NCT01991808||Single Group Assignment||Diagnostic||||||||
1423044|NCT01991795|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423045|NCT01991782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423046|NCT01991769|Randomized|Crossover Assignment||Prevention||Single||||||t
1423047|NCT01991756|||Cohort||Prospective|||||||
1423048|NCT01991743|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1423049|NCT01991717|Randomized|Parallel Assignment||Treatment||Single|||||t|
1423050|NCT01991704|||Case-Only||Prospective|||||||
1423051|NCT01991691||Single Group Assignment||Supportive Care||None (Open Label)||||||
1423052|NCT01991678|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423053|NCT01991665|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1423054|NCT01991652|||Cohort||Prospective|||||||
1423055|NCT01991639|Randomized|Parallel Assignment||||None (Open Label)||||||
1423056|NCT01991626|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1423057|NCT01991613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423058|NCT01991600|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1423059|NCT01991587|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423060|NCT01991574|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1423061|NCT01991561|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423062|NCT01991548||Single Group Assignment||Treatment||None (Open Label)||||||
1423063|NCT01991535||||||Single|||t|||
1423064|NCT01991522|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1423065|NCT01991509|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1423066|NCT01991483|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1423067|NCT01991470||Sequential Assignment||Treatment||None (Open Label)||||||
1423068|NCT01991457||Single Group Assignment||Treatment||None (Open Label)||||||
1423069|NCT01991444|||Case-Only||Prospective|||||||
1423070|NCT01991431|||Case-Only||Prospective|||||||
1423071|NCT01991418|||||Prospective|||||||
1423072|NCT01991405|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1423073|NCT01991392|Randomized|Parallel Assignment||||None (Open Label)||||||
1423074|NCT01991379||Single Group Assignment||Treatment||None (Open Label)||||||
1423075|NCT01991366|||Case Control||Retrospective|||||||
1423076|NCT01991353|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423077|NCT01991340|||Cohort||Prospective|||||||
1423078|NCT01991327|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423079|NCT01991314||Single Group Assignment||Treatment||None (Open Label)|This was an open label trial|||||
1423080|NCT01991301||Single Group Assignment||Treatment||None (Open Label)||||||
1423081|NCT01991288|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1423082|NCT01991275|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1423083|NCT01991262|||Cohort||Prospective|||||||
1423084|NCT01991249||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423085|NCT01991236|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423086|NCT01991223|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1423087|NCT01991210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423088|NCT01991197|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1423089|NCT01991184|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423090|NCT01991171|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423091|NCT01991158||Single Group Assignment||Treatment||None (Open Label)||||||
1423092|NCT01991145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423093|NCT01991132||Single Group Assignment||||None (Open Label)||||||
1423094|NCT01991119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423095|NCT01991106|Randomized|Parallel Assignment||Prevention||Single||||||t
1423096|NCT01991093|||||Prospective|||||||
1423097|NCT01991080|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423098|NCT01991067|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423099|NCT01991054|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423100|NCT01991041|||Cohort||Prospective|||||||
1423101|NCT01991028|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1423102|NCT01991015|||||Cross-Sectional|||||||
1423103|NCT01991002||Single Group Assignment||Treatment||None (Open Label)||||||
1423104|NCT01990989|||Cohort||Prospective|||||||
1423105|NCT01990976|||Cohort||Prospective|||||||
1423106|NCT01990963|||Cohort||Prospective|||||||
1423107|NCT01990950||Single Group Assignment||Treatment||None (Open Label)||||||
1423108|NCT01990937|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1423109|NCT01990924|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1423110|NCT01990911|Randomized|Parallel Assignment||Prevention||Single|||t|||
1423111|NCT01990898||Single Group Assignment||Treatment||None (Open Label)||||||
1423112|NCT01990885|Randomized|Crossover Assignment||Treatment||Triple||A Two-Part, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Safety And Systemic Exposure Of Single Escalating Administrations And Repeated Administration Of Bl-7010 In Well-Controlled Celiac Patients|t||t|t
1423113|NCT01990872|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1423114|NCT01990859||Single Group Assignment||Treatment||None (Open Label)||||||
1423115|NCT01990846|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423116|NCT01990833|||Case Control||Prospective|||||||
1423117|NCT01990820|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423118|NCT01990807||Single Group Assignment||Treatment||None (Open Label)||||||
1423119|NCT01990794|||Cohort||Prospective|||||||
1423120|NCT01990781|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423121|NCT01990768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423122|NCT01990755|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423123|NCT01990742|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1423124|NCT01990729|||Cohort||Prospective|||||||
1423125|NCT01990716|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1423126|NCT01990703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423127|NCT01990690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423128|NCT01990677|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1423129|NCT01990664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423130|NCT01990651|||Cohort||Prospective|||||||
1423131|NCT01990638|||Case Control||Prospective|||||||
1423132|NCT01990625|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1423133|NCT01990612|Randomized|Parallel Assignment||Prevention||None (Open Label)||Randomized trial of 6000 women at 38 weeks 0 days to 38 weeks 6 days randomized to one of two arms: elective induction of labor between 39 weeks 0 days and 39 weeks 4 days; or expectant management (unless a medical indication arises) until at least 40 weeks 5 days.||||
1423134|NCT01990599|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1423135|NCT01990586||||||||||||
1423136|NCT01990573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423137|NCT01990560||Single Group Assignment||Treatment||None (Open Label)||||||
1423138|NCT01990547|||Cohort||Prospective|||||||
1423139|NCT01990534||Single Group Assignment||Treatment||None (Open Label)||||||
1423140|NCT01990521||Single Group Assignment||Treatment||None (Open Label)||||||
1423141|NCT01990508|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423142|NCT01990495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423143|NCT01990482|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423144|NCT01990469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423145|NCT01990456|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1423146|NCT01990443|Randomized|Parallel Assignment||||None (Open Label)||||||
1423147|NCT01990430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423148|NCT01990417||Single Group Assignment||Health Services Research||Single|||||t|
1423149|NCT01990404|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1423150|NCT01990391|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1423151|NCT01990378||||||||||||
1423152|NCT01990365|||Case-Only||Prospective|||||||
1423153|NCT01990352||Single Group Assignment||Treatment||None (Open Label)||||||
1423154|NCT01990339|||Cohort||Prospective|||||||
1423155|NCT01990326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423156|NCT01990313||Single Group Assignment||Other||None (Open Label)||||||
1423157|NCT01990300|||Cohort||Prospective|||||||
1423158|NCT01990287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423159|NCT01990274|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1423160|NCT01990261|||Cohort||Prospective|||||||
1423161|NCT01990248|||Cohort||Prospective|||||||
1423162|NCT01990235|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1423163|NCT01990222|||Case-Only||Prospective|||||||
1423164|NCT01990209||Single Group Assignment||Treatment||None (Open Label)||||||
1423165|NCT01990196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423166|NCT01990183|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1423167|NCT01990170|||Cohort||Prospective|||||||
1423168|NCT01990157||Single Group Assignment||Treatment||None (Open Label)||||||
1423169|NCT01990144|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423170|NCT01990131|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423171|NCT01990118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423172|NCT01990105|||Cohort||Prospective|||||||
1423173|NCT01990092|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1423174|NCT01990079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423175|NCT01990066|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423176|NCT01990053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423178|NCT01990027|||Cohort||Prospective|||||||
1423179|NCT01990014|||Case-Only||Prospective|||||||
1423180|NCT01990001|Randomized|Parallel Assignment||||None (Open Label)||||||
1423181|NCT01989988|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423182|NCT01989975|||Case-Only||Prospective|||||||
1423183|NCT01989962|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1423184|NCT01989949||Single Group Assignment||Basic Science||None (Open Label)||||||
1423185|NCT01989936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423186|NCT01989923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423187|NCT01989910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423188|NCT01989897||Single Group Assignment||||Double|||t||t|
1423189|NCT01989884||Single Group Assignment||Treatment||None (Open Label)||||||
1423190|NCT01989871|Non-Randomized|Factorial Assignment||Prevention||Single||||||t
1423191|NCT01989858|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1423192|NCT01989845||Single Group Assignment||Treatment||None (Open Label)||||||
1423193|NCT01989832|||Cohort||Prospective|||||||
1423194|NCT01989819|||Cohort||Prospective|||||||
1423195|NCT01989806|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423196|NCT01989793|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1423197|NCT01989780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423198|NCT01989767|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423199|NCT01989754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423200|NCT01989741||Single Group Assignment||Health Services Research||None (Open Label)||||||
1423201|NCT01989728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423202|NCT01989715||Single Group Assignment||||None (Open Label)||||||
1423203|NCT01989702|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423204|NCT01989689|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1423205|NCT01989676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423206|NCT01989663|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1423207|NCT01989650|Randomized|Parallel Assignment||||Single|||t|||
1423208|NCT01989637|Randomized|Crossover Assignment||||Double|||t||t|
1423209|NCT01989624|||Cohort||Prospective|||||||
1423210|NCT01989611||Single Group Assignment||Prevention||None (Open Label)||||||
1423211|NCT01989598||Single Group Assignment||Treatment||None (Open Label)||||||
1423212|NCT01989585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423213|NCT01989572|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1423214|NCT01989559||Single Group Assignment||Prevention||None (Open Label)||||||
1423215|NCT01989546||Single Group Assignment||Treatment||None (Open Label)||||||
1423216|NCT01989533|Randomized|Parallel Assignment||Prevention||||||||
1423217|NCT01989520|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1423218|NCT01989507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423219|NCT01989494|||Cohort||Prospective|||||||
1423220|NCT01989481|||Cohort||Prospective|||||||
1423221|NCT01989468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423222|NCT01989455|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1423223|NCT01989442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423224|NCT01989429|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423225|NCT01989416|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423226|NCT01989403|||Cohort||Prospective|||||||
1423227|NCT01989390||||||||||||
1423228|NCT01989377||||||||||||
1423229|NCT01989364|||Cohort||Prospective|||||||
1423230|NCT01989351|||Cohort||Prospective|||||||
1423231|NCT01989338|||Case-Only||Prospective|||||||
1423232|NCT01989325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423233|NCT01989312|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1423234|NCT01989299|||Cohort||Prospective|||||||
1423235|NCT01989286|||Case Control||Prospective|||||||
1423236|NCT01989273|||Cohort||Prospective|||||||
1423237|NCT01989260|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1423238|NCT01989247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423239|NCT01989234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423240|NCT01989221|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1423241|NCT01989208|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1423242|NCT01989195||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423243|NCT01989182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423244|NCT01989169|Randomized|Crossover Assignment||||None (Open Label)||||||
1423245|NCT01989156|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1423246|NCT01989143|Randomized|||Basic Science||Double|||t||t|
1423247|NCT01989130|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1423248|NCT01989117|||Case-Control||Prospective|||||||
1423249|NCT01989104|||Other||Cross-Sectional|||||||
1423250|NCT01989091|Randomized|Parallel Assignment||Prevention||Single||||||t
1423251|NCT01989078||Single Group Assignment||Treatment||None (Open Label)||Participants will all receive the study medication in addition to the standard of care treatment. There is no control group for this pilot study.||||
1423252|NCT01989065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423253|NCT01989052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423254|NCT01989039|||Cohort||Retrospective|||||||
1423255|NCT01989026|Randomized|Parallel Assignment||Prevention||Single||||t||
1423256|NCT01989013||Single Group Assignment||Treatment||None (Open Label)||||||
1423257|NCT01989000|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1423258|NCT01988987|||Cohort||Prospective|||||||
1423259|NCT01988974|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423260|NCT01988961||Single Group Assignment||Treatment||None (Open Label)||||||
1423261|NCT01988948||Single Group Assignment||Basic Science||None (Open Label)||||||
1423262|NCT01988935|Randomized|Parallel Assignment||Treatment||Single||||||t
1423263|NCT01988922|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1423264|NCT01988909||Single Group Assignment||Treatment||None (Open Label)||||||
1423265|NCT01988896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423266|NCT01988883|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1423267|NCT01988870||Single Group Assignment||Treatment||None (Open Label)||||||
1423268|NCT01988857||Single Group Assignment||Prevention||None (Open Label)||||||
1423269|NCT01988844|||Cohort||Prospective|||||||
1423270|NCT01988831|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423271|NCT01988818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423272|NCT01988805|||Cohort||Cross-Sectional|||||||
1423273|NCT01988792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423274|NCT01988779|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423275|NCT01988766|||Cohort||Retrospective|||||||
1423276|NCT01988753|||Other||Prospective|||||||
1423277|NCT01988740|||Case-Only||Cross-Sectional|||||||
1423278|NCT01988727||||||||||||
1423279|NCT01988714|Randomized|Single Group Assignment||Treatment||Single|||t|||
1423280|NCT01988701|||Case Control||Cross-Sectional|||||||
1423281|NCT01988688||Single Group Assignment||Treatment||None (Open Label)||||||
1423282|NCT01988675|||Cohort||Prospective|||||||
1423283|NCT01988662|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423284|NCT01988649|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1423285|NCT01988636|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1423286|NCT01988623||Single Group Assignment||Treatment||None (Open Label)||||||
1423287|NCT01988610||Single Group Assignment||Treatment||None (Open Label)||||||
1423288|NCT01988597|||Case Control||Cross-Sectional|||||||
1423289|NCT01988584|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1423290|NCT01988571|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423291|NCT01988558|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423292|NCT01988545|Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1423293|NCT01988532|||Cohort||Cross-Sectional|||||||
1423294|NCT01988519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423295|NCT01988506||Single Group Assignment||Treatment||None (Open Label)||||||
1423296|NCT01988493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423297|NCT01988480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423298|NCT01988467|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1423299|NCT01988454|||Case Control||Cross-Sectional|||||||
1423300|NCT01988441|||Cohort||Prospective|||||||
1423301|NCT01988428|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1423302|NCT01988415||Single Group Assignment||Treatment||Single|||t|||
1423303|NCT01988402|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423304|NCT01988389|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1423305|NCT01988376|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1423306|NCT01988363||Single Group Assignment||Treatment||None (Open Label)||||||
1423307|NCT01988350|||Cohort||Prospective|||||||
1423308|NCT01988337|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1423309|NCT01988324||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423310|NCT01988311|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1423311|NCT01988298|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423312|NCT01988285|||Cohort||Prospective|||||||
1423313|NCT01988272|||Case-Only||Prospective|||||||
1423314|NCT01988259|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423315|NCT01988246|Randomized|Single Group Assignment||Prevention||Single|||t|||
1423316|NCT01988233|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423317|NCT01988220|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423318|NCT01988207|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423319|NCT01988194|Randomized|Parallel Assignment||Treatment||Single||||||t
1423320|NCT01988181|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1423321|NCT01988168|Randomized|Parallel Assignment||Treatment||Single||||||t
1423322|NCT01988155|Randomized|Parallel Assignment||Treatment||Single||||||t
1423323|NCT01988142||Single Group Assignment||Treatment||None (Open Label)||||||
1423324|NCT01988129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423325|NCT01988116|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1423326|NCT01988103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423327|NCT01988090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423328|NCT01988077||Single Group Assignment||Treatment||None (Open Label)||||||
1423329|NCT01988064|Randomized|Parallel Assignment||Prevention||Single||||||t
1423330|NCT01988038|||Cohort||Prospective|||||||
1423331|NCT01988025||||||||||||
1423332|NCT01988012||Single Group Assignment||Treatment||None (Open Label)||||||
1423333|NCT01987999||Single Group Assignment||Treatment||None (Open Label)||||||
1423334|NCT01987986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423335|NCT01987973|Randomized|Parallel Assignment||Treatment||Single||||||t
1423336|NCT01987960|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423337|NCT01987947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423338|NCT01987934|||Case Control||Prospective|||||||
1423339|NCT01987921|||Cohort||Prospective|||||||
1423340|NCT01987908|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423341|NCT01987895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423342|NCT01987882|||Cohort||Prospective|||||||
1423343|NCT01987869|||Case-Only||Cross-Sectional|||||||
1423344|NCT01987856|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423345|NCT01987843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423346|NCT01987830||Single Group Assignment||Basic Science||None (Open Label)||||||
1423347|NCT01987817|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423348|NCT01987804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423349|NCT01987791|||Case Control||Retrospective|||||||
1423350|NCT01987778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423351|NCT01987765|||Cohort||Prospective|||||||
1423352|NCT01987752|||Cohort||Prospective|||||||
1423353|NCT01987739|Randomized|Crossover Assignment||||Triple|||t||t|t
1423354|NCT01987726|||Case-Only||Prospective|||||||
1423355|NCT01987713||Single Group Assignment||Prevention||Single|||||t|
1423356|NCT01987700|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423357|NCT01987687|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1423358|NCT01987674|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423359|NCT01987661|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423360|NCT01987648|||Cohort||Prospective|||||||
1423361|NCT01987635|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423362|NCT01987622|Randomized|Parallel Assignment||Treatment||Single||||||t
1423363|NCT01987609|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423364|NCT01987596|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1423365|NCT01987583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423366|NCT01987570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423367|NCT01987557|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423368|NCT01987544|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423369|NCT01987531||Single Group Assignment||Treatment||None (Open Label)||||||
1423370|NCT01987518|||Cohort||Retrospective|||||||
1423371|NCT01987505||Single Group Assignment||Treatment||None (Open Label)||||||
1423372|NCT01987492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423373|NCT01987479||Single Group Assignment||Treatment||None (Open Label)||||||
1423374|NCT01987466|||Cohort||Prospective|||||||
1423375|NCT01987453|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423376|NCT01987440|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1423377|NCT01987427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423378|NCT01987414|Randomized|Parallel Assignment||Treatment||Single||||||t
1423379|NCT01987401|||Cohort||Cross-Sectional|||||||
1423380|NCT01987388|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1423381|NCT01987375||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423382|NCT01987362|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423383|NCT01987349|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1423384|NCT01987336|||Case-Only||Prospective|||||||
1423385|NCT01987323||Single Group Assignment||Treatment||None (Open Label)||||||
1423386|NCT01987310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423387|NCT01987297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423388|NCT01987284|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1423389|NCT01987271|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423390|NCT01987258|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423391|NCT01987245|||Case-Only||Prospective|||||||
1423392|NCT01987232||Sequential Assignment||Treatment||None (Open Label)||||||
1423393|NCT01987219|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1423394|NCT01987206|Randomized|Crossover Assignment||||None (Open Label)||||||
1423395|NCT01987193|||Cohort||Prospective|||||||
1423396|NCT01987180|||Case Control||Prospective|||||||
1423397|NCT01987167||Single Group Assignment||Treatment||None (Open Label)||||||
1423398|NCT01987154|Randomized|Single Group Assignment||||Triple|||t|t|t|
1423399|NCT01987141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423400|NCT01987128|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1423401|NCT01987115|Randomized|Parallel Assignment||Treatment||Single||||||t
1423402|NCT01987102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423403|NCT01987089|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423404|NCT01987076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423405|NCT01987063|||Cohort||Prospective|||||||
1423406|NCT01987037|||Case-Only||Prospective|||||||
1423407|NCT01987024|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1423408|NCT01987011|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1423409|NCT01986998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423410|NCT01986985||Single Group Assignment||||None (Open Label)||||||
1423411|NCT01986972|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1423412|NCT01986959|Randomized|Parallel Assignment||Prevention||Single|||||t|
1423413|NCT01986946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423414|NCT01986933|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423415|NCT01986920|Randomized|Parallel Assignment||Treatment||Double||The three tests solutions and the placebo solution are each applied topically to 1 of 4 target lesions on the backs of each subject (determined by the randomization schedule). If needed a second treatment may be applied at Visit 5.|t||t|
1423416|NCT01986907||Single Group Assignment||Treatment||None (Open Label)||||||
1423417|NCT01986894|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1423418|NCT01986881|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423419|NCT01986868||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423420|NCT01986855|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423421|NCT01986842|Randomized|Parallel Assignment||Prevention||Single|||t|||
1423422|NCT01986829||Single Group Assignment||Treatment||None (Open Label)||||||
1423423|NCT01986816|||Cohort||Prospective|||||||
1423424|NCT01986803|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423425|NCT01986790|Randomized|Parallel Assignment||Prevention||Single|||t|||
1423426|NCT01986777|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423427|NCT01986764|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1423428|NCT01986751|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423429|NCT01986738|||Cohort||Prospective|||||||
1423430|NCT01986725|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1423431|NCT01986712|||Cohort||Prospective|||||||
1423432|NCT01986699|||||Prospective|||||||
1423433|NCT01986686|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1423434|NCT01986673|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423435|NCT01986660||Single Group Assignment||||None (Open Label)||||||
1423436|NCT01986647|Randomized|Parallel Assignment||Treatment||Single||||||t
1423437|NCT01986634||Single Group Assignment||Treatment||Double|||t|||t
1423438|NCT01986621|||Cohort||Prospective|||||||
1423439|NCT01986608|Randomized|Crossover Assignment||||None (Open Label)||||||
1423440|NCT01986595|||||Cross-Sectional|||||||
1423441|NCT01986582|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423442|NCT01986569||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423443|NCT01986556|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1423444|NCT01986543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423445|NCT01986530|||Cohort||Prospective|||||||
1423446|NCT01986517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423447|NCT01986504|||Cohort||Prospective|||||||
1423448|NCT01986491|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423449|NCT01986478|||Cohort||Prospective|||||||
1423450|NCT01986465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423451|NCT01986452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423452|NCT01986439|||Cohort||Prospective|||||||
1423453|NCT01986426|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423454|NCT01986413|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423455|NCT01986400|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1423456|NCT01986387|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1423457|NCT01986374||Single Group Assignment||Treatment||None (Open Label)||||||
1423458|NCT01986361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423459|NCT01986348|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423460|NCT01986335|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1423461|NCT01986322|Randomized|Parallel Assignment||Prevention||Single||||||t
1423462|NCT01986309|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1423463|NCT01986296||Single Group Assignment||Treatment||None (Open Label)||||||
1423464|NCT01986283|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1423465|NCT01986270|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423466|NCT01986257||Single Group Assignment||Treatment||None (Open Label)||||||
1423467|NCT01986244|||Cohort||Prospective|||||||
1423468|NCT01986231||Single Group Assignment||Basic Science||None (Open Label)||||||
1423469|NCT01986218|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423470|NCT01986205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423471|NCT01986192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423472|NCT01986179|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1423473|NCT01986166|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423474|NCT01986153|||Case Control||Cross-Sectional|||||||
1423475|NCT01986140|Randomized|Parallel Assignment||Treatment||Single|One blinded observer assesses the patient outcome|||t||
1423476|NCT01986127|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423477|NCT01986114||Single Group Assignment||Treatment||None (Open Label)||||||
1423478|NCT01986101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423479|NCT01986088|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423480|NCT01986075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423481|NCT01986062|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1423482|NCT01986049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423483|NCT01986036|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1423484|NCT01986023|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1423485|NCT01986010|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1423486|NCT01985997|||||Prospective|||||||
1423487|NCT01985984|||Cohort||Prospective|||||||
1423488|NCT01985971||||Diagnostic||||||||
1423489|NCT01985958||Single Group Assignment||Diagnostic||||||||
1423490|NCT01985945|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423491|NCT01985932||Single Group Assignment||Diagnostic||||||||
1423492|NCT01985919||||Diagnostic||||||||
1423493|NCT01985906||Single Group Assignment||Treatment||None (Open Label)||||||
1423494|NCT01985893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423495|NCT01985880|||Case-Control||Prospective|||||||
1423496|NCT01985867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423497|NCT01985854|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423498|NCT01985841||Single Group Assignment||Treatment||None (Open Label)||||||
1423499|NCT01985828|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423500|NCT01985815|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1423501|NCT01985802||Single Group Assignment||Treatment||None (Open Label)||||||
1423502|NCT01985789|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1423503|NCT01985776|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1423504|NCT01985763||Single Group Assignment||Treatment||None (Open Label)||||||
1423505|NCT01985750|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1423506|NCT01985737|||Case Control||Prospective|||||||
1423507|NCT01985724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423508|NCT01985711|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1423509|NCT01985698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423510|NCT01985685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423511|NCT01985672|||Cohort||Prospective|||||||
1423512|NCT01985659|||Cohort||Retrospective|||||||
1423513|NCT01985646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423514|NCT01985633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423515|NCT01985620|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423516|NCT01985607|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1423517|NCT01985594|Randomized|Parallel Assignment||Prevention||Single|||t|||
1423518|NCT01985581|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1423519|NCT01985568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423520|NCT01985555||Single Group Assignment||Treatment||None (Open Label)||||||
1423521|NCT01985542|Non-Randomized|Factorial Assignment||Basic Science||Single|||||t|
1423522|NCT01985529|Randomized|Single Group Assignment||Treatment||Single||||||t
1423523|NCT01985516|Randomized|Parallel Assignment||||None (Open Label)||||||
1423524|NCT01985503|||Cohort||Prospective|||||||
1423525|NCT01985490||Single Group Assignment||Treatment||None (Open Label)||||||
1423526|NCT01985477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423527|NCT01985464||Single Group Assignment||Treatment||None (Open Label)||||||
1423528|NCT01985451||Single Group Assignment||Treatment||None (Open Label)||||||
1423529|NCT01985438|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423530|NCT01985425|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423531|NCT01985412|||Cohort||Prospective|||||||
1423532|NCT01985399|||Cohort||Prospective|||||||
1423533|NCT01985386|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1423534|NCT01985373||Single Group Assignment||Treatment||None (Open Label)||||||
1423535|NCT01985360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423536|NCT01985347|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1423537|NCT01985334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423538|NCT01985321|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423539|NCT01985308|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423540|NCT01985295||Single Group Assignment||Treatment||None (Open Label)||||||
1423541|NCT01985282|||||Cross-Sectional|||||||
1423542|NCT01985269|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423543|NCT01985256||Single Group Assignment||Treatment||None (Open Label)||||||
1423544|NCT01985243|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423545|NCT01985230||Single Group Assignment||Treatment||None (Open Label)||||||
1423546|NCT01985217|||||Prospective|||||||
1423547|NCT01985204|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1423548|NCT01985191|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423549|NCT01985178||Single Group Assignment||Treatment||None (Open Label)||||||
1423550|NCT01985165||Single Group Assignment||Treatment||None (Open Label)||||||
1423551|NCT01985152|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1423552|NCT01985139|Non-Randomized|Parallel Assignment||Screening||Single|||t|||
1423553|NCT01985126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423554|NCT01985113|||Cohort||Prospective|||||||
1423555|NCT01985100||Single Group Assignment||Treatment||None (Open Label)||||||
1423556|NCT01985087||Single Group Assignment||Treatment||None (Open Label)||||||
1423557|NCT01985074|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423558|NCT01985061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423559|NCT01985048|||Cohort||Prospective|||||||
1423560|NCT01985035|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423561|NCT01985022|Randomized|Parallel Assignment||Treatment||Single||||||t
1423562|NCT01985009||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423563|NCT01984996||Single Group Assignment||Treatment||None (Open Label)||||||
1423564|NCT01984983|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423565|NCT01984970|||||Prospective|||||||
1423566|NCT01984957||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423567|NCT01984944|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1423568|NCT01984931|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1423569|NCT01984918|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1423570|NCT01984905|||Cohort||Prospective|||||||
1423571|NCT01984892||Single Group Assignment||Treatment||None (Open Label)||||||
1423572|NCT01984879|||Case-Only||Prospective|||||||
1423573|NCT01984866|||Case-Only||Prospective|||||||
1423574|NCT01984853|||Cohort||Prospective|||||||
1423575|NCT01984840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423576|NCT01984827|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1423577|NCT01984814|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423578|NCT01984801|Randomized|Single Group Assignment||Treatment||Single|||t|||
1423579|NCT01984788|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1423580|NCT01984775|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423581|NCT01984762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423582|NCT01984749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423583|NCT01984736||Single Group Assignment||Treatment||None (Open Label)||||||
1423584|NCT01984723||Single Group Assignment||Treatment||None (Open Label)||||||
1423585|NCT01984710||Single Group Assignment||Treatment||None (Open Label)||||||
1423586|NCT01984697|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423587|NCT01984684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423588|NCT01984671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423589|NCT01984658||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1423590|NCT01984645|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1423591|NCT01984632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423592|NCT01984619|||Cohort||Prospective|||||||
1423593|NCT01984606|Randomized|Parallel Assignment||Treatment||Double||||||
1423594|NCT01984593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423595|NCT01984580|Randomized|Parallel Assignment||Prevention||Single|||t|||
1423596|NCT01984567|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1423597|NCT01984554|||Cohort||Prospective|||||||
1423598|NCT01984541||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423599|NCT01984528||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423600|NCT01984515||Single Group Assignment||Treatment||None (Open Label)||||||
1423601|NCT01984502||Single Group Assignment||Treatment||None (Open Label)||||||
1423602|NCT01984489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423603|NCT01984476|||Case-Control||Cross-Sectional|||||||
1423604|NCT01984463|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423605|NCT01984450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423606|NCT01984437|||Cohort||Prospective|||||||
1423607|NCT01984424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423608|NCT01984411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423609|NCT01984398|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1423610|NCT01984385|||Cohort||Prospective|||||||
1423611|NCT01984372|||Cohort||Prospective|||||||
1423612|NCT01984359||||Diagnostic||||||||
1423613|NCT01984346|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423614|NCT01984333|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423615|NCT01984320|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423616|NCT01984307|||Cohort||Retrospective|||||||
1423617|NCT01984294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423618|NCT01984281|Randomized|Parallel Assignment||Other||Single||||||t
1423619|NCT01984268|Randomized|Parallel Assignment||Treatment||Single||||||t
1423620|NCT01984255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423621|NCT01984242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423622|NCT01984229|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423623|NCT01984216|Randomized|Parallel Assignment||||None (Open Label)||||||
1423624|NCT01984203|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423625|NCT01984190|||Cohort||Prospective|||||||
1423626|NCT01984177|||Case Control||Cross-Sectional|||||||
1423627|NCT01984164|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1423628|NCT01984151||||||||||||
1423629|NCT01984138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423630|NCT01984125|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1423631|NCT01984112|Randomized|Parallel Assignment||Treatment||Single||||||t
1423632|NCT01984099|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1423633|NCT01984086|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423634|NCT01984073|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1423635|NCT01984060|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1423636|NCT01984047|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1423637|NCT01984034|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1423638|NCT01984021|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423639|NCT01984008|Randomized|Parallel Assignment||Treatment||Single||||||t
1423640|NCT01983995|||Cohort||Prospective|||||||
1423641|NCT01983982|||Cohort||Prospective|||||||
1423642|NCT01983969||Single Group Assignment||Treatment||None (Open Label)||||||
1423643|NCT01983956|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1423644|NCT01983943|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1423645|NCT01983930|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423646|NCT01983917||Single Group Assignment||Supportive Care||None (Open Label)||||||
1423647|NCT01983904|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1423648|NCT01983891||Single Group Assignment||Prevention||None (Open Label)||||||
1423649|NCT01983878||Single Group Assignment||Treatment||None (Open Label)||||||
1423650|NCT01983865||Single Group Assignment||Basic Science||Single|||t|||
1423651|NCT01983852|||Cohort||Retrospective|||||||
1423652|NCT01983839|||Case-Only||Cross-Sectional|||||||
1423653|NCT01983826|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1423654|NCT01983813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423655|NCT01983800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423656|NCT01983787|||Case-Only||Prospective|||||||
1423657|NCT01983774|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423658|NCT01983761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423659|NCT01983748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423660|NCT01983735|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423661|NCT01983722||||||||||||
1423662|NCT01983709||Single Group Assignment||Treatment||None (Open Label)||||||
1423663|NCT01983696|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423664|NCT01983683|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423665|NCT01983670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423666|NCT01983657|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423667|NCT01983644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423668|NCT01983631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423669|NCT01983618|Randomized|Parallel Assignment||Prevention||Single||||||t
1423670|NCT01983605||Single Group Assignment||Basic Science||None (Open Label)||||||
1423671|NCT01983592|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1423672|NCT01983579|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1423673|NCT01983566|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423674|NCT01983553|||Cohort||Prospective|||||||
1423675|NCT01983540|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423676|NCT01983527|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423677|NCT01983514|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1423678|NCT01983501||Single Group Assignment||Treatment||None (Open Label)||||||
1423679|NCT01983488|||Cohort||Retrospective|||||||
1423680|NCT01983475|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423681|NCT01983462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423682|NCT01983449||Single Group Assignment||Treatment||None (Open Label)||||||
1423683|NCT01983436|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423684|NCT01983423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423685|NCT01983410|||Cohort||Prospective|||||||
1423686|NCT01983397|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1423687|NCT01983384|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1423688|NCT01983371||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423689|NCT01983358|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1423690|NCT01983345|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423691|NCT01983332|||Cohort||Prospective|||||||
1423692|NCT01983319|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1423693|NCT01983306|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1423694|NCT01983293|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423695|NCT01983280||Single Group Assignment||Treatment||None (Open Label)||||||
1423696|NCT01983267|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1423697|NCT01983254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423698|NCT01983241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423699|NCT01983228|Randomized|Parallel Assignment||Treatment||Double||Intervention participants will receive a pedometer-mediated walking intervention that will incorporate Action Planning and the use of MI and CBT techniques. The intervention will be delivered in 6 telephone counseling sessions over three months.|||t|t
1423700|NCT01983215||Single Group Assignment||Treatment||None (Open Label)||||||
1423701|NCT01983202|||Cohort||Prospective|||||||
1423702|NCT01983189||Single Group Assignment||Treatment||Double|||t|||t
1423703|NCT01983176|||Case-Only||Retrospective|||||||
1423704|NCT01983163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423705|NCT01983150|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1423706|NCT01983137|||Cohort||Prospective|||||||
1423707|NCT01983124||Single Group Assignment||Treatment||None (Open Label)||||||
1423708|NCT01983111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423709|NCT01983098|||||Prospective|||||||
1423710|NCT01983085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423711|NCT01983072|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1423712|NCT01983059|||Cohort||Prospective|||||||
1423713|NCT01983046|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1423714|NCT01983033|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423715|NCT01983020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423716|NCT01983007|Randomized|Single Group Assignment||Diagnostic||Double||||t|t|
1423717|NCT01982994|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1423718|NCT01982981|Randomized|Parallel Assignment||||Single|||t|||
1423719|NCT01982968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423720|NCT01982955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423721|NCT01982942|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423722|NCT01982929|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423723|NCT01982916|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423724|NCT01982903|||Cohort||Prospective|||||||
1423725|NCT01982890|||Cohort||Prospective|||||||
1423726|NCT01982877|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423727|NCT01982864||Single Group Assignment||||None (Open Label)||||||
1423728|NCT01982851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423729|NCT01982838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423730|NCT01982825|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423731|NCT01982812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423732|NCT01982799|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1423733|NCT01982786|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1423734|NCT01982773|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423735|NCT01982760|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423736|NCT01982747|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1423737|NCT01982734|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1423738|NCT01982721||||||||||||
1423739|NCT01982708|||Case-Only||Prospective|||||||
1423740|NCT01982695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423741|NCT01982682||Single Group Assignment||Treatment||None (Open Label)||||||
1423742|NCT01982669|||Ecologic or Community||Cross-Sectional|||||||
1423743|NCT01982656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423744|NCT01982643||Single Group Assignment||Treatment||None (Open Label)||||||
1423745|NCT01982630|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423746|NCT01982617|Randomized|Parallel Assignment||||Single||||||t
1423747|NCT01982604|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423748|NCT01982591|||Cohort||Prospective|||||||
1423749|NCT01982578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423750|NCT01982565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423751|NCT01982552|||Cohort||Prospective|||||||
1423752|NCT01982539||Single Group Assignment||Treatment||None (Open Label)||||||
1423753|NCT01982526|||Cohort||Prospective|||||||
1423754|NCT01982513|||Case-Only||Prospective|||||||
1423755|NCT01982500|||Cohort||Other|||||||
1423756|NCT01982487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423757|NCT01982474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423758|NCT01982461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423759|NCT01982448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423760|NCT01982435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423761|NCT01982422|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423762|NCT01982409||Single Group Assignment||Prevention||None (Open Label)||||||
1423763|NCT01982396|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423764|NCT01982383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423765|NCT01982357|||Case-Only||Cross-Sectional|||||||
1423766|NCT01982344|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423767|NCT01982331|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423768|NCT01982318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423769|NCT01982305|Randomized|Parallel Assignment||Treatment||Single||||||t
1423770|NCT01982292|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1423771|NCT01982279|||Cohort||Cross-Sectional|||||||
1423772|NCT01982266||Single Group Assignment||Treatment||None (Open Label)||||||
1423773|NCT01982253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423774|NCT01982240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423775|NCT01982227|||||Prospective|||||||
1423776|NCT01982214|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423777|NCT01982201|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1423778|NCT01982188|||Cohort||Prospective|||||||
1423779|NCT01982175||Single Group Assignment||Treatment||None (Open Label)||||||
1423780|NCT01982162|||Cohort||Prospective|||||||
1423781|NCT01982149|||Case-Control||Prospective|||||||
1423782|NCT01982136|||Cohort||Prospective|||||||
1423783|NCT01982123||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423784|NCT01982110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423785|NCT01982097|||Cohort||Prospective|||||||
1423786|NCT01982084|||Other||Other|||||||
1423787|NCT01982071||Single Group Assignment||Treatment||None (Open Label)||||||
1423788|NCT01982058|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1423789|NCT01982045|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1423790|NCT01982032|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423791|NCT01982019|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1423792|NCT01982006|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423793|NCT01981993|||Cohort||Prospective|||||||
1423794|NCT01981980|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1423795|NCT01981967|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423796|NCT01981954||Single Group Assignment||Treatment||None (Open Label)||||||
1423797|NCT01981941||Single Group Assignment||Treatment||None (Open Label)||||||
1423798|NCT01981928|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1423799|NCT01981915|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1423800|NCT01981902|||Case-Only||Cross-Sectional|||||||
1423801|NCT01981889||Single Group Assignment||||None (Open Label)||||||
1423802|NCT01981876|||Cohort||Prospective|||||||
1423803|NCT01981863|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1423804|NCT01981850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423805|NCT01981837||Single Group Assignment||Treatment||None (Open Label)||||||
1423806|NCT01981824|||Case Control||Prospective|||||||
1423807|NCT01981811||Single Group Assignment||Treatment||None (Open Label)||||||
1423808|NCT01981798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423809|NCT01981785|||Case-Control||Prospective|||||||
1423810|NCT01981772|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1423811|NCT01981759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423812|NCT01981746|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1423813|NCT01981733||||Basic Science||None (Open Label)||||||
1423814|NCT01981720||Single Group Assignment||Treatment||None (Open Label)||||||
1423815|NCT01981707||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423816|NCT01981694|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1423817|NCT01981681|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1423818|NCT01981668||Single Group Assignment||Treatment||None (Open Label)||||||
1423819|NCT01981655|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1423820|NCT01981642||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423821|NCT01981629|||Case-Only||Prospective|||||||
1423822|NCT01981616|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1423823|NCT01981603|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1423824|NCT01981590||Single Group Assignment||Treatment||None (Open Label)||||||
1423825|NCT01981577|||Case Control||Cross-Sectional|||||||
1423826|NCT01981564|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1423827|NCT01981551||Single Group Assignment||Treatment||None (Open Label)||||||
1423828|NCT01981538|||Cohort||Prospective|||||||
1423829|NCT01981525||Single Group Assignment||Treatment||None (Open Label)||||||
1423830|NCT01981499|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1423831|NCT01981486|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1423832|NCT01981473|||||Cross-Sectional|||||||
1423833|NCT01981460|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423834|NCT01981447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423835|NCT01981434|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423836|NCT01981421|||Case-Only||Prospective|||||||
1423837|NCT01981408||Single Group Assignment||||None (Open Label)||||||
1423838|NCT01981395|Randomized|Crossover Assignment||||Double|||t||t|
1423839|NCT01981382|||Case Control||Prospective|||||||
1423840|NCT01981369|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423841|NCT01981356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423842|NCT01981343|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1423843|NCT01981330||Single Group Assignment||Treatment||None (Open Label)||||||
1423844|NCT01981317|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1423845|NCT01981304|||||Prospective|||||||
1423846|NCT01981291|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1423847|NCT01981278|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423848|NCT01981265|||Case Control||Prospective|||||||
1423849|NCT01981252||Single Group Assignment||Treatment||Single||||||t
1423850|NCT01981239|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1423851|NCT01981226||Single Group Assignment||Treatment||None (Open Label)||||||
1423852|NCT01981213|||Case-Only|||||||||
1423853|NCT01981200||Single Group Assignment||Treatment||None (Open Label)||||||
1423854|NCT01981187||Single Group Assignment||Treatment||None (Open Label)||||||
1423855|NCT01981174|Randomized|Single Group Assignment||||Triple|||t||t|t
1423856|NCT01981161|||Other||Prospective|||||||
1423857|NCT01981148|||Cohort||Prospective|||||||
1423858|NCT01981135|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1423859|NCT01981122|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1423860|NCT01981109|||Case-Only||Prospective|||||||
1423861|NCT01981096|Randomized|Parallel Assignment||Treatment||Single||||||t
1423862|NCT01981083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423863|NCT01981070|Randomized|Parallel Assignment||Treatment||Single||||||t
1423864|NCT01981057|||Case-Crossover||Prospective|||||||
1423865|NCT01981044||Single Group Assignment||Treatment||None (Open Label)||||||
1423866|NCT01981031|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1423867|NCT01981018||Single Group Assignment||Treatment||None (Open Label)||||||
1423868|NCT01981005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423869|NCT01980992|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1423870|NCT01980979||Single Group Assignment||Supportive Care||None (Open Label)||||||
1423871|NCT01980966|Randomized|Parallel Assignment||Other||Double|||t||t|
1423872|NCT01980953|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1423873|NCT01980940|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1423874|NCT01980927||Single Group Assignment||Treatment||None (Open Label)||||||
1423875|NCT01980914|||Other||Prospective|||||||
1423876|NCT01980901|||Cohort||Prospective|||||||
1423877|NCT01980888|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423878|NCT01980875|Randomized|Parallel Assignment||Treatment||None (Open Label)||Safety Run-In Phase: Single Group; Randomized Phase: Parallel||||
1423879|NCT01980862|||Cohort||Prospective|||||||
1423880|NCT01980849|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423881|NCT01980836|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423882|NCT01980823||Single Group Assignment||Treatment||None (Open Label)||||||
1423883|NCT01980810||Single Group Assignment||Treatment||None (Open Label)||||||
1423884|NCT01980797|||Cohort||Prospective|||||||
1423885|NCT01980784|||Cohort||Prospective|||||||
1423886|NCT01980771|Randomized|Parallel Assignment||Prevention||Single||||||t
1423887|NCT01980758||Single Group Assignment||Treatment||None (Open Label)||||||
1423888|NCT01980745|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423889|NCT01980732||||||||||||
1423890|NCT01980719|||Case Control||Prospective|||||||
1423891|NCT01980706|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423892|NCT01980693||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423893|NCT01980680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423894|NCT01980667||Single Group Assignment||Treatment||None (Open Label)||||||
1423895|NCT01980654|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423896|NCT01980641|Randomized|Crossover Assignment||Treatment||Single|||||t|
1423897|NCT01980628||Single Group Assignment||Treatment||None (Open Label)||||||
1423898|NCT01980615|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1423899|NCT01980602|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423900|NCT01980589||Single Group Assignment||Treatment||None (Open Label)||||||
1423901|NCT01980576|||Cohort||Prospective|||||||
1423902|NCT01980563|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423903|NCT01980550||Single Group Assignment||||Double|||||t|t
1423904|NCT01980537|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423905|NCT01980524|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1423906|NCT01980511|||Cohort||Prospective|||||||
1423907|NCT01980498|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423908|NCT01980485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423909|NCT01980472||Single Group Assignment||Other||None (Open Label)||Chemotherapy Regimen Plus Bevacizumab||||
1423910|NCT01980459||Single Group Assignment||Prevention||None (Open Label)||||||
1423911|NCT01980446||Single Group Assignment||||None (Open Label)||||||
1423912|NCT01980433|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1423913|NCT01980420||Single Group Assignment||Treatment||None (Open Label)||||||
1423914|NCT01980407||Single Group Assignment||Treatment||None (Open Label)||||||
1423915|NCT01980394||Single Group Assignment||Treatment||None (Open Label)||||||
1423916|NCT01980381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423917|NCT01980368|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1423918|NCT01980355|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423919|NCT01980342||Single Group Assignment||Other||None (Open Label)||||||
1423920|NCT01980329||Single Group Assignment||Basic Science||None (Open Label)||||||
1423921|NCT01980316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423922|NCT01980303|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1423923|NCT01980290|||Cohort||Prospective|||||||
1423924|NCT01980277||Single Group Assignment||Treatment||None (Open Label)||||||
1423925|NCT01980264||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423926|NCT01980251|||Cohort||Prospective|||||||
1423927|NCT01980238|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423928|NCT01980225|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423929|NCT01980212|||||Prospective|||||||
1423930|NCT01980199||Single Group Assignment||Treatment||None (Open Label)||||||
1423931|NCT01980186||||||||||||
1423932|NCT01980173|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423933|NCT01980160|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1423934|NCT01980147|Randomized|Parallel Assignment||Prevention||Single||||||t
1423935|NCT01980134|||Cohort||Cross-Sectional|||||||
1423936|NCT01980121|||Case-Only||Prospective|||||||
1423937|NCT01980108|Randomized|Parallel Assignment||||Single|||||t|
1423938|NCT01980095|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423939|NCT01980082|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1423940|NCT01980069|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1423941|NCT01980056||Sequential Assignment||Treatment||None (Open Label)||Dose level 1: Vosaroxin 50 mg^m2 IV on Days 1 and 4 of 28 day cycle Dose level 2: Vosaroxin 72 mg^m2 IV on Days 1 and 4 of 28 day cycle Dose level 3: Vosaroxin 50 mg^m2 IV on Days 1, 4, 8 and 11 of 28 day cycle||||
1423942|NCT01980043||Single Group Assignment||Treatment||None (Open Label)||||||
1423943|NCT01980030||Single Group Assignment||Treatment||None (Open Label)||||||
1423944|NCT01980017|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423945|NCT01980004|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423946|NCT01979991||Single Group Assignment||Basic Science||Single|||||t|
1423947|NCT01979978|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1423948|NCT01979965|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1423949|NCT01979952|Randomized|Parallel Assignment||Treatment||Double||||||
1423950|NCT01979939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423951|NCT01979926|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1423952|NCT01979913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1423953|NCT01979900|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1423954|NCT01979887|||Cohort||Prospective|||||||
1423955|NCT01979874|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423956|NCT01979861||Single Group Assignment||Treatment||None (Open Label)||||||
1423957|NCT01979848|||Case-Only||Prospective|||||||
1423958|NCT01979835||Single Group Assignment||Prevention||None (Open Label)||||||
1423959|NCT01979822|||Cohort||Prospective|||||||
1423960|NCT01979809|Randomized|Factorial Assignment||Prevention||Single|||t|||
1423961|NCT01979796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423962|NCT01979783|||Case Control||Cross-Sectional|||||||
1423963|NCT01979770|||Cohort||Prospective|||||||
1423964|NCT01979757|Randomized|Parallel Assignment||Treatment||Single|||||t|
1423965|NCT01979744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423966|NCT01979731|Randomized|Single Group Assignment||Prevention||Single|||||t|
1423967|NCT01979718|Randomized|Parallel Assignment||Treatment||Single||||||t
1423968|NCT01979705|||Cohort||Prospective|||||||
1423969|NCT01979692||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423970|NCT01979679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423971|NCT01979666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423972|NCT01979653|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1423973|NCT01979640|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1423974|NCT01979627|Randomized|Parallel Assignment||Treatment||Single|||t|||
1423975|NCT01979614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423976|NCT01979601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423977|NCT01979588|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1423978|NCT01979575|||Cohort||Prospective|||||||
1423979|NCT01979562|||Cohort||Prospective|||||||
1423980|NCT01979549|||Cohort||Prospective|||||||
1423981|NCT01979536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423982|NCT01979523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1423983|NCT01979510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423984|NCT01979497|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1423985|NCT01979484|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1423986|NCT01979471|Randomized|Single Group Assignment||Treatment||Single|||t|||
1423987|NCT01979458||Single Group Assignment||Diagnostic||None (Open Label)||||||
1423988|NCT01979445|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1423989|NCT01979432||Single Group Assignment||Diagnostic||||||||
1423990|NCT01979419|||Case Control||Prospective|||||||
1423991|NCT01979406|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1423992|NCT01979393|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423993|NCT01979380|Randomized|Parallel Assignment||||Double|||t||t|
1423994|NCT01979367||Single Group Assignment||Treatment||None (Open Label)||||||
1423995|NCT01979354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1423996|NCT01979341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1423997|NCT01979328|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1423998|NCT01979315|||Case-Control||Cross-Sectional|||||||
1423999|NCT01979302|Non-Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1424000|NCT01979289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424001|NCT01979276||Single Group Assignment||Treatment||None (Open Label)||||||
1424002|NCT01979263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424003|NCT01979250|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424004|NCT01979237|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424005|NCT01979224|Randomized|Parallel Assignment||Treatment||Double||||t||t
1424006|NCT01979211||Single Group Assignment||Treatment||None (Open Label)||||||
1424007|NCT01979198|||Case Control||Prospective|||||||
1424008|NCT01979185|Randomized|Crossover Assignment||||None (Open Label)||||||
1424009|NCT01979172|||||Prospective|||||||
1424010|NCT01979159||Single Group Assignment||Treatment||None (Open Label)||||||
1424011|NCT01979146|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1424012|NCT01979133||Single Group Assignment||Treatment||None (Open Label)||||||
1424013|NCT01979120|||Cohort||Prospective|||||||
1424014|NCT01979107|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424015|NCT01979094|||Other||Prospective|||||||
1424016|NCT01979081|||Case-Control||Prospective|||||||
1424017|NCT01979068|||Case Control||Prospective|||||||
1424018|NCT01979055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424019|NCT01979042|||Cohort||Prospective|||||||
1424020|NCT01979029|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424021|NCT01979016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424022|NCT01979003||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424023|NCT01978990|||Cohort||Prospective|||||||
1424024|NCT01978977|||Cohort|||||||||
1424025|NCT01978964||Single Group Assignment||Treatment||None (Open Label)||||||
1424026|NCT01978951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424027|NCT01978938|Randomized|Parallel Assignment||Treatment||Triple|Except for the responsible study site pharmacist or designee and separate unblinded clinical research associates to monitor drug supply and adherence to study drug blinding and randomization procedures, all study staff and participants were blinded to treatment assignment.||t||t|t
1424028|NCT01978925|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424029|NCT01978912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424030|NCT01978899|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1424031|NCT01978886|||Cohort||Cross-Sectional|||||||
1424032|NCT01978873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424033|NCT01978860||Single Group Assignment||Treatment||None (Open Label)||||||
1424034|NCT01978847|||Other||Retrospective|||||||
1424035|NCT01978834|||Cohort||Cross-Sectional|||||||
1424036|NCT01978821||Single Group Assignment||Treatment||None (Open Label)||||||
1424037|NCT01978808|||Case-Only||Prospective|||||||
1424038|NCT01978795|Randomized|Parallel Assignment||||None (Open Label)||||||
1424039|NCT01978782|Randomized|Crossover Assignment||||None (Open Label)||||||
1424040|NCT01978769|||Case Control||Cross-Sectional|||||||
1424041|NCT01978756|||Case-Only||Cross-Sectional|||||||
1424042|NCT01978743||Single Group Assignment||Basic Science||None (Open Label)||||||
1424043|NCT01978730|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424044|NCT01978717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424045|NCT01978704|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424046|NCT01978691|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1424047|NCT01978678|||Cohort||Prospective|||||||
1424048|NCT01978665|Randomized|Crossover Assignment||||Double|||t||t|
1424049|NCT01978652|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424050|NCT01978639|||Cohort||Prospective|||||||
1424051|NCT01978626|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1424052|NCT01978613|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424053|NCT01978600|Randomized|Parallel Assignment||Treatment||Single||||||t
1424054|NCT01978587|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424055|NCT01978574|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1424056|NCT01978561|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1424057|NCT01978548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424058|NCT01978535|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424059|NCT01978522|Randomized|Single Group Assignment||Other||Double|||t|||t
1424060|NCT01978509|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1424061|NCT01978496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424062|NCT01978483|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1424063|NCT01978470||Single Group Assignment||||None (Open Label)||||||
1424064|NCT01978457|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1424065|NCT01978444|Randomized|Parallel Assignment||Prevention||Single|In this trial, patients and the follow-up staff are masked to the treatment allocation.||t|||
1424066|NCT01978431|Randomized|Factorial Assignment||Other||Quadruple|||t|t|t|t
1424067|NCT01978418|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424068|NCT01978405|Randomized|Parallel Assignment||Prevention||Single|||t|||
1424069|NCT01978392|Randomized|Parallel Assignment||Prevention||Single||||||t
1424070|NCT01978379|||Cohort||Prospective|||||||
1424071|NCT01978366|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424072|NCT01978353|Randomized|Parallel Assignment||Treatment||Single||||||t
1424073|NCT01978340|||||Prospective|||||||
1424074|NCT01978327|Randomized|Crossover Assignment||Treatment||Single|||t|||
1424075|NCT01978314|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||This pilot study was a prospective, open-label, single site study designed to evaluate the safety of the FAST mGFR Test™ in healthy adult volunteers, patients with varying degrees of renal impairment and hemodynamically stable AKI.||||
1424076|NCT01978301|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1424077|NCT01978288|||Case-Only||Prospective|||||||
1424078|NCT01978275|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1424079|NCT01978262||Single Group Assignment||Other||None (Open Label)||||||
1424080|NCT01978249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424081|NCT01978236|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424082|NCT01978223|||Case Control||Prospective|||||||
1424083|NCT01978210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424084|NCT01978184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424085|NCT01978171|||Cohort||Prospective|||||||
1424086|NCT01978158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424087|NCT01978145|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1424088|NCT01978132|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1424089|NCT01978119|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1424090|NCT01978106|||Cohort||Retrospective|||||||
1424091|NCT01978093|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424092|NCT01978080|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1424093|NCT01978067|||Case-Only||Prospective|||||||
1424094|NCT01978054|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1424095|NCT01978041|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1424096|NCT01978028|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424097|NCT01978015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424098|NCT01978002|||Case Control||Prospective|||||||
1424099|NCT01977989|Randomized|Parallel Assignment||Prevention||Single|||t|||
1424100|NCT01977976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424101|NCT01977963|||Cohort||Prospective|||||||
1424102|NCT01977950|||Case-Only||Cross-Sectional|||||||
1424103|NCT01977937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424104|NCT01977924|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1424105|NCT01977911||Single Group Assignment||Treatment||None (Open Label)||||||
1424106|NCT01977898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424107|NCT01977885||Single Group Assignment||Treatment||None (Open Label)||||||
1424108|NCT01977872|Randomized|Parallel Assignment||Prevention||Single||||||t
1424109|NCT01977859|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1424110|NCT01977846|||Case-Only||Other|||||||
1424111|NCT01977833|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424112|NCT01977820|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424113|NCT01977807|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424114|NCT01977794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424115|NCT01977781|Randomized|Parallel Assignment||Treatment||Single|||||t|
1424116|NCT01977768|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1424117|NCT01977755|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424118|NCT01977742|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1424119|NCT01977729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424120|NCT01977716|||Cohort||Prospective|||||||
1424121|NCT01977703|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424122|NCT01977690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424123|NCT01977677||Single Group Assignment||Treatment||None (Open Label)||||||
1424124|NCT01977664|||Case-Only||Cross-Sectional|||||||
1424125|NCT01977651||Single Group Assignment||Treatment||None (Open Label)||||||
1424126|NCT01977638||Single Group Assignment||Treatment||None (Open Label)||||||
1424127|NCT01977625|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1424128|NCT01977612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424129|NCT01977599|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1424130|NCT01977586||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424131|NCT01977573|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424132|NCT01977560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424133|NCT01977547|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424134|NCT01977534|||Case-Only||Prospective|||||||
1424135|NCT01977521|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1424136|NCT01977508|||Cohort||Prospective|||||||
1424137|NCT01977495|Randomized|Parallel Assignment||||Single|||t|||
1424138|NCT01977482|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1424139|NCT01977469|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424140|NCT01977456||Single Group Assignment||Treatment||None (Open Label)||||||
1424141|NCT01977443|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424142|NCT01977430|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424143|NCT01977417|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424144|NCT01977404|||Cohort||Prospective|||||||
1424145|NCT01977391|||Cohort||Prospective|||||||
1424146|NCT01977378|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424147|NCT01977365|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424148|NCT01977352|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1424149|NCT01977339|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1424150|NCT01977326|Randomized|Parallel Assignment||Treatment||Single|||||t|
1424151|NCT01977313|||Case-Only||Cross-Sectional|||||||
1424152|NCT01977300|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424153|NCT01977287|||Case Control||Prospective|||||||
1424154|NCT01977274||Single Group Assignment||Basic Science||None (Open Label)||||||
1424155|NCT01977261|Randomized|Parallel Assignment||Treatment||Single||||||t
1424156|NCT01977248||Single Group Assignment||Treatment||None (Open Label)||||||
1424157|NCT01977235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424158|NCT01977222||Single Group Assignment||Treatment||None (Open Label)||||||
1424159|NCT01977209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424160|NCT01977196||Single Group Assignment||Prevention||None (Open Label)||||||
1424161|NCT01977183|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1424162|NCT01977170||Single Group Assignment||Prevention||None (Open Label)||||||
1424163|NCT01977157|||||Prospective|||||||
1424164|NCT01977144|Randomized|Parallel Assignment||Other||Double|||t||t|
1424165|NCT01977131||Single Group Assignment||Treatment||Single|||t|||
1424166|NCT01977118|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1424167|NCT01977105||Single Group Assignment||Prevention||None (Open Label)||||||
1424168|NCT01977092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424169|NCT01977079|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1424170|NCT01977066|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1424171|NCT01977053|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1424172|NCT01977040|||Cohort||Retrospective|||||||
1424173|NCT01977027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424174|NCT01977014|||Cohort||Other|||||||
1424175|NCT01977001|||Case-Only||Prospective|||||||
1424176|NCT01976988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424177|NCT01976975|||Case-Control||Cross-Sectional|||||||
1424178|NCT01976962||Single Group Assignment||Treatment||None (Open Label)||||||
1424179|NCT01976949|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1424180|NCT01976936|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424181|NCT01976923|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424182|NCT01976910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424183|NCT01976897|||Cohort||Cross-Sectional|||||||
1424184|NCT01976884|||Case Control||Prospective|||||||
1424185|NCT01976871||Single Group Assignment||Treatment||None (Open Label)||||||
1424186|NCT01976858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424187|NCT01976845|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424188|NCT01976832|Randomized|Parallel Assignment||Treatment||Single||||||t
1424189|NCT01976819||Single Group Assignment||Supportive Care||None (Open Label)||||||
1424190|NCT01976806|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1424191|NCT01976793|||Cohort||Retrospective|||||||
1424192|NCT01976780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424193|NCT01976767|||Cohort||Prospective|||||||
1424194|NCT01976754|Randomized|Single Group Assignment||Supportive Care||Double|||t|||t
1424195|NCT01976741||Single Group Assignment||Treatment||None (Open Label)||||||
1424196|NCT01976728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424197|NCT01976715|||Cohort||Prospective|||||||
1424198|NCT01976702|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1424199|NCT01976689|||Case Control||Retrospective|||||||
1424200|NCT01976676|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1424201|NCT01976663|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424202|NCT01976650|||Cohort||Prospective|||||||
1424203|NCT01976637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424204|NCT01976624|||Cohort||Prospective|||||||
1424205|NCT01976611|||Cohort||Prospective|||||||
1424206|NCT01976598|||Cohort||Prospective|||||||
1424207|NCT01976585||Single Group Assignment||Treatment||None (Open Label)||||||
1424208|NCT01976572|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424209|NCT01976559||Single Group Assignment||Diagnostic||Single||||||t
1424210|NCT01976546|||Case-Only||Prospective|||||||
1424211|NCT01976533|||Cohort||Retrospective|||||||
1424212|NCT01976520||Single Group Assignment||Treatment||None (Open Label)||||||
1424213|NCT01976507||Single Group Assignment||Treatment||None (Open Label)||||||
1424214|NCT01976494|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1424215|NCT01976481|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1424216|NCT01976468|||Case-Only||Prospective|||||||
1424217|NCT01976455|||Case-Crossover||Other|||||||
1424218|NCT01976442|||Cohort||Retrospective|||||||
1424219|NCT01976429|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1424220|NCT01976416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424221|NCT01976403|Randomized|Single Group Assignment||Prevention||Single|||t|||
1424222|NCT01976390|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424223|NCT01976377|||Case Control||Retrospective|||||||
1424224|NCT01976364||||Treatment||None (Open Label)|The sub-study will be participant, care provider, investigator and outcomes assessor masked.|||||
1424225|NCT01976351|||Cohort||Prospective|||||||
1424226|NCT01976338|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424227|NCT01976325|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424228|NCT01976312|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424229|NCT01976299|Randomized|Parallel Assignment||Prevention||Single|||t|||
1424230|NCT01976286|Randomized|Single Group Assignment||Treatment||Single||||||t
1424231|NCT01976273|Randomized|Single Group Assignment||Treatment||Single||||||t
1424232|NCT01976260|Randomized|Single Group Assignment||Treatment||Single||||||t
1424233|NCT01976247|Randomized|Single Group Assignment||Other||Single||||||t
1424234|NCT01976234|Randomized|Parallel Assignment||Screening||Double|||t||t|
1424235|NCT01976221||Single Group Assignment||Health Services Research||Single|||||t|
1424236|NCT01976208|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424237|NCT01976195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424238|NCT01976182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424239|NCT01976169||Single Group Assignment||Treatment||None (Open Label)||||||
1424240|NCT01976156|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1424241|NCT01976143||Single Group Assignment||Treatment||None (Open Label)||||||
1424242|NCT01976130||Single Group Assignment||Basic Science||None (Open Label)||||||
1424243|NCT01976117||Single Group Assignment||||None (Open Label)||||||
1424244|NCT01976104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424245|NCT01976091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424246|NCT01976078|||Cohort||Prospective|||||||
1424247|NCT01976065|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1424248|NCT01976052|||Case-Control||Prospective|||||||
1424249|NCT01976039|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1424250|NCT01976026|Randomized|Parallel Assignment||Treatment||Single||||||t
1424251|NCT01976013||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424252|NCT01976000|||Case Control||Prospective|||||||
1424253|NCT01975987||Single Group Assignment||Prevention||None (Open Label)||||||
1424254|NCT01975974|||Case-Only||Prospective|||||||
1424255|NCT01975961|Randomized|Crossover Assignment||||None (Open Label)||||||
1424256|NCT01975948|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1424257|NCT01975935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424258|NCT01975922|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424259|NCT01975909|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1424260|NCT01975896|Randomized|Parallel Assignment||Prevention||Single|||t|||
1424261|NCT01975883|||Cohort||Prospective|||||||
1424262|NCT01975870|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424263|NCT01975857|Randomized|Parallel Assignment||Treatment||Single||||||t
1424264|NCT01975844||Single Group Assignment||Treatment||None (Open Label)||||||
1424265|NCT01975831||Single Group Assignment||Treatment||None (Open Label)||||||
1424266|NCT01975818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424267|NCT01975805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424268|NCT01975792|||Cohort||Prospective|||||||
1424269|NCT01975779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424270|NCT01975766||Single Group Assignment||Treatment||None (Open Label)||||||
1424271|NCT01975753|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424272|NCT01975740|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1424273|NCT01975727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424274|NCT01975714|Randomized|Crossover Assignment||Treatment||Single|||||t|
1424275|NCT01975701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424276|NCT01975688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424277|NCT01975675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424278|NCT01975662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424279|NCT01975649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424280|NCT01975636||Single Group Assignment||Treatment||None (Open Label)||||||
1424281|NCT01975623||Single Group Assignment||Treatment||None (Open Label)||||||
1424282|NCT01975610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424283|NCT01975597||Single Group Assignment||Basic Science||None (Open Label)||||||
1424284|NCT01975584||Single Group Assignment||Other||None (Open Label)||||||
1424285|NCT01975571|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424286|NCT01975558|||Case-Control||Prospective|||||||
1424287|NCT01975545|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1424288|NCT01975532|||Case-Only||Prospective|||||||
1424289|NCT01975519||Single Group Assignment||Treatment||None (Open Label)||||||
1424290|NCT01975506|||Cohort||Cross-Sectional|||||||
1424291|NCT01975493|||Other||Prospective|||||||
1424292|NCT01975480||Single Group Assignment||Treatment||None (Open Label)|Open Label.|||||
1424293|NCT01975467|||Case Control||Retrospective|||||||
1424294|NCT01975454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424295|NCT01975441|Randomized|Parallel Assignment||Treatment||Single||||||t
1424296|NCT01975428|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424297|NCT01975415|||Cohort||Prospective|||||||
1424298|NCT01975402|||Case-Only||Prospective|||||||
1424299|NCT01975389|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424300|NCT01975376|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424301|NCT01975363|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424302|NCT01975350|||Cohort||Prospective|||||||
1424303|NCT01975337|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1424304|NCT01975324|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1424305|NCT01975311|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424306|NCT01975298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424307|NCT01975285|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424308|NCT01975272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424309|NCT01975259|||Case Control||Prospective|||||||
1424310|NCT01975246|Randomized|Parallel Assignment||Treatment||Double||||||
1424311|NCT01975233|||Case-Only||Prospective|||||||
1424312|NCT01975220|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424313|NCT01975207|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1424314|NCT01975194||Single Group Assignment||Treatment||None (Open Label)||||||
1424315|NCT01975181|||Cohort||Prospective|||||||
1424316|NCT01975168|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1424317|NCT01975155|||Case Control||Prospective|||||||
1424318|NCT01975142||Single Group Assignment||Treatment||None (Open Label)||||||
1424319|NCT01975129||Single Group Assignment||Treatment||None (Open Label)||||||
1424320|NCT01975116||Single Group Assignment||Treatment||None (Open Label)||||||
1424321|NCT01975103|Randomized|Parallel Assignment||Treatment||Double|One arm receives laser treatment and second arm received powerless laser treatment as a Sham group.||t||t|
1424322|NCT01975090||Single Group Assignment||Prevention||None (Open Label)||||||
1424323|NCT01975077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424324|NCT01975064|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1424325|NCT01975051||Single Group Assignment||Treatment||None (Open Label)||||||
1424326|NCT01975038|||Cohort||Prospective|||||||
1424327|NCT01975025|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424328|NCT01975012|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424329|NCT01974999|||Cohort||Retrospective|||||||
1424330|NCT01974986|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1424331|NCT01974973||Single Group Assignment||Treatment||None (Open Label)||||||
1424332|NCT01974947|||Cohort||Prospective|||||||
1424333|NCT01974934||Single Group Assignment||Treatment||None (Open Label)||||||
1424334|NCT01974921||Single Group Assignment||Basic Science||None (Open Label)||||||
1424335|NCT01974908||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424336|NCT01974895|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1424337|NCT01974882|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1424338|NCT01974869|||Cohort||Prospective|||||||
1424339|NCT01974856|||Cohort||Prospective|||||||
1424340|NCT01974843|||Case-Only||Prospective|||||||
1424341|NCT01974830|||Cohort||Prospective|||||||
1424342|NCT01974817||Single Group Assignment||Treatment||None (Open Label)||||||
1424343|NCT01974804|||Cohort||Prospective|||||||
1424344|NCT01974791||Single Group Assignment||Treatment||None (Open Label)||||||
1424345|NCT01974778|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1424346|NCT01974765||Single Group Assignment||Treatment||None (Open Label)||||||
1424347|NCT01974752|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424348|NCT01974739|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1424349|NCT01974726|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1424350|NCT01974713|||Cohort||Prospective|||||||
1424351|NCT01974700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424352|NCT01974687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424353|NCT01974674||Single Group Assignment||Treatment||None (Open Label)||||||
1424354|NCT01974661||Single Group Assignment||Treatment||None (Open Label)||||||
1424355|NCT01974648|Randomized|Parallel Assignment||||Triple|||t||t|t
1424356|NCT01974635||Single Group Assignment||Treatment||None (Open Label)||||||
1424357|NCT01974622||Single Group Assignment||Treatment||None (Open Label)||||||
1424358|NCT01974609|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1424359|NCT01974596|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1424360|NCT01974583|||Case Control||Prospective|||||||
1424361|NCT01974570|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1424362|NCT01974557||Single Group Assignment||Basic Science||None (Open Label)||||||
1424363|NCT01974544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424364|NCT01974531|||||Prospective|||||||
1424365|NCT01974518|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1424366|NCT01974505||Single Group Assignment||||None (Open Label)||||||
1424367|NCT01974492|Randomized|Parallel Assignment||Treatment||Single||||||t
1424368|NCT01974479||Single Group Assignment||Treatment||None (Open Label)||To determine the feasibility, safety and efficacy of anti-CD19 redirected NK cells infusion in research participants with B-Lineage Acute Lymphoblastic Leukemia (B-ALL) who have persistent disease as determined by MRD methods after intensive chemotherapy.||||
1424369|NCT01974466|Randomized|Single Group Assignment||Treatment||Single|||t|||
1424370|NCT01974453|||Cohort||Prospective|||||||
1424371|NCT01974440|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424372|NCT01974427|||Cohort||Prospective|||||||
1424373|NCT01974414|Randomized|Parallel Assignment||Treatment||Single|||||t|
1424374|NCT01974401|Randomized|Parallel Assignment||Prevention||Single|||||t|
1424375|NCT01974388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424376|NCT01974375|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424377|NCT01974362|||Case-Control||Cross-Sectional|||||||
1424378|NCT01974349|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1424379|NCT01974336|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1424380|NCT01974323|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424381|NCT01974310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424382|NCT01974297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424383|NCT01974284||Single Group Assignment||Treatment||None (Open Label)||||||
1424384|NCT01974271|||Cohort||Prospective|||||||
1424385|NCT01974258|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424386|NCT01974245|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424387|NCT01974232|||Case-Only||Retrospective|||||||
1424388|NCT01974219|||Case-Control||Prospective|||||||
1424389|NCT01974206|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424390|NCT01974193|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1424391|NCT01974180|||Case-Control||Prospective|||||||
1424392|NCT01974167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424393|NCT01974154|||Case-Control||Prospective|||||||
1424394|NCT01974141|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424395|NCT01974128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424396|NCT01974115||Single Group Assignment||Treatment||None (Open Label)||||||
1424397|NCT01974102|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424398|NCT01974089|||Cohort||Prospective|||||||
1424399|NCT01974076|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424400|NCT01974063|||Case-Control||Prospective|||||||
1424401|NCT01974050||Single Group Assignment||Health Services Research||None (Open Label)||||||
1424402|NCT01974037|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1424403|NCT01974024|Randomized|Crossover Assignment||Treatment||Single|||t|||
1424404|NCT01974011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424405|NCT01973998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424406|NCT01973985|||Cohort||Prospective|||||||
1424407|NCT01973972|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424408|NCT01973959|||||Prospective|||||||
1424409|NCT01973946|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1424410|NCT01973933||Single Group Assignment||Treatment||None (Open Label)||||||
1424411|NCT01973920||Single Group Assignment||Treatment||None (Open Label)||||||
1424412|NCT01973907|Randomized|Parallel Assignment||Treatment||Single||||||t
1424413|NCT01973894|||Cohort||Prospective|||||||
1424414|NCT01973881|||Case-Only||Prospective|||||||
1424415|NCT01973868||Single Group Assignment||Treatment||None (Open Label)||||||
1424416|NCT01973855|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1424417|NCT01973842|Randomized|Parallel Assignment||Treatment||Single||||||t
1424418|NCT01973829||Single Group Assignment||Supportive Care||None (Open Label)||||||
1424419|NCT01973816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424420|NCT01973803|||Case-Only||Prospective|||||||
1424421|NCT01973790||Single Group Assignment||Treatment||None (Open Label)||||||
1424422|NCT01973777||Single Group Assignment||Prevention||None (Open Label)||intrauterine contraceptive device IUB||||
1424423|NCT01973764|Randomized|Parallel Assignment||Treatment||Single||||||t
1424424|NCT01973751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424425|NCT01973738|||Case Control||Prospective|||||||
1424426|NCT01973725||Single Group Assignment||Treatment||None (Open Label)||||||
1424427|NCT01973712|Randomized|Parallel Assignment||Treatment||Single||||||t
1424428|NCT01973699|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1424429|NCT01973686|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1424430|NCT01973673|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1424431|NCT01973660|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424432|NCT01973647|Randomized|Parallel Assignment||Treatment||Single||||||t
1424433|NCT01973634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424434|NCT01973621||||||||||||
1424435|NCT01973608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424436|NCT01973595|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1424437|NCT01973582|||Cohort||Prospective|||||||
1424438|NCT01973569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424439|NCT01973556|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1424440|NCT01973543|Non-Randomized|Single Group Assignment||Treatment||Single||VY-AADC01||||t
1424441|NCT01973530|Randomized|Parallel Assignment||Treatment||Single||||||t
1424442|NCT01973517|||Case-Only||Cross-Sectional|||||||
1424443|NCT01973504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424444|NCT01973491||Single Group Assignment||Treatment||None (Open Label)||||||
1424445|NCT01973478|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1424446|NCT01973465||Single Group Assignment||Treatment||None (Open Label)||||||
1424447|NCT01973452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424448|NCT01973439||Single Group Assignment||Treatment||None (Open Label)||||||
1424449|NCT01973426|||Case-Only||Prospective|||||||
1424450|NCT01973413|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424451|NCT01973400|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1424452|NCT01973387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424453|NCT01973374|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424454|NCT01973361|Randomized|Parallel Assignment||Treatment||Single||||||t
1424455|NCT01973348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424456|NCT01973335|Randomized|Factorial Assignment||Treatment||Triple||||t|t|t
1424457|NCT01973322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424458|NCT01973309|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424459|NCT01973296|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424460|NCT01973283||Single Group Assignment||Treatment||None (Open Label)||||||
1424461|NCT01973270|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1424462|NCT01973257||Parallel Assignment||Diagnostic||Single|||t|||
1424463|NCT01973244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424464|NCT01973231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424465|NCT01973218|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1424466|NCT01973205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424467|NCT01973192|||Cohort||Prospective|||||||
1424468|NCT01973179|||Cohort||Prospective|||||||
1424469|NCT01973166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424470|NCT01973153|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424471|NCT01973140||Single Group Assignment||||None (Open Label)||||||
1424472|NCT01973127|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1424473|NCT01973114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424474|NCT01973101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424475|NCT01973088|||Cohort||Prospective|||||||
1424476|NCT01973075|||Case-Control||Cross-Sectional|||||||
1424477|NCT01973062||Single Group Assignment||Treatment||None (Open Label)||||||
1424478|NCT01973049|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424479|NCT01973036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424480|NCT01973023|||||Retrospective|||||||
1424481|NCT01973010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424482|NCT01972997||Single Group Assignment||Diagnostic||Double|||t||t|
1424483|NCT01972984||Single Group Assignment||Treatment||None (Open Label)||||||
1424484|NCT01972971||Single Group Assignment||Health Services Research||None (Open Label)||||||
1424485|NCT01972958|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1424486|NCT01972945|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1424487|NCT01972932|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1424488|NCT01972919||Single Group Assignment||Treatment||None (Open Label)||||||
1424489|NCT01972906|Randomized|Parallel Assignment||Treatment||Single||||||t
1424490|NCT01972893|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1424491|NCT01972880|Randomized|Crossover Assignment||||None (Open Label)||||||
1424492|NCT01972867||Single Group Assignment||Treatment||None (Open Label)||||||
1424493|NCT01972854|Randomized|Parallel Assignment||Treatment||Single||||||t
1424494|NCT01972841|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424495|NCT01972828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424496|NCT01972815|||Case-Only||Prospective|||||||
1424497|NCT01972802|||Case Control||Prospective|||||||
1424498|NCT01972789|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424499|NCT01972776|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1424500|NCT01972763|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424501|NCT01972750||Single Group Assignment||Treatment||None (Open Label)||||||
1424502|NCT01972737||Single Group Assignment||Prevention||None (Open Label)||||||
1424503|NCT01972724|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424504|NCT01972711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424505|NCT01972698|Randomized|Parallel Assignment||||Single||||||t
1424506|NCT01972685||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424507|NCT01972672||Single Group Assignment||Treatment||None (Open Label)||||||
1424508|NCT01972659|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1424509|NCT01972646|||Cohort||Prospective|||||||
1424510|NCT01972633|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424511|NCT01972620|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424512|NCT01972607|Randomized|Parallel Assignment||Prevention||Single|||||t|
1424513|NCT01972594|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424514|NCT01972581|Randomized|Parallel Assignment||||Single|||||t|
1424515|NCT01972568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424516|NCT01972555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424517|NCT01972542|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1424518|NCT01972529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424519|NCT01972516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424520|NCT01972503|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424521|NCT01972490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424522|NCT01972477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424523|NCT01972464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424524|NCT01972451|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1424525|NCT01972438|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1424526|NCT01972425|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1424527|NCT01972412||Single Group Assignment||Supportive Care||None (Open Label)||||||
1424528|NCT01972399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424529|NCT01972386|||Case-Only||Prospective|||||||
1424530|NCT01972373||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424531|NCT01972360|||Other||Prospective|||||||
1424532|NCT01972347||Single Group Assignment||Treatment||None (Open Label)||||||
1424533|NCT01972334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424534|NCT01972321|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424535|NCT01972308|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1424536|NCT01972295|||Cohort||Prospective|||||||
1424537|NCT01972282|||Cohort||Prospective|||||||
1424538|NCT01972269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424539|NCT01972256|||Cohort||Retrospective|||||||
1424540|NCT01972243|||Cohort||Prospective|||||||
1424541|NCT01972230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424542|NCT01972217|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424543|NCT01972204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424544|NCT01972191|||Cohort||Retrospective|||||||
1424545|NCT01972178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424546|NCT01972165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424547|NCT01972152|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1424548|NCT01972139|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424549|NCT01972126|||Cohort||Prospective|||||||
1424550|NCT01972113|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424551|NCT01972100|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1424552|NCT01972087|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1424553|NCT01972074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424554|NCT01972061|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424555|NCT01972048|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424556|NCT01972035|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424557|NCT01972022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424558|NCT01972009|||Case Control||Cross-Sectional|||||||
1424559|NCT01971996|||Case-Only||Prospective|||||||
1424560|NCT01971983|Randomized|Parallel Assignment||Treatment||Single||||||t
1424561|NCT01971970|||Cohort||Prospective|||||||
1424562|NCT01971957|||Case-Only||Prospective|||||||
1424563|NCT01971944|||Cohort||Prospective|||||||
1424564|NCT01971931|||Case-Only||Prospective|||||||
1424565|NCT01971918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424566|NCT01971905|||Cohort||Retrospective|||||||
1424567|NCT01971892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424568|NCT01971879|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1424569|NCT01971866|||Case-Only||Prospective|||||||
1424570|NCT01971853|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424571|NCT01971840|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1424572|NCT01971827|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1424573|NCT01971814||Single Group Assignment||Basic Science||None (Open Label)||||||
1424574|NCT01971801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424575|NCT01971788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424576|NCT01971775|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424577|NCT01971762|||Cohort||Prospective|||||||
1424578|NCT01971749|||Cohort||Prospective|||||||
1424579|NCT01971736|||Case Control||Prospective|||||||
1424580|NCT01971723|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1424581|NCT01971710|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1424582|NCT01971697|||||Prospective|||||||
1424583|NCT01971684|||Cohort||Prospective|||||||
1424584|NCT01971671|||||Cross-Sectional|||||||
1424585|NCT01971658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424586|NCT01971645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424587|NCT01971632|Randomized|Parallel Assignment||||Double||||||
1424588|NCT01971619|||Case-Only||Prospective|||||||
1424589|NCT01971606|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1424590|NCT01971593|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424591|NCT01971580|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1424592|NCT01971567|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424593|NCT01971554|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424594|NCT01971541|Randomized|Parallel Assignment||Treatment||Single||||||
1424595|NCT01971528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424596|NCT01971515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424597|NCT01971502|Randomized|Parallel Assignment||Treatment||Single||||||
1424598|NCT01971489||Single Group Assignment||Treatment||None (Open Label)||||||
1424599|NCT01971476||Single Group Assignment||Treatment||None (Open Label)||||||
1424600|NCT01971463||Single Group Assignment||||None (Open Label)||||||
1424601|NCT01971450|||Cohort||Prospective|||||||
1424602|NCT01971437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424603|NCT01971424|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1424604|NCT01971411|||Cohort||Prospective|||||||
1424605|NCT01971398|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1424606|NCT01971385|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424607|NCT01971372|||Case-Only||Prospective|||||||
1424608|NCT01971359|||Case-Only||Prospective|||||||
1424609|NCT01971346||Single Group Assignment||Treatment||None (Open Label)||||||
1424610|NCT01971333|||Cohort||Prospective|||||||
1424611|NCT01971320|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424612|NCT01971307|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1424613|NCT01971294|||Cohort||Prospective|||||||
1424614|NCT01971281|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424615|NCT01971268|||Case Control||Cross-Sectional|||||||
1424616|NCT01971255|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1424617|NCT01971242|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424618|NCT01971229|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1424619|NCT01971216|Randomized|Parallel Assignment||Other||Single|||t|||
1424620|NCT01971203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424621|NCT01971190|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1424622|NCT01971177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424623|NCT01971164|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424624|NCT01971151|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424625|NCT01971138|||||Retrospective|||||||
1424626|NCT01971125|||Case-Only||Prospective|||||||
1424627|NCT01971112|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424628|NCT01971099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424629|NCT01971086|||||Prospective|||||||
1424630|NCT01971073|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424631|NCT01971060||Single Group Assignment||Treatment||None (Open Label)||||||
1424632|NCT01971047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424633|NCT01971034||Single Group Assignment||Treatment||None (Open Label)||||||
1424634|NCT01971021|Randomized|Parallel Assignment||Supportive Care||Double||open label pragmatic|||t|t
1424635|NCT01971008|Randomized|Crossover Assignment||Treatment||Single|||t|||
1424636|NCT01970995|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1424637|NCT01970982|Randomized|Parallel Assignment||||None (Open Label)||||||
1424638|NCT01970969|||Cohort||Prospective|||||||
1424639|NCT01970943|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1424640|NCT01970930|||Other||Prospective|||||||
1424641|NCT01970917|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1424642|NCT01970904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424643|NCT01970891||Single Group Assignment||Supportive Care||Single|||t|||
1424644|NCT01970878|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424645|NCT01970865|Non-Randomized|||Treatment||None (Open Label)||||||
1424646|NCT01970852|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424647|NCT01970839||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424648|NCT01970826|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1424649|NCT01970813|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424650|NCT01970800||Single Group Assignment||Other||None (Open Label)||This study was changed to a retrospective chart review. There was no prospective component.||||
1424651|NCT01970787||Single Group Assignment||Treatment||None (Open Label)||||||
1424652|NCT01970774||Single Group Assignment||Supportive Care||None (Open Label)||||||
1424653|NCT01970761|||Case-Only||Retrospective|||||||
1424654|NCT01970748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424655|NCT01970735||Single Group Assignment||Basic Science||None (Open Label)||||||
1424656|NCT01970722||Single Group Assignment||Treatment||None (Open Label)||||||
1424657|NCT01970709|||Cohort|||||||||
1424658|NCT01970696|||Other||Other|||||||
1424659|NCT01970683|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1424660|NCT01970670|||Cohort||Prospective|||||||
1424661|NCT01970657|||Cohort||Prospective|||||||
1424662|NCT01970644|||Cohort||Prospective|||||||
1424663|NCT01970631|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1424664|NCT01970618|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1424665|NCT01970605|||Cohort||Prospective|||||||
1424666|NCT01970592||Single Group Assignment||Treatment||Single||||||t
1424667|NCT01970579|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424668|NCT01970566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424669|NCT01970553||Single Group Assignment||Treatment||None (Open Label)||||||
1424670|NCT01970540||Single Group Assignment||Treatment||None (Open Label)||||||
1424671|NCT01970527||Single Group Assignment||Treatment||None (Open Label)||||||
1424672|NCT01970514||Single Group Assignment||Treatment||None (Open Label)||||||
1424673|NCT01970501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424674|NCT01970488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424675|NCT01970475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424676|NCT01970462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424677|NCT01970449|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1424678|NCT01970436|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424679|NCT01970423|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1424680|NCT01970410||Single Group Assignment||Treatment||None (Open Label)||||||
1424681|NCT01970397|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424682|NCT01970384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424683|NCT01970371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424684|NCT01970358||Single Group Assignment||Prevention||None (Open Label)||||||
1424685|NCT01970345|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1424686|NCT01970332|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1424687|NCT01970319|||Cohort||Prospective|||||||
1424688|NCT01970306||Single Group Assignment||Treatment||None (Open Label)||||||
1424689|NCT01970293|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1424690|NCT01970280|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424691|NCT01970267|Randomized|Parallel Assignment||Treatment||Single||||||t
1424692|NCT01970254|||Case-Only||Prospective|||||||
1424693|NCT01970241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424694|NCT01970228|Non-Randomized|Parallel Assignment||Diagnostic||Single||Intra-individual comparison of two diagnostic PET imaging tracers|t|||
1424695|NCT01970215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424696|NCT01970202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424697|NCT01970189|||Cohort||Prospective|||||||
1424698|NCT01970176|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1424699|NCT01970163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424700|NCT01970150||Single Group Assignment||Basic Science||None (Open Label)||||||
1424701|NCT01970137||||||||||||
1424702|NCT01970124||||||||||||
1424703|NCT01970111||||||||||||
1424704|NCT01970098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424705|NCT01970072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424706|NCT01970059|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424707|NCT01970046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424708|NCT01970033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424709|NCT01970020||Single Group Assignment||Treatment||None (Open Label)||||||
1424710|NCT01970007||Single Group Assignment||Treatment||None (Open Label)||||||
1424711|NCT01969994||Single Group Assignment||||None (Open Label)||||||
1424712|NCT01969981|||Cohort||Prospective|||||||
1424713|NCT01969968|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1424714|NCT01969955||Single Group Assignment||Treatment||None (Open Label)||||||
1424715|NCT01969942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424716|NCT01969929|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1424717|NCT01969916||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424718|NCT01969903|Randomized|Parallel Assignment||Treatment||Single|||||t|
1424719|NCT01969890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424720|NCT01969877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424721|NCT01969864|Randomized|Parallel Assignment||Other||Single|||||t|
1424722|NCT01969851||Single Group Assignment||Treatment||None (Open Label)||||||
1424723|NCT01969838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424724|NCT01969825|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1424725|NCT01969812|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1424726|NCT01969799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424727|NCT01969786|Randomized|Parallel Assignment||Prevention||Single||||||t
1424728|NCT01969773|Randomized|Single Group Assignment||Treatment||Quadruple|The attending doctors, patients, and study nurses did not know which solution was injected to their bladders, to keep the study in a double-blind condition.|The patients were allocated to the treatment or control group by permuted block randomization code in a 2:1 ratio|t|t|t|t
1424729|NCT01969760|Randomized|Parallel Assignment||Prevention||Single|||t|||
1424730|NCT01969747|Randomized|Parallel Assignment||Treatment||Double||||||
1424731|NCT01969734||Single Group Assignment||Treatment||None (Open Label)||||||
1424732|NCT01969721|Randomized|Crossover Assignment||Treatment||Double||||||
1424733|NCT01969708|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424734|NCT01969695||Single Group Assignment||Treatment||None (Open Label)||||||
1424735|NCT01969682||Single Group Assignment||Basic Science||None (Open Label)||||||
1424736|NCT01969669||Single Group Assignment||Basic Science||None (Open Label)||||||
1424737|NCT01969656||||||||||||
1424738|NCT01969643|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424739|NCT01969630|Randomized|Parallel Assignment||Treatment||Single||||||t
1424740|NCT01969617|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1424741|NCT01969604|Randomized|Parallel Assignment||Prevention||Single||||||t
1424742|NCT01969591|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1424743|NCT01969578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424744|NCT01969565||Single Group Assignment||Treatment||None (Open Label)||||||
1424745|NCT01969552|||||Prospective|||||||
1424746|NCT01969539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424747|NCT01969526|Randomized|Parallel Assignment||Prevention||Single||||||t
1424748|NCT01969513|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424749|NCT01969500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424750|NCT01969487|Randomized|Parallel Assignment||||Double||||t||t
1424751|NCT01969474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424752|NCT01969461|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424753|NCT01969448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424754|NCT01969435||Single Group Assignment||Treatment||None (Open Label)||||||
1424755|NCT01969422|||Case-Only||Retrospective|||||||
1424756|NCT01969409|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424757|NCT01969396|Randomized|Parallel Assignment||||Single|||t|||
1424758|NCT01969383||Single Group Assignment||||None (Open Label)||||||
1424759|NCT01969370|Randomized|Parallel Assignment||Other||Single||||||t
1424760|NCT01969357|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424761|NCT01969344|||Cohort||Prospective|||||||
1424762|NCT01969331|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424763|NCT01969318|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424764|NCT01969305|Randomized|Parallel Assignment||Prevention||Single|||t|||
1424765|NCT01969292|Randomized|Parallel Assignment||||Single|||t|||
1424766|NCT01969279|||Case-Only||Prospective|||||||
1424767|NCT01969266||Single Group Assignment||Treatment||None (Open Label)||||||
1424768|NCT01969253|||Cohort||Prospective|||||||
1424769|NCT01969240|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1424770|NCT01969227||Single Group Assignment||Treatment||None (Open Label)||||||
1424771|NCT01969214||Single Group Assignment||Treatment||None (Open Label)||||||
1424772|NCT01969201|Randomized|Parallel Assignment||Treatment||Single|||||t|
1424773|NCT01969188|||Cohort||Prospective|||||||
1424774|NCT01969175|Randomized|Parallel Assignment||Treatment||Single||||||t
1424775|NCT01969162|||Cohort||Prospective|||||||
1424776|NCT01969149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424777|NCT01969136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424778|NCT01969123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424779|NCT01969110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424780|NCT01969097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424781|NCT01969084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424782|NCT01969071|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1424783|NCT01969058|Randomized|Parallel Assignment||Treatment||None (Open Label)|open label|Participants were randomized 2:1 to Isotretinoin arm and no study treatment arm. The primary endpoints were compared between the 2 study arms.||||
1424784|NCT01969045|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1424785|NCT01969032||Single Group Assignment||Treatment||None (Open Label)||||||
1424786|NCT01969019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424787|NCT01969006|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424788|NCT01968993||Single Group Assignment||Treatment||None (Open Label)||||||
1424789|NCT01968980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424790|NCT01968967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424791|NCT01968954|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424792|NCT01968941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424793|NCT01968928|||Case-Only||Cross-Sectional|||||||
1424794|NCT01968915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424795|NCT01968902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424796|NCT01968889|||Cohort||Prospective|||||||
1424797|NCT01968876|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1424798|NCT01968863|||Case-Only||Prospective|||||||
1424799|NCT01968850|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1424800|NCT01968837||Single Group Assignment||Screening||None (Open Label)||||||
1424801|NCT01968824|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424802|NCT01968811||Single Group Assignment||Treatment||None (Open Label)||||||
1424803|NCT01968798|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424804|NCT01968785|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424953|NCT01966835|Randomized|Parallel Assignment||||Single||||||t
1424805|NCT01968772||Single Group Assignment||Supportive Care||None (Open Label)||||||
1424806|NCT01968759|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424807|NCT01968746|||Cohort||Prospective|||||||
1424808|NCT01968733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424809|NCT01968720|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1424810|NCT01968707|Randomized|Parallel Assignment||Prevention||Single||||||t
1424811|NCT01968694|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1424812|NCT01968681||Single Group Assignment||Treatment||Single||||||t
1424813|NCT01968668|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424814|NCT01968655||||||||||||
1424815|NCT01968642|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1424816|NCT01968629||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424817|NCT01968616||Single Group Assignment||Treatment||None (Open Label)||||||
1424818|NCT01968603|||Case-Only||Retrospective|||||||
1424819|NCT01968590|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1424820|NCT01968577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424821|NCT01968564|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1424822|NCT01968551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424823|NCT01968538|||Other||Prospective|||||||
1424824|NCT01968525|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424825|NCT01968512|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1424826|NCT01968499|||Cohort||Prospective|||||||
1424827|NCT01968486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424828|NCT01968473||Single Group Assignment||Supportive Care||Single|||t|||
1424829|NCT01968460|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424830|NCT01968447|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1424831|NCT01968434|Randomized|Parallel Assignment||Treatment||Single||||||t
1424832|NCT01968421|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424833|NCT01968408|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424834|NCT01968395||Single Group Assignment||Other||None (Open Label)||||||
1424835|NCT01968382|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424836|NCT01968369|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1424837|NCT01968356|Randomized|Parallel Assignment||Prevention||Single||||||t
1424838|NCT01968343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424839|NCT01968330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424840|NCT01968317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424841|NCT01968304||Single Group Assignment||||None (Open Label)||||||
1424842|NCT01968291|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424843|NCT01968278|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424844|NCT01968265|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1424845|NCT01968252|||Cohort||Cross-Sectional|||||||
1424846|NCT01968239|Randomized|Parallel Assignment||Treatment||Single||||||t
1424847|NCT01968226||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424848|NCT01968213|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424849|NCT01968200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424850|NCT01968187|Randomized|Parallel Assignment||Treatment||Double||||||
1424851|NCT01968174|||Case-Only||Prospective|||||||
1424852|NCT01968161||Single Group Assignment||Treatment||None (Open Label)||||||
1424853|NCT01968148|||Cohort||Prospective|||||||
1424854|NCT01968135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424855|NCT01968122|||Cohort||Prospective|||||||
1424856|NCT01968109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424857|NCT01968096|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424858|NCT01968083|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1424859|NCT01968070|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1424860|NCT01968057|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1424861|NCT01968044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424862|NCT01968031|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424863|NCT01968018||Single Group Assignment||Treatment||None (Open Label)||||||
1424864|NCT01968005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424865|NCT01967992|Randomized|Parallel Assignment||Treatment||Single||||||t
1424866|NCT01967979|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1424867|NCT01967966|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1424868|NCT01967953|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1424869|NCT01967940|Randomized|Parallel Assignment||Treatment||Double|Part 1 Sentinel Cohort: Open-label, non-randomized Part 1 Randomized Cohort: Double-blind, randomized Part 2: Open-label, non-randomized|Part 1 (Sentinel Cohort followed by a Randomized Cohort), 14-day washout period, then Part 2|t||t|
1424870|NCT01967927||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424871|NCT01967914|||Cohort||Prospective|||||||
1424872|NCT01967901|Randomized|Crossover Assignment||Prevention||Single||||||t
1424873|NCT01967888|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424874|NCT01967875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424875|NCT01967862||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424876|NCT01967849|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1424877|NCT01967836||Single Group Assignment||Prevention||None (Open Label)||||||
1424878|NCT01967823||Single Group Assignment||Treatment||None (Open Label)||||||
1425490|NCT01959815|||Cohort||Prospective|||||||
1424879|NCT01967810|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424880|NCT01967797|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1424881|NCT01967784||Single Group Assignment||Prevention||None (Open Label)||||||
1424882|NCT01967771||Single Group Assignment||||None (Open Label)||||||
1424883|NCT01967758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424884|NCT01967745|||Cohort||Cross-Sectional|||||||
1424885|NCT01967732|Randomized|Crossover Assignment||||None (Open Label)||||||
1424886|NCT01967719|Randomized|Crossover Assignment||||None (Open Label)||||||
1424887|NCT01967706|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1424888|NCT01967693|||Case-Only||Retrospective|||||||
1424889|NCT01967680|Randomized|Parallel Assignment||Treatment||Single||||||t
1424890|NCT01967667|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1424891|NCT01967654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424892|NCT01967641||Single Group Assignment||Treatment||None (Open Label)|Following induction, patients were stabilized beginning on Day 2 on one of three blinded doses of buprenorphine/naloxone (2/0.5, 8/2, or 16/4 mg per day) for a week then underwent laboratory testing for a second week. Each blinded buprenorphine dose was administered in equal divided doses according to a QID dosing schedule, and each dose was maintained for a two-week period, with the second week including laboratory testing.|||||
1424893|NCT01967628|Randomized|Single Group Assignment||Basic Science||Triple|||t|t|t|
1424894|NCT01967615|||Cohort||Retrospective|||||||
1424895|NCT01967602|||Cohort||Prospective|||||||
1424896|NCT01967589|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424897|NCT01967576||Single Group Assignment||Treatment||None (Open Label)||||||
1424898|NCT01967563|||||Prospective|||||||
1424899|NCT01967550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424900|NCT01967537||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424901|NCT01967524|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424902|NCT01967511|||Case-Control||Cross-Sectional|||||||
1424903|NCT01967498|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424904|NCT01967485|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1424905|NCT01967472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424906|NCT01967459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424907|NCT01967446|||Case Control||Prospective|||||||
1424908|NCT01967433|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1424909|NCT01967420|Randomized|Parallel Assignment||Treatment||Single||||t||
1424910|NCT01967407||Single Group Assignment||Treatment||None (Open Label)||||||
1424911|NCT01967394|Randomized|Single Group Assignment||||Double|||t|||t
1424912|NCT01967381|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1424913|NCT01967368|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424914|NCT01967355||Single Group Assignment||Treatment||None (Open Label)||||||
1424915|NCT01967342|Randomized|Parallel Assignment||Treatment||Single||||||t
1424916|NCT01967329|Randomized|Parallel Assignment||Treatment||Single||||||t
1424917|NCT01967303|||Case Control||Cross-Sectional|||||||
1424918|NCT01967290|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424919|NCT01967277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424920|NCT01967264|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1424921|NCT01967251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424922|NCT01967238|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1424923|NCT01967225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424924|NCT01967212|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1424925|NCT01967199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424926|NCT01967186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424927|NCT01967173|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1424928|NCT01967160|||Cohort||Prospective|||||||
1424929|NCT01967147|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1424930|NCT01967134|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424931|NCT01967121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424932|NCT01967108|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424933|NCT01967095||Single Group Assignment||Treatment||None (Open Label)||||||
1424934|NCT01967082|||Case-Control||Prospective|||||||
1424935|NCT01967069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424936|NCT01967056|||Cohort||Prospective|||||||
1424937|NCT01967043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424938|NCT01967030|||Cohort||Prospective|||||||
1424939|NCT01967017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424940|NCT01967004||Single Group Assignment||Supportive Care||None (Open Label)||||||
1424941|NCT01966991|||Cohort||Prospective|||||||
1424942|NCT01966978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424943|NCT01966965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424944|NCT01966952|||Cohort||Prospective|||||||
1424945|NCT01966939|||Case Control||Prospective|||||||
1424946|NCT01966926|Randomized|Parallel Assignment||||None (Open Label)||||||
1424947|NCT01966913||Single Group Assignment||Treatment||None (Open Label)||||||
1424948|NCT01966900|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424949|NCT01966887|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424950|NCT01966874|||Cohort||Prospective|||||||
1424951|NCT01966861|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1424952|NCT01966848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424954|NCT01966822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424955|NCT01966809||Single Group Assignment||Treatment||None (Open Label)||||||
1424956|NCT01966796|||Cohort||Retrospective|||||||
1424957|NCT01966783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424958|NCT01966770|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1424959|NCT01966757|||||Cross-Sectional|||||||
1424960|NCT01966744|||Other||Prospective|||||||
1424961|NCT01966731||Single Group Assignment||Treatment||None (Open Label)||||||
1424962|NCT01966718||Single Group Assignment||Treatment||None (Open Label)||||||
1424963|NCT01966705|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424964|NCT01966692|Randomized|Crossover Assignment||Other||Double|||t|t||
1424965|NCT01966679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424966|NCT01966666|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1424967|NCT01966653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424968|NCT01966640||Single Group Assignment||Diagnostic||None (Open Label)||||||
1424969|NCT01966627|||Cohort||Prospective|||||||
1424970|NCT01966614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424971|NCT01966601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1424972|NCT01966588|||Cohort||Prospective|||||||
1424973|NCT01966575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424974|NCT01966562|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1424975|NCT01966549|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424976|NCT01966536||Single Group Assignment||Treatment||None (Open Label)||||||
1424977|NCT01966523|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1424978|NCT01966510||Single Group Assignment||Treatment||None (Open Label)||||||
1424979|NCT01966497|||Cohort||Prospective|||||||
1424980|NCT01966484|Randomized|Parallel Assignment||Treatment||Single|||t|||
1424981|NCT01966471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424982|NCT01966458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424983|NCT01966445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1424984|NCT01966432||Single Group Assignment||Screening||None (Open Label)||This is a single group, non-randomized, pilot study that explores the feasibility of applying SBIRT to adult with high-risk diabetes.||||
1424985|NCT01966419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1424986|NCT01966406|Randomized|Parallel Assignment||||None (Open Label)||||||
1424987|NCT01966393|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424988|NCT01966380|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1424989|NCT01966367||Single Group Assignment||Treatment||None (Open Label)||||||
1424990|NCT01966354|Randomized|Parallel Assignment||Prevention||Single|||t|||
1424991|NCT01966341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424992|NCT01966328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424993|NCT01966315|||Case Control||Prospective|||||||
1424994|NCT01966302||Single Group Assignment||Treatment||None (Open Label)||||||
1424995|NCT01966289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1424996|NCT01966276|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1424997|NCT01966263|Randomized|Parallel Assignment||Treatment||Single||||||t
1424998|NCT01966250|Randomized|Parallel Assignment||Treatment||Single|||||t|
1424999|NCT01966237|||Case Control||Prospective|||||||
1425000|NCT01966224|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425001|NCT01966211||||||||||||
1425002|NCT01966198||Single Group Assignment||Basic Science||None (Open Label)||||||
1425003|NCT01966185|Randomized|Parallel Assignment||||Single||||||t
1425004|NCT01966172|Randomized|Parallel Assignment||Treatment||Single||||||t
1425005|NCT01966159|Randomized|Parallel Assignment||Treatment||Single||||||t
1425006|NCT01966146||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425007|NCT01966133|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425008|NCT01966120|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425009|NCT01966107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425010|NCT01966094|||Case-Control||Prospective|||||||
1425011|NCT01966081|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1425012|NCT01966068||Single Group Assignment||Health Services Research||None (Open Label)||||||
1425013|NCT01966055||Single Group Assignment||Treatment||None (Open Label)||||||
1425014|NCT01966042||Single Group Assignment||Treatment||None (Open Label)||||||
1425015|NCT01966029||Single Group Assignment||Treatment||None (Open Label)||||||
1425016|NCT01966016|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1425017|NCT01966003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425018|NCT01965990|||Case-Only||Prospective|||||||
1425019|NCT01965977||Single Group Assignment||Basic Science||None (Open Label)||||||
1425020|NCT01965964|||Case-Only||Prospective|||||||
1425021|NCT01965951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425022|NCT01965938|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425023|NCT01965925|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425024|NCT01965912||Single Group Assignment||Treatment||None (Open Label)||||||
1425025|NCT01965899||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425026|NCT01965886|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425027|NCT01965873|Randomized|Parallel Assignment||Treatment||Single||||||t
1425028|NCT01965860|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1425029|NCT01965847|Randomized|Parallel Assignment||Other||Single||||||t
1425030|NCT01965834||Single Group Assignment||Treatment||None (Open Label)||||||
1425031|NCT01965821|Randomized|Crossover Assignment||Treatment||Single||||||t
1425032|NCT01965808|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1425033|NCT01965795|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1425034|NCT01965782||Single Group Assignment||Basic Science||None (Open Label)||||||
1425035|NCT01965769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425036|NCT01965756|Randomized|Crossover Assignment||Treatment||Quadruple||This pilot study used a randomized, double-blinded, placebo-controlled 16 week crossover design to examine the effects of metformin on biochemical, neurophysiological, and cognitive biomarkers of AD.|t|t|t|t
1425037|NCT01965743||Single Group Assignment||||None (Open Label)||||||
1425038|NCT01965730|Randomized|Factorial Assignment||Other||Double|||t||t|
1425039|NCT01965717|||Case-Control||Prospective|||||||
1425040|NCT01965704|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425041|NCT01965691||Single Group Assignment||Supportive Care||Single|||t|||
1425042|NCT01965678|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1425043|NCT01965665||Single Group Assignment||Treatment||None (Open Label)||||||
1425044|NCT01965652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425045|NCT01965639||Single Group Assignment||Supportive Care||None (Open Label)||||||
1425046|NCT01965626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425047|NCT01965613||Single Group Assignment||Treatment||None (Open Label)||||||
1425048|NCT01965600|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1425049|NCT01965587|Randomized|Parallel Assignment||Prevention||Single|||t|||
1425050|NCT01965574||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425051|NCT01965561|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1425052|NCT01965548|||Cohort||Retrospective|||||||
1425053|NCT01965535|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425054|NCT01965522|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1425055|NCT01965509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425056|NCT01965496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425057|NCT01965483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||"ONCE-WEEKLY HYPOFRACTIONATED RADIOTHERAPY FOR BREAST CANCER:~PHASE II NON-RANDOMIZED CLINICAL TRIAL"||||
1425058|NCT01965470|Randomized|Parallel Assignment||Prevention||||||||
1425059|NCT01965457|||Cohort||Prospective|||||||
1425060|NCT01965444|||Cohort||Prospective|||||||
1425061|NCT01965431|Randomized|Crossover Assignment||Treatment||Single||||||
1425062|NCT01965418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425063|NCT01965405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425064|NCT01965392|Randomized|Single Group Assignment||Treatment||Single||||t||
1425065|NCT01965379|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425066|NCT01965366|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425067|NCT01965353||Single Group Assignment||Treatment||None (Open Label)||||||
1425068|NCT01965340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425069|NCT01965327||Single Group Assignment||Treatment||None (Open Label)||||||
1425070|NCT01965314|Randomized|Parallel Assignment||Treatment||Single||||||t
1425071|NCT01965301|Randomized|Parallel Assignment||||Double|||t||t|
1425072|NCT01965288|Randomized|Crossover Assignment||Treatment||Single|||t|||
1425073|NCT01965275||Single Group Assignment||Treatment||None (Open Label)||||||
1425074|NCT01965262|Randomized|Crossover Assignment||Treatment||Single|||t|||
1425075|NCT01965249|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1425076|NCT01965236|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1425077|NCT01965223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425078|NCT01965210|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1425079|NCT01965184|Randomized|Parallel Assignment||Treatment||Single||||||t
1425080|NCT01965171|||Cohort||Prospective|||||||
1425081|NCT01965158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425082|NCT01965145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425083|NCT01965132|||Cohort||Prospective|||||||
1425084|NCT01965119||Single Group Assignment||Treatment||None (Open Label)||||||
1425085|NCT01965106|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1425086|NCT01965093|||Cohort||Prospective|||||||
1425087|NCT01965080||Single Group Assignment||Treatment||None (Open Label)||||||
1425088|NCT01965067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425089|NCT01965054|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1425090|NCT01965041||Single Group Assignment||Treatment||None (Open Label)||||||
1425091|NCT01965028||Single Group Assignment||Treatment||None (Open Label)||||||
1425092|NCT01965015||Single Group Assignment||Treatment||None (Open Label)||||||
1425093|NCT01965002||Single Group Assignment||Treatment||None (Open Label)||||||
1425094|NCT01964989|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425095|NCT01964976|||Cohort||Prospective|||||||
1425096|NCT01964963|||Cohort||Prospective|||||||
1425097|NCT01964950|||Cohort||Prospective|||||||
1425098|NCT01964937|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1425099|NCT01964924||Single Group Assignment||Treatment||None (Open Label)||||||
1425100|NCT01964911||Single Group Assignment||Treatment||None (Open Label)||||||
1425101|NCT01964898|Randomized|Parallel Assignment||Treatment||Single||||||t
1425102|NCT01964885|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1425103|NCT01964872|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425647|NCT01957761|||Cohort||Retrospective|||||||
1425104|NCT01964859||Single Group Assignment||Basic Science||None (Open Label)|Sites are labeled as A, B and C and masked for outcomes assessors-- but these are all in the same subject.|||||
1425105|NCT01964846|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1425106|NCT01964833|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1425107|NCT01964820|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1425108|NCT01964807|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1425109|NCT01964794|||Case-Only||Cross-Sectional|||||||
1425110|NCT01964781|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1425111|NCT01964768||Single Group Assignment||Diagnostic||Double|||t||t|
1425112|NCT01964755||Single Group Assignment||Treatment||None (Open Label)||||||
1425113|NCT01964742||Single Group Assignment||||None (Open Label)||||||
1425114|NCT01964729|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425115|NCT01964716|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425116|NCT01964703|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425117|NCT01964690|||Cohort||Prospective|||||||
1425118|NCT01964677||Single Group Assignment||Treatment||None (Open Label)||||||
1425119|NCT01964664|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425120|NCT01964651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425121|NCT01964638||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425122|NCT01964625||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425123|NCT01964612|||Case-Only||Prospective|||||||
1425124|NCT01964599|Randomized|Crossover Assignment||Other||Double|||t||t|
1425125|NCT01964586|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425126|NCT01964573|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1425127|NCT01964560||Single Group Assignment||Treatment||None (Open Label)||||||
1425128|NCT01964547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425129|NCT01964534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425130|NCT01964521||Single Group Assignment||Treatment||None (Open Label)||||||
1425131|NCT01964508|||Cohort||Prospective|||||||
1425132|NCT01964495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425133|NCT01964482|Randomized|Parallel Assignment||Treatment||Single||||||t
1425134|NCT01964469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425135|NCT01964456|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1425136|NCT01964443|||Cohort||Prospective|||||||
1425137|NCT01964430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425138|NCT01964417|Randomized|Parallel Assignment||||Single|||||t|
1425139|NCT01964404|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1425140|NCT01964391||Single Group Assignment||Treatment||None (Open Label)||||||
1425141|NCT01964378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425142|NCT01964365|Randomized|Crossover Assignment||||None (Open Label)||||||
1425143|NCT01964352|Randomized|Parallel Assignment||Treatment||Double||||||
1425144|NCT01964339|||Other||Prospective|||||||
1425145|NCT01964326||||Treatment||None (Open Label)||||||
1425146|NCT01964313|||Cohort||Prospective|||||||
1425147|NCT01964300||Single Group Assignment||Treatment||None (Open Label)||||||
1425148|NCT01964287||Single Group Assignment||Treatment||None (Open Label)||||||
1425149|NCT01964274|||Cohort||Prospective|||||||
1425150|NCT01964261||Single Group Assignment||Basic Science||None (Open Label)||||||
1425151|NCT01964248|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425152|NCT01964235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425153|NCT01964222|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425154|NCT01964209|||Cohort||Prospective|||||||
1425155|NCT01964196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425156|NCT01964183||Single Group Assignment||||None (Open Label)||||||
1425157|NCT01964170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425158|NCT01964157||Single Group Assignment||Treatment||None (Open Label)||||||
1425159|NCT01964144|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425160|NCT01964131|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1425161|NCT01964118|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425162|NCT01964105|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1425163|NCT01964092|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425164|NCT01964079|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425165|NCT01964066|Randomized|Parallel Assignment||Prevention||Single||||||t
1425166|NCT01964053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425167|NCT01964040|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1425168|NCT01964027||Single Group Assignment||Treatment||None (Open Label)||||||
1425169|NCT01964014||Single Group Assignment||Treatment||None (Open Label)||||||
1425170|NCT01964001|Randomized|Parallel Assignment||Prevention||Single|||t|||
1425171|NCT01963988|||Cohort||Prospective|||||||
1425172|NCT01963962|||Cohort||Prospective|||||||
1425173|NCT01963949|||Case Control||Prospective|||||||
1425174|NCT01963936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425175|NCT01963923|Randomized|Parallel Assignment||Treatment||Single||||||t
1425176|NCT01963910|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1425177|NCT01963897|||Cohort||Prospective|||||||
1425178|NCT01963884|||Cohort||Prospective|||||||
1425179|NCT01963871||Single Group Assignment||Treatment||None (Open Label)||||||
1425180|NCT01963858|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425181|NCT01963845|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425182|NCT01963832|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425183|NCT01963819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425184|NCT01963806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425185|NCT01963793|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1425186|NCT01963780||Single Group Assignment||Treatment||None (Open Label)||||||
1425187|NCT01963767|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1425188|NCT01963754|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1425189|NCT01963741|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1425190|NCT01963728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425191|NCT01963715||Single Group Assignment||Treatment||None (Open Label)||||||
1425192|NCT01963702|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425193|NCT01963689|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425194|NCT01963676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425195|NCT01963663|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1425196|NCT01963650|||Cohort||Prospective|||||||
1425197|NCT01963637||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425198|NCT01963624|||Cohort||Cross-Sectional|||||||
1425199|NCT01963611|Randomized|Parallel Assignment||Treatment||Single||||||t
1425200|NCT01963598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425201|NCT01963585|||Cohort||Prospective|||||||
1425202|NCT01963572|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1425203|NCT01963559|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1425204|NCT01963546|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425205|NCT01963533|||Case-Only||Prospective|||||||
1425206|NCT01963520|||Cohort||Prospective|||||||
1425207|NCT01963507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425208|NCT01963494|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425209|NCT01963481||Single Group Assignment||Treatment||None (Open Label)||||||
1425210|NCT01963468|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425211|NCT01963455||Single Group Assignment||Treatment||None (Open Label)||||||
1425212|NCT01963442|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425213|NCT01963429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425214|NCT01963416|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1425215|NCT01963403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425216|NCT01963390|||Cohort||Prospective|||||||
1425217|NCT01963377|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1425218|NCT01963364||Single Group Assignment||Basic Science||None (Open Label)||||||
1425219|NCT01963351|||Cohort||Prospective|||||||
1425220|NCT01963338|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1425221|NCT01963325||Single Group Assignment||Treatment||None (Open Label)||||||
1425222|NCT01963312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425223|NCT01963299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425224|NCT01963286||Single Group Assignment||Treatment||None (Open Label)||||||
1425225|NCT01963273||Single Group Assignment||Treatment||None (Open Label)||||||
1425226|NCT01963260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425227|NCT01963247|||Cohort||Prospective|||||||
1425228|NCT01963234||Single Group Assignment||Treatment||None (Open Label)||||||
1425229|NCT01963221||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425230|NCT01963208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425231|NCT01963195||Single Group Assignment||Treatment||None (Open Label)||||||
1425232|NCT01963182||Single Group Assignment||Treatment||None (Open Label)||||||
1425233|NCT01963169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425234|NCT01963156|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425235|NCT01963143|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425236|NCT01963130|||Case Control||Cross-Sectional|||||||
1425237|NCT01963117|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425238|NCT01963104|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1425239|NCT01963091|Randomized|Parallel Assignment||Other||Double|||t||t|
1425240|NCT01963078|Randomized|Crossover Assignment||Other||Double|||t||t|
1425241|NCT01963065|||Cohort||Prospective|||||||
1425242|NCT01963052|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425243|NCT01963039|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425244|NCT01963026||Single Group Assignment||Treatment||None (Open Label)||||||
1425245|NCT01963013|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425246|NCT01963000|||Cohort||Retrospective|||||||
1425247|NCT01962987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425248|NCT01962974||Single Group Assignment||Treatment||None (Open Label)||||||
1425249|NCT01962961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425250|NCT01962948||Single Group Assignment||Treatment||None (Open Label)||||||
1425251|NCT01962935|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1425252|NCT01962922|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425253|NCT01962909||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425254|NCT01962896||Single Group Assignment||Treatment||None (Open Label)||||||
1425255|NCT01962883|Randomized|Parallel Assignment||Treatment||Single||||||t
1425256|NCT01962870|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426110|NCT01951729||Single Group Assignment||Basic Science||Single|||t|||
1425257|NCT01962857|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1425258|NCT01962844|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425259|NCT01962831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425260|NCT01962818|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425261|NCT01962805|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1425262|NCT01962792|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425263|NCT01962779|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1425264|NCT01962766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425265|NCT01962753||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425266|NCT01962740|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425267|NCT01962727|||||Cross-Sectional|||||||
1425268|NCT01962714|Randomized|Parallel Assignment||Treatment||Single||||||t
1425269|NCT01962701|||Case Control||Cross-Sectional|||||||
1425270|NCT01962688|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1425271|NCT01962675|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1425272|NCT01962662|Randomized|Parallel Assignment||Treatment||Single||||||t
1425273|NCT01962649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425274|NCT01962636||Single Group Assignment||Treatment||None (Open Label)||||||
1425275|NCT01962623|Randomized|Parallel Assignment||Treatment||Single||||||t
1425276|NCT01962610|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1425277|NCT01962597|Randomized|Parallel Assignment||Treatment||Single||||||t
1425278|NCT01962584|||Cohort||Prospective|||||||
1425279|NCT01962571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425280|NCT01962558|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1425281|NCT01962545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425282|NCT01962532|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425283|NCT01962519|Randomized|Parallel Assignment||||None (Open Label)||||||
1425284|NCT01962506|||Cohort||Prospective|||||||
1425285|NCT01962493|Randomized|Parallel Assignment||Prevention||Single|||||t|
1425286|NCT01962480|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1425287|NCT01962467|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425288|NCT01962454|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1425289|NCT01962441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425290|NCT01962428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425291|NCT01962415|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425292|NCT01962402||Single Group Assignment||Treatment||None (Open Label)||||||
1425293|NCT01962389||Single Group Assignment||Treatment||None (Open Label)||||||
1425294|NCT01962376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425295|NCT01962363||Single Group Assignment||Treatment||None (Open Label)||||||
1425296|NCT01962350|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425297|NCT01962337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425298|NCT01962324||Single Group Assignment||Treatment||None (Open Label)||||||
1425299|NCT01962311||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425300|NCT01962298|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1425301|NCT01962285||Single Group Assignment||Basic Science||None (Open Label)||||||
1425302|NCT01962272|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425303|NCT01962259|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1425304|NCT01962246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425305|NCT01962233||Single Group Assignment||Treatment||None (Open Label)||||||
1425306|NCT01962220|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425307|NCT01962207|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425308|NCT01962194||Single Group Assignment||Treatment||None (Open Label)||||||
1425309|NCT01962181|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1425310|NCT01962168|||Cohort||Prospective|||||||
1425311|NCT01962155|||Cohort||Prospective|||||||
1425312|NCT01962142|||Other||Prospective|||||||
1425313|NCT01962129|||Case-Only|||||||||
1425314|NCT01962116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425315|NCT01962103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425316|NCT01962090|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425317|NCT01962077||Single Group Assignment||Treatment||None (Open Label)||||||
1425318|NCT01962064|Non-Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1425319|NCT01962051|||Case-Only||Prospective|||||||
1425320|NCT01962038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425321|NCT01962025|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1425322|NCT01962012|Randomized|Crossover Assignment||Treatment||Single|||t|||
1425323|NCT01961999|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425324|NCT01961986|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425325|NCT01961973|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425326|NCT01961960||Single Group Assignment||Prevention||None (Open Label)||||||
1425327|NCT01961947|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425328|NCT01961934||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425329|NCT01961921||Single Group Assignment||Treatment||None (Open Label)||||||
1425330|NCT01961908|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425331|NCT01961895|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425332|NCT01961882|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425333|NCT01961869|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425334|NCT01961856|Randomized|Parallel Assignment||Treatment||Single||||||t
1425335|NCT01961843||Single Group Assignment||Treatment||None (Open Label)||||||
1425336|NCT01961830||Single Group Assignment||Treatment||None (Open Label)||||||
1425337|NCT01961817|Randomized|Crossover Assignment||||None (Open Label)||||||
1425338|NCT01961804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425339|NCT01961791|||Cohort||Retrospective|||||||
1425340|NCT01961778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425341|NCT01961765||Single Group Assignment||Treatment||None (Open Label)||||||
1425342|NCT01961752|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1425343|NCT01961739|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425344|NCT01961726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425345|NCT01961713|||Case-Only||Prospective|||||||
1425346|NCT01961700|Randomized|Parallel Assignment||Treatment||Single||||||t
1425347|NCT01961687||Single Group Assignment||Prevention||None (Open Label)||||||
1425348|NCT01961674|Randomized|Crossover Assignment||||Double|||t||t|
1425349|NCT01961661|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1425350|NCT01961648|Randomized|Crossover Assignment||Treatment||Single|||t|||
1425351|NCT01961635|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1425352|NCT01961622|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425353|NCT01961609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425354|NCT01961596|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1425355|NCT01961583||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425356|NCT01961570|||Cohort||Prospective|||||||
1425357|NCT01961557|||Case-Control||Prospective|||||||
1425358|NCT01961544||Single Group Assignment||Treatment||None (Open Label)||||||
1425359|NCT01961531||Single Group Assignment||Treatment||None (Open Label)||||||
1425360|NCT01961518|||Case-Only||Retrospective|||||||
1425361|NCT01961505|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1425362|NCT01961492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425363|NCT01961479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425364|NCT01961466|||Case-Only||Prospective|||||||
1425365|NCT01961453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425366|NCT01961440|||Case-Only||Prospective|||||||
1425367|NCT01961427|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1425368|NCT01961414||Single Group Assignment||Treatment||None (Open Label)||||||
1425369|NCT01961401|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425370|NCT01961388|||Cohort||Prospective|||||||
1425371|NCT01961375|||Cohort||Prospective|||||||
1425372|NCT01961362|||Cohort||Prospective|||||||
1425373|NCT01961349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425374|NCT01961336|Randomized|Parallel Assignment||Treatment||Single||||||t
1425375|NCT01961323||Single Group Assignment||Treatment||None (Open Label)||||||
1425376|NCT01961310|||Cohort||Cross-Sectional|||||||
1425377|NCT01961297||Single Group Assignment||Treatment||None (Open Label)||||||
1425378|NCT01961284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425379|NCT01961271||Single Group Assignment||Treatment||None (Open Label)||||||
1425380|NCT01961258|||Cohort|||||||||
1425381|NCT01961245|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1425382|NCT01961232|||Cohort||Prospective|||||||
1425383|NCT01961219|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1425384|NCT01961206|||Cohort||Prospective|||||||
1425385|NCT01961193|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425386|NCT01961180|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1425387|NCT01961167||Single Group Assignment||Treatment||None (Open Label)||||||
1425388|NCT01961154||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425389|NCT01961141|||Case-Only||Retrospective|||||||
1425390|NCT01961128||Single Group Assignment||Supportive Care||None (Open Label)||||||
1425391|NCT01961115||Single Group Assignment||Treatment||None (Open Label)||||||
1425392|NCT01961102|||Case-Only|||||||||
1425393|NCT01961089|Non-Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1425394|NCT01961076|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425395|NCT01961063||Single Group Assignment||Treatment||None (Open Label)||||||
1425396|NCT01961050|Randomized|Parallel Assignment||Prevention||Single||||||t
1425397|NCT01961037||Single Group Assignment||Prevention||None (Open Label)||||||
1425398|NCT01961024|||Cohort||Cross-Sectional|||||||
1425399|NCT01961011|||Cohort||Prospective|||||||
1425400|NCT01960998|Randomized|Parallel Assignment||Treatment||Single||||t||
1425401|NCT01960985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425402|NCT01960972||Single Group Assignment||Prevention||None (Open Label)||||||
1425403|NCT01960946|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425404|NCT01960933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425405|NCT01960920|Randomized|Crossover Assignment||||Triple|||t|t||t
1425406|NCT01960907|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425407|NCT01960894|||Case-Only||Prospective|||||||
1425408|NCT01960881|||Cohort||Prospective|||||||
1425409|NCT01960868|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425410|NCT01960855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425411|NCT01960842||Single Group Assignment||Treatment||None (Open Label)||||||
1425412|NCT01960829||Single Group Assignment||Treatment||None (Open Label)||||||
1425413|NCT01960816||Single Group Assignment||Treatment||None (Open Label)||||||
1425414|NCT01960803||Single Group Assignment||Treatment||None (Open Label)||||||
1425415|NCT01960790|||Cohort||Prospective|||||||
1425416|NCT01960777|Randomized|Parallel Assignment||Treatment||Single||||||t
1425417|NCT01960764|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1425418|NCT01960751||Single Group Assignment||Screening||None (Open Label)||||||
1425419|NCT01960738|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1425420|NCT01960725|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|Open Label|||||
1425421|NCT01960712|Randomized|Single Group Assignment||Treatment||Single|||t|||
1425422|NCT01960699|||Cohort||Prospective|||||||
1425423|NCT01960686|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425424|NCT01960673|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425425|NCT01960660|Randomized|Crossover Assignment||||None (Open Label)||||||
1425426|NCT01960647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425427|NCT01960634|||||Prospective|||||||
1425428|NCT01960621||Single Group Assignment||Treatment||Double|||t||t|
1425429|NCT01960608|||||Retrospective|||||||
1425430|NCT01960595|Randomized|Parallel Assignment||Treatment||Single||||||t
1425431|NCT01960582|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425432|NCT01960569|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425433|NCT01960556|||Cohort||Prospective|||||||
1425434|NCT01960543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425435|NCT01960530|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1425436|NCT01960517||Single Group Assignment||Basic Science||None (Open Label)||||||
1425437|NCT01960504||Single Group Assignment||Treatment||None (Open Label)||||||
1425438|NCT01960491||Single Group Assignment||Treatment||None (Open Label)||||||
1425439|NCT01960478||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425440|NCT01960465|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1425441|NCT01960452|||Case-Control||Cross-Sectional|||||||
1425442|NCT01960439|||Cohort||Retrospective|||||||
1425443|NCT01960426|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1425444|NCT01960413|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425445|NCT01960400|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1425446|NCT01960387||Single Group Assignment||Treatment||None (Open Label)||||||
1425447|NCT01960374|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425448|NCT01960361||Single Group Assignment||Treatment||None (Open Label)||||||
1425449|NCT01960348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425450|NCT01960335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425451|NCT01960322||Single Group Assignment||Treatment||None (Open Label)||||||
1425452|NCT01960309|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425453|NCT01960296|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425454|NCT01960283|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425455|NCT01960270|Randomized|Crossover Assignment||Treatment||Single|||t|||
1425456|NCT01960257|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425457|NCT01960244|||Cohort||Prospective|||||||
1425458|NCT01960231|||Other||Prospective|||||||
1425459|NCT01960218|||Case-Only||Prospective|||||||
1425460|NCT01960205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425461|NCT01960192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425462|NCT01960179||Single Group Assignment||Treatment||None (Open Label)||||||
1425463|NCT01960166|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425464|NCT01960153|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425465|NCT01960140|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1425466|NCT01960127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425467|NCT01960114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425468|NCT01960101|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425469|NCT01960088|||Other||Cross-Sectional|||||||
1425470|NCT01960075|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425471|NCT01960062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425472|NCT01960049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425473|NCT01960036|Randomized|Parallel Assignment||Treatment||Single||||||t
1425474|NCT01960023||Single Group Assignment||Treatment||None (Open Label)||||||
1425475|NCT01960010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425476|NCT01959997|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1425477|NCT01959984|Randomized|Crossover Assignment||||None (Open Label)||||||
1425478|NCT01959971||Crossover Assignment||Basic Science||Single||Single-sequence crossover|t|||
1425479|NCT01959958|||Cohort||Prospective|||||||
1425480|NCT01959945|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1425481|NCT01959932|Randomized|Parallel Assignment||||None (Open Label)||||||
1425482|NCT01959919|||Case-Only||Prospective|||||||
1425483|NCT01959906|||Cohort||Retrospective|||||||
1425484|NCT01959893|||||Prospective|||||||
1425485|NCT01959880|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425486|NCT01959867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425487|NCT01959854|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425488|NCT01959841|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425489|NCT01959828||Single Group Assignment||Treatment||None (Open Label)||||||
1425491|NCT01959802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425492|NCT01959789|||Case Control||Prospective|||||||
1425493|NCT01959776||Single Group Assignment||Treatment||||||||
1425494|NCT01959763|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1425495|NCT01959750|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1425496|NCT01959737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425497|NCT01959724||Single Group Assignment||Treatment||None (Open Label)||||||
1425498|NCT01959711|Randomized|Parallel Assignment||Treatment||Single||||||t
1425499|NCT01959698||Single Group Assignment||Treatment||None (Open Label)||||||
1425500|NCT01959685||Single Group Assignment||Treatment||None (Open Label)||||||
1425501|NCT01959672||Single Group Assignment||Treatment||None (Open Label)||||||
1425502|NCT01959659|||Cohort||Retrospective|||||||
1425503|NCT01959646|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1425504|NCT01959633||Single Group Assignment||Treatment||None (Open Label)||||||
1425505|NCT01959620|Randomized|Parallel Assignment||Prevention||Single||||||t
1425506|NCT01959607|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1425507|NCT01959594|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1425508|NCT01959581||Single Group Assignment||Treatment||None (Open Label)|Coders are blind to which study phase participants are in|||||
1425509|NCT01959568|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425510|NCT01959555|||||Retrospective|||||||
1425511|NCT01959542||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425512|NCT01959529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425513|NCT01959516|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1425514|NCT01959503|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425515|NCT01959490|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1425516|NCT01959477||Single Group Assignment||Treatment||None (Open Label)||||||
1425517|NCT01959464|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1425518|NCT01959451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425519|NCT01959438||Single Group Assignment||Treatment||None (Open Label)||||||
1425520|NCT01959425|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1425521|NCT01959412|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1425522|NCT01959399||Single Group Assignment||||None (Open Label)||||||
1425523|NCT01959386|||Cohort||Prospective|||||||
1425524|NCT01959373|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425525|NCT01959360|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425526|NCT01959347|Randomized|Parallel Assignment||Treatment||Single||||t||
1425527|NCT01959334|Randomized|Parallel Assignment||||None (Open Label)||||||
1425528|NCT01959321|||Other||Prospective|||||||
1425529|NCT01959308|||||Retrospective|||||||
1425530|NCT01959295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425531|NCT01959282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425532|NCT01959269|||Cohort||Prospective|||||||
1425533|NCT01959256|Randomized|Parallel Assignment||Treatment||Single||||||t
1425534|NCT01959243|Randomized|Parallel Assignment||||Double|||t||t|
1425535|NCT01959230|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425536|NCT01959217||Single Group Assignment||Treatment||None (Open Label)||||||
1425537|NCT01959204||Single Group Assignment||Treatment||None (Open Label)||||||
1425538|NCT01959191|||Case Control||Prospective|||||||
1425539|NCT01959178||||||||||||
1425540|NCT01959165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425541|NCT01959152||Single Group Assignment||Treatment||None (Open Label)||||||
1425542|NCT01959139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425543|NCT01959126||Single Group Assignment||Basic Science||None (Open Label)||||||
1425544|NCT01959113|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425545|NCT01959100|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425546|NCT01959087|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1425547|NCT01959074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425548|NCT01959061||Single Group Assignment||Treatment||None (Open Label)||||||
1425549|NCT01959048||Single Group Assignment||Treatment||None (Open Label)||||||
1425550|NCT01959035||Single Group Assignment||Treatment||None (Open Label)||||||
1425551|NCT01959022||Single Group Assignment||Treatment||None (Open Label)||||||
1425552|NCT01959009|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425553|NCT01958996||Single Group Assignment||Treatment||||||||
1425554|NCT01958983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425555|NCT01958970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425556|NCT01958957||Single Group Assignment||Treatment||None (Open Label)||||||
1425557|NCT01958944||Single Group Assignment||Treatment||None (Open Label)||||||
1425558|NCT01958931|||Case-Only||Prospective|||||||
1425559|NCT01958918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425560|NCT01958905||Single Group Assignment||Treatment||None (Open Label)||||||
1425561|NCT01958892|||Cohort||Retrospective|||||||
1425562|NCT01958879|Randomized|Parallel Assignment||Treatment||Single||||||t
1425563|NCT01958866|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425564|NCT01958853||Single Group Assignment||Treatment||None (Open Label)||||||
1425565|NCT01958840|Randomized|Single Group Assignment||Treatment||Single||||||t
1425566|NCT01958827||Single Group Assignment||Treatment||None (Open Label)||||||
1425567|NCT01958814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425568|NCT01958801|Randomized|Parallel Assignment||||Single||||||t
1425569|NCT01958788||Single Group Assignment||Treatment||None (Open Label)||||||
1425570|NCT01958775|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1425571|NCT01958762||Single Group Assignment||Prevention||None (Open Label)||||||
1425572|NCT01958749|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425573|NCT01958736|Randomized|Parallel Assignment||Treatment||Single||||||t
1425574|NCT01958723|||Cohort||Prospective|||||||
1425575|NCT01958710|||Cohort||Retrospective|||||||
1425576|NCT01958697|||Cohort||Retrospective|||||||
1425577|NCT01958684|||Cohort||Prospective|||||||
1425578|NCT01958671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425579|NCT01958645|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1425580|NCT01958632|||Case Control||Prospective|||||||
1425581|NCT01958619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425582|NCT01958606|Randomized|Parallel Assignment||Treatment||Single||||||t
1425583|NCT01958593|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1425584|NCT01958580||Single Group Assignment||Treatment||None (Open Label)||||||
1425585|NCT01958567|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425586|NCT01958554|Randomized|Parallel Assignment||Treatment||Single||||||t
1425587|NCT01958541|Randomized|Parallel Assignment||Treatment||Single||||||t
1425588|NCT01958528|||Cohort||Prospective|||||||
1425589|NCT01958515|||Case-Control||Prospective|||||||
1425590|NCT01958502||Single Group Assignment||Treatment||None (Open Label)||||||
1425591|NCT01958489|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1425592|NCT01958476|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1425593|NCT01958463||Single Group Assignment||Treatment||None (Open Label)||||||
1425594|NCT01958450|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1425595|NCT01958437|Randomized|Crossover Assignment||Treatment||Double|Double blinded|Transcranial Direct Current Stimulation|t||t|
1425596|NCT01958424|||Cohort||Prospective|||||||
1425597|NCT01958411|||Case Control||Cross-Sectional|||||||
1425598|NCT01958398|Randomized|Parallel Assignment||Treatment||Single|||||t|
1425599|NCT01958385|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1425600|NCT01958372|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425601|NCT01958359|Randomized|Parallel Assignment||Treatment||Single|||||t|
1425602|NCT01958346|Randomized|Parallel Assignment||||None (Open Label)||||||
1425603|NCT01958333|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425604|NCT01958320|Randomized|Parallel Assignment||Treatment||Single||Early routine, mandated PDA treatment versus Conservative treatment only if Rescue criteria are met||||t
1425605|NCT01958307|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425606|NCT01958294||Single Group Assignment||Treatment||None (Open Label)||||||
1425607|NCT01958281|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1425608|NCT01958268|||||Prospective|||||||
1425609|NCT01958255||Single Group Assignment||Other||None (Open Label)||||||
1425610|NCT01958242||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425611|NCT01958229|||Cohort||Prospective|||||||
1425612|NCT01958216||Single Group Assignment||||None (Open Label)||||||
1425613|NCT01958203|||||Retrospective|||||||
1425614|NCT01958190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425615|NCT01958177||Single Group Assignment||Treatment||None (Open Label)||||||
1425616|NCT01958164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425617|NCT01958151|||Cohort||Prospective|||||||
1425618|NCT01958138|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1425619|NCT01958125|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1425620|NCT01958112||Single Group Assignment||Treatment||None (Open Label)||||||
1425621|NCT01958099|Randomized|Parallel Assignment||Prevention||Single|||||t|
1425622|NCT01958086||Single Group Assignment||Basic Science||None (Open Label)||||||
1425623|NCT01958073|Randomized|Parallel Assignment||Prevention||Single|||t|||
1425624|NCT01958060|Randomized|Single Group Assignment||Treatment||Single||||||
1425625|NCT01958047||Single Group Assignment||Basic Science||None (Open Label)||||||
1425626|NCT01958034|Randomized|Parallel Assignment||Treatment||Single||||||t
1425627|NCT01958021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425628|NCT01958008|Randomized|Single Group Assignment||Treatment||Double||||||
1425629|NCT01957995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425630|NCT01957982||||||||||||
1425631|NCT01957969|||Cohort||Prospective|||||||
1425632|NCT01957956||Single Group Assignment||Treatment||None (Open Label)||||||
1425633|NCT01957943|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1425634|NCT01957930|||Case Control||Prospective|||||||
1425635|NCT01957917|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425636|NCT01957904||Single Group Assignment||Treatment||None (Open Label)||||||
1425637|NCT01957891|||Cohort||Prospective|||||||
1425638|NCT01957878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425639|NCT01957865|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425640|NCT01957852|||Cohort||Retrospective|||||||
1425641|NCT01957839|Randomized|Single Group Assignment||Treatment||Single|||t|||
1425642|NCT01957826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425643|NCT01957813|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425644|NCT01957800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425645|NCT01957787||Single Group Assignment||Treatment||None (Open Label)||||||
1425646|NCT01957774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425648|NCT01957748|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425649|NCT01957735|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1425650|NCT01957722|Randomized|Single Group Assignment||Treatment||Single||||||t
1425651|NCT01957709||Single Group Assignment||Basic Science||None (Open Label)||||||
1425652|NCT01957696|||Cohort||Prospective|||||||
1425653|NCT01957683||Single Group Assignment||Treatment||None (Open Label)||||||
1425654|NCT01957670||Single Group Assignment||Treatment||None (Open Label)||||||
1425655|NCT01957657|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425656|NCT01957644|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425657|NCT01957631|Randomized|Parallel Assignment||Treatment||Single||||||t
1425658|NCT01957618|||Cohort||Prospective|||||||
1425659|NCT01957605|||||Cross-Sectional|||||||
1425660|NCT01957592|||Ecologic or Community||Cross-Sectional|||||||
1425661|NCT01957579||Single Group Assignment||Treatment||None (Open Label)||||||
1425662|NCT01957566||Single Group Assignment||Screening||None (Open Label)||||||
1425663|NCT01957553|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1425664|NCT01957540|Randomized|Crossover Assignment||Treatment||Single||||||t
1425665|NCT01957527|||Case-Only||Prospective|||||||
1425666|NCT01957514|||Case-Only||Prospective|||||||
1425667|NCT01957501|||Case-Control||Cross-Sectional|||||||
1425668|NCT01957488|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1425669|NCT01957475|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1425670|NCT01957462|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1425671|NCT01957449|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1425672|NCT01957436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425673|NCT01957423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425674|NCT01957410|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425675|NCT01957397|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1425676|NCT01957384|Randomized|Crossover Assignment||||None (Open Label)||||||
1425677|NCT01957371||Single Group Assignment||Treatment||Single||||||t
1425678|NCT01957358||Single Group Assignment||Health Services Research||None (Open Label)||||||
1425679|NCT01957345|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425680|NCT01957332||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425681|NCT01957319|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425682|NCT01957306||Single Group Assignment||Treatment||None (Open Label)||||||
1425683|NCT01957293|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1425684|NCT01957280||Single Group Assignment||Treatment||None (Open Label)||||||
1425685|NCT01957267|||Cohort||Prospective|||||||
1425686|NCT01957254|||||Prospective|||||||
1425687|NCT01957241|||Cohort||Prospective|||||||
1425688|NCT01957228||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425689|NCT01957215|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425690|NCT01957202|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1425691|NCT01957189||Single Group Assignment||Treatment||None (Open Label)||||||
1425692|NCT01957176|Non-Randomized|||Treatment||None (Open Label)||||||
1425693|NCT01957163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425694|NCT01957150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425695|NCT01957137|Randomized|Crossover Assignment||Treatment||Single|||t|||
1425696|NCT01957124|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1425697|NCT01957111|||Case Control||Cross-Sectional|||||||
1425698|NCT01957098|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1425699|NCT01957085|||Cohort||Retrospective|||||||
1425700|NCT01957072|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1425701|NCT01957059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425702|NCT01957046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425703|NCT01957033|Randomized|Factorial Assignment||Treatment||Single||||||t
1425704|NCT01957020|||Case-Only||Retrospective|||||||
1425705|NCT01957007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425706|NCT01956994|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1425707|NCT01956981|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425708|NCT01956968|||Case-Only||Cross-Sectional|||||||
1425709|NCT01956955|Randomized|Parallel Assignment||||Double|||t||t|
1425710|NCT01956942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425711|NCT01956929|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1425712|NCT01956916|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1425713|NCT01956903||Single Group Assignment||Treatment||None (Open Label)||||||
1425714|NCT01956890||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425715|NCT01956877|||Cohort||Prospective|||||||
1425716|NCT01956864|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1425717|NCT01956851|||Case Control||Cross-Sectional|||||||
1425718|NCT01956838|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1425719|NCT01956825|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425720|NCT01956812|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425721|NCT01956799|||Cohort||Prospective|||||||
1425722|NCT01956786|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425723|NCT01956773|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425724|NCT01956760|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425725|NCT01956747|||Case-Only||Prospective|||||||
1425726|NCT01956734||Single Group Assignment||Treatment||None (Open Label)||||||
1425727|NCT01956721|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1425728|NCT01956708|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1425729|NCT01956695||Single Group Assignment||Treatment||None (Open Label)||||||
1425730|NCT01956682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425731|NCT01956669||||Treatment||None (Open Label)||||||
1425732|NCT01956656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425733|NCT01956643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425734|NCT01956630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425735|NCT01956617||Single Group Assignment||||Double|||t|||t
1425736|NCT01956604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425737|NCT01956591|||Cohort||Retrospective|||||||
1425738|NCT01956578||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425739|NCT01956565|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1425740|NCT01956552||Single Group Assignment||||None (Open Label)||||||
1425741|NCT01956539|||Cohort||Prospective|||||||
1425742|NCT01956526||||Treatment||None (Open Label)||||||
1425743|NCT01956513||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425744|NCT01956500|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425745|NCT01956487||Single Group Assignment||Other||None (Open Label)||||||
1425746|NCT01956474||Single Group Assignment||Treatment||None (Open Label)||||||
1425747|NCT01956461|||Case-Only||Prospective|||||||
1425748|NCT01956448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425749|NCT01956435|Randomized|Single Group Assignment||Treatment||Single||||||t
1425750|NCT01956422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425751|NCT01956409||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425752|NCT01956396||Single Group Assignment||Prevention||None (Open Label)||||||
1425753|NCT01956383||Single Group Assignment||Prevention||None (Open Label)||||||
1425754|NCT01956370|Randomized|Parallel Assignment||Prevention||Single||||||t
1425755|NCT01956357|Randomized|Parallel Assignment||Treatment||Single||||||t
1425756|NCT01956344|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1425757|NCT01956331|||Cohort||Prospective|||||||
1425758|NCT01956318|Randomized|Parallel Assignment||Treatment||Single||||||t
1425759|NCT01956305|Randomized|Crossover Assignment||Treatment||Single|||t|||
1425760|NCT01956292|||Case-Only||Prospective|||||||
1425761|NCT01956279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425762|NCT01956266|Randomized|Parallel Assignment||Treatment||Single||||||t
1425763|NCT01956253||||||||||||
1425764|NCT01956240|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1425765|NCT01956227|Randomized|Parallel Assignment||Prevention||Single||||||t
1425766|NCT01956214|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425767|NCT01956201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425768|NCT01956188|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1425769|NCT01956175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425770|NCT01956162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425771|NCT01956149||Single Group Assignment||Treatment||None (Open Label)||||||
1425772|NCT01956136|Randomized|Crossover Assignment||Treatment||Single||||||t
1425773|NCT01956123|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1425774|NCT01956110|Randomized|Parallel Assignment||Treatment||Single||||||t
1425775|NCT01956097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425776|NCT01956084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425777|NCT01956071|||Case-Only||Cross-Sectional|||||||
1425778|NCT01956058||Single Group Assignment||Treatment||None (Open Label)||||||
1425779|NCT01956045|||||Cross-Sectional|||||||
1425780|NCT01956032|||||Prospective|||||||
1425781|NCT01956019||Single Group Assignment||Basic Science||None (Open Label)||||||
1425782|NCT01956006||Single Group Assignment||Treatment||None (Open Label)||||||
1425783|NCT01955993|||Cohort||Prospective|||||||
1425784|NCT01955980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425785|NCT01955967|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1425786|NCT01955954||Single Group Assignment||Treatment||None (Open Label)||||||
1425787|NCT01955941|||Cohort||Prospective|||||||
1425788|NCT01955928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425789|NCT01955915|||Cohort||Prospective|||||||
1425790|NCT01955902|||Cohort||Prospective|||||||
1425791|NCT01955889|Randomized|Parallel Assignment||Treatment||Single||||||t
1425792|NCT01955876|||Case-Only||Prospective|||||||
1425793|NCT01955863|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1425794|NCT01955850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425795|NCT01955837|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425796|NCT01955824|Randomized|Parallel Assignment||Treatment||Single|||t|||
1425797|NCT01955811||Single Group Assignment||||None (Open Label)||||||
1425798|NCT01955798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425799|NCT01955785|Randomized|Crossover Assignment||Treatment||Single||||||t
1425800|NCT01955772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425801|NCT01955759|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1425802|NCT01955746|||Family-Based||Cross-Sectional|||||||
1425803|NCT01955733||Single Group Assignment||Treatment||None (Open Label)||||||
1425804|NCT01955720|Randomized|Crossover Assignment||Treatment||Double||||||
1425805|NCT01955707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425806|NCT01955694|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425807|NCT01955681|||||Retrospective|||||||
1425808|NCT01955668|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425809|NCT01955655|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1425810|NCT01955642|||Case-Only||Prospective|||||||
1425811|NCT01955629||Single Group Assignment||Treatment||None (Open Label)||||||
1425812|NCT01955616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425813|NCT01955603|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425814|NCT01955590|Randomized|Parallel Assignment||Treatment||Single||||||t
1425815|NCT01955577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425816|NCT01955564|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425817|NCT01955551|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1425818|NCT01955538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425819|NCT01955525|||Cohort||Prospective|||||||
1425820|NCT01955512|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1425821|NCT01955499||Single Group Assignment||Treatment||None (Open Label)||||||
1425822|NCT01955486||Single Group Assignment||Basic Science||None (Open Label)||||||
1425823|NCT01955473||Single Group Assignment||Treatment||None (Open Label)||||||
1425824|NCT01955460||Single Group Assignment||Treatment||None (Open Label)||||||
1425825|NCT01955447|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1425826|NCT01955434||Single Group Assignment||Treatment||None (Open Label)||||||
1425827|NCT01955421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425828|NCT01955408|||Cohort||Prospective|||||||
1425829|NCT01955395|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1425830|NCT01955382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425831|NCT01955369|||Cohort||Prospective|||||||
1425832|NCT01955356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425833|NCT01955343|||Other||Prospective|||||||
1425834|NCT01955330|||Cohort||Prospective|||||||
1425835|NCT01955317|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425836|NCT01955304|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425837|NCT01955291|Randomized|Parallel Assignment||Treatment||Single||||||t
1425838|NCT01955278||Single Group Assignment||Prevention||None (Open Label)||||||
1425839|NCT01955265|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1425840|NCT01955252||Single Group Assignment||Treatment||None (Open Label)||||||
1425841|NCT01955239|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1425842|NCT01955226|Randomized|Parallel Assignment||Prevention||Single||||||t
1425843|NCT01955213|||Case-Control||Prospective|||||||
1425844|NCT01955200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425845|NCT01955187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425846|NCT01955174|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1425847|NCT01955161|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425848|NCT01955148|||Case-Only||Prospective|||||||
1425849|NCT01955135|Randomized|Parallel Assignment||Treatment||Single|||||t|
1425850|NCT01955122|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1425851|NCT01955109||Single Group Assignment||Treatment||None (Open Label)||||||
1425852|NCT01955096|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1425853|NCT01955083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425854|NCT01955070|Randomized|Parallel Assignment||||None (Open Label)||||||
1425855|NCT01955057|||Case Control||Prospective|||||||
1425856|NCT01955044|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425857|NCT01955031|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425858|NCT01955018|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1425859|NCT01955005|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425860|NCT01954992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425861|NCT01954979||Single Group Assignment||Treatment||None (Open Label)||||||
1425862|NCT01954966|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1425863|NCT01954953|||Cohort||Prospective|||||||
1425864|NCT01954940|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425865|NCT01954927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425866|NCT01954914||Single Group Assignment||Treatment||None (Open Label)||||||
1425867|NCT01954901|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425868|NCT01954888|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1425869|NCT01954875|||||Prospective|||||||
1425870|NCT01954862|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425871|NCT01954849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425872|NCT01954836|Randomized|Crossover Assignment||Treatment||Single||||||t
1425873|NCT01954823|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425874|NCT01954810||Single Group Assignment||Prevention||None (Open Label)||||||
1425875|NCT01954797|||Case-Control||Prospective|||||||
1425876|NCT01954784||Single Group Assignment||Treatment||None (Open Label)||||||
1425877|NCT01954771|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425878|NCT01954758|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425879|NCT01954745||Single Group Assignment||Treatment||None (Open Label)||||||
1425880|NCT01954732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425881|NCT01954719|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1425882|NCT01954706|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425883|NCT01954693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425884|NCT01954680|Randomized|Parallel Assignment||Treatment||Triple|Neither participant nor independent evaluator knows group assignment in R33 phase randomized controlled trial.|"R21 phase was an open phase 1a trial for feasibility and acceptability with enrollment goal including intervention development of 20.~R33 phase enrollment goal of 40 including double-blind placebo-controlled randomized trial of 2 versions of video game potential intervention."|t|t||t
1425885|NCT01954667|||Case Control||Prospective|||||||
1425886|NCT01954654|Randomized|Parallel Assignment||Treatment||Single||||||t
1425887|NCT01954641|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1425888|NCT01954628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425889|NCT01954615|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425890|NCT01954602|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1425891|NCT01954589|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1425892|NCT01954576||Single Group Assignment||Treatment||None (Open Label)||||||
1425893|NCT01954563|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425894|NCT01954550|Randomized|Parallel Assignment||Treatment||Single||||||t
1425895|NCT01954537|||Cohort||Prospective|||||||
1425896|NCT01954524||Single Group Assignment||Treatment||None (Open Label)||||||
1425897|NCT01954511||Single Group Assignment||Treatment||None (Open Label)||||||
1425898|NCT01954498|Randomized|Parallel Assignment||Treatment||Single||||||t
1425899|NCT01954485|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1425900|NCT01954472|Randomized|Parallel Assignment||Treatment||Single|||||t|
1425901|NCT01954459|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1425902|NCT01954446|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1425903|NCT01954433|||Other||Prospective|||||||
1425904|NCT01954420|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425905|NCT01954407|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1425906|NCT01954394||Single Group Assignment||Treatment||None (Open Label)||||||
1425907|NCT01954381|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1425908|NCT01954368|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425909|NCT01954355||Single Group Assignment||Treatment||None (Open Label)||||||
1425910|NCT01954342|||Cohort||Prospective|||||||
1425911|NCT01954329|||Cohort||Cross-Sectional|||||||
1425912|NCT01954316||Single Group Assignment||Treatment||None (Open Label)||||||
1425913|NCT01954303|||||Retrospective|||||||
1425914|NCT01954290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425915|NCT01954277|Randomized|Crossover Assignment||Treatment||Single|||||t|
1425916|NCT01954264||Single Group Assignment||Other||None (Open Label)||||||
1425917|NCT01954251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1425918|NCT01954238|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1425919|NCT01954225||Single Group Assignment||Treatment||None (Open Label)||||||
1425920|NCT01954212|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1425921|NCT01954199|Randomized|Parallel Assignment||Treatment||Single||||||t
1425922|NCT01954186|Randomized|Single Group Assignment||||Single|||t|||
1425923|NCT01954173||Single Group Assignment||Treatment||None (Open Label)||||||
1425924|NCT01954160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425925|NCT01954147|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1425926|NCT01954134|||Case Control||Prospective|||||||
1425927|NCT01954121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425928|NCT01954108|Randomized|Parallel Assignment||Treatment||Single||||||t
1425929|NCT01954095|||Cohort||Prospective|||||||
1425930|NCT01954082|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425931|NCT01954069||Single Group Assignment||Health Services Research||None (Open Label)||||||
1425932|NCT01954056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425933|NCT01954043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425934|NCT01954030|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425935|NCT01954017|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425936|NCT01954004|||Cohort||Prospective|||||||
1425937|NCT01953991|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425938|NCT01953978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425939|NCT01953952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425940|NCT01953939||Single Group Assignment||||None (Open Label)||||||
1425941|NCT01953926|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425942|NCT01953913||Single Group Assignment||Treatment||None (Open Label)||||||
1425943|NCT01953900||Single Group Assignment||Treatment||None (Open Label)||||||
1425944|NCT01953887|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1425945|NCT01953874|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425946|NCT01953861|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1425947|NCT01953848|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1425948|NCT01953835|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1425949|NCT01953822|||Cohort||Retrospective|||||||
1425950|NCT01953809|Randomized|Factorial Assignment||Treatment||Single|||t|||
1425951|NCT01953796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425952|NCT01953783||Single Group Assignment||Treatment||None (Open Label)||||||
1425953|NCT01953770|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426740|NCT01943500|||Case-Control||Cross-Sectional|||||||
1425954|NCT01953757|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1425955|NCT01953744|Randomized|Parallel Assignment||Treatment||Single||||||t
1425956|NCT01953731||Single Group Assignment||Basic Science||None (Open Label)||||||
1425957|NCT01953718|||Case-Only||Retrospective|||||||
1425958|NCT01953705|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1425959|NCT01953692|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425960|NCT01953679|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1425961|NCT01953666|Randomized|Parallel Assignment||Treatment||Single||||||t
1425962|NCT01953653|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1425963|NCT01953640|||Cohort||Prospective|||||||
1425964|NCT01953627||Single Group Assignment||Treatment||None (Open Label)||||||
1425965|NCT01953614|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1425966|NCT01953601|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1425967|NCT01953588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425968|NCT01953575||Single Group Assignment||Diagnostic||None (Open Label)||||||
1425969|NCT01953562|||Cohort||Prospective|||||||
1425970|NCT01953549|Randomized|Parallel Assignment||Treatment||Single||||||t
1425971|NCT01953536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1425972|NCT01953523||Single Group Assignment||Treatment||None (Open Label)||||||
1425973|NCT01953510|Randomized|Parallel Assignment||Prevention||Single||||||t
1425974|NCT01953497|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1425975|NCT01953484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1425976|NCT01953471|||Case-Only||Prospective|||||||
1425977|NCT01953458|||Cohort||Prospective|||||||
1425978|NCT01953445||Single Group Assignment||Treatment||None (Open Label)||||||
1425979|NCT01953432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1425980|NCT01953419||Single Group Assignment||Treatment||None (Open Label)||||||
1425981|NCT01953406||Single Group Assignment||Treatment||None (Open Label)||||||
1425982|NCT01953393||||Basic Science||||||||
1425983|NCT01953380|Randomized|Parallel Assignment||Prevention||Single||||||t
1425984|NCT01953367|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1425985|NCT01953354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1425986|NCT01953341|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1425987|NCT01953328|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1425988|NCT01953315||Single Group Assignment||Treatment||None (Open Label)||||||
1425989|NCT01953302||Single Group Assignment||Treatment||None (Open Label)||||||
1425990|NCT01953289|||Cohort||Prospective|||||||
1425991|NCT01953276|||Cohort||Prospective|||||||
1425992|NCT01953263||Single Group Assignment||Treatment||None (Open Label)||||||
1425993|NCT01953250|||Cohort||Prospective|||||||
1425994|NCT01953237|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1425995|NCT01953224|Randomized|Parallel Assignment||Prevention||Single||||||t
1425996|NCT01953211|||Cohort||Prospective|||||||
1425997|NCT01953198|||Cohort||Prospective|||||||
1425998|NCT01953185|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1425999|NCT01953172|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1426000|NCT01953159|||Case-Control||Retrospective|||||||
1426001|NCT01953146|||Cohort||Retrospective|||||||
1426002|NCT01953133|Randomized|Parallel Assignment||||Single|||||t|
1426003|NCT01953120||Single Group Assignment||Prevention||None (Open Label)||||||
1426004|NCT01953107|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1426005|NCT01953094|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1426006|NCT01953081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426007|NCT01953068|||Case-Control||Prospective|||||||
1426008|NCT01953055||Single Group Assignment||Treatment||None (Open Label)||||||
1426009|NCT01953042|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426010|NCT01953029|||Cohort||Prospective|||||||
1426011|NCT01953016|||Cohort||Other|||||||
1426012|NCT01953003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426013|NCT01952990||Single Group Assignment||Treatment||None (Open Label)||||||
1426014|NCT01952977|Randomized|Crossover Assignment||||Single|||t|||
1426015|NCT01952964|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1426016|NCT01952951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426017|NCT01952938|||Cohort||Prospective|||||||
1426018|NCT01952925|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426019|NCT01952912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426020|NCT01952899|||Cohort||Prospective|||||||
1426021|NCT01952886|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1426022|NCT01952873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426023|NCT01952860||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426024|NCT01952847|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1426025|NCT01952834||Single Group Assignment||Treatment||None (Open Label)||||||
1426026|NCT01952821|||Case-Only||Prospective|||||||
1426027|NCT01952808|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1426028|NCT01952795|Randomized|Parallel Assignment||Treatment||Single|||||t|
1426029|NCT01952782||Single Group Assignment||Prevention||None (Open Label)||||||
1426030|NCT01952769||Single Group Assignment||Treatment||None (Open Label)||||||
1426031|NCT01952756|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426032|NCT01952743|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1426033|NCT01952730||Single Group Assignment||Prevention||None (Open Label)||||||
1426034|NCT01952717|||Case Control||Retrospective|||||||
1426035|NCT01952704|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426036|NCT01952691||Single Group Assignment||Treatment||None (Open Label)||||||
1426037|NCT01952678|||Cohort||Retrospective|||||||
1426038|NCT01952665|Randomized|Crossover Assignment||Treatment||Single|||t|||
1426039|NCT01952652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426040|NCT01952639|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426041|NCT01952626|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426042|NCT01952613||Single Group Assignment||Treatment||None (Open Label)||||||
1426043|NCT01952600|||||Prospective|||||||
1426044|NCT01952587|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1426045|NCT01952574|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1426046|NCT01952561|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426047|NCT01952548|Randomized|Parallel Assignment||||Double|||t||t|
1426048|NCT01952535|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426049|NCT01952522|Randomized|Parallel Assignment||Treatment||Single||||||t
1426050|NCT01952509|||Cohort||Prospective|||||||
1426051|NCT01952496||Single Group Assignment||Treatment||None (Open Label)||||||
1426052|NCT01952483|||Cohort||Prospective|||||||
1426053|NCT01952470|Randomized|Single Group Assignment||Treatment||Single||||||t
1426054|NCT01952457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426055|NCT01952444|Randomized|Parallel Assignment||||None (Open Label)||||||
1426056|NCT01952431|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1426057|NCT01952418|Randomized|Parallel Assignment||Diagnostic||Single|15 endoscopists and 1805 patients on which procedures were performed were randomly assigned to each room.||t|||
1426058|NCT01952405|Randomized|Parallel Assignment||Treatment||Single||||||t
1426059|NCT01952392|||Cohort||Prospective|||||||
1426060|NCT01952379|||Case-Crossover||Cross-Sectional|||||||
1426061|NCT01952366|||Cohort||Prospective|||||||
1426062|NCT01952353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426063|NCT01952340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426064|NCT01952327||Single Group Assignment||Treatment||None (Open Label)||||||
1426065|NCT01952314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426066|NCT01952301|Randomized|Parallel Assignment||Treatment||Single||||||t
1426067|NCT01952288|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426068|NCT01952275|||Case-Only||Cross-Sectional|||||||
1426069|NCT01952262|||Other||Prospective|||||||
1426070|NCT01952249|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426071|NCT01952236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426072|NCT01952223|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1426073|NCT01952210|Randomized|Parallel Assignment||Prevention||Single||||||t
1426074|NCT01952197||Single Group Assignment||||Single||||||t
1426075|NCT01952184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426076|NCT01952171|||Cohort||Cross-Sectional|||||||
1426077|NCT01952158|||||Prospective|||||||
1426078|NCT01952145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426079|NCT01952132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426080|NCT01952119|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426081|NCT01952106|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426082|NCT01952093|||Cohort||Prospective|||||||
1426083|NCT01952080|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426084|NCT01952067|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426085|NCT01952054||Single Group Assignment||Treatment||None (Open Label)||||||
1426086|NCT01952041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426087|NCT01952028|||Cohort||Cross-Sectional|||||||
1426088|NCT01952015||Single Group Assignment||Treatment||None (Open Label)||||||
1426089|NCT01952002|||Case-Only||Prospective|||||||
1426090|NCT01951989|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426091|NCT01951976||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426092|NCT01951963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426093|NCT01951950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426094|NCT01951937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426095|NCT01951924|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1426096|NCT01951911|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1426097|NCT01951898|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1426098|NCT01951885|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426099|NCT01951872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426100|NCT01951859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426101|NCT01951846|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1426102|NCT01951833|||Case Control||Prospective|||||||
1426103|NCT01951820|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1426104|NCT01951807|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1426105|NCT01951794|||Ecologic or Community||Cross-Sectional|||||||
1426106|NCT01951781||Single Group Assignment||Diagnostic||Single||||t||
1426107|NCT01951768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426108|NCT01951755|||Cohort||Prospective|||||||
1426109|NCT01951742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426111|NCT01951716|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1426112|NCT01951703|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1426113|NCT01951690||Single Group Assignment||Treatment||None (Open Label)||||||
1426114|NCT01951677|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1426115|NCT01951664|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426116|NCT01951651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426117|NCT01951638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426118|NCT01951625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426119|NCT01951612|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426120|NCT01951599||Single Group Assignment||Basic Science||None (Open Label)||||||
1426121|NCT01951586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426122|NCT01951573|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1426123|NCT01951560|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426124|NCT01951547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426125|NCT01951534|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1426126|NCT01951521|Randomized|Parallel Assignment||Treatment||None (Open Label)||cohort multiple randomized controlled trial||||
1426127|NCT01951508||Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1426128|NCT01951482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426129|NCT01951469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426130|NCT01951456|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426131|NCT01951443|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1426132|NCT01951430|||Case-Only||Prospective|||||||
1426133|NCT01951417||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426134|NCT01951404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426135|NCT01951391||Single Group Assignment||Health Services Research||None (Open Label)||||||
1426136|NCT01951378|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426137|NCT01951365|||Cohort||Retrospective|||||||
1426138|NCT01951352||Single Group Assignment||Health Services Research||None (Open Label)||||||
1426139|NCT01951339|Randomized|Parallel Assignment||Other||Double|||t||t|
1426140|NCT01951326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426141|NCT01951313||Single Group Assignment||Basic Science||Single||||t||
1426142|NCT01951300||Single Group Assignment||Basic Science||None (Open Label)||||||
1426143|NCT01951287|Randomized|Crossover Assignment||Basic Science||Single||||||t
1426144|NCT01951274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426145|NCT01951261|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426146|NCT01951248||Single Group Assignment||Treatment||None (Open Label)||||||
1426147|NCT01951235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426148|NCT01951222|Randomized|Crossover Assignment||Treatment||Double||||||
1426149|NCT01951209|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1426150|NCT01951196|||Case Control||Cross-Sectional|||||||
1426151|NCT01951183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426152|NCT01951170||Single Group Assignment||Treatment||None (Open Label)||||||
1426153|NCT01951157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426154|NCT01951144|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1426155|NCT01951131||||||||||||
1426156|NCT01951118||Single Group Assignment||Prevention||None (Open Label)||||||
1426157|NCT01951105|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426158|NCT01951092||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426159|NCT01951079||Single Group Assignment||Treatment||None (Open Label)||||||
1426160|NCT01951066|Randomized|Crossover Assignment||||None (Open Label)||||||
1426161|NCT01951053|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1426162|NCT01951040|||Cohort||Retrospective|||||||
1426163|NCT01951027|Randomized|Parallel Assignment||Screening||Double|||t||t|
1426164|NCT01951014|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1426165|NCT01951001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426166|NCT01950988|Randomized|Parallel Assignment||||Single||||||
1426167|NCT01950975|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1426168|NCT01950962|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1426169|NCT01950949||Single Group Assignment||||None (Open Label)||||||
1426170|NCT01950936|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426171|NCT01950923|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426172|NCT01950910|||||Prospective|||||||
1426173|NCT01950897|||||Prospective|||||||
1426174|NCT01950884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426175|NCT01950871||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426176|NCT01950858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426177|NCT01950845|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1426178|NCT01950832|||Case Control||Prospective|||||||
1426179|NCT01950819|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open-label study||||
1426180|NCT01950806|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1426181|NCT01950793|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426182|NCT01950780||Single Group Assignment||Treatment||None (Open Label)||||||
1426183|NCT01950767||||||||||||
1426184|NCT01950754|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1426185|NCT01950741||Single Group Assignment||Treatment||None (Open Label)||||||
1426186|NCT01950728|Randomized|Parallel Assignment||Treatment||Single||||||t
1426187|NCT01950715||Single Group Assignment||Treatment||None (Open Label)||||||
1426188|NCT01950702|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426189|NCT01950689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426190|NCT01950676|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426191|NCT01950663||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426192|NCT01950650|||Ecologic or Community||Cross-Sectional|||||||
1426193|NCT01950637|||Ecologic or Community||Cross-Sectional|||||||
1426194|NCT01950624|||Cohort||Other|||||||
1426195|NCT01950611||Single Group Assignment||Treatment||None (Open Label)||||||
1426196|NCT01950598|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426197|NCT01950585|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426198|NCT01950572|||Case-Only||Prospective|||||||
1426199|NCT01950559|||Cohort||Prospective|||||||
1426200|NCT01950546||Single Group Assignment||Treatment||Double|||t||t|
1426201|NCT01950533|||Cohort||Prospective|||||||
1426202|NCT01950520|||Cohort||Prospective|||||||
1426203|NCT01950507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426204|NCT01950494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426205|NCT01950481|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426206|NCT01950468|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1426207|NCT01950455||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426208|NCT01950442||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426209|NCT01950429|||Cohort||Other|||||||
1426210|NCT01950416|Randomized|Parallel Assignment||Treatment||Single||||||t
1426211|NCT01950403|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1426212|NCT01950390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426213|NCT01950377|||Other||Prospective|||||||
1426214|NCT01950364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426215|NCT01950351||Single Group Assignment||Treatment||None (Open Label)||||||
1426216|NCT01950338|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1426217|NCT01950325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426218|NCT01950312||Single Group Assignment||Treatment||None (Open Label)||||||
1426219|NCT01950299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426220|NCT01950286|||Cohort||Prospective|||||||
1426221|NCT01950273|Randomized|Parallel Assignment||Treatment||Double||||||
1426222|NCT01950260|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426223|NCT01950247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426224|NCT01950234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426225|NCT01950221|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426226|NCT01950208|||Cohort||Prospective|||||||
1426227|NCT01950195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426228|NCT01950182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426229|NCT01950169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426230|NCT01950156||Single Group Assignment||Treatment||None (Open Label)||||||
1426231|NCT01950143|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1426232|NCT01950130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426233|NCT01950117|Randomized|Parallel Assignment||Treatment||Single||||||t
1426234|NCT01950104|Randomized|Parallel Assignment||||None (Open Label)||||||
1426235|NCT01950091|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1426236|NCT01950078|||||Prospective|||||||
1426237|NCT01950065|Randomized|Parallel Assignment||Treatment||Single||||||t
1426238|NCT01950052|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1426239|NCT01950039|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1426240|NCT01950026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426241|NCT01950013|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1426242|NCT01950000|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1426243|NCT01949987|Randomized|Parallel Assignment||||Single||||||t
1426244|NCT01949974|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426245|NCT01949961|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426246|NCT01949948|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426247|NCT01949935|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426248|NCT01949922||Single Group Assignment||Treatment||None (Open Label)||||||
1426249|NCT01949909|Randomized|Parallel Assignment||Prevention||Single|||t|||
1426250|NCT01949896|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426251|NCT01949883||Single Group Assignment||Treatment||None (Open Label)||||||
1426252|NCT01949870||Single Group Assignment||Treatment||None (Open Label)||||||
1426253|NCT01949857|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1426254|NCT01949844||Single Group Assignment||Basic Science||None (Open Label)||||||
1426255|NCT01949831|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1426256|NCT01949818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426257|NCT01949805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426258|NCT01949792|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426259|NCT01949779|||Case-Only||Prospective|||||||
1426260|NCT01949766||||||||||||
1426261|NCT01949753|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1426262|NCT01949740|||Cohort||Prospective|||||||
1426263|NCT01949727|||Cohort||Prospective|||||||
1426264|NCT01949714|||Cohort||Prospective|||||||
1426265|NCT01949701||Single Group Assignment||Treatment||None (Open Label)||||||
1426266|NCT01949688|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426267|NCT01949675|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426268|NCT01949662|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1426269|NCT01949649|Randomized|Parallel Assignment||Prevention||Single||||||t
1426270|NCT01949636|||Cohort||Prospective|||||||
1426271|NCT01949623|||Case-Control||Prospective|||||||
1426272|NCT01949610||Single Group Assignment||Treatment||None (Open Label)||||||
1426273|NCT01949597|||Cohort||Prospective|||||||
1426274|NCT01949584||Single Group Assignment||Treatment||None (Open Label)||||||
1426275|NCT01949571||Single Group Assignment||Prevention||Double|||t||t|
1426276|NCT01949558|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426277|NCT01949545|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1426278|NCT01949532|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1426279|NCT01949519||Single Group Assignment||Treatment||None (Open Label)||||||
1426280|NCT01949506||Single Group Assignment||Treatment||None (Open Label)||||||
1426281|NCT01949493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426282|NCT01949480|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426283|NCT01949467|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1426284|NCT01949454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426285|NCT01949441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426286|NCT01949428|||Cohort|||||||||
1426287|NCT01949415|||Cohort||Prospective|||||||
1426288|NCT01949402|||Cohort||Prospective|||||||
1426289|NCT01949389||Single Group Assignment||Treatment||None (Open Label)||||||
1426290|NCT01949376|||Case-Control||Prospective|||||||
1426291|NCT01949363|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426292|NCT01949350|Non-Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1426293|NCT01949337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426294|NCT01949324|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426295|NCT01949311||Single Group Assignment||Treatment||None (Open Label)||||||
1426296|NCT01949298|Randomized|Parallel Assignment||Treatment||Double||||t||t
1426297|NCT01949285|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1426298|NCT01949272|||Cohort||Prospective|||||||
1426299|NCT01949259|||Cohort||Retrospective|||||||
1426300|NCT01949246|||Cohort||Prospective|||||||
1426301|NCT01949233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426302|NCT01949220|||Cohort||Prospective|||||||
1426303|NCT01949207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426304|NCT01949194||Single Group Assignment||Treatment||None (Open Label)||||||
1426305|NCT01949181||Single Group Assignment||Basic Science||None (Open Label)||||||
1426306|NCT01949168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426307|NCT01949155|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1426308|NCT01949142|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1426309|NCT01949129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426310|NCT01949116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426311|NCT01949103|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1426312|NCT01949090|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426313|NCT01949077|||Cohort||Retrospective|||||||
1426314|NCT01949064|Randomized|Parallel Assignment||Treatment||Single|||||t|
1426315|NCT01949051|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1426316|NCT01949038|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1426317|NCT01949025|Randomized|Sequential Assignment||Prevention||Single||||||t
1426318|NCT01949012|Randomized|Parallel Assignment||Prevention||Single|||t|||
1426319|NCT01948999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426320|NCT01948986|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426321|NCT01948973|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1426322|NCT01948960|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1426323|NCT01948947|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426324|NCT01948934||Single Group Assignment||Treatment||None (Open Label)||||||
1426325|NCT01948921|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1426326|NCT01948908|Randomized|Parallel Assignment||Treatment||Single||||||t
1426327|NCT01948895||Single Group Assignment||Treatment||None (Open Label)||||||
1426328|NCT01948882||Single Group Assignment||Prevention||None (Open Label)||||||
1426329|NCT01948869|Randomized|Parallel Assignment||Treatment||Single|||||t|
1426330|NCT01948856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426331|NCT01948843||Single Group Assignment||Treatment||None (Open Label)||||||
1426332|NCT01948830|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1426333|NCT01948817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426334|NCT01948804|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1426335|NCT01948791||Single Group Assignment||Treatment||None (Open Label)||||||
1426336|NCT01948778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426337|NCT01948765|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426338|NCT01948752|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1426339|NCT01948739||Single Group Assignment||Treatment||None (Open Label)||||||
1426340|NCT01948726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426341|NCT01948713|Randomized|Parallel Assignment||Treatment||Single||||||t
1426342|NCT01948700|Randomized|Parallel Assignment||Prevention||Single|||t|||
1426343|NCT01948687|||Case-Only||Prospective|||||||
1426344|NCT01948674|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1426345|NCT01948661|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426346|NCT01948648|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1426347|NCT01948635|Randomized|Parallel Assignment||Treatment||Single||||||t
1426348|NCT01948622|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1426349|NCT01948609|||Cohort||Prospective|||||||
1426350|NCT01948596||Single Group Assignment||Treatment||None (Open Label)||||||
1426351|NCT01948583|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426352|NCT01948570|||Case-Control||Prospective|||||||
1426353|NCT01948557||Single Group Assignment||Prevention||Single||||||t
1426354|NCT01948544|||Cohort||Prospective|||||||
1426355|NCT01948531||Single Group Assignment||Treatment||None (Open Label)||||||
1426356|NCT01948518||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426357|NCT01948505|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426358|NCT01948492||Single Group Assignment||Other||None (Open Label)||||||
1426359|NCT01948479|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426360|NCT01948466|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426361|NCT01948453|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1426362|NCT01948440|Non-Randomized|Parallel Assignment||Prevention||Double|||t|t||
1426363|NCT01948427|||Cohort||Prospective|||||||
1426364|NCT01948414|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1426365|NCT01948401||Single Group Assignment||||None (Open Label)||||||
1426366|NCT01948388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426367|NCT01948375|Randomized|Crossover Assignment||Other||Single|||t|||
1426368|NCT01948362|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1426369|NCT01948349|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426370|NCT01948336|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426371|NCT01948323|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1426372|NCT01948310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426373|NCT01948297|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426374|NCT01948284|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1426375|NCT01948271||Single Group Assignment||Treatment||None (Open Label)||||||
1426376|NCT01948258||Single Group Assignment||Other||None (Open Label)||||||
1426377|NCT01948245|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426378|NCT01948232||Single Group Assignment||Treatment||None (Open Label)||||||
1426379|NCT01948219||Single Group Assignment||Treatment||None (Open Label)||||||
1426380|NCT01948206|||Cohort||Prospective|||||||
1426381|NCT01948193||Single Group Assignment||Prevention||None (Open Label)||||||
1426382|NCT01948180||Single Group Assignment||Treatment||None (Open Label)||||||
1426383|NCT01948167|Randomized|Parallel Assignment||Prevention||Single||||||t
1426384|NCT01948154|||Case-Control||Prospective|||||||
1426385|NCT01948141||Single Group Assignment||Treatment||None (Open Label)||||||
1426386|NCT01948128|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426387|NCT01948115|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426388|NCT01948102|||||Prospective|||||||
1426389|NCT01948089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426390|NCT01948076|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1426391|NCT01948063|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1426392|NCT01948050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426393|NCT01948037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426394|NCT01948024|Randomized|Crossover Assignment||||None (Open Label)||||||
1426395|NCT01948011|Randomized|Crossover Assignment||||None (Open Label)||||||
1426396|NCT01947998|||Cohort||Prospective|||||||
1426397|NCT01947985|||Cohort||Prospective|||||||
1426398|NCT01947972||Single Group Assignment||Prevention||None (Open Label)||||||
1426399|NCT01947959|||Cohort||Prospective|||||||
1426400|NCT01947946|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426401|NCT01947933|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1426402|NCT01947920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426403|NCT01947907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426404|NCT01947894|||Cohort||Prospective|||||||
1426405|NCT01947881|||Cohort||Prospective|||||||
1426406|NCT01947868|||Case-Only||Prospective|||||||
1426407|NCT01947855|Randomized|Parallel Assignment||Treatment||Double||||||
1426408|NCT01947842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426409|NCT01947829|||Case-Only||Prospective|||||||
1426410|NCT01947816|||Cohort||Prospective|||||||
1426411|NCT01947803||Single Group Assignment||Treatment||None (Open Label)||||||
1426412|NCT01947790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426413|NCT01947777||Single Group Assignment||Basic Science||None (Open Label)||||||
1426414|NCT01947764|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426415|NCT01947751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426416|NCT01947738|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426417|NCT01947712|Randomized|Crossover Assignment||Basic Science||Single||||||t
1426418|NCT01947699|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426419|NCT01947686|||Case-Only||Retrospective|||||||
1426420|NCT01947673|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1426421|NCT01947660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426422|NCT01947647|Randomized|Parallel Assignment||Treatment||Single||||||t
1426423|NCT01947634||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426424|NCT01947621|||Cohort|||||||||
1426425|NCT01947608||||||||||||
1426426|NCT01947595|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426427|NCT01947582||Single Group Assignment||Treatment||None (Open Label)||||||
1426428|NCT01947569|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426429|NCT01947556|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426430|NCT01947543|||Other||Prospective|||||||
1426431|NCT01947530|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1426432|NCT01947517|||Other||Prospective|||||||
1426433|NCT01947504|Randomized|Parallel Assignment||Treatment||Single||||||t
1426434|NCT01947491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426435|NCT01947478|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426436|NCT01947465|||Cohort||Prospective|||||||
1426437|NCT01947452|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426438|NCT01947439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426439|NCT01947426|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1426440|NCT01947413|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426441|NCT01947400|||Ecologic or Community||Prospective|||||||
1426442|NCT01947387|||||Retrospective|||||||
1426443|NCT01947374|Randomized|Parallel Assignment||Treatment||Single||||||t
1426444|NCT01947361|||Cohort||Retrospective|||||||
1426445|NCT01947348||Single Group Assignment||Treatment||None (Open Label)||||||
1426446|NCT01947335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426447|NCT01947322||Single Group Assignment||Treatment||None (Open Label)||||||
1426448|NCT01947309|||Cohort||Prospective|||||||
1426449|NCT01947296|||Case-Control||Prospective|||||||
1426450|NCT01947283|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1426451|NCT01947270|||Other||Prospective|||||||
1426452|NCT01947257||Single Group Assignment||Basic Science||None (Open Label)||||||
1426453|NCT01947244|Randomized|Parallel Assignment||Prevention||Single||||||t
1426454|NCT01947231|Randomized|Crossover Assignment||Treatment||Single|||||t|
1426455|NCT01947218|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1426456|NCT01947205|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1426457|NCT01947192|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1426458|NCT01947179|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426459|NCT01947166||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426460|NCT01947153|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426461|NCT01947140|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426462|NCT01947127|||Cohort||Prospective|||||||
1426463|NCT01947114|Randomized|||Treatment||Single|||t|||
1426464|NCT01947101||Single Group Assignment||Treatment||None (Open Label)||||||
1426465|NCT01947088|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426466|NCT01947075|||Cohort||Prospective|||||||
1426467|NCT01947062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426468|NCT01947049|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1426469|NCT01947036|||Case Control||Cross-Sectional|||||||
1426470|NCT01947023||Single Group Assignment||Treatment||None (Open Label)||||||
1426471|NCT01947010|Randomized|Single Group Assignment||Prevention||Single|||||t|
1426472|NCT01946997|||Case-Control||Prospective|||||||
1426473|NCT01946984|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1426474|NCT01946971|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1426475|NCT01946958|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1426476|NCT01946945|Randomized|Parallel Assignment||Screening||Double|||t|||t
1426477|NCT01946932|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1426478|NCT01946919|||Cohort||Prospective|||||||
1426479|NCT01946906|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1426480|NCT01946893|Randomized|Parallel Assignment||||Double|||||t|t
1426481|NCT01946880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426482|NCT01946867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426483|NCT01946854|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1426484|NCT01946841||Single Group Assignment||Treatment||None (Open Label)||||||
1426485|NCT01946828||Single Group Assignment||||None (Open Label)||||||
1426486|NCT01946815||Single Group Assignment||Treatment||None (Open Label)||||||
1426487|NCT01946802||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426488|NCT01946789||Single Group Assignment||Treatment||None (Open Label)||||||
1426489|NCT01946776||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426490|NCT01946763|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1426491|NCT01946750|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426492|NCT01946737|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1426493|NCT01946724|||Other||Other|||||||
1426494|NCT01946711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426495|NCT01946698|||Case Control||Prospective|||||||
1426496|NCT01946672||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426497|NCT01946659|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1426498|NCT01946646||Single Group Assignment||Treatment||None (Open Label)||||||
1426499|NCT01946633|Randomized|Single Group Assignment||Diagnostic||Triple|||t||t|t
1426500|NCT01946620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426501|NCT01946607|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1426502|NCT01946594|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426503|NCT01946581|||||Retrospective|||||||
1426504|NCT01946568||Single Group Assignment||||None (Open Label)||||||
1426505|NCT01946555|||Cohort||Prospective|||||||
1426506|NCT01946542|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1426507|NCT01946529|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426508|NCT01946516|||Cohort||Prospective|||||||
1426509|NCT01946503|||Case-Only||Retrospective|||||||
1426510|NCT01946490|||Cohort||Retrospective|||||||
1426511|NCT01946477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426512|NCT01946464|||||Prospective|||||||
1426513|NCT01946451|||Case Control||Retrospective|||||||
1426514|NCT01946438|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426515|NCT01946425|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426516|NCT01946412|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426517|NCT01946399||Single Group Assignment||Treatment||None (Open Label)||||||
1426518|NCT01946386|Randomized|Single Group Assignment||Treatment||Single|||||t|
1426519|NCT01946373|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426520|NCT01946360||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426521|NCT01946347|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1426522|NCT01946334||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426523|NCT01946321||Single Group Assignment||Treatment||None (Open Label)||||||
1426524|NCT01946308||Single Group Assignment||Treatment||Single||||||t
1426525|NCT01946295|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426526|NCT01946282|Randomized|Single Group Assignment||Health Services Research||Double|||t||t|
1426527|NCT01946269|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426528|NCT01946256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426529|NCT01946243||Single Group Assignment||Diagnostic||Single||||||t
1426530|NCT01946230|||||Prospective|||||||
1426531|NCT01946217|||Cohort||Prospective|||||||
1426532|NCT01946204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426533|NCT01946191|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426534|NCT01946178||Single Group Assignment||Treatment||None (Open Label)||||||
1426535|NCT01946165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426536|NCT01946152||Single Group Assignment||Treatment||None (Open Label)||||||
1426537|NCT01946139||Single Group Assignment||Screening||None (Open Label)||||||
1426538|NCT01946126|||Cohort||Retrospective|||||||
1426539|NCT01946113|||Cohort|||||||||
1426540|NCT01946100||Single Group Assignment||Treatment||None (Open Label)||||||
1426541|NCT01946087|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1426542|NCT01946074|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426543|NCT01946061||Single Group Assignment||Treatment||None (Open Label)||||||
1426544|NCT01946048||Single Group Assignment||Treatment||None (Open Label)||||||
1426545|NCT01946035|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1426546|NCT01946022|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1426547|NCT01946009||Single Group Assignment||Treatment||None (Open Label)||||||
1426548|NCT01945996|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1426549|NCT01945983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426550|NCT01945970|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1426551|NCT01945957|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1426552|NCT01945944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426553|NCT01945931|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426554|NCT01945918|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426555|NCT01945905|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1426556|NCT01945892|||Case Control||Prospective|||||||
1426557|NCT01945879||Single Group Assignment||Treatment||None (Open Label)||||||
1426558|NCT01945866|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426559|NCT01945853||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426560|NCT01945840|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1426561|NCT01945827|||Case-Only||Prospective|||||||
1426562|NCT01945814|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426563|NCT01945801|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1426564|NCT01945788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426565|NCT01945775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426566|NCT01945762|||Cohort||Prospective|||||||
1426567|NCT01945749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426568|NCT01945736|||Cohort||Prospective|||||||
1426569|NCT01945723|||Case-Only||Cross-Sectional|||||||
1426570|NCT01945710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426571|NCT01945697|||Case-Control||Prospective|||||||
1426572|NCT01945684|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426573|NCT01945671|||Cohort||Prospective|||||||
1426574|NCT01945658|||Cohort||Prospective|||||||
1426575|NCT01945645||Single Group Assignment||Prevention||Single||||||t
1426576|NCT01945632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426577|NCT01945619||||||||||||
1426578|NCT01945606||Single Group Assignment||Treatment||Single|||t|||
1426579|NCT01945593||Single Group Assignment||Prevention||None (Open Label)||||||
1426580|NCT01945580|||Cohort||Prospective|||||||
1426581|NCT01945567|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1426582|NCT01945554|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426583|NCT01945541|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1426584|NCT01945528|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426585|NCT01945515|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426586|NCT01945502|||Case Control||Prospective|||||||
1426587|NCT01945489|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426588|NCT01945476|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1426589|NCT01945463|||Cohort||Cross-Sectional|||||||
1426590|NCT01945450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426591|NCT01945437|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426592|NCT01945424|||Case-Only||Prospective|||||||
1426593|NCT01945411|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426594|NCT01945398|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426595|NCT01945385|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1426596|NCT01945372|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426597|NCT01945359|||Cohort||Prospective|||||||
1426598|NCT01945346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426599|NCT01945333|Randomized|Parallel Assignment||Treatment||Single||||||t
1426600|NCT01945320|||Cohort||Prospective|||||||
1426601|NCT01945307|||Cohort||Prospective|||||||
1426602|NCT01945294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426603|NCT01945281|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426604|NCT01945268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426605|NCT01945255|||Cohort||Prospective|||||||
1426606|NCT01945242|||Cohort||Prospective|||||||
1426607|NCT01945229|||Cohort||Prospective|||||||
1426608|NCT01945216|||Cohort||Prospective|||||||
1426609|NCT01945203|||Cohort||Prospective|||||||
1426610|NCT01945190|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1426611|NCT01945177|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1426612|NCT01945164||||||||||||
1426613|NCT01945151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426614|NCT01945138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426615|NCT01945125|Randomized|Parallel Assignment||||None (Open Label)||||||
1426616|NCT01945112||Single Group Assignment||Prevention||None (Open Label)||||||
1426617|NCT01945099|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426618|NCT01945086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426619|NCT01945073|Randomized|Factorial Assignment||||None (Open Label)||||||
1426620|NCT01945060|Randomized|Crossover Assignment||||None (Open Label)||||||
1426621|NCT01945047|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1426622|NCT01945034|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426623|NCT01945021||Single Group Assignment||Treatment||None (Open Label)||||||
1426624|NCT01945008|||Cohort||Prospective|||||||
1426625|NCT01944995|Randomized|Crossover Assignment||||None (Open Label)||||||
1426626|NCT01944982||Single Group Assignment||Treatment||None (Open Label)||||||
1426627|NCT01944969||Single Group Assignment||Treatment||None (Open Label)||||||
1426628|NCT01944956|||||Prospective|||||||
1426629|NCT01944943||Single Group Assignment||Treatment||None (Open Label)||||||
1426630|NCT01944930|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1426631|NCT01944917|||Case Control||Prospective|||||||
1426632|NCT01944904|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1426633|NCT01944891|||Ecologic or Community||Cross-Sectional|||||||
1426634|NCT01944878|||Case Control||Retrospective|||||||
1426635|NCT01944865|Randomized|Parallel Assignment||||Single|||t|||
1426636|NCT01944852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426637|NCT01944839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426638|NCT01944826|||Cohort||Prospective|||||||
1426639|NCT01944813|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426640|NCT01944800|Randomized|Parallel Assignment||Treatment||Single||||||t
1426641|NCT01944787|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426642|NCT01944774|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426643|NCT01944761|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426644|NCT01944748|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426645|NCT01944735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426646|NCT01944722||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426647|NCT01944709||Single Group Assignment||Treatment||None (Open Label)||||||
1426648|NCT01944696|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426649|NCT01944683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426650|NCT01944670||Single Group Assignment||Treatment||None (Open Label)||||||
1426651|NCT01944657|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426652|NCT01944644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426653|NCT01944631|Randomized|Parallel Assignment||Treatment||Double||||||
1426654|NCT01944618|||||Prospective|||||||
1426655|NCT01944605|||Cohort||Prospective|||||||
1426656|NCT01944592|Randomized|Parallel Assignment||||Single||||||t
1426657|NCT01944579|Randomized|Crossover Assignment||||Double|||||t|t
1426658|NCT01944566||Single Group Assignment||Treatment||None (Open Label)||||||
1426659|NCT01944553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426660|NCT01944540|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426661|NCT01944527|||Cohort|||||||||
1426662|NCT01944514|||Case Control||Prospective|||||||
1426663|NCT01944501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426664|NCT01944488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426665|NCT01944475|||Case-Only|||||||||
1426666|NCT01944462||Single Group Assignment||Health Services Research||None (Open Label)||||||
1426667|NCT01944449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426668|NCT01944436|||Cohort||Prospective|||||||
1426669|NCT01944423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426670|NCT01944410||Single Group Assignment||Treatment||None (Open Label)||||||
1426671|NCT01944397|||Cohort||Retrospective|||||||
1426672|NCT01944384|Randomized|Single Group Assignment||Treatment||Single|||t|||
1426673|NCT01944371|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1426674|NCT01944358|||Cohort||Prospective|||||||
1426675|NCT01944345|||Case-Only||Prospective|||||||
1426676|NCT01944332||Single Group Assignment||Treatment||None (Open Label)||||||
1426677|NCT01944319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426678|NCT01944306|||Cohort||Prospective|||||||
1426679|NCT01944293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426680|NCT01944280|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1426681|NCT01944267|Randomized|Parallel Assignment||Treatment||Single||||||t
1426682|NCT01944254|Randomized|Crossover Assignment||||None (Open Label)||||||
1426683|NCT01944241|||Cohort||Retrospective|||||||
1426684|NCT01944228|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1426685|NCT01944215|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1426686|NCT01944202|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1426687|NCT01944189|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426688|NCT01944176|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1426689|NCT01944163|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1426690|NCT01944150|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426691|NCT01944137|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426692|NCT01944124|Randomized|Parallel Assignment||Prevention||||||||
1426693|NCT01944111||Single Group Assignment||Treatment||None (Open Label)||||||
1426694|NCT01944098|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1426695|NCT01944085|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1426696|NCT01944072|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1426697|NCT01944059|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426698|NCT01944046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426699|NCT01944033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426700|NCT01944020||Single Group Assignment||Treatment||None (Open Label)||||||
1426701|NCT01944007|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1426702|NCT01943994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426703|NCT01943981|||Case-Only||Prospective|||||||
1426704|NCT01943968|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1426705|NCT01943955||Single Group Assignment||Treatment||None (Open Label)||||||
1426706|NCT01943942|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1426707|NCT01943929|||Cohort||Cross-Sectional|||||||
1426708|NCT01943916|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1426709|NCT01943903|||Cohort||Prospective|||||||
1426710|NCT01943890||Single Group Assignment||Treatment||None (Open Label)||||||
1426711|NCT01943877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1426712|NCT01943864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426713|NCT01943851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426714|NCT01943838||Single Group Assignment||Treatment||None (Open Label)||||||
1426715|NCT01943825|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426716|NCT01943812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426717|NCT01943799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426718|NCT01943786|||Cohort||Prospective|||||||
1426719|NCT01943773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426720|NCT01943760|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426721|NCT01943747|||Case-Only||Prospective|||||||
1426722|NCT01943734||Single Group Assignment||Screening||None (Open Label)||||||
1426723|NCT01943721||Single Group Assignment||Prevention||None (Open Label)||||||
1426724|NCT01943708|Randomized|Crossover Assignment||Treatment||Single|||t|||
1426725|NCT01943695|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1426726|NCT01943682||Single Group Assignment||Treatment||None (Open Label)||||||
1426727|NCT01943669||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426728|NCT01943656||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426729|NCT01943643||Single Group Assignment||Treatment||None (Open Label)||||||
1426730|NCT01943630|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426731|NCT01943617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426732|NCT01943604||Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1426733|NCT01943591|Randomized|Parallel Assignment||Treatment||Single||||||t
1426734|NCT01943578|||Cohort||Prospective|||||||
1426735|NCT01943565|Randomized|Parallel Assignment||Other||Double|||t||t|
1426736|NCT01943552|Randomized|Parallel Assignment||Treatment||Double||||||
1426737|NCT01943539||Single Group Assignment||Treatment||None (Open Label)||||||
1426738|NCT01943526|||Case-Only||Other|||||||
1426739|NCT01943513|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426741|NCT01943487||Single Group Assignment||Basic Science||None (Open Label)||||||
1426742|NCT01943474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426743|NCT01943461||Single Group Assignment||Treatment||None (Open Label)||||||
1426744|NCT01943448|||Case-Only||Prospective|||||||
1426745|NCT01943435|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1426746|NCT01943422|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1426747|NCT01943409|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1426748|NCT01943396|Randomized|Single Group Assignment||Treatment||Single||||||t
1426749|NCT01943383|||Cohort||Cross-Sectional|||||||
1426750|NCT01943370|Randomized|Single Group Assignment||Other||Single|||||t|
1426751|NCT01943357||Single Group Assignment||Other||None (Open Label)||||||
1426752|NCT01943344||Single Group Assignment||Treatment||None (Open Label)||||||
1426753|NCT01943331|||Case-Crossover||Prospective|||||||
1426754|NCT01943318|||Cohort||Prospective|||||||
1426755|NCT01943305|Randomized|Parallel Assignment||||None (Open Label)||||||
1426756|NCT01943292||Single Group Assignment||Treatment||None (Open Label)||||||
1426757|NCT01943279|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426758|NCT01943266||Single Group Assignment||Other||None (Open Label)||||||
1426759|NCT01943253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426760|NCT01943240|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1426761|NCT01943227|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1426762|NCT01943214|||Cohort||Prospective|||||||
1426763|NCT01943201|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1426764|NCT01943188||Single Group Assignment||Treatment||None (Open Label)||||||
1426765|NCT01943175|||Case Control||Cross-Sectional|||||||
1426766|NCT01943162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426767|NCT01943149|||Cohort||Prospective|||||||
1426768|NCT01943136|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426769|NCT01943123|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1426770|NCT01943110||Single Group Assignment||Prevention||None (Open Label)||||||
1426771|NCT01943097|||Case-Crossover||Cross-Sectional|||||||
1426772|NCT01943084|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426773|NCT01943071|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426774|NCT01943058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426775|NCT01943045|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1426776|NCT01943032|||Case Control||Prospective|||||||
1426777|NCT01943019||Single Group Assignment||Treatment||None (Open Label)||||||
1426778|NCT01943006|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1426779|NCT01942993||Single Group Assignment||Treatment||None (Open Label)||||||
1426780|NCT01942980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426781|NCT01942967|||Case-Crossover||Prospective|||||||
1426782|NCT01942954|Randomized|Parallel Assignment||Treatment||Single||||||t
1426783|NCT01942941||Single Group Assignment||Treatment||None (Open Label)||||||
1426784|NCT01942928|Randomized|Parallel Assignment||Treatment||Single|||||t|
1426785|NCT01942915||Single Group Assignment||Treatment||None (Open Label)||||||
1426786|NCT01942902||Single Group Assignment||Treatment||None (Open Label)||||||
1426787|NCT01942889|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1426788|NCT01942876|Randomized|Parallel Assignment||Prevention||Single||||||t
1426789|NCT01942863|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1426790|NCT01942850|||||Prospective|||||||
1426791|NCT01942837||Single Group Assignment||Treatment||None (Open Label)||||||
1426792|NCT01942824|Randomized|Parallel Assignment||Health Services Research||Double||||t||t
1426793|NCT01942811|Randomized|Parallel Assignment||Prevention||Single||||||t
1426794|NCT01942798|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426795|NCT01942785||Single Group Assignment||Treatment||None (Open Label)||||||
1426796|NCT01942772||Single Group Assignment||Treatment||None (Open Label)||||||
1426797|NCT01942759|||Case-Only||Cross-Sectional|||||||
1426798|NCT01942746|Non-Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1426799|NCT01942733||Single Group Assignment||Treatment||None (Open Label)||||||
1426800|NCT01942720||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426801|NCT01942707|Randomized|Parallel Assignment||Prevention||Single|The patient will not know if the Scarpa´s fascia has been removed or preserved.||t|||
1426802|NCT01942694|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426803|NCT01942681||Single Group Assignment||Treatment||None (Open Label)||||||
1426804|NCT01942668|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426805|NCT01942655||Single Group Assignment||Basic Science||None (Open Label)||||||
1426806|NCT01942642|||Case-Only||Prospective|||||||
1426807|NCT01942629|||Cohort||Retrospective|||||||
1426808|NCT01942616|Randomized|Single Group Assignment||Screening||Single|||t|||
1426809|NCT01942603|||Case-Control||Prospective|||||||
1426810|NCT01942590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426811|NCT01942577|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1426812|NCT01942564|||Case-Control||Cross-Sectional|||||||
1426813|NCT01942551|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1426814|NCT01942538|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426815|NCT01942525|||Cohort||Retrospective|||||||
1426816|NCT01942512|||Cohort||Prospective|||||||
1426817|NCT01942499|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1426818|NCT01942486||Single Group Assignment||Treatment||None (Open Label)||||||
1426819|NCT01942473|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426820|NCT01942460||Single Group Assignment||Treatment||None (Open Label)||||||
1426821|NCT01942447|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426822|NCT01942434|||Cohort||Prospective|||||||
1426823|NCT01942421||Single Group Assignment||Treatment||None (Open Label)||||||
1426824|NCT01942408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426825|NCT01942395|Randomized|Crossover Assignment||Treatment||Single|||||t|
1426826|NCT01942382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426827|NCT01942369|||Case-Only||Prospective|||||||
1426828|NCT01942356|Randomized|Parallel Assignment||||Single|||t|||
1426829|NCT01942343|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1426830|NCT01942330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426831|NCT01942317|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426832|NCT01942304|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426833|NCT01942291|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1426834|NCT01942278|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1426835|NCT01942265|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1426836|NCT01942252|||Case Control||Prospective|||||||
1426837|NCT01942239|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1426838|NCT01942226|||Cohort||Cross-Sectional|||||||
1426839|NCT01942213|||Cohort||Prospective|||||||
1426840|NCT01942200|||Other||Prospective|||||||
1426841|NCT01942187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426842|NCT01942174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426843|NCT01942161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426844|NCT01942148||Single Group Assignment||Treatment||None (Open Label)||||||
1426845|NCT01942135|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426846|NCT01942122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426847|NCT01942109|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426848|NCT01942096|||Cohort||Prospective|||||||
1426849|NCT01942083||Sequential Assignment||Treatment||None (Open Label)||Dose escalation study||||
1426850|NCT01942070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426851|NCT01942057|||Cohort||Cross-Sectional|||||||
1426852|NCT01942044|Randomized|Parallel Assignment||Treatment||Single|||||t|
1426853|NCT01942031|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426854|NCT01942018||Single Group Assignment||Treatment||None (Open Label)||||||
1426855|NCT01942005|||Cohort||Prospective|||||||
1426856|NCT01941992|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426857|NCT01941979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426858|NCT01941966||Single Group Assignment||Treatment||None (Open Label)||||||
1426859|NCT01941953||Single Group Assignment||Treatment||None (Open Label)||||||
1426860|NCT01941940||Single Group Assignment||Treatment||None (Open Label)||||||
1426861|NCT01941927||Single Group Assignment||Treatment||None (Open Label)||||||
1426862|NCT01941914||Single Group Assignment||Treatment||None (Open Label)||||||
1426863|NCT01941901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426864|NCT01941888|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1426865|NCT01941875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426866|NCT01941862|Randomized|Factorial Assignment||Treatment||Single|||t|||
1426867|NCT01941849||Single Group Assignment||Treatment||None (Open Label)||||||
1426868|NCT01941836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426869|NCT01941823|||Cohort||Prospective|||||||
1426870|NCT01941810||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426871|NCT01941797|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1426872|NCT01941784||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426873|NCT01941771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426874|NCT01941758||Single Group Assignment||Basic Science||None (Open Label)||||||
1426875|NCT01941745|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426876|NCT01941732||Single Group Assignment||Treatment||None (Open Label)||||||
1426877|NCT01941719|Randomized|Parallel Assignment||Prevention||Single|||||t|
1426878|NCT01941706|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1426879|NCT01941693|Randomized|Parallel Assignment||Treatment||Single||||||t
1426880|NCT01941680|||Ecologic or Community||Prospective|||||||
1426881|NCT01941667|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1426882|NCT01941654||Single Group Assignment||Treatment||None (Open Label)||RT + Oral TKI||||
1426883|NCT01941641||Single Group Assignment||Treatment||None (Open Label)||||||
1426884|NCT01941628|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1426885|NCT01941615||Single Group Assignment||Treatment||None (Open Label)||||||
1426886|NCT01941602|||Case-Only||Retrospective|||||||
1426887|NCT01941589|Randomized|Parallel Assignment||Treatment||Single|||||t|
1426888|NCT01941576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426889|NCT01941563|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426890|NCT01941550||Single Group Assignment||Treatment||None (Open Label)||||||
1426891|NCT01941537|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426892|NCT01941524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426893|NCT01941511||Crossover Assignment||||Triple|||t|t|t|
1426894|NCT01941498||Single Group Assignment||Treatment||None (Open Label)||||||
1426895|NCT01941485||Single Group Assignment||Treatment||None (Open Label)||||||
1426896|NCT01941472||Single Group Assignment||Screening||None (Open Label)||||||
1426897|NCT01941459|||Cohort||Prospective|||||||
1426898|NCT01941446|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1426899|NCT01941433|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426900|NCT01941420|||Cohort||Prospective|||||||
1426901|NCT01941407||Single Group Assignment||Treatment||None (Open Label)||||||
1426902|NCT01941394|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426903|NCT01941381|||Cohort||Prospective|||||||
1426904|NCT01941368|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1426905|NCT01941355|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1426906|NCT01941342|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426907|NCT01941329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426908|NCT01941316||Single Group Assignment||Treatment||None (Open Label)||||||
1426909|NCT01941303|||Cohort||Retrospective|||||||
1426910|NCT01941290|||Other||Prospective|||||||
1426911|NCT01941277|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1426912|NCT01941264|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1426913|NCT01941251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426914|NCT01941238|||Cohort||Prospective|||||||
1426915|NCT01941225|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1426916|NCT01941212|Randomized|Parallel Assignment||Treatment||Single||||||t
1426917|NCT01941199|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1426918|NCT01941186|Randomized|Parallel Assignment||||None (Open Label)||||||
1426919|NCT01941173||Single Group Assignment||Treatment||None (Open Label)||||||
1426920|NCT01941160|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1426921|NCT01941147||Single Group Assignment||Treatment||None (Open Label)||||||
1426922|NCT01941134||Single Group Assignment||Treatment||None (Open Label)||||||
1426923|NCT01941121||Single Group Assignment||Health Services Research||None (Open Label)||||||
1426924|NCT01941108|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426925|NCT01941095||Single Group Assignment||Treatment||None (Open Label)||||||
1426926|NCT01941082|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426927|NCT01941069|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1426928|NCT01941056||Single Group Assignment||Supportive Care||None (Open Label)||||||
1426929|NCT01941043|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426930|NCT01941030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426931|NCT01941017|||Case Control||Cross-Sectional|||||||
1426932|NCT01941004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426933|NCT01940991|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426934|NCT01940978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426935|NCT01940965|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426936|NCT01940952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426937|NCT01940939|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426938|NCT01940926||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426939|NCT01940913|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426940|NCT01940900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426941|NCT01940887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426942|NCT01940874|||Cohort||Prospective|||||||
1426943|NCT01940861|||Cohort||Prospective|||||||
1426944|NCT01940848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426945|NCT01940835|||Case-Control||Prospective|||||||
1426946|NCT01940822|Randomized|Crossover Assignment||Other||Double|||t||t|
1426947|NCT01940809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426948|NCT01940796||Single Group Assignment||Treatment||None (Open Label)||||||
1426949|NCT01940783||Single Group Assignment||Diagnostic||None (Open Label)||||||
1426950|NCT01940770|||Cohort||Prospective|||||||
1426951|NCT01940757|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1426952|NCT01940744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426953|NCT01940731||Single Group Assignment||Treatment||None (Open Label)||||||
1426954|NCT01940718||Single Group Assignment||Treatment||None (Open Label)||||||
1426955|NCT01940705|Randomized|Parallel Assignment||Treatment||Single||||||t
1426956|NCT01940692|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1426957|NCT01940679|Randomized|Crossover Assignment||||Triple|||t||t|t
1426958|NCT01940666|||Case Control||Retrospective|||||||
1426959|NCT01940653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426960|NCT01940640|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1426961|NCT01940627|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1426962|NCT01940614|||Cohort||Prospective|||||||
1426963|NCT01940601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426964|NCT01940588|||Case-Only||Prospective|||||||
1426965|NCT01940575|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426966|NCT01940562||Single Group Assignment||Treatment||None (Open Label)||||||
1426967|NCT01940549|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426968|NCT01940536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426969|NCT01940523|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1426970|NCT01940510|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1426971|NCT01940497|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1426972|NCT01940484|||Cohort||Prospective|||||||
1426973|NCT01940471|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426974|NCT01940458||||||||||||
1426975|NCT01940445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426976|NCT01940432|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426977|NCT01940419|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1426978|NCT01940406||Single Group Assignment||Treatment||None (Open Label)||||||
1426979|NCT01940393|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1426980|NCT01940380|||Other||Retrospective|||||||
1426981|NCT01940367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426982|NCT01940354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426983|NCT01940341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426984|NCT01940328|||Case-Control||Prospective|||||||
1426985|NCT01940315|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1426986|NCT01940302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1426987|NCT01940289|Non-Randomized|Single Group Assignment||Basic Science||Single|||||t|
1426988|NCT01940276||Parallel Assignment||Treatment||None (Open Label)||||||
1426989|NCT01940263|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1426990|NCT01940250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1426991|NCT01940237||Single Group Assignment||Treatment||None (Open Label)||||||
1426992|NCT01940224|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1426993|NCT01940211||||||||||||
1426994|NCT01940198|||Cohort||Retrospective|||||||
1426995|NCT01940185|||Cohort||Prospective|||||||
1426996|NCT01940172||Single Group Assignment||Treatment||None (Open Label)||||||
1426997|NCT01940159|Randomized|Single Group Assignment||Treatment||Single|||t|||
1426998|NCT01940146|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1426999|NCT01940133||Single Group Assignment||Treatment||None (Open Label)||||||
1427000|NCT01940120||Single Group Assignment||Treatment||None (Open Label)||||||
1427001|NCT01940107|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427002|NCT01940094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427003|NCT01940081|||Cohort||Prospective|||||||
1427004|NCT01940068|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1427005|NCT01940055|Randomized|Parallel Assignment||Treatment||Single||||||t
1427006|NCT01940042|Randomized|Factorial Assignment||Prevention||Single|||t|||
1427007|NCT01940029|||Cohort||Prospective|||||||
1427008|NCT01940016|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427009|NCT01940003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427010|NCT01939990|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1427011|NCT01939977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427012|NCT01939964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427013|NCT01939951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427014|NCT01939938||Single Group Assignment||Health Services Research||None (Open Label)||||||
1427015|NCT01939925|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1427016|NCT01939912||Single Group Assignment||Treatment||None (Open Label)||||||
1427017|NCT01939899||Single Group Assignment||Treatment||None (Open Label)||||||
1427018|NCT01939886|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1427019|NCT01939873|Randomized|Single Group Assignment||Screening||Double|||t||t|
1427020|NCT01939860|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427021|NCT01939847|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427022|NCT01939834|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1427023|NCT01939821|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1427024|NCT01939808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427025|NCT01939795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427026|NCT01939782|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1427027|NCT01939769|Randomized|Parallel Assignment||Treatment||||||||
1427028|NCT01939756||Single Group Assignment||Treatment||None (Open Label)||||||
1427029|NCT01939743|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427030|NCT01939730||Single Group Assignment||Treatment||None (Open Label)||||||
1427031|NCT01939717|Randomized|Parallel Assignment||Treatment||Single||||||t
1427032|NCT01939704|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427033|NCT01939691|Randomized|Parallel Assignment||Treatment||Single|Masked outcome assessment (evaluation of OCT and visual acuity)|Randomized 3 arm (1:1:1) parallel design comparative effectiveness trial||||t
1427034|NCT01939678|||Case-Control||Prospective|||||||
1427035|NCT01939665||Single Group Assignment||Treatment||None (Open Label)||||||
1427036|NCT01939652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427037|NCT01939639|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1427038|NCT01939626||Single Group Assignment||Basic Science||Single|||||t|
1427039|NCT01939613|||Case Control||Prospective|||||||
1427040|NCT01939600||Single Group Assignment||||None (Open Label)||||||
1427041|NCT01939587|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1427042|NCT01939574||Single Group Assignment||Treatment||None (Open Label)||||||
1427043|NCT01939561|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1427044|NCT01939548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427045|NCT01939535|||Case-Only||Prospective|||||||
1427046|NCT01939522||Single Group Assignment||Prevention||None (Open Label)||||||
1427047|NCT01939509||Single Group Assignment||Health Services Research||None (Open Label)||||||
1427048|NCT01939496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427049|NCT01939483||Single Group Assignment||Treatment||None (Open Label)||||||
1427050|NCT01939470|||Cohort||Prospective|||||||
1427051|NCT01939457||Single Group Assignment||Treatment||None (Open Label)||||||
1427052|NCT01939444|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1427053|NCT01939431|||||Retrospective|||||||
1427054|NCT01939418||Single Group Assignment||Treatment||None (Open Label)||||||
1427055|NCT01939405|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1427056|NCT01939392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427057|NCT01939379|Randomized|Single Group Assignment||Treatment||Single|||t|||
1427058|NCT01939366|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427059|NCT01939353|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1427060|NCT01939340|||Cohort||Prospective|||||||
1427061|NCT01939327||Single Group Assignment||Treatment||None (Open Label)||||||
1427062|NCT01939314|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427063|NCT01939301|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427064|NCT01939288|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1427065|NCT01939275||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427066|NCT01939262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427067|NCT01939249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427068|NCT01939236|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427069|NCT01939223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427070|NCT01939210|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1427071|NCT01939197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427072|NCT01939184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427073|NCT01939171|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427074|NCT01939158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427075|NCT01939145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427076|NCT01939132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427077|NCT01939119|||Case-Only||Prospective|||||||
1427078|NCT01939106||Single Group Assignment||||None (Open Label)||||||
1427079|NCT01939093|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427080|NCT01939080|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427081|NCT01939067|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1427082|NCT01939054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427083|NCT01939041|Randomized|Parallel Assignment||Treatment||Single||||||t
1427084|NCT01939028||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427085|NCT01939015|Randomized|Parallel Assignment||Treatment||Single||||||t
1427086|NCT01939002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427087|NCT01938989|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1427088|NCT01938976|Randomized|Parallel Assignment||Prevention||Single|||t|||
1427089|NCT01938963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427090|NCT01938950|Randomized|Parallel Assignment||Treatment||Single||||||t
1427091|NCT01938937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427092|NCT01938924|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427093|NCT01938911|Randomized|Factorial Assignment||Treatment||Single|||t|||
1427094|NCT01938898|Randomized|Single Group Assignment||Other||Double|||t|||t
1427095|NCT01938885|||Case-Only||Retrospective|||||||
1427096|NCT01938872|||Cohort||Prospective|||||||
1427097|NCT01938859|Randomized|Parallel Assignment||Treatment||Single||||||t
1427098|NCT01938846|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427099|NCT01938833||Single Group Assignment||Treatment||None (Open Label)||||||
1427100|NCT01938820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427101|NCT01938807|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427102|NCT01938794|||Other||Cross-Sectional|||||||
1427103|NCT01938781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427104|NCT01938768|||Cohort||Prospective|||||||
1427105|NCT01938755|Randomized|Crossover Assignment||Treatment||Double||||||
1427106|NCT01938742|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1427107|NCT01938729||Single Group Assignment||Treatment||None (Open Label)||||||
1427108|NCT01938716||Single Group Assignment||Basic Science||None (Open Label)||||||
1427109|NCT01938690|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1427110|NCT01938677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427111|NCT01938664|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1427112|NCT01938651||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427113|NCT01938638|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427114|NCT01938625|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427115|NCT01938612|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427116|NCT01938599|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427117|NCT01938586|||Case Control||Prospective|||||||
1427118|NCT01938573||Single Group Assignment||Treatment||None (Open Label)||||||
1427119|NCT01938560|||||Prospective|||||||
1427120|NCT01938547||Single Group Assignment||Treatment||None (Open Label)||||||
1427121|NCT01938534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427122|NCT01938521|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427123|NCT01938508|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427124|NCT01938495|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427125|NCT01938482|Randomized|Single Group Assignment||Treatment||Single|||t|||
1427126|NCT01938469|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1427127|NCT01938456|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427128|NCT01938443|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427129|NCT01938430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427130|NCT01938417|||Cohort||Prospective|||||||
1427131|NCT01938404|||Cohort||Prospective|||||||
1427132|NCT01938391||Single Group Assignment||Treatment||None (Open Label)||||||
1427133|NCT01938378||Single Group Assignment||Treatment||None (Open Label)||||||
1427134|NCT01938365|||Cohort||Prospective|||||||
1427135|NCT01938352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427136|NCT01938339||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427137|NCT01938326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427138|NCT01938313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427139|NCT01938300|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427140|NCT01938287||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427141|NCT01938274|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1427142|NCT01938261|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427143|NCT01938248|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427144|NCT01938235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427145|NCT01938222|||Cohort||Prospective|||||||
1427146|NCT01938209|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427147|NCT01938196||||||||||||
1427148|NCT01938183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427149|NCT01938170||Single Group Assignment||Treatment||None (Open Label)||||||
1427150|NCT01938157||Single Group Assignment||Screening||None (Open Label)||||||
1427151|NCT01938144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427152|NCT01938131|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427153|NCT01938118|Randomized|Parallel Assignment||Prevention||Single|||t|||
1427154|NCT01938105||Single Group Assignment||Treatment||None (Open Label)||||||
1427155|NCT01938092|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427156|NCT01938079|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427157|NCT01938066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427158|NCT01938053|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1427159|NCT01938040|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1427160|NCT01938027||Single Group Assignment||Treatment||None (Open Label)||||||
1427161|NCT01938014|||Cohort||Prospective|||||||
1427162|NCT01938001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427163|NCT01937988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427164|NCT01937975|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427165|NCT01937949||Single Group Assignment||Treatment||None (Open Label)||||||
1427166|NCT01937936|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427167|NCT01937923|||Cohort||Prospective|||||||
1427168|NCT01937910|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1427169|NCT01937897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427170|NCT01937884|Randomized|Parallel Assignment||Treatment||Single||||||t
1427171|NCT01937871|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427172|NCT01937858|||Cohort||Prospective|||||||
1427173|NCT01937845|||Other||Prospective|||||||
1427174|NCT01937832|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427175|NCT01937819|Randomized|Parallel Assignment||||None (Open Label)||||||
1427176|NCT01937806|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427177|NCT01937793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427178|NCT01937780|||Cohort||Prospective|||||||
1427179|NCT01937767|Randomized|Parallel Assignment||Treatment||Single|||||t|
1427180|NCT01937754|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1427181|NCT01937728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427182|NCT01937715|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427183|NCT01937702||Single Group Assignment||Basic Science||Double|||t||t|
1427184|NCT01937689||Single Group Assignment||Treatment||None (Open Label)||||||
1427185|NCT01937676|||Cohort||Prospective|||||||
1427186|NCT01937663||||||||||||
1427187|NCT01937650|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1427188|NCT01937637||Single Group Assignment||Supportive Care||None (Open Label)||||||
1427189|NCT01937624|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1427190|NCT01937611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427191|NCT01937598|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1427192|NCT01937585|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427193|NCT01937572|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1427194|NCT01937559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427195|NCT01937546|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1427196|NCT01937533|||Case-Only||Prospective|||||||
1427197|NCT01937520|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1427198|NCT01937507||Single Group Assignment||Treatment||None (Open Label)||||||
1427199|NCT01937494||Single Group Assignment||Prevention||None (Open Label)||||||
1427200|NCT01937481|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427201|NCT01937468||Single Group Assignment||Treatment||None (Open Label)||||||
1427202|NCT01937455|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427203|NCT01937442||Single Group Assignment||||None (Open Label)||||||
1427204|NCT01937429|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1427205|NCT01937416||Single Group Assignment||Treatment||None (Open Label)||||||
1427206|NCT01937403|||Cohort||Prospective|||||||
1427207|NCT01937390|||Cohort||Prospective|||||||
1427208|NCT01937377|||Cohort||Prospective|||||||
1427209|NCT01937364|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1427210|NCT01937351||Single Group Assignment||Treatment||None (Open Label)||||||
1427211|NCT01937338|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1427212|NCT01937325|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1427213|NCT01937312|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427214|NCT01937299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427215|NCT01937286|||Case-Crossover||Retrospective|||||||
1427216|NCT01937273|||Cohort||Prospective|||||||
1427217|NCT01937260|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1427218|NCT01937247|Non-Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1427219|NCT01937234|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1427220|NCT01937221|||Case-Control||Prospective|||||||
1427221|NCT01937208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427222|NCT01937195||Single Group Assignment||Treatment||None (Open Label)||||||
1427223|NCT01937182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427224|NCT01937169|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427225|NCT01937156|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427226|NCT01937143|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1427227|NCT01937130|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427228|NCT01937117||Single Group Assignment||Treatment||None (Open Label)||||||
1427229|NCT01937104|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1427230|NCT01937091|||Case Control||Retrospective|||||||
1427231|NCT01937078||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1427232|NCT01937065|||Cohort||Retrospective|||||||
1427233|NCT01937052|||Cohort||Prospective|||||||
1427234|NCT01937039|||Other||Prospective|||||||
1427235|NCT01937026|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1427236|NCT01937013|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1427237|NCT01937000||||||||||||
1427238|NCT01936987||||||||||||
1427239|NCT01936974|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427240|NCT01936961||Single Group Assignment||Treatment||None (Open Label)||||||
1427241|NCT01936948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427242|NCT01936935|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1427243|NCT01936922||Single Group Assignment||Prevention||None (Open Label)||||||
1427244|NCT01936909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427245|NCT01936896||Single Group Assignment||Treatment||None (Open Label)||||||
1427246|NCT01936883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427247|NCT01936870|||Case-Only||Prospective|||||||
1427248|NCT01936857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427249|NCT01936844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427250|NCT01936831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427251|NCT01936818|||Case-Only||Prospective|||||||
1427252|NCT01936805|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427253|NCT01936792|||Case Control||Prospective|||||||
1427254|NCT01936779|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1427255|NCT01936766|||Case-Control||Prospective|||||||
1427256|NCT01936753|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||This is a prospective paired cohort study||||
1427257|NCT01936740|Randomized|Parallel Assignment||||Double|||t||t|
1427258|NCT01936727|Randomized|Parallel Assignment||||Double|||t||t|
1427259|NCT01936714|Randomized|Parallel Assignment||||Double|||t||t|
1427260|NCT01936701|Randomized|Parallel Assignment||||Double|||t||t|
1427261|NCT01936688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427262|NCT01936675|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1427263|NCT01936662|Randomized|Parallel Assignment||||Double|||t|||t
1427264|NCT01936649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427265|NCT01936636|||||Prospective|||||||
1427266|NCT01936623|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427267|NCT01936610|Randomized|Parallel Assignment||||Single||||||t
1427268|NCT01936597|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1427269|NCT01936584|||Cohort||Prospective|||||||
1427270|NCT01936571|||Cohort||Prospective|||||||
1427271|NCT01936558|||Case Control|||||||||
1427272|NCT01936545|Randomized|Parallel Assignment||Prevention||Single|||t|||
1427273|NCT01936532||Single Group Assignment||Treatment||None (Open Label)||||||
1427274|NCT01936519|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427275|NCT01936506|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427276|NCT01936493|||Case-Only||Prospective|||||||
1427277|NCT01936480|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1427278|NCT01936467|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1427279|NCT01936454|||||Prospective|||||||
1427280|NCT01936441|Randomized|Parallel Assignment||Treatment||Single||||||t
1427281|NCT01936428||Single Group Assignment||||None (Open Label)||||||
1427282|NCT01936415|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427283|NCT01936402|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1427284|NCT01936389|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427285|NCT01936376|||Case Control||Prospective|||||||
1427286|NCT01936363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427287|NCT01936350|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427288|NCT01936337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427289|NCT01936324|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427290|NCT01936311|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427291|NCT01936298|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1427292|NCT01936285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427293|NCT01936272|Randomized|Single Group Assignment||Treatment||Single|||||t|
1427294|NCT01936259||||||||||||
1427295|NCT01936246|Randomized|Parallel Assignment||Prevention||Single||||||t
1427296|NCT01936233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427297|NCT01936220|Randomized|Parallel Assignment||Treatment||Single||||||t
1427298|NCT01936207|||Cohort||Prospective|||||||
1427299|NCT01936194|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1427300|NCT01936181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427301|NCT01936168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427302|NCT01936155||Single Group Assignment||Treatment||None (Open Label)||||||
1427303|NCT01936142|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427304|NCT01936129|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427305|NCT01936116|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427306|NCT01936103|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427307|NCT01936090||Single Group Assignment||Treatment||None (Open Label)||||||
1427308|NCT01936077|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427309|NCT01936064|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427310|NCT01936051||||||||||||
1427311|NCT01936038|Randomized|Parallel Assignment||Treatment||Single||||||t
1427312|NCT01936025|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1427313|NCT01936012|Randomized|Crossover Assignment||Treatment||Single|||||t|
1427314|NCT01935999||Single Group Assignment||||None (Open Label)||||||
1427315|NCT01935986|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427316|NCT01935973|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427317|NCT01935960|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1427318|NCT01935947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427319|NCT01935934||Single Group Assignment||Treatment||None (Open Label)||||||
1427320|NCT01935921||Single Group Assignment||Treatment||None (Open Label)||||||
1427321|NCT01935908|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427322|NCT01935895|||Case Control||Prospective|||||||
1427323|NCT01935882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427324|NCT01935869|Randomized|Single Group Assignment||||Single|||||t|
1427325|NCT01935856||Single Group Assignment||Treatment||None (Open Label)||||||
1427326|NCT01935843||Single Group Assignment||Treatment||None (Open Label)||||||
1427327|NCT01935830||Single Group Assignment||Other||None (Open Label)||||||
1427328|NCT01935817|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427329|NCT01935804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427330|NCT01935791|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1427331|NCT01935778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427332|NCT01935765|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1427333|NCT01935752|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1427334|NCT01935739|||Case Control||Prospective|||||||
1427335|NCT01935726|||||Prospective|||||||
1427336|NCT01935713|Randomized|Parallel Assignment||Prevention||Single|||||t|
1427337|NCT01935700||Single Group Assignment||Treatment||None (Open Label)||||||
1427338|NCT01935687||Crossover Assignment||Treatment||None (Open Label)||||||
1427339|NCT01935674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427340|NCT01935661|||Case-Control||Prospective|||||||
1427341|NCT01935648|||Case-Only||Prospective|||||||
1427342|NCT01935635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427343|NCT01935622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427344|NCT01935609|Randomized|Single Group Assignment||Treatment||Single|||||t|
1427345|NCT01935596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427346|NCT01935583|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427347|NCT01935570|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1427348|NCT01935557|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427349|NCT01935544|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427350|NCT01935531||Single Group Assignment||Basic Science||None (Open Label)||||||
1427351|NCT01935518||Single Group Assignment||Treatment||None (Open Label)||||||
1427352|NCT01935505|||||Prospective|||||||
1427353|NCT01935492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427354|NCT01935479|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1427355|NCT01935466|||Cohort||Retrospective|||||||
1427356|NCT01935453||Single Group Assignment||Treatment||None (Open Label)||||||
1427357|NCT01935440|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1427358|NCT01935427|||||Prospective|||||||
1427359|NCT01935414|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427360|NCT01935401|||Case Control||Prospective|||||||
1427361|NCT01935388|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427362|NCT01935375|Randomized|Parallel Assignment||Treatment||Single||||||t
1427363|NCT01935362|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1427364|NCT01935349|||Cohort||Prospective|||||||
1427365|NCT01935336||Single Group Assignment||Treatment||None (Open Label)||||||
1427366|NCT01935323|Randomized|Parallel Assignment||Prevention||Single||||||t
1427367|NCT01935310||Single Group Assignment||Treatment||Single|||t|||
1427368|NCT01935297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427369|NCT01935284|||||Prospective|||||||
1427370|NCT01935271|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427371|NCT01935258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427372|NCT01935245|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427373|NCT01935232|||Cohort||Cross-Sectional|||||||
1427374|NCT01935219|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1427375|NCT01935206|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1427376|NCT01935193||Single Group Assignment||Treatment||None (Open Label)||||||
1427377|NCT01935180|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1427378|NCT01935167|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427379|NCT01935154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427380|NCT01935141|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1427381|NCT01935128||Single Group Assignment||Treatment||None (Open Label)||||||
1427382|NCT01935115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427383|NCT01935102|||Cohort||Retrospective|||||||
1427384|NCT01935089||Single Group Assignment||Treatment||None (Open Label)||||||
1427385|NCT01935076|||Cohort||Prospective|||||||
1427386|NCT01935063|Randomized|Parallel Assignment||Treatment||Single||||||t
1427387|NCT01935050||Single Group Assignment||Treatment||None (Open Label)||||||
1427388|NCT01935024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427389|NCT01935011|||Case-Only||Prospective|||||||
1427390|NCT01934998|||Case Control||Cross-Sectional|||||||
1427391|NCT01934985|||Cohort||Prospective|||||||
1427392|NCT01934972|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427393|NCT01934959||Single Group Assignment||Treatment||Double|||t||t|
1427394|NCT01934946|Randomized|Parallel Assignment||Treatment||Single||||||t
1427395|NCT01934933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427396|NCT01934920|||Other||Prospective|||||||
1427397|NCT01934907|Randomized|Parallel Assignment||Prevention||Single||||||t
1427398|NCT01934894||Single Group Assignment||Treatment||None (Open Label)||||||
1427399|NCT01934881|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427400|NCT01934868|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking is possible at this point in time.|This is a study comparing prolotherapy treatments with an active control, which happens to be the gold standard treatment for radicular pain.||||
1427401|NCT01934855|||Cohort||Prospective|||||||
1427402|NCT01934842|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1427403|NCT01934829|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427404|NCT01934816|Randomized|Crossover Assignment||Health Services Research||Triple|||t||t|t
1427405|NCT01934803|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427406|NCT01934790||Single Group Assignment||Treatment||None (Open Label)||||||
1427407|NCT01934777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427408|NCT01934764|||||Prospective|||||||
1427409|NCT01934751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427410|NCT01934738|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1427411|NCT01934725|||Case-Control||Prospective|||||||
1427412|NCT01934712|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1427413|NCT01934699|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1427414|NCT01934686|||Ecologic or Community||Cross-Sectional|||||||
1427415|NCT01934673|||Ecologic or Community||Cross-Sectional|||||||
1427416|NCT01934660|||Cohort||Prospective|||||||
1427417|NCT01934647|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427418|NCT01934634||Single Group Assignment||Treatment||None (Open Label)||||||
1427419|NCT01934621|Randomized|Parallel Assignment||Treatment||Single||||||t
1427420|NCT01934608|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1427421|NCT01934595|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427422|NCT01934582||Single Group Assignment||||None (Open Label)||||||
1427423|NCT01934569||Single Group Assignment||Basic Science||None (Open Label)||||||
1427424|NCT01934556|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1427425|NCT01934543|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1427426|NCT01934530|Randomized|Parallel Assignment||Treatment||Single||||||t
1427427|NCT01934517|||Case-Only||Prospective|||||||
1427428|NCT01934504|||Cohort||Prospective|||||||
1427429|NCT01934491|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427430|NCT01934478|||Case-Only||Prospective|||||||
1427431|NCT01934465|||Cohort|||||||||
1427432|NCT01934452|||Case-Control||Prospective|||||||
1427433|NCT01934439||Single Group Assignment||Treatment||None (Open Label)||||||
1427434|NCT01934426|||Cohort||Prospective|||||||
1427435|NCT01934413|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1427436|NCT01934400|||Case-Only||Prospective|||||||
1427437|NCT01934387|||Case-Only||Prospective|||||||
1427438|NCT01934374|Randomized|Single Group Assignment||Treatment||Single|||t|||
1427439|NCT01934361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427440|NCT01934348|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427441|NCT01934335|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427442|NCT01934322|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1427443|NCT01934309|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1427444|NCT01934296||Single Group Assignment||Basic Science||None (Open Label)||||||
1427445|NCT01934283||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427446|NCT01934270||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427447|NCT01934257|Randomized|Parallel Assignment||||Triple|||t|t|t|
1427448|NCT01934244|||Cohort||Prospective|||||||
1427449|NCT01934231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427450|NCT01934218|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427451|NCT01934205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427452|NCT01934192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427453|NCT01934179|||Case-Only||Prospective|||||||
1427454|NCT01934166||Single Group Assignment||||None (Open Label)||||||
1427455|NCT01934153|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427456|NCT01934140|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427457|NCT01934127|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427458|NCT01934114|||Cohort||Prospective|||||||
1427459|NCT01934101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427460|NCT01934088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427461|NCT01934075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427462|NCT01934062|||Cohort||Retrospective|||||||
1427463|NCT01934049|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427464|NCT01934036|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427465|NCT01934023|Randomized|Crossover Assignment||||Double|||t||t|
1427466|NCT01934010||Single Group Assignment||Treatment||None (Open Label)||||||
1427467|NCT01933997||Single Group Assignment||Basic Science||None (Open Label)||||||
1427468|NCT01933984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427469|NCT01933971|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1427470|NCT01933958|||Cohort||Prospective|||||||
1427471|NCT01933945|||Cohort||Prospective|||||||
1427472|NCT01933932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427473|NCT01933919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427474|NCT01933906||Single Group Assignment||Treatment||None (Open Label)||||||
1427475|NCT01933893|||Case Control||Prospective|||||||
1427476|NCT01933880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427477|NCT01933867|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1427478|NCT01933854|||Cohort||Prospective|||||||
1427479|NCT01933841|||Case-Control||Prospective|||||||
1427480|NCT01933828|Randomized|Parallel Assignment||Treatment||Single|||||t|
1427481|NCT01933815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427482|NCT01933802||Single Group Assignment||Treatment||None (Open Label)||||||
1427483|NCT01933789|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427484|NCT01933776|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427485|NCT01933763|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1427486|NCT01933750|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427487|NCT01933737|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1427488|NCT01933724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427489|NCT01933711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427490|NCT01933698|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1427491|NCT01933685|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1427492|NCT01933672|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1427493|NCT01933659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427494|NCT01933646|||Case-Only||Prospective|||||||
1427495|NCT01933633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427496|NCT01933620|||Cohort||Prospective|||||||
1427497|NCT01933607||Single Group Assignment||||None (Open Label)||||||
1427498|NCT01933594|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427499|NCT01933581|||Cohort||Prospective|||||||
1427500|NCT01933568||Single Group Assignment||Treatment||None (Open Label)||||||
1427501|NCT01933555|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427502|NCT01933542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427503|NCT01933529|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427504|NCT01933516||Single Group Assignment||Treatment||None (Open Label)||||||
1427505|NCT01933503|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1427506|NCT01933490|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1427507|NCT01933477|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1427508|NCT01933464|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427509|NCT01933451|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1427510|NCT01933438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427511|NCT01933425|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1427512|NCT01933412|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427513|NCT01933399|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427514|NCT01933386|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427515|NCT01933373|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427516|NCT01933360|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427517|NCT01933347||Single Group Assignment||Treatment||None (Open Label)||||||
1427518|NCT01933334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427519|NCT01933321||Single Group Assignment||Treatment||None (Open Label)||||||
1427520|NCT01933308|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1427521|NCT01933295|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427522|NCT01933282||Single Group Assignment||Treatment||None (Open Label)||||||
1427523|NCT01933269||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427524|NCT01933256|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1427525|NCT01933243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427526|NCT01933230||Single Group Assignment||||None (Open Label)||||||
1427527|NCT01933217|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1427528|NCT01933204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427529|NCT01933191|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1427530|NCT01933178||Single Group Assignment||||None (Open Label)||||||
1427531|NCT01933165||Single Group Assignment||||None (Open Label)||||||
1427532|NCT01933152|||Cohort||Retrospective|||||||
1427533|NCT01933139|Randomized|Parallel Assignment||||None (Open Label)||||||
1427534|NCT01933126|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427535|NCT01933113||Single Group Assignment||Treatment||None (Open Label)||||||
1427536|NCT01933100|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427537|NCT01933087|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427538|NCT01933074|||Case-Only||Prospective|||||||
1427539|NCT01933061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427540|NCT01933048|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1427541|NCT01933035|||Cohort||Prospective|||||||
1427542|NCT01933022||Single Group Assignment||Other||None (Open Label)||||||
1427543|NCT01933009|||Cohort||Prospective|||||||
1427544|NCT01932996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427545|NCT01932983|||Case Control||Cross-Sectional|||||||
1427546|NCT01932970||Single Group Assignment||Treatment||None (Open Label)||||||
1427547|NCT01932957|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427548|NCT01932944|||Cohort||Prospective|||||||
1427549|NCT01932931|Randomized|Parallel Assignment||Prevention||Quadruple|Vitamin D supplementation and placebo are given as tablets, manufactured by the same company, and with equal size, shape, and taste.|"Two models are used, both a cross sectional study and a RCT. Corss sectional study: Patients (n=21) treated with citalopram (SSRI) due to major depressive disorder (MDD) are investigated for changes in bone mineral density, physcial performance (muscle strength, mobility, and balance), and pain sensitivity when compared to healthy controls (n=50).~RCT: Half of the patients and half of the controls are randomised (by double-blinding) to recieve either high dose vitamin D supplementation (2000 IU/day) of placebo for 12 months. All the primary endpoints from the cross sectional study will be assessed again after 6 and 12 months."|t|t|t|t
1427550|NCT01932918|||Cohort||Prospective|||||||
1427551|NCT01932905|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1427552|NCT01932892|||Case-Only||Cross-Sectional|||||||
1427553|NCT01932879|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1427554|NCT01932866|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427555|NCT01932853|||Case-Only||Prospective|||||||
1427556|NCT01932840|||Ecologic or Community||Cross-Sectional|||||||
1427557|NCT01932827|||Ecologic or Community||Cross-Sectional|||||||
1427558|NCT01932814|||Cohort||Retrospective|||||||
1427559|NCT01932801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427560|NCT01932788|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427561|NCT01932775||Single Group Assignment||Treatment||None (Open Label)||||||
1427562|NCT01932762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427563|NCT01932749|Randomized|Parallel Assignment||Treatment||Single||||||t
1427564|NCT01932736||Single Group Assignment||Basic Science||None (Open Label)||||||
1427565|NCT01932723||Single Group Assignment||Treatment||None (Open Label)||||||
1427566|NCT01932710||Single Group Assignment||Prevention||None (Open Label)||||||
1427567|NCT01932697||Single Group Assignment||Treatment||None (Open Label)||||||
1427568|NCT01932684|Randomized|Crossover Assignment||Treatment||Single||||t||
1427569|NCT01932671|||Cohort||Prospective|||||||
1427570|NCT01932658||Single Group Assignment||Treatment||None (Open Label)||||||
1427571|NCT01932645|||Case-Control||Prospective|||||||
1427572|NCT01932632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427573|NCT01932619|||Case-Only|||||||||
1427574|NCT01932606|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427575|NCT01932593|Randomized|Single Group Assignment||Treatment||Triple|Double Blind|autologous bone marrow cells|t|t|t|
1427576|NCT01932580||Single Group Assignment||Treatment||None (Open Label)||||||
1427577|NCT01932567|Randomized|Crossover Assignment||||Single||||||t
1427578|NCT01932554|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427579|NCT01932541||Single Group Assignment||Treatment||None (Open Label)||||||
1427580|NCT01932528||Single Group Assignment||Treatment||None (Open Label)||||||
1427581|NCT01932515||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427582|NCT01932502||Single Group Assignment||Treatment||None (Open Label)||||||
1427583|NCT01932489||Single Group Assignment||Other||None (Open Label)||||||
1427584|NCT01932476|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1427585|NCT01932463||Single Group Assignment||Treatment||None (Open Label)||||||
1427586|NCT01932450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427587|NCT01932437|Randomized|Parallel Assignment||||Double|||t||t|
1427588|NCT01932424||Single Group Assignment||||Double|||t|t||
1427589|NCT01932411|||Cohort||Retrospective|||||||
1427590|NCT01932398|||Case Control||Cross-Sectional|||||||
1427591|NCT01932385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427592|NCT01932372|||Cohort||Prospective|||||||
1427593|NCT01932359|Randomized|Parallel Assignment||Treatment||Single||||||t
1427594|NCT01932346|||Case-Only||Cross-Sectional|||||||
1427595|NCT01932333|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427596|NCT01932320|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427597|NCT01932307||Single Group Assignment||Prevention||None (Open Label)||||||
1427598|NCT01932294|||Cohort||Prospective|||||||
1427599|NCT01932281|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1427600|NCT01932268||Single Group Assignment||Basic Science||None (Open Label)||||||
1427601|NCT01932255|||Case Control||Retrospective|||||||
1427602|NCT01932242|Randomized|Parallel Assignment||||Double|||t||t|
1427603|NCT01932229||Single Group Assignment||Treatment||None (Open Label)||||||
1427604|NCT01932216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427605|NCT01932203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427606|NCT01932190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427607|NCT01932177|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427608|NCT01932164||Single Group Assignment||Treatment||None (Open Label)||||||
1427609|NCT01932151||Single Group Assignment||Treatment||None (Open Label)||||||
1427610|NCT01932138|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1427611|NCT01932125|||Cohort||Prospective|||||||
1427612|NCT01932112||Single Group Assignment||Treatment||None (Open Label)||||||
1427613|NCT01932099||Single Group Assignment||Treatment||None (Open Label)||||||
1427614|NCT01932086|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427615|NCT01932073|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427616|NCT01932060|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1427617|NCT01932047|||||Prospective|||||||
1427618|NCT01932034|||Case-Only||Prospective|||||||
1427619|NCT01932021||Single Group Assignment||Treatment||None (Open Label)||||||
1427620|NCT01932008|||Case Control||Cross-Sectional|||||||
1427621|NCT01931995|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1427622|NCT01931982|Randomized|Crossover Assignment||Treatment||Single|||||t|
1427623|NCT01931969|||Case-Only||Prospective|||||||
1427624|NCT01931956|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427625|NCT01931943||Single Group Assignment||Treatment||None (Open Label)||||||
1427626|NCT01931930|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1427627|NCT01931917|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1427628|NCT01931904|||Cohort||Prospective|||||||
1427629|NCT01931891|||Case Control||Cross-Sectional|||||||
1427630|NCT01931878|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1427631|NCT01931865||Single Group Assignment||Treatment||None (Open Label)||||||
1427632|NCT01931852|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1427633|NCT01931839|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427634|NCT01931826|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427635|NCT01931813|||Case-Only||Retrospective|||||||
1427636|NCT01931800|||Cohort||Prospective|||||||
1427637|NCT01931787||Single Group Assignment||Treatment||None (Open Label)||||||
1427638|NCT01931774|||Case Control||Prospective|||||||
1427639|NCT01931761|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1427640|NCT01931748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427641|NCT01931735|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1427642|NCT01931722|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1427643|NCT01931709||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427644|NCT01931696|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427645|NCT01931683||Single Group Assignment||Treatment||Double|||t||t|
1427646|NCT01931670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427647|NCT01931657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427648|NCT01931644|||Cohort||Cross-Sectional|||||||
1427649|NCT01931631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427650|NCT01931618|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427651|NCT01931605||Single Group Assignment||Treatment||None (Open Label)||||||
1427652|NCT01931592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427653|NCT01931579||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427654|NCT01931566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427655|NCT01931553|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1427656|NCT01931540|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1427657|NCT01931527|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1427658|NCT01931514|Randomized|||||||||||
1427659|NCT01931501|Randomized|||||||||||
1427660|NCT01931488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427661|NCT01931475|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427662|NCT01931462||Single Group Assignment||Treatment||None (Open Label)||||||
1427663|NCT01931449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427664|NCT01931436||Single Group Assignment||Basic Science||None (Open Label)||||||
1427665|NCT01931423|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427666|NCT01931410|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1427667|NCT01931397|||Cohort||Prospective|||||||
1427668|NCT01931384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427669|NCT01931371|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427670|NCT01931358|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1427671|NCT01931345|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427672|NCT01931332|Randomized|Parallel Assignment||Treatment||Single|||||t|
1427673|NCT01931319||Single Group Assignment||Treatment||None (Open Label)||||||
1427674|NCT01931306||||||||||||
1427675|NCT01931293||Single Group Assignment||Screening||None (Open Label)||||||
1427676|NCT01931280|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1427677|NCT01931267|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1427678|NCT01931254|||Case-Control||Prospective|||||||
1427679|NCT01931241|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1427680|NCT01931228|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427681|NCT01931215|Randomized|Parallel Assignment||Treatment||Quadruple|pharmacy providing identical sets of study drugs and placebo, computerized random sequence generation, sequence held by the pharmacy until study completion|treatment versus placebo|t|t|t|t
1427682|NCT01931202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427683|NCT01931189|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1427684|NCT01931176|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427685|NCT01931163||Single Group Assignment||Treatment||None (Open Label)||||||
1427686|NCT01931150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427687|NCT01931137|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427688|NCT01931124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427689|NCT01931111|||Other||Cross-Sectional|||||||
1427690|NCT01931098|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427691|NCT01931085||||||||||||
1427692|NCT01931072|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1427693|NCT01931059|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1427694|NCT01931046|Randomized|Single Group Assignment||Treatment||None (Open Label)|open label|||||
1427695|NCT01931033||Single Group Assignment||Treatment||None (Open Label)||||||
1427696|NCT01931020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427697|NCT01931007|Randomized|Single Group Assignment||Treatment||Single|||t|||
1427698|NCT01930994|||Cohort||Retrospective|||||||
1427699|NCT01930981|||Other||Prospective|||||||
1427700|NCT01930968|||Cohort||Prospective|||||||
1427701|NCT01930955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427702|NCT01930942||Single Group Assignment||Treatment||None (Open Label)||||||
1427703|NCT01930929|||Cohort||Retrospective|||||||
1427704|NCT01930916||Single Group Assignment||||None (Open Label)||||||
1427705|NCT01930903|Non-Randomized|Single Group Assignment||Treatment||||||||
1427706|NCT01930890|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427707|NCT01930877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427708|NCT01930864||Single Group Assignment||Treatment||None (Open Label)||||||
1427709|NCT01930851|||Cohort||Retrospective|||||||
1427710|NCT01930838|||Case Control||Cross-Sectional|||||||
1427711|NCT01930812||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427712|NCT01930799||Single Group Assignment||Health Services Research||None (Open Label)||||||
1427713|NCT01930786|||Case-Only||Prospective|||||||
1427714|NCT01930773|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427715|NCT01930760|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427716|NCT01930747|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1427717|NCT01930734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427718|NCT01930721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427719|NCT01930708||Single Group Assignment||Treatment||None (Open Label)||||||
1427720|NCT01930695|||Case-Only||Prospective|||||||
1427721|NCT01930682|Randomized|Parallel Assignment||Treatment||Single||||||t
1427722|NCT01930669||Single Group Assignment||Basic Science||None (Open Label)||||||
1427723|NCT01930656|||Case-Only||Prospective|||||||
1427724|NCT01930643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427725|NCT01930630||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427726|NCT01930617|||Case-Only||Retrospective|||||||
1427727|NCT01930604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427728|NCT01930591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427729|NCT01930578|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1427730|NCT01930565|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1427731|NCT01930552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427732|NCT01930539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427733|NCT01930526||Single Group Assignment||Treatment||None (Open Label)||||||
1427734|NCT01930513|||Cohort||Prospective|||||||
1427735|NCT01930500|Randomized|Parallel Assignment||Treatment||Single||||||t
1427736|NCT01930487|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1427737|NCT01930474|||Case-Only||Prospective|||||||
1427738|NCT01930461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427739|NCT01930448|||Case Control||Prospective|||||||
1427740|NCT01930435||Single Group Assignment||Supportive Care||None (Open Label)||humidification feasibility and efficacy||||
1427741|NCT01930422|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427742|NCT01930409|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1427743|NCT01930396|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1427744|NCT01930383|||Case-Only||Prospective|||||||
1427745|NCT01930370||Crossover Assignment||Treatment||None (Open Label)||||||
1427746|NCT01930357|Randomized|Parallel Assignment||Prevention||Single||||||t
1427747|NCT01930344|Randomized|Parallel Assignment||||Double|||t|||t
1427748|NCT01930331|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427749|NCT01930318|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1427750|NCT01930305|||Case Control||Prospective|||||||
1427751|NCT01930292|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427752|NCT01930279|||Case Control||Prospective|||||||
1427753|NCT01930266|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427754|NCT01930253||Single Group Assignment||Treatment||None (Open Label)||||||
1427755|NCT01930240|Randomized|Crossover Assignment||||Double|||t||t|
1427756|NCT01930227|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1427757|NCT01930214|||Cohort||Prospective|||||||
1427758|NCT01930201|||Cohort||Retrospective|||||||
1427759|NCT01930188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427760|NCT01930175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427761|NCT01930162||Single Group Assignment||Basic Science||None (Open Label)||||||
1427762|NCT01930149|Randomized|Parallel Assignment||Prevention||Single||||||t
1427763|NCT01930136|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427764|NCT01930123|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427765|NCT01930110|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427766|NCT01930097|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427767|NCT01930084|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1427768|NCT01930071||Single Group Assignment||Treatment||None (Open Label)||||||
1427769|NCT01930058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427770|NCT01930045|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427771|NCT01930032|||Other||Prospective|||||||
1427772|NCT01930019|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1427773|NCT01930006||Single Group Assignment||Treatment||None (Open Label)||||||
1427774|NCT01929993|Randomized|Parallel Assignment||Treatment||Single||||||t
1427775|NCT01929980||Single Group Assignment||Treatment||None (Open Label)||||||
1427776|NCT01929967|||Cohort||Prospective|||||||
1427777|NCT01929954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427778|NCT01929941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427779|NCT01929928|||Cohort||Prospective|||||||
1427780|NCT01929915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427781|NCT01929902|||Cohort||Prospective|||||||
1427782|NCT01929889||Single Group Assignment||Treatment||None (Open Label)||||||
1427783|NCT01929876||Single Group Assignment||||None (Open Label)||||||
1427784|NCT01929863|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1427785|NCT01929850|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427786|NCT01929837|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427787|NCT01929824|||Cohort||Prospective|||||||
1427788|NCT01929811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427789|NCT01929798|Randomized|Crossover Assignment||||None (Open Label)||||||
1427790|NCT01929785|||Case Control||Prospective|||||||
1427791|NCT01929772|||Cohort||Prospective|||||||
1427792|NCT01929759||Single Group Assignment||Basic Science||None (Open Label)||Treatment switch study||||
1427793|NCT01929746|Randomized|Parallel Assignment||Treatment||Single|||t|||
1427794|NCT01929733|||||Retrospective|||||||
1427795|NCT01929720|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427796|NCT01929707|Randomized|Sequential Assignment||Basic Science||Double|||t||t|
1427797|NCT01929694|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1427798|NCT01929681|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427799|NCT01929668|Randomized|Parallel Assignment||Screening||Single||||||t
1427800|NCT01929655||Single Group Assignment||Treatment||None (Open Label)||||||
1427801|NCT01929642||Single Group Assignment||Treatment||None (Open Label)||||||
1427802|NCT01929629|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1427803|NCT01929616||Single Group Assignment||Treatment||None (Open Label)||||||
1427804|NCT01929603||Single Group Assignment||||None (Open Label)||||||
1427805|NCT01929590|Randomized|Parallel Assignment||Diagnostic||Triple||||t|t|t
1427806|NCT01929577|Randomized|Crossover Assignment||||None (Open Label)||||||
1427807|NCT01929564|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1427808|NCT01929551|Randomized|Factorial Assignment||||None (Open Label)||||||
1427809|NCT01929538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427810|NCT01929525|||Cohort||Prospective|||||||
1427811|NCT01929512|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427812|NCT01929499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427813|NCT01929486|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427814|NCT01929473|||Cohort||Prospective|||||||
1427815|NCT01929460|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427816|NCT01929447|||||Prospective|||||||
1427817|NCT01929434|Randomized|Parallel Assignment||Treatment||Single||||||t
1427818|NCT01929421||Single Group Assignment||Treatment||None (Open Label)||||||
1427819|NCT01929408|||Cohort||Prospective|||||||
1427820|NCT01929395|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1427821|NCT01929382|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1427822|NCT01929369|||Case Control||Prospective|||||||
1427823|NCT01929356||Single Group Assignment||Treatment||None (Open Label)||||||
1427824|NCT01929343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427825|NCT01929330|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1427826|NCT01929317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427827|NCT01929304|||Cohort||Prospective|||||||
1427828|NCT01929291|||Cohort||Prospective|||||||
1427829|NCT01929278|Randomized|Single Group Assignment||Other||Single||||||t
1427830|NCT01929265||Single Group Assignment||Treatment||None (Open Label)||||||
1427831|NCT01929252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427832|NCT01929239||Single Group Assignment||Treatment||None (Open Label)||||||
1427833|NCT01929226|Randomized|Parallel Assignment||||Double|||t||t|
1427834|NCT01929213|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427835|NCT01929200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427836|NCT01929187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427837|NCT01929174|||Case-Control||Prospective|||||||
1427838|NCT01929161|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1427839|NCT01929148|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1427840|NCT01929135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427841|NCT01929122|Randomized|Parallel Assignment||Prevention||Single|||t|||
1427842|NCT01929109|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1427843|NCT01929096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427844|NCT01929083|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1427845|NCT01929070|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427846|NCT01929057|||Cohort||Cross-Sectional|||||||
1427847|NCT01929044|Randomized|Parallel Assignment||Treatment||Double||||||
1427848|NCT01929031|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427849|NCT01929018|Randomized|Parallel Assignment||Treatment||Single||||||t
1427850|NCT01929005|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1427851|NCT01928992|||Cohort||Retrospective|||||||
1427852|NCT01928979|||||Retrospective|||||||
1427853|NCT01928966|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1427854|NCT01928953|||Cohort||Prospective|||||||
1427855|NCT01928940||Single Group Assignment||Treatment||None (Open Label)||||||
1427856|NCT01928927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427857|NCT01928914|Randomized|Parallel Assignment||Other||Single|||t|||
1427858|NCT01928901|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1427859|NCT01928888|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1427860|NCT01928875|Randomized|Parallel Assignment||Treatment||Single||||||t
1427861|NCT01928862|Randomized|Parallel Assignment||Treatment||Single||||||t
1427862|NCT01928849|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427863|NCT01928836|||Case Control||Prospective|||||||
1427864|NCT01928823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427865|NCT01928810|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1427866|NCT01928797|Randomized|Parallel Assignment||Treatment||None (Open Label)|The investigator assigned the subject to one of the groups. Care provided followed the protocol for the group and the investigator analyzed the outcome results.|Investigator randomly assigns the subjects into one of the two groups. Control group and Interventional group||||
1427867|NCT01928784|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427868|NCT01928771|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427869|NCT01928758|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1427870|NCT01928745|||Cohort||Prospective|||||||
1427871|NCT01928732|Randomized|Parallel Assignment||Treatment||Single||||||t
1427872|NCT01928719|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1427873|NCT01928706|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1427874|NCT01928693|Randomized|Parallel Assignment||Treatment||Single|||||t|
1427875|NCT01928680||Single Group Assignment||Treatment||None (Open Label)||||||
1427876|NCT01928667|||Case Control||Retrospective|||||||
1427877|NCT01928654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427878|NCT01928641|||Case-Only||Prospective|||||||
1427879|NCT01928628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427880|NCT01928615|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427881|NCT01928602|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1427882|NCT01928589|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized trial of PBI with concurrent or sequential chemotherapy||||
1427883|NCT01928576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427884|NCT01928563|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427885|NCT01928550|||Case-Only||Prospective|||||||
1427886|NCT01928537||Single Group Assignment||Treatment||None (Open Label)||||||
1427887|NCT01928524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427888|NCT01928511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427889|NCT01928498|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1427890|NCT01928485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427891|NCT01928472|Randomized|Parallel Assignment||Prevention||Single|||t|||
1427892|NCT01928459|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427893|NCT01928446|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427894|NCT01928433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427895|NCT01928420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427896|NCT01928407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427897|NCT01928394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427898|NCT01928381|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427899|NCT01928368|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427900|NCT01928355|||||Prospective|||||||
1427901|NCT01928342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427902|NCT01928329|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427903|NCT01928316|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427904|NCT01928303|||Case Control||Prospective|||||||
1427905|NCT01928290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1427906|NCT01928277|||||Prospective|||||||
1427907|NCT01928264|Randomized|Parallel Assignment||Treatment||Single||||||t
1427908|NCT01928251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427909|NCT01928238|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1427910|NCT01928225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427911|NCT01928212|||Case Control||Retrospective|||||||
1427912|NCT01928199|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427913|NCT01928186||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427914|NCT01928173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427915|NCT01928160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427916|NCT01928147|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427917|NCT01928134|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1427918|NCT01928121|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1427919|NCT01928108|||Cohort||Prospective|||||||
1427920|NCT01928095|||Other||Prospective|||||||
1427921|NCT01928082||Single Group Assignment||Treatment||None (Open Label)||||||
1427922|NCT01928069|Randomized|||Treatment||||||||
1427923|NCT01928056|Randomized|||Treatment||None (Open Label)||||||
1427924|NCT01928043||Single Group Assignment||Treatment||None (Open Label)||||||
1427925|NCT01928030||Single Group Assignment||Supportive Care||None (Open Label)||||||
1427926|NCT01928017|||||Prospective|||||||
1427927|NCT01928004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427928|NCT01927991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427929|NCT01927978|||Case-Only||Prospective|||||||
1427930|NCT01927965||Single Group Assignment||Treatment||None (Open Label)||||||
1427931|NCT01927952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427932|NCT01927939|||Case-Only||Prospective|||||||
1427933|NCT01927926|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1427934|NCT01927913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427935|NCT01927900|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1427936|NCT01927887||Single Group Assignment||Diagnostic||None (Open Label)||||||
1427937|NCT01927874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427938|NCT01927861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427939|NCT01927848|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1427940|NCT01927835|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1427941|NCT01927822|||Case Control||Retrospective|||||||
1427942|NCT01927809|||Other||Prospective|||||||
1427943|NCT01927783|||Ecologic or Community||Prospective|||||||
1427944|NCT01927770|||||Prospective|||||||
1427945|NCT01927757||Single Group Assignment||Treatment||None (Open Label)||||||
1427946|NCT01927744|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427947|NCT01927731|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427948|NCT01927718||Single Group Assignment||Treatment||None (Open Label)||||||
1427949|NCT01927705||Single Group Assignment||Treatment||None (Open Label)||||||
1427950|NCT01927692|||Case-Only||Prospective|||||||
1427951|NCT01927679|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1427952|NCT01927666||Single Group Assignment||Basic Science||None (Open Label)||||||
1427953|NCT01927653|||Case-Control||Prospective|||||||
1427954|NCT01927640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427955|NCT01927627||Single Group Assignment||Treatment||None (Open Label)||||||
1427956|NCT01927614|||Cohort||Prospective|||||||
1427957|NCT01927601|||Cohort||Prospective|||||||
1427958|NCT01927588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427959|NCT01927575|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1427960|NCT01927562||Single Group Assignment||Treatment||None (Open Label)||||||
1427961|NCT01927549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427962|NCT01927536|||Cohort||Prospective|||||||
1427963|NCT01927523|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1427964|NCT01927510|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1427965|NCT01927497|Randomized|Parallel Assignment||Treatment||Single||||||t
1427966|NCT01927484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427967|NCT01927471|||Case-Control||Cross-Sectional|||||||
1427968|NCT01927458||Single Group Assignment||Other||None (Open Label)||||||
1427969|NCT01927445|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1427970|NCT01927432|||Case-Control||Prospective|||||||
1427971|NCT01927419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427972|NCT01927406|Randomized|Parallel Assignment||Prevention||Single||||||t
1427973|NCT01927393|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427974|NCT01927380|||Cohort||Prospective|||||||
1428661|NCT01918410|Randomized|Parallel Assignment||||Single|||t|||
1427975|NCT01927367|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1427976|NCT01927354|||Cohort|||||||||
1427977|NCT01927341|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1427978|NCT01927328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427979|NCT01927315|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1427980|NCT01927302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427981|NCT01927289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1427982|NCT01927276|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1427983|NCT01927263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427984|NCT01927250||Single Group Assignment||Supportive Care||None (Open Label)||||||
1427985|NCT01927237|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1427986|NCT01927224|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1427987|NCT01927198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1427988|NCT01927185|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1427989|NCT01927172|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1427990|NCT01927159|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1427991|NCT01927146|||Case-Only||Retrospective|||||||
1427992|NCT01927133|||Cohort||Prospective|||||||
1427993|NCT01927120||Single Group Assignment||Prevention||None (Open Label)||||||
1427994|NCT01927107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427995|NCT01927094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1427996|NCT01927081|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1427997|NCT01927068||Single Group Assignment||Treatment||None (Open Label)||||||
1427998|NCT01927055|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1427999|NCT01927042|Randomized|Parallel Assignment||Treatment||Single||||||t
1428000|NCT01927029|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1428001|NCT01927016|||Cohort||Retrospective|||||||
1428002|NCT01927003||Single Group Assignment||Treatment||None (Open Label)||||||
1428003|NCT01926990|||Cohort||Prospective|||||||
1428004|NCT01926977|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1428005|NCT01926964|||Case-Only||Prospective|||||||
1428006|NCT01926951||Single Group Assignment||Treatment||None (Open Label)||||||
1428007|NCT01926938|||||Cross-Sectional|||||||
1428008|NCT01926925|||||Cross-Sectional|||||||
1428009|NCT01926912|||Cohort||Prospective|||||||
1428010|NCT01926899||Single Group Assignment||Prevention||None (Open Label)||||||
1428011|NCT01926886||Single Group Assignment||Treatment||None (Open Label)||||||
1428012|NCT01926873|||Cohort||Prospective|||||||
1428013|NCT01926860|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428014|NCT01926847|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1428015|NCT01926834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428016|NCT01926821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428017|NCT01926808|||Cohort||Retrospective|||||||
1428018|NCT01926795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428019|NCT01926782|Randomized|Parallel Assignment||Treatment||Quadruple||The study was conducted in 2 separate populations concurrently: subjects receiving concomitant statin therapy and subjects not receiving concomitant statin therapy. Subjects receiving concomitant statin were to receive stable daily doses of rosuvastatin, atorvastatin, or simvastatin for at least 4 weeks. Background treatment with other lipid-modifying therapy (LMT) was allowed for all patients, provided they had been on a stable dose for at least 4 weeks (6 weeks for fenofibrate) prior to study entry.|t|t|t|t
1428020|NCT01926769||Single Group Assignment||Treatment||None (Open Label)||||||
1428021|NCT01926756|Randomized|Parallel Assignment||Prevention||Single|||t|||
1428022|NCT01926743||Single Group Assignment||Treatment||None (Open Label)||||||
1428023|NCT01926730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428024|NCT01926717|||Case Control||Retrospective|||||||
1428025|NCT01926704|||Cohort||Prospective|||||||
1428026|NCT01926691|||Cohort||Prospective|||||||
1428027|NCT01926678|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1428028|NCT01926665||Single Group Assignment||Treatment||None (Open Label)||||||
1428029|NCT01926652|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428030|NCT01926639||Single Group Assignment||Treatment||None (Open Label)||||||
1428031|NCT01926626||Single Group Assignment||Treatment||None (Open Label)||||||
1428032|NCT01926613|Randomized|Parallel Assignment||Treatment||Single||||||t
1428033|NCT01926600|||Case Control||Prospective|||||||
1428034|NCT01926587||Single Group Assignment||Treatment||None (Open Label)||||||
1428035|NCT01926574|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1428036|NCT01926561|||Case-Crossover||Prospective|||||||
1428037|NCT01926548|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428038|NCT01926535|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1428039|NCT01926522|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1428040|NCT01926509|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428041|NCT01926496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428042|NCT01926483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428043|NCT01926470|Randomized|Parallel Assignment||||Single||||t||
1428044|NCT01926457|Randomized|Parallel Assignment||Treatment||Single||||t||
1428045|NCT01926444|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1428046|NCT01926431|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428047|NCT01926418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428741|NCT01917370|||Case Control||Prospective|||||||
1428048|NCT01926405|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1428049|NCT01926392|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428050|NCT01926379|Randomized|Parallel Assignment||||None (Open Label)||||||
1428051|NCT01926366|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1428052|NCT01926353|||Cohort||Retrospective|||||||
1428053|NCT01926340|||Case-Control||Prospective|||||||
1428054|NCT01926327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428055|NCT01926314|Randomized|Parallel Assignment||Prevention||Single||||||t
1428056|NCT01926301|||Case Control||Prospective|||||||
1428057|NCT01926288|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428058|NCT01926275|Randomized|Parallel Assignment||Treatment||Single||||||t
1428059|NCT01926262|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1428060|NCT01926249|||Cohort||Prospective|||||||
1428061|NCT01926236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428062|NCT01926223||||||||||||
1428063|NCT01926210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428064|NCT01926197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428065|NCT01926184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428066|NCT01926171||Single Group Assignment||Treatment||None (Open Label)||||||
1428067|NCT01926158|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1428068|NCT01926145|||||Prospective|||||||
1428069|NCT01926132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428070|NCT01926119||Single Group Assignment||Treatment||None (Open Label)||||||
1428071|NCT01926106|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1428072|NCT01926093|||Cohort||Prospective|||||||
1428073|NCT01926080|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428074|NCT01926067|||||Prospective|||||||
1428075|NCT01926054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428076|NCT01926041|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428077|NCT01926028|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1428078|NCT01926015|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428079|NCT01926002|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1428080|NCT01925989|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428081|NCT01925976||Single Group Assignment||Treatment||None (Open Label)||||||
1428082|NCT01925963|||Cohort||Prospective|||||||
1428083|NCT01925950|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428084|NCT01925937|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1428085|NCT01925924|Randomized|Parallel Assignment||Prevention||Single||||||t
1428086|NCT01925911||Single Group Assignment||Basic Science||None (Open Label)||||||
1428087|NCT01925898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428088|NCT01925885|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428089|NCT01925872|||Cohort||Retrospective|||||||
1428090|NCT01925859||Single Group Assignment||Treatment||None (Open Label)||||||
1428091|NCT01925846|||Cohort||Retrospective|||||||
1428092|NCT01925833|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428093|NCT01925820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428094|NCT01925807||Single Group Assignment||Prevention||None (Open Label)||||||
1428095|NCT01925794||Single Group Assignment||Treatment||None (Open Label)||||||
1428096|NCT01925781|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428097|NCT01925768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428098|NCT01925755|||Cohort||Prospective|||||||
1428099|NCT01925742|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1428100|NCT01925729|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1428101|NCT01925716|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1428102|NCT01925703||Single Group Assignment||Treatment||None (Open Label)||||||
1428103|NCT01925690|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1428104|NCT01925677||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428105|NCT01925664|Randomized|Parallel Assignment||Prevention||Single||||||t
1428106|NCT01925651|Randomized|Parallel Assignment||Treatment||Single||||||t
1428107|NCT01925638||Single Group Assignment||||None (Open Label)||||||
1428108|NCT01925625|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1428109|NCT01925612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428110|NCT01925599|||Case-Only||Prospective|||||||
1428111|NCT01925586|||Cohort||Prospective|||||||
1428112|NCT01925573||Single Group Assignment||Treatment||None (Open Label)||||||
1428113|NCT01925560|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1428114|NCT01925547|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1428115|NCT01925534|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428116|NCT01925521|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1428117|NCT01925508|||Case Control||Cross-Sectional|||||||
1428118|NCT01925495||Single Group Assignment||Basic Science||None (Open Label)||||||
1428119|NCT01925482|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428120|NCT01925469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428121|NCT01925456||Single Group Assignment||||None (Open Label)||||||
1428122|NCT01925443|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428123|NCT01925430|||Case-Crossover||Cross-Sectional|||||||
1428124|NCT01925417||Single Group Assignment||Treatment||None (Open Label)||||||
1428125|NCT01925404|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1428126|NCT01925391|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1428127|NCT01925378||Single Group Assignment||Treatment||None (Open Label)||||||
1428128|NCT01925365|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1428129|NCT01925352||Single Group Assignment||Treatment||None (Open Label)||||||
1428130|NCT01925339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428131|NCT01925313|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428132|NCT01925300|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428133|NCT01925287|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1428134|NCT01925274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428135|NCT01925261|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1428136|NCT01925248|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428137|NCT01925235|||Cohort||Retrospective|||||||
1428138|NCT01925222|||Cohort||Cross-Sectional|||||||
1428139|NCT01925209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428140|NCT01925196|||||Prospective|||||||
1428141|NCT01925183|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428142|NCT01925170||Single Group Assignment||Diagnostic||Single|||||t|
1428143|NCT01925157|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1428144|NCT01925144|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1428145|NCT01925131||Single Group Assignment||Treatment||None (Open Label)||||||
1428146|NCT01925118||Single Group Assignment||Treatment||None (Open Label)||||||
1428147|NCT01925105|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428148|NCT01925092||Single Group Assignment||Treatment||None (Open Label)||||||
1428149|NCT01925079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428150|NCT01925066||Single Group Assignment||Treatment||None (Open Label)||||||
1428151|NCT01925053|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428152|NCT01925040|Randomized|Parallel Assignment||Treatment||Single|||||t|
1428153|NCT01925027||Single Group Assignment||Treatment||None (Open Label)||||||
1428154|NCT01925014|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1428155|NCT01925001|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1428156|NCT01924988||Single Group Assignment||Treatment||None (Open Label)||||||
1428157|NCT01924975|Randomized|Parallel Assignment||Other||Single|||t|||
1428158|NCT01924962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428159|NCT01924949||Single Group Assignment||Treatment||None (Open Label)||||||
1428160|NCT01924936|Non-Randomized|Sequential Assignment||Prevention||Double|||t|||t
1428161|NCT01924923|||Case-Only||Prospective|||||||
1428162|NCT01924910|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428163|NCT01924897|Randomized|||Treatment||||||||
1428164|NCT01924884|||Case-Control||Other|||||||
1428165|NCT01924871|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428166|NCT01924858||Single Group Assignment||Treatment||None (Open Label)||||||
1428167|NCT01924845||Single Group Assignment||Treatment||None (Open Label)||||||
1428168|NCT01924832|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428169|NCT01924819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428170|NCT01924806|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428171|NCT01924793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428172|NCT01924780|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1428173|NCT01924767|Randomized|Single Group Assignment||Treatment||Double||||||
1428174|NCT01924754|||||Retrospective|||||||
1428175|NCT01924741|||Cohort||Prospective|||||||
1428176|NCT01924728|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428177|NCT01924715|||Case Control||Retrospective|||||||
1428178|NCT01924702|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428179|NCT01924689||Single Group Assignment||Treatment||None (Open Label)||||||
1428180|NCT01924676|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428181|NCT01924663|||Case-Only|||||||||
1428182|NCT01924650|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428183|NCT01924637|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1428184|NCT01924624|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428185|NCT01924611|Randomized|Parallel Assignment||Treatment||Single||||||t
1428186|NCT01924598||Single Group Assignment||Other||None (Open Label)||||||
1428187|NCT01924585|||Cohort||Prospective|||||||
1428188|NCT01924572|Non-Randomized|Factorial Assignment||Prevention||Single||||||t
1428189|NCT01924559|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1428190|NCT01924546|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1428191|NCT01924533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428192|NCT01924520|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1428193|NCT01924507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428194|NCT01924494|||Cohort||Prospective|||||||
1428195|NCT01924481|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1428196|NCT01924468|Non-Randomized|Crossover Assignment||Prevention||||||||
1428197|NCT01924455|||Cohort||Prospective|||||||
1428198|NCT01924442|||Cohort||Prospective|||||||
1428199|NCT01924429|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1428200|NCT01924416|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1428201|NCT01924403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428202|NCT01924390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428203|NCT01924377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428204|NCT01924364|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||split-person study in which different parts of the same person may be assigned to receive different interventions, randomization occurs in regards to which site receives TGI or no TGI per site.||||
1428205|NCT01924351||Single Group Assignment||Treatment||None (Open Label)||||||
1428206|NCT01924338|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1428207|NCT01924325|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428208|NCT01924312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428209|NCT01924299|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1428210|NCT01924286|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1428211|NCT01924273||Single Group Assignment||Treatment||None (Open Label)||||||
1428212|NCT01924260||Single Group Assignment||Treatment||None (Open Label)||||||
1428213|NCT01924247|Randomized|Parallel Assignment||Treatment||Single||||||t
1428214|NCT01924234|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1428215|NCT01924221|||Cohort||Prospective|||||||
1428216|NCT01924208|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1428217|NCT01924195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428218|NCT01924182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428219|NCT01924169||Single Group Assignment||Other||None (Open Label)||||||
1428220|NCT01924156||Single Group Assignment||Treatment||None (Open Label)||||||
1428221|NCT01924143||Single Group Assignment||Treatment||None (Open Label)||||||
1428222|NCT01924130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428223|NCT01924117||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428224|NCT01924104|Randomized|Factorial Assignment||Treatment||Single|||t|||
1428225|NCT01924091|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1428226|NCT01924078||Single Group Assignment||Treatment||None (Open Label)||||||
1428227|NCT01924065|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1428228|NCT01924052|Non-Randomized|Parallel Assignment||||Double|||t|||t
1428229|NCT01924039|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1428230|NCT01924026|||Case Control||Cross-Sectional|||||||
1428231|NCT01924013|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1428232|NCT01924000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428233|NCT01923987||Single Group Assignment||Treatment||None (Open Label)||||||
1428234|NCT01923974|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1428235|NCT01923961|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428236|NCT01923948|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428237|NCT01923935||Single Group Assignment||Treatment||None (Open Label)||||||
1428238|NCT01923922||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428239|NCT01923909|Randomized|Parallel Assignment||Treatment||Single||||||t
1428240|NCT01923896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428241|NCT01923883|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1428242|NCT01923870|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428243|NCT01923857|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428244|NCT01923844|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1428245|NCT01923831|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1428246|NCT01923818|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428247|NCT01923805|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1428248|NCT01923792|||Cohort||Prospective|||||||
1428249|NCT01923779|||Cohort||Prospective|||||||
1428250|NCT01923766||Single Group Assignment||Treatment||None (Open Label)||||||
1428251|NCT01923753|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1428252|NCT01923740|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1428253|NCT01923727||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428254|NCT01923714|||Case-Only||Prospective|||||||
1428255|NCT01923701|Randomized|Parallel Assignment||Prevention||Single||||||t
1428256|NCT01923688|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1428257|NCT01923675|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1428258|NCT01923662||Single Group Assignment||Treatment||None (Open Label)||||||
1428259|NCT01923649|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1428260|NCT01923636||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428261|NCT01923623|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1428262|NCT01923610||Single Group Assignment||Treatment||None (Open Label)||||||
1428263|NCT01923597|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428264|NCT01923584|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428265|NCT01923571|||Cohort||Prospective|||||||
1428266|NCT01923558|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428267|NCT01923545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428268|NCT01923519|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1428269|NCT01923506||Single Group Assignment||Treatment||None (Open Label)||||||
1428270|NCT01923493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428271|NCT01923480|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1428272|NCT01923467||Single Group Assignment||Treatment||None (Open Label)||||||
1428273|NCT01923454||Single Group Assignment||Treatment||None (Open Label)||||||
1428274|NCT01923441|||Cohort||Prospective|||||||
1428275|NCT01923428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428276|NCT01923415|||Case-Only||Cross-Sectional|||||||
1428277|NCT01923402|||Cohort||Cross-Sectional|||||||
1428278|NCT01923389|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1428279|NCT01923376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428280|NCT01923363||Single Group Assignment||Basic Science||None (Open Label)||||||
1428281|NCT01923350|Randomized|Parallel Assignment||Prevention||Single|||t|||
1428282|NCT01923337||Single Group Assignment||Treatment||None (Open Label)||||||
1428283|NCT01923324|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428284|NCT01923311|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428285|NCT01923298||Single Group Assignment||Treatment||None (Open Label)||||||
1428286|NCT01923285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428287|NCT01923272|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1428288|NCT01923259|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428289|NCT01923246|Randomized|Factorial Assignment||Prevention||Single|||||t|
1428290|NCT01923233||Single Group Assignment||Treatment||None (Open Label)||||||
1428291|NCT01923220|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428292|NCT01923207|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428293|NCT01923194|Randomized|Parallel Assignment||Treatment||Single||||||t
1428294|NCT01923181|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428295|NCT01923168|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428296|NCT01923155|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1428297|NCT01923142|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428298|NCT01923129|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428299|NCT01923116||Single Group Assignment||Treatment||None (Open Label)||||||
1428300|NCT01923103|||Cohort||Prospective|||||||
1428301|NCT01923090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428302|NCT01923077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428303|NCT01923064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428304|NCT01923051|||Cohort||Prospective|||||||
1428305|NCT01923038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428306|NCT01923025||Single Group Assignment||||None (Open Label)||||||
1428307|NCT01923012|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1428308|NCT01922999|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428309|NCT01922986|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1428310|NCT01922973|||||Prospective|||||||
1428311|NCT01922960||Single Group Assignment||Basic Science||None (Open Label)||||||
1428312|NCT01922947|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428313|NCT01922934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428314|NCT01922921|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428315|NCT01922908|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428316|NCT01922895|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1428317|NCT01922882|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1428318|NCT01922869||Single Group Assignment||Basic Science||None (Open Label)||||||
1428319|NCT01922856|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428320|NCT01922843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428321|NCT01922830|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428322|NCT01922817|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1428323|NCT01922804|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1428324|NCT01922791|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1428325|NCT01922778||Single Group Assignment||Treatment||None (Open Label)||||||
1428326|NCT01922765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428327|NCT01922752||Single Group Assignment||Treatment||None (Open Label)||||||
1428328|NCT01922739||Single Group Assignment||Treatment||None (Open Label)||||||
1428329|NCT01922726|||Cohort||Prospective|||||||
1428330|NCT01922713|Randomized|Parallel Assignment||||Single|||||t|
1428331|NCT01922700|||Ecologic or Community||Cross-Sectional|||||||
1428332|NCT01922687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428333|NCT01922674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428334|NCT01922661|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1428335|NCT01922648|||Cohort||Prospective|||||||
1428336|NCT01922635||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428337|NCT01922622|||Cohort||Prospective|||||||
1428338|NCT01922609|||Case Control||Cross-Sectional|||||||
1428339|NCT01922596|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428340|NCT01922583||Single Group Assignment||Treatment||None (Open Label)||||||
1428341|NCT01922570||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428342|NCT01922557|||Case Control||Prospective|||||||
1428343|NCT01922544|||Case Control||Retrospective|||||||
1428344|NCT01922531|||Case Control||Prospective|||||||
1428345|NCT01922518|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428346|NCT01922505|||Case-Only||Prospective|||||||
1428347|NCT01922492|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428348|NCT01922479|Randomized|Parallel Assignment||Treatment||Single||||||t
1428349|NCT01922466|Randomized|Parallel Assignment||Treatment||Single||||||t
1428350|NCT01922453|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428351|NCT01922440|||Other||Prospective|||||||
1428352|NCT01922427|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428353|NCT01922414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428354|NCT01922401||Single Group Assignment||Prevention||Single||||||t
1428355|NCT01922388|||Case-Only||Prospective|||||||
1428356|NCT01922375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428357|NCT01922362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428358|NCT01922349|Randomized|Parallel Assignment||Treatment||Double||||||
1428359|NCT01922336|Randomized|Parallel Assignment||Other||Single|||t|||
1428360|NCT01922323|||Case-Only||Prospective|||||||
1428361|NCT01922310||Single Group Assignment||Health Services Research||||||||
1428362|NCT01922297|Randomized|Factorial Assignment||Treatment||Single||||||t
1428363|NCT01922284|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428364|NCT01922271|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1428365|NCT01922258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428366|NCT01922245|Non-Randomized|Crossover Assignment||Treatment||Double|||t|t||
1428367|NCT01922232|||Cohort||Prospective|||||||
1428368|NCT01922219||Single Group Assignment||Treatment||None (Open Label)||||||
1428369|NCT01922206|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1428370|NCT01922193|Randomized|Parallel Assignment||Treatment||Single||||||t
1428371|NCT01922180|||Cohort||Prospective|||||||
1428372|NCT01922167|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1428373|NCT01922154||Single Group Assignment||Treatment||None (Open Label)||||||
1428374|NCT01922141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428375|NCT01922128|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428376|NCT01922115|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1428377|NCT01922102|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428378|NCT01922089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428379|NCT01922076||Single Group Assignment||Treatment||None (Open Label)||||||
1428380|NCT01922063|Randomized|Parallel Assignment||Treatment||Single||||||t
1428381|NCT01922050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428382|NCT01922037||Single Group Assignment||Treatment||None (Open Label)||||||
1428383|NCT01922024|||Cohort||Prospective|||||||
1428384|NCT01922011|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428385|NCT01921998|||Case-Only||Prospective|||||||
1428386|NCT01921985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428387|NCT01921972|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428388|NCT01921959|||Cohort||Prospective|||||||
1428389|NCT01921946|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1428390|NCT01921933||Single Group Assignment||Treatment||None (Open Label)||||||
1428391|NCT01921920|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428392|NCT01921907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428393|NCT01921894|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1428394|NCT01921881||Single Group Assignment||||None (Open Label)||||||
1428395|NCT01921868||Single Group Assignment||Treatment||None (Open Label)||||||
1428396|NCT01921855|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1428397|NCT01921842|Randomized|Parallel Assignment||Prevention||Single||||||t
1428398|NCT01921829|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428399|NCT01921816||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428400|NCT01921803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428401|NCT01921790||Single Group Assignment||Treatment||None (Open Label)||||||
1428402|NCT01921777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428403|NCT01921764|Randomized|Parallel Assignment||Treatment||Single||||||t
1428404|NCT01921751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428405|NCT01921738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428406|NCT01921725||Single Group Assignment||Treatment||None (Open Label)||||||
1428407|NCT01921712|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1428408|NCT01921699||Single Group Assignment||Basic Science||None (Open Label)||||||
1428409|NCT01921686|||Case-Control||Prospective|||||||
1428410|NCT01921673||Single Group Assignment||Treatment||None (Open Label)||||||
1428411|NCT01921660||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428412|NCT01921647|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1428413|NCT01921634|Non-Randomized|Single Group Assignment||Diagnostic||||||||
1428414|NCT01921621|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1428415|NCT01921608||Single Group Assignment||Prevention||None (Open Label)||||||
1428416|NCT01921595|Randomized|Parallel Assignment||||None (Open Label)||||||
1428417|NCT01921582|Randomized|Parallel Assignment||Treatment||Single||||||t
1428418|NCT01921569|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428419|NCT01921556|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1428420|NCT01921543|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1428421|NCT01921530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428422|NCT01921517|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1428423|NCT01921504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428424|NCT01921491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428425|NCT01921478|||Cohort||Retrospective|||||||
1428426|NCT01921465|||Cohort||Prospective|||||||
1428427|NCT01921452||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428428|NCT01921439|Randomized|Parallel Assignment||Other||Single|||t|||
1428429|NCT01921426||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428430|NCT01921413|||Case Control||Prospective|||||||
1428431|NCT01921400|||Case-Control||Cross-Sectional|||||||
1428432|NCT01921387||Single Group Assignment||Treatment||None (Open Label)||||||
1428900|NCT01915290|||||Cross-Sectional|||||||
1428433|NCT01921374|Non-Randomized|Parallel Assignment||Screening||Single|||||t|
1428434|NCT01921361|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1428435|NCT01921348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428436|NCT01921335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428437|NCT01921322|Randomized|Parallel Assignment||Treatment||None (Open Label)||Subjects randomly assigned to undergo treatment using either the Paradigm 722 insulin pump or multiple daily insulin injections.||||
1428438|NCT01921309|Randomized|Single Group Assignment||Treatment||Single|||t|||
1428439|NCT01921296||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428440|NCT01921283|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1428441|NCT01921270||Single Group Assignment||Treatment||None (Open Label)|Evaluators will review the videotaped examinations, presented in a random order, using the Global Dystonia Rating scale (GDS). The evaluators will rate the dystonia at baseline (injection visit) and 6 weeks after injection.|||||
1428442|NCT01921257|Non-Randomized|Single Group Assignment||Treatment||Single||||t||
1428443|NCT01921244|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1428444|NCT01921231|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428445|NCT01921218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428446|NCT01921205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428447|NCT01921192|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428448|NCT01921179|Randomized|Crossover Assignment||Treatment||Single||||||t
1428449|NCT01921166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428450|NCT01921153|Non-Randomized|Crossover Assignment||Prevention||Single|||t|||
1428451|NCT01921140|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1428452|NCT01921127|||Cohort||Retrospective|||||||
1428453|NCT01921114|Randomized|Parallel Assignment||Treatment||Single||||||t
1428454|NCT01921101|Randomized|Parallel Assignment||Treatment||Single||||||t
1428455|NCT01921088|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1428456|NCT01921075|||Cohort||Prospective|||||||
1428457|NCT01921062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428458|NCT01921049|||Cohort||Prospective|||||||
1428459|NCT01921036|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1428460|NCT01921023|||Case-Only||Prospective|||||||
1428461|NCT01921010|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428462|NCT01920997|||Case Control|||||||||
1428463|NCT01920984|Non-Randomized|Single Group Assignment||Basic Science||Single||||||t
1428464|NCT01920971|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428465|NCT01920958|||Cohort||Prospective|||||||
1428466|NCT01920945||Single Group Assignment||Treatment||None (Open Label)||||||
1428467|NCT01920932||Single Group Assignment||Treatment||None (Open Label)||||||
1428468|NCT01920919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428469|NCT01920906||Single Group Assignment||Basic Science||None (Open Label)||||||
1428470|NCT01920893|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428471|NCT01920880|||Case Control||Prospective|||||||
1428472|NCT01920867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428473|NCT01920854|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428474|NCT01920841|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428475|NCT01920828|||Cohort||Prospective|||||||
1428476|NCT01920815|||Cohort||Prospective|||||||
1428477|NCT01920802|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428478|NCT01920789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428479|NCT01920776|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428480|NCT01920763|||Cohort||Prospective|||||||
1428481|NCT01920750|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428482|NCT01920737||Single Group Assignment||Treatment||None (Open Label)||||||
1428483|NCT01920724|||||Cross-Sectional|||||||
1428484|NCT01920711|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428485|NCT01920698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428486|NCT01920685|Randomized|Parallel Assignment||Treatment||Single||||||t
1428487|NCT01920672|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1428488|NCT01920659|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428489|NCT01920646|Randomized|||||||||||
1428490|NCT01920633|||Cohort||Prospective|||||||
1428491|NCT01920620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428492|NCT01920607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428493|NCT01920594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428494|NCT01920581|||Case-Only||Prospective|||||||
1428495|NCT01920568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428496|NCT01920555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428497|NCT01920542|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1428498|NCT01920529|Randomized|Parallel Assignment||Treatment||Single|||||t|
1428499|NCT01920516|||Cohort||Prospective|||||||
1428500|NCT01920503|||Cohort||Prospective|||||||
1428501|NCT01920490|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1428502|NCT01920477|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428503|NCT01920464|||||Retrospective|||||||
1428504|NCT01920451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428505|NCT01920438|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1428506|NCT01920425|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1428507|NCT01920412||Single Group Assignment||Prevention||None (Open Label)||||||
1428508|NCT01920399|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1428509|NCT01920386|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428510|NCT01920373|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1428511|NCT01920360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428512|NCT01920347|||Cohort||Prospective|||||||
1428513|NCT01920334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428514|NCT01920321||Single Group Assignment||Treatment||None (Open Label)||||||
1428515|NCT01920308|||Cohort||Prospective|||||||
1428516|NCT01920295|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428517|NCT01920282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428518|NCT01920269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428519|NCT01920256|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1428520|NCT01920243|Randomized|Parallel Assignment||Treatment||Single||||||t
1428521|NCT01920230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428522|NCT01920217|||Case Control||Prospective|||||||
1428523|NCT01920204||Single Group Assignment||Treatment||None (Open Label)||||||
1428524|NCT01920191||Single Group Assignment||Treatment||None (Open Label)||||||
1428525|NCT01920178|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428526|NCT01920165|||Ecologic or Community||Retrospective|||||||
1428527|NCT01920152|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1428528|NCT01920139||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428529|NCT01920126|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1428530|NCT01920113|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428531|NCT01920100|||Cohort||Prospective|||||||
1428532|NCT01920087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428533|NCT01920074||Single Group Assignment||Treatment||None (Open Label)||||||
1428534|NCT01920061|Non-Randomized|||Basic Science||None (Open Label)||||||
1428535|NCT01920048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428536|NCT01920035|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1428537|NCT01920022|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428538|NCT01920009|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1428539|NCT01919996||Single Group Assignment||Treatment||None (Open Label)||||||
1428540|NCT01919983|||Case-Control||Cross-Sectional|||||||
1428541|NCT01919970|Randomized|Parallel Assignment||Treatment||Single||||||t
1428542|NCT01919957||Single Group Assignment||Basic Science||None (Open Label)||||||
1428543|NCT01919944|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1428544|NCT01919931|||Case Control||Retrospective|||||||
1428545|NCT01919918|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1428546|NCT01919905|Randomized|Parallel Assignment||||Double|||t||t|
1428547|NCT01919892||Single Group Assignment||Treatment||None (Open Label)||||||
1428548|NCT01919879|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428549|NCT01919866||Single Group Assignment||Treatment||None (Open Label)||||||
1428550|NCT01919853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428551|NCT01919840|Randomized|Parallel Assignment||Prevention||Single|||t|||
1428552|NCT01919827||Single Group Assignment||Treatment||None (Open Label)||||||
1428553|NCT01919814|Randomized|Crossover Assignment||||Double|||t||t|
1428554|NCT01919801|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1428555|NCT01919788|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1428556|NCT01919775|||Cohort||Cross-Sectional|||||||
1428557|NCT01919762|||Case Control||Prospective|||||||
1428558|NCT01919749||Single Group Assignment||Treatment||None (Open Label)||||||
1428559|NCT01919736|Randomized|Parallel Assignment||Prevention||Single|||t|||
1428560|NCT01919723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428561|NCT01919710||Single Group Assignment||Treatment||None (Open Label)||||||
1428562|NCT01919697|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428563|NCT01919684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428564|NCT01919671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428565|NCT01919658|Randomized|Parallel Assignment||Treatment||Single||||||t
1428566|NCT01919645|Randomized|Parallel Assignment||Treatment||Single||||||t
1428567|NCT01919632||Single Group Assignment||Prevention||None (Open Label)||||||
1428568|NCT01919619||Single Group Assignment||Treatment||None (Open Label)||||||
1428569|NCT01919606|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428570|NCT01919593|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428571|NCT01919580|||Case Control|||||||||
1428572|NCT01919567|||Case Control|||||||||
1428573|NCT01919554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428574|NCT01919541||Single Group Assignment||Basic Science||None (Open Label)||||||
1428575|NCT01919528||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428576|NCT01919515||Single Group Assignment||Treatment||None (Open Label)||||||
1428577|NCT01919502||Single Group Assignment||Health Services Research||None (Open Label)||||||
1428578|NCT01919489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428579|NCT01919476|Randomized|Crossover Assignment||Prevention||Single|||||t|
1428580|NCT01919463|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428581|NCT01919450|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428582|NCT01919437||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428583|NCT01919424|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428584|NCT01919411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428585|NCT01919398||Single Group Assignment||Treatment||None (Open Label)||||||
1428586|NCT01919385||Single Group Assignment||Basic Science||None (Open Label)||||||
1428587|NCT01919372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428588|NCT01919359|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1428589|NCT01919346|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1428590|NCT01919333|||Cohort||Prospective|||||||
1428591|NCT01919320|||Case-Control||Cross-Sectional|||||||
1428592|NCT01919307||Single Group Assignment||Treatment||None (Open Label)||||||
1428593|NCT01919294||Single Group Assignment||Treatment||None (Open Label)||||||
1428594|NCT01919281|Randomized|Parallel Assignment||Treatment||Single||||||t
1428595|NCT01919268|Randomized|Parallel Assignment||Treatment||Single||||||t
1428596|NCT01919255|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1428597|NCT01919242|||Cohort||Prospective|||||||
1428598|NCT01919229|Randomized|Parallel Assignment||||None (Open Label)||||||
1428599|NCT01919216|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428600|NCT01919203||Single Group Assignment||Prevention||Single|||||t|
1428601|NCT01919190|Randomized|Parallel Assignment||Treatment||Single||||||t
1428602|NCT01919177|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1428603|NCT01919164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428604|NCT01919151|||Cohort||Prospective|||||||
1428605|NCT01919138|||Case-Only||Retrospective|||||||
1428606|NCT01919125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428607|NCT01919112|Randomized|Parallel Assignment||Treatment||Quadruple|Investigators and subjects will be masked to the trail arm assignments at randomization. The investigator reviewing outcome data will also be masked to the trial assignments.|The trial will randomize subjects to anodal transcranial direct current stimulation (tDCS) versus sham stimulation, both of them carried out in combination with standardized swallowing exercises|t|t|t|t
1428608|NCT01919099|||Cohort||Other|||||||
1428609|NCT01919086||Single Group Assignment||Treatment||None (Open Label)||||||
1428610|NCT01919073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428611|NCT01919060|||Cohort||Prospective|||||||
1428612|NCT01919047|||Cohort||Prospective|||||||
1428613|NCT01919034|||Case-Control||Prospective|||||||
1428614|NCT01919021||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428615|NCT01919008|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1428616|NCT01918995|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1428617|NCT01918982|||Cohort||Prospective|||||||
1428618|NCT01918969|||Cohort||Prospective|||||||
1428619|NCT01918956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428620|NCT01918943|||Cohort||Prospective|||||||
1428621|NCT01918930||Single Group Assignment||Basic Science||None (Open Label)||||||
1428622|NCT01918917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428623|NCT01918904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428624|NCT01918891|Randomized|Parallel Assignment||Treatment||Single||||||t
1428625|NCT01918878||Single Group Assignment||Treatment||None (Open Label)||||||
1428626|NCT01918865|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428627|NCT01918852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428628|NCT01918839|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1428629|NCT01918826|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428630|NCT01918813||Single Group Assignment||Prevention||None (Open Label)||||||
1428631|NCT01918800|Randomized|Parallel Assignment||Other||Single|||t|||
1428632|NCT01918787||Single Group Assignment||Treatment||None (Open Label)||||||
1428633|NCT01918774||Single Group Assignment||Health Services Research||None (Open Label)||||||
1428634|NCT01918761||Single Group Assignment||Treatment||None (Open Label)||||||
1428635|NCT01918748||Single Group Assignment||Treatment||None (Open Label)||||||
1428636|NCT01918735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428637|NCT01918722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428638|NCT01918709|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428639|NCT01918696|Randomized|Parallel Assignment||Treatment||Single|||||t|
1428640|NCT01918683||||Treatment||||||||
1428641|NCT01918670|||Cohort||Prospective|||||||
1428642|NCT01918657|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428643|NCT01918644||Single Group Assignment||Treatment||None (Open Label)||||||
1428644|NCT01918631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428645|NCT01918618|||Case Control||Retrospective|||||||
1428646|NCT01918605|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428647|NCT01918592||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428648|NCT01918579|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428649|NCT01918566|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1428650|NCT01918553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428651|NCT01918540|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428652|NCT01918527|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428653|NCT01918514||||||||||||
1428654|NCT01918501||Single Group Assignment||Basic Science||None (Open Label)||||||
1428655|NCT01918488|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1428656|NCT01918475|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1428657|NCT01918462|||Cohort||Prospective|||||||
1428658|NCT01918449|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428659|NCT01918436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428660|NCT01918423|||Cohort||Prospective|||||||
1428662|NCT01918397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428663|NCT01918384|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428664|NCT01918371|||Case-Only||Retrospective|||||||
1428665|NCT01918358|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428666|NCT01918345|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1428667|NCT01918332|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1428668|NCT01918319|Randomized|Parallel Assignment||Prevention||Single||||||t
1428669|NCT01918306|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1428670|NCT01918293|Randomized|Parallel Assignment||||None (Open Label)||||||
1428671|NCT01918280|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428672|NCT01918267|||Cohort||Prospective|||||||
1428673|NCT01918254|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428674|NCT01918241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428675|NCT01918228|Randomized|Factorial Assignment||Prevention||Single||||||t
1428676|NCT01918215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428677|NCT01918202|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1428678|NCT01918189||Single Group Assignment||Treatment||None (Open Label)||||||
1428679|NCT01918176||Crossover Assignment||Basic Science||None (Open Label)||||||
1428680|NCT01918163|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1428681|NCT01918150|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428682|NCT01918137|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428683|NCT01918124||Single Group Assignment||Treatment||None (Open Label)||||||
1428684|NCT01918111|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428685|NCT01918098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428686|NCT01918085|Randomized|Crossover Assignment||||None (Open Label)||||||
1428687|NCT01918072|||Ecologic or Community||Retrospective|||||||
1428688|NCT01918059|Randomized|Parallel Assignment||Treatment||Single||||||t
1428689|NCT01918046|||Cohort||Prospective|||||||
1428690|NCT01918033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428691|NCT01918020|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428692|NCT01918007|Randomized|Parallel Assignment||Treatment||Single|||||t|
1428693|NCT01917994|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1428694|NCT01917981||Single Group Assignment||Diagnostic||Single||||||t
1428695|NCT01917968|||Cohort||Prospective|||||||
1428696|NCT01917955|||Cohort||Prospective|||||||
1428697|NCT01917942|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428698|NCT01917929||Single Group Assignment||Treatment||None (Open Label)||||||
1428699|NCT01917916|Randomized|Parallel Assignment||Treatment||Double||||||
1428700|NCT01917903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428701|NCT01917890|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1428702|NCT01917877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428703|NCT01917864||Single Group Assignment||Treatment||None (Open Label)||||||
1428704|NCT01917851|||||Prospective|||||||
1428705|NCT01917838||Single Group Assignment||Treatment||None (Open Label)||||||
1428706|NCT01917825||Single Group Assignment||Treatment||None (Open Label)||||||
1428707|NCT01917812|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1428708|NCT01917799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428709|NCT01917786|||Case Control||Prospective|||||||
1428710|NCT01917773||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428711|NCT01917760|||||Prospective|||||||
1428712|NCT01917747|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428713|NCT01917734|||Cohort||Retrospective|||||||
1428714|NCT01917721|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428715|NCT01917708||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428716|NCT01917695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428717|NCT01917682|||Cohort||Other|||||||
1428718|NCT01917669|||Cohort||Prospective|||||||
1428719|NCT01917656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428720|NCT01917643|||Cohort||Retrospective|||||||
1428721|NCT01917630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428722|NCT01917617|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428723|NCT01917604|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428724|NCT01917591|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428725|NCT01917578|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428726|NCT01917565|||Case-Crossover||Cross-Sectional|||||||
1428727|NCT01917552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428728|NCT01917539|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1428729|NCT01917526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428730|NCT01917513|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428731|NCT01917500|||Cohort|||||||||
1428732|NCT01917487|||||Prospective|||||||
1428733|NCT01917474|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428734|NCT01917461|||Cohort||Prospective|||||||
1428735|NCT01917448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428736|NCT01917435|Randomized|Parallel Assignment||Treatment||Single||||||t
1428737|NCT01917422|||Case Control|||||||||
1428738|NCT01917409|Randomized|Parallel Assignment||Treatment||Single||||||t
1428739|NCT01917396||||||||||||
1428740|NCT01917383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428742|NCT01917357|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428743|NCT01917344||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428744|NCT01917331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428745|NCT01917318|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1428746|NCT01917305|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428747|NCT01917292|Randomized|Parallel Assignment||Prevention||Single||||||t
1428748|NCT01917279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428749|NCT01917266|||Cohort||Prospective|||||||
1428750|NCT01917253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428751|NCT01917240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428752|NCT01917227||Single Group Assignment||Health Services Research||None (Open Label)||||||
1428753|NCT01917214|||Case-Only||Retrospective|||||||
1428754|NCT01917201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428755|NCT01917188|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1428756|NCT01917175|||Cohort||Prospective|||||||
1428757|NCT01917162|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1428758|NCT01917149|Randomized|Parallel Assignment||Treatment||Single||||||t
1428759|NCT01917136||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428760|NCT01917123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428761|NCT01917110|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428762|NCT01917097|||Cohort||Retrospective|||||||
1428763|NCT01917084||Single Group Assignment||||None (Open Label)||||||
1428764|NCT01917071||Single Group Assignment||Treatment||None (Open Label)||||||
1428765|NCT01917058|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428766|NCT01917045|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1428767|NCT01917032|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1428768|NCT01917019|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428769|NCT01917006|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1428770|NCT01916993|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1428771|NCT01916980|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428772|NCT01916967|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428773|NCT01916954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428774|NCT01916941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428775|NCT01916928|||Cohort||Prospective|||||||
1428776|NCT01916915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428777|NCT01916902|Randomized|Parallel Assignment||||Single||||||t
1428778|NCT01916889||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428779|NCT01916876|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1428780|NCT01916863|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1428781|NCT01916850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428782|NCT01916837|||||Prospective|||||||
1428783|NCT01916824|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1428784|NCT01916811|||Case Control||Retrospective|||||||
1428785|NCT01916798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428786|NCT01916785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428787|NCT01916772|||Cohort||Prospective|||||||
1428788|NCT01916759|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1428789|NCT01916746||Single Group Assignment||Treatment||None (Open Label)||||||
1428790|NCT01916733|||Cohort||Prospective|||||||
1428791|NCT01916720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428792|NCT01916707|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1428793|NCT01916694|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1428794|NCT01916681|Randomized|Parallel Assignment||Treatment||Single||||||t
1428795|NCT01916668|||Case Control||Cross-Sectional|||||||
1428796|NCT01916655|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428797|NCT01916642|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1428798|NCT01916629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428799|NCT01916616||Single Group Assignment||Treatment||None (Open Label)||||||
1428800|NCT01916603|Randomized|Single Group Assignment||Prevention||Double|||||t|t
1428801|NCT01916590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428802|NCT01916577|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428803|NCT01916564|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1428804|NCT01916538|||Case Control||Retrospective|||||||
1428805|NCT01916525|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428806|NCT01916512|||Case-Control||Cross-Sectional|||||||
1428807|NCT01916499|||Case-Only||Prospective|||||||
1428808|NCT01916486|Randomized|Parallel Assignment||Treatment||Single||||||t
1428809|NCT01916473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428810|NCT01916460||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428811|NCT01916447||Single Group Assignment||Treatment||None (Open Label)||||||
1428812|NCT01916434|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1428813|NCT01916421|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1428814|NCT01916408|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428815|NCT01916395|||Case-Crossover||Prospective|||||||
1428816|NCT01916382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428817|NCT01916369||Single Group Assignment||Treatment||None (Open Label)||||||
1428818|NCT01916356||Single Group Assignment||Health Services Research||None (Open Label)||||||
1428819|NCT01916343|Randomized|Parallel Assignment||||Single||||||t
1428820|NCT01916330|||Case-Only||Prospective|||||||
1428821|NCT01916317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428822|NCT01916304||Single Group Assignment||Treatment||None (Open Label)||||||
1428823|NCT01916291||Parallel Assignment||Treatment||None (Open Label)||||||
1428824|NCT01916278||||||||||||
1428825|NCT01916265|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1428826|NCT01916252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428827|NCT01916239|Randomized|Parallel Assignment||Treatment||Single|||||t|
1428828|NCT01916226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428829|NCT01916213|Randomized|Crossover Assignment||Treatment||Single||||t||
1428830|NCT01916200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428831|NCT01916187||Single Group Assignment||Treatment||None (Open Label)||||||
1428832|NCT01916174|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1428833|NCT01916161|||Cohort||Prospective|||||||
1428834|NCT01916148||||||||||||
1428835|NCT01916135||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428836|NCT01916122||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428837|NCT01916109||Single Group Assignment||Treatment||None (Open Label)||||||
1428838|NCT01916096|||Case-Only||Prospective|||||||
1428839|NCT01916083||||||||||||
1428840|NCT01916070|||Cohort||Prospective|||||||
1428841|NCT01916057||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428842|NCT01916044|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428843|NCT01916031|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1428844|NCT01916018||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428845|NCT01916005||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428846|NCT01915992|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1428847|NCT01915979|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428848|NCT01915966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428849|NCT01915953|||||Prospective|||||||
1428850|NCT01915940|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428851|NCT01915927||Single Group Assignment||Treatment||None (Open Label)||||||
1428852|NCT01915914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428853|NCT01915901|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428854|NCT01915888|||Cohort||Retrospective|||||||
1428855|NCT01915875||Single Group Assignment||Supportive Care||None (Open Label)||||||
1428856|NCT01915862|||Cohort||Prospective|||||||
1428857|NCT01915849|Randomized|Crossover Assignment||||Double|||t||t|
1428858|NCT01915836||Single Group Assignment||Prevention||None (Open Label)||||||
1428859|NCT01915823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428860|NCT01915810|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428861|NCT01915797|||Cohort||Other|||||||
1428862|NCT01915784|Randomized|Crossover Assignment||||None (Open Label)||||||
1428863|NCT01915771||Single Group Assignment||||None (Open Label)||||||
1428864|NCT01915758|Randomized|Parallel Assignment||Other||Single|||||t|
1428865|NCT01915745|Randomized|Parallel Assignment||||None (Open Label)||||||
1428866|NCT01915732|Randomized|Parallel Assignment||Treatment||Single||||||t
1428867|NCT01915719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428868|NCT01915706|Randomized|Parallel Assignment||Prevention||Single|||||t|
1428869|NCT01915693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428870|NCT01915680|||Case-Control||Cross-Sectional|||||||
1428871|NCT01915667|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1428872|NCT01915654|||Case Control||Retrospective|||||||
1428873|NCT01915641|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1428874|NCT01915628|||Case Control||Prospective|||||||
1428875|NCT01915615|||Case-Only||Prospective|||||||
1428876|NCT01915602||Single Group Assignment||Treatment||None (Open Label)||||||
1428877|NCT01915589||Single Group Assignment||Treatment||None (Open Label)||||||
1428878|NCT01915576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428879|NCT01915563|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428880|NCT01915550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428881|NCT01915537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428882|NCT01915524||Single Group Assignment||Treatment||None (Open Label)||||||
1428883|NCT01915511|||Cohort||Prospective|||||||
1428884|NCT01915498||Single Group Assignment||Treatment||None (Open Label)||||||
1428885|NCT01915485||Single Group Assignment||Treatment||None (Open Label)||||||
1428886|NCT01915472|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428887|NCT01915459|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428888|NCT01915446|||Cohort||Prospective|||||||
1428889|NCT01915433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428890|NCT01915420|||Cohort||Prospective|||||||
1428891|NCT01915407|||Cohort||Cross-Sectional|||||||
1428892|NCT01915394|||Cohort||Prospective|||||||
1428893|NCT01915381|Randomized|Crossover Assignment||Treatment||Single|||||t|
1428894|NCT01915368|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428895|NCT01915355||Single Group Assignment||Treatment||None (Open Label)||||||
1428896|NCT01915342||Single Group Assignment||Basic Science||None (Open Label)||||||
1428897|NCT01915329|Randomized|Parallel Assignment||Basic Science||Single||||||t
1428898|NCT01915316|||Cohort||Cross-Sectional|||||||
1428899|NCT01915303||Single Group Assignment||Treatment||None (Open Label)||||||
1428901|NCT01915277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1428902|NCT01915264|||Cohort||Prospective|||||||
1428903|NCT01915251|||||Prospective|||||||
1428904|NCT01915238|||||Prospective|||||||
1428905|NCT01915225|||Cohort||Prospective|||||||
1428906|NCT01915212|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1428907|NCT01915199|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428908|NCT01915186|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1428909|NCT01915173|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1428910|NCT01915160|Randomized|Parallel Assignment||Treatment||Single||||||t
1428911|NCT01915147|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1428912|NCT01915134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428913|NCT01915121|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428914|NCT01915108|Randomized|Parallel Assignment||Prevention||Single||||||t
1428915|NCT01915095|Randomized|Crossover Assignment||Treatment||Single|||t|||
1428916|NCT01915082|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1428917|NCT01915069||Single Group Assignment||Basic Science||None (Open Label)||||||
1428918|NCT01915056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428919|NCT01915043|Randomized|Crossover Assignment||Prevention||Triple||||t|t|t
1428920|NCT01915030|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1428921|NCT01915017|Randomized|Factorial Assignment||Treatment||Single||||||t
1428922|NCT01915004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428923|NCT01914991|Randomized|Parallel Assignment||Treatment||Single||||||t
1428924|NCT01914978|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428925|NCT01914965|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1428926|NCT01914952|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428927|NCT01914939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428928|NCT01914926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428929|NCT01914913||Single Group Assignment||Treatment||None (Open Label)||||||
1428930|NCT01914900||Single Group Assignment||Treatment||None (Open Label)||||||
1428931|NCT01914887||Single Group Assignment||Treatment||None (Open Label)||||||
1428932|NCT01914874|Randomized|Parallel Assignment||Treatment||Single||||||t
1428933|NCT01914861|||Cohort||Prospective|||||||
1428934|NCT01914848|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1428935|NCT01914835||Single Group Assignment||Treatment||None (Open Label)||||||
1428936|NCT01914822|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1428937|NCT01914809|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1428938|NCT01914796|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1428939|NCT01914783|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1428940|NCT01914770|||||Retrospective|||||||
1428941|NCT01914757|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1428942|NCT01914744|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428943|NCT01914731||Single Group Assignment||Treatment||None (Open Label)||||||
1428944|NCT01914718||Single Group Assignment||Treatment||None (Open Label)||||||
1428945|NCT01914705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428946|NCT01914692|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1428947|NCT01914679||Sequential Assignment||Treatment||Single|Participants did not know when the stimulation was occurring or not.|All participants went through a 4 week sham period, followed by a 12 week intervention with the device.|t|||
1428948|NCT01914666||Single Group Assignment||Treatment||None (Open Label)||||||
1428949|NCT01914653|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428950|NCT01914640|||Ecologic or Community||Cross-Sectional|||||||
1428951|NCT01914627|Randomized|Parallel Assignment||Treatment||Single||||||t
1428952|NCT01914614|||||Prospective|||||||
1428953|NCT01914601|Randomized|Crossover Assignment||Prevention||Single|||||t|
1428954|NCT01914588|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1428955|NCT01914575||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428956|NCT01914562|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1428957|NCT01914549||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428958|NCT01914536|||Cohort||Prospective|||||||
1428959|NCT01914523|Randomized|Parallel Assignment||Prevention||Single||||||t
1428960|NCT01914510||Single Group Assignment||Treatment||None (Open Label)||||||
1428961|NCT01914497||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428962|NCT01914484||Single Group Assignment||Treatment||None (Open Label)||||||
1428963|NCT01914471|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428964|NCT01914458||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428965|NCT01914445|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1428966|NCT01914432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1428967|NCT01914419|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428968|NCT01914406|Randomized|Crossover Assignment||Treatment||Single||||||t
1428969|NCT01914393||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1428970|NCT01914380|||Cohort||Prospective|||||||
1428971|NCT01914367|Randomized|Parallel Assignment||||None (Open Label)||||||
1428972|NCT01914354|||Case Control|||||||||
1428973|NCT01914341|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1428974|NCT01914328|||Cohort||Prospective|||||||
1428975|NCT01914315|Randomized|Parallel Assignment||Treatment||Single||||||t
1428976|NCT01914302|||Case-Only||Cross-Sectional|||||||
1428977|NCT01914289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428978|NCT01914276|||Cohort||Prospective|||||||
1428979|NCT01914263|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1428980|NCT01914250|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1428981|NCT01914237||Single Group Assignment||Treatment||None (Open Label)||||||
1428982|NCT01914224|Randomized|Parallel Assignment||Treatment||Single|||t|||
1428983|NCT01914211|||Cohort||Prospective|||||||
1428984|NCT01914198|||Cohort||Prospective|||||||
1428985|NCT01914185|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1428986|NCT01914172|||Cohort||Cross-Sectional|||||||
1428987|NCT01914159||Single Group Assignment||Treatment||None (Open Label)||||||
1428988|NCT01914146|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1428989|NCT01914133|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1428990|NCT01914120|||Case-Only||Prospective|||||||
1428991|NCT01914107|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428992|NCT01914094|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1428993|NCT01914081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428994|NCT01914068|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1428995|NCT01914055|Randomized|Parallel Assignment||Treatment||Single||||||t
1428996|NCT01914042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1428997|NCT01914029|||Case-Only||Prospective|||||||
1428998|NCT01914016||Single Group Assignment||Diagnostic||None (Open Label)||||||
1428999|NCT01914003|||Case-Control||Prospective|||||||
1429000|NCT01913990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429001|NCT01913977||Single Group Assignment||Treatment||None (Open Label)||||||
1429002|NCT01913964|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429003|NCT01913951||Single Group Assignment||Treatment||None (Open Label)||||||
1429004|NCT01913938|||Case-Only||Prospective|||||||
1429005|NCT01913925|Randomized|Parallel Assignment||||Double|||t||t|
1429006|NCT01913912|Randomized|Crossover Assignment||||Double|||t||t|
1429007|NCT01913899|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429008|NCT01913886||Single Group Assignment||Treatment||None (Open Label)||||||
1429009|NCT01913873||Single Group Assignment||Screening||None (Open Label)||||||
1429010|NCT01913860|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1429011|NCT01913847|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429012|NCT01913834|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1429013|NCT01913808|Randomized|Parallel Assignment||Treatment||Single||||||t
1429014|NCT01913795|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429015|NCT01913782|||Case-Control||Prospective|||||||
1429016|NCT01913769|||Case Control||Prospective|||||||
1429017|NCT01913756|Randomized|Parallel Assignment||Prevention||Single||||||t
1429018|NCT01913743|||Case-Only||Cross-Sectional|||||||
1429019|NCT01913730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429020|NCT01913717||Single Group Assignment||Treatment||None (Open Label)||||||
1429021|NCT01913704|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429022|NCT01913691|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429023|NCT01913678|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1429024|NCT01913665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429025|NCT01913652||Single Group Assignment||Treatment||None (Open Label)||||||
1429026|NCT01913639||Single Group Assignment||Treatment||None (Open Label)||||||
1429027|NCT01913626||Single Group Assignment||Treatment||None (Open Label)||||||
1429028|NCT01913613||Single Group Assignment||Treatment||None (Open Label)||||||
1429029|NCT01913600||Single Group Assignment||Treatment||None (Open Label)||||||
1429030|NCT01913587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429031|NCT01913574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429032|NCT01913561||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429033|NCT01913548|||Case Control||Prospective|||||||
1429034|NCT01913535|Randomized|Parallel Assignment||Treatment||Quadruple||sequential parallel comparison design (SPCD) with two phases|t|t|t|t
1429035|NCT01913522|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429036|NCT01913509|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429037|NCT01913496|Randomized|Parallel Assignment||||None (Open Label)||||||
1429038|NCT01913483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429039|NCT01913470|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1429040|NCT01913457|||Cohort||Prospective|||||||
1429041|NCT01913444||Single Group Assignment||Treatment||None (Open Label)||||||
1429042|NCT01913431|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429043|NCT01913418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429044|NCT01913405||Single Group Assignment||Treatment||None (Open Label)||||||
1429045|NCT01913392||Single Group Assignment||Treatment||None (Open Label)||||||
1429046|NCT01913379|Randomized|Parallel Assignment||||None (Open Label)||||||
1429047|NCT01913366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429048|NCT01913353|Randomized|Parallel Assignment||Prevention||Single||||||t
1429049|NCT01913340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429050|NCT01913327|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429051|NCT01913314||Single Group Assignment||Basic Science||None (Open Label)||||||
1429052|NCT01913301|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1429053|NCT01913288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429054|NCT01913275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429055|NCT01913262|||Cohort||Prospective|||||||
1429056|NCT01913249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429057|NCT01913236|Randomized|Parallel Assignment||||None (Open Label)||||||
1429058|NCT01913223||Single Group Assignment||Treatment||None (Open Label)||||||
1429059|NCT01913210|||||Prospective|||||||
1429060|NCT01913197||Single Group Assignment||Treatment||None (Open Label)||||||
1429061|NCT01913184|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1429062|NCT01913171|Randomized|Crossover Assignment||||None (Open Label)||||||
1429063|NCT01913158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429064|NCT01913145||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429065|NCT01913132|Randomized|Parallel Assignment||Prevention||Single||2 study subgroups: 1) OPEN arm for open procedures 2) EVAR arm for endovascular aortic repair||t||
1429066|NCT01913119|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429067|NCT01913106||Single Group Assignment||Treatment||None (Open Label)||||||
1429068|NCT01913093|||Case-Control||Prospective|||||||
1429069|NCT01913080|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1429070|NCT01913067||Single Group Assignment||Treatment||None (Open Label)||||||
1429071|NCT01913054|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1429072|NCT01913041|||Cohort||Prospective|||||||
1429073|NCT01913028|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1429074|NCT01913015|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429075|NCT01913002|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1429076|NCT01912989||Single Group Assignment||Treatment||None (Open Label)||||||
1429077|NCT01912976|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1429078|NCT01912963|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Of note, this is not a parallel assignment rather one Phase I arm and two Phase II arms all independently evaluated.||||
1429079|NCT01912950|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429080|NCT01912937||Single Group Assignment||Treatment||None (Open Label)||||||
1429081|NCT01912924||Single Group Assignment||Treatment||None (Open Label)||||||
1429082|NCT01912911|||Case-Only||Prospective|||||||
1429083|NCT01912898|||Cohort||Prospective|||||||
1429084|NCT01912885|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1429085|NCT01912872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429086|NCT01912859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429087|NCT01912846|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1429088|NCT01912833|||Cohort||Prospective|||||||
1429089|NCT01912820|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1429090|NCT01912807|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429091|NCT01912794||Single Group Assignment||Treatment||None (Open Label)||||||
1429092|NCT01912781|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1429093|NCT01912768|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1429094|NCT01912755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429095|NCT01912742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429096|NCT01912729|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1429097|NCT01912716|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429098|NCT01912703|||Cohort||Retrospective|||||||
1429099|NCT01912690|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429100|NCT01912677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429101|NCT01912651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429102|NCT01912638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429103|NCT01912625||Single Group Assignment||Treatment||None (Open Label)||||||
1429104|NCT01912612||Single Group Assignment||Treatment||None (Open Label)||||||
1429105|NCT01912599|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1429106|NCT01912586|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429107|NCT01912573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429108|NCT01912560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429109|NCT01912547|||Cohort||Prospective|||||||
1429110|NCT01912534|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429111|NCT01912521|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429112|NCT01912508|||Case Control|||||||||
1429113|NCT01912495||Single Group Assignment||Treatment||None (Open Label)||||||
1429114|NCT01912482|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1429115|NCT01912469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429116|NCT01912456|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1429117|NCT01912443|||Cohort||Prospective|||||||
1429118|NCT01912430|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1429119|NCT01912417|Randomized|Crossover Assignment||Treatment||Single||||||t
1429120|NCT01912404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429121|NCT01912391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429122|NCT01912378|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1429123|NCT01912365|||Cohort||Prospective|||||||
1429124|NCT01912352||Single Group Assignment||Basic Science||None (Open Label)||||||
1429125|NCT01912339|Randomized|Crossover Assignment||Treatment||Single|||t|||
1429126|NCT01912326|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429127|NCT01912313||Single Group Assignment||Basic Science||None (Open Label)||||||
1429128|NCT01912300||||||||||||
1429129|NCT01912287|Randomized|Parallel Assignment||Treatment||Single||||||t
1429130|NCT01912274||Single Group Assignment||Treatment||None (Open Label)||||||
1429131|NCT01912261|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429132|NCT01912248|||Case-Only||Cross-Sectional|||||||
1429133|NCT01912235|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1429134|NCT01912222|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429135|NCT01912209|Randomized|Parallel Assignment||Treatment||Single||||||t
1429136|NCT01912196|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429137|NCT01912183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429138|NCT01912170|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429139|NCT01912157|Randomized|Single Group Assignment||Other||Single|||t|||
1429140|NCT01912144||Single Group Assignment||Basic Science||None (Open Label)||||||
1429141|NCT01912131|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1429142|NCT01912118|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1429143|NCT01912105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429144|NCT01912092||Single Group Assignment||Treatment||None (Open Label)||||||
1429145|NCT01912066|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429146|NCT01912053||Single Group Assignment||Treatment||None (Open Label)||||||
1429147|NCT01912040|||Cohort||Prospective|||||||
1429148|NCT01912027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429149|NCT01912014||Single Group Assignment||Health Services Research||None (Open Label)||||||
1429150|NCT01912001||Single Group Assignment||Prevention||None (Open Label)||||||
1429151|NCT01911988|||Cohort||Prospective|||||||
1429152|NCT01911975|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1429153|NCT01911962|||Case Control||Prospective|||||||
1429154|NCT01911949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429155|NCT01911936|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429156|NCT01911923|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1429157|NCT01911910|Randomized|Parallel Assignment||Prevention||Single||||||t
1429158|NCT01911897||Single Group Assignment||Treatment||None (Open Label)||||||
1429159|NCT01911884||Single Group Assignment||||None (Open Label)||||||
1429160|NCT01911871|||Cohort||Prospective|||||||
1429161|NCT01911858||Single Group Assignment||||None (Open Label)||||||
1429162|NCT01911845||Single Group Assignment||Treatment||None (Open Label)||||||
1429163|NCT01911832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429164|NCT01911819|Randomized|Factorial Assignment||Treatment||Single|||t|||
1429165|NCT01911806|Randomized|Parallel Assignment||Treatment||Single||||||t
1429166|NCT01911793|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429167|NCT01911780|Randomized|Parallel Assignment||Treatment||Double||||||
1429168|NCT01911767|||Cohort||Prospective|||||||
1429169|NCT01911754||Single Group Assignment||Prevention||None (Open Label)||||||
1429170|NCT01911741|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1429171|NCT01911728|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429172|NCT01911715||Single Group Assignment||Basic Science||None (Open Label)||||||
1429173|NCT01911702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429174|NCT01911689|||Case Control||Prospective|||||||
1429175|NCT01911676|Randomized|Crossover Assignment||Treatment||Single|||t|||
1429176|NCT01911663|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429177|NCT01911650|Randomized|Parallel Assignment||Treatment||Single||||||t
1429178|NCT01911637|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1429179|NCT01911624|Randomized|Parallel Assignment||||None (Open Label)||||||
1429180|NCT01911611|Randomized|Parallel Assignment||Other||Double|||t||t|
1429181|NCT01911598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429182|NCT01911585|Randomized|Parallel Assignment||Treatment||Single||||||t
1429183|NCT01911572|||Family-Based||Other|||||||
1429184|NCT01911559|||Case-Only||Prospective|||||||
1429185|NCT01911546||Single Group Assignment||Prevention||None (Open Label)||||||
1429186|NCT01911533||Single Group Assignment||Treatment||None (Open Label)||||||
1429187|NCT01911520|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429188|NCT01911507||Single Group Assignment||Treatment||None (Open Label)||||||
1429189|NCT01911494|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1429190|NCT01911481|Randomized|Parallel Assignment||||Single||||t||
1429191|NCT01911468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429192|NCT01911455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429193|NCT01911442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429194|NCT01911429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429195|NCT01911416||Single Group Assignment||Treatment||None (Open Label)||||||
1429196|NCT01911403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429197|NCT01911390|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1429198|NCT01911377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429199|NCT01911364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429200|NCT01911351|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1429201|NCT01911338|Randomized|Crossover Assignment||||Double|||||t|t
1429202|NCT01911325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429203|NCT01911312|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429204|NCT01911299|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1429205|NCT01911286|||Cohort||Prospective|||||||
1429206|NCT01911273|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429207|NCT01911260|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1429208|NCT01911247||Single Group Assignment||Treatment||None (Open Label)||||||
1429209|NCT01911234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429210|NCT01911221|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1429211|NCT01911208|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1429212|NCT01911195|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1429213|NCT01911182|Randomized|Crossover Assignment||Treatment||Single||||||t
1429214|NCT01911169|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1429215|NCT01911156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429216|NCT01911143|||Cohort||Retrospective|||||||
1429217|NCT01911130|||Cohort||Prospective|||||||
1429218|NCT01911117|||Case-Only||Prospective|||||||
1429219|NCT01911104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429220|NCT01911091|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1429221|NCT01911078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429222|NCT01911065|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429223|NCT01911052|Randomized|Parallel Assignment||Treatment||Single|||||t|
1429224|NCT01911039||Single Group Assignment||Treatment||None (Open Label)||||||
1429225|NCT01911026|Randomized|Parallel Assignment||Treatment||Single|||||t|
1429226|NCT01911013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429227|NCT01911000||Single Group Assignment||Treatment||None (Open Label)||||||
1429228|NCT01910987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429229|NCT01910974||Single Group Assignment||Treatment||None (Open Label)||||||
1429230|NCT01910961|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429231|NCT01910948||Single Group Assignment||Supportive Care||Single|||t|||
1429232|NCT01910935|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1429233|NCT01910922|||Case-Crossover||Prospective|||||||
1429234|NCT01910909||Single Group Assignment||Treatment||None (Open Label)||||||
1429235|NCT01910896|Randomized|Parallel Assignment||Treatment||Single|||||t|
1429236|NCT01910883|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1429237|NCT01910870||Single Group Assignment||Treatment||None (Open Label)||||||
1429238|NCT01910857|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1429239|NCT01910844||Single Group Assignment||Treatment||None (Open Label)||||||
1429240|NCT01910831|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429241|NCT01910818|Randomized|Factorial Assignment||Treatment||Single||||||t
1429242|NCT01910805|Randomized|Parallel Assignment||Prevention||Single||||||t
1429243|NCT01910792|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1429244|NCT01910779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429245|NCT01910766|Randomized|Parallel Assignment||Treatment||Single|||||t|
1429246|NCT01910753||Single Group Assignment||Prevention||None (Open Label)||||||
1429247|NCT01910740|Randomized|Parallel Assignment||Treatment||Single||||||t
1429248|NCT01910727||Single Group Assignment||Prevention||None (Open Label)||||||
1429249|NCT01910714|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429250|NCT01910701||Single Group Assignment||Prevention||None (Open Label)||||||
1429251|NCT01910688||Single Group Assignment||Treatment||None (Open Label)||||||
1429252|NCT01910675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429253|NCT01910662|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1429254|NCT01910649||Single Group Assignment||Treatment||None (Open Label)||||||
1429255|NCT01910636||Single Group Assignment||Treatment||None (Open Label)||||||
1429256|NCT01910623|||Case Control||Cross-Sectional|||||||
1429257|NCT01910610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429258|NCT01910597||Single Group Assignment||Treatment||None (Open Label)||||||
1429259|NCT01910584|||Case-Only||Prospective|||||||
1429260|NCT01910571|Randomized|Crossover Assignment||||Double|||t||t|
1429261|NCT01910558|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1429262|NCT01910545||Single Group Assignment||Treatment||None (Open Label)||||||
1429263|NCT01910532||Single Group Assignment||Treatment||None (Open Label)||||||
1429264|NCT01910519|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1429265|NCT01910506||Single Group Assignment||Basic Science||None (Open Label)||||||
1429266|NCT01910493|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1429267|NCT01910480||Single Group Assignment||Basic Science||None (Open Label)||||||
1429268|NCT01910467|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429269|NCT01910454|Randomized|Parallel Assignment||Treatment||Single||||||t
1429270|NCT01910441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429271|NCT01910428||Single Group Assignment||Treatment||None (Open Label)||||||
1429272|NCT01910415|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1429273|NCT01910402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429274|NCT01910389|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429275|NCT01910376|||Case-Control||Prospective|||||||
1429276|NCT01910363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429277|NCT01910350|Randomized|Parallel Assignment||Prevention||Single|||t|||
1429278|NCT01910337|||Cohort||Prospective|||||||
1429279|NCT01910324|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1429280|NCT01910311|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1429281|NCT01910298|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429282|NCT01910285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429283|NCT01910272|||Cohort||Prospective|||||||
1429284|NCT01910259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429285|NCT01910246||Single Group Assignment||Treatment||None (Open Label)||||||
1429286|NCT01910233|||Cohort||Prospective|||||||
1429287|NCT01910220|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429288|NCT01910194|Randomized|Parallel Assignment||||None (Open Label)||||||
1429289|NCT01910181|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429290|NCT01910168|||Case Control||Prospective|||||||
1429291|NCT01910155|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429292|NCT01910142|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1429293|NCT01910129|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1429294|NCT01910116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429295|NCT01910103|||Cohort||Prospective|||||||
1429296|NCT01910090|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1429297|NCT01910077|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429298|NCT01910064||Single Group Assignment||Treatment||None (Open Label)||||||
1429299|NCT01910051|||Case-Control||Prospective|||||||
1429300|NCT01910038||Single Group Assignment||Treatment||None (Open Label)||||||
1429301|NCT01910025||Single Group Assignment||Treatment||None (Open Label)||||||
1429302|NCT01910012||Single Group Assignment||Treatment||None (Open Label)||||||
1429303|NCT01909999|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1429304|NCT01909986|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1429305|NCT01909973|Randomized|Parallel Assignment||Treatment||Single||||||t
1429306|NCT01909960|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1429307|NCT01909947|||Cohort||Prospective|||||||
1429308|NCT01909934||Single Group Assignment||Treatment||None (Open Label)||||||
1429309|NCT01909921|||Case-Only||Retrospective|||||||
1429310|NCT01909908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429311|NCT01909895|Randomized|Parallel Assignment||Other||Double|||||t|t
1429312|NCT01909882||Single Group Assignment||Supportive Care||Double|||t|t||
1429313|NCT01909869||Single Group Assignment||Treatment||None (Open Label)||||||
1429314|NCT01909856|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1429315|NCT01909843|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429316|NCT01909830||Single Group Assignment||Treatment||None (Open Label)||||||
1429317|NCT01909817|||Cohort||Retrospective|||||||
1429318|NCT01909804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429319|NCT01909791|Randomized|Parallel Assignment||Treatment||Single||||||t
1429320|NCT01909778||Single Group Assignment||Treatment||None (Open Label)||||||
1429321|NCT01909765|Randomized|Parallel Assignment||||Triple|||t||t|t
1429322|NCT01909752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429323|NCT01909739|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1429324|NCT01909726|||Cohort||Cross-Sectional|||||||
1429325|NCT01909713||Single Group Assignment||Treatment||None (Open Label)||||||
1429326|NCT01909700||Single Group Assignment||Treatment||None (Open Label)||||||
1429327|NCT01909687||||||||||||
1429328|NCT01909674|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429329|NCT01909661|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429330|NCT01909648||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429331|NCT01909635|Randomized|Factorial Assignment||Other||Single|||t|||
1429332|NCT01909622|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1429333|NCT01909609|Randomized|Parallel Assignment||Other||Single|||||t|
1429334|NCT01909596||Single Group Assignment||Treatment||Single|||t|||
1429335|NCT01909583|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1429336|NCT01909570|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1429337|NCT01909557|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429338|NCT01909544|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1429339|NCT01909531|||Case-Only||Prospective|||||||
1429340|NCT01909518|||Cohort||Retrospective|||||||
1429341|NCT01909505|||Cohort||Prospective|||||||
1429342|NCT01909492|||Case-Control||Prospective|||||||
1429343|NCT01909479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429344|NCT01909466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429345|NCT01909453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429346|NCT01909440|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1429347|NCT01909427|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429348|NCT01909414|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1429349|NCT01909401||Single Group Assignment||Treatment||None (Open Label)||||||
1429350|NCT01909388||Single Group Assignment||Treatment||None (Open Label)||||||
1429351|NCT01909375|||Other||Prospective|||||||
1429352|NCT01909362|||Case Control||Prospective|||||||
1429353|NCT01909349|Randomized|Parallel Assignment||Prevention||Single|||t|||
1429354|NCT01909336|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1429355|NCT01909323|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1429356|NCT01909310|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429357|NCT01909297|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429358|NCT01909284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429359|NCT01909271|Randomized|Parallel Assignment||Prevention||Single|||t|||
1429360|NCT01909258|||Case-Only||Cross-Sectional|||||||
1429361|NCT01909245||Single Group Assignment||Treatment||None (Open Label)||||||
1429362|NCT01909232|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429363|NCT01909219|Randomized|Parallel Assignment||Treatment||Single|||||t|
1429364|NCT01909193|Randomized|Parallel Assignment||Treatment||Single||||||t
1429365|NCT01909180|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1429366|NCT01909167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429367|NCT01909154||Single Group Assignment||Treatment||None (Open Label)||||||
1429368|NCT01909141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429369|NCT01909128|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1429370|NCT01909115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429371|NCT01909102|Randomized|Parallel Assignment||Treatment||Single||||||t
1429372|NCT01909089||Single Group Assignment||Treatment||None (Open Label)||||||
1429373|NCT01909076|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429374|NCT01909063|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429375|NCT01909050|||Other||Prospective|||||||
1429376|NCT01909037||Single Group Assignment||Treatment||None (Open Label)||||||
1429377|NCT01909024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429378|NCT01909011|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1429379|NCT01908998||Single Group Assignment||Screening||None (Open Label)||||||
1429380|NCT01908985||||||||||||
1429381|NCT01908972|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429382|NCT01908959|Randomized|Parallel Assignment||Basic Science||Single||||||t
1429383|NCT01908946|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1429384|NCT01908933||Single Group Assignment||Treatment||None (Open Label)||||||
1429385|NCT01908920|Randomized|Parallel Assignment||||Double|||t|||t
1429386|NCT01908907|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429387|NCT01908894|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1429388|NCT01908881|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1429389|NCT01908868|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1429390|NCT01908855|Randomized|Parallel Assignment||Treatment||Single||||||t
1429391|NCT01908842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429392|NCT01908829|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429393|NCT01908816||Single Group Assignment||Treatment||None (Open Label)||||||
1429394|NCT01908803|Randomized|Parallel Assignment||Treatment||Single|||||t|
1429395|NCT01908790|||Cohort||Prospective|||||||
1429396|NCT01908777||Single Group Assignment||Treatment||None (Open Label)||||||
1429397|NCT01908764|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1429398|NCT01908751|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1429399|NCT01908738|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1429400|NCT01908725||Single Group Assignment||Treatment||None (Open Label)||||||
1429401|NCT01908712||Single Group Assignment||Treatment||None (Open Label)||||||
1429402|NCT01908699|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429403|NCT01908686|Randomized|Crossover Assignment||Treatment||Single||||||t
1429404|NCT01908673|Randomized|Parallel Assignment||Treatment||Single||||||t
1429405|NCT01908660|||Cohort||Prospective|||||||
1429406|NCT01908647|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429407|NCT01908634|Randomized|Crossover Assignment||Other||Single|||t|||
1429408|NCT01908621|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429409|NCT01908595|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429410|NCT01908582|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1429411|NCT01908569|Randomized|Parallel Assignment||Other||Double|||t|t||
1429412|NCT01908556||Single Group Assignment||Treatment||None (Open Label)||||||
1429413|NCT01908543||Single Group Assignment||Treatment||None (Open Label)||||||
1429414|NCT01908530||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429415|NCT01908517||Single Group Assignment||Health Services Research||None (Open Label)||||||
1429416|NCT01908504||Single Group Assignment||Other||None (Open Label)||||||
1429417|NCT01908491|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1429418|NCT01908478||Single Group Assignment||Treatment||None (Open Label)||||||
1429419|NCT01908465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429420|NCT01908452|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1429421|NCT01908439||Single Group Assignment||Basic Science||None (Open Label)||||||
1429422|NCT01908426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429423|NCT01908413||Single Group Assignment||Treatment||None (Open Label)||||||
1429424|NCT01908400||Single Group Assignment||Treatment||None (Open Label)||||||
1429425|NCT01908387||Single Group Assignment||Treatment||None (Open Label)||||||
1429426|NCT01908374|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1429427|NCT01908361|Randomized|Factorial Assignment||Treatment||Single||||||t
1429428|NCT01908348||Single Group Assignment||Basic Science||None (Open Label)||||||
1429429|NCT01908335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429430|NCT01908322|||Cohort||Prospective|||||||
1429431|NCT01908309|Randomized|Parallel Assignment||Prevention||Single||||||t
1429432|NCT01908296||Single Group Assignment||Other||None (Open Label)||||||
1429433|NCT01908283|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429434|NCT01908270|Randomized|Parallel Assignment||Treatment||Single||||||t
1429435|NCT01908257|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1429436|NCT01908244|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1429437|NCT01908231|||Cohort||Prospective|||||||
1429438|NCT01908218|||Ecologic or Community||Retrospective|||||||
1429439|NCT01908205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429440|NCT01908192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429441|NCT01908179|||||Prospective|||||||
1429442|NCT01908166||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429443|NCT01908153|||Cohort||Cross-Sectional|||||||
1429444|NCT01908140|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429445|NCT01908127|Randomized|Parallel Assignment||||Double|||||t|t
1429446|NCT01908114|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1429447|NCT01908101||Single Group Assignment||Treatment||None (Open Label)||||||
1429448|NCT01908088||Single Group Assignment||Treatment||None (Open Label)||||||
1429449|NCT01908075|||Cohort||Retrospective|||||||
1429450|NCT01908062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429451|NCT01908049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429452|NCT01908036|||Cohort||Prospective|||||||
1429453|NCT01908023||Single Group Assignment||Treatment||None (Open Label)||||||
1429454|NCT01908010|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1429455|NCT01907997|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429456|NCT01907984|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1429457|NCT01907971|||Cohort||Prospective|||||||
1429458|NCT01907958|||Case-Only||Prospective|||||||
1429459|NCT01907945|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1429460|NCT01907932||Single Group Assignment||Other||None (Open Label)||||||
1429461|NCT01907919|||Case Control||Prospective|||||||
1429462|NCT01907906|Randomized|Crossover Assignment||Treatment||Single|||t|||
1429463|NCT01907893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429464|NCT01907880|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429465|NCT01907867|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429466|NCT01907854|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429467|NCT01907841|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429468|NCT01907828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429469|NCT01907815||Single Group Assignment||Treatment||None (Open Label)||||||
1429470|NCT01907802||Single Group Assignment||Treatment||None (Open Label)||||||
1429471|NCT01907789|||Cohort||Prospective|||||||
1429472|NCT01907776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429473|NCT01907763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429474|NCT01907750|Randomized|Parallel Assignment||Prevention||Single|||t|||
1429475|NCT01907737|Randomized|Crossover Assignment||||Triple|||t|t||t
1429476|NCT01907724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429477|NCT01907711|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1429478|NCT01907698|||Case Control||Prospective|||||||
1429479|NCT01907685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429480|NCT01907672|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1429481|NCT01907659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429482|NCT01907646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429483|NCT01907633|||Case Control||Retrospective|||||||
1429484|NCT01907620|Non-Randomized|Parallel Assignment||||Triple|||t|t|t|
1429485|NCT01907607||Single Group Assignment||Treatment||None (Open Label)||||||
1429486|NCT01907594|Randomized|Parallel Assignment||||Double|||t||t|
1429487|NCT01907581||Single Group Assignment||Prevention||None (Open Label)||||||
1429488|NCT01907568|||Case Control||Cross-Sectional|||||||
1429489|NCT01907555|||Cohort||Prospective|||||||
1429490|NCT01907542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429491|NCT01907529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429492|NCT01907516|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429493|NCT01907503|Randomized|Parallel Assignment||||None (Open Label)||||||
1429494|NCT01907490||Single Group Assignment||Treatment||None (Open Label)||||||
1429495|NCT01907477|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1429496|NCT01907464|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1429497|NCT01907451|||Cohort||Prospective|||||||
1429498|NCT01907438|||Case Control||Cross-Sectional|||||||
1429499|NCT01907425||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429500|NCT01907412|Randomized|Parallel Assignment||Prevention||Single||||||t
1429501|NCT01907399|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1429502|NCT01907386||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429503|NCT01907373|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429504|NCT01907360|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1429505|NCT01907347|||Cohort||Prospective|||||||
1429506|NCT01907334|Randomized|Crossover Assignment||||Single||||||t
1429507|NCT01907321|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429508|NCT01907308||Single Group Assignment||Treatment||None (Open Label)||||||
1429509|NCT01907295|||Cohort||Prospective|||||||
1429510|NCT01907282|Randomized|Factorial Assignment||Treatment||Single||||||t
1429511|NCT01907269|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1429512|NCT01907256|Randomized|Factorial Assignment||Treatment||Single||||||t
1429513|NCT01907243|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429514|NCT01907230|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429515|NCT01907217|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1429516|NCT01907204|Randomized|Parallel Assignment||Treatment||Single||||||t
1429517|NCT01907191|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429518|NCT01907178|||Case-Only||Prospective|||||||
1429519|NCT01907165|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429520|NCT01907152|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1429521|NCT01907139|Randomized|Factorial Assignment||Treatment||Single||||||t
1429522|NCT01907126|Randomized|Parallel Assignment||Treatment||Single||||||t
1429523|NCT01907113|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429524|NCT01907100|Randomized|Parallel Assignment||Treatment||Double||||||
1429525|NCT01907087||Single Group Assignment||Treatment||None (Open Label)||||||
1429526|NCT01907074||Single Group Assignment||Diagnostic||||||||
1429527|NCT01907061|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429528|NCT01907048|||Other||Cross-Sectional|||||||
1429529|NCT01907035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429530|NCT01907022||Single Group Assignment||Treatment||None (Open Label)||||||
1429531|NCT01907009|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429532|NCT01906996|||Case Control||Prospective|||||||
1429533|NCT01906983|||Cohort||Prospective|||||||
1429534|NCT01906970||Single Group Assignment||Other||None (Open Label)||||||
1429535|NCT01906957|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429536|NCT01906944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429537|NCT01906931|Randomized|Crossover Assignment||Treatment||Single||||||t
1429538|NCT01906918|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1429539|NCT01906905|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429540|NCT01906892|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1429541|NCT01906879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429542|NCT01906866|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429543|NCT01906853|Randomized|Parallel Assignment||Prevention||Single||||||t
1429544|NCT01906840|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429545|NCT01906827|||Case Control||Prospective|||||||
1429546|NCT01906814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429547|NCT01906801|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429548|NCT01906788|Randomized|Single Group Assignment||||None (Open Label)||||||
1429549|NCT01906775|||Case-Only||Prospective|||||||
1429550|NCT01906762|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1429551|NCT01906749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429552|NCT01906736||||||||||||
1429553|NCT01906723||||Supportive Care||||||||
1429554|NCT01906710|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1429555|NCT01906697|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429556|NCT01906684||Single Group Assignment||Treatment||None (Open Label)||||||
1429557|NCT01906671|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429558|NCT01906658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429559|NCT01906645|Randomized|||Health Services Research||Single||||||t
1429560|NCT01906632||Single Group Assignment||Treatment||None (Open Label)||||||
1429561|NCT01906619|||Case Control||Prospective|||||||
1429562|NCT01906606|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1429563|NCT01906593|||Ecologic or Community|||||||||
1429564|NCT01906580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429565|NCT01906567|||Ecologic or Community||Prospective|||||||
1429566|NCT01906554||Single Group Assignment||||Triple|||t||t|t
1429567|NCT01906541||Single Group Assignment||Treatment||None (Open Label)||||||
1429568|NCT01906528||Single Group Assignment||Treatment||None (Open Label)||||||
1429569|NCT01906515|Randomized|Parallel Assignment||Prevention||Single||||||t
1429570|NCT01906502||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429571|NCT01906489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429572|NCT01906476|Randomized|Parallel Assignment||Treatment||Single||||||t
1429573|NCT01906463|||Cohort||Prospective|||||||
1429574|NCT01906450|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1429575|NCT01906437|||Case-Only||Prospective|||||||
1429576|NCT01906424|Randomized|Crossover Assignment||Treatment||Single||||||t
1429577|NCT01906411|||Case-Crossover||Cross-Sectional|||||||
1429578|NCT01906398||Single Group Assignment||Treatment||None (Open Label)||||||
1429579|NCT01906385||Single Group Assignment||Treatment||None (Open Label)||||||
1429580|NCT01906372||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1429581|NCT01906359|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1429582|NCT01906346|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1429583|NCT01906333|Randomized|Crossover Assignment||||None (Open Label)||||||
1429584|NCT01906320|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429585|NCT01906307||Single Group Assignment||Treatment||None (Open Label)||||||
1429586|NCT01906294|||Case-Only||Prospective|||||||
1429587|NCT01906281|||Cohort||Prospective|||||||
1429588|NCT01906268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429589|NCT01906255|||Case-Control||Retrospective|||||||
1429590|NCT01906242|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1429591|NCT01906229|||Cohort||Prospective|||||||
1429592|NCT01906216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429593|NCT01906203|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1429594|NCT01906190||Single Group Assignment||Prevention||None (Open Label)||||||
1429595|NCT01906177|||Cohort||Prospective|||||||
1429596|NCT01906164|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429597|NCT01906151||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429598|NCT01906138||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429599|NCT01906125||Single Group Assignment||Basic Science||None (Open Label)||||||
1429600|NCT01906112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429601|NCT01906099|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1429602|NCT01906086|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1429603|NCT01906073|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429604|NCT01906060||Single Group Assignment||Treatment||None (Open Label)||||||
1429605|NCT01906047|||Cohort||Prospective|||||||
1429606|NCT01906034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429607|NCT01906021||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429608|NCT01906008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429609|NCT01905995|||Case-Only||Prospective|||||||
1429610|NCT01905982|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429611|NCT01905969|||Cohort||Retrospective|||||||
1429612|NCT01905956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429613|NCT01905943||Single Group Assignment||Treatment||None (Open Label)||||||
1429614|NCT01905930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429615|NCT01905917|Randomized|Parallel Assignment||Treatment||Single||||||t
1429616|NCT01905904|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1429617|NCT01905891|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1429618|NCT01905878|Randomized|Parallel Assignment||Basic Science||None (Open Label)||This study was open label-single arm trial, which was done at Pharmacology and Therapeutic Department and Clinical Pathologic Department of Faculty Medicine of University of Indonesia Cipto Mangunkusumo Hospital. The study drug was enteric coated DLBS1033 tablet, which contained 490 mg bioactive protein fraction; and produced by PT Dexa Medica, Tangerang, Indonesia.||||
1429619|NCT01905865|||Cohort||Cross-Sectional|||||||
1429620|NCT01905852|||||Prospective|||||||
1429621|NCT01905839|||||Prospective|||||||
1429622|NCT01905826|||Other||Prospective|||||||
1429623|NCT01905813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429624|NCT01905800|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429625|NCT01905787|||Case-Only||Retrospective|||||||
1429626|NCT01905774|||Cohort||Retrospective|||||||
1429627|NCT01905761|||Cohort||Prospective|||||||
1429628|NCT01905748|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1429629|NCT01905735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429630|NCT01905722|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1429631|NCT01905709||Single Group Assignment||Treatment||None (Open Label)||||||
1429632|NCT01905696||Single Group Assignment||Basic Science||None (Open Label)||||||
1429633|NCT01905683||Single Group Assignment||Treatment||None (Open Label)||||||
1429634|NCT01905670||Single Group Assignment||Treatment||None (Open Label)||||||
1429635|NCT01905657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429636|NCT01905644|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429637|NCT01905631||||||||||||
1429638|NCT01905618|Randomized|Factorial Assignment||Prevention||Single||||||t
1429639|NCT01905605|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429640|NCT01905592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429641|NCT01905579|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1429642|NCT01905566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429643|NCT01905553|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429644|NCT01905540|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429645|NCT01905527|||Cohort||Prospective|||||||
1429646|NCT01905514|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1429647|NCT01905501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429648|NCT01905488|||||Prospective|||||||
1429649|NCT01905475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429650|NCT01905462|||Cohort||Retrospective|||||||
1429651|NCT01905449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429652|NCT01905436|||Ecologic or Community||Cross-Sectional|||||||
1429653|NCT01905423|||Ecologic or Community||Cross-Sectional|||||||
1429654|NCT01905410|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429655|NCT01905397|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429656|NCT01905384|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1429657|NCT01905371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429658|NCT01905358|||Cohort||Prospective|||||||
1429659|NCT01905345|Randomized|Parallel Assignment||Other||Single|||t|||
1429660|NCT01905332|Randomized|Parallel Assignment||Screening||Single||||||t
1429661|NCT01905319|||Ecologic or Community||Prospective|||||||
1429662|NCT01905306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429663|NCT01905293|Randomized|Crossover Assignment||Prevention||Single|||t|||
1429664|NCT01905280|Randomized|Parallel Assignment||Treatment||Single||||||t
1429665|NCT01905267|Randomized|Parallel Assignment||Prevention||Single||||||t
1429666|NCT01905254||Single Group Assignment||Diagnostic||Single|||||t|
1429667|NCT01905241||||||||||||
1429668|NCT01905228||Single Group Assignment||Treatment||None (Open Label)||||||
1429669|NCT01905215|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1429670|NCT01905202||Single Group Assignment||Treatment||None (Open Label)||||||
1429671|NCT01905189||Single Group Assignment||Treatment||None (Open Label)||||||
1429672|NCT01905176|Randomized|Factorial Assignment||Supportive Care||Double|||||t|t
1429673|NCT01905163||Single Group Assignment||Treatment||None (Open Label)||||||
1429674|NCT01905150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429675|NCT01905137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429676|NCT01905124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429677|NCT01905111||Single Group Assignment||Treatment||None (Open Label)||||||
1429678|NCT01905098|Randomized|Factorial Assignment||||None (Open Label)||||||
1429679|NCT01905085|||Cohort||Prospective|||||||
1429680|NCT01905072|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1429681|NCT01905059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429682|NCT01905046|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1429683|NCT01905033|||Cohort||Prospective|||||||
1429684|NCT01905020|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429685|NCT01905007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429686|NCT01904994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429687|NCT01904981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429688|NCT01904968|||Cohort||Retrospective|||||||
1429689|NCT01904955|||Cohort||Prospective|||||||
1429690|NCT01904942|||Cohort||Retrospective|||||||
1429691|NCT01904929||Single Group Assignment||||None (Open Label)||||||
1429692|NCT01904916||Single Group Assignment||Other||None (Open Label)||||||
1429693|NCT01904903||Single Group Assignment||Treatment||None (Open Label)||||||
1429694|NCT01904890|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429695|NCT01904877|||Ecologic or Community||Prospective|||||||
1429696|NCT01904864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429697|NCT01904851|||Cohort||Other|||||||
1429698|NCT01904838|||Ecologic or Community||Prospective|||||||
1429699|NCT01904825|||Cohort||Prospective|||||||
1429700|NCT01904812||Single Group Assignment||Health Services Research||None (Open Label)||||||
1429701|NCT01904799||Single Group Assignment||Other||None (Open Label)||||||
1429702|NCT01904786|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429703|NCT01904773|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1429704|NCT01904760|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429705|NCT01904747||Crossover Assignment||Basic Science||None (Open Label)||||||
1429706|NCT01904734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429707|NCT01904721|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429708|NCT01904708|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1429709|NCT01904695|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429710|NCT01904682||Single Group Assignment||Treatment||None (Open Label)||||||
1429711|NCT01904669|||Cohort||Prospective|||||||
1429712|NCT01904656|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1429713|NCT01904643||Single Group Assignment||Treatment||None (Open Label)||||||
1429714|NCT01904630|||Family-Based||Cross-Sectional|||||||
1429715|NCT01904617|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429716|NCT01904604|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1429717|NCT01904591||Single Group Assignment||Treatment||None (Open Label)||||||
1429718|NCT01904578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429719|NCT01904565||Single Group Assignment||Treatment||None (Open Label)||||||
1429720|NCT01904552|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1429721|NCT01904539|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1429722|NCT01904526||Single Group Assignment||Other||None (Open Label)||||||
1429723|NCT01904513|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429724|NCT01904500|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429725|NCT01904487||Single Group Assignment||Basic Science||None (Open Label)||||||
1429726|NCT01904474|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1429727|NCT01904461|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429728|NCT01904448||Single Group Assignment||Treatment||None (Open Label)||||||
1429729|NCT01904422|Randomized|Parallel Assignment||Treatment||Single|||||t|
1429730|NCT01904409|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429731|NCT01904396||Single Group Assignment||||None (Open Label)||||||
1429732|NCT01904383|||Cohort||Prospective|||||||
1429733|NCT01904357|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1429734|NCT01904344||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429735|NCT01904331|||Cohort||Cross-Sectional|||||||
1429736|NCT01904318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429737|NCT01904305|||Cohort||Prospective|||||||
1429738|NCT01904292||Single Group Assignment||Treatment||None (Open Label)||||||
1429739|NCT01904279|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429740|NCT01904266|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1429741|NCT01904253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429742|NCT01904240|||Case Control||Cross-Sectional|||||||
1429743|NCT01904227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429744|NCT01904214||Parallel Assignment||Other||None (Open Label)||||||
1429745|NCT01904201|||Cohort||Cross-Sectional|||||||
1429746|NCT01904188|||Cohort||Retrospective|||||||
1429747|NCT01904175|||Case-Only||Prospective|||||||
1429748|NCT01904162|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429749|NCT01904149|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429750|NCT01904136||Single Group Assignment||Treatment||None (Open Label)||||||
1429751|NCT01904123||Single Group Assignment||Treatment||None (Open Label)||||||
1429752|NCT01904110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429753|NCT01904097|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429754|NCT01904084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429755|NCT01904071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429756|NCT01904058|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429757|NCT01904045|||Other||Prospective|||||||
1429758|NCT01904032|Randomized|Parallel Assignment||Treatment||Quadruple||Participants are randomized to either 50,000 international units of weekly vitamin D3 or to 5,000 international units of weekly vitamin D3 using a 1:1 allocation|t|t|t|t
1429759|NCT01904019|||Cohort||Prospective|||||||
1429760|NCT01904006|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429761|NCT01903993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429762|NCT01903980|||Case-Crossover||Cross-Sectional|||||||
1429763|NCT01903967|||Case-Control||Retrospective|||||||
1429764|NCT01903954|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429765|NCT01903941|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429766|NCT01903928||Single Group Assignment||Treatment||None (Open Label)||||||
1429767|NCT01903915|||Case Control||Prospective|||||||
1429768|NCT01903902||Single Group Assignment||Treatment||None (Open Label)||||||
1429769|NCT01903889|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1429770|NCT01903876|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429771|NCT01903863|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1429772|NCT01903850||Single Group Assignment||Treatment||Single||||||t
1429773|NCT01903837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429774|NCT01903824|Randomized|Crossover Assignment||||Double|||t||t|
1429775|NCT01903811|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429776|NCT01903798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429777|NCT01903785|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1429778|NCT01903772|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1429779|NCT01903759||Single Group Assignment||||None (Open Label)||||||
1429780|NCT01903746|||Cohort||Prospective|||||||
1429781|NCT01903733||||||None (Open Label)||||||
1429782|NCT01903720||Single Group Assignment||Treatment||None (Open Label)||||||
1429783|NCT01903707|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429784|NCT01903694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429785|NCT01903681|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1429786|NCT01903668|||Cohort||Retrospective|||||||
1429787|NCT01903655|Randomized|Parallel Assignment||||None (Open Label)||||||
1429788|NCT01903642|Randomized|Single Group Assignment||||None (Open Label)||||||
1429789|NCT01903629|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1429790|NCT01903616|||Cohort||Prospective|||||||
1429791|NCT01903603|||Cohort||Prospective|||||||
1429792|NCT01903590|Randomized|Parallel Assignment||Treatment||Single||||||t
1429793|NCT01903577|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1429794|NCT01903564|||Cohort||Prospective|||||||
1429795|NCT01903551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429796|NCT01903538|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1429797|NCT01903525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429798|NCT01903512|||Case-Only||Prospective|||||||
1429799|NCT01903499|Randomized|Single Group Assignment||||Single|||t|||
1429800|NCT01903486||Single Group Assignment||Treatment||None (Open Label)||||||
1429801|NCT01903473|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429802|NCT01903460|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429803|NCT01903447|Randomized|Parallel Assignment||Treatment||Single||||||t
1429804|NCT01903434|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1429805|NCT01903421|Randomized|Parallel Assignment||Prevention||None (Open Label)||The proposed study will be a prospective, multicenter, cluster randomization clinical trial comparing two different anesthetic techniques in elderly patients (> 65 years of age) undergoing urology/orthopedic/general surgery. The study will follow a cluster design; patients undergoing orthopedic or vascular surgery will have spinal anesthesia, where standard practice. Patients undergoing urology or general surgery will receive general anesthesia, also where it is standard practice. Patients with severe dementia will be excluded.||||
1429806|NCT01903408|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429807|NCT01903395|Randomized|Parallel Assignment||Prevention||Single|||t|||
1429808|NCT01903382|||Cohort||Retrospective|||||||
1429809|NCT01903369|||Case-Only||Cross-Sectional|||||||
1429810|NCT01903356|||Other||Prospective|||||||
1429811|NCT01903343|||Case-Only||Cross-Sectional|||||||
1429812|NCT01903330|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429813|NCT01903317|||Cohort||Prospective|||||||
1429814|NCT01903304|Randomized|Parallel Assignment||Prevention||Single|||||t|
1429815|NCT01903291|||Cohort||Prospective|||||||
1429816|NCT01903278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429817|NCT01903265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429818|NCT01903252|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind||t|t|t|t
1429819|NCT01903239||Single Group Assignment||Treatment||None (Open Label)||||||
1429820|NCT01903226|Randomized|Parallel Assignment||Treatment||Single|||||t|
1429821|NCT01903213|||Case-Only||Prospective|||||||
1429822|NCT01903200|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1429823|NCT01903187|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429824|NCT01903174||Single Group Assignment||Treatment||None (Open Label)||||||
1429825|NCT01903161|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1429826|NCT01903148|||Cohort||Cross-Sectional|||||||
1429827|NCT01903135|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1429828|NCT01903122|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429829|NCT01903109|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429830|NCT01903096|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1429831|NCT01903083||Single Group Assignment||Treatment||None (Open Label)||||||
1429832|NCT01903070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429833|NCT01903057|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1429834|NCT01903044||Single Group Assignment||Treatment||None (Open Label)||||||
1429835|NCT01903031|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429836|NCT01903018||Parallel Assignment||Treatment||Single||||||t
1429837|NCT01903005||Single Group Assignment||Treatment||None (Open Label)||||||
1429838|NCT01902992|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429839|NCT01902979|Randomized|Parallel Assignment||Treatment||Single||||||t
1429840|NCT01902966||Single Group Assignment||Supportive Care||None (Open Label)||||||
1429841|NCT01902953||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429842|NCT01902940|||Cohort||Retrospective|||||||
1429843|NCT01902927||Single Group Assignment||||Quadruple|||t|t|t|t
1429844|NCT01902914|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1429845|NCT01902901|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1429846|NCT01902888|||Cohort||Retrospective|||||||
1429847|NCT01902875|||Case Control||Prospective|||||||
1429848|NCT01902862||Single Group Assignment||Treatment||None (Open Label)||||||
1429849|NCT01902849|||Case Control||Prospective|||||||
1429850|NCT01902836|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429851|NCT01902823|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1429852|NCT01902810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429853|NCT01902797||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429854|NCT01902784|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1429855|NCT01902771||Single Group Assignment||Treatment||None (Open Label)||||||
1429856|NCT01902758|Non-Randomized|Parallel Assignment||||Triple|||t|t|t|
1429857|NCT01902745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429858|NCT01902732||Single Group Assignment||Treatment||None (Open Label)||||||
1429859|NCT01902719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429860|NCT01902693|||Case-Only||Prospective|||||||
1429861|NCT01902680||Single Group Assignment||Treatment||None (Open Label)||||||
1429862|NCT01902667|||Cohort||Prospective|||||||
1429863|NCT01902654|||Cohort||Retrospective|||||||
1429864|NCT01902641|Randomized|Single Group Assignment||Treatment||Single|||t|||
1429865|NCT01902628|||Cohort||Prospective|||||||
1429866|NCT01902615|||Cohort||Retrospective|||||||
1429867|NCT01902602|||Cohort||Prospective|||||||
1429868|NCT01902589|||Cohort||Prospective|||||||
1429869|NCT01902576|||Cohort||Prospective|||||||
1429870|NCT01902563||||||||||||
1429871|NCT01902550|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1429872|NCT01902537|||Cohort||Cross-Sectional|||||||
1429873|NCT01902524||Single Group Assignment||Treatment||None (Open Label)||||||
1429874|NCT01902511|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429875|NCT01902498|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1429876|NCT01902485|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429877|NCT01902472|||Case-Only||Prospective|||||||
1429878|NCT01902459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429879|NCT01902446|||Cohort||Prospective|||||||
1429880|NCT01902433|Randomized|Parallel Assignment||Treatment||Single||||||t
1429881|NCT01902420|||Cohort||Cross-Sectional|||||||
1429882|NCT01902407|||Cohort||Prospective|||||||
1429883|NCT01902394|Randomized|Parallel Assignment||||Triple|||t||t|t
1429884|NCT01902381||Single Group Assignment||Treatment||None (Open Label)||||||
1429885|NCT01902368|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1429886|NCT01902355|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1429887|NCT01902342|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1429888|NCT01902329|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429889|NCT01902316|||Case-Only||Retrospective|||||||
1429890|NCT01902303|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429891|NCT01902290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429892|NCT01902277|||||Prospective|||||||
1429893|NCT01902264||Single Group Assignment||Prevention||None (Open Label)||||||
1429894|NCT01902251|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1429895|NCT01902238||Single Group Assignment||Treatment||None (Open Label)||||||
1429896|NCT01902225||Single Group Assignment||Treatment||None (Open Label)||||||
1429897|NCT01902212||Single Group Assignment||||None (Open Label)||||||
1429898|NCT01902199|Randomized|Parallel Assignment||Treatment||Single|||t|||
1429899|NCT01902186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429900|NCT01902173||Single Group Assignment||Treatment||None (Open Label)||||||
1429901|NCT01902160||Single Group Assignment||Treatment||None (Open Label)||||||
1429902|NCT01902147|||Case-Only||Prospective|||||||
1429903|NCT01902134|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429904|NCT01902121|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429905|NCT01902108|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1429906|NCT01902095|Randomized|Parallel Assignment||Prevention||Single|||||t|
1429907|NCT01902082|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429908|NCT01902069|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1429909|NCT01902056|Randomized|Parallel Assignment||Treatment||Single||||||t
1429910|NCT01902043|||Cohort||Prospective|||||||
1429911|NCT01902030|||Cohort||Retrospective|||||||
1429912|NCT01902017|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429913|NCT01902004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429914|NCT01901991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429915|NCT01901978||Single Group Assignment||Health Services Research||None (Open Label)||||||
1429916|NCT01901965|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1429917|NCT01901952|Randomized|Parallel Assignment||Prevention||Single||||||t
1429918|NCT01901939||Single Group Assignment||Prevention||None (Open Label)||observational||||
1429919|NCT01901926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429920|NCT01901913|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429921|NCT01901887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429922|NCT01901874||||||||||||
1429923|NCT01901861|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1429924|NCT01901848|Randomized|Parallel Assignment||Treatment||Single||||||t
1429925|NCT01901835|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1429926|NCT01901822|Randomized|Parallel Assignment||Treatment||Single||||||t
1429927|NCT01901809|Randomized|Factorial Assignment||Treatment||Single||||||t
1429928|NCT01901796|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1429929|NCT01901783|Randomized|Parallel Assignment||Treatment||Single||||||t
1429930|NCT01901770|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1429931|NCT01901757|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429932|NCT01901744||Single Group Assignment||Treatment||None (Open Label)||||||
1429933|NCT01901731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429934|NCT01901718|||Cohort||Prospective|||||||
1429935|NCT01901705|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429936|NCT01901692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429937|NCT01901679||Single Group Assignment||Basic Science||None (Open Label)||||||
1429938|NCT01901666||Single Group Assignment||Diagnostic||None (Open Label)||||||
1429939|NCT01901653||Single Group Assignment||Treatment||None (Open Label)||||||
1429940|NCT01901640||Single Group Assignment||Treatment||None (Open Label)||||||
1429941|NCT01901627|||Cohort||Prospective|||||||
1429942|NCT01901614|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429943|NCT01901601|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1429944|NCT01901588|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1429945|NCT01901575||Single Group Assignment||Treatment||None (Open Label)||||||
1429946|NCT01901562||Single Group Assignment||Treatment||None (Open Label)||||||
1429947|NCT01901549|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1429948|NCT01901536|Randomized|Parallel Assignment||Prevention||Single||||||t
1429949|NCT01901523||Single Group Assignment||Health Services Research||None (Open Label)||||||
1429950|NCT01901510|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1429951|NCT01901497|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1429952|NCT01901484|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1429953|NCT01901471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429954|NCT01901458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429955|NCT01901445|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1429956|NCT01901432||Single Group Assignment||Treatment||None (Open Label)||||||
1429957|NCT01901419|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1429958|NCT01901406|||Case-Only||Prospective|||||||
1429959|NCT01901393|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429960|NCT01901380|||Cohort||Prospective|||||||
1429961|NCT01901367|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429962|NCT01901354|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1429963|NCT01901341|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429964|NCT01901328|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429965|NCT01901315|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1429966|NCT01901302|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1429967|NCT01901289||Single Group Assignment||Treatment||None (Open Label)||||||
1429968|NCT01901276||Single Group Assignment||Basic Science||None (Open Label)||||||
1429969|NCT01901263|||Cohort||Prospective|||||||
1429970|NCT01901250|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1429971|NCT01901237||Single Group Assignment||Supportive Care||None (Open Label)||||||
1429972|NCT01901224|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1429973|NCT01901211|Randomized|Crossover Assignment||Treatment||Single||||||t
1429974|NCT01901198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429975|NCT01901185||Single Group Assignment||Treatment||None (Open Label)||||||
1429976|NCT01901172|Randomized|Crossover Assignment||||None (Open Label)||||||
1429977|NCT01901159|Randomized|Crossover Assignment||||None (Open Label)||||||
1429978|NCT01901146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1429979|NCT01901133|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1429980|NCT01901120|||Case-Only||Prospective|||||||
1429981|NCT01901107|||Cohort||Prospective|||||||
1429982|NCT01901094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429983|NCT01901081||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1429984|NCT01901068|||Cohort||Prospective|||||||
1429985|NCT01901055|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1429986|NCT01901042|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1429987|NCT01901029|||Cohort||Cross-Sectional|||||||
1429988|NCT01901016|Randomized|Parallel Assignment||Treatment||Single||||||t
1429989|NCT01901003|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1429990|NCT01900990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429991|NCT01900977|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1429992|NCT01900964|Randomized|Parallel Assignment||Treatment||Single||||||t
1429993|NCT01900951||Single Group Assignment||Treatment||None (Open Label)||||||
1429994|NCT01900938|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1429995|NCT01900925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1429996|NCT01900912|Randomized|Parallel Assignment||||None (Open Label)||||||
1429997|NCT01900899|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1429998|NCT01900886|||||Prospective|||||||
1429999|NCT01900873|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430000|NCT01900860|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1430001|NCT01900847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430002|NCT01900834|||Cohort||Prospective|||||||
1430003|NCT01900821|||Ecologic or Community||Prospective|||||||
1430004|NCT01900808|||Cohort||Prospective|||||||
1430005|NCT01900795|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430006|NCT01900782|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430007|NCT01900769||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430008|NCT01900756|Randomized|Parallel Assignment||Prevention||Single||||||t
1430009|NCT01900743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430010|NCT01900730|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430011|NCT01900717|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1430012|NCT01900704|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430013|NCT01900691||Single Group Assignment||Treatment||None (Open Label)||||||
1430014|NCT01900678||Single Group Assignment||Treatment||None (Open Label)||||||
1430015|NCT01900665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430016|NCT01900652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430017|NCT01900639|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1430018|NCT01900626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430019|NCT01900613|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430020|NCT01900600|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1430021|NCT01900587|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430022|NCT01900574||Single Group Assignment||Treatment||None (Open Label)||||||
1430023|NCT01900561|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1430024|NCT01900548|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430025|NCT01900535|||Cohort||Prospective|||||||
1430026|NCT01900522|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1430027|NCT01900509||Single Group Assignment||Treatment||None (Open Label)||||||
1430028|NCT01900496||Single Group Assignment||Treatment||None (Open Label)||||||
1430029|NCT01900483|||Case Control||Cross-Sectional|||||||
1430030|NCT01900470|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1430031|NCT01900457|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430032|NCT01900444||Single Group Assignment||Prevention||None (Open Label)||||||
1430033|NCT01900431|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430034|NCT01900418|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1430035|NCT01900405|||Cohort||Prospective|||||||
1430036|NCT01900392|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1430037|NCT01900379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430038|NCT01900366|||Case Control||Prospective|||||||
1430039|NCT01900353|Randomized|Parallel Assignment||Prevention||Single|||||t|
1430040|NCT01900340|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1430041|NCT01900327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430042|NCT01900314|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1430043|NCT01900301|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430044|NCT01900288|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1430045|NCT01900275|||Cohort||Prospective|||||||
1430046|NCT01900262|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430047|NCT01900249|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430048|NCT01900236|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1430049|NCT01900223|||Case-Only||Cross-Sectional|||||||
1430050|NCT01900210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430051|NCT01900197|||Cohort||Prospective|||||||
1430052|NCT01900184|Randomized|Parallel Assignment||||Triple|||t||t|t
1430053|NCT01900171|Randomized|Parallel Assignment||||Triple|||t||t|t
1430054|NCT01900158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430055|NCT01900132|||Case-Only||Prospective|||||||
1430056|NCT01900119|||Cohort||Prospective|||||||
1430057|NCT01900106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430058|NCT01900093||Single Group Assignment||Treatment||None (Open Label)||||||
1430059|NCT01900080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430060|NCT01900067|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430061|NCT01900054||Single Group Assignment||Treatment||None (Open Label)||||||
1430062|NCT01900041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430063|NCT01900028||Single Group Assignment||||None (Open Label)||||||
1430064|NCT01900015|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430065|NCT01900002||Single Group Assignment||Treatment||None (Open Label)||||||
1430066|NCT01899989|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430067|NCT01899976||Single Group Assignment||Treatment||None (Open Label)||||||
1430068|NCT01899963|||Cohort||Prospective|||||||
1430069|NCT01899950|||Case-Only||Prospective|||||||
1430070|NCT01899937||||||||||||
1430071|NCT01899924|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1430072|NCT01899911||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430073|NCT01899898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430074|NCT01899885|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430075|NCT01899872||Single Group Assignment||Prevention||Single|||||t|
1430076|NCT01899859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430077|NCT01899846|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1430078|NCT01899833||Parallel Assignment||Diagnostic||None (Open Label)||Patients receive typical imaging agent for rest and stress imaging then receive investigational imaging agent for rest and stress imaging||||
1430079|NCT01899820|Randomized|Parallel Assignment||Treatment||Single||||t||
1430080|NCT01899807||Single Group Assignment||Treatment||None (Open Label)||||||
1430081|NCT01899794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430082|NCT01899781||Single Group Assignment||Treatment||None (Open Label)||||||
1430083|NCT01899768|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1430084|NCT01899755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430085|NCT01899742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430086|NCT01899729|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430087|NCT01899716|Randomized|Parallel Assignment||Treatment||Single||||||t
1430088|NCT01899703|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1430089|NCT01899690|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430090|NCT01899677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430091|NCT01899664||Single Group Assignment||Treatment||None (Open Label)||"Subjects will undergo the following:~A full International Standards for Neurological Classification of SCI exam will be completed to determine exact function and type of spinal cord injury.~A phone interview will be completed at both preoperative and postoperative time points.~Quality of life before and after surgical intervention will be derived from standardized questionnaires: Spinal Cord Independence Measure (SCIM), SF-36, Novak scale, and pain questionnaires.~Additional qualitative and quantitative data on donor and recipient nerve function and tissue will be derived from preoperative electrodiagnostic studies.~Specimens of the donor and recipient nerve are collected for histologic analysis during the operative procedure. Those trimmed nerve specimens are then analyzed for clinical purposes to give patients an idea of expected outcome in a more timely fashion."||||
1430092|NCT01899651|||Cohort||Prospective|||||||
1430093|NCT01899638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430094|NCT01899625|Randomized|Parallel Assignment||Treatment||Single||||||t
1430095|NCT01899612|||Case Control||Cross-Sectional|||||||
1430096|NCT01899599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430097|NCT01899586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430098|NCT01899573||Single Group Assignment||Treatment||None (Open Label)||||||
1430099|NCT01899560|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1430100|NCT01899547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430101|NCT01899534|Randomized|Parallel Assignment||Screening||Single||||||t
1430102|NCT01899521|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430103|NCT01899508||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1430104|NCT01899495||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430105|NCT01899482|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1430106|NCT01899469|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430107|NCT01899456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430108|NCT01899443|||Cohort||Prospective|||||||
1430109|NCT01899430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430110|NCT01899417|||Case Control||Retrospective|||||||
1430111|NCT01899404||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430112|NCT01899391|||Cohort||Prospective|||||||
1430113|NCT01899378|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430114|NCT01899365|||Cohort||Prospective|||||||
1430115|NCT01899352|Non-Randomized|Single Group Assignment||||Single|||t|||
1430116|NCT01899339|||Case-Only||Prospective|||||||
1430117|NCT01899326||Single Group Assignment||Treatment||None (Open Label)||||||
1430118|NCT01899313|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430119|NCT01899300||Single Group Assignment||Treatment||None (Open Label)||||||
1430120|NCT01899287|Randomized|Parallel Assignment||Prevention||Single||||||t
1430121|NCT01899274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430122|NCT01899261||Single Group Assignment||Treatment||None (Open Label)||||||
1430123|NCT01899248|||Cohort||Prospective|||||||
1430124|NCT01899235||||Treatment||||||||
1430125|NCT01899222||Single Group Assignment||Other||None (Open Label)||||||
1430126|NCT01899209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430127|NCT01899196||Single Group Assignment||||None (Open Label)||||||
1430128|NCT01899183|||Case-Only||Prospective|||||||
1430129|NCT01899170|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430130|NCT01899157|||||Cross-Sectional|||||||
1430131|NCT01899144|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1430132|NCT01899131||Single Group Assignment||Treatment||None (Open Label)||||||
1430133|NCT01899118||Single Group Assignment||Treatment||None (Open Label)||||||
1430134|NCT01899105|Randomized|Crossover Assignment||||None (Open Label)||||||
1430135|NCT01899092||Single Group Assignment||Treatment||None (Open Label)||||||
1430136|NCT01899079|||Cohort||Prospective|||||||
1430137|NCT01899066|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430138|NCT01899053|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430139|NCT01899040|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430140|NCT01899027|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430141|NCT01899001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430142|NCT01898975|||Case-Only||Prospective|||||||
1430143|NCT01898962||Single Group Assignment||Treatment||None (Open Label)||||||
1430144|NCT01898949||Single Group Assignment||Treatment||None (Open Label)||||||
1430145|NCT01898936|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1430146|NCT01898923|Randomized|Parallel Assignment||Treatment||Single||||||t
1430147|NCT01898910|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430148|NCT01898897|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430149|NCT01898884|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430150|NCT01898871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430151|NCT01898858|||Case-Only||Prospective|||||||
1430152|NCT01898845|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430153|NCT01898832|||Case Control||Prospective|||||||
1430154|NCT01898819|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1430155|NCT01898806|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430156|NCT01898793|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1430157|NCT01898780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430158|NCT01898767|||Cohort||Prospective|||||||
1430159|NCT01898754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430160|NCT01898741||Single Group Assignment||Treatment||None (Open Label)||||||
1430161|NCT01898728|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1430162|NCT01898715||Single Group Assignment||Treatment||None (Open Label)||||||
1430163|NCT01898702|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1430164|NCT01898689|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1430165|NCT01898676|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1430166|NCT01898663||Single Group Assignment||Treatment||None (Open Label)||||||
1430167|NCT01898650|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1430168|NCT01898637|Non-Randomized|Parallel Assignment||Diagnostic||Single||||t||
1430169|NCT01898624|||Case-Only||Prospective|||||||
1430170|NCT01898611|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1430171|NCT01898598|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430172|NCT01898585||Single Group Assignment||Treatment||None (Open Label)||||||
1430173|NCT01898572|||Case Control||Prospective|||||||
1430174|NCT01898559|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1430175|NCT01898546|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430176|NCT01898533|||Case-Only||Prospective|||||||
1430177|NCT01898520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430178|NCT01898507||Single Group Assignment||Other||Single|All subjects were blinded to the nicotine content of the study cigarettes.||t|||
1430179|NCT01898494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430180|NCT01898481|||Case-Only||Cross-Sectional|||||||
1430181|NCT01898468|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430182|NCT01898455||Single Group Assignment||Treatment||None (Open Label)||||||
1430183|NCT01898442|Randomized|Parallel Assignment||Treatment||Single||||||t
1430184|NCT01898429|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1430185|NCT01898416||Single Group Assignment||Treatment||None (Open Label)||||||
1430186|NCT01898403||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430187|NCT01898390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430188|NCT01898377||Single Group Assignment||Treatment||None (Open Label)||||||
1430189|NCT01898364|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430190|NCT01898351||Single Group Assignment||Basic Science||None (Open Label)||||||
1430191|NCT01898338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430192|NCT01898325|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1430193|NCT01898312|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1430194|NCT01898299|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430195|NCT01898286||Single Group Assignment||Treatment||None (Open Label)||||||
1430196|NCT01898273||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430197|NCT01898260|Randomized|Crossover Assignment||||Double|||t||t|
1430198|NCT01898247|Randomized|Single Group Assignment||Other||Double|||t|||t
1430199|NCT01898234|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430200|NCT01898221|Randomized|Crossover Assignment||Treatment||Single|||t|||
1430201|NCT01898208|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1430202|NCT01898195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430203|NCT01898182||Single Group Assignment||||None (Open Label)||||||
1430204|NCT01898169||Single Group Assignment||Basic Science||None (Open Label)||||||
1430205|NCT01898156||Single Group Assignment||Treatment||None (Open Label)||||||
1430206|NCT01898143|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1430207|NCT01898130||Single Group Assignment||Treatment||None (Open Label)||||||
1430208|NCT01898117|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1430209|NCT01898104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430210|NCT01898091|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1430211|NCT01898078||Single Group Assignment||Treatment||None (Open Label)||||||
1430212|NCT01898065||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430213|NCT01898052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430214|NCT01898039||Single Group Assignment||Treatment||None (Open Label)||||||
1430215|NCT01898026|Randomized|Crossover Assignment||||Triple|||t||t|t
1430216|NCT01898013|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430217|NCT01898000|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430218|NCT01897987|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1430219|NCT01897974|||Cohort||Prospective|||||||
1430220|NCT01897961|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1430221|NCT01897948|Randomized|Parallel Assignment||||Double||||||
1430222|NCT01897935|||Case Control||Cross-Sectional|||||||
1430223|NCT01897922|Randomized|Parallel Assignment||||Double||||||
1430224|NCT01897909|||Case-Control||Prospective|||||||
1430225|NCT01897896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430226|NCT01897883|||Case-Crossover||Cross-Sectional|||||||
1430227|NCT01897870||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430228|NCT01897857|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1430229|NCT01897844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430230|NCT01897831||Single Group Assignment||Treatment||None (Open Label)||||||
1430231|NCT01897818||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430232|NCT01897805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430233|NCT01897792|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1430234|NCT01897779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430235|NCT01897766|||Cohort||Retrospective|||||||
1430236|NCT01897753|||Case-Only||Retrospective|||||||
1430237|NCT01897740||||||||||||
1430238|NCT01897727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430239|NCT01897714||Single Group Assignment||Treatment||None (Open Label)||||||
1430240|NCT01897701|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1430241|NCT01897688||Single Group Assignment||Treatment||None (Open Label)||||||
1430242|NCT01897675|Randomized|Parallel Assignment||Treatment||Single||||||t
1430243|NCT01897662|Randomized|Parallel Assignment||||Triple|||t|t|t|
1430244|NCT01897649|Randomized|Parallel Assignment||||Triple|||t|t|t|
1430245|NCT01897636||Single Group Assignment||Treatment||None (Open Label)||||||
1430246|NCT01897623||||Screening||||||||
1430247|NCT01897610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430248|NCT01897597|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430249|NCT01897584||Single Group Assignment||Prevention||None (Open Label)||||||
1430250|NCT01897571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430251|NCT01897558|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430252|NCT01897545|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430253|NCT01897532|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430254|NCT01897519|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430255|NCT01897506|||Case-Control||Prospective|||||||
1430256|NCT01897493|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1430257|NCT01897480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430258|NCT01897467|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430259|NCT01897454||Single Group Assignment||Treatment||None (Open Label)||||||
1430260|NCT01897441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430261|NCT01897428|Randomized|Crossover Assignment||||None (Open Label)||||||
1430262|NCT01897415||Single Group Assignment||Treatment||None (Open Label)||||||
1430263|NCT01897402|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430264|NCT01897389|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430265|NCT01897376|Randomized|Parallel Assignment||Prevention||Single||||||t
1430266|NCT01897363|||Case-Only||Prospective|||||||
1430267|NCT01897350|||||Prospective|||||||
1430268|NCT01897337|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430269|NCT01897324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430270|NCT01897311|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430271|NCT01897298|Randomized|Parallel Assignment||Prevention||Double||||t||t
1430272|NCT01897285||Single Group Assignment||||Single|||||t|
1430273|NCT01897272|||Cohort||Prospective|||||||
1430274|NCT01897259|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430275|NCT01897246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430276|NCT01897233||Single Group Assignment||Treatment||None (Open Label)||||||
1430277|NCT01897220|||Cohort||Prospective|||||||
1430278|NCT01897207||Single Group Assignment||Treatment||None (Open Label)||||||
1430279|NCT01897194|||Case Control||Prospective|||||||
1430280|NCT01897181|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1430281|NCT01897168|||Cohort||Prospective|||||||
1430282|NCT01897155|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1430283|NCT01897142|Randomized|||Basic Science||Double|||t||t|
1430284|NCT01897129|||Case Control||Cross-Sectional|||||||
1430285|NCT01897116||Single Group Assignment||Treatment||Single|||t|||
1430286|NCT01897103|||Cohort||Prospective|||||||
1430287|NCT01897090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430288|NCT01897077|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430289|NCT01897064|Randomized|Parallel Assignment||Treatment||Single||||||t
1430290|NCT01897051|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430291|NCT01897038||Parallel Assignment||Treatment||None (Open Label)||||||
1430292|NCT01897025|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430293|NCT01897012||Single Group Assignment||Treatment||None (Open Label)||||||
1430294|NCT01896999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430295|NCT01896986|||Cohort||Prospective|||||||
1430296|NCT01896973||Single Group Assignment||Treatment||None (Open Label)||||||
1430297|NCT01896960|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430298|NCT01896947|||Case-Only||Prospective|||||||
1430299|NCT01896934||Single Group Assignment||Basic Science||None (Open Label)||||||
1430300|NCT01896921||Single Group Assignment||Treatment||None (Open Label)||||||
1430301|NCT01896908|Randomized|Parallel Assignment||Treatment||Single||||t||
1430302|NCT01896895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430303|NCT01896882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430304|NCT01896869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430305|NCT01896856|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430306|NCT01896843|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430307|NCT01896830|Randomized|Parallel Assignment||Prevention||Single||||||t
1430308|NCT01896791|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430309|NCT01896778|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430310|NCT01896765|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430311|NCT01896752|||Cohort||Prospective|||||||
1430312|NCT01896739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430313|NCT01896726||Single Group Assignment||Basic Science||None (Open Label)||||||
1430314|NCT01896713||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430315|NCT01896700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430316|NCT01896687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430317|NCT01896674|||Case-Only||Retrospective|||||||
1430318|NCT01896661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430319|NCT01896648|||Cohort|||||||||
1430320|NCT01896635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430321|NCT01896622|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430322|NCT01896609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430323|NCT01896596|Randomized|Parallel Assignment||Prevention||Single||||||t
1430324|NCT01896583|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430325|NCT01896570|||Case Control||Prospective|||||||
1430326|NCT01896557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430327|NCT01896544|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430328|NCT01896531|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430329|NCT01896518|Randomized|Parallel Assignment||Prevention||Single|||||t|
1430330|NCT01896505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430331|NCT01896492|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1430332|NCT01896479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430333|NCT01896466|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1430334|NCT01896453|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1430335|NCT01896440|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1430336|NCT01896427|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1430337|NCT01896414|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430338|NCT01896401||Single Group Assignment||Treatment||None (Open Label)||||||
1430339|NCT01896388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430340|NCT01896375|||Case-Only||Cross-Sectional|||||||
1430341|NCT01896362|||Ecologic or Community||Cross-Sectional|||||||
1430342|NCT01896349|Randomized|Parallel Assignment||Treatment||Single||||||t
1430343|NCT01896336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430344|NCT01896323|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1430345|NCT01896310|||Cohort||Prospective|||||||
1430346|NCT01896297||Single Group Assignment||Treatment||None (Open Label)||||||
1430347|NCT01896284||Single Group Assignment||Treatment||None (Open Label)||||||
1430348|NCT01896271||Single Group Assignment||Treatment||None (Open Label)||||||
1430349|NCT01896258|||||Cross-Sectional|||||||
1430350|NCT01896245|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1430351|NCT01896232|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430352|NCT01896219|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1430353|NCT01896206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430354|NCT01896193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430355|NCT01896180|Randomized|Parallel Assignment||Treatment||Single||||||t
1430356|NCT01896167|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1430357|NCT01896154|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1430358|NCT01896141||||||||||||
1430359|NCT01896128|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1430360|NCT01896115|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1430361|NCT01896102||Single Group Assignment||Treatment||None (Open Label)||||||
1430362|NCT01896089|||Cohort||Prospective|||||||
1430363|NCT01896076|||||Cross-Sectional|||||||
1430364|NCT01896063||Crossover Assignment||Prevention||Double|||||t|t
1430365|NCT01896050|||Cohort||Prospective|||||||
1430366|NCT01896037||Single Group Assignment||Treatment||None (Open Label)||||||
1430367|NCT01896024|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430368|NCT01896011|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430369|NCT01895998||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430370|NCT01895985||Single Group Assignment||Treatment||None (Open Label)||||||
1430371|NCT01895972||Single Group Assignment||Treatment||None (Open Label)||||||
1430372|NCT01895959||Single Group Assignment||Basic Science||None (Open Label)||||||
1430373|NCT01895946|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430374|NCT01895933|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430375|NCT01895920||Single Group Assignment||Basic Science||None (Open Label)||||||
1430376|NCT01895907|||Cohort||Prospective|||||||
1430377|NCT01895894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430378|NCT01895881|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430379|NCT01895868|Randomized|Parallel Assignment||||Single||||||t
1430380|NCT01895855|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430381|NCT01895842||Single Group Assignment||Treatment||None (Open Label)||||||
1430382|NCT01895829||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430383|NCT01895816||Single Group Assignment||Supportive Care||Single||||t||
1430384|NCT01895803|||Family-Based||Prospective|||||||
1430385|NCT01895790||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430386|NCT01895777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430387|NCT01895764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430388|NCT01895751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430389|NCT01895738|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1430390|NCT01895725|||Cohort||Prospective|||||||
1430391|NCT01895712|||Other||Prospective|||||||
1430392|NCT01895699|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1430393|NCT01895686|||Cohort||Prospective|||||||
1430394|NCT01895673|||Cohort||Prospective|||||||
1430395|NCT01895660|Randomized|Factorial Assignment||Treatment||Single||||||t
1430396|NCT01895647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430397|NCT01895634||Single Group Assignment||Treatment||None (Open Label)||||||
1430398|NCT01895621|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430399|NCT01895608|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430400|NCT01895595|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1430401|NCT01895582|||Case-Only||Prospective|||||||
1430402|NCT01895569||Single Group Assignment||Treatment||None (Open Label)||||||
1430403|NCT01895556|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1430404|NCT01895543||Single Group Assignment||Treatment||None (Open Label)||||||
1430405|NCT01895530|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1430406|NCT01895517|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1430407|NCT01895504|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1430408|NCT01895491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430409|NCT01895478|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1430410|NCT01895465||Single Group Assignment||||None (Open Label)||||||
1430411|NCT01895452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430412|NCT01895439||Single Group Assignment||Treatment||None (Open Label)||||||
1430413|NCT01895426|||Case-Only||Prospective|||||||
1430414|NCT01895413||Single Group Assignment||Treatment||None (Open Label)||||||
1430415|NCT01895400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430416|NCT01895387|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430417|NCT01895374|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430418|NCT01895361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430419|NCT01895348|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430420|NCT01895335||Single Group Assignment||Treatment||None (Open Label)||||||
1430421|NCT01895322||Single Group Assignment||Treatment||None (Open Label)||||||
1430422|NCT01895309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430423|NCT01895296|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1430424|NCT01895283||Single Group Assignment||Prevention||None (Open Label)||||||
1430425|NCT01895270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430426|NCT01895257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430427|NCT01895244|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430428|NCT01895231|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430429|NCT01895218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430430|NCT01895205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430431|NCT01895192||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430432|NCT01895179|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1430433|NCT01895166|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1430434|NCT01895153|||Cohort||Prospective|||||||
1430435|NCT01895140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430436|NCT01895127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430437|NCT01895114|||||Prospective|||||||
1430438|NCT01895101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430439|NCT01895088||Single Group Assignment||Treatment||None (Open Label)||||||
1430440|NCT01895075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430441|NCT01895062|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1430442|NCT01895049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430443|NCT01895036||Single Group Assignment||Treatment||None (Open Label)||||||
1430444|NCT01895023|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430445|NCT01895010|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1430446|NCT01894997||Single Group Assignment||Prevention||None (Open Label)||||||
1430447|NCT01894984|||Cohort||Prospective|||||||
1430448|NCT01894971||Single Group Assignment||Treatment||Double|||t||t|
1430449|NCT01894958|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430450|NCT01894945|||Cohort||Prospective|||||||
1430451|NCT01894932|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1430452|NCT01894919|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430453|NCT01894906|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430454|NCT01894893|||Cohort||Prospective|||||||
1430455|NCT01894880|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1430456|NCT01894867|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430457|NCT01894854|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430458|NCT01894841|Randomized|Parallel Assignment||Prevention||Single||||||t
1430459|NCT01894828|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1430460|NCT01894815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430461|NCT01894802||Single Group Assignment||Other||None (Open Label)||||||
1430462|NCT01894789|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1430463|NCT01894776||Single Group Assignment||||None (Open Label)||||||
1430464|NCT01894763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430465|NCT01894750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430466|NCT01894737|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1430467|NCT01894724||Single Group Assignment||Treatment||None (Open Label)||||||
1430468|NCT01894711|||Cohort||Retrospective|||||||
1430469|NCT01894698||||||||||||
1430470|NCT01894685|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430471|NCT01894672||Single Group Assignment||Treatment||None (Open Label)||||||
1430472|NCT01894659|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1430473|NCT01894646|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1430474|NCT01894633|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430475|NCT01894620|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1430476|NCT01894607||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430477|NCT01894594||Single Group Assignment||Treatment||None (Open Label)||||||
1430478|NCT01894581|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430479|NCT01894568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430480|NCT01894555||Single Group Assignment||Basic Science||None (Open Label)||||||
1430481|NCT01894542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430482|NCT01894529|||Cohort||Prospective|||||||
1430483|NCT01894516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430484|NCT01894503||Single Group Assignment||Treatment||None (Open Label)||Bilateral in-office placement of the S8 Sinus Implant (mometasone furoate, 1350 mcg) in the ethmoid sinuses||||
1430485|NCT01894490|||Cohort||Prospective|||||||
1430486|NCT01894477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430487|NCT01894464|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430488|NCT01894451||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430489|NCT01894438|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430490|NCT01894425|||Cohort||Prospective|||||||
1430491|NCT01894412|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1430492|NCT01894399|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430493|NCT01894386|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430494|NCT01894373||Single Group Assignment||Treatment||None (Open Label)||||||
1430495|NCT01894360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430496|NCT01894347|||Cohort||Prospective|||||||
1430497|NCT01894334|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430498|NCT01894321|||Case Control||Retrospective|||||||
1430499|NCT01894308|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430500|NCT01894295|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1430501|NCT01894282|Randomized|Parallel Assignment||Treatment||Single||||||t
1430502|NCT01894269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430503|NCT01894256|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1430504|NCT01894243|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1430505|NCT01894230|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430506|NCT01894217||Single Group Assignment||Prevention||None (Open Label)||||||
1430507|NCT01894204||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430508|NCT01894191|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1430509|NCT01894178|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430510|NCT01894165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430511|NCT01894152|||Cohort||Prospective|||||||
1430512|NCT01894139|Randomized|Parallel Assignment||Prevention||Single||||||t
1430513|NCT01894126|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430514|NCT01894113|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1430515|NCT01894100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430516|NCT01894087|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430517|NCT01894074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430518|NCT01894061||Single Group Assignment||Treatment||None (Open Label)||||||
1430519|NCT01894048||Single Group Assignment||Treatment||None (Open Label)||||||
1430520|NCT01894035|||Cohort||Prospective|||||||
1430521|NCT01894022||Single Group Assignment||Treatment||None (Open Label)||||||
1430522|NCT01894009|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430523|NCT01893996|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1430524|NCT01893983|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1430525|NCT01893970|Randomized|Parallel Assignment||Prevention||Single||||||t
1430526|NCT01893957|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430527|NCT01893944|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1430528|NCT01893931|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1430529|NCT01893918|||Cohort||Prospective|||||||
1430530|NCT01893905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430531|NCT01893892|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1430532|NCT01893879|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1430533|NCT01893866|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1430534|NCT01893853|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1430535|NCT01893840||Single Group Assignment||||None (Open Label)||||||
1430536|NCT01893827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430537|NCT01893814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430538|NCT01893801||Single Group Assignment||Treatment||None (Open Label)||||||
1430539|NCT01893788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430540|NCT01893775||Single Group Assignment||Treatment||None (Open Label)||||||
1430541|NCT01893762||Single Group Assignment||Treatment||None (Open Label)||||||
1430542|NCT01893749|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1430543|NCT01893736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430544|NCT01893723|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1430545|NCT01893710|||Case-Control||Prospective|||||||
1430546|NCT01893697|||Case-Crossover||Prospective|||||||
1430547|NCT01893684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430548|NCT01893671|||Case-Only||Prospective|||||||
1430549|NCT01893658|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1430550|NCT01893645|||Case-Only||Cross-Sectional|||||||
1430551|NCT01893632|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430552|NCT01893619|||Cohort||Prospective|||||||
1430553|NCT01893606|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1430554|NCT01893593|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430555|NCT01893580|Randomized|Parallel Assignment||Treatment||Double||||t||t
1430556|NCT01893567||Single Group Assignment||Treatment||None (Open Label)||||||
1430557|NCT01893554|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430558|NCT01893541|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430559|NCT01893528|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1430560|NCT01893515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430561|NCT01893502|Randomized|Parallel Assignment||Treatment||Single||||||t
1430562|NCT01893489|Non-Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1430563|NCT01893476|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1430564|NCT01893463|||||Prospective|||||||
1430565|NCT01893450|Randomized|Parallel Assignment||Treatment||Single||||t||
1430566|NCT01893437|Randomized|Parallel Assignment||||Double|||t||t|
1430567|NCT01893424|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1430568|NCT01893411|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430569|NCT01893398|Randomized|Parallel Assignment||||Single||||||t
1430570|NCT01893385|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1430571|NCT01893372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430572|NCT01893359|Randomized|Parallel Assignment||Treatment||Single||||||t
1430573|NCT01893346|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1430574|NCT01893333|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430575|NCT01893320||Single Group Assignment||Treatment||None (Open Label)||||||
1430576|NCT01893307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430577|NCT01893294||Single Group Assignment||Treatment||None (Open Label)||||||
1430578|NCT01893281||Single Group Assignment||Treatment||None (Open Label)||||||
1430579|NCT01893268|||Cohort||Prospective|||||||
1430580|NCT01893255|||Cohort||Prospective|||||||
1430581|NCT01893242|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430582|NCT01893229|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430583|NCT01893216|||Cohort||Cross-Sectional|||||||
1430584|NCT01893203|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1430585|NCT01893190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430586|NCT01893177|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430587|NCT01893164|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430588|NCT01893151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430589|NCT01893138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430590|NCT01893125|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1430591|NCT01893112|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1430592|NCT01893099|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430593|NCT01893086|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430594|NCT01893073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430595|NCT01893060|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430596|NCT01893047|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1430597|NCT01893034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430598|NCT01893021|||Cohort||Prospective|||||||
1430599|NCT01893008|Randomized|Parallel Assignment||Prevention||Single||||||t
1430600|NCT01892995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430601|NCT01892982|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1430602|NCT01892969|||Cohort||Prospective|||||||
1430603|NCT01892956|||Case-Only||Prospective|||||||
1430604|NCT01892943|||Case-Only||Retrospective|||||||
1430605|NCT01892930||Single Group Assignment||Treatment||None (Open Label)||||||
1430606|NCT01892917|||Other||Prospective|||||||
1430607|NCT01892904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430608|NCT01892891|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1430609|NCT01892878||Single Group Assignment||Treatment||None (Open Label)||||||
1430610|NCT01892865|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1430611|NCT01892852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430612|NCT01892839|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1430613|NCT01892826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430614|NCT01892813|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1430615|NCT01892800|||Cohort||Prospective|||||||
1430616|NCT01892787|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430617|NCT01892774|||Case-Only||Prospective|||||||
1430618|NCT01892761|||||Retrospective|||||||
1430619|NCT01892748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430620|NCT01892722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430621|NCT01892709||Single Group Assignment||Treatment||None (Open Label)||||||
1430622|NCT01892696||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430623|NCT01892683|||Cohort||Prospective|||||||
1430624|NCT01892670|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1430625|NCT01892657||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430626|NCT01892644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430627|NCT01892631|Randomized|Parallel Assignment||||None (Open Label)||||||
1430628|NCT01892618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430629|NCT01892605||Single Group Assignment||Treatment||None (Open Label)||||||
1430630|NCT01892592|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430631|NCT01892579|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1430632|NCT01892566|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1430633|NCT01892553|Randomized|Parallel Assignment||||Single|||t|||
1430634|NCT01892540||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430635|NCT01892527||Single Group Assignment||Treatment||None (Open Label)||||||
1430636|NCT01892514|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430637|NCT01892501||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430638|NCT01892488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430639|NCT01892475|Randomized|Parallel Assignment||Prevention||Single||||||t
1430640|NCT01892462|||Cohort||Prospective|||||||
1430641|NCT01892449|Randomized|Parallel Assignment||||Double|||t|||t
1430642|NCT01892436||Parallel Assignment||Treatment||Double|||t||t|
1430643|NCT01892423||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430644|NCT01892410||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430645|NCT01892397||Single Group Assignment||Treatment||None (Open Label)||||||
1430646|NCT01892384|Randomized|Parallel Assignment||Treatment||Double||||||
1430647|NCT01892371||Single Group Assignment||Treatment||None (Open Label)||||||
1430648|NCT01892358|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430649|NCT01892345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430650|NCT01892332|Non-Randomized|Single Group Assignment||Treatment||Double|||t||t|
1430651|NCT01892319|||Cohort||Prospective|||||||
1430652|NCT01892306|Randomized|Parallel Assignment||Treatment||Single||||||t
1430653|NCT01892293||Single Group Assignment||Treatment||None (Open Label)||||||
1430654|NCT01892280|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1430655|NCT01892267|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1430656|NCT01892254|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1430657|NCT01892241|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430658|NCT01892228||Single Group Assignment||Health Services Research||None (Open Label)||||||
1430659|NCT01892215|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430660|NCT01892202||||||||||||
1430661|NCT01892189|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1430662|NCT01892176||Single Group Assignment||Treatment||None (Open Label)||||||
1430663|NCT01892163|Randomized|Parallel Assignment||Treatment||Single||||||t
1430664|NCT01892150||Single Group Assignment||||Triple|||t||t|t
1430665|NCT01892137||Single Group Assignment||Treatment||None (Open Label)||||||
1430666|NCT01892124|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430667|NCT01892111|Randomized|Parallel Assignment||Treatment||Single||||||t
1430668|NCT01892098|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1430669|NCT01892085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430670|NCT01892072|||Case Control||Prospective|||||||
1430671|NCT01892059|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430672|NCT01892046||Single Group Assignment||Treatment||None (Open Label)||||||
1430673|NCT01892033||Single Group Assignment||Treatment||None (Open Label)||||||
1430674|NCT01892020|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430675|NCT01892007|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1430676|NCT01891994||Single Group Assignment||Treatment||None (Open Label)||||||
1430677|NCT01891981||Single Group Assignment||Treatment||None (Open Label)||||||
1430678|NCT01891968||Single Group Assignment||Treatment||None (Open Label)||||||
1430679|NCT01891955|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430680|NCT01891942|Randomized|Factorial Assignment||Diagnostic||Single|||t|||
1430681|NCT01891929|Randomized|Parallel Assignment||Treatment||Single||||||t
1430682|NCT01891916|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430683|NCT01891903|||||Prospective|||||||
1430684|NCT01891890|Randomized|Parallel Assignment||Treatment||Single||||||t
1430685|NCT01891877|||Case Control||Retrospective|||||||
1430686|NCT01891864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430687|NCT01891851||Single Group Assignment||Treatment||None (Open Label)||||||
1430688|NCT01891838|Randomized|Parallel Assignment||Treatment||Single||||t||
1430689|NCT01891825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430690|NCT01891812||Single Group Assignment||Treatment||None (Open Label)||||||
1430691|NCT01891799|||Other||Prospective|||||||
1430692|NCT01891786|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430693|NCT01891773|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1430694|NCT01891760|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430695|NCT01891747||Single Group Assignment||Treatment||None (Open Label)||||||
1430696|NCT01891734|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1430697|NCT01891721|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430698|NCT01891708|||Case-Only||Prospective|||||||
1430699|NCT01891695||Single Group Assignment||Treatment||None (Open Label)||||||
1430700|NCT01891682|||Cohort||Prospective|||||||
1430701|NCT01891669||Single Group Assignment||Treatment||None (Open Label)||||||
1430702|NCT01891656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430703|NCT01891643|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430704|NCT01891630|||Ecologic or Community||Prospective|||||||
1430705|NCT01891617|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430706|NCT01891604||Parallel Assignment||||||||||
1430707|NCT01891591|||Cohort||Prospective|||||||
1430708|NCT01891578|||Cohort||Prospective|||||||
1430709|NCT01891565|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1430710|NCT01891552|||Cohort||Prospective|||||||
1430711|NCT01891539|||Cohort||Prospective|||||||
1430712|NCT01891526|||Case Control||Prospective|||||||
1430713|NCT01891513|||Case-Control||Prospective|||||||
1430714|NCT01891500|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430715|NCT01891487|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430716|NCT01891474|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1430717|NCT01891461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430718|NCT01891448|Randomized|Parallel Assignment||Other||Single|||t|||
1430719|NCT01891435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430720|NCT01891422|||Cohort||Other|||||||
1430721|NCT01891409||Single Group Assignment||Prevention||None (Open Label)||||||
1430722|NCT01891396|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430723|NCT01891383|||Case Control||Cross-Sectional|||||||
1430724|NCT01891370|||Cohort||Cross-Sectional|||||||
1430725|NCT01891357||Single Group Assignment||Treatment||None (Open Label)||||||
1430726|NCT01891344||Single Group Assignment||Treatment||None (Open Label)||||||
1430727|NCT01891331|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430728|NCT01891318||Single Group Assignment||Treatment||None (Open Label)||||||
1430729|NCT01891305|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430730|NCT01891292|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430731|NCT01891279|Randomized|Parallel Assignment||||Triple|||t|t|t|
1430732|NCT01891266|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430733|NCT01891253|||Cohort||Prospective|||||||
1430734|NCT01891240|||Case Control||Prospective|||||||
1430735|NCT01891227||Single Group Assignment||Treatment||None (Open Label)||||||
1430736|NCT01891214|||Cohort||Prospective|||||||
1430737|NCT01891201|||Cohort||Prospective|||||||
1430738|NCT01891188|||Cohort||Prospective|||||||
1430739|NCT01891175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430740|NCT01891162|||Case Control||Cross-Sectional|||||||
1430741|NCT01891149|||Cohort||Cross-Sectional|||||||
1430742|NCT01891136||Single Group Assignment||Treatment||None (Open Label)||||||
1430743|NCT01891123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430744|NCT01891110|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430745|NCT01891097|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1430746|NCT01891084|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1430747|NCT01891071|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1430748|NCT01891058|Randomized|Factorial Assignment||Treatment||Single|||||t|
1430749|NCT01891045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430750|NCT01891032|||Case-Only||Prospective|||||||
1430751|NCT01891019||Single Group Assignment||Treatment||None (Open Label)||||||
1430752|NCT01891006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430753|NCT01890993|||Cohort||Retrospective|||||||
1430754|NCT01890980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430755|NCT01890967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430756|NCT01890954|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430757|NCT01890941||||||||||||
1430758|NCT01890928|||Cohort||Prospective|||||||
1430759|NCT01890915|||Case Control||Prospective|||||||
1430760|NCT01890902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430761|NCT01890889|Randomized|Parallel Assignment||||Triple|||t|t|t|
1430762|NCT01890876|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430763|NCT01890863|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430764|NCT01890850|||Case Control||Retrospective|||||||
1430765|NCT01890837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430766|NCT01890824|||Cohort||Prospective|||||||
1430767|NCT01890811||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430768|NCT01890798||Single Group Assignment||Treatment||None (Open Label)||||||
1430769|NCT01890785|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430770|NCT01890772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430771|NCT01890759||Single Group Assignment||Prevention||None (Open Label)||||||
1430772|NCT01890746|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430773|NCT01890733|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430774|NCT01890720|Randomized|Parallel Assignment||Prevention||Single||||||t
1430775|NCT01890707|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430776|NCT01890694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430777|NCT01890681|Randomized|Parallel Assignment||Prevention||Single||||||t
1430778|NCT01890668|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430779|NCT01890655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430780|NCT01890642|Randomized|Parallel Assignment||Treatment||Single||||||t
1430781|NCT01890629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430782|NCT01890616||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430783|NCT01890603|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1430784|NCT01890590||Single Group Assignment||Treatment||None (Open Label)||Cyberknife treatment||||
1430785|NCT01890577|||Cohort||Prospective|||||||
1430786|NCT01890564|||Case-Only||Prospective|||||||
1430787|NCT01890551|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1430788|NCT01890538|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1430789|NCT01890525|||Cohort||Prospective|||||||
1430790|NCT01890512|||Cohort||Prospective|||||||
1430791|NCT01890499|Randomized|Single Group Assignment||Treatment||Single||||||t
1430792|NCT01890486|||Other||Prospective|||||||
1430793|NCT01890473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430794|NCT01890460|||Case-Only||Prospective|||||||
1430795|NCT01890447|||Cohort||Cross-Sectional|||||||
1430796|NCT01890434||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430797|NCT01890421||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430798|NCT01890408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430799|NCT01890395||Single Group Assignment||Basic Science||None (Open Label)||||||
1430800|NCT01890382|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430801|NCT01890369|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1430802|NCT01890356||Single Group Assignment||Treatment||None (Open Label)||||||
1430803|NCT01890343|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1430804|NCT01890330|Randomized|Parallel Assignment||||Double|||t||t|
1430805|NCT01890317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430806|NCT01890304||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430807|NCT01890291|||||Prospective|||||||
1430808|NCT01890278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430809|NCT01890265|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430810|NCT01890252|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430811|NCT01890239|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1430812|NCT01890226|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1430813|NCT01890213||Single Group Assignment||Treatment||None (Open Label)||||||
1430814|NCT01890200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430815|NCT01890187|||Case-Only||Prospective|||||||
1430816|NCT01890174|||Case-Only||Prospective|||||||
1430817|NCT01890161|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1430818|NCT01890148|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1430819|NCT01890135|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1430820|NCT01890122|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1430821|NCT01890109|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1430822|NCT01890096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430823|NCT01890083|Randomized|Parallel Assignment||Prevention||Single||||||t
1430824|NCT01890070|Randomized|Crossover Assignment||||None (Open Label)||||||
1430825|NCT01890057|Non-Randomized|Parallel Assignment||||Double|||t|||t
1430826|NCT01890044|||Cohort||Prospective|||||||
1430827|NCT01890031|Randomized|Parallel Assignment||||None (Open Label)||||||
1430828|NCT01890018|Randomized|Factorial Assignment||Health Services Research||Single|||||t|
1430829|NCT01890005|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430830|NCT01889992|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430831|NCT01889979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430832|NCT01889966||Single Group Assignment||Treatment||None (Open Label)||||||
1430833|NCT01889953||Single Group Assignment||Treatment||None (Open Label)||||||
1430834|NCT01889940|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1430835|NCT01889927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430836|NCT01889914|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1430837|NCT01889901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430838|NCT01889888||Single Group Assignment||Treatment||None (Open Label)||||||
1430839|NCT01889875|Randomized|Parallel Assignment||Basic Science||Single||||||t
1430840|NCT01889862|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430841|NCT01889849|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1430842|NCT01889836|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430843|NCT01889823|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430844|NCT01889810|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1430845|NCT01889797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430846|NCT01889784|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1430847|NCT01889771|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1430848|NCT01889758|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430849|NCT01889745||||||||||||
1430850|NCT01889732|||Cohort||Retrospective|||||||
1430851|NCT01889719|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430852|NCT01889706|||Cohort||Prospective|||||||
1430853|NCT01889693|||Case Control||Prospective|||||||
1430854|NCT01889680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430855|NCT01889667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430856|NCT01889654|||Other||Prospective|||||||
1430857|NCT01889641|||Cohort||Prospective|||||||
1430858|NCT01889628|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1430859|NCT01889615|||Cohort||Prospective|||||||
1430860|NCT01889602|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1430861|NCT01889589|||||Cross-Sectional|||||||
1430862|NCT01889576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430863|NCT01889563|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1430864|NCT01889550|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1430865|NCT01889537|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1430866|NCT01889524|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430867|NCT01889511|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1430868|NCT01889498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430869|NCT01889485|||Ecologic or Community||Prospective|||||||
1430870|NCT01889472|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430871|NCT01889459|||Cohort||Prospective|||||||
1430872|NCT01889446|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1430873|NCT01889433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430874|NCT01889420||Single Group Assignment||Treatment||None (Open Label)||||||
1430875|NCT01889407|||Case Control||Prospective|||||||
1430876|NCT01889394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430877|NCT01889381||Single Group Assignment||Treatment||None (Open Label)||||||
1430878|NCT01889368|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1430879|NCT01889355||Single Group Assignment||Basic Science||None (Open Label)||||||
1430880|NCT01889342|Randomized|Parallel Assignment||Treatment||Single||||||t
1430881|NCT01889329|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1430882|NCT01889316||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430883|NCT01889303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430884|NCT01889290||Single Group Assignment||Treatment||None (Open Label)||||||
1430885|NCT01889277|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430886|NCT01889264|||Cohort||Prospective|||||||
1430887|NCT01889251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430888|NCT01889238||Single Group Assignment||Treatment||None (Open Label)||||||
1430889|NCT01889225|||Cohort||Prospective|||||||
1430890|NCT01889212||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430891|NCT01889199|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430892|NCT01889186||Single Group Assignment||Treatment||None (Open Label)||||||
1430893|NCT01889173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430894|NCT01889160|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1430895|NCT01889147|Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1430896|NCT01889134|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430897|NCT01889121|||Cohort||Retrospective|||||||
1430898|NCT01889108|Randomized|Parallel Assignment||Treatment||Single||||||t
1430899|NCT01889095|Randomized|Parallel Assignment||Treatment||Single|||t|||
1430900|NCT01889082|Randomized|Parallel Assignment||Treatment||Single||||||t
1430901|NCT01889069||Single Group Assignment||Treatment||None (Open Label)||||||
1430902|NCT01889056|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1430903|NCT01889043|||Cohort||Prospective|||||||
1430904|NCT01889030|||||Cross-Sectional|||||||
1430905|NCT01889017|||Cohort||Retrospective|||||||
1430906|NCT01889004|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430907|NCT01888991|Randomized|Crossover Assignment||Prevention||Single|||t|||
1430908|NCT01888978|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430909|NCT01888965||Single Group Assignment||Treatment||None (Open Label)||||||
1430910|NCT01888952||Single Group Assignment||Treatment||None (Open Label)||||||
1430911|NCT01888939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430912|NCT01888926|||||Prospective|||||||
1430913|NCT01888913|||Cohort||Prospective|||||||
1430914|NCT01888900|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1430915|NCT01888887||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430916|NCT01888874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430917|NCT01888861|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1430918|NCT01888848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430919|NCT01888835|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1430920|NCT01888822|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430921|NCT01888809|Randomized|Parallel Assignment||Prevention||Single||||||t
1430922|NCT01888796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430923|NCT01888783|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430924|NCT01888770|||Case Control||Prospective|||||||
1430925|NCT01888757|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430926|NCT01888744|Randomized|Parallel Assignment||Treatment||Single|||||t|
1430927|NCT01888731|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430928|NCT01888718|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430929|NCT01888705|||||Cross-Sectional|||||||
1430930|NCT01888692|||||Prospective|||||||
1430931|NCT01888679||Single Group Assignment||Prevention||None (Open Label)||||||
1430932|NCT01888666|||Cohort||Prospective|||||||
1430933|NCT01888653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430934|NCT01888640|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1430935|NCT01888627||Single Group Assignment||Treatment||None (Open Label)||||||
1430936|NCT01888614|||Case-Only||Prospective|||||||
1430937|NCT01888601|||Cohort||Prospective|||||||
1430938|NCT01888588|||Cohort||Retrospective|||||||
1430939|NCT01888575|||Cohort||Retrospective|||||||
1430940|NCT01888562||Single Group Assignment||Treatment||None (Open Label)||||||
1430941|NCT01888549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430942|NCT01888536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430943|NCT01888523|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1430944|NCT01888510||Single Group Assignment||Diagnostic||None (Open Label)||||||
1430945|NCT01888497|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1430946|NCT01888484||Single Group Assignment||Treatment||None (Open Label)||||||
1430947|NCT01888471|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1430948|NCT01888458||Single Group Assignment||Treatment||None (Open Label)||||||
1430949|NCT01888445|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430950|NCT01888432|Randomized|Parallel Assignment||Treatment||Single||This was a 24-month, multicenter, open-label, randomized, controlled study||t||
1430951|NCT01888419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430952|NCT01888406|Randomized|Parallel Assignment||Prevention||Single||||||t
1430953|NCT01888393|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1430954|NCT01888380|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1430955|NCT01888367|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1430956|NCT01888354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430957|NCT01888341|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430958|NCT01888328|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430959|NCT01888315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430960|NCT01888302||Single Group Assignment||Treatment||None (Open Label)||||||
1430961|NCT01888289|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430962|NCT01888276|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1430963|NCT01888263|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430964|NCT01888250|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430965|NCT01888237|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1430966|NCT01888224|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430967|NCT01888211|Randomized|Crossover Assignment||||Double|||t||t|
1430968|NCT01888198|||Cohort||Other|||||||
1430969|NCT01888185|||Case-Control||Prospective|||||||
1430970|NCT01888172|Randomized|Parallel Assignment||Treatment||Single|||||t|
1430971|NCT01888159|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1430972|NCT01888146|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1430973|NCT01888133|Randomized|Crossover Assignment||||None (Open Label)||||||
1430974|NCT01888120|||Case-Only||Prospective|||||||
1430975|NCT01888107||Single Group Assignment||Treatment||None (Open Label)||||||
1430976|NCT01888094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430977|NCT01888081||Single Group Assignment||Treatment||None (Open Label)||||||
1430978|NCT01888068|||Cohort||Cross-Sectional|||||||
1430979|NCT01888055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430980|NCT01888042||Single Group Assignment||Treatment||None (Open Label)||||||
1430981|NCT01888029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430982|NCT01888016|Randomized|Parallel Assignment||Treatment||Single||||||t
1430983|NCT01888003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430984|NCT01887990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430985|NCT01887977||Single Group Assignment||||None (Open Label)||||||
1430986|NCT01887964|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1430987|NCT01887951|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1430988|NCT01887938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430989|NCT01887925|||Cohort||Prospective|||||||
1430990|NCT01887912|Randomized|Parallel Assignment||Prevention||Single||||||t
1430991|NCT01887899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430992|NCT01887886|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1430993|NCT01887873||Single Group Assignment||Treatment||None (Open Label)||||||
1430994|NCT01887860||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430995|NCT01887847|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1430996|NCT01887834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1430997|NCT01887821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1430998|NCT01887808||Single Group Assignment||Supportive Care||None (Open Label)||||||
1430999|NCT01887795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431000|NCT01887782|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431001|NCT01887769|||Cohort||Retrospective|||||||
1431002|NCT01887756||Single Group Assignment||Treatment||None (Open Label)||||||
1431003|NCT01887743||Single Group Assignment||Basic Science||None (Open Label)||||||
1431004|NCT01887730|Randomized|Parallel Assignment||Prevention||Single|||||t|
1431005|NCT01887717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431006|NCT01887704|Randomized|Parallel Assignment||Treatment||Single||||||t
1431007|NCT01887691||Single Group Assignment||Treatment||None (Open Label)||||||
1431008|NCT01887678|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431009|NCT01887665||Single Group Assignment||Treatment||None (Open Label)||||||
1431010|NCT01887652|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431011|NCT01887639|||Cohort||Prospective|||||||
1431012|NCT01887626|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1431013|NCT01887613|||Case-Only||Prospective|||||||
1431014|NCT01887600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431015|NCT01887587||Single Group Assignment||Treatment||None (Open Label)||||||
1431016|NCT01887574||Single Group Assignment||Other||None (Open Label)||||||
1431017|NCT01887561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1431018|NCT01887548|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1431019|NCT01887535|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431020|NCT01887522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431021|NCT01887509||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431022|NCT01887496|||Case-Only||Prospective|||||||
1431023|NCT01887483|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1431024|NCT01887470|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431025|NCT01887457||Single Group Assignment||Treatment||None (Open Label)||||||
1431026|NCT01887444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431027|NCT01887431|Randomized|Parallel Assignment||Treatment||Single||||||t
1431028|NCT01887418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431029|NCT01887405|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1431030|NCT01887392|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1431031|NCT01887379|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431032|NCT01887366|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431033|NCT01887353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431034|NCT01887340|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1431035|NCT01887327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431036|NCT01887314|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1431037|NCT01887301|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431038|NCT01887288||Single Group Assignment||Treatment||None (Open Label)||||||
1431039|NCT01887275|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431040|NCT01887262|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1431041|NCT01887249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431042|NCT01887236|Randomized|Parallel Assignment||Prevention||Single|||t|||
1431043|NCT01887223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431044|NCT01887210|Randomized|Parallel Assignment||Prevention||Single||||||t
1431045|NCT01887197|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1431046|NCT01887184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431047|NCT01887171|Randomized|Parallel Assignment||Prevention||Double||||t||t
1431048|NCT01887158|Randomized|Parallel Assignment||Treatment||Single||||t||
1431049|NCT01887145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431050|NCT01887132|Randomized|Parallel Assignment||Treatment||Double||||||
1431051|NCT01887119|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1431052|NCT01887106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431053|NCT01887093|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431054|NCT01887080|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1431055|NCT01887067||Single Group Assignment||Treatment||None (Open Label)||||||
1431056|NCT01887054|Randomized|Parallel Assignment||Treatment||Single||||||t
1431057|NCT01887041|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431058|NCT01887028|Randomized|Crossover Assignment||||Single|||t|||
1431059|NCT01887015|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1431060|NCT01887002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431061|NCT01886989|Randomized|Crossover Assignment||Prevention||Single|||t|||
1431062|NCT01886976||Single Group Assignment||Treatment||None (Open Label)||||||
1431063|NCT01886963|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1431064|NCT01886950|||Cohort||Prospective|||||||
1431065|NCT01886937|Randomized|Crossover Assignment||Other||Double|||t||t|
1431066|NCT01886924|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431067|NCT01886911|Randomized|Parallel Assignment||||None (Open Label)||||||
1431068|NCT01886898|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1431069|NCT01886885|||Cohort||Prospective|||||||
1431070|NCT01886872|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431071|NCT01886859||Single Group Assignment||Treatment||None (Open Label)||||||
1431072|NCT01886846|||Case-Crossover||Prospective|||||||
1431073|NCT01886833|||Cohort||Prospective|||||||
1431074|NCT01886820||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431075|NCT01886807|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1431076|NCT01886794|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1431077|NCT01886781|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431078|NCT01886768|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431079|NCT01886755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431080|NCT01886742|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431081|NCT01886729|Randomized|||||None (Open Label)||||||
1431082|NCT01886716|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431083|NCT01886703||Single Group Assignment||Supportive Care||None (Open Label)||||||
1431084|NCT01886690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431085|NCT01886677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431086|NCT01886664|Randomized|Parallel Assignment||Prevention||Single|||t|||
1431087|NCT01886651|||Cohort||Retrospective|||||||
1431088|NCT01886638||Single Group Assignment||Treatment||None (Open Label)||||||
1431089|NCT01886625||Single Group Assignment||Treatment||None (Open Label)||||||
1431090|NCT01886612||Single Group Assignment||Prevention||None (Open Label)||||||
1431091|NCT01886599|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1431092|NCT01886586|Randomized|Parallel Assignment||Prevention||Single||||||t
1431093|NCT01886573||Single Group Assignment||Treatment||None (Open Label)||||||
1431094|NCT01886560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431095|NCT01886547|||Ecologic or Community||Cross-Sectional|||||||
1431096|NCT01886534|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1431097|NCT01886521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431098|NCT01886508|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431099|NCT01886495|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1431100|NCT01886482|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1431101|NCT01886469|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431102|NCT01886456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431103|NCT01886443||Single Group Assignment||Prevention||Single|||t|||
1431104|NCT01886430|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431105|NCT01886417|||Case Control||Cross-Sectional|||||||
1431106|NCT01886404|||Other||Cross-Sectional|||||||
1431107|NCT01886391||Single Group Assignment||Health Services Research||Single|||t|||
1431108|NCT01886378||Single Group Assignment||Treatment||None (Open Label)||||||
1431109|NCT01886365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431110|NCT01886352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431111|NCT01886339|||Ecologic or Community||Prospective|||||||
1431112|NCT01886326|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431113|NCT01886313|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431114|NCT01886300|||Cohort||Prospective|||||||
1431115|NCT01886287||Single Group Assignment||Treatment||None (Open Label)||||||
1431116|NCT01886274|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431117|NCT01886261|||Cohort||Prospective|||||||
1431118|NCT01886248||Single Group Assignment||Treatment||None (Open Label)||||||
1431119|NCT01886235||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431120|NCT01886222|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1431121|NCT01886209|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431122|NCT01886196|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1431123|NCT01886183|Randomized|Parallel Assignment||Treatment||Single||||||t
1431124|NCT01886170|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1431125|NCT01886157|Randomized|Parallel Assignment||Treatment||Single||||t||
1431126|NCT01886144|||Cohort||Prospective|||||||
1431127|NCT01886131||Single Group Assignment||Basic Science||None (Open Label)||||||
1431128|NCT01886118|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1431129|NCT01886105||Single Group Assignment||Treatment||None (Open Label)||||||
1431130|NCT01886092|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1431131|NCT01886079|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1431132|NCT01886066||Single Group Assignment||Diagnostic||None (Open Label)||This is an Investigator-Initiated Prospective Trial (not a clinical trial, as ICG not a novel drug that is being used as intervention).||||
1431133|NCT01886053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431134|NCT01886040|||Case-Only||Retrospective|||||||
1431135|NCT01886027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431136|NCT01886014|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1431137|NCT01886001|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431138|NCT01885988|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431139|NCT01885975|||Case-Only||Prospective|||||||
1431140|NCT01885962|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431141|NCT01885949||Single Group Assignment||Treatment||None (Open Label)||||||
1431142|NCT01885936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431143|NCT01885923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431144|NCT01885910||Single Group Assignment||Treatment||None (Open Label)||||||
1431145|NCT01885897||Single Group Assignment||Treatment||None (Open Label)||||||
1431146|NCT01885884|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431147|NCT01885871||Single Group Assignment||Treatment||None (Open Label)||||||
1431148|NCT01885858|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1431149|NCT01885845|Randomized|Parallel Assignment||||None (Open Label)||||||
1431150|NCT01885832||Single Group Assignment||Treatment||None (Open Label)||||||
1431151|NCT01885819||Single Group Assignment||Treatment||None (Open Label)||||||
1431152|NCT01885806|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1431153|NCT01885793|||Case-Only||Prospective|||||||
1431154|NCT01885780||Single Group Assignment||Treatment||None (Open Label)||||||
1431155|NCT01885767|||Case-Only||Other|||||||
1431156|NCT01885754|||Cohort||Prospective|||||||
1431157|NCT01885741||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431158|NCT01885728|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1431159|NCT01885715|Randomized|Parallel Assignment||Treatment||Single||||||t
1431160|NCT01885702|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431161|NCT01885689||Single Group Assignment||Treatment||None (Open Label)||||||
1431162|NCT01885676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431163|NCT01885663||Single Group Assignment||Treatment||None (Open Label)||UCB therapy for TBI patient||||
1431164|NCT01885650|Randomized|Crossover Assignment||Treatment||Single|||||t|
1431165|NCT01885637|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1431166|NCT01885624||Single Group Assignment||Other||None (Open Label)||||||
1431167|NCT01885611|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1431168|NCT01885598|||Case-Only||Prospective|||||||
1431169|NCT01885585|||Case-Only||Prospective|||||||
1431170|NCT01885572||Single Group Assignment||Treatment||None (Open Label)||||||
1431171|NCT01885559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431172|NCT01885546||Single Group Assignment||Basic Science||None (Open Label)||||||
1431173|NCT01885533|||Cohort||Retrospective|||||||
1431174|NCT01885520|Randomized|Crossover Assignment||||None (Open Label)||||||
1431175|NCT01885507|||Case Control||Prospective|||||||
1431176|NCT01885494|||Cohort||Prospective|||||||
1431177|NCT01885481|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1431178|NCT01885468|||Case-Only||Prospective|||||||
1431179|NCT01885455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431180|NCT01885442||Single Group Assignment||Treatment||None (Open Label)||||||
1431181|NCT01885429|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1431182|NCT01885416|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1431183|NCT01885403||Single Group Assignment||Basic Science||None (Open Label)||||||
1431184|NCT01885390||Single Group Assignment||Treatment||None (Open Label)||||||
1431185|NCT01885377|Randomized|Parallel Assignment||Treatment||Single||||||t
1431186|NCT01885364|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1431187|NCT01885351|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1431188|NCT01885338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431189|NCT01885325|Randomized|Parallel Assignment||Prevention||Single||||||t
1431190|NCT01885312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431191|NCT01885299|||Cohort||Other|||||||
1431192|NCT01885286||Single Group Assignment||Treatment||None (Open Label)||||||
1431193|NCT01885273|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1431194|NCT01885260|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431195|NCT01885247|||Cohort||Prospective|||||||
1431196|NCT01885234|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1431197|NCT01885221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431198|NCT01885208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431199|NCT01885195||Single Group Assignment||Treatment||None (Open Label)||||||
1431200|NCT01885182|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431201|NCT01885169|||Cohort||Prospective|||||||
1431202|NCT01885156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431203|NCT01885143|||Cohort||Prospective|||||||
1431204|NCT01885130||Single Group Assignment||Supportive Care||None (Open Label)||||||
1431205|NCT01885117|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1431206|NCT01885104|Randomized|Parallel Assignment||Treatment||Single|||||t|
1431207|NCT01885091||Single Group Assignment||Treatment||None (Open Label)||||||
1431208|NCT01885078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431209|NCT01885065||Single Group Assignment||Supportive Care||None (Open Label)||||||
1431210|NCT01885052|Randomized|Parallel Assignment||Treatment||Single|||||t|
1431211|NCT01885039|||Case-Only||Cross-Sectional|||||||
1431212|NCT01885026|Randomized|Parallel Assignment||Treatment||Single|||||t|
1431213|NCT01885013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431214|NCT01885000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431215|NCT01884987|||Cohort||Prospective|||||||
1431216|NCT01884974|||Case Control||Retrospective|||||||
1431217|NCT01884961||Single Group Assignment||Treatment||None (Open Label)||||||
1431218|NCT01884948|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1431219|NCT01884935||Single Group Assignment||Treatment||None (Open Label)||||||
1431220|NCT01884922||Single Group Assignment||Treatment||None (Open Label)||||||
1431221|NCT01884909|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431222|NCT01884896|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431223|NCT01884883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1431224|NCT01884870||Single Group Assignment||Treatment||None (Open Label)||||||
1431225|NCT01884857|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431226|NCT01884844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431227|NCT01884831||Single Group Assignment||Treatment||Double|||||t|t
1431228|NCT01884818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431229|NCT01884805||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431230|NCT01884792|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1431231|NCT01884779|||Other||Cross-Sectional|||||||
1431232|NCT01884766|||Other||Prospective|||||||
1431233|NCT01884753|||Cohort||Prospective|||||||
1431234|NCT01884740||Single Group Assignment||Treatment||None (Open Label)||||||
1431235|NCT01884727|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1431236|NCT01884714||Single Group Assignment||Basic Science||None (Open Label)||||||
1431237|NCT01884701||Single Group Assignment||Treatment||None (Open Label)||||||
1431238|NCT01884688||Single Group Assignment||Prevention||None (Open Label)||||||
1431239|NCT01884675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431240|NCT01884662|Randomized|Parallel Assignment||Treatment||Single||||||t
1431241|NCT01884649|||||Cross-Sectional|||||||
1431242|NCT01884636||Single Group Assignment||||None (Open Label)||||||
1431243|NCT01884623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431244|NCT01884610|||Cohort||Prospective|||||||
1431245|NCT01884597|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431246|NCT01884584||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431247|NCT01884571||Single Group Assignment||Treatment||None (Open Label)||||||
1431248|NCT01884558||Single Group Assignment||||None (Open Label)||||||
1431249|NCT01884545|Randomized|Factorial Assignment||Prevention||Single||||||t
1431250|NCT01884532|||Cohort||Cross-Sectional|||||||
1431251|NCT01884519|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431252|NCT01884506|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1431253|NCT01884493|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1431254|NCT01884480|||Cohort||Retrospective|||||||
1431255|NCT01884467|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1431256|NCT01884454|||Case Control||Cross-Sectional|||||||
1431257|NCT01884441||Single Group Assignment||Treatment||None (Open Label)||||||
1431258|NCT01884428||Single Group Assignment||Treatment||None (Open Label)||||||
1431259|NCT01884415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431260|NCT01884402|||||Prospective|||||||
1431261|NCT01884389|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431262|NCT01884376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1431263|NCT01884363|Randomized|Parallel Assignment||||None (Open Label)||||||
1431264|NCT01884350|Randomized|Parallel Assignment||||None (Open Label)||||||
1431265|NCT01884337||Single Group Assignment||Treatment||None (Open Label)||||||
1431266|NCT01884324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431267|NCT01884311||Single Group Assignment||Other||None (Open Label)||||||
1431268|NCT01884298||Single Group Assignment||Treatment||Triple|||t||t|t
1431269|NCT01884285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431270|NCT01884272|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1431271|NCT01884259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431272|NCT01884246|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1431273|NCT01884233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431274|NCT01884220|||Cohort|||||||||
1431275|NCT01884207|||Cohort||Prospective|||||||
1431276|NCT01884194|||Cohort||Retrospective|||||||
1431277|NCT01884181|||Case-Control||Prospective|||||||
1431278|NCT01884168|||Cohort||Prospective|||||||
1431279|NCT01884155||Single Group Assignment||Treatment||None (Open Label)||allogeneic cord blood for stroke patients||||
1431280|NCT01884142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431281|NCT01884129|||Cohort||Prospective|||||||
1431282|NCT01884116|Randomized|Parallel Assignment||||Single|||||t|
1431283|NCT01884103|||Cohort||Prospective|||||||
1431284|NCT01884090|Randomized|Parallel Assignment||Prevention||Single|||t|||
1431285|NCT01884077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431286|NCT01884064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431287|NCT01884051|||Cohort||Prospective|||||||
1431288|NCT01884038|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1431289|NCT01884025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431290|NCT01884012|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1431291|NCT01883999||Single Group Assignment||Treatment||None (Open Label)||||||
1431292|NCT01883986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431293|NCT01883973|||Cohort||Prospective|||||||
1431294|NCT01883960|||Cohort||Prospective|||||||
1431295|NCT01883947|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1431296|NCT01883934|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1431297|NCT01883921|||Cohort||Prospective|||||||
1431298|NCT01883908|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431299|NCT01883895||Single Group Assignment||Treatment||None (Open Label)||three treatment design, all participants will perform two exercise sessions (isometric exercise, concentric exercise), as well as a control session in a randomized manner. (This is not a cross-over design as each participant will have their own randomized order of sessions of exercise & control sessions.)||||
1431300|NCT01883882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431301|NCT01883869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431302|NCT01883856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431303|NCT01883843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431304|NCT01883830|Randomized|Parallel Assignment||Treatment||Single||||||t
1431305|NCT01883817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431306|NCT01883804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1431307|NCT01883791|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1431308|NCT01883778|||Cohort||Cross-Sectional|||||||
1431309|NCT01883765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431310|NCT01883752|Randomized|Parallel Assignment||Treatment||Single||||||t
1431311|NCT01883739||Single Group Assignment||Supportive Care||Single||||||t
1431312|NCT01883726|Randomized|Parallel Assignment||Treatment||Single||||||t
1431313|NCT01883713|||Cohort||Prospective|||||||
1431314|NCT01883700|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1431315|NCT01883687|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431316|NCT01883674|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431317|NCT01883661||Single Group Assignment||Treatment||None (Open Label)||||||
1431318|NCT01883648|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1431319|NCT01883635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431320|NCT01883622|||Cohort||Retrospective|||||||
1431321|NCT01883609|Randomized|Parallel Assignment||Basic Science||Single||||||t
1431322|NCT01883596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431323|NCT01883583||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431324|NCT01883570|Randomized|Parallel Assignment||||Single|||||t|
1431325|NCT01883557||||||||||||
1431326|NCT01883544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431327|NCT01883531|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1431328|NCT01883518||Single Group Assignment||Treatment||None (Open Label)||||||
1431329|NCT01883505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431330|NCT01883492|Randomized|Parallel Assignment||Treatment||Single||||||t
1431331|NCT01883479|Randomized|Parallel Assignment||Prevention||Single||||||t
1431332|NCT01883466|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1431333|NCT01883453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431334|NCT01883440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431335|NCT01883427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431336|NCT01883414|Randomized|Parallel Assignment||Treatment||Single||||||t
1431337|NCT01883401|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431338|NCT01883388|||Cohort||Prospective|||||||
1431339|NCT01883375|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1431340|NCT01883362|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1431341|NCT01883349|||Case-Control||Prospective|||||||
1431342|NCT01883336|||Case-Only||Retrospective|||||||
1431343|NCT01883323||Single Group Assignment||Treatment||None (Open Label)||||||
1431344|NCT01883310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431345|NCT01883297||Single Group Assignment||Treatment||None (Open Label)||||||
1431346|NCT01883284|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1431347|NCT01883271|Randomized|Parallel Assignment||Other||Single||||||t
1431348|NCT01883258|Randomized|Parallel Assignment||Other||Single||||||t
1431349|NCT01883245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431350|NCT01883232|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1431351|NCT01883219||Single Group Assignment||Treatment||None (Open Label)||||||
1431352|NCT01883206|||Cohort||Other|||||||
1431353|NCT01883193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431354|NCT01883180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431355|NCT01883167|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1431356|NCT01883154||||||||||||
1431357|NCT01883141||Single Group Assignment||Treatment||None (Open Label)||||||
1431435|NCT01882127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431358|NCT01883128|Non-Randomized|Single Group Assignment||Diagnostic||Single||Whole-body MRI and Focal salvage therapy|||t|
1431359|NCT01883115|||Cohort||Prospective|||||||
1431360|NCT01883102|Non-Randomized|Factorial Assignment||Supportive Care||Double|||t||t|
1431361|NCT01883089||Single Group Assignment||Treatment||None (Open Label)||||||
1431362|NCT01883076||Single Group Assignment||Treatment||None (Open Label)||||||
1431363|NCT01883063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431364|NCT01883050|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431365|NCT01883037|||Cohort||Prospective|||||||
1431366|NCT01883024||Single Group Assignment||||None (Open Label)||||||
1431367|NCT01883011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431368|NCT01882998|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431369|NCT01882985||Single Group Assignment||Treatment||None (Open Label)||||||
1431370|NCT01882972|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1431371|NCT01882959|||||Prospective|||||||
1431372|NCT01882946||Single Group Assignment||Treatment||None (Open Label)||||||
1431373|NCT01882933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431374|NCT01882920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431375|NCT01882907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431376|NCT01882894|Randomized|Parallel Assignment||Treatment||Single||||||t
1431377|NCT01882881|Randomized|Crossover Assignment||Prevention||Single|||||t|
1431378|NCT01882868||Single Group Assignment||Treatment||None (Open Label)||||||
1431379|NCT01882855|||Case-Only||Cross-Sectional|||||||
1431380|NCT01882842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431381|NCT01882829||Single Group Assignment||Treatment||None (Open Label)||||||
1431382|NCT01882816||Single Group Assignment||Treatment||None (Open Label)||||||
1431383|NCT01882803||Single Group Assignment||Treatment||None (Open Label)||||||
1431384|NCT01882790|||Case-Only||Cross-Sectional|||||||
1431385|NCT01882777|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431386|NCT01882764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431387|NCT01882751|||Case-Control||Prospective|||||||
1431388|NCT01882738|||Cohort||Prospective|||||||
1431389|NCT01882725||Single Group Assignment||Treatment||None (Open Label)||||||
1431390|NCT01882712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431391|NCT01882699||Single Group Assignment||Treatment||None (Open Label)||||||
1431392|NCT01882686||Single Group Assignment||Treatment||None (Open Label)||||||
1431393|NCT01882673|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431394|NCT01882660||Single Group Assignment||Other||None (Open Label)||||||
1431395|NCT01882647|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431396|NCT01882634||Single Group Assignment||Screening||None (Open Label)||||||
1431397|NCT01882621|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1431398|NCT01882608|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431399|NCT01882595|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1431400|NCT01882582|||Cohort||Prospective|||||||
1431401|NCT01882569|||Cohort||Prospective|||||||
1431402|NCT01882556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431403|NCT01882543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431404|NCT01882530|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1431405|NCT01882517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431406|NCT01882504||Single Group Assignment||Treatment||None (Open Label)||||||
1431407|NCT01882491|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431408|NCT01882478|||Cohort||Prospective|||||||
1431409|NCT01882465|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1431410|NCT01882452|Randomized|Parallel Assignment||Treatment||Single||||||t
1431411|NCT01882439|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431412|NCT01882426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431413|NCT01882413|||Case-Only||Prospective|||||||
1431414|NCT01882400||Single Group Assignment||Prevention||None (Open Label)||||||
1431415|NCT01882387||Single Group Assignment||Supportive Care||None (Open Label)||||||
1431416|NCT01882374||Single Group Assignment||Supportive Care||None (Open Label)||||||
1431417|NCT01882361|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1431418|NCT01882348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431419|NCT01882335|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1431420|NCT01882322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431421|NCT01882309||||||||||||
1431422|NCT01882296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431423|NCT01882283|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1431424|NCT01882270|||Case-Only||Prospective|||||||
1431425|NCT01882257|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1431426|NCT01882244|Randomized|Crossover Assignment||Treatment||Single||||||t
1431427|NCT01882231||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431428|NCT01882218|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431429|NCT01882205|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1431430|NCT01882192|Randomized|Parallel Assignment||Prevention||Single|||||t|
1431431|NCT01882179|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431432|NCT01882166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431433|NCT01882153|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431434|NCT01882140|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431436|NCT01882114|||Cohort||Prospective|||||||
1431437|NCT01882101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431438|NCT01882088||Single Group Assignment||Treatment||None (Open Label)||||||
1431439|NCT01882075|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431440|NCT01882062||Single Group Assignment||Treatment||None (Open Label)||||||
1431441|NCT01882049||Single Group Assignment||Treatment||None (Open Label)||||||
1431442|NCT01882036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431443|NCT01882023|||Case Control||Cross-Sectional|||||||
1431444|NCT01882010|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431445|NCT01881997|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1431446|NCT01881984||Single Group Assignment||Treatment||None (Open Label)||||||
1431447|NCT01881971|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1431448|NCT01881958||Single Group Assignment||Treatment||None (Open Label)||||||
1431449|NCT01881945||Single Group Assignment||Basic Science||None (Open Label)||||||
1431450|NCT01881932|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1431451|NCT01881919|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1431452|NCT01881906|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1431453|NCT01881893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431454|NCT01881880||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431455|NCT01881867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431456|NCT01881854|||Cohort||Cross-Sectional|||||||
1431457|NCT01881841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431458|NCT01881828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431459|NCT01881815||||||||||||
1431460|NCT01881802|||Cohort||Cross-Sectional|||||||
1431461|NCT01881789|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431462|NCT01881776|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1431463|NCT01881763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431464|NCT01881750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431465|NCT01881737||Single Group Assignment||Treatment||None (Open Label)||||||
1431466|NCT01881724|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431467|NCT01881711|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1431468|NCT01881698|||Cohort||Prospective|||||||
1431469|NCT01881685|||Cohort||Prospective|||||||
1431470|NCT01881672|||Cohort||Prospective|||||||
1431471|NCT01881659|||Other||Prospective|||||||
1431472|NCT01881646||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431473|NCT01881633|Randomized|Parallel Assignment||||Double|||t||t|
1431474|NCT01881620||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431475|NCT01881607|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431476|NCT01881594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431477|NCT01881581|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431478|NCT01881568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431479|NCT01881555|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1431480|NCT01881542|||Cohort||Prospective|||||||
1431481|NCT01881529|||Cohort||Cross-Sectional|||||||
1431482|NCT01881516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431483|NCT01881503||Single Group Assignment||Treatment||None (Open Label)||||||
1431484|NCT01881490|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1431485|NCT01881477||Single Group Assignment||Treatment||None (Open Label)||||||
1431486|NCT01881464|||Cohort||Prospective|||||||
1431487|NCT01881451|||Case-Only||Prospective|||||||
1431488|NCT01881438|||||Retrospective|||||||
1431489|NCT01881425|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431490|NCT01881412|Randomized|Parallel Assignment||Treatment||Single||||||t
1431491|NCT01881399||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431492|NCT01881386|||Cohort||Prospective|||||||
1431493|NCT01881373|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431494|NCT01881360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431495|NCT01881347|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1431496|NCT01881334||||||||||||
1431497|NCT01881321|Randomized|Parallel Assignment||Prevention||Single||||||t
1431498|NCT01881308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431499|NCT01881295|Randomized|Crossover Assignment||Other||Single|||t|||
1431500|NCT01881282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431501|NCT01881269|||Cohort||Prospective|||||||
1431502|NCT01881256|||Cohort||Prospective|||||||
1431503|NCT01881243|||Cohort||Prospective|||||||
1431504|NCT01881230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431505|NCT01881217|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431506|NCT01881204|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1431507|NCT01881191|||Case Control||Prospective|||||||
1431508|NCT01881178|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1431509|NCT01881165|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1431510|NCT01881152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431511|NCT01881139||Single Group Assignment||Health Services Research||None (Open Label)||||||
1431512|NCT01881126|Randomized|Parallel Assignment||Treatment||Single|||||t|
1431513|NCT01881113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431514|NCT01881100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431515|NCT01881087|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431516|NCT01881074|||Cohort||Prospective|||||||
1431517|NCT01881061|||Case Control||Prospective|||||||
1431518|NCT01881048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431519|NCT01881035||Single Group Assignment||Treatment||None (Open Label)||||||
1431520|NCT01881022|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431521|NCT01881009|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431522|NCT01880996|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431523|NCT01880983|||Cohort||Prospective|||||||
1431524|NCT01880970|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1431525|NCT01880957|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1431526|NCT01880944|||Cohort||Prospective|||||||
1431527|NCT01880931|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1431528|NCT01880918|||||Retrospective|||||||
1431529|NCT01880905|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1431530|NCT01880892||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431531|NCT01880879||Single Group Assignment||Treatment||None (Open Label)||||||
1431532|NCT01880866||Single Group Assignment||Treatment||None (Open Label)||||||
1431533|NCT01880853|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1431534|NCT01880840|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1431535|NCT01880827|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1431536|NCT01880814|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1431537|NCT01880801|||Cohort||Prospective|||||||
1431538|NCT01880788|||Case Control||Prospective|||||||
1431539|NCT01880775|Randomized|Parallel Assignment||||None (Open Label)||||||
1431540|NCT01880762|||Case-Only||Prospective|||||||
1431541|NCT01880749||Single Group Assignment||Other||None (Open Label)||||||
1431542|NCT01880736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431543|NCT01880723|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1431544|NCT01880710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431545|NCT01880697||Single Group Assignment||Prevention||None (Open Label)||||||
1431546|NCT01880684|||Cohort||Prospective|||||||
1431547|NCT01880671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431548|NCT01880658||Single Group Assignment||Treatment||None (Open Label)||||||
1431549|NCT01880645||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431550|NCT01880632||Single Group Assignment||Treatment||None (Open Label)||||||
1431551|NCT01880619|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431552|NCT01880606|||Case-Only||Prospective|||||||
1431553|NCT01880593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431554|NCT01880580|||Cohort||Prospective|||||||
1431555|NCT01880567||Single Group Assignment||Treatment||None (Open Label)||||||
1431556|NCT01880554||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431557|NCT01880541|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1431558|NCT01880528|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1431559|NCT01880515|Randomized|Parallel Assignment||Treatment||Single|||||t|
1431560|NCT01880502|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1431561|NCT01880489|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431562|NCT01880476||Single Group Assignment||Health Services Research||None (Open Label)||||||
1431563|NCT01880463|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1431564|NCT01880450|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1431565|NCT01880437||Single Group Assignment||Treatment||None (Open Label)||||||
1431566|NCT01880424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431567|NCT01880411||Single Group Assignment||Treatment||None (Open Label)||||||
1431568|NCT01880398|||Case-Only||Prospective|||||||
1431569|NCT01880385||Single Group Assignment||Treatment||None (Open Label)||||||
1431570|NCT01880372|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1431571|NCT01880359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431572|NCT01880346|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1431573|NCT01880333||Single Group Assignment||Treatment||None (Open Label)||||||
1431574|NCT01880320|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431575|NCT01880307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431576|NCT01880294|||Cohort||Cross-Sectional|||||||
1431577|NCT01880281|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1431578|NCT01880268|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431579|NCT01880255|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431580|NCT01880242|||Other||Prospective|||||||
1431581|NCT01880229|||Case-Control||Prospective|||||||
1431582|NCT01880216|Randomized|Parallel Assignment||Treatment||Single||||||t
1431583|NCT01880203||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431584|NCT01880190|Randomized|Parallel Assignment||||Double|||t|||t
1431585|NCT01880177|||||Cross-Sectional|||||||
1431586|NCT01880164|||Cohort||Prospective|||||||
1431587|NCT01880151|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1431588|NCT01880138|Randomized|Parallel Assignment||||Single|||t|||
1431589|NCT01880125|Randomized|Crossover Assignment||||None (Open Label)||||||
1431590|NCT01880112|Randomized|Parallel Assignment||Basic Science||Single||||||t
1431591|NCT01880099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431592|NCT01880086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431593|NCT01880073||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431594|NCT01880060|Randomized|Single Group Assignment||Treatment||Single|||t|||
1431595|NCT01880047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431596|NCT01880034|||Other||Other|||||||
1431597|NCT01880021|||Case-Only||Prospective|||||||
1431598|NCT01880008|||Case-Only||Prospective|||||||
1431599|NCT01879995|||Cohort||Cross-Sectional|||||||
1431600|NCT01879982|||Cohort||Prospective|||||||
1431601|NCT01879969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431602|NCT01879956|Randomized|Parallel Assignment||Treatment||Single||||||t
1431603|NCT01879943||Single Group Assignment||Diagnostic||Single||||||t
1431604|NCT01879930|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431605|NCT01879917|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431606|NCT01879904||Single Group Assignment||Treatment||None (Open Label)||||||
1431607|NCT01879891|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1431608|NCT01879878|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431609|NCT01879865|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1431610|NCT01879852|Randomized|Parallel Assignment||Treatment||Single||||||t
1431611|NCT01879839|Randomized|Parallel Assignment||Prevention||None (Open Label)||One arm with controlled diet, second arm as control group with no diet.||||
1431612|NCT01879826|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1431613|NCT01879813|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1431614|NCT01879800|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431615|NCT01879787|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431616|NCT01879774||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431617|NCT01879761|||Cohort||Prospective|||||||
1431618|NCT01879748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431619|NCT01879735|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1431620|NCT01879722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431621|NCT01879709|Randomized|Parallel Assignment||||Single||||||t
1431622|NCT01879696|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431623|NCT01879683||Single Group Assignment||Treatment||None (Open Label)||||||
1431624|NCT01879670|||Case Control||Prospective|||||||
1431625|NCT01879657||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431626|NCT01879644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431627|NCT01879631|||Case-Only||Retrospective|||||||
1431628|NCT01879618||Single Group Assignment||Treatment||None (Open Label)||||||
1431629|NCT01879605|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1431630|NCT01879592|||Case-Control||Cross-Sectional|||||||
1431631|NCT01879579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431632|NCT01879566|||Case-Only||Prospective|||||||
1431633|NCT01879553|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1431634|NCT01879540|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1431635|NCT01879527|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431636|NCT01879514|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1431637|NCT01879501|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1431638|NCT01879488|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431639|NCT01879475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431640|NCT01879462|Randomized|Crossover Assignment||Treatment||Single|||t|||
1431641|NCT01879449|||Cohort||Cross-Sectional|||||||
1431642|NCT01879436|||Other||Other|||||||
1431643|NCT01879423|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431644|NCT01879410|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431645|NCT01879397|||Cohort||Prospective|||||||
1431646|NCT01879384||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431647|NCT01879371|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431648|NCT01879358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431649|NCT01879345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431650|NCT01879332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431651|NCT01879319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431652|NCT01879293|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1431653|NCT01879280|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431654|NCT01879267|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431655|NCT01879254|||Case-Only||Prospective|||||||
1431656|NCT01879241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431657|NCT01879228|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1431658|NCT01879215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431659|NCT01879202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431660|NCT01879189|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1431661|NCT01879176|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431662|NCT01879163|Randomized|Parallel Assignment||Prevention||Single|||t|||
1431663|NCT01879150||Single Group Assignment||Treatment||None (Open Label)||||||
1431664|NCT01879137|||Cohort||Prospective|||||||
1431665|NCT01879124|||Cohort||Prospective|||||||
1431666|NCT01879111|Randomized|Factorial Assignment||Screening||Single||||||t
1431667|NCT01879098|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1431668|NCT01879085||Single Group Assignment||Treatment||None (Open Label)||||||
1431669|NCT01879072|||Cohort||Prospective|||||||
1431670|NCT01879059||Single Group Assignment||Basic Science||None (Open Label)||||||
1431671|NCT01879046||Single Group Assignment||Other||None (Open Label)||||||
1431672|NCT01879033|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1431673|NCT01879020|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1431674|NCT01879007|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431675|NCT01878994|Randomized|Parallel Assignment||Prevention||Single||||||t
1431676|NCT01878981|||Case Control||Prospective|||||||
1431677|NCT01878968|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1431678|NCT01878955|||Other||Prospective|||||||
1431679|NCT01878942||Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1431680|NCT01878929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431681|NCT01878916|||Cohort||Prospective|||||||
1431682|NCT01878903|||Case-Only||Prospective|||||||
1431683|NCT01878890||Single Group Assignment||Treatment||None (Open Label)||||||
1431684|NCT01878877|||Ecologic or Community||Cross-Sectional|||||||
1431685|NCT01878864|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431686|NCT01878851|||Case-Only||Prospective|||||||
1431687|NCT01878838|Randomized|Crossover Assignment||Treatment||Single|||t|||
1431688|NCT01878825|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431689|NCT01878812|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431690|NCT01878799||Single Group Assignment||Treatment||None (Open Label)||||||
1431691|NCT01878786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431692|NCT01878773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431693|NCT01878760|||Cohort||Prospective|||||||
1431694|NCT01878747|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431695|NCT01878734|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431696|NCT01878721|||Case-Only||Prospective|||||||
1431697|NCT01878708||Single Group Assignment||Treatment||None (Open Label)||||||
1431698|NCT01878695||Single Group Assignment||Treatment||None (Open Label)||||||
1431699|NCT01878682|||Cohort||Prospective|||||||
1431700|NCT01878669|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1431701|NCT01878656|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1431702|NCT01878643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431703|NCT01878630|Randomized|Parallel Assignment||Treatment||None (Open Label)||Remote patient management with telemedical devices (ECG, scale, blood-pressure device)||||
1431704|NCT01878617|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431705|NCT01878604|||Case-Only||Retrospective|||||||
1431706|NCT01878591|||Cohort||Prospective|||||||
1431707|NCT01878578|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1431708|NCT01878565|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431709|NCT01878552|||Cohort||Prospective|||||||
1431710|NCT01878539||Single Group Assignment||Prevention||None (Open Label)||||||
1431711|NCT01878526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431712|NCT01878513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431713|NCT01878500||Single Group Assignment||Treatment||None (Open Label)||||||
1431714|NCT01878487||Single Group Assignment||Treatment||None (Open Label)||||||
1431715|NCT01878474|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1431716|NCT01878461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431717|NCT01878448||Single Group Assignment||Treatment||None (Open Label)||||||
1431718|NCT01878435|Randomized|Parallel Assignment||||None (Open Label)||||||
1431719|NCT01878422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431720|NCT01878409|||Case Control||Cross-Sectional|||||||
1431721|NCT01878396|||Cohort||Prospective|||||||
1431722|NCT01878383|||Cohort||Prospective|||||||
1431723|NCT01878370|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1431724|NCT01878357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431725|NCT01878344|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1431726|NCT01878331|||Other||Prospective|||||||
1431727|NCT01878318||Single Group Assignment||Treatment||None (Open Label)||||||
1431728|NCT01878305|||Case-Only||Prospective|||||||
1431729|NCT01878292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431730|NCT01878279|||Cohort||Prospective|||||||
1431731|NCT01878266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431732|NCT01878253||Single Group Assignment||Treatment||None (Open Label)||||||
1431733|NCT01878240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431734|NCT01878227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431735|NCT01878214|Randomized|Parallel Assignment||Prevention||Single|||t|||
1431736|NCT01878201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431737|NCT01878188|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431738|NCT01878175||Single Group Assignment||Treatment||None (Open Label)||||||
1431739|NCT01878162||Single Group Assignment||Prevention||None (Open Label)||||||
1431740|NCT01878149|||Cohort||Retrospective|||||||
1431741|NCT01878136|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1431742|NCT01878123|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1431743|NCT01878110||Single Group Assignment||Treatment||None (Open Label)||||||
1431744|NCT01878097|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431745|NCT01878084|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431746|NCT01878071|||||Cross-Sectional|||||||
1431747|NCT01878058||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431748|NCT01878045|||Case-Only||Prospective|||||||
1431749|NCT01878032|||Case-Control||Prospective|||||||
1431750|NCT01878019|||||Prospective|||||||
1431831|NCT01876966|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1431751|NCT01878006|Randomized|Crossover Assignment||Other||Double|Bliniding|Crossover study - participants receive active and placebo treatments in randomized order.|t||t|
1431752|NCT01877993|||Cohort||Cross-Sectional|||||||
1431753|NCT01877980|||Case-Only||Prospective|||||||
1431754|NCT01877967|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1431755|NCT01877954|||Cohort||Retrospective|||||||
1431756|NCT01877941||Single Group Assignment||Diagnostic||Single||||||t
1431757|NCT01877928|Randomized|Parallel Assignment||Treatment||Single||||||t
1431758|NCT01877915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431759|NCT01877902|||Cohort||Retrospective|||||||
1431760|NCT01877889|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1431761|NCT01877876|||||Prospective|||||||
1431762|NCT01877863||Single Group Assignment||Treatment||None (Open Label)||||||
1431763|NCT01877850|||Case Control||Prospective|||||||
1431764|NCT01877837||Single Group Assignment||Treatment||None (Open Label)||||||
1431765|NCT01877824|Randomized|Parallel Assignment||||Single||||||t
1431766|NCT01877811||Single Group Assignment||Treatment||None (Open Label)||||||
1431767|NCT01877798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431768|NCT01877785|Randomized|Parallel Assignment||||Double|||t||t|
1431769|NCT01877772|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431770|NCT01877759||Single Group Assignment||Treatment||None (Open Label)||||||
1431771|NCT01877746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431772|NCT01877733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431773|NCT01877720|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431774|NCT01877707||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431775|NCT01877694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431776|NCT01877681|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431777|NCT01877668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431778|NCT01877655|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1431779|NCT01877642|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1431780|NCT01877629|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1431781|NCT01877616||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431782|NCT01877603|||Case Control||Cross-Sectional|||||||
1431783|NCT01877590|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1431784|NCT01877577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431785|NCT01877564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431786|NCT01877551|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1431787|NCT01877538|||||Cross-Sectional|||||||
1431788|NCT01877525|||Cohort||Prospective|||||||
1431789|NCT01877512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431790|NCT01877499|||Cohort||Prospective|||||||
1431791|NCT01877486|||Case-Only||Prospective|||||||
1431792|NCT01877473|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431793|NCT01877460|Randomized|Crossover Assignment||Prevention||Single|||t|||
1431794|NCT01877447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431795|NCT01877434|||Case-Only||Prospective|||||||
1431796|NCT01877421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431797|NCT01877408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431798|NCT01877395|Randomized|Parallel Assignment||Prevention||Single||||||t
1431799|NCT01877382||Single Group Assignment||Treatment||None (Open Label)||||||
1431800|NCT01877369||||||||||||
1431801|NCT01877356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431802|NCT01877343||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431803|NCT01877330|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431804|NCT01877317||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431805|NCT01877304|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431806|NCT01877291|||Cohort||Cross-Sectional|||||||
1431807|NCT01877278|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431808|NCT01877265|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1431809|NCT01877252|||Cohort||Prospective|||||||
1431810|NCT01877239|||Other||Prospective|||||||
1431811|NCT01877226||Single Group Assignment||Treatment||None (Open Label)||||||
1431812|NCT01877213|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431813|NCT01877200|||Ecologic or Community||Cross-Sectional|||||||
1431814|NCT01877187||Single Group Assignment||Other||None (Open Label)||||||
1431815|NCT01877174|||||Prospective|||||||
1431816|NCT01877161|Randomized|Crossover Assignment||Treatment||Single|||t|||
1431817|NCT01877148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431818|NCT01877135|||Cohort|||||||||
1431819|NCT01877122|Randomized|Parallel Assignment||||Single|||t|||
1431820|NCT01877109|||Cohort||Prospective|||||||
1431821|NCT01877096|Randomized|Parallel Assignment||||None (Open Label)||||||
1431822|NCT01877083||Single Group Assignment||Treatment||None (Open Label)||||||
1431823|NCT01877070|||Family-Based||Prospective|||||||
1431824|NCT01877057||Single Group Assignment||Prevention||None (Open Label)||||||
1431825|NCT01877044|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431826|NCT01877031|Randomized|Parallel Assignment||Other||Single|||t|||
1431827|NCT01877018|Randomized|Parallel Assignment||Screening||Single|||t|||
1431828|NCT01877005||Single Group Assignment||Treatment||None (Open Label)||||||
1431829|NCT01876992|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1431830|NCT01876979|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1432452|NCT01868854|||Cohort||Prospective|||||||
1431832|NCT01876953||Single Group Assignment||Treatment||None (Open Label)||||||
1431833|NCT01876940|Randomized|Parallel Assignment||||None (Open Label)||||||
1431834|NCT01876927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431835|NCT01876914|||Case-Only||Prospective|||||||
1431836|NCT01876901|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431837|NCT01876888|||Cohort||Prospective|||||||
1431838|NCT01876875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431839|NCT01876862||Single Group Assignment||||None (Open Label)||||||
1431840|NCT01876849||Single Group Assignment||Treatment||None (Open Label)||||||
1431841|NCT01876836|Randomized|Crossover Assignment||||Single|||t|||
1431842|NCT01876823||Single Group Assignment||Treatment||None (Open Label)||||||
1431843|NCT01876810|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1431844|NCT01876797|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431845|NCT01876784|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431846|NCT01876771||Single Group Assignment||Treatment||None (Open Label)||||||
1431847|NCT01876758|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431848|NCT01876745|||Cohort||Retrospective|||||||
1431849|NCT01876732||Single Group Assignment||||None (Open Label)||||||
1431850|NCT01876719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431851|NCT01876706||Single Group Assignment||Treatment||None (Open Label)||||||
1431852|NCT01876693|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431853|NCT01876680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431854|NCT01876667|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431855|NCT01876654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431856|NCT01876641||Single Group Assignment||Treatment||None (Open Label)||||||
1431857|NCT01876628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431858|NCT01876615|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1431859|NCT01876602|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1431860|NCT01876589|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431861|NCT01876576|Randomized|Parallel Assignment||||Single|||||t|
1431862|NCT01876563|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431863|NCT01876550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431864|NCT01876537|Randomized|Parallel Assignment||Treatment||||||||
1431865|NCT01876524|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1431866|NCT01876511|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431867|NCT01876498|||Cohort||Prospective|||||||
1431868|NCT01876485|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1431869|NCT01876472|||Cohort||Prospective|||||||
1431870|NCT01876459|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1431871|NCT01876446||Single Group Assignment||Treatment||None (Open Label)||||||
1431872|NCT01876433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431873|NCT01876420||Single Group Assignment||Treatment||None (Open Label)||||||
1431874|NCT01876407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431875|NCT01876394|Randomized|Crossover Assignment||||Triple|||t||t|t
1431876|NCT01876381||Single Group Assignment||Treatment||None (Open Label)||||||
1431877|NCT01876368|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431878|NCT01876355|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431879|NCT01876342|Randomized|Parallel Assignment||Treatment||Single||||||t
1431880|NCT01876329|||Case Control||Cross-Sectional|||||||
1431881|NCT01876316|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1431882|NCT01876303|||Family-Based||Retrospective|||||||
1431883|NCT01876290|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1431884|NCT01876277|||Cohort||Cross-Sectional|||||||
1431885|NCT01876264|Randomized|Parallel Assignment||Treatment||Single||||||t
1431886|NCT01876251||||Treatment||None (Open Label)||||||
1431887|NCT01876238|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1431888|NCT01876225|Randomized|Crossover Assignment||Treatment||Single|||t|||
1431889|NCT01876212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431890|NCT01876199|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431891|NCT01876186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431892|NCT01876173|Randomized|Parallel Assignment||Health Services Research||||||||
1431893|NCT01876160|Randomized|Parallel Assignment||||Single||||||t
1431894|NCT01876147|||Case-Crossover||Prospective|||||||
1431895|NCT01876134|||Cohort||Prospective|||||||
1431896|NCT01876121|||Case-Only||Prospective|||||||
1431897|NCT01876108|Randomized|Parallel Assignment||Treatment||Double||||t||t
1431898|NCT01876095|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1431899|NCT01876082|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431900|NCT01876069|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1431901|NCT01876056|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431902|NCT01876043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1431903|NCT01876030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431904|NCT01876017||Single Group Assignment||Treatment||None (Open Label)||||||
1431905|NCT01876004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431906|NCT01875991|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431907|NCT01875978|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1431908|NCT01875965|||Case Control||Prospective|||||||
1431909|NCT01875952||Single Group Assignment||Prevention||None (Open Label)||||||
1431910|NCT01875939|Randomized|Crossover Assignment||||None (Open Label)||||||
1431911|NCT01875926|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431912|NCT01875913|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1431913|NCT01875900|Randomized|Parallel Assignment||Other||Single||||||t
1431914|NCT01875887|||Case-Only||Retrospective|||||||
1431915|NCT01875874||Single Group Assignment||Treatment||None (Open Label)||||||
1431916|NCT01875861|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1431917|NCT01875848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431918|NCT01875835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431919|NCT01875822||Single Group Assignment||Treatment||None (Open Label)||||||
1431920|NCT01875809|||Case Control||Prospective|||||||
1431921|NCT01875796|Randomized|Parallel Assignment||Treatment||Single||||||t
1431922|NCT01875783||Single Group Assignment||Diagnostic||Double|Primary diabetes care specialists masked to results of OCT intervention|||t|t|
1431923|NCT01875770|||Cohort||Prospective|||||||
1431924|NCT01875757|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1431925|NCT01875744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431926|NCT01875731|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1431927|NCT01875718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431928|NCT01875705|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1431929|NCT01875692|||Cohort||Prospective|||||||
1431930|NCT01875679|Randomized|Parallel Assignment||||Single|||||t|
1431931|NCT01875666|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1431932|NCT01875653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431933|NCT01875640|||Other||Prospective|||||||
1431934|NCT01875627|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1431935|NCT01875614||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431936|NCT01875601|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431937|NCT01875588|||||Retrospective|||||||
1431938|NCT01875575|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1431939|NCT01875562||Single Group Assignment||Treatment||None (Open Label)||||||
1431940|NCT01875549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431941|NCT01875536|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1431942|NCT01875523|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1431943|NCT01875510|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1431944|NCT01875497||Single Group Assignment||Basic Science||Double|||t||t|
1431945|NCT01875484|||Cohort||Prospective|||||||
1431946|NCT01875471|Randomized|Parallel Assignment||Other||Single|||t|||
1431947|NCT01875458|||Ecologic or Community||Prospective|||||||
1431948|NCT01875445|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1431949|NCT01875419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431950|NCT01875406||Single Group Assignment||Supportive Care||None (Open Label)||||||
1431951|NCT01875393||Single Group Assignment||Treatment||None (Open Label)||||||
1431952|NCT01875380||Single Group Assignment||Treatment||None (Open Label)||||||
1431953|NCT01875367|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431954|NCT01875354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431955|NCT01875341|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1431956|NCT01875328|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431957|NCT01875315||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431958|NCT01875302|||Case-Only||Cross-Sectional|||||||
1431959|NCT01875289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431960|NCT01875276|||Cohort||Retrospective|||||||
1431961|NCT01875263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431962|NCT01875250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431963|NCT01875237||Single Group Assignment||Treatment||None (Open Label)||||||
1431964|NCT01875224|Randomized|Parallel Assignment||||None (Open Label)||||||
1431965|NCT01875198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431966|NCT01875185||Single Group Assignment||Diagnostic||None (Open Label)||||||
1431967|NCT01875172|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431968|NCT01875159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431969|NCT01875146|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431970|NCT01875133|Randomized|Crossover Assignment||||None (Open Label)||||||
1431971|NCT01875120|||Cohort||Prospective|||||||
1431972|NCT01875107||Single Group Assignment||Treatment||None (Open Label)||||||
1431973|NCT01875094|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1431974|NCT01875081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431975|NCT01875068|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1431976|NCT01875055|Randomized|Crossover Assignment||Treatment||Single||||t||
1431977|NCT01875042|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431978|NCT01875029|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1431979|NCT01875016||Single Group Assignment||Treatment||None (Open Label)||||||
1431980|NCT01875003|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1431981|NCT01874990|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1431982|NCT01874977|Randomized|Parallel Assignment||Treatment||Single|||t|||
1431983|NCT01874964|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1431984|NCT01874951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1431985|NCT01874938||Single Group Assignment||Treatment||None (Open Label)||||||
1431986|NCT01874925||||||||||||
1431987|NCT01874912|||Cohort||Cross-Sectional|||||||
1431988|NCT01874899|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1431989|NCT01874886|||Case-Control||Cross-Sectional|||||||
1431990|NCT01874873||Single Group Assignment||Treatment||None (Open Label)||||||
1431991|NCT01874860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431992|NCT01874847|Randomized|Parallel Assignment||Treatment||Quadruple|Double blinded|Placebo controlled|t|t|t|t
1431993|NCT01874834|Randomized|Factorial Assignment||Diagnostic||Double|||t||t|
1431994|NCT01874821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1431995|NCT01874808||||||||||||
1431996|NCT01874795|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1431997|NCT01874782||Single Group Assignment||Treatment||None (Open Label)||||||
1431998|NCT01874769|||Cohort|||||||||
1431999|NCT01874756|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432000|NCT01874743||Single Group Assignment||||None (Open Label)||||||
1432001|NCT01874730|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432002|NCT01874717|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432003|NCT01874704||Parallel Assignment||Screening||Single|||t|||
1432004|NCT01874691|||Case-Only||Prospective|||||||
1432005|NCT01874678||Single Group Assignment||Treatment||None (Open Label)||||||
1432006|NCT01874665|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432007|NCT01874652||Single Group Assignment||||None (Open Label)||||||
1432008|NCT01874639|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432009|NCT01874626|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432010|NCT01874613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432011|NCT01874600|||Cohort||Prospective|||||||
1432012|NCT01874587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432013|NCT01874574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432014|NCT01874561|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432015|NCT01874548|||Case Control||Prospective|||||||
1432016|NCT01874535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432017|NCT01874522|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432018|NCT01874509|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432019|NCT01874496|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1432020|NCT01874483|Randomized|Parallel Assignment||Treatment||Double||||||
1432021|NCT01874470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432022|NCT01874457|||||Prospective|||||||
1432023|NCT01874444|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1432024|NCT01874431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432025|NCT01874418||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432026|NCT01874405|||Case-Only||Retrospective|||||||
1432027|NCT01874392||Single Group Assignment||Treatment||None (Open Label)||||||
1432028|NCT01874379|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432029|NCT01874366|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432030|NCT01874353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432031|NCT01874340|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432032|NCT01874327|Randomized|Parallel Assignment||Treatment||Single||||t||
1432033|NCT01874314|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432034|NCT01874301|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432035|NCT01874288|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1432036|NCT01874275|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1432037|NCT01874262|Randomized|Parallel Assignment||||None (Open Label)||||||
1432038|NCT01874249|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1432039|NCT01874236|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1432040|NCT01874223|||Case-Only||Prospective|||||||
1432041|NCT01874210|||Case Control||Cross-Sectional|||||||
1432042|NCT01874197||Single Group Assignment||Treatment||None (Open Label)||||||
1432043|NCT01874184|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1432044|NCT01874171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432045|NCT01874158|||Cohort||Prospective|||||||
1432046|NCT01874145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432047|NCT01874132|Randomized|Parallel Assignment||Prevention||Single|||t|||
1432048|NCT01874119|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1432049|NCT01874106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432050|NCT01874093|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1432051|NCT01874080|Randomized|Crossover Assignment||||None (Open Label)||||||
1432052|NCT01874067|||Case-Only||Prospective|||||||
1432053|NCT01874054||Single Group Assignment||Treatment||None (Open Label)||||||
1432054|NCT01874041|Randomized|Parallel Assignment||Treatment||Single||||||t
1432055|NCT01874028||Single Group Assignment||Treatment||None (Open Label)||||||
1432056|NCT01874015|Randomized|Parallel Assignment||Treatment||Single|||||t|
1432057|NCT01874002|||Cohort||Prospective|||||||
1432058|NCT01873989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432059|NCT01873976|||Cohort||Prospective|||||||
1432060|NCT01873963|||Cohort||Prospective|||||||
1432061|NCT01873950|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1432062|NCT01873937|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432063|NCT01873924|||Cohort||Prospective|||||||
1432064|NCT01873911|||Cohort||Prospective|||||||
1432065|NCT01873898||Single Group Assignment||Supportive Care||None (Open Label)||||||
1432066|NCT01873885|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1432067|NCT01873872|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432068|NCT01873859|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432069|NCT01873846||||||||||||
1432070|NCT01873833||Single Group Assignment||Treatment||None (Open Label)||||||
1432071|NCT01873820|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1432072|NCT01873807|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432073|NCT01873794|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1432074|NCT01873781|||Cohort||Prospective|||||||
1432075|NCT01873768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432076|NCT01873755||Single Group Assignment||Health Services Research||None (Open Label)||||||
1432077|NCT01873742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432078|NCT01873729||Single Group Assignment||Treatment||None (Open Label)||||||
1432079|NCT01873716|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1432080|NCT01873703|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432081|NCT01873690|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1432082|NCT01873677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432083|NCT01873664||Single Group Assignment||Prevention||None (Open Label)||||||
1432084|NCT01873651||Single Group Assignment||Treatment||None (Open Label)||||||
1432085|NCT01873638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432086|NCT01873625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432087|NCT01873612|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1432088|NCT01873599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432089|NCT01873586||Single Group Assignment||Treatment||None (Open Label)||||||
1432090|NCT01873573|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432091|NCT01873560|||Cohort||Prospective|||||||
1432092|NCT01873547|Randomized|Parallel Assignment||Treatment||Single||cell therapy or rehabitation treatment||||t
1432093|NCT01873534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432094|NCT01873521|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432095|NCT01873508|Randomized|Crossover Assignment||||None (Open Label)||||||
1432096|NCT01873495||Single Group Assignment||Treatment||None (Open Label)||||||
1432097|NCT01873482||Single Group Assignment||Supportive Care||None (Open Label)||||||
1432098|NCT01873469|||Cohort||Prospective|||||||
1432099|NCT01873456|Randomized|Parallel Assignment||Treatment||Single||||||t
1432100|NCT01873443||Single Group Assignment||Treatment||None (Open Label)||||||
1432101|NCT01873430|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1432102|NCT01873417||Single Group Assignment||Treatment||None (Open Label)||||||
1432103|NCT01873404|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432104|NCT01873391|Randomized|Parallel Assignment||||Single|||t|||
1432105|NCT01873378|Randomized|Parallel Assignment||Treatment||Single|||||t|
1432106|NCT01873365|||Cohort||Prospective|||||||
1432107|NCT01873352|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432108|NCT01873339||Single Group Assignment||Treatment||None (Open Label)||||||
1432109|NCT01873326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432110|NCT01873313|||Case-Only||Prospective|||||||
1432111|NCT01873300||Single Group Assignment||Treatment||None (Open Label)||||||
1432112|NCT01873287|||Cohort||Prospective|||||||
1432113|NCT01873274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432114|NCT01873261|||Cohort||Prospective|||||||
1432115|NCT01873248||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432116|NCT01873235|||Cohort||Prospective|||||||
1432117|NCT01873222|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432118|NCT01873196|Randomized|Parallel Assignment||||None (Open Label)||||||
1432119|NCT01873183|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432120|NCT01873170|||Cohort||Prospective|||||||
1432121|NCT01873157|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432122|NCT01873144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432123|NCT01873131|Randomized|Parallel Assignment||Prevention||Single||||||t
1432124|NCT01873118|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1432125|NCT01873105||Single Group Assignment||||None (Open Label)||||||
1432126|NCT01873092|||Cohort||Prospective|||||||
1432127|NCT01873079|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432128|NCT01873066|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432129|NCT01873053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432130|NCT01873040|Randomized|Parallel Assignment||Prevention||Single||||||t
1432131|NCT01873027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432132|NCT01873014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432133|NCT01873001||Single Group Assignment||Treatment||None (Open Label)||||||
1432134|NCT01872988|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432135|NCT01872975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432136|NCT01872962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432137|NCT01872949|||Case-Only||Prospective|||||||
1432138|NCT01872936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432139|NCT01872923||Single Group Assignment||Treatment||None (Open Label)||||||
1432140|NCT01872910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433393|NCT01856504|||Cohort||Prospective|||||||
1432141|NCT01872897|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432142|NCT01872884|Randomized|Parallel Assignment||Prevention||Single||||||t
1432143|NCT01872871|Randomized|Single Group Assignment||Supportive Care||Triple||||t|t|t
1432144|NCT01872858|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432145|NCT01872845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432146|NCT01872832|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432147|NCT01872819||Single Group Assignment||Treatment||None (Open Label)||||||
1432148|NCT01872806||Single Group Assignment||||Single|||t|||
1432149|NCT01872793|||Cohort||Prospective|||||||
1432150|NCT01872780|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1432151|NCT01872767|||Cohort||Prospective|||||||
1432152|NCT01872754|Randomized|Single Group Assignment||Treatment||Single||||t||
1432153|NCT01872741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432154|NCT01872728|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432155|NCT01872715||Single Group Assignment||Treatment||None (Open Label)||||||
1432156|NCT01872702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432157|NCT01872689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432158|NCT01872676|Randomized|Parallel Assignment||Treatment||Single||||||t
1432159|NCT01872663|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1432160|NCT01872650|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1432161|NCT01872637|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432162|NCT01872624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432163|NCT01872611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432164|NCT01872598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432165|NCT01872585||Single Group Assignment||Treatment||None (Open Label)||||||
1432166|NCT01872572|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1432167|NCT01872559|||Cohort||Prospective|||||||
1432168|NCT01872546||||||||||||
1432169|NCT01872533||Single Group Assignment||Prevention||None (Open Label)||||||
1432170|NCT01872520|||Cohort||Prospective|||||||
1432171|NCT01872507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432172|NCT01872494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432173|NCT01872481|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432174|NCT01872468|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432175|NCT01872455|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432176|NCT01872442||||||||||||
1432177|NCT01872429|||Cohort||Retrospective|||||||
1432178|NCT01872416||Single Group Assignment||Treatment||None (Open Label)||||||
1432179|NCT01872403||Single Group Assignment||Treatment||None (Open Label)||||||
1432180|NCT01872390|Randomized|Parallel Assignment||||None (Open Label)||||||
1432181|NCT01872377||Single Group Assignment||Treatment||None (Open Label)||||||
1432182|NCT01872364|||Cohort||Retrospective|||||||
1432183|NCT01872351|||Case-Only||Retrospective|||||||
1432184|NCT01872338|Randomized|Parallel Assignment||Treatment||Single||||||t
1432185|NCT01872325|||Cohort||Prospective|||||||
1432186|NCT01872312||Single Group Assignment||||None (Open Label)||||||
1432187|NCT01872299|||Cohort||Prospective|||||||
1432188|NCT01872286|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1432189|NCT01872273|||Case-Only||Prospective|||||||
1432190|NCT01872260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432191|NCT01872247|||Cohort||Prospective|||||||
1432192|NCT01872234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432193|NCT01872221||Single Group Assignment||Other||None (Open Label)||||||
1432194|NCT01872208||Single Group Assignment||Treatment||None (Open Label)||||||
1432195|NCT01872195|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432196|NCT01872182|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432197|NCT01872169||Single Group Assignment||Screening||None (Open Label)||||||
1432198|NCT01872156|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432199|NCT01872143||Single Group Assignment||Treatment||None (Open Label)||||||
1432200|NCT01872130|||Cohort||Prospective|||||||
1432201|NCT01872117|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1432202|NCT01872104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432203|NCT01872091|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1432204|NCT01872078|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1432205|NCT01872065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432206|NCT01872052||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432207|NCT01872039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432208|NCT01872026|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1432209|NCT01872013|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1432210|NCT01872000|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432211|NCT01871987|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1432212|NCT01871974|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1432213|NCT01871961||Single Group Assignment||Treatment||None (Open Label)||||||
1432214|NCT01871948|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1432215|NCT01871935|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1432216|NCT01871922|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1432217|NCT01871909|||Case-Only||Prospective|||||||
1432218|NCT01871896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432219|NCT01871883|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1432220|NCT01871870||Single Group Assignment||Treatment||None (Open Label)||||||
1432221|NCT01871857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432222|NCT01871844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432223|NCT01871831||||||||||||
1432224|NCT01871818|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1432225|NCT01871805|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432226|NCT01871792|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432227|NCT01871779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432228|NCT01871766|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432229|NCT01871753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432230|NCT01871740|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432231|NCT01871727||Single Group Assignment||Treatment||None (Open Label)||||||
1432232|NCT01871714||||||||||||
1432233|NCT01871701|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432234|NCT01871688||Single Group Assignment||Treatment||Triple|||t||t|t
1432235|NCT01871675|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432236|NCT01871662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432237|NCT01871649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432238|NCT01871636|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1432239|NCT01871623|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432240|NCT01871610|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432241|NCT01871597||Single Group Assignment||Treatment||None (Open Label)||||||
1432242|NCT01871584|Randomized|Parallel Assignment||||Single||||||t
1432243|NCT01871571||Single Group Assignment||Treatment||None (Open Label)||||||
1432244|NCT01871558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432245|NCT01871545||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432246|NCT01871532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432247|NCT01871519||Single Group Assignment||Treatment||None (Open Label)||||||
1432248|NCT01871506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432249|NCT01871493|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1432250|NCT01871480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432251|NCT01871467||Single Group Assignment||Other||None (Open Label)||||||
1432252|NCT01871454||Single Group Assignment||Treatment||None (Open Label)||||||
1432253|NCT01871441||Single Group Assignment||Treatment||None (Open Label)||||||
1432254|NCT01871428|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432255|NCT01871415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432256|NCT01871402|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432257|NCT01871389|||||Prospective|||||||
1432258|NCT01871376|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432259|NCT01871363||Single Group Assignment||Treatment||None (Open Label)||||||
1432260|NCT01871350|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1432261|NCT01871337||Single Group Assignment||Treatment||None (Open Label)||||||
1432262|NCT01871324||Single Group Assignment||Other||None (Open Label)||||||
1432263|NCT01871311||Single Group Assignment||Treatment||None (Open Label)||||||
1432264|NCT01871298|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1432265|NCT01871285|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1432266|NCT01871272|||Cohort||Prospective|||||||
1432267|NCT01871259|||Case Control||Prospective|||||||
1432268|NCT01871246|||Case-Only||Prospective|||||||
1432269|NCT01871233||||||||||||
1432270|NCT01871220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432271|NCT01871207|||Case Control||Cross-Sectional|||||||
1432272|NCT01871194|||Cohort||Prospective|||||||
1432273|NCT01871181|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1432274|NCT01871168|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1432275|NCT01871155|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1432276|NCT01871142|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1432277|NCT01871129|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432278|NCT01871116|Randomized|Parallel Assignment||Treatment||None (Open Label)||Weight loss intervention versus self-directed weight loss.||||
1432279|NCT01871103||Single Group Assignment||Treatment||Single||||||t
1432280|NCT01871090|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432281|NCT01871077||Single Group Assignment||Treatment||None (Open Label)||||||
1432282|NCT01871064|||Cohort||Prospective|||||||
1432283|NCT01871051|||||Retrospective|||||||
1432284|NCT01871038|||Case Control||Prospective|||||||
1432285|NCT01871025|Randomized|Parallel Assignment||Prevention||Single||||||t
1432286|NCT01871012|||Cohort||Prospective|||||||
1432287|NCT01870999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432288|NCT01870986|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1432289|NCT01870973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432290|NCT01870960|Randomized|Crossover Assignment||||None (Open Label)||||||
1432291|NCT01870947|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432292|NCT01870934|||||Prospective|||||||
1432293|NCT01870921||Single Group Assignment||Treatment||None (Open Label)||||||
1432294|NCT01870908|||Case-Only||Prospective|||||||
1432295|NCT01870895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432296|NCT01870882|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432297|NCT01870869||||||||||||
1432298|NCT01870856|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1432299|NCT01870843||Single Group Assignment||Treatment||None (Open Label)||||||
1432300|NCT01870830|Randomized|Crossover Assignment||||None (Open Label)||||||
1432301|NCT01870817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432302|NCT01870804|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1432303|NCT01870791||Single Group Assignment||Treatment||None (Open Label)||||||
1432304|NCT01870778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432305|NCT01870765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432306|NCT01870752||||Treatment||||||||
1432307|NCT01870739|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432308|NCT01870726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432309|NCT01870713|||Case Control||Prospective|||||||
1432310|NCT01870700|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1432311|NCT01870687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432312|NCT01870674|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1432313|NCT01870661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432314|NCT01870648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432315|NCT01870635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432316|NCT01870622|Randomized|Single Group Assignment||Diagnostic||Double|||||t|t
1432317|NCT01870609|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432318|NCT01870596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432319|NCT01870583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432320|NCT01870570|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1432321|NCT01870557|||Cohort||Cross-Sectional|||||||
1432322|NCT01870544|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432323|NCT01870531|||Cohort||Prospective|||||||
1432324|NCT01870518|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1432325|NCT01870505|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432326|NCT01870492|||Cohort||Retrospective|||||||
1432327|NCT01870479|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432328|NCT01870466|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1432329|NCT01870453|||Cohort||Prospective|||||||
1432330|NCT01870440||Single Group Assignment||Treatment||None (Open Label)||||||
1432331|NCT01870427||Single Group Assignment||Treatment||None (Open Label)||||||
1432332|NCT01870414||Single Group Assignment||Treatment||None (Open Label)||||||
1432333|NCT01870401|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432334|NCT01870388|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1432335|NCT01870375|||Cohort||Prospective|||||||
1432336|NCT01870362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432337|NCT01870349|||Cohort||Cross-Sectional|||||||
1432338|NCT01870336|Randomized|Crossover Assignment||Treatment||Single|||t|||
1432339|NCT01870323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432340|NCT01870310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432341|NCT01870297|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1432342|NCT01870284|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432343|NCT01870271||Single Group Assignment||Treatment||None (Open Label)||||||
1432344|NCT01870258|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1432345|NCT01870245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432346|NCT01870232||Single Group Assignment||Treatment||None (Open Label)||||||
1432347|NCT01870219|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1432348|NCT01870206|Randomized|Parallel Assignment||||Triple|||t|t|t|
1432349|NCT01870193|||Case-Control||Prospective|||||||
1432350|NCT01870180|Randomized|Parallel Assignment||Treatment||Single|||||t|
1432351|NCT01870167|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1432352|NCT01870154|Randomized|Parallel Assignment||||None (Open Label)||||||
1432353|NCT01870141|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432354|NCT01870128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432355|NCT01870115|Randomized|Parallel Assignment||Treatment||Quadruple||Melatonin (5mg), strontium (citrate; 450mg) vitamin D3 (2000IU)and vitamin K2 (MK7; 60mcg)|t|t|t|t
1432356|NCT01870102|Randomized|Crossover Assignment||||None (Open Label)||||||
1432357|NCT01870089||Single Group Assignment||Treatment||None (Open Label)||||||
1432358|NCT01870076|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1432359|NCT01870063|||Cohort||Prospective|||||||
1432360|NCT01870050|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1432361|NCT01870037|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432362|NCT01870024|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432363|NCT01870011|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432364|NCT01869998|||Case Control||Prospective|||||||
1432365|NCT01869985|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432366|NCT01869972|||Case Control||Prospective|||||||
1432367|NCT01869959|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1432368|NCT01869946|||Case-Only||Prospective|||||||
1432369|NCT01869933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432370|NCT01869920|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432371|NCT01869907|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432372|NCT01869894|Randomized|Parallel Assignment||Treatment||Single|||||t|
1432373|NCT01869881|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432374|NCT01869868|||Case-Only||Prospective|||||||
1432375|NCT01869855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432376|NCT01869842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432377|NCT01869829|||Cohort||Prospective|||||||
1432378|NCT01869816|||Cohort||Cross-Sectional|||||||
1432379|NCT01869803||||||||||||
1432380|NCT01869790||Single Group Assignment||Treatment||None (Open Label)||||||
1432381|NCT01869777||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432382|NCT01869764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432383|NCT01869751|||Case-Only||Prospective|||||||
1432384|NCT01869738|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432385|NCT01869725||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432386|NCT01869712|Randomized|Parallel Assignment||Treatment||Single||||||t
1432387|NCT01869699|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432388|NCT01869686||Single Group Assignment||||None (Open Label)||||||
1432389|NCT01869673|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432390|NCT01869660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432391|NCT01869647|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432392|NCT01869634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432393|NCT01869621||Single Group Assignment||Basic Science||None (Open Label)||||||
1432394|NCT01869608||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432395|NCT01869595|||Cohort||Prospective|||||||
1432396|NCT01869582|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1432397|NCT01869569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432398|NCT01869556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432399|NCT01869543|Randomized|Crossover Assignment||Other||Double|||t|t||
1432400|NCT01869530|||Cohort||Prospective|||||||
1432401|NCT01869517|Randomized|Parallel Assignment||Treatment||||||||
1432402|NCT01869504||Single Group Assignment||Treatment||None (Open Label)||||||
1432403|NCT01869491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432404|NCT01869478|Randomized|Parallel Assignment||Treatment||Single||||||t
1432405|NCT01869465|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432406|NCT01869452|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1432407|NCT01869439||Single Group Assignment||Other||None (Open Label)||||||
1432408|NCT01869426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432409|NCT01869413|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432410|NCT01869400|||Other||Prospective|||||||
1432411|NCT01869387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432412|NCT01869374|Randomized|Parallel Assignment||Treatment||Triple||Electroconvulsive Therapy / Magnetic Seizure Therapy|t|t||t
1432413|NCT01869361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432414|NCT01869348|Randomized|Parallel Assignment||Prevention||Single||||||t
1432415|NCT01869335|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1432416|NCT01869322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432417|NCT01869309|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432418|NCT01869296|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1432419|NCT01869283|Randomized|Parallel Assignment||Treatment||Single||||||t
1432420|NCT01869270|||Cohort||Retrospective|||||||
1432421|NCT01869257|Randomized|Parallel Assignment||Treatment||Single||||||t
1432422|NCT01869244|||Cohort||Prospective|||||||
1432423|NCT01869231|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1432424|NCT01869218|||Case-Only||Cross-Sectional|||||||
1432425|NCT01869205||Single Group Assignment||Treatment||None (Open Label)||Bronchoscopioc lung volume reduction by endobronchial valve||||
1432426|NCT01869192|Randomized|Crossover Assignment||Treatment||None (Open Label)||randomized sequence of therapy.||||
1432427|NCT01869179|Randomized|Parallel Assignment||||None (Open Label)||||||
1432428|NCT01869166||Single Group Assignment||Treatment||None (Open Label)||||||
1432429|NCT01869153|||Cohort||Other|||||||
1432430|NCT01869140|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1432431|NCT01869127|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432432|NCT01869114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432433|NCT01869101|||Case Control||Prospective|||||||
1432434|NCT01869088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432435|NCT01869075|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1432436|NCT01869062|Randomized|Parallel Assignment||Other||Double||CRT-D device|t|||t
1432437|NCT01869049|||Cohort||Prospective|||||||
1432438|NCT01869036|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432439|NCT01869023||Single Group Assignment||Treatment||None (Open Label)||||||
1432440|NCT01869010|||Case-Control||Prospective|||||||
1432441|NCT01868997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432442|NCT01868984|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432443|NCT01868971||Single Group Assignment||Screening||None (Open Label)||||||
1432444|NCT01868958|||Case Control||Prospective|||||||
1432445|NCT01868945|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1432446|NCT01868932|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432447|NCT01868919||Single Group Assignment||Health Services Research||None (Open Label)||||||
1432448|NCT01868906|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432449|NCT01868893||Single Group Assignment||Treatment||None (Open Label)||||||
1432450|NCT01868880|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432451|NCT01868867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432453|NCT01868841|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432454|NCT01868828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432455|NCT01868802|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432456|NCT01868789|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432457|NCT01868776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432458|NCT01868763|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1432459|NCT01868750|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1432460|NCT01868737|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432461|NCT01868724|||Cohort||Prospective|||||||
1432462|NCT01868711||Single Group Assignment||Treatment||None (Open Label)||||||
1432463|NCT01868698|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1432464|NCT01868685|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1432465|NCT01868672|Randomized|Parallel Assignment||Treatment||Single||||||t
1432466|NCT01868659|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432467|NCT01868646|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1432468|NCT01868633|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1432469|NCT01868620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432470|NCT01868607|||Case-Only||Cross-Sectional|||||||
1432471|NCT01868594|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1432472|NCT01868581|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1432473|NCT01868568|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1432474|NCT01868555|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432475|NCT01868542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432476|NCT01868529|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1432477|NCT01868516|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432478|NCT01868503||Single Group Assignment||Treatment||None (Open Label)||||||
1432479|NCT01868490||Single Group Assignment||Treatment||None (Open Label)||||||
1432480|NCT01868477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432481|NCT01868464|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432482|NCT01868451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432483|NCT01868438|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432484|NCT01868425|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1432485|NCT01868412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432486|NCT01868399|||Cohort||Prospective|||||||
1432487|NCT01868386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432488|NCT01868373||Single Group Assignment||Treatment||None (Open Label)||||||
1432489|NCT01868360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432490|NCT01868347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432491|NCT01868334|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1432492|NCT01868321|||Cohort||Prospective|||||||
1432493|NCT01868308|||Cohort||Prospective|||||||
1432494|NCT01868295|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1432495|NCT01868282|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1432496|NCT01868269||Single Group Assignment||Treatment||None (Open Label)||||||
1432497|NCT01868256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432498|NCT01868243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432499|NCT01868230|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1432500|NCT01868217|||Cohort||Retrospective|||||||
1432501|NCT01868204|||Case-Only||Cross-Sectional|||||||
1432502|NCT01868191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432503|NCT01868178|||Case-Only||Prospective|||||||
1432504|NCT01868165|||Cohort||Prospective|||||||
1432505|NCT01868152|||Cohort|||||||||
1432506|NCT01868139||Single Group Assignment||Treatment||None (Open Label)||||||
1432507|NCT01868126|Randomized|Parallel Assignment||Treatment||Single|||||t|
1432508|NCT01868113|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1432509|NCT01868100||Single Group Assignment||Supportive Care||None (Open Label)||||||
1432510|NCT01868087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432511|NCT01868074|Randomized|Parallel Assignment||Treatment||Single||||||t
1432512|NCT01868061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432513|NCT01868048|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1432514|NCT01868035||Single Group Assignment||Treatment||None (Open Label)||||||
1432515|NCT01868022|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432516|NCT01868009|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432517|NCT01867996|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432518|NCT01867983|Randomized|Parallel Assignment||Treatment||Single|||||t|
1432519|NCT01867970|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432520|NCT01867957|Randomized|Parallel Assignment||Prevention||Single|||t|||
1432521|NCT01867944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432522|NCT01867931|||Case Control||Prospective|||||||
1432523|NCT01867918|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432524|NCT01867905|||Cohort||Prospective|||||||
1432525|NCT01867892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432526|NCT01867879|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1432527|NCT01867866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432528|NCT01867853|||Case-Only||Prospective|||||||
1432529|NCT01867840|||Cohort|||||||||
1432530|NCT01867827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432531|NCT01867814||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432532|NCT01867801|||Cohort||Prospective|||||||
1432533|NCT01867788|||Case Control||Prospective|||||||
1432534|NCT01867775|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432535|NCT01867762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432536|NCT01867749|Randomized|Parallel Assignment||Treatment||Single||||||t
1432537|NCT01867736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432538|NCT01867723|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1432539|NCT01867710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432540|NCT01867697|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1432541|NCT01867684|Randomized|Parallel Assignment||Treatment||Single||||||t
1432542|NCT01867671|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432543|NCT01867658||Single Group Assignment||Treatment||None (Open Label)||||||
1432544|NCT01867645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432545|NCT01867632|||Cohort||Other|||||||
1432546|NCT01867606|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1432547|NCT01867593||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432548|NCT01867580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432549|NCT01867567|Randomized|Parallel Assignment||||Single|||||t|
1432550|NCT01867554|||Cohort||Prospective|||||||
1432551|NCT01867541|||Cohort||Prospective|||||||
1432552|NCT01867528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432553|NCT01867515|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1432554|NCT01867502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432555|NCT01867489|||Cohort||Prospective|||||||
1432556|NCT01867476|||Case-Only||Prospective|||||||
1432557|NCT01867463|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1432558|NCT01867450|||Other||Cross-Sectional|||||||
1432559|NCT01867437|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1432560|NCT01867424|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432561|NCT01867411|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432562|NCT01867398|||||Prospective|||||||
1432563|NCT01867385|||||Other|||||||
1432564|NCT01867372|||||Other|||||||
1432565|NCT01867359|||Case-Control||Other|||||||
1432566|NCT01867346|||||Prospective|||||||
1432567|NCT01867333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432568|NCT01867320||Single Group Assignment||Treatment||None (Open Label)||||||
1432569|NCT01867307|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432570|NCT01867294|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1432571|NCT01867281|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1432572|NCT01867268|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1432573|NCT01867255||Single Group Assignment||Basic Science||None (Open Label)||||||
1432574|NCT01867242|Randomized|Single Group Assignment||||None (Open Label)||||||
1432575|NCT01867229|||||Prospective|||||||
1432576|NCT01867216|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1432577|NCT01867203|||Cohort||Prospective|||||||
1432578|NCT01867190||Single Group Assignment||Treatment||None (Open Label)||||||
1432579|NCT01867177|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432580|NCT01867164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432581|NCT01867151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432582|NCT01867138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432583|NCT01867125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432584|NCT01867112|Randomized|Parallel Assignment||Prevention||Single|||t|||
1432585|NCT01867099|||Cohort||Prospective|||||||
1432586|NCT01867086||Single Group Assignment||Treatment||None (Open Label)||||||
1432587|NCT01867073|||Cohort||Prospective|||||||
1432588|NCT01867060||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432589|NCT01867047|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432590|NCT01867034|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432591|NCT01867021|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432592|NCT01867008||||||||||||
1432593|NCT01866995|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432594|NCT01866982|Randomized|Parallel Assignment||Prevention||Single|||||t|
1432595|NCT01866969||Single Group Assignment||Supportive Care||None (Open Label)||||||
1432596|NCT01866956|||Cohort||Cross-Sectional|||||||
1432597|NCT01866943|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432598|NCT01866930|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432599|NCT01866917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432600|NCT01866904|||Cohort||Prospective|||||||
1432601|NCT01866891||Single Group Assignment||Treatment||None (Open Label)||||||
1432602|NCT01866878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432603|NCT01866865|||||Retrospective|||||||
1432604|NCT01866852|||Family-Based||Prospective|||||||
1432605|NCT01866839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432606|NCT01866826|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1432607|NCT01866813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432608|NCT01866800|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432609|NCT01866787|||Cohort||Prospective|||||||
1433705|NCT01852448|||Cohort||Prospective|||||||
1432610|NCT01866774|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1432611|NCT01866761|||Cohort||Prospective|||||||
1432612|NCT01866748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432613|NCT01866735|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1432614|NCT01866722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432615|NCT01866709|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1432616|NCT01866696||Single Group Assignment||Treatment||None (Open Label)||||||
1432617|NCT01866683|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1432618|NCT01866670|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432619|NCT01866657|Randomized|Parallel Assignment||Treatment||Single||||t||
1432620|NCT01866644|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432621|NCT01866631|||Cohort||Retrospective|||||||
1432622|NCT01866618|||Cohort||Prospective|||||||
1432623|NCT01866605|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1432624|NCT01866592||Single Group Assignment||Treatment||None (Open Label)||||||
1432625|NCT01866579|||Case-Only||Prospective|||||||
1432626|NCT01866566|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432627|NCT01866553||Single Group Assignment||Treatment||None (Open Label)||||||
1432628|NCT01866540||Single Group Assignment||Prevention||None (Open Label)||||||
1432629|NCT01866527|||Cohort||Prospective|||||||
1432630|NCT01866514||Single Group Assignment||||None (Open Label)||||||
1432631|NCT01866501||Single Group Assignment||||None (Open Label)||||||
1432632|NCT01866488|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432633|NCT01866475|Randomized|Parallel Assignment||||None (Open Label)||||||
1432634|NCT01866462|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1432635|NCT01866449||Single Group Assignment||Treatment||None (Open Label)||||||
1432636|NCT01866436|Randomized|Parallel Assignment||||Single||||||t
1432637|NCT01866423||Single Group Assignment||Treatment||None (Open Label)||||||
1432638|NCT01866410||Single Group Assignment||Treatment||None (Open Label)||||||
1432639|NCT01866397||Single Group Assignment||||None (Open Label)||||||
1432640|NCT01866384||||Treatment||||||||
1432641|NCT01866371|||Case-Control||Prospective|||||||
1432642|NCT01866358|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1432643|NCT01866345|Randomized|Parallel Assignment||Treatment||Single||||||t
1432644|NCT01866332|Randomized|Parallel Assignment||Treatment||Single||||||t
1432645|NCT01866319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432646|NCT01866306|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1432647|NCT01866293||Single Group Assignment||Treatment||None (Open Label)||||||
1432648|NCT01866280|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1432649|NCT01866267||Single Group Assignment||Treatment||None (Open Label)||||||
1432650|NCT01866254|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432651|NCT01866241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432652|NCT01866228|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1432653|NCT01866215|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1432654|NCT01866202|||Cohort||Prospective|||||||
1432655|NCT01866189||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432656|NCT01866176|Randomized|Crossover Assignment||Treatment||Single|||t|||
1432657|NCT01866163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432658|NCT01866150|||Cohort||Retrospective|||||||
1432659|NCT01866137|||Case-Only||Prospective|||||||
1432660|NCT01866124|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432661|NCT01866111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432662|NCT01866098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432663|NCT01866085|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432664|NCT01866072|||Case Control||Prospective|||||||
1432665|NCT01866059|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1432666|NCT01866046||Single Group Assignment||Prevention||None (Open Label)||||||
1432667|NCT01866033||Single Group Assignment||Treatment||None (Open Label)||||||
1432668|NCT01866020|||Case-Only||Prospective|||||||
1432669|NCT01866007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432670|NCT01865994|||Case-Only||Prospective|||||||
1432671|NCT01865981|||Other||Other|||||||
1432672|NCT01865968|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432673|NCT01865955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432674|NCT01865942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432675|NCT01865929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432676|NCT01865916|Randomized|Parallel Assignment||||None (Open Label)||||||
1432677|NCT01865903|||Cohort||Prospective|||||||
1432678|NCT01865890|||Cohort||Prospective|||||||
1432679|NCT01865877|||Cohort||Prospective|||||||
1432680|NCT01865864|||Cohort||Prospective|||||||
1432681|NCT01865851|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1432682|NCT01865838|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432683|NCT01865825|||Case-Control||Prospective|||||||
1432684|NCT01865812||Single Group Assignment||Basic Science||None (Open Label)||||||
1432685|NCT01865799|||Case-Only||Retrospective|||||||
1432686|NCT01865786|||Cohort||Retrospective|||||||
1432687|NCT01865773||Single Group Assignment||||None (Open Label)||||||
1432688|NCT01865760|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1432689|NCT01865747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432690|NCT01865734|Randomized|Parallel Assignment||Treatment||Single||||||t
1432691|NCT01865721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432692|NCT01865708||Single Group Assignment||Other||None (Open Label)||||||
1432693|NCT01865695|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432694|NCT01865682|||Case-Only||Prospective|||||||
1432695|NCT01865669|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432696|NCT01865656|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1432697|NCT01865643|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432698|NCT01865630||Single Group Assignment||Prevention||None (Open Label)||||||
1432699|NCT01865617||Single Group Assignment||Treatment||None (Open Label)||||||
1432700|NCT01865604|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1432701|NCT01865591||Single Group Assignment||Treatment||None (Open Label)||||||
1432702|NCT01865578|Randomized|Crossover Assignment||Treatment||Single|||t|||
1432703|NCT01865565|||Case-Only||Prospective|||||||
1432704|NCT01865552|Randomized|Crossover Assignment||||Single|||t|||
1432705|NCT01865539|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1432706|NCT01865526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432707|NCT01865513|||Cohort||Prospective|||||||
1432708|NCT01865500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432709|NCT01865487|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432710|NCT01865474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432711|NCT01865461|||Case-Control||Prospective|||||||
1432712|NCT01865448|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432713|NCT01865435||Single Group Assignment||||None (Open Label)||||||
1432714|NCT01865422||Single Group Assignment||||None (Open Label)||||||
1432715|NCT01865409||Single Group Assignment||Basic Science||None (Open Label)||||||
1432716|NCT01865396|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1432717|NCT01865383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432718|NCT01865370|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1432719|NCT01865357|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432720|NCT01865344|||Cohort||Prospective|||||||
1432721|NCT01865331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432722|NCT01865318|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432723|NCT01865305|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1432724|NCT01865292|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1432725|NCT01865279|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1432726|NCT01865266|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432727|NCT01865253||Single Group Assignment||Treatment||None (Open Label)||||||
1432728|NCT01865240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432729|NCT01865227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432730|NCT01865201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432731|NCT01865188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432732|NCT01865175|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432733|NCT01865162||Single Group Assignment||Treatment||None (Open Label)||||||
1432734|NCT01865149|||Case-Only||Retrospective|||||||
1432735|NCT01865136|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1432736|NCT01865123|Randomized|Parallel Assignment||Treatment||Single|||||t|
1432737|NCT01865110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432738|NCT01865097|Randomized|Parallel Assignment||Treatment||Single||||||t
1432739|NCT01865084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432740|NCT01865071|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432741|NCT01865058|||Cohort||Prospective|||||||
1432742|NCT01865045|||Case-Only||Retrospective|||||||
1432743|NCT01865032|||Case-Only||Prospective|||||||
1432744|NCT01865019|||Case Control||Prospective|||||||
1432745|NCT01865006|||Case Control||Prospective|||||||
1432746|NCT01864993|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1432747|NCT01864980|||Cohort||Prospective|||||||
1432748|NCT01864967|||||Cross-Sectional|||||||
1432749|NCT01864954|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432750|NCT01864941|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1432751|NCT01864928|||Cohort||Prospective|||||||
1432752|NCT01864915|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1432753|NCT01864902||Single Group Assignment||Treatment||None (Open Label)||||||
1432754|NCT01864889||Single Group Assignment||Treatment||None (Open Label)||||||
1432755|NCT01864876|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1432756|NCT01864863|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1432757|NCT01864850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432758|NCT01864837|||||Prospective|||||||
1432759|NCT01864824|Non-Randomized|Single Group Assignment||Other||Single|||t|||
1432760|NCT01864811|Randomized|Parallel Assignment||Treatment||Single||||||t
1432761|NCT01864798||Single Group Assignment||Treatment||None (Open Label)||||||
1432762|NCT01864785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432763|NCT01864772||Single Group Assignment||Treatment||None (Open Label)||||||
1432764|NCT01864759||Single Group Assignment||Treatment||None (Open Label)||||||
1432765|NCT01864746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432766|NCT01864733|Randomized|Parallel Assignment||||None (Open Label)||||||
1432767|NCT01864720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432768|NCT01864707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432769|NCT01864694|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432770|NCT01864681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432771|NCT01864668|||Cohort||Prospective|||||||
1432772|NCT01864655|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1432773|NCT01864642|Randomized|Single Group Assignment||Treatment||Single||||||t
1432774|NCT01864629|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1432775|NCT01864616|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432776|NCT01864603|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1432777|NCT01864590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432778|NCT01864577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432779|NCT01864564|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1432780|NCT01864551|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432781|NCT01864538||Single Group Assignment||Treatment||None (Open Label)||||||
1432782|NCT01864525|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1432783|NCT01864512|||Cohort||Prospective|||||||
1432784|NCT01864499||||||||||||
1432785|NCT01864486||Single Group Assignment||Treatment||None (Open Label)||||||
1432786|NCT01864473||Single Group Assignment||Treatment||None (Open Label)||||||
1432787|NCT01864460|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1432788|NCT01864447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432789|NCT01864434|||Case Control||Retrospective|||||||
1432790|NCT01864421|||Case-Control||Prospective|||||||
1432791|NCT01864408|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1432792|NCT01864395|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1432793|NCT01864382|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1432794|NCT01864369|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432795|NCT01864356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432796|NCT01864343||Single Group Assignment||Treatment||None (Open Label)||||||
1432797|NCT01864330|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1432798|NCT01864317|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1432799|NCT01864304|||Cohort||Cross-Sectional|||||||
1432800|NCT01864291||Single Group Assignment||Treatment||None (Open Label)||||||
1432801|NCT01864278|||Case-Only||Prospective|||||||
1432802|NCT01864265|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432803|NCT01864252|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1432804|NCT01864239|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432805|NCT01864226|Randomized|Parallel Assignment||||Double|||t||t|
1432806|NCT01864213||Single Group Assignment||Health Services Research||Quadruple|||t|t|t|t
1432807|NCT01864200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432808|NCT01864187|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432809|NCT01864174|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432810|NCT01864161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432811|NCT01864148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432812|NCT01864135||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432813|NCT01864122|||Case-Control||Cross-Sectional|||||||
1432814|NCT01864109|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432815|NCT01864096|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432816|NCT01864083|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432817|NCT01864070||Single Group Assignment||Treatment||None (Open Label)||||||
1432818|NCT01864057|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1432819|NCT01864044|||Cohort||Prospective|||||||
1432820|NCT01864031|||Cohort||Prospective|||||||
1432821|NCT01864018||Single Group Assignment||Treatment||None (Open Label)||||||
1432822|NCT01864005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432823|NCT01863992|||Other||Prospective|||||||
1432824|NCT01863979|||Cohort||Retrospective|||||||
1432825|NCT01863966|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432826|NCT01863953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432827|NCT01863940|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432828|NCT01863927||Single Group Assignment||Basic Science||None (Open Label)||||||
1432829|NCT01863914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432830|NCT01863901||Single Group Assignment||Treatment||None (Open Label)||||||
1432831|NCT01863888|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432832|NCT01863875|||Cohort||Prospective|||||||
1432833|NCT01863862||Single Group Assignment||Treatment||None (Open Label)||||||
1432834|NCT01863849||Single Group Assignment||||None (Open Label)||||||
1432835|NCT01863836|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432836|NCT01863823|Randomized|Single Group Assignment||Treatment||Single|||||t|
1432837|NCT01863810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432838|NCT01863797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432839|NCT01863784||Single Group Assignment||Treatment||None (Open Label)||||||
1432840|NCT01863771|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432841|NCT01863758||Single Group Assignment||Prevention||None (Open Label)||||||
1432842|NCT01863745|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432843|NCT01863732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432844|NCT01863719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432845|NCT01863706|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1432846|NCT01863693|||Cohort||Prospective|||||||
1432847|NCT01863680||Single Group Assignment||Treatment||None (Open Label)||||||
1432848|NCT01863667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432849|NCT01863654|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1432850|NCT01863641|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432851|NCT01863628|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1432852|NCT01863615|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1432853|NCT01863602|||||Prospective|||||||
1432854|NCT01863589|||||Prospective|||||||
1432855|NCT01863576|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1432856|NCT01863563||Single Group Assignment||Treatment||None (Open Label)||Quickclot||||
1432857|NCT01863550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432858|NCT01863537|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1432859|NCT01863524|||||Prospective|||||||
1432860|NCT01863511|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1432861|NCT01863498|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432862|NCT01863485||Single Group Assignment||Treatment||None (Open Label)||||||
1432863|NCT01863472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432864|NCT01863459|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1432865|NCT01863446|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1432866|NCT01863433||Single Group Assignment||Prevention||None (Open Label)||||||
1432867|NCT01863420|||Cohort||Prospective|||||||
1432868|NCT01863407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432869|NCT01863394|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432870|NCT01863381||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432871|NCT01863368|Randomized|Parallel Assignment||Treatment||Single||||||t
1432872|NCT01863355|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1432873|NCT01863342|||Cohort||Prospective|||||||
1432874|NCT01863329|||Case-Only||Prospective|||||||
1432875|NCT01863316|Randomized|Parallel Assignment||||Single|||t|||
1432876|NCT01863303|||Cohort||Prospective|||||||
1432877|NCT01863290|||Cohort||Prospective|||||||
1432878|NCT01863277|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432879|NCT01863264||Single Group Assignment||Supportive Care||None (Open Label)||||||
1432880|NCT01863251|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1432881|NCT01863238|||Cohort||Prospective|||||||
1432882|NCT01863225|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1432883|NCT01863212|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1432884|NCT01863199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432885|NCT01863186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432886|NCT01863173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432887|NCT01863160|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1432888|NCT01863147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432889|NCT01863134|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1432890|NCT01863121|||Cohort||Prospective|||||||
1432891|NCT01863108||Single Group Assignment||Treatment||None (Open Label)||||||
1432892|NCT01863095|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1432893|NCT01863082||Single Group Assignment||Prevention||None (Open Label)||||||
1432894|NCT01863069|Randomized|||Basic Science||Double|||t||t|
1432895|NCT01863056|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1432896|NCT01863043|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432897|NCT01863030|||Case-Only||Prospective|||||||
1432898|NCT01863017|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432899|NCT01863004||Single Group Assignment||Treatment||None (Open Label)||||||
1432900|NCT01862991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432901|NCT01862978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432902|NCT01862965||Single Group Assignment||Treatment||None (Open Label)||||||
1432903|NCT01862952|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1432904|NCT01862939|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1432905|NCT01862926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432906|NCT01862913|Randomized|Parallel Assignment||Treatment||Single||||||t
1432907|NCT01862900|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432908|NCT01862887|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1432909|NCT01862874|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1432910|NCT01862861|||Cohort||Prospective|||||||
1432911|NCT01862848|||Cohort||Prospective|||||||
1432912|NCT01862835|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1432913|NCT01862822|Randomized|Parallel Assignment||||None (Open Label)||||||
1432914|NCT01862809|||Case-Control||Other|||||||
1432915|NCT01862796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432916|NCT01862783|||||Prospective|||||||
1432917|NCT01862770|||||Prospective|||||||
1432918|NCT01862757|||||Prospective|||||||
1432919|NCT01862744|||||Prospective|||||||
1432920|NCT01862731|||Cohort||Prospective|||||||
1432921|NCT01862718||Single Group Assignment||Treatment||None (Open Label)||||||
1432922|NCT01862705|Randomized|Parallel Assignment||||Single|||t|||
1432923|NCT01862692|Randomized|Parallel Assignment||Treatment||Single||||||t
1432924|NCT01862679|Randomized|Crossover Assignment||Treatment||Single|||t|||
1432925|NCT01862666|||Cohort||Prospective|||||||
1432926|NCT01862653|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1432927|NCT01862640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432928|NCT01862627|||Case-Only||Retrospective|||||||
1432929|NCT01862614|||Case-Crossover||Prospective|||||||
1432930|NCT01862601||Single Group Assignment||Treatment||None (Open Label)||||||
1432931|NCT01862588|||Cohort||Prospective|||||||
1432932|NCT01862562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432933|NCT01862549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432934|NCT01862536|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432935|NCT01862523|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432936|NCT01862510|||Cohort||Prospective|||||||
1432937|NCT01862497|||Cohort||Cross-Sectional|||||||
1432938|NCT01862484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432939|NCT01862471||Single Group Assignment||Prevention||None (Open Label)||||||
1432940|NCT01862458|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1432941|NCT01862445|||Case-Only||Retrospective|||||||
1432942|NCT01862432|Randomized|Parallel Assignment||||None (Open Label)||||||
1432943|NCT01862419|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432944|NCT01862406|Randomized|Parallel Assignment||||Single|||t|||
1432945|NCT01862393|Randomized|Crossover Assignment||||Single|||t|||
1432946|NCT01862380|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432947|NCT01862367|||Cohort||Prospective|||||||
1432948|NCT01862354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432949|NCT01862341||Single Group Assignment||Treatment||None (Open Label)||||||
1432950|NCT01862328|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1432951|NCT01862315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432952|NCT01862302|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432953|NCT01862289||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432954|NCT01862276|||Case-Only||Retrospective|||||||
1432955|NCT01862263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432956|NCT01862250||Single Group Assignment||Treatment||None (Open Label)||||||
1432957|NCT01862237|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1432958|NCT01862224|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1432959|NCT01862211|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1432960|NCT01862198||Single Group Assignment||Treatment||None (Open Label)||||||
1432961|NCT01862185|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1432962|NCT01862172||Single Group Assignment||Basic Science||None (Open Label)||||||
1432963|NCT01862159|||Cohort||Prospective|||||||
1432964|NCT01862146|||Case Control||Cross-Sectional|||||||
1432965|NCT01862133|||Cohort||Prospective|||||||
1432966|NCT01862120|Randomized|Parallel Assignment||Treatment||Single|||t|||
1432967|NCT01862107|||||Prospective|||||||
1432968|NCT01862081|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432969|NCT01862068|||Cohort||Prospective|||||||
1432970|NCT01862055|||Cohort||Retrospective|||||||
1432971|NCT01862042||Single Group Assignment||Supportive Care||None (Open Label)||||||
1432972|NCT01862029||Single Group Assignment||Treatment||None (Open Label)||||||
1432973|NCT01862016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432974|NCT01862003||Single Group Assignment||Treatment||None (Open Label)||||||
1432975|NCT01861990||Single Group Assignment||Treatment||None (Open Label)||||||
1432976|NCT01861977|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1432977|NCT01861964|Randomized|Single Group Assignment||||Double|||t||t|
1432978|NCT01861951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432979|NCT01861938||Single Group Assignment||Treatment||None (Open Label)||||||
1432980|NCT01861925|||Cohort||Prospective|||||||
1432981|NCT01861912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432982|NCT01861899|||Case-Only||Prospective|||||||
1432983|NCT01861886||Single Group Assignment||Prevention||None (Open Label)||||||
1432984|NCT01861873||Single Group Assignment||Treatment||None (Open Label)||||||
1432985|NCT01861860||Single Group Assignment||Diagnostic||None (Open Label)||||||
1432986|NCT01861847|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1432987|NCT01861834||||||||||||
1432988|NCT01861821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432989|NCT01861808||Single Group Assignment||Other||None (Open Label)||||||
1432990|NCT01861795|||Case-Only||Prospective|||||||
1432991|NCT01861782|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1432992|NCT01861769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432993|NCT01861756|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1432994|NCT01861743|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1432995|NCT01861730|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1432996|NCT01861717||Single Group Assignment||Treatment||None (Open Label)||||||
1432997|NCT01861704|Randomized|Parallel Assignment||||Single|||t|||
1432998|NCT01861691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1432999|NCT01861678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433000|NCT01861665|Randomized|Single Group Assignment||Treatment||Single||Patients are acting as their own control receiving Bupivicaine (Marcaine) on both sides. One arm is pre incision the other arm is post incision.|t|||
1433001|NCT01861652||Single Group Assignment||Treatment||None (Open Label)||||||
1433002|NCT01861639|Randomized|Parallel Assignment||||Single|||t|||
1433003|NCT01861626|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433004|NCT01861613||Single Group Assignment||Prevention||None (Open Label)||||||
1433005|NCT01861600|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433006|NCT01861587|Randomized|Parallel Assignment||Other||Double|||t|t||
1433007|NCT01861574|Randomized|Crossover Assignment||Other||Single|||t|||
1433008|NCT01861561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433009|NCT01861548|||Cohort||Prospective|||||||
1433010|NCT01861535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433011|NCT01861522|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433012|NCT01861509||Single Group Assignment||Basic Science||None (Open Label)||||||
1433013|NCT01861496||Single Group Assignment||Treatment||None (Open Label)||||||
1433014|NCT01861483|||Case-Only||Retrospective|||||||
1433015|NCT01861470|||Cohort||Prospective|||||||
1433016|NCT01861457|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1433017|NCT01861444|||Cohort||Prospective|||||||
1433018|NCT01861431|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1433019|NCT01861418|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433020|NCT01861405|||Case Control||Prospective|||||||
1433021|NCT01861392|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433022|NCT01861379|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433023|NCT01861366|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1433024|NCT01861353|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1433025|NCT01861340||Single Group Assignment||Basic Science||None (Open Label)||||||
1433026|NCT01861327|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433027|NCT01861314||Single Group Assignment||Treatment||None (Open Label)||||||
1433028|NCT01861301||Single Group Assignment||Treatment||None (Open Label)||||||
1433029|NCT01861288|||Other||Prospective|||||||
1433030|NCT01861275|||Case Control||Prospective|||||||
1433031|NCT01861262||Single Group Assignment||Diagnostic||Single|||||t|
1433032|NCT01861249||Single Group Assignment||Treatment||None (Open Label)||||||
1433033|NCT01861236|||Cohort||Prospective|||||||
1433034|NCT01861223||Single Group Assignment||Treatment||None (Open Label)||||||
1433035|NCT01861210|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1433036|NCT01861197||Single Group Assignment||Treatment||None (Open Label)||||||
1433037|NCT01861184|||Case Control||Prospective|||||||
1433038|NCT01861171|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1433039|NCT01861158|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1433040|NCT01861145|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433041|NCT01861132|||Cohort||Prospective|||||||
1433042|NCT01861119|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1433043|NCT01861106|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433044|NCT01861093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433045|NCT01861080|||Cohort||Prospective|||||||
1433046|NCT01861067|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1433047|NCT01861054||Single Group Assignment||Treatment||None (Open Label)||||||
1433048|NCT01861041|Randomized|Parallel Assignment||||Triple|||t||t|t
1433049|NCT01861028|||Cohort||Prospective|||||||
1433050|NCT01861015|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433051|NCT01861002|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433052|NCT01860989|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433053|NCT01860976|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433054|NCT01860963|Non-Randomized|Parallel Assignment||Screening||Single||||||t
1433055|NCT01860950|Randomized|Parallel Assignment||Other||Double|||t||t|
1433056|NCT01860937|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433057|NCT01860924|Randomized|Parallel Assignment||Treatment||Single||||||t
1433058|NCT01860911|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1433059|NCT01860898||Single Group Assignment||Basic Science||None (Open Label)||||||
1433060|NCT01860885|||Cohort||Retrospective|||||||
1433061|NCT01860872|||Case-Control||Prospective|||||||
1433062|NCT01860859|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1433063|NCT01860846|||Cohort||Prospective|||||||
1433064|NCT01860833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433065|NCT01860820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433066|NCT01860807|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433067|NCT01860794||Single Group Assignment||Treatment||None (Open Label)||||||
1433068|NCT01860781||Single Group Assignment||Treatment||None (Open Label)||||||
1433069|NCT01860768|||Cohort||Prospective|||||||
1433070|NCT01860755|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1433071|NCT01860742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433072|NCT01860729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433073|NCT01860716|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1433074|NCT01860703|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1433075|NCT01860690||Single Group Assignment||Treatment||None (Open Label)||||||
1433076|NCT01860677|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1433077|NCT01860664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433078|NCT01860651|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1433079|NCT01860638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433080|NCT01860625|Randomized|Single Group Assignment||Treatment||Single|||t|||
1433081|NCT01860612|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433082|NCT01860599|Randomized|Crossover Assignment||Prevention||Single||||||t
1433083|NCT01860586||Single Group Assignment||Treatment||None (Open Label)||Outcomes were compared to a retrospective, historical control group.||||
1433084|NCT01860573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433085|NCT01860560|Randomized|Crossover Assignment||Treatment||Single|||||t|
1433086|NCT01860547|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1433087|NCT01860534|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1433088|NCT01860521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433089|NCT01860508||Single Group Assignment||Treatment||None (Open Label)||||||
1433090|NCT01860495|||Cohort||Prospective|||||||
1433091|NCT01860482||Single Group Assignment||Treatment||None (Open Label)||||||
1433092|NCT01860469|Randomized|Parallel Assignment||Prevention||Single||||||
1433093|NCT01860456|||Cohort||Prospective|||||||
1433094|NCT01860443|Randomized|Parallel Assignment||Treatment||Single||||||t
1433095|NCT01860430||Single Group Assignment||Treatment||None (Open Label)||||||
1433096|NCT01860417|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1433097|NCT01860404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433098|NCT01860391||Single Group Assignment||||Single||||||t
1433099|NCT01860378|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1433100|NCT01860365|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1433101|NCT01860352||Single Group Assignment||Other||None (Open Label)||||||
1433102|NCT01860339|||Case-Control||Cross-Sectional|||||||
1433103|NCT01860326||Single Group Assignment||||None (Open Label)||||||
1433104|NCT01860313|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433105|NCT01860300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433106|NCT01860287|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1433107|NCT01860274|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1433108|NCT01860261|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433109|NCT01860248|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1433110|NCT01860235|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1433111|NCT01860222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433112|NCT01860209|Randomized|Parallel Assignment||||None (Open Label)||||||
1433113|NCT01860196|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1433114|NCT01860183|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433115|NCT01860170|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433116|NCT01860157|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433117|NCT01860144|||Cohort||Prospective|||||||
1433118|NCT01860131|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1433119|NCT01860118|||Cohort||Prospective|||||||
1433120|NCT01860105|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1433121|NCT01860092|||Cohort||Prospective|||||||
1433122|NCT01860079|Randomized|Parallel Assignment||Treatment||Single||||||t
1433123|NCT01860066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433124|NCT01860053|Randomized|Parallel Assignment||Treatment||Single||||||t
1433125|NCT01860040|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433126|NCT01860027|||Cohort||Prospective|||||||
1433127|NCT01860014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433128|NCT01860001|||Cohort||Prospective|||||||
1433129|NCT01859988|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433130|NCT01859975||||||||||||
1433131|NCT01859962|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433132|NCT01859949||Single Group Assignment||Treatment||None (Open Label)||||||
1433133|NCT01859936|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1433134|NCT01859923|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433135|NCT01859910|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1433136|NCT01859897|||Cohort||Prospective|||||||
1433137|NCT01859884|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1433138|NCT01859871|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1433139|NCT01859858|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1433140|NCT01859845|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1433141|NCT01859832|||Case-Only||Prospective|||||||
1433142|NCT01859819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433143|NCT01859806|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433144|NCT01859793|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1433145|NCT01859780||Single Group Assignment||Basic Science||None (Open Label)||||||
1433146|NCT01859767||Single Group Assignment||||None (Open Label)||||||
1433147|NCT01859754|||Cohort||Prospective|||||||
1433148|NCT01859741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433149|NCT01859728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433150|NCT01859715|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433151|NCT01859702||Single Group Assignment||Basic Science||None (Open Label)||||||
1433152|NCT01859689||Single Group Assignment||Treatment||None (Open Label)||||||
1433153|NCT01859663|||Case-Control||Retrospective|||||||
1433154|NCT01859650|||Cohort||Prospective|||||||
1433155|NCT01859637||Single Group Assignment||Treatment||None (Open Label)||||||
1433156|NCT01859624||Single Group Assignment||Treatment||None (Open Label)||||||
1433157|NCT01859611||Single Group Assignment||Treatment||None (Open Label)||||||
1433158|NCT01859598|||Case-Only||Prospective|||||||
1433942|NCT01849354|||Case Control||Prospective|||||||
1433159|NCT01859585|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1433160|NCT01859572|||Case-Only||Prospective|||||||
1433161|NCT01859559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433162|NCT01859546|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1433163|NCT01859533|Randomized|Parallel Assignment||Prevention||Single||||||t
1433164|NCT01859520||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433165|NCT01859507||Single Group Assignment||Treatment||Single||||||t
1433166|NCT01859494||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433167|NCT01859481|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433168|NCT01859468|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433169|NCT01859455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433170|NCT01859442|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1433171|NCT01859429|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1433172|NCT01859416|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433173|NCT01859403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433174|NCT01859390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433175|NCT01859377|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433176|NCT01859364|||||Prospective|||||||
1433177|NCT01859351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433178|NCT01859338|||Cohort||Prospective|||||||
1433179|NCT01859325|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1433180|NCT01859312||Single Group Assignment||Treatment||None (Open Label)||||||
1433181|NCT01859299|||Case-Control||Prospective|||||||
1433182|NCT01859286|||Cohort||Prospective|||||||
1433183|NCT01859273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433184|NCT01859260|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433185|NCT01859247|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1433186|NCT01859234||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433187|NCT01859221|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433188|NCT01859195|||Other||Cross-Sectional|||||||
1433189|NCT01859182||Single Group Assignment||Treatment||None (Open Label)||||||
1433190|NCT01859169|||Case Control||Prospective|||||||
1433191|NCT01859156|||Case-Only||Prospective|||||||
1433192|NCT01859143|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1433193|NCT01859130||Single Group Assignment||Treatment||None (Open Label)||||||
1433194|NCT01859117|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433195|NCT01859104||Single Group Assignment||Treatment||None (Open Label)||||||
1433196|NCT01859091||Single Group Assignment||||None (Open Label)||||||
1433197|NCT01859078||Single Group Assignment||Basic Science||None (Open Label)||||||
1433198|NCT01859065|Randomized|Crossover Assignment||Prevention||Single|||t|||
1433199|NCT01859052|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433200|NCT01859039|||Cohort||Prospective|||||||
1433201|NCT01859026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433202|NCT01859013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433203|NCT01859000|Randomized|Factorial Assignment||Treatment||Single||||||t
1433204|NCT01858987|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1433205|NCT01858974|||Case-Only||Prospective|||||||
1433206|NCT01858961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433207|NCT01858948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433208|NCT01858935|Randomized|Single Group Assignment||Other||Triple|||t||t|t
1433209|NCT01858922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433210|NCT01858909|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433211|NCT01858896|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433212|NCT01858883||Single Group Assignment||Treatment||None (Open Label)||||||
1433213|NCT01858870|||Case-Only||Retrospective|||||||
1433214|NCT01858857|||Cohort||Prospective|||||||
1433215|NCT01858844|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433216|NCT01858831|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1433217|NCT01858818|||Cohort||Prospective|||||||
1433218|NCT01858805|||Cohort||Prospective|||||||
1433219|NCT01858792||||||||||||
1433220|NCT01858779|||Cohort||Prospective|||||||
1433221|NCT01858766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433222|NCT01858753|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433223|NCT01858740||Single Group Assignment||Treatment||None (Open Label)||||||
1433224|NCT01858727|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1433225|NCT01858714|Randomized|Parallel Assignment||Treatment||Single||||||t
1433226|NCT01858701|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1433227|NCT01858688||Single Group Assignment||Diagnostic||None (Open Label)||Evaluation of accuracy of the MRI relative to biopsy||||
1433228|NCT01858675||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433229|NCT01858662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433230|NCT01858649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433231|NCT01858636|||Cohort||Prospective|||||||
1433232|NCT01858623|Randomized|Crossover Assignment||||None (Open Label)||||||
1433233|NCT01858610|Randomized|Crossover Assignment||||None (Open Label)||||||
1433234|NCT01858597|||Case Control||Cross-Sectional|||||||
1433235|NCT01858584|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433236|NCT01858571|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1434796|NCT01838187||||||||||||
1433237|NCT01858558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433238|NCT01858545|Randomized|Parallel Assignment||Treatment||Single||||||t
1433239|NCT01858532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433240|NCT01858519|||||Prospective|||||||
1433241|NCT01858506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433242|NCT01858493|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433243|NCT01858480|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433244|NCT01858467|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433245|NCT01858454|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433246|NCT01858441||Single Group Assignment||Other||None (Open Label)||||||
1433247|NCT01858428|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433248|NCT01858415||Single Group Assignment||Treatment||None (Open Label)||||||
1433249|NCT01858402|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1433250|NCT01858389|Non-Randomized|||Treatment||None (Open Label)||||||
1433251|NCT01858376||Single Group Assignment||Other||None (Open Label)||||||
1433252|NCT01858363|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433253|NCT01858350|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433254|NCT01858337|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1433255|NCT01858324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433256|NCT01858311|||Cohort||Prospective|||||||
1433257|NCT01858298|Randomized|Parallel Assignment||Treatment||Single||||||t
1433258|NCT01858285|||Cohort||Cross-Sectional|||||||
1433259|NCT01858272||Single Group Assignment||||None (Open Label)||||||
1433260|NCT01858259|||Cohort||Prospective|||||||
1433261|NCT01858246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433262|NCT01858233|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1433263|NCT01858220|||Case-Only||Prospective|||||||
1433264|NCT01858207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433265|NCT01858194|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433266|NCT01858181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433267|NCT01858168|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433268|NCT01858155||Single Group Assignment||Supportive Care||None (Open Label)||||||
1433269|NCT01858142|Randomized|Parallel Assignment||Prevention||Single||||||t
1433270|NCT01858129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433271|NCT01858116||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433272|NCT01858103||||||||||||
1433273|NCT01858090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433274|NCT01858077|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433275|NCT01858064||Single Group Assignment||Treatment||None (Open Label)||||||
1433276|NCT01858051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433277|NCT01858038|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1433278|NCT01858025||Single Group Assignment||Treatment||None (Open Label)||||||
1433279|NCT01858012|||Cohort||Prospective|||||||
1433280|NCT01857999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433281|NCT01857986|Randomized|Parallel Assignment||Prevention||Single|||t|||
1433282|NCT01857973||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1433283|NCT01857960|||Case-Only||Cross-Sectional|||||||
1433284|NCT01857947||Single Group Assignment||Diagnostic||Single|||||t|
1433285|NCT01857934||Single Group Assignment||Treatment||None (Open Label)||||||
1433286|NCT01857921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433287|NCT01857908|||Case Control||Prospective|||||||
1433288|NCT01857895|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433289|NCT01857882|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1433290|NCT01857869|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433291|NCT01857856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433292|NCT01857843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433293|NCT01857830|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1433294|NCT01857817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433295|NCT01857804|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433296|NCT01857791||Single Group Assignment||Treatment||None (Open Label)||||||
1433297|NCT01857778|||Case-Crossover||Prospective|||||||
1433298|NCT01857765|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1433299|NCT01857752||Single Group Assignment||Treatment||None (Open Label)||||||
1433300|NCT01857726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433301|NCT01857713||Single Group Assignment||Prevention||None (Open Label)||||||
1433302|NCT01857700|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1433303|NCT01857687|||Cohort||Retrospective|||||||
1433304|NCT01857674|||||Prospective|||||||
1433305|NCT01857661|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433306|NCT01857648|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1433307|NCT01857635|||Case-Only||Prospective|||||||
1433308|NCT01857622|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433309|NCT01857609|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433310|NCT01857596||Single Group Assignment||Treatment||None (Open Label)||||||
1433311|NCT01857583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433312|NCT01857570|||Cohort||Prospective|||||||
1433313|NCT01857557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433314|NCT01857544||Single Group Assignment||Treatment||None (Open Label)||||||
1433315|NCT01857531||Single Group Assignment||Treatment||None (Open Label)||||||
1433316|NCT01857518|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1433317|NCT01857505|||Case-Only||Retrospective|||||||
1433318|NCT01857492|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1433319|NCT01857479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433320|NCT01857466|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433321|NCT01857453||Single Group Assignment||Treatment||None (Open Label)||||||
1433322|NCT01857440|||Case-Control||Cross-Sectional|||||||
1433323|NCT01857427|||Cohort||Prospective|||||||
1433324|NCT01857401|||Case-Only||Prospective|||||||
1433325|NCT01857388|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433326|NCT01857375|||||Prospective|||||||
1433327|NCT01857362|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433328|NCT01857349|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1433329|NCT01857336||Single Group Assignment||Treatment||None (Open Label)||||||
1433330|NCT01857323||Single Group Assignment||Treatment||None (Open Label)||||||
1433331|NCT01857310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433332|NCT01857297|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433333|NCT01857284|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433334|NCT01857271||Single Group Assignment||Treatment||None (Open Label)||||||
1433335|NCT01857258|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1433336|NCT01857245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433337|NCT01857232|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1433338|NCT01857219||Single Group Assignment||Basic Science||None (Open Label)||||||
1433339|NCT01857206|Randomized|Parallel Assignment||Prevention||Single|||t|||
1433340|NCT01857193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433341|NCT01857180|Randomized|Parallel Assignment||||Single|||t|||
1433342|NCT01857167|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1433343|NCT01857154|Randomized|Parallel Assignment||||Triple|||t|t|t|
1433344|NCT01857141|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1433345|NCT01857128|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433346|NCT01857115||Single Group Assignment||Treatment||None (Open Label)||||||
1433347|NCT01857102|Randomized|Crossover Assignment||Treatment||Single|||t|||
1433348|NCT01857089||Single Group Assignment||Basic Science||None (Open Label)||||||
1433349|NCT01857076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433350|NCT01857063|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1433351|NCT01857050|||Case Control||Retrospective|||||||
1433352|NCT01857037||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433353|NCT01857024|||Case-Only||Prospective|||||||
1433354|NCT01857011|Randomized|Parallel Assignment||Treatment||Single||||||t
1433355|NCT01856998|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433356|NCT01856985||Single Group Assignment||Treatment||None (Open Label)||||||
1433357|NCT01856972|Randomized|Parallel Assignment||Treatment||Single||||||t
1433358|NCT01856959|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1433359|NCT01856946||Single Group Assignment||Treatment||None (Open Label)||||||
1433360|NCT01856933||Single Group Assignment||Treatment||None (Open Label)||||||
1433361|NCT01856920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433362|NCT01856907|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433363|NCT01856894|||Case Control||Prospective|||||||
1433364|NCT01856881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433365|NCT01856868||Single Group Assignment||Treatment||None (Open Label)||||||
1433366|NCT01856855||Single Group Assignment||Treatment||None (Open Label)||||||
1433367|NCT01856842|Randomized|Single Group Assignment||Treatment||Single|||t|||
1433368|NCT01856829|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1433369|NCT01856816|Randomized|Crossover Assignment||||Single|||||t|
1433370|NCT01856803|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433371|NCT01856790|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433372|NCT01856777|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1433373|NCT01856764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433374|NCT01856751|||Cohort||Prospective|||||||
1433375|NCT01856738|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1433376|NCT01856725|Randomized|Parallel Assignment||Treatment||Single||||||t
1433377|NCT01856712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433378|NCT01856699|||Case-Control||Prospective|||||||
1433379|NCT01856686|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1433380|NCT01856673|Randomized|Parallel Assignment||Prevention||Single||||||t
1433381|NCT01856660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433382|NCT01856647|||Cohort||Prospective|||||||
1433383|NCT01856634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433384|NCT01856621|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1433385|NCT01856608|||||Prospective|||||||
1433386|NCT01856595|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1433387|NCT01856582||Single Group Assignment||Treatment||None (Open Label)||||||
1433388|NCT01856569|||Cohort||Other|||||||
1433389|NCT01856556|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433390|NCT01856543|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433391|NCT01856530|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1433392|NCT01856517|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1433394|NCT01856491||Single Group Assignment||Treatment||None (Open Label)||||||
1433395|NCT01856478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433396|NCT01856465|||Cohort||Prospective|||||||
1433397|NCT01856452|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433398|NCT01856439||Single Group Assignment||Other||None (Open Label)||||||
1433399|NCT01856426|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433400|NCT01856413||Single Group Assignment||Prevention||None (Open Label)||||||
1433401|NCT01856400|||Case Control||Prospective|||||||
1433402|NCT01856387|||Case-Only||Retrospective|||||||
1433403|NCT01856374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433404|NCT01856361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433405|NCT01856348||Single Group Assignment||Prevention||None (Open Label)||||||
1433406|NCT01856335||Single Group Assignment||Other||None (Open Label)||||||
1433407|NCT01856322|Randomized|Parallel Assignment||Treatment||Double||||||
1433408|NCT01856309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433409|NCT01856296|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1433410|NCT01856283||Single Group Assignment||Treatment||None (Open Label)||||||
1433411|NCT01856270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433412|NCT01856257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433413|NCT01856244|Randomized|Parallel Assignment||Treatment||Single||||||t
1433414|NCT01856231||Single Group Assignment||Treatment||None (Open Label)||Lifestyle physical activity self-efficacy||||
1433415|NCT01856218||Single Group Assignment||Treatment||None (Open Label)||||||
1433416|NCT01856205|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1433417|NCT01856192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433418|NCT01856179|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1433419|NCT01856166|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1433420|NCT01856153|Randomized|Crossover Assignment||Other||Single|||t|||
1433421|NCT01856140|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433422|NCT01856127|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433423|NCT01856114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433424|NCT01856101||Single Group Assignment||Treatment||None (Open Label)||||||
1433425|NCT01856088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433426|NCT01856075|||Cohort|||||||||
1433427|NCT01856062|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433428|NCT01856049||Single Group Assignment||Basic Science||None (Open Label)||||||
1433429|NCT01856036||Single Group Assignment||Treatment||None (Open Label)||||||
1433430|NCT01856023|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433431|NCT01856010|||Case Control||Prospective|||||||
1433432|NCT01855997|||Cohort||Other|||||||
1433433|NCT01855984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433434|NCT01855971|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433435|NCT01855958|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1433436|NCT01855945|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1433437|NCT01855932||Single Group Assignment||Treatment||Single|||t|||
1433438|NCT01855919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433439|NCT01855906|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433440|NCT01855893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433441|NCT01855880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433442|NCT01855867||Single Group Assignment||Prevention||None (Open Label)||||||
1433443|NCT01855854||Single Group Assignment||Treatment||None (Open Label)||||||
1433444|NCT01855841|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433445|NCT01855828||Single Group Assignment||Treatment||None (Open Label)||||||
1433446|NCT01855815|||Case-Only||Retrospective|||||||
1433447|NCT01855802||||||||||||
1433448|NCT01855789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433449|NCT01855776|Randomized|Factorial Assignment||||None (Open Label)||||||
1433450|NCT01855763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433451|NCT01855750|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433452|NCT01855737|||||Prospective|||||||
1433453|NCT01855724||Single Group Assignment||Treatment||None (Open Label)||||||
1433454|NCT01855711||Single Group Assignment||Treatment||None (Open Label)||||||
1433455|NCT01855698|||Case-Only||Prospective|||||||
1433456|NCT01855685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433457|NCT01855672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433458|NCT01855659|||||Prospective|||||||
1433459|NCT01855646||Single Group Assignment||Health Services Research||None (Open Label)||||||
1433460|NCT01855633|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433461|NCT01855620|||Cohort||Prospective|||||||
1433462|NCT01855607|Randomized|Single Group Assignment||Supportive Care||Triple|||t||t|t
1433463|NCT01855594|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433464|NCT01855581|||||Retrospective|||||||
1433465|NCT01855568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433466|NCT01855555|||Cohort||Prospective|||||||
1433467|NCT01855542|Randomized|Parallel Assignment||Prevention||Single||||||t
1433468|NCT01855529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433469|NCT01855516|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433470|NCT01855503|||Case-Only||Prospective|||||||
1433471|NCT01855490||Single Group Assignment||Treatment||None (Open Label)||||||
1433472|NCT01855477||Single Group Assignment||Other||None (Open Label)||||||
1433473|NCT01855464|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433474|NCT01855451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433475|NCT01855438|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1433476|NCT01855425||Single Group Assignment||Diagnostic||None (Open Label)||Predicate CT Scan and Investigational Cone Beam Scan||||
1433477|NCT01855412|||Cohort||Prospective|||||||
1433478|NCT01855399|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1433479|NCT01855386|||Case-Control||Prospective|||||||
1433480|NCT01855373|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1433481|NCT01855360||Single Group Assignment||Treatment||None (Open Label)||||||
1433482|NCT01855347|||Cohort||Prospective|||||||
1433483|NCT01855334|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1433484|NCT01855321|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433485|NCT01855308|||Cohort||Prospective|||||||
1433486|NCT01855295||Single Group Assignment||Prevention||None (Open Label)||||||
1433487|NCT01855282|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1433488|NCT01855269|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1433489|NCT01855256|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433490|NCT01855243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433491|NCT01855230|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1433492|NCT01855217|Randomized|Parallel Assignment||||Triple|||t|t|t|
1433493|NCT01855204|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1433494|NCT01855191|||Cohort||Prospective|||||||
1433495|NCT01855178|||||Prospective|||||||
1433496|NCT01855165|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1433497|NCT01855152|Randomized|Factorial Assignment||Treatment||Single||||||t
1433498|NCT01855139|||Cohort||Prospective|||||||
1433499|NCT01855126|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1433500|NCT01855113|||Case Control||Prospective|||||||
1433501|NCT01855100|||Cohort||Prospective|||||||
1433502|NCT01855087|||Case-Only||Retrospective|||||||
1433503|NCT01855074||Single Group Assignment||Treatment||None (Open Label)||||||
1433504|NCT01855061|||Cohort||Prospective|||||||
1433505|NCT01855048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433506|NCT01855035|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433507|NCT01855022|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433508|NCT01855009|Randomized|Parallel Assignment||||Triple|||t|t|t|
1433509|NCT01854996|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1433510|NCT01854983|||Case-Only||Prospective|||||||
1433511|NCT01854970||Single Group Assignment||Treatment||None (Open Label)||||||
1433512|NCT01854957|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1433513|NCT01854944||Single Group Assignment||Treatment||None (Open Label)||||||
1433514|NCT01854931||Single Group Assignment||Prevention||None (Open Label)||||||
1433515|NCT01854918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433516|NCT01854905|||Case-Only||Prospective|||||||
1433517|NCT01854892|Randomized|Factorial Assignment||Other||Single|||||t|
1433518|NCT01854879||||||||||||
1433519|NCT01854866||Single Group Assignment||Treatment||None (Open Label)||||||
1433520|NCT01854853|Randomized|Parallel Assignment||Prevention||Single||||||t
1433521|NCT01854840|||Case-Only||Prospective|||||||
1433522|NCT01854827||Single Group Assignment||Treatment||None (Open Label)||||||
1433523|NCT01854814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433524|NCT01854801||Single Group Assignment||Treatment||None (Open Label)||||||
1433525|NCT01854788|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433526|NCT01854775|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433527|NCT01854762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433528|NCT01854749||Single Group Assignment||Treatment||None (Open Label)||||||
1433529|NCT01854736|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1433530|NCT01854723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433531|NCT01854710|Randomized|Crossover Assignment||Other||Quadruple||Single-center, randomized, double-blind, double-dummy, 2-dose, 3-period, active- and placebo-controlled, crossover QT/QTc and pharmacokinetic (PK) study of ADASUVE in healthy volunteers. All dosing and treatment-day follow-up in the study was conducted in the clinical research unit (CRU)|t|t|t|t
1433532|NCT01854697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433533|NCT01854684||Single Group Assignment||Treatment||None (Open Label)||||||
1433534|NCT01854671|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1433535|NCT01854658|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433536|NCT01854645|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433537|NCT01854632|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1433538|NCT01854619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433539|NCT01854606||Single Group Assignment||Treatment||None (Open Label)||||||
1433540|NCT01854593|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1433541|NCT01854580|||Cohort||Prospective|||||||
1433542|NCT01854567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433543|NCT01854554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433544|NCT01854541|||Cohort|||||||||
1433545|NCT01854528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433546|NCT01854515|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1433547|NCT01854502|Randomized|Factorial Assignment||Prevention||Single|||||t|
1433548|NCT01854489|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1433549|NCT01854476|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1433550|NCT01854463|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433551|NCT01854450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433552|NCT01854437|||Case Control||Prospective|||||||
1433553|NCT01854424|||Case-Only||Prospective|||||||
1433554|NCT01854411|||Cohort||Prospective|||||||
1433555|NCT01854398|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433556|NCT01854385||Single Group Assignment||Treatment||None (Open Label)||||||
1433557|NCT01854372||Single Group Assignment||Treatment||None (Open Label)||||||
1433558|NCT01854359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433559|NCT01854346|Randomized|Parallel Assignment||Treatment||Single||||||t
1433560|NCT01854333||Single Group Assignment||Diagnostic||Single|||||t|
1433561|NCT01854320|Randomized|Parallel Assignment||Treatment||Single||||||t
1433562|NCT01854307||Single Group Assignment||Health Services Research||None (Open Label)||||||
1433563|NCT01854294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433564|NCT01854281|||Case Control||Cross-Sectional|||||||
1433565|NCT01854268||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433566|NCT01854255||Single Group Assignment||Treatment||None (Open Label)||||||
1433567|NCT01854242|||Cohort||Prospective|||||||
1433568|NCT01854229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433569|NCT01854216|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1433570|NCT01854203|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433571|NCT01854190|||Case Control||Prospective|||||||
1433572|NCT01854177|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1433573|NCT01854164|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1433574|NCT01854151|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1433575|NCT01854138|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433576|NCT01854125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433577|NCT01854112|||Case-Only||Retrospective|||||||
1433578|NCT01854099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433579|NCT01854086|||Case-Only||Prospective|||||||
1433580|NCT01854073|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1433581|NCT01854060|||Cohort||Retrospective|||||||
1433582|NCT01854047|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433583|NCT01854034||Single Group Assignment||Treatment||None (Open Label)||||||
1433584|NCT01854021|Randomized|Parallel Assignment||||None (Open Label)||||||
1433585|NCT01854008|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433586|NCT01853995|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433587|NCT01853982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433588|NCT01853969|||Cohort||Prospective|||||||
1433589|NCT01853956|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1433590|NCT01853943|||Case Control||Prospective|||||||
1433591|NCT01853930|Randomized|Parallel Assignment||Treatment||Single||||||t
1433592|NCT01853917|||Cohort||Prospective|||||||
1433593|NCT01853904|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1433594|NCT01853891|Randomized|Crossover Assignment||||Single||||||t
1433595|NCT01853878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433596|NCT01853865|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1433597|NCT01853852|Randomized|Crossover Assignment||||Single|||t|||
1433598|NCT01853839|||Case-Only||Prospective|||||||
1433599|NCT01853826||Single Group Assignment||Treatment||None (Open Label)||||||
1433600|NCT01853813||Single Group Assignment||Treatment||Single|||t|||
1433601|NCT01853800|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1433602|NCT01853787|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1433603|NCT01853774|Randomized|Parallel Assignment||Prevention||Single|||t|||
1433604|NCT01853761|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1433605|NCT01853748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433606|NCT01853735|||Cohort||Prospective|||||||
1433607|NCT01853722|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433608|NCT01853709|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433609|NCT01853696|Randomized|Parallel Assignment||Prevention||Single||||||t
1433610|NCT01853683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433611|NCT01853670|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433612|NCT01853657|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1433613|NCT01853644||Single Group Assignment||Treatment||None (Open Label)||||||
1433614|NCT01853631|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433615|NCT01853618|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1433616|NCT01853605|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433617|NCT01853592|||||Prospective|||||||
1433618|NCT01853579|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433619|NCT01853566||Single Group Assignment||Prevention||Single|||t|||
1433620|NCT01853553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433621|NCT01853540|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433622|NCT01853527|||Cohort||Prospective|||||||
1433623|NCT01853514|||Other||Cross-Sectional|||||||
1433624|NCT01853501||Single Group Assignment||Treatment||None (Open Label)||||||
1433625|NCT01853488|||Case Control||Prospective|||||||
1433626|NCT01853475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433627|NCT01853462|Randomized|Parallel Assignment||Treatment||Single||||||t
1433628|NCT01853449|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1433629|NCT01853436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433630|NCT01853423||Single Group Assignment||Treatment||None (Open Label)||||||
1433631|NCT01853410||Single Group Assignment||Basic Science||None (Open Label)||||||
1433632|NCT01853397|Randomized|Parallel Assignment||Treatment||Single||||||t
1433633|NCT01853384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433634|NCT01853371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433635|NCT01853358||Single Group Assignment||Treatment||None (Open Label)||||||
1433636|NCT01853345|||Cohort||Prospective|||||||
1433637|NCT01853332|||Cohort||Cross-Sectional|||||||
1433638|NCT01853319||Single Group Assignment||Treatment||None (Open Label)||||||
1433639|NCT01853306|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433640|NCT01853293|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433641|NCT01853280|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433642|NCT01853267|Randomized|Parallel Assignment||Treatment||Single||||t||
1433643|NCT01853254||Single Group Assignment||Treatment||None (Open Label)||||||
1433644|NCT01853241|||Case-Only||Prospective|||||||
1433645|NCT01853228||Single Group Assignment||Treatment||None (Open Label)||||||
1433646|NCT01853215||Single Group Assignment||||None (Open Label)||||||
1433647|NCT01853202|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433648|NCT01853189|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1433649|NCT01853176|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433650|NCT01853163||Single Group Assignment||Screening||None (Open Label)||||||
1433651|NCT01853150|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433652|NCT01853137|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433653|NCT01853124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433654|NCT01853111||Single Group Assignment||Treatment||None (Open Label)||||||
1433655|NCT01853098||Single Group Assignment||Treatment||None (Open Label)||||||
1433656|NCT01853085|||Case-Only||Prospective|||||||
1433657|NCT01853072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433658|NCT01853059|||Cohort||Prospective|||||||
1433659|NCT01853046|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433660|NCT01853033|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433661|NCT01853020|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1433662|NCT01853007|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1433663|NCT01852994|Randomized|Factorial Assignment||Treatment||Single|||||t|
1433664|NCT01852981|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433665|NCT01852968|||Case-Control||Prospective|||||||
1433666|NCT01852955|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1433667|NCT01852942|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433668|NCT01852929|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1433669|NCT01852916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433670|NCT01852903|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1433671|NCT01852890|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433672|NCT01852877|||Cohort||Prospective|||||||
1433673|NCT01852864||Single Group Assignment||Basic Science||None (Open Label)||||||
1433674|NCT01852851|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1433675|NCT01852838|||Case Control||Prospective|||||||
1433676|NCT01852825|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1433677|NCT01852812|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433678|NCT01852799||Single Group Assignment||Treatment||None (Open Label)||||||
1433679|NCT01852786|||Case Control||Prospective|||||||
1433680|NCT01852773|||Cohort||Prospective|||||||
1433681|NCT01852760|||Cohort||Cross-Sectional|||||||
1433682|NCT01852747|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433683|NCT01852734||Single Group Assignment||Treatment||None (Open Label)||||||
1433684|NCT01852721|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433685|NCT01852708|||Cohort||Prospective|||||||
1433686|NCT01852695|Randomized|Parallel Assignment||||None (Open Label)||||||
1433687|NCT01852682||Single Group Assignment||Treatment||None (Open Label)||||||
1433688|NCT01852669|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1433689|NCT01852656|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1433690|NCT01852643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433691|NCT01852630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433692|NCT01852617|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1433693|NCT01852604|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433694|NCT01852591||Single Group Assignment||||None (Open Label)||||||
1433695|NCT01852578||Single Group Assignment||Treatment||None (Open Label)||||||
1433696|NCT01852565||Single Group Assignment||Treatment||None (Open Label)||||||
1433697|NCT01852552|||Cohort||Prospective|||||||
1433698|NCT01852539||Single Group Assignment||Treatment||Double|||t||t|
1433699|NCT01852526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433700|NCT01852513|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1433701|NCT01852500|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433702|NCT01852487|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433703|NCT01852474||Single Group Assignment||Treatment||None (Open Label)||||||
1433704|NCT01852461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433706|NCT01852435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433707|NCT01852422|||Cohort||Prospective|||||||
1433708|NCT01852409||Single Group Assignment||Treatment||None (Open Label)||||||
1433709|NCT01852396||Single Group Assignment||Supportive Care||None (Open Label)||||||
1433710|NCT01852383||Single Group Assignment||Treatment||None (Open Label)||||||
1433711|NCT01852370||Single Group Assignment||Treatment||None (Open Label)||||||
1433712|NCT01852357|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1433713|NCT01852344|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1433714|NCT01852331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433715|NCT01852318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433716|NCT01852305|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1433717|NCT01852292|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433718|NCT01852279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433719|NCT01852266|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1433720|NCT01852253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433721|NCT01852240|||Cohort||Cross-Sectional|||||||
1433722|NCT01852227|||Case-Only||Retrospective|||||||
1433723|NCT01852214|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1433724|NCT01852201|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1433725|NCT01852188|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1433726|NCT01852175|Randomized|Parallel Assignment||Treatment||Single||||||t
1433727|NCT01852162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433728|NCT01852149||Single Group Assignment||Treatment||None (Open Label)||||||
1433729|NCT01852136||||||||||||
1433730|NCT01852123|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1433731|NCT01852110|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433732|NCT01852097|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433733|NCT01852084||||||||||||
1433734|NCT01852071||Single Group Assignment||Treatment||None (Open Label)||||||
1433735|NCT01852058|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433736|NCT01852045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433737|NCT01852032||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433738|NCT01852019|Randomized|Single Group Assignment||||None (Open Label)||||||
1433739|NCT01852006|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433740|NCT01851993|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1433741|NCT01851980|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1433742|NCT01851967||Single Group Assignment||Treatment||None (Open Label)||||||
1433743|NCT01851954||Single Group Assignment||Prevention||None (Open Label)||||||
1433744|NCT01851941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433745|NCT01851928|||Cohort||Prospective|||||||
1433746|NCT01851915|Randomized|Parallel Assignment||Treatment||Single||||||t
1433747|NCT01851902|||Cohort||Prospective|||||||
1433748|NCT01851889|||Cohort||Prospective|||||||
1433749|NCT01851876|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433750|NCT01851863|Randomized|Parallel Assignment||Treatment||Single||||||t
1433751|NCT01851850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433752|NCT01851837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433753|NCT01851824||Single Group Assignment||||None (Open Label)||||||
1433754|NCT01851811|||||Retrospective|||||||
1433755|NCT01851798|||Cohort||Prospective|||||||
1433756|NCT01851785|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1433757|NCT01851772||Single Group Assignment||Treatment||None (Open Label)||||||
1433758|NCT01851759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433759|NCT01851746|||Case Control||Prospective|||||||
1433760|NCT01851733|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433761|NCT01851720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433762|NCT01851707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433763|NCT01851694|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1433764|NCT01851681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433765|NCT01851668|||Case-Control||Prospective|||||||
1433766|NCT01851655|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1433767|NCT01851642|||Case-Control||Prospective|||||||
1433768|NCT01851629|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433769|NCT01851616|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1433770|NCT01851603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433771|NCT01851590|Randomized|Parallel Assignment||Treatment||Single|||||t|
1433772|NCT01851577|Randomized|Parallel Assignment||Prevention||Single||||||t
1433773|NCT01851564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433774|NCT01851551||Single Group Assignment||Treatment||None (Open Label)||||||
1433775|NCT01851538|||Cohort||Prospective|||||||
1433776|NCT01851525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433777|NCT01851512|Randomized|Crossover Assignment||Treatment||Single|||t|||
1433778|NCT01851499|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433779|NCT01851486|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1433780|NCT01851473|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1433781|NCT01851460||Single Group Assignment||Treatment||None (Open Label)||||||
1433782|NCT01851447|||||Prospective|||||||
1433783|NCT01851434|||Cohort||Prospective|||||||
1433784|NCT01851421|||Case-Control||Cross-Sectional|||||||
1433785|NCT01851408||Single Group Assignment||Treatment||None (Open Label)||||||
1433786|NCT01851395|||Cohort||Prospective|||||||
1433787|NCT01851382|||Case-Only||Prospective|||||||
1433788|NCT01851369||Single Group Assignment||Treatment||None (Open Label)||||||
1433789|NCT01851356|||||Prospective|||||||
1433790|NCT01851343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433791|NCT01851330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433792|NCT01851317|||Cohort||Prospective|||||||
1433793|NCT01851304|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1433794|NCT01851278|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1433795|NCT01851265|Randomized|Crossover Assignment||Other||Single||||||t
1433796|NCT01851252||Single Group Assignment||Supportive Care||None (Open Label)||||||
1433797|NCT01851239|||Case-Only||Retrospective|||||||
1433798|NCT01851226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433799|NCT01851213|||Cohort||Prospective|||||||
1433800|NCT01851200||Single Group Assignment||Treatment||None (Open Label)||||||
1433801|NCT01851187|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1433802|NCT01851174||Single Group Assignment||Treatment||None (Open Label)||||||
1433803|NCT01851161|||Case Control||Prospective|||||||
1433804|NCT01851148|Randomized|Parallel Assignment||Treatment||Single||||||t
1433805|NCT01851135|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1433806|NCT01851122|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1433807|NCT01851109|Randomized|Parallel Assignment||Prevention||Single|||||t|
1433808|NCT01851096||Single Group Assignment||Treatment||None (Open Label)||||||
1433809|NCT01851083|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1433810|NCT01851070|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433811|NCT01851057|Randomized|Single Group Assignment||Treatment||Single|||||t|
1433812|NCT01851044|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433813|NCT01851031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433814|NCT01851018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433815|NCT01851005|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1433816|NCT01850992|Randomized|Crossover Assignment||||Triple|||t||t|t
1433817|NCT01850979|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1433818|NCT01850966|||Case-Control||Prospective|||||||
1433819|NCT01850953|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1433820|NCT01850940|||Cohort||Prospective|||||||
1433821|NCT01850927|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433822|NCT01850914|||Case Control||Cross-Sectional|||||||
1433823|NCT01850901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433824|NCT01850888||Single Group Assignment||Treatment||None (Open Label)||||||
1433825|NCT01850875|Randomized|Parallel Assignment||Treatment||Single||||||t
1433826|NCT01850862|Randomized|Parallel Assignment||Treatment||Single||||||t
1433827|NCT01850849|Randomized|Parallel Assignment||||Single|||t|||
1433828|NCT01850836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433829|NCT01850823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433830|NCT01850810|Randomized|Crossover Assignment||||None (Open Label)||||||
1433831|NCT01850797|||Case-Only||Prospective|||||||
1433832|NCT01850784|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1433833|NCT01850771|Randomized|Crossover Assignment||Treatment||Single|||t|||
1433834|NCT01850758|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433835|NCT01850745|||Cohort||Other|||||||
1433836|NCT01850732||||Screening||||||||
1433837|NCT01850719|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433838|NCT01850706|||Case Control||Prospective|||||||
1433839|NCT01850693|||Cohort|||||||||
1433840|NCT01850680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433841|NCT01850667||Single Group Assignment||Treatment||None (Open Label)||||||
1433842|NCT01850654|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1433843|NCT01850641||Single Group Assignment||Treatment||None (Open Label)||||||
1433844|NCT01850628|||Cohort||Prospective|||||||
1433845|NCT01850615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433846|NCT01850602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433847|NCT01850589|Randomized|Parallel Assignment||Prevention||Single|||t|||
1433848|NCT01850576|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1433849|NCT01850563||Single Group Assignment||Treatment||None (Open Label)||||||
1433850|NCT01850550|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433851|NCT01850537||Single Group Assignment||Treatment||None (Open Label)||||||
1433852|NCT01850524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433853|NCT01850511||Single Group Assignment||Treatment||None (Open Label)||||||
1433854|NCT01850498|||Cohort||Prospective|||||||
1433855|NCT01850485|||||Prospective|||||||
1433856|NCT01850472|||Cohort||Cross-Sectional|||||||
1433857|NCT01850459|||Case-Control||Prospective|||||||
1433858|NCT01850446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433859|NCT01850433||Single Group Assignment||Treatment||None (Open Label)||||||
1433860|NCT01850420|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1433861|NCT01850407||Single Group Assignment||Screening||None (Open Label)||||||
1433862|NCT01850394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433863|NCT01850381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433864|NCT01850368||Single Group Assignment||Treatment||None (Open Label)||||||
1433865|NCT01850355||Single Group Assignment||Treatment||None (Open Label)||||||
1433866|NCT01850342||Single Group Assignment||Treatment||None (Open Label)||||||
1433867|NCT01850329|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1433868|NCT01850316||Single Group Assignment||Health Services Research||None (Open Label)||||||
1433869|NCT01850303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433870|NCT01850290|||Case-Only||Prospective|||||||
1433871|NCT01850277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433872|NCT01850264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433873|NCT01850251|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1433874|NCT01850238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433875|NCT01850225||Single Group Assignment||Treatment||None (Open Label)||||||
1433876|NCT01850212|||Cohort||Cross-Sectional|||||||
1433877|NCT01850199|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1433878|NCT01850186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433879|NCT01850173|Randomized|Parallel Assignment||Treatment||Single||||||t
1433880|NCT01850160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433881|NCT01850147||Single Group Assignment||Treatment||None (Open Label)||||||
1433882|NCT01850134|Randomized|Crossover Assignment||||None (Open Label)||||||
1433883|NCT01850121|||Case-Only||Prospective|||||||
1433884|NCT01850108||Single Group Assignment||Treatment||None (Open Label)||||||
1433885|NCT01850095|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1433886|NCT01850082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433887|NCT01850069|||Cohort||Prospective|||||||
1433888|NCT01850056|Randomized|Parallel Assignment||Treatment||Single||||||t
1433889|NCT01850043|||Ecologic or Community||Prospective|||||||
1433890|NCT01850030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433891|NCT01850017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433892|NCT01850004||Single Group Assignment||Other||None (Open Label)||||||
1433893|NCT01849991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433894|NCT01849978|Randomized|Parallel Assignment||Treatment||||||||
1433895|NCT01849965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433896|NCT01849952|||Cohort||Prospective|||||||
1433897|NCT01849939||Single Group Assignment||Treatment||None (Open Label)||||||
1433898|NCT01849926|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433899|NCT01849913|Randomized|Single Group Assignment||Treatment||Single|||t|||
1433900|NCT01849900|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433901|NCT01849887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433902|NCT01849874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433903|NCT01849861||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433904|NCT01849848||Single Group Assignment||Treatment||None (Open Label)||||||
1433905|NCT01849835|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1433906|NCT01849822||Single Group Assignment||Basic Science||None (Open Label)||||||
1433907|NCT01849809||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1433908|NCT01849796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433909|NCT01849783||Single Group Assignment||Treatment||None (Open Label)||||||
1433910|NCT01849770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433911|NCT01849757|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433912|NCT01849744||Single Group Assignment||Treatment||None (Open Label)||||||
1433913|NCT01849731|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433914|NCT01849718|||Case-Control||Other|||||||
1433915|NCT01849705|||Case Control||Cross-Sectional|||||||
1433916|NCT01849692|Randomized|Parallel Assignment||Treatment||Single||||||t
1433917|NCT01849679|||Case-Only||Prospective|||||||
1433918|NCT01849666|Randomized|Parallel Assignment||||None (Open Label)||||||
1433919|NCT01849653|||Cohort||Prospective|||||||
1433920|NCT01849640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433921|NCT01849627|Randomized|Parallel Assignment||Treatment||Single||||||t
1433922|NCT01849614|||Cohort||Prospective|||||||
1433923|NCT01849601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1433924|NCT01849588||Single Group Assignment||Treatment||None (Open Label)||||||
1433925|NCT01849575|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433926|NCT01849562|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433927|NCT01849549|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1433928|NCT01849536||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433929|NCT01849523|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433930|NCT01849510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433931|NCT01849497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433932|NCT01849484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433933|NCT01849471|||Ecologic or Community||Prospective|||||||
1433934|NCT01849458|||Cohort||Prospective|||||||
1433935|NCT01849445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433936|NCT01849432|||Case Control||Cross-Sectional|||||||
1433937|NCT01849419||Single Group Assignment||Basic Science||Double|||t||t|
1433938|NCT01849406|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1433939|NCT01849393|||Case-Only||Prospective|||||||
1433940|NCT01849380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433941|NCT01849367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433943|NCT01849341|Randomized|Parallel Assignment||||Single||||||t
1433944|NCT01849328|||Case Control||Cross-Sectional|||||||
1433945|NCT01849315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1433946|NCT01849302|Randomized|Crossover Assignment||Prevention||Single|||t|||
1433947|NCT01849289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433948|NCT01849276||Single Group Assignment||Treatment||None (Open Label)||||||
1433949|NCT01849263||Single Group Assignment||Treatment||None (Open Label)||||||
1433950|NCT01849250|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1433951|NCT01849237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433952|NCT01849224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433953|NCT01849211||Single Group Assignment||||None (Open Label)||||||
1433954|NCT01849198|Randomized|Single Group Assignment||||None (Open Label)||||||
1433955|NCT01849185|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1433956|NCT01849172|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1433957|NCT01849159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433958|NCT01849146|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433959|NCT01849133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433960|NCT01849120|||Case-Only||Prospective|||||||
1433961|NCT01849107||Single Group Assignment||Diagnostic||None (Open Label)||||||
1433962|NCT01849094|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433963|NCT01849081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433964|NCT01849068|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1433965|NCT01849055|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1433966|NCT01849042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433967|NCT01849029|Randomized|Crossover Assignment||Treatment||Single||||||t
1433968|NCT01849016|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1433969|NCT01849003|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433970|NCT01848990|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1433971|NCT01848977||Single Group Assignment||Diagnostic||Double|||||t|t
1433972|NCT01848964||Single Group Assignment||Treatment||None (Open Label)||||||
1433973|NCT01848951|||||Prospective|||||||
1433974|NCT01848938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433975|NCT01848925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433976|NCT01848912|||Cohort||Prospective|||||||
1433977|NCT01848899|Randomized|Parallel Assignment||||Single||||||t
1433978|NCT01848886|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1433979|NCT01848873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1433980|NCT01848860|Randomized|Parallel Assignment||Treatment||Single|||t|||
1433981|NCT01848847|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1433982|NCT01848834|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433983|NCT01848821|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1433984|NCT01848808|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1433985|NCT01848795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433986|NCT01848782|Randomized|Parallel Assignment||||Single|||t|||
1433987|NCT01848769|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1433988|NCT01848756||Single Group Assignment||Treatment||None (Open Label)||||||
1433989|NCT01848743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433990|NCT01848730|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1433991|NCT01848717||Single Group Assignment||Treatment||None (Open Label)||||||
1433992|NCT01848704|Randomized|Parallel Assignment||||Single|||t|||
1433993|NCT01848691|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1433994|NCT01848665|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1433995|NCT01848652||Single Group Assignment||Treatment||None (Open Label)||||||
1433996|NCT01848639|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1433997|NCT01848626|||Case Control||Cross-Sectional|||||||
1433998|NCT01848613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1433999|NCT01848600|Randomized|Parallel Assignment||||Single|||t|||
1434000|NCT01848587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434001|NCT01848574|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434002|NCT01848561|||Cohort||Prospective|||||||
1434003|NCT01848548|||Case-Only||Prospective|||||||
1434004|NCT01848535|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434005|NCT01848522||||||||||||
1434006|NCT01848509|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434007|NCT01848496|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1434008|NCT01848483|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1434009|NCT01848470|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434010|NCT01848457|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1434011|NCT01848444|||Cohort||Prospective|||||||
1434012|NCT01848431|||Cohort||Prospective|||||||
1434013|NCT01848418|||Other||Prospective|||||||
1434014|NCT01848392|||Cohort||Prospective|||||||
1434015|NCT01848379|Randomized|Parallel Assignment||Basic Science||Single||||||t
1434016|NCT01848366||Single Group Assignment||Treatment||None (Open Label)||||||
1434017|NCT01848353|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1434018|NCT01848340|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1434019|NCT01848327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434020|NCT01848314||Single Group Assignment||||None (Open Label)||||||
1434021|NCT01848301||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434022|NCT01848288|Randomized|Single Group Assignment||||Single|||t|||
1434023|NCT01848275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434024|NCT01848262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434025|NCT01848249|||Cohort||Prospective|||||||
1434026|NCT01848236|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434027|NCT01848223|||||Prospective|||||||
1434028|NCT01848210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434029|NCT01848197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434030|NCT01848184|||Cohort||Prospective|||||||
1434031|NCT01848171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434032|NCT01848158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434033|NCT01848145||Single Group Assignment||Treatment||None (Open Label)||||||
1434034|NCT01848132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434035|NCT01848119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434036|NCT01848106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434037|NCT01848093|||Cohort||Retrospective|||||||
1434038|NCT01848080|Randomized|Parallel Assignment||Treatment||Single||||||t
1434039|NCT01848067||Single Group Assignment||Treatment||None (Open Label)||||||
1434040|NCT01848054|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434041|NCT01848041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434042|NCT01848028|||Cohort||Prospective|||||||
1434043|NCT01848015|||||Prospective|||||||
1434044|NCT01848002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434045|NCT01847989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434046|NCT01847976||Single Group Assignment||Treatment||None (Open Label)||||||
1434047|NCT01847963|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434048|NCT01847950|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1434049|NCT01847937|||Case-Control||Prospective|||||||
1434050|NCT01847924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434051|NCT01847911|Randomized|Parallel Assignment||Other||Double|||||t|t
1434052|NCT01847898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434053|NCT01847885|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434054|NCT01847872|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434055|NCT01847859|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1434056|NCT01847846||||||||||||
1434057|NCT01847833|||Other||Prospective|||||||
1434058|NCT01847820|||Case-Only||Prospective|||||||
1434059|NCT01847807|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434060|NCT01847794||Single Group Assignment||Basic Science||None (Open Label)||||||
1434061|NCT01847781|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1434062|NCT01847768|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1434063|NCT01847755||Single Group Assignment||Treatment||None (Open Label)||||||
1434064|NCT01847742|Randomized|Parallel Assignment||Treatment||Single||||||t
1434065|NCT01847729|||Other||Prospective|||||||
1434066|NCT01847716|||Cohort||Other|||||||
1434067|NCT01847703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434068|NCT01847690|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434069|NCT01847677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434070|NCT01847664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434071|NCT01847651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434072|NCT01847638|Randomized|Parallel Assignment||Treatment||Single|||||t|
1434073|NCT01847625||||||||||||
1434074|NCT01847612|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1434075|NCT01847599|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434076|NCT01847586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434077|NCT01847573|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434078|NCT01847560|||Cohort||Retrospective|||||||
1434079|NCT01847547|||Cohort||Retrospective|||||||
1434080|NCT01847534|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1434081|NCT01847521||Single Group Assignment||Treatment||None (Open Label)||||||
1434082|NCT01847508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434083|NCT01847495||Single Group Assignment||Treatment||None (Open Label)||||||
1434084|NCT01847482||Single Group Assignment||Treatment||None (Open Label)||||||
1434085|NCT01847469|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1434086|NCT01847456|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1434087|NCT01847443|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434088|NCT01847430||Single Group Assignment||Prevention||None (Open Label)||||||
1434089|NCT01847417|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434090|NCT01847404|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434091|NCT01847391|Randomized|Factorial Assignment||Treatment||Single|||t|||
1434092|NCT01847378|||Cohort||Prospective|||||||
1434093|NCT01847365||Single Group Assignment||Treatment||Single|||||t|
1434094|NCT01847352|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1434095|NCT01847339|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1434096|NCT01847326||Single Group Assignment||Treatment||None (Open Label)||||||
1434097|NCT01847313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434098|NCT01847300|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1434099|NCT01847287|||Case-Only||Prospective|||||||
1434100|NCT01847274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434101|NCT01847261|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1434102|NCT01847248|||Case Control||Prospective|||||||
1434103|NCT01847235||Single Group Assignment||Treatment||None (Open Label)||||||
1434104|NCT01847222|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1434105|NCT01847209||Single Group Assignment||Treatment||None (Open Label)||||||
1434106|NCT01847196||Single Group Assignment||Prevention||None (Open Label)||||||
1434107|NCT01847183|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434108|NCT01847170||Single Group Assignment||Basic Science||None (Open Label)||||||
1434109|NCT01847157|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434110|NCT01847144|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1434111|NCT01847131|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434112|NCT01847118||Single Group Assignment||Treatment||None (Open Label)||||||
1434113|NCT01847105||Single Group Assignment||Supportive Care||Single|||||t|
1434114|NCT01847092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434115|NCT01847079|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1434116|NCT01847066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434117|NCT01847053|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1434118|NCT01847040|||Cohort||Prospective|||||||
1434119|NCT01847027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434120|NCT01847014||Single Group Assignment||Treatment||None (Open Label)||||||
1434121|NCT01847001||Single Group Assignment||Other||None (Open Label)||||||
1434122|NCT01846988|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434123|NCT01846975||Single Group Assignment||Treatment||None (Open Label)||||||
1434124|NCT01846962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434125|NCT01846949|||Cohort||Prospective|||||||
1434126|NCT01846936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434127|NCT01846923||Single Group Assignment||Prevention||None (Open Label)||||||
1434128|NCT01846910|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434129|NCT01846884|||Cohort||Prospective|||||||
1434130|NCT01846871||Single Group Assignment||Treatment||None (Open Label)||||||
1434131|NCT01846858|||Cohort||Prospective|||||||
1434132|NCT01846845|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1434133|NCT01846832||Single Group Assignment||Treatment||None (Open Label)||||||
1434134|NCT01846819|||Cohort||Prospective|||||||
1434135|NCT01846806||Single Group Assignment||Treatment||None (Open Label)||||||
1434136|NCT01846793||Single Group Assignment||Treatment||None (Open Label)||||||
1434137|NCT01846780|||Case Control||Prospective|||||||
1434138|NCT01846767|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1434139|NCT01846754|||Cohort||Prospective|||||||
1434140|NCT01846741||Single Group Assignment||Treatment||None (Open Label)||||||
1434141|NCT01846728||Single Group Assignment||||None (Open Label)||||||
1434142|NCT01846715||Single Group Assignment||Treatment||None (Open Label)||||||
1434143|NCT01846702|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1434144|NCT01846689||Single Group Assignment||Treatment||None (Open Label)||||||
1434145|NCT01846676|Non-Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1434146|NCT01846663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434147|NCT01846650|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434148|NCT01846637|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434149|NCT01846624||Single Group Assignment||Treatment||None (Open Label)||||||
1434150|NCT01846611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434151|NCT01846598|||Cohort||Prospective|||||||
1434152|NCT01846585|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434153|NCT01846572|||Case-Only||Prospective|||||||
1434154|NCT01846559|Randomized|Parallel Assignment||||None (Open Label)||||||
1434155|NCT01846546|||Case-Only||Prospective|||||||
1434156|NCT01846533|||Cohort||Cross-Sectional|||||||
1434157|NCT01846520|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1434158|NCT01846507||Single Group Assignment||Treatment||None (Open Label)||||||
1434159|NCT01846494|||Case-Control||Prospective|||||||
1434160|NCT01846481|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1434161|NCT01846468|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1434162|NCT01846455|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434163|NCT01846442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434164|NCT01846429||Single Group Assignment||Supportive Care||None (Open Label)||||||
1434165|NCT01846416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434166|NCT01846403||Single Group Assignment||Health Services Research||None (Open Label)||||||
1434167|NCT01846390||Single Group Assignment||Treatment||None (Open Label)||||||
1434168|NCT01846377|Randomized|Parallel Assignment||Prevention||Single||||||t
1434169|NCT01846364||Single Group Assignment||Basic Science||None (Open Label)||||||
1434170|NCT01846351|||||Retrospective|||||||
1434171|NCT01846338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434172|NCT01846325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434173|NCT01846312|||Cohort||Prospective|||||||
1434174|NCT01846299|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434175|NCT01846286|||Case-Only||Prospective|||||||
1434176|NCT01846273|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434177|NCT01846260|||Cohort||Prospective|||||||
1434178|NCT01846247|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1434179|NCT01846234|||Cohort||Prospective|||||||
1434180|NCT01846221|Randomized|Parallel Assignment||Treatment||Quadruple|"Group assignment will be performed by opening a previously prepared numbered opaque envelope containing the assignment CLO or FENT. The investigator preparing the study drug will not reveal the group assignment. The investigator administering the drug (different from the investigator preparing the drug) and assessing the outcomes will be blinded to the group assignment. The participant will also be blinded to the group assignment."|"Subjects will randomly receive either a mixture of 100 mcg of clonidine and 12.5 mg of bupivacaine for a total volume of 10 ml (CLON group) and the other group will receive 100 mcg of fentanyl and 12.5 mg of bupivacaine for a total volume of 10 ml (FENT group). If the treatment is declared a failure, the patient will receive the alternative of the initial treatment."|t|t|t|t
1434181|NCT01846208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434182|NCT01846195|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1434183|NCT01846182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434184|NCT01846169||Single Group Assignment||Prevention||None (Open Label)||||||
1434185|NCT01846156|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1434186|NCT01846143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434187|NCT01846130|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1434188|NCT01846117|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1434189|NCT01846104||Single Group Assignment||Prevention||None (Open Label)||||||
1434190|NCT01846091||Single Group Assignment||Treatment||None (Open Label)||||||
1434191|NCT01846078||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434192|NCT01846065|||Other||Prospective|||||||
1434193|NCT01846052|||Cohort||Prospective|||||||
1434194|NCT01846039||Single Group Assignment||Treatment||None (Open Label)||||||
1434195|NCT01846026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434196|NCT01846013|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1434197|NCT01846000|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434198|NCT01845987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434199|NCT01845974|Randomized|Parallel Assignment||Other||Single|||t|||
1434200|NCT01845961||||Diagnostic||||||||
1434201|NCT01845948|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1434202|NCT01845935||Single Group Assignment||Treatment||None (Open Label)||||||
1434203|NCT01845922|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434204|NCT01845909|||Cohort||Prospective|||||||
1434205|NCT01845896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434206|NCT01845883||Single Group Assignment||Basic Science||None (Open Label)||||||
1434207|NCT01845870|||Case Control||Retrospective|||||||
1434208|NCT01845857||Single Group Assignment||||None (Open Label)||||||
1434209|NCT01845844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434210|NCT01845831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434211|NCT01845818|||Cohort||Prospective|||||||
1434212|NCT01845805|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434213|NCT01845792|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434214|NCT01845779||Single Group Assignment||||None (Open Label)||||||
1434215|NCT01845766|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1434216|NCT01845753|||Cohort||Prospective|||||||
1434217|NCT01845740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434218|NCT01845727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434219|NCT01845714|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1434220|NCT01845701|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1434221|NCT01845688|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434222|NCT01845675||Single Group Assignment||Treatment||None (Open Label)||||||
1434223|NCT01845662|||Cohort||Retrospective|||||||
1434224|NCT01845649|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434225|NCT01845636||Single Group Assignment||Treatment||None (Open Label)||||||
1434226|NCT01845623|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434227|NCT01845610|Randomized|Parallel Assignment||Treatment||Single||||||t
1434228|NCT01845597|||Case-Only||Retrospective|||||||
1434229|NCT01845584||Single Group Assignment||Treatment||None (Open Label)||||||
1434230|NCT01845571|||Case-Only||Other|||||||
1434231|NCT01845558|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1434232|NCT01845545|Randomized|Parallel Assignment||Other||Single||||||t
1434233|NCT01845532|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1434234|NCT01845519|Randomized|Parallel Assignment||Prevention||Single|||t|||
1434235|NCT01845506|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1434236|NCT01845493|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434237|NCT01845480|Randomized|Parallel Assignment||Prevention||Single||||||t
1434238|NCT01845467|||Cohort||Prospective|||||||
1434239|NCT01845454|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434240|NCT01845441|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1434241|NCT01845428||Single Group Assignment||Prevention||None (Open Label)||||||
1434242|NCT01845415|Non-Randomized|Factorial Assignment||Prevention||Single|||t|||
1434243|NCT01845402|||Cohort||Prospective|||||||
1434244|NCT01845389|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434245|NCT01845376|Randomized|Parallel Assignment||Treatment||Single||||||t
1434246|NCT01845363||Single Group Assignment||Treatment||Single|||||t|
1434247|NCT01845350||Single Group Assignment||Treatment||None (Open Label)||||||
1434248|NCT01845337|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1434249|NCT01845324|||Cohort||Prospective|||||||
1434250|NCT01845311||Single Group Assignment||Treatment||None (Open Label)||||||
1434251|NCT01845298||Single Group Assignment||Basic Science||None (Open Label)||||||
1434252|NCT01845285|||Case-Only||Prospective|||||||
1434253|NCT01845272|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1434254|NCT01845259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434255|NCT01845246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434256|NCT01845233|||Case-Only||Cross-Sectional|||||||
1434257|NCT01845220|Non-Randomized|Single Group Assignment||Prevention||Double|||t|||t
1434258|NCT01845207|||Cohort||Prospective|||||||
1434259|NCT01845194||Single Group Assignment||Basic Science||None (Open Label)||||||
1434260|NCT01845181|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434261|NCT01845168|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434262|NCT01845155|Randomized|Parallel Assignment||Treatment||Single||||||t
1434263|NCT01845142|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1434264|NCT01845129|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1434265|NCT01845116||Single Group Assignment||Treatment||None (Open Label)||||||
1434266|NCT01845103|||Cohort||Prospective|||||||
1434267|NCT01845090|Randomized|Parallel Assignment||Treatment||Single||||||t
1434268|NCT01845077|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434269|NCT01845064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434270|NCT01845051|||Case Control||Prospective|||||||
1434271|NCT01845038|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434272|NCT01845025|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434273|NCT01845012||Single Group Assignment||Treatment||None (Open Label)||||||
1434274|NCT01844999|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1434275|NCT01844986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434276|NCT01844973|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1434277|NCT01844960|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434278|NCT01844947||Single Group Assignment||Treatment||None (Open Label)||||||
1434279|NCT01844934|Randomized|Parallel Assignment||Treatment||Single||2 arms, one intervention, one control||||t
1434280|NCT01844921|||Case-Only||Prospective|||||||
1434281|NCT01844908||Single Group Assignment||Treatment||None (Open Label)||||||
1434282|NCT01844895||Single Group Assignment||Treatment||None (Open Label)||||||
1434283|NCT01844882|||||Retrospective|||||||
1434284|NCT01844869||Single Group Assignment||Treatment||None (Open Label)||||||
1434285|NCT01844856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434286|NCT01844843||Single Group Assignment||Treatment||None (Open Label)||||||
1434287|NCT01844830|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434288|NCT01844817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434289|NCT01844804|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1434290|NCT01844791||Single Group Assignment||Treatment||None (Open Label)||||||
1434291|NCT01844778|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434292|NCT01844765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434293|NCT01844752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434294|NCT01844739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434295|NCT01844726|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434296|NCT01844713|Randomized|Parallel Assignment||Prevention||Single|||t|||
1434297|NCT01844700|Randomized|Parallel Assignment||||None (Open Label)||||||
1434298|NCT01844687|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1434299|NCT01844674||Single Group Assignment||Other||None (Open Label)||||||
1434300|NCT01844661||Single Group Assignment||Treatment||None (Open Label)||||||
1434301|NCT01844648|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1434302|NCT01844635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434303|NCT01844622||Single Group Assignment||Supportive Care||None (Open Label)||||||
1434304|NCT01844609|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434305|NCT01844596|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434306|NCT01844583||Single Group Assignment||Treatment||None (Open Label)||||||
1434307|NCT01844570|||Cohort||Prospective|||||||
1434308|NCT01844557|||Cohort||Prospective|||||||
1434309|NCT01844544|||Case-Only||Prospective|||||||
1434310|NCT01844531|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434311|NCT01844518||Single Group Assignment||Treatment||None (Open Label)||||||
1434312|NCT01844505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434313|NCT01844492|Randomized|Single Group Assignment||Supportive Care||Single||Sample size listed is for patients (n=1420), for whom 809 surrogates completed long-term follow-up||||t
1434314|NCT01844479|Randomized|Crossover Assignment||Prevention||Single||||||t
1434315|NCT01844466||Single Group Assignment||Treatment||None (Open Label)||||||
1434316|NCT01844453|Randomized|Parallel Assignment||Treatment||Single||||t||
1434317|NCT01844440||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434318|NCT01844427|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434319|NCT01844414|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434320|NCT01844401|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434321|NCT01844388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434322|NCT01844375|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1434323|NCT01844362||Single Group Assignment||Treatment||None (Open Label)||||||
1434324|NCT01844349|||||Cross-Sectional|||||||
1434325|NCT01844336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434326|NCT01844323|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1434327|NCT01844310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434328|NCT01844297||Single Group Assignment||Treatment||None (Open Label)||||||
1434329|NCT01844284|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434330|NCT01844271|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1434331|NCT01844258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434332|NCT01844245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434333|NCT01844232||Single Group Assignment||Treatment||None (Open Label)||||||
1434334|NCT01844219|||Cohort||Retrospective|||||||
1434335|NCT01844206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434336|NCT01844193|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1434337|NCT01844180|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434338|NCT01844167|Randomized|Parallel Assignment||Treatment||Single||||||t
1434339|NCT01844154|||Case Control||Cross-Sectional|||||||
1434340|NCT01844141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434341|NCT01844128|||Cohort||Prospective|||||||
1434342|NCT01844115|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434343|NCT01844102||Single Group Assignment||Prevention||None (Open Label)||||||
1434344|NCT01844089|||||Prospective|||||||
1434345|NCT01844076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434346|NCT01844063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434347|NCT01844050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434348|NCT01844037||Single Group Assignment||Treatment||None (Open Label)||||||
1434349|NCT01844024|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434350|NCT01844011|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434351|NCT01843998||Single Group Assignment||Treatment||None (Open Label)||||||
1434352|NCT01843985||||||||||||
1434353|NCT01843972|Randomized|Parallel Assignment||Treatment||Single||||||
1434354|NCT01843959|||Cohort||Cross-Sectional|||||||
1434355|NCT01843946|||||Prospective|||||||
1434356|NCT01843933|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434357|NCT01843920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434358|NCT01843907|Randomized|Parallel Assignment||Prevention||Single|||||t|
1434359|NCT01843894|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1434360|NCT01843881|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1434361|NCT01843868||Single Group Assignment||Supportive Care||None (Open Label)||||||
1434362|NCT01843855|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1434363|NCT01843842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434364|NCT01843829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434365|NCT01843816|||Cohort||Cross-Sectional|||||||
1434366|NCT01843803|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1434367|NCT01843790|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434368|NCT01843777|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1434369|NCT01843764|||Cohort||Prospective|||||||
1434370|NCT01843751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434371|NCT01843738||Single Group Assignment||Treatment||None (Open Label)||||||
1434372|NCT01843725|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434373|NCT01843712|||Cohort||Cross-Sectional|||||||
1434374|NCT01843699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434375|NCT01843686|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1434376|NCT01843673||Single Group Assignment||Basic Science||None (Open Label)||||||
1434377|NCT01843660||Single Group Assignment||Treatment||None (Open Label)||||||
1434378|NCT01843647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434379|NCT01843634||Single Group Assignment||Treatment||None (Open Label)||||||
1434380|NCT01843621||Single Group Assignment||Prevention||None (Open Label)||||||
1434381|NCT01843608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434382|NCT01843595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434383|NCT01843582|||Case-Only||Cross-Sectional|||||||
1434384|NCT01843569||Single Group Assignment||Treatment||None (Open Label)||||||
1434385|NCT01843556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434386|NCT01843543|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434387|NCT01843530|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434388|NCT01843517|||Cohort||Prospective|||||||
1434389|NCT01843504|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434390|NCT01843491||Single Group Assignment||Health Services Research||None (Open Label)||||||
1434391|NCT01843478|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434392|NCT01843465|||Cohort||Prospective|||||||
1434393|NCT01843452||Single Group Assignment||Treatment||None (Open Label)||||||
1434394|NCT01843439||Single Group Assignment||Prevention||None (Open Label)||||||
1434395|NCT01843426||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434396|NCT01843413||Single Group Assignment||Treatment||None (Open Label)||Dose escalation for radiotherapy||||
1434397|NCT01843400|||Cohort||Prospective|||||||
1434398|NCT01843387|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434399|NCT01843374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434400|NCT01843361|||Case-Only||Prospective|||||||
1434401|NCT01843348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434402|NCT01843335|||Case-Only||Prospective|||||||
1434403|NCT01843322||Single Group Assignment||Treatment||None (Open Label)||||||
1434404|NCT01843309|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1434405|NCT01843296|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1434406|NCT01843283|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1434407|NCT01843270|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434408|NCT01843257|||Other||Other|||||||
1434409|NCT01843244|||Cohort||Prospective|||||||
1434410|NCT01843231|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434411|NCT01843218||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434412|NCT01843205|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1434413|NCT01843192|||Cohort||Prospective|||||||
1434414|NCT01843179||Single Group Assignment||Treatment||None (Open Label)||||||
1434415|NCT01843166|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1434416|NCT01843153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434417|NCT01843140|||Cohort||Prospective|||||||
1434418|NCT01843127|Randomized|Crossover Assignment||Treatment||Single|||t|||
1434419|NCT01843114|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1434420|NCT01843101|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1434421|NCT01843088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434422|NCT01843075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434423|NCT01843062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434424|NCT01843049||Single Group Assignment||Treatment||None (Open Label)||||||
1434425|NCT01843036|Randomized|Parallel Assignment||Prevention||Single||||||t
1434426|NCT01843023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434427|NCT01843010|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1434428|NCT01842997||Single Group Assignment||Prevention||None (Open Label)||||||
1434429|NCT01842984|Randomized|Parallel Assignment||Treatment||Single||||||t
1434430|NCT01842971||Single Group Assignment||Treatment||None (Open Label)||||||
1434431|NCT01842958|Randomized|Parallel Assignment||Treatment||Single||||||t
1434432|NCT01842945|Randomized|Parallel Assignment||Treatment||Single||||||t
1434433|NCT01842932|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1434434|NCT01842919|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1434435|NCT01842906|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1434436|NCT01842893|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1434437|NCT01842880|||Cohort||Cross-Sectional|||||||
1434438|NCT01842867|||Cohort||Cross-Sectional|||||||
1434439|NCT01842854|||Cohort||Cross-Sectional|||||||
1434440|NCT01842841||Single Group Assignment||Treatment||None (Open Label)||||||
1434441|NCT01842828|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1434442|NCT01842815||Single Group Assignment||Treatment||None (Open Label)||||||
1434443|NCT01842802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434444|NCT01842789|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1434445|NCT01842776|||Cohort||Prospective|||||||
1434446|NCT01842763|||||Cross-Sectional|||||||
1434447|NCT01842750||Single Group Assignment||||None (Open Label)||||||
1434448|NCT01842737|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1434449|NCT01842724|Randomized|||Treatment||||||||
1434450|NCT01842711|||Cohort||Cross-Sectional|||||||
1434451|NCT01842698||Single Group Assignment||Treatment||None (Open Label)||||||
1434452|NCT01842685||Single Group Assignment||Treatment||None (Open Label)||||||
1434453|NCT01842672||Single Group Assignment||Treatment||None (Open Label)||||||
1434454|NCT01842659||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434455|NCT01842646||Single Group Assignment||Treatment||None (Open Label)||||||
1434456|NCT01842633|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434457|NCT01842620|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1434458|NCT01842607||Single Group Assignment||Treatment||None (Open Label)||||||
1434459|NCT01842594||Single Group Assignment||Treatment||None (Open Label)||||||
1434460|NCT01842581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434461|NCT01842568|||Cohort||Prospective|||||||
1434462|NCT01842555|||Cohort||Other|||||||
1434463|NCT01842542||Single Group Assignment||Treatment||None (Open Label)||||||
1434464|NCT01842529|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434465|NCT01842516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434466|NCT01842503|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1434467|NCT01842490|||Case Control||Prospective|||||||
1434468|NCT01842477||Single Group Assignment||Treatment||None (Open Label)||||||
1434469|NCT01842464|||Cohort||Retrospective|||||||
1434470|NCT01842451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434471|NCT01842438|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1434472|NCT01842425|||Case-Only||Prospective|||||||
1434473|NCT01842412|||Case Control||Prospective|||||||
1434474|NCT01842399|Randomized|Parallel Assignment||Prevention||||||||
1434475|NCT01842386||Single Group Assignment||Treatment||None (Open Label)||||||
1434476|NCT01842373|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1434477|NCT01842360|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1434478|NCT01842347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434479|NCT01842334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434480|NCT01842321||Single Group Assignment||Treatment||None (Open Label)||||||
1434481|NCT01842308||Single Group Assignment||Treatment||None (Open Label)||||||
1434482|NCT01842295||Single Group Assignment||Screening||None (Open Label)||||||
1434483|NCT01842282||Single Group Assignment||Treatment||None (Open Label)||||||
1434484|NCT01842269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434485|NCT01842256|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434486|NCT01842243|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1434487|NCT01842230|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434488|NCT01842217|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1434489|NCT01842204|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1434490|NCT01842191|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434491|NCT01842178|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1434492|NCT01842165||Single Group Assignment||Treatment||None (Open Label)||||||
1434493|NCT01842139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434494|NCT01842126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434495|NCT01842113|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1434496|NCT01842100|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434497|NCT01842087|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1434498|NCT01842074||Single Group Assignment||Treatment||None (Open Label)||||||
1434499|NCT01842061|Randomized|Parallel Assignment||Prevention||Single||||||t
1434500|NCT01842048|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1434501|NCT01842035||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434502|NCT01842022|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1434503|NCT01842009||Single Group Assignment||Treatment||None (Open Label)||||||
1434504|NCT01841996|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434505|NCT01841983|Randomized|Single Group Assignment||||None (Open Label)||||||
1434506|NCT01841970||Single Group Assignment||Treatment||None (Open Label)||||||
1434507|NCT01841957|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434508|NCT01841944|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1434509|NCT01841931||Single Group Assignment||Treatment||None (Open Label)||||||
1434510|NCT01841918|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1434511|NCT01841905|||Cohort||Prospective|||||||
1434512|NCT01841892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434513|NCT01841879|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434514|NCT01841866|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434515|NCT01841853|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1434516|NCT01841840|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1434517|NCT01841827|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1434518|NCT01841814||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434519|NCT01841801|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1434520|NCT01841788|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1434521|NCT01841775||Single Group Assignment||Treatment||None (Open Label)||||||
1434522|NCT01841762||Single Group Assignment||Treatment||None (Open Label)||||||
1434523|NCT01841749||Single Group Assignment||||None (Open Label)||||||
1434524|NCT01841736|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434525|NCT01841723||Single Group Assignment||Treatment||None (Open Label)||||||
1434526|NCT01841710|||Cohort||Cross-Sectional|||||||
1434527|NCT01841697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434528|NCT01841684|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434529|NCT01841671|Randomized|Parallel Assignment||Treatment||Single||||||t
1434530|NCT01841658|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1434531|NCT01841645||Single Group Assignment||Basic Science||None (Open Label)||||||
1434532|NCT01841632||Single Group Assignment||Treatment||None (Open Label)||||||
1434533|NCT01841619||Single Group Assignment||Treatment||None (Open Label)||||||
1434534|NCT01841606|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434535|NCT01841593|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434536|NCT01841580|||Case-Only||Prospective|||||||
1434537|NCT01841567||Single Group Assignment||Treatment||None (Open Label)||||||
1434538|NCT01841554||Single Group Assignment||Treatment||None (Open Label)||||||
1434539|NCT01841541|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434540|NCT01841528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434541|NCT01841515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434542|NCT01841502|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1434543|NCT01841489|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434544|NCT01841476||Single Group Assignment||Treatment||None (Open Label)||||||
1434545|NCT01841463||Single Group Assignment||Treatment||None (Open Label)||||||
1434546|NCT01841450|Non-Randomized|||Treatment||None (Open Label)||||||
1434547|NCT01841437|||Cohort||Prospective|||||||
1434548|NCT01841424|Randomized|Parallel Assignment||Treatment||Single||||||t
1434549|NCT01841411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434550|NCT01841398|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434551|NCT01841385|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434552|NCT01841372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434553|NCT01841359||Single Group Assignment||Treatment||None (Open Label)||||||
1434554|NCT01841346|||Case-Only||Prospective|||||||
1434555|NCT01841333||Single Group Assignment||Treatment||None (Open Label)||||||
1434556|NCT01841320|Randomized|Parallel Assignment||||None (Open Label)||||||
1434557|NCT01841307||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434558|NCT01841294|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1434559|NCT01841281|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434560|NCT01841268|||Case-Control||Prospective|||||||
1434561|NCT01841255|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434562|NCT01841242|Randomized|Parallel Assignment||Prevention||None (Open Label)||2 randomized groups||||
1434563|NCT01841229||||||||||||
1434564|NCT01841216|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1434565|NCT01841203|||Cohort||Prospective|||||||
1434566|NCT01841190|||Cohort||Prospective|||||||
1434567|NCT01841177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434568|NCT01841164|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1434569|NCT01841151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434570|NCT01841138|||Cohort||Prospective|||||||
1434571|NCT01841125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434572|NCT01841112|Randomized|Parallel Assignment||Treatment||Double||||||
1434573|NCT01841099|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1434574|NCT01841086|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434575|NCT01841073|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1434576|NCT01841060||Single Group Assignment||||None (Open Label)||||||
1434577|NCT01841047||Single Group Assignment||Treatment||None (Open Label)||||||
1434578|NCT01841034|||Cohort||Prospective|||||||
1434579|NCT01841021||Single Group Assignment||Treatment||None (Open Label)||||||
1434580|NCT01841008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434581|NCT01840995|||||Prospective|||||||
1434582|NCT01840982|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434583|NCT01840969|||Case-Only||Prospective|||||||
1434584|NCT01840956||Single Group Assignment||Treatment||None (Open Label)||||||
1434585|NCT01840943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434586|NCT01840930|||Cohort||Prospective|||||||
1434587|NCT01840917|||Case-Crossover||Prospective|||||||
1434588|NCT01840904|||Case-Crossover||Prospective|||||||
1434589|NCT01840891|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1434590|NCT01840878|||Case-Crossover||Prospective|||||||
1434591|NCT01840865|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1434592|NCT01840852|||Case-Crossover||Prospective|||||||
1434593|NCT01840839|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1434594|NCT01840826|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434595|NCT01840813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434596|NCT01840800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434597|NCT01840787||Single Group Assignment||||Single|||t|||
1434598|NCT01840774|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1434599|NCT01840761|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434600|NCT01840748|||Cohort||Prospective|||||||
1434601|NCT01840735|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1434602|NCT01840722|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434603|NCT01840709|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1434604|NCT01840696||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434605|NCT01840683||Single Group Assignment||Treatment||None (Open Label)||||||
1434606|NCT01840670|||Case-Only||Prospective|||||||
1434607|NCT01840657|||Case-Only||Prospective|||||||
1434608|NCT01840644|||||Cross-Sectional|||||||
1434609|NCT01840631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434610|NCT01840618|||Case-Control||Cross-Sectional|||||||
1434611|NCT01840605|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1434612|NCT01840592||Single Group Assignment||Treatment||None (Open Label)||||||
1434613|NCT01840579|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434614|NCT01840566||Single Group Assignment||Treatment||None (Open Label)||||||
1434615|NCT01840553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434616|NCT01840540||Single Group Assignment||Treatment||None (Open Label)||||||
1434617|NCT01840527|||Case-Control||Prospective|||||||
1434618|NCT01840514|||Cohort||Prospective|||||||
1434619|NCT01840501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434620|NCT01840488||Single Group Assignment||Treatment||None (Open Label)||||||
1434621|NCT01840475|||Cohort||Prospective|||||||
1434622|NCT01840462|||Case Control||Prospective|||||||
1434623|NCT01840449|||Cohort||Prospective|||||||
1434624|NCT01840436|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1434625|NCT01840423|Randomized|Crossover Assignment||||Double|||t||t|
1434626|NCT01840410|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434627|NCT01840397|||Cohort||Prospective|||||||
1434628|NCT01840384|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1434629|NCT01840371|Randomized|Parallel Assignment||||Single|||t|||
1434630|NCT01840358||Single Group Assignment||||None (Open Label)||||||
1434631|NCT01840345||Single Group Assignment||Treatment||None (Open Label)||||||
1434632|NCT01840332||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434633|NCT01840319|||Case-Only||Retrospective|||||||
1434634|NCT01840306|||Cohort||Prospective|||||||
1434635|NCT01840293|||Cohort||Other|||||||
1434636|NCT01840280|||Other||Prospective|||||||
1434637|NCT01840267|||||Prospective|||||||
1434638|NCT01840254|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1435034|NCT01835054|||Cohort||Prospective|||||||
1434639|NCT01840241|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1434640|NCT01840228|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1434641|NCT01840215|||||Prospective|||||||
1434642|NCT01840202|||Case Control||Cross-Sectional|||||||
1434643|NCT01840189|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434644|NCT01840176|Randomized|Parallel Assignment||Other||Double|||t|||t
1434645|NCT01840163|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1434646|NCT01840150||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434647|NCT01840137||Single Group Assignment||Treatment||None (Open Label)||||||
1434648|NCT01840124||Single Group Assignment||Treatment||None (Open Label)||||||
1434649|NCT01840111||Single Group Assignment||Basic Science||None (Open Label)||||||
1434650|NCT01840098|Randomized|Crossover Assignment||Treatment||Single|||t|||
1434651|NCT01840085||Single Group Assignment||Treatment||None (Open Label)||||||
1434652|NCT01840072|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434653|NCT01840059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434654|NCT01840046||Single Group Assignment||Treatment||None (Open Label)||||||
1434655|NCT01840033|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434656|NCT01840020|||Case-Only||Prospective|||||||
1434657|NCT01840007||Single Group Assignment||Treatment||None (Open Label)||||||
1434658|NCT01839994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434659|NCT01839981||Single Group Assignment||Treatment||None (Open Label)||||||
1434660|NCT01839968|||Case-Only||Prospective|||||||
1434661|NCT01839955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434662|NCT01839942|||Cohort||Retrospective|||||||
1434663|NCT01839929||Single Group Assignment||Treatment||None (Open Label)||||||
1434664|NCT01839916||Single Group Assignment||Treatment||None (Open Label)||||||
1434665|NCT01839903|Non-Randomized|Parallel Assignment||Prevention||Double|||t|t||
1434666|NCT01839890|Randomized|Parallel Assignment||||None (Open Label)||||||
1434667|NCT01839877||Single Group Assignment||Treatment||None (Open Label)||||||
1434668|NCT01839864||Single Group Assignment||Treatment||Triple||||t|t|t
1434669|NCT01839851|||Cohort||Prospective|||||||
1434670|NCT01839838||||Treatment||||||||
1434671|NCT01839825|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434672|NCT01839812||Single Group Assignment||Supportive Care||None (Open Label)||||||
1434673|NCT01839799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434674|NCT01839786|||Other||Other|||||||
1434675|NCT01839773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434676|NCT01839760|||Cohort||Prospective|||||||
1434677|NCT01839747||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434678|NCT01839734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434679|NCT01839721|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1434680|NCT01839708|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1434681|NCT01839695||Single Group Assignment||Treatment||None (Open Label)||||||
1434682|NCT01839682|||Case-Only||Prospective|||||||
1434683|NCT01839669|Randomized|Parallel Assignment||Treatment||Single||||||t
1434684|NCT01839656|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434685|NCT01839643|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1434686|NCT01839630|||Case-Control||Prospective|||||||
1434687|NCT01839617|Randomized|Parallel Assignment||Treatment||Single||||||t
1434688|NCT01839604||Single Group Assignment||Treatment||None (Open Label)||||||
1434689|NCT01839591||Single Group Assignment||Basic Science||None (Open Label)||||||
1434690|NCT01839578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434691|NCT01839565|||Case-Only||Prospective|||||||
1434692|NCT01839552||Single Group Assignment||Supportive Care||None (Open Label)||||||
1434693|NCT01839539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434694|NCT01839526||Single Group Assignment||Basic Science||None (Open Label)||||||
1434695|NCT01839513|||Cohort||Prospective|||||||
1434696|NCT01839500|||Cohort||Prospective|||||||
1434697|NCT01839487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434698|NCT01839474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434699|NCT01839461|||Case-Only||Prospective|||||||
1434700|NCT01839448|||Cohort||Prospective|||||||
1434701|NCT01839435||Single Group Assignment||||None (Open Label)||||||
1434702|NCT01839422|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1434703|NCT01839409|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1434704|NCT01839396|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1434705|NCT01839383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434706|NCT01839370|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434707|NCT01839357||Single Group Assignment||Treatment||None (Open Label)||||||
1434708|NCT01839344|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1434709|NCT01839331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434710|NCT01839318|Randomized|Crossover Assignment||||None (Open Label)||||||
1434711|NCT01839305||Single Group Assignment||Treatment||None (Open Label)||||||
1434712|NCT01839292|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1434713|NCT01839279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434714|NCT01839266|||Cohort||Retrospective|||||||
1434715|NCT01839253|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1434716|NCT01839240||Single Group Assignment||Treatment||None (Open Label)||||||
1435189|NCT01833039||||||||||||
1434717|NCT01839227||Single Group Assignment||Screening||None (Open Label)||||||
1434718|NCT01839214|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1434719|NCT01839201|Randomized|Parallel Assignment||||Single|||||t|
1434720|NCT01839188||Single Group Assignment||Prevention||None (Open Label)||||||
1434721|NCT01839175|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434722|NCT01839162|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434723|NCT01839149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434724|NCT01839136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434725|NCT01839123|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1434726|NCT01839110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434727|NCT01839097||Single Group Assignment||Treatment||None (Open Label)||||||
1434728|NCT01839084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434729|NCT01839071||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434730|NCT01839058|||Cohort||Prospective|||||||
1434731|NCT01839045|||Case-Only||Prospective|||||||
1434732|NCT01839032||Single Group Assignment||Treatment||None (Open Label)||||||
1434733|NCT01839019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434734|NCT01839006|||Cohort||Retrospective|||||||
1434735|NCT01838993|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1434736|NCT01838980||Single Group Assignment||Screening||None (Open Label)||||||
1434737|NCT01838967|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434738|NCT01838954|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434739|NCT01838941||Single Group Assignment||Treatment||None (Open Label)||||||
1434740|NCT01838928||Single Group Assignment||Basic Science||Single|||||t|
1434741|NCT01838915|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1434742|NCT01838902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434743|NCT01838889|Randomized|Parallel Assignment||Treatment||Single||||||t
1434744|NCT01838876||Single Group Assignment||Treatment||None (Open Label)||||||
1434745|NCT01838863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434746|NCT01838850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434747|NCT01838824|Randomized|Crossover Assignment||Treatment||Single||||||t
1434748|NCT01838811||Single Group Assignment||Treatment||Single||||||t
1434749|NCT01838798|||Cohort||Prospective|||||||
1434750|NCT01838785||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434751|NCT01838772||Single Group Assignment||Treatment||None (Open Label)||||||
1434752|NCT01838759|||Cohort||Prospective|||||||
1434753|NCT01838746|||Cohort||Retrospective|||||||
1434754|NCT01838733|||Cohort||Prospective|||||||
1434755|NCT01838720|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434756|NCT01838707|Randomized|Parallel Assignment||Treatment||Double||||t||t
1434757|NCT01838694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434758|NCT01838681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434759|NCT01838668|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434760|NCT01838655||Single Group Assignment||Treatment||None (Open Label)||||||
1434761|NCT01838642|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434762|NCT01838629|||Ecologic or Community||Cross-Sectional|||||||
1434763|NCT01838616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434764|NCT01838603|||Other||Other|||||||
1434765|NCT01838590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434766|NCT01838577|||Cohort||Prospective|||||||
1434767|NCT01838564|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1434768|NCT01838551||Single Group Assignment||Treatment||None (Open Label)||||||
1434769|NCT01838538|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434770|NCT01838525|||Case Control||Prospective|||||||
1434771|NCT01838512|||Cohort||Prospective|||||||
1434772|NCT01838499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434773|NCT01838486||Single Group Assignment||Treatment||None (Open Label)||||||
1434774|NCT01838473|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1434775|NCT01838460|Randomized|Crossover Assignment||Treatment||Single|||t|||
1434776|NCT01838447|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1434777|NCT01838434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434778|NCT01838421|||Cohort||Retrospective|||||||
1434779|NCT01838408|Randomized|Parallel Assignment||||Single|||||t|
1434780|NCT01838395||Single Group Assignment||Treatment||None (Open Label)||||||
1434781|NCT01838382||Single Group Assignment||Treatment||None (Open Label)||||||
1434782|NCT01838369||Single Group Assignment||Treatment||None (Open Label)||||||
1434783|NCT01838356|||Case-Only||Prospective|||||||
1434784|NCT01838343|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1434785|NCT01838330|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1434786|NCT01838317||Single Group Assignment||Treatment||None (Open Label)||||||
1434787|NCT01838304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434788|NCT01838291|||Cohort||Prospective|||||||
1434789|NCT01838278||Single Group Assignment||Treatment||None (Open Label)||||||
1434790|NCT01838265|||Cohort||Prospective|||||||
1434791|NCT01838252|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1434792|NCT01838239||Single Group Assignment||Basic Science||None (Open Label)||||||
1434793|NCT01838226|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1434794|NCT01838213|||||Prospective|||||||
1434795|NCT01838200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434797|NCT01838174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434798|NCT01838161|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434799|NCT01838148|||Other||Prospective|||||||
1434800|NCT01838135|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434801|NCT01838122|||Cohort||Prospective|||||||
1434802|NCT01838109|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434803|NCT01838096||Single Group Assignment||Treatment||None (Open Label)||||||
1434804|NCT01838083|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434805|NCT01838070|||Cohort||Prospective|||||||
1434806|NCT01838057|||Cohort||Prospective|||||||
1434807|NCT01838044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434808|NCT01838031|Non-Randomized|Parallel Assignment||Screening||Single|||t|||
1434809|NCT01838018|||Case-Control||Cross-Sectional|||||||
1434810|NCT01838005|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1434811|NCT01837992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434812|NCT01837979|||Cohort||Prospective|||||||
1434813|NCT01837966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434814|NCT01837953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434815|NCT01837940|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434816|NCT01837927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434817|NCT01837914|Randomized|Crossover Assignment||Treatment||Single||||||t
1434818|NCT01837901|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434819|NCT01837888|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1434820|NCT01837875|Randomized|Single Group Assignment||Health Services Research||Single||||t||
1434821|NCT01837862|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434822|NCT01837849|||Case Control||Prospective|||||||
1434823|NCT01837836||Single Group Assignment||Prevention||None (Open Label)||||||
1434824|NCT01837823||Single Group Assignment||Treatment||None (Open Label)||||||
1434825|NCT01837810|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1434826|NCT01837797|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434827|NCT01837784|||Cohort||Prospective|||||||
1434828|NCT01837771|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1434829|NCT01837758|||Cohort||Prospective|||||||
1434830|NCT01837745|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1434831|NCT01837732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434832|NCT01837719|Randomized|Crossover Assignment||||None (Open Label)||||||
1434833|NCT01837706|||Cohort||Prospective|||||||
1434834|NCT01837693|Randomized|Parallel Assignment||Screening||Single||||||t
1434835|NCT01837680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434836|NCT01837667||Single Group Assignment||Treatment||None (Open Label)||||||
1434837|NCT01837654||Single Group Assignment||Treatment||None (Open Label)||||||
1434838|NCT01837641|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1434839|NCT01837628|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434840|NCT01837615||Single Group Assignment||Treatment||None (Open Label)||||||
1434841|NCT01837602||Single Group Assignment||Treatment||None (Open Label)||||||
1434842|NCT01837589||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434843|NCT01837576||Single Group Assignment||||Single|||||t|
1434844|NCT01837563|||Cohort||Prospective|||||||
1434845|NCT01837550|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1434846|NCT01837537|||Cohort||Prospective|||||||
1434847|NCT01837524|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1434848|NCT01837511|||Cohort||Retrospective|||||||
1434849|NCT01837498|||Cohort||Prospective|||||||
1434850|NCT01837485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434851|NCT01837472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434852|NCT01837459|||Cohort||Prospective|||||||
1434853|NCT01837446|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1434854|NCT01837433|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434855|NCT01837420|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1434856|NCT01837407||Single Group Assignment||Treatment||Single|||t|||
1434857|NCT01837394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434858|NCT01837381||Single Group Assignment||Treatment||None (Open Label)||||||
1434859|NCT01837368|||Case-Only||Cross-Sectional|||||||
1434860|NCT01837355|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1434861|NCT01837342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434862|NCT01837329||Single Group Assignment||Treatment||None (Open Label)||||||
1434863|NCT01837316|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434864|NCT01837303|||Cohort||Cross-Sectional|||||||
1434865|NCT01837290|Randomized|Parallel Assignment||||Double|||t||t|
1434866|NCT01837277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434867|NCT01837264||Single Group Assignment||Treatment||None (Open Label)||||||
1434868|NCT01837251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434869|NCT01837238|Randomized|Parallel Assignment||||Single|||t|||
1434870|NCT01837225|||Cohort||Prospective|||||||
1434871|NCT01837199|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1434872|NCT01837186|||Cohort||Retrospective|||||||
1434873|NCT01837173|||Cohort||Retrospective|||||||
1434874|NCT01837160|||Cohort||Prospective|||||||
1434875|NCT01837147|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434876|NCT01837134|Randomized|Parallel Assignment||Treatment||Single||||||t
1434877|NCT01837121|Randomized|Parallel Assignment||Health Services Research||Double||||t||t
1434878|NCT01837108|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1434879|NCT01837095||Single Group Assignment||Treatment||None (Open Label)||||||
1434880|NCT01837082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434881|NCT01837069|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1434882|NCT01837056|||Case-Only||Prospective|||||||
1434883|NCT01837043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434884|NCT01837030|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1434885|NCT01837017|Randomized|Parallel Assignment||Prevention||Single||||||t
1434886|NCT01837004||Single Group Assignment||Treatment||Triple|||t||t|t
1434887|NCT01836991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434888|NCT01836978|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1434889|NCT01836965||Single Group Assignment||Treatment||None (Open Label)||||||
1434890|NCT01836952|||Cohort||Prospective|||||||
1434891|NCT01836939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434892|NCT01836926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434893|NCT01836913|||Cohort||Prospective|||||||
1434894|NCT01836900|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1434895|NCT01836887|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1434896|NCT01836874|||Case-Only||Prospective|||||||
1434897|NCT01836861||Single Group Assignment||Basic Science||None (Open Label)||||||
1434898|NCT01836848||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434899|NCT01836835|||Case Control||Prospective|||||||
1434900|NCT01836822||Single Group Assignment||Diagnostic||Single|||||t|
1434901|NCT01836809|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1434902|NCT01836796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434903|NCT01836783|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434904|NCT01836770|||Cohort||Prospective|||||||
1434905|NCT01836757|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1434906|NCT01836744|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1434907|NCT01836731|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434908|NCT01836718|||Case-Control||Prospective|||||||
1434909|NCT01836705|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1434910|NCT01836692||Single Group Assignment||Treatment||None (Open Label)||||||
1434911|NCT01836679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434912|NCT01836666|||Ecologic or Community||Prospective|||||||
1434913|NCT01836653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434914|NCT01836640|||||Prospective|||||||
1434915|NCT01836627|Randomized|Parallel Assignment||Treatment||Single|||||t|
1434916|NCT01836614|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1434917|NCT01836601|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1434918|NCT01836588|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1434919|NCT01836575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434920|NCT01836562||Single Group Assignment||Treatment||None (Open Label)||||||
1434921|NCT01836549||Single Group Assignment||Treatment||None (Open Label)||||||
1434922|NCT01836536||Single Group Assignment||Basic Science||None (Open Label)||||||
1434923|NCT01836523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434924|NCT01836510|||Cohort||Prospective|||||||
1434925|NCT01836497|||Case-Only||Prospective|||||||
1434926|NCT01836484|||Case-Only||Retrospective|||||||
1434927|NCT01836471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434928|NCT01836458|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434929|NCT01836445|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1434930|NCT01836432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434931|NCT01836419|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434932|NCT01836406|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1434933|NCT01836393|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434934|NCT01836380|Randomized|Parallel Assignment||Treatment||Single|||||t|
1434935|NCT01836367||Single Group Assignment||||None (Open Label)||||||
1434936|NCT01836354|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434937|NCT01836341||Single Group Assignment||Treatment||None (Open Label)||||||
1434938|NCT01836328|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1434939|NCT01836315|||Cohort||Prospective|||||||
1434940|NCT01836302|||Case-Only||Prospective|||||||
1434941|NCT01836289||Single Group Assignment||Treatment||None (Open Label)||||||
1434942|NCT01836276|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434943|NCT01836263|||Cohort||Prospective|||||||
1434944|NCT01836237|Randomized|Parallel Assignment||Prevention||Single|||t|||
1434945|NCT01836224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1434946|NCT01836211|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1434947|NCT01836198|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1434948|NCT01836185|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1434949|NCT01836172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434950|NCT01836159|Randomized|Parallel Assignment||||Single||||||t
1434951|NCT01836146||Single Group Assignment||Treatment||None (Open Label)||||||
1434952|NCT01836133|||Cohort||Prospective|||||||
1434953|NCT01836120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1434954|NCT01836107||||||||||||
1434955|NCT01836094|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1434956|NCT01836081||Single Group Assignment||Diagnostic||None (Open Label)||||||
1434957|NCT01836068||Single Group Assignment||Basic Science||None (Open Label)||||||
1434958|NCT01836055|||Case Control||Cross-Sectional|||||||
1434959|NCT01836042|||Cohort||Retrospective|||||||
1434960|NCT01836029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434961|NCT01836016|Randomized|Parallel Assignment||Treatment||Single||||||t
1434962|NCT01836003|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1434963|NCT01835990|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1434964|NCT01835977|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434965|NCT01835964||Single Group Assignment||||None (Open Label)||||||
1434966|NCT01835951|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1434967|NCT01835938|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1434968|NCT01835925|||Case Control||Prospective|||||||
1434969|NCT01835912|Randomized|Crossover Assignment||||Double|||t||t|
1434970|NCT01835899|Randomized|Parallel Assignment||Treatment||Double||||||
1434971|NCT01835886||Single Group Assignment||Health Services Research||None (Open Label)||||||
1434972|NCT01835873|Randomized|Parallel Assignment||Treatment||Single|||t|||
1434973|NCT01835860||Single Group Assignment||Treatment||None (Open Label)||||||
1434974|NCT01835847||Single Group Assignment||Treatment||None (Open Label)||||||
1434975|NCT01835834||Single Group Assignment||Treatment||None (Open Label)||||||
1434976|NCT01835821||Single Group Assignment||Treatment||None (Open Label)||||||
1434977|NCT01835808|||Cohort||Prospective|||||||
1434978|NCT01835795|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1434979|NCT01835782|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1434980|NCT01835769||||||||||||
1434981|NCT01835756|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434982|NCT01835743|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1434983|NCT01835730|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1434984|NCT01835717|||Cohort||Cross-Sectional|||||||
1434985|NCT01835704|||Ecologic or Community||Prospective|||||||
1434986|NCT01835691|Randomized|Parallel Assignment||Treatment||Single|||||t|
1434987|NCT01835678|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1434988|NCT01835665||Single Group Assignment||||None (Open Label)||||||
1434989|NCT01835652|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1434990|NCT01835639||Single Group Assignment||Treatment||None (Open Label)||||||
1434991|NCT01835626||Single Group Assignment||Treatment||None (Open Label)||||||
1434992|NCT01835613||Single Group Assignment||Treatment||None (Open Label)||||||
1434993|NCT01835600|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1434994|NCT01835587||Single Group Assignment||Treatment||None (Open Label)||||||
1434995|NCT01835574||Single Group Assignment||Prevention||None (Open Label)||||||
1434996|NCT01835561|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1434997|NCT01835548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1434998|NCT01835535||Single Group Assignment||Treatment||None (Open Label)||||||
1434999|NCT01835522|||Cohort||Cross-Sectional|||||||
1435000|NCT01835509|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435001|NCT01835496||Single Group Assignment||||None (Open Label)||||||
1435002|NCT01835483|||Case Control||Retrospective|||||||
1435003|NCT01835470||Single Group Assignment||Treatment||None (Open Label)||||||
1435004|NCT01835457|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1435005|NCT01835444|||||Prospective|||||||
1435006|NCT01835431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435007|NCT01835418|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435008|NCT01835405|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435009|NCT01835392|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1435010|NCT01835379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435011|NCT01835366||||||||||||
1435012|NCT01835353|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1435013|NCT01835340||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435014|NCT01835327|||Case-Control||Prospective|||||||
1435015|NCT01835314||||||||||||
1435016|NCT01835301|||Cohort||Prospective|||||||
1435017|NCT01835288||Single Group Assignment||Treatment||None (Open Label)||||||
1435018|NCT01835275|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1435019|NCT01835262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435020|NCT01835249|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1435021|NCT01835236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435022|NCT01835223||Single Group Assignment||Treatment||None (Open Label)||||||
1435023|NCT01835210|||Cohort||Retrospective|||||||
1435024|NCT01835197|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1435025|NCT01835184||Single Group Assignment||Treatment||None (Open Label)||||||
1435026|NCT01835158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435027|NCT01835145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435028|NCT01835132||Single Group Assignment||Treatment||None (Open Label)||Subcutaneous injection of 60 mg gevokizumab||||
1435029|NCT01835119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435030|NCT01835106|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1435031|NCT01835093||Single Group Assignment||Treatment||None (Open Label)||||||
1435032|NCT01835080|||Cohort||Prospective|||||||
1435033|NCT01835067|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1435035|NCT01835041||Single Group Assignment||Treatment||None (Open Label)||||||
1435036|NCT01835028|||Cohort||Prospective|||||||
1435037|NCT01835015|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1435038|NCT01835002||Single Group Assignment||Treatment||None (Open Label)||||||
1435039|NCT01834989|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1435040|NCT01834976|||Cohort||Prospective|||||||
1435041|NCT01834963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435042|NCT01834950||Single Group Assignment||Other||None (Open Label)||||||
1435043|NCT01834937|||Cohort||Prospective|||||||
1435044|NCT01834924|Non-Randomized|Single Group Assignment||Health Services Research||Single||||||t
1435045|NCT01834911||Single Group Assignment||Treatment||None (Open Label)||||||
1435046|NCT01834898|||||Prospective|||||||
1435047|NCT01834885|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435048|NCT01834872|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435049|NCT01834859|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435050|NCT01834846|Randomized|Parallel Assignment||Treatment||Single||||||t
1435051|NCT01834833|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435052|NCT01834820|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1435053|NCT01834807|||Cohort||Retrospective|||||||
1435054|NCT01834794||Single Group Assignment||Treatment||None (Open Label)||||||
1435055|NCT01834781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435056|NCT01834768||Single Group Assignment||Treatment||None (Open Label)||||||
1435057|NCT01834755||Single Group Assignment||Health Services Research||None (Open Label)||||||
1435058|NCT01834742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435059|NCT01834729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435060|NCT01834716|Randomized|Parallel Assignment||Prevention||Single||||||t
1435061|NCT01834703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435062|NCT01834690|||Cohort|||||||||
1435063|NCT01834677|||Cohort||Prospective|||||||
1435064|NCT01834664||Single Group Assignment||Treatment||None (Open Label)||||||
1435065|NCT01834651||Single Group Assignment||Treatment||None (Open Label)||||||
1435066|NCT01834638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435067|NCT01834625|||Case-Control||Prospective|||||||
1435068|NCT01834612|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1435069|NCT01834599|||Cohort||Prospective|||||||
1435070|NCT01834586||Single Group Assignment||Treatment||None (Open Label)||||||
1435071|NCT01834573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435072|NCT01834560|||Cohort||Prospective|||||||
1435073|NCT01834547|Randomized|Crossover Assignment||Health Services Research||Triple|||t|t|t|
1435074|NCT01834534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435075|NCT01834521|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435076|NCT01834508||Single Group Assignment||Treatment||None (Open Label)||||||
1435077|NCT01834495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435078|NCT01834482|Randomized|Parallel Assignment||Treatment||Single||||||t
1435079|NCT01834469||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435080|NCT01834456|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1435081|NCT01834443|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435082|NCT01834430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435083|NCT01834417|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1435084|NCT01834404|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435085|NCT01834391|||Case Control||Prospective|||||||
1435086|NCT01834378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435087|NCT01834365|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1435088|NCT01834352|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1435089|NCT01834339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435090|NCT01834326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435091|NCT01834313|||Cohort||Cross-Sectional|||||||
1435092|NCT01834300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435093|NCT01834287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435094|NCT01834274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435095|NCT01834261|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1435096|NCT01834248||Single Group Assignment||Treatment||None (Open Label)||||||
1435097|NCT01834235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435098|NCT01834222|||Cohort||Prospective|||||||
1435099|NCT01834209||||||||||||
1435100|NCT01834196||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1435101|NCT01834183|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435102|NCT01834170||Single Group Assignment||Treatment||None (Open Label)||||||
1435103|NCT01834157|||Cohort||Prospective|||||||
1435104|NCT01834144|Randomized|Parallel Assignment||Other||Single||||||t
1435105|NCT01834131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435106|NCT01834118|||Cohort||Prospective|||||||
1435107|NCT01834105|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1435108|NCT01834092|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1435109|NCT01834079||Single Group Assignment||Treatment||None (Open Label)||||||
1435110|NCT01834066||Single Group Assignment||Treatment||None (Open Label)||||||
1435111|NCT01834053||Single Group Assignment||Treatment||None (Open Label)||||||
1435112|NCT01834040||Single Group Assignment||Treatment||None (Open Label)||||||
1435113|NCT01834027|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435114|NCT01834014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435115|NCT01834001|||Cohort||Prospective|||||||
1435116|NCT01833988|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435117|NCT01833975||Single Group Assignment||Treatment||None (Open Label)||||||
1435118|NCT01833962|||Cohort||Retrospective|||||||
1435119|NCT01833949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435120|NCT01833936|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1435121|NCT01833923||Single Group Assignment||Treatment||None (Open Label)||||||
1435122|NCT01833910|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1435123|NCT01833897||Single Group Assignment||Treatment||None (Open Label)||||||
1435124|NCT01833884||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435125|NCT01833871||Single Group Assignment||Diagnostic||Triple|||t|t|t|
1435126|NCT01833858|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435127|NCT01833845||Single Group Assignment||Treatment||None (Open Label)||||||
1435128|NCT01833832||Single Group Assignment||Treatment||None (Open Label)||||||
1435129|NCT01833819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435130|NCT01833806||Single Group Assignment||Supportive Care||None (Open Label)||||||
1435131|NCT01833793|||Cohort||Prospective|||||||
1435132|NCT01833780|||Cohort||Prospective|||||||
1435133|NCT01833767||Single Group Assignment||Treatment||None (Open Label)||||||
1435134|NCT01833754|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435135|NCT01833741||Single Group Assignment||Treatment||None (Open Label)||||||
1435136|NCT01833728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435137|NCT01833715|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1435138|NCT01833702|||Cohort||Prospective|||||||
1435139|NCT01833689|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1435140|NCT01833676|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435141|NCT01833663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435142|NCT01833650|Randomized|Factorial Assignment||Prevention||Single|||||t|
1435143|NCT01833637|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435144|NCT01833624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435145|NCT01833611|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435146|NCT01833598|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435147|NCT01833585||Single Group Assignment||Treatment||None (Open Label)||||||
1435148|NCT01833572||Single Group Assignment||Treatment||None (Open Label)||||||
1435149|NCT01833559|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435150|NCT01833546|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435151|NCT01833533|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435152|NCT01833520||Single Group Assignment||Treatment||None (Open Label)||||||
1435153|NCT01833507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435154|NCT01833494||Single Group Assignment||Treatment||None (Open Label)||||||
1435155|NCT01833481|||Case Control||Retrospective|||||||
1435156|NCT01833468|||Case-Crossover||Cross-Sectional|||||||
1435157|NCT01833455|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1435158|NCT01833442|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1435159|NCT01833429|||Cohort|||||||||
1435160|NCT01833416|||Cohort||Prospective|||||||
1435161|NCT01833403||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435162|NCT01833390||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435163|NCT01833377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435164|NCT01833364||Single Group Assignment||Treatment||None (Open Label)||||||
1435165|NCT01833351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435166|NCT01833338||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435167|NCT01833325||Single Group Assignment||Treatment||None (Open Label)||||||
1435168|NCT01833312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435169|NCT01833299|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1435170|NCT01833286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435171|NCT01833273||Single Group Assignment||Treatment||None (Open Label)||||||
1435172|NCT01833260|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435173|NCT01833247|||Case-Only||Prospective|||||||
1435174|NCT01833234|||Cohort||Prospective|||||||
1435175|NCT01833221||Single Group Assignment||Basic Science||None (Open Label)||||||
1435176|NCT01833208||Single Group Assignment||Treatment||None (Open Label)||||||
1435177|NCT01833195|||Cohort||Prospective|||||||
1435178|NCT01833182|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435179|NCT01833169||Single Group Assignment||Treatment||None (Open Label)||||||
1435180|NCT01833156||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435181|NCT01833143||Single Group Assignment||Treatment||None (Open Label)||||||
1435182|NCT01833130|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435183|NCT01833117|Randomized|Parallel Assignment||Treatment||Single||||||t
1435184|NCT01833104|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1435185|NCT01833091|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435186|NCT01833078||Single Group Assignment||Treatment||None (Open Label)||||||
1435187|NCT01833065|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435188|NCT01833052|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1435190|NCT01833026|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1435191|NCT01833013||Single Group Assignment||||None (Open Label)||||||
1435192|NCT01833000||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435193|NCT01832987||Single Group Assignment||||None (Open Label)||||||
1435194|NCT01832974|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1435195|NCT01832961|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435196|NCT01832948||Single Group Assignment||Treatment||None (Open Label)||||||
1435197|NCT01832935|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1435198|NCT01832922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435199|NCT01832909|Randomized|Crossover Assignment||||Single||||||t
1435200|NCT01832896||Single Group Assignment||Treatment||None (Open Label)||||||
1435201|NCT01832883|||Case-Control||Prospective|||||||
1435202|NCT01832870||Single Group Assignment||Treatment||None (Open Label)||||||
1435203|NCT01832857||Single Group Assignment||Treatment||None (Open Label)||||||
1435204|NCT01832844|Randomized|Parallel Assignment||||Single|||t|||
1435205|NCT01832831|||Case Control||Prospective|||||||
1435206|NCT01832818||Single Group Assignment||Treatment||None (Open Label)||||||
1435207|NCT01832805||Single Group Assignment||Treatment||Triple|||t|t||t
1435208|NCT01832792|Randomized|Parallel Assignment||Treatment||||||||
1435209|NCT01832779|||Other||Prospective|||||||
1435210|NCT01832766|Randomized|Crossover Assignment||||Triple|||t||t|t
1435211|NCT01832753|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1435212|NCT01832740|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1435213|NCT01832727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435214|NCT01832714|||Case Control||Prospective|||||||
1435215|NCT01832701|Randomized|Crossover Assignment||||Triple|||t||t|t
1435216|NCT01832688|||Cohort||Prospective|||||||
1435217|NCT01832675|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435218|NCT01832662|Randomized|Crossover Assignment||||Triple|||t||t|t
1435219|NCT01832649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435220|NCT01832636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435221|NCT01832623||Single Group Assignment||Health Services Research||None (Open Label)||||||
1435222|NCT01832610|||Case-Only||Other|||||||
1435223|NCT01832597|||Cohort||Retrospective|||||||
1435224|NCT01832584|Randomized|Parallel Assignment||||Double|||t||t|
1435225|NCT01832571||Single Group Assignment||||None (Open Label)||||||
1435226|NCT01832558||||Treatment||||||||
1435227|NCT01832545|Randomized|Parallel Assignment||Treatment||Single|||||t|
1435228|NCT01832532|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435229|NCT01832519|||Cohort||Prospective|||||||
1435230|NCT01832506||Single Group Assignment||Treatment||None (Open Label)||||||
1435231|NCT01832493||Single Group Assignment||Treatment||None (Open Label)||||||
1435232|NCT01832480|Randomized|Parallel Assignment||Treatment||None (Open Label)|This was an open label study|||||
1435233|NCT01832467||Single Group Assignment||Treatment||None (Open Label)||||||
1435234|NCT01832454||Single Group Assignment||||None (Open Label)||||||
1435235|NCT01832441||Single Group Assignment||Treatment||None (Open Label)||||||
1435236|NCT01832428||Single Group Assignment||Treatment||None (Open Label)||||||
1435237|NCT01832415|||Cohort||Prospective|||||||
1435238|NCT01832402|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1435239|NCT01832389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435240|NCT01832376||Single Group Assignment||Treatment||None (Open Label)||||||
1435241|NCT01832363|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435242|NCT01832350||Single Group Assignment||Supportive Care||None (Open Label)||||||
1435243|NCT01832337|Randomized|Parallel Assignment||Prevention||Single|||t|||
1435244|NCT01832324|||Case-Control||Prospective|||||||
1435245|NCT01832311|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435246|NCT01832298|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435247|NCT01832285||Single Group Assignment||Treatment||None (Open Label)||||||
1435248|NCT01832272|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435249|NCT01832259|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435250|NCT01832246|||Case-Only||Prospective|||||||
1435251|NCT01832233||Single Group Assignment||Treatment||None (Open Label)||||||
1435252|NCT01832220|||Case-Only||Cross-Sectional|||||||
1435253|NCT01832207|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435254|NCT01832194||Single Group Assignment||Treatment||None (Open Label)||||||
1435255|NCT01832181|||Cohort||Prospective|||||||
1435256|NCT01832168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435257|NCT01832155|Randomized|Parallel Assignment||||Single||||||t
1435258|NCT01832129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435259|NCT01832116||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435260|NCT01832103||Single Group Assignment||Treatment||None (Open Label)||||||
1435261|NCT01832090|Randomized|Crossover Assignment||Treatment||Single||||||t
1435262|NCT01832077|||Case Control||Prospective|||||||
1435263|NCT01832064||Single Group Assignment||||None (Open Label)||||||
1435264|NCT01832051||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435265|NCT01832038||Single Group Assignment||Treatment||None (Open Label)||||||
1435266|NCT01832025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435267|NCT01832012|Randomized|Parallel Assignment||Basic Science||Single||||||t
1435424|NCT01829945|||Case Control||Cross-Sectional|||||||
1435268|NCT01831999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435269|NCT01831986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435270|NCT01831973||Single Group Assignment||Treatment||None (Open Label)||||||
1435271|NCT01831960||Single Group Assignment||Treatment||None (Open Label)||||||
1435272|NCT01831947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435273|NCT01831934|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1435274|NCT01831921|Randomized|Parallel Assignment||Prevention||Single||||||t
1435275|NCT01831908|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435276|NCT01831895||Single Group Assignment||Treatment||None (Open Label)||||||
1435277|NCT01831882|||Case Control||Prospective|||||||
1435278|NCT01831869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435279|NCT01831856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435280|NCT01831843|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1435281|NCT01831830|Randomized|Parallel Assignment||Treatment||Single||||||t
1435282|NCT01831817|Randomized|Parallel Assignment||Treatment||Single|||||t|
1435283|NCT01831804|Randomized|Parallel Assignment||Treatment||Single|||||t|
1435284|NCT01831791||Single Group Assignment||Treatment||None (Open Label)||||||
1435285|NCT01831778|||Cohort||Prospective|||||||
1435286|NCT01831765|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435287|NCT01831752|||Case-Only||Retrospective|||||||
1435288|NCT01831739|||Cohort||Prospective|||||||
1435289|NCT01831726||Single Group Assignment||Treatment||None (Open Label)||||||
1435290|NCT01831713|||Cohort||Prospective|||||||
1435291|NCT01831700|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435292|NCT01831687|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435293|NCT01831674|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435294|NCT01831661|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435295|NCT01831648||Single Group Assignment||Health Services Research||None (Open Label)||||||
1435296|NCT01831635|||Case Control||Retrospective|||||||
1435297|NCT01831622|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1435298|NCT01831609|||Cohort||Prospective|||||||
1435299|NCT01831596||Single Group Assignment||Treatment||None (Open Label)||||||
1435300|NCT01831583|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1435301|NCT01831570||Single Group Assignment||Other||None (Open Label)||||||
1435302|NCT01831557|||Case-Only||Prospective|||||||
1435303|NCT01831544||Single Group Assignment||Treatment||None (Open Label)||||||
1435304|NCT01831531||Single Group Assignment||Treatment||None (Open Label)||||||
1435305|NCT01831518||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435306|NCT01831505||Single Group Assignment||Basic Science||None (Open Label)||||||
1435307|NCT01831492|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1435308|NCT01831479||Single Group Assignment||Treatment||None (Open Label)||||||
1435309|NCT01831466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435310|NCT01831453|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435311|NCT01831440|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435312|NCT01831427|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435313|NCT01831414|Randomized|Crossover Assignment||||None (Open Label)||||||
1435314|NCT01831401|Randomized|Factorial Assignment||||Single||||||t
1435315|NCT01831388||Single Group Assignment||Supportive Care||None (Open Label)||||||
1435316|NCT01831375|Randomized|Parallel Assignment||Prevention||Single|||t|||
1435317|NCT01831362|Randomized|Sequential Assignment||Treatment||Single||||||t
1435318|NCT01831336|||Other||Prospective|||||||
1435319|NCT01831323|||||Prospective|||||||
1435320|NCT01831310|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1435321|NCT01831297|||Cohort||Prospective|||||||
1435322|NCT01831284|||Cohort||Prospective|||||||
1435323|NCT01831271|Randomized|Parallel Assignment||Treatment||Single||||||t
1435324|NCT01831258|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1435325|NCT01831245|||Cohort||Prospective|||||||
1435326|NCT01831232||Single Group Assignment||Treatment||None (Open Label)||||||
1435327|NCT01831219|||Case Control||Prospective|||||||
1435328|NCT01831206|Randomized|Parallel Assignment||Treatment||Single||||||t
1435329|NCT01831193|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435330|NCT01831180|||Case-Control||Other|||||||
1435331|NCT01831167|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1435332|NCT01831154|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1435333|NCT01831141|||Cohort||Prospective|||||||
1435334|NCT01831128|||Cohort||Prospective|||||||
1435335|NCT01831115|||Cohort||Prospective|||||||
1435336|NCT01831102|||Case-Only||Cross-Sectional|||||||
1435337|NCT01831089||Single Group Assignment||Treatment||None (Open Label)||||||
1435338|NCT01831076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435339|NCT01831063|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1435340|NCT01831050|Randomized|Factorial Assignment||Prevention||Single||||||t
1435341|NCT01831037|||Cohort||Prospective|||||||
1435342|NCT01831024|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435343|NCT01831011|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435344|NCT01830998|||Case Control||Prospective|||||||
1435345|NCT01830985||Single Group Assignment||Treatment||None (Open Label)||||||
1435346|NCT01830972|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435347|NCT01830959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435348|NCT01830946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435349|NCT01830933|Randomized|Parallel Assignment||Prevention||Single|||t|||
1435350|NCT01830920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435351|NCT01830907|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435352|NCT01830894|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1435353|NCT01830881|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435354|NCT01830868|||Other||Prospective|||||||
1435355|NCT01830855|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1435356|NCT01830842|Non-Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1435357|NCT01830829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435358|NCT01830816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435359|NCT01830803|||Other||Prospective|||||||
1435360|NCT01830790|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1435361|NCT01830777||Single Group Assignment||Treatment||None (Open Label)||||||
1435362|NCT01830764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435363|NCT01830751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435364|NCT01830738|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435365|NCT01830725|||Case Control||Prospective|||||||
1435366|NCT01830712|||Cohort||Retrospective|||||||
1435367|NCT01830699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435368|NCT01830686|Randomized|Parallel Assignment||||Double|||t||t|
1435369|NCT01830673|||Case Control||Prospective|||||||
1435370|NCT01830660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435371|NCT01830647|||Cohort||Prospective|||||||
1435372|NCT01830634||Single Group Assignment||Prevention||None (Open Label)||||||
1435373|NCT01830621|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435374|NCT01830608|||Cohort||Prospective|||||||
1435375|NCT01830595|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1435376|NCT01830582|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1435377|NCT01830569|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435378|NCT01830556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435379|NCT01830543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435380|NCT01830530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435381|NCT01830517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435382|NCT01830504||Single Group Assignment||Treatment||None (Open Label)||||||
1435383|NCT01830491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435384|NCT01830478||Single Group Assignment||Treatment||None (Open Label)||||||
1435385|NCT01830465||Single Group Assignment||Treatment||None (Open Label)||||||
1435386|NCT01830452|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1435387|NCT01830439|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435388|NCT01830426|||Case Control||Prospective|||||||
1435389|NCT01830413|||Cohort||Prospective|||||||
1435390|NCT01830400|||||Prospective|||||||
1435391|NCT01830387|||Case Control|||||||||
1435392|NCT01830374|||Cohort||Other|||||||
1435393|NCT01830361||Single Group Assignment||Treatment||None (Open Label)||||||
1435394|NCT01830348|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435395|NCT01830335|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1435396|NCT01830322|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435397|NCT01830309|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1435398|NCT01830296|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1435399|NCT01830283|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435400|NCT01830270||Single Group Assignment||Treatment||None (Open Label)||||||
1435401|NCT01830257||Single Group Assignment||Prevention||None (Open Label)||||||
1435402|NCT01830244||Single Group Assignment||Treatment||None (Open Label)||||||
1435403|NCT01830231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435404|NCT01830218|||Case-Only||Prospective|||||||
1435405|NCT01830205|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435406|NCT01830192|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1435407|NCT01830166||Single Group Assignment||Health Services Research||None (Open Label)||||||
1435408|NCT01830153|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435409|NCT01830140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435410|NCT01830127|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435411|NCT01830114||Single Group Assignment||Treatment||None (Open Label)||||||
1435412|NCT01830101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435413|NCT01830088|Randomized|Parallel Assignment||Treatment||Single|The outcome assessors (HAM-D) are masked and do not know the treatment arm of the participant|The two treatment arms are i) Attachment Based Family Therapy and ii) Treatment as usual||||t
1435414|NCT01830075|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435415|NCT01830062||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435416|NCT01830049|||Case Control||Cross-Sectional|||||||
1435417|NCT01830036|||||Prospective|||||||
1435418|NCT01830023|||Family-Based||Prospective|||||||
1435419|NCT01830010|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435420|NCT01829997||Single Group Assignment||Treatment||None (Open Label)||||||
1435421|NCT01829984|||Cohort||Prospective|||||||
1435422|NCT01829971||Single Group Assignment||Treatment||None (Open Label)||||||
1435423|NCT01829958|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435425|NCT01829932|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435426|NCT01829919||Single Group Assignment||Treatment||None (Open Label)||||||
1435427|NCT01829906|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435428|NCT01829893|Randomized|Crossover Assignment||||None (Open Label)||||||
1435429|NCT01829880|||Cohort||Prospective|||||||
1435430|NCT01829867||Single Group Assignment||Treatment||None (Open Label)||||||
1435431|NCT01829854|||||Prospective|||||||
1435432|NCT01829841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435433|NCT01829828|||Cohort||Prospective|||||||
1435434|NCT01829815|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435435|NCT01829802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435436|NCT01829789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435437|NCT01829776||Single Group Assignment||Prevention||None (Open Label)||||||
1435438|NCT01829763||Single Group Assignment||Treatment||None (Open Label)||||||
1435439|NCT01829750|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435440|NCT01829737|||||Prospective|||||||
1435441|NCT01829724|||Cohort||Prospective|||||||
1435442|NCT01829711||Single Group Assignment||Treatment||None (Open Label)||||||
1435443|NCT01829698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435444|NCT01829685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435445|NCT01829672||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435446|NCT01829659|||Cohort||Prospective|||||||
1435447|NCT01829646||Single Group Assignment||||None (Open Label)||||||
1435448|NCT01829633|||Cohort||Retrospective|||||||
1435449|NCT01829620|Randomized|Parallel Assignment||Treatment||Single||||||t
1435450|NCT01829607|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435451|NCT01829594||Single Group Assignment||Supportive Care||None (Open Label)||||||
1435452|NCT01829581|||Cohort||Retrospective|||||||
1435453|NCT01829568||Single Group Assignment||Treatment||None (Open Label)||||||
1435454|NCT01829555||Single Group Assignment||Supportive Care||None (Open Label)||||||
1435455|NCT01829542|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1435456|NCT01829529||Single Group Assignment||Prevention||None (Open Label)||||||
1435457|NCT01829516|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1435458|NCT01829503||Single Group Assignment||Treatment||None (Open Label)||||||
1435459|NCT01829490|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435460|NCT01829477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435461|NCT01829464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435462|NCT01829451|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1435463|NCT01829438|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1435464|NCT01829425|Randomized|Parallel Assignment||Treatment||Single|||||t|
1435465|NCT01829412||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435466|NCT01829399|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1435467|NCT01829386|||Cohort||Prospective|||||||
1435468|NCT01829373||Single Group Assignment||Treatment||None (Open Label)||||||
1435469|NCT01829360|Randomized|Single Group Assignment||Treatment||Single||||||t
1435470|NCT01829347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435471|NCT01829334|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1435472|NCT01829321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435473|NCT01829308|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1435474|NCT01829295|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1435475|NCT01829282|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435476|NCT01829269|||Cohort||Prospective|||||||
1435477|NCT01829256|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1435478|NCT01829243|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1435479|NCT01829230|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435480|NCT01829217||Single Group Assignment||Treatment||None (Open Label)||||||
1435481|NCT01829204|||Cohort||Prospective|||||||
1435482|NCT01829191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435483|NCT01829178|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1435484|NCT01829165|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1435485|NCT01829152|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1435486|NCT01829139|||Case Control||Prospective|||||||
1435487|NCT01829126|||Cohort||Prospective|||||||
1435488|NCT01829113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435489|NCT01829100|Randomized|Parallel Assignment||Treatment||Single||||||t
1435490|NCT01829087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435491|NCT01829074|||Cohort||Prospective|||||||
1435492|NCT01829061||||||||||||
1435493|NCT01829048|Randomized|||Basic Science||Double|||t||t|
1435494|NCT01829035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435495|NCT01829022|||Case-Only||Prospective|||||||
1435496|NCT01829009|Randomized|Parallel Assignment||Treatment||Single|||||t|
1435497|NCT01828996|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1435498|NCT01828983|Randomized|Parallel Assignment||Treatment||Single||||||t
1435499|NCT01828970||Single Group Assignment||Treatment||None (Open Label)||||||
1435500|NCT01828957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435501|NCT01828944|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1435502|NCT01828931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435503|NCT01828918||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435504|NCT01828905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435505|NCT01828892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435506|NCT01828879||Single Group Assignment||Treatment||None (Open Label)||||||
1435507|NCT01828866|Randomized|Parallel Assignment||Treatment||Single||||||t
1435508|NCT01828853|||Case Control||Prospective|||||||
1435509|NCT01828840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435510|NCT01828827|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435511|NCT01828814|||Ecologic or Community||Prospective|||||||
1435512|NCT01828801|||Cohort||Cross-Sectional|||||||
1435513|NCT01828788|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435514|NCT01828775|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435515|NCT01828762||Single Group Assignment||Treatment||None (Open Label)||||||
1435516|NCT01828749|||Cohort||Prospective|||||||
1435517|NCT01828736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435518|NCT01828723||Single Group Assignment||Treatment||None (Open Label)||||||
1435519|NCT01828710|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1435520|NCT01828697|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435521|NCT01828684|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1435522|NCT01828671|Randomized|Factorial Assignment||Supportive Care||Double|||t||t|
1435523|NCT01828658|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1435524|NCT01828645|Randomized|Parallel Assignment||||Triple||||t|t|t
1435525|NCT01828632|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1435526|NCT01828619|||Case-Only||Prospective|||||||
1435527|NCT01828606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435528|NCT01828593|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1435529|NCT01828580||Single Group Assignment||Supportive Care||None (Open Label)||||||
1435530|NCT01828567|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1435531|NCT01828554||Single Group Assignment||Basic Science||None (Open Label)||||||
1435532|NCT01828541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435533|NCT01828528|||Cohort||Prospective|||||||
1435534|NCT01828515|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1435535|NCT01828502|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435536|NCT01828489|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1435537|NCT01828476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435538|NCT01828463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435539|NCT01828437|Randomized|||Treatment||None (Open Label)||||||
1435540|NCT01828424|||Cohort||Prospective|||||||
1435541|NCT01828411|||Case-Only||Cross-Sectional|||||||
1435542|NCT01828398|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1435543|NCT01828385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435544|NCT01828372||Single Group Assignment||Screening||None (Open Label)||||||
1435545|NCT01828359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435546|NCT01828346||Single Group Assignment||Treatment||None (Open Label)||||||
1435547|NCT01828333|||||Prospective|||||||
1435548|NCT01828320|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1435549|NCT01828307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435550|NCT01828294||Single Group Assignment||Treatment||None (Open Label)||||||
1435551|NCT01828281|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435552|NCT01828268|||Cohort||Prospective|||||||
1435553|NCT01828255||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435554|NCT01828242|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1435555|NCT01828229|Randomized|Parallel Assignment||Prevention||Single||||||t
1435556|NCT01828216|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1435557|NCT01828203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435558|NCT01828190||Single Group Assignment||Treatment||None (Open Label)||||||
1435559|NCT01828177|Randomized|Parallel Assignment||Treatment||Single|||||t|
1435560|NCT01828164|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1435561|NCT01828151|||Cohort||Retrospective|||||||
1435562|NCT01828138|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1435563|NCT01828125|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1435564|NCT01828112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435565|NCT01828099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435566|NCT01828086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435567|NCT01828073|||Cohort||Prospective|||||||
1435568|NCT01828060|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1435569|NCT01828047|||Cohort||Prospective|||||||
1435570|NCT01828034||Single Group Assignment||Treatment||None (Open Label)||||||
1435571|NCT01828021||Single Group Assignment||Treatment||None (Open Label)||||||
1435572|NCT01828008|||Case Control||Prospective|||||||
1435573|NCT01827995|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1435574|NCT01827982|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435575|NCT01827969||Single Group Assignment||||None (Open Label)||||||
1435576|NCT01827956||||||||||||
1435577|NCT01827943||Single Group Assignment||Treatment||None (Open Label)||||||
1435578|NCT01827930||Single Group Assignment||Treatment||None (Open Label)||||||
1435579|NCT01827917||Single Group Assignment||Prevention||None (Open Label)||||||
1435580|NCT01827904|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1435581|NCT01827891|Randomized|Parallel Assignment||Prevention||Single||||||t
1435582|NCT01827878|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435583|NCT01827865|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435584|NCT01827852|||Cohort||Prospective|||||||
1435585|NCT01827839||Single Group Assignment||Prevention||None (Open Label)||||||
1435586|NCT01827826|Randomized|Parallel Assignment||Prevention||Single|||||t|
1435587|NCT01827813|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1435588|NCT01827800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435589|NCT01827787|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435590|NCT01827774||Single Group Assignment||Treatment||None (Open Label)||||||
1435591|NCT01827761|||Cohort||Prospective|||||||
1435592|NCT01827748|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1435593|NCT01827735||Single Group Assignment||Basic Science||None (Open Label)||||||
1435594|NCT01827722|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435595|NCT01827709||Single Group Assignment||||None (Open Label)||||||
1435596|NCT01827696|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1435597|NCT01827683|Randomized|Crossover Assignment||Treatment||Single||||||t
1435598|NCT01827670|Randomized|Parallel Assignment||Treatment||Single|||||t|
1435599|NCT01827657|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435600|NCT01827644|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435601|NCT01827631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435602|NCT01827618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435603|NCT01827605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435604|NCT01827592|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435605|NCT01827579|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435606|NCT01827566|Randomized|Crossover Assignment||Diagnostic||Double|||t|t||
1435607|NCT01827553|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1435608|NCT01827540|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1435609|NCT01827527|||Cohort||Prospective|||||||
1435610|NCT01827514|||Cohort|||||||||
1435611|NCT01827501|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435612|NCT01827488||||||||||||
1435613|NCT01827475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435614|NCT01827462|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435615|NCT01827449||Single Group Assignment||Treatment||None (Open Label)||||||
1435616|NCT01827436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435617|NCT01827423||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435618|NCT01827410|||Cohort||Retrospective|||||||
1435619|NCT01827397|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1435620|NCT01827384|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435621|NCT01827371|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435622|NCT01827358|Randomized|Single Group Assignment||Prevention||||||||
1435623|NCT01827345||Single Group Assignment||Treatment||None (Open Label)||||||
1435624|NCT01827332|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435625|NCT01827319|||Cohort||Prospective|||||||
1435626|NCT01827306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435627|NCT01827293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435628|NCT01827280|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435629|NCT01827267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435630|NCT01827254|||Cohort||Retrospective|||||||
1435631|NCT01827241|||Cohort||Prospective|||||||
1435632|NCT01827228|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435633|NCT01827215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435634|NCT01827202|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1435635|NCT01827189|||Case-Control||Prospective|||||||
1435636|NCT01827176|||Case-Only||Retrospective|||||||
1435637|NCT01827163||Single Group Assignment||Treatment||None (Open Label)||||||
1435638|NCT01827150||Single Group Assignment||Basic Science||None (Open Label)||||||
1435639|NCT01827137||Single Group Assignment||Treatment||None (Open Label)||||||
1435640|NCT01827124|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1435641|NCT01827111||Single Group Assignment||Treatment||None (Open Label)||||||
1435642|NCT01827098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435643|NCT01827085|||||Prospective|||||||
1435644|NCT01827072||Single Group Assignment||Treatment||None (Open Label)||||||
1435645|NCT01827059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435646|NCT01827046|Randomized|Parallel Assignment||Treatment||Single||||||t
1435647|NCT01827033||Single Group Assignment||Treatment||None (Open Label)||||||
1435648|NCT01827020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435649|NCT01827007||Single Group Assignment||Treatment||None (Open Label)||||||
1435650|NCT01826994||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435651|NCT01826981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435652|NCT01826968|Randomized|Parallel Assignment||Prevention||Double||||t||t
1435653|NCT01826955|||Case Control||Prospective|||||||
1435654|NCT01826942|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435655|NCT01826929|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1435656|NCT01826916|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435657|NCT01826903|||Cohort||Cross-Sectional|||||||
1435658|NCT01826890|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435659|NCT01826877||Single Group Assignment||Treatment||None (Open Label)||||||
1435660|NCT01826864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435661|NCT01826851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435662|NCT01826838||Single Group Assignment||Treatment||None (Open Label)||||||
1435663|NCT01826825|||Cohort||Prospective|||||||
1435664|NCT01826812|||Case-Control||Prospective|||||||
1435665|NCT01826799|||Cohort||Prospective|||||||
1435666|NCT01826786|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1435667|NCT01826773|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1435668|NCT01826760|||Case Control||Cross-Sectional|||||||
1435669|NCT01826747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435670|NCT01826734|||Case-Only||Prospective|||||||
1435671|NCT01826721|Randomized|Parallel Assignment||||None (Open Label)||||||
1435672|NCT01826708||Single Group Assignment||||None (Open Label)||||||
1435673|NCT01826695|Randomized|Single Group Assignment||Treatment||Single|||t|||
1435674|NCT01826682|Randomized|Single Group Assignment||Treatment||Single|||||t|
1435675|NCT01826669|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1435676|NCT01826656|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1435677|NCT01826630|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1435678|NCT01826617|||Ecologic or Community||Cross-Sectional|||||||
1435679|NCT01826604|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1435680|NCT01826591|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1435681|NCT01826578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435682|NCT01826565|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435683|NCT01826552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435684|NCT01826539|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1435685|NCT01826526|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1435686|NCT01826513|Randomized|Crossover Assignment||Treatment||Single|||t|||
1435687|NCT01826500|||Case Control||Prospective|||||||
1435688|NCT01826487|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435689|NCT01826474|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435690|NCT01826461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435691|NCT01826448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435692|NCT01826435||Single Group Assignment||Health Services Research||None (Open Label)||||||
1435693|NCT01826422|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1435694|NCT01826409|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1435695|NCT01826396||Single Group Assignment||Treatment||None (Open Label)||||||
1435696|NCT01826383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435697|NCT01826370|||Cohort||Prospective|||||||
1435698|NCT01826357|||Cohort||Retrospective|||||||
1435699|NCT01826344|||Cohort||Prospective|||||||
1435700|NCT01826331|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1435701|NCT01826318|Randomized|Parallel Assignment||||Triple|||t||t|t
1435702|NCT01826305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435703|NCT01826292|||Other||Retrospective|||||||
1435704|NCT01826279|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1435705|NCT01826266|Randomized|Single Group Assignment||Treatment||Single|||t|||
1435706|NCT01826253|||Cohort||Retrospective|||||||
1435707|NCT01826240||Single Group Assignment||Treatment||None (Open Label)||||||
1435708|NCT01826227||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435709|NCT01826214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435710|NCT01826201||Single Group Assignment||Treatment||Double|||t|||t
1435711|NCT01826188|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435712|NCT01826175|Randomized|Parallel Assignment||||Single||||||t
1435713|NCT01826162|Randomized|Crossover Assignment||||Double|||t||t|
1435714|NCT01826149|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1435715|NCT01826136|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435716|NCT01826123|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1435717|NCT01826110||Single Group Assignment||Basic Science||None (Open Label)||||||
1435718|NCT01826097||Single Group Assignment||Screening||Single||||||
1435719|NCT01826071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435720|NCT01826058|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435721|NCT01826045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435722|NCT01826032|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1435723|NCT01826019|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1435724|NCT01826006|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1435725|NCT01825993|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435726|NCT01825980|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1435727|NCT01825967|||Case-Only||Prospective|||||||
1435728|NCT01825954|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435729|NCT01825941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435730|NCT01825928|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435731|NCT01825915|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1435732|NCT01825902||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435733|NCT01825889|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1435734|NCT01825876|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1435735|NCT01825863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435736|NCT01825850|Randomized|Crossover Assignment||||None (Open Label)||||||
1435737|NCT01825837|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435738|NCT01825824||Single Group Assignment||Treatment||None (Open Label)||||||
1435739|NCT01825811|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435740|NCT01825798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435741|NCT01825785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435742|NCT01825772|||Cohort||Cross-Sectional|||||||
1435743|NCT01825759||Single Group Assignment||Treatment||None (Open Label)||||||
1435744|NCT01825746|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435745|NCT01825733|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1435746|NCT01825720|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1435747|NCT01825707||Single Group Assignment||||None (Open Label)||||||
1435748|NCT01825694|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435749|NCT01825681|Randomized|Crossover Assignment||Treatment||Single|||t|||
1435750|NCT01825668|Randomized|Crossover Assignment||||Double|||t||t|
1435751|NCT01825655|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435752|NCT01825642|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435753|NCT01825629|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1435754|NCT01825616|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1435755|NCT01825603||Single Group Assignment||Treatment||None (Open Label)||||||
1435756|NCT01825590|||Cohort||Retrospective|||||||
1435757|NCT01825577||Single Group Assignment||Prevention||None (Open Label)||||||
1435758|NCT01825564|||Cohort||Prospective|||||||
1435759|NCT01825551|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435760|NCT01825538|||Cohort||Retrospective|||||||
1435761|NCT01825525||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435762|NCT01825512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435763|NCT01825499|||Cohort||Prospective|||||||
1435764|NCT01825486|||Cohort||Prospective|||||||
1435765|NCT01825473|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435766|NCT01825460|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1435767|NCT01825447|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1435768|NCT01825434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435769|NCT01825421|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435770|NCT01825408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435771|NCT01825395||||||||||||
1435772|NCT01825382|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1435773|NCT01825369||Single Group Assignment||Treatment||None (Open Label)||||||
1435774|NCT01825356|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435775|NCT01825343|||Case-Only||Retrospective|||||||
1435776|NCT01825330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435777|NCT01825317|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1435778|NCT01825304|Randomized|Parallel Assignment||Treatment||Single|||||t|
1435779|NCT01825291|||Cohort||Retrospective|||||||
1435780|NCT01825278|||Cohort||Prospective|||||||
1435781|NCT01825252|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435782|NCT01825239||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435783|NCT01825226|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1435784|NCT01825213|||Cohort||Retrospective|||||||
1435785|NCT01825200|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1435786|NCT01825187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435787|NCT01825174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435788|NCT01825161|||Cohort||Prospective|||||||
1435789|NCT01825148|||Case Control||Prospective|||||||
1435790|NCT01825135|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435791|NCT01825122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435792|NCT01825109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435793|NCT01825096|||Case-Only|||||||||
1435794|NCT01825083|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1435795|NCT01825070|Randomized|Single Group Assignment||||Double|||t||t|
1435796|NCT01825057|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1435797|NCT01825044|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1435798|NCT01825031|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1435799|NCT01825018|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435800|NCT01825005|||Cohort||Prospective|||||||
1435801|NCT01824992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435802|NCT01824979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435803|NCT01824966|||Cohort||Retrospective|||||||
1435804|NCT01824953|||Case Control||Prospective|||||||
1435805|NCT01824940|Randomized|Factorial Assignment||Prevention||None (Open Label)|Given the nature of the intervention, masking to treatment group is not possible.|||||
1435806|NCT01824927|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1435807|NCT01824914||Single Group Assignment||Diagnostic||Single||||||t
1435808|NCT01824901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435809|NCT01824888|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1435810|NCT01824875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435811|NCT01824862|||Case Control||Prospective|||||||
1435812|NCT01824849|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435813|NCT01824836||Single Group Assignment||Supportive Care||None (Open Label)||||||
1435814|NCT01824823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435815|NCT01824810|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435816|NCT01824797|||Cohort||Prospective|||||||
1435817|NCT01824784|||Cohort||Prospective|||||||
1435818|NCT01824771|||Case-Only||Prospective|||||||
1435819|NCT01824758|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1435820|NCT01824745|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1435821|NCT01824732|||||Prospective|||||||
1435822|NCT01824719|||||Prospective|||||||
1435823|NCT01824706|||Cohort||Prospective|||||||
1435824|NCT01824693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435825|NCT01824680||Single Group Assignment||Treatment||None (Open Label)||||||
1435826|NCT01824667|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1435827|NCT01824654||Single Group Assignment||Supportive Care||None (Open Label)||||||
1435828|NCT01824641|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435829|NCT01824628|||Cohort||Prospective|||||||
1435830|NCT01824615||Single Group Assignment||Treatment||None (Open Label)||||||
1435831|NCT01824602|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435832|NCT01824589|Randomized|Crossover Assignment||Treatment||Single|||t|||
1435833|NCT01824576||Single Group Assignment||Treatment||None (Open Label)||||||
1435834|NCT01824563|||Cohort||Prospective|||||||
1435835|NCT01824550|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435836|NCT01824537|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1435837|NCT01824524||Single Group Assignment||Treatment||None (Open Label)||||||
1435838|NCT01824511||Single Group Assignment||Basic Science||None (Open Label)||||||
1435839|NCT01824498|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1435840|NCT01824485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435841|NCT01824472|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435842|NCT01824459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435843|NCT01824446||Single Group Assignment||Basic Science||None (Open Label)||||||
1435844|NCT01824433|Randomized|Parallel Assignment||Treatment||Single||||||t
1435845|NCT01824420|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking was designed in this study|Prospective, open-label study. The overactive bladder patients maintained their previous antimuscarinic medication and we flexibly added on the second antimuscarinic drug (oxybutynin ER 5 mg QD) or not.||||
1435846|NCT01824407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435847|NCT01824394|Randomized|Parallel Assignment||Treatment||Single|||t|||
1435848|NCT01824381||Single Group Assignment||Treatment||None (Open Label)||||||
1435849|NCT01824368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435850|NCT01824355||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435851|NCT01824342||Single Group Assignment||Treatment||None (Open Label)||||||
1435852|NCT01824329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435853|NCT01824316|||Cohort||Prospective|||||||
1435854|NCT01824303|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435855|NCT01824290|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435856|NCT01824277|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435857|NCT01824264|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435858|NCT01824251||Single Group Assignment||Treatment||None (Open Label)||||||
1435859|NCT01824238|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435860|NCT01824225|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435861|NCT01824212|||Case-Only||Prospective|||||||
1435862|NCT01824199||Single Group Assignment||Treatment||None (Open Label)||||||
1435863|NCT01824186|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1435864|NCT01824173|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1435865|NCT01824160||Single Group Assignment||Treatment||None (Open Label)||||||
1435866|NCT01824147|||Cohort||Prospective|||||||
1435867|NCT01824134|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1435868|NCT01824121|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1435869|NCT01824108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435870|NCT01824095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435871|NCT01824082|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1435872|NCT01824069||Single Group Assignment||Treatment||None (Open Label)||||||
1435873|NCT01824056||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435874|NCT01824043||Single Group Assignment||Treatment||None (Open Label)||||||
1435875|NCT01824030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435876|NCT01824017||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435877|NCT01824004||Single Group Assignment||Treatment||None (Open Label)||||||
1435878|NCT01823991|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1435879|NCT01823978||Single Group Assignment||Treatment||None (Open Label)||||||
1435880|NCT01823965||Single Group Assignment||Treatment||None (Open Label)||||||
1435881|NCT01823952||||||||||||
1435882|NCT01823939|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435883|NCT01823926|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1435884|NCT01823913||Single Group Assignment||Treatment||None (Open Label)||||||
1435885|NCT01823900||Single Group Assignment||Treatment||None (Open Label)||||||
1435886|NCT01823887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435887|NCT01823874|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1435888|NCT01823861|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1435889|NCT01823848|Randomized|Single Group Assignment||Treatment||Triple||||t|t|t
1435890|NCT01823835|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435891|NCT01823822|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435892|NCT01823809||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435893|NCT01823796|||Case Control||Prospective|||||||
1435894|NCT01823783|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1435895|NCT01823770|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435896|NCT01823757|||Case Control||Prospective|||||||
1435897|NCT01823744||Single Group Assignment||Basic Science||None (Open Label)||||||
1435898|NCT01823731|||Case-Only||Prospective|||||||
1435899|NCT01823718||Single Group Assignment||Treatment||None (Open Label)||||||
1435900|NCT01823705||Single Group Assignment||Treatment||None (Open Label)||||||
1435901|NCT01823692||Single Group Assignment||Diagnostic||Single||||||t
1435902|NCT01823679||Single Group Assignment||Treatment||None (Open Label)||||||
1435903|NCT01823666|||Cohort||Prospective|||||||
1435904|NCT01823653||Single Group Assignment||Treatment||None (Open Label)||||||
1435905|NCT01823640|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1435906|NCT01823627||Single Group Assignment||Diagnostic||None (Open Label)||||||
1435907|NCT01823614|||Cohort||Cross-Sectional|||||||
1435908|NCT01823601|Randomized|Parallel Assignment||||Double|||t|||t
1435909|NCT01823588|Randomized|Parallel Assignment||Prevention||Single|||||t|
1435910|NCT01823575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435911|NCT01823562|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435912|NCT01823549|||Cohort||Prospective|||||||
1435913|NCT01823536|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1435914|NCT01823523|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1435915|NCT01823510|Randomized|Crossover Assignment||Treatment||Single||||||t
1435916|NCT01823497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435917|NCT01823484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435918|NCT01823471|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1435919|NCT01823458|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1435920|NCT01823445||Single Group Assignment||Prevention||None (Open Label)||||||
1435921|NCT01823432|||Cohort||Other|||||||
1435922|NCT01823419|||Case-Only||Cross-Sectional|||||||
1435923|NCT01823406|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1435924|NCT01823393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435925|NCT01823380||Single Group Assignment||Basic Science||None (Open Label)||||||
1435926|NCT01823367|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435927|NCT01823354|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1435928|NCT01823341|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435929|NCT01823328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435930|NCT01823315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435931|NCT01823302|Randomized|Parallel Assignment||Treatment||Single||||||t
1435932|NCT01823289||Single Group Assignment||Treatment||None (Open Label)||||||
1435933|NCT01823276|Randomized|Parallel Assignment||||Double|||t||t|
1435934|NCT01823263|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1435935|NCT01823250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435936|NCT01823237|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1435937|NCT01823224|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1435938|NCT01823211|||Cohort||Prospective|||||||
1435939|NCT01823198||Single Group Assignment||Treatment||None (Open Label)||||||
1435940|NCT01823185|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435941|NCT01823172||Single Group Assignment||Basic Science||None (Open Label)||||||
1435942|NCT01823159|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1435943|NCT01823146|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1435944|NCT01823133|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435945|NCT01823120|Randomized|Parallel Assignment||Prevention||Single||||||t
1435946|NCT01823107||Single Group Assignment||Treatment||None (Open Label)||||||
1435947|NCT01823094|||Case-Only||Prospective|||||||
1435948|NCT01823081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435949|NCT01823068||Single Group Assignment||Treatment||None (Open Label)||||||
1435950|NCT01823055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435951|NCT01823042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435952|NCT01823029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435953|NCT01823016|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435954|NCT01823003|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435955|NCT01822990|||Case Control||Prospective|||||||
1435956|NCT01822977||Single Group Assignment||||None (Open Label)||||||
1435957|NCT01822964|Randomized|Parallel Assignment||Prevention||Single||||||t
1435958|NCT01822951|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1435959|NCT01822938|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1435960|NCT01822925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435961|NCT01822912|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435962|NCT01822899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435963|NCT01822886||Single Group Assignment||Treatment||None (Open Label)||||||
1435964|NCT01822873|||Other||Prospective|||||||
1435965|NCT01822860|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1435966|NCT01822847|||Case-Crossover||Cross-Sectional|||||||
1435967|NCT01822834|||Cohort||Prospective|||||||
1435968|NCT01822821|Randomized|Parallel Assignment||Other||Double|||t|t||
1435969|NCT01822808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435970|NCT01822795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435971|NCT01822782|||Case Control||Cross-Sectional|||||||
1435972|NCT01822769|Randomized|Parallel Assignment||Treatment||Single||||||t
1435973|NCT01822756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435974|NCT01822743|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1435975|NCT01822730|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1435976|NCT01822717|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1435977|NCT01822704|Randomized|Parallel Assignment||Treatment||Single||||||t
1435978|NCT01822691||Single Group Assignment||Treatment||None (Open Label)||||||
1435979|NCT01822678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1435980|NCT01822665|Randomized|Crossover Assignment||Treatment||Single||||||t
1435981|NCT01822652|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1435982|NCT01822639|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1435983|NCT01822626|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1435984|NCT01822613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435985|NCT01822600|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435986|NCT01822587|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1435987|NCT01822574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435988|NCT01822561||Single Group Assignment||Treatment||None (Open Label)||||||
1435989|NCT01822548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435990|NCT01822535|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1435991|NCT01822522||Single Group Assignment||Treatment||None (Open Label)||||||
1435992|NCT01822509||Single Group Assignment||Treatment||None (Open Label)||||||
1435993|NCT01822496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1435994|NCT01822483|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1435995|NCT01822470|||Case-Control||Prospective|||||||
1435996|NCT01822457|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1435997|NCT01822444|||Cohort||Prospective|||||||
1435998|NCT01822431|||Case Control||Cross-Sectional|||||||
1435999|NCT01822418||Single Group Assignment||Treatment||None (Open Label)||||||
1436000|NCT01822405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436001|NCT01822392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436002|NCT01822379||Single Group Assignment||Treatment||Triple|Will perform cell separation using either diaspase or trypsin|diaspase versus trypsin for cell separation|t||t|t
1436003|NCT01822366|Randomized|Parallel Assignment||Treatment||Single||||||t
1436004|NCT01822353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436005|NCT01822340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436006|NCT01822327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436007|NCT01822314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436008|NCT01822301||Single Group Assignment||Treatment||None (Open Label)||||||
1436009|NCT01822288|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436010|NCT01822275||Single Group Assignment||Treatment||None (Open Label)||||||
1436011|NCT01822262|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436012|NCT01822249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436013|NCT01822236|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1436014|NCT01822223|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436015|NCT01822210||Single Group Assignment||Treatment||None (Open Label)||||||
1436016|NCT01822197||Single Group Assignment||Treatment||None (Open Label)||||||
1436017|NCT01822184|||Cohort||Prospective|||||||
1436018|NCT01822171||Single Group Assignment||Supportive Care||None (Open Label)||||||
1436019|NCT01822158||Single Group Assignment||||None (Open Label)||||||
1436020|NCT01822145|||Cohort||Prospective|||||||
1436021|NCT01822132|Randomized|Parallel Assignment||||Triple|||t|t|t|
1436022|NCT01822119||Single Group Assignment||Treatment||None (Open Label)||||||
1436023|NCT01822106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436024|NCT01822093||Single Group Assignment||Treatment||None (Open Label)||||||
1436025|NCT01822080|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436026|NCT01822067|||Case-Control||Prospective|||||||
1436027|NCT01822054|||Case-Control||Prospective|||||||
1436028|NCT01822041|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436029|NCT01822028|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1436030|NCT01822015||Single Group Assignment||Treatment||None (Open Label)||||||
1436031|NCT01822002|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436032|NCT01821989|Randomized|Parallel Assignment||Prevention||Double||||t||t
1436033|NCT01821976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436034|NCT01821963||Single Group Assignment||Treatment||None (Open Label)||||||
1436035|NCT01821950|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436036|NCT01821937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436037|NCT01821924|||Cohort||Retrospective|||||||
1436038|NCT01821911|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436039|NCT01821898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436040|NCT01821885|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436041|NCT01821872|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1436042|NCT01821859||Single Group Assignment||Treatment||None (Open Label)||||||
1436043|NCT01821846|||Cohort||Prospective|||||||
1436044|NCT01821833|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1436045|NCT01821820|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1436046|NCT01821807|||||Prospective|||||||
1436047|NCT01821781||Single Group Assignment||Treatment||None (Open Label)||||||
1436048|NCT01821768|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436049|NCT01821755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436050|NCT01821742|||Cohort||Prospective|||||||
1436051|NCT01821729||Single Group Assignment||Treatment||None (Open Label)||||||
1436052|NCT01821716||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436053|NCT01821703|Randomized|Crossover Assignment||||Double|||t|t||
1436054|NCT01821690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436055|NCT01821677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436056|NCT01821664|||Cohort||Prospective|||||||
1436057|NCT01821651|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436058|NCT01821638|||Cohort||Prospective|||||||
1436059|NCT01821625||Single Group Assignment||Treatment||None (Open Label)||||||
1436060|NCT01821612||Single Group Assignment||Treatment||None (Open Label)||||||
1436061|NCT01821599|Randomized|Parallel Assignment||Treatment||Single||||||t
1436062|NCT01821586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436063|NCT01821573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436064|NCT01821560|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436065|NCT01821547||Single Group Assignment||Basic Science||None (Open Label)||||||
1436066|NCT01821534|||Cohort||Prospective|||||||
1436067|NCT01821521|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1436068|NCT01821508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436069|NCT01821495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436070|NCT01821482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436071|NCT01821469||Single Group Assignment||Treatment||None (Open Label)||||||
1436072|NCT01821456|||Cohort||Prospective|||||||
1436073|NCT01821443||Single Group Assignment||Treatment||None (Open Label)||||||
1436074|NCT01821430|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1436075|NCT01821417|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436076|NCT01821404|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1436077|NCT01821391|Randomized|Parallel Assignment||Treatment||Single|||||t|
1436078|NCT01821378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436079|NCT01821365|||||Prospective|||||||
1436080|NCT01821352|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436081|NCT01821339|||Case-Only||Prospective|||||||
1436082|NCT01821326|||||Retrospective|||||||
1436083|NCT01821313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436084|NCT01821300|||Case-Control||Cross-Sectional|||||||
1436085|NCT01821287|||Case Control||Prospective|||||||
1436086|NCT01821274|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1436087|NCT01821261||||||||||||
1436088|NCT01821248||Single Group Assignment||Treatment||None (Open Label)||||||
1436089|NCT01821235|Randomized|Crossover Assignment||Treatment||Single|||t|||
1436090|NCT01821222|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436091|NCT01821209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436092|NCT01821196||Single Group Assignment||Basic Science||None (Open Label)||||||
1436093|NCT01821183|||||Cross-Sectional|||||||
1436094|NCT01821170|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1436095|NCT01821157|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436096|NCT01821144|Randomized|Parallel Assignment||Prevention||Single||||||t
1436097|NCT01821131|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1436098|NCT01821118|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436099|NCT01821105||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436100|NCT01821092|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436101|NCT01821079|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1436102|NCT01821066||Single Group Assignment||Basic Science||None (Open Label)||||||
1436103|NCT01821053|||Cohort||Prospective|||||||
1436104|NCT01821040|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436105|NCT01821027||Single Group Assignment||Treatment||None (Open Label)||||||
1436106|NCT01821014|Randomized|Parallel Assignment||Diagnostic||Triple||||t|t|t
1436107|NCT01821001||Single Group Assignment||Treatment||None (Open Label)||||||
1436108|NCT01820988|||||Cross-Sectional|||||||
1436109|NCT01820975|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1436110|NCT01820962|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436111|NCT01820949|||Ecologic or Community||Prospective|||||||
1436112|NCT01820936|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1436113|NCT01820923||Single Group Assignment||Treatment||Triple|||t|t||t
1436114|NCT01820910||Single Group Assignment||Treatment||None (Open Label)||||||
1436115|NCT01820897|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436116|NCT01820884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436117|NCT01820871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436118|NCT01820858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436119|NCT01820845|||Cohort||Prospective|||||||
1436120|NCT01820832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436121|NCT01820819|||Cohort||Prospective|||||||
1436122|NCT01820806||Single Group Assignment||Treatment||None (Open Label)||||||
1436123|NCT01820793||Single Group Assignment||Treatment||None (Open Label)||||||
1436124|NCT01820780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436125|NCT01820767|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436126|NCT01820754||Single Group Assignment||Treatment||None (Open Label)||||||
1436127|NCT01820741||||||||||||
1436128|NCT01820728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436129|NCT01820715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436130|NCT01820702|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1436131|NCT01820689||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436132|NCT01820676|||Cohort||Prospective|||||||
1436133|NCT01820663|Randomized|Parallel Assignment||Treatment||Single||||||t
1436134|NCT01820650|||Cohort||Prospective|||||||
1436135|NCT01820637||Single Group Assignment||Treatment||None (Open Label)||||||
1436136|NCT01820624||Single Group Assignment||Treatment||None (Open Label)||||||
1436137|NCT01820611|||Cohort||Other|||||||
1436138|NCT01820598|Randomized|Crossover Assignment||Treatment||Single|||||t|
1436139|NCT01820585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436140|NCT01820572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436141|NCT01820559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436142|NCT01820546|||Case-Only||Prospective|||||||
1436143|NCT01820533|||Case-Only||Cross-Sectional|||||||
1436144|NCT01820520||Single Group Assignment||Treatment||None (Open Label)||||||
1436145|NCT01820507|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436146|NCT01820494||Single Group Assignment||||None (Open Label)||||||
1436147|NCT01820481|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436148|NCT01820468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436149|NCT01820455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436150|NCT01820442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436151|NCT01820429|||Cohort||Prospective|||||||
1436152|NCT01820416|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436153|NCT01820403|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1436154|NCT01820390|||Cohort||Prospective|||||||
1436155|NCT01820377|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1436156|NCT01820364||Single Group Assignment||Treatment||None (Open Label)||||||
1436157|NCT01820351||||Basic Science||||||||
1436158|NCT01820338|Randomized|Parallel Assignment||Treatment||Single||||||t
1436159|NCT01820325|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436160|NCT01820312|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436161|NCT01820299||Single Group Assignment||Treatment||None (Open Label)||||||
1436162|NCT01820286|Randomized|Parallel Assignment||Treatment||Single||||||t
1436163|NCT01820273|||Case-Control||Prospective|||||||
1436164|NCT01820260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436165|NCT01820247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436166|NCT01820234|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1436167|NCT01820221|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1436168|NCT01820208|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436169|NCT01820195|Randomized|Parallel Assignment||Prevention||Double||||t||t
1436170|NCT01820182||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436171|NCT01820169||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436172|NCT01820156|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1436173|NCT01820143|Randomized|Crossover Assignment||||None (Open Label)||||||
1436174|NCT01820130||Single Group Assignment||Treatment||None (Open Label)||||||
1436175|NCT01820117|||Case-Control||Other|||||||
1436176|NCT01820104|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1436177|NCT01820091|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436178|NCT01820078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436179|NCT01820065|||Cohort||Prospective|||||||
1436180|NCT01820052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436181|NCT01820039||Single Group Assignment||Health Services Research||None (Open Label)||||||
1436182|NCT01820026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436183|NCT01820013|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436184|NCT01820000||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436185|NCT01819987|Randomized|Parallel Assignment||Prevention||Triple|Participants, investigator and outcome assessor were blinded to the group assignment.|A randomized, controlled study was used. The intervention group received tablet based intervention and the control group received printed health information relevant to preschool-aged children in Chinese over the eight weeks.|t||t|t
1436186|NCT01819974|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436187|NCT01819961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436188|NCT01819948||Single Group Assignment||Prevention||None (Open Label)||||||
1436189|NCT01819935|||Cohort||Retrospective|||||||
1436190|NCT01819922|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1436191|NCT01819909|Randomized|Parallel Assignment||Treatment||Single|||||t|
1436192|NCT01819896|||Cohort||Cross-Sectional|||||||
1436193|NCT01819883|||Cohort||Prospective|||||||
1436194|NCT01819870|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1436195|NCT01819857|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1436196|NCT01819844||Single Group Assignment||Treatment||None (Open Label)||||||
1436197|NCT01819831||Single Group Assignment||Treatment||None (Open Label)||||||
1436198|NCT01819818|||Cohort||Prospective|||||||
1436199|NCT01819805|||Cohort||Prospective|||||||
1436200|NCT01819792||Single Group Assignment||Other||None (Open Label)||||||
1436201|NCT01819779|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1436202|NCT01819766|||Case-Control||Cross-Sectional|||||||
1436203|NCT01819753|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436204|NCT01819740|||Case-Only||Prospective|||||||
1436205|NCT01819727|Randomized|Parallel Assignment||Treatment||None (Open Label)|"All subjects receive Study Drug. Subjects will be randomized (1:1) to titrate up to one of two dose regimens: 20 mg/day or 40 mg/day.Eligible subjects will be randomized 1:1 using an IWRS to titrate to one of two dose regimens:~20 mg/day or 40 mg/day. The randomization will be stratified by blood Phe levels of 600 to 900 µmol/L and >900 µmol/ using the last available blood Phe concentration prior to Day 1 of the study."|||||
1436206|NCT01819714||Single Group Assignment||Supportive Care||None (Open Label)||||||
1436207|NCT01819701|Randomized|Parallel Assignment||Prevention||Single|||t|||
1436208|NCT01819688||Single Group Assignment||Health Services Research||None (Open Label)||||||
1436209|NCT01819675|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1436210|NCT01819662|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1436211|NCT01819649|Randomized|Parallel Assignment||Prevention||Triple||AMENDMENT TO STUDY DESIGN: Towards the end of the intervention period, it was decided to follow-up participants for an additional ten years via Danish public registries for data on morbidity and mortality.|t|t|t|
1436212|NCT01819636|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436213|NCT01819623|Randomized|Parallel Assignment||Treatment||Single||||||t
1436214|NCT01819610||Single Group Assignment||Treatment||None (Open Label)||||||
1436215|NCT01819597||Single Group Assignment||Treatment||None (Open Label)||||||
1436216|NCT01819584|||Cohort||Prospective|||||||
1436217|NCT01819571|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436218|NCT01819558||Single Group Assignment||Treatment||None (Open Label)||||||
1436219|NCT01819545|||Case Control||Cross-Sectional|||||||
1436220|NCT01819532|Randomized|Single Group Assignment||Treatment||Single||||||t
1436221|NCT01819519|Randomized|Parallel Assignment||Prevention||Single||||||t
1436222|NCT01819506|Randomized|Parallel Assignment||Treatment||Single||||||t
1436223|NCT01819493|Randomized|Single Group Assignment||Prevention||Single||||||t
1436224|NCT01819480||Single Group Assignment||Treatment||None (Open Label)||||||
1436225|NCT01819467|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1436226|NCT01819454|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436227|NCT01819441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436228|NCT01819428||Single Group Assignment||Treatment||None (Open Label)||||||
1436229|NCT01819415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436230|NCT01819402|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436231|NCT01819389||Single Group Assignment||Treatment||None (Open Label)||||||
1436232|NCT01819376|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1436233|NCT01819363|||Cohort||Prospective|||||||
1436234|NCT01819350|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1436235|NCT01819337|||Cohort||Prospective|||||||
1436236|NCT01819324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436237|NCT01819311|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436238|NCT01819298|||Cohort||Prospective|||||||
1436239|NCT01819285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436240|NCT01819272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436241|NCT01819259|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1436242|NCT01819246|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436243|NCT01819233||Single Group Assignment||Treatment||None (Open Label)||||||
1436244|NCT01819220|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436245|NCT01819207||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436246|NCT01819194||Single Group Assignment||Supportive Care||Single|||t|||
1436247|NCT01819181|||Cohort||Prospective|||||||
1436248|NCT01819168|||||Retrospective|||||||
1436249|NCT01819155|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436250|NCT01819142||Single Group Assignment||Treatment||None (Open Label)||||||
1436251|NCT01819129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436252|NCT01819116|||Cohort||Prospective|||||||
1436253|NCT01819103|||Cohort||Prospective|||||||
1436254|NCT01819090|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1436255|NCT01819077|||||Prospective|||||||
1436256|NCT01819064|||Cohort||Prospective|||||||
1436257|NCT01819051||Single Group Assignment||Treatment||None (Open Label)||||||
1436258|NCT01819038|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436259|NCT01819025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436260|NCT01819012|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436261|NCT01818999||Single Group Assignment||Treatment||None (Open Label)||||||
1436262|NCT01818986||Single Group Assignment||Treatment||None (Open Label)||||||
1436263|NCT01818973||Single Group Assignment||Treatment||None (Open Label)||||||
1436264|NCT01818960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436265|NCT01818947|||Case-Only||Retrospective|||||||
1436266|NCT01818934|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1436267|NCT01818921|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436268|NCT01818908||Single Group Assignment||Treatment||None (Open Label)||||||
1436269|NCT01818895|||Cohort||Prospective|||||||
1436270|NCT01818882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436271|NCT01818869|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1436272|NCT01818856||Single Group Assignment||Treatment||None (Open Label)||||||
1436273|NCT01818843||Single Group Assignment||Treatment||None (Open Label)||||||
1436274|NCT01818830|||Case Control||Retrospective|||||||
1436275|NCT01818817|||||Prospective|||||||
1436276|NCT01818804|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436277|NCT01818791|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1436278|NCT01818778|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1436279|NCT01818765||Single Group Assignment||Treatment||None (Open Label)||||||
1436280|NCT01818752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436281|NCT01818739||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436282|NCT01818726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436283|NCT01818713||Single Group Assignment||Treatment||None (Open Label)||||||
1436284|NCT01818700||Single Group Assignment||Supportive Care||None (Open Label)||||||
1436285|NCT01818687||Single Group Assignment||Treatment||None (Open Label)||||||
1436286|NCT01818674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436287|NCT01818661||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436288|NCT01818648|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1436289|NCT01818635|||Case Control||Prospective|||||||
1436290|NCT01818622|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436291|NCT01818609||Single Group Assignment||Basic Science||None (Open Label)||||||
1436292|NCT01818596||Single Group Assignment||Treatment||None (Open Label)||||||
1436293|NCT01818583|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436294|NCT01818570|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1436295|NCT01818557|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1436296|NCT01818544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436297|NCT01818531|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436298|NCT01818518|||Cohort||Prospective|||||||
1436299|NCT01818505|||Case Control||Prospective|||||||
1436300|NCT01818492||Single Group Assignment||Treatment||None (Open Label)||||||
1436301|NCT01818479||Single Group Assignment||Treatment||None (Open Label)||||||
1436302|NCT01818466|||Cohort||Retrospective|||||||
1436303|NCT01818453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436304|NCT01818440|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436305|NCT01818427|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436306|NCT01818414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436307|NCT01818401|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436308|NCT01818388|||Case-Only||Prospective|||||||
1436309|NCT01818375|Randomized|Single Group Assignment||Prevention||Single|||t|||
1436310|NCT01818362|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436311|NCT01818349|Randomized|Parallel Assignment||Treatment||Single||||||t
1436312|NCT01818336||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436313|NCT01818323||Single Group Assignment||Other||None (Open Label)|Open label|||||
1436314|NCT01818310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436315|NCT01818297|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1436316|NCT01818284||Single Group Assignment||Treatment||None (Open Label)||||||
1436317|NCT01818271|Randomized|Parallel Assignment||Treatment||Single||||||t
1436318|NCT01818258|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436319|NCT01818245|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1436320|NCT01818232||Single Group Assignment||Treatment||None (Open Label)||||||
1436321|NCT01818219||Single Group Assignment||Basic Science||None (Open Label)||||||
1436322|NCT01818206||Single Group Assignment||Basic Science||None (Open Label)||||||
1436323|NCT01818193|||Case-Only||Prospective|||||||
1436324|NCT01818180|Randomized|||||Double|||t||t|
1436325|NCT01818167|Randomized|Crossover Assignment||Treatment||Single|||||t|
1436326|NCT01818154|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1436327|NCT01818141|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open-label|||||
1436328|NCT01818128|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436329|NCT01818115|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436330|NCT01818102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436331|NCT01818089|||Cohort||Prospective|||||||
1436332|NCT01818076||Single Group Assignment||Treatment||None (Open Label)||||||
1436333|NCT01818063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436334|NCT01818050||Single Group Assignment||Treatment||None (Open Label)||||||
1436335|NCT01818037|||Case-Only||Prospective|||||||
1436336|NCT01818024|Randomized|Single Group Assignment||Treatment||Single|||t|||
1436337|NCT01818011|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436338|NCT01817998|Randomized|Parallel Assignment||Treatment||Single||||||t
1436339|NCT01817985|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436340|NCT01817972|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436341|NCT01817959|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1436342|NCT01817946|||Case-Only||Cross-Sectional|||||||
1436343|NCT01817933||Single Group Assignment||Treatment||None (Open Label)||||||
1436344|NCT01817920||Single Group Assignment||Health Services Research||None (Open Label)||||||
1436345|NCT01817907|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1436346|NCT01817894||Single Group Assignment||Treatment||Single||||||t
1436347|NCT01817881|||Cohort||Prospective|||||||
1436348|NCT01817868|||Cohort||Prospective|||||||
1436349|NCT01817855|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1436350|NCT01817842|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436351|NCT01817829|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436352|NCT01817816|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1436353|NCT01817803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436354|NCT01817790|Randomized|Parallel Assignment||||Triple|||t||t|t
1436355|NCT01817777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436356|NCT01817764|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436357|NCT01817751||Single Group Assignment||Treatment||None (Open Label)||||||
1436358|NCT01817738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436359|NCT01817725||Single Group Assignment||Treatment||None (Open Label)||||||
1436360|NCT01817712|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436361|NCT01817699|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1436362|NCT01817686|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1436363|NCT01817673|Randomized|Parallel Assignment||||Double|||t||t|
1436364|NCT01817660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436365|NCT01817647|||Case-Only||Prospective|||||||
1436366|NCT01817634|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436367|NCT01817621|Randomized|Parallel Assignment||Treatment||Single||||||t
1436368|NCT01817608|||Cohort||Prospective|||||||
1436369|NCT01817595|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1436370|NCT01817582|Randomized|Parallel Assignment||Treatment||Single|||||t|
1436371|NCT01817569|||Cohort||Prospective|||||||
1436372|NCT01817556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436373|NCT01817543||Single Group Assignment||Treatment||None (Open Label)||||||
1436374|NCT01817530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436375|NCT01817517||Single Group Assignment||Treatment||None (Open Label)||||||
1436376|NCT01817504|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1436377|NCT01817491|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436378|NCT01817478||Crossover Assignment||Diagnostic||None (Open Label)||||||
1436379|NCT01817465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436380|NCT01817452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436381|NCT01817439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436382|NCT01817426|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436383|NCT01817413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436384|NCT01817400|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1436385|NCT01817387|Randomized|Factorial Assignment||Treatment||Single||||||t
1436386|NCT01817374||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436387|NCT01817361|||Case-Only||Cross-Sectional|||||||
1436388|NCT01817348|Randomized|Parallel Assignment||Treatment||Single||||||t
1436389|NCT01817335||Single Group Assignment||Supportive Care||None (Open Label)||||||
1436390|NCT01817322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436391|NCT01817309||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436392|NCT01817296||Single Group Assignment||Treatment||None (Open Label)||||||
1436393|NCT01817283|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1436394|NCT01817270||Single Group Assignment||Prevention||None (Open Label)||||||
1436395|NCT01817257|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1436396|NCT01817244|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436397|NCT01817231|||Case Control||Prospective|||||||
1436398|NCT01817218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436399|NCT01817205||Single Group Assignment||Treatment||None (Open Label)||||||
1436400|NCT01817192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436401|NCT01817179||Single Group Assignment||Treatment||None (Open Label)||||||
1436402|NCT01817166|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1436403|NCT01817153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436404|NCT01817140|||Case-Only||Prospective|||||||
1436405|NCT01817127|||Cohort||Prospective|||||||
1436406|NCT01817114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436407|NCT01817101|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1436408|NCT01817088|Randomized|Parallel Assignment||Other||Single||||||t
1436409|NCT01817075|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1436410|NCT01817062|||Cohort||Retrospective|||||||
1436411|NCT01817049|Randomized|Parallel Assignment||Prevention||Single|||t|||
1436412|NCT01817036|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436413|NCT01817023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436414|NCT01817010|Randomized|Parallel Assignment||Treatment||Single||||||t
1436415|NCT01816997|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436416|NCT01816984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436417|NCT01816971||Single Group Assignment||Treatment||None (Open Label)||||||
1436418|NCT01816958|||Case Control||Retrospective|||||||
1436419|NCT01816945|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436420|NCT01816932|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436421|NCT01816919||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436422|NCT01816906|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436423|NCT01816893|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1436424|NCT01816880|||Cohort||Prospective|||||||
1436425|NCT01816867|||Case-Only||Prospective|||||||
1436426|NCT01816854|||Case-Only||Prospective|||||||
1436427|NCT01816841|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1436428|NCT01816828|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1436429|NCT01816815|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1436430|NCT01816802|||Cohort||Prospective|||||||
1436431|NCT01816789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436432|NCT01816776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436433|NCT01816763|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1436434|NCT01816750|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1436435|NCT01816737|||Case Control||Prospective|||||||
1436436|NCT01816724|||Case-Only||Prospective|||||||
1436437|NCT01816711|||Case Control||Retrospective|||||||
1436438|NCT01816698|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436439|NCT01816685|Randomized|Parallel Assignment||Prevention||Single||||||t
1436440|NCT01816672|Randomized|Parallel Assignment||Treatment||Single||||||t
1436441|NCT01816659|Randomized|Parallel Assignment||||None (Open Label)||||||
1436442|NCT01816646||Single Group Assignment||Treatment||None (Open Label)||||||
1436443|NCT01816633||Single Group Assignment||Treatment||None (Open Label)||||||
1436444|NCT01816620||Single Group Assignment||Treatment||None (Open Label)||||||
1436445|NCT01816607|||Cohort||Prospective|||||||
1436446|NCT01816594|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436447|NCT01816581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436448|NCT01816568|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436449|NCT01816555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436450|NCT01816542||Single Group Assignment||Screening||None (Open Label)||||||
1436451|NCT01816529|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1436452|NCT01816516|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1436453|NCT01816503|||Cohort||Prospective|||||||
1436454|NCT01816490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436455|NCT01816477|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436456|NCT01816464||Single Group Assignment||Basic Science||None (Open Label)||||||
1436457|NCT01816451|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1436458|NCT01816438|||Cohort||Prospective|||||||
1436459|NCT01816425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436460|NCT01816412|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436461|NCT01816399|||Cohort||Retrospective|||||||
1436462|NCT01816386|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1436463|NCT01816373||Single Group Assignment||Treatment||None (Open Label)||||||
1436464|NCT01816360|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1436465|NCT01816347|||Cohort||Retrospective|||||||
1436466|NCT01816334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436467|NCT01816321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436468|NCT01816308|||Case-Control||Prospective|||||||
1436469|NCT01816295|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436470|NCT01816282|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436471|NCT01816269|||Cohort||Retrospective|||||||
1436472|NCT01816256||Single Group Assignment||Screening||None (Open Label)||||||
1436473|NCT01816243||Single Group Assignment||Treatment||None (Open Label)||||||
1436474|NCT01816230||Single Group Assignment||Treatment||None (Open Label)||||||
1436475|NCT01816217||Single Group Assignment||||None (Open Label)||||||
1436476|NCT01816204|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436477|NCT01816191||Single Group Assignment||Treatment||None (Open Label)||||||
1436478|NCT01816178||Single Group Assignment||Treatment||None (Open Label)||||||
1436479|NCT01816165|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1436480|NCT01816152|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1436481|NCT01816139|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436482|NCT01816126|||Case Control||Prospective|||||||
1436483|NCT01816113|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436484|NCT01816100||Single Group Assignment||Health Services Research||None (Open Label)||||||
1436485|NCT01816087||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436486|NCT01816074|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1436487|NCT01816061|Randomized|Parallel Assignment||Treatment||Single||||||t
1436488|NCT01816048||Single Group Assignment||Treatment||None (Open Label)||||||
1436489|NCT01816035||Single Group Assignment||Treatment||None (Open Label)||||||
1436490|NCT01816022|||Case Control||Prospective|||||||
1436491|NCT01816009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436492|NCT01815996|||Case-Control||Prospective|||||||
1436493|NCT01815983||Single Group Assignment||Other||None (Open Label)||||||
1436494|NCT01815970||Single Group Assignment||Supportive Care||None (Open Label)||||||
1436495|NCT01815957|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436496|NCT01815944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436497|NCT01815931|||Cohort||Prospective|||||||
1436498|NCT01815918|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436499|NCT01815905|Randomized|Parallel Assignment||Treatment||Double||||t||t
1436942|NCT01810107|||Cohort||Prospective|||||||
1436500|NCT01815892|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1436501|NCT01815879|||Case-Only||Retrospective|||||||
1436502|NCT01815866|||Case Control||Prospective|||||||
1436503|NCT01815853|Randomized|Parallel Assignment||Treatment||None (Open Label)||Neoadjuvant Chemoradiotherapy versus Neoadjuvant Chemotherapy||||
1436504|NCT01815840|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436505|NCT01815827|Randomized|Parallel Assignment||||None (Open Label)||||||
1436506|NCT01815814|Randomized|Parallel Assignment||Treatment||Single||||||t
1436507|NCT01815801|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436508|NCT01815788||Single Group Assignment||Supportive Care||None (Open Label)||||||
1436509|NCT01815775||Single Group Assignment||||None (Open Label)||||||
1436510|NCT01815762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436511|NCT01815749||Single Group Assignment||Treatment||None (Open Label)||||||
1436512|NCT01815736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436513|NCT01815723|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436514|NCT01815710|||Other||Other|||||||
1436515|NCT01815697|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with benign prostatic hyperplasia are assigned to two groups in parallel for the duration of the study||||
1436516|NCT01815684|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1436517|NCT01815671|Randomized|Parallel Assignment||||Single|||t|||
1436518|NCT01815658|||Case-Only||Retrospective|||||||
1436519|NCT01815645|Randomized|Parallel Assignment||Treatment||None (Open Label)|Both participants and researchers know the treatment alocations|||||
1436520|NCT01815632|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1436521|NCT01815619|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1436522|NCT01815606|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1436523|NCT01815593|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with erectile dysfunction are assigned to two groups in parallel for the duration of the study||||
1436524|NCT01815580|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1436525|NCT01815567|||Case-Control||Prospective|||||||
1436526|NCT01815554|||Case-Only||Prospective|||||||
1436527|NCT01815541||Single Group Assignment||Treatment||None (Open Label)||||||
1436528|NCT01815528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436529|NCT01815515||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436530|NCT01815502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436531|NCT01815489|||Case Control||Prospective|||||||
1436532|NCT01815476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436533|NCT01815463|||Cohort||Prospective|||||||
1436534|NCT01815450|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1436535|NCT01815437|Randomized|Parallel Assignment||Other||Double|||t||t|
1436536|NCT01815424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436537|NCT01815411|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1436538|NCT01815398|Randomized|Parallel Assignment||Treatment||Single||||||t
1436539|NCT01815385|||Ecologic or Community||Prospective|||||||
1436540|NCT01815372|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436541|NCT01815359|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436542|NCT01815346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436543|NCT01815333||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436544|NCT01815320||Single Group Assignment||||None (Open Label)||||||
1436545|NCT01815307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436546|NCT01815294|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1436547|NCT01815281|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1436548|NCT01815268|Randomized|Parallel Assignment||Prevention||Single||||||t
1436549|NCT01815255|||Cohort||Prospective|||||||
1436550|NCT01815242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436551|NCT01815229|||Cohort||Prospective|||||||
1436552|NCT01815216|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1436553|NCT01815203|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1436554|NCT01815190|||Cohort||Retrospective|||||||
1436555|NCT01815177|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436556|NCT01815164|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436557|NCT01815138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436558|NCT01815125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436559|NCT01815112|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1436560|NCT01815099||Single Group Assignment||Treatment||None (Open Label)||||||
1436561|NCT01815086||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436562|NCT01815073|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436563|NCT01815047|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1436564|NCT01815034|||Case-Only||Prospective|||||||
1436565|NCT01815021|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1436566|NCT01815008||Single Group Assignment||Prevention||None (Open Label)||||||
1436567|NCT01814995||Single Group Assignment||Prevention||None (Open Label)||||||
1436568|NCT01814982||Single Group Assignment||Treatment||None (Open Label)||||||
1436569|NCT01814969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436570|NCT01814956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436571|NCT01814943|||Cohort||Retrospective|||||||
1436572|NCT01814930|Randomized|Parallel Assignment||||None (Open Label)||||||
1436573|NCT01814917|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436574|NCT01814904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436575|NCT01814891|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1436576|NCT01814878|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436577|NCT01814865|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1436578|NCT01814852|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436579|NCT01814839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436580|NCT01814826||Single Group Assignment||Treatment||None (Open Label)||||||
1436581|NCT01814813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436582|NCT01814800||Single Group Assignment||Treatment||None (Open Label)||||||
1436583|NCT01814787|Randomized|Parallel Assignment||Screening||Single|||||t|
1436584|NCT01814774|||Cohort||Retrospective|||||||
1436585|NCT01814761|||Case-Only||Prospective|||||||
1436586|NCT01814748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436587|NCT01814735|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1436588|NCT01814722|||Cohort||Prospective|||||||
1436589|NCT01814709|Randomized|Parallel Assignment||||None (Open Label)||||||
1436590|NCT01814696|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1436591|NCT01814683|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436592|NCT01814670||Single Group Assignment||Treatment||None (Open Label)||||||
1436593|NCT01814657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436594|NCT01814644|Randomized|Parallel Assignment||Treatment||Single||||t||
1436595|NCT01814631|||Case-Only||Prospective|||||||
1436596|NCT01814618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436597|NCT01814605|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1436598|NCT01814592|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1436599|NCT01814579|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436600|NCT01814566|||Cohort||Prospective|||||||
1436601|NCT01814553||Parallel Assignment||Treatment||None (Open Label)||||||
1436602|NCT01814540|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1436603|NCT01814527|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1436604|NCT01814514|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436605|NCT01814501||Single Group Assignment||Treatment||None (Open Label)||||||
1436606|NCT01814488||Single Group Assignment||Treatment||None (Open Label)||||||
1436607|NCT01814475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436608|NCT01814462||Single Group Assignment||Basic Science||None (Open Label)||||||
1436609|NCT01814449|||Case Control||Prospective|||||||
1436610|NCT01814436||Single Group Assignment||Treatment||None (Open Label)||||||
1436611|NCT01814423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436612|NCT01814410|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1436613|NCT01814397|||Cohort||Prospective|||||||
1436614|NCT01814384|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436615|NCT01814371|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436616|NCT01814358|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1436617|NCT01814345|||Other||Prospective|||||||
1436618|NCT01814332|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436619|NCT01814319|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1436620|NCT01814306|Randomized|Parallel Assignment||||Double|||t|||t
1436621|NCT01814293|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1436622|NCT01814280||Single Group Assignment||Prevention||None (Open Label)||||||
1436623|NCT01814267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436624|NCT01814254|||Cohort||Prospective|||||||
1436625|NCT01814241||Single Group Assignment||Other||None (Open Label)||||||
1436626|NCT01814228||Single Group Assignment||Treatment||None (Open Label)||||||
1436627|NCT01814215|Randomized|Parallel Assignment||Prevention||Single|||||t|
1436628|NCT01814202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436629|NCT01814189|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436630|NCT01814176|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436631|NCT01814163|||Case-Only||Prospective|||||||
1436632|NCT01814150|||Cohort||Prospective|||||||
1436633|NCT01814137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436634|NCT01814124|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436635|NCT01814111|Randomized|Parallel Assignment||Treatment||Single||||||t
1436636|NCT01814098||Single Group Assignment||Treatment||None (Open Label)||||||
1436637|NCT01814085||Single Group Assignment||Treatment||None (Open Label)||||||
1436638|NCT01814072|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1436639|NCT01814059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436640|NCT01814046|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436641|NCT01814033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436642|NCT01814020||||||||||||
1436643|NCT01814007||Single Group Assignment||Other||None (Open Label)||||||
1436644|NCT01813994|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436645|NCT01813981|Randomized|Crossover Assignment||Prevention||Single|||||t|
1436646|NCT01813968|Randomized|Single Group Assignment||Treatment||Single|||t|||
1436647|NCT01813955||Single Group Assignment||Health Services Research||Triple|||t||t|t
1436648|NCT01813942|||||Retrospective|||||||
1436649|NCT01813929|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1436650|NCT01813916||Single Group Assignment||Basic Science||Single|||||t|
1436651|NCT01813903|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436652|NCT01813890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436653|NCT01813877|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436654|NCT01813864||Single Group Assignment||Health Services Research||None (Open Label)||||||
1436655|NCT01813851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436656|NCT01813838|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436657|NCT01813825|||||Prospective|||||||
1436658|NCT01813812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436659|NCT01813799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436660|NCT01813786|Randomized|Parallel Assignment||Treatment||Single||||||t
1436661|NCT01813773|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436662|NCT01813760||Single Group Assignment||Treatment||None (Open Label)||||||
1436663|NCT01813747||Single Group Assignment||Treatment||None (Open Label)||||||
1436664|NCT01813734||Single Group Assignment||Treatment||None (Open Label)||||||
1436665|NCT01813721|||Case-Only||Prospective|||||||
1436666|NCT01813708|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1436667|NCT01813695|||Case Control||Prospective|||||||
1436668|NCT01813682|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1436669|NCT01813669|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436670|NCT01813656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436671|NCT01813643|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436672|NCT01813630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436673|NCT01813617|||Cohort||Prospective|||||||
1436674|NCT01813604|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436675|NCT01813591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436676|NCT01813578||Single Group Assignment||Treatment||None (Open Label)||||||
1436677|NCT01813565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436678|NCT01813552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436679|NCT01813539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436680|NCT01813526||Single Group Assignment||||Single|||t|||
1436681|NCT01813513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436682|NCT01813500|||Case-Control||Prospective|||||||
1436683|NCT01813487||Single Group Assignment||Treatment||None (Open Label)||||||
1436684|NCT01813474||Single Group Assignment||Treatment||None (Open Label)||||||
1436685|NCT01813461||Single Group Assignment||||None (Open Label)||||||
1436686|NCT01813448|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1436687|NCT01813435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436688|NCT01813422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436689|NCT01813409||||||||||||
1436690|NCT01813396|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436691|NCT01813383|||Case-Only||Prospective|||||||
1436692|NCT01813370|||Cohort||Prospective|||||||
1436693|NCT01813357|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436694|NCT01813344|||||Retrospective|||||||
1436695|NCT01813331|||Case-Only||Cross-Sectional|||||||
1436696|NCT01813318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436697|NCT01813305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436698|NCT01813292|||Cohort||Cross-Sectional|||||||
1436699|NCT01813279||Single Group Assignment||Treatment||None (Open Label)||||||
1436700|NCT01813266|||Cohort||Prospective|||||||
1436701|NCT01813253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436702|NCT01813240|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1436703|NCT01813227||Single Group Assignment||Treatment||None (Open Label)||||||
1436704|NCT01813214|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436705|NCT01813201|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436706|NCT01813188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436707|NCT01813175|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1436708|NCT01813162|Randomized|Crossover Assignment||||None (Open Label)||||||
1436709|NCT01813149||Single Group Assignment||Supportive Care||None (Open Label)||||||
1436710|NCT01813136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436711|NCT01813123|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436712|NCT01813110|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1436713|NCT01813097|||Case Control||Prospective|||||||
1436714|NCT01813084|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436715|NCT01813071|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436716|NCT01813058|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436717|NCT01813045|||Cohort||Prospective|||||||
1436718|NCT01813032|||Case Control||Prospective|||||||
1436719|NCT01813019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436720|NCT01813006|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1436721|NCT01812993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436722|NCT01812980||Single Group Assignment||Basic Science||None (Open Label)||||||
1436723|NCT01812967|Randomized|Crossover Assignment||Prevention||||||||
1436724|NCT01812954|||Other||Retrospective|||||||
1436725|NCT01812941|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1436726|NCT01812928|Randomized|Parallel Assignment||Treatment||Double||||t||t
1436727|NCT01812915|Randomized|Parallel Assignment||||Triple|||t||t|t
1436728|NCT01812902|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436729|NCT01812889|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1436730|NCT01812876|||Cohort||Prospective|||||||
1436731|NCT01812863|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436732|NCT01812850|||Cohort||Prospective|||||||
1436733|NCT01812837|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436734|NCT01812824|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436735|NCT01812811|||||Prospective|||||||
1436736|NCT01812798|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1436737|NCT01812785|||Cohort||Prospective|||||||
1436738|NCT01812772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436739|NCT01812759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436740|NCT01812746||Single Group Assignment||Treatment||None (Open Label)||||||
1436741|NCT01812733|||Cohort||Prospective|||||||
1436742|NCT01812720||Single Group Assignment||Treatment||None (Open Label)||||||
1436743|NCT01812707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436744|NCT01812694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436745|NCT01812681|||Cohort||Prospective|||||||
1436746|NCT01812668||Single Group Assignment||Treatment||None (Open Label)||||||
1436747|NCT01812655|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1436748|NCT01812642|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436749|NCT01812629||Single Group Assignment||Treatment||None (Open Label)||||||
1436750|NCT01812616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436751|NCT01812603||Single Group Assignment||Treatment||None (Open Label)||||||
1436752|NCT01812590|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1436753|NCT01812577|||||Prospective|||||||
1436754|NCT01812564|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436755|NCT01812551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436756|NCT01812538|Randomized|Crossover Assignment||||Single|||t|||
1436757|NCT01812525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436758|NCT01812512|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436759|NCT01812499|||||Retrospective|||||||
1436760|NCT01812486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436761|NCT01812473|||Case-Only||Prospective|||||||
1436762|NCT01812460|Randomized|Parallel Assignment||Prevention||Single||||||t
1436763|NCT01812447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436764|NCT01812434|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1436765|NCT01812421||||Prevention||None (Open Label)||||||
1436766|NCT01812395|Randomized|Parallel Assignment||Prevention||Single||||||t
1436767|NCT01812382||Single Group Assignment||Treatment||None (Open Label)||||||
1436768|NCT01812369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436769|NCT01812356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436770|NCT01812343||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436771|NCT01812330|Randomized|Parallel Assignment||Treatment||Single||||||t
1436772|NCT01812317|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1436773|NCT01812304|Randomized|Parallel Assignment||||Double|||t|||t
1436774|NCT01812291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436775|NCT01812278|Randomized|Parallel Assignment||Treatment||Single|||||t|
1436776|NCT01812265|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1436777|NCT01812252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436778|NCT01812239|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436779|NCT01812226|||Case Control||Prospective|||||||
1436780|NCT01812213||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436781|NCT01812200|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1436782|NCT01812187||Single Group Assignment||Treatment||None (Open Label)||||||
1436783|NCT01812174|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients in one arm are recipients of the 17mm On-X Aortic Valve. Patients in the second arm are recipients of the 23mm On-X Mitral Valve. Since double valve cases are exclusionary, these two arms are mutually exclusive and non-randomized.||||
1436784|NCT01812161|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436785|NCT01812148|||Case-Crossover||Retrospective|||||||
1436786|NCT01812135|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1436787|NCT01812122|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1436788|NCT01812109||Single Group Assignment||Diagnostic||None (Open Label)|"The probe will be laid on the exposed testis (intraoperative testicular tissue). Each measurement is painless and takes <15 seconds each. The NIRS probe will be placed on the anterior testis to obtain the three sets of three measurements. Thus, the unaffected testis will serve as the patient's own control. NIRS #2-4 will not delay detorsion of the affected testis. Surgeons will be blinded to these NIRS results, thus the decision during the operation will not be affected.~All participants' NIRS results will be blinded to the surgeons."|Those that accept study participation after informed consent will receive standard of care therapy for the acute scrotum and will be evaluated by NIRS. The NIRS measurements will not bias the treatments performed or not performed on the study patients, permitting standard of care treatment unbiased. The clinical data will be collected prospectively for each patient utilizing REDCap Data Collection Management and stored in the REDCap databases and the photographic database. Photographs will be taken of the scrotum. In addition, select participants will be asked if they will allow us to videotape the NIRS measurements.||||
1436789|NCT01812096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436790|NCT01812083|||Case Control||Cross-Sectional|||||||
1436791|NCT01812070|Randomized|Parallel Assignment||Treatment||Single|||||t|
1436792|NCT01812057|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436793|NCT01812044|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1436794|NCT01812031||Single Group Assignment||Diagnostic||Single|||||t|
1436795|NCT01812018||Single Group Assignment||Treatment||None (Open Label)||||||
1436796|NCT01812005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436797|NCT01811992||Single Group Assignment||Treatment||None (Open Label)||||||
1436798|NCT01811979|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1436799|NCT01811966|Randomized|Parallel Assignment||Treatment||Single|||||t|
1436800|NCT01811953|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1436801|NCT01811940|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436802|NCT01811927||Single Group Assignment||Treatment||None (Open Label)||||||
1436803|NCT01811914||Single Group Assignment||Treatment||None (Open Label)||||||
1436804|NCT01811901|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1436805|NCT01811888|||Cohort||Prospective|||||||
1436806|NCT01811875||Single Group Assignment||Treatment||None (Open Label)||||||
1436807|NCT01811862|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436808|NCT01811849|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1436809|NCT01811836||Single Group Assignment||Treatment||None (Open Label)||||||
1436810|NCT01811823||Single Group Assignment||Basic Science||None (Open Label)||||||
1436811|NCT01811810||||Treatment||||||||
1436812|NCT01811797|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436813|NCT01811784|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436814|NCT01811771|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436815|NCT01811758|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1436816|NCT01811745|Randomized|Parallel Assignment||Treatment||Single||||||t
1436817|NCT01811732|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436818|NCT01811719|Randomized|Parallel Assignment||Prevention||Single|||t|||
1436819|NCT01811706|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1436820|NCT01811693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436821|NCT01811680||Single Group Assignment||Treatment||None (Open Label)||||||
1436822|NCT01811667||Single Group Assignment||Treatment||None (Open Label)||||||
1436823|NCT01811654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436824|NCT01811641|||Cohort||Prospective|||||||
1436825|NCT01811628|||Case-Only||Prospective|||||||
1436826|NCT01811615|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1436827|NCT01811602|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1436828|NCT01811589|Randomized|Parallel Assignment||Treatment||Single||||||t
1436829|NCT01811576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436830|NCT01811563|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1436831|NCT01811550|||Cohort||Prospective|||||||
1436832|NCT01811537||Single Group Assignment||Treatment||Double|||t|||t
1436833|NCT01811524|||Cohort||Retrospective|||||||
1436834|NCT01811511|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1436835|NCT01811498||Single Group Assignment||Treatment||None (Open Label)||||||
1436836|NCT01811485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436837|NCT01811472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436838|NCT01811459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436839|NCT01811446|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436840|NCT01811433|||||Prospective|||||||
1436841|NCT01811420|Randomized|Parallel Assignment||Treatment||Single|||||t|
1436842|NCT01811407|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436843|NCT01811394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436844|NCT01811381|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1436845|NCT01811368||Single Group Assignment||Treatment||None (Open Label)||||||
1436846|NCT01811355|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1436847|NCT01811342|||Case-Only||Retrospective|||||||
1436848|NCT01811329|Randomized|Crossover Assignment||Treatment||Single|||t|||
1436849|NCT01811316|Randomized|Parallel Assignment||Other||Double|||t||t|
1436850|NCT01811303|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1436851|NCT01811290|||Other||Prospective|||||||
1436852|NCT01811277||Single Group Assignment||Treatment||None (Open Label)||||||
1436853|NCT01811264|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1436854|NCT01811251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436855|NCT01811238||Single Group Assignment||Supportive Care||None (Open Label)||||||
1436856|NCT01811225|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1436857|NCT01811212||Single Group Assignment||Treatment||None (Open Label)||||||
1436858|NCT01811199|||Case Control||Prospective|||||||
1436859|NCT01811186|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1436860|NCT01811173|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436861|NCT01811160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436862|NCT01811147|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436863|NCT01811134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436864|NCT01811121|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436865|NCT01811108|||Cohort|||||||||
1436866|NCT01811095|Randomized|Crossover Assignment||||Single||||||t
1436867|NCT01811082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436868|NCT01811069|||Case Control||Prospective|||||||
1436869|NCT01811056|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1436870|NCT01811043|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1436871|NCT01811030||Single Group Assignment||Treatment||None (Open Label)||||||
1436872|NCT01811017|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1436873|NCT01811004|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1436874|NCT01810991||Single Group Assignment||Treatment||None (Open Label)||||||
1436875|NCT01810978|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436876|NCT01810965||Single Group Assignment||Treatment||None (Open Label)||||||
1436877|NCT01810952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436878|NCT01810939|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436879|NCT01810926|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1436880|NCT01810913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436881|NCT01810900|Randomized|Parallel Assignment||Prevention||Single||||||t
1436882|NCT01810887||Single Group Assignment||Treatment||None (Open Label)||||||
1436883|NCT01810874|Randomized|Parallel Assignment||||Single||||||t
1436884|NCT01810861|||Other||Retrospective|||||||
1436885|NCT01810848|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1436886|NCT01810835|||Cohort||Retrospective|||||||
1436887|NCT01810822|||Case-Only||Cross-Sectional|||||||
1436888|NCT01810809|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436889|NCT01810796|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436890|NCT01810783||Single Group Assignment||Treatment||None (Open Label)||||||
1436891|NCT01810770||Single Group Assignment||Treatment||None (Open Label)||||||
1436892|NCT01810757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436893|NCT01810744|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1436894|NCT01810731|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436895|NCT01810718||Single Group Assignment||Treatment||None (Open Label)||||||
1436896|NCT01810705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436897|NCT01810692|||||Cross-Sectional|||||||
1436898|NCT01810679||Single Group Assignment||Treatment||None (Open Label)||||||
1436899|NCT01810666||Single Group Assignment||Treatment||None (Open Label)||||||
1436900|NCT01810653|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1436901|NCT01810640|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436902|NCT01810627||||||||||||
1436903|NCT01810614||Single Group Assignment||Prevention||None (Open Label)||||||
1436904|NCT01810601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436905|NCT01810588||Single Group Assignment||Treatment||None (Open Label)||||||
1436906|NCT01810575|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1436907|NCT01810562|Randomized|Factorial Assignment||Basic Science||Single||||||t
1436908|NCT01810549|Randomized|Crossover Assignment||||Double|||t||t|
1436909|NCT01810536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436910|NCT01810523|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1436911|NCT01810510|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1436912|NCT01810497|Randomized|Parallel Assignment||Treatment||Double||||t||t
1436913|NCT01810484|Randomized|Parallel Assignment||Treatment||Single||||||t
1436914|NCT01810471||Single Group Assignment||Prevention||None (Open Label)||||||
1436915|NCT01810458|||Cohort||Prospective|||||||
1436916|NCT01810445|||Case-Only||Prospective|||||||
1436917|NCT01810432|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1436918|NCT01810419||Single Group Assignment||Diagnostic||None (Open Label)||||||
1436919|NCT01810406|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1436920|NCT01810393|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1436921|NCT01810380|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436922|NCT01810367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436923|NCT01810354|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1436924|NCT01810341|||Cohort||Prospective|||||||
1436925|NCT01810328|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1436926|NCT01810315|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1436927|NCT01810302|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436928|NCT01810289|Randomized|Crossover Assignment||Treatment||None (Open Label)||Clinic level stepped wedge design where each clinic has an amount of time in the pre-intervention or standard of care condition and then crosses over in the intervention condition||||
1436929|NCT01810276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436930|NCT01810263|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1436931|NCT01810250|||Other||Prospective|||||||
1436932|NCT01810237||Single Group Assignment||Prevention||None (Open Label)||||||
1436933|NCT01810224|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436934|NCT01810211|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436935|NCT01810198|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1436936|NCT01810185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436937|NCT01810172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436938|NCT01810159|Randomized|Parallel Assignment||Health Services Research||Single|We used an R software random number generator to randomly assign eligible participants to either CC or usual care. We used a concealed randomization protocol where neither participant nor researcher (outside of the statistician doing the randomization) was aware of the randomization until after the baseline interview. None of the participants or providers was blinded to treatment allocation after randomization. Interviewers were blinded to treatment allocation|||||t
1436939|NCT01810146||Single Group Assignment||Basic Science||None (Open Label)||||||
1436940|NCT01810133|||Cohort||Retrospective|||||||
1436941|NCT01810120||Single Group Assignment||Treatment||None (Open Label)||||||
1436943|NCT01810094|||Case-Only||Prospective|||||||
1436944|NCT01810081|||Cohort||Prospective|||||||
1436945|NCT01810068|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1436946|NCT01810042||Single Group Assignment||Treatment||None (Open Label)||||||
1436947|NCT01810029|Randomized|Parallel Assignment||Prevention||Single||||||t
1436948|NCT01810016|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436949|NCT01810003|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1436950|NCT01809990||Single Group Assignment||Treatment||None (Open Label)||||||
1436951|NCT01809977|Randomized|Parallel Assignment||Treatment||Single||||||t
1436952|NCT01809964|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1436953|NCT01809951|||Case-Only||Prospective|||||||
1436954|NCT01809938|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1436955|NCT01809925|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1436956|NCT01809912||Single Group Assignment||Treatment||None (Open Label)||||||
1436957|NCT01809899|Randomized|Parallel Assignment||Other||Single|||t|||
1436958|NCT01809886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436959|NCT01809873|Randomized|Parallel Assignment||Health Services Research||||||||
1436960|NCT01809860||Single Group Assignment||||None (Open Label)||||||
1436961|NCT01809847||Single Group Assignment||Treatment||None (Open Label)||||||
1436962|NCT01809834|Randomized|Parallel Assignment||||Double|||t||t|
1436963|NCT01809821|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436964|NCT01809808|||Cohort||Prospective|||||||
1436965|NCT01809795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436966|NCT01809782|||Cohort||Prospective|||||||
1436967|NCT01809769|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1436968|NCT01809756||||Prevention||||||||
1436969|NCT01809743|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1436970|NCT01809730|||Cohort||Prospective|||||||
1436971|NCT01809717||Single Group Assignment||Prevention||None (Open Label)||||||
1436972|NCT01809704|||Cohort||Prospective|||||||
1436973|NCT01809691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436974|NCT01809678|Randomized|Parallel Assignment||Treatment||Single||||||t
1436975|NCT01809665|||Case-Only||Prospective|||||||
1436976|NCT01809652||Single Group Assignment||Supportive Care||None (Open Label)||||||
1436977|NCT01809639|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1436978|NCT01809626|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1436979|NCT01809613|||Cohort||Prospective|||||||
1436980|NCT01809600|||Case-Only||Retrospective|||||||
1436981|NCT01809587||Single Group Assignment||Treatment||None (Open Label)||||||
1436982|NCT01809574|||Cohort||Prospective|||||||
1436983|NCT01809561|||Case Control||Prospective|||||||
1436984|NCT01809548|Randomized|Parallel Assignment||Treatment||None (Open Label)|After interim analysis switch from prospective randomised to baseline adaptive randomised controlled - stratified according birthweight below /equal 800g and equal/more than 801 grams|||||
1436985|NCT01809535|Randomized|Parallel Assignment||Prevention||Single||||||t
1436986|NCT01809522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436987|NCT01809509|||Cohort||Prospective|||||||
1436988|NCT01809496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436989|NCT01809483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436990|NCT01809470|Randomized|Parallel Assignment||Basic Science||Single||||||t
1436991|NCT01809457|Randomized|Parallel Assignment||||Double|||||t|t
1436992|NCT01809444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436993|NCT01809431|Randomized|Parallel Assignment||Treatment||Single|||t|||
1436994|NCT01809418||Single Group Assignment||Treatment||None (Open Label)||||||
1436995|NCT01809405|||Cohort||Prospective|||||||
1436996|NCT01809392|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1436997|NCT01809379||Single Group Assignment||Treatment||None (Open Label)||||||
1436998|NCT01809366|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1436999|NCT01809353|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1437000|NCT01809340|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437001|NCT01809327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437002|NCT01809314|||Cohort||Prospective|||||||
1437003|NCT01809301|Randomized|Crossover Assignment||||None (Open Label)||||||
1437004|NCT01809288|||||Prospective|||||||
1437005|NCT01809275|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437006|NCT01809262|Randomized|Crossover Assignment||Treatment||Double||||||
1437007|NCT01809249|||Cohort||Prospective|||||||
1437008|NCT01809236||Single Group Assignment||Treatment||None (Open Label)||||||
1437009|NCT01809223|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437010|NCT01809210||Single Group Assignment||Treatment||None (Open Label)||||||
1437011|NCT01809197|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1437012|NCT01809184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437013|NCT01809171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437014|NCT01809158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437015|NCT01809145||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437016|NCT01809132|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437017|NCT01809119|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1437018|NCT01809106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437019|NCT01809093|||Case-Only||Prospective|||||||
1437020|NCT01809080|||Cohort||Prospective|||||||
1437021|NCT01809067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437022|NCT01809054|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437023|NCT01809041|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1437024|NCT01809028|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1437025|NCT01809015|||Cohort||Prospective|||||||
1437026|NCT01809002|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437027|NCT01808989|||Cohort||Prospective|||||||
1437028|NCT01808976|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1437029|NCT01808963|||Case-Only||Prospective|||||||
1437030|NCT01808950|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1437031|NCT01808937|||Cohort||Prospective|||||||
1437032|NCT01808911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437033|NCT01808898|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1437034|NCT01808885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437035|NCT01808872|||||Prospective|||||||
1437036|NCT01808859|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437037|NCT01808846|||Case-Control||Prospective|||||||
1437038|NCT01808833|||||Cross-Sectional|||||||
1437039|NCT01808820|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437040|NCT01808807|||Case Control||Retrospective|||||||
1437041|NCT01808794|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437042|NCT01808781|Randomized|Factorial Assignment||Treatment||Single|||||t|
1437043|NCT01808768||Single Group Assignment||Treatment||None (Open Label)||||||
1437044|NCT01808755|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437045|NCT01808742|||Cohort||Prospective|||||||
1437046|NCT01808729|||Case Control||Cross-Sectional|||||||
1437047|NCT01808716|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437048|NCT01808703|Randomized|Parallel Assignment||Treatment||Single||||||t
1437049|NCT01808690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437050|NCT01808677|||Cohort||Prospective|||||||
1437051|NCT01808664|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1437052|NCT01808651||Single Group Assignment||Treatment||None (Open Label)||||||
1437053|NCT01808638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437054|NCT01808625||Single Group Assignment||Other||None (Open Label)||||||
1437055|NCT01808612|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437056|NCT01808599||Single Group Assignment||Treatment||None (Open Label)||||||
1437057|NCT01808586|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437058|NCT01808573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437059|NCT01808560|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437060|NCT01808547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437061|NCT01808534||Single Group Assignment||Treatment||None (Open Label)||||||
1437062|NCT01808521||Single Group Assignment||Treatment||None (Open Label)||||||
1437063|NCT01808508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437064|NCT01808495|||||Prospective|||||||
1437065|NCT01808482|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437066|NCT01808469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437067|NCT01808456|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1437068|NCT01808443|Randomized|Parallel Assignment||Treatment||Single||||||t
1437069|NCT01808430|||Cohort||Prospective|||||||
1437070|NCT01808417||Single Group Assignment||Diagnostic||None (Open Label)|There is no masking in this study as all study subjects receive the same intervention.|||||
1437071|NCT01808404||Single Group Assignment||Treatment||None (Open Label)||||||
1437072|NCT01808391|||Cohort||Prospective|||||||
1437073|NCT01808378||Single Group Assignment||Treatment||None (Open Label)||||||
1437074|NCT01808365|||Case-Only||Cross-Sectional|||||||
1437075|NCT01808352||Single Group Assignment||Prevention||None (Open Label)||||||
1437076|NCT01808339|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1437077|NCT01808326||Single Group Assignment||Treatment||None (Open Label)||||||
1437078|NCT01808313||Single Group Assignment||Treatment||None (Open Label)||||||
1437079|NCT01808300|Randomized|Crossover Assignment||||None (Open Label)||||||
1437080|NCT01808287|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437081|NCT01808274||Single Group Assignment||Treatment||None (Open Label)||||||
1437082|NCT01808261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437083|NCT01808248||Single Group Assignment||Treatment||None (Open Label)||||||
1437084|NCT01808235||Single Group Assignment||Prevention||None (Open Label)||||||
1437085|NCT01808222||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437086|NCT01808209|Randomized|Crossover Assignment||||Single|||||t|
1437087|NCT01808196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437088|NCT01808183|||Cohort||Prospective|||||||
1437089|NCT01808170|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1437090|NCT01808157|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1437091|NCT01808144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437092|NCT01808131|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437093|NCT01808118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437094|NCT01808105|Randomized|Parallel Assignment||||Triple|||t|t|t|
1437095|NCT01808092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437096|NCT01808079||||||||||||
1437097|NCT01808066||Single Group Assignment||Treatment||None (Open Label)||||||
1437098|NCT01808053|||Case-Only||Prospective|||||||
1437099|NCT01808040||Single Group Assignment||Treatment||None (Open Label)||||||
1437100|NCT01808027|||Cohort||Prospective|||||||
1437101|NCT01808014|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1437102|NCT01808001|||||Prospective|||||||
1437103|NCT01807988|Randomized|Parallel Assignment||Prevention||Single||||||t
1437104|NCT01807975||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437105|NCT01807962|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1437106|NCT01807949|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437107|NCT01807936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437108|NCT01807923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437109|NCT01807910|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1437110|NCT01807897|Randomized|Parallel Assignment||Treatment||Single||Continuous positive airway pressure (CPAP) and supplemental oxygen||||t
1437111|NCT01807884|Randomized|Crossover Assignment||Prevention||Single||||||t
1437112|NCT01807871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437113|NCT01807858|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1437114|NCT01807845|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1437115|NCT01807832||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437116|NCT01807819|||Cohort||Prospective|||||||
1437117|NCT01807806|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1437118|NCT01807793|Randomized|Parallel Assignment||Other||Single||||||t
1437119|NCT01807780||Single Group Assignment||Prevention||None (Open Label)||||||
1437120|NCT01807767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437121|NCT01807754|||Cohort||Prospective|||||||
1437122|NCT01807741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437123|NCT01807728|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1437124|NCT01807715|||Cohort||Prospective|||||||
1437125|NCT01807702||Single Group Assignment||Health Services Research||None (Open Label)||||||
1437126|NCT01807689|||Case-Only||Prospective|||||||
1437127|NCT01807676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437128|NCT01807663|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1437129|NCT01807650|Randomized|Single Group Assignment||Treatment||Single||||||t
1437130|NCT01807637|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437131|NCT01807624||Single Group Assignment||Treatment||None (Open Label)||||||
1437132|NCT01807611||Single Group Assignment||Treatment||None (Open Label)||||||
1437133|NCT01807598||Single Group Assignment||Treatment||None (Open Label)||||||
1437134|NCT01807585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437135|NCT01807572|||Cohort||Prospective|||||||
1437136|NCT01807559|||Case-Only||Prospective|||||||
1437137|NCT01807546||Single Group Assignment||Treatment||None (Open Label)||||||
1437138|NCT01807533|Randomized|Parallel Assignment||Prevention||Single||||||t
1437139|NCT01807520|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437140|NCT01807507|||Case-Only||Prospective|||||||
1437141|NCT01807494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437142|NCT01807481||Single Group Assignment||Treatment||None (Open Label)||||||
1437143|NCT01807468||Single Group Assignment||Treatment||None (Open Label)||||||
1437144|NCT01807455||Single Group Assignment||Treatment||None (Open Label)||||||
1437145|NCT01807442|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437146|NCT01807429|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437147|NCT01807416|Randomized|Parallel Assignment||Treatment||Single||||||t
1437148|NCT01807403|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1437149|NCT01807390|||Cohort||Prospective|||||||
1437150|NCT01807377|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1437151|NCT01807364|||Cohort||Cross-Sectional|||||||
1437152|NCT01807351|||Cohort||Retrospective|||||||
1437153|NCT01807338||||||||||||
1437154|NCT01807325|||Cohort||Prospective|||||||
1437155|NCT01807312|Randomized|Parallel Assignment||||Triple|||t|t|t|
1437156|NCT01807299|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437157|NCT01807286||Single Group Assignment||Treatment||None (Open Label)||||||
1437158|NCT01807273|||Cohort||Prospective|||||||
1437159|NCT01807260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437160|NCT01807247|||Cohort||Prospective|||||||
1437161|NCT01807234|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1437162|NCT01807221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437163|NCT01807208|Randomized|Parallel Assignment||Prevention||Single|||||t|
1437164|NCT01807195|||Case-Only||Retrospective|||||||
1437165|NCT01807182||Single Group Assignment||Treatment||None (Open Label)||||||
1437166|NCT01807169||Single Group Assignment||Prevention||None (Open Label)||||||
1437167|NCT01807156||Single Group Assignment||Treatment||None (Open Label)||||||
1437168|NCT01807143|||Cohort||Retrospective|||||||
1437169|NCT01807130|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437170|NCT01807117||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437171|NCT01807104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437172|NCT01807091||Single Group Assignment||Treatment||None (Open Label)||||||
1437173|NCT01807078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437174|NCT01807065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437175|NCT01807052|||Case-Only||Retrospective|||||||
1437176|NCT01807039|||Cohort||Retrospective|||||||
1437177|NCT01807026|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1437178|NCT01807013|||Cohort||Prospective|||||||
1437179|NCT01807000||Single Group Assignment||||None (Open Label)||||||
1437180|NCT01806987|Randomized|Parallel Assignment||Prevention||Single||||||t
1437181|NCT01806974|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437182|NCT01806961|||Cohort||Prospective|||||||
1437183|NCT01806948|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437184|NCT01806935|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437185|NCT01806922|Randomized|Parallel Assignment||Treatment||Single||||||t
1437186|NCT01806909|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437187|NCT01806896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437188|NCT01806883|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437189|NCT01806870||Single Group Assignment||Other||None (Open Label)||||||
1437190|NCT01806857|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1437191|NCT01806844|||Case-Only||Prospective|||||||
1437192|NCT01806831||Single Group Assignment||Treatment||None (Open Label)||||||
1437193|NCT01806818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437194|NCT01806805|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1437195|NCT01806792|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437196|NCT01806779|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1437197|NCT01806766|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437198|NCT01806753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437199|NCT01806740||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437200|NCT01806727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437201|NCT01806714|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1437202|NCT01806701||Single Group Assignment||Basic Science||None (Open Label)||||||
1437203|NCT01806688|Randomized|Crossover Assignment||Other||Single|||t|||
1437204|NCT01806675||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437205|NCT01806662|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1437206|NCT01806649||Single Group Assignment||Treatment||None (Open Label)||||||
1437207|NCT01806636|||Cohort||Prospective|||||||
1437208|NCT01806623||Parallel Assignment||Treatment||None (Open Label)||||||
1437209|NCT01806610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437210|NCT01806597|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437211|NCT01806584|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437212|NCT01806571||Single Group Assignment||Treatment||None (Open Label)||||||
1437213|NCT01806558||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437214|NCT01806545|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437215|NCT01806532|||Case-Only||Prospective|||||||
1437216|NCT01806519||Single Group Assignment||Treatment||Single|||t|||
1437217|NCT01806506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437218|NCT01806493|||Cohort||Cross-Sectional|||||||
1437219|NCT01806480|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1437220|NCT01806467|||Cohort||Prospective|||||||
1437221|NCT01806454|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437222|NCT01806441|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1437223|NCT01806428|||Cohort||Prospective|||||||
1437224|NCT01806415|Randomized|Parallel Assignment||||Triple|||t|t|t|
1437225|NCT01806402|||Cohort||Prospective|||||||
1437226|NCT01806389|||Cohort||Prospective|||||||
1437227|NCT01806376||Single Group Assignment||Prevention||None (Open Label)||||||
1437228|NCT01806363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437229|NCT01806350|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437230|NCT01806337||Single Group Assignment||Treatment||None (Open Label)||||||
1437231|NCT01806324|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437232|NCT01806311|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437233|NCT01806298||Single Group Assignment||Treatment||None (Open Label)||||||
1437234|NCT01806285|||Case Control||Prospective|||||||
1437235|NCT01806272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437236|NCT01806259|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1437237|NCT01806246||Single Group Assignment||Treatment||None (Open Label)||||||
1437238|NCT01806233|Randomized|Parallel Assignment||Treatment||Single||||||t
1437239|NCT01806220|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1437240|NCT01806207|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437241|NCT01806194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437242|NCT01806181||Single Group Assignment||Supportive Care||None (Open Label)||||||
1437243|NCT01806168|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437244|NCT01806155|||Cohort||Prospective|||||||
1437245|NCT01806142|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1437246|NCT01806129|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437247|NCT01806116||Single Group Assignment||Treatment||None (Open Label)||||||
1437248|NCT01806103|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437249|NCT01806090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437250|NCT01806077||Single Group Assignment||Treatment||Single|||t|||
1437251|NCT01806064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437252|NCT01806051|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1437253|NCT01806038|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1437254|NCT01806025|||Cohort||Retrospective|||||||
1437255|NCT01806012|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437256|NCT01805999|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1437257|NCT01805986|||Case Control||Prospective|||||||
1437258|NCT01805973|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1437259|NCT01805960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437260|NCT01805947|||Cohort||Prospective|||||||
1437261|NCT01805934|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437262|NCT01805921|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437263|NCT01805908||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437264|NCT01805895|Randomized|Parallel Assignment||Treatment||Single||||||t
1437265|NCT01805882|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437266|NCT01805869|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437267|NCT01805856|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437268|NCT01805843|||Cohort||Prospective|||||||
1437269|NCT01805830|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437270|NCT01805817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437271|NCT01805804|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1437272|NCT01805791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437273|NCT01805778|||Cohort||Prospective|||||||
1437274|NCT01805765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437275|NCT01805752|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437276|NCT01805739|||Cohort||Other|||||||
1437277|NCT01805726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437278|NCT01805713|||Cohort||Prospective|||||||
1437279|NCT01805700|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1437280|NCT01805687||Single Group Assignment||Treatment||None (Open Label)||||||
1437281|NCT01805674|||Case-Only||Prospective|||||||
1437282|NCT01805661|Randomized|Parallel Assignment||Treatment||Single||||t||
1437283|NCT01805648||Single Group Assignment||Treatment||None (Open Label)||||||
1437284|NCT01805635|||Cohort||Retrospective|||||||
1437285|NCT01805622|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1437286|NCT01805609||Single Group Assignment||Supportive Care||None (Open Label)||||||
1437287|NCT01805596|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1437288|NCT01805583|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1437289|NCT01805570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437290|NCT01805557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437291|NCT01805544|||Cohort||Prospective|||||||
1437292|NCT01805531|||Cohort||Prospective|||||||
1437293|NCT01805518|Randomized|Crossover Assignment||||Triple|||t||t|t
1437294|NCT01805505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437295|NCT01805492|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437296|NCT01805479|Randomized|Parallel Assignment||||Single|||t|||
1437297|NCT01805466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437298|NCT01805453|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437299|NCT01805440|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1437300|NCT01805427|||Cohort||Prospective|||||||
1437301|NCT01805414|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1437302|NCT01805401|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1437303|NCT01805388|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437304|NCT01805375||||Treatment||||||||
1437305|NCT01805362|Randomized|Parallel Assignment||||None (Open Label)||||||
1437306|NCT01805349||Single Group Assignment||Basic Science||None (Open Label)||||||
1437307|NCT01805336|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1437308|NCT01805323|||Case-Only||Retrospective|||||||
1437309|NCT01805310|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1437310|NCT01805297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437311|NCT01805284||Single Group Assignment||||None (Open Label)||||||
1437312|NCT01805271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437313|NCT01805258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437314|NCT01805245|Randomized|Parallel Assignment||Treatment||Single||||||t
1437315|NCT01805232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437316|NCT01805219|||Cohort||Prospective|||||||
1437317|NCT01805206||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437318|NCT01805193|||Cohort||Cross-Sectional|||||||
1437319|NCT01805180|Randomized|Crossover Assignment||||None (Open Label)||||||
1437320|NCT01805167||Single Group Assignment||Health Services Research||None (Open Label)||||||
1437321|NCT01805154|||Cohort||Prospective|||||||
1437322|NCT01805141|||Cohort||Cross-Sectional|||||||
1437323|NCT01805128|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1437324|NCT01805115|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437325|NCT01805102|||Case Control||Prospective|||||||
1437326|NCT01805089|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437327|NCT01805076|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1437328|NCT01805063|||Case-Crossover||Prospective|||||||
1437329|NCT01805050|||Cohort||Other|||||||
1437330|NCT01805037||Single Group Assignment||Treatment||None (Open Label)||||||
1437331|NCT01805024||Single Group Assignment||Treatment||None (Open Label)||||||
1437332|NCT01805011|||Cohort||Retrospective|||||||
1437333|NCT01804998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437334|NCT01804985||Single Group Assignment||Treatment||None (Open Label)||||||
1437335|NCT01804972|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1437336|NCT01804959|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437337|NCT01804946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437338|NCT01804933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437339|NCT01804920|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437340|NCT01804907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437341|NCT01804894|||Cohort||Prospective|||||||
1437342|NCT01804881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437343|NCT01804868|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1437344|NCT01804855|Randomized|Parallel Assignment||Treatment||Single||||||t
1437345|NCT01804842|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1437346|NCT01804829|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437347|NCT01804816|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437348|NCT01804803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437349|NCT01804790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437350|NCT01804777|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1437351|NCT01804764|||Case-Only||Prospective|||||||
1437352|NCT01804751|||Cohort||Prospective|||||||
1437353|NCT01804738|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1437354|NCT01804725|||Case-Only||Cross-Sectional|||||||
1437355|NCT01804712||Single Group Assignment||Treatment||None (Open Label)||||||
1437356|NCT01804699|||Family-Based||Prospective|||||||
1437357|NCT01804686||Single Group Assignment||Treatment||None (Open Label)||||||
1437358|NCT01804673||Single Group Assignment||Treatment||None (Open Label)||||||
1437359|NCT01804660|||Cohort||Prospective|||||||
1437360|NCT01804647|||Cohort||Prospective|||||||
1437361|NCT01804634||Single Group Assignment||Treatment||None (Open Label)||||||
1437362|NCT01804621|Randomized|Parallel Assignment||Prevention||Single|||t|||
1437363|NCT01804608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437364|NCT01804595|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1437365|NCT01804582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437366|NCT01804569|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437367|NCT01804556||Single Group Assignment||Treatment||None (Open Label)||||||
1437368|NCT01804543|||Cohort||Prospective|||||||
1437369|NCT01804530||Single Group Assignment||Treatment||None (Open Label)||||||
1437370|NCT01804517|||Case Control||Prospective|||||||
1437371|NCT01804504|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437372|NCT01804491|||Cohort|||||||||
1437373|NCT01804478||Single Group Assignment||Basic Science||None (Open Label)||||||
1437374|NCT01804465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437375|NCT01804452|||Cohort||Prospective|||||||
1437376|NCT01804439|||Cohort||Prospective|||||||
1437377|NCT01804426|||Cohort||Prospective|||||||
1437378|NCT01804413|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1437379|NCT01804400|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1437380|NCT01804387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437381|NCT01804374||Single Group Assignment||Treatment||None (Open Label)||||||
1437382|NCT01804361|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1437383|NCT01804348||Single Group Assignment||Screening||Double|||t||t|
1437384|NCT01804335||Single Group Assignment||Treatment||None (Open Label)||||||
1437385|NCT01804322|Randomized|Parallel Assignment||Treatment||Single||||||t
1437386|NCT01804309|||Cohort||Retrospective|||||||
1437387|NCT01804296|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437388|NCT01804283|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1437389|NCT01804270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437390|NCT01804257||Single Group Assignment||Health Services Research||None (Open Label)||||||
1437391|NCT01804244||Single Group Assignment||Treatment||None (Open Label)||||||
1437392|NCT01804231||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437393|NCT01804218|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437394|NCT01804205|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1437395|NCT01804192|Randomized|Factorial Assignment||Treatment||Single|||t|||
1437396|NCT01804179|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1437397|NCT01804166||Single Group Assignment||Other||None (Open Label)||||||
1437398|NCT01804153||Single Group Assignment||Treatment||None (Open Label)||||||
1437399|NCT01804140|||Cohort||Prospective|||||||
1437400|NCT01804127||Single Group Assignment||Treatment||None (Open Label)||||||
1437401|NCT01804114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437402|NCT01804101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437403|NCT01804088||Single Group Assignment||Treatment||None (Open Label)||||||
1437404|NCT01804075|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1437405|NCT01804062|||Cohort||Prospective|||||||
1437406|NCT01804049|Randomized|Parallel Assignment||Other||Double|||t||t|
1437407|NCT01804036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437408|NCT01804023|||||Prospective|||||||
1437409|NCT01804010|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1437410|NCT01803997|Randomized|Crossover Assignment||||None (Open Label)||||||
1437411|NCT01803984|||Cohort||Cross-Sectional|||||||
1437412|NCT01803971||Single Group Assignment||Treatment||None (Open Label)||||||
1437413|NCT01803958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437414|NCT01803945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437415|NCT01803932|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1437416|NCT01803919|Randomized|Parallel Assignment||Prevention||Single||||||t
1437417|NCT01803906|||Case-Only||Prospective|||||||
1437418|NCT01803893|||Case Control||Prospective|||||||
1437419|NCT01803880|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437420|NCT01803867|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1437421|NCT01803854|||Cohort||Prospective|||||||
1437422|NCT01803841|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437423|NCT01803828|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437424|NCT01803815|||Cohort||Prospective|||||||
1437425|NCT01803802|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1437426|NCT01803789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437427|NCT01803776||Single Group Assignment||Prevention||None (Open Label)||||||
1437428|NCT01803763|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1437429|NCT01803750|||Cohort||Prospective|||||||
1437430|NCT01803737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437431|NCT01803724|||Cohort||Prospective|||||||
1437432|NCT01803711|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437433|NCT01803698|Randomized|Parallel Assignment||Prevention||Single|||t|||
1437434|NCT01803685|||Cohort||Prospective|||||||
1437435|NCT01803672|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437436|NCT01803659|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437437|NCT01803646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437438|NCT01803633|Randomized|Crossover Assignment||Treatment||Single|||t|||
1437439|NCT01803607|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437440|NCT01803594|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437441|NCT01803581|Randomized|Parallel Assignment||Treatment||Single|||||t|
1437442|NCT01803568|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1437443|NCT01803555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437444|NCT01803542||Single Group Assignment||Treatment||None (Open Label)||||||
1437445|NCT01803529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437446|NCT01803516|||Cohort||Prospective|||||||
1437447|NCT01803503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437448|NCT01803490|||Cohort||Prospective|||||||
1437449|NCT01803477|Randomized|Parallel Assignment||Treatment||Single|||||t|
1437450|NCT01803464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437451|NCT01803451|Non-Randomized|Factorial Assignment||Other||Single|||t|||
1437452|NCT01803438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437453|NCT01803425|||Cohort||Prospective|||||||
1437454|NCT01803412|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437455|NCT01803399|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1437456|NCT01803386|||Case Control||Cross-Sectional|||||||
1437457|NCT01803373|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437458|NCT01803360|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437459|NCT01803347|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437460|NCT01803334|Randomized|Parallel Assignment||||None (Open Label)||||||
1437461|NCT01803321|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1437462|NCT01803308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437463|NCT01803295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437464|NCT01803282|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437465|NCT01803269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437466|NCT01803256|||||Cross-Sectional|||||||
1437467|NCT01803243|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437468|NCT01803230|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437469|NCT01803217|Randomized|Crossover Assignment||Treatment||Single|||t|||
1437470|NCT01803204|Randomized|Crossover Assignment||Health Services Research||Single|||||t|
1437471|NCT01803191|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437472|NCT01803178|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1437473|NCT01803165|||Cohort||Prospective|||||||
1437474|NCT01803152|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437475|NCT01803139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437476|NCT01803126|||Case-Only||Prospective|||||||
1437477|NCT01803113|||||Prospective|||||||
1437478|NCT01803100|||Cohort||Prospective|||||||
1437479|NCT01803087|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437480|NCT01803074|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437481|NCT01803061|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437482|NCT01803048|||Case-Control||Cross-Sectional|||||||
1437483|NCT01803035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437484|NCT01803022|||Cohort||Prospective|||||||
1437485|NCT01803009||Single Group Assignment||Prevention||None (Open Label)||||||
1437486|NCT01802996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437487|NCT01802983|||Case Control||Retrospective|||||||
1437488|NCT01802970||Single Group Assignment||Treatment||None (Open Label)||||||
1437489|NCT01802957||Single Group Assignment||||None (Open Label)||||||
1437490|NCT01802944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437491|NCT01802931|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1437492|NCT01802918|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1437493|NCT01802905||Single Group Assignment||||None (Open Label)||||||
1437494|NCT01802892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437495|NCT01802879||Single Group Assignment||Treatment||None (Open Label)||||||
1437496|NCT01802866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437497|NCT01802853|Randomized|Crossover Assignment||||None (Open Label)||||||
1437498|NCT01802840|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1437499|NCT01802827|||Cohort||Prospective|||||||
1437500|NCT01802814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437501|NCT01802801||||||||||||
1437502|NCT01802788|||Cohort||Prospective|||||||
1437503|NCT01802775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437504|NCT01802762||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437505|NCT01802749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437506|NCT01802736|Randomized|Parallel Assignment||Treatment||Single||||||t
1437507|NCT01802723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437508|NCT01802710|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437509|NCT01802697|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1437510|NCT01802684||Single Group Assignment||Treatment||None (Open Label)||||||
1437511|NCT01802671|Randomized|Parallel Assignment||Treatment||Single||||||t
1437512|NCT01802658|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437513|NCT01802645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437514|NCT01802632||Single Group Assignment||Treatment||None (Open Label)||||||
1437515|NCT01802619|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1437516|NCT01802606|||Cohort||Prospective|||||||
1437517|NCT01802593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437518|NCT01802580|Randomized|Parallel Assignment||Treatment||Single|||||t|
1437519|NCT01802567||Single Group Assignment||Treatment||None (Open Label)||||||
1437520|NCT01802554|Randomized|Parallel Assignment||Treatment||Single||||||t
1437521|NCT01802541|Randomized|Parallel Assignment||||Double|||t||t|
1437522|NCT01802528|||Cohort||Retrospective|||||||
1437523|NCT01802515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437524|NCT01802502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437525|NCT01802489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437526|NCT01802476||Crossover Assignment||Basic Science||None (Open Label)||||||
1437527|NCT01802463|||||Prospective|||||||
1437528|NCT01802450|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437529|NCT01802437|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1437530|NCT01802424||Single Group Assignment||Prevention||None (Open Label)||||||
1437531|NCT01802411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437532|NCT01802398|||Cohort||Prospective|||||||
1437533|NCT01802385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437534|NCT01802372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437535|NCT01802359|||Cohort||Prospective|||||||
1437536|NCT01802346|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437537|NCT01802333|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437538|NCT01802320||Single Group Assignment||Treatment||None (Open Label)||||||
1437539|NCT01802307||Single Group Assignment||Treatment||None (Open Label)||||||
1437540|NCT01802294|Randomized|Parallel Assignment||Treatment||Single||||||t
1437541|NCT01802281|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1437542|NCT01802268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437543|NCT01802255|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1437544|NCT01802242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437545|NCT01802229|Randomized|Parallel Assignment||Prevention||Single|||t|||
1437546|NCT01802216|Randomized|Parallel Assignment||Treatment||Single||||||t
1437547|NCT01802203|||Cohort||Prospective|||||||
1437548|NCT01802190|||||Prospective|||||||
1437549|NCT01802177|Randomized|Single Group Assignment||Treatment||Single||||||t
1437550|NCT01802164|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437551|NCT01802151|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1437552|NCT01802138||Single Group Assignment||Treatment||None (Open Label)||||||
1437553|NCT01802125|||Case-Crossover||Retrospective|||||||
1437554|NCT01802112|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437555|NCT01802099|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437556|NCT01802086|Randomized|Parallel Assignment||Prevention||Single|||||t|
1437557|NCT01802073||Single Group Assignment||Treatment||None (Open Label)||||||
1437558|NCT01802060|||Cohort||Prospective|||||||
1437559|NCT01802047|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1437560|NCT01802034|||Cohort||Prospective|||||||
1437561|NCT01802021|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1437562|NCT01802008|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1437563|NCT01801995||||||||||||
1437564|NCT01801982|||||Prospective|||||||
1437565|NCT01801969|||Cohort||Retrospective|||||||
1437566|NCT01801956|Randomized|Parallel Assignment||Prevention||Single|||||t|
1437567|NCT01801943|Randomized|Parallel Assignment||||Single|||||t|
1437568|NCT01801930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437569|NCT01801917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437570|NCT01801904||Single Group Assignment||Treatment||None (Open Label)||||||
1437571|NCT01801891|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437572|NCT01801878|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1437573|NCT01801865||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437574|NCT01801852||Single Group Assignment||Treatment||None (Open Label)||||||
1437575|NCT01801839|||Case Control||Prospective|||||||
1437576|NCT01801826|||Case-Only||Prospective|||||||
1437577|NCT01801813|||Cohort||Prospective|||||||
1437578|NCT01801800|||Cohort||Prospective|||||||
1437579|NCT01801787|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1437580|NCT01801774|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437581|NCT01801761|||Case Control||Cross-Sectional|||||||
1437582|NCT01801748||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437583|NCT01801735||Single Group Assignment||Treatment||None (Open Label)||||||
1437584|NCT01801722|||Other||Cross-Sectional|||||||
1437585|NCT01801709||Single Group Assignment||Treatment||None (Open Label)||||||
1437586|NCT01801696|Randomized|Parallel Assignment||Treatment||Single||||||t
1437587|NCT01801683|Non-Randomized|Parallel Assignment||||Single|||||t|
1437588|NCT01801670|||Cohort||Prospective|||||||
1437589|NCT01801657|||Case Control||Prospective|||||||
1437590|NCT01801644||Single Group Assignment||Treatment||None (Open Label)||||||
1437591|NCT01801631|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437592|NCT01801618|||||Cross-Sectional|||||||
1437593|NCT01801605|Randomized|Crossover Assignment||||Double|||t|t||
1437594|NCT01801592|||Cohort||Other|||||||
1437595|NCT01801579|||Cohort||Prospective|||||||
1437596|NCT01801566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437597|NCT01801553|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437598|NCT01801540|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1437599|NCT01801527|Randomized|Parallel Assignment||Treatment||Single|||||t|
1437600|NCT01801514||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437601|NCT01801501|||Cohort||Prospective|||||||
1437602|NCT01801488|||Case Control||Prospective|||||||
1437603|NCT01801475|Randomized|Parallel Assignment||||None (Open Label)||||||
1437604|NCT01801462|Randomized|Parallel Assignment||Prevention||Single||||||t
1437605|NCT01801449||Single Group Assignment||Treatment||None (Open Label)||||||
1437606|NCT01801436||Single Group Assignment||Treatment||None (Open Label)||||||
1437607|NCT01801423||Single Group Assignment||Treatment||None (Open Label)||||||
1437608|NCT01801410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437609|NCT01801397||Single Group Assignment||Treatment||None (Open Label)||||||
1437610|NCT01801384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437611|NCT01801371||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437612|NCT01801358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437613|NCT01801345|Randomized|Crossover Assignment||||Single||||||t
1437614|NCT01801332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437615|NCT01801319|Non-Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1437616|NCT01801306||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437617|NCT01801293||Single Group Assignment||Treatment||None (Open Label)||||||
1437618|NCT01801280|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437619|NCT01801267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437620|NCT01801254|Randomized|Parallel Assignment||Prevention||Single|||t|||
1437621|NCT01801241||||||||||||
1437622|NCT01801228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437623|NCT01801202||Single Group Assignment||Treatment||None (Open Label)||||||
1437624|NCT01801189|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1437625|NCT01801176||Single Group Assignment||||None (Open Label)||||||
1437626|NCT01801163||Single Group Assignment||Treatment||None (Open Label)||||||
1437627|NCT01801150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437628|NCT01801137||Single Group Assignment||Treatment||None (Open Label)||||||
1437629|NCT01801124||Single Group Assignment||Treatment||None (Open Label)||||||
1437630|NCT01801111||Single Group Assignment||Treatment||None (Open Label)||||||
1437631|NCT01801098|||Cohort|||||||||
1437632|NCT01801085|||Cohort||Prospective|||||||
1437633|NCT01801072|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437634|NCT01801059|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1437635|NCT01801046||Single Group Assignment||Treatment||None (Open Label)||||||
1437636|NCT01801033|||||Prospective|||||||
1437637|NCT01801020||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437638|NCT01801007||Single Group Assignment||Treatment||None (Open Label)||||||
1437639|NCT01800994|||||Prospective|||||||
1437640|NCT01800981|||||Prospective|||||||
1437641|NCT01800968|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437642|NCT01800955|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437643|NCT01800942|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1437644|NCT01800929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437645|NCT01800916|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1437646|NCT01800903|Randomized|Crossover Assignment||Treatment||Single|||t|||
1437647|NCT01800890|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1437648|NCT01800877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437649|NCT01800864|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1437650|NCT01800851|Randomized|Crossover Assignment||||None (Open Label)||||||
1437651|NCT01800838||Single Group Assignment||Treatment||None (Open Label)||||||
1437652|NCT01800825|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437653|NCT01800812|Non-Randomized|||||None (Open Label)||||||
1437654|NCT01800799|Randomized|Parallel Assignment||Treatment||None (Open Label)|No masking|||||
1437655|NCT01800786|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1437656|NCT01800773|Randomized|Parallel Assignment||Treatment||Single||||||t
1437657|NCT01800760||Single Group Assignment||Prevention||None (Open Label)||||||
1437658|NCT01800747|Randomized|Parallel Assignment||Treatment||None (Open Label)||Antibiotic treatment versus delayed antibiotic treatment||||
1437659|NCT01800734||Single Group Assignment||||None (Open Label)||||||
1437660|NCT01800721|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1437661|NCT01800708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437662|NCT01800695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437663|NCT01800682|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437664|NCT01800669|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1437665|NCT01800656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437666|NCT01800643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437667|NCT01800630||Single Group Assignment||Other||None (Open Label)||||||
1437668|NCT01800617||Single Group Assignment||Treatment||None (Open Label)||||||
1437669|NCT01800604|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437670|NCT01800591|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1437671|NCT01800578|||Case-Only||Prospective|||||||
1437672|NCT01800565||Single Group Assignment||Diagnostic||Single||||t||
1437673|NCT01800552|||Case-Only||Cross-Sectional|||||||
1437674|NCT01800539|Randomized|Parallel Assignment||Treatment||Single||||||t
1437675|NCT01800526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437676|NCT01800513|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437677|NCT01800500|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437678|NCT01800487|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437679|NCT01800474|||||Cross-Sectional|||||||
1437680|NCT01800461|Randomized|Parallel Assignment||Treatment||Single||||||t
1437681|NCT01800448|||Cohort||Prospective|||||||
1437682|NCT01800435|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437683|NCT01800422|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437684|NCT01800409|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437685|NCT01800396|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1437686|NCT01800383|||Case Control||Cross-Sectional|||||||
1437687|NCT01800370|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1437688|NCT01800357|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437689|NCT01800344|Randomized|Parallel Assignment||||Double|||t|||t
1437690|NCT01800331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437691|NCT01800318|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1437692|NCT01800305|Randomized|Parallel Assignment||||None (Open Label)||||||
1437693|NCT01800292||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437694|NCT01800279|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1437695|NCT01800266|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1437696|NCT01800253|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1437697|NCT01800240||||||||||||
1437698|NCT01800227||||||||||||
1437699|NCT01800214|||Cohort||Prospective|||||||
1437700|NCT01800201|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1437701|NCT01800188|||Case-Only||Prospective|||||||
1437702|NCT01800175|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1437703|NCT01800162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437704|NCT01800149|Randomized|Parallel Assignment||Treatment||Single||||||t
1437705|NCT01800136||Single Group Assignment||Treatment||None (Open Label)||||||
1437706|NCT01800123|||Cohort||Prospective|||||||
1437707|NCT01800110|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1437708|NCT01800097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437709|NCT01800084||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437710|NCT01800071||||Treatment||||||||
1437711|NCT01800058|||Case-Only||Prospective|||||||
1437712|NCT01800045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437713|NCT01800032|||Cohort||Prospective|||||||
1437714|NCT01800019|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1437715|NCT01800006|||Cohort||Prospective|||||||
1437716|NCT01799993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437717|NCT01799980|||Cohort||Prospective|||||||
1437718|NCT01799967|||Cohort||Prospective|||||||
1437719|NCT01799954|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437720|NCT01799941||Single Group Assignment||Treatment||None (Open Label)||||||
1437721|NCT01799915|||Cohort||Prospective|||||||
1437722|NCT01799902|||Case-Only||Prospective|||||||
1437723|NCT01799889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437724|NCT01799876|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437725|NCT01799863|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437726|NCT01799850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437727|NCT01799837|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1437728|NCT01799824|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437729|NCT01799811|||Cohort||Prospective|||||||
1437730|NCT01799798||Single Group Assignment||Treatment||None (Open Label)||||||
1437731|NCT01799785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437732|NCT01799772|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437733|NCT01799759|Randomized|Parallel Assignment||Prevention||Single||||||t
1437734|NCT01799746|||Case-Crossover||Other|||||||
1437735|NCT01799733|Randomized|Crossover Assignment||Treatment||Single|||||t|
1437736|NCT01799720|Randomized|Parallel Assignment||Prevention||Single|||||t|
1437737|NCT01799707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437738|NCT01799694||Single Group Assignment||Treatment||None (Open Label)||||||
1437739|NCT01799681|Randomized|Parallel Assignment||Treatment||Single|||||t|
1437740|NCT01799668|||Cohort||Prospective|||||||
1437741|NCT01799655|||Cohort||Prospective|||||||
1437742|NCT01799642|||Case Control|||||||||
1437743|NCT01799629|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437744|NCT01799616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437745|NCT01799603|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437746|NCT01799590||Single Group Assignment||Treatment||None (Open Label)||||||
1437747|NCT01799577|||Case Control||Cross-Sectional|||||||
1437748|NCT01799564|Randomized|Parallel Assignment||Treatment||Double||||t||t
1437749|NCT01799551|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437750|NCT01799538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437751|NCT01799525||Single Group Assignment||Treatment||Single|||t|||
1437752|NCT01799512|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437753|NCT01799499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437754|NCT01799486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437755|NCT01799473|||Cohort||Prospective|||||||
1437756|NCT01799460|||Cohort||Retrospective|||||||
1437757|NCT01799447||Single Group Assignment||Prevention||None (Open Label)||||||
1437758|NCT01799434||Single Group Assignment||Prevention||None (Open Label)||||||
1437759|NCT01799421|||Cohort||Prospective|||||||
1437760|NCT01799408|||Case Control||Prospective|||||||
1437761|NCT01799395|||Cohort||Prospective|||||||
1437762|NCT01799382|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1437763|NCT01799369|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1437764|NCT01799356|Randomized|Parallel Assignment||Treatment||Single|||||t|
1437765|NCT01799343||Single Group Assignment||Treatment||Single||||||t
1437766|NCT01799330|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1437767|NCT01799317|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1437768|NCT01799304|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437769|NCT01799291|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1437770|NCT01799278||Single Group Assignment||Treatment||None (Open Label)||||||
1437771|NCT01799265|Randomized|Crossover Assignment||Treatment||Single||||||t
1437772|NCT01799252|||Cohort||Prospective|||||||
1437773|NCT01799239|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1437774|NCT01799226|Randomized|Parallel Assignment||||Double|||t|||t
1437775|NCT01799213|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437776|NCT01799200|||||Cross-Sectional|||||||
1437777|NCT01799187|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437778|NCT01799174|Randomized|Parallel Assignment||||Triple|||t||t|t
1437779|NCT01799161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437780|NCT01799148|||Cohort||Prospective|||||||
1437781|NCT01799135||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437782|NCT01799122||||Treatment||||||||
1437783|NCT01799109|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437784|NCT01799096|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1437785|NCT01799083||Single Group Assignment||Treatment||None (Open Label)||||||
1437786|NCT01799070|||Cohort||Prospective|||||||
1437787|NCT01799057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437788|NCT01799044||Single Group Assignment||Treatment||None (Open Label)||||||
1437789|NCT01799031|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437790|NCT01799018|||Case Control||Prospective|||||||
1437791|NCT01799005|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437792|NCT01798992|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1437793|NCT01798979||Single Group Assignment||Treatment||None (Open Label)||||||
1437794|NCT01798966||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437795|NCT01798953|||Case Control||Retrospective|||||||
1437796|NCT01798940||||||||||||
1437797|NCT01798927||Single Group Assignment||Treatment||None (Open Label)||||||
1437798|NCT01798914||||||||||||
1437799|NCT01798901||Single Group Assignment||Treatment||None (Open Label)||||||
1437800|NCT01798888|Randomized|Crossover Assignment||Treatment||||||||
1437801|NCT01798875|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437802|NCT01798862|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437803|NCT01798849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437804|NCT01798836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437805|NCT01798823|||Cohort||Prospective|||||||
1437806|NCT01798810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437807|NCT01798797|||Other||Prospective|||||||
1437808|NCT01798784|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437809|NCT01798771|Randomized|Parallel Assignment||Treatment||Single||||||t
1437810|NCT01798745|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437811|NCT01798732||Single Group Assignment||Treatment||None (Open Label)||||||
1437812|NCT01798719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437813|NCT01798706|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437814|NCT01798693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437815|NCT01798680|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437816|NCT01798667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437817|NCT01798654|||Cohort||Prospective|||||||
1437818|NCT01798641|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1437819|NCT01798628|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437820|NCT01798602|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1437821|NCT01798589||Single Group Assignment||Health Services Research||None (Open Label)||||||
1437822|NCT01798576|||Cohort||Prospective|||||||
1437823|NCT01798563|||Case-Control||Prospective|||||||
1437824|NCT01798550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437825|NCT01798537|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1437826|NCT01798524|||Cohort||Retrospective|||||||
1437827|NCT01798511|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437828|NCT01798498||Single Group Assignment||Treatment||None (Open Label)||||||
1437829|NCT01798485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437830|NCT01798472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437831|NCT01798459|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1437832|NCT01798446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1437833|NCT01798433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437834|NCT01798420|||Case Control||Prospective|||||||
1437835|NCT01798407|Non-Randomized|Sequential Assignment||Treatment||Quadruple|During staggered withdrawal phase, double blind discontinuation will be attempted on either the 12 or 13 month visit. Stimulation intensity will be decreased by 50% and then completely discontinued two weeks later. Subjects will be seen every 2 weeks until 15 months post activation or escape criteria are met. These escape criteria include relapse at 2 visits, hospitalization, active suicidal ideation, or withdrawing consent. If any of these criteria are met, the blind will be broken and open treatment will be resumed.|all subjects will receive bilateral surgical implantation of DBS system. Those who respond at 12 months will enter a randomized, staggered withdrawal phase. See masking description below.|t|t|t|t
1437836|NCT01798394|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1437837|NCT01798381|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437838|NCT01798368||Single Group Assignment||||None (Open Label)||||||
1437839|NCT01798355|Randomized|Parallel Assignment||Treatment||Single||||||t
1437840|NCT01798342|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1437841|NCT01798329|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437842|NCT01798316|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437843|NCT01798303|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437844|NCT01798290|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1437845|NCT01798277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437846|NCT01798264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437847|NCT01798251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437848|NCT01798238|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437849|NCT01798225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437850|NCT01798212||Single Group Assignment||Treatment||None (Open Label)||||||
1437851|NCT01798199||Single Group Assignment||Health Services Research||None (Open Label)||||||
1437852|NCT01798186|Randomized|Parallel Assignment||Diagnostic||Single|Participants are blind to the THC concentrations of cannabis being administered|Between subjects Phase I study|t|||
1437853|NCT01798173|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437854|NCT01798160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437855|NCT01798147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437856|NCT01798134||Single Group Assignment||Treatment||None (Open Label)||||||
1437857|NCT01798121|Randomized|Single Group Assignment||||Double|||t||t|
1437858|NCT01798108||Single Group Assignment||Other||None (Open Label)||||||
1437859|NCT01798095|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1437860|NCT01798082|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1437861|NCT01798069|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1437862|NCT01798056|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1437863|NCT01798043|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1437864|NCT01798030|||Other||Retrospective|||||||
1437865|NCT01798017||Single Group Assignment||Health Services Research||None (Open Label)||||||
1437866|NCT01798004||Single Group Assignment||Treatment||None (Open Label)||||||
1437867|NCT01797991|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437868|NCT01797978|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437869|NCT01797965||Single Group Assignment||Treatment||None (Open Label)||||||
1437870|NCT01797952|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437871|NCT01797939|||Case Control||Retrospective|||||||
1437872|NCT01797926|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437873|NCT01797913||Single Group Assignment||Treatment||None (Open Label)||||||
1437874|NCT01797900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437875|NCT01797887|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437876|NCT01797874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437877|NCT01797861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437878|NCT01797848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437879|NCT01797835|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437880|NCT01797822||Single Group Assignment||Treatment||None (Open Label)||||||
1437881|NCT01797809|||Cohort||Prospective|||||||
1437882|NCT01797796|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1437883|NCT01797783|Randomized|Parallel Assignment||Treatment||Single|||t|||
1437884|NCT01797770|||||Prospective|||||||
1437885|NCT01797757|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1437886|NCT01797744|Randomized|Parallel Assignment||Treatment||Single|||||t|
1437887|NCT01797731|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437888|NCT01797718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437889|NCT01797705||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437890|NCT01797692||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437891|NCT01797679|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1437892|NCT01797666||||||||||||
1437893|NCT01797653|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437894|NCT01797640|||Cohort||Retrospective|||||||
1437895|NCT01797627|||Cohort||Prospective|||||||
1437896|NCT01797614|||Case-Only||Prospective|||||||
1437897|NCT01797601|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1437898|NCT01797588|Randomized|Single Group Assignment||Treatment||Single||||||t
1437899|NCT01797575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437900|NCT01797562||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437901|NCT01797549|||Case Control||Cross-Sectional|||||||
1437902|NCT01797536|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437903|NCT01797523||Single Group Assignment||Treatment||None (Open Label)||||||
1437904|NCT01797510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437905|NCT01797497|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1437906|NCT01797484|Randomized|Parallel Assignment||Treatment||Single||||||t
1437907|NCT01797471||Single Group Assignment||Treatment||None (Open Label)||||||
1437908|NCT01797458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437909|NCT01797445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437910|NCT01797432||Single Group Assignment||Treatment||None (Open Label)||||||
1437911|NCT01797419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437912|NCT01797406|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1437913|NCT01797393|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1437914|NCT01797380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437915|NCT01797367|||Other||Prospective|||||||
1437916|NCT01797354|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1437917|NCT01797341|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437918|NCT01797328|Randomized|Parallel Assignment||Basic Science||Single||||||t
1437919|NCT01797315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437920|NCT01797302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437921|NCT01797289||Single Group Assignment||Diagnostic||None (Open Label)||||||
1437922|NCT01797276||||||||||||
1437923|NCT01797263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437924|NCT01797250|||Case-Only|||||||||
1437925|NCT01797237|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437926|NCT01797224|||Cohort||Prospective|||||||
1437927|NCT01797211|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1437928|NCT01797198|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1437929|NCT01797185||Single Group Assignment||Other||None (Open Label)||||||
1437930|NCT01797172|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1437931|NCT01797159||Single Group Assignment||Treatment||None (Open Label)||||||
1437932|NCT01797146|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1437933|NCT01797133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437934|NCT01797120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437935|NCT01797107|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1437936|NCT01797094|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437937|NCT01797081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437938|NCT01797068|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1437939|NCT01797055||Single Group Assignment||Treatment||None (Open Label)||||||
1437940|NCT01797042|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1437941|NCT01797029|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1437942|NCT01797016|||Case Control||Prospective|||||||
1437943|NCT01797003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437944|NCT01796990|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437945|NCT01796977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437946|NCT01796964|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1437947|NCT01796951||Single Group Assignment||Prevention||None (Open Label)||||||
1437948|NCT01796938|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1437949|NCT01796925||Single Group Assignment||Treatment||None (Open Label)||||||
1437950|NCT01796912|Randomized|Crossover Assignment||Treatment||Single|||t|||
1437951|NCT01796899|Randomized|Crossover Assignment||||None (Open Label)||||||
1437952|NCT01796886||Single Group Assignment||Treatment||None (Open Label)||||||
1437953|NCT01796873|||Case Control||Prospective|||||||
1437954|NCT01796860||Single Group Assignment||Treatment||None (Open Label)||||||
1437955|NCT01796847|||Case-Only||Cross-Sectional|||||||
1437956|NCT01796834||Single Group Assignment||Treatment||None (Open Label)||||||
1437957|NCT01796821|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437958|NCT01796808|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1437959|NCT01796795|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1437960|NCT01796782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437961|NCT01796769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437962|NCT01796756|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1437963|NCT01796743|||Case-Control||Prospective|||||||
1437964|NCT01796730|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1437965|NCT01796717|Randomized|Parallel Assignment||Treatment||Single|||||t|
1437966|NCT01796704|||Case Control||Cross-Sectional|||||||
1437967|NCT01796691|||Case Control||Retrospective|||||||
1437968|NCT01796678|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1437969|NCT01796665|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437970|NCT01796652|||Cohort||Prospective|||||||
1437971|NCT01796639|||Cohort||Retrospective|||||||
1437972|NCT01796626|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437973|NCT01796613|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1437974|NCT01796600|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1437975|NCT01796587|||Cohort||Prospective|||||||
1437976|NCT01796574||Single Group Assignment||Treatment||None (Open Label)||||||
1437977|NCT01796561|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1437978|NCT01796548||Single Group Assignment||Treatment||None (Open Label)||||||
1437979|NCT01796535|||Case-Only|||||||||
1437980|NCT01796522|Randomized|Parallel Assignment||Treatment||Single|||||t|
1437981|NCT01796509|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1437982|NCT01796496|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1437983|NCT01796483|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1437984|NCT01796470||Single Group Assignment||Treatment||None (Open Label)||||||
1437985|NCT01796457|||Other||Prospective|||||||
1437986|NCT01796444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437987|NCT01796431||Single Group Assignment||Treatment||None (Open Label)||||||
1437988|NCT01796418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1437989|NCT01796405|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437990|NCT01796392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437991|NCT01796379|Randomized|Parallel Assignment||Prevention||Single||||||t
1437992|NCT01796366|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1437993|NCT01796353|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1437994|NCT01796340|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1437995|NCT01796327||Crossover Assignment||Basic Science||None (Open Label)||||||
1437996|NCT01796314|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1437997|NCT01796301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437998|NCT01796288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1437999|NCT01796275|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438000|NCT01796262|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438001|NCT01796249|||Cohort||Prospective|||||||
1438002|NCT01796236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438003|NCT01796223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438004|NCT01796210|||Cohort||Prospective|||||||
1438005|NCT01796197||Single Group Assignment||Treatment||None (Open Label)||||||
1438006|NCT01796184|||||Cross-Sectional|||||||
1438007|NCT01796171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438008|NCT01796158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438009|NCT01796145|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1438010|NCT01796132|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1438011|NCT01796119|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438012|NCT01796106|Randomized|Parallel Assignment||Prevention||Single||||||t
1438013|NCT01796093|||Case-Crossover||Prospective|||||||
1438014|NCT01796080|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1438015|NCT01796067|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1438016|NCT01796054|Randomized|Parallel Assignment||||None (Open Label)||||||
1438017|NCT01796041||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438018|NCT01796028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438019|NCT01796015|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1438020|NCT01796002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438021|NCT01795989||Single Group Assignment||||None (Open Label)||||||
1438022|NCT01795976||Single Group Assignment||Treatment||None (Open Label)||||||
1438023|NCT01795963|Randomized|Parallel Assignment||Prevention||Single|||t|||
1438024|NCT01795950|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438025|NCT01795937|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438026|NCT01795924||Single Group Assignment||Treatment||None (Open Label)||||||
1438027|NCT01795911||Single Group Assignment||Treatment||None (Open Label)||||||
1438028|NCT01795898||Single Group Assignment||Treatment||None (Open Label)||||||
1438029|NCT01795885||Single Group Assignment||Other||None (Open Label)||||||
1438030|NCT01795872||Single Group Assignment||Treatment||None (Open Label)||||||
1438031|NCT01795859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438032|NCT01795846|||||Prospective|||||||
1438033|NCT01795833|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438034|NCT01795820|Randomized|Parallel Assignment||||Single|||t|||
1438035|NCT01795807||||||||||||
1438036|NCT01795794||Single Group Assignment||Treatment||None (Open Label)||||||
1438037|NCT01795781|||Cohort||Prospective|||||||
1438038|NCT01795768|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438039|NCT01795755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438040|NCT01795742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438041|NCT01795729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438042|NCT01795716|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438043|NCT01795703||Single Group Assignment||Treatment||None (Open Label)||||||
1438044|NCT01795690|||Cohort||Prospective|||||||
1438045|NCT01795677||Single Group Assignment||Treatment||None (Open Label)||||||
1438046|NCT01795664|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1438047|NCT01795651||||||||||||
1438048|NCT01795638|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1438049|NCT01795625|||Cohort||Prospective|||||||
1438050|NCT01795612|Randomized|Parallel Assignment||||None (Open Label)||||||
1438051|NCT01795599|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438052|NCT01795586||Single Group Assignment||Treatment||None (Open Label)||||||
1438053|NCT01795573||Single Group Assignment||Prevention||None (Open Label)||||||
1438054|NCT01795560|||Case-Only||Prospective|||||||
1438055|NCT01795547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438056|NCT01795534|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1438057|NCT01795521||Single Group Assignment||Treatment||None (Open Label)||||||
1438058|NCT01795508|Randomized|Parallel Assignment||Treatment||Single||||||t
1438059|NCT01795495|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1438060|NCT01795482|Randomized|Parallel Assignment||Treatment||Single||||||t
1438061|NCT01795469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438062|NCT01795456|||Case-Control||Prospective|||||||
1438063|NCT01795443|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1438064|NCT01795430||Single Group Assignment||Treatment||None (Open Label)||||||
1438065|NCT01795417||Single Group Assignment||Treatment||None (Open Label)||||||
1438066|NCT01795404|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438067|NCT01795391|||Cohort||Prospective|||||||
1438068|NCT01795378||Single Group Assignment||Treatment||None (Open Label)||||||
1438069|NCT01795365|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438070|NCT01795352|||||Retrospective|||||||
1438071|NCT01795339|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1438072|NCT01795326|||||Cross-Sectional|||||||
1438073|NCT01795313||Single Group Assignment||Treatment||None (Open Label)||||||
1438074|NCT01795300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438075|NCT01795287|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438076|NCT01795274||Single Group Assignment||Treatment||None (Open Label)||||||
1438077|NCT01795261|||Case Control||Prospective|||||||
1438078|NCT01795248|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1438079|NCT01795235|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1438080|NCT01795222|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1438081|NCT01795209|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438082|NCT01795196|||Case-Only||Prospective|||||||
1438083|NCT01795183||Single Group Assignment||Treatment||None (Open Label)||||||
1438084|NCT01795170|||Cohort||Prospective|||||||
1438085|NCT01795157|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1438086|NCT01795144|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1438087|NCT01795131|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1438088|NCT01795118||||||||||||
1438089|NCT01795105|||Case-Only||Prospective|||||||
1438090|NCT01795092|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438091|NCT01795079|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438092|NCT01795066||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438093|NCT01795053|Randomized|Parallel Assignment||Treatment||Single||||t||
1438094|NCT01795040|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1438095|NCT01795027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438096|NCT01795014|||||Prospective|||||||
1438097|NCT01795001|||Case-Control||Prospective|||||||
1438098|NCT01794988|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1438099|NCT01794975|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1438100|NCT01794962|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438101|NCT01794949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438102|NCT01794936|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1438103|NCT01794923|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438104|NCT01794910|Randomized|Parallel Assignment||Treatment||Single|||||t|
1438105|NCT01794897|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1438106|NCT01794884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438107|NCT01794871|||||Retrospective|||||||
1438108|NCT01794858||Single Group Assignment||Treatment||None (Open Label)||||||
1438109|NCT01794845||Single Group Assignment||Treatment||None (Open Label)||||||
1438110|NCT01794832|||Case-Only||Prospective|||||||
1438111|NCT01794819||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438112|NCT01794806|Randomized|Parallel Assignment||Treatment||Single||||||t
1438113|NCT01794793||Single Group Assignment||Treatment||None (Open Label)||||||
1438114|NCT01794780||Parallel Assignment||Treatment||None (Open Label)||||||
1438115|NCT01794767|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1438116|NCT01794754|Randomized|Parallel Assignment||Prevention||Single|||||t|
1438117|NCT01794741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438118|NCT01794728|||Cohort||Prospective|||||||
1438119|NCT01794715|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1438120|NCT01794702||Single Group Assignment||Treatment||None (Open Label)||||||
1438121|NCT01794689|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1438122|NCT01794676|||Family-Based||Prospective|||||||
1438123|NCT01794663|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1438124|NCT01794650||Single Group Assignment||Basic Science||None (Open Label)||||||
1438125|NCT01794637|||Cohort||Prospective|||||||
1438126|NCT01794624|Randomized|Single Group Assignment||Treatment||Single||||||t
1438127|NCT01794611||Single Group Assignment||Diagnostic||Single||||||t
1438128|NCT01794598|Randomized|Parallel Assignment||||Triple|||t||t|t
1438129|NCT01794585|Randomized|Parallel Assignment||Treatment||Single||||||t
1438130|NCT01794572||Single Group Assignment||Treatment||None (Open Label)||||||
1438131|NCT01794559|Randomized|Parallel Assignment||Treatment||Double|"The subject is masked as to assignment to Control or Treatment Group.~The blinded subject acts as the blinded rater in providing the primary outcome measure of the QIDS-SR16"|This study is prospective in nature. Control group subjects will be treated according to treatment as usual. Experimental group physicians will follow the guidance of the subject's PEER Interactive Report. Subjects will be washed out of medications prior to EEG. The wash out period for outpatients is no longer than 14 days. Subjects will be followed for 6 months after baseline, or until the patient has achieved maximum medical improvement (MMI). Subjects will be seen on a routine basis and assessments will be made at each interaction to evaluate the patient's improvement in mental health. Subjects will be closely evaluated for any psychiatric specific adverse events. The investigator is allowed to treat the patient according to best medical judgment, which may include adding or changing medications, seeing the patient more frequently, or other interventions such as the use of sleep aids.|t|||t
1438132|NCT01794546|Randomized|Crossover Assignment||Treatment||Single||||||t
1438133|NCT01794533|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1438134|NCT01794520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438135|NCT01794507|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438136|NCT01794494|||Case Control||Prospective|||||||
1438137|NCT01794481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438138|NCT01794468|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1438139|NCT01794455|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1438140|NCT01794442|||||Prospective|||||||
1438141|NCT01794429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438142|NCT01794416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438143|NCT01794403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438144|NCT01794390|||Case-Only||Cross-Sectional|||||||
1438145|NCT01794377|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438146|NCT01794364||Crossover Assignment||Basic Science||Double|||t||t|
1438147|NCT01794351|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1438148|NCT01794338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438149|NCT01794325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438150|NCT01794312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438151|NCT01794299||Single Group Assignment||Prevention||None (Open Label)||||||
1438152|NCT01794286|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1438153|NCT01794273|Randomized|Parallel Assignment||Other||Double|||t||t|
1438154|NCT01794260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438155|NCT01794247|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1438156|NCT01794234|||Cohort||Prospective|||||||
1438157|NCT01794221|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438158|NCT01794208|Randomized|Parallel Assignment||Treatment||Single||||||t
1438159|NCT01794195|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1438160|NCT01794182|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1438161|NCT01794169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438162|NCT01794156|Randomized|Parallel Assignment||Treatment||Single||||||t
1438163|NCT01794143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438164|NCT01794130|||Case-Only||Prospective|||||||
1438165|NCT01794117||Single Group Assignment||Treatment||None (Open Label)||||||
1438166|NCT01794104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438167|NCT01794091|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1438168|NCT01794078|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438169|NCT01794065|||Cohort||Prospective|||||||
1438170|NCT01794052||Single Group Assignment||Health Services Research||None (Open Label)||||||
1438171|NCT01794039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438172|NCT01794026||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438173|NCT01794013|Randomized|Parallel Assignment||Treatment||Single||||||t
1438174|NCT01794000|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438175|NCT01793987|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438176|NCT01793974|||Case-Control||Prospective|||||||
1438177|NCT01793961|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1438178|NCT01793948|Randomized|Parallel Assignment||Prevention||Double||||||
1438179|NCT01793935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438180|NCT01793922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438181|NCT01793909||Single Group Assignment||Treatment||None (Open Label)||||||
1438182|NCT01793896|Randomized|Parallel Assignment||Prevention||None (Open Label)||After a placebo phase with no intervention in the first 25 subjects recruited, overweight or obese patients were randomly assigned to one of 3 treatments: hypocaloric diet, high intensity interval training or both interventions simultaneously, for 3 months.||||
1438183|NCT01793883|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438184|NCT01793870|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1438185|NCT01793857|||Family-Based||Cross-Sectional|||||||
1438186|NCT01793844|||Case Control||Prospective|||||||
1438187|NCT01793831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438188|NCT01793818|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1438189|NCT01793805|||Cohort||Prospective|||||||
1438190|NCT01793792||Single Group Assignment||Treatment||None (Open Label)||Low Profile Visualized Intraluminal Support device||||
1438191|NCT01793779|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1438192|NCT01793766|Randomized|Parallel Assignment||||Double|||t||t|
1438193|NCT01793753|||Case-Only||Prospective|||||||
1438194|NCT01793740|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438195|NCT01793727||Single Group Assignment||Treatment||None (Open Label)||||||
1438196|NCT01793714|||Case-Only||Prospective|||||||
1438197|NCT01793701||Single Group Assignment||Treatment||None (Open Label)||||||
1438198|NCT01793688|||Case-Control||Prospective|||||||
1438199|NCT01793675|||Cohort||Prospective|||||||
1438200|NCT01793662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438201|NCT01793649|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1438202|NCT01793636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438203|NCT01793623|||Case-Only||Prospective|||||||
1438204|NCT01793610|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438205|NCT01793597|||Cohort||Prospective|||||||
1438206|NCT01793584|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1438207|NCT01793571|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438208|NCT01793558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438209|NCT01793545|||Cohort||Prospective|||||||
1438210|NCT01793532|||Case-Control||Prospective|||||||
1438211|NCT01793519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438212|NCT01793506|||Cohort||Prospective|||||||
1438213|NCT01793493|Randomized|Parallel Assignment||Treatment||Single||||||t
1438214|NCT01793480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438215|NCT01793467|||Cohort||Prospective|||||||
1438216|NCT01793454|Randomized|Parallel Assignment||Prevention||Single||||||t
1438217|NCT01793441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438218|NCT01793428|||Case-Only||Prospective|||||||
1438219|NCT01793415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438220|NCT01793402|||Cohort||Prospective|||||||
1438221|NCT01793389|Randomized|Single Group Assignment||Treatment||Single||||||t
1438222|NCT01793376|||||Retrospective|||||||
1438223|NCT01793363||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438224|NCT01793350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438225|NCT01793337|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1438226|NCT01793324|||||Retrospective|||||||
1438227|NCT01793311|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1438228|NCT01793298|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1438229|NCT01793285|||Cohort||Retrospective|||||||
1438230|NCT01793272||Single Group Assignment||Treatment||None (Open Label)||||||
1438231|NCT01793259|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438232|NCT01793246|||Cohort||Prospective|||||||
1438233|NCT01793233||||||||||||
1438234|NCT01793220|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1438235|NCT01793207|||Case Control||Prospective|||||||
1438236|NCT01793194|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438237|NCT01793181|||Case Control||Prospective|||||||
1438238|NCT01793168|||Case-Only||Prospective|||||||
1438239|NCT01793155|Randomized|Parallel Assignment||Prevention||Single||||||t
1438240|NCT01793142|||Cohort||Prospective|||||||
1438241|NCT01793129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438242|NCT01793116|||Cohort||Prospective|||||||
1438243|NCT01793103|||Cohort||Prospective|||||||
1438244|NCT01793090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438245|NCT01793077|||Case-Only||Prospective|||||||
1438246|NCT01793064|Randomized|Parallel Assignment||Prevention||Single|||t|||
1438247|NCT01793051|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438248|NCT01793038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438249|NCT01793025||Single Group Assignment||Treatment||None (Open Label)||||||
1438250|NCT01793012|||Cohort||Prospective|||||||
1438251|NCT01792999|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1438252|NCT01792986||Single Group Assignment||Other||None (Open Label)||||||
1438253|NCT01792973|||Cohort||Prospective|||||||
1438254|NCT01792960|||Cohort||Prospective|||||||
1438255|NCT01792947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438256|NCT01792934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438257|NCT01792921|||Case-Crossover||Prospective|||||||
1438258|NCT01792908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438259|NCT01792895|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438260|NCT01792882|||Other||Prospective|||||||
1438261|NCT01792869||||||||||||
1438262|NCT01792856|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438263|NCT01792843|||Case-Only||Prospective|||||||
1438264|NCT01792830|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438265|NCT01792817|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1438266|NCT01792804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438267|NCT01792791|||Cohort||Prospective|||||||
1438268|NCT01792778|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1438269|NCT01792765|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438270|NCT01792752|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438271|NCT01792739|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1438272|NCT01792726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438273|NCT01792713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438274|NCT01792700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438275|NCT01792687||Single Group Assignment||Treatment||None (Open Label)||||||
1438276|NCT01792674|Randomized|Parallel Assignment||||Single||||||t
1438277|NCT01792661|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1438278|NCT01792648|Randomized|Crossover Assignment||Treatment||Single|||||t|
1438279|NCT01792635|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1438280|NCT01792622|||||Prospective|||||||
1438281|NCT01792609|Randomized|Parallel Assignment||Treatment||Single||||||t
1438282|NCT01792596|Randomized|Crossover Assignment||||None (Open Label)||||||
1438283|NCT01792583|||Cohort||Prospective|||||||
1438284|NCT01792570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438285|NCT01792557|Randomized|Parallel Assignment||Treatment||Single||||||t
1438286|NCT01792544|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1438287|NCT01792531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438288|NCT01792518|Randomized|Parallel Assignment||Treatment||Double||||||
1438289|NCT01792505||Single Group Assignment||Treatment||None (Open Label)||||||
1438290|NCT01792492|||Cohort||Prospective|||||||
1438291|NCT01792479|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438292|NCT01792466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438293|NCT01792453||Single Group Assignment||Basic Science||None (Open Label)||||||
1438294|NCT01792440|||Cohort||Cross-Sectional|||||||
1438295|NCT01792427|||Cohort||Prospective|||||||
1438296|NCT01792414|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438297|NCT01792401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438298|NCT01792388|Randomized|Single Group Assignment||||Triple|||t||t|t
1438299|NCT01792375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438300|NCT01792362||Single Group Assignment||Treatment||None (Open Label)||||||
1438301|NCT01792349|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438302|NCT01792336|||||Prospective|||||||
1438303|NCT01792323|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1438304|NCT01792310|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438305|NCT01792297|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1438306|NCT01792284|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438307|NCT01792271|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1438308|NCT01792258|||Case-Only||Prospective|||||||
1438309|NCT01792245|Randomized|Single Group Assignment||Treatment||Single||||||t
1438310|NCT01792232|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1438311|NCT01792219||Single Group Assignment||||None (Open Label)||||||
1438312|NCT01792206|Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1438313|NCT01792193|||Cohort||Prospective|||||||
1438314|NCT01792180|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1438315|NCT01792167|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438316|NCT01792154|||Case Control||Prospective|||||||
1438317|NCT01792141|||Cohort||Prospective|||||||
1438318|NCT01792115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438319|NCT01792102||Single Group Assignment||Treatment||None (Open Label)||||||
1438320|NCT01792089|||Case Control||Cross-Sectional|||||||
1438321|NCT01792063|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1438322|NCT01792050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438323|NCT01792037|Randomized|Crossover Assignment||Prevention||Single|||||t|
1438324|NCT01792024||Single Group Assignment||Treatment||None (Open Label)||||||
1438325|NCT01792011||Single Group Assignment||Diagnostic||Single||||||t
1438326|NCT01791998||Single Group Assignment||Treatment||None (Open Label)||||||
1438327|NCT01791985||Single Group Assignment||Treatment||None (Open Label)||||||
1438328|NCT01791972|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1438329|NCT01791959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438330|NCT01791946|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438331|NCT01791933|||Cohort||Prospective|||||||
1438332|NCT01791920|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438333|NCT01791907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438334|NCT01791894||Single Group Assignment||Basic Science||None (Open Label)||||||
1438335|NCT01791881|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438336|NCT01791868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438337|NCT01791855|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1438338|NCT01791842|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1438339|NCT01791829|||Cohort||Prospective|||||||
1438340|NCT01791816||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438341|NCT01791803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438342|NCT01791790|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1438343|NCT01791777|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1438344|NCT01791764|||Cohort||Prospective|||||||
1438345|NCT01791751|Randomized|Parallel Assignment||||None (Open Label)||||||
1438346|NCT01791738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438347|NCT01791725|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438348|NCT01791712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438349|NCT01791699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438350|NCT01791686||Single Group Assignment||Treatment||None (Open Label)||||||
1438351|NCT01791673||Single Group Assignment||Treatment||None (Open Label)||||||
1438352|NCT01791660||Single Group Assignment||Treatment||None (Open Label)||||||
1438353|NCT01791647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438354|NCT01791634|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438355|NCT01791621||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438356|NCT01791608|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1438357|NCT01791595||Single Group Assignment||Treatment||None (Open Label)||||||
1438358|NCT01791582|||||Prospective|||||||
1438359|NCT01791569|||||Prospective|||||||
1438360|NCT01791556|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1438361|NCT01791543||Single Group Assignment||Treatment||None (Open Label)||||||
1438362|NCT01791530|||Cohort||Prospective|||||||
1438363|NCT01791517|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1438364|NCT01791504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438365|NCT01791491||Single Group Assignment||Treatment||None (Open Label)||||||
1438366|NCT01791478||Single Group Assignment||Treatment||None (Open Label)||||||
1438367|NCT01791465||Single Group Assignment||Treatment||None (Open Label)||||||
1438368|NCT01791452|||||Prospective|||||||
1438369|NCT01791439|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1438370|NCT01791426|Randomized|Parallel Assignment||||Single|||||t|
1438371|NCT01791413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438372|NCT01791400|Randomized|Parallel Assignment||Treatment||Single||||||t
1438373|NCT01791387||Single Group Assignment||Treatment||None (Open Label)||||||
1438374|NCT01791374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438375|NCT01791361|||||Retrospective|||||||
1438376|NCT01791348||Single Group Assignment||||None (Open Label)||||||
1438377|NCT01791335|||Case-Only||Prospective|||||||
1438378|NCT01791322|||Cohort||Prospective|||||||
1438379|NCT01791309||Single Group Assignment||Treatment||None (Open Label)||||||
1438380|NCT01791296|Randomized|Parallel Assignment||Prevention||Quadruple|Blinding for participants, care providers, investigator and outcomes assessor|RCT|t|t|t|t
1438381|NCT01791283|||Cohort||Prospective|||||||
1438382|NCT01791270|||Case Control||Prospective|||||||
1438383|NCT01791257|||Case Control||Prospective|||||||
1438384|NCT01791244|Randomized|Parallel Assignment||Treatment||Single|||||t|
1438385|NCT01791231||Single Group Assignment||Treatment||None (Open Label)||||||
1438386|NCT01791218|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438387|NCT01791205|||Cohort|||||||||
1438388|NCT01791192|Randomized|Parallel Assignment||Treatment||Single||||||t
1438389|NCT01791179||Single Group Assignment||Treatment||None (Open Label)||||||
1438390|NCT01791166||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438391|NCT01791153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438392|NCT01791140|||Cohort||Prospective|||||||
1438393|NCT01791127|||Case-Only||Prospective|||||||
1438394|NCT01791114|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1438395|NCT01791101||Single Group Assignment||Treatment||None (Open Label)||||||
1438396|NCT01791088||Single Group Assignment||Treatment||None (Open Label)||||||
1438397|NCT01791075|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438398|NCT01791062||Single Group Assignment||Treatment||None (Open Label)||||||
1438399|NCT01791049|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1438400|NCT01791036|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438401|NCT01791023||Single Group Assignment||Basic Science||None (Open Label)||||||
1438402|NCT01791010|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1438403|NCT01790997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438404|NCT01790984|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1438405|NCT01790971|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438406|NCT01790958|||Case Control||Retrospective|||||||
1438407|NCT01790945|||Ecologic or Community||Prospective|||||||
1438408|NCT01790932||Single Group Assignment||Treatment||None (Open Label)||||||
1438409|NCT01790919|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438410|NCT01790906|Randomized|Parallel Assignment||Treatment||Single||||||t
1438411|NCT01790893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438412|NCT01790880|Randomized|Parallel Assignment||Treatment||Single||||||t
1438413|NCT01790867||||||||||||
1438414|NCT01790854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438415|NCT01790841|||Case Control||Prospective|||||||
1438416|NCT01790828|||||Prospective|||||||
1438417|NCT01790815|||Cohort||Prospective|||||||
1438418|NCT01790802|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1438419|NCT01790789|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1438420|NCT01790776|Randomized|Parallel Assignment||||None (Open Label)||||||
1438421|NCT01790763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438422|NCT01790750||Single Group Assignment||||None (Open Label)||||||
1438423|NCT01790737|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438424|NCT01790724|Randomized|Parallel Assignment||Treatment||Single||||||t
1438425|NCT01790711||Parallel Assignment||Treatment||None (Open Label)||||||
1438426|NCT01790698|||Cohort||Prospective|||||||
1438427|NCT01790685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438428|NCT01790672|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1438429|NCT01790659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438430|NCT01790646|||Cohort||Prospective|||||||
1438431|NCT01790633|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1438432|NCT01790620|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1438433|NCT01790607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438434|NCT01790594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438435|NCT01790581|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1438436|NCT01790568||Single Group Assignment||Prevention||None (Open Label)||||||
1438437|NCT01790555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438438|NCT01790542|Randomized|Parallel Assignment||||Double|||||t|t
1438439|NCT01790529|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1438440|NCT01790516|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438441|NCT01790503|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1438442|NCT01790490|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1438443|NCT01790477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438444|NCT01790464|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1438445|NCT01790451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438446|NCT01790438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438447|NCT01790425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438448|NCT01790412|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438449|NCT01790399||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438450|NCT01790386|||||Prospective|||||||
1438451|NCT01790373|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1438452|NCT01790360|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1438453|NCT01790347|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438454|NCT01790334|||Case-Crossover||Prospective|||||||
1438455|NCT01790321|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1438456|NCT01790308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438457|NCT01790295||Single Group Assignment||Treatment||None (Open Label)||||||
1438458|NCT01790282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438459|NCT01790269|||Case-Only||Prospective|||||||
1438460|NCT01790256|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1438461|NCT01790243||Single Group Assignment||Treatment||None (Open Label)||||||
1438462|NCT01790230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438463|NCT01790217|||Cohort||Prospective|||||||
1438464|NCT01790204||Single Group Assignment||Prevention||None (Open Label)||||||
1438465|NCT01790191|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1438466|NCT01790178|Randomized|Parallel Assignment||||Single||||||t
1438467|NCT01790165|Randomized|Crossover Assignment||Screening||Quadruple|||t|t|t|t
1438468|NCT01790152||||||||||||
1438469|NCT01790139|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1438470|NCT01790126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438471|NCT01790113|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438472|NCT01790100|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438473|NCT01790087|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1438474|NCT01790074|Randomized|Parallel Assignment||Treatment||Single||||||t
1438475|NCT01790061|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438476|NCT01790048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438477|NCT01790035|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438478|NCT01790022||Single Group Assignment||Treatment||None (Open Label)||||||
1438479|NCT01790009|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1438480|NCT01789996|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1438481|NCT01789983|||Cohort||Prospective|||||||
1438482|NCT01789970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438483|NCT01789957||Single Group Assignment||Treatment||None (Open Label)||||||
1438484|NCT01789944|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438485|NCT01789931||Single Group Assignment||Prevention||None (Open Label)||||||
1438486|NCT01789918||Single Group Assignment||Treatment||None (Open Label)||||||
1438487|NCT01789905|||Case-Only||Retrospective|||||||
1438488|NCT01789892||Single Group Assignment||Diagnostic||Single||||||
1438489|NCT01789879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438490|NCT01789866|||Cohort||Prospective|||||||
1438491|NCT01789853|Randomized|Parallel Assignment||Treatment||Single||||||t
1438492|NCT01789840|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438493|NCT01789827|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1438494|NCT01789814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438885|NCT01784679|||Other||Prospective|||||||
1438495|NCT01789801|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438496|NCT01789788|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438497|NCT01789775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438498|NCT01789762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438499|NCT01789749|Randomized|Parallel Assignment||Prevention||Single|Patients were blinded to the treatment allocation. The endoscopists performing the index and surveillance procedures were not blinded to the treatment.||t|||
1438500|NCT01789736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438501|NCT01789723|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438502|NCT01789710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438503|NCT01789697|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1438504|NCT01789684|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1438505|NCT01789671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438506|NCT01789658|Randomized|Parallel Assignment||Prevention||Single|||||t|
1438507|NCT01789645|Randomized|Parallel Assignment||Treatment||Single||||||t
1438508|NCT01789619|||Cohort||Prospective|||||||
1438509|NCT01789606||Single Group Assignment||Treatment||None (Open Label)||||||
1438510|NCT01789593|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1438511|NCT01789580|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1438512|NCT01789567||Single Group Assignment||Treatment||None (Open Label)||||||
1438513|NCT01789554|Randomized|Single Group Assignment||Health Services Research||Quadruple|||t|t|t|t
1438514|NCT01789541|||Case Control||Prospective|||||||
1438515|NCT01789528|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1438516|NCT01789515|||Cohort||Retrospective|||||||
1438517|NCT01789502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438518|NCT01789489|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1438519|NCT01789476|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438520|NCT01789463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438521|NCT01789450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438522|NCT01789437||Parallel Assignment||Diagnostic||None (Open Label)||||||
1438523|NCT01789424|||Case-Only||Prospective|||||||
1438524|NCT01789411|||Cohort||Prospective|||||||
1438525|NCT01789398|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438526|NCT01789385||Single Group Assignment||Treatment||None (Open Label)||||||
1438527|NCT01789372|||Case Control||Prospective|||||||
1438528|NCT01789359||Single Group Assignment||Basic Science||None (Open Label)||||||
1438529|NCT01789346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438530|NCT01789333||Single Group Assignment||Treatment||None (Open Label)||30 patients will be treated at 9 mw/cm2.||||
1438531|NCT01789320||Single Group Assignment||Treatment||None (Open Label)||||||
1438532|NCT01789307|Randomized|Crossover Assignment||||Double|||t|||t
1438533|NCT01789294|Randomized|Single Group Assignment||Treatment||Single|||||t|
1438534|NCT01789281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438535|NCT01789268|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1438536|NCT01789255||Single Group Assignment||Supportive Care||None (Open Label)||||||
1438537|NCT01789242||Single Group Assignment||Treatment||None (Open Label)||||||
1438538|NCT01789229|||Case-Control||Other|||||||
1438539|NCT01789216|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438540|NCT01789203|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1438541|NCT01789190|||Cohort||Prospective|||||||
1438542|NCT01789177|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438543|NCT01789164|||Case Control||Cross-Sectional|||||||
1438544|NCT01789151||||||||||||
1438545|NCT01789138|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438546|NCT01789125|Randomized|Parallel Assignment||Treatment||Single||||||t
1438547|NCT01789112||Single Group Assignment||Basic Science||None (Open Label)||||||
1438548|NCT01789099||Single Group Assignment||Treatment||None (Open Label)||||||
1438549|NCT01789086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438550|NCT01789073|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438551|NCT01789060|||Cohort||Retrospective|||||||
1438552|NCT01789047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438553|NCT01789034|||Cohort||Prospective|||||||
1438554|NCT01789021||||||||||||
1438555|NCT01789008|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1438556|NCT01788995|||Cohort||Prospective|||||||
1438557|NCT01788982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438558|NCT01788969|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1438559|NCT01788956|||Cohort||Prospective|||||||
1438560|NCT01788943|||Cohort||Prospective|||||||
1438561|NCT01788930|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1438562|NCT01788917||Single Group Assignment||Treatment||None (Open Label)||||||
1438563|NCT01788904|||Cohort||Prospective|||||||
1438564|NCT01788891|||Cohort||Prospective|||||||
1438565|NCT01788878||Single Group Assignment||Prevention||None (Open Label)||||||
1438566|NCT01788865||Single Group Assignment||Treatment||None (Open Label)||||||
1438567|NCT01788852|||Cohort||Prospective|||||||
1438568|NCT01788839|||Cohort||Prospective|||||||
1438569|NCT01788826|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438570|NCT01788813|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438571|NCT01788800|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438572|NCT01788787|||Cohort||Prospective|||||||
1438573|NCT01788774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438574|NCT01788761|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1438575|NCT01788748|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438576|NCT01788735|||Cohort||Prospective|||||||
1438577|NCT01788722|||Cohort||Prospective|||||||
1438578|NCT01788709|Randomized|Parallel Assignment||Screening||Single||||||t
1438579|NCT01788696|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1438580|NCT01788683|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438581|NCT01788670|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1438582|NCT01788657|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438583|NCT01788644|||Cohort||Prospective|||||||
1438584|NCT01788631|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438585|NCT01788618|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1438586|NCT01788605||Single Group Assignment||Supportive Care||None (Open Label)||||||
1438587|NCT01788592|||Cohort||Prospective|||||||
1438588|NCT01788579|Randomized|Parallel Assignment||Screening||Single|||t|||
1438589|NCT01788566||Single Group Assignment||Treatment||None (Open Label)||||||
1438590|NCT01788553|||Case-Only||Prospective|||||||
1438591|NCT01788540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438592|NCT01788527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438593|NCT01788514||Single Group Assignment||||None (Open Label)||||||
1438594|NCT01788501|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438595|NCT01788488|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438596|NCT01788475|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1438597|NCT01788462|||Cohort||Prospective|||||||
1438598|NCT01788449|||||Prospective|||||||
1438599|NCT01788436|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1438600|NCT01788423|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1438601|NCT01788410|||Cohort||Prospective|||||||
1438602|NCT01788397|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1438603|NCT01788384|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438604|NCT01788371|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438605|NCT01788358||Single Group Assignment||Treatment||None (Open Label)||||||
1438606|NCT01788345|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1438607|NCT01788332|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438608|NCT01788319||Single Group Assignment||Treatment||Double|||t||t|
1438609|NCT01788306|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438610|NCT01788293|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1438611|NCT01788280||Single Group Assignment||Treatment||None (Open Label)||||||
1438612|NCT01788267|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1438613|NCT01788254||Single Group Assignment||Basic Science||None (Open Label)||||||
1438614|NCT01788241|||Cohort||Prospective|||||||
1438615|NCT01788228|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438616|NCT01788215|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438617|NCT01788202|||Case-Only||Prospective|||||||
1438618|NCT01788189||Single Group Assignment||Treatment||None (Open Label)||||||
1438619|NCT01788176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438620|NCT01788163||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438621|NCT01788150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438622|NCT01788137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438623|NCT01788124|||Cohort||Prospective|||||||
1438624|NCT01788111|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438625|NCT01788098|||Case Control||Cross-Sectional|||||||
1438626|NCT01788085||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438627|NCT01788072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438628|NCT01788059||Single Group Assignment||Treatment||None (Open Label)||||||
1438629|NCT01788046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438630|NCT01788033|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438631|NCT01788020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438632|NCT01788007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438633|NCT01787994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438634|NCT01787981||||||||||||
1438635|NCT01787968|||Cohort||Prospective|||||||
1438636|NCT01787955|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438637|NCT01787942|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1438638|NCT01787929|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1438639|NCT01787916|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1438640|NCT01787903|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438641|NCT01787877|||Cohort||Prospective|||||||
1438642|NCT01787864|||Cohort||Other|||||||
1438643|NCT01787851|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438644|NCT01787838||Single Group Assignment||Health Services Research||None (Open Label)||||||
1438645|NCT01787825|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1438646|NCT01787812|||Case-Only||Prospective|||||||
1438647|NCT01787799||Single Group Assignment||Treatment||None (Open Label)||||||
1438648|NCT01787786|||Cohort||Prospective|||||||
1438649|NCT01787773||Single Group Assignment||Prevention||None (Open Label)||||||
1438650|NCT01787760|Randomized|Parallel Assignment||Treatment||Single|||||t|
1438651|NCT01787747|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1438652|NCT01787721|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438653|NCT01787708|Randomized|Single Group Assignment||Treatment||Single||||||t
1438654|NCT01787695|Randomized|Single Group Assignment||Treatment||Single||||||t
1438655|NCT01787682||Single Group Assignment||Supportive Care||None (Open Label)||||||
1438656|NCT01787669|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1438657|NCT01787656|||Other||Other|||||||
1438658|NCT01787643||Single Group Assignment||Prevention||None (Open Label)||||||
1438659|NCT01787630||Single Group Assignment||Treatment||None (Open Label)||||||
1438660|NCT01787617|Randomized|Parallel Assignment||Prevention||Single||||||t
1438661|NCT01787604|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438662|NCT01787591|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1438663|NCT01787578||Single Group Assignment||Treatment||None (Open Label)||||||
1438664|NCT01787565|||Cohort||Prospective|||||||
1438665|NCT01787552||Single Group Assignment||Treatment||None (Open Label)||||||
1438666|NCT01787539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438667|NCT01787526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438668|NCT01787513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438669|NCT01787500|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438670|NCT01787487|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438671|NCT01787474||Single Group Assignment||Treatment||None (Open Label)||||||
1438672|NCT01787461|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1438673|NCT01787448|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1438674|NCT01787435|||Cohort||Retrospective|||||||
1438675|NCT01787422|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1438676|NCT01787409||Single Group Assignment||Treatment||None (Open Label)||||||
1438677|NCT01787396|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438678|NCT01787383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438679|NCT01787370|||Cohort||Prospective|||||||
1438680|NCT01787357|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1438681|NCT01787344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438682|NCT01787331||Single Group Assignment||Treatment||None (Open Label)||||||
1438683|NCT01787318|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438684|NCT01787305|||Case-Control||Other|||||||
1438685|NCT01787292|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1438686|NCT01787279||Single Group Assignment||Treatment||None (Open Label)||||||
1438687|NCT01787266|||Cohort||Prospective|||||||
1438688|NCT01787253|||Case Control||Prospective|||||||
1438689|NCT01787240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438690|NCT01787227|||Case-Only||Prospective|||||||
1438691|NCT01787214|Randomized|Crossover Assignment||Treatment||Single||||||t
1438692|NCT01787188|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438693|NCT01787175|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1438694|NCT01787162|||Cohort||Prospective|||||||
1438695|NCT01787149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438696|NCT01787136||||||||||||
1438697|NCT01787123|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438698|NCT01787110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438699|NCT01787097||Single Group Assignment||Basic Science||None (Open Label)||||||
1438700|NCT01787084|||Cohort||Prospective|||||||
1438701|NCT01787071|||Cohort||Prospective|||||||
1438702|NCT01787058|||Cohort||Prospective|||||||
1438703|NCT01787045|Randomized|Parallel Assignment||Basic Science||Single||||||t
1438704|NCT01787032|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438705|NCT01787019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438706|NCT01787006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438707|NCT01786993|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438708|NCT01786980|||||Prospective|||||||
1438709|NCT01786967||Single Group Assignment||Treatment||None (Open Label)||||||
1438710|NCT01786954|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1438711|NCT01786941|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1438712|NCT01786928|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438713|NCT01786915|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1438714|NCT01786902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438715|NCT01786889||Single Group Assignment||Prevention||None (Open Label)||||||
1438716|NCT01786876||Single Group Assignment||Basic Science||None (Open Label)||||||
1438717|NCT01786863|||Cohort||Prospective|||||||
1438718|NCT01786850||||||||||||
1438719|NCT01786837|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438720|NCT01786824|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1438721|NCT01786811|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1438722|NCT01786798||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438723|NCT01786785|||Other||Prospective|||||||
1438724|NCT01786772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438725|NCT01786759|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1438726|NCT01786746|Randomized|Single Group Assignment||Treatment||Single||||||t
1438727|NCT01786733|Randomized|Parallel Assignment||Treatment||Single||||||t
1438728|NCT01786720|||Cohort||Retrospective|||||||
1438729|NCT01786707|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438730|NCT01786694||Single Group Assignment||Prevention||None (Open Label)||||||
1438731|NCT01786681|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1438732|NCT01786668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438733|NCT01786655|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1438734|NCT01786642|||Cohort||Prospective|||||||
1438735|NCT01786629|Randomized|Parallel Assignment||Treatment||Single||||||t
1438736|NCT01786616|||Cohort||Prospective|||||||
1438737|NCT01786603|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1438738|NCT01786590||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438739|NCT01786577|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1438740|NCT01786564|||Ecologic or Community||Cross-Sectional|||||||
1438741|NCT01786551||Single Group Assignment||Prevention||None (Open Label)||||||
1438742|NCT01786538|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438743|NCT01786525|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1438744|NCT01786512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438745|NCT01786499||Single Group Assignment||Treatment||||||||
1438746|NCT01786486|||Case-Only||Prospective|||||||
1438747|NCT01786473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438748|NCT01786460|||Cohort||Prospective|||||||
1438749|NCT01786447|||Case Control||Prospective|||||||
1438750|NCT01786434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438751|NCT01786421|||Cohort||Retrospective|||||||
1438752|NCT01786408|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1438753|NCT01786395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438754|NCT01786382|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1438755|NCT01786369|||Ecologic or Community||Cross-Sectional|||||||
1438756|NCT01786356|Randomized|Parallel Assignment||||Double|||t||t|
1438757|NCT01786343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438758|NCT01786330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438759|NCT01786317|||Case Control||Prospective|||||||
1438760|NCT01786304|||Cohort||Prospective|||||||
1438761|NCT01786291|||Case Control||Prospective|||||||
1438762|NCT01786278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438763|NCT01786265|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438764|NCT01786252|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1438765|NCT01786239|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1438766|NCT01786226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438767|NCT01786213|||||Retrospective|||||||
1438768|NCT01786200|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1438769|NCT01786187|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438770|NCT01786174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438771|NCT01786161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438772|NCT01786148|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1438773|NCT01786135||Single Group Assignment||Treatment||None (Open Label)||||||
1438774|NCT01786122|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438775|NCT01786109|Randomized|Parallel Assignment||||Double|||t||t|
1438776|NCT01786096||Single Group Assignment||Treatment||None (Open Label)||||||
1438777|NCT01786083|Non-Randomized|Parallel Assignment||Treatment||Single||||t||
1438778|NCT01786070|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1438779|NCT01786057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438780|NCT01786044|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1438781|NCT01786031||Single Group Assignment||Diagnostic||None (Open Label)||||||
1438782|NCT01786018||Single Group Assignment||Treatment||None (Open Label)||||||
1438783|NCT01786005|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438784|NCT01785992||Single Group Assignment||Treatment||None (Open Label)||||||
1438785|NCT01785979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438786|NCT01785966|Randomized|Parallel Assignment||||None (Open Label)||||||
1438787|NCT01785953|||Case-Only||Retrospective|||||||
1438788|NCT01785940||Single Group Assignment||Treatment||None (Open Label)||||||
1438789|NCT01785927|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1438790|NCT01785914|||Case-Only||Retrospective|||||||
1438791|NCT01785901|||Case-Only||Cross-Sectional|||||||
1438792|NCT01785888|||Cohort||Prospective|||||||
1438793|NCT01785875||Single Group Assignment||Treatment||None (Open Label)||||||
1438794|NCT01785862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438795|NCT01785849|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438796|NCT01785836|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438797|NCT01785823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438798|NCT01785810||||Treatment||||||||
1438799|NCT01785797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438800|NCT01785784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438801|NCT01785771||Single Group Assignment||Treatment||None (Open Label)||||||
1438802|NCT01785758|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438803|NCT01785745|Randomized|Parallel Assignment||Treatment||Single|||||t|
1438804|NCT01785732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438805|NCT01785719||Single Group Assignment||Basic Science||None (Open Label)||The researchers plan to recruit two cohorts of overweight women to the study: (1) those with irregular menstrual cycles and/or PCOS and (2) those with regular menstrual cycles. Both of the cohorts will receive the same intervention.||||
1438806|NCT01785706|||Cohort||Prospective|||||||
1438807|NCT01785693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438808|NCT01785680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438809|NCT01785667|||Cohort||Prospective|||||||
1438810|NCT01785654||||||||||||
1438811|NCT01785641|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438812|NCT01785628|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1438813|NCT01785615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438814|NCT01785602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438815|NCT01785589||Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1438816|NCT01785576|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1438817|NCT01785563||Single Group Assignment||Treatment||None (Open Label)||||||
1438818|NCT01785550|||Case Control||Prospective|||||||
1438819|NCT01785537|||Cohort||Prospective|||||||
1438820|NCT01785524|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1438821|NCT01785511|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1438822|NCT01785498|Randomized|Parallel Assignment||Prevention||Single||||||t
1438823|NCT01785485|||Case Control||Prospective|||||||
1438824|NCT01785472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438825|NCT01785459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438826|NCT01785446|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1438827|NCT01785433|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438828|NCT01785420|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438829|NCT01785407|Randomized|Parallel Assignment||Prevention||Single|||t|||
1438830|NCT01785394|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438831|NCT01785381|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1438832|NCT01785368|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1438833|NCT01785355||Single Group Assignment||Treatment||None (Open Label)||||||
1438834|NCT01785342|||Cohort||Prospective|||||||
1438835|NCT01785329|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1438836|NCT01785316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438837|NCT01785303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438838|NCT01785290|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1438839|NCT01785277|||Cohort||Prospective|||||||
1438840|NCT01785264|Randomized|Parallel Assignment||Treatment||Single||||||t
1438841|NCT01785251||Single Group Assignment||Basic Science||None (Open Label)||||||
1438842|NCT01785238||Parallel Assignment||Health Services Research||None (Open Label)||||||
1438843|NCT01785225||Single Group Assignment||||None (Open Label)||||||
1438844|NCT01785212|Randomized|Parallel Assignment||Treatment||Single|||t|||
1438845|NCT01785199|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438846|NCT01785186|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438847|NCT01785173|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438848|NCT01785160|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438849|NCT01785147|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438850|NCT01785134|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438851|NCT01785121|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1438852|NCT01785108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438853|NCT01785095||Single Group Assignment||Treatment||None (Open Label)||||||
1438854|NCT01785082|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1438855|NCT01785069||||||||||||
1438856|NCT01785056|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438857|NCT01785043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438858|NCT01785030||Single Group Assignment||Treatment||None (Open Label)||||||
1438859|NCT01785017|||Case Control||Prospective|||||||
1438860|NCT01785004|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1438861|NCT01784991|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438862|NCT01784978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438863|NCT01784965|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1438864|NCT01784952|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1438865|NCT01784939|||Cohort||Prospective|||||||
1438866|NCT01784926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438867|NCT01784913||Single Group Assignment||Treatment||None (Open Label)||||||
1438868|NCT01784900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438869|NCT01784887|Randomized|Single Group Assignment||Treatment||Single||||||t
1438870|NCT01784874|Randomized|Parallel Assignment||Prevention||Single||||||t
1438871|NCT01784861|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438872|NCT01784848|Randomized|Parallel Assignment||Treatment||Single||||||t
1438873|NCT01784835|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1438874|NCT01784822|||Cohort||Prospective|||||||
1438875|NCT01784809|Randomized|Parallel Assignment||Prevention||Single||||||t
1438876|NCT01784796|Randomized|Parallel Assignment||Prevention||Single|||||t|
1438877|NCT01784783|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438878|NCT01784770|||Case-Only||Retrospective|||||||
1438879|NCT01784757|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1438880|NCT01784744|||Case-Control||Prospective|||||||
1438881|NCT01784731|||Case-Only||Cross-Sectional|||||||
1438882|NCT01784718||||||||||||
1438883|NCT01784705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438884|NCT01784692|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1438886|NCT01784666|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1438887|NCT01784653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438888|NCT01784640||Single Group Assignment||Treatment||None (Open Label)||||||
1438889|NCT01784627|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438890|NCT01784614|Randomized|Crossover Assignment||||Double|||t||t|
1438891|NCT01784601|||Case-Control||Prospective|||||||
1438892|NCT01784588|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438893|NCT01784575|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1438894|NCT01784562||||||||||||
1438895|NCT01784549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438896|NCT01784536||Single Group Assignment||Treatment||None (Open Label)||||||
1438897|NCT01784523|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1438898|NCT01784510|Randomized|Parallel Assignment||||Single||||||t
1438899|NCT01784497|||Cohort||Prospective|||||||
1438900|NCT01784484|||||Prospective|||||||
1438901|NCT01784471||Single Group Assignment||Supportive Care||None (Open Label)||||||
1438902|NCT01784458|||Cohort||Prospective|||||||
1438903|NCT01784445|Randomized|Parallel Assignment||Prevention||Single||||||t
1438904|NCT01784432|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1438905|NCT01784419|Randomized|Crossover Assignment||Screening||Triple|||t|t|t|
1438906|NCT01784406|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1438907|NCT01784393|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1438908|NCT01784380|||Case Control|||||||||
1438909|NCT01784367||Single Group Assignment||Treatment||None (Open Label)||||||
1438910|NCT01784354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438911|NCT01784341|||Case-Control||Prospective|||||||
1438912|NCT01784328||Single Group Assignment||Treatment||None (Open Label)||||||
1438913|NCT01784315|||||Prospective|||||||
1438914|NCT01784302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438915|NCT01784289|||Cohort||Cross-Sectional|||||||
1438916|NCT01784276|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1438917|NCT01784263|Randomized|Parallel Assignment||Treatment||Single||||||t
1438918|NCT01784250|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1438919|NCT01784237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438920|NCT01784224||Single Group Assignment||Treatment||None (Open Label)||||||
1438921|NCT01784211|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1438922|NCT01784198||Single Group Assignment||Basic Science||Single|||t|||
1438923|NCT01784185||Single Group Assignment||Diagnostic||Single|||||t|
1438924|NCT01784172|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1438925|NCT01784159|Randomized|Parallel Assignment||Treatment||Quadruple|placebo||t|t|t|t
1438926|NCT01784146|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438927|NCT01784133|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438928|NCT01784120||Single Group Assignment||Treatment||None (Open Label)||||||
1438929|NCT01784107||Single Group Assignment||Treatment||None (Open Label)||||||
1438930|NCT01784094|||Cohort||Cross-Sectional|||||||
1438931|NCT01784081|||Cohort||Prospective|||||||
1438932|NCT01784068||Single Group Assignment||Other||None (Open Label)||||||
1438933|NCT01784055|||Cohort||Prospective|||||||
1438934|NCT01784042|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438935|NCT01784029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438936|NCT01784016|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1438937|NCT01784003|||Other||Cross-Sectional|||||||
1438938|NCT01783990|||Cohort||Prospective|||||||
1438939|NCT01783977|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1438940|NCT01783964||Single Group Assignment||Basic Science||None (Open Label)||||||
1438941|NCT01783951|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438942|NCT01783938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438943|NCT01783925|||Cohort||Prospective|||||||
1438944|NCT01783912|Randomized|Factorial Assignment||Treatment||Single|||t|||
1438945|NCT01783899||Single Group Assignment||Treatment||None (Open Label)||||||
1438946|NCT01783886|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1438947|NCT01783873|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1438948|NCT01783860|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1438949|NCT01783847|Non-Randomized|Parallel Assignment||Treatment||Single||||t||
1438950|NCT01783834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438951|NCT01783821|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1438952|NCT01783808|Randomized|Parallel Assignment||Treatment||Single||||||t
1438953|NCT01783795||Single Group Assignment||Screening||None (Open Label)||||||
1438954|NCT01783782|Randomized|Single Group Assignment||||Single|||||t|
1438955|NCT01783769|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438956|NCT01783756||Single Group Assignment||Treatment||None (Open Label)||||||
1438957|NCT01783743|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1438958|NCT01783730|||Cohort||Prospective|||||||
1438959|NCT01783717||Single Group Assignment||Treatment||None (Open Label)||||||
1439028|NCT01782820|||Case-Crossover||Prospective|||||||
1439029|NCT01782807|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1439030|NCT01782794|||Family-Based||Cross-Sectional|||||||
1439031|NCT01782781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439032|NCT01782768||Single Group Assignment||Treatment||Single|||t|||
1438960|NCT01783704|Randomized|Parallel Assignment||Supportive Care||Double|"Study PI (Magaziner) and Co-PI (Craik) and members of the Clinical Coordinating Center (Orwig, Lewis) are blinded to treatment assignment.~Clinical site PIs and clinical site coordinators who are responsible for assigning work and/or assessing for treatment fidelity of PTs in both groups are unblinded.~Staff who perform evaluations (clinical site visits and telephone interviews) after randomization and the Independent Safety Monitor (ISM) who will be blinded to treatment assignment.~The PTs only know specific information about the intervention he/she is delivering. To minimize contamination of the interventions, each PT provides only one of the interventions and PTs do not have contact with participants in the other group or with PTs providing the intervention to the other group. As PTs are hired for the study, they are assigned at random to one of the interventions."||||t|t
1438961|NCT01783691||Single Group Assignment||Treatment||None (Open Label)||||||
1438962|NCT01783678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438963|NCT01783665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438964|NCT01783652|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438965|NCT01783639||Single Group Assignment||Prevention||None (Open Label)||||||
1438966|NCT01783626|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1438967|NCT01783613|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438968|NCT01783600||Single Group Assignment||Treatment||None (Open Label)||||||
1438969|NCT01783587|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438970|NCT01783574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1438971|NCT01783561|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1438972|NCT01783548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438973|NCT01783535|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438974|NCT01783522|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1438975|NCT01783509|||Cohort||Prospective|||||||
1438976|NCT01783496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438977|NCT01783483|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1438978|NCT01783470||Single Group Assignment||Basic Science||None (Open Label)||||||
1438979|NCT01783457|Randomized|Parallel Assignment||Treatment||Single||||||t
1438980|NCT01783444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438981|NCT01783431||Single Group Assignment||Treatment||None (Open Label)||||||
1438982|NCT01783418|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1438983|NCT01783405|||Case Control||Retrospective|||||||
1438984|NCT01783392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438985|NCT01783379|||Case-Only||Prospective|||||||
1438986|NCT01783366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438987|NCT01783353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1438988|NCT01783340|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1438989|NCT01783327|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1438990|NCT01783314|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1438991|NCT01783301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1438992|NCT01783288||Single Group Assignment||Screening||None (Open Label)||||||
1438993|NCT01783275|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1438994|NCT01783262|Randomized|||Treatment||Double|||t|||t
1438995|NCT01783249|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1438996|NCT01783236|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1438997|NCT01783223|||Cohort||Prospective|||||||
1438998|NCT01783210|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1438999|NCT01783197|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439000|NCT01783184|||Cohort||Prospective|||||||
1439001|NCT01783171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439002|NCT01783158|||Case-Only||Prospective|||||||
1439003|NCT01783145|||Cohort||Prospective|||||||
1439004|NCT01783132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439005|NCT01783119|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439006|NCT01783106|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439007|NCT01783093|||Case-Only||Retrospective|||||||
1439008|NCT01783080||Single Group Assignment||Treatment||None (Open Label)||||||
1439009|NCT01783067|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439010|NCT01783054||Single Group Assignment||Treatment||None (Open Label)||||||
1439011|NCT01783041|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439012|NCT01783028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439013|NCT01783015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439014|NCT01783002|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1439015|NCT01782989|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439016|NCT01782976||Single Group Assignment||Treatment||None (Open Label)||||||
1439017|NCT01782963||Single Group Assignment||Treatment||None (Open Label)||||||
1439018|NCT01782950||Single Group Assignment||Treatment||None (Open Label)||||||
1439019|NCT01782937||Single Group Assignment||Treatment||None (Open Label)||||||
1439020|NCT01782924|Randomized|Parallel Assignment||Treatment||||||||
1439021|NCT01782911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439022|NCT01782898|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1439023|NCT01782885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439024|NCT01782872|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1439025|NCT01782859|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439026|NCT01782846|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1439027|NCT01782833|||Other||Prospective|||||||
1439033|NCT01782755|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439034|NCT01782742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439035|NCT01782729||Single Group Assignment||Treatment||None (Open Label)||||||
1439036|NCT01782716||||||||||||
1439037|NCT01782703|||Case-Control||Cross-Sectional|||||||
1439038|NCT01782690|||Cohort||Prospective|||||||
1439039|NCT01782677||Single Group Assignment||Treatment||None (Open Label)||||||
1439040|NCT01782664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439041|NCT01782651|||Cohort||Retrospective|||||||
1439042|NCT01782638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439043|NCT01782625|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1439044|NCT01782612|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1439045|NCT01782599||Single Group Assignment||Basic Science||None (Open Label)||||||
1439046|NCT01782586|||Cohort||Prospective|||||||
1439047|NCT01782573|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439048|NCT01782560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439049|NCT01782547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439050|NCT01782534|||Case-Only||Retrospective|||||||
1439051|NCT01782521|Randomized|Parallel Assignment||Treatment||Single||||||t
1439052|NCT01782508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439053|NCT01782495|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439054|NCT01782482|Randomized|Parallel Assignment||||Single|||t|||
1439055|NCT01782469|||Case-Only||Prospective|||||||
1439056|NCT01782456||Single Group Assignment||||None (Open Label)||||||
1439057|NCT01782443||Single Group Assignment||Treatment||None (Open Label)||||||
1439058|NCT01782430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439059|NCT01782417||Single Group Assignment||Treatment||None (Open Label)||||||
1439060|NCT01782404||Single Group Assignment||Treatment||None (Open Label)||||||
1439061|NCT01782391|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1439062|NCT01782378|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1439063|NCT01782365|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1439064|NCT01782352|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1439065|NCT01782339||Single Group Assignment||Treatment||None (Open Label)||||||
1439066|NCT01782326|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439067|NCT01782313||Single Group Assignment||Treatment||None (Open Label)||||||
1439068|NCT01782300|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1439069|NCT01782287|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439070|NCT01782274|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439071|NCT01782261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439072|NCT01782248|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1439073|NCT01782235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439074|NCT01782222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439075|NCT01782209|||Case-Only||Prospective|||||||
1439076|NCT01782196|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1439077|NCT01782183||Single Group Assignment||Diagnostic||Single||||||t
1439078|NCT01782170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439079|NCT01782157|||Cohort||Prospective|||||||
1439080|NCT01782144|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439081|NCT01782131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439082|NCT01782118|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1439083|NCT01782105|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439084|NCT01782092|||Case-Only||Prospective|||||||
1439085|NCT01782079||Single Group Assignment||Basic Science||None (Open Label)||||||
1439086|NCT01782066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439087|NCT01782053|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1439088|NCT01782040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439089|NCT01782027||Single Group Assignment||Basic Science||None (Open Label)||||||
1439090|NCT01782014|Randomized|Parallel Assignment||Screening||Single|||t|||
1439091|NCT01782001|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1439092|NCT01781988|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439093|NCT01781975|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439094|NCT01781962|||Cohort||Prospective|||||||
1439095|NCT01781949|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439096|NCT01781936||Single Group Assignment||Treatment||None (Open Label)||||||
1439097|NCT01781923|Randomized|Parallel Assignment||||None (Open Label)||||||
1439098|NCT01781910|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1439099|NCT01781897|Randomized|Parallel Assignment||Treatment||Single||||||t
1439100|NCT01781884|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439101|NCT01781871|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439102|NCT01781858|||Cohort||Prospective|||||||
1439103|NCT01781845||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439104|NCT01781832||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439105|NCT01781819||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439106|NCT01781806|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439107|NCT01781793|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1439108|NCT01781780|Randomized|Parallel Assignment||||None (Open Label)||||||
1439109|NCT01781767|||Case Control||Prospective|||||||
1439110|NCT01781754|||Case-Only||Prospective|||||||
1439111|NCT01781741||Single Group Assignment||Treatment||None (Open Label)||||||
1439112|NCT01781728|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439113|NCT01781715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439114|NCT01781702|Randomized|Single Group Assignment||Supportive Care||Double|||t|t||
1439115|NCT01781689|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1439116|NCT01781676|||Cohort||Prospective|||||||
1439117|NCT01781663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439118|NCT01781650|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439119|NCT01781637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439120|NCT01781624|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1439121|NCT01781611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439122|NCT01781598|||Cohort||Prospective|||||||
1439123|NCT01781585|||Case-Crossover||Prospective|||||||
1439124|NCT01781572|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439125|NCT01781559|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1439126|NCT01781546|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439127|NCT01781533||Single Group Assignment||Basic Science||None (Open Label)||||||
1439128|NCT01781520|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439129|NCT01781507|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1439130|NCT01781494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439131|NCT01781481|||Cohort||Cross-Sectional|||||||
1439132|NCT01781468|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1439133|NCT01781455||Single Group Assignment||Treatment||None (Open Label)||||||
1439134|NCT01781442|||Cohort||Prospective|||||||
1439135|NCT01781429||Single Group Assignment||Treatment||None (Open Label)||||||
1439136|NCT01781416|||Case-Only||Prospective|||||||
1439137|NCT01781403||Single Group Assignment||Treatment||None (Open Label)||||||
1439138|NCT01781390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439139|NCT01781377|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1439140|NCT01781364||Single Group Assignment||Prevention||None (Open Label)||||||
1439141|NCT01781351||Single Group Assignment||Prevention||None (Open Label)||||||
1439142|NCT01781338|Randomized|Single Group Assignment||||None (Open Label)||||||
1439143|NCT01781325|Randomized|Parallel Assignment||||None (Open Label)||||||
1439144|NCT01781312|Randomized|Parallel Assignment||||None (Open Label)||||||
1439145|NCT01781299|Randomized|Parallel Assignment||Treatment||Single||We are looking at 2 products called Acellular Dermal Matrix (ADM) implant to evaluate the outcomes of 2 specific ADM products: SurgiMend PRS and AlloDerm RTU.|t|||
1439146|NCT01781286|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1439147|NCT01781273|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1439148|NCT01781260|||Cohort||Prospective|||||||
1439149|NCT01781247|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439150|NCT01781234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439151|NCT01781221|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439152|NCT01781208||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439153|NCT01781195|||Cohort||Prospective|||||||
1439154|NCT01781182|||Cohort||Prospective|||||||
1439155|NCT01781169|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439156|NCT01781156|||Case Control||Prospective|||||||
1439157|NCT01781143||Single Group Assignment||Health Services Research||None (Open Label)||||||
1439158|NCT01781130|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1439159|NCT01781117||Single Group Assignment||Treatment||None (Open Label)||||||
1439160|NCT01781104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439161|NCT01781091|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1439162|NCT01781078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439163|NCT01781065|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439164|NCT01781052|||Cohort||Prospective|||||||
1439165|NCT01781039|||Cohort||Cross-Sectional|||||||
1439166|NCT01781026||Single Group Assignment||Treatment||None (Open Label)||||||
1439167|NCT01781013|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439168|NCT01781000|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439169|NCT01780987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439170|NCT01780974|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1439171|NCT01780961|||Case-Only||Prospective|||||||
1439172|NCT01780948|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1439173|NCT01780935|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1439174|NCT01780922|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1439175|NCT01780909|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1439176|NCT01780896|||Cohort||Prospective|||||||
1439177|NCT01780883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439178|NCT01780870|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1439179|NCT01780857|||Cohort||Prospective|||||||
1439180|NCT01780844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439181|NCT01780831|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439182|NCT01780818|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439183|NCT01780805|||Cohort||Prospective|||||||
1439184|NCT01780792|Randomized|Parallel Assignment||Treatment||Single|||||t|
1439185|NCT01780779|||Case-Only||Prospective|||||||
1439186|NCT01780766|||Case-Only||Prospective|||||||
1439266|NCT01779713|||Case Control||Prospective|||||||
1439187|NCT01780753||Single Group Assignment||Treatment||None (Open Label)||||||
1439188|NCT01780740|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439189|NCT01780727|Randomized|Parallel Assignment||Treatment||Single||"Arm 1 receives normal saline per the standard of care determined by the anesthesiologist.~Arm 2 receives normal saline or furosemide per the results of the intraoperative echocardiogram."||||t
1439190|NCT01780714|Randomized|Parallel Assignment||||None (Open Label)||||||
1439191|NCT01780701|||Case-Crossover||Prospective|||||||
1439192|NCT01780688|Randomized|Crossover Assignment||||None (Open Label)||||||
1439193|NCT01780675|Randomized|Crossover Assignment||Treatment||Single|||t|||
1439194|NCT01780662||Single Group Assignment||Treatment||None (Open Label)||||||
1439195|NCT01780649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439196|NCT01780636||Single Group Assignment||Treatment||None (Open Label)||||||
1439197|NCT01780623|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1439198|NCT01780610|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439199|NCT01780597|||Case-Control||Prospective|||||||
1439200|NCT01780584|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439201|NCT01780571|Randomized|Parallel Assignment||Prevention||Single|||t|||
1439202|NCT01780558|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439203|NCT01780545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439204|NCT01780532||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439205|NCT01780519|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1439206|NCT01780506|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439207|NCT01780493||Single Group Assignment||Treatment||None (Open Label)||||||
1439208|NCT01780480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439209|NCT01780467|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1439210|NCT01780454||Single Group Assignment||Treatment||None (Open Label)||||||
1439211|NCT01780441|||Cohort||Prospective|||||||
1439212|NCT01780428|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1439213|NCT01780415|||Cohort||Other|||||||
1439214|NCT01780402||Single Group Assignment||Supportive Care||Double|||t|t||
1439215|NCT01780389||Single Group Assignment||Treatment||None (Open Label)||||||
1439216|NCT01780376||Single Group Assignment||Basic Science||None (Open Label)||||||
1439217|NCT01780363|||Case Control||Prospective|||||||
1439218|NCT01780350||Single Group Assignment||Treatment||None (Open Label)||||||
1439219|NCT01780337|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439220|NCT01780324|Randomized|Parallel Assignment||Treatment||Single||||||t
1439221|NCT01780311||||||||||||
1439222|NCT01780298|||Case Control||Cross-Sectional|||||||
1439223|NCT01780285|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1439224|NCT01780272|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1439225|NCT01780259|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439226|NCT01780246||Single Group Assignment||Treatment||None (Open Label)||||||
1439227|NCT01780233|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439228|NCT01780220|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439229|NCT01780207||||||||||||
1439230|NCT01780194||||||||||||
1439231|NCT01780181|||Case Control||Prospective|||||||
1439232|NCT01780168|||Cohort||Prospective|||||||
1439233|NCT01780155|||||Prospective|||||||
1439234|NCT01780142|||||Prospective|||||||
1439235|NCT01780129|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439236|NCT01780116|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1439237|NCT01780103|||Case-Only||Retrospective|||||||
1439238|NCT01780090||Single Group Assignment||Treatment||None (Open Label)||||||
1439239|NCT01780077|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1439240|NCT01780064|Randomized|Parallel Assignment||||None (Open Label)||||||
1439241|NCT01780051|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439242|NCT01780038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439243|NCT01780025|||Case Control||Prospective|||||||
1439244|NCT01780012|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439245|NCT01779999|||Cohort||Prospective|||||||
1439246|NCT01779986|||Cohort||Prospective|||||||
1439247|NCT01779973||Single Group Assignment||Health Services Research||None (Open Label)||||||
1439248|NCT01779960|||||Prospective|||||||
1439249|NCT01779947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439250|NCT01779921|||Cohort||Prospective|||||||
1439251|NCT01779908|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1439252|NCT01779895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439253|NCT01779882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439254|NCT01779869||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439255|NCT01779856||Single Group Assignment||||None (Open Label)||||||
1439256|NCT01779843||Single Group Assignment||Treatment||None (Open Label)||||||
1439257|NCT01779830|Randomized|Crossover Assignment||||Double|||t||t|
1439258|NCT01779817|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1439259|NCT01779804|||Cohort||Prospective|||||||
1439260|NCT01779791||Single Group Assignment||Treatment||None (Open Label)||||||
1439261|NCT01779778|||Cohort||Prospective|||||||
1439262|NCT01779765|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1439263|NCT01779752|||Cohort||Prospective|||||||
1439264|NCT01779739|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1439265|NCT01779726|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439267|NCT01779700|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1439268|NCT01779687|Randomized|Crossover Assignment||||None (Open Label)||||||
1439269|NCT01779674|||Cohort||Prospective|||||||
1439270|NCT01779661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439271|NCT01779648|Randomized|Parallel Assignment||Prevention||Single|||t|||
1439272|NCT01779635|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||Randomized initiation with oXiris versus M150 (conventional filter), with cross-over for subsequent circuits.||||
1439273|NCT01779622||Single Group Assignment||Basic Science||None (Open Label)||||||
1439274|NCT01779609|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1439275|NCT01779596|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1439276|NCT01779583|||Case Control||Prospective|||||||
1439277|NCT01779570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439278|NCT01779557|Randomized|Parallel Assignment||Treatment||Single||||||t
1439279|NCT01779544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439280|NCT01779531|||Case Control||Prospective|||||||
1439281|NCT01779518||||||||||||
1439282|NCT01779505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439283|NCT01779492|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1439284|NCT01779479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439285|NCT01779466|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439286|NCT01779453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439287|NCT01779440|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1439288|NCT01779427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439289|NCT01779414|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1439290|NCT01779401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439291|NCT01779388|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1439292|NCT01779375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439293|NCT01779362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439294|NCT01779349||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439295|NCT01779336||Single Group Assignment||Treatment||None (Open Label)||||||
1439296|NCT01779323|||Cohort||Prospective|||||||
1439297|NCT01779310|||Case-Only||Prospective|||||||
1439298|NCT01779297|||Cohort||Prospective|||||||
1439299|NCT01779284|Randomized|Crossover Assignment||Treatment||Single|||||t|
1439300|NCT01779271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439301|NCT01779258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439302|NCT01779245|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1439303|NCT01779232|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439304|NCT01779219|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1439305|NCT01779206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439306|NCT01779193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439307|NCT01779180|||Cohort||Prospective|||||||
1439308|NCT01779167||Single Group Assignment||Treatment||None (Open Label)||||||
1439309|NCT01779154|||Cohort||Prospective|||||||
1439310|NCT01779141|||Cohort||Prospective|||||||
1439311|NCT01779128||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439312|NCT01779115|||Case-Only|||||||||
1439313|NCT01779102|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1439314|NCT01779089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439315|NCT01779076|Randomized|Parallel Assignment||Prevention||Single|||t|||
1439316|NCT01779063|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1439317|NCT01779050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439318|NCT01779037|||Other||Other|||||||
1439319|NCT01779024|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1439320|NCT01779011|||Cohort||Prospective|||||||
1439321|NCT01778998|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1439322|NCT01778985|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1439323|NCT01778972|Randomized|Parallel Assignment||Treatment||Single||||||t
1439324|NCT01778959|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439325|NCT01778946||Single Group Assignment||Treatment||None (Open Label)||||||
1439326|NCT01778933||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439327|NCT01778920||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439328|NCT01778907|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1439329|NCT01778894|||Case-Control||Prospective|||||||
1439330|NCT01778881|Randomized|Parallel Assignment||Treatment||Single||||||t
1439331|NCT01778868|||Cohort||Cross-Sectional|||||||
1439332|NCT01778855|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1439333|NCT01778842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439334|NCT01778829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439335|NCT01778816|||Cohort||Retrospective|||||||
1439336|NCT01778803||Single Group Assignment||Treatment||None (Open Label)||||||
1439337|NCT01778790||||Treatment||Double||Deep Brain Stimulation|t|||t
1439338|NCT01778777||Single Group Assignment||Treatment||None (Open Label)||||||
1439339|NCT01778764|||Cohort|||||||||
1439340|NCT01778751|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1439341|NCT01778738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439342|NCT01778725|||Cohort||Prospective|||||||
1439343|NCT01778712||Single Group Assignment||Prevention||None (Open Label)||||||
1439344|NCT01778699|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439345|NCT01778686|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1439346|NCT01778673|||Cohort||Prospective|||||||
1439347|NCT01778660|Randomized|Parallel Assignment||Treatment||Single||||||t
1439348|NCT01778647|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1439349|NCT01778634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439350|NCT01778621|Randomized|Parallel Assignment||Treatment||Single||||||t
1439351|NCT01778608|||Cohort||Prospective|||||||
1439352|NCT01778595|||Ecologic or Community||Cross-Sectional|||||||
1439353|NCT01778582|||Other||Prospective|||||||
1439354|NCT01778569|||Case-Only||Prospective|||||||
1439355|NCT01778556|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439356|NCT01778543|||Cohort||Prospective|||||||
1439357|NCT01778530||Single Group Assignment||Treatment||None (Open Label)||||||
1439358|NCT01778517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439359|NCT01778504|||Cohort||Other|||||||
1439360|NCT01778491|||||Prospective|||||||
1439361|NCT01778478|||Cohort||Prospective|||||||
1439362|NCT01778465|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439363|NCT01778452|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1439364|NCT01778439||Single Group Assignment||Treatment||None (Open Label)||||||
1439365|NCT01778426|||Cohort||Prospective|||||||
1439366|NCT01778413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439367|NCT01778400|Randomized|Parallel Assignment||Treatment||Single||||||t
1439368|NCT01778387|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1439369|NCT01778374|Randomized|Parallel Assignment||Screening||Single|||t|||
1439370|NCT01778361|||Cohort||Prospective|||||||
1439371|NCT01778348|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439372|NCT01778335|Randomized|Parallel Assignment||Treatment||Single||||||t
1439373|NCT01778322|||Cohort||Prospective|||||||
1439374|NCT01778309||Single Group Assignment||Basic Science||Double|||t|||t
1439375|NCT01778296||Single Group Assignment||Treatment||Single||||||t
1439376|NCT01778283|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1439377|NCT01778270|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1439378|NCT01778257|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1439379|NCT01778244|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1439380|NCT01778231|Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1439381|NCT01778218|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1439382|NCT01778205|||Cohort||Prospective|||||||
1439383|NCT01778192|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1439384|NCT01778179|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439385|NCT01778166|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1439386|NCT01778153|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439387|NCT01778140|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439388|NCT01778127|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1439389|NCT01778114|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1439390|NCT01778101||Single Group Assignment||Treatment||None (Open Label)||||||
1439391|NCT01778088||Single Group Assignment||Treatment||None (Open Label)||||||
1439392|NCT01778075|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439393|NCT01778062|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439394|NCT01778049|Randomized|Parallel Assignment||Treatment||Double||||||
1439395|NCT01778036|||Cohort||Prospective|||||||
1439396|NCT01778023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439397|NCT01778010|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1439398|NCT01777997||Single Group Assignment||Treatment||None (Open Label)||||||
1439399|NCT01777984|||Case Control||Prospective|||||||
1439400|NCT01777971|||Case-Only||Prospective|||||||
1439401|NCT01777958|||Cohort||Prospective|||||||
1439402|NCT01777945|||Cohort||Prospective|||||||
1439403|NCT01777932|||Cohort||Prospective|||||||
1439404|NCT01777919||Single Group Assignment||Treatment||None (Open Label)||||||
1439405|NCT01777906|||Cohort||Prospective|||||||
1439406|NCT01777893|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439407|NCT01777880||||||||||||
1439408|NCT01777867|||Case-Control||Prospective|||||||
1439409|NCT01777854|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439410|NCT01777841|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439411|NCT01777828|||Cohort||Prospective|||||||
1439412|NCT01777815||Single Group Assignment||Treatment||None (Open Label)||||||
1439413|NCT01777802|||Cohort||Prospective|||||||
1439414|NCT01777789|||Case Control||Cross-Sectional|||||||
1439415|NCT01777776|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439416|NCT01777763|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1439417|NCT01777750|Randomized|Parallel Assignment||Treatment||Single||||||t
1439418|NCT01777737|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439419|NCT01777724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439420|NCT01777711|Randomized|Parallel Assignment||Treatment||||||||
1439421|NCT01777698|||Cohort||Prospective|||||||
1439422|NCT01777685||Single Group Assignment||||None (Open Label)||||||
1439423|NCT01777672|Randomized|Parallel Assignment||Treatment||Single||||||t
1439424|NCT01777659|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439425|NCT01777646||Single Group Assignment||Treatment||None (Open Label)||||||
1439426|NCT01777633||Single Group Assignment||Treatment||None (Open Label)||||||
1439427|NCT01777620|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439428|NCT01777607||Single Group Assignment||Treatment||None (Open Label)||||||
1439429|NCT01777594||Single Group Assignment||Treatment||None (Open Label)||||||
1439430|NCT01777581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439431|NCT01777568|||Cohort||Prospective|||||||
1439432|NCT01777555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439433|NCT01777542|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1439434|NCT01777529|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1439435|NCT01777516||||||||||||
1439436|NCT01777503|Randomized|Parallel Assignment||Treatment||Single||||||t
1439437|NCT01777490|Randomized|Single Group Assignment||Supportive Care||Single|Research Assistant conducting follow-up interviews is blinded as to dyad arm assignment|||||t
1439438|NCT01777477||Single Group Assignment||Treatment||None (Open Label)||||||
1439439|NCT01777464|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1439440|NCT01777451|||Case-Only||Prospective|||||||
1439441|NCT01777438|||Case Control||Prospective|||||||
1439442|NCT01777425|||Case Control||Cross-Sectional|||||||
1439443|NCT01777412||Single Group Assignment||Treatment||None (Open Label)||||||
1439444|NCT01777386|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439445|NCT01777373|||Case Control||Cross-Sectional|||||||
1439446|NCT01777360||Single Group Assignment||Treatment||None (Open Label)||||||
1439447|NCT01777347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439448|NCT01777334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439449|NCT01777321|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439450|NCT01777308|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439451|NCT01777295|Randomized|Parallel Assignment||Prevention||Single|||t|||
1439452|NCT01777282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439453|NCT01777269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439454|NCT01777256|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439455|NCT01777243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439456|NCT01777230|||Cohort||Prospective|||||||
1439457|NCT01777217|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439458|NCT01777204|||Cohort||Prospective|||||||
1439459|NCT01777191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439460|NCT01777178||Single Group Assignment||Treatment||None (Open Label)||||||
1439461|NCT01777165|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439462|NCT01777152|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439463|NCT01777139||Single Group Assignment||Treatment||None (Open Label)||||||
1439464|NCT01777126|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1439465|NCT01777113|Randomized|Single Group Assignment||Treatment||Single||||||t
1439466|NCT01777100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439467|NCT01777087||Single Group Assignment||Basic Science||None (Open Label)||||||
1439468|NCT01777074|||Cohort||Cross-Sectional|||||||
1439469|NCT01777061||||||||||||
1439470|NCT01777048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439471|NCT01777035|Randomized|Parallel Assignment||Treatment||Single||||||t
1439472|NCT01777022|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1439473|NCT01777009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439474|NCT01776996||||||||||||
1439475|NCT01776983|||Cohort|||||||||
1439476|NCT01776970|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1439477|NCT01776957|||Cohort||Retrospective|||||||
1439478|NCT01776944|||Case-Only||Cross-Sectional|||||||
1439479|NCT01776931||Single Group Assignment||Basic Science||None (Open Label)||||||
1439480|NCT01776918|||Case-Only||Cross-Sectional|||||||
1439481|NCT01776905|||Case-Control||Prospective|||||||
1439482|NCT01776892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439483|NCT01776879|||Case Control||Prospective|||||||
1439484|NCT01776866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439485|NCT01776853|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1439486|NCT01776840|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439487|NCT01776827|||Cohort||Retrospective|||||||
1439488|NCT01776814|||||Prospective|||||||
1439489|NCT01776801||Single Group Assignment||Basic Science||None (Open Label)||||||
1439490|NCT01776788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439491|NCT01776775|Randomized|Parallel Assignment||Prevention||Single|||||t|
1439492|NCT01776762|Randomized|Parallel Assignment||Treatment||Single|||||t|
1439493|NCT01776749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439494|NCT01776736||Single Group Assignment||Treatment||None (Open Label)||||||
1439495|NCT01776723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439496|NCT01776710|Randomized|Parallel Assignment||Treatment||Single||||||t
1439497|NCT01776697||||||||||||
1439498|NCT01776684|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1439499|NCT01776671||Single Group Assignment||Treatment||None (Open Label)||||||
1439500|NCT01776658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439501|NCT01776645||Single Group Assignment||Treatment||None (Open Label)||||||
1439502|NCT01776632|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1439503|NCT01776619|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1439504|NCT01776606|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439505|NCT01776593|||Cohort||Retrospective|||||||
1439506|NCT01776580|||Cohort||Prospective|||||||
1439507|NCT01776567|Randomized|Parallel Assignment||||Single||||||t
1439508|NCT01776554|Randomized|Parallel Assignment||Prevention||Single|||t|||
1439509|NCT01776541|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1439510|NCT01776528|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1439511|NCT01776515||||||||||||
1439512|NCT01776502|||Cohort||Prospective|||||||
1439513|NCT01776489|||Cohort||Prospective|||||||
1439514|NCT01776476|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439515|NCT01776463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439516|NCT01776450||||||||||||
1439517|NCT01776437|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1439518|NCT01776424|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439519|NCT01776411||Single Group Assignment||Treatment||None (Open Label)||||||
1439520|NCT01776398|||Case-Control||Prospective|||||||
1439521|NCT01776385|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439522|NCT01776372|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1439523|NCT01776359|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1439524|NCT01776346|||Case Control||Prospective|||||||
1439525|NCT01776333|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1439526|NCT01776320||Single Group Assignment||Treatment||None (Open Label)||||||
1439527|NCT01776307|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439528|NCT01776294|||Ecologic or Community||Cross-Sectional|||||||
1439529|NCT01776281|Randomized|Parallel Assignment||Prevention||Single||||t||
1439530|NCT01776268|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1439531|NCT01776255|Randomized|Crossover Assignment||Prevention||Single||||||t
1439532|NCT01776242|||Cohort||Prospective|||||||
1439533|NCT01776229|Randomized|Crossover Assignment||Treatment||Single||||||t
1439534|NCT01776216|Randomized|Crossover Assignment||Prevention||Single||||||t
1439535|NCT01776203|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439536|NCT01776190||Single Group Assignment||Treatment||None (Open Label)||||||
1439537|NCT01776177|||Cohort||Retrospective|||||||
1439538|NCT01776164|||Cohort||Cross-Sectional|||||||
1439539|NCT01776151|||||Prospective|||||||
1439540|NCT01776138|||Other||Prospective|||||||
1439541|NCT01776125|||Cohort||Retrospective|||||||
1439542|NCT01776112|Randomized|Parallel Assignment||Treatment||Single||||||t
1439543|NCT01776099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439544|NCT01776086||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439545|NCT01776073|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1439546|NCT01776060|||Cohort||Other|||||||
1439547|NCT01776047|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439548|NCT01776034|Randomized|Parallel Assignment||Prevention||Single||||||t
1439549|NCT01776021|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439550|NCT01776008||Single Group Assignment||Treatment||None (Open Label)||||||
1439551|NCT01775995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439552|NCT01775982|||Cohort||Prospective|||||||
1439553|NCT01775969|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439554|NCT01775956|||Case-Only||Retrospective|||||||
1439555|NCT01775943|||Case-Only||Retrospective|||||||
1439556|NCT01775930||Single Group Assignment||Treatment||None (Open Label)||||||
1439557|NCT01775917|||||Prospective|||||||
1439558|NCT01775904|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1439559|NCT01775891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439560|NCT01775878|Randomized|Parallel Assignment||Treatment||Single||||||t
1439561|NCT01775865|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439562|NCT01775852|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439563|NCT01775839|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1439564|NCT01775826|||Cohort||Cross-Sectional|||||||
1439565|NCT01775813|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439566|NCT01775800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439567|NCT01775787|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1439568|NCT01775774||Single Group Assignment||Treatment||None (Open Label)||||||
1439569|NCT01775761|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1439570|NCT01775748|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1439571|NCT01775735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439572|NCT01775722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439573|NCT01775709||Single Group Assignment||Prevention||None (Open Label)||||||
1439574|NCT01775696|||Cohort||Prospective|||||||
1439575|NCT01775683|||Case Control||Retrospective|||||||
1439576|NCT01775670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439577|NCT01775657|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439578|NCT01775644|||Cohort||Prospective|||||||
1439579|NCT01775631|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439580|NCT01775618|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439581|NCT01775605|Randomized|Parallel Assignment||||Single|||t|||
1439582|NCT01775592||Single Group Assignment||Treatment||None (Open Label)||||||
1439583|NCT01775579|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439584|NCT01775566|||Case-Crossover||Prospective|||||||
1439585|NCT01775553||Single Group Assignment||Treatment||None (Open Label)||||||
1439586|NCT01775540|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1439587|NCT01775527||Single Group Assignment||||None (Open Label)||||||
1439588|NCT01775514|||Cohort||Prospective|||||||
1439589|NCT01775501||Single Group Assignment||Treatment||None (Open Label)||||||
1439590|NCT01775488||Single Group Assignment||Treatment||None (Open Label)||||||
1439591|NCT01775475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439592|NCT01775462|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439593|NCT01775449|Randomized|Parallel Assignment||Prevention||Single|||t|||
1439594|NCT01775436|Randomized|Parallel Assignment||Supportive Care||Single|Assessor did not know which study arm the participant was randomized to.|||||t
1439595|NCT01775423||Single Group Assignment||Treatment||None (Open Label)||||||
1439596|NCT01775410||Single Group Assignment||Treatment||None (Open Label)||||||
1439597|NCT01775397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439598|NCT01775384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439599|NCT01775371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439600|NCT01775358|Randomized|Single Group Assignment||Treatment||Single|||t|||
1439601|NCT01775345|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439602|NCT01775332|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1439603|NCT01775319|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1439604|NCT01775306|||Cohort||Prospective|||||||
1439605|NCT01775293||Single Group Assignment||Treatment||None (Open Label)||||||
1439606|NCT01775280||Single Group Assignment||Treatment||None (Open Label)||||||
1439607|NCT01775267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439608|NCT01775254|||Cohort||Prospective|||||||
1439609|NCT01775241|||Cohort||Prospective|||||||
1439610|NCT01775228|Randomized|Parallel Assignment||||Single||||||t
1439611|NCT01775215|||Cohort||Prospective|||||||
1439612|NCT01775202|||Cohort||Retrospective|||||||
1439613|NCT01775189|Randomized|Crossover Assignment||Other||Double|||t||t|
1439614|NCT01775176|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1439615|NCT01775163|||Cohort||Prospective|||||||
1439616|NCT01775150|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439617|NCT01775137|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1439618|NCT01775124|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439619|NCT01775111|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1439620|NCT01775098|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439621|NCT01775085|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1439622|NCT01775072|||Cohort||Prospective|||||||
1439623|NCT01775059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439624|NCT01775046|||Cohort||Prospective|||||||
1439625|NCT01775033|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1439626|NCT01775020||Single Group Assignment||||None (Open Label)||||||
1439627|NCT01775007||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439628|NCT01774994||Single Group Assignment||Basic Science||||||||
1439629|NCT01774981|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439630|NCT01774968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439631|NCT01774955|||Cohort||Prospective|||||||
1439632|NCT01774942||Single Group Assignment||Treatment||None (Open Label)||"Because it is unethical to withhold treatment that is known to be efficacious for severe periodontal infections, there is no control group that would not be treated or that would receive delayed treatment. Enrollment criteria included end-stage (terminal) periodontal infection of all teeth, which is a condition that must be treated immediately due to its severity and potential for very severe consequences."||||
1439633|NCT01774929||Single Group Assignment||Treatment||None (Open Label)||||||
1439634|NCT01774916|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1439635|NCT01774903||Single Group Assignment||Treatment||None (Open Label)||||||
1439636|NCT01774890|||Case-Crossover||Cross-Sectional|||||||
1439637|NCT01774877|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439638|NCT01774864|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439639|NCT01774851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439640|NCT01774838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439641|NCT01774825|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439642|NCT01774812|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1439643|NCT01774799|Randomized|Parallel Assignment||Other||Double|||||t|t
1439644|NCT01774786|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439645|NCT01774773|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439646|NCT01774760||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439647|NCT01774747|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1439648|NCT01774734|Randomized|Parallel Assignment||Treatment||Single||||||t
1439649|NCT01774721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439650|NCT01774708|||Cohort||Prospective|||||||
1439651|NCT01774695||Single Group Assignment||Treatment||None (Open Label)||||||
1439652|NCT01774682||Single Group Assignment||Treatment||None (Open Label)||||||
1439653|NCT01774669|Randomized|Parallel Assignment||Treatment||Single||||||t
1439654|NCT01774656||Single Group Assignment||Treatment||None (Open Label)||||||
1439655|NCT01774643|||Cohort||Prospective|||||||
1439656|NCT01774630||Single Group Assignment||Treatment||None (Open Label)||||||
1439657|NCT01774617||Single Group Assignment||Diagnostic||Single||||||t
1439658|NCT01774604|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439659|NCT01774591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440503|NCT01763593|||Case-Only||Prospective|||||||
1439660|NCT01774578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439661|NCT01774565|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised parallel (phase 1-3) and randomised crossover (phase 4)||||
1439662|NCT01774552|||Case-Only||Prospective|||||||
1439663|NCT01774539|||Cohort||Prospective|||||||
1439664|NCT01774526||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439665|NCT01774513||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439666|NCT01774500|||Cohort||Prospective|||||||
1439667|NCT01774487||Single Group Assignment||Treatment||None (Open Label)||||||
1439668|NCT01774474|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1439669|NCT01774461|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1439670|NCT01774448|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1439671|NCT01774435||Single Group Assignment||Treatment||None (Open Label)||||||
1439672|NCT01774422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439673|NCT01774409||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439674|NCT01774396|Randomized|Parallel Assignment||Treatment||Single|||||t|
1439675|NCT01774383|||Case-Only||Prospective|||||||
1439676|NCT01774370|||Other||Prospective|||||||
1439677|NCT01774357|||Cohort||Prospective|||||||
1439678|NCT01774344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439679|NCT01774331|||Cohort||Other|||||||
1439680|NCT01774318||Single Group Assignment||Supportive Care||None (Open Label)||||||
1439681|NCT01774305|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439682|NCT01774292|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1439683|NCT01774279|||Case-Only||Prospective|||||||
1439684|NCT01774266|||Cohort||Prospective|||||||
1439685|NCT01774253||Single Group Assignment||Treatment||None (Open Label)||||||
1439686|NCT01774240|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439687|NCT01774227|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439688|NCT01774214|Randomized|Crossover Assignment||Treatment||Single||||||t
1439689|NCT01774201|Randomized|Parallel Assignment||Treatment||Single|||||t|
1439690|NCT01774188|||Case Control||Prospective|||||||
1439691|NCT01774175|||Case Control||Prospective|||||||
1439692|NCT01774162|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1439693|NCT01774149|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1439694|NCT01774136|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1439695|NCT01774123|||Case Control||Prospective|||||||
1439696|NCT01774110||Single Group Assignment||Treatment||None (Open Label)||||||
1439697|NCT01774097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439698|NCT01774084|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439699|NCT01774071|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1439700|NCT01774058||Single Group Assignment||Treatment||None (Open Label)||||||
1439701|NCT01774045|Randomized|Parallel Assignment||||Triple|||t|t|t|
1439702|NCT01774032||Single Group Assignment||Prevention||None (Open Label)||||||
1439703|NCT01774019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439704|NCT01774006|||Cohort||Prospective|||||||
1439705|NCT01773993|||Case-Only||Prospective|||||||
1439706|NCT01773980|||Ecologic or Community||Prospective|||||||
1439707|NCT01773967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439708|NCT01773954||Single Group Assignment||Treatment||None (Open Label)||||||
1439709|NCT01773941||||||||||||
1439710|NCT01773928|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1439711|NCT01773915|||Cohort||Prospective|||||||
1439712|NCT01773902|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1439713|NCT01773889||Single Group Assignment||Treatment||None (Open Label)||||||
1439714|NCT01773876|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439715|NCT01773863|||Cohort||Prospective|||||||
1439716|NCT01773850|||Case-Only||Prospective|||||||
1439717|NCT01773837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439718|NCT01773824|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439719|NCT01773811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439720|NCT01773798|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1439721|NCT01773785||Single Group Assignment||Treatment||None (Open Label)||||||
1439722|NCT01773772|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1439723|NCT01773759|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439724|NCT01773746|Randomized|Parallel Assignment||Treatment||Single||||t||
1439725|NCT01773733|||Cohort||Prospective|||||||
1439726|NCT01773720|||Case-Only||Prospective|||||||
1439727|NCT01773707|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1439728|NCT01773694|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1439729|NCT01773681|||Case-Control||Cross-Sectional|||||||
1439730|NCT01773668||Single Group Assignment||Treatment||None (Open Label)||||||
1439731|NCT01773655|||Cohort||Prospective|||||||
1439732|NCT01773642|Randomized|Parallel Assignment||Other||Single||||||t
1439733|NCT01773629|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439734|NCT01773616|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439735|NCT01773603|Randomized|Parallel Assignment||||None (Open Label)||||||
1439736|NCT01773590|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1439737|NCT01773577|||Cohort||Prospective|||||||
1439738|NCT01773564|Randomized|Parallel Assignment||Prevention||Single||||||t
1439739|NCT01773551|||Case-Control||Prospective|||||||
1439740|NCT01773538|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1439741|NCT01773525|||Cohort||Prospective|||||||
1439742|NCT01773512||Single Group Assignment||Treatment||None (Open Label)||||||
1439743|NCT01773499|||Cohort||Prospective|||||||
1439744|NCT01773486|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439745|NCT01773473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439746|NCT01773460|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439747|NCT01773447|Randomized|Parallel Assignment||Supportive Care||Double||||||
1439748|NCT01773434||Single Group Assignment||Treatment||None (Open Label)||||||
1439749|NCT01773421|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439750|NCT01773408|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439751|NCT01773395|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439752|NCT01773382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439753|NCT01773369|Randomized|Factorial Assignment||Treatment||Single||||||t
1439754|NCT01773356|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1439755|NCT01773343|Randomized|Parallel Assignment||Treatment||Single||||||t
1439756|NCT01773330||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439757|NCT01773317|Randomized|Parallel Assignment||Treatment||Single|||||t|
1439758|NCT01773304|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1439759|NCT01773291|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1439760|NCT01773278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439761|NCT01773265||||||||||||
1439762|NCT01773252||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439763|NCT01773239||Single Group Assignment||Treatment||None (Open Label)||||||
1439764|NCT01773226||Single Group Assignment||Treatment||None (Open Label)||||||
1439765|NCT01773213|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1439766|NCT01773200|||Cohort||Prospective|||||||
1439767|NCT01773187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439768|NCT01773174||Single Group Assignment||Treatment||None (Open Label)||||||
1439769|NCT01773161|||Cohort||Prospective|||||||
1439770|NCT01773148||Single Group Assignment||Treatment||None (Open Label)||||||
1439771|NCT01773135|||Case-Only||Cross-Sectional|||||||
1439772|NCT01773122|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1439773|NCT01773109||Single Group Assignment||Treatment||||||||
1439774|NCT01773096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439775|NCT01773083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439776|NCT01773070||Single Group Assignment||Other||None (Open Label)||||||
1439777|NCT01773057|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1439778|NCT01773044|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1439779|NCT01773031|||Case-Only||Prospective|||||||
1439780|NCT01773018||Single Group Assignment||Treatment||None (Open Label)||||||
1439781|NCT01773005|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1439782|NCT01772992|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1439783|NCT01772979||Single Group Assignment||Treatment||None (Open Label)||||||
1439784|NCT01772966|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1439785|NCT01772953||Single Group Assignment||Treatment||None (Open Label)||||||
1439786|NCT01772940|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1439787|NCT01772927|||Cohort||Prospective|||||||
1439788|NCT01772914|||Case-Only||Prospective|||||||
1439789|NCT01772901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439790|NCT01772888|||Cohort||Prospective|||||||
1439791|NCT01772875|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439792|NCT01772862|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1439793|NCT01772849|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1439794|NCT01772836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439795|NCT01772823|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439796|NCT01772810||Single Group Assignment||Treatment||None (Open Label)||||||
1439797|NCT01772797||Single Group Assignment||Treatment||None (Open Label)||||||
1439798|NCT01772784|Randomized|Crossover Assignment||||Double|||t||t|
1439799|NCT01772771|||Case-Only||Prospective|||||||
1439800|NCT01772758|Non-Randomized|Parallel Assignment||Other||Double|||t||t|
1439801|NCT01772745|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439802|NCT01772732||Single Group Assignment||Treatment||None (Open Label)||||||
1439803|NCT01772719||Single Group Assignment||Treatment||None (Open Label)||||||
1439804|NCT01772706|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439805|NCT01772693|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1439806|NCT01772680||Single Group Assignment||||None (Open Label)||||||
1439807|NCT01772667|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439808|NCT01772654|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1439809|NCT01772641|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1439810|NCT01772628|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439811|NCT01772615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439812|NCT01772602|||Other||Other|||||||
1439813|NCT01772589|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1439814|NCT01772576||Single Group Assignment||Treatment||None (Open Label)||||||
1439815|NCT01772563||Single Group Assignment||Treatment||None (Open Label)||||||
1439816|NCT01772550|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1439817|NCT01772537|Randomized|Parallel Assignment||Other||Double|||t|||t
1439818|NCT01772524|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1439819|NCT01772511|||Cohort||Prospective|||||||
1439820|NCT01772498||Single Group Assignment||Treatment||None (Open Label)||||||
1439821|NCT01772485|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1439822|NCT01772472||Parallel Assignment||Treatment||None (Open Label)||||||
1439823|NCT01772459|||Cohort||Prospective|||||||
1439824|NCT01772446|Randomized|Parallel Assignment||||None (Open Label)||||||
1439825|NCT01772433|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439826|NCT01772420|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439827|NCT01772407|||Cohort||Prospective|||||||
1439828|NCT01772394|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439829|NCT01772381||Single Group Assignment||Prevention||None (Open Label)||||||
1439830|NCT01772368|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1439831|NCT01772355||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439832|NCT01772342||Single Group Assignment||Treatment||Single|||t|||
1439833|NCT01772329|Randomized|Parallel Assignment||Prevention||Single|||||t|
1439834|NCT01772316||Single Group Assignment||Treatment||None (Open Label)||||||
1439835|NCT01772303||Single Group Assignment||Treatment||None (Open Label)||||||
1439836|NCT01772290|Randomized|Parallel Assignment||||None (Open Label)||||||
1439837|NCT01772277|||Case Control||Retrospective|||||||
1439838|NCT01772264|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1439839|NCT01772251|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1439840|NCT01772238|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1439841|NCT01772225|||Cohort||Retrospective|||||||
1439842|NCT01772212|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1439843|NCT01772199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439844|NCT01772186|Randomized|Parallel Assignment||Treatment||Single||||||t
1439845|NCT01772173|||Cohort||Retrospective|||||||
1439846|NCT01772160|||Cohort||Prospective|||||||
1439847|NCT01772147|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439848|NCT01772134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439849|NCT01772121|||Cohort||Prospective|||||||
1439850|NCT01772108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439851|NCT01772095|||||Prospective|||||||
1439852|NCT01772082|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439853|NCT01772069|||Case-Control||Prospective|||||||
1439854|NCT01772056|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1439855|NCT01772043|||Cohort||Prospective|||||||
1439856|NCT01772030||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439857|NCT01772017||Single Group Assignment||Treatment||None (Open Label)||||||
1439858|NCT01772004||Single Group Assignment||Treatment||None (Open Label)||||||
1439859|NCT01771991|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439860|NCT01771978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439861|NCT01771965|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1439862|NCT01771952|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1439863|NCT01771939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439864|NCT01771926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439865|NCT01771913|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1439866|NCT01771900|Randomized|Parallel Assignment||Prevention||Single||||||t
1439867|NCT01771887||Single Group Assignment||Prevention||None (Open Label)||||||
1439868|NCT01771874||Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1439869|NCT01771861|||Cohort||Prospective|||||||
1439870|NCT01771848|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1439871|NCT01771835|||Cohort||Prospective|||||||
1439872|NCT01771822|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1439873|NCT01771809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439874|NCT01771796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439875|NCT01771783|Randomized|Crossover Assignment||||None (Open Label)||||||
1439876|NCT01771770|||Cohort||Prospective|||||||
1439877|NCT01771757|||Cohort||Prospective|||||||
1439878|NCT01771744|||Case Control||Retrospective|||||||
1439879|NCT01771731|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1439880|NCT01771718|||Case-Only||Retrospective|||||||
1439881|NCT01771705|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439882|NCT01771692|Randomized|Parallel Assignment||Treatment||Single||||||t
1439883|NCT01771679||Single Group Assignment||Treatment||None (Open Label)||||||
1439884|NCT01771666||Single Group Assignment||Diagnostic||None (Open Label)||||||
1439885|NCT01771653|||Cohort||Prospective|||||||
1439886|NCT01771640||Single Group Assignment||Treatment||None (Open Label)||||||
1439887|NCT01771627|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439888|NCT01771614|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1439889|NCT01771601|||Case-Only||Prospective|||||||
1439890|NCT01771588|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1439891|NCT01771575|Randomized|Parallel Assignment||Treatment||Single||||||t
1439892|NCT01771562|||Cohort||Prospective|||||||
1439893|NCT01771549|||Case-Only||Prospective|||||||
1439894|NCT01771536|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1439895|NCT01771523|Randomized|Parallel Assignment||Screening||Double|||t||t|
1439896|NCT01771497|||Case-Only||Prospective|||||||
1439897|NCT01771484|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1441740|NCT01747460|||||Prospective|||||||
1439898|NCT01771471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439899|NCT01771458|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439900|NCT01771445|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1439901|NCT01771432|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439902|NCT01771419|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439903|NCT01771406|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439904|NCT01771393|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1439905|NCT01771380|||Cohort||Cross-Sectional|||||||
1439906|NCT01771367|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1439907|NCT01771354|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1439908|NCT01771341|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1439909|NCT01771328|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1439910|NCT01771315|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1439911|NCT01771302|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439912|NCT01771289||Single Group Assignment||Treatment||None (Open Label)||||||
1439913|NCT01771276||Single Group Assignment||Treatment||None (Open Label)||||||
1439914|NCT01771263||Single Group Assignment||Treatment||None (Open Label)||||||
1439915|NCT01771250|Randomized|Crossover Assignment||||None (Open Label)||||||
1439916|NCT01771237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439917|NCT01771224|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439918|NCT01771211|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1439919|NCT01771198||Single Group Assignment||Treatment||None (Open Label)||||||
1439920|NCT01771185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439921|NCT01771172|||Cohort||Prospective|||||||
1439922|NCT01771159||Single Group Assignment||Treatment||None (Open Label)||||||
1439923|NCT01771146||Single Group Assignment||Treatment||None (Open Label)||||||
1439924|NCT01771133|Randomized|Parallel Assignment||Treatment||Single|||||t|
1439925|NCT01771120|||||Cross-Sectional|||||||
1439926|NCT01771107||Single Group Assignment||Treatment||None (Open Label)||||||
1439927|NCT01771094|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1439928|NCT01771081|||Cohort|||||||||
1439929|NCT01771068|Randomized|Parallel Assignment||Treatment||Single||||||t
1439930|NCT01771055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439931|NCT01771042|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439932|NCT01771029|||Cohort||Prospective|||||||
1439933|NCT01771016|||Case-Only||Retrospective|||||||
1439934|NCT01771003|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439935|NCT01770990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439936|NCT01770977|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1439937|NCT01770964|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1439938|NCT01770951|||||Retrospective|||||||
1439939|NCT01770938|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1439940|NCT01770925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439941|NCT01770912|||Cohort||Prospective|||||||
1439942|NCT01770899|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1439943|NCT01770886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439944|NCT01770873|Randomized|Parallel Assignment||Prevention||Single||||||t
1439945|NCT01770860|Randomized|Single Group Assignment||||Single||||||t
1439946|NCT01770847|||Case-Control||Cross-Sectional|||||||
1439947|NCT01770834|||Cohort||Prospective|||||||
1439948|NCT01770821|Randomized|Factorial Assignment||Treatment||Single||||||t
1439949|NCT01770808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439950|NCT01770795||Single Group Assignment||Treatment||None (Open Label)||||||
1439951|NCT01770782|Randomized|Parallel Assignment||Treatment||Single||||||t
1439952|NCT01770769|Randomized|Parallel Assignment||Treatment||Single|||||t|
1439953|NCT01770756|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1439954|NCT01770743|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1439955|NCT01770730|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1439956|NCT01770717|||Case-Only||Retrospective|||||||
1439957|NCT01770704|||Cohort|||||||||
1439958|NCT01770691||Single Group Assignment||Treatment||None (Open Label)||||||
1439959|NCT01770678|Randomized|Parallel Assignment||Treatment||Single||||||t
1439960|NCT01770665|||Cohort||Prospective|||||||
1439961|NCT01770652|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1439962|NCT01770639|||Case-Only||Retrospective|||||||
1439963|NCT01770626||Single Group Assignment||Health Services Research||None (Open Label)||||||
1439964|NCT01770613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1439965|NCT01770600|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1439966|NCT01770587||Single Group Assignment||Treatment||None (Open Label)||||||
1439967|NCT01770574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439968|NCT01770561||Single Group Assignment||Basic Science||None (Open Label)||||||
1439969|NCT01770548|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1439970|NCT01770535|||Case-Only||Prospective|||||||
1439971|NCT01770522|||Cohort||Other|||||||
1439972|NCT01770509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439973|NCT01770496|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1439974|NCT01770483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439975|NCT01770470|||Case-Only||Prospective|||||||
1439976|NCT01770457|||Case-Only||Cross-Sectional|||||||
1439977|NCT01770444|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1439978|NCT01770431|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439979|NCT01770418||Single Group Assignment||Treatment||None (Open Label)||||||
1439980|NCT01770405|||Cohort||Prospective|||||||
1439981|NCT01770392|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1439982|NCT01770379|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1439983|NCT01770366|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1439984|NCT01770353|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1439985|NCT01770340|Randomized|Parallel Assignment||Treatment||Single|||t|||
1439986|NCT01770327|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1439987|NCT01770314|Randomized|Parallel Assignment||Prevention||Single|||t|||
1439988|NCT01770301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439989|NCT01770288||Single Group Assignment||Screening||None (Open Label)||||||
1439990|NCT01770275|||Case-Only||Retrospective|||||||
1439991|NCT01770262|||Cohort||Cross-Sectional|||||||
1439992|NCT01770249||Single Group Assignment||||None (Open Label)||||||
1439993|NCT01770236|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1439994|NCT01770223||Single Group Assignment||Treatment||None (Open Label)||||||
1439995|NCT01770210|||||Prospective|||||||
1439996|NCT01770197|||Case Control||Prospective|||||||
1439997|NCT01770184|Randomized|Parallel Assignment||Treatment||Single||||||t
1439998|NCT01770171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1439999|NCT01770158|||Other||Prospective|||||||
1440000|NCT01770145||Single Group Assignment||Treatment||None (Open Label)||||||
1440001|NCT01770132||Single Group Assignment||Treatment||None (Open Label)||||||
1440002|NCT01770119||Single Group Assignment||Prevention||None (Open Label)||||||
1440003|NCT01770106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440004|NCT01770093|||Case-Only||Prospective|||||||
1440005|NCT01770080|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440006|NCT01770067|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1440007|NCT01770054|||Ecologic or Community||Cross-Sectional|||||||
1440008|NCT01770041|||Cohort||Prospective|||||||
1440009|NCT01770028|||Cohort||Prospective|||||||
1440010|NCT01770015||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440011|NCT01770002|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1440012|NCT01769989|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440013|NCT01769976|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1440014|NCT01769963||Single Group Assignment||||None (Open Label)||||||
1440015|NCT01769950||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440016|NCT01769937||Single Group Assignment||Treatment||None (Open Label)||||||
1440017|NCT01769924|||Cohort||Prospective|||||||
1440018|NCT01769911||Single Group Assignment||Treatment||None (Open Label)||||||
1440019|NCT01769898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440020|NCT01769885||Single Group Assignment||Treatment||None (Open Label)||||||
1440021|NCT01769872||Single Group Assignment||Treatment||None (Open Label)||||||
1440022|NCT01769859|||Ecologic or Community||Cross-Sectional|||||||
1440023|NCT01769846|Randomized|Parallel Assignment||Treatment||Single||||||t
1440024|NCT01769833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440025|NCT01769820|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440026|NCT01769807||Single Group Assignment||Treatment||None (Open Label)||||||
1440027|NCT01769794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440028|NCT01769781|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440029|NCT01769768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440030|NCT01769755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440031|NCT01769742|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440032|NCT01769729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440033|NCT01769716||Single Group Assignment||Treatment||None (Open Label)||allogeneic cord blood transplantation for children with developmental delay||||
1440034|NCT01769703||Single Group Assignment||Treatment||None (Open Label)||||||
1440035|NCT01769690||Single Group Assignment||Other||Double|Participant was blinded to the DBS settings during the sleep study but investigator was not; however, the investigator was blinded to the DBS setting during the interpretation of the sleep study.||t||t|
1440036|NCT01769677|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440037|NCT01769664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440038|NCT01769651|||Cohort||Cross-Sectional|||||||
1440039|NCT01769638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440040|NCT01769625|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1440041|NCT01769612|||Cohort||Prospective|||||||
1440042|NCT01769599|||Cohort||Retrospective|||||||
1440043|NCT01769586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440044|NCT01769573|Non-Randomized|Single Group Assignment||Other||Single|||t|||
1440045|NCT01769560|Randomized|Single Group Assignment||Health Services Research||Double|||t||t|
1440046|NCT01769547||Single Group Assignment||Treatment||None (Open Label)||||||
1440047|NCT01769534|||Other||Prospective|||||||
1440048|NCT01769521||Single Group Assignment||||None (Open Label)||||||
1440049|NCT01769508||Single Group Assignment||Treatment||None (Open Label)||||||
1440050|NCT01769495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440051|NCT01769482|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1440052|NCT01769469|||Cohort||Prospective|||||||
1440053|NCT01769456||Single Group Assignment||Prevention||None (Open Label)||||||
1440054|NCT01769443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440055|NCT01769430|||Case-Only||Cross-Sectional|||||||
1440056|NCT01769417|Randomized|Single Group Assignment||||Double|||t||t|
1440057|NCT01769404|Randomized|Crossover Assignment||||None (Open Label)||||||
1440058|NCT01769391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440059|NCT01769378|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440060|NCT01769365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440061|NCT01769352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440062|NCT01769339||Single Group Assignment||Treatment||None (Open Label)||||||
1440063|NCT01769326|Randomized|Parallel Assignment||Treatment||Single||||||t
1440064|NCT01769313|Randomized|Parallel Assignment||Treatment||Single||||t||
1440065|NCT01769300|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1440066|NCT01769287|||Cohort||Prospective|||||||
1440067|NCT01769274|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1440068|NCT01769261|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1440069|NCT01769248|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1440070|NCT01769235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440071|NCT01769222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440072|NCT01769209||Single Group Assignment||Treatment||None (Open Label)||||||
1440073|NCT01769196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440074|NCT01769183||Single Group Assignment||Treatment||None (Open Label)||||||
1440075|NCT01769170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440076|NCT01769157|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440077|NCT01769144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440078|NCT01769131|||Case-Only||Prospective|||||||
1440079|NCT01769118|||||Prospective|||||||
1440080|NCT01769105|Randomized|Crossover Assignment||Treatment||Single|||||t|
1440081|NCT01769092|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1440082|NCT01769079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440083|NCT01769066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440084|NCT01769053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440085|NCT01769040|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1440086|NCT01769027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440087|NCT01769014|||Cohort||Retrospective|||||||
1440088|NCT01769001|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440089|NCT01768988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440090|NCT01768975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440091|NCT01768962|Randomized|Crossover Assignment||||None (Open Label)||||||
1440092|NCT01768949||Single Group Assignment||Screening||None (Open Label)||||||
1440093|NCT01768936|||Cohort||Prospective|||||||
1440094|NCT01768923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440095|NCT01768910|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1440096|NCT01768897||Single Group Assignment||Treatment||None (Open Label)||||||
1440097|NCT01768884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440098|NCT01768871|||Cohort||Prospective|||||||
1440099|NCT01768858|||Cohort||Prospective|||||||
1440100|NCT01768845||Single Group Assignment||Treatment||None (Open Label)||||||
1440101|NCT01768832|Randomized|Parallel Assignment||Treatment||Single||||||t
1440102|NCT01768819|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1440103|NCT01768806|Randomized|Parallel Assignment||Treatment||Single||||||t
1440104|NCT01768793|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1440105|NCT01768780||Single Group Assignment||||None (Open Label)||||||
1440106|NCT01768767|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1440107|NCT01768754|||Cohort||Prospective|||||||
1440108|NCT01768741|Randomized|Single Group Assignment||Treatment||Single||||||t
1440109|NCT01768728|Randomized|Parallel Assignment||Treatment||Single||||||t
1440110|NCT01768715|||Case Control||Prospective|||||||
1440111|NCT01768702|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440112|NCT01768689|Non-Randomized|Parallel Assignment||Treatment||Double|The adherence assessed per study protocol was masked to participants and care providers during the preintervention and post intervention phases. At the time of intervention participants were notified once of their adherence as part of the feedback-based intervention||t|t||
1440113|NCT01768676|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440114|NCT01768663|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440115|NCT01768650|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440116|NCT01768637|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440117|NCT01768624|||Case-Only||Retrospective|||||||
1440118|NCT01768611|||Case-Only||Cross-Sectional|||||||
1440119|NCT01768598|||Cohort||Prospective|||||||
1440120|NCT01768585|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1440121|NCT01768572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440122|NCT01768559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440123|NCT01768546|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440124|NCT01768533|||Family-Based||Cross-Sectional|||||||
1440125|NCT01768520|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440126|NCT01768507|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1440127|NCT01768494|||Cohort||Prospective|||||||
1440128|NCT01768481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440129|NCT01768468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440130|NCT01768455|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440131|NCT01768442|||Case-Control||Prospective|||||||
1440132|NCT01768429|Randomized|Parallel Assignment||||None (Open Label)||||||
1440133|NCT01768416|||Case-Only||Prospective|||||||
1440134|NCT01768403|||Cohort||Prospective|||||||
1440135|NCT01768390|Randomized|Parallel Assignment||Prevention||Single||||t||
1440136|NCT01768377|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1440137|NCT01768364|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440138|NCT01768351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440139|NCT01768338||Single Group Assignment||Treatment||None (Open Label)||||||
1440140|NCT01768325|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1440141|NCT01768312|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440142|NCT01768299|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1440143|NCT01768286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440144|NCT01768273||Single Group Assignment||Treatment||None (Open Label)||||||
1440145|NCT01768260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440146|NCT01768247||Single Group Assignment||Treatment||None (Open Label)||||||
1440147|NCT01768234|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1440148|NCT01768221||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440149|NCT01768208||Single Group Assignment||||None (Open Label)||||||
1440150|NCT01768195||Single Group Assignment||Treatment||None (Open Label)||||||
1440151|NCT01768182|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1440152|NCT01768169|||Cohort||Prospective|||||||
1440153|NCT01768156||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440154|NCT01768143|||Cohort||Prospective|||||||
1440155|NCT01768130|||Cohort||Prospective|||||||
1440156|NCT01768117||Single Group Assignment||Prevention||None (Open Label)||||||
1440157|NCT01768104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440158|NCT01768091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440159|NCT01768078|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440160|NCT01768065|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1440161|NCT01768052|||Case-Only||Prospective|||||||
1440162|NCT01768039|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440163|NCT01768026|||Cohort||Prospective|||||||
1440164|NCT01768013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440165|NCT01768000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440166|NCT01767987|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1440167|NCT01767974|||Cohort||Prospective|||||||
1440168|NCT01767961||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440169|NCT01767948|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440170|NCT01767935||Single Group Assignment||Treatment||None (Open Label)||||||
1440171|NCT01767922|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1440172|NCT01767909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440173|NCT01767896|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1440174|NCT01767883|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1440175|NCT01767870|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1440176|NCT01767857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440177|NCT01767844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440178|NCT01767831|||Case-Crossover||Prospective|||||||
1440179|NCT01767818|||Cohort||Prospective|||||||
1440180|NCT01767805|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1440181|NCT01767792||Single Group Assignment||Treatment||None (Open Label)||||||
1440182|NCT01767779|||Cohort||Prospective|||||||
1440183|NCT01767766||Single Group Assignment||Treatment||None (Open Label)||||||
1440184|NCT01767753||Single Group Assignment||||None (Open Label)||||||
1440185|NCT01767740|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440186|NCT01767727||Single Group Assignment||Treatment||None (Open Label)||||||
1440187|NCT01767714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440188|NCT01767701||Single Group Assignment||Treatment||None (Open Label)||||||
1440189|NCT01767688|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440190|NCT01767675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440191|NCT01767662|Randomized|Parallel Assignment||Treatment||Single||||||t
1440192|NCT01767649|||Cohort||Prospective|||||||
1440193|NCT01767636||Single Group Assignment||Treatment||None (Open Label)||||||
1440194|NCT01767623|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440195|NCT01767610|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1440196|NCT01767597|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1440197|NCT01767584|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1440198|NCT01767571|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1440199|NCT01767558||Single Group Assignment||Treatment||None (Open Label)||||||
1440200|NCT01767545|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440201|NCT01767532|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1440202|NCT01767519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440203|NCT01767506|Randomized|Parallel Assignment||Treatment||Single||||||t
1440204|NCT01767493||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440205|NCT01767480|Randomized|Parallel Assignment||Treatment||Single||||||t
1440206|NCT01767467|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1440207|NCT01767454|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440208|NCT01767441|||Cohort||Prospective|||||||
1440209|NCT01767428|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440210|NCT01767415||Single Group Assignment||Treatment||None (Open Label)||||||
1440211|NCT01767402|Randomized|Parallel Assignment||Prevention||Single|||t|||
1440212|NCT01767389|||Cohort||Retrospective|||||||
1440213|NCT01767376|Randomized|Parallel Assignment||Prevention||Single|||t|||
1440214|NCT01767363|||Cohort||Retrospective|||||||
1440215|NCT01767350|||Cohort||Retrospective|||||||
1440216|NCT01767337|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1440217|NCT01767324|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1440218|NCT01767311|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440219|NCT01767298|Randomized|Crossover Assignment||||None (Open Label)||||||
1440220|NCT01767285|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440221|NCT01767272|Randomized|Crossover Assignment||||None (Open Label)||||||
1440222|NCT01767259|Randomized|Crossover Assignment||||None (Open Label)||||||
1440223|NCT01767246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440224|NCT01767233|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440225|NCT01767220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440226|NCT01767207|||Case-Only||Prospective|||||||
1440227|NCT01767194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440228|NCT01767181|Randomized|Parallel Assignment||Treatment||Single||||||t
1440229|NCT01767168|||Cohort||Prospective|||||||
1440230|NCT01767155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440231|NCT01767142||Single Group Assignment||Other||None (Open Label)||||||
1440232|NCT01767129|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1440233|NCT01767116|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440234|NCT01767103|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1440235|NCT01767090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440236|NCT01767077|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1440237|NCT01767064|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1440238|NCT01767051|||Case Control||Prospective|||||||
1440239|NCT01767038||Single Group Assignment||||None (Open Label)||||||
1440240|NCT01767025|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1440241|NCT01767012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440242|NCT01766999|||Case-Only||Prospective|||||||
1440243|NCT01766986|||Cohort||Retrospective|||||||
1440244|NCT01766973|||Case-Control||Prospective|||||||
1440245|NCT01766960|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1440246|NCT01766947||Single Group Assignment||||None (Open Label)||||||
1440247|NCT01766934|||Cohort||Prospective|||||||
1440248|NCT01766921|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1440249|NCT01766908|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1440250|NCT01766895|||Cohort||Prospective|||||||
1440251|NCT01766882|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1440252|NCT01766869|||Case-Only||Prospective|||||||
1440253|NCT01766856|||Cohort||Prospective|||||||
1440254|NCT01766843|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1440255|NCT01766830||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440256|NCT01766817|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440257|NCT01766804|Randomized|Parallel Assignment||Treatment||Quadruple|Randomization was computer based in blocks of eight to ensure an equal number of participants in each randomization group. The randomization scheme was generated by using the web site Randomization.com ⟨http://www.randomization.com⟩. The randomization center was located at the same hospital as one of the recruitment sites (OUH). The randomization list was sent directly and exclusively to the research secretariat in charge of treatment allocation. Bovine colostrum or the placebo supplement was provided in identical foil sachets differing only in randomization code. Participants, their treating physicians, and any individual involved in the coordination and implementation of the trial were masked to treatment allocation.||t|t|t|t
1440258|NCT01766791|Randomized|Factorial Assignment||Treatment||Single|||||t|
1440259|NCT01766778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440260|NCT01766765|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440261|NCT01766752|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440262|NCT01766739||Single Group Assignment||Treatment||None (Open Label)||||||
1440263|NCT01766726|||Cohort||Prospective|||||||
1440264|NCT01766713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440265|NCT01766700|Randomized|Parallel Assignment||||None (Open Label)||||||
1440266|NCT01766687|Randomized|Parallel Assignment||Treatment||Single|Research staff and participants were aware of the randomized group assignment; however, outcome assessors (technicians performing the laboratory measurements for the primary and secondary outcomes) are blinded to the random allocation, and the trial statistician will be blinded to patient allocation for the primary analysis|||||t
1440267|NCT01766674|Randomized|Crossover Assignment||Treatment||Single||||||t
1440268|NCT01766661|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440269|NCT01766648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440270|NCT01766622|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1440271|NCT01766609|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1440272|NCT01766596||Single Group Assignment||||None (Open Label)||||||
1440273|NCT01766583||Single Group Assignment||Treatment||None (Open Label)||||||
1440274|NCT01766570|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1440275|NCT01766557|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440276|NCT01766544|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1440277|NCT01766531||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440278|NCT01766518||Single Group Assignment||Treatment||None (Open Label)||||||
1440279|NCT01766505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440280|NCT01766492|||Cohort||Prospective|||||||
1440281|NCT01766479||Single Group Assignment||Screening||Single||||t||
1440282|NCT01766466|Randomized|Factorial Assignment||||None (Open Label)||||||
1440283|NCT01766453|Randomized|Parallel Assignment||Prevention||Single||||||t
1440284|NCT01766440||Single Group Assignment||Treatment||None (Open Label)||||||
1440285|NCT01766427|||Case Control||Cross-Sectional|||||||
1440286|NCT01766414|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1440287|NCT01766401|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440288|NCT01766388|||Case-Only||Prospective|||||||
1440289|NCT01766375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440290|NCT01766362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440291|NCT01766349|||Cohort||Prospective|||||||
1440292|NCT01766336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440293|NCT01766323|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1440294|NCT01766310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440295|NCT01766297||Single Group Assignment||Treatment||None (Open Label)||||||
1440296|NCT01766284||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440297|NCT01766271|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1440298|NCT01766258|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1440299|NCT01766245|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1440300|NCT01766232|||||Prospective|||||||
1440301|NCT01766219||Single Group Assignment||Treatment||None (Open Label)||||||
1440302|NCT01766206||Single Group Assignment||Prevention||None (Open Label)||||||
1440303|NCT01766193|||Cohort||Retrospective|||||||
1440304|NCT01766180|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1440305|NCT01766167||Single Group Assignment||Basic Science||None (Open Label)||||||
1440306|NCT01766154|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440307|NCT01766141|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1440308|NCT01766128|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1440309|NCT01766115||Single Group Assignment||Prevention||None (Open Label)||||||
1440310|NCT01766102|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1440311|NCT01766089|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1440312|NCT01766076|Randomized|Crossover Assignment||Treatment||Double||||t|t|
1440313|NCT01766063|||Cohort||Prospective|||||||
1440314|NCT01766050||Single Group Assignment||Basic Science||None (Open Label)||||||
1440315|NCT01766037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440316|NCT01766024|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1440317|NCT01766011||Single Group Assignment||||None (Open Label)||||||
1440318|NCT01765998|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1440319|NCT01765985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440320|NCT01765972|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1440321|NCT01765959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440322|NCT01765946|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440323|NCT01765933||Single Group Assignment||||None (Open Label)||||||
1440324|NCT01765920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440325|NCT01765907||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440326|NCT01765894|||Case Control||Cross-Sectional|||||||
1440327|NCT01765881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440328|NCT01765868||Single Group Assignment||Basic Science||None (Open Label)||||||
1440329|NCT01765855||Single Group Assignment||Basic Science||None (Open Label)||||||
1440330|NCT01765842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440331|NCT01765829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440332|NCT01765816|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1440333|NCT01765803||Single Group Assignment||||None (Open Label)||||||
1440334|NCT01765790|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440335|NCT01765777|Randomized|Parallel Assignment||Treatment||Single|||||t|
1440336|NCT01765764|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440337|NCT01765751|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1440338|NCT01765738|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1440339|NCT01765725|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1440340|NCT01765712|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440341|NCT01765699|||||Retrospective|||||||
1440342|NCT01765686|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440343|NCT01765673|||Cohort||Prospective|||||||
1440344|NCT01765660|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440345|NCT01765647||Single Group Assignment||||None (Open Label)||||||
1440346|NCT01765634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440347|NCT01765621|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1440348|NCT01765608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440349|NCT01765595|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1440350|NCT01765582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440351|NCT01765569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440352|NCT01765556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440353|NCT01765543||Single Group Assignment||Treatment||None (Open Label)||||||
1440354|NCT01765530|Randomized|Parallel Assignment||Prevention||Single||||||t
1440355|NCT01765517|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1440356|NCT01765504|||Cohort||Prospective|||||||
1440357|NCT01765491|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1440358|NCT01765478|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440359|NCT01765465|Randomized|Parallel Assignment||Prevention||Single|||t|||
1440360|NCT01765452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440361|NCT01765439|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1440362|NCT01765426|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1440363|NCT01765413|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1440364|NCT01765400|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440365|NCT01765387|Non-Randomized|Crossover Assignment||||Single|||t|||
1440366|NCT01765374||Single Group Assignment||Treatment||None (Open Label)||||||
1440367|NCT01765361|||Other||Prospective|||||||
1440368|NCT01765348|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440369|NCT01765335||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440370|NCT01765322|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440371|NCT01765309||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1440372|NCT01765296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440373|NCT01765283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440374|NCT01765270|Randomized|Parallel Assignment||||Triple|||t|t|t|
1440375|NCT01765257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440376|NCT01765244|Randomized|Parallel Assignment||Treatment||None (Open Label)||Bioengineered anterior human corneal substitute Amniotic membrane corneal graft||||
1440377|NCT01765231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440378|NCT01765218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440379|NCT01765205|||Case Control||Prospective|||||||
1440380|NCT01765192|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1440381|NCT01765179||Single Group Assignment||Treatment||None (Open Label)||||||
1440382|NCT01765166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440383|NCT01765153|Randomized|Crossover Assignment||Treatment||Single||||||t
1440384|NCT01765140||||||||||||
1440385|NCT01765127|||Cohort||Retrospective|||||||
1440386|NCT01765114||Single Group Assignment||Treatment||None (Open Label)||||||
1440387|NCT01765101|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440388|NCT01765088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440389|NCT01765075|||Case-Only||Cross-Sectional|||||||
1440390|NCT01765062|||Cohort||Prospective|||||||
1440391|NCT01765049|||Cohort||Prospective|||||||
1440392|NCT01765036||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440393|NCT01765023|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1440394|NCT01765010|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1440395|NCT01764997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440396|NCT01764984|Randomized|Parallel Assignment||Treatment||Single||||||t
1440397|NCT01764971|||Case-Only||Prospective|||||||
1440398|NCT01764958|||Cohort||Prospective|||||||
1440399|NCT01764945|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440400|NCT01764932||Single Group Assignment||Treatment||None (Open Label)||||||
1440401|NCT01764919||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440402|NCT01764906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440403|NCT01764893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440404|NCT01764880||Single Group Assignment||Treatment||None (Open Label)||||||
1440405|NCT01764867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440406|NCT01764854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440407|NCT01764841|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440408|NCT01764828||Single Group Assignment||Other||None (Open Label)||||||
1440409|NCT01764815||Single Group Assignment||Basic Science||None (Open Label)||||||
1440410|NCT01764802|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440411|NCT01764789||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440412|NCT01764776||Single Group Assignment||Treatment||None (Open Label)||||||
1440413|NCT01764763|||Cohort||Retrospective|||||||
1440414|NCT01764750|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1440415|NCT01764737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440416|NCT01764724|||Ecologic or Community||Cross-Sectional|||||||
1440417|NCT01764711||Single Group Assignment||Other||None (Open Label)||||||
1440418|NCT01764698|Randomized|Parallel Assignment||Treatment||Single||||||t
1440419|NCT01764685|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440420|NCT01764672|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1440421|NCT01764659|||Case-Only||Prospective|||||||
1440422|NCT01764646|Randomized|Parallel Assignment||Treatment||None (Open Label)||5 x 7.25 Gy delivery in 2 alternative time Schedule: over 9 days every other treatment or over 28 days once a week||||
1440423|NCT01764633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440424|NCT01764620|Randomized|Crossover Assignment||Prevention||Single|||t|||
1440425|NCT01764607||Single Group Assignment||Treatment||None (Open Label)||||||
1440426|NCT01764594|Randomized|Parallel Assignment||||Single|||||t|
1440427|NCT01764581|Randomized|Parallel Assignment||Treatment||Single||||||t
1440428|NCT01764568|Randomized|Factorial Assignment||Treatment||Single||||||t
1440429|NCT01764555|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1440430|NCT01764542||Single Group Assignment||Prevention||None (Open Label)||||||
1440431|NCT01764529|||Cohort||Other|||||||
1440432|NCT01764516|||Case Control||Cross-Sectional|||||||
1440433|NCT01764503|||||Prospective|||||||
1440434|NCT01764490|||Cohort||Retrospective|||||||
1440435|NCT01764477||Single Group Assignment||Treatment||None (Open Label)||||||
1440436|NCT01764464|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1440437|NCT01764451|Randomized|Parallel Assignment||Treatment||Single||||||t
1440438|NCT01764438|||Cohort||Prospective|||||||
1440439|NCT01764425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440440|NCT01764412|||Cohort||Prospective|||||||
1440441|NCT01764399|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440442|NCT01764386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440443|NCT01764373||Single Group Assignment||||None (Open Label)||||||
1440444|NCT01764360||Single Group Assignment||Treatment||None (Open Label)||||||
1440445|NCT01764347||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440446|NCT01764334|Randomized|Parallel Assignment||Diagnostic||Quadruple|Blinding of FFR result|Diagnostic intervention using fractional flow reserve|t|t|t|t
1440447|NCT01764321|||Cohort||Prospective|||||||
1440448|NCT01764308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440449|NCT01764295|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1440450|NCT01764282|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440451|NCT01764269|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1440452|NCT01764256|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1440453|NCT01764243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440454|NCT01764230|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440455|NCT01764217|||Cohort||Prospective|||||||
1440456|NCT01764204|||Cohort||Prospective|||||||
1440457|NCT01764191||||||||||||
1440458|NCT01764178|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1440459|NCT01764165|Randomized|Parallel Assignment||Treatment||Single||||||t
1440460|NCT01764152||Single Group Assignment||Prevention||None (Open Label)||||||
1440461|NCT01764139|||Cohort||Prospective|||||||
1440462|NCT01764126|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1440463|NCT01764113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440464|NCT01764100||Single Group Assignment||Treatment||None (Open Label)||||||
1440465|NCT01764087||Single Group Assignment||Treatment||None (Open Label)||||||
1440466|NCT01764074||Single Group Assignment||Treatment||None (Open Label)||||||
1440467|NCT01764061|||||Prospective|||||||
1440468|NCT01764048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440469|NCT01764035|Randomized|Parallel Assignment||Treatment||Single||||||t
1440470|NCT01764022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440471|NCT01764009||Single Group Assignment||Treatment||None (Open Label)||||||
1440472|NCT01763996|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1440473|NCT01763983|Randomized|Factorial Assignment||Treatment||Single||||||t
1440474|NCT01763970||Single Group Assignment||Treatment||None (Open Label)||||||
1440475|NCT01763957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440476|NCT01763944|Randomized|Parallel Assignment||Treatment||Single||||||t
1440477|NCT01763931|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1440478|NCT01763918|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440479|NCT01763905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440480|NCT01763892|||Cohort||Prospective|||||||
1440481|NCT01763879|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1440482|NCT01763866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440483|NCT01763853|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440484|NCT01763840||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440485|NCT01763827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440486|NCT01763814|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1440487|NCT01763801|Randomized|Parallel Assignment||Prevention||Single|||t|||
1440488|NCT01763788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440489|NCT01763775|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1440490|NCT01763762|Randomized|Parallel Assignment||Treatment||Single||||||t
1440491|NCT01763749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440492|NCT01763736||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440493|NCT01763723||Single Group Assignment||Basic Science||None (Open Label)||||||
1440494|NCT01763710|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1440495|NCT01763697|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1440496|NCT01763684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440497|NCT01763671|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440498|NCT01763658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440499|NCT01763645|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440500|NCT01763632|||Cohort||Prospective|||||||
1440501|NCT01763619||Single Group Assignment||Treatment||None (Open Label)||||||
1440502|NCT01763606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440504|NCT01763580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440505|NCT01763567|||||Prospective|||||||
1440506|NCT01763554|||Cohort||Retrospective|||||||
1440507|NCT01763541|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1440508|NCT01763528|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1440509|NCT01763515||Single Group Assignment||Treatment||None (Open Label)||||||
1440510|NCT01763502|Randomized|Parallel Assignment||||None (Open Label)||||||
1440511|NCT01763489|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1440512|NCT01763476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440513|NCT01763463|||Cohort||Prospective|||||||
1440514|NCT01763450||Single Group Assignment||Treatment||None (Open Label)||||||
1440515|NCT01763437|Randomized|Parallel Assignment||Treatment||Single||||||t
1440516|NCT01763424|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440517|NCT01763411|||Cohort||Retrospective|||||||
1440518|NCT01763398|||Cohort||Prospective|||||||
1440519|NCT01763385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440520|NCT01763372|||Case Control||Prospective|||||||
1440521|NCT01763359|||Cohort||Prospective|||||||
1440522|NCT01763346|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1440523|NCT01763333|Randomized|Single Group Assignment||Treatment||Single||||||
1440524|NCT01763320|Randomized|Parallel Assignment||Treatment||Single||||||t
1440525|NCT01763307|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1440526|NCT01763294|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440527|NCT01763281|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1440528|NCT01763268||Single Group Assignment||Prevention||None (Open Label)||||||
1440529|NCT01763255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440530|NCT01763242|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440531|NCT01763229||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440532|NCT01763216|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1440533|NCT01763203|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1440534|NCT01763190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440535|NCT01763177|Randomized|Parallel Assignment||Prevention||Single||||||t
1440536|NCT01763164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440537|NCT01763151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440538|NCT01763138|Randomized|Factorial Assignment||Prevention||Single|||t|||
1440539|NCT01763125|||Case-Control||Other|||||||
1440540|NCT01763112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440541|NCT01763099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440542|NCT01763086||Single Group Assignment||Treatment||None (Open Label)||||||
1440543|NCT01763073|||Other||Cross-Sectional|||||||
1440544|NCT01763060|||Case-Only||Cross-Sectional|||||||
1440545|NCT01763047|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440546|NCT01763034|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1440547|NCT01763021||Single Group Assignment||Treatment||None (Open Label)||||||
1440548|NCT01763008|||Case-Only||Prospective|||||||
1440549|NCT01762995|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440550|NCT01762982|Randomized|Single Group Assignment||Treatment||Single|||||t|
1440551|NCT01762969||Single Group Assignment||Treatment||None (Open Label)||||||
1440552|NCT01762956|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440553|NCT01762943|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1440554|NCT01762930|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1440555|NCT01762917|||Cohort||Prospective|||||||
1440556|NCT01762904||Single Group Assignment||Prevention||Single||||||t
1440557|NCT01762891||Single Group Assignment||Treatment||Triple|||t|t|t|
1440558|NCT01762878|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440559|NCT01762865|||Case-Only||Prospective|||||||
1440560|NCT01762852|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440561|NCT01762839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440562|NCT01762826|||Case Control||Prospective|||||||
1440563|NCT01762813|||Cohort||Prospective|||||||
1440564|NCT01762800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440565|NCT01762787|Randomized|Crossover Assignment||Other||Single|||t|||
1440566|NCT01762774|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1440567|NCT01762761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440568|NCT01762748||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440569|NCT01762735|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1440570|NCT01762722||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440571|NCT01762709|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1440572|NCT01762696|Randomized|Parallel Assignment||Treatment||Single|||||t|
1440573|NCT01762683|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1440574|NCT01762670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440575|NCT01762657|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440576|NCT01762644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440577|NCT01762631|||Other||Prospective|||||||
1440578|NCT01762618|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440579|NCT01762605|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440580|NCT01762592||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440581|NCT01762579|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1440582|NCT01762566|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1440583|NCT01762553|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440584|NCT01762540|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1440585|NCT01762527||Single Group Assignment||Treatment||None (Open Label)||||||
1440586|NCT01762514|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440587|NCT01762501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440588|NCT01762488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440589|NCT01762475|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1440590|NCT01762462|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440591|NCT01762449|||Cohort|||||||||
1440592|NCT01762436|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440593|NCT01762423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440594|NCT01762410||Single Group Assignment||Treatment||None (Open Label)||||||
1440595|NCT01762397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440596|NCT01762384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440597|NCT01762371||Single Group Assignment||Basic Science||None (Open Label)||||||
1440598|NCT01762358|Randomized|Parallel Assignment||Treatment||Single|||||t|
1440599|NCT01762345||Single Group Assignment||Treatment||None (Open Label)||||||
1440600|NCT01762332|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1440601|NCT01762319|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1440602|NCT01762306|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1440603|NCT01762293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440604|NCT01762280||Single Group Assignment||Treatment||None (Open Label)||||||
1440605|NCT01762267|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1440606|NCT01762254|Randomized|Parallel Assignment||Treatment||Single||||||t
1440607|NCT01762241|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1440608|NCT01762228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440609|NCT01762215||Single Group Assignment||||None (Open Label)||||||
1440610|NCT01762202||Single Group Assignment||Treatment||None (Open Label)||||||
1440611|NCT01762189|||Cohort||Prospective|||||||
1440612|NCT01762176|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440613|NCT01762163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440614|NCT01762150||Single Group Assignment||Treatment||None (Open Label)||||||
1440615|NCT01762137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440616|NCT01762124||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1440617|NCT01762111|||Cohort||Prospective|||||||
1440618|NCT01762098|||Case-Only||Prospective|||||||
1440619|NCT01762085|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1440620|NCT01762072|Randomized|Parallel Assignment||Prevention||Single|||t|||
1440621|NCT01762059|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440622|NCT01762046||Single Group Assignment||Basic Science||None (Open Label)||||||
1440623|NCT01762033||Single Group Assignment||Treatment||None (Open Label)||||||
1440624|NCT01762020|Randomized|Factorial Assignment||Treatment||Single|within patient randomization. One half of breast received Cavilon and other receives standard of care treatment. Care provider is blinded as to portion receiving treatment.|within patient randomization of Cavilon skin spray||t||
1440625|NCT01762007|||Case Control||Prospective|||||||
1440626|NCT01761994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440627|NCT01761981|||Cohort||Prospective|||||||
1440628|NCT01761968||Single Group Assignment||Treatment||None (Open Label)||||||
1440629|NCT01761955|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1440630|NCT01761942|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440631|NCT01761929||Single Group Assignment||Treatment||None (Open Label)||||||
1440632|NCT01761916|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1440633|NCT01761903|||Case-Control||Prospective|||||||
1440634|NCT01761890|||Case-Only||Prospective|||||||
1440635|NCT01761877|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440636|NCT01761864|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1440637|NCT01761851|||Case-Only||Prospective|||||||
1440638|NCT01761838|Non-Randomized|Parallel Assignment||Treatment||Double||||t||t
1440639|NCT01761825|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1440640|NCT01761812||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440641|NCT01761799|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1440642|NCT01761786|Randomized|Parallel Assignment||Screening||Single||||||t
1440643|NCT01761773|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440644|NCT01761760|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1440645|NCT01761747||Single Group Assignment||Treatment||None (Open Label)||||||
1440646|NCT01761734|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1440647|NCT01761721|||Cohort||Prospective|||||||
1440648|NCT01761708|||Cohort||Prospective|||||||
1440649|NCT01761695|||Cohort||Prospective|||||||
1440650|NCT01761682|||Cohort||Prospective|||||||
1440651|NCT01761669|||||Prospective|||||||
1440652|NCT01761656|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440653|NCT01761643|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1440654|NCT01761630|||Cohort||Prospective|||||||
1440655|NCT01761617|Randomized|Parallel Assignment||Treatment||Single||||||t
1440656|NCT01761604||Single Group Assignment||Treatment||None (Open Label)||||||
1440657|NCT01761591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440658|NCT01761578||Single Group Assignment||Treatment||None (Open Label)||||||
1440659|NCT01761565|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1440660|NCT01761552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440661|NCT01761539|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440662|NCT01761526|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1440663|NCT01761513|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440664|NCT01761500||Single Group Assignment||Treatment||None (Open Label)||||||
1440665|NCT01761487||Single Group Assignment||||None (Open Label)||||||
1440666|NCT01761474|||Cohort||Prospective|||||||
1440667|NCT01761461|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1440668|NCT01761448||Single Group Assignment||Basic Science||None (Open Label)||||||
1440669|NCT01761435|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440670|NCT01761422|||Cohort||Prospective|||||||
1440671|NCT01761409|||Case-Only||Retrospective|||||||
1440672|NCT01761396|Randomized|Parallel Assignment||Treatment||Single||||||t
1440673|NCT01761383||Single Group Assignment||Treatment||None (Open Label)||||||
1440674|NCT01761370|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440675|NCT01761357||Single Group Assignment||Health Services Research||None (Open Label)||||||
1440676|NCT01761344||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440677|NCT01761331|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1440678|NCT01761318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440679|NCT01761305|Randomized|Parallel Assignment||Treatment||Single||||||t
1440680|NCT01761292||Single Group Assignment||Treatment||None (Open Label)||||||
1440681|NCT01761279|||Cohort||Prospective|||||||
1440682|NCT01761266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440683|NCT01761253|||Other||Retrospective|||||||
1440684|NCT01761240||Single Group Assignment||Treatment||None (Open Label)||||||
1440685|NCT01761227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440686|NCT01761214|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440687|NCT01761201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440688|NCT01761188|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440689|NCT01761175|Randomized|Parallel Assignment||Treatment||Single||||||t
1440690|NCT01761162|||Case-Only||Prospective|||||||
1440691|NCT01761149|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1440692|NCT01761136|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440693|NCT01761123||Single Group Assignment||Prevention||None (Open Label)||||||
1440694|NCT01761110|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440695|NCT01761097|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1440696|NCT01761084|Randomized|Parallel Assignment||Prevention||Single||||||t
1440697|NCT01761071|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1440698|NCT01761058|||Cohort||Prospective|||||||
1440699|NCT01761045|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1440700|NCT01761032|||Case Control||Cross-Sectional|||||||
1440701|NCT01761019||Single Group Assignment||Treatment||None (Open Label)||||||
1440702|NCT01761006|||Case-Only||Prospective|||||||
1440703|NCT01760993||Single Group Assignment||Treatment||None (Open Label)||||||
1440704|NCT01760980|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1440705|NCT01760967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440706|NCT01760954|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440707|NCT01760941||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440708|NCT01760928|||Cohort||Retrospective|||||||
1440709|NCT01760915|||Cohort||Prospective|||||||
1440710|NCT01760902|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1440711|NCT01760889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440712|NCT01760876||Single Group Assignment||Treatment||None (Open Label)||||||
1440713|NCT01760863|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440714|NCT01760850|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440715|NCT01760837||Single Group Assignment||Treatment||None (Open Label)||||||
1440716|NCT01760824|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440717|NCT01760811||Single Group Assignment||Treatment||None (Open Label)||||||
1440718|NCT01760798|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440719|NCT01760785|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440720|NCT01760772|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1440721|NCT01760759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440722|NCT01760746|||Case Control||Prospective|||||||
1440723|NCT01760733|||Cohort||Prospective|||||||
1440724|NCT01760720|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440725|NCT01760707|Randomized|Parallel Assignment||Treatment||Single||||||t
1440726|NCT01760694|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440727|NCT01760681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440728|NCT01760668|||Cohort||Cross-Sectional|||||||
1440729|NCT01760655||Single Group Assignment||Treatment||None (Open Label)||||||
1440730|NCT01760642||Single Group Assignment||Treatment||None (Open Label)||||||
1440731|NCT01760629||Single Group Assignment||Treatment||None (Open Label)||||||
1440732|NCT01760616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440733|NCT01760603||Single Group Assignment||Treatment||None (Open Label)||||||
1440734|NCT01760590|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440735|NCT01760577|Randomized|Parallel Assignment||Treatment||Single||||||t
1440736|NCT01760564||Single Group Assignment||Treatment||None (Open Label)||||||
1440737|NCT01760551|||Case Control||Retrospective|||||||
1440738|NCT01760538|Randomized|Parallel Assignment||Treatment||Single||||||t
1440739|NCT01760525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440740|NCT01760512|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440741|NCT01760499||Single Group Assignment||Treatment||None (Open Label)||||||
1440742|NCT01760486|Randomized|Parallel Assignment||Treatment||Single||||||t
1440743|NCT01760473|Randomized|Crossover Assignment||Basic Science||Double||In this study's design, all participants received each of the 9 intranasal test drugs under investigation. This study employed a Latin-square randomization procedure, therefore, the sequence of testing for the 9 intranasal drugs was unique for each participant.|t|||t
1440744|NCT01760460|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440745|NCT01760447|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440746|NCT01760434||Single Group Assignment||Treatment||None (Open Label)||||||
1440747|NCT01760421||Single Group Assignment||Treatment||None (Open Label)||||||
1440748|NCT01760408|||||Prospective|||||||
1440749|NCT01760395|||Cohort||Retrospective|||||||
1440750|NCT01760382|||Cohort||Prospective|||||||
1440751|NCT01760369|||Case-Only||Prospective|||||||
1440752|NCT01760356|||Cohort||Prospective|||||||
1440753|NCT01760343|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1440754|NCT01760330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440755|NCT01760317|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440756|NCT01760304|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1440757|NCT01760291||Single Group Assignment||Prevention||None (Open Label)||||||
1440758|NCT01760278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440759|NCT01760265|||Cohort||Prospective|||||||
1440760|NCT01760252||Single Group Assignment||Other||None (Open Label)||||||
1440761|NCT01760239|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1440762|NCT01760226||Single Group Assignment||Treatment||None (Open Label)||||||
1440763|NCT01760213|Randomized|Single Group Assignment||Treatment||Single||||||t
1440764|NCT01760200|||||Retrospective|||||||
1440765|NCT01760187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440766|NCT01760174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440767|NCT01760161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440768|NCT01760148|||Cohort||Prospective|||||||
1440769|NCT01760135|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440770|NCT01760122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440771|NCT01760109||Single Group Assignment||Treatment||None (Open Label)||||||
1440772|NCT01760096|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440773|NCT01760083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440774|NCT01760070|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440775|NCT01760057|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1440776|NCT01760044||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1440777|NCT01760031|||Case Control||Prospective|||||||
1440778|NCT01760018|Randomized|Parallel Assignment||||Double|||t||t|
1440779|NCT01760005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440780|NCT01759992|Randomized|Factorial Assignment||Treatment||Single|||||t|
1440781|NCT01759979|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440782|NCT01759966|||Case-Control||Prospective|||||||
1440783|NCT01759953|Randomized|Parallel Assignment||||None (Open Label)||||||
1440784|NCT01759940|Randomized|Parallel Assignment||Treatment||Single||||||t
1440785|NCT01759927|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440786|NCT01759914|||Cohort||Prospective|||||||
1440787|NCT01759901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440788|NCT01759888||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440789|NCT01759875|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1440790|NCT01759862|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440791|NCT01759849|||Cohort||Prospective|||||||
1440792|NCT01759836|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1440793|NCT01759823|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440794|NCT01759810|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440795|NCT01759797||Single Group Assignment||Treatment||None (Open Label)||||||
1440796|NCT01759784||Single Group Assignment||Treatment||None (Open Label)||||||
1440797|NCT01759771|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440798|NCT01759758|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1440799|NCT01759745|||Case Control||Prospective|||||||
1440800|NCT01759732||Single Group Assignment||Treatment||None (Open Label)||||||
1440801|NCT01759719|||Case-Only||Prospective|||||||
1440802|NCT01759706|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440803|NCT01759693|||Case Control||Prospective|||||||
1440804|NCT01759680|Randomized|Parallel Assignment||Treatment||Single|||||t|
1440805|NCT01759667||Parallel Assignment||Diagnostic||None (Open Label)||||||
1440806|NCT01759654||Single Group Assignment||Prevention||None (Open Label)||||||
1440807|NCT01759641|||Case-Only||Prospective|||||||
1440808|NCT01759628|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440809|NCT01759615|Randomized|Parallel Assignment||||Single||||||t
1440810|NCT01759602||Single Group Assignment||Treatment||None (Open Label)||||||
1440811|NCT01759589|Randomized|Crossover Assignment||Treatment||Single||||||t
1440812|NCT01759576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440813|NCT01759563||Single Group Assignment||Prevention||None (Open Label)||||||
1440814|NCT01759550|||Case-Only||Prospective|||||||
1440815|NCT01759537|Randomized|Single Group Assignment||Treatment||Single|||||t|
1440816|NCT01759524|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440817|NCT01759511||Single Group Assignment||Treatment||None (Open Label)||||||
1440818|NCT01759498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440819|NCT01759485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440820|NCT01759472|||Case Control||Prospective|||||||
1440821|NCT01759459|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1440822|NCT01759446|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1440823|NCT01759433|||Cohort||Prospective|||||||
1440824|NCT01759420|||Cohort||Prospective|||||||
1440825|NCT01759407|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1440826|NCT01759394|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440827|NCT01759381|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440828|NCT01759368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440829|NCT01759355|||Cohort||Prospective|||||||
1440830|NCT01759342|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440831|NCT01759329|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1440832|NCT01759316|Randomized|Factorial Assignment||Treatment||Single||||||t
1440833|NCT01759303||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1440834|NCT01759290|||Cohort||Prospective|||||||
1440835|NCT01759277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440836|NCT01759264|||Case-Only||Prospective|||||||
1440837|NCT01759251|||||Prospective|||||||
1440838|NCT01759238||Single Group Assignment||Treatment||None (Open Label)||||||
1440839|NCT01759225|||Case-Only||Retrospective|||||||
1440840|NCT01759212||Single Group Assignment||Treatment||None (Open Label)||||||
1440841|NCT01759199||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440842|NCT01759186|||Cohort||Prospective|||||||
1440843|NCT01759173|||Cohort||Prospective|||||||
1440844|NCT01759160|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1440845|NCT01759147||Single Group Assignment||Treatment||None (Open Label)||||||
1440846|NCT01759134||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440847|NCT01759121|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440848|NCT01759108|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1440849|NCT01759095|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440850|NCT01759082|||Case-Only||Prospective|||||||
1440851|NCT01759069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440852|NCT01759056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440853|NCT01759043|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440854|NCT01759030|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440855|NCT01759017|||Cohort||Prospective|||||||
1440856|NCT01759004|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1440857|NCT01758991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440858|NCT01758978|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440859|NCT01758965|Randomized|Parallel Assignment||Prevention||Single|||t|||
1440860|NCT01758952|||Cohort||Prospective|||||||
1440861|NCT01758939|||Cohort|||||||||
1440862|NCT01758926|||Case Control||Prospective|||||||
1440863|NCT01758913||Single Group Assignment||Treatment||None (Open Label)||||||
1440864|NCT01758900|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1440865|NCT01758887|||Case Control||Prospective|||||||
1440866|NCT01758874|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440867|NCT01758861|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1440868|NCT01758848|||Cohort||Prospective|||||||
1440869|NCT01758835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440870|NCT01758822|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440871|NCT01758809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440872|NCT01758796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440873|NCT01758783|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440874|NCT01758770|||Family-Based||Prospective|||||||
1440875|NCT01758757||Single Group Assignment||Treatment||None (Open Label)||||||
1440876|NCT01758744||Single Group Assignment||Treatment||None (Open Label)||||||
1440877|NCT01758731||Single Group Assignment||Treatment||None (Open Label)||||||
1440878|NCT01758718||Single Group Assignment||Treatment||None (Open Label)||||||
1440879|NCT01758705|||Cohort||Prospective|||||||
1440880|NCT01758692|||Case-Control||Prospective|||||||
1440881|NCT01758679||Single Group Assignment||Treatment||None (Open Label)||||||
1440882|NCT01758666||Single Group Assignment||Treatment||None (Open Label)||||||
1440883|NCT01758653|||Cohort||Prospective|||||||
1440884|NCT01758640|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1440885|NCT01758627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440886|NCT01758614|Randomized|Parallel Assignment||Treatment||Single||||||t
1440887|NCT01758601|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440888|NCT01758588|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1440889|NCT01758575|||Cohort||Prospective|||||||
1440890|NCT01758562|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440891|NCT01758549|Randomized|Parallel Assignment||Prevention||Single|||t|||
1440892|NCT01758536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440893|NCT01758523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440894|NCT01758510||Single Group Assignment||Treatment||None (Open Label)||||||
1440895|NCT01758497|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1440896|NCT01758484||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440897|NCT01758471|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1440898|NCT01758458||Single Group Assignment||Treatment||None (Open Label)||||||
1440899|NCT01758445||Single Group Assignment||Treatment||None (Open Label)||||||
1440900|NCT01758432|Randomized|Parallel Assignment||Treatment||Quadruple||"This study has four modules with a total of 21 cohorts, each module was reported and submitted separately.~Module 1, NCT01758432 (54 subjects with 7cohorts including placebo); Module 2, NCT03578146 (48 subjects with 6 cohorts including placebo); Module 3, NCT03551730 (27 subjects with 4 cohorts including placebo); Module 4, NCT03551743 (28 subjects with 4 cohorts including placebo)"|t|t|t|t
1440901|NCT01758419|||Case Control||Prospective|||||||
1440902|NCT01758406|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440903|NCT01758393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440904|NCT01758380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440905|NCT01758367||Single Group Assignment||Treatment||None (Open Label)||||||
1440906|NCT01758354||Single Group Assignment||Screening||None (Open Label)||||||
1440907|NCT01758341||Single Group Assignment||Treatment||None (Open Label)||||||
1440908|NCT01758328||Single Group Assignment||Treatment||None (Open Label)||||||
1440909|NCT01758315|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1440910|NCT01758302|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1440911|NCT01758289|||Cohort||Prospective|||||||
1440912|NCT01758276|||Cohort||Retrospective|||||||
1440913|NCT01758263|||Cohort||Retrospective|||||||
1440914|NCT01758250|||Case-Control||Prospective|||||||
1440915|NCT01758237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440916|NCT01758224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440917|NCT01758211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440918|NCT01758198|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440919|NCT01758185|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1440920|NCT01758172|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1440921|NCT01758159|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1440922|NCT01758146|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440923|NCT01758133|||Case Control||Prospective|||||||
1440924|NCT01758120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440925|NCT01758107|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440926|NCT01758094|||Case Control||Prospective|||||||
1440927|NCT01758081|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1440928|NCT01758068|Randomized|Parallel Assignment||Prevention||Single||||||t
1440929|NCT01758055||Single Group Assignment||Treatment||None (Open Label)||||||
1440930|NCT01758042||Single Group Assignment||Treatment||None (Open Label)||||||
1440931|NCT01758029|||Cohort||Prospective|||||||
1440932|NCT01758016|||Cohort||Prospective|||||||
1440933|NCT01758003|||Cohort||Cross-Sectional|||||||
1440934|NCT01757990|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1440935|NCT01757977|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440936|NCT01757964||Single Group Assignment||Treatment||None (Open Label)||||||
1440937|NCT01757951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440938|NCT01757938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440939|NCT01757925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440940|NCT01757912||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440941|NCT01757899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440942|NCT01757886|||Cohort||Prospective|||||||
1440943|NCT01757873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440944|NCT01757860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440945|NCT01757847|Randomized|Parallel Assignment||Treatment||Single||||||t
1440946|NCT01757834||Single Group Assignment||Diagnostic||None (Open Label)||||||
1440947|NCT01757821|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1440948|NCT01757808|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440949|NCT01757795|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440950|NCT01757782|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440951|NCT01757769||Single Group Assignment||Treatment||None (Open Label)||||||
1440952|NCT01757756||Single Group Assignment||Basic Science||Single|||||t|
1440953|NCT01757743|||Case-Only||Prospective|||||||
1440954|NCT01757730|||Case-Control||Prospective|||||||
1440955|NCT01757717||Single Group Assignment||Supportive Care||None (Open Label)||||||
1440956|NCT01757704|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1440957|NCT01757691|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1440958|NCT01757678||Single Group Assignment||Diagnostic||Double|No Masking|prospective, multicenter study to evaluate the diagnostic performance of cCTA plus FFRCT employing ≥64-detector row CT scanners for the detection and exclusion of significant obstructive CAD, as defined by invasively-measured FFR, the reference standard||||
1440959|NCT01757665||Single Group Assignment||Treatment||None (Open Label)||||||
1440960|NCT01757639||Single Group Assignment||Treatment||None (Open Label)||||||
1440961|NCT01757626||Single Group Assignment||Treatment||None (Open Label)||||||
1440962|NCT01757613|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1440963|NCT01757600|||Case-Only||Retrospective|||||||
1440964|NCT01757587|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1440965|NCT01757574||Single Group Assignment||Treatment||None (Open Label)||||||
1440966|NCT01757561|||Case Control||Prospective|||||||
1440967|NCT01757548|Randomized|Parallel Assignment||Treatment||Single||||||t
1440968|NCT01757535|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440969|NCT01757522|||Cohort||Prospective|||||||
1440970|NCT01757509|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1440971|NCT01757496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440972|NCT01757483|||||Cross-Sectional|||||||
1440973|NCT01757470|||Cohort||Prospective|||||||
1440974|NCT01757457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440975|NCT01757444|Randomized|Parallel Assignment||Treatment||Single|||t|||
1440976|NCT01757431||Single Group Assignment||Treatment||None (Open Label)||||||
1440977|NCT01757418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440978|NCT01757405|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1440979|NCT01757392||Single Group Assignment||Treatment||None (Open Label)||||||
1440980|NCT01757379|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1440981|NCT01757366|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440982|NCT01757353|Randomized|Parallel Assignment||Prevention||Single|||t|||
1440983|NCT01757340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440984|NCT01757327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440985|NCT01757314|||Cohort||Prospective|||||||
1440986|NCT01757301|Randomized|Parallel Assignment||Treatment||Single||||||t
1440987|NCT01757288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440988|NCT01757275|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1440989|NCT01757262|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1440990|NCT01757249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440991|NCT01757236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440992|NCT01757223|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1440993|NCT01757210|||Case-Only||Prospective|||||||
1440994|NCT01757197||Single Group Assignment||Treatment||None (Open Label)||||||
1440995|NCT01757184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1440996|NCT01757171|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1440997|NCT01757158||Single Group Assignment||Treatment||None (Open Label)||||||
1440998|NCT01757145||Single Group Assignment||Treatment||None (Open Label)||||||
1440999|NCT01757132||Single Group Assignment||Other||None (Open Label)||||||
1441000|NCT01757119||Single Group Assignment||Treatment||None (Open Label)||||||
1441001|NCT01757106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441002|NCT01757093|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1441003|NCT01757080|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1441004|NCT01757067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441005|NCT01757054|Randomized|Parallel Assignment||||None (Open Label)||||||
1441006|NCT01757041|||Cohort||Prospective|||||||
1441007|NCT01757028|||Case Control||Prospective|||||||
1441008|NCT01757015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441009|NCT01757002|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1441010|NCT01756989||Single Group Assignment||Treatment||None (Open Label)||||||
1441011|NCT01756976|||Cohort||Prospective|||||||
1441012|NCT01756963|||Cohort||Prospective|||||||
1441013|NCT01756950|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441014|NCT01756937|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441015|NCT01756924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441016|NCT01756911||Single Group Assignment||Treatment||None (Open Label)||||||
1441017|NCT01756898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441018|NCT01756885|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441019|NCT01756872|||Cohort||Prospective|||||||
1441020|NCT01756859|||Cohort||Cross-Sectional|||||||
1441021|NCT01756846|Randomized|Crossover Assignment||||None (Open Label)||||||
1441022|NCT01756833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441023|NCT01756820|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441024|NCT01756807||Single Group Assignment||Treatment||None (Open Label)||||||
1441025|NCT01756794|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441026|NCT01756781|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1441027|NCT01756768||Single Group Assignment||Basic Science||None (Open Label)||||||
1441028|NCT01756755|Randomized|Parallel Assignment||Treatment||Single||||||t
1441029|NCT01756742|Randomized|Single Group Assignment||Treatment||Single||||||t
1441030|NCT01756729|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441031|NCT01756716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441032|NCT01756703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441033|NCT01756690|||Cohort||Prospective|||||||
1441034|NCT01756664|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1441035|NCT01756651|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1441036|NCT01756638||Single Group Assignment||Treatment||None (Open Label)||||||
1441037|NCT01756625|||Cohort||Prospective|||||||
1441038|NCT01756612|||Cohort||Prospective|||||||
1441039|NCT01756599||Single Group Assignment||Health Services Research||None (Open Label)||||||
1441040|NCT01756586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441041|NCT01756573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441042|NCT01756560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441043|NCT01756547|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1441044|NCT01756534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441045|NCT01756521|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1441046|NCT01756508|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441047|NCT01756495|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1441048|NCT01756482|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441049|NCT01756469|Randomized|Parallel Assignment||Prevention||Single|||||t|
1441050|NCT01756456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441051|NCT01756443|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441052|NCT01756430|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441053|NCT01756417||Single Group Assignment||Treatment||None (Open Label)||||||
1441054|NCT01756404|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1441055|NCT01756391|||Cohort||Prospective|||||||
1441056|NCT01756378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441057|NCT01756365||Single Group Assignment||Treatment||None (Open Label)||||||
1441058|NCT01756352||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441059|NCT01756339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441060|NCT01756326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441061|NCT01756313||Single Group Assignment||Treatment||Single||||||t
1441062|NCT01756300||Single Group Assignment||Treatment||None (Open Label)||||||
1441063|NCT01756287|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441064|NCT01756274||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441065|NCT01756261|||Cohort||Prospective|||||||
1441066|NCT01756248|||Cohort||Prospective|||||||
1441067|NCT01756235|||||Prospective|||||||
1441068|NCT01756222|||Case-Only||Prospective|||||||
1441069|NCT01756209|||||Prospective|||||||
1441070|NCT01756196|||Case-Only||Prospective|||||||
1441071|NCT01756183||Single Group Assignment||Treatment||None (Open Label)||||||
1441072|NCT01756170|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441073|NCT01756157|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1441074|NCT01756144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441075|NCT01756131|Randomized|Single Group Assignment||||Single|||||t|
1441076|NCT01756118||Single Group Assignment||Treatment||None (Open Label)||||||
1441077|NCT01756105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441078|NCT01756092||Single Group Assignment||Treatment||None (Open Label)||||||
1441079|NCT01756079||Single Group Assignment||Treatment||None (Open Label)||||||
1441080|NCT01756066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441081|NCT01756053|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1441082|NCT01756040||Single Group Assignment||Screening||None (Open Label)||||||
1441083|NCT01756027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441084|NCT01756014|||Case Control||Cross-Sectional|||||||
1441085|NCT01756001|||Cohort||Prospective|||||||
1441086|NCT01755988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441087|NCT01755975||Single Group Assignment||Treatment||None (Open Label)||||||
1441088|NCT01755962|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1441089|NCT01755949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441090|NCT01755936|||Cohort||Prospective|||||||
1441091|NCT01755923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441092|NCT01755910|||Case Control||Prospective|||||||
1441093|NCT01755897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441094|NCT01755884||Single Group Assignment||Treatment||None (Open Label)||||||
1441095|NCT01755871||Single Group Assignment||Treatment||None (Open Label)||||||
1441096|NCT01755858|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1441097|NCT01755845|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441098|NCT01755832|||Cohort||Prospective|||||||
1441099|NCT01755819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441100|NCT01755806|||Case Control||Retrospective|||||||
1441101|NCT01755780|||Case Control||Prospective|||||||
1441102|NCT01755767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441103|NCT01755754|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1441104|NCT01755741|Randomized|Crossover Assignment||Other||None (Open Label)||IPM 029 is an open-label, randomized, two-period, crossover non-inferiority trial conducted at two research centers in the U.S. to assess condom functionality during vaginal intercourse in healthy, monogamous heterosexual, sexually active couples.||||
1441105|NCT01755728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441106|NCT01755715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441107|NCT01755702|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1441108|NCT01755689|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441109|NCT01755676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441110|NCT01755663|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1441111|NCT01755650|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441112|NCT01755637|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441113|NCT01755624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441114|NCT01755611|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1441115|NCT01755598|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441116|NCT01755585|||Case Control||Prospective|||||||
1441117|NCT01755572|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1441118|NCT01755559|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1441119|NCT01755546||Single Group Assignment||Treatment||None (Open Label)||||||
1441120|NCT01755533|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441121|NCT01755520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441122|NCT01755507|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441123|NCT01755494|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1441124|NCT01755481|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441125|NCT01755468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441126|NCT01755455|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1441127|NCT01755442|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1441128|NCT01755429|||||Retrospective|||||||
1441129|NCT01755416|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441130|NCT01755403||Single Group Assignment||Treatment||None (Open Label)||||||
1441131|NCT01755390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441132|NCT01755377|||Cohort||Prospective|||||||
1441133|NCT01755364||Single Group Assignment||Prevention||None (Open Label)||||||
1441134|NCT01755351|||Cohort||Cross-Sectional|||||||
1441135|NCT01755338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441136|NCT01755325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441137|NCT01755312|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1441138|NCT01755299|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1441139|NCT01755286|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1441140|NCT01755273|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441141|NCT01755260|Randomized|Single Group Assignment||Treatment||Single||||||t
1441142|NCT01755247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441143|NCT01755234|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441144|NCT01755221||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441145|NCT01755208||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441146|NCT01755195||Single Group Assignment||Treatment||None (Open Label)||||||
1441147|NCT01755182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441148|NCT01755169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441149|NCT01755156|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441150|NCT01755143|Randomized|Parallel Assignment||||None (Open Label)||||||
1441151|NCT01755130||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441152|NCT01755117|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441153|NCT01755104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441154|NCT01755091|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441155|NCT01755078|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441156|NCT01755065|||Cohort||Cross-Sectional|||||||
1441157|NCT01755052|||Cohort||Prospective|||||||
1441158|NCT01755039|||Cohort||Prospective|||||||
1441159|NCT01755026|Randomized|Parallel Assignment||Basic Science||Single||||||t
1441160|NCT01755013||Single Group Assignment||Supportive Care||None (Open Label)||||||
1441161|NCT01755000|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441162|NCT01754987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441163|NCT01754974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441164|NCT01754961|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441165|NCT01754948|||Ecologic or Community||Prospective|||||||
1441166|NCT01754935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441167|NCT01754922|||||Cross-Sectional|||||||
1441168|NCT01754909|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1441169|NCT01754896|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1441170|NCT01754883||Single Group Assignment||Basic Science||None (Open Label)||||||
1441171|NCT01754870||Single Group Assignment||Treatment||None (Open Label)||||||
1441172|NCT01754857||Single Group Assignment||Treatment||None (Open Label)||||||
1441173|NCT01754844|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1441174|NCT01754831||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1441175|NCT01754818|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1441176|NCT01754805||Single Group Assignment||||None (Open Label)||||||
1441177|NCT01754792|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1441178|NCT01754779|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1441179|NCT01754766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441180|NCT01754753|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441181|NCT01754740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441182|NCT01754727|||||Prospective|||||||
1441183|NCT01754714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441184|NCT01754701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441185|NCT01754688|||||Prospective|||||||
1441186|NCT01754675|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1441187|NCT01754662|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441188|NCT01754649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441189|NCT01754636|||Cohort||Prospective|||||||
1441190|NCT01754623||Single Group Assignment||Treatment||None (Open Label)||||||
1441191|NCT01754610|||Cohort||Prospective|||||||
1441192|NCT01754597||Single Group Assignment||Treatment||None (Open Label)||||||
1441193|NCT01754584|||Case-Only||Prospective|||||||
1441194|NCT01754571|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1441195|NCT01754558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441196|NCT01754545|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1441197|NCT01754532|||Cohort||Prospective|||||||
1441198|NCT01754519||Single Group Assignment||Treatment||None (Open Label)||||||
1441199|NCT01754506|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441200|NCT01754493||Single Group Assignment||Treatment||None (Open Label)||||||
1441201|NCT01754480|Randomized|Parallel Assignment||Treatment||||||||
1441202|NCT01754467||Single Group Assignment||Supportive Care||None (Open Label)||||||
1441203|NCT01754454||Single Group Assignment||Treatment||None (Open Label)||||||
1441204|NCT01754441|||||Prospective|||||||
1441205|NCT01754428|||Case-Only||Prospective|||||||
1441206|NCT01754415|Non-Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1441207|NCT01754402|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose escalation with 3+3 cohort design plus Dose expansion at the Maximum tolerated dose.||||
1441208|NCT01754389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441209|NCT01754376||Single Group Assignment||Treatment||None (Open Label)||||||
1441210|NCT01754363||Single Group Assignment||Treatment||None (Open Label)||||||
1441211|NCT01754350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441212|NCT01754337|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441213|NCT01754324|||Cohort||Prospective|||||||
1441214|NCT01754311|||Case-Control||Retrospective|||||||
1441215|NCT01754298|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441216|NCT01754285|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441217|NCT01754272|||||Retrospective|||||||
1441218|NCT01754259|Randomized|Crossover Assignment||Other||Double||Subject will receive labeled bottles containing tablets with ranolazine 500 mg or a matching placebo provided by the sponsor. Each patient will receive both ranolazine and placebo for 4 weeks, but both the investigator and subject are blinded to the order.|t||t|
1441219|NCT01754246|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441220|NCT01754233||Single Group Assignment||Treatment||None (Open Label)||||||
1441221|NCT01754220||Single Group Assignment||Treatment||None (Open Label)||||||
1441222|NCT01754207|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441223|NCT01754194|||Cohort||Prospective|||||||
1441224|NCT01754181|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1441225|NCT01754168|||Cohort||Prospective|||||||
1441226|NCT01754155||Single Group Assignment||Prevention||None (Open Label)||||||
1441227|NCT01754142|||Case-Only||Prospective|||||||
1441228|NCT01754129|||Cohort||Prospective|||||||
1441229|NCT01754116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441230|NCT01754103||Single Group Assignment||||None (Open Label)||||||
1441231|NCT01754090|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441232|NCT01754077|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1441233|NCT01754064|||Cohort||Prospective|||||||
1441234|NCT01754051|||Cohort||Prospective|||||||
1441235|NCT01754038|||Cohort||Prospective|||||||
1441236|NCT01754025|||Family-Based||Prospective|||||||
1441237|NCT01754012|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441238|NCT01753999|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1441239|NCT01753986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441240|NCT01753973|||Cohort||Prospective|||||||
1441241|NCT01753960|||Case Control||Prospective|||||||
1441242|NCT01753947|Randomized|Parallel Assignment||||Single|||t|||
1441243|NCT01753934|||||Prospective|||||||
1441244|NCT01753921|||Cohort||Cross-Sectional|||||||
1441245|NCT01753908|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1441246|NCT01753895|||Case Control||Prospective|||||||
1441247|NCT01753882|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1441248|NCT01753869|Randomized|Crossover Assignment||Treatment||Single||||||t
1441249|NCT01753856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441250|NCT01753843|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441251|NCT01753830|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1441252|NCT01753817|||Cohort||Prospective|||||||
1441253|NCT01753804|||Case-Only||Prospective|||||||
1441254|NCT01753791|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1441255|NCT01753778||Single Group Assignment||Treatment||None (Open Label)||||||
1441256|NCT01753765||Single Group Assignment||Treatment||None (Open Label)||||||
1441257|NCT01753752|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1441258|NCT01753739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441259|NCT01753726|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1441260|NCT01753713|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441261|NCT01753700|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1441262|NCT01753687||Single Group Assignment||Basic Science||Single||||||t
1441263|NCT01753674|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1441264|NCT01753661|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1441265|NCT01753648|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1441266|NCT01753635|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441267|NCT01753622|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441268|NCT01753609||Single Group Assignment||Treatment||None (Open Label)||||||
1441269|NCT01753596|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1441270|NCT01753583|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1441271|NCT01753570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441272|NCT01753557||Single Group Assignment||Treatment||None (Open Label)||||||
1441273|NCT01753544|||Case-Only||Prospective|||||||
1441274|NCT01753531|||Cohort||Prospective|||||||
1441275|NCT01753518|Randomized|Parallel Assignment||Treatment||Single||||||t
1441276|NCT01753505||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441277|NCT01753492||Single Group Assignment||Treatment||None (Open Label)||||||
1441278|NCT01753479||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441279|NCT01753466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441280|NCT01753453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441281|NCT01753440||Single Group Assignment||Treatment||None (Open Label)||||||
1441282|NCT01753427|||Case-Only||Cross-Sectional|||||||
1441283|NCT01753414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441284|NCT01753401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441285|NCT01753388||Single Group Assignment||Treatment||None (Open Label)||||||
1441286|NCT01753375|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1441287|NCT01753362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441288|NCT01753349|||Cohort||Prospective|||||||
1441289|NCT01753336||Single Group Assignment||Treatment||None (Open Label)||||||
1441290|NCT01753323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441291|NCT01753310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441292|NCT01753297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441293|NCT01753284|||Case-Only||Retrospective|||||||
1441294|NCT01753271|Randomized|Parallel Assignment||Treatment||Single||||||t
1441295|NCT01753258|||Case Control||Prospective|||||||
1441296|NCT01753245|||Cohort||Cross-Sectional|||||||
1441297|NCT01753232|||Cohort||Prospective|||||||
1441298|NCT01753219|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1441299|NCT01753206|||||Cross-Sectional|||||||
1441300|NCT01753193||Single Group Assignment||Treatment||None (Open Label)||This is an Open Label Extension study.||||
1441301|NCT01753180|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441302|NCT01753167||Parallel Assignment||Treatment||Double|||t||t|
1441303|NCT01753154|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441304|NCT01753141|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441305|NCT01753128||Single Group Assignment||Treatment||Double|||t||t|
1441306|NCT01753115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441307|NCT01753102|Randomized|Parallel Assignment||Treatment||Single||||||t
1441308|NCT01753089||Single Group Assignment||Treatment||None (Open Label)||||||
1441309|NCT01753076|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441310|NCT01753063||Single Group Assignment||Health Services Research||None (Open Label)||||||
1441311|NCT01753050|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1441312|NCT01753037|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1441313|NCT01753024|||Cohort||Prospective|||||||
1441314|NCT01753011|||Cohort||Prospective|||||||
1441315|NCT01752998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441316|NCT01752985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441317|NCT01752972|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441318|NCT01752959|Randomized|Parallel Assignment||||None (Open Label)||||||
1441319|NCT01752946|||||Prospective|||||||
1441320|NCT01752933||Single Group Assignment||Treatment||None (Open Label)||||||
1441321|NCT01752920||Single Group Assignment||Treatment||None (Open Label)||||||
1441322|NCT01752907|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1441323|NCT01752894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441324|NCT01752881||Single Group Assignment||Prevention||None (Open Label)||||||
1441325|NCT01752868|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441326|NCT01752855||Single Group Assignment||Treatment||None (Open Label)||||||
1441327|NCT01752842|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441328|NCT01752829|||Cohort||Prospective|||||||
1441329|NCT01752816|Randomized|Parallel Assignment||Basic Science||Triple||||t|t|t
1441330|NCT01752803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441331|NCT01752790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441332|NCT01752777|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1441333|NCT01752764|Randomized|Crossover Assignment||Prevention||Single|||||t|
1441334|NCT01752751|||Cohort||Prospective|||||||
1441335|NCT01752738|||Cohort||Prospective|||||||
1441336|NCT01752725|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441337|NCT01752712|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441338|NCT01752699|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1441339|NCT01752686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441340|NCT01752673|Randomized|Parallel Assignment||||None (Open Label)||||||
1441341|NCT01752660|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1441342|NCT01752647||Single Group Assignment||Screening||None (Open Label)||||||
1441343|NCT01752634|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441344|NCT01752621|||Case Control||Retrospective|||||||
1441345|NCT01752608|Randomized|Parallel Assignment||Treatment||Single||||||t
1441346|NCT01752595|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441347|NCT01752582|Randomized|Parallel Assignment||||None (Open Label)||||||
1441348|NCT01752569||Single Group Assignment||Treatment||None (Open Label)||||||
1441349|NCT01752556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441350|NCT01752543|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1441351|NCT01752530|Randomized|Parallel Assignment||Treatment||Single||||||t
1441352|NCT01752517|||Cohort||Prospective|||||||
1441353|NCT01752504||Single Group Assignment||Prevention||None (Open Label)||||||
1441354|NCT01752491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441355|NCT01752478|||Case-Only||Prospective|||||||
1441356|NCT01752465|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441357|NCT01752452|||Case Control||Prospective|||||||
1441358|NCT01752439|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441359|NCT01752426||Single Group Assignment||Treatment||None (Open Label)||||||
1441360|NCT01752413|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1441361|NCT01752400||Single Group Assignment||Treatment||None (Open Label)||||||
1441362|NCT01752387|||||Retrospective|||||||
1441363|NCT01752374|||Cohort||Prospective|||||||
1441364|NCT01752361|||Case Control||Prospective|||||||
1441365|NCT01752348|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1441366|NCT01752335||Single Group Assignment||Supportive Care||None (Open Label)||||||
1441367|NCT01752322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441368|NCT01752309|||Cohort||Prospective|||||||
1441369|NCT01752296|||Case-Only||Cross-Sectional|||||||
1441370|NCT01752283|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441371|NCT01752270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441372|NCT01752257||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441373|NCT01752244|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1441374|NCT01752231|||Cohort||Prospective|||||||
1441375|NCT01752218||Single Group Assignment||Treatment||None (Open Label)||||||
1441376|NCT01752205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441377|NCT01752192|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1441378|NCT01752179|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1441379|NCT01752166|||Case-Only||Prospective|||||||
1441380|NCT01752153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441381|NCT01752140|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441382|NCT01752127|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441383|NCT01752114|||Cohort||Prospective|||||||
1441384|NCT01752101|||Cohort||Prospective|||||||
1441385|NCT01752088|||Case-Only||Prospective|||||||
1441386|NCT01752075|||Case-Only||Prospective|||||||
1441387|NCT01752062|||Case-Only||Prospective|||||||
1441388|NCT01752049|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1441389|NCT01752036||Single Group Assignment||Treatment||None (Open Label)||||||
1441390|NCT01752023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441391|NCT01752010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441392|NCT01751997|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441393|NCT01751984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441394|NCT01751971|Randomized|Crossover Assignment||Treatment||Single|Participants were not informed whether they were breathing supplemental inspired oxygen or sham (air) on the study night. Technicians and investigators performing the study were not masked in order to carefully ensure delivery of treatment.||t|||
1441395|NCT01751958|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441396|NCT01751945|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441397|NCT01751932||Single Group Assignment||Treatment||None (Open Label)||||||
1441398|NCT01751919|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441399|NCT01751906|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441400|NCT01751893|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1441401|NCT01751880||Single Group Assignment||Supportive Care||None (Open Label)||||||
1441402|NCT01751867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441403|NCT01751854|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1441404|NCT01751841|||Case-Only||Retrospective|||||||
1441405|NCT01751828||Single Group Assignment||||None (Open Label)||||||
1441406|NCT01751815|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1441407|NCT01751802|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1441408|NCT01751789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441409|NCT01751776|Randomized|Parallel Assignment||Treatment||Double||||||
1441410|NCT01751763|||Cohort||Prospective|||||||
1441411|NCT01751750||Single Group Assignment||Prevention||None (Open Label)||||||
1441412|NCT01751737||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441413|NCT01751724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441414|NCT01751698|Randomized|Parallel Assignment||Treatment||Single||||||t
1441415|NCT01751685|Randomized|Parallel Assignment||Treatment||Single||||||t
1441416|NCT01751672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441417|NCT01751659|||Cohort||Prospective|||||||
1441418|NCT01751646|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1441419|NCT01751633|||Cohort||Prospective|||||||
1441420|NCT01751620|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441421|NCT01751607|||Cohort||Prospective|||||||
1441422|NCT01751594|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1441423|NCT01751581|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1441424|NCT01751568||Single Group Assignment||Treatment||None (Open Label)||||||
1441425|NCT01751555||Single Group Assignment||Treatment||None (Open Label)||||||
1441426|NCT01751542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441427|NCT01751529||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441428|NCT01751516|||Case-Only||Prospective|||||||
1441429|NCT01751503|Randomized|Parallel Assignment||Treatment||Single||||||t
1441430|NCT01751490|Randomized|Parallel Assignment||Treatment||Single||||||t
1441431|NCT01751477|||Cohort||Prospective|||||||
1441432|NCT01751464||Single Group Assignment||Prevention||None (Open Label)||||||
1441433|NCT01751451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441434|NCT01751438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441435|NCT01751425||Single Group Assignment||Treatment||None (Open Label)||||||
1441436|NCT01751412||Single Group Assignment||Treatment||None (Open Label)||||||
1441437|NCT01751399|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441438|NCT01751386|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1441439|NCT01751373|Randomized|Crossover Assignment||Treatment||Single|||||t|
1441440|NCT01751360||||Treatment||||||||
1441441|NCT01751347|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1441442|NCT01751334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441443|NCT01751321||Parallel Assignment||Treatment||Double|||t||t|
1441444|NCT01751308|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441445|NCT01751295|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441446|NCT01751282|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1441447|NCT01751269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441448|NCT01751256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441449|NCT01751243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441450|NCT01751230|Randomized|Parallel Assignment||Prevention||Single|||||t|
1441451|NCT01751217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441452|NCT01751204|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1441453|NCT01751191|||Cohort||Prospective|||||||
1441454|NCT01751178|Randomized|Parallel Assignment||Treatment||Single|||||t|
1441455|NCT01751165|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441456|NCT01751152|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441457|NCT01751139||Single Group Assignment||Other||None (Open Label)||||||
1441458|NCT01751126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441459|NCT01751113|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1441460|NCT01751100|Randomized|Parallel Assignment||Prevention||Single||||t||
1441461|NCT01751087|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441462|NCT01751074|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441463|NCT01751061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441464|NCT01751048|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441465|NCT01751035|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1441466|NCT01751022||Single Group Assignment||Treatment||None (Open Label)||||||
1441467|NCT01751009|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441468|NCT01750996|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1441469|NCT01750983||Single Group Assignment||Treatment||None (Open Label)||||||
1441470|NCT01750970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441471|NCT01750957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441472|NCT01750944|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441473|NCT01750931|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441474|NCT01750918|Randomized|||Treatment||None (Open Label)||||||
1441475|NCT01750905|Randomized|Parallel Assignment||||Triple|||t|t|t|
1441476|NCT01750892|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441477|NCT01750879|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1441478|NCT01750866||Single Group Assignment||Treatment||None (Open Label)||||||
1441479|NCT01750853|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1441480|NCT01750840|||Cohort||Prospective|||||||
1441481|NCT01750827||Single Group Assignment||Treatment||None (Open Label)||||||
1441482|NCT01750814|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441483|NCT01750801|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1441484|NCT01750788|||Cohort||Prospective|||||||
1441485|NCT01750775|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441486|NCT01750762||Single Group Assignment||Treatment||None (Open Label)||||||
1441487|NCT01750749||Single Group Assignment||Treatment||None (Open Label)||||||
1441488|NCT01750736|Randomized|Parallel Assignment||Treatment||Single||||||t
1441489|NCT01750723|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1441490|NCT01750710|||||Cross-Sectional|||||||
1441491|NCT01750697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441492|NCT01750684|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441493|NCT01750671|||Cohort|||||||||
1441494|NCT01750658|||Case-Crossover||Prospective|||||||
1441495|NCT01750645||||||||||||
1441496|NCT01750632||Single Group Assignment||Treatment||None (Open Label)||||||
1441497|NCT01750619|||Cohort||Prospective|||||||
1441498|NCT01750606|||Cohort||Cross-Sectional|||||||
1441499|NCT01750593||Single Group Assignment||Treatment||None (Open Label)||||||
1441500|NCT01750580|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441501|NCT01750567||Single Group Assignment||Treatment||None (Open Label)||||||
1441502|NCT01750554|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441503|NCT01750541|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441504|NCT01750528|||Case Control||Cross-Sectional|||||||
1441505|NCT01750515||||||||||||
1441506|NCT01750502|||Cohort||Prospective|||||||
1441507|NCT01750489|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1441508|NCT01750476|||Cohort||Prospective|||||||
1441509|NCT01750463|||Cohort||Prospective|||||||
1441510|NCT01750450|||Cohort||Prospective|||||||
1441511|NCT01750437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441512|NCT01750424|Randomized|Parallel Assignment||Treatment||Single||||||t
1441513|NCT01750411|||Cohort||Prospective|||||||
1441514|NCT01750398||Single Group Assignment||Treatment||None (Open Label)||||||
1441515|NCT01750385|Randomized|Parallel Assignment||Prevention||Single|||t|||
1441516|NCT01750372|||Case-Only||Cross-Sectional|||||||
1441517|NCT01750359|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1441518|NCT01750346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441519|NCT01750333|||Cohort||Retrospective|||||||
1441520|NCT01750320||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441521|NCT01750307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441522|NCT01750294||Single Group Assignment||Treatment||None (Open Label)||||||
1441523|NCT01750281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441524|NCT01750268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441525|NCT01750255|Randomized|Parallel Assignment||||None (Open Label)||||||
1441526|NCT01750242|||Cohort||Retrospective|||||||
1441527|NCT01750229|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1441528|NCT01750216|||Cohort||Prospective|||||||
1441529|NCT01750203||||||||||||
1441530|NCT01750190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441531|NCT01750177|Randomized|Crossover Assignment||Prevention||Single|||t|||
1441532|NCT01750164|||Case-Only||Prospective|||||||
1441533|NCT01750151|Randomized|Crossover Assignment||Prevention||Single|||t|||
1441534|NCT01750138|Randomized|Parallel Assignment||||Double|||t||t|
1441535|NCT01750125|||Cohort||Prospective|||||||
1441536|NCT01750112||Single Group Assignment||Treatment||None (Open Label)||||||
1441537|NCT01750099|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441538|NCT01750086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441539|NCT01750073||Single Group Assignment||Treatment||None (Open Label)||||||
1441540|NCT01750060|Randomized|Single Group Assignment||||None (Open Label)||||||
1441541|NCT01750047|||||Cross-Sectional|||||||
1441542|NCT01750034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441543|NCT01750021|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1441544|NCT01750008|Randomized|Parallel Assignment||Treatment||Single||Study compares two laparoscopic interventions for the treatment of symptomatic uterine fibroids.||||t
1441545|NCT01749995|||Cohort||Prospective|||||||
1441546|NCT01749982|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1441547|NCT01749969||Parallel Assignment||Treatment||None (Open Label)||||||
1441548|NCT01749956||Single Group Assignment||Treatment||None (Open Label)||||||
1441549|NCT01749943|||Cohort||Cross-Sectional|||||||
1441550|NCT01749930|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441551|NCT01749917|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1441552|NCT01749904|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441553|NCT01749891|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441554|NCT01749878|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1441555|NCT01749865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441556|NCT01749852|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1441557|NCT01749839|||Case Control||Prospective|||||||
1441558|NCT01749826|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1441559|NCT01749813|||Cohort||Prospective|||||||
1441560|NCT01749800|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441561|NCT01749787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441562|NCT01749774||Single Group Assignment||Supportive Care||None (Open Label)||||||
1441563|NCT01749761|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1441564|NCT01749748||Single Group Assignment||Basic Science||None (Open Label)||||||
1441565|NCT01749735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441566|NCT01749722||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441567|NCT01749709|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1441568|NCT01749696||||||||||||
1441569|NCT01749683|||||Prospective|||||||
1441570|NCT01749670|||Case Control||Prospective|||||||
1441571|NCT01749657|Randomized|Parallel Assignment||Treatment||Single||||||t
1441572|NCT01749644|||Cohort||Prospective|||||||
1441573|NCT01749631|||||Prospective|||||||
1441574|NCT01749618|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441575|NCT01749605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441576|NCT01749592||Single Group Assignment||Treatment||None (Open Label)||||||
1441577|NCT01749579|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441578|NCT01749566|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441579|NCT01749553|Randomized|Parallel Assignment||Treatment||Single||||||t
1441580|NCT01749540||Single Group Assignment||Treatment||None (Open Label)||||||
1441581|NCT01749527||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441582|NCT01749514||Single Group Assignment||Treatment||None (Open Label)||||||
1441583|NCT01749501|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441584|NCT01749488|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441585|NCT01749475|||||Prospective|||||||
1441586|NCT01749462|||Cohort||Prospective|||||||
1441587|NCT01749449|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441588|NCT01749436|||Cohort||Prospective|||||||
1441589|NCT01749423|||Case-Only||Retrospective|||||||
1441590|NCT01749410|||Case-Only||Retrospective|||||||
1441591|NCT01749397||Single Group Assignment||Treatment||None (Open Label)||||||
1441592|NCT01749384||Single Group Assignment||Treatment||None (Open Label)||||||
1441593|NCT01749371|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441594|NCT01749358|Randomized|Parallel Assignment||Treatment||Single||||||t
1441595|NCT01749345|||Cohort||Cross-Sectional|||||||
1441596|NCT01749332||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441597|NCT01749319|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441598|NCT01749306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441599|NCT01749293||Single Group Assignment||Treatment||None (Open Label)||||||
1441600|NCT01749280|||||Prospective|||||||
1441601|NCT01749267||Single Group Assignment||Treatment||None (Open Label)||||||
1441602|NCT01749254|||||Prospective|||||||
1441603|NCT01749241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441604|NCT01749228|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441605|NCT01749215|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441606|NCT01749202|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441607|NCT01749189|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1441608|NCT01749176|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1441609|NCT01749163|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1441610|NCT01749150||Parallel Assignment||Treatment||None (Open Label)||||||
1441611|NCT01749137|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1441612|NCT01749124||Single Group Assignment||Health Services Research||None (Open Label)||||||
1441613|NCT01749111|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441614|NCT01749098|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1441615|NCT01749085|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1441616|NCT01749072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441617|NCT01749059|||Cohort||Prospective|||||||
1441618|NCT01749046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441619|NCT01749033|Randomized|Parallel Assignment||||Double|||t|||t
1441620|NCT01749020|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1441621|NCT01749007|||Cohort||Other|||||||
1441622|NCT01748994|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1441623|NCT01748981|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1441624|NCT01748968|||Cohort||Retrospective|||||||
1441625|NCT01748955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441626|NCT01748942|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1441627|NCT01748929|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441628|NCT01748916|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1441629|NCT01748903|||Cohort||Prospective|||||||
1441630|NCT01748890||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441631|NCT01748877|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441632|NCT01748864||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441633|NCT01748851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441634|NCT01748838|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1441635|NCT01748825|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1441636|NCT01748812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441637|NCT01748799|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1441638|NCT01748786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441639|NCT01748773||Single Group Assignment||Treatment||None (Open Label)||||||
1441640|NCT01748760|Randomized|Parallel Assignment||Treatment||Single||||||t
1441641|NCT01748747|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441642|NCT01748734||Single Group Assignment||Supportive Care||None (Open Label)||||||
1441643|NCT01748721||Single Group Assignment||Treatment||None (Open Label)||||||
1441644|NCT01748708|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1441645|NCT01748695|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1441646|NCT01748682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441647|NCT01748669|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441648|NCT01748656|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441649|NCT01748643|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1441650|NCT01748630|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441651|NCT01748617|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1441652|NCT01748604|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1441653|NCT01748591|||Cohort||Prospective|||||||
1441654|NCT01748578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441655|NCT01748565|||Cohort||Prospective|||||||
1441656|NCT01748552|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1441657|NCT01748539|Randomized|Parallel Assignment||Treatment||Double||||||
1441658|NCT01748526|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441659|NCT01748513|||Case-Crossover||Prospective|||||||
1441660|NCT01748500||Single Group Assignment||Treatment||None (Open Label)||||||
1441661|NCT01748487||Single Group Assignment||Prevention||None (Open Label)||||||
1441662|NCT01748474|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1441663|NCT01748461|Randomized|Parallel Assignment||||Single|||t|||
1441664|NCT01748448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441665|NCT01748435|||Cohort||Prospective|||||||
1441666|NCT01748422|||Cohort||Prospective|||||||
1441667|NCT01748409||Single Group Assignment||Health Services Research||None (Open Label)||||||
1441668|NCT01748396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441669|NCT01748383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441670|NCT01748370|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441671|NCT01748357|||Case Control||Prospective|||||||
1441672|NCT01748344|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1441673|NCT01748331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441674|NCT01748318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441675|NCT01748305||Single Group Assignment||Treatment||None (Open Label)||||||
1441676|NCT01748292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441677|NCT01748279|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441678|NCT01748266|||Cohort||Prospective|||||||
1441679|NCT01748253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441680|NCT01748240||Single Group Assignment||Treatment||None (Open Label)||||||
1441681|NCT01748227||Single Group Assignment||Health Services Research||None (Open Label)||||||
1441682|NCT01748214|||Case-Crossover||Prospective|||||||
1441683|NCT01748201||Single Group Assignment||Treatment||None (Open Label)||||||
1441684|NCT01748188|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441685|NCT01748175||Single Group Assignment||Other||None (Open Label)||||||
1441686|NCT01748162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441687|NCT01748149||Single Group Assignment||Treatment||None (Open Label)||||||
1441688|NCT01748136||Single Group Assignment||Prevention||None (Open Label)||||||
1441689|NCT01748123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441690|NCT01748110|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441691|NCT01748097|Non-Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1441692|NCT01748084|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441693|NCT01748071|||Case Control||Prospective|||||||
1441694|NCT01748058|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441695|NCT01748045|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1441696|NCT01748032|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441697|NCT01748019||Single Group Assignment||Treatment||None (Open Label)||||||
1441698|NCT01748006|||Cohort||Prospective|||||||
1441699|NCT01747993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441700|NCT01747980||Single Group Assignment||Treatment||None (Open Label)||||||
1441701|NCT01747967||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441702|NCT01747954|Randomized|Single Group Assignment||Treatment||Single|||||t|
1441703|NCT01747941|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1441704|NCT01747928||Parallel Assignment||||None (Open Label)||||||
1441705|NCT01747915|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441706|NCT01747902|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441707|NCT01747889|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441708|NCT01747876||Single Group Assignment||Treatment||None (Open Label)||||||
1441709|NCT01747863|||Cohort||Prospective|||||||
1441710|NCT01747850|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441711|NCT01747837|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441712|NCT01747824|||Cohort||Prospective|||||||
1441713|NCT01747811|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1441714|NCT01747798||Single Group Assignment||Treatment||None (Open Label)||||||
1441715|NCT01747785|||Case Control||Prospective|||||||
1441716|NCT01747772||Single Group Assignment||Diagnostic||Single|Biopsy specimens were assessed via Meta-analysis of Histological Data in Viral Hepatitis (METAVIR) criteria by a pathologist who was blinded to the shear-wave elastography (SWE) values.|||||t
1441717|NCT01747759|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1441718|NCT01747746|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441719|NCT01747733|||Case-Only||Prospective|||||||
1441720|NCT01747720|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441721|NCT01747707||Single Group Assignment||Treatment||None (Open Label)||||||
1441722|NCT01747694|Randomized|Parallel Assignment||Treatment||Single||||||t
1441723|NCT01747681|||Case-Only||Retrospective|||||||
1441724|NCT01747668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441725|NCT01747655|||||Prospective|||||||
1441726|NCT01747642|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441727|NCT01747629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441728|NCT01747616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441729|NCT01747603|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1441730|NCT01747590||Single Group Assignment||Basic Science||Triple|||t||t|t
1441731|NCT01747577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441732|NCT01747564||Single Group Assignment||||None (Open Label)||||||
1441733|NCT01747551|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1441734|NCT01747538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441735|NCT01747525|||Case-Control||Cross-Sectional|||||||
1441736|NCT01747512|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441737|NCT01747499|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441738|NCT01747486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441739|NCT01747473|||||Prospective|||||||
1441741|NCT01747447|Randomized|Factorial Assignment||Prevention||Triple|Double Blind||t||t|t
1441742|NCT01747434|||Cohort||Cross-Sectional|||||||
1441743|NCT01747421|||Cohort||Prospective|||||||
1441744|NCT01747408||Single Group Assignment||Treatment||None (Open Label)||||||
1441745|NCT01747395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441746|NCT01747382||||||||||||
1441747|NCT01747369|||Case-Only||Prospective|||||||
1441748|NCT01747356||Single Group Assignment||Treatment||None (Open Label)||||||
1441749|NCT01747343||Single Group Assignment||Treatment||None (Open Label)||||||
1441750|NCT01747330|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441751|NCT01747317||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441752|NCT01747304|||Case-Control||Cross-Sectional|||||||
1441753|NCT01747291|||Cohort||Prospective|||||||
1441754|NCT01747278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441755|NCT01747265||||||||||||
1441756|NCT01747252|Randomized|Crossover Assignment||||Triple|||t||t|t
1441757|NCT01747239||Single Group Assignment||Treatment||None (Open Label)||||||
1441758|NCT01747226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441759|NCT01747213|Randomized|Single Group Assignment||Treatment||||||||
1441760|NCT01747200|Randomized|Single Group Assignment||Basic Science||||||||
1441761|NCT01747187|||Cohort||Prospective|||||||
1441762|NCT01747174|Randomized|Parallel Assignment||Prevention||Single||||||t
1441763|NCT01747161|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441764|NCT01747148|Randomized|Single Group Assignment||Treatment||||||||
1441765|NCT01747135||Single Group Assignment||Treatment||None (Open Label)||||||
1441766|NCT01747122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441767|NCT01747109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441768|NCT01747096||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441769|NCT01747083|Randomized|Crossover Assignment||||None (Open Label)||||||
1441770|NCT01747070|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441771|NCT01747057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441772|NCT01747044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441773|NCT01747031||Single Group Assignment||Diagnostic||Triple|||t|t|t|
1441774|NCT01747018|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1441775|NCT01747005|||Case Control||Prospective|||||||
1441776|NCT01746992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441777|NCT01746979|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441778|NCT01746966|||Case Control||Prospective|||||||
1441779|NCT01746953|||Cohort||Prospective|||||||
1441780|NCT01746940|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441781|NCT01746927|||Case-Only||Prospective|||||||
1441782|NCT01746914|||Cohort||Prospective|||||||
1441783|NCT01746901|Randomized|Crossover Assignment||Other||Double|||t||t|
1441784|NCT01746888|||Case-Only||Prospective|||||||
1441785|NCT01746875|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441786|NCT01746862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441787|NCT01746849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441788|NCT01746836||Single Group Assignment||Treatment||None (Open Label)||||||
1441789|NCT01746823|||Case Control||Prospective|||||||
1441790|NCT01746810||Single Group Assignment||Treatment||None (Open Label)||||||
1441791|NCT01746797|||Cohort||Prospective|||||||
1441792|NCT01746784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441793|NCT01746771||Single Group Assignment||Treatment||None (Open Label)||||||
1441794|NCT01746758|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1441795|NCT01746745||Single Group Assignment||||None (Open Label)||||||
1441796|NCT01746732|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1441797|NCT01746719|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441798|NCT01746706|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441799|NCT01746693|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1441800|NCT01746680||Single Group Assignment||Treatment||None (Open Label)||||||
1441801|NCT01746667|Randomized|Parallel Assignment||Treatment||Single||||||t
1441802|NCT01746654|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1441803|NCT01746641|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441804|NCT01746628|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1441805|NCT01746615|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1441806|NCT01746602|Randomized|Parallel Assignment||Basic Science||Single||||||t
1441807|NCT01746589||Single Group Assignment||Treatment||None (Open Label)||||||
1441808|NCT01746576||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441809|NCT01746563|Randomized|Single Group Assignment||Treatment||Single|||t|||
1441810|NCT01746550||Single Group Assignment||Treatment||None (Open Label)||||||
1441811|NCT01746537|||Cohort||Prospective|||||||
1441812|NCT01746524||Single Group Assignment||Treatment||None (Open Label)||||||
1441813|NCT01746511|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441814|NCT01746498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441815|NCT01746485||Single Group Assignment||||None (Open Label)||||||
1441816|NCT01746472|Randomized|Factorial Assignment||||Double|||t||t|
1441817|NCT01746459|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1441818|NCT01746446|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1441896|NCT01745419|||Case Control||Retrospective|||||||
1441819|NCT01746433|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441820|NCT01746420|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441821|NCT01746407|||Case-Only||Prospective|||||||
1441822|NCT01746394|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441823|NCT01746381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441824|NCT01746368|Randomized|Parallel Assignment||||None (Open Label)||||||
1441825|NCT01746355|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1441826|NCT01746342|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441827|NCT01746329|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1441828|NCT01746303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441829|NCT01746290|Randomized|Single Group Assignment||Health Services Research||Quadruple|||t|t|t|t
1441830|NCT01746277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441831|NCT01746264||Single Group Assignment||Prevention||None (Open Label)||||||
1441832|NCT01746251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441833|NCT01746238||Single Group Assignment||Treatment||None (Open Label)||||||
1441834|NCT01746225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441835|NCT01746212|||Cohort||Prospective|||||||
1441836|NCT01746199|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441837|NCT01746186|||Cohort||Prospective|||||||
1441838|NCT01746173||Single Group Assignment||Treatment||None (Open Label)||||||
1441839|NCT01746160||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441840|NCT01746147|||Case-Only||Prospective|||||||
1441841|NCT01746134|||Cohort||Prospective|||||||
1441842|NCT01746121|||Family-Based||Cross-Sectional|||||||
1441843|NCT01746108|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441844|NCT01746095|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441845|NCT01746082|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441846|NCT01746069|Randomized|Parallel Assignment||Treatment||Single||||||t
1441847|NCT01746056||Single Group Assignment||Treatment||None (Open Label)||||||
1441848|NCT01746043|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441849|NCT01746030|||||Prospective|||||||
1441850|NCT01746017|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1441851|NCT01746004||Single Group Assignment||Basic Science||None (Open Label)||||||
1441852|NCT01745991|||Cohort||Prospective|||||||
1441853|NCT01745978|Randomized|Parallel Assignment||Treatment||Single||||||t
1441854|NCT01745965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441855|NCT01745952|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1441856|NCT01745939|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1441857|NCT01745926|||Cohort||Prospective|||||||
1441858|NCT01745913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441859|NCT01745900|||Cohort||Cross-Sectional|||||||
1441860|NCT01745887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441861|NCT01745874|||Cohort||Prospective|||||||
1441862|NCT01745861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441863|NCT01745848||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1441864|NCT01745835|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1441865|NCT01745822|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441866|NCT01745809||||||||||||
1441867|NCT01745796|||Cohort||Prospective|||||||
1441868|NCT01745783|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1441869|NCT01745770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441870|NCT01745757|||Cohort||Prospective|||||||
1441871|NCT01745744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441872|NCT01745731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441873|NCT01745718||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441874|NCT01745705|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1441875|NCT01745692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441876|NCT01745679||Single Group Assignment||Health Services Research||None (Open Label)||||||
1441877|NCT01745666|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1441878|NCT01745653|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441879|NCT01745640||Single Group Assignment||Treatment||None (Open Label)||||||
1441880|NCT01745627||Single Group Assignment||Treatment||None (Open Label)||||||
1441881|NCT01745614|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1441882|NCT01745601|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1441883|NCT01745588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441884|NCT01745575|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1441885|NCT01745562|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1441886|NCT01745549|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441887|NCT01745536|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1441888|NCT01745523|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1441889|NCT01745510|Randomized|Parallel Assignment||Prevention||Triple||The intervention was the docosahexaenoic acid, a nutraceutical derived from the omega 3 fatty acids.|t|t||t
1441890|NCT01745497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441891|NCT01745484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441892|NCT01745471|||Case-Control||Prospective|||||||
1441893|NCT01745458|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1441894|NCT01745445||Single Group Assignment||Treatment||None (Open Label)||||||
1441895|NCT01745432|Randomized|Parallel Assignment||Prevention||Single|||t|||
1441897|NCT01745406|||Cohort||Prospective|||||||
1441898|NCT01745393|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1441899|NCT01745380|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441900|NCT01745367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441901|NCT01745354||Single Group Assignment||Treatment||None (Open Label)||||||
1441902|NCT01745341|||Cohort||Prospective|||||||
1441903|NCT01745328|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441904|NCT01745315|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441905|NCT01745302|||Case Control||Prospective|||||||
1441906|NCT01745289|||Other||Prospective|||||||
1441907|NCT01745276|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1441908|NCT01745263|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1441909|NCT01745250|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1441910|NCT01745237|||Cohort||Prospective|||||||
1441911|NCT01745224|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441912|NCT01745211|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441913|NCT01745198|||Case Control||Retrospective|||||||
1441914|NCT01745185|||Cohort||Prospective|||||||
1441915|NCT01745172||Single Group Assignment||Treatment||None (Open Label)||||||
1441916|NCT01745159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441917|NCT01745146|Randomized|Parallel Assignment||Treatment||Single||||||t
1441918|NCT01745133|Randomized|Parallel Assignment||Treatment||Single|||||t|
1441919|NCT01745120||Single Group Assignment||Treatment||None (Open Label)||||||
1441920|NCT01745107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441921|NCT01745094||Single Group Assignment||Treatment||None (Open Label)||||||
1441922|NCT01745081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441923|NCT01745068|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1441924|NCT01745055|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1441925|NCT01745042|||Cohort||Cross-Sectional|||||||
1441926|NCT01745029|||Case-Only||Prospective|||||||
1441927|NCT01745016|Randomized|Factorial Assignment||||Double|||t||t|
1441928|NCT01745003||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441929|NCT01744990||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441930|NCT01744977|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1441931|NCT01744964|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1441932|NCT01744951|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1441933|NCT01744938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441934|NCT01744925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441935|NCT01744912||Single Group Assignment||Treatment||None (Open Label)||||||
1441936|NCT01744899|||Case Control||Cross-Sectional|||||||
1441937|NCT01744886|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441938|NCT01744873|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441939|NCT01744860|||Cohort||Prospective|||||||
1441940|NCT01744847|Randomized|Parallel Assignment||Treatment||Single|||t|||
1441941|NCT01744834|||Cohort||Prospective|||||||
1441942|NCT01744821|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1441943|NCT01744808|Randomized|Crossover Assignment||||None (Open Label)||||||
1441944|NCT01744795||Single Group Assignment||Diagnostic||Double|||t||t|
1441945|NCT01744782||Single Group Assignment||Treatment||None (Open Label)||||||
1441946|NCT01744769|||Case-Only||Prospective|||||||
1441947|NCT01744756||Single Group Assignment||Treatment||None (Open Label)||||||
1441948|NCT01744743|Randomized|Parallel Assignment||Prevention||Single||||||t
1441949|NCT01744730||Single Group Assignment||Basic Science||None (Open Label)||||||
1441950|NCT01744717|||Cohort||Prospective|||||||
1441951|NCT01744704|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1441952|NCT01744691||Single Group Assignment||Treatment||None (Open Label)||||||
1441953|NCT01744678||Single Group Assignment||||None (Open Label)||||||
1441954|NCT01744665|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441955|NCT01744652|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441956|NCT01744639||Single Group Assignment||Diagnostic||None (Open Label)||||||
1441957|NCT01744626||Single Group Assignment||Treatment||None (Open Label)||||||
1441958|NCT01744613|||Cohort||Prospective|||||||
1441959|NCT01744600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441960|NCT01744587|Randomized|Parallel Assignment||Prevention||Single|||t|||
1441961|NCT01744574|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1441962|NCT01744561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441963|NCT01744548|Randomized|Crossover Assignment||Treatment||Single||||||t
1441964|NCT01744535|Randomized|Parallel Assignment||Treatment||Single||||||t
1441965|NCT01744522|||Cohort||Prospective|||||||
1441966|NCT01744509||Single Group Assignment||Diagnostic||Single||||||t
1441967|NCT01744496|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1441968|NCT01744483|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1441969|NCT01744470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441970|NCT01744457|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1441971|NCT01744444|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1441972|NCT01744431|||Case-Only||Prospective|||||||
1441973|NCT01744418||Single Group Assignment||Treatment||None (Open Label)||||||
1441974|NCT01744405|||Cohort||Prospective|||||||
1441975|NCT01744392||Single Group Assignment||Health Services Research||None (Open Label)||||||
1441976|NCT01744379|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441977|NCT01744366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441978|NCT01744353|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441979|NCT01744340|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1441980|NCT01744327|||Case Control||Prospective|||||||
1441981|NCT01744314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441982|NCT01744301|||Cohort||Retrospective|||||||
1441983|NCT01744288|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1441984|NCT01744275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441985|NCT01744262|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1441986|NCT01744249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1441987|NCT01744236|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441988|NCT01744223||Single Group Assignment||Treatment||None (Open Label)||||||
1441989|NCT01744210|||Cohort||Prospective|||||||
1441990|NCT01744197|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1441991|NCT01744184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1441992|NCT01744171||Single Group Assignment||Treatment||None (Open Label)||||||
1441993|NCT01744158|||Cohort||Cross-Sectional|||||||
1441994|NCT01744145|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1441995|NCT01744132|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1441996|NCT01744119|||Cohort||Prospective|||||||
1441997|NCT01744106|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441998|NCT01744093|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1441999|NCT01744080|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442000|NCT01744067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442001|NCT01744054||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442002|NCT01744041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442003|NCT01744028|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442004|NCT01744015|Randomized|Crossover Assignment||Treatment||Single||||t||
1442005|NCT01744002|Randomized|Parallel Assignment||Treatment||Single||||||t
1442006|NCT01743989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442007|NCT01743976|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442008|NCT01743963|Randomized|Parallel Assignment||Prevention||Single|||t|||
1442009|NCT01743950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442010|NCT01743937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442011|NCT01743924|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1442012|NCT01743911|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1442013|NCT01743898|||Case Control||Prospective|||||||
1442014|NCT01743885|Randomized|Parallel Assignment||Treatment||Single|||||t|
1442015|NCT01743872|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1442016|NCT01743859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442017|NCT01743846|||Case-Only||Prospective|||||||
1442018|NCT01743833|Randomized|Factorial Assignment||Treatment||Single||||||t
1442019|NCT01743820|Randomized|Parallel Assignment||Treatment||Single||||||t
1442020|NCT01743807|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442021|NCT01743794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442022|NCT01743781|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442023|NCT01743768|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442024|NCT01743755|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442025|NCT01743742||Single Group Assignment||Prevention||None (Open Label)||||||
1442026|NCT01743729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442027|NCT01743716|||Other||Cross-Sectional|||||||
1442028|NCT01743703||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442029|NCT01743690|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1442030|NCT01743677|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1442031|NCT01743664|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1442032|NCT01743651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442033|NCT01743638||Single Group Assignment||Treatment||None (Open Label)||||||
1442034|NCT01743625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442035|NCT01743612|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1442036|NCT01743599|||Case Control||Prospective|||||||
1442037|NCT01743586||Single Group Assignment||Treatment||None (Open Label)||||||
1442038|NCT01743573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442039|NCT01743560||Single Group Assignment||Treatment||None (Open Label)||||||
1442040|NCT01743547|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442041|NCT01743534|||Case-Only||Prospective|||||||
1442042|NCT01743521|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442043|NCT01743508|Randomized|Parallel Assignment||Treatment||Single|||||t|
1442044|NCT01743495||Single Group Assignment||Health Services Research||None (Open Label)||||||
1442045|NCT01743482||Single Group Assignment||Treatment||None (Open Label)||||||
1442046|NCT01743469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442047|NCT01743456|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442048|NCT01743443||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442049|NCT01743430|Randomized|Factorial Assignment||Treatment||Single|||||t|
1442050|NCT01743417|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442051|NCT01743404|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1442052|NCT01743391|Randomized|Parallel Assignment||||None (Open Label)||||||
1442053|NCT01743378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442054|NCT01743365||Single Group Assignment||Treatment||None (Open Label)||||||
1442055|NCT01743352|||Case Control||Prospective|||||||
1442056|NCT01743339|Randomized|Parallel Assignment||Treatment||Single||||||t
1442057|NCT01743326|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442058|NCT01743313|||Cohort||Prospective|||||||
1442059|NCT01743300|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1442060|NCT01743287|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442061|NCT01743274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442062|NCT01743261|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1442063|NCT01743248|||Cohort||Prospective|||||||
1442064|NCT01743235|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442065|NCT01743222|Randomized|Single Group Assignment||Treatment||Single|||t|||
1442066|NCT01743209|||Cohort||Retrospective|||||||
1442067|NCT01743196||||||||||||
1442068|NCT01743183||Single Group Assignment||Treatment||None (Open Label)||||||
1442069|NCT01743170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442070|NCT01743157||Single Group Assignment||Treatment||None (Open Label)||||||
1442071|NCT01743144|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1442072|NCT01743131|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1442073|NCT01743118||Single Group Assignment||Treatment||Single||||||t
1442074|NCT01743105||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442075|NCT01743092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442076|NCT01743079|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442077|NCT01743066|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442078|NCT01743053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442079|NCT01743040|||Cohort||Prospective|||||||
1442080|NCT01743027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442081|NCT01743014|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442082|NCT01743001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442083|NCT01742988|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442084|NCT01742975|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1442085|NCT01742962|||Cohort||Cross-Sectional|||||||
1442086|NCT01742949|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1442087|NCT01742936|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1442088|NCT01742923|Randomized|Parallel Assignment||Prevention||Single||||||t
1442089|NCT01742910|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1442090|NCT01742897||Single Group Assignment||Treatment||None (Open Label)||||||
1442091|NCT01742884|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442092|NCT01742871|||Case Control||Cross-Sectional|||||||
1442093|NCT01742858|||Cohort||Prospective|||||||
1442094|NCT01742845|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1442095|NCT01742832|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1442096|NCT01742819|||Cohort||Prospective|||||||
1442097|NCT01742806|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442098|NCT01742793|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442099|NCT01742780|Randomized|Parallel Assignment||||None (Open Label)||||||
1442100|NCT01742767||Parallel Assignment||Treatment||||||||
1442101|NCT01742754||Single Group Assignment||Basic Science||None (Open Label)||||||
1442102|NCT01742741|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442103|NCT01742728|||Cohort||Cross-Sectional|||||||
1442104|NCT01742715|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442105|NCT01742702|||Other||Prospective|||||||
1442106|NCT01742689|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442107|NCT01742676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442108|NCT01742663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442109|NCT01742650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442110|NCT01742637|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442111|NCT01742624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442112|NCT01742611||Single Group Assignment||Treatment||None (Open Label)||||||
1442113|NCT01742598|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442114|NCT01742585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442115|NCT01742572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442116|NCT01742559|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1442117|NCT01742546|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442118|NCT01742533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442119|NCT01742520|Randomized|Parallel Assignment||Prevention||Single||||||t
1442120|NCT01742507|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442121|NCT01742494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442122|NCT01742481|Randomized|Parallel Assignment||Prevention||Single||||||t
1442123|NCT01742468|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1442124|NCT01742455|||Cohort||Prospective|||||||
1442125|NCT01742442|||Cohort||Prospective|||||||
1442126|NCT01742429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442127|NCT01742416|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442128|NCT01742403||Single Group Assignment||Treatment||None (Open Label)||||||
1442129|NCT01742390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442130|NCT01742377|||Case-Only||Prospective|||||||
1442131|NCT01742364|Randomized|Parallel Assignment||Prevention||Single|||||t|
1442132|NCT01742351||Single Group Assignment||Treatment||None (Open Label)||||||
1442133|NCT01742338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442134|NCT01742325||Single Group Assignment||Health Services Research||None (Open Label)||||||
1442135|NCT01742312|||Cohort||Prospective|||||||
1442136|NCT01742299||Single Group Assignment||Treatment||None (Open Label)||||||
1442137|NCT01742286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442138|NCT01742273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442139|NCT01742260||Single Group Assignment||Treatment||None (Open Label)||||||
1442140|NCT01742247||Single Group Assignment||Prevention||None (Open Label)||||||
1442141|NCT01742234|||Case-Only||Cross-Sectional|||||||
1442142|NCT01742221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442143|NCT01742208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442144|NCT01742195|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1442145|NCT01742182|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442146|NCT01742169|Randomized|Parallel Assignment||Screening||Double|||t|||t
1442147|NCT01742156|||Cohort||Prospective|||||||
1442148|NCT01742143|||Cohort||Prospective|||||||
1442149|NCT01742130|Randomized|Parallel Assignment||Prevention||Single||||||t
1442150|NCT01742117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442151|NCT01742104|||Cohort|||||||||
1442152|NCT01742091|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1442153|NCT01742078|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1442154|NCT01742065|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1442155|NCT01742052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442156|NCT01742039|||Cohort||Prospective|||||||
1442157|NCT01742026|||Case-Only||Prospective|||||||
1442158|NCT01742013|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442159|NCT01742000|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1442160|NCT01741987|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1442161|NCT01741974|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1442162|NCT01741961|||Case Control||Retrospective|||||||
1442163|NCT01741948|||Case Control||Prospective|||||||
1442164|NCT01741935|||Cohort||Prospective|||||||
1442165|NCT01741922|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1442166|NCT01741909||Single Group Assignment||Treatment||None (Open Label)||||||
1442167|NCT01741896|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442168|NCT01741883|Randomized|Parallel Assignment||Prevention||Single||||||t
1442169|NCT01741870|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1442170|NCT01741857||Single Group Assignment||Treatment||None (Open Label)||||||
1442171|NCT01741844|||Case-Only||Prospective|||||||
1442172|NCT01741831|||Case-Only||Prospective|||||||
1442173|NCT01741818|||Case-Only||Prospective|||||||
1442174|NCT01741805|||Cohort||Prospective|||||||
1442175|NCT01741792||Single Group Assignment||Treatment||None (Open Label)||||||
1442176|NCT01741779|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442177|NCT01741766|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442178|NCT01741753||Single Group Assignment||Treatment||None (Open Label)||||||
1442179|NCT01741740|||Cohort||Retrospective|||||||
1442180|NCT01741727||Single Group Assignment||Treatment||None (Open Label)||||||
1442181|NCT01741714|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442182|NCT01741701|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442183|NCT01741688|||Cohort||Prospective|||||||
1442184|NCT01741675|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442185|NCT01741662||Single Group Assignment||||None (Open Label)||||||
1442186|NCT01741649|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442187|NCT01741636||Single Group Assignment||Supportive Care||None (Open Label)||||||
1442188|NCT01741623|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442189|NCT01741610|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1442190|NCT01741597||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442191|NCT01741584|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1442192|NCT01741571|Randomized|Sequential Assignment||Diagnostic||Single||||||t
1442193|NCT01741558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442194|NCT01741545|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442195|NCT01741532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442196|NCT01741519|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1442197|NCT01741506|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442198|NCT01741493|Randomized|Single Group Assignment||Other||Triple|||t|t|t|
1442199|NCT01741480|Randomized|Parallel Assignment||Prevention||Single|||t|||
1442200|NCT01741467||Single Group Assignment||Prevention||None (Open Label)||||||
1442201|NCT01741454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442202|NCT01741441|||Cohort||Prospective|||||||
1442203|NCT01741428|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442204|NCT01741415|Randomized|Parallel Assignment||Treatment||Single||||||t
1442205|NCT01741402|Randomized|Parallel Assignment||Treatment||Single||||||t
1442206|NCT01741389|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1442207|NCT01741376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442208|NCT01741363|Randomized|Parallel Assignment||Prevention||Single||||||t
1442209|NCT01741350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442210|NCT01741337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442211|NCT01741324|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1442212|NCT01741311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442213|NCT01741298|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1442214|NCT01741285|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442215|NCT01741272|Randomized|Parallel Assignment||Treatment||Single||||||t
1442216|NCT01741259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442217|NCT01741246|||||Prospective|||||||
1442218|NCT01741233||Single Group Assignment||Basic Science||None (Open Label)||||||
1442219|NCT01741220|||Cohort||Prospective|||||||
1442220|NCT01741207|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1442221|NCT01741194|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1442222|NCT01741181|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442223|NCT01741168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442224|NCT01741155|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442225|NCT01741142|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442226|NCT01741129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442227|NCT01741116||Single Group Assignment||Treatment||None (Open Label)||||||
1442228|NCT01741103|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442229|NCT01741090||Single Group Assignment||Treatment||None (Open Label)||||||
1442230|NCT01741077|||Cohort||Cross-Sectional|||||||
1442231|NCT01741064|||Cohort||Retrospective|||||||
1442232|NCT01741051|Randomized|Parallel Assignment||Prevention||Single||||||t
1442233|NCT01741038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442234|NCT01741025|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442235|NCT01741012||Single Group Assignment||Prevention||None (Open Label)||||||
1442236|NCT01740999|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442237|NCT01740986|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442238|NCT01740973|||Cohort||Retrospective|||||||
1442239|NCT01740960|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1442240|NCT01740947|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442241|NCT01740934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442242|NCT01740921|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442243|NCT01740908|||Case Control||Prospective|||||||
1442244|NCT01740895|||Case-Only||Prospective|||||||
1442245|NCT01740882|||Cohort||Retrospective|||||||
1442246|NCT01740869|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442247|NCT01740856|Randomized|Parallel Assignment||Treatment||Single|||||t|
1442248|NCT01740843|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1442249|NCT01740830|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1442250|NCT01740817|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1442251|NCT01740804|||Case-Only||Prospective|||||||
1442252|NCT01740791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442253|NCT01740778|||Case Control||Cross-Sectional|||||||
1442254|NCT01740765|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1442255|NCT01740752|Randomized|Parallel Assignment||Treatment||Single||||||t
1442256|NCT01740739|||Case-Only||Prospective|||||||
1442257|NCT01740726|Randomized|Parallel Assignment||Treatment||Single||||||t
1442258|NCT01740713|Randomized|Parallel Assignment||||Single|||||t|
1442259|NCT01740700||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1442260|NCT01740687|||Cohort||Prospective|||||||
1442261|NCT01740674|Randomized|Parallel Assignment||||None (Open Label)||||||
1442262|NCT01740661|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1442263|NCT01740648||Single Group Assignment||Treatment||None (Open Label)||||||
1442264|NCT01740635|Randomized|Parallel Assignment||Treatment||Single||||||t
1442265|NCT01740622|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442266|NCT01740609|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1442267|NCT01740596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442268|NCT01740583||Single Group Assignment||Treatment||None (Open Label)||||||
1442269|NCT01740570||Single Group Assignment||Treatment||None (Open Label)||||||
1442270|NCT01740557||Single Group Assignment||Treatment||None (Open Label)||||||
1442271|NCT01740544|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1442272|NCT01740531|Randomized|Crossover Assignment||Other||Double|||t||t|
1442273|NCT01740518|||Case Control||Prospective|||||||
1442274|NCT01740505|Randomized|Parallel Assignment||Treatment||Single||||||t
1442275|NCT01740492|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442276|NCT01740479|Randomized|Parallel Assignment||Prevention||Single||||||t
1442277|NCT01740466|||Ecologic or Community||Retrospective|||||||
1442278|NCT01740453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442279|NCT01740440||Single Group Assignment||||None (Open Label)||||||
1442280|NCT01740427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442281|NCT01740414|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1442282|NCT01740401||Single Group Assignment||Treatment||None (Open Label)||||||
1442283|NCT01740388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442284|NCT01740375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442285|NCT01740362|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442286|NCT01740349|||Case Control||Prospective|||||||
1442287|NCT01740336|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442288|NCT01740323|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1442289|NCT01740310|Randomized|Factorial Assignment||||None (Open Label)||||||
1442290|NCT01740297|Randomized|Parallel Assignment||Treatment||None (Open Label)||"Phase 1b was an open-label, multicenter single-arm part of the study to evaluate safety of talimogene laherparepvec in combination with ipilimumab.~Phase 2 was an open-label multicenter, randomized design to further assess safety and to evaluate efficacy of talimogene laherparepvec in combination with ipilimumab."||||
1442291|NCT01740284|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1442292|NCT01740271||Single Group Assignment||Treatment||None (Open Label)||||||
1442293|NCT01740258||Single Group Assignment||Treatment||None (Open Label)||||||
1442294|NCT01740245||||||||||||
1442295|NCT01740232|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442296|NCT01740219|Randomized|Parallel Assignment||||None (Open Label)||||||
1442297|NCT01740206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442298|NCT01740193|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442299|NCT01740180|||Cohort||Prospective|||||||
1442300|NCT01740167||Single Group Assignment||Prevention||Single|||t|||
1442301|NCT01740154||Single Group Assignment||Supportive Care||None (Open Label)||||||
1442302|NCT01740141|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442303|NCT01740128|Randomized|Crossover Assignment||Treatment||Single||||||t
1442304|NCT01740115|||Cohort||Prospective|||||||
1442305|NCT01740102|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442306|NCT01740089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442307|NCT01740076|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442308|NCT01740063|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442309|NCT01740050|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442310|NCT01740037|Randomized|Parallel Assignment||Treatment||Single||||||t
1442311|NCT01740024||Single Group Assignment||||None (Open Label)||||||
1442312|NCT01740011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442313|NCT01739998|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1442314|NCT01739985|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442315|NCT01739972|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1442316|NCT01739959|||||Prospective|||||||
1442317|NCT01739946|||Case-Control||Prospective|||||||
1442318|NCT01739933|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1442319|NCT01739920|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1442320|NCT01739907|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1442321|NCT01739894||Single Group Assignment||Treatment||None (Open Label)||||||
1442322|NCT01739881||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442323|NCT01739868||Single Group Assignment||||None (Open Label)||||||
1442324|NCT01739855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442325|NCT01739842|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442326|NCT01739829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442327|NCT01739816|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1442328|NCT01739803|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442329|NCT01739790|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442330|NCT01739777|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1442331|NCT01739764||Single Group Assignment||Treatment||None (Open Label)||||||
1442332|NCT01739751|Randomized|Parallel Assignment||Treatment||Single||||||t
1442333|NCT01739738|||Cohort||Prospective|||||||
1442334|NCT01739725||Single Group Assignment||Treatment||None (Open Label)||||||
1442335|NCT01739712|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1442336|NCT01739699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442337|NCT01739686|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1442338|NCT01739673||Single Group Assignment||Treatment||None (Open Label)||||||
1442339|NCT01739660||Single Group Assignment||||None (Open Label)||||||
1442340|NCT01739647|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1442341|NCT01739634||Single Group Assignment||Treatment||None (Open Label)||||||
1442342|NCT01739621|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442343|NCT01739608|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1442344|NCT01739595|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442345|NCT01739582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442346|NCT01739569|Randomized|Crossover Assignment||||Single||||||t
1442347|NCT01739556|Randomized|Parallel Assignment||Treatment||Single||||||t
1442348|NCT01739543|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1442349|NCT01739530||Single Group Assignment||Treatment||None (Open Label)||||||
1442350|NCT01739517||Single Group Assignment||Treatment||None (Open Label)||||||
1442351|NCT01739504||Single Group Assignment||Treatment||None (Open Label)||||||
1442352|NCT01739491|||Cohort||Prospective|||||||
1442353|NCT01739478|Randomized|Parallel Assignment||||None (Open Label)||||||
1442354|NCT01739465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442355|NCT01739452|||Case-Control||Retrospective|||||||
1442356|NCT01739439||Single Group Assignment||Treatment||None (Open Label)||||||
1442357|NCT01739426||Single Group Assignment||Treatment||None (Open Label)||||||
1442358|NCT01739413|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442359|NCT01739400||Single Group Assignment||Treatment||None (Open Label)||||||
1442360|NCT01739387|||Case-Crossover||Prospective|||||||
1442361|NCT01739374||Single Group Assignment||Treatment||None (Open Label)||||||
1442362|NCT01739361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442363|NCT01739348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442364|NCT01739335|Randomized|Parallel Assignment||Treatment||Double|Double blinded Placebo-controlled||t||t|
1442365|NCT01739322||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442366|NCT01739309||Single Group Assignment||Treatment||None (Open Label)||||||
1442367|NCT01739296|Randomized|Parallel Assignment||Treatment||Single|||||t|
1442368|NCT01739283|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1442369|NCT01739270|Randomized|Parallel Assignment||Treatment||Single|||||t|
1442370|NCT01739257|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1442371|NCT01739244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442372|NCT01739231|Randomized|Parallel Assignment||Treatment||Quadruple|Part A of the study was masked to the participant, care provider, investigator, and outcomes assessor. Part B was open label.||t|t|t|t
1442373|NCT01739218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442374|NCT01739205|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442375|NCT01739192|Randomized|Factorial Assignment||Basic Science||Triple|||t|t||t
1442376|NCT01739179|||Case-Only||Prospective|||||||
1442377|NCT01739166|Randomized|Crossover Assignment||||None (Open Label)||||||
1442378|NCT01739153|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1442379|NCT01739140||Single Group Assignment||Treatment||None (Open Label)||||||
1442380|NCT01739127|||Case Control||Prospective|||||||
1442381|NCT01739114|Randomized|Single Group Assignment||Prevention||Single||||||t
1442382|NCT01739101|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442383|NCT01739088|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1442384|NCT01739075|||Cohort||Prospective|||||||
1442385|NCT01739062|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1442386|NCT01739049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442387|NCT01739036|Randomized|Parallel Assignment||Basic Science||Single||||||t
1442388|NCT01739023||Single Group Assignment||Treatment||None (Open Label)||||||
1442389|NCT01739010|||Other||Prospective|||||||
1442390|NCT01738997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442391|NCT01738984|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1442392|NCT01738971|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1442393|NCT01738958|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442394|NCT01738945||Single Group Assignment||Prevention||Single|||t|||
1442395|NCT01738932|||Case Control||Cross-Sectional|||||||
1442396|NCT01738919|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1442397|NCT01738906|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1442398|NCT01738893|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1442399|NCT01738880|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1442400|NCT01738867|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1442401|NCT01738854|Randomized|Crossover Assignment||||Single||||t||
1442402|NCT01738841|||Cohort||Prospective|||||||
1442403|NCT01738828|||Case Control||Prospective|||||||
1442404|NCT01738815||Single Group Assignment||Basic Science||None (Open Label)||||||
1442405|NCT01738802|Randomized|Single Group Assignment||||Triple|||t|t|t|
1442406|NCT01738789|||Cohort||Prospective|||||||
1442407|NCT01738776|||Case Control||Cross-Sectional|||||||
1442408|NCT01738763|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1442409|NCT01738750|Randomized|Parallel Assignment||||None (Open Label)||||||
1442410|NCT01738737|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1442411|NCT01738724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442412|NCT01738711|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442413|NCT01738698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442414|NCT01738685|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1442415|NCT01738672||Single Group Assignment||Treatment||None (Open Label)||||||
1442416|NCT01738659||Single Group Assignment||Treatment||Double|||t||t|
1442417|NCT01738646||Single Group Assignment||Treatment||None (Open Label)||||||
1442418|NCT01738633|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1442419|NCT01738620|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1442420|NCT01738607|Randomized|Factorial Assignment||Treatment||Single|||t|||
1442421|NCT01738594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442422|NCT01738581|Randomized|Crossover Assignment||Treatment||Single||||||t
1442423|NCT01738568||Single Group Assignment||Basic Science||None (Open Label)||||||
1442424|NCT01738555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442425|NCT01738542|Randomized|Parallel Assignment||Treatment||Single|||||t|
1442426|NCT01738529|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1442427|NCT01738516|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1442428|NCT01738503|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442429|NCT01738490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442430|NCT01738477|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442431|NCT01738464|||Case-Control||Prospective|||||||
1442432|NCT01738451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442433|NCT01738438||Single Group Assignment||Treatment||None (Open Label)||||||
1442434|NCT01738425|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1442435|NCT01738412|||Case-Only||Prospective|||||||
1442436|NCT01738399|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1442437|NCT01738386|||||Retrospective|||||||
1442438|NCT01738373|||||Prospective|||||||
1442439|NCT01738360||Single Group Assignment||Treatment||None (Open Label)||||||
1442440|NCT01738347||Single Group Assignment||Other||None (Open Label)||||||
1442441|NCT01738334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442442|NCT01738321|||Cohort||Prospective|||||||
1442443|NCT01738308|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442444|NCT01738295|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1442445|NCT01738282|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442446|NCT01738269|||Cohort||Retrospective|||||||
1442447|NCT01738256|Randomized|Parallel Assignment||||None (Open Label)||||||
1442448|NCT01738243|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442449|NCT01738230||||||||||||
1442450|NCT01738217||Single Group Assignment||||None (Open Label)||||||
1442451|NCT01738204|||Case-Control||Prospective|||||||
1442452|NCT01738191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442453|NCT01738178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442454|NCT01738165||Single Group Assignment||Treatment||None (Open Label)||||||
1442455|NCT01738152||Single Group Assignment||Treatment||None (Open Label)||||||
1442456|NCT01738139||Single Group Assignment||Treatment||None (Open Label)||||||
1442457|NCT01738126|||Cohort|||||||||
1442458|NCT01738113|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442459|NCT01738100|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1442460|NCT01738087|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442461|NCT01738074|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1442462|NCT01738061|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1442463|NCT01738048|||Case Control||Cross-Sectional|||||||
1442464|NCT01738035|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1442465|NCT01738022||Single Group Assignment||||None (Open Label)||||||
1442466|NCT01738009||Single Group Assignment||||None (Open Label)||||||
1442467|NCT01737996|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442468|NCT01737983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442469|NCT01737970|||Case-Only||Retrospective|||||||
1442470|NCT01737957|Randomized|Single Group Assignment||Treatment||Single||||||t
1442471|NCT01737944|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442472|NCT01737931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442473|NCT01737918|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442474|NCT01737905|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1442475|NCT01737892|Randomized|Crossover Assignment||Treatment||Single||||||t
1442476|NCT01737879||Single Group Assignment||Treatment||None (Open Label)||||||
1442477|NCT01737866|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442478|NCT01737853|||Case-Crossover||Prospective|||||||
1442479|NCT01737840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442480|NCT01737827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442481|NCT01737814|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442482|NCT01737801||Single Group Assignment||Treatment||None (Open Label)||||||
1442483|NCT01737788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442484|NCT01737775|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1442485|NCT01737762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442486|NCT01737749|||Cohort||Prospective|||||||
1442487|NCT01737736|||Cohort||Prospective|||||||
1442488|NCT01737723|||Case Control||Prospective|||||||
1442489|NCT01737710|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442490|NCT01737697|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1442491|NCT01737684|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442492|NCT01737671||Single Group Assignment||Treatment||None (Open Label)||||||
1442493|NCT01737658|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442494|NCT01737645|||Cohort||Prospective|||||||
1442495|NCT01737632|Randomized|Factorial Assignment||Treatment||Single||||||t
1442496|NCT01737619||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442497|NCT01737606||Single Group Assignment||Health Services Research||None (Open Label)||||||
1442498|NCT01737593|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1442499|NCT01737580|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442500|NCT01737567|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1442501|NCT01737554|||Cohort||Prospective|||||||
1442502|NCT01737541|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1442503|NCT01737528|||Cohort||Prospective|||||||
1442504|NCT01737515|||Cohort||Prospective|||||||
1442505|NCT01737502||Single Group Assignment||Treatment||None (Open Label)||||||
1442506|NCT01737489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442507|NCT01737476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442508|NCT01737463|Randomized|Parallel Assignment||Prevention||Single|||t|||
1442509|NCT01737450||Single Group Assignment||Treatment||None (Open Label)||||||
1442510|NCT01737437|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1442511|NCT01737424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442512|NCT01737411|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442513|NCT01737398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442514|NCT01737385|||Case-Only||Prospective|||||||
1442515|NCT01737372|||Cohort||Cross-Sectional|||||||
1442516|NCT01737359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442517|NCT01737346||Single Group Assignment||Treatment||None (Open Label)||||||
1442518|NCT01737333|||Case-Only||Prospective|||||||
1442519|NCT01737320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442520|NCT01737307|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1442521|NCT01737294|||Cohort||Prospective|||||||
1442522|NCT01737281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442523|NCT01737268||Single Group Assignment||Treatment||None (Open Label)||||||
1442524|NCT01737255|||Case-Control||Prospective|||||||
1442525|NCT01737242|||Case-Only||Prospective|||||||
1442526|NCT01737229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442527|NCT01737216|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442528|NCT01737203|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1442529|NCT01737190|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442530|NCT01737177||Single Group Assignment||Treatment||None (Open Label)||||||
1442531|NCT01737164|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442532|NCT01737151|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442533|NCT01737138|Randomized|Parallel Assignment||Treatment||Single||||||t
1442534|NCT01737125|||Case-Only|||||||||
1442535|NCT01737112||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442536|NCT01737099|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442537|NCT01737086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442538|NCT01737073|Randomized|Factorial Assignment||Treatment||Single||||||t
1442539|NCT01737060|Randomized|Parallel Assignment||Treatment||Single||||||t
1442540|NCT01737047|||Cohort||Prospective|||||||
1442541|NCT01737034|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442542|NCT01737021|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442543|NCT01737008|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442544|NCT01736995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442545|NCT01736982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442546|NCT01736969|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1442547|NCT01736956|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442548|NCT01736943||Single Group Assignment||Treatment||None (Open Label)||||||
1442549|NCT01736930|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442550|NCT01736917||Single Group Assignment||Treatment||None (Open Label)||||||
1442551|NCT01736904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442552|NCT01736891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442553|NCT01736878|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442554|NCT01736865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442555|NCT01736852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442556|NCT01736839|||Cohort||Prospective|||||||
1442557|NCT01736826|||Cohort||Prospective|||||||
1442558|NCT01736813|||Case-Only||Prospective|||||||
1442559|NCT01736800||Single Group Assignment||Treatment||None (Open Label)||||||
1442560|NCT01736787|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442561|NCT01736774|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442562|NCT01736761||Single Group Assignment||Treatment||None (Open Label)||||||
1442563|NCT01736748|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442564|NCT01736735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442565|NCT01736722||Single Group Assignment||Treatment||None (Open Label)||||||
1442566|NCT01736709||Single Group Assignment||Prevention||None (Open Label)||||||
1442567|NCT01736696|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442568|NCT01736683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442569|NCT01736670|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442570|NCT01736657||Single Group Assignment||Treatment||None (Open Label)||||||
1442571|NCT01736644|Randomized|Factorial Assignment||Treatment||Single|||t|||
1442572|NCT01736631||Single Group Assignment||Treatment||None (Open Label)||||||
1442573|NCT01736618|||Cohort||Other|||||||
1442574|NCT01736605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442575|NCT01736592||Single Group Assignment||Treatment||None (Open Label)||||||
1442576|NCT01736579|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442577|NCT01736566|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1442578|NCT01736553|||Cohort||Prospective|||||||
1442579|NCT01736540||Single Group Assignment||Other||None (Open Label)||||||
1442580|NCT01736527||Single Group Assignment||||None (Open Label)||||||
1442581|NCT01736514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442582|NCT01736501|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1442583|NCT01736488|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442584|NCT01736475|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442585|NCT01736462||Single Group Assignment||||None (Open Label)||||||
1442586|NCT01736449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442587|NCT01736436||Single Group Assignment||Treatment||None (Open Label)||||||
1442588|NCT01736423||Single Group Assignment||Treatment||None (Open Label)||||||
1442589|NCT01736410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442590|NCT01736397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442591|NCT01736384|||Other||Prospective|||||||
1442592|NCT01736371|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442593|NCT01736358|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1442594|NCT01736345|||Cohort||Prospective|||||||
1442595|NCT01736332|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1442596|NCT01736319|||||Prospective|||||||
1442597|NCT01736306|||Cohort||Cross-Sectional|||||||
1442598|NCT01736293|||Cohort||Prospective|||||||
1442599|NCT01736280|||||Prospective|||||||
1442600|NCT01736267||Single Group Assignment||Treatment||None (Open Label)||||||
1442601|NCT01736254|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1442602|NCT01736241|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1442603|NCT01736228|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442604|NCT01736215|||Case-Only||Prospective|||||||
1442605|NCT01736202|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1442606|NCT01736189|||Cohort||Prospective|||||||
1442607|NCT01736176||Single Group Assignment||Treatment||None (Open Label)||||||
1442608|NCT01736163|||Case Control||Retrospective|||||||
1442609|NCT01736150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442610|NCT01736137|||Case Control|||||||||
1442611|NCT01736124|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1442612|NCT01736111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442613|NCT01736098|Randomized|Parallel Assignment||||None (Open Label)||||||
1442614|NCT01736085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442615|NCT01736072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442616|NCT01736059||Single Group Assignment||Treatment||None (Open Label)||||||
1442617|NCT01736046|||Cohort||Prospective|||||||
1442618|NCT01736033|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442619|NCT01736020|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1442620|NCT01736007|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1442621|NCT01735994|Randomized|Crossover Assignment||Prevention||Single|||t|||
1442622|NCT01735981|Non-Randomized|Crossover Assignment||Treatment||Single|||||t|
1442623|NCT01735968||Single Group Assignment||Treatment||None (Open Label)||||||
1442624|NCT01735955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442625|NCT01735942|Randomized|Single Group Assignment||Treatment||Single||||||t
1442626|NCT01735929|Randomized|Parallel Assignment||Treatment||Single||||||t
1442627|NCT01735916|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442628|NCT01735903|||Cohort||Prospective|||||||
1442629|NCT01735890|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442630|NCT01735877|Randomized|Parallel Assignment||Treatment||Single||||||t
1442631|NCT01735864|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442632|NCT01735851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442633|NCT01735838|||||Prospective|||||||
1442634|NCT01735825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442635|NCT01735812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442636|NCT01735799|||||Prospective|||||||
1442637|NCT01735786|||Cohort||Retrospective|||||||
1442638|NCT01735773|||Cohort||Cross-Sectional|||||||
1442639|NCT01735760|||Case-Crossover||Prospective|||||||
1442640|NCT01735747||Single Group Assignment||Treatment||None (Open Label)||||||
1442641|NCT01735734|||Case-Only||Prospective|||||||
1442642|NCT01735721|Randomized|Crossover Assignment||Treatment||Single||||||t
1442643|NCT01735708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442644|NCT01735695|||Case-Only||Prospective|||||||
1442645|NCT01735682|Randomized|Parallel Assignment||Treatment||Single||||||t
1442646|NCT01735669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442647|NCT01735656|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442648|NCT01735643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442649|NCT01735630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442650|NCT01735617||Single Group Assignment||Treatment||None (Open Label)||||||
1442651|NCT01735604||Single Group Assignment||Treatment||None (Open Label)||||||
1442652|NCT01735591|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442653|NCT01735578|||Case-Only||Prospective|||||||
1442654|NCT01735565|||Cohort||Prospective|||||||
1442655|NCT01735552|||Case-Only||Prospective|||||||
1442656|NCT01735539|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442657|NCT01735526|||Cohort||Prospective|||||||
1442658|NCT01735513|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1442659|NCT01735500|||Cohort||Prospective|||||||
1442660|NCT01735487|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1442661|NCT01735474|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1442662|NCT01735461||Single Group Assignment||Prevention||None (Open Label)||||||
1442663|NCT01735448|||Cohort||Prospective|||||||
1442664|NCT01735435|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442665|NCT01735422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442666|NCT01735409|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442667|NCT01735396||Single Group Assignment||Treatment||None (Open Label)||||||
1442668|NCT01735383|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442669|NCT01735370|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442670|NCT01735357|Randomized|Parallel Assignment||Prevention||Single|||t|||
1442671|NCT01735344|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442672|NCT01735331|||Case Control||Prospective|||||||
1442673|NCT01735318|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442674|NCT01735305|||Cohort||Prospective|||||||
1442675|NCT01735292||Single Group Assignment||||None (Open Label)||||||
1442676|NCT01735279|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442677|NCT01735266|Randomized|Parallel Assignment||Screening||Double|||t|||t
1442678|NCT01735253||Single Group Assignment||Treatment||None (Open Label)||||||
1442679|NCT01735240|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1442680|NCT01735227|Randomized|Parallel Assignment||Prevention||Single||||||t
1442681|NCT01735214|||Case-Only||Prospective|||||||
1442682|NCT01735201|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442683|NCT01735188||||||||||||
1442684|NCT01735175|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1442685|NCT01735162|||Cohort||Prospective|||||||
1442686|NCT01735149|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442687|NCT01735136|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442688|NCT01735123|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1442689|NCT01735110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442690|NCT01735097|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442691|NCT01735084|Randomized|Parallel Assignment||Prevention||Single||||||t
1442692|NCT01735071|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a multicentre, randomized, non-comparative phase II study aimed at assessing efficacy and safety of two regimens according to a Bryant and Day two-stage design||||
1442693|NCT01735058|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442694|NCT01735045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442695|NCT01735032||||||||||||
1442696|NCT01735019||Single Group Assignment||Prevention||Double|||t|||t
1442697|NCT01735006|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442698|NCT01734993||Single Group Assignment||Treatment||None (Open Label)||||||
1442699|NCT01734980||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442700|NCT01734967||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442701|NCT01734954|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442702|NCT01734941|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442703|NCT01734928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442704|NCT01734915|||Cohort||Prospective|||||||
1442705|NCT01734902|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442706|NCT01734889||Single Group Assignment||Treatment||None (Open Label)||||||
1442707|NCT01734876|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442708|NCT01734863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442709|NCT01734850|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442710|NCT01734837|||Cohort||Prospective|||||||
1442711|NCT01734824|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442712|NCT01734811|Randomized|Parallel Assignment||Prevention||Double||Randomized, double-blind, placebo-controlled, multi centre, parallel-group study|t||t|
1442713|NCT01734798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442714|NCT01734785|Randomized|Parallel Assignment||Treatment||Double||||||
1442715|NCT01734772|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442716|NCT01734759||Single Group Assignment||Health Services Research||None (Open Label)||||||
1442717|NCT01734746||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442718|NCT01734733||Single Group Assignment||Treatment||None (Open Label)||||||
1442719|NCT01734720|||Cohort||Retrospective|||||||
1442720|NCT01734707|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1442721|NCT01734694|Randomized|Parallel Assignment||Prevention||Single||||||t
1442722|NCT01734681||Single Group Assignment||Treatment||None (Open Label)||||||
1442723|NCT01734668|||||Prospective|||||||
1442724|NCT01734655|||Cohort||Cross-Sectional|||||||
1442725|NCT01734642|||Cohort||Prospective|||||||
1442726|NCT01734629|||Cohort||Prospective|||||||
1442727|NCT01734616|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442728|NCT01734603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442729|NCT01734590|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1442730|NCT01734577|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1442731|NCT01734564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442732|NCT01734551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442733|NCT01734538|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1442734|NCT01734525||Single Group Assignment||Treatment||None (Open Label)||||||
1442735|NCT01734512||Single Group Assignment||Treatment||None (Open Label)||||||
1442736|NCT01734499|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442737|NCT01734486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442738|NCT01734473|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1442739|NCT01734460|||Cohort||Prospective|||||||
1442740|NCT01734447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442741|NCT01734434|||Ecologic or Community||Prospective|||||||
1442742|NCT01734421|Randomized|Parallel Assignment||Treatment||Single||||||t
1442743|NCT01734408|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1442744|NCT01734395|||Case-Only||Prospective|||||||
1442745|NCT01734382|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442746|NCT01734369|||Case-Control||Other|||||||
1442747|NCT01734356||||||None (Open Label)||||||
1442748|NCT01734343|Randomized|Parallel Assignment||||Double|||t||t|
1442749|NCT01734330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442750|NCT01734317||Single Group Assignment||Treatment||None (Open Label)||||||
1442751|NCT01734304||Single Group Assignment||Treatment||None (Open Label)||||||
1442752|NCT01734291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442753|NCT01734278|||Cohort||Prospective|||||||
1442754|NCT01734265|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442755|NCT01734252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442756|NCT01734239|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1442757|NCT01734226|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442758|NCT01734213|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442759|NCT01734200|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442760|NCT01734187|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442761|NCT01734174|||Case-Only||Prospective|||||||
1442762|NCT01734161|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442763|NCT01734148|Randomized|Parallel Assignment||Treatment||Single||||||t
1442764|NCT01734135|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1442765|NCT01734122|||Cohort||Prospective|||||||
1442766|NCT01734109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442767|NCT01734096|Non-Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1442768|NCT01734083|Randomized|Parallel Assignment||Treatment||Single||||||t
1442769|NCT01734070||Single Group Assignment||Basic Science||None (Open Label)||||||
1442770|NCT01734057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442771|NCT01734044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442772|NCT01734018|||Cohort||Prospective|||||||
1442773|NCT01734005|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442774|NCT01733992|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442775|NCT01733979|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442776|NCT01733966|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442777|NCT01733953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442778|NCT01733940|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1442779|NCT01733927||Single Group Assignment||||None (Open Label)||||||
1442780|NCT01733914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442781|NCT01733901|Randomized|Parallel Assignment||Treatment||Single||||||t
1442782|NCT01733888|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442783|NCT01733875|Randomized|Single Group Assignment||||None (Open Label)||||||
1442784|NCT01733862|||Ecologic or Community||Retrospective|||||||
1442785|NCT01733849|||Cohort||Prospective|||||||
1442786|NCT01733836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442787|NCT01733823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442788|NCT01733810||Single Group Assignment||Basic Science||None (Open Label)||||||
1442789|NCT01733797|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442790|NCT01733784||Single Group Assignment||||None (Open Label)||||||
1442791|NCT01733771|||Cohort||Prospective|||||||
1442792|NCT01733758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442793|NCT01733745|Randomized|Parallel Assignment||Treatment||Single|||||t|
1442794|NCT01733732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442795|NCT01733719|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1442796|NCT01733706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442797|NCT01733693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442798|NCT01733680|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442799|NCT01733667|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442800|NCT01733654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442801|NCT01733641|||Cohort||Prospective|||||||
1442802|NCT01733628|||Case-Only||Prospective|||||||
1442803|NCT01733615|||Case-Only||Prospective|||||||
1442804|NCT01733602|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442805|NCT01733589||Single Group Assignment||Treatment||None (Open Label)||||||
1442806|NCT01733576|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1442807|NCT01733563|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442808|NCT01733550|||Cohort||Prospective|||||||
1442809|NCT01733537|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442810|NCT01733524|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442811|NCT01733511|||Cohort||Prospective|||||||
1442812|NCT01733485|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442813|NCT01733472|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1442814|NCT01733459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442815|NCT01733446|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1442816|NCT01733433||Single Group Assignment||Prevention||None (Open Label)||||||
1442817|NCT01733420|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1442818|NCT01733407|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1442819|NCT01733394|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1442820|NCT01733381|||Case Control||Prospective|||||||
1442821|NCT01733368|||Other||Prospective|||||||
1442822|NCT01733355|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1442823|NCT01733342|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442824|NCT01733329|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1442825|NCT01733316||Single Group Assignment||Treatment||None (Open Label)||||||
1442826|NCT01733303||Crossover Assignment||Treatment||Triple|||t||t|t
1442827|NCT01733290|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442828|NCT01733277|||Case Control||Cross-Sectional|||||||
1442829|NCT01733264||||||||||||
1442830|NCT01733251||||||||||||
1442831|NCT01733238||Single Group Assignment||Treatment||None (Open Label)||||||
1442832|NCT01733212|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442833|NCT01733199|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1442834|NCT01733186||Single Group Assignment||Treatment||None (Open Label)||||||
1442835|NCT01733173|||Cohort||Prospective|||||||
1442836|NCT01733160|||Cohort||Prospective|||||||
1442837|NCT01733147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442838|NCT01733134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442839|NCT01733121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442840|NCT01733108||Single Group Assignment||Treatment||None (Open Label)||||||
1442841|NCT01733095||Single Group Assignment||Treatment||None (Open Label)||||||
1442842|NCT01733082|||Cohort||Prospective|||||||
1442843|NCT01733069|||Cohort||Cross-Sectional|||||||
1442844|NCT01733056|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442845|NCT01733043|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1442846|NCT01733030|||Other||Cross-Sectional|||||||
1442847|NCT01733017|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442848|NCT01733004|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442849|NCT01732991||Single Group Assignment||Treatment||None (Open Label)||||||
1442850|NCT01732978||Single Group Assignment||Basic Science||None (Open Label)||||||
1442851|NCT01732965|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442852|NCT01732952|||Case-Only||Cross-Sectional|||||||
1442853|NCT01732939|||Cohort||Prospective|||||||
1442854|NCT01732926|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442855|NCT01732913|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442856|NCT01732900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442857|NCT01732887|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442858|NCT01732874|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1442859|NCT01732861||Single Group Assignment||Treatment||None (Open Label)||||||
1442860|NCT01732848|||Cohort||Cross-Sectional|||||||
1442861|NCT01732835||Single Group Assignment||Treatment||None (Open Label)||||||
1442862|NCT01732822|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442863|NCT01732809|Randomized|Parallel Assignment||||Double|||t||t|
1442864|NCT01732796|Randomized|Parallel Assignment||Treatment||Double||||||
1442865|NCT01732783|||Cohort||Prospective|||||||
1442866|NCT01732770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442867|NCT01732757|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442868|NCT01732744|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1442869|NCT01732731|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1442870|NCT01732718|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1442871|NCT01732705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442872|NCT01732692|Randomized|Parallel Assignment||Treatment||Single|||||t|
1442873|NCT01732679|||Cohort||Prospective|||||||
1442874|NCT01732666|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1442875|NCT01732653|Randomized|Parallel Assignment||Treatment||Single||||||t
1442876|NCT01732640||Single Group Assignment||Treatment||None (Open Label)||||||
1442877|NCT01732627|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442878|NCT01732614||Single Group Assignment||Treatment||None (Open Label)||||||
1442879|NCT01732601|Randomized|Parallel Assignment||Treatment||Single||||||t
1442880|NCT01732588|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1442881|NCT01732575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442882|NCT01732562|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1442883|NCT01732549|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442884|NCT01732536|Randomized|Parallel Assignment||Treatment||Double|Participants were blindfolded and earmuffed during the baseline procedure and follow-up endoscopic examinations. Implants were removed at Day 60 to allow blinded assessment of bilateral polyp grade at Day 90 by a centralized videoendoscopy review by a panel of 3 independent sinus surgeons.||t|||t
1442885|NCT01732523|||Cohort||Prospective|||||||
1442886|NCT01732510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442887|NCT01732497||Single Group Assignment||Treatment||None (Open Label)||||||
1442888|NCT01732484|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1442889|NCT01732471||Single Group Assignment||Treatment||None (Open Label)||||||
1442890|NCT01732458|Randomized|Parallel Assignment||Treatment||Double|This study will be conducted as a partially blinded study. PK samples will not be collected from participants in the control group. To maintain a partial blind, approximately 3 participants randomly selected from each age group in each of the aprepitant treatment groups will not have PK sampling. All participants will remain blinded to the study treatment. The investigator and Sponsor will be blinded to the study medication in participants not providing PK samples. The investigator and Sponsor will remain blinded to the aprepitant dose given to participants from whom PK samples will be collected.||t||t|
1442891|NCT01732445||Single Group Assignment||Supportive Care||None (Open Label)||||||
1442892|NCT01732432|||||Retrospective|||||||
1442893|NCT01732419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442894|NCT01732406|||Cohort||Prospective|||||||
1442895|NCT01732393|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442896|NCT01732380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442897|NCT01732367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442898|NCT01732354|||Cohort||Prospective|||||||
1442899|NCT01732341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442900|NCT01732328|Randomized|Parallel Assignment||Prevention||Single|||t|||
1442901|NCT01732315|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1442902|NCT01732302|Randomized|Parallel Assignment||Prevention||Single||||||t
1442903|NCT01732289|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1442904|NCT01732276||Single Group Assignment||Treatment||None (Open Label)||||||
1442905|NCT01732263|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442906|NCT01732250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442907|NCT01732237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442908|NCT01732224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442909|NCT01732211|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1442910|NCT01732198|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1442911|NCT01732185||Single Group Assignment||Basic Science||None (Open Label)||||||
1442912|NCT01732172|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442913|NCT01732159|Randomized|Parallel Assignment||||None (Open Label)||||||
1442914|NCT01732146|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442915|NCT01732133||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442916|NCT01732120|Randomized|Parallel Assignment||Treatment||Single|||t|||
1442917|NCT01732107||Single Group Assignment||Treatment||None (Open Label)||||||
1442918|NCT01732094||Single Group Assignment||Treatment||None (Open Label)||||||
1442919|NCT01732081|||Cohort||Prospective|||||||
1442920|NCT01732068||Single Group Assignment||Treatment||None (Open Label)||||||
1442921|NCT01732055|Randomized|Parallel Assignment||Treatment||Single||||||t
1442922|NCT01732042|||Cohort||Prospective|||||||
1442923|NCT01732029||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442924|NCT01732016||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442925|NCT01732003|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1442926|NCT01731990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442927|NCT01731977|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1442928|NCT01731964||Single Group Assignment||Treatment||None (Open Label)||||||
1442929|NCT01731951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442930|NCT01731938|Randomized|Parallel Assignment||Treatment||Single||||||t
1442931|NCT01731925|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442932|NCT01731912||Single Group Assignment||Treatment||None (Open Label)||||||
1442933|NCT01731899|||Cohort||Prospective|||||||
1442934|NCT01731886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442935|NCT01731873|||Case-Only||Prospective|||||||
1442936|NCT01731860||Single Group Assignment||Diagnostic||None (Open Label)||||||
1442937|NCT01731847||Single Group Assignment||Treatment||Single||||||t
1442938|NCT01731834|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1442939|NCT01731821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442940|NCT01731808|Randomized|Parallel Assignment||||None (Open Label)||||||
1442941|NCT01731795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442942|NCT01731782|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1442943|NCT01731769|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1442944|NCT01731756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442945|NCT01731743||Single Group Assignment||Treatment||None (Open Label)||||||
1442946|NCT01731730|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442947|NCT01731717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442948|NCT01731704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442949|NCT01731691|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1442950|NCT01731678||Single Group Assignment||Treatment||None (Open Label)|Open label rTMS|||||
1442951|NCT01731665|||Cohort|||||||||
1442952|NCT01731652||Single Group Assignment||Treatment||None (Open Label)||||||
1442953|NCT01731639||Single Group Assignment||Diagnostic||Double|||t|||t
1442954|NCT01731613|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1442955|NCT01731600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1442956|NCT01731587||Single Group Assignment||Basic Science||None (Open Label)||||||
1442957|NCT01731574|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1442958|NCT01731561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442959|NCT01731548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442960|NCT01731535|||||Retrospective|||||||
1442961|NCT01731522||Single Group Assignment||Other||None (Open Label)||||||
1442962|NCT01731509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442963|NCT01731496|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1442964|NCT01731483|||Case-Only||Prospective|||||||
1442965|NCT01731470||Single Group Assignment||Treatment||None (Open Label)||||||
1442966|NCT01731457|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1442967|NCT01731444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442968|NCT01731431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442969|NCT01731418|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442970|NCT01731405||||||||||||
1442971|NCT01731392|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1442972|NCT01731379|||Case-Only||Cross-Sectional|||||||
1442973|NCT01731366|Randomized|Crossover Assignment||||Single|||||t|
1442974|NCT01731353|||Case-Only||Prospective|||||||
1442975|NCT01731340|Randomized|Parallel Assignment||Prevention||Single||||||t
1442976|NCT01731327|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1442977|NCT01731314|Randomized|Single Group Assignment||Other||Single|||t|||
1442978|NCT01731301||Single Group Assignment||Treatment||None (Open Label)||||||
1442979|NCT01731288|||Other||Retrospective|||||||
1442980|NCT01731275|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442981|NCT01731262|||Case Control|||||||||
1442982|NCT01731249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1442983|NCT01731236|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1442984|NCT01731223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1442985|NCT01731210||Single Group Assignment||Treatment||None (Open Label)||NANO LV lead||||
1442986|NCT01731197|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1442987|NCT01731184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442988|NCT01731171|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1442989|NCT01731158|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1442990|NCT01731145|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1442991|NCT01731132|||Cohort||Prospective|||||||
1442992|NCT01731119||Single Group Assignment||Treatment||None (Open Label)||||||
1442993|NCT01731106|||Cohort||Prospective|||||||
1442994|NCT01731093|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1442995|NCT01731080|||Case Control||Prospective|||||||
1442996|NCT01731067|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1442997|NCT01731054|||Cohort||Prospective|||||||
1442998|NCT01731041|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1442999|NCT01731028|||Cohort||Prospective|||||||
1443000|NCT01731015|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1443001|NCT01731002|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443002|NCT01730989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443003|NCT01730976||Single Group Assignment||Treatment||None (Open Label)||||||
1443004|NCT01730963|||Case-Only||Cross-Sectional|||||||
1443005|NCT01730950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443006|NCT01730937|Randomized|Parallel Assignment||Treatment||Single||||||t
1443007|NCT01730924|Randomized|||Treatment||||||||
1443008|NCT01730911|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1443009|NCT01730898|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1443010|NCT01730885|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1443011|NCT01730872|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443012|NCT01730859|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1443013|NCT01730846|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1443014|NCT01730833||Single Group Assignment||Treatment||None (Open Label)||||||
1443015|NCT01730820|||||Prospective|||||||
1443016|NCT01730807||Single Group Assignment||Treatment||None (Open Label)||||||
1443017|NCT01730794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443018|NCT01730781|||Other||Other|||||||
1443019|NCT01730768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443020|NCT01730755||||||||||||
1443021|NCT01730742|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1443022|NCT01730729||Single Group Assignment||Treatment||None (Open Label)||||||
1443023|NCT01730716||Single Group Assignment||Treatment||None (Open Label)||||||
1443024|NCT01730703|||Cohort||Prospective|||||||
1443025|NCT01730690|||Cohort||Prospective|||||||
1443026|NCT01730677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443027|NCT01730664||Single Group Assignment||Other||None (Open Label)||||||
1443028|NCT01730651||Single Group Assignment||Treatment||None (Open Label)||||||
1443029|NCT01730638||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443030|NCT01730625|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1443031|NCT01730612||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443032|NCT01730599|||Cohort|||||||||
1443033|NCT01730586||Single Group Assignment||Treatment||None (Open Label)||||||
1443034|NCT01730573|Randomized|Parallel Assignment||Treatment||Single||||||t
1443035|NCT01730560|Randomized|Crossover Assignment||Other||Single|||t|||
1443036|NCT01730547|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443037|NCT01730534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443038|NCT01730521|||Case-Only||Prospective|||||||
1443039|NCT01730508|||Cohort||Prospective|||||||
1443040|NCT01730495||Single Group Assignment||Treatment||None (Open Label)||||||
1443041|NCT01730482||Single Group Assignment||Treatment||None (Open Label)||||||
1443042|NCT01730469||Single Group Assignment||Treatment||None (Open Label)||||||
1443043|NCT01730456||Single Group Assignment||Treatment||None (Open Label)||||||
1443044|NCT01730443|||Case-Only||Prospective|||||||
1443045|NCT01730430|||Case Control||Cross-Sectional|||||||
1443046|NCT01730417||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443047|NCT01730404|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443048|NCT01730391|||Case-Only||Cross-Sectional|||||||
1443049|NCT01730378|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443050|NCT01730365|||Case-Only||Cross-Sectional|||||||
1443051|NCT01730352|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443052|NCT01730339|Randomized|||Treatment||Double|||t||t|
1443053|NCT01730326|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443054|NCT01730313|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443055|NCT01730300|||Cohort||Prospective|||||||
1443056|NCT01730287|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443057|NCT01730274|||Case Control||Prospective|||||||
1443058|NCT01730261||Single Group Assignment||Treatment||None (Open Label)||||||
1443059|NCT01730248|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443060|NCT01730235|||Case Control||Prospective|||||||
1443061|NCT01730222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443062|NCT01730209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443063|NCT01730196|Randomized|Parallel Assignment||Prevention||Single|||||t|
1443064|NCT01730183||Single Group Assignment||Treatment||None (Open Label)||||||
1443065|NCT01730170|||Cohort||Prospective|||||||
1443066|NCT01730157||Single Group Assignment||Treatment||None (Open Label)||||||
1443067|NCT01730144|||Other||Prospective|||||||
1443068|NCT01730131|||Cohort||Prospective|||||||
1443069|NCT01730118|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1443070|NCT01730105|||Cohort||Prospective|||||||
1443071|NCT01730092|||Cohort||Prospective|||||||
1443072|NCT01730079|||Cohort||Prospective|||||||
1443073|NCT01730066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443074|NCT01730053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443075|NCT01730040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443076|NCT01730027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443077|NCT01730014|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1443078|NCT01730001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443079|NCT01729988||Single Group Assignment||Treatment||None (Open Label)||||||
1443080|NCT01729975|||Cohort||Prospective|||||||
1443081|NCT01729962|||Case-Only||Prospective|||||||
1443082|NCT01729949|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1443083|NCT01729936|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1443084|NCT01729923||Single Group Assignment||Treatment||None (Open Label)||||||
1443085|NCT01729910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443086|NCT01729897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443087|NCT01729884||Single Group Assignment||Treatment||None (Open Label)||||||
1443088|NCT01729871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443089|NCT01729858|||Cohort||Prospective|||||||
1443090|NCT01729845||Single Group Assignment||Treatment||None (Open Label)||||||
1443091|NCT01729832||Single Group Assignment||Supportive Care||None (Open Label)||||||
1443092|NCT01729819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443093|NCT01729806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443094|NCT01729793|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1443095|NCT01729780|Randomized|Parallel Assignment||Prevention||Single|||t|||
1443096|NCT01729767|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443097|NCT01729754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443098|NCT01729741|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1443099|NCT01729728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443100|NCT01729715|Randomized|Parallel Assignment||Treatment||Single||||||t
1443101|NCT01729702||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443102|NCT01729689||Single Group Assignment||Supportive Care||None (Open Label)||||||
1443103|NCT01729676|||Cohort||Prospective|||||||
1443104|NCT01729663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443105|NCT01729650|Randomized|Parallel Assignment||Prevention||Single||||||t
1443106|NCT01729637|||||Prospective|||||||
1443107|NCT01729624|||||Prospective|||||||
1443108|NCT01729611|||Cohort||Prospective|||||||
1443109|NCT01729598|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1443110|NCT01729585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443111|NCT01729572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443112|NCT01729559|Randomized|Parallel Assignment||Prevention||Single||||||t
1443113|NCT01729546||||||||||||
1443114|NCT01729533|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443115|NCT01729520||Single Group Assignment||Basic Science||Single||||||t
1443116|NCT01729507|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443117|NCT01729494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443118|NCT01729481|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443119|NCT01729468|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443120|NCT01729455|||Cohort||Prospective|||||||
1443121|NCT01729442|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1443122|NCT01729429|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1443123|NCT01729416|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1443124|NCT01729403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443125|NCT01729390|Randomized|Crossover Assignment||Prevention||Single|||t|||
1443126|NCT01729377|||Cohort||Prospective|||||||
1443127|NCT01729364|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443128|NCT01729351|||Cohort||Retrospective|||||||
1443129|NCT01729338||Single Group Assignment||Treatment||None (Open Label)||||||
1443130|NCT01729325|Randomized|Single Group Assignment||Prevention||Single||||||t
1443131|NCT01729312|||Case-Control||Prospective|||||||
1443132|NCT01729299|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1443133|NCT01729286|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443134|NCT01729273||Single Group Assignment||Prevention||None (Open Label)||||||
1443135|NCT01729260||Single Group Assignment||Treatment||None (Open Label)||||||
1443136|NCT01729247|||Case-Only||Prospective|||||||
1443137|NCT01729234|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1443138|NCT01729221|||Cohort||Prospective|||||||
1443139|NCT01729208|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443140|NCT01729195||Single Group Assignment||Treatment||Single|||t|||
1443141|NCT01729182|||Cohort||Prospective|||||||
1443142|NCT01729169|||Case-Crossover||Prospective|||||||
1443143|NCT01729156|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1443144|NCT01729143|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1443145|NCT01729130|||Cohort||Prospective|||||||
1443146|NCT01729117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443147|NCT01729104|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443148|NCT01729091||Single Group Assignment||Treatment||None (Open Label)||||||
1443149|NCT01729078|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1443150|NCT01729065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443151|NCT01729052|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1443152|NCT01729039|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443153|NCT01729026|Randomized|Parallel Assignment||Treatment||Single||||||t
1443154|NCT01729013|||Cohort||Prospective|||||||
1443155|NCT01729000|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443156|NCT01728987|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1443157|NCT01728974||Single Group Assignment||||None (Open Label)||||||
1443158|NCT01728961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443159|NCT01728948|||Cohort||Prospective|||||||
1443160|NCT01728935||Single Group Assignment||Treatment||None (Open Label)||||||
1443161|NCT01728922|Randomized|Parallel Assignment||Treatment||Quadruple|similar appearance of placebo and active drug|double-blind, dose ranging, two doses of vitamin D, randomised parallel groups with placebo arms in clinically isolated syndrome and heathy control participants|t|t|t|t
1443162|NCT01728909|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1443163|NCT01728896|Randomized|Parallel Assignment||Prevention||||||||
1443164|NCT01728883|||Case-Only||Prospective|||||||
1443165|NCT01728870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443166|NCT01728857||Single Group Assignment||Other||None (Open Label)||||||
1443167|NCT01728844||||||||||||
1443168|NCT01728831|||Cohort||Prospective|||||||
1443169|NCT01728818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443170|NCT01728805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443171|NCT01728792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443172|NCT01728779||Single Group Assignment||Treatment||None (Open Label)||||||
1443173|NCT01728766|||Cohort||Prospective|||||||
1443174|NCT01728753|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443175|NCT01728740|Randomized|Crossover Assignment||||None (Open Label)||||||
1443176|NCT01728727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443177|NCT01728714|||Case-Control||Prospective|||||||
1443178|NCT01728701|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443179|NCT01728688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443180|NCT01728675|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443181|NCT01728662||Single Group Assignment||Treatment||None (Open Label)||||||
1443182|NCT01728649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443183|NCT01728636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443184|NCT01728623||Single Group Assignment||Treatment||None (Open Label)||||||
1443185|NCT01728610|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1443186|NCT01728597|||Other||Other|||||||
1443187|NCT01728584|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443188|NCT01728571|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1443189|NCT01728558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443190|NCT01728545|||Case-Only||Prospective|||||||
1443191|NCT01728532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443192|NCT01728519|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1443193|NCT01728506||Single Group Assignment||Supportive Care||None (Open Label)||||||
1443194|NCT01728493|||Case Control||Prospective|||||||
1443195|NCT01728480||Single Group Assignment||Treatment||None (Open Label)||||||
1443196|NCT01728467|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443197|NCT01728454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443198|NCT01728441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443199|NCT01728428|||||Retrospective|||||||
1443200|NCT01728415|Randomized|Factorial Assignment||Treatment||Single||||||t
1443201|NCT01728402|||Cohort||Prospective|||||||
1443202|NCT01728389||Single Group Assignment||Treatment||None (Open Label)||||||
1443203|NCT01728376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443204|NCT01728363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443205|NCT01728350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443206|NCT01728337||Single Group Assignment||Treatment||Double|||t||t|
1443207|NCT01728324|Randomized|Parallel Assignment||Treatment||Double||||||
1443208|NCT01728311||Single Group Assignment||Treatment||None (Open Label)||||||
1443209|NCT01728298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443210|NCT01728285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443211|NCT01728272|Randomized|Single Group Assignment||Treatment||Single|||||t|
1443212|NCT01728259||Single Group Assignment||Treatment||None (Open Label)||||||
1443213|NCT01728246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443214|NCT01728233||Single Group Assignment||Treatment||None (Open Label)||||||
1443215|NCT01728220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443216|NCT01728207||Single Group Assignment||Treatment||None (Open Label)||||||
1443217|NCT01728194||Single Group Assignment||Basic Science||None (Open Label)||||||
1443218|NCT01728181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443219|NCT01728168|||Case Control||Cross-Sectional|||||||
1443220|NCT01728155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443221|NCT01728142|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1443222|NCT01728129|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1443223|NCT01728116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443224|NCT01728103|||Cohort||Prospective|||||||
1443225|NCT01728090|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443226|NCT01728077||Single Group Assignment||Treatment||None (Open Label)||||||
1443227|NCT01728064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443228|NCT01728051||||||||||||
1443229|NCT01728038||Single Group Assignment||Treatment||None (Open Label)||||||
1443230|NCT01728025||Single Group Assignment||Prevention||None (Open Label)||||||
1443231|NCT01728012|||Case-Only||Cross-Sectional|||||||
1443232|NCT01727999|||Cohort||Prospective|||||||
1443233|NCT01727986||||Treatment||None (Open Label)||||||
1443234|NCT01727973||Single Group Assignment||Treatment||None (Open Label)||||||
1443235|NCT01727960|||Cohort||Prospective|||||||
1443236|NCT01727947||Single Group Assignment||Diagnostic||Double|||t|||t
1443237|NCT01727934||Single Group Assignment||Treatment||None (Open Label)||||||
1443238|NCT01727921|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1443239|NCT01727908|Randomized|Parallel Assignment||Prevention||Single||||||t
1443240|NCT01727895|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1443241|NCT01727882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443242|NCT01727869|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443243|NCT01727856|||Cohort||Prospective|||||||
1443244|NCT01727843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443245|NCT01727830|||Case Control||Prospective|||||||
1443246|NCT01727817|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443247|NCT01727804||Single Group Assignment||Prevention||Double|||t||t|
1443248|NCT01727791|Non-Randomized|||||None (Open Label)||||||
1443249|NCT01727778||Single Group Assignment||Treatment||None (Open Label)||||||
1443250|NCT01727765|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443251|NCT01727752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443252|NCT01727739|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443253|NCT01727726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443254|NCT01727713||Single Group Assignment||Treatment||None (Open Label)||||||
1443255|NCT01727700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443256|NCT01727687||Single Group Assignment||||None (Open Label)||||||
1443257|NCT01727674|||Ecologic or Community||Retrospective|||||||
1443258|NCT01727661|||Case Control||Cross-Sectional|||||||
1443259|NCT01727648|Randomized|Factorial Assignment||Treatment||Single||||||t
1443260|NCT01727635||Single Group Assignment||Supportive Care||Single|||||t|
1443261|NCT01727622||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443262|NCT01727609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443263|NCT01727596||Single Group Assignment||Treatment||Triple||||t|t|t
1443264|NCT01727583|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1443265|NCT01727570|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1443266|NCT01727557|Randomized|Parallel Assignment||Treatment||Single||||||t
1443267|NCT01727544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443268|NCT01727531||Single Group Assignment||Treatment||None (Open Label)||||||
1443269|NCT01727518|||Cohort||Prospective|||||||
1443270|NCT01727505|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443271|NCT01727492|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1443272|NCT01727479|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1443273|NCT01727466||Single Group Assignment||Treatment||Single||||||t
1443274|NCT01727453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443275|NCT01727440|||Case-Control||Retrospective|||||||
1443276|NCT01727427|||Cohort||Prospective|||||||
1443277|NCT01727414|Randomized|Crossover Assignment||Treatment||Quadruple||Every participant receives placebo and three different dose of MPH for one week each in a triple blinded fashion|t|t|t|t
1443278|NCT01727401||Single Group Assignment||Prevention||None (Open Label)||||||
1443279|NCT01727388|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1443280|NCT01727375|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443281|NCT01727362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443282|NCT01727349|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443283|NCT01727336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443284|NCT01727310|||Case-Only|||||||||
1443285|NCT01727297||Single Group Assignment||Screening||None (Open Label)||||||
1443286|NCT01727284||Single Group Assignment||Treatment||None (Open Label)||||||
1443287|NCT01727271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443288|NCT01727258|Randomized|Parallel Assignment||||Single|||||t|
1443289|NCT01727245|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1443290|NCT01727232|||Cohort||Retrospective|||||||
1443291|NCT01727219|||Cohort||Cross-Sectional|||||||
1443292|NCT01727206||Single Group Assignment||Treatment||None (Open Label)||||||
1443293|NCT01727193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443294|NCT01727180|||Case-Only||Cross-Sectional|||||||
1443295|NCT01727167|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1443296|NCT01727154|||Case-Only||Prospective|||||||
1443297|NCT01727141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443298|NCT01727128|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1443299|NCT01727115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443300|NCT01727089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443301|NCT01727076||Single Group Assignment||Treatment||None (Open Label)||||||
1443302|NCT01727063|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443303|NCT01727050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443304|NCT01727037||Single Group Assignment||Treatment||None (Open Label)||||||
1443305|NCT01727024|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443306|NCT01727011||Single Group Assignment||Treatment||None (Open Label)||||||
1443307|NCT01726998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443308|NCT01726985|||Cohort||Prospective|||||||
1443309|NCT01726972|||Cohort||Retrospective|||||||
1443310|NCT01726959|||Cohort||Prospective|||||||
1443311|NCT01726946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443312|NCT01726933|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443313|NCT01726920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443314|NCT01726907|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443315|NCT01726894||Single Group Assignment||||None (Open Label)||||||
1443316|NCT01726881|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1443317|NCT01726868||Single Group Assignment||Treatment||None (Open Label)||||||
1443318|NCT01726855|||Case Control||Retrospective|||||||
1443319|NCT01726842|||Case Control||Prospective|||||||
1443320|NCT01726829|Randomized|Crossover Assignment||Treatment||Single|||||t|
1443321|NCT01726816|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443322|NCT01726803|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1443323|NCT01726790|||Case-Only||Prospective|||||||
1443324|NCT01726777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443325|NCT01726764||Single Group Assignment||||None (Open Label)||||||
1443326|NCT01726751|Randomized|Crossover Assignment||Treatment||Single||Spinal cord stimulation|t|||
1443327|NCT01726738||Single Group Assignment||Treatment||None (Open Label)||||||
1443328|NCT01726725|||Case Control||Prospective|||||||
1443329|NCT01726712|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443330|NCT01726699|||Case-Only||Prospective|||||||
1443331|NCT01726686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443332|NCT01726673|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443333|NCT01726660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443334|NCT01726647||||||||||||
1443335|NCT01726634||Single Group Assignment||||Double|||t||t|
1443336|NCT01726621||Single Group Assignment||||None (Open Label)||||||
1443337|NCT01726608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443338|NCT01726595|||Cohort||Prospective|||||||
1443339|NCT01726582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443340|NCT01726569|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443341|NCT01726556|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1443342|NCT01726543|Randomized|Parallel Assignment||Treatment||Single|||||t|
1443343|NCT01726530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443344|NCT01726517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443345|NCT01726504|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1443346|NCT01726491|||Cohort||Prospective|||||||
1443347|NCT01726478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443348|NCT01726465|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1443349|NCT01726452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443350|NCT01726439|||Cohort||Prospective|||||||
1443351|NCT01726426|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443352|NCT01726413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443353|NCT01726400|||Case-Only||Prospective|||||||
1443354|NCT01726387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443355|NCT01726374||Single Group Assignment||Treatment||None (Open Label)||||||
1443356|NCT01726361|Randomized|Parallel Assignment||Treatment||Single||||||t
1443357|NCT01726348|||Case-Only||Prospective|||||||
1443358|NCT01726335||Single Group Assignment||Treatment||None (Open Label)||||||
1443359|NCT01726322|||Cohort||Prospective|||||||
1443360|NCT01726309|||Cohort||Prospective|||||||
1443361|NCT01726296||Single Group Assignment||Health Services Research||None (Open Label)||||||
1443362|NCT01726283|||Case-Only||Prospective|||||||
1443363|NCT01726270||Single Group Assignment||Treatment||None (Open Label)||||||
1443364|NCT01726257||Single Group Assignment||Treatment||None (Open Label)||||||
1443365|NCT01726244|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443366|NCT01726231|||Case-Only||Cross-Sectional|||||||
1443367|NCT01726218|||Case-Control||Prospective|||||||
1443368|NCT01726205|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1443369|NCT01726192|Randomized|Parallel Assignment||Treatment||Single||||||t
1443370|NCT01726179|Randomized|Parallel Assignment||Treatment||Single|||||t|
1443371|NCT01726166|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1443372|NCT01726153|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443373|NCT01726140|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443374|NCT01726127|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1443375|NCT01726114||Single Group Assignment||||None (Open Label)||||||
1443376|NCT01726088|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1443377|NCT01726075|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443378|NCT01726062|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1443379|NCT01726049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443380|NCT01726036|Randomized|Single Group Assignment||||Single||||||t
1443381|NCT01726023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443382|NCT01726010||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443383|NCT01725997|Randomized|Parallel Assignment||Treatment||Single||||||t
1443384|NCT01725984|||Cohort|||||||||
1443385|NCT01725971|||||Cross-Sectional|||||||
1443386|NCT01725958||Single Group Assignment||Treatment||None (Open Label)||||||
1443387|NCT01725945|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1443388|NCT01725932|Randomized|Parallel Assignment||Treatment||Single||||||t
1443389|NCT01725919|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443390|NCT01725906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443391|NCT01725893|||Case-Only||Retrospective|||||||
1443392|NCT01725880|||Cohort||Prospective|||||||
1443393|NCT01725867|Randomized|Parallel Assignment||Treatment||Single||||||t
1443394|NCT01725854|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443395|NCT01725841|||||Retrospective|||||||
1443396|NCT01725828|Randomized|Parallel Assignment||Prevention||Single||||||t
1443397|NCT01725815|Randomized|Parallel Assignment||Treatment||Single||||||t
1443398|NCT01725802|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443399|NCT01725789|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443400|NCT01725776||Single Group Assignment||Prevention||None (Open Label)||||||
1443401|NCT01725763||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443402|NCT01725750|Randomized|Parallel Assignment||Treatment||Single||||||t
1443403|NCT01725737|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443404|NCT01725724|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443405|NCT01725711||Single Group Assignment||Treatment||None (Open Label)||||||
1443406|NCT01725698||Single Group Assignment||Treatment||Single||||||t
1443407|NCT01725685|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1443408|NCT01725672|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443409|NCT01725659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443410|NCT01725646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443411|NCT01725633|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443412|NCT01725620|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1443413|NCT01725607|Randomized|Parallel Assignment||Treatment||Single||||||t
1443414|NCT01725594|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1443415|NCT01725581|||||Prospective|||||||
1443416|NCT01725568|||Case-Only||Prospective|||||||
1443417|NCT01725555|Randomized|Crossover Assignment||||None (Open Label)||||||
1443418|NCT01725542||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443419|NCT01725529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443420|NCT01725516||||||||||||
1443421|NCT01725503||Single Group Assignment||Basic Science||None (Open Label)||||||
1443422|NCT01725490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443423|NCT01725477|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1443424|NCT01725464||Single Group Assignment||Treatment||None (Open Label)||||||
1443425|NCT01725451|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1443426|NCT01725438||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443427|NCT01725425|Randomized|Crossover Assignment||Treatment||Single|||t|||
1443428|NCT01725412|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443429|NCT01725399|Randomized|Single Group Assignment||Prevention||Double||||t||t
1443430|NCT01725386|||Cohort||Prospective|||||||
1443431|NCT01725373|||Cohort||Prospective|||||||
1443432|NCT01725360||Single Group Assignment||Treatment||None (Open Label)||||||
1443433|NCT01725347|||Other||Cross-Sectional|||||||
1443434|NCT01725334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443435|NCT01725321|||Cohort||Prospective|||||||
1443436|NCT01725308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443437|NCT01725295|Randomized|Parallel Assignment||Treatment||Single||||||
1443438|NCT01725282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443439|NCT01725269|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443440|NCT01725256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443441|NCT01725243|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443442|NCT01725230|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1443443|NCT01725217||Single Group Assignment||Prevention||None (Open Label)||||||
1443444|NCT01725204||Single Group Assignment||Treatment||None (Open Label)||||||
1443445|NCT01725191||Single Group Assignment||Treatment||None (Open Label)||||||
1443446|NCT01725178|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1443447|NCT01725165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443448|NCT01725152|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443449|NCT01725139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443450|NCT01725126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443451|NCT01725113|Randomized|Crossover Assignment||Treatment||Single|||t|||
1443452|NCT01725100|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1443453|NCT01725087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443454|NCT01725074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443455|NCT01725061|||Cohort||Prospective|||||||
1443456|NCT01725048|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443457|NCT01725035|||Case Control||Prospective|||||||
1443458|NCT01725022|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1443459|NCT01725009|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1443460|NCT01724996|||Cohort||Prospective|||||||
1443461|NCT01724983|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443462|NCT01724970|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443463|NCT01724957|||Cohort||Prospective|||||||
1443464|NCT01724944||Single Group Assignment||Treatment||None (Open Label)||||||
1443465|NCT01724931|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443466|NCT01724918|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1443467|NCT01724905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443468|NCT01724892|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1443469|NCT01724879||Single Group Assignment||Treatment||None (Open Label)||||||
1443470|NCT01724866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443471|NCT01724853|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1443472|NCT01724840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443473|NCT01724827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443474|NCT01724814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443475|NCT01724801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443476|NCT01724788|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443477|NCT01724775|||Cohort||Prospective|||||||
1443478|NCT01724762||Single Group Assignment||||None (Open Label)||||||
1443479|NCT01724749|||Cohort||Prospective|||||||
1443480|NCT01724736|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1443481|NCT01724723|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443482|NCT01724710|||Case Control||Prospective|||||||
1443483|NCT01724697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443484|NCT01724684|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1443485|NCT01724671|||Case Control||Retrospective|||||||
1443486|NCT01724658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443487|NCT01724645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443488|NCT01724632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443489|NCT01724619|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1443490|NCT01724606||Single Group Assignment||Treatment||None (Open Label)||||||
1443491|NCT01724593|||Cohort||Prospective|||||||
1443492|NCT01724580||||||||||||
1443493|NCT01724567|Randomized|Parallel Assignment||Prevention||Single||||||t
1443494|NCT01724554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443495|NCT01724541||||||||||||
1443496|NCT01724528|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443497|NCT01724515|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1443498|NCT01724502|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1443499|NCT01724489|Randomized|Parallel Assignment||Other||Double|||t||t|
1443500|NCT01724476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443501|NCT01724463|||Cohort||Prospective|||||||
1443502|NCT01724450|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443503|NCT01724437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443504|NCT01724424|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1443505|NCT01724411|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1443506|NCT01724398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443507|NCT01724385||Single Group Assignment||Treatment||None (Open Label)||||||
1443508|NCT01724372|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443509|NCT01724359||Single Group Assignment||Treatment||None (Open Label)||||||
1443510|NCT01724346|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)|Open label study|||||
1443511|NCT01724333|||Cohort||Cross-Sectional|||||||
1443512|NCT01724320||Single Group Assignment||Treatment||None (Open Label)||||||
1443513|NCT01724307|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443514|NCT01724294|||Cohort||Prospective|||||||
1443515|NCT01724281|||Cohort||Prospective|||||||
1443516|NCT01724268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443517|NCT01724255|||Cohort||Prospective|||||||
1443518|NCT01724242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443519|NCT01724229||Single Group Assignment||Treatment||None (Open Label)||||||
1443520|NCT01724216||Single Group Assignment||||None (Open Label)||||||
1443521|NCT01724203|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1443522|NCT01724190|Randomized|Parallel Assignment||||Triple|||t|t|t|
1443523|NCT01724177||Single Group Assignment||Treatment||None (Open Label)||||||
1443524|NCT01724164|Randomized|Parallel Assignment||Treatment||Single||||||t
1443525|NCT01724151|||Case Control||Cross-Sectional|||||||
1443526|NCT01724138|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443527|NCT01724125|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1443528|NCT01724112|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443529|NCT01724099|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443530|NCT01724086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443531|NCT01724073|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443532|NCT01724060|||Case Control||Prospective|||||||
1443533|NCT01724047|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1443534|NCT01724034|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443535|NCT01724021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443536|NCT01723995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443537|NCT01723982|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443538|NCT01723969|||Case-Only||Prospective|||||||
1443539|NCT01723956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443540|NCT01723943|Randomized|Parallel Assignment||Supportive Care||Double||||||
1443541|NCT01723930|||Cohort||Prospective|||||||
1443542|NCT01723917|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1443543|NCT01723904||Single Group Assignment||Treatment||None (Open Label)||||||
1443544|NCT01723891|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443545|NCT01723878|||Cohort||Prospective|||||||
1443546|NCT01723865|||Case Control||Prospective|||||||
1443547|NCT01723852|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443548|NCT01723839||Single Group Assignment||Treatment||None (Open Label)||||||
1443549|NCT01723826||Single Group Assignment||Treatment||None (Open Label)||||||
1443550|NCT01723813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443551|NCT01723800||Single Group Assignment||Treatment||None (Open Label)||||||
1443552|NCT01723787|||Family-Based||Prospective|||||||
1443553|NCT01723774|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443554|NCT01723761|||Cohort||Prospective|||||||
1443555|NCT01723748|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1443556|NCT01723735|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1443557|NCT01723722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443558|NCT01723709|||Cohort||Prospective|||||||
1443559|NCT01723696|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1443560|NCT01723683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443561|NCT01723670|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443562|NCT01723657||Single Group Assignment||Treatment||None (Open Label)||||||
1443563|NCT01723644|Randomized|Parallel Assignment||Other||Single||||t||
1443564|NCT01723631|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1443565|NCT01723618|Randomized|Parallel Assignment||||None (Open Label)||||||
1443566|NCT01723605|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1443567|NCT01723592|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1443568|NCT01723579||Single Group Assignment||Treatment||None (Open Label)||||||
1443569|NCT01723566|||Cohort||Prospective|||||||
1443570|NCT01723553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443571|NCT01723540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443572|NCT01723527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443573|NCT01723514|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443574|NCT01723501|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443575|NCT01723488|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1443576|NCT01723475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443577|NCT01723462|||Cohort||Prospective|||||||
1443578|NCT01723449|||Cohort||Prospective|||||||
1443579|NCT01723436|Randomized|Parallel Assignment||||Single|||t|||
1443580|NCT01723423|||Cohort||Prospective|||||||
1443581|NCT01723410|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1443582|NCT01723397|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1443583|NCT01723384|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443584|NCT01723371||Single Group Assignment||Treatment||None (Open Label)||||||
1443585|NCT01723358||Single Group Assignment||Treatment||None (Open Label)||||||
1443586|NCT01723345|Randomized|Parallel Assignment||Prevention||Single||||||t
1443587|NCT01723332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443588|NCT01723319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443589|NCT01723306||Single Group Assignment||Treatment||None (Open Label)||||||
1443590|NCT01723293|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1443591|NCT01723280|||Case Control||Prospective|||||||
1443592|NCT01723267|Randomized|Parallel Assignment||||None (Open Label)||||||
1443593|NCT01723254|Randomized|||Treatment||Quadruple|||t|t|t|t
1443594|NCT01723241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443595|NCT01723228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443596|NCT01723215|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1443597|NCT01723202|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443598|NCT01723189|||Case Control||Prospective|||||||
1443599|NCT01723176|||Cohort||Prospective|||||||
1443600|NCT01723163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443601|NCT01723150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443602|NCT01723137|||Cohort||Prospective|||||||
1443603|NCT01723124||Single Group Assignment||Diagnostic||Single|||||t|
1443604|NCT01723111|||Case-Control||Prospective|||||||
1443605|NCT01723098|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1443606|NCT01723085|||Cohort||Prospective|||||||
1443607|NCT01723072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443608|NCT01723059|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443609|NCT01723046||Single Group Assignment||Supportive Care||Single||||||t
1443610|NCT01723033|||Case Control||Prospective|||||||
1443611|NCT01723020||Single Group Assignment||Treatment||None (Open Label)||||||
1443612|NCT01723007|Randomized|Parallel Assignment||||Single|||||t|
1443613|NCT01722994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443614|NCT01722981|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1443615|NCT01722968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443616|NCT01722955|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1443617|NCT01722942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443618|NCT01722929|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Participants had the skin sensor measure temperature both near a surgery site and also near a non-surgery site. There is one intervention (skin sensor) and the participants were assigned to both arms surgery side and non-surgery side in parallel."||||
1443619|NCT01722916||Single Group Assignment||Basic Science||None (Open Label)||||||
1443620|NCT01722903|||Cohort||Prospective|||||||
1443621|NCT01722890|||Cohort||Retrospective|||||||
1443622|NCT01722877||Single Group Assignment||Treatment||None (Open Label)||||||
1443623|NCT01722864||Single Group Assignment||Treatment||None (Open Label)||||||
1443624|NCT01722851|||Cohort||Prospective|||||||
1443625|NCT01722838|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443626|NCT01722825||Single Group Assignment||Treatment||None (Open Label)||||||
1443627|NCT01722812|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443628|NCT01722799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443629|NCT01722786|||Cohort||Prospective|||||||
1443630|NCT01722773|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443631|NCT01722760|||Cohort||Prospective|||||||
1443632|NCT01722747|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443633|NCT01722734|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1443634|NCT01722721|||Case-Only||Prospective|||||||
1443635|NCT01722708|Randomized|Crossover Assignment||Treatment||Single||||||t
1443636|NCT01722695|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443637|NCT01722682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443638|NCT01722669|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1443639|NCT01722656||Single Group Assignment||Treatment||None (Open Label)||||||
1443640|NCT01722643|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443641|NCT01722630|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443642|NCT01722617|Randomized|Parallel Assignment||||None (Open Label)||||||
1443643|NCT01722604|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1443644|NCT01722591||Single Group Assignment||||None (Open Label)||||||
1443645|NCT01722578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443646|NCT01722565|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443647|NCT01722552|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1443648|NCT01722539|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443649|NCT01722526||Single Group Assignment||Treatment||None (Open Label)||||||
1443650|NCT01722513||Single Group Assignment||Prevention||Single|||t|||
1443651|NCT01722500|||Cohort||Cross-Sectional|||||||
1443652|NCT01722487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443653|NCT01722474||Single Group Assignment||Screening||None (Open Label)||||||
1443654|NCT01722461|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443655|NCT01722448|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1443656|NCT01722435|||Cohort||Prospective|||||||
1443657|NCT01722422|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1443658|NCT01722409|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443659|NCT01722396||Single Group Assignment||Treatment||None (Open Label)||||||
1443660|NCT01722383|||Cohort||Prospective|||||||
1443661|NCT01722370|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1443662|NCT01722357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443663|NCT01722344|Randomized|Parallel Assignment||Other||Single||||||t
1443664|NCT01722331|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443665|NCT01722318|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443666|NCT01722305||Single Group Assignment||Treatment||None (Open Label)||||||
1443667|NCT01722292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443668|NCT01722279|||Case-Only||Cross-Sectional|||||||
1443669|NCT01722266|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443670|NCT01722253|||Case Control||Retrospective|||||||
1443671|NCT01722240|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443672|NCT01722227|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443673|NCT01722214|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1443674|NCT01722201|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443675|NCT01722188|||Case-Only||Prospective|||||||
1443676|NCT01722175|Randomized|Parallel Assignment||Treatment||Single||||||t
1443677|NCT01722162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443678|NCT01722149||Sequential Assignment||Treatment||None (Open Label)||Adoptive Transfer of re-directed FAP-specific T cells||||
1443679|NCT01722136|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443680|NCT01722123|Randomized|Parallel Assignment||Other||Single|||t|||
1443681|NCT01722110|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443682|NCT01722097|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1443683|NCT01722084|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443684|NCT01722071|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1443685|NCT01722058||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443686|NCT01722045||Single Group Assignment||Treatment||None (Open Label)||||||
1443687|NCT01722032|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1443688|NCT01722019|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443689|NCT01722006|||Case-Only|||||||||
1443690|NCT01721993|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1443691|NCT01721980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443692|NCT01721967||Single Group Assignment||Supportive Care||None (Open Label)||||||
1443693|NCT01721954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443694|NCT01721941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443695|NCT01721928|||Case-Control||Prospective|||||||
1443696|NCT01721915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443697|NCT01721902|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1443698|NCT01721889|||Case-Only||Prospective|||||||
1443699|NCT01721876|Randomized|Parallel Assignment||Treatment||Double||||||
1443700|NCT01721863|Randomized|Parallel Assignment||Treatment||Single||||||t
1443701|NCT01721850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443702|NCT01721837|||Cohort||Prospective|||||||
1443703|NCT01721824|Randomized|Parallel Assignment||||Single||||||t
1443704|NCT01721811|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1443705|NCT01721798|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443706|NCT01721785|||Cohort||Prospective|||||||
1443707|NCT01721772|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443708|NCT01721759||Single Group Assignment||Treatment||None (Open Label)||||||
1443709|NCT01721746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443710|NCT01721733|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443711|NCT01721720|||Cohort||Prospective|||||||
1443712|NCT01721707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443713|NCT01721694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443714|NCT01721681||Single Group Assignment||Prevention||None (Open Label)||||||
1443715|NCT01721668|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1443716|NCT01721655|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1443717|NCT01721642||Single Group Assignment||Treatment||None (Open Label)||||||
1443718|NCT01721629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443719|NCT01721616|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1443720|NCT01721603||Single Group Assignment||Treatment||None (Open Label)||||||
1443721|NCT01721590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443722|NCT01721577||Single Group Assignment||Treatment||None (Open Label)||||||
1443723|NCT01721564||Single Group Assignment||Treatment||None (Open Label)||||||
1443724|NCT01721551|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1443725|NCT01721538|Randomized|Parallel Assignment||Prevention||Single|||||t|
1443726|NCT01721525||Single Group Assignment||Treatment||None (Open Label)||||||
1443727|NCT01721512|||Cohort||Prospective|||||||
1443728|NCT01721499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443729|NCT01721486|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1443730|NCT01721473|||Other||Prospective|||||||
1443731|NCT01721460||Single Group Assignment||Treatment||None (Open Label)||||||
1443732|NCT01721447||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443733|NCT01721434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443734|NCT01721421|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1443735|NCT01721408|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1443736|NCT01721395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443737|NCT01721382||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443738|NCT01721369|||Cohort||Prospective|||||||
1443739|NCT01721356|||Cohort||Cross-Sectional|||||||
1443740|NCT01721343|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443741|NCT01721330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443742|NCT01721317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443743|NCT01721304|Randomized|Parallel Assignment||||None (Open Label)||||||
1443744|NCT01721291|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1443745|NCT01721278|||Cohort||Prospective|||||||
1443746|NCT01721265|||Cohort||Prospective|||||||
1443747|NCT01721252|||Cohort||Prospective|||||||
1443748|NCT01721239|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1443749|NCT01721226|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443750|NCT01721213|||||Prospective|||||||
1443751|NCT01721200|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1443752|NCT01721187|||Case Control||Cross-Sectional|||||||
1443753|NCT01721174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443754|NCT01721161|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443755|NCT01721148||Single Group Assignment||Basic Science||None (Open Label)||||||
1443756|NCT01721135|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1443757|NCT01721122||||||||||||
1443758|NCT01721109||Single Group Assignment||Treatment||None (Open Label)||||||
1443759|NCT01721096|||Cohort||Prospective|||||||
1443760|NCT01721083|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1443761|NCT01721070|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1443762|NCT01721057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443763|NCT01721044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443764|NCT01721031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443765|NCT01721018||Single Group Assignment||Treatment||None (Open Label)||||||
1443766|NCT01721005||Single Group Assignment||Prevention||None (Open Label)||||||
1443767|NCT01720992|Randomized|Parallel Assignment||||None (Open Label)||||||
1443768|NCT01720979|||Cohort||Retrospective|||||||
1443769|NCT01720966|||Cohort||Prospective|||||||
1443770|NCT01720953|||Case Control||Prospective|||||||
1443771|NCT01720940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443772|NCT01720927|||Case-Only||Prospective|||||||
1443773|NCT01720914|||Cohort||Prospective|||||||
1443774|NCT01720901||Single Group Assignment||Treatment||None (Open Label)||||||
1443775|NCT01720888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443776|NCT01720875||Single Group Assignment||Treatment||None (Open Label)||||||
1443777|NCT01720862|||Case Control||Cross-Sectional|||||||
1443778|NCT01720849|||Cohort||Prospective|||||||
1443779|NCT01720836|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443780|NCT01720823||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443781|NCT01720810|||Case-Only||Prospective|||||||
1443782|NCT01720797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443783|NCT01720784|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1443784|NCT01720771|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443785|NCT01720758|||Other||Prospective|||||||
1443786|NCT01720745|||Cohort||Prospective|||||||
1443787|NCT01720732|Randomized|Parallel Assignment||Treatment||Single||||||t
1443788|NCT01720719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443789|NCT01720706|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443790|NCT01720693|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1443791|NCT01720680||Single Group Assignment||Treatment||None (Open Label)||||||
1443792|NCT01720667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443793|NCT01720654|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443794|NCT01720641|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443795|NCT01720628|||Case Control||Prospective|||||||
1443796|NCT01720615||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443797|NCT01720602||Single Group Assignment||Treatment||None (Open Label)||||||
1443798|NCT01720589|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1443799|NCT01720576|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1443800|NCT01720563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443801|NCT01720550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443802|NCT01720537|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1443803|NCT01720524|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443804|NCT01720511|Randomized|Crossover Assignment||Prevention||Single|||t|||
1443805|NCT01720498|Non-Randomized|Parallel Assignment||Prevention||Double|||t||t|
1443806|NCT01720485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443807|NCT01720472|||Cohort||Prospective|||||||
1443808|NCT01720459|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443809|NCT01720446|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443810|NCT01720433|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1443811|NCT01720420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443812|NCT01720407|Randomized|Parallel Assignment||Treatment||None (Open Label)|Surgeon does not know the result of randomization.|||||
1443813|NCT01720394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443814|NCT01720381|||Case Control||Prospective|||||||
1443815|NCT01720368|||||Prospective|||||||
1443816|NCT01720355|||||Prospective|||||||
1443817|NCT01720342|||Cohort||Prospective|||||||
1443818|NCT01720329|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1443819|NCT01720316|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443820|NCT01720303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443821|NCT01720290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443822|NCT01720277|Randomized|Parallel Assignment||Prevention||Single||||||t
1443823|NCT01720264||Single Group Assignment||Treatment||None (Open Label)||||||
1443824|NCT01720251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443825|NCT01720238|||Cohort||Prospective|||||||
1443826|NCT01720225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443827|NCT01720212|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1443828|NCT01720199|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443829|NCT01720186|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1443830|NCT01720173||Single Group Assignment||Treatment||None (Open Label)||||||
1443831|NCT01720160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443832|NCT01720147||Single Group Assignment||Prevention||None (Open Label)||||||
1443833|NCT01720134|||Cohort||Retrospective|||||||
1443834|NCT01720121|Randomized|Factorial Assignment||||Single||||||t
1443835|NCT01720108|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443836|NCT01720095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443837|NCT01720082|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1443838|NCT01720069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443839|NCT01720056|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1443840|NCT01720043||Single Group Assignment||Treatment||None (Open Label)||||||
1443841|NCT01720030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443842|NCT01720017|Randomized|Parallel Assignment||||Single||||||t
1443843|NCT01720004|Randomized|Parallel Assignment||Treatment||Single|||||t|
1443844|NCT01719991|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443845|NCT01719978|Non-Randomized|Single Group Assignment||Treatment||Double|||t||t|
1443846|NCT01719965|||Cohort||Prospective|||||||
1443847|NCT01719952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443848|NCT01719926|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1443849|NCT01719913|Randomized|Crossover Assignment||||None (Open Label)||||||
1443850|NCT01719900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443851|NCT01719887|Randomized|Parallel Assignment||Treatment||Single||||||t
1443852|NCT01719874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443853|NCT01719861||Single Group Assignment||Treatment||None (Open Label)||||||
1443854|NCT01719848|||Case-Only||Prospective|||||||
1443855|NCT01719835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443856|NCT01719822|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1443857|NCT01719809|||Other||Prospective|||||||
1443858|NCT01719796|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443859|NCT01719783|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1443860|NCT01719770|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1443861|NCT01719757||Single Group Assignment||Treatment||None (Open Label)||||||
1443862|NCT01719744||Single Group Assignment||Treatment||None (Open Label)||||||
1443863|NCT01719731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443864|NCT01719718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443865|NCT01719705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443866|NCT01719692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443867|NCT01719679|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1443868|NCT01719666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443869|NCT01719653|Randomized|Parallel Assignment||Treatment||Single|||||t|
1443870|NCT01719640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443871|NCT01719627|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1443872|NCT01719614||Single Group Assignment||Treatment||None (Open Label)||||||
1443873|NCT01719601|||Case-Only||Prospective|||||||
1443874|NCT01719588|||Case-Only||Prospective|||||||
1443875|NCT01719575|Randomized|Crossover Assignment||||Double|||t||t|
1443876|NCT01719562||Single Group Assignment||Diagnostic||None (Open Label)||||||
1443877|NCT01719549||Single Group Assignment||Treatment||None (Open Label)||||||
1443878|NCT01719536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443879|NCT01719523||Single Group Assignment||Treatment||None (Open Label)||||||
1443880|NCT01719510||Single Group Assignment||Screening||None (Open Label)||||||
1443881|NCT01719497|||Case-Control||Prospective|||||||
1443882|NCT01719484|||Case-Control||Prospective|||||||
1443883|NCT01719471|||Case Control||Prospective|||||||
1443884|NCT01719458|||Case-Control||Prospective|||||||
1443885|NCT01719445|||Cohort||Prospective|||||||
1443886|NCT01719432|||Case-Control||Prospective|||||||
1443887|NCT01719419|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1443888|NCT01719406|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443889|NCT01719393|||Case Control||Prospective|||||||
1443890|NCT01719380|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443891|NCT01719367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443892|NCT01719354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443893|NCT01719341|||Cohort||Prospective|||||||
1443894|NCT01719328||Single Group Assignment||Treatment||None (Open Label)||||||
1443895|NCT01719315|||Case-Control||Prospective|||||||
1443896|NCT01719302||Single Group Assignment||Treatment||None (Open Label)||||||
1443897|NCT01719289|Randomized|Parallel Assignment||Treatment||Single||||||t
1443898|NCT01719276|Randomized|Parallel Assignment||Treatment||Single||||||t
1443899|NCT01719263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443900|NCT01719250||Single Group Assignment||Treatment||None (Open Label)||||||
1443901|NCT01719237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443902|NCT01719224|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443903|NCT01719211|||Other||Prospective|||||||
1443904|NCT01719198|||Cohort||Prospective|||||||
1443905|NCT01719185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443906|NCT01719172||Single Group Assignment||Treatment||None (Open Label)||||||
1443907|NCT01719159||Single Group Assignment||Treatment||None (Open Label)||||||
1443908|NCT01719146|||Cohort||Prospective|||||||
1443909|NCT01719133||Single Group Assignment||Screening||None (Open Label)||||||
1443910|NCT01719120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443911|NCT01719107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443912|NCT01719094|||Case-Control||Prospective|||||||
1443913|NCT01719081|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443914|NCT01719068|||Cohort||Prospective|||||||
1443915|NCT01719055|||Cohort||Prospective|||||||
1443916|NCT01719042|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1443917|NCT01719029|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1443918|NCT01719016|||Other||Prospective|||||||
1443919|NCT01719003|Randomized|Parallel Assignment||Treatment||Double||||||
1443920|NCT01718990|||Cohort||Prospective|||||||
1443921|NCT01718977|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443922|NCT01718964|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1443923|NCT01718951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443924|NCT01718938|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443925|NCT01718925|||Cohort||Cross-Sectional|||||||
1443926|NCT01718912|Randomized|Crossover Assignment||Treatment||Single|||||t|
1443927|NCT01718899|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1443928|NCT01718886|||Cohort||Prospective|||||||
1443929|NCT01718873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443930|NCT01718860|||Cohort||Prospective|||||||
1443931|NCT01718847||Single Group Assignment||Treatment||None (Open Label)||||||
1443932|NCT01718834|Non-Randomized|Single Group Assignment||Prevention||Single|||||t|
1443933|NCT01718821|||Ecologic or Community||Prospective|||||||
1443934|NCT01718808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443935|NCT01718795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443936|NCT01718782|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443937|NCT01718769|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443938|NCT01718756|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443939|NCT01718743||Single Group Assignment||Treatment||None (Open Label)||||||
1443940|NCT01718730|||Case-Control||Cross-Sectional|||||||
1443941|NCT01718717|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1443942|NCT01718704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443943|NCT01718691||Single Group Assignment||Treatment||None (Open Label)||||||
1443944|NCT01718678|Randomized|Parallel Assignment||Treatment||Single||||||t
1443945|NCT01718652||Single Group Assignment||Treatment||None (Open Label)||||||
1443946|NCT01718639|Randomized|Crossover Assignment||Treatment||Single|||t|||
1443947|NCT01718626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443948|NCT01718613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1443949|NCT01718600|||Cohort||Prospective|||||||
1443950|NCT01718587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443951|NCT01718574|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1443952|NCT01718561|Randomized|Parallel Assignment||Prevention||Single||||||t
1443953|NCT01718548|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1443954|NCT01718535|||||Prospective|||||||
1443955|NCT01718522|||Cohort||Prospective|||||||
1443956|NCT01718509|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443957|NCT01718496|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1443958|NCT01718483|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443959|NCT01718470|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1443960|NCT01718457||Single Group Assignment||Treatment||None (Open Label)||||||
1443961|NCT01718444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443962|NCT01718431|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1443963|NCT01718418|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1443964|NCT01718405||Single Group Assignment||Basic Science||||||||
1443965|NCT01718392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443966|NCT01718379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443967|NCT01718366|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443968|NCT01718353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443969|NCT01718340|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1443970|NCT01718327||Single Group Assignment||Treatment||None (Open Label)||||||
1443971|NCT01718314|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1443972|NCT01718301||Single Group Assignment||Treatment||None (Open Label)||||||
1443973|NCT01718288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443974|NCT01718275|||Case-Control||Prospective|||||||
1443975|NCT01718262|||Cohort||Prospective|||||||
1443976|NCT01718249||Single Group Assignment||Treatment||Single|||t|||
1443977|NCT01718236|Randomized|Factorial Assignment||Treatment||Single|||t|||
1443978|NCT01718223||Single Group Assignment||Treatment||None (Open Label)||||||
1443979|NCT01718210|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443980|NCT01718197|||Cohort||Prospective|||||||
1443981|NCT01718184||Single Group Assignment||Treatment||None (Open Label)||||||
1443982|NCT01718171|||Case Control||Prospective|||||||
1443983|NCT01718158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443984|NCT01718145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443985|NCT01718132|||Cohort||Prospective|||||||
1443986|NCT01718119|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443987|NCT01718106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443988|NCT01718093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443989|NCT01718080|||Case-Control||Cross-Sectional|||||||
1443990|NCT01718067|Randomized|Parallel Assignment||Treatment||Single|||t|||
1443991|NCT01718054|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1443992|NCT01718041||Single Group Assignment||Treatment||None (Open Label)||||||
1443993|NCT01718028|Randomized|Parallel Assignment||Treatment||Single|||||t|
1443994|NCT01718015|||Case-Only||Prospective|||||||
1443995|NCT01718002||Single Group Assignment||Health Services Research||None (Open Label)||||||
1443996|NCT01717989|||Cohort||Prospective|||||||
1443997|NCT01717976|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1443998|NCT01717963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1443999|NCT01717950|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444000|NCT01717937|||Cohort||Prospective|||||||
1444001|NCT01717924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444002|NCT01717911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444003|NCT01717898||Single Group Assignment||Treatment||None (Open Label)||||||
1444004|NCT01717885|||Cohort||Prospective|||||||
1444005|NCT01717872|Randomized|Parallel Assignment||Treatment||Single||||||t
1444006|NCT01717859||Single Group Assignment||Other||None (Open Label)||||||
1444007|NCT01717846|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444008|NCT01717833|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444009|NCT01717820||Single Group Assignment||Basic Science||Double|||t||t|
1444010|NCT01717807|||Cohort||Prospective|||||||
1444011|NCT01717794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444012|NCT01717781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444013|NCT01717768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444014|NCT01717755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444015|NCT01717742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444016|NCT01717729|Randomized|Parallel Assignment||Treatment||Single|||||t|
1444017|NCT01717716|Randomized|Crossover Assignment||Prevention||Single|||t|||
1444018|NCT01717703|Randomized|Crossover Assignment||Prevention||Single|||t|||
1444019|NCT01717690|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444020|NCT01717677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444021|NCT01717664||Single Group Assignment||Treatment||None (Open Label)||||||
1444022|NCT01717651|||Case-Only||Prospective|||||||
1444023|NCT01717638|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444024|NCT01717625|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444025|NCT01717612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444026|NCT01717599|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1444027|NCT01717586|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444028|NCT01717573|Randomized|Parallel Assignment||Treatment||Single||||||t
1444029|NCT01717560||Single Group Assignment||Treatment||None (Open Label)||||||
1444030|NCT01717547||Single Group Assignment||Treatment||None (Open Label)||||||
1444031|NCT01717534|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1444032|NCT01717521|||Cohort||Prospective|||||||
1444033|NCT01717508|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444034|NCT01717495|||Cohort||Prospective|||||||
1444035|NCT01717482|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444036|NCT01717469|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444037|NCT01717456|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444038|NCT01717443|||Cohort||Prospective|||||||
1444039|NCT01717430|||Cohort||Prospective|||||||
1444040|NCT01717417|Randomized|Parallel Assignment||Treatment||Single||||||t
1444041|NCT01717404||Single Group Assignment||Treatment||None (Open Label)||||||
1444042|NCT01717391||Single Group Assignment||Treatment||None (Open Label)||||||
1444043|NCT01717378|||Cohort||Prospective|||||||
1444044|NCT01717365|||Cohort||Retrospective|||||||
1444045|NCT01717352|Randomized|Parallel Assignment||Treatment||Single||||||t
1444046|NCT01717339|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1444047|NCT01717326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444048|NCT01717313|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1444049|NCT01717300|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444050|NCT01717287|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444051|NCT01717274|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1444052|NCT01717261||Single Group Assignment||Treatment||None (Open Label)||||||
1444053|NCT01717248||Single Group Assignment||Treatment||None (Open Label)||||||
1444054|NCT01717235|Randomized|Crossover Assignment||||None (Open Label)||||||
1444055|NCT01717222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444056|NCT01717209||Single Group Assignment||Treatment||None (Open Label)||||||
1444057|NCT01717196||Single Group Assignment||Diagnostic||Single|||||t|
1444058|NCT01717183|Randomized|Parallel Assignment||Treatment||Double||||||
1444059|NCT01717170|Randomized|Parallel Assignment||Treatment||Single||||||t
1444060|NCT01717157|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444061|NCT01717144|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1444062|NCT01717131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444063|NCT01717118|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1444064|NCT01717105|||Cohort||Prospective|||||||
1444065|NCT01717092|||Cohort||Prospective|||||||
1444066|NCT01717079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444067|NCT01717066|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1444068|NCT01717053||Single Group Assignment||Treatment||None (Open Label)||||||
1444069|NCT01717040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444070|NCT01717027|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1444071|NCT01717014||Single Group Assignment||Treatment||None (Open Label)||||||
1444072|NCT01717001|||Case Control||Prospective|||||||
1444073|NCT01716988|||Case-Only||Prospective|||||||
1444074|NCT01716975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444075|NCT01716962|||Cohort||Prospective|||||||
1444076|NCT01716949||Single Group Assignment||Treatment||None (Open Label)||||||
1444077|NCT01716936|||Cohort||Retrospective|||||||
1444078|NCT01716923|Randomized|Parallel Assignment||||Triple|||t|t|t|
1444079|NCT01716910|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1444080|NCT01716897|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444081|NCT01716884|||Cohort||Prospective|||||||
1444082|NCT01716871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444083|NCT01716858||Single Group Assignment||Treatment||None (Open Label)||||||
1444084|NCT01716845|||Cohort||Prospective|||||||
1444085|NCT01716832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444086|NCT01716819||Single Group Assignment||||None (Open Label)||||||
1444087|NCT01716806|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444088|NCT01716793||Single Group Assignment||Treatment||None (Open Label)||||||
1444089|NCT01716780|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1444090|NCT01716767|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1444091|NCT01716754|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444092|NCT01716741||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444093|NCT01716728||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444094|NCT01716715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444095|NCT01716702|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1444096|NCT01716689||Single Group Assignment||Treatment||None (Open Label)||||||
1444097|NCT01716676||||||||||||
1444098|NCT01716663|||||Prospective|||||||
1444099|NCT01716650|||Case-Only||Prospective|||||||
1444100|NCT01716637|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1444101|NCT01716624|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444102|NCT01716611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444103|NCT01716598||Single Group Assignment||Treatment||None (Open Label)||||||
1444104|NCT01716585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444105|NCT01716572|Randomized|Parallel Assignment||Treatment||Single||||||t
1444106|NCT01716559|||Cohort||Prospective|||||||
1444107|NCT01716546||Single Group Assignment||Treatment||None (Open Label)||||||
1444108|NCT01716533|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1444109|NCT01716520|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1444110|NCT01716507|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1444111|NCT01716494|||Cohort||Prospective|||||||
1444112|NCT01716481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444113|NCT01716468||Single Group Assignment||||None (Open Label)||||||
1444114|NCT01716455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444115|NCT01716442|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444116|NCT01716429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444117|NCT01716416|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444118|NCT01716403|||Cohort||Prospective|||||||
1444119|NCT01716390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444120|NCT01716377|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1444121|NCT01716364||Single Group Assignment||Treatment||None (Open Label)||||||
1444122|NCT01716351|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444123|NCT01716338|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444124|NCT01716325|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1444125|NCT01716312|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1444126|NCT01716299|||||Prospective|||||||
1444127|NCT01716286|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1444128|NCT01716273|Randomized|Parallel Assignment||Treatment||Single||||||t
1444129|NCT01716260|||Cohort||Prospective|||||||
1444130|NCT01716247||Single Group Assignment||Diagnostic||Single||||||t
1444131|NCT01716234|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444132|NCT01716221|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1444133|NCT01716208||Single Group Assignment||Treatment||None (Open Label)||||||
1444134|NCT01716195|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444135|NCT01716182|||||Prospective|||||||
1444136|NCT01716169||Single Group Assignment||Treatment||None (Open Label)||||||
1444137|NCT01716156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444138|NCT01716143||Single Group Assignment||Treatment||None (Open Label)||||||
1444139|NCT01716130|||Cohort||Prospective|||||||
1444140|NCT01716117||Single Group Assignment||Treatment||None (Open Label)||||||
1444141|NCT01716104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444142|NCT01716091|||Case Control||Prospective|||||||
1444143|NCT01716078|||Cohort||Prospective|||||||
1444144|NCT01716065|||Cohort||Prospective|||||||
1444145|NCT01716052|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1444146|NCT01716039|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1444147|NCT01716026|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444148|NCT01716013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444149|NCT01716000|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1444150|NCT01715987|||Case-Control||Prospective|||||||
1444151|NCT01715974|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444152|NCT01715961||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444153|NCT01715948|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444154|NCT01715935||Single Group Assignment||||None (Open Label)||||||
1444155|NCT01715922||Single Group Assignment||Treatment||None (Open Label)||||||
1444156|NCT01715909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444157|NCT01715896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444158|NCT01715883||Single Group Assignment||Prevention||None (Open Label)||||||
1444159|NCT01715870|||Ecologic or Community||Cross-Sectional|||||||
1444160|NCT01715857|||Case-Only||Prospective|||||||
1444161|NCT01715844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444162|NCT01715831||Single Group Assignment||Treatment||None (Open Label)||||||
1444163|NCT01715818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444164|NCT01715805|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1444165|NCT01715792|||||Retrospective|||||||
1444166|NCT01715779|||Cohort||Prospective|||||||
1444167|NCT01715766|||Cohort||Prospective|||||||
1444168|NCT01715753|Randomized|Parallel Assignment||Prevention||Single|||t|||
1444169|NCT01715740|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444170|NCT01715727|||Case Control||Prospective|||||||
1444171|NCT01715714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444172|NCT01715701|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444173|NCT01715688|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1444174|NCT01715675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444175|NCT01715662|Randomized|Parallel Assignment||Treatment||Single||||||t
1444176|NCT01715649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444177|NCT01715636||Single Group Assignment||Prevention||None (Open Label)||||||
1444178|NCT01715623|||Cohort||Prospective|||||||
1444179|NCT01715610|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1444180|NCT01715597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444181|NCT01715584|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1444182|NCT01715571||Single Group Assignment||Treatment||None (Open Label)||||||
1444183|NCT01715558|||Other||Prospective|||||||
1444184|NCT01715545|||Cohort||Retrospective|||||||
1444185|NCT01715532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444186|NCT01715519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444187|NCT01715506||Single Group Assignment||Supportive Care||Single|||t|||
1444188|NCT01715493|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1444189|NCT01715480||Single Group Assignment||Basic Science||None (Open Label)||||||
1444190|NCT01715467|||Cohort||Prospective|||||||
1444191|NCT01715454||||||||||||
1444192|NCT01715441|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444193|NCT01715428|||Case-Only||Prospective|||||||
1444194|NCT01715415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444195|NCT01715402|||Cohort||Prospective|||||||
1444196|NCT01715389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444197|NCT01715376|||Cohort||Prospective|||||||
1444198|NCT01715363||Single Group Assignment||Treatment||None (Open Label)||||||
1444199|NCT01715350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444200|NCT01715337||Single Group Assignment||Basic Science||None (Open Label)||||||
1444201|NCT01715324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444202|NCT01715311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444203|NCT01715298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444204|NCT01715285|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444205|NCT01715272|Randomized|Parallel Assignment||Treatment||Single||||t||
1444206|NCT01715259||Single Group Assignment||Treatment||None (Open Label)||||||
1444207|NCT01715246|Randomized|Parallel Assignment||Treatment||Single||||t||
1444208|NCT01715233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444209|NCT01715220|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444210|NCT01715207|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1444211|NCT01715194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444212|NCT01715181|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1444213|NCT01715168|Randomized|Crossover Assignment||Treatment||Single||||||t
1444214|NCT01715155|||Cohort||Retrospective|||||||
1444215|NCT01715142||Single Group Assignment||Treatment||None (Open Label)||||||
1444216|NCT01715129||Single Group Assignment||Treatment||None (Open Label)||||||
1444217|NCT01715116||Single Group Assignment||Treatment||None (Open Label)||||||
1444218|NCT01715103|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1444219|NCT01715090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444220|NCT01715077||Single Group Assignment||Treatment||None (Open Label)||||||
1444221|NCT01715064|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1444222|NCT01715051|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444223|NCT01715038|Randomized|Parallel Assignment||Prevention||Single|||||t|
1444224|NCT01715025||Single Group Assignment||Treatment||None (Open Label)||||||
1444225|NCT01715012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444226|NCT01714999|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444227|NCT01714986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444228|NCT01714973||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1444229|NCT01714960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444230|NCT01714947||Single Group Assignment||Treatment||None (Open Label)||||||
1444231|NCT01714934|||Cohort||Prospective|||||||
1444232|NCT01714921|||Cohort||Prospective|||||||
1444233|NCT01714908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444234|NCT01714895|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1444235|NCT01714882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444236|NCT01714869||Single Group Assignment||Treatment||None (Open Label)||||||
1444237|NCT01714856|Randomized|Crossover Assignment||||None (Open Label)||||||
1444238|NCT01714843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444239|NCT01714830|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1444240|NCT01714817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444241|NCT01714804||Single Group Assignment||Treatment||None (Open Label)||||||
1444242|NCT01714791|Randomized|Parallel Assignment||Treatment||Single||||||t
1444243|NCT01714778|||Cohort||Prospective|||||||
1444244|NCT01714765||Single Group Assignment||Treatment||None (Open Label)||||||
1444245|NCT01714752||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444246|NCT01714739|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444247|NCT01714726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444248|NCT01714713|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444249|NCT01714700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444250|NCT01714687|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444251|NCT01714674|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1444252|NCT01714661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444253|NCT01714648||Single Group Assignment||Prevention||None (Open Label)||||||
1444254|NCT01714635|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1444255|NCT01714622|||Cohort||Prospective|||||||
1444256|NCT01714609|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444257|NCT01714596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444258|NCT01714583|||||Retrospective|||||||
1444259|NCT01714570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444260|NCT01714557|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444261|NCT01714544||Single Group Assignment||Treatment||None (Open Label)||||||
1444262|NCT01714531|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444263|NCT01714518|||Case-Only||Prospective|||||||
1444264|NCT01714505|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444265|NCT01714492|||Cohort||Cross-Sectional|||||||
1444266|NCT01714479|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1444267|NCT01714466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444268|NCT01714440|||Cohort||Prospective|||||||
1444269|NCT01714427|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1444270|NCT01714414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444271|NCT01714401|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1444272|NCT01714388||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444273|NCT01714375|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444274|NCT01714362|||Cohort||Prospective|||||||
1444275|NCT01714349||Single Group Assignment||Treatment||None (Open Label)||||||
1444276|NCT01714336|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444277|NCT01714323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444278|NCT01714310|Randomized|Parallel Assignment||Treatment||Quadruple||Initial arm for open-label titration of lisdexamfetamine followed by randomization of participants who retain eligibility to double blind adjunctive fluoxetine or placebo.|t|t|t|t
1444279|NCT01714297|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1444280|NCT01714284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444281|NCT01714271|Randomized|Parallel Assignment||Prevention||Single||||||t
1444282|NCT01714258||Single Group Assignment||Supportive Care||None (Open Label)||||||
1444283|NCT01714245|||Case-Only||Prospective|||||||
1444284|NCT01714232||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444285|NCT01714219|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444286|NCT01714206|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444287|NCT01714193||Single Group Assignment||Treatment||None (Open Label)||||||
1444288|NCT01714180|||Case Control||Prospective|||||||
1444289|NCT01714167|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444290|NCT01714154|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1444291|NCT01714141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444292|NCT01714128|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1444293|NCT01714115||||||||||||
1444294|NCT01714102|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444295|NCT01714089|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1444296|NCT01714076|||Cohort||Prospective|||||||
1444297|NCT01714063|||Case-Only||Prospective|||||||
1444298|NCT01714050|Randomized|Parallel Assignment||Prevention||Single||||||t
1444299|NCT01714037|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444300|NCT01714024|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1444919|NCT01705938|Randomized|Single Group Assignment||||Single|||t|||
1444301|NCT01714011|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444302|NCT01713998|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444303|NCT01713985|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444304|NCT01713972|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444305|NCT01713959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444306|NCT01713946|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444307|NCT01713933||Single Group Assignment||Treatment||None (Open Label)||||||
1444308|NCT01713920||Single Group Assignment||Treatment||None (Open Label)||||||
1444309|NCT01713907||Single Group Assignment||Treatment||None (Open Label)||||||
1444310|NCT01713894|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1444311|NCT01713881|||Cohort||Retrospective|||||||
1444312|NCT01713868|Randomized|Factorial Assignment||Prevention||Single|||t|||
1444313|NCT01713855||Single Group Assignment||||None (Open Label)||||||
1444314|NCT01713842||Single Group Assignment||Treatment||None (Open Label)||||||
1444315|NCT01713829|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1444316|NCT01713816|||Case-Control||Cross-Sectional|||||||
1444317|NCT01713803||||||||||||
1444318|NCT01713790||Single Group Assignment||Treatment||None (Open Label)||||||
1444319|NCT01713777|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1444320|NCT01713764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444321|NCT01713751|Randomized|Parallel Assignment||Treatment||Single||||||t
1444322|NCT01713738||Single Group Assignment||Treatment||None (Open Label)||||||
1444323|NCT01713725|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1444324|NCT01713712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444325|NCT01713699||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444326|NCT01713686||Single Group Assignment||Treatment||Single||||||t
1444327|NCT01713673|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444328|NCT01713660||Single Group Assignment||Treatment||None (Open Label)||||||
1444329|NCT01713647|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444330|NCT01713634|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1444331|NCT01713621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444332|NCT01713608|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1444333|NCT01713595||Single Group Assignment||Treatment||None (Open Label)||||||
1444334|NCT01713582|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444335|NCT01713569|Non-Randomized|Parallel Assignment||Other||Single||||||t
1444336|NCT01713556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444337|NCT01713543|Randomized|Parallel Assignment||Prevention||Single||||||t
1444338|NCT01713530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444339|NCT01713517|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444340|NCT01713504|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1444341|NCT01713491|||Cohort||Prospective|||||||
1444342|NCT01713478|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1444343|NCT01713465||Single Group Assignment||Supportive Care||Single||||||t
1444344|NCT01713452|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444345|NCT01713439||Single Group Assignment||Treatment||None (Open Label)||||||
1444346|NCT01713426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444347|NCT01713413|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444348|NCT01713400|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444349|NCT01713387||Single Group Assignment||Treatment||None (Open Label)||||||
1444350|NCT01713374|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1444351|NCT01713361|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444352|NCT01713348|Randomized|Parallel Assignment||||None (Open Label)||||||
1444353|NCT01713335|||||Prospective|||||||
1444354|NCT01713322|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444355|NCT01713309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444356|NCT01713296||Single Group Assignment||Treatment||None (Open Label)||||||
1444357|NCT01713283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444358|NCT01713270|Randomized|Parallel Assignment||Treatment||Single||||||t
1444359|NCT01713257|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1444360|NCT01713244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444361|NCT01713231|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1444362|NCT01713218||Single Group Assignment||Treatment||None (Open Label)||||||
1444363|NCT01713205|||Cohort||Prospective|||||||
1444364|NCT01713192|||Cohort||Prospective|||||||
1444365|NCT01713179|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1444366|NCT01713166|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444367|NCT01713153|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444368|NCT01713140||Single Group Assignment||Basic Science||None (Open Label)||||||
1444369|NCT01713127|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1444370|NCT01713114|Randomized|Crossover Assignment||||Double|||t|||t
1444371|NCT01713101|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444372|NCT01713088|Randomized|Parallel Assignment||Prevention||Single||||||t
1444373|NCT01713075|||Cohort||Prospective|||||||
1444374|NCT01713062|||Cohort||Prospective|||||||
1444375|NCT01713049||Single Group Assignment||Diagnostic||Single||||||t
1444376|NCT01713036||Single Group Assignment||Treatment||None (Open Label)||||||
1444377|NCT01713023|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1444378|NCT01713010|||Case-Only||Prospective|||||||
1444379|NCT01712997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444380|NCT01712984|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444381|NCT01712971|||Case Control||Prospective|||||||
1444382|NCT01712958|||Cohort||Retrospective|||||||
1444383|NCT01712945|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1444384|NCT01712919||Single Group Assignment||Treatment||None (Open Label)||||||
1444385|NCT01712906|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1444386|NCT01712893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444387|NCT01712880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444388|NCT01712867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444389|NCT01712854|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1444390|NCT01712841|||Case-Control||Prospective|||||||
1444391|NCT01712828|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1444392|NCT01712815||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444393|NCT01712802|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444394|NCT01712789||Single Group Assignment||Treatment||None (Open Label)||||||
1444395|NCT01712776|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444396|NCT01712763|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444397|NCT01712750|||Cohort||Prospective|||||||
1444398|NCT01712737|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1444399|NCT01712724|Randomized|Parallel Assignment||Treatment||Single||||||t
1444400|NCT01712711|Randomized|Parallel Assignment||Treatment||Double||||t||t
1444401|NCT01712698|||Cohort||Prospective|||||||
1444402|NCT01712685||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444403|NCT01712672|||Case-Only||Prospective|||||||
1444404|NCT01712659||Single Group Assignment||Treatment||None (Open Label)||||||
1444405|NCT01712646|Randomized|Parallel Assignment||Treatment||||||||
1444406|NCT01712633|||||Prospective|||||||
1444407|NCT01712620|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444408|NCT01712607|Randomized|Crossover Assignment||Treatment||Single||||||t
1444409|NCT01712594|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444410|NCT01712581||Single Group Assignment||Basic Science||None (Open Label)||||||
1444411|NCT01712568|Randomized|Crossover Assignment||||None (Open Label)||||||
1444412|NCT01712555||Single Group Assignment||Treatment||None (Open Label)||||||
1444413|NCT01712542|||Case-Only||Prospective|||||||
1444414|NCT01712529|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444415|NCT01712516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444416|NCT01712503|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1444417|NCT01712490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444418|NCT01712477|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444419|NCT01712464|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1444420|NCT01712451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444421|NCT01712438||Single Group Assignment||Treatment||None (Open Label)||||||
1444422|NCT01712425|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444423|NCT01712412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444424|NCT01712399||Single Group Assignment||Treatment||None (Open Label)||||||
1444425|NCT01712386|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1444426|NCT01712373|Randomized|Parallel Assignment||Treatment||Single||||||t
1444427|NCT01712360|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444428|NCT01712347|||Cohort||Prospective|||||||
1444429|NCT01712334|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444430|NCT01712321|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1444431|NCT01712308|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444432|NCT01712295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444433|NCT01712282|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1444434|NCT01712269||Single Group Assignment||Basic Science||None (Open Label)||||||
1444435|NCT01712256||Single Group Assignment||Treatment||None (Open Label)||||||
1444436|NCT01712243|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1444437|NCT01712230|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1444438|NCT01712217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444439|NCT01712204|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1444440|NCT01712191||Single Group Assignment||Treatment||None (Open Label)||||||
1444441|NCT01712178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444442|NCT01712165|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1444443|NCT01712152|||Cohort||Prospective|||||||
1444444|NCT01712139|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444445|NCT01712126|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444446|NCT01712113|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444447|NCT01712100|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444448|NCT01712087|||Case Control||Prospective|||||||
1444449|NCT01712074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444450|NCT01712061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444451|NCT01712048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444452|NCT01712035|||Case-Control||Prospective|||||||
1444453|NCT01712022|||Cohort||Prospective|||||||
1444454|NCT01712009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444455|NCT01711996|||Cohort||Prospective|||||||
1444456|NCT01711983||Single Group Assignment||Treatment||None (Open Label)||||||
1444457|NCT01711970|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444458|NCT01711957|||Cohort||Prospective|||||||
1444459|NCT01711944|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1444460|NCT01711931|Randomized|Parallel Assignment||Treatment||Single||||||t
1444461|NCT01711918||Single Group Assignment||Treatment||None (Open Label)||||||
1444462|NCT01711905|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1444463|NCT01711892|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1444464|NCT01711879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444465|NCT01711866||Single Group Assignment||Treatment||None (Open Label)||||||
1444466|NCT01711853||Single Group Assignment||Treatment||None (Open Label)||||||
1444467|NCT01711840|||Cohort||Prospective|||||||
1444468|NCT01711827||Single Group Assignment||||None (Open Label)||||||
1444469|NCT01711814||Single Group Assignment||Treatment||None (Open Label)||||||
1444470|NCT01711801|Randomized|Parallel Assignment||||Double|||t||t|
1444471|NCT01711788||Single Group Assignment||Treatment||None (Open Label)||||||
1444472|NCT01711775|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1444473|NCT01711762|Randomized|Single Group Assignment||||None (Open Label)||||||
1444474|NCT01711749|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1444475|NCT01711736|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444476|NCT01711723|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444477|NCT01711710||Single Group Assignment||Treatment||None (Open Label)||||||
1444478|NCT01711697||Single Group Assignment||Treatment||None (Open Label)||||||
1444479|NCT01711684||Single Group Assignment||Treatment||None (Open Label)||||||
1444480|NCT01711671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444481|NCT01711658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444482|NCT01711645||Single Group Assignment||Prevention||||||||
1444483|NCT01711632||Single Group Assignment||Treatment||None (Open Label)||||||
1444484|NCT01711619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444485|NCT01711606|||Cohort||Prospective|||||||
1444486|NCT01711593||Single Group Assignment||Basic Science||None (Open Label)||||||
1444487|NCT01711580|||Cohort||Prospective|||||||
1444488|NCT01711567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444489|NCT01711554||Single Group Assignment||Treatment||None (Open Label)||||||
1444490|NCT01711541|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444491|NCT01711528|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444492|NCT01711515||Single Group Assignment||Treatment||None (Open Label)||||||
1444493|NCT01711502|||Cohort||Retrospective|||||||
1444494|NCT01711489||Single Group Assignment||||None (Open Label)||||||
1444495|NCT01711476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444496|NCT01711463|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1444497|NCT01711450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444498|NCT01711437|Randomized|Single Group Assignment||||Single|||||t|
1444499|NCT01711424|||Cohort||Prospective|||||||
1444500|NCT01711411||||||||||||
1444501|NCT01711398||Single Group Assignment||Treatment||None (Open Label)||||||
1444502|NCT01711385|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1444503|NCT01711372|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1444504|NCT01711359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444505|NCT01711346|Randomized|Crossover Assignment||||Single|||t|||
1444506|NCT01711333||Single Group Assignment||Treatment||None (Open Label)||||||
1444507|NCT01711320|Randomized|Crossover Assignment||Treatment||Single|||t|||
1444508|NCT01711307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444509|NCT01711294|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1444510|NCT01711281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444511|NCT01711268|||Cohort||Prospective|||||||
1444512|NCT01711255|||Case-Control||Cross-Sectional|||||||
1444513|NCT01711242|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444514|NCT01711229|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444515|NCT01711216|||||Prospective|||||||
1444516|NCT01711203|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444517|NCT01711190|||Cohort||Prospective|||||||
1444518|NCT01711177|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444519|NCT01711164|||Case Control||Prospective|||||||
1444520|NCT01711151|||Case Control||Prospective|||||||
1444521|NCT01711138|||Case Control||Prospective|||||||
1444522|NCT01711125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444523|NCT01711112||Single Group Assignment||Treatment||None (Open Label)||||||
1444524|NCT01711099||Single Group Assignment||Treatment||None (Open Label)||||||
1444525|NCT01711086|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1444526|NCT01711073||Single Group Assignment||Treatment||None (Open Label)||||||
1444527|NCT01711060||||||||||||
1444528|NCT01711047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444529|NCT01711034||Single Group Assignment||Treatment||None (Open Label)||||||
1444530|NCT01711021|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1444531|NCT01711008|Randomized|Crossover Assignment||||None (Open Label)||||||
1444532|NCT01710995|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444533|NCT01710982|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444534|NCT01710969|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444535|NCT01710956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444536|NCT01710943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444537|NCT01710930||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444538|NCT01710917|||Cohort||Prospective|||||||
1444539|NCT01710904|||Cohort||Prospective|||||||
1444540|NCT01710891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444541|NCT01710878||Single Group Assignment||Treatment||None (Open Label)||||||
1444542|NCT01710865||Single Group Assignment||Prevention||None (Open Label)||||||
1444543|NCT01710852|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1444544|NCT01710839|Randomized|Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1444545|NCT01710826|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1444546|NCT01710813|||Cohort||Prospective|||||||
1444547|NCT01710800|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1444548|NCT01710787|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1444549|NCT01710774|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444550|NCT01710761|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1444551|NCT01710748|Randomized|Parallel Assignment||Treatment||Single||||||t
1444552|NCT01710735|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1444553|NCT01710722|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1444554|NCT01710709||Single Group Assignment||Treatment||None (Open Label)||||||
1444555|NCT01710696|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444556|NCT01710683|||Cohort||Retrospective|||||||
1444557|NCT01710670|Randomized|Crossover Assignment||Other||Double|||t||t|
1444558|NCT01710657|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1444559|NCT01710644|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1444560|NCT01710631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444561|NCT01710618|||Cohort||Prospective|||||||
1444562|NCT01710605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444563|NCT01710592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444564|NCT01710579|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1444565|NCT01710566|Randomized|Parallel Assignment||Prevention||Single|||t|||
1444566|NCT01710553|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1444567|NCT01710540|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1444568|NCT01710527|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1444569|NCT01710514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444570|NCT01710501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444571|NCT01710488|Randomized|Parallel Assignment||Treatment||Single|||||t|
1444572|NCT01710462|Randomized|Parallel Assignment||Treatment||Single|||||t|
1444573|NCT01710449|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1444574|NCT01710436|||Case Control||Prospective|||||||
1444575|NCT01710423|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444576|NCT01710410|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444577|NCT01710397|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1444578|NCT01710384|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444579|NCT01710371|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1444580|NCT01710358|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444581|NCT01710345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444582|NCT01710332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444583|NCT01710319|||Case-Control||Prospective|||||||
1444584|NCT01710306|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1444585|NCT01710293|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1444586|NCT01710280|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1444587|NCT01710267|||Cohort||Prospective|||||||
1444588|NCT01710254||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444589|NCT01710228|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1444590|NCT01710215|Randomized|Parallel Assignment||Screening||Single||||||t
1444591|NCT01710202|||Case Control|||||||||
1444592|NCT01710189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444593|NCT01710176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444594|NCT01710163|Randomized|Parallel Assignment||Treatment||Single||||||t
1444595|NCT01710150|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444596|NCT01710137|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444597|NCT01710124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444598|NCT01710111|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1444599|NCT01710098|||Case Control||Prospective|||||||
1444600|NCT01710085||Single Group Assignment||Diagnostic||Double|||||t|t
1444601|NCT01710072|Randomized|Single Group Assignment||Basic Science||Single||||||t
1444602|NCT01710059||Single Group Assignment||Health Services Research||None (Open Label)||||||
1444603|NCT01710046|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1444604|NCT01710033|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1444605|NCT01710020|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1444606|NCT01710007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444607|NCT01709994|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444608|NCT01709981|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1444609|NCT01709968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444610|NCT01709955|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1444611|NCT01709942|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444612|NCT01709929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444613|NCT01709916|||Case-Only||Prospective|||||||
1444614|NCT01709903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444615|NCT01709890|||Cohort||Prospective|||||||
1444616|NCT01709877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444617|NCT01709864|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444618|NCT01709851|||Case-Only||Prospective|||||||
1444619|NCT01709838||Single Group Assignment||Treatment||None (Open Label)||||||
1444620|NCT01709825|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1444621|NCT01709812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444622|NCT01709799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444623|NCT01709786|||Cohort||Prospective|||||||
1444624|NCT01709773||Single Group Assignment||Treatment||None (Open Label)||||||
1444625|NCT01709760|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1444626|NCT01709747||Single Group Assignment||Treatment||None (Open Label)||||||
1444627|NCT01709734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444628|NCT01709721|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1444629|NCT01709708|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444630|NCT01709695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444631|NCT01709682|Randomized|Parallel Assignment||Treatment||Single||||||t
1444632|NCT01709669|||Cohort||Prospective|||||||
1444633|NCT01709656|Randomized|Parallel Assignment||||None (Open Label)||||||
1444634|NCT01709643|Randomized|Crossover Assignment||Basic Science||Single||||||t
1444635|NCT01709630|||Cohort||Prospective|||||||
1444636|NCT01709617|Randomized|Crossover Assignment||||Double|||t||t|
1444637|NCT01709604|||Cohort||Prospective|||||||
1444638|NCT01709591|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444639|NCT01709578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444640|NCT01709565|||Cohort||Prospective|||||||
1444641|NCT01709552|Randomized|Parallel Assignment||Treatment||Single||||||t
1444642|NCT01709539|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1444643|NCT01709526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444644|NCT01709513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444645|NCT01709500|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444646|NCT01709487||Single Group Assignment||Treatment||None (Open Label)||||||
1444647|NCT01709474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444648|NCT01709461|||Case-Only||Prospective|||||||
1444649|NCT01709448|||Cohort||Prospective|||||||
1444650|NCT01709435||Single Group Assignment||Treatment||None (Open Label)||||||
1444651|NCT01709422|Randomized|Parallel Assignment||||None (Open Label)||||||
1444652|NCT01709409|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1444653|NCT01709396||Single Group Assignment||Treatment||None (Open Label)||||||
1444654|NCT01709383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444655|NCT01709370||Single Group Assignment||Treatment||None (Open Label)||||||
1444656|NCT01709357|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444657|NCT01709344|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1444658|NCT01709331||Single Group Assignment||Treatment||None (Open Label)||||||
1444659|NCT01709318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444660|NCT01709305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444661|NCT01709292|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444662|NCT01709279||Single Group Assignment||Treatment||None (Open Label)||||||
1444663|NCT01709266|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1444664|NCT01709253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444665|NCT01709240||Single Group Assignment||Treatment||None (Open Label)||||||
1444666|NCT01709227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444667|NCT01709214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444668|NCT01709201|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444669|NCT01709188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444670|NCT01709175|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1444671|NCT01709162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444672|NCT01709149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444673|NCT01709136||Single Group Assignment||Treatment||None (Open Label)||||||
1444674|NCT01709123|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444675|NCT01709110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444676|NCT01709097|||Case Control||Prospective|||||||
1444677|NCT01709084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444678|NCT01709071|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444679|NCT01709058|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444680|NCT01709045|||Cohort||Prospective|||||||
1444681|NCT01709032||Single Group Assignment||Treatment||None (Open Label)||||||
1444682|NCT01709019|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1444758|NCT01708031||Single Group Assignment||Health Services Research||Single|||t|||
1444759|NCT01708018|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444683|NCT01709006||Single Group Assignment||Treatment||None (Open Label)||IMRT by helical tomotherapy with concomitant chemotherapy at 70 Gy in 33 fractions on GTV, 59.4 Gy in 33 fractions on CTV1 and 43.2 Gy in 24 fractions on CTV 2, where CTV 2 would include only level 2 and 3 contralateral and ipsilateral level 4.||||
1444684|NCT01708993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444685|NCT01708980||Single Group Assignment||Treatment||None (Open Label)||||||
1444686|NCT01708967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444687|NCT01708954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444688|NCT01708941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444689|NCT01708928|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444690|NCT01708915|Randomized|Parallel Assignment||Treatment||Double||||||
1444691|NCT01708902|Randomized|Factorial Assignment||Treatment||Double||||||
1444692|NCT01708889|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1444693|NCT01708876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444694|NCT01708863|||Cohort||Prospective|||||||
1444695|NCT01708850||Single Group Assignment||Treatment||None (Open Label)||||||
1444696|NCT01708837|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444697|NCT01708824|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1444698|NCT01708811|||Case-Only||Prospective|||||||
1444699|NCT01708798|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1444700|NCT01708785|Randomized|Parallel Assignment||Treatment||Single||||||t
1444701|NCT01708772|||Case Control||Prospective|||||||
1444702|NCT01708759|||Case Control||Prospective|||||||
1444703|NCT01708746|||Case Control||Prospective|||||||
1444704|NCT01708733|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1444705|NCT01708720|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1444706|NCT01708707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444707|NCT01708694|Randomized|Parallel Assignment||Other||Double|||t||t|
1444708|NCT01708681|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1444709|NCT01708668|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444710|NCT01708655||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444711|NCT01708642|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1444712|NCT01708629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444713|NCT01708616||Crossover Assignment||||Double|||t||t|
1444714|NCT01708603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444715|NCT01708590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444716|NCT01708577|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1444717|NCT01708564|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1444718|NCT01708551|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444719|NCT01708538|Randomized|Single Group Assignment||Treatment||Single|||t|||
1444720|NCT01708525||Single Group Assignment||Treatment||Single||||||t
1444721|NCT01708512||Single Group Assignment||Treatment||Single||||||t
1444722|NCT01708499||Single Group Assignment||Treatment||Single||||||t
1444723|NCT01708486|||||Prospective|||||||
1444724|NCT01708473|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444725|NCT01708460||Single Group Assignment||Treatment||None (Open Label)||||||
1444726|NCT01708447|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1444727|NCT01708434||Single Group Assignment||Treatment||None (Open Label)||||||
1444728|NCT01708421|||Cohort||Prospective|||||||
1444729|NCT01708408|||Other||Prospective|||||||
1444730|NCT01708395|||||Prospective|||||||
1444731|NCT01708382||Single Group Assignment||Treatment||None (Open Label)||||||
1444732|NCT01708369|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1444733|NCT01708356|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1444734|NCT01708343|Randomized|Parallel Assignment||Treatment||Single||||||t
1444735|NCT01708330|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444736|NCT01708317||Single Group Assignment||Screening||None (Open Label)||||||
1444737|NCT01708304||Single Group Assignment||Treatment||None (Open Label)||||||
1444738|NCT01708291|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1444739|NCT01708278|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444740|NCT01708265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444741|NCT01708252||Single Group Assignment||Treatment||None (Open Label)||||||
1444742|NCT01708239|||Cohort||Prospective|||||||
1444743|NCT01708226||Single Group Assignment||Treatment||None (Open Label)||||||
1444744|NCT01708213||Single Group Assignment||Treatment||None (Open Label)||||||
1444745|NCT01708200||Single Group Assignment||Treatment||Single|||t|||
1444746|NCT01708187|Randomized|Parallel Assignment||Treatment||Single||||||t
1444747|NCT01708174|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444748|NCT01708161||Single Group Assignment||Treatment||None (Open Label)||||||
1444749|NCT01708148|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1444750|NCT01708135||Single Group Assignment||Supportive Care||None (Open Label)||||||
1444751|NCT01708122|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1444752|NCT01708109|Randomized|Single Group Assignment||Treatment||Single|||t|||
1444753|NCT01708096|Randomized|Parallel Assignment||||None (Open Label)||||||
1444754|NCT01708083|||Cohort||Prospective|||||||
1444755|NCT01708070|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1444756|NCT01708057|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1444757|NCT01708044|Randomized|Crossover Assignment||Treatment||Single|||t|||
1444760|NCT01708005|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444761|NCT01707992|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444762|NCT01707979|||Case Control||Cross-Sectional|||||||
1444763|NCT01707966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444764|NCT01707953|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444765|NCT01707940|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444766|NCT01707927|||Cohort||Prospective|||||||
1444767|NCT01707914|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1444768|NCT01707901|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1444769|NCT01707888|||Case-Only||Prospective|||||||
1444770|NCT01707875|||Case-Only||Prospective|||||||
1444771|NCT01707862|||Cohort||Retrospective|||||||
1444772|NCT01707849|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1444773|NCT01707836|||Family-Based||Cross-Sectional|||||||
1444774|NCT01707823||Single Group Assignment||Basic Science||None (Open Label)||||||
1444775|NCT01707810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444776|NCT01707797|||Cohort||Prospective|||||||
1444777|NCT01707784|||Cohort||Cross-Sectional|||||||
1444778|NCT01707771|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444779|NCT01707758|||||Prospective|||||||
1444780|NCT01707745||Single Group Assignment||Treatment||None (Open Label)||||||
1444781|NCT01707732|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444782|NCT01707719|||Case-Control||Cross-Sectional|||||||
1444783|NCT01707706|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444784|NCT01707693|Randomized|Parallel Assignment||Prevention||Single|||t|||
1444785|NCT01707680|||Cohort||Retrospective|||||||
1444786|NCT01707667|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444787|NCT01707654||Single Group Assignment||Treatment||None (Open Label)||||||
1444788|NCT01707641|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444789|NCT01707628|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1444790|NCT01707615|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444791|NCT01707602|Randomized|Parallel Assignment||||None (Open Label)||||||
1444792|NCT01707589|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1444793|NCT01707576||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444794|NCT01707563|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1444795|NCT01707550|||Cohort||Prospective|||||||
1444796|NCT01707537||Single Group Assignment||Prevention||None (Open Label)||||||
1444797|NCT01707524|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1444798|NCT01707511|||Cohort||Prospective|||||||
1444799|NCT01707498|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1444800|NCT01707485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444801|NCT01707472|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444802|NCT01707459|||Cohort||Prospective|||||||
1444803|NCT01707446|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444804|NCT01707433|||Cohort|||||||||
1444805|NCT01707420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444806|NCT01707407|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1444807|NCT01707394|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1444808|NCT01707381|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444809|NCT01707368|||Cohort||Prospective|||||||
1444810|NCT01707355|Randomized|Single Group Assignment||Prevention||Double|||||t|t
1444811|NCT01707342||Single Group Assignment||Treatment||None (Open Label)||||||
1444812|NCT01707329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444813|NCT01707316|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1444814|NCT01707303|Randomized|Parallel Assignment||Treatment||Single||||||t
1444815|NCT01707290|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444816|NCT01707277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444817|NCT01707264||Sequential Assignment||Treatment||None (Open Label)||||||
1444818|NCT01707251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444819|NCT01707238|Randomized|Crossover Assignment||||Double|||t||t|
1444820|NCT01707225||Single Group Assignment||Treatment||None (Open Label)||||||
1444821|NCT01707212|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444822|NCT01707199||Single Group Assignment||Treatment||None (Open Label)||||||
1444823|NCT01707186|||Cohort||Prospective|||||||
1444824|NCT01707173|Randomized|Parallel Assignment||||None (Open Label)||||||
1444825|NCT01707160|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1444826|NCT01707147|||Other||Prospective|||||||
1444827|NCT01707134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444828|NCT01707121|||Cohort||Prospective|||||||
1444829|NCT01707108||Single Group Assignment||Treatment||None (Open Label)||||||
1444830|NCT01707095|Randomized|Parallel Assignment||||Single||||||t
1444831|NCT01707082|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1444832|NCT01707069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444833|NCT01707056|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444834|NCT01707043|Randomized|Crossover Assignment||Other||Single|||||t|
1444835|NCT01707030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444836|NCT01707017|Randomized|Parallel Assignment||||Single|||t|||
1444837|NCT01707004||Single Group Assignment||Treatment||None (Open Label)||||||
1444838|NCT01706991|||Case Control||Prospective|||||||
1444839|NCT01706978|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444840|NCT01706965|Randomized|Parallel Assignment||Treatment||Single||||||t
1444841|NCT01706952|Randomized|Parallel Assignment||Other||Single||||t||
1444842|NCT01706939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444843|NCT01706926|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444844|NCT01706913|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1444845|NCT01706900|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1444846|NCT01706887||Single Group Assignment||Basic Science||None (Open Label)||||||
1444847|NCT01706874|||Case-Control||Prospective|||||||
1444848|NCT01706861||Single Group Assignment||Treatment||None (Open Label)||||||
1444849|NCT01706848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444850|NCT01706835||Single Group Assignment||Treatment||None (Open Label)||||||
1444851|NCT01706822||Single Group Assignment||Treatment||None (Open Label)||||||
1444852|NCT01706809|||Case Control||Prospective|||||||
1444853|NCT01706796|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444854|NCT01706783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444855|NCT01706770|Randomized|Parallel Assignment||||None (Open Label)||||||
1444856|NCT01706757|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1444857|NCT01706744|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1444858|NCT01706731|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1444859|NCT01706718|Randomized|Crossover Assignment||Prevention||Single|||t|||
1444860|NCT01706705||Single Group Assignment||Other||None (Open Label)||||||
1444861|NCT01706692|||Cohort||Prospective|||||||
1444862|NCT01706679|Randomized|Parallel Assignment||Treatment||Double||||||
1444863|NCT01706666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444864|NCT01706653|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1444865|NCT01706640|||||Prospective|||||||
1444866|NCT01706627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444867|NCT01706614|||Cohort||Prospective|||||||
1444868|NCT01706601|||Cohort||Retrospective|||||||
1444869|NCT01706588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444870|NCT01706575||Single Group Assignment||Treatment||None (Open Label)||||||
1444871|NCT01706562|||Cohort||Retrospective|||||||
1444872|NCT01706549|||Cohort||Prospective|||||||
1444873|NCT01706536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444874|NCT01706523||Single Group Assignment||Treatment||None (Open Label)||||||
1444875|NCT01706510|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444876|NCT01706497|||Cohort||Prospective|||||||
1444877|NCT01706484|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1444878|NCT01706471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444879|NCT01706458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444880|NCT01706445|Randomized|Single Group Assignment||||Single||||||t
1444881|NCT01706432||Single Group Assignment||Treatment||None (Open Label)||||||
1444882|NCT01706419|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1444883|NCT01706406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444884|NCT01706393|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1444885|NCT01706380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444886|NCT01706367|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1444887|NCT01706354|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1444888|NCT01706341|Randomized|Parallel Assignment||Treatment||Single|||||t|
1444889|NCT01706328|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444890|NCT01706315|Randomized|Parallel Assignment||Treatment||Single|||||t|
1444891|NCT01706302|||||Retrospective|||||||
1444892|NCT01706289|||Case Control||Prospective|||||||
1444893|NCT01706276|||Cohort||Retrospective|||||||
1444894|NCT01706263||Single Group Assignment||Treatment||None (Open Label)||||||
1444895|NCT01706250|Randomized|Single Group Assignment||Treatment||Single||||||t
1444896|NCT01706237||Single Group Assignment||Treatment||None (Open Label)||||||
1444897|NCT01706224|||Cohort||Cross-Sectional|||||||
1444898|NCT01706211|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444899|NCT01706198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444900|NCT01706185|||Cohort||Retrospective|||||||
1444901|NCT01706172|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1444902|NCT01706159|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444903|NCT01706146||Single Group Assignment||Prevention||None (Open Label)||||||
1444904|NCT01706133||Single Group Assignment||Health Services Research||Single||||||t
1444905|NCT01706120||Single Group Assignment||Treatment||None (Open Label)||||||
1444906|NCT01706107|||Cohort||Prospective|||||||
1444907|NCT01706094||Single Group Assignment||Treatment||Single||||||t
1444908|NCT01706081|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1444909|NCT01706068|||Case-Only||Retrospective|||||||
1444910|NCT01706055|||Cohort||Prospective|||||||
1444911|NCT01706042|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1444912|NCT01706029|||Cohort||Prospective|||||||
1444913|NCT01706016||Single Group Assignment||Treatment||None (Open Label)||||||
1444914|NCT01706003|||Ecologic or Community||Prospective|||||||
1444915|NCT01705990|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444916|NCT01705977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444917|NCT01705964|Randomized|Parallel Assignment||Treatment||Single||||||t
1444918|NCT01705951|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1444920|NCT01705925|||Cohort||Prospective|||||||
1444921|NCT01705912|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1444922|NCT01705899|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444923|NCT01705886|||Cohort||Prospective|||||||
1444924|NCT01705873|||Cohort||Retrospective|||||||
1444925|NCT01705860|||||Prospective|||||||
1444926|NCT01705847||Single Group Assignment||Treatment||None (Open Label)||||||
1444927|NCT01705834|||Case-Only||Prospective|||||||
1444928|NCT01705821|||Case-Only||Prospective|||||||
1444929|NCT01705808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444930|NCT01705795|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1444931|NCT01705782|Randomized|Crossover Assignment||Treatment||Single|||t|||
1444932|NCT01705769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444933|NCT01705756|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444934|NCT01705743|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444935|NCT01705730|||Cohort||Prospective|||||||
1444936|NCT01705717|||Cohort||Retrospective|||||||
1444937|NCT01705704|||Cohort||Retrospective|||||||
1444938|NCT01705691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444939|NCT01705678|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1444940|NCT01705665|||Cohort||Prospective|||||||
1444941|NCT01705652|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444942|NCT01705639||Single Group Assignment||Basic Science||None (Open Label)||||||
1444943|NCT01705626|||Case-Control||Prospective|||||||
1444944|NCT01705613|||Ecologic or Community||Prospective|||||||
1444945|NCT01705600||Parallel Assignment||Treatment||Single|||t|||
1444946|NCT01705587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444947|NCT01705574|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1444948|NCT01705561|||Case-Only||Retrospective|||||||
1444949|NCT01705548||Single Group Assignment||Treatment||None (Open Label)||||||
1444950|NCT01705535|Randomized|Parallel Assignment||Treatment||Single|||||t|
1444951|NCT01705522|||Cohort||Prospective|||||||
1444952|NCT01705509||Single Group Assignment||Supportive Care||None (Open Label)||||||
1444953|NCT01705496||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444954|NCT01705483|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1444955|NCT01705470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444956|NCT01705457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1444957|NCT01705444||Single Group Assignment||Treatment||None (Open Label)||||||
1444958|NCT01705431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444959|NCT01705418|||Cohort||Prospective|||||||
1444960|NCT01705405||Single Group Assignment||||None (Open Label)||||||
1444961|NCT01705392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444962|NCT01705379||||||||||||
1444963|NCT01705366|||Cohort||Prospective|||||||
1444964|NCT01705353|||Cohort||Prospective|||||||
1444965|NCT01705340||Single Group Assignment||Treatment||None (Open Label)||||||
1444966|NCT01705327|||Cohort||Cross-Sectional|||||||
1444967|NCT01705314|Randomized|Parallel Assignment||||Triple|||t|t|t|
1444968|NCT01705301|||Cohort||Prospective|||||||
1444969|NCT01705288|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1444970|NCT01705275|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1444971|NCT01705262|||Case-Only||Prospective|||||||
1444972|NCT01705249|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1444973|NCT01705236|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1444974|NCT01705223|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1444975|NCT01705210|||Cohort||Cross-Sectional|||||||
1444976|NCT01705197|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1444977|NCT01705184||Single Group Assignment||Treatment||None (Open Label)||||||
1444978|NCT01705171|||Case-Control||Prospective|||||||
1444979|NCT01705158||Single Group Assignment||Treatment||None (Open Label)||||||
1444980|NCT01705145||Single Group Assignment||Treatment||None (Open Label)||||||
1444981|NCT01705132|||Family-Based||Prospective|||||||
1444982|NCT01705119||Single Group Assignment||Treatment||None (Open Label)||||||
1444983|NCT01705106||Single Group Assignment||Treatment||None (Open Label)||||||
1444984|NCT01705093|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1444985|NCT01705080|||Cohort||Prospective|||||||
1444986|NCT01705067||Single Group Assignment||Treatment||None (Open Label)||||||
1444987|NCT01705054|||Case-Only||Prospective|||||||
1444988|NCT01705041||Single Group Assignment||Diagnostic||None (Open Label)||||||
1444989|NCT01705015|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1444990|NCT01705002|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444991|NCT01704989|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1444992|NCT01704976|Randomized|Parallel Assignment||Treatment||Single|||t|||
1444993|NCT01704963||Single Group Assignment||Treatment||None (Open Label)||||||
1444994|NCT01704950|||Cohort||Prospective|||||||
1444995|NCT01704937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444996|NCT01704924|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1444997|NCT01704911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1444998|NCT01704898|Randomized|Crossover Assignment||Treatment||Single|||||t|
1444999|NCT01704885|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1445000|NCT01704872||Single Group Assignment||Treatment||None (Open Label)||||||
1445001|NCT01704859|Randomized|Factorial Assignment||Prevention||Triple|Double Blind||t||t|t
1445002|NCT01704846|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445003|NCT01704833|Randomized|Parallel Assignment||Treatment||Single||||||t
1445004|NCT01704820|Randomized|Parallel Assignment||Screening||Single|||t|||
1445005|NCT01704807|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1445006|NCT01704794|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445007|NCT01704781|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1445008|NCT01704768|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1445009|NCT01704755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445010|NCT01704742|||Cohort||Prospective|||||||
1445011|NCT01704729|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1445012|NCT01704716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445013|NCT01704703||Single Group Assignment||Treatment||None (Open Label)||||||
1445014|NCT01704690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445015|NCT01704677|Randomized|Parallel Assignment||Treatment||Single||||||t
1445016|NCT01704664|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1445017|NCT01704651|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1445018|NCT01704638|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1445019|NCT01704625|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1445020|NCT01704612|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1445021|NCT01704599||Single Group Assignment||Treatment||None (Open Label)||||||
1445022|NCT01704586|Randomized|Parallel Assignment||Treatment||Single||||||t
1445023|NCT01704573|||Cohort||Prospective|||||||
1445024|NCT01704560|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1445025|NCT01704547|||Other||Prospective|||||||
1445026|NCT01704534||Single Group Assignment||Treatment||None (Open Label)||||||
1445027|NCT01704521|Randomized|Parallel Assignment||||None (Open Label)||||||
1445028|NCT01704508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445029|NCT01704495|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445030|NCT01704482|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1445031|NCT01704469|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1445032|NCT01704456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445033|NCT01704443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445034|NCT01704430|Randomized|Parallel Assignment||Prevention||Quadruple||Glutamine|t|t|t|t
1445035|NCT01704417|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445036|NCT01704404|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1445037|NCT01704391|||Cohort||Prospective|||||||
1445038|NCT01704378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445039|NCT01704365|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445040|NCT01704352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445041|NCT01704339||Single Group Assignment||Treatment||None (Open Label)||||||
1445042|NCT01704326|||||Prospective|||||||
1445043|NCT01704313|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1445044|NCT01704300|||Cohort||Retrospective|||||||
1445045|NCT01704287|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445046|NCT01704274|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1445047|NCT01704261|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445048|NCT01704248|Randomized|Crossover Assignment||Treatment||Single||||||t
1445049|NCT01704235|||Ecologic or Community||Cross-Sectional|||||||
1445050|NCT01704222|||Cohort||Prospective|||||||
1445051|NCT01704209|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1445052|NCT01704196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445053|NCT01704183|||Cohort||Prospective|||||||
1445054|NCT01704170||Single Group Assignment||Treatment||None (Open Label)||||||
1445055|NCT01704157||Single Group Assignment||Treatment||None (Open Label)||||||
1445056|NCT01704144|||Cohort||Prospective|||||||
1445057|NCT01704131|||Cohort||Prospective|||||||
1445058|NCT01704118|Randomized|Parallel Assignment||||Single||||||t
1445059|NCT01704105|Randomized|Parallel Assignment||Prevention||Single|Analysts and lab technicians were masked to intervention status. Outcome collectors were not informed of intervention status, but could have inferred status from observing intervention hardware during household visits.||||t|
1445060|NCT01704092|||Case Control||Prospective|||||||
1445061|NCT01704079|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445062|NCT01704066|||Cohort||Prospective|||||||
1445063|NCT01704053|||Case Control||Prospective|||||||
1445064|NCT01704040|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1445065|NCT01704027||Single Group Assignment||Treatment||None (Open Label)||||||
1445066|NCT01704014|||Case Control||Prospective|||||||
1445067|NCT01704001|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445068|NCT01703988|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445069|NCT01703975|Randomized|Parallel Assignment||||Single||||||t
1445070|NCT01703962|||Case Control||Prospective|||||||
1445071|NCT01703949|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445072|NCT01703936|Randomized|Parallel Assignment||||None (Open Label)||||||
1445073|NCT01703923|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1445074|NCT01703910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445075|NCT01703897|||Cohort||Prospective|||||||
1445076|NCT01703884|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445077|NCT01703871|||Cohort||Prospective|||||||
1445078|NCT01703858|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445079|NCT01703845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445080|NCT01703832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445081|NCT01703819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445082|NCT01703806|||Cohort||Prospective|||||||
1445083|NCT01703793|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445084|NCT01703780|||||Prospective|||||||
1445085|NCT01703767|||Case Control||Retrospective|||||||
1445086|NCT01703754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445087|NCT01703741||Single Group Assignment||Treatment||None (Open Label)||||||
1445088|NCT01703728|||Cohort||Prospective|||||||
1445089|NCT01703715|||Cohort||Prospective|||||||
1445090|NCT01703702|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1445091|NCT01703689|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1445092|NCT01703676|||Case Control||Prospective|||||||
1445093|NCT01703663|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445094|NCT01703650|||Cohort||Prospective|||||||
1445095|NCT01703637|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445096|NCT01703624|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1445097|NCT01703611|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445098|NCT01703598||Single Group Assignment||Treatment||None (Open Label)||Asleep Deep Brain Stimulation||||
1445099|NCT01703585|||Cohort||Prospective|||||||
1445100|NCT01703572||Single Group Assignment||Treatment||None (Open Label)||||||
1445101|NCT01703559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445102|NCT01703546||Single Group Assignment||Treatment||None (Open Label)||||||
1445103|NCT01703533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445104|NCT01703520|||Cohort||Retrospective|||||||
1445105|NCT01703507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445106|NCT01703494|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445107|NCT01703481|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445108|NCT01703468|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445109|NCT01703455||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445110|NCT01703442|||Cohort||Prospective|||||||
1445111|NCT01703429|||Cohort||Prospective|||||||
1445112|NCT01703416|||Cohort||Prospective|||||||
1445113|NCT01703403|||Case-Crossover||Retrospective|||||||
1445114|NCT01703390|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445115|NCT01703377|||Case-Crossover||Cross-Sectional|||||||
1445116|NCT01703364||Single Group Assignment||Treatment||None (Open Label)||||||
1445117|NCT01703351|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445118|NCT01703338|||Case-Crossover||Cross-Sectional|||||||
1445119|NCT01703325|Randomized|Single Group Assignment||Treatment||Single||||||t
1445120|NCT01703312|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445121|NCT01703299|||Cohort||Prospective|||||||
1445122|NCT01703286|Randomized|Crossover Assignment||Treatment||Double||||||
1445123|NCT01703273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445124|NCT01703260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445125|NCT01703247|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1445126|NCT01703234||Single Group Assignment||Treatment||Single|||t|||
1445127|NCT01703221|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445128|NCT01703208|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445129|NCT01703195||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445130|NCT01703182|||Cohort||Prospective|||||||
1445131|NCT01703169||Single Group Assignment||Treatment||None (Open Label)||||||
1445132|NCT01703156|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1445133|NCT01703143||Single Group Assignment||Treatment||None (Open Label)||||||
1445134|NCT01703130||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1445135|NCT01703117|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445136|NCT01703104|Randomized|Crossover Assignment||Treatment||Single||||t||
1445137|NCT01703091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445138|NCT01703078|Randomized|Single Group Assignment||Treatment||Single|||||t|
1445139|NCT01703065|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Treatment is open label and non-randomized. Split in to two patient populations - metastatic CRPC and non-metastatic CRPC.|Two separate patient population arms (metastatic CRPC and non-metastatic CRPC) but both populations are given the same interventional treatment and the same safety assessments.||||
1445140|NCT01703052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445141|NCT01703039|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445142|NCT01703026|||Cohort||Prospective|||||||
1445143|NCT01703013|||Cohort||Prospective|||||||
1445144|NCT01703000||Single Group Assignment||Treatment||None (Open Label)||||||
1445145|NCT01702987|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1445146|NCT01702974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445147|NCT01702961||Single Group Assignment||Treatment||None (Open Label)||||||
1445148|NCT01702948|||||Retrospective|||||||
1445149|NCT01702935|||||Prospective|||||||
1445150|NCT01702922|||Case-Only||Cross-Sectional|||||||
1445151|NCT01702909||Single Group Assignment||Treatment||None (Open Label)||||||
1445152|NCT01702896||Single Group Assignment||Treatment||None (Open Label)||||||
1445153|NCT01702883|Randomized|Factorial Assignment||Other||Double|||t||t|
1445154|NCT01702870|||||Prospective|||||||
1445155|NCT01702857|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1445156|NCT01702844||Single Group Assignment||Treatment||None (Open Label)||||||
1445157|NCT01702831||Single Group Assignment||Treatment||None (Open Label)||||||
1445158|NCT01702818|||Other||Cross-Sectional|||||||
1445159|NCT01702805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445160|NCT01702792||Single Group Assignment||Treatment||None (Open Label)||||||
1445161|NCT01702779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445162|NCT01702766||Parallel Assignment||Prevention||||||||
1445163|NCT01702753|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1445164|NCT01702740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445165|NCT01702727|Randomized|Parallel Assignment||Treatment||Single||||||t
1445166|NCT01702714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445167|NCT01702701|Randomized|Parallel Assignment||Treatment||Single|||||t|
1445168|NCT01702688||Single Group Assignment||Other||None (Open Label)||||||
1445169|NCT01702675|Randomized|Parallel Assignment||||Double|||t||t|
1445170|NCT01702662||Single Group Assignment||Treatment||None (Open Label)||||||
1445171|NCT01702649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445172|NCT01702636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445173|NCT01702623|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445174|NCT01702610||Single Group Assignment||Treatment||None (Open Label)||||||
1445175|NCT01702597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445176|NCT01702584|||Cohort||Prospective|||||||
1445177|NCT01702571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445178|NCT01702558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445179|NCT01702545|||Case-Only||Prospective|||||||
1445180|NCT01702532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445181|NCT01702519|Randomized|Crossover Assignment||||Single||||||t
1445182|NCT01702506|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1445183|NCT01702493|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1445184|NCT01702480|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1445185|NCT01702467|Randomized|Crossover Assignment||Treatment||Single|||t|||
1445186|NCT01702454|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445187|NCT01702441||Single Group Assignment||Treatment||None (Open Label)||||||
1445188|NCT01702428|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1445189|NCT01702415|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445190|NCT01702402|Randomized|Parallel Assignment||||None (Open Label)||||||
1445191|NCT01702389||Single Group Assignment||Prevention||Triple|||t||t|t
1445192|NCT01702376|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1445193|NCT01702363||Single Group Assignment||Treatment||None (Open Label)||||||
1445194|NCT01702350|Randomized|Parallel Assignment||Other||Single|||t|||
1445195|NCT01702337||||||||||||
1445196|NCT01702324||Single Group Assignment||Treatment||None (Open Label)||||||
1445197|NCT01702311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445198|NCT01702298||Single Group Assignment||Treatment||None (Open Label)||||||
1445199|NCT01702285||Single Group Assignment||Treatment||None (Open Label)||||||
1445200|NCT01702272|||Cohort||Prospective|||||||
1445201|NCT01702259|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445202|NCT01702246||Single Group Assignment||Treatment||None (Open Label)||||||
1445203|NCT01702233|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445204|NCT01702220|Randomized|Parallel Assignment||Treatment||Single||||||t
1445205|NCT01702207|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1445206|NCT01702194|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445207|NCT01702181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445208|NCT01702168|||Cohort||Prospective|||||||
1445209|NCT01702155||Single Group Assignment||Treatment||None (Open Label)||||||
1445210|NCT01702142|||Case-Only||Prospective|||||||
1445211|NCT01702129||Single Group Assignment||Treatment||None (Open Label)||||||
1445212|NCT01702116|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1445213|NCT01702103|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1445214|NCT01702090||Single Group Assignment||Treatment||None (Open Label)||||||
1445215|NCT01702077|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1445216|NCT01702064||Single Group Assignment||Treatment||None (Open Label)||||||
1445217|NCT01702051|||Cohort||Retrospective|||||||
1445218|NCT01702038||Single Group Assignment||Treatment||None (Open Label)||||||
1445219|NCT01702025|Randomized|Parallel Assignment||Prevention||Single|||t|||
1445220|NCT01702012|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445221|NCT01701999||Single Group Assignment||Other||None (Open Label)||||||
1445222|NCT01701986||Single Group Assignment||Treatment||None (Open Label)||||||
1445223|NCT01701973|Randomized|Crossover Assignment||Other||Double|||t||t|
1445224|NCT01701960|||Cohort||Prospective|||||||
1445225|NCT01701947||||||||||||
1445226|NCT01701934|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445227|NCT01701921|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1445228|NCT01701908|||Cohort||Prospective|||||||
1445229|NCT01701895|||Case-Only||Prospective|||||||
1445230|NCT01701882||Single Group Assignment||Treatment||None (Open Label)||||||
1445231|NCT01701869|||Case Control||Cross-Sectional|||||||
1445232|NCT01701856||Single Group Assignment||Treatment||None (Open Label)||||||
1445233|NCT01701843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445234|NCT01701830|||Case Control||Cross-Sectional|||||||
1445235|NCT01701817|||Cohort||Retrospective|||||||
1445236|NCT01701804|||Cohort||Prospective|||||||
1445237|NCT01701791|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445238|NCT01701778|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1445239|NCT01701765|||Cohort||Prospective|||||||
1445240|NCT01701752|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1445241|NCT01701739|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1445242|NCT01701726|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445243|NCT01701713|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1445244|NCT01701700|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445245|NCT01701687|||Cohort||Prospective|||||||
1445246|NCT01701674||Single Group Assignment||Treatment||None (Open Label)||||||
1445247|NCT01701661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445248|NCT01701648|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1445249|NCT01701635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445250|NCT01701622||Single Group Assignment||Treatment||None (Open Label)||||||
1445251|NCT01701609|Randomized|Parallel Assignment||Treatment||Single||||||t
1445252|NCT01701596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445253|NCT01701583||Single Group Assignment||Treatment||None (Open Label)||||||
1445254|NCT01701570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445255|NCT01701557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445256|NCT01701544|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1445257|NCT01701531||Single Group Assignment||Treatment||None (Open Label)||||||
1445258|NCT01701518||Single Group Assignment||Treatment||None (Open Label)||||||
1445259|NCT01701505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445260|NCT01701492|||Cohort||Prospective|||||||
1445261|NCT01701479||Single Group Assignment||Treatment||None (Open Label)||||||
1445262|NCT01701466|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445263|NCT01701453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445264|NCT01701440||Single Group Assignment||Treatment||None (Open Label)||||||
1445265|NCT01701427|||Cohort||Prospective|||||||
1445266|NCT01701414|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445267|NCT01701401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445268|NCT01701388||Single Group Assignment||Other||None (Open Label)||||||
1445269|NCT01701375|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445270|NCT01701362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445271|NCT01701349|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445272|NCT01701336||Single Group Assignment||Treatment||None (Open Label)||||||
1445273|NCT01701323||Single Group Assignment||Treatment||None (Open Label)||||||
1445274|NCT01701310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445275|NCT01701297|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445276|NCT01701284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445277|NCT01701271||Single Group Assignment||Treatment||None (Open Label)||||||
1445278|NCT01701258|Randomized|Parallel Assignment||Basic Science||Triple||There were four groups of subjects: those with a history of child sexual abuse that are currently experiencing a major depressive episode, those with a history of child sexual abuse without a current or past diagnosis of major depressive disorder, those without a history of child sexual abuse that are currently experiencing a major depressive episode, and those with without a history of child sexual abuse and without a current or past diagnosis of major depressive disorder. Within each group, half of the subjects were assigned to receive the study drug (amisulpride) and half to receive a placebo for the fMRI session (session 2 or 3).|t|t|t|
1445279|NCT01701245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445280|NCT01701232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445281|NCT01701219|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445282|NCT01701206|Randomized|Parallel Assignment||Other||Single|||t|||
1445283|NCT01701193|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1445284|NCT01701180|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1445285|NCT01701167|||Case-Only||Cross-Sectional|||||||
1445286|NCT01701154|||Cohort||Prospective|||||||
1445287|NCT01701141|||Case-Control||Prospective|||||||
1445288|NCT01701128|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1445289|NCT01701115|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1445290|NCT01701102|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445291|NCT01701089|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445292|NCT01701076||Single Group Assignment||Treatment||None (Open Label)||||||
1445293|NCT01701063||Single Group Assignment||Treatment||None (Open Label)||||||
1445294|NCT01701050|||Cohort||Prospective|||||||
1445295|NCT01701037||Single Group Assignment||Other||None (Open Label)||||||
1445296|NCT01701024|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445297|NCT01701011|Randomized|Parallel Assignment||||Triple|||t|t|t|
1445298|NCT01700998|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1445299|NCT01700985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445300|NCT01700972||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445301|NCT01700959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445302|NCT01700946|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445303|NCT01700933|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445304|NCT01700920||Single Group Assignment||Treatment||None (Open Label)||||||
1445305|NCT01700907|Randomized|Parallel Assignment||Treatment||Single|||||t|
1445306|NCT01700894|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1445307|NCT01700881|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1445308|NCT01700868|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1445309|NCT01700855|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1445310|NCT01700842||||||||||||
1445311|NCT01700829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445312|NCT01700816|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1445313|NCT01700803|Randomized|Single Group Assignment||Prevention||Single|||t|||
1445314|NCT01700790||Single Group Assignment||Treatment||None (Open Label)||||||
1445315|NCT01700777|Randomized|Parallel Assignment||Treatment||Single||||||t
1445316|NCT01700764||||||||||||
1445317|NCT01700751|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445318|NCT01700738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445319|NCT01700725|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445320|NCT01700712|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1445321|NCT01700699|||Cohort||Retrospective|||||||
1445322|NCT01700686|||Case-Only||Prospective|||||||
1445323|NCT01700673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445324|NCT01700660|||Case Control||Prospective|||||||
1445325|NCT01700647|||Other||Prospective|||||||
1445326|NCT01700634|||Case-Crossover||Cross-Sectional|||||||
1445327|NCT01700621|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445328|NCT01700608|||Case-Only||Prospective|||||||
1445329|NCT01700595||Single Group Assignment||Treatment||None (Open Label)||||||
1445330|NCT01700582|||Cohort||Prospective|||||||
1445331|NCT01700569||Single Group Assignment||Treatment||None (Open Label)||||||
1445332|NCT01700556|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1445333|NCT01700543|||Cohort||Prospective|||||||
1445334|NCT01700530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445335|NCT01700517|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1445336|NCT01700504|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1445337|NCT01700491|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1445338|NCT01700478||Single Group Assignment||Prevention||Double|||t|t||
1445339|NCT01700465|||Case-Only||Prospective|||||||
1445340|NCT01700452|||Cohort||Prospective|||||||
1445341|NCT01700439||Single Group Assignment||Treatment||None (Open Label)||||||
1445342|NCT01700426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445343|NCT01700413||Single Group Assignment||Treatment||None (Open Label)||||||
1445344|NCT01700400||Single Group Assignment||Treatment||None (Open Label)||||||
1445345|NCT01700387|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445346|NCT01700374|||Cohort||Prospective|||||||
1445347|NCT01700361|||Other||Cross-Sectional|||||||
1445348|NCT01700348|Randomized|Parallel Assignment||Treatment||Single|||||t|
1445349|NCT01700335||Single Group Assignment||Treatment||None (Open Label)||||||
1445350|NCT01700322|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1445351|NCT01700309|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445352|NCT01700296|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1445353|NCT01700283|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1445354|NCT01700270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445355|NCT01700257||Single Group Assignment||Screening||None (Open Label)||||||
1445356|NCT01700244||Single Group Assignment||Treatment||None (Open Label)||||||
1445357|NCT01700231|||Case-Only||Prospective|||||||
1445358|NCT01700218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445359|NCT01700205|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1445360|NCT01700192|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445361|NCT01700179||Single Group Assignment||Treatment||None (Open Label)||||||
1445362|NCT01700166||Single Group Assignment||Treatment||None (Open Label)||||||
1445363|NCT01700153|Randomized|Parallel Assignment||Treatment||Single||||||t
1445364|NCT01700140||Parallel Assignment||||Double||||||
1445365|NCT01700127|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1445366|NCT01700114|||Cohort||Prospective|||||||
1445367|NCT01700101|||Cohort||Prospective|||||||
1445368|NCT01700088|||Case-Only||Prospective|||||||
1445369|NCT01700075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445370|NCT01700062|Randomized|Parallel Assignment||||None (Open Label)||||||
1445371|NCT01700049||Single Group Assignment||Treatment||None (Open Label)||||||
1445372|NCT01700036||Single Group Assignment||Treatment||None (Open Label)||||||
1445373|NCT01700023|||Cohort||Prospective|||||||
1445374|NCT01700010||Single Group Assignment||Treatment||None (Open Label)||||||
1445375|NCT01699997|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1445376|NCT01699984|||Cohort||Prospective|||||||
1445377|NCT01699971|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445378|NCT01699958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445379|NCT01699945|||||Retrospective|||||||
1445380|NCT01699932|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445381|NCT01699919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445382|NCT01699906||Single Group Assignment||Basic Science||None (Open Label)||||||
1445383|NCT01699893||Single Group Assignment||Health Services Research||None (Open Label)||||||
1445384|NCT01699880|||Case Control||Prospective|||||||
1445385|NCT01699867|||Cohort||Prospective|||||||
1445386|NCT01699854|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445387|NCT01699841|||Cohort||Prospective|||||||
1445388|NCT01699828|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1445389|NCT01699815|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445390|NCT01699802||Single Group Assignment||Basic Science||None (Open Label)||||||
1445391|NCT01699789|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1445392|NCT01699776|Randomized|Crossover Assignment||Treatment||Single|||||t|
1445393|NCT01699763||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445394|NCT01699750|Randomized|Parallel Assignment||||Single|||t|||
1445395|NCT01699737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445396|NCT01699724|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1445397|NCT01699711|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445398|NCT01699698|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1445399|NCT01699685|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1445400|NCT01699672|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1445401|NCT01699659|||Case-Only||Retrospective|||||||
1445402|NCT01699646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445403|NCT01699633|||Cohort||Prospective|||||||
1445404|NCT01699620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445405|NCT01699607||Single Group Assignment||||None (Open Label)||||||
1445406|NCT01699594|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1445407|NCT01699581||Single Group Assignment||Treatment||None (Open Label)||||||
1445408|NCT01699568|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1445409|NCT01699555|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445410|NCT01699542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445411|NCT01699529||Single Group Assignment||Treatment||None (Open Label)||||||
1445412|NCT01699516|||Case Control||Prospective|||||||
1445413|NCT01699503|Randomized|Parallel Assignment||Screening||Single||||||t
1445414|NCT01699490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445415|NCT01699477|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1445416|NCT01699464|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445417|NCT01699451|||Other||Prospective|||||||
1445418|NCT01699438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445419|NCT01699425|Randomized|Parallel Assignment||Treatment||Single||||||t
1445420|NCT01699412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445421|NCT01699399|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1445422|NCT01699386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445423|NCT01699373|Randomized|Parallel Assignment||Treatment||Single||||||t
1445424|NCT01699360||Single Group Assignment||Treatment||None (Open Label)||||||
1445425|NCT01699347||Single Group Assignment||Treatment||None (Open Label)||||||
1445426|NCT01699334|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445427|NCT01699321|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445428|NCT01699308|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445429|NCT01699295|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1445430|NCT01699282|Randomized|Parallel Assignment||||None (Open Label)||||||
1445431|NCT01699269||Single Group Assignment||Screening||Single|||t|||
1445432|NCT01699256|Randomized|Parallel Assignment||Treatment||Single|||||t|
1445433|NCT01699243|||Case-Only||Prospective|||||||
1445434|NCT01699230|Randomized|Parallel Assignment||||None (Open Label)||||||
1445435|NCT01699217|||Cohort||Prospective|||||||
1445436|NCT01699204|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1445437|NCT01699191|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445438|NCT01699178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445439|NCT01699165|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1445440|NCT01699152||Single Group Assignment||Treatment||None (Open Label)||||||
1445441|NCT01699139|Randomized|Crossover Assignment||Treatment||Single||||||t
1445442|NCT01699126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445443|NCT01699113|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1445444|NCT01699100||Single Group Assignment||Treatment||Single|||||t|
1445445|NCT01699087||Single Group Assignment||Treatment||None (Open Label)||||||
1445446|NCT01699074|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1445447|NCT01699061|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1445448|NCT01699048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445449|NCT01699035|||||Cross-Sectional|||||||
1445450|NCT01699022||Single Group Assignment||Prevention||None (Open Label)||||||
1445451|NCT01699009|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1445452|NCT01698996|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445453|NCT01698983|||Cohort||Prospective|||||||
1445454|NCT01698970|Randomized|Parallel Assignment||||Double|||t||t|
1445455|NCT01698957|||Case-Only||Prospective|||||||
1445456|NCT01698944|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445457|NCT01698931|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445458|NCT01698918|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445459|NCT01698905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445460|NCT01698892|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1445461|NCT01698879||Single Group Assignment||Treatment||None (Open Label)||||||
1445462|NCT01698866||Single Group Assignment||Prevention||None (Open Label)||||||
1445463|NCT01698853|||||Prospective|||||||
1445464|NCT01698840|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1445465|NCT01698827|||Cohort||Prospective|||||||
1445466|NCT01698814|Randomized|Parallel Assignment||||Double|||t||t|
1445467|NCT01698801||Single Group Assignment||Treatment||None (Open Label)||||||
1445468|NCT01698788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445469|NCT01698775|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445470|NCT01698762|||Case-Control||Prospective|||||||
1445471|NCT01698749||Single Group Assignment||Treatment||None (Open Label)||||||
1445472|NCT01698736|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445473|NCT01698723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445474|NCT01698710||Single Group Assignment||Treatment||None (Open Label)||||||
1445475|NCT01698697|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1445476|NCT01698684|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445477|NCT01698671||Single Group Assignment||Treatment||None (Open Label)||||||
1445478|NCT01698658||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445479|NCT01698645|||Cohort||Prospective|||||||
1445480|NCT01698632|||Cohort||Prospective|||||||
1445481|NCT01698619|||Cohort||Prospective|||||||
1445482|NCT01698606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445483|NCT01698593|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1445484|NCT01698580|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1445485|NCT01698567|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445486|NCT01698554|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445487|NCT01698541|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445488|NCT01698528|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1445489|NCT01698515|||Case-Only||Cross-Sectional|||||||
1445490|NCT01698502|||Case-Crossover||Cross-Sectional|||||||
1445491|NCT01698489|||Other||Cross-Sectional|||||||
1445492|NCT01698476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445493|NCT01698463||Single Group Assignment||Prevention||None (Open Label)||||||
1445494|NCT01698450||Single Group Assignment||Basic Science||None (Open Label)||||||
1445495|NCT01698437||Single Group Assignment||Basic Science||None (Open Label)||||||
1445496|NCT01698424|||Case-Only||Cross-Sectional|||||||
1445497|NCT01698411|||Cohort|||||||||
1445498|NCT01698398|Randomized|||||Double|||t||t|
1445499|NCT01698385|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445500|NCT01698372|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1445501|NCT01698359|||||Prospective|||||||
1445502|NCT01698346|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445503|NCT01698333||Single Group Assignment||Treatment||None (Open Label)||||||
1445504|NCT01698320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445505|NCT01698307|Randomized|Parallel Assignment||Treatment||None (Open Label)||algorithm||||
1445506|NCT01698294|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1445507|NCT01698281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445508|NCT01698268|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445509|NCT01698255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445510|NCT01698242|Randomized|Parallel Assignment||Prevention||Single||||||t
1445511|NCT01698229|||Case-Only||Cross-Sectional|||||||
1445512|NCT01698216|||Case-Only||Prospective|||||||
1445513|NCT01698203|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1445514|NCT01698190|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1445515|NCT01698177|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1445516|NCT01698164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445517|NCT01698151|||Case-Only||Prospective|||||||
1445518|NCT01698138|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445519|NCT01698125|||Cohort||Prospective|||||||
1445520|NCT01698112|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445521|NCT01698099|||Cohort||Retrospective|||||||
1445522|NCT01698086|Randomized|Parallel Assignment||Treatment||Single|||||t|
1445523|NCT01698073|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445524|NCT01698060|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1445525|NCT01698047|Randomized|Parallel Assignment||Prevention||Single||||||t
1445526|NCT01698034|Randomized|Parallel Assignment||Treatment||Single||||||t
1445527|NCT01698021|||Cohort||Prospective|||||||
1445528|NCT01698008|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||One group is standard of care. The other is given the opportunity to use a new mobile app for reporting blood sugars.||||
1445529|NCT01697995|||Case Control|||||||||
1445530|NCT01697982|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1445531|NCT01697969||Single Group Assignment||||None (Open Label)||||||
1445532|NCT01697956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445533|NCT01697943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445534|NCT01697930||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445535|NCT01697917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445536|NCT01697904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445537|NCT01697891||Single Group Assignment||Supportive Care||None (Open Label)||||||
1445538|NCT01697878|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t||t
1445539|NCT01697865|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445540|NCT01697852|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445541|NCT01697839|||Case-Only||Prospective|||||||
1445542|NCT01697826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445543|NCT01697813||||||||||||
1445544|NCT01697800|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1445545|NCT01697787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445546|NCT01697774||||||||||||
1445547|NCT01697761|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1445548|NCT01697748|Randomized|Parallel Assignment||Prevention||Single||||||t
1445549|NCT01697735|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1445550|NCT01697722|||Cohort||Retrospective|||||||
1445551|NCT01697709|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445552|NCT01697696|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445553|NCT01697683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445554|NCT01697670||Single Group Assignment||Treatment||None (Open Label)||||||
1445555|NCT01697657|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445556|NCT01697644|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445557|NCT01697631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445558|NCT01697618|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1445559|NCT01697605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445560|NCT01697592|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445561|NCT01697579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445562|NCT01697566|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445563|NCT01697553|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1445564|NCT01697540|||Case-Only||Prospective|||||||
1445565|NCT01697527||Single Group Assignment||Treatment||None (Open Label)||||||
1445566|NCT01697514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445567|NCT01697501||Single Group Assignment||Other||None (Open Label)||||||
1445568|NCT01697488|||Cohort||Prospective|||||||
1445569|NCT01697475|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1445570|NCT01697462|||Cohort||Prospective|||||||
1445571|NCT01697449|||Cohort||Prospective|||||||
1445572|NCT01697436|Randomized|Crossover Assignment||||None (Open Label)||||||
1445573|NCT01697423|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1445574|NCT01697410|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445575|NCT01697397|||Case Control||Prospective|||||||
1445576|NCT01697384||Single Group Assignment||Treatment||None (Open Label)||||||
1445577|NCT01697371||Single Group Assignment||Treatment||None (Open Label)||||||
1445578|NCT01697358|Randomized|Parallel Assignment||Treatment||None (Open Label)||Period I (from randomization to 6 months) is the randomized parallel group comparative phase. Day zero for the study is the point of randomization. The randomization ratio is 1:1 (SCS+OMM to OMM). For the SCS+OMM arm, the screening test and/or implant occurred after randomization. Period II (6 to 24 months) is the long-term observational follow-up phase.||||
1445579|NCT01697345||Single Group Assignment||Treatment||None (Open Label)||||||
1445580|NCT01697332||Single Group Assignment||Basic Science||None (Open Label)||||||
1445581|NCT01697319||Single Group Assignment||Treatment||None (Open Label)||||||
1445582|NCT01697306|Randomized|Parallel Assignment||||None (Open Label)||||||
1445583|NCT01697293||Single Group Assignment||Treatment||None (Open Label)||||||
1445584|NCT01697280|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1445585|NCT01697267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445586|NCT01697254|||Cohort||Prospective|||||||
1445587|NCT01697241|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1445588|NCT01697228|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1445589|NCT01697215|||Case-Only||Prospective|||||||
1445590|NCT01697202|||Case-Only||Prospective|||||||
1445591|NCT01697189|Randomized|Parallel Assignment||Prevention||Single||||||t
1445592|NCT01697176|||Cohort||Prospective|||||||
1445593|NCT01697163|||||Prospective|||||||
1445594|NCT01697150||Single Group Assignment||Treatment||None (Open Label)||||||
1445595|NCT01697137|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1445596|NCT01697124||Single Group Assignment||Prevention||Single||||||t
1445597|NCT01697111|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445598|NCT01697098|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445599|NCT01697085|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1445600|NCT01697072|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445601|NCT01697059||Single Group Assignment||Treatment||None (Open Label)||||||
1445602|NCT01697046||Single Group Assignment||Prevention||None (Open Label)||||||
1445603|NCT01697020|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445604|NCT01697007|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1445605|NCT01696994|Randomized|Parallel Assignment||Screening||Single|||||t|
1445606|NCT01696981|Randomized|Parallel Assignment||Screening||Single|||||t|
1445607|NCT01696968|Randomized|Parallel Assignment||Screening||Single|||||t|
1445608|NCT01696955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445609|NCT01696942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445610|NCT01696929||Single Group Assignment||Treatment||None (Open Label)||||||
1445611|NCT01696916||Single Group Assignment||Basic Science||None (Open Label)||||||
1445612|NCT01696903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445613|NCT01696890|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445614|NCT01696877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445615|NCT01696864|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445616|NCT01696851|||Case Control||Prospective|||||||
1445617|NCT01696838|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1445618|NCT01696825|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445619|NCT01696812||Single Group Assignment||Screening||None (Open Label)||||||
1445620|NCT01696799|Randomized|Parallel Assignment||Treatment||Single|||||t|
1445621|NCT01696786||Single Group Assignment||Treatment||None (Open Label)||||||
1445622|NCT01696773|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1445623|NCT01696760|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1445624|NCT01696747|||Cohort||Prospective|||||||
1445625|NCT01696734||Single Group Assignment||Treatment||None (Open Label)||||||
1445626|NCT01696721|||Cohort||Prospective|||||||
1445627|NCT01696708|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1445628|NCT01696695|||Cohort||Prospective|||||||
1445629|NCT01696682|Randomized|Factorial Assignment||Treatment||Single|||||t|
1445630|NCT01696669||Single Group Assignment||Treatment||None (Open Label)||||||
1445631|NCT01696656|||Cohort||Retrospective|||||||
1445632|NCT01696643|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445633|NCT01696630|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1445634|NCT01696617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445635|NCT01696604|Randomized|Crossover Assignment||Other||Double|||t||t|
1445636|NCT01696591|||Case Control||Prospective|||||||
1445637|NCT01696578|Randomized|Parallel Assignment||Treatment||Single||||||t
1445638|NCT01696565|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1445639|NCT01696552|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445640|NCT01696539|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1445641|NCT01696526|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1445642|NCT01696513|Randomized|Parallel Assignment||Treatment||Single||||||t
1445643|NCT01696500||Single Group Assignment||Treatment||None (Open Label)||||||
1445644|NCT01696487|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1445645|NCT01696474||Single Group Assignment||Treatment||None (Open Label)||||||
1445646|NCT01696461||Single Group Assignment||Treatment||None (Open Label)||||||
1445647|NCT01696448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445648|NCT01696435|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1445649|NCT01696422|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1445650|NCT01696409|||Cohort||Prospective|||||||
1445651|NCT01696396|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445652|NCT01696383||Single Group Assignment||Treatment||None (Open Label)||||||
1445653|NCT01696370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445654|NCT01696357|||Case Control||Prospective|||||||
1445655|NCT01696344|||Cohort||Prospective|||||||
1445656|NCT01696331||Single Group Assignment||Health Services Research||None (Open Label)||||||
1445657|NCT01696318|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445658|NCT01696305|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1445659|NCT01696292|||Case-Only||Cross-Sectional|||||||
1445660|NCT01696279|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445661|NCT01696266|||Cohort||Cross-Sectional|||||||
1445662|NCT01696253|||Case-Only||Other|||||||
1445663|NCT01696240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445664|NCT01696227|||||Prospective|||||||
1445665|NCT01696214|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1445666|NCT01696201|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1445667|NCT01696188|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1445668|NCT01696175|||Cohort||Prospective|||||||
1445669|NCT01696162|Randomized|Single Group Assignment||Treatment||Single||||||t
1445670|NCT01696149||Single Group Assignment||Basic Science||Double|||t|||t
1445671|NCT01696136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445672|NCT01696123||Single Group Assignment||Treatment||None (Open Label)||||||
1445673|NCT01696110|Randomized|Parallel Assignment||Treatment||Single||||||t
1445674|NCT01696097||Single Group Assignment||Treatment||None (Open Label)||||||
1445675|NCT01696084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445676|NCT01696071|Randomized|Crossover Assignment||Treatment||Double||||||
1445677|NCT01696058|Randomized|Parallel Assignment||Treatment||Double||||||
1445678|NCT01696045||Parallel Assignment||Treatment||None (Open Label)||||||
1445679|NCT01696032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445680|NCT01696019|Randomized|Parallel Assignment||Prevention||Single||||||t
1445681|NCT01696006|||Case-Only||Prospective|||||||
1445682|NCT01695993|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1445683|NCT01695980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445684|NCT01695967|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445685|NCT01695954|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1445686|NCT01695941||Single Group Assignment||Treatment||None (Open Label)||||||
1445687|NCT01695928|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1445688|NCT01695915|||Case Control||Prospective|||||||
1445689|NCT01695902|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445690|NCT01695889|||Case Control||Retrospective|||||||
1445691|NCT01695876|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1445692|NCT01695863|Randomized|Parallel Assignment||Screening||Single|||||t|
1445928|NCT01692795|||Cohort||Retrospective|||||||
1445693|NCT01695850|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445694|NCT01695837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445695|NCT01695824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445696|NCT01695811|||Case Control||Prospective|||||||
1445697|NCT01695798|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445698|NCT01695785|||Case Control||Cross-Sectional|||||||
1445699|NCT01695772||Single Group Assignment||Treatment||None (Open Label)||||||
1445700|NCT01695759|Randomized|Parallel Assignment||Treatment||Single|||||t|
1445701|NCT01695746|||Cohort||Prospective|||||||
1445702|NCT01695733|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1445703|NCT01695720||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445704|NCT01695707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445705|NCT01695694|Randomized|Parallel Assignment||Prevention||Single|||t|||
1445706|NCT01695681||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445707|NCT01695668|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445708|NCT01695655|||Cohort||Prospective|||||||
1445709|NCT01695642|||Cohort||Prospective|||||||
1445710|NCT01695629|||Cohort||Prospective|||||||
1445711|NCT01695616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445712|NCT01695603|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1445713|NCT01695590||Single Group Assignment||Treatment||None (Open Label)||||||
1445714|NCT01695577|Randomized|Parallel Assignment||Treatment||Single||||||t
1445715|NCT01695564|||Case-Control||Retrospective|||||||
1445716|NCT01695551|||Cohort||Prospective|||||||
1445717|NCT01695538||Single Group Assignment||Treatment||None (Open Label)||||||
1445718|NCT01695525||Single Group Assignment||Treatment||None (Open Label)||||||
1445719|NCT01695512|||Cohort||Prospective|||||||
1445720|NCT01695499|||Cohort||Prospective|||||||
1445721|NCT01695486|||Case-Only||Prospective|||||||
1445722|NCT01695473||Single Group Assignment||Treatment||None (Open Label)||||||
1445723|NCT01695460|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1445724|NCT01695447|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1445725|NCT01695434|||Case Control||Prospective|||||||
1445726|NCT01695421|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1445727|NCT01695408|||Cohort||Prospective|||||||
1445728|NCT01695395|||Case Control||Cross-Sectional|||||||
1445729|NCT01695382|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1445730|NCT01695369|Randomized|Parallel Assignment||||Single|||t|||
1445731|NCT01695356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445732|NCT01695343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445733|NCT01695330||Single Group Assignment||Treatment||None (Open Label)||||||
1445734|NCT01695317|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1445735|NCT01695304|Randomized|Parallel Assignment||Prevention||None (Open Label)|This is an intervention trial of ceramic water filters, and as such cannot be masked. The intervention participants received the CWFs during the trial and the control group after the trial was over.|||||
1445736|NCT01695291|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445737|NCT01695278|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1445738|NCT01695265|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1445739|NCT01695252|Randomized|||Treatment||||||||
1445740|NCT01695239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445741|NCT01695226|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1445742|NCT01695213|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445743|NCT01695200||Single Group Assignment||Treatment||None (Open Label)||||||
1445744|NCT01695187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445745|NCT01695174||Single Group Assignment||Treatment||None (Open Label)||||||
1445746|NCT01695161|||Case Control||Prospective|||||||
1445747|NCT01695148|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445748|NCT01695135|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445749|NCT01695122||Single Group Assignment||Treatment||None (Open Label)||||||
1445750|NCT01695109|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1445751|NCT01695096|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1445752|NCT01695083|||Case-Only||Prospective|||||||
1445753|NCT01695070||Single Group Assignment||Treatment||None (Open Label)||||||
1445754|NCT01695057||Single Group Assignment||Treatment||None (Open Label)||||||
1445755|NCT01695044||Single Group Assignment||Treatment||None (Open Label)||||||
1445756|NCT01695031|Randomized|Parallel Assignment||||Double|||t|t||
1445757|NCT01695018|||Cohort||Prospective|||||||
1445758|NCT01695005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445759|NCT01694992|Randomized|Parallel Assignment||Treatment||Single||||||t
1445760|NCT01694979|||Case-Only||Cross-Sectional|||||||
1445761|NCT01694966|Randomized|Parallel Assignment||Screening||Double|||t||t|
1445762|NCT01694953|||Cohort||Prospective|||||||
1445763|NCT01694940|||Cohort||Prospective|||||||
1445764|NCT01694927||Single Group Assignment||Treatment||None (Open Label)||||||
1445765|NCT01694914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445766|NCT01694901|||Cohort||Prospective|||||||
1445767|NCT01694888||Single Group Assignment||||None (Open Label)||||||
1445768|NCT01694875|||Cohort||Retrospective|||||||
1445769|NCT01694862|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1445770|NCT01694849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445771|NCT01694836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445772|NCT01694823||Single Group Assignment||Treatment||None (Open Label)||||||
1445773|NCT01694810|Randomized|Parallel Assignment||Treatment||Single|||||t|
1445774|NCT01694797|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445775|NCT01694784|Randomized|Parallel Assignment||Prevention||Single|||t|||
1445776|NCT01694771|Randomized|Parallel Assignment||Treatment||Double||||||
1445777|NCT01694758|||Cohort||Prospective|||||||
1445778|NCT01694745|||Cohort||Prospective|||||||
1445779|NCT01694732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445780|NCT01694719|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1445781|NCT01694706|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445782|NCT01694693|||Other||Retrospective|||||||
1445783|NCT01694680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445784|NCT01694667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445785|NCT01694654|||Cohort||Retrospective|||||||
1445786|NCT01694641|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1445787|NCT01694628|Randomized|Parallel Assignment||Treatment||Single||||||t
1445788|NCT01694615|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1445789|NCT01694602|||Case-Only||Prospective|||||||
1445790|NCT01694589||Single Group Assignment||Treatment||None (Open Label)||||||
1445791|NCT01694576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445792|NCT01694563|||Cohort||Prospective|||||||
1445793|NCT01694550|||Cohort||Prospective|||||||
1445794|NCT01694537|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1445795|NCT01694524|||Cohort||Retrospective|||||||
1445796|NCT01694511|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1445797|NCT01694498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445798|NCT01694485|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445799|NCT01694472||Single Group Assignment||Supportive Care||None (Open Label)||||||
1445800|NCT01694459|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445801|NCT01694446||Single Group Assignment||Basic Science||Single|||t|||
1445802|NCT01694433|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1445803|NCT01694420||Single Group Assignment||Treatment||None (Open Label)||||||
1445804|NCT01694407|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1445805|NCT01694394|||Cohort||Prospective|||||||
1445806|NCT01694381|||Cohort||Prospective|||||||
1445807|NCT01694368|||Other||Prospective|||||||
1445808|NCT01694355||Single Group Assignment||Treatment||None (Open Label)||||||
1445809|NCT01694342|||Cohort||Prospective|||||||
1445810|NCT01694329|||Cohort||Retrospective|||||||
1445811|NCT01694316|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1445812|NCT01694303|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1445813|NCT01694290|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445814|NCT01694277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445815|NCT01694264|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1445816|NCT01694251|||Case-Only||Prospective|||||||
1445817|NCT01694238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445818|NCT01694225||Single Group Assignment||Supportive Care||None (Open Label)||||||
1445819|NCT01694212|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1445820|NCT01694199|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445821|NCT01694186|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1445822|NCT01694173|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445823|NCT01694160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445824|NCT01694147|||Case-Only||Prospective|||||||
1445825|NCT01694134|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445826|NCT01694121|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445827|NCT01694108|Randomized|Single Group Assignment||Prevention||Single||||||t
1445828|NCT01694095|||Case-Only||Prospective|||||||
1445829|NCT01694082|Randomized|Parallel Assignment||Prevention||Single|||t|||
1445830|NCT01694069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445831|NCT01694056|Randomized|Crossover Assignment||Prevention||Single|||||t|
1445832|NCT01694043|Randomized|Factorial Assignment||Treatment||Single|||t|||
1445833|NCT01694030|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1445834|NCT01694017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445835|NCT01694004||Single Group Assignment||Basic Science||None (Open Label)||||||
1445836|NCT01693991|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1445837|NCT01693978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445838|NCT01693965||Single Group Assignment||Basic Science||None (Open Label)||||||
1445839|NCT01693952||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445840|NCT01693939||Single Group Assignment||Treatment||None (Open Label)||||||
1445841|NCT01693926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445842|NCT01693913|Non-Randomized|Parallel Assignment||Treatment||Double|||t|t||
1445843|NCT01693900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445844|NCT01693887|||Case Control||Prospective|||||||
1445845|NCT01693874|Randomized|Parallel Assignment||Treatment||Single||||||t
1445846|NCT01693861|||Case-Only||Prospective|||||||
1445847|NCT01693848|||Case Control||Prospective|||||||
1445848|NCT01693835|||Case Control||Prospective|||||||
1445849|NCT01693822||Single Group Assignment||Treatment||None (Open Label)||||||
1445850|NCT01693809||Single Group Assignment||Screening||Single|||||t|
1445851|NCT01693796||Single Group Assignment||Prevention||None (Open Label)||||||
1445852|NCT01693783||Single Group Assignment||Treatment||None (Open Label)||||||
1445853|NCT01693770||Single Group Assignment||Treatment||None (Open Label)||||||
1445854|NCT01693757|||Case Control||Prospective|||||||
1445855|NCT01693744|||Case Control||Prospective|||||||
1445856|NCT01693731|||||Cross-Sectional|||||||
1445857|NCT01693718||Single Group Assignment||Treatment||None (Open Label)||||||
1445858|NCT01693705|||Case Control||Retrospective|||||||
1445859|NCT01693692|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445860|NCT01693679|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445861|NCT01693666|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445862|NCT01693653|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445863|NCT01693640||Single Group Assignment||Treatment||None (Open Label)||||||
1445864|NCT01693627|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445865|NCT01693614|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1445866|NCT01693601||Single Group Assignment||Treatment||None (Open Label)||||||
1445867|NCT01693588||Single Group Assignment||Supportive Care||None (Open Label)||||||
1445868|NCT01693575||Single Group Assignment||Treatment||None (Open Label)||||||
1445869|NCT01693562||Single Group Assignment||Treatment||None (Open Label)||||||
1445870|NCT01693549||Single Group Assignment||Treatment||None (Open Label)||||||
1445871|NCT01693536|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445872|NCT01693523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445873|NCT01693510|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1445874|NCT01693497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445875|NCT01693484||Single Group Assignment||Prevention||None (Open Label)||||||
1445876|NCT01693471|||Cohort||Prospective|||||||
1445877|NCT01693458|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1445878|NCT01693445||Single Group Assignment||Treatment||None (Open Label)||||||
1445879|NCT01693432||Single Group Assignment||Treatment||None (Open Label)||||||
1445880|NCT01693419||Single Group Assignment||Treatment||None (Open Label)||||||
1445881|NCT01693406|||Cohort||Prospective|||||||
1445882|NCT01693393||Single Group Assignment||Treatment||None (Open Label)||||||
1445883|NCT01693380|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1445884|NCT01693367|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445885|NCT01693354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445886|NCT01693341|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1445887|NCT01693328|||Cohort||Prospective|||||||
1445888|NCT01693315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445889|NCT01693302|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445890|NCT01693289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445891|NCT01693276||Single Group Assignment||Treatment||None (Open Label)||||||
1445892|NCT01693263|||Cohort||Prospective|||||||
1445893|NCT01693250|Randomized|Parallel Assignment||Prevention||Double|Primary care providers and outcome assessors were blinded to the group assignment.|A randomized control study design with an active control group was used.||t||t
1445894|NCT01693237|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1445895|NCT01693224||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445896|NCT01693211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445897|NCT01693198||Single Group Assignment||Diagnostic||None (Open Label)||||||
1445898|NCT01693185|Randomized|Parallel Assignment||Treatment||Single||||||t
1445899|NCT01693172|Randomized|Parallel Assignment||Prevention||Single||||||t
1445900|NCT01693159|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445901|NCT01693146|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1445902|NCT01693133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445903|NCT01693120||Single Group Assignment||Treatment||None (Open Label)||Treatment with Phased RF Ablation System||||
1445904|NCT01693107|||Cohort||Prospective|||||||
1445905|NCT01693094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445906|NCT01693081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445907|NCT01693068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445908|NCT01693055||Single Group Assignment||Treatment||None (Open Label)||||||
1445909|NCT01693042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445910|NCT01693029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445911|NCT01693016|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1445912|NCT01693003|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445913|NCT01692990|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1445914|NCT01692977|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1445915|NCT01692964||||||||||||
1445916|NCT01692951|||Case-Control||Retrospective|||||||
1445917|NCT01692938|||Case-Only||Prospective|||||||
1445918|NCT01692925|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445919|NCT01692912|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1445920|NCT01692899|||||Retrospective|||||||
1445921|NCT01692886|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1445922|NCT01692873||Single Group Assignment||Other||None (Open Label)||||||
1445923|NCT01692860|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1445924|NCT01692847|||Cohort||Prospective|||||||
1445925|NCT01692834|Randomized|Crossover Assignment||||Single|||t|||
1445926|NCT01692821|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1445927|NCT01692808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445929|NCT01692782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1445930|NCT01692769|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445931|NCT01692756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445932|NCT01692743|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1445933|NCT01692730|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445934|NCT01692717|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445935|NCT01692704||Single Group Assignment||Treatment||None (Open Label)||||||
1445936|NCT01692691||Single Group Assignment||Treatment||None (Open Label)||||||
1445937|NCT01692678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445938|NCT01692665|||Case-Only||Prospective|||||||
1445939|NCT01692652|Randomized|Parallel Assignment||Treatment||Single|||t|||
1445940|NCT01692639|||Case-Only||Prospective|||||||
1445941|NCT01692626|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1445942|NCT01692613|||Case Control||Prospective|||||||
1445943|NCT01692600|||Case Control||Cross-Sectional|||||||
1445944|NCT01692587|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1445945|NCT01692574|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1445946|NCT01692561|||Case-Control||Prospective|||||||
1445947|NCT01692548|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445948|NCT01692535|Randomized|Parallel Assignment||||Single|||t|||
1445949|NCT01692522|Randomized|Parallel Assignment||||Single|||t|||
1445950|NCT01692509|||Cohort||Prospective|||||||
1445951|NCT01692496||Single Group Assignment||Treatment||None (Open Label)||||||
1445952|NCT01692483|||Cohort||Prospective|||||||
1445953|NCT01692470|||Case-Only||Prospective|||||||
1445954|NCT01692457|||Case-Only||Prospective|||||||
1445955|NCT01692444|||Case Control||Prospective|||||||
1445956|NCT01692431|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1445957|NCT01692418|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445958|NCT01692405|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1445959|NCT01692392|||Cohort||Prospective|||||||
1445960|NCT01692379|Randomized|Parallel Assignment||Treatment||Single||||||t
1445961|NCT01692366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445962|NCT01692353|||Cohort||Cross-Sectional|||||||
1445963|NCT01692340|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1445964|NCT01692327|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1445965|NCT01692314||Single Group Assignment||Health Services Research||None (Open Label)||||||
1445966|NCT01692301|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1445967|NCT01692288|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1445968|NCT01692275|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1445969|NCT01692262|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1445970|NCT01692249|Randomized|Parallel Assignment||Treatment||Single|||||t|
1445971|NCT01692236|||||Prospective|||||||
1445972|NCT01692223|||Family-Based||Prospective|||||||
1445973|NCT01692210|||Cohort||Prospective|||||||
1445974|NCT01692197||Single Group Assignment||Treatment||None (Open Label)||||||
1445975|NCT01692184|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1445976|NCT01692171|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445977|NCT01692158|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1445978|NCT01692145||Parallel Assignment||Treatment||Double||||||
1445979|NCT01692132|||Cohort||Prospective|||||||
1445980|NCT01692119|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1445981|NCT01692106||Single Group Assignment||Treatment||None (Open Label)||||||
1445982|NCT01692093|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1445983|NCT01692080|||Ecologic or Community||Prospective|||||||
1445984|NCT01692067|||Case-Control||Cross-Sectional|||||||
1445985|NCT01692054|||Case Control||Retrospective|||||||
1445986|NCT01692041|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1445987|NCT01692028|||Ecologic or Community||Cross-Sectional|||||||
1445988|NCT01692015|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1445989|NCT01692002|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1445990|NCT01691989||Parallel Assignment||Treatment||Double|||t||t|
1445991|NCT01691976|Randomized|Parallel Assignment||||None (Open Label)||||||
1445992|NCT01691963|Randomized|Parallel Assignment||||None (Open Label)||||||
1445993|NCT01691950|||Cohort|||||||||
1445994|NCT01691937|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1445995|NCT01691924|Randomized|Parallel Assignment||||Double|||t||t|
1445996|NCT01691911|Randomized|Parallel Assignment||Prevention||Single||||||t
1445997|NCT01691898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1445998|NCT01691885|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1445999|NCT01691872|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1446000|NCT01691859||Single Group Assignment||Treatment||None (Open Label)||||||
1446001|NCT01691846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446002|NCT01691833|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1446003|NCT01691820|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1446004|NCT01691807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446005|NCT01691794|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446006|NCT01691781||Single Group Assignment||Other||None (Open Label)|Open Label|||||
1446007|NCT01691768|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446008|NCT01691755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446009|NCT01691742|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1446010|NCT01691729|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446011|NCT01691716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446012|NCT01691703||Single Group Assignment||||Single||||||t
1446013|NCT01691690|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446014|NCT01691677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446015|NCT01691664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446016|NCT01691651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446017|NCT01691638|||Case Control||Retrospective|||||||
1446018|NCT01691625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446019|NCT01691612||Single Group Assignment||Other||None (Open Label)||||||
1446020|NCT01691599|||Case-Only||Prospective|||||||
1446021|NCT01691586|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446022|NCT01691573|||Cohort||Prospective|||||||
1446023|NCT01691560|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446024|NCT01691547|Randomized|Parallel Assignment||Other||Double|||t||t|
1446025|NCT01691534|Randomized|Parallel Assignment||Treatment||Single||||||t
1446026|NCT01691521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446027|NCT01691508|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446028|NCT01691495|||||Retrospective|||||||
1446029|NCT01691482|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446030|NCT01691469|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446031|NCT01691456|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446032|NCT01691443||Single Group Assignment||Health Services Research||None (Open Label)||||||
1446033|NCT01691430|Randomized|Parallel Assignment||Prevention||Quadruple||Participants were randomized to cranberry or placebo capsules.|t|t|t|t
1446034|NCT01691417||||||||||||
1446035|NCT01691404|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1446036|NCT01691391|||Cohort||Prospective|||||||
1446037|NCT01691378|Randomized|Crossover Assignment||Treatment||Single||||||t
1446038|NCT01691365|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1446039|NCT01691352|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1446040|NCT01691339|Randomized|Parallel Assignment||Prevention||Single||||||t
1446041|NCT01691326|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446042|NCT01691313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446043|NCT01691300||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446044|NCT01691287||Single Group Assignment||Supportive Care||None (Open Label)||||||
1446045|NCT01691274|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1446046|NCT01691261||Single Group Assignment||Treatment||None (Open Label)||||||
1446047|NCT01691248|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1446048|NCT01691235|||Cohort||Prospective|||||||
1446049|NCT01691222||Single Group Assignment||||None (Open Label)||||||
1446050|NCT01691209|Randomized|Parallel Assignment||Treatment||Single|||||t|
1446051|NCT01691196|||Cohort||Cross-Sectional|||||||
1446052|NCT01691183|||Cohort||Prospective|||||||
1446053|NCT01691170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446054|NCT01691157|Randomized|Parallel Assignment||Treatment||Single||||||t
1446055|NCT01691144|||Case-Only||Cross-Sectional|||||||
1446056|NCT01691131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446057|NCT01691118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446058|NCT01691105|Randomized|Parallel Assignment||Treatment||Single|||||t|
1446059|NCT01691092||Single Group Assignment||Other||None (Open Label)||||||
1446060|NCT01691079|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1446061|NCT01691066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446062|NCT01691053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446063|NCT01691040||Single Group Assignment||Treatment||None (Open Label)||||||
1446064|NCT01691027||Single Group Assignment||Treatment||None (Open Label)||All eligible subjects trained on three computer-based training modules. SLO assessment of changes in fine manual task performance and in retinal functional geography was done before and after each training module.||||
1446065|NCT01691014|||Cohort||Prospective|||||||
1446066|NCT01691001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446067|NCT01690988|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1446068|NCT01690975|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1446069|NCT01690962|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446070|NCT01690949|Randomized|Crossover Assignment||Treatment||Single|||t|||
1446071|NCT01690936|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446072|NCT01690923|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446073|NCT01690910|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446074|NCT01690897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446075|NCT01690884|Randomized|Parallel Assignment||Other||Single|||t|||
1446076|NCT01690871||Single Group Assignment||Treatment||None (Open Label)||||||
1446077|NCT01690858|||Case Control||Prospective|||||||
1446078|NCT01690845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446079|NCT01690832|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446080|NCT01690819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446081|NCT01690806|||Case Control||Prospective|||||||
1446082|NCT01690793||||||||||||
1446083|NCT01690780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446084|NCT01690767|Randomized|Parallel Assignment||Treatment||Single||||||t
1446085|NCT01690754|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446086|NCT01690741||Single Group Assignment||Treatment||None (Open Label)||||||
1446087|NCT01690728|Randomized|Parallel Assignment||Prevention||Single||||||t
1446088|NCT01690715|||Cohort||Retrospective|||||||
1446089|NCT01690702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446090|NCT01690689||Single Group Assignment||Treatment||None (Open Label)||||||
1446091|NCT01690676|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1446092|NCT01690663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446093|NCT01690650||Single Group Assignment||Basic Science||None (Open Label)||||||
1446094|NCT01690637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446095|NCT01690624||Single Group Assignment||Treatment||None (Open Label)||||||
1446096|NCT01690611|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1446097|NCT01690598||Single Group Assignment||Treatment||None (Open Label)||||||
1446098|NCT01690585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446099|NCT01690572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446100|NCT01690559|||Case-Only||Prospective|||||||
1446101|NCT01690546||Single Group Assignment||Treatment||None (Open Label)||||||
1446102|NCT01690533|||Case-Only||Prospective|||||||
1446103|NCT01690520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446104|NCT01690507||Single Group Assignment||Treatment||None (Open Label)||||||
1446105|NCT01690494|Randomized|Parallel Assignment||Prevention||Single||||||t
1446106|NCT01690481|||Cohort||Prospective|||||||
1446107|NCT01690468||Single Group Assignment||Treatment||None (Open Label)||||||
1446108|NCT01690455|||Cohort||Prospective|||||||
1446109|NCT01690442|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446110|NCT01690429||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446111|NCT01690416|Randomized|Crossover Assignment||||Single|||t|||
1446112|NCT01690403|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1446113|NCT01690390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446114|NCT01690377||Single Group Assignment||Treatment||None (Open Label)||||||
1446115|NCT01690364|Randomized|Parallel Assignment||||Double|||t|||t
1446116|NCT01690351|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446117|NCT01690338|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1446118|NCT01690325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446119|NCT01690312|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446120|NCT01690299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446121|NCT01690286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446122|NCT01690273|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446123|NCT01690260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446124|NCT01690247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446125|NCT01690234|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1446126|NCT01690221|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446127|NCT01690208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446128|NCT01690195||Single Group Assignment||Treatment||None (Open Label)||||||
1446129|NCT01690182|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1446130|NCT01690169|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446131|NCT01690156|||Case Control||Prospective|||||||
1446132|NCT01690143||Single Group Assignment||Treatment||None (Open Label)||||||
1446133|NCT01690130|Randomized|Crossover Assignment||Treatment||Single|||t|||
1446134|NCT01690117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446135|NCT01690104|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1446136|NCT01690091|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446137|NCT01690078|||Cohort||Prospective|||||||
1446138|NCT01690065||Single Group Assignment||Treatment||None (Open Label)||||||
1446139|NCT01690052|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446140|NCT01690039|||Case-Only||Prospective|||||||
1446141|NCT01690026|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1446142|NCT01690013|||Case Control||Cross-Sectional|||||||
1446143|NCT01690000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446144|NCT01689987||Single Group Assignment||Treatment||None (Open Label)||||||
1446145|NCT01689974|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446146|NCT01689961|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1446147|NCT01689948||Single Group Assignment||Supportive Care||None (Open Label)||||||
1446148|NCT01689935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446149|NCT01689922|||Other||Prospective|||||||
1446150|NCT01689909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446151|NCT01689896|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1446152|NCT01689883||Single Group Assignment||Basic Science||None (Open Label)||The investigators will use a system to inject small currents in the arm while subjects perform upper-limb movements. Subjects will perform multiple trials. During half of the trials, subjects will receive actual stimulation. During the other half, subjects will receive sham stimulation.||||
1446153|NCT01689870|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446154|NCT01689857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446155|NCT01689844|Randomized|Parallel Assignment||Treatment||Single||||||t
1446156|NCT01689831|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1446157|NCT01689818|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446158|NCT01689805|||Case Control||Prospective|||||||
1446159|NCT01689792|Randomized|Parallel Assignment||Screening||Single|||||t|
1446160|NCT01689779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446161|NCT01689766||Single Group Assignment||||None (Open Label)||||||
1446162|NCT01689753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446163|NCT01689740|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1446164|NCT01689727||Single Group Assignment||||None (Open Label)||||||
1446165|NCT01689714||Single Group Assignment||||None (Open Label)||||||
1446166|NCT01689701|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1446167|NCT01689688|||Cohort||Prospective|||||||
1446168|NCT01689675|Randomized|Single Group Assignment||Prevention||Single|||t|||
1446169|NCT01689662||Single Group Assignment||||None (Open Label)||||||
1446170|NCT01689649||Single Group Assignment||Treatment||None (Open Label)||||||
1446171|NCT01689636||Single Group Assignment||||None (Open Label)||||||
1446172|NCT01689623|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446173|NCT01689610|||Cohort||Prospective|||||||
1446174|NCT01689597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446175|NCT01689584||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446176|NCT01689571|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1446177|NCT01689558||Single Group Assignment||Treatment||Single||||t||
1446178|NCT01689545|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1446179|NCT01689532|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1446180|NCT01689519|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1446181|NCT01689506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446182|NCT01689493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446183|NCT01689480|||Cohort||Prospective|||||||
1446184|NCT01689467|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1446185|NCT01689454|||Cohort||Prospective|||||||
1446186|NCT01689441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446187|NCT01689428|||Cohort||Prospective|||||||
1446188|NCT01689415|||Case-Only||Prospective|||||||
1446189|NCT01689402|||Cohort||Prospective|||||||
1446190|NCT01689389|||Cohort||Prospective|||||||
1446191|NCT01689376||||||||||||
1446192|NCT01689363|Randomized|Crossover Assignment||Screening||Triple|||t|t|t|
1446193|NCT01689350|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446194|NCT01689337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446195|NCT01689324||Single Group Assignment||Prevention||None (Open Label)||||||
1446196|NCT01689311||Single Group Assignment||Treatment||None (Open Label)||||||
1446197|NCT01689298|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446198|NCT01689285|Randomized|Crossover Assignment||||None (Open Label)||||||
1446199|NCT01689272||Single Group Assignment||Treatment||None (Open Label)||||||
1446200|NCT01689259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446201|NCT01689246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446202|NCT01689233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446203|NCT01689220||Single Group Assignment||Treatment||None (Open Label)||||||
1446204|NCT01689207|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1446205|NCT01689194||Single Group Assignment||Treatment||None (Open Label)||||||
1446206|NCT01689181|||Case Control||Cross-Sectional|||||||
1446207|NCT01689168|Randomized|Parallel Assignment||Treatment||Single||||||t
1446208|NCT01689155|||Cohort||Prospective|||||||
1446209|NCT01689142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446210|NCT01689129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446211|NCT01689116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446212|NCT01689103|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446213|NCT01689090|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1446214|NCT01689077|Randomized|Parallel Assignment||Treatment||Single||||||t
1446215|NCT01689064|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446216|NCT01689051|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1446217|NCT01689038||Single Group Assignment||Basic Science||None (Open Label)||||||
1446218|NCT01689025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446219|NCT01689012||Single Group Assignment||Prevention||Single||||||t
1446220|NCT01688999||Single Group Assignment||Treatment||None (Open Label)||||||
1446221|NCT01688986|||Cohort||Retrospective|||||||
1446222|NCT01688973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446223|NCT01688960|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446224|NCT01688947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446225|NCT01688934|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446226|NCT01688921|Randomized|Parallel Assignment||Prevention||Single||||||t
1446227|NCT01688908|Randomized|Parallel Assignment||Screening||Single||||||t
1446228|NCT01688895|||Cohort||Other|||||||
1446229|NCT01688882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446230|NCT01688869|||Cohort||Prospective|||||||
1446231|NCT01688856|Randomized|Parallel Assignment||Treatment||Single||||||t
1446232|NCT01688843||Single Group Assignment||Treatment||None (Open Label)||||||
1446233|NCT01688830|Randomized|Parallel Assignment||Treatment||Double||||||
1446234|NCT01688817|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1446235|NCT01688804||Single Group Assignment||Treatment||None (Open Label)||||||
1446236|NCT01688791|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446237|NCT01688778|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446238|NCT01688765|||Case Control||Prospective|||||||
1446239|NCT01688752|||Cohort||Prospective|||||||
1446240|NCT01688739|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1446241|NCT01688726|Randomized|Parallel Assignment||Treatment||Single|||||t|
1446242|NCT01688713||Single Group Assignment||Treatment||None (Open Label)||||||
1446243|NCT01688700||Single Group Assignment||Treatment||None (Open Label)||||||
1446244|NCT01688687|||Cohort||Prospective|||||||
1446245|NCT01688674|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1446246|NCT01688661|||Case-Crossover||Prospective|||||||
1446247|NCT01688648|Randomized|Parallel Assignment||||Double|||t|||t
1446248|NCT01688635|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1446249|NCT01688622||Single Group Assignment||||None (Open Label)||||||
1446250|NCT01688609||Single Group Assignment||Treatment||None (Open Label)||||||
1446251|NCT01688596|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1446252|NCT01688583|||Cohort||Prospective|||||||
1446253|NCT01688570|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1446254|NCT01688557|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1446255|NCT01688544||Single Group Assignment||Basic Science||None (Open Label)||||||
1446256|NCT01688531||Single Group Assignment||Basic Science||Single|||||t|
1446257|NCT01688518|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1446258|NCT01688505|||Cohort||Retrospective|||||||
1446259|NCT01688492||Single Group Assignment||Treatment||None (Open Label)||||||
1446260|NCT01688479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446261|NCT01688466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446262|NCT01688453|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1446263|NCT01688440||Single Group Assignment||Prevention||None (Open Label)||||||
1446264|NCT01688427|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1446265|NCT01688414||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446266|NCT01688401||Single Group Assignment||Other||None (Open Label)||||||
1446267|NCT01688388||Single Group Assignment||Treatment||None (Open Label)||||||
1446268|NCT01688375||Single Group Assignment||Supportive Care||None (Open Label)||||||
1446269|NCT01688362|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1446270|NCT01688349|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1446271|NCT01688336||Single Group Assignment||Treatment||None (Open Label)||||||
1446272|NCT01688323|||Other||Prospective|||||||
1446273|NCT01688310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446274|NCT01688297|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1446275|NCT01688284|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1446276|NCT01688271|||Case-Only||Prospective|||||||
1446277|NCT01688258|||Other||Prospective|||||||
1446278|NCT01688245|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1446279|NCT01688232|||Cohort||Prospective|||||||
1446280|NCT01688219|||Cohort||Prospective|||||||
1446281|NCT01688206|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446282|NCT01688193|||Case-Crossover||Prospective|||||||
1446283|NCT01688180|||Case Control||Prospective|||||||
1446284|NCT01688167|Randomized|Parallel Assignment||Prevention||Single|||||t|
1446285|NCT01688154|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1446286|NCT01688141|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1446287|NCT01688128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446288|NCT01688115|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1446289|NCT01688102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446290|NCT01688089|Randomized|Crossover Assignment||||Double|||t||t|
1446291|NCT01688076|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1446292|NCT01688063|||Cohort||Retrospective|||||||
1446293|NCT01688050||Single Group Assignment||Treatment||None (Open Label)||||||
1446294|NCT01688037|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446295|NCT01688024|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1446296|NCT01688011|||Cohort||Prospective|||||||
1446297|NCT01687998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446298|NCT01687985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446299|NCT01687972|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1446300|NCT01687959|Randomized|Single Group Assignment||Treatment||Single|||t|||
1446301|NCT01687946|||Case Control||Prospective|||||||
1446302|NCT01687933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446303|NCT01687920|Randomized|Crossover Assignment||||None (Open Label)||||||
1446304|NCT01687907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446305|NCT01687894|||Cohort||Prospective|||||||
1446306|NCT01687881|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1446307|NCT01687868||Single Group Assignment||Prevention||None (Open Label)||||||
1446308|NCT01687855|||Case Control||Prospective|||||||
1446309|NCT01687842|||Family-Based||Prospective|||||||
1446310|NCT01687829|||Case Control||Retrospective|||||||
1446311|NCT01687816|||||Prospective|||||||
1446312|NCT01687803|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1446313|NCT01687790||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446314|NCT01687777|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446315|NCT01687764|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1446316|NCT01687751|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1446317|NCT01687738|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446318|NCT01687725|||Cohort||Prospective|||||||
1446319|NCT01687712|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1446320|NCT01687699||Single Group Assignment||Prevention||Single||||||t
1446321|NCT01687686|||Cohort||Retrospective|||||||
1446322|NCT01687673||Single Group Assignment||Treatment||None (Open Label)||||||
1446323|NCT01687660|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446324|NCT01687647||Single Group Assignment||Screening||Double|||t|||t
1446325|NCT01687634|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1446326|NCT01687621|||Cohort||Prospective|||||||
1446327|NCT01687608||Single Group Assignment||Treatment||None (Open Label)||||||
1446328|NCT01687595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446329|NCT01687582||Single Group Assignment||Treatment||None (Open Label)||||||
1446330|NCT01687569|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1446331|NCT01687556|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1446332|NCT01687543|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1446333|NCT01687530||Single Group Assignment||Treatment||None (Open Label)||||||
1446334|NCT01687517|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446335|NCT01687504|||Cohort||Prospective|||||||
1446336|NCT01687491|Randomized|Parallel Assignment||Treatment||Single|||||t|
1446337|NCT01687478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446338|NCT01687465|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446339|NCT01687452|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1446340|NCT01687439||Single Group Assignment||Treatment||None (Open Label)||||||
1446341|NCT01687426|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446342|NCT01687413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446343|NCT01687400||Single Group Assignment||Treatment||None (Open Label)||||||
1446344|NCT01687387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446345|NCT01687374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446346|NCT01687361|Randomized|Parallel Assignment||||Double|||t||t|
1446347|NCT01687348||Single Group Assignment||Treatment||None (Open Label)||||||
1446348|NCT01687335|||Cohort||Prospective|||||||
1446349|NCT01687322|||||Prospective|||||||
1446350|NCT01687309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446351|NCT01687296|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446352|NCT01687283|Randomized|Parallel Assignment||Treatment||Single|||||t|
1446353|NCT01687270||Single Group Assignment||Treatment||None (Open Label)||||||
1446354|NCT01687257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446355|NCT01687244|Randomized|Parallel Assignment||Treatment||Single|The participant did not know if they received a high or low dose.||t|||
1446356|NCT01687231|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446357|NCT01687218|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1446358|NCT01687205|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1446359|NCT01687192|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1446360|NCT01687179||Sequential Assignment||Treatment||None (Open Label)||||||
1446361|NCT01687166|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446362|NCT01687153|||Cohort||Prospective|||||||
1446363|NCT01687140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446364|NCT01687127|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1446365|NCT01687114||Single Group Assignment||Basic Science||None (Open Label)||||||
1446366|NCT01687101||Single Group Assignment||Treatment||None (Open Label)||||||
1446367|NCT01687088|||Case Control||Prospective|||||||
1446368|NCT01687075||Single Group Assignment||Treatment||None (Open Label)||||||
1446369|NCT01687062|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1446370|NCT01687049||Single Group Assignment||Treatment||None (Open Label)||||||
1446371|NCT01687036||Single Group Assignment||Treatment||None (Open Label)||||||
1446372|NCT01687023|||Cohort||Cross-Sectional|||||||
1446373|NCT01687010|||||Prospective|||||||
1446374|NCT01686997|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446375|NCT01686984||Single Group Assignment||Basic Science||None (Open Label)||||||
1446376|NCT01686971|||Case-Only||Prospective|||||||
1446377|NCT01686958||Single Group Assignment||Treatment||None (Open Label)||||||
1446378|NCT01686945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446379|NCT01686932|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446380|NCT01686919||Single Group Assignment||Treatment||None (Open Label)||||||
1446381|NCT01686906||Single Group Assignment||Treatment||None (Open Label)||||||
1446382|NCT01686893|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446383|NCT01686880||Single Group Assignment||Treatment||None (Open Label)||||||
1446384|NCT01686867|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1446385|NCT01686854|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446386|NCT01686841||Single Group Assignment||Other||None (Open Label)||||||
1446387|NCT01686828|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446388|NCT01686815|||Case Control||Cross-Sectional|||||||
1446389|NCT01686802|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446390|NCT01686789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446391|NCT01686776|Non-Randomized|Parallel Assignment||Other||None (Open Label)||3 parallell Groups were measured regarding plasma volume and transcapillary escape rate of albumin where commercial 125I-iodinated human serum albumin was compared to hospital manufactured 123I- iodinated human serum albumin||||
1446392|NCT01686763|||Cohort||Prospective|||||||
1446393|NCT01686750|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1446394|NCT01686737|Randomized|Parallel Assignment||Treatment||Single||||||t
1446395|NCT01686724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446396|NCT01686711||Parallel Assignment||Treatment||||||||
1446397|NCT01686698|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446398|NCT01686685|||Cohort||Prospective|||||||
1446399|NCT01686672|Randomized|Crossover Assignment||Treatment||Single||||||t
1446400|NCT01686659|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1446401|NCT01686646|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446402|NCT01686633|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1446403|NCT01686620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446404|NCT01686607|||Cohort||Retrospective|||||||
1446405|NCT01686594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446406|NCT01686581|||Case-Only||Prospective|||||||
1446407|NCT01686568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446408|NCT01686555|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446409|NCT01686542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446410|NCT01686529|Randomized|Parallel Assignment||||None (Open Label)||||||
1446411|NCT01686516|||Case-Crossover||Retrospective|||||||
1446412|NCT01686503|Randomized|Parallel Assignment||Prevention||Single||||||t
1446413|NCT01686490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446414|NCT01686477|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446415|NCT01686464|Randomized|Parallel Assignment||Treatment||Single||||||t
1446416|NCT01686451|Randomized|Parallel Assignment||||None (Open Label)||||||
1446417|NCT01686438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446418|NCT01686425|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1446419|NCT01686412|Non-Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1446420|NCT01686399||Single Group Assignment||Prevention||None (Open Label)||||||
1446421|NCT01686386||Single Group Assignment||Treatment||None (Open Label)||||||
1446422|NCT01686373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446423|NCT01686360|Randomized|Factorial Assignment||Other||Single|||t|||
1446424|NCT01686347|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1446425|NCT01686334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446426|NCT01686321||Single Group Assignment||Treatment||None (Open Label)||||||
1446427|NCT01686308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446428|NCT01686295|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1446429|NCT01686282|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446430|NCT01686269|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1446431|NCT01686256||Single Group Assignment||||None (Open Label)||||||
1446432|NCT01686243|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1446433|NCT01686230|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1446434|NCT01686217|Randomized|Parallel Assignment||||None (Open Label)||||||
1446435|NCT01686204|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1446436|NCT01686191|||Cohort||Retrospective|||||||
1446437|NCT01686178|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446438|NCT01686165||Single Group Assignment||Treatment||None (Open Label)||||||
1446439|NCT01686152|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1446440|NCT01686139||Single Group Assignment||Treatment||None (Open Label)||||||
1446441|NCT01686126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446442|NCT01686113|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1446443|NCT01686100|Randomized|Parallel Assignment||Treatment||Single|||||t|
1446444|NCT01686087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446445|NCT01686074|||Case-Control||Cross-Sectional|||||||
1446446|NCT01686061||||||||||||
1446447|NCT01686048|||Case-Only||Prospective|||||||
1446448|NCT01686022||||||||||||
1446449|NCT01686009||Single Group Assignment||Treatment||None (Open Label)||||||
1446450|NCT01685996|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1446451|NCT01685983||Single Group Assignment||Treatment||None (Open Label)||||||
1446452|NCT01685970|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1446453|NCT01685957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446454|NCT01685944|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1446455|NCT01685931||Single Group Assignment||Treatment||None (Open Label)||||||
1446456|NCT01685918|||Cohort||Prospective|||||||
1446457|NCT01685905|||Cohort||Retrospective|||||||
1446458|NCT01685892|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1446459|NCT01685879|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1446460|NCT01685866|Randomized|Parallel Assignment||||Single||||||t
1446461|NCT01685853|Randomized|Parallel Assignment||Treatment||Single||||t||
1446462|NCT01685840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446463|NCT01685827|Randomized|Parallel Assignment||Treatment||Single||||||t
1446464|NCT01685814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446465|NCT01685801|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1446466|NCT01685788|||Case-Only||Prospective|||||||
1446467|NCT01685775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446468|NCT01685762||Single Group Assignment||Treatment||None (Open Label)||||||
1446469|NCT01685749|||Case-Only||Prospective|||||||
1446470|NCT01685736|||Case-Only||Prospective|||||||
1446471|NCT01685723|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446472|NCT01685710|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446473|NCT01685697|Randomized|Parallel Assignment||Treatment||Single||||||t
1446474|NCT01685684|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446475|NCT01685671|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446476|NCT01685658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446477|NCT01685645||Single Group Assignment||Diagnostic||Single|||t|||
1446478|NCT01685632|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1446479|NCT01685619|||Cohort||Prospective|||||||
1446480|NCT01685606||Single Group Assignment||Treatment||None (Open Label)||||||
1446481|NCT01685593|Randomized|Parallel Assignment||Prevention||Single|||||t|
1446482|NCT01685580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446483|NCT01685567||Single Group Assignment||Prevention||None (Open Label)||||||
1446484|NCT01685554|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446485|NCT01685541|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1446486|NCT01685528||Single Group Assignment||Treatment||None (Open Label)||||||
1446487|NCT01685515|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446488|NCT01685502|||Case-Only||Prospective|||||||
1446489|NCT01685489|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446490|NCT01685476||Single Group Assignment||||Single|||t|||
1446491|NCT01685463|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446492|NCT01685450||Single Group Assignment||||Single|||t|||
1446493|NCT01685437||Single Group Assignment||Treatment||None (Open Label)||||||
1446494|NCT01685424|||Cohort||Retrospective|||||||
1446495|NCT01685411||Single Group Assignment||Treatment||None (Open Label)||||||
1446496|NCT01685398|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1446497|NCT01685385|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1446498|NCT01685372|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1446499|NCT01685359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446500|NCT01685346||Single Group Assignment||Supportive Care||None (Open Label)||||||
1446501|NCT01685333|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446502|NCT01685320|Randomized|Parallel Assignment||Prevention||Single|||t|||
1446503|NCT01685307|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1446504|NCT01685294|Randomized|Parallel Assignment||Treatment||Single||||||t
1446505|NCT01685281|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446506|NCT01685268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446507|NCT01685255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446508|NCT01685242|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446509|NCT01685229|||Cohort||Prospective|||||||
1446510|NCT01685216||Single Group Assignment||Treatment||None (Open Label)||||||
1446511|NCT01685203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446512|NCT01685190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446513|NCT01685177|||Cohort||Prospective|||||||
1446514|NCT01685164|||Case-Only||Prospective|||||||
1446515|NCT01685151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446516|NCT01685138||Single Group Assignment||Treatment||None (Open Label)||||||
1446517|NCT01685125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446518|NCT01685112|||Cohort||Retrospective|||||||
1446519|NCT01685099|||Case Control||Prospective|||||||
1446520|NCT01685086|||Cohort||Prospective|||||||
1446521|NCT01685073|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446522|NCT01685060||Single Group Assignment||Treatment||None (Open Label)||||||
1446523|NCT01685047|||Case Control||Prospective|||||||
1446524|NCT01685034||Single Group Assignment||Treatment||None (Open Label)||||||
1446525|NCT01685021||Single Group Assignment||Treatment||None (Open Label)||||||
1446526|NCT01685008||Single Group Assignment||Treatment||None (Open Label)||||||
1446527|NCT01684995||Parallel Assignment||Treatment||||||||
1446528|NCT01684982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446529|NCT01684969|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1446530|NCT01684956|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446531|NCT01684943|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446532|NCT01684930|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1446533|NCT01684917|Randomized|Factorial Assignment||Diagnostic||Double|||t|||t
1446534|NCT01684904||Single Group Assignment||Treatment||None (Open Label)||||||
1446535|NCT01684891|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1446536|NCT01684878|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446537|NCT01684865|||Cohort||Prospective|||||||
1446538|NCT01684852|||Case Control||Prospective|||||||
1446539|NCT01684839||Single Group Assignment||Treatment||Single|||t|||
1446540|NCT01684826|Non-Randomized|||Treatment||None (Open Label)||||||
1446541|NCT01684813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446542|NCT01684800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446543|NCT01684787|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446544|NCT01684774|||Case Control||Prospective|||||||
1446545|NCT01684761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446546|NCT01684748|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1446547|NCT01684735|||Cohort||Prospective|||||||
1446548|NCT01684722|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1446549|NCT01684709|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446550|NCT01684696|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1446551|NCT01684683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446552|NCT01684670||Single Group Assignment||Treatment||None (Open Label)||||||
1446553|NCT01684657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446554|NCT01684644|Randomized|Parallel Assignment||Treatment||Single||||||t
1446555|NCT01684631|||Cohort||Prospective|||||||
1446556|NCT01684618||Single Group Assignment||Basic Science||None (Open Label)||||||
1446557|NCT01684605|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446558|NCT01684592|Randomized|Parallel Assignment||Treatment||Single||||||t
1446559|NCT01684579||Single Group Assignment||Supportive Care||None (Open Label)||||||
1446560|NCT01684566|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446561|NCT01684553|Randomized|Crossover Assignment||||Single|||t|||
1446562|NCT01684540|||Case-Only||Prospective|||||||
1446563|NCT01684527|||Case Control||Prospective|||||||
1446564|NCT01684514|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1446565|NCT01684501|||Case-Only||Cross-Sectional|||||||
1446566|NCT01684488|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1446567|NCT01684475||Single Group Assignment||Treatment||Double|||t||t|
1446568|NCT01684462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446569|NCT01684449||Single Group Assignment||Treatment||None (Open Label)||||||
1446570|NCT01684436||Single Group Assignment||Treatment||None (Open Label)||||||
1446571|NCT01684423|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446572|NCT01684410|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446573|NCT01684397||Single Group Assignment||Treatment||None (Open Label)||||||
1446574|NCT01684384||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446575|NCT01684371|||Cohort||Prospective|||||||
1446576|NCT01684358|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446577|NCT01684345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446578|NCT01684332|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1446579|NCT01684319|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1446580|NCT01684306|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1446581|NCT01684293|Randomized|Parallel Assignment||Treatment||Single||||||t
1446582|NCT01684280|||Case Control||Cross-Sectional|||||||
1446583|NCT01684267|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446584|NCT01684254|||Cohort||Cross-Sectional|||||||
1446585|NCT01684241||Single Group Assignment||Treatment||None (Open Label)||||||
1446586|NCT01684228|||Case Control||Prospective|||||||
1446587|NCT01684215|Non-Randomized|||Treatment||None (Open Label)||||||
1446588|NCT01684202||Single Group Assignment||Treatment||None (Open Label)||||||
1446589|NCT01684189|||Case-Only||Prospective|||||||
1446590|NCT01684176|Randomized|Parallel Assignment||Prevention||Single||||||t
1446591|NCT01684163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446592|NCT01684150||Single Group Assignment||Treatment||None (Open Label)||||||
1446593|NCT01684137|Randomized|Parallel Assignment||||Double|||t||t|
1446594|NCT01684124|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446595|NCT01684111||Single Group Assignment||Treatment||None (Open Label)||||||
1446596|NCT01684098||Single Group Assignment||||None (Open Label)||||||
1446597|NCT01684085|Randomized|Parallel Assignment||Prevention||Single|||t|||
1446598|NCT01684072|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1446599|NCT01684059|||Case Control||Retrospective|||||||
1446600|NCT01684046|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1446601|NCT01684033|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1446602|NCT01684020|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1446603|NCT01684007|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446604|NCT01683994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446605|NCT01683981||Single Group Assignment||||None (Open Label)||||||
1446606|NCT01683968|||Cohort||Prospective|||||||
1446607|NCT01683955|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446608|NCT01683942|||Case-Only||Retrospective|||||||
1446609|NCT01683929|Randomized|Crossover Assignment||Screening||Single|||t|||
1446610|NCT01683916|||Case-Control||Prospective|||||||
1446611|NCT01683903|||Cohort||Prospective|||||||
1446612|NCT01683890|||Cohort||Prospective|||||||
1446613|NCT01683877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446614|NCT01683864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446615|NCT01683851|||||Prospective|||||||
1446616|NCT01683838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446617|NCT01683825|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1446618|NCT01683812||Single Group Assignment||Treatment||None (Open Label)||||||
1446619|NCT01683799|Randomized|Parallel Assignment||Basic Science||Single||||||t
1446620|NCT01683786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446621|NCT01683773|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446622|NCT01683760|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1446623|NCT01683747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446624|NCT01683734|||Cohort||Prospective|||||||
1446625|NCT01683721|||Cohort||Prospective|||||||
1446626|NCT01683708|||Case Control||Prospective|||||||
1446627|NCT01683695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446628|NCT01683682||Single Group Assignment||Treatment||None (Open Label)||||||
1446629|NCT01683669|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1446630|NCT01683656|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446631|NCT01683643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446632|NCT01683630|||Cohort||Retrospective|||||||
1446633|NCT01683617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446634|NCT01683604|||Cohort||Prospective|||||||
1446635|NCT01683591|||Case-Only||Retrospective|||||||
1446636|NCT01683578|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1446637|NCT01683565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446638|NCT01683552|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446639|NCT01683539|Randomized|Parallel Assignment||Treatment||Single||||||t
1446640|NCT01683526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446641|NCT01683513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446642|NCT01683500||Single Group Assignment||Treatment||None (Open Label)||||||
1446643|NCT01683487|||Case-Only||Retrospective|||||||
1446644|NCT01683474||Single Group Assignment||Treatment||None (Open Label)||||||
1446645|NCT01683461|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446646|NCT01683448|||Cohort||Retrospective|||||||
1446647|NCT01683435||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446648|NCT01683422||Single Group Assignment||Treatment||None (Open Label)||||||
1446649|NCT01683409|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446650|NCT01683396|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446651|NCT01683383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446652|NCT01683370|||Case-Only||Prospective|||||||
1446653|NCT01683357|||Cohort||Prospective|||||||
1446654|NCT01683331|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446655|NCT01683318||Single Group Assignment||Treatment||None (Open Label)||||||
1446656|NCT01683305|||Cohort|||||||||
1446657|NCT01683292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446658|NCT01683279||Single Group Assignment||Treatment||None (Open Label)||||||
1446659|NCT01683266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446660|NCT01683253|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446661|NCT01683240||Single Group Assignment||Treatment||None (Open Label)||||||
1446662|NCT01683227|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1446663|NCT01683214|||Case-Control||Prospective|||||||
1446664|NCT01683201|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1446665|NCT01683188|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1446666|NCT01683175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446667|NCT01683162|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1446668|NCT01683149||Single Group Assignment||Treatment||None (Open Label)||||||
1446669|NCT01683136||Single Group Assignment||Treatment||None (Open Label)||||||
1446670|NCT01683123|||||Retrospective|||||||
1446671|NCT01683110||||||||||||
1446672|NCT01683097|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1446673|NCT01683084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446674|NCT01683071|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1446675|NCT01683058||Single Group Assignment||Treatment||None (Open Label)||||||
1446676|NCT01683045||Single Group Assignment||Treatment||None (Open Label)||||||
1446677|NCT01683032||Single Group Assignment||Treatment||Triple|||t||t|t
1446678|NCT01683019|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446679|NCT01683006|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1446680|NCT01682993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446681|NCT01682980|Randomized|Parallel Assignment||Treatment||Single|||||t|
1446682|NCT01682967|||Case Control||Prospective|||||||
1446683|NCT01682954|Randomized|Parallel Assignment||Prevention||Single||||||t
1446684|NCT01682941|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446685|NCT01682928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446686|NCT01682915||||||||||||
1446687|NCT01682902|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446688|NCT01682889|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1446689|NCT01682876|Randomized|Parallel Assignment||Prevention||Single||||||t
1446690|NCT01682863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446691|NCT01682850|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446692|NCT01682837|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1446693|NCT01682824||||||||||||
1446694|NCT01682811|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446695|NCT01682798|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1446696|NCT01682785|||Case-Only||Prospective|||||||
1446697|NCT01682772||Single Group Assignment||Treatment||None (Open Label)||||||
1446698|NCT01682759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446699|NCT01682746||Single Group Assignment||Treatment||None (Open Label)||||||
1446700|NCT01682733||Single Group Assignment||Treatment||None (Open Label)||||||
1446701|NCT01682720|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446702|NCT01682707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446703|NCT01682694|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1446704|NCT01682681|||Cohort||Prospective|||||||
1446705|NCT01682668||Single Group Assignment||Basic Science||None (Open Label)||||||
1446706|NCT01682655|||Cohort||Prospective|||||||
1446707|NCT01682642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446708|NCT01682629|Randomized|Factorial Assignment||||Single||||||t
1446709|NCT01682616||Single Group Assignment||Treatment||None (Open Label)||||||
1446710|NCT01682603||Single Group Assignment||Treatment||None (Open Label)||||||
1446711|NCT01682590|Randomized|Parallel Assignment||Other||None (Open Label)||"To investigate whether early initiation of RRT (within 12 hours after a diagnosis of acute renal insufficiency at thefailure stage according to the RIFLE Criteria), will reduce 90-day mortality as compared to deferred initiation of RRT(48 to 60 hours after diagnosis), in intensive care unit (ICU) patients with septic shock who develop acute renal failure"||||
1446712|NCT01682577|Randomized|Crossover Assignment||Treatment||Single|||||t|
1446713|NCT01682564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446714|NCT01682551|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1446715|NCT01682538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446716|NCT01682525||Single Group Assignment||Treatment||None (Open Label)||||||
1446717|NCT01682512|Randomized|Parallel Assignment||Treatment||Double||||||
1446718|NCT01682499||Single Group Assignment||Prevention||None (Open Label)||||||
1446719|NCT01682486|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1446720|NCT01682473|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446721|NCT01682460||Single Group Assignment||Treatment||None (Open Label)||||||
1446722|NCT01682447|Randomized|Parallel Assignment||Other||Single||||||t
1446723|NCT01682434|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1446724|NCT01682421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446725|NCT01682408|Randomized|||Basic Science||None (Open Label)||||||
1446726|NCT01682395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446727|NCT01682382|||Cohort||Prospective|||||||
1446728|NCT01682369|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1446729|NCT01682356|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446730|NCT01682343|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1446731|NCT01682330|||Cohort||Cross-Sectional|||||||
1446732|NCT01682317|Randomized|Parallel Assignment||Treatment||Single||||||t
1446733|NCT01682304|||Case Control||Prospective|||||||
1446734|NCT01682291|Randomized|Parallel Assignment||Prevention||Single|||t|||
1446735|NCT01682278|||Cohort||Prospective|||||||
1446736|NCT01682265|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1446737|NCT01682252|||||Prospective|||||||
1446738|NCT01682239|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1446739|NCT01682226|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446740|NCT01682213||Single Group Assignment||Treatment||None (Open Label)||||||
1446741|NCT01682200||Single Group Assignment||Treatment||None (Open Label)||||||
1446742|NCT01682187|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446743|NCT01682174|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1446744|NCT01682161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446745|NCT01682148|Randomized|Parallel Assignment||Treatment||Single||||||t
1446746|NCT01682135||Single Group Assignment||Treatment||None (Open Label)||||||
1446747|NCT01682122|||Cohort||Prospective|||||||
1446748|NCT01682109|Randomized|Parallel Assignment||||None (Open Label)||||||
1446749|NCT01682096|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1446750|NCT01682083|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446751|NCT01682070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446752|NCT01682057||Single Group Assignment||Treatment||None (Open Label)||||||
1446753|NCT01682044||Single Group Assignment||Treatment||None (Open Label)||||||
1446754|NCT01682031|Randomized|Parallel Assignment||Supportive Care||Double||||||
1446755|NCT01682018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446756|NCT01682005|||Cohort||Retrospective|||||||
1446757|NCT01681992|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1446758|NCT01681979|||Cohort||Retrospective|||||||
1446759|NCT01681966||Single Group Assignment||Treatment||None (Open Label)||||||
1446760|NCT01681953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446761|NCT01681940||Single Group Assignment||Treatment||None (Open Label)||||||
1446762|NCT01681927|||Case-Only||Prospective|||||||
1446763|NCT01681914|||Cohort||Prospective|||||||
1446764|NCT01681901|||Cohort||Cross-Sectional|||||||
1446765|NCT01681888||Single Group Assignment||Treatment||None (Open Label)||||||
1446766|NCT01681875|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1446767|NCT01681862||Single Group Assignment||Treatment||None (Open Label)||||||
1446768|NCT01681849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446769|NCT01681836|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1446770|NCT01681823||Single Group Assignment||Treatment||None (Open Label)||Dietary Supplement: PectaSol-C Modified Citrus Pectin (MCP) Oral administration of PectaSol-C MCP (4.8 grams in six capsules three times a day away from food).||||
1446771|NCT01681810||Single Group Assignment||Treatment||None (Open Label)||||||
1446772|NCT01681797||Single Group Assignment||Other||None (Open Label)||||||
1446773|NCT01681784|||Cohort||Prospective|||||||
1446774|NCT01681771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446775|NCT01681758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446776|NCT01681745||Single Group Assignment||Treatment||None (Open Label)||||||
1446777|NCT01681732|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446778|NCT01681719|Randomized|Factorial Assignment||Supportive Care||Triple|||t||t|t
1446779|NCT01681706|||||Prospective|||||||
1446780|NCT01681693||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446781|NCT01681680||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446782|NCT01681667|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1446783|NCT01681654|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1446784|NCT01681641|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1446785|NCT01681628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446786|NCT01681615|Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1446787|NCT01681602|Randomized|Parallel Assignment||Treatment||Single||||||t
1446788|NCT01681589|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1446789|NCT01681576|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1446790|NCT01681563||Single Group Assignment||Treatment||None (Open Label)||||||
1446791|NCT01681550||Single Group Assignment||Treatment||None (Open Label)||||||
1446792|NCT01681537||Single Group Assignment||Treatment||None (Open Label)||||||
1446793|NCT01681524||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446794|NCT01681511|Randomized|Parallel Assignment||Prevention||Single||||||t
1446795|NCT01681498|||Cohort||Prospective|||||||
1446796|NCT01681485|||Case-Only||Prospective|||||||
1446797|NCT01681472|Randomized|Parallel Assignment||Treatment||Single|||||t|
1446798|NCT01681459|||Case Control||Prospective|||||||
1446799|NCT01681446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446800|NCT01681433|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446801|NCT01681420|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1446802|NCT01681407|||Case Control||Prospective|||||||
1446803|NCT01681394|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1446804|NCT01681381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446805|NCT01681368||Single Group Assignment||Treatment||None (Open Label)||||||
1446806|NCT01681355||Single Group Assignment||||None (Open Label)||||||
1446807|NCT01681342|||Case-Only||Prospective|||||||
1446808|NCT01681329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446809|NCT01681316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446810|NCT01681303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446811|NCT01681290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446812|NCT01681277|Randomized|Single Group Assignment||Treatment||Double||||||
1446813|NCT01681264|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1446814|NCT01681251|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1446815|NCT01681238|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1446816|NCT01681225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446817|NCT01681212||Single Group Assignment||Treatment||None (Open Label)||||||
1446818|NCT01681199||Single Group Assignment||Treatment||None (Open Label)||||||
1446819|NCT01681186|Randomized|Crossover Assignment||||Double|||t||t|
1446820|NCT01681173|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1446821|NCT01681160|Randomized|Single Group Assignment||Treatment||Single||||||t
1446822|NCT01681147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446823|NCT01681134|Randomized|Crossover Assignment||||None (Open Label)||||||
1446824|NCT01681121|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446825|NCT01681108||Single Group Assignment||Treatment||None (Open Label)||||||
1446826|NCT01681095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446827|NCT01681082|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1446828|NCT01681069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446829|NCT01681056|Randomized|Parallel Assignment||Treatment||Single||||||t
1446830|NCT01681043|Randomized|Crossover Assignment||Prevention||Single|||||t|
1446831|NCT01681030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446832|NCT01681017|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1446833|NCT01681004|Randomized|Parallel Assignment||Treatment||None (Open Label)||Parallel group randomized controlled trial||||
1446834|NCT01680991|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446835|NCT01680978||Crossover Assignment||||Double|||t||t|
1446836|NCT01680965||Single Group Assignment||Treatment||None (Open Label)||||||
1446837|NCT01680952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446838|NCT01680939|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446839|NCT01680926||Single Group Assignment||Supportive Care||None (Open Label)||||||
1446840|NCT01680913|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446841|NCT01680900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446842|NCT01680887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446843|NCT01680874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446844|NCT01680861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446845|NCT01680848|||Cohort||Cross-Sectional|||||||
1446846|NCT01680835||Single Group Assignment||Treatment||None (Open Label)||||||
1446847|NCT01680822|||Cohort||Retrospective|||||||
1446848|NCT01680809|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446849|NCT01680796||Single Group Assignment||Treatment||None (Open Label)||||||
1446850|NCT01680783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446851|NCT01680770|||Cohort||Prospective|||||||
1446852|NCT01680757||Single Group Assignment||||None (Open Label)||||||
1446853|NCT01680744|Randomized|Single Group Assignment||Prevention||Single||||||t
1446854|NCT01680731|||Case Control||Retrospective|||||||
1446855|NCT01680718|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1446856|NCT01680705|Randomized|Parallel Assignment||Treatment||Single|||||t|
1446857|NCT01680692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446858|NCT01680679|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1446859|NCT01680666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446860|NCT01680653|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1446861|NCT01680640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446862|NCT01680627|||Cohort||Prospective|||||||
1446863|NCT01680614|||Cohort||Prospective|||||||
1446864|NCT01680601|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1446865|NCT01680588||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446866|NCT01680575|||Cohort||Prospective|||||||
1446867|NCT01680562|||Case-Only||Prospective|||||||
1446868|NCT01680549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446869|NCT01680536||Single Group Assignment||Treatment||None (Open Label)||||||
1446870|NCT01680523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446871|NCT01680510|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1446872|NCT01680497||Single Group Assignment||Treatment||None (Open Label)||||||
1446873|NCT01680484|Randomized|Parallel Assignment||||Single|||||t|
1446874|NCT01680471|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1446875|NCT01680458|||Case-Only||Prospective|||||||
1446876|NCT01680445|||||Cross-Sectional|||||||
1446877|NCT01680432|Randomized|Crossover Assignment||||None (Open Label)||||||
1446878|NCT01680419|Randomized|Parallel Assignment||||None (Open Label)||||||
1446879|NCT01680406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446880|NCT01680393|Randomized|Parallel Assignment||Treatment||Single||||t||
1446881|NCT01680380|||Case-Only||Cross-Sectional|||||||
1446882|NCT01680367|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1446883|NCT01680354|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446884|NCT01680341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446885|NCT01680328|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1446886|NCT01680315|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1446887|NCT01680302|Randomized|Parallel Assignment||Prevention||Single||||||t
1446888|NCT01680289|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1446889|NCT01680276|Randomized|Parallel Assignment||Treatment||Single||||||t
1446890|NCT01680263|Randomized|Parallel Assignment||Treatment||Single||||||t
1446891|NCT01680250||Single Group Assignment||Treatment||None (Open Label)||||||
1446892|NCT01680237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446893|NCT01680224|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446894|NCT01680211|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1446895|NCT01680198|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1446896|NCT01680185|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446897|NCT01680172|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1446898|NCT01680159||Single Group Assignment||Treatment||None (Open Label)||||||
1446899|NCT01680146|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1446900|NCT01680133|||Case Control||Cross-Sectional|||||||
1446901|NCT01680120||Single Group Assignment||Treatment||None (Open Label)||||||
1446902|NCT01680107|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1446903|NCT01680094||Single Group Assignment||Treatment||None (Open Label)||||||
1446904|NCT01680081||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446905|NCT01680068||Single Group Assignment||Treatment||None (Open Label)||||||
1446906|NCT01680055|||Case Control||Prospective|||||||
1446907|NCT01680042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446908|NCT01680029||Single Group Assignment||Treatment||None (Open Label)||||||
1446909|NCT01680016|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446910|NCT01680003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446911|NCT01679990|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1446912|NCT01679977|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1446913|NCT01679964||Single Group Assignment||Treatment||None (Open Label)||||||
1446914|NCT01679951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446915|NCT01679938|Randomized|Parallel Assignment||Prevention||Single||||||t
1446916|NCT01679925|||Cohort||Prospective|||||||
1446917|NCT01679912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446918|NCT01679899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446919|NCT01679886||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446920|NCT01679873|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1446921|NCT01679860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446922|NCT01679847|||Case-Only|||||||||
1446923|NCT01679834|||Cohort||Prospective|||||||
1446924|NCT01679821|||Cohort||Cross-Sectional|||||||
1446925|NCT01679808|||Case-Only||Cross-Sectional|||||||
1446926|NCT01679795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446927|NCT01679782|||Case Control||Cross-Sectional|||||||
1446928|NCT01679769|||||Prospective|||||||
1446929|NCT01679756|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1446930|NCT01679743|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1446931|NCT01679730|||Case Control||Prospective|||||||
1446932|NCT01679717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446933|NCT01679704||Single Group Assignment||||None (Open Label)||||||
1446934|NCT01679691|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1446935|NCT01679678|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446936|NCT01679665|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1446937|NCT01679652|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1446938|NCT01679639|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1446939|NCT01679626||||||||||||
1446940|NCT01679613|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446941|NCT01679600|Randomized|Parallel Assignment||Treatment||Single||||||t
1446942|NCT01679587|Randomized|Crossover Assignment||||Single|||t|||
1446943|NCT01679574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446944|NCT01679561||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1446945|NCT01679548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446946|NCT01679535||Single Group Assignment||Prevention||None (Open Label)||||||
1446947|NCT01679522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446948|NCT01679509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446949|NCT01679496|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1446950|NCT01679483|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1446951|NCT01679470||Single Group Assignment||Treatment||None (Open Label)||||||
1446952|NCT01679457|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446953|NCT01679444||Single Group Assignment||||None (Open Label)||||||
1446954|NCT01679431|||Cohort||Prospective|||||||
1446955|NCT01679418|Randomized|Parallel Assignment||||None (Open Label)||||||
1446956|NCT01679405||Single Group Assignment||Treatment||None (Open Label)||||||
1446957|NCT01679392||Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1446958|NCT01679379|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1446959|NCT01679366|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446960|NCT01679353|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446961|NCT01679340|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1446962|NCT01679327||Single Group Assignment||Treatment||None (Open Label)||||||
1446963|NCT01679314|Randomized|Parallel Assignment||Treatment||Single|||t|||
1446964|NCT01679301|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1446965|NCT01679288||Single Group Assignment||Screening||None (Open Label)||||||
1446966|NCT01679275||Single Group Assignment||Diagnostic||None (Open Label)||||||
1446967|NCT01679262||Single Group Assignment||Prevention||Single||||||t
1446968|NCT01679249|||Case-Only||Prospective|||||||
1446969|NCT01679236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446970|NCT01679223|||Case-Only||Cross-Sectional|||||||
1446971|NCT01679210|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1446972|NCT01679197||Single Group Assignment||Treatment||None (Open Label)||||||
1446973|NCT01679184|||Case-Only||Prospective|||||||
1446974|NCT01679171|||Cohort||Prospective|||||||
1446975|NCT01679158|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1446976|NCT01679145|||Case Control||Prospective|||||||
1446977|NCT01679132|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1446978|NCT01679119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446979|NCT01679106|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1446980|NCT01679093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446981|NCT01679080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446982|NCT01679067|||Cohort||Prospective|||||||
1446983|NCT01679054|||Cohort||Retrospective|||||||
1446984|NCT01679041||Single Group Assignment||Treatment||None (Open Label)||||||
1446985|NCT01679028|Randomized|Parallel Assignment||||Double|||t||t|
1446986|NCT01679015|||Case-Only||Prospective|||||||
1446987|NCT01679002|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446988|NCT01678989|||||Prospective|||||||
1446989|NCT01678976|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446990|NCT01678963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1446991|NCT01678950|||Cohort||Prospective|||||||
1446992|NCT01678937|||Case Control||Prospective|||||||
1446993|NCT01678924|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1446994|NCT01678911|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1446995|NCT01678898|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1446996|NCT01678885|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1446997|NCT01678872||Single Group Assignment||Other||None (Open Label)||||||
1446998|NCT01678859|||Case Control||Prospective|||||||
1446999|NCT01678846|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447000|NCT01678833|||||Other|||||||
1447001|NCT01678820|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447002|NCT01678807|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447003|NCT01678794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447004|NCT01678781|||Case Control||Prospective|||||||
1447005|NCT01678755|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447006|NCT01678742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447007|NCT01678729|||Cohort||Retrospective|||||||
1447008|NCT01678716|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1447009|NCT01678703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447010|NCT01678690||Single Group Assignment||||None (Open Label)||||||
1447011|NCT01678677|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1447012|NCT01678664||Single Group Assignment||Treatment||None (Open Label)||||||
1447013|NCT01678651|Randomized|Parallel Assignment||Treatment||Single|||||t|
1447014|NCT01678638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447015|NCT01678625|||Case Control||Prospective|||||||
1447016|NCT01678612|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447017|NCT01678599||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447018|NCT01678586|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1447019|NCT01678573|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447020|NCT01678560|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1447021|NCT01678547|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1447022|NCT01678534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447023|NCT01678521|||Case-Only||Prospective|||||||
1447024|NCT01678508|||Cohort||Retrospective|||||||
1447025|NCT01678495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447026|NCT01678482||Single Group Assignment||Treatment||Single|||t|||
1447027|NCT01678469||Single Group Assignment||Prevention||None (Open Label)||||||
1447028|NCT01678456|||Cohort||Prospective|||||||
1447029|NCT01678443||Single Group Assignment||Treatment||None (Open Label)||||||
1447030|NCT01678430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447031|NCT01678417||Single Group Assignment||Treatment||None (Open Label)||||||
1447032|NCT01678404||Single Group Assignment||Treatment||None (Open Label)||||||
1447033|NCT01678391||Single Group Assignment||Treatment||None (Open Label)||||||
1447034|NCT01678378|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447035|NCT01678365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447036|NCT01678352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447037|NCT01678339|||Cohort||Retrospective|||||||
1447038|NCT01678326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447039|NCT01678313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447040|NCT01678300|||Cohort||Prospective|||||||
1447041|NCT01678287|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1447042|NCT01678274|||Cohort||Prospective|||||||
1447043|NCT01678261|||Cohort||Cross-Sectional|||||||
1447044|NCT01678248|||Cohort||Retrospective|||||||
1447045|NCT01678235|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1447046|NCT01678222|||||Prospective|||||||
1447047|NCT01678209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447048|NCT01678196|Randomized|Parallel Assignment||||None (Open Label)||||||
1447049|NCT01678183|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1447050|NCT01678170|||Case-Only||Prospective|||||||
1447051|NCT01678157|||Cohort||Prospective|||||||
1447052|NCT01678144||Single Group Assignment||Treatment||None (Open Label)||||||
1447053|NCT01678131|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1447054|NCT01678118|||Case-Only||Retrospective|||||||
1447055|NCT01678105||Single Group Assignment||Treatment||None (Open Label)||||||
1447056|NCT01678092|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1447057|NCT01678079|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447058|NCT01678066|||Cohort||Prospective|||||||
1447059|NCT01678053|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447060|NCT01678040|||Cohort||Prospective|||||||
1447061|NCT01678027|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447062|NCT01678014||Single Group Assignment||Treatment||None (Open Label)||||||
1447063|NCT01678001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447064|NCT01677988||Single Group Assignment||Treatment||None (Open Label)||||||
1447065|NCT01677975||||||||||||
1447066|NCT01677962||Single Group Assignment||Treatment||None (Open Label)||||||
1447067|NCT01677949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447068|NCT01677936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447069|NCT01677923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447070|NCT01677910|Randomized|Parallel Assignment||Treatment||Quadruple||Participants were randomized to one of three treatment arms in the double-blind treatment period. After completion of the double-blind treatment period, participants entered an open-label treatment period.|t|t|t|t
1447071|NCT01677897||Single Group Assignment||Treatment||None (Open Label)||||||
1447072|NCT01677884||Single Group Assignment||Treatment||None (Open Label)||||||
1447073|NCT01677871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447074|NCT01677858||Sequential Assignment||Treatment||None (Open Label)||||||
1447075|NCT01677845||Single Group Assignment||Treatment||None (Open Label)||||||
1447076|NCT01677832||||||||||||
1447077|NCT01677819||||||||||||
1447078|NCT01677806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447079|NCT01677793||||||||||||
1447080|NCT01677780||Single Group Assignment||Treatment||None (Open Label)||||||
1447081|NCT01677767|||Cohort||Prospective|||||||
1447082|NCT01677754|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447083|NCT01677741|Randomized|||Treatment||None (Open Label)||||||
1447084|NCT01677728|||Case Control||Prospective|||||||
1447085|NCT01677715|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1447086|NCT01677702|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1447087|NCT01677689|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447088|NCT01677676|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1447089|NCT01677663|||Family-Based|||||||||
1447090|NCT01677650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447091|NCT01677637|||||Prospective|||||||
1447092|NCT01677624||Single Group Assignment||Treatment||None (Open Label)||||||
1447093|NCT01677611|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1447094|NCT01677598|||Case-Only||Prospective|||||||
1447095|NCT01677585|||Cohort||Prospective|||||||
1447096|NCT01677572|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447097|NCT01677559|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447098|NCT01677546|Randomized|Parallel Assignment||||None (Open Label)||||||
1447099|NCT01677533|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447100|NCT01677520|||Case-Only||Cross-Sectional|||||||
1447101|NCT01677507|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447102|NCT01677494|||Cohort||Prospective|||||||
1447103|NCT01677481|||Cohort||Prospective|||||||
1447104|NCT01677468|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447105|NCT01677455|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447106|NCT01677442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447107|NCT01677429|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1447108|NCT01677416|||||Cross-Sectional|||||||
1447109|NCT01677403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447110|NCT01677390||Single Group Assignment||Treatment||None (Open Label)||||||
1447111|NCT01677377|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1447112|NCT01677364|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447113|NCT01677351|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447114|NCT01677338|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1447115|NCT01677325||Single Group Assignment||Treatment||Single|||t|||
1447116|NCT01677312|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1447117|NCT01677299|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1447118|NCT01677286||Single Group Assignment||Treatment||None (Open Label)||||||
1447119|NCT01677273|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1447120|NCT01677260|Randomized|Crossover Assignment||Treatment||Single|||||t|
1447121|NCT01677247|Randomized|Crossover Assignment||Treatment||Single|||||t|
1447122|NCT01677234|||Cohort||Prospective|||||||
1447123|NCT01677221||Single Group Assignment||Treatment||None (Open Label)||||||
1447124|NCT01677208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447125|NCT01677195|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1447126|NCT01677182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447127|NCT01677169|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447128|NCT01677156|||Cohort||Prospective|||||||
1447129|NCT01677143|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1447130|NCT01677130|||Cohort||Prospective|||||||
1447131|NCT01677117|||Case-Crossover||Retrospective|||||||
1447132|NCT01677104|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1447133|NCT01677091|Randomized|Factorial Assignment||Treatment||Single||||||t
1447134|NCT01677078|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447135|NCT01677065|||Case-Crossover||Prospective|||||||
1447136|NCT01677052|||||Prospective|||||||
1447137|NCT01677039|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1447138|NCT01677026|||Case-Only||Prospective|||||||
1447139|NCT01677013|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447140|NCT01677000|||Case-Only||Prospective|||||||
1447141|NCT01676987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447142|NCT01676974|||Ecologic or Community||Prospective|||||||
1447143|NCT01676961||Single Group Assignment||Supportive Care||None (Open Label)||||||
1447144|NCT01676948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447145|NCT01676935||Single Group Assignment||Treatment||None (Open Label)||||||
1447146|NCT01676922|||Cohort||Prospective|||||||
1447147|NCT01676909|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1447148|NCT01676896|Randomized|Parallel Assignment||||Single||||||t
1447149|NCT01676883||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447150|NCT01676870|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447151|NCT01676857|||Cohort||Prospective|||||||
1447152|NCT01676844|Randomized|Crossover Assignment||Treatment||Single||||||t
1447153|NCT01676831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447154|NCT01676818||Single Group Assignment||Treatment||None (Open Label)||||||
1447155|NCT01676805|||Cohort||Prospective|||||||
1447156|NCT01676792||Single Group Assignment||Treatment||None (Open Label)||||||
1447157|NCT01676779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447158|NCT01676766|||Case-Only||Prospective|||||||
1447159|NCT01676753||Single Group Assignment||Treatment||None (Open Label)||||||
1447160|NCT01676740|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447161|NCT01676727|||Cohort||Prospective|||||||
1447162|NCT01676714||Single Group Assignment||Treatment||None (Open Label)||||||
1447163|NCT01676701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447164|NCT01676688|||Cohort||Prospective|||||||
1447165|NCT01676675|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1447166|NCT01676662|Randomized|Crossover Assignment||Treatment||Single|||t|||
1447167|NCT01676649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447168|NCT01676636|||Cohort||Prospective|||||||
1447169|NCT01676623|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447170|NCT01676610|||Cohort||Prospective|||||||
1447171|NCT01676597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447172|NCT01676584|Randomized|Parallel Assignment||||Double|||t||t|
1447173|NCT01676571||Single Group Assignment||Treatment||None (Open Label)||||||
1447174|NCT01676558||Single Group Assignment||Treatment||None (Open Label)||||||
1447175|NCT01676545|||Case Control||Retrospective|||||||
1447176|NCT01676532|||Cohort||Prospective|||||||
1447177|NCT01676519|||Cohort||Prospective|||||||
1447178|NCT01676506||Single Group Assignment||Treatment||None (Open Label)||||||
1447179|NCT01676493||Single Group Assignment||Treatment||None (Open Label)||||||
1447180|NCT01676480|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447181|NCT01676467|||Cohort||Cross-Sectional|||||||
1447182|NCT01676454|||Cohort||Prospective|||||||
1447183|NCT01676441||Single Group Assignment||Treatment||None (Open Label)||||||
1447184|NCT01676428||Single Group Assignment||Treatment||None (Open Label)||||||
1447185|NCT01676415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447186|NCT01676402|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447187|NCT01676389|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447188|NCT01676376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447189|NCT01676363||Single Group Assignment||Treatment||None (Open Label)||||||
1447190|NCT01676350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447191|NCT01676337|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447192|NCT01676324|||Cohort||Prospective|||||||
1447193|NCT01676311|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447194|NCT01676298|||||Prospective|||||||
1447195|NCT01676285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447196|NCT01676272|||Cohort||Prospective|||||||
1447197|NCT01676259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447198|NCT01676246|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1447199|NCT01676233|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447200|NCT01676220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447201|NCT01676207|||Cohort||Cross-Sectional|||||||
1447202|NCT01676194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447203|NCT01676181|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1447204|NCT01676168|||Case Control||Prospective|||||||
1447205|NCT01676155|||Case Control||Prospective|||||||
1447206|NCT01676142|||Case Control||Prospective|||||||
1447207|NCT01676129|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447208|NCT01676116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447209|NCT01676103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447210|NCT01676090|||||Cross-Sectional|||||||
1447211|NCT01676077|||Cohort||Prospective|||||||
1447212|NCT01676064|Randomized|Parallel Assignment||Prevention||Single|||||t|
1447213|NCT01676051|||Cohort||Prospective|||||||
1447214|NCT01676038|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447215|NCT01676025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447216|NCT01676012|||Case-Only||Cross-Sectional|||||||
1447217|NCT01675999|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447218|NCT01675986||||||||||||
1447219|NCT01675973|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447220|NCT01675960|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1447221|NCT01675947|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447222|NCT01675934|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1447223|NCT01675921|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447224|NCT01675908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447225|NCT01675895|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447226|NCT01675882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447227|NCT01675869|Randomized|Parallel Assignment||Prevention||Double||||t||t
1447228|NCT01675856|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||"Patients are randomized in a 1:1 ratio. The patient is randomized to receive;~Urgent endoscopy (defined by endoscopy within 6 hours from first consultation by GI specialists at PWH) or~Early endoscopy (defined by endoscopy next morning and within 24 hours from first consultation by GI specialists at PWH)"||||
1447229|NCT01675843|Randomized|Parallel Assignment||Treatment||Single||||||t
1447230|NCT01675830||Single Group Assignment||Prevention||None (Open Label)||||||
1447231|NCT01675817|||||Prospective|||||||
1447232|NCT01675804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447233|NCT01675791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447234|NCT01675778||Single Group Assignment||Treatment||None (Open Label)||||||
1447235|NCT01675765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447236|NCT01675752|||Cohort||Cross-Sectional|||||||
1447237|NCT01675739|Randomized|Parallel Assignment||||Single|||||t|
1447238|NCT01675726||Single Group Assignment||Other||None (Open Label)||||||
1447239|NCT01675713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447240|NCT01675700||Single Group Assignment||Treatment||None (Open Label)||||||
1447241|NCT01675687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447242|NCT01675674||||||||||||
1447243|NCT01675661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447244|NCT01675648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447245|NCT01675635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447246|NCT01675622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447247|NCT01675609|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447248|NCT01675596||Single Group Assignment||Treatment||None (Open Label)||||||
1447249|NCT01675583|||Case Control||Retrospective|||||||
1447250|NCT01675570|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447251|NCT01675557|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447252|NCT01675544|||Cohort||Prospective|||||||
1447253|NCT01675531||Single Group Assignment||Supportive Care||None (Open Label)||||||
1447254|NCT01675518|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1447255|NCT01675505|||Cohort||Prospective|||||||
1447256|NCT01675492||Single Group Assignment||Treatment||None (Open Label)||||||
1447257|NCT01675479||Single Group Assignment||Treatment||None (Open Label)||||||
1447258|NCT01675466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447259|NCT01675453|Randomized|Parallel Assignment||Prevention||Single|||t|||
1447260|NCT01675440|||Cohort||Prospective|||||||
1447261|NCT01675427|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1447262|NCT01675414|||Cohort|||||||||
1447263|NCT01675401|Randomized|Parallel Assignment||Basic Science||Single||||||t
1447264|NCT01675388||Single Group Assignment||Treatment||None (Open Label)||||||
1447265|NCT01675375||Single Group Assignment||Supportive Care||None (Open Label)||||||
1447266|NCT01675362|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1447267|NCT01675349||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447268|NCT01675336|||Case Control||Retrospective|||||||
1447269|NCT01675323|||Case-Control||Prospective|||||||
1447270|NCT01675310|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447271|NCT01675297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447272|NCT01675284|Randomized|Parallel Assignment||Prevention||Single||||||t
1447273|NCT01675271|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447274|NCT01675258|||Case Control||Cross-Sectional|||||||
1447275|NCT01675245|||Case-Only||Prospective|||||||
1447276|NCT01675232|Randomized|Parallel Assignment||Treatment||Single|||||t|
1447277|NCT01675219|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1447278|NCT01675206|Randomized|Parallel Assignment||Prevention||Single|||t|||
1447279|NCT01675193|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1447280|NCT01675180|Randomized|Parallel Assignment||Other||Double|||t|t||
1447281|NCT01675167|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447282|NCT01675154|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1447283|NCT01675141||Single Group Assignment||Treatment||None (Open Label)||||||
1447284|NCT01675128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447285|NCT01675115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447286|NCT01675102|||Cohort||Prospective|||||||
1447287|NCT01675089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447288|NCT01675076|Randomized|Parallel Assignment||Treatment||Single||||||t
1447289|NCT01675063||Single Group Assignment||Other||None (Open Label)||||||
1447290|NCT01675050|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1447291|NCT01675037|||Cohort||Prospective|||||||
1447292|NCT01675024|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447293|NCT01675011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447294|NCT01674998|||Case-Only||Cross-Sectional|||||||
1447295|NCT01674985||Single Group Assignment||Treatment||None (Open Label)||||||
1447296|NCT01674972|||Case Control||Prospective|||||||
1447297|NCT01674959||Single Group Assignment||Treatment||None (Open Label)||||||
1447298|NCT01674946|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1447299|NCT01674933|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447300|NCT01674920||Single Group Assignment||Treatment||None (Open Label)||||||
1447301|NCT01674907|||Cohort||Prospective|||||||
1447302|NCT01674894|||Cohort||Prospective|||||||
1447303|NCT01674881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447304|NCT01674868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447305|NCT01674855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447306|NCT01674842||Single Group Assignment||Treatment||None (Open Label)||||||
1447307|NCT01674829||Single Group Assignment||Treatment||None (Open Label)||||||
1447308|NCT01674816|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447309|NCT01674803|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447310|NCT01674790|Randomized|Factorial Assignment||Treatment||Single||||||t
1447311|NCT01674777|Randomized|Crossover Assignment||||None (Open Label)||||||
1447312|NCT01674764|||Cohort||Prospective|||||||
1447313|NCT01674751|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447314|NCT01674738|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447315|NCT01674725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447316|NCT01674712|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447317|NCT01674699|||Cohort||Prospective|||||||
1447318|NCT01674686|Randomized|Factorial Assignment||Treatment||Single|||t|||
1447319|NCT01674673|||Case Control||Prospective|||||||
1447320|NCT01674660|||Case Control||Cross-Sectional|||||||
1447321|NCT01674647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447322|NCT01674634||Single Group Assignment||Treatment||None (Open Label)||||||
1447323|NCT01674621|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447324|NCT01674608|||Cohort||Prospective|||||||
1447325|NCT01674595||Single Group Assignment||Treatment||None (Open Label)||||||
1447326|NCT01674582||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447327|NCT01674569|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447328|NCT01674556||Single Group Assignment||Treatment||None (Open Label)||||||
1447329|NCT01674543|Randomized|Parallel Assignment||Treatment||Double||||t||t
1447330|NCT01674530|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447331|NCT01674517|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447332|NCT01674504|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447333|NCT01674491|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1447334|NCT01674478|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447335|NCT01674465|||||Prospective|||||||
1447336|NCT01674452|Randomized|Parallel Assignment||Treatment||Single||||||t
1447337|NCT01674439|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447338|NCT01674426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447339|NCT01674413|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447340|NCT01674400||||||||||||
1447341|NCT01674387|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447342|NCT01674374|Randomized|Parallel Assignment||Supportive Care||Double||||||
1447343|NCT01674361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447344|NCT01674348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447345|NCT01674335|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447346|NCT01674322||Single Group Assignment||Treatment||None (Open Label)||||||
1447347|NCT01674309||Single Group Assignment||Treatment||None (Open Label)||||||
1447348|NCT01674296|||Cohort||Prospective|||||||
1447349|NCT01674283|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447350|NCT01674270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447351|NCT01674257|||Cohort||Prospective|||||||
1447352|NCT01674244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447353|NCT01674231|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1447354|NCT01674218|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1447355|NCT01674205|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1447356|NCT01674192||Single Group Assignment||Treatment||None (Open Label)||||||
1447357|NCT01674179|||Case Control||Retrospective|||||||
1447358|NCT01674166||Single Group Assignment||Treatment||None (Open Label)||||||
1447359|NCT01674153||Single Group Assignment||Supportive Care||None (Open Label)||||||
1447360|NCT01674140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447361|NCT01674127|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447362|NCT01674114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447363|NCT01674101||Single Group Assignment||Supportive Care||None (Open Label)||||||
1447364|NCT01674088|||Case Control||Prospective|||||||
1447365|NCT01674075|||Case-Only||Prospective|||||||
1447366|NCT01674062|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447367|NCT01674049|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1447368|NCT01674036|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447369|NCT01674023|||Case Control||Prospective|||||||
1447370|NCT01674010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447371|NCT01673997|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447372|NCT01673984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447373|NCT01673971|||Cohort||Other|||||||
1447374|NCT01673958|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447375|NCT01673945|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1447376|NCT01673932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447377|NCT01673919||Single Group Assignment||Treatment||None (Open Label)||||||
1447378|NCT01673906||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447379|NCT01673893|||Cohort||Prospective|||||||
1447380|NCT01673880|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447381|NCT01673867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447382|NCT01673854||Single Group Assignment||Treatment||None (Open Label)||||||
1447383|NCT01673841|||Case-Only||Prospective|||||||
1447384|NCT01673828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447385|NCT01673815|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1447386|NCT01673802||Single Group Assignment||Treatment||None (Open Label)||Single arm study, with dose adjustment.||||
1447387|NCT01673789||Single Group Assignment||Treatment||None (Open Label)||||||
1447388|NCT01673776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447389|NCT01673763|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1447390|NCT01673750|||Cohort||Prospective|||||||
1447391|NCT01673737|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447392|NCT01673724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447393|NCT01673711|||Other||Prospective|||||||
1447394|NCT01673698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447395|NCT01673685|Randomized|Crossover Assignment||Treatment||None (Open Label)||Portable oxygen concentrators vs oxygen cylinders||||
1447396|NCT01673672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447397|NCT01673659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447398|NCT01673646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447399|NCT01673633|||Case Control||Prospective|||||||
1447400|NCT01673620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447401|NCT01673607||||||||||||
1447402|NCT01673594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447403|NCT01673581|||Cohort||Prospective|||||||
1447404|NCT01673568|Randomized|Parallel Assignment||Prevention||Single|||||t|
1447405|NCT01673555|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1447406|NCT01673542||||||||||||
1447407|NCT01673529|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1447408|NCT01673516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447409|NCT01673503|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447410|NCT01673490||Single Group Assignment||Treatment||None (Open Label)||||||
1447411|NCT01673464|||Cohort||Prospective|||||||
1447412|NCT01673451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447413|NCT01673438||Single Group Assignment||Treatment||None (Open Label)||||||
1447414|NCT01673425||Single Group Assignment||Basic Science||None (Open Label)||||||
1447415|NCT01673412||Single Group Assignment||||None (Open Label)||||||
1447416|NCT01673399|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1447417|NCT01673386|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1447418|NCT01673373||Single Group Assignment||Treatment||None (Open Label)||||||
1447419|NCT01673360|||Cohort||Prospective|||||||
1447420|NCT01673347||Single Group Assignment||Treatment||None (Open Label)||||||
1447421|NCT01673334||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447422|NCT01673321|Randomized|Single Group Assignment||Prevention||Single|||t|||
1447423|NCT01673308||Single Group Assignment||Treatment||None (Open Label)||||||
1447424|NCT01673295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447425|NCT01673282|||Cohort||Prospective|||||||
1447426|NCT01673269||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447427|NCT01673256|||Cohort||Prospective|||||||
1447428|NCT01673243|||Cohort||Prospective|||||||
1447429|NCT01673230||Single Group Assignment||||None (Open Label)||||||
1447430|NCT01673217||Single Group Assignment||Treatment||None (Open Label)||||||
1447431|NCT01673204|Randomized|Parallel Assignment||Screening||Double|||t||t|
1447432|NCT01673191|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447433|NCT01673178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447434|NCT01673165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447435|NCT01673152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447436|NCT01673139|Randomized|Parallel Assignment||Prevention||Single||||||t
1447437|NCT01673126|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1447438|NCT01673113|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1447439|NCT01673100|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447440|NCT01673087||Single Group Assignment||Basic Science||None (Open Label)||||||
1447441|NCT01673074||||Treatment||||||||
1447442|NCT01673061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447443|NCT01673048||Single Group Assignment||Treatment||None (Open Label)||||||
1447444|NCT01673035|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447445|NCT01673022||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447446|NCT01673009||Single Group Assignment||Treatment||None (Open Label)||||||
1447447|NCT01672996|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1447448|NCT01672983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447449|NCT01672970|||Cohort||Prospective|||||||
1447450|NCT01672957|||Cohort||Prospective|||||||
1447451|NCT01672944|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1447452|NCT01672931|||Case Control||Prospective|||||||
1447453|NCT01672918|||||Prospective|||||||
1447454|NCT01672905|||Cohort||Retrospective|||||||
1447455|NCT01672892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447456|NCT01672879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447457|NCT01672866|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447458|NCT01672853|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1447459|NCT01672840|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447460|NCT01672827||Single Group Assignment||Diagnostic||Single||||||t
1447461|NCT01672814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447462|NCT01672801|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447463|NCT01672788|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447464|NCT01672775|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447465|NCT01672762||Single Group Assignment||Treatment||None (Open Label)||||||
1447466|NCT01672749|||Cohort||Prospective|||||||
1447467|NCT01672736||Single Group Assignment||Treatment||None (Open Label)||||||
1447468|NCT01672723|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1447469|NCT01672710|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pilot||||
1447470|NCT01672697|Randomized|Parallel Assignment||Prevention||Single||||||t
1447471|NCT01672684|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1447472|NCT01672671||Single Group Assignment||Treatment||None (Open Label)||||||
1447473|NCT01672658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447474|NCT01672645|Randomized|||Treatment||Quadruple|||t|t|t|t
1447475|NCT01672632||Single Group Assignment||Other||None (Open Label)||||||
1447476|NCT01672619|||Cohort||Prospective|||||||
1447477|NCT01672606||Single Group Assignment||Supportive Care||None (Open Label)||||||
1447478|NCT01672593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447479|NCT01672580|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1447480|NCT01672567|Randomized|Crossover Assignment||Prevention||Single|||||t|
1447481|NCT01672554||Single Group Assignment||Treatment||None (Open Label)||||||
1447482|NCT01672541|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447483|NCT01672528|||Cohort||Prospective|||||||
1447484|NCT01672515|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447485|NCT01672502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447486|NCT01672489|||Cohort|||||||||
1447487|NCT01672476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447488|NCT01672463||Single Group Assignment||Treatment||None (Open Label)||||||
1447489|NCT01672450||Single Group Assignment||Treatment||None (Open Label)||||||
1447490|NCT01672437|Randomized|Parallel Assignment||Prevention||Single||||||t
1447491|NCT01672424|||Case Control||Prospective|||||||
1447492|NCT01672411|||Case-Only||Prospective|||||||
1447493|NCT01672398|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447494|NCT01672385|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447495|NCT01672372|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447496|NCT01672359|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447497|NCT01672346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447498|NCT01672333||Single Group Assignment||Treatment||None (Open Label)||||||
1447499|NCT01672320|||Cohort||Prospective|||||||
1447500|NCT01672307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447501|NCT01672294|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1447502|NCT01672281|Randomized|Parallel Assignment||||None (Open Label)||||||
1447503|NCT01672268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447504|NCT01672255|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1447505|NCT01672242|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1447506|NCT01672229||Single Group Assignment||Treatment||None (Open Label)||||||
1447507|NCT01672216|Randomized|Parallel Assignment||Treatment||Single||||||t
1447508|NCT01672203|||Case Control||Prospective|||||||
1447509|NCT01672190|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447510|NCT01672177|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1447511|NCT01672164|||Cohort||Prospective|||||||
1447512|NCT01672151|||Case-Only||Prospective|||||||
1447513|NCT01672138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447514|NCT01672125|||Case Control||Cross-Sectional|||||||
1447515|NCT01672112|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1447516|NCT01672099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447517|NCT01672086|||Cohort||Retrospective|||||||
1447518|NCT01672073|||Case-Only||Prospective|||||||
1447519|NCT01672060|Randomized|Parallel Assignment||Prevention||Single|||||t|
1447520|NCT01672047|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447521|NCT01672034|||Case-Only||Prospective|||||||
1447522|NCT01672021||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447523|NCT01672008|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1447524|NCT01671995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447525|NCT01671982||Single Group Assignment||Treatment||None (Open Label)||||||
1447526|NCT01671969||Single Group Assignment||Treatment||None (Open Label)||||||
1447527|NCT01671956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447528|NCT01671943||Single Group Assignment||Treatment||None (Open Label)||||||
1447529|NCT01671930|||Cohort||Cross-Sectional|||||||
1447530|NCT01671917|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447531|NCT01671904|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447532|NCT01671891|||Cohort||Prospective|||||||
1447533|NCT01671878|Randomized|Crossover Assignment||||None (Open Label)||||||
1447534|NCT01671865|||Cohort||Prospective|||||||
1447535|NCT01671852|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1447536|NCT01671839||Single Group Assignment||Treatment||None (Open Label)||||||
1447537|NCT01671826|||Cohort||Prospective|||||||
1447538|NCT01671813||Single Group Assignment||Treatment||None (Open Label)||||||
1447539|NCT01671800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447540|NCT01671787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447541|NCT01671774|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447542|NCT01671761|||Cohort||Prospective|||||||
1447543|NCT01671748|Randomized|Parallel Assignment||Treatment||Single||||||t
1447544|NCT01671735|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447545|NCT01671722|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447546|NCT01671709|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447547|NCT01671696|||Case-Control||Cross-Sectional|||||||
1447548|NCT01671683|||Case-Only||Prospective|||||||
1447549|NCT01671670|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447550|NCT01671657|||Case Control|||||||||
1447551|NCT01671644|||Case Control|||||||||
1447552|NCT01671631|||Cohort||Prospective|||||||
1447553|NCT01671618|||Cohort||Prospective|||||||
1447554|NCT01671605|||Case-Only||Retrospective|||||||
1447555|NCT01671592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447556|NCT01671579||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447557|NCT01671566|Randomized|Parallel Assignment||||Single||||||t
1447558|NCT01671553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447559|NCT01671540|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1447560|NCT01671527|||Case Control||Prospective|||||||
1447561|NCT01671514|Randomized|Parallel Assignment||||Double|||t||t|
1447562|NCT01671501|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447563|NCT01671488||Single Group Assignment||Treatment||None (Open Label)||||||
1447564|NCT01671475|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1447565|NCT01671462||||||||||||
1447566|NCT01671449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447567|NCT01671436||Single Group Assignment||Treatment||None (Open Label)||||||
1447568|NCT01671423|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1447569|NCT01671410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447570|NCT01671397|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447571|NCT01671384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447572|NCT01671371|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1447573|NCT01671358|||Cohort||Prospective|||||||
1447574|NCT01671345|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1447575|NCT01671332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447576|NCT01671319||Single Group Assignment||Treatment||None (Open Label)||||||
1447577|NCT01671306|||Case Control||Cross-Sectional|||||||
1447578|NCT01671293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447579|NCT01671280|||Case-Only||Prospective|||||||
1447580|NCT01671267|Randomized|Parallel Assignment||Treatment||Single||||||t
1447581|NCT01671254|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1447582|NCT01671241|Randomized|||Prevention||None (Open Label)||||||
1447583|NCT01671228|Randomized|Parallel Assignment||||Single|||t|||
1447584|NCT01671215|||Cohort||Prospective|||||||
1447585|NCT01671189|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447586|NCT01671176||Single Group Assignment||Treatment||None (Open Label)||||||
1447587|NCT01671163|||Case-Only||Prospective|||||||
1447588|NCT01671150|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1447589|NCT01671137|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447590|NCT01671124|||Cohort||Prospective|||||||
1447591|NCT01671111||Single Group Assignment||Treatment||None (Open Label)||||||
1447592|NCT01671098|||Case-Only||Prospective|||||||
1447593|NCT01671085|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1447594|NCT01671072|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447595|NCT01671059|||Cohort||Prospective|||||||
1447596|NCT01671046|||Cohort||Prospective|||||||
1447597|NCT01671033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447598|NCT01671020|Randomized|Crossover Assignment||||None (Open Label)||||||
1447599|NCT01671007|||Cohort||Prospective|||||||
1447600|NCT01670994||Single Group Assignment||Treatment||None (Open Label)||||||
1447601|NCT01670981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447602|NCT01670968|||Cohort||Prospective|||||||
1447603|NCT01670955|Randomized|Single Group Assignment||Treatment||Single|||t|||
1447604|NCT01670942|||Cohort||Prospective|||||||
1447605|NCT01670929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447606|NCT01670916|||Case Control|||||||||
1447607|NCT01670903|||Cohort||Prospective|||||||
1447608|NCT01670890|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447609|NCT01670877|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447610|NCT01670864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447611|NCT01670851|||Cohort||Prospective|||||||
1447612|NCT01670838|||Cohort||Prospective|||||||
1447613|NCT01670825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447614|NCT01670812||Single Group Assignment||Treatment||None (Open Label)||||||
1447615|NCT01670799||Single Group Assignment||Other||None (Open Label)||||||
1447616|NCT01670786|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447617|NCT01670773|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1447618|NCT01670760||Single Group Assignment||Basic Science||None (Open Label)||||||
1447619|NCT01670747|||Cohort||Prospective|||||||
1447620|NCT01670734|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1447621|NCT01670721||Single Group Assignment||Treatment||None (Open Label)||||||
1447622|NCT01670708|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1447623|NCT01670695|||Cohort||Prospective|||||||
1447624|NCT01670682|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447625|NCT01670669||Single Group Assignment||Treatment||None (Open Label)||||||
1447626|NCT01670656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447627|NCT01670643|||Case-Crossover||Prospective|||||||
1447628|NCT01670630|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1447629|NCT01670617||Single Group Assignment||Treatment||None (Open Label)||||||
1447630|NCT01670604|Randomized|Parallel Assignment||||Single|||t|||
1447631|NCT01670591|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447632|NCT01670578|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447633|NCT01670565|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447634|NCT01670552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447635|NCT01670539|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1447636|NCT01670526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447637|NCT01670513|Randomized|Parallel Assignment||Treatment||Single|||||t|
1447638|NCT01670500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447639|NCT01670487|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1447640|NCT01670474|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447641|NCT01670461|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1447642|NCT01670448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447643|NCT01670435|||Case-Only||Prospective|||||||
1447644|NCT01670422|||Case Control||Retrospective|||||||
1447645|NCT01670409||Single Group Assignment||Treatment||None (Open Label)||||||
1447646|NCT01670396|||Case Control||Retrospective|||||||
1447647|NCT01670383|||Cohort||Prospective|||||||
1447648|NCT01670370||Single Group Assignment||Treatment||None (Open Label)||||||
1447649|NCT01670357|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447650|NCT01670344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447651|NCT01670331|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1447652|NCT01670318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447653|NCT01670305|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447654|NCT01670292||Single Group Assignment||Treatment||None (Open Label)||||||
1447655|NCT01670279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447656|NCT01670266|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447657|NCT01670253|Randomized|Parallel Assignment||Diagnostic||Double||||t|t|
1447658|NCT01670240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447659|NCT01670227|Randomized|Parallel Assignment||Prevention||Single|||t|||
1447660|NCT01670214|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447661|NCT01670201||Single Group Assignment||Treatment||None (Open Label)||||||
1447662|NCT01670188|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447663|NCT01670175||Single Group Assignment||Treatment||None (Open Label)||||||
1447664|NCT01670162||Single Group Assignment||Treatment||None (Open Label)||||||
1447665|NCT01670149|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447666|NCT01670136|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1447667|NCT01670123|Randomized|Parallel Assignment||Treatment||Single||||||t
1447668|NCT01670110|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1447669|NCT01670097|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1447670|NCT01670084||Single Group Assignment||Treatment||None (Open Label)||||||
1447671|NCT01670071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447672|NCT01670058|||Cohort||Retrospective|||||||
1447673|NCT01670045|||Cohort||Prospective|||||||
1447674|NCT01670032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447675|NCT01670019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447676|NCT01670006||||||||||||
1447677|NCT01669993|||Case-Only||Prospective|||||||
1447678|NCT01669980|Randomized|Parallel Assignment||Treatment||Single||||||t
1447679|NCT01669967|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1447680|NCT01669954|||Case Control||Cross-Sectional|||||||
1447681|NCT01669941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447682|NCT01669928|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447683|NCT01669915|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1447684|NCT01669902|||Cohort||Prospective|||||||
1447685|NCT01669889|||Cohort||Prospective|||||||
1447686|NCT01669876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447687|NCT01669863||Single Group Assignment||Treatment||None (Open Label)||||||
1447688|NCT01669850|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447689|NCT01669837|||Cohort||Prospective|||||||
1447690|NCT01669824|||||Prospective|||||||
1447691|NCT01669811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447692|NCT01669798||Single Group Assignment||Treatment||None (Open Label)||||||
1447693|NCT01669785|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447694|NCT01669772|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1447695|NCT01669759|||||Cross-Sectional|||||||
1447696|NCT01669746||Single Group Assignment||Treatment||Single||||||t
1447697|NCT01669733|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1447698|NCT01669720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447699|NCT01669707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447700|NCT01669694|||Cohort||Prospective|||||||
1447701|NCT01669681|||Cohort||Prospective|||||||
1447702|NCT01669668||Single Group Assignment||Treatment||None (Open Label)||||||
1447703|NCT01669655|||Family-Based||Prospective|||||||
1447704|NCT01669642||Single Group Assignment||Supportive Care||None (Open Label)||||||
1447705|NCT01669629|Randomized|Crossover Assignment||Other||Double|||t||t|
1447706|NCT01669616|||Cohort||Cross-Sectional|||||||
1447707|NCT01669603|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1447708|NCT01669590|||Cohort||Prospective|||||||
1447709|NCT01669577|||Cohort||Prospective|||||||
1447710|NCT01669564|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447711|NCT01669551|||Case-Only||Prospective|||||||
1447712|NCT01669538|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447713|NCT01669525|||Cohort||Prospective|||||||
1447714|NCT01669512|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447715|NCT01669499|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1447716|NCT01669486|||Cohort||Prospective|||||||
1447717|NCT01669473|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447718|NCT01669460||Single Group Assignment||Supportive Care||None (Open Label)||||||
1447719|NCT01669447||Single Group Assignment||Supportive Care||None (Open Label)||||||
1447720|NCT01669434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447721|NCT01669421||Single Group Assignment||Treatment||None (Open Label)||||||
1447722|NCT01669408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447723|NCT01669395|Randomized|Parallel Assignment||Treatment||Single|||||t|
1447724|NCT01669382|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447725|NCT01669369|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447726|NCT01669356|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447727|NCT01669343|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447728|NCT01669330|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447729|NCT01669317|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1447730|NCT01669304|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1447731|NCT01669291|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447732|NCT01669278|Randomized|Parallel Assignment||||Single||||||t
1447733|NCT01669265|||Cohort||Retrospective|||||||
1447734|NCT01669252||Single Group Assignment||Treatment||None (Open Label)||||||
1447735|NCT01669239||Single Group Assignment||Treatment||None (Open Label)||||||
1447736|NCT01669226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447737|NCT01669213|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1447738|NCT01669200|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447739|NCT01669187|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447740|NCT01669174|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1447741|NCT01669161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447742|NCT01669148|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1447743|NCT01669135||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447744|NCT01669122|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447745|NCT01669109|Randomized|Parallel Assignment||Treatment||Single||||||t
1447746|NCT01669096||Single Group Assignment||||None (Open Label)||||||
1447747|NCT01669083|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447748|NCT01669070|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447749|NCT01669057|||Case Control||Cross-Sectional|||||||
1447750|NCT01669044|||Case Control||Prospective|||||||
1447751|NCT01669031|Randomized|Parallel Assignment||Diagnostic||Triple||||t|t|t
1447752|NCT01669018|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1447753|NCT01669005|||Cohort||Prospective|||||||
1447754|NCT01668992|Randomized|Parallel Assignment||Prevention||Single|||t|||
1447755|NCT01668979|||Cohort||Cross-Sectional|||||||
1447756|NCT01668966||Single Group Assignment||Treatment||None (Open Label)||||||
1447757|NCT01668953|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447758|NCT01668940|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1447759|NCT01668927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447760|NCT01668914||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447761|NCT01668901|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447762|NCT01668888|||Cohort||Cross-Sectional|||||||
1447763|NCT01668875|Randomized|Crossover Assignment||||None (Open Label)||||||
1447764|NCT01668862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447765|NCT01668849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447766|NCT01668836|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447767|NCT01668823||Single Group Assignment||Treatment||None (Open Label)||||||
1447768|NCT01668810|||Ecologic or Community||Prospective|||||||
1447769|NCT01668797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447770|NCT01668784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447771|NCT01668771|||||Prospective|||||||
1447772|NCT01668758|||||Other|||||||
1447773|NCT01668745|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447774|NCT01668732|||Case-Only||Cross-Sectional|||||||
1447775|NCT01668719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447776|NCT01668706|||Cohort||Prospective|||||||
1447777|NCT01668693|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1447778|NCT01668680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447779|NCT01668667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447780|NCT01668654||Single Group Assignment||Treatment||None (Open Label)||||||
1447781|NCT01668641|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447782|NCT01668628|||Cohort||Prospective|||||||
1447783|NCT01668615|||Case-Only||Prospective|||||||
1447784|NCT01668602|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Prospective, Unblinded Non-randomized||||
1447785|NCT01668589|||Cohort||Prospective|||||||
1447786|NCT01668576|||Cohort||Cross-Sectional|||||||
1447787|NCT01668563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447788|NCT01668550||Single Group Assignment||Treatment||None (Open Label)||||||
1447789|NCT01668537|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447790|NCT01668524||Single Group Assignment||Treatment||None (Open Label)||||||
1447791|NCT01668511|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447792|NCT01668498|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447793|NCT01668485|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1447794|NCT01668472|||Cohort||Prospective|||||||
1447795|NCT01668459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447796|NCT01668446|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1447797|NCT01668433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447798|NCT01668420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447799|NCT01668407|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1447800|NCT01668394|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447801|NCT01668381|||Case-Only||Prospective|||||||
1447802|NCT01668368||Single Group Assignment||Treatment||None (Open Label)||||||
1447881|NCT01667341|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447803|NCT01668355|Non-Randomized|Parallel Assignment||Treatment||Single||medical home tailored for people with serious mental illness||||t
1447804|NCT01668342|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1447805|NCT01668329|||Cohort||Prospective|||||||
1447806|NCT01668316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447807|NCT01668303|Randomized|Factorial Assignment||Treatment||Single||||||t
1447808|NCT01668290|||Cohort||Prospective|||||||
1447809|NCT01668277|Randomized|Parallel Assignment||Treatment||Single|||||t|
1447810|NCT01668264|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1447811|NCT01668251|||Case Control||Prospective|||||||
1447812|NCT01668238|||||Cross-Sectional|||||||
1447813|NCT01668225|||Case-Only||Prospective|||||||
1447814|NCT01668212|||Case-Only||Prospective|||||||
1447815|NCT01668199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447816|NCT01668186|||Cohort||Other|||||||
1447817|NCT01668173||Single Group Assignment||Treatment||None (Open Label)||||||
1447818|NCT01668160||Single Group Assignment||Treatment||None (Open Label)||||||
1447819|NCT01668147||Sequential Assignment||Other||None (Open Label)||||||
1447820|NCT01668134||Single Group Assignment||Treatment||None (Open Label)||||||
1447821|NCT01668121|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1447822|NCT01668108|||Other||Prospective|||||||
1447823|NCT01668095|||Case-Only||Retrospective|||||||
1447824|NCT01668082||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447825|NCT01668069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447826|NCT01668056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447827|NCT01668043|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447828|NCT01668030|Randomized|Sequential Assignment||Treatment||Triple|Participants received both the test drug and the standard of care, one on each side of the face.||t|t||t
1447829|NCT01668017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447830|NCT01668004||Single Group Assignment||Treatment||None (Open Label)||||||
1447831|NCT01667991|||Case-Only||Prospective|||||||
1447832|NCT01667978|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447833|NCT01667965|||Case-Only||Prospective|||||||
1447834|NCT01667952|||Family-Based||Prospective|||||||
1447835|NCT01667939|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447836|NCT01667926|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447837|NCT01667913||Single Group Assignment||Screening||None (Open Label)||||||
1447838|NCT01667900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447839|NCT01667887|||Cohort||Prospective|||||||
1447840|NCT01667874|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447841|NCT01667861|||||Cross-Sectional|||||||
1447842|NCT01667848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447843|NCT01667835|Randomized|Parallel Assignment||Prevention||Single|||||t|
1447844|NCT01667822|Randomized|Parallel Assignment||Treatment||Single||||||t
1447845|NCT01667809|Randomized|Parallel Assignment||Treatment||Single||||||t
1447846|NCT01667796||Single Group Assignment||Other||None (Open Label)||||||
1447847|NCT01667783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447848|NCT01667770|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447849|NCT01667757|||Case-Only||Cross-Sectional|||||||
1447850|NCT01667744||Single Group Assignment||Treatment||Double|||t|||t
1447851|NCT01667731|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447852|NCT01667718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447853|NCT01667705|||Case-Only||Cross-Sectional|||||||
1447854|NCT01667692|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1447855|NCT01667679|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1447856|NCT01667666||Single Group Assignment||Prevention||None (Open Label)||||||
1447857|NCT01667653|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447858|NCT01667640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447859|NCT01667627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447860|NCT01667614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447861|NCT01667601|Randomized|Parallel Assignment||Treatment||Single||||||t
1447862|NCT01667588|||Cohort||Prospective|||||||
1447863|NCT01667575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447864|NCT01667562||Single Group Assignment||Treatment||None (Open Label)||||||
1447865|NCT01667549|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1447866|NCT01667536||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447867|NCT01667523|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1447868|NCT01667510|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1447869|NCT01667497|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1447870|NCT01667484|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447871|NCT01667471|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447872|NCT01667458|||Cohort||Prospective|||||||
1447873|NCT01667445|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447874|NCT01667432|||Cohort||Prospective|||||||
1447875|NCT01667419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447876|NCT01667406||Single Group Assignment||Treatment||None (Open Label)||||||
1447877|NCT01667393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447878|NCT01667380|||Cohort||Prospective|||||||
1447879|NCT01667367|Randomized|Crossover Assignment||||Single|||t|||
1447880|NCT01667354|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447882|NCT01667328|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447883|NCT01667315||Single Group Assignment||Treatment||Triple|||t||t|t
1447884|NCT01667302||Single Group Assignment||Treatment||None (Open Label)||||||
1447885|NCT01667289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447886|NCT01667276|||||Prospective|||||||
1447887|NCT01667263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447888|NCT01667250|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1447889|NCT01667237||Single Group Assignment||Prevention||None (Open Label)||||||
1447890|NCT01667224|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1447891|NCT01667211||Single Group Assignment||Treatment||None (Open Label)||||||
1447892|NCT01667198|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1447893|NCT01667185|||Cohort||Prospective|||||||
1447894|NCT01667172||Single Group Assignment||Diagnostic||Double|||t|t||
1447895|NCT01667159|Randomized|Parallel Assignment||Treatment||Single||||||t
1447896|NCT01667146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447897|NCT01667133|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447898|NCT01667120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447899|NCT01667107|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447900|NCT01667094|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447901|NCT01667081|||Cohort||Prospective|||||||
1447902|NCT01667068|||Cohort||Prospective|||||||
1447903|NCT01667055|||Cohort||Cross-Sectional|||||||
1447904|NCT01667042|||Cohort||Cross-Sectional|||||||
1447905|NCT01667029|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1447906|NCT01667016|||Other||Prospective|||||||
1447907|NCT01667003|||Other||Prospective|||||||
1447908|NCT01666990|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1447909|NCT01666977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447910|NCT01666964|||Case-Only||Prospective|||||||
1447911|NCT01666951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447912|NCT01666938|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1447913|NCT01666925|Randomized|Parallel Assignment||Prevention||Single|||t|||
1447914|NCT01666912|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447915|NCT01666899||Single Group Assignment||Basic Science||None (Open Label)||||||
1447916|NCT01666886||Single Group Assignment||Treatment||None (Open Label)||||||
1447917|NCT01666873|||Cohort||Prospective|||||||
1447918|NCT01666860|||Cohort||Prospective|||||||
1447919|NCT01666847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447920|NCT01666834|||Cohort||Cross-Sectional|||||||
1447921|NCT01666821|||Ecologic or Community||Prospective|||||||
1447922|NCT01666808|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447923|NCT01666795|||Cohort||Retrospective|||||||
1447924|NCT01666782|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1447925|NCT01666769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447926|NCT01666756||Single Group Assignment||Treatment||None (Open Label)||||||
1447927|NCT01666743||Single Group Assignment||Treatment||None (Open Label)||||||
1447928|NCT01666730||Single Group Assignment||Treatment||None (Open Label)||||||
1447929|NCT01666717|||Case Control||Retrospective|||||||
1447930|NCT01666704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447931|NCT01666691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447932|NCT01666678|Randomized|Crossover Assignment||||None (Open Label)||||||
1447933|NCT01666665|Randomized|Single Group Assignment||Treatment||Single|||t|||
1447934|NCT01666652|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447935|NCT01666639|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447936|NCT01666626|||Cohort||Prospective|||||||
1447937|NCT01666613|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1447938|NCT01666600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447939|NCT01666587|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1447940|NCT01666574|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1447941|NCT01666561|Randomized|Crossover Assignment||||None (Open Label)||||||
1447942|NCT01666548|||Cohort||Retrospective|||||||
1447943|NCT01666535|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447944|NCT01666522|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1447945|NCT01666509|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1447946|NCT01666496|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1447947|NCT01666483|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447948|NCT01666470|||Cohort||Cross-Sectional|||||||
1447949|NCT01666457|||Other||Prospective|||||||
1447950|NCT01666444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447951|NCT01666431||Single Group Assignment||Treatment||None (Open Label)||||||
1447952|NCT01666418||Single Group Assignment||Treatment||None (Open Label)||||||
1447953|NCT01666405||Single Group Assignment||Treatment||None (Open Label)||||||
1447954|NCT01666392|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1447955|NCT01666379|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1447956|NCT01666366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447957|NCT01666353||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447958|NCT01666340|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447959|NCT01666327||Single Group Assignment||Treatment||None (Open Label)||||||
1447960|NCT01666314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447961|NCT01666301|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447962|NCT01666288|||Case-Only||Prospective|||||||
1447963|NCT01666275|||Case-Only||Prospective|||||||
1447964|NCT01666262|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1447965|NCT01666249||Single Group Assignment||Prevention||None (Open Label)||||||
1447966|NCT01666236||Single Group Assignment||Treatment||None (Open Label)||||||
1447967|NCT01666223|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1447968|NCT01666210|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1447969|NCT01666197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1447970|NCT01666184|||Case-Only||Prospective|||||||
1447971|NCT01666171||||||||||||
1447972|NCT01666158|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1447973|NCT01666145||Single Group Assignment||Treatment||None (Open Label)||||||
1447974|NCT01666132|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447975|NCT01666119||Single Group Assignment||Treatment||None (Open Label)||||||
1447976|NCT01666106|||Case-Only||Prospective|||||||
1447977|NCT01666093||Single Group Assignment||Treatment||None (Open Label)||||||
1447978|NCT01666080||Single Group Assignment||Treatment||None (Open Label)||||||
1447979|NCT01666067|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447980|NCT01666054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447981|NCT01666041|Randomized|Parallel Assignment||Treatment||Single|||t|||
1447982|NCT01666028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1447983|NCT01666015|Randomized|Parallel Assignment||||Single||||||t
1447984|NCT01666002|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447985|NCT01665989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447986|NCT01665976|Randomized|Crossover Assignment||||None (Open Label)||||||
1447987|NCT01665963|Randomized|Parallel Assignment||Treatment||Single||||t||
1447988|NCT01665950|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1447989|NCT01665937||Single Group Assignment||Treatment||None (Open Label)||||||
1447990|NCT01665924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1447991|NCT01665911|Randomized|Crossover Assignment||||Double|||||t|t
1447992|NCT01665898|Randomized|Single Group Assignment||Treatment||Single|||t|||
1447993|NCT01665885|Randomized|Parallel Assignment||Treatment||Single||||||t
1447994|NCT01665872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1447995|NCT01665859|||Cohort||Prospective|||||||
1447996|NCT01665846||Single Group Assignment||Diagnostic||None (Open Label)||||||
1447997|NCT01665833|||||Retrospective|||||||
1447998|NCT01665820|||Cohort||Prospective|||||||
1447999|NCT01665807|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1448000|NCT01665794|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1448001|NCT01665781|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448002|NCT01665768||Single Group Assignment||Treatment||None (Open Label)||||||
1448003|NCT01665755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448004|NCT01665742|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1448005|NCT01665729|||Case-Only||Prospective|||||||
1448006|NCT01665716|||Case Control||Cross-Sectional|||||||
1448007|NCT01665703||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448008|NCT01665690|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448009|NCT01665677|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1448010|NCT01665664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448011|NCT01665651|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1448012|NCT01665638|Randomized|Crossover Assignment||||Triple|||t|t|t|
1448013|NCT01665625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448014|NCT01665612|Randomized|Crossover Assignment||||Triple|||t|t|t|
1448015|NCT01665599||Single Group Assignment||Treatment||None (Open Label)||||||
1448016|NCT01665586|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1448017|NCT01665573|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1448018|NCT01665560|||Cohort||Prospective|||||||
1448019|NCT01665547||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1448020|NCT01665534||Single Group Assignment||Treatment||Single|||||t|
1448021|NCT01665521|Randomized|Parallel Assignment||Treatment||Single||||||t
1448022|NCT01665508||Single Group Assignment||Treatment||None (Open Label)||||||
1448023|NCT01665495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448024|NCT01665482|Randomized|Crossover Assignment||Prevention||Single|||t|||
1448025|NCT01665469|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1448026|NCT01665456|||Case Control||Retrospective|||||||
1448027|NCT01665430||Single Group Assignment||Treatment||None (Open Label)||||||
1448028|NCT01665417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448029|NCT01665404|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1448030|NCT01665391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448031|NCT01665378|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1448032|NCT01665365|Randomized|Parallel Assignment||Treatment||Single||||||t
1448033|NCT01665352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448034|NCT01665339|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1448035|NCT01665326|||Cohort||Prospective|||||||
1448036|NCT01665313|||Cohort||Cross-Sectional|||||||
1448037|NCT01665300|||Case-Only||Prospective|||||||
1448038|NCT01665287|||Case-Only||Prospective|||||||
1448039|NCT01665274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448040|NCT01665261|||Cohort||Prospective|||||||
1448041|NCT01665248||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448042|NCT01665235|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448043|NCT01665222|Randomized|Crossover Assignment||||None (Open Label)||||||
1448044|NCT01665209|Randomized|Crossover Assignment||||None (Open Label)||||||
1448045|NCT01665196||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448046|NCT01665183||Single Group Assignment||Treatment||None (Open Label)||||||
1448047|NCT01665170|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1448048|NCT01665157|Randomized|Parallel Assignment||||Single|||||t|
1448049|NCT01665144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448050|NCT01665131||Single Group Assignment||Treatment||None (Open Label)||||||
1448051|NCT01665118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448052|NCT01665105|Non-Randomized|Factorial Assignment||Basic Science||Single|||t|||
1448053|NCT01665092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448054|NCT01665079||Single Group Assignment||Supportive Care||None (Open Label)||||||
1448055|NCT01665066|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1448056|NCT01665053|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448057|NCT01665040||Single Group Assignment||Treatment||None (Open Label)||||||
1448058|NCT01665027|Randomized|Parallel Assignment||Treatment||Single|||||t|
1448059|NCT01665014||Single Group Assignment||Treatment||None (Open Label)||||||
1448060|NCT01665001||Single Group Assignment||Treatment||None (Open Label)||||||
1448061|NCT01664988|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448062|NCT01664975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448063|NCT01664962|||Case Control||Cross-Sectional|||||||
1448064|NCT01664949|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448065|NCT01664936|||Cohort||Prospective|||||||
1448066|NCT01664923|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448067|NCT01664910||Single Group Assignment||Treatment||None (Open Label)||||||
1448068|NCT01664897||Single Group Assignment||Treatment||None (Open Label)||||||
1448069|NCT01664884|||Ecologic or Community||Cross-Sectional|||||||
1448070|NCT01664871||Single Group Assignment||Treatment||None (Open Label)||||||
1448071|NCT01664858|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1448072|NCT01664845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448073|NCT01664832|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1448074|NCT01664819|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1448075|NCT01664806|Randomized|Parallel Assignment||Basic Science||Single||||||t
1448076|NCT01664793|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1448077|NCT01664780|||Cohort||Prospective|||||||
1448078|NCT01664767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448079|NCT01664754||Single Group Assignment||Treatment||None (Open Label)||||||
1448080|NCT01664741|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448081|NCT01664728||Single Group Assignment||Treatment||None (Open Label)||||||
1448082|NCT01664715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448083|NCT01664702|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1448084|NCT01664689|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448085|NCT01664676|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1448086|NCT01664663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448087|NCT01664650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448088|NCT01664637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448089|NCT01664624|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448090|NCT01664611|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448091|NCT01664598||Single Group Assignment||Treatment||None (Open Label)||||||
1448092|NCT01664585|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448093|NCT01664572|||||Prospective|||||||
1448094|NCT01664559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448095|NCT01664546|||Case-Only||Prospective|||||||
1448096|NCT01664533|||Cohort||Prospective|||||||
1448097|NCT01664520||Single Group Assignment||Basic Science||None (Open Label)||||||
1448098|NCT01664507|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448099|NCT01664494|||Cohort||Prospective|||||||
1448100|NCT01664273||Single Group Assignment||Treatment||None (Open Label)||||||
1448101|NCT01664260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448102|NCT01664247|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448103|NCT01664234|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1448104|NCT01664221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448105|NCT01664195|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448106|NCT01664182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448107|NCT01664169|||Cohort||Retrospective|||||||
1448108|NCT01664156|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448109|NCT01664143|Randomized|Parallel Assignment||||Double|||t||t|
1448110|NCT01664130||Single Group Assignment||Treatment||None (Open Label)||||||
1448111|NCT01664117|||Cohort||Cross-Sectional|||||||
1448112|NCT01664104|||Cohort||Prospective|||||||
1448113|NCT01664091||Single Group Assignment||Treatment||None (Open Label)||||||
1448114|NCT01664078||Single Group Assignment||Treatment||None (Open Label)||||||
1448115|NCT01664065|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1448116|NCT01664052|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1448117|NCT01664039|Randomized|Parallel Assignment||Treatment||Single||||||t
1448118|NCT01664026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448119|NCT01664013||Single Group Assignment||Treatment||None (Open Label)||||||
1448120|NCT01664000||Single Group Assignment||Treatment||None (Open Label)||||||
1448121|NCT01663987|Randomized|Parallel Assignment||Treatment||Double||||||
1448122|NCT01663974|||Cohort||Prospective|||||||
1448123|NCT01663961||Single Group Assignment||Basic Science||None (Open Label)||||||
1448124|NCT01663948|||Cohort||Prospective|||||||
1448125|NCT01663935||Single Group Assignment||Treatment||None (Open Label)||||||
1448126|NCT01663922|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1448127|NCT01663909|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448128|NCT01663896|||Case Control||Prospective|||||||
1448129|NCT01663883||Single Group Assignment||Basic Science||None (Open Label)||||||
1448130|NCT01663870|||Cohort||Prospective|||||||
1448131|NCT01663857|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448132|NCT01663844|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1448133|NCT01663831|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448134|NCT01663818||Single Group Assignment||Treatment||None (Open Label)||||||
1448135|NCT01663805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448136|NCT01663792|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1448137|NCT01663779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448138|NCT01663766||Single Group Assignment||Treatment||None (Open Label)||||||
1448139|NCT01663753||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448140|NCT01663740|Randomized|||Other||None (Open Label)||||||
1448141|NCT01663727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448142|NCT01663714|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448143|NCT01663701|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448144|NCT01663688|||Case-Only||Prospective|||||||
1448145|NCT01663675|||Cohort||Prospective|||||||
1448146|NCT01663662|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448147|NCT01663649|Randomized|Parallel Assignment||Treatment||Single||||||t
1448148|NCT01663636|||Cohort||Prospective|||||||
1448149|NCT01663623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448150|NCT01663610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448151|NCT01663597|||Cohort||Prospective|||||||
1448152|NCT01663584||||||||||||
1448153|NCT01663571|||Case-Only||Prospective|||||||
1448154|NCT01663558|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448155|NCT01663545|||Cohort||Prospective|||||||
1448156|NCT01663532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448157|NCT01663519|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448158|NCT01663506|||Cohort||Prospective|||||||
1448159|NCT01663493|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1448160|NCT01663480|||Case-Only||Prospective|||||||
1448161|NCT01663467|Randomized|Parallel Assignment||Treatment||Single||||||t
1448162|NCT01663454||Single Group Assignment||Treatment||None (Open Label)||||||
1448163|NCT01663441|Randomized|Crossover Assignment||Prevention||Single|||t|||
1448164|NCT01663428|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448165|NCT01663415||Single Group Assignment||Treatment||None (Open Label)||||||
1448166|NCT01663402|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1448167|NCT01663389|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448168|NCT01663376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448169|NCT01663363||Single Group Assignment||Treatment||None (Open Label)||||||
1448170|NCT01663350|||Cohort||Prospective|||||||
1448171|NCT01663337|Randomized|Parallel Assignment||Treatment||Single||||||t
1448172|NCT01663324|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448173|NCT01663311|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448174|NCT01663298|||Cohort||Prospective|||||||
1448175|NCT01663285||Single Group Assignment||Treatment||None (Open Label)||||||
1448176|NCT01663272||Single Group Assignment||Treatment||None (Open Label)||||||
1448177|NCT01663259||Single Group Assignment||Treatment||None (Open Label)||||||
1448178|NCT01663246|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448179|NCT01663233|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448180|NCT01663220|||Case-Crossover||Prospective|||||||
1448181|NCT01663207|||Case-Crossover||Prospective|||||||
1448182|NCT01663194|||Cohort||Prospective|||||||
1448183|NCT01663181|||Cohort||Prospective|||||||
1448184|NCT01663168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448185|NCT01663155|||Cohort||Prospective|||||||
1448186|NCT01663142|||Cohort||Prospective|||||||
1448187|NCT01663129|||Cohort||Prospective|||||||
1448188|NCT01663116|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448189|NCT01663103|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1448190|NCT01663090||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448191|NCT01663077||Single Group Assignment||Treatment||None (Open Label)||||||
1448192|NCT01663064||Single Group Assignment||Treatment||None (Open Label)||||||
1448193|NCT01663051|||Cohort||Prospective|||||||
1448194|NCT01663038|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448195|NCT01663025|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448196|NCT01663012||Single Group Assignment||Treatment||None (Open Label)||||||
1448197|NCT01662999|Randomized|Crossover Assignment||||None (Open Label)||||||
1448198|NCT01662986|Randomized|Parallel Assignment||Treatment||Double||||||
1448199|NCT01662973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448200|NCT01662960|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1448201|NCT01662947|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1448202|NCT01662934|Randomized|Parallel Assignment||Treatment||Single|||||t|
1448203|NCT01662921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448204|NCT01662908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448205|NCT01662895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448206|NCT01662882|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1448207|NCT01662869|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448208|NCT01662856|Randomized|Parallel Assignment||Treatment||||||||
1448209|NCT01662843|||Case Control||Prospective|||||||
1448210|NCT01662830|||Case-Only||Retrospective|||||||
1448211|NCT01662817|||Cohort||Prospective|||||||
1448212|NCT01662804||Single Group Assignment||Treatment||None (Open Label)||||||
1448213|NCT01662791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448214|NCT01662778|Randomized|Crossover Assignment||Treatment||Single|||t|||
1448215|NCT01662765|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448216|NCT01662752||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448217|NCT01662739|||Cohort||Prospective|||||||
1448218|NCT01662726||Single Group Assignment||Treatment||None (Open Label)||||||
1448219|NCT01662713||Single Group Assignment||Other||None (Open Label)||||||
1448220|NCT01662700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448221|NCT01662687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448222|NCT01662674|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448223|NCT01662661|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448224|NCT01662648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448225|NCT01662635|||Cohort||Cross-Sectional|||||||
1448226|NCT01662622||Single Group Assignment||Treatment||None (Open Label)||||||
1448227|NCT01662609|||Case-Only||Prospective|||||||
1448228|NCT01662596|||||Cross-Sectional|||||||
1448229|NCT01662583|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1448230|NCT01662570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448231|NCT01662557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448232|NCT01662544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448233|NCT01662531||Single Group Assignment||Treatment||None (Open Label)||||||
1448234|NCT01662518||Single Group Assignment||Treatment||None (Open Label)||intervention group: 25-gauge biodegradable implant containing 350 μg of dexamethasone (DDS-25) for the treatment of decreased vision due to macular edema associated with central or branch retinal vein occlusion.||||
1448235|NCT01662505||Single Group Assignment||Treatment||None (Open Label)||||||
1448236|NCT01662492|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448237|NCT01662479||||||||||||
1448238|NCT01662466|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1448239|NCT01662453|||Case-Control||Retrospective|||||||
1448240|NCT01662440|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1448241|NCT01662427|||Cohort||Prospective|||||||
1448242|NCT01662414|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1448243|NCT01662401|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1448244|NCT01662388|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1448245|NCT01662375|||Family-Based||Prospective|||||||
1448246|NCT01662362||Single Group Assignment||||None (Open Label)||||||
1448247|NCT01662349||Single Group Assignment||Treatment||None (Open Label)||||||
1448248|NCT01662336|||Case-Only||Prospective|||||||
1448249|NCT01662323|Randomized|Parallel Assignment||Treatment||Single||||t||
1448250|NCT01662310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448251|NCT01662297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448252|NCT01662284|||Case-Only||Prospective|||||||
1448253|NCT01662271|||Cohort||Prospective|||||||
1448254|NCT01662258|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448255|NCT01662232|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1448256|NCT01662219|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1448257|NCT01662206|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1448258|NCT01662193|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448259|NCT01662180|||Cohort||Prospective|||||||
1448260|NCT01662167|Randomized|Parallel Assignment||Treatment||Single||||||t
1448261|NCT01662154|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448262|NCT01662141|||||Prospective|||||||
1448263|NCT01662128||Single Group Assignment||Treatment||None (Open Label)||||||
1448264|NCT01662115|Randomized|Factorial Assignment||Treatment||Single|||||t|
1448265|NCT01662102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448266|NCT01662089|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1448267|NCT01662076||Single Group Assignment||||None (Open Label)||||||
1448268|NCT01662063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448269|NCT01662050||Single Group Assignment||Treatment||None (Open Label)||||||
1448270|NCT01662037|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448271|NCT01662024||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1448272|NCT01662011|Randomized|Parallel Assignment||Treatment||Single||||||t
1448273|NCT01661998|||Case-Control||Prospective|||||||
1448274|NCT01661985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448275|NCT01661972|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1448276|NCT01661959|||Case-Control||Prospective|||||||
1448277|NCT01661946|Randomized|Parallel Assignment||||None (Open Label)||||||
1448278|NCT01661933||Single Group Assignment||Prevention||Single||||||t
1448279|NCT01661920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448280|NCT01661907|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448281|NCT01661894|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448282|NCT01661881||Single Group Assignment||Treatment||None (Open Label)||||||
1448283|NCT01661868|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448284|NCT01661855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448285|NCT01661842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448286|NCT01661829|||Cohort||Prospective|||||||
1448287|NCT01661816|||Cohort||Prospective|||||||
1448288|NCT01661803|||Case Control||Prospective|||||||
1448289|NCT01661790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448290|NCT01661777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448291|NCT01661764|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1448292|NCT01661751|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1448293|NCT01661738||Single Group Assignment||Prevention||None (Open Label)||||||
1448294|NCT01661725||Single Group Assignment||Prevention||None (Open Label)||||||
1448295|NCT01661712|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1448296|NCT01661699|||Case-Only||Prospective|||||||
1448297|NCT01661686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448298|NCT01661673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448299|NCT01661660|Non-Randomized|Parallel Assignment||||Single||||||t
1448300|NCT01661647||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448301|NCT01661634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448302|NCT01661621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448303|NCT01661608||Single Group Assignment||Basic Science||None (Open Label)||||||
1448304|NCT01661595|Randomized|Crossover Assignment||Treatment||Triple||"Subjects were assigned to one of 4 arms:~Sildenafil (50mg/day) for weeks 0-4. Placebo for weeks 5-8.~Tadalafil (10mg/day) for weeks 0-4. Placebo for weeks 5-8.~Placebo for weeks 0-4. Sildenafil (50mg/day) for weeks 5-8.~Placebo for weeks 0-4. Tadalafil (10mg/day) for weeks 5-8."|t|t|t|
1448305|NCT01661582|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1448306|NCT01661569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448307|NCT01661556|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448308|NCT01661543|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1448309|NCT01661530|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1448310|NCT01661517||Single Group Assignment||Screening||None (Open Label)||||||
1448311|NCT01661504|Randomized|Parallel Assignment||Screening||Single|||t|||
1448312|NCT01661491|||Case-Control||Prospective|||||||
1448313|NCT01661478|||Cohort||Cross-Sectional|||||||
1448314|NCT01661465|||||Retrospective|||||||
1448315|NCT01661452|||||Cross-Sectional|||||||
1448316|NCT01661439|||Cohort||Prospective|||||||
1448317|NCT01661426|Randomized|Crossover Assignment||Prevention||Quadruple||The study employed a 2 x 2 crossover design: LF vs. LC diets and more IR vs. more IS. Study participants were classified as more IR or more IS based on the median AUC for insulin concentrations measured from an oral glucose tolerance test (OGTT) prior to randomization. Participants above the median were considered more IR and those below the median were considered more IS. A random number generator was used to stratify the randomization to LF vs. LC by insulin resistance status and gender. Participants followed their assigned diet for 6 months and then switched to the opposite diet for another 6 months.|t|t|t|t
1448318|NCT01661413|||Cohort||Prospective|||||||
1448319|NCT01661400|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448320|NCT01661387|||Case-Only||Prospective|||||||
1448321|NCT01661374|||Case Control||Prospective|||||||
1448322|NCT01661361|||Cohort||Prospective|||||||
1448323|NCT01661348|||Case Control||Prospective|||||||
1448324|NCT01661335|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1448325|NCT01661322|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448326|NCT01661309|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1448327|NCT01661296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448328|NCT01661283||Single Group Assignment||Treatment||None (Open Label)||||||
1448329|NCT01661270|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448330|NCT01661257||Single Group Assignment||Basic Science||None (Open Label)||||||
1448331|NCT01661244|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448332|NCT01661231||Single Group Assignment||Treatment||None (Open Label)||||||
1448333|NCT01661218|||Cohort||Prospective|||||||
1448334|NCT01661205||Single Group Assignment||Treatment||None (Open Label)||||||
1448335|NCT01661192|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448336|NCT01661179||Single Group Assignment||Treatment||None (Open Label)||||||
1448337|NCT01661166||||Treatment||||||||
1448338|NCT01661153|||Cohort||Prospective|||||||
1448339|NCT01661140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448340|NCT01661127|||Case-Only||Prospective|||||||
1448341|NCT01661114||Single Group Assignment||Treatment||None (Open Label)||||||
1448342|NCT01661101|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1448343|NCT01661088||Single Group Assignment||Treatment||None (Open Label)||||||
1448344|NCT01661075|||Ecologic or Community||Prospective|||||||
1448345|NCT01661062||Single Group Assignment||Treatment||None (Open Label)||||||
1448346|NCT01661049|||Cohort||Retrospective|||||||
1448347|NCT01661036|||Other||Cross-Sectional|||||||
1448348|NCT01661023|||Case-Control||Retrospective|||||||
1448349|NCT01661010|||||Other|||||||
1448350|NCT01660997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448351|NCT01660984|||Cohort||Prospective|||||||
1448352|NCT01660971||Single Group Assignment||Treatment||None (Open Label)||||||
1448353|NCT01660958|Randomized|Factorial Assignment||Prevention||Quadruple||"The infant phase is a factorial design.~The preschool phase is a cluster-randomized trial (MNP/placebo nested within high/low-quality preschools)."|t|t|t|t
1448354|NCT01660945|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448355|NCT01660932|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448356|NCT01660919|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448357|NCT01660906||Single Group Assignment||Treatment||None (Open Label)||||||
1448358|NCT01660893|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448359|NCT01660880|||Case-Only||Cross-Sectional|||||||
1448360|NCT01660867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448361|NCT01660854|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1448362|NCT01660841||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448363|NCT01660828|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448364|NCT01660815||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448365|NCT01660802|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448366|NCT01660789||Single Group Assignment||Treatment||None (Open Label)||||||
1448367|NCT01660776|||Case-Crossover||Prospective|||||||
1448368|NCT01660763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448369|NCT01660750||Single Group Assignment||Treatment||None (Open Label)||||||
1448370|NCT01660737|||Cohort||Prospective|||||||
1448371|NCT01660724|Randomized|Parallel Assignment||||Single|||||t|
1448372|NCT01660711||Single Group Assignment||Treatment||None (Open Label)||||||
1448373|NCT01660698|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448374|NCT01660685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448375|NCT01660672||Single Group Assignment||Treatment||None (Open Label)||||||
1448376|NCT01660659|Randomized|Parallel Assignment||Other||Single|||||t|
1448377|NCT01660646|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1448378|NCT01660633||Single Group Assignment||Treatment||None (Open Label)||||||
1448379|NCT01660620|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1448380|NCT01660607||Single Group Assignment||Treatment||None (Open Label)||||||
1448381|NCT01660594|||Cohort||Retrospective|||||||
1448382|NCT01660581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448383|NCT01660568|||Cohort||Retrospective|||||||
1448384|NCT01660555|||Case-Only||Cross-Sectional|||||||
1448385|NCT01660542||Single Group Assignment||Treatment||None (Open Label)||||||
1448386|NCT01660529||Single Group Assignment||Treatment||||||||
1448387|NCT01660516|||Case-Crossover||Cross-Sectional|||||||
1448388|NCT01660503|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1448389|NCT01660490|||Case-Only||Retrospective|||||||
1448390|NCT01660477|Randomized|Parallel Assignment||||None (Open Label)||||||
1448391|NCT01660464||Single Group Assignment||Treatment||None (Open Label)||||||
1448392|NCT01660451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448393|NCT01660438|||Cohort||Prospective|||||||
1448394|NCT01660425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448395|NCT01660412|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1448396|NCT01660399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448397|NCT01660386|Randomized|Crossover Assignment||||None (Open Label)||||||
1448398|NCT01660373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448399|NCT01660360||Single Group Assignment||Treatment||None (Open Label)||||||
1448400|NCT01660347||Single Group Assignment||Supportive Care||None (Open Label)||||||
1448401|NCT01660334|||Case-Only||Retrospective|||||||
1448402|NCT01660321||Single Group Assignment||Health Services Research||None (Open Label)||||||
1448403|NCT01660308|||Case Control||Prospective|||||||
1448404|NCT01660295|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448405|NCT01660256|Randomized|Parallel Assignment||Treatment||Single||||||t
1448406|NCT01660243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448407|NCT01660230|Randomized|Parallel Assignment||Other||Double|||t||t|
1448408|NCT01660217|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1448409|NCT01660204|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448410|NCT01660191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448411|NCT01660178|||||Retrospective|||||||
1448412|NCT01660165|||Cohort||Prospective|||||||
1448413|NCT01660152|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448414|NCT01660139|||Other||Prospective|||||||
1448415|NCT01660126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448416|NCT01660113||||||||||||
1448417|NCT01660100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448418|NCT01660087||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448419|NCT01660074|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1448420|NCT01660061|||Cohort||Prospective|||||||
1448421|NCT01660048|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448422|NCT01660035|||Cohort||Prospective|||||||
1448423|NCT01660022|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1448424|NCT01660009|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1448425|NCT01659996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448426|NCT01659983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448427|NCT01659970|||Cohort||Prospective|||||||
1448428|NCT01659957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448429|NCT01659944||Crossover Assignment||Basic Science||None (Open Label)||||||
1448430|NCT01659931|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448431|NCT01659918|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448432|NCT01659905|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448433|NCT01659892|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448434|NCT01659879|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1448435|NCT01659866|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448436|NCT01659853|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1448437|NCT01659840|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448438|NCT01659827|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448439|NCT01659814|||Case Control|||||||||
1448440|NCT01659801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448441|NCT01659788|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1448442|NCT01659775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448443|NCT01659762||Single Group Assignment||Treatment||None (Open Label)||||||
1448444|NCT01659749||Single Group Assignment||Prevention||None (Open Label)||||||
1448445|NCT01659736|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448446|NCT01659723|Randomized|Parallel Assignment||Treatment||Single||||||t
1448447|NCT01659710|||Case Control||Prospective|||||||
1448448|NCT01659697|||Family-Based||Prospective|||||||
1448449|NCT01659684||Single Group Assignment||Prevention||None (Open Label)||||||
1448450|NCT01659671|Randomized|Parallel Assignment||Treatment||Single||||||t
1448451|NCT01659658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448452|NCT01659645||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448453|NCT01659632|||Case-Only||Retrospective|||||||
1448454|NCT01659619|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1448455|NCT01659606||Single Group Assignment||Treatment||None (Open Label)||||||
1448456|NCT01659593|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448457|NCT01659580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448458|NCT01659567|||Cohort||Prospective|||||||
1448459|NCT01659554||Single Group Assignment||Treatment||None (Open Label)||||||
1448460|NCT01659541||Single Group Assignment||Treatment||None (Open Label)||||||
1448461|NCT01659528|||Cohort||Prospective|||||||
1448462|NCT01659515||||||||||||
1448463|NCT01659502||Single Group Assignment||Treatment||None (Open Label)||||||
1448464|NCT01659489|||Cohort||Prospective|||||||
1448465|NCT01659476|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1448466|NCT01659463|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1448467|NCT01659450|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1448468|NCT01659437|Randomized|Parallel Assignment||Treatment||Single||||||t
1448469|NCT01659424||Single Group Assignment||Treatment||None (Open Label)||||||
1448470|NCT01659411|||Cohort||Prospective|||||||
1448471|NCT01659398|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448472|NCT01659385|||Other||Cross-Sectional|||||||
1448473|NCT01659372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448474|NCT01659359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448475|NCT01659346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448476|NCT01659333|||Cohort||Cross-Sectional|||||||
1448477|NCT01659320||Single Group Assignment||Treatment||None (Open Label)||||||
1448478|NCT01659307|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1448479|NCT01659294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448480|NCT01659281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448481|NCT01659268|Randomized|Parallel Assignment||||Single||||||t
1448482|NCT01659255||Single Group Assignment||Treatment||None (Open Label)||||||
1448483|NCT01659242|Randomized|Parallel Assignment||Treatment||Single||||||t
1448484|NCT01659229|||Cohort||Prospective|||||||
1448485|NCT01659216|||Cohort||Prospective|||||||
1448486|NCT01659203|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448487|NCT01659190|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448488|NCT01659177|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1448489|NCT01659164||Single Group Assignment||Treatment||None (Open Label)||||||
1448490|NCT01659151||Single Group Assignment||Treatment||None (Open Label)||||||
1448491|NCT01659138|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448492|NCT01659125||Single Group Assignment||Treatment||None (Open Label)||||||
1448493|NCT01659112|Randomized|Parallel Assignment||Treatment||Single||||||t
1448494|NCT01659099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448495|NCT01659086|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1448496|NCT01659073||Single Group Assignment||Basic Science||None (Open Label)||||||
1448497|NCT01659060|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1448498|NCT01659047||Single Group Assignment||Treatment||None (Open Label)||||||
1448499|NCT01659034||Single Group Assignment||Treatment||None (Open Label)||||||
1448500|NCT01659021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448810|NCT01654926|||Cohort||Prospective|||||||
1448501|NCT01659008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448502|NCT01658995|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448503|NCT01658982|||Cohort||Prospective|||||||
1448504|NCT01658956|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448505|NCT01658943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448506|NCT01658930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448507|NCT01658917|||Case-Only||Prospective|||||||
1448508|NCT01658904|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448509|NCT01658891|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1448510|NCT01658878|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448511|NCT01658865|||Case-Only||Prospective|||||||
1448512|NCT01658852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448513|NCT01658839||Single Group Assignment||Treatment||None (Open Label)||||||
1448514|NCT01658826|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1448515|NCT01658813||Single Group Assignment||Treatment||None (Open Label)||||||
1448516|NCT01658800||Single Group Assignment||Prevention||None (Open Label)||||||
1448517|NCT01658787|||Cohort||Prospective|||||||
1448518|NCT01658774|Randomized|Single Group Assignment||Treatment||Single||||||t
1448519|NCT01658761||Single Group Assignment||Treatment||Single|||||t|
1448520|NCT01658748|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1448521|NCT01658735|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448522|NCT01658722|||||Prospective|||||||
1448523|NCT01658709|||Cohort||Prospective|||||||
1448524|NCT01658696|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1448525|NCT01658683|Randomized|Parallel Assignment||Prevention||Single|||||t|
1448526|NCT01658670|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1448527|NCT01658657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448528|NCT01658644|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448529|NCT01658631|||Cohort||Prospective|||||||
1448530|NCT01658618|||Cohort||Prospective|||||||
1448531|NCT01658605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448532|NCT01658592|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1448533|NCT01658579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448534|NCT01658553||Single Group Assignment||Basic Science||Single|||t|||
1448535|NCT01658540|||Case-Only||Prospective|||||||
1448536|NCT01658527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448537|NCT01658514|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1448538|NCT01658501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448539|NCT01658488|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448540|NCT01658475|||Cohort||Prospective|||||||
1448541|NCT01658462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448542|NCT01658449|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1448543|NCT01658436||Single Group Assignment||Treatment||None (Open Label)||||||
1448544|NCT01658423|||Cohort||Cross-Sectional|||||||
1448545|NCT01658410|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1448546|NCT01658397||Single Group Assignment||Other||None (Open Label)||||||
1448547|NCT01658384|||Cohort||Prospective|||||||
1448548|NCT01658371|||||Cross-Sectional|||||||
1448549|NCT01658358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448550|NCT01658345|||Cohort||Prospective|||||||
1448551|NCT01658332||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448552|NCT01658319||Single Group Assignment||Treatment||None (Open Label)||||||
1448553|NCT01658306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448554|NCT01658293|Randomized|Parallel Assignment||Treatment||Single||||||t
1448555|NCT01658280|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1448556|NCT01658267||Single Group Assignment||Treatment||None (Open Label)||||||
1448557|NCT01658254|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1448558|NCT01658241||Single Group Assignment||Basic Science||None (Open Label)||||||
1448559|NCT01658228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448560|NCT01658215|Randomized|Crossover Assignment||||None (Open Label)||||||
1448561|NCT01658202|Randomized|Crossover Assignment||||None (Open Label)||||||
1448562|NCT01658189||||||||||||
1448563|NCT01658176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448564|NCT01658163|||Case Control||Prospective|||||||
1448565|NCT01658150||Single Group Assignment||Supportive Care||None (Open Label)||||||
1448566|NCT01658137|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448567|NCT01658124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448568|NCT01658111|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1448569|NCT01658098|||||Prospective|||||||
1448570|NCT01658085|||Case Control||Prospective|||||||
1448571|NCT01658072|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1448572|NCT01658059|Randomized|Crossover Assignment||||Triple|||t|t|t|
1448573|NCT01658046|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448574|NCT01658033||Single Group Assignment||Treatment||None (Open Label)||||||
1448575|NCT01658020|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448576|NCT01658007||Single Group Assignment||Treatment||None (Open Label)||||||
1448577|NCT01657994||Single Group Assignment||Treatment||None (Open Label)||||||
1448578|NCT01657981|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1448579|NCT01657968|||Case Control||Prospective|||||||
1448580|NCT01657955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448581|NCT01657942||Single Group Assignment||Treatment||None (Open Label)||||||
1448582|NCT01657929|Randomized|Single Group Assignment||Prevention||Single||||||t
1448583|NCT01657916|||Cohort||Prospective|||||||
1448584|NCT01657903|Randomized|Crossover Assignment||Treatment||Single|||||t|
1448585|NCT01657890|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1448586|NCT01657877|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1448587|NCT01657864|||||Cross-Sectional|||||||
1448588|NCT01657851|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448589|NCT01657838|Randomized|Parallel Assignment||||None (Open Label)||||||
1448590|NCT01657825||Single Group Assignment||||None (Open Label)||||||
1448591|NCT01657812|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1448592|NCT01657799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448593|NCT01657786||Single Group Assignment||||None (Open Label)||||||
1448594|NCT01657773|||Case Control||Cross-Sectional|||||||
1448595|NCT01657760|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1448596|NCT01657747||Single Group Assignment||Diagnostic||Single|||||t|
1448597|NCT01657734|||Case-Only||Prospective|||||||
1448598|NCT01657721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448599|NCT01657708|Randomized|Crossover Assignment||||Double|||t|t||
1448600|NCT01657695|||Cohort||Prospective|||||||
1448601|NCT01657682|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448602|NCT01657669||Single Group Assignment||Treatment||None (Open Label)||||||
1448603|NCT01657656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448604|NCT01657643|Randomized|Parallel Assignment||||Triple|||t||t|t
1448605|NCT01657630|||Case-Only||Prospective|||||||
1448606|NCT01657617||Single Group Assignment||Treatment||None (Open Label)||||||
1448607|NCT01657604|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1448608|NCT01657591||Single Group Assignment||Treatment||None (Open Label)||||||
1448609|NCT01657578|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1448610|NCT01657565|||||Retrospective|||||||
1448611|NCT01657552|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1448612|NCT01657539|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1448613|NCT01657526|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1448614|NCT01657513||Single Group Assignment||Treatment||None (Open Label)||||||
1448615|NCT01657500|Randomized|Parallel Assignment||||Double|||t|||t
1448616|NCT01657487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448617|NCT01657474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448618|NCT01657461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448619|NCT01657448|Randomized|Parallel Assignment||Treatment||Single|||||t|
1448620|NCT01657435||Single Group Assignment||Treatment||None (Open Label)||||||
1448621|NCT01657422|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448622|NCT01657409|Randomized|Parallel Assignment||Treatment||Single|Participants did not aware how many injections were performed|Patients were randomized to receive different injection number of onabotulinumtoxinA|t|||
1448623|NCT01657396|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448624|NCT01657383|||Cohort||Prospective|||||||
1448625|NCT01657370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448626|NCT01657357|||Cohort||Prospective|||||||
1448627|NCT01657344|||Cohort||Cross-Sectional|||||||
1448628|NCT01657331||Single Group Assignment||Treatment||None (Open Label)||||||
1448629|NCT01657318|||Cohort||Prospective|||||||
1448630|NCT01657305|Randomized|Single Group Assignment||Treatment||Single||||||t
1448631|NCT01657292|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448632|NCT01657279||Single Group Assignment||Diagnostic||Double|||||t|t
1448633|NCT01657266|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448634|NCT01657253|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448635|NCT01657240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448636|NCT01657227|Randomized|Parallel Assignment||Prevention||Single|Participating FCUs were not told about their intervention assignment (groups 1-4) until the last patient agreed to participate at every FCU. To warrant patient participation and cooperation, interventions could neither be blinded to patients nor to healthcare professionals. Data analysis is blinded to the intervention assignment.|||||t
1448637|NCT01657214||Single Group Assignment||Treatment||None (Open Label)||||||
1448638|NCT01657201|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448639|NCT01657188|||Cohort||Prospective|||||||
1448640|NCT01657175|Randomized|Parallel Assignment||Prevention||Single||||t||
1448641|NCT01657162||Single Group Assignment||Treatment||None (Open Label)||||||
1448642|NCT01657149|Randomized|Parallel Assignment||Treatment||Single||||||t
1448643|NCT01657136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448644|NCT01657123|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1448645|NCT01657110||Single Group Assignment||Treatment||None (Open Label)||||||
1448646|NCT01657097|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1448647|NCT01657084|Randomized|Crossover Assignment||Treatment||Single|||t|||
1448648|NCT01657071|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448649|NCT01657058|Randomized|Crossover Assignment||Treatment||Single|||t|||
1448650|NCT01657045|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1448651|NCT01657032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448652|NCT01657019||Single Group Assignment||Treatment||None (Open Label)||||||
1448653|NCT01657006|||Cohort||Prospective|||||||
1448654|NCT01656993|||Cohort||Prospective|||||||
1448655|NCT01656980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448656|NCT01656967|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1448657|NCT01656954|||||Prospective|||||||
1448658|NCT01656941|||Cohort||Prospective|||||||
1448659|NCT01656928|Randomized|Parallel Assignment||Prevention||Single||||||t
1448660|NCT01656915|||Case Control|||||||||
1448661|NCT01656902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448662|NCT01656889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448663|NCT01656876|Randomized|Factorial Assignment||Treatment||Single|||||t|
1448664|NCT01656863|||Case-Only||Prospective|||||||
1448665|NCT01656850|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448666|NCT01656837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448667|NCT01656824||||||||||||
1448668|NCT01656811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448669|NCT01656798|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1448670|NCT01656785||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448671|NCT01656772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448672|NCT01656759|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1448673|NCT01656746||Single Group Assignment||Treatment||None (Open Label)||||||
1448674|NCT01656733|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448675|NCT01656720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448676|NCT01656707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448677|NCT01656694|||Cohort||Other|||||||
1448678|NCT01656681|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1448679|NCT01656668|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448680|NCT01656655|||Cohort||Cross-Sectional|||||||
1448681|NCT01656642|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1448682|NCT01656629|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1448683|NCT01656616|||Cohort||Retrospective|||||||
1448684|NCT01656603||Single Group Assignment||Treatment||None (Open Label)||||||
1448685|NCT01656590||Single Group Assignment||Treatment||None (Open Label)||||||
1448686|NCT01656577|Randomized|Parallel Assignment||Treatment||Double||||||
1448687|NCT01656564|||Cohort||Prospective|||||||
1448688|NCT01656551|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1448689|NCT01656538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448690|NCT01656525|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448691|NCT01656512|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448692|NCT01656499|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1448693|NCT01656486||Single Group Assignment||Supportive Care||None (Open Label)||||||
1448694|NCT01656473||Single Group Assignment||Treatment||None (Open Label)||||||
1448695|NCT01656460|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448696|NCT01656447|||Cohort||Prospective|||||||
1448697|NCT01656434|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448698|NCT01656421|||Cohort||Prospective|||||||
1448699|NCT01656408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448700|NCT01656395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448701|NCT01656382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448702|NCT01656369|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448703|NCT01656356||||||||||||
1448704|NCT01656343|||Cohort||Retrospective|||||||
1448705|NCT01656330|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1448706|NCT01656317|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448707|NCT01656304||Single Group Assignment||Treatment||None (Open Label)||||||
1448708|NCT01656278|Randomized|Parallel Assignment||Treatment||Single||||||t
1448709|NCT01656265||Single Group Assignment||Treatment||None (Open Label)||||||
1448710|NCT01656252|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448711|NCT01656239|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448712|NCT01656226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448713|NCT01656213|Randomized|Parallel Assignment||Treatment||Single||||||t
1448714|NCT01656200||Single Group Assignment||Basic Science||None (Open Label)||||||
1448715|NCT01656187|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1448716|NCT01656174|||Cohort||Prospective|||||||
1448717|NCT01656161||Single Group Assignment||Treatment||None (Open Label)||||||
1448718|NCT01656148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448719|NCT01656135||Single Group Assignment||Basic Science||None (Open Label)||||||
1448720|NCT01656122||Single Group Assignment||Treatment||None (Open Label)||||||
1448721|NCT01656109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448722|NCT01656096|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448723|NCT01656083|||Case Control||Cross-Sectional|||||||
1448724|NCT01656070|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1448725|NCT01656057|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1448726|NCT01656044|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448727|NCT01656031||Single Group Assignment||Treatment||None (Open Label)||||||
1448728|NCT01656018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448729|NCT01656005|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448730|NCT01655992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448731|NCT01655979|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448732|NCT01655966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448733|NCT01655953|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1448734|NCT01655940|||Case-Only||Prospective|||||||
1448735|NCT01655927|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1448736|NCT01655914|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448737|NCT01655901|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1448738|NCT01655888||Single Group Assignment||Treatment||None (Open Label)||||||
1448739|NCT01655875||Single Group Assignment||Treatment||None (Open Label)||||||
1448740|NCT01655862|||Case-Only||Prospective|||||||
1448741|NCT01655849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448742|NCT01655836||Single Group Assignment||Treatment||None (Open Label)||||||
1448743|NCT01655823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448744|NCT01655810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448745|NCT01655797|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448746|NCT01655784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448747|NCT01655771|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448748|NCT01655758|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1448749|NCT01655745|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1448750|NCT01655732||Single Group Assignment||Treatment||None (Open Label)||||||
1448751|NCT01655719||Single Group Assignment||Treatment||None (Open Label)||||||
1448752|NCT01655706|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1448753|NCT01655693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448754|NCT01655680|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448755|NCT01655667|||Cohort||Retrospective|||||||
1448756|NCT01655654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448757|NCT01655641|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448758|NCT01655628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448759|NCT01655615||Single Group Assignment||Prevention||None (Open Label)||||||
1448760|NCT01655602|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1448761|NCT01655589|||Case-Only||Retrospective|||||||
1448762|NCT01655576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448763|NCT01655563|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1448764|NCT01655550|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1448765|NCT01655537|||Case-Only||Prospective|||||||
1448766|NCT01655524||Single Group Assignment||Diagnostic||Single||||||t
1448767|NCT01655511|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1448768|NCT01655498||Single Group Assignment||Treatment||None (Open Label)||||||
1448769|NCT01655485||Single Group Assignment||Prevention||Single||||||t
1448770|NCT01655472|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1448771|NCT01655459|||Cohort||Cross-Sectional|||||||
1448772|NCT01655446|Randomized|Factorial Assignment||Treatment||Single||||||t
1448773|NCT01655433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448774|NCT01655420|||Cohort||Prospective|||||||
1448775|NCT01655407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448776|NCT01655394|||Cohort||Prospective|||||||
1448777|NCT01655381||Single Group Assignment||Treatment||None (Open Label)||||||
1448778|NCT01655368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448779|NCT01655355|||Cohort||Prospective|||||||
1448780|NCT01655342|||Cohort||Prospective|||||||
1448781|NCT01655329|||Case Control||Prospective|||||||
1448782|NCT01655316||Single Group Assignment||Treatment||Single|||t|||
1448783|NCT01655303|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1448784|NCT01655290|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1448785|NCT01655277|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448786|NCT01655264|Randomized|Parallel Assignment||Treatment||Single||||||t
1448787|NCT01655251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448788|NCT01655238|||Cohort||Retrospective|||||||
1448789|NCT01655225|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448790|NCT01655212|Randomized|Parallel Assignment||Treatment||Single||||||t
1448791|NCT01655199||Single Group Assignment||Diagnostic||Double|||t|||t
1448792|NCT01655186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448793|NCT01655173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448794|NCT01655160|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1448795|NCT01655147||Crossover Assignment||Treatment||None (Open Label)||||||
1448796|NCT01655134||Single Group Assignment||||None (Open Label)||||||
1448797|NCT01655121|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448798|NCT01655108|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1448799|NCT01655095|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1448800|NCT01655082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448801|NCT01655069|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448802|NCT01655056|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1448803|NCT01655043||Single Group Assignment||Diagnostic||Single||||||t
1448804|NCT01655030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448805|NCT01655017|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1448806|NCT01655004||Single Group Assignment||Treatment||None (Open Label)||||||
1448807|NCT01654991|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1448808|NCT01654965||Single Group Assignment||Treatment||None (Open Label)||||||
1448809|NCT01654939||Single Group Assignment||Prevention||None (Open Label)||||||
1448811|NCT01654913||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448812|NCT01654900|||Cohort||Retrospective|||||||
1448813|NCT01654887|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1448814|NCT01654874|Non-Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1448815|NCT01654861||Single Group Assignment||Treatment||None (Open Label)||||||
1448816|NCT01654848|||Cohort||Prospective|||||||
1448817|NCT01654835|Randomized|Parallel Assignment||Other||Single|||t|||
1448818|NCT01654822|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1448819|NCT01654809|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1448820|NCT01654796|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448821|NCT01654783|||Cohort||Prospective|||||||
1448822|NCT01654770|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448823|NCT01654731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448824|NCT01654718|Randomized|Crossover Assignment||||None (Open Label)||||||
1448825|NCT01654705|Randomized|Crossover Assignment||||None (Open Label)||||||
1448826|NCT01654692||Single Group Assignment||Treatment||None (Open Label)||||||
1448827|NCT01654679|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1448828|NCT01654666|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1448829|NCT01654653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448830|NCT01654640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448831|NCT01654627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448832|NCT01654614|||Case Control||Prospective|||||||
1448833|NCT01654601|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1448834|NCT01654588|||Case-Only||Prospective|||||||
1448835|NCT01654575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448836|NCT01654562|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1448837|NCT01654549|Randomized|Parallel Assignment||Treatment||Double||||t||t
1448838|NCT01654536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448839|NCT01654523||Single Group Assignment||Treatment||None (Open Label)||||||
1448840|NCT01654510|Randomized|Parallel Assignment||Treatment||Single||||||t
1448841|NCT01654497||Single Group Assignment||Treatment||None (Open Label)||||||
1448842|NCT01654484|Randomized|Parallel Assignment||Treatment||Single|||||t|
1448843|NCT01654471|||Case-Only||Prospective|||||||
1448844|NCT01654458|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448845|NCT01654445||Single Group Assignment||Treatment||None (Open Label)||||||
1448846|NCT01654432|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1448847|NCT01654419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448848|NCT01654406|Randomized|Parallel Assignment||Treatment||Single||||||t
1448849|NCT01654393|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1448850|NCT01654380|Randomized|Crossover Assignment||||None (Open Label)||||||
1448851|NCT01654367||Single Group Assignment||Treatment||None (Open Label)||||||
1448852|NCT01654354|||Case Control||Prospective|||||||
1448853|NCT01654341|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448854|NCT01654328|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448855|NCT01654315|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1448856|NCT01654302|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1448857|NCT01654289|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448858|NCT01654276||Single Group Assignment||Treatment||None (Open Label)||||||
1448859|NCT01654263|Randomized|Parallel Assignment||Prevention||||||||
1448860|NCT01654250|Randomized|||Treatment||Quadruple|||t|t|t|t
1448861|NCT01654237||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448862|NCT01654224|Randomized|Parallel Assignment||Prevention||Single|||t|||
1448863|NCT01654211|Randomized|Crossover Assignment||||Single|||t|||
1448864|NCT01654198|||Case-Only||Cross-Sectional|||||||
1448865|NCT01654185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448866|NCT01654172|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1448867|NCT01654159|Randomized|Parallel Assignment||Treatment||Single|||||t|
1448868|NCT01654146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448869|NCT01654133||Single Group Assignment||Other||None (Open Label)||||||
1448870|NCT01654120|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448871|NCT01654107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448872|NCT01654094|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448873|NCT01654081||Single Group Assignment||Treatment||None (Open Label)||||||
1448874|NCT01654068|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448875|NCT01654055|||Cohort||Prospective|||||||
1448876|NCT01654042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448877|NCT01654029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448878|NCT01654016|Randomized|Parallel Assignment||Basic Science||Single||||||t
1448879|NCT01654003|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448880|NCT01653990|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1448881|NCT01653977|Randomized|Parallel Assignment||||None (Open Label)||||||
1448882|NCT01653964||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448883|NCT01653951|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1448884|NCT01653938|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1448885|NCT01653925|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1448886|NCT01653912||Single Group Assignment||Treatment||None (Open Label)||||||
1448887|NCT01653899||Single Group Assignment||Treatment||None (Open Label)||||||
1448888|NCT01653886|Randomized|Crossover Assignment||||Single|||t|||
1448889|NCT01653873|||Cohort||Retrospective|||||||
1448890|NCT01653860|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448891|NCT01653847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448892|NCT01653834||Single Group Assignment||Treatment||None (Open Label)||||||
1448893|NCT01653821||Single Group Assignment||Treatment||None (Open Label)||||||
1448894|NCT01653808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448895|NCT01653795|Randomized|Parallel Assignment||||Double|||t|||t
1448896|NCT01653782|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1448897|NCT01653769|||Cohort||Other|||||||
1448898|NCT01653756|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1448899|NCT01653743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448900|NCT01653730|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1448901|NCT01653717||Single Group Assignment||Treatment||None (Open Label)||||||
1448902|NCT01653704|Randomized|Single Group Assignment||||Double|||t|||t
1448903|NCT01653691|Randomized|Parallel Assignment||Treatment||Single||||||t
1448904|NCT01653678|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1448905|NCT01653665|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1448906|NCT01653652|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1448907|NCT01653639|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448908|NCT01653626||Single Group Assignment||Prevention||Double|||||t|t
1448909|NCT01653613||||||||||||
1448910|NCT01653600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448911|NCT01653587|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448912|NCT01653574||Single Group Assignment||Treatment||None (Open Label)||||||
1448913|NCT01653561||Single Group Assignment||Treatment||None (Open Label)||||||
1448914|NCT01653548|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1448915|NCT01653535|Randomized|Parallel Assignment||Prevention||Single|||t|||
1448916|NCT01653522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448917|NCT01653509|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448918|NCT01653496||Single Group Assignment||Treatment||None (Open Label)||||||
1448919|NCT01653483|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1448920|NCT01653470|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448921|NCT01653457|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448922|NCT01653444|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448923|NCT01653431|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1448924|NCT01653418||Single Group Assignment||Treatment||None (Open Label)||||||
1448925|NCT01653405|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1448926|NCT01653392|||Case-Control||Prospective|||||||
1448927|NCT01653379||Single Group Assignment||Treatment||None (Open Label)||||||
1448928|NCT01653366|Randomized|Parallel Assignment||Treatment||Single|||||t|
1448929|NCT01653353||Single Group Assignment||Prevention||None (Open Label)||||||
1448930|NCT01653340||Single Group Assignment||Treatment||None (Open Label)||||||
1448931|NCT01653327|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1448932|NCT01653314|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1448933|NCT01653301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448934|NCT01653288|Randomized|Parallel Assignment||Prevention||Single||||||t
1448935|NCT01653275||Single Group Assignment||Treatment||None (Open Label)||||||
1448936|NCT01653262||Single Group Assignment||Treatment||None (Open Label)||||||
1448937|NCT01653249||Single Group Assignment||||None (Open Label)||||||
1448938|NCT01653236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448939|NCT01653223|Randomized|Parallel Assignment||Prevention||Single|||t|||
1448940|NCT01653210|||Case-Only||Prospective|||||||
1448941|NCT01653197|Randomized|Parallel Assignment||Prevention||Single|||t|||
1448942|NCT01653184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448943|NCT01653171|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1448944|NCT01653158||Single Group Assignment||Treatment||None (Open Label)||||||
1448945|NCT01653145|Randomized|Crossover Assignment||||Single|||t|||
1448946|NCT01653132|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1448947|NCT01653119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448948|NCT01653106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448949|NCT01653093||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448950|NCT01653080||Single Group Assignment||Diagnostic||None (Open Label)||||||
1448951|NCT01653067||Single Group Assignment||Treatment||None (Open Label)||||||
1448952|NCT01653054|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1448953|NCT01653041||Single Group Assignment||Treatment||None (Open Label)||||||
1448954|NCT01653028||Single Group Assignment||Treatment||None (Open Label)||||||
1448955|NCT01653015|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1448956|NCT01653002|||Cohort||Prospective|||||||
1448957|NCT01652989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448958|NCT01652976||Single Group Assignment||Treatment||None (Open Label)||||||
1448959|NCT01652963|Randomized|Parallel Assignment||||Triple|||t||t|t
1448960|NCT01652950|Randomized|Parallel Assignment||Prevention||Single|||||t|
1448961|NCT01652937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1448962|NCT01652924|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1448963|NCT01652911||Single Group Assignment||Treatment||None (Open Label)||||||
1448964|NCT01652898|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1448965|NCT01652885||Single Group Assignment||Treatment||None (Open Label)||||||
1448966|NCT01652872|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448967|NCT01652859|Randomized|Crossover Assignment||||None (Open Label)||||||
1448968|NCT01652846||||||||||||
1448969|NCT01652833|||||Cross-Sectional|||||||
1448970|NCT01652820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448971|NCT01652807|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1448972|NCT01652794||Single Group Assignment||Treatment||None (Open Label)||||||
1448973|NCT01652781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448974|NCT01652768|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448975|NCT01652755|||Case Control||Prospective|||||||
1448976|NCT01652742||Single Group Assignment||Treatment||None (Open Label)||||||
1448977|NCT01652729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448978|NCT01652716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448979|NCT01652703|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1448980|NCT01652690|||Cohort||Prospective|||||||
1448981|NCT01652677|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448982|NCT01652664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448983|NCT01652651||Single Group Assignment||Supportive Care||None (Open Label)||||||
1448984|NCT01652638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1448985|NCT01652625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448986|NCT01652612|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1448987|NCT01652599||Single Group Assignment||Treatment||None (Open Label)||||||
1448988|NCT01652586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448989|NCT01652573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1448990|NCT01652560|||||Prospective|||||||
1448991|NCT01652547|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1448992|NCT01652534|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1448993|NCT01652521|||Cohort||Prospective|||||||
1448994|NCT01652508|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1448995|NCT01652495|Randomized|Parallel Assignment||Treatment||Single|||t|||
1448996|NCT01652482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448997|NCT01652469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1448998|NCT01652456|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1448999|NCT01652443|||Case-Only||Cross-Sectional|||||||
1449000|NCT01652430|||Cohort||Cross-Sectional|||||||
1449001|NCT01652417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449002|NCT01652404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449003|NCT01652391|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1449004|NCT01652378|||Case Control||Cross-Sectional|||||||
1449005|NCT01652365|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1449006|NCT01652352|||Case Control|||||||||
1449007|NCT01652339|Randomized|Crossover Assignment||||None (Open Label)||||||
1449008|NCT01652326|||Cohort||Retrospective|||||||
1449009|NCT01652313||Single Group Assignment||Treatment||None (Open Label)||||||
1449010|NCT01652300|Randomized|Parallel Assignment||Prevention||Single|||||t|
1449011|NCT01652287|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1449012|NCT01652274|||Case Control||Cross-Sectional|||||||
1449013|NCT01652261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449014|NCT01652248|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449015|NCT01652235||Single Group Assignment||Treatment||None (Open Label)||||||
1449016|NCT01652222|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1449017|NCT01652209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449018|NCT01652196||Single Group Assignment||Treatment||None (Open Label)||||||
1449019|NCT01652183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449020|NCT01652170|||Cohort||Prospective|||||||
1449021|NCT01652157|||Cohort||Prospective|||||||
1449022|NCT01652144||Single Group Assignment||Treatment||None (Open Label)||||||
1449023|NCT01652131||Single Group Assignment||||None (Open Label)||||||
1449024|NCT01652118|Randomized|Crossover Assignment||Prevention||Single||||t||
1449025|NCT01652105|Randomized|Parallel Assignment||Treatment||Single||||t||
1449026|NCT01652092|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449027|NCT01652079||Single Group Assignment||Treatment||None (Open Label)||||||
1449028|NCT01652066|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1449029|NCT01652053|||Cohort||Prospective|||||||
1449030|NCT01652040|Randomized|Factorial Assignment||Health Services Research||Single|||||t|
1449031|NCT01652027|||Cohort||Prospective|||||||
1449032|NCT01652014|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449033|NCT01652001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449034|NCT01651988|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1449035|NCT01651975||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449036|NCT01651962|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449037|NCT01651949|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449038|NCT01651936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449039|NCT01651923|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449040|NCT01651910|||Cohort||Prospective|||||||
1449041|NCT01651897|||Cohort||Prospective|||||||
1449042|NCT01651884|Randomized|Crossover Assignment||Treatment||Single||||||
1449043|NCT01651871|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449044|NCT01651858|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1449045|NCT01651845|||Cohort||Prospective|||||||
1449046|NCT01651832|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1449047|NCT01651819||Single Group Assignment||Treatment||None (Open Label)||||||
1449048|NCT01651806|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1449049|NCT01651793|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1449050|NCT01651780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449051|NCT01651767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449052|NCT01651754||Single Group Assignment||||None (Open Label)||||||
1449053|NCT01651741|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1449054|NCT01651728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449055|NCT01651715|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449056|NCT01651702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449057|NCT01651689|||Case-Only||Prospective|||||||
1449058|NCT01651676||Single Group Assignment||Screening||None (Open Label)||||||
1449059|NCT01651663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449060|NCT01651650||Single Group Assignment||Other||None (Open Label)||||||
1449061|NCT01651637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449062|NCT01651624|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1449063|NCT01651611|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449064|NCT01651598|Randomized|Parallel Assignment||Treatment||Double||||||
1449065|NCT01651585||Single Group Assignment||Treatment||None (Open Label)||||||
1449066|NCT01651572|Randomized|Parallel Assignment||Prevention||Single|||t|||
1449067|NCT01651559|||Cohort||Prospective|||||||
1449068|NCT01651546||Single Group Assignment||||None (Open Label)||||||
1449069|NCT01651533|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1449070|NCT01651520|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1449071|NCT01651507|||Case-Only||Retrospective|||||||
1449072|NCT01651494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449073|NCT01651481|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449074|NCT01651468||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449075|NCT01651455|||Cohort||Retrospective|||||||
1449076|NCT01651442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449077|NCT01651429||Single Group Assignment||Screening||None (Open Label)||||||
1449078|NCT01651416|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1449079|NCT01651403|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449080|NCT01651390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449081|NCT01651377|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1449082|NCT01651364|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1449083|NCT01651351|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1449084|NCT01651338||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449085|NCT01651325||Single Group Assignment||||None (Open Label)||||||
1449086|NCT01651312||Single Group Assignment||Basic Science||None (Open Label)||||||
1449087|NCT01651299|||||Prospective|||||||
1449088|NCT01651286|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1449089|NCT01651273|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449090|NCT01651260||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449091|NCT01651247|||||Retrospective|||||||
1449092|NCT01651234|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449093|NCT01651221|Randomized|Single Group Assignment||Other||Single|||t|||
1449094|NCT01651208|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1449095|NCT01651195|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1449096|NCT01651182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449097|NCT01651169|Non-Randomized|Parallel Assignment||||Single||||||t
1449098|NCT01651156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449099|NCT01651143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449100|NCT01651130|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449101|NCT01651117|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449102|NCT01651104||Single Group Assignment||Prevention||None (Open Label)||||||
1449103|NCT01651091|Randomized|Parallel Assignment||||Single||||||t
1449104|NCT01651078|||Cohort||Prospective|||||||
1449105|NCT01651065|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449106|NCT01651052||Single Group Assignment||Treatment||None (Open Label)||||||
1449107|NCT01651039||Single Group Assignment||Treatment||None (Open Label)||||||
1449108|NCT01651026|||Cohort||Prospective|||||||
1449109|NCT01651013|||Cohort||Prospective|||||||
1449110|NCT01651000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449111|NCT01650987|||Cohort||Prospective|||||||
1449112|NCT01650974|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1449113|NCT01650961|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1449114|NCT01650948|||Cohort||Prospective|||||||
1449115|NCT01650935|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449116|NCT01650922|||Cohort||Retrospective|||||||
1449117|NCT01650909|||||Prospective|||||||
1449118|NCT01650896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449119|NCT01650883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449120|NCT01650870|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449121|NCT01650857|||Cohort||Prospective|||||||
1449122|NCT01650844|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1449123|NCT01650831||Single Group Assignment||Diagnostic||Single|||||t|
1449124|NCT01650818|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1449125|NCT01650805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449126|NCT01650792|Randomized|Parallel Assignment||Treatment||Single||||||t
1449127|NCT01650779||Single Group Assignment||Treatment||None (Open Label)||||||
1449128|NCT01650766|||Case-Only||Prospective|||||||
1449129|NCT01650753|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1449130|NCT01650740|Randomized|Parallel Assignment||Treatment||Single||||||t
1449131|NCT01650727||Single Group Assignment||Treatment||None (Open Label)||||||
1449132|NCT01650714||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449133|NCT01650701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449134|NCT01650688|||Case-Only||Retrospective|||||||
1449135|NCT01650675|Randomized|Parallel Assignment||Screening||Double|||t|||t
1449136|NCT01650662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449137|NCT01650649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449138|NCT01650636|Randomized|Parallel Assignment||Other||Single|||t|||
1449139|NCT01650623|Randomized|Parallel Assignment||Treatment||Single||||||t
1449140|NCT01650610||Single Group Assignment||Treatment||None (Open Label)||||||
1449141|NCT01650597|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1449142|NCT01650584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449143|NCT01650571|||Cohort||Prospective|||||||
1449144|NCT01650558|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1449145|NCT01650545|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1449146|NCT01650532|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1449147|NCT01650519|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449148|NCT01650506||Single Group Assignment||Treatment||None (Open Label)||||||
1449149|NCT01650493|||||Prospective|||||||
1449150|NCT01650480|Randomized|Factorial Assignment||Supportive Care||Single|||||t|
1449151|NCT01650467|||Cohort||Cross-Sectional|||||||
1449152|NCT01650454|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1449153|NCT01650441||Single Group Assignment||Treatment||None (Open Label)||||||
1449154|NCT01650428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449155|NCT01650415|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449156|NCT01650402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449157|NCT01650389|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1449158|NCT01650376||Single Group Assignment||Treatment||None (Open Label)||||||
1449159|NCT01650363|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1449160|NCT01650350||Single Group Assignment||Treatment||None (Open Label)||||||
1449161|NCT01650337|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1449162|NCT01650324|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1449163|NCT01650311|||Cohort||Prospective|||||||
1449164|NCT01650298|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1449165|NCT01650285||Single Group Assignment||Treatment||None (Open Label)||||||
1449166|NCT01650272|Randomized|Single Group Assignment||Treatment||Single||||||t
1449167|NCT01650259|||Cohort||Prospective|||||||
1449168|NCT01650246||Single Group Assignment||Treatment||None (Open Label)||||||
1449169|NCT01650233|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449170|NCT01650220|||Cohort||Cross-Sectional|||||||
1449171|NCT01650207|Randomized|Factorial Assignment||Treatment||Single|||t|||
1449172|NCT01650194||Single Group Assignment||Treatment||None (Open Label)||||||
1449173|NCT01650181|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1449174|NCT01650168|||Cohort||Prospective|||||||
1449175|NCT01650155|Randomized|Single Group Assignment||Treatment||Single||||||
1449176|NCT01650142|||Cohort||Prospective|||||||
1449177|NCT01650129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449178|NCT01650116|||Case-Only||Cross-Sectional|||||||
1449179|NCT01650103|||Case-Only||Cross-Sectional|||||||
1449180|NCT01650090||Single Group Assignment||Prevention||None (Open Label)||||||
1449181|NCT01650077|||Cohort||Retrospective|||||||
1449182|NCT01650064|||Cohort||Prospective|||||||
1449183|NCT01650051|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449184|NCT01650038|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449185|NCT01650025|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1449186|NCT01650012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449187|NCT01649999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449188|NCT01649986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449189|NCT01649973|||Case-Crossover||Prospective|||||||
1449190|NCT01649960||Single Group Assignment||Treatment||None (Open Label)||||||
1449191|NCT01649947|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449192|NCT01649934|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1449193|NCT01649921|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1449194|NCT01649908|||||Prospective|||||||
1449195|NCT01649895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449196|NCT01649882||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449197|NCT01649869|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449355|NCT01647685|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1449198|NCT01649856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449199|NCT01649843||Single Group Assignment||Treatment||None (Open Label)||||||
1449200|NCT01649830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449201|NCT01649817|||Cohort||Retrospective|||||||
1449202|NCT01649804||Single Group Assignment||Treatment||None (Open Label)||||||
1449203|NCT01649791||Single Group Assignment||Treatment||None (Open Label)||||||
1449204|NCT01649778|||Other||Prospective|||||||
1449205|NCT01649765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449206|NCT01649752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449207|NCT01649739||Single Group Assignment||Treatment||None (Open Label)||||||
1449208|NCT01649726|Randomized|Parallel Assignment||||None (Open Label)||||||
1449209|NCT01649713||Single Group Assignment||Prevention||None (Open Label)||||||
1449210|NCT01649700||Single Group Assignment||Treatment||None (Open Label)||||||
1449211|NCT01649687||Single Group Assignment||Treatment||None (Open Label)||||||
1449212|NCT01649674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449213|NCT01649661|||Case-Crossover||Prospective|||||||
1449214|NCT01649648||Single Group Assignment||Treatment||None (Open Label)||||||
1449215|NCT01649635||Single Group Assignment||Treatment||None (Open Label)||||||
1449216|NCT01649622||Single Group Assignment||Treatment||None (Open Label)||||||
1449217|NCT01649609|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449218|NCT01649596|Randomized|Parallel Assignment||Prevention||None (Open Label)|Open label.|||||
1449219|NCT01649583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449220|NCT01649570|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449221|NCT01649557||Single Group Assignment||Treatment||None (Open Label)||||||
1449222|NCT01649544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449223|NCT01649531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449224|NCT01649518|||||Retrospective|||||||
1449225|NCT01649505|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1449226|NCT01649492|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1449227|NCT01649479|Non-Randomized|Single Group Assignment||Basic Science||Single||||||t
1449228|NCT01649466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449229|NCT01649453|||Case-Only||Prospective|||||||
1449230|NCT01649440|||Case Control||Prospective|||||||
1449231|NCT01649427|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1449232|NCT01649401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449233|NCT01649388||Single Group Assignment||Treatment||None (Open Label)||||||
1449234|NCT01649375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449235|NCT01649362|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449236|NCT01649349||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449237|NCT01649336||Single Group Assignment||Treatment||None (Open Label)||||||
1449238|NCT01649310|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1449239|NCT01649297|Randomized|Parallel Assignment||Treatment||Double||||||
1449240|NCT01649284||||||||||||
1449241|NCT01649271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449242|NCT01649258||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449243|NCT01649245||Single Group Assignment||Treatment||None (Open Label)||||||
1449244|NCT01649232|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1449245|NCT01649219|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449246|NCT01649206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449247|NCT01649193|||Cohort||Prospective|||||||
1449248|NCT01649180||Single Group Assignment||Treatment||None (Open Label)||||||
1449249|NCT01649167|||Cohort||Prospective|||||||
1449250|NCT01649154|Randomized|Factorial Assignment||Treatment||Single|||t|||
1449251|NCT01649141||Single Group Assignment||Treatment||None (Open Label)||||||
1449252|NCT01649128|||Cohort||Prospective|||||||
1449253|NCT01649115|Randomized|Parallel Assignment||Prevention||Single|||t|||
1449254|NCT01649102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449255|NCT01649089||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449256|NCT01649063|||||Prospective|||||||
1449257|NCT01649050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449258|NCT01649037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449259|NCT01649024||Single Group Assignment||Treatment||None (Open Label)||||||
1449260|NCT01649011|||Cohort||Prospective|||||||
1449261|NCT01648998|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1449262|NCT01648985|||Cohort||Prospective|||||||
1449263|NCT01648972||||||||||||
1449264|NCT01648959|||Cohort||Prospective|||||||
1449265|NCT01648946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449266|NCT01648933||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449267|NCT01648920|||Case-Only||Prospective|||||||
1449268|NCT01648907|||Cohort||Prospective|||||||
1449269|NCT01648894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449270|NCT01648881|||Cohort||Prospective|||||||
1449271|NCT01648868|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449272|NCT01648855|||Case-Only||Prospective|||||||
1449273|NCT01648842|||Case Control||Prospective|||||||
1449274|NCT01648829|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1449275|NCT01648816|||Cohort||Prospective|||||||
1449276|NCT01648803|||Case-Only||Prospective|||||||
1449277|NCT01648790|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1449278|NCT01648777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449279|NCT01648764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449280|NCT01648751|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1449281|NCT01648738|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449282|NCT01648725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449283|NCT01648712|Randomized|Parallel Assignment||||Double|||t||t|
1449284|NCT01648699||Single Group Assignment||Treatment||None (Open Label)||||||
1449285|NCT01648686|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1449286|NCT01648673|||Cohort||Prospective|||||||
1449287|NCT01648660|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1449288|NCT01648647|||Case-Only||Prospective|||||||
1449289|NCT01648634|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1449290|NCT01648621|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449291|NCT01648608||Single Group Assignment||Treatment||None (Open Label)||||||
1449292|NCT01648595|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1449293|NCT01648582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449294|NCT01648569|||Cohort||Retrospective|||||||
1449295|NCT01648556||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449296|NCT01648543|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1449297|NCT01648530|||Cohort||Prospective|||||||
1449298|NCT01648517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449299|NCT01648504||Single Group Assignment||||None (Open Label)||||||
1449300|NCT01648491||Single Group Assignment||Treatment||None (Open Label)||||||
1449301|NCT01648478||Single Group Assignment||Basic Science||None (Open Label)||||||
1449302|NCT01648465||Single Group Assignment||Treatment||None (Open Label)||||||
1449303|NCT01648452||Single Group Assignment||Treatment||None (Open Label)||||||
1449304|NCT01648348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449305|NCT01648335||Parallel Assignment||Treatment||||||||
1449306|NCT01648322|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449307|NCT01648309|||Cohort||Prospective|||||||
1449308|NCT01648296|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1449309|NCT01648283||Single Group Assignment||Other||None (Open Label)||||||
1449310|NCT01648270||Single Group Assignment||Other||None (Open Label)||||||
1449311|NCT01648257|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449312|NCT01648244||Single Group Assignment||Treatment||None (Open Label)||||||
1449313|NCT01648231|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449314|NCT01648218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449315|NCT01648205|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1449316|NCT01648192|Randomized|Crossover Assignment||Treatment||Single|||t|||
1449317|NCT01648179|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449318|NCT01648166|||Case-Control||Prospective|||||||
1449319|NCT01648153|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1449320|NCT01648140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449321|NCT01648127||Single Group Assignment||Health Services Research||None (Open Label)||||||
1449322|NCT01648114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449323|NCT01648101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449324|NCT01648088|||||Cross-Sectional|||||||
1449325|NCT01648075|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1449326|NCT01648062|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1449327|NCT01648049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449328|NCT01648036|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449329|NCT01648023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449330|NCT01648010|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1449331|NCT01647997|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1449332|NCT01647984|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1449333|NCT01647971||Single Group Assignment||Treatment||None (Open Label)||||||
1449334|NCT01647958|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449335|NCT01647945|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449336|NCT01647932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449337|NCT01647919|Randomized|Parallel Assignment||||Triple|||t||t|t
1449338|NCT01647906|||Cohort||Prospective|||||||
1449339|NCT01647893|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1449340|NCT01647880|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449341|NCT01647867||Single Group Assignment||Basic Science||None (Open Label)||||||
1449342|NCT01647854||Single Group Assignment||Health Services Research||None (Open Label)||||||
1449343|NCT01647841|||Cohort||Prospective|||||||
1449344|NCT01647828|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449345|NCT01647815||Single Group Assignment||Basic Science||None (Open Label)||||||
1449346|NCT01647802|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1449347|NCT01647789||Single Group Assignment||Treatment||None (Open Label)||||||
1449348|NCT01647776|||Case-Control||Prospective|||||||
1449349|NCT01647763|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449350|NCT01647750|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449351|NCT01647737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449352|NCT01647724|||Cohort||Prospective|||||||
1449353|NCT01647711||Single Group Assignment||Treatment||None (Open Label)||||||
1449354|NCT01647698|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1449356|NCT01647672||Single Group Assignment||Treatment||None (Open Label)||||||
1449357|NCT01647659|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1449358|NCT01647646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449359|NCT01647633||Single Group Assignment||Treatment||None (Open Label)||||||
1449360|NCT01647620|Randomized|||Treatment||Quadruple|||t|t|t|t
1449361|NCT01647607|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1449362|NCT01647594|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1449363|NCT01647581|Randomized|Parallel Assignment||Prevention||Single||||||t
1449364|NCT01647568|||Case Control||Prospective|||||||
1449365|NCT01647555|||Cohort||Prospective|||||||
1449366|NCT01647542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449367|NCT01647529||Single Group Assignment||Treatment||None (Open Label)||||||
1449368|NCT01647516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449369|NCT01647503|||Case Control||Cross-Sectional|||||||
1449370|NCT01647490|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1449371|NCT01647477|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449372|NCT01647464|||Case-Only||Prospective|||||||
1449373|NCT01647451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449374|NCT01647438|Randomized|Parallel Assignment||Prevention||Single||||||t
1449375|NCT01647425|||Cohort||Prospective|||||||
1449376|NCT01647412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449377|NCT01647399|||Cohort||Prospective|||||||
1449378|NCT01647386|||Case-Only||Prospective|||||||
1449379|NCT01647373|||Case-Only||Cross-Sectional|||||||
1449380|NCT01647360|||Case-Only||Prospective|||||||
1449381|NCT01647347|Randomized|Crossover Assignment||Prevention||Single||||||t
1449382|NCT01647334||Single Group Assignment||Treatment||None (Open Label)||||||
1449383|NCT01647321|Randomized|Parallel Assignment||Treatment||Single||||||t
1449384|NCT01647308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449385|NCT01647295|||Case Control||Prospective|||||||
1449386|NCT01647282|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449387|NCT01647269|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1449388|NCT01647256|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1449389|NCT01647243|Randomized|Parallel Assignment||Treatment||Single||||||t
1449390|NCT01647230|||Cohort||Prospective|||||||
1449391|NCT01647217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449392|NCT01647204|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1449393|NCT01647191|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449394|NCT01647178|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1449395|NCT01647165|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449396|NCT01647152|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449397|NCT01646866|||Cohort||Prospective|||||||
1449398|NCT01646853||Single Group Assignment||Treatment||||||||
1449399|NCT01646840|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1449400|NCT01646827|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1449401|NCT01646814|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1449402|NCT01646801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449403|NCT01646788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449404|NCT01646775|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1449405|NCT01646762||Single Group Assignment||Treatment||None (Open Label)||||||
1449406|NCT01646749|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1449407|NCT01646736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449408|NCT01646723||Single Group Assignment||Health Services Research||None (Open Label)||||||
1449409|NCT01646710||Single Group Assignment||||||||||
1449410|NCT01646697||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449411|NCT01646684||Single Group Assignment||Treatment||None (Open Label)||||||
1449412|NCT01646671|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449413|NCT01646645||Single Group Assignment||Treatment||None (Open Label)||||||
1449414|NCT01646632|Randomized|Parallel Assignment||Treatment||Single||||||t
1449415|NCT01646619|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1449416|NCT01646606|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1449417|NCT01646593||||||||||||
1449418|NCT01646580||Single Group Assignment||||None (Open Label)||||||
1449419|NCT01646567||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1449420|NCT01646554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449421|NCT01646541|||Case-Control||Prospective|||||||
1449422|NCT01646528|||||Prospective|||||||
1449423|NCT01646515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449424|NCT01646502|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449425|NCT01646489|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449426|NCT01646476|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449427|NCT01646463|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1449428|NCT01646450||Single Group Assignment||Treatment||None (Open Label)||||||
1449429|NCT01646437|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1449430|NCT01646424|||Cohort||Retrospective|||||||
1449431|NCT01646411|||Case-Only||Cross-Sectional|||||||
1449432|NCT01646398|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1449433|NCT01646385|||Cohort||Retrospective|||||||
1449434|NCT01646372|Randomized|Parallel Assignment||Other||Double|||t|||t
1449435|NCT01646359||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449436|NCT01646346||Single Group Assignment||Treatment||None (Open Label)||||||
1449437|NCT01646333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449438|NCT01646320|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449439|NCT01646307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449440|NCT01646294|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1449441|NCT01646281|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1449442|NCT01646268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449443|NCT01646255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449444|NCT01646242|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1449445|NCT01646229|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449446|NCT01646216||Single Group Assignment||Treatment||None (Open Label)||Split belt treadmill||||
1449447|NCT01646203||Single Group Assignment||Treatment||None (Open Label)||||||
1449448|NCT01646190|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1449449|NCT01646177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449450|NCT01646164|||Cohort||Retrospective|||||||
1449451|NCT01646151|||Cohort||Prospective|||||||
1449452|NCT01646138||Single Group Assignment||Basic Science||None (Open Label)||||||
1449453|NCT01646125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449454|NCT01646112|||||Retrospective|||||||
1449455|NCT01646099|Randomized|Parallel Assignment||Prevention||Single|||t|||
1449456|NCT01646086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449457|NCT01646073|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449458|NCT01646060||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449459|NCT01646047|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1449460|NCT01646034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449461|NCT01646021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449462|NCT01646008|||||Prospective|||||||
1449463|NCT01645995|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1449464|NCT01645982|||Case-Only||Prospective|||||||
1449465|NCT01645969|||Cohort||Prospective|||||||
1449466|NCT01645956|||Cohort||Prospective|||||||
1449467|NCT01645943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449468|NCT01645930||Single Group Assignment||Treatment||None (Open Label)||||||
1449469|NCT01645917||Single Group Assignment||Treatment||None (Open Label)||||||
1449470|NCT01645904|||Family-Based||Prospective|||||||
1449471|NCT01645891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449472|NCT01645878|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1449473|NCT01645865|||Cohort||Prospective|||||||
1449474|NCT01645852|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1449475|NCT01645839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449476|NCT01645826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449477|NCT01645800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449478|NCT01645787|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1449479|NCT01645774|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1449480|NCT01645761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449481|NCT01645748||Single Group Assignment||Treatment||None (Open Label)||||||
1449482|NCT01645735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449483|NCT01645722||Single Group Assignment||Treatment||None (Open Label)||||||
1449484|NCT01645709|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1449485|NCT01645696|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1449486|NCT01645566|Randomized|Parallel Assignment||||Single|||t|||
1449487|NCT01645475||Single Group Assignment||Treatment||None (Open Label)||||||
1449488|NCT01645449|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449489|NCT01645436|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1449490|NCT01645423|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449491|NCT01645410|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449492|NCT01645397|||Cohort||Prospective|||||||
1449493|NCT01645384|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449494|NCT01645371|||Case-Only||Cross-Sectional|||||||
1449495|NCT01645358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449496|NCT01645345||Single Group Assignment||Treatment||None (Open Label)||||||
1449497|NCT01645332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449498|NCT01645319|||Cohort||Prospective|||||||
1449499|NCT01645306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449500|NCT01645293||Single Group Assignment||Treatment||None (Open Label)||||||
1449501|NCT01645280|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1449502|NCT01645267||Single Group Assignment||Treatment||None (Open Label)||||||
1449503|NCT01645254||Single Group Assignment||||None (Open Label)||||||
1449504|NCT01645241||Single Group Assignment||Treatment||None (Open Label)||||||
1449505|NCT01645228|||Case Control||Prospective|||||||
1449506|NCT01645215||Single Group Assignment||Treatment||None (Open Label)||||||
1449507|NCT01645202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449508|NCT01645189||Single Group Assignment||Treatment||None (Open Label)||||||
1449509|NCT01645176||Single Group Assignment||Treatment||None (Open Label)||||||
1449510|NCT01645163||Single Group Assignment||||||||||
1449511|NCT01645150|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449512|NCT01645137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449513|NCT01645124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449514|NCT01645111||Single Group Assignment||Treatment||None (Open Label)||||||
1449515|NCT01645098|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449516|NCT01645085|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1449517|NCT01645072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449518|NCT01645059|||Cohort||Cross-Sectional|||||||
1449519|NCT01645046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449520|NCT01645033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449521|NCT01645020|||Case Control||Cross-Sectional|||||||
1449522|NCT01645007|||Cohort||Prospective|||||||
1449523|NCT01644994||Single Group Assignment||Treatment||None (Open Label)||Open Label, single dose local intracavitary application of Cisplatin bound to Fibrin after surgery (removal of Tumor)||||
1449524|NCT01644981|||Cohort||Prospective|||||||
1449525|NCT01644968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449526|NCT01644955||Single Group Assignment||Treatment||None (Open Label)||||||
1449527|NCT01644942|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1449528|NCT01644929|Randomized|Crossover Assignment||Other||Double|||t||t|
1449529|NCT01644916|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1449530|NCT01644903|||Cohort||Prospective|||||||
1449531|NCT01644890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449532|NCT01644877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449533|NCT01644864|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1449534|NCT01644851|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449535|NCT01644838|Randomized|Parallel Assignment||||Double|||t||t|
1449536|NCT01644825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449537|NCT01644812|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449538|NCT01644799||Single Group Assignment||Treatment||None (Open Label)||||||
1449539|NCT01644786|||Cohort||Prospective|||||||
1449540|NCT01644773||Single Group Assignment||Treatment||None (Open Label)||||||
1449541|NCT01644760||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449542|NCT01644747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449543|NCT01644734||Single Group Assignment||||||||||
1449544|NCT01644721|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449545|NCT01644708|||Cohort||Prospective|||||||
1449546|NCT01644695|||Case-Only|||||||||
1449547|NCT01644682|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1449548|NCT01644669||Single Group Assignment||Treatment||None (Open Label)||Single 20Gy dose of electronic brachytherapy (IORT)||||
1449549|NCT01644656||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449550|NCT01644643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449551|NCT01644630|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1449552|NCT01644617|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449553|NCT01644604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449554|NCT01644591||Single Group Assignment||Treatment||None (Open Label)||||||
1449555|NCT01644578||Single Group Assignment||Treatment||None (Open Label)||||||
1449556|NCT01644565|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449557|NCT01644552|||Case-Only||Retrospective|||||||
1449558|NCT01644539|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1449559|NCT01644526||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1449560|NCT01644513|||Case Control||Prospective|||||||
1449561|NCT01644500|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449562|NCT01644487|Randomized|Parallel Assignment||Treatment||None (Open Label)||Provisional stenting with SMART(n=173), Provisional stenting with Complete SE(n=173)||||
1449563|NCT01644474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449564|NCT01644461||Single Group Assignment||Treatment||None (Open Label)||||||
1449565|NCT01644448|Randomized|Parallel Assignment||||None (Open Label)||||||
1449566|NCT01644435|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449567|NCT01644422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449568|NCT01644409|||Cohort||Prospective|||||||
1449569|NCT01644396||Single Group Assignment||Treatment||None (Open Label)||||||
1449570|NCT01644383|Randomized|Parallel Assignment||||None (Open Label)||||||
1449571|NCT01644370|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1449572|NCT01644357|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1449573|NCT01644344|Randomized|Parallel Assignment||Treatment||Single||||t||
1449574|NCT01644331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449575|NCT01644318|||Case Control||Cross-Sectional|||||||
1449576|NCT01644305|||Case-Control||Cross-Sectional|||||||
1449577|NCT01644292||Single Group Assignment||Treatment||None (Open Label)||||||
1449578|NCT01644279|||Cohort||Cross-Sectional|||||||
1449579|NCT01644253|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449580|NCT01644240|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1449581|NCT01644227|||Cohort||Retrospective|||||||
1449582|NCT01644214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449583|NCT01644201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449584|NCT01644188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449585|NCT01644175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449586|NCT01644162||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449587|NCT01644149|Randomized|Parallel Assignment||Prevention||Single||||||t
1449588|NCT01644136||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449589|NCT01644123|||Cohort||Prospective|||||||
1449590|NCT01644110||Single Group Assignment||Treatment||None (Open Label)||||||
1449591|NCT01644097|Randomized|Parallel Assignment||Supportive Care||Double||||||
1449592|NCT01644084|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1449593|NCT01644071||Single Group Assignment||Basic Science||Double|||t||t|
1449594|NCT01644058||Single Group Assignment||Treatment||None (Open Label)|Investigators were not involved in data analysis|||||
1449595|NCT01644045||Single Group Assignment||Treatment||None (Open Label)||||||
1449596|NCT01644032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449597|NCT01644019||Single Group Assignment||Treatment||None (Open Label)||||||
1449598|NCT01644006|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449599|NCT01643993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449600|NCT01643980|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449601|NCT01643967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449602|NCT01643954|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1449603|NCT01643941|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1449604|NCT01643928|Randomized|||Treatment||Triple|||t||t|t
1449605|NCT01643915|Randomized|Crossover Assignment||||None (Open Label)||||||
1449606|NCT01643902||Single Group Assignment||Treatment||None (Open Label)||||||
1449607|NCT01643889|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1449608|NCT01643876||Single Group Assignment||Treatment||None (Open Label)||||||
1449609|NCT01643863|||Cohort||Prospective|||||||
1449610|NCT01643850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449611|NCT01643837|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1449612|NCT01643824||Single Group Assignment||Treatment||None (Open Label)||||||
1449613|NCT01643811|||Case Control||Prospective|||||||
1449614|NCT01643798|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1449615|NCT01643785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449616|NCT01643772||Single Group Assignment||Treatment||None (Open Label)||||||
1449617|NCT01643759||Single Group Assignment||Treatment||None (Open Label)||||||
1449618|NCT01643746|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449619|NCT01643733|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1449620|NCT01643720|||Case Control||Prospective|||||||
1449621|NCT01643707|||Other||Prospective|||||||
1449622|NCT01643694|Randomized|Parallel Assignment||||Single|||||t|
1449623|NCT01643681|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449624|NCT01643668||Single Group Assignment||Treatment||None (Open Label)||||||
1449625|NCT01643655||Single Group Assignment||Treatment||None (Open Label)||||||
1449626|NCT01643642|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449627|NCT01643629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449628|NCT01643616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449629|NCT01643603||Single Group Assignment||Treatment||None (Open Label)||||||
1449630|NCT01643590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449631|NCT01643577|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449632|NCT01643564|||Case Control||Cross-Sectional|||||||
1449633|NCT01643551|||Case Control||Prospective|||||||
1449634|NCT01643538|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1449635|NCT01643525||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449636|NCT01643512|||Family-Based||Cross-Sectional|||||||
1449637|NCT01643499||Single Group Assignment||Treatment||None (Open Label)||||||
1449638|NCT01643486|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449639|NCT01643473|Randomized|Single Group Assignment||Treatment||Single||||||t
1449640|NCT01643460||Single Group Assignment||Treatment||None (Open Label)||||||
1449641|NCT01643447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449642|NCT01643434|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449643|NCT01643421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449644|NCT01643408|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449645|NCT01643395|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449646|NCT01643382|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449647|NCT01643369|Randomized|Parallel Assignment||Treatment||Single||||||t
1449648|NCT01643356|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449649|NCT01643343|||Case Control||Cross-Sectional|||||||
1449650|NCT01643330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449651|NCT01643317|||Cohort||Prospective|||||||
1449652|NCT01643304|||||Cross-Sectional|||||||
1449653|NCT01643291||Single Group Assignment||Treatment||None (Open Label)||||||
1449654|NCT01643278||Single Group Assignment||Treatment||None (Open Label)||||||
1449655|NCT01643265|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1449656|NCT01643252|Randomized|Parallel Assignment||Treatment||Single||||||t
1449657|NCT01643239|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1449658|NCT01643226|Randomized|Parallel Assignment||Treatment||Single||||||t
1449659|NCT01643213|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1449660|NCT01643200||Single Group Assignment||Treatment||None (Open Label)||||||
1449661|NCT01643187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449662|NCT01643174|||Case-Only||Retrospective|||||||
1450680|NCT01629849|Randomized|Parallel Assignment||Treatment||Double||||||
1449663|NCT01643161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449664|NCT01643148|||Case Control||Prospective|||||||
1449665|NCT01643135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449666|NCT01643122|||Cohort||Prospective|||||||
1449667|NCT01643109|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449668|NCT01643096|Randomized|Crossover Assignment||||Double|||t||t|
1449669|NCT01643083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449670|NCT01643070|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1449671|NCT01643057|||Case-Only||Prospective|||||||
1449672|NCT01643044|Randomized|Parallel Assignment||Screening||Double|||t|||t
1449673|NCT01643031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449674|NCT01643018|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1449675|NCT01643005|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449676|NCT01642992|||Cohort||Retrospective|||||||
1449677|NCT01642979|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449678|NCT01642966|Randomized|Crossover Assignment||Treatment||Single||||||t
1449679|NCT01642953||Single Group Assignment||Treatment||None (Open Label)||||||
1449680|NCT01642940|Randomized|Crossover Assignment||Treatment||Single||||||t
1449681|NCT01642927|||Case-Only||Cross-Sectional|||||||
1449682|NCT01642914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449683|NCT01642901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449684|NCT01642888|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1449685|NCT01642875|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449686|NCT01642862|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1449687|NCT01642849|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449688|NCT01642836|Randomized|Parallel Assignment||Treatment||Single||||||t
1449689|NCT01642823|||Case-Only||Retrospective|||||||
1449690|NCT01642810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449691|NCT01642797|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1449692|NCT01642784|||Case Control||Cross-Sectional|||||||
1449693|NCT01642771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449694|NCT01642758||Single Group Assignment||Treatment||None (Open Label)||||||
1449695|NCT01642745|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1449696|NCT01642732||Single Group Assignment||Treatment||None (Open Label)||||||
1449697|NCT01642719|Randomized|Parallel Assignment||Basic Science||Single||||||t
1449698|NCT01642706|||Case Control||Prospective|||||||
1449699|NCT01642693|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1449700|NCT01642680|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1449701|NCT01642667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449702|NCT01642654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449703|NCT01642641|Randomized|Parallel Assignment||Treatment||Single||||||t
1449704|NCT01642628|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1449705|NCT01642615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449706|NCT01642602||Single Group Assignment||Treatment||None (Open Label)||||||
1449707|NCT01642589|Randomized|Parallel Assignment||Prevention||Single||||||t
1449708|NCT01642576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449709|NCT01642563|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1449710|NCT01642550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449711|NCT01642537||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449712|NCT01642524|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1449713|NCT01642511|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1449714|NCT01642498|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449715|NCT01642485|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1449716|NCT01642472||Single Group Assignment||Treatment||None (Open Label)||||||
1449717|NCT01642459|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449718|NCT01642446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449719|NCT01642433|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1449720|NCT01642420|||Case Control||Prospective|||||||
1449721|NCT01642407||Single Group Assignment||Treatment||None (Open Label)||||||
1449722|NCT01642394|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||"Intervention group The complete intervention consists of group sessions (8 to 15 people) lasting 2.5 hours, once a week for six weeks. These sessions are structured with the aim of enabling participants to acquire knowledge and skills related to the disease and its management, placing a strong emphasis on proactive tools to achieve healthier lifestyles (in terms of diet, physical exercise, management of emotions, and correct use of medication, among others).~Control group Patients assigned to the control group will receive usual care for secondary prevention of DM2 in accordance with the Osakidetza primary care protocols, which are based on clinical practice guidelines."||||
1449723|NCT01642381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449724|NCT01642368|Randomized|Single Group Assignment||Treatment||Single|||t|||
1449725|NCT01642355|Randomized|Parallel Assignment||Prevention||Single||||||t
1449726|NCT01642342|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449727|NCT01642329|||Cohort||Prospective|||||||
1449728|NCT01642316|Randomized|Parallel Assignment||||Single|||t|||
1449729|NCT01642303|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1449730|NCT01642277|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1449731|NCT01642264|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1449732|NCT01642251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449733|NCT01642238|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449734|NCT01642225|||Case-Only||Retrospective|||||||
1449735|NCT01642212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449736|NCT01642199|Randomized|Parallel Assignment||Treatment||Single||||||t
1449737|NCT01642186|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449738|NCT01642173|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1449739|NCT01642160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449740|NCT01642147|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449741|NCT01642134|Randomized|Parallel Assignment||Treatment||Single||||||t
1449742|NCT01642121|||Case Control||Retrospective|||||||
1449743|NCT01642108||Single Group Assignment||Treatment||None (Open Label)||||||
1449744|NCT01642095|||Cohort||Retrospective|||||||
1449745|NCT01642082||Single Group Assignment||Treatment||None (Open Label)||||||
1449746|NCT01642069|||Cohort||Retrospective|||||||
1449747|NCT01642056|Non-Randomized|Crossover Assignment||Treatment||Double|||t||t|
1449748|NCT01642043|||Cohort||Prospective|||||||
1449749|NCT01642030|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1449750|NCT01642017||Single Group Assignment||Treatment||None (Open Label)||||||
1449751|NCT01642004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449752|NCT01641991|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449753|NCT01641978|||||Prospective|||||||
1449754|NCT01641965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449755|NCT01641952|||Cohort||Prospective|||||||
1449756|NCT01641939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449757|NCT01641926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449758|NCT01641913||Single Group Assignment||Treatment||None (Open Label)||||||
1449759|NCT01641900|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1449760|NCT01641887|||Cohort||Prospective|||||||
1449761|NCT01641874|Randomized|Parallel Assignment||Treatment||Single||||||t
1449762|NCT01641861|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449763|NCT01641848||Single Group Assignment||Treatment||None (Open Label)||||||
1449764|NCT01641835|||Case-Only||Prospective|||||||
1449765|NCT01641822|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449766|NCT01641809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449767|NCT01641796||||||||||||
1449768|NCT01641783||Single Group Assignment||Treatment||None (Open Label)||||||
1449769|NCT01641770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449770|NCT01641757||Single Group Assignment||Treatment||None (Open Label)||||||
1449771|NCT01641744|Randomized|Parallel Assignment||Treatment||Single||||||t
1449772|NCT01641731|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449773|NCT01641718|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1449774|NCT01641705|||||Cross-Sectional|||||||
1449775|NCT01641692|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1449776|NCT01641679|||Cohort||Prospective|||||||
1449777|NCT01641666|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449778|NCT01641653|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449779|NCT01641640||Single Group Assignment||Treatment||None (Open Label)||||||
1449780|NCT01641627||Single Group Assignment||Treatment||None (Open Label)||||||
1449781|NCT01641614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449782|NCT01641601|Randomized|Parallel Assignment||Treatment||Double||||t||t
1449783|NCT01641588||Single Group Assignment||Basic Science||None (Open Label)||||||
1449784|NCT01641575||Single Group Assignment||Treatment||None (Open Label)||||||
1449785|NCT01641562|||Case-Only||Prospective|||||||
1449786|NCT01641549|Randomized|Parallel Assignment||Treatment||Single||||||t
1449787|NCT01641536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449788|NCT01641523|||Cohort||Prospective|||||||
1449789|NCT01641510|Randomized|Parallel Assignment||Prevention||Single|||t|||
1449790|NCT01641497|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1449791|NCT01641484||Single Group Assignment||Other||None (Open Label)||||||
1449792|NCT01641471|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1449793|NCT01641458||Single Group Assignment||Treatment||None (Open Label)||||||
1449794|NCT01641445|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449795|NCT01641432|Randomized|Parallel Assignment||||Double|||t|t||
1449796|NCT01641419|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1449797|NCT01641406|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449798|NCT01641393|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1449799|NCT01641380|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1449800|NCT01641367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449801|NCT01641354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449802|NCT01641341|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1449803|NCT01641328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449804|NCT01641315|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1449805|NCT01641302|||||Prospective|||||||
1449806|NCT01641289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449807|NCT01641276|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1449808|NCT01641263|Randomized|Parallel Assignment||Prevention||Single||||||t
1449809|NCT01641250|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449810|NCT01641237|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1450681|NCT01629836||||||||||||
1449811|NCT01641224|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449812|NCT01641211|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1449813|NCT01641198||Single Group Assignment||Treatment||Double|||t|t||
1449814|NCT01641185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449815|NCT01641172|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1449816|NCT01641159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449817|NCT01641146|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449818|NCT01641133|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1449819|NCT01641120|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1449820|NCT01641107||Single Group Assignment||Treatment||None (Open Label)||||||
1449821|NCT01641094|||Cohort||Prospective|||||||
1449822|NCT01641081|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1449823|NCT01641068|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1449824|NCT01641055|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1449825|NCT01641042|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449826|NCT01641029|||Case-Only||Prospective|||||||
1449827|NCT01641016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449828|NCT01641003|||||Prospective|||||||
1449829|NCT01640990|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1449830|NCT01640977|||Cohort||Prospective|||||||
1449831|NCT01640964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449832|NCT01640951|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449833|NCT01640925|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449834|NCT01640912|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1449835|NCT01640899||Single Group Assignment||Treatment||None (Open Label)||||||
1449836|NCT01640886|||Case Control||Prospective|||||||
1449837|NCT01640873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449838|NCT01640860|||||Prospective|||||||
1449839|NCT01640847|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449840|NCT01640834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449841|NCT01640821|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449842|NCT01640808|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1449843|NCT01640795||||||||||||
1449844|NCT01640782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449845|NCT01640769|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449846|NCT01640756||Single Group Assignment||Treatment||None (Open Label)||||||
1449847|NCT01640743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449848|NCT01640730||Single Group Assignment||Treatment||None (Open Label)||||||
1449849|NCT01640717|||||Retrospective|||||||
1449850|NCT01640704|Randomized|Factorial Assignment||||Double||||||
1449851|NCT01640691||Single Group Assignment||Prevention||None (Open Label)||||||
1449852|NCT01640678|Randomized|Parallel Assignment||Treatment||Single||||||t
1449853|NCT01640665||Single Group Assignment||Treatment||None (Open Label)||||||
1449854|NCT01640652|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1449855|NCT01640639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449856|NCT01640626|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449857|NCT01640613|||Cohort||Prospective|||||||
1449858|NCT01640600|||Case-Control||Other|||||||
1449859|NCT01640587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449860|NCT01640574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449861|NCT01640561|Randomized|Parallel Assignment||Treatment||Single||||||t
1449862|NCT01640548|||Cohort||Retrospective|||||||
1449863|NCT01640535|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449864|NCT01640522|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1449865|NCT01640509||Single Group Assignment||Treatment||None (Open Label)||||||
1449866|NCT01640496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449867|NCT01640483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449868|NCT01640470|Randomized|Parallel Assignment||Treatment||Single||||||t
1449869|NCT01640457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449870|NCT01640444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449871|NCT01640431|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449872|NCT01640418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449873|NCT01640405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449874|NCT01640392|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449875|NCT01640379|Randomized|Parallel Assignment||Prevention||Single|||||t|
1449876|NCT01640366|Randomized|Parallel Assignment||Prevention||Single||||||t
1449877|NCT01640353|||Cohort||Prospective|||||||
1449878|NCT01640340|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1449879|NCT01640327||Single Group Assignment||Prevention||None (Open Label)||||||
1449880|NCT01640314||Single Group Assignment||Prevention||None (Open Label)||||||
1449881|NCT01640301|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449882|NCT01640288|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1449883|NCT01640275|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1449884|NCT01640262|||Case-Only||Prospective|||||||
1449885|NCT01640249|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1449886|NCT01640236|||||Prospective|||||||
1449887|NCT01640223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449888|NCT01640210||Single Group Assignment||Treatment||None (Open Label)||||||
1449889|NCT01640197|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1449890|NCT01640184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449891|NCT01640171||Single Group Assignment||Treatment||Single|||t|||
1449892|NCT01640158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449893|NCT01640145|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1449894|NCT01640119|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449895|NCT01640106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449896|NCT01640093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449897|NCT01640080|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449898|NCT01640067||Single Group Assignment||||None (Open Label)||||||
1449899|NCT01640054||Single Group Assignment||Treatment||None (Open Label)||||||
1449900|NCT01640041||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1449901|NCT01640028|||Case-Only||Prospective|||||||
1449902|NCT01640015|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1449903|NCT01640002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449904|NCT01639989|||Cohort||Prospective|||||||
1449905|NCT01639976|||Cohort||Prospective|||||||
1449906|NCT01639950|||Cohort||Prospective|||||||
1449907|NCT01639937|||Cohort||Prospective|||||||
1449908|NCT01639924|||Cohort||Prospective|||||||
1449909|NCT01639911||Single Group Assignment||Treatment||None (Open Label)||||||
1449910|NCT01639898|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449911|NCT01639885|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449912|NCT01639872|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449913|NCT01639859||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449914|NCT01639846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449915|NCT01639833|Randomized|Single Group Assignment||Treatment||Single|||t|||
1449916|NCT01639820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449917|NCT01639807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449918|NCT01639794|||Cohort||Prospective|||||||
1449919|NCT01639781|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1449920|NCT01639768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449921|NCT01639755||Single Group Assignment||Other||None (Open Label)||||||
1449922|NCT01639742||Single Group Assignment||Other||None (Open Label)||||||
1449923|NCT01639729|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1449924|NCT01639716||||||||||||
1449925|NCT01639703||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449926|NCT01639690||Single Group Assignment||Treatment||None (Open Label)||||||
1449927|NCT01639677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449928|NCT01639664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449929|NCT01639651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449930|NCT01639638|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449931|NCT01639625||Single Group Assignment||||None (Open Label)||||||
1449932|NCT01639612||Single Group Assignment||Supportive Care||None (Open Label)||||||
1449933|NCT01639599|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1449934|NCT01639586|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1449935|NCT01639573|||Cohort||Prospective|||||||
1449936|NCT01639560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449937|NCT01639547|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1449938|NCT01639534|||Case-Only||Other|||||||
1449939|NCT01639521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449940|NCT01639508||Single Group Assignment||Treatment||None (Open Label)||||||
1449941|NCT01639495||Single Group Assignment||Treatment||None (Open Label)||This study had a single arm: catheter ablation for PAF||||
1449942|NCT01639482|||Case Control||Prospective|||||||
1449943|NCT01639469|Randomized|Parallel Assignment||Other||Single||||||t
1449944|NCT01639456|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1449945|NCT01639443|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1449946|NCT01639430|||Cohort||Retrospective|||||||
1449947|NCT01639417|||Cohort||Cross-Sectional|||||||
1449948|NCT01639404||Single Group Assignment||Treatment||None (Open Label)||||||
1449949|NCT01639391||Single Group Assignment||Basic Science||None (Open Label)||||||
1449950|NCT01639378|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1449951|NCT01639365|||Cohort||Prospective|||||||
1449952|NCT01639352||Single Group Assignment||Treatment||None (Open Label)||||||
1449953|NCT01639339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449954|NCT01639326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449955|NCT01639313|||Cohort||Prospective|||||||
1449956|NCT01639300|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449957|NCT01639287|||||Retrospective|||||||
1449958|NCT01639274||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449959|NCT01639261||Single Group Assignment||Treatment||None (Open Label)||||||
1449960|NCT01639248||Single Group Assignment||Treatment||None (Open Label)||||||
1449961|NCT01639235|||Case-Control||Cross-Sectional|||||||
1449962|NCT01639222||Single Group Assignment||Treatment||None (Open Label)||||||
1449963|NCT01639209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449964|NCT01639196|Randomized|Parallel Assignment||Treatment||Single|||t|||
1449965|NCT01639183|Randomized|Parallel Assignment||Prevention||Single||||||t
1449966|NCT01639170||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449967|NCT01639157|Randomized|Crossover Assignment||Basic Science||Triple|||t|t||t
1449968|NCT01639144|Randomized|Parallel Assignment||Prevention||Single|||t|||
1449969|NCT01639131||Single Group Assignment||Treatment||None (Open Label)||||||
1449970|NCT01639118|||Cohort||Prospective|||||||
1449971|NCT01639105|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449972|NCT01639092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449973|NCT01639079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449974|NCT01639066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449975|NCT01639053|||Cohort||Prospective|||||||
1449976|NCT01639040|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1449977|NCT01639027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1449978|NCT01639014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449979|NCT01639001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449980|NCT01638988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449981|NCT01638975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449982|NCT01638962|Randomized|Parallel Assignment||Treatment||Single||||||t
1449983|NCT01638949|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1449984|NCT01638936||Single Group Assignment||Treatment||None (Open Label)||||||
1449985|NCT01638923|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1449986|NCT01638910||Single Group Assignment||Prevention||None (Open Label)||||||
1449987|NCT01638897|||Other||Prospective|||||||
1449988|NCT01638884|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1449989|NCT01638871|Randomized|Parallel Assignment||Treatment||Single|||||t|
1449990|NCT01638858||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449991|NCT01638845|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1449992|NCT01638832||Single Group Assignment||Diagnostic||None (Open Label)||||||
1449993|NCT01638819|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1449994|NCT01638806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1449995|NCT01638793|Randomized|Parallel Assignment||||Single|||t|||
1449996|NCT01638780|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1449997|NCT01638767|Randomized|Parallel Assignment||||None (Open Label)||||||
1449998|NCT01638754||Single Group Assignment||Treatment||None (Open Label)||||||
1449999|NCT01638741|||Case-Only||Prospective|||||||
1450000|NCT01638728|||Case-Crossover||Prospective|||||||
1450001|NCT01638715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450002|NCT01638702|Randomized|Parallel Assignment||Prevention||Single|||t|||
1450003|NCT01638689||Single Group Assignment||Basic Science||None (Open Label)||||||
1450004|NCT01638676||Single Group Assignment||Treatment||None (Open Label)||||||
1450005|NCT01638663|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1450006|NCT01638650|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450007|NCT01638637|||Cohort||Cross-Sectional|||||||
1450008|NCT01638624|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1450009|NCT01638611|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1450010|NCT01638598|Randomized|Parallel Assignment||Treatment||Double||||||
1450011|NCT01638585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450012|NCT01638572|||Cohort||Retrospective|||||||
1450013|NCT01638559||Single Group Assignment||Treatment||None (Open Label)||||||
1450014|NCT01638546|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450015|NCT01638533||Single Group Assignment||Treatment||None (Open Label)||||||
1450016|NCT01638520|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450017|NCT01638507||Single Group Assignment||Treatment||None (Open Label)||||||
1450018|NCT01638494||Factorial Assignment||Treatment||None (Open Label)||||||
1450019|NCT01638481|||Case-Only||Prospective|||||||
1450020|NCT01638468||Single Group Assignment||Treatment||None (Open Label)||||||
1450021|NCT01638455||Single Group Assignment||Other||||||||
1450022|NCT01638442|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450023|NCT01638429||Single Group Assignment||Treatment||None (Open Label)||||||
1450024|NCT01638416|Randomized|Parallel Assignment||Treatment||Quadruple|Two staff not involved in the direct care of each patient checked the red-cell units, and concealed the collection and expiry dates from clinical staff using a bag with opaque panels (Australia, Ireland and Saudi Arabia), or an obscuring sticker (NZ and Finland).||t|t|t|t
1450025|NCT01638403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450026|NCT01638390||Single Group Assignment||Treatment||None (Open Label)||||||
1450027|NCT01638377|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450028|NCT01638364|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1450029|NCT01638351|Randomized|Parallel Assignment||Treatment||Single||||||t
1450030|NCT01638338|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1450031|NCT01638325|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1450032|NCT01638312|||Case Control||Prospective|||||||
1450033|NCT01638299||Single Group Assignment||Treatment||None (Open Label)||||||
1450034|NCT01638286|||Case-Crossover||Cross-Sectional|||||||
1450035|NCT01638273|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450036|NCT01638260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450037|NCT01638247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450038|NCT01638234|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1450039|NCT01638221|||||Prospective|||||||
1451787|NCT01615393|Randomized|Crossover Assignment||||Single|||t|||
1450040|NCT01638208|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450041|NCT01638195||Single Group Assignment||Treatment||None (Open Label)||||||
1450042|NCT01638182|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450043|NCT01638169|||Case-Only|||||||||
1450044|NCT01638156|||Case-Only||Prospective|||||||
1450045|NCT01638143|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1450046|NCT01638130|||Cohort||Prospective|||||||
1450047|NCT01638117|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1450048|NCT01638104|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1450049|NCT01638091||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450050|NCT01638078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450051|NCT01638065|||||Prospective|||||||
1450052|NCT01638052|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1450053|NCT01638039|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1450054|NCT01638026||Single Group Assignment||Treatment||None (Open Label)||||||
1450055|NCT01638013||Single Group Assignment||Treatment||None (Open Label)||||||
1450056|NCT01638000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450057|NCT01637987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450058|NCT01637974|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1450059|NCT01637961||Single Group Assignment||Treatment||None (Open Label)||||||
1450060|NCT01637948|Randomized|Parallel Assignment||Treatment||Single|||||t|
1450061|NCT01637935|||Cohort||Prospective|||||||
1450062|NCT01637922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450063|NCT01637909|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450064|NCT01637896|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1450065|NCT01637883|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1450066|NCT01637870||Single Group Assignment||Prevention||None (Open Label)||||||
1450067|NCT01637857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450068|NCT01637844|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450069|NCT01637831||Single Group Assignment||Treatment||None (Open Label)||||||
1450070|NCT01637818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450071|NCT01637805||Single Group Assignment||Supportive Care||None (Open Label)||||||
1450072|NCT01637792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450073|NCT01637779|Randomized|Parallel Assignment||||Single|||t|||
1450074|NCT01637766||Single Group Assignment||Treatment||None (Open Label)||||||
1450075|NCT01637753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450076|NCT01637740|||Case Control||Retrospective|||||||
1450077|NCT01637727|||Case Control||Retrospective|||||||
1450078|NCT01637714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450079|NCT01637701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450080|NCT01637688|||Cohort||Prospective|||||||
1450081|NCT01637675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450082|NCT01637662|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1450083|NCT01637649|||||Cross-Sectional|||||||
1450084|NCT01637636|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1450085|NCT01637623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450086|NCT01637610|||Cohort||Prospective|||||||
1450087|NCT01637597|||||Prospective|||||||
1450088|NCT01637584|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450089|NCT01637571|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450090|NCT01637558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450091|NCT01637545|Randomized|Parallel Assignment||Prevention||Single|||t|||
1450092|NCT01637532|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450093|NCT01637519|||Cohort||Prospective|||||||
1450094|NCT01637506|||Case-Control||Prospective|||||||
1450095|NCT01637493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450096|NCT01637480|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450097|NCT01637467|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450098|NCT01637454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450099|NCT01637441|Randomized|Parallel Assignment||Treatment||Single||||||t
1450100|NCT01637428||Crossover Assignment||Supportive Care||None (Open Label)||||||
1450101|NCT01637415|||Cohort||Prospective|||||||
1450102|NCT01637402||Single Group Assignment||Treatment||None (Open Label)||||||
1450103|NCT01637389|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1450104|NCT01637376||Single Group Assignment||Treatment||None (Open Label)||||||
1450105|NCT01637363|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1450106|NCT01637350|||Case Control||Prospective|||||||
1450107|NCT01637337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450108|NCT01637324|||Cohort||Prospective|||||||
1450109|NCT01637311||Single Group Assignment||Treatment||None (Open Label)||||||
1450110|NCT01637298|||Cohort||Prospective|||||||
1450111|NCT01637285|Randomized|Parallel Assignment||||None (Open Label)||||||
1450112|NCT01637272|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450113|NCT01637259|Randomized|Single Group Assignment||||None (Open Label)||||||
1450114|NCT01637246|||Cohort||Retrospective|||||||
1450115|NCT01637233|||||Prospective|||||||
1450116|NCT01637220|||Case-Control||Prospective|||||||
1450117|NCT01637207|Randomized|Parallel Assignment||||Single||||||t
1450118|NCT01637194||Single Group Assignment||Treatment||None (Open Label)||||||
1452102|NCT01611272|||Cohort||Prospective|||||||
1450119|NCT01637181|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450120|NCT01637168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450121|NCT01637155||Single Group Assignment||Treatment||None (Open Label)||||||
1450122|NCT01637142|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450123|NCT01637129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450124|NCT01637116|||||Prospective|||||||
1450125|NCT01637103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450126|NCT01637090||Single Group Assignment||Treatment||None (Open Label)||||||
1450127|NCT01637077|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1450128|NCT01637064|||Case-Only|||||||||
1450129|NCT01637051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450130|NCT01637038|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1450131|NCT01637025|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450132|NCT01637012||Single Group Assignment||Treatment||None (Open Label)||||||
1450133|NCT01636999||Single Group Assignment||Treatment||Single|||t|||
1450134|NCT01636986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450135|NCT01636973||Single Group Assignment||||Double|||t|||t
1450136|NCT01636960||Single Group Assignment||Treatment||None (Open Label)||||||
1450137|NCT01636947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450138|NCT01636934|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450139|NCT01636908||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450140|NCT01636895||Single Group Assignment||Prevention||None (Open Label)||||||
1450141|NCT01636882||Single Group Assignment||Treatment||None (Open Label)||||||
1450142|NCT01636869||Single Group Assignment||Basic Science||None (Open Label)||||||
1450143|NCT01636856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450144|NCT01636843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450145|NCT01636830|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1450146|NCT01636817|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450147|NCT01636804|||Cohort||Prospective|||||||
1450148|NCT01636791|Randomized|Parallel Assignment||Treatment||Single||||||t
1450149|NCT01636778||Single Group Assignment||Treatment||None (Open Label)||||||
1450150|NCT01636765|||Case-Only||Prospective|||||||
1450151|NCT01636752|Randomized|Parallel Assignment||Treatment||Single||||||t
1450152|NCT01636739|||Cohort||Prospective|||||||
1450153|NCT01636726|||||Retrospective|||||||
1450154|NCT01636713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450155|NCT01636700|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450156|NCT01636687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450157|NCT01636674||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450158|NCT01636661|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1450159|NCT01636648|||Cohort||Prospective|||||||
1450160|NCT01636635|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1450161|NCT01636622||Single Group Assignment||Treatment||None (Open Label)||||||
1450162|NCT01636609||Parallel Assignment||Treatment||None (Open Label)||||||
1450163|NCT01636596||Single Group Assignment||Treatment||None (Open Label)||||||
1450164|NCT01636583|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450165|NCT01636570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450166|NCT01636557||Single Group Assignment||Basic Science||None (Open Label)||||||
1450167|NCT01636544||Single Group Assignment||Basic Science||None (Open Label)||||||
1450168|NCT01636531|Randomized|Parallel Assignment||||None (Open Label)||||||
1450169|NCT01636518|||Cohort||Prospective|||||||
1450170|NCT01636505|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1450171|NCT01636492|Randomized|Parallel Assignment||||Double|||t||t|
1450172|NCT01636479||Single Group Assignment||Treatment||None (Open Label)||||||
1450173|NCT01636466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450174|NCT01636453||Single Group Assignment||Treatment||None (Open Label)||||||
1450175|NCT01636440||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450176|NCT01636427|||Case-Only||Retrospective|||||||
1450177|NCT01636414|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450178|NCT01636401||||||||||||
1450179|NCT01636388||Single Group Assignment||Treatment||None (Open Label)||||||
1450180|NCT01636375|||Case-Control||Prospective|||||||
1450181|NCT01636362||Single Group Assignment||Treatment||None (Open Label)||||||
1450182|NCT01636349|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450183|NCT01636336|Non-Randomized|Parallel Assignment||||Single|||t|||
1450184|NCT01636323|Non-Randomized|Parallel Assignment||||Single|||t|||
1450185|NCT01636310|Non-Randomized|Parallel Assignment||||Single|||t|||
1450186|NCT01636297|Randomized|Parallel Assignment||Treatment||Single||||||t
1450187|NCT01636284||Single Group Assignment||Treatment||None (Open Label)||||||
1450188|NCT01636271|||Cohort||Prospective|||||||
1450189|NCT01636258|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450190|NCT01636245|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1450191|NCT01636232|||Case Control||Prospective|||||||
1450192|NCT01636219|||Cohort||Cross-Sectional|||||||
1450193|NCT01636206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450194|NCT01636193|||Cohort||Prospective|||||||
1450195|NCT01636180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450196|NCT01636167||Single Group Assignment||Health Services Research||None (Open Label)||||||
1450197|NCT01636154|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1450198|NCT01636141|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1450199|NCT01636128|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1450200|NCT01636115|||Case-Crossover||Prospective|||||||
1450201|NCT01636102||Single Group Assignment||Prevention||None (Open Label)||||||
1450202|NCT01636089|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1450203|NCT01636076|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450204|NCT01636063|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450205|NCT01636050|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1450206|NCT01636037||Single Group Assignment||Treatment||None (Open Label)||||||
1450207|NCT01636024|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1450208|NCT01636011|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1450209|NCT01635998|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1450210|NCT01635985|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450211|NCT01635972||Single Group Assignment||||None (Open Label)||||||
1450212|NCT01635959|||||Cross-Sectional|||||||
1450213|NCT01635946||Single Group Assignment||||None (Open Label)||||||
1450214|NCT01635933|Randomized|Parallel Assignment||||Single|||t|||
1450215|NCT01635920|Randomized|Parallel Assignment||||None (Open Label)||||||
1450216|NCT01635907||Single Group Assignment||Treatment||||||||
1450217|NCT01635894|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1450218|NCT01635881||Single Group Assignment||Treatment||None (Open Label)||||||
1450219|NCT01635868|||Cohort||Prospective|||||||
1450220|NCT01635855||Single Group Assignment||Treatment||None (Open Label)||||||
1450221|NCT01635842|||Cohort||Prospective|||||||
1450222|NCT01635829|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1450223|NCT01635816|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1450224|NCT01635803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450225|NCT01635790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450226|NCT01635777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450227|NCT01635764||Single Group Assignment||Treatment||None (Open Label)||||||
1450228|NCT01635751|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450229|NCT01635738|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1450230|NCT01635725|||Case-Only||Prospective|||||||
1450231|NCT01635712||Single Group Assignment||Treatment||None (Open Label)||||||
1450232|NCT01635699|||Case-Only||Prospective|||||||
1450233|NCT01635686|Randomized|||||Double||||||
1450234|NCT01635673|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1450235|NCT01635660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450236|NCT01635647|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1450237|NCT01635634|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1450238|NCT01635621|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450239|NCT01635608|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450240|NCT01635595|||Cohort||Retrospective|||||||
1450241|NCT01635582|Randomized|Parallel Assignment||Treatment||Single||||||t
1450242|NCT01635569|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450243|NCT01635556|||Cohort||Prospective|||||||
1450244|NCT01635543|||Cohort||Prospective|||||||
1450245|NCT01635530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450246|NCT01635517|||Cohort||Prospective|||||||
1450247|NCT01635504||Single Group Assignment||Treatment||None (Open Label)||||||
1450248|NCT01635491|||Case-Only||Prospective|||||||
1450249|NCT01635478|||Case-Only||Prospective|||||||
1450250|NCT01635465|||Case Control||Prospective|||||||
1450251|NCT01635452|||Case-Only||Prospective|||||||
1450252|NCT01635439|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450253|NCT01635426|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1450254|NCT01635413|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1450255|NCT01635400|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450256|NCT01635387|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450257|NCT01635374||Single Group Assignment||Treatment||None (Open Label)||||||
1450258|NCT01635361|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1450259|NCT01635348|Randomized|Parallel Assignment||Treatment||Single||||||t
1450260|NCT01635335|Randomized|Parallel Assignment||Prevention||Single|||t|||
1450261|NCT01635322|||Cohort||Prospective|||||||
1450262|NCT01635309|||Cohort||Prospective|||||||
1450263|NCT01635296|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450264|NCT01635283||Single Group Assignment||Treatment||None (Open Label)||||||
1450265|NCT01635270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450266|NCT01635257|||Cohort||Prospective|||||||
1450267|NCT01635244|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450268|NCT01635231|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1450269|NCT01635218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450270|NCT01635205|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450271|NCT01635192|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1450272|NCT01635179||Single Group Assignment||Prevention||Double|||t||t|
1450273|NCT01635166||Single Group Assignment||Treatment||None (Open Label)||||||
1450274|NCT01635153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450275|NCT01635140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450276|NCT01635127|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1450277|NCT01635114|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1450278|NCT01635101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450279|NCT01635088|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450280|NCT01635075|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1450281|NCT01635062|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1450282|NCT01635049|||Cohort||Prospective|||||||
1450283|NCT01635036|||Cohort||Prospective|||||||
1450284|NCT01635023|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450285|NCT01635010|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450286|NCT01634997|||Cohort||Prospective|||||||
1450287|NCT01634984|||Case Control||Retrospective|||||||
1450288|NCT01634971|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450289|NCT01634958|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1450290|NCT01634945|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1450291|NCT01634932|Randomized|Crossover Assignment||Prevention||Single|||t|||
1450292|NCT01634919|||Cohort||Prospective|||||||
1450293|NCT01634906||Single Group Assignment||Basic Science||None (Open Label)||||||
1450294|NCT01634893||Single Group Assignment||Treatment||None (Open Label)||||||
1450295|NCT01634880||Single Group Assignment||Treatment||None (Open Label)||||||
1450296|NCT01634867|||Case Control||Prospective|||||||
1450297|NCT01634854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450298|NCT01634841|Randomized|Parallel Assignment||Prevention||Single|||||t|
1450299|NCT01634828|||Cohort||Prospective|||||||
1450300|NCT01634815||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450301|NCT01634802|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1450302|NCT01634789|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450303|NCT01634776|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1450304|NCT01634763|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1450305|NCT01634750|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450306|NCT01634737|||Case Control||Prospective|||||||
1450307|NCT01634724|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1450308|NCT01634711||Single Group Assignment||Treatment||None (Open Label)||||||
1450309|NCT01634698|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1450310|NCT01634685||Single Group Assignment||Treatment||None (Open Label)||||||
1450311|NCT01634672|||Cohort||Prospective|||||||
1450312|NCT01634659|Randomized|Crossover Assignment||Treatment||Single|||t|||
1450313|NCT01634646||Single Group Assignment||||Double|||t||t|
1450314|NCT01634633|||||Cross-Sectional|||||||
1450315|NCT01634620|||Case-Only||Prospective|||||||
1450316|NCT01634607|||Cohort||Prospective|||||||
1450317|NCT01634594|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1450318|NCT01634568|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1450319|NCT01634555||Single Group Assignment||Treatment||None (Open Label)||||||
1450320|NCT01634542|||Cohort||Prospective|||||||
1450321|NCT01634529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450322|NCT01634516|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450323|NCT01634503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450324|NCT01634490|||Cohort||Prospective|||||||
1450325|NCT01634477|||Cohort||Prospective|||||||
1450326|NCT01634464|||Cohort||Prospective|||||||
1450327|NCT01634451|Randomized|Parallel Assignment||||None (Open Label)||||||
1450328|NCT01634438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450329|NCT01634425|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1450330|NCT01634412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450331|NCT01634399||||||||||||
1450332|NCT01634386||||||||||||
1450333|NCT01634373||||||||||||
1450334|NCT01634360||Single Group Assignment||Treatment||None (Open Label)||||||
1450335|NCT01634347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450336|NCT01634334|Randomized|Parallel Assignment||Prevention||Single||||||t
1450337|NCT01634321|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450338|NCT01634308||||||||||||
1450339|NCT01634295|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450340|NCT01634282||Single Group Assignment||Treatment||None (Open Label)||||||
1450341|NCT01634269||Single Group Assignment||Treatment||None (Open Label)||||||
1450342|NCT01634256|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1450343|NCT01634243||Single Group Assignment||Treatment||None (Open Label)||||||
1450344|NCT01634230||Single Group Assignment||Supportive Care||None (Open Label)||||||
1450345|NCT01634217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450346|NCT01634204|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450347|NCT01634191|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1450348|NCT01634178|Randomized|Crossover Assignment||||None (Open Label)||||||
1450349|NCT01634165|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1450350|NCT01634152|Randomized|Parallel Assignment||Treatment||Double||||||
1450351|NCT01634139|Randomized|Parallel Assignment||Treatment||Double||||||
1450352|NCT01634126|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1450353|NCT01634113|Randomized|Parallel Assignment||Treatment||Double||||||
1450354|NCT01634100|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1450355|NCT01634087|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450356|NCT01634074|||Cohort||Prospective|||||||
1450357|NCT01634061|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450358|NCT01634048|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450359|NCT01634035|||Case-Crossover||Retrospective|||||||
1450360|NCT01634022||Single Group Assignment||Treatment||None (Open Label)||||||
1450361|NCT01634009|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1450362|NCT01633996||Single Group Assignment||Treatment||None (Open Label)||||||
1450363|NCT01633983|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450364|NCT01633970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450365|NCT01633957|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1450366|NCT01633944|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450367|NCT01633931|||Cohort||Prospective|||||||
1450368|NCT01633918|Randomized|Parallel Assignment||||None (Open Label)||||||
1450369|NCT01633905|||Case Control||Prospective|||||||
1450370|NCT01633892||Single Group Assignment||Treatment||None (Open Label)||||||
1450371|NCT01633879|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450372|NCT01633866|||||Prospective|||||||
1450373|NCT01633853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450374|NCT01633840|Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1450375|NCT01633827|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1450376|NCT01633814|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1450377|NCT01633801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450378|NCT01633788|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450379|NCT01633775|||Cohort||Prospective|||||||
1450380|NCT01633762||Single Group Assignment||Basic Science||None (Open Label)||||||
1450381|NCT01633749||Single Group Assignment||||None (Open Label)||||||
1450382|NCT01633736||Single Group Assignment||Treatment||Single||||||t
1450383|NCT01633723|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1450384|NCT01633710|||Case-Only||Cross-Sectional|||||||
1450385|NCT01633697|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1450386|NCT01633684|||Case Control||Prospective|||||||
1450387|NCT01633671|||Case Control||Retrospective|||||||
1450388|NCT01633658|Randomized|Parallel Assignment||||Single|||t|||
1450389|NCT01633645||Single Group Assignment||Treatment||None (Open Label)||||||
1450390|NCT01633632|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1450391|NCT01633619|||Cohort||Prospective|||||||
1450392|NCT01633606|||Cohort||Prospective|||||||
1450393|NCT01633593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450394|NCT01633580|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450395|NCT01633567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450396|NCT01633554|||Case Control||Cross-Sectional|||||||
1450397|NCT01633541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450398|NCT01633528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450399|NCT01633515||Single Group Assignment||Treatment||None (Open Label)||||||
1450400|NCT01633502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450401|NCT01633489|||Cohort||Prospective|||||||
1450402|NCT01633476|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1450403|NCT01633463|||Case-Only||Prospective|||||||
1450404|NCT01633450|Randomized|Crossover Assignment||||Single|||t|||
1450405|NCT01633437|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450406|NCT01633424|||Cohort||Retrospective|||||||
1450407|NCT01633411|||Cohort||Prospective|||||||
1450408|NCT01633398|||Other||Prospective|||||||
1450409|NCT01633385|||Case Control||Prospective|||||||
1450410|NCT01633372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450411|NCT01633359|Randomized|Parallel Assignment||Treatment||Single||||||t
1450412|NCT01633346|||Cohort||Prospective|||||||
1450413|NCT01633333|Randomized|Parallel Assignment||Screening||Single|||t|||
1450414|NCT01633320|||Cohort||Prospective|||||||
1450415|NCT01633307|Randomized|Parallel Assignment||||None (Open Label)||||||
1450416|NCT01633294|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450417|NCT01633281||Single Group Assignment||Treatment||None (Open Label)||||||
1450418|NCT01633268|||Cohort||Prospective|||||||
1450419|NCT01633255|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1450420|NCT01633242|||||Prospective|||||||
1450421|NCT01633229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450422|NCT01633216|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1450423|NCT01633203|||Cohort||Prospective|||||||
1450424|NCT01633190|||Cohort||Other|||||||
1450425|NCT01633177|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1450426|NCT01633164|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1450427|NCT01633151|||||Prospective|||||||
1450428|NCT01633138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450429|NCT01633125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450430|NCT01633112|Randomized|Parallel Assignment||Treatment||Single||||||t
1450431|NCT01633099||Single Group Assignment||Treatment||None (Open Label)||||||
1450432|NCT01633086|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1450433|NCT01633073|Randomized|Parallel Assignment||||Double|||t|||t
1450434|NCT01633060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450435|NCT01633047|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450436|NCT01633034|||Case-Control||Cross-Sectional|||||||
1450437|NCT01633021|||Family-Based||Cross-Sectional|||||||
1450438|NCT01633008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450439|NCT01632995||Single Group Assignment||Prevention||None (Open Label)||||||
1450440|NCT01632982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450441|NCT01632969|||Family-Based||Retrospective|||||||
1450442|NCT01632956|||Cohort||Prospective|||||||
1450443|NCT01632943||Single Group Assignment||Treatment||None (Open Label)||||||
1450444|NCT01632930|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1450445|NCT01632917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450446|NCT01632904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450447|NCT01632891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450448|NCT01632878|||Cohort||Prospective|||||||
1450449|NCT01632865||Single Group Assignment||Treatment||None (Open Label)||||||
1450450|NCT01632852||Single Group Assignment||Treatment||None (Open Label)||||||
1450451|NCT01632839|||Cohort||Prospective|||||||
1450452|NCT01632826||||||||||||
1450453|NCT01632813|||Cohort||Prospective|||||||
1450454|NCT01632800||Single Group Assignment||Basic Science||Double|||t||t|
1450455|NCT01632787|||Cohort||Prospective|||||||
1450456|NCT01632774|||Case-Only||Retrospective|||||||
1450457|NCT01632761|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1450458|NCT01632748|Non-Randomized|Crossover Assignment||||Single|||t|||
1450459|NCT01632735|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1450460|NCT01632722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450461|NCT01632709|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450462|NCT01632696||Single Group Assignment||Other||None (Open Label)||||||
1450463|NCT01632683|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1450464|NCT01632670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450465|NCT01632657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450466|NCT01632644|||Cohort||Cross-Sectional|||||||
1450467|NCT01632631|||Case Control||Prospective|||||||
1450468|NCT01632618|Randomized|Parallel Assignment||Treatment||Single||||||t
1450469|NCT01632605||Single Group Assignment||||None (Open Label)||||||
1450470|NCT01632592|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450471|NCT01632579|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1450472|NCT01632566|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1450473|NCT01632553|||Case Control||Prospective|||||||
1450474|NCT01632540|||Cohort||Prospective|||||||
1450475|NCT01632527||Single Group Assignment||Treatment||None (Open Label)||||||
1450476|NCT01632514|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450477|NCT01632501||Single Group Assignment||Treatment||None (Open Label)||||||
1450478|NCT01632488|||Case Control||Prospective|||||||
1450479|NCT01632475|||Case-Only||Prospective|||||||
1450480|NCT01632462|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1450481|NCT01632449|Randomized|Crossover Assignment||||Single|||t|||
1450482|NCT01632436|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450483|NCT01632423|||Case-Only||Prospective|||||||
1450484|NCT01632410|||Cohort||Prospective|||||||
1450485|NCT01632397|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450486|NCT01632384||Single Group Assignment||Other||None (Open Label)||||||
1450487|NCT01632371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450488|NCT01632358||Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1450489|NCT01632345|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450490|NCT01632332||Single Group Assignment||Treatment||None (Open Label)||||||
1450491|NCT01632319|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450492|NCT01632306|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450493|NCT01632293||Single Group Assignment||Treatment||None (Open Label)||||||
1450494|NCT01632280|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450495|NCT01632267|||Cohort||Retrospective|||||||
1450496|NCT01632254|||||Cross-Sectional|||||||
1450497|NCT01632241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450498|NCT01632228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450499|NCT01632215|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450500|NCT01632202|Randomized|Parallel Assignment||Prevention||Single|||t|||
1450501|NCT01632189||Single Group Assignment||Basic Science||None (Open Label)||||||
1450502|NCT01632176|Randomized|Parallel Assignment||Prevention||Single|||t|||
1450503|NCT01632163|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450504|NCT01632150||Single Group Assignment||Treatment||None (Open Label)||||||
1450505|NCT01632137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450506|NCT01632124|||Cohort||Prospective|||||||
1450507|NCT01632111|||Cohort||Retrospective|||||||
1450508|NCT01632098|||Cohort||Prospective|||||||
1450509|NCT01632085|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1450510|NCT01632072|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450511|NCT01632059|||Cohort||Prospective|||||||
1450512|NCT01632046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450513|NCT01632033|||Cohort||Prospective|||||||
1450514|NCT01632020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450515|NCT01632007||||Treatment||Quadruple|||t|t|t|t
1450516|NCT01631994|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1450517|NCT01631981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450518|NCT01631968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450519|NCT01631955|||Case-Only||Prospective|||||||
1450520|NCT01631942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450521|NCT01631929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450522|NCT01631916|Randomized|Parallel Assignment||Treatment||Single|||||t|
1450523|NCT01631903|Randomized|Crossover Assignment||Treatment||Single|||t|||
1450524|NCT01631890|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450525|NCT01631877|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450526|NCT01631864|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1450527|NCT01631851||Single Group Assignment||Treatment||None (Open Label)||||||
1450528|NCT01631838|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1450529|NCT01631825||Single Group Assignment||Treatment||None (Open Label)||||||
1450530|NCT01631812||Single Group Assignment||Treatment||None (Open Label)||||||
1450531|NCT01631799|Randomized|Parallel Assignment||Treatment||Single||||||t
1450532|NCT01631786|||Case-Only||Prospective|||||||
1450533|NCT01631773|||Cohort||Prospective|||||||
1450534|NCT01631760|||Cohort||Prospective|||||||
1450535|NCT01631747|Randomized|Parallel Assignment||Prevention||Single||||||t
1450536|NCT01631721|||Cohort||Prospective|||||||
1450537|NCT01631708|Randomized|Single Group Assignment||Treatment||Single|||t|||
1450538|NCT01631695|||Cohort||Cross-Sectional|||||||
1450539|NCT01631682|Randomized|Parallel Assignment||||None (Open Label)||||||
1450540|NCT01631669|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450541|NCT01631656|Randomized|Parallel Assignment||Treatment||Single||||||t
1450542|NCT01631643||Single Group Assignment||Treatment||None (Open Label)||||||
1450543|NCT01631630|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450544|NCT01631617|Randomized|Parallel Assignment||Treatment||Single|||||t|
1450545|NCT01631604||Factorial Assignment||Treatment||||||||
1450546|NCT01631591|||Other||Other|||||||
1450547|NCT01631578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450548|NCT01631565|Randomized|Parallel Assignment||Treatment||Single||||||t
1450549|NCT01631552||Single Group Assignment||Treatment||None (Open Label)||||||
1450550|NCT01631539||Single Group Assignment||Treatment||None (Open Label)||||||
1450551|NCT01631526||Single Group Assignment||Treatment||None (Open Label)||||||
1450552|NCT01631513||Single Group Assignment||Treatment||None (Open Label)||||||
1450553|NCT01631500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450554|NCT01631487|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450555|NCT01631474|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450556|NCT01631461|||Case Control||Prospective|||||||
1450557|NCT01631448|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1450558|NCT01631435||Single Group Assignment||||None (Open Label)||||||
1450559|NCT01631422|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1450560|NCT01631409|||Cohort||Prospective|||||||
1450561|NCT01631396|||Case Control||Prospective|||||||
1450562|NCT01631383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450563|NCT01631370||Single Group Assignment||Treatment||None (Open Label)||||||
1450564|NCT01631357|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1450565|NCT01631344|Randomized|Parallel Assignment||Treatment||Single||||||t
1450566|NCT01631331||Single Group Assignment||Treatment||None (Open Label)||||||
1450567|NCT01631318||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450568|NCT01631305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450569|NCT01631292|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1450570|NCT01631279||Single Group Assignment||Treatment||None (Open Label)||||||
1450571|NCT01631266|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1450572|NCT01631253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450573|NCT01631240|||||Cross-Sectional|||||||
1450574|NCT01631227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450575|NCT01631214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450576|NCT01631201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450577|NCT01631188||Single Group Assignment||||None (Open Label)||||||
1450578|NCT01631175||Single Group Assignment||Supportive Care||None (Open Label)||||||
1450579|NCT01631162||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450580|NCT01631149|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1450581|NCT01631136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450582|NCT01631123||Single Group Assignment||Basic Science||None (Open Label)||||||
1450583|NCT01631110|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450584|NCT01631097||Single Group Assignment||Basic Science||None (Open Label)||||||
1450585|NCT01631084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450586|NCT01631071|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450587|NCT01631058||Single Group Assignment||Treatment||None (Open Label)||||||
1450588|NCT01631045|||Case Control||Cross-Sectional|||||||
1450589|NCT01631032|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450590|NCT01631019|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450591|NCT01631006|Randomized|Crossover Assignment||Treatment||Single|||||t|
1450592|NCT01630993|Randomized|Parallel Assignment||Prevention||Single||||||t
1450593|NCT01630980|||||Prospective|||||||
1450594|NCT01630967||Single Group Assignment||Treatment||None (Open Label)||||||
1450595|NCT01630954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450596|NCT01630941|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1450597|NCT01630928||Single Group Assignment||Treatment||None (Open Label)||||||
1450598|NCT01630915||||||||||||
1450599|NCT01630902||||||||||||
1450600|NCT01630889||Single Group Assignment||Treatment||None (Open Label)||||||
1450601|NCT01630876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450602|NCT01630863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450603|NCT01630850||Single Group Assignment||Treatment||None (Open Label)||||||
1450604|NCT01630837|Randomized|Parallel Assignment||||Single|||||t|
1450605|NCT01630824|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1450606|NCT01630811|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1450607|NCT01630798||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450608|NCT01630785|||Case Control||Retrospective|||||||
1450609|NCT01630772||Single Group Assignment||Basic Science||Single|||||t|
1450610|NCT01630759|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1450611|NCT01630746||||Treatment||||||||
1450612|NCT01630733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450613|NCT01630720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450614|NCT01630707||||||||||||
1450615|NCT01630694|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1450616|NCT01630681|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1450617|NCT01630668|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450618|NCT01630655||||||||||||
1450619|NCT01630642||||||||||||
1450620|NCT01630629|||Cohort||Prospective|||||||
1450621|NCT01630616|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450622|NCT01630603|||Cohort||Cross-Sectional|||||||
1450623|NCT01630590||Single Group Assignment||Treatment||None (Open Label)||||||
1450624|NCT01630577||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450625|NCT01630564||Single Group Assignment||Treatment||None (Open Label)||||||
1450626|NCT01630551|Randomized|Parallel Assignment||Treatment||Double||Omega 3 fatty acid|t||t|
1450627|NCT01630538||Single Group Assignment||Treatment||None (Open Label)||||||
1450628|NCT01630525|||Case Control||Prospective|||||||
1450629|NCT01630512|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450630|NCT01630499|Randomized|Parallel Assignment||Prevention||Single||||||t
1450631|NCT01630486|||Cohort||Prospective|||||||
1450632|NCT01630473|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450633|NCT01630460|||Case-Control||Prospective|||||||
1450634|NCT01630447|||Case-Only||Prospective|||||||
1450635|NCT01630434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450636|NCT01630421|||Family-Based||Prospective|||||||
1450637|NCT01630408||Single Group Assignment||Treatment||None (Open Label)||||||
1450638|NCT01630395|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1450639|NCT01630382|||Case Control||Prospective|||||||
1450640|NCT01630369|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450641|NCT01630356|Randomized|Parallel Assignment||Prevention||Single|||t|||
1450642|NCT01630343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450643|NCT01630330|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1450644|NCT01630317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450645|NCT01630304|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1450646|NCT01630291||Single Group Assignment||Treatment||None (Open Label)||||||
1450647|NCT01630278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450648|NCT01630265|Randomized|Parallel Assignment||||None (Open Label)||||||
1450649|NCT01630252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450650|NCT01630239||Single Group Assignment||Treatment||None (Open Label)||||||
1450651|NCT01630226||Single Group Assignment||Treatment||None (Open Label)||||||
1450652|NCT01630213|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1450653|NCT01630200|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450654|NCT01630187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450655|NCT01630174|||Cohort||Prospective|||||||
1450656|NCT01630161|Randomized|Parallel Assignment||Prevention||Single||||||t
1450657|NCT01630148|Randomized|Parallel Assignment||Prevention||Single|||t|||
1450658|NCT01630135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450659|NCT01630122|||Case-Only||Prospective|||||||
1450660|NCT01630109|Randomized|Parallel Assignment||||Double|||t||t|
1450661|NCT01630096|Randomized|Single Group Assignment||||None (Open Label)||||||
1450662|NCT01630083|Randomized|Parallel Assignment||Treatment||||||||
1450663|NCT01630070||Single Group Assignment||Treatment||None (Open Label)||||||
1450664|NCT01630057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450665|NCT01630044||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450666|NCT01630031|||Case Control||Prospective|||||||
1450667|NCT01630018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450668|NCT01630005||Single Group Assignment||Treatment||None (Open Label)||||||
1450669|NCT01629992|Randomized|Parallel Assignment||Treatment||Single||||t||
1450670|NCT01629979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450671|NCT01629966|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450672|NCT01629953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450673|NCT01629940||||||||||||
1450674|NCT01629927||||||||||||
1450675|NCT01629914||Single Group Assignment||Other||None (Open Label)||||||
1450676|NCT01629901||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450677|NCT01629888|Randomized|Parallel Assignment||||Double|||t||t|
1450678|NCT01629875|Randomized|||Treatment||Double|||t||t|
1450679|NCT01629862|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450682|NCT01629823|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450683|NCT01629810||Crossover Assignment||Treatment||None (Open Label)||||||
1450684|NCT01629797||Single Group Assignment||||None (Open Label)||||||
1450685|NCT01629784||Single Group Assignment||||None (Open Label)||||||
1450686|NCT01629771|||Case Control||Prospective|||||||
1450687|NCT01629758|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450688|NCT01629745|||Case-Only||Retrospective|||||||
1450689|NCT01629732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450690|NCT01629719|||||Prospective|||||||
1450691|NCT01629706|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1450692|NCT01629693|Randomized|Parallel Assignment||||Single|||t|||
1450693|NCT01629680|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1450694|NCT01629667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450695|NCT01629654||Single Group Assignment||Prevention||Single||||||t
1450696|NCT01629641|||Cohort||Prospective|||||||
1450697|NCT01629628|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450698|NCT01629615||Single Group Assignment||Treatment||None (Open Label)||||||
1450699|NCT01629602||Single Group Assignment||Treatment||Single||||||t
1450700|NCT01629589|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450701|NCT01629576|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450702|NCT01629563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450703|NCT01629550|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450704|NCT01629537|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1450705|NCT01629524|||Cohort||Cross-Sectional|||||||
1450706|NCT01629511||Single Group Assignment||Treatment||None (Open Label)||||||
1450707|NCT01629498|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450708|NCT01629485|Randomized|Parallel Assignment||Prevention||Single||||||t
1450709|NCT01629472|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450710|NCT01629459||Single Group Assignment||Treatment||None (Open Label)||Resistance exercise training||||
1450711|NCT01629446||Single Group Assignment||Basic Science||None (Open Label)||||||
1450712|NCT01629433|||Cohort||Prospective|||||||
1450713|NCT01629420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450714|NCT01629407|||Cohort||Prospective|||||||
1450715|NCT01629394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450716|NCT01629381|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1450717|NCT01629368|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1450718|NCT01629355|||Case Control||Cross-Sectional|||||||
1450719|NCT01629342|||Cohort||Prospective|||||||
1450720|NCT01629329|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450721|NCT01629316|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1450722|NCT01629303|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1450723|NCT01629290|Randomized|Crossover Assignment||Treatment||Single|||t|||
1450724|NCT01629277|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1450725|NCT01629264|||Cohort||Prospective|||||||
1450726|NCT01629251|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1450727|NCT01629238||||||||||||
1450728|NCT01629225||Single Group Assignment||Treatment||Single|||t|||
1450729|NCT01629212||||Treatment||||||||
1450730|NCT01629199|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450731|NCT01629186||Single Group Assignment||Supportive Care||None (Open Label)||||||
1450732|NCT01629173|Non-Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1450733|NCT01629160|||Cohort||Prospective|||||||
1450734|NCT01629147|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1450735|NCT01629134|||Cohort||Prospective|||||||
1450736|NCT01629121|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1450737|NCT01629108|||Cohort||Prospective|||||||
1450738|NCT01629095|||Cohort||Retrospective|||||||
1450739|NCT01629082|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450740|NCT01629069||Single Group Assignment||Supportive Care||None (Open Label)||||||
1450741|NCT01629056|Randomized|Parallel Assignment||Treatment||Single||||t||
1450742|NCT01629043|||Other||Prospective|||||||
1450743|NCT01629030|||||Retrospective|||||||
1450744|NCT01629017|||Case Control||Prospective|||||||
1450745|NCT01629004|Randomized|Factorial Assignment||Screening||Single|||t|||
1450746|NCT01628991|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450747|NCT01628978|||||Prospective|||||||
1450748|NCT01628965||Single Group Assignment||Treatment||None (Open Label)||||||
1450749|NCT01628952|Randomized|Parallel Assignment||Treatment||Single|||||t|
1450750|NCT01628939|||Case Control||Prospective|||||||
1450751|NCT01628926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450752|NCT01628913|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450753|NCT01628900|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1450754|NCT01628887||Single Group Assignment||Supportive Care||None (Open Label)||||||
1450755|NCT01628874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450756|NCT01628861|Randomized|Parallel Assignment||Prevention||Single||||||t
1450757|NCT01628848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450758|NCT01628835|Randomized|Parallel Assignment||Prevention||Single|||t|||
1450759|NCT01628822|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450760|NCT01628809|Randomized|Parallel Assignment||Treatment||Single|||||t|
1450761|NCT01628796||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450762|NCT01628783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450763|NCT01628770|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450764|NCT01628757|||Cohort||Prospective|||||||
1450765|NCT01628744|||Case-Only||Retrospective|||||||
1450766|NCT01628731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450767|NCT01628718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450768|NCT01628705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450769|NCT01628692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450770|NCT01628679||Single Group Assignment||Treatment||None (Open Label)||||||
1450771|NCT01628666|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1450772|NCT01628653||Single Group Assignment||Treatment||None (Open Label)||||||
1450773|NCT01628640|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450774|NCT01628627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450775|NCT01628614|||Case-Only||Prospective|||||||
1450776|NCT01628601|||Cohort||Prospective|||||||
1450777|NCT01628588|||Case-Only||Prospective|||||||
1450778|NCT01628575|||Cohort||Retrospective|||||||
1450779|NCT01628562|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450780|NCT01628549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450781|NCT01628536||Single Group Assignment||Treatment||None (Open Label)||||||
1450782|NCT01628523|||||Prospective|||||||
1450783|NCT01628510|Randomized|Parallel Assignment||Treatment||Single||||||t
1450784|NCT01628497|||Other||Cross-Sectional|||||||
1450785|NCT01628484||Single Group Assignment||Treatment||None (Open Label)||||||
1450786|NCT01628471||Single Group Assignment||Treatment||None (Open Label)||||||
1450787|NCT01628458||Single Group Assignment||Treatment||None (Open Label)||||||
1450788|NCT01628445|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450789|NCT01628432|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1450790|NCT01628419||Single Group Assignment||Health Services Research||None (Open Label)||||||
1450791|NCT01628406|||Case Control||Retrospective|||||||
1450792|NCT01628393|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450793|NCT01628380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450794|NCT01628367|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450795|NCT01628354||Single Group Assignment||Treatment||None (Open Label)||||||
1450796|NCT01628341|||Ecologic or Community||Retrospective|||||||
1450797|NCT01628328|||Case Control||Prospective|||||||
1450798|NCT01628315|||Cohort||Retrospective|||||||
1450799|NCT01628302|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1450800|NCT01628289|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1450801|NCT01628276|Randomized|Crossover Assignment||||Single||||||t
1450802|NCT01628263|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1450803|NCT01628250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450804|NCT01628237|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1450805|NCT01628224|||Cohort||Prospective|||||||
1450806|NCT01628211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450807|NCT01628198||Single Group Assignment||Treatment||None (Open Label)||||||
1450808|NCT01628185|||Cohort||Prospective|||||||
1450809|NCT01628172|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450810|NCT01628159||Single Group Assignment||Treatment||None (Open Label)||||||
1450811|NCT01628146||Single Group Assignment||Treatment||None (Open Label)||||||
1450812|NCT01628133|||Cohort||Prospective|||||||
1450813|NCT01628120||Single Group Assignment||Treatment||None (Open Label)||||||
1450814|NCT01628107||Single Group Assignment||Treatment||None (Open Label)||||||
1450815|NCT01628094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450816|NCT01628081|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450817|NCT01628068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450818|NCT01628055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450819|NCT01628042|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450820|NCT01628029|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1450821|NCT01628016|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450822|NCT01628003|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1450823|NCT01627990|||Cohort||Prospective|||||||
1450824|NCT01627977||Single Group Assignment||Supportive Care||None (Open Label)||||||
1450825|NCT01627964|||Case-Only||Retrospective|||||||
1450826|NCT01627951|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1450827|NCT01627938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450828|NCT01627925|Randomized|Parallel Assignment||Prevention||Single||||||t
1450829|NCT01627912|Randomized|Crossover Assignment||Prevention||Single|||t|||
1450830|NCT01627899||Single Group Assignment||Other||None (Open Label)||||||
1450831|NCT01627886|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1450832|NCT01627873|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1450833|NCT01627860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450834|NCT01627847|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1450835|NCT01627834|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1450836|NCT01627821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450837|NCT01627808|||Case-Only||Cross-Sectional|||||||
1450838|NCT01627795||Single Group Assignment||Treatment||None (Open Label)||||||
1450839|NCT01627782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450840|NCT01627769|||Other||Cross-Sectional|||||||
1450841|NCT01627756|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1450842|NCT01627743|||Cohort||Prospective|||||||
1450843|NCT01627730|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1450844|NCT01627717||Single Group Assignment||Basic Science||None (Open Label)||||||
1450845|NCT01627704||Single Group Assignment||Treatment||None (Open Label)||||||
1450846|NCT01627691||Single Group Assignment||Treatment||None (Open Label)||||||
1450847|NCT01627678|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450848|NCT01627665|Randomized|Crossover Assignment||||None (Open Label)||||||
1450849|NCT01627652||Single Group Assignment||Basic Science||None (Open Label)||||||
1450850|NCT01627639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450851|NCT01627626|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1450852|NCT01627613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450853|NCT01627600|||Ecologic or Community||Cross-Sectional|||||||
1450854|NCT01627587|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1450855|NCT01627574|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1450856|NCT01627561|Randomized|Parallel Assignment||Prevention||Single|||t|||
1450857|NCT01627548|Randomized|||Treatment||None (Open Label)||||||
1450858|NCT01627535||Single Group Assignment||Treatment||None (Open Label)||||||
1450859|NCT01627522|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450860|NCT01627509|||Cohort||Prospective|||||||
1450861|NCT01627496|||Cohort||Cross-Sectional|||||||
1450862|NCT01627483|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450863|NCT01627470|||Cohort||Prospective|||||||
1450864|NCT01627457||Single Group Assignment||Basic Science||None (Open Label)||||||
1450865|NCT01627444|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1450866|NCT01627431||Single Group Assignment||Basic Science||None (Open Label)||||||
1450867|NCT01627418|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1450868|NCT01627405||||||||||||
1450869|NCT01627392||Single Group Assignment||Basic Science||None (Open Label)||||||
1450870|NCT01627379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450871|NCT01627366|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1450872|NCT01627353|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1450873|NCT01627340|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450874|NCT01627327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450875|NCT01627314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450876|NCT01627301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450877|NCT01627288|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450878|NCT01627275||Single Group Assignment||Treatment||None (Open Label)||||||
1450879|NCT01627262|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450880|NCT01627249|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450881|NCT01627236|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450882|NCT01627223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450883|NCT01627210|||Cohort||Prospective|||||||
1450884|NCT01627197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450885|NCT01627184|||Cohort||Prospective|||||||
1450886|NCT01627171|Randomized|Parallel Assignment||Treatment||Single|||||t|
1450887|NCT01627158|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1450888|NCT01627145||Single Group Assignment||Treatment||None (Open Label)||||||
1450889|NCT01627132||Single Group Assignment||Treatment||None (Open Label)||||||
1450890|NCT01627119|||Case-Only||Retrospective|||||||
1450891|NCT01627106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450892|NCT01627093|||Cohort||Other|||||||
1450893|NCT01627080|||Cohort||Prospective|||||||
1450894|NCT01627067||Single Group Assignment||Treatment||None (Open Label)||||||
1450895|NCT01627054||Single Group Assignment||Treatment||None (Open Label)||||||
1450896|NCT01627041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450897|NCT01627028|||Case-Crossover||Prospective|||||||
1450898|NCT01627015|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1450899|NCT01627002|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450900|NCT01626989|Randomized|Crossover Assignment||Treatment||Single|||t|||
1450901|NCT01626976|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1450902|NCT01626963|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450903|NCT01626950|||Case Control||Cross-Sectional|||||||
1450904|NCT01626937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450905|NCT01626924||Single Group Assignment||Treatment||None (Open Label)||||||
1450906|NCT01626911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450907|NCT01626898|Randomized|Parallel Assignment||Prevention||Single||||||t
1450908|NCT01626885||Single Group Assignment||Treatment||None (Open Label)||||||
1450909|NCT01626872|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450910|NCT01626859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450911|NCT01626846|||Cohort||Cross-Sectional|||||||
1450912|NCT01626833|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1450913|NCT01626820|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1450914|NCT01626807|Randomized|Parallel Assignment||Prevention||Single||||||t
1450915|NCT01626794|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1450916|NCT01626781||||||||||||
1450917|NCT01626768|||||Prospective|||||||
1450918|NCT01626755|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1450919|NCT01626742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450920|NCT01626729|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450921|NCT01626716|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1450922|NCT01626703|Randomized|Parallel Assignment||Screening||Double|||t|||t
1450923|NCT01626690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450924|NCT01626677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450925|NCT01626664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450926|NCT01626651||Single Group Assignment||Treatment||None (Open Label)||||||
1450927|NCT01626638||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450928|NCT01626625|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1450929|NCT01626612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450930|NCT01626599||Single Group Assignment||||None (Open Label)||||||
1450931|NCT01626586|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450932|NCT01626573|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450933|NCT01626560|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1450934|NCT01626547|||Cohort||Prospective|||||||
1450935|NCT01626534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450936|NCT01626521|||Cohort||Prospective|||||||
1450937|NCT01626508|||Cohort||Prospective|||||||
1450938|NCT01626495||Single Group Assignment||Treatment||None (Open Label)||||||
1450939|NCT01626482|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1450940|NCT01626469|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1450941|NCT01626456|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1450942|NCT01626443|Randomized|Parallel Assignment||||None (Open Label)||||||
1450943|NCT01626430|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1450944|NCT01626417||Single Group Assignment||||None (Open Label)||||||
1450945|NCT01626404|||Cohort||Prospective|||||||
1450946|NCT01626391|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450947|NCT01626378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1450948|NCT01626365|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1450949|NCT01626352||Single Group Assignment||Treatment||None (Open Label)||||||
1450950|NCT01626339||||||||||||
1450951|NCT01626326|||Cohort||Prospective|||||||
1450952|NCT01626313|Randomized|||Supportive Care||None (Open Label)||||||
1450953|NCT01626300|||Case-Control||Retrospective|||||||
1450954|NCT01626287|Randomized|Parallel Assignment||||Single|||||t|
1450955|NCT01626274||Single Group Assignment||Basic Science||None (Open Label)||||||
1450956|NCT01626261|||Cohort||Prospective|||||||
1450957|NCT01626248|||Cohort|||||||||
1450958|NCT01626235|||||Prospective|||||||
1450959|NCT01626222||Single Group Assignment||Treatment||None (Open Label)||||||
1450960|NCT01626209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1450961|NCT01626196|||Ecologic or Community||Prospective|||||||
1450962|NCT01626183|||Case-Only||Retrospective|||||||
1450963|NCT01626170|||Cohort||Retrospective|||||||
1450964|NCT01626157|||Cohort||Prospective|||||||
1450965|NCT01626144|||Case-Only||Prospective|||||||
1450966|NCT01626131|Randomized|Parallel Assignment||Treatment||Single|||t|||
1450967|NCT01626118|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450968|NCT01626105|||Cohort||Prospective|||||||
1450969|NCT01626092||Single Group Assignment||Treatment||None (Open Label)||||||
1450970|NCT01626079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450971|NCT01626066||Single Group Assignment||Diagnostic||None (Open Label)||||||
1450972|NCT01626053|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1450973|NCT01626040|||Case-Only||Prospective|||||||
1450974|NCT01626027|||Cohort||Prospective|||||||
1450975|NCT01626014|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1450976|NCT01626001|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1450977|NCT01625988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1450978|NCT01625975|||Case-Only||Retrospective|||||||
1450979|NCT01625962|||Cohort||Prospective|||||||
1450980|NCT01625949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450981|NCT01625936||Single Group Assignment||Treatment||||||||
1450982|NCT01625923||Single Group Assignment||Treatment||None (Open Label)||||||
1450983|NCT01625910|Randomized|Parallel Assignment||Treatment||Single||||||t
1450984|NCT01625897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450985|NCT01625884|||Cohort||Cross-Sectional|||||||
1450986|NCT01625871||Single Group Assignment||Treatment||None (Open Label)||||||
1450987|NCT01625858|||Cohort||Prospective|||||||
1450988|NCT01625845|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1450989|NCT01625832|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1450990|NCT01625819|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1450991|NCT01625806|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1450992|NCT01625793|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1450993|NCT01625780|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1450994|NCT01625767||Single Group Assignment||Treatment||Single||||t||
1450995|NCT01625754|||Cohort||Prospective|||||||
1450996|NCT01625741||Single Group Assignment||Treatment||None (Open Label)||||||
1450997|NCT01625728|||Case-Control||Prospective|||||||
1450998|NCT01625715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1450999|NCT01625702|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1451000|NCT01625689|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1451001|NCT01625676|Randomized|Parallel Assignment||Treatment||Single||||||t
1451002|NCT01625663|||Case-Control||Cross-Sectional|||||||
1451003|NCT01625650|||Cohort||Prospective|||||||
1451004|NCT01625637|Randomized|Parallel Assignment||Treatment||Single||||t||
1451005|NCT01625624|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1451006|NCT01625611||Single Group Assignment||Treatment||None (Open Label)||||||
1451007|NCT01625598|||Case-Only||Prospective|||||||
1451008|NCT01625585|||Cohort|||||||||
1451009|NCT01625572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451010|NCT01625559||Single Group Assignment||Treatment||None (Open Label)||||||
1451011|NCT01625546|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451012|NCT01625533|||Cohort||Prospective|||||||
1451013|NCT01625520||Single Group Assignment||Treatment||None (Open Label)||||||
1451014|NCT01625507||Single Group Assignment||Treatment||None (Open Label)||||||
1451015|NCT01625494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451016|NCT01625481||Single Group Assignment||Treatment||None (Open Label)||||||
1451017|NCT01625468|Randomized|Parallel Assignment||Treatment||Single||||||t
1451018|NCT01625455|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1451019|NCT01625442|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451020|NCT01625429||Single Group Assignment||Treatment||None (Open Label)||||||
1451021|NCT01625416|Randomized|Parallel Assignment||Treatment||Single||||||t
1451022|NCT01625403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451023|NCT01625390|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451024|NCT01625377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451025|NCT01625364|Randomized|Parallel Assignment||Treatment||Single||||||t
1451026|NCT01625351||Single Group Assignment||Treatment||None (Open Label)||||||
1451027|NCT01625338|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451028|NCT01625325|||Cohort||Prospective|||||||
1451029|NCT01625312|||Cohort||Prospective|||||||
1451030|NCT01625299|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1451031|NCT01625286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451032|NCT01625273|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451033|NCT01625260||Single Group Assignment||Treatment||None (Open Label)||||||
1451034|NCT01625247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451035|NCT01625234||Single Group Assignment||Treatment||None (Open Label)||||||
1451036|NCT01625221||Single Group Assignment||Treatment||None (Open Label)||||||
1451037|NCT01625208|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451038|NCT01625195|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1451039|NCT01625182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451040|NCT01625169||Single Group Assignment||||None (Open Label)||||||
1451041|NCT01625156||Single Group Assignment||Treatment||None (Open Label)||||||
1451042|NCT01625143|||Case-Only||Retrospective|||||||
1451043|NCT01625130|Randomized|Crossover Assignment||||Triple|||t||t|t
1451044|NCT01625117|Randomized|Parallel Assignment||Treatment||Single||||||t
1451045|NCT01625104|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1451046|NCT01625091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451047|NCT01625078||Single Group Assignment||Treatment||None (Open Label)||||||
1451048|NCT01625065|||Case-Crossover||Prospective|||||||
1451049|NCT01625052||Single Group Assignment||Treatment||None (Open Label)||||||
1451050|NCT01625039|Randomized|Parallel Assignment||Treatment||Single||||||t
1451051|NCT01625026|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1451052|NCT01625013||Single Group Assignment||Treatment||None (Open Label)||||||
1451053|NCT01625000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451054|NCT01624987|Randomized|Parallel Assignment||Treatment||Single||||||t
1451055|NCT01624974|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451056|NCT01624961|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1451057|NCT01624948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451058|NCT01624935|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451059|NCT01624922|||Cohort||Prospective|||||||
1451060|NCT01624909|||Cohort||Prospective|||||||
1451061|NCT01624896|||Case-Only||Retrospective|||||||
1451062|NCT01624883|||Case-Only||Retrospective|||||||
1451063|NCT01624870|||Cohort||Prospective|||||||
1451064|NCT01624857|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1451065|NCT01624844||Single Group Assignment||||None (Open Label)||||||
1451066|NCT01624831|||Cohort||Prospective|||||||
1451067|NCT01624818|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1451068|NCT01624805||Single Group Assignment||Treatment||None (Open Label)||||||
1451069|NCT01624792|Randomized|Parallel Assignment||Other||Double|||t||t|
1451070|NCT01624779||Factorial Assignment||Treatment||None (Open Label)||||||
1451071|NCT01624766|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451072|NCT01624753||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451073|NCT01624740|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451074|NCT01624727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451075|NCT01624714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451076|NCT01624701||Single Group Assignment||Treatment||None (Open Label)||||||
1451077|NCT01624688|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451078|NCT01624675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451079|NCT01624662|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451080|NCT01624649|||Case-Only||Prospective|||||||
1451081|NCT01624636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451082|NCT01624623|||Cohort||Prospective|||||||
1451083|NCT01624610|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451084|NCT01624597|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1451085|NCT01624584|Randomized|Factorial Assignment||Treatment||Single||||||t
1451086|NCT01624571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451087|NCT01624558|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451088|NCT01624545|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1451089|NCT01624532|Randomized|Parallel Assignment||Prevention||Single|||t|||
1451090|NCT01624519||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451091|NCT01624506|||Other||Other|||||||
1451092|NCT01624493|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451093|NCT01624480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451094|NCT01624467||Single Group Assignment||Treatment||None (Open Label)||||||
1451095|NCT01624454|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1451096|NCT01624441||Single Group Assignment||Treatment||None (Open Label)||||||
1451097|NCT01624428|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1451098|NCT01624415|||Cohort||Prospective|||||||
1451099|NCT01624402|Randomized|Parallel Assignment||Treatment||Single||||||t
1451100|NCT01624389||Single Group Assignment||Diagnostic||Single|||t|||
1451101|NCT01624376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451102|NCT01624363|||Case-Only||Prospective|||||||
1451103|NCT01624350|||||Prospective|||||||
1451104|NCT01624337|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451105|NCT01624324|||Cohort||Prospective|||||||
1451106|NCT01624311|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451107|NCT01624298|Randomized|Parallel Assignment||Treatment||Single||||||t
1451108|NCT01624285|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451109|NCT01624272|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1451110|NCT01624259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451111|NCT01624246||Single Group Assignment||Treatment||None (Open Label)||||||
1451112|NCT01624233||Single Group Assignment||Treatment||None (Open Label)||||||
1451113|NCT01624220|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451114|NCT01624207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451115|NCT01624194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451116|NCT01624181|||Case-Only||Prospective|||||||
1451117|NCT01624168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451118|NCT01624155||Single Group Assignment||Prevention||None (Open Label)||||||
1451119|NCT01624142|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451120|NCT01624129|||Case-Only||Prospective|||||||
1451121|NCT01624116|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451122|NCT01624103|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451123|NCT01624090||Single Group Assignment||Treatment||None (Open Label)||||||
1451124|NCT01624077||Single Group Assignment||Treatment||None (Open Label)||||||
1451125|NCT01624064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451126|NCT01624051|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451127|NCT01624038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451128|NCT01624025|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451129|NCT01624012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451130|NCT01623986|||Cohort||Prospective|||||||
1451131|NCT01623973|Randomized|Parallel Assignment||Treatment||Single||||||t
1451132|NCT01623960|||Cohort||Cross-Sectional|||||||
1451133|NCT01623947|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1451134|NCT01623934|||Cohort||Prospective|||||||
1451135|NCT01623921|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451136|NCT01623908||Single Group Assignment||Treatment||None (Open Label)||||||
1451137|NCT01623895|||Case-Only||Prospective|||||||
1451138|NCT01623882|||Case Control||Prospective|||||||
1451139|NCT01623869||Single Group Assignment||Treatment||None (Open Label)||||||
1451140|NCT01623856|||Case Control||Retrospective|||||||
1451141|NCT01623843|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451142|NCT01623830|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451143|NCT01623817|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451144|NCT01623804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451145|NCT01623791|||Cohort||Prospective|||||||
1451146|NCT01623778|||Cohort||Prospective|||||||
1451147|NCT01623765|||Case-Only||Prospective|||||||
1451148|NCT01623752|||Cohort||Prospective|||||||
1451149|NCT01623739|Randomized|Parallel Assignment||Treatment||Single||||||t
1451150|NCT01623726|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451151|NCT01623713|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451152|NCT01623700|||Cohort||Retrospective|||||||
1451153|NCT01623687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451154|NCT01623674|||||Prospective|||||||
1451155|NCT01623661||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451156|NCT01623648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451157|NCT01623635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451158|NCT01623622|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1451159|NCT01623609|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1451160|NCT01623596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451161|NCT01623583|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451162|NCT01623570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451163|NCT01623557|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1451164|NCT01623544|||Cohort||Retrospective|||||||
1451165|NCT01623531|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451166|NCT01623518||Single Group Assignment||||None (Open Label)||||||
1451167|NCT01623505|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451168|NCT01623492|||Cohort||Prospective|||||||
1451169|NCT01623479|||Case-Only||Cross-Sectional|||||||
1451170|NCT01623466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451171|NCT01623453|||||Prospective|||||||
1451172|NCT01623440|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451173|NCT01623427|Randomized|Parallel Assignment||Prevention||Single||||||t
1451174|NCT01623414|||Cohort||Prospective|||||||
1451175|NCT01623401||Single Group Assignment||Other||None (Open Label)||||||
1451176|NCT01623388|||Case Control||Prospective|||||||
1451177|NCT01623375|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451178|NCT01623362|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1451179|NCT01623349|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451180|NCT01623336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451181|NCT01623323||Single Group Assignment||Treatment||None (Open Label)||||||
1451182|NCT01623310||Single Group Assignment||Treatment||None (Open Label)||||||
1451183|NCT01623297|||Case Control||Prospective|||||||
1451184|NCT01623284||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451185|NCT01623271||Single Group Assignment||Treatment||None (Open Label)||||||
1451186|NCT01623258|||Cohort||Prospective|||||||
1451187|NCT01623245|||Cohort||Prospective|||||||
1451188|NCT01623232|Randomized|Parallel Assignment||Prevention||Double||||||
1451189|NCT01623219||Single Group Assignment||Treatment||None (Open Label)||||||
1451190|NCT01623206||Single Group Assignment||Other||None (Open Label)||||||
1451191|NCT01623193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451192|NCT01623180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451193|NCT01623167||Single Group Assignment||Treatment||None (Open Label)||||||
1451194|NCT01623154||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451195|NCT01623141|||Case Control||Prospective|||||||
1451196|NCT01623128|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1451197|NCT01623115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451198|NCT01623102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451199|NCT01623089|||Case-Only||Prospective|||||||
1451200|NCT01623076|||Cohort||Prospective|||||||
1451201|NCT01623063|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1451202|NCT01623050||Single Group Assignment||Treatment||None (Open Label)||||||
1451203|NCT01623037||Single Group Assignment||Other||None (Open Label)||||||
1451204|NCT01623024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451205|NCT01623011|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451206|NCT01622998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451207|NCT01622972|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1451208|NCT01622959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451209|NCT01622946|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1451210|NCT01622933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451211|NCT01622920||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451212|NCT01622907|||Cohort||Prospective|||||||
1451213|NCT01622894|||Case-Only||Prospective|||||||
1451214|NCT01622881|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451215|NCT01622868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451216|NCT01622855|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1451217|NCT01622842|||Case-Only||Cross-Sectional|||||||
1451218|NCT01622829|Randomized|Factorial Assignment||Treatment||Single|||t|||
1451219|NCT01622816|||||Prospective|||||||
1451220|NCT01622803|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451221|NCT01622790|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1451222|NCT01622777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451223|NCT01622764||Single Group Assignment||||None (Open Label)||||||
1451224|NCT01622751|||Case Control||Prospective|||||||
1451225|NCT01622725|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451226|NCT01622712||Single Group Assignment||Treatment||None (Open Label)||||||
1451227|NCT01622699|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1451228|NCT01622686|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1451229|NCT01622673|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451230|NCT01622660||Single Group Assignment||Treatment||None (Open Label)||||||
1451231|NCT01622647|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451232|NCT01622634|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451233|NCT01622621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451234|NCT01622608|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1451235|NCT01622595|||Case-Only||Retrospective|||||||
1451236|NCT01622582|||||Retrospective|||||||
1451237|NCT01622569|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451238|NCT01622556||Single Group Assignment||Treatment||None (Open Label)||||||
1451239|NCT01622543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451240|NCT01622530|||Case-Control||Cross-Sectional|||||||
1451241|NCT01622517|||Cohort||Prospective|||||||
1451242|NCT01622504|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451243|NCT01622491|||Case Control||Retrospective|||||||
1451244|NCT01622478|||Cohort||Prospective|||||||
1451245|NCT01622465|Randomized|Parallel Assignment||Treatment||Double||||t||t
1451246|NCT01622452|||||Prospective|||||||
1451247|NCT01622439||Single Group Assignment||Treatment||None (Open Label)||||||
1451248|NCT01622426|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451249|NCT01622413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451250|NCT01622400|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451251|NCT01622387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451252|NCT01622374|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1451253|NCT01622361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451254|NCT01622348|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1451255|NCT01622335|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1451256|NCT01622322|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1451257|NCT01622309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451258|NCT01622296|Randomized|Crossover Assignment||Supportive Care||Double|||t|t||
1451259|NCT01622283|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1451260|NCT01622270|||Case-Only|||||||||
1451261|NCT01622257|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1451262|NCT01622244|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451263|NCT01622231||Single Group Assignment||Treatment||None (Open Label)||||||
1451264|NCT01622218|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451265|NCT01622205|Randomized|Parallel Assignment||Treatment||Single||||||t
1451266|NCT01622192||Single Group Assignment||Diagnostic||Single|||||t|
1451267|NCT01622179|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451268|NCT01622166|Randomized|Parallel Assignment||Treatment||Single||||||t
1451269|NCT01622153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451270|NCT01622140|||Cohort||Prospective|||||||
1451271|NCT01622127|||Cohort||Prospective|||||||
1451272|NCT01622114|Randomized|Parallel Assignment||||None (Open Label)||||||
1451273|NCT01622101|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1451274|NCT01622088||Single Group Assignment||Treatment||None (Open Label)||||||
1451275|NCT01622075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451276|NCT01622062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451277|NCT01622049||||||||||||
1451278|NCT01622036|||Ecologic or Community||Prospective|||||||
1451279|NCT01622023|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451280|NCT01622010|Randomized|Parallel Assignment||Treatment||Single||||||t
1451281|NCT01621997|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451282|NCT01621984||Single Group Assignment||Treatment||Single||||||t
1451283|NCT01621971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451284|NCT01621958|Randomized|Parallel Assignment||Prevention||Single|||t|||
1451285|NCT01621945|||Cohort||Prospective|||||||
1451286|NCT01621932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451287|NCT01621919|||Cohort||Prospective|||||||
1451288|NCT01621906|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1451289|NCT01621893|||Case-Only||Prospective|||||||
1451290|NCT01621880|Randomized|Parallel Assignment||Treatment||Single||||||t
1451291|NCT01621867|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1451292|NCT01621854||Single Group Assignment||Treatment||None (Open Label)||||||
1451293|NCT01621841|||Case Control||Prospective|||||||
1451294|NCT01621828|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1451295|NCT01621815|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1451296|NCT01621802|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451297|NCT01621789||Single Group Assignment||Supportive Care||None (Open Label)||||||
1451298|NCT01621776|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451299|NCT01621763|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451300|NCT01621750|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451301|NCT01621737|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451302|NCT01621724||Single Group Assignment||Treatment||None (Open Label)||||||
1451303|NCT01621711|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1451304|NCT01621698|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451305|NCT01621685||Single Group Assignment||||None (Open Label)||||||
1451306|NCT01621672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451307|NCT01621659|Randomized|Parallel Assignment||Supportive Care||Single||Supportive care intervention||||t
1451308|NCT01621646|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451309|NCT01621633|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1451310|NCT01621620||Single Group Assignment||Basic Science||None (Open Label)||||||
1451311|NCT01621607|||||Retrospective|||||||
1451312|NCT01621594|||Cohort||Prospective|||||||
1451313|NCT01621581|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451314|NCT01621568||Single Group Assignment||Treatment||None (Open Label)||||||
1451315|NCT01621555|||Cohort||Prospective|||||||
1451316|NCT01621542||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1451317|NCT01621529|||Cohort||Prospective|||||||
1451318|NCT01621516|||Case Control||Prospective|||||||
1451319|NCT01621503||Parallel Assignment||Diagnostic||None (Open Label)||||||
1451320|NCT01621490|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1451321|NCT01621477||Single Group Assignment||Treatment||None (Open Label)||||||
1451322|NCT01621464|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1451323|NCT01621451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451324|NCT01621438|||Cohort||Prospective|||||||
1451325|NCT01621425|||Case-Only||Prospective|||||||
1451326|NCT01621412|||Cohort||Cross-Sectional|||||||
1451327|NCT01621399|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451328|NCT01621386||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451329|NCT01621373||Single Group Assignment||Treatment||None (Open Label)||||||
1451330|NCT01621360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451331|NCT01621347|||Case-Only||Retrospective|||||||
1451332|NCT01621334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451333|NCT01621321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451334|NCT01621308|||||Prospective|||||||
1451335|NCT01621295||||||||||||
1451336|NCT01621282|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1451337|NCT01621269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451338|NCT01621256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451339|NCT01621243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451340|NCT01621230|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1451341|NCT01621217||Single Group Assignment||Treatment||None (Open Label)||||||
1451342|NCT01621204|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451343|NCT01621191||Single Group Assignment||Treatment||None (Open Label)||||||
1451344|NCT01621178|Randomized|Parallel Assignment||Treatment||None (Open Label)|Dulaglutide dose was blinded to participant, care provider, investigator and outcomes assessor.|||||
1451345|NCT01621165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451346|NCT01621152|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1451347|NCT01621139|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451348|NCT01621126||Single Group Assignment||Prevention||None (Open Label)||||||
1451349|NCT01621113|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451350|NCT01621100||Single Group Assignment||Treatment||None (Open Label)||||||
1451351|NCT01621087|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451352|NCT01621074|Randomized|Crossover Assignment||||Double|||t|||t
1451353|NCT01621061|||Case Control||Prospective|||||||
1451354|NCT01621048|||||Prospective|||||||
1451355|NCT01621035|||Cohort||Prospective|||||||
1451356|NCT01621022|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1451357|NCT01621009|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1451358|NCT01620996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451359|NCT01620983|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1451360|NCT01620970||Single Group Assignment||Treatment||None (Open Label)||||||
1451361|NCT01620957|||Cohort||Prospective|||||||
1451362|NCT01620944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451363|NCT01620931|Randomized|Parallel Assignment||||Single|||||t|
1451364|NCT01620918||Single Group Assignment||Basic Science||None (Open Label)||||||
1451365|NCT01620905||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451366|NCT01620892|||Cohort||Cross-Sectional|||||||
1451367|NCT01620866|Randomized|Parallel Assignment||Treatment||Single||||||t
1451368|NCT01620853|||Cohort||Retrospective|||||||
1451369|NCT01620840|||Case-Only||Prospective|||||||
1451370|NCT01620827|Randomized|Parallel Assignment||||None (Open Label)||||||
1451371|NCT01620814|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451372|NCT01620801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451373|NCT01620788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451374|NCT01620775|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1451375|NCT01620762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451376|NCT01620749||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451377|NCT01620736||Single Group Assignment||Treatment||None (Open Label)||||||
1451378|NCT01620723|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451379|NCT01620710|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451380|NCT01620697|||Cohort||Prospective|||||||
1451381|NCT01620684|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451382|NCT01620671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451383|NCT01620658|Randomized|Parallel Assignment||||Double||||t||t
1451384|NCT01620645|||Cohort||Prospective|||||||
1451385|NCT01620632|||Case-Only||Prospective|||||||
1451386|NCT01620619|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451387|NCT01620606|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451388|NCT01620593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451389|NCT01620580|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451390|NCT01620567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451391|NCT01620554|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451392|NCT01620541|||Cohort||Prospective|||||||
1451393|NCT01620528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451394|NCT01620515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451395|NCT01620502|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1451396|NCT01620489|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451397|NCT01620476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451398|NCT01620463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451399|NCT01620450|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451400|NCT01620437|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451401|NCT01620424|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451402|NCT01620411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451403|NCT01620398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451404|NCT01620385||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451405|NCT01620372|||Cohort||Retrospective|||||||
1451406|NCT01620359||Single Group Assignment||Treatment||None (Open Label)||||||
1451407|NCT01620346|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451408|NCT01620333|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451409|NCT01620320|||Cohort||Prospective|||||||
1451410|NCT01620307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451411|NCT01620294|Randomized|Parallel Assignment||Prevention||Double||||t||t
1451412|NCT01620281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451413|NCT01620268|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451414|NCT01620255|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451415|NCT01620242||Single Group Assignment||Treatment||None (Open Label)||||||
1451416|NCT01620229||Single Group Assignment||Treatment||None (Open Label)||||||
1451417|NCT01620216|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451418|NCT01620203|||Case-Control||Prospective|||||||
1451419|NCT01620190||Single Group Assignment||Treatment||None (Open Label)||||||
1451420|NCT01620177|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1451421|NCT01620164|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1451422|NCT01620151|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451423|NCT01620138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451424|NCT01620125||Single Group Assignment||Treatment||None (Open Label)||||||
1451425|NCT01620112|Randomized|Parallel Assignment||Treatment||Single||||t||
1451426|NCT01620099|Randomized|Parallel Assignment||||None (Open Label)||||||
1451427|NCT01620086|Randomized|Crossover Assignment||Treatment||Single|||t|||
1451428|NCT01620073|Randomized|Parallel Assignment||Prevention||Single||||t||
1451429|NCT01620060||Single Group Assignment||Treatment||None (Open Label)||||||
1451430|NCT01620047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451431|NCT01620034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451432|NCT01620021|||Case Control||Prospective|||||||
1451433|NCT01620008|Randomized|Parallel Assignment||Prevention||Single||randomized trial (with a preference arm)||||t
1451434|NCT01619995|||Cohort||Prospective|||||||
1451435|NCT01619982|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451436|NCT01619969|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451437|NCT01619956|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451438|NCT01619943|||Cohort||Prospective|||||||
1451439|NCT01619930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451440|NCT01619917|Randomized|Single Group Assignment||Treatment||Single||||||t
1451441|NCT01619904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451442|NCT01619891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451443|NCT01619878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451444|NCT01619865||Single Group Assignment||Diagnostic||None (Open Label)|The Octreoscan and 68Ga-DOTA-tyr3-Octreotide PET scans are read independently by two certified nuclear medicine physicians for discordant positive lesions.|||||
1451445|NCT01619852|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1451446|NCT01619839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451447|NCT01619826|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1451448|NCT01619813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451449|NCT01619800|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1451450|NCT01619787|||||Cross-Sectional|||||||
1451451|NCT01619774||Single Group Assignment||Treatment||None (Open Label)||||||
1451452|NCT01619761||Single Group Assignment||Treatment||None (Open Label)||||||
1451453|NCT01619748|||Case Control||Cross-Sectional|||||||
1451454|NCT01619735|||Cohort||Prospective|||||||
1451455|NCT01619722|||Cohort||Prospective|||||||
1451456|NCT01619709|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1451457|NCT01619696||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451458|NCT01619683|Non-Randomized|Parallel Assignment||||Single|||t|||
1451459|NCT01619670|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451460|NCT01619657|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451461|NCT01619644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451462|NCT01619631|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451463|NCT01619618|||Other||Other|||||||
1451464|NCT01619605||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451465|NCT01619592|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451466|NCT01619579||Single Group Assignment||Treatment||None (Open Label)||||||
1451467|NCT01619566|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451468|NCT01619553|||Case-Control||Prospective|||||||
1451469|NCT01619540|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1451470|NCT01619527|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451471|NCT01619514|||Cohort||Retrospective|||||||
1451472|NCT01619501|||Cohort||Retrospective|||||||
1451473|NCT01619488||Single Group Assignment||Treatment||None (Open Label)||||||
1451474|NCT01619475|||Cohort||Cross-Sectional|||||||
1451475|NCT01619462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451476|NCT01619449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451477|NCT01619436|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451478|NCT01619423|Randomized|Parallel Assignment||Treatment||Triple||The study is a three arm study, however, we changed the high dose in the secord part of the study, from 10 micromol/kg (part 2a) to 5 mictomol/kg (part 2b)|t|t|t|
1451479|NCT01619410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451480|NCT01619397||Single Group Assignment||Other||None (Open Label)||||||
1451481|NCT01619384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451482|NCT01619371|||Case-Only||Prospective|||||||
1451483|NCT01619358|||Cohort||Prospective|||||||
1451484|NCT01619345|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451485|NCT01619332||Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451486|NCT01619319|Randomized|Parallel Assignment||Prevention||Single|||t|||
1451487|NCT01619306|||Cohort||Cross-Sectional|||||||
1451488|NCT01619293|||Cohort||Prospective|||||||
1451489|NCT01619280||Single Group Assignment||Treatment||None (Open Label)||||||
1451490|NCT01619267|||Case-Control||Prospective|||||||
1451491|NCT01619254|Randomized|Factorial Assignment||Prevention||Single|||t|||
1451492|NCT01619241|||Case-Only||Prospective|||||||
1451493|NCT01619228|Randomized|Parallel Assignment||Basic Science||Single||||||t
1451494|NCT01619215|||Cohort||Prospective|||||||
1451495|NCT01619202|Randomized|Parallel Assignment||Prevention||Single||||||t
1451496|NCT01619189||Single Group Assignment||Treatment||Single||||||t
1451497|NCT01619176|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1451498|NCT01619163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451499|NCT01619150|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1451500|NCT01619137|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451501|NCT01619124|||Cohort||Prospective|||||||
1451502|NCT01619111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451503|NCT01619098|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1451504|NCT01619085||Single Group Assignment||Treatment||None (Open Label)||||||
1451505|NCT01619072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451506|NCT01619059|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451507|NCT01619046|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451508|NCT01619033|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451509|NCT01619020|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1451510|NCT01619007|||Cohort||Prospective|||||||
1451511|NCT01618994|||Case-Control||Prospective|||||||
1451512|NCT01618981||||||||||||
1451513|NCT01618968|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451514|NCT01618955||Single Group Assignment||Treatment||None (Open Label)||||||
1451515|NCT01618942|Randomized|Single Group Assignment||||Single|||t|||
1451516|NCT01618929|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1451517|NCT01618916|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1451518|NCT01618903|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451519|NCT01618890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451520|NCT01618877|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451521|NCT01618864||Single Group Assignment||Treatment||None (Open Label)||||||
1451522|NCT01618851||Single Group Assignment||Treatment||None (Open Label)||||||
1451523|NCT01618838||Single Group Assignment||Treatment||None (Open Label)||||||
1451524|NCT01618825|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451525|NCT01618812|||Cohort||Prospective|||||||
1451526|NCT01618799|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451527|NCT01618786|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451528|NCT01618773|||Cohort||Prospective|||||||
1451529|NCT01618760|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451530|NCT01618747|||Cohort||Prospective|||||||
1451531|NCT01618734|||Cohort||Retrospective|||||||
1451532|NCT01618721|||Cohort||Prospective|||||||
1451533|NCT01618708|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1451534|NCT01618695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451535|NCT01618682|||Case-Only||Retrospective|||||||
1451536|NCT01618669|Randomized|Parallel Assignment||||None (Open Label)||||||
1451537|NCT01618656|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451538|NCT01618643|||Cohort||Prospective|||||||
1451539|NCT01618630|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1451540|NCT01618617|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1451541|NCT01618604|||Case-Only||Prospective|||||||
1451542|NCT01618591|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451543|NCT01618578|||Case Control||Prospective|||||||
1451544|NCT01618565|Randomized|Parallel Assignment||||Double|||t|||t
1451545|NCT01618552|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451546|NCT01618539|||Cohort||Prospective|||||||
1451547|NCT01618526|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1451548|NCT01618513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451549|NCT01618500|||Cohort||Prospective|||||||
1451550|NCT01618487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451551|NCT01618474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451552|NCT01618461|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1451553|NCT01618448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451554|NCT01618435|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451555|NCT01618422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451556|NCT01618409|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1451557|NCT01618396||Single Group Assignment||Treatment||Single|||||t|
1451558|NCT01618383||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451559|NCT01618370||Single Group Assignment||Treatment||None (Open Label)||||||
1451560|NCT01618357||Single Group Assignment||Treatment||None (Open Label)||||||
1451561|NCT01618344|||Other||Prospective|||||||
1451562|NCT01618331|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1451563|NCT01618318|||Cohort||Cross-Sectional|||||||
1451564|NCT01618305|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451565|NCT01618292|||Cohort||Retrospective|||||||
1451566|NCT01618279|||Case-Only||Prospective|||||||
1451567|NCT01618266|||Cohort||Prospective|||||||
1451568|NCT01618253||Single Group Assignment||Treatment||None (Open Label)||||||
1451569|NCT01618240|||Cohort||Prospective|||||||
1451570|NCT01618227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451571|NCT01618214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451572|NCT01618201|||Case Control||Prospective|||||||
1451573|NCT01618188|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451574|NCT01618175||Single Group Assignment||Treatment||None (Open Label)||||||
1451575|NCT01618162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451576|NCT01618149|||Cohort||Prospective|||||||
1451577|NCT01618136|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451578|NCT01618123|||Cohort||Prospective|||||||
1451579|NCT01618110|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451580|NCT01618097|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1451581|NCT01618084|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451582|NCT01618071|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1451583|NCT01618058|||Case-Control||Prospective|||||||
1451584|NCT01618045|||Other||Other|||||||
1451585|NCT01618032|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451586|NCT01618019|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1451587|NCT01618006|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1451588|NCT01617993|||Cohort||Prospective|||||||
1451589|NCT01617980||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451590|NCT01617967||Single Group Assignment||Treatment||None (Open Label)||||||
1451591|NCT01617954|||Case-Only||Prospective|||||||
1451592|NCT01617941|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451593|NCT01617928||Single Group Assignment||Treatment||None (Open Label)||||||
1451594|NCT01617915|||Cohort||Prospective|||||||
1451595|NCT01617902|||Cohort||Prospective|||||||
1451596|NCT01617889|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1451597|NCT01617876|||Case-Only||Prospective|||||||
1451598|NCT01617863|||Case Control||Prospective|||||||
1451599|NCT01617850|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451600|NCT01617837|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451601|NCT01617824|Randomized|Crossover Assignment||Prevention||Single|||t|||
1451602|NCT01617811||Single Group Assignment||Health Services Research||None (Open Label)||||||
1451603|NCT01617798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451604|NCT01617785|||Cohort||Prospective|||||||
1451605|NCT01617772|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1451606|NCT01617759|||Cohort||Retrospective|||||||
1451607|NCT01617746|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1451608|NCT01617733||Single Group Assignment||Treatment||None (Open Label)||||||
1451609|NCT01617720|||Cohort||Prospective|||||||
1451610|NCT01617707|Randomized|Parallel Assignment||Other||Double|||t||t|
1451611|NCT01617694|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1451612|NCT01617681|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451613|NCT01617668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451614|NCT01617655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451615|NCT01617642|||Case Control||Cross-Sectional|||||||
1451616|NCT01617629||Single Group Assignment||Treatment||None (Open Label)||||||
1451617|NCT01617616|||Cohort||Prospective|||||||
1451618|NCT01617603|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1451619|NCT01617590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451620|NCT01617577|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1451621|NCT01617564|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1451622|NCT01617551|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1451623|NCT01617538|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451624|NCT01617525|Randomized|Crossover Assignment||Prevention||Single||||||t
1451625|NCT01617512||Single Group Assignment||Basic Science||None (Open Label)||||||
1451626|NCT01617499|||Cohort||Prospective|||||||
1451627|NCT01617486||Single Group Assignment||Prevention||None (Open Label)||||||
1451628|NCT01617473|Randomized|Parallel Assignment||||None (Open Label)||||||
1451629|NCT01617460||Single Group Assignment||Treatment||None (Open Label)||||||
1451630|NCT01617447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451631|NCT01617434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451632|NCT01617421|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1451633|NCT01617408|||||Prospective|||||||
1451634|NCT01617395|||||Other|||||||
1451635|NCT01617382|||Case-Only||Prospective|||||||
1451636|NCT01617369|Randomized|Crossover Assignment||Treatment||None (Open Label)||Subjects completed mucociliary clearance measurements (via gamma scintigraphy) at baseline, 30 minutes after inhaling 2.8% NaCl, and 4 hours after inhaling 2.8% NaCl at separate study visits to characterize acute vs. sustained effects of inhaled 2.8% NaCl on this physiologic process.||||
1451637|NCT01617356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451638|NCT01617343|Randomized|Parallel Assignment||Treatment||Single||||||t
1451639|NCT01617330|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1451640|NCT01617317|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451641|NCT01617304|Randomized|Parallel Assignment||Prevention||Single|||t|||
1451642|NCT01617291|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451643|NCT01617278|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1451644|NCT01617265|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451645|NCT01617252|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1451646|NCT01617239|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451647|NCT01617226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451648|NCT01617213||Single Group Assignment||Treatment||None (Open Label)||||||
1451649|NCT01617200|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451650|NCT01617187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451651|NCT01617174|||Cohort||Prospective|||||||
1451652|NCT01617161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451653|NCT01617148||Single Group Assignment||Treatment||None (Open Label)||||||
1451654|NCT01617135|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1451655|NCT01617122||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451656|NCT01617109|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451657|NCT01617096|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1451658|NCT01617083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451659|NCT01617070||Single Group Assignment||Treatment||None (Open Label)||||||
1451660|NCT01617057|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451661|NCT01617044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451662|NCT01617031|||Cohort||Prospective|||||||
1451663|NCT01617018|||Cohort||Prospective|||||||
1451664|NCT01617005|||Cohort||Prospective|||||||
1451665|NCT01616992|||Case Control||Prospective|||||||
1451666|NCT01616979|||Case-Only||Prospective|||||||
1451667|NCT01616966|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1451668|NCT01616953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451669|NCT01616940|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1451670|NCT01616927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451671|NCT01616914|||Cohort||Prospective|||||||
1451672|NCT01616901||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451673|NCT01616888||Single Group Assignment||Treatment||None (Open Label)||||||
1451674|NCT01616875||Single Group Assignment||Treatment||None (Open Label)||||||
1451675|NCT01616862|||Cohort||Prospective|||||||
1451676|NCT01616849||Single Group Assignment||Treatment||None (Open Label)||||||
1451677|NCT01616836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451678|NCT01616823|||Cohort||Retrospective|||||||
1451679|NCT01616810||||||||||||
1451680|NCT01616797|Randomized|Single Group Assignment||Treatment||Single|||t|||
1451681|NCT01616784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451682|NCT01616771||Single Group Assignment||||None (Open Label)||||||
1451683|NCT01616758||Single Group Assignment||Treatment||None (Open Label)||||||
1451684|NCT01616745|||Cohort||Prospective|||||||
1451685|NCT01616732|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451686|NCT01616719||Single Group Assignment||Treatment||None (Open Label)||||||
1451687|NCT01616693|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1451688|NCT01616680||Single Group Assignment||Supportive Care||None (Open Label)||||||
1451689|NCT01616667|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451690|NCT01616654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451691|NCT01616641|||Case Control||Cross-Sectional|||||||
1451692|NCT01616628|Randomized|Parallel Assignment||Prevention||Single|||t|||
1451693|NCT01616615|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451694|NCT01616602|Randomized|Parallel Assignment||||Single||||||
1451695|NCT01616589|||Cohort||Prospective|||||||
1451696|NCT01616576|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451697|NCT01616563||Single Group Assignment||Treatment||None (Open Label)||||||
1451698|NCT01616550|||Cohort||Prospective|||||||
1451699|NCT01616537||Single Group Assignment||||None (Open Label)||||||
1451700|NCT01616524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451701|NCT01616511|||Cohort||Prospective|||||||
1451702|NCT01616498|||Case-Control||Prospective|||||||
1451703|NCT01616485|Randomized|Crossover Assignment||Treatment||Double||||||
1451704|NCT01616472|||Case Control||Retrospective|||||||
1451705|NCT01616459|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1451706|NCT01616446|||Case-Only||Prospective|||||||
1451707|NCT01616433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451708|NCT01616420|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1451709|NCT01616407||Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1451710|NCT01616394|||Cohort||Prospective|||||||
1451711|NCT01616381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451712|NCT01616368||Single Group Assignment||Treatment||None (Open Label)||||||
1451713|NCT01616355||Single Group Assignment||Basic Science||None (Open Label)||||||
1451714|NCT01616342|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451715|NCT01616329|||||Retrospective|||||||
1451716|NCT01616316|Randomized|Parallel Assignment||Treatment||Single||||t||
1451717|NCT01616303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451718|NCT01616290||Single Group Assignment||Treatment||None (Open Label)||||||
1451719|NCT01616277|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1451720|NCT01616264|||||Prospective|||||||
1451721|NCT01616251|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1451722|NCT01616238|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451723|NCT01616225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451724|NCT01616212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451725|NCT01616199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451726|NCT01616186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451727|NCT01616173|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1451728|NCT01616160||Single Group Assignment||Basic Science||None (Open Label)||||||
1451729|NCT01616147|Randomized|Parallel Assignment||Prevention||Single||||||t
1451730|NCT01616134|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1451731|NCT01616121|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451732|NCT01616108||Single Group Assignment||Treatment||None (Open Label)||||||
1451733|NCT01616095|||Case-Control||Cross-Sectional|||||||
1451734|NCT01616082|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1451735|NCT01616069|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1451736|NCT01616056||Single Group Assignment||Supportive Care||None (Open Label)||||||
1451737|NCT01616043|Randomized|Single Group Assignment||Treatment||Single||||||t
1451738|NCT01616030||Single Group Assignment||Treatment||None (Open Label)||||||
1451739|NCT01616017|||||Prospective|||||||
1451740|NCT01616004|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1451741|NCT01615991||Single Group Assignment||Treatment||None (Open Label)||||||
1451742|NCT01615978|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451743|NCT01615965||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451744|NCT01615952|||Cohort||Prospective|||||||
1451745|NCT01615939|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451746|NCT01615926|||Cohort||Prospective|||||||
1451747|NCT01615913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451748|NCT01615900|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1451749|NCT01615887|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451750|NCT01615874|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451751|NCT01615861||Single Group Assignment||||None (Open Label)||||||
1451752|NCT01615848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451753|NCT01615835||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451754|NCT01615822|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451755|NCT01615809||Single Group Assignment||Treatment||None (Open Label)||||||
1451756|NCT01615796|Randomized|Single Group Assignment||Other||Single|||t|||
1451757|NCT01615783|||Cohort||Retrospective|||||||
1451758|NCT01615770|Randomized|Factorial Assignment||Treatment||Single|||||t|
1451759|NCT01615757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451760|NCT01615744|||Case Control||Prospective|||||||
1451761|NCT01615731|Randomized|Parallel Assignment||Treatment||Single||||||t
1451762|NCT01615718|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1451763|NCT01615705|||Cohort||Prospective|||||||
1451764|NCT01615692|||Cohort||Prospective|||||||
1451765|NCT01615679|||Cohort||Prospective|||||||
1451766|NCT01615666|||Case Control||Prospective|||||||
1451767|NCT01615653|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451768|NCT01615640|||Case-Only||Prospective|||||||
1451769|NCT01615627|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1451770|NCT01615614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451771|NCT01615601|||Cohort||Prospective|||||||
1451772|NCT01615588||Single Group Assignment||Basic Science||Single|||||t|
1451773|NCT01615575|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1451774|NCT01615562|||Case Control||Cross-Sectional|||||||
1451775|NCT01615549|Randomized|Parallel Assignment||||None (Open Label)||||||
1451776|NCT01615536|Randomized|Parallel Assignment||Treatment||Single||||||t
1451777|NCT01615523|||Cohort||Prospective|||||||
1451778|NCT01615510|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1451779|NCT01615497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451780|NCT01615484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451781|NCT01615471|Randomized|Parallel Assignment||Treatment||Single||||||t
1451782|NCT01615458|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1451783|NCT01615445|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1451784|NCT01615432||Single Group Assignment||Treatment||None (Open Label)||||||
1451785|NCT01615419|||Cohort||Prospective|||||||
1451786|NCT01615406||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451788|NCT01615380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451789|NCT01615367|Randomized|Parallel Assignment||Treatment||Single||||||t
1451790|NCT01615354|Randomized|Crossover Assignment||||Double|||t||t|
1451791|NCT01615341|||Cohort||Prospective|||||||
1451792|NCT01615328|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451793|NCT01615315|||Cohort||Retrospective|||||||
1451794|NCT01615302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451795|NCT01615289|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1451796|NCT01615276|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1451797|NCT01615263|Randomized|Parallel Assignment||||Single||||t||
1451798|NCT01615250|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451799|NCT01615237|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1451800|NCT01615224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451801|NCT01615211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451802|NCT01615198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451803|NCT01615185|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451804|NCT01615172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451805|NCT01615159|Randomized|Parallel Assignment||Prevention||Single||||||t
1451806|NCT01615146|Randomized|Parallel Assignment||Treatment||Single||||||t
1451807|NCT01615120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451808|NCT01615107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451809|NCT01615094|||Cohort||Prospective|||||||
1451810|NCT01615081|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1451811|NCT01615068|||Cohort||Prospective|||||||
1451812|NCT01615055|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451813|NCT01615042||Single Group Assignment||Treatment||None (Open Label)||||||
1451814|NCT01615029||Single Group Assignment||Treatment||None (Open Label)||||||
1451815|NCT01615016|Randomized|Parallel Assignment||Other||Quadruple|Intervention team whose members are not part of the patients' care team. Blinded for type of intervention|Randomized, double blind|t|t|t|t
1451816|NCT01615003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451817|NCT01614990|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451818|NCT01614977|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451819|NCT01614964|Randomized|Parallel Assignment||Treatment||Single||||||t
1451820|NCT01614951|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1451821|NCT01614938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451822|NCT01614925||||||||||||
1451823|NCT01614912||Single Group Assignment||Treatment||None (Open Label)||||||
1451824|NCT01614899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451825|NCT01614886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451826|NCT01614873|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1451827|NCT01614860|||Cohort||Prospective|||||||
1451828|NCT01614847|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451829|NCT01614834|||||Prospective|||||||
1451830|NCT01614821||Single Group Assignment||Treatment||None (Open Label)||||||
1451831|NCT01614808|||Case Control||Retrospective|||||||
1451832|NCT01614795||Single Group Assignment||Treatment||None (Open Label)||||||
1451833|NCT01614782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451834|NCT01614769|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451835|NCT01614756|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451836|NCT01614743|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1451837|NCT01614730|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1451838|NCT01614717|Randomized|Crossover Assignment||Treatment||Single|||||t|
1451839|NCT01614704|||Cohort||Prospective|||||||
1451840|NCT01614691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451841|NCT01614678|Randomized|Crossover Assignment||Device Feasibility||Double|||t|||t
1451842|NCT01614665|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1451843|NCT01614652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451844|NCT01614639|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1451845|NCT01614626|||Cohort||Prospective|||||||
1451846|NCT01614613||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451847|NCT01614600||Single Group Assignment||Treatment||None (Open Label)||||||
1451848|NCT01614587|||Case-Control||Prospective|||||||
1451849|NCT01614574||Single Group Assignment||Treatment||None (Open Label)||||||
1451850|NCT01614561|||Case-Only||Cross-Sectional|||||||
1451851|NCT01614548|||Cohort||Retrospective|||||||
1451852|NCT01614535|Randomized|Parallel Assignment||Prevention||Single||||||t
1451853|NCT01614522|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1451854|NCT01614509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451855|NCT01614496||||||||||||
1451856|NCT01614483|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1451857|NCT01614470|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1451858|NCT01614457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451859|NCT01614444|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451860|NCT01614431||Single Group Assignment||Treatment||None (Open Label)||||||
1451861|NCT01614418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451862|NCT01614405|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1451863|NCT01614392|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451864|NCT01614379|||Case Control||Prospective|||||||
1451865|NCT01614366|Non-Randomized|Factorial Assignment||Treatment||Single|||t|||
1451866|NCT01614353|||Cohort||Prospective|||||||
1451867|NCT01614340|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1451868|NCT01614327|||Case-Only||Prospective|||||||
1451869|NCT01614314|Randomized|Parallel Assignment||||None (Open Label)||||||
1451870|NCT01614301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451871|NCT01614288|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451872|NCT01614275|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451873|NCT01614262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451874|NCT01614249|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1451875|NCT01614236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451876|NCT01614223|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1451877|NCT01614210||Single Group Assignment||Treatment||None (Open Label)||||||
1451878|NCT01614197||Single Group Assignment||Treatment||None (Open Label)||||||
1451879|NCT01614184||Single Group Assignment||Treatment||None (Open Label)||||||
1451880|NCT01614171||Single Group Assignment||Treatment||None (Open Label)||||||
1451881|NCT01614158|||Case Control||Prospective|||||||
1451882|NCT01614145|||Cohort||Prospective|||||||
1451883|NCT01614132||Single Group Assignment||Treatment||None (Open Label)||||||
1451884|NCT01614119||Single Group Assignment||Basic Science||Single|||t|||
1451885|NCT01614106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451886|NCT01614093|Randomized|Crossover Assignment||Treatment||Quadruple||All participants will receive both active drug and placebo, differences between treatment conditions will be analyzed due to small sample order effects will not be analyzed|t|t|t|t
1451887|NCT01614080|||Cohort||Prospective|||||||
1451888|NCT01614067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451889|NCT01614054|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1451890|NCT01614041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451891|NCT01614028||||||||||||
1451892|NCT01614015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451893|NCT01614002|||||Prospective|||||||
1451894|NCT01613989|Randomized|Parallel Assignment||Treatment||Single|||t|||
1451895|NCT01613976|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451896|NCT01613963|||Cohort||Retrospective|||||||
1451897|NCT01613950||Single Group Assignment||Treatment||None (Open Label)||||||
1451898|NCT01613937||Single Group Assignment||Prevention||None (Open Label)||||||
1451899|NCT01613924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451900|NCT01613911|||Case-Only||Cross-Sectional|||||||
1451901|NCT01613898|||Case-Only||Prospective|||||||
1451902|NCT01613885|||Other||Other|||||||
1451903|NCT01613872|Randomized|Parallel Assignment||Treatment||Single||||||t
1451904|NCT01613859|||||Prospective|||||||
1451905|NCT01613846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451906|NCT01613833|||Cohort||Prospective|||||||
1451907|NCT01613820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451908|NCT01613807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451909|NCT01613794|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1451910|NCT01613781|Randomized|Parallel Assignment||||Single||||||t
1451911|NCT01613768||Single Group Assignment||Treatment||None (Open Label)||||||
1451912|NCT01613755|Randomized|Crossover Assignment||||None (Open Label)||||||
1451913|NCT01613742||||||||||||
1451914|NCT01613729|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1451915|NCT01613716||Single Group Assignment||Treatment||None (Open Label)||||||
1451916|NCT01613703||Single Group Assignment||Treatment||None (Open Label)||||||
1451917|NCT01613690|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1451918|NCT01613677|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451919|NCT01613664|Randomized|Parallel Assignment||Treatment||Single||||||t
1451920|NCT01613651|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1451921|NCT01613638|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1451922|NCT01613625||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451923|NCT01613612|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451924|NCT01613599|||Cohort||Prospective|||||||
1451925|NCT01613586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451926|NCT01613573||Single Group Assignment||Treatment||None (Open Label)||||||
1451927|NCT01613560|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451928|NCT01613547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451929|NCT01613534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451930|NCT01613521||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451931|NCT01613508|Randomized|Parallel Assignment||Treatment||Single||||||t
1451932|NCT01613495|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1451933|NCT01613482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451934|NCT01613469||Single Group Assignment||Treatment||None (Open Label)||||||
1451935|NCT01613456|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1451936|NCT01613443|||Other||Retrospective|||||||
1451937|NCT01613430|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1451938|NCT01613417|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1451939|NCT01613404|||Cohort||Prospective|||||||
1451940|NCT01613391|||Cohort||Prospective|||||||
1451941|NCT01613378|||Cohort||Prospective|||||||
1451942|NCT01613365|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451943|NCT01613352|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1451944|NCT01613339|Randomized|Parallel Assignment||Treatment||Single||||||t
1451945|NCT01613326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451946|NCT01613313|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451947|NCT01613300||Single Group Assignment||Treatment||None (Open Label)||||||
1451948|NCT01613287||Single Group Assignment||Treatment||None (Open Label)||||||
1451949|NCT01613274|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1451950|NCT01613261||Single Group Assignment||Treatment||None (Open Label)||||||
1451951|NCT01613248|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451952|NCT01613235|Randomized|Parallel Assignment||Treatment||Single||||||t
1451953|NCT01613222|Non-Randomized|Single Group Assignment||||||||||
1451954|NCT01613209||Single Group Assignment||Treatment||None (Open Label)||||||
1451955|NCT01613196||Single Group Assignment||Diagnostic||None (Open Label)||||||
1451956|NCT01613183|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1451957|NCT01613170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451958|NCT01613157|||Cohort||Prospective|||||||
1451959|NCT01613144|||Cohort||Prospective|||||||
1451960|NCT01613131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451961|NCT01613118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451962|NCT01613105|||Cohort||Prospective|||||||
1451963|NCT01613092|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1451964|NCT01613079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451965|NCT01613066||Single Group Assignment||Treatment||None (Open Label)||||||
1451966|NCT01613053||||||||||||
1451967|NCT01613040|Randomized|Parallel Assignment||||Double|||t||t|
1451968|NCT01613027|||Cohort||Prospective|||||||
1451969|NCT01613014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451970|NCT01613001|||Case Control||Retrospective|||||||
1451971|NCT01612988||Single Group Assignment||Treatment||None (Open Label)||||||
1451972|NCT01612975|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1451973|NCT01612962|||Cohort||Retrospective|||||||
1451974|NCT01612949|||Cohort||Prospective|||||||
1451975|NCT01612936||Single Group Assignment||Basic Science||None (Open Label)||||||
1451976|NCT01612923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451977|NCT01612910||Single Group Assignment||Treatment||None (Open Label)||||||
1451978|NCT01612897|Randomized|Parallel Assignment||Screening||Single||||||t
1451979|NCT01612884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451980|NCT01612871||Single Group Assignment||Treatment||None (Open Label)||||||
1451981|NCT01612858|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451982|NCT01612845|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451983|NCT01612832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1451984|NCT01612819|||Cohort||Prospective|||||||
1451985|NCT01612806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451986|NCT01612793|||Case-Only||Prospective|||||||
1451987|NCT01612780||Single Group Assignment||Treatment||None (Open Label)||||||
1451988|NCT01612767||Single Group Assignment||Treatment||None (Open Label)||||||
1451989|NCT01612754|Non-Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1451990|NCT01612741|||Cohort||Prospective|||||||
1451991|NCT01612728|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1451992|NCT01612715|||Case-Only||Prospective|||||||
1451993|NCT01612702|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1451994|NCT01612689||Single Group Assignment||||None (Open Label)||||||
1451995|NCT01612676||Single Group Assignment||Treatment||None (Open Label)||||||
1451996|NCT01612663|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1451997|NCT01612650|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1451998|NCT01612637|Randomized|Parallel Assignment||Treatment||Single|||||t|
1451999|NCT01612624|||Case Control||Prospective|||||||
1452000|NCT01612611|||Cohort||Prospective|||||||
1452001|NCT01612598||Single Group Assignment||Supportive Care||None (Open Label)||||||
1452002|NCT01612585|||Cohort||Retrospective|||||||
1452003|NCT01612572|||Cohort||Prospective|||||||
1452004|NCT01612559|||Cohort||Prospective|||||||
1452005|NCT01612546||Single Group Assignment||Treatment||None (Open Label)||||||
1452006|NCT01612533|||Cohort||Prospective|||||||
1452007|NCT01612520|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452008|NCT01612507|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1452009|NCT01612494|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1452010|NCT01612481|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452011|NCT01612468|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1452012|NCT01612455|Randomized|Parallel Assignment||Treatment||Single||||||t
1452013|NCT01612442|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452014|NCT01612429||Single Group Assignment||Treatment||None (Open Label)||||||
1452015|NCT01612416|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1452016|NCT01612403|||Case Control||Retrospective|||||||
1452017|NCT01612390|||Case Control||Prospective|||||||
1452018|NCT01612377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452019|NCT01612364|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1452020|NCT01612351||Single Group Assignment||Treatment||None (Open Label)||||||
1452021|NCT01612338|Randomized|Parallel Assignment||Screening||Single|||t|||
1452022|NCT01612325||Single Group Assignment||Treatment||None (Open Label)||||||
1452023|NCT01612312|Randomized|Parallel Assignment||Treatment||Single||||||t
1452024|NCT01612299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452025|NCT01612286||Single Group Assignment||Treatment||None (Open Label)||||||
1452026|NCT01612273|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1452027|NCT01612260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452028|NCT01612247||Single Group Assignment||||None (Open Label)||||||
1452029|NCT01612234|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1452030|NCT01612221|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1452031|NCT01612208|||Cohort||Prospective|||||||
1452032|NCT01612195||Single Group Assignment||Treatment||None (Open Label)||||||
1452033|NCT01612182|||||Retrospective|||||||
1452034|NCT01612169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452035|NCT01612156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452036|NCT01612143|Randomized|Crossover Assignment||||None (Open Label)||||||
1452037|NCT01612130|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1452038|NCT01612117|||Cohort||Prospective|||||||
1452039|NCT01612104||Single Group Assignment||Treatment||None (Open Label)||||||
1452040|NCT01612091|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1452041|NCT01612078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452042|NCT01612065|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452043|NCT01612052|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1452044|NCT01612039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452045|NCT01612026|||Case Control||Prospective|||||||
1452046|NCT01612013|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452047|NCT01612000|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452048|NCT01611987|Randomized|Parallel Assignment||Treatment||Single||||||t
1452049|NCT01611974|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452050|NCT01611961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452051|NCT01611948|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1452052|NCT01611935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452053|NCT01611922|||Cohort||Prospective|||||||
1452054|NCT01611909|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1452055|NCT01611896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452056|NCT01611883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452057|NCT01611857||Single Group Assignment||Treatment||None (Open Label)||||||
1452058|NCT01611844|Randomized|Single Group Assignment||Diagnostic||Double|||t|||t
1452059|NCT01611831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452060|NCT01611818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452061|NCT01611805|Randomized|Crossover Assignment||Other||Double|||t||t|
1452062|NCT01611792|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452063|NCT01611779||Single Group Assignment||Treatment||None (Open Label)||||||
1452064|NCT01611766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452065|NCT01611753|Randomized|Parallel Assignment||||None (Open Label)||||||
1452066|NCT01611740|||Cohort||Prospective|||||||
1452067|NCT01611727||Single Group Assignment||Treatment||None (Open Label)||||||
1452068|NCT01611714|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1452069|NCT01611701|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452070|NCT01611688|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452071|NCT01611675||Single Group Assignment||Treatment||None (Open Label)||||||
1452072|NCT01611662||Single Group Assignment||Treatment||None (Open Label)||||||
1452073|NCT01611649|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1452074|NCT01611636|||Cohort||Retrospective|||||||
1452075|NCT01611623||Single Group Assignment||Treatment||None (Open Label)||||||
1452076|NCT01611610|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1452077|NCT01611597||Single Group Assignment||Basic Science||None (Open Label)||||||
1452078|NCT01611584||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452079|NCT01611571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452080|NCT01611558||Single Group Assignment||Treatment||None (Open Label)||||||
1452081|NCT01611545|||Cohort||Prospective|||||||
1452082|NCT01611532|||Cohort||Prospective|||||||
1452083|NCT01611519|||||Prospective|||||||
1452084|NCT01611506||Single Group Assignment||Treatment||None (Open Label)||||||
1452085|NCT01611493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452086|NCT01611480||||||||||||
1452087|NCT01611467|Randomized|Parallel Assignment||||None (Open Label)||||||
1452088|NCT01611454|Randomized|Parallel Assignment||||Single||||||t
1452089|NCT01611441|||Cohort||Prospective|||||||
1452090|NCT01611428|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1452091|NCT01611415|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1452092|NCT01611402|||Cohort||Cross-Sectional|||||||
1452093|NCT01611389|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452094|NCT01611376||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452095|NCT01611363|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1452096|NCT01611350|Randomized|Factorial Assignment||Prevention||Single|||t|||
1452097|NCT01611337||Single Group Assignment||Other||None (Open Label)||||||
1452098|NCT01611324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452099|NCT01611311|Randomized|Parallel Assignment||Treatment||Double||||||
1452100|NCT01611298||Single Group Assignment||Prevention||None (Open Label)||||||
1452101|NCT01611285|||Other||Other|||||||
1452103|NCT01611259||Single Group Assignment||Treatment||None (Open Label)||||||
1452104|NCT01611246||||||||||||
1452105|NCT01611233|||Cohort||Prospective|||||||
1452106|NCT01611220|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452107|NCT01611207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452108|NCT01611194|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1452109|NCT01611181|Randomized|Parallel Assignment||Treatment||Single|||||t|
1452110|NCT01611168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452111|NCT01611155|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1452112|NCT01611142||Single Group Assignment||Treatment||None (Open Label)||||||
1452113|NCT01611129|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452114|NCT01611116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452115|NCT01611103|Randomized|Crossover Assignment||Treatment||Single|||t|||
1452116|NCT01611090|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452117|NCT01611077||Single Group Assignment||Treatment||None (Open Label)||||||
1452118|NCT01611064|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1452119|NCT01611051|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452120|NCT01611038|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1452121|NCT01611025|||Ecologic or Community||Retrospective|||||||
1452122|NCT01611012|||Cohort||Prospective|||||||
1452123|NCT01610999|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452124|NCT01610986|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1452125|NCT01610973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452126|NCT01610960|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1452127|NCT01610947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452128|NCT01610934|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1452129|NCT01610921||Single Group Assignment||Diagnostic||Single|||t|||
1452130|NCT01610908|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1452131|NCT01610895|Randomized|Parallel Assignment||||Single||||||t
1452132|NCT01610882|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1452133|NCT01610869|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452134|NCT01610856|Randomized|Parallel Assignment||||Triple||||t|t|t
1452135|NCT01610843|||Cohort||Prospective|||||||
1452136|NCT01610830|||Cohort||Prospective|||||||
1452137|NCT01610817|||||Prospective|||||||
1452138|NCT01610804|||||Prospective|||||||
1452139|NCT01610791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452140|NCT01610778|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1452141|NCT01610765|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452142|NCT01610752|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452143|NCT01610739||Single Group Assignment||||None (Open Label)||||||
1452144|NCT01610726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452145|NCT01610713||Single Group Assignment||Treatment||None (Open Label)||||||
1452146|NCT01610700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452147|NCT01610687||Single Group Assignment||Treatment||None (Open Label)||||||
1452148|NCT01610674|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1452149|NCT01610661|Randomized|Crossover Assignment||Treatment||Single|||||t|
1452150|NCT01610648|||Case-Only||Prospective|||||||
1452151|NCT01610635|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1452152|NCT01610622|||||Prospective|||||||
1452153|NCT01610609|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1452154|NCT01610596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452155|NCT01610583|||||Prospective|||||||
1452156|NCT01610570|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452157|NCT01610557|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1452158|NCT01610544|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1452159|NCT01610531||Single Group Assignment||Other||None (Open Label)||||||
1452160|NCT01610518|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1452161|NCT01610505|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452162|NCT01610492||Single Group Assignment||Treatment||None (Open Label)||||||
1452163|NCT01610479||Single Group Assignment||Treatment||None (Open Label)||||||
1452164|NCT01610466|Randomized|Single Group Assignment||||Single||||||t
1452165|NCT01610453|||Cohort||Prospective|||||||
1452166|NCT01610440||Single Group Assignment||Treatment||None (Open Label)||||||
1452167|NCT01610427||Single Group Assignment||Basic Science||None (Open Label)||||||
1452168|NCT01610414|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1452169|NCT01610401|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452170|NCT01610388|Randomized|Single Group Assignment||Other||Double|||t||t|
1452171|NCT01610375||Single Group Assignment||Health Services Research||None (Open Label)||||||
1452172|NCT01610362|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452173|NCT01610349||||||||||||
1452174|NCT01610336||Single Group Assignment||Treatment||None (Open Label)||||||
1452175|NCT01610323|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1452176|NCT01610310|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1452177|NCT01610297||Single Group Assignment||Treatment||None (Open Label)||||||
1452178|NCT01610284|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452179|NCT01610271|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452180|NCT01610258||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452181|NCT01610245|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452182|NCT01610232|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1452183|NCT01610219|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452184|NCT01610206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452185|NCT01610193|||Cohort||Prospective|||||||
1452186|NCT01610180||Single Group Assignment||Treatment||None (Open Label)||||||
1452187|NCT01610167|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452188|NCT01610154||Single Group Assignment||Treatment||None (Open Label)||||||
1452189|NCT01610141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452190|NCT01610128|||||Prospective|||||||
1452191|NCT01610115|||Case-Only||Prospective|||||||
1452192|NCT01610102|||Cohort||Retrospective|||||||
1452193|NCT01610089||Single Group Assignment||||None (Open Label)||||||
1452194|NCT01610076|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1452195|NCT01610063|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1452196|NCT01610050|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452197|NCT01610037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452198|NCT01610024|Randomized|Single Group Assignment||||Double||||t|t|
1452199|NCT01610011||Single Group Assignment||Basic Science||None (Open Label)||||||
1452200|NCT01609998|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452201|NCT01609985|||Case-Only||Prospective|||||||
1452202|NCT01609972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452203|NCT01609959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452204|NCT01609946||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452205|NCT01609933||Single Group Assignment||Treatment||None (Open Label)||||||
1452206|NCT01609920||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452207|NCT01609907|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452208|NCT01609894|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452209|NCT01609881|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1452210|NCT01609868|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1452211|NCT01609855|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1452212|NCT01609842|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1452213|NCT01609829|||Cohort|||||||||
1452214|NCT01609816||Single Group Assignment||Treatment||None (Open Label)||||||
1452215|NCT01609803|||Cohort||Retrospective|||||||
1452216|NCT01609790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452217|NCT01609777||Single Group Assignment||||None (Open Label)||||||
1452218|NCT01609764|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1452219|NCT01609751||Single Group Assignment||Treatment||None (Open Label)||||||
1452220|NCT01609738|||Cohort||Prospective|||||||
1452221|NCT01609725|Randomized|Parallel Assignment||Prevention||Single||||||t
1452222|NCT01609712|||Cohort||Prospective|||||||
1452223|NCT01609699|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452224|NCT01609686|||Cohort||Prospective|||||||
1452225|NCT01609673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452226|NCT01609660|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452227|NCT01609647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452228|NCT01609634|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1452229|NCT01609621|||Case-Only||Prospective|||||||
1452230|NCT01609608|Randomized|Parallel Assignment||Treatment||Single|||||t|
1452231|NCT01609595||Single Group Assignment||Treatment||None (Open Label)||||||
1452232|NCT01609582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452233|NCT01609569|||||Prospective|||||||
1452234|NCT01609556||Single Group Assignment||Treatment||None (Open Label)||||||
1452235|NCT01609543||Single Group Assignment||Treatment||None (Open Label)||||||
1452236|NCT01609530|Randomized|Parallel Assignment||Treatment||Double|Using sealed envelope assignment, the participant will be placed in study Arm 1 or 2. The investigator will not be masked because the investigator will administer the standard of care cryotherapy or the experimental laser treatment. The outcome assessor will be masked to study group assignment for gathering data from trial participants.|Randomized Clinical Trail of standard cryotherapy compared with laser treatment|t|||t
1452237|NCT01609517|||Cohort||Prospective|||||||
1452238|NCT01609504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452239|NCT01609491|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1452240|NCT01609478|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452241|NCT01609465|||Cohort||Prospective|||||||
1452242|NCT01609452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452243|NCT01609439|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1452244|NCT01609426|||Case-Only||Other|||||||
1452245|NCT01609413|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1452246|NCT01609400|||||Prospective|||||||
1452247|NCT01609387|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452248|NCT01609374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|since the study is concurrently controlled, masking is not possible|non-randomized, concurrent ACDF control||||
1452249|NCT01609361|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1452250|NCT01609348|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452251|NCT01609335||Single Group Assignment||Basic Science||None (Open Label)||||||
1452252|NCT01609322|Randomized|Parallel Assignment||Treatment||Single||||||t
1452253|NCT01609309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452254|NCT01609296||Single Group Assignment||Treatment||None (Open Label)||||||
1452255|NCT01609283||Single Group Assignment||Treatment||None (Open Label)||||||
1452256|NCT01609270|||Cohort||Prospective|||||||
1452257|NCT01609257|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452258|NCT01609244|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452259|NCT01609231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452260|NCT01609218|Randomized|Crossover Assignment||||None (Open Label)||||||
1452261|NCT01609205||Single Group Assignment||Treatment||Single||||||t
1452262|NCT01609192||Single Group Assignment||Treatment||None (Open Label)||||||
1452263|NCT01609179||Single Group Assignment||Treatment||None (Open Label)||||||
1452264|NCT01609166|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1452265|NCT01609153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452266|NCT01609140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452267|NCT01609127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452268|NCT01609114|||Case Control||Prospective|||||||
1452269|NCT01609101|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1452270|NCT01609088||Single Group Assignment||Basic Science||None (Open Label)||||||
1452271|NCT01609075|||Cohort||Prospective|||||||
1452272|NCT01609062|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1452273|NCT01609049|||Cohort||Prospective|||||||
1452274|NCT01609036|||Cohort||Prospective|||||||
1452275|NCT01609023|||Cohort||Prospective|||||||
1452276|NCT01609010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452277|NCT01608997|||Ecologic or Community||Prospective|||||||
1452278|NCT01608984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452279|NCT01608971|||Cohort||Prospective|||||||
1452280|NCT01608958|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1452281|NCT01608945|||Case Control||Prospective|||||||
1452282|NCT01608932|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452283|NCT01608919||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452284|NCT01608906|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452285|NCT01608893|Randomized|Parallel Assignment||Treatment||Single||||||t
1452286|NCT01608880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452287|NCT01608867||Single Group Assignment||Treatment||None (Open Label)||||||
1452288|NCT01608854|||Cohort||Prospective|||||||
1452289|NCT01608841|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1452290|NCT01608828|||Case-Control||Prospective|||||||
1452291|NCT01608815||Single Group Assignment||Prevention||None (Open Label)||||||
1452292|NCT01608802|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452293|NCT01608789||Single Group Assignment||Treatment||None (Open Label)||||||
1452294|NCT01608776|Randomized|Parallel Assignment||Treatment||Single||||||t
1452295|NCT01608763|Randomized|Factorial Assignment||Treatment||Single|||t|||
1452296|NCT01608750|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1452297|NCT01608737|Randomized|Parallel Assignment||Treatment||Double||||||
1452298|NCT01608724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452299|NCT01608711||Single Group Assignment||Treatment||None (Open Label)||||||
1452300|NCT01608698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452301|NCT01608685|||Case-Only||Cross-Sectional|||||||
1452302|NCT01608672|||Case-Only||Cross-Sectional|||||||
1452303|NCT01608659|||Case-Only||Retrospective|||||||
1452304|NCT01608646||Single Group Assignment||Treatment||None (Open Label)||||||
1452305|NCT01608633|Randomized|Parallel Assignment||Treatment||Single|||||t|
1452306|NCT01608620|||||Prospective|||||||
1452307|NCT01608607|||||Prospective|||||||
1452308|NCT01608594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452309|NCT01608581||Single Group Assignment||Prevention||None (Open Label)||||||
1452310|NCT01608568|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452311|NCT01608555|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452312|NCT01608542|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1452313|NCT01608529||Single Group Assignment||Treatment||None (Open Label)||||||
1452314|NCT01608516||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452315|NCT01608503||Single Group Assignment||Supportive Care||Single|||||t|
1452316|NCT01608490|Randomized|Parallel Assignment||Treatment||None (Open Label)||One group received standard of care and LVRC and the control group received only standard of care.||||
1452317|NCT01608477|||Case-Only||Cross-Sectional|||||||
1452318|NCT01608464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452319|NCT01608451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452320|NCT01608438|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1452321|NCT01608425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452322|NCT01608412|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452323|NCT01608399|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452324|NCT01608386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452325|NCT01608373|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452326|NCT01608360|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452327|NCT01608347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452328|NCT01608334|Randomized|Parallel Assignment||||Double|||t||t|
1452405|NCT01607320|Randomized|Parallel Assignment||Treatment||Single|||||t|
1452406|NCT01607307|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1452407|NCT01607294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452408|NCT01607281|||||Prospective|||||||
1452329|NCT01608321|Randomized|Parallel Assignment||Treatment||Triple|rTMS sham involves using the same paddle applied to the head, the side (one shielded internally from the magnetic pulse by aluminum) turned toward the head is randomized. A small shock is also given in both circumstances to disguise the sensation produced by the active rTMS.|Double-blind study of rTMS versus sham|t|t|t|
1452330|NCT01608308|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1452331|NCT01608295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452332|NCT01608282|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1452333|NCT01608269||Single Group Assignment||Treatment||None (Open Label)||||||
1452334|NCT01608256|||Cohort||Cross-Sectional|||||||
1452335|NCT01608243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452336|NCT01608230|||Case-Only||Prospective|||||||
1452337|NCT01608217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452338|NCT01608204|||||Prospective|||||||
1452339|NCT01608191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452340|NCT01608178|||||Prospective|||||||
1452341|NCT01608165|Randomized|Parallel Assignment||||None (Open Label)||||||
1452342|NCT01608152|||Cohort||Prospective|||||||
1452343|NCT01608139||Single Group Assignment||Treatment||None (Open Label)||||||
1452344|NCT01608126|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1452345|NCT01608113|||Cohort||Prospective|||||||
1452346|NCT01608100||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452347|NCT01608087|Randomized|Parallel Assignment||Treatment||Single||||||
1452348|NCT01608074||Single Group Assignment||Prevention||None (Open Label)||||||
1452349|NCT01608061|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452350|NCT01608048|Randomized|Parallel Assignment||Treatment||Single||||||t
1452351|NCT01608035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452352|NCT01608022||Single Group Assignment||Treatment||None (Open Label)||||||
1452353|NCT01608009||Single Group Assignment||Treatment||None (Open Label)||||||
1452354|NCT01607996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452355|NCT01607983||Single Group Assignment||Treatment||None (Open Label)||||||
1452356|NCT01607970|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1452357|NCT01607957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452358|NCT01607944|||Case Control||Cross-Sectional|||||||
1452359|NCT01607931|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1452360|NCT01607918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452361|NCT01607905||Single Group Assignment||Treatment||None (Open Label)||||||
1452362|NCT01607892||Single Group Assignment||Treatment||None (Open Label)||||||
1452363|NCT01607879|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452364|NCT01607866|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452365|NCT01607853|Randomized|Single Group Assignment||||Single|||||t|
1452366|NCT01607840|Randomized|Crossover Assignment||Treatment||Single|||t|||
1452367|NCT01607827|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1452368|NCT01607814|||Case Control||Cross-Sectional|||||||
1452369|NCT01607801|||Cohort||Retrospective|||||||
1452370|NCT01607788|||Cohort||Prospective|||||||
1452371|NCT01607775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452372|NCT01607762|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1452373|NCT01607749|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452374|NCT01607736|Non-Randomized|Crossover Assignment||Treatment||Single|||||t|
1452375|NCT01607723|Randomized|Crossover Assignment||Treatment||Single|||t|||
1452376|NCT01607710|||Case Control||Cross-Sectional|||||||
1452377|NCT01607697|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1452378|NCT01607684|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1452379|NCT01607671|Randomized|Parallel Assignment||Treatment||Single||||||t
1452380|NCT01607658|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452381|NCT01607645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452382|NCT01607632||Single Group Assignment||Treatment||None (Open Label)||||||
1452383|NCT01607619||Single Group Assignment||Supportive Care||Single|||t|||
1452384|NCT01607606||||||||||||
1452385|NCT01607593|||Cohort||Retrospective|||||||
1452386|NCT01607580|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452387|NCT01607554||Single Group Assignment||Treatment||None (Open Label)||||||
1452388|NCT01607541|Randomized|Parallel Assignment||||None (Open Label)||||||
1452389|NCT01607528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452390|NCT01607515||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452391|NCT01607502|||Cohort||Prospective|||||||
1452392|NCT01607489||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452393|NCT01607476|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1452394|NCT01607463|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1452395|NCT01607450|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1452396|NCT01607437|||Case-Only||Retrospective|||||||
1452397|NCT01607424|Randomized|Parallel Assignment||Treatment||Single||||||t
1452398|NCT01607411|Randomized|Crossover Assignment||Treatment||Single|||||t|
1452399|NCT01607398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452400|NCT01607385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452401|NCT01607372|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1452402|NCT01607359|||Case-Control||Retrospective|||||||
1452403|NCT01607346||Single Group Assignment||Treatment||None (Open Label)||||||
1452404|NCT01607333|||||Retrospective|||||||
1452409|NCT01607268|||Case Control||Cross-Sectional|||||||
1452410|NCT01607255|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452411|NCT01607242|||Cohort||Prospective|||||||
1452412|NCT01607229|||||Cross-Sectional|||||||
1452413|NCT01607216|||Cohort||Prospective|||||||
1452414|NCT01607203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452415|NCT01607190|||Cohort||Prospective|||||||
1452416|NCT01607177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452417|NCT01607164||Single Group Assignment||Prevention||None (Open Label)||||||
1452418|NCT01607151|Randomized|Parallel Assignment||Treatment||Single||||||t
1452419|NCT01607138|||Cohort||Retrospective|||||||
1452420|NCT01607125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452421|NCT01607112|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452422|NCT01607099|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1452423|NCT01607086|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1452424|NCT01607073||Single Group Assignment||Treatment||None (Open Label)||||||
1452425|NCT01607060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452426|NCT01607047|||Cohort||Prospective|||||||
1452427|NCT01607034|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452428|NCT01607021|||Case-Only||Prospective|||||||
1452429|NCT01607008||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452430|NCT01606995|||Cohort||Prospective|||||||
1452431|NCT01606982||||||||||||
1452432|NCT01606969|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1452433|NCT01606956|Randomized|Parallel Assignment||||Double||||t|t|
1452434|NCT01606943|||Cohort||Retrospective|||||||
1452435|NCT01606930|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1452436|NCT01606917|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1452437|NCT01606904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452438|NCT01606891|Randomized|Factorial Assignment||Other||Double|||||t|t
1452439|NCT01606878|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452440|NCT01606865|||Cohort||Prospective|||||||
1452441|NCT01606852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452442|NCT01606839|||Cohort||Prospective|||||||
1452443|NCT01606826|||Cohort||Prospective|||||||
1452444|NCT01606813|Randomized|Factorial Assignment||Treatment||Single||||||t
1452445|NCT01606800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452446|NCT01606787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452447|NCT01606774||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452448|NCT01606761|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452449|NCT01606748||Single Group Assignment||Treatment||None (Open Label)||||||
1452450|NCT01606735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452451|NCT01606722|||Cohort||Prospective|||||||
1452452|NCT01606709|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1452453|NCT01606696|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1452454|NCT01606683|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1452455|NCT01606670|||Cohort||Prospective|||||||
1452456|NCT01606657|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1452457|NCT01606644|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452458|NCT01606631|||Case Control||Prospective|||||||
1452459|NCT01606618|||Cohort||Prospective|||||||
1452460|NCT01606605|||Cohort||Retrospective|||||||
1452461|NCT01606592|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1452462|NCT01606579|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452463|NCT01606566||Single Group Assignment||Treatment||None (Open Label)||||||
1452464|NCT01606553|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1452465|NCT01606540|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1452466|NCT01606527|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1452467|NCT01606514|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1452468|NCT01606501|||Cohort||Prospective|||||||
1452469|NCT01606488|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1452470|NCT01606475||||||||||||
1452471|NCT01606462|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1452472|NCT01606449|||Cohort||Retrospective|||||||
1452473|NCT01606436|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1452474|NCT01606423|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1452475|NCT01606410|||Cohort||Cross-Sectional|||||||
1452476|NCT01606397|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1452477|NCT01606384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452478|NCT01606371|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1452479|NCT01606358|||Cohort||Prospective|||||||
1452480|NCT01606345||Single Group Assignment||Treatment||None (Open Label)||||||
1452481|NCT01606332|Randomized|Parallel Assignment||Treatment||Single||||||t
1452482|NCT01606319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452483|NCT01606306|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1452484|NCT01606293|||Cohort||Prospective|||||||
1452485|NCT01606280|||Cohort||Retrospective|||||||
1452486|NCT01606267|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1452487|NCT01606254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452488|NCT01606241||Single Group Assignment||Treatment||None (Open Label)||||||
1452489|NCT01606228||Single Group Assignment||Treatment||None (Open Label)||||||
1452490|NCT01606215|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1452491|NCT01606202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452492|NCT01606189|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1452493|NCT01606176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452494|NCT01606163|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1452495|NCT01606150|Randomized|Single Group Assignment||Treatment||Single||||||t
1452496|NCT01606137||Single Group Assignment||Treatment||None (Open Label)||||||
1452497|NCT01606124|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452498|NCT01606111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452499|NCT01606098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452500|NCT01606085|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452501|NCT01606072||Single Group Assignment||||None (Open Label)||||||
1452502|NCT01606059|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1452503|NCT01606046|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1452504|NCT01606033|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452505|NCT01606020|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1452506|NCT01606007|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452507|NCT01605994|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1452508|NCT01605981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452509|NCT01605968|Randomized|Parallel Assignment||Treatment||Single||||||t
1452510|NCT01605955|||||Prospective|||||||
1452511|NCT01605942|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452512|NCT01605929||Single Group Assignment||Treatment||None (Open Label)||||||
1452513|NCT01605916||Single Group Assignment||Treatment||None (Open Label)||||||
1452514|NCT01605903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452515|NCT01605890||Single Group Assignment||Treatment||None (Open Label)||||||
1452516|NCT01605877||Single Group Assignment||Treatment||None (Open Label)||||||
1452517|NCT01605864||Single Group Assignment||Treatment||None (Open Label)||||||
1452518|NCT01605851||Single Group Assignment||Treatment||None (Open Label)||||||
1452519|NCT01605838|||Cohort||Prospective|||||||
1452520|NCT01605825|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1452521|NCT01605812|||Case Control||Prospective|||||||
1452522|NCT01605799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452523|NCT01605786|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452524|NCT01605773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452525|NCT01605760|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1452526|NCT01605747|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452527|NCT01605734|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452528|NCT01605721||Single Group Assignment||Treatment||None (Open Label)||||||
1452529|NCT01605708|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1452530|NCT01605695|||Cohort||Prospective|||||||
1452531|NCT01605682|Randomized|Crossover Assignment||||Double|||t||t|
1452532|NCT01605669|||Cohort||Prospective|||||||
1452533|NCT01605656|||Cohort||Prospective|||||||
1452534|NCT01605643|||Cohort||Prospective|||||||
1452535|NCT01605630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452536|NCT01605617|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1452537|NCT01605604|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452538|NCT01605591|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1452539|NCT01605578||Single Group Assignment||Basic Science||None (Open Label)||||||
1452540|NCT01605565||Parallel Assignment||Basic Science||None (Open Label)||||||
1452541|NCT01605552|Randomized|Parallel Assignment||Prevention||Single||||||t
1452542|NCT01605539|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1452543|NCT01605526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452544|NCT01605513||Single Group Assignment||Treatment||None (Open Label)||||||
1452545|NCT01605500|||Case-Only||Prospective|||||||
1452546|NCT01605487|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1452547|NCT01605474|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452548|NCT01605461||Single Group Assignment||Basic Science||None (Open Label)||||||
1452549|NCT01605448|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452550|NCT01605435|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1452551|NCT01605422|||||Prospective|||||||
1452552|NCT01605409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452553|NCT01605396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452554|NCT01605383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452555|NCT01605370|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1452556|NCT01605357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452557|NCT01605344|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1452558|NCT01605331||Single Group Assignment||Treatment||None (Open Label)||||||
1452559|NCT01605318||Single Group Assignment||Treatment||None (Open Label)||||||
1452560|NCT01605305||Single Group Assignment||Treatment||Single|||||t|
1452561|NCT01605292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452562|NCT01605279|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452563|NCT01605266|||Cohort||Prospective|||||||
1452564|NCT01605253|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452565|NCT01605240|Randomized|Single Group Assignment||Treatment||Single|||t|||
1452566|NCT01605227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452567|NCT01605214|||Cohort||Prospective|||||||
1452568|NCT01605201||Single Group Assignment||Treatment||None (Open Label)||||||
1452569|NCT01605188|||Case-Crossover||Prospective|||||||
1452570|NCT01605175|||Case-Crossover||Prospective|||||||
1452571|NCT01605162||Single Group Assignment||Treatment||None (Open Label)||||||
1452572|NCT01605149|||Case-Only||Prospective|||||||
1452573|NCT01605136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452574|NCT01605123|||Case-Control||Prospective|||||||
1452575|NCT01605110|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1452576|NCT01605097||Single Group Assignment||Treatment||None (Open Label)||||||
1452577|NCT01605084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452578|NCT01605071|Randomized|Crossover Assignment||Other||Single|||t|||
1452579|NCT01605058|||Cohort||Retrospective|||||||
1452580|NCT01605045|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1452581|NCT01605032||Single Group Assignment||Treatment||None (Open Label)||||||
1452582|NCT01605019|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452583|NCT01605006||Single Group Assignment||Treatment||None (Open Label)||||||
1452584|NCT01604993|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1452585|NCT01604980||Single Group Assignment||Treatment||None (Open Label)||||||
1452586|NCT01604967||||||||||||
1452587|NCT01604954|Randomized|Factorial Assignment||||Single|||t|||
1452588|NCT01604941||Single Group Assignment||Treatment||None (Open Label)||||||
1452589|NCT01604928|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452590|NCT01604915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452591|NCT01604902|||Case-Only||Prospective|||||||
1452592|NCT01604889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452593|NCT01604876|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452594|NCT01604863|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452595|NCT01604850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452596|NCT01604837|||Case Control|||||||||
1452597|NCT01604824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452598|NCT01604811|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1452599|NCT01604798|||Case Control||Prospective|||||||
1452600|NCT01604785|Randomized|Parallel Assignment||Treatment||Single||||||t
1452601|NCT01604772||Single Group Assignment||Treatment||None (Open Label)||||||
1452602|NCT01604759||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452603|NCT01604746||Single Group Assignment||Prevention||None (Open Label)||||||
1452604|NCT01604733|||||Cross-Sectional|||||||
1452605|NCT01604720|||||Prospective|||||||
1452606|NCT01604707|Randomized|Parallel Assignment||Treatment||Single|||||t|
1452607|NCT01604694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452608|NCT01604681|Randomized|Parallel Assignment||||Double|||t||t|
1452609|NCT01604668|||Cohort|||||||||
1452610|NCT01604655|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1452611|NCT01604642||Single Group Assignment||Basic Science||None (Open Label)||||||
1452612|NCT01604629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452613|NCT01604616|||Case Control||Retrospective|||||||
1452614|NCT01604603|||Cohort||Retrospective|||||||
1452615|NCT01604590|||Case-Only||Prospective|||||||
1452616|NCT01604577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452617|NCT01604564|||Cohort||Prospective|||||||
1452618|NCT01604551|||||Prospective|||||||
1452619|NCT01604538|||Cohort||Prospective|||||||
1452620|NCT01604525|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452621|NCT01604512||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452622|NCT01604499|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452623|NCT01604486|||||Retrospective|||||||
1452624|NCT01604473|||Cohort||Prospective|||||||
1452625|NCT01604460|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452626|NCT01604447|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452627|NCT01604434|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452628|NCT01604421|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452629|NCT01604408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452630|NCT01604395|||Cohort|||||||||
1452631|NCT01604382|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1452632|NCT01604369||Single Group Assignment||Treatment||None (Open Label)||||||
1452633|NCT01604356||Single Group Assignment||Treatment||None (Open Label)||||||
1452634|NCT01604343|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452635|NCT01604330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452636|NCT01604317|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452637|NCT01604304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452638|NCT01604291|||Cohort||Prospective|||||||
1452639|NCT01604278|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452640|NCT01604265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452641|NCT01604252|||Cohort||Prospective|||||||
1452642|NCT01604239||Single Group Assignment||Treatment||None (Open Label)||||||
1452643|NCT01604226|||||Prospective|||||||
1452644|NCT01604213|Randomized|Parallel Assignment||Treatment||Single||||||t
1452645|NCT01604200|||||Prospective|||||||
1452646|NCT01604187|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1452647|NCT01604174|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1452648|NCT01604161|||Cohort||Prospective|||||||
1452649|NCT01604148|||Cohort||Retrospective|||||||
1452650|NCT01604135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452651|NCT01604122|||Other||Cross-Sectional|||||||
1452652|NCT01604109|Non-Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452653|NCT01604096|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1452654|NCT01604083|||Cohort||Prospective|||||||
1452655|NCT01604070|||Case Control||Prospective|||||||
1452656|NCT01604057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452657|NCT01604044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452658|NCT01604031||Single Group Assignment||Treatment||None (Open Label)||||||
1452659|NCT01604018|||Cohort||Prospective|||||||
1452660|NCT01604005|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452661|NCT01603992||||||||||||
1452662|NCT01603979||Single Group Assignment||Treatment||None (Open Label)||||||
1452663|NCT01603966|||Case-Crossover||Prospective|||||||
1452664|NCT01603953|||Cohort||Prospective|||||||
1452665|NCT01603940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452666|NCT01603927|||Cohort||Prospective|||||||
1452667|NCT01603914|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452668|NCT01603901|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452669|NCT01603888|||Case-Control||Cross-Sectional|||||||
1452670|NCT01603875|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452671|NCT01603862||Single Group Assignment||Treatment||None (Open Label)||||||
1452672|NCT01603849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452673|NCT01603836||Parallel Assignment||Treatment||Single||||||t
1452674|NCT01603784|Randomized|Factorial Assignment||Prevention||Single||||||t
1452675|NCT01603771|||Case Control||Prospective|||||||
1452676|NCT01603758|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1452677|NCT01603732|||Cohort||Prospective|||||||
1452678|NCT01603719|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452679|NCT01603563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452680|NCT01603550|Randomized|Crossover Assignment||||Double|||t||t|
1452681|NCT01603537|||Ecologic or Community||Retrospective|||||||
1452682|NCT01603524|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452683|NCT01603511||Single Group Assignment||Treatment||None (Open Label)||||||
1452684|NCT01603498|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1452685|NCT01603407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452686|NCT01603823|||Cohort||Prospective|||||||
1452687|NCT01603810|||Case-Only||Prospective|||||||
1452688|NCT01603797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452689|NCT01603745|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452690|NCT01603706|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452691|NCT01603693|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1452692|NCT01603680|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1452693|NCT01603667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452694|NCT01603654|Randomized|Parallel Assignment||Treatment||Single|||||t|
1452695|NCT01603641||Single Group Assignment||Treatment||None (Open Label)||||||
1452696|NCT01603628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452697|NCT01603615||Single Group Assignment||Treatment||None (Open Label)||||||
1452698|NCT01603602|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452699|NCT01603589|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452700|NCT01603576||Single Group Assignment||Treatment||None (Open Label)||||||
1452701|NCT01603485||Single Group Assignment||Basic Science||None (Open Label)||||||
1452702|NCT01603472|||Case Control||Cross-Sectional|||||||
1452703|NCT01603459||Single Group Assignment||Treatment||None (Open Label)||||||
1452704|NCT01603446|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452705|NCT01603433||Single Group Assignment||Treatment||None (Open Label)||||||
1452706|NCT01603420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452707|NCT01603394||Single Group Assignment||Treatment||None (Open Label)||||||
1452708|NCT01603381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452709|NCT01603368|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452710|NCT01603355||Single Group Assignment||Treatment||None (Open Label)||||||
1452711|NCT01603342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452712|NCT01603329|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1452713|NCT01603316|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1452714|NCT01603303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452715|NCT01603290|||Cohort||Prospective|||||||
1452716|NCT01603277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452717|NCT01603264|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1452718|NCT01603251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452719|NCT01603238||Single Group Assignment||Treatment||None (Open Label)||||||
1452720|NCT01603225|||Cohort||Prospective|||||||
1452721|NCT01603212||Single Group Assignment||Treatment||None (Open Label)||||||
1452722|NCT01603199|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452723|NCT01603186|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452724|NCT01603173|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452725|NCT01603160|||||Prospective|||||||
1452726|NCT01603147|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1452727|NCT01603134|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452728|NCT01603121|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1452729|NCT01603108|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1452730|NCT01603095|||Case-Only||Prospective|||||||
1452731|NCT01603082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452732|NCT01603069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452733|NCT01603056|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452734|NCT01603043|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452735|NCT01603030|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452736|NCT01603017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452737|NCT01603004|||Cohort||Prospective|||||||
1452738|NCT01602991||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452739|NCT01602978|||Cohort||Prospective|||||||
1452740|NCT01602965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452741|NCT01602952||Single Group Assignment||Treatment||None (Open Label)||||||
1452742|NCT01602939||Single Group Assignment||Treatment||None (Open Label)||||||
1452743|NCT01602926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452744|NCT01602913|||Cohort||Retrospective|||||||
1452745|NCT01602900|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452746|NCT01602887|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1452747|NCT01602874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452748|NCT01602861|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452749|NCT01602848|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1452750|NCT01602835|||Cohort||Cross-Sectional|||||||
1452751|NCT01602822||Single Group Assignment||Prevention||None (Open Label)||||||
1452752|NCT01602809|||||Prospective|||||||
1452753|NCT01602796|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1452754|NCT01602783||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452755|NCT01602770|||Cohort||Prospective|||||||
1452756|NCT01602757||Single Group Assignment||Basic Science||None (Open Label)||||||
1452757|NCT01602744|Randomized|Parallel Assignment||Screening||Single|||t|||
1452758|NCT01602731||Single Group Assignment||Supportive Care||None (Open Label)||||||
1452759|NCT01602718|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452760|NCT01602705|Randomized|Parallel Assignment||Prevention||Single||||||t
1452761|NCT01602692|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452762|NCT01602679|Randomized|Crossover Assignment||Basic Science||Quadruple||Randomized, placebo-controlled, crossover study|t|t|t|t
1452763|NCT01602666||Single Group Assignment||Treatment||None (Open Label)||||||
1452764|NCT01602653|Randomized|Parallel Assignment||Treatment||Single|||||t|
1452765|NCT01602640|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1452766|NCT01602627||Single Group Assignment||Treatment||None (Open Label)||||||
1452767|NCT01602614|||Other||Prospective|||||||
1452768|NCT01602601|||Case-Only||Cross-Sectional|||||||
1452769|NCT01602588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452770|NCT01602575||Single Group Assignment||Treatment||None (Open Label)||||||
1452771|NCT01602562||Single Group Assignment||Prevention||None (Open Label)||||||
1452772|NCT01602549|Randomized|Parallel Assignment||||Double|||t||t|
1452773|NCT01602536|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452774|NCT01602523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452775|NCT01602510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452776|NCT01602497|Randomized|Parallel Assignment||Treatment||Single|||t|||
1452777|NCT01602484|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1452778|NCT01602471||Single Group Assignment||||None (Open Label)||||||
1452779|NCT01602458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452780|NCT01602445|||Cohort||Prospective|||||||
1452781|NCT01602432|||Cohort||Prospective|||||||
1452782|NCT01602419|||Case-Only||Prospective|||||||
1452783|NCT01602406||Single Group Assignment||Treatment||None (Open Label)||||||
1452784|NCT01602393|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452785|NCT01602380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452786|NCT01602367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452787|NCT01602354|||Cohort||Prospective|||||||
1452788|NCT01602341|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452789|NCT01602328|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452790|NCT01602315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452791|NCT01602302||Single Group Assignment||Treatment||None (Open Label)||||||
1452792|NCT01602289|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452793|NCT01602276|Randomized|Crossover Assignment||Treatment||Single|||t|||
1452794|NCT01602263|||Case-Control||Cross-Sectional|||||||
1452795|NCT01602250|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1452796|NCT01602237|||Cohort||Other|||||||
1452797|NCT01602224|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452798|NCT01602211|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1452799|NCT01602198|Randomized|Parallel Assignment||||Double|||t|||t
1452800|NCT01602185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452801|NCT01602172|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1452802|NCT01602159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452803|NCT01602146|||Cohort||Prospective|||||||
1452804|NCT01602133||Single Group Assignment||||None (Open Label)||||||
1452805|NCT01602120|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452806|NCT01602107|Randomized|Parallel Assignment||Treatment||Single||||||t
1452807|NCT01602094|||Case Control||Cross-Sectional|||||||
1452808|NCT01602081|||Cohort||Prospective|||||||
1452809|NCT01602068|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452810|NCT01602055|Randomized|Crossover Assignment||||None (Open Label)||||||
1452811|NCT01602042|||Cohort||Prospective|||||||
1452812|NCT01602029|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1452813|NCT01602016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452814|NCT01602003|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452815|NCT01601990|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452816|NCT01601977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452817|NCT01601964|||Case-Only||Prospective|||||||
1452818|NCT01601951|||Cohort||Prospective|||||||
1452819|NCT01601938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452820|NCT01601925||Single Group Assignment||Treatment||None (Open Label)||||||
1452821|NCT01601912|||Case Control||Cross-Sectional|||||||
1452822|NCT01601899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452823|NCT01601886|||Cohort||Retrospective|||||||
1452824|NCT01601873|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452825|NCT01601860|Randomized|Parallel Assignment||Treatment||Single|||||t|
1452826|NCT01601847|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452827|NCT01601834|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1452828|NCT01601821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452829|NCT01601808|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452830|NCT01601795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452831|NCT01601782||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452832|NCT01601769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452833|NCT01601756|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1452834|NCT01601743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452835|NCT01601730|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1452836|NCT01601717|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1452837|NCT01601704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452838|NCT01601691||Single Group Assignment||Supportive Care||None (Open Label)||||||
1452839|NCT01601678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452840|NCT01601665|||Cohort||Prospective|||||||
1452841|NCT01601652||Single Group Assignment||Treatment||None (Open Label)||||||
1452842|NCT01601639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452843|NCT01601626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452844|NCT01601613|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452845|NCT01601600|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452846|NCT01601587|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1452847|NCT01601574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452848|NCT01601561|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1452849|NCT01601548|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452850|NCT01601535||Single Group Assignment||Treatment||None (Open Label)||||||
1452851|NCT01601522|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1452852|NCT01601509|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1452853|NCT01601496||Single Group Assignment||||None (Open Label)||||||
1452854|NCT01601483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452855|NCT01601470||Single Group Assignment||||None (Open Label)||||||
1452856|NCT01601457|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452857|NCT01601444||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452858|NCT01601431|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1452859|NCT01601418|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1452860|NCT01601405|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1452861|NCT01601392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452862|NCT01601379|||Case-Only||Prospective|||||||
1452863|NCT01601366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452864|NCT01601353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452865|NCT01601340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452866|NCT01601327|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452867|NCT01601314|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452868|NCT01601301||Single Group Assignment||Treatment||None (Open Label)||||||
1452869|NCT01601288|||Case-Only||Prospective|||||||
1452870|NCT01601275|||Case-Only||Prospective|||||||
1452871|NCT01601262||Single Group Assignment||Treatment||None (Open Label)||||||
1452872|NCT01601249|Randomized|Parallel Assignment||||None (Open Label)||||||
1452873|NCT01601236|Randomized|Parallel Assignment||Treatment||Double||The 32U group was discontinued after 2 patients met pre-specified criteria related to tolerability and patients assigned to the 32U were re-assigned to the 16U group.|t||t|
1452874|NCT01601223|||Cohort||Prospective|||||||
1452875|NCT01601210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452876|NCT01601197|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452877|NCT01601184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452878|NCT01601171|||Case Control|||||||||
1452879|NCT01601158||Single Group Assignment||Treatment||None (Open Label)||||||
1452880|NCT01601145|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1452881|NCT01601132|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1452882|NCT01601119|||Cohort||Prospective|||||||
1452883|NCT01601106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452884|NCT01601093|Randomized|Factorial Assignment||Treatment||Single|||t|||
1452885|NCT01601080|||Cohort||Retrospective|||||||
1452886|NCT01601067|Randomized|Parallel Assignment||Treatment||Single||||||t
1452887|NCT01601054|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1452888|NCT01601041|||Cohort||Prospective|||||||
1452889|NCT01601028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452890|NCT01601015|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1452891|NCT01601002||Single Group Assignment||||None (Open Label)||||||
1452892|NCT01600989|||Cohort||Prospective|||||||
1452893|NCT01600976|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452894|NCT01600963|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452895|NCT01600950|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1452896|NCT01600937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452897|NCT01600924|||Cohort||Prospective|||||||
1452898|NCT01600911||Single Group Assignment||Treatment||None (Open Label)||||||
1452899|NCT01600898|||Cohort||Prospective|||||||
1452900|NCT01600885|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1452901|NCT01600872|||Cohort||Prospective|||||||
1452902|NCT01600859|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452903|NCT01600846|||Cohort||Prospective|||||||
1452904|NCT01600833|||Cohort||Retrospective|||||||
1452905|NCT01600820|Randomized|Parallel Assignment||||Double|||t||t|
1452906|NCT01600807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452907|NCT01600794|||Case-Only||Prospective|||||||
1452908|NCT01600781|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452909|NCT01600768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452910|NCT01600755||Single Group Assignment||Treatment||None (Open Label)||||||
1452911|NCT01600742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452912|NCT01600729|||Cohort||Prospective|||||||
1452913|NCT01600716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452914|NCT01600703|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1452915|NCT01600690|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452916|NCT01600677|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1452917|NCT01600664|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452918|NCT01600651|Randomized|Crossover Assignment||Treatment||Single|||t|||
1452919|NCT01600638||Single Group Assignment||Other||None (Open Label)||||||
1452920|NCT01600625||Single Group Assignment||Treatment||None (Open Label)||||||
1452921|NCT01600612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452922|NCT01600599|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1452923|NCT01600586|Randomized|Parallel Assignment||Treatment||Single||||||t
1452924|NCT01600573||Single Group Assignment||Treatment||None (Open Label)||||||
1452925|NCT01600560|||Cohort||Prospective|||||||
1452926|NCT01600547|||Case Control||Prospective|||||||
1452927|NCT01600534|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1452928|NCT01600521|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1452929|NCT01600508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452930|NCT01600495|Randomized|Parallel Assignment||Treatment||Single|||||t|
1452931|NCT01600482|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452932|NCT01600469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452933|NCT01600456|Randomized|Parallel Assignment||Treatment||Single||||||t
1452934|NCT01600443|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452935|NCT01600430|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452936|NCT01600417|||Case-Only||Prospective|||||||
1452937|NCT01600404|||Cohort||Prospective|||||||
1452938|NCT01600391|Randomized|Parallel Assignment||Treatment||Single||||||t
1452939|NCT01600378|||Case-Only||Prospective|||||||
1452940|NCT01600365|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452941|NCT01600352|||Case-Only||Prospective|||||||
1452942|NCT01600339||Single Group Assignment||Treatment||None (Open Label)||||||
1452943|NCT01600326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452944|NCT01600313||Single Group Assignment||Treatment||Single|||||t|
1452945|NCT01600300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452946|NCT01600287|Randomized|Parallel Assignment||||Single|||t|||
1452947|NCT01600274||Single Group Assignment||Treatment||None (Open Label)||||||
1452948|NCT01600261|||||Prospective|||||||
1452949|NCT01600248||Single Group Assignment||Treatment||None (Open Label)||||||
1452950|NCT01600235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452951|NCT01600222||Single Group Assignment||Treatment||None (Open Label)||||||
1452952|NCT01600209|||Case-Only|||||||||
1452953|NCT01600196|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452954|NCT01600183|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1452955|NCT01600170|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1452956|NCT01600157||Single Group Assignment||Health Services Research||None (Open Label)||||||
1452957|NCT01600144|||||Prospective|||||||
1452958|NCT01600131|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1452959|NCT01600118|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452960|NCT01600105||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452961|NCT01600092|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1452962|NCT01600079|||Cohort||Prospective|||||||
1452963|NCT01600066|||Cohort||Prospective|||||||
1452964|NCT01600053||Single Group Assignment||Treatment||None (Open Label)||||||
1452965|NCT01600040||Single Group Assignment||Treatment||None (Open Label)||||||
1452966|NCT01600027|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452967|NCT01600014|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452968|NCT01600001|Randomized|Parallel Assignment||Treatment||Double||||||
1452969|NCT01599988|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1452970|NCT01599975|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1452971|NCT01599962|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1452972|NCT01599949||Single Group Assignment||Treatment||None (Open Label)||||||
1452973|NCT01599936||Single Group Assignment||Treatment||None (Open Label)||||||
1452974|NCT01599923||Single Group Assignment||Treatment||None (Open Label)||||||
1452975|NCT01599910|||Cohort||Prospective|||||||
1452976|NCT01599897|Randomized|Single Group Assignment||Prevention||Single||||||t
1452977|NCT01599884|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1452978|NCT01599871|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1452979|NCT01599858|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1452980|NCT01599845|||Case-Only||Cross-Sectional|||||||
1452981|NCT01599832||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452982|NCT01599819|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1452983|NCT01599806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1452984|NCT01599793||Single Group Assignment||Diagnostic||None (Open Label)||||||
1452985|NCT01599780|||Case-Control||Prospective|||||||
1452986|NCT01599767|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1452987|NCT01599754|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1452988|NCT01599741|Non-Randomized|||Treatment||None (Open Label)||||||
1452989|NCT01599728|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1452990|NCT01599715|Randomized|Single Group Assignment||Prevention||Single|||||t|
1452991|NCT01599702|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1452992|NCT01599689|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452993|NCT01599676|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1452994|NCT01599663|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1452995|NCT01599650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1452996|NCT01599637|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1452997|NCT01599624|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1452998|NCT01599611|||Case Control||Prospective|||||||
1452999|NCT01599598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453000|NCT01599585|Randomized|Parallel Assignment||Treatment||Single||||||t
1453001|NCT01599572||Single Group Assignment||Prevention||Double|||t||t|
1453002|NCT01599559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453003|NCT01599546|||Cohort||Prospective|||||||
1453004|NCT01599533||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453005|NCT01599520|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1453006|NCT01599507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453007|NCT01599494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453008|NCT01599481|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1453009|NCT01599468|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1453010|NCT01599455|||Cohort||Prospective|||||||
1453011|NCT01599442|||Cohort||Prospective|||||||
1453012|NCT01599429|||Case-Only||Prospective|||||||
1453013|NCT01599416|Randomized|Parallel Assignment||Treatment||Triple|same capsule appearance and bottle without any marks for identification to participants, care providers and investigators except serial numbers|"U-relax Group: U-relax capsules Day 1-5: take two capsuals of oral U-relax everyday before sleep Day 6-360: take one capsule of oral U-relax everyday before sleep~Control Group: Placebo capsules Day 1-5: take two capsuals of oral placebo everyday before sleep Day 6-360: take one capsual of oral placebo everyday before sleep"|t|t|t|
1453014|NCT01599403|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453015|NCT01599390|||||Retrospective|||||||
1453016|NCT01599377|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453017|NCT01599364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453018|NCT01599351|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1453019|NCT01599338||Single Group Assignment||Health Services Research||None (Open Label)||||||
1453020|NCT01599325||Single Group Assignment||Treatment||None (Open Label)||||||
1453021|NCT01599312|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1453022|NCT01599299|||Case-Only||Cross-Sectional|||||||
1453023|NCT01599286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453024|NCT01599273|Randomized|Parallel Assignment||Treatment||Single||||||t
1453025|NCT01599260||Single Group Assignment||Treatment||None (Open Label)||||||
1453026|NCT01599247|||Cohort||Prospective|||||||
1453027|NCT01599234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453028|NCT01599221|||Cohort|||||||||
1453029|NCT01599208|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1453030|NCT01599195|||Case-Only||Prospective|||||||
1453031|NCT01599182|||Cohort||Prospective|||||||
1453032|NCT01599169|Randomized|Parallel Assignment||||Double|||t||t|
1453033|NCT01599156||Single Group Assignment||Treatment||None (Open Label)||||||
1453034|NCT01599143||Single Group Assignment||Health Services Research||None (Open Label)||||||
1453035|NCT01599130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453036|NCT01599117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453975|NCT01586832|||Cohort||Prospective|||||||
1453037|NCT01599104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453038|NCT01599091||||||||||||
1453039|NCT01599078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453040|NCT01599065|||Cohort||Prospective|||||||
1453041|NCT01599052|||Case-Control||Prospective|||||||
1453042|NCT01599039|||||Prospective|||||||
1453043|NCT01599026|||||Cross-Sectional|||||||
1453044|NCT01599013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453045|NCT01599000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453046|NCT01598987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453047|NCT01598974|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453048|NCT01598961|Randomized|Parallel Assignment||||Single||||||t
1453049|NCT01598948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453050|NCT01598935|Randomized|Parallel Assignment||||Double|||t||t|
1453051|NCT01598922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453052|NCT01598909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453053|NCT01598896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453054|NCT01598883|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453055|NCT01598870|||Cohort||Prospective|||||||
1453056|NCT01598857|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453057|NCT01598844|||Cohort||Prospective|||||||
1453058|NCT01598831|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453059|NCT01598818|||||Prospective|||||||
1453060|NCT01598805||Single Group Assignment||Health Services Research||Single|||t|||
1453061|NCT01598792||Single Group Assignment||Treatment||None (Open Label)||||||
1453062|NCT01598779|||Case-Only||Prospective|||||||
1453063|NCT01598766||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453064|NCT01598753|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1453065|NCT01598740|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453066|NCT01598727||Single Group Assignment||Treatment||None (Open Label)||||||
1453067|NCT01598714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453068|NCT01598701|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1453069|NCT01598688|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1453070|NCT01598675|Randomized|Parallel Assignment||Treatment||Single||||||t
1453071|NCT01598662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453072|NCT01598649|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1453073|NCT01598636||Single Group Assignment||Treatment||None (Open Label)||||||
1453074|NCT01598623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453075|NCT01598610||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453076|NCT01598597|||Cohort||Prospective|||||||
1453077|NCT01598584|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1453078|NCT01598571|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1453079|NCT01598558|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1453080|NCT01598545||Single Group Assignment||Treatment||Single||||||t
1453081|NCT01598532||Single Group Assignment||Treatment||None (Open Label)||||||
1453082|NCT01598519|Randomized|Parallel Assignment||Prevention||Single|||t|||
1453083|NCT01598506||Single Group Assignment||Treatment||Single||||||t
1453084|NCT01598493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453085|NCT01598480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453086|NCT01598467||Single Group Assignment||Treatment||None (Open Label)||||||
1453087|NCT01598454||Single Group Assignment||Treatment||None (Open Label)||||||
1453088|NCT01598441|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453089|NCT01598428|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1453090|NCT01598415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453091|NCT01598402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453092|NCT01598389|Randomized|Crossover Assignment||Prevention||Single|||t|||
1453093|NCT01598376|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1453094|NCT01598363|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453095|NCT01598350||Single Group Assignment||Treatment||Single||||||t
1453096|NCT01598337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453097|NCT01598324|||Cohort||Prospective|||||||
1453098|NCT01598311|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453099|NCT01598298|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453100|NCT01598285|||Case-Only||Retrospective|||||||
1453101|NCT01598272|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1453102|NCT01598259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453103|NCT01598246|||Case-Control||Prospective|||||||
1453104|NCT01598233||Single Group Assignment||Treatment||None (Open Label)||||||
1453105|NCT01598220|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453106|NCT01598207|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453107|NCT01598194||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453108|NCT01598181|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1453109|NCT01598168||Single Group Assignment||Treatment||None (Open Label)||||||
1453110|NCT01598155|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453111|NCT01598142|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453112|NCT01598129||Single Group Assignment||Treatment||None (Open Label)||||||
1453113|NCT01598116|||Case-Control||Prospective|||||||
1453114|NCT01598103|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1453115|NCT01598090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453116|NCT01598077|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453117|NCT01598064|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1453118|NCT01598051|||Case-Only||Prospective|||||||
1453119|NCT01598038||Single Group Assignment||Treatment||None (Open Label)||||||
1453120|NCT01598025|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453121|NCT01598012|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1453122|NCT01597999||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453123|NCT01597986||Single Group Assignment||||None (Open Label)||||||
1453124|NCT01597973|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453125|NCT01597960|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453126|NCT01597947|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453127|NCT01597934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453128|NCT01597921|||Cohort||Cross-Sectional|||||||
1453129|NCT01597908|Randomized|||Treatment||None (Open Label)||||||
1453130|NCT01597895|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453131|NCT01597882|||Cohort|||||||||
1453132|NCT01597869|||Case-Only||Prospective|||||||
1453133|NCT01597856|Randomized|Parallel Assignment||Treatment||Single||||||t
1453134|NCT01597843|Randomized|Parallel Assignment||||None (Open Label)||||||
1453135|NCT01597830|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453136|NCT01597817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453137|NCT01597804||Single Group Assignment||Supportive Care||None (Open Label)||||||
1453138|NCT01597791|Randomized|Parallel Assignment||Prevention||Single||||||t
1453139|NCT01597778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453140|NCT01597765|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1453141|NCT01597752||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453142|NCT01597739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453143|NCT01597726|Randomized|Parallel Assignment||Treatment||Single||||t||
1453144|NCT01597713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453145|NCT01597700|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1453146|NCT01597687||Single Group Assignment||||None (Open Label)||||||
1453147|NCT01597674|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1453148|NCT01597661|||Case Control||Retrospective|||||||
1453149|NCT01597648|Randomized|Crossover Assignment||||None (Open Label)||||||
1453150|NCT01597635|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453151|NCT01597622||Single Group Assignment||Treatment||None (Open Label)||||||
1453152|NCT01597609|Randomized|Parallel Assignment||Other||Single|||t|||
1453153|NCT01597596|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453154|NCT01597583|Randomized|Parallel Assignment||||None (Open Label)||||||
1453155|NCT01597570|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453156|NCT01597557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453157|NCT01597544|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453158|NCT01597531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453159|NCT01597518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453160|NCT01597505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453161|NCT01597492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453162|NCT01597479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453163|NCT01597466|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453164|NCT01597453||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453165|NCT01597440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453166|NCT01597427|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453167|NCT01597414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453168|NCT01597401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453169|NCT01597388||Single Group Assignment||Basic Science||None (Open Label)||||||
1453170|NCT01597375|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1453171|NCT01597362|Randomized|Single Group Assignment||Treatment||Single|||t|||
1453172|NCT01597349|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453173|NCT01597336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453174|NCT01597323|||Case Control||Prospective|||||||
1453175|NCT01597310|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453176|NCT01597297|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453177|NCT01597284|||Other||Prospective|||||||
1453178|NCT01597271||||||||||||
1453179|NCT01597258|||Case-Only||Prospective|||||||
1453180|NCT01597245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453181|NCT01597232|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453182|NCT01597219|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453183|NCT01597206|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1453184|NCT01597193|Non-Randomized|||Treatment||None (Open Label)||||||
1453185|NCT01597180|||Cohort||Prospective|||||||
1453186|NCT01597167|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1453187|NCT01597154|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453188|NCT01597141|Randomized|Parallel Assignment||Prevention||Single||||||t
1453189|NCT01597128|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453190|NCT01597115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453191|NCT01597102|||||Prospective|||||||
1453192|NCT01597089|||Case-Only||Prospective|||||||
1453193|NCT01597076|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1453194|NCT01597063|||Case-Only||Prospective|||||||
1453195|NCT01597050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453196|NCT01597037|Randomized|Parallel Assignment||Treatment||Single||||||t
1453197|NCT01597024|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1453198|NCT01597011|||Case Control||Prospective|||||||
1453199|NCT01596998|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1453200|NCT01596985|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1453201|NCT01596972|Randomized|Parallel Assignment||||None (Open Label)||||||
1453202|NCT01596959|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453203|NCT01596946|Randomized|Single Group Assignment||||None (Open Label)||||||
1453204|NCT01596933|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1453205|NCT01596920|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453206|NCT01596907|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1453207|NCT01596894|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453208|NCT01596881|||Case-Control||Prospective|||||||
1453209|NCT01596868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453210|NCT01596855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453211|NCT01596842|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1453212|NCT01596829|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1453213|NCT01596816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453214|NCT01596803|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1453215|NCT01596790||Single Group Assignment||||None (Open Label)||||||
1453216|NCT01596777|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1453217|NCT01596764|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1453218|NCT01596751||Single Group Assignment||Treatment||None (Open Label)||||||
1453219|NCT01596738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453220|NCT01596725|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1453221|NCT01596712|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1453222|NCT01596699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453223|NCT01596686|Randomized|Parallel Assignment||||Single||||||t
1453224|NCT01596673|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1453225|NCT01596660|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453226|NCT01596647||Single Group Assignment||Treatment||None (Open Label)||||||
1453227|NCT01596634||Single Group Assignment||Supportive Care||None (Open Label)||||||
1453228|NCT01596621||Single Group Assignment||Treatment||None (Open Label)||||||
1453229|NCT01596608||Single Group Assignment||Treatment||None (Open Label)||||||
1453230|NCT01596595|||Case-Only||Prospective|||||||
1453231|NCT01596582|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1453232|NCT01596569|Randomized|Parallel Assignment||Device Feasibility||Triple|||t||t|t
1453233|NCT01596556|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453234|NCT01596543||Single Group Assignment||Basic Science||None (Open Label)||||||
1453235|NCT01596530|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1453236|NCT01596517||Single Group Assignment||Treatment||None (Open Label)||||||
1453237|NCT01596504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453238|NCT01596491|||Cohort||Prospective|||||||
1453239|NCT01596478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453240|NCT01596465|Randomized|Parallel Assignment||||None (Open Label)||||||
1453241|NCT01596452|||Cohort||Prospective|||||||
1453242|NCT01596439|||Cohort||Prospective|||||||
1453243|NCT01596426|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453244|NCT01596413|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453245|NCT01596400|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453246|NCT01596387||Single Group Assignment||Supportive Care||None (Open Label)||||||
1453247|NCT01596374|||Cohort||Retrospective|||||||
1453248|NCT01596361|||Cohort||Retrospective|||||||
1453249|NCT01596348|||Case-Only||Cross-Sectional|||||||
1453250|NCT01596335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453251|NCT01596322|||Cohort||Prospective|||||||
1453252|NCT01596309|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453253|NCT01596296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453254|NCT01596283|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453255|NCT01596270|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1453256|NCT01596257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453257|NCT01596244||Single Group Assignment||Treatment||None (Open Label)||||||
1453258|NCT01596231|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453259|NCT01596218||Single Group Assignment||Treatment||None (Open Label)||||||
1453260|NCT01596205|Randomized|Parallel Assignment||Prevention||Single||||||t
1453261|NCT01596192|||Cohort||Prospective|||||||
1453262|NCT01596179|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453263|NCT01596166|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1453264|NCT01596153|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1453265|NCT01596140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453266|NCT01596127||Single Group Assignment||Treatment||None (Open Label)||||||
1453267|NCT01596114||Single Group Assignment||Treatment||None (Open Label)||||||
1453268|NCT01596101|||Case Control||Prospective|||||||
1453269|NCT01596088||||Treatment||None (Open Label)||||||
1453270|NCT01596075||Single Group Assignment||Treatment||None (Open Label)||||||
1453271|NCT01596062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453272|NCT01596049|||Cohort||Prospective|||||||
1453273|NCT01596036|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1453274|NCT01596023||Single Group Assignment||Prevention||Single|||t|||
1453275|NCT01596010|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1453276|NCT01595997|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453277|NCT01595984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453278|NCT01595971|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1453279|NCT01595958|Randomized|Parallel Assignment||Treatment||Single||||||t
1453280|NCT01595945|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453281|NCT01595932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453282|NCT01595919|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1453283|NCT01595906||Single Group Assignment||Prevention||None (Open Label)||||||
1453284|NCT01595893|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1453285|NCT01595880|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453286|NCT01595867|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1453287|NCT01595854|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453288|NCT01595841|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453289|NCT01595828||Single Group Assignment||Treatment||None (Open Label)||||||
1453290|NCT01595815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453291|NCT01595802|Non-Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1453292|NCT01595789|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1453293|NCT01595776||Single Group Assignment||Treatment||Single||||||t
1453294|NCT01595763|||Cohort||Prospective|||||||
1453295|NCT01595750|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453296|NCT01595737|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1453297|NCT01595724|||Cohort||Prospective|||||||
1453298|NCT01595711|||Cohort||Prospective|||||||
1453299|NCT01595698|Randomized|Parallel Assignment||Treatment||Double||||t||t
1453300|NCT01595685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453301|NCT01595672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453302|NCT01595659|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1453303|NCT01595646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453304|NCT01595633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453305|NCT01595620|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1453306|NCT01595607|Randomized|Parallel Assignment||Prevention||Single||||||t
1453307|NCT01595594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453308|NCT01595581|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1453309|NCT01595568|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1453310|NCT01595555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453311|NCT01595542|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1453312|NCT01595529|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453313|NCT01595516|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1453314|NCT01595503|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1453315|NCT01595490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453316|NCT01595477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453317|NCT01595464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453318|NCT01595451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453319|NCT01595438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453320|NCT01595425|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453321|NCT01595412|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453322|NCT01595399|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1453323|NCT01595386|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453324|NCT01595373|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1453325|NCT01595360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453326|NCT01595347|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453327|NCT01595334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453328|NCT01595321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453329|NCT01595308||Single Group Assignment||Treatment||None (Open Label)||||||
1453330|NCT01595295|||Other||Other|||||||
1453331|NCT01595282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453332|NCT01595269|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1453333|NCT01595256|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1453334|NCT01595243|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453335|NCT01595230|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453336|NCT01595217|Randomized|Parallel Assignment||Diagnostic||Quadruple|Two experienced professors of radiology observed and analyzed the images separately. They were not involved in image acquisition and were blinded to the patients' clinical, surgical and histological information. Conventional MR sequences were qualitatively analyzed in the first reading session, including T2WI, FIESTA, 2D MRCP and 3D MRCP sequences, and after one week, DWI under three different b values with ADC map combined with the preceding conventional sequences were analyzed respectively as the second reading session.||t|t|t|t
1453337|NCT01595204||Single Group Assignment||Treatment||None (Open Label)||||||
1453338|NCT01595191|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453339|NCT01595178||Single Group Assignment||Screening||None (Open Label)||||||
1453340|NCT01595165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453341|NCT01595152|Randomized|Parallel Assignment||Treatment||Single||||||t
1453342|NCT01595139|||Case-Only||Prospective|||||||
1453343|NCT01595126|||Case-Only||Prospective|||||||
1453344|NCT01595113|||Cohort||Retrospective|||||||
1453345|NCT01595100|||Cohort||Cross-Sectional|||||||
1453346|NCT01595087||Single Group Assignment||Treatment||None (Open Label)||||||
1453347|NCT01595074||||||||||||
1453348|NCT01595061||Single Group Assignment||Treatment||None (Open Label)||||||
1453349|NCT01595035|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1453350|NCT01595022|Randomized|Parallel Assignment||Prevention||Single|||t|||
1453351|NCT01595009||Single Group Assignment||Treatment||None (Open Label)||||||
1453352|NCT01594996|||Case-Only||Retrospective|||||||
1453353|NCT01594983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453354|NCT01594970|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1453355|NCT01594957|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1453356|NCT01594944|||Case-Only||Prospective|||||||
1453357|NCT01594931|Randomized|Parallel Assignment||Treatment||Double||||||
1453358|NCT01594918||Single Group Assignment||Treatment||None (Open Label)||||||
1453359|NCT01594905||Single Group Assignment||Treatment||None (Open Label)||||||
1453360|NCT01594892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453361|NCT01594879||Single Group Assignment||Treatment||None (Open Label)||||||
1453362|NCT01594866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453363|NCT01594853||Single Group Assignment||Treatment||None (Open Label)||||||
1453364|NCT01594840|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453365|NCT01594827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453366|NCT01594814|||Cohort||Prospective|||||||
1453367|NCT01594801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453368|NCT01594788|||Cohort||Prospective|||||||
1453369|NCT01594775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453370|NCT01594762|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453371|NCT01594749|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1453372|NCT01594736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453373|NCT01594723||Single Group Assignment||Treatment||None (Open Label)||||||
1453374|NCT01594710|||Cohort||Prospective|||||||
1453375|NCT01594697||Single Group Assignment||Treatment||None (Open Label)||||||
1453376|NCT01594684|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1453377|NCT01594671|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1453378|NCT01594658|||Case Control||Prospective|||||||
1453379|NCT01594645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453380|NCT01594632|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1453381|NCT01594619|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453382|NCT01594606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453383|NCT01594593|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453384|NCT01594580|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1453385|NCT01594567|||||Prospective|||||||
1453386|NCT01594554|||Cohort||Prospective|||||||
1453387|NCT01594541|||||Retrospective|||||||
1453388|NCT01594528||Single Group Assignment||Prevention||None (Open Label)||||||
1453389|NCT01594515|Randomized|Parallel Assignment||Treatment||Single||||||
1453390|NCT01594502|||Case-Control||Cross-Sectional|||||||
1453391|NCT01594489|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1453392|NCT01594476|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453393|NCT01594463|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1453394|NCT01594450|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453395|NCT01594437|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453396|NCT01594424||Single Group Assignment||Treatment||None (Open Label)||||||
1453397|NCT01594411|||Cohort||Prospective|||||||
1453398|NCT01594398|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453399|NCT01594385|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453400|NCT01594372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453401|NCT01594359|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1453402|NCT01594346|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453403|NCT01594333|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453404|NCT01594320|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1453405|NCT01594307|||||Prospective|||||||
1453406|NCT01594294|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1453407|NCT01594281|Randomized|Parallel Assignment||Treatment||Single||||||t
1453408|NCT01594268||Single Group Assignment||Other||None (Open Label)||||||
1453409|NCT01594255|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1453410|NCT01594242||Single Group Assignment||Treatment||||||||
1453411|NCT01594229||Single Group Assignment||Treatment||None (Open Label)||||||
1453412|NCT01594216||Single Group Assignment||Treatment||None (Open Label)||||||
1453413|NCT01594203|||Cohort||Prospective|||||||
1453414|NCT01594190|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1453415|NCT01594177||Single Group Assignment||Treatment||None (Open Label)||||||
1453416|NCT01594164||Single Group Assignment||||None (Open Label)||||||
1453417|NCT01594151||Single Group Assignment||||None (Open Label)||||||
1453418|NCT01594138|||Case-Control||Prospective|||||||
1453419|NCT01594125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453420|NCT01594112|||Cohort||Prospective|||||||
1453421|NCT01594099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453422|NCT01594086||Single Group Assignment||Treatment||None (Open Label)||||||
1453423|NCT01594073|||Cohort||Prospective|||||||
1453424|NCT01594060|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453425|NCT01594047|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453426|NCT01594034|||||Prospective|||||||
1453427|NCT01594021|Randomized|Parallel Assignment||Prevention||Single|||t|||
1453428|NCT01594008||Single Group Assignment||Basic Science||Single|||t|||
1453429|NCT01593995||Single Group Assignment||Treatment||None (Open Label)||||||
1453430|NCT01593982|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1453431|NCT01593969|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453432|NCT01593956||||Treatment||||||||
1453433|NCT01593943|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453434|NCT01593930|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1453435|NCT01593917|||Cohort||Prospective|||||||
1453436|NCT01593904|||Case Control||Retrospective|||||||
1453437|NCT01593891|||Case-Only||Retrospective|||||||
1453438|NCT01593878|Randomized|Parallel Assignment||||Double|||t||t|
1453439|NCT01593865|||Case Control||Prospective|||||||
1453440|NCT01593852|Randomized|Parallel Assignment||||None (Open Label)||||||
1453441|NCT01593839|||Case-Only||Cross-Sectional|||||||
1453442|NCT01593826|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1453443|NCT01593813|||Cohort||Prospective|||||||
1453444|NCT01593800||Single Group Assignment||Supportive Care||None (Open Label)||||||
1453445|NCT01593787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453446|NCT01593774|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1453447|NCT01593761||Single Group Assignment||Treatment||None (Open Label)||||||
1453448|NCT01593748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453449|NCT01593735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453450|NCT01593722|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453451|NCT01593709|||Other||Prospective|||||||
1453452|NCT01593696|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1453453|NCT01593683|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453454|NCT01593670||Single Group Assignment||Treatment||None (Open Label)||||||
1453455|NCT01593657||Single Group Assignment||Supportive Care||None (Open Label)||||||
1453456|NCT01593644||Single Group Assignment||||Single|||t|||
1453457|NCT01593631|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1453458|NCT01593618|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1453459|NCT01593605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453460|NCT01593592|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1453461|NCT01593579|||||Prospective|||||||
1453462|NCT01593566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453463|NCT01593553|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453464|NCT01593540|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1453465|NCT01593527|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453466|NCT01593514|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453467|NCT01593501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453468|NCT01593488||Single Group Assignment||Treatment||None (Open Label)||||||
1453469|NCT01593475||Single Group Assignment||Treatment||None (Open Label)||||||
1453470|NCT01593462||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453471|NCT01593449|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453472|NCT01593436|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453473|NCT01593423|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453474|NCT01593410||Single Group Assignment||Treatment||None (Open Label)||||||
1453475|NCT01593397||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453476|NCT01593384|||Cohort||Prospective|||||||
1453477|NCT01593371|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453478|NCT01593358|||Case-Only||Retrospective|||||||
1453479|NCT01593345|Randomized|Parallel Assignment||Treatment||Single||||||t
1453480|NCT01593332|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453481|NCT01593319|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1453482|NCT01593306|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453483|NCT01593293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453484|NCT01593280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453485|NCT01593267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453486|NCT01593254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453487|NCT01593241||Single Group Assignment||Treatment||None (Open Label)||||||
1453488|NCT01593228||Single Group Assignment||Treatment||None (Open Label)||||||
1453489|NCT01593215|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1453490|NCT01593202|Randomized|Parallel Assignment||Treatment||Single||||||t
1453491|NCT01593189|Randomized|Parallel Assignment||Prevention||Single||||||t
1453492|NCT01593176|||Cohort||Prospective|||||||
1453493|NCT01593163|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453494|NCT01593150|Randomized|Parallel Assignment||Treatment||Single||||||t
1453495|NCT01593137|Randomized|Parallel Assignment||||None (Open Label)||||||
1453496|NCT01593124|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453497|NCT01593111|Randomized|Parallel Assignment||Prevention||Single||||t||
1453498|NCT01593098|||Case-Control||Prospective|||||||
1453499|NCT01593085|||Cohort||Prospective|||||||
1453500|NCT01593072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453501|NCT01593059|||||Prospective|||||||
1453502|NCT01593046|Randomized|Parallel Assignment||||None (Open Label)||||||
1453503|NCT01593033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453504|NCT01593020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453505|NCT01593007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453506|NCT01592994|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453507|NCT01592981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453508|NCT01592968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453509|NCT01592955||Single Group Assignment||Treatment||None (Open Label)||||||
1453510|NCT01592942|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453511|NCT01592929||Single Group Assignment||Other||None (Open Label)||||||
1453512|NCT01592916|||Case-Control||Prospective|||||||
1453513|NCT01592903|||Case-Only||Prospective|||||||
1453514|NCT01592890|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1453515|NCT01592877|||Case-Only||Prospective|||||||
1453516|NCT01592864|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453517|NCT01592851|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453518|NCT01592838|||Ecologic or Community||Retrospective|||||||
1453519|NCT01592825|||Cohort||Prospective|||||||
1453520|NCT01592812||Single Group Assignment||Treatment||None (Open Label)||||||
1453521|NCT01592799||Single Group Assignment||Other||None (Open Label)||||||
1453522|NCT01592786||Single Group Assignment||Treatment||None (Open Label)||||||
1453523|NCT01592773||Single Group Assignment||Treatment||None (Open Label)||||||
1453524|NCT01592760|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1453525|NCT01592747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453526|NCT01592734|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453527|NCT01592721||Single Group Assignment||Treatment||None (Open Label)||||||
1453528|NCT01592708||Single Group Assignment||Prevention||None (Open Label)||||||
1453529|NCT01592695|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1453530|NCT01592682|Randomized|Parallel Assignment||Prevention||Single|||t|||
1453531|NCT01592669|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453532|NCT01592656|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453533|NCT01592643||Single Group Assignment||Supportive Care||None (Open Label)||||||
1453534|NCT01592630|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453535|NCT01592617||Single Group Assignment||Treatment||None (Open Label)||||||
1453536|NCT01592604|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453537|NCT01592578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453538|NCT01592565||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453539|NCT01592552|||Cohort||Cross-Sectional|||||||
1453540|NCT01592539|||Case Control||Cross-Sectional|||||||
1453541|NCT01592526|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453542|NCT01592513|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1453543|NCT01592500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453544|NCT01592487|||Cohort||Prospective|||||||
1453545|NCT01592474|||Cohort||Prospective|||||||
1453546|NCT01592461|||Cohort||Prospective|||||||
1453547|NCT01592448|||Case Control||Cross-Sectional|||||||
1453548|NCT01592435|||Case-Only||Prospective|||||||
1453549|NCT01592422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453550|NCT01592409|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1453551|NCT01592396||Single Group Assignment||Treatment||None (Open Label)||||||
1453552|NCT01592383||Single Group Assignment||Treatment||None (Open Label)||||||
1453553|NCT01592370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453554|NCT01592357|Randomized|Parallel Assignment||Treatment||Single||||||t
1453555|NCT01592344|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1453556|NCT01592331|Randomized|Parallel Assignment||||Double|||t||t|
1453557|NCT01592318|Randomized|Crossover Assignment||||None (Open Label)||||||
1453558|NCT01592305||Parallel Assignment||||None (Open Label)||||||
1453559|NCT01592292|||Cohort||Prospective|||||||
1453560|NCT01592279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453561|NCT01592266|||Cohort||Prospective|||||||
1453562|NCT01592253||Single Group Assignment||||None (Open Label)||||||
1453563|NCT01592240|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1453564|NCT01592227|Randomized|Crossover Assignment||||None (Open Label)||||||
1453565|NCT01592214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453566|NCT01592201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453567|NCT01592188|Randomized|Parallel Assignment||||Single||||||t
1453568|NCT01592175|||Cohort||Cross-Sectional|||||||
1453569|NCT01592162|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453570|NCT01592149|||Cohort||Cross-Sectional|||||||
1453571|NCT01592136||||||||||||
1453572|NCT01592123|||Cohort||Prospective|||||||
1453573|NCT01592110|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453574|NCT01592097|||Cohort||Prospective|||||||
1453575|NCT01592084|||Cohort||Prospective|||||||
1453576|NCT01592071||Single Group Assignment||Supportive Care||None (Open Label)||||||
1453577|NCT01592058|||Cohort||Retrospective|||||||
1453578|NCT01592045|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453579|NCT01592032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453580|NCT01592019|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453581|NCT01592006||Single Group Assignment||Treatment||None (Open Label)||||||
1453582|NCT01591993|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1453583|NCT01591980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453584|NCT01591967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453585|NCT01591954||Single Group Assignment||||None (Open Label)||||||
1453586|NCT01591941|Randomized|Parallel Assignment||Prevention||Single||||||t
1453587|NCT01591928|||Cohort||Prospective|||||||
1453588|NCT01591915|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1453589|NCT01591902|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1453590|NCT01591889|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453591|NCT01591876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453592|NCT01591863||Single Group Assignment||Treatment||None (Open Label)||||||
1453593|NCT01591850||Parallel Assignment||||None (Open Label)||||||
1453594|NCT01591837|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453595|NCT01591824|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1453596|NCT01591811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453597|NCT01591798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453598|NCT01591785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453599|NCT01591772|||Case-Crossover||Prospective|||||||
1453600|NCT01591759|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453601|NCT01591746|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1453602|NCT01591733||Single Group Assignment||Treatment||None (Open Label)||||||
1453603|NCT01591720||Single Group Assignment||Treatment||None (Open Label)||||||
1453604|NCT01591707|Randomized|Parallel Assignment||Treatment||Single||||||t
1453605|NCT01591694|||Cohort||Prospective|||||||
1453606|NCT01591681|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453607|NCT01591668|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453608|NCT01591655|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453609|NCT01591642|||||Cross-Sectional|||||||
1453610|NCT01591629|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1453611|NCT01591616|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1453612|NCT01591603|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1453613|NCT01591590||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453614|NCT01591577||Single Group Assignment||Treatment||None (Open Label)||||||
1453615|NCT01591564||Single Group Assignment||Treatment||None (Open Label)||||||
1453616|NCT01591551||Single Group Assignment||Supportive Care||None (Open Label)||||||
1453617|NCT01591538|||Cohort||Prospective|||||||
1453618|NCT01591525|||Ecologic or Community||Prospective|||||||
1453619|NCT01591512|||Cohort||Prospective|||||||
1453620|NCT01591499|Randomized|Crossover Assignment||Treatment||Single|||t|||
1453621|NCT01591486|||Case Control||Prospective|||||||
1453622|NCT01591473|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1453623|NCT01591460|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453624|NCT01591447|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453625|NCT01591434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453626|NCT01591421||Single Group Assignment||Treatment||None (Open Label)||||||
1453627|NCT01591408|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453628|NCT01591395|Randomized|Parallel Assignment||Treatment||Single||||||t
1453629|NCT01591382|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1453630|NCT01591369||||||||||||
1453631|NCT01591356||Single Group Assignment||Treatment||None (Open Label)||||||
1453632|NCT01591343||Single Group Assignment||Prevention||None (Open Label)||||||
1453633|NCT01591330|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453634|NCT01591317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453635|NCT01591304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453636|NCT01591291|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1453637|NCT01591278|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1453638|NCT01591265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453639|NCT01591252|||Cohort||Cross-Sectional|||||||
1453640|NCT01591239|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1453641|NCT01591226|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1453642|NCT01591213|||Case-Only||Prospective|||||||
1453643|NCT01591200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453644|NCT01591187|||Case-Only||Prospective|||||||
1453645|NCT01591174|||Cohort||Prospective|||||||
1453646|NCT01591161|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453647|NCT01591148|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1453648|NCT01591135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453649|NCT01591122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453650|NCT01591109|||||Retrospective|||||||
1453651|NCT01591096||Single Group Assignment||Treatment||None (Open Label)||||||
1453652|NCT01591083|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453653|NCT01591070|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1453654|NCT01591057|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453655|NCT01591044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453656|NCT01591031|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1453657|NCT01591018|Randomized|Parallel Assignment||Prevention||Single||||||t
1453658|NCT01591005|Randomized|Parallel Assignment||Prevention||Single||||||t
1453659|NCT01590992|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1453660|NCT01590979|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1453661|NCT01590966||Single Group Assignment||Treatment||None (Open Label)||||||
1453662|NCT01590953|||Case Control||Prospective|||||||
1453663|NCT01590940|||Cohort||Prospective|||||||
1453664|NCT01590927||||||||||||
1453665|NCT01590914|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453666|NCT01590901||Single Group Assignment||Supportive Care||None (Open Label)||||||
1453667|NCT01590888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453668|NCT01590875|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1453669|NCT01590862|||Cohort||Cross-Sectional|||||||
1453670|NCT01590849|Non-Randomized|Parallel Assignment||||Single||||||t
1453671|NCT01590836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453672|NCT01590823||Single Group Assignment||Basic Science||None (Open Label)||||||
1453673|NCT01590810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453674|NCT01590797|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1453675|NCT01590784|||||Cross-Sectional|||||||
1453676|NCT01590771|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1453677|NCT01590758|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453678|NCT01590745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453679|NCT01590732||Single Group Assignment||Treatment||None (Open Label)||||||
1453680|NCT01590719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453681|NCT01590706|||Case-Only||Cross-Sectional|||||||
1453682|NCT01590693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453683|NCT01590680||||||||||||
1453684|NCT01590667|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1453685|NCT01590654|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453686|NCT01590641|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453687|NCT01590628||Single Group Assignment||Treatment||None (Open Label)||||||
1453688|NCT01590615|||Cohort||Prospective|||||||
1453689|NCT01590602|||Case-Only||Prospective|||||||
1453690|NCT01590589|||Cohort||Other|||||||
1453691|NCT01590576|||||Retrospective|||||||
1453692|NCT01590563||Single Group Assignment||Prevention||None (Open Label)||||||
1453693|NCT01590550|||Case-Only||Prospective|||||||
1453694|NCT01590537|||Case-Only||Prospective|||||||
1453695|NCT01590524|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1453696|NCT01590511|||Cohort||Prospective|||||||
1453697|NCT01590498|||Cohort||Prospective|||||||
1453698|NCT01590485|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1453699|NCT01590472|||Case-Only||Cross-Sectional|||||||
1453700|NCT01590459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453701|NCT01590446|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1453702|NCT01590433|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453703|NCT01590420||Single Group Assignment||Treatment||None (Open Label)||||||
1453704|NCT01590407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453705|NCT01590394||Single Group Assignment||Treatment||None (Open Label)||||||
1453706|NCT01590381|||Cohort||Prospective|||||||
1453707|NCT01590368|Randomized|Parallel Assignment||||None (Open Label)||||||
1453708|NCT01590355|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453709|NCT01590342|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1453710|NCT01590329||Single Group Assignment||Treatment||None (Open Label)||||||
1453711|NCT01590316|Randomized|Parallel Assignment||Prevention||Single||||||t
1453712|NCT01590303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453713|NCT01590290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453714|NCT01590277|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1453715|NCT01590264||Single Group Assignment||Treatment||None (Open Label)||||||
1453716|NCT01590251|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1453717|NCT01590238||Single Group Assignment||Treatment||None (Open Label)||||||
1453718|NCT01590225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453719|NCT01590212|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1453720|NCT01590199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453721|NCT01590186||||||||||||
1453722|NCT01590173|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453723|NCT01590160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453724|NCT01590147|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453725|NCT01590134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453726|NCT01590121|||||Retrospective|||||||
1453727|NCT01590108|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1453728|NCT01590095|Randomized|Parallel Assignment||Prevention||Single|||||t|
1453729|NCT01590082||Single Group Assignment||Treatment||None (Open Label)||||||
1453730|NCT01590069||Single Group Assignment||Treatment||None (Open Label)||||||
1453731|NCT01590056|||Case-Only||Prospective|||||||
1453732|NCT01590043|||Case Control||Cross-Sectional|||||||
1453733|NCT01590030|Randomized|Parallel Assignment||Treatment||Single||||||t
1453734|NCT01590017||Single Group Assignment||Treatment||None (Open Label)||||||
1453735|NCT01590004|||Case-Only||Prospective|||||||
1453736|NCT01589991|Randomized|Crossover Assignment||Prevention||Single|||||t|
1453737|NCT01589978||Single Group Assignment||Treatment||None (Open Label)||||||
1453738|NCT01589965|Randomized|Parallel Assignment||Prevention||Single|||t|||
1453739|NCT01589952||Single Group Assignment||Treatment||None (Open Label)||||||
1453740|NCT01589939|||Cohort||Prospective|||||||
1453741|NCT01589926|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1453742|NCT01589913|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453743|NCT01589900|||Cohort||Retrospective|||||||
1453744|NCT01589874|||Cohort||Prospective|||||||
1453745|NCT01589861||Single Group Assignment||Treatment||None (Open Label)||||||
1453746|NCT01589848||||||||||||
1453747|NCT01589835|Randomized|Single Group Assignment||Prevention||Single||||||t
1453748|NCT01589822|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453749|NCT01589809||Single Group Assignment||Treatment||None (Open Label)||||||
1453750|NCT01589796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453751|NCT01589783|||Cohort||Cross-Sectional|||||||
1453752|NCT01589770|||Case-Control||Prospective|||||||
1453753|NCT01589757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453754|NCT01589744||Single Group Assignment||Health Services Research||None (Open Label)||||||
1453755|NCT01589731|||Case Control||Cross-Sectional|||||||
1453756|NCT01589718|Randomized|Single Group Assignment||Treatment||Single|||||t|
1453757|NCT01589705|||Cohort||Cross-Sectional|||||||
1453758|NCT01589692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453759|NCT01589679|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453760|NCT01589666||Single Group Assignment||Treatment||None (Open Label)||||||
1453761|NCT01589653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453762|NCT01589640|||Cohort||Prospective|||||||
1453763|NCT01589627|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453764|NCT01589614|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453765|NCT01589601|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453766|NCT01589588|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1453767|NCT01589575|||Cohort||Prospective|||||||
1453768|NCT01589562|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1453769|NCT01589549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453770|NCT01589536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453771|NCT01589523||Single Group Assignment||Treatment||None (Open Label)||||||
1453772|NCT01589510|||Cohort||Prospective|||||||
1453773|NCT01589497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453774|NCT01589484||Single Group Assignment||Treatment||None (Open Label)||||||
1453775|NCT01589471||Single Group Assignment||Treatment||None (Open Label)||||||
1453776|NCT01589458|Randomized|Crossover Assignment||Prevention||Single|||||t|
1453777|NCT01589445|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1453778|NCT01589432|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1453779|NCT01589419||Single Group Assignment||Treatment||None (Open Label)||||||
1453780|NCT01589406|||Cohort||Prospective|||||||
1453781|NCT01589393|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1453782|NCT01589380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453783|NCT01589367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453784|NCT01589354|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453785|NCT01589341|||Cohort||Retrospective|||||||
1453786|NCT01589328|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1453787|NCT01589315||Single Group Assignment||Treatment||None (Open Label)||||||
1453788|NCT01589302||Single Group Assignment||Treatment||None (Open Label)||||||
1453789|NCT01589289||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453790|NCT01589276|||Case-Control||Prospective|||||||
1453791|NCT01589263|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453792|NCT01589250|||||Prospective|||||||
1453793|NCT01589237||Single Group Assignment||Treatment||None (Open Label)||||||
1453794|NCT01589224|||Cohort||Prospective|||||||
1453795|NCT01589211|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453796|NCT01589198|||Case-Control||Prospective|||||||
1453797|NCT01589185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453798|NCT01589172|||Cohort||Prospective|||||||
1453799|NCT01589159||Single Group Assignment||Treatment||None (Open Label)||||||
1453800|NCT01589146|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453801|NCT01589133|||Case Control||Prospective|||||||
1453802|NCT01589120|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1453803|NCT01589107|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1453804|NCT01589094||Single Group Assignment||Treatment||None (Open Label)||||||
1453805|NCT01589081|Non-Randomized|Parallel Assignment||||Double|||t||t|
1453806|NCT01589068|Non-Randomized|Parallel Assignment||||Double|||t||t|
1453807|NCT01589055|Non-Randomized|Parallel Assignment||||Single|||t|||
1453808|NCT01589042|||Cohort||Prospective|||||||
1453809|NCT01589029||Single Group Assignment||Treatment||None (Open Label)||||||
1453810|NCT01589016|||Case Control||Prospective|||||||
1453811|NCT01589003|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1453812|NCT01588990||Single Group Assignment||Treatment||None (Open Label)||||||
1453813|NCT01588977|||Case Control||Prospective|||||||
1453814|NCT01588964||Single Group Assignment||Treatment||None (Open Label)||||||
1453815|NCT01588951|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453816|NCT01588938|||Cohort||Prospective|||||||
1453817|NCT01588925|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453818|NCT01588912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453819|NCT01588899||Single Group Assignment||Treatment||None (Open Label)||||||
1453820|NCT01588886|||Cohort||Retrospective|||||||
1453821|NCT01588873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453822|NCT01588860|||Case-Only||Retrospective|||||||
1453823|NCT01588847|Randomized|Parallel Assignment||Treatment||Single||||||t
1453824|NCT01588834|||Cohort||Prospective|||||||
1453825|NCT01588821||Single Group Assignment||Treatment||None (Open Label)||||||
1453826|NCT01588808|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1453827|NCT01588795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453828|NCT01588782||Single Group Assignment||Treatment||None (Open Label)||||||
1453829|NCT01588769||Single Group Assignment||Treatment||None (Open Label)||||||
1453830|NCT01588756|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1453831|NCT01588743||Single Group Assignment||Treatment||None (Open Label)||||||
1453832|NCT01588730|Randomized|Parallel Assignment||Treatment||Single||||||t
1453833|NCT01588717||Single Group Assignment||Treatment||None (Open Label)||||||
1453834|NCT01588704||Single Group Assignment||Treatment||None (Open Label)||||||
1453835|NCT01588691|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1453836|NCT01588678||Single Group Assignment||Treatment||None (Open Label)||||||
1453837|NCT01588665|||Case-Only||Prospective|||||||
1453838|NCT01588639|||Cohort||Prospective|||||||
1453839|NCT01588626||Single Group Assignment||Basic Science||None (Open Label)||||||
1453840|NCT01588600|Randomized|Crossover Assignment||Prevention||Single|||t|||
1453841|NCT01588587|||Cohort||Prospective|||||||
1453842|NCT01588574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453843|NCT01588561|Randomized|Crossover Assignment||Other||Double|||t||t|
1453844|NCT01588548|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453845|NCT01588535|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1453846|NCT01588522||Single Group Assignment||Prevention||None (Open Label)||||||
1453847|NCT01588509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453848|NCT01588496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453849|NCT01588483|||Case-Only||Prospective|||||||
1453850|NCT01588470||Single Group Assignment||Treatment||None (Open Label)||"this study includes single arm intervention with pioglitazone. T2DM individuals will be studied at baseline and after 6 months treatment.~as a reference group, healthy subjects will be studied in cross sectional fashion. Because healthy subjects will not be treated nor restudied at 6 months, they can not be considered a separate arm in the study but rather a reference group"||||
1453851|NCT01588457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453852|NCT01588444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453853|NCT01588431||Single Group Assignment||Treatment||None (Open Label)||||||
1453854|NCT01588418|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1453855|NCT01588405||Single Group Assignment||Treatment||None (Open Label)||||||
1453856|NCT01588392|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453857|NCT01588379|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453858|NCT01588366|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1453859|NCT01588353||Single Group Assignment||Treatment||None (Open Label)||||||
1453860|NCT01588340|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1453861|NCT01588327|||Case Control||Prospective|||||||
1453862|NCT01588314|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1453863|NCT01588301|Randomized|Parallel Assignment||Screening||Single|||t|||
1453864|NCT01588288||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453865|NCT01588275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453866|NCT01588262|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453867|NCT01588249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453868|NCT01588236|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453869|NCT01588223|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1453870|NCT01588210|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1453871|NCT01588197|Randomized|Parallel Assignment||||None (Open Label)||||||
1453872|NCT01588184||Single Group Assignment||Treatment||None (Open Label)||||||
1453873|NCT01588171|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1453874|NCT01588158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453875|NCT01588145||Single Group Assignment||Treatment||None (Open Label)||||||
1453876|NCT01588132|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1453877|NCT01588119|||Cohort||Prospective|||||||
1453878|NCT01588106|||Case-Control||Prospective|||||||
1453879|NCT01588093|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1453880|NCT01588080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453881|NCT01588067|||Cohort||Prospective|||||||
1453882|NCT01588054|||Case-Only||Prospective|||||||
1453883|NCT01588041|||Cohort||Prospective|||||||
1453884|NCT01588015|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453885|NCT01588002|Randomized|Crossover Assignment||||None (Open Label)||||||
1453886|NCT01587989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453887|NCT01587976|||Cohort||Prospective|||||||
1453888|NCT01587963|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1453889|NCT01587950|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1453890|NCT01587937|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1453891|NCT01587924|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1453892|NCT01587911|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1453893|NCT01587898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453894|NCT01587885|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453895|NCT01587872||Single Group Assignment||Diagnostic||None (Open Label)||||||
1453896|NCT01587859|||Case-Only||Retrospective|||||||
1453897|NCT01587846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453898|NCT01587833|||||Retrospective|||||||
1453899|NCT01587820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453900|NCT01587807|Randomized|Single Group Assignment||Other||Single|||t|||
1453901|NCT01587794|||Case-Only||Cross-Sectional|||||||
1453902|NCT01587781|||Cohort||Prospective|||||||
1453903|NCT01587768|||||Retrospective|||||||
1453904|NCT01587755|Randomized|Parallel Assignment||||None (Open Label)||||||
1453905|NCT01587742|||||Retrospective|||||||
1453906|NCT01587729|||||Retrospective|||||||
1453907|NCT01587716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453908|NCT01587703|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453909|NCT01587690|||Case Control||Cross-Sectional|||||||
1453910|NCT01587677|||Cohort||Prospective|||||||
1453911|NCT01587664||Single Group Assignment||Treatment||None (Open Label)||||||
1453912|NCT01587651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453913|NCT01587638|||||Retrospective|||||||
1453914|NCT01587625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453915|NCT01587612||||||||||||
1453916|NCT01587599|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453917|NCT01587586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453918|NCT01587573|||Case-Control||Prospective|||||||
1453919|NCT01587560|Randomized|Parallel Assignment||Treatment||Single||||||t
1453920|NCT01587547|||Cohort||Retrospective|||||||
1453921|NCT01587534|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1453922|NCT01587521|||||Cross-Sectional|||||||
1453923|NCT01587508|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453924|NCT01587495||Single Group Assignment||Treatment||None (Open Label)||||||
1453925|NCT01587482|||Cohort||Prospective|||||||
1453926|NCT01587469|||Cohort||Prospective|||||||
1453927|NCT01587456|||Cohort||Prospective|||||||
1453928|NCT01587443|||||Cross-Sectional|||||||
1453929|NCT01587430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453930|NCT01587417|Randomized|Parallel Assignment||Treatment||Double||||||
1453931|NCT01587404|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1453932|NCT01587391|Randomized|Parallel Assignment||Treatment||Double||||||
1453933|NCT01587378|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1453934|NCT01587365|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1453935|NCT01587352||Single Group Assignment||Treatment||None (Open Label)||||||
1453936|NCT01587339|||||Retrospective|||||||
1453937|NCT01587326||Single Group Assignment||Treatment||None (Open Label)||||||
1453938|NCT01587313|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453939|NCT01587300|||Other||Prospective|||||||
1453940|NCT01587287|||Cohort||Prospective|||||||
1453941|NCT01587274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453942|NCT01587261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1453943|NCT01587248|Randomized|Parallel Assignment||Prevention||Single|||t|||
1453944|NCT01587235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453945|NCT01587222||Single Group Assignment||Treatment||None (Open Label)||||||
1453946|NCT01587209|||Case-Only||Prospective|||||||
1453947|NCT01587196||Single Group Assignment||Treatment||None (Open Label)||||||
1453948|NCT01587183|Randomized|Parallel Assignment||Prevention||Single|||t|||
1453949|NCT01587170||||||||||||
1453950|NCT01587157||Single Group Assignment||Prevention||||||||
1453951|NCT01587144|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1453952|NCT01587131|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453953|NCT01587118||Single Group Assignment||Treatment||None (Open Label)||||||
1453954|NCT01587105|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1453955|NCT01587092|Randomized|Single Group Assignment||||None (Open Label)||||||
1453956|NCT01587079|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1453957|NCT01587066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453958|NCT01587053|||Cohort||Prospective|||||||
1453959|NCT01587040|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453960|NCT01587027|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1453961|NCT01587014|||Case-Only||Prospective|||||||
1453962|NCT01587001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453963|NCT01586988|Randomized|Parallel Assignment||||Single||||||t
1453964|NCT01586975|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453965|NCT01586962||Single Group Assignment||||None (Open Label)||||||
1453966|NCT01586949|Randomized|Parallel Assignment||Treatment||Single|||||t|
1453967|NCT01586936|||Cohort||Retrospective|||||||
1453968|NCT01586923|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1453969|NCT01586910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453970|NCT01586897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453971|NCT01586884||Single Group Assignment||Treatment||None (Open Label)||||||
1453972|NCT01586871|||Case-Control||Cross-Sectional|||||||
1453973|NCT01586858|||Cohort||Prospective|||||||
1453974|NCT01586845|Randomized|Parallel Assignment||Prevention||Single||||||t
1453976|NCT01586819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453977|NCT01586806|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1453978|NCT01586793|Randomized|Parallel Assignment||Treatment||Single||||||t
1453979|NCT01586780|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1453980|NCT01586767|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453981|NCT01586754|||Cohort||Cross-Sectional|||||||
1453982|NCT01586741|Randomized|Parallel Assignment||Treatment||Single|||t|||
1453983|NCT01586728|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1453984|NCT01586715||Single Group Assignment||Treatment||None (Open Label)||||||
1453985|NCT01586702|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453986|NCT01586689|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453987|NCT01586676|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1453988|NCT01586663|Randomized|Parallel Assignment||Treatment||Single||||||t
1453989|NCT01586650|Randomized|Parallel Assignment||Treatment||Single||||||t
1453990|NCT01586637|Randomized|Parallel Assignment||Treatment||Single||||||t
1453991|NCT01586624||||Treatment||None (Open Label)||||||
1453992|NCT01586611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1453993|NCT01586598|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1453994|NCT01586585|||Cohort||Prospective|||||||
1453995|NCT01586572|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1453996|NCT01586559|||Cohort||Prospective|||||||
1453997|NCT01586546|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1453998|NCT01586533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1453999|NCT01586520|||Case-Control||Prospective|||||||
1454000|NCT01586507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454001|NCT01586494|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454002|NCT01586481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454003|NCT01586468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454004|NCT01586455|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454005|NCT01586442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454006|NCT01586429|||Cohort||Prospective|||||||
1454007|NCT01586416||Single Group Assignment||Supportive Care||None (Open Label)||||||
1454008|NCT01586403|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454009|NCT01586390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454010|NCT01586377|||Case Control||Prospective|||||||
1454011|NCT01586364||Single Group Assignment||Treatment||None (Open Label)||||||
1454012|NCT01586351|||Case-Only||Prospective|||||||
1454013|NCT01586338||Single Group Assignment||Treatment||None (Open Label)||||||
1454014|NCT01586325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454015|NCT01586312|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454016|NCT01586299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454017|NCT01586286|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454018|NCT01586273||Single Group Assignment||Treatment||None (Open Label)||||||
1454019|NCT01586260||Single Group Assignment||Prevention||None (Open Label)||||||
1454020|NCT01586247|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1454021|NCT01586234|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454022|NCT01586221||Single Group Assignment||Supportive Care||None (Open Label)||||||
1454023|NCT01586208|Randomized|Single Group Assignment||Treatment||Single|||t|||
1454024|NCT01586195||Single Group Assignment||Treatment||None (Open Label)||||||
1454025|NCT01586182||Single Group Assignment||Treatment||None (Open Label)||||||
1454026|NCT01586169||Single Group Assignment||Treatment||None (Open Label)||||||
1454027|NCT01586156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454028|NCT01586143|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1454029|NCT01586130|Randomized|Parallel Assignment||||Single|||t|||
1454030|NCT01586117||Single Group Assignment||Prevention||None (Open Label)||||||
1454031|NCT01586104||Single Group Assignment||Treatment||None (Open Label)||||||
1454032|NCT01586091|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1454033|NCT01586065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454034|NCT01586052||Single Group Assignment||Treatment||None (Open Label)||||||
1454035|NCT01586039|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1454036|NCT01586026|||Cohort||Retrospective|||||||
1454037|NCT01586013||Single Group Assignment||Health Services Research||None (Open Label)||||||
1454038|NCT01586000|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454039|NCT01585987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454040|NCT01585974|||Cohort||Prospective|||||||
1454041|NCT01585961|||Case-Only||Prospective|||||||
1454042|NCT01585948|||Case-Control||Cross-Sectional|||||||
1454043|NCT01585935|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1454044|NCT01585922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454045|NCT01585909|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1454046|NCT01585896||Single Group Assignment||Treatment||None (Open Label)||||||
1454047|NCT01585883|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454048|NCT01585870||Single Group Assignment||Treatment||None (Open Label)||||||
1454049|NCT01585857|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454050|NCT01585844|||Case Control||Prospective|||||||
1454051|NCT01585831|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454052|NCT01585818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454053|NCT01585805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454054|NCT01585792||||Treatment||||||||
1454055|NCT01585779|||Cohort||Prospective|||||||
1454056|NCT01585766|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454057|NCT01585753|||||Prospective|||||||
1454058|NCT01585740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454059|NCT01585727|Randomized|Parallel Assignment||Prevention||Single|||t|||
1454060|NCT01585701||Single Group Assignment||Treatment||None (Open Label)||||||
1454061|NCT01585688||Single Group Assignment||Treatment||None (Open Label)||||||
1454062|NCT01585675|||Other||Prospective|||||||
1454063|NCT01585662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454064|NCT01585649||Single Group Assignment||Supportive Care||None (Open Label)||||||
1454065|NCT01585636|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1454066|NCT01585623|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454067|NCT01585610|Randomized|Parallel Assignment||Treatment||Single||||||t
1454068|NCT01585597||Single Group Assignment||Treatment||None (Open Label)||||||
1454069|NCT01585584||Single Group Assignment||Treatment||None (Open Label)||||||
1454070|NCT01585571|||Case-Control||Prospective|||||||
1454071|NCT01585558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454072|NCT01585545|||Case-Only||Prospective|||||||
1454073|NCT01585532|||Case-Only||Prospective|||||||
1454074|NCT01585519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454075|NCT01585506|||Other||Prospective|||||||
1454076|NCT01585493|Randomized|Parallel Assignment||Prevention||Single||||||t
1454077|NCT01585480|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1454078|NCT01585467|||||Prospective|||||||
1454079|NCT01585454|||Cohort||Prospective|||||||
1454080|NCT01585441|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454081|NCT01585428|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454082|NCT01585415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454083|NCT01585402||Single Group Assignment||Treatment||None (Open Label)||||||
1454084|NCT01585389|||Case-Only||Retrospective|||||||
1454085|NCT01585376|||Case-Only||Retrospective|||||||
1454086|NCT01585350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454087|NCT01585337|||Case-Only||Prospective|||||||
1454088|NCT01585324|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454089|NCT01585311|||Cohort||Retrospective|||||||
1454090|NCT01585298||Single Group Assignment||Treatment||None (Open Label)||||||
1454091|NCT01585285|Randomized|Parallel Assignment||Treatment||Single||||||t
1454092|NCT01585272||Single Group Assignment||Treatment||None (Open Label)||||||
1454093|NCT01585259|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1454094|NCT01585246|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1454095|NCT01585233|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454096|NCT01585220|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1454097|NCT01585207||Single Group Assignment||Treatment||None (Open Label)||||||
1454098|NCT01585194||Single Group Assignment||Treatment||None (Open Label)||||||
1454099|NCT01585181|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1454100|NCT01585168|Randomized|Crossover Assignment||Treatment||Double||All subjects received both the study drug and placebo. Family history was the main variable of interest, and randomization was stratified by this variable.|t|t||
1454101|NCT01585155||Single Group Assignment||Treatment||None (Open Label)||||||
1454102|NCT01585142||Single Group Assignment||||None (Open Label)||||||
1454103|NCT01585129|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454104|NCT01585103||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454105|NCT01585090||Parallel Assignment||Prevention||Single|||||t|
1454106|NCT01585077|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1454107|NCT01585064|||Cohort||Prospective|||||||
1454108|NCT01585051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454109|NCT01585038|Randomized|Parallel Assignment||Treatment||Single||||||t
1454110|NCT01585025||Single Group Assignment||Treatment||None (Open Label)||||||
1454111|NCT01585012||Single Group Assignment||||None (Open Label)||||||
1454112|NCT01584999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454113|NCT01584986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454114|NCT01584973|||Case-Crossover||Cross-Sectional|||||||
1454115|NCT01584960|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1454116|NCT01584947|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1454117|NCT01584934|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1454118|NCT01584921|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1454119|NCT01584908|||Cohort||Prospective|||||||
1454120|NCT01584895|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1454121|NCT01584882|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1454122|NCT01584869||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454123|NCT01584856|||Cohort||Prospective|||||||
1454124|NCT01584843|Randomized|Parallel Assignment||Treatment||Single||||||t
1454125|NCT01584830|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454126|NCT01584817|Randomized|Parallel Assignment||Screening||Double|||||t|t
1454127|NCT01584804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454128|NCT01584791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454129|NCT01584778|||Case Control||Prospective|||||||
1454130|NCT01584765|||Cohort||Retrospective|||||||
1454131|NCT01584752|||Case-Only||Prospective|||||||
1454132|NCT01584739|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1454133|NCT01584726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454134|NCT01584713||Single Group Assignment||Treatment||None (Open Label)||||||
1454135|NCT01584700||Single Group Assignment||Treatment||None (Open Label)||||||
1454136|NCT01584687||Single Group Assignment||Treatment||None (Open Label)||||||
1454137|NCT01584674|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454138|NCT01584661|||Cohort||Prospective|||||||
1454139|NCT01584648|Randomized|||Treatment||Quadruple|||t|t|t|t
1454140|NCT01584635||Single Group Assignment||Treatment||None (Open Label)||||||
1454141|NCT01584622||Single Group Assignment||Diagnostic||Double|||||t|t
1454142|NCT01584609|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454143|NCT01584596|Randomized|Parallel Assignment||Treatment||Single||||||t
1454144|NCT01584583|||||Prospective|||||||
1454145|NCT01584570|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1454146|NCT01584557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454147|NCT01584544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454148|NCT01584531||Single Group Assignment||Treatment||None (Open Label)||||||
1454149|NCT01584518|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1454150|NCT01584505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454151|NCT01584492|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1454152|NCT01584479|||Cohort||Retrospective|||||||
1454153|NCT01584466||Single Group Assignment||Treatment||None (Open Label)||||||
1454154|NCT01584453|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1454155|NCT01584440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454156|NCT01584427|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1454157|NCT01584414|||||Prospective|||||||
1454158|NCT01584401|||Cohort||Prospective|||||||
1454159|NCT01584388||Single Group Assignment||Treatment||None (Open Label)||||||
1454160|NCT01584375|Randomized|Parallel Assignment||Prevention||Single||||||t
1454161|NCT01584362|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454162|NCT01584336||Single Group Assignment||Treatment||None (Open Label)||||||
1454163|NCT01584323|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454164|NCT01584310|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454165|NCT01584297||Single Group Assignment||Treatment||None (Open Label)||||||
1454166|NCT01584284||Single Group Assignment||Treatment||None (Open Label)||||||
1454167|NCT01584271|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454168|NCT01584258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454169|NCT01584245||Single Group Assignment||||||||||
1454170|NCT01584232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454171|NCT01584219|||Cohort||Prospective|||||||
1454172|NCT01584206||Single Group Assignment||Basic Science||None (Open Label)||||||
1454173|NCT01584193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454174|NCT01584180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454175|NCT01584167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454176|NCT01584154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454177|NCT01584141|||Case-Control||Retrospective|||||||
1454178|NCT01584128|||Cohort||Prospective|||||||
1454179|NCT01584115||Single Group Assignment||Treatment||None (Open Label)||||||
1454180|NCT01584102|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1454181|NCT01584076||Single Group Assignment||Treatment||None (Open Label)||||||
1454182|NCT01584063|Randomized|Parallel Assignment||Prevention||Single||||||t
1454183|NCT01584050|Randomized|Parallel Assignment||||Double|||t||t|
1454184|NCT01584037|||||Prospective|||||||
1454185|NCT01584024|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454186|NCT01584011|||Cohort||Prospective|||||||
1454187|NCT01583998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454188|NCT01583985|Randomized|Parallel Assignment||Treatment||Single||||||t
1454189|NCT01583972|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1454190|NCT01583959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454191|NCT01583946|||Cohort|||||||||
1454192|NCT01583933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454193|NCT01583920||Single Group Assignment||Treatment||None (Open Label)||||||
1454194|NCT01583907|||Cohort||Prospective|||||||
1454195|NCT01583894|||Case-Only||Cross-Sectional|||||||
1454196|NCT01583881|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454197|NCT01583868||||||||||||
1454198|NCT01583855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454199|NCT01583842|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1454200|NCT01583829|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1454201|NCT01583816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454202|NCT01583803|||Cohort||Prospective|||||||
1454203|NCT01583790|||Case-Only||Retrospective|||||||
1454204|NCT01583777||Single Group Assignment||Treatment||None (Open Label)||||||
1454205|NCT01583751||Single Group Assignment||Treatment||Single|||t|||
1454206|NCT01583738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454207|NCT01583725|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454208|NCT01583712||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454209|NCT01583699||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454210|NCT01583686|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454211|NCT01583673|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1454212|NCT01583660|||Cohort||Prospective|||||||
1454213|NCT01583647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454214|NCT01583634|||Cohort||Prospective|||||||
1454215|NCT01583621|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1454216|NCT01583608|||Cohort||Prospective|||||||
1454217|NCT01583595|||Cohort||Prospective|||||||
1454218|NCT01583582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454219|NCT01583569|||Case Control||Retrospective|||||||
1454220|NCT01583556|||Cohort||Prospective|||||||
1454221|NCT01583543||Single Group Assignment||Treatment||None (Open Label)||||||
1454222|NCT01583530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454223|NCT01583517|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1454224|NCT01583504|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454225|NCT01583491|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1454226|NCT01583478|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454227|NCT01583465|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454228|NCT01583452|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1454229|NCT01583439||Single Group Assignment||Prevention||None (Open Label)||||||
1454230|NCT01583426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454231|NCT01583413||Single Group Assignment||Treatment||None (Open Label)||||||
1454232|NCT01583400|Randomized|Parallel Assignment||Treatment||Single||||||t
1454233|NCT01583387|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1454234|NCT01583374|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454235|NCT01583361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454236|NCT01583348|||Case-Only||Prospective|||||||
1454237|NCT01583335|Randomized|Parallel Assignment||Prevention||Single|||t|||
1454238|NCT01583322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454239|NCT01583309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454240|NCT01583296|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454241|NCT01583283||Single Group Assignment||Treatment||None (Open Label)||||||
1454242|NCT01583270|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1454243|NCT01583257||Single Group Assignment||||||||||
1454244|NCT01583244|||Case-Only||Prospective|||||||
1454245|NCT01583231|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1454246|NCT01583218|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1454247|NCT01583205||Single Group Assignment||Treatment||None (Open Label)||||||
1454248|NCT01583192|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454249|NCT01583179|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1454250|NCT01583166|Randomized|Single Group Assignment||Other||Quadruple|||t|t|t|t
1454251|NCT01583153|Randomized|Parallel Assignment||Treatment||Single||||||t
1454252|NCT01583140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454253|NCT01583127|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1454254|NCT01583114|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454255|NCT01583101|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1454256|NCT01583088|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1454257|NCT01583075|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1454258|NCT01583062|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1454259|NCT01583049|||Cohort||Prospective|||||||
1454260|NCT01583036||Single Group Assignment||Basic Science||None (Open Label)||||||
1454261|NCT01583023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454262|NCT01583010|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1454263|NCT01582997||Single Group Assignment||Treatment||None (Open Label)||||||
1454264|NCT01582984|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1454265|NCT01582971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454266|NCT01582958|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454267|NCT01582945||Single Group Assignment||Treatment||None (Open Label)||||||
1454268|NCT01582932||Single Group Assignment||Treatment||None (Open Label)||||||
1454269|NCT01582919|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1454270|NCT01582906|||Cohort||Prospective|||||||
1454271|NCT01582893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454272|NCT01582880||Single Group Assignment||Treatment||None (Open Label)||||||
1454273|NCT01582867|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454274|NCT01582854|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454275|NCT01582841|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1454276|NCT01582828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454277|NCT01582815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454278|NCT01582802|||Cohort||Prospective|||||||
1454279|NCT01582789|Randomized|Crossover Assignment||Treatment||Single|||t|||
1454280|NCT01582776||Single Group Assignment||Treatment||None (Open Label)||||||
1454281|NCT01582763|||Cohort||Prospective|||||||
1454282|NCT01582750|||Cohort||Prospective|||||||
1454283|NCT01582737|||Case-Only||Prospective|||||||
1454284|NCT01582724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454285|NCT01582711|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454286|NCT01582698||Single Group Assignment||Prevention||None (Open Label)||||||
1454287|NCT01582685|Randomized|Parallel Assignment||Prevention||Single|||||t|
1454288|NCT01582672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454289|NCT01582659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454290|NCT01582646|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1454291|NCT01582633|Randomized|Parallel Assignment||Prevention||Single||||||t
1454292|NCT01582620||Single Group Assignment||Health Services Research||None (Open Label)||||||
1454293|NCT01582607|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1454294|NCT01582594|||Case-Only||Prospective|||||||
1454295|NCT01582581|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454296|NCT01582568|||Cohort||Prospective|||||||
1454297|NCT01582555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454298|NCT01582542||Single Group Assignment||Treatment||None (Open Label)||||||
1454299|NCT01582529|||Cohort||Prospective|||||||
1454300|NCT01582516||Single Group Assignment||Treatment||None (Open Label)||||||
1454301|NCT01582503|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454302|NCT01582490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454303|NCT01582477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454304|NCT01582464|||Ecologic or Community||Prospective|||||||
1454305|NCT01582451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454306|NCT01582438||||||||||||
1454307|NCT01582425||Single Group Assignment||||None (Open Label)||||||
1454308|NCT01582412||Single Group Assignment||||None (Open Label)||||||
1454309|NCT01582399|Randomized|Parallel Assignment||||None (Open Label)||||||
1454310|NCT01582386||||||||||||
1454311|NCT01582373||Single Group Assignment||Treatment||None (Open Label)||||||
1454312|NCT01582360|||Cohort||Prospective|||||||
1454313|NCT01582347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454314|NCT01582334|||Cohort||Other|||||||
1454315|NCT01582321|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1454316|NCT01582308|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454317|NCT01582295||Single Group Assignment||Treatment||None (Open Label)||||||
1454318|NCT01582282|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1454319|NCT01582269|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454320|NCT01582256||||||||||||
1454321|NCT01582243||Single Group Assignment||Treatment||None (Open Label)||||||
1454322|NCT01582230|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454323|NCT01582217|||Case-Only||Prospective|||||||
1454324|NCT01582204||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454325|NCT01582191||Single Group Assignment||Treatment||None (Open Label)||||||
1454326|NCT01582178|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1454327|NCT01582165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454328|NCT01582152|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454329|NCT01582139|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454330|NCT01582126|Randomized|Parallel Assignment||Treatment||Single|||||t|
1454331|NCT01582113|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454332|NCT01582100||Single Group Assignment||Treatment||None (Open Label)||||||
1454333|NCT01582087|||Cohort||Retrospective|||||||
1454334|NCT01582074|||Case-Control||Prospective|||||||
1454335|NCT01582061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454336|NCT01582048||Single Group Assignment||Treatment||None (Open Label)||||||
1454337|NCT01582035|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454338|NCT01582022|Randomized|||Supportive Care||Single|||t|||
1454339|NCT01582009||Single Group Assignment||Treatment||None (Open Label)||||||
1454340|NCT01581996||Single Group Assignment||Treatment||None (Open Label)||||||
1454341|NCT01581983|Randomized|Parallel Assignment||Treatment||Single||||||t
1454342|NCT01581970||Single Group Assignment||Treatment||None (Open Label)||||||
1454343|NCT01581957|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1454344|NCT01581944|Randomized|Parallel Assignment||Treatment||Single||||t||
1454345|NCT01581931|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454346|NCT01581918||Single Group Assignment||Prevention||None (Open Label)||||||
1454347|NCT01581905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454348|NCT01581892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454349|NCT01581879|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454350|NCT01581866|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454351|NCT01581853||Single Group Assignment||Treatment||None (Open Label)||||||
1454352|NCT01581840||Single Group Assignment||Treatment||None (Open Label)||||||
1454353|NCT01581827|||Cohort||Prospective|||||||
1454354|NCT01581814|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454355|NCT01581801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454356|NCT01581788|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454357|NCT01581775|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454358|NCT01581762|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1454359|NCT01581749||Single Group Assignment||Treatment||None (Open Label)||||||
1454360|NCT01581736||Single Group Assignment||Basic Science||None (Open Label)||||||
1454361|NCT01581723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454362|NCT01581710|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1454363|NCT01581697||||||||||||
1454364|NCT01581684|Randomized|Single Group Assignment||Treatment||Single||||||
1454365|NCT01581671|||Cohort||Prospective|||||||
1454366|NCT01581658|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454367|NCT01581645||Single Group Assignment||Treatment||None (Open Label)||||||
1454368|NCT01581632||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454369|NCT01581619||Single Group Assignment||Treatment||None (Open Label)||||||
1454370|NCT01581606|||Case-Only||Prospective|||||||
1454371|NCT01581593||Single Group Assignment||Treatment||None (Open Label)||||||
1454372|NCT01581580|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1454373|NCT01581567|||||Other|||||||
1454374|NCT01581554|||Case-Only||Prospective|||||||
1454375|NCT01581541|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1454376|NCT01581528|||Case-Only||Retrospective|||||||
1454377|NCT01581515|Randomized|Parallel Assignment||Treatment||Single|||||t|
1454378|NCT01581502|||Case-Only||Prospective|||||||
1454379|NCT01581489|||Cohort||Prospective|||||||
1454380|NCT01581476|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1454381|NCT01581463||Single Group Assignment||Treatment||None (Open Label)||||||
1454382|NCT01581450|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1454383|NCT01581437||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454384|NCT01581424|||Cohort||Prospective|||||||
1454385|NCT01581411||Single Group Assignment||Treatment||None (Open Label)||||||
1454386|NCT01581398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454387|NCT01581385|||Case-Only||Cross-Sectional|||||||
1454388|NCT01581372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454389|NCT01581359|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454390|NCT01581346||Single Group Assignment||||None (Open Label)||||||
1454391|NCT01581333|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1454392|NCT01581320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454393|NCT01581307||Single Group Assignment||Treatment||None (Open Label)||||||
1454394|NCT01581294|||Cohort||Prospective|||||||
1454395|NCT01581281|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1454396|NCT01581255|||Cohort||Prospective|||||||
1454397|NCT01581242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454398|NCT01581229|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454399|NCT01581216|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454400|NCT01581203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454401|NCT01581190||Single Group Assignment||Treatment||None (Open Label)||||||
1454402|NCT01581177|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1454403|NCT01581164|||Cohort||Prospective|||||||
1454404|NCT01581151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454405|NCT01581138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454406|NCT01581125|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1454407|NCT01581112|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454408|NCT01581099|||Case-Control||Prospective|||||||
1454409|NCT01581086|||Cohort||Retrospective|||||||
1454410|NCT01581073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454411|NCT01581060||Single Group Assignment||Treatment||None (Open Label)||||||
1454412|NCT01581047|||Cohort||Prospective|||||||
1454413|NCT01581034|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1454414|NCT01581021|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454415|NCT01581008|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454416|NCT01580995|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454417|NCT01580982|||Other||Prospective|||||||
1454418|NCT01580969||Single Group Assignment||Treatment||None (Open Label)||||||
1454419|NCT01580956|Randomized|Crossover Assignment||Treatment||Single|||t|||
1454420|NCT01580943|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1454421|NCT01580930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454422|NCT01580917|||Case Control||Cross-Sectional|||||||
1454423|NCT01580904|Randomized|Factorial Assignment||Treatment||Single||||t||
1454424|NCT01580891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454425|NCT01580878|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454426|NCT01580865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454427|NCT01580852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454428|NCT01580839|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454429|NCT01580826|Randomized|Parallel Assignment||Prevention||Single|||t|||
1454430|NCT01580813|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1454431|NCT01580800|||Cohort||Prospective|||||||
1454432|NCT01580787|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1454433|NCT01580774|||Case-Control||Prospective|||||||
1454434|NCT01580761|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1454435|NCT01580748||Single Group Assignment||Treatment||None (Open Label)||||||
1454436|NCT01580735||Single Group Assignment||Treatment||None (Open Label)||||||
1454437|NCT01580722|Randomized|Parallel Assignment||Treatment||Single||||||t
1454438|NCT01580709|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1454439|NCT01580696|Randomized|Sequential Assignment||Treatment||None (Open Label)||3+3 dose escalation study of E39 + GM-CSF in HLA-A2+ patients with HLA-A2- patients followed as a control arm||||
1454440|NCT01580683|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1454441|NCT01580670||Single Group Assignment||Treatment||None (Open Label)||||||
1454442|NCT01580657|Randomized|Factorial Assignment||||None (Open Label)||||||
1454443|NCT01580644|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454444|NCT01580631|||Case-Control||Prospective|||||||
1454445|NCT01580618|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1454446|NCT01580605|||Cohort||Prospective|||||||
1454447|NCT01580592|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454448|NCT01580579|||Cohort||Prospective|||||||
1454449|NCT01580566|||Cohort||Prospective|||||||
1454450|NCT01580553|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1454451|NCT01580540|||Case Control|||||||||
1454452|NCT01580527|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454453|NCT01580514|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454454|NCT01580501||Single Group Assignment||Treatment||None (Open Label)||||||
1454455|NCT01580488||Single Group Assignment||||Single|||||t|
1454456|NCT01580475||Single Group Assignment||Treatment||Single|||||t|
1454457|NCT01580462|||||Prospective|||||||
1454458|NCT01580436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454459|NCT01580423|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1454460|NCT01580410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454461|NCT01580397||Single Group Assignment||Treatment||None (Open Label)||||||
1454462|NCT01580384|||Cohort||Prospective|||||||
1454463|NCT01580371||Single Group Assignment||Treatment||None (Open Label)||||||
1454464|NCT01580358|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1454465|NCT01580345|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1454466|NCT01580332|||Cohort||Prospective|||||||
1454467|NCT01580319|Randomized|Parallel Assignment||Treatment||Single||||||t
1454468|NCT01580306|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454469|NCT01580293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454470|NCT01580280|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454471|NCT01580267|||Case-Only||Prospective|||||||
1454472|NCT01580254|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1454473|NCT01580241|||Cohort||Prospective|||||||
1454474|NCT01580228|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454475|NCT01580215|||Cohort||Prospective|||||||
1454476|NCT01580202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454477|NCT01580189|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1454478|NCT01580176||Single Group Assignment||||None (Open Label)||||||
1454479|NCT01580163|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454480|NCT01580150|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1454481|NCT01580137|||Cohort||Prospective|||||||
1454482|NCT01580124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454483|NCT01580111|Randomized|Parallel Assignment||Treatment||Single||||t||
1454484|NCT01580098|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454485|NCT01580085|||Case Control||Cross-Sectional|||||||
1454486|NCT01580072|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454487|NCT01580046|Randomized|Parallel Assignment||Prevention||Single|||t|||
1454488|NCT01580033|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1454489|NCT01580020|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454490|NCT01580007|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1454491|NCT01579994||Single Group Assignment||Treatment||None (Open Label)||||||
1454492|NCT01579981||Single Group Assignment||Basic Science||Single|||t|||
1454493|NCT01579968|||Cohort||Prospective|||||||
1454494|NCT01579955|||Cohort||Prospective|||||||
1454495|NCT01579942|||Case-Control||Prospective|||||||
1454496|NCT01579929||Single Group Assignment||Treatment||None (Open Label)||||||
1454497|NCT01579916|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1454498|NCT01579903|Randomized|Crossover Assignment||||None (Open Label)||||||
1454499|NCT01579890||||||||||||
1454500|NCT01579877|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454501|NCT01579864|Randomized|Parallel Assignment||Treatment||Single||||t||
1454502|NCT01579851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454503|NCT01579838||Single Group Assignment||Treatment||None (Open Label)||||||
1454504|NCT01579825|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454505|NCT01579812||Single Group Assignment||Treatment||None (Open Label)||||||
1454506|NCT01579799|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1454507|NCT01579786|Randomized|Parallel Assignment||Treatment||Double||||t||t
1454508|NCT01579773|||Cohort||Prospective|||||||
1454509|NCT01579760|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454510|NCT01579747|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454511|NCT01579734|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1454512|NCT01579721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454513|NCT01579708|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454514|NCT01579695|||Cohort||Prospective|||||||
1454515|NCT01579682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454516|NCT01579669||Single Group Assignment||Health Services Research||None (Open Label)||||||
1454517|NCT01579656|Randomized|Crossover Assignment||Prevention||Single|||t|||
1454518|NCT01579643|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454519|NCT01579630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454520|NCT01579617|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454521|NCT01579604|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454522|NCT01579591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454523|NCT01579578|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454524|NCT01579565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454525|NCT01579552|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454526|NCT01579539||Single Group Assignment||Treatment||None (Open Label)||||||
1454527|NCT01579526|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1454528|NCT01579513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454529|NCT01579500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454530|NCT01579487||Single Group Assignment||Other||None (Open Label)||||||
1454531|NCT01579474|Randomized|Parallel Assignment||Treatment||Double||||||
1454532|NCT01579461|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1454533|NCT01579448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454534|NCT01579435|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1454535|NCT01579422||Single Group Assignment||Treatment||None (Open Label)||||||
1454536|NCT01579409|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1454537|NCT01579396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454538|NCT01579383|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1454539|NCT01579370|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1454540|NCT01579357|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1454541|NCT01579344|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1454542|NCT01579331||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454543|NCT01579318||Single Group Assignment||Treatment||None (Open Label)||||||
1454544|NCT01579305|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454545|NCT01579292|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454546|NCT01579279|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454547|NCT01579266|||||Prospective|||||||
1454548|NCT01579253|||Cohort||Prospective|||||||
1454549|NCT01579240||Single Group Assignment||Prevention||None (Open Label)||||||
1454550|NCT01579227|||Cohort||Prospective|||||||
1454551|NCT01579214|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||"This is a quasi-experimental design study with two periods of study. The pre-intervention period serves as the control group. During the intervention period, participants received one of three message types to be informed of their test results: 1) a standard message informing their abnormal result, 2) the standard message protected by a PIN number code, and 3) a coded texted message ABCDEFG.~For our a priori hypotheses about the effect of receiving an SMS message on outcomes, we compared results for participants in the pre-intervention period with all those in the post-intervention period. This was a non-randomized intervention.~For our primary outcome (time to ART initiation) we assessed all participants with abnormal CD4 count results who were ART-naive at study enrollment. For our secondary outcome (time to clinic return) we looked at all study participants with abnormal CD4 counts."||||
1454552|NCT01579201||Single Group Assignment||Treatment||Triple|||t|t||t
1454553|NCT01579188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454554|NCT01579175|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454555|NCT01579162|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1454556|NCT01579149|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1454557|NCT01579136|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454558|NCT01579123|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454559|NCT01579110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454560|NCT01579097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454561|NCT01579084|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454562|NCT01579071|Randomized|Parallel Assignment||||Double|||t||t|
1454563|NCT01579058|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454564|NCT01579045|Randomized|Crossover Assignment||Treatment||Single|||t|||
1454565|NCT01579032|||Cohort||Cross-Sectional|||||||
1454566|NCT01579019||Parallel Assignment||Treatment||Double|||t||t|
1454567|NCT01579006|||Cohort||Prospective|||||||
1454568|NCT01578993|||Cohort||Prospective|||||||
1454569|NCT01578980||Single Group Assignment||Treatment||None (Open Label)||||||
1454570|NCT01578967||Single Group Assignment||Treatment||None (Open Label)||||||
1454571|NCT01578954||Single Group Assignment||Treatment||None (Open Label)||||||
1454572|NCT01578941|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1454573|NCT01578928|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454574|NCT01578915|||Case-Control||Prospective|||||||
1454575|NCT01578902||Single Group Assignment||Treatment||None (Open Label)||||||
1454576|NCT01578889|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1454577|NCT01578876|Randomized|Parallel Assignment||Treatment||Single||||||t
1454578|NCT01578863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454579|NCT01578850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454580|NCT01578837|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454581|NCT01578824|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1454582|NCT01578811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454583|NCT01578798|||Cohort||Prospective|||||||
1454584|NCT01578785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454585|NCT01578772||Single Group Assignment||Treatment||None (Open Label)||||||
1454586|NCT01578759|Randomized|Parallel Assignment||Prevention||Single|||t|||
1454587|NCT01578746|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454588|NCT01578733||Crossover Assignment||Health Services Research||None (Open Label)||||||
1454589|NCT01578720||Single Group Assignment||Treatment||None (Open Label)||||||
1454590|NCT01578707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454591|NCT01578694|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1454592|NCT01578681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454593|NCT01578668|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454594|NCT01578655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454595|NCT01578642||Single Group Assignment||Treatment||None (Open Label)||||||
1454596|NCT01578629|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1454597|NCT01578616|||Case Control||Cross-Sectional|||||||
1454598|NCT01578603|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1454599|NCT01578590|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1454600|NCT01578577|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454601|NCT01578564||Single Group Assignment||Treatment||None (Open Label)||||||
1454602|NCT01578551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454603|NCT01578538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454604|NCT01578525|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1454605|NCT01578512|Randomized|Parallel Assignment||Treatment||Single||||||t
1454606|NCT01578499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454607|NCT01578486||Single Group Assignment||Treatment||None (Open Label)||||||
1454608|NCT01578473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454609|NCT01578460|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1454610|NCT01578447|Randomized|Crossover Assignment||||None (Open Label)||||||
1454611|NCT01578434|Randomized|Parallel Assignment||Treatment||Single||||||t
1454612|NCT01578421|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454613|NCT01578408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454614|NCT01578395|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1454615|NCT01578382|||Case Control||Prospective|||||||
1454616|NCT01578369|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454617|NCT01578356|||Cohort||Prospective|||||||
1454618|NCT01578343||Single Group Assignment||Treatment||None (Open Label)||||||
1454619|NCT01578330||Single Group Assignment||Supportive Care||None (Open Label)||||||
1454620|NCT01578317|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1454621|NCT01578304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454622|NCT01578291|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1454623|NCT01578278|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454624|NCT01578265|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454625|NCT01578252|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454626|NCT01578239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454627|NCT01578226|||Cohort||Prospective|||||||
1454628|NCT01578213||Single Group Assignment||Other||None (Open Label)||||||
1454629|NCT01578200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454630|NCT01578187||Single Group Assignment||||None (Open Label)||||||
1454631|NCT01578174|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1454632|NCT01578161|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1454633|NCT01578148|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454634|NCT01578135|||Cohort||Prospective|||||||
1454635|NCT01578122|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454636|NCT01578109||Single Group Assignment||Treatment||None (Open Label)||||||
1454637|NCT01578096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454638|NCT01578083|||Case Control||Cross-Sectional|||||||
1454639|NCT01578070|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454640|NCT01578057|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1454641|NCT01578044|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1454642|NCT01578031|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454643|NCT01578018|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1454644|NCT01578005|||Cohort||Prospective|||||||
1454645|NCT01577992|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1454646|NCT01577979|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1454647|NCT01577966||Single Group Assignment||Treatment||None (Open Label)||||||
1454648|NCT01577953|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454649|NCT01577940|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1454650|NCT01577927|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454651|NCT01577914|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454652|NCT01577901||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454653|NCT01577888||Single Group Assignment||Treatment||None (Open Label)||||||
1454654|NCT01577875|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1454655|NCT01577862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454656|NCT01577849|Randomized|Crossover Assignment||||None (Open Label)||||||
1454657|NCT01577836|||Case-Only||Prospective|||||||
1454658|NCT01577823||||||||||||
1454659|NCT01577810||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454660|NCT01577797|Randomized|Crossover Assignment||Treatment||Single|||||t|
1454661|NCT01577784||Single Group Assignment||Treatment||None (Open Label)||||||
1454662|NCT01577771|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454663|NCT01577758||Single Group Assignment||Treatment||None (Open Label)||||||
1454664|NCT01577745||Single Group Assignment||Treatment||None (Open Label)||||||
1454665|NCT01577732||Single Group Assignment||Prevention||None (Open Label)||||||
1454666|NCT01577719|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454667|NCT01577706|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1454668|NCT01577693|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454669|NCT01577680|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1454670|NCT01577667|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1454671|NCT01577654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454672|NCT01577628|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454673|NCT01577615|Randomized|Parallel Assignment||Treatment||Single||||||t
1454674|NCT01577602|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1454675|NCT01577589|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1454676|NCT01577576|||Cohort||Cross-Sectional|||||||
1454677|NCT01577563|||Case-Only||Cross-Sectional|||||||
1454678|NCT01577550|Randomized|Parallel Assignment||Treatment||Double||||||
1454679|NCT01577537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454680|NCT01577524|Randomized|Parallel Assignment||Prevention||Single|||t|||
1454681|NCT01577511|||Cohort||Prospective|||||||
1454682|NCT01577498|||||Prospective|||||||
1454683|NCT01577485|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1454684|NCT01577472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454685|NCT01577459|Randomized|Crossover Assignment||Other||Double|||t||t|
1454686|NCT01577446|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454687|NCT01577433||||||||||||
1454688|NCT01577420|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1454689|NCT01577407|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1454690|NCT01577394||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454691|NCT01577381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454692|NCT01577368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454693|NCT01577355||Single Group Assignment||Basic Science||None (Open Label)||||||
1454694|NCT01577342|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454695|NCT01577329|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454696|NCT01577316|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454697|NCT01577303|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454698|NCT01577290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454699|NCT01577277|||Cohort||Cross-Sectional|||||||
1454700|NCT01577264|||Cohort||Prospective|||||||
1454701|NCT01577251|||||Prospective|||||||
1454702|NCT01577238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454703|NCT01577225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454704|NCT01577212||Single Group Assignment||Treatment||None (Open Label)||||||
1454705|NCT01577199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454706|NCT01577186||Single Group Assignment||Treatment||None (Open Label)||||||
1454707|NCT01577173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454708|NCT01577160||Single Group Assignment||Treatment||None (Open Label)||||||
1454709|NCT01577147||Single Group Assignment||Basic Science||None (Open Label)||||||
1454710|NCT01577134|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1454711|NCT01577121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454712|NCT01577108|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1454713|NCT01577095|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454714|NCT01577082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454715|NCT01577069|||Cohort||Prospective|||||||
1454716|NCT01577056|Randomized|Single Group Assignment||Treatment||Single||||||t
1454717|NCT01577043|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454718|NCT01577030|Randomized|Crossover Assignment||Treatment||Single||||||t
1454719|NCT01577017||Single Group Assignment||Treatment||None (Open Label)||||||
1454720|NCT01577004||Single Group Assignment||Basic Science||None (Open Label)||||||
1454721|NCT01576991|||Cohort||Prospective|||||||
1454722|NCT01576978|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454723|NCT01576965|Randomized|Parallel Assignment||Other||Single||||t||
1454724|NCT01576952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454725|NCT01576939||Single Group Assignment||Treatment||None (Open Label)||||||
1454726|NCT01576926|||||Prospective|||||||
1454727|NCT01576913|Randomized|Crossover Assignment||||Single|||||t|
1454728|NCT01576900|||Case Control||Prospective|||||||
1454729|NCT01576887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454730|NCT01576874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454731|NCT01576861|Randomized|Parallel Assignment||Treatment||Single|||||t|
1454732|NCT01576848|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1454733|NCT01576835|||Case-Only||Prospective|||||||
1454734|NCT01576822|Randomized|Parallel Assignment||||None (Open Label)||||||
1454735|NCT01576809||Single Group Assignment||||None (Open Label)||||||
1454736|NCT01576796||Single Group Assignment||Treatment||None (Open Label)||||||
1454737|NCT01576783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454738|NCT01576770|Randomized|Parallel Assignment||Treatment||Single||||||t
1454739|NCT01576757|||Other||Prospective|||||||
1454740|NCT01576744|||Case-Only||Prospective|||||||
1454741|NCT01576731|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454742|NCT01576718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454743|NCT01576705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454744|NCT01576692||Single Group Assignment||Treatment||None (Open Label)||||||
1454745|NCT01576679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454746|NCT01576666||Single Group Assignment||||None (Open Label)||||||
1454747|NCT01576653|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1454748|NCT01576640||Single Group Assignment||Treatment||None (Open Label)||||||
1454749|NCT01576627|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1454750|NCT01576614|||Cohort||Prospective|||||||
1454751|NCT01576601|||Cohort||Prospective|||||||
1454752|NCT01576588||Single Group Assignment||Treatment||None (Open Label)||||||
1454753|NCT01576575|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1454754|NCT01576562|||Case-Control||Prospective|||||||
1454755|NCT01576549||Single Group Assignment||Treatment||None (Open Label)||||||
1454756|NCT01576536|||Cohort||Prospective|||||||
1454757|NCT01576523|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1454758|NCT01576510|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1454759|NCT01576497|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1454760|NCT01576484||Single Group Assignment||Treatment||None (Open Label)||||||
1454761|NCT01576471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454762|NCT01576458|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1454763|NCT01576445|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454764|NCT01576432|Randomized|Parallel Assignment||Treatment||Single||||t||
1454765|NCT01576419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454766|NCT01576406|Non-Randomized|||Basic Science||None (Open Label)||||||
1454767|NCT01576393|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454768|NCT01576380||Single Group Assignment||Treatment||None (Open Label)||||||
1454769|NCT01576367|Non-Randomized|Single Group Assignment||Treatment||||||||
1454770|NCT01576354|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1454771|NCT01576341||Single Group Assignment||Treatment||None (Open Label)||||||
1454772|NCT01576328|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454773|NCT01576315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454774|NCT01576302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454775|NCT01576289|||Cohort||Prospective|||||||
1454776|NCT01576276|Randomized|Parallel Assignment||Other||Single|||t|||
1454777|NCT01576263|||Cohort||Retrospective|||||||
1454778|NCT01576250||Single Group Assignment||Basic Science||None (Open Label)||||||
1454779|NCT01576237|||Other||Prospective|||||||
1454780|NCT01576224|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1454781|NCT01576211|||Case Control||Retrospective|||||||
1454782|NCT01576198|||Case-Only||Retrospective|||||||
1454783|NCT01576185|||Case-Only||Prospective|||||||
1454784|NCT01576172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454785|NCT01576159|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1454786|NCT01576146||Single Group Assignment||Treatment||None (Open Label)||||||
1454787|NCT01576133|Randomized|Parallel Assignment||Prevention||Single|Outcomes assessor did not know which study group the person they visited was in and told participant not to reveal it.|"Time limited home based intervention of a Nurse, Occupational Therapist, and a handyman to work with low income older adults to assess, prioritize and meet their functional goals."||||t
1454788|NCT01576120|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1454789|NCT01576107|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454790|NCT01576094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454791|NCT01576081||Single Group Assignment||Basic Science||None (Open Label)||||||
1454792|NCT01576068||Single Group Assignment||Screening||None (Open Label)||||||
1454793|NCT01576055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454794|NCT01576042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454795|NCT01576029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454796|NCT01576016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454797|NCT01576003|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1454798|NCT01575990|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1454799|NCT01575977|||Other||Prospective|||||||
1454800|NCT01575964|||Case-Control||Prospective|||||||
1454801|NCT01575951||Single Group Assignment||Screening||None (Open Label)||||||
1454802|NCT01575938|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454803|NCT01575925|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1454804|NCT01575912|||Cohort||Prospective|||||||
1454805|NCT01575899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454806|NCT01575886|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1454807|NCT01575873|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454808|NCT01575860||Single Group Assignment||Treatment||||||||
1454809|NCT01575847|||||Prospective|||||||
1454810|NCT01575834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454811|NCT01575821|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1454812|NCT01575808|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454813|NCT01575795|Randomized|Parallel Assignment||Treatment||Single||||||t
1454814|NCT01575782||Single Group Assignment||Treatment||None (Open Label)||||||
1454815|NCT01575769||Single Group Assignment||Treatment||None (Open Label)||||||
1454816|NCT01575756|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454817|NCT01575743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454818|NCT01575730|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454819|NCT01575717|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454820|NCT01575704|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454821|NCT01575678|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1454822|NCT01575665||Single Group Assignment||Treatment||None (Open Label)||||||
1454823|NCT01575652|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454824|NCT01575639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454825|NCT01575626|Randomized|Parallel Assignment||||None (Open Label)||||||
1454826|NCT01575613|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454827|NCT01575600|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1454828|NCT01575587|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454829|NCT01575574||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454830|NCT01575561||Single Group Assignment||Treatment||None (Open Label)||||||
1454831|NCT01575548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454832|NCT01575535|||||Retrospective|||||||
1454833|NCT01575522||Single Group Assignment||Treatment||None (Open Label)||||||
1454834|NCT01575509||Single Group Assignment||||None (Open Label)||||||
1454835|NCT01575496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454836|NCT01575483|||Case-Only||Prospective|||||||
1454837|NCT01575470||Single Group Assignment||Treatment||None (Open Label)||||||
1454838|NCT01575457|Randomized|Parallel Assignment||||Single||||||t
1454839|NCT01575444|||Cohort||Prospective|||||||
1454840|NCT01575431|||||Prospective|||||||
1454841|NCT01575418|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1454842|NCT01575405|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1454843|NCT01575392|||||Cross-Sectional|||||||
1454844|NCT01575366|Randomized|Crossover Assignment||Treatment||Single||||||t
1454845|NCT01575353|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454846|NCT01575340|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1454847|NCT01575327|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1454848|NCT01575314|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454849|NCT01575301||Single Group Assignment||Basic Science||None (Open Label)||||||
1454850|NCT01575288|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454851|NCT01575275||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454852|NCT01575262|Randomized|Parallel Assignment||||Single||||||t
1454853|NCT01575249|||Case Control||Prospective|||||||
1454854|NCT01575236|Randomized|Parallel Assignment||Treatment||Single|||||t|
1454855|NCT01575223|Randomized|Parallel Assignment||Treatment||Single|||||t|
1454856|NCT01575210||||||||||||
1454857|NCT01575197|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454858|NCT01575184|Randomized|Parallel Assignment||||Single||||||t
1454859|NCT01575171|||Case Control||Prospective|||||||
1454860|NCT01575158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454861|NCT01575145|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454862|NCT01575132|||Case-Only||Retrospective|||||||
1454863|NCT01575119|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1454864|NCT01575106||Single Group Assignment||Other||None (Open Label)||||||
1454865|NCT01575093||Single Group Assignment||||None (Open Label)||||||
1454866|NCT01575080||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454867|NCT01575067|||||Prospective|||||||
1454868|NCT01575054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454869|NCT01575041|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1454870|NCT01575028|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1454871|NCT01575015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454872|NCT01575002|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1454873|NCT01574989|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1454874|NCT01574976|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1454875|NCT01574963|||Cohort||Prospective|||||||
1454876|NCT01574950|||Cohort||Prospective|||||||
1454877|NCT01574937||Single Group Assignment||Treatment||None (Open Label)||||||
1454878|NCT01574924|||Cohort||Prospective|||||||
1454879|NCT01574911|||Case-Only||Prospective|||||||
1454880|NCT01574898|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454881|NCT01574885|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454882|NCT01574872|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454883|NCT01574859|||Cohort||Retrospective|||||||
1454884|NCT01574846|||Case-Only||Prospective|||||||
1454885|NCT01574833|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1454886|NCT01574820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454887|NCT01574807||Single Group Assignment||Treatment||Double|||t||t|
1454888|NCT01574794|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1454889|NCT01574781|||||Prospective|||||||
1454890|NCT01574768||Single Group Assignment||Treatment||None (Open Label)||||||
1454891|NCT01574755|||Cohort||Retrospective|||||||
1454892|NCT01574742||Single Group Assignment||Treatment||None (Open Label)||||||
1454893|NCT01574729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454894|NCT01574716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454895|NCT01574703|Randomized|Single Group Assignment||||None (Open Label)||||||
1454896|NCT01574690|||Cohort||Prospective|||||||
1454897|NCT01574677|||Case-Only||Prospective|||||||
1454898|NCT01574664|||Cohort||Prospective|||||||
1454899|NCT01574651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454900|NCT01574638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454901|NCT01574625|||Case-Control||Prospective|||||||
1454902|NCT01574612||Single Group Assignment||Treatment||None (Open Label)||||||
1454903|NCT01574599|Randomized|Crossover Assignment||Treatment||Single||||||t
1454904|NCT01574586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454905|NCT01574573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454906|NCT01574560|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1454907|NCT01574547|||Case Control||Prospective|||||||
1454908|NCT01574534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454909|NCT01574521|||Case Control||Prospective|||||||
1454910|NCT01574508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454911|NCT01574495|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1454912|NCT01574482|Randomized|Parallel Assignment||||Double|||t||t|
1454913|NCT01574469|Randomized|Parallel Assignment||||Double|||t||t|
1454914|NCT01574456|||Case Control||Prospective|||||||
1454915|NCT01574443|||Case-Only||Prospective|||||||
1454916|NCT01574430|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1454917|NCT01574417|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1454918|NCT01574404||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454919|NCT01574391|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454920|NCT01574378|Randomized|Parallel Assignment||Treatment||Single||||||t
1454921|NCT01574365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454922|NCT01574352|Randomized|Parallel Assignment||Prevention||Single|||||t|
1454923|NCT01574339||Single Group Assignment||Treatment||None (Open Label)||||||
1454924|NCT01574326|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1454925|NCT01574313|Randomized|Parallel Assignment||Treatment||Single||||||t
1454926|NCT01574300|||Other||Prospective|||||||
1454927|NCT01574287||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454928|NCT01574274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454929|NCT01574261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454930|NCT01574248|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454931|NCT01574235|||Cohort||Prospective|||||||
1454932|NCT01574222||Single Group Assignment||Treatment||None (Open Label)|No masking|||||
1454933|NCT01574209|||Case Control||Prospective|||||||
1454934|NCT01574196|||Cohort||Prospective|||||||
1454935|NCT01574183|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454936|NCT01574170||Single Group Assignment||Other||None (Open Label)||||||
1454937|NCT01574157|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1454938|NCT01574144|||Cohort||Prospective|||||||
1454939|NCT01574131|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1454940|NCT01574118|Randomized|Single Group Assignment||Treatment||Single||||||t
1454941|NCT01574105|||Cohort||Prospective|||||||
1454942|NCT01574092||Single Group Assignment||Treatment||None (Open Label)||||||
1454943|NCT01574079|Randomized|Parallel Assignment||Treatment||Single|||||t|
1454944|NCT01574066||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454945|NCT01574053|||Other||Prospective|||||||
1454946|NCT01574040||Single Group Assignment||Prevention||None (Open Label)||||||
1454947|NCT01574027|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1454948|NCT01574014|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454949|NCT01574001|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1454950|NCT01573988|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1454951|NCT01573975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454952|NCT01573962|||Cohort||Prospective|||||||
1454953|NCT01573949||Single Group Assignment||Treatment||None (Open Label)||||||
1454954|NCT01573936||Single Group Assignment||Treatment||None (Open Label)||||||
1454955|NCT01573923|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454956|NCT01573910|Randomized|Parallel Assignment||Treatment||Single||||||t
1454957|NCT01573897|||Cohort||Cross-Sectional|||||||
1454958|NCT01573884|||Case-Only||Prospective|||||||
1454959|NCT01573871||Single Group Assignment||Treatment||None (Open Label)||||||
1454960|NCT01573858|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454961|NCT01573845|Randomized|Parallel Assignment||||None (Open Label)||||||
1454962|NCT01573832|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1454963|NCT01573819|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1454964|NCT01573806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454965|NCT01573793|Randomized|Parallel Assignment||||Single|||t|||
1454966|NCT01573780||Single Group Assignment||Treatment||None (Open Label)||||||
1454967|NCT01573767|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454968|NCT01573754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454969|NCT01573741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1454970|NCT01573728|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1454971|NCT01573715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454972|NCT01573702||Single Group Assignment||Treatment||None (Open Label)||For all patients, all sites of progressive disease will be treated with local ablation (primarily stereotactic radiosurgery) followed by the EGFR-TKI erlotinib until disease progression.||||
1454973|NCT01573689||Single Group Assignment||Supportive Care||None (Open Label)||||||
1454974|NCT01573676|||Case-Only||Prospective|||||||
1454975|NCT01573663|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1454976|NCT01573650|||Case-Control||Prospective|||||||
1454977|NCT01573637|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454978|NCT01573624|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1454979|NCT01573611|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1454980|NCT01573598|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1454981|NCT01573585|Randomized|Parallel Assignment||Treatment||Single||||||t
1454982|NCT01573572||Single Group Assignment||Other||None (Open Label)||||||
1454983|NCT01573559|||||Cross-Sectional|||||||
1454984|NCT01573546|Randomized|Parallel Assignment||Treatment||Single||||||t
1454985|NCT01573533||Single Group Assignment||Treatment||None (Open Label)||||||
1454986|NCT01573520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454987|NCT01573507||Single Group Assignment||Treatment||None (Open Label)||Hypertonic lactate||||
1454988|NCT01573494||Single Group Assignment||Diagnostic||None (Open Label)||||||
1454989|NCT01573481|Randomized|Parallel Assignment||Treatment||Single|||t|||
1454990|NCT01573468|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1454991|NCT01573442|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1454992|NCT01573429|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1454993|NCT01573416|Randomized|Parallel Assignment||Prevention||Single||||||t
1454994|NCT01573403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1454995|NCT01573390|||Other||Prospective|||||||
1454996|NCT01573377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1454997|NCT01573364|||Cohort||Prospective|||||||
1454998|NCT01573351||Single Group Assignment||Treatment||None (Open Label)||||||
1454999|NCT01573338||Single Group Assignment||Treatment||None (Open Label)||||||
1455000|NCT01573325||||||||||||
1455001|NCT01573312|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1455002|NCT01573299|Randomized|Parallel Assignment||||None (Open Label)||||||
1455003|NCT01573286|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455004|NCT01573273|Randomized|Parallel Assignment||Other||Double|||t||t|
1455005|NCT01573260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455006|NCT01573247||Single Group Assignment||Treatment||None (Open Label)||||||
1455007|NCT01573234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455008|NCT01573221|||Cohort||Prospective|||||||
1455009|NCT01573208||Single Group Assignment||Treatment||None (Open Label)||||||
1455010|NCT01573195|||||Retrospective|||||||
1455011|NCT01573182||Single Group Assignment||Prevention||None (Open Label)||||||
1455012|NCT01573169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455013|NCT01573156||Single Group Assignment||Treatment||None (Open Label)||||||
1455014|NCT01573143|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1455015|NCT01573130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455016|NCT01573117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455017|NCT01573104|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1455018|NCT01573091|||Cohort||Prospective|||||||
1455019|NCT01573078|||Other||Cross-Sectional|||||||
1455020|NCT01573065||Single Group Assignment||Prevention||None (Open Label)||||||
1455021|NCT01573052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455022|NCT01573039|||Cohort||Prospective|||||||
1455023|NCT01573026|||Case-Only||Prospective|||||||
1455024|NCT01573013|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1455025|NCT01573000|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455026|NCT01572987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455027|NCT01572974|||Case-Only||Prospective|||||||
1455028|NCT01572961|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1455029|NCT01572948|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1455030|NCT01572935|||||Cross-Sectional|||||||
1455031|NCT01572922||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455032|NCT01572909|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1455033|NCT01572896|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455034|NCT01572883|||Cohort||Prospective|||||||
1455035|NCT01572870|||Cohort||Prospective|||||||
1455036|NCT01572857|||Other||Prospective|||||||
1455037|NCT01572844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1455038|NCT01572831|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1455039|NCT01572818|Randomized|Parallel Assignment||Treatment||Single|||||t|
1455040|NCT01572805|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1455041|NCT01572792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455042|NCT01572779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455043|NCT01572766|Randomized|Parallel Assignment||Prevention||Single|||t|||
1455044|NCT01572753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455045|NCT01572740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455046|NCT01572727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455047|NCT01572714|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455048|NCT01572701||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455049|NCT01572688||Single Group Assignment||Treatment||None (Open Label)||||||
1455050|NCT01572675|||Cohort||Prospective|||||||
1455051|NCT01572662||Single Group Assignment||Treatment||None (Open Label)||||||
1455052|NCT01572649|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455053|NCT01572636|||Cohort||Prospective|||||||
1455054|NCT01572623|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1455055|NCT01572610||Single Group Assignment||Treatment||None (Open Label)||||||
1455056|NCT01572597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455057|NCT01572584|||Case-Only||Prospective|||||||
1455058|NCT01572571|||Case-Only||Prospective|||||||
1455059|NCT01572558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455060|NCT01572545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455061|NCT01572532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455062|NCT01572519||Single Group Assignment||Treatment||None (Open Label)||||||
1455063|NCT01572506|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1455064|NCT01572493|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1455065|NCT01572480||Single Group Assignment||Treatment||None (Open Label)||||||
1455066|NCT01572467|||Case-Only||Retrospective|||||||
1455067|NCT01572454|Randomized|Parallel Assignment||||Single|||t|||
1455068|NCT01572441|||Cohort||Prospective|||||||
1455069|NCT01572428|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455070|NCT01572415|||Cohort||Prospective|||||||
1455071|NCT01572402|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1455072|NCT01572389|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1455073|NCT01572376|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1455074|NCT01572363||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455075|NCT01572350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455076|NCT01572337|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455077|NCT01572324||Single Group Assignment||Treatment||None (Open Label)||||||
1455078|NCT01572311|Randomized|Parallel Assignment||Prevention||Single||||||t
1455079|NCT01572298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455080|NCT01572285|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455081|NCT01572272|||Cohort||Prospective|||||||
1455082|NCT01572259|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1455083|NCT01572246|||Cohort||Prospective|||||||
1455084|NCT01572233|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455085|NCT01572220|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455086|NCT01572207|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455087|NCT01572194||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455088|NCT01572181||Single Group Assignment||Treatment||None (Open Label)||||||
1455089|NCT01572168||Single Group Assignment||Supportive Care||None (Open Label)||||||
1455090|NCT01572155|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1455091|NCT01572142|||Case-Only||Cross-Sectional|||||||
1455092|NCT01572129|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1455093|NCT01572116|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1455094|NCT01572103|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1455095|NCT01572090|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1455096|NCT01572077||Single Group Assignment||Basic Science||None (Open Label)||||||
1455097|NCT01572064||Single Group Assignment||Diagnostic||Single||||||t
1455098|NCT01572051|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1455099|NCT01572038||Single Group Assignment||Treatment||None (Open Label)||||||
1455100|NCT01572025|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455101|NCT01572012|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455102|NCT01571999|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1455103|NCT01571986|||Other||Prospective|||||||
1455104|NCT01571973|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455105|NCT01571960|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1455106|NCT01571947|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1455107|NCT01571934|||Cohort||Prospective|||||||
1455108|NCT01571921|Randomized|Crossover Assignment||Treatment||Single|||t|||
1455109|NCT01571908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455110|NCT01571895||Single Group Assignment||Treatment||None (Open Label)||||||
1455111|NCT01571882|Randomized|Parallel Assignment||||Double|||t||t|
1455112|NCT01571869|Randomized|Crossover Assignment||||Single|||t|||
1455113|NCT01571856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455114|NCT01571843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455115|NCT01571830|||||Prospective|||||||
1455116|NCT01571817||Single Group Assignment||Treatment||None (Open Label)||||||
1455117|NCT01571804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455118|NCT01571791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455119|NCT01571778|Randomized|Single Group Assignment||Prevention||Single||||||t
1455120|NCT01571765|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1455121|NCT01571752|||||Other|||||||
1455122|NCT01571739|||||Prospective|||||||
1455123|NCT01571726|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1455124|NCT01571713|||Case-Only||Prospective|||||||
1455125|NCT01571700|||Case-Control||Other|||||||
1455126|NCT01571687|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1455127|NCT01571674|Randomized|Parallel Assignment||Treatment||Single||||||t
1455128|NCT01571661|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1455129|NCT01571648||Single Group Assignment||Treatment||None (Open Label)||||||
1455130|NCT01571635|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455131|NCT01571622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455132|NCT01571609|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1455133|NCT01571596||Single Group Assignment||Treatment||None (Open Label)||||||
1455134|NCT01571583||Single Group Assignment||Treatment||None (Open Label)||||||
1455135|NCT01571570|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455136|NCT01571557|||Cohort||Prospective|||||||
1455137|NCT01571544|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455138|NCT01571531|||Other||Prospective|||||||
1455139|NCT01571518|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455140|NCT01571505|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1455141|NCT01571492|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1455142|NCT01571479|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455143|NCT01571466|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1455144|NCT01571453|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455145|NCT01571440|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1455146|NCT01571427|Randomized|Parallel Assignment||Prevention||Single|||||t|
1455147|NCT01571414|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455148|NCT01571401|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1455149|NCT01571388|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1455150|NCT01571375|||Case-Control||Prospective|||||||
1455151|NCT01571362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455152|NCT01571349|||Case-Only||Prospective|||||||
1455153|NCT01571336|||Case-Only||Prospective|||||||
1455154|NCT01571323|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1455155|NCT01571310|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1455156|NCT01571297|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455157|NCT01571284||Single Group Assignment||Treatment||None (Open Label)||||||
1455158|NCT01571271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455159|NCT01571258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455160|NCT01571245|||Cohort||Prospective|||||||
1455161|NCT01571232|Randomized|Parallel Assignment||Treatment||Single||||||t
1455162|NCT01571219||Single Group Assignment||Treatment||None (Open Label)||||||
1455163|NCT01571206||Single Group Assignment||Treatment||None (Open Label)||||||
1455164|NCT01571180|||Cohort||Prospective|||||||
1455165|NCT01571167|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1455166|NCT01571141||||||||||||
1455167|NCT01571128|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455168|NCT01571115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455169|NCT01571102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455170|NCT01571089||Single Group Assignment||Treatment||None (Open Label)||||||
1455171|NCT01571076|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455172|NCT01571063|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1455173|NCT01571050|Randomized|Crossover Assignment||Prevention||Single|||||t|
1455174|NCT01571037|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455175|NCT01571024||Single Group Assignment||Treatment||None (Open Label)||||||
1455176|NCT01571011|Randomized|Crossover Assignment||Prevention||Single||||||t
1455177|NCT01570998||Single Group Assignment||Treatment||None (Open Label)||||||
1455178|NCT01570985|Randomized|Parallel Assignment||Treatment||Single||||||t
1455179|NCT01570972||Single Group Assignment||Treatment||None (Open Label)||||||
1455180|NCT01570959|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455181|NCT01570946|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455182|NCT01570933|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455183|NCT01570920||Single Group Assignment||Supportive Care||Single||||||t
1455184|NCT01570907|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455185|NCT01570894|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455186|NCT01570881|||Cohort||Prospective|||||||
1455187|NCT01570868||Single Group Assignment||Treatment||None (Open Label)||||||
1455188|NCT01570855|||Cohort||Prospective|||||||
1455189|NCT01570842||Single Group Assignment||Basic Science||None (Open Label)||||||
1455190|NCT01570829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455191|NCT01570816||Single Group Assignment||Treatment||None (Open Label)||||||
1455192|NCT01570803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455193|NCT01570790|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455194|NCT01570777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455195|NCT01570764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455196|NCT01570751|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455197|NCT01570738|||Other||Prospective|||||||
1455198|NCT01570725|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1455199|NCT01570712|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1455200|NCT01570699|||Case Control||Cross-Sectional|||||||
1455201|NCT01570686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455202|NCT01570673|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455203|NCT01570660||Single Group Assignment||Basic Science||None (Open Label)||||||
1455204|NCT01570647|||Cohort||Cross-Sectional|||||||
1455205|NCT01570634||Single Group Assignment||Treatment||None (Open Label)||||||
1455206|NCT01570621||Single Group Assignment||Treatment||None (Open Label)||||||
1455207|NCT01570608|Randomized|Parallel Assignment||Treatment||Single||||||t
1455208|NCT01570595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455209|NCT01570582||Single Group Assignment||Treatment||None (Open Label)||||||
1455210|NCT01570569|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1455211|NCT01570556|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1455212|NCT01570543|||Case-Only||Cross-Sectional|||||||
1455213|NCT01570530|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455214|NCT01570517||Single Group Assignment||Treatment||None (Open Label)||||||
1455215|NCT01570504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455216|NCT01570491|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1455217|NCT01570478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455218|NCT01570465|||Case-Only||Prospective|||||||
1455219|NCT01570452|||Case Control||Prospective|||||||
1455220|NCT01570439|||Cohort||Prospective|||||||
1455221|NCT01570426|||Case-Control||Cross-Sectional|||||||
1455222|NCT01570413|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1455223|NCT01570400|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455224|NCT01570387||Single Group Assignment||Treatment||None (Open Label)||||||
1455225|NCT01570374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455226|NCT01570361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455227|NCT01570348||Single Group Assignment||Treatment||None (Open Label)||||||
1455228|NCT01570335|||Cohort||Cross-Sectional|||||||
1455229|NCT01570322|||Cohort||Prospective|||||||
1455230|NCT01570309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455231|NCT01570296||Single Group Assignment||Treatment||None (Open Label)||||||
1455232|NCT01570283||Single Group Assignment||Treatment||None (Open Label)||||||
1455233|NCT01570270||Single Group Assignment||Treatment||Single|||t|||
1455234|NCT01570257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455235|NCT01570244|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455236|NCT01570231|Randomized|Parallel Assignment||Prevention||Single|||||t|
1455237|NCT01570218|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1455238|NCT01570205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455239|NCT01570192|Randomized|Parallel Assignment||Treatment||Double|This is an open-label study with 1:1 randomization between two active treatment groups.||t||t|
1455240|NCT01570179|Randomized|Parallel Assignment||Treatment||Double||||t||t
1455241|NCT01570166|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1455242|NCT01570153|||Cohort||Prospective|||||||
1455243|NCT01570140|||Cohort||Prospective|||||||
1455244|NCT01570127|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455245|NCT01570114|||Cohort||Retrospective|||||||
1455246|NCT01570101||Single Group Assignment||Treatment||None (Open Label)||||||
1455247|NCT01570088|Randomized|Parallel Assignment||||Double|||t||t|
1455248|NCT01570075|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1455249|NCT01570062|Randomized|Crossover Assignment||Prevention||Single|||t|||
1455250|NCT01570049||Single Group Assignment||Treatment||None (Open Label)||||||
1455251|NCT01570036|Randomized|Parallel Assignment||Prevention||Single|||t|||
1455252|NCT01570023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455253|NCT01570010|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1455254|NCT01569997|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455255|NCT01569984||Single Group Assignment||Treatment||None (Open Label)||||||
1455256|NCT01569971|||Cohort||Prospective|||||||
1455257|NCT01569958|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455258|NCT01569945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455259|NCT01569932|||Cohort||Prospective|||||||
1455260|NCT01569919||Single Group Assignment||Treatment||None (Open Label)||||||
1455261|NCT01569906|||Case Control||Prospective|||||||
1455262|NCT01569893|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455263|NCT01569880|||Case-Only||Prospective|||||||
1455264|NCT01569867|||Cohort||Prospective|||||||
1455265|NCT01569854|||Cohort||Prospective|||||||
1455266|NCT01569841|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455267|NCT01569828|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455268|NCT01569815||Single Group Assignment||Basic Science||None (Open Label)||||||
1455269|NCT01569802|||Cohort||Retrospective|||||||
1455270|NCT01569789|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1455271|NCT01569776|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1455272|NCT01569763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455273|NCT01569750||Single Group Assignment||Treatment||None (Open Label)||||||
1455274|NCT01569737|||Other||Prospective|||||||
1455275|NCT01569724||Single Group Assignment||Treatment||None (Open Label)||||||
1455276|NCT01569711|||||Prospective|||||||
1455277|NCT01569698|||Other||Prospective|||||||
1455278|NCT01569685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455279|NCT01569672|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1455280|NCT01569659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455281|NCT01569646|||Case-Only||Retrospective|||||||
1455282|NCT01569633|Randomized|Crossover Assignment||Treatment||Double||||t|t|
1455283|NCT01569620|Randomized|Parallel Assignment||Prevention||Single||||||t
1455284|NCT01569607|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455285|NCT01569594|||Case-Only||Prospective|||||||
1455286|NCT01569581|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1455287|NCT01569568|||Cohort||Prospective|||||||
1455288|NCT01569555|||Case Control||Prospective|||||||
1455289|NCT01569542|||Case Control||Prospective|||||||
1455290|NCT01569529|||Case-Control||Cross-Sectional|||||||
1455291|NCT01569516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455292|NCT01569503||Single Group Assignment||Treatment||None (Open Label)||||||
1455293|NCT01569490|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455294|NCT01569477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455295|NCT01569464|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455296|NCT01569451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455297|NCT01569438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455298|NCT01569425|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455299|NCT01569412||Single Group Assignment||Treatment||None (Open Label)||||||
1455300|NCT01569399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455301|NCT01569386|Randomized|Crossover Assignment||Treatment||Single||||||t
1455302|NCT01569373|||Cohort||Prospective|||||||
1455303|NCT01569360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455304|NCT01569347|||Cohort||Retrospective|||||||
1455305|NCT01569334|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1455306|NCT01569321||Single Group Assignment||||None (Open Label)||||||
1455307|NCT01569308|||Cohort||Cross-Sectional|||||||
1455308|NCT01569295|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1455309|NCT01569282|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455310|NCT01569269|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1455311|NCT01569256|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1455312|NCT01569243|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455313|NCT01569230|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1455314|NCT01569217|||Cohort||Prospective|||||||
1455315|NCT01569204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455316|NCT01569191|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455317|NCT01569178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455318|NCT01569165|Randomized|Crossover Assignment||Prevention||Single||||||t
1455319|NCT01569152|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455320|NCT01569139|||||Retrospective|||||||
1455321|NCT01569126|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1455322|NCT01569113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455323|NCT01569100|||Cohort||Prospective|||||||
1455324|NCT01569087|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455325|NCT01569074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455326|NCT01569061|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1455327|NCT01569048|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1455328|NCT01569035||Single Group Assignment||Treatment||Double|||t||t|
1455329|NCT01569022|Randomized|Crossover Assignment||Treatment||None (Open Label)||randomized trial||||
1455330|NCT01569009|||Cohort||Cross-Sectional|||||||
1455331|NCT01568996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455332|NCT01568983|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1455333|NCT01568970|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455334|NCT01568957|Randomized|Parallel Assignment||Treatment||Single||||||t
1455335|NCT01568944|Randomized|Parallel Assignment||||Single||||t||
1455336|NCT01568931|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455337|NCT01568918|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1455338|NCT01568905|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1455339|NCT01568892|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1455340|NCT01568879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455341|NCT01568866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455342|NCT01568853||Single Group Assignment||Screening||None (Open Label)||||||
1455343|NCT01568840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455344|NCT01568827|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1455345|NCT01568814|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1455346|NCT01568801|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1455347|NCT01568788|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455348|NCT01568775||Single Group Assignment||||None (Open Label)||||||
1455349|NCT01568762|Randomized|Parallel Assignment||||Double|||t||t|
1455350|NCT01568749|Randomized|Crossover Assignment||||Double|||t||t|
1455351|NCT01568736|||Case-Only||Prospective|||||||
1455352|NCT01568723|||Cohort||Prospective|||||||
1455353|NCT01568710|||||Prospective|||||||
1455354|NCT01568697|||Case-Control||Prospective|||||||
1455355|NCT01568684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455356|NCT01568671|||||Prospective|||||||
1455357|NCT01568658|||||Prospective|||||||
1455358|NCT01568645|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455359|NCT01568632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455360|NCT01568619|||||Prospective|||||||
1455361|NCT01568606||Single Group Assignment||Screening||None (Open Label)||||||
1455362|NCT01568593|Randomized|Parallel Assignment||Treatment||Single|||||t|
1455363|NCT01568580||Single Group Assignment||Treatment||None (Open Label)||||||
1455364|NCT01568567|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1455365|NCT01568554|||Cohort||Prospective|||||||
1455366|NCT01568541|Non-Randomized|Crossover Assignment||Prevention||Single||||||t
1455367|NCT01568528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455368|NCT01568515|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1455369|NCT01568502|||Cohort||Prospective|||||||
1455370|NCT01568489|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455371|NCT01568476|Randomized|Parallel Assignment||Other||Double|||t||t|
1455372|NCT01568463|||Other||Prospective|||||||
1455373|NCT01568450|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1455374|NCT01568437|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455375|NCT01568424||Single Group Assignment||Treatment||None (Open Label)||||||
1455376|NCT01568411|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455377|NCT01568398||||Treatment||||||||
1455378|NCT01568385||||Treatment||||||||
1455379|NCT01568372|Randomized|Parallel Assignment||Other||Single|||t|||
1455380|NCT01568359|||Case Control||Prospective|||||||
1455381|NCT01568346|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455382|NCT01568333||Single Group Assignment||Treatment||None (Open Label)||||||
1455383|NCT01568320||Single Group Assignment||Treatment||None (Open Label)||||||
1455384|NCT01568307||Single Group Assignment||Treatment||None (Open Label)||||||
1455385|NCT01568294||Single Group Assignment||Treatment||None (Open Label)||||||
1455386|NCT01568281|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455387|NCT01568268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455388|NCT01568255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455389|NCT01568242||Single Group Assignment||Basic Science||None (Open Label)||||||
1455390|NCT01568229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455391|NCT01568216|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455392|NCT01568203|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1455393|NCT01568190||Single Group Assignment||Treatment||None (Open Label)||||||
1455394|NCT01568177|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455395|NCT01568164||Single Group Assignment||Treatment||None (Open Label)||||||
1455396|NCT01568151|Randomized|Parallel Assignment||Screening||Single||||||t
1455397|NCT01568138||Single Group Assignment||Treatment||None (Open Label)||||||
1455398|NCT01568125|||Cohort||Prospective|||||||
1455399|NCT01568112|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1455400|NCT01568099|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455401|NCT01568086|||Cohort||Prospective|||||||
1455402|NCT01568073|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455403|NCT01568060|||Cohort||Prospective|||||||
1455404|NCT01568047|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455405|NCT01568034|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1455406|NCT01568021|||Cohort||Prospective|||||||
1455407|NCT01568008|||Cohort||Prospective|||||||
1455408|NCT01567995|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455409|NCT01567982||Single Group Assignment||Basic Science||Single|||t|||
1455410|NCT01567969|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1455411|NCT01567956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455412|NCT01567943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455413|NCT01567930||Single Group Assignment||Treatment||None (Open Label)||||||
1455414|NCT01567917|||Cohort||Prospective|||||||
1455415|NCT01567904|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1455416|NCT01567891||Single Group Assignment||Treatment||None (Open Label)||||||
1455417|NCT01567878||||||||||||
1455418|NCT01567865|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1455419|NCT01567852|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1455420|NCT01567839|Randomized|Crossover Assignment||||Triple|||t||t|t
1455421|NCT01567826|Randomized|Parallel Assignment||Treatment||Single|||||t|
1455422|NCT01567813|||Cohort||Retrospective|||||||
1455423|NCT01567800||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455424|NCT01567787|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455425|NCT01567774|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1455426|NCT01567761|||||Prospective|||||||
1455427|NCT01567748|||Case-Only||Prospective|||||||
1455428|NCT01567735||Single Group Assignment||Treatment||None (Open Label)||||||
1455429|NCT01567722|||Cohort||Prospective|||||||
1455430|NCT01567709||Single Group Assignment||Treatment||None (Open Label)||||||
1455431|NCT01567696|||Case-Only||Prospective|||||||
1455432|NCT01567683||||||||||||
1455433|NCT01567670|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1455434|NCT01567657|Randomized|Single Group Assignment||||Single|||t|||
1455435|NCT01567644||Single Group Assignment||Treatment||None (Open Label)||||||
1455436|NCT01567631|Randomized|Parallel Assignment||Treatment||Single||||||t
1455437|NCT01567618||Single Group Assignment||Treatment||None (Open Label)||||||
1455438|NCT01567605|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1455439|NCT01567592||Single Group Assignment||Treatment||None (Open Label)||||||
1455440|NCT01567579|||Case-Only||Prospective|||||||
1455441|NCT01567566|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455442|NCT01567553|||Cohort||Prospective|||||||
1455443|NCT01567540||Single Group Assignment||Treatment||None (Open Label)||||||
1455444|NCT01567527|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455445|NCT01567514|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455446|NCT01567501|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455447|NCT01567488||Single Group Assignment||Treatment||None (Open Label)||||||
1455448|NCT01567475||Single Group Assignment||Treatment||None (Open Label)||||||
1455449|NCT01567462|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455450|NCT01567449|||Case Control||Retrospective|||||||
1455451|NCT01567436||Single Group Assignment||Prevention||None (Open Label)||||||
1455452|NCT01567423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455453|NCT01567410|Randomized|Factorial Assignment||||Single|||t|||
1455454|NCT01567397|||Cohort||Prospective|||||||
1455455|NCT01567384||Single Group Assignment||Treatment||None (Open Label)||||||
1455456|NCT01567371||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455457|NCT01567358|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455458|NCT01567345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455459|NCT01567332|Randomized|Crossover Assignment||||Double|||t||t|
1455460|NCT01567319|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1455461|NCT01567306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455462|NCT01567280|||Cohort||Prospective|||||||
1455463|NCT01567267|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1455464|NCT01567254|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1455465|NCT01567241|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1455466|NCT01567228|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1455467|NCT01567215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455468|NCT01567202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455469|NCT01567189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455470|NCT01567176||Single Group Assignment||Basic Science||None (Open Label)||||||
1455471|NCT01567163||Single Group Assignment||Treatment||None (Open Label)||||||
1455472|NCT01567150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455473|NCT01567137|||Case-Only||Prospective|||||||
1455474|NCT01567124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455475|NCT01567111||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455476|NCT01567098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455477|NCT01567085||Single Group Assignment||Treatment||None (Open Label)||||||
1455478|NCT01567072|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455479|NCT01567059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455480|NCT01567046|||Cohort||Retrospective|||||||
1455481|NCT01567033||Single Group Assignment||Prevention||None (Open Label)||||||
1455482|NCT01567020|||Case Control||Prospective|||||||
1455483|NCT01567007|Randomized|Parallel Assignment||||None (Open Label)||||||
1455484|NCT01566994|Randomized|Factorial Assignment||Prevention||Single|||||t|
1455485|NCT01566981|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455486|NCT01566968|||Cohort||Prospective|||||||
1455487|NCT01566955||Single Group Assignment||Treatment||None (Open Label)||||||
1455488|NCT01566942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455489|NCT01566929|Randomized|Parallel Assignment||Treatment||Single||||||t
1455490|NCT01566916||||Treatment||||||||
1455491|NCT01566903|||Case-Control||Prospective|||||||
1455492|NCT01566890|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1455493|NCT01566877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455494|NCT01566864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455495|NCT01566851|||Cohort||Retrospective|||||||
1455496|NCT01566838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455497|NCT01566825|Randomized|Parallel Assignment||||Triple|||t||t|t
1455498|NCT01566812|Randomized|Parallel Assignment||Prevention||Single||||||t
1455499|NCT01566799||Single Group Assignment||Treatment||Double|||t||t|
1455500|NCT01566786|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455501|NCT01566773|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1455502|NCT01566760|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1455503|NCT01566747||Single Group Assignment||Treatment||None (Open Label)||||||
1455504|NCT01566734|Randomized|Parallel Assignment||Prevention||Single|||t|||
1455505|NCT01566721|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455506|NCT01566708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455507|NCT01566695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455508|NCT01566682|||Case-Only||Prospective|||||||
1455509|NCT01566669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455510|NCT01566656||Single Group Assignment||Treatment||None (Open Label)||||||
1455511|NCT01566643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455512|NCT01566630|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455513|NCT01566617|Randomized|Parallel Assignment||||Double|||t|t||
1455514|NCT01566604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455515|NCT01566591|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455516|NCT01566578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455517|NCT01566565|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455518|NCT01566552||Single Group Assignment||Treatment||None (Open Label)||||||
1455519|NCT01566539|Randomized|Factorial Assignment||Basic Science||Triple|||t|t|t|
1455520|NCT01566526|||Cohort||Retrospective|||||||
1455521|NCT01566513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455522|NCT01566500|||||Cross-Sectional|||||||
1455523|NCT01566487|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455524|NCT01566474|Randomized|Parallel Assignment||Prevention||Single||||||t
1455525|NCT01566461|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455526|NCT01566448||Single Group Assignment||Treatment||None (Open Label)||||||
1455527|NCT01566435||Single Group Assignment||Treatment||None (Open Label)||||||
1455528|NCT01566422|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455529|NCT01566409|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455530|NCT01566396||Single Group Assignment||Treatment||None (Open Label)||||||
1455531|NCT01566383||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455532|NCT01566370|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455533|NCT01566357|Randomized|Crossover Assignment||||Single||||||t
1455534|NCT01566344|Randomized|Parallel Assignment||Treatment||Single||||||t
1455535|NCT01566331|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1455536|NCT01566318|Randomized|Parallel Assignment||Prevention||Single||||||t
1455537|NCT01566305|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1455538|NCT01566292|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1455539|NCT01566279||Single Group Assignment||Other||None (Open Label)||||||
1455540|NCT01566266|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1455541|NCT01566253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455542|NCT01566240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455543|NCT01566227||Single Group Assignment||Treatment||Single|||t|||
1455544|NCT01566214|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1455545|NCT01566201|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1455546|NCT01566188|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1455547|NCT01566175||Single Group Assignment||Treatment||None (Open Label)||||||
1455548|NCT01566162||Single Group Assignment||Treatment||None (Open Label)||||||
1455549|NCT01566149|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455550|NCT01566136|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1455551|NCT01566123||Single Group Assignment||Treatment||None (Open Label)||||||
1455552|NCT01566110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455553|NCT01566097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455554|NCT01566084|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1455555|NCT01566071||Single Group Assignment||Diagnostic||||||||
1455556|NCT01566058|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455557|NCT01566045|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1455558|NCT01566032|||Cohort||Prospective|||||||
1455559|NCT01566019||Single Group Assignment||||None (Open Label)||||||
1455560|NCT01566006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455561|NCT01565993|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455562|NCT01565980|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1455563|NCT01565967|||Cohort||Prospective|||||||
1455564|NCT01565954|||Cohort||Prospective|||||||
1455565|NCT01565941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455566|NCT01565928||||Treatment||None (Open Label)||||||
1455567|NCT01565915|Randomized|Parallel Assignment||Treatment||Single||||||t
1455568|NCT01565902|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1455569|NCT01565889|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455570|NCT01565876||Single Group Assignment||Basic Science||None (Open Label)||||||
1455571|NCT01565863|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455572|NCT01565850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455573|NCT01565837||Single Group Assignment||Treatment||None (Open Label)||||||
1455574|NCT01565824|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455575|NCT01565811|||Case-Only||Prospective|||||||
1455576|NCT01565798|Randomized|Single Group Assignment||Prevention||Single||||||t
1455577|NCT01565785|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455578|NCT01565772||Single Group Assignment||Treatment||None (Open Label)||||||
1455579|NCT01565759||Single Group Assignment||Basic Science||None (Open Label)||||||
1455580|NCT01565746|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455581|NCT01565733|||Cohort||Prospective|||||||
1455582|NCT01565720|Randomized|Parallel Assignment||||Double|||t||t|
1455583|NCT01565707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455584|NCT01565694||Single Group Assignment||Treatment||None (Open Label)||||||
1455585|NCT01565681|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1455586|NCT01565668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455587|NCT01565655|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1455588|NCT01565642|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1455589|NCT01565629|Randomized|Parallel Assignment||Treatment||Single||||||t
1455590|NCT01565616||Single Group Assignment||Treatment||None (Open Label)||||||
1455591|NCT01565603|||Case-Only||Cross-Sectional|||||||
1455592|NCT01565590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455593|NCT01565577||Single Group Assignment||Health Services Research||None (Open Label)||||||
1455594|NCT01565564|Randomized|Parallel Assignment||Prevention||Single|||t|||
1455595|NCT01565551|||Cohort||Prospective|||||||
1455596|NCT01565538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455597|NCT01565525|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1455598|NCT01565512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455599|NCT01565499||Single Group Assignment||Treatment||None (Open Label)||||||
1455600|NCT01565486|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455601|NCT01565473|||Case Control||Cross-Sectional|||||||
1455602|NCT01565460|||Cohort||Prospective|||||||
1455603|NCT01565447|||||Cross-Sectional|||||||
1455604|NCT01565434||||Screening||||||||
1455605|NCT01565421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455606|NCT01565408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455607|NCT01565395|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1455608|NCT01565382||Single Group Assignment||Diagnostic||Single||||||t
1455609|NCT01565369||Single Group Assignment||Diagnostic||Single||||||t
1455610|NCT01565356||Single Group Assignment||Diagnostic||Single||||||t
1455611|NCT01565343|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1455612|NCT01565330|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1455613|NCT01565317|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1455614|NCT01565304|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455615|NCT01565291|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455616|NCT01565278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455617|NCT01565265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455618|NCT01565252|Non-Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1455619|NCT01565239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455620|NCT01565226|||Case-Only||Prospective|||||||
1455621|NCT01565213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455622|NCT01565200||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455623|NCT01565187|||Cohort||Prospective|||||||
1455624|NCT01565174|||Cohort||Cross-Sectional|||||||
1455625|NCT01565161|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455626|NCT01565148|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1455627|NCT01565135|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1455628|NCT01565122|||Cohort||Prospective|||||||
1455629|NCT01565109|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455630|NCT01565096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455631|NCT01565083|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455632|NCT01565070|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1455633|NCT01565057||Crossover Assignment||Basic Science||None (Open Label)||||||
1455634|NCT01565044|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1455635|NCT01565031|||Cohort||Prospective|||||||
1455636|NCT01565018|Randomized|Crossover Assignment||||None (Open Label)||||||
1455637|NCT01565005|||Case-Control||Prospective|||||||
1455638|NCT01564992|||Cohort||Prospective|||||||
1455639|NCT01564979|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1455640|NCT01564966|||Cohort||Prospective|||||||
1455641|NCT01564953|||||Cross-Sectional|||||||
1455642|NCT01564940||||||||||||
1455643|NCT01564927|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455644|NCT01564914||Single Group Assignment||Treatment||None (Open Label)||||||
1455645|NCT01564901|||Cohort||Prospective|||||||
1455646|NCT01564888|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455647|NCT01564875|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1455648|NCT01564862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455649|NCT01564849|||Case Control||Prospective|||||||
1455650|NCT01564836||Single Group Assignment||Treatment||None (Open Label)||||||
1455651|NCT01564823|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455652|NCT01564810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455653|NCT01564797|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455654|NCT01564784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455655|NCT01564771|||Case-Only||Prospective|||||||
1455656|NCT01564758|||Cohort||Prospective|||||||
1455657|NCT01564745||Single Group Assignment||Basic Science||None (Open Label)||||||
1455658|NCT01564732|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455659|NCT01564719|Randomized|Sequential Assignment||Treatment||Single|Assessors of metabolic syndrome indicators did not know participants' treatment group.|We used a randomized, multiple baseline design in which 3 cohorts were randomly assigned to start date, thereby creating 2 waiting cohorts. Cohort 1 immediately received the intervention; Cohort 2 waited one year and then received the intervention. Cohort 3 waited two years and then received the intervention. Data were collected from Cohorts 2 and 3 while waiting.||||t
1455660|NCT01564706||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455661|NCT01564693|||Case Control||Cross-Sectional|||||||
1455662|NCT01564680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455663|NCT01564667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455664|NCT01564654|||Case-Only||Retrospective|||||||
1455665|NCT01564641|||Cohort||Prospective|||||||
1455666|NCT01564628|||Case-Only||Cross-Sectional|||||||
1455667|NCT01564615|Randomized|Parallel Assignment||Prevention||Single||||||t
1455668|NCT01564602||Single Group Assignment||Treatment||Single||||||t
1455669|NCT01564589||||||||||||
1455670|NCT01564576|Randomized|Parallel Assignment||Treatment||Single|||||t|
1455671|NCT01564563|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455672|NCT01564550|||Case Control||Prospective|||||||
1455673|NCT01564537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455674|NCT01564524|||Case Control||Prospective|||||||
1455675|NCT01564511|Randomized|Single Group Assignment||Treatment||Single|||t|||
1455676|NCT01564498|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455677|NCT01564485|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1455678|NCT01564472|||Case-Only||Retrospective|||||||
1455679|NCT01564459|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455680|NCT01564446||Single Group Assignment||Health Services Research||None (Open Label)||||||
1455681|NCT01564433|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1455682|NCT01564420|||Case Control||Prospective|||||||
1455683|NCT01564407|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1455684|NCT01564394|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1455685|NCT01564381|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1455686|NCT01564368||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455687|NCT01564355|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455688|NCT01564342|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1455689|NCT01564329|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455690|NCT01564316|||Cohort||Retrospective|||||||
1455691|NCT01564303|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1455692|NCT01564290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455693|NCT01564277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455694|NCT01564264||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455695|NCT01564251|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455696|NCT01564238|Randomized|Crossover Assignment||Prevention||Single|||t|||
1455697|NCT01564225||Single Group Assignment||Treatment||None (Open Label)||||||
1455698|NCT01564212|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1455699|NCT01564199|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455700|NCT01564186|||Case Control||Prospective|||||||
1455701|NCT01564173|||Case-Only||Cross-Sectional|||||||
1455702|NCT01564160|Randomized|Crossover Assignment||||Double|||t|||t
1455703|NCT01564147|Randomized|Parallel Assignment||||None (Open Label)||||||
1455704|NCT01564134|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1455705|NCT01564121|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455706|NCT01564108||Single Group Assignment||Treatment||None (Open Label)||||||
1455707|NCT01564095|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455708|NCT01564082|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455709|NCT01564069|||Cohort||Cross-Sectional|||||||
1455710|NCT01564056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455711|NCT01564043||Single Group Assignment||Treatment||None (Open Label)||||||
1455712|NCT01564030|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1455713|NCT01564017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455714|NCT01564004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455715|NCT01563991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455716|NCT01563978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455717|NCT01563965|Randomized|Parallel Assignment||Treatment||Double||||t||t
1455718|NCT01563952|Randomized|Parallel Assignment||Treatment||Single|||||t|
1455719|NCT01563939|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1455720|NCT01563926|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455721|NCT01563913|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1455722|NCT01563900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455723|NCT01563887|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1455724|NCT01563874|||Case-Only||Retrospective|||||||
1455725|NCT01563861|||Other||Retrospective|||||||
1455726|NCT01563848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455727|NCT01563835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455728|NCT01563822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455729|NCT01563809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455730|NCT01563796|||Case Control||Prospective|||||||
1455731|NCT01563783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455732|NCT01563770|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1455733|NCT01563757|||Case Control||Prospective|||||||
1455734|NCT01563744|Randomized|Parallel Assignment||Treatment||Single|||||t|
1455735|NCT01563731|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1455736|NCT01563718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455737|NCT01563705||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455738|NCT01563692|||Cohort||Prospective|||||||
1455739|NCT01563679|||||Prospective|||||||
1455740|NCT01563653||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455741|NCT01563640|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1455742|NCT01563627|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455743|NCT01563614||Single Group Assignment||Treatment||None (Open Label)||||||
1455744|NCT01563601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455745|NCT01563588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455746|NCT01563575|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455747|NCT01563562||Single Group Assignment||Treatment||None (Open Label)||||||
1455748|NCT01563536|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455749|NCT01563523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455750|NCT01563510|Randomized|Parallel Assignment||Treatment||Single||||||t
1455751|NCT01563497|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455752|NCT01563484|||Case Control||Prospective|||||||
1455753|NCT01563471|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455754|NCT01563458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455755|NCT01563445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455756|NCT01563432|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455757|NCT01563419|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455758|NCT01563406|Randomized|Factorial Assignment||Prevention||Double|||t|t||
1455759|NCT01563393|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455760|NCT01563380|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1455761|NCT01563367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455762|NCT01563354|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455763|NCT01563341||Single Group Assignment||Treatment||None (Open Label)||||||
1455764|NCT01563328|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1455765|NCT01563315|||Cohort||Prospective|||||||
1455766|NCT01563302||Single Group Assignment||Treatment||None (Open Label)||||||
1455767|NCT01563289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455768|NCT01563276|||Case Control||Cross-Sectional|||||||
1455769|NCT01563263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455770|NCT01563250|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1455771|NCT01563237||Single Group Assignment||Treatment||None (Open Label)||||||
1455772|NCT01563224||Crossover Assignment||Basic Science||Triple|||t||t|t
1455773|NCT01563211|||Cohort||Prospective|||||||
1455774|NCT01563198||Single Group Assignment||Health Services Research||None (Open Label)||||||
1455775|NCT01563185||Single Group Assignment||Treatment||None (Open Label)||||||
1455776|NCT01563172|Randomized|Crossover Assignment||Treatment||Single|||||t|
1455777|NCT01563159|||Ecologic or Community||Retrospective|||||||
1455778|NCT01563146|||Ecologic or Community||Retrospective|||||||
1455779|NCT01563133||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455780|NCT01563120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455781|NCT01563107|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1455782|NCT01563094|||Cohort||Prospective|||||||
1455783|NCT01563081||Single Group Assignment||Treatment||None (Open Label)||||||
1455784|NCT01563068||Single Group Assignment||Other||None (Open Label)||||||
1455785|NCT01563055||Single Group Assignment||Treatment||None (Open Label)||||||
1455786|NCT01563042|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1455787|NCT01563029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455788|NCT01563016|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455789|NCT01563003|Randomized|Parallel Assignment||Treatment||Single||||||t
1455790|NCT01562990||Single Group Assignment||Treatment||None (Open Label)||||||
1455791|NCT01562977||Single Group Assignment||Treatment||None (Open Label)||||||
1455792|NCT01562964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455793|NCT01562951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455794|NCT01562938|Randomized|Parallel Assignment||||Double|||t||t|
1455795|NCT01562925|Randomized|Parallel Assignment||Prevention||Single||||||t
1455796|NCT01562912|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455797|NCT01562899|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455798|NCT01562886||Single Group Assignment||Treatment||None (Open Label)||||||
1455799|NCT01562873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455800|NCT01562860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455801|NCT01562847|||Case Control||Prospective|||||||
1455802|NCT01562834|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455803|NCT01562821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455804|NCT01562808||Single Group Assignment||Basic Science||Single|||t|||
1455805|NCT01562795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455806|NCT01562782||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455807|NCT01562769|||Case-Crossover||Prospective|||||||
1455808|NCT01562756||Single Group Assignment||Treatment||None (Open Label)||||||
1455809|NCT01562743||Single Group Assignment||Treatment||None (Open Label)||||||
1455810|NCT01562730|||Cohort||Prospective|||||||
1455811|NCT01562717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455812|NCT01562704|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455813|NCT01562691|Randomized|Factorial Assignment||Treatment||Single|||t|||
1455814|NCT01562678|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1455815|NCT01562665|||Case-Only||Prospective|||||||
1455816|NCT01562652||Single Group Assignment||Treatment||None (Open Label)||||||
1455817|NCT01562639|||Cohort||Prospective|||||||
1455818|NCT01562626||Single Group Assignment||Treatment||None (Open Label)||||||
1455819|NCT01562613|||||Prospective|||||||
1455820|NCT01562600|||Cohort||Prospective|||||||
1455821|NCT01562587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455822|NCT01562574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455823|NCT01562561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455824|NCT01562548|Randomized|Single Group Assignment||Treatment||Single|||t|||
1455825|NCT01562535|Randomized|Parallel Assignment||Treatment||Single||||||t
1455826|NCT01562522|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455827|NCT01562509|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1455828|NCT01562496|Randomized|Parallel Assignment||Treatment||Single||||||t
1455829|NCT01562483|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1455830|NCT01562470|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1455831|NCT01562457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455832|NCT01562444||Single Group Assignment||Prevention||None (Open Label)||||||
1455833|NCT01562431|Randomized|Parallel Assignment||||None (Open Label)||||||
1455834|NCT01562418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455835|NCT01562405||Single Group Assignment||Treatment||None (Open Label)||||||
1455836|NCT01562392|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1455837|NCT01562379|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455838|NCT01562366|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1455839|NCT01562353|||Case Control||Retrospective|||||||
1455840|NCT01562340|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1455841|NCT01562327|||Cohort||Prospective|||||||
1455842|NCT01562314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455843|NCT01562301||Single Group Assignment||Treatment||None (Open Label)||||||
1455844|NCT01562288|||Case-Only||Retrospective|||||||
1455845|NCT01562275|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455846|NCT01562262|||Case Control||Cross-Sectional|||||||
1455847|NCT01562249|Randomized|Parallel Assignment||||Single|||t|||
1455848|NCT01562236|||Cohort||Prospective|||||||
1455849|NCT01562223||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455850|NCT01562210||Single Group Assignment||Treatment||None (Open Label)||||||
1455851|NCT01562197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455852|NCT01562184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455853|NCT01562171|Randomized|Parallel Assignment||||None (Open Label)||||||
1455854|NCT01562158|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455855|NCT01562145|||Case Control||Prospective|||||||
1455856|NCT01562132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455857|NCT01562119|||Case Control||Retrospective|||||||
1455858|NCT01562106||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455859|NCT01562093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455860|NCT01562080|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455861|NCT01562067|||Cohort||Prospective|||||||
1455862|NCT01562054|||Cohort||Prospective|||||||
1455863|NCT01562041||Single Group Assignment||||None (Open Label)||||||
1455864|NCT01562028||Single Group Assignment||Treatment||None (Open Label)||||||
1455865|NCT01562015||Single Group Assignment||Treatment||None (Open Label)||||||
1455866|NCT01562002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455867|NCT01561989|Randomized|Parallel Assignment||Treatment||Double||||||
1455868|NCT01561976|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1455869|NCT01561963||Single Group Assignment||||None (Open Label)||||||
1455870|NCT01561950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455871|NCT01561937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455872|NCT01561924|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1455873|NCT01561911||||||None (Open Label)||||||
1455874|NCT01561898||Single Group Assignment||Treatment||None (Open Label)||||||
1455875|NCT01561885|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1455876|NCT01561872|||Case-Only||Prospective|||||||
1455877|NCT01561859|Randomized|Parallel Assignment||Treatment||Single||||t||
1455878|NCT01561846|Randomized|Crossover Assignment||Treatment||Single|||t|||
1455879|NCT01561833||Single Group Assignment||Treatment||None (Open Label)||||||
1455880|NCT01561820|Randomized|Parallel Assignment||Prevention||Single||||||t
1455881|NCT01561807|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455882|NCT01561794||Single Group Assignment||Treatment||None (Open Label)||||||
1455883|NCT01561781|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1455884|NCT01561768|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1455885|NCT01561755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455886|NCT01561742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455887|NCT01561729||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455888|NCT01561716|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455889|NCT01561703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455890|NCT01561690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455891|NCT01561677|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1455892|NCT01561664|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1455893|NCT01561651|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1455894|NCT01561638|Randomized|Parallel Assignment||Treatment||Single|||||t|
1455895|NCT01561625||Single Group Assignment||Basic Science||None (Open Label)||||||
1455896|NCT01561612|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455897|NCT01561599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455898|NCT01561586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455899|NCT01561573||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455900|NCT01561560|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455901|NCT01561547|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1455902|NCT01561534|||Cohort||Prospective|||||||
1455903|NCT01561521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1455904|NCT01561508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455905|NCT01561495||||Treatment||||||||
1455906|NCT01561482||Single Group Assignment||Treatment||None (Open Label)||||||
1455907|NCT01561469|||Cohort||Retrospective|||||||
1455908|NCT01561456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455909|NCT01561443|||Cohort||Prospective|||||||
1455910|NCT01561430|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1455911|NCT01561417|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455912|NCT01561404||Single Group Assignment||Basic Science||None (Open Label)||||||
1455913|NCT01561391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455914|NCT01561378|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1455915|NCT01561365|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1455916|NCT01561352|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455917|NCT01561326|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1455918|NCT01561313|Randomized|Crossover Assignment||Treatment||Single|||t|||
1455919|NCT01561300|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1455920|NCT01561287|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1455921|NCT01561274|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1455922|NCT01561261||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455923|NCT01561248|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1455924|NCT01561235|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1455925|NCT01561222|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1455926|NCT01561209|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1455927|NCT01561196|Randomized|Crossover Assignment||Prevention||Single|||t|||
1455928|NCT01561183|Randomized|Parallel Assignment||Treatment||Single|||t|||
1455929|NCT01561170|||Case-Only||Retrospective|||||||
1455930|NCT01561157|||Cohort||Other|||||||
1455931|NCT01561144|||Cohort||Other|||||||
1455932|NCT01561131|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1455933|NCT01561118|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1455934|NCT01561105|Randomized|Parallel Assignment||Treatment||Single||||||t
1455935|NCT01561092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455936|NCT01561079||Single Group Assignment||Basic Science||None (Open Label)||||||
1455937|NCT01561066|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455938|NCT01561053|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1455939|NCT01561040||Single Group Assignment||Treatment||None (Open Label)||||||
1455940|NCT01561027|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1455941|NCT01561014||Single Group Assignment||Treatment||None (Open Label)||||||
1455942|NCT01561001||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455943|NCT01560988|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455944|NCT01560975||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455945|NCT01560962||||||||||||
1455946|NCT01560949||Single Group Assignment||Treatment||None (Open Label)||||||
1455947|NCT01560936|||Cohort||Prospective|||||||
1455948|NCT01560923|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1455949|NCT01560910|||Cohort||Prospective|||||||
1455950|NCT01560897||Single Group Assignment||Diagnostic||None (Open Label)||||||
1455951|NCT01560884|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1455952|NCT01560871|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1455953|NCT01560858|||Case-Only||Retrospective|||||||
1455954|NCT01560845|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455955|NCT01560832|||Cohort||Prospective|||||||
1455956|NCT01560819||Single Group Assignment||Treatment||None (Open Label)||||||
1455957|NCT01560806|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1455958|NCT01560793||Single Group Assignment||Prevention||Triple|||t|t|t|
1455959|NCT01560780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455960|NCT01560767|Randomized|Factorial Assignment||Supportive Care||Double|||t|||t
1455961|NCT01560754|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1455962|NCT01560741|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1455963|NCT01560728|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455964|NCT01560715||Single Group Assignment||Treatment||None (Open Label)||||||
1455965|NCT01560702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455966|NCT01560689|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455967|NCT01560676|Randomized|Parallel Assignment||Prevention||Single||||||t
1455968|NCT01560663|||Case-Control||Prospective|||||||
1455969|NCT01560650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455970|NCT01560637||Single Group Assignment||Treatment||None (Open Label)||||||
1455971|NCT01560624|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455972|NCT01560611|||Case-Only||Prospective|||||||
1455973|NCT01560598|||Case Control||Prospective|||||||
1455974|NCT01560585||Single Group Assignment||Treatment||None (Open Label)||||||
1455975|NCT01560572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455976|NCT01560559||Single Group Assignment||Treatment||None (Open Label)||||||
1455977|NCT01560546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1455978|NCT01560533|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1455979|NCT01560520|||Cohort||Prospective|||||||
1455980|NCT01560507|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455981|NCT01560494|Randomized|Parallel Assignment||||Single||||||t
1455982|NCT01560481|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1455983|NCT01560468||Single Group Assignment||Prevention||None (Open Label)||||||
1455984|NCT01560455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455985|NCT01560442|||||Cross-Sectional|||||||
1455986|NCT01560429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456852|NCT01549080|||Case Control||Prospective|||||||
1455987|NCT01560416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455988|NCT01560403||Single Group Assignment||Treatment||None (Open Label)||||||
1455989|NCT01560390|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1455990|NCT01560377||Single Group Assignment||Supportive Care||None (Open Label)||||||
1455991|NCT01560364|||||Prospective|||||||
1455992|NCT01560351|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1455993|NCT01560338|||Cohort||Prospective|||||||
1455994|NCT01560325||Single Group Assignment||Treatment||None (Open Label)||||||
1455995|NCT01560312|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1455996|NCT01560299|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1455997|NCT01560286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1455998|NCT01560273|||Cohort||Prospective|||||||
1455999|NCT01560260||Single Group Assignment||Treatment||None (Open Label)||||||
1456000|NCT01560247|||Cohort||Prospective|||||||
1456001|NCT01560234|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1456002|NCT01560221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456003|NCT01560208|||Case-Only||Prospective|||||||
1456004|NCT01560195|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1456005|NCT01560182||Single Group Assignment||Treatment||None (Open Label)||||||
1456006|NCT01560169|||||Prospective|||||||
1456007|NCT01560156||||||||||||
1456008|NCT01560143||Single Group Assignment||||None (Open Label)||||||
1456009|NCT01560130|Randomized|Parallel Assignment||Treatment||Single||||||t
1456010|NCT01560117||Single Group Assignment||Treatment||||||||
1456011|NCT01560104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456012|NCT01560091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456013|NCT01560078|||Cohort||Prospective|||||||
1456014|NCT01560065||||||||||||
1456015|NCT01560052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456016|NCT01560039|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456017|NCT01560026|||Cohort||Retrospective|||||||
1456018|NCT01560013||Single Group Assignment||Treatment||None (Open Label)||||||
1456019|NCT01560000|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1456020|NCT01559987|Randomized|Parallel Assignment||Basic Science||Single||||t||
1456021|NCT01559974|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456022|NCT01559961||Single Group Assignment||Treatment||None (Open Label)||||||
1456023|NCT01559948|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1456024|NCT01559935||Single Group Assignment||Treatment||None (Open Label)||||||
1456025|NCT01559922|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456026|NCT01559909||Single Group Assignment||Treatment||None (Open Label)||||||
1456027|NCT01559896||Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1456028|NCT01559883|||Cohort||Prospective|||||||
1456029|NCT01559870|||Case-Only||Prospective|||||||
1456030|NCT01559857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456031|NCT01559844||Single Group Assignment||Treatment||None (Open Label)||||||
1456032|NCT01559831||Single Group Assignment||||None (Open Label)||||||
1456033|NCT01559818||Single Group Assignment||Treatment||None (Open Label)||||||
1456034|NCT01559805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456035|NCT01559792|||Case-Only||Prospective|||||||
1456036|NCT01559779|||Case Control||Prospective|||||||
1456037|NCT01559766|||||Cross-Sectional|||||||
1456038|NCT01559753|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456039|NCT01559740|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1456040|NCT01559727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456041|NCT01559714|||Cohort||Prospective|||||||
1456042|NCT01559701||Single Group Assignment||Treatment||None (Open Label)||||||
1456043|NCT01559688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456044|NCT01559675|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456045|NCT01559662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456046|NCT01559649|||Cohort||Prospective|||||||
1456047|NCT01559636|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456048|NCT01559623|||||Retrospective|||||||
1456049|NCT01559610|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1456050|NCT01559597|Randomized|Parallel Assignment||Prevention||Single|||t|||
1456051|NCT01559584|Randomized|Parallel Assignment||Treatment||Single||||||t
1456052|NCT01559571|||Cohort||Prospective|||||||
1456053|NCT01559558|||Case-Only||Retrospective|||||||
1456054|NCT01559545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456055|NCT01559532|||Cohort||Prospective|||||||
1456056|NCT01559519||Single Group Assignment||Prevention||None (Open Label)||||||
1456057|NCT01559506|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1456058|NCT01559493|||Cohort||Prospective|||||||
1456059|NCT01559480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456060|NCT01559467|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456061|NCT01559454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456062|NCT01559441|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1456063|NCT01559428|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1456064|NCT01559415|Randomized|Parallel Assignment||Prevention||Single||||||t
1456065|NCT01559402|Randomized|Factorial Assignment||Treatment||Single|||t|||
1456066|NCT01559389||Single Group Assignment||Supportive Care||None (Open Label)||||||
1456067|NCT01559376|||Case-Control||Prospective|||||||
1456853|NCT01549067|||||Cross-Sectional|||||||
1456068|NCT01559363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456069|NCT01559350|||Case Control||Prospective|||||||
1456070|NCT01559337||Single Group Assignment||Treatment||None (Open Label)||||||
1456071|NCT01559324|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456072|NCT01559311|Randomized|Parallel Assignment||Prevention||Single||||||t
1456073|NCT01559298|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456074|NCT01559285|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1456075|NCT01559272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456076|NCT01559259|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456077|NCT01559246|||Case Control||Prospective|||||||
1456078|NCT01559233||Single Group Assignment||Treatment||None (Open Label)||||||
1456079|NCT01559220||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1456080|NCT01559207|||Cohort||Prospective|||||||
1456081|NCT01559194|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1456082|NCT01559181|||Case-Control||Prospective|||||||
1456083|NCT01559168||Single Group Assignment||Treatment||None (Open Label)||||||
1456084|NCT01559155|||Cohort||Cross-Sectional|||||||
1456085|NCT01559142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456086|NCT01559129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456087|NCT01559116|Randomized|Crossover Assignment||Treatment||Double||||||
1456088|NCT01559103|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1456089|NCT01559090|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456090|NCT01559077|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456091|NCT01559064|||Cohort||Prospective|||||||
1456092|NCT01559051||Single Group Assignment||Treatment||None (Open Label)||||||
1456093|NCT01559038|||Cohort||Prospective|||||||
1456094|NCT01559025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456095|NCT01559012|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1456096|NCT01558999|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456097|NCT01558986|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1456098|NCT01558973|||Cohort||Prospective|||||||
1456099|NCT01558960||Single Group Assignment||Treatment||None (Open Label)||||||
1456100|NCT01558947|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456101|NCT01558934||Single Group Assignment||Treatment||None (Open Label)||||||
1456102|NCT01558921|Randomized|Parallel Assignment||Treatment||Single||standard arm: 5.5 weeks chemoradiation -> surgery -> optional chemotherapy experimental arm: 5x5Gy -> 12 wks chemotherapy -> surgery||||t
1456103|NCT01558908||Single Group Assignment||Treatment||None (Open Label)||||||
1456104|NCT01558895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456105|NCT01558882|||Cohort||Prospective|||||||
1456106|NCT01558869||Single Group Assignment||Treatment||None (Open Label)||||||
1456107|NCT01558856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456108|NCT01558843|||Cohort|||||||||
1456109|NCT01558830|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456110|NCT01558817|Randomized|Parallel Assignment||||None (Open Label)||||||
1456111|NCT01558804|||Cohort||Prospective|||||||
1456112|NCT01558791|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1456113|NCT01558778||Single Group Assignment||Supportive Care||None (Open Label)||||||
1456114|NCT01558765|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456115|NCT01558752|Randomized|Factorial Assignment||Treatment||Single||||t||
1456116|NCT01558739||Single Group Assignment||Treatment||None (Open Label)||||||
1456117|NCT01558726|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1456118|NCT01558713|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1456119|NCT01558700|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1456120|NCT01558687|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1456121|NCT01558674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456122|NCT01558661||Single Group Assignment||Treatment||None (Open Label)||||||
1456123|NCT01558648|||Cohort||Prospective|||||||
1456124|NCT01558635||Single Group Assignment||Treatment||None (Open Label)||||||
1456125|NCT01558622|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1456126|NCT01558609||||||||||||
1456127|NCT01558596|Randomized|Parallel Assignment||Prevention||Single|||t|||
1456128|NCT01558583|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1456129|NCT01558570|||Case-Only||Prospective|||||||
1456130|NCT01558557||Single Group Assignment||Treatment||None (Open Label)||||||
1456131|NCT01558544||Single Group Assignment||Other||None (Open Label)||||||
1456132|NCT01558531|||Case Control||Prospective|||||||
1456133|NCT01558518|||Cohort||Prospective|||||||
1456134|NCT01558505|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456135|NCT01558492||Single Group Assignment||Treatment||None (Open Label)||||||
1456136|NCT01558479|||Family-Based||Cross-Sectional|||||||
1456137|NCT01558466|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456138|NCT01558453||Single Group Assignment||Treatment||None (Open Label)||||||
1456139|NCT01558440|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456140|NCT01558427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456141|NCT01558414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456142|NCT01558401||Single Group Assignment||Treatment||Single||||||t
1456143|NCT01558388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456144|NCT01558375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456145|NCT01558362||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456146|NCT01558349|||Cohort||Prospective|||||||
1456147|NCT01558336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456148|NCT01558323||Parallel Assignment||||None (Open Label)||||||
1456149|NCT01558310|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1456150|NCT01558297|Randomized|Parallel Assignment||Treatment||Single||||||t
1456151|NCT01558284|||Cohort||Cross-Sectional|||||||
1456152|NCT01558271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456153|NCT01558258|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1456154|NCT01558245|Randomized|Parallel Assignment||Prevention||Single|||||t|
1456155|NCT01558232||Single Group Assignment||Treatment||None (Open Label)||||||
1456156|NCT01558219||Single Group Assignment||Treatment||None (Open Label)||||||
1456157|NCT01558206|||Case-Only||Prospective|||||||
1456158|NCT01558193|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1456159|NCT01558180|Randomized|Parallel Assignment||Treatment||Single||||||t
1456160|NCT01558167||Single Group Assignment||Treatment||None (Open Label)||||||
1456161|NCT01558154|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1456162|NCT01558141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456163|NCT01558128||Single Group Assignment||Treatment||None (Open Label)||||||
1456164|NCT01558115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456165|NCT01558102|||Case-Only||Retrospective|||||||
1456166|NCT01558089|||Cohort||Prospective|||||||
1456167|NCT01558076|||Cohort||Cross-Sectional|||||||
1456168|NCT01558063|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456169|NCT01558050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456170|NCT01558037|||Cohort||Prospective|||||||
1456171|NCT01558024|||Case Control||Cross-Sectional|||||||
1456172|NCT01558011||Single Group Assignment||Treatment||None (Open Label)||||||
1456173|NCT01557998|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456174|NCT01557985||Single Group Assignment||Supportive Care||None (Open Label)||||||
1456175|NCT01557972|||Cohort||Prospective|||||||
1456176|NCT01557959||Single Group Assignment||Treatment||None (Open Label)||||||
1456177|NCT01557946|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Open-label administration of citalopram to participants with major depressive disorder. MRI scans performed at baseline and days 3, 7, and 42. An age- and gender-matched group of healthy volunteers did not receive citalopram and received on MRI scan to perform between-group baseline analyses.||||
1456178|NCT01557933|||Case-Only||Prospective|||||||
1456179|NCT01557920|Randomized|Crossover Assignment||Prevention||Single|||t|||
1456180|NCT01557907|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456181|NCT01557894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456182|NCT01557881||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456183|NCT01557868|Randomized|Parallel Assignment||||Triple|||t|t||t
1456184|NCT01557855|||Cohort||Prospective|||||||
1456185|NCT01557842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456186|NCT01557829|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456187|NCT01557816|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1456188|NCT01557803|||Cohort||Prospective|||||||
1456189|NCT01557790||||Treatment||||||||
1456190|NCT01557777|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1456191|NCT01557764||Single Group Assignment||Treatment||None (Open Label)||||||
1456192|NCT01557751||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456193|NCT01557738|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1456194|NCT01557725|||Cohort||Prospective|||||||
1456195|NCT01557712|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1456196|NCT01557699|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456197|NCT01557686||Single Group Assignment||Supportive Care||None (Open Label)||||||
1456198|NCT01557673|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1456199|NCT01557660||Single Group Assignment||Treatment||None (Open Label)||||||
1456200|NCT01557647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456201|NCT01557634|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456202|NCT01557621|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1456203|NCT01557608|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1456204|NCT01557595||Single Group Assignment||Treatment||None (Open Label)||||||
1456205|NCT01557582||Single Group Assignment||||None (Open Label)||||||
1456206|NCT01557569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456207|NCT01557556|||||Prospective|||||||
1456208|NCT01557543|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456209|NCT01557517|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456210|NCT01557504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456211|NCT01557491|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1456212|NCT01557478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456213|NCT01557465|||Cohort||Prospective|||||||
1456214|NCT01557452||Single Group Assignment||Treatment||None (Open Label)||||||
1456215|NCT01557439|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456216|NCT01557426||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456217|NCT01557413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456218|NCT01557400||Single Group Assignment||Treatment||None (Open Label)||||||
1456219|NCT01557387|||Case-Only||Prospective|||||||
1456220|NCT01557374|Randomized|Parallel Assignment||Treatment||Single||||||t
1456221|NCT01557361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456222|NCT01557348|||Cohort||Prospective|||||||
1456223|NCT01557335|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456224|NCT01557322|||Cohort||Retrospective|||||||
1456225|NCT01557309|||Case-Only||Prospective|||||||
1456226|NCT01557296|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456227|NCT01557283|||Cohort||Prospective|||||||
1456228|NCT01557270|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1456229|NCT01557257|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1456230|NCT01557244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456231|NCT01557231|||Cohort||Prospective|||||||
1456232|NCT01557218|Randomized|Crossover Assignment||||None (Open Label)||||||
1456233|NCT01557205||||||||||||
1456234|NCT01557192|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456235|NCT01557179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456236|NCT01557166|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456237|NCT01557153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456238|NCT01557140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456239|NCT01557127|||Cohort||Prospective|||||||
1456240|NCT01557114||Single Group Assignment||Treatment||None (Open Label)||||||
1456241|NCT01557101|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456242|NCT01557088||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456243|NCT01557075|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456244|NCT01557062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456245|NCT01557049|Randomized|Parallel Assignment||Treatment||Single||||||t
1456246|NCT01557036|||Case-Only||Prospective|||||||
1456247|NCT01557023|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456248|NCT01557010|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456249|NCT01556997|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456250|NCT01556984|||Case Control||Prospective|||||||
1456251|NCT01556971|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1456252|NCT01556958|||Case Control||Prospective|||||||
1456253|NCT01556945|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1456254|NCT01556932|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1456255|NCT01556919|||Case-Only||Prospective|||||||
1456256|NCT01556906||Single Group Assignment||Treatment||None (Open Label)||||||
1456257|NCT01556893||Single Group Assignment||Treatment||None (Open Label)||||||
1456258|NCT01556880|Randomized|Parallel Assignment||Prevention||Single||||t||
1456259|NCT01556867|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1456260|NCT01556854|||||Prospective|||||||
1456261|NCT01556841|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456262|NCT01556828|||||Prospective|||||||
1456263|NCT01556815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456264|NCT01556802|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456265|NCT01556789||Single Group Assignment||Treatment||None (Open Label)||||||
1456266|NCT01556776|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456267|NCT01556763|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456268|NCT01556750||||||||||||
1456269|NCT01556737|Randomized|Crossover Assignment||||Triple|||t||t|t
1456270|NCT01556724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456271|NCT01556711|||Case Control||Prospective|||||||
1456272|NCT01556698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456273|NCT01556685|Non-Randomized|||Treatment||||||||
1456274|NCT01556672||Single Group Assignment||Treatment||None (Open Label)||||||
1456275|NCT01556659|Randomized|Parallel Assignment||Treatment||Single||||||t
1456276|NCT01556646||Single Group Assignment||Treatment||None (Open Label)||||||
1456277|NCT01556633|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456278|NCT01556620|||Cohort||Prospective|||||||
1456279|NCT01556607|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1456280|NCT01556594|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456281|NCT01556581|Randomized|Parallel Assignment||Treatment||Single||||||t
1456282|NCT01556568||Single Group Assignment||Treatment||None (Open Label)||||||
1456283|NCT01556555|||Case-Only||Prospective|||||||
1456284|NCT01556542|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456285|NCT01556529|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456286|NCT01556516|||Cohort||Prospective|||||||
1456287|NCT01556503|||Cohort||Cross-Sectional|||||||
1456288|NCT01556490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456289|NCT01556477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456290|NCT01556464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456291|NCT01556451||Single Group Assignment||Prevention||None (Open Label)||||||
1456292|NCT01556438|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456293|NCT01556425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456294|NCT01556412|||Cohort||Prospective|||||||
1456295|NCT01556399|||Case-Control||Prospective|||||||
1456296|NCT01556386|||||Retrospective|||||||
1456297|NCT01556373|||Case-Control||Prospective|||||||
1456298|NCT01556360|||Cohort||Prospective|||||||
1456299|NCT01556347||Single Group Assignment||Treatment||None (Open Label)||||||
1456300|NCT01556334|Randomized|Single Group Assignment||Prevention||Single||||||t
1456301|NCT01556321|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1457251|NCT01543880|||Cohort||Retrospective|||||||
1456302|NCT01556308||Single Group Assignment||Basic Science||None (Open Label)||||||
1456303|NCT01556295|||||Cross-Sectional|||||||
1456304|NCT01556282||Single Group Assignment||Treatment||None (Open Label)||||||
1456305|NCT01556256|Randomized|Parallel Assignment||Supportive Care||Single||||||
1456306|NCT01556243||Single Group Assignment||Treatment||None (Open Label)||||||
1456307|NCT01556230|||Cohort||Prospective|||||||
1456308|NCT01556217|Randomized|Parallel Assignment||||Double|||t||t|
1456309|NCT01556204|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456310|NCT01556191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456311|NCT01556178|||Cohort||Prospective|||||||
1456312|NCT01556165|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456313|NCT01556152|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456314|NCT01556139|Randomized|Single Group Assignment||Treatment||Single|||t|||
1456315|NCT01556126||Single Group Assignment||Treatment||None (Open Label)||||||
1456316|NCT01556113|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456317|NCT01556100||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456318|NCT01556087|Randomized|Parallel Assignment||Treatment||Single||||||t
1456319|NCT01556074||Single Group Assignment||Treatment||None (Open Label)||||||
1456320|NCT01556061|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456321|NCT01556048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456322|NCT01556035||Single Group Assignment||Treatment||None (Open Label)||||||
1456323|NCT01556022|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456324|NCT01556009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456325|NCT01555996|Randomized|Parallel Assignment||Prevention||Single||||||t
1456326|NCT01555983|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1456327|NCT01555970|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1456328|NCT01555957|Randomized|Parallel Assignment||Prevention||Single|||t|||
1456329|NCT01555944|||Cohort||Prospective|||||||
1456330|NCT01555931|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456331|NCT01555918|Randomized|Crossover Assignment||||None (Open Label)||||||
1456332|NCT01555905||Single Group Assignment||Prevention||None (Open Label)||||||
1456333|NCT01555892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456334|NCT01555879|||Case-Only||Retrospective|||||||
1456335|NCT01555866|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1456336|NCT01555853|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456337|NCT01555840||Single Group Assignment||Diagnostic||Single|||||t|
1456338|NCT01555827|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456339|NCT01555814||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456340|NCT01555801|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1456341|NCT01555788||Single Group Assignment||Treatment||None (Open Label)||||||
1456342|NCT01555775|Randomized|Crossover Assignment||||Single|||t|||
1456343|NCT01555762|||Cohort||Prospective|||||||
1456344|NCT01555749|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1456345|NCT01555736|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456346|NCT01555723|||Cohort||Prospective|||||||
1456347|NCT01555710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456348|NCT01555697|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1456349|NCT01555684|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456350|NCT01555671|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456351|NCT01555658|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456352|NCT01555645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456353|NCT01555632|Randomized|Parallel Assignment||Treatment||Double||||||
1456354|NCT01555619|||Case-Only||Prospective|||||||
1456355|NCT01555606|||Case-Only||Prospective|||||||
1456356|NCT01555593||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456357|NCT01555580||Single Group Assignment||Treatment||None (Open Label)||||||
1456358|NCT01555567|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456359|NCT01555554|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1456360|NCT01555541||Single Group Assignment||Treatment||None (Open Label)||||||
1456361|NCT01555528|||Cohort||Other|||||||
1456362|NCT01555515||Single Group Assignment||Treatment||None (Open Label)||||||
1456363|NCT01555502|||Cohort||Prospective|||||||
1456364|NCT01555489||Single Group Assignment||Treatment||None (Open Label)||||||
1456365|NCT01555476|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1456366|NCT01555463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456367|NCT01555450|Randomized|Parallel Assignment||Screening||Single||||t||
1456368|NCT01555437|||||Prospective|||||||
1456369|NCT01555424|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1456370|NCT01555411|||Cohort||Prospective|||||||
1456371|NCT01555398|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456372|NCT01555385|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1456373|NCT01555372|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456374|NCT01555359|||Cohort||Prospective|||||||
1456375|NCT01555346|||Case-Only||Prospective|||||||
1456376|NCT01555333||Single Group Assignment||Treatment||None (Open Label)||||||
1456377|NCT01555320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456378|NCT01555307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456379|NCT01555294|||||Prospective|||||||
1456380|NCT01555281||Single Group Assignment||Treatment||None (Open Label)||||||
1456381|NCT01555268|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456382|NCT01555255|||Case-Only||Prospective|||||||
1456383|NCT01555242||Single Group Assignment||Treatment||None (Open Label)||||||
1456384|NCT01555229|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1456385|NCT01555216|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456386|NCT01555203|Randomized|Parallel Assignment||Prevention||Single|||t|||
1456387|NCT01555190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456388|NCT01555177|||Case Control||Prospective|||||||
1456389|NCT01555164|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456390|NCT01555151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456391|NCT01555138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456392|NCT01555125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456393|NCT01555112||Single Group Assignment||Treatment||None (Open Label)||||||
1456394|NCT01555099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456395|NCT01555086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456396|NCT01555073|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1456397|NCT01555060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456398|NCT01555047|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1456399|NCT01555034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456400|NCT01555021|||Cohort||Prospective|||||||
1456401|NCT01555008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456402|NCT01554995|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1456403|NCT01554982||Single Group Assignment||Treatment||None (Open Label)||||||
1456404|NCT01554969||Single Group Assignment||Treatment||None (Open Label)||||||
1456405|NCT01554956||Single Group Assignment||Treatment||None (Open Label)||||||
1456406|NCT01554943|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456407|NCT01554930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456408|NCT01554917||Single Group Assignment||Treatment||None (Open Label)||||||
1456409|NCT01554904||Single Group Assignment||Treatment||None (Open Label)||||||
1456410|NCT01554891|||Cohort||Prospective|||||||
1456411|NCT01554878|||||Prospective|||||||
1456412|NCT01554865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456413|NCT01554852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456414|NCT01554839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456415|NCT01554826|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1456416|NCT01554813|Randomized|Parallel Assignment||Prevention||Single|||t|||
1456417|NCT01554800||Single Group Assignment||Treatment||None (Open Label)||||||
1456418|NCT01554787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456419|NCT01554774|||Case-Only||Cross-Sectional|||||||
1456420|NCT01554761||Single Group Assignment||Treatment||None (Open Label)||||||
1456421|NCT01554748||Single Group Assignment||Treatment||None (Open Label)||Implantation of TMC total joint arthroplasty in a patient cohort||||
1456422|NCT01554735||Single Group Assignment||Treatment||None (Open Label)||||||
1456423|NCT01554722|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1456424|NCT01554709|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456425|NCT01554696|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456426|NCT01554683|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1456427|NCT01554670|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456428|NCT01554657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456429|NCT01554644|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456430|NCT01554631|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1456431|NCT01554618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456432|NCT01554605|||Case-Crossover||Prospective|||||||
1456433|NCT01554592|Randomized|Crossover Assignment||Treatment||Single|||t|||
1456434|NCT01554579|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456435|NCT01554566||Single Group Assignment||Treatment||None (Open Label)||||||
1456436|NCT01554553|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1456437|NCT01554540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456438|NCT01554527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456439|NCT01554514||Single Group Assignment||Treatment||None (Open Label)||||||
1456440|NCT01554501|||Case Control||Prospective|||||||
1456441|NCT01554488|Randomized|Parallel Assignment||||None (Open Label)||||||
1456442|NCT01554475|||Cohort||Prospective|||||||
1456443|NCT01554462|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1456444|NCT01554449|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456445|NCT01554436||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456446|NCT01554423|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456447|NCT01554410||Single Group Assignment||Treatment||None (Open Label)||||||
1456448|NCT01554397|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456449|NCT01554384|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1456450|NCT01554371||Single Group Assignment||Treatment||None (Open Label)||||||
1456451|NCT01554358|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1456452|NCT01554345|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1456453|NCT01554332|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1456454|NCT01554319|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456455|NCT01554306|||Case-Only||Prospective|||||||
1456456|NCT01554293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456457|NCT01554280||Single Group Assignment||Prevention||None (Open Label)||||||
1456458|NCT01554267||Single Group Assignment||Prevention||None (Open Label)||||||
1456459|NCT01554254||Single Group Assignment||Treatment||None (Open Label)||||||
1456460|NCT01554241|Randomized|Parallel Assignment||||Single|||t|||
1456461|NCT01554228|||Cohort||Prospective|||||||
1456462|NCT01554215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456463|NCT01554202|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456464|NCT01554189|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456465|NCT01554176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456466|NCT01554163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456467|NCT01554150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456468|NCT01554137|Randomized|Parallel Assignment||||Double|||t||t|
1456469|NCT01554124||Single Group Assignment||Treatment||None (Open Label)||||||
1456470|NCT01554111|Randomized|Parallel Assignment||Treatment||Double||||t||t
1456471|NCT01554098|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1456472|NCT01554085|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456473|NCT01554072|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1456474|NCT01554059||Single Group Assignment||Treatment||None (Open Label)||||||
1456475|NCT01554046||Single Group Assignment||Treatment||None (Open Label)||||||
1456476|NCT01554033|||Case-Crossover||Cross-Sectional|||||||
1456477|NCT01554020|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1456478|NCT01554007|||Cohort||Prospective|||||||
1456479|NCT01553994|||Cohort||Retrospective|||||||
1456480|NCT01553981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456481|NCT01553968|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1456482|NCT01553955||Single Group Assignment||Health Services Research||None (Open Label)||||||
1456483|NCT01553942||Single Group Assignment||Treatment||None (Open Label)||||||
1456484|NCT01553929|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456485|NCT01553916||Single Group Assignment||Supportive Care||None (Open Label)||||||
1456486|NCT01553903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456487|NCT01553890|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456488|NCT01553877|Randomized|Parallel Assignment||Prevention||Single||||t||
1456489|NCT01553851||Single Group Assignment||Treatment||None (Open Label)||||||
1456490|NCT01553838||Crossover Assignment||Diagnostic||None (Open Label)||||||
1456491|NCT01553825|||Cohort||Prospective|||||||
1456492|NCT01553812|||||Cross-Sectional|||||||
1456493|NCT01553799|||Cohort||Prospective|||||||
1456494|NCT01553786||Single Group Assignment||Treatment||None (Open Label)||||||
1456495|NCT01553773|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456496|NCT01553760|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1456497|NCT01553747|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456498|NCT01553734|||Cohort||Prospective|||||||
1456499|NCT01553721|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456500|NCT01553708|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1456501|NCT01553695|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1456502|NCT01553682|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456503|NCT01553669|Randomized|Parallel Assignment||Treatment||Single||||||t
1456504|NCT01553656||Single Group Assignment||Treatment||None (Open Label)||||||
1456505|NCT01553643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456506|NCT01553630|Randomized|Parallel Assignment||||None (Open Label)||||||
1456507|NCT01553617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456508|NCT01553604|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1456509|NCT01553591|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456510|NCT01553578|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1456511|NCT01553565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456512|NCT01553552|||Case Control||Cross-Sectional|||||||
1456513|NCT01553539||Single Group Assignment||Treatment||None (Open Label)||||||
1456514|NCT01553526|||||Prospective|||||||
1456515|NCT01553513|||Cohort||Prospective|||||||
1456516|NCT01553500|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456517|NCT01553487|Randomized|Parallel Assignment||Basic Science||Single||||||t
1456518|NCT01553474|||||Prospective|||||||
1456519|NCT01553461|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456520|NCT01553448|||Case Control||Prospective|||||||
1456521|NCT01553435|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1456522|NCT01553422|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456523|NCT01553409|||Cohort||Prospective|||||||
1456524|NCT01553396|||Case-Only|||||||||
1456525|NCT01553383|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456526|NCT01553370|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1456527|NCT01553357||Single Group Assignment||Treatment||None (Open Label)||||||
1456528|NCT01553344|||Case-Only||Prospective|||||||
1456529|NCT01553331|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456530|NCT01553318|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1456531|NCT01553305|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1456532|NCT01553292||Single Group Assignment||Treatment||None (Open Label)||||||
1456533|NCT01553279|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456534|NCT01553266|||Cohort||Retrospective|||||||
1456535|NCT01553253|||Cohort||Prospective|||||||
1456536|NCT01553240||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456537|NCT01553227||Single Group Assignment||Treatment||None (Open Label)||||||
1456538|NCT01553214|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1456539|NCT01553201|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1456540|NCT01553188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456541|NCT01553175|||Case-Only||Retrospective|||||||
1456542|NCT01553162|||Case-Only||Retrospective|||||||
1456543|NCT01553149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456544|NCT01553136|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456545|NCT01553123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456546|NCT01553110|||Case-Control||Prospective|||||||
1456547|NCT01553097|||||Prospective|||||||
1456548|NCT01553084|Randomized|Factorial Assignment||Treatment||Single|||t|||
1456549|NCT01553071||Single Group Assignment||Treatment||None (Open Label)||||||
1456550|NCT01553058|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1456551|NCT01553045|||Case Control||Prospective|||||||
1456552|NCT01553032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456553|NCT01553019|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456554|NCT01553006|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456555|NCT01552993|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1456556|NCT01552980||Single Group Assignment||Treatment||None (Open Label)||||||
1456557|NCT01552967||Single Group Assignment||Treatment||None (Open Label)||||||
1456558|NCT01552954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456559|NCT01552941||Single Group Assignment||Treatment||None (Open Label)||||||
1456560|NCT01552928|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1456561|NCT01552915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456562|NCT01552902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456563|NCT01552889|Randomized|Parallel Assignment||Treatment||Single||||||t
1456564|NCT01552876|Randomized|Crossover Assignment||Treatment||Single|||t|||
1456565|NCT01552863|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1456566|NCT01552850|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1456567|NCT01552837|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456568|NCT01552824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456569|NCT01552811|||Case Control||Prospective|||||||
1456570|NCT01552798|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456571|NCT01552785|||Case-Only||Prospective|||||||
1456572|NCT01552772||Single Group Assignment||Treatment||None (Open Label)||||||
1456573|NCT01552759|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456574|NCT01552746|||Cohort||Prospective|||||||
1456575|NCT01552733|Randomized|Parallel Assignment||Treatment||Single||||||t
1456576|NCT01552720|||Case-Only||Retrospective|||||||
1456577|NCT01552707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456578|NCT01552694|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456579|NCT01552681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456580|NCT01552668|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1456581|NCT01552655||Single Group Assignment||Diagnostic||Single|||||t|
1456582|NCT01552642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456583|NCT01552629|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456584|NCT01552616|Randomized|Parallel Assignment||Prevention||Single||||||t
1456585|NCT01552603||Single Group Assignment||Treatment||None (Open Label)||||||
1456586|NCT01552590|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456587|NCT01552577|||Case-Control||Cross-Sectional|||||||
1456588|NCT01552564|||Case-Only||Prospective|||||||
1456589|NCT01552551|Randomized|Parallel Assignment||Prevention||Single||||||t
1456590|NCT01552538||Single Group Assignment||Treatment||None (Open Label)||||||
1456591|NCT01552525|||Cohort||Prospective|||||||
1456592|NCT01552512|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456593|NCT01552499|Randomized|Parallel Assignment||||None (Open Label)||||||
1456594|NCT01552486|Randomized|Parallel Assignment||||Single||||||t
1456595|NCT01552473|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456596|NCT01552460|||Cohort||Cross-Sectional|||||||
1456597|NCT01552447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456598|NCT01552434|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456599|NCT01552421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456600|NCT01552408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456601|NCT01552395|||||Prospective|||||||
1456602|NCT01552382|||Cohort||Retrospective|||||||
1456603|NCT01552369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456604|NCT01552356||Single Group Assignment||Treatment||None (Open Label)||||||
1456605|NCT01552343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456606|NCT01552330|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456607|NCT01552317|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456608|NCT01552304|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1456609|NCT01552291|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1456610|NCT01552265|||Cohort||Prospective|||||||
1456611|NCT01552252|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1456612|NCT01552239||Single Group Assignment||Treatment||None (Open Label)||||||
1456613|NCT01552226|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1456614|NCT01552213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456615|NCT01552200|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1456616|NCT01552187|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1456617|NCT01552174|||Ecologic or Community||Retrospective|||||||
1456618|NCT01552161|||Cohort||Prospective|||||||
1456619|NCT01552148|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456620|NCT01552135|||Case-Only||Prospective|||||||
1456621|NCT01552122|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456622|NCT01552109|||||Prospective|||||||
1456623|NCT01552096|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456624|NCT01552083||Single Group Assignment||Screening||None (Open Label)||||||
1456625|NCT01552070|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456626|NCT01552057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456627|NCT01552044|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1456628|NCT01552031|||Cohort||Prospective|||||||
1456629|NCT01552018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456630|NCT01552005|||Cohort|||||||||
1456631|NCT01551992|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456632|NCT01551979|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1456633|NCT01551966||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456634|NCT01551953|Randomized|Parallel Assignment||Other||Single||||||t
1456635|NCT01551940|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456636|NCT01551927|||||Prospective|||||||
1456637|NCT01551914|Randomized|Parallel Assignment||Treatment||Single||||||t
1456638|NCT01551901||Single Group Assignment||Treatment||None (Open Label)||||||
1456639|NCT01551888|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1456640|NCT01551875|||||Prospective|||||||
1456641|NCT01551862|||Cohort||Prospective|||||||
1456642|NCT01551849|||Case-Only||Prospective|||||||
1456643|NCT01551836|Randomized|Crossover Assignment||||Single|||t|||
1456644|NCT01551823|Randomized|Parallel Assignment||Prevention||Single||||||t
1456645|NCT01551810|Randomized|Parallel Assignment||Prevention||Single||||||t
1456646|NCT01551797|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456647|NCT01551784|||||Retrospective|||||||
1456648|NCT01551771|Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1456649|NCT01551758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456650|NCT01551745||Single Group Assignment||Treatment||None (Open Label)||||||
1456651|NCT01551732|Randomized|Parallel Assignment||Treatment||Single||||||t
1456652|NCT01551719|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456653|NCT01551706|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1456654|NCT01551693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456655|NCT01551680||Single Group Assignment||Treatment||None (Open Label)||||||
1456656|NCT01551667|||Case Control||Prospective|||||||
1456657|NCT01551654|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456658|NCT01551641|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456659|NCT01551628||Single Group Assignment||Treatment||None (Open Label)||||||
1456660|NCT01551615||Single Group Assignment||Basic Science||None (Open Label)||||||
1456661|NCT01551602|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1456662|NCT01551589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456663|NCT01551576|||Other||Prospective|||||||
1456664|NCT01551563|||Cohort||Prospective|||||||
1456665|NCT01551550|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456666|NCT01551537|||Cohort||Prospective|||||||
1456667|NCT01551524||Single Group Assignment||Treatment||None (Open Label)||||||
1456668|NCT01551511|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456669|NCT01551498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456670|NCT01551485|Randomized|Parallel Assignment||||Double|||t||t|
1456671|NCT01551472|||Cohort||Prospective|||||||
1456672|NCT01551459|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456673|NCT01551446||Single Group Assignment||Treatment||None (Open Label)||||||
1456674|NCT01551433|||Cohort||Prospective|||||||
1456675|NCT01551420|||Cohort||Prospective|||||||
1456676|NCT01551407||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456677|NCT01551394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456678|NCT01551381|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456679|NCT01551368|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456680|NCT01551355|Randomized|Parallel Assignment||||Single||||||t
1456681|NCT01551342|||Cohort||Prospective|||||||
1456682|NCT01551329||Single Group Assignment||Treatment||Triple|||t|t|t|
1456683|NCT01551316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456684|NCT01551303|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1456685|NCT01551290|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456686|NCT01551277|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1456687|NCT01551264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456688|NCT01551251|||Cohort||Retrospective|||||||
1456689|NCT01551238|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456690|NCT01551225|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456691|NCT01551212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456692|NCT01551199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456693|NCT01551186|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456694|NCT01551173|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456695|NCT01551160||Single Group Assignment||Health Services Research||None (Open Label)||||||
1456696|NCT01551147|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1456697|NCT01551134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456698|NCT01551121|||||Prospective|||||||
1456699|NCT01551108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456700|NCT01551095||Single Group Assignment||Supportive Care||None (Open Label)||||||
1456701|NCT01551082|||Cohort||Retrospective|||||||
1456702|NCT01551069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456703|NCT01551056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456704|NCT01551043||Single Group Assignment||Treatment||None (Open Label)||||||
1456705|NCT01551030||Single Group Assignment||Treatment||None (Open Label)||||||
1456706|NCT01551017|||Case Control||Prospective|||||||
1456707|NCT01551004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456708|NCT01550978|Randomized|Parallel Assignment||Prevention||Single|||t|||
1456709|NCT01550965||Single Group Assignment||Treatment||None (Open Label)||||||
1456710|NCT01550952|||Cohort||Prospective|||||||
1456711|NCT01550939||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456712|NCT01550926|Randomized|Crossover Assignment||||None (Open Label)||||||
1456713|NCT01550913|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456714|NCT01550900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456715|NCT01550887||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456716|NCT01550874|Randomized|Single Group Assignment||Other||Single||||||t
1456717|NCT01550861||Single Group Assignment||Treatment||None (Open Label)||||||
1456718|NCT01550848||Single Group Assignment||Treatment||None (Open Label)||||||
1456719|NCT01550835|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456720|NCT01550822|Randomized|Parallel Assignment||Prevention||Single||||||t
1456721|NCT01550809|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1456722|NCT01550796|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456723|NCT01550783|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1456724|NCT01550770||Single Group Assignment||Basic Science||None (Open Label)||||||
1456725|NCT01550757|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1456726|NCT01550744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456727|NCT01550731|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1456728|NCT01550718|Randomized|Parallel Assignment||Treatment||Single||||||t
1456729|NCT01550705||Single Group Assignment||Treatment||None (Open Label)||||||
1456730|NCT01550679|||Cohort||Prospective|||||||
1456731|NCT01550666|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1456732|NCT01550653|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1456733|NCT01550640|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1456734|NCT01550627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456735|NCT01550614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456736|NCT01550601|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456737|NCT01550588|Randomized|Parallel Assignment||Prevention||Single|||t|||
1456738|NCT01550575|||Cohort||Retrospective|||||||
1456739|NCT01550562|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1456740|NCT01550549||Single Group Assignment||Diagnostic||Single||||||t
1456741|NCT01550536|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1456742|NCT01550523||Single Group Assignment||Treatment||None (Open Label)||||||
1456743|NCT01550510||Single Group Assignment||Treatment||None (Open Label)||||||
1456744|NCT01550497|Randomized|Parallel Assignment||Treatment||Single||||||t
1456745|NCT01550484||Single Group Assignment||Diagnostic||Single||||||t
1456746|NCT01550471|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456747|NCT01550458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456748|NCT01550445||Single Group Assignment||Treatment||None (Open Label)||||||
1456749|NCT01550432|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1456750|NCT01550419|Randomized|Parallel Assignment||Prevention||Single|||t|||
1456751|NCT01550406|Randomized|Parallel Assignment||Prevention||Single|||t|||
1456752|NCT01550393|||Case-Only||Retrospective|||||||
1456753|NCT01550380||Single Group Assignment||Treatment||None (Open Label)||||||
1456754|NCT01550367||Single Group Assignment||Treatment||None (Open Label)||||||
1456755|NCT01550354|Randomized|Parallel Assignment||||Double||||t|t|
1456756|NCT01550341|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456757|NCT01550328|||Cohort||Prospective|||||||
1456758|NCT01550315|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1456759|NCT01550302|Randomized|Parallel Assignment||Treatment||Single|||t|||
1456760|NCT01550289|Randomized|Parallel Assignment||Prevention||Single||||||t
1456761|NCT01550276|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1456762|NCT01550263|||Cohort||Prospective|||||||
1456763|NCT01550250|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1456764|NCT01550237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456765|NCT01550224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456766|NCT01550211|||Case Control||Prospective|||||||
1456767|NCT01550198|||Cohort||Prospective|||||||
1456768|NCT01550185||Single Group Assignment||Treatment||None (Open Label)||||||
1456769|NCT01550172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456770|NCT01550159|||Cohort||Prospective|||||||
1456771|NCT01550146|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1456772|NCT01550133|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1456773|NCT01550120|||Case-Crossover||Prospective|||||||
1456774|NCT01550107|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456775|NCT01550094|||Cohort||Prospective|||||||
1456776|NCT01550081|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1456777|NCT01550068|||Ecologic or Community||Cross-Sectional|||||||
1456778|NCT01550055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456779|NCT01550042|||Cohort||Prospective|||||||
1456780|NCT01550029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456781|NCT01550016|||Cohort||Prospective|||||||
1456782|NCT01550003||Single Group Assignment||Treatment||None (Open Label)||||||
1456783|NCT01549990|||Cohort||Retrospective|||||||
1456784|NCT01549977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456785|NCT01549964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456786|NCT01549951||Single Group Assignment||Treatment||None (Open Label)||||||
1456787|NCT01549938|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1456788|NCT01549925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456789|NCT01549912|||Case Control||Retrospective|||||||
1456790|NCT01549899|Randomized|Parallel Assignment||Treatment||Single||||||t
1456791|NCT01549886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456792|NCT01549873|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1456793|NCT01549860|Randomized|Parallel Assignment||Treatment||Single||||||t
1456794|NCT01549847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456795|NCT01549834|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456796|NCT01549808||Single Group Assignment||Treatment||None (Open Label)||||||
1456797|NCT01549795||Single Group Assignment||Treatment||None (Open Label)||||||
1456798|NCT01549782|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1456799|NCT01549769||Single Group Assignment||Treatment||None (Open Label)||||||
1456800|NCT01549756|||Case-Only||Retrospective|||||||
1456801|NCT01549743|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1456802|NCT01549730||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456803|NCT01549717||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456804|NCT01549704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456805|NCT01549691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456806|NCT01549678|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456807|NCT01549665||Single Group Assignment||Treatment||None (Open Label)||||||
1456808|NCT01549652|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1456809|NCT01549639|||Case-Only||Prospective|||||||
1456810|NCT01549626|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1456811|NCT01549613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456812|NCT01549600|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1456813|NCT01549587|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456814|NCT01549574||Single Group Assignment||Basic Science||None (Open Label)||||||
1456815|NCT01549561|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1456816|NCT01549548||||||||||||
1456817|NCT01549535|Randomized|Parallel Assignment||Screening||Single|||t|||
1456818|NCT01549522|||||Retrospective|||||||
1456819|NCT01549509||Single Group Assignment||Prevention||None (Open Label)||||||
1456820|NCT01549496||Single Group Assignment||Treatment||None (Open Label)||||||
1456821|NCT01549483|||Case Control||Cross-Sectional|||||||
1456822|NCT01549470|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1456823|NCT01549457|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1456824|NCT01549444|||Cohort||Prospective|||||||
1456825|NCT01549431||Single Group Assignment||Treatment||None (Open Label)||||||
1456826|NCT01549418|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1456827|NCT01549405|Randomized|Parallel Assignment||||Double|||t|||t
1456828|NCT01549392|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456829|NCT01549379|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456830|NCT01549366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456831|NCT01549353|Randomized|Parallel Assignment||||Single||||||t
1456832|NCT01549340|||Ecologic or Community||Retrospective|||||||
1456833|NCT01549327|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1456834|NCT01549314|||Cohort||Prospective|||||||
1456835|NCT01549301|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456836|NCT01549288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456837|NCT01549275|||Case-Only||Prospective|||||||
1456838|NCT01549262|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1456839|NCT01549249||Single Group Assignment||Treatment||Single|||||t|
1456840|NCT01549236||Single Group Assignment||Treatment||None (Open Label)||||||
1456841|NCT01549223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456842|NCT01549210|||Cohort||Prospective|||||||
1456843|NCT01549197|||Cohort||Prospective|||||||
1456844|NCT01549184|||Cohort||Retrospective|||||||
1456845|NCT01549171|||Case Control||Prospective|||||||
1456846|NCT01549158|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456847|NCT01549145||Single Group Assignment||Treatment||None (Open Label)||||||
1456848|NCT01549132|||Cohort||Prospective|||||||
1456849|NCT01549119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456850|NCT01549106|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1456851|NCT01549093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456854|NCT01549054|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456855|NCT01549041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456856|NCT01549028||Single Group Assignment||Treatment||None (Open Label)||||||
1456857|NCT01549015||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456858|NCT01549002|Randomized|Parallel Assignment||Treatment||Single||||||t
1456859|NCT01548989|||Case-Only||Cross-Sectional|||||||
1456860|NCT01548976|||Case-Only||Cross-Sectional|||||||
1456861|NCT01548963|Randomized|Parallel Assignment||Treatment||Single||||||t
1456862|NCT01548950||Single Group Assignment||Treatment||None (Open Label)||||||
1456863|NCT01548937||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456864|NCT01548924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456865|NCT01548911||Single Group Assignment||Treatment||None (Open Label)||||||
1456866|NCT01548898||Single Group Assignment||Treatment||None (Open Label)||||||
1456867|NCT01548885||Single Group Assignment||Diagnostic||None (Open Label)||||||
1456868|NCT01548872|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1456869|NCT01548859|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1456870|NCT01548846||Single Group Assignment||||None (Open Label)||||||
1456871|NCT01548833|Randomized|Crossover Assignment||Treatment||Single|||||t|
1456872|NCT01548820|||Cohort||Retrospective|||||||
1456873|NCT01548807||||Treatment||||||||
1456874|NCT01548794|Randomized|Parallel Assignment||||Double|||t||t|
1456875|NCT01548781|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1456876|NCT01548768|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1456877|NCT01548755|||Case-Only||Prospective|||||||
1456878|NCT01548742|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1456879|NCT01548729||Single Group Assignment||Treatment||None (Open Label)||||||
1456880|NCT01548716|||Case-Only||Prospective|||||||
1456881|NCT01548703|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1456882|NCT01548690||Single Group Assignment||Treatment||None (Open Label)||||||
1456883|NCT01548677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456884|NCT01548664|Randomized|Parallel Assignment||Treatment||Single||||||t
1456885|NCT01548651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456886|NCT01548638||Single Group Assignment||Treatment||None (Open Label)||||||
1456887|NCT01548625|||Cohort||Prospective|||||||
1456888|NCT01548612|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456889|NCT01548599|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1456890|NCT01548586|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1456891|NCT01548573||Single Group Assignment||Treatment||None (Open Label)||||||
1456892|NCT01548560|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1456893|NCT01548547|Randomized|Parallel Assignment||||Double|||||t|t
1456894|NCT01548534|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1456895|NCT01548521||Single Group Assignment||Treatment||None (Open Label)||||||
1456896|NCT01548508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456897|NCT01548495|||Cohort||Prospective|||||||
1456898|NCT01548482||Single Group Assignment||Treatment||None (Open Label)||||||
1456899|NCT01548469|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456900|NCT01548456|||Cohort||Prospective|||||||
1456901|NCT01548443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456902|NCT01548430|Randomized|Single Group Assignment||||Double|||t||t|
1456903|NCT01548417|Randomized|Parallel Assignment||||Triple|||t||t|t
1456904|NCT01548404|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456905|NCT01548391|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1456906|NCT01548378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456907|NCT01548365|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1456908|NCT01548352|||Cohort||Prospective|||||||
1456909|NCT01548339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456910|NCT01548326|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1456911|NCT01548313|||Cohort||Prospective|||||||
1456912|NCT01548300|||Ecologic or Community||Prospective|||||||
1456913|NCT01548287|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456914|NCT01548274||Single Group Assignment||Treatment||None (Open Label)||||||
1456915|NCT01548261|||Case-Only|||||||||
1456916|NCT01548248|||Cohort||Prospective|||||||
1456917|NCT01548235|||Cohort||Prospective|||||||
1456918|NCT01548222|||Case-Only||Prospective|||||||
1456919|NCT01548209|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1456920|NCT01548196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456921|NCT01548183|Randomized|Parallel Assignment||Prevention||Single||||||t
1456922|NCT01548170|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456923|NCT01548157|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1456924|NCT01548144|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456925|NCT01548131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456926|NCT01548118|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1456927|NCT01548105|||Case Control||Prospective|||||||
1456928|NCT01548092||Single Group Assignment||Treatment||None (Open Label)||||||
1456929|NCT01548079|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1456930|NCT01548066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456931|NCT01548053||Single Group Assignment||Health Services Research||Single||||||t
1456932|NCT01548040|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1456933|NCT01548027|Randomized|Parallel Assignment||Treatment||Single||||||t
1456934|NCT01548014||Single Group Assignment||Supportive Care||None (Open Label)||||||
1456935|NCT01548001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456936|NCT01547988|Randomized|Parallel Assignment||Treatment||Single||||||t
1456937|NCT01547975|||Case-Crossover||Retrospective|||||||
1456938|NCT01547962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456939|NCT01547949|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1456940|NCT01547936|||Case-Only||Cross-Sectional|||||||
1456941|NCT01547923|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456942|NCT01547910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456943|NCT01547897|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456944|NCT01547884|||||Cross-Sectional|||||||
1456945|NCT01547871|||||Other|||||||
1456946|NCT01547858|||Other||Cross-Sectional|||||||
1456947|NCT01547845|||Case-Only||Prospective|||||||
1456948|NCT01547832|||||Prospective|||||||
1456949|NCT01547819|||||Prospective|||||||
1456950|NCT01547806||Single Group Assignment||Treatment||None (Open Label)||||||
1456951|NCT01547793|||||Prospective|||||||
1456952|NCT01547780|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456953|NCT01547767|||Case-Only||Other|||||||
1456954|NCT01547754|||||Prospective|||||||
1456955|NCT01547741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456956|NCT01547728||Single Group Assignment||Treatment||None (Open Label)||||||
1456957|NCT01547715|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1456958|NCT01547702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456959|NCT01547689||Single Group Assignment||Treatment||None (Open Label)||||||
1456960|NCT01547676|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1456961|NCT01547663|||Case-Only||Prospective|||||||
1456962|NCT01547650|||Case Control||Prospective|||||||
1456963|NCT01547637|Randomized|Parallel Assignment||Treatment||Single||||||t
1456964|NCT01547624|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1456965|NCT01547611|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456966|NCT01547598|Randomized|Parallel Assignment||Treatment||Single|||||t|
1456967|NCT01547585|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1456968|NCT01547572|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1456969|NCT01547559|Randomized|Parallel Assignment||Prevention||Single|||||t|
1456970|NCT01547546|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1456971|NCT01547533|||Cohort||Prospective|||||||
1456972|NCT01547520|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1456973|NCT01547507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456974|NCT01547494|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1456975|NCT01547481|||Case-Control||Prospective|||||||
1456976|NCT01547468|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1456977|NCT01547455|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1456978|NCT01547442||Single Group Assignment||Treatment||None (Open Label)||||||
1456979|NCT01547429||Single Group Assignment||Treatment||None (Open Label)||||||
1456980|NCT01547416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456981|NCT01547403|||Cohort||Prospective|||||||
1456982|NCT01547390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1456983|NCT01547377|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1456984|NCT01547364|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1456985|NCT01547351|||Cohort||Prospective|||||||
1456986|NCT01547338|||Case-Only||Cross-Sectional|||||||
1456987|NCT01547325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456988|NCT01547312|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1456989|NCT01547299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456990|NCT01547286||Single Group Assignment||Basic Science||None (Open Label)||||||
1456991|NCT01547273|Randomized|Single Group Assignment||Treatment||Single||||||t
1456992|NCT01547260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456993|NCT01547247|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1456994|NCT01547234|||||Prospective|||||||
1456995|NCT01547221|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1456996|NCT01547208|Randomized|Parallel Assignment||Treatment||Single||||||t
1456997|NCT01547195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1456998|NCT01547182|Randomized|Parallel Assignment||Treatment||Single||||||t
1456999|NCT01547169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457000|NCT01547156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457001|NCT01547143||Single Group Assignment||Treatment||None (Open Label)||||||
1457002|NCT01547130|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457003|NCT01547117|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1457004|NCT01547104|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1457005|NCT01547091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457006|NCT01547078|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1457007|NCT01547065|||Case-Only||Prospective|||||||
1457008|NCT01547052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457009|NCT01547039|||Cohort||Prospective|||||||
1457010|NCT01547026|Randomized|Parallel Assignment||Treatment||Single||||||t
1457011|NCT01547013|||Case-Control||Prospective|||||||
1457012|NCT01547000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457013|NCT01546987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457014|NCT01546974|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457015|NCT01546961||Single Group Assignment||Treatment||None (Open Label)||||||
1457016|NCT01546948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457017|NCT01546935||Single Group Assignment||Treatment||None (Open Label)||||||
1457018|NCT01546922|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457019|NCT01546909||Single Group Assignment||Prevention||None (Open Label)||||||
1457020|NCT01546896|Randomized|Parallel Assignment||Treatment||Single||||||t
1457021|NCT01546883||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457022|NCT01546870|||Case-Only||Prospective|||||||
1457023|NCT01546857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457024|NCT01546844|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1457025|NCT01546831||||||||||||
1457026|NCT01546818|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1457027|NCT01546805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457028|NCT01546792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457029|NCT01546779||Single Group Assignment||Treatment||None (Open Label)||||||
1457030|NCT01546766|||Case-Control||Prospective|||||||
1457031|NCT01546753|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1457032|NCT01546740|||Ecologic or Community||Retrospective|||||||
1457033|NCT01546727|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1457034|NCT01546714|||Cohort||Prospective|||||||
1457035|NCT01546701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457036|NCT01546688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457037|NCT01546675|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457038|NCT01546662|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1457039|NCT01546649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457040|NCT01546636|Randomized|Parallel Assignment||Prevention||Single|||t|||
1457041|NCT01546623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457042|NCT01546610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457043|NCT01546597||Single Group Assignment||||None (Open Label)||||||
1457044|NCT01546584||||||||||||
1457045|NCT01546571|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457046|NCT01546558||Single Group Assignment||||None (Open Label)||||||
1457047|NCT01546545|||Case-Only||Prospective|||||||
1457048|NCT01546532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457049|NCT01546519|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457050|NCT01546506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457051|NCT01546493|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1457052|NCT01546480|||Case Control||Prospective|||||||
1457053|NCT01546467|Randomized|Parallel Assignment||Treatment||Single||||||t
1457054|NCT01546454|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1457055|NCT01546441|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457056|NCT01546428||Single Group Assignment||Treatment||None (Open Label)||||||
1457057|NCT01546415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457058|NCT01546402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457059|NCT01546389|Randomized|Parallel Assignment||||Double|||t||t|
1457060|NCT01546376|||||Prospective|||||||
1457061|NCT01546363|||Cohort||Prospective|||||||
1457062|NCT01546350|Randomized|Parallel Assignment||Screening||Double|||t|||t
1457063|NCT01546337|||Case-Only||Prospective|||||||
1457064|NCT01546324|||||Cross-Sectional|||||||
1457065|NCT01546311|||Case-Only||Cross-Sectional|||||||
1457066|NCT01546298|||Cohort||Prospective|||||||
1457067|NCT01546285||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457068|NCT01546272|Randomized|Parallel Assignment||Treatment||Single||||||t
1457069|NCT01546259|Randomized|Parallel Assignment||Screening||Single|||t|||
1457070|NCT01546246|Randomized|Parallel Assignment||Screening||Single|||t|||
1457071|NCT01546233|||Case Control||Cross-Sectional|||||||
1457072|NCT01546220|Randomized|Parallel Assignment||Screening||Single|||t|||
1457073|NCT01546207||Single Group Assignment||Supportive Care||None (Open Label)||||||
1457074|NCT01546194|||Cohort||Prospective|||||||
1457075|NCT01546181|||Case Control||Prospective|||||||
1457076|NCT01546168|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1457077|NCT01546155||Single Group Assignment||Other||None (Open Label)||||||
1457078|NCT01546142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457079|NCT01546129|Randomized|Single Group Assignment||Treatment||Single|||t|||
1457080|NCT01546116||Single Group Assignment||Treatment||None (Open Label)||||||
1457081|NCT01546103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457082|NCT01546090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457083|NCT01546077|Randomized|Parallel Assignment||Treatment||Single||||||t
1457084|NCT01546064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457085|NCT01546051|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1457086|NCT01546038|Randomized|||Treatment||None (Open Label)||||||
1457087|NCT01546025|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457088|NCT01546012|Randomized|Crossover Assignment||||None (Open Label)||||||
1457089|NCT01545999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457090|NCT01545986|Randomized|Parallel Assignment||Treatment||Single||||||t
1457091|NCT01545973|||Case Control||Cross-Sectional|||||||
1457092|NCT01545960|||Case Control||Cross-Sectional|||||||
1457093|NCT01545947|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457094|NCT01545934|Randomized|Parallel Assignment||Prevention||Single||||||t
1457095|NCT01545921|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457096|NCT01545908|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457097|NCT01545882||Single Group Assignment||Treatment||None (Open Label)||||||
1457098|NCT01545869||Single Group Assignment||Treatment||None (Open Label)||||||
1457099|NCT01545856|||Cohort||Retrospective|||||||
1457100|NCT01545843|Randomized|Parallel Assignment||Treatment||Single||||||t
1457101|NCT01545830|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457102|NCT01545817||Single Group Assignment||Treatment||None (Open Label)||||||
1457103|NCT01545804||Single Group Assignment||Treatment||None (Open Label)||||||
1457104|NCT01545791|||Cohort||Prospective|||||||
1457105|NCT01545778|||Cohort||Retrospective|||||||
1457106|NCT01545765||Single Group Assignment||Treatment||None (Open Label)||||||
1457107|NCT01545752|Randomized|Parallel Assignment||||Single|||t|||
1457108|NCT01545739|||Case-Only||Prospective|||||||
1457109|NCT01545726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457110|NCT01545713|||Case-Only||Prospective|||||||
1457111|NCT01545700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457112|NCT01545687|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1457113|NCT01545674|||Cohort||Prospective|||||||
1457114|NCT01545661|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1457115|NCT01545648||Single Group Assignment||Treatment||None (Open Label)||||||
1457116|NCT01545635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457117|NCT01545622|||Other||Retrospective|||||||
1457118|NCT01545609|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457119|NCT01545596|Randomized|Parallel Assignment||Prevention||Single|||t|||
1457120|NCT01545583|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457121|NCT01545570|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457122|NCT01545557||Single Group Assignment||Treatment||None (Open Label)||||||
1457123|NCT01545544|||Case-Only|||||||||
1457124|NCT01545531|||Cohort||Prospective|||||||
1457125|NCT01545518||Single Group Assignment||Treatment||Double|||t||t|
1457126|NCT01545505|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1457127|NCT01545492|||Cohort||Prospective|||||||
1457128|NCT01545479||Single Group Assignment||Health Services Research||None (Open Label)||||||
1457129|NCT01545466|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457130|NCT01545453|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457131|NCT01545440|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457132|NCT01545427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457133|NCT01545414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457134|NCT01545401|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1457135|NCT01545388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457136|NCT01545375|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457137|NCT01545362|||Cohort||Prospective|||||||
1457138|NCT01545349|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1457139|NCT01545336|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457140|NCT01545323||Single Group Assignment||Treatment||None (Open Label)||||||
1457141|NCT01545310||Single Group Assignment||||None (Open Label)||||||
1457142|NCT01545297|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1457143|NCT01545284||Single Group Assignment||Treatment||None (Open Label)||||||
1457144|NCT01545271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457145|NCT01545258|Randomized|Parallel Assignment||Basic Science||Single||||||t
1457146|NCT01545245|||Cohort||Prospective|||||||
1457147|NCT01545232|Randomized|Parallel Assignment||Treatment||Single||||||t
1457148|NCT01545219|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1457149|NCT01545206|||Cohort||Retrospective|||||||
1457150|NCT01545193|||Cohort||Prospective|||||||
1457151|NCT01545180|||Cohort||Prospective|||||||
1457152|NCT01545167|||Case-Control||Prospective|||||||
1457153|NCT01545154|||Cohort||Prospective|||||||
1457154|NCT01545141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457155|NCT01545128|||Case Control||Prospective|||||||
1457156|NCT01545115|||Cohort||Prospective|||||||
1457157|NCT01545102|||Cohort||Prospective|||||||
1457158|NCT01545089|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1457159|NCT01545076|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457160|NCT01545063|||Other||Prospective|||||||
1457161|NCT01545050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457162|NCT01545037|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457163|NCT01545024|||Case-Only||Prospective|||||||
1457164|NCT01545011|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457165|NCT01544998|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1457166|NCT01544985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457167|NCT01544972|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1457168|NCT01544959|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457169|NCT01544946|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457170|NCT01544933|||Cohort||Retrospective|||||||
1457171|NCT01544920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457172|NCT01544907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457173|NCT01544894|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457174|NCT01544881|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1457175|NCT01544868||Parallel Assignment||Supportive Care||None (Open Label)||||||
1457176|NCT01544855||Single Group Assignment||Basic Science||None (Open Label)||||||
1457177|NCT01544842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457178|NCT01544829|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1457179|NCT01544816|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1457180|NCT01544803|Randomized|Factorial Assignment||Treatment||Single|||||t|
1457181|NCT01544790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457182|NCT01544777|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1457183|NCT01544764|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1457184|NCT01544751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457185|NCT01544738|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457186|NCT01544725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457187|NCT01544712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457188|NCT01544699|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1457189|NCT01544686|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457190|NCT01544673|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1457191|NCT01544660|||Cohort||Prospective|||||||
1457192|NCT01544647|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457193|NCT01544634|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1457194|NCT01544621|||Case-Only||Prospective|||||||
1457195|NCT01544608|||Case-Only||Retrospective|||||||
1457196|NCT01544595|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457197|NCT01544582|||Cohort||Prospective|||||||
1457198|NCT01544569|||Case-Only||Retrospective|||||||
1457199|NCT01544556|||Case Control||Prospective|||||||
1457200|NCT01544543|||Cohort||Retrospective|||||||
1457201|NCT01544530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457202|NCT01544517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457203|NCT01544504||Single Group Assignment||Prevention||None (Open Label)||||||
1457204|NCT01544491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457205|NCT01544478||Single Group Assignment||Prevention||None (Open Label)||||||
1457206|NCT01544465|Randomized|Parallel Assignment||Treatment||Single||||||t
1457207|NCT01544452|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1457208|NCT01544439|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457209|NCT01544426|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457210|NCT01544413||Single Group Assignment||Treatment||None (Open Label)||||||
1457211|NCT01544400|||||Prospective|||||||
1457212|NCT01544387|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457213|NCT01544374|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1457214|NCT01544361|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457215|NCT01544348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457216|NCT01544335|||Cohort||Prospective|||||||
1457217|NCT01544322||Single Group Assignment||Treatment||None (Open Label)||||||
1457218|NCT01544309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457219|NCT01544296|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457220|NCT01544283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457221|NCT01544270|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1457222|NCT01544257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457223|NCT01544244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457224|NCT01544231|||Cohort||Prospective|||||||
1457225|NCT01544218|||Case-Only||Cross-Sectional|||||||
1457226|NCT01544205|Randomized|Parallel Assignment||Treatment||Single||||||t
1457227|NCT01544192|Randomized|Parallel Assignment||Prevention||Single|||||t|
1457228|NCT01544179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457229|NCT01544166|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1457230|NCT01544153|Randomized|Factorial Assignment||Treatment||Single|||t|||
1457231|NCT01544140|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1457232|NCT01544127|Randomized|Parallel Assignment||Treatment||Single||||||t
1457233|NCT01544114||Single Group Assignment||Treatment||None (Open Label)||||||
1457234|NCT01544101|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1457235|NCT01544088|Randomized|Parallel Assignment||Treatment||Single||||||t
1457236|NCT01544075|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1457237|NCT01544062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457238|NCT01544049|||Cohort||Retrospective|||||||
1457239|NCT01544036||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457240|NCT01544023|||Cohort||Retrospective|||||||
1457241|NCT01544010|Randomized|Factorial Assignment||Treatment||Single||||||t
1457242|NCT01543997|Randomized|Parallel Assignment||Treatment||Single||||||t
1457243|NCT01543984|Randomized|Parallel Assignment||Prevention||Single||||||t
1457244|NCT01543971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457245|NCT01543958||Single Group Assignment||Treatment||None (Open Label)||||||
1457246|NCT01543945|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457247|NCT01543932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457248|NCT01543919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457249|NCT01543906||Single Group Assignment||Treatment||None (Open Label)||||||
1457250|NCT01543893|Randomized|Parallel Assignment||Prevention||Single||||||t
1457252|NCT01543867|||Cohort||Retrospective|||||||
1457253|NCT01543854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457254|NCT01543841|||Cohort||Retrospective|||||||
1457255|NCT01543828|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1457256|NCT01543815|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457257|NCT01543802||Single Group Assignment||Treatment||None (Open Label)||||||
1457258|NCT01543789|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457259|NCT01543776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457260|NCT01543763||Single Group Assignment||Treatment||None (Open Label)||||||
1457261|NCT01543750|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1457262|NCT01543737|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457263|NCT01543724||Single Group Assignment||Basic Science||None (Open Label)||||||
1457264|NCT01543711|||Cohort||Cross-Sectional|||||||
1457265|NCT01543698|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1457266|NCT01543685|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457267|NCT01543672|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457268|NCT01543659||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457269|NCT01543646|||Cohort||Prospective|||||||
1457270|NCT01543633||Single Group Assignment||Basic Science||None (Open Label)||||||
1457271|NCT01543620|||Case Control||Prospective|||||||
1457272|NCT01543607||Single Group Assignment||Treatment||None (Open Label)||||||
1457273|NCT01543594|||Cohort||Prospective|||||||
1457274|NCT01543581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457275|NCT01543568||Single Group Assignment||Treatment||None (Open Label)||||||
1457276|NCT01543555|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457277|NCT01543542||Single Group Assignment||Treatment||None (Open Label)||||||
1457278|NCT01543529|Randomized|Crossover Assignment||Other||Double|||t||t|
1457279|NCT01543516|||Case Control||Cross-Sectional|||||||
1457280|NCT01543503|||Cohort||Prospective|||||||
1457281|NCT01543490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457282|NCT01543477|||Cohort||Prospective|||||||
1457283|NCT01543464||Single Group Assignment||Treatment||None (Open Label)||||||
1457284|NCT01543451|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457285|NCT01543438|Randomized|Parallel Assignment||Prevention||Single||||||
1457286|NCT01543425|||Case Control||Cross-Sectional|||||||
1457287|NCT01543412||Single Group Assignment||Treatment||None (Open Label)||||||
1457288|NCT01543399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457289|NCT01543386|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457290|NCT01543373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457291|NCT01543360|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457292|NCT01543347||Single Group Assignment||Treatment||None (Open Label)||||||
1457293|NCT01543334|||Case-Only||Cross-Sectional|||||||
1457294|NCT01543321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457295|NCT01543308|||Case Control||Prospective|||||||
1457296|NCT01543295|||Cohort||Prospective|||||||
1457297|NCT01543282|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1457298|NCT01543269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457299|NCT01543256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457300|NCT01543243|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1457301|NCT01543230||Single Group Assignment||Treatment||None (Open Label)||||||
1457302|NCT01543217|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457303|NCT01543204||Single Group Assignment||Treatment||None (Open Label)||||||
1457304|NCT01543191|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1457305|NCT01543178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457306|NCT01543165|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457307|NCT01543152|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457308|NCT01543139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457309|NCT01543126|||Cohort||Prospective|||||||
1457310|NCT01543113||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457311|NCT01543100||Single Group Assignment||Basic Science||None (Open Label)||||||
1457312|NCT01543087||||Other||None (Open Label)||||||
1457313|NCT01543074|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1457314|NCT01543061|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1457315|NCT01543048|||Cohort||Prospective|||||||
1457316|NCT01543035||Single Group Assignment||Treatment||None (Open Label)||||||
1457317|NCT01543022||Single Group Assignment||Treatment||None (Open Label)||||||
1457318|NCT01543009|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1457319|NCT01542983|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457320|NCT01542970|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457321|NCT01542957|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457322|NCT01542944||Single Group Assignment||Treatment||None (Open Label)||||||
1457323|NCT01542931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457324|NCT01542918||Single Group Assignment||Treatment||None (Open Label)||||||
1457325|NCT01542905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457326|NCT01542892|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1457327|NCT01542879||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457328|NCT01542866||Single Group Assignment||Other||None (Open Label)||||||
1457329|NCT01542853|||Cohort||Prospective|||||||
1457330|NCT01542840|||Cohort||Prospective|||||||
1457809|NCT01536587||Single Group Assignment||Treatment||Single|||t|||
1457331|NCT01542827|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1457332|NCT01542814|||Case-Only||Prospective|||||||
1457333|NCT01542801|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457334|NCT01542788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457335|NCT01542775|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457336|NCT01542762|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457337|NCT01542749|||Cohort||Prospective|||||||
1457338|NCT01542736||Single Group Assignment||Treatment||None (Open Label)||||||
1457339|NCT01542723|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457340|NCT01542710||Single Group Assignment||Treatment||None (Open Label)||||||
1457341|NCT01542697|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457342|NCT01542684||Single Group Assignment||Treatment||None (Open Label)||||||
1457343|NCT01542671|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1457344|NCT01542658|||Case Control||Retrospective|||||||
1457345|NCT01542645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457346|NCT01542632|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1457347|NCT01542619|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457348|NCT01542606||Single Group Assignment||Diagnostic||Single|||||t|
1457349|NCT01542593||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457350|NCT01542580|||Cohort||Prospective|||||||
1457351|NCT01542567|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1457352|NCT01542554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457353|NCT01542541|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1457354|NCT01542528|Randomized|Parallel Assignment||Treatment||Single||||||t
1457355|NCT01542515|||Cohort||Prospective|||||||
1457356|NCT01542502|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1457357|NCT01542489|||Cohort||Prospective|||||||
1457358|NCT01542476|||Cohort||Prospective|||||||
1457359|NCT01542463|||Cohort||Prospective|||||||
1457360|NCT01542450|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457361|NCT01542437||Single Group Assignment||Treatment||None (Open Label)||||||
1457362|NCT01542424|||Cohort||Prospective|||||||
1457363|NCT01542411|||Case Control||Retrospective|||||||
1457364|NCT01542398|Randomized|Parallel Assignment||Treatment||Single||||||t
1457365|NCT01542385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457366|NCT01542372|Randomized|Parallel Assignment||Treatment||Single||||||t
1457367|NCT01542359|Randomized|Parallel Assignment||Treatment||Single||||||t
1457368|NCT01542346|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457369|NCT01542333|||Case-Only||Retrospective|||||||
1457370|NCT01542320|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1457371|NCT01542307|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1457372|NCT01542294||Single Group Assignment||Treatment||None (Open Label)||||||
1457373|NCT01542281|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457374|NCT01542268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457375|NCT01542255||Single Group Assignment||Treatment||None (Open Label)||||||
1457376|NCT01542242||Single Group Assignment||Treatment||None (Open Label)||||||
1457377|NCT01542229|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1457378|NCT01542216|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457379|NCT01542203|||Cohort||Prospective|||||||
1457380|NCT01542190|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457381|NCT01542177|||Cohort||Prospective|||||||
1457382|NCT01542164|||Other||Cross-Sectional|||||||
1457383|NCT01542151|Randomized|Single Group Assignment||||None (Open Label)||||||
1457384|NCT01542138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457385|NCT01542125|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1457386|NCT01542112|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1457387|NCT01542099|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457388|NCT01542086|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1457389|NCT01542073||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457390|NCT01542060|||Cohort||Prospective|||||||
1457391|NCT01542047||Single Group Assignment||Treatment||None (Open Label)||||||
1457392|NCT01542034|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457393|NCT01542021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457394|NCT01542008|Randomized|Parallel Assignment||Treatment||Single||||||t
1457395|NCT01541995|||Cohort||Prospective|||||||
1457396|NCT01541982|||Cohort||Prospective|||||||
1457397|NCT01541969|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457398|NCT01541956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457399|NCT01541943|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457400|NCT01541930||Single Group Assignment||Treatment||None (Open Label)||||||
1457401|NCT01541917|Randomized|Parallel Assignment||Treatment||Single||||||t
1457402|NCT01541904|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457403|NCT01541891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457404|NCT01541878|||Cohort||Prospective|||||||
1457405|NCT01541865||Single Group Assignment||Treatment||None (Open Label)||||||
1457406|NCT01541852|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1457407|NCT01541839|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457408|NCT01541826|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1457409|NCT01541813|||Cohort||Prospective|||||||
1457410|NCT01541800|||Case-Only||Prospective|||||||
1457411|NCT01541774||Single Group Assignment||Treatment||None (Open Label)||||||
1457412|NCT01541761|Randomized|Parallel Assignment||Prevention||Single||||||t
1457413|NCT01541748|||Cohort||Prospective|||||||
1457414|NCT01541735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457415|NCT01541722|||Cohort||Prospective|||||||
1457416|NCT01541709||Single Group Assignment||Treatment||None (Open Label)||||||
1457417|NCT01541696|||Cohort||Prospective|||||||
1457418|NCT01541683|Randomized|Parallel Assignment||||None (Open Label)||||||
1457419|NCT01541670||Single Group Assignment||Treatment||None (Open Label)||||||
1457420|NCT01541657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457421|NCT01541644||Single Group Assignment||Supportive Care||None (Open Label)||||||
1457422|NCT01541631|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1457423|NCT01541618|||Cohort||Prospective|||||||
1457424|NCT01541605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457425|NCT01541592|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1457426|NCT01541579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457427|NCT01541566|||Case Control||Prospective|||||||
1457428|NCT01541553|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457429|NCT01541540|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1457430|NCT01541527|||Cohort||Prospective|||||||
1457431|NCT01541514|||Cohort||Prospective|||||||
1457432|NCT01541501|||Cohort||Prospective|||||||
1457433|NCT01541488|Randomized|Parallel Assignment||Treatment||Single||||||
1457434|NCT01541475|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457435|NCT01541462|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457436|NCT01541449|||Case Control||Retrospective|||||||
1457437|NCT01541436|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1457438|NCT01541423|||Case-Only||Prospective|||||||
1457439|NCT01541410||Single Group Assignment||Treatment||None (Open Label)||||||
1457440|NCT01541397|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457441|NCT01541384|Randomized|Parallel Assignment||Prevention||Single|||||t|
1457442|NCT01541371||Single Group Assignment||Treatment||None (Open Label)||||||
1457443|NCT01541358||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457444|NCT01541345|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457445|NCT01541332||Single Group Assignment||Treatment||None (Open Label)||||||
1457446|NCT01541319|||||Prospective|||||||
1457447|NCT01541306|||Case-Only||Prospective|||||||
1457448|NCT01541293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457449|NCT01541280||Single Group Assignment||Treatment||None (Open Label)||||||
1457450|NCT01541267|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457451|NCT01541254||Single Group Assignment||Treatment||None (Open Label)||||||
1457452|NCT01541241|||Case Control||Cross-Sectional|||||||
1457453|NCT01541228|Randomized|Crossover Assignment||Treatment||Single|||t|||
1457454|NCT01541215|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457455|NCT01541202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457456|NCT01541189||Single Group Assignment||Treatment||None (Open Label)||||||
1457457|NCT01541176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457458|NCT01541163|||Cohort||Prospective|||||||
1457459|NCT01541150|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457460|NCT01541137|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457461|NCT01541124||Single Group Assignment||Treatment||None (Open Label)||||||
1457462|NCT01541111||Single Group Assignment||Treatment||Double|||t||t|
1457463|NCT01541098|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1457464|NCT01541085|||||Retrospective|||||||
1457465|NCT01541072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457466|NCT01541059|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457467|NCT01541046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457468|NCT01541033|||Case Control||Prospective|||||||
1457469|NCT01541020|||Case Control||Cross-Sectional|||||||
1457470|NCT01541007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457471|NCT01540994||Single Group Assignment||Treatment||None (Open Label)||||||
1457472|NCT01540981|Randomized|Parallel Assignment||Prevention||Single||||||t
1457473|NCT01540968|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1457474|NCT01540955|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457475|NCT01540942|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457476|NCT01540929|||Cohort||Retrospective|||||||
1457477|NCT01540916|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1457478|NCT01540903|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1457479|NCT01540890|||Case Control||Prospective|||||||
1457480|NCT01540877|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1457481|NCT01540864|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457482|NCT01540851|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1457483|NCT01540838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457484|NCT01540825|Randomized|Parallel Assignment||Treatment||Double||||||
1457485|NCT01540812|||Case-Only||Prospective|||||||
1457486|NCT01540799|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457487|NCT01540786|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1457488|NCT01540773|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1457489|NCT01540760|Randomized|Parallel Assignment||||Double|||t||t|
1457490|NCT01540747||||||||||||
1457491|NCT01540734|Randomized|Crossover Assignment||||None (Open Label)||||||
1457492|NCT01540721|Randomized|Crossover Assignment||||None (Open Label)||||||
1457493|NCT01540708|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457494|NCT01540695|||Cohort||Prospective|||||||
1457495|NCT01540682||Single Group Assignment||Treatment||||||||
1457496|NCT01540669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457497|NCT01540656|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457498|NCT01540643|||Cohort||Prospective|||||||
1457499|NCT01540630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457500|NCT01540617|||Case Control||Cross-Sectional|||||||
1457501|NCT01540604||||||||||||
1457502|NCT01540591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457503|NCT01540578|||||Retrospective|||||||
1457504|NCT01540565||Single Group Assignment||Treatment||None (Open Label)||||||
1457505|NCT01540552|||Case-Only||Retrospective|||||||
1457506|NCT01540539|Randomized|Parallel Assignment||||Triple|||t||t|t
1457507|NCT01540526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457508|NCT01540513||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457509|NCT01540500||Single Group Assignment||Basic Science||None (Open Label)||||||
1457510|NCT01540487|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457511|NCT01540474|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457512|NCT01540461||Single Group Assignment||Basic Science||None (Open Label)||||||
1457513|NCT01540448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457514|NCT01540435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457515|NCT01540422|||Case-Only||Prospective|||||||
1457516|NCT01540409||Single Group Assignment||Treatment||None (Open Label)||||||
1457517|NCT01540396|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1457518|NCT01540383|Randomized|Parallel Assignment||Treatment||Single||||||t
1457519|NCT01540370|||Cohort||Prospective|||||||
1457520|NCT01540357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457521|NCT01540344||Single Group Assignment||Treatment||None (Open Label)||||||
1457522|NCT01540331||Single Group Assignment||Treatment||Single||||t||
1457523|NCT01540318|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1457524|NCT01540305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457525|NCT01540292||Single Group Assignment||Treatment||None (Open Label)||||||
1457526|NCT01540279|||Cohort||Prospective|||||||
1457527|NCT01540266|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1457528|NCT01540253||Single Group Assignment||Treatment||None (Open Label)||||||
1457529|NCT01540240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457530|NCT01540227|||Cohort||Prospective|||||||
1457531|NCT01540214|||Cohort||Prospective|||||||
1457532|NCT01540201|Randomized|Parallel Assignment||||Double|||t|||t
1457533|NCT01540188|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457534|NCT01540175|||Case-Only||Prospective|||||||
1457535|NCT01540162|||Cohort||Prospective|||||||
1457536|NCT01540149|||Case-Only||Prospective|||||||
1457537|NCT01540136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457538|NCT01540123|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1457539|NCT01540110||Single Group Assignment||Treatment||None (Open Label)||||||
1457540|NCT01540084|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457541|NCT01540071||Single Group Assignment||Treatment||None (Open Label)||||||
1457542|NCT01540058|Randomized|Parallel Assignment||||None (Open Label)||||||
1457543|NCT01540045|||Cohort||Prospective|||||||
1457544|NCT01540032|Randomized|Crossover Assignment||Treatment||Single||||||t
1457545|NCT01540019||Single Group Assignment||Treatment||None (Open Label)||||||
1457546|NCT01540006|||Cohort||Prospective|||||||
1457547|NCT01539993|||||Prospective|||||||
1457548|NCT01539980||Single Group Assignment||Treatment||Single|||t|||
1457549|NCT01539967||Single Group Assignment||Prevention||None (Open Label)||||||
1457550|NCT01539954|||Case-Only||Cross-Sectional|||||||
1457551|NCT01539941||Single Group Assignment||Treatment||None (Open Label)||||||
1457552|NCT01539928|||Case-Only||Prospective|||||||
1457553|NCT01539915||Single Group Assignment||||||||||
1457554|NCT01539902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457555|NCT01539889||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457556|NCT01539876||Single Group Assignment||Basic Science||None (Open Label)||||||
1457557|NCT01539863|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1457558|NCT01539850||Single Group Assignment||Treatment||None (Open Label)||||||
1457559|NCT01539837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457560|NCT01539824||Single Group Assignment||Treatment||None (Open Label)||||||
1457561|NCT01539811|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457562|NCT01539798|Randomized|Crossover Assignment||||Single||||||t
1457563|NCT01539785|Randomized|Parallel Assignment||Treatment||Double||||||
1457564|NCT01539772|||Cohort||Prospective|||||||
1457565|NCT01539759|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457566|NCT01539746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457567|NCT01539733|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457568|NCT01539720|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1457569|NCT01539707|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1457570|NCT01539694||||||||||||
1457571|NCT01539681|||Cohort||Prospective|||||||
1457572|NCT01539668|||||Prospective|||||||
1458820|NCT01523288|||Case Control|||||||||
1457573|NCT01539655|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1457574|NCT01539642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457575|NCT01539629|||Case-Only||Prospective|||||||
1457576|NCT01539616|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457577|NCT01539603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457578|NCT01539590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457579|NCT01539577|||Cohort||Prospective|||||||
1457580|NCT01539564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457581|NCT01539551|||Cohort||Prospective|||||||
1457582|NCT01539538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457583|NCT01539525|Randomized|Parallel Assignment||Treatment||None (Open Label)|Participants received a behavioral intervention that could not be masked. Outcome data were self report and urine tests rom the participants.|||||
1457584|NCT01539512|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457585|NCT01539499|||Case-Only||Retrospective|||||||
1457586|NCT01539486|||Other||Retrospective|||||||
1457587|NCT01539473|Randomized|Single Group Assignment||||Double|||t||t|
1457588|NCT01539460||Single Group Assignment||Treatment||None (Open Label)||||||
1457589|NCT01539447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457590|NCT01539434|Randomized|Parallel Assignment||Treatment||Single||||||t
1457591|NCT01539421||Single Group Assignment||Treatment||None (Open Label)||||||
1457592|NCT01539408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457593|NCT01539395|||Cohort||Cross-Sectional|||||||
1457594|NCT01539382|Randomized|Parallel Assignment||Prevention||Single|||t|||
1457595|NCT01539369|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1457596|NCT01539356|||Case-Only||Prospective|||||||
1457597|NCT01539343||Single Group Assignment||Treatment||None (Open Label)||||||
1457598|NCT01539330||Single Group Assignment||||None (Open Label)||||||
1457599|NCT01539317|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457600|NCT01539304|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457601|NCT01539291|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457602|NCT01539278|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457603|NCT01539265|Randomized|Parallel Assignment||Treatment||Double||||||
1457604|NCT01539252|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457605|NCT01539239|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457606|NCT01539226|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1457607|NCT01539213|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1457608|NCT01539200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457609|NCT01539187||Single Group Assignment||Treatment||None (Open Label)||||||
1457610|NCT01539174||Single Group Assignment||Treatment||None (Open Label)||||||
1457611|NCT01539161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457612|NCT01539148|||Cohort||Prospective|||||||
1457613|NCT01539135|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1457614|NCT01539122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457615|NCT01539109|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457616|NCT01539096|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457617|NCT01539083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457618|NCT01539070|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457619|NCT01539057|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457620|NCT01539044|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1457621|NCT01539031|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457622|NCT01539018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457623|NCT01539005|||Cohort||Prospective|||||||
1457624|NCT01538992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457625|NCT01538979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457626|NCT01538966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457627|NCT01538953|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457628|NCT01538940|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1457629|NCT01538927|Randomized|Parallel Assignment||Treatment||Single||||||t
1457630|NCT01538914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457631|NCT01538901|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457632|NCT01538888||Single Group Assignment||Supportive Care||Triple|||t||t|t
1457633|NCT01538875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457634|NCT01538862||Single Group Assignment||Treatment||None (Open Label)||||||
1457635|NCT01538849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457636|NCT01538836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457637|NCT01538823|||Cohort||Prospective|||||||
1457638|NCT01538810|||Ecologic or Community||Prospective|||||||
1457639|NCT01538797|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1457640|NCT01538784|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1457641|NCT01538771|Randomized|Parallel Assignment||Treatment||Single||||||t
1457642|NCT01538758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457643|NCT01538745|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457644|NCT01538732||Single Group Assignment||Treatment||None (Open Label)||||||
1457645|NCT01538719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457646|NCT01538706||Single Group Assignment||Supportive Care||None (Open Label)||||||
1457647|NCT01538693|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1457648|NCT01538680||||||||||||
1457649|NCT01538667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457650|NCT01538654|||Cohort||Prospective|||||||
1457651|NCT01538641||Single Group Assignment||Treatment||None (Open Label)||||||
1457652|NCT01538628|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457653|NCT01538615|Randomized|Parallel Assignment||Prevention||None (Open Label)|This is a behavioral intervention. Masking is not feasible.|||||
1457654|NCT01538602|||Case-Only||Prospective|||||||
1457655|NCT01538589|||Cohort||Prospective|||||||
1457656|NCT01538576|||Cohort||Prospective|||||||
1457657|NCT01538563||Single Group Assignment||Treatment||None (Open Label)||||||
1457658|NCT01538550|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1457659|NCT01538537||Single Group Assignment||Treatment||None (Open Label)||||||
1457660|NCT01538524|||Case-Only|||||||||
1457661|NCT01538511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457662|NCT01538498|||Case-Only||Prospective|||||||
1457663|NCT01538485||Single Group Assignment||Prevention||None (Open Label)||||||
1457664|NCT01538472||Single Group Assignment||Treatment||None (Open Label)||||||
1457665|NCT01538459|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457666|NCT01538446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457667|NCT01538433|||||Retrospective|||||||
1457668|NCT01538420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457669|NCT01538407|Randomized|Parallel Assignment||Basic Science||Single||||||t
1457670|NCT01538394|Randomized|Parallel Assignment||||Double|||t|t||
1457671|NCT01538381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457672|NCT01538368|||Cohort||Prospective|||||||
1457673|NCT01538355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457674|NCT01538342|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1457675|NCT01538329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457676|NCT01538316|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1457677|NCT01538303|||Cohort||Prospective|||||||
1457678|NCT01538290|||Cohort||Cross-Sectional|||||||
1457679|NCT01538277|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457680|NCT01538264|||Case-Only||Cross-Sectional|||||||
1457681|NCT01538251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457682|NCT01538238||Single Group Assignment||Treatment||None (Open Label)||||||
1457683|NCT01538225|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457684|NCT01538212|||Case-Only||Retrospective|||||||
1457685|NCT01538199|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457686|NCT01538186|||Cohort||Retrospective|||||||
1457687|NCT01538173|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457688|NCT01538160||Single Group Assignment||Treatment||None (Open Label)||||||
1457689|NCT01538147|||Case-Control||Prospective|||||||
1457690|NCT01538134|||Case Control||Prospective|||||||
1457691|NCT01538121|||Case Control||Prospective|||||||
1457692|NCT01538108|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457693|NCT01538095||Single Group Assignment||Treatment||None (Open Label)||||||
1457694|NCT01538082|||Cohort||Prospective|||||||
1457695|NCT01538069|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457696|NCT01538056||Single Group Assignment||Treatment||None (Open Label)||||||
1457697|NCT01538043|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457698|NCT01538030|||Cohort||Prospective|||||||
1457699|NCT01538017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457700|NCT01538004|||Case-Crossover||Prospective|||||||
1457701|NCT01537991|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457702|NCT01537978||Single Group Assignment||Treatment||None (Open Label)||||||
1457703|NCT01537965|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1457704|NCT01537952|||Case-Only||Prospective|||||||
1457705|NCT01537939||Single Group Assignment||Prevention||None (Open Label)||||||
1457706|NCT01537926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457707|NCT01537913|||Case-Only||Prospective|||||||
1457708|NCT01537900||Single Group Assignment||Treatment||None (Open Label)||||||
1457709|NCT01537887|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1457710|NCT01537874|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457711|NCT01537861||Single Group Assignment||Treatment||None (Open Label)||||||
1457712|NCT01537848|||Case-Only||Retrospective|||||||
1457713|NCT01537835|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1457714|NCT01537822|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457715|NCT01537809|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1457716|NCT01537796|Randomized|Parallel Assignment||Treatment||Single||||||t
1457717|NCT01537783|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457718|NCT01537770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457719|NCT01537757|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457720|NCT01537744||Single Group Assignment||Treatment||None (Open Label)||||||
1457721|NCT01537731|||Case-Only||Prospective|||||||
1457722|NCT01537718||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457723|NCT01537705||Single Group Assignment||Treatment||None (Open Label)||||||
1457724|NCT01537692|Randomized|Crossover Assignment||||None (Open Label)||||||
1457725|NCT01537679|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1457726|NCT01537666|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457727|NCT01537653|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457728|NCT01537640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457729|NCT01537627|Randomized|Parallel Assignment||Treatment||Single||||||t
1457730|NCT01537614||||||||||||
1457731|NCT01537601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457732|NCT01537588|Randomized|Parallel Assignment||Treatment||Single||||||t
1457733|NCT01537575|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457734|NCT01537562|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457735|NCT01537549||Single Group Assignment||Treatment||None (Open Label)||||||
1457736|NCT01537536||Single Group Assignment||Treatment||None (Open Label)||||||
1457737|NCT01537523|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1457738|NCT01537510|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457739|NCT01537497|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1457740|NCT01537484|Randomized|Factorial Assignment||Other||Single||||||t
1457741|NCT01537471|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1457742|NCT01537458|||Cohort||Retrospective|||||||
1457743|NCT01537445|||Case-Only||Prospective|||||||
1457744|NCT01537432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457745|NCT01537419|Randomized|Parallel Assignment||Treatment||Single||||||t
1457746|NCT01537406|||Case-Only||Retrospective|||||||
1457747|NCT01537393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457748|NCT01537380||Single Group Assignment||Other||None (Open Label)||||||
1457749|NCT01537367|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1457750|NCT01537354|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457751|NCT01537341|Randomized|Parallel Assignment||Treatment||Single||||||t
1457752|NCT01537328|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457753|NCT01537315|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457754|NCT01537302||Single Group Assignment||Treatment||None (Open Label)||||||
1457755|NCT01537289|Randomized|Parallel Assignment||Treatment||Single||||||t
1457756|NCT01537276|Non-Randomized|Crossover Assignment||Diagnostic||Double||||t|t|
1457757|NCT01537263|||Case-Only||Prospective|||||||
1457758|NCT01537250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457759|NCT01537237|||Case Control||Prospective|||||||
1457760|NCT01537224||Single Group Assignment||Basic Science||None (Open Label)||||||
1457761|NCT01537211|Randomized|Crossover Assignment||Treatment||Single||||||t
1457762|NCT01537198|||Case-Only||Prospective|||||||
1457763|NCT01537185|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1457764|NCT01537172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457765|NCT01537159|||Cohort||Prospective|||||||
1457766|NCT01537146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457767|NCT01537133|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1457768|NCT01537120||Single Group Assignment||Diagnostic||Single|||t|||
1457769|NCT01537107||Single Group Assignment||Treatment||None (Open Label)||||||
1457770|NCT01537094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457771|NCT01537081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457772|NCT01537068|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457773|NCT01537055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457774|NCT01537042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457775|NCT01537029||Single Group Assignment||Other||None (Open Label)||||||
1457776|NCT01537016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457777|NCT01537003|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1457778|NCT01536990|||Case-Only||Prospective|||||||
1457779|NCT01536977||Single Group Assignment||Supportive Care||None (Open Label)||||||
1457780|NCT01536964|Randomized|Crossover Assignment||||None (Open Label)||||||
1457781|NCT01536951|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1457782|NCT01536938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457783|NCT01536925|||Case-Only||Prospective|||||||
1457784|NCT01536912|||Case-Only|||||||||
1457785|NCT01536899|||Cohort||Prospective|||||||
1457786|NCT01536886|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1457787|NCT01536873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457788|NCT01536860|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1457789|NCT01536847|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1457790|NCT01536834||Single Group Assignment||Treatment||None (Open Label)||||||
1457791|NCT01536821|||||Prospective|||||||
1457792|NCT01536808||Single Group Assignment||Prevention||None (Open Label)||||||
1457793|NCT01536795|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457794|NCT01536782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457795|NCT01536769|||Case Control||Cross-Sectional|||||||
1457796|NCT01536756|Randomized|Parallel Assignment||Treatment||Single||||||t
1457797|NCT01536743||Single Group Assignment||Treatment||None (Open Label)||||||
1457798|NCT01536730|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457799|NCT01536717|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457800|NCT01536704|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1457801|NCT01536691|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1457802|NCT01536678|Randomized|Crossover Assignment||||None (Open Label)||||||
1457803|NCT01536665|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457804|NCT01536652|||Cohort||Prospective|||||||
1457805|NCT01536639|||Cohort||Prospective|||||||
1457806|NCT01536626|||Cohort||Prospective|||||||
1457807|NCT01536613|||Cohort||Prospective|||||||
1457808|NCT01536600|||Cohort||Prospective|||||||
1457810|NCT01536574||Single Group Assignment||Treatment||None (Open Label)||||||
1457811|NCT01536561||Single Group Assignment||Treatment||None (Open Label)||||||
1457812|NCT01536548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457813|NCT01536535|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457814|NCT01536522|Randomized|Single Group Assignment||Other||Quadruple||feasibility and palatability of a food product for asthma|t|t|t|t
1457815|NCT01536509|Randomized|Parallel Assignment||Treatment||Single|||||t|
1457816|NCT01536496|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1457817|NCT01536483|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457818|NCT01536470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457819|NCT01536457|||||Retrospective|||||||
1457820|NCT01536444||Single Group Assignment||Treatment||None (Open Label)||||||
1457821|NCT01536431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457822|NCT01536418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457823|NCT01536405|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457824|NCT01536392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457825|NCT01536379|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457826|NCT01536366|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457827|NCT01536353|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457828|NCT01536340|||Cohort||Prospective|||||||
1457829|NCT01536327|||Cohort||Prospective|||||||
1457830|NCT01536314||Single Group Assignment||Prevention||None (Open Label)||||||
1457831|NCT01536301|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457832|NCT01536288|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1457833|NCT01536275|Randomized|Parallel Assignment||Treatment||Single||||||t
1457834|NCT01536262|Randomized|Parallel Assignment||Treatment||Double||||||
1457835|NCT01536249|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457836|NCT01536236|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457837|NCT01536223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457838|NCT01536210|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457839|NCT01536197|||Cohort||Prospective|||||||
1457840|NCT01536184|Randomized|Parallel Assignment||Treatment||Single||||||t
1457841|NCT01536171|||Case-Only||Prospective|||||||
1457842|NCT01536158|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457843|NCT01536145||Single Group Assignment||Treatment||None (Open Label)||||||
1457844|NCT01536132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457845|NCT01536119|Randomized|Parallel Assignment||Treatment||Single||||||t
1457846|NCT01536106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457847|NCT01536093|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1457848|NCT01536080|||Case Control||Retrospective|||||||
1457849|NCT01536067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457850|NCT01536054||Single Group Assignment||Treatment||None (Open Label)||||||
1457851|NCT01536041|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457852|NCT01536028|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1457853|NCT01536015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457854|NCT01536002||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457855|NCT01535989||Single Group Assignment||Treatment||None (Open Label)||||||
1457856|NCT01535976|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1457857|NCT01535963|||Cohort||Prospective|||||||
1457858|NCT01535950|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457859|NCT01535937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457860|NCT01535924||Single Group Assignment||Treatment||None (Open Label)||||||
1457861|NCT01535911||Single Group Assignment||Treatment||None (Open Label)||||||
1457862|NCT01535898|||Cohort||Prospective|||||||
1457863|NCT01535885||Single Group Assignment||Prevention||None (Open Label)||||||
1457864|NCT01535872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457865|NCT01535859|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457866|NCT01535846|Randomized|Parallel Assignment||||None (Open Label)||||||
1457867|NCT01535833||Single Group Assignment||Treatment||None (Open Label)||||||
1457868|NCT01535820|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457869|NCT01535807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457870|NCT01535794|||Cohort||Cross-Sectional|||||||
1457871|NCT01535781|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1457872|NCT01535768|Randomized|Parallel Assignment||Treatment||Single||||||t
1457873|NCT01535755|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1457874|NCT01535742|Randomized|Parallel Assignment||||Single||||t||
1457875|NCT01535729|||Cohort||Prospective|||||||
1457876|NCT01535716|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1457877|NCT01535703|||Cohort||Prospective|||||||
1457878|NCT01535690||Single Group Assignment||Treatment||Single|||||t|
1457879|NCT01535677|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1457880|NCT01535664|||Cohort|||||||||
1457881|NCT01535651|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457882|NCT01535638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457883|NCT01535625||Single Group Assignment||Treatment||None (Open Label)||||||
1457884|NCT01535612||Single Group Assignment||Treatment||None (Open Label)||||||
1457885|NCT01535599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457886|NCT01535586|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1457887|NCT01535573|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457888|NCT01535560|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457889|NCT01535547||Single Group Assignment||||None (Open Label)||||||
1457890|NCT01535534|||Cohort||Prospective|||||||
1457891|NCT01535521||||||||||||
1457892|NCT01535508||Single Group Assignment||Treatment||None (Open Label)||||||
1457893|NCT01535495|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457894|NCT01535482|Randomized|Parallel Assignment||Treatment||Single||||||t
1457895|NCT01535469||Single Group Assignment||Prevention||Single||||||t
1457896|NCT01535456||Single Group Assignment||Diagnostic||None (Open Label)||||||
1457897|NCT01535443||Single Group Assignment||Treatment||None (Open Label)||||||
1457898|NCT01535430|||Cohort||Prospective|||||||
1457899|NCT01535417|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457900|NCT01535404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457901|NCT01535391||Single Group Assignment||Treatment||None (Open Label)||||||
1457902|NCT01535378|||Case-Only||Prospective|||||||
1457903|NCT01535365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457904|NCT01535352|Randomized|Parallel Assignment||Treatment||Single||||||t
1457905|NCT01535339|||Cohort||Prospective|||||||
1457906|NCT01535326|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1457907|NCT01535313|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1457908|NCT01535300|||Case-Only||Prospective|||||||
1457909|NCT01535287|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457910|NCT01535274|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457911|NCT01535261||Single Group Assignment||Treatment||None (Open Label)||||||
1457912|NCT01535248|||Cohort||Cross-Sectional|||||||
1457913|NCT01535235|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457914|NCT01535222|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1457915|NCT01535209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457916|NCT01535196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457917|NCT01535183||Single Group Assignment||Treatment||None (Open Label)||||||
1457918|NCT01535170|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457919|NCT01535157||Single Group Assignment||Treatment||None (Open Label)||||||
1457920|NCT01535144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457921|NCT01535131|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1457922|NCT01535118|||Ecologic or Community||Prospective|||||||
1457923|NCT01535105|||Cohort||Cross-Sectional|||||||
1457924|NCT01535092|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457925|NCT01535079|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1457926|NCT01535066|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1457927|NCT01535053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457928|NCT01535040|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1457929|NCT01535027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457930|NCT01535014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457931|NCT01535001|Randomized|Parallel Assignment||Treatment||Single||||||t
1457932|NCT01534975|Randomized|Parallel Assignment||Diagnostic||Triple||randomized cohort into 4 groups - each group with a different contrast agent (omnipaque, visipaque 280, visipaque 320, isovue)|t|t|t|
1457933|NCT01534962|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457934|NCT01534949||Single Group Assignment||Treatment||None (Open Label)||||||
1457935|NCT01534936|||Cohort||Prospective|||||||
1457936|NCT01534923|||Cohort||Prospective|||||||
1457937|NCT01534910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457938|NCT01534897||Single Group Assignment||Treatment||None (Open Label)||||||
1457939|NCT01534884|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457940|NCT01534871|Randomized|Parallel Assignment||Prevention||Single||||||t
1457941|NCT01534858||Single Group Assignment||Supportive Care||None (Open Label)||||||
1457942|NCT01534845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457943|NCT01534832||Single Group Assignment||Basic Science||Double|||||t|t
1457944|NCT01534819|||Cohort||Prospective|||||||
1457945|NCT01534806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457946|NCT01534793|||Cohort||Prospective|||||||
1457947|NCT01534780|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1457948|NCT01534754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457949|NCT01534741|Randomized|Crossover Assignment||||None (Open Label)||||||
1457950|NCT01534728|||Case-Only||Prospective|||||||
1457951|NCT01534715||Single Group Assignment||Treatment||None (Open Label)||||||
1457952|NCT01534702||Single Group Assignment||Treatment||None (Open Label)||||||
1457953|NCT01534689||Single Group Assignment||Treatment||None (Open Label)||||||
1457954|NCT01534676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1457955|NCT01534663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457956|NCT01534650|||Case-Only||Prospective|||||||
1457957|NCT01534637||Single Group Assignment||Supportive Care||None (Open Label)||||||
1457958|NCT01534624|||||Prospective|||||||
1457959|NCT01534598||Single Group Assignment||Treatment||None (Open Label)||||||
1457960|NCT01534585||Single Group Assignment||Treatment||None (Open Label)||||||
1457961|NCT01534572|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1457962|NCT01534559|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1457963|NCT01534546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457964|NCT01534533|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457965|NCT01534520|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1457966|NCT01534507|||||Prospective|||||||
1457967|NCT01534494||Single Group Assignment||Treatment||None (Open Label)||||||
1457968|NCT01534481|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457969|NCT01534468|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457970|NCT01534455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457971|NCT01534442|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1457972|NCT01534429|||Cohort||Prospective|||||||
1457973|NCT01534416|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1457974|NCT01534403||Single Group Assignment||Treatment||None (Open Label)||||||
1457975|NCT01534390|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457976|NCT01534377|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457977|NCT01534364|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1457978|NCT01534351|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1457979|NCT01534338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457980|NCT01534325|Randomized|Parallel Assignment||Treatment||Single|||t|||
1457981|NCT01534312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457982|NCT01534299|||Case-Only||Prospective|||||||
1457983|NCT01534286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1457984|NCT01534273|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1457985|NCT01534260||Single Group Assignment||Treatment||None (Open Label)||||||
1457986|NCT01534247|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1457987|NCT01534234|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457988|NCT01534221|Randomized|Parallel Assignment||Treatment||Single||||||t
1457989|NCT01534208|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457990|NCT01534195|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1457991|NCT01534182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457992|NCT01534169||Single Group Assignment||Treatment||Double|||t||t|
1457993|NCT01534143||Single Group Assignment||Treatment||None (Open Label)||||||
1457994|NCT01534130|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1457995|NCT01534117|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1457996|NCT01534104||Single Group Assignment||Prevention||None (Open Label)||||||
1457997|NCT01534091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1457998|NCT01534078||Single Group Assignment||Treatment||None (Open Label)||||||
1457999|NCT01534065||Single Group Assignment||Treatment||None (Open Label)||||||
1458000|NCT01534052||Single Group Assignment||Treatment||None (Open Label)||||||
1458001|NCT01534039|Randomized|Crossover Assignment||||None (Open Label)||||||
1458002|NCT01534026|Randomized|Crossover Assignment||Treatment||Single|||t|||
1458003|NCT01534013||Single Group Assignment||Treatment||None (Open Label)||||||
1458004|NCT01534000|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1458005|NCT01533987|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1458006|NCT01533974|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1458007|NCT01533961|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1458008|NCT01533948||Single Group Assignment||Treatment||None (Open Label)||||||
1458009|NCT01533935|Randomized|Crossover Assignment||Treatment||Double||||||
1458010|NCT01533922|Randomized|Crossover Assignment||Treatment||Double||||||
1458011|NCT01533909|||||Cross-Sectional|||||||
1458012|NCT01533896|Randomized|Parallel Assignment||Treatment||Single||||||t
1458013|NCT01533883|||Cohort||Prospective|||||||
1458014|NCT01533870|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1458015|NCT01533857|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458016|NCT01533844|||||Prospective|||||||
1458017|NCT01533831||||||||||||
1458018|NCT01533818|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1458019|NCT01533805|Randomized|Parallel Assignment||Treatment||Single||||||t
1458020|NCT01533792|Randomized|Parallel Assignment||Treatment||Single|||t|||
1458021|NCT01533779|||Cohort||Prospective|||||||
1458022|NCT01533766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458023|NCT01533753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458024|NCT01533740|||Cohort||Prospective|||||||
1458025|NCT01533727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458026|NCT01533714||Single Group Assignment||Treatment||None (Open Label)||||||
1458027|NCT01533701||Single Group Assignment||Prevention||None (Open Label)||||||
1458028|NCT01533688|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1458029|NCT01533675|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1458030|NCT01533662|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1458031|NCT01533649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458032|NCT01533636|||Case-Control||Cross-Sectional|||||||
1458033|NCT01533623||Single Group Assignment||Basic Science||Single|||t|||
1458034|NCT01533610||Single Group Assignment||Supportive Care||None (Open Label)||||||
1458035|NCT01533597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458036|NCT01533584|||Case-Only||Cross-Sectional|||||||
1458037|NCT01533571|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1458038|NCT01533558|||Case-Only||Prospective|||||||
1458039|NCT01533545|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1458040|NCT01533532|Randomized|Parallel Assignment||Treatment||Double||||||
1458041|NCT01533519|Randomized|Crossover Assignment||||Double|||t||t|
1458042|NCT01533506||||||||||||
1458043|NCT01533493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458044|NCT01533480|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458045|NCT01533467|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458046|NCT01533454|Randomized|Factorial Assignment||Health Services Research||Single||||t||
1458047|NCT01533441|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1458048|NCT01533428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458049|NCT01533415|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458050|NCT01533402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458051|NCT01533389|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458052|NCT01533376|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1458053|NCT01533363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458054|NCT01533350|||Case Control||Prospective|||||||
1458055|NCT01533337||Single Group Assignment||Treatment||None (Open Label)||||||
1458056|NCT01533324||Single Group Assignment||Treatment||None (Open Label)||||||
1458057|NCT01533311|||Cohort||Prospective|||||||
1458058|NCT01533298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458059|NCT01533285|Randomized|Crossover Assignment||Treatment||Single|||t|||
1458060|NCT01533272|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458061|NCT01533259||Single Group Assignment||Treatment||None (Open Label)||||||
1458062|NCT01533246||Single Group Assignment||Treatment||None (Open Label)||||||
1458063|NCT01533233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458064|NCT01533220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458065|NCT01533207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458066|NCT01533194||Single Group Assignment||Treatment||None (Open Label)||||||
1458067|NCT01533181|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458068|NCT01533168|||Case Control||Retrospective|||||||
1458069|NCT01533155|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1458070|NCT01533142|||Case Control||Prospective|||||||
1458071|NCT01533129|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458072|NCT01533116|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458073|NCT01533103||||||||||||
1458074|NCT01533090|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1458075|NCT01533077|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458076|NCT01533064|||Case-Only||Retrospective|||||||
1458077|NCT01533051|||Cohort||Prospective|||||||
1458078|NCT01533038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458079|NCT01533025|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458080|NCT01533012||Single Group Assignment||Treatment||Single|||||t|
1458081|NCT01532999|Randomized|Parallel Assignment||Treatment||Single||||||t
1458082|NCT01532986|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1458083|NCT01532973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458084|NCT01532960||Single Group Assignment||Treatment||None (Open Label)||||||
1458085|NCT01532947|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1458086|NCT01532934|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458087|NCT01532921|||Cohort||Prospective|||||||
1458088|NCT01532908|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1458089|NCT01532895|||Cohort||Prospective|||||||
1458090|NCT01532882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458091|NCT01532869|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458092|NCT01532856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458093|NCT01532843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458094|NCT01532830||Single Group Assignment||Treatment||None (Open Label)||||||
1458095|NCT01532817||Single Group Assignment||Treatment||None (Open Label)||||||
1458096|NCT01532804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458097|NCT01532791|||Case Control||Prospective|||||||
1458098|NCT01532778|||Cohort||Prospective|||||||
1458099|NCT01532765|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1458100|NCT01532752||||||||||||
1458101|NCT01532739|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458102|NCT01532726|||Case Control||Prospective|||||||
1458103|NCT01532713||Single Group Assignment||Prevention||None (Open Label)||||||
1458104|NCT01532700||Single Group Assignment||Treatment||None (Open Label)||||||
1458105|NCT01532687|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458106|NCT01532674|Randomized|Parallel Assignment||Treatment||Single||||||t
1458107|NCT01532661|||Cohort||Prospective|||||||
1458108|NCT01532648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458109|NCT01532635||Single Group Assignment||Treatment||None (Open Label)||||||
1458110|NCT01532622|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458111|NCT01532609|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458112|NCT01532596|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1458113|NCT01532583|||Case-Only||Retrospective|||||||
1458114|NCT01532570||Single Group Assignment||Treatment||None (Open Label)||||||
1458115|NCT01532544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458116|NCT01532531|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1458117|NCT01532518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458118|NCT01532505|||Case Control||Prospective|||||||
1458119|NCT01532492|||Cohort||Prospective|||||||
1458120|NCT01532479|||Cohort||Prospective|||||||
1458121|NCT01532466|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1458122|NCT01532453|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458123|NCT01532440||||||||||||
1458124|NCT01532427|||Cohort||Prospective|||||||
1458125|NCT01532414|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458126|NCT01532401||||||||||||
1458127|NCT01532388|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458128|NCT01532375|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1458129|NCT01532362|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458130|NCT01532349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458131|NCT01532336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458132|NCT01532323|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1458133|NCT01532310|||Cohort||Prospective|||||||
1458134|NCT01532297|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458135|NCT01532284|Randomized|Single Group Assignment||Screening||Triple|||t|t||t
1458136|NCT01532271|||Cohort||Prospective|||||||
1458137|NCT01532258|Randomized|Parallel Assignment||||None (Open Label)||||||
1458138|NCT01532245|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1458139|NCT01532232|||Case Control||Prospective|||||||
1458140|NCT01532219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458141|NCT01532206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458142|NCT01532193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458143|NCT01532180|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458144|NCT01532167|||Cohort||Prospective|||||||
1458145|NCT01532154|||Cohort||Prospective|||||||
1458146|NCT01532141|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458147|NCT01532128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458148|NCT01532115|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458149|NCT01532102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458150|NCT01532089|Randomized|Parallel Assignment||Treatment||Single||||||t
1458151|NCT01532076|Randomized|Parallel Assignment||Treatment||Single||||||t
1458152|NCT01532063||Single Group Assignment||Other||None (Open Label)||||||
1458153|NCT01532050||Single Group Assignment||Treatment||Double|||t|t||
1458154|NCT01532037|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1458155|NCT01532024|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1458156|NCT01532011||Single Group Assignment||Treatment||None (Open Label)||||||
1458157|NCT01531998||Single Group Assignment||Treatment||None (Open Label)||||||
1458158|NCT01531985|||Case-Only||Prospective|||||||
1458159|NCT01531972|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1458160|NCT01531959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458161|NCT01531946|||Case-Only||Prospective|||||||
1458162|NCT01531933|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458163|NCT01531920|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1458164|NCT01531907|||Case Control||Prospective|||||||
1458165|NCT01531894|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458166|NCT01531881|||Cohort||Prospective|||||||
1458167|NCT01531868|Randomized|Single Group Assignment||||Double|||t||t|
1458168|NCT01531855||Single Group Assignment||Basic Science||None (Open Label)||||||
1458169|NCT01531842|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458170|NCT01531829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458171|NCT01531816||Single Group Assignment||Treatment||None (Open Label)||||||
1458172|NCT01531803|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458173|NCT01531790||Single Group Assignment||Treatment||None (Open Label)||||||
1458174|NCT01531777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458175|NCT01531764||Single Group Assignment||Treatment||None (Open Label)||||||
1458176|NCT01531751||Single Group Assignment||Treatment||None (Open Label)||||||
1458177|NCT01531738|||Case Control||Prospective|||||||
1458178|NCT01531725||Single Group Assignment||Treatment||None (Open Label)||||||
1458179|NCT01531712||Single Group Assignment||Treatment||None (Open Label)||||||
1458180|NCT01531699|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458181|NCT01531686|||Case-Only||Prospective|||||||
1458182|NCT01531673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458183|NCT01531660||Single Group Assignment||||None (Open Label)||||||
1458184|NCT01531647|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1458185|NCT01531634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458186|NCT01531621|||Cohort||Prospective|||||||
1458187|NCT01531608|||Cohort||Prospective|||||||
1458188|NCT01531595||Single Group Assignment||Treatment||None (Open Label)||||||
1458189|NCT01531582||Single Group Assignment||Treatment||None (Open Label)||||||
1458190|NCT01531569||Single Group Assignment||||None (Open Label)||||||
1458191|NCT01531556||Single Group Assignment||Basic Science||None (Open Label)||||||
1458192|NCT01531543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458193|NCT01531530|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458194|NCT01531517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458195|NCT01531504||Single Group Assignment||Treatment||None (Open Label)||||||
1458196|NCT01531491|Randomized|Parallel Assignment||||Double|||t|||t
1458197|NCT01531478|||Cohort||Prospective|||||||
1458198|NCT01531465|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1458199|NCT01531452||Single Group Assignment||Treatment||None (Open Label)||||||
1458200|NCT01531439|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1458201|NCT01531426|||Cohort||Prospective|||||||
1458202|NCT01531413||Single Group Assignment||Prevention||Single|||t|||
1458203|NCT01531400|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458204|NCT01531387|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458205|NCT01531374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458206|NCT01531361|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458207|NCT01531348||Single Group Assignment||Other||None (Open Label)||||||
1458208|NCT01531335|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1458209|NCT01531322|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1458210|NCT01531309||Single Group Assignment||||None (Open Label)||||||
1458211|NCT01531296|||Cohort||Cross-Sectional|||||||
1458212|NCT01531283|Randomized|Crossover Assignment||||Single|||t|||
1458213|NCT01531257|||Cohort||Prospective|||||||
1458214|NCT01531244||Single Group Assignment||Treatment||None (Open Label)||||||
1458215|NCT01531231|||Cohort||Prospective|||||||
1458216|NCT01531218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458217|NCT01531205||Single Group Assignment||Treatment||None (Open Label)||||||
1458218|NCT01531192|Randomized|Parallel Assignment||Prevention||Single|||t|||
1458219|NCT01531179|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1458220|NCT01531166|||Cohort||Prospective|||||||
1458221|NCT01531153|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458222|NCT01531140|Randomized|Parallel Assignment||Treatment||Single||||||t
1458223|NCT01531127|||Cohort||Prospective|||||||
1458224|NCT01531114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458225|NCT01531101|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1458226|NCT01531088|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1458227|NCT01531075|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458228|NCT01531062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458229|NCT01531049|Randomized|Parallel Assignment||Prevention||Single|||t|||
1458230|NCT01531036||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458231|NCT01531023|||Case Control||Prospective|||||||
1458232|NCT01531010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458233|NCT01530997||Single Group Assignment||Treatment||None (Open Label)||||||
1458234|NCT01530984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458235|NCT01530971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458236|NCT01530958|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1458237|NCT01530945|||Cohort||Prospective|||||||
1458238|NCT01530932|||Cohort||Prospective|||||||
1458239|NCT01530919|||Cohort||Cross-Sectional|||||||
1458240|NCT01530906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458241|NCT01530893|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1458242|NCT01530880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458243|NCT01530867|||Cohort||Cross-Sectional|||||||
1458244|NCT01530854|||Cohort||Prospective|||||||
1458245|NCT01530841|Randomized|Parallel Assignment||Treatment||Single|||t|||
1458246|NCT01530828|||Case-Only||Prospective|||||||
1458247|NCT01530815||Single Group Assignment||Treatment||Triple|||t|t|t|
1458248|NCT01530802|Randomized|Parallel Assignment||||Single|||t|||
1458249|NCT01530789|||Case-Only||Prospective|||||||
1458250|NCT01530776|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458251|NCT01530763|Randomized|Parallel Assignment||Treatment||Single||||||t
1458252|NCT01530750|||Cohort||Prospective|||||||
1458253|NCT01530737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458254|NCT01530724|Randomized|Factorial Assignment||Treatment||Triple||||t|t|t
1458255|NCT01530711||Single Group Assignment||Treatment||None (Open Label)||||||
1458256|NCT01530698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458257|NCT01530685|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458258|NCT01530672||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458259|NCT01530659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458260|NCT01530646|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458261|NCT01530620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458262|NCT01530607|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458263|NCT01530594|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458264|NCT01530581|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458265|NCT01530568|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1458266|NCT01530555||Single Group Assignment||Treatment||None (Open Label)||||||
1458267|NCT01530542|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1458268|NCT01530529|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1458269|NCT01530516|Randomized|Parallel Assignment||Treatment||Single||||||t
1458270|NCT01530503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458271|NCT01530490|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458272|NCT01530477|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1458273|NCT01530464|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458274|NCT01530451|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1458275|NCT01530438|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1458276|NCT01530425|||Cohort||Prospective|||||||
1458277|NCT01530412|Randomized|Parallel Assignment||Prevention||Single||||||t
1458278|NCT01530399|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1458279|NCT01530386||Single Group Assignment||||None (Open Label)||||||
1458280|NCT01530373|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1458281|NCT01530360||Single Group Assignment||Prevention||None (Open Label)||||||
1458282|NCT01530347||Single Group Assignment||Supportive Care||None (Open Label)||||||
1458283|NCT01530334||Single Group Assignment||Treatment||None (Open Label)||||||
1458284|NCT01530321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458285|NCT01530308|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458286|NCT01530295|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1458287|NCT01530282||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458288|NCT01530269||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458289|NCT01530256||Single Group Assignment||Treatment||None (Open Label)||||||
1458290|NCT01530243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458291|NCT01530230|Randomized|Single Group Assignment||||Triple|||t|t|t|
1458292|NCT01530217||Single Group Assignment||Treatment||Triple|||t||t|t
1458293|NCT01530204|Randomized|Parallel Assignment||Prevention||Single||||||t
1458294|NCT01530191|||Case Control||Prospective|||||||
1458295|NCT01530178|Randomized|Crossover Assignment||Treatment||Single|||t|||
1458296|NCT01530165|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1458297|NCT01530152||Single Group Assignment||Supportive Care||None (Open Label)||||||
1458298|NCT01530139|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458299|NCT01530126|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458300|NCT01530113||||||||||||
1458301|NCT01530100|||||Prospective|||||||
1458302|NCT01530087||Single Group Assignment||Treatment||None (Open Label)||||||
1458303|NCT01530074||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458304|NCT01530061|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1458305|NCT01530048|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458306|NCT01530035|Randomized|Parallel Assignment||Prevention||Single||||||t
1458307|NCT01530022|Randomized|Crossover Assignment||||Double|||t||t|
1458308|NCT01530009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458309|NCT01529996|Randomized|Single Group Assignment||Treatment||Single||||||t
1458310|NCT01529983|Randomized|Crossover Assignment||Treatment||Single||||||t
1458311|NCT01529970|||||Cross-Sectional|||||||
1458312|NCT01529957|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1458313|NCT01529944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458314|NCT01529931||Single Group Assignment||||None (Open Label)||||||
1458315|NCT01529918|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1458316|NCT01529905|||Cohort||Prospective|||||||
1458317|NCT01529892|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1458318|NCT01529879|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458319|NCT01529866|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458320|NCT01529853|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458321|NCT01529840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458322|NCT01529827||Single Group Assignment||Treatment||None (Open Label)||||||
1458323|NCT01529814|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458324|NCT01529801|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458325|NCT01529788||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1458326|NCT01529775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458327|NCT01529762|||Cohort||Prospective|||||||
1458328|NCT01529749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458329|NCT01529736|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458330|NCT01529723|||Cohort||Prospective|||||||
1458331|NCT01529710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458332|NCT01529697|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1458333|NCT01529684||Single Group Assignment||||None (Open Label)||||||
1458334|NCT01529671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458335|NCT01529658|Randomized|Parallel Assignment||Prevention||Single|||t|||
1458336|NCT01529645|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1458337|NCT01529632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458338|NCT01529619||Single Group Assignment||Treatment||None (Open Label)||||||
1458339|NCT01529606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458340|NCT01529593||Single Group Assignment||Treatment||None (Open Label)||||||
1458341|NCT01529580|Randomized|Single Group Assignment||Treatment||Single||||||t
1458342|NCT01529567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458343|NCT01529554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458344|NCT01529541|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458345|NCT01529528|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458346|NCT01529515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458347|NCT01529502|Randomized|Crossover Assignment||Basic Science||Single||||||t
1458348|NCT01529489|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458349|NCT01529476|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1458350|NCT01529463|||Cohort||Prospective|||||||
1458351|NCT01529450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458352|NCT01529437|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458353|NCT01529424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458354|NCT01529411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458355|NCT01529398|Randomized|Parallel Assignment||Treatment||Single||||||t
1458356|NCT01529385|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1458357|NCT01529372||Single Group Assignment||Treatment||None (Open Label)||||||
1458358|NCT01529359|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458359|NCT01529346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458360|NCT01529333||Single Group Assignment||Treatment||None (Open Label)||||||
1458361|NCT01529320||Single Group Assignment||Supportive Care||Single|||t|||
1458362|NCT01529307||Single Group Assignment||Treatment||None (Open Label)||||||
1458363|NCT01529294|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1458364|NCT01529281|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458365|NCT01529268|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458366|NCT01529255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458367|NCT01529242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458368|NCT01529229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458369|NCT01529216|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458370|NCT01529203||Single Group Assignment||||None (Open Label)||||||
1458371|NCT01529190|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458372|NCT01529177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458373|NCT01529164||Single Group Assignment||Treatment||None (Open Label)||||||
1458374|NCT01529151|Randomized|Factorial Assignment||Treatment||Single||||t||
1458375|NCT01529138|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458376|NCT01529125|||Case Control||Prospective|||||||
1458377|NCT01529112|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458378|NCT01529099||Single Group Assignment||Treatment||None (Open Label)||||||
1458379|NCT01529086|||Cohort||Retrospective|||||||
1458380|NCT01529073||Single Group Assignment||Treatment||None (Open Label)||||||
1458381|NCT01529060|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1458382|NCT01529047|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458383|NCT01529034||Single Group Assignment||Treatment||None (Open Label)||||||
1458384|NCT01529021|||Case Control||Prospective|||||||
1458385|NCT01529008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458386|NCT01528995|Randomized|Parallel Assignment||Treatment||Single||||||t
1458387|NCT01528982|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458388|NCT01528969|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458389|NCT01528956|||Case-Only||Retrospective|||||||
1458390|NCT01528943|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1458391|NCT01528930||Single Group Assignment||Treatment||None (Open Label)||||||
1458392|NCT01528917|||Cohort||Retrospective|||||||
1458393|NCT01528904|||Case Control||Prospective|||||||
1458394|NCT01528891|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1458395|NCT01528878|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458396|NCT01528865||Single Group Assignment||Prevention||None (Open Label)||||||
1458397|NCT01528852|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458398|NCT01528839|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458399|NCT01528826||Single Group Assignment||Treatment||None (Open Label)||||||
1458400|NCT01528813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458401|NCT01528800|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458402|NCT01528787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458403|NCT01528774|||Case-Control||Prospective|||||||
1458404|NCT01528761|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458405|NCT01528748|||Cohort||Prospective|||||||
1458406|NCT01528735|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458407|NCT01528722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458408|NCT01528709|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458409|NCT01528696|Randomized|Parallel Assignment||Prevention||Single||||||t
1458410|NCT01528683||Single Group Assignment||Treatment||None (Open Label)||||||
1458411|NCT01528670|||Other||Prospective|||||||
1458412|NCT01528657|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458413|NCT01528644|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1458414|NCT01528631|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1458415|NCT01528618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458416|NCT01528605|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458417|NCT01528592||Single Group Assignment||Basic Science||None (Open Label)||||||
1458418|NCT01528579|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458419|NCT01528566|Randomized|Parallel Assignment||Treatment||Single||||||t
1458420|NCT01528553|Randomized|Parallel Assignment||Treatment||Single||||t||
1458421|NCT01528540|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458422|NCT01528514|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458423|NCT01528501||Single Group Assignment||Treatment||None (Open Label)||||||
1458424|NCT01528488|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458425|NCT01528475|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1458426|NCT01528462|||Cohort||Prospective|||||||
1458427|NCT01528449|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458428|NCT01528436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458429|NCT01528423|||Case-Only||Prospective|||||||
1458430|NCT01528410|Randomized|Parallel Assignment||Treatment||None (Open Label)||The study will be a single center, open-label trial.||||
1458431|NCT01528397||Single Group Assignment||Treatment||None (Open Label)||||||
1458432|NCT01528384||Single Group Assignment||Treatment||None (Open Label)||||||
1458433|NCT01528371|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1458434|NCT01528358|||Cohort||Prospective|||||||
1458435|NCT01528345|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1458436|NCT01528332|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1458437|NCT01528319||Single Group Assignment||Treatment||None (Open Label)||||||
1458438|NCT01528306|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1458439|NCT01528293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458440|NCT01528280||Single Group Assignment||Basic Science||None (Open Label)||||||
1458441|NCT01528267|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1458442|NCT01528254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458443|NCT01528241||Single Group Assignment||||None (Open Label)||||||
1458444|NCT01528228|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1458445|NCT01528215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458446|NCT01528202|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1458447|NCT01528189|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1458448|NCT01528176|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1458449|NCT01528163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458450|NCT01528150|||Cohort||Prospective|||||||
1458451|NCT01528137||Single Group Assignment||Treatment||None (Open Label)||||||
1458452|NCT01528124|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1458453|NCT01528111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458454|NCT01528098|||Case Control||Prospective|||||||
1458455|NCT01528085||Single Group Assignment||Treatment||None (Open Label)||||||
1458456|NCT01528072||Single Group Assignment||Treatment||None (Open Label)||||||
1458457|NCT01528059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458458|NCT01528046||Single Group Assignment||Treatment||None (Open Label)||||||
1458459|NCT01528033|Randomized|Parallel Assignment||Treatment||Single||||||t
1458460|NCT01528020|Randomized|Parallel Assignment||Treatment||Single||||||t
1458461|NCT01528007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458462|NCT01527994|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458463|NCT01527981||Single Group Assignment||Treatment||Single||||||t
1458464|NCT01527968|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458465|NCT01527955||Single Group Assignment||Treatment||None (Open Label)||||||
1458466|NCT01527942|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1458467|NCT01527929|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458468|NCT01527916|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458469|NCT01527903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458470|NCT01527890|||Cohort||Retrospective|||||||
1458471|NCT01527877||Single Group Assignment||Treatment||None (Open Label)||||||
1458472|NCT01527864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458473|NCT01527851|||Cohort||Cross-Sectional|||||||
1458474|NCT01527838||Single Group Assignment||Treatment||None (Open Label)||||||
1458475|NCT01527825|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1458476|NCT01527812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458477|NCT01527799|||Cohort||Cross-Sectional|||||||
1458478|NCT01527786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458479|NCT01527773|||Cohort||Prospective|||||||
1458480|NCT01527760||Single Group Assignment||Treatment||None (Open Label)||||||
1458481|NCT01527747|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1458482|NCT01527734|Randomized|Crossover Assignment||Screening||Quadruple|||t|t|t|t
1458483|NCT01527721|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458484|NCT01527708|||Case Control||Prospective|||||||
1458485|NCT01527695|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1458486|NCT01527682||Single Group Assignment||Treatment||None (Open Label)||||||
1458487|NCT01527669|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458488|NCT01527656|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458489|NCT01527643|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458490|NCT01527630|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458491|NCT01527617|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1458492|NCT01527604|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1458493|NCT01527591||Single Group Assignment||Prevention||None (Open Label)||||||
1458494|NCT01527578|||Cohort||Prospective|||||||
1458495|NCT01527565|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458496|NCT01527552|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458497|NCT01527539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458498|NCT01527526|||Case Control||Prospective|||||||
1458499|NCT01527513|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458500|NCT01527500|Randomized|Parallel Assignment||Treatment||Single|||t|||
1458501|NCT01527487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458502|NCT01527474||Single Group Assignment||Treatment||None (Open Label)||||||
1458503|NCT01527461|||||Prospective|||||||
1458504|NCT01527448||Single Group Assignment||Treatment||None (Open Label)||||||
1458505|NCT01527435|||Case Control||Retrospective|||||||
1458506|NCT01527422||Single Group Assignment||Treatment||None (Open Label)||||||
1458507|NCT01527409|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458508|NCT01527396|||Cohort||Prospective|||||||
1458509|NCT01527383|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1458510|NCT01527370||Single Group Assignment||Prevention||None (Open Label)||||||
1458511|NCT01527357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1458512|NCT01527344|||Case-Only||Prospective|||||||
1458513|NCT01527331|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1458514|NCT01527318|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458515|NCT01527305||Single Group Assignment||Treatment||None (Open Label)||||||
1458516|NCT01527292|Randomized|Parallel Assignment||Treatment||Single||||||t
1458517|NCT01527279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458518|NCT01527266|Randomized|Crossover Assignment||||Double|||t||t|
1458519|NCT01527253|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1458520|NCT01527240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458521|NCT01527227|||Case Control||Cross-Sectional|||||||
1458522|NCT01527214|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1458523|NCT01527201|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1458524|NCT01527188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458525|NCT01527175|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1458526|NCT01527162|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458527|NCT01527149||Single Group Assignment||Treatment||None (Open Label)||||||
1458528|NCT01527136||Single Group Assignment||Treatment||None (Open Label)||||||
1458529|NCT01527123||Single Group Assignment||Basic Science||None (Open Label)||||||
1458530|NCT01527110||Single Group Assignment||Treatment||None (Open Label)||||||
1458531|NCT01527097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458532|NCT01527084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458533|NCT01527058||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458534|NCT01527045||Single Group Assignment||Prevention||None (Open Label)||||||
1458535|NCT01527032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458536|NCT01527019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458537|NCT01527006||Single Group Assignment||Treatment||None (Open Label)||||||
1458538|NCT01526980|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458539|NCT01526967|||Cohort||Prospective|||||||
1458540|NCT01526954|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1458541|NCT01526941|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458542|NCT01526928||Single Group Assignment||Treatment||None (Open Label)||||||
1458543|NCT01526915|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458544|NCT01526902|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458545|NCT01526889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458546|NCT01526876||Single Group Assignment||Treatment||None (Open Label)||||||
1458547|NCT01526863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458548|NCT01526850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458549|NCT01526837||Single Group Assignment||Treatment||None (Open Label)||||||
1458550|NCT01526824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458551|NCT01526811|||Cohort||Prospective|||||||
1458552|NCT01526798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458553|NCT01526785||Single Group Assignment||Treatment||None (Open Label)||||||
1458554|NCT01526772|||Cohort||Prospective|||||||
1458555|NCT01526759|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1458556|NCT01526746|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1458557|NCT01526733|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1458558|NCT01526720|||Family-Based||Cross-Sectional|||||||
1458559|NCT01526707||Single Group Assignment||Health Services Research||None (Open Label)||||||
1458560|NCT01526694||Single Group Assignment||Treatment||None (Open Label)||||||
1458561|NCT01526681||||||||||||
1458562|NCT01526668|Randomized|Parallel Assignment||Treatment||Single|||t|||
1458563|NCT01526655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458564|NCT01526642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458565|NCT01526629|||Cohort||Prospective|||||||
1458566|NCT01526616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458567|NCT01526603||Single Group Assignment||Treatment||None (Open Label)||||||
1458568|NCT01526590||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458569|NCT01526577|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458570|NCT01526564|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458571|NCT01526551||Single Group Assignment||Prevention||None (Open Label)||||||
1458572|NCT01526538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458573|NCT01526525|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458574|NCT01526512||Single Group Assignment||Treatment||None (Open Label)||||||
1458575|NCT01526499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458576|NCT01526486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458577|NCT01526473||Single Group Assignment||Other||None (Open Label)||||||
1458578|NCT01526460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458579|NCT01526447|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1458580|NCT01526434|||Cohort||Prospective|||||||
1458581|NCT01526421|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1458582|NCT01526408|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1458583|NCT01526395|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458584|NCT01526382|Randomized|Parallel Assignment||Treatment||Single|||t|||
1458585|NCT01526369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458586|NCT01526356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458587|NCT01526343||Single Group Assignment||Treatment||None (Open Label)||||||
1458588|NCT01526330|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1458589|NCT01526317|Randomized|Crossover Assignment||||None (Open Label)||||||
1458590|NCT01526304|||Cohort||Prospective|||||||
1458591|NCT01526291|||Cohort||Prospective|||||||
1458592|NCT01526278||Single Group Assignment||Treatment||None (Open Label)||||||
1458593|NCT01526265|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1458594|NCT01526252|||Other||Prospective|||||||
1458595|NCT01526239|Randomized|Parallel Assignment||Screening||Double|||t|t||
1458596|NCT01526226|Randomized|Crossover Assignment||Treatment||Single||||||t
1458597|NCT01526213|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1458598|NCT01526200|||Cohort||Retrospective|||||||
1458599|NCT01526187|||Cohort||Prospective|||||||
1458600|NCT01526174|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458601|NCT01526161|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458602|NCT01526148|Randomized|Parallel Assignment||Treatment||Single||||||t
1458603|NCT01526135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458604|NCT01526122|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458605|NCT01526109|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1458606|NCT01526096|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458607|NCT01526083|Randomized|Crossover Assignment||||None (Open Label)||||||
1458608|NCT01526070|||Cohort||Prospective|||||||
1458609|NCT01526057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458610|NCT01526044|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1458611|NCT01526031|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1458612|NCT01526018|||Cohort||Prospective|||||||
1458613|NCT01526005|||Case Control||Prospective|||||||
1458614|NCT01525992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458615|NCT01525979|Randomized|Factorial Assignment||Treatment||Single||||||t
1458616|NCT01525966||Single Group Assignment||Treatment||None (Open Label)||||||
1458617|NCT01525953|||Cohort||Retrospective|||||||
1458618|NCT01525940||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458619|NCT01525927|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458620|NCT01525914|||Cohort||Retrospective|||||||
1458621|NCT01525901|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1458622|NCT01525888|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458623|NCT01525875|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1458624|NCT01525862||Single Group Assignment||Treatment||None (Open Label)||||||
1458625|NCT01525849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458626|NCT01525836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458627|NCT01525823||Single Group Assignment||||None (Open Label)||||||
1458628|NCT01525810|||Cohort||Prospective|||||||
1458629|NCT01525797|||Case-Only||Prospective|||||||
1458630|NCT01525784|||Cohort||Prospective|||||||
1458631|NCT01525771||Single Group Assignment||Treatment||None (Open Label)||||||
1458632|NCT01525758|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458633|NCT01525745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458634|NCT01525732||Single Group Assignment||Treatment||None (Open Label)||||||
1458635|NCT01525719||Single Group Assignment||Treatment||None (Open Label)||||||
1458636|NCT01525706||Single Group Assignment||Treatment||None (Open Label)||||||
1458637|NCT01525693|||Cohort||Prospective|||||||
1458638|NCT01525680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458639|NCT01525667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458640|NCT01525654|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1458641|NCT01525641|||Case-Only||Prospective|||||||
1458642|NCT01525628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458643|NCT01525615|Randomized|Parallel Assignment||Treatment||Double||||||
1458644|NCT01525602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458645|NCT01525589||Single Group Assignment||Treatment||None (Open Label)||||||
1458646|NCT01525576|Randomized|Parallel Assignment||Treatment||Single||||||t
1458647|NCT01525563|||||Prospective|||||||
1458648|NCT01525550||||Other||None (Open Label)||||||
1458649|NCT01525537|Randomized|Parallel Assignment||Treatment||Single|||t|||
1458650|NCT01525524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458651|NCT01525511|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458652|NCT01525498|||Cohort||Prospective|||||||
1458653|NCT01525485|||Case Control||Prospective|||||||
1458654|NCT01525472|||Cohort||Cross-Sectional|||||||
1458655|NCT01525459|||Cohort||Prospective|||||||
1458656|NCT01525446||Single Group Assignment||Treatment||None (Open Label)||||||
1458657|NCT01525433|Randomized|Parallel Assignment||Prevention||Single||||||t
1458658|NCT01525420|Randomized|Parallel Assignment||Treatment||Single|||t|||
1458659|NCT01525407||Single Group Assignment||Supportive Care||None (Open Label)||||||
1458660|NCT01525394|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1458661|NCT01525381|||Cohort||Prospective|||||||
1458662|NCT01525368|||Case Control||Prospective|||||||
1458663|NCT01525355|||Cohort||Prospective|||||||
1458664|NCT01525329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458665|NCT01525316|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458666|NCT01525303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458667|NCT01525290|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458668|NCT01525277|||Cohort||Prospective|||||||
1458669|NCT01525264|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1458670|NCT01525251|||||Prospective|||||||
1458671|NCT01525238|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1458672|NCT01525225||Single Group Assignment||||None (Open Label)||||||
1458673|NCT01525212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458674|NCT01525199|||Case Control||Retrospective|||||||
1458675|NCT01525186|||Ecologic or Community||Cross-Sectional|||||||
1458676|NCT01525173|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1458677|NCT01525160|||Case Control||Prospective|||||||
1458678|NCT01525147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458679|NCT01525134||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458680|NCT01525121|Randomized|Crossover Assignment||Treatment||Single|||||t|
1458681|NCT01525108|Randomized|Parallel Assignment||Treatment||Single||||||t
1458682|NCT01525095|||Case Control||Prospective|||||||
1458683|NCT01525082||Single Group Assignment||Treatment||None (Open Label)||||||
1458684|NCT01525069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458685|NCT01525056||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458686|NCT01525043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458687|NCT01525017||Single Group Assignment||Treatment||None (Open Label)||||||
1458688|NCT01525004|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458689|NCT01524991||Single Group Assignment||Treatment||None (Open Label)||||||
1458690|NCT01524978|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458691|NCT01524965|Randomized|Parallel Assignment||Treatment||Single||||||t
1458692|NCT01524952||Single Group Assignment||Treatment||None (Open Label)||||||
1458693|NCT01524939||Single Group Assignment||Treatment||None (Open Label)||||||
1458694|NCT01524926|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458695|NCT01524913|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1458696|NCT01524900|||||Prospective|||||||
1458697|NCT01524887|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458698|NCT01524874|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458699|NCT01524861|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1458700|NCT01524848||Single Group Assignment||Treatment||None (Open Label)||||||
1458701|NCT01524835|||Cohort||Cross-Sectional|||||||
1458702|NCT01524822|||Cohort||Other|||||||
1458703|NCT01524809|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458704|NCT01524796|||Cohort||Prospective|||||||
1458705|NCT01524783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458706|NCT01524770|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458707|NCT01524757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458708|NCT01524744|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1458709|NCT01524731|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1458710|NCT01524718|Randomized|Parallel Assignment||Prevention||Single|||t|||
1458711|NCT01524705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458712|NCT01524692||Single Group Assignment||Treatment||None (Open Label)||||||
1458713|NCT01524679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458714|NCT01524666|||Case-Only||Prospective|||||||
1458715|NCT01524653|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1458716|NCT01524640|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458717|NCT01524627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458718|NCT01524614|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1458719|NCT01524601||Single Group Assignment||Treatment||None (Open Label)||||||
1458720|NCT01524588|||Cohort||Prospective|||||||
1458721|NCT01524575|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458722|NCT01524562|||||Other|||||||
1458723|NCT01524549|||Cohort||Cross-Sectional|||||||
1458724|NCT01524536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458725|NCT01524523|||||Prospective|||||||
1458726|NCT01524510||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458727|NCT01524497|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1458728|NCT01524484|||||Retrospective|||||||
1458729|NCT01524471||Single Group Assignment||||None (Open Label)||||||
1458730|NCT01524458||Single Group Assignment||Treatment||None (Open Label)||||||
1458731|NCT01524445|||Case-Only||Retrospective|||||||
1458732|NCT01524432|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1458733|NCT01524419|||||Prospective|||||||
1458734|NCT01524406|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1458735|NCT01524393|||||Cross-Sectional|||||||
1458736|NCT01524380|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458737|NCT01524367|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458738|NCT01524354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458739|NCT01524341|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458740|NCT01524328|||Cohort||Cross-Sectional|||||||
1458741|NCT01524315|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1458742|NCT01524302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458743|NCT01524289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458744|NCT01524276|||Cohort||Prospective|||||||
1458745|NCT01524263||||||||||||
1458746|NCT01524250|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1458747|NCT01524237|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458748|NCT01524224||Single Group Assignment||Treatment||None (Open Label)||||||
1458749|NCT01524211||Single Group Assignment||Treatment||None (Open Label)||All eligible subjects will receive treatment with the investigational t-Branch Endovascular Graft||||
1458750|NCT01524198|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458751|NCT01524185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458752|NCT01524172|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458753|NCT01524159|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458754|NCT01524146|||Case-Only||Prospective|||||||
1458755|NCT01524133|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458756|NCT01524120|||||Prospective|||||||
1458757|NCT01524107|||Case Control||Retrospective|||||||
1458758|NCT01524094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458759|NCT01524081|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1458760|NCT01524068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458761|NCT01524055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458762|NCT01524042||Single Group Assignment||Health Services Research||Single||||||t
1458763|NCT01524029|||Cohort||Prospective|||||||
1458764|NCT01524016||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458765|NCT01524003|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1458766|NCT01523990|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1458767|NCT01523977||Single Group Assignment||Treatment||None (Open Label)||||||
1458768|NCT01523964|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1458769|NCT01523951|||Cohort||Prospective|||||||
1458770|NCT01523938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458771|NCT01523925|Randomized|Factorial Assignment||Treatment||Single||||||t
1458772|NCT01523912||Single Group Assignment||Treatment||None (Open Label)||||||
1458773|NCT01523899|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1458774|NCT01523886|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1458775|NCT01523873|||Cohort||Prospective|||||||
1458776|NCT01523860||Single Group Assignment||Treatment||None (Open Label)||||||
1458777|NCT01523847||Single Group Assignment||Treatment||None (Open Label)||||||
1458778|NCT01523834||Single Group Assignment||Treatment||None (Open Label)||||||
1458779|NCT01523821|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||The study will have three escalating alpha 1 anti-trypsin (AAT) dose cohorts with six patients in each cohort (Phase I). Based on response and toxicity, an additional six patients will be enrolled in the optimal dose (Phase II).||||
1458780|NCT01523808|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458781|NCT01523795|Randomized|Parallel Assignment||||None (Open Label)||||||
1458782|NCT01523782|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1458783|NCT01523769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458784|NCT01523756|Randomized|Crossover Assignment||||None (Open Label)||||||
1458785|NCT01523743|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1458786|NCT01523730|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1458787|NCT01523717|||Case-Only||Prospective|||||||
1458788|NCT01523704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458789|NCT01523691|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1458790|NCT01523678||Single Group Assignment||Prevention||None (Open Label)||||||
1458791|NCT01523665|||Cohort||Prospective|||||||
1458792|NCT01523652|||Cohort||Prospective|||||||
1458793|NCT01523639|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458794|NCT01523626|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1458795|NCT01523613|Randomized|Parallel Assignment||Treatment||Double|Although material allocation was masked to evaluators, at times a difference in appearance (translucency) of the restorations at recall may have given it away.||t|||t
1458796|NCT01523600|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1458797|NCT01523587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458798|NCT01523574|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458799|NCT01523561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458800|NCT01523548||Single Group Assignment||Treatment||None (Open Label)||||||
1458801|NCT01523535|Randomized|Parallel Assignment||Basic Science||Double|Participants were randomized to condition. Vascular reactivity testing was performed by operator who was blind to condition and outcomes assessment from that testing was also blind.||||t|t
1458802|NCT01523522|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1458803|NCT01523509||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458804|NCT01523496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458805|NCT01523483|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1458806|NCT01523470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458807|NCT01523457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458808|NCT01523444|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458809|NCT01523431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458810|NCT01523418|||Cohort||Prospective|||||||
1458811|NCT01523405|||Case-Only||Cross-Sectional|||||||
1458812|NCT01523392|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458813|NCT01523379||||||||||||
1458814|NCT01523366|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458815|NCT01523353|Randomized|Parallel Assignment||Treatment||Double||||t||t
1458816|NCT01523340|||Case-Only||Prospective|||||||
1458817|NCT01523327|||||Cross-Sectional|||||||
1458818|NCT01523314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458819|NCT01523301|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458821|NCT01523275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458822|NCT01523262|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458823|NCT01523249|||Cohort||Prospective|||||||
1458824|NCT01523236|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1458825|NCT01523223||Single Group Assignment||Treatment||None (Open Label)||||||
1458826|NCT01523210|||Case-Crossover||Prospective|||||||
1458827|NCT01523197||Single Group Assignment||Treatment||None (Open Label)||||||
1458828|NCT01523184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458829|NCT01523171||Single Group Assignment||Treatment||None (Open Label)||||||
1458830|NCT01523158||Single Group Assignment||Basic Science||None (Open Label)||||||
1458831|NCT01523145|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458832|NCT01523132|||Cohort||Prospective|||||||
1458833|NCT01523119|Randomized|Crossover Assignment||||None (Open Label)||||||
1458834|NCT01523106|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1458835|NCT01523093|Randomized|Crossover Assignment||||None (Open Label)||||||
1458836|NCT01523080|Randomized|Crossover Assignment||||None (Open Label)||||||
1458837|NCT01523067|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458838|NCT01523054|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1458839|NCT01523041|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1458840|NCT01523028|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1458841|NCT01523015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458842|NCT01523002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458843|NCT01522989||Single Group Assignment||Treatment||None (Open Label)||||||
1458844|NCT01522976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458845|NCT01522963|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1458846|NCT01522950|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458847|NCT01522937||Single Group Assignment||Treatment||None (Open Label)||||||
1458848|NCT01522924|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458849|NCT01522911||Single Group Assignment||Treatment||None (Open Label)||||||
1458850|NCT01522898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458851|NCT01522885|Randomized|Parallel Assignment||Treatment||Single||||||t
1458852|NCT01522872|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458853|NCT01522859|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458854|NCT01522846|||Case-Only||Prospective|||||||
1458855|NCT01522833|||Cohort||Retrospective|||||||
1458856|NCT01522820|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458857|NCT01522807|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1458858|NCT01522794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458859|NCT01522781|||Cohort||Prospective|||||||
1458860|NCT01522768||Single Group Assignment||Treatment||None (Open Label)||||||
1458861|NCT01522755|||Cohort||Prospective|||||||
1458862|NCT01522742|||Cohort||Prospective|||||||
1458863|NCT01522729|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1458864|NCT01522716||Single Group Assignment||Treatment||None (Open Label)||||||
1458865|NCT01522703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458866|NCT01522690||Single Group Assignment||Basic Science||None (Open Label)||||||
1458867|NCT01522677||Single Group Assignment||Treatment||None (Open Label)||||||
1458868|NCT01522664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458869|NCT01522651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458870|NCT01522638|||Family-Based||Cross-Sectional|||||||
1458871|NCT01522625|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1458872|NCT01522612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458873|NCT01522599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458874|NCT01522586|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1458875|NCT01522573|||Case-Only||Prospective|||||||
1458876|NCT01522560|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1458877|NCT01522547|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458878|NCT01522534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458879|NCT01522521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458880|NCT01522508|||||Prospective|||||||
1458881|NCT01522495|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1458882|NCT01522482|Randomized|Crossover Assignment||Prevention||Single|||t|||
1458883|NCT01522469||Single Group Assignment||Treatment||None (Open Label)||||||
1458884|NCT01522456|Randomized|Parallel Assignment||Treatment||Single|||||t|
1458885|NCT01522443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458886|NCT01522430|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1458887|NCT01522417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458888|NCT01522404|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1458889|NCT01522391|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458890|NCT01522378||Single Group Assignment||Treatment||None (Open Label)||||||
1458891|NCT01522365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458892|NCT01522352||Parallel Assignment||||None (Open Label)||||||
1458893|NCT01522339||Single Group Assignment||||None (Open Label)||||||
1458894|NCT01522326|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1458895|NCT01522313|||Cohort||Retrospective|||||||
1458896|NCT01522300||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458897|NCT01522287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458898|NCT01522274|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458899|NCT01522261|Randomized|Parallel Assignment||||Single||||t||
1458900|NCT01522248|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1458901|NCT01522235|Randomized|Parallel Assignment||Treatment||Quadruple|To prevent unblinding because of observed efficacy, adverse events or changes in laboratory values, each site will have both a treating investigator and an examining investigator. The treating investigator will assess the participant's clinical response and laboratory findings. The treating investigator will make all clinical treatment decisions. The examining investigator will monitor only the clinical autonomic symptoms and quality of life scores, and autonomic tests. Both the treating and examining investigators should be physicians. To prevent infusion unblinding, infusions of IVIG and placebo will occur in opaque bags.||t|t|t|t
1458902|NCT01522222|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1458903|NCT01522209||Single Group Assignment||Diagnostic||None (Open Label)||||||
1458904|NCT01522196|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1458905|NCT01522183|||Other||Other|||||||
1458906|NCT01522170|||Case-Only||Other|||||||
1458907|NCT01522157||Single Group Assignment||Treatment||None (Open Label)||||||
1458908|NCT01522144||Single Group Assignment||||None (Open Label)||||||
1458909|NCT01522131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458910|NCT01522118||Single Group Assignment||Supportive Care||None (Open Label)||||||
1458911|NCT01522105||Single Group Assignment||Treatment||None (Open Label)||||||
1458912|NCT01522092||Single Group Assignment||Treatment||None (Open Label)||||||
1458913|NCT01522079||Single Group Assignment||Treatment||None (Open Label)||||||
1458914|NCT01522066|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458915|NCT01522053|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458916|NCT01522040|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1458917|NCT01522027||Single Group Assignment||Supportive Care||None (Open Label)||||||
1458918|NCT01522014|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1458919|NCT01522001|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458920|NCT01521988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458921|NCT01521975||Single Group Assignment||Treatment||None (Open Label)||||||
1458922|NCT01521962|Randomized|Parallel Assignment||||||||||
1458923|NCT01521949||Single Group Assignment||Treatment||None (Open Label)||||||
1458924|NCT01521936|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458925|NCT01521923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458926|NCT01521910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458927|NCT01521897|||Case-Only||Prospective|||||||
1458928|NCT01521884|||||Prospective|||||||
1458929|NCT01521871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458930|NCT01521858|||Case-Only||Retrospective|||||||
1458931|NCT01521845|Randomized|Parallel Assignment||Prevention||Single||||||t
1458932|NCT01521832|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1458933|NCT01521819||Single Group Assignment||Treatment||None (Open Label)||||||
1458934|NCT01521806|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1458935|NCT01521793||Single Group Assignment||Treatment||None (Open Label)||||||
1458936|NCT01521780|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1458937|NCT01521767|Randomized|Crossover Assignment||||None (Open Label)||||||
1458938|NCT01521754|||Cohort||Other|||||||
1458939|NCT01521741|||Cohort||Prospective|||||||
1458940|NCT01521728|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1458941|NCT01521715||Single Group Assignment||Treatment||None (Open Label)||||||
1458942|NCT01521702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458943|NCT01521689||Single Group Assignment||Treatment||None (Open Label)||||||
1458944|NCT01521676||Single Group Assignment||Basic Science||None (Open Label)||||||
1458945|NCT01521663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458946|NCT01521650|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1458947|NCT01521637|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1458948|NCT01521624|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1458949|NCT01521611||Single Group Assignment||Treatment||None (Open Label)||||||
1458950|NCT01521598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458951|NCT01521585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458952|NCT01521572||Single Group Assignment||Basic Science||None (Open Label)||||||
1458953|NCT01521559|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1458954|NCT01521546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458955|NCT01521533||Single Group Assignment||Treatment||None (Open Label)||||||
1458956|NCT01521520|||Case-Control||Prospective|||||||
1458957|NCT01521507|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458958|NCT01521494|Randomized|Parallel Assignment||Treatment||Double||||||
1458959|NCT01521481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458960|NCT01521468|||Cohort||Prospective|||||||
1458961|NCT01521455|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1458962|NCT01521442|Randomized|Crossover Assignment||Treatment||Single||||||t
1458963|NCT01521429|||Cohort||Prospective|||||||
1458964|NCT01521416|||Case-Only||Retrospective|||||||
1458965|NCT01521403|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1458966|NCT01521390|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1458967|NCT01521377|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1458968|NCT01521364||Single Group Assignment||Treatment||None (Open Label)||||||
1458969|NCT01521351|||Cohort||Prospective|||||||
1458970|NCT01521338|||Cohort||Prospective|||||||
1458971|NCT01521325||Single Group Assignment||Basic Science||None (Open Label)||||||
1458972|NCT01521312|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458973|NCT01521299||Single Group Assignment||Treatment||None (Open Label)||||||
1458974|NCT01521286|||Cohort||Prospective|||||||
1458975|NCT01521273|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1458976|NCT01521260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458977|NCT01521247|Randomized|Parallel Assignment||||None (Open Label)||||||
1458978|NCT01521234|Randomized|Single Group Assignment||Treatment||Single||||||t
1458979|NCT01521221|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1458980|NCT01521208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458981|NCT01521195||Single Group Assignment||Supportive Care||None (Open Label)||||||
1458982|NCT01521182|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1458983|NCT01521169|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1458984|NCT01521156|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1458985|NCT01521143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1458986|NCT01521130|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1458987|NCT01521117|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1458988|NCT01521104|||Cohort||Prospective|||||||
1458989|NCT01521091|||Cohort||Prospective|||||||
1458990|NCT01521078|Randomized|Parallel Assignment||Prevention||Single|||||t|
1458991|NCT01521065|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1458992|NCT01521052||Single Group Assignment||Treatment||None (Open Label)||||||
1458993|NCT01521039|||Cohort||Prospective|||||||
1458994|NCT01521026|Randomized|Parallel Assignment||Treatment||Single||||||t
1458995|NCT01521013|Randomized|Parallel Assignment||Treatment||Single||||||t
1458996|NCT01521000|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1458997|NCT01520987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1458998|NCT01520974|Randomized|Parallel Assignment||||Triple|||t||t|t
1458999|NCT01520961|||Case Control||Prospective|||||||
1459000|NCT01520948|Randomized|Parallel Assignment||Treatment||Single||||||t
1459001|NCT01520935|||||Retrospective|||||||
1459002|NCT01520922||Single Group Assignment||Treatment||None (Open Label)||||||
1459003|NCT01520909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459004|NCT01520896|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1459005|NCT01520883|||Cohort||Cross-Sectional|||||||
1459006|NCT01520870||Single Group Assignment||Treatment||None (Open Label)||||||
1459007|NCT01520857|Randomized|Parallel Assignment||Treatment||Single||||||t
1459008|NCT01520844||Single Group Assignment||Other||None (Open Label)||||||
1459009|NCT01520831|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459010|NCT01520818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459011|NCT01520805||Single Group Assignment||Treatment||None (Open Label)||||||
1459012|NCT01520792||Crossover Assignment||Treatment||Double|||t||t|
1459013|NCT01520779|||Cohort||Retrospective|||||||
1459014|NCT01520766|Randomized|Parallel Assignment||Treatment||Single||||||t
1459015|NCT01520753|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459016|NCT01520740|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459017|NCT01520727|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1459018|NCT01520714|Randomized|Parallel Assignment||||None (Open Label)||||||
1459019|NCT01520701|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459020|NCT01520688|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459021|NCT01520675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459022|NCT01520662|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459023|NCT01520649|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459024|NCT01520636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459025|NCT01520623||Single Group Assignment||Prevention||None (Open Label)||||||
1459026|NCT01520610|||Case Control||Prospective|||||||
1459027|NCT01520597|||Case-Control||Prospective|||||||
1459028|NCT01520584|Randomized|Parallel Assignment||||Triple|||t|t|t|
1459029|NCT01520571|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1459030|NCT01520558|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459031|NCT01520545||Single Group Assignment||Treatment||None (Open Label)||||||
1459032|NCT01520532||Single Group Assignment||Basic Science||None (Open Label)||||||
1459033|NCT01520519||Single Group Assignment||Treatment||None (Open Label)||||||
1459034|NCT01520506||Single Group Assignment||Treatment||None (Open Label)||||||
1459035|NCT01520493||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459036|NCT01520480|||Case Control||Retrospective|||||||
1459037|NCT01520467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459038|NCT01520454|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459039|NCT01520441||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459040|NCT01520428|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459041|NCT01520415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459042|NCT01520402||Single Group Assignment||Basic Science||None (Open Label)||||||
1459043|NCT01520389|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459044|NCT01520376|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1459045|NCT01520363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459046|NCT01520350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459047|NCT01520337|||Case-Only||Prospective|||||||
1459048|NCT01520324|||Case-Only||Prospective|||||||
1459049|NCT01520311||Single Group Assignment||Treatment||None (Open Label)||||||
1459050|NCT01520298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459051|NCT01520285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459052|NCT01520272|||Cohort||Cross-Sectional|||||||
1459053|NCT01520259|||Case-Control||Retrospective|||||||
1459054|NCT01520246|||Case-Only||Retrospective|||||||
1459055|NCT01520233|||Cohort||Retrospective|||||||
1459056|NCT01520220|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459057|NCT01520207|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1459058|NCT01520194|||Case-Only||Retrospective|||||||
1459059|NCT01520181||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459060|NCT01520168|||Case-Only||Retrospective|||||||
1459061|NCT01520155|||Case Control||Prospective|||||||
1459062|NCT01520142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459063|NCT01520129||Single Group Assignment||Treatment||None (Open Label)||||||
1459064|NCT01520116|Randomized|Parallel Assignment||Treatment||Single|||||t|
1459065|NCT01520103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459066|NCT01520090|||||Cross-Sectional|||||||
1459067|NCT01520077||Single Group Assignment||Treatment||None (Open Label)||||||
1459068|NCT01520064|||Cohort||Prospective|||||||
1459069|NCT01520051|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1459070|NCT01520038||||Treatment||||||||
1459071|NCT01520025||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459072|NCT01520012|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459073|NCT01519999|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1459074|NCT01519986|Randomized|Parallel Assignment||||Double|||t||t|
1459075|NCT01519973||Single Group Assignment||Other||None (Open Label)||||||
1459076|NCT01519960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459077|NCT01519947|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459078|NCT01519934|||Cohort||Retrospective|||||||
1459079|NCT01519921|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459080|NCT01519908|||Case-Only||Prospective|||||||
1459081|NCT01519895|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459082|NCT01519882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459083|NCT01519869||Single Group Assignment||Treatment||None (Open Label)||||||
1459084|NCT01519856|||||Prospective|||||||
1459085|NCT01519843|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1459086|NCT01519830|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459087|NCT01519817||Single Group Assignment||Treatment||None (Open Label)||||||
1459088|NCT01519804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459089|NCT01519791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459090|NCT01519778||Single Group Assignment||Other||None (Open Label)||||||
1459091|NCT01519765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459092|NCT01519752|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459093|NCT01519739||Single Group Assignment||Treatment||None (Open Label)||||||
1459094|NCT01519726||||||||||||
1459095|NCT01519713|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459096|NCT01519700|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1459097|NCT01519687||Single Group Assignment||Treatment||None (Open Label)||||||
1459098|NCT01519674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459099|NCT01519661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459100|NCT01519648|||Cohort||Prospective|||||||
1459101|NCT01519635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459102|NCT01519622|||Ecologic or Community||Prospective|||||||
1459103|NCT01519609|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1459104|NCT01519596|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459105|NCT01519583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459106|NCT01519570|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1459107|NCT01519557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459108|NCT01519544|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459109|NCT01519531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459110|NCT01519518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459111|NCT01519505|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459112|NCT01519492||Single Group Assignment||Treatment||None (Open Label)||||||
1459113|NCT01519479|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459114|NCT01519466|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459115|NCT01519453|Randomized|Parallel Assignment||Treatment||Single||||||t
1459116|NCT01519440|||Case-Crossover||Prospective|||||||
1459117|NCT01519427||Single Group Assignment||Treatment||None (Open Label)||||||
1459118|NCT01519414|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459119|NCT01519401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459120|NCT01519388|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1459121|NCT01519375|||Cohort||Retrospective|||||||
1459122|NCT01519362|||Case-Only||Retrospective|||||||
1459123|NCT01519349|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1459124|NCT01519336|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1459125|NCT01519323||Single Group Assignment||Treatment||None (Open Label)||||||
1459126|NCT01519310|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459127|NCT01519297||Single Group Assignment||Screening||None (Open Label)||||||
1459128|NCT01519284|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459129|NCT01519271|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1459130|NCT01519258|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459131|NCT01519245|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1459132|NCT01519232|||Case-Only||Prospective|||||||
1459133|NCT01519219|||Case-Only||Prospective|||||||
1459134|NCT01519206||Single Group Assignment||Treatment||None (Open Label)||||||
1459135|NCT01519193|Randomized|Single Group Assignment||Treatment||Single||||||t
1459136|NCT01519180|||Case Control||Prospective|||||||
1459137|NCT01519167||Single Group Assignment||Treatment||None (Open Label)||||||
1459138|NCT01519154|Randomized|Parallel Assignment||||Triple|||t|t|t|
1459139|NCT01519141|||Cohort||Prospective|||||||
1459140|NCT01519128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459141|NCT01519115|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459142|NCT01519102|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459143|NCT01519089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459144|NCT01519076||Single Group Assignment||Treatment||None (Open Label)||||||
1459145|NCT01519063|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1459146|NCT01519050|||Cohort||Prospective|||||||
1459147|NCT01519037|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1459148|NCT01519024|||Case Control||Cross-Sectional|||||||
1459149|NCT01519011|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459150|NCT01518998|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1459151|NCT01518985|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1459152|NCT01518972|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1459153|NCT01518959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459154|NCT01518946|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1459155|NCT01518933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459156|NCT01518920|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1459157|NCT01518907|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459158|NCT01518894|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1459159|NCT01518881|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459160|NCT01518868||||||||||||
1459161|NCT01518855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459162|NCT01518842||Single Group Assignment||Treatment||None (Open Label)||intravitreal injection of autologous bone marrow stem cells||||
1459163|NCT01518829|||Case Control||Prospective|||||||
1459164|NCT01518816|||Case Control||Prospective|||||||
1459165|NCT01518803|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1459166|NCT01518790||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459167|NCT01518777||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459168|NCT01518764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459169|NCT01518751|||Case Control||Prospective|||||||
1459170|NCT01518738|Randomized|Parallel Assignment||Basic Science||Single||||||t
1459171|NCT01518725|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1459172|NCT01518712|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459173|NCT01518699|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1459174|NCT01518686||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459175|NCT01518673|||Cohort||Prospective|||||||
1459176|NCT01518660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459177|NCT01518647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459178|NCT01518634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459179|NCT01518621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459180|NCT01518608|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1459181|NCT01518595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459182|NCT01518582|||Cohort||Prospective|||||||
1459183|NCT01518569|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1459184|NCT01518556||Single Group Assignment||Treatment||None (Open Label)||||||
1459185|NCT01518543|||Case-Only||Prospective|||||||
1459186|NCT01518530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459187|NCT01518517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459188|NCT01518504|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1459189|NCT01518491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459190|NCT01518478|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459191|NCT01518465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459192|NCT01518452|Randomized|Parallel Assignment||Treatment||Single||||||t
1459193|NCT01518439|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459194|NCT01518426||Single Group Assignment||Supportive Care||None (Open Label)||||||
1459195|NCT01518413||Single Group Assignment||Treatment||None (Open Label)||||||
1459196|NCT01518400|||Cohort||Prospective|||||||
1459197|NCT01518387||Single Group Assignment||Treatment||None (Open Label)||||||
1459198|NCT01518374||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459199|NCT01518348||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459200|NCT01518335|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1459201|NCT01518322|||Case-Only||Prospective|||||||
1459202|NCT01518309||Single Group Assignment||Treatment||None (Open Label)||||||
1459203|NCT01518296||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459204|NCT01518283||Single Group Assignment||Treatment||None (Open Label)||||||
1459205|NCT01518270|||Ecologic or Community||Prospective|||||||
1459206|NCT01518257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459207|NCT01518244||Single Group Assignment||Treatment||None (Open Label)||||||
1459208|NCT01518231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459209|NCT01518218|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459210|NCT01518205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459211|NCT01518192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459212|NCT01518179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459213|NCT01518166|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459214|NCT01518153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459215|NCT01518140|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1459216|NCT01518127||Single Group Assignment||Treatment||None (Open Label)||intravitreal injection of autologous bone marrow stem cells||||
1459217|NCT01518114|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1459218|NCT01518101|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459219|NCT01518088|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1459220|NCT01518075|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459221|NCT01518062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459222|NCT01518049|||Cohort||Prospective|||||||
1459223|NCT01518036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459224|NCT01518023|||Cohort||Prospective|||||||
1459225|NCT01518010||Single Group Assignment||Basic Science||None (Open Label)||||||
1459226|NCT01517997|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459227|NCT01517984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459228|NCT01517971|||Cohort||Retrospective|||||||
1459229|NCT01517958|||Case Control||Prospective|||||||
1459230|NCT01517945|||Cohort||Retrospective|||||||
1459231|NCT01517932|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1459232|NCT01517919|Randomized|Parallel Assignment||Treatment||Single||||||t
1459233|NCT01517906|Randomized|Parallel Assignment||Treatment||Single||||||t
1459234|NCT01517893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459235|NCT01517880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459236|NCT01517867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459237|NCT01517854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459238|NCT01517841|||Cohort||Prospective|||||||
1459239|NCT01517828|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459240|NCT01517815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459241|NCT01517802||Single Group Assignment||Treatment||None (Open Label)||||||
1459242|NCT01517789||Single Group Assignment||||None (Open Label)||||||
1459243|NCT01517776||Single Group Assignment||Treatment||None (Open Label)||||||
1459244|NCT01517763|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459245|NCT01517750|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459246|NCT01517737||||||||||||
1459247|NCT01517724||Single Group Assignment||Treatment||None (Open Label)||||||
1459248|NCT01517711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459249|NCT01517698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459250|NCT01517685|Non-Randomized|Single Group Assignment||Basic Science||Single||||||t
1459251|NCT01517672||Single Group Assignment||||None (Open Label)||||||
1459252|NCT01517659||Single Group Assignment||Other||None (Open Label)||||||
1459253|NCT01517646||Single Group Assignment||Other||None (Open Label)||||||
1459254|NCT01517633||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459255|NCT01517620|Randomized|Parallel Assignment||Treatment||Single||||||t
1459256|NCT01517607|||Cohort||Prospective|||||||
1459257|NCT01517594|||||Prospective|||||||
1459258|NCT01517581|||Cohort||Retrospective|||||||
1459259|NCT01517568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459260|NCT01517555|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459261|NCT01517542|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459262|NCT01517529|||Case-Only||Prospective|||||||
1459263|NCT01517516|||Case Control||Cross-Sectional|||||||
1459264|NCT01517503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459265|NCT01517490|||||Prospective|||||||
1459266|NCT01517477|Randomized|Parallel Assignment||Treatment||Single||||||t
1459267|NCT01517464||Single Group Assignment||Treatment||None (Open Label)||||||
1459268|NCT01517451||Single Group Assignment||Treatment||None (Open Label)||||||
1459269|NCT01517438|Non-Randomized|Single Group Assignment||Prevention||Double|||||t|t
1459270|NCT01517425|||Case-Control||Retrospective|||||||
1459271|NCT01517412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459272|NCT01517399||Sequential Assignment||Other||None (Open Label)||||||
1459273|NCT01517386|||Cohort||Cross-Sectional|||||||
1459274|NCT01517373|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459275|NCT01517360|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459276|NCT01517347|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459277|NCT01517334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459278|NCT01517321|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459279|NCT01517308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459280|NCT01517295|Randomized|Parallel Assignment||||None (Open Label)||||||
1459281|NCT01517282|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459282|NCT01517269|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459283|NCT01517256|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459284|NCT01517243||Single Group Assignment||Treatment||None (Open Label)||||||
1459285|NCT01517230|Randomized|Parallel Assignment||||None (Open Label)||||||
1459286|NCT01517217|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459287|NCT01517204|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1459288|NCT01517191|||Case-Control||Prospective|||||||
1459289|NCT01517178|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459290|NCT01517165|Randomized|Parallel Assignment||Treatment||||||||
1459291|NCT01517152|||Cohort||Prospective|||||||
1459292|NCT01517139|||Other||Cross-Sectional|||||||
1459293|NCT01517126|||||Prospective|||||||
1459294|NCT01517113|||||Prospective|||||||
1459295|NCT01517100|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1459296|NCT01517087|||Cohort||Prospective|||||||
1459297|NCT01517074||Single Group Assignment||Treatment||None (Open Label)||||||
1459298|NCT01517061|||||Retrospective|||||||
1459299|NCT01517048|||Case-Control||Cross-Sectional|||||||
1459300|NCT01517035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459301|NCT01517022|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1459302|NCT01517009||Single Group Assignment||Treatment||None (Open Label)||||||
1459303|NCT01516996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459304|NCT01516983||Single Group Assignment||Treatment||None (Open Label)||||||
1459305|NCT01516970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459306|NCT01516957|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459307|NCT01516944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459308|NCT01516931|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1459309|NCT01516918||Single Group Assignment||Treatment||None (Open Label)||||||
1459310|NCT01516905|||Cohort||Prospective|||||||
1459311|NCT01516892||Single Group Assignment||Treatment||None (Open Label)||||||
1459312|NCT01516879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459313|NCT01516866|||Case-Control||Prospective|||||||
1459314|NCT01516853||Single Group Assignment||Basic Science||None (Open Label)||||||
1459315|NCT01516840|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459316|NCT01516827|Randomized|Parallel Assignment||Treatment||Single||||||t
1459317|NCT01516814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459318|NCT01516801|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1459319|NCT01516788||Single Group Assignment||Basic Science||None (Open Label)||||||
1459320|NCT01516775|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1459321|NCT01516762||||||||||||
1459322|NCT01516749||Single Group Assignment||Treatment||None (Open Label)||||||
1459323|NCT01516736|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1459324|NCT01516723|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459325|NCT01516710|Randomized|Parallel Assignment||Treatment||Single||||||t
1459326|NCT01516697|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1459327|NCT01516684|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1459328|NCT01516671|||Cohort||Prospective|||||||
1459329|NCT01516658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459330|NCT01516645||Single Group Assignment||Treatment||None (Open Label)||||||
1459331|NCT01516632|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459332|NCT01516619||Single Group Assignment||Prevention||None (Open Label)||||||
1459333|NCT01516606||Single Group Assignment||Treatment||None (Open Label)||||||
1459334|NCT01516593||Single Group Assignment||Treatment||None (Open Label)||||||
1459335|NCT01516580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459336|NCT01516567||Single Group Assignment||Treatment||None (Open Label)||||||
1459337|NCT01516554|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1459338|NCT01516541|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459339|NCT01516528|||Case-Only||Prospective|||||||
1459340|NCT01516515|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459341|NCT01516502|Randomized|Factorial Assignment||Treatment||Single|||t|||
1459342|NCT01516489|Randomized|Parallel Assignment||Prevention||Single|||||t|
1459343|NCT01516476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459344|NCT01516463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459345|NCT01516450|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459346|NCT01516437|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459347|NCT01516424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459348|NCT01516411|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459349|NCT01516398|||Case-Only||Prospective|||||||
1459350|NCT01516385|||Cohort||Prospective|||||||
1459351|NCT01516372|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1459352|NCT01516359|||||Prospective|||||||
1459353|NCT01516346|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459354|NCT01516333|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1459355|NCT01516320|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459356|NCT01516307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459357|NCT01516294||Single Group Assignment||Treatment||None (Open Label)||||||
1459358|NCT01516281|||Case Control||Cross-Sectional|||||||
1459359|NCT01516268|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1459360|NCT01516255|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459361|NCT01516242|||Cohort||Prospective|||||||
1459362|NCT01516229|||Cohort||Prospective|||||||
1459363|NCT01516216|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459364|NCT01516203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459365|NCT01516190|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459366|NCT01516177|||Cohort||Prospective|||||||
1459367|NCT01516164|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459368|NCT01516151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459369|NCT01516138|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459370|NCT01516125|||Case-Only||Cross-Sectional|||||||
1459371|NCT01516112|||Case-Only||Prospective|||||||
1459372|NCT01516099|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459373|NCT01516086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459374|NCT01516073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459375|NCT01516060|Randomized|Parallel Assignment||Screening||Double|||t||t|
1459376|NCT01516047|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459377|NCT01516034||Single Group Assignment||Treatment||None (Open Label)||||||
1459378|NCT01516021|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1459379|NCT01516008|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1459380|NCT01515995|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459381|NCT01515982|Randomized|Parallel Assignment||Treatment||Single|||||t|
1459382|NCT01515969||Single Group Assignment||Treatment||None (Open Label)||||||
1459383|NCT01515956||Single Group Assignment||Treatment||None (Open Label)||||||
1459384|NCT01515943|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1459385|NCT01515930|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459386|NCT01515917|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459387|NCT01515904|||Case-Control||Prospective|||||||
1459388|NCT01515891||Single Group Assignment||Treatment||None (Open Label)||||||
1459389|NCT01515878|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459390|NCT01515865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459391|NCT01515852|Randomized|Parallel Assignment||||None (Open Label)||||||
1459392|NCT01515839||Single Group Assignment||Treatment||None (Open Label)||||||
1459393|NCT01515826|Randomized|Parallel Assignment||Treatment||Single|||||t|
1459394|NCT01515813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459395|NCT01515800|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1459396|NCT01515787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459397|NCT01515774|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459398|NCT01515761|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1459399|NCT01515748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459400|NCT01515735|||Case Control||Prospective|||||||
1459401|NCT01515722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459402|NCT01515709|||Cohort||Prospective|||||||
1459403|NCT01515696|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459404|NCT01515683|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459405|NCT01515670|||Cohort||Prospective|||||||
1459406|NCT01515657|Randomized|Crossover Assignment||Prevention||Single||||||t
1459407|NCT01515644|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1459408|NCT01515631|||Case-Only||Retrospective|||||||
1459409|NCT01515618||||||||||||
1459410|NCT01515605|||Cohort||Prospective|||||||
1459411|NCT01515592|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459412|NCT01515579|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459413|NCT01515566|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1459414|NCT01515553|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459415|NCT01515540|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1459416|NCT01515527||Single Group Assignment||Treatment||None (Open Label)||||||
1459417|NCT01515514|||Cohort||Prospective|||||||
1459418|NCT01515501||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459419|NCT01515488|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1459420|NCT01515475|Randomized|Parallel Assignment||Treatment||Single||||||t
1459421|NCT01515462||Single Group Assignment||Treatment||None (Open Label)||This will be a single-arm study. All subjects will receive OTL-103 gene therapy and will be followed up for 8 years post gene therapy||||
1459422|NCT01515449|||Cohort||Prospective|||||||
1459423|NCT01515436|Randomized|||Treatment||Single|||||t|
1459424|NCT01515423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459425|NCT01515410|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459426|NCT01515397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459427|NCT01515384|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1459428|NCT01515371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459429|NCT01515358|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459430|NCT01515345|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459431|NCT01515332|||Cohort||Prospective|||||||
1459432|NCT01515319|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459433|NCT01515306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459434|NCT01515293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459435|NCT01515280|||Case-Only||Cross-Sectional|||||||
1459436|NCT01515267|||||Prospective|||||||
1459437|NCT01515254|Randomized|Parallel Assignment||Treatment||Single||||||t
1459438|NCT01515241||Single Group Assignment||Treatment||None (Open Label)||||||
1459439|NCT01515228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459440|NCT01515215|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1459441|NCT01515202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459442|NCT01515189|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459443|NCT01515176||Single Group Assignment||Treatment||None (Open Label)||||||
1459444|NCT01515163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459445|NCT01515150|||Cohort||Prospective|||||||
1459446|NCT01515137|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459447|NCT01515124|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1459448|NCT01515111|||||Cross-Sectional|||||||
1459449|NCT01515098|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1459450|NCT01515085|||Case-Only||Prospective|||||||
1459451|NCT01515072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459452|NCT01515059|||Cohort||Prospective|||||||
1459453|NCT01515046||Single Group Assignment||Treatment||None (Open Label)||||||
1459454|NCT01515033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459455|NCT01515020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459456|NCT01515007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459457|NCT01514994||Single Group Assignment||Treatment||None (Open Label)||||||
1459458|NCT01514981|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1459459|NCT01514968|Randomized|Crossover Assignment||||None (Open Label)||||||
1459460|NCT01514955|Non-Randomized|Single Group Assignment||Treatment||||||||
1459461|NCT01514942||||||||||||
1459462|NCT01514929|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459463|NCT01514916||Single Group Assignment||Treatment||None (Open Label)||||||
1459464|NCT01514903|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459465|NCT01514890|||Cohort||Other|||||||
1459466|NCT01514877||Single Group Assignment||Treatment||None (Open Label)||||||
1459467|NCT01514864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459468|NCT01514851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459469|NCT01514838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459470|NCT01514825|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1459471|NCT01514812|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1459472|NCT01514799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459473|NCT01514786|Randomized|Parallel Assignment||Prevention||Single|||t|||
1459474|NCT01514773|||Case-Control||Other|||||||
1459475|NCT01514760||Single Group Assignment||Treatment||None (Open Label)||||||
1459476|NCT01514747|||Cohort||Prospective|||||||
1459477|NCT01514734||Single Group Assignment||Treatment||None (Open Label)||||||
1459478|NCT01514721||Single Group Assignment||Treatment||None (Open Label)||||||
1459479|NCT01514708||Single Group Assignment||Prevention||None (Open Label)||||||
1459480|NCT01514695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459481|NCT01514682|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459482|NCT01514669|||Cohort||Cross-Sectional|||||||
1459483|NCT01514656|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459484|NCT01514643|||Case-Control||Prospective|||||||
1459485|NCT01514630||Single Group Assignment||Treatment||None (Open Label)||||||
1459486|NCT01514617||Single Group Assignment||Diagnostic||Single|||||t|
1459487|NCT01514604|||Cohort||Prospective|||||||
1459488|NCT01514591|||Cohort||Prospective|||||||
1459489|NCT01514578|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459490|NCT01514565|||Cohort||Prospective|||||||
1459491|NCT01514552|Randomized|Crossover Assignment||Prevention||Single|||t|||
1459492|NCT01514539|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459493|NCT01514526||Single Group Assignment||Treatment||None (Open Label)||||||
1459494|NCT01514513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459495|NCT01514500|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1459496|NCT01514487|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459497|NCT01514461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459498|NCT01514448||Single Group Assignment||Treatment||None (Open Label)||||||
1459499|NCT01514435||Single Group Assignment||Treatment||None (Open Label)||||||
1459500|NCT01514422||Single Group Assignment||Treatment||None (Open Label)||||||
1459501|NCT01514409|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459502|NCT01514396||Single Group Assignment||Treatment||None (Open Label)||||||
1459503|NCT01514383||Single Group Assignment||Treatment||None (Open Label)||||||
1459504|NCT01514370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459505|NCT01514357|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459506|NCT01514344||Single Group Assignment||Treatment||None (Open Label)||||||
1459507|NCT01514331|Randomized|Parallel Assignment||||None (Open Label)||||||
1459508|NCT01514318|||Cohort||Prospective|||||||
1459509|NCT01514305|||Cohort||Cross-Sectional|||||||
1459510|NCT01514292||Single Group Assignment||Treatment||None (Open Label)||||||
1459511|NCT01514279|Randomized|Parallel Assignment||Treatment||Single||||||t
1459512|NCT01514266|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1459513|NCT01514253|Randomized|Crossover Assignment||||Double||||t|t|
1459514|NCT01514240|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459515|NCT01514227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459516|NCT01514214|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459517|NCT01514201||Single Group Assignment||Treatment||None (Open Label)||||||
1459518|NCT01514188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459519|NCT01514175||Single Group Assignment||Supportive Care||Triple|||t|t|t|
1459520|NCT01514162||Single Group Assignment||Treatment||None (Open Label)||||||
1459521|NCT01514149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459522|NCT01514136||Single Group Assignment||||None (Open Label)||||||
1459523|NCT01514123|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459524|NCT01514110||Single Group Assignment||Treatment||None (Open Label)||||||
1459525|NCT01514097|||Case-Only||Prospective|||||||
1459526|NCT01514084|||Cohort||Prospective|||||||
1459527|NCT01514071||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459528|NCT01514058|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1459529|NCT01514045|||Ecologic or Community||Cross-Sectional|||||||
1459530|NCT01514032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459531|NCT01514019|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459532|NCT01514006|||Cohort||Prospective|||||||
1459533|NCT01513993|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1459534|NCT01513980|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1459535|NCT01513967|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459536|NCT01513954|||Case Control||Prospective|||||||
1459537|NCT01513941||Single Group Assignment||Treatment||None (Open Label)||||||
1459538|NCT01513928||Single Group Assignment||Basic Science||None (Open Label)||||||
1459539|NCT01513915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459540|NCT01513902|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459541|NCT01513863|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459542|NCT01513850||Single Group Assignment||Prevention||None (Open Label)||||||
1459543|NCT01513837|||Case-Only||Prospective|||||||
1459544|NCT01513824|Randomized|Parallel Assignment||Treatment||Single|||||t|
1459545|NCT01513811|Randomized|Parallel Assignment||Treatment||Single||||||t
1459546|NCT01513798|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1459547|NCT01513785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459548|NCT01513772|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1459549|NCT01513759||Single Group Assignment||Treatment||None (Open Label)||||||
1459550|NCT01513746|||Cohort||Cross-Sectional|||||||
1459551|NCT01513733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459552|NCT01513720|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459553|NCT01513707|||Cohort||Prospective|||||||
1459554|NCT01513694||Single Group Assignment||Treatment||None (Open Label)||||||
1459555|NCT01513681|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459556|NCT01513668|Randomized|Crossover Assignment||||None (Open Label)||||||
1459557|NCT01513655|Randomized|Parallel Assignment||Prevention||Single||||||t
1459558|NCT01513642|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459559|NCT01513629|||Cohort||Retrospective|||||||
1459560|NCT01513616|Randomized|Parallel Assignment||Treatment||Single||||||t
1459561|NCT01513603||Single Group Assignment||Treatment||None (Open Label)||||||
1459562|NCT01513590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459563|NCT01513577|Randomized|Parallel Assignment||||None (Open Label)||||||
1459564|NCT01513564||Single Group Assignment||||Single|||t|||
1459565|NCT01513551|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1459566|NCT01513538|||Case-Only||Prospective|||||||
1459567|NCT01513525|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459568|NCT01513512||||||||||||
1459569|NCT01513499|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1459570|NCT01513486|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459571|NCT01513473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459572|NCT01513460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459573|NCT01513447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459574|NCT01513434|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1459575|NCT01513421|||Cohort||Prospective|||||||
1459576|NCT01513408||Single Group Assignment||Other||None (Open Label)||||||
1459577|NCT01513395|Randomized|Parallel Assignment||Prevention||Single||||||t
1459578|NCT01513382||Single Group Assignment||Treatment||None (Open Label)||||||
1459579|NCT01513369|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459580|NCT01513356||Single Group Assignment||||None (Open Label)||||||
1459581|NCT01513343|Randomized|Parallel Assignment||Prevention||Single|||t|||
1459582|NCT01513330|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1459583|NCT01513317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459584|NCT01513304||||Treatment||||||||
1459585|NCT01513291|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1459586|NCT01513278|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1459587|NCT01513265|Non-Randomized|Parallel Assignment||Health Services Research||Single||||t||
1459588|NCT01513252||Single Group Assignment||Prevention||None (Open Label)||||||
1459589|NCT01513239|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459590|NCT01513226||Single Group Assignment||Supportive Care||None (Open Label)||||||
1459591|NCT01513213|||Case-Only||Cross-Sectional|||||||
1459592|NCT01513200|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1459593|NCT01513187||Single Group Assignment||Treatment||None (Open Label)||||||
1459594|NCT01513174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459595|NCT01513161|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1459596|NCT01513148|Randomized|Parallel Assignment||||Double|||t||t|
1459597|NCT01513135|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459598|NCT01513122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459599|NCT01513109||Single Group Assignment||Treatment||None (Open Label)||||||
1459600|NCT01513096|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1459601|NCT01513083||Parallel Assignment||Treatment||None (Open Label)||||||
1459602|NCT01513070|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459603|NCT01513057|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459604|NCT01513044|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459605|NCT01513031||Single Group Assignment||Health Services Research||None (Open Label)||||||
1459606|NCT01513018|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1459607|NCT01513005||Single Group Assignment||Treatment||None (Open Label)||||||
1459608|NCT01512992|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1459609|NCT01512979|Randomized|Parallel Assignment||Treatment||Double||||||
1459610|NCT01512966||Single Group Assignment||Treatment||None (Open Label)||||||
1459611|NCT01512953|Randomized|Parallel Assignment||Treatment||Single||||||t
1459612|NCT01512940||Single Group Assignment||Treatment||None (Open Label)||||||
1459613|NCT01512927|||Cohort||Prospective|||||||
1459614|NCT01512914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459615|NCT01512901||||||||||||
1459616|NCT01512888||Single Group Assignment||Treatment||None (Open Label)||||||
1459617|NCT01512875|||Case-Only||Prospective|||||||
1459618|NCT01512862|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459619|NCT01512849|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459620|NCT01512836|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1459621|NCT01512823|Randomized|Parallel Assignment||||Single||||||t
1459622|NCT01512810|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459623|NCT01512797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459624|NCT01512784|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459625|NCT01512771|||Case-Crossover||Prospective|||||||
1459626|NCT01512758||Single Group Assignment||Treatment||None (Open Label)||||||
1459627|NCT01512745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459628|NCT01512732||||||||||||
1459629|NCT01512719||Single Group Assignment||Treatment||None (Open Label)||||||
1459630|NCT01512706|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1459631|NCT01512693|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459632|NCT01512680||Single Group Assignment||||None (Open Label)||||||
1459633|NCT01512667|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459634|NCT01512654|Randomized|Crossover Assignment||||None (Open Label)||||||
1459635|NCT01512641||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459636|NCT01512628|Randomized|Parallel Assignment||||None (Open Label)||||||
1459637|NCT01512615|Randomized|Parallel Assignment||Prevention||Single||RCT||||t
1459638|NCT01512602|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1459639|NCT01512589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459640|NCT01512576|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1459641|NCT01512563|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1459642|NCT01512550|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459643|NCT01512537|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1459644|NCT01512524||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459645|NCT01512511|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1459646|NCT01512498|||Cohort||Cross-Sectional|||||||
1459647|NCT01512485|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459648|NCT01512472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459649|NCT01512459|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459650|NCT01512446|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459651|NCT01512433|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459652|NCT01512420|||Cohort||Prospective|||||||
1459653|NCT01512407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459654|NCT01512394|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459655|NCT01512381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459656|NCT01512368||Single Group Assignment||||None (Open Label)||||||
1459657|NCT01512355|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1459658|NCT01512342|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1459659|NCT01512329|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1459660|NCT01512316|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1459661|NCT01512303|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459662|NCT01512290|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459663|NCT01512277|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1459664|NCT01512264|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459665|NCT01512251||Single Group Assignment||Treatment||None (Open Label)||||||
1459666|NCT01512238|||||Retrospective|||||||
1459667|NCT01512225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459668|NCT01512212||Single Group Assignment||Diagnostic||Single|||||t|
1459669|NCT01512199|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459670|NCT01512186|||Case-Only||Prospective|||||||
1459671|NCT01512173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460131|NCT01506102||Single Group Assignment||Diagnostic||Single|||t|||
1459672|NCT01512160|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459673|NCT01512147||Single Group Assignment||Prevention||None (Open Label)||||||
1459674|NCT01512134||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1459675|NCT01512121|||Other||Prospective|||||||
1459676|NCT01512108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459677|NCT01512095|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459678|NCT01512082|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1459679|NCT01512069|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1459680|NCT01512056|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459681|NCT01512043|Randomized|Parallel Assignment||||Double|||t||t|
1459682|NCT01512030|||Cohort||Prospective|||||||
1459683|NCT01512017|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459684|NCT01512004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459685|NCT01511991||Single Group Assignment||Basic Science||Single||||||t
1459686|NCT01511978|Randomized|Parallel Assignment||Treatment||Quadruple||This was a multicenter, randomized, double-blind, placebo-controlled withdrawal study to assess the safety and efficacy of 3,4-DAP in subjects on a stable regimen of all LEMS-related treatments, including 3,4-DAP, for a minimum of 3 months prior to study entry. Subjects who met all study entry criteria were randomized in a 1:1 ratio to continue their current treatment regimen (Group A, continuous 3,4-DAP) or tapered withdrawal from 3,4-DAP (Group B, taper to placebo).|t|t|t|t
1459687|NCT01511965|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459688|NCT01511952|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1459689|NCT01511939|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1459690|NCT01511926|||Cohort||Retrospective|||||||
1459691|NCT01511913|||Cohort||Prospective|||||||
1459692|NCT01511900|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1459693|NCT01511887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459694|NCT01511874||Single Group Assignment||Treatment||None (Open Label)||||||
1459695|NCT01511861|||Cohort||Cross-Sectional|||||||
1459696|NCT01511848|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459697|NCT01511835||||||||||||
1459698|NCT01511822||||||||||||
1459699|NCT01511809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459700|NCT01511796||Single Group Assignment||Treatment||None (Open Label)||||||
1459701|NCT01511783|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459702|NCT01511770|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459703|NCT01511757|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459704|NCT01511744|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1459705|NCT01511731|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459706|NCT01511718|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459707|NCT01511705|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459708|NCT01511692|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459709|NCT01511679|||Cohort||Prospective|||||||
1459710|NCT01511666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459711|NCT01511653|||Case-Control||Prospective|||||||
1459712|NCT01511640|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1459713|NCT01511627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459714|NCT01511614|||Cohort||Cross-Sectional|||||||
1459715|NCT01511601|||||Prospective|||||||
1459716|NCT01511588|||Case-Only||Prospective|||||||
1459717|NCT01511575|||Case Control||Retrospective|||||||
1459718|NCT01511562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459719|NCT01511549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459720|NCT01511536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459721|NCT01511523|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1459722|NCT01511510|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1459723|NCT01511497|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1459724|NCT01511484|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459725|NCT01511471||Single Group Assignment||Treatment||Single||||||t
1459726|NCT01511458|||||Prospective|||||||
1459727|NCT01511445|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1459728|NCT01511432|Randomized|Crossover Assignment||||None (Open Label)||||||
1459729|NCT01511419|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1459730|NCT01511406||Single Group Assignment||Treatment||Single||||||t
1459731|NCT01511393|||Case-Only||Prospective|||||||
1459732|NCT01511380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459733|NCT01511367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459734|NCT01511354|||Cohort||Prospective|||||||
1459735|NCT01511341|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1459736|NCT01511328|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1459737|NCT01511315||Single Group Assignment||Treatment||None (Open Label)||||||
1459738|NCT01511302|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459739|NCT01511289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459740|NCT01511276|Randomized|Parallel Assignment||Basic Science||Single|Analyses of the blood assays and MRI data were masked.|||||t
1459741|NCT01511263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459742|NCT01511250|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1459743|NCT01511237||Single Group Assignment||Prevention||None (Open Label)||||||
1459744|NCT01511224|||Cohort||Prospective|||||||
1459745|NCT01511211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459746|NCT01511198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459747|NCT01511185|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459748|NCT01511172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459749|NCT01511159|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459750|NCT01511146||Single Group Assignment||Treatment||None (Open Label)||||||
1459751|NCT01511133|||Other||Retrospective|||||||
1459752|NCT01511120||Single Group Assignment||Supportive Care||Triple|||t||t|t
1459753|NCT01511107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459754|NCT01511094||Single Group Assignment||Treatment||None (Open Label)||||||
1459755|NCT01511081|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459756|NCT01511068||Single Group Assignment||Treatment||None (Open Label)||||||
1459757|NCT01511055||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459758|NCT01511042|||Cohort||Cross-Sectional|||||||
1459759|NCT01511029|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459760|NCT01511016|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459761|NCT01511003||Single Group Assignment||Treatment||None (Open Label)||||||
1459762|NCT01510990||Single Group Assignment||Treatment||None (Open Label)||||||
1459763|NCT01510977|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1459764|NCT01510964|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1459765|NCT01510951|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1459766|NCT01510938|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1459767|NCT01510912||Single Group Assignment||Treatment||None (Open Label)||||||
1459768|NCT01510899|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1459769|NCT01510886|||||Retrospective|||||||
1459770|NCT01510873|||Case Control||Cross-Sectional|||||||
1459771|NCT01510860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459772|NCT01510847||Single Group Assignment||Supportive Care||None (Open Label)||||||
1459773|NCT01510834||Single Group Assignment||Health Services Research||None (Open Label)||||||
1459774|NCT01510821|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459775|NCT01510808|||Case Control||Retrospective|||||||
1459776|NCT01510795|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1459777|NCT01510782|Randomized|Single Group Assignment||Treatment||Single||||||
1459778|NCT01510769|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459779|NCT01510756||Single Group Assignment||Treatment||None (Open Label)||||||
1459780|NCT01510743|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459781|NCT01510730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459782|NCT01510717|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1459783|NCT01510704|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1459784|NCT01510691|||||Prospective|||||||
1459785|NCT01510678|Randomized|Factorial Assignment||Prevention||Single||||||t
1459786|NCT01510665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459787|NCT01510652|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459788|NCT01510639|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459789|NCT01510626||Single Group Assignment||Treatment||None (Open Label)||||||
1459790|NCT01510613||Single Group Assignment||Treatment||None (Open Label)||||||
1459791|NCT01510600|||Cohort||Retrospective|||||||
1459792|NCT01510587|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459793|NCT01510574|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1459794|NCT01510561|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459795|NCT01510548|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459796|NCT01510535|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459797|NCT01510522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459798|NCT01510509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459799|NCT01510496|||Cohort||Prospective|||||||
1459800|NCT01510483|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1459801|NCT01510470|||Case-Only||Prospective|||||||
1459802|NCT01510457|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459803|NCT01510431||Single Group Assignment||Treatment||None (Open Label)||||||
1459804|NCT01510418|||Cohort||Prospective|||||||
1459805|NCT01510405|||Cohort||Prospective|||||||
1459806|NCT01510392|||Other||Prospective|||||||
1459807|NCT01510379|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459808|NCT01510366|Randomized|Parallel Assignment||Prevention||Single||||||t
1459809|NCT01510353|Randomized|Parallel Assignment||Prevention||Single||||||t
1459810|NCT01510340|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459811|NCT01510327||Single Group Assignment||Treatment||None (Open Label)||||||
1459812|NCT01510314||||||||||||
1459813|NCT01510301||Single Group Assignment||Supportive Care||None (Open Label)||||||
1459814|NCT01510288||Single Group Assignment||Treatment||None (Open Label)||||||
1459815|NCT01510275|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1459816|NCT01510262|Randomized|Parallel Assignment||Prevention||Single|||t|||
1459817|NCT01510249|||Case Control||Retrospective|||||||
1459818|NCT01510236|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459819|NCT01510223|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1459820|NCT01510210|||Case-Only||Prospective|||||||
1459821|NCT01510197|||Case-Only||Prospective|||||||
1459822|NCT01510184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459823|NCT01510171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459824|NCT01510158|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1459825|NCT01510145||Single Group Assignment||Treatment||None (Open Label)||||||
1459826|NCT01510132||Single Group Assignment||Treatment||None (Open Label)||||||
1459827|NCT01510119||Single Group Assignment||Treatment||||||||
1459828|NCT01510093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459829|NCT01510080|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1459830|NCT01510067|||Cohort||Prospective|||||||
1459831|NCT01510054||||||||||||
1459832|NCT01510041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459833|NCT01510028|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459834|NCT01510015|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459835|NCT01510002|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459836|NCT01509989|||||Prospective|||||||
1459837|NCT01509976|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1459838|NCT01509963|||Cohort||Prospective|||||||
1459839|NCT01509950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459840|NCT01509937|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459841|NCT01509924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459842|NCT01509911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459843|NCT01509898||Single Group Assignment||Treatment||None (Open Label)||||||
1459844|NCT01509885||||||||||||
1459845|NCT01509872|Randomized|Parallel Assignment||Treatment||Double||||t||t
1459846|NCT01509859|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1459847|NCT01509846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459848|NCT01509833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459849|NCT01509807|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1459850|NCT01509794|Randomized|Parallel Assignment||||Single|||t|||
1459851|NCT01509781|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1459852|NCT01509768|||Cohort||Prospective|||||||
1459853|NCT01509755||||||||||||
1459854|NCT01509742|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459855|NCT01509729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459856|NCT01509716|||||Cross-Sectional|||||||
1459857|NCT01509703||Single Group Assignment||Basic Science||None (Open Label)||||||
1459858|NCT01509690||Single Group Assignment||Health Services Research||None (Open Label)||||||
1459859|NCT01509677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459860|NCT01509664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459861|NCT01509651||Single Group Assignment||Treatment||None (Open Label)||||||
1459862|NCT01509638|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1459863|NCT01509625|||Cohort||Retrospective|||||||
1459864|NCT01509612|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1459865|NCT01509599|Randomized|Parallel Assignment||Prevention||Single|||||t|
1459866|NCT01509586|Randomized|Parallel Assignment||||None (Open Label)||||||
1459867|NCT01509573|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459868|NCT01509560||Single Group Assignment||Treatment||None (Open Label)||||||
1459869|NCT01509547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459870|NCT01509534|||Cohort||Prospective|||||||
1459871|NCT01509521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459872|NCT01509508|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459873|NCT01509495||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459874|NCT01509482|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1459875|NCT01509469|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1459876|NCT01509456|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1459877|NCT01509443|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459878|NCT01509430|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1459879|NCT01509417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459880|NCT01509404|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459881|NCT01509391||Single Group Assignment||Treatment||None (Open Label)||||||
1459882|NCT01509378|||Cohort||Prospective|||||||
1459883|NCT01509365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459884|NCT01509352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459885|NCT01509339||Single Group Assignment||Treatment||None (Open Label)||||||
1459886|NCT01509326|Randomized|Parallel Assignment||Treatment||Single||||||t
1459887|NCT01509313|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459888|NCT01509300||Single Group Assignment||Treatment||None (Open Label)||||||
1459889|NCT01509287|||Case-Only||Cross-Sectional|||||||
1459890|NCT01509274|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459891|NCT01509261|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459892|NCT01509248|||Cohort||Prospective|||||||
1459893|NCT01509235|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459894|NCT01509222|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459895|NCT01509209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459896|NCT01509196|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459897|NCT01509183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459898|NCT01509170|||Case-Only||Prospective|||||||
1459899|NCT01509157|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459900|NCT01509144|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1459901|NCT01509131|Randomized|Parallel Assignment||Treatment||Single||||||t
1459902|NCT01509118|||Case-Only||Prospective|||||||
1459903|NCT01509105|||Case-Only||Prospective|||||||
1459904|NCT01509092|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1459905|NCT01509079|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1459906|NCT01509066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459907|NCT01509053||Single Group Assignment||Treatment||None (Open Label)||||||
1459908|NCT01509040|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459909|NCT01509027|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1459910|NCT01509014|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1459911|NCT01509001|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459912|NCT01508988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459913|NCT01508975|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1459914|NCT01508962|||Cohort||Prospective|||||||
1459915|NCT01508949|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459916|NCT01508936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459917|NCT01508923|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459918|NCT01508910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459919|NCT01508897|Randomized|Crossover Assignment||Treatment||Single|||t|||
1459920|NCT01508884|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1459921|NCT01508871|||Cohort||Prospective|||||||
1459922|NCT01508858|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1459923|NCT01508845|Randomized|Parallel Assignment||Treatment||Single|||t|||
1459924|NCT01508832|Randomized|Crossover Assignment||||Double|||t|||t
1459925|NCT01508819|||Cohort||Prospective|||||||
1459926|NCT01508806|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459927|NCT01508793|Randomized|Parallel Assignment||Treatment||Single||||||t
1459928|NCT01508780||Single Group Assignment||||None (Open Label)||||||
1459929|NCT01508767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459930|NCT01508754|Randomized|Parallel Assignment||Treatment||Single||||||t
1459931|NCT01508741|Randomized|Parallel Assignment||||Double|||t|t||
1459932|NCT01508728|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459933|NCT01508715|Randomized|Parallel Assignment||Treatment||Single||||||t
1459934|NCT01508702|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1459935|NCT01508689|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1459936|NCT01508676|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1459937|NCT01508663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459938|NCT01508650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459939|NCT01508637|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1459940|NCT01508624|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459941|NCT01508611|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1459942|NCT01508598|||Case-Only||Cross-Sectional|||||||
1459943|NCT01508585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459944|NCT01508572||Single Group Assignment||Treatment||None (Open Label)||||||
1459945|NCT01508559|||Cohort||Prospective|||||||
1459946|NCT01508546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459947|NCT01508533|||Cohort||Prospective|||||||
1459948|NCT01508520|||Case-Only||Prospective|||||||
1459949|NCT01508507|||Case Control||Retrospective|||||||
1459950|NCT01508494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459951|NCT01508481|||Cohort||Prospective|||||||
1459952|NCT01508468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459953|NCT01508455||Single Group Assignment||Treatment||None (Open Label)||||||
1459954|NCT01508429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459955|NCT01508416|||Case-Only||Prospective|||||||
1459956|NCT01508403|||||Prospective|||||||
1459957|NCT01508390||Single Group Assignment||Treatment||None (Open Label)||||||
1459958|NCT01508377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459959|NCT01508364|||Cohort||Prospective|||||||
1459960|NCT01508351|||Case-Only||Prospective|||||||
1459961|NCT01508338|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1459962|NCT01508325|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459963|NCT01508312|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459964|NCT01508299|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1459965|NCT01508286||||||||||||
1459966|NCT01508273|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1459967|NCT01508260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459968|NCT01508247|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1459969|NCT01508221||Single Group Assignment||Prevention||None (Open Label)||||||
1459970|NCT01508208||Single Group Assignment||Diagnostic||None (Open Label)||||||
1459971|NCT01508195|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459972|NCT01508182|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1459973|NCT01508169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459974|NCT01508156|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459975|NCT01508143|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1459976|NCT01508130|||Cohort||Prospective|||||||
1459977|NCT01508117||Single Group Assignment||Treatment||None (Open Label)||||||
1459978|NCT01508104||Single Group Assignment||Treatment||None (Open Label)||||||
1459979|NCT01508091||Single Group Assignment||Basic Science||None (Open Label)||||||
1459980|NCT01508078|||Other||Cross-Sectional|||||||
1459981|NCT01508065|||Cohort||Prospective|||||||
1459982|NCT01508052|Randomized|Parallel Assignment||Prevention||Single||||||t
1459983|NCT01508039||Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1459984|NCT01508026|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1459985|NCT01508013|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1459986|NCT01508000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459987|NCT01507987|||Cohort||Prospective|||||||
1459988|NCT01507974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1459989|NCT01507961|||Cohort||Retrospective|||||||
1459990|NCT01507948|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1459991|NCT01507935|Randomized|Parallel Assignment||||Triple|||t|t|t|
1459992|NCT01507922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1459993|NCT01507909|||Cohort||Prospective|||||||
1459994|NCT01507896||Single Group Assignment||Treatment||None (Open Label)||||||
1459995|NCT01507883|||Case Control||Prospective|||||||
1459996|NCT01507870|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1459997|NCT01507857|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1459998|NCT01507844||Crossover Assignment||Treatment||Double|||t||t|
1459999|NCT01507831|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460000|NCT01507818|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460001|NCT01507805|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460002|NCT01507792||Single Group Assignment||Treatment||None (Open Label)||||||
1460003|NCT01507779|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1460004|NCT01507766|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460005|NCT01507753|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1460006|NCT01507740|||Case-Only||Prospective|||||||
1460007|NCT01507727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460008|NCT01507714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460009|NCT01507701||Single Group Assignment||||None (Open Label)||||||
1460010|NCT01507688|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1460011|NCT01507675|||Ecologic or Community||Cross-Sectional|||||||
1460012|NCT01507662|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1460013|NCT01507649|Randomized|Parallel Assignment||Prevention||Single||||||t
1460014|NCT01507636|Randomized|Parallel Assignment||Treatment||Single||||||t
1460015|NCT01507623|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460016|NCT01507610|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460017|NCT01507597|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1460018|NCT01507584|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1460019|NCT01507571||Single Group Assignment||Supportive Care||None (Open Label)||||||
1460020|NCT01507558||Single Group Assignment||Treatment||None (Open Label)||||||
1460021|NCT01507545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460022|NCT01507532||Single Group Assignment||Other||None (Open Label)||||||
1460023|NCT01507519||Single Group Assignment||Treatment||None (Open Label)||BioMime™ Sirolimus-Eluting Coronary Stent System||||
1460024|NCT01507506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460025|NCT01507493||||||||||||
1460026|NCT01507480||Single Group Assignment||Treatment||Double|||t||t|
1460027|NCT01507467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460028|NCT01507454|||Cohort||Prospective|||||||
1460029|NCT01507441|||Case-Only||Retrospective|||||||
1460030|NCT01507428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460031|NCT01507415|||Cohort||Prospective|||||||
1460032|NCT01507402|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460033|NCT01507389|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460034|NCT01507376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460035|NCT01507363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460036|NCT01507350|||Cohort||Prospective|||||||
1460037|NCT01507337|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460038|NCT01507311|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460039|NCT01507298|||||Prospective|||||||
1460040|NCT01507285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460041|NCT01507272|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460042|NCT01507259|||Case-Crossover||Prospective|||||||
1460043|NCT01507246|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1460044|NCT01507233|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1460045|NCT01507220|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1460046|NCT01507207||Single Group Assignment||Treatment||None (Open Label)||||||
1460047|NCT01507194|Randomized|Parallel Assignment||Treatment||Single|||||t|
1460048|NCT01507181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460049|NCT01507168|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460050|NCT01507155|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1460051|NCT01507142|||Case-Control||Cross-Sectional|||||||
1460052|NCT01507129|||Case-Only||Cross-Sectional|||||||
1460053|NCT01507116|||Ecologic or Community||Prospective|||||||
1460054|NCT01507103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460055|NCT01507090|||Cohort||Prospective|||||||
1460056|NCT01507077|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460057|NCT01507064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460058|NCT01507051|Randomized|Parallel Assignment||||Single|||t|||
1460059|NCT01507038|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460060|NCT01507025|||Case Control||Retrospective|||||||
1460061|NCT01507012|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1460062|NCT01506999|||Cohort||Prospective|||||||
1460063|NCT01506986|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1460064|NCT01506973||||Treatment||||||||
1460065|NCT01506960||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460066|NCT01506947||Single Group Assignment||Treatment||None (Open Label)||||||
1460067|NCT01506934|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1460068|NCT01506921|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1460069|NCT01506908|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460070|NCT01506895|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460071|NCT01506882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460072|NCT01506869|||Cohort||Prospective|||||||
1460073|NCT01506856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460074|NCT01506843|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1460075|NCT01506830|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460076|NCT01506817|||Case Control||Cross-Sectional|||||||
1460077|NCT01506804|Randomized|Parallel Assignment||Treatment||Single||||||t
1460078|NCT01506791|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460079|NCT01506778|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1460080|NCT01506765|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1460081|NCT01506752|Randomized|Crossover Assignment||||None (Open Label)||||||
1460082|NCT01506739|Randomized|Crossover Assignment||||None (Open Label)||||||
1460083|NCT01506726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460084|NCT01506713|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460085|NCT01506700|||Cohort||Prospective|||||||
1460086|NCT01506687|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1460087|NCT01506674|||Cohort||Prospective|||||||
1460088|NCT01506661|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460089|NCT01506648||||||||||||
1460090|NCT01506635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460091|NCT01506622|Randomized|Parallel Assignment||||Double||||t|t|
1460092|NCT01506609|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460093|NCT01506596||Single Group Assignment||Treatment||None (Open Label)||||||
1460094|NCT01506583|||||Prospective|||||||
1460095|NCT01506570|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1460096|NCT01506557|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1460097|NCT01506544|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1460098|NCT01506531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460099|NCT01506518|||Cohort||Prospective|||||||
1460100|NCT01506505|Randomized|Crossover Assignment||Treatment||Single||||||t
1460101|NCT01506492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460102|NCT01506479|Randomized|Parallel Assignment||Treatment||Single||||||t
1460103|NCT01506466||Single Group Assignment||||None (Open Label)||||||
1460104|NCT01506453|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1460105|NCT01506440|||Case-Only||Prospective|||||||
1460106|NCT01506427||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460107|NCT01506414||Single Group Assignment||Treatment||None (Open Label)||||||
1460108|NCT01506401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460109|NCT01506388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460110|NCT01506375|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460111|NCT01506362||Single Group Assignment||Treatment||None (Open Label)||||||
1460112|NCT01506349|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1460113|NCT01506336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460114|NCT01506323|Randomized|Parallel Assignment||Treatment||Single||||||t
1460115|NCT01506310|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1460116|NCT01506297|||Cohort||Prospective|||||||
1460117|NCT01506284|||||Prospective|||||||
1460118|NCT01506271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460119|NCT01506258|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460120|NCT01506245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460121|NCT01506232|||Cohort||Prospective|||||||
1460122|NCT01506219|Randomized|Parallel Assignment||Treatment||Single|"The geriatrician was blinded to the primary endpoint data that were drawn from the National Patient Registry via Researcher Service. The dataset was generated by the Registry's staff blinded to the patient allocation.~It was impossible to blind the participants and their relatives or the geriatrician and the rehabilitation units' staff to the allocation group.~The research nurse was not blinded to patient allocation for practical reasons. The research occupational therapist was blinded to treatment allocation."|A pragmatic open assessor-blinded clinical randomized controlled trial with two parallel groups.||||t
1460123|NCT01506206|||Cohort||Cross-Sectional|||||||
1460124|NCT01506193|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460125|NCT01506180|||Cohort||Cross-Sectional|||||||
1460126|NCT01506167|||Cohort||Prospective|||||||
1460127|NCT01506154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460128|NCT01506141||Single Group Assignment||Treatment||None (Open Label)||||||
1460129|NCT01506128|||Case-Only||Prospective|||||||
1460130|NCT01506115||Single Group Assignment||Treatment||None (Open Label)||||||
1460132|NCT01506089|Randomized|Parallel Assignment||||None (Open Label)||||||
1460133|NCT01506076|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460134|NCT01506063|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460135|NCT01506050|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460136|NCT01506037|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460137|NCT01506024|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460138|NCT01506011|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460139|NCT01505998|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460140|NCT01505985|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1460141|NCT01505972|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1460142|NCT01505959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460143|NCT01505946|||Cohort||Prospective|||||||
1460144|NCT01505933|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1460145|NCT01505920|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460146|NCT01505907|Randomized|Single Group Assignment||||Triple|||t|t|t|
1460147|NCT01505894|Randomized|Single Group Assignment||Treatment||Double||||||
1460148|NCT01505881|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460149|NCT01505868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460150|NCT01505855|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1460151|NCT01505842|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1460152|NCT01505829|||Cohort||Prospective|||||||
1460153|NCT01505816||Single Group Assignment||Treatment||None (Open Label)||||||
1460154|NCT01505803|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460155|NCT01505790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460156|NCT01505777|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460157|NCT01505764|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460158|NCT01505751|||Case-Only||Retrospective|||||||
1460159|NCT01505738|||Cohort||Prospective|||||||
1460160|NCT01505725|||||Other|||||||
1460161|NCT01505712|||Other||Retrospective|||||||
1460162|NCT01505699|||Other||Retrospective|||||||
1460163|NCT01505686||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460164|NCT01505673|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460165|NCT01505660|Randomized|Parallel Assignment||Supportive Care||||||||
1460166|NCT01505647|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460167|NCT01505634|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460168|NCT01505621|||Case Control||Prospective|||||||
1460169|NCT01505608|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460170|NCT01505595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460171|NCT01505582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460172|NCT01505569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460173|NCT01505556|||Case Control||Cross-Sectional|||||||
1460174|NCT01505543|||Case Control||Cross-Sectional|||||||
1460175|NCT01505530|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460176|NCT01505517|||Case Control||Cross-Sectional|||||||
1460177|NCT01505504|||Case-Only||Retrospective|||||||
1460178|NCT01505491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460179|NCT01505478|||Cohort||Prospective|||||||
1460180|NCT01505465|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1460181|NCT01505452|||Other||Cross-Sectional|||||||
1460182|NCT01505439||Single Group Assignment||Treatment||None (Open Label)||||||
1460183|NCT01505426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460184|NCT01505413||Single Group Assignment||Treatment||None (Open Label)||||||
1460185|NCT01505400|||Cohort||Retrospective|||||||
1460186|NCT01505387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460187|NCT01505374|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1460188|NCT01505361|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1460189|NCT01505348|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1460190|NCT01505335|||Case-Only||Prospective|||||||
1460191|NCT01505322|||Cohort||Retrospective|||||||
1460192|NCT01505309||Single Group Assignment||Treatment||None (Open Label)||||||
1460193|NCT01505296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460194|NCT01505283|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1460195|NCT01505270|||Case-Only||Retrospective|||||||
1460196|NCT01505257|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1460197|NCT01505244||Single Group Assignment||||None (Open Label)||||||
1460198|NCT01505231|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1460199|NCT01505218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460200|NCT01505205|||Cohort||Prospective|||||||
1460201|NCT01505192||Single Group Assignment||Prevention||Single|||t|||
1460202|NCT01505179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460203|NCT01505166|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460204|NCT01505153||Single Group Assignment||Treatment||None (Open Label)||||||
1460205|NCT01505140|Randomized|Parallel Assignment||Prevention||Single||||||t
1460206|NCT01505127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460207|NCT01505114|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1460208|NCT01505101|Randomized|Parallel Assignment||Treatment||Single||||||t
1460209|NCT01505088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460210|NCT01505075||Single Group Assignment||Treatment||None (Open Label)||||||
1460211|NCT01505062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460212|NCT01505049|||||Prospective|||||||
1460213|NCT01505036|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460214|NCT01505023|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460215|NCT01505010|Randomized|Parallel Assignment||Treatment||Single||||||t
1460216|NCT01504997||Single Group Assignment||Treatment||None (Open Label)||||||
1460217|NCT01504984|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460218|NCT01504971|||Cohort||Prospective|||||||
1460219|NCT01504958|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1460220|NCT01504945|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1460221|NCT01504932|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460222|NCT01504919|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460223|NCT01504906|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1460224|NCT01504893|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460225|NCT01504880|||Cohort||Prospective|||||||
1460226|NCT01504867|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1460227|NCT01504854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460228|NCT01504841|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460229|NCT01504828||Single Group Assignment||Basic Science||None (Open Label)||||||
1460230|NCT01504815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460231|NCT01504802|||Cohort||Prospective|||||||
1460232|NCT01504789|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1460233|NCT01504776||Single Group Assignment||Treatment||None (Open Label)||||||
1460234|NCT01504763||Single Group Assignment||Prevention||None (Open Label)||||||
1460235|NCT01504750|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460236|NCT01504737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460237|NCT01504724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460238|NCT01504711||Single Group Assignment||Supportive Care||None (Open Label)||||||
1460239|NCT01504698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460240|NCT01504685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460241|NCT01504672|Randomized|Parallel Assignment||||Single||||||t
1460242|NCT01504659|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1460243|NCT01504646|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1460244|NCT01504633|Randomized|Factorial Assignment||||Quadruple|||t|t|t|t
1460245|NCT01504620|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1460246|NCT01504607|||Case-Only||Prospective|||||||
1460247|NCT01504594||Single Group Assignment||Treatment||None (Open Label)||||||
1460248|NCT01504581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460249|NCT01504568|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460250|NCT01504555|||Case-Only||Prospective|||||||
1460251|NCT01504542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460252|NCT01504529|||Cohort||Retrospective|||||||
1460253|NCT01504516|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460254|NCT01504503|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460255|NCT01504490||Single Group Assignment||Treatment||None (Open Label)||||||
1460256|NCT01504477||Single Group Assignment||Treatment||None (Open Label)||||||
1460257|NCT01504464|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460258|NCT01504451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460259|NCT01504438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460260|NCT01504425|||Cohort||Prospective|||||||
1460261|NCT01504412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460262|NCT01504399|||Cohort||Prospective|||||||
1460263|NCT01504386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460264|NCT01504373|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460265|NCT01504360|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460266|NCT01504347|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460267|NCT01504334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460268|NCT01504321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460269|NCT01504308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460270|NCT01504295|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460271|NCT01504282|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1460272|NCT01504256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460273|NCT01504243|||Case Control||Prospective|||||||
1460274|NCT01504230|||Cohort||Cross-Sectional|||||||
1460275|NCT01504217|||Cohort||Cross-Sectional|||||||
1460276|NCT01504204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460277|NCT01504191|Randomized|Parallel Assignment||Treatment||Single||||||t
1460278|NCT01504178|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1460279|NCT01504165|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1460280|NCT01504152|||Cohort||Retrospective|||||||
1460281|NCT01504139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460282|NCT01504126||Single Group Assignment||Treatment||None (Open Label)||||||
1460283|NCT01504113|||Cohort||Prospective|||||||
1460284|NCT01504100|||Cohort||Prospective|||||||
1460285|NCT01504087|||Case Control||Prospective|||||||
1460286|NCT01504074|||Cohort||Prospective|||||||
1460287|NCT01504061|Randomized|Single Group Assignment||||Single|||||t|
1460288|NCT01504048||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460289|NCT01504035|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460290|NCT01504022|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460291|NCT01504009||Single Group Assignment||Treatment||None (Open Label)||||||
1460292|NCT01503996|||Cohort||Prospective|||||||
1460293|NCT01503983||Single Group Assignment||Treatment||None (Open Label)||||||
1460294|NCT01503970||Single Group Assignment||Treatment||None (Open Label)||||||
1460295|NCT01503957|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1460296|NCT01503944|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1460297|NCT01503931|||Case Control||Prospective|||||||
1460298|NCT01503918|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460299|NCT01503905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460300|NCT01503892|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460301|NCT01503879|||||Prospective|||||||
1460302|NCT01503866||Single Group Assignment||Basic Science||None (Open Label)||||||
1460303|NCT01503853|||||Prospective|||||||
1460304|NCT01503840|Randomized|Parallel Assignment||||Triple|||t|t|t|
1460305|NCT01503827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460306|NCT01503814|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460307|NCT01503801|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460308|NCT01503788|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460309|NCT01503775|||Cohort||Prospective|||||||
1460310|NCT01503762|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460311|NCT01503749|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1460312|NCT01503736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460313|NCT01503723|||Cohort||Prospective|||||||
1460314|NCT01503710|||Cohort||Cross-Sectional|||||||
1460315|NCT01503697|||Cohort||Cross-Sectional|||||||
1460316|NCT01503684|||Cohort||Prospective|||||||
1460317|NCT01503671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460318|NCT01503658||Parallel Assignment||Treatment||None (Open Label)||||||
1460319|NCT01503645|||||Cross-Sectional|||||||
1460320|NCT01503632|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460321|NCT01503619|||Cohort||Retrospective|||||||
1460322|NCT01503606|Randomized|Parallel Assignment||Treatment||Single||||||t
1460323|NCT01503593|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1460324|NCT01503580||Single Group Assignment||Treatment||None (Open Label)||||||
1460325|NCT01503567|||Ecologic or Community||Cross-Sectional|||||||
1460326|NCT01503554|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1460327|NCT01503541|||||Retrospective|||||||
1460328|NCT01503528|Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a prospective randomized clinical trial. For safety and logistical reasons, it cannot be blinded. In the perioperative period multiple factors contribute to discharge readiness. The major impediments to early discharge include poor pain control, opioid related adverse events, surgical/ medical complications, inability to achieve physiotherapy end points and patient's unwillingness to be discharged. We want to compare head to head, two previously evaluated fast-track paradigms. We are not comparing just the analgesic technique alone. We are comparing the pathways where the analgesic regimes are a component and differ, keeping the common factors similar between the groups. If a technique does not allow early ambulation, patients cannot be ready for discharge and thus resource utilization will be affected.||||
1460329|NCT01503515|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460330|NCT01503502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460331|NCT01503489|||Cohort||Prospective|||||||
1460332|NCT01503476|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1460333|NCT01503463|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1460334|NCT01503450|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460335|NCT01503437|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460336|NCT01503424|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460337|NCT01503411|||Cohort||Prospective|||||||
1460338|NCT01503398|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460339|NCT01503385||Single Group Assignment||Treatment||None (Open Label)||||||
1460340|NCT01503372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460341|NCT01503359|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460342|NCT01503346||Single Group Assignment||Supportive Care||Single|||t|||
1460343|NCT01503333|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460344|NCT01503320|Randomized|Factorial Assignment||Prevention||Triple|||t|t||t
1460345|NCT01503307|||Case-Only||Prospective|||||||
1460346|NCT01503294|||Case-Only||Prospective|||||||
1460347|NCT01503281|Randomized|Parallel Assignment||Treatment||Single|||||t|
1460348|NCT01503268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460349|NCT01503255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460350|NCT01503242||Single Group Assignment||Treatment||None (Open Label)||||||
1460351|NCT01503229||Single Group Assignment||Treatment||None (Open Label)||||||
1460352|NCT01503216|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1460353|NCT01503203|Randomized|Factorial Assignment||Treatment||Single||||||t
1460354|NCT01503190|||Other||Retrospective|||||||
1460355|NCT01503177||Single Group Assignment||Treatment||None (Open Label)||||||
1460356|NCT01503164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460357|NCT01503151|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1460358|NCT01503138|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1460359|NCT01503125|||Cohort||Prospective|||||||
1460360|NCT01503112|||Cohort||Prospective|||||||
1460361|NCT01503099|||Case Control||Prospective|||||||
1460362|NCT01503086|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1460363|NCT01503073|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1460364|NCT01503060|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1460365|NCT01503047|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460366|NCT01503034|||Case-Control||Retrospective|||||||
1460367|NCT01503021|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1460368|NCT01503008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460369|NCT01502995|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460370|NCT01502982||Single Group Assignment||Treatment||None (Open Label)||||||
1460371|NCT01502969|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1460372|NCT01502956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460373|NCT01502943|Randomized|Parallel Assignment||||Triple|||t||t|t
1460374|NCT01502930|Randomized|Parallel Assignment||Treatment||Single||||||t
1460375|NCT01502917||Single Group Assignment||Treatment||None (Open Label)||||||
1460376|NCT01502904|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460377|NCT01502891|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1460378|NCT01502878|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460379|NCT01502865|||Other||Retrospective|||||||
1460380|NCT01502852|||Ecologic or Community|||||||||
1460381|NCT01502839|||Cohort||Retrospective|||||||
1460382|NCT01502826|||Case Control||Cross-Sectional|||||||
1460383|NCT01502813||Single Group Assignment||Treatment||None (Open Label)||||||
1460384|NCT01502800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460385|NCT01502787|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1460386|NCT01502774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460387|NCT01502761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460388|NCT01502748||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460389|NCT01502735|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460390|NCT01502722|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1460391|NCT01502709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460392|NCT01502696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460393|NCT01502683|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460394|NCT01502670||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460395|NCT01502657||Single Group Assignment||Supportive Care||None (Open Label)||||||
1460396|NCT01502644|Non-Randomized|Parallel Assignment||Treatment||Double|During the first 2 weeks of treatment participants took short-acting morphine or oxycodone for 1 week and placebo for 1 week in random order. Participants and investigators were blinded during this period. The remainder of the study was conducted in an open-label design.||t||t|
1460397|NCT01502631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460398|NCT01502618||Single Group Assignment||Prevention||None (Open Label)||||||
1460399|NCT01502605||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460400|NCT01502592|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460401|NCT01502579|||||Prospective|||||||
1460402|NCT01502566|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1460403|NCT01502553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460404|NCT01502540|||Cohort||Prospective|||||||
1460405|NCT01502527||Single Group Assignment||Treatment||None (Open Label)||||||
1460406|NCT01502514||Single Group Assignment||Treatment||None (Open Label)||||||
1460407|NCT01502501||Single Group Assignment||Treatment||None (Open Label)||||||
1460408|NCT01502488||Single Group Assignment||Treatment||None (Open Label)||||||
1460409|NCT01502475|||Case-Only||Cross-Sectional|||||||
1460410|NCT01502462|||Cohort||Prospective|||||||
1460411|NCT01502449|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460412|NCT01502436|||Case Control||Retrospective|||||||
1460413|NCT01502423|Randomized|Crossover Assignment||Treatment||Single|||t|||
1460414|NCT01502410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460415|NCT01502397|||Cohort||Prospective|||||||
1460416|NCT01502384|||Cohort|||||||||
1460417|NCT01502371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460418|NCT01502358|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460419|NCT01502345|Randomized|Parallel Assignment||Prevention||Single|||t|||
1460420|NCT01502332|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1460421|NCT01502319|||Other||Other|||||||
1460422|NCT01502306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460423|NCT01502293|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460424|NCT01502280|Randomized|Single Group Assignment||Treatment||Single|||t|||
1460425|NCT01502267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460426|NCT01502254|Randomized|Parallel Assignment||||None (Open Label)||||||
1460427|NCT01502241|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460428|NCT01502228||Single Group Assignment||Other||None (Open Label)||||||
1460429|NCT01502215|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1460430|NCT01502202|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1460431|NCT01502189||Single Group Assignment||Supportive Care||None (Open Label)||||||
1460432|NCT01502176|||Cohort||Retrospective|||||||
1460433|NCT01502163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460434|NCT01502150|||Cohort||Prospective|||||||
1460435|NCT01502137|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460436|NCT01502124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460437|NCT01502111|||Cohort||Prospective|||||||
1460438|NCT01502098|Randomized|Parallel Assignment||Treatment||Single|||||t|
1460439|NCT01502085||Single Group Assignment||Treatment||None (Open Label)||||||
1460440|NCT01502072|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460441|NCT01502059|Randomized|Parallel Assignment||Treatment||Single||||||t
1460442|NCT01502046|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460443|NCT01502033||Single Group Assignment||Treatment||None (Open Label)||||||
1460444|NCT01502020|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460445|NCT01502007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460446|NCT01501994|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460447|NCT01501981|||Cohort||Prospective|||||||
1460448|NCT01501968|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460449|NCT01501955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460450|NCT01501942|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1460451|NCT01501929|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1460452|NCT01501916|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1460453|NCT01501903|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1460454|NCT01501890|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1460455|NCT01501877|Randomized|Parallel Assignment||Treatment||Single||||||t
1460456|NCT01501864|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460457|NCT01501851|||Cohort||Prospective|||||||
1460458|NCT01501838|||Cohort||Prospective|||||||
1460459|NCT01501825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460460|NCT01501812|||Case Control||Prospective|||||||
1460461|NCT01501799|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460462|NCT01501786|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1460463|NCT01501773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460464|NCT01501760|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460465|NCT01501747|Randomized|Crossover Assignment||||Triple|||t|t||t
1460466|NCT01501734||Single Group Assignment||Treatment||None (Open Label)||||||
1460467|NCT01501721|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1460468|NCT01501708||Single Group Assignment||Treatment||None (Open Label)||||||
1460469|NCT01501695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460470|NCT01501682|||||Retrospective|||||||
1460471|NCT01501669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460472|NCT01501656|||Cohort||Prospective|||||||
1460473|NCT01501643|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460474|NCT01501630|||||Prospective|||||||
1460475|NCT01501617|Randomized|||Treatment||Triple|||t||t|t
1460476|NCT01501604||Single Group Assignment||Treatment||None (Open Label)||||||
1460477|NCT01501591|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1460478|NCT01501578|||Case-Control||Retrospective|||||||
1460479|NCT01501565|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460480|NCT01501552|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1460481|NCT01501539|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460482|NCT01501526|||Case-Only||Retrospective|||||||
1460483|NCT01501513|Randomized|Parallel Assignment||Treatment||Single||||||t
1460484|NCT01501500|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1460485|NCT01501487|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1460486|NCT01501474|||Cohort||Prospective|||||||
1460487|NCT01501461|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460488|NCT01501448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460489|NCT01501435|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460490|NCT01501422|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460491|NCT01501409|Randomized|Crossover Assignment||||Double|||t||t|
1460492|NCT01501396|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460493|NCT01501383|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460494|NCT01501370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460495|NCT01501357|Randomized|Parallel Assignment||Prevention||Single|||||t|
1460496|NCT01501344||Single Group Assignment||Prevention||None (Open Label)||||||
1460497|NCT01501331|||Cohort||Prospective|||||||
1460498|NCT01501318|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1460499|NCT01501305|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1460500|NCT01501292|||Cohort||Prospective|||||||
1460501|NCT01501279|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1460502|NCT01501266|||Cohort||Prospective|||||||
1460503|NCT01501253|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460504|NCT01501240|||Case-Only||Prospective|||||||
1460505|NCT01501227|Randomized|Parallel Assignment||Treatment||Single||||||t
1460506|NCT01501214|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460507|NCT01501201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460508|NCT01501188|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1460509|NCT01501175|||Case-Only||Cross-Sectional|||||||
1460510|NCT01501162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460511|NCT01501149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460512|NCT01501136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460513|NCT01501123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460514|NCT01501110|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460515|NCT01501097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460516|NCT01501084|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1460517|NCT01501071|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460518|NCT01501058|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460519|NCT01501045|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1460520|NCT01501032||Single Group Assignment||Treatment||None (Open Label)||||||
1460521|NCT01501019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460522|NCT01501006|||Cohort||Prospective|||||||
1460523|NCT01500993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460524|NCT01500980|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1460525|NCT01500967|Randomized|Parallel Assignment||Treatment||Single||||||t
1460526|NCT01500954|||Case Control||Prospective|||||||
1460527|NCT01500941|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460528|NCT01500928||Single Group Assignment||Treatment||None (Open Label)||||||
1460529|NCT01500915||Single Group Assignment||Treatment||None (Open Label)||||||
1460530|NCT01500902||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460531|NCT01500889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460532|NCT01500876||Single Group Assignment||Treatment||None (Open Label)||||||
1460533|NCT01500863|Randomized|Factorial Assignment||Treatment||Single|||||t|
1460534|NCT01500850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460535|NCT01500837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460536|NCT01500824||Single Group Assignment||Treatment||None (Open Label)||||||
1460537|NCT01500811||Single Group Assignment||Treatment||None (Open Label)||||||
1460538|NCT01500798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460539|NCT01500785|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460540|NCT01500772||Single Group Assignment||Treatment||None (Open Label)||||||
1460541|NCT01500759|||Cohort||Prospective|||||||
1460542|NCT01500746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460543|NCT01500733|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460544|NCT01500720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460545|NCT01500707||Single Group Assignment||Treatment||None (Open Label)||||||
1460546|NCT01500694||Single Group Assignment||Treatment||None (Open Label)||||||
1460547|NCT01500681|||Cohort||Prospective|||||||
1460548|NCT01500668|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1460549|NCT01500655|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1460550|NCT01500642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460551|NCT01500629|Randomized|Crossover Assignment||||Double|||t||t|
1460552|NCT01500616||Single Group Assignment||Treatment||None (Open Label)||||||
1460553|NCT01500603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460554|NCT01500590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460555|NCT01500577|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460556|NCT01500564|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460557|NCT01500551||Single Group Assignment||Treatment||None (Open Label)||||||
1460558|NCT01500538||Single Group Assignment||Treatment||None (Open Label)||||||
1460559|NCT01500525|||Case Control||Prospective|||||||
1460560|NCT01500512||||||||||||
1460561|NCT01500499|||Cohort||Retrospective|||||||
1460562|NCT01500486|||Cohort||Prospective|||||||
1460563|NCT01500473||Single Group Assignment||Treatment||Single|||t|||
1460564|NCT01500447|||Family-Based||Prospective|||||||
1460565|NCT01500434||Single Group Assignment||Treatment||None (Open Label)||||||
1460566|NCT01500421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460567|NCT01500408|Randomized|Crossover Assignment||||Single|||t|||
1460568|NCT01500395|||Case-Only||Prospective|||||||
1460569|NCT01500382|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460570|NCT01500369|Randomized|Parallel Assignment||Prevention||Single|||t|||
1460571|NCT01500356|Randomized|Parallel Assignment||Treatment||Single||||||t
1460572|NCT01500343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460573|NCT01500330|Randomized|Parallel Assignment||Treatment||Single||||||t
1460574|NCT01500317|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1460575|NCT01500304||Single Group Assignment||Treatment||None (Open Label)||||||
1460576|NCT01500291|||Cohort||Prospective|||||||
1460577|NCT01500278|Randomized|Parallel Assignment||Treatment||Single||||||t
1460578|NCT01500265|||Case Control||Prospective|||||||
1460579|NCT01500252|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460580|NCT01500226|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460581|NCT01500213|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460582|NCT01500200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460583|NCT01500187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460584|NCT01500174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460585|NCT01500161||Single Group Assignment||Treatment||None (Open Label)||||||
1460586|NCT01500148||Single Group Assignment||Treatment||None (Open Label)||||||
1460587|NCT01500135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460588|NCT01500122||Single Group Assignment||||None (Open Label)||||||
1460589|NCT01500109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460590|NCT01500096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460821|NCT01497080|||Cohort||Prospective|||||||
1460591|NCT01500083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460592|NCT01500070||Single Group Assignment||Treatment||None (Open Label)||||||
1460593|NCT01500057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460594|NCT01500044|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460595|NCT01500031||Single Group Assignment||Treatment||None (Open Label)||||||
1460596|NCT01500018|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1460597|NCT01500005|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460598|NCT01499992|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1460599|NCT01499979|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460600|NCT01499966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460601|NCT01499953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460602|NCT01499940||Single Group Assignment||Supportive Care||None (Open Label)||||||
1460603|NCT01499927|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1460604|NCT01499914||Single Group Assignment||Prevention||None (Open Label)||||||
1460605|NCT01499901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460606|NCT01499888||Single Group Assignment||Treatment||None (Open Label)||||||
1460607|NCT01499875||Single Group Assignment||Treatment||None (Open Label)||||||
1460608|NCT01499862||Single Group Assignment||Treatment||None (Open Label)||||||
1460609|NCT01499849|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460610|NCT01499836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460611|NCT01499823|||Cohort||Prospective|||||||
1460612|NCT01499810||Single Group Assignment||Treatment||None (Open Label)||||||
1460613|NCT01499797|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1460614|NCT01499784||Single Group Assignment||Treatment||None (Open Label)||||||
1460615|NCT01499771|Randomized|Crossover Assignment||||None (Open Label)||||||
1460616|NCT01499758|Randomized|Crossover Assignment||||None (Open Label)||||||
1460617|NCT01499745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460618|NCT01499732|||Cohort||Prospective|||||||
1460619|NCT01499719|||Cohort||Prospective|||||||
1460620|NCT01499706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460621|NCT01499693|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1460622|NCT01499680|||Case Control||Prospective|||||||
1460623|NCT01499667|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460624|NCT01499654||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460625|NCT01499641|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1460626|NCT01499628|Randomized|Parallel Assignment||Treatment||Single||||||t
1460627|NCT01499615|||Case-Only||Prospective|||||||
1460628|NCT01499602|Randomized|Parallel Assignment||Treatment||Single||||||t
1460629|NCT01499589|||Cohort||Prospective|||||||
1460630|NCT01499576||Single Group Assignment||Screening||None (Open Label)||||||
1460631|NCT01499563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460632|NCT01499550|Randomized|Crossover Assignment||Treatment||Single||||||t
1460633|NCT01499537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460634|NCT01499524|||Case-Control||Prospective|||||||
1460635|NCT01499511|||||Retrospective|||||||
1460636|NCT01499498||Single Group Assignment||Treatment||None (Open Label)||||||
1460637|NCT01499485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460638|NCT01499472|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1460639|NCT01499459||Single Group Assignment||Treatment||None (Open Label)||||||
1460640|NCT01499446|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460641|NCT01499433||Single Group Assignment||Treatment||None (Open Label)||||||
1460642|NCT01499420|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1460643|NCT01499407|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460644|NCT01499394|||Cohort||Prospective|||||||
1460645|NCT01499381|||Cohort||Prospective|||||||
1460646|NCT01499368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460647|NCT01499355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460648|NCT01499342|||Case-Only||Prospective|||||||
1460649|NCT01499329|||Case-Only||Prospective|||||||
1460650|NCT01499316|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1460651|NCT01499303||Single Group Assignment||Treatment||None (Open Label)||||||
1460652|NCT01499290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460653|NCT01499277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460654|NCT01499264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460655|NCT01499251||Single Group Assignment||Treatment||None (Open Label)||||||
1460656|NCT01499238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460657|NCT01499225|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1460658|NCT01499212|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1460659|NCT01499199||Single Group Assignment||Treatment||None (Open Label)||||||
1460660|NCT01499186|Randomized|Parallel Assignment||Treatment||Single|||||t|
1460661|NCT01499173||Single Group Assignment||Other||None (Open Label)||||||
1460662|NCT01499160||Single Group Assignment||Treatment||None (Open Label)|No masking was done|sequential treatment assignment, no masking is done||||
1460663|NCT01499147|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460664|NCT01499134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460665|NCT01499121||Single Group Assignment||Treatment||None (Open Label)||||||
1460666|NCT01499108||Single Group Assignment||Treatment||None (Open Label)||||||
1460822|NCT01497067||||||||||||
1460667|NCT01499095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460668|NCT01499082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460669|NCT01499069||Single Group Assignment||||None (Open Label)||||||
1460670|NCT01499056||Single Group Assignment||Treatment||None (Open Label)||||||
1460671|NCT01499043||Single Group Assignment||Treatment||None (Open Label)||||||
1460672|NCT01499030||||||||||||
1460673|NCT01499017|Randomized|Crossover Assignment||||Double|||t||t|
1460674|NCT01499004|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1460675|NCT01498991||Single Group Assignment||Treatment||None (Open Label)||||||
1460676|NCT01498978||Single Group Assignment||Treatment||None (Open Label)||||||
1460677|NCT01498965|||Cohort||Prospective|||||||
1460678|NCT01498952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460679|NCT01498939|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460680|NCT01498926|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460681|NCT01498913|||Cohort||Prospective|||||||
1460682|NCT01498900|||Cohort||Prospective|||||||
1460683|NCT01498887||Parallel Assignment||Treatment||None (Open Label)||||||
1460684|NCT01498874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460685|NCT01498861|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1460686|NCT01498848|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460687|NCT01498835||Single Group Assignment||Treatment||None (Open Label)||||||
1460688|NCT01498822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460689|NCT01498809|||Case-Only||Prospective|||||||
1460690|NCT01498796||||||||||||
1460691|NCT01498783||Single Group Assignment||Treatment||None (Open Label)||||||
1460692|NCT01498770|||Cohort||Retrospective|||||||
1460693|NCT01498757|||Cohort||Prospective|||||||
1460694|NCT01498744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460695|NCT01498731|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1460696|NCT01498718|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1460697|NCT01498705|||Cohort||Prospective|||||||
1460698|NCT01498692||Single Group Assignment||Treatment||None (Open Label)||||||
1460699|NCT01498679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460700|NCT01498666|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1460701|NCT01498653|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460702|NCT01498640|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460703|NCT01498627|||Case Control||Prospective|||||||
1460704|NCT01498614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460705|NCT01498601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460706|NCT01498588||Single Group Assignment||Treatment||None (Open Label)||||||
1460707|NCT01498575|Randomized|Parallel Assignment||Prevention||Single||||||t
1460708|NCT01498562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460709|NCT01498549|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460710|NCT01498536||Single Group Assignment||Supportive Care||None (Open Label)||||||
1460711|NCT01498523|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1460712|NCT01498510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460713|NCT01498497|||Cohort||Prospective|||||||
1460714|NCT01498484||Single Group Assignment||Treatment||None (Open Label)||||||
1460715|NCT01498471|||Cohort||Prospective|||||||
1460716|NCT01498458||Single Group Assignment||Treatment||None (Open Label)||||||
1460717|NCT01498445|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460718|NCT01498432|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1460719|NCT01498419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460720|NCT01498406|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460721|NCT01498393||Single Group Assignment||Treatment||None (Open Label)||||||
1460722|NCT01498380||Single Group Assignment||Treatment||None (Open Label)||||||
1460723|NCT01498367|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1460724|NCT01498354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460725|NCT01498341||||||||||||
1460726|NCT01498328|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460727|NCT01498315|||Case-Only||Prospective|||||||
1460728|NCT01498302|||Cohort||Retrospective|||||||
1460729|NCT01498289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460730|NCT01498276|||Family-Based||Cross-Sectional|||||||
1460731|NCT01498263|||Family-Based||Cross-Sectional|||||||
1460732|NCT01498250|||Case Control||Prospective|||||||
1460733|NCT01498237||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460734|NCT01498224|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460735|NCT01498211||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460736|NCT01498198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460737|NCT01498185|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460738|NCT01498172|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460739|NCT01498159|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1460740|NCT01498146|||||Prospective|||||||
1460741|NCT01498133|Randomized|Parallel Assignment||Prevention||Single||||||t
1460742|NCT01498120||Single Group Assignment||Treatment||None (Open Label)||||||
1460743|NCT01498107||Single Group Assignment||Health Services Research||||||||
1460744|NCT01498094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460745|NCT01498081|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460823|NCT01497054|||Cohort||Prospective|||||||
1460746|NCT01498068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460747|NCT01498055|||Case Control||Prospective|||||||
1460748|NCT01498042|||Cohort||Prospective|||||||
1460749|NCT01498029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460750|NCT01498016||Single Group Assignment||Treatment||None (Open Label)||||||
1460751|NCT01498003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460752|NCT01497990||Single Group Assignment||Treatment||None (Open Label)||||||
1460753|NCT01497977|Randomized|Parallel Assignment||Prevention||Single|||t|||
1460754|NCT01497964||Single Group Assignment||Treatment||None (Open Label)||||||
1460755|NCT01497951|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1460756|NCT01497938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460757|NCT01497925||Single Group Assignment||Treatment||None (Open Label)||||||
1460758|NCT01497912|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1460759|NCT01497899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460760|NCT01497886|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1460761|NCT01497873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460762|NCT01497860||Single Group Assignment||Treatment||None (Open Label)||||||
1460763|NCT01497847|||Cohort||Prospective|||||||
1460764|NCT01497834||Single Group Assignment||Treatment||None (Open Label)||||||
1460765|NCT01497821|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460766|NCT01497808||Parallel Assignment||Treatment||None (Open Label)||||||
1460767|NCT01497782|Randomized|Parallel Assignment||||None (Open Label)||||||
1460768|NCT01497769|Randomized|Parallel Assignment||Prevention||Single|||t|||
1460769|NCT01497756||Single Group Assignment||||None (Open Label)||||||
1460770|NCT01497743|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1460771|NCT01497730||Single Group Assignment||Treatment||None (Open Label)||||||
1460772|NCT01497717||Single Group Assignment||Treatment||None (Open Label)||||||
1460773|NCT01497704||Single Group Assignment||Treatment||None (Open Label)||||||
1460774|NCT01497691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460775|NCT01497678||Single Group Assignment||Treatment||None (Open Label)||||||
1460776|NCT01497665||Single Group Assignment||Treatment||None (Open Label)||||||
1460777|NCT01497652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460778|NCT01497639|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1460779|NCT01497626||Single Group Assignment||Treatment||None (Open Label)||||||
1460780|NCT01497613|Randomized|Parallel Assignment||Prevention||Single||||||t
1460781|NCT01497600|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460782|NCT01497587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460783|NCT01497574|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460784|NCT01497561|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460785|NCT01497548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460786|NCT01497535|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460787|NCT01497522||Parallel Assignment||Treatment||Double|||t||t|
1460788|NCT01497509|Randomized|Parallel Assignment||||Double|||t||t|
1460789|NCT01497496||Single Group Assignment||Treatment||None (Open Label)||||||
1460790|NCT01497483|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1460791|NCT01497470||Single Group Assignment||||None (Open Label)||||||
1460792|NCT01497457||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460793|NCT01497444||Single Group Assignment||Treatment||None (Open Label)||||||
1460794|NCT01497431|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460795|NCT01497418|||Cohort|||||||||
1460796|NCT01497405|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460797|NCT01497392||Single Group Assignment||Treatment||None (Open Label)||||||
1460798|NCT01497379|Randomized|Single Group Assignment||Treatment||Single|||t|||
1460799|NCT01497366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460800|NCT01497353|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460801|NCT01497340|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460802|NCT01497327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460803|NCT01497314||Single Group Assignment||||None (Open Label)||||||
1460804|NCT01497301|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1460805|NCT01497288|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460806|NCT01497275||Single Group Assignment||Treatment||None (Open Label)||||||
1460807|NCT01497262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460808|NCT01497249|Randomized|Crossover Assignment||Treatment||Single|||t|||
1460809|NCT01497236|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1460810|NCT01497223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460811|NCT01497210||Single Group Assignment||Treatment||None (Open Label)||||||
1460812|NCT01497197|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460813|NCT01497184|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460814|NCT01497171|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1460815|NCT01497158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460816|NCT01497145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460817|NCT01497132|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460818|NCT01497119|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460819|NCT01497106|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1460820|NCT01497093||Single Group Assignment||Treatment||None (Open Label)||||||
1460824|NCT01497041||Single Group Assignment||Treatment||None (Open Label)||||||
1460825|NCT01497028|||Cohort||Prospective|||||||
1460826|NCT01497015|Randomized|Single Group Assignment||Supportive Care||Single|||||t|
1460827|NCT01497002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460828|NCT01496989|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1460829|NCT01496976||Single Group Assignment||Treatment||None (Open Label)||||||
1460830|NCT01496963|||Case Control||Cross-Sectional|||||||
1460831|NCT01496950|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460832|NCT01496937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460833|NCT01496924||Single Group Assignment||Treatment||None (Open Label)||||||
1460834|NCT01496911|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1460835|NCT01496898|||Ecologic or Community||Prospective|||||||
1460836|NCT01496885|||||Prospective|||||||
1460837|NCT01496872|||Cohort||Prospective|||||||
1460838|NCT01496859||Single Group Assignment||Treatment||None (Open Label)||||||
1460839|NCT01496846|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460840|NCT01496833||Single Group Assignment||Treatment||Single|||t|||
1460841|NCT01496820|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1460842|NCT01496807||Single Group Assignment||Treatment||None (Open Label)||||||
1460843|NCT01496794|||Case-Only||Prospective|||||||
1460844|NCT01496781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460845|NCT01496768|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460846|NCT01496755|Randomized|Parallel Assignment||||Double|||t||t|
1460847|NCT01496742|Randomized|Parallel Assignment||Treatment||Double||||||
1460848|NCT01496729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460849|NCT01496716|||Cohort||Prospective|||||||
1460850|NCT01496703|||Cohort||Retrospective|||||||
1460851|NCT01496690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460852|NCT01496677|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1460853|NCT01496664||Single Group Assignment||Treatment||None (Open Label)||||||
1460854|NCT01496651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460855|NCT01496638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460856|NCT01496625|||Cohort||Prospective|||||||
1460857|NCT01496612|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1460858|NCT01496599|||Cohort||Prospective|||||||
1460859|NCT01496586|||Cohort||Cross-Sectional|||||||
1460860|NCT01496573|||Case-Only||Retrospective|||||||
1460861|NCT01496560|||Cohort||Prospective|||||||
1460862|NCT01496547||Single Group Assignment||Treatment||None (Open Label)||||||
1460863|NCT01496534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460864|NCT01496521|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1460865|NCT01496508|Randomized|Parallel Assignment||Prevention||Single||||||t
1460866|NCT01496495||Single Group Assignment||Treatment||None (Open Label)||||||
1460867|NCT01496482||||||||||||
1460868|NCT01496469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460869|NCT01496456|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460870|NCT01496443||Single Group Assignment||||Single|||t|||
1460871|NCT01496430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460872|NCT01496417||Single Group Assignment||Treatment||None (Open Label)||||||
1460873|NCT01496404|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460874|NCT01496391|||Case Control||Prospective|||||||
1460875|NCT01496378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460876|NCT01496365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460877|NCT01496352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460878|NCT01496339|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460879|NCT01496326|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460880|NCT01496313|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460881|NCT01496300|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460882|NCT01496287||Single Group Assignment||Treatment||None (Open Label)||||||
1460883|NCT01496274|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460884|NCT01496261|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460885|NCT01496248||Single Group Assignment||Treatment||None (Open Label)||||||
1460886|NCT01496235|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460887|NCT01496222|||Cohort||Prospective|||||||
1460888|NCT01496209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460889|NCT01496196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460890|NCT01496183|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1460891|NCT01496170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460892|NCT01496157||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460893|NCT01496144|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1460894|NCT01496131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460895|NCT01496118||Single Group Assignment||Treatment||None (Open Label)||||||
1460896|NCT01496105|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1460897|NCT01496092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460898|NCT01496079|||Cohort||Prospective|||||||
1460899|NCT01496066|Randomized|Parallel Assignment||Treatment||Single||Phase 3 medical device study||||t
1460900|NCT01496053|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460901|NCT01496040||Single Group Assignment||||None (Open Label)||||||
1460902|NCT01496027|||Case-Only||Prospective|||||||
1460903|NCT01496014|||Cohort||Prospective|||||||
1460904|NCT01496001||Single Group Assignment||||None (Open Label)||||||
1460905|NCT01495988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460906|NCT01495975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460907|NCT01495962|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1460908|NCT01495949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460909|NCT01495936|Randomized|Crossover Assignment||Basic Science||Single||||||t
1460910|NCT01495923|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1460911|NCT01495910||Single Group Assignment||Treatment||None (Open Label)||||||
1460912|NCT01495897|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1460913|NCT01495884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460914|NCT01495871|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1460915|NCT01495858|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460916|NCT01495845||Single Group Assignment||||None (Open Label)||||||
1460917|NCT01495832|Randomized|Parallel Assignment||||None (Open Label)||||||
1460918|NCT01495819|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1460919|NCT01495806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460920|NCT01495793||Single Group Assignment||Other||None (Open Label)||||||
1460921|NCT01495780||Single Group Assignment||Prevention||None (Open Label)||||||
1460922|NCT01495767|||Cohort|||||||||
1460923|NCT01495754|Randomized|Crossover Assignment||Treatment||Single|||t|||
1460924|NCT01495741|||Cohort||Retrospective|||||||
1460925|NCT01495728|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1460926|NCT01495715||||||||||||
1460927|NCT01495702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460928|NCT01495689|Randomized|Parallel Assignment||Treatment||Single||||||t
1460929|NCT01495676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460930|NCT01495663||Single Group Assignment||Treatment||None (Open Label)||||||
1460931|NCT01495650|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460932|NCT01495637||Single Group Assignment||Treatment||None (Open Label)||||||
1460933|NCT01495624|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1460934|NCT01495611|||Case-Only||Prospective|||||||
1460935|NCT01495598|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460936|NCT01495585|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1460937|NCT01495572|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460938|NCT01495546|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1460939|NCT01495533|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460940|NCT01495520|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1460941|NCT01495507|||Case-Only||Prospective|||||||
1460942|NCT01495494|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460943|NCT01495481||Single Group Assignment||Treatment||None (Open Label)||||||
1460944|NCT01495468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460945|NCT01495455|||Case Control||Cross-Sectional|||||||
1460946|NCT01495442|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1460947|NCT01495429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460948|NCT01495403||Single Group Assignment||Supportive Care||None (Open Label)||||||
1460949|NCT01495390|||Case-Only||Prospective|||||||
1460950|NCT01495377|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1460951|NCT01495364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1460952|NCT01495351||Single Group Assignment||Treatment||None (Open Label)||||||
1460953|NCT01495338|Randomized|Parallel Assignment||Treatment||Single|||||t|
1460954|NCT01495325|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1460955|NCT01495312||Single Group Assignment||Treatment||None (Open Label)||||||
1460956|NCT01495299|||Cohort||Prospective|||||||
1460957|NCT01495286||Single Group Assignment||Treatment||None (Open Label)||||||
1460958|NCT01495273|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460959|NCT01495260||Single Group Assignment||Treatment||None (Open Label)||||||
1460960|NCT01495247|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460961|NCT01495234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460962|NCT01495221||Single Group Assignment||Treatment||None (Open Label)||||||
1460963|NCT01495208||Single Group Assignment||Treatment||None (Open Label)||||||
1460964|NCT01495195|Randomized|Parallel Assignment||Treatment||Single|||t|||
1460965|NCT01495182|Randomized|Crossover Assignment||Prevention||Single|||t|||
1460966|NCT01495169||Single Group Assignment||Treatment||None (Open Label)||||||
1460967|NCT01495156|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1460968|NCT01495143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460969|NCT01495130||Single Group Assignment||Diagnostic||None (Open Label)||||||
1460970|NCT01495117|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1460971|NCT01495104|Randomized|Single Group Assignment||||None (Open Label)||||||
1460972|NCT01495091|||||Cross-Sectional|||||||
1460973|NCT01495078|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1460974|NCT01495065|Randomized|Single Group Assignment||Other||Single|||t|||
1460975|NCT01495052|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1460976|NCT01495039|Randomized|Parallel Assignment||Prevention||Single||||||t
1460977|NCT01495026|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460978|NCT01495013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1460979|NCT01495000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460980|NCT01494987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1460981|NCT01494974|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1460982|NCT01494961|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1460983|NCT01494948|Non-Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1460984|NCT01494935|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1460985|NCT01494922|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1460986|NCT01494909||Single Group Assignment||Other||None (Open Label)||||||
1460987|NCT01494896|||Case-Only||Prospective|||||||
1460988|NCT01494883|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1460989|NCT01494870||Single Group Assignment||Treatment||None (Open Label)||||||
1460990|NCT01494857||Single Group Assignment||Treatment||None (Open Label)||||||
1460991|NCT01494844||Single Group Assignment||||None (Open Label)||||||
1460992|NCT01494831|Randomized|Parallel Assignment||Treatment||Single||||||t
1460993|NCT01494818|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1460994|NCT01494805|Randomized|Parallel Assignment||Treatment||Single||||||t
1460995|NCT01494792|||||Prospective|||||||
1460996|NCT01494779|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1460997|NCT01494766||Single Group Assignment||Treatment||None (Open Label)||||||
1460998|NCT01494753|Randomized|Crossover Assignment||Treatment||Single|||||t|
1460999|NCT01494740|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1461000|NCT01494727|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461001|NCT01494714||Single Group Assignment||||Single||||||t
1461002|NCT01494701|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461003|NCT01494688|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461004|NCT01494675||Parallel Assignment||||Triple|||t|t|t|
1461005|NCT01494662|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461006|NCT01494649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461007|NCT01494636|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461008|NCT01494623|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461009|NCT01494610|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1461010|NCT01494597||Single Group Assignment||||None (Open Label)||||||
1461011|NCT01494584||Single Group Assignment||Treatment||None (Open Label)||||||
1461012|NCT01494571|||Case-Only||Prospective|||||||
1461013|NCT01494558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461014|NCT01494545||Single Group Assignment||Treatment||None (Open Label)||||||
1461015|NCT01494532|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461016|NCT01494519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461017|NCT01494506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461018|NCT01494493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461019|NCT01494480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461020|NCT01494467|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461021|NCT01494454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461022|NCT01494441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461023|NCT01494428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461024|NCT01494415||Single Group Assignment||Treatment||None (Open Label)||||||
1461025|NCT01494402|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1461026|NCT01494389|||Case Control||Prospective|||||||
1461027|NCT01494376||||||||||||
1461028|NCT01494363||Single Group Assignment||Treatment||None (Open Label)||||||
1461029|NCT01494350||Single Group Assignment||Treatment||None (Open Label)||||||
1461030|NCT01494337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461031|NCT01494324||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461032|NCT01494311|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1461033|NCT01494298|||Cohort||Prospective|||||||
1461034|NCT01494285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461035|NCT01494272|||Cohort||Prospective|||||||
1461036|NCT01494259|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461037|NCT01494246|Randomized|Parallel Assignment||||Single||||||t
1461038|NCT01494233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461039|NCT01494220|||Cohort||Prospective|||||||
1461040|NCT01494207||Single Group Assignment||Prevention||Single|||t|||
1461041|NCT01494194|Randomized|Single Group Assignment||||None (Open Label)||||||
1461042|NCT01494181|||Other||Prospective|||||||
1461043|NCT01494168||||||||||||
1461044|NCT01494155||Single Group Assignment||Treatment||None (Open Label)||||||
1461045|NCT01494142|||Case-Control||Prospective|||||||
1461046|NCT01494116|Randomized|Parallel Assignment||Treatment||Single||||||t
1461047|NCT01494103||Single Group Assignment||Treatment||None (Open Label)||||||
1461048|NCT01494090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461049|NCT01494077|||||Prospective|||||||
1461050|NCT01494064|||Cohort|||||||||
1461051|NCT01494051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461052|NCT01494038|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1461053|NCT01494025||Single Group Assignment||Basic Science||None (Open Label)||||||
1461054|NCT01494012||Single Group Assignment||Treatment||None (Open Label)||||||
1461055|NCT01493999|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1461056|NCT01493986||Single Group Assignment||Treatment||Single||||||t
1461057|NCT01493973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461058|NCT01493960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461059|NCT01493947|Randomized|Parallel Assignment||Treatment||Single|||||t|
1461060|NCT01493934|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1461061|NCT01493921|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461062|NCT01493908|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461063|NCT01493895|Randomized|Parallel Assignment||||Single|||t|||
1461064|NCT01493882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461065|NCT01493869|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461066|NCT01493856|Randomized|Crossover Assignment||||None (Open Label)||||||
1461067|NCT01493843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461068|NCT01493830|||Case-Only||Retrospective|||||||
1461069|NCT01493817|||Case-Only||Retrospective|||||||
1461070|NCT01493804|||||Prospective|||||||
1461071|NCT01493791|Randomized|Parallel Assignment||Treatment||||||||
1461072|NCT01493778||Single Group Assignment||Treatment||None (Open Label)||||||
1461073|NCT01493765|||Other||Prospective|||||||
1461074|NCT01493752|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1461075|NCT01493739|||Case-Only||Prospective|||||||
1461076|NCT01493726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461077|NCT01493713||Single Group Assignment||Other||None (Open Label)||||||
1461078|NCT01493700|Randomized|Crossover Assignment||Prevention||Single||||||t
1461079|NCT01493687|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461080|NCT01493674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461081|NCT01493661|||||Cross-Sectional|||||||
1461082|NCT01493648|Randomized|Parallel Assignment||||Double|||t||t|
1461083|NCT01493635|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1461084|NCT01493622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461085|NCT01493609|Randomized|Parallel Assignment||Treatment||Single||||||t
1461086|NCT01493596|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1461087|NCT01493583|||Case Control||Cross-Sectional|||||||
1461088|NCT01493570|Randomized|Parallel Assignment||Treatment||Double||||||
1461089|NCT01493557|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461090|NCT01493544|||Cohort||Cross-Sectional|||||||
1461091|NCT01493531|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461092|NCT01493518|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1461093|NCT01493505|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461094|NCT01493492|||Case Control||Prospective|||||||
1461095|NCT01493479||Single Group Assignment||Treatment||None (Open Label)||||||
1461096|NCT01493466|||||Prospective|||||||
1461097|NCT01493453||Single Group Assignment||Treatment||None (Open Label)||||||
1461098|NCT01493440||Single Group Assignment||Treatment||None (Open Label)||||||
1461099|NCT01493427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461100|NCT01493414||Single Group Assignment||Treatment||None (Open Label)||||||
1461101|NCT01493401||Single Group Assignment||||None (Open Label)||||||
1461102|NCT01493388|||Cohort||Retrospective|||||||
1461103|NCT01493375|||Cohort||Prospective|||||||
1461104|NCT01493362|||Case Control||Cross-Sectional|||||||
1461105|NCT01493349|||||Cross-Sectional|||||||
1461106|NCT01493336|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461107|NCT01493323|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461108|NCT01493310|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461109|NCT01493297|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1461110|NCT01493284||Single Group Assignment||Treatment||None (Open Label)||||||
1461111|NCT01493271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461112|NCT01493258|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1461113|NCT01493245||Single Group Assignment||Treatment||None (Open Label)||||||
1461114|NCT01493232|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1461115|NCT01493219|||Case-Control||Prospective|||||||
1461116|NCT01493206||Single Group Assignment||Treatment||None (Open Label)||||||
1461117|NCT01493193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461118|NCT01493180|Randomized|Parallel Assignment||Treatment||Single|||||t|
1461119|NCT01493167||Single Group Assignment||Treatment||None (Open Label)||||||
1461120|NCT01493154|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461121|NCT01493141|||Cohort||Prospective|||||||
1461122|NCT01493128|||Case-Control||Cross-Sectional|||||||
1461123|NCT01493115|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461124|NCT01493102|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1461125|NCT01493089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461126|NCT01493076|||Cohort||Prospective|||||||
1461127|NCT01493063|||Cohort||Prospective|||||||
1461128|NCT01493050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461129|NCT01493037||Single Group Assignment||Treatment||None (Open Label)||||||
1461130|NCT01493024|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1461131|NCT01493011|Randomized|Parallel Assignment||Treatment||Single||||||t
1461132|NCT01492998||Single Group Assignment||Treatment||None (Open Label)||||||
1461133|NCT01492985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461134|NCT01492972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461135|NCT01492959|||Cohort||Prospective|||||||
1461136|NCT01492946|||Cohort||Retrospective|||||||
1461137|NCT01492933|||Cohort||Cross-Sectional|||||||
1461138|NCT01492920|Randomized|Parallel Assignment||Supportive Care||Double||||||
1461139|NCT01492907|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1461140|NCT01492894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461141|NCT01492881||Single Group Assignment||Treatment||None (Open Label)||||||
1461142|NCT01492868|||Cohort||Prospective|||||||
1461143|NCT01492855|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1461144|NCT01492842|||Cohort||Cross-Sectional|||||||
1461145|NCT01492829||Single Group Assignment||Prevention||None (Open Label)||||||
1461146|NCT01492816||Single Group Assignment||Prevention||None (Open Label)||||||
1461147|NCT01492803|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1461148|NCT01492790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461149|NCT01492777|||||Prospective|||||||
1461150|NCT01492764|||Case-Control||Other|||||||
1461151|NCT01492751|||Cohort||Prospective|||||||
1461152|NCT01492738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461153|NCT01492725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461154|NCT01492712|Randomized|Parallel Assignment||Other||Single|||t|||
1461155|NCT01492699||Single Group Assignment||Treatment||None (Open Label)||||||
1461156|NCT01492686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461157|NCT01492673||Single Group Assignment||Treatment||None (Open Label)||||||
1461158|NCT01492660|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461159|NCT01492647|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461160|NCT01492634||Single Group Assignment||||None (Open Label)||||||
1461161|NCT01492621||Single Group Assignment||Basic Science||None (Open Label)||||||
1461162|NCT01492608|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1461163|NCT01492595|||Cohort||Prospective|||||||
1461164|NCT01492582||Single Group Assignment||Prevention||None (Open Label)||||||
1461165|NCT01492569|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1461166|NCT01492556||Single Group Assignment||Treatment||None (Open Label)||||||
1461167|NCT01492543||Single Group Assignment||Treatment||None (Open Label)||||||
1461168|NCT01492530|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461169|NCT01492517|Randomized|Crossover Assignment||||Triple|||t||t|t
1461170|NCT01492504|||Cohort||Prospective|||||||
1461171|NCT01492491|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461172|NCT01492478|||Cohort||Prospective|||||||
1461173|NCT01492465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461174|NCT01492452||Single Group Assignment||||Single|||t|||
1461175|NCT01492439|Randomized|Parallel Assignment||Treatment||Single||||||t
1461176|NCT01492426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461177|NCT01492413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461178|NCT01492400|Randomized|Parallel Assignment||Treatment||Single||||||t
1461179|NCT01492387|Randomized|Parallel Assignment||Treatment||Single||||||t
1461180|NCT01492374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461181|NCT01492361|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1461182|NCT01492348|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1461183|NCT01492335|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1461184|NCT01492322|||Cohort|||||||||
1461185|NCT01492309|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461186|NCT01492296|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1461187|NCT01492283|||Cohort||Prospective|||||||
1461188|NCT01492270||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461189|NCT01492257|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1461190|NCT01492244|||Cohort||Prospective|||||||
1461191|NCT01492231|||||Retrospective|||||||
1461192|NCT01492218|||Cohort||Prospective|||||||
1461193|NCT01492205|||Cohort||Prospective|||||||
1461194|NCT01492192||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461195|NCT01492179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461196|NCT01492166|||Cohort||Prospective|||||||
1461197|NCT01492153|||Cohort||Prospective|||||||
1461198|NCT01492140|Randomized|Single Group Assignment||Treatment||Single||||||t
1461199|NCT01492127||Single Group Assignment||||None (Open Label)||||||
1461200|NCT01492114|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1461201|NCT01492101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461202|NCT01492088|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461203|NCT01492075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461204|NCT01492062||Single Group Assignment||Treatment||None (Open Label)||||||
1461205|NCT01492049|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1461206|NCT01492036|||Cohort||Prospective|||||||
1461207|NCT01492023|||Case Control||Prospective|||||||
1461208|NCT01492010|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461209|NCT01491997|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1461210|NCT01491984|Randomized|Crossover Assignment||Treatment||Single|||t|||
1461211|NCT01491971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461212|NCT01491958|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1461213|NCT01491945||Single Group Assignment||Treatment||None (Open Label)||||||
1461214|NCT01491932|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461215|NCT01491919|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461216|NCT01491906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461217|NCT01491893|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1461218|NCT01491880|Randomized|Parallel Assignment||Treatment||Single||||||t
1461219|NCT01491867||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461220|NCT01491854||Single Group Assignment||Other||None (Open Label)||||||
1461221|NCT01491841||Single Group Assignment||Treatment||None (Open Label)||||||
1461222|NCT01491828||Single Group Assignment||||None (Open Label)||||||
1461223|NCT01491815|Randomized|Parallel Assignment||Treatment||Single||||||t
1461224|NCT01491802|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1461225|NCT01491789||Single Group Assignment||Treatment||None (Open Label)||||||
1461226|NCT01491776|||Cohort||Prospective|||||||
1461227|NCT01491763||Single Group Assignment||Treatment||None (Open Label)||||||
1461228|NCT01491750|Randomized|Parallel Assignment||Treatment||Single|||||t|
1461229|NCT01491737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461230|NCT01491724|||||Cross-Sectional|||||||
1461231|NCT01491711|Randomized|Parallel Assignment||Treatment||Single|||||t|
1461232|NCT01491698|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1461233|NCT01491685|||Case Control||Prospective|||||||
1461234|NCT01491672||Single Group Assignment||Treatment||None (Open Label)||||||
1461235|NCT01491659|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1461236|NCT01491646|||Case Control||Cross-Sectional|||||||
1461237|NCT01491633||Single Group Assignment||Treatment||None (Open Label)||||||
1461238|NCT01491620|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461239|NCT01491607||Single Group Assignment||Treatment||None (Open Label)||||||
1461240|NCT01491594||Single Group Assignment||Prevention||None (Open Label)||||||
1461241|NCT01491581|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1461242|NCT01491568||Single Group Assignment||Treatment||None (Open Label)||||||
1461243|NCT01491555|||Case Control||Prospective|||||||
1461244|NCT01491542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461245|NCT01491529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461246|NCT01491516||Single Group Assignment||Treatment||None (Open Label)||||||
1461247|NCT01491503|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461248|NCT01491490|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461249|NCT01491477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461250|NCT01491464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461251|NCT01491451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461252|NCT01491438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461253|NCT01491425|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461254|NCT01491412|||Case-Only||Prospective|||||||
1461255|NCT01491399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461256|NCT01491386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461257|NCT01491373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461258|NCT01491360||Single Group Assignment||Treatment||None (Open Label)||||||
1461259|NCT01491347|||Cohort||Prospective|||||||
1461260|NCT01491334|||Case Control||Prospective|||||||
1461261|NCT01491321|Randomized|Parallel Assignment||Treatment||Single||||||t
1461262|NCT01491308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461263|NCT01491295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461264|NCT01491282|||Case Control||Prospective|||||||
1461265|NCT01491269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461266|NCT01491256|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461267|NCT01491243|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1461268|NCT01491230|||Cohort||Prospective|||||||
1461269|NCT01491217||Single Group Assignment||Treatment||None (Open Label)||||||
1461270|NCT01491204||Single Group Assignment||Treatment||None (Open Label)||||||
1461271|NCT01491191|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1461272|NCT01491178|||Case-Only||Prospective|||||||
1461273|NCT01491165||Single Group Assignment||Treatment||None (Open Label)||||||
1461274|NCT01491152|Randomized|Crossover Assignment||Treatment||Single||||||t
1461275|NCT01491139||Single Group Assignment||Treatment||None (Open Label)||||||
1461276|NCT01491126|||Cohort||Prospective|||||||
1461277|NCT01491113|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1461278|NCT01491100|||Cohort||Prospective|||||||
1461279|NCT01491087||Single Group Assignment||Prevention||None (Open Label)||||||
1461280|NCT01491074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461281|NCT01491061|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461282|NCT01491048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461283|NCT01491035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461284|NCT01491022|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1461285|NCT01491009|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461286|NCT01490996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461287|NCT01490983|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1461288|NCT01490970|||Cohort||Retrospective|||||||
1461289|NCT01490957|||Cohort||Prospective|||||||
1461290|NCT01490944|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461291|NCT01490931||Single Group Assignment||Treatment||None (Open Label)||||||
1461292|NCT01490918|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461293|NCT01490905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461294|NCT01490892||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461295|NCT01490879|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461296|NCT01490866||Single Group Assignment||Treatment||None (Open Label)||||||
1461297|NCT01490853|||Case-Only||Retrospective|||||||
1461298|NCT01490840||Parallel Assignment||Treatment||None (Open Label)||||||
1461299|NCT01490827|||Cohort||Prospective|||||||
1461300|NCT01490814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461301|NCT01490801|||Cohort||Retrospective|||||||
1461302|NCT01490788|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461303|NCT01490775|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1461304|NCT01490762|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1461305|NCT01490749||Single Group Assignment||Treatment||None (Open Label)||||||
1461306|NCT01490736||Single Group Assignment||Treatment||Triple|||t||t|t
1461307|NCT01490723||Single Group Assignment||Treatment||None (Open Label)||||||
1461308|NCT01490710|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1461309|NCT01490697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461310|NCT01490684|||Cohort||Prospective|||||||
1461311|NCT01490671|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1461312|NCT01490658|Randomized|Crossover Assignment||Treatment||Single|||||t|
1461313|NCT01490645|||Case-Only||Prospective|||||||
1461314|NCT01490632|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461315|NCT01490619|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461316|NCT01490606|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461317|NCT01490593|||Other||Prospective|||||||
1461318|NCT01490580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461319|NCT01490567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461320|NCT01490554||Single Group Assignment||Treatment||None (Open Label)||||||
1461321|NCT01490541|||||Prospective|||||||
1461322|NCT01490528|||Cohort||Retrospective|||||||
1461323|NCT01490515|Randomized|Parallel Assignment||||None (Open Label)||||||
1461324|NCT01490502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461325|NCT01490489||Single Group Assignment||||None (Open Label)||||||
1461326|NCT01490476||Single Group Assignment||Treatment||None (Open Label)||||||
1461327|NCT01490463|||Cohort||Prospective|||||||
1461328|NCT01490450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461329|NCT01490437||Single Group Assignment||Treatment||None (Open Label)||||||
1461330|NCT01490424|||Case Control||Prospective|||||||
1461331|NCT01490411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461332|NCT01490398||Single Group Assignment||Treatment||None (Open Label)||||||
1461333|NCT01490385|Randomized|Single Group Assignment||Treatment||Single|||||t|
1461334|NCT01490372|||Case-Control||Cross-Sectional|||||||
1461335|NCT01490359|Randomized|Parallel Assignment||Prevention||Single|Participants were masked to intervention arm at time of recruitment.||t|||
1461336|NCT01490346|||Cohort||Prospective|||||||
1461337|NCT01490333|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1461338|NCT01490320|Randomized|Parallel Assignment||Prevention||Single||||||t
1461339|NCT01490307|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461340|NCT01490294|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1461341|NCT01490281|Randomized|Factorial Assignment||Treatment||Single|||||t|
1461342|NCT01490268|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461343|NCT01490255|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1461344|NCT01490229|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461345|NCT01490216||Single Group Assignment||Treatment||None (Open Label)||||||
1461346|NCT01490203|||Cohort||Prospective|||||||
1461347|NCT01490190||Single Group Assignment||Prevention||None (Open Label)||||||
1461348|NCT01490177||Single Group Assignment||Treatment||None (Open Label)||||||
1461349|NCT01490164|||Case-Only||Prospective|||||||
1461350|NCT01490151||Single Group Assignment||Treatment||None (Open Label)||||||
1461351|NCT01490138|||Cohort||Prospective|||||||
1461352|NCT01490125|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461353|NCT01490112|||Cohort||Prospective|||||||
1461354|NCT01490099|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461355|NCT01490086|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461356|NCT01490073|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1461357|NCT01490060|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461358|NCT01490047|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461359|NCT01490034|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1461360|NCT01490021|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1461361|NCT01490008|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461362|NCT01489995|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461363|NCT01489982|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461364|NCT01489969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461365|NCT01489956|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461366|NCT01489943||Single Group Assignment||Treatment||None (Open Label)||||||
1461367|NCT01489930|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1461368|NCT01489917|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461369|NCT01489904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461370|NCT01489891|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1461371|NCT01489878|||Cohort||Prospective|||||||
1461372|NCT01489865||Single Group Assignment||Treatment||None (Open Label)||||||
1461373|NCT01489852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461374|NCT01489839|||Cohort||Prospective|||||||
1461375|NCT01489826|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461376|NCT01489813|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461377|NCT01489800|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461378|NCT01489787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461379|NCT01489774|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461380|NCT01489761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461381|NCT01489748|||Cohort||Prospective|||||||
1461382|NCT01489735|||Cohort||Prospective|||||||
1461383|NCT01489722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461384|NCT01489709|||Cohort||Prospective|||||||
1461385|NCT01489696|Randomized|Crossover Assignment||||None (Open Label)||||||
1461386|NCT01489683|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461387|NCT01489670|||Cohort||Prospective|||||||
1461388|NCT01489657|||Case-Only||Prospective|||||||
1461389|NCT01489644|Randomized|Crossover Assignment||Treatment||Single|||||t|
1461390|NCT01489631|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1461391|NCT01489618|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461392|NCT01489605|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461393|NCT01489592|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1461394|NCT01489579|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1461395|NCT01489566|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461396|NCT01489553|||Case-Only||Prospective|||||||
1461397|NCT01489540|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1461398|NCT01489527|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1461399|NCT01489514|||||Prospective|||||||
1461400|NCT01489501||Single Group Assignment||Treatment||None (Open Label)||||||
1461401|NCT01489488|Randomized|Crossover Assignment||||None (Open Label)||||||
1461402|NCT01489475|||Case-Only||Prospective|||||||
1461403|NCT01489462|Randomized|Parallel Assignment||Treatment||Single||||||t
1461404|NCT01489449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461405|NCT01489436|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1461406|NCT01489423|||Other||Retrospective|||||||
1461407|NCT01489410|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461408|NCT01489397|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1461409|NCT01489384|||Cohort||Prospective|||||||
1461410|NCT01489371||Single Group Assignment||Treatment||None (Open Label)||||||
1461411|NCT01489358|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461412|NCT01489345|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461413|NCT01489332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461414|NCT01489319|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1461415|NCT01489306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461416|NCT01489293|||Case-Control||Other|||||||
1461417|NCT01489280|||Cohort||Retrospective|||||||
1461418|NCT01489267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461419|NCT01489254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461420|NCT01489241|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1461421|NCT01489228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461422|NCT01489215|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1461423|NCT01489202|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1461424|NCT01489189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461425|NCT01489176||Single Group Assignment||Diagnostic||Single||||||t
1461426|NCT01489163|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1461427|NCT01489150|||Case-Only||Prospective|||||||
1461428|NCT01489137||Single Group Assignment||Prevention||None (Open Label)||||||
1461429|NCT01489124|Randomized|Crossover Assignment||||None (Open Label)||||||
1461430|NCT01489111|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461431|NCT01489098|||Case Control||Prospective|||||||
1461432|NCT01489085|||Case-Only||Prospective|||||||
1461433|NCT01489072|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1461434|NCT01489059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461435|NCT01489046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461436|NCT01489033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461437|NCT01489020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461438|NCT01489007|||Cohort||Prospective|||||||
1461439|NCT01488994||Single Group Assignment||Treatment||None (Open Label)||||||
1461440|NCT01488981||Single Group Assignment||Treatment||Single||||||t
1461441|NCT01488968|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461442|NCT01488955|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461443|NCT01488942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461444|NCT01488929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461445|NCT01488916|||Case Control||Cross-Sectional|||||||
1461446|NCT01488903|||Case Control||Cross-Sectional|||||||
1461447|NCT01488890|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461448|NCT01488877|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1461449|NCT01488864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461450|NCT01488851|||Cohort||Prospective|||||||
1461451|NCT01488838|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461452|NCT01488825|Randomized|Parallel Assignment||Treatment||Single||||||t
1461453|NCT01488812|||Cohort||Retrospective|||||||
1461454|NCT01488799|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461455|NCT01488786||Single Group Assignment||Supportive Care||None (Open Label)||||||
1461456|NCT01488773|||Case-Crossover||Retrospective|||||||
1461457|NCT01488760|||Case Control||Cross-Sectional|||||||
1461458|NCT01488747|Randomized|Single Group Assignment||Treatment||Single|||t|||
1461459|NCT01488734|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1461460|NCT01488721|||Case-Only||Prospective|||||||
1461461|NCT01488708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461462|NCT01488695|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1461463|NCT01488682|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461464|NCT01488669|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461465|NCT01488656|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1461466|NCT01488643|||Case Control||Prospective|||||||
1461467|NCT01488630|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1461468|NCT01488617|||Cohort||Prospective|||||||
1461469|NCT01488604|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461470|NCT01488591|||||Prospective|||||||
1461471|NCT01488578|||Case-Only||Prospective|||||||
1461472|NCT01488565||Single Group Assignment||Treatment||None (Open Label)||||||
1461473|NCT01488552||Single Group Assignment||Treatment||None (Open Label)||||||
1461474|NCT01488539|Randomized|Parallel Assignment||Treatment||Single||||||t
1461475|NCT01488526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461476|NCT01488513||Single Group Assignment||Treatment||None (Open Label)||||||
1461477|NCT01488500|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1461478|NCT01488487||Single Group Assignment||Treatment||None (Open Label)||||||
1461479|NCT01488474|||Case Control||Prospective|||||||
1461480|NCT01488461|||Family-Based|||||||||
1461481|NCT01488448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461482|NCT01488435|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1461483|NCT01488422|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1461484|NCT01488409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461485|NCT01488396||Single Group Assignment||Treatment||None (Open Label)||||||
1461486|NCT01488383|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461487|NCT01488370|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1461488|NCT01488357|||Cohort||Prospective|||||||
1461489|NCT01488344||Single Group Assignment||Treatment||None (Open Label)||||||
1461490|NCT01488331|||Cohort||Prospective|||||||
1461491|NCT01488318||Single Group Assignment||Treatment||None (Open Label)||||||
1461492|NCT01488305|Randomized|Factorial Assignment||||None (Open Label)||||||
1461493|NCT01488292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461494|NCT01488279|Randomized|Crossover Assignment||Treatment||Double|Drugs were dispensed by the pharmacy with both the patient and investigator blinded|Double blind, placebo controlled crossover study|t||t|
1461495|NCT01488266|Randomized|Parallel Assignment||Treatment||Single||||||t
1461496|NCT01488253||Single Group Assignment||Prevention||None (Open Label)||||||
1461497|NCT01488240|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461498|NCT01488227|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1461499|NCT01488214|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1461500|NCT01488201|Randomized|Parallel Assignment||Treatment||Single||||||
1461501|NCT01488188|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1461502|NCT01488175|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461503|NCT01488162|||Cohort||Prospective|||||||
1461504|NCT01488149|||Cohort||Prospective|||||||
1461505|NCT01488136|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1461506|NCT01488123||Single Group Assignment||Supportive Care||None (Open Label)||||||
1461507|NCT01488110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461508|NCT01488097||Single Group Assignment||Treatment||None (Open Label)||||||
1461509|NCT01488084|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461510|NCT01488071|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461511|NCT01488058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461512|NCT01488045|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1461513|NCT01488032|||Case Control||Prospective|||||||
1461514|NCT01488019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461515|NCT01488006|||Cohort||Prospective|||||||
1461516|NCT01487993|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461517|NCT01487980|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1461518|NCT01487967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461519|NCT01487954|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1461520|NCT01487941|||Case-Only||Prospective|||||||
1461521|NCT01487928|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1461522|NCT01487915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461523|NCT01487902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461524|NCT01487889|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1461525|NCT01487876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461526|NCT01487863|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1461527|NCT01487850||||Diagnostic||||||||
1461528|NCT01487837|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461529|NCT01487824|||Case Control||Prospective|||||||
1461530|NCT01487811|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461531|NCT01487798|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461532|NCT01487785||Single Group Assignment||Treatment||None (Open Label)||||||
1461533|NCT01487772|||Cohort||Prospective|||||||
1461534|NCT01487759|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1461535|NCT01487746|||Case Control||Prospective|||||||
1461536|NCT01487733|||Other||Retrospective|||||||
1461537|NCT01487720||Single Group Assignment||Treatment||None (Open Label)||||||
1461538|NCT01487707|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461539|NCT01487694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461540|NCT01487681||||||||||||
1461541|NCT01487668|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1461542|NCT01487655|||||Prospective|||||||
1461543|NCT01487642|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461544|NCT01487629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461545|NCT01487616|||Case Control||Prospective|||||||
1461546|NCT01487603|||Other||Prospective|||||||
1461547|NCT01487590|Randomized|Parallel Assignment||||Single|||t|||
1461548|NCT01487577||Single Group Assignment||Treatment||None (Open Label)||||||
1461549|NCT01487564||Single Group Assignment||Treatment||None (Open Label)||||||
1461550|NCT01487551||Single Group Assignment||Treatment||None (Open Label)||||||
1461551|NCT01487538|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1461552|NCT01487525|Randomized|Parallel Assignment||||Double|||t|||t
1461553|NCT01487512|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461554|NCT01487499|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461555|NCT01487486|||Case Control||Prospective|||||||
1461556|NCT01487473|Randomized|Crossover Assignment||Treatment||Single|||||t|
1461557|NCT01487460|Randomized|Parallel Assignment||||Double|||t||t|
1461558|NCT01487447|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461559|NCT01487434||Single Group Assignment||Prevention||None (Open Label)||||||
1461560|NCT01487421|||Cohort||Prospective|||||||
1461561|NCT01487408|||Cohort||Prospective|||||||
1461562|NCT01487395|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461563|NCT01487382|||Cohort||Prospective|||||||
1461564|NCT01487369|||Cohort||Prospective|||||||
1461565|NCT01487356|||||Prospective|||||||
1461566|NCT01487343|||Cohort||Prospective|||||||
1461567|NCT01487330||Single Group Assignment||Treatment||None (Open Label)||||||
1461568|NCT01487317|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1461569|NCT01487304|||Cohort||Prospective|||||||
1461570|NCT01487291|||Case Control||Cross-Sectional|||||||
1461571|NCT01487278|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461572|NCT01487265||Single Group Assignment||Treatment||None (Open Label)||||||
1461573|NCT01487252|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1461574|NCT01487239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461575|NCT01487226||Single Group Assignment||Treatment||None (Open Label)||||||
1461576|NCT01487213|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1461577|NCT01487200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461578|NCT01487187|Randomized|Parallel Assignment||Prevention||Single||||||t
1461579|NCT01487174|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461580|NCT01487161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461581|NCT01487148|||||Prospective|||||||
1461582|NCT01487135|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461583|NCT01487122|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461584|NCT01487109|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461585|NCT01487096|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461586|NCT01487083||Single Group Assignment||Treatment||None (Open Label)||||||
1461587|NCT01487070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461588|NCT01487057|||Cohort||Prospective|||||||
1461589|NCT01487044||||||||||||
1461590|NCT01487031|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1461591|NCT01487018|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1461592|NCT01487005|||||Prospective|||||||
1461593|NCT01486992||Single Group Assignment||Treatment||None (Open Label)||||||
1461594|NCT01486979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461595|NCT01486966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461596|NCT01486953|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1461597|NCT01486940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461598|NCT01486927||Single Group Assignment||Treatment||None (Open Label)||||||
1461599|NCT01486914|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461600|NCT01486901|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461601|NCT01486888|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461602|NCT01486875|||Cohort||Prospective|||||||
1461603|NCT01486862|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461604|NCT01486849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461605|NCT01486836|||Case-Only||Prospective|||||||
1461606|NCT01486823|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1461607|NCT01486810||Single Group Assignment||Treatment||None (Open Label)||||||
1461608|NCT01486797||Single Group Assignment||Treatment||None (Open Label)||||||
1461609|NCT01486784|Non-Randomized|||Treatment||||||||
1461610|NCT01486771|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1461611|NCT01486758|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461612|NCT01486745|||Case Control||Prospective|||||||
1461613|NCT01486732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461614|NCT01486719||Single Group Assignment||Treatment||Single||||||t
1461615|NCT01486706|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461616|NCT01486693|||Cohort||Retrospective|||||||
1461617|NCT01486680|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461618|NCT01486667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461619|NCT01486654|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461620|NCT01486641|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461621|NCT01486628|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461622|NCT01486615|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461623|NCT01486602||Single Group Assignment||Treatment||None (Open Label)||||||
1461624|NCT01486589|||Cohort||Prospective|||||||
1461625|NCT01486576|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461626|NCT01486563|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1461627|NCT01486550|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461628|NCT01486537|||Other||Prospective|||||||
1461629|NCT01486524|||||Retrospective|||||||
1461630|NCT01486511|||Cohort||Prospective|||||||
1461631|NCT01486498|||Case Control||Prospective|||||||
1461632|NCT01486485|Randomized|Parallel Assignment||||None (Open Label)||||||
1461633|NCT01486472|||Cohort||Prospective|||||||
1461634|NCT01486459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461635|NCT01486446|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461636|NCT01486433|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461637|NCT01486420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461638|NCT01486407|||Case Control||Prospective|||||||
1461639|NCT01486394|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1461640|NCT01486381|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461641|NCT01486368||Single Group Assignment||Treatment||None (Open Label)||||||
1461642|NCT01486355|Randomized|||Prevention||||||||
1461643|NCT01486342|||||Prospective|||||||
1461644|NCT01486329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461645|NCT01486316|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1461646|NCT01486303||Single Group Assignment||Treatment||None (Open Label)||||||
1461647|NCT01486290|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461648|NCT01486277||Single Group Assignment||Treatment||None (Open Label)||||||
1461649|NCT01486264|Randomized|Single Group Assignment||Treatment||Single||||||t
1461650|NCT01486251||Single Group Assignment||||None (Open Label)||||||
1461651|NCT01486238|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461652|NCT01486225|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1461653|NCT01486212||||||||||||
1461654|NCT01486199|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1461655|NCT01486186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461656|NCT01486173|||Cohort||Prospective|||||||
1461657|NCT01486160|||Case-Only||Prospective|||||||
1461658|NCT01486147|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1461659|NCT01486134||Single Group Assignment||Treatment||None (Open Label)||||||
1461660|NCT01486121|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461661|NCT01486108|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1461662|NCT01486095|Randomized|Parallel Assignment||Treatment||Single||||||t
1461663|NCT01486082|||Cohort||Prospective|||||||
1461664|NCT01486069|||Case-Only||Prospective|||||||
1461665|NCT01486056|||Case-Only||Prospective|||||||
1461666|NCT01486043||Single Group Assignment||Treatment||None (Open Label)||||||
1461667|NCT01486030|||Cohort||Prospective|||||||
1461668|NCT01486017|Randomized|Crossover Assignment||||None (Open Label)||||||
1461669|NCT01486004||Single Group Assignment||Treatment||None (Open Label)||||||
1461670|NCT01485991|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461671|NCT01485978|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461672|NCT01485965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461673|NCT01485952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461674|NCT01485939|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1461675|NCT01485926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461676|NCT01485913|Randomized|Parallel Assignment||Supportive Care||Single|The methodologist who performed the randomisation was not directly involved in the recruitment of patients. Recruiting physicians were blinded to the allocation sequence.|||t||
1461677|NCT01485900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461678|NCT01485887|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461679|NCT01485874||Single Group Assignment||Treatment||None (Open Label)||||||
1461680|NCT01485861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461681|NCT01485848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461682|NCT01485835||Single Group Assignment||Treatment||None (Open Label)||||||
1461683|NCT01485822|||Cohort||Prospective|||||||
1461684|NCT01485809||Single Group Assignment||Treatment||None (Open Label)||||||
1461685|NCT01485796||Single Group Assignment||Treatment||None (Open Label)||||||
1461686|NCT01485783|||Case-Only||Prospective|||||||
1461687|NCT01485770|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1461688|NCT01485757||Single Group Assignment||Treatment||None (Open Label)||||||
1461689|NCT01485744||Single Group Assignment||Treatment||None (Open Label)||||||
1461690|NCT01485731||Single Group Assignment||Treatment||None (Open Label)||||||
1461691|NCT01485718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461692|NCT01485705||Single Group Assignment||Health Services Research||None (Open Label)||||||
1461693|NCT01485692|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1461694|NCT01485679||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461695|NCT01485666|||Cohort||Prospective|||||||
1461696|NCT01485653||Single Group Assignment||Treatment||Triple|||t||t|t
1461697|NCT01485640||Single Group Assignment||Treatment||None (Open Label)||||||
1461698|NCT01485627|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1461699|NCT01485614|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461700|NCT01485601|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461701|NCT01485588||Single Group Assignment||Treatment||None (Open Label)||||||
1461702|NCT01485575|||Cohort||Prospective|||||||
1461703|NCT01485562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461704|NCT01485549|||Case-Control||Prospective|||||||
1461705|NCT01485536||Single Group Assignment||Treatment||None (Open Label)||||||
1461706|NCT01485523|||Case Control||Prospective|||||||
1461707|NCT01485510|Randomized|Parallel Assignment||Prevention||Single||||||t
1461708|NCT01485497||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461709|NCT01485484|||Case-Only||Prospective|||||||
1461710|NCT01485471|||Case-Control||Cross-Sectional|||||||
1461711|NCT01485458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461712|NCT01485445|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1461713|NCT01485432|||||Prospective|||||||
1461714|NCT01485419|||Cohort||Prospective|||||||
1461715|NCT01485406|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1461716|NCT01485393|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1461717|NCT01485380||Single Group Assignment||||None (Open Label)||||||
1461718|NCT01485367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461719|NCT01485354||Single Group Assignment||Treatment||None (Open Label)||||||
1461720|NCT01485341|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1461721|NCT01485328|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461722|NCT01485315|Randomized|Parallel Assignment||Treatment||Single||||||t
1461723|NCT01485302|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461724|NCT01485289|||Case-Only||Prospective|||||||
1461725|NCT01485276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461726|NCT01485263|||Case-Only||Prospective|||||||
1461727|NCT01485250|||||Prospective|||||||
1461728|NCT01485237|||Case Control||Retrospective|||||||
1461729|NCT01485224||Single Group Assignment||Treatment||None (Open Label)||||||
1461730|NCT01485211||Single Group Assignment||Treatment||None (Open Label)||||||
1461731|NCT01485198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461732|NCT01485185|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1461733|NCT01485172|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1461734|NCT01485159|||Case-Only||Cross-Sectional|||||||
1461735|NCT01485146|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1461736|NCT01485133|||Case Control||Prospective|||||||
1461737|NCT01485120||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461738|NCT01485107||Single Group Assignment||Treatment||None (Open Label)||||||
1461739|NCT01485094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461740|NCT01485081||Single Group Assignment||Treatment||None (Open Label)||||||
1461741|NCT01485068||Single Group Assignment||Treatment||None (Open Label)||||||
1461742|NCT01485055||Single Group Assignment||Treatment||None (Open Label)||||||
1461743|NCT01485042||Single Group Assignment||Other||None (Open Label)||||||
1461744|NCT01485029|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1461745|NCT01485016|||Case-Only||Prospective|||||||
1461746|NCT01485003|||Case-Only||Prospective|||||||
1461747|NCT01484990||Single Group Assignment||Other||None (Open Label)||||||
1461748|NCT01484977||Single Group Assignment||Treatment||None (Open Label)||||||
1461749|NCT01484964|Randomized|Crossover Assignment||||None (Open Label)||||||
1461750|NCT01484951||Single Group Assignment||Treatment||None (Open Label)||||||
1461751|NCT01484938||Single Group Assignment||Supportive Care||None (Open Label)||||||
1461752|NCT01484925|||Cohort||Prospective|||||||
1461753|NCT01484912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461754|NCT01484899|||Case Control||Prospective|||||||
1461755|NCT01484886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461756|NCT01484873||Single Group Assignment||Treatment||None (Open Label)||||||
1461757|NCT01484860||Single Group Assignment||Treatment||None (Open Label)||||||
1461758|NCT01484847||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461759|NCT01484834|Randomized|Parallel Assignment||Other||Double|||t||t|
1461760|NCT01484821|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1461761|NCT01484808|||Case Control||Retrospective|||||||
1461762|NCT01484795|Randomized|Crossover Assignment||||None (Open Label)||||||
1461763|NCT01484782|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461764|NCT01484769|||Cohort||Cross-Sectional|||||||
1461765|NCT01484756|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1461766|NCT01484743|||Cohort||Prospective|||||||
1461767|NCT01484730|||Case-Only||Cross-Sectional|||||||
1461768|NCT01484717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461769|NCT01484704|||Case Control||Prospective|||||||
1461770|NCT01484691|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1461771|NCT01484678|||Case-Control||Prospective|||||||
1461772|NCT01484665||Single Group Assignment||Screening||None (Open Label)||||||
1461773|NCT01484652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461774|NCT01484639|Randomized|Parallel Assignment||||None (Open Label)||||||
1461775|NCT01484626||Single Group Assignment||Treatment||None (Open Label)||||||
1461776|NCT01484613|||Case-Only||Prospective|||||||
1461777|NCT01484600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461778|NCT01484587|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461779|NCT01484574|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461780|NCT01484561|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1461781|NCT01484548|Randomized|Single Group Assignment||Prevention||Single||||||t
1461782|NCT01484535|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1461783|NCT01484522|||Cohort||Prospective|||||||
1461784|NCT01484509|||Case-Only||Cross-Sectional|||||||
1461785|NCT01484496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461786|NCT01484483|||Cohort||Prospective|||||||
1461787|NCT01484470|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461788|NCT01484457||Single Group Assignment||Treatment||None (Open Label)||||||
1461789|NCT01484444|||Cohort||Prospective|||||||
1461790|NCT01484431||Single Group Assignment||Treatment||None (Open Label)||||||
1461791|NCT01484418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461792|NCT01484405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461793|NCT01484392|||Cohort||Prospective|||||||
1461794|NCT01484379||Single Group Assignment||Treatment||None (Open Label)||||||
1461795|NCT01484366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461796|NCT01484353||Single Group Assignment||Treatment||None (Open Label)||||||
1461797|NCT01484340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461798|NCT01484327|||||Prospective|||||||
1461799|NCT01484314||Single Group Assignment||Treatment||None (Open Label)||||||
1461800|NCT01484301|||Cohort||Prospective|||||||
1461801|NCT01484288||Single Group Assignment||Treatment||None (Open Label)||||||
1461802|NCT01484275|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461803|NCT01484262|||Cohort||Prospective|||||||
1461804|NCT01484249||Single Group Assignment||Supportive Care||None (Open Label)||||||
1461805|NCT01484236|||Other||Cross-Sectional|||||||
1461806|NCT01484223|Randomized|Parallel Assignment||||None (Open Label)||||||
1461807|NCT01484210||Single Group Assignment||Treatment||Double|||t||t|
1461808|NCT01484197|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1461809|NCT01484184|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1461810|NCT01484171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461811|NCT01484158|||Case-Only||Prospective|||||||
1461812|NCT01484145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461813|NCT01484132||Single Group Assignment||Treatment||None (Open Label)||||||
1461814|NCT01484119|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461815|NCT01484106|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1461816|NCT01484093||Single Group Assignment||Treatment||None (Open Label)||||||
1461817|NCT01484080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461818|NCT01484067|Randomized|Parallel Assignment||Treatment||Single|||||t|
1461819|NCT01484054|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461820|NCT01484041||Single Group Assignment||Treatment||None (Open Label)||||||
1461821|NCT01484028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461822|NCT01484015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461823|NCT01484002|||Cohort||Retrospective|||||||
1461824|NCT01483989||Single Group Assignment||Treatment||None (Open Label)||||||
1461825|NCT01483976|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1461826|NCT01483963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461827|NCT01483950|||Cohort||Cross-Sectional|||||||
1461828|NCT01483937|Randomized|Parallel Assignment||Treatment||Single||||||t
1461829|NCT01483924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461830|NCT01483911|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461831|NCT01483898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461832|NCT01483885|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461833|NCT01483872|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461834|NCT01483859||Single Group Assignment||||None (Open Label)||||||
1461835|NCT01483846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461836|NCT01483833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461837|NCT01483820||Single Group Assignment||Treatment||None (Open Label)||||||
1461838|NCT01483807|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1461839|NCT01483794|||||Retrospective|||||||
1461840|NCT01483781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461841|NCT01483768||Single Group Assignment||Treatment||None (Open Label)||||||
1461842|NCT01483755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461843|NCT01483742|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461844|NCT01483729|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461845|NCT01483716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461846|NCT01483703|||Case-Only||Cross-Sectional|||||||
1461847|NCT01483690||Single Group Assignment||Treatment||None (Open Label)||||||
1461848|NCT01483677|Randomized|Parallel Assignment||||None (Open Label)||||||
1461849|NCT01483664|||Cohort||Prospective|||||||
1462005|NCT01481636|||Case-Only||Cross-Sectional|||||||
1461850|NCT01483651|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1461851|NCT01483638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461852|NCT01483625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461853|NCT01483612|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1461854|NCT01483599|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461855|NCT01483586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461856|NCT01483573|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1461857|NCT01483560|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461858|NCT01483547|||Case Control||Prospective|||||||
1461859|NCT01483534||Single Group Assignment||Treatment||None (Open Label)||||||
1461860|NCT01483521||Single Group Assignment||Treatment||None (Open Label)||||||
1461861|NCT01483508|Randomized|Crossover Assignment||||Double|||t||t|
1461862|NCT01483495|||Case-Control||Cross-Sectional|||||||
1461863|NCT01483482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461864|NCT01483469|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1461865|NCT01483456||Single Group Assignment||Prevention||None (Open Label)||||||
1461866|NCT01483443|Randomized|Parallel Assignment||Treatment||Single||||||t
1461867|NCT01483430|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461868|NCT01483417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461869|NCT01483404|||Case-Only||Prospective|||||||
1461870|NCT01483391|Randomized|Parallel Assignment||Prevention||Single||||||t
1461871|NCT01483378|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1461872|NCT01483365||Parallel Assignment||Supportive Care||None (Open Label)||||||
1461873|NCT01483352||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461874|NCT01483339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461875|NCT01483326|||Cohort||Prospective|||||||
1461876|NCT01483313|||Cohort||Prospective|||||||
1461877|NCT01483300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461878|NCT01483287|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1461879|NCT01483274|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461880|NCT01483261|Randomized|Parallel Assignment||Treatment||Single||||||t
1461881|NCT01483248|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461882|NCT01483235|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1461883|NCT01483222|Randomized|Parallel Assignment||Prevention||Single||||||t
1461884|NCT01483209||Single Group Assignment||Treatment||None (Open Label)||||||
1461885|NCT01483196||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461886|NCT01483183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461887|NCT01483170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461888|NCT01483157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461889|NCT01483144|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461890|NCT01483131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461891|NCT01483118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461892|NCT01483105|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1461893|NCT01483092|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1461894|NCT01483079|||Cohort||Prospective|||||||
1461895|NCT01483066|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1461896|NCT01483053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461897|NCT01483040||Single Group Assignment||Screening||None (Open Label)||||||
1461898|NCT01483027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461899|NCT01483014||Single Group Assignment||Treatment||None (Open Label)||||||
1461900|NCT01483001||Single Group Assignment||||None (Open Label)||||||
1461901|NCT01482988|||||Prospective|||||||
1461902|NCT01482975|Randomized|Factorial Assignment||Prevention||Single|||t|||
1461903|NCT01482962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461904|NCT01482949||Single Group Assignment||Treatment||None (Open Label)||||||
1461905|NCT01482936||Single Group Assignment||Treatment||None (Open Label)||||||
1461906|NCT01482923|||Cohort||Prospective|||||||
1461907|NCT01482910|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461908|NCT01482897|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461909|NCT01482884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461910|NCT01482871|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461911|NCT01482858|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1461912|NCT01482845|Randomized|Parallel Assignment||||Triple|||t|t|t|
1461913|NCT01482832|Randomized|Parallel Assignment||Prevention||Single||||||t
1461914|NCT01482819|Randomized|Factorial Assignment||Treatment||Single|||t|||
1461915|NCT01482806|Randomized|Factorial Assignment||Treatment||Single||||||t
1461916|NCT01482793|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461917|NCT01482780|Randomized|Single Group Assignment||Treatment||Single|||t|||
1461918|NCT01482767|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461919|NCT01482754||Single Group Assignment||Treatment||None (Open Label)||||||
1461920|NCT01482741|||Cohort||Prospective|||||||
1461921|NCT01482728||Single Group Assignment||Basic Science||None (Open Label)||||||
1461922|NCT01482715|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1461923|NCT01482702|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1461924|NCT01482689|Randomized|Parallel Assignment||||None (Open Label)||||||
1461925|NCT01482676|||Case Control||Cross-Sectional|||||||
1461926|NCT01482663|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461927|NCT01482650|Randomized|Parallel Assignment||Treatment||Single|||t|||
1461928|NCT01482637|||Case-Only||Cross-Sectional|||||||
1461929|NCT01482624|Randomized|Parallel Assignment||Treatment||Single||||||t
1461930|NCT01482611|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1461931|NCT01482598|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461932|NCT01482585|||Case Control||Prospective|||||||
1461933|NCT01482572|||Case Control||Prospective|||||||
1461934|NCT01482559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461935|NCT01482546|||Cohort||Prospective|||||||
1461936|NCT01482533|||Cohort||Prospective|||||||
1461937|NCT01482520|||Cohort||Retrospective|||||||
1461938|NCT01482507|||Cohort||Prospective|||||||
1461939|NCT01482494||||||||||||
1461940|NCT01482481|||Cohort||Prospective|||||||
1461941|NCT01482468|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1461942|NCT01482455|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1461943|NCT01482442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461944|NCT01482429|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1461945|NCT01482416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461946|NCT01482403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461947|NCT01482390|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461948|NCT01482377|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461949|NCT01482364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461950|NCT01482351||Single Group Assignment||||Single||||||t
1461951|NCT01482338|Randomized|Parallel Assignment||Treatment||Single||||||t
1461952|NCT01482325||Single Group Assignment||Diagnostic||None (Open Label)||||||
1461953|NCT01482312|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461954|NCT01482299||Single Group Assignment||Treatment||None (Open Label)||||||
1461955|NCT01482286|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1461956|NCT01482273|Randomized|Parallel Assignment||Treatment||Single||||||t
1461957|NCT01482260|||Cohort||Prospective|||||||
1461958|NCT01482247|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1461959|NCT01482234|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1461960|NCT01482221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461961|NCT01482208|||Case-Only||Prospective|||||||
1461962|NCT01482195||Single Group Assignment||Treatment||None (Open Label)||||||
1461963|NCT01482182|||Case-Only||Prospective|||||||
1461964|NCT01482169|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1461965|NCT01482156||Single Group Assignment||Treatment||None (Open Label)||||||
1461966|NCT01482143|Randomized|Parallel Assignment||||None (Open Label)||||||
1461967|NCT01482130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461968|NCT01482117|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1461969|NCT01482104|Randomized|Parallel Assignment||Treatment||Single||||||t
1461970|NCT01482091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461971|NCT01482078|||Cohort||Prospective|||||||
1461972|NCT01482065||Single Group Assignment||Treatment||None (Open Label)||||||
1461973|NCT01482052|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1461974|NCT01482039|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1461975|NCT01482026|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1461976|NCT01482013|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1461977|NCT01482000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461978|NCT01481987|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1461979|NCT01481974||Single Group Assignment||Treatment||None (Open Label)||||||
1461980|NCT01481961||Single Group Assignment||Treatment||None (Open Label)||||||
1461981|NCT01481948|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1461982|NCT01481935|Randomized|Parallel Assignment||||Single||||t||
1461983|NCT01481922|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1461984|NCT01481909|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1461985|NCT01481896|||Cohort||Retrospective|||||||
1461986|NCT01481883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461987|NCT01481870|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1461988|NCT01481857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461989|NCT01481844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461990|NCT01481831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461991|NCT01481818||Single Group Assignment||Prevention||None (Open Label)||||||
1461992|NCT01481805|||Cohort||Retrospective|||||||
1461993|NCT01481792|||Cohort||Prospective|||||||
1461994|NCT01481779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461995|NCT01481766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1461996|NCT01481753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1461997|NCT01481740|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1461998|NCT01481727|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1461999|NCT01481714|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1462000|NCT01481701||Single Group Assignment||Treatment||None (Open Label)||||||
1462001|NCT01481688|Randomized|Crossover Assignment||Treatment||Single||||||t
1462002|NCT01481675|||Case-Only||Prospective|||||||
1462003|NCT01481662|||Case-Only||Other|||||||
1462004|NCT01481649|||Cohort||Prospective|||||||
1462006|NCT01481623||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462007|NCT01481610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462008|NCT01481597|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462009|NCT01481584|Randomized|Crossover Assignment||Screening||Quadruple|||t|t|t|t
1462010|NCT01481571||Single Group Assignment||Treatment||None (Open Label)||||||
1462011|NCT01481558|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1462012|NCT01481545||Single Group Assignment||Treatment||None (Open Label)||||||
1462013|NCT01481532||Single Group Assignment||Treatment||None (Open Label)||||||
1462014|NCT01481519|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462015|NCT01481506|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462016|NCT01481493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462017|NCT01481480|Randomized|Parallel Assignment||Treatment||Single||||||t
1462018|NCT01481467|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462019|NCT01481454|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462020|NCT01481441||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462021|NCT01481428|Randomized|Parallel Assignment||Prevention||Single|||t|||
1462022|NCT01481415|||||Retrospective|||||||
1462023|NCT01481402|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1462024|NCT01481389|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462025|NCT01481376|||Cohort||Retrospective|||||||
1462026|NCT01481363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462027|NCT01481350||Single Group Assignment||Treatment||None (Open Label)||||||
1462028|NCT01481337|||Cohort||Prospective|||||||
1462029|NCT01481324|||Case-Only||Prospective|||||||
1462030|NCT01481311|||Case-Only||Cross-Sectional|||||||
1462031|NCT01481298|||Cohort||Retrospective|||||||
1462032|NCT01481285|||Case-Only||Cross-Sectional|||||||
1462033|NCT01481272||Single Group Assignment||Treatment||None (Open Label)||||||
1462034|NCT01481259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462035|NCT01481246|||Cohort||Prospective|||||||
1462036|NCT01481233||Single Group Assignment||Treatment||None (Open Label)||||||
1462037|NCT01481220||Single Group Assignment||Treatment||None (Open Label)||||||
1462038|NCT01481207|||Cohort||Prospective|||||||
1462039|NCT01481194||Single Group Assignment||Treatment||None (Open Label)||||||
1462040|NCT01481181|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1462041|NCT01481168|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1462042|NCT01481155||Single Group Assignment||Treatment||Single|||||t|
1462043|NCT01481142||Single Group Assignment||Treatment||None (Open Label)||||||
1462044|NCT01481129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462045|NCT01481116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462046|NCT01481103|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462047|NCT01481090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462048|NCT01481077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462049|NCT01481064|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462050|NCT01481051||Single Group Assignment||Treatment||None (Open Label)||||||
1462051|NCT01481038|||Cohort||Prospective|||||||
1462052|NCT01481025|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462053|NCT01481012|||Cohort||Prospective|||||||
1462054|NCT01480999|||Cohort||Prospective|||||||
1462055|NCT01480986||Single Group Assignment||Treatment||None (Open Label)||||||
1462056|NCT01480973||Single Group Assignment||Treatment||None (Open Label)||||||
1462057|NCT01480960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462058|NCT01480947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462059|NCT01480934|||Case Control||Prospective|||||||
1462060|NCT01480921|Randomized|Parallel Assignment||Treatment||Single||||||t
1462061|NCT01480908|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1462062|NCT01480895|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462063|NCT01480882|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462064|NCT01480869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462065|NCT01480856|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462066|NCT01480843||Single Group Assignment||Treatment||None (Open Label)||||||
1462067|NCT01480830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462068|NCT01480817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462069|NCT01480804|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462070|NCT01480791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462071|NCT01480778|Randomized|Parallel Assignment||Treatment||Single|||||t|
1462072|NCT01480765|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462073|NCT01480752|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462074|NCT01480739|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1462075|NCT01480726|||Cohort||Prospective|||||||
1462076|NCT01480713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462077|NCT01480700|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462078|NCT01480687|Randomized|Crossover Assignment||Treatment||Single|||t|||
1462079|NCT01480674|||Cohort||Other|||||||
1462080|NCT01480661|Randomized|Parallel Assignment||||Triple|||t|t|t|
1462081|NCT01480648|Randomized|Parallel Assignment||Treatment||Single||||||
1462082|NCT01480635|||Cohort||Prospective|||||||
1462083|NCT01480622||Single Group Assignment||Treatment||None (Open Label)||||||
1462084|NCT01480609|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462085|NCT01480596|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462086|NCT01480583|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462087|NCT01480570||||||||||||
1462088|NCT01480557|Randomized|Parallel Assignment||||Single||||||t
1462089|NCT01480544|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462090|NCT01480531||Single Group Assignment||Treatment||None (Open Label)||||||
1462091|NCT01480518|||Case-Only||Retrospective|||||||
1462092|NCT01480505|||Cohort||Retrospective|||||||
1462093|NCT01480492||Single Group Assignment||||None (Open Label)||||||
1462094|NCT01480479|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462095|NCT01480466|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1462096|NCT01480453|||Cohort||Prospective|||||||
1462097|NCT01480440|||Cohort||Prospective|||||||
1462098|NCT01480427|||Case-Only||Prospective|||||||
1462099|NCT01480414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462100|NCT01480401|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1462101|NCT01480388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462102|NCT01480375|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1462103|NCT01480362|Randomized|Parallel Assignment||Treatment||Single|Wound photographs are analysed by blinded outcome assessors|||||t
1462104|NCT01480349|||Cohort||Prospective|||||||
1462105|NCT01480336|Randomized|Parallel Assignment||||Double|||t||t|
1462106|NCT01480323||Single Group Assignment||Treatment||None (Open Label)||||||
1462107|NCT01480310|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1462108|NCT01480297||Single Group Assignment||Treatment||None (Open Label)||||||
1462109|NCT01480284|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462110|NCT01480271|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1462111|NCT01480258|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462112|NCT01480245|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462113|NCT01480232|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462114|NCT01480219|||Cohort||Retrospective|||||||
1462115|NCT01480206|||Cohort||Prospective|||||||
1462116|NCT01480193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462117|NCT01480180|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462118|NCT01480167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462119|NCT01480154||Single Group Assignment||Treatment||None (Open Label)||||||
1462120|NCT01480141||Single Group Assignment||Treatment||None (Open Label)||||||
1462121|NCT01480128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462122|NCT01480115|||Cohort||Prospective|||||||
1462123|NCT01480102|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462124|NCT01480089|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462125|NCT01480076||Single Group Assignment||Treatment||None (Open Label)||||||
1462126|NCT01480063|||Cohort||Prospective|||||||
1462127|NCT01480050||Single Group Assignment||Treatment||None (Open Label)||||||
1462128|NCT01480037|||Case Control||Cross-Sectional|||||||
1462129|NCT01480024|||Cohort||Prospective|||||||
1462130|NCT01480011||Single Group Assignment||Prevention||None (Open Label)||||||
1462131|NCT01479998|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462132|NCT01479985|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462133|NCT01479972|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462134|NCT01479959|Randomized|Crossover Assignment||Treatment||Single||||||t
1462135|NCT01479946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462136|NCT01479933|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1462137|NCT01479920|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1462138|NCT01479907|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1462139|NCT01479894|||Cohort||Retrospective|||||||
1462140|NCT01479881|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462141|NCT01479868||Single Group Assignment||Treatment||None (Open Label)||||||
1462142|NCT01479855|||Case Control||Prospective|||||||
1462143|NCT01479842||Single Group Assignment||Treatment||None (Open Label)||||||
1462144|NCT01479829|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462145|NCT01479816|||Ecologic or Community||Retrospective|||||||
1462146|NCT01479803|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1462147|NCT01479790|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1462148|NCT01479777||Single Group Assignment||Treatment||None (Open Label)||||||
1462149|NCT01479764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462150|NCT01479751|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1462151|NCT01479738||Single Group Assignment||Treatment||Single||||||t
1462152|NCT01479725|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462153|NCT01479712|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462154|NCT01479699|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1462155|NCT01479686|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462156|NCT01479673|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1462157|NCT01479660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462158|NCT01479647|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1462159|NCT01479634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462160|NCT01479621|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462474|NCT01475500|||Cohort||Prospective|||||||
1462161|NCT01479608|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462162|NCT01479595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462163|NCT01479582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462164|NCT01479569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462165|NCT01479556|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1462166|NCT01479543|Randomized|Parallel Assignment||||Triple|||t||t|t
1462167|NCT01479530|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462168|NCT01479517|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462169|NCT01479504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462170|NCT01479491|||Case-Only||Retrospective|||||||
1462171|NCT01479478|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462172|NCT01479465|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462173|NCT01479452|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462174|NCT01479439||Single Group Assignment||Treatment||None (Open Label)||||||
1462175|NCT01479426|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462176|NCT01479413|||Case-Only||Prospective|||||||
1462177|NCT01479400|||Case Control||Prospective|||||||
1462178|NCT01479387|||Case-Only||Prospective|||||||
1462179|NCT01479374|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462180|NCT01479361|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462181|NCT01479348|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1462182|NCT01479322|||Case Control||Prospective|||||||
1462183|NCT01479296|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462184|NCT01479283|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1462185|NCT01479270|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1462186|NCT01479257|||Cohort||Prospective|||||||
1462187|NCT01479244|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462188|NCT01479231||Single Group Assignment||Treatment||None (Open Label)||||||
1462189|NCT01479218||Single Group Assignment||Treatment||None (Open Label)||||||
1462190|NCT01479205|||Case Control||Prospective|||||||
1462191|NCT01479192|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462192|NCT01479179||Single Group Assignment||Treatment||None (Open Label)||||||
1462193|NCT01479166|||Case Control||Cross-Sectional|||||||
1462194|NCT01479153|Randomized|Parallel Assignment||Prevention||Single||||||t
1462195|NCT01479140|||Cohort||Prospective|||||||
1462196|NCT01479127||Single Group Assignment||Treatment||None (Open Label)||||||
1462197|NCT01479114|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1462198|NCT01479101|||Case-Only||Prospective|||||||
1462199|NCT01479088||Single Group Assignment||Treatment||None (Open Label)||||||
1462200|NCT01479075|Randomized|Crossover Assignment||Treatment||Single|||t|||
1462201|NCT01479062|Randomized|Parallel Assignment||Prevention||Single||||||t
1462202|NCT01479049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462203|NCT01479036|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462204|NCT01479023|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462205|NCT01479010||Single Group Assignment||Treatment||None (Open Label)||||||
1462206|NCT01478997|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462207|NCT01478984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462208|NCT01478971||Single Group Assignment||Treatment||None (Open Label)||||||
1462209|NCT01478958|Randomized|Parallel Assignment||Prevention||Single|||t|||
1462210|NCT01478945|Randomized|Parallel Assignment||||Triple|||t||t|t
1462211|NCT01478932||Single Group Assignment||Supportive Care||None (Open Label)||||||
1462212|NCT01478919|||Cohort||Prospective|||||||
1462213|NCT01478906|||||Prospective|||||||
1462214|NCT01478893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462215|NCT01478880|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462216|NCT01478867|||Cohort||Retrospective|||||||
1462217|NCT01478854||Single Group Assignment||Treatment||None (Open Label)||||||
1462218|NCT01478841|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462219|NCT01478828|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462220|NCT01478815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462221|NCT01478802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462222|NCT01478789|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1462223|NCT01478776|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462224|NCT01478763|||Cohort||Prospective|||||||
1462225|NCT01478750|Randomized|Crossover Assignment||Treatment||Single|||t|||
1462226|NCT01478737|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1462227|NCT01478724|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462228|NCT01478711|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462229|NCT01478698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462230|NCT01478685|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462231|NCT01478672|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1462232|NCT01478659|Randomized|Parallel Assignment||||Double|||t||t|
1462233|NCT01478646|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462234|NCT01478633||Single Group Assignment||Treatment||None (Open Label)||||||
1462235|NCT01478620||Single Group Assignment||Treatment||None (Open Label)||||||
1462236|NCT01478607|Randomized|Parallel Assignment||Treatment||Single||||||t
1462237|NCT01478594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462475|NCT01475487|Randomized|Parallel Assignment||||Single||||||t
1462238|NCT01478581|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462239|NCT01478568||Crossover Assignment||||None (Open Label)||||||
1462240|NCT01478555|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1462241|NCT01478542|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1462242|NCT01478529|Randomized|Crossover Assignment||||None (Open Label)||||||
1462243|NCT01478516||Single Group Assignment||Treatment||None (Open Label)||||||
1462244|NCT01478503|Randomized|Parallel Assignment||||Triple|||t||t|t
1462245|NCT01478490|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1462246|NCT01478477|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1462247|NCT01478464|Randomized|Factorial Assignment||Prevention||Single||||||t
1462248|NCT01478451|Randomized|Crossover Assignment||Prevention||Single||||||t
1462249|NCT01478438||Single Group Assignment||Treatment||None (Open Label)||||||
1462250|NCT01478425|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462251|NCT01478412|||Case-Only||Retrospective|||||||
1462252|NCT01478399|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462253|NCT01478386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462254|NCT01478373||Single Group Assignment||Treatment||None (Open Label)||||||
1462255|NCT01478360|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462256|NCT01478347|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1462257|NCT01478334|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462258|NCT01478321||Single Group Assignment||Treatment||None (Open Label)||||||
1462259|NCT01478308||Single Group Assignment||Treatment||None (Open Label)||||||
1462260|NCT01478295|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462261|NCT01478282|Non-Randomized|Crossover Assignment||||Single|||t|||
1462262|NCT01478269|||Cohort||Retrospective|||||||
1462263|NCT01478256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462264|NCT01478243|||Case-Only||Cross-Sectional|||||||
1462265|NCT01478230|Randomized|Crossover Assignment||||None (Open Label)||||||
1462266|NCT01478217|||Case Control|||||||||
1462267|NCT01478204|||Cohort||Prospective|||||||
1462268|NCT01478191|||Cohort||Retrospective|||||||
1462269|NCT01478178||Single Group Assignment||Treatment||None (Open Label)||||||
1462270|NCT01478165|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462271|NCT01478152||Single Group Assignment||Treatment||None (Open Label)||||||
1462272|NCT01478139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462273|NCT01478126|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1462274|NCT01478113|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462275|NCT01478100|||Case-Only||Retrospective|||||||
1462276|NCT01478087||Single Group Assignment||Treatment||None (Open Label)||||||
1462277|NCT01478074||Single Group Assignment||Treatment||None (Open Label)||||||
1462278|NCT01478061||Single Group Assignment||Treatment||None (Open Label)||||||
1462279|NCT01478048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462280|NCT01478035|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462281|NCT01478022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462282|NCT01478009|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462283|NCT01477996|Randomized|Parallel Assignment||Treatment||Single||||||t
1462284|NCT01477983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462285|NCT01477970|||||Prospective|||||||
1462286|NCT01477957||Single Group Assignment||Basic Science||None (Open Label)||||||
1462287|NCT01477944|||||Retrospective|||||||
1462288|NCT01477931||Single Group Assignment||Treatment||None (Open Label)||||||
1462289|NCT01477918|||Case-Only||Cross-Sectional|||||||
1462290|NCT01477905|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462291|NCT01477892|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1462292|NCT01477879|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1462293|NCT01477866|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462294|NCT01477853|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462295|NCT01477840||Parallel Assignment||Prevention||Double|||t|||t
1462296|NCT01477827|||Cohort||Prospective|||||||
1462297|NCT01477814|Randomized|Parallel Assignment||Screening||Single|||||t|
1462298|NCT01477801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462299|NCT01477788|||Cohort||Retrospective|||||||
1462300|NCT01477775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462301|NCT01477762|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1462302|NCT01477749||Single Group Assignment||||None (Open Label)||||||
1462303|NCT01477736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462304|NCT01477723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462305|NCT01477710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462306|NCT01477697|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462307|NCT01477684|||||Retrospective|||||||
1462308|NCT01477671|||Ecologic or Community||Prospective|||||||
1462309|NCT01477658|||Cohort||Prospective|||||||
1462310|NCT01477645|||Ecologic or Community||Prospective|||||||
1462311|NCT01477632|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462312|NCT01477619|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1462313|NCT01477606||Single Group Assignment||Treatment||None (Open Label)||||||
1462314|NCT01477593|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1462315|NCT01477580|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462316|NCT01477567|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1462317|NCT01477554|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1462318|NCT01477541|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1462319|NCT01477528|||Cohort||Prospective|||||||
1462320|NCT01477515|||Case Control||Prospective|||||||
1462321|NCT01477502|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462322|NCT01477489||Single Group Assignment||Treatment||None (Open Label)||||||
1462323|NCT01477476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462324|NCT01477463|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1462325|NCT01477450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462326|NCT01477437|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1462327|NCT01477424|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1462328|NCT01477411|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1462329|NCT01477398|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1462330|NCT01477385|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1462331|NCT01477372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462332|NCT01477359|||Cohort||Prospective|||||||
1462333|NCT01477346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462334|NCT01477333||Single Group Assignment||Treatment||None (Open Label)||||||
1462335|NCT01477320|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1462336|NCT01477307|||Other||Prospective|||||||
1462337|NCT01477294|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1462338|NCT01477281|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462339|NCT01477268||Single Group Assignment||Treatment||None (Open Label)||||||
1462340|NCT01477255|||Case Control||Prospective|||||||
1462341|NCT01477242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462342|NCT01477229|||Cohort||Prospective|||||||
1462343|NCT01477216|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1462344|NCT01477203|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1462345|NCT01477190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462346|NCT01477177||Single Group Assignment||Treatment||None (Open Label)||||||
1462347|NCT01477164|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1462348|NCT01477151|Randomized|Parallel Assignment||Treatment||Single||||||t
1462349|NCT01477138|||Case Control||Prospective|||||||
1462350|NCT01477125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462351|NCT01477112|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1462352|NCT01477099|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462353|NCT01477086|||Cohort||Prospective|||||||
1462354|NCT01477073|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462355|NCT01477060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462356|NCT01477047|||Cohort||Prospective|||||||
1462357|NCT01477034|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1462358|NCT01477021||Single Group Assignment||Treatment||None (Open Label)||||||
1462359|NCT01477008|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462360|NCT01476995|||Case Control||Cross-Sectional|||||||
1462361|NCT01476982|||Case-Only||Cross-Sectional|||||||
1462362|NCT01476969||Single Group Assignment||Prevention||Double|||t|||t
1462363|NCT01476956|||Case-Only||Prospective|||||||
1462364|NCT01476943|||Cohort||Other|||||||
1462365|NCT01476930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462366|NCT01476917||Single Group Assignment||Treatment||None (Open Label)||||||
1462367|NCT01476904|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462368|NCT01476891|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462369|NCT01476878||Single Group Assignment||Treatment||None (Open Label)||||||
1462370|NCT01476865|||||Cross-Sectional|||||||
1462371|NCT01476839||Single Group Assignment||Treatment||None (Open Label)||||||
1462372|NCT01476826||||||||||||
1462373|NCT01476813|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1462374|NCT01476800|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1462375|NCT01476787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462376|NCT01476774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462377|NCT01476761||Single Group Assignment||Treatment||None (Open Label)||||||
1462378|NCT01476748|Randomized|Single Group Assignment||Treatment||Single|||t|||
1462379|NCT01476735|Randomized|Parallel Assignment||Treatment||Single||||||t
1462380|NCT01476722|Non-Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1462381|NCT01476709|||||Prospective|||||||
1462382|NCT01476696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462383|NCT01476683|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1462384|NCT01476670|||Cohort||Prospective|||||||
1462385|NCT01476657||Single Group Assignment||Treatment||None (Open Label)||||||
1462386|NCT01476644|||Cohort||Prospective|||||||
1462387|NCT01476631|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462388|NCT01476618|||Cohort||Retrospective|||||||
1462389|NCT01476605|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1462390|NCT01476592||Single Group Assignment||Treatment||None (Open Label)||||||
1462391|NCT01476579||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462392|NCT01476566|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462393|NCT01476553||Single Group Assignment||Treatment||None (Open Label)||||||
1462394|NCT01476540||Single Group Assignment||Treatment||None (Open Label)||||||
1462395|NCT01476527||Single Group Assignment||Treatment||None (Open Label)||||||
1462396|NCT01476514||Parallel Assignment||Basic Science||None (Open Label)||||||
1462397|NCT01476501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462398|NCT01476488||Single Group Assignment||Treatment||None (Open Label)||||||
1462399|NCT01476475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462400|NCT01476462|||Case-Only||Retrospective|||||||
1462401|NCT01476449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462402|NCT01476436|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1462403|NCT01476423|||Cohort||Prospective|||||||
1462404|NCT01476410||Single Group Assignment||Treatment||None (Open Label)||||||
1462405|NCT01476397||||||||||||
1462406|NCT01476384|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1462407|NCT01476371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462408|NCT01476358|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1462409|NCT01476345|Randomized|Crossover Assignment||||Double|||t||t|
1462410|NCT01476332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462411|NCT01476319|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462412|NCT01476306|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462413|NCT01476293|||Case-Only||Retrospective|||||||
1462414|NCT01476280|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462415|NCT01476267|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1462416|NCT01476254|||Case Control||Prospective|||||||
1462417|NCT01476241|||Cohort||Retrospective|||||||
1462418|NCT01476228||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462419|NCT01476215|Randomized|Crossover Assignment||||None (Open Label)||||||
1462420|NCT01476202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462421|NCT01476189|Randomized|Crossover Assignment||||None (Open Label)||||||
1462422|NCT01476176|Randomized|Crossover Assignment||||Double|||t||t|
1462423|NCT01476163||||||||||||
1462424|NCT01476150|||Ecologic or Community||Cross-Sectional|||||||
1462425|NCT01476137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462426|NCT01476124|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1462427|NCT01476111|||Cohort||Prospective|||||||
1462428|NCT01476098|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1462429|NCT01476085||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462430|NCT01476072||Single Group Assignment||Basic Science||None (Open Label)||||||
1462431|NCT01476059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462432|NCT01476046|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1462433|NCT01476033|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1462434|NCT01476020|||Cohort||Prospective|||||||
1462435|NCT01476007|Randomized|Parallel Assignment||Treatment||Single||||||t
1462436|NCT01475994|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1462437|NCT01475981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462438|NCT01475968|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1462439|NCT01475955|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1462440|NCT01475942|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1462441|NCT01475929|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1462442|NCT01475916|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1462443|NCT01475903|||||Prospective|||||||
1462444|NCT01475890|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462445|NCT01475877|||||Prospective|||||||
1462446|NCT01475864|||Case-Only||Prospective|||||||
1462447|NCT01475851||Single Group Assignment||Treatment||None (Open Label)||||||
1462448|NCT01475838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462449|NCT01475825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462450|NCT01475812|||||Cross-Sectional|||||||
1462451|NCT01475799||Single Group Assignment||Treatment||None (Open Label)||||||
1462452|NCT01475786|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462453|NCT01475773|||||Prospective|||||||
1462454|NCT01475760|Randomized|Single Group Assignment||Treatment||Single|||t|||
1462455|NCT01475747|||Cohort||Prospective|||||||
1462456|NCT01475734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462457|NCT01475721|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462458|NCT01475708|||Case Control||Prospective|||||||
1462459|NCT01475695||Single Group Assignment||Other||None (Open Label)||||||
1462460|NCT01475682|||Cohort||Prospective|||||||
1462461|NCT01475669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462462|NCT01475656|||Cohort||Prospective|||||||
1462463|NCT01475643|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1462464|NCT01475630|Randomized|Factorial Assignment||Treatment||Single||||||t
1462465|NCT01475617|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462466|NCT01475604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462467|NCT01475591||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1462468|NCT01475578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462469|NCT01475565|||Cohort||Prospective|||||||
1462470|NCT01475552|Randomized|Parallel Assignment||Treatment||Single||||||t
1462471|NCT01475539|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462472|NCT01475526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462473|NCT01475513|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||Same drug (orthocyclen) was administered to 2 groups (Caucasian women of reproductive age, and African American women of reproductive age)||||
1462476|NCT01475474||Single Group Assignment||Treatment||None (Open Label)||||||
1462477|NCT01475461|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462478|NCT01475448|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1462479|NCT01475435|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1462480|NCT01475422|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1462481|NCT01475409||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462482|NCT01475396|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1462483|NCT01475383|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1462484|NCT01475370||Single Group Assignment||Treatment||None (Open Label)||||||
1462485|NCT01475357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462486|NCT01475344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462487|NCT01475331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462488|NCT01475318||Single Group Assignment||Treatment||None (Open Label)||||||
1462489|NCT01475305|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1462490|NCT01475292|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462491|NCT01475279||Single Group Assignment||||None (Open Label)||||||
1462492|NCT01475266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462493|NCT01475253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462494|NCT01475240|||Case Control||Cross-Sectional|||||||
1462495|NCT01475227|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462496|NCT01475214|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462497|NCT01475201|Randomized|Parallel Assignment||Treatment||Single||||||t
1462498|NCT01475188|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1462499|NCT01475175||Single Group Assignment||Treatment||None (Open Label)||||||
1462500|NCT01475162||Single Group Assignment||Treatment||None (Open Label)||||||
1462501|NCT01475149|||Cohort||Prospective|||||||
1462502|NCT01475136||Single Group Assignment||Basic Science||None (Open Label)||||||
1462503|NCT01475123|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462504|NCT01475110|||Case-Only||Prospective|||||||
1462505|NCT01475097|Randomized|Parallel Assignment||||Double|||t||t|
1462506|NCT01475084||Single Group Assignment||Diagnostic||Single||||||t
1462507|NCT01475071|Randomized|Single Group Assignment||Treatment||Single|||||t|
1462508|NCT01475058||Single Group Assignment||Treatment||None (Open Label)||||||
1462509|NCT01475045|||||Prospective|||||||
1462510|NCT01475032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462511|NCT01475019|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462512|NCT01475006|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462513|NCT01474993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462514|NCT01474980|||Cohort||Retrospective|||||||
1462515|NCT01474967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462516|NCT01474954|||Cohort||Prospective|||||||
1462517|NCT01474941|Randomized|Parallel Assignment||||Double|||t||t|
1462518|NCT01474928|Randomized|Parallel Assignment||Prevention||Single|||t|||
1462519|NCT01474915|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462520|NCT01474902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462521|NCT01474889||Single Group Assignment||Other||None (Open Label)||||||
1462522|NCT01474876|||||Prospective|||||||
1462523|NCT01474863|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1462524|NCT01474850|Randomized|Parallel Assignment||Prevention||Single|||t|||
1462525|NCT01474837|Randomized|Parallel Assignment||Treatment||Single||||||t
1462526|NCT01474824|||Cohort||Prospective|||||||
1462527|NCT01474811|||Cohort||Prospective|||||||
1462528|NCT01474798||Single Group Assignment||Treatment||None (Open Label)||||||
1462529|NCT01474785|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1462530|NCT01474772|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1462531|NCT01474759|Randomized|Parallel Assignment||Treatment||Single||||||t
1462532|NCT01474746|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462533|NCT01474733||Single Group Assignment||Health Services Research||None (Open Label)||||||
1462534|NCT01474720|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462535|NCT01474707|Randomized|Parallel Assignment||Prevention||Single|||t|||
1462536|NCT01474694|||Case-Only||Prospective|||||||
1462537|NCT01474681||Single Group Assignment||Treatment||None (Open Label)||||||
1462538|NCT01474668|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462539|NCT01474655|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1462540|NCT01474642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462541|NCT01474629|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1462542|NCT01474616||Single Group Assignment||Supportive Care||None (Open Label)||||||
1462543|NCT01474603|||Case-Only||Prospective|||||||
1462544|NCT01474590|Randomized|Parallel Assignment||Treatment||Single|||||t|
1462545|NCT01474577|||Cohort||Retrospective|||||||
1462546|NCT01474564|||Cohort||Prospective|||||||
1462547|NCT01474551||Single Group Assignment||Treatment||None (Open Label)||||||
1462548|NCT01474538|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1462549|NCT01474525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462550|NCT01474512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462551|NCT01474499|Randomized|Parallel Assignment||Treatment||Single||||||t
1462552|NCT01474486||Single Group Assignment||Other||None (Open Label)|Open Label|||||
1462553|NCT01474473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462554|NCT01474460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462555|NCT01474447||Single Group Assignment||Treatment||None (Open Label)||||||
1462556|NCT01474434|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1462557|NCT01474421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462558|NCT01474408|Randomized|Crossover Assignment||Treatment||Single|||||t|
1462559|NCT01474395|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1462560|NCT01474382|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462561|NCT01474369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462562|NCT01474356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462563|NCT01474343||Single Group Assignment||Treatment||None (Open Label)||||||
1462564|NCT01474330|Randomized|Parallel Assignment||||Double|||t||t|
1462565|NCT01474317||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462566|NCT01474304|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1462567|NCT01474291|||Cohort||Prospective|||||||
1462568|NCT01474278|Randomized|Crossover Assignment||||Double|||t||t|
1462569|NCT01474265|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462570|NCT01474252|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1462571|NCT01474239|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462572|NCT01474226||Single Group Assignment||Health Services Research||None (Open Label)||||||
1462573|NCT01474213|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1462574|NCT01474200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462575|NCT01474187||Single Group Assignment||Treatment||None (Open Label)||||||
1462576|NCT01474174|||Other||Prospective|||||||
1462577|NCT01474161|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462578|NCT01474148||Single Group Assignment||Treatment||None (Open Label)||||||
1462579|NCT01474135|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462580|NCT01474122|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462581|NCT01474109|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462582|NCT01474096|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462583|NCT01474083|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1462584|NCT01474070|||Cohort||Prospective|||||||
1462585|NCT01474057|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1462586|NCT01474044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462587|NCT01474031|||Cohort||Prospective|||||||
1462588|NCT01474018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462589|NCT01474005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462590|NCT01473992|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462591|NCT01473979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462592|NCT01473966|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462593|NCT01473953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462594|NCT01473940||Single Group Assignment||Treatment||None (Open Label)||||||
1462595|NCT01473927|||Case-Only||Cross-Sectional|||||||
1462596|NCT01473914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462597|NCT01473901|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462598|NCT01473888||Single Group Assignment||||None (Open Label)||||||
1462599|NCT01473875||Single Group Assignment||Treatment||None (Open Label)||||||
1462600|NCT01473862|||Case-Only||Prospective|||||||
1462601|NCT01473849|||Cohort||Prospective|||||||
1462602|NCT01473836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462603|NCT01473823|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462604|NCT01473810|Randomized|Factorial Assignment||Treatment||Single|||t|||
1462605|NCT01473797||Single Group Assignment||Treatment||None (Open Label)||||||
1462606|NCT01473784||Single Group Assignment||Treatment||None (Open Label)||||||
1462607|NCT01473771|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462608|NCT01473758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462609|NCT01473745|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462610|NCT01473732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462611|NCT01473719|Randomized|Parallel Assignment||Treatment||Single||||||t
1462612|NCT01473706|||||Prospective|||||||
1462613|NCT01473693|||Cohort||Prospective|||||||
1462614|NCT01473680|||Cohort||Prospective|||||||
1462615|NCT01473667|Randomized|Parallel Assignment||||None (Open Label)||||||
1462616|NCT01473654|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462617|NCT01473641|||Cohort||Prospective|||||||
1462618|NCT01473628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462619|NCT01473615|Randomized|Parallel Assignment||Treatment||Single||||||t
1462620|NCT01473602|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462621|NCT01473589|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462622|NCT01473576|Randomized|Parallel Assignment||||Double|||t||t|
1462623|NCT01473563||Single Group Assignment||||None (Open Label)||||||
1462624|NCT01473550|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1462625|NCT01473537|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1462626|NCT01473524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462627|NCT01473511|Randomized|Parallel Assignment||Treatment||Single||||||t
1462628|NCT01473498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462629|NCT01473485||Single Group Assignment||Treatment||None (Open Label)||||||
1462630|NCT01473472|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462631|NCT01473459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462632|NCT01473446|Randomized|Parallel Assignment||Treatment||Single||||||t
1462633|NCT01473433|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462634|NCT01473420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462635|NCT01473407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462636|NCT01473394|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462637|NCT01473381|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462638|NCT01473368|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1462639|NCT01473355||Single Group Assignment||Treatment||None (Open Label)||||||
1462640|NCT01473342||Single Group Assignment||||None (Open Label)||||||
1462641|NCT01473329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462642|NCT01473316|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462643|NCT01473303|Randomized|||Treatment||None (Open Label)||||||
1462644|NCT01473290|Randomized|Parallel Assignment||Supportive Care||Double||||||
1462645|NCT01473277|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1462646|NCT01473264|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1462647|NCT01473251|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462648|NCT01473238|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1462649|NCT01473225|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1462650|NCT01473199||Single Group Assignment||Treatment||None (Open Label)||||||
1462651|NCT01473186|||Cohort||Prospective|||||||
1462652|NCT01473173|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1462653|NCT01473160|Randomized|Single Group Assignment||Treatment||Single|||||t|
1462654|NCT01473147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462655|NCT01473134||||||||||||
1462656|NCT01473121|||Other||Prospective|||||||
1462657|NCT01473108|Randomized|Crossover Assignment||||Single|||t|||
1462658|NCT01473095||Single Group Assignment||Treatment||None (Open Label)||||||
1462659|NCT01473082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462660|NCT01473069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462661|NCT01473056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462662|NCT01473043||||||||||||
1462663|NCT01473030|||Case-Control||Cross-Sectional|||||||
1462664|NCT01473017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462665|NCT01473004||Single Group Assignment||Treatment||None (Open Label)||||||
1462666|NCT01472991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462667|NCT01472978|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1462668|NCT01472965|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462669|NCT01472952|||Cohort||Prospective|||||||
1462670|NCT01472939|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462671|NCT01472926|Randomized|Parallel Assignment||Treatment||Single||||||t
1462672|NCT01472913|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462673|NCT01472900|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1462674|NCT01472887||Single Group Assignment||Treatment||None (Open Label)||||||
1462675|NCT01472874||Single Group Assignment||Treatment||None (Open Label)||||||
1462676|NCT01472861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462677|NCT01472848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462678|NCT01472835|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1462679|NCT01472822|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1462680|NCT01472809|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462681|NCT01472796|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462682|NCT01472783||Single Group Assignment||Treatment||None (Open Label)||||||
1462683|NCT01472770||Single Group Assignment||Treatment||None (Open Label)||||||
1462684|NCT01472757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462685|NCT01472744|Randomized|Parallel Assignment||Treatment||Single||||||t
1462686|NCT01472731||Single Group Assignment||Treatment||None (Open Label)||||||
1462687|NCT01472718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462688|NCT01472705|||Cohort||Prospective|||||||
1462689|NCT01472692|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462690|NCT01472679|||Cohort||Retrospective|||||||
1462691|NCT01472666|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1462692|NCT01472653||Single Group Assignment||Treatment||None (Open Label)||||||
1462693|NCT01472640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462694|NCT01472627|||Case-Only||Prospective|||||||
1462695|NCT01472614||Single Group Assignment||Treatment||None (Open Label)||||||
1462696|NCT01472601|||Cohort||Prospective|||||||
1462697|NCT01472588|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462698|NCT01472575|||Case-Only||Retrospective|||||||
1462699|NCT01472562||Single Group Assignment||Treatment||None (Open Label)||||||
1462700|NCT01472549|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462701|NCT01472536|Randomized|Factorial Assignment||Prevention||Single||||||t
1462702|NCT01472523|||Other||Other|||||||
1462703|NCT01472510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462704|NCT01472497||Single Group Assignment||Treatment||Double|||t||t|
1462705|NCT01472484|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1462706|NCT01472471|||||Prospective|||||||
1462707|NCT01472458|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1462708|NCT01472445|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1462709|NCT01472432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462710|NCT01472419|||||Retrospective|||||||
1462711|NCT01472406||Single Group Assignment||Treatment||None (Open Label)||||||
1462712|NCT01472393|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462713|NCT01472380|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1462714|NCT01472367|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462715|NCT01472354|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462716|NCT01472341|||Cohort||Prospective|||||||
1462717|NCT01472328|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1462718|NCT01472315|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462719|NCT01472302|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462720|NCT01472289||Single Group Assignment||Treatment||None (Open Label)||||||
1462721|NCT01472276|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462722|NCT01472263|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1462723|NCT01472250|||Cohort||Prospective|||||||
1462724|NCT01472237|Randomized|Parallel Assignment||Prevention||Single|||||t|
1462725|NCT01472224|||||Prospective|||||||
1462726|NCT01472211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462727|NCT01472198|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462728|NCT01472185|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462729|NCT01472172||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462730|NCT01472159|Randomized|Parallel Assignment||Treatment||Single|||||t|
1462731|NCT01472146||Single Group Assignment||Treatment||None (Open Label)||||||
1462732|NCT01472133|||Cohort||Prospective|||||||
1462733|NCT01472120|||Case Control||Prospective|||||||
1462734|NCT01472107|||Case-Only||Retrospective|||||||
1462735|NCT01472094|||Cohort||Prospective|||||||
1462736|NCT01472081|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462737|NCT01472068||Single Group Assignment||Treatment||None (Open Label)||||||
1462738|NCT01472055||Single Group Assignment||Treatment||None (Open Label)||||||
1462739|NCT01472042|||Cohort||Prospective|||||||
1462740|NCT01472029||Single Group Assignment||Treatment||None (Open Label)||||||
1462741|NCT01472016|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462742|NCT01472003|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1462743|NCT01471990|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1462744|NCT01471977|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1462745|NCT01471964||Single Group Assignment||Treatment||None (Open Label)||||||
1462746|NCT01471951||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462747|NCT01471938|||Case-Only||Cross-Sectional|||||||
1462748|NCT01471925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462749|NCT01471912||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462750|NCT01471899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462751|NCT01471886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462752|NCT01471873|||Case Control||Prospective|||||||
1462753|NCT01471860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462754|NCT01471847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462755|NCT01471834||Single Group Assignment||Treatment||None (Open Label)||||||
1462756|NCT01471821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462757|NCT01471808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462758|NCT01471795|||Cohort||Prospective|||||||
1462759|NCT01471782||Single Group Assignment||Treatment||None (Open Label)||||||
1462760|NCT01471769|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1462761|NCT01471756|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1462762|NCT01471743|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462763|NCT01471730|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462764|NCT01471717|Randomized|Factorial Assignment||Health Services Research||Quadruple|||t|t|t|t
1462765|NCT01471704|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1462766|NCT01471691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462767|NCT01471678|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462768|NCT01471665|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1462769|NCT01471587|||Cohort||Prospective|||||||
1462770|NCT01471561|||Cohort||Retrospective|||||||
1462771|NCT01471548||Single Group Assignment||Treatment||None (Open Label)||||||
1462772|NCT01471431|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462773|NCT01471418|Non-Randomized|Parallel Assignment||Diagnostic||Double||||t|t|
1462774|NCT01471379|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462775|NCT01471366|Randomized|Parallel Assignment||||Single||||||t
1462776|NCT01471353||Single Group Assignment||Treatment||None (Open Label)||||||
1462777|NCT01471340|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462778|NCT01471652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462779|NCT01471639||Single Group Assignment||Treatment||None (Open Label)||||||
1462780|NCT01471626||Single Group Assignment||Diagnostic||None (Open Label)||||||
1462781|NCT01471613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462782|NCT01471600|Randomized|Parallel Assignment||||None (Open Label)||||||
1462783|NCT01471574||Single Group Assignment||Treatment||None (Open Label)||||||
1462784|NCT01471535||Single Group Assignment||Treatment||None (Open Label)||||||
1462785|NCT01471522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462786|NCT01471509|Randomized|Crossover Assignment||Other||Single|||t|||
1462787|NCT01471496|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462788|NCT01471483|||Cohort||Prospective|||||||
1462789|NCT01471470||Single Group Assignment||Treatment||None (Open Label)||||||
1462790|NCT01471457|Randomized|Parallel Assignment||Prevention||Single||||||t
1462791|NCT01471444|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462792|NCT01471405|||Cohort||Retrospective|||||||
1462793|NCT01471392||Single Group Assignment||Diagnostic||Single|||||t|
1462794|NCT01471327|Randomized|Parallel Assignment||Other||Single|||t|||
1462795|NCT01471314|||Case-Only||Cross-Sectional|||||||
1462796|NCT01471301|||Case Control||Cross-Sectional|||||||
1462797|NCT01471288|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1462798|NCT01471275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462799|NCT01471262|||Case Control||Retrospective|||||||
1462800|NCT01471249|||Other||Prospective|||||||
1462801|NCT01471236||Single Group Assignment||Treatment||None (Open Label)||||||
1462802|NCT01471223|||Cohort||Other|||||||
1462803|NCT01471210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462804|NCT01471197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462805|NCT01471184|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1462806|NCT01471171|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1462807|NCT01471158|Randomized|Crossover Assignment||Treatment||Single|||t|||
1462808|NCT01471145||Single Group Assignment||Basic Science||None (Open Label)||||||
1462809|NCT01471132||Single Group Assignment||Treatment||None (Open Label)||||||
1462810|NCT01471119|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462811|NCT01471106|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462812|NCT01471093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462813|NCT01471080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462814|NCT01471067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462815|NCT01471054|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462816|NCT01471041||Single Group Assignment||Treatment||None (Open Label)||||||
1462817|NCT01471028|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462818|NCT01471015|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462819|NCT01471002||Single Group Assignment||Treatment||None (Open Label)||||||
1462820|NCT01470989||Single Group Assignment||Treatment||None (Open Label)||||||
1462821|NCT01470976|Randomized|Single Group Assignment||Supportive Care||Double|||t|||t
1462822|NCT01470963|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462823|NCT01470950||Single Group Assignment||Basic Science||None (Open Label)||||||
1462824|NCT01470937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462825|NCT01470924|||Cohort||Prospective|||||||
1462826|NCT01470911|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462827|NCT01470898|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1462828|NCT01470885|||Cohort||Prospective|||||||
1462829|NCT01470859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462830|NCT01470846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462831|NCT01470833|Randomized|Parallel Assignment||Treatment||Single||||||t
1462832|NCT01470820|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1462833|NCT01470807||Single Group Assignment||Treatment||None (Open Label)||||||
1462834|NCT01470794||Single Group Assignment||Treatment||None (Open Label)||||||
1462835|NCT01470781|Randomized|Parallel Assignment||Treatment||Triple|assessment staff, investigator, and participants blind to group membership.||t||t|t
1462836|NCT01470768|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1462837|NCT01470755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462838|NCT01470742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462839|NCT01470729|||||Prospective|||||||
1462840|NCT01470716||Single Group Assignment||Treatment||None (Open Label)||||||
1462841|NCT01470703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462842|NCT01470690|Randomized|Crossover Assignment||||None (Open Label)||||||
1462843|NCT01470677|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1462844|NCT01470664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462845|NCT01470651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462846|NCT01470638|||Case-Only||Cross-Sectional|||||||
1462847|NCT01470625||Single Group Assignment||||None (Open Label)||||||
1462848|NCT01470612|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462849|NCT01470599|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462850|NCT01470586|Randomized|Factorial Assignment||||Triple|||t|t|t|
1462851|NCT01470573||Single Group Assignment||Treatment||None (Open Label)||||||
1462852|NCT01470560|Randomized|Parallel Assignment||Treatment||Single||||||t
1462853|NCT01470547|||Cohort||Prospective|||||||
1462854|NCT01470534|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1462855|NCT01470521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462856|NCT01470508|Randomized|Parallel Assignment||Treatment||Single||||||t
1462857|NCT01470495|Non-Randomized|Parallel Assignment||Other||Double||||t||t
1462858|NCT01470482|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462859|NCT01470469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462860|NCT01470456||Single Group Assignment||Treatment||None (Open Label)||||||
1462861|NCT01470443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462862|NCT01470430|||Case Control||Prospective|||||||
1462863|NCT01470417|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462864|NCT01470404|||Cohort||Prospective|||||||
1462865|NCT01470391|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462866|NCT01470378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462867|NCT01470365||Single Group Assignment||Treatment||None (Open Label)||||||
1462868|NCT01470352|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462869|NCT01470339|Randomized|Parallel Assignment||||Double|||||t|t
1462870|NCT01470326|||Case-Only||Prospective|||||||
1462871|NCT01470313|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1462872|NCT01470300|Randomized|Crossover Assignment||Prevention||Single|||t|||
1462873|NCT01470287||Single Group Assignment||Prevention||None (Open Label)||||||
1462874|NCT01470274|||Cohort||Prospective|||||||
1462875|NCT01470261|||Cohort||Prospective|||||||
1462876|NCT01470248||Single Group Assignment||Treatment||None (Open Label)||||||
1462877|NCT01470235|||Case Control||Retrospective|||||||
1462878|NCT01470222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462879|NCT01470209||Single Group Assignment||Treatment||None (Open Label)||||||
1462880|NCT01470196||Single Group Assignment||Treatment||None (Open Label)||||||
1462881|NCT01470183|||Case Control||Prospective|||||||
1462882|NCT01470170|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1462883|NCT01470157|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462884|NCT01470144||Single Group Assignment||Treatment||None (Open Label)||||||
1462885|NCT01470131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462886|NCT01470118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462887|NCT01470105|||Cohort||Prospective|||||||
1462888|NCT01470092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462889|NCT01470079||||||||||||
1462890|NCT01470066|||Cohort||Prospective|||||||
1462891|NCT01470053|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1462892|NCT01470040|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1462893|NCT01470027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462894|NCT01470014|||Cohort||Prospective|||||||
1462895|NCT01470001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462896|NCT01469988|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1462897|NCT01469975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462898|NCT01469962|||Cohort||Prospective|||||||
1462899|NCT01469949|||Case Control||Prospective|||||||
1462900|NCT01469936|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1462901|NCT01469923|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1462902|NCT01469910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462903|NCT01469897|||Cohort||Cross-Sectional|||||||
1462904|NCT01469884|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1462905|NCT01469871|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462906|NCT01469858||Single Group Assignment||Basic Science||None (Open Label)||||||
1462907|NCT01469845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462908|NCT01469832||Single Group Assignment||Treatment||None (Open Label)||||||
1462909|NCT01469819||Single Group Assignment||Treatment||None (Open Label)||||||
1462910|NCT01469806|||Case-Only||Prospective|||||||
1462911|NCT01469793|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462912|NCT01469780|||Cohort||Retrospective|||||||
1462913|NCT01469767||Single Group Assignment||Treatment||None (Open Label)||||||
1462914|NCT01469754|||Cohort||Prospective|||||||
1462915|NCT01469741||Single Group Assignment||Supportive Care||Single|||t|||
1462916|NCT01469728|Randomized|Parallel Assignment||Treatment||Single|||t|||
1462917|NCT01469715||Single Group Assignment||Supportive Care||None (Open Label)||||||
1462918|NCT01469702|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462919|NCT01469689|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1462920|NCT01469676|Randomized|Single Group Assignment||Prevention||Single|||t|||
1462921|NCT01469663|||||Cross-Sectional|||||||
1462922|NCT01469650|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1462923|NCT01469637|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462924|NCT01469624|Randomized|Parallel Assignment||Prevention||Double||||t||t
1462925|NCT01469611||Single Group Assignment||Treatment||None (Open Label)||||||
1462926|NCT01469598||Single Group Assignment||Treatment||None (Open Label)||||||
1462927|NCT01469585|Randomized|Parallel Assignment||Treatment||Single||||||t
1462928|NCT01469572||Single Group Assignment||Treatment||None (Open Label)||||||
1462929|NCT01469559|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1462930|NCT01469546||Single Group Assignment||Treatment||None (Open Label)||||||
1462931|NCT01469533|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1462932|NCT01469520|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1462933|NCT01469507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462934|NCT01469494|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1462935|NCT01469481||Single Group Assignment||Basic Science||None (Open Label)||||||
1462936|NCT01469468||Single Group Assignment||Basic Science||None (Open Label)||||||
1462937|NCT01469455||Single Group Assignment||Treatment||None (Open Label)||||||
1462938|NCT01469442|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462939|NCT01469429|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462940|NCT01469416|Randomized|Crossover Assignment||||None (Open Label)||||||
1462941|NCT01469403|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1462942|NCT01469377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462943|NCT01469364||Single Group Assignment||Treatment||None (Open Label)||||||
1462944|NCT01469351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462945|NCT01469338||Single Group Assignment||Supportive Care||None (Open Label)||||||
1462946|NCT01469325|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1462947|NCT01469312|Randomized|Crossover Assignment||||Single|||t|||
1462948|NCT01469299|||Cohort||Prospective|||||||
1462949|NCT01469286|Randomized|Crossover Assignment||Treatment||Single|||t|||
1462950|NCT01469273|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462951|NCT01469260|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462952|NCT01469247||Single Group Assignment||Treatment||None (Open Label)||||||
1462953|NCT01469234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462954|NCT01469221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462955|NCT01469208|||Cohort||Prospective|||||||
1462956|NCT01469195|||Case Control||Prospective|||||||
1462957|NCT01469182|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462958|NCT01469169||Single Group Assignment||Treatment||None (Open Label)||||||
1462959|NCT01469156|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1462960|NCT01469143|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1462961|NCT01469130||Single Group Assignment||Treatment||None (Open Label)||||||
1462962|NCT01469117|||Case-Only||Prospective|||||||
1462963|NCT01469104|Randomized|Crossover Assignment||||None (Open Label)||||||
1462964|NCT01469091|Randomized|Parallel Assignment||Prevention||Single|||||t|
1462965|NCT01469078|Randomized|Parallel Assignment||||None (Open Label)||||||
1462966|NCT01469065|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1462967|NCT01469052|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462968|NCT01469039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462969|NCT01469026|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1462970|NCT01469013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462971|NCT01469000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462972|NCT01468987|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1462973|NCT01468974||Single Group Assignment||Treatment||None (Open Label)||||||
1462974|NCT01468961||Single Group Assignment||Treatment||None (Open Label)||||||
1462975|NCT01468948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462976|NCT01468935|||Cohort||Prospective|||||||
1462977|NCT01468922||Single Group Assignment||Treatment||None (Open Label)||||||
1462978|NCT01468909|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462979|NCT01468896||Single Group Assignment||Treatment||None (Open Label)||||||
1462980|NCT01468883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462981|NCT01468857|||Cohort||Prospective|||||||
1462982|NCT01468844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1462983|NCT01468831||Parallel Assignment||Treatment||Double|||t||t|
1462984|NCT01468818||Single Group Assignment||Treatment||None (Open Label)||||||
1462985|NCT01468805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1462986|NCT01468792|||Cohort||Prospective|||||||
1462987|NCT01468779|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462988|NCT01468766|Randomized|Parallel Assignment||Treatment||Single||||||t
1462989|NCT01468753||Single Group Assignment||Prevention||None (Open Label)||||||
1462990|NCT01468740||Single Group Assignment||Treatment||None (Open Label)||||||
1462991|NCT01468727|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1462992|NCT01468714||Single Group Assignment||Basic Science||None (Open Label)||||||
1462993|NCT01468701|||Cohort||Prospective|||||||
1462994|NCT01468688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1462995|NCT01468675|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1462996|NCT01468662|||Case-Only||Prospective|||||||
1462997|NCT01468649||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1462998|NCT01468636|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1462999|NCT01468623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463000|NCT01468610||Single Group Assignment||Treatment||None (Open Label)||||||
1463001|NCT01468597|||Cohort||Prospective|||||||
1463002|NCT01468584||Single Group Assignment||Treatment||None (Open Label)||||||
1463003|NCT01468571|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1463004|NCT01468558|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463005|NCT01468545|||Case Control||Prospective|||||||
1463006|NCT01468532||Single Group Assignment||Treatment||None (Open Label)||||||
1463007|NCT01468519|Randomized|Parallel Assignment||Treatment||Single||||||t
1463008|NCT01468506|||Cohort||Prospective|||||||
1463009|NCT01468493|||Cohort||Prospective|||||||
1463010|NCT01468480|Randomized|Parallel Assignment||Treatment||Single||||||t
1463011|NCT01468467||Single Group Assignment||Treatment||None (Open Label)||||||
1463012|NCT01468454||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463013|NCT01468441|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463014|NCT01468428|||Case Control||Prospective|||||||
1463015|NCT01468415|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463016|NCT01468402|||Cohort||Prospective|||||||
1463017|NCT01468389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463018|NCT01468376|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463019|NCT01468363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463020|NCT01468350|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1463021|NCT01468337||Single Group Assignment||Treatment||None (Open Label)||||||
1463022|NCT01468324|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463023|NCT01468311||Single Group Assignment||Treatment||None (Open Label)||||||
1463024|NCT01468298|Randomized|Parallel Assignment||Treatment||Single||||||t
1463025|NCT01468285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463026|NCT01468272|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463027|NCT01468259|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463028|NCT01468246|||Cohort||Prospective|||||||
1463029|NCT01468233|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463030|NCT01468220|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1463031|NCT01468207|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463032|NCT01468194|Non-Randomized|Single Group Assignment||Prevention||Single||||||t
1463033|NCT01468181|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463034|NCT01468168|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463035|NCT01468155||Single Group Assignment||Treatment||None (Open Label)||||||
1463036|NCT01468142|||Cohort||Prospective|||||||
1463037|NCT01468129||||||||||||
1463038|NCT01468116|||Case Control||Prospective|||||||
1463039|NCT01468103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463040|NCT01468090|||Cohort||Prospective|||||||
1463041|NCT01468077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463042|NCT01468064|Randomized|Parallel Assignment||Treatment||Single||||||t
1463043|NCT01468051|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463044|NCT01468038|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463045|NCT01468025|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1463046|NCT01468012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463047|NCT01467999||Single Group Assignment||Treatment||None (Open Label)||||||
1463048|NCT01467986|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1463049|NCT01467973|||Cohort||Prospective|||||||
1463050|NCT01467960|||Cohort|||||||||
1463051|NCT01467947||Single Group Assignment||Treatment||None (Open Label)||||||
1463052|NCT01467934|||||Prospective|||||||
1463053|NCT01467921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463054|NCT01467908||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463055|NCT01467882||Single Group Assignment||Treatment||None (Open Label)||||||
1463056|NCT01467869|||Case-Control||Prospective|||||||
1463057|NCT01467856|||Case-Only||Prospective|||||||
1463058|NCT01467843|Randomized|Parallel Assignment||Treatment||Single||||||t
1463059|NCT01467830|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463060|NCT01467817|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1463061|NCT01467804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463062|NCT01467791|||Case-Only||Prospective|||||||
1463063|NCT01467778|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1463064|NCT01467765|Randomized|Crossover Assignment||Treatment||Single||||||t
1463065|NCT01467752||Single Group Assignment||Treatment||Single|||t|||
1463066|NCT01467739|Randomized|Parallel Assignment||||None (Open Label)||||||
1463067|NCT01467726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463068|NCT01467713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463069|NCT01467700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463070|NCT01467687|Randomized|Crossover Assignment||||None (Open Label)||||||
1463071|NCT01467674|||Case Control||Cross-Sectional|||||||
1463072|NCT01467661||Single Group Assignment||Treatment||None (Open Label)||||||
1463073|NCT01467648|Randomized|Parallel Assignment||||None (Open Label)||||||
1463074|NCT01467635|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1463075|NCT01467622|||Cohort||Prospective|||||||
1463076|NCT01467609|||Cohort||Prospective|||||||
1463077|NCT01467596|Non-Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463078|NCT01467583|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1463079|NCT01467570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463080|NCT01467557|||Cohort||Prospective|||||||
1463081|NCT01467544|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463082|NCT01467531|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1463083|NCT01467518|Randomized|Single Group Assignment||||None (Open Label)||||||
1463084|NCT01467505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463085|NCT01467492|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463086|NCT01467479|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463087|NCT01467466|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1463088|NCT01467453|||Case-Only||Prospective|||||||
1463089|NCT01467440|||Case Control||Retrospective|||||||
1463090|NCT01467427||Single Group Assignment||Treatment||None (Open Label)||||||
1463091|NCT01467414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463092|NCT01467401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463093|NCT01467388|||Case Control||Retrospective|||||||
1463094|NCT01467375|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463095|NCT01467362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463096|NCT01467349|||Case Control||Retrospective|||||||
1463633|NCT01460316|||Cohort||Prospective|||||||
1463097|NCT01467336|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463098|NCT01467323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463099|NCT01467310||Single Group Assignment||Basic Science||None (Open Label)||||||
1463100|NCT01467297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463101|NCT01467284|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463102|NCT01467271|||Cohort||Prospective|||||||
1463103|NCT01467258||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463104|NCT01467245|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463105|NCT01467232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463106|NCT01467219||Single Group Assignment||||None (Open Label)||||||
1463107|NCT01467206|Randomized|Parallel Assignment||Treatment||Single||||||t
1463108|NCT01467193|||Cohort||Prospective|||||||
1463109|NCT01467180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463110|NCT01467167|||Case-Control||Prospective|||||||
1463111|NCT01467154|||Case Control||Prospective|||||||
1463112|NCT01467141|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463113|NCT01467128|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463114|NCT01467115||Single Group Assignment||Treatment||None (Open Label)||||||
1463115|NCT01467102|||Cohort||Prospective|||||||
1463116|NCT01467089|||Case-Only||Cross-Sectional|||||||
1463117|NCT01467076|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1463118|NCT01467063|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1463119|NCT01467050|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463120|NCT01467037|||Case Control||Prospective|||||||
1463121|NCT01467024|||Cohort||Retrospective|||||||
1463122|NCT01467011|||Case-Only||Prospective|||||||
1463123|NCT01466998|Randomized|Parallel Assignment||Treatment||Single||||||t
1463124|NCT01466985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463125|NCT01466972||Single Group Assignment||Treatment||None (Open Label)||||||
1463126|NCT01466959|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1463127|NCT01466946|||Case-Only||Prospective|||||||
1463128|NCT01466933|Randomized|Parallel Assignment||Prevention||Single||||||t
1463129|NCT01466920|||Cohort||Prospective|||||||
1463130|NCT01466907|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463131|NCT01466894|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1463132|NCT01466881||Single Group Assignment||Treatment||None (Open Label)||||||
1463133|NCT01466868||Single Group Assignment||Treatment||None (Open Label)||||||
1463134|NCT01466855||Single Group Assignment||Treatment||None (Open Label)||||||
1463135|NCT01466842|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463136|NCT01466829|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1463137|NCT01466816|Randomized|Crossover Assignment||Prevention||Single|||t|||
1463138|NCT01466803|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1463139|NCT01466790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463140|NCT01466777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463141|NCT01466764|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463142|NCT01466751|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1463143|NCT01466738|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1463144|NCT01466725|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463145|NCT01466712|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1463146|NCT01466699|||Cohort||Cross-Sectional|||||||
1463147|NCT01466686||Single Group Assignment||Treatment||None (Open Label)||||||
1463148|NCT01466673|Randomized|Parallel Assignment||Treatment||Single|||||t|
1463149|NCT01466660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463150|NCT01466647||Single Group Assignment||Treatment||None (Open Label)||||||
1463151|NCT01466634|||||Retrospective|||||||
1463152|NCT01466621|||||Retrospective|||||||
1463153|NCT01466608||Single Group Assignment||Treatment||None (Open Label)||||||
1463154|NCT01466595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463155|NCT01466582|||Cohort||Prospective|||||||
1463156|NCT01466569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463157|NCT01466556|||Ecologic or Community||Prospective|||||||
1463158|NCT01466543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463159|NCT01466530|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1463160|NCT01466517|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1463161|NCT01466504|||Cohort||Prospective|||||||
1463162|NCT01466491|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463163|NCT01466478||Single Group Assignment||||Single|||||t|
1463164|NCT01466465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463165|NCT01466452|Randomized|Parallel Assignment||||None (Open Label)||||||
1463166|NCT01466439|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1463167|NCT01466426|||Case Control||Prospective|||||||
1463168|NCT01466413||Single Group Assignment||Basic Science||Single|||t|||
1463169|NCT01466400|||||Prospective|||||||
1463170|NCT01466387|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463171|NCT01466374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463172|NCT01466361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463173|NCT01466348|Randomized|Crossover Assignment||Treatment||Single|||||t|
1463174|NCT01466335|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1463175|NCT01466322|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463176|NCT01466309|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463177|NCT01466296|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1463178|NCT01466283|||Case Control||Retrospective|||||||
1463179|NCT01466270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463180|NCT01466257|||Other||Retrospective|||||||
1463181|NCT01466244|||Other||Retrospective|||||||
1463182|NCT01466231||Single Group Assignment||Treatment||None (Open Label)||||||
1463183|NCT01466218|||Case-Only||Cross-Sectional|||||||
1463184|NCT01466205|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1463185|NCT01466192||Single Group Assignment||Treatment||None (Open Label)||||||
1463186|NCT01466179||Single Group Assignment||Treatment||None (Open Label)||||||
1463187|NCT01466166|||Case-Only||Prospective|||||||
1463188|NCT01466153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463189|NCT01466140|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1463190|NCT01466127|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1463191|NCT01466114|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463192|NCT01466101|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1463193|NCT01466088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463194|NCT01466075||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463195|NCT01466062|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1463196|NCT01466049|||Cohort||Prospective|||||||
1463197|NCT01466036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463198|NCT01466023|||Case-Control||Prospective|||||||
1463199|NCT01466010|||Cohort||Retrospective|||||||
1463200|NCT01465997|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1463201|NCT01465984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463202|NCT01465971|||Cohort||Prospective|||||||
1463203|NCT01465958|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463204|NCT01465945|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463205|NCT01465932|Randomized|Parallel Assignment||Treatment||Single||||||t
1463206|NCT01465919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463207|NCT01465906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463208|NCT01465893|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463209|NCT01465880|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1463210|NCT01465867|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1463211|NCT01465854|||Case-Only||Prospective|||||||
1463212|NCT01465841||Single Group Assignment||Treatment||None (Open Label)||||||
1463213|NCT01465828|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463214|NCT01465815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463215|NCT01465802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463216|NCT01465789|||Cohort||Prospective|||||||
1463217|NCT01465776||Single Group Assignment||Treatment||None (Open Label)||||||
1463218|NCT01465763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463219|NCT01465750|||Case-Only||Retrospective|||||||
1463220|NCT01465737|||Case-Only||Retrospective|||||||
1463221|NCT01465724||Single Group Assignment||Treatment||None (Open Label)||||||
1463222|NCT01465711|||Case Control||Prospective|||||||
1463223|NCT01465698|Randomized|Factorial Assignment||Treatment||Single||||||t
1463224|NCT01465685||Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1463225|NCT01465672|||Cohort||Prospective|||||||
1463226|NCT01465659|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463227|NCT01465646|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1463228|NCT01465633|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1463229|NCT01465620|Randomized|Parallel Assignment||Treatment||Single||||||t
1463230|NCT01465607|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1463231|NCT01465594|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1463232|NCT01465581|||Cohort||Prospective|||||||
1463233|NCT01465568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463234|NCT01465555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463235|NCT01465542|||Case-Only||Retrospective|||||||
1463236|NCT01465529|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1463237|NCT01465516|||Cohort||Prospective|||||||
1463238|NCT01465503|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1463239|NCT01465490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463240|NCT01465477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463241|NCT01465464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463242|NCT01465451|Randomized|Parallel Assignment||Treatment||Single||||||t
1463243|NCT01465438||Single Group Assignment||Treatment||None (Open Label)||||||
1463244|NCT01465425|||Case-Control||Retrospective|||||||
1463245|NCT01465412|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463246|NCT01465399|Randomized|Parallel Assignment||Treatment||||||||
1463247|NCT01465386||Single Group Assignment||Treatment||None (Open Label)||||||
1463248|NCT01465373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463249|NCT01465360|||Case-Only||Cross-Sectional|||||||
1463250|NCT01465347||Single Group Assignment||Treatment||None (Open Label)||||||
1463251|NCT01465334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463252|NCT01465308|Randomized|Parallel Assignment||Treatment||Single|||||t|
1463253|NCT01465295||Single Group Assignment||Treatment||None (Open Label)||||||
1463254|NCT01465282|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1463255|NCT01465269|Randomized|Parallel Assignment||Treatment||Single||||||t
1463256|NCT01465256|Randomized|Crossover Assignment||||Single|||||t|
1463257|NCT01465243||Single Group Assignment||Treatment||None (Open Label)||||||
1463258|NCT01465230||Single Group Assignment||Treatment||None (Open Label)||||||
1463259|NCT01465217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463260|NCT01465204|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463261|NCT01465191|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1463262|NCT01465178|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1463263|NCT01465165|||Case-Control||Cross-Sectional|||||||
1463264|NCT01465152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463265|NCT01465139|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1463266|NCT01465126|||Case-Only||Retrospective|||||||
1463267|NCT01465113|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463268|NCT01465100||Single Group Assignment||Treatment||None (Open Label)||||||
1463269|NCT01465087||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463270|NCT01465074|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1463271|NCT01465061|||Ecologic or Community||Cross-Sectional|||||||
1463272|NCT01465048|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1463273|NCT01465035|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463274|NCT01465022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463275|NCT01465009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463276|NCT01464996|Randomized|Parallel Assignment||||Single|||t|||
1463277|NCT01464983|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463278|NCT01464970|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1463279|NCT01464957|Randomized|Parallel Assignment||Prevention||Single||||||t
1463280|NCT01464944|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463281|NCT01464931||Single Group Assignment||Treatment||None (Open Label)||||||
1463282|NCT01464918||Single Group Assignment||Treatment||None (Open Label)||||||
1463283|NCT01464905|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463284|NCT01464892|Randomized|Factorial Assignment||Treatment||Single||||||t
1463285|NCT01464879|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463286|NCT01464866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463287|NCT01464853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463288|NCT01464840|||Cohort||Prospective|||||||
1463289|NCT01464827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463290|NCT01464814|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1463291|NCT01464801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463292|NCT01464788|Randomized|Parallel Assignment||Treatment||Single||||||t
1463293|NCT01464775|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1463294|NCT01464762||||||||||||
1463295|NCT01464749|Randomized|Parallel Assignment||Treatment||Single||||||t
1463296|NCT01464736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463297|NCT01464723||Single Group Assignment||Treatment||None (Open Label)||||||
1463298|NCT01464710|||Cohort||Prospective|||||||
1463299|NCT01464697|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1463300|NCT01464684|||Cohort||Prospective|||||||
1463301|NCT01464671|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463302|NCT01464658||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463303|NCT01464645|||Cohort||Prospective|||||||
1463304|NCT01464632|||Cohort||Prospective|||||||
1463305|NCT01464619|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463306|NCT01464606|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463307|NCT01464593||Single Group Assignment||Treatment||None (Open Label)||||||
1463308|NCT01464580||||||||||||
1463309|NCT01464567|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463310|NCT01464554|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463311|NCT01464541||Single Group Assignment||||None (Open Label)||||||
1463312|NCT01464528|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463313|NCT01464515|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1463314|NCT01464502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463315|NCT01464489|Randomized|Parallel Assignment||||Single|||||t|
1463316|NCT01464476|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463317|NCT01464463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463318|NCT01464450|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463319|NCT01464437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463320|NCT01464424|Randomized|Crossover Assignment||Treatment||Single||||||t
1463321|NCT01464411|||Cohort||Prospective|||||||
1463322|NCT01464398|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1463323|NCT01464385|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1463324|NCT01464372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463325|NCT01464359||Single Group Assignment||Treatment||None (Open Label)||||||
1463326|NCT01464346|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1463327|NCT01464333|||Cohort||Prospective|||||||
1463328|NCT01464320|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1463329|NCT01464307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463330|NCT01464294|||Case Control||Prospective|||||||
1463331|NCT01464281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463332|NCT01464268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463333|NCT01464255|Randomized|Crossover Assignment||||Single|||t|||
1463334|NCT01464242|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1463335|NCT01464229|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1463336|NCT01464216|||Cohort||Prospective|||||||
1463337|NCT01464203|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1463338|NCT01464190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463339|NCT01464177|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463340|NCT01464164|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463341|NCT01464151|||Cohort||Prospective|||||||
1463342|NCT01464138||Single Group Assignment||Treatment||None (Open Label)||||||
1463343|NCT01464125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463344|NCT01464112|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463345|NCT01464099|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1463346|NCT01464086|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1463347|NCT01464073|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463348|NCT01464060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463349|NCT01464047|||Case-Only||Prospective|||||||
1463350|NCT01464034||Single Group Assignment||Treatment||None (Open Label)||||||
1463351|NCT01464021|||Cohort||Prospective|||||||
1463352|NCT01464008|||Case-Only||Retrospective|||||||
1463353|NCT01463995|||Cohort||Prospective|||||||
1463354|NCT01463982||Single Group Assignment||Treatment||None (Open Label)||||||
1463355|NCT01463969|||Case Control||Cross-Sectional|||||||
1463356|NCT01463956||Single Group Assignment||Treatment||None (Open Label)||||||
1463357|NCT01463943|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463358|NCT01463930|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463359|NCT01463917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463360|NCT01463904|||Cohort||Prospective|||||||
1463361|NCT01463891|||Cohort||Prospective|||||||
1463362|NCT01463878|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1463363|NCT01463865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463364|NCT01463852||Single Group Assignment||Basic Science||None (Open Label)||||||
1463365|NCT01463839|||||Cross-Sectional|||||||
1463366|NCT01463826|||||Cross-Sectional|||||||
1463367|NCT01463813|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1463368|NCT01463800|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463369|NCT01463787|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463370|NCT01463774|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463371|NCT01463761|||Cohort||Prospective|||||||
1463372|NCT01463748|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463373|NCT01463735||Single Group Assignment||Treatment||None (Open Label)||||||
1463374|NCT01463722||Single Group Assignment||Diagnostic||Single||||||t
1463375|NCT01463709||Single Group Assignment||Treatment||None (Open Label)||||||
1463376|NCT01463696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463377|NCT01463683|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1463378|NCT01463670||Single Group Assignment||Treatment||None (Open Label)||||||
1463379|NCT01463657|Randomized|Single Group Assignment||Treatment||Single|||t|||
1463380|NCT01463644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463381|NCT01463631||Single Group Assignment||Treatment||None (Open Label)||||||
1463382|NCT01463618||||||||||||
1463383|NCT01463605||Single Group Assignment||Treatment||None (Open Label)||||||
1463384|NCT01463592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463385|NCT01463579|Randomized|Parallel Assignment||Treatment||Single||||||t
1463386|NCT01463566|||Case-Only||Prospective|||||||
1463387|NCT01463553|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463388|NCT01463540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463389|NCT01463527|Randomized|Single Group Assignment||Prevention||Single|||||t|
1463390|NCT01463514|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1463391|NCT01463501|Randomized|Parallel Assignment||Treatment||Single||||||t
1463392|NCT01463488|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463393|NCT01463475||Single Group Assignment||||None (Open Label)||||||
1463394|NCT01463462|||Case-Only||Prospective|||||||
1463395|NCT01463449|||Case Control||Prospective|||||||
1463396|NCT01463436|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1463397|NCT01463423||Single Group Assignment||Treatment||None (Open Label)||||||
1463398|NCT01463410|||Case-Only|||||||||
1463399|NCT01463397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463400|NCT01463384||Single Group Assignment||Treatment||None (Open Label)||||||
1463401|NCT01463371|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1463402|NCT01463358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463403|NCT01463345|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463404|NCT01463332|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1463405|NCT01463319|Randomized|Parallel Assignment||||Single|||||t|
1463406|NCT01463306||||Treatment||None (Open Label)||||||
1463407|NCT01463293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463408|NCT01463280|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1463409|NCT01463267|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1463410|NCT01463254|||||Prospective|||||||
1463411|NCT01463241||Single Group Assignment||Treatment||None (Open Label)||||||
1463412|NCT01463228|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463413|NCT01463215||Single Group Assignment||Treatment||None (Open Label)||||||
1463414|NCT01463202|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463415|NCT01463189|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463416|NCT01463176|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463417|NCT01463163|Randomized|Parallel Assignment||Treatment||Single||||||t
1463418|NCT01463150|Randomized|Crossover Assignment||Treatment||Single||||||t
1463419|NCT01463137|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463420|NCT01463124|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463421|NCT01463111||Single Group Assignment||Other||None (Open Label)||||||
1463422|NCT01463098|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463423|NCT01463085|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1463424|NCT01463072||Single Group Assignment||Treatment||None (Open Label)||||||
1463425|NCT01463059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463426|NCT01463046||Single Group Assignment||Treatment||None (Open Label)||||||
1463427|NCT01463033|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463428|NCT01463020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463429|NCT01463007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463430|NCT01462994|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1463431|NCT01462981|||Cohort||Retrospective|||||||
1463432|NCT01462968|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463433|NCT01462955||||||||||||
1463434|NCT01462942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463435|NCT01462929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463436|NCT01462916|||Case-Crossover||Prospective|||||||
1463437|NCT01462903||Single Group Assignment||Treatment||None (Open Label)||||||
1463438|NCT01462890|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized Phase III study||||
1463439|NCT01462877||Single Group Assignment||Treatment||None (Open Label)||||||
1463440|NCT01462864|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463441|NCT01462851|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1463442|NCT01462838||Single Group Assignment||Treatment||None (Open Label)||||||
1463443|NCT01462825|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1463444|NCT01462812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463445|NCT01462799|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463446|NCT01462786|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463447|NCT01462773||Single Group Assignment||Treatment||None (Open Label)||||||
1463448|NCT01462760|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1463449|NCT01462747||Single Group Assignment||Treatment||None (Open Label)||||||
1463450|NCT01462734|||Case-Only||Prospective|||||||
1463451|NCT01462721|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463452|NCT01462708||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463453|NCT01462695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463454|NCT01462682|||||Retrospective|||||||
1463455|NCT01462669|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463456|NCT01462656|||Cohort||Prospective|||||||
1463457|NCT01462643|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463458|NCT01462630||Single Group Assignment||Treatment||None (Open Label)||||||
1463459|NCT01462617|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1463460|NCT01462604|||Case-Only||Prospective|||||||
1463461|NCT01462591|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1463462|NCT01462578||Single Group Assignment||Treatment||None (Open Label)||||||
1463463|NCT01462565||Single Group Assignment||Treatment||None (Open Label)||||||
1463464|NCT01462552|||Cohort||Retrospective|||||||
1463465|NCT01462539|||Cohort||Prospective|||||||
1463466|NCT01462526|||Case-Control||Prospective|||||||
1463467|NCT01462513|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463468|NCT01462500||Single Group Assignment||Treatment||None (Open Label)||||||
1463469|NCT01462487|||Cohort||Retrospective|||||||
1463470|NCT01462474|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463471|NCT01462461|||Cohort||Prospective|||||||
1463472|NCT01462448|||Case-Control||Cross-Sectional|||||||
1463473|NCT01462435|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463474|NCT01462422|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1463475|NCT01462409|Randomized|Crossover Assignment||Treatment||Single|||t|||
1463476|NCT01462396||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1463477|NCT01462383|||Cohort||Retrospective|||||||
1463478|NCT01462370|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1463479|NCT01462357|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1463480|NCT01462344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463481|NCT01462331|Randomized|Parallel Assignment||||Triple|||t|t|t|
1463482|NCT01462318||Single Group Assignment||Other||None (Open Label)||||||
1463483|NCT01462305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463484|NCT01462292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463485|NCT01462279||Single Group Assignment||Treatment||None (Open Label)||||||
1463486|NCT01462266|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463487|NCT01462253||Single Group Assignment||Treatment||None (Open Label)||||||
1463488|NCT01462240|||Case-Only||Retrospective|||||||
1463489|NCT01462227|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1463490|NCT01462214|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463491|NCT01462201|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463492|NCT01462188|Randomized|Parallel Assignment||Treatment||Single||||||t
1463493|NCT01462175|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463494|NCT01462162|||Cohort||Prospective|||||||
1463495|NCT01462149||Single Group Assignment||Treatment||None (Open Label)||||||
1463496|NCT01462136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463497|NCT01462123|||||Prospective|||||||
1463498|NCT01462110||||||||||||
1463499|NCT01462097|Randomized|Parallel Assignment||Other||Single||||||t
1463500|NCT01462084|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1463501|NCT01462071|||Cohort||Prospective|||||||
1463502|NCT01462058|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1463503|NCT01462045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463504|NCT01462032|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1463505|NCT01462019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463506|NCT01462006|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1463507|NCT01461993|Randomized|||Prevention||Triple|||t|t|t|
1463508|NCT01461980|Randomized|||Prevention||Quadruple|||t|t|t|t
1463509|NCT01461967|Randomized|Crossover Assignment||||Double|||t||t|
1463510|NCT01461954|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1463511|NCT01461941|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463512|NCT01461928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463513|NCT01461915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463514|NCT01461902|||Cohort||Prospective|||||||
1463515|NCT01461889|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1463516|NCT01461876|||Case Control||Retrospective|||||||
1463517|NCT01461863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463518|NCT01461850|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients will be randomly assigned (1:1 ratio) to undergo either PDS followed by systemic adjuvant chemotherapy, or NACT followed by IDS. Random assignment will be centralised at the Institutional clinical trial center using a block-randomisation computer-generated list (maximum allowable percentage deviation = 10%). Allocation will be concealed to patients and investigators. Patients and investigators will not be masked to group assignment.||||
1463519|NCT01461837||Single Group Assignment||Treatment||None (Open Label)||||||
1463520|NCT01461824|Randomized|Parallel Assignment||Treatment||Single||||||t
1463521|NCT01461811|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463522|NCT01461798|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1463523|NCT01461785|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1463524|NCT01461772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463525|NCT01461759||Single Group Assignment||Treatment||None (Open Label)||||||
1463526|NCT01461746||Single Group Assignment||Treatment||None (Open Label)||||||
1463527|NCT01461733|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1463528|NCT01461720|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1463529|NCT01461707|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463530|NCT01461694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463531|NCT01461681|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1463532|NCT01461668|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1463533|NCT01461655|Randomized|Single Group Assignment||Treatment||Single|||||t|
1463534|NCT01461642|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463535|NCT01461629|||Case-Only||Prospective|||||||
1463536|NCT01461616|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463537|NCT01461603|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1463538|NCT01461590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463539|NCT01461577||Single Group Assignment||Treatment||None (Open Label)||||||
1463540|NCT01461564|Randomized|Parallel Assignment||Screening||Single|||t|||
1463541|NCT01461551|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463542|NCT01461538|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463543|NCT01461525|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463544|NCT01461512|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1463545|NCT01461499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463546|NCT01461486|Randomized|Parallel Assignment||Treatment||Single|||||t|
1463547|NCT01461473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463548|NCT01461460|Randomized|Crossover Assignment||Other||Double|||t|t||
1463549|NCT01461447||Single Group Assignment||||None (Open Label)||||||
1463550|NCT01461434|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1463551|NCT01461421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463552|NCT01461408|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1463553|NCT01461395|||Cohort||Prospective|||||||
1463554|NCT01461382|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1463555|NCT01461369|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463556|NCT01461356|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463557|NCT01461343|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1463634|NCT01460303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463635|NCT01460290||Single Group Assignment||Treatment||None (Open Label)||||||
1463636|NCT01460277|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1463637|NCT01460264|||Cohort||Prospective|||||||
1463558|NCT01461330|Randomized|Parallel Assignment||Prevention||None (Open Label)||"intervention: DASH diet plus exercise DASH diet adapted to the usual diet of Brazilian type 2 diabetic patients = prescription of a normocaloric diet including fruits, vegetables, grain products, low fat dairy foods, legumes, without sugar, and with limited fat Exercises: the recommended physical activity will consist of using a pedometer during the experimental period.~active comparator = ADA diet = Adoption of ADA diet."||||
1463559|NCT01461317||Single Group Assignment||Treatment||None (Open Label)||||||
1463560|NCT01461304||||||||||||
1463561|NCT01461291|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463562|NCT01461278|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463563|NCT01461265||Single Group Assignment||Supportive Care||None (Open Label)||||||
1463564|NCT01461252||Single Group Assignment||Supportive Care||None (Open Label)||||||
1463565|NCT01461239|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463566|NCT01461226|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463567|NCT01461213|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463568|NCT01461200|||Case Control||Prospective|||||||
1463569|NCT01461187|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463570|NCT01461174|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1463571|NCT01461161|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1463572|NCT01461148||Single Group Assignment||Treatment||None (Open Label)||||||
1463573|NCT01461109||Single Group Assignment||||None (Open Label)||||||
1463574|NCT01461096|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1463575|NCT01461083||Single Group Assignment||||None (Open Label)||||||
1463576|NCT01461070|||Case-Control||Cross-Sectional|||||||
1463577|NCT01461057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463578|NCT01461044|||Cohort|||||||||
1463579|NCT01461031|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1463580|NCT01461018||Single Group Assignment||Treatment||None (Open Label)||||||
1463581|NCT01461005||Single Group Assignment||Treatment||None (Open Label)||||||
1463582|NCT01460992|||Case-Only||Prospective|||||||
1463583|NCT01460979||Single Group Assignment||Treatment||None (Open Label)||||||
1463584|NCT01460966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463585|NCT01460953||Single Group Assignment||Health Services Research||None (Open Label)||||||
1463586|NCT01460940||Single Group Assignment||Treatment||None (Open Label)||||||
1463587|NCT01460927||Single Group Assignment||Treatment||None (Open Label)||||||
1463588|NCT01460914|||Case-Only||Prospective|||||||
1463589|NCT01460901||Single Group Assignment||Treatment||None (Open Label)||||||
1463590|NCT01460888|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463591|NCT01460875||Single Group Assignment||Treatment||None (Open Label)||||||
1463592|NCT01460862|||Cohort||Retrospective|||||||
1463593|NCT01460849|||Cohort||Retrospective|||||||
1463594|NCT01460836|||||Retrospective|||||||
1463595|NCT01460823||Single Group Assignment||Treatment||None (Open Label)||||||
1463596|NCT01460810||Single Group Assignment||Prevention||None (Open Label)||||||
1463597|NCT01460797|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463598|NCT01460784|||Cohort||Cross-Sectional|||||||
1463599|NCT01460771|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1463600|NCT01460758|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463601|NCT01460745|||||Retrospective|||||||
1463602|NCT01460732|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1463603|NCT01460719||Single Group Assignment||Prevention||None (Open Label)||||||
1463604|NCT01460706|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1463605|NCT01460693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463606|NCT01460680|||Case Control||Prospective|||||||
1463607|NCT01460667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463608|NCT01460654|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463609|NCT01460641|||Other||Prospective|||||||
1463610|NCT01460628||Single Group Assignment||Treatment||None (Open Label)||||||
1463611|NCT01460615||||||||||||
1463612|NCT01460602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463613|NCT01460589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463614|NCT01460576|||Cohort||Prospective|||||||
1463615|NCT01460563|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1463616|NCT01460550|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1463617|NCT01460537|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463618|NCT01460524|||Cohort||Prospective|||||||
1463619|NCT01460511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463620|NCT01460498|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463621|NCT01460472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463622|NCT01460459|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463623|NCT01460446|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1463624|NCT01460433|||Cohort||Prospective|||||||
1463625|NCT01460420||Single Group Assignment||Treatment||None (Open Label)||||||
1463626|NCT01460407||Single Group Assignment||Treatment||None (Open Label)||||||
1463627|NCT01460394|||Cohort||Prospective|||||||
1463628|NCT01460381|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463629|NCT01460368|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1463630|NCT01460355|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463631|NCT01460342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463632|NCT01460329|||Cohort||Prospective|||||||
1463638|NCT01460251||Single Group Assignment||Treatment||None (Open Label)||||||
1463639|NCT01460238|||Cohort||Prospective|||||||
1463640|NCT01460225||Single Group Assignment||Health Services Research||None (Open Label)||||||
1463641|NCT01460212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463642|NCT01460199|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1463643|NCT01460186||||Other||||||||
1463644|NCT01460173|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1463645|NCT01460160||Single Group Assignment||Treatment||None (Open Label)||||||
1463646|NCT01460147||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463647|NCT01460134|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463648|NCT01460121|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463649|NCT01460108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463650|NCT01460095||Single Group Assignment||||None (Open Label)||||||
1463651|NCT01460082|||Case-Only||Cross-Sectional|||||||
1463652|NCT01460069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463653|NCT01460056|||Cohort||Retrospective|||||||
1463654|NCT01460043|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1463655|NCT01460030||||Treatment||||||||
1463656|NCT01460017|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1463657|NCT01460004||Single Group Assignment||Supportive Care||None (Open Label)||||||
1463658|NCT01459991|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463659|NCT01459978|||Other||Prospective|||||||
1463660|NCT01459965|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463661|NCT01459952|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1463662|NCT01459939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463663|NCT01459926|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463664|NCT01459913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463665|NCT01459900|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1463666|NCT01459887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463667|NCT01459874|||Cohort||Prospective|||||||
1463668|NCT01459861|Randomized|Parallel Assignment||Treatment||Single||||t||
1463669|NCT01459848|Randomized|Parallel Assignment||||Double|||||t|t
1463670|NCT01459835|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1463671|NCT01459822|||Case Control||Prospective|||||||
1463672|NCT01459809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463673|NCT01459796|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463674|NCT01459783|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1463675|NCT01459770|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1463676|NCT01459757|||||Retrospective|||||||
1463677|NCT01459744|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1463678|NCT01459731|||Cohort||Prospective|||||||
1463679|NCT01459718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463680|NCT01459705|Randomized|Parallel Assignment||Treatment||Single||||||t
1463681|NCT01459692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463682|NCT01459679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463683|NCT01459666|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463684|NCT01459653|||Case-Only||Prospective|||||||
1463685|NCT01459640|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463686|NCT01459627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463687|NCT01459614||Single Group Assignment||Treatment||None (Open Label)||||||
1463688|NCT01459601|Randomized|Single Group Assignment||Treatment||Single|||t|||
1463689|NCT01459588|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463690|NCT01459575|||Cohort||Prospective|||||||
1463691|NCT01459562||||||||||||
1463692|NCT01459549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463693|NCT01459536|||Case-Control||Prospective|||||||
1463694|NCT01459523|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463695|NCT01459510|Randomized|Single Group Assignment||Supportive Care||Single|||||t|
1463696|NCT01459497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463697|NCT01459484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463698|NCT01459471||Single Group Assignment||Treatment||None (Open Label)||||||
1463699|NCT01459458|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463700|NCT01459445||Single Group Assignment||Treatment||None (Open Label)||||||
1463701|NCT01459432|||Cohort||Prospective|||||||
1463702|NCT01459419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463703|NCT01459406|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1463704|NCT01459393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463705|NCT01459380|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463706|NCT01459367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463707|NCT01459354|||Case Control||Prospective|||||||
1463708|NCT01459341|||Case-Only||Prospective|||||||
1463709|NCT01459328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463710|NCT01459315||Single Group Assignment||Treatment||None (Open Label)||||||
1463711|NCT01459302|||Other||Prospective|||||||
1463712|NCT01459289|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1463713|NCT01459276|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1463714|NCT01459263|||Case-Only||Prospective|||||||
1463715|NCT01459250|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1463716|NCT01459237|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1463717|NCT01459224|||Cohort||Prospective|||||||
1463718|NCT01459211||Single Group Assignment||Treatment||None (Open Label)||||||
1463719|NCT01459198|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1463720|NCT01459185||Single Group Assignment||Treatment||None (Open Label)||||||
1463721|NCT01459172||Single Group Assignment||Prevention||None (Open Label)||||||
1463722|NCT01459159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463723|NCT01459146|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463724|NCT01459133||Single Group Assignment||Treatment||None (Open Label)||||||
1463725|NCT01459120|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1463726|NCT01459107||Single Group Assignment||Treatment||None (Open Label)||||||
1463727|NCT01459094|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463728|NCT01459081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463729|NCT01459068|Randomized|Parallel Assignment||Treatment||Single||||||t
1463730|NCT01459055|||Cohort||Prospective|||||||
1463731|NCT01459042|||Ecologic or Community||Cross-Sectional|||||||
1463732|NCT01459029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463733|NCT01459016||Single Group Assignment||Basic Science||None (Open Label)||||||
1463734|NCT01459003|Randomized|Parallel Assignment||||None (Open Label)||||||
1463735|NCT01458990|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||PPI withdrawal (decompensated patients only) and PPI initiation (compensated and decompensated patients)||||
1463736|NCT01458977|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1463737|NCT01458964|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1463738|NCT01458951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463739|NCT01458938|||Case-Control||Prospective|||||||
1463740|NCT01458925||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463741|NCT01458912|Randomized|Parallel Assignment||Treatment||Double||||||
1463742|NCT01458899|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1463743|NCT01458886|Randomized|Parallel Assignment||Treatment||Double||||||
1463744|NCT01458873|Non-Randomized|Crossover Assignment||Diagnostic||Triple|||t|t||t
1463745|NCT01458860|||Case-Crossover||Prospective|||||||
1463746|NCT01458847|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463747|NCT01458834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463748|NCT01458821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463749|NCT01458808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463750|NCT01458795|Non-Randomized|Single Group Assignment||Treatment||||||||
1463751|NCT01458782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463752|NCT01458769|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463753|NCT01458756|||Case-Only||Prospective|||||||
1463754|NCT01458743|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1463755|NCT01458730||Single Group Assignment||Treatment||None (Open Label)||||||
1463756|NCT01458717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463757|NCT01458704|||Case-Only||Prospective|||||||
1463758|NCT01458691|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463759|NCT01458678|Randomized|Parallel Assignment||Treatment||Single||||||t
1463760|NCT01458665|Randomized|Parallel Assignment||Treatment||Single||||||t
1463761|NCT01458652||Single Group Assignment||Treatment||Single|||||t|
1463762|NCT01458639|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||t
1463763|NCT01458626|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1463764|NCT01458613|||Cohort||Prospective|||||||
1463765|NCT01458600|Randomized|Parallel Assignment||Prevention||Single||||||t
1463766|NCT01458587|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463767|NCT01458574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463768|NCT01458561|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463769|NCT01458548||Single Group Assignment||Treatment||None (Open Label)||||||
1463770|NCT01458535|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463771|NCT01458522|Randomized|Crossover Assignment||Treatment||Single|||||t|
1463772|NCT01458509|||Cohort||Prospective|||||||
1463773|NCT01458496|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1463774|NCT01458483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463775|NCT01458470|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463776|NCT01458457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463777|NCT01458444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463778|NCT01458431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463779|NCT01458418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463780|NCT01458405|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1463781|NCT01458392||Single Group Assignment||Treatment||None (Open Label)||||||
1463782|NCT01458366||Single Group Assignment||Treatment||None (Open Label)||||||
1463783|NCT01458353|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1463784|NCT01458340|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463785|NCT01458327||Single Group Assignment||Treatment||None (Open Label)||||||
1463786|NCT01458314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463787|NCT01458301|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463788|NCT01458288||Single Group Assignment||Treatment||None (Open Label)||||||
1463789|NCT01458275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463790|NCT01458262|||Cohort||Prospective|||||||
1463791|NCT01458249||Single Group Assignment||Treatment||None (Open Label)||||||
1463792|NCT01458236|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463793|NCT01458223|Randomized|Parallel Assignment||Prevention||Single||||||t
1463794|NCT01458210||Single Group Assignment||Treatment||None (Open Label)||||||
1463795|NCT01458197|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1463796|NCT01458184|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1463797|NCT01458171||Single Group Assignment||Treatment||None (Open Label)||||||
1463798|NCT01458158|||Case Control||Cross-Sectional|||||||
1463799|NCT01458145|Randomized|Parallel Assignment||Prevention||Single||||||t
1463800|NCT01458132|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1463801|NCT01458119||Single Group Assignment||Treatment||None (Open Label)||||||
1463802|NCT01458106||Single Group Assignment||Treatment||None (Open Label)||||||
1463803|NCT01458093|||Cohort||Prospective|||||||
1463804|NCT01458080|||Case Control||Retrospective|||||||
1463805|NCT01458067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463806|NCT01458054|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463807|NCT01458041|||Cohort||Prospective|||||||
1463808|NCT01458028|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1463809|NCT01458015|Randomized|Parallel Assignment||||None (Open Label)||||||
1463810|NCT01458002|Randomized|Factorial Assignment||Prevention||Single|||||t|
1463811|NCT01457989|||||Prospective|||||||
1463812|NCT01457976|||||Cross-Sectional|||||||
1463813|NCT01457963|||Cohort||Prospective|||||||
1463814|NCT01457950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463815|NCT01457937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463816|NCT01457924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463817|NCT01457911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463818|NCT01457898|Randomized|Single Group Assignment||||None (Open Label)||||||
1463819|NCT01457885||Single Group Assignment||Treatment||None (Open Label)||||||
1463820|NCT01457872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463821|NCT01457859|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1463822|NCT01457846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463823|NCT01457833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463824|NCT01457820|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1463825|NCT01457807|Randomized|Parallel Assignment||||Double|||t||t|
1463826|NCT01457794|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1463827|NCT01457781|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1463828|NCT01457768|||Cohort||Prospective|||||||
1463829|NCT01457755|||Cohort||Prospective|||||||
1463830|NCT01457742|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1463831|NCT01457729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463832|NCT01457716|Randomized|Crossover Assignment||||None (Open Label)||||||
1463833|NCT01457703|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1463834|NCT01457690|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1463835|NCT01457677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463836|NCT01457664|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1463837|NCT01457651|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463838|NCT01457638|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463839|NCT01457625|||Cohort||Prospective|||||||
1463840|NCT01457612|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463841|NCT01457599|||Cohort||Prospective|||||||
1463842|NCT01457586|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1463843|NCT01457573||Single Group Assignment||Treatment||None (Open Label)||||||
1463844|NCT01457560||Single Group Assignment||Prevention||None (Open Label)||||||
1463845|NCT01457547|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463846|NCT01457534|||Case Control||Retrospective|||||||
1463847|NCT01457521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463848|NCT01457508|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463849|NCT01457495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463850|NCT01457482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463851|NCT01457469|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1463852|NCT01457456|||Cohort||Prospective|||||||
1463853|NCT01457443|||Cohort||Prospective|||||||
1463854|NCT01457430||Single Group Assignment||Treatment||None (Open Label)||||||
1463855|NCT01457417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463856|NCT01457404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463857|NCT01457391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463858|NCT01457378|||Case Control||Retrospective|||||||
1463859|NCT01457365|||Cohort||Cross-Sectional|||||||
1463860|NCT01457352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463861|NCT01457339|Randomized|Parallel Assignment||||Double|||t||t|
1463862|NCT01457326|||Case Control||Prospective|||||||
1463863|NCT01457313|||||Prospective|||||||
1463864|NCT01457300|||Case Control||Prospective|||||||
1463865|NCT01457287|||Case Control||Prospective|||||||
1463866|NCT01457274|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1463867|NCT01457261|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463868|NCT01457248|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463869|NCT01457235|Randomized|Parallel Assignment||Treatment||Single|||||t|
1463870|NCT01457222|Randomized|Factorial Assignment||Prevention||Single|||||t|
1463871|NCT01457209||Single Group Assignment||Treatment||None (Open Label)||||||
1463872|NCT01457196||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463873|NCT01457183||Single Group Assignment||||None (Open Label)||||||
1463874|NCT01457170|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1463875|NCT01457144||Single Group Assignment||Treatment||None (Open Label)||||||
1463876|NCT01457131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463877|NCT01457118||Single Group Assignment||Treatment||None (Open Label)||||||
1463878|NCT01457105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463879|NCT01457092||Single Group Assignment||Treatment||None (Open Label)||||||
1463880|NCT01457079|||Cohort|||||||||
1463881|NCT01457066|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1463882|NCT01457053|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1463883|NCT01457040|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463884|NCT01457027|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1463885|NCT01457014|Randomized|Crossover Assignment||Treatment||Single|||t|||
1463886|NCT01457001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463887|NCT01456975|Randomized|Parallel Assignment||Treatment||Single|||||t|
1463888|NCT01456962|||Cohort||Prospective|||||||
1463889|NCT01456949||Single Group Assignment||Treatment||None (Open Label)||||||
1463890|NCT01456936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463891|NCT01456923||||Treatment||||||||
1463892|NCT01456910|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1463893|NCT01456897||Single Group Assignment||Treatment||None (Open Label)||||||
1463894|NCT01456884|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1463895|NCT01456871|||Cohort||Cross-Sectional|||||||
1463896|NCT01456858|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1463897|NCT01456845|||Case Control||Prospective|||||||
1463898|NCT01456832|||Case-Only||Retrospective|||||||
1463899|NCT01456819|Randomized|Parallel Assignment||Treatment||Single||||||t
1463900|NCT01456806|Randomized|Factorial Assignment||||None (Open Label)||||||
1463901|NCT01456793|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463902|NCT01456780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463903|NCT01456767|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1463904|NCT01456754|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1463905|NCT01456741|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1463906|NCT01456728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463907|NCT01456715|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463908|NCT01456702|Randomized|Parallel Assignment||||None (Open Label)||||||
1463909|NCT01456689|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463910|NCT01456676||Single Group Assignment||Treatment||None (Open Label)||||||
1463911|NCT01456663||Parallel Assignment||||None (Open Label)||||||
1463912|NCT01456650|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1463913|NCT01456637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463914|NCT01456624|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1463915|NCT01456611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463916|NCT01456598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463917|NCT01456585||Single Group Assignment||Treatment||||||||
1463918|NCT01456572|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1463919|NCT01456559|||Case-Only||Prospective|||||||
1463920|NCT01456546|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1463921|NCT01456533|||Cohort||Prospective|||||||
1463922|NCT01456520|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1463923|NCT01456507|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1463924|NCT01456494|Randomized|Parallel Assignment||||Single||||||t
1463925|NCT01456481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463926|NCT01456468||Single Group Assignment||Treatment||None (Open Label)||||||
1463927|NCT01456455|||Cohort|||||||||
1463928|NCT01456442|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1463929|NCT01456429||Single Group Assignment||Diagnostic||None (Open Label)||||||
1463930|NCT01456416|||Cohort||Prospective|||||||
1463931|NCT01456403|||Cohort||Cross-Sectional|||||||
1463932|NCT01456390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463933|NCT01456377|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1463934|NCT01456364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463935|NCT01456351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463936|NCT01456338|Randomized|Parallel Assignment||Treatment||Single||||||t
1463937|NCT01456325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463938|NCT01456312|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463939|NCT01456299|Randomized|Parallel Assignment||||Single|||||t|
1463940|NCT01456286|Randomized|Parallel Assignment||Treatment||Single||||||t
1463941|NCT01456273|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1463942|NCT01456260|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463943|NCT01456247|Randomized|Parallel Assignment||Prevention||Single|||t|||
1463944|NCT01456234|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1463945|NCT01456221|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1463946|NCT01456208|||Cohort||Cross-Sectional|||||||
1463947|NCT01456195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463948|NCT01456182|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1463949|NCT01456169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463950|NCT01456156||Single Group Assignment||Treatment||None (Open Label)||||||
1463951|NCT01456143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463952|NCT01456130||Single Group Assignment||||None (Open Label)||||||
1463953|NCT01456117|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1463954|NCT01456104||Single Group Assignment||Treatment||None (Open Label)||||||
1463955|NCT01456091|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463956|NCT01456078||Single Group Assignment||Treatment||None (Open Label)||||||
1463957|NCT01456065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463958|NCT01456052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463959|NCT01456039||Single Group Assignment||Treatment||None (Open Label)||||||
1463960|NCT01456026|Randomized|Crossover Assignment||||Double|||t||t|
1463961|NCT01456013|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463962|NCT01456000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463963|NCT01455987|||Cohort||Retrospective|||||||
1463964|NCT01455974||Single Group Assignment||Treatment||None (Open Label)||||||
1463965|NCT01455961|||||Retrospective|||||||
1463966|NCT01455948|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1463967|NCT01455935|Randomized|Factorial Assignment||Treatment||Single||||||t
1463968|NCT01455922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463969|NCT01455909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463970|NCT01455896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463971|NCT01455883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463972|NCT01455870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463973|NCT01455857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1463974|NCT01455844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1463975|NCT01455831|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1463976|NCT01455818|||Cohort||Prospective|||||||
1463977|NCT01455805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463978|NCT01455792|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1463979|NCT01455779||Single Group Assignment||Treatment||None (Open Label)||||||
1463980|NCT01455766|||Cohort||Prospective|||||||
1463981|NCT01455753|||Other||Retrospective|||||||
1463982|NCT01455740|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||The study used a randomized trial design for two treatment arms: (i) Participants in the provider visit incentive (PVI) arm were told that they would receive $30 after attending each scheduled provider visit (a CCT). (ii) Participants in the incentive choice (IC) were given a choice between the above CCT and a commitment contract, which made the $30 payment conditional on the patient attending the provider visit and meeting an ART adherence threshold. A block randomization scheme, stratified on whether or no the majority of the participant's three previous viral load measurements were suppressed, assigned 21 individuals to the PVI arm and 19 to the IC arm.||||
1463983|NCT01455727|Randomized|Parallel Assignment||Treatment||Single|||t|||
1463984|NCT01455714|||Case Control||Prospective|||||||
1463985|NCT01455701||Single Group Assignment||Treatment||None (Open Label)||||||
1463986|NCT01455688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463987|NCT01455675|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1463988|NCT01455662|||Cohort||Prospective|||||||
1463989|NCT01455649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1463990|NCT01455636|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1463991|NCT01455623|||Cohort||Prospective|||||||
1463992|NCT01455610|||Case-Only||Prospective|||||||
1463993|NCT01455597||Single Group Assignment||Treatment||None (Open Label)||||||
1463994|NCT01455584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463995|NCT01455571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463996|NCT01455558||Crossover Assignment||Treatment||None (Open Label)||||||
1463997|NCT01455545|||||Cross-Sectional|||||||
1463998|NCT01455532|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1463999|NCT01455519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464000|NCT01455506||Single Group Assignment||Treatment||None (Open Label)||||||
1464001|NCT01455493||Single Group Assignment||Treatment||None (Open Label)||||||
1464002|NCT01455480||Single Group Assignment||Treatment||None (Open Label)||||||
1464003|NCT01455467|Randomized|Parallel Assignment||Treatment||Single||||||t
1464004|NCT01455454|||Cohort||Prospective|||||||
1464005|NCT01455441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464006|NCT01455428|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464007|NCT01455415|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1464008|NCT01455402|||Cohort||Prospective|||||||
1464009|NCT01455389||Single Group Assignment||Treatment||None (Open Label)||||||
1464010|NCT01455376|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464011|NCT01455363||Single Group Assignment||||None (Open Label)||||||
1464012|NCT01455350|Randomized|Parallel Assignment||Treatment||Single||||||t
1464013|NCT01455337|Randomized|Parallel Assignment||Treatment||Single|||||t|
1464014|NCT01455324|||Case-Only||Cross-Sectional|||||||
1464015|NCT01455311|||Case-Only||Cross-Sectional|||||||
1464016|NCT01455298||Single Group Assignment||Screening||None (Open Label)||||||
1464017|NCT01455285||||Treatment||||||||
1464018|NCT01455272||Single Group Assignment||Prevention||None (Open Label)||||||
1464019|NCT01455259||Single Group Assignment||Treatment||None (Open Label)||||||
1464020|NCT01455246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464021|NCT01455233|Randomized|Parallel Assignment||||Single|||||t|
1464022|NCT01455220||Single Group Assignment||Supportive Care||None (Open Label)||||||
1464023|NCT01455207|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1464024|NCT01455194|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464025|NCT01455181||Single Group Assignment||Treatment||None (Open Label)||||||
1464026|NCT01455168|||Case Control||Prospective|||||||
1464027|NCT01455155|Randomized|Parallel Assignment||Treatment||Single||||||t
1464028|NCT01455142|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1464029|NCT01455129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464030|NCT01455116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464031|NCT01455103|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1464032|NCT01455090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464033|NCT01455077|||Ecologic or Community||Prospective|||||||
1464034|NCT01455064|||Cohort||Prospective|||||||
1464035|NCT01455051||Single Group Assignment||Treatment||None (Open Label)||||||
1464036|NCT01455038|||Case Control||Cross-Sectional|||||||
1464037|NCT01455025||Single Group Assignment||Treatment||None (Open Label)||||||
1464038|NCT01455012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464039|NCT01454999|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1464040|NCT01454986|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464041|NCT01454973|||Case-Crossover||Prospective|||||||
1464042|NCT01454960|Randomized|Factorial Assignment||Treatment||Single|||t|||
1464043|NCT01454947|Randomized|Factorial Assignment||Treatment||Single|||t|||
1464044|NCT01454934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464045|NCT01454921|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1464046|NCT01454908|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464047|NCT01454895|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1464048|NCT01454882|||||Cross-Sectional|||||||
1464049|NCT01454869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464050|NCT01454856|||Cohort||Prospective|||||||
1464051|NCT01454843|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464052|NCT01454830|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464053|NCT01454817|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1464054|NCT01454804|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464055|NCT01454791|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1464056|NCT01454778||Single Group Assignment||Prevention||None (Open Label)||||||
1464057|NCT01454765|||||Prospective|||||||
1464058|NCT01454752|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1464059|NCT01454739|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464060|NCT01454726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464061|NCT01454713|||Case-Only||Retrospective|||||||
1464062|NCT01454700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464063|NCT01454687||Single Group Assignment||Treatment||None (Open Label)||||||
1464064|NCT01454674|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1464065|NCT01454661|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1464066|NCT01454648|||Case Control||Retrospective|||||||
1464067|NCT01454635||Single Group Assignment||Treatment||None (Open Label)||||||
1464068|NCT01454622|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464069|NCT01454609|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464070|NCT01454596|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1464071|NCT01454583|||Case-Only||Prospective|||||||
1464072|NCT01454570|||Cohort||Prospective|||||||
1464073|NCT01454557|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464074|NCT01454544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464075|NCT01454531||Single Group Assignment||Treatment||None (Open Label)||||||
1464076|NCT01454518|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1464077|NCT01454505|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464078|NCT01454492|||Case Control||Prospective|||||||
1464079|NCT01454479||Single Group Assignment||Treatment||None (Open Label)||||||
1464080|NCT01454466|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1464081|NCT01454453||Single Group Assignment||Treatment||None (Open Label)||||||
1464082|NCT01454440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464083|NCT01454427|||Cohort||Prospective|||||||
1464084|NCT01454414|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1464085|NCT01454401||Single Group Assignment||Treatment||None (Open Label)||||||
1464086|NCT01454388|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1464087|NCT01454375|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1464088|NCT01454362|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1464089|NCT01454349|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464090|NCT01454336||Single Group Assignment||Treatment||None (Open Label)||||||
1464091|NCT01454323||Single Group Assignment||Treatment||None (Open Label)||||||
1464092|NCT01454310|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464093|NCT01454297|||Cohort||Prospective|||||||
1464094|NCT01454284|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464095|NCT01454271||Single Group Assignment||Prevention||None (Open Label)||||||
1464096|NCT01454258|||Cohort||Cross-Sectional|||||||
1464642|NCT01447134|||||Prospective|||||||
1464097|NCT01454245|Randomized|Crossover Assignment||||None (Open Label)||||||
1464098|NCT01454232|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1464099|NCT01454219|Randomized|Single Group Assignment||||None (Open Label)||||||
1464100|NCT01454206|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1464101|NCT01454193|||Cohort||Retrospective|||||||
1464102|NCT01454180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464103|NCT01454167|||||Prospective|||||||
1464104|NCT01454154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464105|NCT01454141|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1464106|NCT01454128|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464107|NCT01454115|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1464108|NCT01454102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464109|NCT01454089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464110|NCT01454076|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1464111|NCT01454063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464112|NCT01454050|||Case-Only||Prospective|||||||
1464113|NCT01454037|||Cohort||Prospective|||||||
1464114|NCT01454024|||Cohort||Prospective|||||||
1464115|NCT01454011|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464116|NCT01453998|Non-Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464117|NCT01453985||||||||||||
1464118|NCT01453972|Randomized|Parallel Assignment||Treatment||Single||||||t
1464119|NCT01453959|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1464120|NCT01453946||Single Group Assignment||Treatment||None (Open Label)||||||
1464121|NCT01453933|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464122|NCT01453920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464123|NCT01453907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464124|NCT01453894|Randomized|Parallel Assignment||Screening||Double|||t|||t
1464125|NCT01453881|Randomized|Parallel Assignment||Treatment||Single|||||t|
1464126|NCT01453868|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1464127|NCT01453855|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464128|NCT01453842|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1464129|NCT01453829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464130|NCT01453816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464131|NCT01453803||Single Group Assignment||Treatment||None (Open Label)||||||
1464132|NCT01453790|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1464133|NCT01453777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464134|NCT01453764||Single Group Assignment||Treatment||None (Open Label)||||||
1464135|NCT01453751||Single Group Assignment||Treatment||None (Open Label)||||||
1464136|NCT01453738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464137|NCT01453725|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464138|NCT01453712|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1464139|NCT01453699|||Cohort||Prospective|||||||
1464140|NCT01453686|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464141|NCT01453673|||||Retrospective|||||||
1464142|NCT01453660|||Cohort||Retrospective|||||||
1464143|NCT01453647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464144|NCT01453634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464145|NCT01453621|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1464146|NCT01453608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464147|NCT01453595||Single Group Assignment||Treatment||None (Open Label)||||||
1464148|NCT01453582|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464149|NCT01453569|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464150|NCT01453556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464151|NCT01453543|Randomized|Single Group Assignment||Treatment||Single|||t|||
1464152|NCT01453530|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1464153|NCT01453517||Single Group Assignment||Prevention||None (Open Label)||||||
1464154|NCT01453504|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464155|NCT01453491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464156|NCT01453478|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1464157|NCT01453465||||||||||||
1464158|NCT01453452||Single Group Assignment||Other||None (Open Label)||||||
1464159|NCT01453439|Randomized|Parallel Assignment||Treatment||Single||||||t
1464160|NCT01453426|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1464161|NCT01453413||Single Group Assignment||||None (Open Label)||||||
1464162|NCT01453400|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464163|NCT01453387|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464164|NCT01453374||Single Group Assignment||Treatment||None (Open Label)||||||
1464165|NCT01453361||Single Group Assignment||Treatment||None (Open Label)||||||
1464166|NCT01453348|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464167|NCT01453335|||Case-Only||Prospective|||||||
1464168|NCT01453322|||Case-Only||Prospective|||||||
1464169|NCT01453309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464170|NCT01453296|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1464171|NCT01453283||||Treatment||||||||
1464172|NCT01453270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464173|NCT01453257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464174|NCT01453244|||Cohort|||||||||
1464175|NCT01453231|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464176|NCT01453218|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1464177|NCT01453205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464178|NCT01453192||Single Group Assignment||Treatment||None (Open Label)||||||
1464179|NCT01453179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464180|NCT01453166|Randomized|Parallel Assignment||Prevention||Single||||||t
1464181|NCT01453153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464182|NCT01453140|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464183|NCT01453127|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1464184|NCT01453114|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1464185|NCT01453101||Single Group Assignment||Treatment||None (Open Label)||||||
1464186|NCT01453088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464187|NCT01453075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464188|NCT01453062|||Cohort||Retrospective|||||||
1464189|NCT01453049|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464190|NCT01453036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464191|NCT01453023|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1464192|NCT01453010||Single Group Assignment||Treatment||None (Open Label)||||||
1464193|NCT01452997|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464194|NCT01452984|||Cohort|||||||||
1464195|NCT01452971|||Case-Only||Prospective|||||||
1464196|NCT01452958|Randomized|Parallel Assignment||||Double|||t|t||
1464197|NCT01452945|||Cohort||Prospective|||||||
1464198|NCT01452932|Randomized|Parallel Assignment||Treatment||Single||||||t
1464199|NCT01452919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464200|NCT01452906|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1464201|NCT01452893|||Cohort||Prospective|||||||
1464202|NCT01452880|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464203|NCT01452867|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464204|NCT01452854|||Cohort||Prospective|||||||
1464205|NCT01452841|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1464206|NCT01452828|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464207|NCT01452815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464208|NCT01452802|||Cohort||Prospective|||||||
1464209|NCT01452789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464210|NCT01452776|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464211|NCT01452763|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464212|NCT01452750|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464213|NCT01452737|Randomized|Parallel Assignment||Treatment||Single||||||t
1464214|NCT01452724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464215|NCT01452711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464216|NCT01452698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464217|NCT01452685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464218|NCT01452672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464219|NCT01452659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464220|NCT01452646||Single Group Assignment||Treatment||None (Open Label)||||||
1464221|NCT01452633|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1464222|NCT01452620|||Cohort||Retrospective|||||||
1464223|NCT01452607|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464224|NCT01452594|||Cohort||Prospective|||||||
1464225|NCT01452581|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464226|NCT01452568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464227|NCT01452555|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1464228|NCT01452542|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464229|NCT01452529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464230|NCT01452516||Single Group Assignment||Treatment||None (Open Label)||||||
1464231|NCT01452503|Randomized|Crossover Assignment||||None (Open Label)||||||
1464232|NCT01452490||Single Group Assignment||Treatment||None (Open Label)||||||
1464233|NCT01452477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464234|NCT01452464|||Cohort||Prospective|||||||
1464235|NCT01452451|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464236|NCT01452438|||Cohort||Prospective|||||||
1464237|NCT01452425||Single Group Assignment||Basic Science||None (Open Label)||||||
1464238|NCT01452412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464239|NCT01452399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464240|NCT01452386|||||Prospective|||||||
1464241|NCT01452373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464242|NCT01452360||||||||||||
1464243|NCT01452347|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464244|NCT01452334||Single Group Assignment||Treatment||None (Open Label)||||||
1464245|NCT01452321|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1464246|NCT01452308|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464247|NCT01452295|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1464248|NCT01452282|||Cohort||Prospective|||||||
1464249|NCT01452269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464250|NCT01452256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464251|NCT01452243|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464252|NCT01452230|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464253|NCT01452217|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1464254|NCT01452204|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464255|NCT01452191|Randomized|Single Group Assignment||Prevention||Single||||||t
1464256|NCT01452178|||Cohort||Prospective|||||||
1464257|NCT01452165|||Cohort||Prospective|||||||
1464258|NCT01452152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464259|NCT01452139|Randomized|Parallel Assignment||Treatment||Single||||||t
1464260|NCT01452126||Single Group Assignment||||Triple|||t|t||t
1464261|NCT01452113|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1464262|NCT01452100|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464263|NCT01452087||Single Group Assignment||Basic Science||None (Open Label)||||||
1464264|NCT01452074||Single Group Assignment||Basic Science||None (Open Label)||||||
1464265|NCT01452061|||Case Control||Cross-Sectional|||||||
1464266|NCT01452048|||Cohort||Cross-Sectional|||||||
1464267|NCT01452035|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1464268|NCT01452022||Single Group Assignment||Treatment||None (Open Label)||||||
1464269|NCT01452009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464270|NCT01451996|Randomized|Parallel Assignment||Other||Triple||||t|t|t
1464271|NCT01451983|||Case Control||Cross-Sectional|||||||
1464272|NCT01451970|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464273|NCT01451957|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1464274|NCT01451944|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1464275|NCT01451931|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1464276|NCT01451918|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1464277|NCT01451905|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1464278|NCT01451892|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1464279|NCT01451879|||Case-Only||Prospective|||||||
1464280|NCT01451866|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464281|NCT01451853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464282|NCT01451840|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1464283|NCT01451827|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464284|NCT01451814|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1464285|NCT01451801|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1464286|NCT01451788|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464287|NCT01451775|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464288|NCT01451762|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464289|NCT01451749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464290|NCT01451736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464291|NCT01451723|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464292|NCT01451710||Single Group Assignment||Treatment||None (Open Label)||||||
1464293|NCT01451697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464294|NCT01451684|||Case-Only||Prospective|||||||
1464295|NCT01451671|||Case Control||Prospective|||||||
1464296|NCT01451658|Randomized|Parallel Assignment||Treatment||Single||||||t
1464297|NCT01451645|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464298|NCT01451632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464299|NCT01451619|Randomized|Parallel Assignment||Treatment||Double||||||
1464300|NCT01451606|Randomized|Parallel Assignment||Treatment||Double|Study drug allocation was determined by University pharmacy, using a random allocation algorithm unknown by researchers or patients.|One group receiving active drug treatment and second group receiving an indistinguishable placebo pill.|t||t|
1464301|NCT01451593|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464302|NCT01451580|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1464303|NCT01451567|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1464304|NCT01451554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464305|NCT01451541|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464306|NCT01451528||Single Group Assignment||Treatment||None (Open Label)||||||
1464307|NCT01451515||Single Group Assignment||Treatment||None (Open Label)||||||
1464308|NCT01451502||Single Group Assignment||Other||None (Open Label)||||||
1464309|NCT01451489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464310|NCT01451476|||||Cross-Sectional|||||||
1464311|NCT01451463|||Case-Control||Prospective|||||||
1464312|NCT01451450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464313|NCT01451437|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464314|NCT01451424|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464315|NCT01451411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464316|NCT01451398|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464317|NCT01451385||Single Group Assignment||Treatment||None (Open Label)||||||
1464318|NCT01451372|||Cohort||Retrospective|||||||
1464319|NCT01451359||Single Group Assignment||Treatment||None (Open Label)||||||
1464320|NCT01451346|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464321|NCT01451333|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464322|NCT01451320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464323|NCT01451307|||Case Control||Cross-Sectional|||||||
1464324|NCT01451294|Randomized|Parallel Assignment||Treatment||Single||||||t
1464325|NCT01451281||||||||||||
1464326|NCT01451268|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464327|NCT01451255|||||Prospective|||||||
1464328|NCT01451242|||Cohort|||||||||
1464329|NCT01451229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464330|NCT01451216|||Case-Only||Prospective|||||||
1464331|NCT01451203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464332|NCT01451190||Single Group Assignment||Treatment||Single||||||t
1464333|NCT01451177||Single Group Assignment||Treatment||Single||||||t
1464334|NCT01451164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464335|NCT01451151||Single Group Assignment||Treatment||Single||||||t
1464336|NCT01451138||Single Group Assignment||Treatment||Single||||||t
1464337|NCT01451125||Single Group Assignment||Treatment||Single||||||t
1464338|NCT01451112||Single Group Assignment||Treatment||Single||||||t
1464339|NCT01451099||Single Group Assignment||Treatment||Single||||||t
1464340|NCT01451086|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1464341|NCT01451073||Single Group Assignment||Treatment||Single||||||t
1464342|NCT01451060|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1464343|NCT01451047||Single Group Assignment||Treatment||Single||||||t
1464344|NCT01451034|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464345|NCT01451021||Single Group Assignment||Treatment||Single||||||t
1464346|NCT01451008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464347|NCT01450995|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464348|NCT01450982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464349|NCT01450969|||Cohort||Prospective|||||||
1464350|NCT01450956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464351|NCT01450943|Randomized|Parallel Assignment||Treatment||Single||||||t
1464352|NCT01450930|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464353|NCT01450917|||Case Control||Retrospective|||||||
1464354|NCT01450904|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1464355|NCT01450891|||Cohort||Prospective|||||||
1464356|NCT01450878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464357|NCT01450865|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1464358|NCT01450852|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464359|NCT01450839|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1464360|NCT01450826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464361|NCT01450813|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1464362|NCT01450800|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464363|NCT01450787|||Case Control||Cross-Sectional|||||||
1464364|NCT01450774|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1464365|NCT01450761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464366|NCT01450748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464367|NCT01450735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464368|NCT01450722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464369|NCT01450709|||Cohort||Prospective|||||||
1464370|NCT01450696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464371|NCT01450683||Single Group Assignment||Treatment||None (Open Label)||||||
1464372|NCT01450670|||Cohort||Prospective|||||||
1464373|NCT01450657|||Cohort||Prospective|||||||
1464374|NCT01450644|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464375|NCT01450631|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464376|NCT01450618|||Cohort||Retrospective|||||||
1464377|NCT01450605|||Case-Only||Prospective|||||||
1464378|NCT01450592|||Cohort||Cross-Sectional|||||||
1464379|NCT01450579|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464380|NCT01450566|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1464381|NCT01450553|||Cohort||Prospective|||||||
1464382|NCT01450540||||||||||||
1464383|NCT01450527|||Case-Only||Prospective|||||||
1464384|NCT01450514|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464385|NCT01450501|||Cohort||Prospective|||||||
1464386|NCT01450488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464387|NCT01450475|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1464388|NCT01450462|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1464389|NCT01450449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464390|NCT01450436|||Cohort||Prospective|||||||
1464391|NCT01450423|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464392|NCT01450410|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1464393|NCT01450397||Single Group Assignment||Treatment||None (Open Label)||||||
1464394|NCT01450384||Single Group Assignment||Treatment||None (Open Label)||||||
1464395|NCT01450371|||||Prospective|||||||
1464396|NCT01450358|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1464397|NCT01450345|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464398|NCT01450332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464399|NCT01450319||Single Group Assignment||Treatment||None (Open Label)||||||
1464400|NCT01450306|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1464401|NCT01450293|Randomized|Parallel Assignment||Prevention||Single||||||t
1464402|NCT01450280|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464403|NCT01450267|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464404|NCT01450254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464405|NCT01450241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464406|NCT01450228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464407|NCT01450215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464408|NCT01450202|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1464409|NCT01450189|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464410|NCT01450176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464411|NCT01450163|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464412|NCT01450150|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1464413|NCT01450137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464414|NCT01450124||Single Group Assignment||Treatment||None (Open Label)||||||
1464415|NCT01450111|Randomized|Parallel Assignment||||Double|||t||t|
1464416|NCT01450098|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1464417|NCT01450085|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1464418|NCT01450072|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464419|NCT01450059|||Cohort||Prospective|||||||
1464420|NCT01450046||Single Group Assignment||Prevention||None (Open Label)||||||
1464421|NCT01450033|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1464422|NCT01450020|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464423|NCT01450007|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1464424|NCT01449994|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1464425|NCT01449981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464426|NCT01449968|||Cohort||Prospective|||||||
1464427|NCT01449955|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464428|NCT01449942|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464429|NCT01449929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464430|NCT01449916|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464431|NCT01449903|||Cohort||Prospective|||||||
1464432|NCT01449890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464433|NCT01449877|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1464434|NCT01449864||||Treatment||||||||
1464435|NCT01449838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464436|NCT01449825|||Cohort||Retrospective|||||||
1464437|NCT01449812|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464438|NCT01449799|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1464439|NCT01449786|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464440|NCT01449773|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1464441|NCT01449760|Randomized|Parallel Assignment||Treatment||Single||||||t
1464442|NCT01449747|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464443|NCT01449734|||Cohort||Prospective|||||||
1464444|NCT01449721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464445|NCT01449708|Randomized|Parallel Assignment||Prevention||Single|||t|||
1464446|NCT01449695|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464447|NCT01449682|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464448|NCT01449669|||Cohort|||||||||
1464449|NCT01449656|||Case Control||Prospective|||||||
1464450|NCT01449643|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1464451|NCT01449630|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1464452|NCT01449617|||Case-Only||Prospective|||||||
1464453|NCT01449604|Randomized|Parallel Assignment||Treatment||Single||||||t
1464454|NCT01449591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464455|NCT01449578|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1464456|NCT01449565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464457|NCT01449552|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1464458|NCT01449539||Single Group Assignment||Treatment||None (Open Label)||||||
1464459|NCT01449526|Randomized|Parallel Assignment||||Double|||t||t|
1464460|NCT01449513|Randomized|Parallel Assignment||||None (Open Label)||||||
1464461|NCT01449500|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1464462|NCT01449487|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1464463|NCT01449474|Randomized|Parallel Assignment||Treatment||Single||||||t
1464464|NCT01449461|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464465|NCT01449448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464466|NCT01449435|||Case-Crossover||Prospective|||||||
1464467|NCT01449422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464468|NCT01449409|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1464469|NCT01449396|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464470|NCT01449383|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1464471|NCT01449370|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464472|NCT01449357|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464473|NCT01449344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464474|NCT01449331|||Cohort||Prospective|||||||
1464475|NCT01449318||Single Group Assignment||Supportive Care||None (Open Label)||||||
1464476|NCT01449305||Single Group Assignment||Health Services Research||None (Open Label)||||||
1464477|NCT01449292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464478|NCT01449279||Single Group Assignment||Treatment||None (Open Label)||||||
1464479|NCT01449266||Single Group Assignment||||None (Open Label)||||||
1464480|NCT01449253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464481|NCT01449240|||Case-Only||Prospective|||||||
1464482|NCT01449227|||Cohort||Prospective|||||||
1464483|NCT01449214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464484|NCT01449201||Single Group Assignment||Treatment||None (Open Label)||||||
1464485|NCT01449188|Randomized|Crossover Assignment||Other||Double|||t||t|
1464486|NCT01449175|||Cohort||Prospective|||||||
1464487|NCT01449162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464488|NCT01449149||||Treatment||||||||
1464489|NCT01449136|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1464490|NCT01449123|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464491|NCT01449110|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464492|NCT01449097|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1464493|NCT01449084|Randomized|Parallel Assignment||Prevention||Single||||t||
1464494|NCT01449071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464495|NCT01449058||Single Group Assignment||Treatment||None (Open Label)||||||
1464496|NCT01449045|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464497|NCT01449032|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464498|NCT01449019|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1464499|NCT01449006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464500|NCT01448993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464501|NCT01448980|Randomized|Parallel Assignment||Treatment||Single||||||t
1464502|NCT01448954|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464503|NCT01448941|Randomized|Parallel Assignment||Treatment||Single||||||t
1464504|NCT01448928|||Case-Only||Prospective|||||||
1464505|NCT01448915|||Cohort||Prospective|||||||
1464506|NCT01448902|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1464507|NCT01448889|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1464508|NCT01448876|||Cohort||Prospective|||||||
1464509|NCT01448863|||Case Control||Prospective|||||||
1464510|NCT01448850|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464511|NCT01448837|Randomized|Crossover Assignment||Treatment||Single|||||t|
1464512|NCT01448824|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1464513|NCT01448811|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1464514|NCT01448798|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1464515|NCT01448785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464516|NCT01448772|Randomized|Crossover Assignment||||None (Open Label)||||||
1464517|NCT01448759||Single Group Assignment||||None (Open Label)||||||
1464518|NCT01448746|Randomized|Parallel Assignment||Prevention||Single|||t|||
1464519|NCT01448733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464520|NCT01448720|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464521|NCT01448707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464522|NCT01448694|||Case-Only||Prospective|||||||
1464523|NCT01448681|||Case-Only||Prospective|||||||
1464524|NCT01448668|||Cohort||Prospective|||||||
1464525|NCT01448655|||Cohort||Prospective|||||||
1464526|NCT01448642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464527|NCT01448629|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464528|NCT01448616|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1464529|NCT01448603|||Cohort||Prospective|||||||
1464530|NCT01448590|||||Retrospective|||||||
1464531|NCT01448577|||Cohort|||||||||
1464532|NCT01448564|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1464533|NCT01448551|Randomized|Parallel Assignment||Treatment||Single||||||t
1464534|NCT01448538|||Cohort||Prospective|||||||
1464535|NCT01448525|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464536|NCT01448512|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1464537|NCT01448499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464538|NCT01448486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464539|NCT01448473|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1464540|NCT01448460|||Cohort||Prospective|||||||
1464541|NCT01448447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464542|NCT01448434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464543|NCT01448421|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1464544|NCT01448408|||Case Control||Prospective|||||||
1464545|NCT01448395|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1464546|NCT01448382|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1464547|NCT01448369|Randomized|Parallel Assignment||Treatment||Single|||||t|
1464548|NCT01448356||Single Group Assignment||Basic Science||None (Open Label)||||||
1464549|NCT01448343||Single Group Assignment||Diagnostic||Single||||||t
1464550|NCT01448330|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464551|NCT01448317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464552|NCT01448304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464553|NCT01448291||Single Group Assignment||Treatment||None (Open Label)||||||
1464554|NCT01448278|Randomized|Parallel Assignment||||None (Open Label)||||||
1464555|NCT01448265||Single Group Assignment||Treatment||None (Open Label)||||||
1464556|NCT01448252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464557|NCT01448239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464558|NCT01448226|||Case Control||Retrospective|||||||
1464559|NCT01448213|Randomized|Parallel Assignment||Prevention||Single|||||t|
1464560|NCT01448200|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464561|NCT01448187|||Cohort||Prospective|||||||
1464562|NCT01448174|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1464563|NCT01448161|||Case-Only||Prospective|||||||
1464564|NCT01448148|Randomized|Parallel Assignment||Treatment||Single||||||t
1464565|NCT01448135|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1464566|NCT01448122|Randomized|Parallel Assignment||Treatment||Single||||||t
1464567|NCT01448109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464568|NCT01448096||Single Group Assignment||Treatment||None (Open Label)||||||
1464569|NCT01448083|||Case-Only||Prospective|||||||
1464570|NCT01448070|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1464571|NCT01448057|Randomized|Parallel Assignment||Treatment||Single|||||t|
1464572|NCT01448044|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464573|NCT01448031|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1464574|NCT01448018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464575|NCT01448005|||Cohort||Prospective|||||||
1464576|NCT01447992||Single Group Assignment||Treatment||None (Open Label)||||||
1464577|NCT01447979||Single Group Assignment||Basic Science||None (Open Label)||||||
1464578|NCT01447966|Randomized|Parallel Assignment||Treatment||Single||||||t
1464579|NCT01447953|Randomized|Parallel Assignment||Treatment||Single||||||t
1464580|NCT01447940|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464581|NCT01447927|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1464582|NCT01447914||Single Group Assignment||Treatment||None (Open Label)||||||
1464583|NCT01447901|||Case Control||Prospective|||||||
1464584|NCT01447888|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464585|NCT01447875||Single Group Assignment||Prevention||None (Open Label)||||||
1464586|NCT01447862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464587|NCT01447849|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1464588|NCT01447836|||Cohort||Prospective|||||||
1464589|NCT01447823|||Cohort||Prospective|||||||
1464590|NCT01447810||Single Group Assignment||Supportive Care||None (Open Label)||||||
1464591|NCT01447797|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464592|NCT01447784|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464593|NCT01447771|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1464594|NCT01447758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464595|NCT01447745|||Cohort||Prospective|||||||
1464596|NCT01447732|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464597|NCT01447719||Single Group Assignment||Diagnostic||None (Open Label)||||||
1464598|NCT01447706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464599|NCT01447693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464600|NCT01447680|||Cohort||Prospective|||||||
1464601|NCT01447667||Single Group Assignment||Diagnostic||None (Open Label)||||||
1464602|NCT01447654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464603|NCT01447641|||Case-Crossover||Prospective|||||||
1464604|NCT01447628|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1464605|NCT01447615|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464606|NCT01447602||Single Group Assignment||Treatment||None (Open Label)||||||
1464607|NCT01447589||Single Group Assignment||Treatment||None (Open Label)||||||
1464608|NCT01447576||Single Group Assignment||Treatment||None (Open Label)||||||
1464609|NCT01447563|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1464610|NCT01447550|||Cohort||Prospective|||||||
1464611|NCT01447537|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464612|NCT01447524||Single Group Assignment||Treatment||None (Open Label)||||||
1464613|NCT01447511|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1464614|NCT01447498|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1464615|NCT01447485||Single Group Assignment||Basic Science||None (Open Label)||||||
1464616|NCT01447472|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1464617|NCT01447459|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1464618|NCT01447446|||Cohort||Prospective|||||||
1464619|NCT01447433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464620|NCT01447420||Single Group Assignment||Treatment||None (Open Label)||||||
1464621|NCT01447407|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464622|NCT01447394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464623|NCT01447381|||Cohort||Prospective|||||||
1464624|NCT01447368|Randomized|Parallel Assignment||Treatment||Single||||||t
1464625|NCT01447355||Single Group Assignment||Prevention||None (Open Label)||||||
1464626|NCT01447342||Single Group Assignment||Treatment||None (Open Label)||||||
1464627|NCT01447329|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464628|NCT01447316|||Case-Only||Prospective|||||||
1464629|NCT01447303|||Case-Only||Prospective|||||||
1464630|NCT01447290|||Cohort||Prospective|||||||
1464631|NCT01447277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464632|NCT01447264|Randomized|Parallel Assignment||Treatment||Single||||||t
1464633|NCT01447251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464634|NCT01447238|||Case-Only||Prospective|||||||
1464635|NCT01447225|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464636|NCT01447212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464637|NCT01447199|||Family-Based||Prospective|||||||
1464638|NCT01447186|||Cohort||Prospective|||||||
1464639|NCT01447173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464640|NCT01447160|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1464641|NCT01447147|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464643|NCT01447121||Single Group Assignment||Diagnostic||None (Open Label)||||||
1464644|NCT01447108||Crossover Assignment||Treatment||Single|||t|||
1464645|NCT01447095|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464646|NCT01447082|||||Retrospective|||||||
1464647|NCT01447069|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464648|NCT01447056||Single Group Assignment||Treatment||None (Open Label)||||||
1464649|NCT01447043|||||Retrospective|||||||
1464650|NCT01447030|||Case-Only||Retrospective|||||||
1464651|NCT01447017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464652|NCT01447004|||Case Control||Prospective|||||||
1464653|NCT01446991|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464654|NCT01446978|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464655|NCT01446965|Randomized|Parallel Assignment||Treatment||Single||||||t
1464656|NCT01446952||Single Group Assignment||Prevention||None (Open Label)||||||
1464657|NCT01446939|||Case Control||Cross-Sectional|||||||
1464658|NCT01446926|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1464659|NCT01446913|Randomized|Parallel Assignment||Treatment||Single|||||t|
1464660|NCT01446900||Single Group Assignment||Treatment||None (Open Label)||||||
1464661|NCT01446887|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1464662|NCT01446874|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1464663|NCT01446861|||Case Control||Cross-Sectional|||||||
1464664|NCT01446848||Single Group Assignment||Treatment||None (Open Label)||||||
1464665|NCT01446835|Randomized|Single Group Assignment||||Single|||t|||
1464666|NCT01446822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464667|NCT01446809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464668|NCT01446796|Randomized|Parallel Assignment||Prevention||Single|||t|||
1464669|NCT01446783|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1464670|NCT01446770||Single Group Assignment||Treatment||None (Open Label)||||||
1464671|NCT01446757|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1464672|NCT01446744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464673|NCT01446731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464674|NCT01446718|||Cohort||Prospective|||||||
1464675|NCT01446705|||Cohort||Retrospective|||||||
1464676|NCT01446692|||||Retrospective|||||||
1464677|NCT01446679|||Cohort||Prospective|||||||
1464678|NCT01446666|||Cohort||Prospective|||||||
1464679|NCT01446653|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1464680|NCT01446640||Single Group Assignment||Treatment||None (Open Label)||||||
1464681|NCT01446627|||Case Control||Retrospective|||||||
1464682|NCT01446614||Single Group Assignment||Treatment||None (Open Label)||||||
1464683|NCT01446601|Randomized|Parallel Assignment||Treatment||Single||||||t
1464684|NCT01446588||Single Group Assignment||Treatment||None (Open Label)||||||
1464685|NCT01446562||Single Group Assignment||Treatment||None (Open Label)||||||
1464686|NCT01446549|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464687|NCT01446536||||||Single|||||t|
1464688|NCT01446523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464689|NCT01446510||||||||||||
1464690|NCT01446497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464691|NCT01446484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464692|NCT01446471|||Cohort||Prospective|||||||
1464693|NCT01446458||Single Group Assignment||Treatment||None (Open Label)||||||
1464694|NCT01446445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464695|NCT01446432|||Cohort||Prospective|||||||
1464696|NCT01446419|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1464697|NCT01446406|Randomized|Parallel Assignment||Treatment||Single||||||t
1464698|NCT01446393|||Case Control||Prospective|||||||
1464699|NCT01446380|||Cohort||Prospective|||||||
1464700|NCT01446367|||Case Control||Prospective|||||||
1464701|NCT01446354|||Cohort||Retrospective|||||||
1464702|NCT01446341|Randomized|Single Group Assignment||Treatment||Single|||||t|
1464703|NCT01446328|Randomized|Parallel Assignment||Treatment||Single||||||t
1464704|NCT01446315|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464705|NCT01446302|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1464706|NCT01446289|Randomized|Parallel Assignment||Prevention||Single|||||t|
1464707|NCT01446276|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1464708|NCT01446263|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1464709|NCT01446250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464710|NCT01446237||Single Group Assignment||Treatment||None (Open Label)||||||
1464711|NCT01446224|||Cohort||Retrospective|||||||
1464712|NCT01446211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464713|NCT01446198|||Case Control||Retrospective|||||||
1464714|NCT01446185||Single Group Assignment||||None (Open Label)||||||
1464715|NCT01446172|||Cohort||Prospective|||||||
1464716|NCT01446159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464717|NCT01446146|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1464718|NCT01446133|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464719|NCT01446120|Randomized|Crossover Assignment||||None (Open Label)||||||
1464720|NCT01446107|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1464721|NCT01446094||Single Group Assignment||Diagnostic||None (Open Label)||||||
1464722|NCT01446081|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464723|NCT01446068|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1464724|NCT01446055|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464725|NCT01446042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464726|NCT01446029|Randomized|Parallel Assignment||Prevention||Single||||||t
1464727|NCT01446016|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464728|NCT01446003|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1464729|NCT01445990||Single Group Assignment||Diagnostic||Single||||t||
1464730|NCT01445977|||Case-Only||Prospective|||||||
1464731|NCT01445964|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464732|NCT01445951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464733|NCT01445938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464734|NCT01445925|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464735|NCT01445899|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464736|NCT01445886|Randomized|Single Group Assignment||Treatment||Single||||||t
1464737|NCT01445873|||Cohort||Retrospective|||||||
1464738|NCT01445860||Single Group Assignment||Basic Science||None (Open Label)||||||
1464739|NCT01445847|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464740|NCT01445834|||||Retrospective|||||||
1464741|NCT01445821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464742|NCT01445808|Randomized|Parallel Assignment||Treatment||Single||||||t
1464743|NCT01445795|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1464744|NCT01445782|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1464745|NCT01445769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464746|NCT01445756|Randomized|Single Group Assignment||Health Services Research||Double|||t||t|
1464747|NCT01445743|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1464748|NCT01445730|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1464749|NCT01445717|||Cohort||Prospective|||||||
1464750|NCT01445704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464751|NCT01445691||Single Group Assignment||Treatment||None (Open Label)||||||
1464752|NCT01445678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464753|NCT01445652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464754|NCT01445639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464755|NCT01445626|||Cohort||Retrospective|||||||
1464756|NCT01445613||Single Group Assignment||Treatment||None (Open Label)||||||
1464757|NCT01445600|||||Prospective|||||||
1464758|NCT01445587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464759|NCT01445561|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464760|NCT01445548||Single Group Assignment||Treatment||None (Open Label)||||||
1464761|NCT01445535||Single Group Assignment||Treatment||None (Open Label)||||||
1464762|NCT01445522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464763|NCT01445509|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1464764|NCT01445483|||Cohort||Prospective|||||||
1464765|NCT01445444|Randomized|Parallel Assignment||Treatment||Single||||||t
1464766|NCT01445431|Randomized|Single Group Assignment||Treatment||Single|||||t|
1464767|NCT01445418|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464768|NCT01445405|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464769|NCT01445392|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464770|NCT01445379|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464771|NCT01445366|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464772|NCT01445340|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464773|NCT01445327|||||Prospective|||||||
1464774|NCT01445314|||Cohort||Other|||||||
1464775|NCT01445301|Randomized|Parallel Assignment||Treatment||Single|||||t|
1464776|NCT01445288|||Cohort||Prospective|||||||
1464777|NCT01445275|||||Retrospective|||||||
1464778|NCT01445262|||||Prospective|||||||
1464779|NCT01445249|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1464780|NCT01445236|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464781|NCT01445223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464782|NCT01445210|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464783|NCT01445197||Single Group Assignment||Treatment||None (Open Label)||||||
1464784|NCT01445171||Single Group Assignment||Treatment||None (Open Label)||||||
1464785|NCT01445158|||Cohort||Prospective|||||||
1464786|NCT01445145|||||Prospective|||||||
1464787|NCT01445132||||Treatment||||||||
1464788|NCT01445119||||Treatment||||||||
1464789|NCT01445106|Non-Randomized|||Treatment||None (Open Label)||||||
1464790|NCT01445080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464791|NCT01445067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464792|NCT01445054||Single Group Assignment||Diagnostic||None (Open Label)||||||
1464793|NCT01445041|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464794|NCT01445028|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464795|NCT01445015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464796|NCT01445002|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464797|NCT01444989|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1464798|NCT01444976|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464799|NCT01444924|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1464800|NCT01444911|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464801|NCT01444898||Single Group Assignment||Treatment||None (Open Label)||||||
1464802|NCT01444885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464803|NCT01444872|Randomized|Crossover Assignment||||Single|||t|||
1464804|NCT01444859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464805|NCT01444846|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464806|NCT01444833||Single Group Assignment||Treatment||None (Open Label)||||||
1464807|NCT01444820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464808|NCT01444807|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1464809|NCT01444794|||Cohort||Prospective|||||||
1464810|NCT01444781|Randomized|Parallel Assignment||Prevention||Single||||||t
1464811|NCT01444768|||Cohort||Prospective|||||||
1464812|NCT01444755|||Case Control||Prospective|||||||
1464813|NCT01444742||Single Group Assignment||Treatment||None (Open Label)||||||
1464814|NCT01444729|||Other||Prospective|||||||
1464815|NCT01444716||Single Group Assignment||Treatment||None (Open Label)||||||
1464816|NCT01444703|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1464817|NCT01444690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464818|NCT01444677|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1464819|NCT01444664||Single Group Assignment||Treatment||None (Open Label)||||||
1464820|NCT01444651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464821|NCT01444638|Randomized|Parallel Assignment||||Single||||||t
1464822|NCT01444625|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1464823|NCT01444612|||Cohort||Retrospective|||||||
1464824|NCT01444599|||Case-Only||Cross-Sectional|||||||
1464825|NCT01444586|||Case-Control||Prospective|||||||
1464826|NCT01444573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464827|NCT01444560|||Cohort||Prospective|||||||
1464828|NCT01444547|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464829|NCT01444534|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464830|NCT01444521||Single Group Assignment||Treatment||None (Open Label)||||||
1464831|NCT01444508|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1464832|NCT01444495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464833|NCT01444482|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1464834|NCT01444469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464835|NCT01444456|||Cohort||Prospective|||||||
1464836|NCT01444443|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464837|NCT01444430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464838|NCT01444417|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464839|NCT01444404|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464840|NCT01444391||Single Group Assignment||Treatment||None (Open Label)||||||
1464841|NCT01444378||Single Group Assignment||Treatment||None (Open Label)||||||
1464842|NCT01444365|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464843|NCT01444352|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464844|NCT01444339|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464845|NCT01444326|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1464846|NCT01444313|Randomized|Parallel Assignment||Prevention||Single||||||t
1464847|NCT01444300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464848|NCT01444287|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1464849|NCT01444274|||Case Control||Prospective|||||||
1464850|NCT01444261|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464851|NCT01444248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464852|NCT01444235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464853|NCT01444222|||Case Control||Cross-Sectional|||||||
1464854|NCT01444209||Single Group Assignment||Treatment||None (Open Label)||||||
1464855|NCT01444196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464856|NCT01444183|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464857|NCT01444170|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1464858|NCT01444157|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1464859|NCT01444144|||Case-Only||Retrospective|||||||
1464860|NCT01444131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464861|NCT01444118||||||None (Open Label)||||||
1464862|NCT01444105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464863|NCT01444092||Single Group Assignment||Treatment||None (Open Label)||||||
1464864|NCT01444079|||Cohort||Prospective|||||||
1464865|NCT01444066|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464866|NCT01444053|||Case-Control||Retrospective|||||||
1464867|NCT01444040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464868|NCT01444027|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464869|NCT01444014||Single Group Assignment||Treatment||None (Open Label)||||||
1464870|NCT01444001|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464871|NCT01443988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464872|NCT01443975|||Cohort||Prospective|||||||
1464873|NCT01443962|Randomized|Crossover Assignment||Prevention||Single||||||t
1464874|NCT01443949|||||Retrospective|||||||
1464875|NCT01443936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464876|NCT01443923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464877|NCT01443910|||Other||Cross-Sectional|||||||
1464878|NCT01443897|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1464879|NCT01443884|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1464880|NCT01443871|Randomized|Parallel Assignment||||Triple|||t||t|t
1464881|NCT01443858|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464882|NCT01443845|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1464883|NCT01443832|||Case-Only||Retrospective|||||||
1464884|NCT01443819|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464885|NCT01443806||Single Group Assignment||Basic Science||None (Open Label)||||||
1464886|NCT01443793|||Cohort||Prospective|||||||
1464887|NCT01443780|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1464888|NCT01443767|||Case-Only||Prospective|||||||
1464889|NCT01443754|||Case-Only||Prospective|||||||
1464890|NCT01443741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464891|NCT01443728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464892|NCT01443715|Randomized|Parallel Assignment||Treatment||Single||||||t
1464893|NCT01443702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464894|NCT01443689|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464895|NCT01443676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464896|NCT01443663|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464897|NCT01443650|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464898|NCT01443637|||Cohort||Prospective|||||||
1464899|NCT01443624||Single Group Assignment||Basic Science||None (Open Label)||||||
1464900|NCT01443611|||Case-Only||Retrospective|||||||
1464901|NCT01443598|||Cohort||Prospective|||||||
1464902|NCT01443585||Single Group Assignment||Treatment||None (Open Label)||||||
1464903|NCT01443572|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464904|NCT01443559|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1464905|NCT01443546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464906|NCT01443533|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1464907|NCT01443520|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1464908|NCT01443507|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1464909|NCT01443494||Single Group Assignment||Treatment||None (Open Label)||||||
1464910|NCT01443481|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464911|NCT01443468|||Family-Based||Prospective|||||||
1464912|NCT01443455|Randomized|Parallel Assignment||Treatment||Single||||||t
1464913|NCT01443442|Randomized|Parallel Assignment||Treatment||Single|||||t|
1464914|NCT01443429|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1464915|NCT01443416|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464916|NCT01443403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464917|NCT01443390||||||||||||
1464918|NCT01443377||Single Group Assignment||Treatment||None (Open Label)||||||
1464919|NCT01443364||Single Group Assignment||Treatment||None (Open Label)||||||
1464920|NCT01443351|||Case-Only||Prospective|||||||
1464921|NCT01443338|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464922|NCT01443325|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1464923|NCT01443312|||Case-Only||Prospective|||||||
1464924|NCT01443299||||||||||||
1464925|NCT01443286||||||||||||
1464926|NCT01443273|||Cohort||Retrospective|||||||
1464927|NCT01443260||Single Group Assignment||Treatment||None (Open Label)||||||
1464928|NCT01443247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464929|NCT01443234|Randomized|Parallel Assignment||Treatment||Single|||t|||
1464930|NCT01443221|Randomized|Crossover Assignment||||None (Open Label)||||||
1464931|NCT01443208|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1464932|NCT01443195|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1464933|NCT01443182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464934|NCT01443169|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1464935|NCT01443156|||Cohort||Prospective|||||||
1464936|NCT01443143|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464937|NCT01443130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464938|NCT01443117|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1464939|NCT01443104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464940|NCT01443091|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464941|NCT01443078||Single Group Assignment||Treatment||None (Open Label)||||||
1464942|NCT01443065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464943|NCT01443052|||Case Control||Prospective|||||||
1464944|NCT01443039||Single Group Assignment||Treatment||None (Open Label)||||||
1464945|NCT01443026|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1464946|NCT01443013|||Cohort||Prospective|||||||
1464947|NCT01443000|||Cohort|||||||||
1464948|NCT01442987|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1464949|NCT01442974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464950|NCT01442961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464951|NCT01442948|||Cohort||Prospective|||||||
1464952|NCT01442935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464953|NCT01442922|||Case-Only||Prospective|||||||
1464954|NCT01442909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464955|NCT01442896|||Cohort||Prospective|||||||
1464956|NCT01442883|||Cohort||Prospective|||||||
1464957|NCT01442870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464958|NCT01442857|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1464959|NCT01442844|Randomized|Parallel Assignment||Treatment||Single||||||t
1464960|NCT01442831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464961|NCT01442818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464962|NCT01442805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464963|NCT01442792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464964|NCT01442779|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464965|NCT01442766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464966|NCT01442753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1464967|NCT01442740|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1464968|NCT01442727|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1464969|NCT01442714||Single Group Assignment||Treatment||None (Open Label)||||||
1464970|NCT01442701|||Cohort||Prospective|||||||
1464971|NCT01442688|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1464972|NCT01442675||Single Group Assignment||Prevention||None (Open Label)||||||
1464973|NCT01442662||Single Group Assignment||Treatment||None (Open Label)||||||
1464974|NCT01442649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464975|NCT01442636||Single Group Assignment||Treatment||None (Open Label)||||||
1464976|NCT01442623|Randomized|Parallel Assignment||Treatment||Single||||||t
1464977|NCT01442610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464978|NCT01442597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464979|NCT01442584||Single Group Assignment||Treatment||Single|||t|||
1464980|NCT01442571|Randomized|Parallel Assignment||Treatment||Single||||||
1464981|NCT01442558|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1464982|NCT01442545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1464983|NCT01442532|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1464984|NCT01442519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1464985|NCT01442506|||Case Control||Prospective|||||||
1464986|NCT01442493|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1464987|NCT01442480|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1464988|NCT01442467|||Case Control||Prospective|||||||
1464989|NCT01442454|||||Prospective|||||||
1464990|NCT01442441|||||Retrospective|||||||
1464991|NCT01442428|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1464992|NCT01442415||Single Group Assignment||Treatment||None (Open Label)||||||
1464993|NCT01442402|||Cohort|||||||||
1464994|NCT01442389||||||||||||
1464995|NCT01442376|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464996|NCT01442363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1464997|NCT01442350|||Cohort||Prospective|||||||
1464998|NCT01442337|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1464999|NCT01442324||Single Group Assignment||Treatment||None (Open Label)||||||
1465000|NCT01442311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465001|NCT01442298|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1465002|NCT01442285|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465003|NCT01442272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465004|NCT01442259||Parallel Assignment||Other||None (Open Label)||||||
1465005|NCT01442246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465006|NCT01442233|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465007|NCT01442220|||Case Control||Prospective|||||||
1465008|NCT01442207|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465009|NCT01442194|||Cohort||Prospective|||||||
1465010|NCT01442181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465011|NCT01442168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465012|NCT01442155|||Cohort||Prospective|||||||
1465013|NCT01442142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465014|NCT01442129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465015|NCT01442116|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1465016|NCT01442103||Single Group Assignment||Treatment||None (Open Label)||||||
1465017|NCT01442090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465018|NCT01442077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465019|NCT01442064||Single Group Assignment||Treatment||None (Open Label)||||||
1465020|NCT01442051||Single Group Assignment||Treatment||None (Open Label)||||||
1465021|NCT01442038|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465022|NCT01442025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465023|NCT01442012|Randomized|Parallel Assignment||Prevention||Single|||t|||
1465024|NCT01441999|Randomized|Parallel Assignment||Prevention||Single|||t|||
1465025|NCT01441986|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1465026|NCT01441973|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465027|NCT01441960|Randomized|Crossover Assignment||Treatment||Double||||t||t
1465028|NCT01441947||Single Group Assignment||Treatment||None (Open Label)||||||
1465029|NCT01441934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465030|NCT01441921|Randomized|Crossover Assignment||Prevention||Single|||||t|
1465031|NCT01441908|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1465032|NCT01441895|||Cohort||Prospective|||||||
1465033|NCT01441882||Single Group Assignment||Treatment||None (Open Label)||||||
1465034|NCT01441869|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1465035|NCT01441856|Randomized|Parallel Assignment||Treatment||Double|The patient, surgical ward physician and surgical ward nurses are blinded up and until postoperative day 4.||t|t||
1465036|NCT01441843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465037|NCT01441830|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1465038|NCT01441817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465039|NCT01441804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465040|NCT01441791|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1465041|NCT01441778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465042|NCT01441765|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465043|NCT01441752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465044|NCT01441739|||Case Control||Prospective|||||||
1465045|NCT01441726|||||Prospective|||||||
1465046|NCT01441713|||Cohort||Cross-Sectional|||||||
1465047|NCT01441700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465048|NCT01441687|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1465049|NCT01441674|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1465050|NCT01441661|||Cohort||Retrospective|||||||
1465051|NCT01441648|||Cohort||Prospective|||||||
1465052|NCT01441635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465053|NCT01441622||Single Group Assignment||Health Services Research||None (Open Label)||||||
1465054|NCT01441609|||Case Control|||||||||
1465055|NCT01441596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465056|NCT01441583|Randomized|Crossover Assignment||Treatment||Single|||t|||
1465057|NCT01441570|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465058|NCT01441557|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1465059|NCT01441544|Randomized|Crossover Assignment||Other||Single|||t|||
1465060|NCT01441531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465061|NCT01441518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465062|NCT01441505|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1465063|NCT01441492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465064|NCT01441479|||||Prospective|||||||
1465065|NCT01441466|||Cohort||Prospective|||||||
1465066|NCT01441453||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465067|NCT01441440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465068|NCT01441427|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1465069|NCT01441414|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465070|NCT01441401|||Case-Only||Prospective|||||||
1465071|NCT01441388|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465072|NCT01441375|||Cohort||Retrospective|||||||
1465073|NCT01441362|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465074|NCT01441349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465075|NCT01441336||Single Group Assignment||Treatment||None (Open Label)||||||
1465076|NCT01441323|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1465077|NCT01441310||Single Group Assignment||Treatment||None (Open Label)||||||
1465078|NCT01441297||Single Group Assignment||Treatment||None (Open Label)||||||
1465079|NCT01441284|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1465080|NCT01441271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465081|NCT01441258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465082|NCT01441245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465083|NCT01441232|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465084|NCT01441219||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465085|NCT01441206|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1465086|NCT01441193|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465087|NCT01441180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465088|NCT01441167|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465089|NCT01441154|||||Prospective|||||||
1465090|NCT01441141|||Case-Control||Retrospective|||||||
1465091|NCT01441128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465092|NCT01441115|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465093|NCT01441102||Single Group Assignment||Treatment||None (Open Label)||||||
1465094|NCT01441089|||Case-Only||Prospective|||||||
1465095|NCT01441076||Single Group Assignment||Treatment||None (Open Label)||||||
1465096|NCT01441063||Single Group Assignment||Treatment||None (Open Label)||||||
1465097|NCT01441037||Single Group Assignment||Treatment||None (Open Label)||||||
1465098|NCT01441024|Randomized|Parallel Assignment||Treatment||||||||
1465099|NCT01441011|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465100|NCT01440998||Single Group Assignment||Treatment||None (Open Label)||||||
1465101|NCT01440985|Randomized|Parallel Assignment||||Single||||||t
1465102|NCT01440972|Randomized|Parallel Assignment||||Triple|||t||t|t
1465103|NCT01440959||Single Group Assignment||Treatment||None (Open Label)||||||
1465104|NCT01440946||Single Group Assignment||Treatment||None (Open Label)||||||
1465105|NCT01440933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465106|NCT01440920|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465107|NCT01440907|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465108|NCT01440894|||Cohort||Retrospective|||||||
1465109|NCT01440881|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1465110|NCT01440868|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465111|NCT01440855|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1465112|NCT01440842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465113|NCT01440829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465114|NCT01440816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465115|NCT01440803|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1465116|NCT01440790|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1465117|NCT01440777|Randomized|Parallel Assignment||||None (Open Label)||||||
1465118|NCT01440764|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1465119|NCT01440751|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465120|NCT01440738|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465121|NCT01440725|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1465122|NCT01440712|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465123|NCT01440699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465124|NCT01440686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465125|NCT01440673|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1465126|NCT01440660|||Cohort||Prospective|||||||
1465127|NCT01440647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465128|NCT01440634|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465129|NCT01440621|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1465130|NCT01440608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465131|NCT01440595|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465132|NCT01440582||Single Group Assignment||Treatment||None (Open Label)||||||
1465133|NCT01440569||Single Group Assignment||Treatment||None (Open Label)||||||
1465134|NCT01440556|||Case Control||Retrospective|||||||
1465135|NCT01440543|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1465136|NCT01440530|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465137|NCT01440517||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465138|NCT01440504|||||Prospective|||||||
1465139|NCT01440491|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465140|NCT01440478|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1465141|NCT01440465|||||Prospective|||||||
1465142|NCT01440452|Randomized|Parallel Assignment||Treatment||Single||||||t
1465143|NCT01440439|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465144|NCT01440426|Randomized|Parallel Assignment||Treatment||Single||||||t
1465145|NCT01440413||Single Group Assignment||Other||None (Open Label)||||||
1465146|NCT01440400|Randomized|Parallel Assignment||||Single||||||t
1465147|NCT01440387|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465148|NCT01440374|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1465149|NCT01440361|Randomized|Parallel Assignment||||Triple|||t|t|t|
1465150|NCT01440348||Single Group Assignment||Treatment||None (Open Label)||||||
1465151|NCT01440335|Randomized|Crossover Assignment||Treatment||||||||
1465152|NCT01440322|Randomized|Parallel Assignment||||None (Open Label)||||||
1465153|NCT01440309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465154|NCT01440296|||Cohort||Prospective|||||||
1465155|NCT01440283||Single Group Assignment||Treatment||None (Open Label)||||||
1465156|NCT01440270||Single Group Assignment||Treatment||None (Open Label)||||||
1465157|NCT01440257|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465158|NCT01440244||Single Group Assignment||Treatment||None (Open Label)||||||
1465159|NCT01440231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465160|NCT01440218|||Cohort||Prospective|||||||
1465161|NCT01440205|Randomized|Parallel Assignment||Prevention||Single|||t|||
1465162|NCT01440192|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465163|NCT01440179||Single Group Assignment||Treatment||None (Open Label)||||||
1465164|NCT01440166|Randomized|Parallel Assignment||||Double|||t||t|
1465165|NCT01440153|Randomized|Parallel Assignment||Prevention||Single||||||t
1465166|NCT01440140|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465167|NCT01440127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465168|NCT01440114|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1465169|NCT01440101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465170|NCT01440088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465171|NCT01440075|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465172|NCT01440062|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465173|NCT01440049|||Cohort||Prospective|||||||
1465174|NCT01440036|||Case Control||Prospective|||||||
1465175|NCT01440023|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1465176|NCT01440010|||Ecologic or Community||Prospective|||||||
1465177|NCT01439997||Single Group Assignment||Treatment||None (Open Label)||||||
1465178|NCT01439984|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465179|NCT01439971|Non-Randomized|Sequential Assignment||Basic Science||None (Open Label)||The was an ascending dose trial with one open label treatment, intervention model was sequential dose escalation.||||
1465180|NCT01439958||Single Group Assignment||Prevention||None (Open Label)||||||
1465181|NCT01439945|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1465182|NCT01439932|Randomized|Single Group Assignment||Treatment||Single|||||t|
1465183|NCT01439919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465184|NCT01439906|||Cohort||Prospective|||||||
1465185|NCT01439893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465186|NCT01439880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465187|NCT01439867||Single Group Assignment||Treatment||None (Open Label)||||||
1465188|NCT01439854|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1465189|NCT01439841|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465190|NCT01439828|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465191|NCT01439815|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1465192|NCT01439802|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1465193|NCT01439789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465194|NCT01439776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465195|NCT01439763|||Cohort||Cross-Sectional|||||||
1465196|NCT01439750|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465197|NCT01439737|||Cohort||Prospective|||||||
1465198|NCT01439724|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1465199|NCT01439711||Single Group Assignment||Treatment||None (Open Label)||||||
1465200|NCT01439698|||Case-Only||Prospective|||||||
1465201|NCT01439685|||Case Control|||||||||
1465202|NCT01439672||Single Group Assignment||Treatment||None (Open Label)||||||
1465203|NCT01439659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465204|NCT01439646|||||Retrospective|||||||
1465205|NCT01439633||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465206|NCT01439620||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465207|NCT01439607||Single Group Assignment||Basic Science||None (Open Label)||||||
1465208|NCT01439594||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465209|NCT01439581|Randomized|Parallel Assignment||Prevention||None (Open Label)||Patients were assigned randomly to either a medical intensive care unit with pressure mapping beds or a unit that did not have them||||
1465210|NCT01439568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465211|NCT01439555||Single Group Assignment||Treatment||None (Open Label)||||||
1465212|NCT01439542||Single Group Assignment||Treatment||None (Open Label)||||||
1465213|NCT01439529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465214|NCT01439516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465215|NCT01439503|Randomized|Parallel Assignment||Prevention||Single|||t|||
1465216|NCT01439490||Single Group Assignment||Diagnostic||Single|||||t|
1465217|NCT01439477|||Ecologic or Community||Prospective|||||||
1465218|NCT01439464|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465219|NCT01439451|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1465220|NCT01439438|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1465221|NCT01439425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465222|NCT01439412|Randomized|Parallel Assignment||Treatment||Single||||||t
1465223|NCT01439399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465224|NCT01439386|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465225|NCT01439373|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465226|NCT01439360|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1465227|NCT01439347|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465228|NCT01439334|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1465229|NCT01439321|||Cohort||Retrospective|||||||
1465230|NCT01439308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465231|NCT01439295|||Cohort||Prospective|||||||
1465232|NCT01439282||Single Group Assignment||Treatment||None (Open Label)||||||
1465233|NCT01439269|Randomized|Parallel Assignment||Treatment||Single||||||t
1465234|NCT01439256|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465235|NCT01439243|Randomized|Crossover Assignment||||None (Open Label)||||||
1465236|NCT01439230|Randomized|Crossover Assignment||||None (Open Label)||||||
1465237|NCT01439217|||Case Control||Cross-Sectional|||||||
1465238|NCT01439204|Randomized|Parallel Assignment||||None (Open Label)||||||
1465239|NCT01439191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465240|NCT01439178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465241|NCT01439165|Randomized|Parallel Assignment||Prevention||Single||||||t
1465242|NCT01439152|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465243|NCT01439139|||Case-Only||Cross-Sectional|||||||
1465244|NCT01439126|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465245|NCT01439113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465246|NCT01439100|Randomized|Parallel Assignment||Treatment||Double||||||
1465247|NCT01439087||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465248|NCT01439074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465249|NCT01439061|||Cohort||Other|||||||
1465250|NCT01439048|||Case Control||Prospective|||||||
1465251|NCT01439035||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465252|NCT01439022|Randomized|Parallel Assignment||Treatment||Single||||||t
1465253|NCT01439009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465254|NCT01438996|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465255|NCT01438983|||Cohort||Retrospective|||||||
1465256|NCT01438970||Single Group Assignment||Treatment||None (Open Label)||||||
1465257|NCT01438957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465258|NCT01438944||Single Group Assignment||Health Services Research||None (Open Label)||||||
1465259|NCT01438931|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465260|NCT01438918|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465261|NCT01438905|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1465262|NCT01438892|||Cohort||Prospective|||||||
1465263|NCT01438879|||Case Control||Prospective|||||||
1465264|NCT01438866||Single Group Assignment||Prevention||None (Open Label)||||||
1465265|NCT01438853|Randomized|Parallel Assignment||Treatment||Single|||||t|
1465266|NCT01438840|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465267|NCT01438827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465268|NCT01438814|Randomized|Parallel Assignment||Treatment||Double||||||
1465269|NCT01438801||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465270|NCT01438788||Single Group Assignment||Treatment||None (Open Label)||||||
1465271|NCT01438775||Single Group Assignment||Treatment||None (Open Label)||||||
1465272|NCT01438762|Randomized|Parallel Assignment||Treatment||Single||||||t
1465273|NCT01438749||Crossover Assignment||||Double|||t||t|
1465274|NCT01438736|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1465275|NCT01438723|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1465276|NCT01438710|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465277|NCT01438697|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465278|NCT01438684|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465279|NCT01438671||Single Group Assignment||Treatment||None (Open Label)||||||
1465280|NCT01438658|||Cohort||Prospective|||||||
1465281|NCT01438645|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1465282|NCT01438632|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1465283|NCT01438619|||Ecologic or Community||Cross-Sectional|||||||
1465284|NCT01438606|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1465285|NCT01438593||Single Group Assignment||Treatment||None (Open Label)||||||
1465286|NCT01438580|Randomized|Parallel Assignment||Treatment||Single||||||t
1465287|NCT01438567|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465288|NCT01438554||Single Group Assignment||Other||None (Open Label)||||||
1465289|NCT01438541||Single Group Assignment||Prevention||None (Open Label)||||||
1465290|NCT01438528|||Cohort||Prospective|||||||
1465291|NCT01438515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465292|NCT01438502||||||||||||
1465293|NCT01438489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465294|NCT01438476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465295|NCT01438463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465296|NCT01438450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465297|NCT01438437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465298|NCT01438424||Single Group Assignment||Treatment||None (Open Label)||||||
1465299|NCT01438411||Single Group Assignment||Treatment||None (Open Label)||||||
1465300|NCT01438398||Single Group Assignment||Treatment||None (Open Label)||||||
1465301|NCT01438385|||Other||Prospective|||||||
1465302|NCT01438372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465303|NCT01438359|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1465304|NCT01438346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465305|NCT01438333|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1465306|NCT01438320|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1465307|NCT01438307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465308|NCT01438294|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1465309|NCT01438281||Single Group Assignment||Treatment||Single|||||t|
1465310|NCT01438268|||Cohort||Prospective|||||||
1465311|NCT01438255|||||Prospective|||||||
1465312|NCT01438242|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1465313|NCT01438229||Single Group Assignment||Treatment||None (Open Label)||||||
1465314|NCT01438216|||Cohort||Prospective|||||||
1465315|NCT01438203|Randomized|Parallel Assignment||Treatment||Single||||||t
1465316|NCT01438190|Randomized|Parallel Assignment||Prevention||Single|||||t|
1465317|NCT01438177||Single Group Assignment||Treatment||None (Open Label)||||||
1465318|NCT01438164|||Cohort||Prospective|||||||
1465319|NCT01438151||Single Group Assignment||||None (Open Label)||||||
1465320|NCT01438138|||Cohort||Retrospective|||||||
1465321|NCT01438125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465322|NCT01438112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465323|NCT01438099|||Cohort||Prospective|||||||
1465324|NCT01438086|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465325|NCT01438073||Single Group Assignment||Other||None (Open Label)||||||
1465326|NCT01438060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465327|NCT01438047|||Cohort||Prospective|||||||
1465328|NCT01438034||Single Group Assignment||Other||None (Open Label)||||||
1465329|NCT01438021||Single Group Assignment||Treatment||None (Open Label)||||||
1465330|NCT01438008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465331|NCT01437995|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465332|NCT01437982|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1465333|NCT01437969|||Cohort||Prospective|||||||
1465334|NCT01437956|||Case Control||Prospective|||||||
1465335|NCT01437943|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465336|NCT01437930|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1465337|NCT01437917|Randomized|Crossover Assignment||||Single|||t|||
1465338|NCT01437904|Randomized|Parallel Assignment||Treatment||Single||||||t
1465339|NCT01437891|||Case Control||Prospective|||||||
1465340|NCT01437878|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465341|NCT01437865||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465342|NCT01437852||Single Group Assignment||Treatment||None (Open Label)||||||
1465343|NCT01437839|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465344|NCT01437826|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1465345|NCT01437813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465346|NCT01437800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465347|NCT01437787|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1465348|NCT01437774|Randomized|Parallel Assignment||Treatment||Single||||||t
1465349|NCT01437761|||Cohort||Prospective|||||||
1465350|NCT01437748|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1465351|NCT01437735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465352|NCT01437722|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1465353|NCT01437709|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465354|NCT01437696|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1465355|NCT01437683|||Cohort||Retrospective|||||||
1465356|NCT01437670|||||Prospective|||||||
1465357|NCT01437657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465358|NCT01437644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465359|NCT01437631|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465360|NCT01437618|||Cohort||Prospective|||||||
1465361|NCT01437605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465362|NCT01437592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465363|NCT01437579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465364|NCT01437566|Randomized|||Treatment||Double|||t||t|
1465365|NCT01437553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465366|NCT01437540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465367|NCT01437527|Randomized|Parallel Assignment||Treatment||Single||||||t
1465368|NCT01437514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465369|NCT01437501|Randomized|Parallel Assignment||Prevention||Single|||t|||
1465370|NCT01437488||Single Group Assignment||Treatment||None (Open Label)||||||
1465371|NCT01437475||Single Group Assignment||Prevention||None (Open Label)||||||
1465372|NCT01437462|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465373|NCT01437449||Single Group Assignment||Treatment||None (Open Label)||||||
1465374|NCT01437436|||Cohort||Prospective|||||||
1465375|NCT01437423||Single Group Assignment||Prevention||None (Open Label)||||||
1465376|NCT01437410|||Case Control||Retrospective|||||||
1465377|NCT01437397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465378|NCT01437384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465379|NCT01437371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465380|NCT01437358|||||Cross-Sectional|||||||
1465381|NCT01437345|||Cohort||Cross-Sectional|||||||
1465382|NCT01437332|||Ecologic or Community||Prospective|||||||
1465383|NCT01437319|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1465384|NCT01437306|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1465385|NCT01437293||Single Group Assignment||Basic Science||Single|||t|||
1465386|NCT01437280||Single Group Assignment||Treatment||None (Open Label)||||||
1465387|NCT01437267|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1465388|NCT01437254|Non-Randomized|Parallel Assignment||Diagnostic||Single|The Nuclear Medicine physicians interpreting the whole body biodistribution pattern of CPERT and GPERT scans were blinded.|||||t
1465389|NCT01437241|||Cohort||Prospective|||||||
1465390|NCT01437228|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465391|NCT01437215|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465392|NCT01437202|||Cohort||Retrospective|||||||
1465393|NCT01437189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465394|NCT01437176|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465395|NCT01437163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465396|NCT01437150|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465397|NCT01437137|Randomized|Parallel Assignment||||Single|||t|||
1465398|NCT01437124|||Cohort||Prospective|||||||
1465399|NCT01437111||Single Group Assignment||Treatment||None (Open Label)||||||
1465400|NCT01437098||Single Group Assignment||Treatment||None (Open Label)||||||
1465401|NCT01437085|||Case-Only||Prospective|||||||
1465402|NCT01437072|||||Cross-Sectional|||||||
1465403|NCT01437059|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465404|NCT01437046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465405|NCT01437033|||Other||Prospective|||||||
1465406|NCT01437020|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465407|NCT01437007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465408|NCT01436994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465409|NCT01436981|||Cohort||Prospective|||||||
1465410|NCT01436968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465411|NCT01436955|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465412|NCT01436942|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1465413|NCT01436929|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1465414|NCT01436916|Randomized|Parallel Assignment||Prevention||Single|||t|||
1465415|NCT01436903||Single Group Assignment||Treatment||None (Open Label)||||||
1465416|NCT01436890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465417|NCT01436877||Single Group Assignment||Treatment||None (Open Label)||||||
1465418|NCT01436864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465496|NCT01435850|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1465497|NCT01435837|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1465419|NCT01436851||Single Group Assignment||Diagnostic||None (Open Label)|The participants were challenged on two occasions, one with placebo extract, and the other with storage mite extract, but in random order, and without the participants knowing when they received allergen or placebo|Participants with storage mite sensitization were challenged with placebo extract and storage mite extract in the nose.||||
1465420|NCT01436838|||Cohort||Prospective|||||||
1465421|NCT01436825|||Cohort||Prospective|||||||
1465422|NCT01436812|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1465423|NCT01436799|Randomized|Parallel Assignment||Prevention||Single|||||t|
1465424|NCT01436786|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1465425|NCT01436773|||Case-Control||Cross-Sectional|||||||
1465426|NCT01436760|||Case-Only||Retrospective|||||||
1465427|NCT01436747|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465428|NCT01436734||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465429|NCT01436721|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465430|NCT01436708|||Case-Only||Prospective|||||||
1465431|NCT01436695|||Cohort||Prospective|||||||
1465432|NCT01436682|||Case Control||Prospective|||||||
1465433|NCT01436669||||||||||||
1465434|NCT01436656|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465435|NCT01436643|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465436|NCT01436630|||Cohort||Cross-Sectional|||||||
1465437|NCT01436617|||||Prospective|||||||
1465438|NCT01436604|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1465439|NCT01436591|||||Prospective|||||||
1465440|NCT01436578|||Cohort||Prospective|||||||
1465441|NCT01436565|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465442|NCT01436552|||Cohort||Prospective|||||||
1465443|NCT01436539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465444|NCT01436526|Randomized|Crossover Assignment||||None (Open Label)||||||
1465445|NCT01436513|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1465446|NCT01436500|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465447|NCT01436487|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465448|NCT01436474|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465449|NCT01436461||||||||||||
1465450|NCT01436448|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1465451|NCT01436435||Single Group Assignment||Treatment||None (Open Label)||||||
1465452|NCT01436422|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1465453|NCT01436409|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1465454|NCT01436396|Randomized|Parallel Assignment||Prevention||Single||||||t
1465455|NCT01436383||Single Group Assignment||Basic Science||None (Open Label)||||||
1465456|NCT01436370|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1465457|NCT01436357|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1465458|NCT01436344|||Case Control||Cross-Sectional|||||||
1465459|NCT01436331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465460|NCT01436318|||Ecologic or Community||Prospective|||||||
1465461|NCT01436305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465462|NCT01436292|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465463|NCT01436279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465464|NCT01436266|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1465465|NCT01436253|||Cohort||Prospective|||||||
1465466|NCT01436240|||Case-Only||Prospective|||||||
1465467|NCT01436227||Single Group Assignment||Treatment||None (Open Label)||||||
1465468|NCT01436214||Single Group Assignment||Treatment||None (Open Label)||||||
1465469|NCT01436201||Single Group Assignment||Treatment||None (Open Label)||||||
1465470|NCT01436188|Randomized|Parallel Assignment||||None (Open Label)||||||
1465471|NCT01436175|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465472|NCT01436162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465473|NCT01436149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465474|NCT01436136|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1465475|NCT01436123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465476|NCT01436110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465477|NCT01436097|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1465478|NCT01436084||Single Group Assignment||Treatment||None (Open Label)||||||
1465479|NCT01436071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465480|NCT01436058||Single Group Assignment||Treatment||None (Open Label)||||||
1465481|NCT01436045|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1465482|NCT01436032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465483|NCT01436019|||Cohort||Prospective|||||||
1465484|NCT01436006|||Case-Only||Retrospective|||||||
1465485|NCT01435993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465486|NCT01435980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465487|NCT01435967|||Ecologic or Community||Retrospective|||||||
1465488|NCT01435954|||Cohort||Retrospective|||||||
1465489|NCT01435941|||Cohort||Retrospective|||||||
1465490|NCT01435928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465491|NCT01435915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465492|NCT01435902|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1465493|NCT01435889|||Cohort||Prospective|||||||
1465494|NCT01435876|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1465495|NCT01435863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466277|NCT01425593|||Case-Only||Prospective|||||||
1465498|NCT01435824|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465499|NCT01435811|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1465500|NCT01435798|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1465501|NCT01435785|||Case-Control||Prospective|||||||
1465502|NCT01435772|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465503|NCT01435759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465504|NCT01435746|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465505|NCT01435733|||Case-Only||Retrospective|||||||
1465506|NCT01435720|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465507|NCT01435707|Non-Randomized|Parallel Assignment||||Single|||t|||
1465508|NCT01435694|Randomized|Parallel Assignment||Treatment||Single||||||t
1465509|NCT01435681|||Case Control||Prospective|||||||
1465510|NCT01435668|Randomized|Parallel Assignment||Prevention||Single|||t|||
1465511|NCT01435655||Single Group Assignment||Treatment||None (Open Label)||||||
1465512|NCT01435642|||Ecologic or Community||Cross-Sectional|||||||
1465513|NCT01435629|||Other||Retrospective|||||||
1465514|NCT01435616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465515|NCT01435603|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1465516|NCT01435590|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1465517|NCT01435577|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465518|NCT01435564|Randomized|Parallel Assignment||Prevention||Single||||||t
1465519|NCT01435551||||||||||||
1465520|NCT01435538|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465521|NCT01435525|||Cohort||Prospective|||||||
1465522|NCT01435512|Randomized|Parallel Assignment||Treatment||Single||||||t
1465523|NCT01435499|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465524|NCT01435486|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465525|NCT01435473|||Cohort||Prospective|||||||
1465526|NCT01435460|Randomized|Parallel Assignment||Treatment||Single|||||t|
1465527|NCT01435447||Single Group Assignment||Treatment||None (Open Label)||||||
1465528|NCT01435434||Single Group Assignment||Treatment||None (Open Label)||||||
1465529|NCT01435421||||||||||||
1465530|NCT01435408|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465531|NCT01435395||Single Group Assignment||Treatment||None (Open Label)||||||
1465532|NCT01435382|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1465533|NCT01435369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465534|NCT01435356|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1465535|NCT01435343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465536|NCT01435330|Randomized|Parallel Assignment||||Double|||t||t|
1465537|NCT01435317||Single Group Assignment||Treatment||None (Open Label)||||||
1465538|NCT01435304|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465539|NCT01435291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465540|NCT01435278||Single Group Assignment||Treatment||None (Open Label)||||||
1465541|NCT01435265|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465542|NCT01435252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465543|NCT01435239|Randomized|Parallel Assignment||||Double|||t||t|
1465544|NCT01435226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465545|NCT01435213|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1465546|NCT01435200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465547|NCT01435187|||Cohort||Prospective|||||||
1465548|NCT01435174||Single Group Assignment||Treatment||None (Open Label)||||||
1465549|NCT01435161|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465550|NCT01435148|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1465551|NCT01435135|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1465552|NCT01435122||Single Group Assignment||Treatment||None (Open Label)||||||
1465553|NCT01435109|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1465554|NCT01435096||Single Group Assignment||Treatment||None (Open Label)||||||
1465555|NCT01435083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465556|NCT01435070|||Cohort||Prospective|||||||
1465557|NCT01435057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465558|NCT01435044|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465559|NCT01435031||Single Group Assignment||Treatment||None (Open Label)||||||
1465560|NCT01435018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465561|NCT01435005|Randomized|Parallel Assignment||Prevention||None (Open Label)||Phase 3 - To compare the effects of a high versus moderate volume exercise intervention on specific biological intermediate endpoints for breast cancer in a group of previously inactive postmenopausal women.||||
1465562|NCT01434992|||Cohort||Prospective|||||||
1465563|NCT01434979|||Case Control||Prospective|||||||
1465564|NCT01434966|Randomized|Parallel Assignment||Treatment||Single||||||t
1465565|NCT01434953|Randomized|Parallel Assignment||Screening||Single|||t|||
1465566|NCT01434940|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1465567|NCT01434927|||Cohort||Prospective|||||||
1465568|NCT01434914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465569|NCT01434901|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1465570|NCT01434888|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1465571|NCT01434862|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465572|NCT01434849|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1465573|NCT01434836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465574|NCT01434823|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465575|NCT01434810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465576|NCT01434797|||Case Control||Prospective|||||||
1465577|NCT01434784|||Cohort||Prospective|||||||
1465578|NCT01434771|||Cohort||Prospective|||||||
1465579|NCT01434758|||Cohort||Prospective|||||||
1465580|NCT01434745|Randomized|Crossover Assignment||Treatment||Single|||t|||
1465581|NCT01434732|Randomized|Parallel Assignment||Treatment||Single|||||t|
1465582|NCT01434719|||Case Control||Retrospective|||||||
1465583|NCT01434706||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465584|NCT01434693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465585|NCT01434680|Randomized|Parallel Assignment||Prevention||Single|||||t|
1465586|NCT01434667|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465587|NCT01434654|||Cohort||Prospective|||||||
1465588|NCT01434641||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465589|NCT01434628|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1465590|NCT01434615|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465591|NCT01434602|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1465592|NCT01434589|Randomized|Parallel Assignment||Treatment||Single||||||t
1465593|NCT01434576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465594|NCT01434563|||Cohort||Prospective|||||||
1465595|NCT01434550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465596|NCT01434537|||Cohort||Retrospective|||||||
1465597|NCT01434524|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1465598|NCT01434511||Single Group Assignment||Treatment||None (Open Label)||||||
1465599|NCT01434498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465600|NCT01434485|||Cohort||Prospective|||||||
1465601|NCT01434472||Single Group Assignment||Treatment||None (Open Label)||||||
1465602|NCT01434459||Single Group Assignment||Treatment||None (Open Label)||||||
1465603|NCT01434446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465604|NCT01434433|||Cohort||Retrospective|||||||
1465605|NCT01434420||Single Group Assignment||||None (Open Label)||||||
1465606|NCT01434407|Randomized|Crossover Assignment||Prevention||Single||||||t
1465607|NCT01434394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465608|NCT01434381|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465609|NCT01434368|||||Prospective|||||||
1465610|NCT01434355|||Family-Based||Prospective|||||||
1465611|NCT01434342|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1465612|NCT01434329|||||Retrospective|||||||
1465613|NCT01434316||Single Group Assignment||Treatment||None (Open Label)||||||
1465614|NCT01434303||Single Group Assignment||Treatment||None (Open Label)||||||
1465615|NCT01434290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465616|NCT01434277|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1465617|NCT01434264|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1465618|NCT01434251|Randomized|Parallel Assignment||Treatment||Single||||||t
1465619|NCT01434238||Single Group Assignment||Prevention||None (Open Label)||||||
1465620|NCT01434225||Single Group Assignment||Treatment||None (Open Label)||||||
1465621|NCT01434212|||Cohort||Prospective|||||||
1465622|NCT01434199|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1465623|NCT01434186|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465624|NCT01434173|||Cohort||Retrospective|||||||
1465625|NCT01434160||Single Group Assignment||Prevention||None (Open Label)||||||
1465626|NCT01434147||Single Group Assignment||Treatment||None (Open Label)||||||
1465627|NCT01434134|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1465628|NCT01434121|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1465629|NCT01434108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465630|NCT01434095||Single Group Assignment||Treatment||None (Open Label)||||||
1465631|NCT01434082|||Case Control||Cross-Sectional|||||||
1465632|NCT01434069||Single Group Assignment||Treatment||None (Open Label)||||||
1465633|NCT01434056|||Cohort||Prospective|||||||
1465634|NCT01434043|||Case-Only||Prospective|||||||
1465635|NCT01434030||Single Group Assignment||||None (Open Label)||||||
1465636|NCT01434017|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1465637|NCT01434004|Randomized|Parallel Assignment||||None (Open Label)||||||
1465638|NCT01433991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465639|NCT01433978|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465640|NCT01433965||Single Group Assignment||Treatment||None (Open Label)||||||
1465641|NCT01433952|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1465642|NCT01433939|||Cohort||Prospective|||||||
1465643|NCT01433926|||Case-Only||Cross-Sectional|||||||
1465644|NCT01433913|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465645|NCT01433900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465646|NCT01433887|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465647|NCT01433874|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1465648|NCT01433861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465649|NCT01433848|||Cohort||Prospective|||||||
1465650|NCT01433835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465651|NCT01433809|||Cohort||Prospective|||||||
1465652|NCT01433796|||Cohort||Prospective|||||||
1465653|NCT01433770||Single Group Assignment||||None (Open Label)||||||
1465654|NCT01433757|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465655|NCT01433744|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465656|NCT01433731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465657|NCT01433718||Single Group Assignment||Treatment||None (Open Label)||||||
1465658|NCT01433705|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Subjects will have a PET scan after IV administration of a radio-labelled tracer, Rb-82 and N-13 or injection of F-18 FDG||||
1465659|NCT01433692|Randomized|Parallel Assignment||||Single|||t|||
1465660|NCT01433679|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1465661|NCT01433666|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1465662|NCT01433653|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1465663|NCT01433640|||Cohort||Prospective|||||||
1465664|NCT01433627|Randomized|Factorial Assignment||Treatment||Single||||||t
1465665|NCT01433614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465666|NCT01433601|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1465667|NCT01433588|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1465668|NCT01433575|Randomized|Crossover Assignment||||None (Open Label)||||||
1465669|NCT01433562|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465670|NCT01433549|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1465671|NCT01433536|||Cohort||Cross-Sectional|||||||
1465672|NCT01433523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465673|NCT01433510||Single Group Assignment||Treatment||None (Open Label)||||||
1465674|NCT01433497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465675|NCT01433484|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465676|NCT01433471|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1465677|NCT01433458|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1465678|NCT01433445||Single Group Assignment||Treatment||None (Open Label)||||||
1465679|NCT01433432|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465680|NCT01433419||Parallel Assignment||||||||||
1465681|NCT01433406||Parallel Assignment||||||||||
1465682|NCT01433393||Parallel Assignment||||||||||
1465683|NCT01433380|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1465684|NCT01433367|||Cohort||Prospective|||||||
1465685|NCT01433354||Single Group Assignment||Treatment||None (Open Label)||||||
1465686|NCT01433341|||||Prospective|||||||
1465687|NCT01433328|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1465688|NCT01433315|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1465689|NCT01433302|||Case Control||Prospective|||||||
1465690|NCT01433289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465691|NCT01433276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465692|NCT01433263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465693|NCT01433250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465694|NCT01433237|||Case Control||Retrospective|||||||
1465695|NCT01433224|||Case-Only||Retrospective|||||||
1465696|NCT01433211|||Cohort||Cross-Sectional|||||||
1465697|NCT01433198|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465698|NCT01433185|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1465699|NCT01433172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465700|NCT01433159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465701|NCT01433146|||Cohort||Prospective|||||||
1465702|NCT01433133||Single Group Assignment||Treatment||None (Open Label)||||||
1465703|NCT01433120|Randomized|Parallel Assignment||Prevention||Single|||t|||
1465704|NCT01433107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465705|NCT01433094|Randomized|Parallel Assignment||Treatment||Single||||||t
1465706|NCT01433081|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1465707|NCT01433068||Single Group Assignment||Treatment||None (Open Label)||||||
1465708|NCT01433055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465709|NCT01433042||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465710|NCT01433029|||Cohort||Prospective|||||||
1465711|NCT01433016|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1465712|NCT01433003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465713|NCT01432990|Randomized|Single Group Assignment||Treatment||Single||||||t
1465714|NCT01432977|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465715|NCT01432964|||Cohort||Prospective|||||||
1465716|NCT01432951|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1465717|NCT01432938|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465718|NCT01432925|Randomized|Parallel Assignment||Treatment||Single||||||t
1465719|NCT01432912||Single Group Assignment||||Single|||t|||
1465720|NCT01432899|||Case-Control||Prospective|||||||
1465721|NCT01432886||Single Group Assignment||Treatment||None (Open Label)||||||
1465722|NCT01432873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465723|NCT01432860|Randomized|Parallel Assignment||Screening||Single|||||t|
1465724|NCT01432847|||Family-Based||Cross-Sectional|||||||
1465725|NCT01432834|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465726|NCT01432821|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1465727|NCT01432795||Single Group Assignment||Treatment||None (Open Label)||||||
1465728|NCT01432782|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1465729|NCT01432769|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465730|NCT01432756|Randomized|Parallel Assignment||Prevention||Single|||||t|
1465731|NCT01432743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465732|NCT01432730|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1465733|NCT01432717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465734|NCT01432704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465735|NCT01432691||Single Group Assignment||Treatment||Single|||t|||
1465736|NCT01432678|||Cohort||Prospective|||||||
1465737|NCT01432665|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465738|NCT01432652|||Cohort||Prospective|||||||
1465739|NCT01432639|Randomized|Parallel Assignment||Treatment||Single||||||t
1465740|NCT01432626||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465741|NCT01432613||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465742|NCT01432600|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465743|NCT01432587|||Cohort||Prospective|||||||
1465744|NCT01432574||Single Group Assignment||Prevention||None (Open Label)||||||
1465745|NCT01432561||Single Group Assignment||||None (Open Label)||||||
1465746|NCT01432548|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465747|NCT01432535|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465748|NCT01432522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465749|NCT01432509||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465750|NCT01432496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465751|NCT01432483||||||||||||
1465752|NCT01432470|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465753|NCT01432457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465754|NCT01432444||Single Group Assignment||Treatment||None (Open Label)||||||
1465755|NCT01432431||Single Group Assignment||Supportive Care||None (Open Label)||||||
1465756|NCT01432418|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1465757|NCT01432405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465758|NCT01432392|||Cohort||Prospective|||||||
1465759|NCT01432379|||Cohort||Prospective|||||||
1465760|NCT01432366|||Cohort||Prospective|||||||
1465761|NCT01432353|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465762|NCT01432340|||Cohort||Prospective|||||||
1465763|NCT01432327|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1465764|NCT01432314||Single Group Assignment||Treatment||None (Open Label)||||||
1465765|NCT01432301||||||||||||
1465766|NCT01432288|||Cohort||Cross-Sectional|||||||
1465767|NCT01432275|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1465768|NCT01432262|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465769|NCT01432249|||Cohort||Prospective|||||||
1465770|NCT01432236|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1465771|NCT01432223||Single Group Assignment||Treatment||None (Open Label)||||||
1465772|NCT01432210|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1465773|NCT01432197|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1465774|NCT01432184|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465775|NCT01432171|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1465776|NCT01432158|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465777|NCT01432145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465778|NCT01432132|||Cohort||Prospective|||||||
1465779|NCT01432119|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465780|NCT01432106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465781|NCT01432093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465782|NCT01432080|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465783|NCT01432067|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1465784|NCT01432054||||||||||||
1465785|NCT01432041||||Prevention||||||||
1465786|NCT01432028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465787|NCT01432015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465788|NCT01432002|||Cohort||Prospective|||||||
1465789|NCT01431989|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1465790|NCT01431976|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465791|NCT01431963|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465792|NCT01431950|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465793|NCT01431937|Randomized|Crossover Assignment||Treatment||Single|||t|||
1465794|NCT01431924|||Cohort||Retrospective|||||||
1465795|NCT01431911|||Cohort||Retrospective|||||||
1465796|NCT01431898||||Treatment||Single|||t|||
1465797|NCT01431885|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1465798|NCT01431872|||Cohort||Prospective|||||||
1465799|NCT01431859|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1465800|NCT01431846|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1465801|NCT01431833|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1465802|NCT01431820|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465803|NCT01431807||Single Group Assignment||Treatment||None (Open Label)||||||
1465804|NCT01431794|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465805|NCT01431781|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465806|NCT01431768|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1465807|NCT01431755|Randomized|Parallel Assignment||||Single|||t|||
1465808|NCT01431742||Single Group Assignment||Treatment||None (Open Label)||||||
1465809|NCT01431729|||Case-Only||Prospective|||||||
1465810|NCT01431716||Single Group Assignment||Treatment||None (Open Label)||||||
1465811|NCT01431703|||Cohort||Prospective|||||||
1465812|NCT01431690|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465813|NCT01431677|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1465814|NCT01431664||||Treatment||None (Open Label)||||||
1465815|NCT01431651||Single Group Assignment||Treatment||Double|||t||t|
1465816|NCT01431638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465817|NCT01431625|Randomized|Parallel Assignment||Treatment||Single|||||t|
1465818|NCT01431612|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1465819|NCT01431599||Single Group Assignment||Treatment||None (Open Label)||||||
1465820|NCT01431586|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1465821|NCT01431573||Single Group Assignment||Treatment||None (Open Label)|"This is an open label study so all participants know what the treatment is."|||||
1465822|NCT01431560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465823|NCT01431547|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465824|NCT01431534|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465825|NCT01431521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465826|NCT01431508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465827|NCT01431495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465828|NCT01431482|||Cohort||Prospective|||||||
1465829|NCT01431469|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1465830|NCT01431456|Randomized|Parallel Assignment||Prevention||Single|||||t|
1465831|NCT01431443|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1465832|NCT01431430|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465833|NCT01431417|||Cohort||Prospective|||||||
1465834|NCT01431404|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1465835|NCT01431391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465836|NCT01431378|||Case-Crossover||Prospective|||||||
1465837|NCT01431365|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1465838|NCT01431352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465839|NCT01431339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465840|NCT01431326|||Cohort||Prospective|||||||
1465841|NCT01431313||Single Group Assignment||Treatment||None (Open Label)||||||
1465842|NCT01431300|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1465843|NCT01431287|Randomized|Parallel Assignment||Treatment||Double||||||
1465844|NCT01431274|Randomized|Parallel Assignment||Treatment||Double||||||
1465845|NCT01431261|Randomized|Parallel Assignment||Treatment||Single||||||t
1465846|NCT01431248|||Cohort||Prospective|||||||
1465847|NCT01431235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465848|NCT01431222|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465849|NCT01431209||Single Group Assignment||Treatment||None (Open Label)||||||
1465850|NCT01431196||Single Group Assignment||Treatment||None (Open Label)||||||
1465851|NCT01431183|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1465852|NCT01431170|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1465853|NCT01431157|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465854|NCT01431144|Randomized|Parallel Assignment||Treatment||Single||||||t
1465855|NCT01431131|Randomized|Parallel Assignment||Treatment||Single||||||t
1465856|NCT01431118|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1465857|NCT01431105||Single Group Assignment||Treatment||None (Open Label)||||||
1465858|NCT01431092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465859|NCT01431079|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1465860|NCT01431066|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1465861|NCT01431053|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465862|NCT01431040|Randomized|Parallel Assignment||||None (Open Label)||||||
1465863|NCT01431027|||Case-Only||Prospective|||||||
1465864|NCT01431014|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1465865|NCT01431001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465866|NCT01430988|||Case Control||Prospective|||||||
1465867|NCT01430975|||Cohort||Prospective|||||||
1465868|NCT01430962|||||Prospective|||||||
1465869|NCT01430949||Single Group Assignment||Treatment||None (Open Label)||||||
1465870|NCT01430936|||||Prospective|||||||
1465871|NCT01430923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465872|NCT01430910|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1465873|NCT01430897|||Cohort||Retrospective|||||||
1465874|NCT01430884|||||Cross-Sectional|||||||
1465875|NCT01430871|||Case Control||Prospective|||||||
1465876|NCT01430858||Single Group Assignment||||None (Open Label)||||||
1465877|NCT01430845|||Case-Only||Retrospective|||||||
1465878|NCT01430832|||Cohort||Prospective|||||||
1465879|NCT01430819|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1465880|NCT01430806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465881|NCT01430793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465882|NCT01430780|||Case Control||Prospective|||||||
1465883|NCT01430767|||Cohort||Prospective|||||||
1465884|NCT01430754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465885|NCT01430741|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1465886|NCT01430728|||Cohort||Prospective|||||||
1465887|NCT01430715|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1466513|NCT01422525|||Cohort||Prospective|||||||
1465888|NCT01430702|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1465889|NCT01430689|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1465890|NCT01430676|||Cohort||Prospective|||||||
1465891|NCT01430663|||Case Control||Prospective|||||||
1465892|NCT01430650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465893|NCT01430637|||Case Control||Retrospective|||||||
1465894|NCT01430624|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1465895|NCT01430611|Randomized|Parallel Assignment||Prevention||Single||||||t
1465896|NCT01430598|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465897|NCT01430585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465898|NCT01430572||Single Group Assignment||Treatment||None (Open Label)||||||
1465899|NCT01430559|Randomized|Parallel Assignment||Other||Double|||t||t|
1465900|NCT01430546|||Cohort||Prospective|||||||
1465901|NCT01430533|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1465902|NCT01430520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465903|NCT01430507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465904|NCT01430494|||Cohort||Prospective|||||||
1465905|NCT01430481|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1465906|NCT01430468|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465907|NCT01430455||Single Group Assignment||Treatment||None (Open Label)||||||
1465908|NCT01430442|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465909|NCT01430429||||||||||||
1465910|NCT01430416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465911|NCT01430403|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1465912|NCT01430390||Single Group Assignment||Treatment||None (Open Label)||||||
1465913|NCT01430377|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465914|NCT01430364|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1465915|NCT01430351|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1465916|NCT01430338|||Cohort||Cross-Sectional|||||||
1465917|NCT01430325|Randomized|Single Group Assignment||||Triple|||t||t|t
1465918|NCT01430312|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1465919|NCT01430299|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465920|NCT01430286|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1465921|NCT01430273|||Cohort||Prospective|||||||
1465922|NCT01430260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465923|NCT01430247||Single Group Assignment||Screening||None (Open Label)||||||
1465924|NCT01430234|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465925|NCT01430221|Randomized|Parallel Assignment||Prevention||Single||||||t
1465926|NCT01430208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465927|NCT01430195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465928|NCT01430182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465929|NCT01430169||Single Group Assignment||Treatment||None (Open Label)||||||
1465930|NCT01430156|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1465931|NCT01430143|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1465932|NCT01430130||Single Group Assignment||Prevention||None (Open Label)||||||
1465933|NCT01430117||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465934|NCT01430104||Single Group Assignment||Treatment||None (Open Label)||||||
1465935|NCT01430091|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1465936|NCT01430078|Randomized|Crossover Assignment||||None (Open Label)||||||
1465937|NCT01430065|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1465938|NCT01430052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465939|NCT01430039|||Cohort||Cross-Sectional|||||||
1465940|NCT01430026|||Case-Only||Retrospective|||||||
1465941|NCT01430013||Single Group Assignment||Treatment||None (Open Label)||||||
1465942|NCT01430000||Single Group Assignment||Treatment||None (Open Label)||||||
1465943|NCT01429987|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465944|NCT01429974|||Case-Only||Prospective|||||||
1465945|NCT01429961||Single Group Assignment||Treatment||None (Open Label)||||||
1465946|NCT01429948|||Case Control||Prospective|||||||
1465947|NCT01429935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465948|NCT01429909|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1465949|NCT01429896|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1465950|NCT01429883|||Cohort||Prospective|||||||
1465951|NCT01429870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465952|NCT01429857|||Cohort||Prospective|||||||
1465953|NCT01429844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1465954|NCT01429831||Single Group Assignment||Treatment||None (Open Label)||||||
1465955|NCT01429818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1465956|NCT01429805||Single Group Assignment||Supportive Care||None (Open Label)||||||
1465957|NCT01429792||Single Group Assignment||Treatment||None (Open Label)||||||
1465958|NCT01429779|Randomized|Single Group Assignment||Supportive Care||Single||||t||
1465959|NCT01429766|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1465960|NCT01429753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465961|NCT01429740|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1465962|NCT01429727|||Cohort||Other|||||||
1465963|NCT01429714|Randomized|Parallel Assignment||Prevention||Single||||t||
1465964|NCT01429701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465965|NCT01429688|Randomized|Crossover Assignment||||None (Open Label)||||||
1465966|NCT01429675|Randomized|Crossover Assignment||||None (Open Label)||||||
1465967|NCT01429662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465968|NCT01429649|Randomized|Parallel Assignment||Treatment||Single||||||t
1465969|NCT01429636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465970|NCT01429623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465971|NCT01429610||Single Group Assignment||Treatment||None (Open Label)||||||
1465972|NCT01429597|||Cohort||Prospective|||||||
1465973|NCT01429584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465974|NCT01429571|||Case Control||Prospective|||||||
1465975|NCT01429558|||Cohort||Prospective|||||||
1465976|NCT01429545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465977|NCT01429532|||Case Control||Prospective|||||||
1465978|NCT01429519||Single Group Assignment||Treatment||None (Open Label)||||||
1465979|NCT01429506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465980|NCT01429493|Randomized|Single Group Assignment||Treatment||Single|||t|||
1465981|NCT01429480|Randomized|Parallel Assignment||Treatment||Single|||||t|
1465982|NCT01429467||Single Group Assignment||Supportive Care||None (Open Label)||||||
1465983|NCT01429454|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465984|NCT01429441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465985|NCT01429428|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1465986|NCT01429415|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465987|NCT01429402|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1465988|NCT01429389|||Case-Only||Prospective|||||||
1465989|NCT01429376||Single Group Assignment||Diagnostic||None (Open Label)||||||
1465990|NCT01429363||Single Group Assignment||Treatment||None (Open Label)||||||
1465991|NCT01429350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1465992|NCT01429337|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1465993|NCT01429324|||Cohort||Prospective|||||||
1465994|NCT01429311|||Other||Prospective|||||||
1465995|NCT01429298|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465996|NCT01429285|Randomized|Parallel Assignment||Treatment||Single|||t|||
1465997|NCT01429272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1465998|NCT01429259||Single Group Assignment||Treatment||None (Open Label)||||||
1465999|NCT01429246|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466000|NCT01429233|||||Prospective|||||||
1466001|NCT01429220|||Cohort||Prospective|||||||
1466002|NCT01429207|||Cohort||Retrospective|||||||
1466003|NCT01429194||Single Group Assignment||Treatment||None (Open Label)||||||
1466004|NCT01429181|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1466005|NCT01429168|Randomized|Parallel Assignment||Treatment||Double||||||
1466006|NCT01429155|||Cohort||Retrospective|||||||
1466007|NCT01429142|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466008|NCT01429129|Randomized|Parallel Assignment||Treatment||Single|||||t|
1466009|NCT01429116||Single Group Assignment||Treatment||None (Open Label)||||||
1466010|NCT01429103|||Cohort||Cross-Sectional|||||||
1466011|NCT01429090|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1466012|NCT01429077|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466013|NCT01429064||Single Group Assignment||Treatment||None (Open Label)||||||
1466014|NCT01429051||Single Group Assignment||Treatment||Double|||t||t|
1466015|NCT01429038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466016|NCT01429025||Single Group Assignment||Treatment||None (Open Label)||||||
1466017|NCT01429012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466018|NCT01428999|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466019|NCT01428986|||Case Control||Prospective|||||||
1466020|NCT01428973|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466021|NCT01428960|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1466022|NCT01428947|||Case-Only||Prospective|||||||
1466023|NCT01428934|||Cohort||Prospective|||||||
1466024|NCT01428921|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466025|NCT01428908|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1466026|NCT01428895|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1466027|NCT01428882|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1466028|NCT01428869|||||Retrospective|||||||
1466029|NCT01428843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466030|NCT01428830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466031|NCT01428817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466032|NCT01428804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466033|NCT01428791|Randomized|Parallel Assignment||Treatment||Single||||||t
1466034|NCT01428778|||Cohort||Prospective|||||||
1466035|NCT01428765|||||Cross-Sectional|||||||
1466036|NCT01428752|||Cohort||Prospective|||||||
1466037|NCT01428739||Single Group Assignment||Treatment||None (Open Label)||||||
1466038|NCT01428726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466039|NCT01428713|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466040|NCT01428700|||Case-Only||Retrospective|||||||
1466041|NCT01428687|Randomized|Parallel Assignment||Treatment||Single||||||t
1466042|NCT01428674|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466043|NCT01428661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466044|NCT01428648|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466045|NCT01428635||Single Group Assignment||Treatment||None (Open Label)||||||
1466046|NCT01428622|Randomized|Crossover Assignment||Treatment||Double||||||
1466047|NCT01428609||Single Group Assignment||||Triple|||t||t|t
1466048|NCT01428596|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466049|NCT01428583||||Supportive Care||None (Open Label)||||||
1466050|NCT01428570|Randomized|Parallel Assignment||||Single|||t|||
1466051|NCT01428557|||Cohort||Prospective|||||||
1466052|NCT01428544|||||Retrospective|||||||
1466053|NCT01428531|||||Prospective|||||||
1466054|NCT01428518|||Case-Only||Prospective|||||||
1466055|NCT01428505||Single Group Assignment||Basic Science||None (Open Label)||||||
1466056|NCT01428492|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466057|NCT01428479|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1466058|NCT01428466|Randomized|Single Group Assignment||Prevention||Single|||t|||
1466059|NCT01428453|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466060|NCT01428440||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466061|NCT01428427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466062|NCT01428414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466063|NCT01428401|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466064|NCT01428388|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466065|NCT01428375|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466066|NCT01428362|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1466067|NCT01428349|Randomized|Crossover Assignment||Treatment||Single|||t|||
1466068|NCT01428336|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Every participant underwent the four interventional tests in random sequence||||
1466069|NCT01428323|Randomized|Parallel Assignment||||None (Open Label)||||||
1466070|NCT01428310|Randomized|Crossover Assignment||||Single|||t|||
1466071|NCT01428297|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1466072|NCT01428284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466073|NCT01428271|||||Prospective|||||||
1466074|NCT01428258|Randomized|Crossover Assignment||Treatment||None (Open Label)||The study is a randomized, two-arm, crossover trial comparing the GMP diet and the AA diet in 30 subjects with PKU > 12 years of age. Subjects were randomized to start with either the GMP diet or the AA diet which they followed for 3-wk at home, followed by a 3-wk washout period when they resumed their usual AA diet, and then 3-wk of either the GMP diet or the AA diet whichever they did not consume first. Each subject served as their own control; there was no control group. We studied medical foods - either AA or GMP medical foods which are not drugs. The FDA did not require that we have an IND.||||
1466075|NCT01428245||Single Group Assignment||Basic Science||None (Open Label)||||||
1466076|NCT01428232|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1466077|NCT01428219||Single Group Assignment||Treatment||None (Open Label)||||||
1466078|NCT01428206|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1466079|NCT01428193||Single Group Assignment||Basic Science||None (Open Label)||||||
1466080|NCT01428180|||Cohort||Prospective|||||||
1466081|NCT01428167|||Case Control||Prospective|||||||
1466082|NCT01428154||Single Group Assignment||Treatment||None (Open Label)||||||
1466083|NCT01428141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466084|NCT01428128||Single Group Assignment||Treatment||None (Open Label)||||||
1466085|NCT01428115|||Cohort||Prospective|||||||
1466086|NCT01428102|||Case-Only||Prospective|||||||
1466087|NCT01428089|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1466088|NCT01428076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466089|NCT01428063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466090|NCT01428050|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466091|NCT01428037|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466092|NCT01428024|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466093|NCT01428011|||Cohort||Prospective|||||||
1466094|NCT01427998|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466095|NCT01427985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466096|NCT01427972|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1466097|NCT01427959|||Cohort||Prospective|||||||
1466098|NCT01427946||Single Group Assignment||Treatment||None (Open Label)||||||
1466099|NCT01427933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466100|NCT01427920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466101|NCT01427907|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466102|NCT01427894|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1466103|NCT01427881||Single Group Assignment||Treatment||None (Open Label)||||||
1466104|NCT01427868|Randomized|Crossover Assignment||||None (Open Label)||||||
1466105|NCT01427855|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1466106|NCT01427842|Randomized|Single Group Assignment||Treatment||Single|||t|||
1466107|NCT01427829|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1466108|NCT01427816|Randomized|Parallel Assignment||Treatment||Double||||||
1466109|NCT01427803|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466110|NCT01427777|||Case-Only||Prospective|||||||
1466111|NCT01427764|Randomized|Single Group Assignment||Treatment||Single|||||t|
1466112|NCT01427751|Randomized|Parallel Assignment||Treatment||Single||||||t
1466113|NCT01427738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466114|NCT01427725|||Cohort||Prospective|||||||
1466115|NCT01427712|||Cohort||Prospective|||||||
1466116|NCT01427699||Single Group Assignment||Treatment||None (Open Label)||||||
1466117|NCT01427686|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1466118|NCT01427673|Randomized|Parallel Assignment||Treatment||Single|||||t|
1466119|NCT01427660|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1466120|NCT01427647|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1466121|NCT01427634|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1466122|NCT01427621|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1466123|NCT01427608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466124|NCT01427595||Single Group Assignment||Basic Science||None (Open Label)||||||
1466125|NCT01427582||||||||||||
1466126|NCT01427569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466127|NCT01427556|||||Prospective|||||||
1466128|NCT01427543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466129|NCT01427530|||Case-Only||Prospective|||||||
1466130|NCT01427517|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466131|NCT01427504|Randomized|Crossover Assignment||||None (Open Label)||||||
1466132|NCT01427491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466133|NCT01427478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466134|NCT01427465|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1466135|NCT01427452|||Cohort||Prospective|||||||
1466136|NCT01427439|||Cohort||Prospective|||||||
1466137|NCT01427426|Randomized|Parallel Assignment||||Triple|||t||t|t
1466138|NCT01427413|||Case-Only||Retrospective|||||||
1466139|NCT01427400|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1466140|NCT01427387|Randomized|Parallel Assignment||||Triple|||t|t|t|
1466141|NCT01427374|||Cohort||Prospective|||||||
1466142|NCT01427361|||Other||Prospective|||||||
1466143|NCT01427348|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1466144|NCT01427335|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1466145|NCT01427322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466146|NCT01427309|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1466147|NCT01427296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466148|NCT01427283|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466149|NCT01427270|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466150|NCT01427257|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466151|NCT01427244||Single Group Assignment||Treatment||None (Open Label)||||||
1466152|NCT01427231|Randomized|Crossover Assignment||||Double|||t||t|
1466153|NCT01427218|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1466154|NCT01427205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466155|NCT01427192|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1466156|NCT01427179|||Family-Based||Other|||||||
1466157|NCT01427166||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466158|NCT01427153|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1466159|NCT01427140|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1466160|NCT01427127|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1466161|NCT01427114||Single Group Assignment||Treatment||None (Open Label)||||||
1466162|NCT01427101|||Cohort||Cross-Sectional|||||||
1466163|NCT01427088||Single Group Assignment||Basic Science||None (Open Label)||||||
1466164|NCT01427075|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466165|NCT01427062|Randomized|Parallel Assignment||Treatment||Single||||||t
1466166|NCT01427049|||Cohort||Prospective|||||||
1466167|NCT01427036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466168|NCT01427023|||Cohort||Cross-Sectional|||||||
1466169|NCT01427010||Single Group Assignment||Treatment||None (Open Label)||Feasibility study||||
1466170|NCT01426997|||Case Control||Cross-Sectional|||||||
1466171|NCT01426984||Crossover Assignment||Diagnostic||Double|||t||t|
1466172|NCT01426971|Randomized|Parallel Assignment||Treatment||Double||||||
1466173|NCT01426958|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466174|NCT01426945|||Case-Only||Retrospective|||||||
1466175|NCT01426932|||Cohort||Prospective|||||||
1466176|NCT01426919|||Cohort||Prospective|||||||
1466177|NCT01426906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466178|NCT01426893|||||Prospective|||||||
1466179|NCT01426880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466180|NCT01426867|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466181|NCT01426854|Randomized|Parallel Assignment||Treatment||Single||||||t
1466182|NCT01426841|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466183|NCT01426828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466184|NCT01426815|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1466185|NCT01426802||Single Group Assignment||Treatment||None (Open Label)||||||
1466186|NCT01426789|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1466187|NCT01426776||Single Group Assignment||Screening||Single|||||t|
1466188|NCT01426763|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1466189|NCT01426750|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466190|NCT01426737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466191|NCT01426724||Single Group Assignment||||None (Open Label)||||||
1466192|NCT01426711|||Other||Other|||||||
1466193|NCT01426698|Randomized|Parallel Assignment||Basic Science||Single||||||t
1466194|NCT01426685|||Cohort||Prospective|||||||
1466195|NCT01426672||Parallel Assignment||Treatment||None (Open Label)||||||
1466196|NCT01426659|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1466197|NCT01426646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466198|NCT01426633||Single Group Assignment||Treatment||None (Open Label)||||||
1466199|NCT01426620||Single Group Assignment||Treatment||None (Open Label)||||||
1466200|NCT01426607|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1466201|NCT01426594|||||Prospective|||||||
1466202|NCT01426581|Randomized|Parallel Assignment||||Single||||||t
1466203|NCT01426568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466204|NCT01426555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466205|NCT01426542|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1466206|NCT01426529||Single Group Assignment||Other||None (Open Label)||||||
1466207|NCT01426516|Randomized|Parallel Assignment||||Single|||t|||
1466208|NCT01426490|Randomized|Factorial Assignment||Prevention||Double|||t|t||
1466209|NCT01426477|||Cohort||Prospective|||||||
1466210|NCT01426464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466211|NCT01426451|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466212|NCT01426438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466213|NCT01426425||Single Group Assignment||Treatment||None (Open Label)||||||
1466214|NCT01426412|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466215|NCT01426399|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466216|NCT01426386|Randomized|Parallel Assignment||Treatment||Single||||||t
1466217|NCT01426373||Single Group Assignment||Treatment||None (Open Label)||||||
1466218|NCT01426360|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1466219|NCT01426347|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466220|NCT01426334||Single Group Assignment||Treatment||None (Open Label)||||||
1466221|NCT01426321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466222|NCT01426308|||Case-Only||Retrospective|||||||
1466223|NCT01426295|Randomized|Parallel Assignment||||None (Open Label)||||||
1466224|NCT01426282|Randomized|Parallel Assignment||||None (Open Label)||||||
1466225|NCT01426269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466226|NCT01426256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466227|NCT01426243|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466228|NCT01426230|||||Prospective|||||||
1466229|NCT01426217|Randomized|Parallel Assignment||Prevention||Single|||||t|
1466230|NCT01426204|||Case-Only||Prospective|||||||
1466231|NCT01426191|||Case-Only||Prospective|||||||
1466232|NCT01426178|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1466233|NCT01426165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466234|NCT01426152|||Cohort||Retrospective|||||||
1466235|NCT01426139|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466236|NCT01426126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466237|NCT01426113|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466238|NCT01426100|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466239|NCT01426087|Randomized|Parallel Assignment||Basic Science||Single||||||t
1466240|NCT01426074||||Treatment||||||||
1466241|NCT01426061|Randomized|Parallel Assignment||Treatment||Single|||||t|
1466242|NCT01426048|||Case-Only||Retrospective|||||||
1466243|NCT01426035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466244|NCT01426022|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1466245|NCT01426009|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1466246|NCT01425996||Sequential Assignment||Treatment||None (Open Label)||||||
1466247|NCT01425983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466248|NCT01425970|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466249|NCT01425957||Single Group Assignment||Prevention||None (Open Label)||||||
1466250|NCT01425944|||Other||Cross-Sectional|||||||
1466251|NCT01425931|||Cohort||Prospective|||||||
1466252|NCT01425918|Randomized|Parallel Assignment||Treatment||Single||||||t
1466253|NCT01425905|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466254|NCT01425892|||Cohort||Prospective|||||||
1466255|NCT01425879||Single Group Assignment||Treatment||None (Open Label)||||||
1466256|NCT01425866|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466257|NCT01425853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466258|NCT01425840|Randomized|Crossover Assignment||Health Services Research||Triple|||t|t|t|
1466259|NCT01425827|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1466260|NCT01425814|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1466261|NCT01425801|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1466262|NCT01425788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466263|NCT01425775|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1466264|NCT01425762|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1466265|NCT01425749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466266|NCT01425736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466267|NCT01425723|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466268|NCT01425710|||Case Control||Prospective|||||||
1466269|NCT01425697|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466270|NCT01425684|||Other||Prospective|||||||
1466271|NCT01425671|||Case-Control||Cross-Sectional|||||||
1466272|NCT01425658|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1466273|NCT01425645|Randomized|Parallel Assignment||Prevention||Single|||t|||
1466274|NCT01425632|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466275|NCT01425619|Randomized|Single Group Assignment||Treatment||Single||||||t
1466276|NCT01425606|||Cohort||Prospective|||||||
1466278|NCT01425580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466279|NCT01425567|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466280|NCT01425554||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466281|NCT01425541||Single Group Assignment||Basic Science||None (Open Label)||||||
1466282|NCT01425528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466283|NCT01425515||Single Group Assignment||Treatment||None (Open Label)||||||
1466284|NCT01425502|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1466285|NCT01425489|||Cohort||Prospective|||||||
1466286|NCT01425476|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1466287|NCT01425463|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466288|NCT01425450|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1466289|NCT01425437|||Case-Only||Prospective|||||||
1466290|NCT01425424|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1466291|NCT01425411|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466292|NCT01425398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466293|NCT01425385|||Cohort||Prospective|||||||
1466294|NCT01425372|||Cohort||Prospective|||||||
1466295|NCT01425359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466296|NCT01425346|||Case-Only||Prospective|||||||
1466297|NCT01425333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466298|NCT01425320|Randomized|Parallel Assignment||||Triple|||t||t|t
1466299|NCT01425307|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466300|NCT01425294|||Other||Prospective|||||||
1466301|NCT01425281|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466302|NCT01425268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466303|NCT01425255|||Case-Crossover||Prospective|||||||
1466304|NCT01425242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466305|NCT01425229|||Cohort||Prospective|||||||
1466306|NCT01425216||Single Group Assignment||Treatment||None (Open Label)||||||
1466307|NCT01425203|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466308|NCT01425190|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466309|NCT01425177|Randomized|Parallel Assignment||Prevention||Single|||t|||
1466310|NCT01425164|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466311|NCT01425151|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1466312|NCT01425138|||Other||Retrospective|||||||
1466313|NCT01425125||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466314|NCT01425112|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466315|NCT01425099||Single Group Assignment||||None (Open Label)||||||
1466316|NCT01425086|||Case-Control||Prospective|||||||
1466317|NCT01425073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466318|NCT01425060|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466319|NCT01425047|||Cohort||Prospective|||||||
1466320|NCT01425034|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466321|NCT01425021|||Case-Only||Prospective|||||||
1466322|NCT01425008||Single Group Assignment||Treatment||None (Open Label)||||||
1466323|NCT01424995|||Case-Only||Prospective|||||||
1466324|NCT01424982||Single Group Assignment||Treatment||None (Open Label)||||||
1466325|NCT01424969|||Cohort||Prospective|||||||
1466326|NCT01424956|||Case Control||Retrospective|||||||
1466327|NCT01424943|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466328|NCT01424930|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466329|NCT01424917|||Cohort||Cross-Sectional|||||||
1466330|NCT01424904||Single Group Assignment||Supportive Care||Double|||t||t|
1466331|NCT01424891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466332|NCT01424878|||||Retrospective|||||||
1466333|NCT01424865|||Case Control||Retrospective|||||||
1466334|NCT01424852|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1466335|NCT01424839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466336|NCT01424826||Single Group Assignment||Treatment||None (Open Label)||||||
1466337|NCT01424813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466338|NCT01424800||Single Group Assignment||Basic Science||None (Open Label)||||||
1466339|NCT01424787|||Cohort|||||||||
1466340|NCT01424774|||Cohort||Prospective|||||||
1466341|NCT01424761|Randomized|Parallel Assignment||Prevention||Single|||t|||
1466342|NCT01424748|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1466343|NCT01424735||Single Group Assignment||Treatment||None (Open Label)||||||
1466344|NCT01424722||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466345|NCT01424709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466346|NCT01424696|||Cohort||Prospective|||||||
1466347|NCT01424683|||Cohort||Prospective|||||||
1466348|NCT01424670|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466349|NCT01424657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466350|NCT01424644|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1466351|NCT01424631|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1466352|NCT01424618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466353|NCT01424605|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1466354|NCT01424592|||Case-Only||Prospective|||||||
1466355|NCT01424579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466356|NCT01424566|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466357|NCT01424553||Single Group Assignment||Prevention||None (Open Label)||||||
1466358|NCT01424540|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1466359|NCT01424527|||Case-Only||Cross-Sectional|||||||
1466360|NCT01424514|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1466361|NCT01424501|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1466362|NCT01424488|Randomized|Parallel Assignment||Treatment||Single|||||t|
1466363|NCT01424475|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1466364|NCT01424462|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466365|NCT01424449||Single Group Assignment||||None (Open Label)||||||
1466366|NCT01424436|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1466367|NCT01424423|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1466368|NCT01424410|||Cohort||Prospective|||||||
1466369|NCT01424397|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1466370|NCT01424384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466371|NCT01424371|||Case Control||Prospective|||||||
1466372|NCT01424358||Parallel Assignment||||Single|||t|||
1466373|NCT01424345|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1466374|NCT01424332|Randomized|Crossover Assignment||||None (Open Label)||||||
1466375|NCT01424319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466376|NCT01424306|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1466377|NCT01424293||Single Group Assignment||||None (Open Label)||||||
1466378|NCT01424280|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1466379|NCT01424267|||Cohort||Prospective|||||||
1466380|NCT01424254|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1466381|NCT01424241||Single Group Assignment||Treatment||None (Open Label)||||||
1466382|NCT01424228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466383|NCT01424215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466384|NCT01424202|Randomized|Single Group Assignment||Prevention||Single||||||t
1466385|NCT01424189|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466386|NCT01424176|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1466387|NCT01424163|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1466388|NCT01424150|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1466389|NCT01424137|Randomized|Crossover Assignment||||None (Open Label)||||||
1466390|NCT01424124|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466391|NCT01424111|||Case-Control||Prospective|||||||
1466392|NCT01424098|Randomized|Parallel Assignment||Treatment||Single||||||t
1466393|NCT01424085|||Case Control||Prospective|||||||
1466394|NCT01424072|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466395|NCT01424059|||Case Control||Prospective|||||||
1466396|NCT01424046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466397|NCT01424033||Single Group Assignment||Treatment||None (Open Label)||||||
1466398|NCT01424020|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1466399|NCT01424007|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466400|NCT01423994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466401|NCT01423981|||Case-Only||Cross-Sectional|||||||
1466402|NCT01423968|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1466403|NCT01423955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466404|NCT01423942|||Case-Only||Prospective|||||||
1466405|NCT01423929|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466406|NCT01423916|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466407|NCT01423903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466408|NCT01423890||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466409|NCT01423877|||Case-Only||Prospective|||||||
1466410|NCT01423864|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466411|NCT01423851||Single Group Assignment||Treatment||None (Open Label)||||||
1466412|NCT01423838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466413|NCT01423825|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1466414|NCT01423812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466415|NCT01423799|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1466416|NCT01423786||Single Group Assignment||Treatment||None (Open Label)||||||
1466417|NCT01423773|Randomized|Crossover Assignment||||Single|||t|||
1466418|NCT01423760|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466419|NCT01423747|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466420|NCT01423734|||Cohort||Prospective|||||||
1466421|NCT01423721|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466422|NCT01423708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466423|NCT01423695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466424|NCT01423682|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1466425|NCT01423669|||Cohort||Cross-Sectional|||||||
1466426|NCT01423656|Randomized|Parallel Assignment||||Single|||t|||
1466427|NCT01423643|||Cohort||Prospective|||||||
1466428|NCT01423630||Single Group Assignment||Treatment||None (Open Label)||||||
1466429|NCT01423617|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466430|NCT01423604|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466431|NCT01423591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466432|NCT01423578|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466433|NCT01423565|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1466434|NCT01423552|||Cohort||Prospective|||||||
1466435|NCT01423539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466436|NCT01423526|Randomized|Single Group Assignment||Basic Science||Triple|||t|t|t|
1466437|NCT01423513|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1466438|NCT01423500|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466439|NCT01423487|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1466440|NCT01423474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466441|NCT01423461|||Cohort||Prospective|||||||
1466442|NCT01423448|Randomized|Parallel Assignment||||None (Open Label)||||||
1466443|NCT01423435|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1466444|NCT01423422|||Case Control||Prospective|||||||
1466445|NCT01423409|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1466446|NCT01423396|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466447|NCT01423383|||Ecologic or Community||Cross-Sectional|||||||
1466448|NCT01423370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466449|NCT01423357|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466450|NCT01423344|||||Prospective|||||||
1466451|NCT01423331||||||||||||
1466452|NCT01423318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466453|NCT01423305|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466454|NCT01423292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466455|NCT01423279|||Other||Other|||||||
1466456|NCT01423266|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466457|NCT01423253||Single Group Assignment||Treatment||None (Open Label)||||||
1466458|NCT01423240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466459|NCT01423227|Randomized|Parallel Assignment||Treatment||Single||||||t
1466460|NCT01423214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466461|NCT01423201|||Cohort||Prospective|||||||
1466462|NCT01423188|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466463|NCT01423175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466464|NCT01423162|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1466465|NCT01423149|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466466|NCT01423136|||Case Control||Prospective|||||||
1466467|NCT01423123|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466468|NCT01423110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466469|NCT01423097|||Ecologic or Community||Cross-Sectional|||||||
1466470|NCT01423084|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1466471|NCT01423071|||Case Control||Prospective|||||||
1466472|NCT01423058||Single Group Assignment||Treatment||None (Open Label)||||||
1466473|NCT01423045|||Cohort||Prospective|||||||
1466474|NCT01423032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466475|NCT01423019|Randomized|Parallel Assignment||||Triple|||t|t|t|
1466476|NCT01423006||Single Group Assignment||Treatment||None (Open Label)||||||
1466477|NCT01422993||Single Group Assignment||Supportive Care||None (Open Label)||||||
1466478|NCT01422980|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1466479|NCT01422967|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1466480|NCT01422954|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1466481|NCT01422941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466482|NCT01422928|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466483|NCT01422915||Single Group Assignment||Treatment||None (Open Label)||||||
1466484|NCT01422902|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1466485|NCT01422889|||Cohort||Prospective|||||||
1466486|NCT01422876|Randomized|Parallel Assignment||Treatment||Double||||||
1466487|NCT01422863||Single Group Assignment||Treatment||None (Open Label)||||||
1466488|NCT01422850||Single Group Assignment||Treatment||None (Open Label)||||||
1466489|NCT01422837|||Other||Prospective|||||||
1466490|NCT01422824|||Cohort||Prospective|||||||
1466491|NCT01422811|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1466492|NCT01422798|||Cohort||Prospective|||||||
1466493|NCT01422785|Randomized|Parallel Assignment||Treatment||Single|||||t|
1466494|NCT01422772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466495|NCT01422759||Single Group Assignment||Basic Science||None (Open Label)||||||
1466496|NCT01422746||Single Group Assignment||Basic Science||None (Open Label)||||||
1466497|NCT01422733||Single Group Assignment||Basic Science||None (Open Label)||||||
1466498|NCT01422720||Single Group Assignment||Treatment||None (Open Label)||||||
1466499|NCT01422707||Single Group Assignment||Basic Science||None (Open Label)||||||
1466500|NCT01422694|||Cohort||Prospective|||||||
1466501|NCT01422681||Single Group Assignment||Supportive Care||None (Open Label)||||||
1466502|NCT01422668|Non-Randomized|Single Group Assignment||||Single|||t|||
1466503|NCT01422655|||Cohort||Prospective|||||||
1466504|NCT01422642|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1466505|NCT01422629||Single Group Assignment||Basic Science||None (Open Label)||||||
1466506|NCT01422616|Randomized|Factorial Assignment||Treatment||Single||||||t
1466507|NCT01422603|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466508|NCT01422590|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466509|NCT01422577|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1466510|NCT01422564|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466511|NCT01422551|Randomized|Parallel Assignment||||Single|||t|||
1466512|NCT01422538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466514|NCT01422512|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1466515|NCT01422499||Single Group Assignment||Treatment||None (Open Label)||||||
1466516|NCT01422486||Single Group Assignment||Treatment||None (Open Label)||||||
1466517|NCT01422473||Single Group Assignment||Treatment||None (Open Label)||||||
1466518|NCT01422460||Single Group Assignment||Treatment||None (Open Label)||||||
1466519|NCT01422447|Randomized|Parallel Assignment||Prevention||Single|||t|||
1466520|NCT01422434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466521|NCT01422421|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1466522|NCT01422408||Single Group Assignment||Supportive Care||None (Open Label)||||||
1466523|NCT01422395|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1466524|NCT01422382|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1466525|NCT01422369|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1466526|NCT01422356|||Cohort||Prospective|||||||
1466527|NCT01422343|||Cohort||Prospective|||||||
1466528|NCT01422330||Single Group Assignment||Treatment||None (Open Label)||||||
1466529|NCT01422317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466530|NCT01422304|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466531|NCT01422291|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1466532|NCT01422278|Randomized|Crossover Assignment||Treatment||Single|||t|||
1466533|NCT01422265|||Cohort||Prospective|||||||
1466534|NCT01422252|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466535|NCT01422239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466536|NCT01422226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466537|NCT01422213|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466538|NCT01422200|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466539|NCT01422187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466540|NCT01422174|||Cohort|||||||||
1466541|NCT01422161|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1466542|NCT01422148|Randomized|Parallel Assignment||Prevention||Single|||t|||
1466543|NCT01422135|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1466544|NCT01422122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466545|NCT01422109|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466546|NCT01422096||Single Group Assignment||Basic Science||None (Open Label)||||||
1466547|NCT01422083|Randomized|Parallel Assignment||Prevention||Single|||||t|
1466548|NCT01422070|||Cohort||Prospective|||||||
1466549|NCT01422057|||Cohort||Prospective|||||||
1466550|NCT01422044|||Cohort||Prospective|||||||
1466551|NCT01422031|||Cohort||Prospective|||||||
1466552|NCT01422018||Single Group Assignment||Treatment||None (Open Label)||||||
1466553|NCT01422005|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466554|NCT01421992|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1466555|NCT01421979|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1466556|NCT01421966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466557|NCT01421953||Single Group Assignment||Supportive Care||None (Open Label)||||||
1466558|NCT01421940|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1466559|NCT01421927||Single Group Assignment||Treatment||None (Open Label)||||||
1466560|NCT01421914||Single Group Assignment||||Single||||||t
1466561|NCT01421901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466562|NCT01421888|||||Prospective|||||||
1466563|NCT01421875|||Other||Retrospective|||||||
1466564|NCT01421862||||||||||||
1466565|NCT01421849||Crossover Assignment||Treatment||None (Open Label)||||||
1466566|NCT01421836|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466567|NCT01421823|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1466568|NCT01421810||Single Group Assignment||Basic Science||None (Open Label)||||||
1466569|NCT01421797||Single Group Assignment||Basic Science||None (Open Label)||||||
1466570|NCT01421784||Single Group Assignment||Other||None (Open Label)||||||
1466571|NCT01421771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466572|NCT01421758|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466573|NCT01421745|Randomized|Parallel Assignment||||Double|||t||t|
1466574|NCT01421732|||Case-Only||Prospective|||||||
1466575|NCT01421719||Single Group Assignment||Treatment||None (Open Label)||||||
1466576|NCT01421706|Randomized|Crossover Assignment||||None (Open Label)||||||
1466577|NCT01421693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466578|NCT01421680|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466579|NCT01421667|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466580|NCT01421654|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466581|NCT01421641|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1466582|NCT01421628|Randomized|Factorial Assignment||Treatment||Single|||t|||
1466583|NCT01421615|Randomized|Single Group Assignment||Treatment||Single|||t|||
1466584|NCT01421602|||Cohort||Prospective|||||||
1466585|NCT01421589|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466586|NCT01421576|Randomized|Crossover Assignment||||None (Open Label)||||||
1466587|NCT01421563|Randomized|Crossover Assignment||||None (Open Label)||||||
1466588|NCT01421550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466589|NCT01421537|||||Prospective|||||||
1466590|NCT01421524|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466591|NCT01421511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466592|NCT01421498|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466593|NCT01421485|Randomized|Parallel Assignment||Prevention||Single|||t|||
1466594|NCT01421472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466595|NCT01421459|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466596|NCT01421446|||Case-Only||Cross-Sectional|||||||
1466597|NCT01421433|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466598|NCT01421420|||Cohort||Prospective|||||||
1466599|NCT01421407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466600|NCT01421394|||Case-Only||Prospective|||||||
1466601|NCT01421381|||Cohort||Prospective|||||||
1466602|NCT01421368|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466603|NCT01421355||Single Group Assignment||||None (Open Label)||||||
1466604|NCT01421342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466605|NCT01421316|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466606|NCT01421303|||Cohort||Prospective|||||||
1466607|NCT01421290|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1466608|NCT01421277|||Cohort||Prospective|||||||
1466609|NCT01421264||Single Group Assignment||Treatment||None (Open Label)||||||
1466610|NCT01421251|||Cohort||Retrospective|||||||
1466611|NCT01421238|Randomized|Parallel Assignment||||None (Open Label)||||||
1466612|NCT01421225|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466613|NCT01421212||Single Group Assignment||Prevention||None (Open Label)||||||
1466614|NCT01421199|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1466615|NCT01421186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466616|NCT01421173||Single Group Assignment||Treatment||None (Open Label)||||||
1466617|NCT01421160||Single Group Assignment||Treatment||None (Open Label)||||||
1466618|NCT01421147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466619|NCT01421134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466620|NCT01421121|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1466621|NCT01421108|Randomized|Parallel Assignment||Prevention||Single||||||t
1466622|NCT01421095||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466623|NCT01421082||Single Group Assignment||Treatment||None (Open Label)||||||
1466624|NCT01421069||||Treatment||None (Open Label)||||||
1466625|NCT01421056|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466626|NCT01421043|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1466627|NCT01421030|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1466628|NCT01421017|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466629|NCT01421004|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466630|NCT01420991|||Case-Only||Prospective|||||||
1466631|NCT01420978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466632|NCT01420965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466633|NCT01420952|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1466634|NCT01420939|||||Prospective|||||||
1466635|NCT01420926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466636|NCT01420913|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1466637|NCT01420900|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466638|NCT01420887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466639|NCT01420874||Single Group Assignment||Treatment||None (Open Label)||||||
1466640|NCT01420861||Single Group Assignment||Treatment||Double|||t|t||
1466641|NCT01420848|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466642|NCT01420835|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466643|NCT01420822|||||Prospective|||||||
1466644|NCT01420809|||Other||Prospective|||||||
1466645|NCT01420796|Randomized|Parallel Assignment||Treatment||Single||3 arms were designed to evaluate the effect of swallowing and breathing exercises to dysphagia in PD patients. The groups were allocated randomly in A) swallowing exercises; b) Breathing exercises or C) Swallowing and breathing exercises||||t
1466646|NCT01420783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466647|NCT01420770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466648|NCT01420757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466649|NCT01420744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466650|NCT01420731|||||Prospective|||||||
1466651|NCT01420718|Randomized|Parallel Assignment||Treatment||Single||||||t
1466652|NCT01420705|||Cohort||Retrospective|||||||
1466653|NCT01420692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466654|NCT01420679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466655|NCT01420666|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466656|NCT01420653|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466657|NCT01420640|Randomized|Parallel Assignment||Treatment||Single||||||t
1466658|NCT01420627|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466659|NCT01420614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466660|NCT01420601|||Case-Only||Prospective|||||||
1466661|NCT01420588|||Cohort||Prospective|||||||
1466662|NCT01420575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466663|NCT01420562|||Cohort||Prospective|||||||
1466664|NCT01420549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466665|NCT01420536|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1466666|NCT01420523|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466667|NCT01420510|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1466668|NCT01420497|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466669|NCT01420484|||Cohort||Prospective|||||||
1466670|NCT01420471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466671|NCT01420458|Randomized|Crossover Assignment||||None (Open Label)||||||
1466672|NCT01420445|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466673|NCT01420432|Randomized|Parallel Assignment||Treatment||Single||||||t
1466674|NCT01420419|Randomized|Parallel Assignment||Treatment||Single||||||t
1466675|NCT01420406|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1466676|NCT01420393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466677|NCT01420367|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1466678|NCT01420354|||Case-Only||Cross-Sectional|||||||
1466679|NCT01420341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466680|NCT01420328|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1466681|NCT01420315|||Cohort||Cross-Sectional|||||||
1466682|NCT01420302|Randomized|Parallel Assignment||Treatment||Single||||||t
1466683|NCT01420289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466684|NCT01420276|||||Prospective|||||||
1466685|NCT01420263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466686|NCT01420250||Single Group Assignment||Treatment||None (Open Label)||||||
1466687|NCT01420237||Single Group Assignment||Treatment||None (Open Label)||||||
1466688|NCT01420224|||||Prospective|||||||
1466689|NCT01420211|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1466690|NCT01420198|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466691|NCT01420185|||Case Control||Retrospective|||||||
1466692|NCT01420172|||Case-Only||Retrospective|||||||
1466693|NCT01420159|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466694|NCT01420146||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466695|NCT01420133|Randomized|Parallel Assignment||||None (Open Label)||||||
1466696|NCT01420120|||Case-Only||Prospective|||||||
1466697|NCT01420107|||Case-Only||Prospective|||||||
1466698|NCT01420094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466699|NCT01420081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466700|NCT01420068|||Other||Prospective|||||||
1466701|NCT01420055||Single Group Assignment||Treatment||None (Open Label)||||||
1466702|NCT01420042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466703|NCT01420029|||Cohort||Prospective|||||||
1466704|NCT01420016|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1466705|NCT01420003||Single Group Assignment||Basic Science||None (Open Label)||||||
1466706|NCT01419990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466707|NCT01419977|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466708|NCT01419964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466709|NCT01419951|Randomized|Parallel Assignment||Treatment||Single||||||t
1466710|NCT01419938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466711|NCT01419925|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1466712|NCT01419912||Crossover Assignment||||||||||
1466713|NCT01419899|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1466714|NCT01419886|||Cohort||Prospective|||||||
1466715|NCT01419873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466716|NCT01419860||Single Group Assignment||Basic Science||None (Open Label)||||||
1466717|NCT01419847|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466718|NCT01419834||Single Group Assignment||Treatment||None (Open Label)||||||
1466719|NCT01419821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466720|NCT01419808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466721|NCT01419795|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466722|NCT01419782||Single Group Assignment||Basic Science||Double|||t||t|
1466723|NCT01419769||Single Group Assignment||Treatment||None (Open Label)||||||
1466724|NCT01419756|||Case-Only||Prospective|||||||
1466725|NCT01419743|||Cohort||Prospective|||||||
1466726|NCT01419730|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1466727|NCT01419717||Single Group Assignment||Treatment||None (Open Label)||||||
1466728|NCT01419704||Single Group Assignment||Treatment||None (Open Label)||||||
1466729|NCT01419691||Single Group Assignment||Treatment||None (Open Label)||||||
1466730|NCT01419678||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466731|NCT01419665|Randomized|Parallel Assignment||Treatment||Quadruple||A subset of patients is switched from GP2013 to MabThera or continued with MabThera during the maintenance phase, for these patients the treatment is finished as an open labeled parallel arm study. The original treatment assignment is kept blinded.|t|t|t|t
1466732|NCT01419652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466733|NCT01419639||Single Group Assignment||Treatment||None (Open Label)||||||
1466734|NCT01419626||||||||||||
1466735|NCT01419613|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466736|NCT01419600|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1466737|NCT01419587||Single Group Assignment||Treatment||None (Open Label)||||||
1466738|NCT01419574|||||Prospective|||||||
1466739|NCT01419561|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466740|NCT01419548|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466741|NCT01419535|Randomized|Crossover Assignment||Treatment||||||||
1466742|NCT01419522|Randomized|Parallel Assignment||Treatment||||||||
1466743|NCT01419509|||Case-Only||Retrospective|||||||
1466744|NCT01419496|||Case-Only||Retrospective|||||||
1466745|NCT01419483||Single Group Assignment||Treatment||None (Open Label)||||||
1466746|NCT01419470|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1466747|NCT01419457|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1466748|NCT01419444|Randomized|Parallel Assignment||Treatment||Single|||||t|
1466749|NCT01419431|||Cohort||Prospective|||||||
1466750|NCT01419418|||Cohort||Prospective|||||||
1466751|NCT01419405|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1466752|NCT01419392|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1466753|NCT01419379|||Cohort|||||||||
1466754|NCT01419366||||||||||||
1466755|NCT01419353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466756|NCT01419340||||||||||||
1466757|NCT01419327|||Case-Only||Prospective|||||||
1466758|NCT01419314|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466759|NCT01419301|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1466760|NCT01419288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466761|NCT01419275|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1466762|NCT01419262|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1466763|NCT01419249|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1466764|NCT01419236|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466765|NCT01419223|||Case Control||Prospective|||||||
1466766|NCT01419210||Single Group Assignment||Supportive Care||None (Open Label)||||||
1466767|NCT01419197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466768|NCT01419184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466769|NCT01419171||Single Group Assignment||Treatment||None (Open Label)||||||
1466770|NCT01419158|||Case-Only||Prospective|||||||
1466771|NCT01419145|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466772|NCT01419132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466773|NCT01419119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466774|NCT01419106|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1466775|NCT01419093|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1466776|NCT01419080|||Cohort||Prospective|||||||
1466777|NCT01419067||Single Group Assignment||Treatment||None (Open Label)||||||
1466778|NCT01419054|||Cohort||Prospective|||||||
1466779|NCT01419041|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1466780|NCT01419028|||Cohort||Retrospective|||||||
1466781|NCT01419015||Single Group Assignment||Treatment||None (Open Label)||||||
1466782|NCT01419002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466783|NCT01418989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466784|NCT01418976||Single Group Assignment||Treatment||None (Open Label)||||||
1466785|NCT01418963|Randomized|Parallel Assignment||||Double|||t||t|
1466786|NCT01418950|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466787|NCT01418937||Single Group Assignment||Prevention||None (Open Label)||||||
1466788|NCT01418924|||Case-Only||Prospective|||||||
1466789|NCT01418911||||||||||||
1466790|NCT01418898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466791|NCT01418885|||Case Control||Cross-Sectional|||||||
1466792|NCT01418872|Randomized|Parallel Assignment||Prevention||Single||||||t
1466793|NCT01418859|||Cohort||Prospective|||||||
1466794|NCT01418846|||Cohort||Prospective|||||||
1466795|NCT01418833|||Case-Only||Prospective|||||||
1466796|NCT01418820|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1466797|NCT01418807|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1466798|NCT01418794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466799|NCT01418781|||Cohort||Prospective|||||||
1466800|NCT01418768|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466801|NCT01418755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466802|NCT01418742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466803|NCT01418729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466804|NCT01418716|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1466805|NCT01418703|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1466806|NCT01418690|||Case Control||Prospective|||||||
1466807|NCT01418677|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466808|NCT01418664|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466809|NCT01418651|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466810|NCT01418638|||Cohort||Prospective|||||||
1466811|NCT01418625||||||||||||
1466812|NCT01418612||||||||||||
1466813|NCT01418599||||||||||||
1466814|NCT01418586||||||||||||
1466815|NCT01418573|Randomized|Crossover Assignment||Treatment||Single||||||t
1466816|NCT01418560|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466817|NCT01418547||||||||||||
1466818|NCT01418534||||||||||||
1466819|NCT01418521|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1466820|NCT01418508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466821|NCT01418495||||||||||||
1466822|NCT01418482||Single Group Assignment||Treatment||None (Open Label)||||||
1466823|NCT01418469|Randomized|Crossover Assignment||||Double|||t||t|
1466824|NCT01418456|Randomized|Single Group Assignment||Treatment||Single||||t||
1466825|NCT01418443||||||||||||
1466826|NCT01418430||||Treatment||||||||
1466827|NCT01418417||||||||||||
1466828|NCT01418404|Randomized|Factorial Assignment||Treatment||Single||||||t
1466829|NCT01418391|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1466830|NCT01418378|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1466831|NCT01418365|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466832|NCT01418352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466833|NCT01418339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466834|NCT01418326|||Cohort||Retrospective|||||||
1466835|NCT01418313|||Cohort||Cross-Sectional|||||||
1466836|NCT01418300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466837|NCT01418287|||Cohort||Prospective|||||||
1466838|NCT01418274|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466839|NCT01418261|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466840|NCT01418248|||Cohort||Prospective|||||||
1466841|NCT01418235|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1466842|NCT01418222||Parallel Assignment||Treatment||Double|||t||t|
1466843|NCT01418209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466844|NCT01418196|||Family-Based||Cross-Sectional|||||||
1466845|NCT01418183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466846|NCT01418170|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466847|NCT01418157|Randomized|Parallel Assignment||||Double|||t||t|
1466848|NCT01418144|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466849|NCT01418131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466850|NCT01418118|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1466851|NCT01418105|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1466852|NCT01418092|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1466853|NCT01418079|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466854|NCT01418066|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1466855|NCT01418053|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466856|NCT01418040|||Cohort||Prospective|||||||
1466857|NCT01418027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466858|NCT01418014|||Cohort||Prospective|||||||
1466859|NCT01418001||Single Group Assignment||Treatment||None (Open Label)||||||
1466860|NCT01417988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466861|NCT01417975|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1466862|NCT01417962|||Cohort||Prospective|||||||
1466863|NCT01417949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466864|NCT01417936||Single Group Assignment||Treatment||None (Open Label)||||||
1466865|NCT01417923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466866|NCT01417910|||Cohort||Prospective|||||||
1466867|NCT01417897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466868|NCT01417884|||Cohort||Prospective|||||||
1466869|NCT01417871|||Case Control||Prospective|||||||
1466870|NCT01417858|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1466871|NCT01417845|Randomized|Parallel Assignment||Treatment||Single|||t|||
1466872|NCT01417832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466873|NCT01417819|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1466874|NCT01417806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466875|NCT01417793|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1466876|NCT01417780|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466877|NCT01417767|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466878|NCT01417754|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1466879|NCT01417741|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1466880|NCT01417728|||Case-Only||Prospective|||||||
1466881|NCT01417715|||Case-Only||Prospective|||||||
1466882|NCT01417702|||Case-Only||Prospective|||||||
1466883|NCT01417689|Randomized|Parallel Assignment||Treatment||Single||||||t
1466884|NCT01417676||Single Group Assignment||Treatment||None (Open Label)||||||
1466885|NCT01417663|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1466886|NCT01417650|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1466887|NCT01417637|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1466888|NCT01417624|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1466889|NCT01417611|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1466890|NCT01417598|Randomized|Parallel Assignment||Treatment||Single||||||t
1466891|NCT01417585|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1466892|NCT01417572|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466893|NCT01417546|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1466894|NCT01417533|||||Prospective|||||||
1466895|NCT01417520|||Cohort||Prospective|||||||
1466896|NCT01417507|||Cohort||Prospective|||||||
1466897|NCT01417494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466898|NCT01417481|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1466899|NCT01417468|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1466900|NCT01417455|||||Prospective|||||||
1466901|NCT01417442|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466902|NCT01417429|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1466903|NCT01417416|||Cohort||Prospective|||||||
1466904|NCT01417403||Single Group Assignment||Treatment||None (Open Label)||||||
1466905|NCT01417390|Randomized|Single Group Assignment||Treatment||Single|||||t|
1466906|NCT01417377|||Cohort||Prospective|||||||
1466907|NCT01417364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466908|NCT01417351|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1466909|NCT01417338|||Cohort||Prospective|||||||
1466910|NCT01417325|||Case-Only||Cross-Sectional|||||||
1466911|NCT01417312|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1466912|NCT01417299|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466913|NCT01417286||Single Group Assignment||Treatment||None (Open Label)||||||
1466914|NCT01417273|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1466915|NCT01417260|||Cohort||Prospective|||||||
1466916|NCT01417247|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466917|NCT01417234|||Cohort||Prospective|||||||
1466918|NCT01417221|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466919|NCT01417208|||Cohort||Prospective|||||||
1466920|NCT01417195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466921|NCT01417182||Single Group Assignment||Screening||None (Open Label)||||||
1466922|NCT01417169||Single Group Assignment||Prevention||None (Open Label)||||||
1466923|NCT01417156||Single Group Assignment||Treatment||None (Open Label)||||||
1466924|NCT01417143||Single Group Assignment||Treatment||None (Open Label)||||||
1466925|NCT01417130|||Cohort||Prospective|||||||
1466926|NCT01417117|||Cohort||Prospective|||||||
1466927|NCT01417104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466928|NCT01417091|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466929|NCT01417078||Single Group Assignment||Treatment||None (Open Label)||||||
1466930|NCT01417065||Single Group Assignment||Treatment||None (Open Label)||||||
1466931|NCT01417052|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1466932|NCT01417026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466933|NCT01417013|Randomized|Crossover Assignment||Treatment||Single|||||t|
1466934|NCT01417000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466935|NCT01416987|||Cohort||Prospective|||||||
1466936|NCT01416974||Single Group Assignment||Treatment||None (Open Label)||||||
1466937|NCT01416961||Single Group Assignment||Treatment||None (Open Label)||||||
1466938|NCT01416948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466939|NCT01416935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466940|NCT01416922|||Cohort||Prospective|||||||
1466941|NCT01416909|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1466942|NCT01416896|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466943|NCT01416883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466944|NCT01416870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466945|NCT01416857|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1466946|NCT01416844||Single Group Assignment||Treatment||None (Open Label)||||||
1466947|NCT01416831|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466948|NCT01416818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466949|NCT01416805|Randomized|Parallel Assignment||Treatment||Single||||||t
1466950|NCT01416792|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1466951|NCT01416779|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1466952|NCT01416766|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1466953|NCT01416753|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466954|NCT01416740||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466955|NCT01416727|Randomized|Parallel Assignment||||Single||||||t
1466956|NCT01416714|||Cohort||Prospective|||||||
1466957|NCT01416701|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466958|NCT01416688|||Other||Prospective|||||||
1466959|NCT01416675|||Cohort||Prospective|||||||
1466960|NCT01416662||Single Group Assignment||Treatment||None (Open Label)||||||
1466961|NCT01416649|||Cohort||Prospective|||||||
1466962|NCT01416636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466963|NCT01416623||Single Group Assignment||Treatment||None (Open Label)||||||
1466964|NCT01416610|||Cohort||Prospective|||||||
1466965|NCT01416597||||||||||||
1466966|NCT01416584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466967|NCT01416571||Single Group Assignment||Prevention||None (Open Label)||||||
1466968|NCT01416558||Single Group Assignment||Treatment||None (Open Label)||||||
1466969|NCT01416545|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1466970|NCT01416532|||Cohort||Prospective|||||||
1466971|NCT01416519|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1466972|NCT01416506|||Cohort||Prospective|||||||
1466973|NCT01416493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1466974|NCT01416480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1466975|NCT01416467|||Case-Only||Other|||||||
1466976|NCT01416454|||Cohort||Prospective|||||||
1466977|NCT01416441||Single Group Assignment||Treatment||None (Open Label)||||||
1466978|NCT01416428|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466979|NCT01416415|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1466980|NCT01416402||Single Group Assignment||Treatment||None (Open Label)||||||
1466981|NCT01416389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466982|NCT01416376|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1466983|NCT01416363|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1466984|NCT01416350|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1466985|NCT01416337||Single Group Assignment||Treatment||None (Open Label)||||||
1466986|NCT01416324|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1466987|NCT01416311|||Other||Prospective|||||||
1466988|NCT01416298||Single Group Assignment||Diagnostic||None (Open Label)||||||
1466989|NCT01416285|||Cohort||Prospective|||||||
1466990|NCT01416272||Single Group Assignment||Supportive Care||None (Open Label)||||||
1466991|NCT01416259|||Cohort||Prospective|||||||
1466992|NCT01416246||Single Group Assignment||Treatment||None (Open Label)||||||
1466993|NCT01416233||Single Group Assignment||Treatment||None (Open Label)||||||
1466994|NCT01416220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1466995|NCT01416207||Single Group Assignment||Basic Science||None (Open Label)||||||
1466996|NCT01416194|||Cohort||Retrospective|||||||
1466997|NCT01416181|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1466998|NCT01416168|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1466999|NCT01416155||Single Group Assignment||Treatment||None (Open Label)||||||
1467000|NCT01416142|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467001|NCT01416129|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467002|NCT01416116|Randomized|Parallel Assignment||Treatment||Single||||||t
1467003|NCT01416103|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467004|NCT01416090|||Case-Control||Prospective|||||||
1467005|NCT01416077|Randomized|Parallel Assignment||Treatment||Single||||||t
1467006|NCT01416064||Single Group Assignment||Treatment||None (Open Label)||||||
1467007|NCT01416051|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1467008|NCT01416038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467009|NCT01416025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467010|NCT01416012|Randomized|Parallel Assignment||||None (Open Label)||||||
1467011|NCT01415999|||Case-Control||Cross-Sectional|||||||
1467012|NCT01415986||Single Group Assignment||Treatment||None (Open Label)||||||
1467013|NCT01415973|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1467014|NCT01415960||Single Group Assignment||Treatment||None (Open Label)||||||
1467015|NCT01415947|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467016|NCT01415934|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1467017|NCT01415921|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467018|NCT01415908|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467019|NCT01415895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467020|NCT01415882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467021|NCT01415869||||||||||||
1467022|NCT01415856|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467023|NCT01415843|||Cohort||Prospective|||||||
1467024|NCT01415830|Randomized|Parallel Assignment||||Triple|||t|t|t|
1467025|NCT01415817|Randomized|Parallel Assignment||||None (Open Label)||||||
1467026|NCT01415804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467027|NCT01415791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467028|NCT01415778|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467029|NCT01415765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467030|NCT01415752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467031|NCT01415739|||Case-Only||Retrospective|||||||
1467032|NCT01415726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467033|NCT01415713||Single Group Assignment||Treatment||None (Open Label)||||||
1467034|NCT01415700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467035|NCT01415687|Randomized|Parallel Assignment||||Single||||||t
1467036|NCT01415674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467037|NCT01415661|Non-Randomized|Parallel Assignment||Prevention||Single|||||t|
1467038|NCT01415648|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1467039|NCT01415635|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1467040|NCT01415622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467041|NCT01415609|||Case-Only||Prospective|||||||
1467042|NCT01415596|Randomized|Parallel Assignment||||Triple|||t|t|t|
1467043|NCT01415583|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467044|NCT01415570|||Cohort||Prospective|||||||
1467045|NCT01415557|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1467046|NCT01415544|||Cohort||Prospective|||||||
1467047|NCT01415531|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467048|NCT01415518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467049|NCT01415505|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467050|NCT01415492|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1467051|NCT01415479|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1467052|NCT01415466|Randomized|Crossover Assignment||||None (Open Label)||||||
1467053|NCT01415453||Single Group Assignment||||None (Open Label)||||||
1467054|NCT01415440|Randomized|Parallel Assignment||Treatment||Quadruple||Two treatment arms plus sample of healthy controls, who were assessed at one time point|t|t|t|t
1467055|NCT01415427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467056|NCT01415414|||Cohort||Prospective|||||||
1467057|NCT01415401||Single Group Assignment||Treatment||None (Open Label)||||||
1467058|NCT01415388|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1467059|NCT01415375|Randomized|Parallel Assignment||Screening||Single||||||t
1467060|NCT01415362|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1467061|NCT01415349|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467062|NCT01415336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467063|NCT01415323|||Cohort||Prospective|||||||
1467064|NCT01415310|||Cohort||Prospective|||||||
1467065|NCT01415297||Single Group Assignment||Treatment||None (Open Label)||||||
1467066|NCT01415284|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1467067|NCT01415271||Single Group Assignment||Supportive Care||None (Open Label)||||||
1467068|NCT01415258|||Case-Only||Prospective|||||||
1467069|NCT01415245|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467070|NCT01415232||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467071|NCT01415219|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467072|NCT01415206|Randomized|Parallel Assignment||Treatment||Single|||||t|
1467073|NCT01415193|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1467074|NCT01415180|||Cohort||Prospective|||||||
1467075|NCT01415167|||Other||Prospective|||||||
1467076|NCT01415154|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467077|NCT01415141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467078|NCT01415128|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467079|NCT01415115|||Cohort||Prospective|||||||
1467080|NCT01415102|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1467081|NCT01415089||Single Group Assignment||Supportive Care||None (Open Label)||||||
1467082|NCT01415076|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1467083|NCT01415063|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1467084|NCT01415050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467085|NCT01415037|||Case-Only||Prospective|||||||
1467086|NCT01415024|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467087|NCT01415011||Single Group Assignment||Treatment||None (Open Label)||||||
1467088|NCT01414998|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467089|NCT01414985|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467090|NCT01414972|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467091|NCT01414959|||Cohort||Prospective|||||||
1467092|NCT01414946|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1467093|NCT01414933|||Cohort||Prospective|||||||
1467094|NCT01414920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467095|NCT01414907|Randomized|Parallel Assignment||Treatment||Single||||||t
1467096|NCT01414894|Randomized|Factorial Assignment||Prevention||Single|||t|||
1467097|NCT01414881|Non-Randomized|Single Group Assignment||||Single|||t|||
1467098|NCT01414868|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1467099|NCT01414855||Single Group Assignment||Treatment||None (Open Label)||||||
1467100|NCT01414842|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467101|NCT01414829|||Case Control||Prospective|||||||
1467102|NCT01414816|||Cohort||Prospective|||||||
1467103|NCT01414803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467104|NCT01414790|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1467105|NCT01414777|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1467106|NCT01414764|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467107|NCT01414751|Randomized|Parallel Assignment||||Single|||t|||
1467108|NCT01414738||Single Group Assignment||Treatment||None (Open Label)||||||
1467109|NCT01414725|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1467110|NCT01414712|||Case-Only||Prospective|||||||
1467111|NCT01414699|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1467112|NCT01414686|Randomized|Crossover Assignment||Treatment||Single||||||t
1467113|NCT01414673|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1467114|NCT01414660|||Case-Only||Other|||||||
1467115|NCT01414647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467116|NCT01414634|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467117|NCT01414621|||Case-Only||Prospective|||||||
1467118|NCT01414608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467119|NCT01414595|||Case-Only||Retrospective|||||||
1467120|NCT01414582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467121|NCT01414569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467122|NCT01414556|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1467123|NCT01414543|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1467124|NCT01414530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467125|NCT01414517|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467126|NCT01414504|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467127|NCT01414491||||||||||||
1467128|NCT01414478|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467129|NCT01414465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467130|NCT01414452|||Cohort||Prospective|||||||
1467131|NCT01414439|||Cohort||Prospective|||||||
1467132|NCT01414426|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467133|NCT01414413|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1467134|NCT01414400|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1467135|NCT01414387|Randomized|Parallel Assignment||Treatment||Single||||||t
1467136|NCT01414374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467137|NCT01414361|||Case-Only||Retrospective|||||||
1467138|NCT01414348|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1467139|NCT01414335|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467140|NCT01414322|||||Prospective|||||||
1467141|NCT01414309|||Cohort||Prospective|||||||
1467142|NCT01414296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467143|NCT01414283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467144|NCT01414270||||||||||||
1467145|NCT01414257|||Case-Only||Prospective|||||||
1467146|NCT01414244|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467147|NCT01414231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467148|NCT01414218|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467149|NCT01414205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467150|NCT01414192|||Cohort||Prospective|||||||
1467151|NCT01414179|||Ecologic or Community||Prospective|||||||
1467152|NCT01414166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467153|NCT01414153|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467154|NCT01414140|||Case-Only||Prospective|||||||
1467155|NCT01414114||Single Group Assignment||Treatment||None (Open Label)||||||
1467156|NCT01414101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467157|NCT01414088|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1467158|NCT01414075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467159|NCT01414062|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1467160|NCT01414049|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1467161|NCT01414036|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1467162|NCT01414023|Randomized|Single Group Assignment||Treatment||Single|||t|||
1467163|NCT01414010|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1467164|NCT01413997|||Case Control||Cross-Sectional|||||||
1467165|NCT01413984|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1467166|NCT01413958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467167|NCT01413945|||Cohort||Prospective|||||||
1467168|NCT01413932|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1467169|NCT01413906||Single Group Assignment||Treatment||None (Open Label)||||||
1467170|NCT01413893|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1467171|NCT01413867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467172|NCT01413854|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467173|NCT01413841|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1467174|NCT01413828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467175|NCT01413815|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1467176|NCT01413802||Single Group Assignment||Prevention||None (Open Label)||||||
1467177|NCT01413789|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467178|NCT01413776|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467179|NCT01413763|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1467180|NCT01413750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467181|NCT01413737|||Cohort||Retrospective|||||||
1467182|NCT01413724|||Cohort||Cross-Sectional|||||||
1467183|NCT01413711||Single Group Assignment||||None (Open Label)||||||
1467184|NCT01413698|||||Retrospective|||||||
1467185|NCT01413685|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1467186|NCT01413672|||||Prospective|||||||
1467187|NCT01413659|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1467188|NCT01413646|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1467189|NCT01413633||Single Group Assignment||Treatment||None (Open Label)||||||
1467190|NCT01413620|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467191|NCT01413607|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467192|NCT01413594|Randomized|Parallel Assignment||Treatment||Single||||||t
1467193|NCT01413581|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467194|NCT01413568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467195|NCT01413555||Single Group Assignment||Prevention||None (Open Label)||||||
1467196|NCT01413542|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1467197|NCT01413529|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1467198|NCT01413516|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467199|NCT01413503||Single Group Assignment||Treatment||None (Open Label)||||||
1467200|NCT01413490|||Cohort||Prospective|||||||
1467201|NCT01413477|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1467202|NCT01413464|||Cohort||Prospective|||||||
1467203|NCT01413451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467204|NCT01413438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467205|NCT01413425|||||Other|||||||
1467206|NCT01413412|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467207|NCT01413399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467208|NCT01413386|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1467209|NCT01413373||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467210|NCT01413360||Single Group Assignment||Treatment||None (Open Label)||||||
1467211|NCT01413347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467212|NCT01413334|||Cohort||Cross-Sectional|||||||
1467213|NCT01413321|||Case-Control||Prospective|||||||
1467214|NCT01413308|||Cohort||Prospective|||||||
1467215|NCT01413295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467216|NCT01413282|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1467217|NCT01413269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467218|NCT01413256|||Cohort|||||||||
1467219|NCT01413243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467220|NCT01413230|||||Prospective|||||||
1467221|NCT01413217|||Case-Crossover||Retrospective|||||||
1467222|NCT01413204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467223|NCT01413191||Single Group Assignment||Treatment||None (Open Label)||||||
1467224|NCT01413178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467225|NCT01413152||Single Group Assignment||||None (Open Label)||||||
1467226|NCT01413139||Single Group Assignment||Treatment||None (Open Label)||||||
1467227|NCT01413126|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467228|NCT01413113||Single Group Assignment||Treatment||None (Open Label)||||||
1467229|NCT01413100||Single Group Assignment||Treatment||None (Open Label)||||||
1467230|NCT01413087|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467231|NCT01413074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467232|NCT01413061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467233|NCT01413048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467234|NCT01413035|Randomized|Parallel Assignment||Treatment||Single||||||t
1467235|NCT01413022|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467236|NCT01413009|||Cohort||Prospective|||||||
1467237|NCT01412996|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467238|NCT01412983|Randomized|Crossover Assignment||Screening||Single|||t|||
1467239|NCT01412970||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467240|NCT01412957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467241|NCT01412944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467242|NCT01412931|||Case Control||Prospective|||||||
1467243|NCT01412918|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1467244|NCT01412905|||Cohort||Prospective|||||||
1467245|NCT01412892||Single Group Assignment||Treatment||None (Open Label)||||||
1467246|NCT01412879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467247|NCT01412866|Randomized|Parallel Assignment||Treatment||Single||||||t
1467248|NCT01412853||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467249|NCT01412840|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467250|NCT01412827||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467251|NCT01412814|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467252|NCT01412801|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467253|NCT01412788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467254|NCT01412775|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1467255|NCT01412762|||Case-Only||Prospective|||||||
1467256|NCT01412749|||Case-Only||Prospective|||||||
1467257|NCT01412736|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467258|NCT01412723|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1467259|NCT01412710|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467260|NCT01412697|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467261|NCT01412684|||Cohort||Prospective|||||||
1467262|NCT01412671|||Case-Only||Prospective|||||||
1467263|NCT01412658|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1467264|NCT01412645|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1467265|NCT01412632|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1467266|NCT01412619|||||Prospective|||||||
1467267|NCT01412606|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1467268|NCT01412593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467269|NCT01412580|||Family-Based||Prospective|||||||
1467270|NCT01412567|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1467271|NCT01412554|||Cohort|||||||||
1467272|NCT01412541|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467273|NCT01412528|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1467274|NCT01412515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467275|NCT01412502|||Cohort||Prospective|||||||
1467276|NCT01412489||Single Group Assignment||Prevention||None (Open Label)||||||
1467277|NCT01412476|||Case Control||Cross-Sectional|||||||
1467278|NCT01412463||Single Group Assignment||Treatment||None (Open Label)||||||
1467279|NCT01412450||Single Group Assignment||Treatment||None (Open Label)||||||
1467280|NCT01412437|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1467281|NCT01412424||Single Group Assignment||Treatment||None (Open Label)||||||
1467282|NCT01412411|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1467283|NCT01412398|||Case-Only||Prospective|||||||
1467284|NCT01412385|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467285|NCT01412372|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467286|NCT01412359||Single Group Assignment||Treatment||None (Open Label)||||||
1467287|NCT01412346|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1467288|NCT01412333|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467289|NCT01412320|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1467290|NCT01412307||Single Group Assignment||Treatment||None (Open Label)||||||
1467291|NCT01412294||Single Group Assignment||Treatment||None (Open Label)||||||
1467292|NCT01412281|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1467293|NCT01412268|||||Prospective|||||||
1467294|NCT01412242||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467295|NCT01412229||Single Group Assignment||Treatment||None (Open Label)||||||
1467296|NCT01412216|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467297|NCT01412203|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467298|NCT01412190|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467299|NCT01412177|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467300|NCT01412164||Single Group Assignment||Treatment||None (Open Label)||||||
1467301|NCT01412151||Single Group Assignment||Treatment||None (Open Label)||||||
1467302|NCT01412138|||||Prospective|||||||
1467303|NCT01412125|||Cohort||Prospective|||||||
1467304|NCT01412112||||||||||||
1467305|NCT01412099|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467306|NCT01412086|||Cohort||Prospective|||||||
1467307|NCT01412073|Randomized|Parallel Assignment||Prevention||Single|||t|||
1467308|NCT01412060|Randomized|Parallel Assignment||Prevention||Quadruple|There was no masking in the Open-Label Phase. There was masking in the Double-Blind Phase||t|t|t|t
1467309|NCT01412047|||Other||Prospective|||||||
1467310|NCT01412034||Single Group Assignment||Treatment||None (Open Label)||||||
1467311|NCT01412021|||Cohort||Prospective|||||||
1467312|NCT01412008||Single Group Assignment||Health Services Research||None (Open Label)||||||
1467313|NCT01411995|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467314|NCT01411982|||Case-Only||Prospective|||||||
1467315|NCT01411969|||Case Control||Prospective|||||||
1467316|NCT01411956|Randomized|Parallel Assignment||||Triple|||t||t|t
1467317|NCT01411943|||Cohort||Prospective|||||||
1467318|NCT01411930|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1467319|NCT01411917|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1467320|NCT01411904||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467321|NCT01411891|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467322|NCT01411878|Randomized|Parallel Assignment||Prevention||Single|||t|||
1467323|NCT01411865|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1467324|NCT01411852|Randomized|Parallel Assignment||Treatment||Single||||t||
1467325|NCT01411839|Randomized|Parallel Assignment||Treatment||Single||||||t
1467326|NCT01411826|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1467327|NCT01411813|||Case-Only||Retrospective|||||||
1467328|NCT01411800|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467329|NCT01411787|Randomized|Parallel Assignment||Prevention||Single||||||t
1467330|NCT01411774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467331|NCT01411761|Randomized|Parallel Assignment||Prevention||Single|||||t|
1467332|NCT01411748|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1467333|NCT01411735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467334|NCT01411722||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467335|NCT01411709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467336|NCT01411696|||Cohort||Retrospective|||||||
1467337|NCT01411683|Randomized|Parallel Assignment||Treatment||Single||||||t
1467338|NCT01411670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467339|NCT01411657||Single Group Assignment||Treatment||None (Open Label)||||||
1467340|NCT01411644|||Cohort||Prospective|||||||
1467341|NCT01411631|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1467342|NCT01411618|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1467343|NCT01411605||Single Group Assignment||Prevention||None (Open Label)||||||
1467344|NCT01411592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467345|NCT01411579|||||Prospective|||||||
1467346|NCT01411566|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467347|NCT01411553|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467348|NCT01411540|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1467349|NCT01411527|||Cohort||Prospective|||||||
1467350|NCT01411514|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467351|NCT01411501|Randomized|Parallel Assignment||Treatment||Single||||||t
1467352|NCT01411488|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||2 Groups were randomly assigned to 1 of 2 different fecal management systems||||
1467353|NCT01411475|||Cohort||Prospective|||||||
1467354|NCT01411462|||Cohort||Prospective|||||||
1467355|NCT01411449|||Case-Only||Prospective|||||||
1467356|NCT01411436|||Case-Only||Prospective|||||||
1467357|NCT01411423|||Case-Only||Prospective|||||||
1467358|NCT01411410||Single Group Assignment||Treatment||None (Open Label)||||||
1467359|NCT01411397|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467360|NCT01411384|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1467361|NCT01411371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467362|NCT01411358|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1467363|NCT01411345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467364|NCT01411332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467365|NCT01411319||Single Group Assignment||Treatment||None (Open Label)||||||
1467366|NCT01411306|||Cohort||Prospective|||||||
1467367|NCT01411293|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1467368|NCT01411280|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1467369|NCT01411267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467370|NCT01411254||||||||||||
1467371|NCT01411241|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467372|NCT01411228|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467373|NCT01411215|||Case Control||Prospective|||||||
1467374|NCT01411202|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467375|NCT01411189||Single Group Assignment||Treatment||None (Open Label)||||||
1467376|NCT01411176|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467377|NCT01411163||Single Group Assignment||Treatment||None (Open Label)||||||
1467378|NCT01411150||Single Group Assignment||Treatment||None (Open Label)||||||
1467379|NCT01411137||Single Group Assignment||Treatment||None (Open Label)||||||
1467380|NCT01411124|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1467381|NCT01411111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467382|NCT01411098||Single Group Assignment||Treatment||None (Open Label)||||||
1467383|NCT01411085||Single Group Assignment||Treatment||None (Open Label)||||||
1467384|NCT01411072|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467385|NCT01411059|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1467386|NCT01411046|||Case-Control||Prospective|||||||
1467387|NCT01411033|||Cohort||Prospective|||||||
1467388|NCT01411020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467389|NCT01411007|||Cohort||Prospective|||||||
1467390|NCT01410994|||Cohort||Prospective|||||||
1467391|NCT01410981|||Cohort||Prospective|||||||
1467392|NCT01410968||Single Group Assignment||Treatment||None (Open Label)||||||
1467393|NCT01410955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467394|NCT01410942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467395|NCT01410929||Single Group Assignment||Treatment||None (Open Label)||||||
1467396|NCT01410916||Single Group Assignment||Treatment||None (Open Label)||||||
1467397|NCT01410903||Single Group Assignment||Treatment||None (Open Label)||||||
1467398|NCT01410890||Single Group Assignment||Other||None (Open Label)||||||
1467399|NCT01410877|||||Cross-Sectional|||||||
1467400|NCT01410864|||Cohort||Other|||||||
1467401|NCT01410851|Randomized|Crossover Assignment||Prevention||Single|||||t|
1467402|NCT01410838|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1467403|NCT01410825||Single Group Assignment||Treatment||None (Open Label)||||||
1467404|NCT01410812|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1467405|NCT01410799||Single Group Assignment||Treatment||None (Open Label)||||||
1467406|NCT01410786|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1467407|NCT01410773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467408|NCT01410760||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467409|NCT01410747|||Cohort||Prospective|||||||
1467410|NCT01410734|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1467411|NCT01410721|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1467412|NCT01410708||Single Group Assignment||Treatment||None (Open Label)||||||
1467413|NCT01410695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467414|NCT01410682|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1467415|NCT01410669|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1467416|NCT01410656|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1467417|NCT01410643|Randomized|Parallel Assignment||Prevention||Single|||t|||
1467418|NCT01410630||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467419|NCT01410617|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467420|NCT01410604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467421|NCT01410591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467422|NCT01410578|||Case Control||Prospective|||||||
1467423|NCT01410565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467424|NCT01410552||Single Group Assignment||Treatment||None (Open Label)||ICD device||||
1467425|NCT01410539|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467426|NCT01410526|||Case Control||Prospective|||||||
1467427|NCT01410513|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467428|NCT01410500||||||||||||
1467429|NCT01410487|||Case-Only||Prospective|||||||
1467430|NCT01410474|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1467431|NCT01410461|||Cohort||Prospective|||||||
1467432|NCT01410448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467433|NCT01410435|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467434|NCT01410422|||Case Control||Prospective|||||||
1467435|NCT01410409|Randomized|Parallel Assignment||Treatment||Single||||||t
1467436|NCT01410396|||Case Control||Prospective|||||||
1467437|NCT01410383|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467438|NCT01410370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467439|NCT01410357|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1467440|NCT01410344||Single Group Assignment||Treatment||None (Open Label)||||||
1467441|NCT01410331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467442|NCT01410318|||Cohort||Prospective|||||||
1467443|NCT01410305|||Case Control||Prospective|||||||
1467444|NCT01410292|Randomized|Crossover Assignment||||Single|||t|||
1467445|NCT01410279|Randomized|Parallel Assignment||Treatment||Single||||||t
1467446|NCT01410266|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1467447|NCT01410253|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1467448|NCT01410240|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467449|NCT01410227|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467450|NCT01410214|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467451|NCT01410201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467452|NCT01410188|Randomized|Parallel Assignment||Treatment||Single|||||t|
1467453|NCT01410175|Randomized|Parallel Assignment||Treatment||Single|||||t|
1467454|NCT01410162|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467455|NCT01410149|Randomized|Crossover Assignment||Treatment||Single||||||t
1467456|NCT01410136||Single Group Assignment||Treatment||None (Open Label)||||||
1467457|NCT01410123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467458|NCT01410110|Randomized|Parallel Assignment||Treatment||Single||||||t
1467459|NCT01410097|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467460|NCT01410084|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467461|NCT01410071|||Cohort||Prospective|||||||
1467462|NCT01410058|||Case-Crossover||Prospective|||||||
1467463|NCT01410045||Single Group Assignment||Prevention||None (Open Label)||||||
1467464|NCT01410032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467465|NCT01410019||Single Group Assignment||Treatment||None (Open Label)||||||
1467466|NCT01410006|||Other||Other|||||||
1467467|NCT01409993|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1467468|NCT01409980|||Cohort|||||||||
1467469|NCT01409967|||Ecologic or Community||Prospective|||||||
1467470|NCT01409954|||Case-Only||Prospective|||||||
1467471|NCT01409941|||Cohort||Prospective|||||||
1467472|NCT01409928||Single Group Assignment||Treatment||None (Open Label)||||||
1467473|NCT01409915|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467474|NCT01409902|||Cohort||Prospective|||||||
1467475|NCT01409889|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467476|NCT01409876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467477|NCT01409863||Single Group Assignment||Treatment||None (Open Label)||||||
1467478|NCT01409850|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1467479|NCT01409837|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1467480|NCT01409824|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1467481|NCT01409811||Single Group Assignment||Treatment||None (Open Label)||||||
1467482|NCT01409798|||Case-Only||Prospective|||||||
1467483|NCT01409785|||Case Control||Prospective|||||||
1467484|NCT01409772|||||Prospective|||||||
1467485|NCT01409759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467486|NCT01409746|||Cohort||Prospective|||||||
1467487|NCT01409733||Single Group Assignment||Treatment||None (Open Label)||||||
1467488|NCT01409720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467489|NCT01409707|Randomized|Parallel Assignment||Treatment||Single||||||t
1467490|NCT01409694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467491|NCT01409681|||Case-Only||Prospective|||||||
1467492|NCT01409668|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1467493|NCT01409655||Single Group Assignment||Prevention||None (Open Label)||||||
1467494|NCT01409642|Randomized|Parallel Assignment||Treatment||Single||||||t
1467495|NCT01409629|||Cohort||Prospective|||||||
1467496|NCT01409616|Randomized|Crossover Assignment||||None (Open Label)||||||
1467497|NCT01409603|Randomized|Crossover Assignment||||None (Open Label)||||||
1467498|NCT01409590|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1467499|NCT01409577|||Cohort||Prospective|||||||
1467500|NCT01409564|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467501|NCT01409551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467502|NCT01409538|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1467503|NCT01409525|||Cohort||Prospective|||||||
1467504|NCT01409512|||Case-Only||Prospective|||||||
1467505|NCT01409499|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467506|NCT01409486|||Cohort||Prospective|||||||
1467507|NCT01409473||Single Group Assignment||Treatment||None (Open Label)||||||
1467508|NCT01409460|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467509|NCT01409447||Single Group Assignment||Treatment||None (Open Label)||||||
1467510|NCT01409434||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467511|NCT01409421|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1467512|NCT01409408|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1467513|NCT01409395|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1467514|NCT01409382|Randomized|Parallel Assignment||Prevention||Single|||t|||
1467515|NCT01409369|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1467516|NCT01409356||Single Group Assignment||Treatment||None (Open Label)||||||
1467517|NCT01409343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467518|NCT01409330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467519|NCT01409317|Randomized|Parallel Assignment||Treatment||Single||||||t
1467520|NCT01409304||Single Group Assignment||Treatment||None (Open Label)||||||
1467521|NCT01409291|||Cohort||Prospective|||||||
1467522|NCT01409278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467523|NCT01409265|||Case-Only||Prospective|||||||
1467524|NCT01409252|||Case-Only||Retrospective|||||||
1467525|NCT01409239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467526|NCT01409226||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467527|NCT01409213|||Cohort||Prospective|||||||
1467528|NCT01409200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467529|NCT01409187||Single Group Assignment||Treatment||None (Open Label)||||||
1467530|NCT01409174||Single Group Assignment||Treatment||None (Open Label)||||||
1467531|NCT01409161||Single Group Assignment||Treatment||None (Open Label)||||||
1467532|NCT01409148|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1467533|NCT01409135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467534|NCT01409122|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1467535|NCT01409109|||Case-Control||Cross-Sectional|||||||
1467536|NCT01409096|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467537|NCT01409083|Randomized|Crossover Assignment||Diagnostic||Double|||t|t||
1467538|NCT01409070|||Cohort||Retrospective|||||||
1467539|NCT01409057|||Cohort||Prospective|||||||
1467540|NCT01409044|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1467541|NCT01409031|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467542|NCT01409018||Single Group Assignment||Treatment||None (Open Label)||||||
1467543|NCT01409005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467544|NCT01408992||Single Group Assignment||Diagnostic||Double|||t|||t
1467545|NCT01408979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467546|NCT01408966|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467547|NCT01408953||Single Group Assignment||Treatment||None (Open Label)||||||
1467548|NCT01408927|||Cohort||Prospective|||||||
1467549|NCT01408914|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1467550|NCT01408901|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1467551|NCT01408888|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467552|NCT01408875|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1467553|NCT01408862|||||Cross-Sectional|||||||
1467554|NCT01408849|Randomized|Parallel Assignment||Treatment||Single||||||t
1467555|NCT01408836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467556|NCT01408823|||Case Control||Prospective|||||||
1467557|NCT01408810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467558|NCT01408797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467559|NCT01408784|||Case-Only||Cross-Sectional|||||||
1467560|NCT01408771|||Cohort||Prospective|||||||
1467561|NCT01408758|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467562|NCT01408745|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467563|NCT01408732|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467564|NCT01408719|Randomized|Crossover Assignment||Prevention||Single|||t|||
1467565|NCT01408706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467566|NCT01408693|Randomized|Parallel Assignment||Treatment||Single||||||t
1467567|NCT01408680|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1467568|NCT01408667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467569|NCT01408654|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467570|NCT01408641|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467571|NCT01408628||Single Group Assignment||||None (Open Label)||||||
1467572|NCT01408615|||Cohort||Prospective|||||||
1467573|NCT01408602|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467574|NCT01408589|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1467575|NCT01408576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467576|NCT01408563||Single Group Assignment||Treatment||None (Open Label)||||||
1467577|NCT01408550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467578|NCT01408537||Single Group Assignment||Prevention||None (Open Label)||||||
1467579|NCT01408524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467580|NCT01408511||Single Group Assignment||Treatment||None (Open Label)||||||
1467581|NCT01408498|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1467582|NCT01408485||Single Group Assignment||Treatment||None (Open Label)||||||
1467583|NCT01408472||Single Group Assignment||Treatment||None (Open Label)||||||
1467584|NCT01408459|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467585|NCT01408446|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467586|NCT01408433|Randomized|Parallel Assignment||||None (Open Label)||||||
1467587|NCT01408420|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467588|NCT01408407|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467589|NCT01408394|Randomized|Crossover Assignment||Treatment||Single|||t|||
1467590|NCT01408381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467591|NCT01408368|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467592|NCT01408355|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1467593|NCT01408342|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467594|NCT01408329|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1467595|NCT01408316|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467596|NCT01408303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467597|NCT01408290|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1467598|NCT01408277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467599|NCT01408264|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467600|NCT01408251|||||Prospective|||||||
1467601|NCT01408238|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1467602|NCT01408225|||Cohort||Prospective|||||||
1467603|NCT01408212||Single Group Assignment||Supportive Care||None (Open Label)||||||
1467604|NCT01408199||Single Group Assignment||Treatment||None (Open Label)||||||
1467605|NCT01408186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467606|NCT01408173||Single Group Assignment||Treatment||None (Open Label)||||||
1467607|NCT01408160||Single Group Assignment||Treatment||None (Open Label)||||||
1467608|NCT01408147|Randomized|Parallel Assignment||Treatment||Single||||||t
1467609|NCT01408134||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467610|NCT01408121|||Cohort||Prospective|||||||
1467611|NCT01408108|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1467612|NCT01408095|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467613|NCT01408082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467614|NCT01408069|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467615|NCT01408056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467616|NCT01408043||Single Group Assignment||Treatment||None (Open Label)||||||
1467617|NCT01408030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467618|NCT01408017||||||||||||
1467619|NCT01408004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467620|NCT01407991|Randomized|Parallel Assignment||||Single||||||t
1467621|NCT01407978|Randomized|Parallel Assignment||Prevention||Single|||t|||
1467622|NCT01407965|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1467623|NCT01407952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467624|NCT01407939|||Cohort||Cross-Sectional|||||||
1467625|NCT01407926|||Cohort||Prospective|||||||
1467626|NCT01407913||Single Group Assignment||Treatment||None (Open Label)||||||
1467627|NCT01407900|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1467628|NCT01407887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467629|NCT01407874|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467630|NCT01407861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467631|NCT01407848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467632|NCT01407835|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1467633|NCT01407822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467634|NCT01407809||Single Group Assignment||Treatment||None (Open Label)||||||
1467635|NCT01407796||Single Group Assignment||Basic Science||None (Open Label)||||||
1467636|NCT01407783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467637|NCT01407770|||Other||Prospective|||||||
1467638|NCT01407757|||Case-Only||Retrospective|||||||
1467639|NCT01407744|||||Retrospective|||||||
1467640|NCT01407731|||Case-Only||Retrospective|||||||
1467641|NCT01407718|||Cohort||Prospective|||||||
1467642|NCT01407705|||Case Control||Prospective|||||||
1467643|NCT01407692|||Other||Prospective|||||||
1467644|NCT01407679||Single Group Assignment||Treatment||None (Open Label)||||||
1467645|NCT01407666|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467646|NCT01407653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467647|NCT01407640||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467648|NCT01407627|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1467649|NCT01407614|Randomized|Single Group Assignment||Prevention||Single||||||t
1467650|NCT01407601|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1467651|NCT01407588|Randomized|Parallel Assignment||Treatment||Single||||||t
1467652|NCT01407575|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467653|NCT01407562||Single Group Assignment||Treatment||None (Open Label)||||||
1467654|NCT01407549|Randomized|Parallel Assignment||Treatment||Single||||||t
1467655|NCT01407536|Randomized|Parallel Assignment||Treatment||Single||||||t
1467656|NCT01407523||Single Group Assignment||Treatment||None (Open Label)||||||
1467657|NCT01407510||Single Group Assignment||Treatment||None (Open Label)||||||
1467658|NCT01407497|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467659|NCT01407484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467660|NCT01407471|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1467661|NCT01407458|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467662|NCT01407445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467663|NCT01407432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467664|NCT01407419|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467665|NCT01407406|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1467666|NCT01407393|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467667|NCT01407380||Single Group Assignment||Treatment||None (Open Label)||||||
1467668|NCT01407367|||Cohort||Prospective|||||||
1467669|NCT01407354|Randomized|Crossover Assignment||Treatment||Single||||||t
1467670|NCT01407341|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1467671|NCT01407328|||Case-Only||Prospective|||||||
1467672|NCT01407315|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1467673|NCT01407302|||Case Control||Prospective|||||||
1467674|NCT01407289|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467675|NCT01407276|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467676|NCT01407263|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1467677|NCT01407250|||||Prospective|||||||
1467678|NCT01407237|||Cohort||Cross-Sectional|||||||
1467679|NCT01407224|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1467680|NCT01407211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467681|NCT01407198||Single Group Assignment||Treatment||None (Open Label)||||||
1467682|NCT01407185||Single Group Assignment||Treatment||Triple|||t|t||t
1467683|NCT01407172|||Cohort||Cross-Sectional|||||||
1467684|NCT01407159|||Cohort||Prospective|||||||
1467685|NCT01407146|||Case-Only||Retrospective|||||||
1467686|NCT01407133|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1467687|NCT01407120|Randomized|Parallel Assignment||Prevention||Single||||||t
1467688|NCT01407107||Single Group Assignment||Treatment||None (Open Label)||||||
1467764|NCT01406106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467765|NCT01406093|||Cohort||Retrospective|||||||
1467993|NCT01403129|||Case-Control||Cross-Sectional|||||||
1467689|NCT01407094|Randomized|Sequential Assignment||Other||Quadruple||"Patients were entered into Stage 1, treated with sertraline (Treatment A) or placebo (Treatment B), and used for the primary analysis which included the identification of potential mediators and moderators of response for these two treatments.~In stage two, responders to Treatment A remained on sertraline, and non-responders were switched to bupropion (Treatment C). Responders to Treatment B remained on placebo, and non-responders were switched to sertraline (Treatment D)."|t|t|t|t
1467690|NCT01407081||Single Group Assignment||Treatment||None (Open Label)||||||
1467691|NCT01407068||Single Group Assignment||Treatment||None (Open Label)||||||
1467692|NCT01407055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467693|NCT01407042|||Case-Only||Prospective|||||||
1467694|NCT01407029|||Other||Prospective|||||||
1467695|NCT01407016|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467696|NCT01407003|Randomized|Parallel Assignment||||Double|||t||t|
1467697|NCT01406990|||Cohort||Prospective|||||||
1467698|NCT01406977||Single Group Assignment||Treatment||None (Open Label)||||||
1467699|NCT01406964|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1467700|NCT01406951|||Case Control||Prospective|||||||
1467701|NCT01406938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467702|NCT01406925|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1467703|NCT01406912|Randomized|Parallel Assignment||||Single||||||t
1467704|NCT01406899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467705|NCT01406886|Randomized|Crossover Assignment||Other||Single|||t|||
1467706|NCT01406873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467707|NCT01406860|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1467708|NCT01406847|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1467709|NCT01406834|||Case Control||Prospective|||||||
1467710|NCT01406821|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467711|NCT01406808|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1467712|NCT01406795||Single Group Assignment||Treatment||None (Open Label)||||||
1467713|NCT01406782|||Other||Retrospective|||||||
1467714|NCT01406769||Single Group Assignment||Supportive Care||None (Open Label)||||||
1467715|NCT01406743|||Cohort||Prospective|||||||
1467716|NCT01406730|Randomized|Crossover Assignment||Treatment||Single||||||t
1467717|NCT01406717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467718|NCT01406704|Randomized|Parallel Assignment||Prevention||Single||||||t
1467719|NCT01406691|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1467720|NCT01406678|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1467721|NCT01406665|||Cohort||Cross-Sectional|||||||
1467722|NCT01406652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467723|NCT01406639||Single Group Assignment||Treatment||None (Open Label)||||||
1467724|NCT01406626|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467725|NCT01406613|||Cohort||Prospective|||||||
1467726|NCT01406600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467727|NCT01406587|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467728|NCT01406574|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1467729|NCT01406561|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467730|NCT01406548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467731|NCT01406535||||||||||||
1467732|NCT01406522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467733|NCT01406509|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1467734|NCT01406496|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467735|NCT01406483||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467736|NCT01406470||Single Group Assignment||Treatment||None (Open Label)||||||
1467737|NCT01406457|||Case-Only||Prospective|||||||
1467738|NCT01406444|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467739|NCT01406431|Randomized|Crossover Assignment||||None (Open Label)||||||
1467740|NCT01406418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467741|NCT01406405|||Case-Control||Prospective|||||||
1467742|NCT01406392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467743|NCT01406379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467744|NCT01406366|||Cohort||Cross-Sectional|||||||
1467745|NCT01406353|Randomized|Parallel Assignment||Treatment||None (Open Label)||early percutaneous mitral commissurotomy||||
1467746|NCT01406340|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1467747|NCT01406327|||Other||Other|||||||
1467748|NCT01406314||Single Group Assignment||Other||None (Open Label)||||||
1467749|NCT01406301|||Cohort||Retrospective|||||||
1467750|NCT01406288|||Cohort||Prospective|||||||
1467751|NCT01406275|||Other||Prospective|||||||
1467752|NCT01406262|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1467753|NCT01406249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467754|NCT01406236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467755|NCT01406223|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1467756|NCT01406210|||Case-Only|||||||||
1467757|NCT01406197|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467758|NCT01406184|Randomized|Parallel Assignment||Prevention||Single||||||t
1467759|NCT01406171||Single Group Assignment||||None (Open Label)||||||
1467760|NCT01406158|Randomized|Crossover Assignment||||None (Open Label)||||||
1467761|NCT01406145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467762|NCT01406132|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1467763|NCT01406119||Single Group Assignment||Treatment||None (Open Label)||||||
1467766|NCT01406080|Randomized|Parallel Assignment||Treatment||Single|||||t|
1467767|NCT01406067|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467768|NCT01406054|Randomized|Parallel Assignment||Prevention||Single|||||t|
1467769|NCT01406041|||Case-Only||Retrospective|||||||
1467770|NCT01406028|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1467771|NCT01406015|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1467772|NCT01406002||Single Group Assignment||||None (Open Label)||||||
1467773|NCT01405989|Randomized|Crossover Assignment||||None (Open Label)||||||
1467774|NCT01405976|Randomized|Parallel Assignment||Treatment||Single|||||t|
1467775|NCT01405963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467776|NCT01405950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467777|NCT01405937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467778|NCT01405924||Single Group Assignment||Prevention||None (Open Label)||||||
1467779|NCT01405911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467780|NCT01405898|Randomized|Parallel Assignment||||Triple|||t||t|t
1467781|NCT01405885|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467782|NCT01405872|||Cohort||Prospective|||||||
1467783|NCT01405859|||Case Control||Cross-Sectional|||||||
1467784|NCT01405846||Single Group Assignment||Treatment||None (Open Label)||||||
1467785|NCT01405833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467786|NCT01405820|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467787|NCT01405807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467788|NCT01405794|Non-Randomized|Crossover Assignment||||Double|||t||t|
1467789|NCT01405781|||Cohort||Other|||||||
1467790|NCT01405768|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1467791|NCT01405755|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467792|NCT01405742|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467793|NCT01405729|||Cohort||Cross-Sectional|||||||
1467794|NCT01405716|Randomized|Parallel Assignment||Treatment||Single||||||t
1467795|NCT01405703|||Cohort||Prospective|||||||
1467796|NCT01405690|||Cohort||Prospective|||||||
1467797|NCT01405677|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467798|NCT01405664|Randomized|Parallel Assignment||Treatment||Single||||||t
1467799|NCT01405651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467800|NCT01405638|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1467801|NCT01405625|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1467802|NCT01405612|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1467803|NCT01405599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467804|NCT01405586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467805|NCT01405573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467806|NCT01405560||Single Group Assignment||Treatment||None (Open Label)||||||
1467807|NCT01405547|||Cohort||Prospective|||||||
1467808|NCT01405534|||Cohort||Prospective|||||||
1467809|NCT01405521|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467810|NCT01405508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467811|NCT01405495|||Cohort||Prospective|||||||
1467812|NCT01405482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467813|NCT01405469||Single Group Assignment||Treatment||None (Open Label)||||||
1467814|NCT01405456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467815|NCT01405443|||Case Control||Prospective|||||||
1467816|NCT01405430||Single Group Assignment||||None (Open Label)||||||
1467817|NCT01405417||Single Group Assignment||Treatment||None (Open Label)||||||
1467818|NCT01405404|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467819|NCT01405391||Single Group Assignment||Treatment||None (Open Label)||||||
1467820|NCT01405378|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1467821|NCT01405365|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1467822|NCT01405352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467823|NCT01405339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467824|NCT01405326|Randomized|Parallel Assignment||||Double|||t||t|
1467825|NCT01405313|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467826|NCT01405300|Randomized|Crossover Assignment||Treatment||Single|||t|||
1467827|NCT01405287|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467828|NCT01405274|Randomized|Parallel Assignment||Treatment||Single||||||t
1467829|NCT01405261|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1467830|NCT01405248|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467831|NCT01405235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467832|NCT01405222|||Cohort||Prospective|||||||
1467833|NCT01405209|||Cohort|||||||||
1467834|NCT01405196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467835|NCT01405183|||Case Control||Prospective|||||||
1467836|NCT01405170|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1467837|NCT01405157|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1467838|NCT01405144|Randomized|Single Group Assignment||Treatment||Single||||||t
1467839|NCT01405131|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1467840|NCT01405118|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1467841|NCT01405105|||Cohort||Cross-Sectional|||||||
1467842|NCT01405092|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1467843|NCT01405079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467844|NCT01405066|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1467845|NCT01405053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467846|NCT01405040|||Cohort||Prospective|||||||
1467847|NCT01405027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467848|NCT01405014||Single Group Assignment||Supportive Care||None (Open Label)||||||
1467849|NCT01405001|||Case-Only||Prospective|||||||
1467850|NCT01404988|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1467851|NCT01404975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467852|NCT01404962|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1467853|NCT01404949||Single Group Assignment||Treatment||None (Open Label)||||||
1467854|NCT01404936||Single Group Assignment||Treatment||None (Open Label)||||||
1467855|NCT01404923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467856|NCT01404910||Single Group Assignment||Prevention||None (Open Label)||||||
1467857|NCT01404897|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1467858|NCT01404884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467859|NCT01404871|Randomized|Crossover Assignment||||Single||||||t
1467860|NCT01404858|||Cohort||Prospective|||||||
1467861|NCT01404845|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1467862|NCT01404832||Single Group Assignment||Diagnostic||None (Open Label)||||||
1467863|NCT01404819|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1467864|NCT01404806|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1467865|NCT01404793|||Cohort||Prospective|||||||
1467866|NCT01404780|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1467867|NCT01404767|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1467868|NCT01404754|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1467869|NCT01404741|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1467870|NCT01404728|||Case-Only||Cross-Sectional|||||||
1467871|NCT01404715|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1467872|NCT01404702||Single Group Assignment||Treatment||None (Open Label)||||||
1467873|NCT01404689|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1467874|NCT01404676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467875|NCT01404663||Single Group Assignment||Treatment||None (Open Label)||||||
1467876|NCT01404650||Single Group Assignment||Treatment||None (Open Label)||||||
1467877|NCT01404637|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467878|NCT01404624|||Case Control|||||||||
1467879|NCT01404611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467880|NCT01404598|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1467881|NCT01404585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467882|NCT01404572|Randomized|Crossover Assignment||||Double|||t||t|
1467883|NCT01404559|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1467884|NCT01404546|Randomized|Parallel Assignment||Prevention||Single||||||t
1467885|NCT01404533|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1467886|NCT01404520|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1467887|NCT01404507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467888|NCT01404494|||||Prospective|||||||
1467889|NCT01404481|||Cohort||Prospective|||||||
1467890|NCT01404468|Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1467891|NCT01404455|Non-Randomized|Parallel Assignment||Screening||Single|||t|||
1467892|NCT01404442|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467893|NCT01404429|Randomized|Parallel Assignment||Treatment||Single||||||t
1467894|NCT01404416|||Cohort||Prospective|||||||
1467895|NCT01404403|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467896|NCT01404390|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1467897|NCT01404377|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1467898|NCT01404364|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1467899|NCT01404351|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467900|NCT01404338|Randomized|Single Group Assignment||Basic Science||Double||||||
1467901|NCT01404325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467902|NCT01404312|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467903|NCT01404299|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1467904|NCT01404286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467905|NCT01404273||Single Group Assignment||Treatment||None (Open Label)||||||
1467906|NCT01404260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467907|NCT01404247||Single Group Assignment||Screening||None (Open Label)||||||
1467908|NCT01404234||Single Group Assignment||Treatment||None (Open Label)||||||
1467909|NCT01404221|||Cohort||Prospective|||||||
1467910|NCT01404208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467911|NCT01404195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467912|NCT01404182|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1467913|NCT01404169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467914|NCT01404156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467915|NCT01404143|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1467916|NCT01404130|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467917|NCT01404117|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467918|NCT01404104||Single Group Assignment||Treatment||None (Open Label)||||||
1468928|NCT01390922|||||Prospective|||||||
1467919|NCT01404091|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1467920|NCT01404078|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467921|NCT01404065|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467922|NCT01404052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1467923|NCT01404039|Randomized|Parallel Assignment||Basic Science||Double||There are 5 experiments: motor learning (3 groups, crossover), sensory learning (4 groups, parallel), observational task (2 groups, parallel), mental imagery (2 groups, parallel), and tDCS over the motor cortex (2 groups, crossover). Please note that the tDCS experiment has never been conducted.|||t|t
1467924|NCT01404026|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1467925|NCT01404013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467926|NCT01404000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467927|NCT01403987|Randomized|Parallel Assignment||||None (Open Label)||||||
1467928|NCT01403974||Single Group Assignment||Treatment||None (Open Label)||||||
1467929|NCT01403961|||Cohort||Prospective|||||||
1467930|NCT01403948||Single Group Assignment||Treatment||None (Open Label)||||||
1467931|NCT01403935|||Cohort||Prospective|||||||
1467932|NCT01403922|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1467933|NCT01403909|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1467934|NCT01403896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467935|NCT01403883|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467936|NCT01403870|||Cohort||Prospective|||||||
1467937|NCT01403857|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1467938|NCT01403844||Single Group Assignment||Basic Science||None (Open Label)||||||
1467939|NCT01403831|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1467940|NCT01403818|Randomized|Crossover Assignment||||None (Open Label)||||||
1467941|NCT01403805|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467942|NCT01403792|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1467943|NCT01403779|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467944|NCT01403766|||Cohort||Prospective|||||||
1467945|NCT01403753|||Cohort||Cross-Sectional|||||||
1467946|NCT01403740||||||||||||
1467947|NCT01403727|||Case Control||Prospective|||||||
1467948|NCT01403714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467949|NCT01403701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467950|NCT01403688|||Case Control||Prospective|||||||
1467951|NCT01403675||Single Group Assignment||Basic Science||None (Open Label)||||||
1467952|NCT01403662||Single Group Assignment||Treatment||None (Open Label)||||||
1467953|NCT01403649|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1467954|NCT01403636|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467955|NCT01403623|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467956|NCT01403610|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467957|NCT01403597||Single Group Assignment||Treatment||None (Open Label)||||||
1467958|NCT01403584||||||||||||
1467959|NCT01403571|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1467960|NCT01403558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467961|NCT01403545|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1467962|NCT01403532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467963|NCT01403519|||Case Control||Prospective|||||||
1467964|NCT01403506|Randomized|Parallel Assignment||Prevention||Single||||||t
1467965|NCT01403493|Randomized|Parallel Assignment||Treatment||Single||||||t
1467966|NCT01403480|||Cohort||Retrospective|||||||
1467967|NCT01403467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467968|NCT01403454|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1467969|NCT01403441||Single Group Assignment||Treatment||None (Open Label)||Precision radiotherapy is delivered on Day 1 using the Cyberknife System to Brodmann area cingulate 25.||||
1467970|NCT01403428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467971|NCT01403415||Single Group Assignment||Treatment||None (Open Label)||||||
1467972|NCT01403402|||Cohort||Prospective|||||||
1467973|NCT01403389|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1467974|NCT01403376|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1467975|NCT01403363|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1467976|NCT01403350|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1467977|NCT01403337|Randomized|Parallel Assignment||Treatment||Single|||t|||
1467978|NCT01403324||Single Group Assignment||||None (Open Label)||||||
1467979|NCT01403311||Single Group Assignment||Treatment||None (Open Label)||||||
1467980|NCT01403298|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467981|NCT01403285||Single Group Assignment||Treatment||None (Open Label)||||||
1467982|NCT01403272|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1467983|NCT01403259||Single Group Assignment||Treatment||None (Open Label)||||||
1467984|NCT01403246||Single Group Assignment||||None (Open Label)||||||
1467985|NCT01403233|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467986|NCT01403220|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1467987|NCT01403207|||Cohort||Prospective|||||||
1467988|NCT01403194||Single Group Assignment||Health Services Research||None (Open Label)||||||
1467989|NCT01403181|||||Prospective|||||||
1467990|NCT01403168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467991|NCT01403155||Single Group Assignment||Prevention||None (Open Label)||||||
1467992|NCT01403142|||Case-Only||Prospective|||||||
1467994|NCT01403116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1467995|NCT01403103||Single Group Assignment||Treatment||None (Open Label)||||||
1467996|NCT01403090||Single Group Assignment||Prevention||None (Open Label)||||||
1467997|NCT01403077||Single Group Assignment||Treatment||None (Open Label)||||||
1467998|NCT01403064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1467999|NCT01403051|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468000|NCT01403038|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1468001|NCT01403025|||Cohort||Prospective|||||||
1468002|NCT01403012|||Cohort||Prospective|||||||
1468003|NCT01402999|||Cohort||Other|||||||
1468004|NCT01402986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468005|NCT01402973|Randomized|Parallel Assignment||||Double|||t|||t
1468006|NCT01402960|Randomized|Crossover Assignment||Device Feasibility||Double|||t||t|
1468007|NCT01402947|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468008|NCT01402934||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1468009|NCT01402921|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468010|NCT01402908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468011|NCT01402895|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468012|NCT01402882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468013|NCT01402869|Randomized|Parallel Assignment||||None (Open Label)||||||
1468014|NCT01402856|||Cohort||Prospective|||||||
1468015|NCT01402843|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1468016|NCT01402830|||Case Control||Retrospective|||||||
1468017|NCT01402817||Single Group Assignment||Treatment||None (Open Label)||||||
1468018|NCT01402804|||Cohort||Prospective|||||||
1468019|NCT01402791|||Cohort||Prospective|||||||
1468020|NCT01402778|||Cohort||Prospective|||||||
1468021|NCT01402765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468022|NCT01402752||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468023|NCT01402739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468024|NCT01402726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468025|NCT01402713|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1468026|NCT01402700||Single Group Assignment||Treatment||None (Open Label)||||||
1468027|NCT01402687|||Cohort||Retrospective|||||||
1468028|NCT01402674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468029|NCT01402661|||Cohort||Prospective|||||||
1468030|NCT01402648|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468031|NCT01402635|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1468032|NCT01402622|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1468033|NCT01402609|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1468034|NCT01402596|Randomized|Crossover Assignment||Diagnostic||Double|||||t|t
1468035|NCT01402583|||Cohort||Retrospective|||||||
1468036|NCT01402570||Single Group Assignment||Treatment||None (Open Label)||||||
1468037|NCT01402557|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468038|NCT01402544||Single Group Assignment||Treatment||None (Open Label)||||||
1468039|NCT01402531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468040|NCT01402518|||Cohort||Prospective|||||||
1468041|NCT01402505|||Cohort||Prospective|||||||
1468042|NCT01402492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468043|NCT01402479|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468044|NCT01402466|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1468045|NCT01402453|Randomized|Parallel Assignment||||None (Open Label)||||||
1468046|NCT01402440||Single Group Assignment||Treatment||None (Open Label)||||||
1468047|NCT01402427|Randomized|Parallel Assignment||||Double|||t||t|
1468048|NCT01402414|Randomized|Crossover Assignment||Treatment||Single|||||t|
1468049|NCT01402401||Single Group Assignment||Treatment||None (Open Label)||||||
1468050|NCT01402388||Single Group Assignment||Treatment||None (Open Label)||||||
1468051|NCT01402375|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1468052|NCT01402362|||Cohort||Prospective|||||||
1468053|NCT01402349|||Cohort||Prospective|||||||
1468054|NCT01402336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468055|NCT01402323|Randomized|||Treatment||Single|||||t|
1468056|NCT01402310|||Cohort||Prospective|||||||
1468057|NCT01402297|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1468058|NCT01402284||Single Group Assignment||Treatment||None (Open Label)||||||
1468059|NCT01402271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468060|NCT01402258||Single Group Assignment||Treatment||None (Open Label)||||||
1468061|NCT01402245|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468062|NCT01402232|||Cohort||Prospective|||||||
1468063|NCT01402219|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1468064|NCT01402206|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1468065|NCT01402193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468066|NCT01402180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468067|NCT01402167|Randomized|Parallel Assignment||Treatment||Single||||||t
1468068|NCT01402154|||Cohort||Prospective|||||||
1468069|NCT01402141|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1468070|NCT01402128|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1468071|NCT01402115|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1468072|NCT01402102|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1468073|NCT01402089||Single Group Assignment||Treatment||None (Open Label)||||||
1468074|NCT01402076|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1468075|NCT01402063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468076|NCT01402050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468077|NCT01402037|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1468078|NCT01402024|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1468079|NCT01402011|Randomized|Parallel Assignment||Treatment||Triple|"For the 25% dextrose and .1% lidocaine and the .1% lidocaine enthesis injections, only the pharmacist knew the contents of each participant's numbered bottle. For the .1% subcutaneous injections, both the pharmacist and the physician where aware of the contents. There was a small c on the label. Only one participant asked the meaning of this letter, and he was told it stood for contents."|Participants were randomly allocated into 3 groups to receive injections of 25% dextrose in .1% lidocaine or .1% lidocaine in the shoulder entheses, the 3rd group received .1% lidocaine subcutaneously above the shoulder entheses.|t|t||t
1468080|NCT01401998|||Cohort||Retrospective|||||||
1468081|NCT01401985||Single Group Assignment||Treatment||Single|||t|||
1468082|NCT01401972|||Case-Only||Prospective|||||||
1468083|NCT01401959|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468084|NCT01401946|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468085|NCT01401933|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1468086|NCT01401920|||Case-Only||Prospective|||||||
1468087|NCT01401907|Randomized|Parallel Assignment||Supportive Care||Single||early palliative care||||t
1468088|NCT01401894|||Case-Only||Cross-Sectional|||||||
1468089|NCT01401881|||Cohort||Prospective|||||||
1468090|NCT01401868|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468091|NCT01401855|||Case-Only||Cross-Sectional|||||||
1468092|NCT01401842|Randomized|Parallel Assignment||Prevention||Single||||||t
1468093|NCT01401829|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1468094|NCT01401816|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1468095|NCT01401803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468096|NCT01401790|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1468097|NCT01401777|||Case Control||Prospective|||||||
1468098|NCT01401764||Single Group Assignment||Basic Science||Double|||t||t|
1468099|NCT01401751||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1468100|NCT01401738|||||Retrospective|||||||
1468101|NCT01401725|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468102|NCT01401712|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1468103|NCT01401699||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468104|NCT01401673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468105|NCT01401660|||Cohort||Prospective|||||||
1468106|NCT01401647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468107|NCT01401634|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468108|NCT01401621|Randomized|Parallel Assignment||Prevention||Single|||t|||
1468109|NCT01401608|||Cohort||Prospective|||||||
1468110|NCT01401595|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468111|NCT01401582|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1468112|NCT01401569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468113|NCT01401556|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1468114|NCT01401543|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468115|NCT01401530||Single Group Assignment||Treatment||None (Open Label)||||||
1468116|NCT01401517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468117|NCT01401504||Single Group Assignment||Treatment||None (Open Label)||||||
1468118|NCT01401491|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468119|NCT01401478|||||Prospective|||||||
1468120|NCT01401465|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468121|NCT01401452|||Cohort||Prospective|||||||
1468122|NCT01401439|||Cohort||Prospective|||||||
1468123|NCT01401426|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468124|NCT01401413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468125|NCT01401400|||Cohort||Retrospective|||||||
1468126|NCT01401387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468127|NCT01401374|||Other||Other|||||||
1468128|NCT01401361||Single Group Assignment||Treatment||None (Open Label)||||||
1468129|NCT01401348|||Cohort||Prospective|||||||
1468130|NCT01401335|Randomized|Single Group Assignment||||None (Open Label)||||||
1468131|NCT01401322||Single Group Assignment||Treatment||None (Open Label)||||||
1468132|NCT01401309|||Cohort||Cross-Sectional|||||||
1468133|NCT01401296|Randomized|Parallel Assignment||Treatment||Single||||||t
1468134|NCT01401283|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468135|NCT01401270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468136|NCT01401257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468137|NCT01401244|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468138|NCT01401231|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1468139|NCT01401218|||Case-Only||Retrospective|||||||
1468140|NCT01401205|||Case-Only||Prospective|||||||
1468141|NCT01401192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468142|NCT01401179|Randomized|Factorial Assignment||Treatment||Single||||||t
1468143|NCT01401166|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1468144|NCT01401153|Randomized|Crossover Assignment||||None (Open Label)||||||
1468145|NCT01401140|Randomized|Parallel Assignment||Prevention||Single|||t|||
1468146|NCT01401127|||Case Control||Prospective|||||||
1468147|NCT01401114|||Case-Only||Prospective|||||||
1468148|NCT01401101|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1468149|NCT01401088||Single Group Assignment||Treatment||None (Open Label)||||||
1468150|NCT01401075|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1468151|NCT01401062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468152|NCT01401049|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468153|NCT01401036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468154|NCT01401023||Single Group Assignment||Treatment||None (Open Label)||||||
1468155|NCT01401010|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468156|NCT01400997|||Cohort||Other|||||||
1468157|NCT01400984|||Cohort||Other|||||||
1468158|NCT01400971|||||Prospective|||||||
1468159|NCT01400958|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1468160|NCT01400945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468161|NCT01400932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468162|NCT01400919||Single Group Assignment||Treatment||None (Open Label)||||||
1468163|NCT01400906|Randomized|Crossover Assignment||Other||Double|||t||t|
1468164|NCT01400893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468165|NCT01400880|||Case-Only||Prospective|||||||
1468166|NCT01400867|Randomized|Parallel Assignment||Treatment||Single|||||t|
1468167|NCT01400854|||Cohort||Prospective|||||||
1468168|NCT01400841||Single Group Assignment||Treatment||None (Open Label)||||||
1468169|NCT01400828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468170|NCT01400815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468171|NCT01400802|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1468172|NCT01400789|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1468173|NCT01400776|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468174|NCT01400763|Randomized|Parallel Assignment||Prevention||Single|||||t|
1468175|NCT01400750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468176|NCT01400737|Randomized|Parallel Assignment||Prevention||Single|||t|||
1468177|NCT01400724|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1468178|NCT01400711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468179|NCT01400698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468180|NCT01400685||Single Group Assignment||Treatment||None (Open Label)||||||
1468181|NCT01400672||Single Group Assignment||Treatment||None (Open Label)||||||
1468182|NCT01400659|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468183|NCT01400646||Single Group Assignment||Treatment||None (Open Label)||||||
1468184|NCT01400633|||Case-Only||Prospective|||||||
1468185|NCT01400620|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468186|NCT01400607|Randomized|Parallel Assignment||Treatment||Single||||||t
1468187|NCT01400594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468188|NCT01400581|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468189|NCT01400568||Single Group Assignment||Basic Science||None (Open Label)||||||
1468190|NCT01400555|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468191|NCT01400542|||Cohort||Prospective|||||||
1468192|NCT01400529|||Case-Only||Cross-Sectional|||||||
1468193|NCT01400516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468194|NCT01400503||Single Group Assignment||Treatment||None (Open Label)||||||
1468195|NCT01400490|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1468196|NCT01400477|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468197|NCT01400464||Single Group Assignment||Treatment||None (Open Label)||||||
1468198|NCT01400451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468199|NCT01400438|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1468200|NCT01400425||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468201|NCT01400412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468202|NCT01400399|||Cohort||Prospective|||||||
1468203|NCT01400386|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1468204|NCT01400373|Randomized|Parallel Assignment||Treatment||Single||||||t
1468205|NCT01400360|Randomized|Parallel Assignment||Treatment||Single||||||t
1468206|NCT01400347|||Cohort||Prospective|||||||
1468207|NCT01400334|||Cohort||Prospective|||||||
1468208|NCT01400321|||Cohort||Prospective|||||||
1468209|NCT01400308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468210|NCT01400295|||Cohort||Prospective|||||||
1468211|NCT01400282|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468212|NCT01400269||Single Group Assignment||Treatment||None (Open Label)||||||
1468213|NCT01400256|Non-Randomized|Single Group Assignment||Treatment||Double|||t|t||
1468214|NCT01400243|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1468215|NCT01400230|||Cohort||Prospective|||||||
1468216|NCT01400217|||Case Control||Retrospective|||||||
1468217|NCT01400204|||Case Control||Prospective|||||||
1468218|NCT01400191|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1468219|NCT01400178|||||Cross-Sectional|||||||
1468220|NCT01400165|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468221|NCT01400152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468222|NCT01400139||Single Group Assignment||Treatment||None (Open Label)||||||
1468223|NCT01400126|||Cohort||Prospective|||||||
1468224|NCT01400113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468225|NCT01400100|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1468226|NCT01400087|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1468227|NCT01400074|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468228|NCT01400061|||Cohort||Prospective|||||||
1468229|NCT01400048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468230|NCT01400035|||Case Control||Prospective|||||||
1468231|NCT01400022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468232|NCT01400009|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468233|NCT01399996|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1468234|NCT01399983|||Cohort||Prospective|||||||
1468235|NCT01399970|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1468236|NCT01399957|||Ecologic or Community||Prospective|||||||
1468237|NCT01399944|||Case-Only||Cross-Sectional|||||||
1468238|NCT01399931|||Cohort||Prospective|||||||
1468239|NCT01399918||Single Group Assignment||Treatment||None (Open Label)||||||
1468240|NCT01399905|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1468241|NCT01399892||Single Group Assignment||Treatment||None (Open Label)||||||
1468242|NCT01399879|||Case-Only||Cross-Sectional|||||||
1468243|NCT01399866|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468244|NCT01399853|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1468245|NCT01399840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468246|NCT01399827|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468247|NCT01399814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468248|NCT01399801|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468249|NCT01399788|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1468250|NCT01399775|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468251|NCT01399762|||Cohort|||||||||
1468252|NCT01399749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468253|NCT01399736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468254|NCT01399723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468255|NCT01399710||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468256|NCT01399697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468257|NCT01399684|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468258|NCT01399671|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1468259|NCT01399658||Single Group Assignment||Treatment||None (Open Label)||||||
1468260|NCT01399645|Randomized|Parallel Assignment||Treatment||Single|||||t|
1468261|NCT01399632|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1468262|NCT01399619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468263|NCT01399606||Single Group Assignment||Treatment||None (Open Label)||||||
1468264|NCT01399593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468265|NCT01399580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468266|NCT01399567|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1468267|NCT01399554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468268|NCT01399541|||Cohort||Prospective|||||||
1468269|NCT01399528|||Cohort|||||||||
1468270|NCT01399515|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468271|NCT01399502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468272|NCT01399489|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468273|NCT01399476||Single Group Assignment||Treatment||None (Open Label)||||||
1468274|NCT01399463||Parallel Assignment||||Single||||||
1468275|NCT01399450||Single Group Assignment||Treatment||None (Open Label)||||||
1468276|NCT01399437|||||Other|||||||
1468277|NCT01399424|Randomized|Parallel Assignment||Prevention||Double||||||
1468278|NCT01399411|||||Other|||||||
1468279|NCT01399398|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1468280|NCT01399385|||||Other|||||||
1468281|NCT01399372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468282|NCT01399359|||Cohort||Prospective|||||||
1468283|NCT01399346|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1468284|NCT01399333|Randomized|Parallel Assignment||Screening||Single|||t|||
1468285|NCT01399320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468286|NCT01399307|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1468287|NCT01399294|||Case-Only||Cross-Sectional|||||||
1468288|NCT01399281|||Cohort||Prospective|||||||
1468289|NCT01399268|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468290|NCT01399255|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1468291|NCT01399242|Randomized|Parallel Assignment||Prevention||Single|||||t|
1468292|NCT01399229|||Case-Only||Cross-Sectional|||||||
1468293|NCT01399216|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1468294|NCT01399203|||Cohort||Prospective|||||||
1468295|NCT01399190|||Cohort||Prospective|||||||
1468296|NCT01399177|||Cohort||Prospective|||||||
1468297|NCT01399164|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1468298|NCT01399151|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1468299|NCT01399138|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468300|NCT01399125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468301|NCT01399112|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1468302|NCT01399099||Single Group Assignment||Treatment||None (Open Label)||||||
1468303|NCT01399086|||Cohort||Retrospective|||||||
1468304|NCT01399073|||Cohort||Prospective|||||||
1468305|NCT01399060|||Case Control||Cross-Sectional|||||||
1468306|NCT01399047|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1468307|NCT01399034|||Case Control||Cross-Sectional|||||||
1468308|NCT01399021|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1468309|NCT01399008|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468310|NCT01398995|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1468311|NCT01398982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468312|NCT01398969|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468313|NCT01398956||Single Group Assignment||Treatment||None (Open Label)||||||
1468314|NCT01398943|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1468315|NCT01398930|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468316|NCT01398917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468317|NCT01398904|||Case Control||Prospective|||||||
1468318|NCT01398891||Single Group Assignment||Treatment||None (Open Label)||||||
1468319|NCT01398878|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1468320|NCT01398865|||Case-Only||Prospective|||||||
1468321|NCT01398852|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1468322|NCT01398839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468323|NCT01398826|||Case Control||Prospective|||||||
1468324|NCT01398813|||||Cross-Sectional|||||||
1468325|NCT01398800|||Case-Only||Retrospective|||||||
1468326|NCT01398787|Randomized|Single Group Assignment||||Single|||t|||
1468327|NCT01398774|||Cohort||Cross-Sectional|||||||
1468328|NCT01398761||Single Group Assignment||Health Services Research||None (Open Label)||||||
1468329|NCT01398748|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1468330|NCT01398722|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468331|NCT01398709|Randomized|Parallel Assignment||||Single|||t|||
1468332|NCT01398696|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1468333|NCT01398683|||||Prospective|||||||
1468334|NCT01398670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468335|NCT01398657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468336|NCT01398644|Randomized|Crossover Assignment||Treatment||Single||||||t
1468337|NCT01398631|||Cohort||Prospective|||||||
1468338|NCT01398618|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468339|NCT01398605|Randomized|Parallel Assignment||||None (Open Label)||||||
1468340|NCT01398592|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468341|NCT01398579|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1468342|NCT01398566||Single Group Assignment||Supportive Care||None (Open Label)||||||
1468343|NCT01398553|Randomized|Parallel Assignment||Treatment||Single||||||t
1468344|NCT01398540|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1468345|NCT01398527|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1468346|NCT01398514|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1468347|NCT01398501||Single Group Assignment||Treatment||None (Open Label)||||||
1468348|NCT01398488|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1468349|NCT01398475|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468350|NCT01398462||Single Group Assignment||Treatment||None (Open Label)||||||
1468351|NCT01398449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468352|NCT01398436|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1468353|NCT01398423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468354|NCT01398410|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468355|NCT01398397|||Case-Only||Retrospective|||||||
1468356|NCT01398384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468357|NCT01398371|Randomized|Crossover Assignment||Treatment||Single|||t|||
1468358|NCT01398358|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468359|NCT01398345|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468360|NCT01398332|||Cohort||Prospective|||||||
1468361|NCT01398319||Single Group Assignment||Prevention||None (Open Label)||||||
1468362|NCT01398306|||Cohort||Cross-Sectional|||||||
1468363|NCT01398293|Randomized|Crossover Assignment||||Double|||t||t|
1468364|NCT01398280|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1468365|NCT01398267|Randomized|Parallel Assignment||||Double|||t||t|
1468366|NCT01398254|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468367|NCT01398241|Randomized|Parallel Assignment||||Double|||t||t|
1468368|NCT01398228|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1468369|NCT01398215|||Cohort||Prospective|||||||
1468370|NCT01398202|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1468371|NCT01398189||Single Group Assignment||Basic Science||None (Open Label)||||||
1468372|NCT01398176|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1468373|NCT01398163|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1468374|NCT01398150|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1468375|NCT01398137|||Cohort||Prospective|||||||
1468376|NCT01398124||Single Group Assignment||Treatment||None (Open Label)||||||
1468377|NCT01398111|Randomized|Crossover Assignment||||None (Open Label)||||||
1468378|NCT01398098|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1468379|NCT01398085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468380|NCT01398072|Randomized|Parallel Assignment||||Single|||t|||
1468381|NCT01398059|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1468382|NCT01398046|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1468383|NCT01398033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468384|NCT01398020|Randomized|Parallel Assignment||||Single|||||t|
1468385|NCT01398007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468386|NCT01397994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468387|NCT01397981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468388|NCT01397968|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468389|NCT01397955|||Case-Only||Prospective|||||||
1468390|NCT01397942|Randomized|Parallel Assignment||Prevention||Single|||t|||
1468391|NCT01397929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468392|NCT01397916|||Case Control||Prospective|||||||
1468393|NCT01397903|||Case-Only||Cross-Sectional|||||||
1468394|NCT01397890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468395|NCT01397877||Single Group Assignment||Treatment||None (Open Label)||||||
1468396|NCT01397864|||Cohort||Prospective|||||||
1468397|NCT01397851|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1468398|NCT01397838||Single Group Assignment||Prevention||None (Open Label)||||||
1468399|NCT01397825|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468400|NCT01397812|||Case-Only||Prospective|||||||
1468401|NCT01397799||Single Group Assignment||Treatment||None (Open Label)||||||
1468402|NCT01397786||Single Group Assignment||Treatment||None (Open Label)||||||
1468403|NCT01397773|||Case Control||Cross-Sectional|||||||
1468404|NCT01397760|||Case-Only||Retrospective|||||||
1468405|NCT01397747|||Case-Only||Prospective|||||||
1468406|NCT01397734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468407|NCT01397721|||||Prospective|||||||
1468408|NCT01397708||Single Group Assignment||Treatment||None (Open Label)||||||
1468409|NCT01397695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468410|NCT01397682|||Case-Only|||||||||
1468411|NCT01397669||Single Group Assignment||Basic Science||None (Open Label)||||||
1468412|NCT01397656|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1468413|NCT01397643|Randomized|Parallel Assignment||Treatment||Single||||||t
1468414|NCT01397630|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468415|NCT01397617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468416|NCT01397604|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1468417|NCT01397591||Single Group Assignment||Treatment||None (Open Label)||||||
1468418|NCT01397578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468419|NCT01397565|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1468420|NCT01397552|Randomized|Parallel Assignment||Other||Double|||t||t|
1468421|NCT01397539|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1468422|NCT01397526|||Case-Only||Prospective|||||||
1468423|NCT01397513|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468424|NCT01397500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468425|NCT01397487||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468426|NCT01397474|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1468427|NCT01397461|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468428|NCT01397448|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468429|NCT01397435|||Case Control||Prospective|||||||
1468430|NCT01397422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468431|NCT01397409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468432|NCT01397396|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468433|NCT01397383|||Cohort||Prospective|||||||
1468434|NCT01397370|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1468435|NCT01397357|||||Prospective|||||||
1468436|NCT01397344|||Case-Only||Cross-Sectional|||||||
1468437|NCT01397331|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1468438|NCT01397318|||Case Control||Prospective|||||||
1468439|NCT01397305||Single Group Assignment||Treatment||None (Open Label)||||||
1468440|NCT01397292|||Cohort||Prospective|||||||
1468441|NCT01397279|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1468442|NCT01397266|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1468443|NCT01397253|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1468444|NCT01397240|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1468445|NCT01397227|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468446|NCT01397214|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468447|NCT01397201|Randomized|Parallel Assignment||Treatment||Double||||||
1468448|NCT01397188|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1468449|NCT01397175|Randomized|Parallel Assignment||Treatment||Single||BES EES ZES-R|t|||
1468450|NCT01397162|Randomized|Parallel Assignment||Treatment||Double||||||
1468451|NCT01397149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468452|NCT01397136|||Cohort||Prospective|||||||
1468453|NCT01397123|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1468454|NCT01397110|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1468455|NCT01397097|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468456|NCT01397084||Single Group Assignment||Treatment||None (Open Label)||||||
1468457|NCT01397071|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1468458|NCT01397058|||Cohort||Prospective|||||||
1468459|NCT01397045|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1468460|NCT01397032|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1468461|NCT01397019||Single Group Assignment||Treatment||None (Open Label)||||||
1468462|NCT01397006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468463|NCT01396993|||Cohort||Prospective|||||||
1468464|NCT01396980|||Cohort||Prospective|||||||
1468465|NCT01396967||Single Group Assignment||||None (Open Label)||||||
1468466|NCT01396954|||Cohort||Prospective|||||||
1468467|NCT01396941||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468468|NCT01396928|||Cohort||Prospective|||||||
1468469|NCT01396915|||Cohort||Retrospective|||||||
1468470|NCT01396902|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1468471|NCT01396889|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1468472|NCT01396876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468473|NCT01396863|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468474|NCT01396850|||Case Control||Prospective|||||||
1468475|NCT01396837||Single Group Assignment||Treatment||None (Open Label)||||||
1468476|NCT01396824|||Cohort||Prospective|||||||
1468477|NCT01396811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468478|NCT01396798|||Cohort||Prospective|||||||
1468479|NCT01396785|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468480|NCT01396772|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468481|NCT01396759|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468482|NCT01396746|||Case-Only||Cross-Sectional|||||||
1468483|NCT01396733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468484|NCT01396720|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1468485|NCT01396707||Single Group Assignment||Treatment||None (Open Label)||||||
1468486|NCT01396694|||Cohort||Prospective|||||||
1468487|NCT01396681||Single Group Assignment||Treatment||None (Open Label)||||||
1468488|NCT01396668||Single Group Assignment||Treatment||None (Open Label)||||||
1468489|NCT01396655||Single Group Assignment||Treatment||None (Open Label)||||||
1468490|NCT01396642|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468491|NCT01396629|||||Prospective|||||||
1468492|NCT01396616||Single Group Assignment||Treatment||None (Open Label)||||||
1468493|NCT01396603|||Cohort||Cross-Sectional|||||||
1468494|NCT01396590|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468495|NCT01396577|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468496|NCT01396564|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468497|NCT01396551||Single Group Assignment||Other||None (Open Label)||||||
1468498|NCT01396538|||Cohort||Prospective|||||||
1468499|NCT01396525||Single Group Assignment||Treatment||None (Open Label)||||||
1468500|NCT01396512|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468501|NCT01396499||Single Group Assignment||Treatment||None (Open Label)||||||
1468502|NCT01396486|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1468503|NCT01396473|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468504|NCT01396460|||Case Control||Cross-Sectional|||||||
1468505|NCT01396447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468506|NCT01396434|||||Prospective|||||||
1468507|NCT01396421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468508|NCT01396408|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468509|NCT01396395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468510|NCT01396382||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468511|NCT01396369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468512|NCT01396356|||Case Control||Prospective|||||||
1468513|NCT01396343|||Case-Control||Cross-Sectional|||||||
1468514|NCT01396330|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1468515|NCT01396317||Single Group Assignment||Treatment||None (Open Label)||||||
1468516|NCT01396304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468517|NCT01396291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468518|NCT01396278|Randomized|Parallel Assignment||Treatment||Double||||||
1468519|NCT01396265|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468520|NCT01396252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468521|NCT01396239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468522|NCT01396226|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1468523|NCT01396213|Randomized|Parallel Assignment||Treatment||Double|double-blind|randomized, double-blind, placebo-controlled|t||t|
1468524|NCT01396200|Non-Randomized|Parallel Assignment||Treatment||||||||
1468525|NCT01396187|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468526|NCT01396174|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1468527|NCT01396161|Randomized|||Basic Science||Double|||t||t|
1468528|NCT01396148|Non-Randomized|||Treatment||None (Open Label)||||||
1468529|NCT01396135|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1468530|NCT01396122||Single Group Assignment||Treatment||None (Open Label)||||||
1468531|NCT01396109|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468532|NCT01396096|||Case-Only||Prospective|||||||
1468533|NCT01396083|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468534|NCT01396070||Single Group Assignment||Treatment||None (Open Label)||||||
1468535|NCT01396057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468536|NCT01396044|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1468537|NCT01396031|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1468538|NCT01396005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468539|NCT01395992|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468540|NCT01395979|Randomized|Parallel Assignment||Prevention||Single||||||t
1468541|NCT01395966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468542|NCT01395953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468543|NCT01395940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468544|NCT01395927|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1468545|NCT01395914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468546|NCT01395901|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468547|NCT01395888|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468548|NCT01395875|||Cohort||Retrospective|||||||
1468549|NCT01395862|||||Prospective|||||||
1468550|NCT01395849|||Other||Prospective|||||||
1468551|NCT01395836|||Cohort||Prospective|||||||
1468552|NCT01395823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468553|NCT01395810|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468554|NCT01395797|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1468555|NCT01395784|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1468556|NCT01395771|Randomized|Single Group Assignment||Treatment||Single|||t|||
1468557|NCT01395758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468558|NCT01395745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468559|NCT01395732||Single Group Assignment||Treatment||None (Open Label)||||||
1468560|NCT01395719|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1468561|NCT01395706|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1468562|NCT01395693||Single Group Assignment||Supportive Care||None (Open Label)||||||
1468563|NCT01395680|||||Prospective|||||||
1468564|NCT01395667||Single Group Assignment||Treatment||None (Open Label)||||||
1468565|NCT01395654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468566|NCT01395641||Single Group Assignment||Treatment||None (Open Label)||||||
1468567|NCT01395628|||Case-Only||Retrospective|||||||
1468568|NCT01395615|||Cohort||Prospective|||||||
1468569|NCT01395602|Randomized|Parallel Assignment||||Double|||t||t|
1468570|NCT01395589|Randomized|Single Group Assignment||Treatment||Single|||||t|
1468571|NCT01395576|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468572|NCT01395563|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468573|NCT01395550|||||Retrospective|||||||
1468574|NCT01395537||Single Group Assignment||Treatment||None (Open Label)||||||
1468575|NCT01395524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468576|NCT01395511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468577|NCT01395498|||Cohort||Prospective|||||||
1468578|NCT01395485|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1468579|NCT01395472|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468580|NCT01395459|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1468581|NCT01395446|||Cohort||Prospective|||||||
1468582|NCT01395433|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468583|NCT01395420|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1468584|NCT01395407|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468585|NCT01395394|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1468586|NCT01395381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468587|NCT01395368|||Cohort||Prospective|||||||
1468588|NCT01395355|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468589|NCT01395342||Single Group Assignment||Prevention||None (Open Label)||||||
1468590|NCT01395329|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1468591|NCT01395316||Single Group Assignment||Treatment||None (Open Label)||||||
1468592|NCT01395303|||||Retrospective|||||||
1468593|NCT01395290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468594|NCT01395277|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1468595|NCT01395264|||Case-Control||Cross-Sectional|||||||
1468596|NCT01395251||Single Group Assignment||Diagnostic||Single||||||t
1468597|NCT01395238|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468598|NCT01395225|||||Prospective|||||||
1468599|NCT01395212|||Case-Only||Prospective|||||||
1468600|NCT01395199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468601|NCT01395186||Single Group Assignment||Treatment||None (Open Label)||||||
1468602|NCT01395173|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1468603|NCT01395160|||Case Control||Cross-Sectional|||||||
1468604|NCT01395147||Single Group Assignment||Treatment||None (Open Label)||||||
1468605|NCT01395134|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1468606|NCT01395121||Single Group Assignment||Treatment||None (Open Label)||||||
1468607|NCT01395108|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1468608|NCT01395095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468609|NCT01395082|||Cohort||Prospective|||||||
1468610|NCT01395069|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1468611|NCT01395056|||Cohort||Prospective|||||||
1468612|NCT01395043||Single Group Assignment||Supportive Care||None (Open Label)||||||
1468613|NCT01395030||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468614|NCT01395017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468615|NCT01395004||Single Group Assignment||Basic Science||None (Open Label)||||||
1468616|NCT01394991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468617|NCT01394978|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468618|NCT01394965||Single Group Assignment||Diagnostic||Single|||t|||
1468619|NCT01394952|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468620|NCT01394939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468621|NCT01394926|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1468622|NCT01394913|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468623|NCT01394900|Randomized|Parallel Assignment||Prevention||Single||||||t
1468624|NCT01394887|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1468625|NCT01394874|Randomized|Parallel Assignment||Treatment||Single|||||t|
1468626|NCT01394861||Single Group Assignment||Treatment||None (Open Label)||||||
1468627|NCT01394848|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1468628|NCT01394835|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468629|NCT01394822|||Cohort||Prospective|||||||
1468630|NCT01394809|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1468631|NCT01394796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468632|NCT01394783|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1468633|NCT01394770|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1468634|NCT01394757|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1468635|NCT01394744|||Cohort||Prospective|||||||
1468636|NCT01394731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468637|NCT01394718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468638|NCT01394705|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1468639|NCT01394692|Randomized|Parallel Assignment||Treatment||Single||||||t
1468640|NCT01394679|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||Patients receive Standard PET imaging with FDG then receive SPECT-CT imaging with investigational EC-DG imaging agent||||
1468641|NCT01394666|||Cohort||Retrospective|||||||
1468642|NCT01394653|Randomized|Crossover Assignment||||None (Open Label)||||||
1468643|NCT01394640|||Cohort||Prospective|||||||
1468644|NCT01394627|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1468645|NCT01394614|||Cohort||Retrospective|||||||
1468646|NCT01394601|||Cohort||Retrospective|||||||
1468647|NCT01394588|||Cohort||Prospective|||||||
1468648|NCT01394575|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468649|NCT01394562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468650|NCT01394549|||Cohort||Prospective|||||||
1468651|NCT01394536|Randomized|Parallel Assignment||Prevention||Single|||t|||
1468652|NCT01394523|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1468653|NCT01394510||Single Group Assignment||Basic Science||None (Open Label)||||||
1468654|NCT01394497|Randomized|Parallel Assignment||Prevention||Single|||t|||
1468655|NCT01394484|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1468656|NCT01394471|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1468657|NCT01394458|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468658|NCT01394445|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1468659|NCT01394432|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1468660|NCT01394419|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1468661|NCT01394406|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1468662|NCT01394393|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1468663|NCT01394380|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468664|NCT01394367|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1468665|NCT01394354||Single Group Assignment||Treatment||None (Open Label)||||||
1468666|NCT01394341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468667|NCT01394328|||Cohort||Prospective|||||||
1468668|NCT01394315|||Cohort||Prospective|||||||
1468669|NCT01394302|||Case-Only||Cross-Sectional|||||||
1468670|NCT01394289||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468671|NCT01394276|||Cohort||Prospective|||||||
1468672|NCT01394263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468673|NCT01394250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468674|NCT01394237|||Case-Only||Prospective|||||||
1468675|NCT01394224|Randomized|Crossover Assignment||||None (Open Label)||||||
1468676|NCT01394211||Single Group Assignment||Treatment||None (Open Label)||||||
1468677|NCT01394198|||Other||Prospective|||||||
1468678|NCT01394185|Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1468679|NCT01394172|||Cohort||Prospective|||||||
1468680|NCT01394159|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1468681|NCT01394146||Single Group Assignment||||None (Open Label)||||||
1468682|NCT01394133|||Cohort||Prospective|||||||
1468683|NCT01394120|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468684|NCT01394107|||Case Control||Prospective|||||||
1468685|NCT01394094|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1468686|NCT01394081|Randomized|Parallel Assignment||Screening||None (Open Label)||Prospective randomized control trial||||
1468687|NCT01394068|||Cohort||Prospective|||||||
1468688|NCT01394055|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1468689|NCT01394042||Single Group Assignment||Diagnostic||||||||
1468690|NCT01394029|||Cohort||Retrospective|||||||
1468691|NCT01394016||Single Group Assignment||Treatment||None (Open Label)||||||
1468692|NCT01394003||Single Group Assignment||Treatment||None (Open Label)||||||
1468693|NCT01393990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468694|NCT01393977|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1468695|NCT01393964|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468696|NCT01393951|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468697|NCT01393938||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468698|NCT01393925|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468699|NCT01393912|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468700|NCT01393899|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468701|NCT01393886||Single Group Assignment||Treatment||None (Open Label)||||||
1468702|NCT01393873|||Cohort||Prospective|||||||
1468703|NCT01393860|||Cohort||Retrospective|||||||
1468704|NCT01393847|||||Prospective|||||||
1468705|NCT01393834|Randomized|Parallel Assignment||||None (Open Label)||||||
1468706|NCT01393821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468707|NCT01393808|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1468708|NCT01393795|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1468709|NCT01393782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468710|NCT01393769||Single Group Assignment||Treatment||None (Open Label)||||||
1468711|NCT01393756||Single Group Assignment||Treatment||None (Open Label)||||||
1468712|NCT01393743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468713|NCT01393730||Single Group Assignment||Treatment||None (Open Label)||||||
1468714|NCT01393717||Single Group Assignment||Treatment||None (Open Label)||||||
1468715|NCT01393704|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468716|NCT01393691|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1468717|NCT01393678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468718|NCT01393665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468719|NCT01393652|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1468720|NCT01393639|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468721|NCT01393626|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468722|NCT01393613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468723|NCT01393600|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1468724|NCT01393587||||||||||||
1468725|NCT01393574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468726|NCT01393561|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468727|NCT01393548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468728|NCT01393535|||Cohort||Prospective|||||||
1468729|NCT01393522|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1468730|NCT01393509||Single Group Assignment||Treatment||None (Open Label)||||||
1468731|NCT01393496|Randomized|Parallel Assignment||Treatment||Single||||||t
1468732|NCT01393483|||Cohort||Prospective|||||||
1468733|NCT01393470|||Cohort||Prospective|||||||
1468734|NCT01393457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468735|NCT01393444||Single Group Assignment||||None (Open Label)||||||
1468736|NCT01393431|||Cohort||Prospective|||||||
1468737|NCT01393418|||Case-Only||Cross-Sectional|||||||
1468738|NCT01393405|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468739|NCT01393392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468740|NCT01393379|||||Prospective|||||||
1468741|NCT01393366|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1468742|NCT01393353|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468743|NCT01393340|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468744|NCT01393327|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1468745|NCT01393314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468746|NCT01393301|Randomized|Parallel Assignment||Treatment||Single|For formative stage of the study, no masking was used as that phase was an open pilot. Outcomes assessor masked during the pilot RCT.|||||t
1468747|NCT01393288|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1468748|NCT01393275|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468749|NCT01393262|||Cohort||Other|||||||
1468750|NCT01393249|||Cohort||Prospective|||||||
1468751|NCT01393236|||||Prospective|||||||
1468752|NCT01393223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468753|NCT01393210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468754|NCT01393197|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1468755|NCT01393184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468756|NCT01393171|Randomized|Parallel Assignment||Treatment||Single||||||t
1468757|NCT01393158||Single Group Assignment||||None (Open Label)||||||
1468758|NCT01393145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468759|NCT01393132|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468760|NCT01393119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468761|NCT01393106||Single Group Assignment||Treatment||None (Open Label)||||||
1468762|NCT01393093|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1468763|NCT01393080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468764|NCT01393067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468765|NCT01393054|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1468766|NCT01393041||Single Group Assignment||Treatment||None (Open Label)||||||
1468767|NCT01393028|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1468768|NCT01393015|Randomized|Parallel Assignment||||None (Open Label)||||||
1468769|NCT01393002|||Cohort||Prospective|||||||
1468770|NCT01392989||Single Group Assignment||Treatment||None (Open Label)||||||
1468771|NCT01392976|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468772|NCT01392963|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1468773|NCT01392950|Randomized|Parallel Assignment||||None (Open Label)||||||
1468774|NCT01392937|Randomized|Parallel Assignment||||Single|||t|||
1468775|NCT01392924||Single Group Assignment||Treatment||None (Open Label)||||||
1468776|NCT01392911|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1468777|NCT01392898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468778|NCT01392885|||Cohort||Prospective|||||||
1468779|NCT01392872||Single Group Assignment||||None (Open Label)||||||
1468780|NCT01392859|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1468781|NCT01392846|||Cohort||Prospective|||||||
1468782|NCT01392833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468783|NCT01392820|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1468784|NCT01392807|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1468785|NCT01392794|Randomized|Crossover Assignment||||None (Open Label)||||||
1468786|NCT01392781|||Case Control||Prospective|||||||
1468787|NCT01392768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468788|NCT01392755|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468789|NCT01392742|||Cohort||Prospective|||||||
1468790|NCT01392729|||Cohort||Prospective|||||||
1468791|NCT01392716|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468792|NCT01392703|Randomized|Crossover Assignment||||None (Open Label)||||||
1468793|NCT01392690|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468794|NCT01392677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468795|NCT01392664|||Case Control||Retrospective|||||||
1468796|NCT01392651|||Case Control||Retrospective|||||||
1468797|NCT01392638|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1468798|NCT01392625|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468799|NCT01392612|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1468800|NCT01392599||Single Group Assignment||Treatment||None (Open Label)||||||
1468801|NCT01392586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468802|NCT01392573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468803|NCT01392560||Single Group Assignment||Treatment||None (Open Label)||||||
1468804|NCT01392547|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1468805|NCT01392534|||Cohort||Prospective|||||||
1468806|NCT01392521||Single Group Assignment||Treatment||None (Open Label)||||||
1468807|NCT01392508|||Case-Only||Prospective|||||||
1468808|NCT01392495|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468809|NCT01392482|||Cohort||Retrospective|||||||
1468810|NCT01392469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468811|NCT01392456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468812|NCT01392443||Single Group Assignment||Treatment||None (Open Label)||||||
1468813|NCT01392430|Randomized|Parallel Assignment||Prevention||Single||||||t
1468814|NCT01392417|||Case Control||Retrospective|||||||
1468815|NCT01392391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468816|NCT01392378|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468817|NCT01392365|||||Prospective|||||||
1468818|NCT01392352||Single Group Assignment||Basic Science||None (Open Label)||||||
1468819|NCT01392339|Non-Randomized|Single Group Assignment||Basic Science||Single|||||t|
1468820|NCT01392326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468821|NCT01392313|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1468822|NCT01392300|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468823|NCT01392287||Single Group Assignment||Basic Science||None (Open Label)||||||
1468824|NCT01392274|||||Prospective|||||||
1468825|NCT01392261||||||||||||
1468826|NCT01392248|||Cohort||Prospective|||||||
1468827|NCT01392235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468828|NCT01392222|||Family-Based||Prospective|||||||
1468829|NCT01392209||Single Group Assignment||Treatment||None (Open Label)||||||
1468830|NCT01392196||Single Group Assignment||Treatment||None (Open Label)||||||
1468831|NCT01392183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468832|NCT01392170||Single Group Assignment||Treatment||None (Open Label)||||||
1468833|NCT01392157|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468834|NCT01392144|||Cohort||Prospective|||||||
1468835|NCT01392131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468836|NCT01392118|||Case Control||Retrospective|||||||
1468837|NCT01392105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468838|NCT01392092|||Case-Only||Prospective|||||||
1468839|NCT01392079||Single Group Assignment||Treatment||None (Open Label)||||||
1468840|NCT01392066|||Cohort||Prospective|||||||
1468841|NCT01392053|Randomized|Parallel Assignment||Treatment||Single|||||t|
1468842|NCT01392040|||Cohort||Prospective|||||||
1468843|NCT01392027||Single Group Assignment||Prevention||None (Open Label)||||||
1468844|NCT01392014|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468845|NCT01392001|||Cohort||Prospective|||||||
1468846|NCT01391988|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1468847|NCT01391975|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1468848|NCT01391962|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468849|NCT01391949|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1468929|NCT01390909|||Cohort||Retrospective|||||||
1468850|NCT01391936|Randomized|Parallel Assignment||Treatment||Single||||||t
1468851|NCT01391923|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1468852|NCT01391910|||Cohort||Prospective|||||||
1468853|NCT01391897|||Cohort||Prospective|||||||
1468854|NCT01391884|||Case Control||Cross-Sectional|||||||
1468855|NCT01391871|||Case Control||Prospective|||||||
1468856|NCT01391858|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1468857|NCT01391845|Randomized|Parallel Assignment||||Single|||t|||
1468858|NCT01391832|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1468859|NCT01391819||Single Group Assignment||Other||None (Open Label)||||||
1468860|NCT01391806|||Cohort||Prospective|||||||
1468861|NCT01391793|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468862|NCT01391780|||||Prospective|||||||
1468863|NCT01391767|||Case Control||Prospective|||||||
1468864|NCT01391754|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1468865|NCT01391741|Randomized|Parallel Assignment||Treatment||Single||||||t
1468866|NCT01391728|Randomized|Parallel Assignment||Treatment||Single|||||t|
1468867|NCT01391715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468868|NCT01391702|||Cohort||Prospective|||||||
1468869|NCT01391689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468870|NCT01391676|||Case Control||Prospective|||||||
1468871|NCT01391663|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1468872|NCT01391650|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1468873|NCT01391637|||Cohort||Prospective|||||||
1468874|NCT01391624|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468875|NCT01391611||Single Group Assignment||Treatment||None (Open Label)||||||
1468876|NCT01391598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468877|NCT01391585|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1468878|NCT01391572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468879|NCT01391559|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468880|NCT01391546|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468881|NCT01391533|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1468882|NCT01391520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468883|NCT01391507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468884|NCT01391494|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1468885|NCT01391481|Randomized|Crossover Assignment||Treatment||Single|||t|||
1468886|NCT01391468|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468887|NCT01391455|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468888|NCT01391442||Single Group Assignment||Prevention||None (Open Label)||||||
1468889|NCT01391429|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1468890|NCT01391416|||Case-Only||Cross-Sectional|||||||
1468891|NCT01391403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468892|NCT01391390|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468893|NCT01391377|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1468894|NCT01391364||||||||||||
1468895|NCT01391351|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1468896|NCT01391338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468897|NCT01391325|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468898|NCT01391312|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468899|NCT01391299|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468900|NCT01391286|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468901|NCT01391273|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468902|NCT01391260||Single Group Assignment||Treatment||None (Open Label)||||||
1468903|NCT01391247|||||Prospective|||||||
1468904|NCT01391234||Single Group Assignment||Treatment||None (Open Label)||||||
1468905|NCT01391221||Single Group Assignment||Basic Science||None (Open Label)||||||
1468906|NCT01391208|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1468907|NCT01391195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468908|NCT01391182|Randomized|Single Group Assignment||||Triple|||t|t|t|
1468909|NCT01391169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1468910|NCT01391156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468911|NCT01391143||Single Group Assignment||Treatment||None (Open Label)||||||
1468912|NCT01391130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468913|NCT01391117|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1468914|NCT01391104|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1468915|NCT01391091|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468916|NCT01391078|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1468917|NCT01391065||Single Group Assignment||Treatment||||||||
1468918|NCT01391052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468919|NCT01391039||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468920|NCT01391026|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1468921|NCT01391013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468922|NCT01391000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468923|NCT01390987|||Cohort||Prospective|||||||
1468924|NCT01390974|||Cohort||Prospective|||||||
1468925|NCT01390961|Randomized|Crossover Assignment||Treatment||Single|||||t|
1468926|NCT01390948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468927|NCT01390935|||||Retrospective|||||||
1468932|NCT01390870|||Other||Cross-Sectional|||||||
1468933|NCT01390857|||Other||Prospective|||||||
1468934|NCT01390844|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468935|NCT01390831|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1468936|NCT01390818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468937|NCT01390805|||Other||Prospective|||||||
1468938|NCT01390792|||Other||Prospective|||||||
1468939|NCT01390779||Single Group Assignment||Diagnostic||None (Open Label)||||||
1468940|NCT01390766|||||Prospective|||||||
1468941|NCT01390753|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468942|NCT01390740|||Cohort||Prospective|||||||
1468943|NCT01390727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468944|NCT01390714|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468945|NCT01390701|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1468946|NCT01390688|||Cohort||Cross-Sectional|||||||
1468947|NCT01390675|||Other||Prospective|||||||
1468948|NCT01390662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468949|NCT01390649||Single Group Assignment||Treatment||None (Open Label)||||||
1468950|NCT01390636|||Case Control||Prospective|||||||
1468951|NCT01390623|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1468952|NCT01390610|||Case Control||Prospective|||||||
1468953|NCT01390597|||Other||Retrospective|||||||
1468954|NCT01390584||Single Group Assignment||Treatment||None (Open Label)|In order to better define the optimal therapy for patients with Stage I/II HL with bulky mediastinal disease in our study, we propose incorporating interim functional imaging with PET scans after 2 cycles of ABVD to risk stratify patients. Extrapolating from data in advanced HL, patients who are PET+ will presumably have a worse outcome; therefore, in this select group therapy will be altered to a more aggressive regimen. An interim PET scan may prospectively identify patients unlikely to be cured with standard CMT and a therapeutic change to escalated BEACOPP may improve outcomes for this subgroup and spare the morbidity of a stem cell transplantation. In contrast, for PET- patients, who presumably will have a better outcome, standard CT will be continued and followed by INRT|PEt||||
1468955|NCT01390571||||Treatment||None (Open Label)||||||
1468956|NCT01390558|||Cohort||Cross-Sectional|||||||
1468957|NCT01390545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468958|NCT01390532|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1468959|NCT01390519|||Cohort||Prospective|||||||
1468960|NCT01390506|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1468961|NCT01390493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468962|NCT01390480|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1468963|NCT01390467|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1468964|NCT01390454|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1468965|NCT01390441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468966|NCT01390428|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468967|NCT01390415|||Cohort||Retrospective|||||||
1468968|NCT01390402||Single Group Assignment||Treatment||None (Open Label)||||||
1468969|NCT01390389|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1468970|NCT01390376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468971|NCT01390363|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1468972|NCT01390350|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468973|NCT01390337||Single Group Assignment||Treatment||None (Open Label)||||||
1468974|NCT01390324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468975|NCT01390311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468976|NCT01390298|||Cohort||Prospective|||||||
1468977|NCT01390285|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1468978|NCT01390272|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1468979|NCT01390259|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1468980|NCT01390246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468981|NCT01390233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468982|NCT01390220|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1468983|NCT01390207|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1468984|NCT01390194|||Case Control||Prospective|||||||
1468985|NCT01390181||Single Group Assignment||Treatment||None (Open Label)||||||
1468986|NCT01390168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468987|NCT01390155|||||Prospective|||||||
1468988|NCT01390142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468989|NCT01390129|Randomized|Parallel Assignment||Treatment||Single|||t|||
1468990|NCT01390116|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1468991|NCT01390103|||Case-Only||Prospective|||||||
1468992|NCT01390090|||Case-Only||Prospective|||||||
1468993|NCT01390077||Single Group Assignment||Treatment||None (Open Label)||||||
1468994|NCT01390064|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468995|NCT01390051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1468996|NCT01390038||Single Group Assignment||Treatment||None (Open Label)||||||
1468997|NCT01390025|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1468998|NCT01390012|Randomized|Parallel Assignment||||None (Open Label)||||||
1468999|NCT01389999|||Cohort||Prospective|||||||
1469000|NCT01389986|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1469001|NCT01389973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469002|NCT01389947|||Case Control||Prospective|||||||
1469003|NCT01389934|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469004|NCT01389921|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1469005|NCT01389908||Single Group Assignment||Supportive Care||None (Open Label)||||||
1469006|NCT01389895|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469007|NCT01389882|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1469008|NCT01389869|Randomized|Crossover Assignment||||Double|||t||t|
1469009|NCT01389856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469010|NCT01389843|||Cohort||Prospective|||||||
1469011|NCT01389830|||Cohort||Prospective|||||||
1469012|NCT01389817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469013|NCT01389804|||Cohort||Prospective|||||||
1469014|NCT01389791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469015|NCT01389778||Single Group Assignment||Treatment||None (Open Label)||||||
1469016|NCT01389765|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469017|NCT01389752|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469018|NCT01389739|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1469019|NCT01389726|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1469020|NCT01389713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469021|NCT01389700|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469022|NCT01389687|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1469023|NCT01389674||Single Group Assignment||Basic Science||None (Open Label)||||||
1469024|NCT01389661||Single Group Assignment||Treatment||None (Open Label)||MSV-H autologous transplantation: Mesenchymal stem cells from bone marrow expanded by GMP-compliant procedure in IBGM cell production unit in autologous plasma scaffold and implanted in maxillary bone cavities after cyst removal||||
1469025|NCT01389648|Randomized|Parallel Assignment||Prevention||Single||||t||
1469026|NCT01389635|||Cohort||Retrospective|||||||
1469027|NCT01389622|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1469028|NCT01389609|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469029|NCT01389596|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469030|NCT01389583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469031|NCT01389570|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469032|NCT01389557||Single Group Assignment||Treatment||Single|||t|||
1469033|NCT01389544||Single Group Assignment||||None (Open Label)||||||
1469034|NCT01389531||Single Group Assignment||||None (Open Label)||||||
1469035|NCT01389518|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1469036|NCT01389505|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469037|NCT01389492|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1469038|NCT01389479|Randomized|Parallel Assignment||Prevention||Double||||||
1469039|NCT01389466|Randomized|Parallel Assignment||Prevention||Single|||t|||
1469040|NCT01389453|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1469041|NCT01389440||Single Group Assignment||Treatment||None (Open Label)||||||
1469042|NCT01389427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469043|NCT01389414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469044|NCT01389401|||Cohort||Prospective|||||||
1469045|NCT01389388|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1469046|NCT01389375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469047|NCT01389362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469048|NCT01389349|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469049|NCT01389336|||Case Control||Prospective|||||||
1469050|NCT01389323||Single Group Assignment||Treatment||None (Open Label)||||||
1469051|NCT01389310|||Cohort||Prospective|||||||
1469052|NCT01389297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469053|NCT01389284|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469054|NCT01389271|||Cohort||Prospective|||||||
1469055|NCT01389258||Single Group Assignment||Treatment||None (Open Label)||||||
1469056|NCT01389245||Single Group Assignment||Treatment||None (Open Label)||||||
1469057|NCT01389232||Single Group Assignment||Treatment||None (Open Label)||||||
1469058|NCT01389219|Randomized|Single Group Assignment||||None (Open Label)||||||
1469059|NCT01389206|||Case-Only||Prospective|||||||
1469060|NCT01389193|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1469061|NCT01389180|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1469062|NCT01389167|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1469063|NCT01389154|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1469064|NCT01389141|||Case-Control||Prospective|||||||
1469065|NCT01389128|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1469066|NCT01389115|||Case Control||Prospective|||||||
1469067|NCT01389102|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469068|NCT01389089|Randomized|Parallel Assignment||Treatment||Single||||||t
1469069|NCT01389076||Single Group Assignment||Treatment||None (Open Label)||||||
1469070|NCT01389063|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469071|NCT01389050|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469072|NCT01389037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469073|NCT01389024|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1469074|NCT01389011|||Case-Only||Prospective|||||||
1469075|NCT01388998|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1469076|NCT01388985|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469077|NCT01388972|||Ecologic or Community||Cross-Sectional|||||||
1469078|NCT01388959|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469079|NCT01388946|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1469080|NCT01388933|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469081|NCT01388920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469082|NCT01388907|Randomized|Parallel Assignment||Treatment||Single||||||t
1469083|NCT01388894|||Case-Crossover||Prospective|||||||
1469084|NCT01388881|Randomized|Parallel Assignment||Treatment||Single||||||t
1469085|NCT01388868|Randomized|Parallel Assignment||||Single||||||t
1469086|NCT01388855|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469087|NCT01388842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469088|NCT01388829|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1469089|NCT01388816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469090|NCT01388803|||Case-Only||Retrospective|||||||
1469091|NCT01388790||Single Group Assignment||Treatment||None (Open Label)||||||
1469092|NCT01388777||Single Group Assignment||Treatment||None (Open Label)||To determine the rate of complete tumor ablation in patients treated with cryoablation, with complete tumor ablation defined as no remaining invasive or in situ carcinoma present upon pathological examination of the targeted lesion.||||
1469093|NCT01388764|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1469094|NCT01388751|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469095|NCT01388738|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1469096|NCT01388725|||Case Control||Prospective|||||||
1469097|NCT01388712|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469098|NCT01388699|||Case-Control||Other|||||||
1469099|NCT01388686|||Cohort||Retrospective|||||||
1469100|NCT01388673||Single Group Assignment||Treatment||None (Open Label)||||||
1469101|NCT01388660|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469102|NCT01388647||Single Group Assignment||Treatment||None (Open Label)||||||
1469103|NCT01388634|||Cohort||Retrospective|||||||
1469104|NCT01388621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469105|NCT01388608|||Cohort||Prospective|||||||
1469106|NCT01388595|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1469107|NCT01388582|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1469108|NCT01388569|||Other||Retrospective|||||||
1469109|NCT01388556|Randomized|Parallel Assignment||Treatment||Single||||||t
1469110|NCT01388543|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1469111|NCT01388530||Single Group Assignment||Treatment||None (Open Label)||||||
1469112|NCT01388517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469113|NCT01388504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469114|NCT01388491|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1469115|NCT01388478||Single Group Assignment||Treatment||None (Open Label)||||||
1469116|NCT01388465|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1469117|NCT01388452|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1469118|NCT01388439|||Cohort||Prospective|||||||
1469119|NCT01388426|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469120|NCT01388413|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469121|NCT01388400|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469122|NCT01388387||Single Group Assignment||Treatment||None (Open Label)||||||
1469123|NCT01388374|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1469124|NCT01388361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469125|NCT01388348||Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1469126|NCT01388335|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1469127|NCT01388322|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469128|NCT01388309|||Cohort||Prospective|||||||
1469129|NCT01388296|||Case-Only||Prospective|||||||
1469130|NCT01388283|||Case Control||Retrospective|||||||
1469131|NCT01388270|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469132|NCT01388257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469133|NCT01388244|Randomized|Parallel Assignment||Screening||Single|||t|||
1469134|NCT01388231|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1469135|NCT01388218|||Case-Crossover||Cross-Sectional|||||||
1469136|NCT01388205|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469137|NCT01388192|||Case-Only||Prospective|||||||
1469138|NCT01388179|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1469139|NCT01388166|||Cohort||Prospective|||||||
1469140|NCT01388153|Randomized|Crossover Assignment||||None (Open Label)||||||
1469141|NCT01388140|||Case Control||Cross-Sectional|||||||
1469142|NCT01388127|||Cohort||Prospective|||||||
1469143|NCT01388114||Single Group Assignment||Diagnostic||None (Open Label)||||||
1469144|NCT01388101||Single Group Assignment||Diagnostic||None (Open Label)||||||
1469145|NCT01388088|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1469146|NCT01388075||Single Group Assignment||Basic Science||Double|||t||t|
1469147|NCT01388062||Single Group Assignment||Diagnostic||Double|||||t|t
1469148|NCT01388049||Single Group Assignment||Diagnostic||Double|||||t|t
1469149|NCT01388036||Single Group Assignment||Basic Science||Single|||t|||
1469150|NCT01388023|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469151|NCT01388010|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1469152|NCT01387997||Single Group Assignment||Diagnostic||Double|||||t|t
1469153|NCT01387984|||Case-Only||Cross-Sectional|||||||
1469154|NCT01387971|||Case-Only||Prospective|||||||
1469155|NCT01387958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469156|NCT01387945|Randomized|Crossover Assignment||Health Services Research||Single|||||t|
1469157|NCT01387932|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1469158|NCT01387919||Single Group Assignment||Basic Science||None (Open Label)||||||
1469159|NCT01387906|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1469160|NCT01387893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469161|NCT01387880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469162|NCT01387867|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469163|NCT01387854||||||||||||
1469164|NCT01387841|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1469165|NCT01387828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469166|NCT01387815|||Cohort||Prospective|||||||
1469167|NCT01387802|||Cohort||Prospective|||||||
1469168|NCT01387789|||Cohort||Prospective|||||||
1469169|NCT01387776|||Cohort||Prospective|||||||
1469170|NCT01387763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469171|NCT01387750|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469172|NCT01387737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469173|NCT01387724|||Cohort||Prospective|||||||
1469174|NCT01387711||Single Group Assignment||||None (Open Label)||||||
1469175|NCT01387698|||Cohort||Prospective|||||||
1469176|NCT01387685|||Case Control||Retrospective|||||||
1469177|NCT01387672|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469178|NCT01387659||Single Group Assignment||Treatment||None (Open Label)||||||
1469179|NCT01387646|Randomized|Parallel Assignment||Prevention||Single|||t|||
1469180|NCT01387633|Randomized|Parallel Assignment||||Single||||||t
1469181|NCT01387620|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1469182|NCT01387607|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469183|NCT01387594|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1469184|NCT01387581|||Case Control||Prospective|||||||
1469185|NCT01387568|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1469186|NCT01387555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469187|NCT01387542||Single Group Assignment||Treatment||None (Open Label)||||||
1469188|NCT01387529|||Cohort||Prospective|||||||
1469189|NCT01387516|Randomized|Factorial Assignment||Treatment||Double||This clinical trial uses a 2 x 2 between groups factorial design to investigate Motivational Interviewing versus Relaxation Therapy and Cognitive Behavior Therapy versus Self-Help Programming.|t|t||
1469190|NCT01387503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469191|NCT01387490|Randomized|Parallel Assignment||Treatment||Single||||||t
1469192|NCT01387477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469193|NCT01387464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469194|NCT01387451|||Case-Only||Cross-Sectional|||||||
1469195|NCT01387438|||Case Control||Cross-Sectional|||||||
1469196|NCT01387425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469197|NCT01387412|||Cohort||Prospective|||||||
1469198|NCT01387399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469199|NCT01387373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469200|NCT01387360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469201|NCT01387347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469202|NCT01387334|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1469203|NCT01387321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469204|NCT01387308|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1469205|NCT01387295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469206|NCT01387282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469207|NCT01387269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469208|NCT01387256|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469209|NCT01387243|||Cohort||Prospective|||||||
1469210|NCT01387230|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1469211|NCT01387217|Randomized|Crossover Assignment||Treatment||Single|||t|||
1469212|NCT01387204|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469213|NCT01387191|||Other||Prospective|||||||
1469214|NCT01387178|||Cohort||Retrospective|||||||
1469215|NCT01387165|||Other||Cross-Sectional|||||||
1469216|NCT01387152|||Cohort||Prospective|||||||
1469217|NCT01387139|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1469218|NCT01387126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469219|NCT01387113|||Cohort||Prospective|||||||
1469220|NCT01387100|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1469221|NCT01387087|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1469222|NCT01387074|||Cohort||Prospective|||||||
1469223|NCT01387061||Single Group Assignment||Treatment||None (Open Label)||||||
1469224|NCT01387048|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469225|NCT01387035|||Cohort||Prospective|||||||
1469226|NCT01387022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469227|NCT01387009|||Other||Cross-Sectional|||||||
1469228|NCT01386996|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1469229|NCT01386983|||Cohort||Retrospective|||||||
1469230|NCT01386970|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1469231|NCT01386957|||Cohort||Prospective|||||||
1469232|NCT01386944|||Cohort||Prospective|||||||
1469233|NCT01386931|||Case-Control||Prospective|||||||
1469234|NCT01386918|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1469235|NCT01386905||Single Group Assignment||Treatment||None (Open Label)||||||
1469236|NCT01386892|||Case-Only||Prospective|||||||
1469237|NCT01386879|Randomized|Parallel Assignment||Prevention||Single|||t|||
1469238|NCT01386866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1469239|NCT01386853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469240|NCT01386840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469241|NCT01386827|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469242|NCT01386814||||||||||||
1469243|NCT01386801|||Case Control||Prospective|||||||
1469244|NCT01386788|||Cohort||Prospective|||||||
1469245|NCT01386775||||||||||||
1469246|NCT01386762|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469247|NCT01386749|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1469248|NCT01386736|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469249|NCT01386723|||Case-Only||Prospective|||||||
1469250|NCT01386710|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469251|NCT01386697|||Case Control||Prospective|||||||
1469252|NCT01386684|||Case-Only||Prospective|||||||
1469253|NCT01386671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469254|NCT01386658||Single Group Assignment||Treatment||None (Open Label)||||||
1469255|NCT01386645|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1469256|NCT01386632|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469257|NCT01386619||Single Group Assignment||Treatment||None (Open Label)||||||
1469258|NCT01386606|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469259|NCT01386593|Randomized|Crossover Assignment||||None (Open Label)||||||
1469260|NCT01386580|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469261|NCT01386567|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469262|NCT01386554|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469263|NCT01386541|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1469264|NCT01386528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469265|NCT01386515|||||Other|||||||
1469266|NCT01386502|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469267|NCT01386489|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469268|NCT01386476|||||Other|||||||
1469269|NCT01386437|||Cohort||Prospective|||||||
1469270|NCT01386424|||Cohort||Prospective|||||||
1469271|NCT01386411|||Family-Based||Prospective|||||||
1469272|NCT01386398|Randomized|||Treatment||None (Open Label)||||||
1469273|NCT01386385|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469274|NCT01386372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469275|NCT01386359|||Cohort||Other|||||||
1469276|NCT01386346||Single Group Assignment||Treatment||None (Open Label)||||||
1469277|NCT01386333|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469278|NCT01386320|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1469279|NCT01386307|||||Cross-Sectional|||||||
1469280|NCT01386294|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469281|NCT01386281|||Case-Only||Prospective|||||||
1469282|NCT01386268|||||Prospective|||||||
1469283|NCT01386255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469284|NCT01386242|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469285|NCT01386229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469286|NCT01386216||Single Group Assignment||Treatment||None (Open Label)||||||
1469287|NCT01386203|||Case Control||Prospective|||||||
1469288|NCT01386190|Randomized|Parallel Assignment||Prevention||Single|||||t|
1469289|NCT01386177||Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1469290|NCT01386164|Randomized|Parallel Assignment||Prevention||Single|||||t|
1469291|NCT01386151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469292|NCT01386138|Randomized|Parallel Assignment||Prevention||Single|||||t|
1469293|NCT01386125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469294|NCT01386112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469295|NCT01386099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469296|NCT01386086||Single Group Assignment||Treatment||None (Open Label)||||||
1469297|NCT01386073|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469298|NCT01386060|Randomized|Crossover Assignment||Treatment||Single||||||t
1469299|NCT01386047|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1469300|NCT01386034|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1469301|NCT01386021||||||||||||
1469302|NCT01386008||Single Group Assignment||Treatment||Double|||t||t|
1469303|NCT01385995|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1469304|NCT01385982||Single Group Assignment||Health Services Research||None (Open Label)||||||
1469305|NCT01385969|||Case Control||Prospective|||||||
1469306|NCT01385956||Single Group Assignment||Treatment||None (Open Label)||||||
1469307|NCT01385943|||Case-Only||Cross-Sectional|||||||
1469308|NCT01385930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469309|NCT01385917|||Cohort||Prospective|||||||
1469310|NCT01385904|||Case-Only||Prospective|||||||
1469311|NCT01385891||Single Group Assignment||Treatment||None (Open Label)||||||
1469312|NCT01385878|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1469313|NCT01385865|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1469314|NCT01385852|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469315|NCT01385839||Single Group Assignment||Treatment||None (Open Label)||||||
1469316|NCT01385826|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1469317|NCT01385813|||Case Control||Retrospective|||||||
1469318|NCT01385800|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1469319|NCT01385787|||Cohort||Prospective|||||||
1469320|NCT01385774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469321|NCT01385761|||Case Control||Prospective|||||||
1469322|NCT01385748|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469323|NCT01385735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469324|NCT01385722|||Cohort||Prospective|||||||
1469325|NCT01385709|||Case-Only||Prospective|||||||
1469326|NCT01385696|Randomized|Crossover Assignment||||None (Open Label)||||||
1469327|NCT01385683|Randomized|Crossover Assignment||||Single||||||t
1469328|NCT01385670|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469329|NCT01385657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469330|NCT01385644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469331|NCT01385631|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1469332|NCT01385618|||Case Control|||||||||
1469333|NCT01385605|||Other||Other|||||||
1469334|NCT01385592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469335|NCT01385579|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469336|NCT01385566|Randomized|Parallel Assignment||Prevention||Single|||t|||
1469337|NCT01385553|Randomized|Parallel Assignment||Treatment||Single||||||t
1469338|NCT01385540|||Case Control||Prospective|||||||
1469339|NCT01385527|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1469340|NCT01385514|||Cohort||Prospective|||||||
1469341|NCT01385501|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1469342|NCT01385488|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1469343|NCT01385475|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1469344|NCT01385449|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469345|NCT01385436|||Cohort||Cross-Sectional|||||||
1469346|NCT01385423||Single Group Assignment||Treatment||None (Open Label)||||||
1469347|NCT01385410|Randomized|Parallel Assignment||||Double|||||t|t
1469348|NCT01385397|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1469349|NCT01385384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469350|NCT01385371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469351|NCT01385358|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1469352|NCT01385345|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1469353|NCT01385332|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469354|NCT01385319|Randomized|Parallel Assignment||Treatment||Single||||||t
1469355|NCT01385306||Single Group Assignment||Supportive Care||None (Open Label)||||||
1469356|NCT01385293||Single Group Assignment||Treatment||None (Open Label)||||||
1469357|NCT01385280||Single Group Assignment||Treatment||None (Open Label)||||||
1469358|NCT01385267|||Case-Only||Prospective|||||||
1469359|NCT01385254|||Case Control||Prospective|||||||
1469360|NCT01385241|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1469361|NCT01385228|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469362|NCT01385215|Randomized|Parallel Assignment||||None (Open Label)||||||
1469363|NCT01385202||Single Group Assignment||Treatment||None (Open Label)||||||
1469364|NCT01385189|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469365|NCT01385176|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1469366|NCT01385163|Randomized|Single Group Assignment||Treatment||Single||||||t
1469367|NCT01385150|||Other||Retrospective|||||||
1469368|NCT01385137|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1469369|NCT01385124|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1469370|NCT01385111|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1469371|NCT01385098||Single Group Assignment||Treatment||None (Open Label)||||||
1469372|NCT01385085|||Case-Crossover||Cross-Sectional|||||||
1469373|NCT01385072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469374|NCT01385059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469375|NCT01385046|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469376|NCT01385033|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1469377|NCT01385020|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469378|NCT01385007||Single Group Assignment||Prevention||None (Open Label)||||||
1469379|NCT01384994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469380|NCT01384981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469381|NCT01384968|Randomized|Crossover Assignment||||Double|||t||t|
1469382|NCT01384955|||Case Control||Retrospective|||||||
1469383|NCT01384942|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1469384|NCT01384929|||Cohort||Prospective|||||||
1469385|NCT01384916|Randomized|Parallel Assignment||Treatment||Single||||||t
1469386|NCT01384903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469387|NCT01384890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469388|NCT01384877|Randomized|Crossover Assignment||Supportive Care||Triple|Double blind performed by pharmacy. Un blinding to occur at end of study. All subjects to be injected with 1 mL of 1% lidocaine subcutaneous prior to the initiation of the study med infusion, which will act as a masking agent.|One-sided McNemar's tests will be carried out to test whether a single infusion of subcutaneous lidocaine will cause a reduction in cancer pain for both the interim and final analyses at the p-values of 0.00153 and 0.02347 respectively.|t|t|t|
1469389|NCT01384864||Single Group Assignment||Screening||None (Open Label)||||||
1469390|NCT01384851|Randomized|Crossover Assignment||Treatment||Single|||t|||
1469391|NCT01384838|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1469392|NCT01384825|||Case-Control||Cross-Sectional|||||||
1469393|NCT01384812|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1469394|NCT01384799||Single Group Assignment||Treatment||None (Open Label)||||||
1469395|NCT01384786|||Cohort||Retrospective|||||||
1469396|NCT01384773||||||||||||
1469397|NCT01384760|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469398|NCT01384747|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1469399|NCT01384734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469400|NCT01384721|||Cohort||Retrospective|||||||
1469401|NCT01384708||Single Group Assignment||Screening||None (Open Label)||||||
1469402|NCT01384695|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1469403|NCT01384682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469404|NCT01384669|||Case Control||Prospective|||||||
1469405|NCT01384656|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469406|NCT01384643|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1469407|NCT01384630||Single Group Assignment||Treatment||None (Open Label)||||||
1469408|NCT01384617|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469409|NCT01384604|||Family-Based||Cross-Sectional|||||||
1469410|NCT01384591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469411|NCT01384578|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469412|NCT01384565|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469413|NCT01384552|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1469414|NCT01384539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469415|NCT01384526|||Case Control||Retrospective|||||||
1469416|NCT01384513||Single Group Assignment||Treatment||None (Open Label)||||||
1469417|NCT01384500|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1469418|NCT01384487|||Case Control||Prospective|||||||
1469419|NCT01384474|||Cohort||Prospective|||||||
1469420|NCT01384461|||Cohort||Prospective|||||||
1469421|NCT01384448|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1469422|NCT01384435|Randomized|Parallel Assignment||Treatment||Double||||||
1469423|NCT01384422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469424|NCT01384409||Single Group Assignment||Treatment||None (Open Label)||||||
1469425|NCT01384396||Single Group Assignment||Treatment||None (Open Label)||||||
1469426|NCT01384383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469427|NCT01384370|||Case Control||Retrospective|||||||
1469428|NCT01384357|||||Retrospective|||||||
1469429|NCT01384344|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1469430|NCT01384331|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1469431|NCT01384318|||Cohort||Prospective|||||||
1469432|NCT01384305|||||Retrospective|||||||
1469433|NCT01384292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469434|NCT01384279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469435|NCT01384266|||Cohort||Prospective|||||||
1469436|NCT01384253||Single Group Assignment||Treatment||None (Open Label)||||||
1469437|NCT01384240||Single Group Assignment||Screening||None (Open Label)||||||
1469438|NCT01384227||Single Group Assignment||Screening||None (Open Label)||||||
1469439|NCT01384214|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469440|NCT01384201|||||Prospective|||||||
1469441|NCT01384188|Randomized|Crossover Assignment||Treatment||Single|||t|||
1469442|NCT01384175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469443|NCT01384162||Single Group Assignment||Treatment||None (Open Label)||||||
1469444|NCT01384149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469445|NCT01384136|||Case Control||Cross-Sectional|||||||
1469446|NCT01384123|||Cohort||Prospective|||||||
1469447|NCT01384110|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1469448|NCT01384097|||Cohort||Retrospective|||||||
1469449|NCT01384084|Randomized|Parallel Assignment||Treatment||Single||||||t
1469450|NCT01384071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469451|NCT01384058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469452|NCT01384045|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1469453|NCT01384032|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469454|NCT01384019|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469455|NCT01384006|||||Prospective|||||||
1469456|NCT01383993|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1469457|NCT01383980|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1469458|NCT01383967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469459|NCT01383954||Single Group Assignment||Treatment||None (Open Label)||||||
1469460|NCT01383941|||Cohort||Cross-Sectional|||||||
1469461|NCT01383928||Single Group Assignment||Treatment||None (Open Label)||||||
1469462|NCT01383915|||Cohort||Prospective|||||||
1469463|NCT01383902|Randomized|Crossover Assignment||||None (Open Label)||||||
1469464|NCT01383889|Randomized|Parallel Assignment||||None (Open Label)||||||
1469465|NCT01383876|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469466|NCT01383863|||Cohort||Prospective|||||||
1469467|NCT01383850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469468|NCT01383837|Randomized|Single Group Assignment||Prevention||Triple|||t|t||t
1469469|NCT01383824||Single Group Assignment||Treatment||None (Open Label)||||||
1469470|NCT01383811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469471|NCT01383798|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1469472|NCT01383785|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469473|NCT01383772||Single Group Assignment||Health Services Research||None (Open Label)||||||
1469474|NCT01383759||Single Group Assignment||Treatment||None (Open Label)||||||
1469475|NCT01383746||Single Group Assignment||Treatment||None (Open Label)||||||
1469476|NCT01383733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469477|NCT01383720||Single Group Assignment||Treatment||None (Open Label)||||||
1469478|NCT01383707||Single Group Assignment||Treatment||None (Open Label)||||||
1469479|NCT01383694|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1469480|NCT01383681|||Case-Only||Retrospective|||||||
1469481|NCT01383668||Single Group Assignment||Treatment||None (Open Label)||||||
1469482|NCT01383655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469483|NCT01383642|||Cohort||Prospective|||||||
1469484|NCT01383629|Randomized|Single Group Assignment||Supportive Care||Triple||||t|t|t
1469485|NCT01383616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469486|NCT01383603||Single Group Assignment||Treatment||None (Open Label)||||||
1469487|NCT01383590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469488|NCT01383577|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1469489|NCT01383564|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469490|NCT01383551|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1469491|NCT01383538||Single Group Assignment||Treatment||None (Open Label)||||||
1469492|NCT01383525||Single Group Assignment||Treatment||None (Open Label)|No masking for treatment. The follow-up and primary endpoint assessment, intra-ocular pressure (IOP) measurement, is performed by masked ophthalmologist.|||||
1469493|NCT01383512|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469494|NCT01383499|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1469495|NCT01383486|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1469496|NCT01383473|||Case-Only||Prospective|||||||
1469497|NCT01383460|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469498|NCT01383447||Single Group Assignment||Treatment||None (Open Label)||||||
1469499|NCT01383434||Single Group Assignment||Treatment||None (Open Label)||||||
1469500|NCT01383421|||Other||Other|||||||
1469501|NCT01383408|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1469502|NCT01383395||Single Group Assignment||Treatment||None (Open Label)||||||
1469503|NCT01383382|||Cohort||Prospective|||||||
1469504|NCT01383369|||||Prospective|||||||
1469505|NCT01383356|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1469506|NCT01383343||Single Group Assignment||Treatment||None (Open Label)||||||
1469507|NCT01383330|Randomized|Parallel Assignment||||None (Open Label)||||||
1469508|NCT01383317|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469509|NCT01383304|||Cohort||Prospective|||||||
1469510|NCT01383291|||Case Control||Retrospective|||||||
1469511|NCT01383278|Randomized|Single Group Assignment||Treatment||Single||||||t
1469512|NCT01383265|Randomized|Single Group Assignment||Screening||Single|||t|||
1469513|NCT01383252|Randomized|Single Group Assignment||Screening||Single|||t|||
1469514|NCT01383239|Randomized|Parallel Assignment||||Single||||||t
1469515|NCT01383226||Single Group Assignment||Diagnostic||None (Open Label)||||||
1469516|NCT01383213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469517|NCT01383200|Randomized|Single Group Assignment||Supportive Care||Double|||||t|t
1469518|NCT01383187|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469519|NCT01383174|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1469520|NCT01383161|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1469521|NCT01383148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469522|NCT01383135|||Cohort||Prospective|||||||
1469523|NCT01383122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469524|NCT01383109||Single Group Assignment||Treatment||None (Open Label)||||||
1469525|NCT01383096|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469526|NCT01383083|||Case-Only||Prospective|||||||
1469527|NCT01383070|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1469528|NCT01383057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469529|NCT01383044|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469530|NCT01383031|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1469531|NCT01383018|||Cohort||Prospective|||||||
1469532|NCT01383005|||Cohort||Cross-Sectional|||||||
1469533|NCT01382992|||Case-Only||Retrospective|||||||
1469534|NCT01382979|Randomized|Parallel Assignment||Prevention||Single|||||t|
1469535|NCT01382966|||||Cross-Sectional|||||||
1469536|NCT01382953|||Cohort||Prospective|||||||
1469537|NCT01382940||Single Group Assignment||Treatment||None (Open Label)||||||
1469538|NCT01382927|||Case Control||Prospective|||||||
1469539|NCT01382914||Single Group Assignment||||None (Open Label)||||||
1469540|NCT01382901|Randomized|Parallel Assignment||Treatment||Double||||||
1469541|NCT01382888|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469542|NCT01382875|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1469543|NCT01382862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469544|NCT01382849|||Case Control||Prospective|||||||
1469545|NCT01382836|||Case Control||Cross-Sectional|||||||
1469786|NCT01379690|||Case Control||Retrospective|||||||
1469546|NCT01382823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469547|NCT01382810|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469548|NCT01382797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469549|NCT01382784|||Case Control||Prospective|||||||
1469550|NCT01382771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469551|NCT01382758|||Case Control||Prospective|||||||
1469552|NCT01382745||Single Group Assignment||Treatment||None (Open Label)||||||
1469553|NCT01382732|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1469554|NCT01382719|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1469555|NCT01382706||Single Group Assignment||Treatment||None (Open Label)||||||
1469556|NCT01382693|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1469557|NCT01382680|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1469558|NCT01382667|||Cohort||Prospective|||||||
1469559|NCT01382654|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1469560|NCT01382641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469561|NCT01382628|||Case-Control||Prospective|||||||
1469562|NCT01382615|||Cohort||Prospective|||||||
1469563|NCT01382602|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469564|NCT01382589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469565|NCT01382576|||Case Control||Cross-Sectional|||||||
1469566|NCT01382563|||Case-Only||Other|||||||
1469567|NCT01382550|||Cohort||Prospective|||||||
1469568|NCT01382537|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1469569|NCT01382524|||Cohort||Prospective|||||||
1469570|NCT01382511||Single Group Assignment||Treatment||None (Open Label)||||||
1469571|NCT01382498|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469572|NCT01382485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469573|NCT01382472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469574|NCT01382459|||Case Control||Prospective|||||||
1469575|NCT01382446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469576|NCT01382433|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1469577|NCT01382420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469578|NCT01382407|||Case-Control||Prospective|||||||
1469579|NCT01382394|||Cohort||Prospective|||||||
1469580|NCT01382381|||Case Control||Prospective|||||||
1469581|NCT01382368|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1469582|NCT01382355|||Cohort||Prospective|||||||
1469583|NCT01382342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469584|NCT01382329|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1469585|NCT01382316|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469586|NCT01382303|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469587|NCT01382290|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1469588|NCT01382277||Single Group Assignment||Treatment||None (Open Label)||||||
1469589|NCT01382264|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1469590|NCT01382251|||||Prospective|||||||
1469591|NCT01382238|Randomized|Crossover Assignment||||None (Open Label)||||||
1469592|NCT01382225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469593|NCT01382212||Single Group Assignment||Treatment||None (Open Label)||||||
1469594|NCT01382199|Randomized|||Prevention||Double||||||
1469595|NCT01382186|||Cohort||Prospective|||||||
1469596|NCT01382173|||Case-Only||Prospective|||||||
1469597|NCT01382160||Single Group Assignment||||None (Open Label)||||||
1469598|NCT01382147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469599|NCT01382134|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469600|NCT01382121|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1469601|NCT01382108|||Case Control||Prospective|||||||
1469602|NCT01382095|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469603|NCT01382082|||Case-Control||Prospective|||||||
1469604|NCT01382069|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1469605|NCT01382056|Randomized|Single Group Assignment||||None (Open Label)||||||
1469606|NCT01382043|||Case-Crossover||Prospective|||||||
1469607|NCT01382030|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469608|NCT01382017|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1469609|NCT01382004|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469610|NCT01381991|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1469611|NCT01381978|||||Cross-Sectional|||||||
1469612|NCT01381965||Single Group Assignment||Treatment||Single|||||t|
1469613|NCT01381952|Non-Randomized|Crossover Assignment||Diagnostic||Double|||||t|t
1469614|NCT01381939|||Cohort||Retrospective|||||||
1469615|NCT01381926|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1469616|NCT01381913|||Case Control||Prospective|||||||
1469617|NCT01381900|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469618|NCT01381887|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1469619|NCT01381874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469620|NCT01381861||Single Group Assignment||Treatment||None (Open Label)||||||
1469621|NCT01381848|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1469622|NCT01381835||Single Group Assignment||Treatment||None (Open Label)||||||
1469623|NCT01381822|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469624|NCT01381809|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469625|NCT01381796|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1469626|NCT01381783|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469627|NCT01381770||Single Group Assignment||Treatment||None (Open Label)||||||
1469628|NCT01381757|||||Prospective|||||||
1469629|NCT01381744|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1469630|NCT01381731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469631|NCT01381718|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1469632|NCT01381705|||Other||Retrospective|||||||
1469633|NCT01381692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469634|NCT01381679|||Cohort||Prospective|||||||
1469635|NCT01381666|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1469636|NCT01381653|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1469637|NCT01381640|Randomized|Crossover Assignment||||None (Open Label)||||||
1469638|NCT01381627|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1469639|NCT01381614|||Cohort||Retrospective|||||||
1469640|NCT01381601|||Cohort||Retrospective|||||||
1469641|NCT01381588|||Other||Cross-Sectional|||||||
1469642|NCT01381575|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469643|NCT01381562|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469644|NCT01381549|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469645|NCT01381536|Randomized|Single Group Assignment||Treatment||Single|||t|||
1469646|NCT01381523|||Cohort||Retrospective|||||||
1469647|NCT01381510|||Cohort||Retrospective|||||||
1469648|NCT01381497|||Cohort||Prospective|||||||
1469649|NCT01381484|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1469650|NCT01381471|||Cohort||Retrospective|||||||
1469651|NCT01381458|||Cohort||Retrospective|||||||
1469652|NCT01381445|Randomized|Crossover Assignment||Other||Double|||t||t|
1469653|NCT01381432|||||Prospective|||||||
1469654|NCT01381419|Randomized|Crossover Assignment||Treatment||Single|||||t|
1469655|NCT01381406|||Cohort||Retrospective|||||||
1469656|NCT01381393|||Cohort||Prospective|||||||
1469657|NCT01381380|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469658|NCT01381367|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469659|NCT01381354||Single Group Assignment||Treatment||None (Open Label)||||||
1469660|NCT01381341|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1469661|NCT01381328|||Case-Only||Prospective|||||||
1469662|NCT01381315|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469663|NCT01381302|||Cohort||Prospective|||||||
1469664|NCT01381289||||||||||||
1469665|NCT01381276|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1469666|NCT01381263|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469667|NCT01381250||Single Group Assignment||Treatment||Single||||||t
1469668|NCT01381237|Randomized|Parallel Assignment||Treatment||Single||||||t
1469669|NCT01381224|||Case-Only||Prospective|||||||
1469670|NCT01381211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469671|NCT01381198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469672|NCT01381185|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1469673|NCT01381172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469674|NCT01381159|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1469675|NCT01381146|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1469676|NCT01381133|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1469677|NCT01381120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469678|NCT01381107|Randomized|Parallel Assignment||||Triple|||t||t|t
1469679|NCT01381094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469680|NCT01381081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469681|NCT01381068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469682|NCT01381055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469683|NCT01381042|||||Retrospective|||||||
1469684|NCT01381029|||Case-Only||Prospective|||||||
1469685|NCT01381016|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1469686|NCT01381003||Single Group Assignment||Treatment||None (Open Label)||||||
1469687|NCT01380990||Single Group Assignment||Treatment||None (Open Label)||||||
1469688|NCT01380977|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1469689|NCT01380964|||Cohort||Prospective|||||||
1469690|NCT01380951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469691|NCT01380938|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469692|NCT01380925|||Family-Based||Cross-Sectional|||||||
1469693|NCT01380912|||Case Control||Prospective|||||||
1469694|NCT01380899|||Case-Control||Cross-Sectional|||||||
1469695|NCT01380886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469696|NCT01380873|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1469697|NCT01380860|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1469698|NCT01380847|||Cohort|||||||||
1469699|NCT01380834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469700|NCT01380821|||Cohort||Prospective|||||||
1469701|NCT01380808||Single Group Assignment||Treatment||None (Open Label)||||||
1469702|NCT01380795||Single Group Assignment||Screening||None (Open Label)||||||
1469703|NCT01380782|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469704|NCT01380769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469705|NCT01380756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469706|NCT01380743|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470026|NCT01376531|||||Prospective|||||||
1469707|NCT01380730|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469708|NCT01380717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469709|NCT01380704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469710|NCT01380691|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1469711|NCT01380678|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469712|NCT01380665|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469713|NCT01380652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469714|NCT01380639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469715|NCT01380626||Parallel Assignment||Basic Science||None (Open Label)||||||
1469716|NCT01380613|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469717|NCT01380600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469718|NCT01380587|||Cohort||Prospective|||||||
1469719|NCT01380574|||Cohort||Retrospective|||||||
1469720|NCT01380561|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1469721|NCT01380548|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1469722|NCT01380535|Randomized|Parallel Assignment||Treatment||Single||||||t
1469723|NCT01380522|Randomized|Crossover Assignment||||None (Open Label)||||||
1469724|NCT01380509|Randomized|Crossover Assignment||||None (Open Label)||||||
1469725|NCT01380496|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1469726|NCT01380483|Randomized|Crossover Assignment||||None (Open Label)||||||
1469727|NCT01380470|||Cohort||Cross-Sectional|||||||
1469728|NCT01380457|Randomized|Crossover Assignment||||None (Open Label)||||||
1469729|NCT01380444|Randomized|Parallel Assignment||Treatment||Single||||||t
1469730|NCT01380431|Randomized|Crossover Assignment||||None (Open Label)||||||
1469731|NCT01380418|||Other||Cross-Sectional|||||||
1469732|NCT01380405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469733|NCT01380392|||Case-Only||Cross-Sectional|||||||
1469734|NCT01380379||Single Group Assignment||Treatment||None (Open Label)||||||
1469735|NCT01380366||Single Group Assignment||Treatment||None (Open Label)||||||
1469736|NCT01380353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469737|NCT01380340|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469738|NCT01380327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469739|NCT01380314|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469740|NCT01380301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469741|NCT01380288|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469742|NCT01380275||Single Group Assignment||Treatment||None (Open Label)||||||
1469743|NCT01380262|||Cohort||Prospective|||||||
1469744|NCT01380249||Single Group Assignment||Treatment||None (Open Label)||||||
1469745|NCT01380236|Randomized|Single Group Assignment||Treatment||Single|||t|||
1469746|NCT01380223|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1469747|NCT01380210|||Case-Only||Retrospective|||||||
1469748|NCT01380197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469749|NCT01380184|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469750|NCT01380171|||Case-Only||Retrospective|||||||
1469751|NCT01380158|Randomized|Parallel Assignment||Prevention||Single|||||t|
1469752|NCT01380145||Single Group Assignment||Treatment||None (Open Label)||||||
1469753|NCT01380132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469754|NCT01380119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469755|NCT01380106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469756|NCT01380093|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1469757|NCT01380080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469758|NCT01380067|||Case Control||Prospective|||||||
1469759|NCT01380054|||Case-Only||Prospective|||||||
1469760|NCT01380041|||Case-Only||Prospective|||||||
1469761|NCT01380028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469762|NCT01380015|Randomized|Parallel Assignment||||Triple|||t||t|t
1469763|NCT01380002|||Family-Based||Cross-Sectional|||||||
1469764|NCT01379989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469765|NCT01379976|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469766|NCT01379963|||Cohort||Retrospective|||||||
1469767|NCT01379950|||Cohort||Prospective|||||||
1469768|NCT01379937|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469769|NCT01379924|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1469770|NCT01379911|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1469771|NCT01379898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469772|NCT01379885|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469773|NCT01379872|||||Retrospective|||||||
1469774|NCT01379846|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469775|NCT01379833|||Case Control||Prospective|||||||
1469776|NCT01379820|Randomized|Parallel Assignment||Treatment||Single||||||t
1469777|NCT01379807|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469778|NCT01379794||||||||||||
1469779|NCT01379781|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469780|NCT01379768|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1469781|NCT01379755|||Cohort||Prospective|||||||
1469782|NCT01379742|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469783|NCT01379729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469784|NCT01379716|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1469787|NCT01379677|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1469788|NCT01379664|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1469789|NCT01379651|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469790|NCT01379638|||Case Control||Prospective|||||||
1469791|NCT01379625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469792|NCT01379612|||Case-Only||Prospective|||||||
1469793|NCT01379599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469794|NCT01379586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469795|NCT01379573||Single Group Assignment||Prevention||None (Open Label)||||||
1469796|NCT01379560|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1469797|NCT01379547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469798|NCT01379534|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469799|NCT01379521|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1469800|NCT01379508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469801|NCT01379495|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1469802|NCT01379482||Single Group Assignment||Treatment||None (Open Label)||||||
1469803|NCT01379469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469804|NCT01379456|Randomized|Parallel Assignment||Treatment||Single||||||t
1469805|NCT01379443|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1469806|NCT01379430|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469807|NCT01379417|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1469808|NCT01379404|||Cohort||Prospective|||||||
1469809|NCT01379391|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469810|NCT01379378||||||||||||
1469811|NCT01379365||Single Group Assignment||Treatment||None (Open Label)||||||
1469812|NCT01379352|||||Prospective|||||||
1469813|NCT01379339|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1469814|NCT01379326||Single Group Assignment||Treatment||None (Open Label)||||||
1469815|NCT01379313|Randomized|Parallel Assignment||||Single|||t|||
1469816|NCT01379300|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469817|NCT01379287||Single Group Assignment||Treatment||None (Open Label)||||||
1469818|NCT01379274||Single Group Assignment||Treatment||None (Open Label)||||||
1469819|NCT01379261|Randomized|Parallel Assignment||Treatment||Single||||||t
1469820|NCT01379248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469821|NCT01379235|Randomized|Parallel Assignment||Treatment||Single||||||t
1469822|NCT01379222||Single Group Assignment||Treatment||None (Open Label)||||||
1469823|NCT01379209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469824|NCT01379196||Single Group Assignment||Treatment||None (Open Label)||||||
1469825|NCT01379183|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1469826|NCT01379170||Single Group Assignment||Basic Science||None (Open Label)||||||
1469827|NCT01379157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469828|NCT01379144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469829|NCT01379131|||||Retrospective|||||||
1469830|NCT01379118|||Case Control||Prospective|||||||
1469831|NCT01379105|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469832|NCT01379092||Single Group Assignment||Diagnostic||None (Open Label)||||||
1469833|NCT01379079|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1469834|NCT01379066|||Cohort||Prospective|||||||
1469835|NCT01379053|||Cohort||Prospective|||||||
1469836|NCT01379040|||Cohort||Prospective|||||||
1469837|NCT01379027|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1469838|NCT01379014|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1469839|NCT01379001|Randomized|Single Group Assignment||||Double|||t||t|
1469840|NCT01378988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469841|NCT01378975|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469842|NCT01378962||Single Group Assignment||Treatment||None (Open Label)||||||
1469843|NCT01378949|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469844|NCT01378936|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1469845|NCT01378923|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1469846|NCT01378910|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1469847|NCT01378897||Single Group Assignment||Supportive Care||None (Open Label)||||||
1469848|NCT01378884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469849|NCT01378871||Single Group Assignment||Treatment||None (Open Label)||||||
1469850|NCT01378858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469851|NCT01378845|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469852|NCT01378832|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469853|NCT01378819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469854|NCT01378806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469855|NCT01378793|Randomized|Parallel Assignment||Treatment||Single|||t|||
1469856|NCT01378780|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469857|NCT01378767|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469858|NCT01378754|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469859|NCT01378741|Randomized|Single Group Assignment||Prevention||Single||||||t
1469860|NCT01378728|||Cohort||Prospective|||||||
1469861|NCT01378715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469862|NCT01378702|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1469863|NCT01378689|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1469864|NCT01378676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469865|NCT01378663|||||Retrospective|||||||
1469866|NCT01378650|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469867|NCT01378637||Single Group Assignment||Treatment||None (Open Label)||||||
1469868|NCT01378624||Single Group Assignment||Basic Science||None (Open Label)||||||
1469869|NCT01378611|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1469870|NCT01378598||Single Group Assignment||Supportive Care||None (Open Label)||||||
1469871|NCT01378585|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1469872|NCT01378572|||Case Control||Prospective|||||||
1469873|NCT01378559|||Case-Only||Retrospective|||||||
1469874|NCT01378546||||||||||||
1469875|NCT01378533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469876|NCT01378520|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1469877|NCT01378507|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469878|NCT01378494|||Cohort|||||||||
1469879|NCT01378481||Single Group Assignment||Treatment||None (Open Label)||||||
1469880|NCT01378468|||Cohort||Prospective|||||||
1469881|NCT01378455|Randomized|Parallel Assignment||Treatment||Single||||||t
1469882|NCT01378442|Randomized|Parallel Assignment||Treatment||Single||||||t
1469883|NCT01378429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469884|NCT01378416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469885|NCT01378403|||Case-Only||Prospective|||||||
1469886|NCT01378390|Randomized|Parallel Assignment||Treatment||Single||||||t
1469887|NCT01378377|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469888|NCT01378364|Randomized|Single Group Assignment||Treatment||Double||||||
1469889|NCT01378351|||Cohort||Prospective|||||||
1469890|NCT01378338|||Case-Only||Prospective|||||||
1469891|NCT01378325|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1469892|NCT01378312|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1469893|NCT01378299||Single Group Assignment||Other||Triple|||t||t|t
1469894|NCT01378286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469895|NCT01378273|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469896|NCT01378260|||Cohort||Prospective|||||||
1469897|NCT01378247|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1469898|NCT01378234|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1469899|NCT01378221|||Cohort||Prospective|||||||
1469900|NCT01378208||Single Group Assignment||Prevention||None (Open Label)||||||
1469901|NCT01378195|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1469902|NCT01378182||Single Group Assignment||Treatment||None (Open Label)||||||
1469903|NCT01378169|||Cohort||Prospective|||||||
1469904|NCT01378156||Single Group Assignment||Treatment||None (Open Label)||||||
1469905|NCT01378143||Single Group Assignment||Treatment||None (Open Label)||||||
1469906|NCT01378130|||Cohort||Prospective|||||||
1469907|NCT01378117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469908|NCT01378104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469909|NCT01378091||Single Group Assignment||Treatment||None (Open Label)||||||
1469910|NCT01378078|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469911|NCT01378065|||Cohort||Prospective|||||||
1469912|NCT01378052|||Case Control||Retrospective|||||||
1469913|NCT01378039|Randomized|Parallel Assignment||||Single|||||t|
1469914|NCT01378026|||Case Control||Retrospective|||||||
1469915|NCT01378013|||Case Control||Prospective|||||||
1469916|NCT01378000|||Case Control||Prospective|||||||
1469917|NCT01377987|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1469918|NCT01377974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469919|NCT01377961|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469920|NCT01377948||Single Group Assignment||Treatment||None (Open Label)||||||
1469921|NCT01377935|||Cohort|||||||||
1469922|NCT01377922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469923|NCT01377909|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1469924|NCT01377896|||||Retrospective|||||||
1469925|NCT01377883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469926|NCT01377870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469927|NCT01377857|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1469928|NCT01377844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469929|NCT01377831|||Cohort||Prospective|||||||
1469930|NCT01377818|Randomized|Crossover Assignment||Treatment||Single|||||t|
1469931|NCT01377805|||Case-Only||Retrospective|||||||
1469932|NCT01377792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469933|NCT01377779|Randomized|Single Group Assignment||Prevention||Single|||t|||
1469934|NCT01377766|||Case Control||Retrospective|||||||
1469935|NCT01377753||Single Group Assignment||Treatment||None (Open Label)||||||
1469936|NCT01377740|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1469937|NCT01377701|||Cohort||Prospective|||||||
1469938|NCT01377688|||Case-Only||Retrospective|||||||
1469939|NCT01377675|||Cohort||Cross-Sectional|||||||
1469940|NCT01377662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469941|NCT01377649|||Cohort||Prospective|||||||
1469942|NCT01377636||Single Group Assignment||Treatment||None (Open Label)||||||
1469943|NCT01377623|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1469944|NCT01377610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469945|NCT01377597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469946|NCT01377584|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1469947|NCT01377571|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1469948|NCT01377558|Randomized|Parallel Assignment||Treatment||Single|||||t|
1469949|NCT01377545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469950|NCT01377532||||||||||||
1469951|NCT01377519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469952|NCT01377506|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1469953|NCT01377493|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1469954|NCT01377480|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469955|NCT01377467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469956|NCT01377454|||Case Control||Cross-Sectional|||||||
1469957|NCT01377441|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1469958|NCT01377428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469959|NCT01377415|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469960|NCT01377402|||Cohort||Prospective|||||||
1469961|NCT01377389||Single Group Assignment||Treatment||None (Open Label)||||||
1469962|NCT01377376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469963|NCT01377363|||||Prospective|||||||
1469964|NCT01377350||Single Group Assignment||Diagnostic||None (Open Label)||||||
1469965|NCT01377337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469966|NCT01377324||Single Group Assignment||Diagnostic||None (Open Label)||||||
1469967|NCT01377311|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469968|NCT01377298|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1469969|NCT01377285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469970|NCT01377272|||||Retrospective|||||||
1469971|NCT01377259|||Case Control||Prospective|||||||
1469972|NCT01377246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469973|NCT01377233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469974|NCT01377220|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1469975|NCT01377207|Randomized|Parallel Assignment||Treatment||Single||||||t
1469976|NCT01377194|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1469977|NCT01377181|||Case Control||Prospective|||||||
1469978|NCT01377168|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469979|NCT01377155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469980|NCT01377142|||Cohort||Prospective|||||||
1469981|NCT01377129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469982|NCT01377103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1469983|NCT01377090|||Cohort||Prospective|||||||
1469984|NCT01377077|Randomized|Single Group Assignment||Treatment||Single||||||t
1469985|NCT01377064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469986|NCT01377051|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1469987|NCT01377038|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1469988|NCT01377025|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1469989|NCT01377012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1469990|NCT01376999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469991|NCT01376986|Randomized|Parallel Assignment||Prevention||Single||||||t
1469992|NCT01376973|||Case Control||Prospective|||||||
1469993|NCT01376960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469994|NCT01376947|||Case Control||Prospective|||||||
1469995|NCT01376934||Parallel Assignment||Health Services Research||None (Open Label)||||||
1469996|NCT01376921|||Cohort||Other|||||||
1469997|NCT01376908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1469998|NCT01376895|Randomized|Single Group Assignment||Prevention||Single|||t|||
1469999|NCT01376882|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1470000|NCT01376869|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1470001|NCT01376856|||Case-Crossover||Prospective|||||||
1470002|NCT01376843|||Case-Crossover||Prospective|||||||
1470003|NCT01376830|||Cohort||Prospective|||||||
1470004|NCT01376817|Randomized|Parallel Assignment||||Triple|||t|t|t|
1470005|NCT01376804||Single Group Assignment||Prevention||None (Open Label)||||||
1470006|NCT01376791|||Case Control||Prospective|||||||
1470007|NCT01376778|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1470008|NCT01376765|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1470009|NCT01376752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470010|NCT01376739|||Case-Only||Prospective|||||||
1470011|NCT01376726|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470012|NCT01376713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470013|NCT01376700||Single Group Assignment||Prevention||None (Open Label)||||||
1470014|NCT01376687|||Cohort||Prospective|||||||
1470015|NCT01376674|||Case-Only||Prospective|||||||
1470016|NCT01376661|||Case-Only||Prospective|||||||
1470017|NCT01376648|||||Prospective|||||||
1470018|NCT01376635|||Case-Crossover|||||||||
1470019|NCT01376622|||||Prospective|||||||
1470020|NCT01376609|||Cohort||Prospective|||||||
1470021|NCT01376596|Randomized|Parallel Assignment||Treatment||Single|||||t|
1470022|NCT01376583|||Case-Only||Prospective|||||||
1470023|NCT01376570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470024|NCT01376557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470025|NCT01376544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470028|NCT01376505|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470029|NCT01376492|||Case Control||Cross-Sectional|||||||
1470030|NCT01376479|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1470031|NCT01376466|||Cohort||Prospective|||||||
1470032|NCT01376453||Single Group Assignment||Treatment||None (Open Label)||||||
1470033|NCT01376440|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470034|NCT01376427||Single Group Assignment||Treatment||None (Open Label)||||||
1470035|NCT01376414|||Cohort||Prospective|||||||
1470036|NCT01376401||Single Group Assignment||Treatment||None (Open Label)||||||
1470037|NCT01376388||Single Group Assignment||Treatment||None (Open Label)||||||
1470038|NCT01376375|Non-Randomized|Single Group Assignment||Treatment||||||||
1470039|NCT01376362||Single Group Assignment||Treatment||None (Open Label)||||||
1470040|NCT01376349|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1470041|NCT01376336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470042|NCT01376323|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470043|NCT01376310|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470044|NCT01376297|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470045|NCT01376284|||||Prospective|||||||
1470046|NCT01376271||||||||||||
1470047|NCT01376258|||Cohort||Retrospective|||||||
1470048|NCT01376245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470049|NCT01376232|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1470050|NCT01376219|||Cohort||Retrospective|||||||
1470051|NCT01376206|||Other||Other|||||||
1470052|NCT01376193|||||Prospective|||||||
1470053|NCT01376180|||||Prospective|||||||
1470054|NCT01376167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470055|NCT01376154|||Other||Other|||||||
1470056|NCT01376141|||Other||Prospective|||||||
1470057|NCT01376128|||Other||Retrospective|||||||
1470058|NCT01376115|||Cohort||Prospective|||||||
1470059|NCT01376102|||||Prospective|||||||
1470060|NCT01376089|Randomized|Parallel Assignment||||Double|||t||t|
1470061|NCT01376076|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470062|NCT01376063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470063|NCT01376050|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470064|NCT01376037|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470065|NCT01376024|||Cohort||Prospective|||||||
1470066|NCT01376011|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1470067|NCT01375998|||Case-Only||Prospective|||||||
1470068|NCT01375985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470069|NCT01375972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470070|NCT01375959|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470071|NCT01375946||Single Group Assignment||Basic Science||None (Open Label)||||||
1470072|NCT01375933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470073|NCT01375920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470074|NCT01375907||Single Group Assignment||||None (Open Label)||||||
1470075|NCT01375894|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1470076|NCT01375881|||Cohort|||||||||
1470077|NCT01375868||Single Group Assignment||Treatment||None (Open Label)||||||
1470078|NCT01375855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470079|NCT01375842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470080|NCT01375829||Single Group Assignment||Treatment||None (Open Label)||||||
1470081|NCT01375816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470082|NCT01375803|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1470083|NCT01375790|Randomized|Parallel Assignment||Treatment||Single||||||t
1470084|NCT01375777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470085|NCT01375764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470086|NCT01375751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470087|NCT01375738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470088|NCT01375725|||Case-Only||Prospective|||||||
1470089|NCT01375712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470090|NCT01375699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470091|NCT01375686|||Cohort||Prospective|||||||
1470092|NCT01375673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470093|NCT01375660|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1470094|NCT01375647|Randomized|Factorial Assignment||Prevention||Single||||||t
1470095|NCT01375634|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1470096|NCT01375621|||Case-Control||Prospective|||||||
1470097|NCT01375608||Single Group Assignment||Treatment||None (Open Label)||||||
1470098|NCT01375595|||||Prospective|||||||
1470099|NCT01375582||Crossover Assignment||Treatment||Double|||t|t||
1470100|NCT01375569||Single Group Assignment||Treatment||None (Open Label)||||||
1470101|NCT01375556|Non-Randomized|Single Group Assignment||Treatment||||||||
1470102|NCT01375543|||||Other|||||||
1470103|NCT01375530|||Other||Other|||||||
1470104|NCT01375504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470105|NCT01375491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470106|NCT01375478|||Cohort||Retrospective|||||||
1470107|NCT01375465|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470108|NCT01375452|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470109|NCT01375439|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470110|NCT01375426|Randomized|Parallel Assignment||Treatment||Double||||||
1470111|NCT01375413|Randomized|Parallel Assignment||||Single||||||t
1470112|NCT01375400||Single Group Assignment||Treatment||None (Open Label)||||||
1470113|NCT01375387|Randomized|Crossover Assignment||||Double|||t||t|
1470114|NCT01375374||Single Group Assignment||Treatment||None (Open Label)||||||
1470115|NCT01375361|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470116|NCT01375348|Randomized|Crossover Assignment||||Double|||t||t|
1470117|NCT01375335|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1470118|NCT01375322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470119|NCT01375309|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470120|NCT01375296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470121|NCT01375283|||Cohort||Prospective|||||||
1470122|NCT01375270|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1470123|NCT01375257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470124|NCT01375244|Randomized|Crossover Assignment||||None (Open Label)||||||
1470125|NCT01375231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470126|NCT01375218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470127|NCT01375205|Randomized|Parallel Assignment||||Single||||||t
1470128|NCT01375179|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470129|NCT01375166|||Case-Control||Prospective|||||||
1470130|NCT01375153|Randomized|Crossover Assignment||Other||Single|||t|||
1470131|NCT01375140||Single Group Assignment||Treatment||None (Open Label)||||||
1470132|NCT01375127|||||Retrospective|||||||
1470133|NCT01375114|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1470134|NCT01375101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470135|NCT01375088|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470136|NCT01375075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470137|NCT01375062||Single Group Assignment||Treatment||None (Open Label)||||||
1470138|NCT01375049||Single Group Assignment||Treatment||None (Open Label)||||||
1470139|NCT01375036|||||Prospective|||||||
1470140|NCT01375023||Single Group Assignment||Treatment||None (Open Label)||||||
1470141|NCT01375010|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470142|NCT01374997||Single Group Assignment||Diagnostic||None (Open Label)||||||
1470143|NCT01374984|||Case-Only||Prospective|||||||
1470144|NCT01374971||Single Group Assignment||Basic Science||None (Open Label)||||||
1470145|NCT01374945||||||||||||
1470146|NCT01374932|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470147|NCT01374919||Single Group Assignment||Treatment||None (Open Label)||||||
1470148|NCT01374906|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470149|NCT01374893|Randomized|Parallel Assignment||Prevention||Single|||t|||
1470150|NCT01374880|||Cohort||Prospective|||||||
1470151|NCT01374867|||Case-Only||Prospective|||||||
1470152|NCT01374854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470153|NCT01374841||Single Group Assignment||Treatment||None (Open Label)||||||
1470154|NCT01374828|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1470155|NCT01374815||Single Group Assignment||Screening||None (Open Label)||||||
1470156|NCT01374802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470157|NCT01374789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470158|NCT01374776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470159|NCT01374763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470160|NCT01374750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470161|NCT01374737|Non-Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1470162|NCT01374724|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1470163|NCT01374711|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470164|NCT01374698|Randomized|Parallel Assignment||Treatment||Single||||||t
1470165|NCT01374685|||||Other|||||||
1470166|NCT01374672|||Cohort||Retrospective|||||||
1470167|NCT01374659|||||Prospective|||||||
1470168|NCT01374646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470169|NCT01374633||Single Group Assignment||Treatment||None (Open Label)||||||
1470170|NCT01374620|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470171|NCT01374607|||Cohort||Prospective|||||||
1470172|NCT01374594||||||||||||
1470173|NCT01374581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470174|NCT01374568|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1470175|NCT01374555|||Cohort||Prospective|||||||
1470176|NCT01374542|||Cohort||Prospective|||||||
1470177|NCT01374516|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470178|NCT01374503|Randomized|Parallel Assignment||Treatment||Single|||t|||
1470179|NCT01374490||Single Group Assignment||Treatment||None (Open Label)||||||
1470180|NCT01374477|||Case Control||Prospective|||||||
1470181|NCT01374464|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1470182|NCT01374451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470183|NCT01374438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470184|NCT01374425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470185|NCT01374412|||Cohort||Prospective|||||||
1470186|NCT01374399|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1470187|NCT01374386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470188|NCT01374373||Single Group Assignment||Treatment||None (Open Label)||||||
1470189|NCT01374360|||Other||Prospective|||||||
1470190|NCT01374347|||Cohort||Prospective|||||||
1470191|NCT01374334|||||Cross-Sectional|||||||
1470192|NCT01374321|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470193|NCT01374308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470194|NCT01374295|Randomized|Parallel Assignment||||Double|||t|t||
1470195|NCT01374282||||||||||||
1470196|NCT01374269|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470197|NCT01374256|||Case Control||Retrospective|||||||
1470198|NCT01374243||||||||||||
1470199|NCT01374230||Single Group Assignment||Treatment||None (Open Label)||||||
1470200|NCT01374217||Single Group Assignment||Treatment||None (Open Label)||||||
1470201|NCT01374204|||Cohort||Prospective|||||||
1470202|NCT01374191|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1470203|NCT01374178|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470204|NCT01374165|||Cohort||Prospective|||||||
1470205|NCT01374152|Randomized|Parallel Assignment||Treatment||Single||||||t
1470206|NCT01374139|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470207|NCT01374126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470208|NCT01374113|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470209|NCT01374100|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1470210|NCT01374087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470211|NCT01374074|||Case Control||Cross-Sectional|||||||
1470212|NCT01374061|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470213|NCT01374048|||Case-Only||Prospective|||||||
1470214|NCT01374035|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1470215|NCT01374022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470216|NCT01374009|||Case Control||Retrospective|||||||
1470217|NCT01373996|||Case-Only||Prospective|||||||
1470218|NCT01373983||Single Group Assignment||||None (Open Label)||||||
1470219|NCT01373970|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470220|NCT01373957|||Cohort||Prospective|||||||
1470221|NCT01373944|||Case Control||Prospective|||||||
1470222|NCT01373931|Randomized|Crossover Assignment||Treatment||Single|||t|||
1470223|NCT01373918|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470224|NCT01373905|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470225|NCT01373892|Randomized|Parallel Assignment||Basic Science||None (Open Label)|Sleeve or gastric bypass operation for obese|||||
1470226|NCT01373879|Randomized|Parallel Assignment||Prevention||Single|||t|||
1470227|NCT01373866|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1470228|NCT01373853|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1470229|NCT01373840|||Case-Control||Prospective|||||||
1470230|NCT01373827|||Cohort||Prospective|||||||
1470231|NCT01373814|||Case-Only||Prospective|||||||
1470232|NCT01373801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470233|NCT01373775|||Cohort||Retrospective|||||||
1470234|NCT01373762|Randomized|Parallel Assignment||Prevention||Single|||||t|
1470235|NCT01373749|Randomized|Parallel Assignment||Treatment||Single||||||t
1470236|NCT01373736||||Diagnostic||||||||
1470237|NCT01373723|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1470238|NCT01373710||Single Group Assignment||Treatment||None (Open Label)||||||
1470239|NCT01373697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470240|NCT01373684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470241|NCT01373671||Single Group Assignment||Diagnostic||None (Open Label)||||||
1470242|NCT01373658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470243|NCT01373645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470244|NCT01373632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470245|NCT01373619|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470246|NCT01373606||Single Group Assignment||Treatment||None (Open Label)||||||
1470247|NCT01373593|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1470248|NCT01373580||Single Group Assignment||Treatment||None (Open Label)||||||
1470249|NCT01373567||Single Group Assignment||Treatment||None (Open Label)||||||
1470250|NCT01373554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470251|NCT01373541|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1470252|NCT01373528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470253|NCT01373515|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1470254|NCT01373502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470255|NCT01373489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470256|NCT01373476|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470257|NCT01373463|Non-Randomized|||Treatment||None (Open Label)||||||
1470258|NCT01373450|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1470259|NCT01373437|||Case-Only||Prospective|||||||
1470260|NCT01373424|||Other||Other|||||||
1470261|NCT01373411|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1470262|NCT01373398||Single Group Assignment||||None (Open Label)||||||
1470263|NCT01373385|||Cohort||Prospective|||||||
1470264|NCT01373372|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470265|NCT01373359|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1470266|NCT01373346||Single Group Assignment||Treatment||None (Open Label)||||||
1470267|NCT01373333||||||||||||
1470268|NCT01373320|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1470269|NCT01373307|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1470270|NCT01373294|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470271|NCT01373281|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470272|NCT01373255|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470273|NCT01373242||Single Group Assignment||Treatment||None (Open Label)||||||
1470274|NCT01373229||Single Group Assignment||Treatment||None (Open Label)||||||
1470275|NCT01373216|Randomized|Parallel Assignment||Treatment||Single|||t|||
1470276|NCT01373203|||Case-Only|||||||||
1470277|NCT01373190|||Case Control||Prospective|||||||
1470278|NCT01373177|||||Prospective|||||||
1470279|NCT01373164|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470280|NCT01373151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470281|NCT01373138|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470282|NCT01373125|||Cohort||Cross-Sectional|||||||
1470283|NCT01373112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470284|NCT01373099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470285|NCT01373086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470286|NCT01373073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470287|NCT01373060|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1470288|NCT01373047||Single Group Assignment||Treatment||None (Open Label)||||||
1470289|NCT01373034|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1470290|NCT01373021|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1470291|NCT01373008|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470292|NCT01372995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470293|NCT01372982|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470294|NCT01372969||Single Group Assignment||Treatment||None (Open Label)||||||
1470295|NCT01372956|||Case-Only||Retrospective|||||||
1470296|NCT01372943||Single Group Assignment||Treatment||None (Open Label)||||||
1470297|NCT01372930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470298|NCT01372917|||Cohort||Cross-Sectional|||||||
1470299|NCT01372904|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470300|NCT01372891|||Case Control||Prospective|||||||
1470301|NCT01372878||Single Group Assignment||Screening||Double|||||t|t
1470302|NCT01372865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470303|NCT01372852|||Cohort||Cross-Sectional|||||||
1470304|NCT01372839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470305|NCT01372826|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470306|NCT01372813||Single Group Assignment||Treatment||None (Open Label)||||||
1470307|NCT01372800|||Cohort||Prospective|||||||
1470308|NCT01372787||||||||||||
1470309|NCT01372774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470310|NCT01372761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470311|NCT01372748|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470312|NCT01372735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470313|NCT01372722|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1470314|NCT01372709|||Cohort||Prospective|||||||
1470315|NCT01372696||Single Group Assignment||Other||None (Open Label)||||||
1470316|NCT01372683|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470317|NCT01372670|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1470318|NCT01372657|||Case-Only||Prospective|||||||
1470319|NCT01372644||Single Group Assignment||Prevention||None (Open Label)||||||
1470320|NCT01372631|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1470321|NCT01372618||Single Group Assignment||Treatment||None (Open Label)||||||
1470322|NCT01372605|Randomized|Parallel Assignment||Treatment||Single||||||t
1470323|NCT01372592|||Cohort||Prospective|||||||
1470324|NCT01372579||Single Group Assignment||Treatment||None (Open Label)||||||
1470325|NCT01372566|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1470326|NCT01372553|||Case-Crossover||Prospective|||||||
1470327|NCT01372540||Single Group Assignment||Treatment||None (Open Label)||||||
1470328|NCT01372527|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1470329|NCT01372514|||Cohort||Prospective|||||||
1470330|NCT01372501||Single Group Assignment||Treatment||None (Open Label)||||||
1470331|NCT01372488|Randomized|Parallel Assignment||Treatment||Single|||||t|
1470332|NCT01372475|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470333|NCT01372462|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470334|NCT01372449|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470335|NCT01372436|||Cohort||Prospective|||||||
1470336|NCT01372423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470337|NCT01372410|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470338|NCT01372397|||Case-Only||Prospective|||||||
1470339|NCT01372384||Single Group Assignment||Treatment||None (Open Label)||||||
1470340|NCT01372371|Randomized|Parallel Assignment||Prevention||Single||||||t
1470341|NCT01372358|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470342|NCT01372345|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470343|NCT01372332|||Case Control||Prospective|||||||
1470344|NCT01372319|||Case Control||Prospective|||||||
1470345|NCT01372306|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470346|NCT01372293||Single Group Assignment||Treatment||None (Open Label)||||||
1470347|NCT01372280|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470348|NCT01372267|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1470349|NCT01372254|Randomized|Parallel Assignment||Treatment||Single|||t|||
1470350|NCT01372241|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1470351|NCT01372228||Single Group Assignment||Treatment||None (Open Label)||||||
1470352|NCT01372215|||Case Control||Prospective|||||||
1470353|NCT01372202|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470354|NCT01372189|||||Prospective|||||||
1470355|NCT01372176|Randomized|Parallel Assignment||||Single||||||t
1470356|NCT01372163|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1470357|NCT01372150|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470358|NCT01372137|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1470359|NCT01372124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470360|NCT01372111||Single Group Assignment||Treatment||None (Open Label)||||||
1470361|NCT01372098|Randomized|Parallel Assignment||Prevention||Single|||t|||
1470362|NCT01372085|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1470363|NCT01372072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470364|NCT01372059|Randomized|Parallel Assignment||Treatment||Single||||||t
1470365|NCT01372046|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1470366|NCT01372033|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1470367|NCT01372020|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1470368|NCT01372007|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1470369|NCT01371994|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470370|NCT01371981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470371|NCT01371968||Single Group Assignment||Other||None (Open Label)||||||
1470372|NCT01371955|||Cohort||Prospective|||||||
1470373|NCT01371942||||||||||||
1470374|NCT01371929|||Case-Control||Prospective|||||||
1470375|NCT01371916|||Case Control||Prospective|||||||
1470376|NCT01371903|||Cohort||Prospective|||||||
1470377|NCT01371890|||Case-Crossover||Prospective|||||||
1470378|NCT01371877|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470379|NCT01371864|||Cohort||Prospective|||||||
1470380|NCT01371851|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470381|NCT01371838|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470382|NCT01371825||Single Group Assignment||Treatment||None (Open Label)||||||
1470383|NCT01371812|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470384|NCT01371799|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470385|NCT01371786|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470386|NCT01371773||Single Group Assignment||Treatment||None (Open Label)||||||
1470387|NCT01371760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470388|NCT01371747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470389|NCT01371734|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470390|NCT01371721||||Treatment||None (Open Label)||||||
1470391|NCT01371708||Single Group Assignment||Treatment||None (Open Label)||||||
1470392|NCT01371695|||Case Control||Prospective|||||||
1470393|NCT01371682|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1470394|NCT01371669|||Cohort||Prospective|||||||
1470395|NCT01371656|Randomized|Parallel Assignment||Supportive Care||Single||||||
1470396|NCT01371643|Randomized|Parallel Assignment||||None (Open Label)||||||
1470397|NCT01371630||Single Group Assignment||Treatment||None (Open Label)||||||
1470398|NCT01371617||Single Group Assignment||Treatment||None (Open Label)||||||
1470399|NCT01371604|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470400|NCT01371591|Randomized|Parallel Assignment||Diagnostic||Single|The provider evaluating the outcomes will not be aware of what group the patient is in.|||||t
1470401|NCT01371578||Parallel Assignment||Treatment||None (Open Label)||||||
1470402|NCT01371565||Single Group Assignment||Treatment||None (Open Label)||||||
1470403|NCT01371552|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470404|NCT01371539|Randomized|Crossover Assignment||Treatment||Single|||t|||
1470405|NCT01371526||Single Group Assignment||Treatment||None (Open Label)||||||
1470406|NCT01371513|||Other||Retrospective|||||||
1470407|NCT01371487|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470408|NCT01371474|||Other||Prospective|||||||
1470409|NCT01371461|||Other||Prospective|||||||
1470410|NCT01371448|||Other||Prospective|||||||
1470411|NCT01371435|||Other||Prospective|||||||
1470412|NCT01371422|Randomized|Single Group Assignment||Treatment||Single|||t|||
1470413|NCT01371409|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1470414|NCT01371396|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1470415|NCT01371383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470416|NCT01371370|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1470417|NCT01371357|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470418|NCT01371344|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1470419|NCT01371331||Single Group Assignment||Prevention||None (Open Label)||||||
1470420|NCT01371318|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1470421|NCT01371305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470422|NCT01371292|Randomized|Parallel Assignment||||None (Open Label)||||||
1470423|NCT01371279|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1470424|NCT01371266|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470425|NCT01371253|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470426|NCT01371240||Single Group Assignment||Diagnostic||Single||||||t
1470427|NCT01371227||Single Group Assignment||Treatment||None (Open Label)||||||
1470428|NCT01371214|Randomized|Crossover Assignment||Prevention||Single||||||t
1470429|NCT01371201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470430|NCT01371188|||Ecologic or Community||Prospective|||||||
1470431|NCT01371175|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470432|NCT01371162|Randomized|Parallel Assignment||||Double|||t||t|
1470433|NCT01371149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470434|NCT01371136|Randomized|Single Group Assignment||||Single||||||t
1470435|NCT01371123|||Case Control||Prospective|||||||
1470436|NCT01371110|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470437|NCT01371097|Randomized|Parallel Assignment||Treatment||Single||||||t
1470438|NCT01371084|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1470439|NCT01371071|||Cohort||Prospective|||||||
1470440|NCT01371058|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470441|NCT01371045|||Case Control||Cross-Sectional|||||||
1470442|NCT01371032|Randomized|Factorial Assignment||Other||Single|||t|||
1470443|NCT01371019|||Cohort||Prospective|||||||
1470444|NCT01371006|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470445|NCT01370993|||Cohort||Prospective|||||||
1470446|NCT01370980|||Case-Only||Prospective|||||||
1470447|NCT01370967|||Cohort||Prospective|||||||
1470448|NCT01370954|||Cohort||Prospective|||||||
1470449|NCT01370941|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1470450|NCT01370928|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1470451|NCT01370915|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1470452|NCT01370902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470453|NCT01370889||Single Group Assignment||Basic Science||None (Open Label)||||||
1470454|NCT01370876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470455|NCT01370863|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470456|NCT01370850|||Cohort||Prospective|||||||
1470457|NCT01370837|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470458|NCT01370824|||||Prospective|||||||
1470459|NCT01370811|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470460|NCT01370798|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470461|NCT01370785||||||||||||
1470462|NCT01370772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470463|NCT01370759||Single Group Assignment||Screening||None (Open Label)||||||
1470464|NCT01370746|||Cohort||Prospective|||||||
1470465|NCT01370733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470466|NCT01370720|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1470467|NCT01370707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470468|NCT01370694||Single Group Assignment||Treatment||None (Open Label)||||||
1470469|NCT01370681|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470470|NCT01370668|Randomized|Parallel Assignment||Treatment||Single|||||t|
1470471|NCT01370655|Randomized|Crossover Assignment||Treatment||Double||||||
1470472|NCT01370642|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470473|NCT01370629|||Cohort||Prospective|||||||
1470474|NCT01370616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470475|NCT01370603|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470476|NCT01370590|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470477|NCT01370577|||Case-Only||Prospective|||||||
1470478|NCT01370564||Single Group Assignment||Treatment||None (Open Label)||||||
1470479|NCT01370551||Single Group Assignment||Treatment||None (Open Label)||||||
1470480|NCT01370538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470481|NCT01370525|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470482|NCT01370512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470483|NCT01370499||Single Group Assignment||Treatment||None (Open Label)||||||
1470484|NCT01370486|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1470485|NCT01370473|||Cohort||Prospective|||||||
1470486|NCT01370460|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470487|NCT01370447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470488|NCT01370434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470489|NCT01370421|||Cohort||Prospective|||||||
1470490|NCT01370408||Single Group Assignment||Prevention||None (Open Label)||||||
1470491|NCT01370395|||Cohort||Prospective|||||||
1470492|NCT01370382|||Cohort||Prospective|||||||
1470493|NCT01370369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470494|NCT01370356|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1470495|NCT01370343|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470496|NCT01370330||||||||||||
1470497|NCT01370317|Randomized|Parallel Assignment||Treatment||Double||||||
1470498|NCT01370304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470499|NCT01370291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470500|NCT01370278|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1470501|NCT01370265|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1470502|NCT01370252|||Case Control||Prospective|||||||
1470503|NCT01370239||Single Group Assignment||Treatment||None (Open Label)||||||
1470504|NCT01370226|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1470505|NCT01370213||Single Group Assignment||Treatment||None (Open Label)||||||
1470506|NCT01370200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470507|NCT01370187|Randomized|Parallel Assignment||Treatment||Single|||||t|
1470508|NCT01370174|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1470509|NCT01370161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470510|NCT01370148|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1470511|NCT01370135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470512|NCT01370122|||Cohort||Prospective|||||||
1470513|NCT01370109|||Cohort||Prospective|||||||
1470514|NCT01370096||Single Group Assignment||Treatment||None (Open Label)||||||
1470515|NCT01370083|Randomized|Parallel Assignment||Treatment||Single||||||t
1470516|NCT01370070||Single Group Assignment||Treatment||None (Open Label)||||||
1470517|NCT01370057|Randomized|Parallel Assignment||Treatment||Single||||||t
1470518|NCT01370044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470519|NCT01370031|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470520|NCT01370018||Single Group Assignment||Treatment||None (Open Label)||||||
1470521|NCT01370005|Randomized|Parallel Assignment||Treatment||Double||||||
1470522|NCT01369992||||||||||||
1470523|NCT01369979|||Case Control||Cross-Sectional|||||||
1470524|NCT01369966|||||Other|||||||
1470525|NCT01369953|||||Prospective|||||||
1470526|NCT01369940|||Cohort||Prospective|||||||
1470527|NCT01369927|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1470528|NCT01369914|||Case-Control||Prospective|||||||
1470529|NCT01369901|Randomized|Parallel Assignment||Treatment||||||||
1470530|NCT01369888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470531|NCT01369875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470532|NCT01369862|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470533|NCT01369849||Single Group Assignment||Treatment||None (Open Label)||||||
1470534|NCT01369836|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1470535|NCT01369823|||Case-Only||Prospective|||||||
1470536|NCT01369810|||||Retrospective|||||||
1470537|NCT01369797|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470538|NCT01369784|||Case-Only||Cross-Sectional|||||||
1470539|NCT01369771||Single Group Assignment||Treatment||None (Open Label)||||||
1470540|NCT01369758||Single Group Assignment||Treatment||None (Open Label)||||||
1470541|NCT01369745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470542|NCT01369732|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470543|NCT01369719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470544|NCT01369706||Single Group Assignment||Other||None (Open Label)||||||
1470545|NCT01369693|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1470546|NCT01369680|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470547|NCT01369667|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1470548|NCT01369654|Randomized|Parallel Assignment||||None (Open Label)||||||
1470549|NCT01369641|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1470550|NCT01369628||Single Group Assignment||Treatment||None (Open Label)||||||
1470551|NCT01369615||Single Group Assignment||Treatment||None (Open Label)||||||
1470552|NCT01369602|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470553|NCT01369589|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470554|NCT01369576|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1470555|NCT01369563|||||Prospective|||||||
1470556|NCT01369550|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470557|NCT01369537|||Cohort||Prospective|||||||
1470558|NCT01369524|||Cohort||Prospective|||||||
1470559|NCT01369511|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470560|NCT01369498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470561|NCT01369485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470562|NCT01369472|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470563|NCT01369459|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470564|NCT01369446|||Case-Only||Prospective|||||||
1470565|NCT01369433|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470566|NCT01369420||Single Group Assignment||Treatment||None (Open Label)||||||
1470567|NCT01369407|||Cohort||Prospective|||||||
1470568|NCT01369394|Randomized|Parallel Assignment||Prevention||Single|||t|||
1470569|NCT01369381|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1470570|NCT01369368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470571|NCT01369355|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470572|NCT01369342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470573|NCT01369329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470574|NCT01369316|Randomized|Parallel Assignment||Treatment||Single|||||t|
1470575|NCT01369303|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470576|NCT01369290|||Case-Only||Prospective|||||||
1470577|NCT01369277|Randomized|Parallel Assignment||||Double|||t||t|
1470578|NCT01369264|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1470579|NCT01369251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470580|NCT01369238|Randomized|Parallel Assignment||Treatment||Single||||||t
1470581|NCT01369225|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470582|NCT01369212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470583|NCT01369199||Single Group Assignment||Treatment||None (Open Label)||||||
1470584|NCT01369186|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1470585|NCT01369173|Randomized|Crossover Assignment||||None (Open Label)||||||
1470586|NCT01369160||||||||||||
1470587|NCT01369147|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470588|NCT01369134|||||Prospective|||||||
1470589|NCT01369121||Single Group Assignment||Treatment||None (Open Label)||||||
1470590|NCT01369108|Randomized|Parallel Assignment||Treatment||Single|||t|||
1470591|NCT01369095|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470592|NCT01369082|||Cohort||Prospective|||||||
1470593|NCT01369069|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1470594|NCT01369056|Randomized|Parallel Assignment||||None (Open Label)||||||
1470595|NCT01369043|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1470596|NCT01369030|||Cohort||Prospective|||||||
1470597|NCT01369017|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1470598|NCT01369004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470599|NCT01368991|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1470600|NCT01368978|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470601|NCT01368965||Single Group Assignment||Treatment||Single||||||t
1470602|NCT01368952|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1470603|NCT01368939|||Cohort||Prospective|||||||
1470604|NCT01368926|Randomized|Crossover Assignment||||Double|||t||t|
1470605|NCT01368913|||Cohort||Prospective|||||||
1470606|NCT01368900||Single Group Assignment||Treatment||Single||||||t
1470607|NCT01368887|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1470608|NCT01368874|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1470609|NCT01368861|||Case Control||Prospective|||||||
1470610|NCT01368848|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470611|NCT01368835||Single Group Assignment||Treatment||Single||||||t
1470612|NCT01368822|||Cohort||Cross-Sectional|||||||
1470613|NCT01368809|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1470614|NCT01368796|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470615|NCT01368783|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470616|NCT01368770|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1470617|NCT01368757||Single Group Assignment||Treatment||None (Open Label)||||||
1470618|NCT01368744|||Case-Only||Prospective|||||||
1470619|NCT01368731|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1470620|NCT01368718|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1470621|NCT01368705|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1470622|NCT01368692|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470623|NCT01368679|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470624|NCT01368666||Single Group Assignment||Treatment||None (Open Label)||||||
1470625|NCT01368653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470626|NCT01368640|||Case-Only||Cross-Sectional|||||||
1470627|NCT01368627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470628|NCT01368614|Randomized|Parallel Assignment||Treatment||Single|||t|||
1470629|NCT01368601|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470630|NCT01368588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470631|NCT01368575|Randomized|Parallel Assignment||Treatment||Single|||t|||
1470632|NCT01368562||Single Group Assignment||Treatment||None (Open Label)||||||
1470633|NCT01368549|||Cohort||Prospective|||||||
1470634|NCT01368536|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470635|NCT01368523||Single Group Assignment||Treatment||None (Open Label)||||||
1470636|NCT01368510|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1470637|NCT01368497||Single Group Assignment||Treatment||None (Open Label)||||||
1470638|NCT01368484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470639|NCT01368471|Randomized|Parallel Assignment||Treatment||Single|||t|||
1470640|NCT01368458|Randomized|Parallel Assignment||Treatment||Single||||||t
1470641|NCT01368445|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1470642|NCT01368432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470643|NCT01368419||Single Group Assignment||Treatment||None (Open Label)||||||
1470644|NCT01368406|Randomized|Parallel Assignment||Prevention||Single||||||t
1470645|NCT01368393|Randomized|Parallel Assignment||Treatment||Double||||t||t
1470646|NCT01368380|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1470647|NCT01368367|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1470648|NCT01368354|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1470649|NCT01368341|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1470650|NCT01368328|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470651|NCT01368315|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1470652|NCT01368302|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1470653|NCT01368289|||Case-Control||Prospective|||||||
1470654|NCT01368276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470655|NCT01368263|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470656|NCT01368250|||Cohort||Prospective|||||||
1470657|NCT01368237|||Case-Only||Cross-Sectional|||||||
1470658|NCT01368224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470659|NCT01368211|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470660|NCT01368198|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1470661|NCT01368185|||Cohort||Retrospective|||||||
1470662|NCT01368172|Randomized|Parallel Assignment||||None (Open Label)||||||
1470663|NCT01368159|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470664|NCT01368146|Randomized|Parallel Assignment||||None (Open Label)||||||
1470665|NCT01368133|||Cohort||Prospective|||||||
1470666|NCT01368120|Randomized|Parallel Assignment||Prevention||Single||||||t
1470667|NCT01368107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470668|NCT01368094|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470669|NCT01368081|Randomized|Parallel Assignment||Treatment||Double||||||
1470670|NCT01368068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470671|NCT01368055|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470672|NCT01368042|||||Prospective|||||||
1470673|NCT01368029|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470674|NCT01368016|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470675|NCT01368003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470676|NCT01367990||Single Group Assignment||Supportive Care||None (Open Label)||||||
1470677|NCT01367977|||Case-Only||Retrospective|||||||
1470678|NCT01367964||Single Group Assignment||Prevention||None (Open Label)||||||
1470679|NCT01367951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470680|NCT01367938|||Case-Control||Prospective|||||||
1470681|NCT01367925|||Case-Control||Prospective|||||||
1470682|NCT01367912|Randomized|Parallel Assignment||Treatment||Single|||||t|
1470683|NCT01367899|||Cohort||Prospective|||||||
1470684|NCT01367886||Single Group Assignment||||None (Open Label)||||||
1470685|NCT01367873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470686|NCT01367860|Randomized|Parallel Assignment||Treatment||Single||||||t
1470687|NCT01367847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470688|NCT01367834|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470689|NCT01367821|||Cohort||Prospective|||||||
1470690|NCT01367808|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1470691|NCT01367795|||Cohort||Prospective|||||||
1470692|NCT01367782|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470693|NCT01367769|||Case-Control||Prospective|||||||
1470694|NCT01367756|Randomized|Parallel Assignment||||Double|||t||t|
1470695|NCT01367743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470696|NCT01367730|||Cohort||Prospective|||||||
1470697|NCT01367717|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1470698|NCT01367704|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1470699|NCT01367691||Single Group Assignment||Treatment||None (Open Label)||||||
1470700|NCT01367678|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1470701|NCT01367665||Single Group Assignment||Treatment||None (Open Label)||||||
1470702|NCT01367652|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470703|NCT01367639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470704|NCT01367626|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470705|NCT01367613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470706|NCT01367600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470707|NCT01367587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470708|NCT01367574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470709|NCT01367561|Randomized|Parallel Assignment||Treatment||Double||||||
1470710|NCT01367548|Randomized|Parallel Assignment||Treatment||Double||||||
1470711|NCT01367535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470712|NCT01367522|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470713|NCT01367509|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470714|NCT01367496|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470715|NCT01367483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470716|NCT01367470|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1470717|NCT01367457|||Case-Only||Retrospective|||||||
1470718|NCT01367444|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470719|NCT01367431|||||Prospective|||||||
1470720|NCT01367418|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470721|NCT01367405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470722|NCT01367392||Single Group Assignment||||None (Open Label)||||||
1470723|NCT01367379|||Case-Crossover||Prospective|||||||
1470724|NCT01367366|||Cohort||Prospective|||||||
1470725|NCT01367353||Parallel Assignment||Basic Science||None (Open Label)||||||
1470726|NCT01367340|Randomized|Parallel Assignment||Treatment||Single||||||t
1470727|NCT01367327|Randomized|Parallel Assignment||Treatment||Single||||||t
1470728|NCT01367314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470729|NCT01367301||Single Group Assignment||Treatment||None (Open Label)||||||
1470730|NCT01367288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470731|NCT01367275||Single Group Assignment||Treatment||None (Open Label)||||||
1470732|NCT01367262||Single Group Assignment||||None (Open Label)||||||
1470733|NCT01367249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470734|NCT01367236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470735|NCT01367223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470736|NCT01367210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470737|NCT01367197|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470738|NCT01367184|||Cohort||Prospective|||||||
1470739|NCT01367171||||||||||||
1470740|NCT01367158|Randomized|Parallel Assignment||Prevention||Single||||t||
1470741|NCT01367145|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1470742|NCT01367132|||Cohort||Prospective|||||||
1470743|NCT01367119|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1470744|NCT01367106|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470745|NCT01367093|||Cohort||Prospective|||||||
1470746|NCT01367080|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470747|NCT01367067|||Cohort||Prospective|||||||
1470748|NCT01367054|Randomized|Crossover Assignment||||None (Open Label)||||||
1470749|NCT01367041|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1470750|NCT01367028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470751|NCT01367015|Randomized|Parallel Assignment||||Single||||||t
1470752|NCT01367002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470753|NCT01366989|||Case-Only||Retrospective|||||||
1470754|NCT01366976|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470755|NCT01366963|||Case Control||Prospective|||||||
1470756|NCT01366950|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1470757|NCT01366937|||Case-Only|||||||||
1470758|NCT01366924|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1470759|NCT01366911|||Other||Prospective|||||||
1470760|NCT01366898||Single Group Assignment||Treatment||None (Open Label)||||||
1470761|NCT01366885||Single Group Assignment||Prevention||None (Open Label)||||||
1470762|NCT01366872|||Case-Only||Retrospective|||||||
1470763|NCT01366859|Randomized|Parallel Assignment||||Double|||t||t|
1470764|NCT01366846|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470765|NCT01366833|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1470766|NCT01366820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470767|NCT01366807|||Cohort||Prospective|||||||
1470768|NCT01366794|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1470769|NCT01366781|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1470770|NCT01366768|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470771|NCT01366742|||Cohort||Prospective|||||||
1470772|NCT01366729|Randomized|Parallel Assignment||Treatment||Single|||||t|
1470773|NCT01366716|Randomized|Parallel Assignment||||Single|||t|||
1470774|NCT01366703|||Cohort||Prospective|||||||
1470775|NCT01366690|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1470776|NCT01366677||Single Group Assignment||Treatment||Single||||||t
1470777|NCT01366664|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1470778|NCT01366651||Single Group Assignment||||None (Open Label)||||||
1470779|NCT01366638|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470780|NCT01366625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470781|NCT01366612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470782|NCT01366599|||Cohort||Retrospective|||||||
1470783|NCT01366586|||||Prospective|||||||
1470784|NCT01366573|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470785|NCT01366560|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470786|NCT01366547|Randomized|Crossover Assignment||||None (Open Label)||||||
1470787|NCT01366534|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1470788|NCT01366521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470789|NCT01366508|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1470790|NCT01366495|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1470791|NCT01366482|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1470792|NCT01366469|||Cohort||Prospective|||||||
1470793|NCT01366456|Randomized|Crossover Assignment||||Double|||t|||t
1470794|NCT01366443|||Case-Only||Prospective|||||||
1470795|NCT01366430|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470796|NCT01366417||Single Group Assignment||||Single||||||t
1470797|NCT01366404|||Cohort||Prospective|||||||
1470798|NCT01366391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470799|NCT01366378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470800|NCT01366365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470801|NCT01366352|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1470802|NCT01366339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470803|NCT01366326||Single Group Assignment||Treatment||None (Open Label)||||||
1470804|NCT01366313|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1470805|NCT01366300|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1470806|NCT01366287|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470807|NCT01366274|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1470808|NCT01366261|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1470809|NCT01366248|||Case-Control||Prospective|||||||
1470810|NCT01366235|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1470811|NCT01366222|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1470812|NCT01366209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470813|NCT01366196|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1470814|NCT01366183||||||||||||
1470815|NCT01366170|||Cohort||Prospective|||||||
1470816|NCT01366157|||Case Control||Prospective|||||||
1470817|NCT01366144||Single Group Assignment||Treatment||None (Open Label)||||||
1470818|NCT01366131|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470819|NCT01366118|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470820|NCT01366105|Randomized|Parallel Assignment||Treatment||Single||||||t
1470821|NCT01366092||Single Group Assignment||Treatment||None (Open Label)||||||
1470822|NCT01366079|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1470823|NCT01366066|Randomized|Parallel Assignment||Treatment||Single||||||t
1470824|NCT01366053|||Case-Only||Prospective|||||||
1470825|NCT01366040|||Cohort||Prospective|||||||
1470826|NCT01366027||||||||||||
1470827|NCT01366014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470828|NCT01366001|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1470829|NCT01365988|||||Other|||||||
1470830|NCT01365975|||Cohort||Retrospective|||||||
1470831|NCT01365962|||Case-Only||Retrospective|||||||
1470832|NCT01365949|||Case-Only||Retrospective|||||||
1470833|NCT01365936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470834|NCT01365923|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1470835|NCT01365910||Single Group Assignment||Treatment||None (Open Label)||||||
1470836|NCT01365897|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1470837|NCT01365884|||Cohort||Prospective|||||||
1470838|NCT01365871|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470839|NCT01365858|Randomized|Single Group Assignment||||Single||||||t
1470840|NCT01365845|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470841|NCT01365832||Single Group Assignment||Treatment||None (Open Label)||||||
1470842|NCT01365819|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470843|NCT01365806|||Cohort||Prospective|||||||
1470844|NCT01365793|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1470845|NCT01365780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470846|NCT01365767|||Case-Only||Cross-Sectional|||||||
1470847|NCT01365754|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1470848|NCT01365741|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470849|NCT01365728|||Case-Control||Prospective|||||||
1470850|NCT01365715|Randomized|Parallel Assignment||Treatment||Single||||t||
1470851|NCT01365702|||Cohort||Prospective|||||||
1470852|NCT01365689||||||||||||
1470853|NCT01365676|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1470854|NCT01365663|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470855|NCT01365650|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470856|NCT01365637|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1470857|NCT01365624||Single Group Assignment||Treatment||None (Open Label)||||||
1470858|NCT01365611|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470859|NCT01365598|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1470860|NCT01365585|||Cohort||Retrospective|||||||
1470861|NCT01365572|Randomized|Single Group Assignment||Treatment||Single|||t|||
1470862|NCT01365559|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470863|NCT01365546||Single Group Assignment||Prevention||None (Open Label)||||||
1470864|NCT01365533|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470865|NCT01365520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470866|NCT01365507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470867|NCT01365494|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470868|NCT01365481||Single Group Assignment||Treatment||None (Open Label)||||||
1470869|NCT01365468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470870|NCT01365455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470871|NCT01365442|||Ecologic or Community|||||||||
1470872|NCT01365429|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1470873|NCT01365416|||||Prospective|||||||
1470874|NCT01365403|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1470875|NCT01365390|||Cohort|||||||||
1470876|NCT01365377|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1470877|NCT01365364|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1470878|NCT01365351|||Case-Only||Prospective|||||||
1470879|NCT01365338|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1470880|NCT01365325|Randomized|Parallel Assignment||Prevention||Single||||||t
1470881|NCT01365312|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470882|NCT01365286|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1470883|NCT01365273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470884|NCT01365260|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470885|NCT01365247|Randomized|Parallel Assignment||Treatment||Single||||||t
1470886|NCT01365234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470887|NCT01365221|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470888|NCT01365208|||Case-Only||Prospective|||||||
1470889|NCT01365195|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1470890|NCT01365182|Randomized|Parallel Assignment||Treatment||Single||||||t
1470891|NCT01365169|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1470892|NCT01365156|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470893|NCT01365143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470894|NCT01365130||Single Group Assignment||Treatment||None (Open Label)||||||
1470895|NCT01365117|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470896|NCT01365104|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1470897|NCT01365091|Randomized|Crossover Assignment||||None (Open Label)||||||
1470898|NCT01365078|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1470899|NCT01365065||Single Group Assignment||Treatment||None (Open Label)||||||
1470900|NCT01365052|Randomized|Parallel Assignment||||Triple|||t|t|t|
1470901|NCT01365039|Randomized|Parallel Assignment||||Single|||||t|
1470902|NCT01365026|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1470903|NCT01365013|Randomized|Parallel Assignment||Prevention||Single||||||t
1470904|NCT01365000|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1470905|NCT01364987||Single Group Assignment||||None (Open Label)||||||
1470906|NCT01364974|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1470907|NCT01364961|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1470908|NCT01364948|Randomized|Parallel Assignment||||Single||||||t
1470909|NCT01364935|||Cohort||Prospective|||||||
1470910|NCT01364922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470911|NCT01364909|Randomized|Parallel Assignment||Treatment||Single||||||t
1470912|NCT01364896|||Cohort||Prospective|||||||
1470913|NCT01364883|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1470914|NCT01364870|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1470915|NCT01364857||Single Group Assignment||Prevention||None (Open Label)||||||
1470916|NCT01364844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470917|NCT01364831|Randomized|Crossover Assignment||||None (Open Label)||||||
1470918|NCT01364818|||Case Control||Prospective|||||||
1470919|NCT01364805||Single Group Assignment||Treatment||None (Open Label)||||||
1470920|NCT01364792|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1470921|NCT01364779|||Case Control||Cross-Sectional|||||||
1470922|NCT01364766|||||Cross-Sectional|||||||
1470923|NCT01364753|||Ecologic or Community||Prospective|||||||
1470924|NCT01364740||Single Group Assignment||Diagnostic||None (Open Label)||||||
1470925|NCT01364727||Single Group Assignment||Other||None (Open Label)||||||
1470926|NCT01364714|||Case-Control||Cross-Sectional|||||||
1470927|NCT01364701|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1470928|NCT01364688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470929|NCT01364675|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470930|NCT01364662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470931|NCT01364649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470932|NCT01364636|||Cohort||Prospective|||||||
1470933|NCT01364623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470934|NCT01364610|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1470935|NCT01364597||Single Group Assignment||Treatment||None (Open Label)||||||
1470936|NCT01364584|Randomized|Parallel Assignment||Other||Double|||t||t|
1470937|NCT01364571|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1470938|NCT01364558|Randomized|Crossover Assignment||||None (Open Label)||||||
1470939|NCT01364545|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1470940|NCT01364532|Randomized|Parallel Assignment||Treatment||Single||||||t
1470941|NCT01364519|Randomized|Crossover Assignment||||Double|||t||t|
1470942|NCT01364506|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1470943|NCT01364493||Single Group Assignment||Treatment||None (Open Label)||||||
1470944|NCT01364480||Single Group Assignment||Other||None (Open Label)||||||
1470945|NCT01364467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470946|NCT01364454|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1470947|NCT01364441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470948|NCT01364428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470949|NCT01364415||Single Group Assignment||Treatment||None (Open Label)||||||
1470950|NCT01364402|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1470951|NCT01364389|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1470952|NCT01364376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470953|NCT01364363|Non-Randomized|||Treatment||None (Open Label)||||||
1470954|NCT01364350|||Cohort||Prospective|||||||
1470955|NCT01364337|Randomized|Crossover Assignment||Treatment||Single|||t|||
1470956|NCT01364324|||Case-Control||Prospective|||||||
1470957|NCT01364311|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1470958|NCT01364298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470959|NCT01364285|||Cohort||Prospective|||||||
1470960|NCT01364272|||Cohort||Prospective|||||||
1470961|NCT01364259|Randomized|Parallel Assignment||Treatment||Single|||t|||
1470962|NCT01364246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470963|NCT01364233||Single Group Assignment||Treatment||None (Open Label)||||||
1470964|NCT01364220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470965|NCT01364207|Randomized|Crossover Assignment||||Double|||t||t|
1470966|NCT01364194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470967|NCT01364181||Single Group Assignment||Treatment||None (Open Label)||||||
1470968|NCT01364168|||Cohort||Prospective|||||||
1470969|NCT01364155|Randomized|Parallel Assignment||Treatment||Single|||t|||
1470970|NCT01364142|||Case-Only||Prospective|||||||
1470971|NCT01364129|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1470972|NCT01364116|||Case-Only||Prospective|||||||
1470973|NCT01364103||Single Group Assignment||Diagnostic||Single||||||t
1470974|NCT01364090|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470975|NCT01364077|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1470976|NCT01364064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470977|NCT01364051||Single Group Assignment||Treatment||None (Open Label)||||||
1470978|NCT01364025|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1470979|NCT01364012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1470980|NCT01363999|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1470981|NCT01363986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470982|NCT01363973|Randomized|Parallel Assignment||Treatment||Single||||||t
1470983|NCT01363960||||||||||||
1470984|NCT01363947|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470985|NCT01363934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1470986|NCT01363921||Single Group Assignment||Treatment||None (Open Label)||||||
1470987|NCT01363908|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470988|NCT01363895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470989|NCT01363882|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1470990|NCT01363869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470991|NCT01363856|||Cohort||Prospective|||||||
1470992|NCT01363843||Single Group Assignment||Treatment||None (Open Label)||||||
1470993|NCT01363830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1470994|NCT01363817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1470995|NCT01363804||Single Group Assignment||Treatment||None (Open Label)||||||
1470996|NCT01363791||||||||||||
1470997|NCT01363778||Single Group Assignment||Treatment||None (Open Label)||||||
1470998|NCT01363765|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1470999|NCT01363752|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471000|NCT01363739|||Cohort||Prospective|||||||
1471001|NCT01363726|||Ecologic or Community||Prospective|||||||
1471002|NCT01363713||||||||||||
1471003|NCT01363700||||||||||||
1471004|NCT01363687|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1471005|NCT01363674|||Cohort||Other|||||||
1471006|NCT01363661|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471007|NCT01363648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471008|NCT01363635|||Cohort||Prospective|||||||
1471009|NCT01363622|||Case Control||Prospective|||||||
1471010|NCT01363609|Randomized|Crossover Assignment||||None (Open Label)||||||
1471011|NCT01363596|||Cohort||Prospective|||||||
1471012|NCT01363583|Randomized|||Treatment||Quadruple|||t|t|t|t
1471013|NCT01363570||Single Group Assignment||Treatment||None (Open Label)||||||
1471014|NCT01363557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471015|NCT01363544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471016|NCT01363531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471017|NCT01363518|||Cohort||Prospective|||||||
1471018|NCT01363505|||Case Control||Prospective|||||||
1471019|NCT01363492||Single Group Assignment||Treatment||None (Open Label)||||||
1471020|NCT01363479|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471021|NCT01363466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471022|NCT01363453|||Case-Only||Prospective|||||||
1471023|NCT01363440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471024|NCT01363427|||Case-Only||Retrospective|||||||
1471025|NCT01363414|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1471026|NCT01363401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471027|NCT01363388|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471028|NCT01363375|||Case Control||Cross-Sectional|||||||
1471029|NCT01363362|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471030|NCT01363349|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471031|NCT01363336|||Case-Only||Prospective|||||||
1471032|NCT01363323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471033|NCT01363310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471034|NCT01363297||||Treatment||None (Open Label)||||||
1471035|NCT01363284||Single Group Assignment||Treatment||None (Open Label)||||||
1471036|NCT01363271|||Cohort||Retrospective|||||||
1471037|NCT01363258|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1471038|NCT01363245|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1471039|NCT01363232||Single Group Assignment||Treatment||None (Open Label)||||||
1471040|NCT01363206||Single Group Assignment||Treatment||None (Open Label)||||||
1471041|NCT01363193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471042|NCT01363180|||Other||Prospective|||||||
1471043|NCT01363167|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471044|NCT01363154|Randomized|Parallel Assignment||Prevention||Single|||||t|
1471045|NCT01363141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471046|NCT01363128||Single Group Assignment||Treatment||None (Open Label)||||||
1471047|NCT01363115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471048|NCT01363102|Randomized|Parallel Assignment||Treatment||Single||||||t
1471049|NCT01363089|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471050|NCT01363076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471051|NCT01363063|Randomized|Parallel Assignment||Other||Double|||t||t|
1471052|NCT01363050||Single Group Assignment||Treatment||None (Open Label)||||||
1471053|NCT01363037|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1471054|NCT01363024|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471055|NCT01363011|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471056|NCT01362998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471057|NCT01362985|||Cohort|||||||||
1471058|NCT01362972|||Cohort||Retrospective|||||||
1471059|NCT01362959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471060|NCT01362946|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471061|NCT01362933|||Cohort||Prospective|||||||
1471062|NCT01362920|||Case Control||Prospective|||||||
1471063|NCT01362907|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471064|NCT01362894|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471065|NCT01362881|||Cohort||Prospective|||||||
1471066|NCT01362868|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1471067|NCT01362855|||||Prospective|||||||
1471068|NCT01362842|||Case-Only||Cross-Sectional|||||||
1471069|NCT01362829|||Cohort||Prospective|||||||
1471070|NCT01362816|||Cohort||Prospective|||||||
1471071|NCT01362803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471072|NCT01362790|Non-Randomized|Parallel Assignment||Treatment||||||||
1471073|NCT01362777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471074|NCT01362764|Randomized|Crossover Assignment||||None (Open Label)||||||
1471075|NCT01362751|||Cohort|||||||||
1471076|NCT01362738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471077|NCT01362725||Single Group Assignment||Treatment||None (Open Label)||||||
1471078|NCT01362712|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1471079|NCT01362699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471080|NCT01362686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471081|NCT01362673|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1471082|NCT01362660|||||Prospective|||||||
1471083|NCT01362647|||Cohort||Prospective|||||||
1471084|NCT01362634|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471085|NCT01362621|||Cohort||Prospective|||||||
1471086|NCT01362608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471087|NCT01362595||Single Group Assignment||Treatment||None (Open Label)||||||
1471088|NCT01362582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471089|NCT01362569|||Cohort||Prospective|||||||
1471090|NCT01362556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471091|NCT01362543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471092|NCT01362530|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1471093|NCT01362517|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471094|NCT01362504|||Case Control||Prospective|||||||
1471095|NCT01362491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471096|NCT01362478|||Case Control||Prospective|||||||
1471097|NCT01362465||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471098|NCT01362452|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471099|NCT01362439||Single Group Assignment||Treatment||None (Open Label)||||||
1471100|NCT01362426|||Case-Only||Prospective|||||||
1471101|NCT01362413|||Cohort||Prospective|||||||
1471102|NCT01362400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471103|NCT01362387|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1471104|NCT01362374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471105|NCT01362361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471106|NCT01362348||Single Group Assignment||Treatment||None (Open Label)||||||
1471107|NCT01362335|||||Prospective|||||||
1471108|NCT01362322|Randomized|Parallel Assignment||Prevention||Single|||t|||
1471109|NCT01362309|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1471110|NCT01362296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471111|NCT01362283|||||Cross-Sectional|||||||
1471112|NCT01362270|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1471113|NCT01362257|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471114|NCT01362244|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471115|NCT01362231|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1471116|NCT01362218|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471117|NCT01362205|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471118|NCT01362192||Single Group Assignment||Treatment||None (Open Label)||||||
1471119|NCT01362179|||Cohort||Other|||||||
1471120|NCT01362166|||Case-Only||Cross-Sectional|||||||
1471121|NCT01362153|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471122|NCT01362140|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1471123|NCT01362127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471124|NCT01362114|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471125|NCT01362101|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1471126|NCT01362088|||Cohort||Prospective|||||||
1471127|NCT01362075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471128|NCT01362062|||Cohort||Prospective|||||||
1471129|NCT01362049|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1471130|NCT01362036||Single Group Assignment||Treatment||None (Open Label)||||||
1471131|NCT01362023|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471132|NCT01362010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471133|NCT01361997|Randomized|Factorial Assignment||Prevention||Single||||||t
1471134|NCT01361984|Randomized|Crossover Assignment||Treatment||Single||||||t
1471135|NCT01361971||Parallel Assignment||Basic Science||None (Open Label)||||||
1471136|NCT01361958|Randomized|Parallel Assignment||Treatment||Double||||||
1471137|NCT01361945||Single Group Assignment||Treatment||None (Open Label)||||||
1471138|NCT01361932|Randomized|Single Group Assignment||||None (Open Label)||||||
1471139|NCT01361919|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1471140|NCT01361906|Randomized|Parallel Assignment||Treatment||Single||||||t
1471141|NCT01361893||Single Group Assignment||Prevention||None (Open Label)||||||
1471142|NCT01361880||Single Group Assignment||Health Services Research||None (Open Label)||||||
1471143|NCT01361867||Single Group Assignment||Basic Science||None (Open Label)||||||
1471144|NCT01361854|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1471145|NCT01361841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471146|NCT01361828|||Cohort||Prospective|||||||
1471147|NCT01361815||Single Group Assignment||Treatment||None (Open Label)||||||
1471148|NCT01361802|Randomized|Parallel Assignment||Treatment||Double||||||
1471149|NCT01361789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471150|NCT01361776|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471151|NCT01361763|Randomized|Crossover Assignment||Treatment||Single||||||t
1471152|NCT01361750|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1471153|NCT01361737|||Case Control||Retrospective|||||||
1471154|NCT01361724|Randomized|Parallel Assignment||Treatment||Single||||||t
1471155|NCT01361711||Single Group Assignment||Treatment||None (Open Label)||||||
1471156|NCT01361698|Randomized|Parallel Assignment||Treatment||Single||||||t
1471157|NCT01361685|||Other||Prospective|||||||
1471158|NCT01361672|||Other||Prospective|||||||
1471159|NCT01361659||Single Group Assignment||Treatment||None (Open Label)||||||
1471160|NCT01361646|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471161|NCT01361633|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471162|NCT01361620||Single Group Assignment||Basic Science||None (Open Label)||||||
1471163|NCT01361607|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471164|NCT01361594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471165|NCT01361581|||Cohort||Prospective|||||||
1471166|NCT01361568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471167|NCT01361555|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471168|NCT01361542||Single Group Assignment||Health Services Research||None (Open Label)||||||
1471169|NCT01361529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471170|NCT01361516|Randomized|Single Group Assignment||Treatment||Single|||||t|
1471171|NCT01361503|||Case Control||Cross-Sectional|||||||
1471172|NCT01361490|||Other||Prospective|||||||
1471173|NCT01361477|||Cohort||Prospective|||||||
1471174|NCT01361464||Single Group Assignment||Treatment||None (Open Label)||||||
1471175|NCT01361451|||Cohort||Prospective|||||||
1471176|NCT01361438||Single Group Assignment||Treatment||None (Open Label)||||||
1471177|NCT01361425|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471178|NCT01361412|Randomized|Parallel Assignment||||Double|||t||t|
1471179|NCT01361399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471180|NCT01361386|||Cohort||Prospective|||||||
1471181|NCT01361373|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1471182|NCT01361360|||Case-Control||Prospective|||||||
1471183|NCT01361347|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471184|NCT01361334||Single Group Assignment||Treatment||None (Open Label)||||||
1471185|NCT01361321|||Cohort||Cross-Sectional|||||||
1471186|NCT01361308|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471187|NCT01361295|Randomized|Parallel Assignment||Treatment||Single||||||t
1471188|NCT01361282|||Case-Only||Cross-Sectional|||||||
1471189|NCT01361269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471190|NCT01361256||Single Group Assignment||Treatment||None (Open Label)||||||
1471191|NCT01361243|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471192|NCT01361230|Randomized|Parallel Assignment||||None (Open Label)||||||
1471193|NCT01361217||Single Group Assignment||Basic Science||None (Open Label)||||||
1471194|NCT01361204|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471195|NCT01361191||Single Group Assignment||Treatment||None (Open Label)||||||
1471196|NCT01361178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471197|NCT01361165||||||||||||
1471198|NCT01361152|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1471199|NCT01361139|||Cohort||Prospective|||||||
1471200|NCT01361126|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471201|NCT01361113||Single Group Assignment||Treatment||None (Open Label)||||||
1471202|NCT01361100||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471203|NCT01361087||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471204|NCT01361074|Randomized|Parallel Assignment||Treatment||Single|||||t|
1471205|NCT01361061|||Cohort||Prospective|||||||
1471206|NCT01361048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471207|NCT01361035|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1471208|NCT01361022|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471209|NCT01361009|||Case-Only||Cross-Sectional|||||||
1471210|NCT01360996|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471211|NCT01360970||Single Group Assignment||Prevention||None (Open Label)||||||
1471212|NCT01360957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471213|NCT01360944|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471214|NCT01360931|||Case Control||Prospective|||||||
1471215|NCT01360918|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471216|NCT01360905|||Cohort||Cross-Sectional|||||||
1471217|NCT01360892|||||Prospective|||||||
1471218|NCT01360879|||||Prospective|||||||
1471219|NCT01360866|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471220|NCT01360853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471221|NCT01360840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471222|NCT01360827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471223|NCT01360814|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1471224|NCT01360801|||Case-Only||Prospective|||||||
1471225|NCT01360788|||Case Control||Cross-Sectional|||||||
1471226|NCT01360775|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1471227|NCT01360762||Single Group Assignment||Prevention||None (Open Label)||||||
1471228|NCT01360749|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1471229|NCT01360736|Randomized|Parallel Assignment||Treatment||Single||||||t
1471230|NCT01360723|||Case Control||Cross-Sectional|||||||
1471231|NCT01360710|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471232|NCT01360697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471233|NCT01360684|||Cohort||Prospective|||||||
1471234|NCT01360671|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471235|NCT01360658||Single Group Assignment||Treatment||None (Open Label)||||||
1471236|NCT01360645|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471237|NCT01360632|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471238|NCT01360619|||Ecologic or Community||Cross-Sectional|||||||
1471239|NCT01360606||Single Group Assignment||Treatment||None (Open Label)||||||
1471240|NCT01360593||Single Group Assignment||Treatment||None (Open Label)||||||
1471241|NCT01360580|||Cohort||Prospective|||||||
1471242|NCT01360567|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471243|NCT01360554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471244|NCT01360541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471245|NCT01360528|||Case Control||Prospective|||||||
1471246|NCT01360515|||Cohort||Prospective|||||||
1471247|NCT01360502|||||Prospective|||||||
1471248|NCT01360476|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471249|NCT01360463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471250|NCT01360450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471251|NCT01360437|Randomized|Crossover Assignment||Treatment||Single||||||t
1471252|NCT01360424||Single Group Assignment||Treatment||None (Open Label)||||||
1471253|NCT01360411|||Case-Only||Prospective|||||||
1471254|NCT01360398||Single Group Assignment||Basic Science||None (Open Label)||||||
1471255|NCT01360385|||Case-Only||Prospective|||||||
1471256|NCT01360372|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471257|NCT01360359|Randomized|Single Group Assignment||Treatment||Single||||||t
1471258|NCT01360346|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471259|NCT01360333||Crossover Assignment||Prevention||None (Open Label)||||||
1471260|NCT01360320|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471261|NCT01360307|||||Cross-Sectional|||||||
1471262|NCT01360294|||||Prospective|||||||
1471263|NCT01360281|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1471264|NCT01360268|||Cohort||Prospective|||||||
1471265|NCT01360255|||Cohort||Prospective|||||||
1471266|NCT01360242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471267|NCT01360229|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1471268|NCT01360216|Randomized|Parallel Assignment||Prevention||Single||||||t
1471269|NCT01360203|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1471270|NCT01360190|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1471271|NCT01360177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471272|NCT01360164|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471273|NCT01360151|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1471274|NCT01360138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471275|NCT01360125|||||Retrospective|||||||
1471276|NCT01360112|||Cohort||Prospective|||||||
1471277|NCT01360099|||||Prospective|||||||
1471278|NCT01360086||Single Group Assignment||Treatment||None (Open Label)||||||
1471279|NCT01360073|||Cohort||Retrospective|||||||
1471280|NCT01360060|||Case Control||Retrospective|||||||
1471281|NCT01360047|||Cohort||Retrospective|||||||
1471282|NCT01360034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471283|NCT01360021|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471284|NCT01360008|||Cohort||Prospective|||||||
1471285|NCT01359995|||Cohort||Retrospective|||||||
1471286|NCT01359982||Single Group Assignment||Treatment||None (Open Label)||||||
1471287|NCT01359969||Single Group Assignment||Treatment||None (Open Label)||||||
1471288|NCT01359956|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1471289|NCT01359943|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471290|NCT01359930|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1471291|NCT01359917|||Case Control||Prospective|||||||
1471292|NCT01359904|Randomized|Parallel Assignment||Treatment||None (Open Label)|no masking|||||
1471293|NCT01359891|||Cohort||Prospective|||||||
1471294|NCT01359878|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1471295|NCT01359865||Single Group Assignment||Treatment||Single||||||t
1471296|NCT01359852|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1471297|NCT01359839||Single Group Assignment||Supportive Care||None (Open Label)||||||
1471298|NCT01359826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471299|NCT01359813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471300|NCT01359800|||||Cross-Sectional|||||||
1471301|NCT01359787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471302|NCT01359774|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471303|NCT01359761|Randomized|Parallel Assignment||Treatment||Single||||||t
1471304|NCT01359748|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1471305|NCT01359735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471306|NCT01359722|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471307|NCT01359709|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1471308|NCT01359696||Single Group Assignment||Treatment||None (Open Label)||||||
1471309|NCT01359683||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471310|NCT01359670|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471311|NCT01359657|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471312|NCT01359644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471313|NCT01359631|||Case-Only||Prospective|||||||
1471314|NCT01359618|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1471315|NCT01359605||Single Group Assignment||Basic Science||None (Open Label)||||||
1471316|NCT01359592|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471317|NCT01359579|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1471318|NCT01359566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471319|NCT01359553|||Case-Only||Cross-Sectional|||||||
1471320|NCT01359540|||Case-Control||Prospective|||||||
1471321|NCT01359527|||Case-Control||Prospective|||||||
1471322|NCT01359514|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471323|NCT01359501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471324|NCT01359488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471325|NCT01359475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471326|NCT01359462||Single Group Assignment||Treatment||None (Open Label)||||||
1471327|NCT01359449|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471328|NCT01359436||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471329|NCT01359423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471330|NCT01359410|Randomized|Parallel Assignment||Treatment||Single|Participant's were blinded to the results of the randomization for 6 weeks.||t|||
1471331|NCT01359397||||||||||||
1471332|NCT01359384|||Case Control||Prospective|||||||
1471333|NCT01359371|||Cohort||Cross-Sectional|||||||
1471334|NCT01359358|||||Retrospective|||||||
1471335|NCT01359345||Single Group Assignment||Screening||None (Open Label)||||||
1471336|NCT01359332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471337|NCT01359319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471338|NCT01359306|||Cohort||Retrospective|||||||
1471339|NCT01359280|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1471340|NCT01359267||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471341|NCT01359254|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471342|NCT01359241|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471343|NCT01359228|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1471344|NCT01359215|||Case Control||Prospective|||||||
1471345|NCT01359202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471346|NCT01359189||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471347|NCT01359176|||Cohort||Prospective|||||||
1471348|NCT01359163|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1471349|NCT01359150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471350|NCT01359137|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1471351|NCT01359124|||Cohort||Prospective|||||||
1471352|NCT01359111||Single Group Assignment||Prevention||None (Open Label)||||||
1471353|NCT01359098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471354|NCT01359085|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1471355|NCT01359072|Randomized|Parallel Assignment||Treatment||Single||||||t
1471356|NCT01359059|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1471357|NCT01359046|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1471358|NCT01359033|||Cohort||Retrospective|||||||
1471359|NCT01359020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471360|NCT01359007||Single Group Assignment||Treatment||None (Open Label)||||||
1471361|NCT01358994|||Cohort||Retrospective|||||||
1471362|NCT01358981|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1471363|NCT01358968||Single Group Assignment||Treatment||None (Open Label)||||||
1471364|NCT01358955|Randomized|Parallel Assignment||Treatment||Single||||||t
1471365|NCT01358942|||Cohort||Prospective|||||||
1471366|NCT01358929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471367|NCT01358916|Randomized|Parallel Assignment||||None (Open Label)||||||
1471368|NCT01358903|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471369|NCT01358890|Randomized|Parallel Assignment||Treatment||Single||||||t
1471370|NCT01358877|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471371|NCT01358864|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471372|NCT01358851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471373|NCT01358838|Randomized|Parallel Assignment||Treatment||Single||||||t
1471374|NCT01358825|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471375|NCT01358812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471376|NCT01358799|||Cohort||Cross-Sectional|||||||
1471377|NCT01358786|Randomized|Crossover Assignment||Prevention||Double||||t||t
1471378|NCT01358773|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471379|NCT01358760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471380|NCT01358747|Randomized|Parallel Assignment||||||||||
1471381|NCT01358734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471382|NCT01358721|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1471383|NCT01358708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471384|NCT01358695|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1471385|NCT01358682||||||||||||
1471386|NCT01358669|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471387|NCT01358656|Randomized|Parallel Assignment||Treatment||Single|||||t|
1471388|NCT01358643|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1471389|NCT01358630|||Case Control||Cross-Sectional|||||||
1471390|NCT01358617|||Case Control||Retrospective|||||||
1471391|NCT01358604|||Case-Only||Retrospective|||||||
1471392|NCT01358591|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1471393|NCT01358578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471394|NCT01358565|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1471395|NCT01358552|||Cohort||Prospective|||||||
1471396|NCT01358539|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471397|NCT01358526|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471398|NCT01358513|||Cohort||Prospective|||||||
1471399|NCT01358500||Single Group Assignment||Treatment||None (Open Label)||||||
1471400|NCT01358487|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471401|NCT01358474|||Case-Control||Cross-Sectional|||||||
1471402|NCT01358461|||Case-Control||Cross-Sectional|||||||
1471403|NCT01358448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471404|NCT01358435|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1471405|NCT01358422|||Cohort||Prospective|||||||
1471406|NCT01358409||Single Group Assignment||Treatment||None (Open Label)||||||
1471407|NCT01358396|||Cohort||Prospective|||||||
1471408|NCT01358383|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1471409|NCT01358370|||Cohort||Retrospective|||||||
1471410|NCT01358357|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471411|NCT01358344|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471412|NCT01358331|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471413|NCT01358318|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1471414|NCT01358305|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1471415|NCT01358292|Randomized|Parallel Assignment||Treatment||Single||||||t
1471416|NCT01358279||Single Group Assignment||Treatment||None (Open Label)||||||
1471417|NCT01358266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471418|NCT01358253|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471419|NCT01358240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471420|NCT01358227|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471421|NCT01358214|||Case Control||Cross-Sectional|||||||
1471422|NCT01358201||Single Group Assignment||Treatment||None (Open Label)||||||
1471423|NCT01358188|||Case-Control||Prospective|||||||
1471424|NCT01358175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471425|NCT01358162|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471426|NCT01358149|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1471427|NCT01358136|||Cohort||Prospective|||||||
1471428|NCT01358123|||Cohort||Prospective|||||||
1471429|NCT01358110|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1471430|NCT01358097|||Case Control||Prospective|||||||
1471431|NCT01358084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471432|NCT01358071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471433|NCT01358058||Single Group Assignment||Treatment||None (Open Label)||||||
1471434|NCT01358045|Randomized|Parallel Assignment||Treatment||Single||||||t
1471435|NCT01358032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471436|NCT01358019||Single Group Assignment||Treatment||None (Open Label)||||||
1471437|NCT01358006||Single Group Assignment||||None (Open Label)||||||
1471438|NCT01357993||Single Group Assignment||Treatment||None (Open Label)||||||
1471439|NCT01357980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471440|NCT01357967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471441|NCT01357954|Randomized|Parallel Assignment||Treatment||Single||||||t
1471442|NCT01357941|||Cohort||Prospective|||||||
1471443|NCT01357928|||Cohort||Prospective|||||||
1471444|NCT01357915|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471445|NCT01357902|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471446|NCT01357889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471447|NCT01357876|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471448|NCT01357863|||Cohort||Prospective|||||||
1471449|NCT01357850|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1471450|NCT01357837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471451|NCT01357824|||Case-Crossover||Prospective|||||||
1471452|NCT01357811|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1471453|NCT01357798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471454|NCT01357785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471455|NCT01357772|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1471456|NCT01357759|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1471457|NCT01357746||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471458|NCT01357733||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471459|NCT01357720|Randomized|Parallel Assignment||Prevention||Single||||t||
1471460|NCT01357707|||Family-Based||Prospective|||||||
1471461|NCT01357694|Randomized|Parallel Assignment||Treatment||Single||||||t
1471462|NCT01357681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471463|NCT01357668|||Cohort||Prospective|||||||
1471464|NCT01357655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471465|NCT01357642|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471466|NCT01357629|||Cohort||Retrospective|||||||
1471467|NCT01357616|Randomized|Parallel Assignment||Treatment||Single|||||t|
1471468|NCT01357603|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1471469|NCT01357590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471470|NCT01357577|Randomized|Parallel Assignment||Treatment||Single||||||t
1471471|NCT01357564|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1471472|NCT01357551|Randomized|Parallel Assignment||Treatment||Single||||||t
1471473|NCT01357538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471474|NCT01357525||Single Group Assignment||Treatment||None (Open Label)||||||
1471475|NCT01357512|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1471476|NCT01357499|||Case Control||Prospective|||||||
1471477|NCT01357486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471478|NCT01357473|||Cohort||Prospective|||||||
1471479|NCT01357460||Single Group Assignment||Treatment||None (Open Label)||||||
1471480|NCT01357447|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1471481|NCT01357434|||Cohort||Prospective|||||||
1471482|NCT01357421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471483|NCT01357408|||Cohort||Prospective|||||||
1471484|NCT01357395||Single Group Assignment||Treatment||None (Open Label)||||||
1471485|NCT01357382|Randomized|Parallel Assignment||Treatment||Single||||||t
1471486|NCT01357369|||Cohort||Prospective|||||||
1471487|NCT01357356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471488|NCT01357343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471489|NCT01357330|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1471490|NCT01357317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471491|NCT01357304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471492|NCT01357291|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471493|NCT01357278|Randomized|Single Group Assignment||Prevention||Single|||||t|
1471494|NCT01357265|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1471495|NCT01357252|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471496|NCT01357239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471497|NCT01357226|||Case-Crossover||Prospective|||||||
1471498|NCT01357213|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471499|NCT01357200|||Case-Only||Prospective|||||||
1471500|NCT01357187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471501|NCT01357174|||Cohort||Retrospective|||||||
1471502|NCT01357161|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471503|NCT01357148|||Cohort||Retrospective|||||||
1471504|NCT01357135|||Other||Prospective|||||||
1471505|NCT01357122|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471506|NCT01357109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471507|NCT01357096|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1471508|NCT01357083|||Case Control||Retrospective|||||||
1471509|NCT01357070|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1471510|NCT01357057|||Cohort||Retrospective|||||||
1471511|NCT01357044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471512|NCT01357031|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1471513|NCT01357018|||Case-Only||Prospective|||||||
1471514|NCT01357005|||Family-Based|||||||||
1471515|NCT01356992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471516|NCT01356979|||Case Control||Prospective|||||||
1471517|NCT01356966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471518|NCT01356953|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471519|NCT01356940|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1471520|NCT01356927|||Cohort||Prospective|||||||
1471521|NCT01356914|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1471522|NCT01356901|||Cohort||Prospective|||||||
1471523|NCT01356888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471524|NCT01356875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471525|NCT01356862|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1471526|NCT01356849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471527|NCT01356836|||Cohort||Prospective|||||||
1471528|NCT01356823|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471529|NCT01356810|Randomized|Parallel Assignment||Prevention||Single|||||t|
1471530|NCT01356797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471531|NCT01356784|Randomized|Parallel Assignment||Prevention||Single||||||t
1471532|NCT01356771|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1471533|NCT01356758|||Case Control||Prospective|||||||
1471534|NCT01356745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471535|NCT01356732||Single Group Assignment||Treatment||None (Open Label)||||||
1471536|NCT01356719|||Case-Only||Prospective|||||||
1471537|NCT01356706|||Cohort||Prospective|||||||
1471538|NCT01356693|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1471539|NCT01356680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471540|NCT01356667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471541|NCT01356654|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1471542|NCT01356641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471543|NCT01356628||Single Group Assignment||Treatment||None (Open Label)||||||
1471544|NCT01356615|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1471545|NCT01356602|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471546|NCT01356589|||Cohort||Retrospective|||||||
1471547|NCT01356576|||Case Control||Cross-Sectional|||||||
1471548|NCT01356563|Randomized|Parallel Assignment||Health Services Research||Double||||t||t
1471549|NCT01356550|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1471550|NCT01356537|||Cohort||Prospective|||||||
1471551|NCT01356524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471552|NCT01356511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471553|NCT01356498|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471554|NCT01356485|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1471555|NCT01356472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471556|NCT01356459|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471557|NCT01356446|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1471558|NCT01356433|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471559|NCT01356420||Single Group Assignment||Treatment||None (Open Label)||||||
1471560|NCT01356407|Randomized|Parallel Assignment||Treatment||Single||||||t
1471561|NCT01356394|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1471562|NCT01356381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471563|NCT01356368||Single Group Assignment||Treatment||None (Open Label)||||||
1471564|NCT01356355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471565|NCT01356342|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1471566|NCT01356329|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471567|NCT01356316||Single Group Assignment||Prevention||None (Open Label)||||||
1471568|NCT01356303||Single Group Assignment||Treatment||None (Open Label)||||||
1471569|NCT01356290||Single Group Assignment||Treatment||None (Open Label)||||||
1471570|NCT01356277|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1471571|NCT01356264|Randomized|Parallel Assignment||Treatment||Single||||||t
1471572|NCT01356251|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1471573|NCT01356238|Randomized|Parallel Assignment||||None (Open Label)||||||
1471574|NCT01356225|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471575|NCT01356212|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471576|NCT01356199|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1471577|NCT01356186|Randomized|Parallel Assignment||Treatment||Single||||||t
1471578|NCT01356173|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471579|NCT01356160|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471580|NCT01356147|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1471581|NCT01356134|||Case Control||Cross-Sectional|||||||
1471582|NCT01356121|Randomized|Single Group Assignment||Treatment||Single|||t|||
1471583|NCT01356108|||Cohort||Prospective|||||||
1471584|NCT01356095|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1471585|NCT01356082|||Case-Only||Prospective|||||||
1471586|NCT01356069|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1471587|NCT01356056|||Cohort||Prospective|||||||
1471588|NCT01356043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471589|NCT01356030|Non-Randomized|Single Group Assignment||Diagnostic||Single||||t||
1471590|NCT01356017|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471591|NCT01356004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471592|NCT01355991|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471593|NCT01355978||Single Group Assignment||Supportive Care||None (Open Label)||||||
1471594|NCT01355965|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471595|NCT01355952||Single Group Assignment||Treatment||None (Open Label)||||||
1471596|NCT01355939|||Cohort||Prospective|||||||
1471597|NCT01355926|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471598|NCT01355913|||Case-Only||Prospective|||||||
1471599|NCT01355900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471600|NCT01355887|||Case-Only||Prospective|||||||
1471601|NCT01355874|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471602|NCT01355861|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471603|NCT01355848|Randomized|Parallel Assignment||Treatment||Single||||||t
1471604|NCT01355835|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1471605|NCT01355822|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471606|NCT01355809|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471607|NCT01355796|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471608|NCT01355783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471609|NCT01355757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471610|NCT01355744|||Cohort||Prospective|||||||
1471611|NCT01355731|||Case-Only||Prospective|||||||
1471612|NCT01355718|||Cohort||Prospective|||||||
1471613|NCT01355705||Single Group Assignment||Treatment||None (Open Label)||||||
1471614|NCT01355692||Single Group Assignment||Treatment||None (Open Label)||||||
1471615|NCT01355679||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471616|NCT01355666|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471617|NCT01355653|Randomized|Crossover Assignment||||None (Open Label)||||||
1471618|NCT01355640|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1471619|NCT01355627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471620|NCT01355614|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471621|NCT01355601|Randomized|Crossover Assignment||||Double||||||
1471622|NCT01355588|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1471623|NCT01355575|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471624|NCT01355562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471625|NCT01355549||Single Group Assignment||Treatment||None (Open Label)||||||
1471626|NCT01355536|||Case Control||Cross-Sectional|||||||
1471627|NCT01355523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471628|NCT01355510|||Cohort||Prospective|||||||
1471629|NCT01355497|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471630|NCT01355484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471631|NCT01355471|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471632|NCT01355458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471633|NCT01355445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471634|NCT01355432|||Cohort||Prospective|||||||
1471635|NCT01355419|||Cohort||Prospective|||||||
1471636|NCT01355406||Single Group Assignment||Treatment||None (Open Label)||||||
1471637|NCT01355393|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471638|NCT01355380|||Cohort||Prospective|||||||
1471639|NCT01355367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471640|NCT01355354|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1471641|NCT01355341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471642|NCT01355328||||||||||||
1471643|NCT01355315|||Case-Only||Prospective|||||||
1471644|NCT01355302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471645|NCT01355289|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471646|NCT01355276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471647|NCT01355263|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1471648|NCT01355237|||Cohort||Prospective|||||||
1471649|NCT01355224|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1471650|NCT01355211|||Cohort||Prospective|||||||
1471651|NCT01355198||Single Group Assignment||Treatment||None (Open Label)||||||
1471652|NCT01355185|||Cohort||Prospective|||||||
1471653|NCT01355172||Single Group Assignment||Prevention||Single||||||t
1471654|NCT01355159|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471655|NCT01355146|||Cohort||Prospective|||||||
1471656|NCT01355133||Single Group Assignment||Treatment||None (Open Label)||||||
1471657|NCT01355120||Single Group Assignment||Treatment||None (Open Label)||||||
1471658|NCT01355107|||Case Control||Prospective|||||||
1471659|NCT01355094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471660|NCT01355081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471661|NCT01355068|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1471662|NCT01355055|||Cohort||Prospective|||||||
1471663|NCT01355042|||Cohort||Prospective|||||||
1471664|NCT01355029||Single Group Assignment||Supportive Care||None (Open Label)||||||
1471665|NCT01355016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471666|NCT01355003|||Cohort||Cross-Sectional|||||||
1471667|NCT01354990|||Cohort||Retrospective|||||||
1471668|NCT01354977||Single Group Assignment||Treatment||None (Open Label)||||||
1471669|NCT01354964|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1471670|NCT01354951||Single Group Assignment||Treatment||None (Open Label)||||||
1471671|NCT01354938|||Case-Only||Prospective|||||||
1471672|NCT01354925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471673|NCT01354912|||Cohort||Prospective|||||||
1471674|NCT01354899|||Case Control||Prospective|||||||
1471675|NCT01354886|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471676|NCT01354873|||Case-Only||Prospective|||||||
1471677|NCT01354860|Randomized|Parallel Assignment||Treatment||Single||||||t
1471678|NCT01354847|||Cohort||Prospective|||||||
1471679|NCT01354834|||Cohort||Prospective|||||||
1471680|NCT01354821|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471681|NCT01354808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471682|NCT01354795|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1471683|NCT01354782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471684|NCT01354769|||Cohort||Prospective|||||||
1471685|NCT01354756|||Cohort||Prospective|||||||
1471686|NCT01354743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471687|NCT01354730|||Cohort||Retrospective|||||||
1471688|NCT01354717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471689|NCT01354704|Randomized|Factorial Assignment||Treatment||Single||||||t
1471690|NCT01354691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471691|NCT01354678|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471692|NCT01354665|||Cohort||Prospective|||||||
1471693|NCT01354652|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1471694|NCT01354639|||Case-Only||Prospective|||||||
1471695|NCT01354626|Randomized|Crossover Assignment||Prevention||Single|||||t|
1471696|NCT01354613|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471697|NCT01354600|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1471698|NCT01354587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471699|NCT01354574|Randomized|Crossover Assignment||Basic Science||Single||||||t
1471700|NCT01354561|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471701|NCT01354548|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471702|NCT01354535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471703|NCT01354522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471704|NCT01354509|||Case Control||Prospective|||||||
1471705|NCT01354496|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1471706|NCT01354483|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1471707|NCT01354470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471708|NCT01354457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471709|NCT01354444|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471710|NCT01354431|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471711|NCT01354418|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471712|NCT01354405|||Cohort||Prospective|||||||
1471713|NCT01354392||Single Group Assignment||Treatment||None (Open Label)||||||
1471714|NCT01354379|Randomized|Parallel Assignment||Prevention||Single||||||t
1471715|NCT01354366|||Cohort||Prospective|||||||
1471716|NCT01354353|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1471717|NCT01354340|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471718|NCT01354327|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471719|NCT01354314|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1471720|NCT01354301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471721|NCT01354288|Randomized|Parallel Assignment||Prevention||Single|||t|||
1471722|NCT01354275|Randomized|Single Group Assignment||||Single|||||t|
1471723|NCT01354262|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471724|NCT01354249|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1471725|NCT01354236|||Case Control||Cross-Sectional|||||||
1471726|NCT01354223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471727|NCT01354210|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1471728|NCT01354197|||Cohort||Prospective|||||||
1471729|NCT01354184||||||||||||
1471730|NCT01354171|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1471731|NCT01354158|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471732|NCT01354145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471733|NCT01354132|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471734|NCT01354119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471735|NCT01354106|Randomized|Parallel Assignment||Basic Science||Single||||||t
1471736|NCT01354093|||Other||Prospective|||||||
1471737|NCT01354080|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471738|NCT01354067|Randomized|Parallel Assignment||Treatment||Single||||||t
1471739|NCT01354054|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471740|NCT01354041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471741|NCT01354028|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1471742|NCT01354015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471743|NCT01354002|||Case-Control||Prospective|||||||
1471744|NCT01353989|||Cohort||Prospective|||||||
1471745|NCT01353976|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471746|NCT01353963|||||Prospective|||||||
1471747|NCT01353950|||Cohort||Prospective|||||||
1471748|NCT01353937|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471749|NCT01353924|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1471750|NCT01353911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471751|NCT01353898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471752|NCT01353885|||Cohort||Prospective|||||||
1471753|NCT01353872|Randomized|Crossover Assignment||||Triple|||t|t|t|
1471754|NCT01353859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471755|NCT01353846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471756|NCT01353833|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1471757|NCT01353820|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1471758|NCT01353807|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1471759|NCT01353794|||Cohort||Prospective|||||||
1471760|NCT01353781|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471761|NCT01353768|||Cohort||Retrospective|||||||
1471762|NCT01353755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471763|NCT01353742|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471764|NCT01353729|Randomized|Crossover Assignment||Other||Double|||t||t|
1471765|NCT01353716|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1471766|NCT01353703|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471767|NCT01353690||Single Group Assignment||Treatment||None (Open Label)||||||
1471768|NCT01353677|||Cohort||Prospective|||||||
1471769|NCT01353664||Single Group Assignment||Treatment||None (Open Label)||||||
1471770|NCT01353651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471771|NCT01353638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471772|NCT01353625||Single Group Assignment||Treatment||None (Open Label)||||||
1471774|NCT01353599||Single Group Assignment||Treatment||None (Open Label)||||||
1471775|NCT01353586||Single Group Assignment||Treatment||None (Open Label)||||||
1471776|NCT01353573|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1471777|NCT01353560|||Other||Cross-Sectional|||||||
1471778|NCT01353547|||Cohort||Prospective|||||||
1471779|NCT01353534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471780|NCT01353521||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471781|NCT01353508|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1471782|NCT01353495|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471783|NCT01353482|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471784|NCT01353469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471785|NCT01353456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471786|NCT01353443|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1471787|NCT01353430|||Case Control||Cross-Sectional|||||||
1471788|NCT01353417|||Cohort||Prospective|||||||
1471789|NCT01353404|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471790|NCT01353391|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471791|NCT01353378||Sequential Assignment||Supportive Care||None (Open Label)||||||
1471792|NCT01353365|||Cohort||Prospective|||||||
1471793|NCT01353352|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471794|NCT01353339|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471795|NCT01353326|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471796|NCT01353313|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1471797|NCT01353300|||Case-Only||Retrospective|||||||
1471798|NCT01353287|||Case Control||Retrospective|||||||
1471799|NCT01353274|||Case-Only||Prospective|||||||
1471800|NCT01353261|||Cohort||Prospective|||||||
1471801|NCT01353248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471802|NCT01353235|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471803|NCT01353222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471804|NCT01353209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471805|NCT01353196|||Case-Control||Prospective|||||||
1471806|NCT01353183|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1471807|NCT01353170|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471808|NCT01353157|||Case-Only||Prospective|||||||
1471809|NCT01353144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471810|NCT01353131|||Cohort||Prospective|||||||
1471811|NCT01353118|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471812|NCT01353105||Single Group Assignment||Treatment||None (Open Label)||||||
1471813|NCT01353092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471814|NCT01353079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471815|NCT01353066||||Treatment||||||||
1471816|NCT01353053|||Cohort||Prospective|||||||
1471817|NCT01353040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471818|NCT01353027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471819|NCT01353014|Randomized|Single Group Assignment||||None (Open Label)||||||
1471820|NCT01353001|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471821|NCT01352988||Single Group Assignment||Treatment||None (Open Label)||||||
1471822|NCT01352975|||Cohort||Prospective|||||||
1471823|NCT01352962||Single Group Assignment||Treatment||None (Open Label)||||||
1471824|NCT01352949|||Cohort||Prospective|||||||
1471825|NCT01352936||||||||||||
1471826|NCT01352923||Single Group Assignment||Basic Science||None (Open Label)||||||
1471827|NCT01352910|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471828|NCT01352897|||Case-Only||Retrospective|||||||
1471829|NCT01352884|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471830|NCT01352871|||Case-Only||Prospective|||||||
1471831|NCT01352858|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1471832|NCT01352845|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471833|NCT01352832|Randomized|Parallel Assignment||Prevention||Single|||t|||
1471834|NCT01352819|||Cohort||Prospective|||||||
1471835|NCT01352806||Single Group Assignment||Supportive Care||None (Open Label)||||||
1471836|NCT01352793|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471837|NCT01352780|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1471838|NCT01352767|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471839|NCT01352754|||Cohort||Prospective|||||||
1471840|NCT01352741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471841|NCT01352728||Single Group Assignment||Treatment||None (Open Label)||||||
1471842|NCT01352715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471843|NCT01352702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471844|NCT01352689|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471845|NCT01352676|||Cohort||Prospective|||||||
1471846|NCT01352663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471847|NCT01352650|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471848|NCT01352637|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1471849|NCT01352624|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1471850|NCT01352611||Single Group Assignment||Treatment||None (Open Label)||||||
1471851|NCT01352598||Single Group Assignment||Treatment||None (Open Label)||||||
1471852|NCT01352585|||Case-Only||Prospective|||||||
1471853|NCT01352572|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1471854|NCT01352559|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1471855|NCT01352546||Single Group Assignment||Treatment||None (Open Label)||||||
1471856|NCT01352533|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471857|NCT01352520||Single Group Assignment||Treatment||None (Open Label)||||||
1471858|NCT01352507|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471859|NCT01352494||Single Group Assignment||Treatment||None (Open Label)||||||
1471860|NCT01352481|Randomized|Parallel Assignment||Treatment||Single||||||t
1471861|NCT01352468|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1471862|NCT01352455|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1471863|NCT01352442||Single Group Assignment||Treatment||None (Open Label)||||||
1471864|NCT01352429|||Cohort||Prospective|||||||
1471865|NCT01352416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471866|NCT01352403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471867|NCT01352390|Randomized|Parallel Assignment||Prevention||Single|||t|||
1471868|NCT01352377|||Cohort||Retrospective|||||||
1471869|NCT01352364|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471870|NCT01352351|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471871|NCT01352338||Single Group Assignment||Treatment||None (Open Label)||||||
1471872|NCT01352325|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471873|NCT01352312||Single Group Assignment||Treatment||None (Open Label)||||||
1471874|NCT01352299|Randomized|Parallel Assignment||||None (Open Label)||||||
1471875|NCT01352286||Single Group Assignment||Treatment||None (Open Label)||||||
1471876|NCT01352273||Single Group Assignment||Treatment||None (Open Label)||||||
1471877|NCT01352260|||Cohort||Prospective|||||||
1471878|NCT01352247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471879|NCT01352234|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471880|NCT01352221|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471881|NCT01352208||Single Group Assignment||Treatment||None (Open Label)||||||
1471882|NCT01352195|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471883|NCT01352182|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1471884|NCT01352143|||Case Control||Prospective|||||||
1471885|NCT01352130|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471886|NCT01352117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471887|NCT01352104||Crossover Assignment||Prevention||None (Open Label)||||||
1471888|NCT01352091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471889|NCT01352078|||Ecologic or Community||Prospective|||||||
1471890|NCT01352065|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1471891|NCT01352052|Randomized|Parallel Assignment||Treatment||Single||||||t
1471892|NCT01352039|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1471893|NCT01352026||Single Group Assignment||||None (Open Label)||||||
1471894|NCT01352013|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471895|NCT01352000|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471896|NCT01351987|||Case-Only|||||||||
1471897|NCT01351974|||Cohort||Prospective|||||||
1471898|NCT01351961||Single Group Assignment||Prevention||None (Open Label)||||||
1471899|NCT01351948|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471900|NCT01351935||Single Group Assignment||Treatment||None (Open Label)||||||
1471901|NCT01351922|||Ecologic or Community||Cross-Sectional|||||||
1471902|NCT01351909||Single Group Assignment||Treatment||None (Open Label)||||||
1471903|NCT01351896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471904|NCT01351883|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471905|NCT01351870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471906|NCT01351857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471907|NCT01351844|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1471908|NCT01351831|Randomized|Parallel Assignment||Treatment||Single||||||t
1471909|NCT01351818|||Cohort||Prospective|||||||
1471910|NCT01351805|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1471911|NCT01351792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471912|NCT01351779|||Cohort||Prospective|||||||
1471913|NCT01351766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471914|NCT01351753|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471915|NCT01351740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471916|NCT01351727|||Case-Only||Prospective|||||||
1471917|NCT01351714||Single Group Assignment||Treatment||None (Open Label)||||||
1471918|NCT01351701|||Case-Only||Prospective|||||||
1471919|NCT01351688||Single Group Assignment||Treatment||None (Open Label)||||||
1471920|NCT01351675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471921|NCT01351662|Randomized|Single Group Assignment||Health Services Research||Single||||t||
1471922|NCT01351649|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471923|NCT01351636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471924|NCT01351623||Single Group Assignment||Treatment||None (Open Label)||||||
1471925|NCT01351610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471926|NCT01351597||Single Group Assignment||Treatment||None (Open Label)||||||
1471927|NCT01351584|||Cohort||Prospective|||||||
1471928|NCT01351571|||Cohort||Prospective|||||||
1471929|NCT01351558|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1471930|NCT01351545|||Other||Prospective|||||||
1472858|NCT01339416|||Cohort||Retrospective|||||||
1471931|NCT01351532|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471932|NCT01351519||Single Group Assignment||Treatment||None (Open Label)||||||
1471933|NCT01351506|||Cohort||Prospective|||||||
1471934|NCT01351493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471935|NCT01351480||Single Group Assignment||Treatment||None (Open Label)||||||
1471936|NCT01351467|||Case-Control||Cross-Sectional|||||||
1471937|NCT01351454|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1471938|NCT01351441||Single Group Assignment||Health Services Research||None (Open Label)||||||
1471939|NCT01351428||Single Group Assignment||Treatment||None (Open Label)||||||
1471940|NCT01351415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471941|NCT01351402|Randomized|||Basic Science||Single||||||
1471942|NCT01351389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471943|NCT01351376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471944|NCT01351363||Single Group Assignment||Screening||None (Open Label)||||||
1471945|NCT01351350|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471946|NCT01351337||Single Group Assignment||Treatment||Single||||||t
1471947|NCT01351324|Randomized|Crossover Assignment||Basic Science||Single||||||t
1471948|NCT01351311|Randomized|Parallel Assignment||Treatment||Single||||||t
1471949|NCT01351298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471950|NCT01351285|Randomized|Parallel Assignment||||Single||||||t
1471951|NCT01351272|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1471952|NCT01351259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471953|NCT01351246||Single Group Assignment||Treatment||None (Open Label)||||||
1471954|NCT01351233|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1471955|NCT01351220|Randomized|Parallel Assignment||Screening||Double|||t|||t
1471956|NCT01351207|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1471957|NCT01351194|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1471958|NCT01351181|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471959|NCT01351168|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1471960|NCT01351155|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1471961|NCT01351142||Single Group Assignment||||||||||
1471962|NCT01351129|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1471963|NCT01351116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471964|NCT01351103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1471965|NCT01351090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1471966|NCT01351077|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1471967|NCT01351064|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1471968|NCT01351051|||Case Control||Cross-Sectional|||||||
1471969|NCT01351038||Single Group Assignment||Treatment||None (Open Label)||||||
1471970|NCT01351025|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1471971|NCT01351012|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1471972|NCT01350999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471973|NCT01350986|Randomized|Parallel Assignment||Treatment||Single|||t|||
1471974|NCT01350973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471975|NCT01350960|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1471976|NCT01350947||Single Group Assignment||Treatment||None (Open Label)||||||
1471977|NCT01350934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471978|NCT01350921||Crossover Assignment||Basic Science||None (Open Label)||||||
1471979|NCT01350908||Single Group Assignment||Other||None (Open Label)||||||
1471980|NCT01350895|||||Retrospective|||||||
1471981|NCT01350882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471982|NCT01350869|||Cohort||Prospective|||||||
1471983|NCT01350856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471984|NCT01350843|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1471985|NCT01350830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471986|NCT01350817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471987|NCT01350804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1471988|NCT01350791|||Cohort||Prospective|||||||
1471989|NCT01350778|||Cohort||Prospective|||||||
1471990|NCT01350765|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1471991|NCT01350752|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1471992|NCT01350739|Randomized|Parallel Assignment||||None (Open Label)||||||
1471993|NCT01350726|||Case Control||Prospective|||||||
1471994|NCT01350713|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1471995|NCT01350700|||Cohort||Other|||||||
1471996|NCT01350687|||Cohort||Prospective|||||||
1471997|NCT01350674||Single Group Assignment||Diagnostic||None (Open Label)||||||
1471998|NCT01350661|||Cohort||Prospective|||||||
1471999|NCT01350648|||||Prospective|||||||
1472000|NCT01350635|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472001|NCT01350622|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472002|NCT01350609|Randomized|Crossover Assignment||||None (Open Label)||||||
1472003|NCT01350596|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1472004|NCT01350583||Single Group Assignment||Supportive Care||None (Open Label)||||||
1472005|NCT01350570|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1472006|NCT01350557|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1472007|NCT01350544|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472008|NCT01350531|Randomized|Parallel Assignment||Treatment||Single||||||t
1472009|NCT01350518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472010|NCT01350505|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1472011|NCT01350492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472012|NCT01350479|||Cohort||Prospective|||||||
1472013|NCT01350466|||Case Control||Prospective|||||||
1472014|NCT01350453|Randomized|Single Group Assignment||Treatment||Single||||||t
1472015|NCT01350440||Single Group Assignment||Treatment||None (Open Label)||||||
1472016|NCT01350427|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1472017|NCT01350414|||Cohort||Prospective|||||||
1472018|NCT01350401||Single Group Assignment||Treatment||None (Open Label)||||||
1472019|NCT01350388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472020|NCT01350375|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1472021|NCT01350362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472022|NCT01350349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472023|NCT01350336||Single Group Assignment||Treatment||None (Open Label)||||||
1472024|NCT01350323|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1472025|NCT01350310|Randomized|Parallel Assignment||Treatment||Single||||||t
1472026|NCT01350297||Single Group Assignment||Treatment||None (Open Label)||||||
1472027|NCT01350284|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1472028|NCT01350271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472029|NCT01350258||Single Group Assignment||Treatment||None (Open Label)||||||
1472030|NCT01350245||Single Group Assignment||Treatment||None (Open Label)||||||
1472031|NCT01350232||Single Group Assignment||Treatment||None (Open Label)||||||
1472032|NCT01350219||Single Group Assignment||Treatment||None (Open Label)||||||
1472033|NCT01350206|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1472034|NCT01350193|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472035|NCT01350180|||Cohort||Prospective|||||||
1472036|NCT01350167|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1472037|NCT01350154|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1472038|NCT01350141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472039|NCT01350128|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1472040|NCT01350115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472041|NCT01350102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472042|NCT01350089|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1472043|NCT01350076|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1472044|NCT01350063|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472045|NCT01350050|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472046|NCT01350037|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472047|NCT01350024|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1472048|NCT01350011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472049|NCT01349998|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1472050|NCT01349985|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472051|NCT01349972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472052|NCT01349959||Single Group Assignment||Treatment||None (Open Label)||||||
1472053|NCT01349946|||Case Control||Prospective|||||||
1472054|NCT01349933||Single Group Assignment||Treatment||None (Open Label)||||||
1472055|NCT01349920|||Cohort||Prospective|||||||
1472056|NCT01349907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472057|NCT01349894|||Cohort|||||||||
1472058|NCT01349881|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1472059|NCT01349868|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1472060|NCT01349855|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1472061|NCT01349842|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1472062|NCT01349829|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472063|NCT01349816|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1472064|NCT01349803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472065|NCT01349790||Single Group Assignment||Treatment||None (Open Label)||||||
1472066|NCT01349777|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472067|NCT01349764|||Cohort||Prospective|||||||
1472068|NCT01349751|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1472069|NCT01349738|||Case Control||Prospective|||||||
1472070|NCT01349725|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1472071|NCT01349712|||Case-Only||Prospective|||||||
1472072|NCT01349699|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1472073|NCT01349686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472074|NCT01349673||Single Group Assignment||Treatment||None (Open Label)||||||
1472075|NCT01349660||Single Group Assignment||Treatment||None (Open Label)||||||
1472076|NCT01349647|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472077|NCT01349634|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472078|NCT01349621|||||Prospective|||||||
1472079|NCT01349608||Single Group Assignment||Treatment||None (Open Label)||||||
1472080|NCT01349595|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472081|NCT01349582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472082|NCT01349569||Single Group Assignment||Treatment||None (Open Label)||||||
1472083|NCT01349556||Single Group Assignment||Prevention||None (Open Label)||||||
1472084|NCT01349543|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1472085|NCT01349530|Randomized|Crossover Assignment||||None (Open Label)||||||
1472086|NCT01349517|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472087|NCT01349504|||Cohort||Prospective|||||||
1472088|NCT01349491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472089|NCT01349478||Single Group Assignment||Supportive Care||None (Open Label)||||||
1472090|NCT01349465|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1472091|NCT01349452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472092|NCT01349439|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472093|NCT01349426|Randomized|Parallel Assignment||||None (Open Label)||||||
1472094|NCT01349413|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1472095|NCT01349400|Randomized|Parallel Assignment||Treatment||Single||Watchful waiting vs. surgical repair||||t
1472096|NCT01349387||Single Group Assignment||Basic Science||None (Open Label)||||||
1472097|NCT01349374|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1472098|NCT01349361||||||||||||
1472099|NCT01349348|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472100|NCT01349335|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472101|NCT01349322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472102|NCT01349309|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1472103|NCT01349296||Single Group Assignment||Treatment||None (Open Label)||||||
1472104|NCT01349283|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1472105|NCT01349270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472106|NCT01349257|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472107|NCT01349244|||Case-Only||Prospective|||||||
1472108|NCT01349231||Single Group Assignment||Treatment||None (Open Label)||||||
1472109|NCT01349218||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472110|NCT01349205|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1472111|NCT01349192|Randomized|Parallel Assignment||Treatment||Single|Although this is an open-label study, the PIs and operational study team will remain blinded to the study arm assignments of the aggregate study population and will not view aggregate study results by study arm until after database lock.||||t|
1472112|NCT01349179|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472113|NCT01349166|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1472114|NCT01349153|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472115|NCT01349140|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1472116|NCT01349127|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1472117|NCT01349114|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1472118|NCT01349101|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472119|NCT01349088||Single Group Assignment||Treatment||None (Open Label)||||||
1472120|NCT01349075|||Cohort||Prospective|||||||
1472121|NCT01349062||Single Group Assignment||Treatment||None (Open Label)||Open Label||||
1472122|NCT01349049|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472123|NCT01349036|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472124|NCT01349023|Randomized|Crossover Assignment||||Single|||t|||
1472125|NCT01349010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472126|NCT01348997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472127|NCT01348984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472128|NCT01348971|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1472129|NCT01348958||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472130|NCT01348945|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1472131|NCT01348932|||Case Control||Retrospective|||||||
1472132|NCT01348919||Single Group Assignment||Treatment||None (Open Label)||||||
1472133|NCT01348906|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1472134|NCT01348893|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472135|NCT01348880|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1472136|NCT01348867|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472137|NCT01348854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472138|NCT01348841|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1472139|NCT01348828||Single Group Assignment||Treatment||None (Open Label)||||||
1472140|NCT01348802|Randomized|Crossover Assignment||Health Services Research||Double|||||t|t
1472141|NCT01348789||Single Group Assignment||Treatment||None (Open Label)||||||
1472142|NCT01348776||Single Group Assignment||Treatment||None (Open Label)||||||
1472143|NCT01348763||Single Group Assignment||||None (Open Label)||||||
1472144|NCT01348750|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472145|NCT01348737|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1472146|NCT01348724||Crossover Assignment||Basic Science||None (Open Label)||||||
1472147|NCT01348711|||Cohort||Prospective|||||||
1472148|NCT01348698|||Cohort||Prospective|||||||
1472149|NCT01348685|Randomized|Crossover Assignment||Prevention||Single|||t|||
1472150|NCT01348672|||Cohort||Prospective|||||||
1472151|NCT01348659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472152|NCT01348646|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1472153|NCT01348633|||Cohort||Prospective|||||||
1472154|NCT01348620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472155|NCT01348607|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1472156|NCT01348594|||Cohort||Prospective|||||||
1472157|NCT01348581||Single Group Assignment||Treatment||None (Open Label)||||||
1472859|NCT01339403|||Cohort||Prospective|||||||
1472158|NCT01348568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472159|NCT01348555|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1472160|NCT01348542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472161|NCT01348529||Single Group Assignment||Treatment||None (Open Label)||||||
1472162|NCT01348516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472163|NCT01348503||Single Group Assignment||Treatment||None (Open Label)||||||
1472164|NCT01348490||Single Group Assignment||Treatment||None (Open Label)||||||
1472165|NCT01348477|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1472166|NCT01348464|||Cohort||Prospective|||||||
1472167|NCT01348451||Single Group Assignment||Treatment||None (Open Label)||||||
1472168|NCT01348438||Single Group Assignment||Treatment||None (Open Label)||||||
1472169|NCT01348425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472170|NCT01348412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472171|NCT01348399|||Cohort||Prospective|||||||
1472172|NCT01348386|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472173|NCT01348373|||Cohort||Prospective|||||||
1472174|NCT01348360|||Cohort||Prospective|||||||
1472175|NCT01348347||Single Group Assignment||Treatment||None (Open Label)||||||
1472176|NCT01348334|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472177|NCT01348321|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472178|NCT01348308|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472179|NCT01348295|||Case-Only||Prospective|||||||
1472180|NCT01348282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472181|NCT01348269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472182|NCT01348256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472183|NCT01348243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472184|NCT01348230|||Cohort||Prospective|||||||
1472185|NCT01348217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472186|NCT01348204||Single Group Assignment||Basic Science||None (Open Label)||||||
1472187|NCT01348191|||Cohort||Prospective|||||||
1472188|NCT01348178|||Cohort||Retrospective|||||||
1472189|NCT01348165|Randomized|Single Group Assignment||Treatment||Single||||||
1472190|NCT01348152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472191|NCT01348139|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1472192|NCT01348126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472193|NCT01348113|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472194|NCT01348100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472195|NCT01348087||Single Group Assignment||Treatment||None (Open Label)||||||
1472196|NCT01348074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472197|NCT01348061|||Case Control||Prospective|||||||
1472198|NCT01348048|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472199|NCT01348035|||Case-Control||Prospective|||||||
1472200|NCT01348022|||Cohort||Prospective|||||||
1472201|NCT01348009||Single Group Assignment||Treatment||None (Open Label)||||||
1472202|NCT01347996||Single Group Assignment||Treatment||None (Open Label)||||||
1472203|NCT01347983|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472204|NCT01347970|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1472205|NCT01347957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472206|NCT01347944|||Cohort|||||||||
1472207|NCT01347931|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472208|NCT01347918|||Case Control||Prospective|||||||
1472209|NCT01347905|||Cohort||Prospective|||||||
1472210|NCT01347892|||Cohort||Other|||||||
1472211|NCT01347879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472212|NCT01347866|Non-Randomized|||Basic Science||None (Open Label)||||||
1472213|NCT01347853|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472214|NCT01347840|||Case-Only||Prospective|||||||
1472215|NCT01347827|||||Prospective|||||||
1472216|NCT01347814|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1472217|NCT01347801|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1472218|NCT01347788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472219|NCT01347775|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472220|NCT01347762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472221|NCT01347749|Randomized|Parallel Assignment||Treatment||Single||||||t
1472222|NCT01347736||Single Group Assignment||Treatment||None (Open Label)||||||
1472223|NCT01347723||Single Group Assignment||Supportive Care||None (Open Label)||||||
1472224|NCT01347710||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472225|NCT01347697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472226|NCT01347684|Randomized|Parallel Assignment||Treatment||Single||||||t
1472227|NCT01347671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472228|NCT01347658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472229|NCT01347645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472230|NCT01347632||Single Group Assignment||Prevention||None (Open Label)|This is an open label study - there was no masking|Open Label||||
1472231|NCT01347619|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1472232|NCT01347606|||||Prospective|||||||
1472233|NCT01347593|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472234|NCT01347580|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472235|NCT01347567|Randomized|Parallel Assignment||||Single|||t|||
1472236|NCT01347554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472237|NCT01347541|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1472238|NCT01347528|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472239|NCT01347515|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1472240|NCT01347502|||Cohort||Prospective|||||||
1472241|NCT01347489|||||Prospective|||||||
1472242|NCT01347476|||Case Control||Retrospective|||||||
1472243|NCT01347463||Single Group Assignment||Treatment||None (Open Label)||||||
1472244|NCT01347450|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1472245|NCT01347437|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472246|NCT01347424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472247|NCT01347411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472248|NCT01347398|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1472249|NCT01347385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472250|NCT01347372||Single Group Assignment||Health Services Research||||||||
1472251|NCT01347359|Randomized|Crossover Assignment||Health Services Research||Double||||t||t
1472252|NCT01347346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472253|NCT01347333|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472254|NCT01347320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472255|NCT01347307|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472256|NCT01347294|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1472257|NCT01347281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472258|NCT01347268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472259|NCT01347255|Randomized|Single Group Assignment||||Single|||||t|
1472260|NCT01347242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472261|NCT01347229|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1472262|NCT01347216|||Cohort||Prospective|||||||
1472263|NCT01347203|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472264|NCT01347190|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472265|NCT01347177|Randomized|Parallel Assignment||||None (Open Label)||||||
1472266|NCT01347164|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472267|NCT01347151|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472268|NCT01347138|Randomized|Parallel Assignment||Screening||Single||||||t
1472269|NCT01347125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472270|NCT01347112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472271|NCT01347099|Randomized|Parallel Assignment||Treatment||Single||||||t
1472272|NCT01347086|Randomized|Parallel Assignment||Treatment||Double||||||
1472273|NCT01347073||Single Group Assignment||Treatment||None (Open Label)||||||
1472274|NCT01347060|||Cohort||Retrospective|||||||
1472275|NCT01347047|||Ecologic or Community||Prospective|||||||
1472276|NCT01347034|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472277|NCT01347021|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1472278|NCT01347008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472279|NCT01346995|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1472280|NCT01346982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472281|NCT01346969|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1472282|NCT01346956|||Case-Only||Prospective|||||||
1472283|NCT01346943|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472284|NCT01346930||Single Group Assignment||Treatment||None (Open Label)||||||
1472285|NCT01346917|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1472286|NCT01346904|||Case Control||Cross-Sectional|||||||
1472287|NCT01346891|||Case Control||Retrospective|||||||
1472288|NCT01346878|||Cohort||Retrospective|||||||
1472289|NCT01346865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472290|NCT01346852|||Cohort||Retrospective|||||||
1472291|NCT01346839|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1472292|NCT01346826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472293|NCT01346813|||Cohort||Prospective|||||||
1472294|NCT01346800|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1472295|NCT01346787||Single Group Assignment||Treatment||None (Open Label)||||||
1472296|NCT01346774|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1472297|NCT01346761|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1472298|NCT01346748|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1472299|NCT01346735|||Case-Only||Prospective|||||||
1472300|NCT01346722|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1472301|NCT01346709|||Cohort||Prospective|||||||
1472302|NCT01346696||Single Group Assignment||Treatment||None (Open Label)||||||
1472303|NCT01346683||Single Group Assignment||Treatment||None (Open Label)||||||
1472304|NCT01346670|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472305|NCT01346657|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472306|NCT01346644|Randomized|Parallel Assignment||||Double|||t||t|
1472307|NCT01346631||Single Group Assignment||Treatment||None (Open Label)||||||
1472308|NCT01346618|||||Cross-Sectional|||||||
1472309|NCT01346605|||||Prospective|||||||
1472310|NCT01346592|Randomized|Parallel Assignment||Prevention||Single|||||t|
1472311|NCT01346579|||Case-Only||Retrospective|||||||
1472312|NCT01346566||Single Group Assignment||Treatment||None (Open Label)||||||
1473089|NCT01336231|||Cohort||Prospective|||||||
1472313|NCT01346553||Single Group Assignment||Treatment||None (Open Label)||||||
1472314|NCT01346540|Randomized|Parallel Assignment||Treatment||Double||||||
1472315|NCT01346527|||Case-Control||Cross-Sectional|||||||
1472316|NCT01346514|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1472317|NCT01346501|||Cohort||Prospective|||||||
1472318|NCT01346488|||Cohort||Prospective|||||||
1472319|NCT01346475|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472320|NCT01346462|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1472321|NCT01346449|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1472322|NCT01346436|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1472323|NCT01346423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472324|NCT01346410||Single Group Assignment||Treatment||None (Open Label)||||||
1472325|NCT01346397|||Case Control||Prospective|||||||
1472326|NCT01346384|||Cohort||Prospective|||||||
1472327|NCT01346371|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472328|NCT01346358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472329|NCT01346345|||Case-Only||Prospective|||||||
1472330|NCT01346332||||||||||||
1472331|NCT01346319|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472332|NCT01346306|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1472333|NCT01346293|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472334|NCT01346280|||||Other|||||||
1472335|NCT01346267|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1472336|NCT01346254|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472337|NCT01346241||Single Group Assignment||Treatment||None (Open Label)||||||
1472338|NCT01346228||Single Group Assignment||Treatment||None (Open Label)||||||
1472339|NCT01346215|Randomized|Parallel Assignment||Prevention||Single|||||t|
1472340|NCT01346202|||Cohort||Retrospective|||||||
1472341|NCT01346189|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1472342|NCT01346176|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1472343|NCT01346163|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1472344|NCT01346150|||Cohort||Retrospective|||||||
1472345|NCT01346137|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1472346|NCT01346124||Single Group Assignment||Treatment||None (Open Label)||||||
1472347|NCT01346111|||Cohort||Prospective|||||||
1472348|NCT01346098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472349|NCT01346085||Single Group Assignment||Treatment||None (Open Label)||||||
1472350|NCT01346072||Single Group Assignment||Treatment||None (Open Label)||||||
1472351|NCT01346059|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1472352|NCT01346046|||Cohort||Cross-Sectional|||||||
1472353|NCT01346033|||Cohort||Cross-Sectional|||||||
1472354|NCT01346020|||Cohort||Retrospective|||||||
1472355|NCT01346007|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472356|NCT01345994||||||||||||
1472357|NCT01345981|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1472358|NCT01345968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472359|NCT01345942|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1472360|NCT01345929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472361|NCT01345916|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472362|NCT01345903||Single Group Assignment||Treatment||None (Open Label)||||||
1472363|NCT01345890|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1472364|NCT01345877||Single Group Assignment||Basic Science||None (Open Label)||||||
1472365|NCT01345864|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1472366|NCT01345851||Single Group Assignment||Treatment||None (Open Label)||||||
1472367|NCT01345838|||Case Control||Prospective|||||||
1472368|NCT01345825|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472369|NCT01345812|Randomized|Parallel Assignment||Treatment||Single||||||t
1472370|NCT01345799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472371|NCT01345786|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1472372|NCT01345773|||Cohort||Prospective|||||||
1472373|NCT01345760|||Case-Only||Retrospective|||||||
1472374|NCT01345747|Randomized|Parallel Assignment||||Single||||||t
1472375|NCT01345734|||Cohort||Prospective|||||||
1472376|NCT01345721|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472377|NCT01345708||Single Group Assignment||Treatment||None (Open Label)||||||
1472378|NCT01345695|||Case Control||Prospective|||||||
1472379|NCT01345682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472380|NCT01345669|Randomized|Parallel Assignment||Treatment||Double||||||
1472381|NCT01345656|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472382|NCT01345643|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472383|NCT01345630|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1472384|NCT01345617|||Case-Control||Prospective|||||||
1472385|NCT01345604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472386|NCT01345591||Single Group Assignment||Treatment||None (Open Label)||||||
1472387|NCT01345578||Single Group Assignment||Treatment||None (Open Label)||||||
1472388|NCT01345565||Single Group Assignment||Treatment||None (Open Label)||||||
1472389|NCT01345552||Single Group Assignment||Treatment||None (Open Label)||||||
1472390|NCT01345539||Single Group Assignment||Treatment||None (Open Label)||||||
1472391|NCT01345526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472392|NCT01345513|||Cohort||Prospective|||||||
1472393|NCT01345500|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472394|NCT01345487|Randomized|Crossover Assignment||Prevention||Single||||||t
1472395|NCT01345461|||Cohort||Prospective|||||||
1472396|NCT01345448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472397|NCT01345435|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472398|NCT01345422||Single Group Assignment||Supportive Care||None (Open Label)||||||
1472399|NCT01345409|||Cohort||Prospective|||||||
1472400|NCT01345396|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472401|NCT01345383|||Case-Only||Prospective|||||||
1472402|NCT01345370|||||Prospective|||||||
1472403|NCT01345357||Single Group Assignment||Treatment||None (Open Label)||||||
1472404|NCT01345344|Randomized|Parallel Assignment||Other||Double|||||t|t
1472405|NCT01345331|Randomized|Crossover Assignment||Treatment||Single|||t|||
1472406|NCT01345318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472407|NCT01345305|||Case-Only||Prospective|||||||
1472408|NCT01345292|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1472409|NCT01345279|||Other||Retrospective|||||||
1472410|NCT01345266||Single Group Assignment||Other||None (Open Label)||||||
1472411|NCT01345253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472412|NCT01345240|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472413|NCT01345227|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472414|NCT01345214||Single Group Assignment||Treatment||None (Open Label)||||||
1472415|NCT01345201||Single Group Assignment||Treatment||None (Open Label)||||||
1472416|NCT01345188|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1472417|NCT01345175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472418|NCT01345162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472419|NCT01345149|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472420|NCT01345136||Single Group Assignment||Treatment||None (Open Label)||||||
1472421|NCT01345123|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1472422|NCT01345110|||Cohort||Prospective|||||||
1472423|NCT01345097|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472424|NCT01345084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472425|NCT01345071|||Cohort||Prospective|||||||
1472426|NCT01345058|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472427|NCT01345045|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472428|NCT01345032|Randomized|Factorial Assignment||Treatment||Single||||||t
1472429|NCT01345019|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1472430|NCT01345006||Single Group Assignment||Other||None (Open Label)||||||
1472431|NCT01344993||Single Group Assignment||Other||None (Open Label)||||||
1472432|NCT01344980|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472433|NCT01344967||Single Group Assignment||Prevention||None (Open Label)||||||
1472434|NCT01344954|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1472435|NCT01344941|||Case-Only||Prospective|||||||
1472436|NCT01344928||||||||||||
1472437|NCT01344915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472438|NCT01344902|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1472439|NCT01344889|||Cohort||Prospective|||||||
1472440|NCT01344876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472441|NCT01344863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472442|NCT01344837|||Cohort||Retrospective|||||||
1472443|NCT01344824||Single Group Assignment||Treatment||None (Open Label)||||||
1472444|NCT01344811|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472445|NCT01344798|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472446|NCT01344785|||Cohort||Cross-Sectional|||||||
1472447|NCT01344772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472448|NCT01344759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472449|NCT01344746|||Case Control||Prospective|||||||
1472450|NCT01344733|||||Prospective|||||||
1472451|NCT01344720|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472452|NCT01344707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472453|NCT01344694|||||Retrospective|||||||
1472454|NCT01344681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472455|NCT01344668|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1472456|NCT01344655|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1472457|NCT01344642|||Cohort||Prospective|||||||
1472458|NCT01344629|Randomized|Crossover Assignment||||None (Open Label)||||||
1472459|NCT01344616|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472460|NCT01344603|||Case Control||Retrospective|||||||
1472461|NCT01344590|Randomized|Single Group Assignment||||None (Open Label)||||||
1472462|NCT01344577|||Cohort||Prospective|||||||
1472463|NCT01344564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472464|NCT01344551|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1472465|NCT01344538|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1472466|NCT01344525|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1472467|NCT01344512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472468|NCT01344499|Randomized|Parallel Assignment||Prevention||Single|||t|||
1472469|NCT01344486|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1472470|NCT01344473|Randomized|Parallel Assignment||Treatment||Single||||||t
1472471|NCT01344460|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1473403|NCT01332136|||Cohort||Prospective|||||||
1472472|NCT01344447||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472473|NCT01344434|||||Retrospective|||||||
1472474|NCT01344421|||Cohort||Prospective|||||||
1472475|NCT01344408|Randomized|Parallel Assignment||Treatment||Single||||||t
1472476|NCT01344395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472477|NCT01344382|Randomized|Parallel Assignment||Treatment||Single||||||t
1472478|NCT01344369|Randomized|Crossover Assignment||||None (Open Label)||||||
1472479|NCT01344356|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472480|NCT01344343|Randomized|Parallel Assignment||||Single||||||t
1472481|NCT01344330|||||Prospective|||||||
1472482|NCT01344317|||Cohort||Prospective|||||||
1472483|NCT01344304|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472484|NCT01344291||Single Group Assignment||Treatment||None (Open Label)||||||
1472485|NCT01344278|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1472486|NCT01344265|||Cohort||Prospective|||||||
1472487|NCT01344252|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1472488|NCT01344239|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1472489|NCT01344226|||Case-Only||Prospective|||||||
1472490|NCT01344213|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1472491|NCT01344200|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472492|NCT01344187|Randomized|Parallel Assignment||Treatment||Single||||||t
1472493|NCT01344174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472494|NCT01344161|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1472495|NCT01344148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472496|NCT01344135|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472497|NCT01344122|Randomized|Parallel Assignment||||None (Open Label)||||||
1472498|NCT01344109|||Case-Control||Prospective|||||||
1472499|NCT01344096|||Case Control||Prospective|||||||
1472500|NCT01344083|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472501|NCT01344070|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1472502|NCT01344057||Single Group Assignment||Prevention||None (Open Label)||||||
1472503|NCT01344044|Randomized|Crossover Assignment||Treatment||Single||||||t
1472504|NCT01344031|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472505|NCT01344018|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472506|NCT01344005|Randomized|||Diagnostic||None (Open Label)||||||
1472507|NCT01343992|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472508|NCT01343979|||Case Control||Retrospective|||||||
1472509|NCT01343966|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472510|NCT01343953||Single Group Assignment||Treatment||None (Open Label)||||||
1472511|NCT01343940|Randomized|Parallel Assignment||Prevention||Single||||||t
1472512|NCT01343927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472513|NCT01343914|||Cohort||Retrospective|||||||
1472514|NCT01343901|||Cohort||Prospective|||||||
1472515|NCT01343888|Randomized|Parallel Assignment||Treatment||Double||||||
1472516|NCT01343875|||Case-Crossover||Retrospective|||||||
1472517|NCT01343862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472518|NCT01343849|||Cohort||Prospective|||||||
1472519|NCT01343836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472520|NCT01343823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472521|NCT01343810|Randomized|Single Group Assignment||Prevention||Single|||||t|
1472522|NCT01343797|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1472523|NCT01343784|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1472524|NCT01343771|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472525|NCT01343758|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472526|NCT01343745|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1472527|NCT01343732|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1472528|NCT01343719|Randomized|Parallel Assignment||||Double||||||
1472529|NCT01343706|Randomized|Parallel Assignment||Treatment||Double||||||
1472530|NCT01343693|||Case-Only||Prospective|||||||
1472531|NCT01343680|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1472532|NCT01343667|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472533|NCT01343654|Randomized|Parallel Assignment||Treatment||Single||||||t
1472534|NCT01343641|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1472535|NCT01343628|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1472536|NCT01343615|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472537|NCT01343602|Randomized|Parallel Assignment||Treatment||Single||||||t
1472538|NCT01343589|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1472539|NCT01343576|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1472540|NCT01343563|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1472541|NCT01343550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472542|NCT01343537||Single Group Assignment||Treatment||None (Open Label)||||||
1472543|NCT01343524||||||||||||
1472544|NCT01343511|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472545|NCT01343498||Single Group Assignment||Treatment||None (Open Label)||||||
1472546|NCT01343485|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472547|NCT01343472|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1472548|NCT01343459||Single Group Assignment||Treatment||None (Open Label)||||||
1472549|NCT01343446|||||Cross-Sectional|||||||
1472550|NCT01343433|||Cohort||Prospective|||||||
1472551|NCT01343420||Single Group Assignment||Other||Single|||t|||
1472552|NCT01343407|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1472553|NCT01343394||Single Group Assignment||Treatment||None (Open Label)||||||
1472554|NCT01343381|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472555|NCT01343368|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472556|NCT01343355||Single Group Assignment||Treatment||None (Open Label)||||||
1472557|NCT01343342||Single Group Assignment||Prevention||None (Open Label)||||||
1472558|NCT01343329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472559|NCT01343316|||Cohort||Prospective|||||||
1472560|NCT01343303|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472561|NCT01343290|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472562|NCT01343277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472563|NCT01343264|||Cohort||Prospective|||||||
1472564|NCT01343251|||Cohort||Prospective|||||||
1472565|NCT01343238|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1472566|NCT01343225|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1472567|NCT01343212|||Case-Only||Prospective|||||||
1472568|NCT01343186|Randomized|Parallel Assignment||||Triple|||t||t|t
1472569|NCT01343173||Single Group Assignment||Treatment||None (Open Label)||||||
1472570|NCT01343160||Single Group Assignment||Treatment||None (Open Label)||||||
1472571|NCT01343147|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472572|NCT01343134|||Cohort||Retrospective|||||||
1472573|NCT01343121||Single Group Assignment||||None (Open Label)||||||
1472574|NCT01343108|||||Prospective|||||||
1472575|NCT01343095|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472576|NCT01343082||Single Group Assignment||Treatment||None (Open Label)||||||
1472577|NCT01343069|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1472578|NCT01343056|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472579|NCT01343043|Non-Randomized|Parallel Assignment||Treatment||||||||
1472580|NCT01343030|||Case-Only||Retrospective|||||||
1472581|NCT01343017|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1472582|NCT01343004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472583|NCT01342991|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1472584|NCT01342978|||Cohort||Prospective|||||||
1472585|NCT01342965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472586|NCT01342952||Single Group Assignment||Treatment||None (Open Label)||||||
1472587|NCT01342939|||Cohort|||||||||
1472588|NCT01342926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472589|NCT01342913|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472590|NCT01342900|Randomized|Single Group Assignment||Prevention||Single|||t|||
1472591|NCT01342887||Single Group Assignment||Treatment||None (Open Label)||||||
1472592|NCT01342874|||Case Control||Prospective|||||||
1472593|NCT01342861|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472594|NCT01342848|||Cohort|||||||||
1472595|NCT01342835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472596|NCT01342822|||Case-Only||Prospective|||||||
1472597|NCT01342809|Randomized|Parallel Assignment||Treatment||Single||||||t
1472598|NCT01342796|Randomized|Parallel Assignment||Prevention||Single|||t|||
1472599|NCT01342783|||Case-Only||Retrospective|||||||
1472600|NCT01342770||Single Group Assignment||Treatment||None (Open Label)||||||
1472601|NCT01342757||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472602|NCT01342744|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1472603|NCT01342731||Single Group Assignment||Treatment||None (Open Label)||||||
1472604|NCT01342718|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472605|NCT01342705|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472606|NCT01342692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472607|NCT01342679||Single Group Assignment||Treatment||None (Open Label)||||||
1472608|NCT01342666|Randomized|Parallel Assignment||Treatment||Single||||||t
1472609|NCT01342653||Single Group Assignment||Treatment||None (Open Label)||||||
1472610|NCT01342640||Single Group Assignment||Treatment||None (Open Label)||||||
1472611|NCT01342627||Single Group Assignment||Treatment||None (Open Label)||||||
1472612|NCT01342614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472613|NCT01342601|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472614|NCT01342588||Single Group Assignment||Supportive Care||None (Open Label)||||||
1472615|NCT01342575||Single Group Assignment||Supportive Care||None (Open Label)||||||
1472616|NCT01342562|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1472617|NCT01342549|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1472618|NCT01342536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472619|NCT01342523|Randomized|Factorial Assignment||Treatment||Single|||t|||
1472620|NCT01342510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472621|NCT01342497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472622|NCT01342484|Randomized|Parallel Assignment||Treatment||Double||||||
1472623|NCT01342471|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472624|NCT01342458|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472625|NCT01342445||Single Group Assignment||Treatment||Double|||t|||t
1472626|NCT01342432|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1472627|NCT01342419|||Case-Crossover|||||||||
1472628|NCT01342406|||||Prospective|||||||
1472629|NCT01342393||||||||||||
1472630|NCT01342380|||||Retrospective|||||||
1472631|NCT01342367||Single Group Assignment||Treatment||None (Open Label)||||||
1472632|NCT01342354||Single Group Assignment||Treatment||None (Open Label)||||||
1472633|NCT01342341|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1472634|NCT01342328|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1472635|NCT01342315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472636|NCT01342302||Single Group Assignment||Supportive Care||None (Open Label)||||||
1472637|NCT01342289|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Participants were initially enrolled on the 90-day arm. When that arm completed enrollment, participants were enrolled on the 120-day arm while safety of the 90-day arm was evaluated. The 90-day arm was found to be safe, so participants were then enrolled on the 60-day arm for the remainder of the study.||||
1472638|NCT01342276|Randomized|Parallel Assignment||Treatment||Single||||||t
1472639|NCT01342263|Randomized|Parallel Assignment||Treatment||Single||||||t
1472640|NCT01342250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472641|NCT01342237||Single Group Assignment||Treatment||None (Open Label)||||||
1472642|NCT01342224||Single Group Assignment||Other||None (Open Label)||||||
1472643|NCT01342211|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472644|NCT01342198|Randomized|Crossover Assignment||||None (Open Label)||||||
1472645|NCT01342185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472646|NCT01342172||Single Group Assignment||Treatment||None (Open Label)||||||
1472647|NCT01342159|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472648|NCT01342146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472649|NCT01342133||||||||||||
1472650|NCT01342120|||Cohort||Retrospective|||||||
1472651|NCT01342107|Randomized|Single Group Assignment||Supportive Care||Double|||||t|t
1472652|NCT01342094||Parallel Assignment||Treatment||Triple|||t||t|t
1472653|NCT01342081||Parallel Assignment||Treatment||Triple|||t||t|t
1472654|NCT01342068|||Case Control||Retrospective|||||||
1472655|NCT01342055|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472656|NCT01342042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472657|NCT01342029|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1472658|NCT01342016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472659|NCT01342003|||Cohort||Retrospective|||||||
1472660|NCT01341990|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1472661|NCT01341977|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1472662|NCT01341964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472663|NCT01341951|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472664|NCT01341938|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472665|NCT01341925|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1472666|NCT01341912||Single Group Assignment||Treatment||None (Open Label)||||||
1472667|NCT01341899||Single Group Assignment||Treatment||None (Open Label)||||||
1472668|NCT01341886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472669|NCT01341873|Randomized|Parallel Assignment||Supportive Care||Single||||||
1472670|NCT01341860|||Case Control||Prospective|||||||
1472671|NCT01341847|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1472672|NCT01341834||Single Group Assignment||Other||None (Open Label)||||||
1472673|NCT01341821|||||Retrospective|||||||
1472674|NCT01341808||Single Group Assignment||Prevention||None (Open Label)||||||
1472675|NCT01341795|||||Retrospective|||||||
1472676|NCT01341782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472677|NCT01341769|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1472678|NCT01341756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472679|NCT01341743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472680|NCT01341730|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472681|NCT01341717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472682|NCT01341704|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1472683|NCT01341691|Non-Randomized|Parallel Assignment||||Single|||t|||
1472684|NCT01341678|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1472685|NCT01341665|||Cohort||Prospective|||||||
1472686|NCT01341652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472687|NCT01341639|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1472688|NCT01341626|Randomized|Parallel Assignment||Prevention||Single||||||t
1472689|NCT01341613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472690|NCT01341600|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472691|NCT01341587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472692|NCT01341574|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472693|NCT01341561|||Cohort||Prospective|||||||
1472694|NCT01341548|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1472695|NCT01341535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472696|NCT01341522|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1472697|NCT01341509|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472698|NCT01341496||Single Group Assignment||Treatment||None (Open Label)||||||
1472699|NCT01341483|||Cohort||Prospective|||||||
1472700|NCT01341470|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1472701|NCT01341457||Single Group Assignment||Treatment||None (Open Label)||||||
1472702|NCT01341444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472703|NCT01341431|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1472704|NCT01341418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472705|NCT01341405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472706|NCT01341392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472707|NCT01341379||Single Group Assignment||Treatment||None (Open Label)||||||
1472708|NCT01341366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472709|NCT01341353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472710|NCT01341340||Single Group Assignment||Treatment||None (Open Label)||||||
1472711|NCT01341327|||Cohort||Prospective|||||||
1472712|NCT01341314|||Cohort||Prospective|||||||
1472713|NCT01341301||Single Group Assignment||Treatment||None (Open Label)||||||
1472714|NCT01341288||Single Group Assignment||Treatment||None (Open Label)||||||
1472715|NCT01341275|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472716|NCT01341262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472717|NCT01341249|Randomized|Crossover Assignment||||None (Open Label)||||||
1472718|NCT01341236|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472719|NCT01341223||||||||||||
1472720|NCT01341210|||Case-Only||Cross-Sectional|||||||
1472721|NCT01341197|||Cohort||Prospective|||||||
1472722|NCT01341184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472723|NCT01341171||||||||||||
1472724|NCT01341158|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472725|NCT01341145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472726|NCT01341132|||Cohort||Prospective|||||||
1472727|NCT01341119|||Cohort||Retrospective|||||||
1472728|NCT01341106||Single Group Assignment||||None (Open Label)||||||
1472729|NCT01341093|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472730|NCT01341080|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472731|NCT01341067|||Cohort||Prospective|||||||
1472732|NCT01341054|Randomized|Parallel Assignment||Treatment||Single||||||t
1472733|NCT01341041|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472734|NCT01341028|Randomized|Parallel Assignment||Basic Science||Single||||||t
1472735|NCT01341015||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472736|NCT01341002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472737|NCT01340989|Randomized|Parallel Assignment||Prevention||Single|||t|||
1472738|NCT01340976|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1472739|NCT01340963|||Cohort||Prospective|||||||
1472740|NCT01340950|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472741|NCT01340937|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1472742|NCT01340924|||Cohort||Prospective|||||||
1472743|NCT01340911|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1472744|NCT01340898|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472745|NCT01340885|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472746|NCT01340872|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472747|NCT01340859|Randomized|Parallel Assignment||Treatment||Single||||||t
1472748|NCT01340846|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472749|NCT01340833||Single Group Assignment||Treatment||None (Open Label)||||||
1472750|NCT01340820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472751|NCT01340807|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472752|NCT01340794||Single Group Assignment||Treatment||None (Open Label)||||||
1472753|NCT01340781|||Cohort||Prospective|||||||
1472754|NCT01340768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472755|NCT01340755||Single Group Assignment||Treatment||None (Open Label)||||||
1472756|NCT01340742|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1472757|NCT01340729||Single Group Assignment||Treatment||None (Open Label)||||||
1472758|NCT01340716|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472759|NCT01340703||Single Group Assignment||Treatment||None (Open Label)||||||
1472760|NCT01340690|Randomized|Parallel Assignment||Treatment||Quadruple|"The verum nutrional supplementation is completely masked and an appropriate Placebo is provided. Up to know, none of the above mentioned is unblinded"|We use the dietary supplementation like a medication and performed the study like a phase 3 medication study, because the dietary supplementation (verum) is available as special preparation in drug stores.|t|t|t|t
1472761|NCT01340677||Crossover Assignment||||None (Open Label)||||||
1472762|NCT01340664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472763|NCT01340651||Single Group Assignment||Treatment||None (Open Label)||||||
1472764|NCT01340638|Randomized|Parallel Assignment||||Double|||t|||t
1472765|NCT01340625|Randomized|Crossover Assignment||||None (Open Label)||||||
1472766|NCT01340612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472767|NCT01340599|Randomized|Parallel Assignment||Treatment||Double||||||
1472768|NCT01340586|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1472769|NCT01340573|||Cohort||Prospective|||||||
1472770|NCT01340560|Randomized|Crossover Assignment||Treatment||Single|||t|||
1472771|NCT01340547||Single Group Assignment||Treatment||None (Open Label)||||||
1472772|NCT01340534|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472773|NCT01340521||Single Group Assignment||Treatment||None (Open Label)||||||
1472774|NCT01340508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472775|NCT01340495||Single Group Assignment||Treatment||None (Open Label)||||||
1472776|NCT01340482||Single Group Assignment||Treatment||None (Open Label)||||||
1472777|NCT01340469|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472778|NCT01340456|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1472779|NCT01340443|||Cohort||Prospective|||||||
1472780|NCT01340430||Single Group Assignment||Treatment||None (Open Label)||||||
1472781|NCT01340417||Single Group Assignment||Screening||None (Open Label)||||||
1472782|NCT01340404|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472783|NCT01340391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472784|NCT01340378|||Case-Only||Prospective|||||||
1472785|NCT01340365|Randomized|Parallel Assignment||Prevention||Single||||||t
1472786|NCT01340352|||Cohort||Prospective|||||||
1472787|NCT01340339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472788|NCT01340326|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472789|NCT01340313|||||Prospective|||||||
1472790|NCT01340300|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1472791|NCT01340287|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1472792|NCT01340274|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472793|NCT01340261|||Case-Only||Prospective|||||||
1472794|NCT01340248|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472795|NCT01340235||Single Group Assignment||Treatment||None (Open Label)||||||
1472796|NCT01340222||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472797|NCT01340209|Randomized|Parallel Assignment||Treatment||Double||||||
1472798|NCT01340196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472799|NCT01340183|Randomized|Single Group Assignment||Basic Science||Triple|||t|t|t|
1472800|NCT01340170|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472801|NCT01340157|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1472802|NCT01340144|||Case Control||Prospective|||||||
1472803|NCT01340131|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472804|NCT01340118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472805|NCT01340105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472806|NCT01340092|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1472807|NCT01340079|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1472808|NCT01340066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472809|NCT01340053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472810|NCT01340040|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472811|NCT01340027|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1472812|NCT01340014|Randomized|Crossover Assignment||Treatment||Single|||t|||
1472813|NCT01340001|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1472814|NCT01339988||Single Group Assignment||Treatment||None (Open Label)||||||
1472815|NCT01339975|||Cohort||Prospective|||||||
1472816|NCT01339962|||Cohort||Retrospective|||||||
1472817|NCT01339949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472818|NCT01339936||Single Group Assignment||Basic Science||None (Open Label)||||||
1472819|NCT01339923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472820|NCT01339910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472821|NCT01339897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472822|NCT01339884|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472823|NCT01339871||Single Group Assignment||Treatment||None (Open Label)||||||
1472824|NCT01339858|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1472825|NCT01339845|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1472826|NCT01339832|||Cohort||Retrospective|||||||
1472827|NCT01339819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472828|NCT01339806|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1472829|NCT01339793|||||Prospective|||||||
1472830|NCT01339780|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1472831|NCT01339767|||||Prospective|||||||
1472832|NCT01339754||Single Group Assignment||Treatment||None (Open Label)||||||
1472833|NCT01339741|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1472834|NCT01339728|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1472835|NCT01339715|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1472836|NCT01339702|||Cohort||Other|||||||
1472837|NCT01339689|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472838|NCT01339676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472839|NCT01339663||Single Group Assignment||Treatment||None (Open Label)||||||
1472840|NCT01339650||Single Group Assignment||Treatment||None (Open Label)||||||
1472841|NCT01339637|||Cohort||Cross-Sectional|||||||
1472842|NCT01339624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472843|NCT01339611|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472844|NCT01339598|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1472845|NCT01339585|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1472846|NCT01339572|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472847|NCT01339559||Single Group Assignment||Treatment||None (Open Label)||||||
1472848|NCT01339546|||Ecologic or Community||Retrospective|||||||
1472849|NCT01339533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472850|NCT01339520|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1472851|NCT01339507|||Case Control||Prospective|||||||
1472852|NCT01339494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472853|NCT01339481|||Cohort||Prospective|||||||
1472854|NCT01339468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472855|NCT01339455||Single Group Assignment||Treatment||None (Open Label)||||||
1472856|NCT01339442|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472857|NCT01339429||Single Group Assignment||Treatment||None (Open Label)||||||
1472860|NCT01339390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472861|NCT01339377||Single Group Assignment||Treatment||None (Open Label)||||||
1472862|NCT01339364|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1472863|NCT01339351|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472864|NCT01339338|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1472865|NCT01339325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472866|NCT01339312|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1472867|NCT01339299|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1472868|NCT01339286||Single Group Assignment||Basic Science||None (Open Label)||||||
1472869|NCT01339273|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1472870|NCT01339260|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1472871|NCT01339247|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1472872|NCT01339234||Single Group Assignment||||None (Open Label)||||||
1472873|NCT01339221|||Case-Only|||||||||
1472874|NCT01339208|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1472875|NCT01339195||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472876|NCT01339182|Randomized|Crossover Assignment||||None (Open Label)||||||
1472877|NCT01339169||Single Group Assignment||Treatment||None (Open Label)||||||
1472878|NCT01339156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472879|NCT01339143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472880|NCT01339130||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472881|NCT01339117|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1472882|NCT01339104||Single Group Assignment||Treatment||None (Open Label)||||||
1472883|NCT01339091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472884|NCT01339078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472885|NCT01339065|Randomized|Parallel Assignment||||Triple|||t|t|t|
1472886|NCT01339052|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472887|NCT01339039|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472888|NCT01339026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472889|NCT01339013||Single Group Assignment||Basic Science||None (Open Label)||||||
1472890|NCT01339000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472891|NCT01338987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472892|NCT01338974|||||Retrospective|||||||
1472893|NCT01338961|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472894|NCT01338948||Single Group Assignment||Treatment||||||||
1472895|NCT01338935|Randomized|Single Group Assignment||||None (Open Label)||||||
1472896|NCT01338922|Randomized|Parallel Assignment||Treatment||None (Open Label)||open multicentre parallel randomised controlled intervention trial with waiting-list-control-group||||
1472897|NCT01338909|Randomized|Parallel Assignment||Treatment||Single||||||t
1472898|NCT01338896|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1472899|NCT01338883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472900|NCT01338870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472901|NCT01338857||Single Group Assignment||Treatment||None (Open Label)||||||
1472902|NCT01338844|Randomized|Parallel Assignment||||Double|||t||t|
1472903|NCT01338831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472904|NCT01338818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472905|NCT01338805|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472906|NCT01338792|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472907|NCT01338779|||Cohort||Prospective|||||||
1472908|NCT01338766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472909|NCT01338753||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472910|NCT01338740|||Case-Only||Prospective|||||||
1472911|NCT01338727|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1472912|NCT01338714|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1472913|NCT01338701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472914|NCT01338688|||Case Control||Prospective|||||||
1472915|NCT01338675||Single Group Assignment||Treatment||None (Open Label)||||||
1472916|NCT01338662|||Case-Control||Prospective|||||||
1472917|NCT01338649|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472918|NCT01338636||Single Group Assignment||Treatment||None (Open Label)||||||
1472919|NCT01338623|Randomized|Crossover Assignment||||None (Open Label)||||||
1472920|NCT01338610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472921|NCT01338597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472922|NCT01338584|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1472923|NCT01338571|||Case Control||Prospective|||||||
1472924|NCT01338558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472925|NCT01338545|||Cohort||Prospective|||||||
1472926|NCT01338532|Randomized|Parallel Assignment||Treatment||Single||||||t
1472927|NCT01338519|||Cohort||Prospective|||||||
1472928|NCT01338506|Randomized|Parallel Assignment||Treatment||Single||||||t
1472929|NCT01338493|||Case-Only||Prospective|||||||
1472930|NCT01338480|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1472931|NCT01338467|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472932|NCT01338454|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1472933|NCT01338441|Randomized|Crossover Assignment||||Triple|||t||t|t
1472934|NCT01338428|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472935|NCT01338415|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472936|NCT01338402|Randomized|Single Group Assignment||||Single||||||t
1472937|NCT01338389|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1472938|NCT01338376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472939|NCT01338363|||Cohort|||||||||
1472940|NCT01338350|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1472941|NCT01338337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472942|NCT01338324|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1472943|NCT01338311|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1472944|NCT01338298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472945|NCT01338285|||Other||Cross-Sectional|||||||
1472946|NCT01338142|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1472947|NCT01338129|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1472948|NCT01338116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472949|NCT01338103||Single Group Assignment||Treatment||None (Open Label)||||||
1472950|NCT01338090|||Cohort||Prospective|||||||
1472951|NCT01338077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1472952|NCT01338064|||||Cross-Sectional|||||||
1472953|NCT01338051||Single Group Assignment||Prevention||None (Open Label)||||||
1472954|NCT01338025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472955|NCT01338012||Single Group Assignment||Treatment||None (Open Label)||||||
1472956|NCT01337999|||Cohort||Prospective|||||||
1472957|NCT01337986|Randomized|Crossover Assignment||Treatment||Single|||t|||
1472958|NCT01337973|Randomized|Factorial Assignment||Treatment||Single||||||t
1472959|NCT01337960|Randomized|Parallel Assignment||||Single||||||t
1472960|NCT01337947|||Cohort||Prospective|||||||
1472961|NCT01337934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472962|NCT01337921|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1472963|NCT01337908|||Cohort||Retrospective|||||||
1472964|NCT01337895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472965|NCT01337882|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1472966|NCT01337869|Randomized|Parallel Assignment||Treatment||Single|||t|||
1472967|NCT01337856|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1472968|NCT01337843|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1472969|NCT01337830|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1472970|NCT01337817|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1472971|NCT01337804|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1472972|NCT01337791|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472973|NCT01337778|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1472974|NCT01337765||Single Group Assignment||Treatment||None (Open Label)||||||
1472975|NCT01337752|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1472976|NCT01337739|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1472977|NCT01337726|Randomized|Parallel Assignment||Treatment||Single||||||t
1472978|NCT01337713|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1472979|NCT01337700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472980|NCT01337687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1472981|NCT01337674|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1472982|NCT01337661|||Case-Only||Prospective|||||||
1472983|NCT01337648|||Case-Only||Prospective|||||||
1472984|NCT01337635|Randomized|Parallel Assignment||Treatment||Single|||||t|
1472985|NCT01337622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1472986|NCT01337609|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1472987|NCT01337596|Randomized|Parallel Assignment||||Double|||t||t|
1472988|NCT01337583|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1472989|NCT01337570|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1472990|NCT01337557|Randomized|Crossover Assignment||Treatment||Single|||||t|
1472991|NCT01337544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472992|NCT01337531|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1472993|NCT01337518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1472994|NCT01337505||Single Group Assignment||Treatment||None (Open Label)||||||
1472995|NCT01337492||Single Group Assignment||Treatment||None (Open Label)||||||
1472996|NCT01337479|||Case-Only||Prospective|||||||
1472997|NCT01337466||Single Group Assignment||Diagnostic||None (Open Label)||||||
1472998|NCT01337453|||Cohort||Prospective|||||||
1472999|NCT01337440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473000|NCT01337427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473001|NCT01337414|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Patient education and self-monitoring vs. customary care||||
1473002|NCT01337401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473003|NCT01337388|||Cohort||Prospective|||||||
1473004|NCT01337375|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473005|NCT01337362|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473006|NCT01337349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473007|NCT01337336|||Cohort||Retrospective|||||||
1473008|NCT01337323|||Cohort||Prospective|||||||
1473009|NCT01337310||Single Group Assignment||Treatment||None (Open Label)||||||
1473010|NCT01337297|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473011|NCT01337271|Randomized|Crossover Assignment||Screening||Double|||t|t||
1473012|NCT01337258|||Cohort||Retrospective|||||||
1473013|NCT01337245||Single Group Assignment||Treatment||None (Open Label)||||||
1473014|NCT01337232|Randomized|Parallel Assignment||Treatment||Single||||||t
1473015|NCT01337219|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473016|NCT01337206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473017|NCT01337193|Randomized|Parallel Assignment||Treatment||Single||||||t
1473018|NCT01337180|||Cohort||Prospective|||||||
1473019|NCT01337167|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473020|NCT01337154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473021|NCT01337141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473022|NCT01337128|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1473023|NCT01337115|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1473024|NCT01337102|Randomized|Single Group Assignment||Supportive Care||Single|||||t|
1473025|NCT01337089||Single Group Assignment||Treatment||None (Open Label)||||||
1473026|NCT01337076||Single Group Assignment||Treatment||None (Open Label)||||||
1473027|NCT01337063|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1473028|NCT01337050|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1473029|NCT01337037|||Case Control||Prospective|||||||
1473030|NCT01337024|||Case Control||Prospective|||||||
1473031|NCT01337011|Randomized|Parallel Assignment||Treatment||Double||Comparison of the effect of CD133pos. bone marrow derived stem cells using the intra-myocardial vs. the intra-coronary route of administration for improving left ventricular function in patients with chronic ischemic cardiomopathy.|t|||t
1473032|NCT01336998|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1473033|NCT01336985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473034|NCT01336972|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473035|NCT01336959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473036|NCT01336946|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473037|NCT01336933||Single Group Assignment||Treatment||None (Open Label)||||||
1473038|NCT01336920||Single Group Assignment||Treatment||None (Open Label)||||||
1473039|NCT01336907|||Cohort||Prospective|||||||
1473040|NCT01336894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473041|NCT01336881|||||Retrospective|||||||
1473042|NCT01336868||||||||||||
1473043|NCT01336855|||Cohort||Prospective|||||||
1473044|NCT01336842||Single Group Assignment||Treatment||None (Open Label)||||||
1473045|NCT01336829|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473046|NCT01336816|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1473047|NCT01336803|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1473048|NCT01336790|||Case-Only||Other|||||||
1473049|NCT01336777|||Case Control||Cross-Sectional|||||||
1473050|NCT01336764|Randomized|Parallel Assignment||Treatment||Double|Physical separation of Care Provider during self-administration of intervention||t|t||
1473051|NCT01336751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473052|NCT01336738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473053|NCT01336725|||Cohort||Prospective|||||||
1473054|NCT01336712||Single Group Assignment||Treatment||None (Open Label)||||||
1473055|NCT01336699|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1473056|NCT01336686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473057|NCT01336673|||Cohort||Prospective|||||||
1473058|NCT01336660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473059|NCT01336647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473060|NCT01336634|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473061|NCT01336621||Single Group Assignment||Treatment||None (Open Label)||||||
1473062|NCT01336608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473063|NCT01336595|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473064|NCT01336582|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473065|NCT01336569||Single Group Assignment||Treatment||None (Open Label)||||||
1473066|NCT01336556||Parallel Assignment||Treatment||Single|||||t|
1473067|NCT01336543||Single Group Assignment||Treatment||None (Open Label)||||||
1473068|NCT01336530|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473069|NCT01336517|||Case Control||Prospective|||||||
1473070|NCT01336478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473071|NCT01336465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473072|NCT01336452||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473073|NCT01336439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473074|NCT01336426|||Case-Only||Prospective|||||||
1473075|NCT01336413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473076|NCT01336400|||Case-Only||Prospective|||||||
1473077|NCT01336387|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473078|NCT01336374|||Ecologic or Community||Prospective|||||||
1473079|NCT01336361|||Case-Only||Cross-Sectional|||||||
1473080|NCT01336348|Randomized|Parallel Assignment||Treatment||Single||||||t
1473081|NCT01336335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473082|NCT01336322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473083|NCT01336309|||||Cross-Sectional|||||||
1473084|NCT01336296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473085|NCT01336283|Randomized|Parallel Assignment||Treatment||Single|||||t|
1473086|NCT01336270|||Cohort|||||||||
1473087|NCT01336257|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1473088|NCT01336244|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1473090|NCT01336218|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1473091|NCT01336205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473092|NCT01336192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473093|NCT01336179|Randomized|Single Group Assignment||Treatment||Single|||||t|
1473094|NCT01336166|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1473095|NCT01336153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473096|NCT01336140|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1473097|NCT01336127|Randomized|Parallel Assignment||Treatment||Single||||||t
1473098|NCT01336114|||Case-Only||Prospective|||||||
1473099|NCT01336101||Single Group Assignment||Treatment||None (Open Label)||||||
1473100|NCT01336088|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473101|NCT01336075|Randomized|Parallel Assignment||Treatment||Single||||||t
1473102|NCT01336062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473103|NCT01336049|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473104|NCT01336036|||Cohort||Prospective|||||||
1473105|NCT01336023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473106|NCT01336010|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473107|NCT01335997|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1473108|NCT01335984|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473109|NCT01335971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473110|NCT01335958||Single Group Assignment||Treatment||None (Open Label)||||||
1473111|NCT01335945||Single Group Assignment||Supportive Care||None (Open Label)||||||
1473112|NCT01335932|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1473113|NCT01335919|||Cohort||Prospective|||||||
1473114|NCT01335906|Randomized|Parallel Assignment||||None (Open Label)||||||
1473115|NCT01335893||Single Group Assignment||Other||None (Open Label)||||||
1473116|NCT01335880|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473117|NCT01335867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473118|NCT01335854|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1473119|NCT01335841|Randomized|Parallel Assignment||||Single|||t|||
1473120|NCT01335828|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1473121|NCT01335815|||Cohort||Prospective|||||||
1473122|NCT01335802|||Case Control||Prospective|||||||
1473123|NCT01335789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473124|NCT01335776|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473125|NCT01335763||Single Group Assignment||Treatment||None (Open Label)||||||
1473126|NCT01335750|Randomized|Crossover Assignment||||Double|||t||t|
1473127|NCT01335737|Randomized|Parallel Assignment||Basic Science||Single||||||t
1473128|NCT01335724|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473129|NCT01335711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473130|NCT01335698||Single Group Assignment||Treatment||None (Open Label)||||||
1473131|NCT01335685||Parallel Assignment||Treatment||None (Open Label)||||||
1473132|NCT01335672|||Cohort||Retrospective|||||||
1473133|NCT01335659|||Cohort||Retrospective|||||||
1473134|NCT01335646|Randomized|Parallel Assignment||Treatment||Single||||||t
1473135|NCT01335633|||Cohort||Prospective|||||||
1473136|NCT01335620||Single Group Assignment||Treatment||None (Open Label)||||||
1473137|NCT01335607|Randomized|Crossover Assignment||||None (Open Label)||||||
1473138|NCT01335594||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473139|NCT01335581||Single Group Assignment||Treatment||Single||||||t
1473140|NCT01335568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473141|NCT01335555|||Cohort||Prospective|||||||
1473142|NCT01335542|Randomized|Parallel Assignment||||Double|||t|||t
1473143|NCT01335529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473144|NCT01335516|||||Prospective|||||||
1473145|NCT01335503|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1473146|NCT01335490|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1473147|NCT01335477|Randomized|Parallel Assignment||Treatment||Double||||||
1473148|NCT01335464|Randomized|Parallel Assignment||Treatment||Double||||||
1473149|NCT01335451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473150|NCT01335438|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473151|NCT01335425|||Case Control||Cross-Sectional|||||||
1473152|NCT01335412|||Cohort||Retrospective|||||||
1473153|NCT01335399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473154|NCT01335386|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1473155|NCT01335373|||Cohort||Prospective|||||||
1473156|NCT01335360|||Cohort||Cross-Sectional|||||||
1473157|NCT01335347|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1473158|NCT01335334||Single Group Assignment||Treatment||None (Open Label)||||||
1473159|NCT01335321|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473160|NCT01335308|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473161|NCT01335295||Single Group Assignment||||None (Open Label)||||||
1473162|NCT01335282|||Cohort||Prospective|||||||
1473163|NCT01335269||Single Group Assignment||Treatment||None (Open Label)||||||
1473164|NCT01335256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473165|NCT01335243||Single Group Assignment||Treatment||None (Open Label)||||||
1473166|NCT01335230|||Case Control||Cross-Sectional|||||||
1473167|NCT01335217||Single Group Assignment||Treatment||None (Open Label)||||||
1473404|NCT01332123||Single Group Assignment||||None (Open Label)||||||
1473168|NCT01335204||Single Group Assignment||Treatment||None (Open Label)||||||
1473169|NCT01335191|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1473170|NCT01335178||Single Group Assignment||Prevention||None (Open Label)||||||
1473171|NCT01335165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473172|NCT01335152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473173|NCT01335139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473174|NCT01335126|Randomized|Crossover Assignment||Treatment||Single|||||t|
1473175|NCT01335113|||Cohort||Prospective|||||||
1473176|NCT01335100|||Case Control||Prospective|||||||
1473177|NCT01335087|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473178|NCT01335074|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473179|NCT01335061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473180|NCT01335048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473181|NCT01335035||Single Group Assignment||Treatment||None (Open Label)||||||
1473182|NCT01335022|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1473183|NCT01335009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473184|NCT01334996|||Case-Only||Prospective|||||||
1473185|NCT01334983|Randomized|Parallel Assignment||Treatment||Single|||||t|
1473186|NCT01334957||Single Group Assignment||Treatment||None (Open Label)||||||
1473187|NCT01334944||Single Group Assignment||Treatment||None (Open Label)||||||
1473188|NCT01334931|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473189|NCT01334918|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1473190|NCT01334905|Randomized|Crossover Assignment||||None (Open Label)||||||
1473191|NCT01334892|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1473192|NCT01334879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473193|NCT01334866|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473194|NCT01334853|||Cohort||Prospective|||||||
1473195|NCT01334840|Randomized|Crossover Assignment||Prevention||Single||||||t
1473196|NCT01334827||||||||||||
1473197|NCT01334814|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1473198|NCT01334801|||Case-Only||Prospective|||||||
1473199|NCT01334788|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1473200|NCT01334775|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473201|NCT01334762|Randomized|Parallel Assignment||Treatment||Single||||||t
1473202|NCT01334749|||Cohort||Prospective|||||||
1473203|NCT01334736|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1473204|NCT01334723|||Cohort||Retrospective|||||||
1473205|NCT01334710||Single Group Assignment||Treatment||None (Open Label)||||||
1473206|NCT01334697|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1473207|NCT01334684||Single Group Assignment||Treatment||None (Open Label)||||||
1473208|NCT01334671|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473209|NCT01334658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473210|NCT01334645|Non-Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1473211|NCT01334632|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1473212|NCT01334619||Single Group Assignment||||Single|||t|||
1473213|NCT01334606|Randomized|Crossover Assignment||||None (Open Label)||||||
1473214|NCT01334593|||Cohort||Prospective|||||||
1473215|NCT01334580|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1473216|NCT01334567||Single Group Assignment||Treatment||None (Open Label)||||||
1473217|NCT01334554|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1473218|NCT01334541|||Case-Control||Cross-Sectional|||||||
1473219|NCT01334528|||Cohort||Prospective|||||||
1473220|NCT01334515|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473221|NCT01334502||Single Group Assignment||Treatment||None (Open Label)||||||
1473222|NCT01334489|Randomized|Parallel Assignment||Prevention||Single||||||t
1473223|NCT01334476|||Other||Other|||||||
1473224|NCT01334463|||Cohort||Prospective|||||||
1473225|NCT01334450|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1473226|NCT01334437|||Case-Only||Cross-Sectional|||||||
1473227|NCT01334424|Randomized|Single Group Assignment||||Single|||t|||
1473228|NCT01334411||||||||||||
1473229|NCT01334398|||Case Control||Prospective|||||||
1473230|NCT01334385|||Case-Only||Cross-Sectional|||||||
1473231|NCT01334372||||||||||||
1473232|NCT01334359|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1473233|NCT01334346|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473234|NCT01334333|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473235|NCT01334320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473236|NCT01334307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473237|NCT01334294|||Cohort||Prospective|||||||
1473238|NCT01334281|||Case Control||Prospective|||||||
1473239|NCT01334268|Randomized|Parallel Assignment||Treatment||Single||||||t
1473240|NCT01334255|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473241|NCT01334242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473242|NCT01334229|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1473243|NCT01334216|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1473244|NCT01334203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473245|NCT01334190||||||||||||
1473246|NCT01334177||Single Group Assignment||Treatment||None (Open Label)||||||
1473247|NCT01334164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473248|NCT01334151|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1473249|NCT01334138||Single Group Assignment||Treatment||None (Open Label)||||||
1473250|NCT01334125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473251|NCT01334112||Single Group Assignment||Treatment||None (Open Label)||||||
1473252|NCT01334099||Single Group Assignment||Treatment||None (Open Label)||||||
1473253|NCT01334086||Single Group Assignment||Prevention||None (Open Label)||||||
1473254|NCT01334073||Single Group Assignment||Treatment||None (Open Label)||||||
1473255|NCT01334060|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473256|NCT01334047||Single Group Assignment||Treatment||None (Open Label)||||||
1473257|NCT01334034|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473258|NCT01334021||Single Group Assignment||Diagnostic||Double|Patients and treating physicians will not be told the results of the experimental tests.||t|t||
1473259|NCT01334008||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473260|NCT01333995|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473261|NCT01333982|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1473262|NCT01333969|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1473263|NCT01333956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473264|NCT01333943|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473265|NCT01333930|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1473266|NCT01333917||Single Group Assignment||||None (Open Label)||||||
1473267|NCT01333904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473268|NCT01333891|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1473269|NCT01333878||Single Group Assignment||Treatment||None (Open Label)||||||
1473270|NCT01333865||Single Group Assignment||Treatment||None (Open Label)||||||
1473271|NCT01333852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473272|NCT01333839|Randomized|Single Group Assignment||Treatment||Single||||||t
1473273|NCT01333826|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473274|NCT01333813||Single Group Assignment||Prevention||None (Open Label)||||||
1473275|NCT01333800|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473276|NCT01333787|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473277|NCT01333774|||Cohort||Prospective|||||||
1473278|NCT01333761||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473279|NCT01333748|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1473280|NCT01333735|||Cohort||Prospective|||||||
1473281|NCT01333722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473282|NCT01333709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473283|NCT01333696||Single Group Assignment||Treatment||None (Open Label)||||||
1473284|NCT01333683|||Cohort||Prospective|||||||
1473285|NCT01333670|Randomized|Parallel Assignment||Treatment||Single||||||t
1473286|NCT01333657|||Case-Only||Prospective|||||||
1473287|NCT01333644|||Cohort||Prospective|||||||
1473288|NCT01333631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473289|NCT01333618|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1473290|NCT01333605||Single Group Assignment||Treatment||None (Open Label)||||||
1473291|NCT01333592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473292|NCT01333579|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1473293|NCT01333566|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473294|NCT01333553|||Case-Only||Prospective|||||||
1473295|NCT01333540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473296|NCT01333527|Randomized|Parallel Assignment||Treatment||Single||||||t
1473297|NCT01333514|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473298|NCT01333501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473299|NCT01333488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473300|NCT01333475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473301|NCT01333462|Randomized|Parallel Assignment||Prevention||Single||||||t
1473302|NCT01333449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473303|NCT01333436|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1473304|NCT01333423||Single Group Assignment||Treatment||None (Open Label)||||||
1473305|NCT01333410|Randomized|Single Group Assignment||Treatment||Single||||||t
1473306|NCT01333397|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473307|NCT01333384||||||||||||
1473308|NCT01333371|Randomized|Parallel Assignment||Treatment||Single||||||t
1473309|NCT01333358||Single Group Assignment||Treatment||None (Open Label)||||||
1473310|NCT01333345|||Case-Only||Cross-Sectional|||||||
1473311|NCT01333332||Single Group Assignment||Treatment||None (Open Label)||||||
1473312|NCT01333319|||Cohort||Prospective|||||||
1473313|NCT01333306||||Basic Science||||||||
1473314|NCT01333293|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473315|NCT01333280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473316|NCT01333267|Non-Randomized|Parallel Assignment||||Single|||t|||
1473317|NCT01333254|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473318|NCT01333241|Randomized|Parallel Assignment||Prevention||Single||||||t
1473319|NCT01333228||Single Group Assignment||Treatment||None (Open Label)||||||
1473320|NCT01333215|||Cohort||Cross-Sectional|||||||
1473321|NCT01333202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473322|NCT01333189|Randomized|Factorial Assignment||Treatment||Single|||t|||
1473323|NCT01333176||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473324|NCT01333163|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1473325|NCT01333150|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1473326|NCT01333137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473327|NCT01333124||Single Group Assignment||Treatment||None (Open Label)||||||
1473328|NCT01333111|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473329|NCT01333098|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473330|NCT01333085||Single Group Assignment||Treatment||None (Open Label)||||||
1473331|NCT01333072|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1473332|NCT01333059|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473333|NCT01333046|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473334|NCT01333033|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473335|NCT01333020|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1473336|NCT01333007|||Cohort||Prospective|||||||
1473337|NCT01332994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473338|NCT01332981|||Cohort||Retrospective|||||||
1473339|NCT01332968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473340|NCT01332955||Single Group Assignment||Treatment||None (Open Label)||||||
1473341|NCT01332942|Randomized|Parallel Assignment||||Single|||t|||
1473342|NCT01332929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473343|NCT01332916|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1473344|NCT01332903||Single Group Assignment||Basic Science||None (Open Label)||||||
1473345|NCT01332890|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473346|NCT01332877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473347|NCT01332864|Randomized|Factorial Assignment||Treatment||Single||||||t
1473348|NCT01332851|Randomized|Parallel Assignment||Treatment||Single||||||t
1473349|NCT01332838|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1473350|NCT01332825|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1473351|NCT01332812|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1473352|NCT01332799|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1473353|NCT01332786||Single Group Assignment||Treatment||None (Open Label)||||||
1473354|NCT01332773|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473355|NCT01332760|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1473356|NCT01332747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473357|NCT01332734|||Case-Only||Prospective|||||||
1473358|NCT01332721||Single Group Assignment||Treatment||None (Open Label)||||||
1473359|NCT01332708|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473360|NCT01332695|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1473361|NCT01332682|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473362|NCT01332669|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473363|NCT01332656|Randomized|Parallel Assignment||Treatment||Double||||||
1473364|NCT01332643|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473365|NCT01332630||Single Group Assignment||Treatment||None (Open Label)||||||
1473366|NCT01332617||Single Group Assignment||Treatment||None (Open Label)||||||
1473367|NCT01332604||Single Group Assignment||Treatment||None (Open Label)||||||
1473368|NCT01332591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473369|NCT01332578|Randomized|Crossover Assignment||||None (Open Label)||||||
1473370|NCT01332565||Single Group Assignment||||None (Open Label)||||||
1473371|NCT01332552|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473372|NCT01332539|||Cohort|||||||||
1473373|NCT01332526|||Case Control||Prospective|||||||
1473374|NCT01332513|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473375|NCT01332500|||Cohort||Retrospective|||||||
1473376|NCT01332487|||Cohort||Retrospective|||||||
1473377|NCT01332474|||Other||Retrospective|||||||
1473378|NCT01332461|||Cohort||Retrospective|||||||
1473379|NCT01332448|||Other||Retrospective|||||||
1473380|NCT01332435|||Cohort||Retrospective|||||||
1473381|NCT01332422|||||Prospective|||||||
1473382|NCT01332409|||||Prospective|||||||
1473383|NCT01332396|||Other||Other|||||||
1473384|NCT01332383|||||Prospective|||||||
1473385|NCT01332370|||Cohort||Retrospective|||||||
1473386|NCT01332357|||Cohort||Retrospective|||||||
1473387|NCT01332344|||Cohort||Retrospective|||||||
1473388|NCT01332331|Randomized|Parallel Assignment||Treatment||Single||||||t
1473389|NCT01332318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473390|NCT01332305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473391|NCT01332292|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1473392|NCT01332279|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473393|NCT01332266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473394|NCT01332253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473395|NCT01332240|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1473396|NCT01332227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473397|NCT01332214|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1473398|NCT01332201|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473399|NCT01332188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473400|NCT01332175|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473401|NCT01332162|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473402|NCT01332149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473405|NCT01332110|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473406|NCT01332097|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473407|NCT01332084||Single Group Assignment||Treatment||None (Open Label)||||||
1473408|NCT01332071|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1473409|NCT01332058||Single Group Assignment||||None (Open Label)||||||
1473410|NCT01332045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473411|NCT01332032|||||Prospective|||||||
1473412|NCT01332019|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473413|NCT01332006||Single Group Assignment||Treatment||None (Open Label)||||||
1473414|NCT01331993|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1473415|NCT01331980|||Case Control||Cross-Sectional|||||||
1473416|NCT01331967|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473417|NCT01331954||Single Group Assignment||Treatment||None (Open Label)||||||
1473418|NCT01331941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473419|NCT01331928|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473420|NCT01331915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473421|NCT01331902|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1473422|NCT01331889|||Cohort||Prospective|||||||
1473423|NCT01331876|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1473424|NCT01331863||Single Group Assignment||Treatment||None (Open Label)||||||
1473425|NCT01331850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473426|NCT01331837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473427|NCT01331824||Single Group Assignment||Treatment||None (Open Label)||||||
1473428|NCT01331811||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473429|NCT01331798|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473430|NCT01331785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473431|NCT01331772|Randomized|Parallel Assignment||||None (Open Label)||||||
1473432|NCT01331759|Randomized|Parallel Assignment||Prevention||Single|||t|||
1473433|NCT01331746|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1473434|NCT01331733|||Cohort||Prospective|||||||
1473435|NCT01331720|||Cohort||Prospective|||||||
1473436|NCT01331707|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473437|NCT01331694|||Cohort||Retrospective|||||||
1473438|NCT01331681|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473439|NCT01331668|||Cohort||Prospective|||||||
1473440|NCT01331655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473441|NCT01331642|||Cohort||Prospective|||||||
1473442|NCT01331629|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473443|NCT01331616||Single Group Assignment||Treatment||None (Open Label)||||||
1473444|NCT01331603|||Case-Only||Prospective|||||||
1473445|NCT01331590||Single Group Assignment||Treatment||None (Open Label)||||||
1473446|NCT01331577|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473447|NCT01331564|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1473448|NCT01331551|||Case-Crossover||Prospective|||||||
1473449|NCT01331538|||||Cross-Sectional|||||||
1473450|NCT01331525||Single Group Assignment||Treatment||None (Open Label)||||||
1473451|NCT01331512|||||Other|||||||
1473452|NCT01331499|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1473453|NCT01331486|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1473454|NCT01331473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473455|NCT01331460|Randomized|Parallel Assignment||Prevention||Single|||||t|
1473456|NCT01331447|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473457|NCT01331434|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473458|NCT01331421|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473459|NCT01331408||Single Group Assignment||||None (Open Label)||||||
1473460|NCT01331395|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473461|NCT01331382|Randomized|Factorial Assignment||||Double|||t||t|
1473462|NCT01331369|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1473463|NCT01331356|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473464|NCT01331343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473465|NCT01331330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473466|NCT01331317|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1473467|NCT01331304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473468|NCT01331291|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473469|NCT01331278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473470|NCT01331265|||Ecologic or Community||Cross-Sectional|||||||
1473471|NCT01331252|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1473472|NCT01331239||Single Group Assignment||Treatment||None (Open Label)||||||
1473473|NCT01331226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473474|NCT01331213|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1473475|NCT01331200|||Case Control||Prospective|||||||
1473476|NCT01331187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473477|NCT01331174|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473478|NCT01331161|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1473479|NCT01331148|Randomized|Parallel Assignment||Prevention||Single|||t|||
1473480|NCT01331135||Single Group Assignment||Treatment||None (Open Label)||||||
1473481|NCT01331122|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1473482|NCT01331109||Single Group Assignment||Treatment||None (Open Label)||||||
1473483|NCT01331096|||||Prospective|||||||
1473484|NCT01331083||Single Group Assignment||Treatment||None (Open Label)||||||
1473485|NCT01331070|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473486|NCT01331057|||||Prospective|||||||
1473487|NCT01331044|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1473488|NCT01331031|||||Cross-Sectional|||||||
1473489|NCT01331018||Single Group Assignment||Treatment||None (Open Label)||||||
1473490|NCT01331005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473491|NCT01330992||Single Group Assignment||Basic Science||None (Open Label)||||||
1473492|NCT01330979||Single Group Assignment||Treatment||None (Open Label)||||||
1473493|NCT01330966||Single Group Assignment||Treatment||None (Open Label)||||||
1473494|NCT01330953|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1473495|NCT01330940|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1473496|NCT01330927|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1473497|NCT01330914|||Cohort||Prospective|||||||
1473498|NCT01330901||Single Group Assignment||Treatment||None (Open Label)||||||
1473499|NCT01330888|||||Cross-Sectional|||||||
1473500|NCT01330875|||Case-Only||Prospective|||||||
1473501|NCT01330862|||Cohort||Prospective|||||||
1473502|NCT01330849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473503|NCT01330823|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473504|NCT01330810|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1473505|NCT01330797|||Case-Crossover||Prospective|||||||
1473506|NCT01330784|||Cohort||Prospective|||||||
1473507|NCT01330771|||Cohort||Prospective|||||||
1473508|NCT01330758|Randomized|Crossover Assignment||||None (Open Label)||||||
1473509|NCT01330745|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1473510|NCT01330732|||Case-Only||Prospective|||||||
1473511|NCT01330719|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473512|NCT01330706|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473513|NCT01330693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473514|NCT01330680|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1473515|NCT01330667|Randomized|Parallel Assignment||Prevention||Single||||||t
1473516|NCT01330654|Randomized|Parallel Assignment||||Single|||||t|
1473517|NCT01330641|Randomized|Parallel Assignment||Treatment||Single||||||t
1473518|NCT01330628|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473519|NCT01330615|Randomized|Single Group Assignment||||Triple|||t|t|t|
1473520|NCT01330602|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1473521|NCT01330589|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1473522|NCT01330576|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473523|NCT01330563|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473524|NCT01330550|Randomized|Crossover Assignment||Prevention||Single||||t||
1473525|NCT01330537|||Cohort||Cross-Sectional|||||||
1473526|NCT01330524|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1473527|NCT01330511|||Cohort||Prospective|||||||
1473528|NCT01330498|||Case-Only||Retrospective|||||||
1473529|NCT01330485|Randomized|Parallel Assignment||Treatment||Single||||||t
1473530|NCT01330472|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1473531|NCT01330459|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473532|NCT01330446|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473533|NCT01330433|Randomized|Parallel Assignment||Treatment||Single||||||t
1473534|NCT01330420||Single Group Assignment||Supportive Care||None (Open Label)||||||
1473535|NCT01330407|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473536|NCT01330394|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473537|NCT01330381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473538|NCT01330368|||Case-Control||Cross-Sectional|||||||
1473539|NCT01330355|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1473540|NCT01330342|||Case Control|||||||||
1473541|NCT01330329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473542|NCT01330316|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473543|NCT01330303|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1473544|NCT01330290|||Cohort||Cross-Sectional|||||||
1473545|NCT01330277|||Cohort||Prospective|||||||
1473546|NCT01330264|||||Prospective|||||||
1473547|NCT01330251|||Case-Control||Prospective|||||||
1473548|NCT01330238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473549|NCT01330199|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473550|NCT01330186|||Case-Only||Prospective|||||||
1473551|NCT01330173||Single Group Assignment||Treatment||None (Open Label)||||||
1473552|NCT01330160|||Cohort||Prospective|||||||
1473553|NCT01330147|||Cohort||Prospective|||||||
1473554|NCT01330134|Randomized|Parallel Assignment||Treatment||Single||||||t
1473555|NCT01330121|Randomized|Parallel Assignment||||None (Open Label)||||||
1473556|NCT01330108||Single Group Assignment||Treatment||None (Open Label)||||||
1473557|NCT01330095|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473558|NCT01330082|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1473559|NCT01330056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473636|NCT01329055|||Cohort||Retrospective|||||||
1473637|NCT01329042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473638|NCT01329029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473560|NCT01330043|Randomized|Parallel Assignment||Treatment||Double|Behavioral therapists were blinded until the end of open-label treatment (26 weeks). Investigators were blinded to treatment assignment until the end of the study.|Participants were randomized to extended or non-extended treatment and followed for 104 weeks.||t|t|
1473561|NCT01330030|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1473562|NCT01330017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473563|NCT01330004|||Cohort||Retrospective|||||||
1473564|NCT01329991|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1473565|NCT01329978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473566|NCT01329965|Randomized|Parallel Assignment||||Single|||t|||
1473567|NCT01329952|||Cohort|||||||||
1473568|NCT01329939|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473569|NCT01329926|||Case-Only||Prospective|||||||
1473570|NCT01329913|Randomized|Parallel Assignment||Treatment||Double||||||
1473571|NCT01329900||Single Group Assignment||Treatment||None (Open Label)||||||
1473572|NCT01329887||Single Group Assignment||Treatment||None (Open Label)||||||
1473573|NCT01329874|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1473574|NCT01329861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473575|NCT01329848|||Cohort||Prospective|||||||
1473576|NCT01329835|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1473577|NCT01329822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473578|NCT01329809|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473579|NCT01329796|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473580|NCT01329783|||Cohort||Retrospective|||||||
1473581|NCT01329770|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1473582|NCT01329757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473583|NCT01329744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473584|NCT01329731|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473585|NCT01329718||Parallel Assignment||Diagnostic||Single||||||t
1473586|NCT01329705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473587|NCT01329692|Randomized|Single Group Assignment||||Single|||t|||
1473588|NCT01329679|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1473589|NCT01329666|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1473590|NCT01329653|Randomized|Parallel Assignment||Basic Science||Single||||||t
1473591|NCT01329640|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473592|NCT01329627||Single Group Assignment||Treatment||None (Open Label)||||||
1473593|NCT01329614|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1473594|NCT01329601|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473595|NCT01329588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473596|NCT01329575|||Cohort||Prospective|||||||
1473597|NCT01329562|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473598|NCT01329549|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473599|NCT01329536|||Case Control||Prospective|||||||
1473600|NCT01329523|||Cohort||Prospective|||||||
1473601|NCT01329510|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1473602|NCT01329497||Single Group Assignment||Treatment||None (Open Label)||||||
1473603|NCT01329484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473604|NCT01329471|||||Prospective|||||||
1473605|NCT01329458|||Case-Only||Prospective|||||||
1473606|NCT01329445|||Cohort||Other|||||||
1473607|NCT01329432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473608|NCT01329419|||Cohort||Prospective|||||||
1473609|NCT01329406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473610|NCT01329393|Randomized|Parallel Assignment||Treatment||Single||||||t
1473611|NCT01329380|||Cohort||Prospective|||||||
1473612|NCT01329367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473613|NCT01329354||Single Group Assignment||Treatment||None (Open Label)||||||
1473614|NCT01329341||Single Group Assignment||Other||None (Open Label)||||||
1473615|NCT01329328|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1473616|NCT01329315|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1473617|NCT01329302|Randomized|Parallel Assignment||||Single||||t||
1473618|NCT01329289||Single Group Assignment||Treatment||None (Open Label)||||||
1473619|NCT01329276|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1473620|NCT01329263|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1473621|NCT01329250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473622|NCT01329237||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473623|NCT01329224|||Cohort||Cross-Sectional|||||||
1473624|NCT01329211|||Cohort||Prospective|||||||
1473625|NCT01329198|Randomized|Parallel Assignment||Treatment||Triple|Programming to be performed for this study by the programming investigator under the supervision of the PI|Prospective blinded staggered onset design|t|t||t
1473626|NCT01329185|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1473627|NCT01329172|Randomized|Parallel Assignment||Treatment||Single|||||t|
1473628|NCT01329159|||Ecologic or Community||Cross-Sectional|||||||
1473629|NCT01329146|||Cohort||Prospective|||||||
1473630|NCT01329133|Randomized|Parallel Assignment||Treatment||Single||||||t
1473631|NCT01329120|||Cohort||Retrospective|||||||
1473632|NCT01329107|Randomized|Parallel Assignment||Prevention||Single||||||t
1473633|NCT01329094|||Case Control||Cross-Sectional|||||||
1473634|NCT01329081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473635|NCT01329068|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473639|NCT01329016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473640|NCT01329003|||||Cross-Sectional|||||||
1473641|NCT01328990||Single Group Assignment||Prevention||None (Open Label)||||||
1473642|NCT01328977|Randomized|Parallel Assignment||||None (Open Label)||||||
1473643|NCT01328964|||Cohort||Retrospective|||||||
1473644|NCT01328951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473645|NCT01328938|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1473646|NCT01328925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473647|NCT01328912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473648|NCT01328899||Single Group Assignment||Treatment||None (Open Label)||||||
1473649|NCT01328886||Single Group Assignment||Treatment||None (Open Label)||||||
1473650|NCT01328873||Single Group Assignment||Treatment||None (Open Label)||||||
1473651|NCT01328860||Single Group Assignment||Treatment||None (Open Label)||||||
1473652|NCT01328834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473653|NCT01328821|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1473654|NCT01328808||Single Group Assignment||Treatment||None (Open Label)||||||
1473655|NCT01328795||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473656|NCT01328782|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473657|NCT01328769|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1473658|NCT01328756|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1473659|NCT01328743|Randomized|Parallel Assignment||Treatment||Single||||||t
1473660|NCT01328730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473661|NCT01328717||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473662|NCT01328704|||Cohort||Prospective|||||||
1473663|NCT01328691|||Cohort||Retrospective|||||||
1473664|NCT01328678|||Case-Only||Prospective|||||||
1473665|NCT01328665|Randomized|Parallel Assignment||Treatment||Single|||||t|
1473666|NCT01328652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473667|NCT01328639|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1473668|NCT01328626|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473669|NCT01328613|||||Other|||||||
1473670|NCT01328600|||||Other|||||||
1473671|NCT01328587||Single Group Assignment||Treatment||None (Open Label)||||||
1473672|NCT01328574||Single Group Assignment||Treatment||None (Open Label)||||||
1473673|NCT01328561|||||Prospective|||||||
1473674|NCT01328548|||Case-Control||Prospective|||||||
1473675|NCT01328535||Single Group Assignment||Treatment||None (Open Label)||||||
1473676|NCT01328522|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473677|NCT01328509|||Case Control||Prospective|||||||
1473678|NCT01328496|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473679|NCT01328483|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473680|NCT01328470|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473681|NCT01328457||Single Group Assignment||Treatment||None (Open Label)||||||
1473682|NCT01328444|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1473683|NCT01328431|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473684|NCT01328418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473685|NCT01328405|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1473686|NCT01328392|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473687|NCT01328379|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473688|NCT01328366|||Cohort||Prospective|||||||
1473689|NCT01328353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473690|NCT01328340|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1473691|NCT01328301|Randomized|Parallel Assignment||Treatment||Single|||||t|
1473692|NCT01328288|||Cohort||Prospective|||||||
1473693|NCT01328275|||Cohort||Prospective|||||||
1473694|NCT01328262|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473695|NCT01328249||Single Group Assignment||Treatment||None (Open Label)||||||
1473696|NCT01328236||Single Group Assignment||Treatment||None (Open Label)||||||
1473697|NCT01328223|||Cohort||Prospective|||||||
1473698|NCT01328210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473699|NCT01328197||Single Group Assignment||Treatment||None (Open Label)||AAA device||||
1473700|NCT01328184|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473701|NCT01328171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473702|NCT01328158|||Cohort||Prospective|||||||
1473703|NCT01328145|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473704|NCT01328132|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473705|NCT01328119|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473706|NCT01328106||Single Group Assignment||Treatment||None (Open Label)||||||
1473707|NCT01328093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473708|NCT01328080|Randomized|Single Group Assignment||Treatment||Single|||||t|
1473709|NCT01328067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473710|NCT01328054||Single Group Assignment||Treatment||Single|||t|||
1473711|NCT01328041||Single Group Assignment||Treatment||None (Open Label)||||||
1473712|NCT01328028|||Case-Only||Retrospective|||||||
1473713|NCT01328015|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1473714|NCT01328002|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473715|NCT01327989|||Cohort||Prospective|||||||
1473716|NCT01327976|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473717|NCT01327963||Single Group Assignment||Treatment||None (Open Label)||||||
1473718|NCT01327950|||Case-Only||Prospective|||||||
1473719|NCT01327937|Randomized|Crossover Assignment||Treatment||Single||||||t
1473720|NCT01327924|||Cohort||Prospective|||||||
1473721|NCT01327911||Single Group Assignment||Treatment||None (Open Label)||||||
1473722|NCT01327898|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473723|NCT01327885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473724|NCT01327872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473725|NCT01327859|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473726|NCT01327846|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473727|NCT01327833|||||Cross-Sectional|||||||
1473728|NCT01327820|||Cohort||Prospective|||||||
1473729|NCT01327807|||||Cross-Sectional|||||||
1473730|NCT01327794|||Cohort||Prospective|||||||
1473731|NCT01327781||Single Group Assignment||Treatment||None (Open Label)||||||
1473732|NCT01327768|Randomized|Crossover Assignment||Treatment||Single|||t|||
1473733|NCT01327755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473734|NCT01327742||||||||||||
1473735|NCT01327729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473736|NCT01327703|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473737|NCT01327690|Randomized|Parallel Assignment||Screening||Single||||||t
1473738|NCT01327677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473739|NCT01327664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473740|NCT01327651|Randomized|Parallel Assignment||Prevention||None (Open Label)||One arm is daily TDF/FTC. One arm is twice weekly TDF/FTC with a post-exposure dose. One arm is as needed TDF/FTC with a post-exposure dose.||||
1473741|NCT01327638|||Cohort||Retrospective|||||||
1473742|NCT01327625||Single Group Assignment||Treatment||None (Open Label)||||||
1473743|NCT01327612|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473744|NCT01327599||Single Group Assignment||Treatment||None (Open Label)||||||
1473745|NCT01327586|Randomized|Parallel Assignment||Treatment||Single||||||t
1473746|NCT01327573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473747|NCT01327560|||Case-Only||Retrospective|||||||
1473748|NCT01327547|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473749|NCT01327534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473750|NCT01327521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473751|NCT01327508|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473752|NCT01327495|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473753|NCT01327482||Single Group Assignment||||None (Open Label)||||||
1473754|NCT01327469|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473755|NCT01327456|Randomized|Parallel Assignment||Treatment||Single|||||t|
1473756|NCT01327443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473757|NCT01327430||Single Group Assignment||Basic Science||None (Open Label)||||||
1473758|NCT01327417|||Case Control||Prospective|||||||
1473759|NCT01327404|||Case Control||Prospective|||||||
1473760|NCT01327391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473761|NCT01327378|||Case Control||Cross-Sectional|||||||
1473762|NCT01327365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473763|NCT01327352||Single Group Assignment||||None (Open Label)||||||
1473764|NCT01327339|||Cohort||Prospective|||||||
1473765|NCT01327326|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1473766|NCT01327313|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473767|NCT01327300|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1473768|NCT01327287|||Case Control||Retrospective|||||||
1473769|NCT01327274||Single Group Assignment||Treatment||None (Open Label)||||||
1473770|NCT01327261|Randomized|Crossover Assignment||||None (Open Label)||||||
1473771|NCT01327248|||Case Control||Cross-Sectional|||||||
1473772|NCT01327235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473773|NCT01327222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473774|NCT01327209|||Case-Only||Prospective|||||||
1473775|NCT01327196|||||Cross-Sectional|||||||
1473776|NCT01327183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473777|NCT01327170|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473778|NCT01327157|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473779|NCT01327144|Randomized|Parallel Assignment||Treatment||Single|||||t|
1473780|NCT01327118|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1473781|NCT01327105||Single Group Assignment||Treatment||None (Open Label)||||||
1473782|NCT01327092|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1473783|NCT01327079|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1473784|NCT01327066|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1473785|NCT01327053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473786|NCT01327040|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1473854|NCT01326143|||Cohort||Prospective|||||||
1473855|NCT01326130|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473856|NCT01326117||Single Group Assignment||Treatment||None (Open Label)||||||
1473857|NCT01326104||Single Group Assignment||Treatment||None (Open Label)||||||
1473858|NCT01326091|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473859|NCT01326078|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1473860|NCT01326065|||Cohort||Prospective|||||||
1473861|NCT01326052|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473787|NCT01327027|Randomized|Crossover Assignment||Basic Science||Double|The Maine Medical Pharmacy prepared drug and placebo doses; when subjects were enrolled, the pharmacy randomly assigned the subject to a condition, and gave the unmarked nasal applicator to the subject, who was accompanied by the nurse/technician. Neither the subject nor the nurse/technician collecting data knw whether it was placebo or drug, nor which dose (20IU or 40IU) the subject would be receiving on the drug day.|"In the work at Maine Medical, each subject received one of two doses of vasopressin (20IU or 40IU) on one test day, and placebo (sterile saline) on the other, in counterbalanced order. All subjects reported back for a 3rd day, 2-21 days after the 2nd test day, for a third test when no drug was administered.~Because preliminary data analysis suggested the drug may have longer lasting, generalized effects on behavioral responses than anticipated, the second study done at Emory University with a single dose and in which subjects were also tested in fMRI, was changed to between-subjects design in which each subject either received placebo or 40IU on an initial test day and were then tested on a follow up test, 2-21 days later, when no drug was given."|t||t|
1473788|NCT01327014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473789|NCT01327001|||Case-Only||Retrospective|||||||
1473790|NCT01326988|||Cohort||Prospective|||||||
1473791|NCT01326975|||Case-Crossover||Prospective|||||||
1473792|NCT01326962||Single Group Assignment||Treatment||None (Open Label)||||||
1473793|NCT01326949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473794|NCT01326936|Randomized|Parallel Assignment||||None (Open Label)||||||
1473795|NCT01326923||Single Group Assignment||Treatment||None (Open Label)||||||
1473796|NCT01326910|Randomized|Parallel Assignment||Treatment||Double||||t||t
1473797|NCT01326897|Randomized|Parallel Assignment||Prevention||Single||||||t
1473798|NCT01326884||Single Group Assignment||Treatment||None (Open Label)||||||
1473799|NCT01326871|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473800|NCT01326858|Randomized|Crossover Assignment||||Double|||t||t|
1473801|NCT01326845|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473802|NCT01326832|||Cohort||Prospective|||||||
1473803|NCT01326819|||Cohort||Prospective|||||||
1473804|NCT01326806|Randomized|Parallel Assignment||Prevention||Single|||t|||
1473805|NCT01326793||Single Group Assignment||Screening||None (Open Label)||||||
1473806|NCT01326780|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473807|NCT01326767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473808|NCT01326754|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473809|NCT01326741|||Cohort||Retrospective|||||||
1473810|NCT01326728|||Case-Control||Prospective|||||||
1473811|NCT01326715|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1473812|NCT01326702||Single Group Assignment||Treatment||None (Open Label)||||||
1473813|NCT01326689|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1473814|NCT01326676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473815|NCT01326663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473816|NCT01326650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473817|NCT01326637|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1473818|NCT01326624|||Cohort||Prospective|||||||
1473819|NCT01326611|Randomized|Crossover Assignment||Prevention||Double||||t|t|
1473820|NCT01326598|||Cohort||Retrospective|||||||
1473821|NCT01326585|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1473822|NCT01326572|||Cohort||Prospective|||||||
1473823|NCT01326559||Single Group Assignment||Treatment||None (Open Label)||||||
1473824|NCT01326546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473825|NCT01326533|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1473826|NCT01326520|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1473827|NCT01326507||Single Group Assignment||Diagnostic||None (Open Label)||||||
1473828|NCT01326494|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473829|NCT01326481||Single Group Assignment||Treatment||None (Open Label)||||||
1473830|NCT01326468|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473831|NCT01326455|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1473832|NCT01326442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473833|NCT01326429|||Case-Only||Prospective|||||||
1473834|NCT01326416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473835|NCT01326403|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1473836|NCT01326390|||Cohort||Prospective|||||||
1473837|NCT01326364|||Cohort||Prospective|||||||
1473838|NCT01326351|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473839|NCT01326338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473840|NCT01326325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473841|NCT01326312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473842|NCT01326299|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1473843|NCT01326286|||Cohort||Prospective|||||||
1473844|NCT01326273|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473845|NCT01326260|||Cohort||Retrospective|||||||
1473846|NCT01326247|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473847|NCT01326234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473848|NCT01326221|||Cohort||Prospective|||||||
1473849|NCT01326208|Randomized|Crossover Assignment||Treatment||Single|||t|||
1473850|NCT01326195|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1473851|NCT01326182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473852|NCT01326169|Randomized|Parallel Assignment||Treatment||Single||||||t
1473853|NCT01326156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473862|NCT01326039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473863|NCT01326026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473864|NCT01326013|||Case-Only||Prospective|||||||
1473865|NCT01326000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473866|NCT01325987|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473867|NCT01325974|||Cohort||Prospective|||||||
1473868|NCT01325961||Single Group Assignment||||None (Open Label)||||||
1473869|NCT01325948|||||Cross-Sectional|||||||
1473870|NCT01325935|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473871|NCT01325922|Randomized|Parallel Assignment||||||||||
1473872|NCT01325909|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1473873|NCT01325896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473874|NCT01325883|||||Prospective|||||||
1473875|NCT01325870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473876|NCT01325857|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1473877|NCT01325844|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1473878|NCT01325831|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473879|NCT01325818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473880|NCT01325805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473881|NCT01325792|||Cohort||Prospective|||||||
1473882|NCT01325779|Randomized|Parallel Assignment||Prevention||Single||||||t
1473883|NCT01325766|Randomized|Parallel Assignment||||None (Open Label)||||||
1473884|NCT01325753||Single Group Assignment||Treatment||None (Open Label)||||||
1473885|NCT01325740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473886|NCT01325727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473887|NCT01325714|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1473888|NCT01325701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473889|NCT01325688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473890|NCT01325675|Randomized|Parallel Assignment||Prevention||Single||||||t
1473891|NCT01325662|||Cohort||Prospective|||||||
1473892|NCT01325649|||Case Control||Prospective|||||||
1473893|NCT01325636||Single Group Assignment||Treatment||None (Open Label)||||||
1473894|NCT01325623||Single Group Assignment||Treatment||None (Open Label)||||||
1473895|NCT01325610||Single Group Assignment||Treatment||None (Open Label)||||||
1473896|NCT01325597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473897|NCT01325584||Single Group Assignment||Treatment||None (Open Label)||||||
1473898|NCT01325571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473899|NCT01325558|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473900|NCT01325545|||Case Control||Prospective|||||||
1473901|NCT01325532|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473902|NCT01325519|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1473903|NCT01325506|||Cohort||Prospective|||||||
1473904|NCT01325493|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1473905|NCT01325480|||Case-Only||Cross-Sectional|||||||
1473906|NCT01325467|||Case-Only||Prospective|||||||
1473907|NCT01325454|||Case Control||Prospective|||||||
1473908|NCT01325441||Single Group Assignment||Treatment||None (Open Label)||||||
1473909|NCT01325428||Single Group Assignment||Treatment||None (Open Label)||||||
1473910|NCT01325415|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1473911|NCT01325402|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1473912|NCT01325389|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1473913|NCT01325376|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1473914|NCT01325363|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1473915|NCT01325350|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473916|NCT01325337|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1473917|NCT01325324|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1473918|NCT01325311|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473919|NCT01325298|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1473920|NCT01325285|||Case-Only||Cross-Sectional|||||||
1473921|NCT01325272|||||Retrospective|||||||
1473922|NCT01325259|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1473923|NCT01325246|||Cohort||Retrospective|||||||
1473924|NCT01325233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473925|NCT01325220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473926|NCT01325207||Single Group Assignment||Treatment||None (Open Label)||||||
1473927|NCT01325194||Single Group Assignment||Treatment||None (Open Label)||||||
1473928|NCT01325181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473929|NCT01325168|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1473930|NCT01325155|||Case-Only||Cross-Sectional|||||||
1473931|NCT01325142|||Case Control||Retrospective|||||||
1473932|NCT01325129|||Cohort||Retrospective|||||||
1473933|NCT01325116|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1473934|NCT01325103||Single Group Assignment||Treatment||None (Open Label)||Mesenchymal stem cell transplantation.||||
1473935|NCT01325090|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1473936|NCT01325077|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473937|NCT01325064|||Cohort||Prospective|||||||
1473938|NCT01325051||Single Group Assignment||Basic Science||None (Open Label)||||||
1473939|NCT01325038|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1473940|NCT01325025|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1473941|NCT01325012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473942|NCT01324999||Single Group Assignment||Treatment||None (Open Label)||||||
1473943|NCT01324986||||||||||||
1473944|NCT01324973|Randomized|Parallel Assignment||Treatment||Single||||||t
1473945|NCT01324960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473946|NCT01324947||Single Group Assignment||Treatment||None (Open Label)||||||
1473947|NCT01324934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473948|NCT01324921|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473949|NCT01324908||Single Group Assignment||Treatment||None (Open Label)||||||
1473950|NCT01324895|||Case Control||Retrospective|||||||
1473951|NCT01324882|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1473952|NCT01324869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473953|NCT01324856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473954|NCT01324843|Randomized|Single Group Assignment||Prevention||Double||||||
1473955|NCT01324830|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473956|NCT01324817|||Case-Only||Cross-Sectional|||||||
1473957|NCT01324804|||Cohort||Prospective|||||||
1473958|NCT01324791||||||||||||
1473959|NCT01324778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473960|NCT01324765|Randomized|Parallel Assignment||Treatment||Single||||||t
1473961|NCT01324752|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1473962|NCT01324739|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1473963|NCT01324726|||Cohort||Prospective|||||||
1473964|NCT01324713|||Case-Only||Cross-Sectional|||||||
1473965|NCT01324700|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1473966|NCT01324687|||Cohort||Prospective|||||||
1473967|NCT01324674|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1473968|NCT01324661|Randomized|Single Group Assignment||||Single|||t|||
1473969|NCT01324648|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1473970|NCT01324635|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473971|NCT01324622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473972|NCT01324609|||Cohort||Prospective|||||||
1473973|NCT01324596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473974|NCT01324583||Single Group Assignment||Treatment||None (Open Label)||||||
1473975|NCT01324570||Single Group Assignment||Treatment||None (Open Label)||||||
1473976|NCT01324557|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473977|NCT01324544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473978|NCT01324531|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473979|NCT01324518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1473980|NCT01324505|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1473981|NCT01324492|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1473982|NCT01324479||Single Group Assignment||Treatment||None (Open Label)||||||
1473983|NCT01324466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473984|NCT01324453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1473985|NCT01324440|Randomized|Parallel Assignment||Prevention||Double||||||
1473986|NCT01324427||Single Group Assignment||Supportive Care||None (Open Label)||||||
1473987|NCT01324414|||Cohort||Prospective|||||||
1473988|NCT01324401|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|The observational control arm (parallel for the first year) was then offered to cross over to active treatment||||
1473989|NCT01324388|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473990|NCT01324375|||Cohort||Prospective|||||||
1473991|NCT01324362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1473992|NCT01324349|Randomized|Parallel Assignment||Treatment||Single|||t|||
1473993|NCT01324336|||Case-Only||Prospective|||||||
1473994|NCT01324323||Single Group Assignment||||None (Open Label)||||||
1473995|NCT01324310||Single Group Assignment||||None (Open Label)||||||
1473996|NCT01324297|||Cohort||Prospective|||||||
1473997|NCT01324284|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1473998|NCT01324271||Single Group Assignment||Treatment||None (Open Label)||||||
1473999|NCT01324258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474000|NCT01324245|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1474001|NCT01324232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474002|NCT01324219|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1474003|NCT01324206||||||||||||
1474004|NCT01324193|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474005|NCT01324180||Single Group Assignment||Treatment||None (Open Label)||||||
1474006|NCT01324167|||Case-Only||Prospective|||||||
1474007|NCT01324141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474008|NCT01324128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474009|NCT01324115||||Treatment||||||||
1474010|NCT01324102|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474011|NCT01324089|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474012|NCT01324076|Randomized|||Treatment||Double||||||
1474013|NCT01324063|Randomized|||Treatment||||||||
1474014|NCT01324050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474015|NCT01324037||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474016|NCT01324024|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1474017|NCT01324011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474018|NCT01323998|||Cohort||Retrospective|||||||
1474019|NCT01323985|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474020|NCT01323972|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474021|NCT01323959|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474022|NCT01323946|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1474023|NCT01323933||Single Group Assignment||Treatment||None (Open Label)||||||
1474024|NCT01323920||Single Group Assignment||Treatment||None (Open Label)||||||
1474025|NCT01323907||Single Group Assignment||Treatment||None (Open Label)||||||
1474026|NCT01323894||||||||||||
1474027|NCT01323881|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1474028|NCT01323868|||Cohort||Prospective|||||||
1474029|NCT01323855|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474030|NCT01323842|||Cohort||Prospective|||||||
1474031|NCT01323829||Single Group Assignment||Treatment||None (Open Label)||||||
1474032|NCT01323816|||Cohort||Retrospective|||||||
1474033|NCT01323803|||Case-Only||Cross-Sectional|||||||
1474034|NCT01323790|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474035|NCT01323777||Single Group Assignment||Treatment||None (Open Label)||||||
1474036|NCT01323764||Single Group Assignment||Diagnostic||Triple|||t|t|t|
1474037|NCT01323751||Single Group Assignment||Treatment||None (Open Label)||||||
1474038|NCT01323738|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1474039|NCT01323725||Single Group Assignment||Prevention||None (Open Label)||||||
1474040|NCT01323712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474041|NCT01323699||Single Group Assignment||Treatment||None (Open Label)||||||
1474042|NCT01323686|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474043|NCT01323673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474044|NCT01323660|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474045|NCT01323647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474046|NCT01323634|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474047|NCT01323621|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474048|NCT01323608|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1474049|NCT01323595|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474050|NCT01323582|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474051|NCT01323569|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1474052|NCT01323556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474053|NCT01323543||Single Group Assignment||Treatment||None (Open Label)||||||
1474054|NCT01323530|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474055|NCT01323517||Single Group Assignment||Treatment||None (Open Label)||||||
1474056|NCT01323504|Randomized|Parallel Assignment||||None (Open Label)||||||
1474057|NCT01323491|||Cohort||Prospective|||||||
1474058|NCT01323478||Single Group Assignment||Treatment||None (Open Label)||||||
1474059|NCT01323465|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474060|NCT01323452|||Cohort||Retrospective|||||||
1474061|NCT01323439|||Other||Prospective|||||||
1474062|NCT01323426||Single Group Assignment||Treatment||None (Open Label)||||||
1474063|NCT01323413|||Cohort||Retrospective|||||||
1474064|NCT01323400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474065|NCT01323387||Single Group Assignment||Treatment||None (Open Label)||||||
1474066|NCT01323374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474067|NCT01323361||Single Group Assignment||Basic Science||None (Open Label)||||||
1474068|NCT01323348|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474069|NCT01323335|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1474070|NCT01323322|||Cohort||Prospective|||||||
1474071|NCT01323309|||Cohort||Prospective|||||||
1474072|NCT01323296|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1474073|NCT01323283|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474074|NCT01323270|Randomized|Parallel Assignment||Prevention||Single|||t|||
1474075|NCT01323257|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474076|NCT01323244||Single Group Assignment||Treatment||None (Open Label)||||||
1474077|NCT01323231|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474078|NCT01323218|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474079|NCT01323205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474080|NCT01323192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474081|NCT01323179|||Cohort||Prospective|||||||
1474082|NCT01323166|||Case Control||Retrospective|||||||
1474083|NCT01323153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474084|NCT01323140||Single Group Assignment||Treatment||None (Open Label)||||||
1474085|NCT01323127|||Case Control||Prospective|||||||
1474086|NCT01323114|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474087|NCT01323101|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474088|NCT01323088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474089|NCT01323075|||Cohort||Prospective|||||||
1474090|NCT01323062||Single Group Assignment||Treatment||None (Open Label)||||||
1474091|NCT01323049|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474092|NCT01323036|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474093|NCT01323023|||||Prospective|||||||
1474094|NCT01323010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474095|NCT01322997|Randomized|Parallel Assignment||Treatment||Single||||||t
1474258|NCT01320865|||Cohort||Prospective|||||||
1474096|NCT01322984|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1474097|NCT01322971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474098|NCT01322958|||Cohort||Prospective|||||||
1474099|NCT01322945|||Cohort||Prospective|||||||
1474100|NCT01322932|||Case-Only||Prospective|||||||
1474101|NCT01322919|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474102|NCT01322906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474103|NCT01322893|||Other||Prospective|||||||
1474104|NCT01322880|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1474105|NCT01322867|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474106|NCT01322854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474107|NCT01322841|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1474108|NCT01322828|Randomized|Parallel Assignment||Treatment||Single||||||t
1474109|NCT01322815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474110|NCT01322802||Single Group Assignment||Treatment||None (Open Label)||||||
1474111|NCT01322789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474112|NCT01322776||Single Group Assignment||Treatment||None (Open Label)||||||
1474113|NCT01322763|||||Prospective|||||||
1474114|NCT01322750|||Cohort||Prospective|||||||
1474115|NCT01322737||Single Group Assignment||||None (Open Label)||||||
1474116|NCT01322724|Randomized|Single Group Assignment||Screening||Double|||t||t|
1474117|NCT01322711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474118|NCT01322698|||Cohort||Prospective|||||||
1474119|NCT01322685|||Case Control||Prospective|||||||
1474120|NCT01322672|||Case-Only||Prospective|||||||
1474121|NCT01322659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474122|NCT01322646|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474123|NCT01322633|||Cohort||Prospective|||||||
1474124|NCT01322620|||Cohort||Cross-Sectional|||||||
1474125|NCT01322607|Randomized|Parallel Assignment||||None (Open Label)||||||
1474126|NCT01322594|Randomized|Single Group Assignment||Treatment||Single|||t|||
1474127|NCT01322581|||Cohort||Prospective|||||||
1474128|NCT01322568|||||Prospective|||||||
1474129|NCT01322555|||||Prospective|||||||
1474130|NCT01322529|||Cohort||Prospective|||||||
1474131|NCT01322516|||Cohort||Prospective|||||||
1474132|NCT01322503|Non-Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1474133|NCT01322490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474134|NCT01322477|||Cohort||Prospective|||||||
1474135|NCT01322464|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474136|NCT01322451|Randomized|Crossover Assignment||||None (Open Label)||||||
1474137|NCT01322438|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1474138|NCT01322425|||Case Control||Prospective|||||||
1474139|NCT01322412|||Other||Prospective|||||||
1474140|NCT01322399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474141|NCT01322386||Single Group Assignment||Treatment||None (Open Label)||||||
1474142|NCT01322373|||Case Control||Prospective|||||||
1474143|NCT01322360||Single Group Assignment||Treatment||None (Open Label)||||||
1474144|NCT01322347|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474145|NCT01322334|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474146|NCT01322321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474147|NCT01322308|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474148|NCT01322295|||Case-Only||Prospective|||||||
1474149|NCT01322282|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1474150|NCT01322269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474151|NCT01322256||Single Group Assignment||Diagnostic||Single||||||t
1474152|NCT01322243|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474153|NCT01322230|Randomized|Factorial Assignment||||Single|||t|||
1474154|NCT01322217|||Cohort||Cross-Sectional|||||||
1474155|NCT01322204||Single Group Assignment||Treatment||None (Open Label)||||||
1474156|NCT01322191|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1474157|NCT01322178||Single Group Assignment||Treatment||None (Open Label)||||||
1474158|NCT01322165|||Cohort||Prospective|||||||
1474159|NCT01322152||Single Group Assignment||Treatment||None (Open Label)||||||
1474160|NCT01322139|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1474161|NCT01322126|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474162|NCT01322113|||Case-Only||Prospective|||||||
1474163|NCT01322100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474164|NCT01322087||Single Group Assignment||Supportive Care||Single||||||t
1474165|NCT01322074|||Cohort||Prospective|||||||
1474166|NCT01322061|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474167|NCT01322048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474168|NCT01322035|||Cohort||Prospective|||||||
1474169|NCT01322022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474170|NCT01322009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474171|NCT01321996||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474172|NCT01321983||||||||||||
1474173|NCT01321970|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1474174|NCT01321957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474175|NCT01321944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474176|NCT01321931|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474177|NCT01321918||||||None (Open Label)||||||
1474178|NCT01321905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474179|NCT01321892|||Case-Only||Cross-Sectional|||||||
1474180|NCT01321879||Single Group Assignment||Treatment||None (Open Label)||||||
1474181|NCT01321866|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1474182|NCT01321853|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474183|NCT01321840|Randomized|Parallel Assignment||Basic Science||Single||||||t
1474184|NCT01321827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474185|NCT01321814|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474186|NCT01321801|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1474187|NCT01321788|||Cohort||Prospective|||||||
1474188|NCT01321775||Single Group Assignment||Treatment||None (Open Label)||||||
1474189|NCT01321762|||Cohort||Prospective|||||||
1474190|NCT01321749|Randomized|Parallel Assignment||Prevention||Single||||||t
1474191|NCT01321736|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1474192|NCT01321723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474193|NCT01321710|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1474194|NCT01321697|||Case-Only||Prospective|||||||
1474195|NCT01321684|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1474196|NCT01321671|Randomized|Crossover Assignment||||None (Open Label)||||||
1474197|NCT01321658|Randomized|Parallel Assignment||Treatment||Single||||||t
1474198|NCT01321645||Single Group Assignment||Treatment||None (Open Label)||||||
1474199|NCT01321632||Single Group Assignment||Treatment||None (Open Label)||||||
1474200|NCT01321619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474201|NCT01321606|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474202|NCT01321593|||Cohort||Prospective|||||||
1474203|NCT01321580||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474204|NCT01321567|||Cohort||Prospective|||||||
1474205|NCT01321554|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474206|NCT01321541|Randomized|Parallel Assignment||Treatment||Single||||||t
1474207|NCT01321528|||Case-Only||Prospective|||||||
1474208|NCT01321515|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474209|NCT01321502|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474210|NCT01321489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474211|NCT01321476|||||Prospective|||||||
1474212|NCT01321463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474213|NCT01321450|||Cohort||Prospective|||||||
1474214|NCT01321437||Single Group Assignment||Treatment||None (Open Label)||||||
1474215|NCT01321424|||Case Control||Cross-Sectional|||||||
1474216|NCT01321411|||Cohort||Prospective|||||||
1474217|NCT01321398|||Cohort||Prospective|||||||
1474218|NCT01321385|||Cohort||Retrospective|||||||
1474219|NCT01321372|||Cohort||Prospective|||||||
1474220|NCT01321359|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474221|NCT01321346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474222|NCT01321333||Single Group Assignment||Treatment||None (Open Label)||||||
1474223|NCT01321320||Single Group Assignment||Basic Science||Single|||||t|
1474224|NCT01321307|||Case Control||Prospective|||||||
1474225|NCT01321294||||||||||||
1474226|NCT01321281|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1474227|NCT01321268|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474228|NCT01321255|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474229|NCT01321242|||Cohort||Prospective|||||||
1474230|NCT01321229|||Cohort||Prospective|||||||
1474231|NCT01321216|||Cohort||Prospective|||||||
1474232|NCT01321203|||Case Control||Prospective|||||||
1474233|NCT01321190|||Case-Only||Cross-Sectional|||||||
1474234|NCT01321177|Randomized|Parallel Assignment||Treatment||Single||||||t
1474235|NCT01321164|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474236|NCT01321151|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474237|NCT01321138|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1474238|NCT01321125|Non-Randomized|Factorial Assignment||Prevention||Single||||||t
1474239|NCT01321112|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1474240|NCT01321099|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1474241|NCT01321086|Randomized|Parallel Assignment||Treatment||Single||||||t
1474242|NCT01321073||Single Group Assignment||Treatment||None (Open Label)||||||
1474243|NCT01321060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474244|NCT01321047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474245|NCT01321034||Single Group Assignment||Treatment||None (Open Label)||||||
1474246|NCT01321021|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1474247|NCT01321008||Single Group Assignment||Treatment||None (Open Label)||||||
1474248|NCT01320995|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1474249|NCT01320982|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474250|NCT01320969|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1474251|NCT01320956|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1474252|NCT01320943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474253|NCT01320930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474254|NCT01320917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474255|NCT01320904|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1474256|NCT01320891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474257|NCT01320878|Randomized|Parallel Assignment||Treatment||Single||||||t
1474259|NCT01320852|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1474260|NCT01320839|||Case-Crossover||Cross-Sectional|||||||
1474261|NCT01320826|||Cohort||Prospective|||||||
1474262|NCT01320813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474263|NCT01320800|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1474264|NCT01320787||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474265|NCT01320774|||Cohort||Prospective|||||||
1474266|NCT01320761|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1474267|NCT01320748|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474268|NCT01320735|||||Prospective|||||||
1474269|NCT01320722|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474270|NCT01320709|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1474271|NCT01320696|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1474272|NCT01320683||Single Group Assignment||Treatment||None (Open Label)||||||
1474273|NCT01320670|||Cohort||Prospective|||||||
1474274|NCT01320657|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474275|NCT01320644|||Cohort||Retrospective|||||||
1474276|NCT01320631|||Other||Prospective|||||||
1474277|NCT01320618|||Cohort||Retrospective|||||||
1474278|NCT01320605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474279|NCT01320592||Single Group Assignment||Treatment||||||||
1474280|NCT01320579|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1474281|NCT01320566|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474282|NCT01320553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474283|NCT01320540|||Cohort||Prospective|||||||
1474284|NCT01320527|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1474285|NCT01320514|||Case Control||Prospective|||||||
1474286|NCT01320501||Single Group Assignment||Treatment||None (Open Label)||||||
1474287|NCT01320488|||Cohort||Prospective|||||||
1474288|NCT01320475|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474289|NCT01320462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474290|NCT01320449|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1474291|NCT01320436|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474292|NCT01320423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474293|NCT01320410|Non-Randomized|||Treatment||Single||||||
1474294|NCT01320397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474295|NCT01320384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474296|NCT01320371|||Cohort||Cross-Sectional|||||||
1474297|NCT01320358||Single Group Assignment||Supportive Care||None (Open Label)||||||
1474298|NCT01320345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474299|NCT01320332|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1474300|NCT01320319|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1474301|NCT01320306|||||Retrospective|||||||
1474302|NCT01320293||Single Group Assignment||Treatment||None (Open Label)||||||
1474303|NCT01320280||Single Group Assignment||Treatment||None (Open Label)||||||
1474304|NCT01320267||Single Group Assignment||Treatment||None (Open Label)||||||
1474305|NCT01320254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474306|NCT01320241|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474307|NCT01320228|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1474308|NCT01320215|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474309|NCT01320202|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474310|NCT01320189|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474311|NCT01320176|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474312|NCT01320163|Randomized|Parallel Assignment||Treatment||Single||||||t
1474313|NCT01320150|||Case-Control||Prospective|||||||
1474314|NCT01320137|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1474315|NCT01320124|||Cohort||Retrospective|||||||
1474316|NCT01320111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474317|NCT01320098|Randomized|Parallel Assignment||Treatment||Single||||||t
1474318|NCT01320085|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474319|NCT01320072|||Case-Control||Prospective|||||||
1474320|NCT01320059||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474321|NCT01320046|||Case Control||Prospective|||||||
1474322|NCT01320033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474323|NCT01320020||Single Group Assignment||Treatment||None (Open Label)||||||
1474324|NCT01320007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474325|NCT01319994|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474326|NCT01319981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474327|NCT01319968|||Case-Only||Prospective|||||||
1474328|NCT01319955|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474329|NCT01319942|||Cohort||Prospective|||||||
1474330|NCT01319929|Randomized|Crossover Assignment||||Double|||t||t|
1474331|NCT01319916||Single Group Assignment||Treatment||None (Open Label)||||||
1474332|NCT01319903|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1474333|NCT01319890|||Case-Only||Prospective|||||||
1474334|NCT01319877|||Cohort||Prospective|||||||
1474335|NCT01319864||Single Group Assignment||Treatment||None (Open Label)||||||
1474336|NCT01319851||Single Group Assignment||Treatment||None (Open Label)||||||
1474337|NCT01319838||Single Group Assignment||Treatment||None (Open Label)||||||
1474338|NCT01319825|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1475129|NCT01309347|||||Cross-Sectional|||||||
1474339|NCT01319812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474340|NCT01319799|||Case-Only||Prospective|||||||
1474341|NCT01319786|Randomized|Parallel Assignment||Treatment||Single||||||t
1474342|NCT01319773|Randomized|Parallel Assignment||||Triple|||t||t|t
1474343|NCT01319760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474344|NCT01319747|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474345|NCT01319734|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474346|NCT01319721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474347|NCT01319708|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474348|NCT01319695|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1474349|NCT01319682|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1474350|NCT01319669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474351|NCT01319656|Non-Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1474352|NCT01319643|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474353|NCT01319630|||Case-Control||Prospective|||||||
1474354|NCT01319617||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474355|NCT01319604|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1474356|NCT01319591|||Cohort||Retrospective|||||||
1474357|NCT01319578|Non-Randomized|Crossover Assignment||||Single|||t|||
1474358|NCT01319565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474359|NCT01319552|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474360|NCT01319539||Single Group Assignment||Treatment||None (Open Label)||||||
1474361|NCT01319526|||Cohort||Prospective|||||||
1474362|NCT01319513|Randomized|Crossover Assignment||||None (Open Label)||||||
1474363|NCT01319500|||||Retrospective|||||||
1474364|NCT01319487|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474365|NCT01319474||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474366|NCT01319461|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1474367|NCT01319448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474368|NCT01319435||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474369|NCT01319422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474370|NCT01319409|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1474371|NCT01319396|||Case-Only||Cross-Sectional|||||||
1474372|NCT01319383||Single Group Assignment||Treatment||None (Open Label)|Open label|All participants eligible for study received the same open label drug||||
1474373|NCT01319370|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474374|NCT01319357|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474375|NCT01319344||Single Group Assignment||Prevention||None (Open Label)||||||
1474376|NCT01319331||Single Group Assignment||Treatment||None (Open Label)||||||
1474377|NCT01319318|||Cohort||Prospective|||||||
1474378|NCT01319305|||Cohort||Prospective|||||||
1474379|NCT01319292|||Ecologic or Community||Prospective|||||||
1474380|NCT01319279|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474381|NCT01319266|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474382|NCT01319253|||Cohort||Prospective|||||||
1474383|NCT01319240|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474384|NCT01319227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474385|NCT01319214|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1474386|NCT01319201|||Cohort||Prospective|||||||
1474387|NCT01319188|Randomized|Parallel Assignment||Screening||Double|||t|t||
1474388|NCT01319175|Randomized|||||Single||||||t
1474389|NCT01319162|||Cohort||Prospective|||||||
1474390|NCT01319149|||Cohort||Retrospective|||||||
1474391|NCT01319136|||Case-Only||Cross-Sectional|||||||
1474392|NCT01319123||Single Group Assignment||Treatment||None (Open Label)||||||
1474393|NCT01319110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474394|NCT01319097||Single Group Assignment||Treatment||None (Open Label)||||||
1474395|NCT01319084|||Case Control||Prospective|||||||
1474396|NCT01319071|||Cohort||Prospective|||||||
1474397|NCT01319058|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474398|NCT01319045||Single Group Assignment||Treatment||None (Open Label)||||||
1474399|NCT01319032|||Cohort||Prospective|||||||
1474400|NCT01319019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474401|NCT01319006|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474402|NCT01318993||Single Group Assignment||Treatment||None (Open Label)||||||
1474403|NCT01318980|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474404|NCT01318967|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1474405|NCT01318954|||Cohort||Prospective|||||||
1474406|NCT01318941|||Cohort||Prospective|||||||
1474407|NCT01318928||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1474408|NCT01318915||Single Group Assignment||Treatment||None (Open Label)||||||
1474409|NCT01318902||Single Group Assignment||Treatment||None (Open Label)||||||
1474410|NCT01318889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474411|NCT01318876|||Cohort||Prospective|||||||
1474412|NCT01318863|||||Prospective|||||||
1474413|NCT01318850|Randomized|Factorial Assignment||Treatment||Single||||||t
1474414|NCT01318837|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1474415|NCT01318824|Randomized|Parallel Assignment||Treatment||Single||||t||
1474416|NCT01318811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474417|NCT01318798|||Cohort||Retrospective|||||||
1475586|NCT01303367|||||Retrospective|||||||
1474418|NCT01318785|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474419|NCT01318772|||Case-Only||Prospective|||||||
1474420|NCT01318759|||Cohort||Prospective|||||||
1474421|NCT01318746|||Cohort||Cross-Sectional|||||||
1474422|NCT01318733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474423|NCT01318720|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474424|NCT01318707|||||Prospective|||||||
1474425|NCT01318694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474426|NCT01318681|Randomized|Crossover Assignment||||Double|||t||t|
1474427|NCT01318668|Randomized|Crossover Assignment||||Triple|||t||t|t
1474428|NCT01318655|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1474429|NCT01318642|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474430|NCT01318629|||Cohort||Prospective|||||||
1474431|NCT01318616|Randomized|Parallel Assignment||||Single||||||t
1474432|NCT01318590|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1474433|NCT01318577||||||||||||
1474434|NCT01318564|||Cohort||Prospective|||||||
1474435|NCT01318551|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1474436|NCT01318538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474437|NCT01318525|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474438|NCT01318512|||Cohort||Prospective|||||||
1474439|NCT01318499|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474440|NCT01318486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474441|NCT01318473||Single Group Assignment||Treatment||None (Open Label)||||||
1474442|NCT01318460|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474443|NCT01318447||Single Group Assignment||Treatment||None (Open Label)||||||
1474444|NCT01318434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474445|NCT01318421||Single Group Assignment||Treatment||None (Open Label)||||||
1474446|NCT01318408||Single Group Assignment||Treatment||None (Open Label)||||||
1474447|NCT01318395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474448|NCT01318382||Single Group Assignment||Other||None (Open Label)||||||
1474449|NCT01318369|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1474450|NCT01318356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474451|NCT01318343|||Cohort||Cross-Sectional|||||||
1474452|NCT01318330||Single Group Assignment||||None (Open Label)||||||
1474453|NCT01318317||Single Group Assignment||Treatment||None (Open Label)||||||
1474454|NCT01318304|||Cohort||Prospective|||||||
1474455|NCT01318291|Randomized|Single Group Assignment||Treatment||Single||||t||
1474456|NCT01318278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474457|NCT01318265|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1474458|NCT01318252|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474459|NCT01318239|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1474460|NCT01318226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474461|NCT01318213|||Other||Prospective|||||||
1474462|NCT01318200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474463|NCT01318187|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1474464|NCT01318174|||Case-Only||Prospective|||||||
1474465|NCT01318161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474466|NCT01318148||Single Group Assignment||Prevention||None (Open Label)||||||
1474467|NCT01318135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474468|NCT01318122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474469|NCT01318109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474470|NCT01318096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474471|NCT01318083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474472|NCT01318070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474473|NCT01318057|||Cohort||Retrospective|||||||
1474474|NCT01318044|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474475|NCT01318031|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1474476|NCT01318018|||Case-Control||Prospective|||||||
1474477|NCT01318005|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1474478|NCT01317992|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474479|NCT01317979|||Case-Only||Prospective|||||||
1474480|NCT01317966|||Cohort||Prospective|||||||
1474481|NCT01317953||||||||||||
1474482|NCT01317940|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474483|NCT01317927||Single Group Assignment||Treatment||None (Open Label)||||||
1474484|NCT01317914||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474485|NCT01317901||Single Group Assignment||Treatment||None (Open Label)||||||
1474486|NCT01317888|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474487|NCT01317875||Single Group Assignment||Treatment||None (Open Label)||||||
1474488|NCT01317862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474489|NCT01317849|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1474490|NCT01317836|||Cohort||Prospective|||||||
1474491|NCT01317823|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1474492|NCT01317810|||Cohort||Prospective|||||||
1474493|NCT01317797|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1474494|NCT01317784|Randomized|Parallel Assignment||Screening||Triple|||t|t||t
1474495|NCT01317771|||Cohort||Retrospective|||||||
1474496|NCT01317758|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1474497|NCT01317745|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1474498|NCT01317732||Single Group Assignment||Other||None (Open Label)||||||
1474499|NCT01317719|||Cohort||Prospective|||||||
1474500|NCT01317706|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1474501|NCT01317693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474502|NCT01317680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474503|NCT01317667|Randomized|Parallel Assignment||||None (Open Label)||||||
1474504|NCT01317654|||Case-Only||Prospective|||||||
1474505|NCT01317641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474506|NCT01317628|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1474507|NCT01317615||Single Group Assignment||Treatment||None (Open Label)||||||
1474508|NCT01317602|||Case-Only||Prospective|||||||
1474509|NCT01317589|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474510|NCT01317576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474511|NCT01317563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474512|NCT01317550|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1474513|NCT01317537|Randomized|Factorial Assignment||||Single|||||t|
1474514|NCT01317524|Randomized|Crossover Assignment||Prevention||Single|||||t|
1474515|NCT01317511|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1474516|NCT01317498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474517|NCT01317485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474518|NCT01317472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474519|NCT01317459|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474520|NCT01317446|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474521|NCT01317433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474522|NCT01317420||Single Group Assignment||Treatment||None (Open Label)||||||
1474523|NCT01317407|||Case-Only||Prospective|||||||
1474524|NCT01317394|||Case-Only||Retrospective|||||||
1474525|NCT01317381|||Cohort||Prospective|||||||
1474526|NCT01317368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474527|NCT01317355|||Cohort||Cross-Sectional|||||||
1474528|NCT01317342|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474529|NCT01317329||Single Group Assignment||Treatment||None (Open Label)||||||
1474530|NCT01317316|||||Prospective|||||||
1474531|NCT01317303|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1474532|NCT01317290|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474533|NCT01317277|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1474534|NCT01317264|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1474535|NCT01317251|Randomized|Crossover Assignment||Prevention||Single||||||t
1474536|NCT01317238||Single Group Assignment||Prevention||None (Open Label)||||||
1474537|NCT01317225|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1474538|NCT01317212||Single Group Assignment||Treatment||None (Open Label)||||||
1474539|NCT01317199|Randomized|Parallel Assignment||Treatment||Double|Phase 1 (Arms 1) - open label Phase 2 (Arms 2-4) - randomized, double-blind|Arm 1: participants in dose-escalation phase (Phase 1) Arms 2-4: Randomized, double-blind (Phase 2); control, low-dose, high-dose|t||t|
1474540|NCT01317186|||Cohort|||||||||
1474541|NCT01317173|||Cohort||Prospective|||||||
1474542|NCT01317160|Randomized|Parallel Assignment||Prevention||Double||||t||t
1474543|NCT01317147|||Case-Only||Prospective|||||||
1474544|NCT01317134|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1474545|NCT01317121|||Case Control||Prospective|||||||
1474546|NCT01317108|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1474547|NCT01317095|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474548|NCT01317082||||||||||||
1474549|NCT01317069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474550|NCT01317030|Randomized|Parallel Assignment||||None (Open Label)||||||
1474551|NCT01317017||Single Group Assignment||Basic Science||None (Open Label)||||||
1474552|NCT01317004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474553|NCT01316991|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1474554|NCT01316978|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1474555|NCT01316965|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474556|NCT01316952|||Case Control||Retrospective|||||||
1474557|NCT01316939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474558|NCT01316926|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1474559|NCT01316913|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474560|NCT01316900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474561|NCT01316887|Randomized|Parallel Assignment||Other||Double|||t||t|
1474562|NCT01316874||Single Group Assignment||Treatment||None (Open Label)||||||
1474563|NCT01316861|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474564|NCT01316848|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474565|NCT01316835|||||Retrospective|||||||
1474566|NCT01316822||Single Group Assignment||Treatment||None (Open Label)||||||
1474567|NCT01316809|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474568|NCT01316796|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474569|NCT01316783|||Cohort||Cross-Sectional|||||||
1474570|NCT01316770|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1474571|NCT01316757||Single Group Assignment||Treatment||None (Open Label)||||||
1474572|NCT01316744|Randomized|||Supportive Care||Double||||||
1474573|NCT01316731||Single Group Assignment||Basic Science||None (Open Label)||||||
1474574|NCT01316718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474575|NCT01316705|||Case-Control||Prospective|||||||
1474576|NCT01316692||Single Group Assignment||Treatment||None (Open Label)||||||
1474577|NCT01316679|||Case-Control||Cross-Sectional|||||||
1474578|NCT01316666|||||Prospective|||||||
1474579|NCT01316653|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474580|NCT01316627|Randomized|Single Group Assignment||Treatment||Single|||t|||
1474581|NCT01316614||Single Group Assignment||Diagnostic||Single||||||t
1474582|NCT01316601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474583|NCT01316588|Randomized|Parallel Assignment||Prevention||Single|||t|||
1474584|NCT01316575|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474585|NCT01316562|||Cohort||Cross-Sectional|||||||
1474586|NCT01316549|||Other||Prospective|||||||
1474587|NCT01316536|Randomized|Single Group Assignment||Supportive Care||Single||||t||
1474588|NCT01316523||Single Group Assignment||Treatment||None (Open Label)||||||
1474589|NCT01316510|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1474590|NCT01316497|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1474591|NCT01316484|||Case-Only||Cross-Sectional|||||||
1474592|NCT01316471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474593|NCT01316458||Single Group Assignment||Treatment||None (Open Label)||||||
1474594|NCT01316445||Single Group Assignment||Treatment||None (Open Label)||||||
1474595|NCT01316432|Randomized|Single Group Assignment||||Single|||t|||
1474596|NCT01316419|||||Prospective|||||||
1474597|NCT01316406|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474598|NCT01316393|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1474599|NCT01316380|Randomized|Parallel Assignment||Treatment||Double||||||
1474600|NCT01316367|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474601|NCT01316354|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1474602|NCT01316341|Randomized|Parallel Assignment||Treatment||Double||||||
1474603|NCT01316328|||Cohort||Prospective|||||||
1474604|NCT01316315|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1474605|NCT01316302|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474606|NCT01316289|||Case-Control||Prospective|||||||
1474607|NCT01316276||Single Group Assignment||Treatment||None (Open Label)||||||
1474608|NCT01316263|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474609|NCT01316250||Single Group Assignment||Treatment||None (Open Label)||||||
1474610|NCT01316237||||||||||||
1474611|NCT01316224|||Case-Only||Prospective|||||||
1474612|NCT01316211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474613|NCT01316198|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474614|NCT01316185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474615|NCT01316172|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1474616|NCT01316159|||Case-Only||Prospective|||||||
1474617|NCT01316146||Single Group Assignment||Treatment||None (Open Label)||||||
1474618|NCT01316133||Single Group Assignment||Treatment||None (Open Label)||||||
1474619|NCT01316120|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1474620|NCT01316107||Single Group Assignment||Treatment||None (Open Label)||||||
1474621|NCT01316094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474622|NCT01316081|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1474623|NCT01316068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474624|NCT01316055|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1474625|NCT01316042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474626|NCT01316029|||Ecologic or Community||Cross-Sectional|||||||
1474627|NCT01316016|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474628|NCT01316003|||Case Control||Prospective|||||||
1474629|NCT01315990||Single Group Assignment||Treatment||None (Open Label)||||||
1474630|NCT01315977|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1474631|NCT01315964|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1474632|NCT01315951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474633|NCT01315938|Randomized|Single Group Assignment||Treatment||Single||||||t
1474634|NCT01315925|||Cohort||Prospective|||||||
1474635|NCT01315912||Single Group Assignment||Treatment||None (Open Label)||||||
1474636|NCT01315899|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1474637|NCT01315886||Single Group Assignment||Treatment||None (Open Label)||||||
1474638|NCT01315873||Single Group Assignment||Treatment||None (Open Label)||||||
1474639|NCT01315860|||Cohort||Prospective|||||||
1474640|NCT01315847|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474641|NCT01315834|||Case Control||Prospective|||||||
1474642|NCT01315821|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1474643|NCT01315808|||Ecologic or Community||Prospective|||||||
1474644|NCT01315795||Single Group Assignment||Treatment||None (Open Label)||||||
1474645|NCT01315782|||Cohort||Prospective|||||||
1474646|NCT01315769|||Case Control||Prospective|||||||
1474647|NCT01315756|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474648|NCT01315743||Single Group Assignment||Health Services Research||None (Open Label)||||||
1474649|NCT01315730||Single Group Assignment||Treatment||Single||||||t
1474650|NCT01315717|||Cohort||Cross-Sectional|||||||
1474651|NCT01315704|||Cohort||Cross-Sectional|||||||
1474652|NCT01315691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474653|NCT01315678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474654|NCT01315665|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1474655|NCT01315652|Randomized|Parallel Assignment||||None (Open Label)||||||
1474656|NCT01315639||Single Group Assignment||Diagnostic||None (Open Label)||||||
1474657|NCT01315626|||||Retrospective|||||||
1474658|NCT01315613|||Case Control||Prospective|||||||
1474659|NCT01315587|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474660|NCT01315574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474661|NCT01315561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474662|NCT01315548|||Case-Control||Prospective|||||||
1474663|NCT01315535|||Cohort||Prospective|||||||
1474664|NCT01315522|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474665|NCT01315509|||Case-Only||Prospective|||||||
1474666|NCT01315496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474667|NCT01315483|Randomized|Parallel Assignment||Prevention||Single||||||t
1474668|NCT01315470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474669|NCT01315457|||Cohort||Retrospective|||||||
1474670|NCT01315444|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1474671|NCT01315431||Single Group Assignment||Treatment||None (Open Label)||||||
1474672|NCT01315418|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1474673|NCT01315405|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1474674|NCT01315392||Parallel Assignment||Treatment||||||||
1474675|NCT01315379|||Case Control||Prospective|||||||
1474676|NCT01315366|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474677|NCT01315353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474678|NCT01315340|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1474679|NCT01315327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474680|NCT01315314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474681|NCT01315301|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474682|NCT01315288|Randomized|Single Group Assignment||||Triple|||t||t|t
1474683|NCT01315275||Single Group Assignment||Treatment||None (Open Label)||||||
1474684|NCT01315262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474685|NCT01315249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474686|NCT01315236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474687|NCT01315223|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474688|NCT01315210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474689|NCT01315197||Single Group Assignment||Treatment||None (Open Label)||||||
1474690|NCT01315184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474691|NCT01315171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474692|NCT01315158|Randomized|Parallel Assignment||Treatment||Single||||||t
1474693|NCT01315145|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474694|NCT01315132||Single Group Assignment||Treatment||None (Open Label)||||||
1474695|NCT01315119|||Cohort||Prospective|||||||
1474696|NCT01315106|||Cohort||Prospective|||||||
1474697|NCT01315093|Randomized|Parallel Assignment||Treatment||Single||||||t
1474698|NCT01315080|||Case Control||Prospective|||||||
1474699|NCT01315067|||Cohort||Cross-Sectional|||||||
1474700|NCT01315054|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1474701|NCT01315041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474702|NCT01315028|Randomized|Parallel Assignment||Treatment||Single||||||t
1474703|NCT01315015|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1474704|NCT01315002|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1474705|NCT01314989|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1474706|NCT01314976|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474707|NCT01314963|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||The unit of study in this trial was sentinel lymph nodes (SLNs) rather individual participants. with the comparison conducted by evaluation of each SLN with the prototype intraoperative handheld gamma camera (pIHGC) and standard of care intraoperative gamma probes (GP).||||
1474708|NCT01314950|Randomized|Parallel Assignment||Treatment||Single||||||t
1474709|NCT01314937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474710|NCT01314924|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1474711|NCT01314911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474712|NCT01314898|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474713|NCT01314885|Randomized|Crossover Assignment||||Double|||t||t|
1474714|NCT01314872|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474715|NCT01314859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474716|NCT01314846|||Case Control||Retrospective|||||||
1474717|NCT01314833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474718|NCT01314820|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1474719|NCT01314807|||Case Control||Prospective|||||||
1474720|NCT01314781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474721|NCT01314768|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1474722|NCT01314755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474723|NCT01314742|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474724|NCT01314729|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1474725|NCT01314716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474726|NCT01314703||Single Group Assignment||||Single||||||t
1474727|NCT01314690|Non-Randomized|Single Group Assignment||Health Services Research||||||||
1474728|NCT01314677|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1474729|NCT01314664|||||Prospective|||||||
1474730|NCT01314651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474731|NCT01314638|||Cohort||Prospective|||||||
1474732|NCT01314625|||Case-Only||Prospective|||||||
1474733|NCT01314612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474734|NCT01314599||Single Group Assignment||||None (Open Label)||||||
1474735|NCT01314586|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1474736|NCT01314573|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474737|NCT01314560|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1474738|NCT01314547|||Cohort||Prospective|||||||
1474739|NCT01314534|||Cohort||Prospective|||||||
1474740|NCT01314521|||Case-Only||Cross-Sectional|||||||
1474741|NCT01314508||Single Group Assignment||Treatment||None (Open Label)||||||
1474742|NCT01314495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474743|NCT01314482|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474744|NCT01314469|||Case-Only||Cross-Sectional|||||||
1474745|NCT01314456|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1474746|NCT01314443|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1474747|NCT01314417||Single Group Assignment||Treatment||None (Open Label)||||||
1474748|NCT01314404|||Case-Only||Prospective|||||||
1474749|NCT01314391|||Case Control||Retrospective|||||||
1474750|NCT01314378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474751|NCT01314365|||Cohort||Prospective|||||||
1474752|NCT01314352|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474753|NCT01314339|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474754|NCT01314326|||Other||Prospective|||||||
1474755|NCT01314313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474756|NCT01314300||Single Group Assignment||Treatment||None (Open Label)||||||
1474757|NCT01314287|||Cohort||Prospective|||||||
1474758|NCT01314274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474759|NCT01314261|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474760|NCT01314248|||Case-Crossover||Prospective|||||||
1474761|NCT01314235|||||Prospective|||||||
1474762|NCT01314222|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474763|NCT01314209||Single Group Assignment||Treatment||None (Open Label)||||||
1474764|NCT01314196|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474765|NCT01314183|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1474766|NCT01314170||Single Group Assignment||Treatment||None (Open Label)||||||
1474767|NCT01314157|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1474768|NCT01314144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474769|NCT01314131||Single Group Assignment||||None (Open Label)||||||
1474770|NCT01314118||Single Group Assignment||Treatment||None (Open Label)||||||
1474771|NCT01314105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474772|NCT01314092|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474773|NCT01314079|||||Prospective|||||||
1474774|NCT01314066|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1474775|NCT01314053|||Case-Only||Retrospective|||||||
1474776|NCT01314040|Randomized|Crossover Assignment||||None (Open Label)||||||
1474777|NCT01314027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474778|NCT01314014||Single Group Assignment||Treatment||None (Open Label)||||||
1474779|NCT01314001|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474780|NCT01313988|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474781|NCT01313975|||Cohort||Prospective|||||||
1474782|NCT01313962|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474783|NCT01313949|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474784|NCT01313936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474785|NCT01313923||Single Group Assignment||Treatment||None (Open Label)||||||
1474786|NCT01313910||Single Group Assignment||Treatment||None (Open Label)||||||
1474787|NCT01313897||Single Group Assignment||Prevention||None (Open Label)||||||
1474788|NCT01313884||Single Group Assignment||Treatment||None (Open Label)||||||
1474789|NCT01313871|||Case-Only||Cross-Sectional|||||||
1474790|NCT01313858|||Cohort||Prospective|||||||
1474791|NCT01313845|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474792|NCT01313832|Randomized|Crossover Assignment||Prevention||Single||||||t
1474793|NCT01313819|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1474794|NCT01313806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474795|NCT01313793|Randomized|Crossover Assignment||||None (Open Label)||||||
1474796|NCT01313780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474797|NCT01313767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474798|NCT01313754|Randomized|Single Group Assignment||Treatment||Single|||t|||
1474799|NCT01313741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474800|NCT01313728|Randomized|Single Group Assignment||Treatment||Single|||||t|
1474801|NCT01313715|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1474802|NCT01313702|Randomized|Parallel Assignment||Treatment||Single||||||t
1474803|NCT01313689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474804|NCT01313676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474805|NCT01313663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474806|NCT01313650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474807|NCT01313637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474808|NCT01313624|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474809|NCT01313611||Single Group Assignment||Treatment||None (Open Label)||||||
1474810|NCT01313598||Single Group Assignment||Treatment||None (Open Label)||||||
1474811|NCT01313585|||Cohort||Retrospective|||||||
1474812|NCT01313572|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1474813|NCT01313559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474814|NCT01313546|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1474815|NCT01313533|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1474816|NCT01313520|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474817|NCT01313507||Single Group Assignment||Treatment||None (Open Label)||||||
1474818|NCT01313494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474819|NCT01313481|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474820|NCT01313468|Randomized|Parallel Assignment||Prevention||Single|||||t|
1474821|NCT01313455|||||Prospective|||||||
1474822|NCT01313442|||Cohort||Prospective|||||||
1474823|NCT01313429||Single Group Assignment||Treatment||None (Open Label)||||||
1474824|NCT01313416||Single Group Assignment||Treatment||None (Open Label)||||||
1474825|NCT01313403|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1474826|NCT01313390|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474827|NCT01313377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474828|NCT01313364||Single Group Assignment||Treatment||None (Open Label)||||||
1474829|NCT01313351||||||||||||
1474830|NCT01313338|||Case-Only||Prospective|||||||
1474831|NCT01313325||Single Group Assignment||Treatment||Single||||||t
1474832|NCT01313312||Single Group Assignment||Treatment||None (Open Label)||||||
1474833|NCT01313299|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474834|NCT01313286|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474835|NCT01313273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474836|NCT01313260|||Case Control||Prospective|||||||
1474837|NCT01313247|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1474838|NCT01313234|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1474839|NCT01313221|Randomized|Parallel Assignment||Treatment||Single||||||t
1474840|NCT01313208|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474841|NCT01313195||||||||||||
1474842|NCT01313182|Randomized|Parallel Assignment||Prevention||Single||||||t
1474843|NCT01313169|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1474844|NCT01313156|||Cohort||Prospective|||||||
1474845|NCT01313143|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1474846|NCT01313130|||Case Control||Prospective|||||||
1474847|NCT01313117||Single Group Assignment||Treatment||None (Open Label)||||||
1474848|NCT01313104||Single Group Assignment||Screening||None (Open Label)||||||
1474849|NCT01313078||Single Group Assignment||Treatment||None (Open Label)||||||
1474850|NCT01313065||Single Group Assignment||Treatment||None (Open Label)||||||
1474851|NCT01313052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474852|NCT01313039||Single Group Assignment||Treatment||None (Open Label)||||||
1474853|NCT01313026|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474854|NCT01313013|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1474855|NCT01313000|||Case-Only||Prospective|||||||
1474856|NCT01312987|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474857|NCT01312961|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474858|NCT01312948||Single Group Assignment||Treatment||None (Open Label)||||||
1474859|NCT01312935|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474860|NCT01312922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474861|NCT01312909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474862|NCT01312883|Randomized|Parallel Assignment||Prevention||Single||||||t
1474863|NCT01312870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474864|NCT01312857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474865|NCT01312844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474866|NCT01312831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474867|NCT01312818||Single Group Assignment||Treatment||None (Open Label)||||||
1474868|NCT01312805|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1474869|NCT01312792|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1474870|NCT01312779||Single Group Assignment||Treatment||None (Open Label)||||||
1474871|NCT01312766|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474872|NCT01312740|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1474873|NCT01312727||Single Group Assignment||Screening||None (Open Label)||||||
1474874|NCT01312714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474875|NCT01312701|||Cohort||Prospective|||||||
1474876|NCT01312688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474877|NCT01312675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474878|NCT01312662|||Case Control||Prospective|||||||
1474879|NCT01312649|Randomized|Parallel Assignment||Basic Science||Single||||||t
1474880|NCT01312636|||Cohort|||||||||
1474881|NCT01312623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474882|NCT01312610|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1474883|NCT01312597|Randomized|Crossover Assignment||Prevention||Single|||t|||
1474884|NCT01312584|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1474885|NCT01312571|Randomized|Crossover Assignment||Treatment||Single||||||t
1474886|NCT01312558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474887|NCT01312545|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1474888|NCT01312532|Randomized|Parallel Assignment||Treatment||Single||||||t
1474889|NCT01312519|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1474890|NCT01312506|||Case Control||Prospective|||||||
1474891|NCT01312493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474892|NCT01312480|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1474893|NCT01312467||Single Group Assignment||Prevention||None (Open Label)||||||
1474894|NCT01312454|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474895|NCT01312441|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474896|NCT01312428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474897|NCT01312415|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474898|NCT01312402|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1474899|NCT01312389|Randomized|Parallel Assignment||Treatment||||||||
1474900|NCT01312376||||Treatment||||||||
1474901|NCT01312363|||Case-Only||Prospective|||||||
1474902|NCT01312350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474903|NCT01312337||Single Group Assignment||Treatment||None (Open Label)||||||
1474904|NCT01312324||Single Group Assignment||Treatment||None (Open Label)||||||
1474905|NCT01312311||Single Group Assignment||Treatment||None (Open Label)||||||
1474906|NCT01312298|Randomized|Single Group Assignment||Treatment||Single||||||t
1474907|NCT01312285|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474908|NCT01312272|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474909|NCT01312259|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1474910|NCT01312246||Single Group Assignment||||None (Open Label)||||||
1474911|NCT01312233|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474912|NCT01312220|||Cohort|||||||||
1474913|NCT01312207|||Case-Only||Retrospective|||||||
1474914|NCT01312194|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1474915|NCT01312181|Randomized|Parallel Assignment||Treatment||Single|Assessors blind to randomization outcomes|||||t
1474916|NCT01312168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474917|NCT01312155|||Case Control||Prospective|||||||
1474918|NCT01312142|||Cohort||Prospective|||||||
1474919|NCT01312129|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1474920|NCT01312116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474921|NCT01312103|Randomized|Parallel Assignment||Other||Single|||t|||
1474922|NCT01312090|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1474923|NCT01312077|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474924|NCT01312064|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474925|NCT01312051|||Other||Cross-Sectional|||||||
1474926|NCT01312038|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1474927|NCT01312025||||||||||||
1474928|NCT01312012|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474929|NCT01311999|||Cohort||Prospective|||||||
1474930|NCT01311986|||Case Control||Prospective|||||||
1474931|NCT01311973|||Cohort||Prospective|||||||
1474932|NCT01311960|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1474933|NCT01311947|||Cohort||Retrospective|||||||
1474934|NCT01311934|||Case-Only||Prospective|||||||
1474935|NCT01311921|||Case Control||Prospective|||||||
1474936|NCT01311908|||Case Control||Prospective|||||||
1474937|NCT01311895|Randomized|Parallel Assignment||Treatment||Single|||t|||
1474938|NCT01311882|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1474939|NCT01311869|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1474940|NCT01311856|||Cohort||Prospective|||||||
1474941|NCT01311830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474942|NCT01311817|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1474943|NCT01311804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474944|NCT01311791|Randomized|Parallel Assignment||Treatment||Single||||||t
1474945|NCT01311778|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1474946|NCT01311765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474947|NCT01311752|||Cohort||Prospective|||||||
1474948|NCT01311739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474949|NCT01311726||||||||||||
1474950|NCT01311713|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474951|NCT01311700|Randomized|Parallel Assignment||Treatment||Single||||||t
1474952|NCT01311687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474953|NCT01311674|Randomized|Parallel Assignment||Prevention||Single|||t|||
1474954|NCT01311661|Randomized|Crossover Assignment||Treatment||Double||||||
1474955|NCT01311648||Single Group Assignment||Treatment||None (Open Label)||||||
1474956|NCT01311635|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474957|NCT01311622|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1474958|NCT01311609||Single Group Assignment||Treatment||None (Open Label)||||||
1474959|NCT01311596|||Cohort||Prospective|||||||
1474960|NCT01311583|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1474961|NCT01311570||Single Group Assignment||Treatment||None (Open Label)||||||
1474962|NCT01311557|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1474963|NCT01311544|||Case-Only||Prospective|||||||
1474964|NCT01311531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474965|NCT01311518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1474966|NCT01311505|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1474967|NCT01311492|Randomized|Parallel Assignment||Treatment||Single|||||t|
1474968|NCT01311479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474969|NCT01311466||Single Group Assignment||Treatment||None (Open Label)||||||
1474970|NCT01311440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474971|NCT01311427|Randomized|Parallel Assignment||Treatment||Single||||||t
1474972|NCT01311414|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1474973|NCT01311401|||Cohort||Prospective|||||||
1474974|NCT01311388|||||Retrospective|||||||
1474975|NCT01311375|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1474976|NCT01311362|||Case-Control||Prospective|||||||
1474977|NCT01311349|||||Prospective|||||||
1474978|NCT01311336|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1474979|NCT01311323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474980|NCT01311310|Randomized|Crossover Assignment||Prevention||Single||||||t
1474981|NCT01311297|||Cohort||Prospective|||||||
1474982|NCT01311284|Randomized|Crossover Assignment||||None (Open Label)||||||
1474983|NCT01311271|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1474984|NCT01311258|||Cohort||Prospective|||||||
1474985|NCT01311245|Randomized|Parallel Assignment||Prevention||Single|||t|||
1474986|NCT01311232|||Case-Control||Retrospective|||||||
1474987|NCT01311219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1474988|NCT01311206|Randomized|Parallel Assignment||||Double|||t|||t
1474989|NCT01311193||||||||||||
1474990|NCT01311180|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1474991|NCT01311167|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474992|NCT01311154|||Cohort|||||||||
1474993|NCT01311141||Single Group Assignment||||None (Open Label)||||||
1474994|NCT01311128||Single Group Assignment||Diagnostic||Single||||||t
1474995|NCT01311115|Randomized|Parallel Assignment||Treatment||Single||||||t
1474996|NCT01311102|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1474997|NCT01311089|||||Prospective|||||||
1474998|NCT01311076|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1474999|NCT01311050|||Case Control||Prospective|||||||
1475000|NCT01311037|||Case Control||Prospective|||||||
1475001|NCT01311024|||Cohort||Cross-Sectional|||||||
1475002|NCT01311011|||Cohort||Prospective|||||||
1475003|NCT01310998|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1475004|NCT01310985|||Case Control||Cross-Sectional|||||||
1475005|NCT01310972|||Cohort||Prospective|||||||
1475006|NCT01310959|||Cohort||Retrospective|||||||
1475007|NCT01310946|||Cohort||Prospective|||||||
1475008|NCT01310933|||||Retrospective|||||||
1475009|NCT01310920|||Case Control|||||||||
1475010|NCT01310907||||||||||||
1475011|NCT01310894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475012|NCT01310881|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1475013|NCT01310868||Single Group Assignment||Treatment||None (Open Label)||||||
1475014|NCT01310855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475015|NCT01310842|||Cohort||Prospective|||||||
1475016|NCT01310829|||Cohort||Prospective|||||||
1475017|NCT01310816|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475018|NCT01310803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475019|NCT01310790|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475020|NCT01310777|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475021|NCT01310764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475022|NCT01310751|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475023|NCT01310738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475024|NCT01310725|Randomized|Single Group Assignment||Treatment||Single||||||t
1475025|NCT01310712|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475026|NCT01310699|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1475027|NCT01310686|||Cohort||Retrospective|||||||
1475028|NCT01310673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475029|NCT01310660|||Cohort||Prospective|||||||
1475030|NCT01310647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475031|NCT01310634|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475032|NCT01310621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475033|NCT01310608|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1475034|NCT01310595|Randomized|Parallel Assignment||Treatment||Single||||||t
1475035|NCT01310582|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1475036|NCT01310569|||Case Control||Prospective|||||||
1475037|NCT01310556|||Case Control||Prospective|||||||
1475038|NCT01310543|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1475039|NCT01310530||Single Group Assignment||Treatment||None (Open Label)||||||
1475040|NCT01310517|||Case-Only||Prospective|||||||
1475041|NCT01310504|Non-Randomized|Parallel Assignment||Health Services Research||Single||||t||
1475042|NCT01310491|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475043|NCT01310478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475044|NCT01310465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475045|NCT01310452|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1475046|NCT01310439|||Case-Crossover||Prospective|||||||
1475047|NCT01310426|||Cohort||Retrospective|||||||
1475048|NCT01310413|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1475049|NCT01310400|Randomized|Parallel Assignment||Treatment||Single|||||t|
1475050|NCT01310387||Single Group Assignment||Supportive Care||None (Open Label)||||||
1475051|NCT01310374|||Cohort||Prospective|||||||
1475052|NCT01310361|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1475053|NCT01310348|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1475054|NCT01310335||Single Group Assignment||Basic Science||None (Open Label)||||||
1475055|NCT01310322|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1475056|NCT01310309|||Cohort||Prospective|||||||
1475057|NCT01310296|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1475058|NCT01310283|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1475059|NCT01310270|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475060|NCT01310257|||Case-Only||Cross-Sectional|||||||
1475061|NCT01310244|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475062|NCT01310231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475063|NCT01310218|Randomized|Parallel Assignment||Treatment||Single|||||t|
1475064|NCT01310205||||||||||||
1475065|NCT01310192||Single Group Assignment||Diagnostic||None (Open Label)||||||
1475066|NCT01310179||Single Group Assignment||Treatment||None (Open Label)||||||
1475067|NCT01310166||Single Group Assignment||Basic Science||None (Open Label)||||||
1475068|NCT01310153|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1475069|NCT01310140|||Cohort||Prospective|||||||
1475070|NCT01310127|Randomized|Parallel Assignment||Treatment||Single|||||t|
1475071|NCT01310114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475072|NCT01310101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475073|NCT01310088|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475074|NCT01310075|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1475075|NCT01310062|||||Cross-Sectional|||||||
1475076|NCT01310049|Randomized|Single Group Assignment||||Single|||t|||
1475077|NCT01310036||Single Group Assignment||Treatment||None (Open Label)||||||
1475078|NCT01310023|||Cohort||Prospective|||||||
1475079|NCT01310010||Single Group Assignment||Treatment||None (Open Label)||||||
1475080|NCT01309997|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475081|NCT01309984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475082|NCT01309971|||Cohort||Cross-Sectional|||||||
1475083|NCT01309958|||Cohort||Cross-Sectional|||||||
1475084|NCT01309945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475085|NCT01309932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475086|NCT01309919|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475087|NCT01309906||||||||||||
1475088|NCT01309893|Randomized|Crossover Assignment||||Single|||t|||
1475089|NCT01309880|Randomized|Crossover Assignment||||Single|||t|||
1475090|NCT01309867||||||||||||
1475091|NCT01309854|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1475092|NCT01309841|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475093|NCT01309828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475094|NCT01309815|||Cohort||Cross-Sectional|||||||
1475095|NCT01309802|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1475096|NCT01309789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475097|NCT01309776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475098|NCT01309763|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475099|NCT01309750|||Cohort||Prospective|||||||
1475100|NCT01309737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475101|NCT01309724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475102|NCT01309711|||Cohort||Prospective|||||||
1475103|NCT01309698|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1475104|NCT01309685|Randomized|Crossover Assignment||Other||||||||
1475105|NCT01309672||Single Group Assignment||Treatment||None (Open Label)||||||
1475106|NCT01309659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475107|NCT01309646|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475108|NCT01309633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475109|NCT01309620|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1475110|NCT01309607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475111|NCT01309594||Single Group Assignment||Treatment||None (Open Label)||||||
1475112|NCT01309581|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1475113|NCT01309568|||Case-Only||Prospective|||||||
1475114|NCT01309555|||Cohort||Other|||||||
1475115|NCT01309542|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475116|NCT01309529|||Case-Only||Prospective|||||||
1475117|NCT01309516|Randomized|Parallel Assignment||Treatment||Single||||||t
1475118|NCT01309503|||Cohort||Cross-Sectional|||||||
1475119|NCT01309490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475120|NCT01309477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475121|NCT01309451|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475122|NCT01309438||Parallel Assignment||Treatment||None (Open Label)||||||
1475123|NCT01309425|Randomized|Crossover Assignment||||None (Open Label)||||||
1475124|NCT01309412||Single Group Assignment||Treatment||None (Open Label)||||||
1475125|NCT01309399|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1475126|NCT01309386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475127|NCT01309373|||Case Control||Retrospective|||||||
1475128|NCT01309360|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1475130|NCT01309334||Single Group Assignment||Diagnostic||None (Open Label)||||||
1475131|NCT01309321|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475132|NCT01309308|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475133|NCT01309295|||Cohort||Prospective|||||||
1475134|NCT01309282|||Cohort||Prospective|||||||
1475135|NCT01309269|||Cohort||Prospective|||||||
1475136|NCT01309256|||Cohort|||||||||
1475137|NCT01309243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475138|NCT01309230||Single Group Assignment||Treatment||None (Open Label)||||||
1475139|NCT01309217|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1475140|NCT01309204|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475141|NCT01309191|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1475142|NCT01309178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475143|NCT01309165|Randomized|Parallel Assignment||Treatment||Single||||||t
1475144|NCT01309152|||Case Control||Prospective|||||||
1475145|NCT01309139|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475146|NCT01309126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475147|NCT01309113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475148|NCT01309100|Randomized|Crossover Assignment||||Single|||t|||
1475149|NCT01309087|||Cohort||Prospective|||||||
1475150|NCT01309074|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475151|NCT01309061|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475152|NCT01309048||Single Group Assignment||Treatment||None (Open Label)||||||
1475153|NCT01309035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475154|NCT01309022||||||||||||
1475155|NCT01309009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475156|NCT01308996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475157|NCT01308983||Single Group Assignment||Treatment||None (Open Label)||||||
1475158|NCT01308970|Randomized|Parallel Assignment||||Double|||t|||t
1475159|NCT01308957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475160|NCT01308944||Single Group Assignment||Treatment||None (Open Label)||||||
1475161|NCT01308931|||Case Control||Prospective|||||||
1475162|NCT01308918|||Cohort||Prospective|||||||
1475163|NCT01308905||Single Group Assignment||Diagnostic||None (Open Label)||PET scans will be performed to show the distribution throughout the body of substances containing a small amount of radioactive material.||||
1475164|NCT01308892|Randomized|Crossover Assignment||||Double|||t||t|
1475165|NCT01308879|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1475166|NCT01308866|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475167|NCT01308853|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1475168|NCT01308840||Single Group Assignment||Treatment||None (Open Label)||||||
1475169|NCT01308827|||Cohort||Prospective|||||||
1475170|NCT01308814|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475171|NCT01308801|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475172|NCT01308788|||Cohort||Prospective|||||||
1475173|NCT01308775|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475174|NCT01308762||Single Group Assignment||||Single|||t|||
1475175|NCT01308749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475176|NCT01308736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475177|NCT01308723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475178|NCT01308710|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1475179|NCT01308697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475180|NCT01308684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475181|NCT01308671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475182|NCT01308658|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475183|NCT01308645||Single Group Assignment||Treatment||None (Open Label)||||||
1475184|NCT01308632|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475185|NCT01308619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475186|NCT01308606|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475187|NCT01308593|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475188|NCT01308580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475189|NCT01308567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475190|NCT01308554|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1475191|NCT01308541|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475192|NCT01308528|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475193|NCT01308515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475194|NCT01308502||Single Group Assignment||Diagnostic||None (Open Label)||||||
1475195|NCT01308489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475196|NCT01308476|||||Prospective|||||||
1475197|NCT01308463|||Cohort||Prospective|||||||
1475198|NCT01308450|||Case-Only||Cross-Sectional|||||||
1475199|NCT01308437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475200|NCT01308424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475201|NCT01308411||Single Group Assignment||Treatment||Double|||t|t||
1475202|NCT01308385|||Cohort||Prospective|||||||
1475203|NCT01308372|||Cohort||Cross-Sectional|||||||
1475204|NCT01308359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475205|NCT01308346|Randomized|Parallel Assignment||||Single|||t|||
1475206|NCT01308333|||Cohort||Prospective|||||||
1475207|NCT01308320|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1475208|NCT01308307|Non-Randomized|Single Group Assignment||Diagnostic||Double||||t||t
1475209|NCT01308294|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475210|NCT01308281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475211|NCT01308268||Single Group Assignment||Treatment||None (Open Label)||||||
1475212|NCT01308255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475213|NCT01308242||Single Group Assignment||Screening||None (Open Label)||||||
1475214|NCT01308229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475215|NCT01308216|Randomized|Parallel Assignment||Treatment||Single||||||t
1475216|NCT01308203|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475217|NCT01308190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475218|NCT01308177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475219|NCT01308164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475220|NCT01308151|Randomized|Parallel Assignment||Treatment||Single||||||t
1475221|NCT01308138|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1475222|NCT01308125||Single Group Assignment||Treatment||None (Open Label)||||||
1475223|NCT01308112|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475224|NCT01308099|||||Cross-Sectional|||||||
1475225|NCT01308086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475226|NCT01308073|||Cohort||Prospective|||||||
1475227|NCT01308060|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475228|NCT01308047|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1475229|NCT01308034||Single Group Assignment||Treatment||None (Open Label)||||||
1475230|NCT01308021|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1475231|NCT01308008|Randomized|Parallel Assignment||Treatment||Single||||||t
1475232|NCT01307995|||Case-Crossover|||||||||
1475233|NCT01307982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475234|NCT01307969|Randomized|Crossover Assignment||Health Services Research||Triple|||t||t|t
1475235|NCT01307956||Single Group Assignment||Treatment||None (Open Label)||||||
1475236|NCT01307943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475237|NCT01307930||Single Group Assignment||Other||None (Open Label)||||||
1475238|NCT01307917|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475239|NCT01307904|Non-Randomized|Parallel Assignment||||Single|||t|||
1475240|NCT01307891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475241|NCT01307878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475242|NCT01307865||Single Group Assignment||Treatment||None (Open Label)||||||
1475243|NCT01307852||Single Group Assignment||Treatment||None (Open Label)||||||
1475244|NCT01307839|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475245|NCT01307826|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475246|NCT01307813||Single Group Assignment||||None (Open Label)||||||
1475247|NCT01307800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475248|NCT01307787|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1475249|NCT01307774|||||Cross-Sectional|||||||
1475250|NCT01307761|||||Retrospective|||||||
1475251|NCT01307748|Randomized|Parallel Assignment||Prevention||Single||||||t
1475252|NCT01307735|||Case Control||Prospective|||||||
1475253|NCT01307722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475254|NCT01307709||||||||||||
1475255|NCT01307696|||Cohort||Retrospective|||||||
1475256|NCT01307683|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475257|NCT01307657||Single Group Assignment||Basic Science||None (Open Label)||||||
1475258|NCT01307644|Randomized|Parallel Assignment||Treatment||Single||||t||
1475259|NCT01307631||Single Group Assignment||Treatment||None (Open Label)||||||
1475260|NCT01307618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475261|NCT01307605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475262|NCT01307592|Non-Randomized|||Treatment||None (Open Label)||||||
1475263|NCT01307579|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475264|NCT01307566||Single Group Assignment||Treatment||None (Open Label)||||||
1475265|NCT01307553|||Cohort||Prospective|||||||
1475266|NCT01307540|Randomized|||Prevention||Triple|||t|t|t|
1475267|NCT01307527||Single Group Assignment||Prevention||None (Open Label)||||||
1475268|NCT01307514|||Case-Crossover||Prospective|||||||
1475269|NCT01307501||Single Group Assignment||Treatment||None (Open Label)||All participants received the same treatment.||||
1475270|NCT01307488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475271|NCT01307475|||Case-Only||Cross-Sectional|||||||
1475272|NCT01307462||Single Group Assignment||Treatment||None (Open Label)||||||
1475273|NCT01307449|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1475274|NCT01307436|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475275|NCT01307423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475276|NCT01307410|||Cohort||Prospective|||||||
1475277|NCT01307397||Single Group Assignment||Treatment||None (Open Label)||||||
1475278|NCT01307384|||Cohort||Prospective|||||||
1475279|NCT01307371|||Case Control||Prospective|||||||
1475280|NCT01307358|Randomized|Parallel Assignment||Treatment||Single||||t||
1475281|NCT01307345|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1475282|NCT01307332||Single Group Assignment||Treatment||None (Open Label)||||||
1475283|NCT01307319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476684|NCT01288976|||Cohort||Prospective|||||||
1475284|NCT01307306|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475285|NCT01307293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475286|NCT01307280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475287|NCT01307267|Non-Randomized|||Treatment||None (Open Label)||||||
1475288|NCT01307254|||Cohort||Prospective|||||||
1475289|NCT01307241|||Case-Only||Prospective|||||||
1475290|NCT01307228|Randomized|Crossover Assignment||Other||Single|||||t|
1475291|NCT01307215|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t||t
1475292|NCT01307202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475293|NCT01307189|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1475294|NCT01307176||Single Group Assignment||Treatment||None (Open Label)||||||
1475295|NCT01307163|||Cohort|||||||||
1475296|NCT01307150|||Case-Crossover||Prospective|||||||
1475297|NCT01307137|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475298|NCT01307124|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1475299|NCT01307111|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475300|NCT01307098|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475301|NCT01307085|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1475302|NCT01307072|||Case Control||Retrospective|||||||
1475303|NCT01307059|||Cohort||Other|||||||
1475304|NCT01307046|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475305|NCT01307033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475306|NCT01307020|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475307|NCT01307007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475308|NCT01306994|||Case-Control||Cross-Sectional|||||||
1475309|NCT01306981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475310|NCT01306968|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475311|NCT01306955|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475312|NCT01306942||Single Group Assignment||Treatment||None (Open Label)||||||
1475313|NCT01306929||Single Group Assignment||Treatment||None (Open Label)||||||
1475314|NCT01306916|||Cohort||Prospective|||||||
1475315|NCT01306903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475316|NCT01306890|||Cohort||Prospective|||||||
1475317|NCT01306877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475318|NCT01306864||Single Group Assignment||Treatment||None (Open Label)||||||
1475319|NCT01306851|Randomized|Parallel Assignment||Prevention||Single|||t|||
1475320|NCT01306838|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1475321|NCT01306825|||Case-Only||Prospective|||||||
1475322|NCT01306812|||||Prospective|||||||
1475323|NCT01306799|||Cohort||Prospective|||||||
1475324|NCT01306786|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475325|NCT01306773|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475326|NCT01306760|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475327|NCT01306747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475328|NCT01306734|||Cohort||Prospective|||||||
1475329|NCT01306721|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1475330|NCT01306708|Randomized|Parallel Assignment||Treatment||Single||||||t
1475331|NCT01306695|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475332|NCT01306682|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475333|NCT01306669|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475334|NCT01306656|Randomized|Parallel Assignment||Treatment||Triple|Patient, investigator and study team will be blinded to study arm ramdomization.|"Active arm:~Month 1: 20,000 IU vitamin D3 once a week, plus daily multivitamin with 400 IU vitamin D.~Months 2-6: 10,000 IU vitamin D3 once a week, plus daily multivitamin with 400 IU vitamin D.~Placebo arm:~Month 1: Placebo once a week plus daily multivitamin with 400 IU vitamin D.~Months 2-6: Placebo every week plus daily multivitamin with 400 IU vitamin D."|t||t|t
1475335|NCT01306643||Single Group Assignment||Treatment||None (Open Label)||||||
1475336|NCT01306630||Single Group Assignment||Treatment||None (Open Label)||||||
1475337|NCT01306617|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475338|NCT01306604|||Cohort||Prospective|||||||
1475339|NCT01306591|Randomized|Single Group Assignment||Treatment||Single|||t|||
1475340|NCT01306578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475341|NCT01306565|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475342|NCT01306552|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475343|NCT01306539|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1475344|NCT01306526|||Case Control||Cross-Sectional|||||||
1475345|NCT01306513||Single Group Assignment||Treatment||None (Open Label)||||||
1475346|NCT01306500|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475347|NCT01306487|||Case Control||Retrospective|||||||
1475348|NCT01306474|||Family-Based||Prospective|||||||
1475349|NCT01306461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475350|NCT01306448||Single Group Assignment||Treatment||None (Open Label)||||||
1475351|NCT01306435|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1475352|NCT01306422|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1475353|NCT01306409|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1475354|NCT01306396|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475355|NCT01306383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475356|NCT01306370|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475357|NCT01306357|||Case-Only||Prospective|||||||
1475358|NCT01306344|||||Retrospective|||||||
1475359|NCT01306331|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475360|NCT01306318|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475361|NCT01306305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475362|NCT01306292|Randomized|Crossover Assignment||||Triple|||t||t|t
1475363|NCT01306279|||Cohort||Prospective|||||||
1475364|NCT01306266|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475365|NCT01306253|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475366|NCT01306240|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475367|NCT01306227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475368|NCT01306214|Randomized|Parallel Assignment||Treatment||Double||||||
1475369|NCT01306201|||Case-Only||Prospective|||||||
1475370|NCT01306188|||Cohort||Prospective|||||||
1475371|NCT01306175|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475372|NCT01306162|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475373|NCT01306149|||Cohort||Prospective|||||||
1475374|NCT01306136|Randomized|Parallel Assignment||Treatment||Single||||||t
1475375|NCT01306123|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475376|NCT01306110|||Cohort||Prospective|||||||
1475377|NCT01306097|Randomized|Parallel Assignment||Prevention||Single||||||t
1475378|NCT01306084|||Case-Control||Prospective|||||||
1475379|NCT01306058||Single Group Assignment||Treatment||None (Open Label)||||||
1475380|NCT01306045|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475381|NCT01306032|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475382|NCT01306019||Single Group Assignment||Treatment||None (Open Label)||||||
1475383|NCT01306006|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475384|NCT01305993||Single Group Assignment||Treatment||None (Open Label)||||||
1475385|NCT01305980||Single Group Assignment||Treatment||None (Open Label)||||||
1475386|NCT01305967||Single Group Assignment||Treatment||None (Open Label)||||||
1475387|NCT01305954|||Case-Only||Prospective|||||||
1475388|NCT01305941||Single Group Assignment||Treatment||None (Open Label)||||||
1475389|NCT01305928|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475390|NCT01305915|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1475391|NCT01305902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475392|NCT01305889|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475393|NCT01305876||Single Group Assignment||Treatment||||||||
1475394|NCT01305863|Randomized|Single Group Assignment||Treatment||Single||||||t
1475395|NCT01305850|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1475396|NCT01305837||Single Group Assignment||Treatment||None (Open Label)||||||
1475397|NCT01305824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475398|NCT01305811|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1475399|NCT01305798|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1475400|NCT01305785|||Cohort||Prospective|||||||
1475401|NCT01305772|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475402|NCT01305759|||Cohort||Prospective|||||||
1475403|NCT01305746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475404|NCT01305733|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475405|NCT01305720||Single Group Assignment||Diagnostic||None (Open Label)||||||
1475406|NCT01305707|Randomized|Parallel Assignment||Prevention||Single||||||t
1475407|NCT01305694||Parallel Assignment||Treatment||None (Open Label)||||||
1475408|NCT01305681|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475409|NCT01305668|||Cohort||Prospective|||||||
1475410|NCT01305655||Single Group Assignment||Treatment||None (Open Label)||||||
1475411|NCT01305642||Single Group Assignment||Treatment||None (Open Label)||||||
1475412|NCT01305629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475413|NCT01305616|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1475414|NCT01305603|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1475415|NCT01305590||Single Group Assignment||Health Services Research||None (Open Label)||"We will survey participants to see if they would prefer more commitment, in the form of a Take-Medication-Get-Paid plan; less commitment, in the form of an Attend-Clinic-Get-Paid plan; or if they would prefer to designate their own levels of commitment.~The study also included 70 individuals in a passive control (PC) arm, who did not receive financial incentives. Individuals in the PC arm were not enrolled in the randomized trial but met basic study eligibility criteria during the same time period."||||
1475416|NCT01305577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475417|NCT01305564||Single Group Assignment||Treatment||None (Open Label)||||||
1475418|NCT01305551|Randomized|Single Group Assignment||||None (Open Label)||||||
1475419|NCT01305538|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475420|NCT01305525|||||Prospective|||||||
1475421|NCT01305512||Single Group Assignment||Treatment||None (Open Label)||||||
1475422|NCT01305499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475423|NCT01305486|||Cohort||Prospective|||||||
1475424|NCT01305473|||Cohort||Cross-Sectional|||||||
1475425|NCT01305460||Single Group Assignment||Treatment||None (Open Label)||||||
1475426|NCT01305447|Randomized|Parallel Assignment||Prevention||Single|||t|||
1475427|NCT01305434|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475428|NCT01305421||Single Group Assignment||Treatment||None (Open Label)||||||
1475429|NCT01305408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475430|NCT01305395|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475431|NCT01305382|||Cohort||Cross-Sectional|||||||
1476759|NCT01287988|||||Cross-Sectional|||||||
1475432|NCT01305369|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1475433|NCT01305356|Randomized|Parallel Assignment||Treatment||Single||||||t
1475434|NCT01305343|||Case-Only||Prospective|||||||
1475435|NCT01305330|||Case-Only||Prospective|||||||
1475436|NCT01305317|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475437|NCT01305304|||Case Control||Cross-Sectional|||||||
1475438|NCT01305291|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1475439|NCT01305278|Randomized|Parallel Assignment||Treatment||Single||||||t
1475440|NCT01305265|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1475441|NCT01305252|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475442|NCT01305239|||Cohort||Prospective|||||||
1475443|NCT01305226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475444|NCT01305213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475445|NCT01305200|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1475446|NCT01305187|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1475447|NCT01305174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475448|NCT01305161||Single Group Assignment||Diagnostic||||||||
1475449|NCT01305148|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475450|NCT01305135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475451|NCT01305122||Single Group Assignment||Treatment||None (Open Label)||||||
1475452|NCT01305109|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475453|NCT01305096|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1475454|NCT01305083|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475455|NCT01305070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475456|NCT01305057|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1475457|NCT01305044|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475458|NCT01305031|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475459|NCT01305018|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475460|NCT01305005|||Cohort||Prospective|||||||
1475461|NCT01304992|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1475462|NCT01304979|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1475463|NCT01304966|||Case-Only||Prospective|||||||
1475464|NCT01304953|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475465|NCT01304940|||Cohort||Cross-Sectional|||||||
1475466|NCT01304927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475467|NCT01304914|||Cohort||Prospective|||||||
1475468|NCT01304901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475469|NCT01304888|Randomized|Parallel Assignment||||None (Open Label)||||||
1475470|NCT01304875|||Case-Only||Cross-Sectional|||||||
1475471|NCT01304862|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475472|NCT01304849||Single Group Assignment||Treatment||None (Open Label)||||||
1475473|NCT01304836|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475474|NCT01304823|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1475475|NCT01304810|||Cohort||Prospective|||||||
1475476|NCT01304797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475477|NCT01304784|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475478|NCT01304771|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1475479|NCT01304758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475480|NCT01304745|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1475481|NCT01304732|||Case-Only||Retrospective|||||||
1475482|NCT01304719|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475483|NCT01304706||Single Group Assignment||Treatment||None (Open Label)||||||
1475484|NCT01304693|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1475485|NCT01304680|||Case-Only||Retrospective|||||||
1475486|NCT01304667|||Cohort||Retrospective|||||||
1475487|NCT01304654|||Case-Only||Prospective|||||||
1475488|NCT01304641|||Cohort||Retrospective|||||||
1475489|NCT01304628|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475490|NCT01304615|Randomized|Parallel Assignment||Treatment||Single||||||t
1475491|NCT01304602||Single Group Assignment||Treatment||None (Open Label)||||||
1475492|NCT01304589||Single Group Assignment||Treatment||None (Open Label)||||||
1475493|NCT01304576|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1475494|NCT01304563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475495|NCT01304550|||Case-Control||Retrospective|||||||
1475496|NCT01304537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475497|NCT01304524|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475498|NCT01304511|||Case-Only||Prospective|||||||
1475499|NCT01304498|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475500|NCT01304485||Single Group Assignment||Diagnostic||None (Open Label)||||||
1475501|NCT01304472|Randomized|Crossover Assignment||Treatment||Single||||||t
1475502|NCT01304459|||Case-Only||Prospective|||||||
1475503|NCT01304446|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475504|NCT01304433|||Cohort||Prospective|||||||
1475505|NCT01304420|||Cohort||Cross-Sectional|||||||
1475506|NCT01304407|||Cohort||Prospective|||||||
1475507|NCT01304394||Single Group Assignment||Treatment||None (Open Label)||||||
1475508|NCT01304381|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1475509|NCT01304368|Randomized|Parallel Assignment||Treatment||||||||
1475510|NCT01304355|||Case Control||Cross-Sectional|||||||
1475511|NCT01304342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475512|NCT01304329|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475513|NCT01304316||Single Group Assignment||Supportive Care||None (Open Label)||||||
1475514|NCT01304303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475515|NCT01304290|Randomized|Single Group Assignment||||None (Open Label)||||||
1475516|NCT01304277||Single Group Assignment||||None (Open Label)||||||
1475517|NCT01304264|||Case-Crossover||Prospective|||||||
1475518|NCT01304251|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475519|NCT01304238|||Cohort||Retrospective|||||||
1475520|NCT01304225|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475521|NCT01304212|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475522|NCT01304199|||Case-Only||Prospective|||||||
1475523|NCT01304186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475524|NCT01304173|||Case-Only||Retrospective|||||||
1475525|NCT01304160||Single Group Assignment||Treatment||None (Open Label)||||||
1475526|NCT01304147|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1475527|NCT01304134|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475528|NCT01304121|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475529|NCT01304108|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1475530|NCT01304095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475531|NCT01304082|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1475532|NCT01304069|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1475533|NCT01304056|||Cohort||Prospective|||||||
1475534|NCT01304043|||Cohort||Prospective|||||||
1475535|NCT01304030|Randomized|Single Group Assignment||||None (Open Label)||||||
1475536|NCT01304017|Randomized|Parallel Assignment||Treatment||Single||||||t
1475537|NCT01304004|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1475538|NCT01303991|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475539|NCT01303978||Single Group Assignment||Prevention||None (Open Label)||||||
1475540|NCT01303965||Single Group Assignment||Treatment||None (Open Label)||||||
1475541|NCT01303952||Single Group Assignment||Treatment||None (Open Label)||||||
1475542|NCT01303939|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||Magnetic resonance images (MRI) of the brain were obtained from glaucoma patients to look at structures and volume. Age, gender, ethnic healthy matches for each glaucoma patient received MRIs of the brain for comparison.||||
1475543|NCT01303926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475544|NCT01303913|||Cohort||Prospective|||||||
1475545|NCT01303900|||Cohort||Prospective|||||||
1475546|NCT01303887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475547|NCT01303874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475548|NCT01303861|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1475549|NCT01303848|||||Prospective|||||||
1475550|NCT01303835|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475551|NCT01303822||Single Group Assignment||Treatment||None (Open Label)||||||
1475552|NCT01303809|Randomized|Parallel Assignment||Treatment||Single||||||t
1475553|NCT01303796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475554|NCT01303783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475555|NCT01303770|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1475556|NCT01303757|Randomized|Parallel Assignment||Treatment||Single||||||t
1475557|NCT01303744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475558|NCT01303731|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475559|NCT01303718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475560|NCT01303705|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475561|NCT01303692|||Case-Only||Prospective|||||||
1475562|NCT01303679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475563|NCT01303666|Randomized|Parallel Assignment||Treatment||Single||||t||
1475564|NCT01303653||Single Group Assignment||Treatment||None (Open Label)||||||
1475565|NCT01303640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475566|NCT01303627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475567|NCT01303614|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1475568|NCT01303601|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1475569|NCT01303588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475570|NCT01303575|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475571|NCT01303562|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1475572|NCT01303549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475573|NCT01303536||Single Group Assignment||Treatment||Single||||||t
1475574|NCT01303523|||Cohort||Prospective|||||||
1475575|NCT01303510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475576|NCT01303497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475577|NCT01303484|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1475578|NCT01303471|Randomized|Single Group Assignment||Health Services Research||Triple|||t|t|t|
1475579|NCT01303458|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1475580|NCT01303445|Randomized|Crossover Assignment||||None (Open Label)||||||
1475581|NCT01303432|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1475582|NCT01303419|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1475583|NCT01303406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475584|NCT01303393|||Cohort||Prospective|||||||
1475585|NCT01303380|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475587|NCT01303354|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475588|NCT01303341||Single Group Assignment||Treatment||None (Open Label)||||||
1475589|NCT01303328|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475590|NCT01303315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475591|NCT01303302|Randomized|Crossover Assignment||Treatment||Single|||t|||
1475592|NCT01303289|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1475593|NCT01303276|||Cohort||Prospective|||||||
1475594|NCT01303263|Randomized|||||||||||
1475595|NCT01303250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475596|NCT01303237|||Cohort||Prospective|||||||
1475597|NCT01303224|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475598|NCT01303211|||Case Control||Prospective|||||||
1475599|NCT01303198|Randomized|Crossover Assignment||Treatment||Single|||t|||
1475600|NCT01303185|||Case Control||Prospective|||||||
1475601|NCT01303172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475602|NCT01303159||Single Group Assignment||Treatment||None (Open Label)||||||
1475603|NCT01303146|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475604|NCT01303133|||Cohort||Cross-Sectional|||||||
1475605|NCT01303120|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475606|NCT01303107|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1475607|NCT01303094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475608|NCT01303081|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1475609|NCT01303068|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1475610|NCT01303055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475611|NCT01303042||Single Group Assignment||Treatment||None (Open Label)||||||
1475612|NCT01303029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475613|NCT01303016|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475614|NCT01303003|Randomized|Crossover Assignment||Treatment||Single|||||t|
1475615|NCT01302990|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475616|NCT01302977|Randomized|Parallel Assignment||Treatment||Single||||||t
1475617|NCT01302964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475618|NCT01302951|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1475619|NCT01302938|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475620|NCT01302925|Randomized|Parallel Assignment||||None (Open Label)||||||
1475621|NCT01302912|||Cohort||Retrospective|||||||
1475622|NCT01302899|Randomized|Crossover Assignment||Treatment||Single|||t|||
1475623|NCT01302886||Single Group Assignment||Treatment||None (Open Label)||||||
1475624|NCT01302873|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1475625|NCT01302860||Single Group Assignment||Treatment||None (Open Label)||||||
1475626|NCT01302847|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475627|NCT01302834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475628|NCT01302821||Single Group Assignment||Diagnostic||None (Open Label)||||||
1475629|NCT01302808||Single Group Assignment||Treatment||None (Open Label)||||||
1475630|NCT01302795||Single Group Assignment||Treatment||None (Open Label)||||||
1475631|NCT01302782|||||Prospective|||||||
1475632|NCT01302769|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475633|NCT01302756|Randomized|Single Group Assignment||||Double|||t||t|
1475634|NCT01302743|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1475635|NCT01302730|||||Prospective|||||||
1475636|NCT01302717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475637|NCT01302704|||Family-Based||Prospective|||||||
1475638|NCT01302691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475639|NCT01302652|||Case Control||Prospective|||||||
1475640|NCT01302639|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1475641|NCT01302626|||Cohort||Prospective|||||||
1475642|NCT01302613||Single Group Assignment||Treatment||None (Open Label)||||||
1475643|NCT01302600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475644|NCT01302587|||Cohort||Prospective|||||||
1475645|NCT01302574|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1475646|NCT01302561|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1475647|NCT01302548|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475648|NCT01302535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475649|NCT01302522|Randomized|||Treatment||Single||||||t
1475650|NCT01302509|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475651|NCT01302496|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475652|NCT01302483|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1475653|NCT01302470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475654|NCT01302457|||Case Control||Prospective|||||||
1475655|NCT01302444|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475656|NCT01302431|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475657|NCT01302418|||Case-Only||Prospective|||||||
1475658|NCT01302405||Single Group Assignment||Treatment||None (Open Label)||||||
1475659|NCT01302392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475660|NCT01302379|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1475661|NCT01302366||Single Group Assignment||Treatment||None (Open Label)||||||
1475662|NCT01302353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475663|NCT01302340|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1475664|NCT01302327||Single Group Assignment||Treatment||None (Open Label)||||||
1475665|NCT01302314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475666|NCT01302301||Single Group Assignment||Treatment||None (Open Label)||||||
1475667|NCT01302288||Single Group Assignment||Treatment||None (Open Label)||||||
1475668|NCT01302275|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1475669|NCT01302262|||||Prospective|||||||
1475670|NCT01302249|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475671|NCT01302236||Single Group Assignment||Treatment||None (Open Label)||||||
1475672|NCT01302223|||Case Control||Cross-Sectional|||||||
1475673|NCT01302210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475674|NCT01302197|||Other||Prospective|||||||
1475675|NCT01302184|Randomized|Parallel Assignment||Treatment||Single||||||t
1475676|NCT01302171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475677|NCT01302158|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1475678|NCT01302145|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1475679|NCT01302132||Single Group Assignment||||None (Open Label)||||||
1475680|NCT01302119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475681|NCT01302106||Single Group Assignment||Treatment||None (Open Label)||||||
1475682|NCT01302093|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1475683|NCT01302080|||Cohort||Prospective|||||||
1475684|NCT01302067|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475685|NCT01302054|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475686|NCT01302041||Single Group Assignment||Treatment||None (Open Label)||||||
1475687|NCT01302028|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1475688|NCT01302015|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475689|NCT01302002|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1475690|NCT01301989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475691|NCT01301976|||||Cross-Sectional|||||||
1475692|NCT01301963|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475693|NCT01301950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475694|NCT01301937|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1475695|NCT01301924|Randomized|Parallel Assignment||Treatment||Single||||t||
1475696|NCT01301911||Single Group Assignment||Treatment||None (Open Label)||||||
1475697|NCT01301898|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475698|NCT01301885|||Case Control||Prospective|||||||
1475699|NCT01301872|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1475700|NCT01301859|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1475701|NCT01301846|||Cohort||Prospective|||||||
1475702|NCT01301833|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475703|NCT01301820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475704|NCT01301807||Single Group Assignment||Treatment||None (Open Label)||||||
1475705|NCT01301794||Single Group Assignment||Basic Science||None (Open Label)||||||
1475706|NCT01301781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475707|NCT01301768|Randomized|Parallel Assignment||Prevention||Single||||||t
1475708|NCT01301755|||Case-Only||Prospective|||||||
1475709|NCT01301742|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475710|NCT01301729||Single Group Assignment||Treatment||None (Open Label)||||||
1475711|NCT01301716||Parallel Assignment||Treatment||None (Open Label)||||||
1475712|NCT01301703||Single Group Assignment||Prevention||None (Open Label)||||||
1475713|NCT01301690|||Cohort||Prospective|||||||
1475714|NCT01301677|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1475715|NCT01301664||||||||||||
1475716|NCT01301651|Randomized|Factorial Assignment||Treatment||Single|||||t|
1475717|NCT01301638|||Case-Only||Retrospective|||||||
1475718|NCT01301625|||Cohort||Prospective|||||||
1475719|NCT01301612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475720|NCT01301599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475721|NCT01301586|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475722|NCT01301573|||Cohort||Prospective|||||||
1475723|NCT01301560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475724|NCT01301534|||Case-Only||Prospective|||||||
1475725|NCT01301521|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1475726|NCT01301508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475727|NCT01301495||Single Group Assignment||Treatment||None (Open Label)||||||
1475728|NCT01301482|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475729|NCT01301469|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1475730|NCT01301456|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475731|NCT01301443||Single Group Assignment||Treatment||None (Open Label)||||||
1475732|NCT01301430||Single Group Assignment||Treatment||None (Open Label)||||||
1475733|NCT01301417|||||Retrospective|||||||
1475734|NCT01301404|Randomized|Parallel Assignment||Prevention||Single||||||t
1475735|NCT01301391||Single Group Assignment||Treatment||None (Open Label)||||||
1475736|NCT01301378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475737|NCT01301365|||Cohort||Prospective|||||||
1475738|NCT01301352|Randomized|Single Group Assignment||Treatment||Single||||||t
1475739|NCT01301339|||||Prospective|||||||
1475740|NCT01301326|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1475741|NCT01301313|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475742|NCT01301300|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1475743|NCT01301287|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475744|NCT01301274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475745|NCT01301261|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475746|NCT01301248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475747|NCT01301235|||Case-Only||Cross-Sectional|||||||
1475748|NCT01301222|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475749|NCT01301209|||Cohort||Prospective|||||||
1475750|NCT01301196|Randomized|Parallel Assignment||Prevention||Single|||||t|
1475751|NCT01301183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475752|NCT01301170|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475753|NCT01301157|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475754|NCT01301144|||||Prospective|||||||
1475755|NCT01301131|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475756|NCT01301118|||Case-Only||Prospective|||||||
1475757|NCT01301105|Randomized|Parallel Assignment||Basic Science||Single||||||t
1475758|NCT01301092|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475759|NCT01301079|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475760|NCT01301066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475761|NCT01301053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475762|NCT01301040|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1475763|NCT01301027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475764|NCT01301014|||Cohort||Prospective|||||||
1475765|NCT01301001|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1475766|NCT01300988|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475767|NCT01300975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475768|NCT01300962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475769|NCT01300949|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Contrast sensitivity, another means of testing vision, will be measured two ways for each participant. One method uses the Pelli-Robson Contrast Sensitivity Chart which is mounted on the wall, the other method uses a new computerized program called Spaeth/Richman Contrast Sensitivity Test also known as SPARCS.||||
1475770|NCT01300936|||Case Control||Prospective|||||||
1475771|NCT01300923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475772|NCT01300910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475773|NCT01300897|||Case-Control||Prospective|||||||
1475774|NCT01300884|||Case-Control||Prospective|||||||
1475775|NCT01300871|||Case-Only||Cross-Sectional|||||||
1475776|NCT01300858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475777|NCT01300845|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475778|NCT01300832||Single Group Assignment||Screening||None (Open Label)||||||
1475779|NCT01300819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475780|NCT01300806|||Cohort||Prospective|||||||
1475781|NCT01300793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475782|NCT01300780|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1475783|NCT01300767|Randomized|Single Group Assignment||Treatment||Single|||t|||
1475784|NCT01300754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475785|NCT01300741|Randomized|Single Group Assignment||Treatment||Single|||t|||
1475786|NCT01300728|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475787|NCT01300715|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475788|NCT01300702|||Cohort||Prospective|||||||
1475789|NCT01300689|||Ecologic or Community||Cross-Sectional|||||||
1475790|NCT01300676|Randomized|Parallel Assignment||Prevention||Single||||||t
1475791|NCT01300663||||||||||||
1475792|NCT01300650||Single Group Assignment||Treatment||None (Open Label)||||||
1475793|NCT01300637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475794|NCT01300624||Single Group Assignment||Treatment||None (Open Label)||||||
1475795|NCT01300611|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1475796|NCT01300598|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475797|NCT01300585||Single Group Assignment||Diagnostic||None (Open Label)||||||
1475798|NCT01300572||Single Group Assignment||Treatment||None (Open Label)||||||
1475799|NCT01300559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475800|NCT01300546|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1475801|NCT01300533|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475802|NCT01300520|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475803|NCT01300507|||Case Control||Prospective|||||||
1475804|NCT01300494|||Case-Only||Prospective|||||||
1475805|NCT01300468||Single Group Assignment||Treatment||None (Open Label)||||||
1475806|NCT01300455|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475807|NCT01300442|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475808|NCT01300429|||Cohort||Prospective|||||||
1475809|NCT01300416|||Cohort||Prospective|||||||
1475810|NCT01300403|Randomized|Crossover Assignment||Treatment||Single|||t|||
1475811|NCT01300390|||Case-Only||Prospective|||||||
1475812|NCT01300377|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1475813|NCT01300364|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475814|NCT01300351|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475815|NCT01300338|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1475816|NCT01300325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475817|NCT01300312|Randomized|Parallel Assignment||Treatment||Single|||||t|
1475818|NCT01300299||Single Group Assignment||Treatment||None (Open Label)||||||
1475819|NCT01300286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475820|NCT01300273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475821|NCT01300260|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1475822|NCT01300247|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475823|NCT01300234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475824|NCT01300221|||Cohort||Prospective|||||||
1475825|NCT01300208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475826|NCT01300195|||Cohort||Prospective|||||||
1475827|NCT01300182|Randomized|Parallel Assignment||Treatment||Single||||||t
1475828|NCT01300169|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1475829|NCT01300156||Single Group Assignment||Treatment||None (Open Label)||||||
1475830|NCT01300143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475831|NCT01300130|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1475832|NCT01300117|||Cohort||Prospective|||||||
1475833|NCT01300104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475834|NCT01300091|||Cohort||Prospective|||||||
1475835|NCT01300078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475836|NCT01300065||||||||||||
1475837|NCT01300052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475838|NCT01300039|||Case Control||Prospective|||||||
1475839|NCT01300026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475840|NCT01300013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475841|NCT01300000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475842|NCT01299987||Single Group Assignment||Treatment||None (Open Label)||||||
1475843|NCT01299974||Single Group Assignment||Supportive Care||None (Open Label)||||||
1475844|NCT01299961|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1475845|NCT01299948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475846|NCT01299935|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1475847|NCT01299922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475848|NCT01299909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475849|NCT01299896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475850|NCT01299883|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1475851|NCT01299870|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475852|NCT01299857||Single Group Assignment||||None (Open Label)||||||
1475853|NCT01299844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475854|NCT01299831|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1475855|NCT01299818|||Cohort||Prospective|||||||
1475856|NCT01299805|Randomized|Parallel Assignment||||Single|||t|||
1475857|NCT01299792|||Cohort||Prospective|||||||
1475858|NCT01299779|Randomized|Parallel Assignment||||Single|||||t|
1475859|NCT01299766|Randomized|Parallel Assignment||Prevention||Single||||||t
1475860|NCT01299753|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475861|NCT01299740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475862|NCT01299727|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475863|NCT01299714|||Cohort||Prospective|||||||
1475864|NCT01299701||Single Group Assignment||Treatment||None (Open Label)||||||
1475865|NCT01299688|||Cohort||Prospective|||||||
1475866|NCT01299675|||Cohort||Prospective|||||||
1475867|NCT01299662||Single Group Assignment||||None (Open Label)||||||
1475868|NCT01299649|||Case Control||Retrospective|||||||
1475869|NCT01299636||Single Group Assignment||||None (Open Label)||||||
1475870|NCT01299623|Randomized|Parallel Assignment||||Triple|||t||t|t
1475871|NCT01299610|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475872|NCT01299597|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475873|NCT01299584|||Cohort||Prospective|||||||
1475874|NCT01299571|||Cohort||Prospective|||||||
1475875|NCT01299558|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1475876|NCT01299545|||Cohort||Cross-Sectional|||||||
1475877|NCT01299532|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1475878|NCT01299519|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1475879|NCT01299506|||Other||Prospective|||||||
1475880|NCT01299493|Randomized|Parallel Assignment||Screening||Single||||||t
1475881|NCT01299480|Randomized|Parallel Assignment||Prevention||Single|||t|||
1475882|NCT01299467|Randomized|Crossover Assignment||||Triple|||t|t|t|
1475883|NCT01299454|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475884|NCT01299441|||Case-Only||Prospective|||||||
1475885|NCT01299428|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1475886|NCT01299415||Single Group Assignment||Treatment||None (Open Label)||||||
1475887|NCT01299402|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1475888|NCT01299389|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475889|NCT01299376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475890|NCT01299363|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1475891|NCT01299350|Randomized|Parallel Assignment||||None (Open Label)||||||
1475892|NCT01299337|||Cohort||Retrospective|||||||
1475893|NCT01299324|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475894|NCT01299311|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1475895|NCT01299298|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475896|NCT01299285||Single Group Assignment||Other||None (Open Label)||||||
1475897|NCT01299272|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1475898|NCT01299259|Randomized|Single Group Assignment||Treatment||Single||||t||
1475899|NCT01299246|Randomized|Single Group Assignment||Screening||Single|||t|||
1475900|NCT01299233|||Case Control||Prospective|||||||
1475901|NCT01299220||Single Group Assignment||Treatment||None (Open Label)||||||
1475902|NCT01299207|||Cohort||Prospective|||||||
1475903|NCT01299194|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1475904|NCT01299181|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475905|NCT01299168|||Cohort||Prospective|||||||
1475906|NCT01299155|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475907|NCT01299142|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1475908|NCT01299129|||Case-Only||Prospective|||||||
1475909|NCT01299116|Randomized|Parallel Assignment||Prevention||None (Open Label)||Partially randomized patient preference trial||||
1475910|NCT01299103|Randomized|Parallel Assignment||Treatment||Single||||||t
1475911|NCT01299090||Single Group Assignment||Treatment||None (Open Label)||||||
1475912|NCT01299077|||Case-Only||Retrospective|||||||
1475913|NCT01299064|||Ecologic or Community||Cross-Sectional|||||||
1475914|NCT01299051|Randomized|Parallel Assignment||||None (Open Label)||||||
1475915|NCT01299038|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475916|NCT01299025|Randomized|Parallel Assignment||Treatment||Single||||||t
1475917|NCT01299012|||Other||Retrospective|||||||
1475918|NCT01298999|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1475919|NCT01298986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475920|NCT01298973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475921|NCT01298960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475922|NCT01298947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475923|NCT01298934||Single Group Assignment||Treatment||None (Open Label)||||||
1475924|NCT01298921|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475925|NCT01298908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475926|NCT01298895|||Cohort||Prospective|||||||
1475927|NCT01298882||Parallel Assignment||Treatment||||||||
1475928|NCT01298869|||Case-Only||Prospective|||||||
1475929|NCT01298856|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475930|NCT01298843||Single Group Assignment||||None (Open Label)||||||
1475931|NCT01298830|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1475932|NCT01298817|Randomized|Parallel Assignment||Prevention||Single|||||t|
1475933|NCT01298804|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1475934|NCT01298791|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1475935|NCT01298778|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1475936|NCT01298765||Single Group Assignment||Treatment||None (Open Label)||||||
1475937|NCT01298752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475938|NCT01298739|||Cohort||Prospective|||||||
1475939|NCT01298726|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1475940|NCT01298713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475941|NCT01298700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475942|NCT01298687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475943|NCT01298674|||Ecologic or Community||Cross-Sectional|||||||
1475944|NCT01298661|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1475945|NCT01298648|||Cohort||Prospective|||||||
1475946|NCT01298635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475947|NCT01298622|||Case Control||Cross-Sectional|||||||
1475948|NCT01298609|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1475949|NCT01298596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475950|NCT01298583|Randomized|Parallel Assignment||Treatment||Single|||t|||
1475951|NCT01298570|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475952|NCT01298557|||Case-Control||Prospective|||||||
1475953|NCT01298544|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1475954|NCT01298531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475955|NCT01298518|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1475956|NCT01298505|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1475957|NCT01298492||||Treatment||||||||
1475958|NCT01298479|||Other||Prospective|||||||
1475959|NCT01298466|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1475960|NCT01298440|||Case-Only||Prospective|||||||
1475961|NCT01298414|||Case-Only||Retrospective|||||||
1475962|NCT01298401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475963|NCT01298388||||||||||||
1475964|NCT01298375|||Cohort||Cross-Sectional|||||||
1475965|NCT01298362|||Cohort||Prospective|||||||
1475966|NCT01298349|||Ecologic or Community||Prospective|||||||
1475967|NCT01298336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475968|NCT01298323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475969|NCT01298310|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1475970|NCT01298297|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475971|NCT01298284|Randomized|Parallel Assignment||Treatment||Single||||||t
1475972|NCT01298271|Randomized|Parallel Assignment||Treatment||Single||||||t
1475973|NCT01298258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1475974|NCT01298245|||Case Control||Cross-Sectional|||||||
1475975|NCT01298232|Randomized|Parallel Assignment||Treatment||Single|||||t|
1475976|NCT01298219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1475977|NCT01298206|||Case Control||Prospective|||||||
1475978|NCT01298193||Single Group Assignment||Treatment||None (Open Label)||||||
1475979|NCT01298180|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475980|NCT01298167|Randomized|Parallel Assignment||Treatment||Single||||||t
1475981|NCT01298154|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1475982|NCT01298141||Single Group Assignment||Treatment||None (Open Label)||||||
1475983|NCT01298128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1475984|NCT01298115|||Case-Only||Prospective|||||||
1475985|NCT01298102||Single Group Assignment||Prevention||None (Open Label)||||||
1475986|NCT01298089|||Cohort||Retrospective|||||||
1475987|NCT01298076|Randomized|Parallel Assignment||Treatment||Single||||||t
1475988|NCT01298063|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1475989|NCT01298050|||Cohort||Retrospective|||||||
1475990|NCT01298037|||Other||Prospective|||||||
1475991|NCT01298024|Randomized|Parallel Assignment||Treatment||Single||||||t
1475992|NCT01298011||Single Group Assignment||Treatment||None (Open Label)||||||
1475993|NCT01297998||Single Group Assignment||Treatment||None (Open Label)||||||
1475994|NCT01297985|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1475995|NCT01297972||Single Group Assignment||Treatment||None (Open Label)||||||
1475996|NCT01297959|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1475997|NCT01297946|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1475998|NCT01297933||||||||||||
1475999|NCT01297920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476000|NCT01297907|||Cohort||Prospective|||||||
1476001|NCT01297894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476002|NCT01297881|||Cohort||Prospective|||||||
1476003|NCT01297868|||Cohort||Prospective|||||||
1476004|NCT01297855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476005|NCT01297842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476006|NCT01297829|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1476007|NCT01297816|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1476008|NCT01297803|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476009|NCT01297790|||Cohort||Prospective|||||||
1476010|NCT01297777||Single Group Assignment||Treatment||None (Open Label)||||||
1476011|NCT01297764||Single Group Assignment||Treatment||None (Open Label)||||||
1476012|NCT01297751||||||||||||
1476013|NCT01297738|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1476014|NCT01297725|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1476015|NCT01297712|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476016|NCT01297699|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476017|NCT01297686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476018|NCT01297673|||Case-Only||Prospective|||||||
1476019|NCT01297660|||Case-Only||Retrospective|||||||
1476020|NCT01297647||Single Group Assignment||Diagnostic||None (Open Label)||||||
1476021|NCT01297634|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1476022|NCT01297621|Randomized|Parallel Assignment||||None (Open Label)||||||
1476023|NCT01297608|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1476024|NCT01297595|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1476025|NCT01297582|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476026|NCT01297569||Single Group Assignment||Treatment||None (Open Label)||||||
1476027|NCT01297556|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476028|NCT01297543|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1476029|NCT01297530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476030|NCT01297517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476031|NCT01297504|||Cohort||Prospective|||||||
1476032|NCT01297491|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476033|NCT01297465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476034|NCT01297452|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476035|NCT01297439|Randomized|Parallel Assignment||Prevention||Single|||t|||
1476036|NCT01297426|||Case Control||Cross-Sectional|||||||
1476037|NCT01297413||Single Group Assignment||Treatment||None (Open Label)||||||
1476038|NCT01297400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476039|NCT01297387|||Cohort||Prospective|||||||
1476040|NCT01297374|Randomized|Parallel Assignment||Treatment||Single|||||t|
1476041|NCT01297361|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1476042|NCT01297348|||Case Control||Retrospective|||||||
1476043|NCT01297335||Single Group Assignment||Treatment||None (Open Label)||||||
1476044|NCT01297322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476045|NCT01297309||Single Group Assignment||Treatment||None (Open Label)||||||
1476046|NCT01297296|||Case-Only||Prospective|||||||
1476047|NCT01297283|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1476048|NCT01297270|Randomized|Parallel Assignment||Treatment||Double||||||
1476049|NCT01297257|||Case-Only||Prospective|||||||
1476050|NCT01297244||Single Group Assignment||Treatment||None (Open Label)||||||
1476051|NCT01297231|||Cohort||Prospective|||||||
1476052|NCT01297218||Single Group Assignment||Treatment||None (Open Label)||||||
1476053|NCT01297205||Single Group Assignment||Treatment||None (Open Label)||||||
1476054|NCT01297192|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1476055|NCT01297179|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1476056|NCT01297166|Randomized|Single Group Assignment||Treatment||Single|||||t|
1476057|NCT01297153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476058|NCT01297140||Single Group Assignment||||None (Open Label)||||||
1476059|NCT01297127|||Cohort||Prospective|||||||
1476060|NCT01297114|||Cohort||Cross-Sectional|||||||
1476061|NCT01297101||||||||||||
1476062|NCT01297088|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1476063|NCT01297075|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1476064|NCT01297062|Randomized|Crossover Assignment||||Triple|||t||t|t
1476065|NCT01297049|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1476066|NCT01297036|Randomized|Crossover Assignment||||None (Open Label)||||||
1476067|NCT01297023|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476068|NCT01297010|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1476069|NCT01296997|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1476070|NCT01296984|||Case Control||Retrospective|||||||
1476071|NCT01296971|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476072|NCT01296958|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1476073|NCT01296945|Randomized|Parallel Assignment||Health Services Research||||||||
1476074|NCT01296932||Single Group Assignment||Treatment||None (Open Label)||||||
1476075|NCT01296919|||Cohort||Prospective|||||||
1476076|NCT01296906|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1476077|NCT01296893|Randomized|Parallel Assignment||Treatment||Single||||||t
1476078|NCT01296880|||Case Control||Prospective|||||||
1476079|NCT01296867|||Cohort||Prospective|||||||
1476080|NCT01296854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476081|NCT01296841|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1476082|NCT01296828|||Case-Only||Cross-Sectional|||||||
1476083|NCT01296815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476084|NCT01296802|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1476085|NCT01296789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476086|NCT01296776|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1476087|NCT01296763||Single Group Assignment||Treatment||None (Open Label)||||||
1476088|NCT01296750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476089|NCT01296737|||Case-Only||Prospective|||||||
1476090|NCT01296724|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1476091|NCT01296711||Single Group Assignment||Treatment||None (Open Label)||||||
1476092|NCT01296698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476093|NCT01296685|||Case Control||Prospective|||||||
1476094|NCT01296672|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1476095|NCT01296659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476096|NCT01296646|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1476097|NCT01296633|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1476098|NCT01296620|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476099|NCT01296607|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1476100|NCT01296594|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476101|NCT01296581||Single Group Assignment||Treatment||None (Open Label)||||||
1476102|NCT01296568||Single Group Assignment||Treatment||None (Open Label)||||||
1476103|NCT01296555|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476104|NCT01296542|||Cohort||Prospective|||||||
1476105|NCT01296529|||Cohort||Cross-Sectional|||||||
1476106|NCT01296516|Randomized|Factorial Assignment||Prevention||Single|||||t|
1476107|NCT01296503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476108|NCT01296490||Single Group Assignment||Basic Science||None (Open Label)||||||
1476109|NCT01296477|||Cohort||Prospective|||||||
1476110|NCT01296464|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476111|NCT01296451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476112|NCT01296438|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1476113|NCT01296425|||Cohort||Other|||||||
1476114|NCT01296412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476115|NCT01296399|||Case Control||Retrospective|||||||
1476116|NCT01296386|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476117|NCT01296373|||Cohort||Prospective|||||||
1476118|NCT01296360|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476119|NCT01296347|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1476120|NCT01296334|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1476121|NCT01296321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476122|NCT01296308|||Cohort||Prospective|||||||
1476123|NCT01296295|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476124|NCT01296282|||Cohort||Prospective|||||||
1476125|NCT01296269|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1476126|NCT01296256||Single Group Assignment||Treatment||None (Open Label)||||||
1476127|NCT01296243||Single Group Assignment||Treatment||None (Open Label)||||||
1476128|NCT01296230||Single Group Assignment||Diagnostic||None (Open Label)||||||
1476129|NCT01296217||Single Group Assignment||||||||||
1476130|NCT01296204|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476131|NCT01296191|Randomized|Parallel Assignment||Prevention||Single|||||t|
1476132|NCT01296178||Single Group Assignment||Treatment||None (Open Label)||||||
1476133|NCT01296165|||Ecologic or Community||Prospective|||||||
1476134|NCT01296152||Single Group Assignment||Treatment||None (Open Label)||||||
1476135|NCT01296139|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1476136|NCT01296126|||||Other|||||||
1476137|NCT01296113||Single Group Assignment||Treatment||None (Open Label)||||||
1476138|NCT01296100|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1476139|NCT01296087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476140|NCT01296074||Single Group Assignment||Prevention||None (Open Label)||||||
1476141|NCT01296061|||Cohort||Prospective|||||||
1476142|NCT01296048|||Cohort||Retrospective|||||||
1476143|NCT01296035||Single Group Assignment||Treatment||None (Open Label)||||||
1476144|NCT01296022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476145|NCT01296009|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1476146|NCT01295970|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476147|NCT01295957|Randomized|Parallel Assignment||Treatment||Single||||||t
1476148|NCT01295944||Single Group Assignment||Treatment||None (Open Label)||||||
1476149|NCT01295931||Single Group Assignment||Diagnostic||None (Open Label)||||||
1476150|NCT01295918|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476151|NCT01295905|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476152|NCT01295892|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476153|NCT01295879||Single Group Assignment||Treatment||None (Open Label)||||||
1476154|NCT01295866|||Cohort|||||||||
1476155|NCT01295853|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476156|NCT01295840||Single Group Assignment||Supportive Care||None (Open Label)||||||
1476157|NCT01295827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476158|NCT01295814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476159|NCT01295801|||Case Control||Prospective|||||||
1476160|NCT01295788|Randomized|Parallel Assignment||Treatment||None (Open Label)||Simultaneous or Delayed initiation of continuous glucose monitoring||||
1476161|NCT01295775|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476162|NCT01295762||Single Group Assignment||Screening||None (Open Label)||||||
1476163|NCT01295749|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1476164|NCT01295736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476165|NCT01295723||Single Group Assignment||Treatment||None (Open Label)||||||
1476166|NCT01295710|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476167|NCT01295697||Single Group Assignment||Treatment||None (Open Label)||||||
1476168|NCT01295684|Randomized|Parallel Assignment||||Double||||||
1476169|NCT01295671|Randomized|Parallel Assignment||Treatment||Single||||||t
1476170|NCT01295658|||Case-Only||Cross-Sectional|||||||
1476171|NCT01295645|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476172|NCT01295632|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476173|NCT01295619||Single Group Assignment||Prevention||None (Open Label)||||||
1476174|NCT01295606||Single Group Assignment||Prevention||None (Open Label)||||||
1476175|NCT01295593||Single Group Assignment||Treatment||None (Open Label)||||||
1476176|NCT01295580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476177|NCT01295567|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476178|NCT01295554|||Case-Only||Prospective|||||||
1476179|NCT01295541|||Cohort||Prospective|||||||
1476180|NCT01295528|||Cohort||Retrospective|||||||
1476181|NCT01295515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476182|NCT01295502||Single Group Assignment||Treatment||None (Open Label)||||||
1476183|NCT01295489||||||||||||
1476184|NCT01295476|||Cohort||Prospective|||||||
1476185|NCT01295463||||||||||||
1476186|NCT01295450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476187|NCT01295437|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1476188|NCT01295424|||Cohort||Prospective|||||||
1476189|NCT01295411||Single Group Assignment||||None (Open Label)||||||
1476190|NCT01295398|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476191|NCT01295385|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476192|NCT01295372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476193|NCT01295359|Randomized|Parallel Assignment||Treatment||Single||||||t
1476194|NCT01295346|||Cohort||Prospective|||||||
1476195|NCT01295333|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476196|NCT01295320||Single Group Assignment||Prevention||None (Open Label)||||||
1476197|NCT01295307||Single Group Assignment||Treatment||None (Open Label)||||||
1476198|NCT01295294|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1476199|NCT01295281|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476200|NCT01295268|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1476201|NCT01295255|||Cohort|||||||||
1476202|NCT01295242|||||Prospective|||||||
1476203|NCT01295229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476204|NCT01295216|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476205|NCT01295203|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1476206|NCT01295190||||||||||||
1476207|NCT01295177|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476208|NCT01295164|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476209|NCT01295151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476210|NCT01295138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476211|NCT01295125|Randomized|Single Group Assignment||Treatment||Single|||t|||
1476212|NCT01295112|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476213|NCT01295099|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476214|NCT01295086|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476215|NCT01295073|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1476216|NCT01295060|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476217|NCT01295047|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1476218|NCT01295034|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476219|NCT01295021|||Cohort||Cross-Sectional|||||||
1476220|NCT01295008|||Cohort||Cross-Sectional|||||||
1476221|NCT01294995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476222|NCT01294982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476223|NCT01294969||Single Group Assignment||Treatment||None (Open Label)||||||
1476224|NCT01294956|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476225|NCT01294943|||Case Control||Prospective|||||||
1476226|NCT01294930|||Cohort||Prospective|||||||
1476227|NCT01294917|Randomized|Crossover Assignment||Other||Single|||||t|
1476228|NCT01294904|||Case-Control||Prospective|||||||
1476229|NCT01294891|||Case Control||Prospective|||||||
1476230|NCT01294878||Single Group Assignment||Treatment||None (Open Label)||||||
1476231|NCT01294865|||Case Control||Prospective|||||||
1476232|NCT01294852|Randomized|Parallel Assignment||Prevention||Single|||t|||
1476233|NCT01294839|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476234|NCT01294826||Single Group Assignment||Treatment||None (Open Label)||||||
1476235|NCT01294813||Single Group Assignment||Basic Science||None (Open Label)||||||
1476236|NCT01294800|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476237|NCT01294787|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1476238|NCT01294774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476239|NCT01294761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476240|NCT01294748|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476241|NCT01294735|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476242|NCT01294722|||Case-Only||Retrospective|||||||
1476243|NCT01294709|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1476244|NCT01294696|||Cohort||Prospective|||||||
1476245|NCT01294683|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1476246|NCT01294670||Single Group Assignment||Treatment||None (Open Label)||||||
1476247|NCT01294657|||Cohort||Prospective|||||||
1476248|NCT01294644|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476249|NCT01294631||Single Group Assignment||Treatment||None (Open Label)||||||
1476250|NCT01294618|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476251|NCT01294605|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1476252|NCT01294592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476253|NCT01294579||||Treatment||None (Open Label)||||||
1476254|NCT01294566|Randomized|Single Group Assignment||Treatment||Single|||t|||
1476255|NCT01294553|||Other||Prospective|||||||
1476256|NCT01294540|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1476257|NCT01294527||Single Group Assignment||Treatment||None (Open Label)||||||
1476258|NCT01294514|||Case-Only||Prospective|||||||
1476259|NCT01294501||Single Group Assignment||Health Services Research||Single|||t|||
1476260|NCT01294488|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1476261|NCT01294475||Single Group Assignment||Prevention||None (Open Label)||||||
1476262|NCT01294462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476263|NCT01294449|||Cohort||Prospective|||||||
1476264|NCT01294436||Single Group Assignment||Treatment||None (Open Label)||||||
1476265|NCT01294423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476266|NCT01294410|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476267|NCT01294397||Single Group Assignment||Treatment||None (Open Label)||||||
1476268|NCT01294384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476269|NCT01294371|||||Prospective|||||||
1476270|NCT01294358||Single Group Assignment||Treatment||None (Open Label)||||||
1476271|NCT01294345|||Cohort||Cross-Sectional|||||||
1476272|NCT01294332|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1476273|NCT01294319|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1476274|NCT01294306||Single Group Assignment||Treatment||None (Open Label)||||||
1476275|NCT01294293||Single Group Assignment||Treatment||None (Open Label)||||||
1476276|NCT01294280|||Case-Only||Retrospective|||||||
1476277|NCT01294267||Single Group Assignment||Supportive Care||None (Open Label)||||||
1476278|NCT01294254|Randomized|Parallel Assignment||Treatment||Single||||||t
1476279|NCT01294241|Non-Randomized|Single Group Assignment||Treatment||Single|Blinded comparison of wound photo series by two independent experts|||||t
1476280|NCT01294228|||Cohort||Prospective|||||||
1476281|NCT01294215|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476282|NCT01294202||Single Group Assignment||Treatment||None (Open Label)||||||
1476283|NCT01294189|||Case-Only||Retrospective|||||||
1476284|NCT01294176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476285|NCT01294163|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476286|NCT01294150|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476287|NCT01294137||Single Group Assignment||Diagnostic||None (Open Label)||||||
1476288|NCT01294124|||Case-Control||Prospective|||||||
1476289|NCT01294111|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1476290|NCT01294098|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1476291|NCT01294085|||Case-Only||Retrospective|||||||
1476292|NCT01294072|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1476293|NCT01294059|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1476294|NCT01294046||Single Group Assignment||Treatment||None (Open Label)||||||
1476295|NCT01294033|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1476296|NCT01294020||Single Group Assignment||Prevention||None (Open Label)||||||
1476297|NCT01294007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476298|NCT01293994|||Cohort||Prospective|||||||
1476299|NCT01293981|||Cohort||Prospective|||||||
1476300|NCT01293968|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1476301|NCT01293955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476302|NCT01293942||Single Group Assignment||Treatment||None (Open Label)||||||
1476303|NCT01293929|||Case Control||Cross-Sectional|||||||
1476304|NCT01293916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476305|NCT01293903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476306|NCT01293890|||Cohort||Prospective|||||||
1476307|NCT01293877|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1476308|NCT01293864|||Case-Only||Prospective|||||||
1476309|NCT01293851|||||Prospective|||||||
1476310|NCT01293838||Single Group Assignment||Treatment||None (Open Label)||||||
1476311|NCT01293825||Single Group Assignment||Treatment||None (Open Label)||||||
1476312|NCT01293812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476313|NCT01293799|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476314|NCT01293786|||Case Control||Cross-Sectional|||||||
1476315|NCT01293773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476316|NCT01293760|Randomized|Parallel Assignment||||None (Open Label)||||||
1476317|NCT01293747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476318|NCT01293734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476319|NCT01293721|Randomized|Parallel Assignment||Treatment||Single||||||t
1476320|NCT01293708|||Cohort||Prospective|||||||
1476321|NCT01293695|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476322|NCT01293682||Single Group Assignment||Prevention||None (Open Label)||||||
1476323|NCT01293669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476324|NCT01293656|||Cohort||Cross-Sectional|||||||
1476325|NCT01293643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476326|NCT01293630|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476327|NCT01293617|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476328|NCT01293604|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1476329|NCT01293591|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1476330|NCT01293578|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1476331|NCT01293565||||||||||||
1476332|NCT01293552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476333|NCT01293539||Single Group Assignment||Treatment||None (Open Label)||||||
1476334|NCT01293526|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476335|NCT01293513||Single Group Assignment||Treatment||None (Open Label)||||||
1476336|NCT01293500|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476337|NCT01293487||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1476338|NCT01293474|||Case Control||Prospective|||||||
1476339|NCT01293461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476340|NCT01293448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476341|NCT01293435|||||Retrospective|||||||
1476342|NCT01293422|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1476343|NCT01293409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476344|NCT01293396|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476345|NCT01293383|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1476346|NCT01293370|||Cohort||Retrospective|||||||
1476347|NCT01293357||Single Group Assignment||||Single|||||t|
1476348|NCT01293344|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476349|NCT01293331|||Cohort||Prospective|||||||
1476350|NCT01293318|||Cohort||Prospective|||||||
1476351|NCT01293305|Randomized|Parallel Assignment||Treatment||Single|||||t|
1476352|NCT01293292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476353|NCT01293279|||||Prospective|||||||
1476354|NCT01293266|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1476355|NCT01293253|Randomized|Factorial Assignment||Prevention||Single||||||t
1476356|NCT01293240||Single Group Assignment||Treatment||None (Open Label)||||||
1476357|NCT01293227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476358|NCT01293214||Single Group Assignment||Treatment||None (Open Label)||||||
1476359|NCT01293201|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1476360|NCT01293188|||Cohort||Prospective|||||||
1476361|NCT01293175|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476362|NCT01293162|||Case Control||Prospective|||||||
1476363|NCT01293149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476364|NCT01293136|||Cohort||Retrospective|||||||
1476365|NCT01293123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476366|NCT01293110|||Case-Only||Prospective|||||||
1476367|NCT01293097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476368|NCT01293084|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1476369|NCT01293071|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1476370|NCT01293058|Randomized|Parallel Assignment||Treatment||Single||||||t
1476371|NCT01293045|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1476372|NCT01293032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476373|NCT01293019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476374|NCT01293006|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1476375|NCT01292993|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476376|NCT01292980|||Cohort||Prospective|||||||
1476377|NCT01292967|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1476378|NCT01292954|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1476379|NCT01292941|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1476380|NCT01292928||Single Group Assignment||Treatment||None (Open Label)||||||
1476381|NCT01292915|||Cohort||Prospective|||||||
1476382|NCT01292902||Parallel Assignment||||None (Open Label)||||||
1476383|NCT01292889|||Case Control||Cross-Sectional|||||||
1476384|NCT01292876||Single Group Assignment||Treatment||None (Open Label)||||||
1476385|NCT01292863|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476386|NCT01292850|||||Prospective|||||||
1476387|NCT01292837||Single Group Assignment||Treatment||None (Open Label)||||||
1476388|NCT01292824|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476389|NCT01292811|Randomized|Parallel Assignment||Treatment||Single||||||t
1476390|NCT01292798||Single Group Assignment||Treatment||None (Open Label)||||||
1476391|NCT01292785|||Case Control||Prospective|||||||
1476392|NCT01292772|||||Prospective|||||||
1476393|NCT01292759|||Case-Only||Prospective|||||||
1476394|NCT01292746||Single Group Assignment||Treatment||None (Open Label)||||||
1476395|NCT01292733||Single Group Assignment||Prevention||None (Open Label)||||||
1476396|NCT01292720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476397|NCT01292707|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1476398|NCT01292694|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1476399|NCT01292681||Single Group Assignment||||None (Open Label)||||||
1476400|NCT01292668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476401|NCT01292655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476402|NCT01292642||Single Group Assignment||Treatment||None (Open Label)||||||
1476403|NCT01292629||Single Group Assignment||Treatment||None (Open Label)||||||
1476404|NCT01292616|||Case-Only||Prospective|||||||
1476405|NCT01292603||Parallel Assignment||Treatment||None (Open Label)||||||
1476406|NCT01292590||Single Group Assignment||Treatment||None (Open Label)||||||
1476407|NCT01292577|Randomized|Parallel Assignment||Treatment||Single||||||t
1476408|NCT01292564|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476409|NCT01292551|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476410|NCT01292538|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476411|NCT01292525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476412|NCT01292512|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476413|NCT01292499|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1476414|NCT01292486||Single Group Assignment||Supportive Care||None (Open Label)||||||
1476415|NCT01292473|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476416|NCT01292460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476417|NCT01292447|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1476418|NCT01292434|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476419|NCT01292421|Randomized|Parallel Assignment||Prevention||Double||||||
1476420|NCT01292408||Single Group Assignment||Treatment||None (Open Label)||||||
1476421|NCT01292395|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1476422|NCT01292382|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476423|NCT01292369|||Case Control||Prospective|||||||
1476424|NCT01292356||Single Group Assignment||Treatment||None (Open Label)||||||
1476425|NCT01292343|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1476426|NCT01292330|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1476427|NCT01292317|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476428|NCT01292304||Single Group Assignment||Treatment||None (Open Label)||||||
1476429|NCT01292291||||Diagnostic||||||||
1476430|NCT01292278|||Cohort||Prospective|||||||
1476431|NCT01292265||Single Group Assignment||Treatment||None (Open Label)||||||
1476432|NCT01292252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476433|NCT01292239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476434|NCT01292226||Single Group Assignment||Treatment||None (Open Label)||||||
1476435|NCT01292213|||Case Control||Prospective|||||||
1476436|NCT01292200|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1476437|NCT01292187|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1476438|NCT01292174|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476439|NCT01292161||Single Group Assignment||Treatment||Single||||||t
1476440|NCT01292148|||Case-Only||Prospective|||||||
1476441|NCT01292135|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476442|NCT01292122|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476443|NCT01292109|||Cohort||Prospective|||||||
1476444|NCT01292096||Single Group Assignment||Health Services Research||None (Open Label)||||||
1476445|NCT01292083||Single Group Assignment||Treatment||None (Open Label)||||||
1476446|NCT01292070||Single Group Assignment||Treatment||None (Open Label)||||||
1476447|NCT01292057|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476448|NCT01292044||Single Group Assignment||Diagnostic||None (Open Label)||||||
1476449|NCT01292031|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476450|NCT01292018|||Cohort||Cross-Sectional|||||||
1476451|NCT01292005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476452|NCT01291992|||Cohort||Prospective|||||||
1476453|NCT01291979|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1476454|NCT01291966|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476455|NCT01291953|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1476456|NCT01291940|Non-Randomized|Single Group Assignment||Prevention||Single|||||t|
1476457|NCT01291927|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476458|NCT01291914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476459|NCT01291901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476460|NCT01291888|||Cohort||Prospective|||||||
1476461|NCT01291875|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476462|NCT01291862||Single Group Assignment||Diagnostic||None (Open Label)||||||
1476463|NCT01291849||Single Group Assignment||Treatment||Double|||t||t|
1476464|NCT01291836|||Cohort||Prospective|||||||
1476465|NCT01291823||Single Group Assignment||Treatment||None (Open Label)||||||
1476466|NCT01291810|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1476467|NCT01291797|||Case Control||Prospective|||||||
1476468|NCT01291784||Single Group Assignment||Treatment||None (Open Label)||||||
1476469|NCT01291771|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476470|NCT01291758|||Cohort||Cross-Sectional|||||||
1476471|NCT01291745|||Cohort||Prospective|||||||
1476472|NCT01291732|Randomized|Parallel Assignment||Treatment||Double||||||
1476473|NCT01291719||Single Group Assignment||Treatment||None (Open Label)||||||
1476474|NCT01291706|||Cohort||Prospective|||||||
1476475|NCT01291693|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476476|NCT01291680|||Case-Only||Prospective|||||||
1476477|NCT01291667|||||Prospective|||||||
1476478|NCT01291654|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1476479|NCT01291641|Randomized|Parallel Assignment||Treatment||Single||||||t
1476480|NCT01291628|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1476481|NCT01291615|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476482|NCT01291602|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1476483|NCT01291589||Single Group Assignment||Prevention||None (Open Label)||||||
1476484|NCT01291576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476485|NCT01291563|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476486|NCT01291550|||||Prospective|||||||
1476487|NCT01291537||||Treatment||||||||
1476488|NCT01291524|Randomized|Crossover Assignment||||None (Open Label)||||||
1476489|NCT01291511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476490|NCT01291498||Single Group Assignment||Treatment||None (Open Label)||||||
1476491|NCT01291485|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1476492|NCT01291472||Single Group Assignment||Treatment||None (Open Label)||||||
1476493|NCT01291459||Single Group Assignment||Treatment||None (Open Label)||||||
1476494|NCT01291446|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1476495|NCT01291433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476496|NCT01291420||Single Group Assignment||Treatment||None (Open Label)||||||
1476497|NCT01291407||Single Group Assignment||Treatment||None (Open Label)||||||
1476498|NCT01291394|||Cohort||Other|||||||
1476499|NCT01291381|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1476500|NCT01291368|||Cohort||Prospective|||||||
1476501|NCT01291355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476502|NCT01291342|||Case Control||Prospective|||||||
1476503|NCT01291329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476504|NCT01291316|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1476505|NCT01291303|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476506|NCT01291290|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1476507|NCT01291277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476508|NCT01291264|||Cohort||Cross-Sectional|||||||
1476509|NCT01291251|||Cohort||Prospective|||||||
1476510|NCT01291238|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1476511|NCT01291225|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476512|NCT01291212|Randomized|Parallel Assignment||Treatment||Single|||||t|
1476513|NCT01291199|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1476514|NCT01291186|Randomized|Parallel Assignment||||Double|||t||t|
1476515|NCT01291173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476516|NCT01291160|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476517|NCT01291147|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476518|NCT01291134|||Cohort||Prospective|||||||
1476519|NCT01291121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476520|NCT01291108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476521|NCT01291095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476522|NCT01291082|||Case-Only||Prospective|||||||
1476523|NCT01291069|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1476524|NCT01291056|Randomized|Crossover Assignment||||Double|||t||t|
1476525|NCT01291043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476526|NCT01291030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476527|NCT01291017||Single Group Assignment||Treatment||None (Open Label)||||||
1476528|NCT01291004|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1476529|NCT01290991||Single Group Assignment||Treatment||None (Open Label)||||||
1476530|NCT01290978|Randomized|Parallel Assignment||||None (Open Label)||||||
1476531|NCT01290965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476532|NCT01290952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476533|NCT01290939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476534|NCT01290926||Single Group Assignment||Treatment||None (Open Label)||||||
1476535|NCT01290913||Single Group Assignment||Treatment||None (Open Label)||||||
1476536|NCT01290900|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1476537|NCT01290887||Single Group Assignment||Treatment||None (Open Label)||||||
1476538|NCT01290874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476539|NCT01290861|||Cohort||Prospective|||||||
1476540|NCT01290848|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476541|NCT01290835||Single Group Assignment||Treatment||None (Open Label)||||||
1476542|NCT01290822|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1476543|NCT01290809|||Case-Crossover||Prospective|||||||
1476544|NCT01290796||Single Group Assignment||Treatment||None (Open Label)||||||
1476545|NCT01290783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476546|NCT01290770|||Case-Only||Prospective|||||||
1476547|NCT01290757|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476548|NCT01290744|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476549|NCT01290731||Single Group Assignment||Treatment||None (Open Label)||||||
1476550|NCT01290718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476551|NCT01290705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476552|NCT01290692||Single Group Assignment||Treatment||None (Open Label)||||||
1476553|NCT01290679|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476554|NCT01290666|||Case-Only||Prospective|||||||
1476555|NCT01290653|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1476556|NCT01290640|||Case Control||Retrospective|||||||
1476557|NCT01290627|||Case-Only||Retrospective|||||||
1476558|NCT01290614|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1476559|NCT01290601|Randomized|Sequential Assignment||Treatment||Quadruple||Only if Cohort 1 met specified endpoint criteria would Cohort 2 begin enrollment|t|t|t|t
1476560|NCT01290588|||Cohort||Other|||||||
1476561|NCT01290575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476562|NCT01290562||Single Group Assignment||Treatment||None (Open Label)||||||
1476563|NCT01290549|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476564|NCT01290536||Single Group Assignment||Treatment||None (Open Label)||||||
1476565|NCT01290523||Single Group Assignment||Treatment||None (Open Label)||||||
1476566|NCT01290510||Single Group Assignment||Treatment||None (Open Label)||||||
1476567|NCT01290497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476568|NCT01290484||Single Group Assignment||Treatment||None (Open Label)||||||
1476569|NCT01290471|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476570|NCT01290458|Non-Randomized|Parallel Assignment||||Double|||t||t|
1476571|NCT01290445|||Cohort||Prospective|||||||
1476572|NCT01290432||Single Group Assignment||Treatment||None (Open Label)||||||
1476573|NCT01290419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476574|NCT01290406|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476575|NCT01290393|||Cohort||Prospective|||||||
1476576|NCT01290380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476577|NCT01290367|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1476578|NCT01290354||Single Group Assignment||Other||None (Open Label)||||||
1476579|NCT01290341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476580|NCT01290328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476581|NCT01290315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476582|NCT01290302|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1476583|NCT01290289|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1476584|NCT01290276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476585|NCT01290263|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476586|NCT01290250|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1476587|NCT01290237|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476588|NCT01290224||Single Group Assignment||Supportive Care||Single|||t|||
1476589|NCT01290211|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476590|NCT01290198|Randomized|Parallel Assignment||||None (Open Label)||||||
1476591|NCT01290185|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1476592|NCT01290172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476593|NCT01290159|||Cohort||Prospective|||||||
1476594|NCT01290146|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476595|NCT01290133|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1476596|NCT01290120||Single Group Assignment||Treatment||None (Open Label)||||||
1476597|NCT01290107|||Cohort||Prospective|||||||
1476598|NCT01290094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476599|NCT01290081|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1476600|NCT01290068|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476601|NCT01290055|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1476602|NCT01290042|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1476603|NCT01290029||Single Group Assignment||Treatment||None (Open Label)||||||
1476604|NCT01290016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476605|NCT01290003|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476606|NCT01289990|Non-Randomized|Parallel Assignment||Treatment||Double||||||
1476607|NCT01289977|||Cohort||Prospective|||||||
1476608|NCT01289964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476609|NCT01289951|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476610|NCT01289938|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1476611|NCT01289925|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1476612|NCT01289912|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476613|NCT01289899|Randomized|Parallel Assignment||||Double|||t||t|
1476614|NCT01289886|Randomized|Parallel Assignment||||Double|||t||t|
1476615|NCT01289873|||Cohort||Prospective|||||||
1476616|NCT01289860|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1476617|NCT01289847||Single Group Assignment||Prevention||None (Open Label)||||||
1476618|NCT01289834|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476619|NCT01289821||Single Group Assignment||Treatment||None (Open Label)||||||
1476620|NCT01289808|Randomized|Crossover Assignment||Prevention||Double||||t|t|
1476621|NCT01289795|||Cohort||Prospective|||||||
1476622|NCT01289782|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476623|NCT01289769|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1476624|NCT01289756|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1476625|NCT01289743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476626|NCT01289730||Single Group Assignment||Treatment||None (Open Label)||||||
1476627|NCT01289717|||Cohort||Prospective|||||||
1476628|NCT01289704|Randomized|Parallel Assignment||Treatment||Single||||||t
1476629|NCT01289691|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1476630|NCT01289678||Single Group Assignment||Treatment||None (Open Label)||||||
1476631|NCT01289665|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476632|NCT01289652|||Cohort||Prospective|||||||
1476633|NCT01289639|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1476634|NCT01289626||Single Group Assignment||Treatment||None (Open Label)||||||
1476635|NCT01289613|||Case-Only||Prospective|||||||
1476636|NCT01289600|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476637|NCT01289587|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1476638|NCT01289574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476639|NCT01289561||Single Group Assignment||Basic Science||Double|||t|||t
1476640|NCT01289548|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1476641|NCT01289535||Single Group Assignment||Prevention||None (Open Label)||||||
1476642|NCT01289522||Single Group Assignment||Treatment||None (Open Label)||||||
1476643|NCT01289509|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476644|NCT01289496||Single Group Assignment||Treatment||None (Open Label)||||||
1476645|NCT01289483|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1476646|NCT01289470|||Cohort||Prospective|||||||
1476647|NCT01289457|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476648|NCT01289444|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1476649|NCT01289431|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1476650|NCT01289418|||Cohort||Prospective|||||||
1476651|NCT01289405|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476652|NCT01289392|Randomized|Parallel Assignment||Treatment||Single|||||t|
1476653|NCT01289379||||||||||||
1476654|NCT01289366|||||Prospective|||||||
1476655|NCT01289353||Single Group Assignment||Treatment||None (Open Label)||||||
1476656|NCT01289340|||Cohort||Prospective|||||||
1476657|NCT01289327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476658|NCT01289314|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476659|NCT01289301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476660|NCT01289288|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476661|NCT01289275|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1476662|NCT01289262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476663|NCT01289249|||Cohort||Prospective|||||||
1476664|NCT01289236|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476665|NCT01289223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476666|NCT01289210||Single Group Assignment||Treatment||None (Open Label)||||||
1476667|NCT01289197|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476668|NCT01289184|||Cohort||Cross-Sectional|||||||
1476669|NCT01289171||Single Group Assignment||Treatment||None (Open Label)||||||
1476670|NCT01289158|||Case-Only||Cross-Sectional|||||||
1476671|NCT01289145|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1476672|NCT01289132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476673|NCT01289119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476674|NCT01289106|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476675|NCT01289093|||Cohort||Prospective|||||||
1476676|NCT01289080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476677|NCT01289067||Single Group Assignment||Treatment||None (Open Label)||||||
1476678|NCT01289054|||Cohort||Prospective|||||||
1476679|NCT01289041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476680|NCT01289028||Single Group Assignment||Treatment||None (Open Label)||||||
1476681|NCT01289015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476682|NCT01289002|||Cohort||Prospective|||||||
1476683|NCT01288989||Single Group Assignment||Treatment||None (Open Label)||||||
1476685|NCT01288963|||Case-Only||Prospective|||||||
1476686|NCT01288950|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1476687|NCT01288937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476688|NCT01288924|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1476689|NCT01288911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476690|NCT01288898|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1476691|NCT01288885|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1476692|NCT01288872|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476693|NCT01288859|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1476694|NCT01288846|||Case-Only||Prospective|||||||
1476695|NCT01288833|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1476696|NCT01288820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476697|NCT01288807||Single Group Assignment||Treatment||None (Open Label)||||||
1476698|NCT01288794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476699|NCT01288781|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1476700|NCT01288768|Randomized|Parallel Assignment||Treatment||Single|||||t|
1476701|NCT01288755|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476702|NCT01288742|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476703|NCT01288729|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1476704|NCT01288716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476705|NCT01288703|||Cohort||Prospective|||||||
1476706|NCT01288690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476707|NCT01288677|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1476708|NCT01288664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476709|NCT01288651||Single Group Assignment||Treatment||None (Open Label)||||||
1476710|NCT01288638|Randomized|Parallel Assignment||Treatment||Single|||||t|
1476711|NCT01288625|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1476712|NCT01288612|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1476713|NCT01288599|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476714|NCT01288586|||Case-Control||Prospective|||||||
1476715|NCT01288573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476716|NCT01288560|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476717|NCT01288547|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1476718|NCT01288534||Single Group Assignment||Treatment||None (Open Label)||||||
1476719|NCT01288521|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1476720|NCT01288508|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476721|NCT01288495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476722|NCT01288482|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476723|NCT01288469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476724|NCT01288456|||Case Control||Prospective|||||||
1476725|NCT01288443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476726|NCT01288430|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476727|NCT01288417|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476728|NCT01288404|Randomized|Single Group Assignment||Treatment||Single||||||t
1476729|NCT01288391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476730|NCT01288378|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1476731|NCT01288365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476732|NCT01288352|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476733|NCT01288339|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476734|NCT01288326|||Cohort||Prospective|||||||
1476735|NCT01288313|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1476736|NCT01288300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476737|NCT01288287|||Cohort||Prospective|||||||
1476738|NCT01288274|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1476739|NCT01288261||Single Group Assignment||Treatment||None (Open Label)||||||
1476740|NCT01288248|Randomized|Parallel Assignment||Treatment||Single||||||t
1476741|NCT01288235||Single Group Assignment||Treatment||None (Open Label)||||||
1476742|NCT01288222||Single Group Assignment||Treatment||None (Open Label)||||||
1476743|NCT01288209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476744|NCT01288196|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1476745|NCT01288183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476746|NCT01288170|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476747|NCT01288157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476748|NCT01288144|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1476749|NCT01288131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476750|NCT01288105||Single Group Assignment||Prevention||None (Open Label)||||||
1476751|NCT01288092|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476752|NCT01288079|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476753|NCT01288066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476754|NCT01288053||Single Group Assignment||Treatment||None (Open Label)||||||
1476755|NCT01288040|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476756|NCT01288027|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476757|NCT01288014|||Case-Only||Prospective|||||||
1476758|NCT01288001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476760|NCT01287975|Randomized|Parallel Assignment||Other||Single||||||t
1476761|NCT01287962|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476762|NCT01287949||Single Group Assignment||Prevention||None (Open Label)||||||
1476763|NCT01287936||Single Group Assignment||Treatment||None (Open Label)||||||
1476764|NCT01287923|||Cohort||Other|||||||
1476765|NCT01287910||Single Group Assignment||||None (Open Label)||||||
1476766|NCT01287897|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476767|NCT01287884|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1476768|NCT01287871|||Cohort||Prospective|||||||
1476769|NCT01287858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476770|NCT01287845|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476771|NCT01287832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476772|NCT01287819|||Case Control||Cross-Sectional|||||||
1476773|NCT01287806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476774|NCT01287793|Randomized|Crossover Assignment||||Double|||t||t|
1476775|NCT01287780|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1476776|NCT01287767|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1476777|NCT01287754|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476778|NCT01287741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476779|NCT01287728||Single Group Assignment||Diagnostic||None (Open Label)||||||
1476780|NCT01287715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476781|NCT01287702|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1476782|NCT01287689|||Cohort||Prospective|||||||
1476783|NCT01287663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476784|NCT01287637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476785|NCT01287624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476786|NCT01287611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476787|NCT01287598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476788|NCT01287585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476789|NCT01287572|||Case-Only||Prospective|||||||
1476790|NCT01287559|||Case Control||Prospective|||||||
1476791|NCT01287546|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476792|NCT01287533|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476793|NCT01287520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476794|NCT01287507|Randomized|Parallel Assignment||Prevention||Single||||t||
1476795|NCT01287494|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1476796|NCT01287481|Randomized|Parallel Assignment||Treatment||Single||||||t
1476797|NCT01287468|||||Prospective|||||||
1476798|NCT01287455|Randomized|Parallel Assignment||||Triple|||t|t|t|
1476799|NCT01287442|||Case-Only||Retrospective|||||||
1476800|NCT01287429|||Cohort||Prospective|||||||
1476801|NCT01287416|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476802|NCT01287403|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1476803|NCT01287390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476804|NCT01287377|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476805|NCT01287364|Randomized|Crossover Assignment||||None (Open Label)||||||
1476806|NCT01287351|||Cohort||Retrospective|||||||
1476807|NCT01287338|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476808|NCT01287325|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1476809|NCT01287312||Single Group Assignment||Treatment||None (Open Label)||||||
1476810|NCT01287299|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476811|NCT01287286|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1476812|NCT01287273|||Cohort||Prospective|||||||
1476813|NCT01287260|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476814|NCT01287247|||Cohort||Prospective|||||||
1476815|NCT01287234||Single Group Assignment||||None (Open Label)||||||
1476816|NCT01287221|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476817|NCT01287208|Randomized|Parallel Assignment||Prevention||Single|||t|||
1476818|NCT01287195||Single Group Assignment||Treatment||None (Open Label)||||||
1476819|NCT01287182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476820|NCT01287169|||||Prospective|||||||
1476821|NCT01287156|||Case-Only||Prospective|||||||
1476822|NCT01287143|||Other||Prospective|||||||
1476823|NCT01287130||Single Group Assignment||Treatment||None (Open Label)||||||
1476824|NCT01287117|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476825|NCT01287104|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1476826|NCT01287091||Single Group Assignment||Treatment||None (Open Label)||||||
1476827|NCT01287078||Single Group Assignment||Treatment||None (Open Label)||||||
1476828|NCT01287065|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1476829|NCT01287052||Single Group Assignment||Treatment||None (Open Label)||||||
1476830|NCT01287039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476831|NCT01287026|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1476832|NCT01287013|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476833|NCT01287000|||Cohort||Prospective|||||||
1476834|NCT01286987||||Treatment||None (Open Label)||||||
1476835|NCT01286974|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1476836|NCT01286961|||Case-Only||Prospective|||||||
1476837|NCT01286948|Randomized|Parallel Assignment||Prevention||Single|||t|||
1476838|NCT01286935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476839|NCT01286922|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1476840|NCT01286909|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476841|NCT01286896||Single Group Assignment||Treatment||None (Open Label)||||||
1476842|NCT01286883|||Case-Only||Prospective|||||||
1476843|NCT01286870||Single Group Assignment||Treatment||None (Open Label)||||||
1476844|NCT01286857||Single Group Assignment||Treatment||None (Open Label)||||||
1476845|NCT01286844|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476846|NCT01286831||Single Group Assignment||Other||None (Open Label)||||||
1476847|NCT01286818||Single Group Assignment||Treatment||None (Open Label)||||||
1476848|NCT01286805|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476849|NCT01286792||||||||||||
1476850|NCT01286779|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476851|NCT01286766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476852|NCT01286753|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476853|NCT01286740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476854|NCT01286727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476855|NCT01286714||Single Group Assignment||Treatment||None (Open Label)||||||
1476856|NCT01286701|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476857|NCT01286688|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476858|NCT01286675||Single Group Assignment||Supportive Care||None (Open Label)||||||
1476859|NCT01286662|||Cohort||Retrospective|||||||
1476860|NCT01286649|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1476861|NCT01286636|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476862|NCT01286623|||Cohort||Prospective|||||||
1476863|NCT01286610||Single Group Assignment||Other||None (Open Label)||||||
1476864|NCT01286597|Randomized|Parallel Assignment||||Double|||t||t|
1476865|NCT01286584|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476866|NCT01286571|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476867|NCT01286558|Randomized|Parallel Assignment||Treatment||Double||||||
1476868|NCT01286545|||Cohort||Prospective|||||||
1476869|NCT01286532|||Cohort||Prospective|||||||
1476870|NCT01286519|||Case-Only||Prospective|||||||
1476871|NCT01286506|||Cohort||Prospective|||||||
1476872|NCT01286493||Single Group Assignment||Treatment||None (Open Label)||||||
1476873|NCT01286480|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476874|NCT01286467|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476875|NCT01286454|Randomized|Crossover Assignment||||None (Open Label)||||||
1476876|NCT01286441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476877|NCT01286428|||Case-Only||Prospective|||||||
1476878|NCT01286415|Randomized|Parallel Assignment||Treatment||Single||||||t
1476879|NCT01286402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476880|NCT01286389|Randomized|Parallel Assignment||Treatment||Single||||||t
1476881|NCT01286376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476882|NCT01286363|||||Cross-Sectional|||||||
1476883|NCT01286350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476884|NCT01286337|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476885|NCT01286324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476886|NCT01286311|Randomized|Parallel Assignment||Prevention||Single|||t|||
1476887|NCT01286298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476888|NCT01286285|||||Prospective|||||||
1476889|NCT01286272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476890|NCT01286259||Single Group Assignment||||None (Open Label)||||||
1476891|NCT01286246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476892|NCT01286233|||Case Control||Prospective|||||||
1476893|NCT01286220|Randomized|Parallel Assignment||Treatment||Double||||||
1476894|NCT01286207|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476895|NCT01286194|||Cohort||Prospective|||||||
1476896|NCT01286181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476897|NCT01286168|Randomized|Factorial Assignment||Prevention||Single|||||t|
1476898|NCT01286155|||Cohort||Prospective|||||||
1476899|NCT01286142|||Cohort||Prospective|||||||
1476900|NCT01286129|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476901|NCT01286116||Single Group Assignment||Treatment||None (Open Label)||||||
1476902|NCT01286103|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1476903|NCT01286090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476904|NCT01286077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476905|NCT01286064|Randomized|Parallel Assignment||Screening||Double|||t||t|
1476906|NCT01286051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476907|NCT01286038||Single Group Assignment||Treatment||None (Open Label)||||||
1476908|NCT01286025|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1476909|NCT01286012|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476910|NCT01285999|Randomized|Parallel Assignment||Treatment||Single|||t|||
1476911|NCT01285986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476912|NCT01285973|||Cohort||Prospective|||||||
1476913|NCT01285960||Single Group Assignment||Treatment||None (Open Label)||||||
1476914|NCT01285947|Randomized|Parallel Assignment||||Single|||t|||
1476915|NCT01285934|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476916|NCT01285921||Single Group Assignment||Diagnostic||Single|||||t|
1476917|NCT01285908|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476918|NCT01285895|||||Prospective|||||||
1476919|NCT01285882|||||Prospective|||||||
1476920|NCT01285869|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1476921|NCT01285856|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1476922|NCT01285843|Randomized|||Treatment||None (Open Label)||||||
1476923|NCT01285830|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476924|NCT01285817||Single Group Assignment||Treatment||None (Open Label)||||||
1476925|NCT01285804|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476926|NCT01285791|||Case-Only||Prospective|||||||
1476927|NCT01285778||Single Group Assignment||Treatment||None (Open Label)||||||
1476928|NCT01285765|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1476929|NCT01285752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476930|NCT01285739|||Case Control||Prospective|||||||
1476931|NCT01285726|||Cohort||Prospective|||||||
1476932|NCT01285713|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476933|NCT01285700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476934|NCT01285687|Randomized|Parallel Assignment||Treatment||Single||||||t
1476935|NCT01285674||Single Group Assignment||Prevention||None (Open Label)||||||
1476936|NCT01285661||Single Group Assignment||Treatment||None (Open Label)||||||
1476937|NCT01285648|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1476938|NCT01285635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476939|NCT01285622|||Cohort||Prospective|||||||
1476940|NCT01285609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476941|NCT01285596|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1476942|NCT01285583||Single Group Assignment||||None (Open Label)||||||
1476943|NCT01285570|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476944|NCT01285557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476945|NCT01285544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476946|NCT01285531|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476947|NCT01285518|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476948|NCT01285505|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1476949|NCT01285492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476950|NCT01285479|||Cohort||Prospective|||||||
1476951|NCT01285466|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476952|NCT01285453||Single Group Assignment||Treatment||None (Open Label)||||||
1476953|NCT01285440|||Case-Only||Prospective|||||||
1476954|NCT01285427|||Case-Only|||||||||
1476955|NCT01285414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1476956|NCT01285401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476957|NCT01285388|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1476958|NCT01285375|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476959|NCT01285362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476960|NCT01285349|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1476961|NCT01285336||||Health Services Research||||||||
1476962|NCT01285323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476963|NCT01285310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476964|NCT01285297|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476965|NCT01285284|Randomized|Parallel Assignment||Treatment||Single||||t||
1476966|NCT01285271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1476967|NCT01285258||Single Group Assignment||Treatment||Single||||||t
1476968|NCT01285245||Single Group Assignment||Treatment||None (Open Label)||||||
1476969|NCT01285232|Randomized|Crossover Assignment||||Triple|||t|t|t|
1476970|NCT01285219|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1476971|NCT01285206|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1476972|NCT01285193|Randomized|Parallel Assignment||Treatment||Single|||||t|
1476973|NCT01285180|||Cohort||Prospective|||||||
1476974|NCT01285167|||Cohort||Prospective|||||||
1476975|NCT01285154|||Case-Only||Retrospective|||||||
1476976|NCT01285141||Single Group Assignment||Prevention||None (Open Label)||||||
1476977|NCT01285115|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1476978|NCT01285102||Single Group Assignment||Treatment||None (Open Label)||||||
1476979|NCT01285089|||Cohort||Prospective|||||||
1476980|NCT01285076|||Cohort||Retrospective|||||||
1476981|NCT01285063||Single Group Assignment||Treatment||None (Open Label)||||||
1476982|NCT01285050||Single Group Assignment||Basic Science||None (Open Label)||||||
1476983|NCT01285037||Single Group Assignment||Treatment||None (Open Label)||||||
1476984|NCT01285024|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1476985|NCT01285011|||Cohort||Prospective|||||||
1476986|NCT01284998|||Cohort||Prospective|||||||
1476987|NCT01284985|||Cohort||Prospective|||||||
1476988|NCT01284972|||Case-Only|||||||||
1476989|NCT01284959|Randomized|Parallel Assignment||||Double|||t||t|
1476990|NCT01284946||Single Group Assignment||Treatment||None (Open Label)||||||
1476991|NCT01284933|||Cohort||Prospective|||||||
1476992|NCT01284920|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1476993|NCT01284907|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1476994|NCT01284894|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1476995|NCT01284881|||Cohort||Prospective|||||||
1476996|NCT01284868|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1476997|NCT01284855|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1476998|NCT01284842|||Case-Only||Cross-Sectional|||||||
1476999|NCT01284829||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477000|NCT01284816||Crossover Assignment||||None (Open Label)||||||
1477001|NCT01284803||Single Group Assignment||||None (Open Label)||||||
1477002|NCT01284790||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477003|NCT01284777|||||Prospective|||||||
1477004|NCT01284764|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1477005|NCT01284751|||Cohort||Cross-Sectional|||||||
1477006|NCT01284738|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1477007|NCT01284725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477008|NCT01284712|||||Prospective|||||||
1477009|NCT01284699||Single Group Assignment||Treatment||None (Open Label)||||||
1477010|NCT01284686|Randomized|Crossover Assignment||||None (Open Label)||||||
1477011|NCT01284673||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477012|NCT01284660|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1477013|NCT01284647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477014|NCT01284634|Randomized|Parallel Assignment||Treatment||Quadruple|This study was partially-blinded. Due to the varying numbers of capsules administered, participants and investigators were not blinded to the treatment cohort (one, two or four capsules), but were blinded to the treatment allocation within each cohort (GWP42003 or placebo)||t|t|t|t
1477015|NCT01284621|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477016|NCT01284608|||Cohort||Prospective|||||||
1477017|NCT01284595||Single Group Assignment||||None (Open Label)||||||
1477018|NCT01284582|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477019|NCT01284569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477020|NCT01284556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477021|NCT01284543|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477022|NCT01284530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477023|NCT01284517|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477024|NCT01284504|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477025|NCT01284491|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1477026|NCT01284478||Single Group Assignment||Treatment||None (Open Label)||||||
1477027|NCT01284465|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477028|NCT01284452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477029|NCT01284439|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477030|NCT01284426|||Cohort||Prospective|||||||
1477031|NCT01284413|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477032|NCT01284400|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477033|NCT01284387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477034|NCT01284374||||||||||||
1477035|NCT01284361|Randomized|Crossover Assignment||||None (Open Label)||||||
1477036|NCT01284348|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1477037|NCT01284335|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477038|NCT01284322||Single Group Assignment||Treatment||None (Open Label)||||||
1477039|NCT01284309|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1477040|NCT01284296||Single Group Assignment||||None (Open Label)||||||
1477041|NCT01284283||Single Group Assignment||Treatment||None (Open Label)||||||
1477042|NCT01284270||Single Group Assignment||||None (Open Label)||||||
1477043|NCT01284257|||Cohort||Prospective|||||||
1477044|NCT01284244|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477045|NCT01284231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477046|NCT01284218|||Cohort||Retrospective|||||||
1477047|NCT01284205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477048|NCT01284192||Single Group Assignment||Treatment||None (Open Label)||||||
1477049|NCT01284179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477050|NCT01284166||Single Group Assignment||Treatment||None (Open Label)||||||
1477051|NCT01284153|||Case-Only||Cross-Sectional|||||||
1477052|NCT01284140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477053|NCT01284127|||Cohort||Prospective|||||||
1477054|NCT01284114||Single Group Assignment||Treatment||None (Open Label)||||||
1477055|NCT01284101|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477056|NCT01284088|Randomized|Parallel Assignment||Prevention||Single||||||t
1477057|NCT01284075|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1477058|NCT01284062|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477059|NCT01284049|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477060|NCT01284036||Single Group Assignment||||Triple|||t|t|t|
1477061|NCT01284023|||Other||Cross-Sectional|||||||
1477062|NCT01284010|||Case-Only||Cross-Sectional|||||||
1477063|NCT01283997|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1477064|NCT01283984|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1477065|NCT01283971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477066|NCT01283958|||Case-Only||Retrospective|||||||
1477067|NCT01283945||Single Group Assignment||Treatment||None (Open Label)||||||
1477068|NCT01283932|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477069|NCT01283919|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477070|NCT01283906|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477071|NCT01283893|||Case Control||Prospective|||||||
1477072|NCT01283880|||Cohort||Prospective|||||||
1477073|NCT01283867|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477074|NCT01283854|Randomized|Parallel Assignment||Prevention||Single||||||t
1477075|NCT01283841|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477076|NCT01283828|||Cohort||Prospective|||||||
1477077|NCT01283815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477078|NCT01283802|||Cohort||Prospective|||||||
1477079|NCT01283789||Single Group Assignment||Treatment||None (Open Label)||||||
1477080|NCT01283776||Single Group Assignment||Prevention||None (Open Label)||||||
1477081|NCT01283763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477082|NCT01283750||Parallel Assignment||Treatment||Single||||||t
1477083|NCT01283737|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477084|NCT01283724||Single Group Assignment||Treatment||None (Open Label)||||||
1477085|NCT01283711||Single Group Assignment||Treatment||None (Open Label)||||||
1477086|NCT01283698|Randomized|Parallel Assignment||Treatment||Single|||||t|
1477087|NCT01283685||Single Group Assignment||Treatment||None (Open Label)||||||
1477088|NCT01283672|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1477089|NCT01283659|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1477090|NCT01283646|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477091|NCT01283633||Single Group Assignment||Treatment||None (Open Label)||||||
1477092|NCT01283620|Randomized|Parallel Assignment||Treatment||Single||||||t
1477093|NCT01283607|Randomized|Parallel Assignment||Prevention||Single|||||t|
1477094|NCT01283594|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477095|NCT01283581|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477096|NCT01283568|||Case Control||Prospective|||||||
1477097|NCT01283555|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1477098|NCT01283542|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477099|NCT01283529|||Cohort||Prospective|||||||
1477100|NCT01283516|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477101|NCT01283503||Single Group Assignment||Treatment||None (Open Label)||||||
1477102|NCT01283490|Randomized|Factorial Assignment||Basic Science||Double|||t|t||
1477103|NCT01283477|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1477104|NCT01283464|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477105|NCT01283451|||Other||Cross-Sectional|||||||
1477106|NCT01283438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477107|NCT01283425|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477108|NCT01283412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477109|NCT01283399|||Cohort||Prospective|||||||
1477110|NCT01283386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477111|NCT01283373||Single Group Assignment||Treatment||None (Open Label)||||||
1477112|NCT01283360|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477113|NCT01283347||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477114|NCT01283334||Single Group Assignment||Treatment||None (Open Label)||||||
1477115|NCT01283321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477116|NCT01283308|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477117|NCT01283295|||Cohort||Prospective|||||||
1477118|NCT01283282|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1477119|NCT01283269|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1477120|NCT01283256|||Cohort||Prospective|||||||
1477121|NCT01283243|||Cohort||Prospective|||||||
1477122|NCT01283230|||Cohort||Prospective|||||||
1477123|NCT01283217|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1477124|NCT01283204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477125|NCT01283191|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477126|NCT01283178||Single Group Assignment||Treatment||None (Open Label)||||||
1477127|NCT01283165|||Cohort||Prospective|||||||
1477128|NCT01283152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477129|NCT01283139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477130|NCT01283126||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477131|NCT01283113|||Cohort||Cross-Sectional|||||||
1477132|NCT01283100|Randomized|Crossover Assignment||||None (Open Label)||||||
1477133|NCT01283087|||Case-Only||Prospective|||||||
1477134|NCT01283074|||Cohort||Prospective|||||||
1477135|NCT01283061|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477136|NCT01283048||Single Group Assignment||Treatment||None (Open Label)||||||
1477137|NCT01283035||Single Group Assignment||Treatment||None (Open Label)||||||
1477138|NCT01283022||Single Group Assignment||Basic Science||None (Open Label)||||||
1477139|NCT01283009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477140|NCT01282996|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477141|NCT01282983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477142|NCT01282970|Randomized|Parallel Assignment||Treatment||Double||||||
1477143|NCT01282957|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1477144|NCT01282944|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1477145|NCT01282931|||Cohort||Cross-Sectional|||||||
1477146|NCT01282918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477147|NCT01282905|||Case Control||Prospective|||||||
1477148|NCT01282892|||Cohort||Prospective|||||||
1477149|NCT01282879||Single Group Assignment||Prevention||None (Open Label)||||||
1477150|NCT01282866||Single Group Assignment||Treatment||None (Open Label)||||||
1477151|NCT01282853|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1477152|NCT01282840||Single Group Assignment||Treatment||None (Open Label)||||||
1477153|NCT01282827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477154|NCT01282814|Randomized|Crossover Assignment||||None (Open Label)||||||
1477155|NCT01282801|Randomized|Crossover Assignment||||None (Open Label)||||||
1477156|NCT01282788|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477157|NCT01282775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477158|NCT01282762|||Cohort||Prospective|||||||
1477159|NCT01282749|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477160|NCT01282736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477161|NCT01282723|||Case-Only||Cross-Sectional|||||||
1477162|NCT01282710|||Case-Only||Cross-Sectional|||||||
1477163|NCT01282697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477164|NCT01282684|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477165|NCT01282671|Randomized|Parallel Assignment||Treatment||Single||||||t
1477166|NCT01282658|||Cohort||Prospective|||||||
1477167|NCT01282645|||Cohort||Retrospective|||||||
1477168|NCT01282632|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1477169|NCT01282619|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477170|NCT01282606|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477171|NCT01282593||Single Group Assignment||||None (Open Label)||||||
1477172|NCT01282580|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477173|NCT01282567||Single Group Assignment||||None (Open Label)||||||
1477174|NCT01282554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477175|NCT01282541|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1477176|NCT01282528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477177|NCT01282515|Randomized|Parallel Assignment||Treatment||Single|||||t|
1477178|NCT01282502||Single Group Assignment||Treatment||None (Open Label)||||||
1477179|NCT01282489||||||||||||
1477180|NCT01282476||Single Group Assignment||Treatment||None (Open Label)||||||
1477181|NCT01282463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477182|NCT01282450||Single Group Assignment||||None (Open Label)||||||
1477183|NCT01282437|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477184|NCT01282424||Single Group Assignment||Treatment||None (Open Label)||||||
1477185|NCT01282411|||Case-Only||Prospective|||||||
1477186|NCT01282398|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1477187|NCT01282385|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1477188|NCT01282372|||||Prospective|||||||
1477189|NCT01282359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477190|NCT01282346||Single Group Assignment||Treatment||None (Open Label)||||||
1477191|NCT01282333||Single Group Assignment||Treatment||None (Open Label)||||||
1477192|NCT01282320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477193|NCT01282307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477194|NCT01282294|||Cohort||Prospective|||||||
1477195|NCT01282281|||Case Control||Prospective|||||||
1477196|NCT01282268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477197|NCT01282255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477198|NCT01282242||Single Group Assignment||Treatment||None (Open Label)||||||
1477199|NCT01282229|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1477200|NCT01282216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477201|NCT01282203|||||Prospective|||||||
1477202|NCT01282190|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477203|NCT01282177|||Cohort||Prospective|||||||
1477204|NCT01282164|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1477205|NCT01282151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477206|NCT01282138|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1477207|NCT01282125|||Cohort||Cross-Sectional|||||||
1477208|NCT01282112|||||Retrospective|||||||
1477209|NCT01282099|||Cohort||Prospective|||||||
1477210|NCT01282086|||||Prospective|||||||
1477211|NCT01282073|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477212|NCT01282060|||Cohort||Prospective|||||||
1477213|NCT01282047|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477214|NCT01282034|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477215|NCT01282021|||Ecologic or Community||Cross-Sectional|||||||
1477216|NCT01282008|||Case-Only||Cross-Sectional|||||||
1477217|NCT01281995|||||Prospective|||||||
1477218|NCT01281982|||||Prospective|||||||
1477219|NCT01281969|Randomized|Parallel Assignment||Treatment||Double||||||
1477220|NCT01281956|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1477221|NCT01281943|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477222|NCT01281930|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1477223|NCT01281917||Single Group Assignment||Treatment||None (Open Label)||||||
1477224|NCT01281904|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477225|NCT01281891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477226|NCT01281878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477227|NCT01281865||Single Group Assignment||Treatment||None (Open Label)||||||
1477228|NCT01281852||Single Group Assignment||Treatment||None (Open Label)||||||
1477229|NCT01281839|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477230|NCT01281826|||Cohort||Prospective|||||||
1477231|NCT01281813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477232|NCT01281800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477233|NCT01281787|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477234|NCT01281774|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477235|NCT01281761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477236|NCT01281748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477237|NCT01281735|||Cohort||Prospective|||||||
1477238|NCT01281722|||Case Control||Prospective|||||||
1477239|NCT01281709|||Case-Only||Retrospective|||||||
1477240|NCT01281696||Single Group Assignment||Treatment||None (Open Label)||||||
1477241|NCT01281683|||Cohort||Prospective|||||||
1477242|NCT01281670|Randomized|Parallel Assignment||||Single|||||t|
1477243|NCT01281657|||Cohort||Prospective|||||||
1477244|NCT01281644|Randomized|Parallel Assignment||Treatment||Single||||||t
1477245|NCT01281631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477246|NCT01281618|||Case-Only||Prospective|||||||
1477247|NCT01281605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477248|NCT01281592||Single Group Assignment||Treatment||None (Open Label)||||||
1477249|NCT01281579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477250|NCT01281566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477251|NCT01281553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477252|NCT01281540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477253|NCT01281527||Single Group Assignment||Treatment||None (Open Label)||||||
1477254|NCT01281514||Single Group Assignment||Treatment||None (Open Label)||||||
1477255|NCT01281501|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477256|NCT01281488|Randomized|Single Group Assignment||Treatment||Single|||||t|
1477257|NCT01281475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477258|NCT01281462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477259|NCT01281436|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1477260|NCT01281410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477261|NCT01281397|||Cohort||Prospective|||||||
1477262|NCT01281384|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1477263|NCT01281371|||Cohort||Prospective|||||||
1477264|NCT01281358|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1477265|NCT01281345|||Case-Only||Prospective|||||||
1477266|NCT01281332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477267|NCT01281319|||Case Control||Prospective|||||||
1477268|NCT01281306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477269|NCT01281293|||Cohort||Prospective|||||||
1477270|NCT01281280|||Cohort||Prospective|||||||
1477271|NCT01281267||Single Group Assignment||Treatment||None (Open Label)||||||
1477272|NCT01281254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477273|NCT01281241|||Case-Only||Prospective|||||||
1477274|NCT01281228|Randomized|Crossover Assignment||||Single|||t|||
1477275|NCT01281215|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1477276|NCT01281202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477277|NCT01281189|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477278|NCT01281176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477279|NCT01281163||Single Group Assignment||Treatment||None (Open Label)||||||
1477280|NCT01281150||Single Group Assignment||Treatment||None (Open Label)||||||
1477281|NCT01281137|||Cohort||Prospective|||||||
1477282|NCT01281124||Single Group Assignment||Treatment||None (Open Label)||||||
1477283|NCT01281111|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1477284|NCT01281098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477285|NCT01281085|||||Prospective|||||||
1477286|NCT01281072||Single Group Assignment||||||||||
1477287|NCT01281059||||||||||||
1477288|NCT01281033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477289|NCT01281020|||Cohort||Prospective|||||||
1477290|NCT01281007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477291|NCT01280994||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477292|NCT01280981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477293|NCT01280968|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1477294|NCT01280955||Single Group Assignment||Treatment||None (Open Label)||||||
1477295|NCT01280942|Randomized|Crossover Assignment||Prevention||None (Open Label)||Random allocation of study wards to intervention and control, with washout period and crossover of assignment.||||
1477296|NCT01280929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477297|NCT01280916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477298|NCT01280903|Randomized|Parallel Assignment||Treatment||Single||||||t
1477299|NCT01280890|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1477300|NCT01280877|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1477301|NCT01280864|||Case-Control||Prospective|||||||
1477302|NCT01280851||Single Group Assignment||Screening||None (Open Label)||||||
1477303|NCT01280838|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477304|NCT01280825|||Cohort||Prospective|||||||
1477305|NCT01280812|Randomized|Parallel Assignment||Prevention||Single||||||t
1477306|NCT01280799|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477307|NCT01280786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477308|NCT01280773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477309|NCT01280760|||Cohort||Prospective|||||||
1477310|NCT01280747|||Cohort||Prospective|||||||
1477311|NCT01280734|Randomized|Crossover Assignment||||Double|||t||t|
1477312|NCT01280721||Single Group Assignment||Treatment||None (Open Label)||||||
1477313|NCT01280708|||Cohort||Prospective|||||||
1477314|NCT01280695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477315|NCT01280682|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477316|NCT01280669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477317|NCT01280656|||Cohort||Prospective|||||||
1477318|NCT01280643|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477319|NCT01280630|||||Retrospective|||||||
1477320|NCT01280617|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477321|NCT01280604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477322|NCT01280591|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477323|NCT01280578|||Cohort||Prospective|||||||
1477324|NCT01280565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477325|NCT01280552|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477326|NCT01280539|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1477327|NCT01280526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477328|NCT01280513|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1477329|NCT01280500|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1477330|NCT01280487||Single Group Assignment||Treatment||None (Open Label)||||||
1477331|NCT01280474|||||Prospective|||||||
1477332|NCT01280461|||Cohort|||||||||
1477333|NCT01280448|||Case Control||Prospective|||||||
1477334|NCT01280435|||||Prospective|||||||
1477335|NCT01280422|||Case-Only||Retrospective|||||||
1477336|NCT01280409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477337|NCT01280396|||Other||Retrospective|||||||
1477338|NCT01280383||Single Group Assignment||Treatment||None (Open Label)||||||
1477339|NCT01280370|||Cohort||Prospective|||||||
1477340|NCT01280357|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1477341|NCT01280344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477342|NCT01280331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477343|NCT01280318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477344|NCT01280305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477345|NCT01280292||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477346|NCT01280279|||Cohort||Prospective|||||||
1477347|NCT01280266|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1477348|NCT01280253|||Case-Only||Prospective|||||||
1477349|NCT01280240|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1477350|NCT01280227|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1477351|NCT01280214||Single Group Assignment||Treatment||None (Open Label)||||||
1477352|NCT01280201||Single Group Assignment||Treatment||None (Open Label)||||||
1477353|NCT01280188||Single Group Assignment||Treatment||None (Open Label)||||||
1477354|NCT01280175|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477355|NCT01280162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477356|NCT01280149|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477357|NCT01280136||Single Group Assignment||Prevention||None (Open Label)||||||
1477358|NCT01280123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477359|NCT01280110|Randomized|Parallel Assignment||Treatment||Single|||||t|
1477360|NCT01280097|||Cohort||Prospective|||||||
1477361|NCT01280084|||Case Control||Prospective|||||||
1477362|NCT01280071||||Basic Science||||||||
1477363|NCT01280058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477364|NCT01280045|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1477365|NCT01280032||Single Group Assignment||Treatment||None (Open Label)||||||
1477366|NCT01280019|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1477367|NCT01280006|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1477368|NCT01279993|Non-Randomized|Single Group Assignment||Supportive Care||||||||
1477369|NCT01279980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477370|NCT01279967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477371|NCT01279954|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1477372|NCT01279941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477373|NCT01279928|||||Cross-Sectional|||||||
1477374|NCT01279915|Randomized|Parallel Assignment||||Triple|||t|t|t|
1477375|NCT01279902||Single Group Assignment||Treatment||None (Open Label)||||||
1477376|NCT01279889|||Cohort||Prospective|||||||
1477377|NCT01279876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477378|NCT01279863|||Case Control||Prospective|||||||
1477379|NCT01279850|||Case-Only||Prospective|||||||
1477380|NCT01279837|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1477381|NCT01279824|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1477382|NCT01279811||Single Group Assignment||Other||None (Open Label)||||||
1477383|NCT01279798||||||||||||
1477384|NCT01279785|||Cohort||Prospective|||||||
1477385|NCT01279772|||Cohort||Prospective|||||||
1477386|NCT01279759|||||Prospective|||||||
1477387|NCT01279746|||Case-Only||Prospective|||||||
1477388|NCT01279733|||Cohort||Prospective|||||||
1477389|NCT01279720|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477390|NCT01279707|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477391|NCT01279694|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477392|NCT01279681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477393|NCT01279668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477394|NCT01279655|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477395|NCT01279642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477396|NCT01279629||||||||||||
1477397|NCT01279616||Single Group Assignment||Treatment||None (Open Label)||||||
1477398|NCT01279603||Single Group Assignment||Treatment||None (Open Label)||||||
1477399|NCT01279590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477400|NCT01279577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477401|NCT01279564|Randomized|Parallel Assignment||||Single|||t|||
1477402|NCT01279551|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477403|NCT01279538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477404|NCT01279525|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477405|NCT01279512|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477406|NCT01279499|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477407|NCT01279486|||Cohort||Prospective|||||||
1477408|NCT01279473||Single Group Assignment||Treatment||None (Open Label)||||||
1477409|NCT01279460|||Cohort||Prospective|||||||
1477410|NCT01279447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477411|NCT01279434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477412|NCT01279421|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1477413|NCT01279408|||Cohort||Prospective|||||||
1477414|NCT01279395|||Cohort||Prospective|||||||
1477415|NCT01279382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477416|NCT01279369|||Cohort||Prospective|||||||
1477417|NCT01279356|||Cohort||Prospective|||||||
1477418|NCT01279343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477419|NCT01279330|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1477420|NCT01279317|Randomized|Crossover Assignment||Treatment||Single|||||t|
1477421|NCT01279304|||Cohort||Prospective|||||||
1477422|NCT01279291|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477423|NCT01279278|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1477424|NCT01279265|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1477425|NCT01279252||Single Group Assignment||Treatment||None (Open Label)||||||
1477426|NCT01279239|||Cohort||Prospective|||||||
1477427|NCT01279226||Single Group Assignment||Treatment||None (Open Label)||||||
1477428|NCT01279213|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477429|NCT01279200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477430|NCT01279187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477431|NCT01279174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477432|NCT01279161|||Case Control||Cross-Sectional|||||||
1477433|NCT01279148|||Case Control||Prospective|||||||
1477434|NCT01279135|Randomized|||Treatment||||||||
1477435|NCT01279122||Single Group Assignment||Treatment||None (Open Label)||||||
1477436|NCT01279109|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477437|NCT01279096||Single Group Assignment||Treatment||None (Open Label)||||||
1477438|NCT01279083|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477439|NCT01279070|Randomized|Parallel Assignment||Treatment||Single||||||t
1477440|NCT01279057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477441|NCT01279044|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477442|NCT01279031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477443|NCT01279018|||Cohort||Cross-Sectional|||||||
1477444|NCT01279005|||||Prospective|||||||
1477445|NCT01278992|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477446|NCT01278979|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1477447|NCT01278966|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477448|NCT01278953|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477449|NCT01278940|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477450|NCT01278927|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1477451|NCT01278914||||||||||||
1477452|NCT01278901|||Cohort||Prospective|||||||
1477453|NCT01278888|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1477454|NCT01278875|||Case Control||Prospective|||||||
1477455|NCT01278862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477456|NCT01278849||Parallel Assignment||Treatment||None (Open Label)||||||
1477457|NCT01278836||Single Group Assignment||Treatment||Single||||||t
1477458|NCT01278823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477459|NCT01278810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477460|NCT01278797|Randomized|Crossover Assignment||Basic Science||Single||||||
1477461|NCT01278784|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1477462|NCT01278771|||Case Control||Retrospective|||||||
1477463|NCT01278758||Parallel Assignment||Treatment||None (Open Label)||||||
1477464|NCT01278745|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477465|NCT01278732|||||Prospective|||||||
1477466|NCT01278719|||Case Control||Prospective|||||||
1477467|NCT01278706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477468|NCT01278693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477469|NCT01278680|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1477470|NCT01278667|||Case-Crossover||Prospective|||||||
1477471|NCT01278654|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1477472|NCT01278641|Randomized|Parallel Assignment||Treatment||Single|||||t|
1477473|NCT01278628||Single Group Assignment||Health Services Research||None (Open Label)||||||
1477474|NCT01278615||Single Group Assignment||Treatment||None (Open Label)||||||
1477475|NCT01278602||Single Group Assignment||Treatment||None (Open Label)||||||
1477476|NCT01278589|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1477477|NCT01278576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477478|NCT01278563|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477479|NCT01278550|||Cohort||Prospective|||||||
1477480|NCT01278537|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1477481|NCT01278524|||Cohort||Prospective|||||||
1477482|NCT01278511||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477483|NCT01278498|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477484|NCT01278485|||Cohort||Retrospective|||||||
1477485|NCT01278472|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477486|NCT01278459|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1477487|NCT01278446|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1477488|NCT01278433||Single Group Assignment||Prevention||None (Open Label)||||||
1477489|NCT01278420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477490|NCT01278407|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477491|NCT01278394||Single Group Assignment||Treatment||None (Open Label)||||||
1477492|NCT01278381|||Case-Only||Prospective|||||||
1477493|NCT01278368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477494|NCT01278355|||Cohort||Prospective|||||||
1477495|NCT01278342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477496|NCT01278329|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1477497|NCT01278316|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1477498|NCT01278303||Single Group Assignment||Treatment||None (Open Label)||||||
1477499|NCT01278290|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1477500|NCT01278277|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1477501|NCT01278264|Randomized|Factorial Assignment||Prevention||Single|||||t|
1477502|NCT01278251|||Case-Only||Retrospective|||||||
1477503|NCT01278238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477504|NCT01278225|||Cohort||Prospective|||||||
1477505|NCT01278212||Single Group Assignment||Treatment||None (Open Label)||||||
1477506|NCT01278199|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1477507|NCT01278186|Randomized|Parallel Assignment||Treatment||Single||||||t
1477508|NCT01278173||Single Group Assignment||Supportive Care||None (Open Label)||||||
1477509|NCT01278160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477510|NCT01278147|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477511|NCT01278134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477512|NCT01278121|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1477513|NCT01278108|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1477514|NCT01278095|Randomized|Parallel Assignment||||None (Open Label)||||||
1477515|NCT01278082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477516|NCT01278069|||Cohort||Prospective|||||||
1477517|NCT01278056||Single Group Assignment||Treatment||None (Open Label)||||||
1477518|NCT01278043|||Case-Only||Prospective|||||||
1477519|NCT01278030|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1477520|NCT01278017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477521|NCT01278004|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1477522|NCT01277991|Randomized|Crossover Assignment||||None (Open Label)||||||
1477523|NCT01277978|||Case Control||Cross-Sectional|||||||
1477524|NCT01277965|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1477525|NCT01277952||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1477526|NCT01277939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477527|NCT01277926|||Case-Only||Prospective|||||||
1477528|NCT01277913|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477529|NCT01277900|||Case-Only||Prospective|||||||
1477530|NCT01277887|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1477531|NCT01277874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477532|NCT01277861|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1477533|NCT01277848|||Other||Prospective|||||||
1477534|NCT01277835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477535|NCT01277822|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477536|NCT01277809|Randomized|Parallel Assignment||Prevention||Single||||||t
1477537|NCT01277796||||||||||||
1477538|NCT01277783||Single Group Assignment||Treatment||None (Open Label)||||||
1477539|NCT01277770|||Cohort||Retrospective|||||||
1477540|NCT01277757||Single Group Assignment||Treatment||None (Open Label)||||||
1477541|NCT01277744||Single Group Assignment||Treatment||None (Open Label)||||||
1477542|NCT01277731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477543|NCT01277718|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477544|NCT01277705|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477545|NCT01277692|Randomized|Single Group Assignment||Other||Double|||t||t|
1477546|NCT01277679|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1477547|NCT01277666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477548|NCT01277653|||Cohort|||||||||
1477549|NCT01277640|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1477550|NCT01277627|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1478328|NCT01267513|||Case-Only||Prospective|||||||
1477551|NCT01277614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477552|NCT01277601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477553|NCT01277588|||Case-Only||Prospective|||||||
1477554|NCT01277575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477555|NCT01277562|||Case Control||Prospective|||||||
1477556|NCT01277549|||Case-Only||Prospective|||||||
1477557|NCT01277536|||Cohort||Prospective|||||||
1477558|NCT01277523|Randomized|Parallel Assignment||Treatment||Double||||||
1477559|NCT01277510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477560|NCT01277497|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477561|NCT01277484||Single Group Assignment||Treatment||None (Open Label)||||||
1477562|NCT01277471|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477563|NCT01277458|||Cohort||Retrospective|||||||
1477564|NCT01277445|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1477565|NCT01277432|||Cohort||Cross-Sectional|||||||
1477566|NCT01277419|||Cohort||Prospective|||||||
1477567|NCT01277406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477568|NCT01277393|||Case-Only||Prospective|||||||
1477569|NCT01277380|||Cohort||Prospective|||||||
1477570|NCT01277367|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477571|NCT01277354|Randomized|Parallel Assignment||Treatment||Single||||||t
1477572|NCT01277341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477573|NCT01277328|||Cohort||Prospective|||||||
1477574|NCT01277315||Single Group Assignment||Treatment||None (Open Label)||||||
1477575|NCT01277302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477576|NCT01277289|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477577|NCT01277276|||Case-Only||Prospective|||||||
1477578|NCT01277263|||Case-Only||Prospective|||||||
1477579|NCT01277250|Randomized|Parallel Assignment||Treatment||Single||||||t
1477580|NCT01277237|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1477581|NCT01277224|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477582|NCT01277211|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477583|NCT01277198|||Case Control||Retrospective|||||||
1477584|NCT01277185|Randomized|Crossover Assignment||Prevention||Single|||t|||
1477585|NCT01277172|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1477586|NCT01277159|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477587|NCT01277146||Single Group Assignment||Treatment||None (Open Label)||||||
1477588|NCT01277133|||Cohort||Prospective|||||||
1477589|NCT01277120|||Cohort||Prospective|||||||
1477590|NCT01277107|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1477591|NCT01277094|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1477592|NCT01277081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477593|NCT01277068|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1477594|NCT01277055|||Cohort||Prospective|||||||
1477595|NCT01277042|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1477596|NCT01277029|||Cohort||Prospective|||||||
1477597|NCT01277016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477598|NCT01277003|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1477599|NCT01276990|Randomized|Parallel Assignment||Treatment||Double||||||
1477600|NCT01276977|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477601|NCT01276964|||Cohort||Prospective|||||||
1477602|NCT01276951|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477603|NCT01276938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477604|NCT01276925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477605|NCT01276912|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477606|NCT01276899|||Case-Only||Prospective|||||||
1477607|NCT01276886|||Cohort||Prospective|||||||
1477608|NCT01276873|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477609|NCT01276860|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1477610|NCT01276847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477611|NCT01276834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477612|NCT01276821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477613|NCT01276808|Randomized|Single Group Assignment||Treatment||Single|||t|||
1477614|NCT01276795|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1477615|NCT01276782||Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1477616|NCT01276769|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477617|NCT01276756|Randomized|Parallel Assignment||Treatment||Single||||||t
1477618|NCT01276743|||Case Control||Cross-Sectional|||||||
1477619|NCT01276730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477620|NCT01276717||Single Group Assignment||Treatment||None (Open Label)||||||
1477621|NCT01276704|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1477622|NCT01276691|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1477623|NCT01276678|||Case Control||Prospective|||||||
1477624|NCT01276665|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1477625|NCT01276652|Randomized|Parallel Assignment||Other||None (Open Label)||Subjects were randomized in 1:1 fashion to receive the Environmental Modification protocol or usual care. Subsequently a third, observational arm was opened to acquire more physiologic data.||||
1477626|NCT01276639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477627|NCT01276626|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477628|NCT01276613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477629|NCT01276600|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1477630|NCT01276587||Single Group Assignment||Treatment||None (Open Label)||||||
1477631|NCT01276574|||Cohort||Prospective|||||||
1477632|NCT01276561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477633|NCT01276548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477634|NCT01276535||Single Group Assignment||Treatment||None (Open Label)||||||
1477635|NCT01276522||Single Group Assignment||Treatment||None (Open Label)||||||
1477636|NCT01276509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477637|NCT01276496||Single Group Assignment||Treatment||None (Open Label)||||||
1477638|NCT01276483|||Cohort||Prospective|||||||
1477639|NCT01276470|||Cohort||Other|||||||
1477640|NCT01276457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477641|NCT01276444|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1477642|NCT01276431|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477643|NCT01276418||Single Group Assignment||Treatment||None (Open Label)||||||
1477644|NCT01276405|||Cohort||Prospective|||||||
1477645|NCT01276392|||Cohort||Prospective|||||||
1477646|NCT01276379||Single Group Assignment||Screening||None (Open Label)||||||
1477647|NCT01276366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477648|NCT01276353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477649|NCT01276340|||Cohort||Prospective|||||||
1477650|NCT01276327|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477651|NCT01276314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477652|NCT01276301|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477653|NCT01276288|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477654|NCT01276275|||Cohort||Retrospective|||||||
1477655|NCT01276262|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1477656|NCT01276249|||Cohort||Prospective|||||||
1477657|NCT01276236||Single Group Assignment||Treatment||None (Open Label)||||||
1477658|NCT01276223|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477659|NCT01276210||Single Group Assignment||Treatment||None (Open Label)||||||
1477660|NCT01276197|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1477661|NCT01276184|Randomized|Parallel Assignment||||Single||||||t
1477662|NCT01276171|Randomized|Parallel Assignment||Treatment||Single||||||t
1477663|NCT01276158|Randomized|Parallel Assignment||Treatment||Single||||||t
1477664|NCT01276145|||Case-Only||Prospective|||||||
1477665|NCT01276132|||Cohort||Prospective|||||||
1477666|NCT01276119|Randomized|Parallel Assignment||||Triple|||t||t|t
1477667|NCT01276106|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477668|NCT01276093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477669|NCT01276080|Randomized|Crossover Assignment||||None (Open Label)||||||
1477670|NCT01276067|Randomized|Crossover Assignment||||None (Open Label)||||||
1477671|NCT01276054|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1477672|NCT01276041||Single Group Assignment||Treatment||None (Open Label)||||||
1477673|NCT01276028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477674|NCT01276015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477675|NCT01276002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477676|NCT01275989|Randomized|Parallel Assignment||Treatment||Single|||||t|
1477677|NCT01275976|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1477678|NCT01275963|||Case Control||Prospective|||||||
1477679|NCT01275950||Single Group Assignment||Prevention||None (Open Label)||||||
1477680|NCT01275937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477681|NCT01275924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477682|NCT01275911|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1477683|NCT01275898|||Cohort|||||||||
1477684|NCT01275885|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477685|NCT01275872|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1477686|NCT01275859||Single Group Assignment||Treatment||None (Open Label)||||||
1477687|NCT01275846||Single Group Assignment||Supportive Care||None (Open Label)||||||
1477688|NCT01275833|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1477689|NCT01275820|||Cohort||Prospective|||||||
1477690|NCT01275807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477691|NCT01275794|||Case-Only||Retrospective|||||||
1477692|NCT01275781||Single Group Assignment||Basic Science||None (Open Label)||||||
1477693|NCT01275768|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477694|NCT01275755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477695|NCT01275742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477696|NCT01275729||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477697|NCT01275716|Randomized|Parallel Assignment||||None (Open Label)||||||
1477698|NCT01275703|||Case-Only||Prospective|||||||
1477699|NCT01275690|||Case-Only||Prospective|||||||
1477700|NCT01275677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477701|NCT01275664||Single Group Assignment||Supportive Care||None (Open Label)||||||
1477702|NCT01275651|||Case-Only||Retrospective|||||||
1477703|NCT01275638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477704|NCT01275625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477705|NCT01275612||Single Group Assignment||Treatment||None (Open Label)||||||
1477706|NCT01275599|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477707|NCT01275586||Single Group Assignment||Treatment||None (Open Label)||||||
1477708|NCT01275573|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1477709|NCT01275560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477710|NCT01275547|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1477711|NCT01275534|||Case-Only||Cross-Sectional|||||||
1477712|NCT01275521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477713|NCT01275508||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477714|NCT01275495|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1477715|NCT01275482|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1477716|NCT01275469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477717|NCT01275456|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1477718|NCT01275443|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1477719|NCT01275430|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1477720|NCT01275417|||Case-Only|||||||||
1477721|NCT01275404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477722|NCT01275391|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1477723|NCT01275378|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1477724|NCT01275365|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1477725|NCT01275352|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1477726|NCT01275339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477727|NCT01275326|||Case-Only|||||||||
1477728|NCT01275313|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1477729|NCT01275300|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1477730|NCT01275287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477731|NCT01275274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477732|NCT01275261|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477733|NCT01275248|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477734|NCT01275235|||Case-Only||Retrospective|||||||
1477735|NCT01275222||Single Group Assignment||Treatment||None (Open Label)||||||
1477736|NCT01275209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477737|NCT01275196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477738|NCT01275183||Single Group Assignment||Treatment||None (Open Label)||||||
1477739|NCT01275170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477740|NCT01275157||Single Group Assignment||||None (Open Label)||||||
1477741|NCT01275144|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1477742|NCT01275131|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1477743|NCT01275118|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477744|NCT01275105|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1477745|NCT01275092||Single Group Assignment||Treatment||None (Open Label)||||||
1477746|NCT01275079|||Cohort||Prospective|||||||
1477747|NCT01275066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477748|NCT01275053||Single Group Assignment||Treatment||None (Open Label)||||||
1477749|NCT01275040|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477750|NCT01275027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477751|NCT01275014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477752|NCT01275001|||Cohort||Prospective|||||||
1477753|NCT01274988|Randomized|Parallel Assignment||Treatment||Single||||||t
1477754|NCT01274975|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477755|NCT01274962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477756|NCT01274949||Single Group Assignment||Treatment||None (Open Label)||||||
1477757|NCT01274936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477758|NCT01274923|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477759|NCT01274910|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477760|NCT01274897|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477761|NCT01274884||Single Group Assignment||Treatment||None (Open Label)||||||
1477762|NCT01274871|||||Retrospective|||||||
1477763|NCT01274858|||Cohort||Retrospective|||||||
1477764|NCT01274845||Crossover Assignment||Treatment||None (Open Label)||||||
1477765|NCT01274832|||Case Control||Prospective|||||||
1477766|NCT01274819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477767|NCT01274806|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1477768|NCT01274793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477769|NCT01274780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477770|NCT01274767|||Cohort||Prospective|||||||
1477771|NCT01274754|||Cohort||Prospective|||||||
1477772|NCT01274741|Randomized|Parallel Assignment||Treatment||Single||||||t
1477773|NCT01274728|||Cohort||Prospective|||||||
1477774|NCT01274715||Single Group Assignment||Treatment||None (Open Label)||||||
1477775|NCT01274702|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477776|NCT01274689|||Cohort||Retrospective|||||||
1477777|NCT01274676|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477778|NCT01274663|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1477779|NCT01274650||Single Group Assignment||Treatment||None (Open Label)||||||
1477780|NCT01274637|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477781|NCT01274624||Single Group Assignment||Treatment||None (Open Label)||||||
1477782|NCT01274611|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477783|NCT01274598||Single Group Assignment||||None (Open Label)||||||
1477784|NCT01274585|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1477785|NCT01274572|||Case-Only||Prospective|||||||
1477786|NCT01274559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477787|NCT01274546|||Case-Only||Prospective|||||||
1477788|NCT01274533||Single Group Assignment||Treatment||None (Open Label)||||||
1477789|NCT01274520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477790|NCT01274507||Single Group Assignment||Basic Science||None (Open Label)||||||
1477791|NCT01274494|||||Prospective|||||||
1477792|NCT01274481||Single Group Assignment||Treatment||None (Open Label)||||||
1477793|NCT01274468|||Case-Only||Prospective|||||||
1477794|NCT01274455||Single Group Assignment||Treatment||None (Open Label)||||||
1477795|NCT01274442|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1477796|NCT01274429||Single Group Assignment||Treatment||None (Open Label)||||||
1477797|NCT01274416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477798|NCT01274403|Randomized|||||None (Open Label)||||||
1477799|NCT01274390|||Cohort||Prospective|||||||
1477800|NCT01274377|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477801|NCT01274364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477802|NCT01274351||Single Group Assignment||Treatment||None (Open Label)||||||
1477803|NCT01274338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477804|NCT01274325|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1477805|NCT01274312||Single Group Assignment||Treatment||None (Open Label)||||||
1477806|NCT01274299|||Cohort||Cross-Sectional|||||||
1477807|NCT01274286||||||||||||
1477808|NCT01274273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477809|NCT01274260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477810|NCT01274247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477811|NCT01274234|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1477812|NCT01274221|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1477813|NCT01274208|||Cohort||Prospective|||||||
1477814|NCT01274195||Single Group Assignment||Treatment||None (Open Label)||||||
1477815|NCT01274182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477816|NCT01274169||||||||||||
1477817|NCT01274156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477818|NCT01274143|Randomized|Parallel Assignment||Prevention||Single||||||t
1477819|NCT01274130|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1477820|NCT01274117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477821|NCT01274104|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1477822|NCT01274091|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1477823|NCT01274078|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1477824|NCT01274065|||Cohort||Prospective|||||||
1477825|NCT01274052|||Cohort||Prospective|||||||
1477826|NCT01274039|||Case-Only||Prospective|||||||
1477827|NCT01274026|||Other||Prospective|||||||
1477828|NCT01274013|||Case-Control||Prospective|||||||
1477829|NCT01274000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477830|NCT01273987|Randomized|Parallel Assignment||Treatment||Single||||||t
1477831|NCT01273974|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477832|NCT01273961||Single Group Assignment||Treatment||Single||||||t
1477833|NCT01273948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477834|NCT01273935|||Case-Only||Retrospective|||||||
1477835|NCT01273922|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477836|NCT01273909|||Cohort||Prospective|||||||
1477837|NCT01273896||Single Group Assignment||Treatment||None (Open Label)||||||
1477838|NCT01273883|Randomized|Crossover Assignment||||Double|||t||t|
1477839|NCT01273870|||Case-Crossover||Prospective|||||||
1477840|NCT01273857|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477841|NCT01273844||Single Group Assignment||Treatment||None (Open Label)||||||
1477842|NCT01273831|Randomized|Parallel Assignment||||Single||||||t
1477843|NCT01273818|Randomized|Parallel Assignment||Prevention||Single|||t|||
1477844|NCT01273805|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||There were 2 arms in this study because the study was amended to evaluate a second cohort of patients treated at a higher dose using the same two-stage statistical design.||||
1477845|NCT01273792|||Cohort||Prospective|||||||
1477846|NCT01273779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477847|NCT01273766|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1477848|NCT01273753||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477849|NCT01273740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477850|NCT01273727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477851|NCT01273714|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477852|NCT01273701|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477853|NCT01273688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477854|NCT01273675|||Case-Only||Prospective|||||||
1477855|NCT01273662||Single Group Assignment||Treatment||None (Open Label)||||||
1477856|NCT01273649||Single Group Assignment||Treatment||None (Open Label)||||||
1477857|NCT01273636|||Case-Only||Retrospective|||||||
1477858|NCT01273623||Single Group Assignment||Treatment||None (Open Label)||||||
1477859|NCT01273610||Single Group Assignment||Treatment||None (Open Label)||||||
1477860|NCT01273597|||Cohort||Prospective|||||||
1477861|NCT01273584|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1477862|NCT01273571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477863|NCT01273558||Parallel Assignment||Treatment||None (Open Label)||||||
1477864|NCT01273545|||Cohort||Retrospective|||||||
1477865|NCT01273532|Randomized|Crossover Assignment||||None (Open Label)||||||
1477866|NCT01273519|||Cohort||Prospective|||||||
1477867|NCT01273506|Randomized|Crossover Assignment||||None (Open Label)||||||
1477868|NCT01273493|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477869|NCT01273480|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1477870|NCT01273467|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1477871|NCT01273454|||Case-Only||Prospective|||||||
1477872|NCT01273441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477873|NCT01273428|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1477874|NCT01273415|||Cohort||Retrospective|||||||
1477875|NCT01273402|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477876|NCT01273389|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1477877|NCT01273376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477878|NCT01273363|||Case-Only||Retrospective|||||||
1477879|NCT01273350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477880|NCT01273337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477881|NCT01273324|||Cohort||Prospective|||||||
1477882|NCT01273311|||||Prospective|||||||
1477883|NCT01273298|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1477884|NCT01273285|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1477885|NCT01273272|Randomized|Parallel Assignment||Treatment||Single||||||t
1477886|NCT01273259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477887|NCT01273246|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1477888|NCT01273233|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1477889|NCT01273220|||||Retrospective|||||||
1477890|NCT01273207||Single Group Assignment||Treatment||None (Open Label)||||||
1477891|NCT01273194|||||Other|||||||
1477892|NCT01273181|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477893|NCT01273168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477894|NCT01273155||Single Group Assignment||Treatment||None (Open Label)||||||
1477895|NCT01273142|||Case-Only||Prospective|||||||
1477896|NCT01273129|||Cohort||Prospective|||||||
1477897|NCT01273116||Single Group Assignment||Supportive Care||None (Open Label)||||||
1477898|NCT01273103||Single Group Assignment||||None (Open Label)||||||
1477899|NCT01273090||Single Group Assignment||Treatment||None (Open Label)||||||
1477900|NCT01273077|||Cohort||Cross-Sectional|||||||
1477901|NCT01273064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477902|NCT01273051||Single Group Assignment||Treatment||None (Open Label)||||||
1477903|NCT01273038|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1477904|NCT01273025|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1477905|NCT01273012|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1477906|NCT01272999|||Case-Only||Prospective|||||||
1477907|NCT01272986|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1477908|NCT01272973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477909|NCT01272960|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477910|NCT01272947|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477911|NCT01272934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477912|NCT01272921|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1477913|NCT01272908||Single Group Assignment||Treatment||None (Open Label)||||||
1477914|NCT01272895||Single Group Assignment||Treatment||None (Open Label)||||||
1477915|NCT01272882||Single Group Assignment||Basic Science||None (Open Label)||||||
1477916|NCT01272869|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1477917|NCT01272856|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477918|NCT01272843|||Cohort||Prospective|||||||
1477919|NCT01272830|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477920|NCT01272817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477921|NCT01272804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477922|NCT01272791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477923|NCT01272778|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1477924|NCT01272765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477925|NCT01272752|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477926|NCT01272739|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477927|NCT01272726|||Case-Only||Prospective|||||||
1477928|NCT01272713|Randomized|Parallel Assignment||Treatment||Single||||||t
1477929|NCT01272700|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1477930|NCT01272687|||Cohort||Prospective|||||||
1477931|NCT01272674|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1477932|NCT01272661|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1477933|NCT01272648|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1477934|NCT01272635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477935|NCT01272622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477936|NCT01272609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477937|NCT01272596|||Cohort||Prospective|||||||
1477938|NCT01272583|Randomized|Crossover Assignment||||Triple|||t|t|t|
1477939|NCT01272570|||Cohort||Prospective|||||||
1477940|NCT01272557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477941|NCT01272544|||Cohort||Prospective|||||||
1477942|NCT01272531|||||Prospective|||||||
1477943|NCT01272518|||Cohort||Prospective|||||||
1477944|NCT01272505|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477945|NCT01272492||Parallel Assignment||Prevention||||||||
1477946|NCT01272479|||Case Control||Cross-Sectional|||||||
1477947|NCT01272466||Single Group Assignment||Treatment||None (Open Label)||||||
1477948|NCT01272453|||Case Control||Prospective|||||||
1477949|NCT01272440|||Cohort||Prospective|||||||
1477950|NCT01272427|Randomized|Crossover Assignment||Prevention||Single|||t|||
1477951|NCT01272414|Randomized|Parallel Assignment||Treatment||Single|||t|||
1477952|NCT01272401|||Case-Only||Prospective|||||||
1477953|NCT01272388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477954|NCT01272375|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1477955|NCT01272362|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477956|NCT01272349|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1477957|NCT01272336|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1477958|NCT01272323|||Cohort||Prospective|||||||
1477959|NCT01272310||Single Group Assignment||Treatment||None (Open Label)||||||
1477960|NCT01272297||Single Group Assignment||Treatment||None (Open Label)||||||
1477961|NCT01272284||Single Group Assignment||Treatment||None (Open Label)||||||
1477962|NCT01272271|||Cohort||Retrospective|||||||
1477963|NCT01272258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477964|NCT01272245||Single Group Assignment||Treatment||None (Open Label)||||||
1477965|NCT01272232|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477966|NCT01272219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1477967|NCT01272206|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1477968|NCT01272193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477969|NCT01272180|Randomized|Parallel Assignment||Prevention||Single||||||t
1477970|NCT01272167|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1477971|NCT01272154|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1477972|NCT01272141||Single Group Assignment||Treatment||None (Open Label)||||||
1477973|NCT01272128|||Cohort||Prospective|||||||
1477974|NCT01272115|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1477975|NCT01272102|||Case-Only||Prospective|||||||
1477976|NCT01272089||Single Group Assignment||Treatment||None (Open Label)||||||
1477977|NCT01272076|||Case-Only||Prospective|||||||
1477978|NCT01272063|||Case-Only||Prospective|||||||
1477979|NCT01272050|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1477980|NCT01272037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477981|NCT01272024|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1477982|NCT01272011|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1477983|NCT01271998|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1477984|NCT01271985|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1477985|NCT01271972|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477986|NCT01271959|||||Retrospective|||||||
1477987|NCT01271946||Single Group Assignment||Diagnostic||None (Open Label)||||||
1477988|NCT01271933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1477989|NCT01271920||Single Group Assignment||Treatment||None (Open Label)||||||
1477990|NCT01271907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477991|NCT01271894|Randomized|Parallel Assignment||Screening||Double|||t||t|
1477992|NCT01271881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477993|NCT01271868|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1477994|NCT01271855|Randomized|Parallel Assignment||Treatment||Quadruple||Participants will be randomized to receive either a belladonna and opioid suppository or a glycerin suppository (placebo) every eight hours after delivery during the first 24 hours after delivery using a 1:1 allocation|t|t|t|t
1477995|NCT01271842|||Case Control||Prospective|||||||
1477996|NCT01271829|Randomized|Crossover Assignment||||Single|||||t|
1477997|NCT01271816|||Cohort||Prospective|||||||
1477998|NCT01271803|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1477999|NCT01271790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478000|NCT01271777|Randomized|Crossover Assignment||Treatment||Single|||t|||
1478001|NCT01271764||Single Group Assignment||Basic Science||None (Open Label)||||||
1478002|NCT01271751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478003|NCT01271738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478004|NCT01271725|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478005|NCT01271712|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478006|NCT01271699|||Cohort||Retrospective|||||||
1478007|NCT01271686||Single Group Assignment||Treatment||None (Open Label)||||||
1478008|NCT01271673|||Cohort||Prospective|||||||
1478009|NCT01271660|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1478010|NCT01271647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478011|NCT01271634|||Case-Only||Prospective|||||||
1478012|NCT01271621|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1478013|NCT01271608|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1478014|NCT01271595|Non-Randomized|Parallel Assignment||Basic Science||Single|||t|||
1478015|NCT01271582||Single Group Assignment||Treatment||None (Open Label)||||||
1478016|NCT01271569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478017|NCT01271556|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1478018|NCT01271543|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478019|NCT01271530|Randomized|Crossover Assignment||Treatment||Single||||||t
1478020|NCT01271517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478021|NCT01271504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478022|NCT01271491|||Case-Control||Prospective|||||||
1478023|NCT01271478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478024|NCT01271465|||Cohort||Prospective|||||||
1478025|NCT01271452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478026|NCT01271439||Single Group Assignment||Treatment||None (Open Label)||||||
1478027|NCT01271426|||Case-Only||Retrospective|||||||
1478028|NCT01271413|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478029|NCT01271400|||Case-Only|||||||||
1478030|NCT01271387|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1478031|NCT01271374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478032|NCT01271361|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478033|NCT01271348|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1478034|NCT01271335|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478035|NCT01271322||Single Group Assignment||Treatment||None (Open Label)||||||
1478036|NCT01271309|||Cohort||Prospective|||||||
1478037|NCT01271296|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1478038|NCT01271283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478039|NCT01271270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478040|NCT01271257|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1478041|NCT01271244|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478042|NCT01271231|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1478043|NCT01271218|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1478044|NCT01271205|||Case-Only||Retrospective|||||||
1478045|NCT01271192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478046|NCT01271179|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1478047|NCT01271166||Single Group Assignment||Treatment||None (Open Label)||||||
1478048|NCT01271153|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1478049|NCT01271140||Single Group Assignment||Treatment||None (Open Label)||||||
1478050|NCT01271127||Single Group Assignment||Screening||None (Open Label)||||||
1478051|NCT01271114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478052|NCT01271101|||Cohort||Prospective|||||||
1478053|NCT01271088|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478054|NCT01271075|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1478055|NCT01271062|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1478056|NCT01271049|Randomized|Parallel Assignment||||Double|||t||t|
1478057|NCT01271036||Single Group Assignment||||None (Open Label)||||||
1478058|NCT01271023||Single Group Assignment||Treatment||None (Open Label)||||||
1478059|NCT01271010||Single Group Assignment||Treatment||None (Open Label)||||||
1478060|NCT01270997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478061|NCT01270984|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478062|NCT01270971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478063|NCT01270958||Single Group Assignment||||None (Open Label)||||||
1478064|NCT01270945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478065|NCT01270932||Single Group Assignment||Treatment||None (Open Label)||||||
1478066|NCT01270919||Single Group Assignment||Treatment||None (Open Label)||||||
1478067|NCT01270906|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478068|NCT01270893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478069|NCT01270880||Single Group Assignment||Treatment||None (Open Label)||||||
1478070|NCT01270867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478071|NCT01270854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478072|NCT01270841|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478073|NCT01270828|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478074|NCT01270815|Randomized|Crossover Assignment||||None (Open Label)||||||
1478075|NCT01270802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478076|NCT01270789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478077|NCT01270776|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478078|NCT01270763|||Cohort||Prospective|||||||
1478079|NCT01270750||Single Group Assignment||Treatment||None (Open Label)||||||
1478080|NCT01270737|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1478081|NCT01270724||Single Group Assignment||Treatment||None (Open Label)||||||
1478082|NCT01270711|||Cohort||Retrospective|||||||
1478083|NCT01270698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478084|NCT01270685|||Cohort||Cross-Sectional|||||||
1478085|NCT01270672|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1478086|NCT01270659|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1478087|NCT01270646||Single Group Assignment||Treatment||None (Open Label)||||||
1478088|NCT01270633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478089|NCT01270620|Randomized|Parallel Assignment||Treatment||Single||||||t
1478090|NCT01270607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478091|NCT01270594|Randomized|Parallel Assignment||Treatment||Single|||||t|
1478092|NCT01270581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478093|NCT01270568|Randomized|Parallel Assignment||Treatment||Single||||||t
1478094|NCT01270555||Single Group Assignment||Treatment||None (Open Label)||||||
1478095|NCT01270542|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478096|NCT01270529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478097|NCT01270516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478098|NCT01270503|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478099|NCT01270490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478100|NCT01270477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478101|NCT01270464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478102|NCT01270451|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1478103|NCT01270438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478104|NCT01270425|||Cohort||Prospective|||||||
1478105|NCT01270412|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478106|NCT01270399|||Case Control||Prospective|||||||
1478107|NCT01270386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478108|NCT01270373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478109|NCT01270360|||Cohort||Prospective|||||||
1478110|NCT01270347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478111|NCT01270334|||Case Control||Prospective|||||||
1478112|NCT01270321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478113|NCT01270308|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478114|NCT01270295|||||Cross-Sectional|||||||
1478115|NCT01270282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478116|NCT01270269|Randomized|Parallel Assignment||Treatment||Single||||||t
1478117|NCT01270256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478118|NCT01270243|||Case Control||Prospective|||||||
1478119|NCT01270230|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478120|NCT01270217|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1478121|NCT01270204|||Case-Control||Cross-Sectional|||||||
1478122|NCT01270191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478123|NCT01270178|||Case-Only||Prospective|||||||
1478124|NCT01270165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478125|NCT01270152|Randomized|Parallel Assignment||||None (Open Label)||||||
1478126|NCT01270139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478127|NCT01270126|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478128|NCT01270113||||||||||||
1478129|NCT01270100||||||||||||
1478130|NCT01270087||Single Group Assignment||Treatment||None (Open Label)||||||
1478131|NCT01270074|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478132|NCT01270061|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1478133|NCT01270048|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478134|NCT01270035||Single Group Assignment||Treatment||None (Open Label)||||||
1478135|NCT01270022|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1478136|NCT01270009|||Cohort||Prospective|||||||
1478137|NCT01269996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478138|NCT01269983|Randomized|Parallel Assignment||Treatment||Single||||||t
1478139|NCT01269970|||Cohort||Prospective|||||||
1478140|NCT01269957|||||Cross-Sectional|||||||
1478141|NCT01269944|||Cohort||Prospective|||||||
1478142|NCT01269931|||Case Control||Prospective|||||||
1478143|NCT01269918|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478144|NCT01269905|||Case Control||Retrospective|||||||
1478145|NCT01269892|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1478146|NCT01269879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478147|NCT01269866|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478148|NCT01269853|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478149|NCT01269840|||Cohort||Retrospective|||||||
1478150|NCT01269827|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478151|NCT01269814|||Case-Only||Prospective|||||||
1478152|NCT01269801|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478153|NCT01269788|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478154|NCT01269775|Randomized|Parallel Assignment||||Single||||||t
1478155|NCT01269762|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478156|NCT01269749|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478157|NCT01269736|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1478158|NCT01269723|Randomized|Parallel Assignment||||Double|||t|t||
1478159|NCT01269710|||Case-Only||Prospective|||||||
1478160|NCT01269697|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1478161|NCT01269684||Single Group Assignment||Treatment||None (Open Label)||||||
1478162|NCT01269671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478163|NCT01269658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478164|NCT01269645|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1478165|NCT01269632|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1478166|NCT01269619|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478167|NCT01269606|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478168|NCT01269593||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478169|NCT01269580|||Case Control||Prospective|||||||
1478170|NCT01269567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478171|NCT01269554|||Case Control||Cross-Sectional|||||||
1478172|NCT01269541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478173|NCT01269528|||Case Control||Prospective|||||||
1478174|NCT01269515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478175|NCT01269502|Randomized|Parallel Assignment||Prevention||Single||||||t
1478176|NCT01269489|||Cohort||Prospective|||||||
1478177|NCT01269476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478178|NCT01269463|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1478179|NCT01269450|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478180|NCT01269437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478181|NCT01269424|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478182|NCT01269411||Single Group Assignment||Treatment||None (Open Label)||||||
1478183|NCT01269398||Single Group Assignment||||||||||
1478184|NCT01269385||Single Group Assignment||Treatment||None (Open Label)||||||
1478185|NCT01269372||Single Group Assignment||||Double||||t|t|
1478186|NCT01269359|||Cohort||Prospective|||||||
1478187|NCT01269346||Single Group Assignment||Treatment||None (Open Label)||||||
1478188|NCT01269333|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1478189|NCT01269320||Single Group Assignment||Treatment||None (Open Label)||||||
1478190|NCT01269307|Randomized|Single Group Assignment||Treatment||Single|||t|||
1478191|NCT01269294|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1478192|NCT01269281|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478193|NCT01269268|||Case Control||Prospective|||||||
1478194|NCT01269255||Single Group Assignment||||None (Open Label)||||||
1478195|NCT01269242|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1478196|NCT01269229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478197|NCT01269216|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1478198|NCT01269203|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1478199|NCT01269190||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478200|NCT01269177|||Cohort||Prospective|||||||
1478201|NCT01269164||Single Group Assignment||Treatment||None (Open Label)||||||
1478202|NCT01269151|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1478203|NCT01269138|||Cohort||Prospective|||||||
1478204|NCT01269125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478205|NCT01269112|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478206|NCT01269099|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478207|NCT01269086|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1478208|NCT01269073|||Cohort||Cross-Sectional|||||||
1478209|NCT01269060||Single Group Assignment||Treatment||None (Open Label)||||||
1478210|NCT01269047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478211|NCT01269034|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478212|NCT01269021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478213|NCT01269008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478214|NCT01268995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478215|NCT01268982|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478216|NCT01268969|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478217|NCT01268956|||Case Control||Prospective|||||||
1478218|NCT01268943|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478219|NCT01268930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478220|NCT01268917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478221|NCT01268904|||Case-Only||Prospective|||||||
1478222|NCT01268891|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478223|NCT01268878|||Cohort||Prospective|||||||
1478224|NCT01268865|||Cohort||Prospective|||||||
1478225|NCT01268852|Randomized|Parallel Assignment||Treatment||Double|Masking was done with generated cmputer randomisation and sealed opaque enveloppes|Compare treatment between two appliance systems|||t|t
1478226|NCT01268839||Single Group Assignment||||None (Open Label)||||||
1478227|NCT01268826|||Case-Only||Prospective|||||||
1478228|NCT01268813|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1478229|NCT01268800|||Cohort||Prospective|||||||
1478230|NCT01268787|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478231|NCT01268774|||Cohort|||||||||
1478232|NCT01268761|Randomized|Parallel Assignment||Treatment||Single|||||t|
1478233|NCT01268748|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1478234|NCT01268735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478235|NCT01268722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478236|NCT01268709||||Treatment||||||||
1478237|NCT01268696|||Case Control||Prospective|||||||
1478238|NCT01268683||Single Group Assignment||Treatment||None (Open Label)||||||
1478239|NCT01268670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478240|NCT01268657||Single Group Assignment||Treatment||None (Open Label)||||||
1478241|NCT01268644||Single Group Assignment||Treatment||None (Open Label)||||||
1478242|NCT01268631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478243|NCT01268618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478244|NCT01268605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478245|NCT01268592||Single Group Assignment||Supportive Care||None (Open Label)||||||
1478246|NCT01268579||Single Group Assignment||Treatment||None (Open Label)||||||
1478247|NCT01268566||Single Group Assignment||Treatment||None (Open Label)||||||
1478248|NCT01268553||Single Group Assignment||Treatment||None (Open Label)||||||
1478249|NCT01268540|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478250|NCT01268527|Randomized|Parallel Assignment||Treatment||||||||
1478251|NCT01268514|||Other||Prospective|||||||
1478252|NCT01268501||Single Group Assignment||Treatment||None (Open Label)||||||
1478253|NCT01268488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478254|NCT01268475|||Case-Only||Prospective|||||||
1478255|NCT01268462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478256|NCT01268449|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478257|NCT01268436|||Cohort||Prospective|||||||
1478258|NCT01268423|Randomized|Parallel Assignment||Prevention||Single||||||t
1478259|NCT01268410|||Cohort||Prospective|||||||
1478260|NCT01268397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478261|NCT01268384||Single Group Assignment||Treatment||None (Open Label)||||||
1478262|NCT01268371|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478263|NCT01268358|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478264|NCT01268345|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1478265|NCT01268332|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478266|NCT01268319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478267|NCT01268306||Single Group Assignment||Supportive Care||None (Open Label)||||||
1478268|NCT01268293||Single Group Assignment||Treatment||None (Open Label)||||||
1478269|NCT01268280|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1478270|NCT01268267||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478271|NCT01268254|||Case Control||Prospective|||||||
1478272|NCT01268241|||Cohort|||||||||
1478273|NCT01268228|||Case Control||Prospective|||||||
1478274|NCT01268215|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478275|NCT01268202||Single Group Assignment||Treatment||None (Open Label)||||||
1478276|NCT01268189|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478277|NCT01268176|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1478278|NCT01268163|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1478279|NCT01268150||Single Group Assignment||Treatment||None (Open Label)||||||
1478280|NCT01268137|Randomized|Crossover Assignment||Treatment||Single||||||t
1478281|NCT01268124|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478282|NCT01268111|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1478283|NCT01268098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478284|NCT01268085|Randomized|Parallel Assignment||Other||Single|||||t|
1478285|NCT01268072|||Cohort||Prospective|||||||
1478286|NCT01268059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478287|NCT01268046|Randomized|Parallel Assignment||Other||Quadruple|Randomization was performed by the Research Pharmacy and the investigative team was blinded.|Each participant was randomized to placebo or estrogen using a block randomized design by age group|t|t|t|t
1478288|NCT01268033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478289|NCT01268020||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478290|NCT01268007|||Cohort||Prospective|||||||
1478291|NCT01267994||Single Group Assignment||Treatment||None (Open Label)||||||
1478292|NCT01267981|Randomized|Parallel Assignment||Treatment||Single|||||t|
1478293|NCT01267968|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1478294|NCT01267955||Single Group Assignment||Treatment||None (Open Label)||||||
1478295|NCT01267942|Randomized|Parallel Assignment||Prevention||Single||||||t
1478296|NCT01267929|Randomized|Parallel Assignment||Treatment||Single||||||t
1478297|NCT01267916|Randomized|Parallel Assignment||||Single||||t||
1478298|NCT01267903|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478299|NCT01267890|||Case-Only||Cross-Sectional|||||||
1478300|NCT01267877|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1478301|NCT01267864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478302|NCT01267851||||||||||||
1478303|NCT01267838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478304|NCT01267825|Randomized|Parallel Assignment||Treatment||Single||||||t
1478305|NCT01267812||Single Group Assignment||Treatment||None (Open Label)||||||
1478306|NCT01267799|||Other||Cross-Sectional|||||||
1478307|NCT01267786|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1478308|NCT01267773|Randomized|Parallel Assignment||Treatment||Single||||||t
1478309|NCT01267760||Single Group Assignment||Treatment||None (Open Label)||||||
1478310|NCT01267747|||Cohort||Prospective|||||||
1478311|NCT01267734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478312|NCT01267721|||Cohort||Prospective|||||||
1478313|NCT01267708|||Cohort||Prospective|||||||
1478314|NCT01267695||Single Group Assignment||Treatment||None (Open Label)||||||
1478315|NCT01267682|Randomized|Parallel Assignment||Treatment||Single||||||t
1478316|NCT01267669|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478317|NCT01267656||||||||||||
1478318|NCT01267643||Single Group Assignment||Treatment||None (Open Label)||||||
1478319|NCT01267630|||Cohort||Prospective|||||||
1478320|NCT01267617|||Case-Only||Prospective|||||||
1478321|NCT01267604|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478322|NCT01267591|||Case Control||Cross-Sectional|||||||
1478323|NCT01267578||Single Group Assignment||Treatment||None (Open Label)||||||
1478324|NCT01267565|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1478325|NCT01267552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478326|NCT01267539|||Case-Only||Prospective|||||||
1478327|NCT01267526|||Cohort||Prospective|||||||
1478329|NCT01267500|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478330|NCT01267487|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1478331|NCT01267474|Randomized|Parallel Assignment||Prevention||Single||||||t
1478332|NCT01267461||||||||||||
1478333|NCT01267448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478334|NCT01267435||Single Group Assignment||Diagnostic||Single||||||t
1478335|NCT01267422||Single Group Assignment||Treatment||None (Open Label)||||||
1478336|NCT01267409|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478337|NCT01267396|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478338|NCT01267383|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478339|NCT01267370|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478340|NCT01267357|||Case Control||Retrospective|||||||
1478341|NCT01267344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478342|NCT01267331|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1478343|NCT01267318|||Cohort||Prospective|||||||
1478344|NCT01267305|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478345|NCT01267292|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1478346|NCT01267279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478347|NCT01267266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478348|NCT01267253||Single Group Assignment||Treatment||None (Open Label)||||||
1478349|NCT01267240||Single Group Assignment||Treatment||None (Open Label)||||||
1478350|NCT01267227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478351|NCT01267214|Randomized|Parallel Assignment||Treatment||Single||||||t
1478352|NCT01267201|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1478353|NCT01267188|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478354|NCT01267175|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1478355|NCT01267162|||Cohort||Prospective|||||||
1478356|NCT01267149||||||||||||
1478357|NCT01267136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478358|NCT01267123|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1478359|NCT01267110|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1478360|NCT01267097|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478361|NCT01267084|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478362|NCT01267071|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478363|NCT01267058|Randomized|Parallel Assignment||Prevention||Single|||t|||
1478364|NCT01267045|Randomized|Parallel Assignment||Treatment||Single||||||t
1478365|NCT01267032|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478366|NCT01267019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478367|NCT01267006|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1478368|NCT01266993|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478369|NCT01266980|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1478370|NCT01266967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478371|NCT01266954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478372|NCT01266941|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1478373|NCT01266928|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478374|NCT01266915|||Cohort||Prospective|||||||
1478375|NCT01266902||Single Group Assignment||Treatment||None (Open Label)||||||
1478376|NCT01266889|||Cohort||Prospective|||||||
1478377|NCT01266876|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478378|NCT01266863||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478379|NCT01266850|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478380|NCT01266837||Single Group Assignment||Treatment||None (Open Label)||||||
1478381|NCT01266824|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1478382|NCT01266811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478383|NCT01266798|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1478384|NCT01266785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478385|NCT01266772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478386|NCT01266759|Randomized|Parallel Assignment||Treatment||Single||||||t
1478387|NCT01266746|||Cohort||Prospective|||||||
1478388|NCT01266733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478389|NCT01266720||Single Group Assignment||Treatment||None (Open Label)||||||
1478390|NCT01266707||Single Group Assignment||Treatment||None (Open Label)||||||
1478391|NCT01266694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478392|NCT01266681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478393|NCT01266668|||Case Control||Cross-Sectional|||||||
1478394|NCT01266655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478395|NCT01266642|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478396|NCT01266629|||Case-Only||Prospective|||||||
1478397|NCT01266616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478398|NCT01266603||Single Group Assignment||Treatment||None (Open Label)||||||
1478399|NCT01266590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478400|NCT01266577|||Other||Prospective|||||||
1478401|NCT01266564|||Cohort||Prospective|||||||
1478402|NCT01266551||||Treatment||||||||
1478403|NCT01266538|||||Prospective|||||||
1478404|NCT01266525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478405|NCT01266512|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478406|NCT01266499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478407|NCT01266486||Single Group Assignment||Basic Science||None (Open Label)||||||
1478408|NCT01266473|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478409|NCT01266460||Single Group Assignment||Treatment||None (Open Label)||||||
1478410|NCT01266447||Single Group Assignment||Treatment||None (Open Label)||||||
1478411|NCT01266434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478412|NCT01266421|||Cohort||Prospective|||||||
1478413|NCT01266408|||Cohort||Prospective|||||||
1478414|NCT01266395|||||Cross-Sectional|||||||
1478415|NCT01266382||||Treatment||||||||
1478416|NCT01266369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478417|NCT01266356|||Case Control|||||||||
1478418|NCT01266343|||Case Control||Retrospective|||||||
1478419|NCT01266330|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1478420|NCT01266317||Single Group Assignment||Treatment||None (Open Label)||||||
1478421|NCT01266304|||Ecologic or Community||Cross-Sectional|||||||
1478422|NCT01266291||Single Group Assignment||Treatment||None (Open Label)||||||
1478423|NCT01266278||Single Group Assignment||Prevention||None (Open Label)||||||
1478424|NCT01266265|||Cohort||Prospective|||||||
1478425|NCT01266252||Single Group Assignment||Treatment||None (Open Label)||||||
1478426|NCT01266239|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1478427|NCT01266226|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478428|NCT01266213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478429|NCT01266200|Randomized|Single Group Assignment||Treatment||Single||||||t
1478430|NCT01266187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478431|NCT01266174|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478432|NCT01266161|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478433|NCT01266148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478434|NCT01266135|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478435|NCT01266122|Randomized|Parallel Assignment||Prevention||Single||||||t
1478436|NCT01266109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478437|NCT01266096||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478438|NCT01266083||Single Group Assignment||Treatment||None (Open Label)||||||
1478439|NCT01266070||Single Group Assignment||Treatment||None (Open Label)||||||
1478440|NCT01266057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478441|NCT01266044|Randomized|Single Group Assignment||Prevention||Single|||t|||
1478442|NCT01266031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478443|NCT01266018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478444|NCT01266005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478445|NCT01265992|||||Prospective|||||||
1478446|NCT01265979|||||Prospective|||||||
1478447|NCT01265966|||Case Control||Prospective|||||||
1478448|NCT01265953|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1478449|NCT01265940||Single Group Assignment||Treatment||None (Open Label)||||||
1478450|NCT01265927|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478451|NCT01265914|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1478452|NCT01265901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478453|NCT01265888|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478454|NCT01265875||Single Group Assignment||Treatment||None (Open Label)||||||
1478455|NCT01265862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478456|NCT01265849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478457|NCT01265836|||Cohort||Prospective|||||||
1478458|NCT01265823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478459|NCT01265810|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t||t
1478460|NCT01265797|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1478461|NCT01265784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478462|NCT01265771|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1478463|NCT01265758|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1478464|NCT01265745|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1478465|NCT01265732|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1478466|NCT01265719|||Cohort||Prospective|||||||
1478467|NCT01265706|||||Prospective|||||||
1478468|NCT01265693|||Cohort||Prospective|||||||
1478469|NCT01265680|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478470|NCT01265667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478471|NCT01265654|||Case-Only||Retrospective|||||||
1478472|NCT01265641|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1478473|NCT01265628|||Cohort||Prospective|||||||
1478474|NCT01265615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478475|NCT01265602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478476|NCT01265589|Randomized|Parallel Assignment||Treatment||Single||||||t
1478477|NCT01265576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478478|NCT01265563|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478479|NCT01265550|Randomized|Parallel Assignment||Treatment||None (Open Label)|Partial Double Blind (Medical Treatment Groups)|||||
1478480|NCT01265537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478481|NCT01265524|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478482|NCT01265511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478483|NCT01265498|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478484|NCT01265485||Single Group Assignment||Treatment||None (Open Label)||||||
1478485|NCT01265472|||||Prospective|||||||
1478486|NCT01265459|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478487|NCT01265446|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478488|NCT01265433|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478489|NCT01265420||Single Group Assignment||Treatment||None (Open Label)||||||
1478490|NCT01265407|||Family-Based||Prospective|||||||
1478491|NCT01265394|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1478492|NCT01265381|||Case-Control||Retrospective|||||||
1478493|NCT01265368||Single Group Assignment||Treatment||None (Open Label)||||||
1478494|NCT01265355|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478495|NCT01265342|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478496|NCT01265329|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1478497|NCT01265316|||Case-Only||Prospective|||||||
1478498|NCT01265303|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1478499|NCT01265290|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1478500|NCT01265277|||Cohort||Prospective|||||||
1478501|NCT01265264|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478502|NCT01265251|||||Cross-Sectional|||||||
1478503|NCT01265238|||Case-Only||Prospective|||||||
1478504|NCT01265225|||Case-Only|||||||||
1478505|NCT01265212|||Ecologic or Community||Cross-Sectional|||||||
1478506|NCT01265199||Single Group Assignment||Treatment||None (Open Label)||||||
1478507|NCT01265186|||||Prospective|||||||
1478508|NCT01265173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478509|NCT01265160|||Case Control||Prospective|||||||
1478510|NCT01265147|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478511|NCT01265134|||Case Control||Prospective|||||||
1478512|NCT01265121|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1478513|NCT01265108|Non-Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1478514|NCT01265095|||Case-Only||Prospective|||||||
1478515|NCT01265082|||Case Control||Prospective|||||||
1478516|NCT01265069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478517|NCT01265056|Randomized|Parallel Assignment||Treatment||Triple|Participant, Care Provider and Investigator are all masked.||t|t|t|
1478518|NCT01265043|Randomized|Parallel Assignment||Treatment||Single||||||t
1478519|NCT01265030||Single Group Assignment||Treatment||None (Open Label)||||||
1478520|NCT01265017|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1478521|NCT01265004|||Case-Only||Prospective|||||||
1478522|NCT01264991|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1478523|NCT01264978|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478524|NCT01264965|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1478525|NCT01264952||Single Group Assignment||Treatment||None (Open Label)||||||
1478526|NCT01264939|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478527|NCT01264926|||Case-Only||Cross-Sectional|||||||
1478528|NCT01264913|||Case Control||Cross-Sectional|||||||
1478529|NCT01264900|Randomized|Parallel Assignment||Treatment||Single||||||t
1478530|NCT01264887||Single Group Assignment||Treatment||None (Open Label)||||||
1478531|NCT01264874|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478532|NCT01264861||Single Group Assignment||Basic Science||None (Open Label)||||||
1478533|NCT01264848||Single Group Assignment||Supportive Care||None (Open Label)||||||
1478534|NCT01264835||Single Group Assignment||Treatment||None (Open Label)||||||
1478535|NCT01264822|||Cohort||Prospective|||||||
1478536|NCT01264809|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1478537|NCT01264796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478538|NCT01264783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478539|NCT01264770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478540|NCT01264757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478541|NCT01264744|||Case Control||Retrospective|||||||
1478542|NCT01264731|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478543|NCT01264718|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1478544|NCT01264705||Single Group Assignment||Treatment||None (Open Label)||||||
1478545|NCT01264692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478546|NCT01264679||Single Group Assignment||Treatment||None (Open Label)||||||
1478547|NCT01264666|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1478548|NCT01264653|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1478549|NCT01264640||Single Group Assignment||Basic Science||None (Open Label)||||||
1478550|NCT01264627|Randomized|Parallel Assignment||Prevention||Single|||||t|
1478551|NCT01264614|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478552|NCT01264601|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478553|NCT01264588|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1478554|NCT01264575|Randomized|Parallel Assignment||||Double|||t|||t
1478555|NCT01264562|||Case Control||Prospective|||||||
1478556|NCT01264549|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478557|NCT01264536|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478558|NCT01264523||Single Group Assignment||||None (Open Label)||||||
1478559|NCT01264510|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478560|NCT01264497|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478561|NCT01264484|||Case-Control||Other|||||||
1478562|NCT01264471|||Case-Only||Cross-Sectional|||||||
1478563|NCT01264458|||Case-Control||Prospective|||||||
1478564|NCT01264445|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478565|NCT01264432||Single Group Assignment||Treatment||None (Open Label)||||||
1478566|NCT01264419||Single Group Assignment||Treatment||None (Open Label)||||||
1478567|NCT01264406|||Case Control|||||||||
1478568|NCT01264393|Randomized|Parallel Assignment||Treatment||Single||||||t
1478569|NCT01264380|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478570|NCT01264367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478571|NCT01264354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478572|NCT01264341||Single Group Assignment||Treatment||None (Open Label)||||||
1478573|NCT01264328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478574|NCT01264315||Single Group Assignment||Treatment||None (Open Label)||||||
1478575|NCT01264302|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478576|NCT01264289|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478577|NCT01264276|||Cohort||Prospective|||||||
1478578|NCT01264263|||Cohort||Cross-Sectional|||||||
1478579|NCT01264250|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1478580|NCT01264237|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478581|NCT01264224|Randomized|Single Group Assignment||||Triple|||t|t|t|
1478582|NCT01264211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478583|NCT01264198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478584|NCT01264185|||Cohort||Prospective|||||||
1478585|NCT01264172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478586|NCT01264159|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478587|NCT01264146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478588|NCT01264133||Factorial Assignment||Treatment||None (Open Label)||||||
1478589|NCT01264120|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1478590|NCT01264107|||||Prospective|||||||
1478591|NCT01264094||Single Group Assignment||Treatment||None (Open Label)||||||
1478592|NCT01264081||Single Group Assignment||Treatment||None (Open Label)||||||
1478593|NCT01264068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478594|NCT01264055|||Cohort||Cross-Sectional|||||||
1478595|NCT01264042||Single Group Assignment||Basic Science||None (Open Label)||||||
1478596|NCT01264029|Randomized|Parallel Assignment||Prevention||||||||
1478597|NCT01264016||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478598|NCT01264003|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1478599|NCT01263990||Single Group Assignment||Supportive Care||None (Open Label)||||||
1478600|NCT01263977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478601|NCT01263964|||Case Control||Prospective|||||||
1478602|NCT01263951||Single Group Assignment||Treatment||None (Open Label)||||||
1478603|NCT01263938||Single Group Assignment||Treatment||None (Open Label)||||||
1478604|NCT01263925|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478605|NCT01263912|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1478606|NCT01263899||Single Group Assignment||Treatment||None (Open Label)||||||
1478607|NCT01263886|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478608|NCT01263873|Randomized|Parallel Assignment||||Single|||t|||
1478609|NCT01263860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478610|NCT01263847|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1478611|NCT01263834|Randomized|Parallel Assignment||Treatment||Single||||||t
1478612|NCT01263821||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478613|NCT01263808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478614|NCT01263782|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478615|NCT01263769||Single Group Assignment||Treatment||None (Open Label)||||||
1478616|NCT01263756|||Case-Only||Cross-Sectional|||||||
1478617|NCT01263743||Single Group Assignment||Supportive Care||None (Open Label)||||||
1478618|NCT01263730|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1478619|NCT01263717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478620|NCT01263704|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478621|NCT01263691|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1478622|NCT01263678|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1478623|NCT01263665||Single Group Assignment||Treatment||None (Open Label)||||||
1478624|NCT01263652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478625|NCT01263639|Randomized|Parallel Assignment||||Triple|||t||t|t
1478626|NCT01263626|||Case Control||Prospective|||||||
1478627|NCT01263613|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1478628|NCT01263600|||Cohort||Prospective|||||||
1478629|NCT01263587|||Cohort||Prospective|||||||
1478630|NCT01263574|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1478631|NCT01263561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478632|NCT01263548|||||Prospective|||||||
1478633|NCT01263535||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478634|NCT01263522|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478635|NCT01263509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478636|NCT01263496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478637|NCT01263483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478638|NCT01263470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478639|NCT01263457|||Cohort||Other|||||||
1478640|NCT01263444||Single Group Assignment||Treatment||None (Open Label)||||||
1478641|NCT01263431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478642|NCT01263418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478643|NCT01263405|||Case-Only||Prospective|||||||
1478644|NCT01263392|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1478645|NCT01263379||Single Group Assignment||Treatment||None (Open Label)||||||
1478646|NCT01263366||Single Group Assignment||Supportive Care||None (Open Label)||||||
1478647|NCT01263353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478648|NCT01263340|||Cohort||Retrospective|||||||
1478649|NCT01263327||Single Group Assignment||Prevention||None (Open Label)||||||
1478650|NCT01263314|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478651|NCT01263301|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1478652|NCT01263288|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478653|NCT01263275||Single Group Assignment||Treatment||None (Open Label)||||||
1478654|NCT01263262|||Cohort||Prospective|||||||
1478655|NCT01263249|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1478656|NCT01263236|Randomized|Parallel Assignment||Other||Double|||t||t|
1478657|NCT01263223|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1478658|NCT01263210|Randomized|Parallel Assignment||Prevention||Single|||||t|
1478659|NCT01263197|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1478660|NCT01263184|||Cohort||Prospective|||||||
1478661|NCT01263171||Single Group Assignment||Treatment||None (Open Label)||||||
1478662|NCT01263158|Randomized|||Treatment||None (Open Label)||||||
1478663|NCT01263145||Single Group Assignment||Treatment||None (Open Label)||||||
1478664|NCT01263132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478665|NCT01263119||Single Group Assignment||Treatment||None (Open Label)||||||
1478666|NCT01263106|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478667|NCT01263093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478668|NCT01263080|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1478669|NCT01263067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478670|NCT01263054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478671|NCT01263041|Randomized|Parallel Assignment||Prevention||Single|||t|||
1478672|NCT01263028||Single Group Assignment||Treatment||None (Open Label)||||||
1478673|NCT01263015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478674|NCT01263002||Single Group Assignment||Treatment||None (Open Label)||||||
1478675|NCT01262989|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1478676|NCT01262976|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1478677|NCT01262963||Single Group Assignment||Treatment||None (Open Label)||||||
1478678|NCT01262950||||||||||||
1478679|NCT01262937|||Case-Only||Prospective|||||||
1478680|NCT01262924|Randomized|Parallel Assignment||Prevention||Single|||t|||
1478681|NCT01262911|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1478682|NCT01262898|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478683|NCT01262885|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478684|NCT01262872|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1478685|NCT01262859||Single Group Assignment||Treatment||None (Open Label)||||||
1478686|NCT01262846|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478687|NCT01262833|||Cohort||Prospective|||||||
1478688|NCT01262820||Single Group Assignment||Treatment||None (Open Label)||||||
1478689|NCT01262807|Randomized|Single Group Assignment||Prevention||Single||||||t
1478690|NCT01262794|Randomized|Parallel Assignment||||Double|||t||t|
1478691|NCT01262781|||Cohort||Prospective|||||||
1478692|NCT01262768|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1478693|NCT01262755|||Case-Only||Cross-Sectional|||||||
1478694|NCT01262742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478695|NCT01262729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478696|NCT01262716|||Case-Only||Prospective|||||||
1478697|NCT01262703||Single Group Assignment||Treatment||None (Open Label)||||||
1478698|NCT01262690|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1478699|NCT01262677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478700|NCT01262664||Single Group Assignment||Treatment||None (Open Label)||||||
1478701|NCT01262651|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478702|NCT01262638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478703|NCT01262625|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1478704|NCT01262612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478705|NCT01262599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478706|NCT01262586|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478707|NCT01262573|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478708|NCT01262560|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1478709|NCT01262547|Randomized|Single Group Assignment||Treatment||Single||||||t
1478710|NCT01262534|||Case-Only||Cross-Sectional|||||||
1478711|NCT01262521|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1478712|NCT01262508|||Case-Only||Prospective|||||||
1478713|NCT01262495||Single Group Assignment||Supportive Care||None (Open Label)||||||
1478714|NCT01262482||Single Group Assignment||Treatment||None (Open Label)||||||
1478715|NCT01262469||Single Group Assignment||Treatment||None (Open Label)||||||
1478716|NCT01262456|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478717|NCT01262443||Single Group Assignment||Treatment||None (Open Label)||||||
1478718|NCT01262430|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478719|NCT01262417|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478720|NCT01262404|||Cohort||Cross-Sectional|||||||
1478721|NCT01262391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478722|NCT01262378|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478723|NCT01262365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478724|NCT01262352|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1478725|NCT01262339||Single Group Assignment||Treatment||Single|||t|||
1478726|NCT01262326|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1478727|NCT01262313|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1478728|NCT01262300||Single Group Assignment||Prevention||None (Open Label)||||||
1478729|NCT01262287|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478730|NCT01262274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478731|NCT01262261|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478732|NCT01262248|||Cohort||Prospective|||||||
1478733|NCT01262235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478734|NCT01262222|||Case-Only||Prospective|||||||
1478735|NCT01262209||Single Group Assignment||Supportive Care||None (Open Label)||||||
1478736|NCT01262196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478737|NCT01262183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478738|NCT01262170|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1478739|NCT01262157|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1478740|NCT01262144|||Case-Only||Retrospective|||||||
1478741|NCT01262131|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478742|NCT01262118|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1478743|NCT01262105|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1478744|NCT01262092|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478745|NCT01262079|||Cohort||Prospective|||||||
1478746|NCT01262066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478747|NCT01262053|Randomized|Factorial Assignment||Other||Single|||||t|
1478748|NCT01262040||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478749|NCT01262027||Single Group Assignment||Treatment||None (Open Label)||||||
1478750|NCT01262014||Single Group Assignment||Treatment||None (Open Label)||||||
1478751|NCT01262001||Single Group Assignment||Treatment||None (Open Label)||||||
1478752|NCT01261988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478753|NCT01261975|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478754|NCT01261962|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1478755|NCT01261949|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478756|NCT01261936|||Case-Crossover||Prospective|||||||
1478757|NCT01261923|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1478758|NCT01261910|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1478759|NCT01261897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478760|NCT01261884|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478761|NCT01261871|||Case Control||Prospective|||||||
1478762|NCT01261858|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478763|NCT01261845|||Ecologic or Community||Cross-Sectional|||||||
1478764|NCT01261832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478765|NCT01261819|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1478766|NCT01261806|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1478767|NCT01261793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478768|NCT01261780|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478769|NCT01261767|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478770|NCT01261754|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1478771|NCT01261741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478772|NCT01261728||Single Group Assignment||Treatment||None (Open Label)||||||
1478773|NCT01261715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478774|NCT01261702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478775|NCT01261689|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1478776|NCT01261676|||Case Control||Retrospective|||||||
1478777|NCT01261663|||Case-Crossover||Prospective|||||||
1478778|NCT01261650|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478779|NCT01261637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478780|NCT01261624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478781|NCT01261611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478782|NCT01261598|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1478783|NCT01261585|||||Prospective|||||||
1478784|NCT01261572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478785|NCT01261559|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1478786|NCT01261546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478787|NCT01261533||Single Group Assignment||Treatment||None (Open Label)||||||
1478788|NCT01261520|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1478789|NCT01261507||||||||||||
1478790|NCT01261494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478791|NCT01261481|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478792|NCT01261468|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1478793|NCT01261455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478794|NCT01261442|||Case Control||Prospective|||||||
1478795|NCT01261429||Single Group Assignment||Treatment||None (Open Label)||||||
1478796|NCT01261416|||Cohort||Prospective|||||||
1478797|NCT01261403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478798|NCT01261390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478799|NCT01261377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478800|NCT01261364|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1478801|NCT01261351|||Case Control||Prospective|||||||
1478802|NCT01261338|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1478803|NCT01261325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478804|NCT01261312|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1478805|NCT01261299||Single Group Assignment||Treatment||None (Open Label)||||||
1478806|NCT01261286||||||||||||
1478807|NCT01261273|||||Prospective|||||||
1478808|NCT01261260|Randomized|Parallel Assignment||||Triple|||t||t|t
1478809|NCT01261247||Single Group Assignment||Treatment||None (Open Label)||||||
1478810|NCT01261234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478811|NCT01261221|||Cohort||Cross-Sectional|||||||
1478812|NCT01261208|||Case-Only||Prospective|||||||
1478813|NCT01261195|||Cohort||Cross-Sectional|||||||
1478814|NCT01261182|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478815|NCT01261169|||Cohort||Prospective|||||||
1478816|NCT01261156|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478817|NCT01261143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478818|NCT01261130|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478819|NCT01261117|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478820|NCT01261104|||Cohort||Retrospective|||||||
1478821|NCT01261091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478822|NCT01261078|Randomized|Parallel Assignment||||Double|||||t|t
1478823|NCT01261065||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478824|NCT01261052|Randomized|Crossover Assignment||Treatment||Single|||t|||
1478825|NCT01261039|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1478826|NCT01261026|||Case Control||Prospective|||||||
1478827|NCT01261013|||Case-Only||Prospective|||||||
1478828|NCT01261000||Single Group Assignment||Treatment||None (Open Label)||||||
1478829|NCT01260987|Randomized|Parallel Assignment||Treatment||Single||||||t
1478830|NCT01260974|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1478831|NCT01260961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478832|NCT01260948|Randomized|Crossover Assignment||||None (Open Label)||||||
1478833|NCT01260935|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478834|NCT01260922|Randomized|Crossover Assignment||||Single||||||
1478835|NCT01260909|||Cohort||Prospective|||||||
1478836|NCT01260896|Randomized|Crossover Assignment||||None (Open Label)||||||
1478837|NCT01260883|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1478838|NCT01260870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478839|NCT01260857|||||Prospective|||||||
1478840|NCT01260844|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1478841|NCT01260831|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478842|NCT01260818|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478843|NCT01260805|Randomized|Crossover Assignment||||None (Open Label)||||||
1478844|NCT01260792|||||Prospective|||||||
1478845|NCT01260779||||||||||||
1478846|NCT01260766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478847|NCT01260753|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1478848|NCT01260740|||Other||Cross-Sectional|||||||
1478849|NCT01260727|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1478850|NCT01260714||Single Group Assignment||Treatment||None (Open Label)||||||
1478851|NCT01260701||Single Group Assignment||Treatment||None (Open Label)||||||
1478852|NCT01260688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478853|NCT01260675|||Other||Other|||||||
1478854|NCT01260662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478855|NCT01260649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478856|NCT01260636|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1478857|NCT01260623|||Other||Prospective|||||||
1478858|NCT01260610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478859|NCT01260597|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478860|NCT01260584|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1478861|NCT01260571||Single Group Assignment||Treatment||Single|||t|||
1478862|NCT01260558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478863|NCT01260545|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1478864|NCT01260532|||Cohort||Prospective|||||||
1478865|NCT01260519|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1478866|NCT01260506||Single Group Assignment||Treatment||None (Open Label)||||||
1478867|NCT01260493|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1478868|NCT01260480||Single Group Assignment||Diagnostic||None (Open Label)||||||
1478869|NCT01260467||Single Group Assignment||Treatment||None (Open Label)||||||
1478870|NCT01260454||Single Group Assignment||Treatment||None (Open Label)||||||
1478871|NCT01260441|Randomized|Parallel Assignment||Prevention||Single|||t|||
1478872|NCT01260428|||Case-Only||Prospective|||||||
1478873|NCT01260415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478874|NCT01260402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479193|NCT01256255|||Cohort||Prospective|||||||
1478875|NCT01260389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478876|NCT01260376|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1478877|NCT01260363|Randomized|Single Group Assignment||Treatment||Single|||||t|
1478878|NCT01260350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478879|NCT01260337|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478880|NCT01260324|||Case Control||Retrospective|||||||
1478881|NCT01260311|||Cohort||Prospective|||||||
1478882|NCT01260298|||Cohort||Prospective|||||||
1478883|NCT01260285|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478884|NCT01260272|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478885|NCT01260259|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478886|NCT01260246|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478887|NCT01260233|Randomized|Single Group Assignment||Treatment||Triple||||t|t|t
1478888|NCT01260220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478889|NCT01260207|Randomized|Parallel Assignment||Treatment||Single||||||t
1478890|NCT01260194||Single Group Assignment||Treatment||None (Open Label)||||||
1478891|NCT01260181||Single Group Assignment||Treatment||None (Open Label)||||||
1478892|NCT01260168|||Case-Only|||||||||
1478893|NCT01260155|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478894|NCT01260142|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478895|NCT01260129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478896|NCT01260116|||Case Control||Prospective|||||||
1478897|NCT01260103|Randomized|Parallel Assignment||Treatment||Single||||||t
1478898|NCT01260090|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1478899|NCT01260077|||Cohort||Cross-Sectional|||||||
1478900|NCT01260064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478901|NCT01260051|||Cohort||Retrospective|||||||
1478902|NCT01260038|||Case-Only||Prospective|||||||
1478903|NCT01260025||Single Group Assignment||Treatment||None (Open Label)||||||
1478904|NCT01260012|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1478905|NCT01259999|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1478906|NCT01259986||Single Group Assignment||Treatment||None (Open Label)||||||
1478907|NCT01259973|Randomized|Crossover Assignment||||Double|||t||t|
1478908|NCT01259960|||Cohort||Prospective|||||||
1478909|NCT01259947||Single Group Assignment||Treatment||None (Open Label)||||||
1478910|NCT01259934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478911|NCT01259921||Single Group Assignment||Treatment||None (Open Label)||||||
1478912|NCT01259908|||Cohort||Prospective|||||||
1478913|NCT01259895|||Case-Crossover||Cross-Sectional|||||||
1478914|NCT01259882|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1478915|NCT01259869||Single Group Assignment||Treatment||None (Open Label)||||||
1478916|NCT01259856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478917|NCT01259843|||Cohort||Prospective|||||||
1478918|NCT01259830|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478919|NCT01259817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478920|NCT01259804||Single Group Assignment||Treatment||None (Open Label)||||||
1478921|NCT01259791|Randomized|Parallel Assignment||Other||Double|||t||t|
1478922|NCT01259778|||Cohort||Other|||||||
1478923|NCT01259765|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478924|NCT01259752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478925|NCT01259739|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1478926|NCT01259726|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478927|NCT01259713|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478928|NCT01259700|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478929|NCT01259687|||Cohort||Prospective|||||||
1478930|NCT01259674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478931|NCT01259661|Randomized|Parallel Assignment||||None (Open Label)||||||
1478932|NCT01259648|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478933|NCT01259635||Parallel Assignment||Supportive Care||Single|||||t|
1478934|NCT01259622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478935|NCT01259609|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1478936|NCT01259596|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1478937|NCT01259583|Randomized|Parallel Assignment||||Single|||t|||
1478938|NCT01259570|Randomized|Parallel Assignment||Prevention||Single|||t|||
1478939|NCT01259557|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478940|NCT01259544|Non-Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1478941|NCT01259531||Single Group Assignment||Treatment||None (Open Label)||||||
1478942|NCT01259518|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478943|NCT01259505||Single Group Assignment||Treatment||None (Open Label)||||||
1478944|NCT01259492|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478945|NCT01259479|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478946|NCT01259466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478947|NCT01259453|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1478948|NCT01259440|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1478949|NCT01259427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478950|NCT01259414|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1478951|NCT01259401|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478952|NCT01259388|Randomized|Crossover Assignment||Treatment||Single||||||t
1478953|NCT01259375||Single Group Assignment||Treatment||None (Open Label)||||||
1478954|NCT01259362|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478955|NCT01259349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1478956|NCT01259336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478957|NCT01259323|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478958|NCT01259310|||Case Control||Prospective|||||||
1478959|NCT01259297|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1478960|NCT01259284|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1478961|NCT01259271||||||||||||
1478962|NCT01259258|Randomized|Parallel Assignment||Treatment||Single|||t|||
1478963|NCT01259245|Randomized|Parallel Assignment||Treatment||Single||||||t
1478964|NCT01259232|||Family-Based||Cross-Sectional|||||||
1478965|NCT01259219|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478966|NCT01259206|||Case Control||Prospective|||||||
1478967|NCT01259193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478968|NCT01259180|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1478969|NCT01259167|||Case Control|||||||||
1478970|NCT01259154|||Case Control||Retrospective|||||||
1478971|NCT01259141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478972|NCT01259128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478973|NCT01259115|Randomized|Crossover Assignment||||Double|||t||t|
1478974|NCT01259102|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1478975|NCT01259089||Single Group Assignment||Treatment||None (Open Label)||||||
1478976|NCT01259076|||Case Control||Prospective|||||||
1478977|NCT01259063||Single Group Assignment||Treatment||None (Open Label)||||||
1478978|NCT01259050|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1478979|NCT01259037|||Case-Only||Prospective|||||||
1478980|NCT01259024||Single Group Assignment||Treatment||None (Open Label)||||||
1478981|NCT01259011|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1478982|NCT01258998||Single Group Assignment||Treatment||None (Open Label)||||||
1478983|NCT01258985|Randomized|Parallel Assignment||Treatment||Single||||||t
1478984|NCT01258972|Randomized|Single Group Assignment||Treatment||Single|||t|||
1478985|NCT01258959|||Cohort||Prospective|||||||
1478986|NCT01258946|||Case Control||Prospective|||||||
1478987|NCT01258933||Single Group Assignment||Treatment||None (Open Label)||||||
1478988|NCT01258920||Single Group Assignment||Treatment||None (Open Label)||||||
1478989|NCT01258907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1478990|NCT01258894|||Case Control||Cross-Sectional|||||||
1478991|NCT01258881|||Case-Only||Retrospective|||||||
1478992|NCT01258868||Single Group Assignment||Treatment||None (Open Label)||||||
1478993|NCT01258855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1478994|NCT01258842|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1478995|NCT01258829|Randomized|Crossover Assignment||Treatment||Double||||t||t
1478996|NCT01258816||Single Group Assignment||Treatment||None (Open Label)||||||
1478997|NCT01258803|Randomized|Crossover Assignment||Treatment||Single|||||t|
1478998|NCT01258790|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1478999|NCT01258777|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479000|NCT01258764|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1479001|NCT01258751|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1479002|NCT01258738|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479003|NCT01258725||Single Group Assignment||Diagnostic||None (Open Label)||||||
1479004|NCT01258712|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479005|NCT01258699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479006|NCT01258686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479007|NCT01258673|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479008|NCT01258660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479009|NCT01258647||Single Group Assignment||Prevention||None (Open Label)||||||
1479010|NCT01258634||Single Group Assignment||Treatment||None (Open Label)||||||
1479011|NCT01258621||Single Group Assignment||Treatment||None (Open Label)||||||
1479012|NCT01258608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479013|NCT01258595|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479014|NCT01258582|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1479015|NCT01258569|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479016|NCT01258556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479017|NCT01258543|||Case-Only||Cross-Sectional|||||||
1479018|NCT01258530|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1479019|NCT01258517|||Cohort||Prospective|||||||
1479020|NCT01258504|||Case-Control||Prospective|||||||
1479021|NCT01258491|Randomized|Crossover Assignment||Basic Science||Double||||||
1479022|NCT01258478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479023|NCT01258465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479024|NCT01258452|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479025|NCT01258439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479026|NCT01258426|||Case Control||Cross-Sectional|||||||
1479027|NCT01258413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479028|NCT01258400||||||||||||
1479029|NCT01258387|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1479030|NCT01258374|||Cohort||Prospective|||||||
1479031|NCT01258361|||Cohort||Prospective|||||||
1479032|NCT01258348||Single Group Assignment||Treatment||None (Open Label)||||||
1479033|NCT01258335|Randomized|||Prevention||Triple|||t|t|t|
1479034|NCT01258322|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479035|NCT01258309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479036|NCT01258296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479037|NCT01258283|||Cohort||Prospective|||||||
1479038|NCT01258270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479039|NCT01258257|Randomized|Parallel Assignment||Treatment||Single||||||t
1479040|NCT01258244|||Other||Prospective|||||||
1479041|NCT01258231|||Cohort||Prospective|||||||
1479042|NCT01258218|||Cohort||Prospective|||||||
1479043|NCT01258205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479044|NCT01258192||Single Group Assignment||Treatment||None (Open Label)||||||
1479045|NCT01258179|||Cohort||Prospective|||||||
1479046|NCT01258166|||Case-Only||Retrospective|||||||
1479047|NCT01258153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479048|NCT01258140|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1479049|NCT01258127|||||Prospective|||||||
1479050|NCT01258114|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479051|NCT01258101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479052|NCT01258088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479053|NCT01258075|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479054|NCT01258062|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1479055|NCT01258049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479056|NCT01258036|||Case Control||Cross-Sectional|||||||
1479057|NCT01258023|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479058|NCT01258010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479059|NCT01257997|||Other||Prospective|||||||
1479060|NCT01257984|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479061|NCT01257971|||Cohort||Cross-Sectional|||||||
1479062|NCT01257958||Single Group Assignment||Treatment||||||||
1479063|NCT01257945|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479064|NCT01257932|||Case-Only||Prospective|||||||
1479065|NCT01257919|Randomized|Crossover Assignment||Treatment||Single|||||t|
1479066|NCT01257906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479067|NCT01257893|Randomized|Crossover Assignment||Screening||Double|||t||t|
1479068|NCT01257880|||Case Control||Cross-Sectional|||||||
1479069|NCT01257867|Randomized|Crossover Assignment||||Double|||t||t|
1479070|NCT01257854|||Cohort||Other|||||||
1479071|NCT01257841|Randomized|Parallel Assignment||||Double|||t||t|
1479072|NCT01257828|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479073|NCT01257815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479074|NCT01257802|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479075|NCT01257789|||Cohort||Prospective|||||||
1479076|NCT01257776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479077|NCT01257763|Randomized|Parallel Assignment||||Double|||t|||t
1479078|NCT01257750||Single Group Assignment||Treatment||None (Open Label)||||||
1479079|NCT01257737||Single Group Assignment||Treatment||None (Open Label)||||||
1479080|NCT01257724|Randomized|Crossover Assignment||||Single|||||t|
1479081|NCT01257711|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1479082|NCT01257698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479083|NCT01257685|||Case Control||Cross-Sectional|||||||
1479084|NCT01257672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479085|NCT01257659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479086|NCT01257646|||Cohort||Prospective|||||||
1479087|NCT01257633|||Cohort||Prospective|||||||
1479088|NCT01257620|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479089|NCT01257607|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479090|NCT01257594|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479091|NCT01257581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479092|NCT01257568||Single Group Assignment||Treatment||None (Open Label)||||||
1479093|NCT01257555|||Cohort||Prospective|||||||
1479094|NCT01257542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479095|NCT01257529|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1479096|NCT01257516|Randomized|Crossover Assignment||||None (Open Label)||||||
1479097|NCT01257503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479098|NCT01257490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479099|NCT01257477|||||Prospective|||||||
1479100|NCT01257464|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1479101|NCT01257451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479102|NCT01257438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479103|NCT01257425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479104|NCT01257412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479105|NCT01257399|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479106|NCT01257386|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479107|NCT01257373|||Cohort||Prospective|||||||
1479108|NCT01257360||Single Group Assignment||Treatment||None (Open Label)||||||
1479109|NCT01257347|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1479110|NCT01257334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479111|NCT01257321|||Case-Crossover||Prospective|||||||
1479112|NCT01257308|||||Prospective|||||||
1479113|NCT01257295|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1479114|NCT01257282|||Cohort||Prospective|||||||
1479115|NCT01257269|||Case-Only||Other|||||||
1479116|NCT01257256|||Case-Only||Cross-Sectional|||||||
1479117|NCT01257243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479118|NCT01257230|Randomized|Parallel Assignment||Treatment||Double||||||
1479119|NCT01257217|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479120|NCT01257204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479121|NCT01257191|Randomized|Crossover Assignment||||Single|||t|||
1479122|NCT01257178|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1479123|NCT01257165|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1479124|NCT01257152|||Case-Only||Prospective|||||||
1479125|NCT01257139|Randomized|Parallel Assignment||||None (Open Label)||||||
1479126|NCT01257126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479127|NCT01257113|Randomized|Parallel Assignment||Treatment||Single||||||t
1479128|NCT01257100|||Case-Control||Other|||||||
1479129|NCT01257087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479130|NCT01257074|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479131|NCT01257061|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479132|NCT01257048|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1479133|NCT01257035|||Case-Only||Prospective|||||||
1479134|NCT01257022|Randomized|Parallel Assignment||Prevention||Single||||||t
1479135|NCT01257009|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479136|NCT01256996|Randomized|Parallel Assignment||Treatment||Single||||||t
1479137|NCT01256983|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479138|NCT01256970|||Cohort||Prospective|||||||
1479139|NCT01256957|Randomized|Crossover Assignment||Prevention||Single|||t|||
1479140|NCT01256944|||Cohort||Prospective|||||||
1479141|NCT01256931|||Case Control||Prospective|||||||
1479142|NCT01256918|||||Cross-Sectional|||||||
1479143|NCT01256905||Single Group Assignment||Treatment||None (Open Label)||||||
1479144|NCT01256892||||||||||||
1479145|NCT01256879|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479146|NCT01256866|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479147|NCT01256853||Single Group Assignment||Treatment||None (Open Label)||||||
1479148|NCT01256840|||Cohort||Cross-Sectional|||||||
1479149|NCT01256827|||Cohort||Cross-Sectional|||||||
1479150|NCT01256814|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1479151|NCT01256801|||Cohort||Prospective|||||||
1479152|NCT01256788|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479153|NCT01256775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479154|NCT01256762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479155|NCT01256749|||Case-Only||Prospective|||||||
1479156|NCT01256736|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479157|NCT01256723|||Case-Only||Prospective|||||||
1479158|NCT01256710|||Cohort||Prospective|||||||
1479159|NCT01256697|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1479160|NCT01256684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479161|NCT01256671||Single Group Assignment||Treatment||None (Open Label)||||||
1479162|NCT01256658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479163|NCT01256645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479164|NCT01256632|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1479165|NCT01256619||Single Group Assignment||Treatment||None (Open Label)||||||
1479166|NCT01256606|||Case Control||Prospective|||||||
1479167|NCT01256593|||Case-Only||Prospective|||||||
1479168|NCT01256580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479169|NCT01256567||Single Group Assignment||Treatment||None (Open Label)||||||
1479170|NCT01256554||Single Group Assignment||Treatment||None (Open Label)||||||
1479171|NCT01256541||Single Group Assignment||Treatment||None (Open Label)||||||
1479172|NCT01256528||Single Group Assignment||Treatment||None (Open Label)||||||
1479173|NCT01256515|Randomized|Parallel Assignment||Prevention||Single||||||t
1479174|NCT01256502||Single Group Assignment||Treatment||None (Open Label)||||||
1479175|NCT01256489||Single Group Assignment||Treatment||None (Open Label)||||||
1479176|NCT01256476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479177|NCT01256463|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479178|NCT01256450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479179|NCT01256437|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479180|NCT01256424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479181|NCT01256411||Single Group Assignment||Treatment||None (Open Label)||||||
1479182|NCT01256398||Single Group Assignment||Treatment||None (Open Label)||||||
1479183|NCT01256385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479184|NCT01256372|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1479185|NCT01256359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479186|NCT01256346|||Case-Only||Prospective|||||||
1479187|NCT01256333|||Case-Only||Prospective|||||||
1479188|NCT01256320|Randomized|Parallel Assignment||Other||Double|||t|t||
1479189|NCT01256307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479190|NCT01256294|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479191|NCT01256281||Single Group Assignment||Treatment||None (Open Label)||||||
1479192|NCT01256268|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479194|NCT01256242|Randomized|Parallel Assignment||Treatment||Single||||||t
1479195|NCT01256229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479196|NCT01256216|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479197|NCT01256203||Single Group Assignment||Prevention||Single||||||t
1479198|NCT01256190|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479199|NCT01256177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479200|NCT01256164|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479201|NCT01256151|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479202|NCT01256138|||Case Control||Retrospective|||||||
1479203|NCT01256125|||Case Control||Retrospective|||||||
1479204|NCT01256112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479205|NCT01256099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479206|NCT01256086|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1479207|NCT01256073||Single Group Assignment||Treatment||None (Open Label)||||||
1479208|NCT01256060||Single Group Assignment||Treatment||None (Open Label)||||||
1479209|NCT01256047|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479210|NCT01256034|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479211|NCT01256021|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479212|NCT01256008|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479213|NCT01255995|||Cohort||Prospective|||||||
1479214|NCT01255982|||Cohort||Prospective|||||||
1479215|NCT01255969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479216|NCT01255956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479217|NCT01255943|||Cohort||Prospective|||||||
1479218|NCT01255930|||Case-Only||Retrospective|||||||
1479219|NCT01255917|||Case Control||Prospective|||||||
1479220|NCT01255904|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1479221|NCT01255891||Single Group Assignment||Prevention||None (Open Label)||||||
1479222|NCT01255878|Randomized|Parallel Assignment||Treatment||Single||||||t
1479223|NCT01255865|||Case-Crossover|||||||||
1479224|NCT01255852|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479225|NCT01255839|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1479226|NCT01255826|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1479227|NCT01255813|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479228|NCT01255800||Single Group Assignment||Treatment||None (Open Label)||||||
1479229|NCT01255787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479230|NCT01255774||Single Group Assignment||Treatment||None (Open Label)||||||
1479231|NCT01255761|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479232|NCT01255748|||Cohort||Prospective|||||||
1479233|NCT01255735|||Cohort||Prospective|||||||
1479234|NCT01255722|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1479235|NCT01255709|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1479236|NCT01255696|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479237|NCT01255683|||Cohort||Prospective|||||||
1479238|NCT01255670|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479239|NCT01255657|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479240|NCT01255644||Single Group Assignment||Treatment||None (Open Label)||||||
1479241|NCT01255631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479242|NCT01255618|||Case-Only||Prospective|||||||
1479243|NCT01255605|||||Cross-Sectional|||||||
1479244|NCT01255592|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479245|NCT01255579|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1479246|NCT01255566|||Cohort||Prospective|||||||
1479247|NCT01255553||Single Group Assignment||Treatment||None (Open Label)||||||
1479248|NCT01255540|||Case Control||Prospective|||||||
1479249|NCT01255527|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479250|NCT01255514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479251|NCT01255501||||||||||||
1479252|NCT01255488|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1479253|NCT01255475|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479254|NCT01255462|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479255|NCT01255449||Single Group Assignment||Diagnostic||None (Open Label)||||||
1479256|NCT01255436|Randomized|Parallel Assignment||Treatment||Single||||||t
1479257|NCT01255423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479258|NCT01255410|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1479259|NCT01255397||Single Group Assignment||Treatment||None (Open Label)||||||
1479260|NCT01255384|||Case Control||Prospective|||||||
1479261|NCT01255371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479262|NCT01255358||Single Group Assignment||Treatment||None (Open Label)||||||
1479263|NCT01255345|||Case Control||Cross-Sectional|||||||
1479264|NCT01255332|||Case-Only||Prospective|||||||
1479265|NCT01255319|||Case-Only||Prospective|||||||
1479266|NCT01255306|||Case Control||Prospective|||||||
1479267|NCT01255293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479268|NCT01255280|Randomized|Parallel Assignment||Treatment||Single||||||t
1479269|NCT01255267|||Cohort||Prospective|||||||
1479270|NCT01255254|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479271|NCT01255241|||Case-Only||Prospective|||||||
1479272|NCT01255228|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1479273|NCT01255215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479274|NCT01255202|||Cohort||Prospective|||||||
1479275|NCT01255189|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1479276|NCT01255176|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479277|NCT01255163|Randomized|Parallel Assignment||Treatment||Quadruple|Double-blind study with code kept by NIA Pharmacist who did not share with Investigators and had no interaction with participants and caregivers.|Double-blind randomized placebo-controlled.|t|t|t|t
1479278|NCT01255150|||Ecologic or Community||Cross-Sectional|||||||
1479279|NCT01255137||Single Group Assignment||Treatment||None (Open Label)||||||
1479280|NCT01255124|||Cohort||Prospective|||||||
1479281|NCT01255111|||Cohort||Prospective|||||||
1479282|NCT01255098|||Case Control|||||||||
1479283|NCT01255085|Randomized|Single Group Assignment||Prevention||Single|||t|||
1479284|NCT01255072|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1479285|NCT01255059|||Case Control||Retrospective|||||||
1479286|NCT01255046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479287|NCT01255033|||Cohort||Prospective|||||||
1479288|NCT01255020|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479289|NCT01255007|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1479290|NCT01254994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479291|NCT01254981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479292|NCT01254968|||Case Control||Prospective|||||||
1479293|NCT01254955|||Cohort||Retrospective|||||||
1479294|NCT01254942|Randomized|Parallel Assignment||Other||Single||||||t
1479295|NCT01254929|||Cohort||Prospective|||||||
1479296|NCT01254916|||Cohort||Prospective|||||||
1479297|NCT01254903||Single Group Assignment||Treatment||None (Open Label)||||||
1479298|NCT01254890||Single Group Assignment||Treatment||None (Open Label)||||||
1479299|NCT01254877|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1479300|NCT01254864|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479301|NCT01254851|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479302|NCT01254838||||||||||||
1479303|NCT01254825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479304|NCT01254812|||Case Control||Retrospective|||||||
1479305|NCT01254799|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479306|NCT01254786|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1479307|NCT01254773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479308|NCT01254760|Randomized|Crossover Assignment||Treatment||Single|||t|||
1479309|NCT01254747|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479310|NCT01254734||Single Group Assignment||Treatment||None (Open Label)||||||
1479311|NCT01254721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479312|NCT01254708|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479313|NCT01254695|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1479314|NCT01254682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479315|NCT01254669|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479316|NCT01254656|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479317|NCT01254643||Single Group Assignment||Prevention||None (Open Label)||||||
1479318|NCT01254630|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1479319|NCT01254617||Single Group Assignment||Treatment||None (Open Label)||||||
1479320|NCT01254604|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479321|NCT01254591||||Diagnostic||||||||
1479322|NCT01254578||Single Group Assignment||Treatment||None (Open Label)||||||
1479323|NCT01254565|Randomized|Sequential Assignment||Treatment||Double|||t||t|
1479324|NCT01254552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1479325|NCT01254539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479326|NCT01254526|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479327|NCT01254513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479328|NCT01254500|||Case Control||Prospective|||||||
1479329|NCT01254487|||Cohort||Prospective|||||||
1479330|NCT01254474|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1479331|NCT01254461|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1479332|NCT01254448|Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1479333|NCT01254435|Randomized|Single Group Assignment||Prevention||Single||||||t
1479334|NCT01254422|Randomized|Parallel Assignment||Prevention||Single||||||t
1479335|NCT01254409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479336|NCT01254396|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479337|NCT01254383|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479338|NCT01254370|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479339|NCT01254357|||Cohort||Prospective|||||||
1479340|NCT01254344|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479341|NCT01254331|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479342|NCT01254318|||Cohort||Retrospective|||||||
1479343|NCT01254305|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479344|NCT01254292|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479345|NCT01254279||Single Group Assignment||Treatment||None (Open Label)||||||
1479346|NCT01254266|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479347|NCT01254253|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479348|NCT01254240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479349|NCT01254227||Single Group Assignment||Treatment||None (Open Label)||||||
1479350|NCT01254214|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1479351|NCT01254201|||Case-Control||Cross-Sectional|||||||
1479352|NCT01254188||Single Group Assignment||Treatment||None (Open Label)||||||
1479353|NCT01254175|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1479354|NCT01254162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479355|NCT01254149|||||Cross-Sectional|||||||
1479356|NCT01254136|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479357|NCT01254123|Randomized|Parallel Assignment||Treatment||Single||||||
1479358|NCT01254110|||||Prospective|||||||
1479359|NCT01254097|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1479360|NCT01254084|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1479361|NCT01254071|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479362|NCT01254058|||Case-Control||Prospective|||||||
1479363|NCT01254045|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1479364|NCT01254032|||||Prospective|||||||
1479365|NCT01254019|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1479366|NCT01254006||||||||||||
1479367|NCT01253993|||Case Control||Cross-Sectional|||||||
1479368|NCT01253980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479369|NCT01253967|||Cohort||Prospective|||||||
1479370|NCT01253954|||Case-Only||Prospective|||||||
1479371|NCT01253941|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1479372|NCT01253928|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1479373|NCT01253915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479374|NCT01253902|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479375|NCT01253889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479376|NCT01253876||||||||||||
1479377|NCT01253863||Single Group Assignment||Diagnostic||Single||||||t
1479378|NCT01253850|||Cohort||Other|||||||
1479379|NCT01253837||Single Group Assignment||Treatment||None (Open Label)||||||
1479380|NCT01253824|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479381|NCT01253811||Single Group Assignment||Treatment||None (Open Label)||||||
1479382|NCT01253798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479383|NCT01253785|||||Prospective|||||||
1479384|NCT01253772|||||Prospective|||||||
1479385|NCT01253759|||Case-Only||Retrospective|||||||
1479386|NCT01253746|||Family-Based||Prospective|||||||
1479387|NCT01253733|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1479388|NCT01253720|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479389|NCT01253707||Single Group Assignment||Treatment||None (Open Label)||||||
1479390|NCT01253694|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479391|NCT01253681||Single Group Assignment||Treatment||None (Open Label)||||||
1479392|NCT01253668||Single Group Assignment||Treatment||None (Open Label)||||||
1479393|NCT01253655|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1479394|NCT01253642||Single Group Assignment||Treatment||None (Open Label)||||||
1479395|NCT01253629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479396|NCT01253616||Single Group Assignment||Treatment||None (Open Label)||||||
1479397|NCT01253603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479398|NCT01253590|||Cohort||Prospective|||||||
1479399|NCT01253577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479400|NCT01253564||Single Group Assignment||Treatment||None (Open Label)||||||
1479401|NCT01253551|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479402|NCT01253525||Single Group Assignment||Treatment||None (Open Label)||||||
1479403|NCT01253512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479404|NCT01253499|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1479405|NCT01253486|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479406|NCT01253473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479407|NCT01253460||Single Group Assignment||Treatment||None (Open Label)||||||
1479408|NCT01253447||Single Group Assignment||Treatment||None (Open Label)||||||
1479409|NCT01253434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479410|NCT01253421|Randomized|Parallel Assignment||Treatment||Double||There were two groups of subjects: currently experiencing a major depressive episode, or normal health controls. The groups were matched for age, gender, and race. Within each group, half of the subjects were assigned to receive the study drug (amisulpride) and half to receive a placebo.|t||t|
1479411|NCT01253408|Randomized|Parallel Assignment||||Double|||t||t|
1479412|NCT01253395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479413|NCT01253382|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1479414|NCT01253369||Single Group Assignment||Treatment||None (Open Label)||||||
1479415|NCT01253356|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479416|NCT01253343|||Cohort||Prospective|||||||
1479417|NCT01253330|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1479418|NCT01253317||Single Group Assignment||Treatment||None (Open Label)||||||
1479419|NCT01253304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479420|NCT01253291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479421|NCT01253278|Randomized|Parallel Assignment||||Double|||t||t|
1479422|NCT01253265|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1479423|NCT01253252||Single Group Assignment||Diagnostic||None (Open Label)||||||
1479424|NCT01253239|||Cohort||Retrospective|||||||
1479425|NCT01253226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479426|NCT01253213||Single Group Assignment||Diagnostic||None (Open Label)||||||
1479504|NCT01252199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479427|NCT01253200|Randomized|Parallel Assignment||Treatment||Single|Subject was not told by investigator if device used was Investigational or Control. The subject could ask the investigator at end of study at 3 months if they wanted to know which device was used.||t|||
1479428|NCT01253187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479429|NCT01253174|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479430|NCT01253161||Single Group Assignment||Treatment||None (Open Label)||||||
1479431|NCT01253148||Single Group Assignment||Treatment||None (Open Label)||||||
1479432|NCT01253135|Randomized|Parallel Assignment||Treatment||Single||||||t
1479433|NCT01253122|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479434|NCT01253109|||Cohort||Prospective|||||||
1479435|NCT01253096||Single Group Assignment||Treatment||None (Open Label)||||||
1479436|NCT01253083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479437|NCT01253070||Single Group Assignment||Treatment||None (Open Label)||||||
1479438|NCT01253057|||Case Control|||||||||
1479439|NCT01253044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479440|NCT01253031|||Cohort||Prospective|||||||
1479441|NCT01253018|Randomized|Parallel Assignment||Treatment||Single||||||t
1479442|NCT01253005|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1479443|NCT01252992|||Other||Prospective|||||||
1479444|NCT01252979||Single Group Assignment||Treatment||None (Open Label)||||||
1479445|NCT01252966|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479446|NCT01252953|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479447|NCT01252940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479448|NCT01252927|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1479449|NCT01252914||Single Group Assignment||Treatment||None (Open Label)||||||
1479450|NCT01252901|||Cohort||Retrospective|||||||
1479451|NCT01252888||Single Group Assignment||Treatment||None (Open Label)||||||
1479452|NCT01252875|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479453|NCT01252862||Single Group Assignment||Treatment||None (Open Label)||||||
1479454|NCT01252849|Randomized|Parallel Assignment||Treatment||Single||iStent 1, 2, or 3 stents||||t
1479455|NCT01252836|Randomized|Parallel Assignment||Treatment||Single||||||t
1479456|NCT01252823||Single Group Assignment||Prevention||None (Open Label)||||||
1479457|NCT01252810|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1479458|NCT01252797|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1479459|NCT01252784|||Case-Only||Prospective|||||||
1479460|NCT01252771||Single Group Assignment||Treatment||None (Open Label)||||||
1479461|NCT01252758|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1479462|NCT01252745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479463|NCT01252732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479464|NCT01252719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479465|NCT01252706|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479466|NCT01252693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479467|NCT01252680|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1479468|NCT01252667||Single Group Assignment||Treatment||None (Open Label)||||||
1479469|NCT01252654|||Case Control||Prospective|||||||
1479470|NCT01252641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479471|NCT01252628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479472|NCT01252615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479473|NCT01252602|||Cohort||Prospective|||||||
1479474|NCT01252589|||Case-Only||Cross-Sectional|||||||
1479475|NCT01252576|||Cohort||Prospective|||||||
1479476|NCT01252563|||Case-Only||Prospective|||||||
1479477|NCT01252550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479478|NCT01252537|||Cohort||Prospective|||||||
1479479|NCT01252524|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479480|NCT01252511|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479481|NCT01252498|||Case-Only||Prospective|||||||
1479482|NCT01252485|||Case-Only||Prospective|||||||
1479483|NCT01252472|||Case Control||Cross-Sectional|||||||
1479484|NCT01252459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479485|NCT01252446|||||Retrospective|||||||
1479486|NCT01252433|Randomized|Crossover Assignment||Prevention||Single|||t|||
1479487|NCT01252420||Single Group Assignment||Treatment||None (Open Label)||||||
1479488|NCT01252407|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1479489|NCT01252394||||||||||||
1479490|NCT01252381|Randomized|Parallel Assignment||Other||Double|||t||t|
1479491|NCT01252368|||Case Control||Prospective|||||||
1479492|NCT01252355|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479493|NCT01252342|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1479494|NCT01252329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479495|NCT01252316|Randomized|Parallel Assignment||Prevention||Single|||t|||
1479496|NCT01252303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479497|NCT01252290||Single Group Assignment||Prevention||None (Open Label)||||||
1479498|NCT01252277||Single Group Assignment||Prevention||None (Open Label)||||||
1479499|NCT01252264|||Case-Control||Retrospective|||||||
1479500|NCT01252251||Single Group Assignment||Treatment||None (Open Label)||||||
1479501|NCT01252238|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1479502|NCT01252225|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1479503|NCT01252212|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1479505|NCT01252186|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1479506|NCT01252173|||||Prospective|||||||
1479507|NCT01252160||Single Group Assignment||Treatment||None (Open Label)||||||
1479508|NCT01252147|||Cohort||Prospective|||||||
1479509|NCT01252134|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1479510|NCT01252121|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1479511|NCT01252108||Single Group Assignment||Treatment||None (Open Label)||||||
1479512|NCT01252095||Single Group Assignment||Treatment||None (Open Label)||||||
1479513|NCT01252082|Randomized|Parallel Assignment||Treatment||Single||||||t
1479514|NCT01252069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479515|NCT01252056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479516|NCT01252043|||Case Control||Retrospective|||||||
1479517|NCT01252030|Randomized|Parallel Assignment||Prevention||Single|||t|||
1479518|NCT01252017||Single Group Assignment||Prevention||None (Open Label)||||||
1479519|NCT01252004|||Cohort||Cross-Sectional|||||||
1479520|NCT01251991|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1479521|NCT01251978|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479522|NCT01251965||Single Group Assignment||Treatment||None (Open Label)||||||
1479523|NCT01251952|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479524|NCT01251939|||Case Control||Prospective|||||||
1479525|NCT01251926|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479526|NCT01251913|||Cohort||Prospective|||||||
1479527|NCT01251900|||Case-Only||Cross-Sectional|||||||
1479528|NCT01251887|Randomized|Parallel Assignment||Treatment||||||||
1479529|NCT01251874||Single Group Assignment||Treatment||None (Open Label)||||||
1479530|NCT01251861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479531|NCT01251848|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479532|NCT01251835|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479533|NCT01251822|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479534|NCT01251809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479535|NCT01251796||Single Group Assignment||Treatment||||||||
1479536|NCT01251783|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479537|NCT01251770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479538|NCT01251757|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1479539|NCT01251744|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1479540|NCT01251731|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1479541|NCT01251718|||Cohort||Prospective|||||||
1479542|NCT01251705|||Cohort||Prospective|||||||
1479543|NCT01251692||Single Group Assignment||Treatment||None (Open Label)||||||
1479544|NCT01251679|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479545|NCT01251666||Single Group Assignment||Screening||Double|||t|||t
1479546|NCT01251653|||Cohort||Prospective|||||||
1479547|NCT01251640||Single Group Assignment||Treatment||None (Open Label)||||||
1479548|NCT01251627||Single Group Assignment||Treatment||None (Open Label)||||||
1479549|NCT01251614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479550|NCT01251601|||||Prospective|||||||
1479551|NCT01251588|||Other||Prospective|||||||
1479552|NCT01251575||Single Group Assignment||Treatment||None (Open Label)||||||
1479553|NCT01251562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479554|NCT01251549||Single Group Assignment||Supportive Care||None (Open Label)||||||
1479555|NCT01251536|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479556|NCT01251523|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1479557|NCT01251510||||||||||||
1479558|NCT01251497||Parallel Assignment||Supportive Care||||||||
1479559|NCT01251484||Single Group Assignment||Treatment||None (Open Label)||||||
1479560|NCT01251471||Single Group Assignment||Basic Science||None (Open Label)||||||
1479561|NCT01251458||Single Group Assignment||Treatment||None (Open Label)||||||
1479562|NCT01251432|||Cohort||Cross-Sectional|||||||
1479563|NCT01251419|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1479564|NCT01251406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479565|NCT01251393|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479566|NCT01251380||Single Group Assignment||Treatment||None (Open Label)||||||
1479567|NCT01251367||Single Group Assignment||Treatment||None (Open Label)||||||
1479568|NCT01251354||Single Group Assignment||Treatment||None (Open Label)||||||
1479569|NCT01251341|Randomized|Parallel Assignment||Prevention||Single||||||t
1479570|NCT01251328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479571|NCT01251315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479572|NCT01251302|||Cohort||Prospective|||||||
1479573|NCT01251289|||Cohort||Retrospective|||||||
1479574|NCT01251276|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479575|NCT01251263|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479576|NCT01251250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479577|NCT01251237|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1479578|NCT01251224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479579|NCT01251211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479580|NCT01251198|||Cohort||Prospective|||||||
1479581|NCT01251185|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479582|NCT01251172||Single Group Assignment||Treatment||None (Open Label)||||||
1479583|NCT01251159|||Other||Retrospective|||||||
1479584|NCT01251146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479585|NCT01251133|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479586|NCT01251120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479587|NCT01251107|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479588|NCT01251094|||Case Control||Prospective|||||||
1479589|NCT01251081||||Treatment||||||||
1479590|NCT01251068|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1479591|NCT01251055|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1479592|NCT01251042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479593|NCT01251029||||||||||||
1479594|NCT01251016|||Cohort||Prospective|||||||
1479595|NCT01251003||Single Group Assignment||Treatment||None (Open Label)||||||
1479596|NCT01250990|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1479597|NCT01250977||||Supportive Care||Double||||||
1479598|NCT01250964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479599|NCT01250951||Single Group Assignment||Treatment||None (Open Label)||||||
1479600|NCT01250938||Single Group Assignment||Treatment||None (Open Label)||||||
1479601|NCT01250925|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1479602|NCT01250912||Single Group Assignment||Treatment||None (Open Label)||||||
1479603|NCT01250899|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479604|NCT01250886|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1479605|NCT01250873||Single Group Assignment||Treatment||None (Open Label)||||||
1479606|NCT01250860|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479607|NCT01250847|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479608|NCT01250834||Single Group Assignment||Treatment||None (Open Label)||||||
1479609|NCT01250821||Single Group Assignment||Treatment||None (Open Label)||||||
1479610|NCT01250808||||||||||||
1479611|NCT01250795|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1479612|NCT01250782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479613|NCT01250769|Randomized|Parallel Assignment||Treatment||Single||||||t
1479614|NCT01250756|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479615|NCT01250743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479616|NCT01250730||Parallel Assignment||||None (Open Label)||||||
1479617|NCT01250717||Single Group Assignment||Treatment||None (Open Label)||||||
1479618|NCT01250704|||Case-Only||Cross-Sectional|||||||
1479619|NCT01250691|||Cohort||Cross-Sectional|||||||
1479620|NCT01250678|||Cohort||Prospective|||||||
1479621|NCT01250665|||Cohort||Cross-Sectional|||||||
1479622|NCT01250652|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1479623|NCT01250639|||Case Control||Prospective|||||||
1479624|NCT01250626|||Case-Only||Prospective|||||||
1479625|NCT01250613|||Family-Based||Retrospective|||||||
1479626|NCT01250600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479627|NCT01250587||Single Group Assignment||Treatment||None (Open Label)||||||
1479628|NCT01250574|||Cohort||Prospective|||||||
1479629|NCT01250561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479630|NCT01250548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479631|NCT01250535|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1479632|NCT01250509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479633|NCT01250496|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479634|NCT01250483|||Case Control||Retrospective|||||||
1479635|NCT01250470||Single Group Assignment||Treatment||None (Open Label)||||||
1479636|NCT01250457||Single Group Assignment||Treatment||None (Open Label)||||||
1479637|NCT01250444|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1479638|NCT01250431|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1479639|NCT01250418|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1479640|NCT01250405|Randomized|Crossover Assignment||||Double|||t||t|
1479641|NCT01250392|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1479642|NCT01250379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479643|NCT01250366|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1479644|NCT01250353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479645|NCT01250340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479646|NCT01250327|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479647|NCT01250314|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1479648|NCT01250301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479649|NCT01250288|||Cohort||Retrospective|||||||
1479650|NCT01250275|Randomized|Parallel Assignment||||Triple|||t|t|t|
1479651|NCT01250262|Randomized|Parallel Assignment||Treatment||Single||||||t
1479652|NCT01250249|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1479653|NCT01250236|||Case Control||Prospective|||||||
1479654|NCT01250223|||Cohort||Prospective|||||||
1479655|NCT01250210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479656|NCT01250197|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1479657|NCT01250184|Randomized|Parallel Assignment||Treatment||Single||||||t
1479658|NCT01250171|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479659|NCT01250158||Single Group Assignment||||None (Open Label)||||||
1479660|NCT01250145|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1479661|NCT01250132||Single Group Assignment||Prevention||None (Open Label)||||||
1479662|NCT01250119||Single Group Assignment||Treatment||None (Open Label)||||||
1479663|NCT01250106|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479664|NCT01250093||||||||||||
1479665|NCT01250080|Randomized|||||Single||||||t
1479666|NCT01250067|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1479667|NCT01250054|Randomized|Crossover Assignment||Treatment||Single|||t|||
1479668|NCT01250041|Randomized|Parallel Assignment||||Triple|||t|t||t
1479669|NCT01250015|||||Prospective|||||||
1479670|NCT01250002|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1479671|NCT01249989|Randomized|Factorial Assignment||Prevention||Single||||||t
1479672|NCT01249976|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1479673|NCT01249963|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1479674|NCT01249950|||||Prospective|||||||
1479675|NCT01249937|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479676|NCT01249924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479677|NCT01249911|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479678|NCT01249898|||Cohort||Prospective|||||||
1479679|NCT01249885||||||||||||
1479680|NCT01249872|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1479681|NCT01249859|||Case Control||Retrospective|||||||
1479682|NCT01249846||||Treatment||||||||
1479683|NCT01249833|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1479684|NCT01249820|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1479685|NCT01249807|||Cohort|||||||||
1479686|NCT01249794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479687|NCT01249781|||Cohort||Cross-Sectional|||||||
1479688|NCT01249768|||Cohort||Prospective|||||||
1479689|NCT01249755|||Cohort||Prospective|||||||
1479690|NCT01249742|Randomized|||Supportive Care||None (Open Label)||||||
1479691|NCT01249729|||Case-Only|||||||||
1479692|NCT01249716|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479693|NCT01249703|||Case Control|||||||||
1479694|NCT01249690|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479695|NCT01249677||Single Group Assignment||Treatment||None (Open Label)||||||
1479696|NCT01249664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479697|NCT01249651||Single Group Assignment||Treatment||None (Open Label)||||||
1479698|NCT01249638|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479699|NCT01249625|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1479700|NCT01249612|Randomized|Crossover Assignment||Treatment||Single|||||t|
1479701|NCT01249599|||||Prospective|||||||
1479702|NCT01249586||||||||||||
1479703|NCT01249573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479704|NCT01249560|||Cohort||Prospective|||||||
1479705|NCT01249547||Single Group Assignment||Treatment||None (Open Label)||||||
1479706|NCT01249534|||Cohort||Retrospective|||||||
1479707|NCT01249521||Single Group Assignment||Treatment||None (Open Label)||||||
1479708|NCT01249508||Single Group Assignment||Health Services Research||None (Open Label)||||||
1479709|NCT01249495||Single Group Assignment||Treatment||None (Open Label)||||||
1479710|NCT01249482|||Case Control||Prospective|||||||
1479711|NCT01249469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479712|NCT01249456|||Case-Only||Retrospective|||||||
1479713|NCT01249443||Single Group Assignment||Treatment||None (Open Label)||||||
1479714|NCT01249430||Single Group Assignment||Treatment||None (Open Label)||||||
1479715|NCT01249417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479716|NCT01249404|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479717|NCT01249391|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1479718|NCT01249378|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479719|NCT01249365||Single Group Assignment||Prevention||None (Open Label)||||||
1479720|NCT01249352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479721|NCT01249339|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1479722|NCT01249326|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1479723|NCT01249313|||Case-Only||Retrospective|||||||
1479724|NCT01249300|||Cohort||Cross-Sectional|||||||
1479725|NCT01249287|||Case Control||Prospective|||||||
1479726|NCT01249274|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479727|NCT01249261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479728|NCT01249248|||Cohort||Prospective|||||||
1479729|NCT01249235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479730|NCT01249222|Randomized|Parallel Assignment||Treatment||Single||||||t
1479731|NCT01249209||Single Group Assignment||Treatment||||||||
1479732|NCT01249196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479733|NCT01249183|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479734|NCT01249170|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1479735|NCT01249157||Single Group Assignment||Diagnostic||None (Open Label)||||||
1479736|NCT01249144|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1479737|NCT01249131|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479738|NCT01249118|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479739|NCT01249105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479740|NCT01249092||Single Group Assignment||Treatment||None (Open Label)||||||
1479741|NCT01249079|||Family-Based|||||||||
1479742|NCT01249066|||||Retrospective|||||||
1479743|NCT01249053|||||Retrospective|||||||
1479744|NCT01249040|Randomized|Parallel Assignment||Treatment||Single||||||
1479745|NCT01249027|||Cohort||Prospective|||||||
1479746|NCT01249014|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1479747|NCT01249001|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479748|NCT01248988|||Cohort||Prospective|||||||
1479749|NCT01248975|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1479750|NCT01248962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479751|NCT01248949||Single Group Assignment||Treatment||None (Open Label)||||||
1479752|NCT01248936||Single Group Assignment||Treatment||None (Open Label)||||||
1479753|NCT01248923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479754|NCT01248910||||||||||||
1479755|NCT01248897|||Case-Only||Prospective|||||||
1479756|NCT01248884|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1479757|NCT01248871|Randomized|Parallel Assignment||Prevention||Single|||t|||
1479758|NCT01248858||Single Group Assignment||Treatment||None (Open Label)||||||
1479759|NCT01248845||Crossover Assignment||Supportive Care||None (Open Label)||||||
1479760|NCT01248832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479761|NCT01248819|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479762|NCT01248806|||Case-Only||Retrospective|||||||
1479763|NCT01248793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479764|NCT01248780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479765|NCT01248767|||Cohort|||||||||
1479766|NCT01248754||Single Group Assignment||Treatment||None (Open Label)||||||
1479767|NCT01248741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479768|NCT01248728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479769|NCT01248715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479770|NCT01248702|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1479771|NCT01248689|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1479772|NCT01248676||Single Group Assignment||||None (Open Label)||||||
1479773|NCT01248663|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479774|NCT01248650|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479775|NCT01248637|||Other||Other|||||||
1479776|NCT01248624|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1479777|NCT01248611||Single Group Assignment||Treatment||None (Open Label)||||||
1479778|NCT01248598|||Case-Only||Cross-Sectional|||||||
1479779|NCT01248585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479780|NCT01248572||Single Group Assignment||Basic Science||None (Open Label)||||||
1479781|NCT01248546|||Cohort||Prospective|||||||
1479782|NCT01248533|||||Prospective|||||||
1479783|NCT01248520|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1479784|NCT01248507|||Cohort||Prospective|||||||
1479785|NCT01248494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479786|NCT01248481|||||Prospective|||||||
1479787|NCT01248468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479788|NCT01248455||Single Group Assignment||Treatment||None (Open Label)||||||
1479789|NCT01248442|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1479790|NCT01248429|||Cohort||Prospective|||||||
1479791|NCT01248416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479792|NCT01248403|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479793|NCT01248390|Randomized|Parallel Assignment||Treatment||Single||||||t
1479794|NCT01248377|||Case-Only||Prospective|||||||
1479795|NCT01248364||Single Group Assignment||Treatment||None (Open Label)||||||
1479796|NCT01248351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479797|NCT01248338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479798|NCT01248325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479799|NCT01248312|||Cohort||Prospective|||||||
1479800|NCT01248299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479801|NCT01248286|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479802|NCT01248273||Single Group Assignment||Treatment||None (Open Label)||||||
1479803|NCT01248260|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479804|NCT01248247|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479805|NCT01248234|Randomized|Parallel Assignment||||None (Open Label)||||||
1479806|NCT01248221|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1479807|NCT01248208|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1479808|NCT01248195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479809|NCT01248182|||Cohort||Prospective|||||||
1479810|NCT01248169|||||Prospective|||||||
1479811|NCT01248156|||Case Control||Prospective|||||||
1479812|NCT01248143|Randomized|Parallel Assignment||Treatment||Single||||||t
1479813|NCT01248130|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479814|NCT01248117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479815|NCT01248104|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479816|NCT01248091|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1479817|NCT01248078|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1479818|NCT01248065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479819|NCT01248052|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1479820|NCT01248039|||Cohort||Prospective|||||||
1479821|NCT01248026|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1479822|NCT01248013||Single Group Assignment||Treatment||None (Open Label)||||||
1479823|NCT01248000|||Cohort||Retrospective|||||||
1479824|NCT01247987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479825|NCT01247974|Randomized|Parallel Assignment||Prevention||Single||||||t
1479826|NCT01247961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479827|NCT01247948|Randomized|Parallel Assignment||Treatment||Single||||||t
1479828|NCT01247935|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1479829|NCT01247922||Single Group Assignment||Treatment||None (Open Label)||||||
1479830|NCT01247909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479831|NCT01247896|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479832|NCT01247883|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1479833|NCT01247870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479834|NCT01247857|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479835|NCT01247844|Randomized|Parallel Assignment||||None (Open Label)||||||
1479836|NCT01247831||Single Group Assignment||Treatment||None (Open Label)||||||
1479837|NCT01247818|Randomized|Parallel Assignment||Treatment||Single||||||t
1479838|NCT01247805|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1479839|NCT01247792|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1479840|NCT01247779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479841|NCT01247766|||Cohort||Prospective|||||||
1479842|NCT01247753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479843|NCT01247740|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1479844|NCT01247727|||Case-Only||Prospective|||||||
1479845|NCT01247714|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1479846|NCT01247701||Single Group Assignment||Treatment||None (Open Label)||||||
1479847|NCT01247688||Single Group Assignment||Treatment||None (Open Label)||||||
1479848|NCT01247675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479849|NCT01247662||||||||||||
1479850|NCT01247649||Single Group Assignment||Diagnostic||None (Open Label)||||||
1479851|NCT01247636|Randomized|Parallel Assignment||Treatment||Single||||||t
1479852|NCT01247623||||||||||||
1479853|NCT01247610|||Cohort|||||||||
1479854|NCT01247597|||Family-Based||Other|||||||
1479855|NCT01247584|||Case-Only||Retrospective|||||||
1479856|NCT01247571||Single Group Assignment||Treatment||None (Open Label)||||||
1479857|NCT01247558|||Cohort||Retrospective|||||||
1479858|NCT01247545|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1479859|NCT01247532|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1479860|NCT01247519|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1479861|NCT01247506|||Case Control||Retrospective|||||||
1479862|NCT01247493||Single Group Assignment||Treatment||None (Open Label)||||||
1479863|NCT01247480|||Cohort||Retrospective|||||||
1479864|NCT01247467|||Cohort||Retrospective|||||||
1479865|NCT01247454|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479866|NCT01247441|||Cohort||Retrospective|||||||
1479867|NCT01247428||Single Group Assignment||Treatment||None (Open Label)||||||
1479868|NCT01247415|||Case Control||Retrospective|||||||
1479869|NCT01247402|Randomized|Parallel Assignment||Treatment||Single||||||t
1479870|NCT01247389|Randomized|Parallel Assignment||Treatment||Single||||||t
1479871|NCT01247376|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1479872|NCT01247363||Single Group Assignment||Other||None (Open Label)||||||
1479873|NCT01247350|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479874|NCT01247337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479875|NCT01247324|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1479876|NCT01247311|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1479877|NCT01247298||Single Group Assignment||Treatment||None (Open Label)||||||
1479878|NCT01247285|Randomized|Crossover Assignment||||None (Open Label)||||||
1479879|NCT01247272|Randomized|Crossover Assignment||||None (Open Label)||||||
1479880|NCT01247259|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479881|NCT01247246|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1479882|NCT01247233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479883|NCT01247220|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479884|NCT01247207||Single Group Assignment||Treatment||None (Open Label)||||||
1479885|NCT01247194|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479886|NCT01247181|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1479887|NCT01247168||Single Group Assignment||Treatment||None (Open Label)||||||
1479888|NCT01247155|||Case Control||Prospective|||||||
1479889|NCT01247142|||||Prospective|||||||
1479890|NCT01247129||Single Group Assignment||Treatment||None (Open Label)||||||
1479891|NCT01247116|||Cohort||Prospective|||||||
1479892|NCT01247103|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1479893|NCT01247090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479894|NCT01247077|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1479895|NCT01247064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479896|NCT01247051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479897|NCT01247038|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479898|NCT01247025|||Cohort||Cross-Sectional|||||||
1479899|NCT01247012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479900|NCT01246999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479901|NCT01246986|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479902|NCT01246973|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1480136|NCT01243892|||Cohort||Prospective|||||||
1479903|NCT01246960|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479904|NCT01246947|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1479905|NCT01246934|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1479906|NCT01246921|Randomized|Parallel Assignment||Treatment||Single||||||t
1479907|NCT01246908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479908|NCT01246895|||Case-Control||Prospective|||||||
1479909|NCT01246882|Randomized|Parallel Assignment||Treatment||Single||||||t
1479910|NCT01246869|||Case-Control||Prospective|||||||
1479911|NCT01246856|||Cohort|||||||||
1479912|NCT01246843|||Case-Only||Prospective|||||||
1479913|NCT01246830|||Case Control||Prospective|||||||
1479914|NCT01246817||Single Group Assignment||Treatment||None (Open Label)||||||
1479915|NCT01246804|Randomized|Crossover Assignment||||None (Open Label)||||||
1479916|NCT01246791||Single Group Assignment||Treatment||None (Open Label)||||||
1479917|NCT01246778|||Case-Only|||||||||
1479918|NCT01246765|||Case-Control||Prospective|||||||
1479919|NCT01246752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479920|NCT01246739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479921|NCT01246726|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1479922|NCT01246713|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1479923|NCT01246700|Randomized|Crossover Assignment||Treatment||Single||||||t
1479924|NCT01246687|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1479925|NCT01246674|||Cohort||Prospective|||||||
1479926|NCT01246661|||||Prospective|||||||
1479927|NCT01246648|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1479928|NCT01246635|Randomized|Single Group Assignment||Treatment||Single|||t|||
1479929|NCT01246622||Single Group Assignment||Treatment||None (Open Label)||||||
1479930|NCT01246609|||Cohort||Prospective|||||||
1479931|NCT01246596|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1479932|NCT01246583|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479933|NCT01246570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479934|NCT01246557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479935|NCT01246544|||Cohort||Prospective|||||||
1479936|NCT01246531|||Case Control||Prospective|||||||
1479937|NCT01246518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479938|NCT01246505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479939|NCT01246492|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1479940|NCT01246479||Single Group Assignment||||None (Open Label)||||||
1479941|NCT01246466||Single Group Assignment||Treatment||None (Open Label)||||||
1479942|NCT01246453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479943|NCT01246440||Single Group Assignment||Treatment||None (Open Label)||||||
1479944|NCT01246427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479945|NCT01246414|||Cohort||Cross-Sectional|||||||
1479946|NCT01246401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479947|NCT01246388|||Cohort||Prospective|||||||
1479948|NCT01246375||Single Group Assignment||Diagnostic||None (Open Label)||||||
1479949|NCT01246362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479950|NCT01246349|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479951|NCT01246336|||Other||Prospective|||||||
1479952|NCT01246323|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479953|NCT01246310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1479954|NCT01246297|Randomized|Parallel Assignment||Treatment||Single||||||t
1479955|NCT01246284|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1479956|NCT01246271|||Cohort||Retrospective|||||||
1479957|NCT01246258|||Case-Only||Cross-Sectional|||||||
1479958|NCT01246245|||Cohort||Prospective|||||||
1479959|NCT01246232|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479960|NCT01246219|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479961|NCT01246206||Single Group Assignment||Treatment||None (Open Label)||||||
1479962|NCT01246193|Randomized|Crossover Assignment||||None (Open Label)||||||
1479963|NCT01246180|Non-Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1479964|NCT01246167|Randomized|Parallel Assignment||Treatment||Single||||||t
1479965|NCT01246154|||Case Control||Prospective|||||||
1479966|NCT01246141|||Case Control||Retrospective|||||||
1479967|NCT01246128|||||Other|||||||
1479968|NCT01246115||||||||||||
1479969|NCT01246102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1479970|NCT01246089||Single Group Assignment||Treatment||None (Open Label)||||||
1479971|NCT01246076||Single Group Assignment||Treatment||None (Open Label)||||||
1479972|NCT01246063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479973|NCT01246050|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479974|NCT01246037|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1479975|NCT01246024||Single Group Assignment||Basic Science||None (Open Label)||||||
1479976|NCT01246011|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1479977|NCT01245998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479978|NCT01245985||Single Group Assignment||Treatment||None (Open Label)||||||
1479979|NCT01245972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479980|NCT01245959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479981|NCT01245946|Randomized|Parallel Assignment||Treatment||Single||||||t
1479982|NCT01245933|||Cohort||Prospective|||||||
1480137|NCT01243879||||||||||||
1479983|NCT01245920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479984|NCT01245907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479985|NCT01245894|Randomized|Parallel Assignment||Treatment||Single|||||t|
1479986|NCT01245881|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1479987|NCT01245868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479988|NCT01245855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1479989|NCT01245842|Randomized|Parallel Assignment||||Double|||||t|t
1479990|NCT01245829|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1479991|NCT01245816|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1479992|NCT01245803|Randomized|Parallel Assignment||Treatment||Single|||t|||
1479993|NCT01245790|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1479994|NCT01245777||Single Group Assignment||Treatment||None (Open Label)||||||
1479995|NCT01245764|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1479996|NCT01245751|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1479997|NCT01245738|||Cohort||Prospective|||||||
1479998|NCT01245725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1479999|NCT01245712||Single Group Assignment||Treatment||None (Open Label)||||||
1480000|NCT01245699|||||Prospective|||||||
1480001|NCT01245686|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480002|NCT01245673||Single Group Assignment||Treatment||None (Open Label)||||||
1480003|NCT01245660||Single Group Assignment||||None (Open Label)||||||
1480004|NCT01245647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480005|NCT01245634|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1480006|NCT01245621|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1480007|NCT01245608|Randomized|Parallel Assignment||Prevention||Single||||||t
1480008|NCT01245595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480009|NCT01245582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480010|NCT01245569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480011|NCT01245556|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480012|NCT01245543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480013|NCT01245530|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480014|NCT01245517||Single Group Assignment||Treatment||None (Open Label)||||||
1480015|NCT01245504|||Cohort||Prospective|||||||
1480016|NCT01245491||Crossover Assignment||Basic Science||Single|||t|||
1480017|NCT01245478|||Case-Only||Retrospective|||||||
1480018|NCT01245465||Single Group Assignment||Treatment||None (Open Label)||||||
1480019|NCT01245452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480020|NCT01245439||Single Group Assignment||Treatment||None (Open Label)||||||
1480021|NCT01245426|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480022|NCT01245413|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1480023|NCT01245400|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1480024|NCT01245387|||Cohort||Prospective|||||||
1480025|NCT01245374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480026|NCT01245361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480027|NCT01245348||||||||||||
1480028|NCT01245335|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480029|NCT01245322||Single Group Assignment||Treatment||None (Open Label)||||||
1480030|NCT01245309|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480031|NCT01245296|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1480032|NCT01245283|Randomized|Parallel Assignment||Treatment||Single||||||t
1480033|NCT01245270|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1480034|NCT01245257|||Case-Crossover||Prospective|||||||
1480035|NCT01245244|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1480036|NCT01245231|||Case-Only||Retrospective|||||||
1480037|NCT01245205||Single Group Assignment||Treatment||None (Open Label)||||||
1480038|NCT01245179||Single Group Assignment||Treatment||None (Open Label)||||||
1480039|NCT01245166|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480040|NCT01245153|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480041|NCT01245140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480042|NCT01245127||Single Group Assignment||Treatment||None (Open Label)||||||
1480043|NCT01245114|||Cohort||Prospective|||||||
1480044|NCT01245101|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480045|NCT01245088|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480046|NCT01245075|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1480047|NCT01245062|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480048|NCT01245049|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480049|NCT01245036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480050|NCT01245023|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480051|NCT01245010|Randomized|Parallel Assignment||Prevention||Single|||||t|
1480052|NCT01244997|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480053|NCT01244984|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480054|NCT01244971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480055|NCT01244958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480056|NCT01244945|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480057|NCT01244932|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1480058|NCT01244906||Single Group Assignment||Treatment||None (Open Label)||||||
1480059|NCT01244893|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1480060|NCT01244880|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1480061|NCT01244867|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480062|NCT01244854|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1480063|NCT01244841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480064|NCT01244828|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480065|NCT01244815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480066|NCT01244802|||Other||Cross-Sectional|||||||
1480067|NCT01244789|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480068|NCT01244776||Single Group Assignment||Treatment||None (Open Label)||||||
1480069|NCT01244763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480070|NCT01244750|||Cohort||Other|||||||
1480071|NCT01244737|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1480072|NCT01244724||Single Group Assignment||Treatment||None (Open Label)||||||
1480073|NCT01244711||Single Group Assignment||Treatment||None (Open Label)||||||
1480074|NCT01244698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480075|NCT01244685|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480076|NCT01244672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480077|NCT01244659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480078|NCT01244646|||Case-Only||Prospective|||||||
1480079|NCT01244633||Single Group Assignment||Treatment||None (Open Label)||||||
1480080|NCT01244620|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480081|NCT01244607|Randomized|||||||||||
1480082|NCT01244594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480083|NCT01244581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480084|NCT01244568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480085|NCT01244555|Randomized|Parallel Assignment||Treatment||Single||||||t
1480086|NCT01244542|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1480087|NCT01244529|Randomized|Crossover Assignment||Other||Double|||t||t|
1480088|NCT01244516|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480089|NCT01244503||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480090|NCT01244490|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480091|NCT01244477|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1480092|NCT01244464|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1480093|NCT01244451||Single Group Assignment||Treatment||None (Open Label)||||||
1480094|NCT01244438||Single Group Assignment||Treatment||None (Open Label)||||||
1480095|NCT01244425|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480096|NCT01244412|||Case-Only|||||||||
1480097|NCT01244399|||Case-Only||Cross-Sectional|||||||
1480098|NCT01244386|||Cohort||Prospective|||||||
1480099|NCT01244373|||Case-Only||Prospective|||||||
1480100|NCT01244360|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1480101|NCT01244347|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480102|NCT01244334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480103|NCT01244321|||Case Control||Prospective|||||||
1480104|NCT01244308|||Case-Only||Prospective|||||||
1480105|NCT01244295|Randomized|Parallel Assignment||Treatment||Single||||||t
1480106|NCT01244282|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1480107|NCT01244269|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1480108|NCT01244256|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1480109|NCT01244243||Single Group Assignment||Treatment||None (Open Label)||||||
1480110|NCT01244230|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480111|NCT01244217|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480112|NCT01244204|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1480113|NCT01244191|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480114|NCT01244178|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1480115|NCT01244165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480116|NCT01244152|Randomized|Parallel Assignment||Prevention||Single||||||t
1480117|NCT01244139|Randomized|Single Group Assignment||||Triple|||t|t|t|
1480118|NCT01244126|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480119|NCT01244113|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1480120|NCT01244100|Randomized|Crossover Assignment||||Single||||||t
1480121|NCT01244087|||Case-Only||Prospective|||||||
1480122|NCT01244074||||||||||||
1480123|NCT01244061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480124|NCT01244048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480125|NCT01244035|Randomized|Crossover Assignment||Treatment||Double||||||
1480126|NCT01244022|||Case-Only||Prospective|||||||
1480127|NCT01244009|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480128|NCT01243996|Randomized|Parallel Assignment||Treatment||Single|||||t|
1480129|NCT01243983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480130|NCT01243970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480131|NCT01243957|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480132|NCT01243944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480133|NCT01243931||Single Group Assignment||Treatment||None (Open Label)||||||
1480134|NCT01243918|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480135|NCT01243905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480138|NCT01243866|Randomized|Parallel Assignment||Treatment||Single||||||t
1480139|NCT01243853|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1480140|NCT01243840|||Cohort||Prospective|||||||
1480141|NCT01243827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480142|NCT01243814|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1480143|NCT01243801|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480144|NCT01243788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480145|NCT01243775||Single Group Assignment||Treatment||None (Open Label)||||||
1480146|NCT01243762|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480147|NCT01243749|||Case-Only||Prospective|||||||
1480148|NCT01243736|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1480149|NCT01243723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480150|NCT01243710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480151|NCT01243697||Single Group Assignment||Treatment||None (Open Label)||||||
1480152|NCT01243684|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1480153|NCT01243671|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480154|NCT01243658|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1480155|NCT01243645||||||||||||
1480156|NCT01243632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480157|NCT01243619||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480158|NCT01243606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480159|NCT01243593|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480160|NCT01243580|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480161|NCT01243567|Randomized|Parallel Assignment||Treatment||Single|||||t|
1480162|NCT01243554|Randomized|Parallel Assignment||Prevention||Single||||||t
1480163|NCT01243541|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480164|NCT01243528|||Cohort||Prospective|||||||
1480165|NCT01243515|||Cohort||Prospective|||||||
1480166|NCT01243502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480167|NCT01243489|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1480168|NCT01243476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480169|NCT01243463|||Cohort||Prospective|||||||
1480170|NCT01243450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480171|NCT01243437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480172|NCT01243424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480173|NCT01243411||Single Group Assignment||Treatment||None (Open Label)||||||
1480174|NCT01243398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480175|NCT01243385||Single Group Assignment||Treatment||None (Open Label)||||||
1480176|NCT01243372|||Case-Only||Retrospective|||||||
1480177|NCT01243359||Single Group Assignment||Treatment||None (Open Label)||||||
1480178|NCT01243346||Single Group Assignment||Treatment||None (Open Label)||||||
1480179|NCT01243333||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480180|NCT01243320|Randomized|Crossover Assignment||||Double|||t||t|
1480181|NCT01243307|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1480182|NCT01243294|Randomized|Crossover Assignment||||None (Open Label)||||||
1480183|NCT01243281|Randomized|Parallel Assignment||Treatment||Single|||||t|
1480184|NCT01243268|||Other||Prospective|||||||
1480185|NCT01243255|||Case-Only||Cross-Sectional|||||||
1480186|NCT01243242|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480187|NCT01243229|||Other||Other|||||||
1480188|NCT01243216|Randomized|Parallel Assignment||||None (Open Label)||||||
1480189|NCT01243203|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1480190|NCT01243190||Single Group Assignment||Treatment||None (Open Label)||||||
1480191|NCT01243177|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480192|NCT01243164|Randomized|Parallel Assignment||Basic Science||Single||||||t
1480193|NCT01243151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480194|NCT01243138|||||Cross-Sectional|||||||
1480195|NCT01243125|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1480196|NCT01243112|Non-Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1480197|NCT01243099|||Case Control||Prospective|||||||
1480198|NCT01243086|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480199|NCT01243073||Single Group Assignment||Treatment||None (Open Label)||||||
1480200|NCT01243060|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1480201|NCT01243047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480202|NCT01243034|||Case-Only||Prospective|||||||
1480203|NCT01243021|||Cohort||Retrospective|||||||
1480204|NCT01243008|Randomized|Single Group Assignment||Treatment||Single|||||t|
1480205|NCT01242995|||Case-Only||Prospective|||||||
1480206|NCT01242982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480207|NCT01242956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480208|NCT01242943|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480209|NCT01242930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480210|NCT01242917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480211|NCT01242904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480212|NCT01242891||||||||||||
1480213|NCT01242878|||Case Control||Cross-Sectional|||||||
1480214|NCT01242865||Single Group Assignment||Treatment||None (Open Label)||||||
1480215|NCT01242852|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1480216|NCT01242839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480217|NCT01242826|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480218|NCT01242813||Single Group Assignment||Treatment||None (Open Label)||||||
1480219|NCT01242800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480220|NCT01242787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480221|NCT01242774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480222|NCT01242761|||Case-Only||Prospective|||||||
1480223|NCT01242748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480224|NCT01242735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480225|NCT01242722|||Case-Only||Prospective|||||||
1480226|NCT01242696|||Case-Only||Prospective|||||||
1480227|NCT01242683|Randomized|Parallel Assignment||Prevention||Single||||||t
1480228|NCT01242670|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1480229|NCT01242657|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480230|NCT01242644|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1480231|NCT01242631||Single Group Assignment||Treatment||None (Open Label)||||||
1480232|NCT01242618||Single Group Assignment||Treatment||None (Open Label)||||||
1480233|NCT01242605||Single Group Assignment||Treatment||None (Open Label)||||||
1480234|NCT01242592|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480235|NCT01242579|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1480236|NCT01242566|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480237|NCT01242553|||Cohort||Prospective|||||||
1480238|NCT01242540|||Case-Only||Cross-Sectional|||||||
1480239|NCT01242527|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480240|NCT01242514|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480241|NCT01242501|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1480242|NCT01242488|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1480243|NCT01242475|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1480244|NCT01242462|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480245|NCT01242449|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1480246|NCT01242436||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480247|NCT01242423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480248|NCT01242410|Randomized|Parallel Assignment||Prevention||Single||||||t
1480249|NCT01242397|Randomized|Crossover Assignment||Treatment||Single|||t|||
1480250|NCT01242384|Randomized|Parallel Assignment||Prevention||Single||||||t
1480251|NCT01242371|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480252|NCT01242358|Randomized|Parallel Assignment||Prevention||Single|||t|||
1480253|NCT01242345|Randomized|Parallel Assignment||Prevention||Single|||t|||
1480254|NCT01242332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480255|NCT01242319|||||Prospective|||||||
1480256|NCT01242306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480257|NCT01242293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480258|NCT01242280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480259|NCT01242267||Single Group Assignment||Treatment||None (Open Label)||||||
1480260|NCT01242254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480261|NCT01242241|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480262|NCT01242228||Single Group Assignment||Treatment||None (Open Label)||||||
1480263|NCT01242215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480264|NCT01242202||Single Group Assignment||Treatment||None (Open Label)||||||
1480265|NCT01242176|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480266|NCT01242163|||Case Control||Prospective|||||||
1480267|NCT01242150|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480268|NCT01242137|||Case Control||Prospective|||||||
1480269|NCT01242124|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480270|NCT01242111||Single Group Assignment||Treatment||None (Open Label)||||||
1480271|NCT01242098|||Cohort||Retrospective|||||||
1480272|NCT01242085|Randomized|Parallel Assignment||Treatment||Single||||||t
1480273|NCT01242072||Single Group Assignment||Treatment||None (Open Label)||||||
1480274|NCT01242059|Randomized|Single Group Assignment||Prevention||Single|||t|||
1480275|NCT01242046|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1480276|NCT01242033|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1480277|NCT01242020|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1480278|NCT01242007||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480279|NCT01241994||||||||||||
1480280|NCT01241981|||Cohort||Prospective|||||||
1480281|NCT01241968|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1480282|NCT01241955|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1480283|NCT01241942|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1480284|NCT01241929|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1480285|NCT01241916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480286|NCT01241903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480287|NCT01241890|||Cohort||Prospective|||||||
1480288|NCT01241877|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1480289|NCT01241864||Single Group Assignment||Treatment||None (Open Label)||||||
1480290|NCT01241851|Non-Randomized|Single Group Assignment||Prevention||||||||
1480291|NCT01241838|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1480292|NCT01241825|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1480293|NCT01241812|Randomized|Single Group Assignment||Treatment||Single|||t|||
1480294|NCT01241799|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1480295|NCT01241786||Single Group Assignment||Treatment||None (Open Label)||||||
1480296|NCT01241773|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480297|NCT01241760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480298|NCT01241747|Randomized|Parallel Assignment||Treatment||Single||||||t
1480299|NCT01241734||Single Group Assignment||Treatment||None (Open Label)||||||
1480300|NCT01241721||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480301|NCT01241708||Single Group Assignment||Treatment||None (Open Label)||||||
1480302|NCT01241695|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1480303|NCT01241682||Single Group Assignment||Treatment||None (Open Label)||||||
1480304|NCT01241669|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1480305|NCT01241656|Randomized|Parallel Assignment||Prevention||Single|||t|||
1480306|NCT01241643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480307|NCT01241630||Single Group Assignment||Treatment||None (Open Label)||||||
1480308|NCT01241617|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480309|NCT01241604||||||||||||
1480310|NCT01241591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480311|NCT01241578||Single Group Assignment||Treatment||None (Open Label)||||||
1480312|NCT01241565||Single Group Assignment||Treatment||None (Open Label)||||||
1480313|NCT01241552|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480314|NCT01241539|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1480315|NCT01241526|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1480316|NCT01241513|Non-Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1480317|NCT01241500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480318|NCT01241487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480319|NCT01241474|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1480320|NCT01241461||Single Group Assignment||Treatment||None (Open Label)||||||
1480321|NCT01241448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480322|NCT01241435||Single Group Assignment||Treatment||None (Open Label)||||||
1480323|NCT01241422|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1480324|NCT01241409|Randomized|Crossover Assignment||||None (Open Label)||||||
1480325|NCT01241396|||Case-Only|||||||||
1480326|NCT01241383||Single Group Assignment||Treatment||None (Open Label)||||||
1480327|NCT01241370|||Case Control||Prospective|||||||
1480328|NCT01241357|||||Prospective|||||||
1480329|NCT01241344|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1480330|NCT01241331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480331|NCT01241318|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480332|NCT01241305|||Cohort||Prospective|||||||
1480333|NCT01241292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480334|NCT01241279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480335|NCT01241266|||Case-Only||Prospective|||||||
1480336|NCT01241253|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1480337|NCT01241240|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480338|NCT01241227|||Cohort||Prospective|||||||
1480339|NCT01241214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480340|NCT01241201|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1480341|NCT01241188|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1480342|NCT01241175|Randomized|||Prevention||Double||||t||t
1480343|NCT01241162||Single Group Assignment||Treatment||None (Open Label)||||||
1480344|NCT01241149|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480345|NCT01241136|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480346|NCT01241123|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1480347|NCT01241110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480348|NCT01241097|Randomized|Parallel Assignment||||Triple|||t|t|t|
1480349|NCT01241084|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480350|NCT01241071|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480351|NCT01241058|||Cohort||Prospective|||||||
1480352|NCT01241045|||Ecologic or Community|||||||||
1480353|NCT01241032|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1480354|NCT01241019|Randomized|Parallel Assignment||Treatment||Single||||||t
1480355|NCT01241006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480356|NCT01240993|Randomized|Parallel Assignment||Treatment||Single||||||t
1480357|NCT01240980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480358|NCT01240967|Non-Randomized|||||None (Open Label)||||||
1480359|NCT01240954|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480360|NCT01240941||Single Group Assignment||Treatment||None (Open Label)||||||
1480361|NCT01240928||Single Group Assignment||Treatment||None (Open Label)||||||
1480362|NCT01240915|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480363|NCT01240902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480364|NCT01240889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480365|NCT01240876|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480366|NCT01240863|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480367|NCT01240850|Randomized|||Treatment||None (Open Label)||||||
1480368|NCT01240837|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1480369|NCT01240824||Single Group Assignment||||None (Open Label)||||||
1480370|NCT01240811|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1480371|NCT01240798|||Cohort||Retrospective|||||||
1480372|NCT01240785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480373|NCT01240772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480374|NCT01240759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480375|NCT01240746|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480376|NCT01240733||||||||||||
1480377|NCT01240720|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480378|NCT01240707||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480379|NCT01240694||Single Group Assignment||Treatment||None (Open Label)||||||
1480380|NCT01240681|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1480381|NCT01240668|||Case-Only||Prospective|||||||
1480382|NCT01240655||Single Group Assignment||Treatment||None (Open Label)||||||
1480383|NCT01240642||Single Group Assignment||Treatment||None (Open Label)||||||
1480384|NCT01240629||Single Group Assignment||Treatment||None (Open Label)||||||
1480385|NCT01240616|||||Prospective|||||||
1480386|NCT01240603|||||Prospective|||||||
1480387|NCT01240590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480388|NCT01240577|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480389|NCT01240551|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1480390|NCT01240538||Single Group Assignment||Treatment||None (Open Label)||||||
1480391|NCT01240525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480392|NCT01240512|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480393|NCT01240499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480394|NCT01240486|||||Prospective|||||||
1480395|NCT01240473||Single Group Assignment||Treatment||None (Open Label)||||||
1480396|NCT01240460|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480397|NCT01240447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480398|NCT01240434|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1480399|NCT01240421||||||||||||
1480400|NCT01240408|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480401|NCT01240395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480402|NCT01240382||||||||||||
1480403|NCT01240369|||Case-Only||Cross-Sectional|||||||
1480404|NCT01240356|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480405|NCT01240343|||Other||Prospective|||||||
1480406|NCT01240330||Single Group Assignment||Prevention||None (Open Label)||||||
1480407|NCT01240317|||Case-Crossover||Prospective|||||||
1480408|NCT01240304||Single Group Assignment||Treatment||None (Open Label)||||||
1480409|NCT01240291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480410|NCT01240278|||Cohort||Prospective|||||||
1480411|NCT01240265|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480412|NCT01240252|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1480413|NCT01240239|||||Prospective|||||||
1480414|NCT01240226|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480415|NCT01240213|Randomized|Parallel Assignment||||Triple|||t|t|t|
1480416|NCT01240200|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480417|NCT01240187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480418|NCT01240174||Single Group Assignment||Health Services Research||None (Open Label)||||||
1480419|NCT01240161|||Case-Only||Prospective|||||||
1480420|NCT01240148|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1480421|NCT01240135|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1480422|NCT01240122|Randomized|Factorial Assignment||Other||Triple|||t||t|t
1480423|NCT01240109|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1480424|NCT01240096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480425|NCT01240083|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480426|NCT01240070|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480427|NCT01240057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480428|NCT01240044|Randomized|Parallel Assignment||Treatment||Single|||||t|
1480429|NCT01240031|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1480430|NCT01240018|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1480431|NCT01240005||Single Group Assignment||Treatment||None (Open Label)||||||
1480432|NCT01239992||Single Group Assignment||Treatment||None (Open Label)||||||
1480433|NCT01239979|||Case Control||Cross-Sectional|||||||
1480434|NCT01239966||Single Group Assignment||Supportive Care||None (Open Label)||||||
1480435|NCT01239953|Randomized|Parallel Assignment||Treatment||Single||||||t
1480436|NCT01239940|Randomized|Parallel Assignment||Treatment||Single||||||t
1480437|NCT01239927|Randomized|Parallel Assignment||Treatment||||||||
1480438|NCT01239914|||Cohort||Retrospective|||||||
1480439|NCT01239901|||Case-Only||Cross-Sectional|||||||
1480440|NCT01239888|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480441|NCT01239875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480442|NCT01239862|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480443|NCT01239849||Single Group Assignment||Treatment||None (Open Label)||||||
1480444|NCT01239836|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1480445|NCT01239823|Randomized|Parallel Assignment||Treatment||Single||||||t
1480446|NCT01239810|||Cohort||Prospective|||||||
1480447|NCT01239797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480448|NCT01239784||Single Group Assignment||Supportive Care||None (Open Label)||||||
1480449|NCT01239771|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1480450|NCT01239758|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480451|NCT01239745|||Case Control||Prospective|||||||
1480452|NCT01239732||Single Group Assignment||Treatment||None (Open Label)||||||
1480453|NCT01239719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480454|NCT01239706||Single Group Assignment||Treatment||None (Open Label)||||||
1480455|NCT01239693|Randomized|Parallel Assignment||Prevention||Single||||||t
1480456|NCT01239680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480457|NCT01239667||Single Group Assignment||Supportive Care||None (Open Label)||||||
1480458|NCT01239654|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1480459|NCT01239641|Randomized|Parallel Assignment||Treatment||Single||||||t
1480460|NCT01239628|||Cohort||Prospective|||||||
1480461|NCT01239615|||Cohort|||||||||
1480462|NCT01239602|||Case Control||Prospective|||||||
1480463|NCT01239589|||Cohort||Retrospective|||||||
1480464|NCT01239576||||||||||||
1480465|NCT01239563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480466|NCT01239550|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1480467|NCT01239537|||Case-Only||Prospective|||||||
1480468|NCT01239524|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1480469|NCT01239511|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480470|NCT01239498|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480471|NCT01239485||Single Group Assignment||Treatment||None (Open Label)||||||
1480472|NCT01239472|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480473|NCT01239459|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1480474|NCT01239446||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480475|NCT01239433|||Case-Only||Prospective|||||||
1480476|NCT01239420|||Case Control||Prospective|||||||
1480477|NCT01239407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480478|NCT01239394||Single Group Assignment||Treatment||None (Open Label)||||||
1480479|NCT01239381||Single Group Assignment||Treatment||None (Open Label)||||||
1480480|NCT01239368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480481|NCT01239355||Single Group Assignment||Treatment||None (Open Label)||||||
1480482|NCT01239342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480483|NCT01239329|||||Cross-Sectional|||||||
1480484|NCT01239316||Single Group Assignment||Treatment||None (Open Label)||||||
1480485|NCT01239303|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1480486|NCT01239277|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1480487|NCT01239251|||Case-Only||Prospective|||||||
1480488|NCT01239238|||Cohort||Prospective|||||||
1480489|NCT01239225||Single Group Assignment||Diagnostic||||||||
1480490|NCT01239212|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480491|NCT01239199||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480492|NCT01239186|||Case-Only||Prospective|||||||
1480493|NCT01239173|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1480494|NCT01239160|Randomized|Parallel Assignment||Treatment||Single||||||t
1480495|NCT01239147|Randomized|Parallel Assignment||||None (Open Label)||||||
1480496|NCT01239134||Single Group Assignment||Treatment||None (Open Label)||||||
1480497|NCT01239121|Non-Randomized|Crossover Assignment||Health Services Research||Double|||t|||t
1480498|NCT01239108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480499|NCT01239095||Single Group Assignment||Treatment||None (Open Label)||||||
1480500|NCT01239082|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1480501|NCT01239069|Randomized|Parallel Assignment||Treatment||Single|||||t|
1480502|NCT01239056|||Case-Only||Prospective|||||||
1480503|NCT01239043|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480504|NCT01239030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480505|NCT01239017|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1480506|NCT01239004|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480507|NCT01238991|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480508|NCT01238978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480509|NCT01238965||Single Group Assignment||Treatment||None (Open Label)||||||
1480510|NCT01238952||Single Group Assignment||Treatment||None (Open Label)||||||
1480511|NCT01238939||Single Group Assignment||Treatment||None (Open Label)||||||
1480512|NCT01238926|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1480513|NCT01238913|||Case-Only||Prospective|||||||
1480514|NCT01238900|||Case-Only||Prospective|||||||
1480515|NCT01238887|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1480516|NCT01238874|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480517|NCT01238861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480518|NCT01238848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480519|NCT01238835||Single Group Assignment||Treatment||None (Open Label)||||||
1480520|NCT01238822|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1480521|NCT01238809|||Cohort||Cross-Sectional|||||||
1480522|NCT01238796|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1480523|NCT01238783|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480524|NCT01238770||Single Group Assignment||Treatment||None (Open Label)||||||
1480525|NCT01238757|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1480526|NCT01238744|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1480527|NCT01238731|||Cohort||Cross-Sectional|||||||
1480528|NCT01238718|Randomized|Parallel Assignment||||Triple|||t||t|t
1480529|NCT01238705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480530|NCT01238692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480531|NCT01238679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480532|NCT01238666|||Case-Only||Prospective|||||||
1480533|NCT01238653|||Case-Only||Prospective|||||||
1480534|NCT01238640|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1480535|NCT01238627|Randomized|Crossover Assignment||Basic Science||Single||||||t
1480536|NCT01238614|Randomized|Factorial Assignment||Screening||Single||||||t
1480537|NCT01238601|||Case-Only||Cross-Sectional|||||||
1480538|NCT01238588||Single Group Assignment||Treatment||None (Open Label)||||||
1480539|NCT01238575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480540|NCT01238562|Randomized|Crossover Assignment||||None (Open Label)||||||
1480541|NCT01238549|||Cohort||Prospective|||||||
1480542|NCT01238536|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480543|NCT01238523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480544|NCT01238510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480545|NCT01238497|||Case-Only||Prospective|||||||
1480546|NCT01238484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480547|NCT01238471|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480548|NCT01238458|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1480549|NCT01238445|||Case-Only||Prospective|||||||
1480550|NCT01238432|||Case-Control||Prospective|||||||
1480551|NCT01238419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480552|NCT01238406|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480553|NCT01238393||Single Group Assignment||Treatment||None (Open Label)||||||
1480554|NCT01238380|||||Cross-Sectional|||||||
1480555|NCT01238367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480556|NCT01238354|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1480557|NCT01238341|||Case-Only||Prospective|||||||
1480558|NCT01238328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480559|NCT01238315||Single Group Assignment||Treatment||None (Open Label)||||||
1480560|NCT01238302|Randomized|Parallel Assignment||Treatment||Single||||||t
1480561|NCT01238289|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1480562|NCT01238276||||||||||||
1480563|NCT01238263|||Case Control||Prospective|||||||
1480564|NCT01238250|||Family-Based||Prospective|||||||
1480565|NCT01238237||Single Group Assignment||Treatment||None (Open Label)||||||
1480566|NCT01238224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480567|NCT01238211||Single Group Assignment||Treatment||None (Open Label)||||||
1480568|NCT01238185||||Treatment||None (Open Label)||||||
1480569|NCT01238172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480570|NCT01238159||Single Group Assignment||Treatment||None (Open Label)||||||
1480571|NCT01238146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480572|NCT01238133||Single Group Assignment||Treatment||None (Open Label)||||||
1480573|NCT01238120|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1480574|NCT01238107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480575|NCT01238094|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480576|NCT01238081|||||Prospective|||||||
1480577|NCT01238068|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1480578|NCT01238055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480579|NCT01238042||Single Group Assignment||Treatment||None (Open Label)||||||
1480580|NCT01238029||Single Group Assignment||Treatment||None (Open Label)||||||
1480581|NCT01238016||Single Group Assignment||Basic Science||None (Open Label)||||||
1480582|NCT01238003|||Cohort||Retrospective|||||||
1480583|NCT01237990|||Case-Only||Prospective|||||||
1480584|NCT01237977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480585|NCT01237964|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480586|NCT01237951||Single Group Assignment||Treatment||None (Open Label)||||||
1480587|NCT01237938||Single Group Assignment||Prevention||None (Open Label)||||||
1480588|NCT01237925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480589|NCT01237912|||Case Control||Cross-Sectional|||||||
1480590|NCT01237899|Randomized|Crossover Assignment||||Double|||t||t|
1480591|NCT01237886|||Cohort||Prospective|||||||
1480592|NCT01237873||Single Group Assignment||Treatment||None (Open Label)||||||
1480593|NCT01237860|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1480594|NCT01237847|Randomized|Factorial Assignment||Treatment||Single||||||t
1480595|NCT01237834|||||Cross-Sectional|||||||
1480596|NCT01237821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480597|NCT01237808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480598|NCT01237795|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1480599|NCT01237782|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1480600|NCT01237769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480601|NCT01237756||Single Group Assignment||Diagnostic||Single||||t||
1480602|NCT01237743|||Case-Only||Prospective|||||||
1480603|NCT01237730|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480604|NCT01237717|||Case-Only||Cross-Sectional|||||||
1480605|NCT01237704|Randomized|Parallel Assignment||Treatment||Single||||||t
1480606|NCT01237691|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1480607|NCT01237678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480608|NCT01237665|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480609|NCT01237652|||Cohort||Prospective|||||||
1480610|NCT01237639|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480611|NCT01237626|||Cohort||Prospective|||||||
1480612|NCT01237613||Single Group Assignment||Treatment||None (Open Label)||||||
1480613|NCT01237600||Single Group Assignment||Treatment||None (Open Label)||||||
1480614|NCT01237587|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480615|NCT01237574|||Cohort||Prospective|||||||
1480616|NCT01237561|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1480617|NCT01237548|||Case Control||Prospective|||||||
1480618|NCT01237535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480619|NCT01237522|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1480620|NCT01237509|||Cohort||Prospective|||||||
1480621|NCT01237496|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480622|NCT01237483||Single Group Assignment||Treatment||None (Open Label)||||||
1480623|NCT01237470|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480624|NCT01237457||Single Group Assignment||Treatment||None (Open Label)||||||
1480625|NCT01237444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480626|NCT01237431|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1480627|NCT01237418|||Cohort||Prospective|||||||
1480628|NCT01237405|||Cohort||Cross-Sectional|||||||
1480629|NCT01237392|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480630|NCT01237379|||Case-Crossover||Retrospective|||||||
1480631|NCT01237366|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480632|NCT01237353||Single Group Assignment||Treatment||None (Open Label)||||||
1480633|NCT01237340||Single Group Assignment||Treatment||None (Open Label)||||||
1480634|NCT01237327||Parallel Assignment||Treatment||None (Open Label)||||||
1480635|NCT01237314|||Case Control||Prospective|||||||
1480636|NCT01237301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480637|NCT01237288|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480638|NCT01237275||Single Group Assignment||Treatment||Triple|||t||t|t
1480639|NCT01237262||Single Group Assignment||Basic Science||None (Open Label)||||||
1480640|NCT01237249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480641|NCT01237236||Single Group Assignment||Treatment||None (Open Label)||||||
1480642|NCT01237223|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1480643|NCT01237210|||Other||Prospective|||||||
1480644|NCT01237197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480645|NCT01237184|||Cohort||Prospective|||||||
1480646|NCT01237171|||Cohort||Prospective|||||||
1480647|NCT01237158|||Case Control||Cross-Sectional|||||||
1480648|NCT01237145|||Case-Control||Prospective|||||||
1480649|NCT01237132|||Cohort||Retrospective|||||||
1480650|NCT01237119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480651|NCT01237106||Single Group Assignment||Treatment||None (Open Label)||||||
1480652|NCT01237093|||Ecologic or Community||Prospective|||||||
1480653|NCT01237080|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480654|NCT01237067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480655|NCT01237054||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480656|NCT01237041|Randomized|Crossover Assignment||Diagnostic||Quadruple|Masking only during the two arms of the randomized trial portion of the study, not during the dose-finding arms.|First, we conducted dose-establishing studies using 250mg every 2 hours x 3 doses (2 subjects), 500mg every two hours x 3 doses (5 subjects), and 500mg hourly x 4 doses (5 subjects). This dose-establishing study was followed by the randomized crossover trial using 500mg hourly x 4 doses in conjunction with growth hormone stimulation testing. The RCT was terminated early because of inability to obtain necessary study medications.|t|t|t|t
1480657|NCT01237028|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1480658|NCT01237015|Randomized|Single Group Assignment||||None (Open Label)||||||
1480659|NCT01237002|||Cohort||Retrospective|||||||
1480660|NCT01236989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480661|NCT01236976|Randomized|Parallel Assignment||Treatment||Single||||||t
1480662|NCT01236963|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480663|NCT01236950|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480664|NCT01236937|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1480665|NCT01236924||||Treatment||||||||
1480666|NCT01236911|||Cohort||Prospective|||||||
1480667|NCT01236898|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480668|NCT01236885||Single Group Assignment||Supportive Care||None (Open Label)||||||
1480669|NCT01236872|Randomized|Crossover Assignment||||Single||||||t
1480670|NCT01236859|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480671|NCT01236846|Randomized|Parallel Assignment||||Double|||t|||t
1480672|NCT01236833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480673|NCT01236820|||Case Control||Cross-Sectional|||||||
1480674|NCT01236807|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1480675|NCT01236794||Single Group Assignment||Prevention||None (Open Label)||||||
1480676|NCT01236781|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1480677|NCT01236768|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480678|NCT01236755||Single Group Assignment||Treatment||Single||||||t
1480679|NCT01236742|Randomized|Parallel Assignment||Treatment||Single||||||t
1480680|NCT01236729|||Cohort||Cross-Sectional|||||||
1480681|NCT01236716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480682|NCT01236703|||Cohort||Retrospective|||||||
1480683|NCT01236690|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480684|NCT01236677|||Cohort||Prospective|||||||
1480685|NCT01236664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480686|NCT01236651|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1480687|NCT01236638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480688|NCT01236625|||Cohort||Prospective|||||||
1480689|NCT01236612|Randomized|Parallel Assignment||Basic Science||Single||||||t
1480690|NCT01236599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480691|NCT01236586|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480692|NCT01236573|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480693|NCT01236560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480694|NCT01236547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480695|NCT01236534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480696|NCT01236521|Randomized|Parallel Assignment||Treatment||Single||||||t
1480697|NCT01236508||Single Group Assignment||Screening||None (Open Label)||||||
1480698|NCT01236495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480699|NCT01236482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480700|NCT01236469|||Cohort||Prospective|||||||
1480701|NCT01236456|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480702|NCT01236443||Single Group Assignment||Treatment||None (Open Label)||||||
1480703|NCT01236430|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480704|NCT01236417||Single Group Assignment||Prevention||None (Open Label)||||||
1480705|NCT01236404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480706|NCT01236391||Single Group Assignment||Treatment||None (Open Label)||||||
1480707|NCT01236378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480708|NCT01236365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480709|NCT01236352|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480710|NCT01236339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480711|NCT01236326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480712|NCT01236313|||Cohort||Prospective|||||||
1480713|NCT01236300||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480714|NCT01236287||||||||||||
1480715|NCT01236274|||||Retrospective|||||||
1480716|NCT01236261|||Case-Only||Prospective|||||||
1480717|NCT01236248|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480718|NCT01236235|||Cohort|||||||||
1480719|NCT01236222|Randomized|Parallel Assignment||Prevention||Single|||||t|
1480720|NCT01236209|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480721|NCT01236196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480722|NCT01236183|||||Prospective|||||||
1480723|NCT01236170|||Cohort||Cross-Sectional|||||||
1480724|NCT01236157|||Cohort||Prospective|||||||
1480725|NCT01236144|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480726|NCT01236131|||||Cross-Sectional|||||||
1480727|NCT01236118|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480728|NCT01236105|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1480729|NCT01236092|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1480730|NCT01236079|Randomized|Parallel Assignment||Prevention||Single|||t|||
1480731|NCT01236066|||Ecologic or Community||Retrospective|||||||
1480732|NCT01236053|||Case-Control||Retrospective|||||||
1480733|NCT01236040|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1480734|NCT01236027|||Case-Only||Cross-Sectional|||||||
1480735|NCT01236014|||Other||Retrospective|||||||
1480736|NCT01236001|||Cohort||Prospective|||||||
1480737|NCT01235988|||Other||Retrospective|||||||
1480738|NCT01235975|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480739|NCT01235962|Randomized|||Treatment||Quadruple|||t|t|t|t
1480740|NCT01235949|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1480741|NCT01235936||Single Group Assignment||Treatment||None (Open Label)||||||
1480742|NCT01235923|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480743|NCT01235910||Single Group Assignment||Treatment||None (Open Label)||||||
1480744|NCT01235897|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480745|NCT01235884|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1480746|NCT01235871|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1480747|NCT01235858|Randomized|Parallel Assignment||Prevention||Single||||||t
1480748|NCT01235845||Single Group Assignment||Treatment||None (Open Label)||||||
1480749|NCT01235832|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1480750|NCT01235819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480751|NCT01235806||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480752|NCT01235793||Single Group Assignment||Treatment||None (Open Label)||||||
1480753|NCT01235780|||Case Control||Retrospective|||||||
1480754|NCT01235767|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480755|NCT01235754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480756|NCT01235741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480757|NCT01235728|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1481066|NCT01231672|||Cohort||Prospective|||||||
1480758|NCT01235715|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1480759|NCT01235702|Randomized|Single Group Assignment||Treatment||Single|||t|||
1480760|NCT01235689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480761|NCT01235676|Randomized|Parallel Assignment||Prevention||Single||||||t
1480762|NCT01235663|Randomized|Parallel Assignment||Prevention||Single||||||t
1480763|NCT01235650|||Case-Only||Retrospective|||||||
1480764|NCT01235637|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480765|NCT01235624||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480766|NCT01235598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480767|NCT01235585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480768|NCT01235572||Single Group Assignment||Health Services Research||None (Open Label)||||||
1480769|NCT01235559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480770|NCT01235546|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480771|NCT01235533|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480772|NCT01235520|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480773|NCT01235507|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480774|NCT01235494||Single Group Assignment||Other||None (Open Label)||||||
1480775|NCT01235481|Randomized|Parallel Assignment||Treatment||Single||||||t
1480776|NCT01235468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480777|NCT01235455|||Cohort||Prospective|||||||
1480778|NCT01235442|Randomized|Parallel Assignment||Treatment||Single||||||t
1480779|NCT01235429|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1480780|NCT01235416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480781|NCT01235403||Single Group Assignment||Treatment||None (Open Label)||||||
1480782|NCT01235390|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1480783|NCT01235377|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1480784|NCT01235364|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480785|NCT01235351|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1480786|NCT01235338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480787|NCT01235325|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1480788|NCT01235312|||Cohort||Prospective|||||||
1480789|NCT01235299|||Cohort||Prospective|||||||
1480790|NCT01235286||Single Group Assignment||Basic Science||Single|||t|||
1480791|NCT01235273|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480792|NCT01235260|||Cohort||Retrospective|||||||
1480793|NCT01235247||||Health Services Research||||||||
1480794|NCT01235234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480795|NCT01235221||Single Group Assignment||Treatment||None (Open Label)||||||
1480796|NCT01235208||Single Group Assignment||Health Services Research||None (Open Label)||||||
1480797|NCT01235195|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1480798|NCT01235182|||Cohort||Prospective|||||||
1480799|NCT01235169||Single Group Assignment||Treatment||||||||
1480800|NCT01235156|||Case Control||Cross-Sectional|||||||
1480801|NCT01235143|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1480802|NCT01235130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480803|NCT01235117|Non-Randomized|||Treatment||||||||
1480804|NCT01235104|||Cohort||Retrospective|||||||
1480805|NCT01235091|Randomized|Parallel Assignment||Prevention||||||||
1480806|NCT01235078|||Case-Only||Prospective|||||||
1480807|NCT01235065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480808|NCT01235052||Single Group Assignment||Health Services Research||None (Open Label)||||||
1480809|NCT01235039|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1480810|NCT01235026|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1480811|NCT01235013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480812|NCT01235000|||Cohort||Prospective|||||||
1480813|NCT01234987|||Case Control||Cross-Sectional|||||||
1480814|NCT01234974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480815|NCT01234961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480816|NCT01234948|||Case Control||Cross-Sectional|||||||
1480817|NCT01234935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480818|NCT01234922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480819|NCT01234909|||Cohort||Prospective|||||||
1480820|NCT01234896|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1480821|NCT01234883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480822|NCT01234870||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480823|NCT01234857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480824|NCT01234844||Single Group Assignment||Supportive Care||None (Open Label)||||||
1480825|NCT01234831|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1480826|NCT01234818||Single Group Assignment||Treatment||None (Open Label)||||||
1480827|NCT01234805||Single Group Assignment||Supportive Care||None (Open Label)||||||
1480828|NCT01234792|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1480829|NCT01234779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480830|NCT01234766||Single Group Assignment||Treatment||None (Open Label)||||||
1480831|NCT01234753|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1480832|NCT01234740||Single Group Assignment||Treatment||None (Open Label)||||||
1480833|NCT01234727|||Cohort||Prospective|||||||
1480834|NCT01234714|||Cohort||Retrospective|||||||
1480835|NCT01234701|||Cohort||Retrospective|||||||
1480836|NCT01234688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480837|NCT01234675|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1480838|NCT01234662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480839|NCT01234649|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1480840|NCT01234636|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1480841|NCT01234623|||Cohort||Prospective|||||||
1480842|NCT01234610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480843|NCT01234597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480844|NCT01234584|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1480845|NCT01234571|||Case-Only||Prospective|||||||
1480846|NCT01234558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480847|NCT01234545|||Cohort||Prospective|||||||
1480848|NCT01234532||Single Group Assignment||Treatment||None (Open Label)|no masking|no masking||||
1480849|NCT01234519|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Phase 1 : conventional 3+3 design. Phase 2: Simon's two-stage design will be utilized. In Stage I, 22 patients will be treated with the dose determined in Phase I. The study will be terminated for futility if no more than 2 patients out of the 22 patients in Stage I are responders. If 3 or more responders are observed, an additional 18 patients will be enrolled. If at least 8 out of the 40 patients are responders, the treatment will be considered worthy of further development.||||
1480850|NCT01234506|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480851|NCT01234493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480852|NCT01234480||||||||||||
1480853|NCT01234467||Single Group Assignment||Treatment||None (Open Label)||||||
1480854|NCT01234454|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1480855|NCT01234441|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1480856|NCT01234428||Single Group Assignment||Treatment||None (Open Label)||||||
1480857|NCT01234415||Parallel Assignment||Treatment||None (Open Label)||||||
1480858|NCT01234402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480859|NCT01234389|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1480860|NCT01234376|||||Prospective|||||||
1480861|NCT01234363||Single Group Assignment||Diagnostic||None (Open Label)||||||
1480862|NCT01234350|||Cohort||Prospective|||||||
1480863|NCT01234337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480864|NCT01234324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480865|NCT01234311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480866|NCT01234298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480867|NCT01234285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480868|NCT01234272|Randomized|Parallel Assignment||Treatment||Single||||||t
1480869|NCT01234259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480870|NCT01234246|||Cohort||Prospective|||||||
1480871|NCT01234233|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1480872|NCT01234220|||Cohort||Retrospective|||||||
1480873|NCT01234207|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1480874|NCT01234194|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1480875|NCT01234181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480876|NCT01234168|||Cohort||Cross-Sectional|||||||
1480877|NCT01234155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480878|NCT01234142|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1480879|NCT01234129|||Case Control||Prospective|||||||
1480880|NCT01234116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480881|NCT01234103|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480882|NCT01234090|||Cohort||Prospective|||||||
1480883|NCT01234077|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1480884|NCT01234064|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1480885|NCT01234051||Single Group Assignment||Treatment||None (Open Label)||||||
1480886|NCT01234038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480887|NCT01234025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480888|NCT01234012||Single Group Assignment||Treatment||None (Open Label)||||||
1480889|NCT01233999||Single Group Assignment||Treatment||Triple|||t|t||t
1480890|NCT01233986|||Case Control||Prospective|||||||
1480891|NCT01233973|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1480892|NCT01233960||Single Group Assignment||Treatment||None (Open Label)||||||
1480893|NCT01233947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480894|NCT01233934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480895|NCT01233921|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480896|NCT01233908|||Case Control||Prospective|||||||
1480897|NCT01233895|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480898|NCT01233882|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480899|NCT01233869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480900|NCT01233843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480901|NCT01233830|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1480902|NCT01233817||Single Group Assignment||Treatment||None (Open Label)||||||
1480903|NCT01233804|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480904|NCT01233791|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480905|NCT01233778|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1480906|NCT01233765|||Case-Control||Prospective|||||||
1480907|NCT01233752|||Cohort||Prospective|||||||
1481143|NCT01230658|||Cohort||Prospective|||||||
1480908|NCT01233739|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480909|NCT01233726|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480910|NCT01233713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480911|NCT01233700|Randomized|Parallel Assignment||Prevention||Single||||||t
1480912|NCT01233687||Single Group Assignment||Treatment||None (Open Label)||||||
1480913|NCT01233674|||||Prospective|||||||
1480914|NCT01233661|Randomized|Parallel Assignment||||Double||||t|t|
1480915|NCT01233648|Randomized|Parallel Assignment||||None (Open Label)||||||
1480916|NCT01233635|Randomized|Parallel Assignment||||None (Open Label)||||||
1480917|NCT01233622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480918|NCT01233609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480919|NCT01233596|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480920|NCT01233583|||Case Control||Prospective|||||||
1480921|NCT01233570||Single Group Assignment||Treatment||None (Open Label)||||||
1480922|NCT01233557|||Case-Only||Prospective|||||||
1480923|NCT01233544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480924|NCT01233531|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1480925|NCT01233518||Single Group Assignment||Diagnostic||Triple|||t|t|t|
1480926|NCT01233505||Single Group Assignment||Treatment||None (Open Label)||||||
1480927|NCT01233492||||Treatment||None (Open Label)||||||
1480928|NCT01233479||||Basic Science||None (Open Label)||||||
1480929|NCT01233453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480930|NCT01233440|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480931|NCT01233427|||Cohort||Prospective|||||||
1480932|NCT01233414|Randomized|Parallel Assignment||Treatment||Single||||||t
1480933|NCT01233401|||Case-Only||Cross-Sectional|||||||
1480934|NCT01233388|||||Prospective|||||||
1480935|NCT01233375|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480936|NCT01233362|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1480937|NCT01233349|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480938|NCT01233336|||Cohort||Prospective|||||||
1480939|NCT01233323|||Case-Only||Prospective|||||||
1480940|NCT01233310|||Cohort||Prospective|||||||
1480941|NCT01233297|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1480942|NCT01233284|Randomized|Crossover Assignment||Treatment||Double||||||
1480943|NCT01233271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480944|NCT01233258|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480945|NCT01233245|||Cohort||Prospective|||||||
1480946|NCT01233232|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1480947|NCT01233219|||Cohort||Prospective|||||||
1480948|NCT01233206|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480949|NCT01233193|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1480950|NCT01233180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480951|NCT01233167|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480952|NCT01233154|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1480953|NCT01233141|||Cohort||Prospective|||||||
1480954|NCT01233128|||Cohort||Retrospective|||||||
1480955|NCT01233115|||Cohort||Retrospective|||||||
1480956|NCT01233102|Randomized|Parallel Assignment||Treatment||Single|||t|||
1480957|NCT01233089|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1480958|NCT01233076|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1480959|NCT01233063|Randomized|Parallel Assignment||Prevention||Single||||||t
1480960|NCT01233050|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1480961|NCT01233037|||Case Control||Prospective|||||||
1480962|NCT01233024|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1480963|NCT01233011|||Case-Only||Prospective|||||||
1480964|NCT01232998|||Cohort||Prospective|||||||
1480965|NCT01232985||Single Group Assignment||Treatment||None (Open Label)||||||
1480966|NCT01232972||Single Group Assignment||Supportive Care||None (Open Label)||||||
1480967|NCT01232959||Single Group Assignment||Treatment||None (Open Label)||||||
1480968|NCT01232946|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1480969|NCT01232933|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1480970|NCT01232920|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1480971|NCT01232907|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480972|NCT01232894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480973|NCT01232881|||||Prospective|||||||
1480974|NCT01232868|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1480975|NCT01232855|||Cohort||Prospective|||||||
1480976|NCT01232842|||Case-Only||Retrospective|||||||
1480977|NCT01232829||Single Group Assignment||Treatment||None (Open Label)||||||
1480978|NCT01232816|||Cohort||Prospective|||||||
1480979|NCT01232803|Randomized|Parallel Assignment||||Single|||t|||
1480980|NCT01232790|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1480981|NCT01232777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480982|NCT01232764|Randomized|||Health Services Research||Single||||||t
1480983|NCT01232751|Randomized|Crossover Assignment||||Triple|||t||t|t
1480984|NCT01232738||Single Group Assignment||Treatment||None (Open Label)||||||
1480985|NCT01232725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1480986|NCT01232712|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480987|NCT01232699|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480988|NCT01232686|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1480989|NCT01232673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480990|NCT01232660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480991|NCT01232647|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1480992|NCT01232634|||Case-Only||Prospective|||||||
1480993|NCT01232621|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1480994|NCT01232608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480995|NCT01232595|Randomized|Parallel Assignment||Treatment||Single||||||t
1480996|NCT01232582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1480997|NCT01232569|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1480998|NCT01232556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1480999|NCT01232543||Single Group Assignment||Treatment||None (Open Label)||||||
1481000|NCT01232530|||Cohort||Prospective|||||||
1481001|NCT01232517|||||Prospective|||||||
1481002|NCT01232504|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481003|NCT01232491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481004|NCT01232478|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1481005|NCT01232465|||Case Control||Cross-Sectional|||||||
1481006|NCT01232452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481007|NCT01232439||Single Group Assignment||Basic Science||None (Open Label)||||||
1481008|NCT01232426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481009|NCT01232413|Randomized|Crossover Assignment||||Triple|||t||t|t
1481010|NCT01232400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481011|NCT01232387|||Case Control||Cross-Sectional|||||||
1481012|NCT01232374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481013|NCT01232361|||Cohort||Prospective|||||||
1481014|NCT01232348|||Cohort||Prospective|||||||
1481015|NCT01232335|||Cohort||Prospective|||||||
1481016|NCT01232322|||Cohort||Prospective|||||||
1481017|NCT01232309|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481018|NCT01232296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481019|NCT01232283|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481020|NCT01232270|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1481021|NCT01232257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481022|NCT01232244||||||||||||
1481023|NCT01232231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481024|NCT01232218|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1481025|NCT01232205|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1481026|NCT01232192|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1481027|NCT01232179|Randomized|||Treatment||Double|||t||t|
1481028|NCT01232166|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1481029|NCT01232153|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481030|NCT01232140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481031|NCT01232127|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1481032|NCT01232114|||Case Control||Prospective|||||||
1481033|NCT01232101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481034|NCT01232088|||Cohort||Prospective|||||||
1481035|NCT01232075|Randomized|Parallel Assignment||Treatment||Single||||||t
1481036|NCT01232062|||Cohort||Retrospective|||||||
1481037|NCT01232049|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1481038|NCT01232036|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1481039|NCT01232023|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481040|NCT01232010|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481041|NCT01231997|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481042|NCT01231984|Randomized|Crossover Assignment||||None (Open Label)||||||
1481043|NCT01231971|||Case-Control||Prospective|||||||
1481044|NCT01231958|||Cohort||Prospective|||||||
1481045|NCT01231945|||||Prospective|||||||
1481046|NCT01231932|||Cohort||Prospective|||||||
1481047|NCT01231919||Single Group Assignment||Treatment||None (Open Label)||||||
1481048|NCT01231906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481049|NCT01231893|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481050|NCT01231880|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481051|NCT01231867|||Cohort||Retrospective|||||||
1481052|NCT01231854|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481053|NCT01231841||Single Group Assignment||Treatment||None (Open Label)||||||
1481054|NCT01231828|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1481055|NCT01231815|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1481056|NCT01231802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481057|NCT01231789|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1481058|NCT01231776|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1481059|NCT01231763|||Cohort||Cross-Sectional|||||||
1481060|NCT01231750|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1481061|NCT01231737|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481062|NCT01231724|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1481063|NCT01231711||Single Group Assignment||Prevention||None (Open Label)||||||
1481064|NCT01231698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481065|NCT01231685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481067|NCT01231659|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481068|NCT01231646|||Case Control||Cross-Sectional|||||||
1481069|NCT01231633|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481070|NCT01231620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481071|NCT01231607|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481072|NCT01231594|Non-Randomized|||Treatment||None (Open Label)||||||
1481073|NCT01231581|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1481074|NCT01231568|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1481075|NCT01231555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481076|NCT01231542|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481077|NCT01231529||Single Group Assignment||Basic Science||None (Open Label)||||||
1481078|NCT01231516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481079|NCT01231503|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481080|NCT01231490|Randomized|Crossover Assignment||||Double|||t||t|
1481081|NCT01231477|||Case Control||Prospective|||||||
1481082|NCT01231464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481083|NCT01231451||Single Group Assignment||Prevention||None (Open Label)||||||
1481084|NCT01231438|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481085|NCT01231425|||Cohort||Prospective|||||||
1481086|NCT01231412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481087|NCT01231399||Single Group Assignment||Treatment||None (Open Label)||||||
1481088|NCT01231386|||Cohort||Other|||||||
1481089|NCT01231373|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1481090|NCT01231360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481091|NCT01231347|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481092|NCT01231334|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481093|NCT01231321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481094|NCT01231308|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481095|NCT01231295|||Cohort||Prospective|||||||
1481096|NCT01231282||Single Group Assignment||||None (Open Label)||||||
1481097|NCT01231269||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481098|NCT01231256|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1481099|NCT01231243|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1481100|NCT01231230|Randomized|Crossover Assignment||||Double|||t||t|
1481101|NCT01231217|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481102|NCT01231204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481103|NCT01231191|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1481104|NCT01231178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481105|NCT01231165|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481106|NCT01231152|||Case-Only||Prospective|||||||
1481107|NCT01231139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481108|NCT01231126|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481109|NCT01231113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481110|NCT01231100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481111|NCT01231087|||Cohort||Prospective|||||||
1481112|NCT01231074|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481113|NCT01231061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481114|NCT01231035|||Cohort||Prospective|||||||
1481115|NCT01231022|||Cohort||Cross-Sectional|||||||
1481116|NCT01231009|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1481117|NCT01230996||Single Group Assignment||Treatment||None (Open Label)||||||
1481118|NCT01230983|Non-Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1481119|NCT01230970|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1481120|NCT01230957|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481121|NCT01230944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481122|NCT01230931|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481123|NCT01230918||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481124|NCT01230905||Single Group Assignment||Screening||None (Open Label)||||||
1481125|NCT01230892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481126|NCT01230879|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1481127|NCT01230866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481128|NCT01230853|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1481129|NCT01230840|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1481130|NCT01230827|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481131|NCT01230814|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1481132|NCT01230801||Single Group Assignment||Treatment||None (Open Label)||||||
1481133|NCT01230788||Single Group Assignment||Treatment||None (Open Label)||||||
1481134|NCT01230775|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1481135|NCT01230762|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481136|NCT01230749|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481137|NCT01230736||Single Group Assignment||Treatment||None (Open Label)||||||
1481138|NCT01230723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481139|NCT01230710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481140|NCT01230697|||Cohort||Prospective|||||||
1481141|NCT01230684||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481142|NCT01230671|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1481144|NCT01230645|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481145|NCT01230632|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1481146|NCT01230619|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481147|NCT01230606|||Case Control||Prospective|||||||
1481148|NCT01230593|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481149|NCT01230580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481150|NCT01230567|||Case Control||Prospective|||||||
1481151|NCT01230554||Single Group Assignment||||None (Open Label)||||||
1481152|NCT01230541|Randomized|Parallel Assignment||||Triple|||t||t|t
1481153|NCT01230528|||Case-Only||Retrospective|||||||
1481154|NCT01230515|||Cohort||Prospective|||||||
1481155|NCT01230502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481156|NCT01230489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481157|NCT01230476||Single Group Assignment||Treatment||None (Open Label)||||||
1481158|NCT01230463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481159|NCT01230450|Randomized|Parallel Assignment||Treatment||Single||||||t
1481160|NCT01230437|||||Prospective|||||||
1481161|NCT01230424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481162|NCT01230411|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481163|NCT01230398||||||||||||
1481164|NCT01230385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481165|NCT01230359|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481166|NCT01230346|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481167|NCT01230320|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1481168|NCT01230307|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1481169|NCT01230294|||Case Control||Prospective|||||||
1481170|NCT01230281|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1481171|NCT01230268|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1481172|NCT01230255|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481173|NCT01230242||Single Group Assignment||Treatment||None (Open Label)||||||
1481174|NCT01230229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481175|NCT01230216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481176|NCT01230203||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481177|NCT01230190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481178|NCT01230177|||Case-Only||Prospective|||||||
1481179|NCT01230164|||||Prospective|||||||
1481180|NCT01230151|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1481181|NCT01230138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481182|NCT01230125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481183|NCT01230112|||||Prospective|||||||
1481184|NCT01230099|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1481185|NCT01230086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481186|NCT01230073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481187|NCT01230060||Single Group Assignment||Treatment||None (Open Label)||||||
1481188|NCT01230047|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481189|NCT01230034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481190|NCT01230021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481191|NCT01230008|||Case Control||Prospective|||||||
1481192|NCT01229995|Randomized|||||||||||
1481193|NCT01229982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481194|NCT01229969|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1481195|NCT01229956|||Case-Only||Retrospective|||||||
1481196|NCT01229943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481197|NCT01229930|Randomized|||Treatment||Double||||||
1481198|NCT01229917||||||||||||
1481199|NCT01229904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481200|NCT01229891|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1481201|NCT01229878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481202|NCT01229865|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481203|NCT01229852||Single Group Assignment||Treatment||None (Open Label)||||||
1481204|NCT01229839|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1481205|NCT01229826|||Cohort||Prospective|||||||
1481206|NCT01229813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481207|NCT01229800|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1481208|NCT01229787|||||Cross-Sectional|||||||
1481209|NCT01229774|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481210|NCT01229761|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1481211|NCT01229748|Randomized|Factorial Assignment||Treatment||Single||||||t
1481212|NCT01229735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481213|NCT01229722|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481214|NCT01229709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481215|NCT01229696|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481216|NCT01229683|||Case-Only||Prospective|||||||
1481217|NCT01229670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481218|NCT01229657|||Cohort||Retrospective|||||||
1481219|NCT01229644|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481220|NCT01229631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481221|NCT01229618|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1481222|NCT01229605||Single Group Assignment||Treatment||None (Open Label)||||||
1481223|NCT01229592|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481224|NCT01229579|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1481225|NCT01229566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481226|NCT01229553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481227|NCT01229540||||||||||||
1481228|NCT01229527|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1481229|NCT01229514|||Case Control||Prospective|||||||
1481230|NCT01229501|||Cohort||Prospective|||||||
1481231|NCT01229488||Single Group Assignment||Basic Science||Single|||t|||
1481232|NCT01229475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481233|NCT01229462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481234|NCT01229449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481235|NCT01229436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481236|NCT01229423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481237|NCT01229410|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1481238|NCT01229397|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481239|NCT01229384|Randomized|Single Group Assignment||Treatment||Single||||t||
1481240|NCT01229371|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1481241|NCT01229358|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481242|NCT01229345|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1481243|NCT01229332|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1481244|NCT01229319|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481245|NCT01229306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481246|NCT01229293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481247|NCT01229280|Randomized|Crossover Assignment||||None (Open Label)||||||
1481248|NCT01229267|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1481249|NCT01229254|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481250|NCT01229241|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1481251|NCT01229228|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481252|NCT01229215|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481253|NCT01229202|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481254|NCT01229189|Randomized|Single Group Assignment||Health Services Research||Quadruple|||t|t|t|t
1481255|NCT01229176|Randomized|Parallel Assignment||Prevention||Single|||t|||
1481256|NCT01229163|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1481257|NCT01229150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481258|NCT01229137|||Case-Only||Prospective|||||||
1481259|NCT01229124|||Case-Only||Retrospective|||||||
1481260|NCT01229111||Single Group Assignment||Treatment||None (Open Label)||||||
1481261|NCT01229098||Single Group Assignment||Treatment||None (Open Label)||||||
1481262|NCT01229085|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481263|NCT01229072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481264|NCT01229059|||Other||Prospective|||||||
1481265|NCT01229046||Single Group Assignment||||None (Open Label)||||||
1481266|NCT01229033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481267|NCT01229020|||Cohort||Prospective|||||||
1481268|NCT01229007||Single Group Assignment||Treatment||None (Open Label)||||||
1481269|NCT01228994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481270|NCT01228981|||Cohort||Prospective|||||||
1481271|NCT01228968|||Case-Only||Cross-Sectional|||||||
1481272|NCT01228955|||Cohort||Prospective|||||||
1481273|NCT01228942|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1481274|NCT01228929|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1481275|NCT01228916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481276|NCT01228903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481277|NCT01228890|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481278|NCT01228877||Single Group Assignment||Other||None (Open Label)||||||
1481279|NCT01228864|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481280|NCT01228851||Single Group Assignment||Treatment||None (Open Label)||||||
1481281|NCT01228838|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481282|NCT01228825|||||Prospective|||||||
1481283|NCT01228812|||Case-Control||Cross-Sectional|||||||
1481284|NCT01228799|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481285|NCT01228786|||Case Control||Cross-Sectional|||||||
1481286|NCT01228773|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481287|NCT01228760|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481288|NCT01228747|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481289|NCT01228734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481290|NCT01228721|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1481291|NCT01228708|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1481292|NCT01228695|||Case-Only||Prospective|||||||
1481293|NCT01228682|||Cohort||Prospective|||||||
1481294|NCT01228669|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1481295|NCT01228656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481296|NCT01228643|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1481297|NCT01228630|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481298|NCT01228617|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1481299|NCT01228604||Single Group Assignment||Treatment||None (Open Label)||||||
1481300|NCT01228591|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481301|NCT01228578|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1481302|NCT01228565|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481303|NCT01228552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481304|NCT01228539|Randomized|Parallel Assignment||Treatment||Single||||||t
1481305|NCT01228526|||Case-Only||Prospective|||||||
1481306|NCT01228513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481307|NCT01228500||Single Group Assignment||Treatment||Double|||t||t|
1481308|NCT01228487|||||Prospective|||||||
1481309|NCT01228474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481310|NCT01228461|||Cohort||Retrospective|||||||
1481311|NCT01228448||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481312|NCT01228435|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481313|NCT01228422|||||Prospective|||||||
1481314|NCT01228409||Single Group Assignment||Treatment||None (Open Label)||||||
1481315|NCT01228396|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1481316|NCT01228383|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481317|NCT01228370||Single Group Assignment||Treatment||None (Open Label)||||||
1481318|NCT01228357|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481319|NCT01228344|||Other||Other|||||||
1481320|NCT01228331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481321|NCT01228318|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481322|NCT01228305|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1481323|NCT01228292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481324|NCT01228279|Randomized|Parallel Assignment||Treatment||Single||||||t
1481325|NCT01228266|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1481326|NCT01228253|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1481327|NCT01228240||||||||||||
1481328|NCT01228227|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481329|NCT01228214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481330|NCT01228201|Randomized|Parallel Assignment||Treatment||Single||||||t
1481331|NCT01228188||Single Group Assignment||Treatment||None (Open Label)||||||
1481332|NCT01228175|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1481333|NCT01228162|Randomized|Parallel Assignment||Treatment||Single||||||t
1481334|NCT01228149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481335|NCT01228136|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481336|NCT01228123|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1481337|NCT01228110|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481338|NCT01228097|||Cohort||Prospective|||||||
1481339|NCT01228084||Single Group Assignment||Treatment||None (Open Label)||||||
1481340|NCT01228071||Single Group Assignment||Treatment||None (Open Label)||||||
1481341|NCT01228058|||Case-Only||Prospective|||||||
1481342|NCT01228045||Single Group Assignment||Treatment||None (Open Label)||||||
1481343|NCT01228032|Randomized|Parallel Assignment||Treatment||Single||||||t
1481344|NCT01228019|||Case-Only||Prospective|||||||
1481345|NCT01228006|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481346|NCT01227993||Single Group Assignment||Treatment||None (Open Label)||||||
1481347|NCT01227980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481348|NCT01227967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481349|NCT01227954||Single Group Assignment||Treatment||None (Open Label)||||||
1481350|NCT01227941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481351|NCT01227928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481352|NCT01227915|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481353|NCT01227902||Single Group Assignment||Treatment||None (Open Label)||||||
1481354|NCT01227889|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481355|NCT01227876|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481356|NCT01227863|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481357|NCT01227850|||Case-Only|||||||||
1481358|NCT01227837|Randomized|||Treatment||Quadruple|||t|t|t|t
1481359|NCT01227824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481360|NCT01227811|Randomized|Crossover Assignment||||None (Open Label)||||||
1481361|NCT01227798|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1481362|NCT01227785|||Cohort||Prospective|||||||
1481363|NCT01227772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481364|NCT01227759|Randomized|Single Group Assignment||Treatment||Single|||||t|
1481365|NCT01227746|||Cohort||Retrospective|||||||
1481366|NCT01227733|||Cohort||Retrospective|||||||
1481367|NCT01227720|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481368|NCT01227707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481369|NCT01227694||Single Group Assignment||Treatment||None (Open Label)||||||
1481370|NCT01227681|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481371|NCT01227668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481372|NCT01227655|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481373|NCT01227642||Single Group Assignment||Treatment||None (Open Label)||||||
1481374|NCT01227629|Randomized|Parallel Assignment||Prevention||||||||
1481375|NCT01227616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481376|NCT01227603|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481377|NCT01227590||Single Group Assignment||Treatment||None (Open Label)||||||
1481378|NCT01227577||Single Group Assignment||Treatment||None (Open Label)||||||
1481379|NCT01227564|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481380|NCT01227551||Single Group Assignment||Treatment||None (Open Label)||||||
1481381|NCT01227538|||Cohort||Prospective|||||||
1481382|NCT01227525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481383|NCT01227512|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481384|NCT01227499|||Cohort||Prospective|||||||
1481385|NCT01227486|||||Prospective|||||||
1481386|NCT01227473|Randomized|Parallel Assignment||Prevention||Single|||||t|
1481387|NCT01227460|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1481388|NCT01227447|||||Prospective|||||||
1481389|NCT01227434|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481390|NCT01227421|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481391|NCT01227408||Single Group Assignment||Treatment||None (Open Label)||||||
1481392|NCT01227395|||Case-Only||Retrospective|||||||
1481393|NCT01227382||Single Group Assignment||||None (Open Label)||||||
1481394|NCT01227369|||Other||Cross-Sectional|||||||
1481395|NCT01227356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481396|NCT01227343|||Cohort||Prospective|||||||
1481397|NCT01227330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481398|NCT01227317|||Case-Only||Prospective|||||||
1481399|NCT01227304||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481400|NCT01227291||Single Group Assignment||Treatment||None (Open Label)||||||
1481401|NCT01227278|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481402|NCT01227265|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481403|NCT01227252|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1481404|NCT01227239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481405|NCT01227226|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1481406|NCT01227213|||||Prospective|||||||
1481407|NCT01227200|Randomized|Crossover Assignment||Treatment||Single|||t|||
1481408|NCT01227187|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481409|NCT01227174||Single Group Assignment||Supportive Care||None (Open Label)||||||
1481410|NCT01227161|||Case-Only|||||||||
1481411|NCT01227148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481412|NCT01227135|Randomized|||Treatment||None (Open Label)||||||
1481413|NCT01227122|||Case-Only||Prospective|||||||
1481414|NCT01227109|||Cohort||Prospective|||||||
1481415|NCT01227096|||Case Control||Retrospective|||||||
1481416|NCT01227083||||||||||||
1481417|NCT01227070|||Cohort||Prospective|||||||
1481418|NCT01227057|Randomized|Parallel Assignment||Treatment||Single||||||t
1481419|NCT01227044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481420|NCT01227031|||Case Control||Prospective|||||||
1481421|NCT01227018||Single Group Assignment||Treatment||None (Open Label)||||||
1481422|NCT01227005|Randomized|Parallel Assignment||Treatment||Single||||||t
1481423|NCT01226992|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481424|NCT01226979||Single Group Assignment||Treatment||None (Open Label)||||||
1481425|NCT01226966|||Cohort||Prospective|||||||
1481426|NCT01226953|Randomized|Parallel Assignment||Prevention||Single||||||t
1481427|NCT01226927|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481428|NCT01226914|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1481429|NCT01226901|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481430|NCT01226888|||Case-Only||Prospective|||||||
1481431|NCT01226875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481432|NCT01226862|||Cohort||Prospective|||||||
1481433|NCT01226849||Single Group Assignment||Treatment||None (Open Label)||||||
1481434|NCT01226836||Single Group Assignment||Treatment||None (Open Label)||||||
1481435|NCT01226823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481436|NCT01226810|||Case-Only||Cross-Sectional|||||||
1481437|NCT01226797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481438|NCT01226784|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1481439|NCT01226771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481440|NCT01226758|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481441|NCT01226745|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481442|NCT01226732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481443|NCT01226719||Single Group Assignment||Treatment||None (Open Label)||||||
1481444|NCT01226706|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1481445|NCT01226693|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1481446|NCT01226680|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481447|NCT01226667|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481448|NCT01226654|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1481449|NCT01226641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481450|NCT01226628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481451|NCT01226615|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481452|NCT01226602|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1481453|NCT01226589|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481454|NCT01226576||Single Group Assignment||Treatment||None (Open Label)||||||
1481531|NCT01225549|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1481532|NCT01225536||Single Group Assignment||Treatment||None (Open Label)||||||
1481455|NCT01226563|Randomized|Parallel Assignment||Prevention||Triple|randomized 2:1 active vs placebo|Multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effects of IK-5001. 306 trials randomized 2:1 active vs placebo|t|t|t|
1481456|NCT01226550||Single Group Assignment||Treatment||None (Open Label)||||||
1481457|NCT01226537|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481458|NCT01226524||Single Group Assignment||Treatment||None (Open Label)||||||
1481459|NCT01226511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481460|NCT01226498|Randomized|Crossover Assignment||Basic Science||Single||||||t
1481461|NCT01226485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481462|NCT01226472||Single Group Assignment||Treatment||None (Open Label)||||||
1481463|NCT01226459|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481464|NCT01226446||Single Group Assignment||Treatment||None (Open Label)||||||
1481465|NCT01226433||||||||||||
1481466|NCT01226420||Single Group Assignment||Treatment||None (Open Label)||||||
1481467|NCT01226407||Single Group Assignment||Treatment||None (Open Label)||||||
1481468|NCT01226394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481469|NCT01226381|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1481470|NCT01226368|||Cohort||Prospective|||||||
1481471|NCT01226355|Randomized|Parallel Assignment||Treatment||Single||||||t
1481472|NCT01226342|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481473|NCT01226329|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1481474|NCT01226316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481475|NCT01226303|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481476|NCT01226290||Single Group Assignment||Treatment||None (Open Label)||||||
1481477|NCT01226277|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481478|NCT01226264||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481479|NCT01226251|||Cohort||Prospective|||||||
1481480|NCT01226238|Randomized|Parallel Assignment||Treatment||Single||||||t
1481481|NCT01226225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481482|NCT01226212|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1481483|NCT01226199|||Cohort||Prospective|||||||
1481484|NCT01226186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481485|NCT01226173|||Case-Only||Prospective|||||||
1481486|NCT01226160|Randomized|Parallel Assignment||Treatment||Single||||||t
1481487|NCT01226147||Single Group Assignment||Treatment||None (Open Label)||||||
1481488|NCT01226134|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481489|NCT01226121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481490|NCT01226108||Single Group Assignment||Treatment||None (Open Label)||||||
1481491|NCT01226095|||||Prospective|||||||
1481492|NCT01226082||Single Group Assignment||Treatment||None (Open Label)||||||
1481493|NCT01226069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481494|NCT01226056||Single Group Assignment||Treatment||None (Open Label)||||||
1481495|NCT01226043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481496|NCT01226030|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481497|NCT01226017||Single Group Assignment||Basic Science||None (Open Label)||||||
1481498|NCT01226004|||Cohort||Prospective|||||||
1481499|NCT01225991||Single Group Assignment||Treatment||None (Open Label)||||||
1481500|NCT01225978|||Cohort||Prospective|||||||
1481501|NCT01225965|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1481502|NCT01225952|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1481503|NCT01225939|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481504|NCT01225926|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481505|NCT01225913||Single Group Assignment||Treatment||None (Open Label)||||||
1481506|NCT01225887||Single Group Assignment||Treatment||None (Open Label)||||||
1481507|NCT01225874|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481508|NCT01225861|||Cohort||Prospective|||||||
1481509|NCT01225848||||Treatment||||||||
1481510|NCT01225835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481511|NCT01225822|Randomized|Parallel Assignment||Prevention||Double||||||
1481512|NCT01225809|||||Retrospective|||||||
1481513|NCT01225796|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1481514|NCT01225783||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481515|NCT01225770|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481516|NCT01225757|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1481517|NCT01225744||Single Group Assignment||Treatment||None (Open Label)||||||
1481518|NCT01225731|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481519|NCT01225718|||Case-Only||Retrospective|||||||
1481520|NCT01225705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481521|NCT01225692||Single Group Assignment||Health Services Research||||||||
1481522|NCT01225679|||Case-Only||Retrospective|||||||
1481523|NCT01225666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481524|NCT01225653|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481525|NCT01225640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481526|NCT01225627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481527|NCT01225614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481528|NCT01225601|||Cohort||Prospective|||||||
1481529|NCT01225575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481530|NCT01225562|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481533|NCT01225523|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481534|NCT01225510|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481535|NCT01225497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481536|NCT01225484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481537|NCT01225471||Single Group Assignment||Treatment||None (Open Label)||||||
1481538|NCT01225458|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481539|NCT01225445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481540|NCT01225432||Single Group Assignment||Treatment||None (Open Label)||||||
1481541|NCT01225419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481542|NCT01225406|||Cohort||Other|||||||
1481543|NCT01225393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481544|NCT01225380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481545|NCT01225367|||Case Control||Prospective|||||||
1481546|NCT01225354||Single Group Assignment||Treatment||Single||||||t
1481547|NCT01225341|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1481548|NCT01225328||Single Group Assignment||||None (Open Label)||||||
1481549|NCT01225315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481550|NCT01225302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481551|NCT01225289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481552|NCT01225276|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481553|NCT01225263|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1481554|NCT01225250|Randomized|Parallel Assignment||Treatment||Single||||||t
1481555|NCT01225237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481556|NCT01225224|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1481557|NCT01225211|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1481558|NCT01225198|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481559|NCT01225185|||Case-Control||Prospective|||||||
1481560|NCT01225172|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481561|NCT01225159|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1481562|NCT01225146|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481563|NCT01225133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481564|NCT01225120||Single Group Assignment||Treatment||None (Open Label)||||||
1481565|NCT01225107|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1481566|NCT01225094|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481567|NCT01225081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481568|NCT01225068|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481569|NCT01225055|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481570|NCT01225042|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1481571|NCT01225029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481572|NCT01225016|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1481573|NCT01225003|||||Prospective|||||||
1481574|NCT01224990||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481575|NCT01224977||Single Group Assignment||Treatment||None (Open Label)||||||
1481576|NCT01224964|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1481577|NCT01224951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481578|NCT01224938|||Cohort||Cross-Sectional|||||||
1481579|NCT01224925|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481580|NCT01224912||Single Group Assignment||Treatment||None (Open Label)||||||
1481581|NCT01224899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481582|NCT01224886|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481583|NCT01224873|||Cohort||Prospective|||||||
1481584|NCT01224860|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481585|NCT01224847|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1481586|NCT01224834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481587|NCT01224821||Single Group Assignment||Treatment||None (Open Label)||||||
1481588|NCT01224808||Single Group Assignment||Treatment||None (Open Label)||||||
1481589|NCT01224795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481590|NCT01224782||||||||||||
1481591|NCT01224769|||Cohort||Retrospective|||||||
1481592|NCT01224756|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481593|NCT01224743|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1481594|NCT01224730||Single Group Assignment||Treatment||None (Open Label)||||||
1481595|NCT01224717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481596|NCT01224704|||||Prospective|||||||
1481597|NCT01224691|||Case-Control||Cross-Sectional|||||||
1481598|NCT01224678|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1481599|NCT01224665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481600|NCT01224652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481601|NCT01224639|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1481602|NCT01224626|||Case-Only||Retrospective|||||||
1481603|NCT01224613|Randomized|Parallel Assignment||Prevention||Single||||||t
1481604|NCT01224600|||Cohort||Prospective|||||||
1481605|NCT01224587|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1481606|NCT01224574|||Cohort||Prospective|||||||
1481607|NCT01224561|||||Prospective|||||||
1481608|NCT01224548|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481609|NCT01224535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481610|NCT01224522|Randomized|Parallel Assignment||Treatment||Single||||||t
1481611|NCT01224509|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1481612|NCT01224496||Single Group Assignment||Supportive Care||None (Open Label)||||||
1481613|NCT01224483|||||Retrospective|||||||
1481614|NCT01224470|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1481615|NCT01224457||Single Group Assignment||||None (Open Label)||||||
1481616|NCT01224444|||Case-Only||Prospective|||||||
1481617|NCT01224431|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1481618|NCT01224418||Single Group Assignment||Treatment||None (Open Label)||||||
1481619|NCT01224405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481620|NCT01224392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481621|NCT01224379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481622|NCT01224366|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481623|NCT01224353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481624|NCT01224340|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481625|NCT01224327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481626|NCT01224314|Randomized|Crossover Assignment||Treatment||Single|||t|||
1481627|NCT01224301|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1481628|NCT01224288||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481629|NCT01224275|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481630|NCT01224262|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1481631|NCT01224249|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1481632|NCT01224236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481633|NCT01224223|||||Prospective|||||||
1481634|NCT01224210||Single Group Assignment||Treatment||None (Open Label)||||||
1481635|NCT01224197|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481636|NCT01224184|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481637|NCT01224171|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481638|NCT01224158||||||||||||
1481639|NCT01224145|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481640|NCT01224132|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1481641|NCT01224119|Randomized|Parallel Assignment||Treatment||Single||||||t
1481642|NCT01224106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481643|NCT01224093|||Cohort||Prospective|||||||
1481644|NCT01224080||Single Group Assignment||Treatment||None (Open Label)||||||
1481645|NCT01224067|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481646|NCT01224054||||||||||||
1481647|NCT01224041||Single Group Assignment||Treatment||None (Open Label)||||||
1481648|NCT01224028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481649|NCT01224015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481650|NCT01224002||||||||||||
1481651|NCT01223989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481652|NCT01223976||Parallel Assignment||Diagnostic||None (Open Label)||||||
1481653|NCT01223963|||Cohort||Retrospective|||||||
1481654|NCT01223950|||Case Control||Prospective|||||||
1481655|NCT01223937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481656|NCT01223924|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481657|NCT01223911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481658|NCT01223898||Single Group Assignment||||None (Open Label)||||||
1481659|NCT01223885||Single Group Assignment||Treatment||None (Open Label)||||||
1481660|NCT01223872|||Cohort||Other|||||||
1481661|NCT01223859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481662|NCT01223833|||||Prospective|||||||
1481663|NCT01223820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481664|NCT01223807|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481665|NCT01223794|||Cohort||Retrospective|||||||
1481666|NCT01223781|Randomized|Single Group Assignment||Treatment||Single||||||t
1481667|NCT01223768||||||||||||
1481668|NCT01223755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481669|NCT01223742||||||||||||
1481670|NCT01223729|Randomized|Parallel Assignment||Treatment||Double||||||
1481671|NCT01223716|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1481672|NCT01223703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481673|NCT01223690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481674|NCT01223677|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481675|NCT01223664|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481676|NCT01223651|Randomized|Crossover Assignment||Prevention||Single|||t|||
1481677|NCT01223638|||Case Control||Prospective|||||||
1481678|NCT01223625|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481679|NCT01223612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481680|NCT01223599|||Case-Only||Prospective|||||||
1481681|NCT01223586|||Cohort||Retrospective|||||||
1481682|NCT01223573|||Cohort||Prospective|||||||
1481683|NCT01223560||Single Group Assignment||Prevention||||||||
1481684|NCT01223547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481685|NCT01223534|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481686|NCT01223521|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1481687|NCT01223482|||Cohort||Retrospective|||||||
1481688|NCT01223469|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481689|NCT01223456|||||Prospective|||||||
1481690|NCT01223443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481691|NCT01223430|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481692|NCT01223404|Randomized|Crossover Assignment||Basic Science||Triple|Only the statistician performing the randomization and the pharmacist dispensing the drugs were aware which drug was given on which day.||t||t|t
1481693|NCT01223391|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481694|NCT01223378|Randomized|Parallel Assignment||Screening||Single|||||t|
1481695|NCT01223365||Single Group Assignment||Treatment||None (Open Label)||||||
1481696|NCT01223352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481697|NCT01223339|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481698|NCT01223326|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481699|NCT01223313||Single Group Assignment||Prevention||None (Open Label)||||||
1481700|NCT01223300|||Case-Only||Prospective|||||||
1481701|NCT01223287|||Cohort||Prospective|||||||
1481702|NCT01223274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481703|NCT01223261|||Cohort||Prospective|||||||
1481704|NCT01223248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481705|NCT01223235||Single Group Assignment||Treatment||None (Open Label)||||||
1481706|NCT01223222|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1481707|NCT01223209||Single Group Assignment||||None (Open Label)||||||
1481708|NCT01223196|Randomized|Parallel Assignment||||Double|||t||t|
1481709|NCT01223183|Randomized|Crossover Assignment||Basic Science||None (Open Label)||Subjects inhale isotonic saline on one imaging day and 7% hypertonic on the other. The order is randomized. There is a period of 5-24 days between imaging days.||||
1481710|NCT01223170|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1481711|NCT01223157|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1481712|NCT01223144|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1481713|NCT01223131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481714|NCT01223118||Single Group Assignment||||None (Open Label)||||||
1481715|NCT01223105|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481716|NCT01223092|||Cohort||Prospective|||||||
1481717|NCT01223079|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481718|NCT01223066|||Cohort||Prospective|||||||
1481719|NCT01223053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481720|NCT01223040||Single Group Assignment||Treatment||None (Open Label)||||||
1481721|NCT01223027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481722|NCT01223014|||||Prospective|||||||
1481723|NCT01223001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481724|NCT01222988||Single Group Assignment||Supportive Care||None (Open Label)||||||
1481725|NCT01222975|Randomized|Crossover Assignment||||None (Open Label)||||||
1481726|NCT01222962|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481727|NCT01222949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481728|NCT01222936||Single Group Assignment||Treatment||None (Open Label)||||||
1481729|NCT01222923|Randomized|Crossover Assignment||||None (Open Label)||||||
1481730|NCT01222910|Randomized|Crossover Assignment||||None (Open Label)||||||
1481731|NCT01222897|Randomized|Crossover Assignment||||None (Open Label)||||||
1481732|NCT01222884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481733|NCT01222871|Randomized|Single Group Assignment||Treatment||None (Open Label)||Patients will be randomized into 2 study groups, experimental and control.||||
1481734|NCT01222858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481735|NCT01222845|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1481736|NCT01222832|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481737|NCT01222819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481738|NCT01222806|Randomized|Parallel Assignment||Treatment||||||||
1481739|NCT01222793|||||Prospective|||||||
1481740|NCT01222780||Single Group Assignment||Treatment||None (Open Label)||||||
1481741|NCT01222767||Single Group Assignment||Treatment||None (Open Label)||||||
1481742|NCT01222754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481743|NCT01222741|||||Prospective|||||||
1481744|NCT01222728|||||Prospective|||||||
1481745|NCT01222715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481746|NCT01222702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481747|NCT01222689||Single Group Assignment||Treatment||None (Open Label)||||||
1481748|NCT01222676||||Treatment||None (Open Label)||||||
1481749|NCT01222663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481750|NCT01222650|Randomized|Parallel Assignment||Treatment||Double||||||
1481751|NCT01222637|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481752|NCT01222624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481753|NCT01222611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481754|NCT01222598|||||Retrospective|||||||
1481755|NCT01222585||Single Group Assignment||Treatment||None (Open Label)||||||
1481756|NCT01222572|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481757|NCT01222559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481758|NCT01222546||Single Group Assignment||Treatment||None (Open Label)||||||
1481759|NCT01222533|Randomized|Crossover Assignment||Treatment||Double||||||
1481760|NCT01222520|Randomized|Parallel Assignment||Treatment||Double||||||
1481761|NCT01222507|||||Prospective|||||||
1481762|NCT01222494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481763|NCT01222481|||Cohort||Prospective|||||||
1481764|NCT01222468|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1481765|NCT01222455|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1481766|NCT01222442|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1481767|NCT01222429|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1481768|NCT01222416|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1481769|NCT01222403|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1481770|NCT01222390||Single Group Assignment||Treatment||None (Open Label)||||||
1481771|NCT01222377||Single Group Assignment||Treatment||None (Open Label)||||||
1481772|NCT01222364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481773|NCT01222351||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481774|NCT01222338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481775|NCT01222325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481776|NCT01222312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481777|NCT01222299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481778|NCT01222286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481779|NCT01222273||Single Group Assignment||Treatment||None (Open Label)||||||
1481780|NCT01222260||Single Group Assignment||Treatment||None (Open Label)||||||
1481781|NCT01222247|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1481782|NCT01222234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481783|NCT01222221||||Treatment||None (Open Label)||||||
1481784|NCT01222208|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481785|NCT01222195|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481786|NCT01222182|||Case Control||Retrospective|||||||
1481787|NCT01222169|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481788|NCT01222156||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481789|NCT01222143||Single Group Assignment||Treatment||None (Open Label)||||||
1481790|NCT01222130|||||Cross-Sectional|||||||
1481791|NCT01222117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481792|NCT01222104|||Cohort||Prospective|||||||
1481793|NCT01222091|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1481794|NCT01222078||Single Group Assignment||Treatment||None (Open Label)||||||
1481795|NCT01222065|||Case Control||Cross-Sectional|||||||
1481796|NCT01222052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481797|NCT01222039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481798|NCT01222026|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481799|NCT01222013||Single Group Assignment||Treatment||None (Open Label)||||||
1481800|NCT01222000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481801|NCT01221987|||Case-Only||Cross-Sectional|||||||
1481802|NCT01221974||Single Group Assignment||Treatment||||||||
1481803|NCT01221961|||||Prospective|||||||
1481804|NCT01221948||Single Group Assignment||Treatment||None (Open Label)||Boston Scientific Vercise Deep Brain Stimulation system will be implanted and each patient will serve as its own control.||||
1481805|NCT01221935|||||Retrospective|||||||
1481806|NCT01221922||Single Group Assignment||Treatment||None (Open Label)||||||
1481807|NCT01221909|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1481808|NCT01221896|||Cohort||Prospective|||||||
1481809|NCT01221883|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1481810|NCT01221870|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481811|NCT01221857||Single Group Assignment||Treatment||None (Open Label)||||||
1481812|NCT01221844|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481813|NCT01221831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481814|NCT01221818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481815|NCT01221805|||Cohort||Prospective|||||||
1481816|NCT01221792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481817|NCT01221779|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481818|NCT01221766|||Case-Only||Prospective|||||||
1481819|NCT01221753||Single Group Assignment||Treatment||None (Open Label)||||||
1481820|NCT01221740||Single Group Assignment||Treatment||None (Open Label)||||||
1481821|NCT01221727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481822|NCT01221714|||Case-Control||Prospective|||||||
1481823|NCT01221701|Randomized|Parallel Assignment||Treatment||Single||||||t
1481824|NCT01221688|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1481825|NCT01221675||Single Group Assignment||Treatment||None (Open Label)||||||
1481826|NCT01221662|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1481827|NCT01221649||Single Group Assignment||Supportive Care||None (Open Label)||||||
1481828|NCT01221636|Randomized|Parallel Assignment||||None (Open Label)||||||
1481829|NCT01221623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481830|NCT01221610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481831|NCT01221597|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481832|NCT01221584|||Cohort||Prospective|||||||
1481833|NCT01221571||Single Group Assignment||Treatment||None (Open Label)||||||
1481834|NCT01221558|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1481835|NCT01221545|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1481836|NCT01221532|Randomized|Parallel Assignment||Prevention||Single||||||t
1481837|NCT01221519|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1481838|NCT01221506||Single Group Assignment||Treatment||None (Open Label)||||||
1481839|NCT01221493||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481840|NCT01221480|||Cohort||Retrospective|||||||
1481841|NCT01221467|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481997|NCT01219426|||||Prospective|||||||
1481842|NCT01221454|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481843|NCT01221441|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481844|NCT01221428|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481845|NCT01221415|||||Prospective|||||||
1481846|NCT01221402|Randomized|Parallel Assignment||Treatment||Quadruple||Original plan was to enroll 138 subjects, but trial was terminated early and total randomized was 38.|t|t|t|t
1481847|NCT01221389|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1481848|NCT01221376||Single Group Assignment||Treatment||None (Open Label)||||||
1481849|NCT01221363|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481850|NCT01221350|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1481851|NCT01221337|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1481852|NCT01221324|||Cohort||Retrospective|||||||
1481853|NCT01221311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481854|NCT01221298|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481855|NCT01221285||Single Group Assignment||Treatment||None (Open Label)||||||
1481856|NCT01221272|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1481857|NCT01221259|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1481858|NCT01221246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481859|NCT01221233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481860|NCT01221220|Randomized|Parallel Assignment||Treatment||Single||||||t
1481861|NCT01221207|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481862|NCT01221194|Randomized|Parallel Assignment||Prevention||Single|||||t|
1481863|NCT01221181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481864|NCT01221168|||Cohort||Prospective|||||||
1481865|NCT01221155|||Cohort|||||||||
1481866|NCT01221142||Single Group Assignment||Treatment||None (Open Label)||||||
1481867|NCT01221129|||||Prospective|||||||
1481868|NCT01221116|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481869|NCT01221103||Single Group Assignment||Treatment||None (Open Label)||||||
1481870|NCT01221090|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481871|NCT01221077|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481872|NCT01221064|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481873|NCT01221051|Randomized|Parallel Assignment||Prevention||Single|||t|||
1481874|NCT01221038|||Case Control|||||||||
1481875|NCT01221025|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1481876|NCT01221012|||Case Control|||||||||
1481877|NCT01220999|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481878|NCT01220986|||Cohort||Prospective|||||||
1481879|NCT01220973||Single Group Assignment||Treatment||None (Open Label)||||||
1481880|NCT01220960|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1481881|NCT01220947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481882|NCT01220934|||Cohort||Prospective|||||||
1481883|NCT01220921|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1481884|NCT01220908||Single Group Assignment||Treatment||None (Open Label)||||||
1481885|NCT01220895|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481886|NCT01220882||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481887|NCT01220869||Single Group Assignment||Treatment||None (Open Label)||||||
1481888|NCT01220856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481889|NCT01220843|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481890|NCT01220830|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481891|NCT01220817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481892|NCT01220804|||Case Control||Prospective|||||||
1481893|NCT01220791|Randomized|Parallel Assignment||Treatment||Single|||||t|
1481894|NCT01220778|Randomized|Parallel Assignment||||||||||
1481895|NCT01220765|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481896|NCT01220752|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481897|NCT01220739|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481898|NCT01220726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481899|NCT01220713|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1481900|NCT01220700|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481901|NCT01220687|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481902|NCT01220674|||Ecologic or Community||Other|||||||
1481903|NCT01220661||Single Group Assignment||Treatment||None (Open Label)||||||
1481904|NCT01220648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481905|NCT01220635|Randomized|Parallel Assignment||Prevention||Single||||||t
1481906|NCT01220622|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1481907|NCT01220609||Single Group Assignment||Treatment||None (Open Label)||||||
1481908|NCT01220596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481909|NCT01220583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481910|NCT01220570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481911|NCT01220557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481912|NCT01220544||Single Group Assignment||Treatment||None (Open Label)||||||
1481913|NCT01220531||||||||||||
1481914|NCT01220518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1481915|NCT01220505|||Case-Only||Prospective|||||||
1481916|NCT01220492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481917|NCT01220479|Randomized|Parallel Assignment||Treatment||Single||||||t
1481918|NCT01220466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481919|NCT01220453|||||Prospective|||||||
1481920|NCT01220440|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1481921|NCT01220427|||||Retrospective|||||||
1481922|NCT01220414|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1481923|NCT01220401||Single Group Assignment||Treatment||None (Open Label)||||||
1481924|NCT01220388|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1481925|NCT01220375||Single Group Assignment||Treatment||None (Open Label)||||||
1481926|NCT01220362|Randomized|Parallel Assignment||||Double|||t||t|
1481927|NCT01220349||Single Group Assignment||Diagnostic||None (Open Label)||||||
1481928|NCT01220336|Randomized|Parallel Assignment||||Single||||||t
1481929|NCT01220323|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481930|NCT01220310||Single Group Assignment||Health Services Research||None (Open Label)||||||
1481931|NCT01220297|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481932|NCT01220284||Single Group Assignment||Treatment||None (Open Label)||||||
1481933|NCT01220271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481934|NCT01220258|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481935|NCT01220245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481936|NCT01220232|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481937|NCT01220219|Randomized|Crossover Assignment||||None (Open Label)||||||
1481938|NCT01220206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481939|NCT01220193|||Cohort||Prospective|||||||
1481940|NCT01220180|||Ecologic or Community||Prospective|||||||
1481941|NCT01220167|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481942|NCT01220154||Single Group Assignment||Treatment||None (Open Label)||||||
1481943|NCT01220141|||Cohort||Prospective|||||||
1481944|NCT01220128|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481945|NCT01220115|||Cohort||Prospective|||||||
1481946|NCT01220102|||Cohort||Prospective|||||||
1481947|NCT01220089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481948|NCT01220076||Single Group Assignment||Screening||None (Open Label)||||||
1481949|NCT01220063||Single Group Assignment||Treatment||None (Open Label)||||||
1481950|NCT01220050|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1481951|NCT01220037|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1481952|NCT01220024|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481953|NCT01220011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481954|NCT01219998|||Cohort||Prospective|||||||
1481955|NCT01219985||Single Group Assignment||Diagnostic||Single||||||t
1481956|NCT01219972|||Cohort||Prospective|||||||
1481957|NCT01219959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481958|NCT01219946|||Case-Only||Cross-Sectional|||||||
1481959|NCT01219933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481960|NCT01219920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481961|NCT01219907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481962|NCT01219894|||Case Control||Prospective|||||||
1481963|NCT01219881|Randomized|Single Group Assignment||Health Services Research||Double|||t|t||
1481964|NCT01219868|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1481965|NCT01219855|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1481966|NCT01219842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481967|NCT01219829|||Cohort||Retrospective|||||||
1481968|NCT01219816|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481969|NCT01219803|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1481970|NCT01219790||Single Group Assignment||Treatment||None (Open Label)||||||
1481971|NCT01219777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481972|NCT01219764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1481973|NCT01219751|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481974|NCT01219738|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1481975|NCT01219725|Randomized|Parallel Assignment||Prevention||Single||||||t
1481976|NCT01219712|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1481977|NCT01219699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481978|NCT01219686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1481979|NCT01219673|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1481980|NCT01219660|||||Prospective|||||||
1481981|NCT01219647|Randomized|Parallel Assignment||Treatment||Single||||||t
1481982|NCT01219621|Randomized|Parallel Assignment||Treatment||Single|||t|||
1481983|NCT01219608|Randomized|Factorial Assignment||Supportive Care||Quadruple|||t|t|t|t
1481984|NCT01219595|Randomized|Single Group Assignment||Basic Science||Single||||||t
1481985|NCT01219582|||Cohort||Prospective|||||||
1481986|NCT01219569|||||Prospective|||||||
1481987|NCT01219556|||Cohort||Prospective|||||||
1481988|NCT01219543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481989|NCT01219530|||||Prospective|||||||
1481990|NCT01219517||Single Group Assignment||||None (Open Label)||||||
1481991|NCT01219504|||||Prospective|||||||
1481992|NCT01219491|||||Prospective|||||||
1481993|NCT01219478|||||Retrospective|||||||
1481994|NCT01219465|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481995|NCT01219452|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1481996|NCT01219439|||Other||Prospective|||||||
1481998|NCT01219413|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1481999|NCT01219400|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1482000|NCT01219387|||||Prospective|||||||
1482001|NCT01219374|||Case-Only||Prospective|||||||
1482002|NCT01219361|||Other||Prospective|||||||
1482003|NCT01219348||Single Group Assignment||Treatment||None (Open Label)||||||
1482004|NCT01219335|||Cohort||Prospective|||||||
1482005|NCT01219322|Randomized|Crossover Assignment||Diagnostic||Double|||t|t||
1482006|NCT01219309|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1482007|NCT01219296||||||||||||
1482008|NCT01219283|||Case Control||Prospective|||||||
1482009|NCT01219270|||Cohort||Prospective|||||||
1482010|NCT01219257|||Case-Only||Prospective|||||||
1482011|NCT01219244|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482012|NCT01219231|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482013|NCT01219218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482014|NCT01219205|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482015|NCT01219192|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482016|NCT01219179|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482017|NCT01219166|||Cohort||Retrospective|||||||
1482018|NCT01219153|Randomized|Parallel Assignment||Treatment||Single||||||t
1482019|NCT01219140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482020|NCT01219127|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482021|NCT01219114|||||Prospective|||||||
1482022|NCT01219101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482023|NCT01219088|Randomized|Parallel Assignment||Treatment||Single||||||t
1482024|NCT01219075|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1482025|NCT01219062|Randomized|Parallel Assignment||Treatment||Single||||||t
1482026|NCT01219049|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482027|NCT01219036|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1482028|NCT01219023||Single Group Assignment||Treatment||Triple|||t|t|t|
1482029|NCT01219010||Single Group Assignment||Treatment||None (Open Label)||||||
1482030|NCT01218997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482031|NCT01218984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482032|NCT01218971|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482033|NCT01218958|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482034|NCT01218945|||||Prospective|||||||
1482035|NCT01218932|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482036|NCT01218919|||Cohort||Prospective|||||||
1482037|NCT01218906|||Cohort||Prospective|||||||
1482038|NCT01218893|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1482039|NCT01218880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482040|NCT01218867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482041|NCT01218854|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1482042|NCT01218841|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482043|NCT01218828|Randomized|Parallel Assignment||Prevention||Single|||t|||
1482044|NCT01218815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482045|NCT01218802|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1482046|NCT01218789||Single Group Assignment||Treatment||None (Open Label)||||||
1482047|NCT01218776|||Cohort||Prospective|||||||
1482048|NCT01218763|||Cohort||Prospective|||||||
1482049|NCT01218750||Single Group Assignment||Treatment||None (Open Label)||||||
1482050|NCT01218737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482051|NCT01218724||||||||||||
1482052|NCT01218711||||||||||||
1482053|NCT01218698||||||||||||
1482054|NCT01218685|||Cohort||Prospective|||||||
1482055|NCT01218672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482056|NCT01218659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482057|NCT01218646|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482058|NCT01218633|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1482059|NCT01218620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482060|NCT01218607|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482061|NCT01218594||Single Group Assignment||Treatment||None (Open Label)||||||
1482062|NCT01218581|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482063|NCT01218568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482064|NCT01218555||Single Group Assignment||Treatment||None (Open Label)||||||
1482065|NCT01218542||Single Group Assignment||Treatment||None (Open Label)||||||
1482066|NCT01218529||Single Group Assignment||Treatment||None (Open Label)||||||
1482067|NCT01218516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482068|NCT01218503||Single Group Assignment||Basic Science||None (Open Label)||||||
1482069|NCT01218490|Randomized|Parallel Assignment||||None (Open Label)||||||
1482070|NCT01218477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482071|NCT01218464|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1482072|NCT01218451|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482073|NCT01218438||Single Group Assignment||Treatment||None (Open Label)||||||
1482074|NCT01218425|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1482075|NCT01218412|Randomized|Parallel Assignment||Prevention||Single|||t|||
1482076|NCT01218399|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482077|NCT01218386|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482078|NCT01218373|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482079|NCT01218360|||Cohort||Prospective|||||||
1482080|NCT01218347||Single Group Assignment||Treatment||None (Open Label)||||||
1482081|NCT01218334|||Case-Only||Prospective|||||||
1482082|NCT01218321|||Case-Control||Prospective|||||||
1482083|NCT01218308|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1482084|NCT01218295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482085|NCT01218282|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1482086|NCT01218269||Single Group Assignment||Treatment||None (Open Label)||||||
1482087|NCT01218256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482088|NCT01218243|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1482089|NCT01218230||Single Group Assignment||Treatment||None (Open Label)||||||
1482090|NCT01218217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482091|NCT01218204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482092|NCT01218191|||Case-Only||Prospective|||||||
1482093|NCT01218178|||Case Control|||||||||
1482094|NCT01218165|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482095|NCT01218152|||||Prospective|||||||
1482096|NCT01218139|||Cohort||Retrospective|||||||
1482097|NCT01218126|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482098|NCT01218113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482099|NCT01218100|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482100|NCT01218087|Randomized|Parallel Assignment||Prevention||Single||||||t
1482101|NCT01218074|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1482102|NCT01218061||Single Group Assignment||Diagnostic||None (Open Label)||||||
1482103|NCT01218048||Single Group Assignment||Treatment||None (Open Label)||||||
1482104|NCT01218035|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482105|NCT01218022||||||||||||
1482106|NCT01218009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482107|NCT01217996|Randomized|Parallel Assignment||Treatment||Single||||||t
1482108|NCT01217983|||Case-Only||Prospective|||||||
1482109|NCT01217970|Randomized|Crossover Assignment||||Double|||t||t|
1482110|NCT01217957|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482111|NCT01217944|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482112|NCT01217931|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482113|NCT01217918|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1482114|NCT01217905|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1482115|NCT01217892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482116|NCT01217879|||Cohort||Prospective|||||||
1482117|NCT01217866|||Cohort||Retrospective|||||||
1482118|NCT01217853|||Cohort||Prospective|||||||
1482119|NCT01217840|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482120|NCT01217827|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1482121|NCT01217814|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482122|NCT01217801|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482123|NCT01217788|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482124|NCT01217775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482125|NCT01217762|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482126|NCT01217749|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482127|NCT01217736|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1482128|NCT01217723|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482129|NCT01217710||Single Group Assignment||Supportive Care||None (Open Label)||||||
1482130|NCT01217697||||||||||||
1482131|NCT01217684|||Cohort||Cross-Sectional|||||||
1482132|NCT01217671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482133|NCT01217658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482134|NCT01217645||Single Group Assignment||Basic Science||None (Open Label)||||||
1482135|NCT01217632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482136|NCT01217619||Single Group Assignment||Treatment||None (Open Label)||||||
1482137|NCT01217606|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482138|NCT01217593|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1482139|NCT01217580|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482140|NCT01217567|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1482141|NCT01217554|||Case Control||Cross-Sectional|||||||
1482142|NCT01217541|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1482143|NCT01217528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482144|NCT01217515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482145|NCT01217502|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1482146|NCT01217489|||Case-Only||Prospective|||||||
1482147|NCT01217476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482148|NCT01217463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482149|NCT01217450||Single Group Assignment||Treatment||None (Open Label)||||||
1482150|NCT01217437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482151|NCT01217424|Randomized|||Supportive Care||||||||
1482152|NCT01217411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482153|NCT01217398||||Treatment||None (Open Label)||||||
1482154|NCT01217385||Single Group Assignment||Diagnostic||None (Open Label)||||||
1482155|NCT01217372|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482156|NCT01217359||Single Group Assignment||||None (Open Label)||||||
1482157|NCT01217346|||Case-Only||Cross-Sectional|||||||
1482158|NCT01217333|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1482159|NCT01217320|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482160|NCT01217307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482161|NCT01217294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482162|NCT01217281|Randomized|Parallel Assignment||Treatment||Single||||||t
1482163|NCT01217268|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1482164|NCT01217255|||Cohort||Prospective|||||||
1482165|NCT01217242|||Cohort||Cross-Sectional|||||||
1482166|NCT01217229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482167|NCT01217216|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482168|NCT01217203||Single Group Assignment||Treatment||None (Open Label)||||||
1482169|NCT01217190|Randomized|Crossover Assignment||||None (Open Label)||||||
1482170|NCT01217177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482171|NCT01217164|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1482172|NCT01217151|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482173|NCT01217138|Randomized|Parallel Assignment||||None (Open Label)||||||
1482174|NCT01217125||Single Group Assignment||Treatment||None (Open Label)||||||
1482175|NCT01217112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482176|NCT01217099|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482177|NCT01217086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482178|NCT01217073|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482179|NCT01217060||Single Group Assignment||Treatment||None (Open Label)||||||
1482180|NCT01217047|Randomized|Parallel Assignment||Treatment||Single||||||t
1482181|NCT01217034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482182|NCT01217021||Single Group Assignment||Diagnostic||None (Open Label)||||||
1482183|NCT01217008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482184|NCT01216995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482185|NCT01216982|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1482186|NCT01216956|Randomized|Crossover Assignment||Basic Science||Double||||||
1482187|NCT01216943||Single Group Assignment||Treatment||None (Open Label)||||||
1482188|NCT01216930|||Cohort||Prospective|||||||
1482189|NCT01216917|||Cohort||Cross-Sectional|||||||
1482190|NCT01216904|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1482191|NCT01216891||Single Group Assignment||Treatment||None (Open Label)||||||
1482192|NCT01216878|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482193|NCT01216865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482194|NCT01216852|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482195|NCT01216839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482196|NCT01216826|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482197|NCT01216813||||||||||||
1482198|NCT01216800|Randomized|||Treatment||||||||
1482199|NCT01216787||Single Group Assignment||Treatment||None (Open Label)||||||
1482200|NCT01216774|Randomized|Parallel Assignment||||Single|||t|||
1482201|NCT01216761|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1482202|NCT01216748||Single Group Assignment||Basic Science||None (Open Label)||||||
1482203|NCT01216735|Randomized|Crossover Assignment||||Double|||t||t|
1482204|NCT01216722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482205|NCT01216709|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1482206|NCT01216696||Single Group Assignment||Treatment||None (Open Label)||||||
1482207|NCT01216683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482208|NCT01216670|||Cohort||Prospective|||||||
1482209|NCT01216657||Single Group Assignment||Treatment||None (Open Label)||||||
1482210|NCT01216644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482211|NCT01216631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482212|NCT01216618|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482213|NCT01216605|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1482214|NCT01216592|||Cohort||Prospective|||||||
1482215|NCT01216579|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1482216|NCT01216566|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482217|NCT01216553|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1482218|NCT01216540|||Cohort||Retrospective|||||||
1482219|NCT01216527|Randomized|Parallel Assignment||Treatment||Single||||||t
1482220|NCT01216514|||Cohort||Prospective|||||||
1482221|NCT01216501|||Cohort||Prospective|||||||
1482222|NCT01216488|Randomized|Parallel Assignment||Treatment||Single||||||t
1482223|NCT01216475|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1482224|NCT01216462|||Cohort||Prospective|||||||
1482225|NCT01216449|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1482226|NCT01216436|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1482227|NCT01216423|||Cohort||Prospective|||||||
1482228|NCT01216410|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482229|NCT01216397|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482230|NCT01216384|Randomized|Parallel Assignment||Treatment||Double||||||
1482231|NCT01216371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482232|NCT01216358|||Case Control||Prospective|||||||
1482233|NCT01216345||Single Group Assignment||Treatment||||||||
1482234|NCT01216332|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482235|NCT01216319||Single Group Assignment||Treatment||None (Open Label)||||||
1482236|NCT01216306|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482237|NCT01216293|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1482238|NCT01216280|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482239|NCT01216267|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1482240|NCT01216254|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482241|NCT01216241|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482242|NCT01216228|||Cohort||Prospective|||||||
1482243|NCT01216215|||Cohort||Prospective|||||||
1482244|NCT01216202|||Cohort||Prospective|||||||
1482245|NCT01216189|||Cohort||Prospective|||||||
1482246|NCT01216176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482247|NCT01216163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482248|NCT01216150|||Cohort||Prospective|||||||
1482249|NCT01216137|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482250|NCT01216124||||||||||||
1482251|NCT01216111||||||||||||
1482252|NCT01216098|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482253|NCT01216085||Single Group Assignment||Treatment||None (Open Label)||||||
1482254|NCT01216072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482255|NCT01216059|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482256|NCT01216046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482257|NCT01216033||Single Group Assignment||Diagnostic||None (Open Label)||||||
1482258|NCT01216020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482259|NCT01216007|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1482260|NCT01215994|||||Cross-Sectional|||||||
1482261|NCT01215981|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482262|NCT01215968|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1482263|NCT01215955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482264|NCT01215942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482265|NCT01215929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482266|NCT01215916|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482267|NCT01215903|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1482268|NCT01215890||||||||||||
1482269|NCT01215877||Single Group Assignment||Treatment||None (Open Label)||||||
1482270|NCT01215864||Single Group Assignment||Treatment||None (Open Label)||||||
1482271|NCT01215851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482272|NCT01215838|||Cohort||Prospective|||||||
1482273|NCT01215825|||Cohort||Retrospective|||||||
1482274|NCT01215812|||Case-Only||Retrospective|||||||
1482275|NCT01215799||Single Group Assignment||Treatment||None (Open Label)||||||
1482276|NCT01215786|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482277|NCT01215773|Randomized|Parallel Assignment||Treatment||Double||||||
1482278|NCT01215760|Randomized|Parallel Assignment||Treatment||Single||||||t
1482279|NCT01215747|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1482280|NCT01215734|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1482281|NCT01215721||Single Group Assignment||Treatment||None (Open Label)||||||
1482282|NCT01215708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482283|NCT01215695|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1482284|NCT01215682|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482285|NCT01215669|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482286|NCT01215656|Randomized|Parallel Assignment||Prevention||Double||||||
1482287|NCT01215643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482288|NCT01215630|||Cohort||Cross-Sectional|||||||
1482289|NCT01215617|Randomized|Parallel Assignment||Prevention||Single|||||t|
1482290|NCT01215604|||Case-Only||Prospective|||||||
1482291|NCT01215591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482292|NCT01215578||Single Group Assignment||Treatment||None (Open Label)||||||
1482293|NCT01215565||Single Group Assignment||Treatment||None (Open Label)||||||
1482294|NCT01215552|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1482295|NCT01215539||Single Group Assignment||Treatment||None (Open Label)||||||
1482296|NCT01215526|||Cohort||Prospective|||||||
1482297|NCT01215513||Single Group Assignment||Treatment||None (Open Label)||||||
1482298|NCT01215500||Single Group Assignment||Treatment||None (Open Label)||||||
1482299|NCT01215487|||Case-Only||Prospective|||||||
1482300|NCT01215474|||Case-Only||Retrospective|||||||
1482301|NCT01215461|||Cohort||Prospective|||||||
1482302|NCT01215448|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1482303|NCT01215435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482304|NCT01215422|||Case-Crossover||Prospective|||||||
1482305|NCT01215409|||Case-Only||Prospective|||||||
1482306|NCT01215396|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1482307|NCT01215383|||Cohort||Prospective|||||||
1482308|NCT01215370|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1482309|NCT01215357||Single Group Assignment||Treatment||Single|||t|||
1482310|NCT01215344|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482311|NCT01215331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482312|NCT01215318|||Case-Only|||||||||
1482313|NCT01215305|||Case-Only||Prospective|||||||
1482314|NCT01215292|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482315|NCT01215279|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1482316|NCT01215266|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1482317|NCT01215253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482318|NCT01215240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482319|NCT01215227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482320|NCT01215214|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482321|NCT01215201|Randomized|Parallel Assignment||Prevention||Single|||||t|
1482322|NCT01215188|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482323|NCT01215175|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1482324|NCT01215162|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482325|NCT01215149|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482326|NCT01215136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482327|NCT01215123|||Cohort||Retrospective|||||||
1482328|NCT01215110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482329|NCT01215097|Randomized|Parallel Assignment||Treatment||Double||||||
1482330|NCT01215084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482331|NCT01215071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482332|NCT01215058|||Cohort||Cross-Sectional|||||||
1482333|NCT01215045|||Case-Only||Prospective|||||||
1482334|NCT01215032||Single Group Assignment||Treatment||None (Open Label)||||||
1482335|NCT01215019|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482336|NCT01214993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482337|NCT01214980|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1482338|NCT01214967|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1482339|NCT01214954|Randomized|Parallel Assignment||Treatment||Single||||||t
1482340|NCT01214941|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1482341|NCT01214928|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1482342|NCT01214915||Single Group Assignment||Treatment||None (Open Label)||||||
1482343|NCT01214902|Randomized|Parallel Assignment||Treatment||Single||||||t
1482344|NCT01214889|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482345|NCT01214876|||Cohort||Prospective|||||||
1482346|NCT01214863|||Case-Only||Prospective|||||||
1482347|NCT01214850|Randomized|Parallel Assignment||Prevention||Single||||||t
1482348|NCT01214837|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482349|NCT01214824||Single Group Assignment||Treatment||None (Open Label)||||||
1482350|NCT01214811||Single Group Assignment||Treatment||None (Open Label)||||||
1482351|NCT01214798|||Case-Only||Retrospective|||||||
1482352|NCT01214785|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482353|NCT01214772|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482354|NCT01214759||Single Group Assignment||Prevention||None (Open Label)||||||
1482355|NCT01214746|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1482356|NCT01214733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482357|NCT01214720|Randomized|Parallel Assignment||Treatment||Double||||||
1482358|NCT01214707|||||Prospective|||||||
1482359|NCT01214694|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1482360|NCT01214681|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1482361|NCT01214668||Single Group Assignment||Treatment||None (Open Label)||||||
1482362|NCT01214655|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482363|NCT01214642|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482364|NCT01214629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482365|NCT01214616||Single Group Assignment||Treatment||None (Open Label)||||||
1482366|NCT01214603||Single Group Assignment||Treatment||None (Open Label)||||||
1482367|NCT01214590||Single Group Assignment||Treatment||None (Open Label)||||||
1482368|NCT01214577||Single Group Assignment||Treatment||None (Open Label)||||||
1482369|NCT01214564||Single Group Assignment||Treatment||None (Open Label)||||||
1482370|NCT01214551|||Other||Prospective|||||||
1482371|NCT01214538|||Case Control||Prospective|||||||
1482372|NCT01214525|||Case-Control||Prospective|||||||
1482373|NCT01214512|||Ecologic or Community||Prospective|||||||
1482374|NCT01214499|Randomized|Parallel Assignment||Treatment||Single||||||t
1482375|NCT01214486||Single Group Assignment||Treatment||None (Open Label)||||||
1482376|NCT01214473|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482377|NCT01214460|||Cohort||Prospective|||||||
1482378|NCT01214447|||Cohort||Prospective|||||||
1482379|NCT01214434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482380|NCT01214421|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482381|NCT01214408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482382|NCT01214395||Single Group Assignment||Prevention||None (Open Label)||||||
1482383|NCT01214382||Single Group Assignment||||None (Open Label)||||||
1482384|NCT01214369|Randomized|Parallel Assignment||||Single|||t|||
1482385|NCT01214356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482386|NCT01214343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482387|NCT01214330||Single Group Assignment||Prevention||None (Open Label)||||||
1482388|NCT01214317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482389|NCT01214304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482390|NCT01214291|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1482391|NCT01214278|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1482392|NCT01214265||Single Group Assignment||Treatment||None (Open Label)||||||
1482393|NCT01214252|||||Retrospective|||||||
1482394|NCT01214239|Randomized|Parallel Assignment||Treatment||Double||||||
1482395|NCT01214226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482396|NCT01214213|||Case Control||Cross-Sectional|||||||
1482397|NCT01214200||Single Group Assignment||Treatment||None (Open Label)||||||
1482398|NCT01214187|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1482399|NCT01214174|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482400|NCT01214161|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1482401|NCT01214148|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482402|NCT01214135|||Case Control||Retrospective|||||||
1482403|NCT01214122||||Basic Science||None (Open Label)||||||
1482404|NCT01214109|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482405|NCT01214096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482406|NCT01214083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482407|NCT01214070|Randomized|Crossover Assignment||Treatment||Single||||||t
1482408|NCT01214057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482409|NCT01214044||Single Group Assignment||Basic Science||Single|||t|||
1482410|NCT01214031|Non-Randomized|Single Group Assignment||Screening||Single||||||t
1482411|NCT01214018|||Cohort||Prospective|||||||
1482412|NCT01214005|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1482413|NCT01213992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482414|NCT01213979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482415|NCT01213966|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482416|NCT01213953|||Case-Only||Prospective|||||||
1482417|NCT01213940|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1482418|NCT01213927|||Cohort||Prospective|||||||
1482419|NCT01213914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482420|NCT01213901|Randomized|Crossover Assignment||Other||Single|||t|||
1482421|NCT01213888|Randomized|Single Group Assignment||||Double|||t|t||
1482422|NCT01213875|Randomized|Parallel Assignment||Treatment||Single||||||t
1482423|NCT01213862|Randomized|Parallel Assignment||Treatment||Single||||||t
1482424|NCT01213849|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1482425|NCT01213836|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1482426|NCT01213823|||Case Control||Retrospective|||||||
1482427|NCT01213810|Non-Randomized|Single Group Assignment||Prevention||Single||||||t
1482428|NCT01213797|||||Prospective|||||||
1482429|NCT01213784|Randomized|Parallel Assignment||Treatment||Single||||||t
1482430|NCT01213771|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1482431|NCT01213758|||Cohort||Prospective|||||||
1482432|NCT01213745|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1482433|NCT01213732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482434|NCT01213719|Randomized|Parallel Assignment||||Double|||t||t|
1482435|NCT01213706|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482436|NCT01213693|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1482437|NCT01213680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482438|NCT01213667||Single Group Assignment||Treatment||None (Open Label)||||||
1482439|NCT01213654|||Cohort||Prospective|||||||
1482440|NCT01213641|||Cohort||Prospective|||||||
1482441|NCT01213628|Randomized|Factorial Assignment||Treatment||Single|||t|||
1482442|NCT01213615|||Cohort||Prospective|||||||
1482443|NCT01213602|||Cohort||Prospective|||||||
1482444|NCT01213589|||Cohort||Prospective|||||||
1482445|NCT01213576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482446|NCT01213563|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1482447|NCT01213550||||||||||||
1482448|NCT01213537|||Cohort||Prospective|||||||
1482449|NCT01213524|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1482450|NCT01213511|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1482451|NCT01213498|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1482452|NCT01213485|||Cohort||Prospective|||||||
1482453|NCT01213472||Single Group Assignment||Treatment||None (Open Label)||||||
1482454|NCT01213459|||Case-Only||Prospective|||||||
1482455|NCT01213446||Single Group Assignment||Treatment||None (Open Label)||||||
1482456|NCT01213433||Single Group Assignment||Treatment||None (Open Label)||||||
1482457|NCT01213420|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482458|NCT01213407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482459|NCT01213394|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482460|NCT01213381|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482461|NCT01213368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482462|NCT01213355|Randomized|Crossover Assignment||Other||Double|||t||t|
1482463|NCT01213342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482464|NCT01213329||Single Group Assignment||Treatment||None (Open Label)||"Phase 1: 50 subjects were to receive study intervention. If any subjects demonstrated persistent donor specific unresponsiveness at the 12 month post-transplant time point, they would proceed into Phase 2. In that phase, the unresponsive subjects would have been randomized to one of three arms that would modify their standard of care immunosuppression.~None of the 50 subjects from Phase 1 demonstrated persistent donor specific unresponsiveness, therefore, phase 2 was never started."||||
1482465|NCT01213316|||Cohort||Prospective|||||||
1482466|NCT01213303|||Cohort|||||||||
1482467|NCT01213290|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1482468|NCT01213277|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1482469|NCT01213264|||Case Control||Prospective|||||||
1482470|NCT01213251|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1482471|NCT01213238|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482472|NCT01213225|||||Prospective|||||||
1482473|NCT01213212|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482474|NCT01213199||Single Group Assignment||Treatment||None (Open Label)||||||
1482475|NCT01213186|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1482476|NCT01213173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482477|NCT01213160||Single Group Assignment||Treatment||None (Open Label)||||||
1482478|NCT01213147|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482479|NCT01213134|||||Cross-Sectional|||||||
1482480|NCT01213121|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1482481|NCT01213108|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482482|NCT01213095||Single Group Assignment||Treatment||None (Open Label)||||||
1482483|NCT01213082|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482484|NCT01213069|||Cohort||Prospective|||||||
1482485|NCT01213056|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482486|NCT01213043|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1482487|NCT01213030|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1482488|NCT01213017||Single Group Assignment||Treatment||None (Open Label)||||||
1482489|NCT01213004|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1482490|NCT01212991|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482491|NCT01212978|Randomized|Parallel Assignment||Prevention||Single|||||t|
1482492|NCT01212965||Single Group Assignment||Treatment||None (Open Label)||||||
1482493|NCT01212952||Single Group Assignment||Treatment||None (Open Label)||||||
1482494|NCT01212939|||Case-Only||Prospective|||||||
1482495|NCT01212926||Single Group Assignment||Diagnostic||None (Open Label)||||||
1482496|NCT01212913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482497|NCT01212900|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482498|NCT01212887||||Treatment||None (Open Label)||||||
1482499|NCT01212874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482500|NCT01212861||Single Group Assignment||Treatment||None (Open Label)||||||
1482501|NCT01212848|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482502|NCT01212835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482503|NCT01212822||Single Group Assignment||Treatment||None (Open Label)||||||
1482504|NCT01212809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482505|NCT01212796|||||Retrospective|||||||
1482506|NCT01212783|Randomized|Parallel Assignment||Treatment||Single||||||t
1482507|NCT01212770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482508|NCT01212757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482509|NCT01212744||Single Group Assignment||Treatment||None (Open Label)||||||
1482510|NCT01212731|||Cohort||Prospective|||||||
1482511|NCT01212718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482512|NCT01212705||||||||||||
1482513|NCT01212692|Randomized|Parallel Assignment||Treatment||Single||||||t
1482514|NCT01212679|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1482515|NCT01212666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482516|NCT01212653|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482517|NCT01212640|||||Prospective|||||||
1482518|NCT01212627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482519|NCT01212614|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482520|NCT01212601|||Cohort|||||||||
1482521|NCT01212588|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482522|NCT01212575|||Case Control||Retrospective|||||||
1482523|NCT01212562|||Case-Only||Prospective|||||||
1482524|NCT01212549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482525|NCT01212536|Randomized|Parallel Assignment||||None (Open Label)||||||
1482526|NCT01212523|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1482527|NCT01212510||Single Group Assignment||Diagnostic||None (Open Label)||||||
1482528|NCT01212497|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1482529|NCT01212484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482530|NCT01212471|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482531|NCT01212458|||||Prospective|||||||
1482532|NCT01212445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482533|NCT01212432|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482534|NCT01212419|||Cohort||Prospective|||||||
1482535|NCT01212406|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482536|NCT01212393|||Other||Prospective|||||||
1482537|NCT01212380||Single Group Assignment||Treatment||None (Open Label)||||||
1482538|NCT01212367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482539|NCT01212354|Randomized|Parallel Assignment||Treatment||Single||||||t
1482540|NCT01212341|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482541|NCT01212328|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482542|NCT01212315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482543|NCT01212302||Single Group Assignment||Treatment||None (Open Label)||||||
1482544|NCT01212289|||Case Control||Prospective|||||||
1482545|NCT01212276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482546|NCT01212263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482547|NCT01212250|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1482548|NCT01212237|||Case Control||Prospective|||||||
1482549|NCT01212224|||||Retrospective|||||||
1482550|NCT01212211|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482551|NCT01212198|||Cohort||Prospective|||||||
1482552|NCT01212185|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1482553|NCT01212172|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1482554|NCT01212159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482555|NCT01212146|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1482556|NCT01212133|||Cohort||Prospective|||||||
1482557|NCT01212120|||Cohort||Prospective|||||||
1482558|NCT01212107|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482559|NCT01212094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482560|NCT01212081|||||Prospective|||||||
1482561|NCT01212068|||Cohort||Retrospective|||||||
1482562|NCT01212055|||Case-Control||Prospective|||||||
1482563|NCT01212042|||Case-Only||Prospective|||||||
1482564|NCT01212029|||||Prospective|||||||
1482565|NCT01212016|||Cohort||Prospective|||||||
1482566|NCT01212003|||Cohort||Prospective|||||||
1482567|NCT01211990|||||Prospective|||||||
1482568|NCT01211977|Randomized|Single Group Assignment||Treatment||Double||||||
1482569|NCT01211964|Randomized|Crossover Assignment||||None (Open Label)||||||
1482570|NCT01211951|Randomized|Parallel Assignment||Treatment||Double||||||
1482571|NCT01211938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482572|NCT01211925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482573|NCT01211912|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1482574|NCT01211899|||Cohort||Prospective|||||||
1482575|NCT01211886|||Cohort||Prospective|||||||
1482576|NCT01211873|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1482577|NCT01211860|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1482578|NCT01211847|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482579|NCT01211834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482580|NCT01211821|Randomized|Crossover Assignment||||None (Open Label)||||||
1482581|NCT01211808|Randomized|Crossover Assignment||||None (Open Label)||||||
1482582|NCT01211795|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1482583|NCT01211782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482584|NCT01211769|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482585|NCT01211756|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1482586|NCT01211743|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1482587|NCT01211730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482588|NCT01211717|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1482589|NCT01211704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482590|NCT01211691|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482591|NCT01211678|||Cohort||Prospective|||||||
1482592|NCT01211665|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482593|NCT01211652|||Cohort||Cross-Sectional|||||||
1482594|NCT01211639|||Case-Only||Cross-Sectional|||||||
1482595|NCT01211626|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1482596|NCT01211613|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482597|NCT01211600|Randomized|Parallel Assignment||||Single||||||t
1482598|NCT01211587|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482599|NCT01211574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482600|NCT01211561|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1482601|NCT01211548|||Cohort||Prospective|||||||
1482602|NCT01211535|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1482603|NCT01211522|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind, placebo controlled||t|t|t|t
1482604|NCT01211509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482605|NCT01211496|Randomized|Factorial Assignment||Prevention||Single|||||t|
1482606|NCT01211483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482607|NCT01211470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482608|NCT01211457||Single Group Assignment||Treatment||None (Open Label)||||||
1482609|NCT01211444||Single Group Assignment||Treatment||None (Open Label)||||||
1482610|NCT01211431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482611|NCT01211418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482612|NCT01211405|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482613|NCT01211392|||||Prospective|||||||
1482614|NCT01211379|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1482615|NCT01211366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482616|NCT01211353|Randomized|Parallel Assignment||Prevention||Single|||t|||
1482617|NCT01211340|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1482618|NCT01211327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482619|NCT01211314||Single Group Assignment||Treatment||None (Open Label)||||||
1482620|NCT01211301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482621|NCT01211288|||Case-Control||Prospective|||||||
1482622|NCT01211275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482623|NCT01211262|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482624|NCT01211249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482625|NCT01211236|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482626|NCT01211223|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1482627|NCT01211210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482628|NCT01211197|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482629|NCT01211184|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482630|NCT01211171|||Cohort||Prospective|||||||
1482631|NCT01211158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482632|NCT01211145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482633|NCT01211132|Randomized|Parallel Assignment||Prevention||Single|||t|||
1482634|NCT01211119||Parallel Assignment||Treatment||None (Open Label)||||||
1482635|NCT01211106|Randomized|Parallel Assignment||Treatment||Single||||||t
1482636|NCT01211093|Randomized|Crossover Assignment||Treatment||Single||||||t
1482637|NCT01211080|||Cohort||Prospective|||||||
1482638|NCT01211067|||Case-Only||Prospective|||||||
1482639|NCT01211054|||Cohort||Prospective|||||||
1482640|NCT01211041|||Case-Only||Retrospective|||||||
1482641|NCT01211028||Single Group Assignment||Treatment||None (Open Label)||||||
1482642|NCT01211015|||Case Control||Prospective|||||||
1482643|NCT01211002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482644|NCT01210989|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482645|NCT01210976|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482646|NCT01210963|||Cohort||Prospective|||||||
1482647|NCT01210950||Single Group Assignment||Treatment||None (Open Label)||||||
1482648|NCT01210937||Single Group Assignment||Treatment||None (Open Label)||||||
1482649|NCT01210924|||Cohort||Prospective|||||||
1482650|NCT01210911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482651|NCT01210898|Randomized|Parallel Assignment||Prevention||Single||||||t
1482652|NCT01210885|Randomized|Parallel Assignment||Prevention||Single||||||t
1482653|NCT01210872||||||||||||
1482654|NCT01210859|||Case Control||Prospective|||||||
1482655|NCT01210846||Single Group Assignment||||None (Open Label)||||||
1482656|NCT01210833|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1482657|NCT01210820|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482658|NCT01210807|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1482659|NCT01210794||||||||||||
1482660|NCT01210781|||Cohort||Prospective|||||||
1482661|NCT01210768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482662|NCT01210755|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1482663|NCT01210742|Randomized|Parallel Assignment||Treatment||Single||||||t
1482664|NCT01210729||Single Group Assignment||Treatment||None (Open Label)||||||
1482665|NCT01210716|Randomized|Crossover Assignment||||None (Open Label)||||||
1482666|NCT01210703|||Case Control||Cross-Sectional|||||||
1482667|NCT01210690|||Cohort||Prospective|||||||
1482668|NCT01210677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482669|NCT01210664||Single Group Assignment||Treatment||None (Open Label)||||||
1482670|NCT01210651|Randomized|Parallel Assignment||Treatment||Single||||||t
1482671|NCT01210638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482672|NCT01210625|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1482673|NCT01210612|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482674|NCT01210599|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1482675|NCT01210586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482676|NCT01210573|||Case-Only||Prospective|||||||
1482677|NCT01210560|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1482678|NCT01210547|||Case-Only||Prospective|||||||
1482679|NCT01210534|||Case-Only||Prospective|||||||
1482680|NCT01210521|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482681|NCT01210508|||Case-Only||Prospective|||||||
1482682|NCT01210495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482683|NCT01210482|||Case-Only||Prospective|||||||
1482684|NCT01210469|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482685|NCT01210456|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482686|NCT01210443|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482687|NCT01210430|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1482688|NCT01210417|||Case-Only||Prospective|||||||
1482689|NCT01210404|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482690|NCT01210391|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1482691|NCT01210378||Single Group Assignment||Treatment||None (Open Label)||||||
1482692|NCT01210365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482693|NCT01210352||Single Group Assignment||Treatment||None (Open Label)||||||
1482694|NCT01210339|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1482695|NCT01210326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482696|NCT01210313|||Case-Only||Prospective|||||||
1482697|NCT01210300|||||Prospective|||||||
1482698|NCT01210287||Single Group Assignment||||None (Open Label)||||||
1482699|NCT01210274|||Case-Only||Prospective|||||||
1482700|NCT01210261|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1482701|NCT01210248|||Case-Only||Cross-Sectional|||||||
1482702|NCT01210235|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1482703|NCT01210222||Single Group Assignment||Treatment||None (Open Label)||||||
1482704|NCT01210209||||||||||||
1482705|NCT01210196|||||Prospective|||||||
1482706|NCT01210183||Single Group Assignment||Treatment||Single||||||t
1482707|NCT01210170|Randomized|Single Group Assignment||Other||Double|||t||t|
1482708|NCT01210157|||Case Control||Cross-Sectional|||||||
1482709|NCT01210144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482710|NCT01210131||Single Group Assignment||Treatment||None (Open Label)||||||
1482711|NCT01210118|Randomized|Parallel Assignment||Prevention||Single|||t|||
1482712|NCT01210105|||||Prospective|||||||
1482713|NCT01210092|||||Prospective|||||||
1482714|NCT01210079|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482715|NCT01210066|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1482716|NCT01210053||Single Group Assignment||Treatment||None (Open Label)||||||
1482717|NCT01210040|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1482718|NCT01210027|||Case-Only||Prospective|||||||
1482719|NCT01210014|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482720|NCT01210001|Randomized|Parallel Assignment||Treatment||Double||||||
1482721|NCT01209988|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482722|NCT01209975|||Case-Only||Prospective|||||||
1482723|NCT01209962|||Cohort||Prospective|||||||
1482724|NCT01209949||Single Group Assignment||Treatment||None (Open Label)||||||
1482725|NCT01209936||Single Group Assignment||Health Services Research||None (Open Label)||||||
1482726|NCT01209923||Single Group Assignment||Health Services Research||None (Open Label)||||||
1482727|NCT01209910|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1482728|NCT01209897|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482729|NCT01209884|||Cohort||Prospective|||||||
1482730|NCT01209871||Single Group Assignment||Treatment||None (Open Label)||||||
1482731|NCT01209858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482732|NCT01209845||Single Group Assignment||Treatment||None (Open Label)||||||
1482733|NCT01209832||Single Group Assignment||Basic Science||None (Open Label)||||||
1482734|NCT01209819|||Cohort||Prospective|||||||
1482735|NCT01209806|Randomized|Parallel Assignment||||Single|||||t|
1482736|NCT01209793|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1482737|NCT01209780|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482738|NCT01209767|Randomized|Parallel Assignment||Treatment||Single||||||t
1482739|NCT01209754|||Cohort||Prospective|||||||
1482740|NCT01209741|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482741|NCT01209728|Randomized|Parallel Assignment||||Double||||||
1482742|NCT01209715|Randomized|Crossover Assignment||||Double|||t||t|
1482743|NCT01209702|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482744|NCT01209689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482745|NCT01209676||Single Group Assignment||Treatment||None (Open Label)||||||
1482746|NCT01209663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482747|NCT01209650||||||||||||
1482748|NCT01209637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482749|NCT01209624|||Cohort||Prospective|||||||
1482750|NCT01209611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482751|NCT01209598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482752|NCT01209585|||Cohort||Prospective|||||||
1482753|NCT01209572|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482754|NCT01209559|||Cohort||Prospective|||||||
1482755|NCT01209546|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1482756|NCT01209533|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1482757|NCT01209520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482758|NCT01209507|||Cohort||Prospective|||||||
1482759|NCT01209494|||Cohort||Prospective|||||||
1482760|NCT01209481|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1482761|NCT01209468|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1482762|NCT01209455|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1482763|NCT01209442||Single Group Assignment||Treatment||None (Open Label)||||||
1482764|NCT01209429|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1482765|NCT01209416|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1482766|NCT01209403|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1482767|NCT01209390|||Cohort||Prospective|||||||
1482768|NCT01209377|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1482769|NCT01209364|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482770|NCT01209351|Randomized|Parallel Assignment||||Double|||t||t|
1482771|NCT01209338|Randomized|Parallel Assignment||||None (Open Label)||||||
1482772|NCT01209325||Single Group Assignment||Prevention||None (Open Label)||||||
1482773|NCT01209312|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482774|NCT01209299|||Other||Retrospective|||||||
1482775|NCT01209286|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482776|NCT01209273|||Cohort||Prospective|||||||
1482777|NCT01209260|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482778|NCT01209247|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1482779|NCT01209234|Randomized|Parallel Assignment||Prevention||Single||||||t
1482780|NCT01209221|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482781|NCT01209208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482782|NCT01209195||Single Group Assignment||Treatment||None (Open Label)||||||
1482783|NCT01209182||||||||||||
1482784|NCT01209169|||Cohort||Prospective|||||||
1482785|NCT01209156||Single Group Assignment||Diagnostic||None (Open Label)||||||
1482786|NCT01209143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482787|NCT01209130||Single Group Assignment||Treatment||None (Open Label)||||||
1482788|NCT01209117|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1482789|NCT01209104|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482790|NCT01209091|||||Cross-Sectional|||||||
1482791|NCT01209078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482792|NCT01209065|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482793|NCT01209052|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1482794|NCT01209039|Randomized|Parallel Assignment||Treatment||Single|||||t|
1482795|NCT01209026|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1482796|NCT01209013||Single Group Assignment||Treatment||None (Open Label)||||||
1482797|NCT01209000|||Cohort||Prospective|||||||
1482798|NCT01208987|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1482799|NCT01208974|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"Phase 1 dose-escalation/de-escalation. An additional expansion cohort at the potential recommended Phase 2 dose"||||
1482800|NCT01208961|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482801|NCT01208948|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482802|NCT01208935|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1482803|NCT01208922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482804|NCT01208909|||Case Control||Prospective|||||||
1482805|NCT01208896||Single Group Assignment||Treatment||None (Open Label)||||||
1482806|NCT01208883||Single Group Assignment||Treatment||None (Open Label)||||||
1482807|NCT01208870|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482808|NCT01208844|||Case Control||Cross-Sectional|||||||
1482809|NCT01208831||Single Group Assignment||Treatment||None (Open Label)||||||
1482810|NCT01208818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482811|NCT01208805|||Cohort||Prospective|||||||
1482812|NCT01208792|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1482813|NCT01208779|||||Prospective|||||||
1482814|NCT01208766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482815|NCT01208753|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1482816|NCT01208740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482817|NCT01208727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482818|NCT01208714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482819|NCT01208701|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1482820|NCT01208688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482821|NCT01208675|||Cohort||Prospective|||||||
1482822|NCT01208662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482823|NCT01208649|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482824|NCT01208636|||Cohort||Cross-Sectional|||||||
1482825|NCT01208623|||Case-Only||Retrospective|||||||
1482826|NCT01208610|||||Prospective|||||||
1482827|NCT01208597|||Case Control||Prospective|||||||
1482828|NCT01208584|||Cohort||Prospective|||||||
1482829|NCT01208571|Randomized|Parallel Assignment||Prevention||Single||||||t
1482830|NCT01208558|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1482831|NCT01208545|||Cohort||Prospective|||||||
1482832|NCT01208532|||Case-Only||Prospective|||||||
1482833|NCT01208519|||Cohort||Prospective|||||||
1482834|NCT01208506|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1482835|NCT01208493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482836|NCT01208480||Single Group Assignment||Treatment||None (Open Label)||||||
1482837|NCT01208467|||Cohort||Retrospective|||||||
1482838|NCT01208454||Single Group Assignment||Treatment||None (Open Label)||||||
1482839|NCT01208441||Single Group Assignment||Treatment||None (Open Label)||||||
1482840|NCT01208428|Randomized|Parallel Assignment||Treatment||Single||||||t
1482841|NCT01208415||Single Group Assignment||Treatment||None (Open Label)||||||
1482842|NCT01208402|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482843|NCT01208389||Single Group Assignment||Treatment||None (Open Label)||||||
1482844|NCT01208376|||Case Control||Cross-Sectional|||||||
1482845|NCT01208363|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482846|NCT01208350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482847|NCT01208337||Single Group Assignment||Treatment||None (Open Label)||||||
1482848|NCT01208324|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1482849|NCT01208311|||Cohort||Prospective|||||||
1482850|NCT01208298||Single Group Assignment||||None (Open Label)||||||
1482851|NCT01208285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482852|NCT01208272|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482853|NCT01208259|Randomized|Parallel Assignment||Treatment||Single|||t|||
1482854|NCT01208246|||Cohort||Prospective|||||||
1482855|NCT01208233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482856|NCT01208220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482857|NCT01208207|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482858|NCT01208194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482859|NCT01208181|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482860|NCT01208168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482861|NCT01208155|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1482862|NCT01208142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482863|NCT01208129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482864|NCT01208116|||Cohort||Prospective|||||||
1482865|NCT01208103||Single Group Assignment||Treatment||None (Open Label)||||||
1483656|NCT01197716|||Cohort||Prospective|||||||
1482866|NCT01208090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482867|NCT01208077|||Cohort||Prospective|||||||
1482868|NCT01208064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482869|NCT01208051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482870|NCT01208038||Single Group Assignment||Supportive Care||None (Open Label)||||||
1482871|NCT01208025|||Other||Prospective|||||||
1482872|NCT01208012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482873|NCT01207999|||Case-Only||Cross-Sectional|||||||
1482874|NCT01207986||Single Group Assignment||Screening||None (Open Label)||||||
1482875|NCT01207973|Randomized|Single Group Assignment||Treatment||Double||||||
1482876|NCT01207960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482877|NCT01207947|||Case-Only||Prospective|||||||
1482878|NCT01207934|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1482879|NCT01207921||Single Group Assignment||Treatment||None (Open Label)||||||
1482880|NCT01207908|Randomized|Parallel Assignment||Treatment||Single||||||t
1482881|NCT01207895||Single Group Assignment||Basic Science||None (Open Label)||||||
1482882|NCT01207869|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1482883|NCT01207856|Randomized|Parallel Assignment||Treatment||Single||||||t
1482884|NCT01207843|||||Retrospective|||||||
1482885|NCT01207830||Single Group Assignment||Treatment||None (Open Label)||||||
1482886|NCT01207817|||Case Control||Prospective|||||||
1482887|NCT01207804||Single Group Assignment||Treatment||None (Open Label)||||||
1482888|NCT01207791|Randomized|Parallel Assignment||Treatment||Single||||||t
1482889|NCT01207778|||Case-Control||Prospective|||||||
1482890|NCT01207765||Single Group Assignment||Treatment||None (Open Label)||||||
1482891|NCT01207752|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482892|NCT01207739|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482893|NCT01207726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482894|NCT01207713|||Case-Only||Retrospective|||||||
1482895|NCT01207700|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1482896|NCT01207687||Single Group Assignment||Treatment||None (Open Label)||||||
1482897|NCT01207674|Non-Randomized|||Other||||||||
1482898|NCT01207661||Single Group Assignment||Treatment||None (Open Label)||||||
1482899|NCT01207648|||Cohort||Retrospective|||||||
1482900|NCT01207635|||Case-Only||Prospective|||||||
1482901|NCT01207622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482902|NCT01207609||Single Group Assignment||Treatment||None (Open Label)||||||
1482903|NCT01207596||Single Group Assignment||Treatment||None (Open Label)||||||
1482904|NCT01207583|||Cohort||Prospective|||||||
1482905|NCT01207570|Randomized|Crossover Assignment||Treatment||Single||||||t
1482906|NCT01207557|Randomized|Parallel Assignment||Prevention||Single|||||t|
1482907|NCT01207544|Randomized|Parallel Assignment||Treatment||Single||||||t
1482908|NCT01207531|||Case Control||Prospective|||||||
1482909|NCT01207518|Randomized|Parallel Assignment||Prevention||Single||||||t
1482910|NCT01207505||Single Group Assignment||Treatment||None (Open Label)||||||
1482911|NCT01207492||Single Group Assignment||Treatment||None (Open Label)||||||
1482912|NCT01207479||Single Group Assignment||Supportive Care||None (Open Label)||||||
1482913|NCT01207466|Randomized|Crossover Assignment||Treatment||Single|||t|||
1482914|NCT01207453|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1482915|NCT01207440|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482916|NCT01207427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482917|NCT01207414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482918|NCT01207401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482919|NCT01207388||Single Group Assignment||Treatment||None (Open Label)||||||
1482920|NCT01207375|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482921|NCT01207362|||Case Control||Cross-Sectional|||||||
1482922|NCT01207349|||Case Control||Prospective|||||||
1482923|NCT01207336|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482924|NCT01207323|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482925|NCT01207310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482926|NCT01207297|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482927|NCT01207284|Randomized|Parallel Assignment||Treatment||Single||||||t
1482928|NCT01207271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482929|NCT01207258|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482930|NCT01207245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482931|NCT01207232|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1482932|NCT01207219|Randomized|Parallel Assignment||Treatment||Single||||||t
1482933|NCT01207206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482934|NCT01207193||Single Group Assignment||Treatment||None (Open Label)||||||
1482935|NCT01207180|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1482936|NCT01207167|||Cohort||Prospective|||||||
1482937|NCT01207154|||Cohort||Prospective|||||||
1482938|NCT01207141|||Cohort||Prospective|||||||
1482939|NCT01207128|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482940|NCT01207115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482941|NCT01207102||Single Group Assignment||Treatment||None (Open Label)||||||
1482942|NCT01207089|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1482943|NCT01207076||Single Group Assignment||Treatment||None (Open Label)||||||
1482944|NCT01207063||Single Group Assignment||Treatment||None (Open Label)||||||
1482945|NCT01207050|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1482946|NCT01207037||Single Group Assignment||Prevention||None (Open Label)||||||
1482947|NCT01207024|||Cohort||Prospective|||||||
1482948|NCT01207011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482949|NCT01206998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482950|NCT01206985|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1482951|NCT01206972|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1482952|NCT01206959|||||Prospective|||||||
1482953|NCT01206946|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1482954|NCT01206933|||Case Control||Cross-Sectional|||||||
1482955|NCT01206920|||Cohort||Prospective|||||||
1482956|NCT01206907||Single Group Assignment||Treatment||None (Open Label)||||||
1482957|NCT01206894||Single Group Assignment||Diagnostic||None (Open Label)||||||
1482958|NCT01206881||Single Group Assignment||Treatment||None (Open Label)||||||
1482959|NCT01206868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482960|NCT01206855|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1482961|NCT01206842|Randomized|Single Group Assignment||Treatment||Single|||||t|
1482962|NCT01206829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482963|NCT01206816|Non-Randomized|||Treatment||None (Open Label)||||||
1482964|NCT01206803|||Cohort||Prospective|||||||
1482965|NCT01206790|Randomized|Parallel Assignment||Treatment||Single||||||t
1482966|NCT01206777||Single Group Assignment||Treatment||None (Open Label)||||||
1482967|NCT01206764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482968|NCT01206751|||Case-Only||Retrospective|||||||
1482969|NCT01206738|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1482970|NCT01206725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482971|NCT01206712|||Case Control||Prospective|||||||
1482972|NCT01206699|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482973|NCT01206686|Randomized|Parallel Assignment||||Single|||t|||
1482974|NCT01206673|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1482975|NCT01206660|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482976|NCT01206647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482977|NCT01206634|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1482978|NCT01206621|||Cohort||Prospective|||||||
1482979|NCT01206608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482980|NCT01206595|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482981|NCT01206582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1482982|NCT01206569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1482983|NCT01206556|||Cohort||Prospective|||||||
1482984|NCT01206543||Single Group Assignment||Treatment||None (Open Label)||||||
1482985|NCT01206530||||Treatment||||||||
1482986|NCT01206517|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1482987|NCT01206504||||||||||||
1482988|NCT01206491|||Case Control||Prospective|||||||
1482989|NCT01206478|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1482990|NCT01206465||Single Group Assignment||Treatment||None (Open Label)||||||
1482991|NCT01206452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1482992|NCT01206439||Single Group Assignment||Treatment||None (Open Label)||||||
1482993|NCT01206426|||Case-Only||Prospective|||||||
1482994|NCT01206413|Randomized|Parallel Assignment||Prevention||Single|||t|||
1482995|NCT01206400|||Case-Only||Prospective|||||||
1482996|NCT01206387|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1482997|NCT01206374|||Cohort||Prospective|||||||
1482998|NCT01206361|||Cohort||Retrospective|||||||
1482999|NCT01206348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483000|NCT01206335||Single Group Assignment||Treatment||None (Open Label)||||||
1483001|NCT01206322|Randomized|Crossover Assignment||||Double|||t||t|
1483002|NCT01206309|||Cohort||Prospective|||||||
1483003|NCT01206296||Single Group Assignment||Treatment||None (Open Label)||||||
1483004|NCT01206283|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483005|NCT01206270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483006|NCT01206257|||Cohort||Prospective|||||||
1483007|NCT01206244|||Case Control||Prospective|||||||
1483008|NCT01206231|||||Prospective|||||||
1483009|NCT01206218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483010|NCT01206205||Single Group Assignment||Treatment||None (Open Label)||||||
1483011|NCT01206192|||Cohort||Retrospective|||||||
1483012|NCT01206179||Single Group Assignment||Treatment||None (Open Label)||||||
1483013|NCT01206166|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483014|NCT01206153|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1483015|NCT01206140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483016|NCT01206127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483017|NCT01206114|||Cohort||Prospective|||||||
1483018|NCT01206101|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483019|NCT01206088||Single Group Assignment||Treatment||None (Open Label)||||||
1483020|NCT01206075|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483021|NCT01206062|Randomized|Parallel Assignment||Treatment||Single||||||t
1483022|NCT01206049|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483023|NCT01206036||Single Group Assignment||Treatment||None (Open Label)||||||
1483024|NCT01206023|||Case-Only||Cross-Sectional|||||||
1483025|NCT01206010|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483026|NCT01205997|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483027|NCT01205984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483028|NCT01205971|Randomized|Parallel Assignment||Prevention||Single||||||t
1483029|NCT01205958|Randomized|Parallel Assignment||Prevention||Single|||||t|
1483030|NCT01205945|||Cohort||Prospective|||||||
1483031|NCT01205932|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1483032|NCT01205919|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483033|NCT01205906|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483034|NCT01205893|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1483035|NCT01205880|Randomized|||Treatment||Single|||||t|
1483036|NCT01205867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483037|NCT01205854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483038|NCT01205841|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483039|NCT01205828||Single Group Assignment||Treatment||None (Open Label)||||||
1483040|NCT01205815|||Other||Prospective|||||||
1483041|NCT01205802|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483042|NCT01205789|||Cohort||Prospective|||||||
1483043|NCT01205776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483044|NCT01205763|||Case-Only||Prospective|||||||
1483045|NCT01205750||Parallel Assignment||Basic Science||None (Open Label)||||||
1483046|NCT01205737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483047|NCT01205724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483048|NCT01205711|Randomized|Parallel Assignment||Treatment||Double||||||
1483049|NCT01205698||||||||||||
1483050|NCT01205685||Single Group Assignment||Treatment||None (Open Label)||||||
1483051|NCT01205672||Single Group Assignment||Treatment||None (Open Label)||||||
1483052|NCT01205659|||Cohort||Retrospective|||||||
1483053|NCT01205646||Single Group Assignment||Screening||None (Open Label)||||||
1483054|NCT01205633|||||Prospective|||||||
1483055|NCT01205620|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1483056|NCT01205607|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1483057|NCT01205594|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1483058|NCT01205581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483059|NCT01205568||Single Group Assignment||Diagnostic||None (Open Label)||||||
1483060|NCT01205555|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1483061|NCT01205542|Randomized|Factorial Assignment||Treatment||Single||||||t
1483062|NCT01205529||Single Group Assignment||Diagnostic||None (Open Label)|All participants and investigators were blinded to the genetic sequencing results at the time of outcome ascertainment|||||
1483063|NCT01205516|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1483064|NCT01205503|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1483065|NCT01205490||||Basic Science||Single||||||t
1483066|NCT01205477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483067|NCT01205464|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1483068|NCT01205451||Single Group Assignment||Treatment||None (Open Label)||||||
1483069|NCT01205438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483070|NCT01205425|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1483071|NCT01205412|||Cohort||Prospective|||||||
1483072|NCT01205399|||Cohort||Cross-Sectional|||||||
1483073|NCT01205386|||Case-Only||Prospective|||||||
1483074|NCT01205373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483075|NCT01205360|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1483076|NCT01205347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483077|NCT01205334||Single Group Assignment||Treatment||None (Open Label)||||||
1483078|NCT01205321|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483079|NCT01205308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483080|NCT01205295|||Cohort||Prospective|||||||
1483081|NCT01205282|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1483082|NCT01205269|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1483083|NCT01205256||Single Group Assignment||Health Services Research||None (Open Label)||||||
1483084|NCT01205243|||Other||Prospective|||||||
1483085|NCT01205230|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483086|NCT01205217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483087|NCT01205204|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1483088|NCT01205191|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1483089|NCT01205178|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1483090|NCT01205165||Single Group Assignment||Treatment||None (Open Label)||||||
1483091|NCT01205152||Single Group Assignment||Treatment||None (Open Label)||||||
1483092|NCT01205139|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483093|NCT01205126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483094|NCT01205100|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483095|NCT01205087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483096|NCT01205074||||||||||||
1483097|NCT01205061|Randomized|Parallel Assignment||Treatment||Single||||||t
1483098|NCT01205048|Randomized|Parallel Assignment||Treatment||Single||||||t
1483099|NCT01205035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483100|NCT01205022|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483101|NCT01205009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483102|NCT01204996|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483103|NCT01204983|||Cohort||Prospective|||||||
1483104|NCT01204970|||Case Control||Prospective|||||||
1483105|NCT01204957|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1483106|NCT01204944|||Cohort||Prospective|||||||
1483107|NCT01204931|||Case Control||Prospective|||||||
1483108|NCT01204918|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483109|NCT01204905||Single Group Assignment||Treatment||None (Open Label)||Single arm treatment study||||
1483110|NCT01204892|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1483111|NCT01204879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483112|NCT01204866|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483113|NCT01204853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483114|NCT01204840|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483115|NCT01204827||Single Group Assignment||Diagnostic||||||||
1483116|NCT01204814|||Other||Cross-Sectional|||||||
1483117|NCT01204801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483118|NCT01204788|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483119|NCT01204775|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483120|NCT01204762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483121|NCT01204749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483122|NCT01204736|||Cohort||Retrospective|||||||
1483123|NCT01204723|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1483124|NCT01204710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483125|NCT01204697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483126|NCT01204684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483127|NCT01204671|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483128|NCT01204658|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1483129|NCT01204645|||Cohort||Prospective|||||||
1483130|NCT01204632|||Cohort||Prospective|||||||
1483131|NCT01204619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483132|NCT01204606|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1483133|NCT01204593|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483134|NCT01204580|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483135|NCT01204567|Randomized|Parallel Assignment||Treatment||Single||||||t
1483136|NCT01204554|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1483137|NCT01204541|||Case Control||Prospective|||||||
1483138|NCT01204528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483139|NCT01204515|||Case Control||Prospective|||||||
1483140|NCT01204502|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483141|NCT01204489|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483142|NCT01204476||Single Group Assignment||Treatment||None (Open Label)||||||
1483143|NCT01204450||Single Group Assignment||Treatment||None (Open Label)||||||
1483144|NCT01204437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483145|NCT01204424|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483146|NCT01204411||Single Group Assignment||Treatment||None (Open Label)||||||
1483147|NCT01204398|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483148|NCT01204385|||Case-Only||Prospective|||||||
1483149|NCT01204372||Single Group Assignment||Treatment||None (Open Label)||||||
1483150|NCT01204359|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1483151|NCT01204346|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1483152|NCT01204333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483153|NCT01204320|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483154|NCT01204307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483155|NCT01204294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483156|NCT01204281|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483157|NCT01204268|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483158|NCT01204255||Single Group Assignment||Supportive Care||None (Open Label)||||||
1483159|NCT01204242|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483160|NCT01204229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483161|NCT01204216|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483162|NCT01204203||Single Group Assignment||Treatment||None (Open Label)||||||
1483163|NCT01204190|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483164|NCT01204177||Single Group Assignment||Treatment||None (Open Label)||||||
1483165|NCT01204164|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483166|NCT01204151|Non-Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1483167|NCT01204138|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1483168|NCT01204125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483169|NCT01204112|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1483170|NCT01204099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483171|NCT01204086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483172|NCT01204073||Single Group Assignment||Treatment||None (Open Label)||||||
1483173|NCT01204060|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1483174|NCT01204047|||Cohort||Prospective|||||||
1483175|NCT01204034||Single Group Assignment||Treatment||None (Open Label)||||||
1483176|NCT01204021|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1483177|NCT01204008|Randomized|Parallel Assignment||Treatment||Single||||||t
1483178|NCT01203995|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483179|NCT01203982|Randomized|Parallel Assignment||Treatment||Single|||||t|
1483180|NCT01203969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483181|NCT01203956|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1483182|NCT01203943|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483183|NCT01203930||Single Group Assignment||Treatment||None (Open Label)||||||
1483184|NCT01203917||Single Group Assignment||Treatment||None (Open Label)||||||
1483185|NCT01203904|||Cohort||Prospective|||||||
1483186|NCT01203891|||Cohort||Retrospective|||||||
1483187|NCT01203878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483188|NCT01203865||||||||||||
1483189|NCT01203852||Single Group Assignment||Treatment||None (Open Label)||||||
1483190|NCT01203839||Single Group Assignment||Treatment||None (Open Label)||||||
1483191|NCT01203826||Single Group Assignment||Treatment||None (Open Label)||||||
1483192|NCT01203813|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1483193|NCT01203800|||||Retrospective|||||||
1483194|NCT01203787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483195|NCT01203774|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483196|NCT01203761|||Case Control||Cross-Sectional|||||||
1483197|NCT01203748|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483198|NCT01203735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483199|NCT01203722|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483200|NCT01203709||Single Group Assignment||Treatment||None (Open Label)||||||
1483201|NCT01203696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483202|NCT01203683|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483203|NCT01203670||Single Group Assignment||||None (Open Label)||||||
1483204|NCT01203657|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1483205|NCT01203644|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483206|NCT01203631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483207|NCT01203618||Single Group Assignment||Treatment||None (Open Label)||||||
1483208|NCT01203605|||Cohort||Prospective|||||||
1483209|NCT01203592||Single Group Assignment||Treatment||None (Open Label)||||||
1483210|NCT01203579|||Cohort||Prospective|||||||
1483211|NCT01203566|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1483212|NCT01203553|||Case-Control||Prospective|||||||
1483213|NCT01203540|Randomized|Parallel Assignment||Treatment||Double||||||
1483214|NCT01203527|||Cohort|||||||||
1483215|NCT01203514|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1483216|NCT01203501|||Cohort||Prospective|||||||
1483217|NCT01203488|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1483218|NCT01203475|||Cohort||Prospective|||||||
1483219|NCT01203462|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483220|NCT01203449|||Cohort||Prospective|||||||
1483221|NCT01203436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483222|NCT01203423|||Cohort||Prospective|||||||
1483223|NCT01203410|||Cohort||Prospective|||||||
1483224|NCT01203397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483225|NCT01203384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483226|NCT01203371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483227|NCT01203358|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483228|NCT01203345|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483229|NCT01203332|||Ecologic or Community||Cross-Sectional|||||||
1483230|NCT01203319|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1483231|NCT01203306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483232|NCT01203293|Randomized|Parallel Assignment||Treatment||Single||||||t
1483233|NCT01203280|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483234|NCT01203267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483235|NCT01203254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483236|NCT01203241|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483237|NCT01203228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483238|NCT01203215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483239|NCT01203202|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483240|NCT01203189|Randomized|Crossover Assignment||Treatment||Single||||||t
1483241|NCT01203176|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483242|NCT01203163|||||Prospective|||||||
1483243|NCT01203150|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483244|NCT01203137|||Cohort||Prospective|||||||
1483245|NCT01203124|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1483246|NCT01203111|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483247|NCT01203098|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483248|NCT01203085|||Case-Only||Prospective|||||||
1483249|NCT01203072|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483250|NCT01203046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483251|NCT01203033|||Other||Prospective|||||||
1483252|NCT01203020||Single Group Assignment||Treatment||None (Open Label)||||||
1483253|NCT01203007|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483254|NCT01202994||Single Group Assignment||Screening||None (Open Label)||||||
1483255|NCT01202981|||Case-Only||Prospective|||||||
1483256|NCT01202968|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1483257|NCT01202955|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1483258|NCT01202942|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483259|NCT01202929|||Case-Control||Prospective|||||||
1483260|NCT01202916|||Case-Control||Cross-Sectional|||||||
1483261|NCT01202903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483262|NCT01202890||Single Group Assignment||Treatment||None (Open Label)||||||
1483263|NCT01202877||Single Group Assignment||Treatment||None (Open Label)||||||
1483264|NCT01202864|||Case-Control||Other|||||||
1483265|NCT01202851|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1483266|NCT01202838|||Case-Only||Prospective|||||||
1483267|NCT01202825|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1483268|NCT01202812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483269|NCT01202799|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1483270|NCT01202786|||Case Control||Prospective|||||||
1483271|NCT01202773|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483272|NCT01202760|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483273|NCT01202747||Single Group Assignment||Treatment||None (Open Label)||||||
1483274|NCT01202734|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1483275|NCT01202721|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483276|NCT01202708||Crossover Assignment||Treatment||None (Open Label)||||||
1483277|NCT01202695|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1483278|NCT01202682|||Case-Only||Prospective|||||||
1483279|NCT01202669|||Case-Only||Prospective|||||||
1483280|NCT01202656|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483281|NCT01202643|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483282|NCT01202630|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483283|NCT01202617|||Cohort||Prospective|||||||
1483284|NCT01202604|||Case-Only||Prospective|||||||
1483285|NCT01202591|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483286|NCT01202578||Single Group Assignment||Treatment||None (Open Label)||||||
1483287|NCT01202565|||||Prospective|||||||
1483288|NCT01202552|Randomized|Parallel Assignment||Prevention||Single|||||t|
1483289|NCT01202539|||Case-Only||Prospective|||||||
1483290|NCT01202526|||Case Control||Prospective|||||||
1483291|NCT01202513|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1483292|NCT01202500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483293|NCT01202487|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483294|NCT01202474|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483295|NCT01202461|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483296|NCT01202448|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1483297|NCT01202435|Randomized|Crossover Assignment||||None (Open Label)||||||
1483298|NCT01202422|Randomized|Crossover Assignment||||None (Open Label)||||||
1483299|NCT01202409||Single Group Assignment||Treatment||None (Open Label)||||||
1483300|NCT01202396|||Case Control||Prospective|||||||
1483301|NCT01202383|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483302|NCT01202370||Single Group Assignment||Treatment||None (Open Label)||||||
1483303|NCT01202357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483304|NCT01202344|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483305|NCT01202331|Randomized|Parallel Assignment||Treatment||Single||||||t
1483306|NCT01202318|||Cohort||Prospective|||||||
1483307|NCT01202305|||Case-Control||Cross-Sectional|||||||
1483308|NCT01202292|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1483309|NCT01202279|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483310|NCT01202266|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1483311|NCT01202253|||Cohort||Retrospective|||||||
1483312|NCT01202240|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1483313|NCT01202227|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483314|NCT01202214|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1483315|NCT01202201|||Cohort||Retrospective|||||||
1483316|NCT01202188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483317|NCT01202175|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483318|NCT01202162|Randomized|Parallel Assignment||||Double|||t|||t
1483319|NCT01202149|Randomized|Parallel Assignment||Treatment||Single|||||t|
1483320|NCT01202136|||Cohort||Prospective|||||||
1483321|NCT01202123|||Case-Only||Prospective|||||||
1483322|NCT01202110|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483323|NCT01202097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483324|NCT01202084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483325|NCT01202071|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483326|NCT01202058|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483327|NCT01202045|||Cohort||Prospective|||||||
1483328|NCT01202032||Single Group Assignment||Treatment||None (Open Label)||||||
1483329|NCT01202019|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483330|NCT01202006|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483331|NCT01201993|||Case-Only||Prospective|||||||
1483332|NCT01201980|||||Prospective|||||||
1483333|NCT01201967|Randomized|Parallel Assignment||Treatment||Single||||||t
1483334|NCT01201954|Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1483335|NCT01201941|||Case-Control||Prospective|||||||
1483336|NCT01201928|||Cohort||Prospective|||||||
1483337|NCT01201915|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483338|NCT01201902|Randomized|Parallel Assignment||Prevention||Single|||t|||
1483339|NCT01201889||||||||||||
1483340|NCT01201876|||||Cross-Sectional|||||||
1483341|NCT01201863|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483342|NCT01201850||Single Group Assignment||Treatment||None (Open Label)||||||
1483343|NCT01201837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483344|NCT01201824||Single Group Assignment||Diagnostic||None (Open Label)||||||
1483345|NCT01201811||Single Group Assignment||Treatment||None (Open Label)||||||
1483346|NCT01201798|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483347|NCT01201785||Single Group Assignment||Diagnostic||None (Open Label)||||||
1483348|NCT01201772|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483349|NCT01201759|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1483350|NCT01201746|Randomized|Parallel Assignment||Treatment||Single|||||t|
1483351|NCT01201733|Randomized|Parallel Assignment||Treatment||Single||||||t
1483352|NCT01201720||Single Group Assignment||Treatment||None (Open Label)||||||
1483353|NCT01201707|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1483354|NCT01201694|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483355|NCT01201681|||Cohort||Prospective|||||||
1483356|NCT01201668|||Cohort||Cross-Sectional|||||||
1483357|NCT01201655|||Case Control||Retrospective|||||||
1483358|NCT01201642|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483359|NCT01201629|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1483360|NCT01201616|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1483361|NCT01201603|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1483362|NCT01201590|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1483363|NCT01201577|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1483364|NCT01201564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483365|NCT01201551|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1483366|NCT01201538||Single Group Assignment||Treatment||None (Open Label)||||||
1483367|NCT01201525|Randomized|Parallel Assignment||Treatment||Single|||||t|
1483368|NCT01201512|||Cohort||Cross-Sectional|||||||
1483369|NCT01201499|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483370|NCT01201486|||Case-Only||Prospective|||||||
1483371|NCT01201473|||Cohort||Cross-Sectional|||||||
1483372|NCT01201460|||Cohort||Cross-Sectional|||||||
1483373|NCT01201447|||Cohort||Cross-Sectional|||||||
1483374|NCT01201434|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1483375|NCT01201421|||||Cross-Sectional|||||||
1483376|NCT01201408|||Cohort||Prospective|||||||
1483377|NCT01201395|||Cohort||Prospective|||||||
1483378|NCT01201382|Randomized|Parallel Assignment||Prevention||Single||||||t
1483379|NCT01201369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483380|NCT01201356|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483381|NCT01201343||Single Group Assignment||Treatment||None (Open Label)||||||
1483382|NCT01201330|||Cohort||Retrospective|||||||
1483383|NCT01201317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483384|NCT01201304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483385|NCT01201291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483386|NCT01201278|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483387|NCT01201265||Single Group Assignment||Treatment||None (Open Label)||||||
1483388|NCT01201252|||Case-Only||Prospective|||||||
1483389|NCT01201239||Single Group Assignment||Treatment||None (Open Label)||||||
1483390|NCT01201226||Single Group Assignment||Basic Science||None (Open Label)||||||
1483391|NCT01201213|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483392|NCT01201200|||Cohort||Prospective|||||||
1483393|NCT01201187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483394|NCT01201174|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483395|NCT01201161|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1483396|NCT01201148||Single Group Assignment||Treatment||None (Open Label)||||||
1483397|NCT01201135|||||Prospective|||||||
1483398|NCT01201122|Randomized|Parallel Assignment||Treatment||Single|||||t|
1483399|NCT01201109|||Case Control||Prospective|||||||
1483400|NCT01201096|||Case Control||Prospective|||||||
1483401|NCT01201083|||Cohort||Prospective|||||||
1483402|NCT01201070|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1483403|NCT01201057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483404|NCT01201044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483405|NCT01201031|||Case-Only|||||||||
1483406|NCT01201018||Single Group Assignment||Treatment||None (Open Label)||||||
1483407|NCT01201005|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1483408|NCT01200992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483409|NCT01200979|||Case-Control||Prospective|||||||
1483410|NCT01200966|||Cohort||Other|||||||
1483411|NCT01200953|||||Prospective|||||||
1483412|NCT01200940|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1483413|NCT01200927|Randomized|Parallel Assignment||Treatment||Single||||||t
1483414|NCT01200914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483415|NCT01200901||Single Group Assignment||Treatment||None (Open Label)||||||
1483416|NCT01200888|||Case-Only||Prospective|||||||
1483417|NCT01200875|||Case-Only||Prospective|||||||
1483418|NCT01200862|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483419|NCT01200849|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1483420|NCT01200836|||||Prospective|||||||
1483421|NCT01200823|||||Other|||||||
1483422|NCT01200810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483423|NCT01200797||Single Group Assignment||Treatment||None (Open Label)||||||
1483424|NCT01200784|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483425|NCT01200771||Single Group Assignment||Diagnostic||None (Open Label)||||||
1483426|NCT01200758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483427|NCT01200745|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483428|NCT01200732|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483429|NCT01200719|Randomized|Parallel Assignment||Treatment||Single||||||t
1483430|NCT01200706|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483431|NCT01200693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483432|NCT01200680|||Case-Control||Other|||||||
1483433|NCT01200667|||Cohort||Cross-Sectional|||||||
1483434|NCT01200654||Single Group Assignment||Treatment||None (Open Label)||||||
1483435|NCT01200641|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483436|NCT01200628|||Cohort||Prospective|||||||
1483437|NCT01200615|Randomized|Factorial Assignment||Prevention||Single|||t|||
1483438|NCT01200602|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1483439|NCT01200589|Randomized|||Treatment||None (Open Label)||||||
1483440|NCT01200576||||||||||||
1483441|NCT01200563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483442|NCT01200550|||Cohort||Prospective|||||||
1483443|NCT01200537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483444|NCT01200524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483445|NCT01200511||Single Group Assignment||Treatment||None (Open Label)||||||
1483446|NCT01200498||Single Group Assignment||Treatment||None (Open Label)||||||
1483447|NCT01200485|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483448|NCT01200472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483449|NCT01200459|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483450|NCT01200446|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1483451|NCT01200433|Randomized|Parallel Assignment||||None (Open Label)||||||
1483452|NCT01200420|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483453|NCT01200407|||||Prospective|||||||
1483454|NCT01200394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483455|NCT01200381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483456|NCT01200368|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1483457|NCT01200355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483458|NCT01200342||Single Group Assignment||Treatment||None (Open Label)||||||
1483459|NCT01200329||Single Group Assignment||Treatment||None (Open Label)||||||
1483460|NCT01200316|Randomized|Single Group Assignment||Treatment||Single|||t|||
1483461|NCT01200303||Single Group Assignment||Diagnostic||None (Open Label)||||||
1483462|NCT01200290||Single Group Assignment||Other||None (Open Label)||||||
1483463|NCT01200277|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483464|NCT01200264|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483465|NCT01200251|Randomized|Crossover Assignment||Treatment||Single||||||t
1483466|NCT01200238|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||The original dose (Cohort A) was amended based on phase 1 data for safety. Therefore there are 2 separate arms reported.||||
1483467|NCT01200225|||Cohort||Prospective|||||||
1483468|NCT01200212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483469|NCT01200199|||Case-Only||Prospective|||||||
1483470|NCT01200186|||Cohort||Prospective|||||||
1483471|NCT01200173|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1483472|NCT01200160|||Case-Only||Prospective|||||||
1483473|NCT01200147|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483474|NCT01200134||Single Group Assignment||Diagnostic||None (Open Label)||||||
1483475|NCT01200121|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483476|NCT01200108||||||||||||
1483477|NCT01200095|||Case-Only||Retrospective|||||||
1483478|NCT01200082|||Cohort||Prospective|||||||
1483479|NCT01200069|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1483480|NCT01200056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483481|NCT01200043||Single Group Assignment||Treatment||None (Open Label)||||||
1483482|NCT01200030|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483483|NCT01200017||||||||||||
1483484|NCT01200004|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483485|NCT01199991|||Cohort||Cross-Sectional|||||||
1483486|NCT01199978||Single Group Assignment||Treatment||None (Open Label)||||||
1483487|NCT01199965|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483488|NCT01199952|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1483489|NCT01199939||Single Group Assignment||Treatment||None (Open Label)||||||
1483490|NCT01199926|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1483491|NCT01199913|||Case Control||Prospective|||||||
1483492|NCT01199900|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483493|NCT01199887||Single Group Assignment||Treatment||None (Open Label)||||||
1483494|NCT01199874|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483495|NCT01199861|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483496|NCT01199848|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1483657|NCT01197703|||Case-Only||Prospective|||||||
1483497|NCT01199835|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483498|NCT01199822||Single Group Assignment||Treatment||None (Open Label)||||||
1483499|NCT01199809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483500|NCT01199783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483501|NCT01199770|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1483502|NCT01199757|||Cohort||Cross-Sectional|||||||
1483503|NCT01199744|||Other||Prospective|||||||
1483504|NCT01199731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483505|NCT01199718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483506|NCT01199705||Single Group Assignment||Treatment||None (Open Label)||||||
1483507|NCT01199692|||Case-Control||Prospective|||||||
1483508|NCT01199679|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483509|NCT01199666|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1483510|NCT01199653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483511|NCT01199640|Randomized|Single Group Assignment||Treatment||Single|||||t|
1483512|NCT01199627|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1483513|NCT01199614||Single Group Assignment||Treatment||None (Open Label)||||||
1483514|NCT01199601|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1483515|NCT01199588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483516|NCT01199575||Single Group Assignment||Treatment||None (Open Label)||||||
1483517|NCT01199562||Single Group Assignment||Supportive Care||None (Open Label)||||||
1483518|NCT01199549||||||||||||
1483519|NCT01199536|||Case-Only||Prospective|||||||
1483520|NCT01199523|Randomized|Crossover Assignment||||Triple|||t||t|t
1483521|NCT01199510|Randomized|Parallel Assignment||Treatment||Single|||||t|
1483522|NCT01199497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483523|NCT01199484||||||||||||
1483524|NCT01199471|||Case-Only||Prospective|||||||
1483525|NCT01199458|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1483526|NCT01199445|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1483527|NCT01199432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483528|NCT01199419|||Cohort||Prospective|||||||
1483529|NCT01199406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483530|NCT01199393|||Case-Only||Prospective|||||||
1483531|NCT01199380|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483532|NCT01199367||Single Group Assignment||Treatment||None (Open Label)||||||
1483533|NCT01199354||Single Group Assignment||||None (Open Label)||||||
1483534|NCT01199341|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1483535|NCT01199328|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483536|NCT01199315|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1483537|NCT01199302||Single Group Assignment||Treatment||None (Open Label)||||||
1483538|NCT01199289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483539|NCT01199276|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483540|NCT01199263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483541|NCT01199250|||||Retrospective|||||||
1483542|NCT01199237|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483543|NCT01199224|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483544|NCT01199211|||Other||Prospective|||||||
1483545|NCT01199198|Randomized|Single Group Assignment||Treatment||Single|||t|||
1483546|NCT01199185|Randomized|Parallel Assignment||Prevention||Single||||||t
1483547|NCT01199172|Randomized|Factorial Assignment||Prevention||Single|||||t|
1483548|NCT01199159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483549|NCT01199146||Single Group Assignment||Treatment||None (Open Label)||||||
1483550|NCT01199133|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483551|NCT01199120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483552|NCT01199107|Randomized|Parallel Assignment||Treatment||Single||||||t
1483553|NCT01199094|||Case Control||Cross-Sectional|||||||
1483554|NCT01199081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483555|NCT01199068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483556|NCT01199055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483557|NCT01199042||Single Group Assignment||Treatment||None (Open Label)||||||
1483558|NCT01199029|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483559|NCT01199016|||Cohort||Prospective|||||||
1483560|NCT01198990|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1483561|NCT01198977|Randomized|Parallel Assignment||Treatment||Single||||||t
1483562|NCT01198964|||Case-Only||Prospective|||||||
1483563|NCT01198938|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1483564|NCT01198925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483565|NCT01198912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483566|NCT01198899|||Cohort||Prospective|||||||
1483567|NCT01198886|Randomized|Parallel Assignment||||Single||||||t
1483568|NCT01198873|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483569|NCT01198860||||||||||||
1483570|NCT01198847|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483571|NCT01198834|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1483572|NCT01198821||Single Group Assignment||Treatment||None (Open Label)||||||
1483573|NCT01198808|||Cohort||Prospective|||||||
1483574|NCT01198795||Single Group Assignment||Treatment||None (Open Label)||||||
1483575|NCT01198782||Single Group Assignment||Treatment||None (Open Label)||||||
1483576|NCT01198769||Single Group Assignment||Prevention||None (Open Label)||||||
1483577|NCT01198756|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1483578|NCT01198743|||Cohort||Prospective|||||||
1483579|NCT01198730||Single Group Assignment||Diagnostic||None (Open Label)||||||
1483580|NCT01198717|||Cohort||Cross-Sectional|||||||
1483581|NCT01198704|||Cohort||Prospective|||||||
1483582|NCT01198691|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483583|NCT01198678||Single Group Assignment||||None (Open Label)||||||
1483584|NCT01198665|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483585|NCT01198652|||Case-Only||Retrospective|||||||
1483586|NCT01198639|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1483587|NCT01198626|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483588|NCT01198613|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483589|NCT01198600|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483590|NCT01198587|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483591|NCT01198574|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1483592|NCT01198561|||Case-Only||Prospective|||||||
1483593|NCT01198548||Single Group Assignment||Treatment||None (Open Label)||||||
1483594|NCT01198535|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483595|NCT01198522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483596|NCT01198509|Randomized|Parallel Assignment||||Single||||||t
1483597|NCT01198496|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483598|NCT01198483|Randomized|Parallel Assignment||Treatment||Single||||||t
1483599|NCT01198470||Single Group Assignment||Treatment||None (Open Label)||||||
1483600|NCT01198457|||Cohort||Prospective|||||||
1483601|NCT01198444|||Cohort||Prospective|||||||
1483602|NCT01198431|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1483603|NCT01198418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483604|NCT01198405|Randomized|Parallel Assignment||Treatment||Single|||||t|
1483605|NCT01198392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483606|NCT01198379|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1483607|NCT01198366|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483608|NCT01198353||Single Group Assignment||Treatment||None (Open Label)||||||
1483609|NCT01198340|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483610|NCT01198327||Single Group Assignment||Treatment||None (Open Label)||||||
1483611|NCT01198314|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483612|NCT01198301|||Cohort||Prospective|||||||
1483613|NCT01198288|Randomized|Parallel Assignment||Treatment||Single||||||t
1483614|NCT01198275|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1483615|NCT01198262|||||Retrospective|||||||
1483616|NCT01198249|Randomized|Crossover Assignment||||None (Open Label)||||||
1483617|NCT01198236||Single Group Assignment||Prevention||None (Open Label)||||||
1483618|NCT01198223|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483619|NCT01198210|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483620|NCT01198197||Single Group Assignment||Diagnostic||None (Open Label)||||||
1483621|NCT01198184||Single Group Assignment||Treatment||None (Open Label)||||||
1483622|NCT01198171|||||Retrospective|||||||
1483623|NCT01198158|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483624|NCT01198145|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1483625|NCT01198132|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1483626|NCT01198119||Single Group Assignment||Diagnostic||None (Open Label)||||||
1483627|NCT01198106|Randomized|Crossover Assignment||Prevention||Single|||t|||
1483628|NCT01198093|||Cohort||Prospective|||||||
1483629|NCT01198080||Single Group Assignment||Treatment||None (Open Label)||||||
1483630|NCT01198067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483631|NCT01198054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483632|NCT01198028||Single Group Assignment||Treatment||None (Open Label)||||||
1483633|NCT01198015|||||Cross-Sectional|||||||
1483634|NCT01198002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483635|NCT01197989|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1483636|NCT01197976|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1483637|NCT01197963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483638|NCT01197950|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1483639|NCT01197937|||Cohort||Retrospective|||||||
1483640|NCT01197924|||Case Control|||||||||
1483641|NCT01197911|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1483642|NCT01197898|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483643|NCT01197885||Single Group Assignment||Treatment||None (Open Label)||||||
1483644|NCT01197872|||||Prospective|||||||
1483645|NCT01197859||||||||||||
1483646|NCT01197846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483647|NCT01197833|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1483648|NCT01197820|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1483649|NCT01197807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483650|NCT01197794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483651|NCT01197781|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1483652|NCT01197768|Randomized|Parallel Assignment||Treatment||Single||||||t
1483653|NCT01197755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483654|NCT01197742|||Cohort||Prospective|||||||
1483655|NCT01197729|||Case-Only||Prospective|||||||
1483658|NCT01197690|||Case Control||Cross-Sectional|||||||
1483659|NCT01197677|||Case-Only||Prospective|||||||
1483660|NCT01197664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483661|NCT01197651|||Cohort||Prospective|||||||
1483662|NCT01197638|||Case-Only||Prospective|||||||
1483663|NCT01197625||Single Group Assignment||Treatment||None (Open Label)||||||
1483664|NCT01197612||Single Group Assignment||Treatment||Triple|||t|t|t|
1483665|NCT01197599|||Case Control||Cross-Sectional|||||||
1483666|NCT01197586|||Cohort||Prospective|||||||
1483667|NCT01197573|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483668|NCT01197560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483669|NCT01197547||Single Group Assignment||Treatment||None (Open Label)||||||
1483670|NCT01197534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483671|NCT01197521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483672|NCT01197508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483673|NCT01197495|Randomized|Crossover Assignment||||Single||||||t
1483674|NCT01197482|||Case Control||Prospective|||||||
1483675|NCT01197469|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1483676|NCT01197456|||Cohort||Prospective|||||||
1483677|NCT01197443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483678|NCT01197430|Randomized|Crossover Assignment||||Single|||t|||
1483679|NCT01197417|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483680|NCT01197404|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483681|NCT01197391|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1483682|NCT01197378||Single Group Assignment||Treatment||None (Open Label)||||||
1483683|NCT01197365|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1483684|NCT01197352|Randomized|Parallel Assignment||Screening||Single||||||t
1483685|NCT01197339|Randomized|Factorial Assignment||Basic Science||Single||||||t
1483686|NCT01197326|||Cohort||Prospective|||||||
1483687|NCT01197313|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483688|NCT01197300|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483689|NCT01197287|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1483690|NCT01197274|||Case-Only||Cross-Sectional|||||||
1483691|NCT01197261|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483692|NCT01197248|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1483693|NCT01197235|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483694|NCT01197222|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1483695|NCT01197209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483696|NCT01197196|Randomized|Parallel Assignment||Treatment||Single||||||t
1483697|NCT01197183|||Cohort||Prospective|||||||
1483698|NCT01197170|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483699|NCT01197157|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483700|NCT01197144|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1483701|NCT01197131|||Cohort||Prospective|||||||
1483702|NCT01197118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483703|NCT01197105|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1483704|NCT01197092|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483705|NCT01197079|||||Prospective|||||||
1483706|NCT01197066||Single Group Assignment||Treatment||None (Open Label)||||||
1483707|NCT01197053|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1483708|NCT01197040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483709|NCT01197027|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483710|NCT01197014|Randomized|Crossover Assignment||||None (Open Label)||||||
1483711|NCT01197001|Randomized|Crossover Assignment||||None (Open Label)||||||
1483712|NCT01196988|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483713|NCT01196975|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1483714|NCT01196962|Randomized|Parallel Assignment||Treatment||Single|||||t|
1483715|NCT01196949|Randomized|Parallel Assignment||Treatment||Single||||||t
1483716|NCT01196936|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1483717|NCT01196923||Single Group Assignment||Treatment||None (Open Label)||||||
1483718|NCT01196910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483719|NCT01196897||Single Group Assignment||Treatment||None (Open Label)||||||
1483720|NCT01196884|||Case-Control||Prospective|||||||
1483721|NCT01196871|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||A 2-stage design was used to study the effects of 2 dose levels of migalastat, while a 2- or 3-period design within each stage enabled study of the effects of one drug on the PK, pharmacodynamics, and safety of the other drug.||||
1483722|NCT01196858|||Cohort||Retrospective|||||||
1483723|NCT01196845|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1483724|NCT01196832|||Case Control||Prospective|||||||
1483725|NCT01196819|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1483726|NCT01196806|||Case-Only||Cross-Sectional|||||||
1483727|NCT01196793|||Cohort||Prospective|||||||
1483728|NCT01196780|||Cohort||Prospective|||||||
1483729|NCT01196767|Randomized|Parallel Assignment||||Double|||t||t|
1483730|NCT01196754||||Screening||||||||
1483731|NCT01196741|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483732|NCT01196728|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1483733|NCT01196715|Randomized|Factorial Assignment||||None (Open Label)||||||
1483734|NCT01196702|||Case Control||Cross-Sectional|||||||
1483735|NCT01196689||Single Group Assignment||Basic Science||None (Open Label)||||||
1483736|NCT01196676|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1483737|NCT01196663|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1483738|NCT01196650|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1483739|NCT01196637|||Case Control||Prospective|||||||
1483740|NCT01196624|Randomized|Factorial Assignment||Diagnostic||Double|||t|||t
1483741|NCT01196611|Randomized|Parallel Assignment||Treatment||Single||||||t
1483742|NCT01196598|Randomized|Parallel Assignment||Treatment||Single||||||t
1483743|NCT01196585|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483744|NCT01196572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483745|NCT01196559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483746|NCT01196546||Single Group Assignment||Treatment||None (Open Label)||||||
1483747|NCT01196533||Single Group Assignment||Screening||Single|||||t|
1483748|NCT01196520|||Case-Control||Cross-Sectional|||||||
1483749|NCT01196507|Randomized|Parallel Assignment||Prevention||Single|||t|||
1483750|NCT01196494|Randomized|Parallel Assignment||||None (Open Label)||||||
1483751|NCT01196481|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483752|NCT01196468|||||Cross-Sectional|||||||
1483753|NCT01196455||Single Group Assignment||Treatment||None (Open Label)||||||
1483754|NCT01196442||Single Group Assignment||Supportive Care||None (Open Label)||||||
1483755|NCT01196429||Single Group Assignment||Treatment||None (Open Label)||||||
1483756|NCT01196416||Single Group Assignment||Treatment||None (Open Label)||||||
1483757|NCT01196403|Randomized|||Treatment||None (Open Label)||||||
1483758|NCT01196390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483759|NCT01196377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483760|NCT01196364|Randomized|Crossover Assignment||Prevention||Single|||t|||
1483761|NCT01196351|Randomized|Crossover Assignment||Prevention||Single|||t|||
1483762|NCT01196338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483763|NCT01196325|||Cohort||Prospective|||||||
1483764|NCT01196312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483765|NCT01196299|||Cohort||Prospective|||||||
1483766|NCT01196286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483767|NCT01196273|||Cohort||Prospective|||||||
1483768|NCT01196260|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1483769|NCT01196247|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483770|NCT01196234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483771|NCT01196221|||Cohort||Prospective|||||||
1483772|NCT01196208||||||||||||
1483773|NCT01196195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483774|NCT01196182|||Cohort||Prospective|||||||
1483775|NCT01196169|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483776|NCT01196156|||Cohort||Prospective|||||||
1483777|NCT01196143|||Cohort||Prospective|||||||
1483778|NCT01196130|||Case-Only||Prospective|||||||
1483779|NCT01196117|Randomized|Crossover Assignment||Treatment||Single|||t|||
1483780|NCT01196104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483781|NCT01196091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483782|NCT01196078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483783|NCT01196065|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1483784|NCT01196052||Single Group Assignment||Treatment||None (Open Label)||||||
1483785|NCT01196039|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483786|NCT01196026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483787|NCT01196013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483788|NCT01196000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483789|NCT01195987|||Cohort||Prospective|||||||
1483790|NCT01195974|Randomized|Crossover Assignment||||Double|||t|t||
1483791|NCT01195961|||||Prospective|||||||
1483792|NCT01195948|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483793|NCT01195922||Single Group Assignment||Treatment||None (Open Label)||||||
1483794|NCT01195896||Single Group Assignment||Treatment||None (Open Label)||||||
1483795|NCT01195883|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483796|NCT01195870|||Cohort||Prospective|||||||
1483797|NCT01195857|||Cohort||Prospective|||||||
1483798|NCT01195844|||Cohort||Prospective|||||||
1483799|NCT01195831|Randomized|Parallel Assignment||Treatment||Single|||||t|
1483800|NCT01195818||Single Group Assignment||Prevention||None (Open Label)||||||
1483801|NCT01195805|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1483802|NCT01195792|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483803|NCT01195779|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483804|NCT01195766||Single Group Assignment||Treatment||None (Open Label)||||||
1483805|NCT01195753||Single Group Assignment||Treatment||None (Open Label)||||||
1483806|NCT01195740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483807|NCT01195727|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1483808|NCT01195714||Single Group Assignment||Treatment||None (Open Label)||||||
1483809|NCT01195701|||Case Control||Prospective|||||||
1483810|NCT01195688|Randomized|Single Group Assignment||Treatment||Double||||||
1483811|NCT01195675|Randomized|Crossover Assignment||Treatment||Double||||||
1483812|NCT01195662|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483813|NCT01195649|||Cohort||Prospective|||||||
1483814|NCT01195636|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483815|NCT01195623|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483816|NCT01195610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483817|NCT01195597||Single Group Assignment||Treatment||None (Open Label)||||||
1483818|NCT01195584|||Cohort||Retrospective|||||||
1483819|NCT01195571||Single Group Assignment||Prevention||None (Open Label)||||||
1483820|NCT01195558|||Case-Only||Cross-Sectional|||||||
1483821|NCT01195545||Single Group Assignment||Treatment||None (Open Label)||||||
1483822|NCT01195532|||Case-Crossover|||||||||
1483823|NCT01195519|||Case-Only||Prospective|||||||
1483824|NCT01195506|||Case-Only||Retrospective|||||||
1483825|NCT01195493|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1483826|NCT01195480|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483827|NCT01195467||Single Group Assignment||Treatment||None (Open Label)||||||
1483828|NCT01195454|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1483829|NCT01195441|||Cohort||Prospective|||||||
1483830|NCT01195428|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483831|NCT01195415||Single Group Assignment||Treatment||None (Open Label)||||||
1483832|NCT01195402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483833|NCT01195389|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483834|NCT01195376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483835|NCT01195363|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483836|NCT01195350|||Cohort||Prospective|||||||
1483837|NCT01195337|||Cohort||Prospective|||||||
1483838|NCT01195324|Randomized|Crossover Assignment||||None (Open Label)||||||
1483839|NCT01195311||Single Group Assignment||Treatment||None (Open Label)||||||
1483840|NCT01195298||Single Group Assignment||Treatment||None (Open Label)||||||
1483841|NCT01195285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483842|NCT01195272|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483843|NCT01195259|||Cohort||Retrospective|||||||
1483844|NCT01195246|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1483845|NCT01195233|Randomized|Crossover Assignment||Supportive Care||Double|||||t|t
1483846|NCT01195220|Randomized|Parallel Assignment||Prevention||Single||||t||
1483847|NCT01195207|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1483848|NCT01195194|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483849|NCT01195181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483850|NCT01195168|||Case Control||Cross-Sectional|||||||
1483851|NCT01195155|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483852|NCT01195142|||Case Control||Cross-Sectional|||||||
1483853|NCT01195129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483854|NCT01195116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483855|NCT01195103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483856|NCT01195090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483857|NCT01195077||Single Group Assignment||Prevention||Single|||t|||
1483858|NCT01195064|||Cohort||Prospective|||||||
1483859|NCT01195051|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1483860|NCT01195038|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1483861|NCT01195025|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483862|NCT01195012|Randomized|||||||||||
1483863|NCT01194999||Single Group Assignment||Treatment||None (Open Label)||||||
1483864|NCT01194986|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1483865|NCT01194973||Single Group Assignment||Treatment||None (Open Label)||||||
1483866|NCT01194960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483867|NCT01194947|||Case-Only||Prospective|||||||
1483868|NCT01194934|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483869|NCT01194908||Single Group Assignment||Treatment||None (Open Label)||||||
1483870|NCT01194895|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483871|NCT01194882|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483872|NCT01194869||Single Group Assignment||Treatment||None (Open Label)||||||
1483873|NCT01194856|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483874|NCT01194843|Randomized|Parallel Assignment||||Double|||t||t|
1483875|NCT01194830|Randomized|Parallel Assignment||Treatment||Double||||||
1483876|NCT01194817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483877|NCT01194804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483878|NCT01194791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483879|NCT01194778|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483880|NCT01194765|Randomized|Parallel Assignment||Treatment||Single||||||t
1483881|NCT01194752||||||||||||
1483882|NCT01194739||||||||||||
1483883|NCT01194726||||||||||||
1483884|NCT01194713|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1483885|NCT01194700|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483886|NCT01194687|||Ecologic or Community||Cross-Sectional|||||||
1483887|NCT01194674||Single Group Assignment||Treatment||None (Open Label)||||||
1483888|NCT01194661|||Cohort||Other|||||||
1483889|NCT01194648||Single Group Assignment||Treatment||None (Open Label)||Multi-Centre Prospective Single Arm Intervention Trial||||
1483890|NCT01194635|||Other||Retrospective|||||||
1483891|NCT01194622|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483892|NCT01194609||Single Group Assignment||Treatment||None (Open Label)||||||
1483893|NCT01194596|Randomized|Parallel Assignment||Prevention||Single|||t|||
1483894|NCT01194583|||Cohort||Prospective|||||||
1483895|NCT01194570|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483896|NCT01194557|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1483897|NCT01194544|||Cohort||Prospective|||||||
1483898|NCT01194531|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1483899|NCT01194518||||Prevention||||||||
1483900|NCT01194505|Randomized|Parallel Assignment||Supportive Care||Triple|The patient, the orphopaedic surgeon and the anesthesiologist in the OR did not know at which group the patient belonged to.||t|t||t
1483901|NCT01194492||Single Group Assignment||Basic Science||None (Open Label)||||||
1483902|NCT01194479|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1483903|NCT01194466|Randomized|Crossover Assignment||Treatment||Single|||||t|
1483904|NCT01194453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483905|NCT01194440||Single Group Assignment||Supportive Care||None (Open Label)||||||
1483906|NCT01194427||Single Group Assignment||Basic Science||None (Open Label)||||||
1483907|NCT01194414|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1483908|NCT01194401|||Cohort||Prospective|||||||
1483909|NCT01194388|||||Prospective|||||||
1483910|NCT01194375|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483911|NCT01194362|||Case-Control||Prospective|||||||
1483912|NCT01194349|||Case-Only||Retrospective|||||||
1483913|NCT01194336|||Cohort||Prospective|||||||
1483914|NCT01194323|||Case-Control||Prospective|||||||
1483915|NCT01194310|||Cohort||Retrospective|||||||
1483916|NCT01194297|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483917|NCT01194284|||Case-Only||Prospective|||||||
1483918|NCT01194271||Single Group Assignment||Treatment||None (Open Label)||||||
1483919|NCT01194258|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483920|NCT01194245|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1483921|NCT01194232|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483922|NCT01194219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483923|NCT01194206||Single Group Assignment||Treatment||None (Open Label)||||||
1483924|NCT01194193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483925|NCT01194180|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483926|NCT01194167||Single Group Assignment||Treatment||None (Open Label)||||||
1483927|NCT01194154|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483928|NCT01194141||Single Group Assignment||Treatment||None (Open Label)||||||
1483929|NCT01194128|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1483930|NCT01194115|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483931|NCT01194102|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1483932|NCT01194089|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1483933|NCT01194076||Single Group Assignment||Treatment||None (Open Label)||||||
1483934|NCT01194063||Single Group Assignment||Treatment||None (Open Label)||||||
1483935|NCT01194050|||Cohort||Prospective|||||||
1483936|NCT01194037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483937|NCT01194024|||Cohort||Prospective|||||||
1483938|NCT01194011||||||||||||
1483939|NCT01193998|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1483940|NCT01193985||Single Group Assignment||Treatment||None (Open Label)||||||
1483941|NCT01193972|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1483942|NCT01193959|||Cohort||Retrospective|||||||
1483943|NCT01193946|||Cohort||Prospective|||||||
1483944|NCT01193933||Single Group Assignment||Treatment||None (Open Label)||||||
1483945|NCT01193920|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483946|NCT01193907|Randomized|Parallel Assignment||Prevention||Single|||t|||
1483947|NCT01193894|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1483948|NCT01193881||Single Group Assignment||Treatment||None (Open Label)||||||
1483949|NCT01193868||Single Group Assignment||Treatment||None (Open Label)||||||
1483950|NCT01193855|Randomized|||Treatment||Double||||||
1483951|NCT01193842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483952|NCT01193829|||Cohort||Prospective|||||||
1483953|NCT01193816|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483954|NCT01193803|||Case Control||Prospective|||||||
1483955|NCT01193790|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483956|NCT01193777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483957|NCT01193764|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1483958|NCT01193751|||Cohort||Prospective|||||||
1483959|NCT01193738|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1483960|NCT01193725|Randomized|Parallel Assignment||Treatment||Single||||||t
1483961|NCT01193712|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483962|NCT01193699||Single Group Assignment||Treatment||None (Open Label)||||||
1483963|NCT01193686|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1483964|NCT01193673|||Case-Only||Cross-Sectional|||||||
1483965|NCT01193660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483966|NCT01193647|||Case-Only||Cross-Sectional|||||||
1483967|NCT01193634|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1483968|NCT01193621|Randomized|Parallel Assignment||||None (Open Label)||||||
1483969|NCT01193608|Randomized|||Treatment||Quadruple|||t|t|t|t
1483970|NCT01193595||Single Group Assignment||Treatment||None (Open Label)||||||
1483971|NCT01193582|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1483972|NCT01193569|||Cohort||Prospective|||||||
1483973|NCT01193556|Randomized|Parallel Assignment||Treatment||Single|||t|||
1483974|NCT01193543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483975|NCT01193530|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1483976|NCT01193517|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483977|NCT01193504|Randomized|Parallel Assignment||Prevention||Single|||||t|
1483978|NCT01193491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483979|NCT01193478|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483980|NCT01193465|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1483981|NCT01193452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483982|NCT01193439|||Case Control||Prospective|||||||
1483983|NCT01193426|||Cohort||Prospective|||||||
1483984|NCT01193413|||Case Control||Prospective|||||||
1483985|NCT01193400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483986|NCT01193387|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1483987|NCT01193374|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483988|NCT01193361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1483989|NCT01193348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483990|NCT01193335|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1483991|NCT01193296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1483992|NCT01193283||Single Group Assignment||Treatment||None (Open Label)||||||
1483993|NCT01193270|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1483994|NCT01193257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483995|NCT01193244|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1483996|NCT01193231|||||Prospective|||||||
1483997|NCT01193218|Randomized|Parallel Assignment||Treatment||Double||||||
1483998|NCT01193205|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1483999|NCT01193192|||Case Control||Retrospective|||||||
1484000|NCT01193179||Single Group Assignment||Treatment||None (Open Label)||||||
1484001|NCT01193166|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484002|NCT01193153|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484003|NCT01193140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484004|NCT01193127|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1484005|NCT01193114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484006|NCT01193101|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484007|NCT01193088|||Cohort||Prospective|||||||
1484008|NCT01193075|||Cohort||Prospective|||||||
1484009|NCT01193062|Randomized|Parallel Assignment||Other||Double|||t||t|
1484010|NCT01193049|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1484011|NCT01193036|||Cohort||Prospective|||||||
1484012|NCT01193023|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1484013|NCT01193010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484014|NCT01192997|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484015|NCT01192984||Single Group Assignment||Treatment||||||||
1484016|NCT01192971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484017|NCT01192958|||Case-Only|||||||||
1484018|NCT01192945|||Cohort||Prospective|||||||
1484019|NCT01192932|||Case-Only||Prospective|||||||
1484020|NCT01192919|||Cohort||Prospective|||||||
1484021|NCT01192906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484022|NCT01192893|||Cohort||Retrospective|||||||
1484023|NCT01192880|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484024|NCT01192867|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484025|NCT01192854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484026|NCT01192841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484027|NCT01192828||Single Group Assignment||Treatment||None (Open Label)||||||
1484028|NCT01192815||Single Group Assignment||Treatment||None (Open Label)||||||
1484029|NCT01192802|Randomized|Single Group Assignment||Treatment||Single||||||t
1484030|NCT01192789|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484031|NCT01192776|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1484032|NCT01192763||Single Group Assignment||Treatment||None (Open Label)||||||
1484033|NCT01192750|||Other||Retrospective|||||||
1484034|NCT01192737|||Cohort||Prospective|||||||
1484035|NCT01192724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484036|NCT01192711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484037|NCT01192698|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484038|NCT01192685||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1484039|NCT01192672|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484040|NCT01192659|||||Prospective|||||||
1484041|NCT01192646|Randomized|Parallel Assignment||||None (Open Label)||||||
1484042|NCT01192633|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1484043|NCT01192620|||Case-Only||Prospective|||||||
1484044|NCT01192607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484045|NCT01192594|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1484046|NCT01192581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484047|NCT01192568||Single Group Assignment||Treatment||None (Open Label)||||||
1484048|NCT01192555||Single Group Assignment||Treatment||None (Open Label)||||||
1484049|NCT01192542|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1484050|NCT01192529|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1484051|NCT01192516|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484052|NCT01192503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484053|NCT01192490|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1484054|NCT01192477|Randomized|Crossover Assignment||||Double|||t||t|
1484055|NCT01192464||Single Group Assignment||Treatment||None (Open Label)||||||
1484056|NCT01192451|||Cohort||Prospective|||||||
1484057|NCT01192438|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484058|NCT01192425|||||Prospective|||||||
1484059|NCT01192412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484060|NCT01192399||Single Group Assignment||Treatment||None (Open Label)||||||
1484061|NCT01192386||||||||||||
1484062|NCT01192373|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1484063|NCT01192360|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484064|NCT01192347|||Case-Only||Prospective|||||||
1484065|NCT01192334|||Case-Only||Prospective|||||||
1484066|NCT01192321|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1484067|NCT01192308||Single Group Assignment||Treatment||None (Open Label)||||||
1484068|NCT01192295||Single Group Assignment||Treatment||None (Open Label)||||||
1484069|NCT01192282|||Cohort||Prospective|||||||
1484070|NCT01192269||Single Group Assignment||Basic Science||None (Open Label)||||||
1484071|NCT01192256|||Cohort||Prospective|||||||
1484072|NCT01192243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484073|NCT01192230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484074|NCT01192217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484075|NCT01192204|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1484076|NCT01192191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484077|NCT01192178|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1484078|NCT01192165|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484079|NCT01192152|Randomized|Crossover Assignment||||None (Open Label)||||||
1484080|NCT01192139|Randomized|Crossover Assignment||||None (Open Label)||||||
1484081|NCT01192126|Randomized|Crossover Assignment||||None (Open Label)||||||
1484082|NCT01192113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484083|NCT01192100|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1484084|NCT01192087||Single Group Assignment||Treatment||None (Open Label)||||||
1484085|NCT01192074|||Cohort||Prospective|||||||
1484086|NCT01192061|||Case Control||Prospective|||||||
1484087|NCT01192048|||Family-Based||Prospective|||||||
1484088|NCT01192035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484089|NCT01192022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484090|NCT01192009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484091|NCT01191996||Single Group Assignment||Treatment||None (Open Label)||||||
1484092|NCT01191983||Single Group Assignment||Treatment||None (Open Label)||||||
1484093|NCT01191970|||Cohort||Prospective|||||||
1484094|NCT01191957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484095|NCT01191944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484096|NCT01191931|||Cohort||Prospective|||||||
1484097|NCT01191918|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1484098|NCT01191905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484099|NCT01191892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484100|NCT01191879|||Case Control||Prospective|||||||
1484101|NCT01191866|||Cohort||Prospective|||||||
1484102|NCT01191853|||Cohort||Prospective|||||||
1484103|NCT01191840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484104|NCT01191827|||Cohort||Cross-Sectional|||||||
1484105|NCT01191814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484106|NCT01191801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484107|NCT01191788|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1484108|NCT01191775||Single Group Assignment||Treatment||None (Open Label)||||||
1484109|NCT01191762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484110|NCT01191749||Single Group Assignment||Treatment||None (Open Label)||||||
1484111|NCT01191736|Randomized|Parallel Assignment||Prevention||Single||||||t
1484112|NCT01191723|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1484113|NCT01191710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484114|NCT01191697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484115|NCT01191684||Single Group Assignment||Treatment||None (Open Label)||||||
1484116|NCT01191671|||Case-Only||Prospective|||||||
1484117|NCT01191658|||Cohort||Prospective|||||||
1484118|NCT01191645|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1484119|NCT01191632|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484120|NCT01191619|Randomized|Parallel Assignment||||Single||||||t
1484121|NCT01191606|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1484122|NCT01191593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484123|NCT01191580|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1484124|NCT01191567|Randomized|Parallel Assignment||Treatment||Single||||||t
1484125|NCT01191554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484126|NCT01191541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484127|NCT01191528|||Cohort||Cross-Sectional|||||||
1484128|NCT01191515|||Case-Only||Prospective|||||||
1484129|NCT01191502|||Case Control||Retrospective|||||||
1484130|NCT01191489|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1484131|NCT01191476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484132|NCT01191463|Randomized|Parallel Assignment||Prevention||Single||||||t
1484133|NCT01191450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484134|NCT01191424|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484135|NCT01191411|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1484136|NCT01191398|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1484137|NCT01191385|||Cohort||Prospective|||||||
1484138|NCT01191372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484139|NCT01191359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484140|NCT01191346|||Case-Only||Prospective|||||||
1484141|NCT01191333|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1484142|NCT01191320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484143|NCT01191307|||||Prospective|||||||
1484144|NCT01191294||Single Group Assignment||||None (Open Label)||||||
1484145|NCT01191281|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484146|NCT01191268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484147|NCT01191255|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1484148|NCT01191242|||Case-Only||Prospective|||||||
1484149|NCT01191229|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484150|NCT01191216||Single Group Assignment||Treatment||None (Open Label)||||||
1484151|NCT01191203|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484152|NCT01191190||Single Group Assignment||Treatment||None (Open Label)||||||
1484153|NCT01191177|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1484154|NCT01191164||Single Group Assignment||Treatment||None (Open Label)||||||
1484155|NCT01191151|||Cohort||Prospective|||||||
1484156|NCT01191138|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1484157|NCT01191125|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1484158|NCT01191112|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484159|NCT01191099|||Cohort||Prospective|||||||
1484160|NCT01191086||Single Group Assignment||Treatment||None (Open Label)||||||
1484161|NCT01191073|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484162|NCT01191060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484163|NCT01191034||Single Group Assignment||Treatment||None (Open Label)||||||
1484164|NCT01191021||Single Group Assignment||||Single|||t|||
1484165|NCT01191008|||Case-Only||Prospective|||||||
1484166|NCT01190995|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1484167|NCT01190982||Single Group Assignment||Treatment||None (Open Label)||||||
1484168|NCT01190969|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1484169|NCT01190943|||Case-Only||Retrospective|||||||
1484170|NCT01190930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484171|NCT01190917|Randomized|Parallel Assignment||Treatment||Single||||||t
1484172|NCT01190904|||Cohort||Prospective|||||||
1484173|NCT01190891|Randomized|Parallel Assignment||Treatment||Single||||||t
1484174|NCT01190878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484175|NCT01190865||Single Group Assignment||Treatment||None (Open Label)||||||
1484176|NCT01190852|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484177|NCT01190839|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484178|NCT01190826|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1484179|NCT01190813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484180|NCT01190800|||Ecologic or Community||Prospective|||||||
1484181|NCT01190787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484182|NCT01190774|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1484183|NCT01190761|Randomized|Crossover Assignment||||None (Open Label)||||||
1484184|NCT01190748|Randomized|Crossover Assignment||||None (Open Label)||||||
1484185|NCT01190735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484186|NCT01190722|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1484187|NCT01190709|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1484188|NCT01190696|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1484189|NCT01190683|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1484190|NCT01190670|Randomized|Crossover Assignment||||None (Open Label)||||||
1484191|NCT01190657|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484192|NCT01190644||Single Group Assignment||Supportive Care||None (Open Label)||||||
1484193|NCT01190631|Non-Randomized|Single Group Assignment||Treatment||Double|||t|t||
1484194|NCT01190618|||Case-Only||Retrospective|||||||
1484195|NCT01190605|||Case-Only||Cross-Sectional|||||||
1484196|NCT01190592|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484197|NCT01190579|||Cohort||Prospective|||||||
1484198|NCT01190566|||Case-Only||Prospective|||||||
1484199|NCT01190553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484200|NCT01190540|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1484201|NCT01190527||Single Group Assignment||Treatment||None (Open Label)||||||
1484202|NCT01190514|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484203|NCT01190501||Single Group Assignment||Diagnostic||None (Open Label)||||||
1484204|NCT01190488|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484205|NCT01190475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484206|NCT01190462||||Treatment||None (Open Label)||||||
1484207|NCT01190449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484208|NCT01190436||Single Group Assignment||Treatment||None (Open Label)||||||
1484209|NCT01190423||Single Group Assignment||Treatment||None (Open Label)||||||
1484210|NCT01190410|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484211|NCT01190397|Randomized|Crossover Assignment||Treatment||Single|||||t|
1484212|NCT01190384|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1484213|NCT01190371||Single Group Assignment||Treatment||None (Open Label)||||||
1484214|NCT01190358|Randomized|Crossover Assignment||Prevention||Single|||t|||
1484215|NCT01190345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484216|NCT01190332|Randomized|Parallel Assignment||||Single|||t|||
1484217|NCT01190319|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1484218|NCT01190306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484219|NCT01190293||Single Group Assignment||Treatment||None (Open Label)||||||
1484220|NCT01190280||||||||||||
1484221|NCT01190267||Single Group Assignment||Treatment||None (Open Label)||||||
1484222|NCT01190254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484223|NCT01190241||Single Group Assignment||Treatment||None (Open Label)||||||
1484224|NCT01190228|Randomized|Parallel Assignment||Prevention||None (Open Label)||This was an open, controlled, multicenter, Phase III trial. Participants in Group 1 were previously vaccinated at 12 to 18 months of age with a single dose of JE-CV vaccine and were to receive a booster dose of JE-CV vaccine on Day 0. This group was not randomized. JE vaccine naïve control children were randomized to receive one single dose of JE-CV on Day 0 (Group 2) or a varicella vaccination on Day 0 (Group 3).||||
1484225|NCT01190215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484226|NCT01190202|||||Cross-Sectional|||||||
1484227|NCT01190189||Single Group Assignment||Prevention||None (Open Label)||||||
1484228|NCT01190176||Single Group Assignment||Prevention||None (Open Label)||||||
1484229|NCT01190163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484230|NCT01190150|Randomized|Crossover Assignment||||None (Open Label)||||||
1484231|NCT01190137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484232|NCT01190124|||Cohort||Retrospective|||||||
1484233|NCT01190111||Single Group Assignment||Treatment||None (Open Label)||||||
1484234|NCT01190098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484235|NCT01190085|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1484236|NCT01190072|||Cohort||Prospective|||||||
1484237|NCT01190059|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1484238|NCT01190046||Single Group Assignment||Basic Science||None (Open Label)||||||
1484239|NCT01190033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484240|NCT01190020|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1484241|NCT01190007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484242|NCT01189994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484243|NCT01189981|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1484244|NCT01189968|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484245|NCT01189955|Randomized|Single Group Assignment||Treatment||Single||||||t
1484246|NCT01189942||Single Group Assignment||Treatment||None (Open Label)||||||
1484247|NCT01189929||Single Group Assignment||Treatment||None (Open Label)||||||
1484248|NCT01189916||Single Group Assignment||Treatment||None (Open Label)||||||
1484249|NCT01189903||||Treatment||||||||
1484250|NCT01189890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484251|NCT01189877|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1484252|NCT01189864|||Cohort||Prospective|||||||
1484253|NCT01189851||Single Group Assignment||Treatment||None (Open Label)||||||
1484254|NCT01189838|||Case-Only||Retrospective|||||||
1484255|NCT01189825||Single Group Assignment||Supportive Care||None (Open Label)||||||
1484256|NCT01189812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484257|NCT01189799|Randomized|Parallel Assignment||||None (Open Label)||||||
1484258|NCT01189786|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484259|NCT01189773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484260|NCT01189760|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484261|NCT01189747|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484262|NCT01189734|Randomized|Parallel Assignment||Treatment||Single|||||t|
1484263|NCT01189721|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484264|NCT01189708|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484265|NCT01189695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484266|NCT01189682|Randomized|Parallel Assignment||Prevention||Single||||||t
1484267|NCT01189669|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1484268|NCT01189656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484269|NCT01189643||Single Group Assignment||Treatment||None (Open Label)||||||
1484270|NCT01189630|||||Prospective|||||||
1484271|NCT01189617||Single Group Assignment||||None (Open Label)||||||
1484272|NCT01189604|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484273|NCT01189591||Single Group Assignment||Basic Science||Single||||||
1484274|NCT01189578|||Case-Only||Cross-Sectional|||||||
1484275|NCT01189565|||Case-Only||Prospective|||||||
1484276|NCT01189552|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1484277|NCT01189526|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484278|NCT01189513||Single Group Assignment||Treatment||None (Open Label)||||||
1484279|NCT01189500|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1484280|NCT01189487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484281|NCT01189474||Single Group Assignment||Treatment||None (Open Label)||||||
1484282|NCT01189461|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484283|NCT01189448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484284|NCT01189435||Single Group Assignment||Treatment||None (Open Label)||||||
1484285|NCT01189422|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1484286|NCT01189409|Randomized|Crossover Assignment||Supportive Care||Quadruple|Double blind using a dummy alternate treatment.|"The primary outcome will be treated as a binomial outcome, expressed as the number of successful trials out of a pre-defined number of trials n = 18. Given this, the primary outcome will be analysed via a generalized mixed effects model. The model will include: (i) fixed effects for treatment, treatment period and their interaction, (ii) fixed effects for the baseline characteristics and (iii) a random patient effect. Including the latter effect in the model will help capture the within-patient correlation among the values of the primary outcome collected in Period I and Period II for the same patient.~All statistical analyses will be conducted using the open-source statistical software package R."|t|t|t|t
1484287|NCT01189396|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1484288|NCT01189383||Single Group Assignment||Treatment||None (Open Label)||||||
1484289|NCT01189370||Sequential Assignment||Treatment||None (Open Label)||||||
1484290|NCT01189357|||Cohort||Retrospective|||||||
1484291|NCT01189344||Parallel Assignment||Basic Science||None (Open Label)||||||
1484292|NCT01189331|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1484293|NCT01189318|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484294|NCT01189305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484295|NCT01189292|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1484296|NCT01189279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484297|NCT01189266||Single Group Assignment||Treatment||None (Open Label)||||||
1484298|NCT01189253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484299|NCT01189240|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484300|NCT01189227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484301|NCT01189214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484302|NCT01189201|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484303|NCT01189188|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484304|NCT01189175|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484305|NCT01189162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484306|NCT01189149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484307|NCT01189136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484308|NCT01189123|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1484309|NCT01189110|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1484310|NCT01189097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484311|NCT01189084|||Cohort||Prospective|||||||
1484312|NCT01189071|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484313|NCT01189058|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1484314|NCT01189045|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484315|NCT01189032||||||||||||
1484316|NCT01189019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484317|NCT01189006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484318|NCT01188993|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1484319|NCT01188980|||Case-Only||Prospective|||||||
1484320|NCT01188967|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484321|NCT01188954|Randomized|Parallel Assignment||Prevention||Single|||t|||
1484322|NCT01188941|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1484323|NCT01188928|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484324|NCT01188915||Single Group Assignment||Prevention||None (Open Label)||||||
1484325|NCT01188902|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484326|NCT01188889||Single Group Assignment||Treatment||None (Open Label)||||||
1484327|NCT01188876||Single Group Assignment||Treatment||None (Open Label)||||||
1484328|NCT01188863|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484329|NCT01188850||Single Group Assignment||Treatment||None (Open Label)||||||
1484330|NCT01188837|Randomized|Parallel Assignment||Treatment||Single||||||t
1484331|NCT01188824|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484332|NCT01188811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484333|NCT01188798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484334|NCT01188785||Single Group Assignment||Treatment||None (Open Label)||||||
1484335|NCT01188772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484336|NCT01188759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484337|NCT01188746||Single Group Assignment||Supportive Care||None (Open Label)||||||
1484338|NCT01188733|Randomized|||Prevention||Quadruple|||t|t|t|t
1484339|NCT01188720|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1484340|NCT01188707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484341|NCT01188694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484342|NCT01188681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484343|NCT01188668|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1484344|NCT01188655|||Case-Only||Prospective|||||||
1484345|NCT01188642|||Case-Only||Prospective|||||||
1484346|NCT01188629|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1484347|NCT01188616||||Treatment||||||||
1484348|NCT01188603||Single Group Assignment||Treatment||None (Open Label)||||||
1484349|NCT01188590|||Case Control||Prospective|||||||
1484350|NCT01188577|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1484351|NCT01188564|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484352|NCT01188551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484353|NCT01188538|Randomized|Parallel Assignment||Treatment||Single|||||t|
1484354|NCT01188525||Single Group Assignment||Treatment||None (Open Label)||||||
1484355|NCT01188512|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484356|NCT01188499|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484357|NCT01188486||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1484358|NCT01188473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484359|NCT01188460|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484360|NCT01188447||Single Group Assignment||Diagnostic||None (Open Label)||||||
1484361|NCT01188434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484362|NCT01188421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484363|NCT01188408||Single Group Assignment||Treatment||None (Open Label)||||||
1484364|NCT01188395|||Ecologic or Community||Cross-Sectional|||||||
1484365|NCT01188382|||Case-Only||Prospective|||||||
1484366|NCT01188369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484367|NCT01188356|||Cohort||Prospective|||||||
1484368|NCT01188343|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484369|NCT01188330|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484370|NCT01188317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484371|NCT01188304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484372|NCT01188291|||Case-Only||Cross-Sectional|||||||
1484373|NCT01188278|||Cohort||Prospective|||||||
1484374|NCT01188265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484375|NCT01188252||Single Group Assignment||Treatment||None (Open Label)||||||
1484376|NCT01188239|||Cohort||Prospective|||||||
1484377|NCT01188226||Single Group Assignment||Treatment||None (Open Label)||||||
1484378|NCT01188213||||||||||||
1484379|NCT01188200|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484380|NCT01188187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484381|NCT01188174||Single Group Assignment||Treatment||None (Open Label)||||||
1484382|NCT01188161|||Cohort||Retrospective|||||||
1484383|NCT01188148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484384|NCT01188135|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1484385|NCT01188122||Single Group Assignment||Supportive Care||None (Open Label)||||||
1484386|NCT01188109||Single Group Assignment||Treatment||None (Open Label)||||||
1484387|NCT01188096||Single Group Assignment||Treatment||None (Open Label)||||||
1484388|NCT01188083|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1484389|NCT01188070|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484390|NCT01188057|Randomized|Crossover Assignment||||None (Open Label)||||||
1484391|NCT01188044|||Cohort||Prospective|||||||
1484392|NCT01188031|Randomized|Crossover Assignment||||None (Open Label)||||||
1484393|NCT01188018|Randomized|Parallel Assignment||Prevention||Single|||t|||
1484394|NCT01188005|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1484395|NCT01187992|Randomized|Parallel Assignment||Treatment||Single||||||t
1484396|NCT01187979|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484397|NCT01187966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484398|NCT01187953|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484399|NCT01187940|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484400|NCT01187927|||||Prospective|||||||
1484401|NCT01187914|||Cohort||Retrospective|||||||
1484402|NCT01187901|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1484403|NCT01187888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484404|NCT01187875|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1484405|NCT01187862|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1484406|NCT01187849|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1484407|NCT01187836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484408|NCT01187823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484409|NCT01187810||Single Group Assignment||Treatment||None (Open Label)||||||
1484410|NCT01187797||Single Group Assignment||Treatment||Single||||||t
1484411|NCT01187784|Randomized|Parallel Assignment||Treatment||Single||||||t
1484412|NCT01187771|Randomized|Parallel Assignment||Treatment||Single|||||t|
1484413|NCT01187758|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484414|NCT01187745|||Cohort||Prospective|||||||
1484415|NCT01187732|Randomized|Parallel Assignment||Prevention||Single||||||t
1484416|NCT01187719|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484417|NCT01187706|||Case Control||Cross-Sectional|||||||
1484418|NCT01187693|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1484419|NCT01187680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484420|NCT01187667|||Case Control|||||||||
1484421|NCT01187654|Randomized|Parallel Assignment||Treatment||Single||||||t
1484422|NCT01187641|||Cohort||Retrospective|||||||
1484423|NCT01187628||Single Group Assignment||Treatment||None (Open Label)||||||
1484424|NCT01187615|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484425|NCT01187602|||Case Control||Prospective|||||||
1484426|NCT01187589|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1484427|NCT01187576|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484428|NCT01187563|||Cohort||Prospective|||||||
1484429|NCT01187550||Single Group Assignment||Treatment||None (Open Label)||||||
1484430|NCT01187537|Randomized|Parallel Assignment||Treatment||Single||||||t
1484431|NCT01187524|||||Other|||||||
1484432|NCT01187511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484433|NCT01187498|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484434|NCT01187485|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484435|NCT01187472|||||Prospective|||||||
1484436|NCT01187459|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1484437|NCT01187446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484438|NCT01187433|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484439|NCT01187420|||Cohort||Prospective|||||||
1484440|NCT01187407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484441|NCT01187394|||Cohort||Prospective|||||||
1484442|NCT01187381|||Cohort||Prospective|||||||
1484443|NCT01187368||Single Group Assignment||Treatment||None (Open Label)||||||
1484444|NCT01187355|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1484445|NCT01187342|||Case-Control||Prospective|||||||
1484446|NCT01187329|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1484447|NCT01187316|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1484448|NCT01187303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484449|NCT01187290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484450|NCT01187277|Randomized|Parallel Assignment||Treatment||Single||||||t
1484451|NCT01187264|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484452|NCT01187251|||Cohort||Prospective|||||||
1484453|NCT01187238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484454|NCT01187225|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1484455|NCT01187212|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484456|NCT01187199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484457|NCT01187186|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1484458|NCT01187173|||Cohort||Prospective|||||||
1484459|NCT01187160||Single Group Assignment||Treatment||None (Open Label)||||||
1484460|NCT01187147||Single Group Assignment||Prevention||None (Open Label)||||||
1484461|NCT01187134|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1484462|NCT01187121|||Cohort||Prospective|||||||
1484463|NCT01187108|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1484464|NCT01187095|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1484465|NCT01187082|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1484466|NCT01187069|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1484467|NCT01187056|Randomized|Parallel Assignment||Prevention||Single||||||t
1484468|NCT01187043|Randomized|Crossover Assignment||Treatment||Single|||t|||
1484469|NCT01187030|||Cohort||Prospective|||||||
1484470|NCT01187017||Single Group Assignment||Treatment||None (Open Label)||||||
1484471|NCT01187004|||Cohort||Prospective|||||||
1484472|NCT01186991|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484473|NCT01186978||Single Group Assignment||Treatment||None (Open Label)||||||
1484474|NCT01186965|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1484475|NCT01186952|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484476|NCT01186939||Single Group Assignment||Treatment||None (Open Label)||||||
1484477|NCT01186926||Single Group Assignment||Treatment||None (Open Label)||||||
1484478|NCT01186913|||Cohort||Prospective|||||||
1484479|NCT01186900|Randomized|Parallel Assignment||Treatment||Single|||||t|
1484480|NCT01186887|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484481|NCT01186874|||Cohort||Cross-Sectional|||||||
1484482|NCT01186861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484483|NCT01186848|Randomized|Parallel Assignment||Treatment||Single||||||t
1484484|NCT01186835|Randomized|Single Group Assignment||Treatment||Single||||||t
1484485|NCT01186822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484486|NCT01186809||Single Group Assignment||Treatment||None (Open Label)||||||
1484487|NCT01186796|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1484488|NCT01186783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484489|NCT01186770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484490|NCT01186757|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1484491|NCT01186744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484492|NCT01186731||Single Group Assignment||||None (Open Label)||||||
1484493|NCT01186718|||Case Control||Cross-Sectional|||||||
1484494|NCT01186705||Single Group Assignment||Treatment||None (Open Label)||||||
1484495|NCT01186692||Single Group Assignment||Treatment||None (Open Label)||||||
1484496|NCT01186679|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484497|NCT01186666|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1484498|NCT01186653|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484499|NCT01186640||Single Group Assignment||Treatment||None (Open Label)||||||
1484500|NCT01186627|||Cohort||Prospective|||||||
1484501|NCT01186614|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484502|NCT01186601||Single Group Assignment||Diagnostic||None (Open Label)||||||
1484503|NCT01186588|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1484504|NCT01186575|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484505|NCT01186562|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1484506|NCT01186549|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484507|NCT01186536|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484508|NCT01186523|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484509|NCT01186510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484510|NCT01186497|Randomized|Crossover Assignment||||None (Open Label)||||||
1484511|NCT01186484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484512|NCT01186471|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1484513|NCT01186458||Single Group Assignment||Treatment||None (Open Label)||||||
1484514|NCT01186445|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484515|NCT01186432||Single Group Assignment||Treatment||None (Open Label)||||||
1484516|NCT01186419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484517|NCT01186406||Single Group Assignment||Treatment||None (Open Label)||||||
1484518|NCT01186393|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1484519|NCT01186380|||Case-Only||Prospective|||||||
1484520|NCT01186367|Randomized|Factorial Assignment||Supportive Care||Single|||||t|
1484521|NCT01186354|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1484522|NCT01186341|||Cohort||Prospective|||||||
1484523|NCT01186328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484524|NCT01186315|Randomized|Parallel Assignment||Treatment||Single||||||t
1484525|NCT01186302|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1484526|NCT01186289|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1484527|NCT01186276|Randomized|Parallel Assignment||||Single|||t|||
1484528|NCT01186263|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1484529|NCT01186250|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1484530|NCT01186237||Single Group Assignment||Prevention||None (Open Label)||||||
1484531|NCT01186224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484532|NCT01186211|||Cohort||Prospective|||||||
1484533|NCT01186198|||Cohort||Prospective|||||||
1484534|NCT01186185||Single Group Assignment||Treatment||None (Open Label)||||||
1484535|NCT01186172|Randomized|Parallel Assignment||Treatment||Single||||||t
1484536|NCT01186159|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1484537|NCT01186146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484538|NCT01186133|||Cohort||Prospective|||||||
1484539|NCT01186120|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484540|NCT01186107|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484541|NCT01186094|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484542|NCT01186081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484543|NCT01186068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484544|NCT01186055|||Case-Crossover||Prospective|||||||
1484545|NCT01186042|||Cohort||Cross-Sectional|||||||
1484546|NCT01186029|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1484547|NCT01186016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484548|NCT01186003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484549|NCT01185990|||Case Control||Cross-Sectional|||||||
1484550|NCT01185977|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484551|NCT01185964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484552|NCT01185951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484553|NCT01185938|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484554|NCT01185925|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1484555|NCT01185912|||Case Control||Prospective|||||||
1484556|NCT01185899|||Cohort||Prospective|||||||
1484557|NCT01185886|||Cohort||Other|||||||
1484558|NCT01185873||Single Group Assignment||Treatment||None (Open Label)||||||
1484559|NCT01185860|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484560|NCT01185847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484561|NCT01185834||Single Group Assignment||Treatment||Single|||t|||
1484562|NCT01185821|Randomized|Parallel Assignment||Treatment||Quadruple|Masking continued during the double blind period of extension only.|This extension study was originally set up as a 2 year dose-blinded extension study to maintain blinding of ongoing Core study. Study was later amended to include a subsequent Open-Label treatment phase after Core study was unblinded. During the Dose-Blinded phase of the extension study patients received the same dose from the Core study. Patients who received placebo in Period 1 during the Core Study were equally randomized to 1 of the 3 active doses of siponimod used during Period 1 (0.5, 2.0, or 10 mg) and patients who received placebo in Period 2 were equally randomized to 1 of the 2 active doses of siponimod used during Period 2 (0.25 mg or 1.25 mg).|t|t|t|t
1484563|NCT01185808|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484564|NCT01185795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484565|NCT01185782|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484566|NCT01185769|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1484567|NCT01185756||Single Group Assignment||Diagnostic||None (Open Label)||||||
1484568|NCT01185743|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1484569|NCT01185730||Single Group Assignment||Prevention||None (Open Label)||||||
1484570|NCT01185717|||||Cross-Sectional|||||||
1484571|NCT01185704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484572|NCT01185691|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484573|NCT01185678|||Cohort||Prospective|||||||
1484574|NCT01185665|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484575|NCT01185652|||Cohort||Prospective|||||||
1484576|NCT01185639||Single Group Assignment||Treatment||None (Open Label)||||||
1484577|NCT01185626|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1484578|NCT01185613|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1484579|NCT01185600|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484580|NCT01185587|||Cohort||Retrospective|||||||
1484581|NCT01185574||Single Group Assignment||Treatment||None (Open Label)||||||
1484582|NCT01185561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484583|NCT01185548||Single Group Assignment||Treatment||None (Open Label)||||||
1484584|NCT01185535|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484585|NCT01185522|||Cohort||Prospective|||||||
1484586|NCT01185509||Single Group Assignment||Treatment||None (Open Label)||The analysis was performed for 2 separate cohorts due to a change in study conduct during the trial (see arm description).||||
1484587|NCT01185496|||Cohort||Prospective|||||||
1484588|NCT01185483|||Case-Only||Prospective|||||||
1484589|NCT01185470||Single Group Assignment||Treatment||None (Open Label)||||||
1484590|NCT01185457|||Case-Crossover||Prospective|||||||
1484591|NCT01185444|Randomized|Parallel Assignment||Treatment||Single||||||t
1484592|NCT01185431|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1484593|NCT01185418|||||Prospective|||||||
1484594|NCT01185405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484595|NCT01185392|||Cohort||Cross-Sectional|||||||
1484596|NCT01185379|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1484597|NCT01185366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484598|NCT01185353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484599|NCT01185340|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484600|NCT01185327|||Case Control||Retrospective|||||||
1484601|NCT01185314||Single Group Assignment||Screening||None (Open Label)||||||
1484602|NCT01185301|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484603|NCT01185288|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484604|NCT01185275|||Cohort||Prospective|||||||
1484605|NCT01185262||Single Group Assignment||Treatment||None (Open Label)||||||
1484606|NCT01185249||Single Group Assignment||Supportive Care||None (Open Label)||||||
1484607|NCT01185236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484608|NCT01185223|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484609|NCT01185210|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1484610|NCT01185197|Randomized|Parallel Assignment||Treatment||Single||||||t
1484611|NCT01185184|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1484612|NCT01185171||Single Group Assignment||Treatment||None (Open Label)||||||
1484613|NCT01185158|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484614|NCT01185145|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484615|NCT01185132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484616|NCT01185119|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1484617|NCT01185093|||Cohort||Prospective|||||||
1484618|NCT01185080|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484619|NCT01185067|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1484620|NCT01185054|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1484621|NCT01185041|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1484622|NCT01185028||Single Group Assignment||Treatment||None (Open Label)||||||
1484623|NCT01185015||Single Group Assignment||Treatment||None (Open Label)||||||
1484624|NCT01185002|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1484625|NCT01184989||Single Group Assignment||Prevention||None (Open Label)||||||
1484626|NCT01184976|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484627|NCT01184963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484628|NCT01184950||||||||||||
1484629|NCT01184937|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484630|NCT01184924|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484631|NCT01184911||Single Group Assignment||Prevention||None (Open Label)||||||
1484632|NCT01184898||Single Group Assignment||Treatment||None (Open Label)||||||
1484633|NCT01184885||Single Group Assignment||Treatment||None (Open Label)||||||
1484634|NCT01184872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484635|NCT01184859|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484636|NCT01184846||Single Group Assignment||Treatment||None (Open Label)||||||
1484637|NCT01184833|||Cohort||Prospective|||||||
1484638|NCT01184820|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1484639|NCT01184807||Single Group Assignment||Treatment||None (Open Label)||||||
1484640|NCT01184794|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1484641|NCT01184781||Single Group Assignment||Diagnostic||None (Open Label)||||||
1484642|NCT01184768|||Cohort||Cross-Sectional|||||||
1484643|NCT01184755|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484644|NCT01184742|||Case-Only||Cross-Sectional|||||||
1484645|NCT01184729|||Case-Only||Prospective|||||||
1484646|NCT01184716|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1484647|NCT01184703|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484648|NCT01184690|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1484649|NCT01184677|Randomized|Parallel Assignment||||Triple|||t||t|t
1484650|NCT01184664|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1484651|NCT01184651|||Cohort||Cross-Sectional|||||||
1484652|NCT01184638|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1484653|NCT01184625|Randomized|Parallel Assignment||Treatment||Single||||||t
1484654|NCT01184612|Randomized|||Treatment||Single||||||t
1484655|NCT01184599||Single Group Assignment||Treatment||None (Open Label)||||||
1484656|NCT01184586|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1484657|NCT01184573|||Case Control||Retrospective|||||||
1484658|NCT01184560|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1484659|NCT01184547|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484660|NCT01184534|||Cohort||Prospective|||||||
1484661|NCT01184521|||Case Control||Prospective|||||||
1484662|NCT01184508|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484663|NCT01184495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484664|NCT01184482||Single Group Assignment||Treatment||None (Open Label)||||||
1484665|NCT01184469|||Cohort||Prospective|||||||
1484666|NCT01184456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484667|NCT01184443|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484668|NCT01184430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484669|NCT01184417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484670|NCT01184404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484671|NCT01184391|Randomized|Crossover Assignment||||None (Open Label)||||||
1484672|NCT01184378|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1484673|NCT01184365|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484674|NCT01184352|||Case-Only||Retrospective|||||||
1484675|NCT01184339|||||Prospective|||||||
1484676|NCT01184326||Single Group Assignment||Treatment||None (Open Label)||||||
1484677|NCT01184313|||Case-Only||Prospective|||||||
1484678|NCT01184300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484679|NCT01184287||Single Group Assignment||Treatment||None (Open Label)||||||
1484680|NCT01184274|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484681|NCT01184261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484682|NCT01184248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484683|NCT01184235|||Cohort||Prospective|||||||
1484684|NCT01184222|Randomized|Factorial Assignment||Treatment||Single|||t|||
1484685|NCT01184209|||Cohort||Prospective|||||||
1484686|NCT01184196|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484687|NCT01184183|||Cohort||Prospective|||||||
1484688|NCT01184170|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1484689|NCT01184157|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1484690|NCT01184144|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1484691|NCT01184131|Randomized|Parallel Assignment||||None (Open Label)||||||
1484692|NCT01184118|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484693|NCT01184105|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484694|NCT01184092|Randomized|Crossover Assignment||||None (Open Label)||||||
1484695|NCT01184079|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484696|NCT01184066|Randomized|Parallel Assignment||Treatment||None (Open Label)|There was no masking. This intervention was open.|||||
1484697|NCT01184053||Single Group Assignment||Treatment||None (Open Label)||||||
1484698|NCT01184040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484699|NCT01184027|||Cohort||Prospective|||||||
1484700|NCT01184014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484701|NCT01184001|Randomized|Crossover Assignment||||None (Open Label)||||||
1484702|NCT01183975|||Cohort||Prospective|||||||
1484703|NCT01183962|Randomized|Parallel Assignment||Prevention||Single||||||t
1484704|NCT01183949||Single Group Assignment||Treatment||None (Open Label)||||||
1484705|NCT01183936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484706|NCT01183923|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1484707|NCT01183910|Randomized|Single Group Assignment||||Double|||t||t|
1484708|NCT01183897||Single Group Assignment||Treatment||None (Open Label)||||||
1484709|NCT01183884||Single Group Assignment||Treatment||None (Open Label)||||||
1484710|NCT01183871|Non-Randomized|Parallel Assignment||Screening||Single||||||t
1484711|NCT01183858|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484712|NCT01183845|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1484713|NCT01183832|||Cohort||Prospective|||||||
1484714|NCT01183819|Randomized|Parallel Assignment||Basic Science||Single||||||t
1484715|NCT01183806|Randomized|Parallel Assignment||Treatment||Single||||||t
1484716|NCT01183793|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1484717|NCT01183780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484718|NCT01183767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484719|NCT01183754|||Cohort||Prospective|||||||
1484720|NCT01183741|||||Prospective|||||||
1484721|NCT01183728||Single Group Assignment||Treatment||None (Open Label)||||||
1484722|NCT01183715|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1484723|NCT01183702|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1484724|NCT01183689|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1484725|NCT01183676|Randomized|Crossover Assignment||||None (Open Label)||||||
1484726|NCT01183663|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484727|NCT01183650||Parallel Assignment||Basic Science||None (Open Label)||||||
1484728|NCT01183637|Randomized|Parallel Assignment||Treatment||Single||||||t
1484729|NCT01183624|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1484730|NCT01183611|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1484731|NCT01183598|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484732|NCT01183585|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484733|NCT01183572|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484734|NCT01183559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484735|NCT01183546|||Case-Only||Prospective|||||||
1484736|NCT01183533||Single Group Assignment||Treatment||None (Open Label)||||||
1484737|NCT01183520|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1484738|NCT01183507|Randomized|Parallel Assignment||Prevention||Single|||||t|
1484739|NCT01183494|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484740|NCT01183481||Single Group Assignment||Prevention||None (Open Label)||||||
1484741|NCT01183468|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484742|NCT01183455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484743|NCT01183442|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484744|NCT01183429||Single Group Assignment||Treatment||None (Open Label)||||||
1484745|NCT01183416||Single Group Assignment||Treatment||None (Open Label)||||||
1484746|NCT01183403|||Cohort||Prospective|||||||
1484747|NCT01183390|Randomized|Crossover Assignment||||None (Open Label)||||||
1484748|NCT01183377|||||Cross-Sectional|||||||
1484749|NCT01183364||Single Group Assignment||Treatment||None (Open Label)||||||
1484750|NCT01183351||Single Group Assignment||Treatment||None (Open Label)||||||
1484751|NCT01183338|||||Prospective|||||||
1484752|NCT01183325|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484753|NCT01183312|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1484754|NCT01183299|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1484755|NCT01183286|Randomized|Parallel Assignment||||None (Open Label)||||||
1484756|NCT01183273|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484757|NCT01183260|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1484758|NCT01183247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484759|NCT01183234|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484760|NCT01183221|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1484761|NCT01183208|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1484762|NCT01183195||||||||||||
1484763|NCT01183182||Single Group Assignment||||None (Open Label)||||||
1484764|NCT01183169|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484765|NCT01183156|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1484766|NCT01183143||Single Group Assignment||Treatment||None (Open Label)||||||
1484767|NCT01183130|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484768|NCT01183117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484769|NCT01183104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484770|NCT01183091|||Cohort||Prospective|||||||
1484771|NCT01183078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484772|NCT01183065||Single Group Assignment||Treatment||None (Open Label)||||||
1484773|NCT01183052||Single Group Assignment||||None (Open Label)||||||
1484774|NCT01183039|Randomized|Parallel Assignment||||None (Open Label)||||||
1484775|NCT01183026|||Cohort||Prospective|||||||
1484776|NCT01183013|Randomized|Parallel Assignment||Treatment||Double||||||
1484777|NCT01183000||||Prevention||||||||
1484778|NCT01182987|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1484779|NCT01182974|Randomized|Parallel Assignment||||None (Open Label)||||||
1484780|NCT01182961|Randomized|Parallel Assignment||Treatment||Single||||||t
1484781|NCT01182948|Randomized|Parallel Assignment||Treatment||Single||||||t
1484782|NCT01182935|||Cohort||Prospective|||||||
1484783|NCT01182922|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1484784|NCT01182909|||Case Control||Cross-Sectional|||||||
1484785|NCT01182883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484786|NCT01182870|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484787|NCT01182857|||||Prospective|||||||
1484788|NCT01182844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484789|NCT01182831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484790|NCT01182818|||Cohort||Prospective|||||||
1484791|NCT01182805||Single Group Assignment||Diagnostic||None (Open Label)||||||
1484792|NCT01182792|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484793|NCT01182779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484794|NCT01182766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484795|NCT01182753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484796|NCT01182740|||||Prospective|||||||
1484797|NCT01182727||Single Group Assignment||Treatment||None (Open Label)||||||
1484798|NCT01182714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484799|NCT01182701|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1484800|NCT01182688|||Case Control||Retrospective|||||||
1484801|NCT01182675|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484802|NCT01182662|Randomized|Parallel Assignment||Treatment||Single||||||t
1484803|NCT01182649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484804|NCT01182636|Randomized|Parallel Assignment||||Double||||||
1484805|NCT01182623|||Cohort||Prospective|||||||
1484806|NCT01182610||Single Group Assignment||Treatment||None (Open Label)||||||
1484807|NCT01182597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484808|NCT01182584|||Cohort||Prospective|||||||
1484809|NCT01182571|||Case-Only||Cross-Sectional|||||||
1484810|NCT01182558|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1484811|NCT01182545|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1484812|NCT01182532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484813|NCT01182519|||Cohort||Prospective|||||||
1484814|NCT01182506|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484815|NCT01182493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484816|NCT01182480||Single Group Assignment||Health Services Research||None (Open Label)||||||
1484817|NCT01182467|||Case-Only||Prospective|||||||
1484818|NCT01182454|||Case Control||Cross-Sectional|||||||
1484819|NCT01182441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484820|NCT01182428|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484821|NCT01182415||Single Group Assignment||Treatment||None (Open Label)||||||
1484822|NCT01182402||Single Group Assignment||Supportive Care||None (Open Label)||||||
1484823|NCT01182389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484824|NCT01182376|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1484825|NCT01182363|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1484826|NCT01182350|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484827|NCT01182337|Randomized|Parallel Assignment||||Double|||t||t|
1484828|NCT01182324|||||Retrospective|||||||
1484829|NCT01182311|||||Prospective|||||||
1484830|NCT01182298|||Cohort||Prospective|||||||
1484831|NCT01182285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484832|NCT01182272||||Treatment||None (Open Label)||||||
1484833|NCT01182259|||Case Control||Prospective|||||||
1484834|NCT01182246||Single Group Assignment||Treatment||None (Open Label)||||||
1484835|NCT01182233||Single Group Assignment||Treatment||None (Open Label)||||||
1484836|NCT01182220|||||Prospective|||||||
1484837|NCT01182207|Randomized|Crossover Assignment||||None (Open Label)||||||
1484838|NCT01182194|Randomized|Crossover Assignment||||None (Open Label)||||||
1484839|NCT01182181|Randomized|Crossover Assignment||||None (Open Label)||||||
1484840|NCT01182168||Single Group Assignment||Treatment||None (Open Label)||||||
1484841|NCT01182155|||Cohort||Prospective|||||||
1484842|NCT01182142|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484843|NCT01182129|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1484844|NCT01182116||Single Group Assignment||Treatment||None (Open Label)||||||
1484845|NCT01182103|||Case Control||Cross-Sectional|||||||
1484846|NCT01182090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484847|NCT01182077|Randomized|Crossover Assignment||||None (Open Label)||||||
1484848|NCT01182064|||Case Control||Prospective|||||||
1484849|NCT01182051|Randomized|Parallel Assignment||Treatment||Single||||||t
1484850|NCT01182038|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1484851|NCT01182025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484852|NCT01182012|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1484853|NCT01181999||Single Group Assignment||Treatment||None (Open Label)||||||
1484854|NCT01181986|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1484855|NCT01181973|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1484856|NCT01181960|||Cohort||Prospective|||||||
1484857|NCT01181947|||Cohort||Prospective|||||||
1484858|NCT01181934|Randomized|Crossover Assignment||||Triple|||t||t|t
1484859|NCT01181921||Single Group Assignment||Basic Science||None (Open Label)||||||
1484860|NCT01181908|Randomized|Crossover Assignment||Other||Double|||t||t|
1484861|NCT01181895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484862|NCT01181882|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1484863|NCT01181869|||Case-Only||Prospective|||||||
1484864|NCT01181856|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484865|NCT01181843|||Other||Prospective|||||||
1484866|NCT01181830|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1484867|NCT01181817|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1484868|NCT01181804|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484869|NCT01181791|Randomized|Parallel Assignment||Prevention||Triple|Administration of placebo|Administration of probiotic Lactobacillus Reuteri|t|t|t|
1484870|NCT01181778|||Cohort||Prospective|||||||
1484871|NCT01181765||Single Group Assignment||Treatment||None (Open Label)||||||
1484872|NCT01181752|||Case Control||Prospective|||||||
1484873|NCT01181739|||Case-Only||Cross-Sectional|||||||
1484874|NCT01181726|Randomized|Crossover Assignment||||None (Open Label)||||||
1484875|NCT01181713|||Case Control||Prospective|||||||
1484876|NCT01181700|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1484877|NCT01181687|||Case-Only||Prospective|||||||
1484878|NCT01181674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484879|NCT01181661|Randomized|Parallel Assignment||Treatment||Single||||t||
1484880|NCT01181648|||Other||Prospective|||||||
1484881|NCT01181635||Single Group Assignment||Treatment||None (Open Label)||||||
1484882|NCT01181622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484883|NCT01181609|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484884|NCT01181596||Single Group Assignment||Supportive Care||None (Open Label)||||||
1484885|NCT01181583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484886|NCT01181570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484887|NCT01181557|||Cohort||Prospective|||||||
1484888|NCT01181544||Single Group Assignment||Treatment||None (Open Label)||||||
1484889|NCT01181531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484890|NCT01181518|||Case-Only||Retrospective|||||||
1484891|NCT01181505|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1484892|NCT01181492||||||||||||
1484893|NCT01181479|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484894|NCT01181466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484895|NCT01181453|Randomized|Parallel Assignment||Treatment||Single||||||
1484896|NCT01181440|Randomized|Parallel Assignment||Treatment||Single||||||
1484897|NCT01181427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484898|NCT01181414|Randomized|Parallel Assignment||Treatment||Single||||||t
1484899|NCT01181401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484900|NCT01181388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484901|NCT01181375||Single Group Assignment||Basic Science||None (Open Label)||||||
1484902|NCT01181362||Single Group Assignment||Diagnostic||None (Open Label)||||||
1484903|NCT01181349|||Cohort|||||||||
1484904|NCT01181336|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484905|NCT01181323|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1484906|NCT01181310|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1484907|NCT01181297||||||||||||
1484908|NCT01181284|||Cohort||Prospective|||||||
1484909|NCT01181271||Single Group Assignment||Treatment||None (Open Label)||||||
1484910|NCT01181258||Single Group Assignment||Treatment||None (Open Label)||||||
1484911|NCT01181245|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484912|NCT01181232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484913|NCT01181219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484914|NCT01181206|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1484915|NCT01181193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484916|NCT01181180|Randomized|Parallel Assignment||Treatment||Single||||||t
1484917|NCT01181167|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484918|NCT01181154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484919|NCT01181141|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1484920|NCT01181128|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484921|NCT01181115||Single Group Assignment||Treatment||None (Open Label)||||||
1484922|NCT01181102|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484923|NCT01181089|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1484924|NCT01181076|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1484925|NCT01181063|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484926|NCT01181050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484927|NCT01181037|||Case Control||Retrospective|||||||
1484928|NCT01181024|Randomized|Parallel Assignment||||Double|||t||t|
1484929|NCT01181011|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484930|NCT01180998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484931|NCT01180985|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484932|NCT01180972|||Ecologic or Community||Prospective|||||||
1484933|NCT01180959||Single Group Assignment||Treatment||None (Open Label)||||||
1484934|NCT01180946|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1484935|NCT01180933|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1484936|NCT01180920|||Case Control||Prospective|||||||
1484937|NCT01180907||||||||||||
1484938|NCT01180894|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484939|NCT01180881|||Cohort||Prospective|||||||
1484940|NCT01180868||||||||||||
1484941|NCT01180855|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1484942|NCT01180842||Single Group Assignment||Treatment||None (Open Label)||||||
1484943|NCT01180829|Randomized|Parallel Assignment||Treatment||Single|||t|||
1484944|NCT01180816||Single Group Assignment||Treatment||None (Open Label)||||||
1484945|NCT01180803|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484946|NCT01180790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484947|NCT01180777|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484948|NCT01180764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484949|NCT01180751||Single Group Assignment||Diagnostic||None (Open Label)||||||
1484950|NCT01180738|Randomized|Parallel Assignment||Treatment||Single||||||t
1484951|NCT01180725||||||||||||
1484952|NCT01180712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484953|NCT01180699|Randomized|Parallel Assignment||Prevention||Single|||||t|
1484954|NCT01180686|Randomized|Parallel Assignment||Treatment||Single||||||t
1484955|NCT01180673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484956|NCT01180660|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1484957|NCT01180647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484958|NCT01180634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484959|NCT01180621||Single Group Assignment||Prevention||None (Open Label)||||||
1484960|NCT01180608|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1484961|NCT01180595|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1484962|NCT01180582||Single Group Assignment||Treatment||None (Open Label)||||||
1484963|NCT01180569||Single Group Assignment||Treatment||None (Open Label)||||||
1484964|NCT01180556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484965|NCT01180543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484966|NCT01180530|||Other||Prospective|||||||
1484967|NCT01180517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484968|NCT01180504||Single Group Assignment||Treatment||None (Open Label)||||||
1484969|NCT01180491||||||||||||
1484970|NCT01180478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484971|NCT01180465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484972|NCT01180452||Single Group Assignment||Diagnostic||None (Open Label)||||||
1484973|NCT01180439||Single Group Assignment||Supportive Care||None (Open Label)||||||
1484974|NCT01180426||Single Group Assignment||Treatment||None (Open Label)||||||
1484975|NCT01180413||Single Group Assignment||Treatment||None (Open Label)||||||
1484976|NCT01180400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484977|NCT01180387|||||Prospective|||||||
1484978|NCT01180374|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1484979|NCT01180361|||Case-Control||Cross-Sectional|||||||
1484980|NCT01180348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1484981|NCT01180335|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1484982|NCT01180322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1484983|NCT01180309|||Case Control||Cross-Sectional|||||||
1484984|NCT01180296|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484985|NCT01180283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484986|NCT01180270|||||Prospective|||||||
1484987|NCT01180257||||||||||||
1484988|NCT01180244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484989|NCT01180231|Non-Randomized|||||Single|||t|||
1484990|NCT01180218||||||||||||
1484991|NCT01180205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1484992|NCT01180192|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1484993|NCT01180179|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1484994|NCT01180166||Single Group Assignment||Treatment||None (Open Label)||||||
1484995|NCT01180153|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1484996|NCT01180140|Randomized|Parallel Assignment||Prevention||Single|||t|||
1484997|NCT01180127|Randomized|Factorial Assignment||Basic Science||Single|||||t|
1484998|NCT01180114|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1484999|NCT01180101|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485000|NCT01180088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485001|NCT01180075|||||Prospective|||||||
1485002|NCT01180062|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1485003|NCT01180049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485004|NCT01180036|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485005|NCT01180023|Randomized|Parallel Assignment||Treatment||Single||||||t
1485006|NCT01180010|||Case-Only||Prospective|||||||
1485007|NCT01179997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485008|NCT01179984||Single Group Assignment||Treatment||None (Open Label)||||||
1485009|NCT01179971|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485010|NCT01179958|Randomized|Parallel Assignment||Basic Science||Single||||||t
1485011|NCT01179945|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1485012|NCT01179932|||Cohort||Prospective|||||||
1485013|NCT01179919||Single Group Assignment||||None (Open Label)||||||
1485014|NCT01179906|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485015|NCT01179893|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1485016|NCT01179880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485017|NCT01179867|Randomized|Parallel Assignment||Prevention||Single||||||t
1485018|NCT01179854|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485019|NCT01179841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485020|NCT01179828|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1485021|NCT01179815|||Cohort||Prospective|||||||
1485022|NCT01179802||Single Group Assignment||Basic Science||None (Open Label)||||||
1485023|NCT01179789|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485024|NCT01179776|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485025|NCT01179763|||Case-Only||Prospective|||||||
1485026|NCT01179750|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485027|NCT01179737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485028|NCT01179724|Randomized|Parallel Assignment||Prevention||Single|||t|||
1485029|NCT01179711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485030|NCT01179698||Single Group Assignment||Treatment||None (Open Label)||||||
1485031|NCT01179685||Single Group Assignment||Diagnostic||None (Open Label)||||||
1485032|NCT01179672|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485033|NCT01179659|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485034|NCT01179646|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485035|NCT01179633|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485036|NCT01179620||Single Group Assignment||Prevention||None (Open Label)||||||
1485037|NCT01179607|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485038|NCT01179594|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1485039|NCT01179581|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1485040|NCT01179568|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1485041|NCT01179555|Randomized|Parallel Assignment||Prevention||Single||||||t
1485042|NCT01179542|||Cohort||Prospective|||||||
1485043|NCT01179529||Single Group Assignment||Treatment||||||||
1485044|NCT01179516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485045|NCT01179503|Randomized|Parallel Assignment||Treatment||Single||||||t
1485046|NCT01179490||Single Group Assignment||Treatment||None (Open Label)||||||
1485047|NCT01179477|||Case-Only||Prospective|||||||
1485048|NCT01179464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485049|NCT01179451|||Cohort||Prospective|||||||
1485050|NCT01179438||Single Group Assignment||||None (Open Label)||||||
1485051|NCT01179425|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1485052|NCT01179412|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485053|NCT01179399||Single Group Assignment||Treatment||None (Open Label)||||||
1485054|NCT01179386|||Case Control||Prospective|||||||
1485055|NCT01179373|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1485056|NCT01179360|||Cohort||Prospective|||||||
1485057|NCT01179347|Randomized|Parallel Assignment||Treatment||Double||||||
1485058|NCT01179334|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485059|NCT01179321||||||||||||
1485060|NCT01179308|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1485061|NCT01179295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485062|NCT01179282|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1485063|NCT01179269||Single Group Assignment||Treatment||None (Open Label)||||||
1485064|NCT01179256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485065|NCT01179243|||Case-Only||Cross-Sectional|||||||
1485066|NCT01179230|||Cohort||Prospective|||||||
1485067|NCT01179217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485068|NCT01179204|||Cohort||Prospective|||||||
1485069|NCT01179191||Single Group Assignment||Supportive Care||None (Open Label)||||||
1485070|NCT01179178|||Case Control||Prospective|||||||
1485071|NCT01179165|||Cohort||Cross-Sectional|||||||
1485072|NCT01179152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485073|NCT01179139|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1485074|NCT01179126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485075|NCT01179113|Randomized|Parallel Assignment||||Double|||t|t||
1485076|NCT01179100|Randomized|Factorial Assignment||||Double|||t|t||
1485077|NCT01179087|||Cohort||Prospective|||||||
1485078|NCT01179074|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485079|NCT01179061|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1485080|NCT01179048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485081|NCT01179035|Randomized|Parallel Assignment||Health Services Research||||||||
1485082|NCT01179022|||Cohort||Prospective|||||||
1485083|NCT01179009|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1485084|NCT01178996|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485085|NCT01178983|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485086|NCT01178970|Randomized|Single Group Assignment||||||||||
1485087|NCT01178957|||Cohort||Prospective|||||||
1485088|NCT01178944||Single Group Assignment||Treatment||None (Open Label)||||||
1485089|NCT01178931|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1485090|NCT01178918|||Cohort||Prospective|||||||
1485091|NCT01178905||Single Group Assignment||Prevention||||||||
1485092|NCT01178892|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1485093|NCT01178879|Randomized|Parallel Assignment||Treatment||Single||||||t
1485094|NCT01178866|||Cohort||Prospective|||||||
1485095|NCT01178853|Randomized|Crossover Assignment||||None (Open Label)||||||
1485096|NCT01178840|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1485097|NCT01178827|Randomized|Parallel Assignment||Treatment||Single||||||t
1485098|NCT01178814||Single Group Assignment||Treatment||None (Open Label)||||||
1485099|NCT01178801|||||Retrospective|||||||
1485100|NCT01178788|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485101|NCT01178775|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485102|NCT01178762|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485103|NCT01178749|||Cohort||Prospective|||||||
1485104|NCT01178736|||Case-Only||Prospective|||||||
1485105|NCT01178723|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1485106|NCT01178710|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1485107|NCT01178697|Randomized|||Treatment||Single|||||t|
1485108|NCT01178684|||Case-Crossover||Cross-Sectional|||||||
1485109|NCT01178671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485110|NCT01178658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485111|NCT01178645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485112|NCT01178632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485113|NCT01178619|||Case Control|||||||||
1485114|NCT01178606|||Case-Only|||||||||
1485115|NCT01178593|Randomized|Parallel Assignment||Treatment||Single||||||t
1485116|NCT01178580|||Cohort||Prospective|||||||
1485117|NCT01178567|||Cohort||Retrospective|||||||
1485118|NCT01178554|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1485119|NCT01178541|||Cohort||Prospective|||||||
1485120|NCT01178528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485121|NCT01178515|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1485122|NCT01178502|||Cohort||Retrospective|||||||
1485123|NCT01178489|||Cohort||Prospective|||||||
1485124|NCT01178476|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485125|NCT01178463|||Cohort||Retrospective|||||||
1485126|NCT01178450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485127|NCT01178437|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485128|NCT01178424|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485129|NCT01178411||Single Group Assignment||Treatment||None (Open Label)||||||
1485130|NCT01178398|||||Cross-Sectional|||||||
1485131|NCT01178385|Randomized|Parallel Assignment||Treatment||Single||||||t
1485132|NCT01178372||||||||||||
1485133|NCT01178359|Randomized|Single Group Assignment||Treatment||Single|||||t|
1485134|NCT01178346|Non-Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1485135|NCT01178333|||Case-Only||Retrospective|||||||
1485136|NCT01178320|||Cohort||Prospective|||||||
1485137|NCT01178307|||Cohort||Prospective|||||||
1485138|NCT01178294||Single Group Assignment||Treatment||None (Open Label)||||||
1485139|NCT01178281|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485140|NCT01178268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485141|NCT01178255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485142|NCT01178242||Single Group Assignment||Treatment||None (Open Label)||||||
1485143|NCT01178229|Randomized|Parallel Assignment||Treatment||Single||||||t
1485144|NCT01178216||Single Group Assignment||Treatment||None (Open Label)||||||
1485145|NCT01178203||Parallel Assignment||Treatment||||||||
1485146|NCT01178190|||Cohort||Prospective|||||||
1485147|NCT01178177|||Cohort||Retrospective|||||||
1485148|NCT01178164||Single Group Assignment||Diagnostic||None (Open Label)||||||
1485149|NCT01178151||Single Group Assignment||Treatment||None (Open Label)||||||
1485150|NCT01178138||Single Group Assignment||Health Services Research||Triple|||t|t|t|
1485151|NCT01178125||Single Group Assignment||Prevention||None (Open Label)||||||
1485152|NCT01178112|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485153|NCT01178099|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1485154|NCT01178086|||Cohort||Prospective|||||||
1485155|NCT01178073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485156|NCT01178060|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1485157|NCT01178047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485158|NCT01178034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485159|NCT01178021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485160|NCT01178008|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1485161|NCT01177995|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1485162|NCT01177982|Randomized|Parallel Assignment||Treatment||Single||||||t
1485163|NCT01177969|Randomized|Parallel Assignment||Treatment||Single||||||t
1485164|NCT01177956||Single Group Assignment||Treatment||None (Open Label)||||||
1485165|NCT01177943|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485166|NCT01177930|||Cohort||Prospective|||||||
1485167|NCT01177917||||||||||||
1485168|NCT01177904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485169|NCT01177891|||Family-Based||Prospective|||||||
1485170|NCT01177865||||Health Services Research||||||||
1485171|NCT01177852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485172|NCT01177839|||Case-Only||Prospective|||||||
1485173|NCT01177826|||Case Control||Prospective|||||||
1485174|NCT01177813|Randomized|Parallel Assignment||Treatment||Double||||||
1485175|NCT01177800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485176|NCT01177787|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1485177|NCT01177774|||Case-Control||Prospective|||||||
1485178|NCT01177761|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1485179|NCT01177748|||Cohort||Prospective|||||||
1485180|NCT01177735||Single Group Assignment||Treatment||None (Open Label)||||||
1485181|NCT01177722|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1485182|NCT01177709||Single Group Assignment||Treatment||None (Open Label)||||||
1485183|NCT01177696|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485184|NCT01177683||Single Group Assignment||Treatment||None (Open Label)||||||
1485185|NCT01177670|||Case-Only||Prospective|||||||
1485186|NCT01177657|||Case Control||Prospective|||||||
1485187|NCT01177644||Single Group Assignment||Treatment||None (Open Label)||||||
1485188|NCT01177631|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1485189|NCT01177618|||Family-Based||Cross-Sectional|||||||
1485190|NCT01177605||||||||||||
1485191|NCT01177592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485192|NCT01177579|Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1485193|NCT01177566|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485194|NCT01177553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485195|NCT01177540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485196|NCT01177527|||Case-Only||Prospective|||||||
1485197|NCT01177514|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1485198|NCT01177501|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485199|NCT01177488|Randomized|Parallel Assignment||Treatment||Single||||||t
1485200|NCT01177475|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1485201|NCT01177462|||Case Control||Cross-Sectional|||||||
1485202|NCT01177449||Single Group Assignment||Treatment||None (Open Label)||||||
1485203|NCT01177436||Single Group Assignment||Diagnostic||None (Open Label)||||||
1485204|NCT01177423|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485205|NCT01177410|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485206|NCT01177397||Single Group Assignment||Treatment||None (Open Label)||||||
1485207|NCT01177384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485208|NCT01177371||Single Group Assignment||Treatment||None (Open Label)||||||
1485209|NCT01177358|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1485210|NCT01177345|||Cohort||Cross-Sectional|||||||
1485211|NCT01177332|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1485212|NCT01177319|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1485213|NCT01177306||Single Group Assignment||Basic Science||None (Open Label)||||||
1485214|NCT01177293|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1485215|NCT01177280|||Case Control||Retrospective|||||||
1485216|NCT01177267|||Case Control||Retrospective|||||||
1485217|NCT01177254|||Case Control||Retrospective|||||||
1485218|NCT01177241|||Case Control||Retrospective|||||||
1485219|NCT01177228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485220|NCT01177215|||Cohort||Prospective|||||||
1485221|NCT01177202|Randomized|Factorial Assignment||Prevention||Single|||t|||
1485222|NCT01177189|Randomized|Crossover Assignment||Treatment||Triple||Participants will consume either a daily oral antioxidant cocktail or a placebo. The oral antioxidant cocktail consists of vitamin C, vitamin E, and alpha lipoic acid.|t||t|t
1485223|NCT01177176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485224|NCT01177163|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485225|NCT01177150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485226|NCT01177137|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1485227|NCT01177124|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485228|NCT01177111|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485229|NCT01177098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485230|NCT01177085|Randomized|Parallel Assignment||Treatment||Single||||||t
1485231|NCT01177072|Randomized|Parallel Assignment||Treatment||Single||||||t
1485232|NCT01177059||Single Group Assignment||Other||None (Open Label)||||||
1485233|NCT01177046|||Cohort||Prospective|||||||
1485234|NCT01177033|||Cohort||Prospective|||||||
1485235|NCT01177020|||Case Control||Retrospective|||||||
1485236|NCT01177007||Single Group Assignment||Treatment||None (Open Label)||||||
1485237|NCT01176994|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1485238|NCT01176981||Single Group Assignment||Treatment||None (Open Label)||||||
1485239|NCT01176968|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1485240|NCT01176955|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485241|NCT01176942|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485242|NCT01176929|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485243|NCT01176916||||||None (Open Label)||||||
1485244|NCT01176903|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1485245|NCT01176890|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1485246|NCT01176877||Single Group Assignment||||None (Open Label)||||||
1485247|NCT01176864|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1485248|NCT01176851|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485249|NCT01176838|||Other||Prospective|||||||
1485250|NCT01176825|Randomized|Parallel Assignment||Treatment||Single||||||t
1485251|NCT01176812|||Case-Only||Other|||||||
1485252|NCT01176799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485253|NCT01176786|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1485254|NCT01176773|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1485255|NCT01176760|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1485256|NCT01176747||Parallel Assignment||Treatment||None (Open Label)||||||
1485257|NCT01176734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485258|NCT01176721|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1485259|NCT01176708|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1485260|NCT01176695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485261|NCT01176682|||Cohort||Prospective|||||||
1485262|NCT01176669||Single Group Assignment||Treatment||None (Open Label)||||||
1485263|NCT01176656|||Cohort||Cross-Sectional|||||||
1485264|NCT01176643|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1485265|NCT01176630|||Case Control||Prospective|||||||
1485266|NCT01176617|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1485267|NCT01176604||Single Group Assignment||Treatment||None (Open Label)||||||
1485268|NCT01176591|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1485269|NCT01176578|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485329|NCT01175798|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485330|NCT01175785||Single Group Assignment||Treatment||None (Open Label)||||||
1485331|NCT01175772||Single Group Assignment||Treatment||None (Open Label)||||||
1485332|NCT01175759|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1485333|NCT01175746|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1485334|NCT01175733||Single Group Assignment||Treatment||None (Open Label)||||||
1485335|NCT01175720|Randomized|Single Group Assignment||Treatment||Single|||t|||
1485336|NCT01175707|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1485337|NCT01175694|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485338|NCT01175681|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1485339|NCT01175668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485340|NCT01175655||Single Group Assignment||Treatment||None (Open Label)||||||
1485270|NCT01176565|Randomized|Parallel Assignment||Treatment||Double|The trial intervention is conducted open-label to avoid concealing clinically necessary patient blood pressure and intravenous drug administration information. Clinical data including SBP values are primarily taken from entries recorded in to the patient's official medical record by hospital staff and are independently monitor-verified. Assessors for the primary outcome (mRS) at 90 days are are unaware of the treatment assignment or in-hospital clinical course of the subjects assessed. De-identified imaging studies are coded independently of subject number so the central imaging reader is unaware of the treatment assignment, clinical findings, or time points of image acquisition for data recorded from imaging. The study (lead) principal investigator and leadership committee members are unable to associate the treatment assignment of subjects to their outcomes or adverse events for purposes of trial decision-making. Adverse events are adjudicated by an independent oversight committee.|Eligible patients are randomized 1:1 via computer-generated treatment assignment within 4.5 hours of neurological symptom onset to either standard or intensive SBP management using intravenous nicardipine hydrochloride as the primary BP control agent through 24 hours from randomization. Enrolled patients from both treatment arms are otherwise treated similarly after 24 hours, according to their medical needs. Standards of care management for spontaneous intracerebral hemorrhage published in the 2010 American Heart Association guidelines are incorporated in to the study protocol. All enrolled patients are followed through 90 days (± 14 days per protocol window; up to ± 30 days data is used) unless death or withdrawal occurs sooner. Primary analysis based on intent-to-treat (ITT) principles.|||t|t
1485271|NCT01176552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485272|NCT01176539|||Case-Only||Cross-Sectional|||||||
1485273|NCT01176526|||||Retrospective|||||||
1485274|NCT01176513|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1485275|NCT01176500|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1485276|NCT01176487|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1485277|NCT01176474|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485278|NCT01176461|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485279|NCT01176448|Randomized|Single Group Assignment||Treatment||Single||||||t
1485280|NCT01176435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485281|NCT01176422|||Case-Only||Cross-Sectional|||||||
1485282|NCT01176409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485283|NCT01176396|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1485284|NCT01176383|Randomized|Parallel Assignment||Prevention||Single|||t|||
1485285|NCT01176370||Single Group Assignment||Treatment||None (Open Label)||||||
1485286|NCT01176357|||Case Control||Cross-Sectional|||||||
1485287|NCT01176344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485288|NCT01176331|||||Retrospective|||||||
1485289|NCT01176318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485290|NCT01176305|||Cohort||Retrospective|||||||
1485291|NCT01176292|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485292|NCT01176279|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1485293|NCT01176266||Single Group Assignment||Treatment||None (Open Label)||||||
1485294|NCT01176253|||Case Control||Prospective|||||||
1485295|NCT01176240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485296|NCT01176227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485297|NCT01176214|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485298|NCT01176201|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485299|NCT01176188|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485300|NCT01176175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485301|NCT01176162|||Case-Only||Prospective|||||||
1485302|NCT01176149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485303|NCT01176136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485304|NCT01176123||||Treatment||||||||
1485305|NCT01176110|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485306|NCT01176097|Randomized|Single Group Assignment||Treatment||Single|||t|||
1485307|NCT01176084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485308|NCT01176071|||Cohort||Retrospective|||||||
1485309|NCT01176058|Randomized|Parallel Assignment||||None (Open Label)||||||
1485310|NCT01176045|||Cohort||Prospective|||||||
1485311|NCT01176032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485312|NCT01176019|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1485313|NCT01176006|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485314|NCT01175993|Randomized|Crossover Assignment||Treatment||Single|||t|||
1485315|NCT01175980||Single Group Assignment||Treatment||None (Open Label)||||||
1485316|NCT01175967|||Case-Only||Prospective|||||||
1485317|NCT01175954||Single Group Assignment||Treatment||None (Open Label)||||||
1485318|NCT01175941|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1485319|NCT01175928|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1485320|NCT01175915|Randomized|Parallel Assignment||Treatment||Single||||||t
1485321|NCT01175902|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485322|NCT01175889|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1485323|NCT01175876|Randomized|Parallel Assignment||Treatment||Single||||t||
1485324|NCT01175863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485325|NCT01175850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485326|NCT01175837||Single Group Assignment||Supportive Care||None (Open Label)||||||
1485327|NCT01175824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485328|NCT01175811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486500|NCT01160510|||Other||Retrospective|||||||
1485341|NCT01175642|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485342|NCT01175629|||Cohort||Cross-Sectional|||||||
1485343|NCT01175616|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485344|NCT01175603|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485345|NCT01175590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485346|NCT01175577|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1485347|NCT01175564|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1485348|NCT01175551|||Cohort||Prospective|||||||
1485349|NCT01175538||||Treatment||||||||
1485350|NCT01175525||Parallel Assignment||||||||||
1485351|NCT01175512|Non-Randomized|Single Group Assignment||||Triple|||t||t|t
1485352|NCT01175499||Single Group Assignment||Diagnostic||Single||||||t
1485353|NCT01175486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485354|NCT01175473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485355|NCT01175460|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485356|NCT01175447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485357|NCT01175434|Randomized|Parallel Assignment||Treatment||Single||||||t
1485358|NCT01175421|||Cohort||Prospective|||||||
1485359|NCT01175408|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485360|NCT01175395||Single Group Assignment||Treatment||None (Open Label)||||||
1485361|NCT01175382|Randomized|Parallel Assignment||Treatment||None (Open Label)||The design of this study is a 3 group randomized trial. Group 1 was randomized to drug only for the first 6 weeks, followed by a step up to drug plus behavior from 6 weeks to 12 weeks. Group 2 was randomized to behavior only for the first 6 weeks, followed by a step up to behavior plus drug from 6 weeks to 12 weeks. Group 3 was randomized to behavior plus drug from baseline to 12 weeks.||||
1485362|NCT01175369|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1485363|NCT01175356||Single Group Assignment||Treatment||None (Open Label)||||||
1485364|NCT01175343||Single Group Assignment||Treatment||None (Open Label)||||||
1485365|NCT01175330|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1485366|NCT01175317|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485367|NCT01175304|||Ecologic or Community||Cross-Sectional|||||||
1485368|NCT01175291|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485369|NCT01175278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485370|NCT01175265|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485371|NCT01175252|||Ecologic or Community||Retrospective|||||||
1485372|NCT01175239||Single Group Assignment||Treatment||None (Open Label)||||||
1485373|NCT01175226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485374|NCT01175213|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485375|NCT01175200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485376|NCT01175187|||Case Control||Retrospective|||||||
1485377|NCT01175174|||||Prospective|||||||
1485378|NCT01175161|Randomized|Parallel Assignment||||None (Open Label)||||||
1485379|NCT01175148|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1485380|NCT01175135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485381|NCT01175122||Single Group Assignment||Prevention||None (Open Label)||||||
1485382|NCT01175109||Single Group Assignment||Treatment||None (Open Label)||||||
1485383|NCT01175096|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485384|NCT01175083|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485385|NCT01175070||Single Group Assignment||Treatment||None (Open Label)||||||
1485386|NCT01175057|||Case Control||Retrospective|||||||
1485387|NCT01175044|Randomized|Parallel Assignment||Prevention||Single|||t|||
1485388|NCT01175031|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1485389|NCT01175018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485390|NCT01175005|||Cohort||Prospective|||||||
1485391|NCT01174992|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485392|NCT01174979|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485393|NCT01174966|||Cohort||Prospective|||||||
1485394|NCT01174953||Single Group Assignment||Prevention||None (Open Label)||||||
1485395|NCT01174940||Single Group Assignment||Treatment||None (Open Label)||||||
1485396|NCT01174927|Randomized|Crossover Assignment||Treatment||Single|||t|||
1485397|NCT01174914|Randomized|Parallel Assignment||Prevention||Single|||t|||
1485398|NCT01174901|||Cohort||Prospective|||||||
1485399|NCT01174888|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485400|NCT01174875|||Cohort||Prospective|||||||
1485401|NCT01174862|||Cohort||Prospective|||||||
1485402|NCT01174849|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485403|NCT01174836||Single Group Assignment||Health Services Research||None (Open Label)||||||
1485404|NCT01174823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485405|NCT01174810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485406|NCT01174797|||Cohort||Retrospective|||||||
1485407|NCT01174784|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485408|NCT01174771|||Cohort||Cross-Sectional|||||||
1485409|NCT01174758|||Cohort||Cross-Sectional|||||||
1485410|NCT01174732|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1485411|NCT01174719|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485412|NCT01174706|Randomized|Single Group Assignment||Health Services Research||Single|||||t|
1485413|NCT01174693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485414|NCT01174680||Single Group Assignment||Diagnostic||None (Open Label)||||||
1485415|NCT01174667|Randomized|Parallel Assignment||Treatment||Single||||||t
1485416|NCT01174654|Randomized|Parallel Assignment||Prevention||Single|||||t|
1485417|NCT01174641|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1485418|NCT01174628|||Cohort||Prospective|||||||
1485419|NCT01174615|||Other||Prospective|||||||
1485420|NCT01174602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485421|NCT01174589|Randomized|Single Group Assignment||Treatment||Single||||||t
1485422|NCT01174576|Randomized|Crossover Assignment||Treatment||Single|||t|||
1485423|NCT01174563||Single Group Assignment||Treatment||None (Open Label)||||||
1485424|NCT01174550|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1485425|NCT01174537||Single Group Assignment||Treatment||None (Open Label)||||||
1485426|NCT01174524|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485427|NCT01174511|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1485428|NCT01174498|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1485429|NCT01174485|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1485430|NCT01174472|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485431|NCT01174459|||Cohort||Prospective|||||||
1485432|NCT01174446|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1485433|NCT01174433||Single Group Assignment||Treatment||None (Open Label)||||||
1485434|NCT01174420|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485435|NCT01174407|||Case Control||Prospective|||||||
1485436|NCT01174394|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1485437|NCT01174381||Single Group Assignment||Prevention||None (Open Label)||||||
1485438|NCT01174368||Single Group Assignment||Treatment||None (Open Label)||||||
1485439|NCT01174355||Single Group Assignment||Treatment||None (Open Label)||||||
1485440|NCT01174342|||Cohort||Prospective|||||||
1485441|NCT01174329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485442|NCT01174316|Randomized|Crossover Assignment||Treatment||Single||||||t
1485443|NCT01174303|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1485444|NCT01174290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485445|NCT01174277|||Case-Only||Prospective|||||||
1485446|NCT01174264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485447|NCT01174251|||Cohort||Prospective|||||||
1485448|NCT01174238|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485449|NCT01174225|Randomized|Parallel Assignment||Prevention||None (Open Label)||Flexi-T380(+) IUD Nova-T200 IUD||||
1485450|NCT01174212|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485451|NCT01174199||Single Group Assignment||Treatment||None (Open Label)||||||
1485452|NCT01174186|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1485453|NCT01174173||Single Group Assignment||Treatment||None (Open Label)||||||
1485454|NCT01174160|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485455|NCT01174147|||Case-Only||Prospective|||||||
1485456|NCT01174134||||||||||||
1485457|NCT01174121|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485458|NCT01174108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485459|NCT01174095|||Case-Only||Retrospective|||||||
1485460|NCT01174082|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1485461|NCT01174069|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485462|NCT01174056|Non-Randomized|Factorial Assignment||Basic Science||Single|||t|||
1485463|NCT01174043||Single Group Assignment||Treatment||None (Open Label)||||||
1485464|NCT01174030|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485465|NCT01174017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485466|NCT01174004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485467|NCT01173991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485468|NCT01173978|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1485469|NCT01173965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485470|NCT01173952|||Case-Only||Prospective|||||||
1485471|NCT01173939|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1485472|NCT01173926|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485473|NCT01173913|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485474|NCT01173900|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485475|NCT01173887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485476|NCT01173874|Randomized|Parallel Assignment||Treatment||Single||||||t
1485477|NCT01173861|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485478|NCT01173848|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485479|NCT01173835||Single Group Assignment||Prevention||None (Open Label)||||||
1485480|NCT01173822|Randomized|Single Group Assignment||Treatment||Double||||||
1485481|NCT01173809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485482|NCT01173796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485483|NCT01173783|||Case-Only||Prospective|||||||
1485484|NCT01173770|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1485485|NCT01173757|Non-Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1485486|NCT01173744|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485487|NCT01173731||Single Group Assignment||Treatment||None (Open Label)||||||
1485488|NCT01173718||Single Group Assignment||Treatment||None (Open Label)||||||
1485489|NCT01173705|||Case-Control||Cross-Sectional|||||||
1485490|NCT01173692|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1487197|NCT01151358|||||Prospective|||||||
1485491|NCT01173679||Single Group Assignment||Treatment||None (Open Label)||||||
1485492|NCT01173666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485493|NCT01173653|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485494|NCT01173640|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1485495|NCT01173627|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485496|NCT01173614|||||Prospective|||||||
1485497|NCT01173601|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485498|NCT01173588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485499|NCT01173575|||Cohort||Prospective|||||||
1485500|NCT01173562||Single Group Assignment||Treatment||None (Open Label)||||||
1485501|NCT01173549|Randomized|Crossover Assignment||||Triple|||t|t|t|
1485502|NCT01173536|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485503|NCT01173523|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485504|NCT01173510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485505|NCT01173497||Single Group Assignment||Treatment||None (Open Label)||||||
1485506|NCT01173484|||Cohort||Prospective|||||||
1485507|NCT01173471|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1485508|NCT01173458|||Case-Only||Prospective|||||||
1485509|NCT01173445|||Cohort||Prospective|||||||
1485510|NCT01173432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485511|NCT01173419|Randomized|Parallel Assignment||Treatment||Single||||||t
1485512|NCT01173406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485513|NCT01173393||Single Group Assignment||Treatment||Single|||t|||
1485514|NCT01173380|Randomized|Crossover Assignment||Treatment||Single||||||t
1485515|NCT01173367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485516|NCT01173354|Randomized|Crossover Assignment||Other||Double|||t||t|
1485517|NCT01173341|||Cohort||Prospective|||||||
1485518|NCT01173328|Randomized|Crossover Assignment||Treatment||Single||||||t
1485519|NCT01173315|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485520|NCT01173302||Single Group Assignment||Health Services Research||None (Open Label)||||||
1485521|NCT01173289||Single Group Assignment||Treatment||None (Open Label)||||||
1485522|NCT01173276||Single Group Assignment||Treatment||None (Open Label)||||||
1485523|NCT01173263|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1485524|NCT01173250||||||||||||
1485525|NCT01173237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485526|NCT01173224|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485527|NCT01173211|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1485528|NCT01173198|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1485529|NCT01173172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485530|NCT01173159||Single Group Assignment||Treatment||None (Open Label)||||||
1485531|NCT01173146|||Cohort||Prospective|||||||
1485532|NCT01173133|||Cohort||Prospective|||||||
1485533|NCT01173120||Single Group Assignment||Treatment||None (Open Label)||||||
1485534|NCT01173107|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1485535|NCT01173094|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485536|NCT01173081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485537|NCT01173068|||Case Control||Prospective|||||||
1485538|NCT01173055|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1485539|NCT01173042|Randomized|Crossover Assignment||Treatment||Single|||t|||
1485540|NCT01173029|||Cohort||Prospective|||||||
1485541|NCT01173016||Single Group Assignment||Treatment||None (Open Label)||||||
1485542|NCT01173003||Single Group Assignment||Health Services Research||None (Open Label)||||||
1485543|NCT01172990|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1485544|NCT01172977|||Case Control||Prospective|||||||
1485545|NCT01172964||Single Group Assignment||Treatment||None (Open Label)||||||
1485546|NCT01172951|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1485547|NCT01172938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485548|NCT01172925|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1485549|NCT01172912|Non-Randomized|||Treatment||None (Open Label)||||||
1485550|NCT01172899|Randomized|Parallel Assignment||Treatment||Single||||||t
1485551|NCT01172886|||Case Control||Retrospective|||||||
1485552|NCT01172873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485553|NCT01172860||Single Group Assignment||Treatment||None (Open Label)||||||
1485554|NCT01172847|Randomized|Crossover Assignment||||None (Open Label)||||||
1485555|NCT01172834|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1485556|NCT01172821|Randomized|Parallel Assignment||Treatment||Double||||||
1485557|NCT01172808|Randomized|Parallel Assignment||Treatment||Double||||||
1485558|NCT01172795|||Case-Crossover||Cross-Sectional|||||||
1485559|NCT01172782|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1485560|NCT01172769||Single Group Assignment||Treatment||None (Open Label)||||||
1485561|NCT01172756|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485562|NCT01172743|||Cohort||Prospective|||||||
1485563|NCT01172730|||Case-Only||Prospective|||||||
1485564|NCT01172717|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485565|NCT01172704|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485566|NCT01172691|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1485567|NCT01172665|||Case-Only|||||||||
1485568|NCT01172652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485569|NCT01172639|Randomized|Parallel Assignment||Treatment||None (Open Label)||Before randomisation patients were stratified to a high-risk or low-risk group according to the presence of risk factors at screening (having erosions, rheumatoid factor and/or anticitrullinated protein antibody and a high disease activity score calculated with C-reactive protein (DAS28-CRP)). Randomisation to treatment arms was performed via a digitally generated sequence. Patients in the high-risk group were randomised into CoBRA Classic, Clim or Avant-Garde arm. Patients in the low-risk group were randomised into CoBRA Slim or Tight Step Up arm.||||
1485570|NCT01172626|||Case-Only||Prospective|||||||
1485571|NCT01172613|||Case Control||Cross-Sectional|||||||
1485572|NCT01172600|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1485573|NCT01172587||Single Group Assignment||Basic Science||None (Open Label)||||||
1485574|NCT01172574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485575|NCT01172561|Randomized|Parallel Assignment||Screening||Triple||||t|t|t
1485576|NCT01172548||Single Group Assignment||Prevention||None (Open Label)||||||
1485577|NCT01172535||Single Group Assignment||Treatment||None (Open Label)||||||
1485578|NCT01172522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485579|NCT01172509|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1485580|NCT01172496|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485581|NCT01172483|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1485582|NCT01172470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485583|NCT01172457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485584|NCT01172444|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485585|NCT01172431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485586|NCT01172418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485587|NCT01172405|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485588|NCT01172392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485589|NCT01172379|Randomized|Parallel Assignment||Treatment||Double||||||
1485590|NCT01172366||||||||||||
1485591|NCT01172353|Randomized|Parallel Assignment||Prevention||Single||||||t
1485592|NCT01172340|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485593|NCT01172327|Randomized|Parallel Assignment||Prevention||Single||||||t
1485594|NCT01172314|Randomized|Crossover Assignment||Other||Double|||t||t|
1485595|NCT01172301|Randomized|Single Group Assignment||||Double|||t||t|
1485596|NCT01172288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485597|NCT01172275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485598|NCT01172262|||Cohort||Prospective|||||||
1485599|NCT01172249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485600|NCT01172236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485601|NCT01172223||Single Group Assignment||Treatment||None (Open Label)||||||
1485602|NCT01172210||||||||||||
1485603|NCT01172197|Randomized|Parallel Assignment||Treatment||Single||||||t
1485604|NCT01172184|||Cohort||Prospective|||||||
1485605|NCT01172171|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485606|NCT01172158|||Case Control||Prospective|||||||
1485607|NCT01172145|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485608|NCT01172132|||Cohort||Prospective|||||||
1485609|NCT01172119|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485610|NCT01172106|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1485611|NCT01172093|||Case-Only||Cross-Sectional|||||||
1485612|NCT01172080|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1485613|NCT01172067|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485614|NCT01172054|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1485615|NCT01172041|||Cohort||Prospective|||||||
1485616|NCT01172028||Single Group Assignment||Treatment||None (Open Label)||||||
1485617|NCT01172015|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1485618|NCT01172002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485619|NCT01171989|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485620|NCT01171976|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485621|NCT01171963|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1485622|NCT01171950||Single Group Assignment||Treatment||None (Open Label)||||||
1485623|NCT01171937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485624|NCT01171924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485625|NCT01171911|Randomized|Parallel Assignment||Treatment||Single||||||t
1485626|NCT01171898|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485627|NCT01171885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485628|NCT01171872|||Case-Control||Cross-Sectional|||||||
1485629|NCT01171859||Single Group Assignment||Treatment||None (Open Label)||||||
1485630|NCT01171846|Randomized|Parallel Assignment||Prevention||Single|||t|||
1485631|NCT01171833|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1485632|NCT01171820|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485633|NCT01171807|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485634|NCT01171794|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1485635|NCT01171781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485636|NCT01171768|||Case Control||Prospective|||||||
1485637|NCT01171755||Single Group Assignment||Treatment||None (Open Label)||||||
1485638|NCT01171742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485639|NCT01171729|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485640|NCT01171716|Randomized|Parallel Assignment||Prevention||Single|||t|||
1485641|NCT01171703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485642|NCT01171690||Single Group Assignment||Treatment||None (Open Label)||||||
1485643|NCT01171677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485644|NCT01171664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485645|NCT01171651|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485646|NCT01171638|||Cohort||Prospective|||||||
1485647|NCT01171625||Single Group Assignment||Treatment||None (Open Label)||||||
1485648|NCT01171612|||Cohort||Prospective|||||||
1485649|NCT01171599|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1485650|NCT01171586|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485651|NCT01171573|||Case-Control||Prospective|||||||
1485652|NCT01171560|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485653|NCT01171547|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1485654|NCT01171534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485655|NCT01171521||Single Group Assignment||Treatment||None (Open Label)||||||
1485656|NCT01171508|||Cohort||Prospective|||||||
1485657|NCT01171495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485658|NCT01171482|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485659|NCT01171469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485660|NCT01171456|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1485661|NCT01171443|||Case-Only||Prospective|||||||
1485662|NCT01171430||Single Group Assignment||Diagnostic||None (Open Label)||||||
1485663|NCT01171417|||Cohort||Prospective|||||||
1485664|NCT01171404|||Cohort||Prospective|||||||
1485665|NCT01171391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485666|NCT01171378||Single Group Assignment||Treatment||None (Open Label)||||||
1485667|NCT01171365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485668|NCT01171352|||Case-Only||Prospective|||||||
1485669|NCT01171339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485670|NCT01171326|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485671|NCT01171313|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1485672|NCT01171300||Single Group Assignment||||None (Open Label)||||||
1485673|NCT01171287|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1485674|NCT01171274|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485675|NCT01171261|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485676|NCT01171248|||Cohort||Cross-Sectional|||||||
1485677|NCT01171235|||Cohort||Prospective|||||||
1485678|NCT01171222|||Cohort||Prospective|||||||
1485679|NCT01171209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485680|NCT01171196|||Cohort||Prospective|||||||
1485681|NCT01171183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485682|NCT01171170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485683|NCT01171157|||Case-Control||Prospective|||||||
1485684|NCT01171144|||Other||Retrospective|||||||
1485685|NCT01171131|||Cohort||Other|||||||
1485686|NCT01171118|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1485687|NCT01171105|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485688|NCT01171092||Single Group Assignment||Treatment||None (Open Label)||||||
1485689|NCT01171079||||||||||||
1485690|NCT01171066||||||||||||
1485691|NCT01171053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485692|NCT01171040|||Cohort||Prospective|||||||
1485693|NCT01171027|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485694|NCT01171014|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1485695|NCT01170988|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485696|NCT01170975|Randomized|Crossover Assignment||||None (Open Label)||||||
1485697|NCT01170962|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485698|NCT01170949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485699|NCT01170936||Single Group Assignment||Treatment||None (Open Label)||||||
1485700|NCT01170923|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1485701|NCT01170910|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1485702|NCT01170897|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1485703|NCT01170884|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485704|NCT01170871|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485705|NCT01170858|Randomized|Parallel Assignment||||None (Open Label)||||||
1485706|NCT01170845|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485707|NCT01170832|||Cohort||Prospective|||||||
1485708|NCT01170819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485709|NCT01170806|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1485710|NCT01170793|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485711|NCT01170780|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1485712|NCT01170767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485713|NCT01170754|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485714|NCT01170741|Randomized|Parallel Assignment||Prevention||Single|||t|||
1485715|NCT01170728|||Cohort||Prospective|||||||
1485716|NCT01170715||Single Group Assignment||Basic Science||None (Open Label)||Participants will be screened and enrolled based on inclusion/exclusion criteria. Those enrolled will have intervention for 52 weeks and assessed for outcome measures along the way.||||
1485717|NCT01170702|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485718|NCT01170689|||Cohort||Cross-Sectional|||||||
1485719|NCT01170676|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485720|NCT01170663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485721|NCT01170650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485722|NCT01170637|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485723|NCT01170624|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1485724|NCT01170611|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485725|NCT01170598||Single Group Assignment||Supportive Care||None (Open Label)||||||
1485726|NCT01170585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485727|NCT01170572|||Cohort||Prospective|||||||
1485728|NCT01170559|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1485729|NCT01170546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485730|NCT01170533|Randomized|Crossover Assignment||||None (Open Label)||||||
1485731|NCT01170520||Single Group Assignment||Treatment||None (Open Label)||||||
1485732|NCT01170507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485733|NCT01170494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485734|NCT01170481|||Case Control||Prospective|||||||
1485735|NCT01170468|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1485736|NCT01170455|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485737|NCT01170442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485738|NCT01170429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485739|NCT01170416|||Cohort||Prospective|||||||
1485740|NCT01170403|||Cohort||Prospective|||||||
1485741|NCT01170390|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1485742|NCT01170377|||Cohort||Prospective|||||||
1485743|NCT01170364|Randomized|Crossover Assignment||Other||Double|||t||t|
1485744|NCT01170351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485745|NCT01170338|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485746|NCT01170325|Randomized|Parallel Assignment||Treatment||Double||||||
1485747|NCT01170312|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485748|NCT01170299|Randomized|||Supportive Care||None (Open Label)||||||
1485749|NCT01170286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485750|NCT01170273|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1485751|NCT01170260|Randomized|Factorial Assignment||Treatment||Single||||||t
1485752|NCT01170247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485753|NCT01170234|||Cohort||Prospective|||||||
1485754|NCT01170221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485755|NCT01170208|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485756|NCT01170195||Single Group Assignment||Treatment||None (Open Label)||||||
1485757|NCT01170182|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485758|NCT01170169|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485759|NCT01170156||Single Group Assignment||Prevention||None (Open Label)||||||
1485760|NCT01170143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485761|NCT01170130||Single Group Assignment||Supportive Care||None (Open Label)||||||
1485762|NCT01170117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485763|NCT01170104||Single Group Assignment||Treatment||None (Open Label)||||||
1485764|NCT01170091|||||Prospective|||||||
1485765|NCT01170078|Randomized|Crossover Assignment||Treatment||Single||||||t
1485766|NCT01170065|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485767|NCT01170052||Single Group Assignment||Treatment||None (Open Label)||||||
1485768|NCT01170039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485769|NCT01170026|Randomized|Parallel Assignment||Treatment||Single||||||t
1485770|NCT01170013|Randomized|Parallel Assignment||Prevention||Single||||||t
1485771|NCT01170000|||Family-Based||Prospective|||||||
1485772|NCT01169987|||Cohort||Prospective|||||||
1485773|NCT01169974|||Cohort||Prospective|||||||
1485774|NCT01169961|||Case-Only||Cross-Sectional|||||||
1485775|NCT01169948|||Case-Only||Cross-Sectional|||||||
1485776|NCT01169935|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1485777|NCT01169922|Randomized|Factorial Assignment||Treatment||Single||||||t
1485778|NCT01169909||Single Group Assignment||Treatment||None (Open Label)||||||
1485779|NCT01169896|||Cohort||Prospective|||||||
1485780|NCT01169883|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1485781|NCT01169870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485782|NCT01169857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485783|NCT01169844||Single Group Assignment||Treatment||None (Open Label)||||||
1485784|NCT01169831|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1485785|NCT01169818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485786|NCT01169805|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1485787|NCT01169792|||Cohort||Retrospective|||||||
1485788|NCT01169779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485789|NCT01169753|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1485790|NCT01169740|||Cohort||Prospective|||||||
1485791|NCT01169727|||Case-Only||Prospective|||||||
1485792|NCT01169714|Randomized|Parallel Assignment||||Double|||t||t|
1485793|NCT01169701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485794|NCT01169688|Randomized|Parallel Assignment||||None (Open Label)||||||
1485795|NCT01169675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485796|NCT01169662|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1485797|NCT01169649||Single Group Assignment||Treatment||None (Open Label)||||||
1485798|NCT01169636|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485799|NCT01169623|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1485800|NCT01169610||Single Group Assignment||Treatment||None (Open Label)||||||
1485801|NCT01169597||Single Group Assignment||Treatment||None (Open Label)||||||
1485802|NCT01169584||Single Group Assignment||Treatment||None (Open Label)||||||
1485803|NCT01169571|||||Prospective|||||||
1485804|NCT01169558||Single Group Assignment||Treatment||None (Open Label)||||||
1485805|NCT01169545|||||Cross-Sectional|||||||
1485806|NCT01169532||Single Group Assignment||Treatment||None (Open Label)||||||
1485807|NCT01169519||Single Group Assignment||Treatment||None (Open Label)||||||
1485808|NCT01169506|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1485809|NCT01169493|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1485810|NCT01169480|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1485811|NCT01169467|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485812|NCT01169454|||Case Control||Prospective|||||||
1485813|NCT01169441|||Cohort|||||||||
1485814|NCT01169428|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1485815|NCT01169415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485816|NCT01169402||Single Group Assignment||Treatment||None (Open Label)||||||
1485817|NCT01169389|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1485818|NCT01169376|||Case-Only||Retrospective|||||||
1485819|NCT01169363|||Other||Retrospective|||||||
1485820|NCT01169350||Single Group Assignment||Diagnostic||None (Open Label)||||||
1485821|NCT01169337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485822|NCT01169324|Randomized|Crossover Assignment||Other||Double|||t||t|
1485823|NCT01169311||Single Group Assignment||Treatment||None (Open Label)||||||
1485824|NCT01169298||Single Group Assignment||Treatment||None (Open Label)||||||
1485825|NCT01169285|||Case-Only||Cross-Sectional|||||||
1485826|NCT01169272|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1485827|NCT01169259|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1485828|NCT01169246|||Cohort||Prospective|||||||
1485829|NCT01169233|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485830|NCT01169220|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1485831|NCT01169207|||Case-Control||Cross-Sectional|||||||
1485832|NCT01169194|||Case-Control||Cross-Sectional|||||||
1485833|NCT01169181|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485834|NCT01169168|||Cohort||Prospective|||||||
1485835|NCT01169155|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1485836|NCT01169142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485837|NCT01169129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485838|NCT01169116||Single Group Assignment||Treatment||None (Open Label)||||||
1485839|NCT01169103|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485840|NCT01169090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485841|NCT01169077|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1485842|NCT01169064|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485843|NCT01169051|||Case-Control||Retrospective|||||||
1485844|NCT01169038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1485845|NCT01169025|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1485846|NCT01169012||Single Group Assignment||Basic Science||None (Open Label)||||||
1485847|NCT01168999|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485848|NCT01168986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485849|NCT01168973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485850|NCT01168960||Single Group Assignment||Treatment||None (Open Label)||||||
1485851|NCT01168947||Single Group Assignment||Treatment||None (Open Label)||||||
1485852|NCT01168934|Randomized|Parallel Assignment||||None (Open Label)||||||
1485853|NCT01168921||Single Group Assignment||Treatment||None (Open Label)||||||
1485854|NCT01168908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485855|NCT01168895|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1485856|NCT01168882||Single Group Assignment||Treatment||None (Open Label)||||||
1485857|NCT01168869|||||Retrospective|||||||
1485858|NCT01168856|||Cohort||Prospective|||||||
1485859|NCT01168843|||Case-Only||Retrospective|||||||
1485860|NCT01168830|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485861|NCT01168817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485862|NCT01168804||Single Group Assignment||Treatment||None (Open Label)||||||
1485863|NCT01168791|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485864|NCT01168778|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1485865|NCT01168765|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485866|NCT01168752|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485867|NCT01168739|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1485868|NCT01168726|Randomized|Parallel Assignment||Prevention||Single|||t|||
1485869|NCT01168713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485870|NCT01168700|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1485871|NCT01168687|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1485872|NCT01168674|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1485873|NCT01168661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485874|NCT01168648|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485875|NCT01168635|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1485876|NCT01168622|||||Cross-Sectional|||||||
1485877|NCT01168609|||Cohort||Prospective|||||||
1485878|NCT01168596|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1485879|NCT01168583|||Cohort||Prospective|||||||
1485880|NCT01168570|||Case Control||Prospective|||||||
1485881|NCT01168557||Single Group Assignment||Basic Science||None (Open Label)||||||
1485882|NCT01168544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485883|NCT01168531|Randomized|Factorial Assignment||Supportive Care||Double||||t|t|
1485884|NCT01168518|||Cohort||Prospective|||||||
1485885|NCT01168505|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485886|NCT01168492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485887|NCT01168479|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485888|NCT01168466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485889|NCT01168453|||Case-Only||Prospective|||||||
1485890|NCT01168440||Single Group Assignment||Treatment||None (Open Label)||||||
1485891|NCT01168427|||Case-Only||Prospective|||||||
1485892|NCT01168414|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485893|NCT01168401|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1485894|NCT01168388|||||Prospective|||||||
1485895|NCT01168375||||||||||||
1485896|NCT01168362|||Cohort||Prospective|||||||
1485897|NCT01168349|||Cohort||Prospective|||||||
1485898|NCT01168336|Randomized|Parallel Assignment||||Triple|||t||t|t
1485899|NCT01168323|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1485900|NCT01168310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485901|NCT01168297|||Cohort||Prospective|||||||
1485902|NCT01168284|Randomized|Single Group Assignment||Other||||||||
1485903|NCT01168271|||Cohort||Prospective|||||||
1485904|NCT01168258|||||Prospective|||||||
1485905|NCT01168245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485906|NCT01168232||Single Group Assignment||Treatment||None (Open Label)||||||
1485907|NCT01168219||Single Group Assignment||Treatment||None (Open Label)||||||
1485908|NCT01168206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485909|NCT01168193||Single Group Assignment||||None (Open Label)||||||
1485910|NCT01168180|Randomized|Parallel Assignment||Treatment||Single||||||t
1485911|NCT01168167|||Case Control||Prospective|||||||
1485912|NCT01168154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485913|NCT01168141||Single Group Assignment||Basic Science||None (Open Label)||||||
1485914|NCT01168128||Single Group Assignment||Health Services Research||None (Open Label)||||||
1485915|NCT01168115|||Case-Only||Cross-Sectional|||||||
1485916|NCT01168102|||Case-Only||Cross-Sectional|||||||
1485917|NCT01168089|||Case-Only||Cross-Sectional|||||||
1485918|NCT01168076|||Case-Only||Cross-Sectional|||||||
1485919|NCT01168063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485920|NCT01168050||Single Group Assignment||Treatment||None (Open Label)||||||
1485921|NCT01168037|||Other||Prospective|||||||
1485922|NCT01168024|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1485923|NCT01168011||Single Group Assignment||Treatment||None (Open Label)||||||
1485924|NCT01167998|||Cohort||Prospective|||||||
1485925|NCT01167985|Non-Randomized|Parallel Assignment||Treatment||Double|||t|t||
1485926|NCT01167972|||Cohort||Prospective|||||||
1485927|NCT01167959|||Case Control||Prospective|||||||
1485928|NCT01167946|Randomized|Parallel Assignment||Treatment||Single||||||t
1485929|NCT01167933|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485930|NCT01167920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485931|NCT01167907|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485932|NCT01167894|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1485933|NCT01167881|Randomized|Parallel Assignment||Treatment||Double||||||
1485934|NCT01167868|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1485935|NCT01167855||Single Group Assignment||Health Services Research||None (Open Label)||||||
1485936|NCT01167842|||Cohort||Retrospective|||||||
1485937|NCT01167829||Single Group Assignment||Health Services Research||None (Open Label)||||||
1485938|NCT01167816||Single Group Assignment||Treatment||None (Open Label)||||||
1485939|NCT01167803|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1485940|NCT01167790|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1485941|NCT01167777|||Cohort||Prospective|||||||
1485942|NCT01167764|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1485943|NCT01167751|Randomized|Parallel Assignment||Treatment||Single||||||t
1485944|NCT01167738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485945|NCT01167725|Randomized|||Treatment||None (Open Label)||||||
1485946|NCT01167712|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485947|NCT01167699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485948|NCT01167686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485949|NCT01167673|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1485950|NCT01167660|||Cohort||Prospective|||||||
1485951|NCT01167647|||Cohort||Prospective|||||||
1485952|NCT01167634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485953|NCT01167621|||Cohort||Prospective|||||||
1485954|NCT01167608|||Ecologic or Community||Cross-Sectional|||||||
1485955|NCT01167595|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485956|NCT01167582|Randomized|Parallel Assignment||Treatment||Single||||||t
1485957|NCT01167569|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1485958|NCT01167556|Randomized|Parallel Assignment||Treatment||Single|||||t|
1485959|NCT01167543|||Case Control||Cross-Sectional|||||||
1485960|NCT01167530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485961|NCT01167517|Randomized|Parallel Assignment||Prevention||Single||||t||
1485962|NCT01167504||||||||||||
1485963|NCT01167491|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1485964|NCT01167478|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1485965|NCT01167465|Randomized|Crossover Assignment||Prevention||Single|||t|||
1485966|NCT01167452||Single Group Assignment||Treatment||None (Open Label)||||||
1485967|NCT01167439|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1485968|NCT01167426|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1485969|NCT01167413|||Cohort||Prospective|||||||
1485970|NCT01167400|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485971|NCT01167387|Randomized|Parallel Assignment||Treatment||Single||||||t
1485972|NCT01167374||Single Group Assignment||Treatment||None (Open Label)||||||
1485973|NCT01167361|||Case-Only||Prospective|||||||
1485974|NCT01167348|Randomized|Parallel Assignment||Treatment||Single||||||t
1485975|NCT01167335|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1485976|NCT01167322|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1485977|NCT01167309|Randomized|Single Group Assignment||||Double|||t||t|
1485978|NCT01167296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485979|NCT01167283|Randomized|Parallel Assignment||||Single|||t|||
1485980|NCT01167270|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1485981|NCT01167257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485982|NCT01167244||Single Group Assignment||Treatment||None (Open Label)||||||
1485983|NCT01167231|||Cohort||Prospective|||||||
1485984|NCT01167218|||||Prospective|||||||
1485985|NCT01167205|Randomized|Parallel Assignment||||Single||||||
1485986|NCT01167192||Single Group Assignment||Treatment||None (Open Label)||||||
1485987|NCT01167179|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485988|NCT01167166||Single Group Assignment||Treatment||None (Open Label)||||||
1485989|NCT01167153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1485990|NCT01167140||Single Group Assignment||Treatment||None (Open Label)||||||
1485991|NCT01167127|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485992|NCT01167114||Single Group Assignment||Treatment||None (Open Label)||||||
1485993|NCT01167101|Randomized|Parallel Assignment||Treatment||Single|||t|||
1485994|NCT01167088|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1485995|NCT01167075|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1485996|NCT01167062|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1485997|NCT01167049|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1485998|NCT01167036|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1485999|NCT01167023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486000|NCT01167010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486001|NCT01166997|Randomized|Parallel Assignment||Treatment||Single||||||t
1486002|NCT01166984|Randomized|Parallel Assignment||||Triple|||t||t|t
1486003|NCT01166971|Randomized|Single Group Assignment||Treatment||Single|||t|||
1486004|NCT01166958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486005|NCT01166945|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1486006|NCT01166932|Randomized|Parallel Assignment||Treatment||Single||||t||
1486007|NCT01166919||Single Group Assignment||Treatment||None (Open Label)||||||
1486008|NCT01166906|||Case-Only||Prospective|||||||
1486009|NCT01166893|||Case-Only||Prospective|||||||
1486010|NCT01166880|||Case-Only||Prospective|||||||
1486011|NCT01166867|||Case-Only||Prospective|||||||
1486012|NCT01166854|||Case-Only||Prospective|||||||
1486013|NCT01166841|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1486014|NCT01166828|Randomized|Parallel Assignment||Prevention||Single||||||
1486015|NCT01166815|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1486016|NCT01166802|||Case-Only||Prospective|||||||
1486017|NCT01166789|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1486018|NCT01166776|||Case-Only||Prospective|||||||
1486019|NCT01166763||Single Group Assignment||Prevention||None (Open Label)||||||
1486020|NCT01166750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486021|NCT01166737|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1486022|NCT01166724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486023|NCT01166711|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486024|NCT01166698|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1486025|NCT01166685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486026|NCT01166672|||Cohort|||||||||
1486027|NCT01166659||Single Group Assignment||Treatment||None (Open Label)||||||
1486028|NCT01166646|Randomized|Parallel Assignment||Treatment||Single|||||t|
1486029|NCT01166633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486030|NCT01166620|||Cohort||Retrospective|||||||
1486031|NCT01166607||||||||||||
1486032|NCT01166594|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486033|NCT01166581|||Cohort||Retrospective|||||||
1486110|NCT01165580||Single Group Assignment||Prevention||None (Open Label)||||||
1486111|NCT01165567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486034|NCT01166568|Randomized|Parallel Assignment||Treatment||None (Open Label)||A non-randomized arm was run in parallel with a randomized sub-study consisting of 2 arms; Immediate Treatment and Deferred Treatment. Upon completion of the 6 month observation period, the Deferred Treatment group then crosses over upon implantation to become part of the overall study group.||||
1486035|NCT01166555|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1486036|NCT01166542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486037|NCT01166529|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1486038|NCT01166516||Single Group Assignment||Treatment||None (Open Label)||||||
1486039|NCT01166503|||Case-Control||Prospective|||||||
1486040|NCT01166490||Single Group Assignment||Treatment||None (Open Label)||||||
1486041|NCT01166477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486042|NCT01166464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486043|NCT01166451|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1486044|NCT01166438|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1486045|NCT01166425|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486046|NCT01166412|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486047|NCT01166399|||Cohort||Prospective|||||||
1486048|NCT01166386|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1486049|NCT01166373|Randomized|Factorial Assignment||Other||Quadruple|||t|t|t|t
1486050|NCT01166360|||Cohort||Prospective|||||||
1486051|NCT01166347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486052|NCT01166334|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486053|NCT01166321||Single Group Assignment||Treatment||None (Open Label)||||||
1486054|NCT01166308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486055|NCT01166295|||Case-Only||Prospective|||||||
1486056|NCT01166282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486057|NCT01166269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486058|NCT01166256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486059|NCT01166243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486060|NCT01166230|||||Retrospective|||||||
1486061|NCT01166217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486062|NCT01166204||Single Group Assignment||Treatment||None (Open Label)||||||
1486063|NCT01166191||Single Group Assignment||Treatment||None (Open Label)||||||
1486064|NCT01166178|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1486065|NCT01166165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486066|NCT01166152|Non-Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1486067|NCT01166139||Single Group Assignment||Treatment||None (Open Label)||||||
1486068|NCT01166126||Single Group Assignment||Treatment||None (Open Label)||||||
1486069|NCT01166113||Single Group Assignment||Treatment||None (Open Label)||||||
1486070|NCT01166100|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486071|NCT01166087|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486072|NCT01166074|||Cohort||Retrospective|||||||
1486073|NCT01166061|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1486074|NCT01166048|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1486075|NCT01166035||Single Group Assignment||Treatment||None (Open Label)||||||
1486076|NCT01166022|Randomized|Parallel Assignment||Treatment||Single||||||t
1486077|NCT01166009|||Cohort||Prospective|||||||
1486078|NCT01165996||Single Group Assignment||Treatment||None (Open Label)||||||
1486079|NCT01165983|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1486080|NCT01165970|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1486081|NCT01165957|||Case Control||Retrospective|||||||
1486082|NCT01165944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486083|NCT01165931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486084|NCT01165918|||Cohort||Prospective|||||||
1486085|NCT01165905||Single Group Assignment||Treatment||None (Open Label)||||||
1486086|NCT01165892|||Cohort||Prospective|||||||
1486087|NCT01165879|||Case Control||Retrospective|||||||
1486088|NCT01165866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486089|NCT01165853|Non-Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1486090|NCT01165840||Single Group Assignment||Treatment||None (Open Label)||||||
1486091|NCT01165827|||Cohort||Prospective|||||||
1486092|NCT01165814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486093|NCT01165801|Randomized|Parallel Assignment||Prevention||Single||||||t
1486094|NCT01165788|||Family-Based||Retrospective|||||||
1486095|NCT01165775|||Cohort||Prospective|||||||
1486096|NCT01165762||Single Group Assignment||Treatment||None (Open Label)||||||
1486097|NCT01165749|||Cohort||Prospective|||||||
1486098|NCT01165736|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1486099|NCT01165723|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486100|NCT01165710|||Cohort||Prospective|||||||
1486101|NCT01165697|||Case-Only||Prospective|||||||
1486102|NCT01165684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486103|NCT01165671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486104|NCT01165658||Single Group Assignment||Treatment||None (Open Label)||||||
1486105|NCT01165645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486106|NCT01165632||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486107|NCT01165619|||Cohort||Cross-Sectional|||||||
1486108|NCT01165606||||||||||||
1486109|NCT01165593|||Cohort||Retrospective|||||||
1486498|NCT01160536|||||Retrospective|||||||
1486112|NCT01165554||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486113|NCT01165541|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486114|NCT01165528|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486115|NCT01165515|||||Prospective|||||||
1486116|NCT01165502|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1486117|NCT01165489|||Case Control||Cross-Sectional|||||||
1486118|NCT01165476|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486119|NCT01165463|Randomized|Parallel Assignment||Prevention||Single|||||t|
1486120|NCT01165450|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1486121|NCT01165437|||Cohort||Cross-Sectional|||||||
1486122|NCT01165424||Single Group Assignment||Treatment||None (Open Label)||||||
1486123|NCT01165411|||Cohort||Retrospective|||||||
1486124|NCT01165398|||Cohort||Retrospective|||||||
1486125|NCT01165385||Single Group Assignment||Treatment||None (Open Label)||||||
1486126|NCT01165372|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1486127|NCT01165359|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486128|NCT01165346||Single Group Assignment||Treatment||None (Open Label)||||||
1486129|NCT01165333|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486130|NCT01165320|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486131|NCT01165307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486132|NCT01165294|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1486133|NCT01165281|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486134|NCT01165268|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1486135|NCT01165255|||Cohort||Retrospective|||||||
1486136|NCT01165242|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1486137|NCT01165229|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1486138|NCT01165216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486139|NCT01165203|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1486140|NCT01165190|||Cohort||Prospective|||||||
1486141|NCT01165177|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1486142|NCT01165164||Single Group Assignment||Treatment||None (Open Label)||||||
1486143|NCT01165151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486144|NCT01165138|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486145|NCT01165125|Randomized|Crossover Assignment||Other||Double|||t||t|
1486146|NCT01165112||Single Group Assignment||Treatment||None (Open Label)||||||
1486147|NCT01165099|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1486148|NCT01165086|Randomized|Crossover Assignment||||Single|||t|||
1486149|NCT01165073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486150|NCT01165060||Single Group Assignment||Treatment||None (Open Label)||||||
1486151|NCT01165047||Single Group Assignment||Treatment||None (Open Label)||||||
1486152|NCT01165034|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1486153|NCT01165021||Single Group Assignment||Treatment||None (Open Label)||||||
1486154|NCT01165008||Single Group Assignment||Treatment||||||||
1486155|NCT01164995||Single Group Assignment||Treatment||None (Open Label)||||||
1486156|NCT01164982||Single Group Assignment||Supportive Care||None (Open Label)||||||
1486157|NCT01164969|||Case-Only||Prospective|||||||
1486158|NCT01164956|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1486159|NCT01164943|Randomized|Parallel Assignment||Treatment||Single|||||t|
1486160|NCT01164930|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486161|NCT01164917|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1486162|NCT01164904|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1486163|NCT01164891||Single Group Assignment||Treatment||None (Open Label)||||||
1486164|NCT01164878|||Cohort||Retrospective|||||||
1486165|NCT01164865|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1486166|NCT01164852|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1486167|NCT01164839|||Cohort||Cross-Sectional|||||||
1486168|NCT01164826|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486169|NCT01164813|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486170|NCT01164800|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486171|NCT01164787|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486172|NCT01164774|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486173|NCT01164761|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486174|NCT01164748|||Cohort||Prospective|||||||
1486175|NCT01164735|||Cohort||Retrospective|||||||
1486176|NCT01164722|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486177|NCT01164709||Single Group Assignment||Treatment||None (Open Label)||||||
1486178|NCT01164696|||Cohort||Prospective|||||||
1486179|NCT01164683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486180|NCT01164670|||Cohort||Prospective|||||||
1486181|NCT01164657|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486182|NCT01164644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486183|NCT01164631|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1486184|NCT01164618|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1486185|NCT01164605||Single Group Assignment||Treatment||None (Open Label)||||||
1486186|NCT01164592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486187|NCT01164579|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486188|NCT01164566||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486189|NCT01164553|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1486190|NCT01164540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486191|NCT01164527||||||||||||
1486192|NCT01164514|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1486193|NCT01164501|Randomized|Parallel Assignment||Treatment||Double||||||
1486194|NCT01164488||Single Group Assignment||Treatment||None (Open Label)||||||
1486195|NCT01164475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486196|NCT01164462|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1486197|NCT01164449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486198|NCT01164436|||Cohort||Prospective|||||||
1486199|NCT01164423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486200|NCT01164410|||Cohort||Prospective|||||||
1486201|NCT01164397|||Case-Only||Retrospective|||||||
1486202|NCT01164384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486203|NCT01164371|||Cohort||Retrospective|||||||
1486204|NCT01164358|||Cohort||Prospective|||||||
1486205|NCT01164345||Single Group Assignment||Treatment||None (Open Label)||||||
1486206|NCT01164332|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1486207|NCT01164319|Randomized|Parallel Assignment||Treatment||Single||||||t
1486208|NCT01164306|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486209|NCT01164293||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486210|NCT01164280||Single Group Assignment||Treatment||||||||
1486211|NCT01164267||Single Group Assignment||Treatment||None (Open Label)||||||
1486212|NCT01164254|||Cohort||Prospective|||||||
1486213|NCT01164241|||Cohort||Prospective|||||||
1486214|NCT01164228|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486215|NCT01164215||Single Group Assignment||Treatment||None (Open Label)||||||
1486216|NCT01164202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486217|NCT01164189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486218|NCT01164176||Single Group Assignment||Treatment||None (Open Label)||||||
1486219|NCT01164163||Single Group Assignment||Treatment||None (Open Label)||||||
1486220|NCT01164150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486221|NCT01164137|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1486222|NCT01164124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486223|NCT01164111|Randomized|Single Group Assignment||Treatment||Single||||||t
1486224|NCT01164098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486225|NCT01164085|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486226|NCT01164072|||Cohort||Prospective|||||||
1486227|NCT01164059|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486228|NCT01164046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486229|NCT01164033|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486230|NCT01164020|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1486231|NCT01164007||Single Group Assignment||Treatment||None (Open Label)||||||
1486232|NCT01163994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486233|NCT01163981|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486234|NCT01163968|Randomized|Parallel Assignment||Treatment||Single||||||t
1486235|NCT01163955|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1486236|NCT01163942|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486237|NCT01163929|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486238|NCT01163916|||||Prospective|||||||
1486239|NCT01163903||Single Group Assignment||Treatment||None (Open Label)||||||
1486240|NCT01163890|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486241|NCT01163877|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1486242|NCT01163864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486243|NCT01163851||Single Group Assignment||Treatment||None (Open Label)||||||
1486244|NCT01163838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486245|NCT01163825|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486246|NCT01163812||Single Group Assignment||Treatment||None (Open Label)||||||
1486247|NCT01163799||Single Group Assignment||Treatment||None (Open Label)||||||
1486248|NCT01163786||Single Group Assignment||Treatment||None (Open Label)||||||
1486249|NCT01163773|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1486250|NCT01163760|Randomized|Crossover Assignment||Treatment||Single|||t|||
1486251|NCT01163747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486252|NCT01163734|Randomized|Parallel Assignment||||Double|||t||t|
1486253|NCT01163721|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486254|NCT01163708|Randomized|Parallel Assignment||||Single|||t|||
1486255|NCT01163695|Randomized|Parallel Assignment||Prevention||Single|||t|||
1486256|NCT01163682|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1486257|NCT01163669|||Cohort||Prospective|||||||
1486258|NCT01163656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486259|NCT01163643|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486260|NCT01163630|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1486261|NCT01163617|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1486262|NCT01163604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486263|NCT01163591|||Case Control||Cross-Sectional|||||||
1486264|NCT01163578|||Other||Prospective|||||||
1486265|NCT01163565|Randomized|Parallel Assignment||Treatment||Single||||||t
1486266|NCT01163552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486267|NCT01163539|||Ecologic or Community||Prospective|||||||
1486268|NCT01163526|||Cohort||Prospective|||||||
1486269|NCT01163513|||Cohort||Retrospective|||||||
1486270|NCT01163500|Randomized|Parallel Assignment||Prevention||Single|||t|||
1486271|NCT01163487||Single Group Assignment||Treatment||None (Open Label)||||||
1486272|NCT01163474|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1486273|NCT01163461|Randomized|Single Group Assignment||Treatment||Single|||t|||
1486274|NCT01163448||Single Group Assignment||Treatment||None (Open Label)||||||
1486275|NCT01163435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486276|NCT01163422|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1486277|NCT01163409|Randomized|Factorial Assignment||Treatment||Single|||t|||
1486278|NCT01163396||Single Group Assignment||Treatment||None (Open Label)||||||
1486279|NCT01163383||||||||||||
1486280|NCT01163370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486281|NCT01163357|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486282|NCT01163344|||Cohort||Prospective|||||||
1486283|NCT01163331||Single Group Assignment||Treatment||None (Open Label)||||||
1486284|NCT01163318|||Cohort||Prospective|||||||
1486285|NCT01163305|||Case-Only||Prospective|||||||
1486286|NCT01163292|||Cohort||Prospective|||||||
1486287|NCT01163279|Randomized|Parallel Assignment||Other||Double|||t|||t
1486288|NCT01163266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486289|NCT01163253||Single Group Assignment||Treatment||None (Open Label)||||||
1486290|NCT01163240|||Cohort||Retrospective|||||||
1486291|NCT01163227|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1486292|NCT01163214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486293|NCT01163201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486294|NCT01163188|||Cohort||Retrospective|||||||
1486295|NCT01163175|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1486296|NCT01163162||Single Group Assignment||Prevention||None (Open Label)||||||
1486297|NCT01163149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486298|NCT01163136|||Cohort||Prospective|||||||
1486299|NCT01163123|||Cohort||Prospective|||||||
1486300|NCT01163110||Single Group Assignment||Treatment||None (Open Label)||||||
1486301|NCT01163097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486302|NCT01163084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486303|NCT01163071||Single Group Assignment||Treatment||None (Open Label)||||||
1486304|NCT01163058|||Cohort||Retrospective|||||||
1486305|NCT01163045|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1486306|NCT01163032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486307|NCT01163019|||Cohort||Prospective|||||||
1486308|NCT01163006||||||||||||
1486309|NCT01162993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486310|NCT01162980|||Case-Only||Prospective|||||||
1486311|NCT01162967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486312|NCT01162954|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1486313|NCT01162941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486314|NCT01162928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486315|NCT01162915||Single Group Assignment||Treatment||None (Open Label)||||||
1486316|NCT01162902|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486317|NCT01162889|Randomized|Parallel Assignment||||Double|||t||t|
1486318|NCT01162876||Single Group Assignment||Other||None (Open Label)||||||
1486319|NCT01162863|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1486320|NCT01162850|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1486321|NCT01162837|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1486322|NCT01162824|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1486323|NCT01162811|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486324|NCT01162798|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1486325|NCT01162785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486326|NCT01162772|||||Prospective|||||||
1486327|NCT01162759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486328|NCT01162746|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1486329|NCT01162733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486330|NCT01162720|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1486331|NCT01162707||Single Group Assignment||Treatment||None (Open Label)||||||
1486332|NCT01162694|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486333|NCT01162681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486334|NCT01162668|||Other||Prospective|||||||
1486335|NCT01162655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486336|NCT01162642|Randomized|Parallel Assignment||Prevention||Single|||t|||
1486337|NCT01162629|||Case-Only||Prospective|||||||
1486338|NCT01162616|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1486339|NCT01162603|Randomized|Crossover Assignment||Treatment||Single|||||t|
1486340|NCT01162590|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1486341|NCT01162577|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1486342|NCT01162564|||Cohort||Prospective|||||||
1486343|NCT01162551||Single Group Assignment||Treatment||None (Open Label)||||||
1486344|NCT01162538|||||Prospective|||||||
1486345|NCT01162525||Single Group Assignment||Treatment||None (Open Label)||||||
1486346|NCT01162512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486347|NCT01162499|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1486348|NCT01162486|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486349|NCT01162473|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486350|NCT01162460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486351|NCT01162447|||Case Control||Cross-Sectional|||||||
1486352|NCT01162434|||Case Control||Cross-Sectional|||||||
1486353|NCT01162421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486354|NCT01162408|||Cohort||Prospective|||||||
1486355|NCT01162395||Single Group Assignment||Treatment||None (Open Label)||||||
1486356|NCT01162382||Single Group Assignment||Basic Science||None (Open Label)||||||
1486357|NCT01162369|||Cohort||Prospective|||||||
1486358|NCT01162356|||Cohort||Prospective|||||||
1486359|NCT01162343|||Cohort||Prospective|||||||
1486360|NCT01162330|||Cohort||Prospective|||||||
1486361|NCT01162317|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1486362|NCT01162304|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486363|NCT01162291|||Case Control||Prospective|||||||
1486364|NCT01162278||Single Group Assignment||Treatment||None (Open Label)||||||
1486365|NCT01162265|||Cohort||Prospective|||||||
1486366|NCT01162252|Randomized|Parallel Assignment||Treatment||Single||||||t
1486367|NCT01162239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486368|NCT01162226|Randomized|Parallel Assignment||Treatment||Single||||||t
1486369|NCT01162213|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1486370|NCT01162200||Single Group Assignment||Treatment||None (Open Label)||||||
1486371|NCT01162187|||Cohort||Retrospective|||||||
1486372|NCT01162174|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1486373|NCT01162161|||Case-Crossover||Prospective|||||||
1486374|NCT01162148|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1486375|NCT01162135||Single Group Assignment||Treatment||None (Open Label)||||||
1486376|NCT01162122|Randomized|Parallel Assignment||Prevention||Single||||||t
1486377|NCT01162109|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1486378|NCT01162096||Single Group Assignment||Treatment||None (Open Label)||||||
1486379|NCT01162083|||Cohort||Prospective|||||||
1486380|NCT01162070|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1486381|NCT01162057|||Case-Only||Prospective|||||||
1486382|NCT01162044|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486383|NCT01162031|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486384|NCT01162018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486385|NCT01162005||Single Group Assignment||Treatment||None (Open Label)||||||
1486386|NCT01161992|||Cohort||Other|||||||
1486387|NCT01161979|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486388|NCT01161966|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486389|NCT01161953|||Family-Based||Other|||||||
1486390|NCT01161940|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486391|NCT01161927|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486392|NCT01161914|Randomized|Parallel Assignment||||Double|||t||t|
1486393|NCT01161901|||||Cross-Sectional|||||||
1486394|NCT01161888||Single Group Assignment||Treatment||None (Open Label)||||||
1486395|NCT01161875|||Cohort||Prospective|||||||
1486396|NCT01161862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486397|NCT01161849|||||Prospective|||||||
1486398|NCT01161836||Single Group Assignment||Basic Science||None (Open Label)||||||
1486399|NCT01161823|||Cohort||Prospective|||||||
1486400|NCT01161810|||Cohort||Prospective|||||||
1486401|NCT01161797|||Cohort||Prospective|||||||
1486402|NCT01161784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486403|NCT01161771|||Case-Only||Prospective|||||||
1486404|NCT01161758|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1486405|NCT01161745|||Case Control||Cross-Sectional|||||||
1486406|NCT01161732|Randomized|Parallel Assignment||Treatment||None (Open Label)||early aortic valve replacement||||
1486407|NCT01161719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486408|NCT01161706|Randomized|Parallel Assignment||||None (Open Label)||||||
1486409|NCT01161693|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486410|NCT01161680|||Cohort||Prospective|||||||
1486411|NCT01161667|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486412|NCT01161654|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486413|NCT01161641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486414|NCT01161628||Single Group Assignment||Treatment||None (Open Label)||||||
1486415|NCT01161615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486416|NCT01161602||||||||||||
1486417|NCT01161589|||Cohort||Cross-Sectional|||||||
1486418|NCT01161576|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||We chose an initial dose two fold lower of 9.0x10^11 genome copies/subject (Group A). Initially, the study plan was to proceed to Group B, which would receive a higher dose of 1.8x10^12 genome copies if the initial dose was well tolerated. However, after assessing the MRI images of the first 6 children who received the dose of 9.0x10^11 gc, we discovered that 4 of the 6 subjects at 6 months and 1 of the 6 subjects at 12 months exhibited varying degrees of T2 hyperintensities related to diffusion restriction at the sites of vector deposition. Although there are no clinical correlates to these MRI findings, we have decided to lower the dose by ½ log to 2.85x10^11 gc for the remaining subjects to be enrolled in protocol #0810010013. The volume of the drug solution will be the same as in Group A, but the concentration of the vector will be ½ log less.||||
1486419|NCT01161563|Randomized|Crossover Assignment||||None (Open Label)||||||
1486420|NCT01161550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486421|NCT01161537|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1486422|NCT01161524|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486423|NCT01161511||Single Group Assignment||Treatment||None (Open Label)||||||
1486424|NCT01161498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486425|NCT01161485|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486426|NCT01161472|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1486427|NCT01161459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486428|NCT01161446|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1486429|NCT01161433|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1486430|NCT01161420||Single Group Assignment||Treatment||None (Open Label)||||||
1486431|NCT01161407|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1486432|NCT01161394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486433|NCT01161381|||Case-Only||Prospective|||||||
1486434|NCT01161368||Single Group Assignment||Treatment||None (Open Label)||||||
1486435|NCT01161355|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1486436|NCT01161342|||Cohort||Prospective|||||||
1486437|NCT01161329|Randomized|Parallel Assignment||Treatment||Single||||||t
1486438|NCT01161316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486439|NCT01161303|||Cohort||Cross-Sectional|||||||
1486440|NCT01161290|Randomized|||Treatment||||||||
1486441|NCT01161277|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1486442|NCT01161264|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486443|NCT01161251|||Cohort||Prospective|||||||
1486444|NCT01161238|||Cohort||Prospective|||||||
1486445|NCT01161225|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1486446|NCT01161212|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486447|NCT01161199|||Cohort||Prospective|||||||
1486448|NCT01161186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486449|NCT01161173|||Cohort||Prospective|||||||
1486450|NCT01161160|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1486451|NCT01161147|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486452|NCT01161134|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486453|NCT01161121||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486454|NCT01161108|Randomized|Crossover Assignment||Treatment||Single|||||t|
1486455|NCT01161095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486456|NCT01161082|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486457|NCT01161069|Randomized|Parallel Assignment||||Double|||t||t|
1486458|NCT01161056||||||||||||
1486459|NCT01161043|||Case-Only||Prospective|||||||
1486460|NCT01161030|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1486461|NCT01161017|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486462|NCT01161004|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1486463|NCT01160991|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1486464|NCT01160978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486465|NCT01160965|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1486466|NCT01160952|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486467|NCT01160939||Single Group Assignment||Supportive Care||||||||
1486468|NCT01160926|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486469|NCT01160913|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1486470|NCT01160900|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1486471|NCT01160887|||Case Control||Cross-Sectional|||||||
1486472|NCT01160874|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1486473|NCT01160861|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1486474|NCT01160848|Randomized|Parallel Assignment||||None (Open Label)||||||
1486475|NCT01160835|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486476|NCT01160822|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1486477|NCT01160809|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486478|NCT01160796|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1486479|NCT01160783|||Family-Based||Cross-Sectional|||||||
1486480|NCT01160770||Single Group Assignment||Treatment||None (Open Label)||||||
1486481|NCT01160757||Single Group Assignment||Treatment||None (Open Label)||||||
1486482|NCT01160744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486483|NCT01160731||Single Group Assignment||Treatment||None (Open Label)||||||
1486484|NCT01160718|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486485|NCT01160705|||Cohort||Prospective|||||||
1486486|NCT01160692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486487|NCT01160679|||Case-Only||Prospective|||||||
1486488|NCT01160666||Single Group Assignment||Treatment||None (Open Label)||||||
1486489|NCT01160653|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486490|NCT01160640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486491|NCT01160627|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1486492|NCT01160614||Single Group Assignment||||None (Open Label)||||||
1486493|NCT01160601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486494|NCT01160588|||Case Control||Prospective|||||||
1486495|NCT01160575|||||Prospective|||||||
1486496|NCT01160562|||||Prospective|||||||
1486497|NCT01160549|||Case-Control||Prospective|||||||
1486501|NCT01160484||Single Group Assignment||Treatment||None (Open Label)||||||
1486502|NCT01160471|||Case-Control||Prospective|||||||
1486503|NCT01160458||Single Group Assignment||Treatment||None (Open Label)||||||
1486504|NCT01160445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486505|NCT01160432|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1486506|NCT01160419||Single Group Assignment||Treatment||None (Open Label)||||||
1486507|NCT01160406|||Cohort||Prospective|||||||
1486508|NCT01160393||Single Group Assignment||Prevention||None (Open Label)||||||
1486509|NCT01160380|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1486510|NCT01160367|Randomized|Single Group Assignment||Supportive Care||Single||||t||
1486511|NCT01160354||Single Group Assignment||Treatment||None (Open Label)||||||
1486512|NCT01160341||Single Group Assignment||Screening||None (Open Label)||||||
1486513|NCT01160328|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1486514|NCT01160315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486515|NCT01160302||Single Group Assignment||Basic Science||None (Open Label)||||||
1486516|NCT01160289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486517|NCT01160276|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486518|NCT01160263|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1486519|NCT01160250||||||||||||
1486520|NCT01160237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486521|NCT01160224|Randomized|Parallel Assignment||Other||Double|||t||t|
1486522|NCT01160211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486523|NCT01160198|Randomized|Parallel Assignment||Other||Single||||||t
1486524|NCT01160185|||||Retrospective|||||||
1486525|NCT01160172|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1486526|NCT01160159|||Case Control||Cross-Sectional|||||||
1486527|NCT01160146|||Case Control||Retrospective|||||||
1486528|NCT01160133|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486529|NCT01160120||Single Group Assignment||||None (Open Label)||||||
1486530|NCT01160107||Single Group Assignment||Treatment||None (Open Label)||||||
1486531|NCT01160094|||Cohort||Prospective|||||||
1486532|NCT01160081|||||Prospective|||||||
1486533|NCT01160068|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486534|NCT01160055|||Cohort||Prospective|||||||
1486535|NCT01160042|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486536|NCT01160029|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486537|NCT01160003|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1486538|NCT01159990|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1486539|NCT01159977|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1486540|NCT01159964|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486541|NCT01159951|||Other||Retrospective|||||||
1486542|NCT01159938|Randomized|Crossover Assignment||||None (Open Label)||||||
1486543|NCT01159925|||Case-Only||Prospective|||||||
1486544|NCT01159912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486545|NCT01159899||Single Group Assignment||Treatment||None (Open Label)||||||
1486546|NCT01159886|Randomized|Parallel Assignment||||None (Open Label)||||||
1486547|NCT01159873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486548|NCT01159860|Randomized|Factorial Assignment||Treatment||Single|||||t|
1486549|NCT01159847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486550|NCT01159834|||Cohort||Prospective|||||||
1486551|NCT01159821||Single Group Assignment||||None (Open Label)||||||
1486552|NCT01159808|Randomized|Factorial Assignment||||Triple|||t|t|t|
1486553|NCT01159795|||Cohort||Prospective|||||||
1486554|NCT01159782|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1486555|NCT01159769||Single Group Assignment||Treatment||None (Open Label)||||||
1486556|NCT01159756||Single Group Assignment||Treatment||None (Open Label)||||||
1486557|NCT01159743|||Cohort||Cross-Sectional|||||||
1486558|NCT01159730|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1486559|NCT01159717|||Case-Only||Retrospective|||||||
1486560|NCT01159704|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1486561|NCT01159691|||Cohort||Prospective|||||||
1486562|NCT01159678||Single Group Assignment||Treatment||None (Open Label)||||||
1486563|NCT01159665|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486564|NCT01159652|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1486565|NCT01159639|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486566|NCT01159626|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1486567|NCT01159613|||||Prospective|||||||
1486568|NCT01159600|Randomized|Parallel Assignment||Treatment||Double||||||
1486569|NCT01159587|||Cohort||Prospective|||||||
1486570|NCT01159574||Single Group Assignment||Treatment||None (Open Label)||||||
1486571|NCT01159561||Single Group Assignment||Prevention||None (Open Label)||||||
1486572|NCT01159548|Randomized|||Prevention||Quadruple|||t|t|t|t
1486573|NCT01159535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486574|NCT01159522||Single Group Assignment||Treatment||None (Open Label)||||||
1486575|NCT01159509|||Case Control||Prospective|||||||
1486576|NCT01159496|Randomized|Single Group Assignment||||Double|||t||t|
1486577|NCT01159483|Randomized|Crossover Assignment||||Double|||t||t|
1486578|NCT01159470|||Cohort||Prospective|||||||
1486579|NCT01159457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486580|NCT01159444|||Case-Only||Retrospective|||||||
1486581|NCT01159431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486582|NCT01159418||Single Group Assignment||Treatment||None (Open Label)||||||
1486583|NCT01159405||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486584|NCT01159392|||Case-Only||Prospective|||||||
1486585|NCT01159379||Single Group Assignment||||None (Open Label)||||||
1486586|NCT01159366|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486587|NCT01159353|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1486588|NCT01159340||||||||||||
1486589|NCT01159327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486590|NCT01159314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486591|NCT01159301||Single Group Assignment||Treatment||None (Open Label)||||||
1486592|NCT01159288||Single Group Assignment||Treatment||None (Open Label)||||||
1486593|NCT01159275|Randomized|Crossover Assignment||||None (Open Label)||||||
1486594|NCT01159262|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486595|NCT01159249|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486596|NCT01159236|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486597|NCT01159223|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486598|NCT01159210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486599|NCT01159197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486600|NCT01159184|||Case-Only||Prospective|||||||
1486601|NCT01159171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486602|NCT01159158|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486603|NCT01159145|Randomized|Single Group Assignment||||Single|||t|||
1486604|NCT01159132|Randomized|Crossover Assignment||||None (Open Label)||||||
1486605|NCT01159119|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1486606|NCT01159106||Crossover Assignment||Diagnostic||None (Open Label)||||||
1486607|NCT01159093|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1486608|NCT01159080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486609|NCT01159067||Single Group Assignment||Supportive Care||None (Open Label)||||||
1486610|NCT01159054||Single Group Assignment||Treatment||None (Open Label)||||||
1486611|NCT01159041|Randomized|Parallel Assignment||Treatment||Single||||||t
1486612|NCT01159028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486613|NCT01159015|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1486614|NCT01159002|||Cohort||Prospective|||||||
1486615|NCT01158989|||Cohort||Prospective|||||||
1486616|NCT01158976|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1486617|NCT01158963||||||||||||
1486618|NCT01158950|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1486619|NCT01158937|Randomized|Crossover Assignment||||None (Open Label)||||||
1486620|NCT01158924||Single Group Assignment||||None (Open Label)||||||
1486621|NCT01158911|||Cohort||Retrospective|||||||
1486622|NCT01158898|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1486623|NCT01158885||Single Group Assignment||Treatment||None (Open Label)||||||
1486624|NCT01158859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486625|NCT01158846|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486626|NCT01158833|||Cohort||Retrospective|||||||
1486627|NCT01158820|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486628|NCT01158807|||Case-Control||Other|||||||
1486629|NCT01158794|||Case-Only||Prospective|||||||
1486630|NCT01158781|Randomized|Single Group Assignment||Treatment||Single||||||t
1486631|NCT01158768|||Ecologic or Community||Prospective|||||||
1486632|NCT01158755|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1486633|NCT01158742|||Cohort||Cross-Sectional|||||||
1486634|NCT01158729|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1486635|NCT01158716|Randomized|Parallel Assignment||Treatment||Single||||||t
1486636|NCT01158703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486637|NCT01158690|Randomized|Parallel Assignment||Other||Single|||t|||
1486638|NCT01158677|||Cohort||Prospective|||||||
1486639|NCT01158664|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486640|NCT01158651||Single Group Assignment||Prevention||None (Open Label)||||||
1486641|NCT01158638|Randomized|Single Group Assignment||Prevention||Single||||||t
1486642|NCT01158625|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486643|NCT01158612|Non-Randomized|Parallel Assignment||Treatment||Double|||t|t||
1486644|NCT01158599|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1486645|NCT01158586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486646|NCT01158573|||Case-Control||Cross-Sectional|||||||
1486647|NCT01158560|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1486648|NCT01158547|||Cohort||Prospective|||||||
1486649|NCT01158534||Single Group Assignment||Treatment||None (Open Label)||||||
1486650|NCT01158521||Single Group Assignment||Treatment||None (Open Label)||||||
1486651|NCT01158508||Single Group Assignment||Treatment||None (Open Label)||||||
1486652|NCT01158495|||Cohort||Prospective|||||||
1486653|NCT01158482|||Case-Only||Prospective|||||||
1486654|NCT01158456|||Cohort||Prospective|||||||
1486655|NCT01158443|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1486656|NCT01158430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486657|NCT01158417|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486658|NCT01158404|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486659|NCT01158391|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486660|NCT01158378|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486661|NCT01158365|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486662|NCT01158352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486663|NCT01158339|Randomized|Parallel Assignment||Treatment||Single||||||t
1486664|NCT01158326|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486665|NCT01158313|||Case Control||Prospective|||||||
1486666|NCT01158300||Single Group Assignment||Treatment||None (Open Label)||||||
1486667|NCT01158287||Single Group Assignment||Treatment||None (Open Label)||||||
1486668|NCT01158274||Single Group Assignment||Treatment||None (Open Label)||||||
1486669|NCT01158261|||Cohort||Prospective|||||||
1486670|NCT01158248||||Treatment||None (Open Label)||||||
1486671|NCT01158235|Randomized|Single Group Assignment||||Triple|||t|t|t|
1486672|NCT01158222||Single Group Assignment||Treatment||None (Open Label)||||||
1486673|NCT01158209|||Cohort||Prospective|||||||
1486674|NCT01158196||Single Group Assignment||Prevention||Single|||t|||
1486675|NCT01158183|||Cohort||Prospective|||||||
1486676|NCT01158170|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486677|NCT01158157|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1486678|NCT01158144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486679|NCT01158131|Randomized|Parallel Assignment||Prevention||Single|||||t|
1486680|NCT01158118|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486681|NCT01158105||Single Group Assignment||Treatment||None (Open Label)||||||
1486682|NCT01158092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486683|NCT01158079||Single Group Assignment||Treatment||None (Open Label)||||||
1486684|NCT01158066||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486685|NCT01158053|||Cohort||Prospective|||||||
1486686|NCT01158040|||Cohort|||||||||
1486687|NCT01158027|||||Cross-Sectional|||||||
1486688|NCT01158014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486689|NCT01158001|Randomized|Parallel Assignment||Treatment||Single||||||t
1486690|NCT01157988||Single Group Assignment||Treatment||None (Open Label)||||||
1486691|NCT01157975|Randomized|Parallel Assignment||||None (Open Label)||||||
1486692|NCT01157962|Randomized|Crossover Assignment||Treatment||Single|||||t|
1486693|NCT01157949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486694|NCT01157936|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1486695|NCT01157923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486696|NCT01157910|||Case Control||Prospective|||||||
1486697|NCT01157897|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486698|NCT01157884|||Cohort||Prospective|||||||
1486699|NCT01157871|Randomized|Parallel Assignment||Treatment||Double||||||
1486700|NCT01157858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486701|NCT01157845|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1486702|NCT01157832|||Case Control||Prospective|||||||
1486703|NCT01157819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486704|NCT01157806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486705|NCT01157793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486706|NCT01157780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486707|NCT01157767|||Cohort||Prospective|||||||
1486708|NCT01157754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486709|NCT01157741|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1486710|NCT01157728|||Cohort||Prospective|||||||
1486711|NCT01157715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486712|NCT01157702|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1486713|NCT01157689|||Case-Only||Prospective|||||||
1486714|NCT01157676|Randomized|Parallel Assignment||Treatment||None (Open Label)||Non inferiority phase 3 randomized clinical trial comparing robotic to open radical cystectomy||||
1486715|NCT01157663|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486716|NCT01157650||Single Group Assignment||Treatment||None (Open Label)||||||
1486717|NCT01157624|Randomized|Factorial Assignment||Health Services Research||Double|||t||t|
1486718|NCT01157611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486719|NCT01157598|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1486720|NCT01157585|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486721|NCT01157572|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486722|NCT01157559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486723|NCT01157546|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1486724|NCT01157533||Single Group Assignment||Treatment||None (Open Label)||||||
1486725|NCT01157520|||Case-Only||Prospective|||||||
1486726|NCT01157507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486727|NCT01157494|||Cohort||Cross-Sectional|||||||
1486728|NCT01157481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486729|NCT01157468|||Case Control||Prospective|||||||
1486730|NCT01157455||Single Group Assignment||Treatment||None (Open Label)||||||
1486731|NCT01157442|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1486732|NCT01157429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486733|NCT01157416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486734|NCT01157403||Single Group Assignment||Treatment||Double|||t||t|
1486735|NCT01157390|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486736|NCT01157377|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486737|NCT01157364|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1486738|NCT01157351|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486739|NCT01157338|Non-Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1486740|NCT01157325|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1486741|NCT01157312|Randomized|Parallel Assignment||Treatment||Single||||||t
1486742|NCT01157299|||Case Control||Prospective|||||||
1486743|NCT01157286|||Ecologic or Community||Retrospective|||||||
1486744|NCT01157273|||Cohort||Cross-Sectional|||||||
1486745|NCT01157260|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486746|NCT01157247||||Treatment||||||||
1486747|NCT01157234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486748|NCT01157221|Randomized|Factorial Assignment||Treatment||Single||||||t
1486749|NCT01157208|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1486750|NCT01157195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486751|NCT01157182|Randomized|Crossover Assignment||||None (Open Label)||||||
1486752|NCT01157169|Randomized|Crossover Assignment||||None (Open Label)||||||
1486753|NCT01157156|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486754|NCT01157143|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486755|NCT01157130|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486756|NCT01157117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486757|NCT01157104|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1486758|NCT01157091||Single Group Assignment||Treatment||None (Open Label)||||||
1486759|NCT01157078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486760|NCT01157065|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486761|NCT01157052|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486762|NCT01157039|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486763|NCT01157026|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486764|NCT01157013||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486765|NCT01157000||Single Group Assignment||||None (Open Label)||||||
1486766|NCT01156987|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1486767|NCT01156974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486768|NCT01156961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486769|NCT01156948|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486770|NCT01156935|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1486771|NCT01156922||Single Group Assignment||Treatment||None (Open Label)||||||
1486772|NCT01156909||Single Group Assignment||Treatment||None (Open Label)||||||
1486773|NCT01156896||Single Group Assignment||Basic Science||None (Open Label)||||||
1486774|NCT01156883|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486775|NCT01156870||Single Group Assignment||Treatment||None (Open Label)||||||
1486776|NCT01156857|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486777|NCT01156844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486778|NCT01156831|||Cohort||Prospective|||||||
1486779|NCT01156818|||Case-Only||Prospective|||||||
1486780|NCT01156805|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486781|NCT01156792|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1486782|NCT01156779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486783|NCT01156766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486784|NCT01156753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486785|NCT01156740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486786|NCT01156727|||Cohort||Retrospective|||||||
1486787|NCT01156714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486788|NCT01156701|||Family-Based||Retrospective|||||||
1486789|NCT01156688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486790|NCT01156675|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486791|NCT01156662|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486792|NCT01156649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486793|NCT01156636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486794|NCT01156623|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1486795|NCT01156610|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1486796|NCT01156597|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1486797|NCT01156584||Single Group Assignment||Treatment||None (Open Label)||||||
1486798|NCT01156571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486799|NCT01156558|||Cohort||Retrospective|||||||
1486800|NCT01156545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486801|NCT01156532|||Cohort||Prospective|||||||
1486802|NCT01156519||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486803|NCT01156506||||||||||||
1486804|NCT01156493|Randomized|Parallel Assignment||Prevention||Quadruple|Standard Formula|Protein Hydrolized Formula|t|t|t|t
1486805|NCT01156480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486806|NCT01156467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486807|NCT01156454|||||Prospective|||||||
1486808|NCT01156441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486809|NCT01156428|||Case-Control||Prospective|||||||
1486810|NCT01156415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486811|NCT01156402|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486812|NCT01156389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486813|NCT01156376|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1486814|NCT01156363||Single Group Assignment||Treatment||None (Open Label)||||||
1486815|NCT01156350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486816|NCT01156337|||Cohort||Prospective|||||||
1486817|NCT01156324|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486818|NCT01156311|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486819|NCT01156298|||Cohort||Prospective|||||||
1486820|NCT01156285|||Cohort||Prospective|||||||
1486821|NCT01156272|||Cohort||Retrospective|||||||
1486822|NCT01156259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486823|NCT01156246|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1486824|NCT01156233|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486825|NCT01156220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486826|NCT01156207|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486827|NCT01156194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486828|NCT01156181|Randomized|Parallel Assignment||Treatment||Single|||||t|
1486829|NCT01156168|||Other||Retrospective|||||||
1486830|NCT01156155|||Case Control||Prospective|||||||
1486831|NCT01156142|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1486832|NCT01156129|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1486833|NCT01156116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486834|NCT01156103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486835|NCT01156090|||Case-Only||Retrospective|||||||
1486836|NCT01156077|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1486837|NCT01156064|||Case Control||Prospective|||||||
1486838|NCT01156051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486839|NCT01156038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486840|NCT01156025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486841|NCT01156012|Randomized|Parallel Assignment||Treatment||Single|||||t|
1486842|NCT01155999|Randomized|Parallel Assignment||Treatment||Single|||||t|
1486843|NCT01155986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486844|NCT01155973|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486845|NCT01155960|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486846|NCT01155947|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486847|NCT01155934|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486848|NCT01155921|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486849|NCT01155908|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486850|NCT01155895|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486851|NCT01155882|||Cohort||Other|||||||
1486852|NCT01155869|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1486853|NCT01155856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486854|NCT01155843|||Case Control||Cross-Sectional|||||||
1486855|NCT01155830|||Cohort||Prospective|||||||
1486856|NCT01155817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486857|NCT01155804|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1486858|NCT01155791||Single Group Assignment||Treatment||None (Open Label)||||||
1486859|NCT01155778|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486860|NCT01155765|Randomized|Crossover Assignment||Treatment||Single||||||t
1486861|NCT01155752|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1486862|NCT01155739|||Cohort||Prospective|||||||
1486863|NCT01155726|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486864|NCT01155713|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486865|NCT01155700||Single Group Assignment||Treatment||None (Open Label)||||||
1486866|NCT01155687|||Case Control|||||||||
1486867|NCT01155674|||Case Control||Prospective|||||||
1486868|NCT01155661||Single Group Assignment||Treatment||None (Open Label)||||||
1486869|NCT01155648|Randomized|Parallel Assignment||||None (Open Label)||||||
1486870|NCT01155635|Randomized|Parallel Assignment||Treatment||Single||||||t
1486871|NCT01155622|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486872|NCT01155609||Single Group Assignment||Supportive Care||None (Open Label)||||||
1486873|NCT01155596|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1486874|NCT01155583||Single Group Assignment||Treatment||None (Open Label)||||||
1486875|NCT01155570|||Cohort||Prospective|||||||
1486876|NCT01155557|Randomized|Parallel Assignment||Treatment||Single||||||t
1486877|NCT01155544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486878|NCT01155531|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486879|NCT01155518|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486880|NCT01155505||Single Group Assignment||Treatment||None (Open Label)||||||
1486881|NCT01155492|||Case Control||Cross-Sectional|||||||
1486882|NCT01155479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486883|NCT01155466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486884|NCT01155453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486885|NCT01155440|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1486886|NCT01155427|||Cohort|||||||||
1486887|NCT01155414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486888|NCT01155401|||Case-Only||Prospective|||||||
1486889|NCT01155388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486890|NCT01155375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486891|NCT01155362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486892|NCT01155349|Randomized|Parallel Assignment||Prevention||Single|||||t|
1486893|NCT01155336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486894|NCT01155323|Randomized|Crossover Assignment||Treatment||Single|||t|||
1486895|NCT01155310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486896|NCT01155297|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1486897|NCT01155284|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486898|NCT01155271|Randomized|Parallel Assignment||Treatment||Single||||||t
1486899|NCT01155258||Single Group Assignment||Treatment||None (Open Label)||||||
1486900|NCT01155245|||Cohort||Prospective|||||||
1486901|NCT01155232|||Cohort||Prospective|||||||
1486902|NCT01155219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486903|NCT01155206|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1486904|NCT01155193|||Cohort||Prospective|||||||
1486905|NCT01155180|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486906|NCT01155167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486907|NCT01155154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486908|NCT01155141||Single Group Assignment||Treatment||None (Open Label)||||||
1486909|NCT01155128|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486910|NCT01155115|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486911|NCT01155102|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486912|NCT01155089|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486913|NCT01155076|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1486914|NCT01155063|||Case Control||Prospective|||||||
1486915|NCT01155050|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1486916|NCT01155037|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486917|NCT01155024|Randomized|Crossover Assignment||Treatment||Single|||t|||
1486918|NCT01155011|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1486919|NCT01154998|||Case Control||Retrospective|||||||
1486920|NCT01154985|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486921|NCT01154972||Single Group Assignment||Diagnostic||None (Open Label)||||||
1486922|NCT01154959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486923|NCT01154946|||Case Control||Retrospective|||||||
1486924|NCT01154933|Randomized|Parallel Assignment||Treatment||Single|||t|||
1486925|NCT01154920|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486926|NCT01154907|||Cohort||Prospective|||||||
1486927|NCT01154894|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486928|NCT01154881|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1486929|NCT01154868||Single Group Assignment||Treatment||None (Open Label)||||||
1486930|NCT01154855|||Case Control||Prospective|||||||
1486931|NCT01154842|||||Cross-Sectional|||||||
1486932|NCT01154829|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1486933|NCT01154816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486934|NCT01154803|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1486935|NCT01154790|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486936|NCT01154777||Crossover Assignment||Treatment||None (Open Label)||||||
1486937|NCT01154764|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486938|NCT01154751||Single Group Assignment||Treatment||None (Open Label)||||||
1486939|NCT01154738|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486940|NCT01154725|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1486941|NCT01154712|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1486942|NCT01154699|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1486943|NCT01154686||Single Group Assignment||Treatment||None (Open Label)||||||
1486944|NCT01154673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486945|NCT01154660|Randomized|Parallel Assignment||||None (Open Label)||||||
1486946|NCT01154647|Randomized|Crossover Assignment||||Triple|||t||t|t
1486947|NCT01154634|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1486948|NCT01154621|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1486949|NCT01154608|Randomized|Crossover Assignment||Basic Science||||||||
1486950|NCT01154595|Randomized|Parallel Assignment||Prevention||Single||||||t
1486951|NCT01154582|Randomized|Crossover Assignment||Basic Science||||||||
1486952|NCT01154569|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1486953|NCT01154556|||||Retrospective|||||||
1486954|NCT01154543|||Cohort||Prospective|||||||
1486955|NCT01154530|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486956|NCT01154517|||||Prospective|||||||
1486957|NCT01154504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486958|NCT01154491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1486959|NCT01154478|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486960|NCT01154465|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1486961|NCT01154452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486962|NCT01154439||Single Group Assignment||Treatment||None (Open Label)||||||
1486963|NCT01154426||Single Group Assignment||Treatment||None (Open Label)||||||
1486964|NCT01154413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486965|NCT01154400|Randomized|Crossover Assignment||||Double|||t||t|
1486966|NCT01154387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486967|NCT01154374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486968|NCT01154361|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1486969|NCT01154348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486970|NCT01154335|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486971|NCT01154322|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486972|NCT01154309|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486973|NCT01154296|Randomized|Parallel Assignment||Screening||Single|||||t|
1486974|NCT01154283|Randomized|Crossover Assignment||Treatment||Single|||t|||
1486975|NCT01154270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486976|NCT01154257|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486977|NCT01154244|||||Prospective|||||||
1486978|NCT01154231|||Cohort||Prospective|||||||
1486979|NCT01154218|Randomized|Crossover Assignment||||None (Open Label)||||||
1486980|NCT01154205|||Case-Only||Prospective|||||||
1486981|NCT01154192|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1486982|NCT01154179|Randomized|Single Group Assignment||Treatment||Single|||t|||
1486983|NCT01154166|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486984|NCT01154153|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1486985|NCT01154140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486986|NCT01154127|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1486987|NCT01154114|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1486988|NCT01154101|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486989|NCT01154088|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1486990|NCT01154075|||Cohort||Prospective|||||||
1486991|NCT01154062|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1486992|NCT01154049||Single Group Assignment||Prevention||None (Open Label)||||||
1486993|NCT01154036|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486994|NCT01154023|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1486995|NCT01154010|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1486996|NCT01153997|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1486997|NCT01153984||Single Group Assignment||Treatment||None (Open Label)||||||
1486998|NCT01153971||Single Group Assignment||Treatment||None (Open Label)||||||
1486999|NCT01153958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487000|NCT01153945||||||||||||
1487001|NCT01153932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487002|NCT01153919|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1487003|NCT01153906|||Cohort||Prospective|||||||
1487004|NCT01153893|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487005|NCT01153880|||||Retrospective|||||||
1487006|NCT01153867||Single Group Assignment||Treatment||None (Open Label)||||||
1487007|NCT01153854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487008|NCT01153841|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487009|NCT01153828|||||Retrospective|||||||
1487010|NCT01153815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487011|NCT01153802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487012|NCT01153789|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1487013|NCT01153776|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1487014|NCT01153763||Single Group Assignment||Treatment||None (Open Label)||||||
1487015|NCT01153750|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487016|NCT01153737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487017|NCT01153724|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487018|NCT01153711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487019|NCT01153698|||Cohort||Prospective|||||||
1487020|NCT01153685|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487021|NCT01153672||Single Group Assignment||Treatment||None (Open Label)||||||
1487022|NCT01153659|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487023|NCT01153646||Single Group Assignment||||None (Open Label)||||||
1487024|NCT01153633|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487025|NCT01153620|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487026|NCT01153607|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1487027|NCT01153594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487028|NCT01153581|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1487029|NCT01153568|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487030|NCT01153555|||Cohort||Prospective|||||||
1487031|NCT01153542|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487032|NCT01153529|||||Retrospective|||||||
1487033|NCT01153516|||Case-Only||Prospective|||||||
1487034|NCT01153503|Randomized|Parallel Assignment||Prevention||Single||||||t
1487035|NCT01153490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487036|NCT01153477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487037|NCT01153464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487038|NCT01153451|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1487039|NCT01153438|||||Prospective|||||||
1487040|NCT01153425|Randomized|Parallel Assignment||Treatment||None (Open Label)||Postmenopausal women, ages ≥ 60 years, indicated for treatment with antiresorptive or anabolic drugs due to severe osteoporosis and high risk of fracture.||||
1487041|NCT01153412|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1487042|NCT01153399|||Case-Only||Prospective|||||||
1487043|NCT01153386|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487044|NCT01153373|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1487045|NCT01153360|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1487046|NCT01153347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487047|NCT01153334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487048|NCT01153321|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1487049|NCT01153308|||Cohort||Prospective|||||||
1487050|NCT01153295|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1487051|NCT01153282||||||||||||
1487052|NCT01153269|||Case-Only||Prospective|||||||
1487053|NCT01153256|Randomized|Parallel Assignment||||Triple|||t|t|t|
1487054|NCT01153243|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487055|NCT01153230|||||Cross-Sectional|||||||
1487056|NCT01153217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487057|NCT01153204|Randomized|Parallel Assignment||Treatment||Single||||||t
1487058|NCT01153191|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1487059|NCT01153165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487060|NCT01153152|||Case-Only||Retrospective|||||||
1487061|NCT01153139|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1487062|NCT01153126|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1487063|NCT01153113|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487064|NCT01153100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487065|NCT01153074||Sequential Assignment||Treatment||None (Open Label)||||||
1487066|NCT01153061||Single Group Assignment||Treatment||None (Open Label)||||||
1487067|NCT01153048|Randomized|Parallel Assignment||Supportive Care||||||||
1487068|NCT01153035||Single Group Assignment||Treatment||None (Open Label)||||||
1487069|NCT01153022|Randomized|Crossover Assignment||Treatment||Single||||||t
1487070|NCT01153009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487071|NCT01152996||Single Group Assignment||Treatment||None (Open Label)||||||
1487072|NCT01152983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487073|NCT01152970|||Case Control||Prospective|||||||
1487074|NCT01152957|Randomized|Parallel Assignment||Supportive Care||None (Open Label)|single blinded|||||
1487075|NCT01152944|||Cohort||Prospective|||||||
1487076|NCT01152931|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487077|NCT01152918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487078|NCT01152905|||Case Control||Prospective|||||||
1487079|NCT01152892|||Cohort||Prospective|||||||
1487080|NCT01152879|||Cohort||Prospective|||||||
1487081|NCT01152866|||Cohort||Prospective|||||||
1487082|NCT01152853||Single Group Assignment||Treatment||None (Open Label)||||||
1487083|NCT01152840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487084|NCT01152827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487085|NCT01152814||Single Group Assignment||Prevention||None (Open Label)||||||
1487086|NCT01152801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487087|NCT01152788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487088|NCT01152775|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1487089|NCT01152762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487090|NCT01152749|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1487091|NCT01152736|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1487092|NCT01152723|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1487093|NCT01152710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487094|NCT01152697||Single Group Assignment||Supportive Care||None (Open Label)||||||
1487095|NCT01152684|||Ecologic or Community||Cross-Sectional|||||||
1487096|NCT01152671|Randomized|Parallel Assignment||||Double|||t||t|
1487097|NCT01152658|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487098|NCT01152645||Single Group Assignment||Treatment||None (Open Label)||||||
1487099|NCT01152632|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1487100|NCT01152619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487101|NCT01152606|||Cohort||Prospective|||||||
1487102|NCT01152593|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1487103|NCT01152580|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1487104|NCT01152567|||Cohort||Retrospective|||||||
1487105|NCT01152554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487106|NCT01152541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487107|NCT01152528|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1487108|NCT01152515|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487109|NCT01152502|||||Cross-Sectional|||||||
1487110|NCT01152489|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1487111|NCT01152476|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1487112|NCT01152463|||Cohort||Prospective|||||||
1487113|NCT01152450|Randomized|Crossover Assignment||Treatment||Double||||||
1487114|NCT01152437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487115|NCT01152424|||Case Control||Prospective|||||||
1487116|NCT01152411||Single Group Assignment||Treatment||None (Open Label)||||||
1487117|NCT01152398||Single Group Assignment||Treatment||None (Open Label)||||||
1487118|NCT01152385|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487119|NCT01152372|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1487120|NCT01152359|Randomized|Parallel Assignment||Treatment||Single||||||t
1487121|NCT01152346|Randomized|Crossover Assignment||||None (Open Label)||||||
1487122|NCT01152333|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1487123|NCT01152320|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1487124|NCT01152307|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1487125|NCT01152294|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1487126|NCT01152281|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1487127|NCT01152268|||Case-Only||Prospective|||||||
1487128|NCT01152255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487129|NCT01152242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487130|NCT01152229|||Case Control||Retrospective|||||||
1487131|NCT01152216||Single Group Assignment||Treatment||None (Open Label)||||||
1487132|NCT01152203||Single Group Assignment||Treatment||None (Open Label)||||||
1487133|NCT01152190|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1487134|NCT01152177|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1487135|NCT01152164|||Cohort||Prospective|||||||
1487136|NCT01152151|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1487137|NCT01152138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487138|NCT01152125||Single Group Assignment||Treatment||None (Open Label)||||||
1487139|NCT01152112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487140|NCT01152099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487141|NCT01152086|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1487142|NCT01152073|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1487143|NCT01152060|||Cohort||Prospective|||||||
1487144|NCT01152047||Single Group Assignment||Treatment||Double|||t|t||
1487145|NCT01152034|Randomized|Parallel Assignment||Treatment||Single||||||t
1487146|NCT01152021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487147|NCT01152008|||Case-Only||Prospective|||||||
1487148|NCT01151995|||Cohort||Retrospective|||||||
1487149|NCT01151982|Randomized|Parallel Assignment||Prevention||Single|||||t|
1487150|NCT01151969|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1487151|NCT01151956|||Cohort||Prospective|||||||
1487152|NCT01151943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487153|NCT01151930||||||||||||
1487154|NCT01151917|||Case-Only||Prospective|||||||
1487155|NCT01151904||Single Group Assignment||Treatment||None (Open Label)||||||
1487156|NCT01151891|||Case-Only||Cross-Sectional|||||||
1487157|NCT01151878|Randomized|Parallel Assignment||Treatment||Quadruple|The participants and researchers conducting the study were blinded. Intervention products were prepared in sachets centrally by the hospital pharmacy by a person not involved in the conduct of the trial. The active product and placebo were packaged in identical sachets and labeled with one of two codes, each allocated to the experimental product or placebo. This procedure was performed by an independent pharmacist, who was the only person aware of the codes' meaning. The appearance and texture of the dry products were identical.||t|t|t|t
1487158|NCT01151865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487159|NCT01151852|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1487160|NCT01151839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487161|NCT01151826|||Cohort||Prospective|||||||
1487162|NCT01151813|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1487163|NCT01151800|Randomized|||Treatment||||||||
1487164|NCT01151787|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1487165|NCT01151774|||Case-Only||Prospective|||||||
1487166|NCT01151761||Single Group Assignment||Treatment||None (Open Label)||||||
1487167|NCT01151748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487168|NCT01151735|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1487169|NCT01151722|Randomized|Parallel Assignment||Prevention||Single||||||t
1487170|NCT01151709|||Cohort||Cross-Sectional|||||||
1487171|NCT01151696|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487172|NCT01151683|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1487173|NCT01151670|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1487174|NCT01151657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487175|NCT01151644|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487176|NCT01151631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487177|NCT01151618||||||||||||
1487178|NCT01151605|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487179|NCT01151592||Single Group Assignment||Treatment||None (Open Label)||||||
1487180|NCT01151579|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1487181|NCT01151566|||Cohort||Prospective|||||||
1487182|NCT01151553||Single Group Assignment||Treatment||None (Open Label)||||||
1487183|NCT01151540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487184|NCT01151527|||Case Control||Cross-Sectional|||||||
1487185|NCT01151514|||Cohort||Retrospective|||||||
1487186|NCT01151501|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487187|NCT01151488||Single Group Assignment||Prevention||None (Open Label)||||||
1487188|NCT01151475|||Case-Only||Prospective|||||||
1487189|NCT01151462||||||||||||
1487190|NCT01151449||Single Group Assignment||Treatment||None (Open Label)||||||
1487191|NCT01151436||Single Group Assignment||Treatment||None (Open Label)||||||
1487192|NCT01151423|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487193|NCT01151410|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487194|NCT01151397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487195|NCT01151384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487196|NCT01151371|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487198|NCT01151345|Randomized|Crossover Assignment||||None (Open Label)||||||
1487199|NCT01151319|Randomized|Parallel Assignment||Prevention||Single|||t|||
1487200|NCT01151306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487201|NCT01151293|||Cohort||Prospective|||||||
1487202|NCT01151280||Single Group Assignment||Treatment||None (Open Label)||||||
1487203|NCT01151267|Randomized|Parallel Assignment||Treatment||Single||||||t
1487204|NCT01151254|Randomized|Parallel Assignment||Prevention||Single||||||t
1487205|NCT01151241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487206|NCT01151228|Randomized|Parallel Assignment||||Triple||||t|t|t
1487207|NCT01151215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487208|NCT01151202|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487209|NCT01151189|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487210|NCT01151176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487211|NCT01150916|Non-Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1487212|NCT01150851|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1487213|NCT01150838|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1487214|NCT01150747|||Case-Only||Prospective|||||||
1487215|NCT01149239|||Case-Only||Prospective|||||||
1487216|NCT01149226|Randomized|Parallel Assignment||||Double|||t|t||
1487217|NCT01151163|||Case Control||Prospective|||||||
1487218|NCT01151150|||Cohort||Prospective|||||||
1487219|NCT01151137|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487220|NCT01151124||Single Group Assignment||Treatment||None (Open Label)||||||
1487221|NCT01151111|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1487222|NCT01151098||Single Group Assignment||Treatment||None (Open Label)||||||
1487223|NCT01151085|||Case-Only||Prospective|||||||
1487224|NCT01151072|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487225|NCT01151059|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1487226|NCT01151046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487227|NCT01151033|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487228|NCT01151020||Single Group Assignment||Treatment||None (Open Label)||||||
1487229|NCT01151007|||Case-Only||Retrospective|||||||
1487230|NCT01150994|Non-Randomized|Single Group Assignment||Screening||Single|||t|||
1487231|NCT01150981|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1487232|NCT01150968||Single Group Assignment||||None (Open Label)||||||
1487233|NCT01150955|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1487234|NCT01150942|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487235|NCT01150929|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1487236|NCT01150903|||Case Control||Cross-Sectional|||||||
1487237|NCT01150890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487238|NCT01150877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487239|NCT01150864|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487240|NCT01150825|||Case Control||Prospective|||||||
1487241|NCT01150812||Single Group Assignment||||None (Open Label)||||||
1487242|NCT01150786|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487243|NCT01150760|||Case Control||Retrospective|||||||
1487244|NCT01150734|||Cohort||Prospective|||||||
1487245|NCT01150721|||||Prospective|||||||
1487246|NCT01150708|||||Prospective|||||||
1487247|NCT01150695|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1487248|NCT01150682||||||||||||
1487249|NCT01150669|||Case-Only||Retrospective|||||||
1487250|NCT01150656|||Case-Only||Retrospective|||||||
1487251|NCT01150643|||Other||Retrospective|||||||
1487252|NCT01150630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487253|NCT01150617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487254|NCT01150604||Single Group Assignment||Treatment||None (Open Label)||||||
1487255|NCT01150591|||Cohort||Prospective|||||||
1487256|NCT01150578|||Cohort||Prospective|||||||
1487257|NCT01150565|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1487258|NCT01150552|||Cohort||Prospective|||||||
1487259|NCT01150539|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487260|NCT01150526|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1487261|NCT01150513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487262|NCT01150500||Single Group Assignment||Treatment||None (Open Label)||||||
1487263|NCT01150487||Single Group Assignment||Diagnostic||None (Open Label)||||||
1487264|NCT01150474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487265|NCT01150461|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487266|NCT01150448|Non-Randomized|||Treatment||None (Open Label)||||||
1487267|NCT01150435|||Case Control||Prospective|||||||
1487268|NCT01150422|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1487269|NCT01150409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487270|NCT01150396|||Cohort||Prospective|||||||
1487271|NCT01150383|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1487272|NCT01150370||Single Group Assignment||Prevention||None (Open Label)||||||
1487273|NCT01150357|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487274|NCT01150344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487275|NCT01150331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487276|NCT01150318||Single Group Assignment||Treatment||None (Open Label)||||||
1487277|NCT01150305|||Case Control||Cross-Sectional|||||||
1487278|NCT01150292|Randomized|Crossover Assignment||||Double|||t||t|
1487279|NCT01150279|||Cohort||Prospective|||||||
1487280|NCT01150266||Single Group Assignment||Treatment||None (Open Label)||||||
1487281|NCT01150253||Crossover Assignment||||||||||
1487282|NCT01150240|||Cohort|||||||||
1487283|NCT01150227||||||||||||
1487284|NCT01150214|||Cohort||Prospective|||||||
1487285|NCT01150201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487286|NCT01150188|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1487287|NCT01150175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487288|NCT01150162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487289|NCT01150149|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487290|NCT01150136|||Case-Only||Cross-Sectional|||||||
1487291|NCT01150123|Randomized|Parallel Assignment||Prevention||Single|||||t|
1487292|NCT01150110||||Treatment||||||||
1487293|NCT01150097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487294|NCT01150084|Randomized|Single Group Assignment||Prevention||Single|||t|||
1487295|NCT01150071|||Cohort||Prospective|||||||
1487296|NCT01150058|||Case-Only||Retrospective|||||||
1487297|NCT01150045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487298|NCT01150032|||Cohort||Prospective|||||||
1487299|NCT01150019|||Case Control||Cross-Sectional|||||||
1487300|NCT01150006|||Case-Only||Cross-Sectional|||||||
1487301|NCT01149993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487302|NCT01149980|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487303|NCT01149967|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487304|NCT01149954|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487305|NCT01149941|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487306|NCT01149928|||Cohort||Cross-Sectional|||||||
1487307|NCT01149915||Single Group Assignment||Treatment||None (Open Label)||||||
1487308|NCT01149902|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487309|NCT01149889||Crossover Assignment||Treatment||None (Open Label)||||||
1487310|NCT01149876|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487311|NCT01149863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487312|NCT01149850||Single Group Assignment||Treatment||None (Open Label)||||||
1487313|NCT01149837|||Cohort||Prospective|||||||
1487314|NCT01149824||Single Group Assignment||||Single|||t|||
1487315|NCT01149811|||Cohort||Prospective|||||||
1487316|NCT01149798||Single Group Assignment||Treatment||None (Open Label)||||||
1487317|NCT01149785|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1487318|NCT01149772|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487319|NCT01149759||Single Group Assignment||Treatment||None (Open Label)||||||
1487320|NCT01149746|Randomized|Crossover Assignment||||None (Open Label)||||||
1487321|NCT01149733|Randomized|Crossover Assignment||||None (Open Label)||||||
1487322|NCT01149720|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487323|NCT01149707|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487324|NCT01149694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487325|NCT01149681||Single Group Assignment||Treatment||None (Open Label)||||||
1487326|NCT01149668|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487327|NCT01149655|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487328|NCT01149642|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487329|NCT01149629|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487330|NCT01149616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487331|NCT01149603||Single Group Assignment||Treatment||None (Open Label)||||||
1487332|NCT01149590|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1487333|NCT01149577||Single Group Assignment||Basic Science||None (Open Label)||||||
1487334|NCT01149564|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1487335|NCT01149551|||Case Control|||||||||
1487336|NCT01149538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487337|NCT01149525|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1487338|NCT01149512|||Cohort||Retrospective|||||||
1487339|NCT01149499|Randomized|Crossover Assignment||||None (Open Label)||||||
1487340|NCT01149486|Randomized|Crossover Assignment||||None (Open Label)||||||
1487341|NCT01149473|Randomized|Crossover Assignment||||None (Open Label)||||||
1487342|NCT01149460|Randomized|Crossover Assignment||||None (Open Label)||||||
1487343|NCT01149447|||Cohort||Prospective|||||||
1487344|NCT01149434|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487345|NCT01149421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487346|NCT01149408||Single Group Assignment||Treatment||None (Open Label)||||||
1487347|NCT01149395||Single Group Assignment||Basic Science||None (Open Label)||||||
1487348|NCT01149382|||Cohort||Prospective|||||||
1487349|NCT01149369|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487350|NCT01149356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487351|NCT01149343|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487352|NCT01149330||Single Group Assignment||Treatment||None (Open Label)||||||
1487353|NCT01149317|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1487354|NCT01149304|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487355|NCT01149291|||Case-Only||Prospective|||||||
1487356|NCT01149278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487357|NCT01149265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487358|NCT01149252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487359|NCT01149213||Single Group Assignment||Treatment||None (Open Label)||||||
1487360|NCT01149200|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487361|NCT01149187|||Case-Only||Prospective|||||||
1487362|NCT01149174|Randomized|Parallel Assignment||Prevention||Single||||||t
1487363|NCT01149161|Randomized|Parallel Assignment||Treatment||Single||||t||
1487364|NCT01149148|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1487365|NCT01149135|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487366|NCT01149122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487367|NCT01149109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487368|NCT01149096|||Case-Only||Prospective|||||||
1487369|NCT01149083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487370|NCT01149070|||Cohort|||||||||
1487371|NCT01149057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487372|NCT01149044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487373|NCT01149031|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487374|NCT01149018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487375|NCT01149005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487376|NCT01148992|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487377|NCT01148979|Randomized|Crossover Assignment||Treatment||Double|Both the study participant and the study investigators making evaluations are blinded to which treatment arm the participants are assigned to (i.e., whether they are receiving placebo or Vyvanse at any given point). Placebo and active medication capsules look identical.|This is a double-blind, placebo-controlled, crossover study in which each subject will act as their own control after being randomly assigned to placebo or Lisdexamfetamine Dimesylate (Vyvanse) for the first 4 weeks of study treatment, then receiving the other for the second 4 weeks of treatment. The two 4-week treatment periods are separated by a washout of 2 weeks.|t||t|
1487378|NCT01148966||Single Group Assignment||Treatment||None (Open Label)||||||
1487379|NCT01148953|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487380|NCT01148940|||Cohort||Prospective|||||||
1487381|NCT01148927|||Case-Only||Prospective|||||||
1487382|NCT01148914|||Case Control||Prospective|||||||
1487383|NCT01148901|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487384|NCT01148888|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487385|NCT01148875|||Cohort||Prospective|||||||
1487386|NCT01148862|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487387|NCT01148849||Single Group Assignment||Treatment||None (Open Label)||||||
1487388|NCT01148836|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487389|NCT01148823|Randomized|Parallel Assignment||||Double|||||t|t
1487390|NCT01148810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487391|NCT01148797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487392|NCT01148784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487393|NCT01148771|Randomized|Crossover Assignment||||None (Open Label)||||||
1487394|NCT01148758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487395|NCT01148745||Single Group Assignment||Basic Science||None (Open Label)||||||
1487396|NCT01148732|||Cohort||Prospective|||||||
1487397|NCT01148719|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1487398|NCT01148706||Single Group Assignment||Treatment||None (Open Label)||||||
1487399|NCT01148693|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487400|NCT01148680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487401|NCT01148667|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1487402|NCT01148654|||Cohort||Prospective|||||||
1487403|NCT01148641|||Case-Crossover||Prospective|||||||
1487404|NCT01148628||Single Group Assignment||Treatment||None (Open Label)||||||
1487405|NCT01148615||Single Group Assignment||Treatment||None (Open Label)||||||
1487406|NCT01148602|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1487407|NCT01148576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487408|NCT01148563|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1487409|NCT01148550|||Cohort||Prospective|||||||
1487410|NCT01148537|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487411|NCT01148524|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487412|NCT01148511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487413|NCT01148498|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1487414|NCT01148485|||Case-Only||Prospective|||||||
1487415|NCT01148472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487416|NCT01148459|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487417|NCT01148446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487418|NCT01148433|||Case-Only||Prospective|||||||
1487419|NCT01148420||Single Group Assignment||Treatment||None (Open Label)||||||
1487420|NCT01148407||||||||||||
1487421|NCT01148394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487422|NCT01148381|||||Other|||||||
1487423|NCT01148368|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1487424|NCT01148355|||||Prospective|||||||
1487425|NCT01148342|Randomized|Crossover Assignment||Other||||||||
1487426|NCT01148329|||Cohort||Prospective|||||||
1487427|NCT01148316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487428|NCT01148303|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1487429|NCT01148290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487430|NCT01148277|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487431|NCT01148264|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1487432|NCT01148251||||||||||||
1487433|NCT01148238|||Cohort||Prospective|||||||
1487434|NCT01148225||Single Group Assignment||Treatment||None (Open Label)||||||
1487435|NCT01148212|||Case-Only|||||||||
1487436|NCT01148199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487437|NCT01148186|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1487438|NCT01148173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487439|NCT01148160|||Case-Only||Prospective|||||||
1487440|NCT01148147|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1487441|NCT01148134|||Case Control||Prospective|||||||
1487442|NCT01148121||Single Group Assignment||||None (Open Label)||||||
1487443|NCT01148108|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487444|NCT01148095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487445|NCT01148082|||Cohort||Prospective|||||||
1487446|NCT01148069||Single Group Assignment||Treatment||None (Open Label)||||||
1487447|NCT01148056||Single Group Assignment||Treatment||None (Open Label)||||||
1487448|NCT01148043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487449|NCT01148030||||||||||||
1487450|NCT01148017|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487451|NCT01148004|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1487452|NCT01147991||||Treatment||||||||
1487453|NCT01147978|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487454|NCT01147965||Single Group Assignment||Treatment||None (Open Label)||||||
1487455|NCT01147952|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1487456|NCT01147939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487457|NCT01147926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487458|NCT01147913|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487459|NCT01147900|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487460|NCT01147887||Single Group Assignment||||None (Open Label)||||||
1487461|NCT01147874|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1487462|NCT01147861|Randomized|Crossover Assignment||Treatment||Single|||t|||
1487463|NCT01147848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487464|NCT01147835|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1487465|NCT01147822|Randomized|||Treatment||None (Open Label)||||||
1487466|NCT01147809|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1487467|NCT01147796|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1487468|NCT01147783|||Cohort||Prospective|||||||
1487469|NCT01147770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487470|NCT01147757|Randomized|Parallel Assignment||||Double|||t|t||
1487471|NCT01147744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487472|NCT01147731|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1487473|NCT01147718||Single Group Assignment||Basic Science||None (Open Label)||||||
1487474|NCT01147705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487475|NCT01147692||Single Group Assignment||Basic Science||None (Open Label)||||||
1487476|NCT01147679|||Case Control||Prospective|||||||
1487477|NCT01147666|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487478|NCT01147653|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1487479|NCT01147640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487480|NCT01147627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487481|NCT01147614|Randomized|Parallel Assignment||Treatment||Single||||||t
1487482|NCT01147601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487483|NCT01147588|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1487484|NCT01147575|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1487485|NCT01147562||Single Group Assignment||||None (Open Label)||||||
1487486|NCT01147549||Single Group Assignment||Basic Science||None (Open Label)||||||
1487487|NCT01147536||Single Group Assignment||Treatment||Single|||t|||
1487488|NCT01147523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487489|NCT01147510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487490|NCT01147497|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487491|NCT01147484||Single Group Assignment||Treatment||None (Open Label)||||||
1487492|NCT01147471|Randomized|Parallel Assignment||||None (Open Label)||||||
1487493|NCT01147458|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1487494|NCT01147445|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487495|NCT01147432|Randomized|Crossover Assignment||||Double|||t||t|
1487496|NCT01147419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487497|NCT01147406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487498|NCT01147393||Single Group Assignment||Treatment||None (Open Label)||||||
1487499|NCT01147380|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487500|NCT01147367|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1487501|NCT01147354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487502|NCT01147341|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487503|NCT01147328|||Cohort||Retrospective|||||||
1487504|NCT01147315||Single Group Assignment||Treatment||None (Open Label)||||||
1487505|NCT01147302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487506|NCT01147289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487507|NCT01147276|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1487508|NCT01147263|||||Prospective|||||||
1487509|NCT01147250|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487510|NCT01147237|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487511|NCT01147224|||Cohort||Prospective|||||||
1487512|NCT01147211||Single Group Assignment||Treatment||None (Open Label)||||||
1487513|NCT01147198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487514|NCT01147185|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487515|NCT01147172||Single Group Assignment||Treatment||None (Open Label)||||||
1487516|NCT01147159||Single Group Assignment||Diagnostic||None (Open Label)||Skin prick test of extracts of allergens in 4 tenfold dilutions.||||
1487517|NCT01147146|Randomized|||Prevention||||||||
1487518|NCT01147133|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1487519|NCT01147120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487520|NCT01147107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487521|NCT01147094||||||||||||
1487522|NCT01147081||Single Group Assignment||Prevention||None (Open Label)||||||
1487523|NCT01147068|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1487524|NCT01147055|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1487525|NCT01147042|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Dose frequency increased from once per week to three times per week, the recommended dose frequency.||||
1487526|NCT01147029||||Treatment||||||||
1487527|NCT01147016||Single Group Assignment||Treatment||None (Open Label)||||||
1487528|NCT01147003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487529|NCT01146990|||Other||Prospective|||||||
1487530|NCT01146977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487531|NCT01146964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487532|NCT01146951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487533|NCT01146938|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1487534|NCT01146925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487535|NCT01146912|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1487536|NCT01146899|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1487537|NCT01146886|Randomized|Parallel Assignment||Treatment||Double||||||
1487538|NCT01146873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487539|NCT01146860|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487540|NCT01146847|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487541|NCT01146834|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487542|NCT01146821|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1487543|NCT01146808||Single Group Assignment||Treatment||None (Open Label)||||||
1487544|NCT01146795||Single Group Assignment||Treatment||None (Open Label)||||||
1487545|NCT01146782||Single Group Assignment||Treatment||Single||||||t
1487546|NCT01146769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487547|NCT01146756||Single Group Assignment||Treatment||None (Open Label)||||||
1487548|NCT01146743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487549|NCT01146730|Randomized|Parallel Assignment||Treatment||Single||||||t
1487550|NCT01146717|Randomized|Parallel Assignment||Prevention||Single||||||t
1487551|NCT01146704|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1487552|NCT01146691|||Ecologic or Community||Prospective|||||||
1487553|NCT01146678|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487554|NCT01146665|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1487555|NCT01146652||Single Group Assignment||Treatment||None (Open Label)||||||
1487556|NCT01146639||Single Group Assignment||Diagnostic||None (Open Label)||||||
1487557|NCT01146626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487558|NCT01146613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487559|NCT01146600|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1487560|NCT01146587|Randomized|Parallel Assignment||Treatment||Single||||||t
1487561|NCT01146574|Randomized|Single Group Assignment||Treatment||Single|||t|||
1487562|NCT01146561|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487563|NCT01146548|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1487564|NCT01146535|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487565|NCT01146522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487566|NCT01146509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487567|NCT01146496|Randomized|Parallel Assignment||Prevention||Single||||||t
1487568|NCT01146483|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1487569|NCT01146470|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487570|NCT01146457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487571|NCT01146444|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487572|NCT01146431|||Case Control||Prospective|||||||
1487573|NCT01146418|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1487574|NCT01146405|||Case Control||Prospective|||||||
1487575|NCT01146392|||||Retrospective|||||||
1487576|NCT01146379|Randomized|Parallel Assignment||Treatment||Single||||||t
1487577|NCT01146366|||Cohort||Prospective|||||||
1487578|NCT01146353|||Cohort||Prospective|||||||
1487579|NCT01146340||Single Group Assignment||Treatment||None (Open Label)||||||
1487580|NCT01146327|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487581|NCT01146314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487582|NCT01146301||||Treatment||||||||
1487583|NCT01146288|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1487584|NCT01146275||Single Group Assignment||||None (Open Label)||||||
1487585|NCT01146262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487586|NCT01146249|||Cohort||Prospective|||||||
1487587|NCT01146236|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1487588|NCT01146223|||Case-Only||Prospective|||||||
1487589|NCT01146210|||Case-Only||Retrospective|||||||
1487590|NCT01146197|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487591|NCT01146184|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1487592|NCT01146171||Single Group Assignment||Treatment||None (Open Label)||||||
1487593|NCT01146158||Single Group Assignment||Treatment||None (Open Label)||||||
1487594|NCT01146145|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487595|NCT01146132|Randomized|Parallel Assignment||||Single|||||t|
1487596|NCT01146119|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487597|NCT01146106|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487598|NCT01146093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487599|NCT01146080|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487600|NCT01146067|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487601|NCT01146054||Single Group Assignment||Treatment||None (Open Label)||||||
1487602|NCT01146041|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487603|NCT01146028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1487604|NCT01146015|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1487605|NCT01146002||Single Group Assignment||Treatment||None (Open Label)||||||
1487606|NCT01145989||Single Group Assignment||Treatment||None (Open Label)||||||
1487607|NCT01145976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487608|NCT01145963|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1487609|NCT01145950|Randomized|Crossover Assignment||||Double|||t||t|
1487610|NCT01145937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487611|NCT01145924||Single Group Assignment||Diagnostic||None (Open Label)||||||
1487612|NCT01145911|||Cohort||Prospective|||||||
1487613|NCT01145898|||Cohort||Prospective|||||||
1487614|NCT01145885|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487615|NCT01145872|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1487616|NCT01145859||Single Group Assignment||||None (Open Label)||||||
1487617|NCT01145846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487618|NCT01145833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487619|NCT01145820|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487620|NCT01145807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487621|NCT01145794|Randomized|Parallel Assignment||Prevention||Single||||||t
1487622|NCT01145781|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487623|NCT01145768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487624|NCT01145755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487625|NCT01145742|Randomized|Single Group Assignment||Health Services Research||||||||
1487626|NCT01145729|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1487627|NCT01145716||Single Group Assignment||Diagnostic||None (Open Label)||||||
1487628|NCT01145703|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1487629|NCT01145690|||Cohort||Retrospective|||||||
1487630|NCT01145677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487631|NCT01145664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487632|NCT01145651||||||||||||
1487633|NCT01145638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487634|NCT01145625|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487635|NCT01145612|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487636|NCT01145599|||Cohort||Prospective|||||||
1487637|NCT01145586|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487638|NCT01145573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487639|NCT01145560|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487640|NCT01145547|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1487641|NCT01145534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487642|NCT01145508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487643|NCT01145495||Single Group Assignment||Treatment||None (Open Label)||||||
1487644|NCT01145482|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1487645|NCT01145469|||Other||Retrospective|||||||
1487646|NCT01145456||Single Group Assignment||Treatment||None (Open Label)||||||
1487647|NCT01145443|||Ecologic or Community||Prospective|||||||
1487648|NCT01145430||Single Group Assignment||Treatment||None (Open Label)||||||
1487649|NCT01145417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487650|NCT01145404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487651|NCT01145391|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1487652|NCT01145378||||||||||||
1487653|NCT01145365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487654|NCT01145352|||Case-Only||Prospective|||||||
1487655|NCT01145339|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487656|NCT01145326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487657|NCT01145313|||Cohort||Retrospective|||||||
1487658|NCT01145300|||Cohort||Prospective|||||||
1487659|NCT01145287|||Cohort||Prospective|||||||
1487660|NCT01145274|||Cohort||Prospective|||||||
1487661|NCT01145261|||Case Control||Prospective|||||||
1487662|NCT01145248|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1487663|NCT01145235|||Cohort||Prospective|||||||
1487664|NCT01145222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487665|NCT01145209|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487666|NCT01145196|||Cohort||Prospective|||||||
1487667|NCT01145183|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1487668|NCT01145170||Single Group Assignment||Treatment||None (Open Label)||||||
1487669|NCT01145157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487670|NCT01145144|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487671|NCT01145131|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1487672|NCT01145118|||Case-Only||Prospective|||||||
1487673|NCT01145105|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1487674|NCT01145092|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1487675|NCT01145079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487676|NCT01145066|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1487677|NCT01145053|||Case-Only||Prospective|||||||
1487678|NCT01145040|||Cohort||Cross-Sectional|||||||
1487679|NCT01145027|Randomized|Parallel Assignment||Basic Science||Single||||||t
1487680|NCT01145014|Randomized|Parallel Assignment||Treatment||Double||||||
1487681|NCT01145001|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1487682|NCT01144988||Single Group Assignment||Diagnostic||None (Open Label)||||||
1487683|NCT01144975|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487684|NCT01144962|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487685|NCT01144949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487686|NCT01144936|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1487687|NCT01144923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487688|NCT01144910|||Cohort||Prospective|||||||
1487689|NCT01144897||Single Group Assignment||Diagnostic||None (Open Label)||||||
1487690|NCT01144884||Single Group Assignment||Treatment||None (Open Label)||||||
1487691|NCT01144871|||Cohort||Cross-Sectional|||||||
1487692|NCT01144858|||Cohort||Prospective|||||||
1487693|NCT01144845|||Cohort||Retrospective|||||||
1487694|NCT01144832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487695|NCT01144819|||Case-Only||Prospective|||||||
1487696|NCT01144806|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487697|NCT01144793|||Cohort||Prospective|||||||
1487698|NCT01144780|||Cohort||Prospective|||||||
1487699|NCT01144767|Randomized|Parallel Assignment||Prevention||Single||||||
1487700|NCT01144754|||Cohort||Prospective|||||||
1487701|NCT01144741|||Case-Only||Cross-Sectional|||||||
1487702|NCT01144728||Single Group Assignment||Treatment||None (Open Label)||||||
1487703|NCT01144715|Randomized|Single Group Assignment||Treatment||Single||||||t
1487704|NCT01144702||Single Group Assignment||Treatment||None (Open Label)||||||
1487705|NCT01144689|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487706|NCT01144676|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1487707|NCT01144663|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487708|NCT01144650|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1487709|NCT01144637|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487710|NCT01144624|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487711|NCT01144611|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487712|NCT01144598|||||Cross-Sectional|||||||
1487713|NCT01144585|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1487714|NCT01144572|||Cohort||Prospective|||||||
1487715|NCT01144559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487716|NCT01144546||Single Group Assignment||Prevention||None (Open Label)||||||
1487717|NCT01144533|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487718|NCT01144520|||Other||Other|||||||
1487719|NCT01144507|||Cohort||Prospective|||||||
1487720|NCT01144494|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1487721|NCT01144481|||Cohort||Prospective|||||||
1487722|NCT01144468|||Cohort||Prospective|||||||
1487723|NCT01144455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487724|NCT01144442||Single Group Assignment||Treatment||None (Open Label)||||||
1487725|NCT01144429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487726|NCT01144416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487727|NCT01144403||Single Group Assignment||Treatment||None (Open Label)||||||
1487728|NCT01144390|Randomized|Parallel Assignment||Treatment||Single||||||t
1487729|NCT01144377|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487730|NCT01144364||Single Group Assignment||Treatment||None (Open Label)||||||
1487731|NCT01144351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487732|NCT01144338|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487733|NCT01144325|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487734|NCT01144312|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487735|NCT01144299|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487736|NCT01144286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487737|NCT01144273|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1487738|NCT01144260|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487739|NCT01144247||Single Group Assignment||Treatment||None (Open Label)||||||
1487740|NCT01144234|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487741|NCT01144221||Single Group Assignment||Treatment||None (Open Label)||||||
1487742|NCT01144208|||Cohort||Prospective|||||||
1487743|NCT01144195||Single Group Assignment||Treatment||None (Open Label)||||||
1487744|NCT01144182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487745|NCT01144169||Single Group Assignment||Treatment||None (Open Label)||||||
1487746|NCT01144156||Single Group Assignment||Treatment||None (Open Label)||||||
1487747|NCT01144143|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487748|NCT01144130|||||Prospective|||||||
1487749|NCT01144117|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1487750|NCT01144104|Randomized|Parallel Assignment||Screening||Single||||||t
1487751|NCT01144091|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487752|NCT01144078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487753|NCT01144065|||Case Control||Prospective|||||||
1487754|NCT01144052|Randomized|Parallel Assignment||Treatment||Single||||||t
1487755|NCT01144039|Randomized|Parallel Assignment||Treatment||||||||
1487756|NCT01144026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487757|NCT01144000||Single Group Assignment||Treatment||None (Open Label)||||||
1487758|NCT01143987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487759|NCT01143974||Single Group Assignment||Treatment||None (Open Label)||||||
1487760|NCT01143961|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1487761|NCT01143948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487762|NCT01143935|||Cohort||Prospective|||||||
1487763|NCT01143922|||Cohort||Prospective|||||||
1487764|NCT01143909|Randomized|Parallel Assignment||Prevention||Single||||||t
1487765|NCT01143896|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1487766|NCT01143883|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487767|NCT01143870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487768|NCT01143857|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1487769|NCT01143844|||Case-Control||Prospective|||||||
1487770|NCT01143831||Single Group Assignment||Basic Science||None (Open Label)||||||
1487771|NCT01143818|||Ecologic or Community||Prospective|||||||
1487772|NCT01143805|Randomized|Crossover Assignment||||None (Open Label)||||||
1487773|NCT01143792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487774|NCT01143779||Single Group Assignment||Treatment||None (Open Label)||||||
1487775|NCT01143766|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1487776|NCT01143753|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487777|NCT01143740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487778|NCT01143727|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1487779|NCT01143714|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487780|NCT01143701|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1487781|NCT01143688|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1487782|NCT01143675|||Case-Only||Prospective|||||||
1487783|NCT01143662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487784|NCT01143649|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1487785|NCT01143636|Randomized|Parallel Assignment||Treatment||Double||For the experiment in patients with pelvic pain, the design is parallel. For the experiment in healthy subjects, the design is crossover.|||t|t
1487786|NCT01143623|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487787|NCT01143610|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487788|NCT01143597|Randomized|Parallel Assignment||Treatment||Single||||||t
1487789|NCT01143584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487790|NCT01143571|||Ecologic or Community||Prospective|||||||
1487791|NCT01143558|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1487792|NCT01143545||Single Group Assignment||Treatment||None (Open Label)||||||
1487793|NCT01143532|||Cohort||Retrospective|||||||
1487794|NCT01143519|||||Other|||||||
1487795|NCT01143506|||||Prospective|||||||
1487796|NCT01143493|||Cohort||Prospective|||||||
1487797|NCT01143480|||||Other|||||||
1487798|NCT01143467|||||Prospective|||||||
1487799|NCT01143454|||Case-Control||Prospective|||||||
1487800|NCT01143441|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487801|NCT01143428|||||Other|||||||
1487802|NCT01143402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487803|NCT01143389|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487804|NCT01143376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487805|NCT01143363|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1487806|NCT01143350|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1487807|NCT01143337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487808|NCT01143324|||Case-Only||Prospective|||||||
1487809|NCT01143311||Single Group Assignment||Basic Science||None (Open Label)||||||
1487810|NCT01143298|Randomized|Crossover Assignment||||None (Open Label)||||||
1487811|NCT01143285|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487812|NCT01143272|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487813|NCT01143259|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487814|NCT01143246|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487815|NCT01143233|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1487816|NCT01143220|||Cohort||Prospective|||||||
1487817|NCT01143207||Single Group Assignment||||None (Open Label)||||||
1487818|NCT01143194|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1488296|NCT01136902|||Case-Only||Prospective|||||||
1487819|NCT01143181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487820|NCT01143168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487821|NCT01143155|||Cohort||Prospective|||||||
1487822|NCT01143142|Randomized|Parallel Assignment||Prevention||Single|||t|||
1487823|NCT01143129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487824|NCT01143116||||||||||||
1487825|NCT01143103|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487826|NCT01143090||Single Group Assignment||Treatment||None (Open Label)||||||
1487827|NCT01143077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487828|NCT01143064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487829|NCT01143051|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1487830|NCT01143038||Single Group Assignment||Treatment||None (Open Label)||||||
1487831|NCT01143025|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487832|NCT01143012|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487833|NCT01142999|Randomized|Parallel Assignment||Prevention||Single||||||t
1487834|NCT01142986|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1487835|NCT01142973|||Cohort||Cross-Sectional|||||||
1487836|NCT01142960|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1487837|NCT01142947||Single Group Assignment||Basic Science||None (Open Label)||||||
1487838|NCT01142934|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487839|NCT01142921|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487840|NCT01142908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487841|NCT01142895|||Case Control||Cross-Sectional|||||||
1487842|NCT01142882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487843|NCT01142869|||Cohort||Prospective|||||||
1487844|NCT01142856||Single Group Assignment||Treatment||None (Open Label)||||||
1487845|NCT01142843||Single Group Assignment||Treatment||None (Open Label)||||||
1487846|NCT01142830|||Cohort||Prospective|||||||
1487847|NCT01142817|||Cohort||Prospective|||||||
1487848|NCT01142804|Randomized|Parallel Assignment||Prevention||Single|||t|||
1487849|NCT01142791||Single Group Assignment||Treatment||None (Open Label)||||||
1487850|NCT01142778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487851|NCT01142765|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487852|NCT01142752|||Case Control||Prospective|||||||
1487853|NCT01142739|||Case Control||Cross-Sectional|||||||
1487854|NCT01142726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487855|NCT01142713||Single Group Assignment||Treatment||None (Open Label)||||||
1487856|NCT01142700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487857|NCT01142687|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1487858|NCT01142674|||Cohort||Prospective|||||||
1487859|NCT01142661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487860|NCT01142648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487861|NCT01142635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487862|NCT01142622|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487863|NCT01142609|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1487864|NCT01142596|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487865|NCT01142583|||Cohort||Prospective|||||||
1487866|NCT01142570|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487867|NCT01142557|||Cohort||Prospective|||||||
1487868|NCT01142544|||Cohort||Prospective|||||||
1487869|NCT01142531|||Case-Only||Prospective|||||||
1487870|NCT01142518|||Case-Only||Prospective|||||||
1487871|NCT01142505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487872|NCT01142492|||Cohort||Prospective|||||||
1487873|NCT01142479|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1487874|NCT01142466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487875|NCT01142453|||Case-Only||Prospective|||||||
1487876|NCT01142440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487877|NCT01142427||||||||||||
1487878|NCT01142414|Randomized|||Treatment||None (Open Label)||||||
1487879|NCT01142401|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1487880|NCT01142388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487881|NCT01142375|||Cohort||Prospective|||||||
1487882|NCT01142362|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487883|NCT01142349|Randomized|Parallel Assignment||Treatment||Single||||||t
1487884|NCT01142336|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1487885|NCT01142323||Single Group Assignment||Treatment||None (Open Label)||||||
1487886|NCT01142310|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1487887|NCT01142297||Single Group Assignment||Treatment||None (Open Label)||||||
1487888|NCT01142284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487889|NCT01142271|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487890|NCT01142258|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487891|NCT01142245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487892|NCT01142232||Single Group Assignment||Treatment||None (Open Label)||||||
1487893|NCT01142219|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487894|NCT01142206|Randomized|Parallel Assignment||Treatment||Single||||||t
1487895|NCT01142193|Randomized|Parallel Assignment||Treatment||Double||||||
1487896|NCT01142180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487897|NCT01142167|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1487898|NCT01142154|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1487899|NCT01142141|Randomized|Parallel Assignment||Treatment||Single|||||t|
1487900|NCT01142128|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1487901|NCT01142115|Randomized|Crossover Assignment||Treatment||Single|||t|||
1487902|NCT01142102||Single Group Assignment||Treatment||None (Open Label)||||||
1487903|NCT01142089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487904|NCT01142076|Randomized|Parallel Assignment||Treatment||Single||||||t
1487905|NCT01142063|||Cohort||Prospective|||||||
1487906|NCT01142050||Single Group Assignment||Treatment||None (Open Label)||||||
1487907|NCT01142037||Single Group Assignment||Prevention||None (Open Label)||||||
1487908|NCT01142024|Randomized|Parallel Assignment||Prevention||Single|||t|||
1487909|NCT01142011||Single Group Assignment||Treatment||None (Open Label)||||||
1487910|NCT01141998|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1487911|NCT01141985||Single Group Assignment||Basic Science||None (Open Label)||||||
1487912|NCT01141972|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1487913|NCT01141959|||Case-Only||Prospective|||||||
1487914|NCT01141946|||Cohort||Prospective|||||||
1487915|NCT01141933|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1487916|NCT01141920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487917|NCT01141907|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1487918|NCT01141894|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1487919|NCT01141881||||Treatment||Single|||||t|
1487920|NCT01141868|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1487921|NCT01141855|Randomized|Single Group Assignment||Prevention||Single|||||t|
1487922|NCT01141842|Randomized|Parallel Assignment||Diagnostic||Double||||t|t|
1487923|NCT01141829|||Case Control||Cross-Sectional|||||||
1487924|NCT01141816||Single Group Assignment||Screening||Single|The radiologist is blinded to either CEUS or CT/MRI.|||||t
1487925|NCT01141803|Randomized|Parallel Assignment||Prevention||Single|||||t|
1487926|NCT01141790|Randomized|||Supportive Care||Single|||||t|
1487927|NCT01141777|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1487928|NCT01141764||Single Group Assignment||Treatment||None (Open Label)||||||
1487929|NCT01141751|||Cohort||Prospective|||||||
1487930|NCT01141738|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1487931|NCT01141725||Single Group Assignment||Treatment||None (Open Label)||||||
1487932|NCT01141712||Single Group Assignment||Treatment||None (Open Label)||||||
1487933|NCT01141699|||Cohort||Retrospective|||||||
1487934|NCT01141686|||Cohort||Retrospective|||||||
1487935|NCT01141673|||Cohort||Prospective|||||||
1487936|NCT01141660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487937|NCT01141647||Single Group Assignment||Treatment||None (Open Label)||||||
1487938|NCT01141634||Single Group Assignment||Treatment||None (Open Label)||||||
1487939|NCT01141621|||Cohort||Prospective|||||||
1487940|NCT01141608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487941|NCT01141595||Single Group Assignment||Treatment||None (Open Label)||||||
1487942|NCT01141569||Single Group Assignment||Treatment||None (Open Label)||||||
1487943|NCT01141556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487944|NCT01141543|||Cohort||Prospective|||||||
1487945|NCT01141530|||Case-Only||Retrospective|||||||
1487946|NCT01141517|||Case Control||Prospective|||||||
1487947|NCT01141504|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1487948|NCT01141491|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1487949|NCT01141478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487950|NCT01141465|||Cohort||Retrospective|||||||
1487951|NCT01141452|||Cohort||Retrospective|||||||
1487952|NCT01141439|||Cohort||Retrospective|||||||
1487953|NCT01141426|Randomized|Parallel Assignment||Treatment||Single||||||t
1487954|NCT01141413|||Cohort||Retrospective|||||||
1487955|NCT01141400|||Cohort||Retrospective|||||||
1487956|NCT01141387|||Cohort||Prospective|||||||
1487957|NCT01141374|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487958|NCT01141361|||Cohort||Prospective|||||||
1487959|NCT01141348|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1487960|NCT01141335|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1487961|NCT01141322|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487962|NCT01141309||Single Group Assignment||Treatment||None (Open Label)||||||
1487963|NCT01141296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487964|NCT01141283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487965|NCT01141270|Randomized|Crossover Assignment||||None (Open Label)||||||
1487966|NCT01141257||Single Group Assignment||Treatment||None (Open Label)||||||
1487967|NCT01141244||Single Group Assignment||Treatment||None (Open Label)||||||
1487968|NCT01141218|||Case-Only||Prospective|||||||
1487969|NCT01141205|Randomized|Parallel Assignment||Treatment||Single|||t|||
1487970|NCT01141192|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1487971|NCT01141179|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487972|NCT01141166|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1487973|NCT01141153|Randomized|Parallel Assignment||Treatment||Single||||||t
1487974|NCT01141140|Randomized|Factorial Assignment||||Single|||t|||
1487975|NCT01141127|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1487976|NCT01141114|Randomized|Parallel Assignment||Screening||Single||||||t
1487977|NCT01141101|||Cohort||Prospective|||||||
1487978|NCT01141088|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487979|NCT01141075||Single Group Assignment||Treatment||None (Open Label)||||||
1487980|NCT01141062||Single Group Assignment||Treatment||None (Open Label)||||||
1487981|NCT01141049|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1487982|NCT01141036|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1487983|NCT01141023||Single Group Assignment||Diagnostic||None (Open Label)||||||
1487984|NCT01141010|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1487985|NCT01140997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487986|NCT01140984||Single Group Assignment||Treatment||None (Open Label)||||||
1487987|NCT01140971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1487988|NCT01140958|||Cohort||Retrospective|||||||
1487989|NCT01140945|||Cohort||Prospective|||||||
1487990|NCT01140932|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1487991|NCT01140919||||||||||||
1487992|NCT01140906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1487993|NCT01140893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487994|NCT01140880|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1487995|NCT01140867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1487996|NCT01140854|||Case Control||Prospective|||||||
1487997|NCT01140841|||Cohort||Prospective|||||||
1487998|NCT01140828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1487999|NCT01140815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488000|NCT01140802|||Case-Control||Prospective|||||||
1488001|NCT01140789|||Case-Control||Prospective|||||||
1488002|NCT01140776|||Case-Only||Prospective|||||||
1488003|NCT01140763|||Case-Only||Prospective|||||||
1488004|NCT01140750|||Case-Only||Cross-Sectional|||||||
1488005|NCT01140737||Single Group Assignment||Treatment||None (Open Label)||||||
1488006|NCT01140724|||Other||Prospective|||||||
1488007|NCT01140711|Non-Randomized|Single Group Assignment||Other||Single|||||t|
1488008|NCT01140698|||Cohort||Prospective|||||||
1488009|NCT01140685|||Case Control||Prospective|||||||
1488010|NCT01140672|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1488011|NCT01140659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488012|NCT01140646||Single Group Assignment||Treatment||None (Open Label)||||||
1488013|NCT01140633|||Cohort||Prospective|||||||
1488014|NCT01140620|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1488015|NCT01140607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488016|NCT01140594|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1488017|NCT01140581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488018|NCT01140568||Single Group Assignment||Treatment||None (Open Label)||||||
1488019|NCT01140555||Single Group Assignment||Treatment||None (Open Label)||||||
1488020|NCT01140542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488021|NCT01140529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488022|NCT01140516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488023|NCT01140503||Single Group Assignment||Treatment||None (Open Label)||||||
1488024|NCT01140490|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488025|NCT01140477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488026|NCT01140464|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1488027|NCT01140451||Single Group Assignment||Treatment||None (Open Label)||||||
1488028|NCT01140438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488029|NCT01140425|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488030|NCT01140412|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488031|NCT01140399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488032|NCT01140386|||Cohort||Retrospective|||||||
1488033|NCT01140373||Single Group Assignment||Treatment||None (Open Label)||||||
1488034|NCT01140360||Single Group Assignment||Treatment||None (Open Label)||||||
1488035|NCT01140347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488036|NCT01140334|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488037|NCT01140321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488038|NCT01140308|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1488039|NCT01140295|Randomized|Parallel Assignment||||Single|||||t|
1488040|NCT01140282|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1488041|NCT01140269|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1488042|NCT01140256|||Cohort||Prospective|||||||
1488043|NCT01140243|Randomized|Parallel Assignment||Treatment||Single|||||t|
1488044|NCT01140230|||Case-Only||Retrospective|||||||
1488045|NCT01140217||Single Group Assignment||Prevention||None (Open Label)||||||
1488046|NCT01140204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488047|NCT01140191||Single Group Assignment||Treatment||None (Open Label)||||||
1488048|NCT01140178||Single Group Assignment||Treatment||None (Open Label)||||||
1488049|NCT01140165|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1488050|NCT01140152|||Case Control||Prospective|||||||
1488051|NCT01140139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488052|NCT01140126||Single Group Assignment||Treatment||None (Open Label)||||||
1488053|NCT01140113|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1488054|NCT01140100|Randomized|Parallel Assignment||Treatment||Single||||||t
1488055|NCT01140087||Single Group Assignment||Treatment||None (Open Label)||||||
1488056|NCT01140074|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1488057|NCT01140061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488058|NCT01140048|||Cohort||Prospective|||||||
1488059|NCT01140035|Randomized|Parallel Assignment||Treatment||Single|||||t|
1488060|NCT01140022|||Cohort||Prospective|||||||
1488061|NCT01140009|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1488062|NCT01139996|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1488063|NCT01139983|||Case Control||Retrospective|||||||
1488064|NCT01139970||Single Group Assignment||Treatment||None (Open Label)||||||
1488065|NCT01139957|||Cohort||Retrospective|||||||
1488066|NCT01139944|||Case-Only||Retrospective|||||||
1488067|NCT01139931|||Case-Only||Retrospective|||||||
1488068|NCT01139918|||Cohort||Prospective|||||||
1488069|NCT01139905||Single Group Assignment||||None (Open Label)||||||
1488070|NCT01139892|||Case-Only||Prospective|||||||
1488071|NCT01139879||Single Group Assignment||Treatment||None (Open Label)||||||
1488072|NCT01139866|||||Prospective|||||||
1488073|NCT01139853|Randomized|Parallel Assignment||Treatment||Single||||||t
1488074|NCT01139840|Randomized|Parallel Assignment||Prevention||Single||||||t
1488075|NCT01139827|||Cohort||Cross-Sectional|||||||
1488076|NCT01139814||Single Group Assignment||Diagnostic||None (Open Label)||||||
1488077|NCT01139801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488078|NCT01139788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488079|NCT01139775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488080|NCT01139762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488081|NCT01139749|Randomized|Parallel Assignment||Treatment||Single||||||t
1488082|NCT01139736||Single Group Assignment||Treatment||None (Open Label)||||||
1488083|NCT01139723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488084|NCT01139710|||Cohort||Prospective|||||||
1488085|NCT01139697|||Case-Only||Prospective|||||||
1488086|NCT01139684|Randomized|Single Group Assignment||||None (Open Label)||||||
1488087|NCT01139671|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1488088|NCT01139658|||Cohort||Prospective|||||||
1488089|NCT01139645|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1488090|NCT01139632|||||Prospective|||||||
1488091|NCT01139619|||Cohort||Retrospective|||||||
1488092|NCT01139606||Single Group Assignment||Basic Science||None (Open Label)||||||
1488093|NCT01139593|||Case Control||Prospective|||||||
1488094|NCT01139580|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488095|NCT01139567|||Case Control||Retrospective|||||||
1488096|NCT01139541|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1488097|NCT01139528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488098|NCT01139515|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1488099|NCT01139502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488100|NCT01139489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488101|NCT01139476|||Cohort||Cross-Sectional|||||||
1488102|NCT01139463|||Cohort||Prospective|||||||
1488103|NCT01139450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488104|NCT01139437|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1488105|NCT01139424||Single Group Assignment||Treatment||None (Open Label)||||||
1488106|NCT01139411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488107|NCT01139398|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488108|NCT01139385|||Case Control||Prospective|||||||
1488109|NCT01139372|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488110|NCT01139359||Single Group Assignment||Treatment||None (Open Label)||||||
1488111|NCT01139346||Single Group Assignment||Treatment||None (Open Label)||||||
1488112|NCT01139333|||Case-Only||Retrospective|||||||
1488113|NCT01139320|||Cohort||Retrospective|||||||
1488114|NCT01139307|||Cohort||Retrospective|||||||
1488115|NCT01139294|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1488116|NCT01139281|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1488117|NCT01139268||||||||||||
1488118|NCT01139255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488119|NCT01139242|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488120|NCT01139229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488121|NCT01139216|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488122|NCT01139203|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1488123|NCT01139190|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1488124|NCT01139177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488125|NCT01139164||Single Group Assignment||Treatment||None (Open Label)||||||
1488126|NCT01139151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488127|NCT01139138||Single Group Assignment||Treatment||None (Open Label)||||||
1488128|NCT01139125||Single Group Assignment||Treatment||None (Open Label)||||||
1488129|NCT01139112|||||Retrospective|||||||
1488130|NCT01139099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488131|NCT01139086|||Case Control||Cross-Sectional|||||||
1488132|NCT01139073|||Case-Only||Cross-Sectional|||||||
1488133|NCT01139060|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488134|NCT01139047|Randomized|Parallel Assignment||Treatment||Single|||||t|
1488135|NCT01139034||Single Group Assignment||Prevention||None (Open Label)||||||
1488136|NCT01139021|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488380|NCT01135797|||Cohort||Retrospective|||||||
1488137|NCT01139008|Randomized|Parallel Assignment||Treatment||Single|||||t|
1488138|NCT01138995|Randomized|Parallel Assignment||Treatment||Single||||||t
1488139|NCT01138982|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488140|NCT01138969|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488141|NCT01138956|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1488142|NCT01138943|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1488143|NCT01138930|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488144|NCT01138917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488145|NCT01138904|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488146|NCT01138891|||Cohort||Retrospective|||||||
1488147|NCT01138878|||||Cross-Sectional|||||||
1488148|NCT01138865|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488149|NCT01138852|Randomized|Parallel Assignment||Prevention||Single|||t|||
1488150|NCT01138839|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1488151|NCT01138826|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1488152|NCT01138813|||Cohort||Prospective|||||||
1488153|NCT01138800|||Case-Only||Prospective|||||||
1488154|NCT01138787|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1488155|NCT01138774|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1488156|NCT01138761|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1488157|NCT01138748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488158|NCT01138735|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488159|NCT01138722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488160|NCT01138709||Single Group Assignment||Supportive Care||None (Open Label)||||||
1488161|NCT01138696|||Cohort||Prospective|||||||
1488162|NCT01138683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488163|NCT01138670|||Cohort||Prospective|||||||
1488164|NCT01138657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488165|NCT01138644|||Case-Only||Prospective|||||||
1488166|NCT01138631|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1488167|NCT01138618|||Case-Crossover||Prospective|||||||
1488168|NCT01138605|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488169|NCT01138592|||Cohort||Prospective|||||||
1488170|NCT01138579|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488171|NCT01138566|||Cohort||Prospective|||||||
1488172|NCT01138553||Single Group Assignment||Treatment||None (Open Label)||||||
1488173|NCT01138540|Randomized|Parallel Assignment||Prevention||Single|||t|||
1488174|NCT01138527|||Cohort||Prospective|||||||
1488175|NCT01138514|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488176|NCT01138501|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488177|NCT01138488|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488178|NCT01138475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488179|NCT01138462|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488180|NCT01138449|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1488181|NCT01138436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488182|NCT01138423|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1488183|NCT01138410||Single Group Assignment||Treatment||None (Open Label)||||||
1488184|NCT01138397|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488185|NCT01138384||Single Group Assignment||Treatment||None (Open Label)||||||
1488186|NCT01138371|||Case-Only||Prospective|||||||
1488187|NCT01138358||||||||||||
1488188|NCT01138345|||Cohort||Cross-Sectional|||||||
1488189|NCT01138332|||Case-Only||Retrospective|||||||
1488190|NCT01138319|||Case-Only||Retrospective|||||||
1488191|NCT01138306|||Case Control||Retrospective|||||||
1488192|NCT01138293|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488193|NCT01138280|Randomized|Parallel Assignment||Treatment||Single||||||t
1488194|NCT01138267|||Cohort||Retrospective|||||||
1488195|NCT01138254|Randomized|Parallel Assignment||Treatment||Single||||||t
1488196|NCT01138241|||Cohort||Cross-Sectional|||||||
1488197|NCT01138228|||Case-Crossover||Prospective|||||||
1488198|NCT01138215|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1488199|NCT01138202|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1488200|NCT01138189|||Case-Control||Prospective|||||||
1488201|NCT01138176|Randomized|Parallel Assignment||Treatment||Single||||||t
1488202|NCT01138163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488203|NCT01138150|Randomized|Parallel Assignment||||Triple|||t|t|t|
1488204|NCT01138137||Single Group Assignment||Treatment||None (Open Label)||||||
1488205|NCT01138124|||Case-Control||Retrospective|||||||
1488206|NCT01138111||Single Group Assignment||Diagnostic||None (Open Label)||||||
1488207|NCT01138098|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488208|NCT01138085|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488209|NCT01138072|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1488210|NCT01138059|||Case-Only||Prospective|||||||
1488211|NCT01138046||Single Group Assignment||Treatment||None (Open Label)||||||
1488212|NCT01138033|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488213|NCT01138020|Randomized|Parallel Assignment||Treatment||Single||||||t
1488214|NCT01138007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488215|NCT01137994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488216|NCT01137981|||Other||Prospective|||||||
1488217|NCT01137968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488218|NCT01137955|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488219|NCT01137942|||Case Control||Prospective|||||||
1488220|NCT01137929|||Case Control||Prospective|||||||
1488221|NCT01137916||Single Group Assignment||Treatment||None (Open Label)||||||
1488222|NCT01137903|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488223|NCT01137890|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1488224|NCT01137877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488225|NCT01137864|Randomized|Parallel Assignment||Treatment||Single||||||t
1488226|NCT01137851|||Cohort||Retrospective|||||||
1488227|NCT01137838|||Cohort||Retrospective|||||||
1488228|NCT01137825|||Case-Only||Prospective|||||||
1488229|NCT01137812|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488230|NCT01137799|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1488231|NCT01137786|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1488232|NCT01137773|Randomized|Parallel Assignment||Prevention||Single|||t|||
1488233|NCT01137760|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1488234|NCT01137747|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488235|NCT01137734||Single Group Assignment||Treatment||None (Open Label)||||||
1488236|NCT01137721|||Case-Control||Prospective|||||||
1488237|NCT01137708|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488238|NCT01137695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488239|NCT01137682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488240|NCT01137669|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1488241|NCT01137656||Single Group Assignment||Basic Science||None (Open Label)||||||
1488242|NCT01137643|||Other||Prospective|||||||
1488243|NCT01137630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488244|NCT01137617|||Case-Only||Cross-Sectional|||||||
1488245|NCT01137604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488246|NCT01137591|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1488247|NCT01137578|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1488248|NCT01137565|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1488249|NCT01137552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488250|NCT01137539||Single Group Assignment||Treatment||None (Open Label)||||||
1488251|NCT01137526|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488252|NCT01137513|||Cohort||Prospective|||||||
1488253|NCT01137500|||Cohort||Prospective|||||||
1488254|NCT01137487|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488255|NCT01137474|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488256|NCT01137461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488257|NCT01137448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488258|NCT01137435||Single Group Assignment||Prevention||None (Open Label)||||||
1488259|NCT01137409|||Cohort||Prospective|||||||
1488260|NCT01137396|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488261|NCT01137383||Single Group Assignment||Treatment||None (Open Label)||||||
1488262|NCT01137370|||Cohort||Prospective|||||||
1488263|NCT01137357|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488264|NCT01137331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488265|NCT01137318|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1488266|NCT01137305|Randomized|Single Group Assignment||||Triple||||t|t|t
1488267|NCT01137292|||Cohort||Prospective|||||||
1488268|NCT01137266|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1488269|NCT01137253|Randomized|Crossover Assignment||Other||Single|||t|||
1488270|NCT01137240|||Cohort||Prospective|||||||
1488271|NCT01137227|||||Retrospective|||||||
1488272|NCT01137214|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488273|NCT01137201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488274|NCT01137188|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1488275|NCT01137175|||Case-Only||Prospective|||||||
1488276|NCT01137162|||Cohort||Prospective|||||||
1488277|NCT01137149|Randomized|Parallel Assignment||Treatment||Single||||||t
1488278|NCT01137136|||Cohort||Prospective|||||||
1488279|NCT01137123|Randomized|Factorial Assignment||Treatment||Single||||||t
1488280|NCT01137110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488281|NCT01137097|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488282|NCT01137084|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1488283|NCT01137071||Single Group Assignment||Treatment||None (Open Label)||||||
1488284|NCT01137058|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488285|NCT01137045|Randomized|Factorial Assignment||Treatment||Single|||t|||
1488286|NCT01137032||Single Group Assignment||Treatment||None (Open Label)||||||
1488287|NCT01137019|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1488288|NCT01137006|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488289|NCT01136993|||Cohort||Prospective|||||||
1488290|NCT01136980|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488291|NCT01136967|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488292|NCT01136954||Single Group Assignment||Treatment||None (Open Label)||||||
1488293|NCT01136941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488294|NCT01136928||Single Group Assignment||Other||None (Open Label)||||||
1488295|NCT01136915|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1488297|NCT01136889|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1488298|NCT01136876|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1488299|NCT01136863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488300|NCT01136850|Randomized|Parallel Assignment||Prevention||Single|||t|||
1488301|NCT01136837|||Cohort||Prospective|||||||
1488302|NCT01136824|||||Prospective|||||||
1488303|NCT01136811||Single Group Assignment||||None (Open Label)||||||
1488304|NCT01136798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488305|NCT01136785|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488306|NCT01136772|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488307|NCT01136759|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1488308|NCT01136746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488309|NCT01136733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488310|NCT01136720|||Case-Only||Prospective|||||||
1488311|NCT01136707|||Cohort||Retrospective|||||||
1488312|NCT01136694|||Cohort||Prospective|||||||
1488313|NCT01136681|||Cohort|||||||||
1488314|NCT01136668|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1488315|NCT01136655|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1488316|NCT01136642|Randomized|Single Group Assignment||Other||||||||
1488317|NCT01136629|||Case-Only||Prospective|||||||
1488318|NCT01136616|||Case-Only||Prospective|||||||
1488319|NCT01136603|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488320|NCT01136590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488321|NCT01136577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488322|NCT01136564|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1488323|NCT01136551|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488324|NCT01136538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488325|NCT01136525|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488326|NCT01136512|||Case Control||Cross-Sectional|||||||
1488327|NCT01136499|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488328|NCT01136486|||Case-Only||Retrospective|||||||
1488329|NCT01136473|||Case-Only||Cross-Sectional|||||||
1488330|NCT01136460|||Case-Only||Retrospective|||||||
1488331|NCT01136447|Randomized|Parallel Assignment||Treatment||Single||||||t
1488332|NCT01136421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488333|NCT01136408|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488334|NCT01136395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488335|NCT01136382|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488336|NCT01136369|||Case-Only||Prospective|||||||
1488337|NCT01136356|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1488338|NCT01136343|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1488339|NCT01136330|||Cohort||Retrospective|||||||
1488340|NCT01136317||||||||||||
1488341|NCT01136304|||Cohort|||||||||
1488342|NCT01136291|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488343|NCT01136278|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1488344|NCT01136265|||Case-Only||Prospective|||||||
1488345|NCT01136252||Single Group Assignment||Treatment||None (Open Label)||||||
1488346|NCT01136239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488347|NCT01136226||Single Group Assignment||Treatment||None (Open Label)||||||
1488348|NCT01136213|||Cohort||Cross-Sectional|||||||
1488349|NCT01136200|Randomized|Parallel Assignment||Treatment||Single||||||t
1488350|NCT01136187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488351|NCT01136174|Randomized|Parallel Assignment||||Double||||||
1488352|NCT01136161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488353|NCT01136148|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488354|NCT01136135|||Cohort||Prospective|||||||
1488355|NCT01136122|Randomized|Parallel Assignment||||Single||||||t
1488356|NCT01136109|||Cohort||Prospective|||||||
1488357|NCT01136096|Randomized|Parallel Assignment||||Double|||t|||t
1488358|NCT01136083|Randomized|Parallel Assignment||Treatment||Single||||||t
1488359|NCT01136070|||Cohort||Prospective|||||||
1488360|NCT01136057|||Cohort||Prospective|||||||
1488361|NCT01136044||Single Group Assignment||Treatment||None (Open Label)||||||
1488362|NCT01136031|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488363|NCT01136018|||||Prospective|||||||
1488364|NCT01136005|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1488365|NCT01135992|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488366|NCT01135979|||Cohort||Prospective|||||||
1488367|NCT01135966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488368|NCT01135953|Randomized|Crossover Assignment||||Single|||t|||
1488369|NCT01135940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488370|NCT01135927|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488371|NCT01135914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488372|NCT01135901||Single Group Assignment||Prevention||None (Open Label)||||||
1488373|NCT01135888|||Case Control||Prospective|||||||
1488374|NCT01135875|||Case Control||Prospective|||||||
1488375|NCT01135862|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488376|NCT01135849|||Cohort||Prospective|||||||
1488377|NCT01135836|Randomized|Parallel Assignment||Prevention||Single|||t|||
1488378|NCT01135823|||Cohort||Prospective|||||||
1488379|NCT01135810|||Case Control||Prospective|||||||
1488381|NCT01135784|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1488382|NCT01135771||||Diagnostic||None (Open Label)||||||
1488383|NCT01135758||Single Group Assignment||Treatment||None (Open Label)||||||
1488384|NCT01135745||Single Group Assignment||Treatment||None (Open Label)||||||
1488385|NCT01135732|||Case Control||Prospective|||||||
1488386|NCT01135719|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488387|NCT01135706|||Cohort||Retrospective|||||||
1488388|NCT01135693|||||Retrospective|||||||
1488389|NCT01135680|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1488390|NCT01135667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488391|NCT01135654|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488392|NCT01135641||Single Group Assignment||Treatment||None (Open Label)||||||
1488393|NCT01135628|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488394|NCT01135615|Randomized|Parallel Assignment||Prevention||Single||||||
1488395|NCT01135602||Single Group Assignment||Treatment||None (Open Label)||||||
1488396|NCT01135589||Single Group Assignment||Prevention||None (Open Label)||||||
1488397|NCT01135576|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1488398|NCT01135563||Parallel Assignment||Treatment||None (Open Label)||||||
1488399|NCT01135550|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1488400|NCT01135537||Single Group Assignment||Treatment||None (Open Label)||||||
1488401|NCT01135524||Single Group Assignment||Treatment||None (Open Label)||||||
1488402|NCT01135511|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488403|NCT01135498|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488404|NCT01135485|||Case-Control||Prospective|||||||
1488405|NCT01135472|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1488406|NCT01135459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488407|NCT01135446|Randomized|Parallel Assignment||||None (Open Label)||||||
1488408|NCT01135433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488409|NCT01135420|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488410|NCT01135407|||||Prospective|||||||
1488411|NCT01135394||Single Group Assignment||Basic Science||None (Open Label)||||||
1488412|NCT01135381|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1488413|NCT01135368||Single Group Assignment||Treatment||None (Open Label)||||||
1488414|NCT01135355|||Cohort||Prospective|||||||
1488415|NCT01135342|Randomized|Parallel Assignment||Prevention||Single|||t|||
1488416|NCT01135329||Single Group Assignment||Treatment||None (Open Label)||||||
1488417|NCT01135316|||Cohort||Prospective|||||||
1488418|NCT01135303||Single Group Assignment||Diagnostic||None (Open Label)||||||
1488419|NCT01135290|Randomized|Single Group Assignment||Treatment||Single||||t||
1488420|NCT01135277|||Cohort||Prospective|||||||
1488421|NCT01135264|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488422|NCT01135251|Randomized|Parallel Assignment||Treatment||Double||||||
1488423|NCT01135238|||Cohort||Retrospective|||||||
1488424|NCT01135225|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488425|NCT01135212|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488426|NCT01135199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488427|NCT01135186||Single Group Assignment||Treatment||None (Open Label)||||||
1488428|NCT01135173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488429|NCT01135160|||Cohort||Prospective|||||||
1488430|NCT01135147|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488431|NCT01135134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488432|NCT01135121|||Cohort||Prospective|||||||
1488433|NCT01135108|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488434|NCT01135095|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1488435|NCT01135082|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488436|NCT01135069|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488437|NCT01135056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488438|NCT01135043|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1488439|NCT01135030|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488440|NCT01135017|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488441|NCT01135004|||Cohort||Prospective|||||||
1488442|NCT01134991|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488443|NCT01134978|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1488444|NCT01134965|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488445|NCT01134952||Single Group Assignment||Prevention||None (Open Label)||||||
1488446|NCT01134939|||Cohort|||||||||
1488447|NCT01134926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488448|NCT01134913|||Cohort||Prospective|||||||
1488449|NCT01134900|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1488450|NCT01134887|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488451|NCT01134874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488452|NCT01134861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488453|NCT01134848|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1488454|NCT01134835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488455|NCT01134822|||Cohort||Prospective|||||||
1488456|NCT01134809|||Cohort||Prospective|||||||
1488457|NCT01134796|||Cohort||Prospective|||||||
1488458|NCT01134783|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1488459|NCT01134770|||Cohort||Cross-Sectional|||||||
1488460|NCT01134757||Single Group Assignment||Diagnostic||None (Open Label)||||||
1488461|NCT01134744|||||Cross-Sectional|||||||
1488462|NCT01134731|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488463|NCT01134718|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488464|NCT01134705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488465|NCT01134692||Parallel Assignment||Prevention||Double||||||
1488466|NCT01134679|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1488467|NCT01134666|||Cohort||Prospective|||||||
1488468|NCT01134653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488469|NCT01134640|||Cohort||Prospective|||||||
1488470|NCT01134627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488471|NCT01134614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488472|NCT01134601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488473|NCT01134588|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488474|NCT01134575||Single Group Assignment||Treatment||None (Open Label)||||||
1488475|NCT01134562|Randomized|Sequential Assignment||Treatment||Triple|||t|t|t|
1488476|NCT01134549|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488477|NCT01134536||Single Group Assignment||Treatment||None (Open Label)||||||
1488478|NCT01134523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488479|NCT01134510|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488480|NCT01134497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488481|NCT01134484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488482|NCT01134471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488483|NCT01134458|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488484|NCT01134445||Single Group Assignment||Treatment||None (Open Label)||||||
1488485|NCT01134432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488486|NCT01134419|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488487|NCT01134406|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488488|NCT01134393|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488489|NCT01134380|||Case Control||Prospective|||||||
1488490|NCT01134367|||||Prospective|||||||
1488491|NCT01134354|||||Prospective|||||||
1488492|NCT01134341||Single Group Assignment||Treatment||None (Open Label)||||||
1488493|NCT01134328|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488494|NCT01134315|||Cohort||Prospective|||||||
1488495|NCT01134302|Randomized|Parallel Assignment||Treatment||Single||||||t
1488496|NCT01134289|Non-Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1488497|NCT01134276|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488498|NCT01134263|Randomized|Parallel Assignment||Prevention||Single||||||t
1488499|NCT01134250||Single Group Assignment||Treatment||None (Open Label)||||||
1488500|NCT01134237|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488501|NCT01134224|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488502|NCT01134211|Randomized|Crossover Assignment||Treatment||Single|||t|||
1488503|NCT01134198|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488504|NCT01134185|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488505|NCT01134172|||Case-Control||Prospective|||||||
1488506|NCT01134159|||Case-Only||Retrospective|||||||
1488507|NCT01134146||Single Group Assignment||Treatment||None (Open Label)||||||
1488508|NCT01134133|Randomized|Parallel Assignment||Prevention||Single||||||t
1488509|NCT01134120||Single Group Assignment||Treatment||None (Open Label)||||||
1488510|NCT01134107|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1488511|NCT01134094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488512|NCT01134081|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488513|NCT01134068|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1488514|NCT01134055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488515|NCT01134042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488516|NCT01134029|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488517|NCT01134016||Single Group Assignment||Treatment||None (Open Label)||||||
1488518|NCT01134003|||Cohort||Cross-Sectional|||||||
1488519|NCT01133990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488520|NCT01133977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488521|NCT01133964|Randomized|Crossover Assignment||Prevention||Single|||||t|
1488522|NCT01133951|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1488523|NCT01133938|||Cohort||Retrospective|||||||
1488524|NCT01133925|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488525|NCT01133912||Single Group Assignment||Treatment||None (Open Label)||||||
1488526|NCT01133899|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1488527|NCT01133886||Single Group Assignment||Treatment||None (Open Label)||||||
1488528|NCT01133873|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1488529|NCT01133860||Single Group Assignment||Treatment||None (Open Label)||||||
1488530|NCT01133847|Randomized|Parallel Assignment||Treatment||Single||||||t
1488531|NCT01133834|||||Prospective|||||||
1488532|NCT01133821|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488533|NCT01133808|||Cohort||Prospective|||||||
1488534|NCT01133795||Single Group Assignment||Treatment||None (Open Label)||||||
1488535|NCT01133782|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1488536|NCT01133769|||Case-Crossover||Prospective|||||||
1488537|NCT01133756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488538|NCT01133743||Single Group Assignment||Treatment||None (Open Label)||||||
1488539|NCT01133730|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488540|NCT01133717|||Cohort||Prospective|||||||
1488541|NCT01133704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488542|NCT01133691|||Case-Only||Prospective|||||||
1488543|NCT01133678|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488544|NCT01133665||Single Group Assignment||Treatment||None (Open Label)||||||
1488545|NCT01133652|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1488546|NCT01133639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488547|NCT01133626|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488548|NCT01133613|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1488549|NCT01133600|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488550|NCT01133587|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488551|NCT01133574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488552|NCT01133561|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488553|NCT01133548|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488554|NCT01133535|||Cohort||Prospective|||||||
1488555|NCT01133522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488556|NCT01133509||Single Group Assignment||Treatment||None (Open Label)||||||
1488557|NCT01133496|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488558|NCT01133483|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488559|NCT01133470|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488560|NCT01133457|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488561|NCT01133444|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488562|NCT01133431|Randomized|Crossover Assignment||||Single|||t|||
1488563|NCT01133418|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1488564|NCT01133405|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1488565|NCT01133392|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488566|NCT01133379|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1488567|NCT01133366|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488568|NCT01133353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488569|NCT01133340|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488570|NCT01133327||Single Group Assignment||Treatment||None (Open Label)||||||
1488571|NCT01133314|||Case-Only||Prospective|||||||
1488572|NCT01133301|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1488573|NCT01133288||Single Group Assignment||||None (Open Label)||||||
1488574|NCT01133275||Single Group Assignment||Treatment||None (Open Label)||||||
1488575|NCT01133262|||||Prospective|||||||
1488576|NCT01133249|||Cohort||Prospective|||||||
1488577|NCT01133236|Randomized|Parallel Assignment||Treatment||Single||||||t
1488578|NCT01133223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488579|NCT01133210|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488580|NCT01133197|||Case Control||Prospective|||||||
1488581|NCT01133184|Randomized|Factorial Assignment||Prevention||Single|||||t|
1488582|NCT01133171|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1488583|NCT01133158||Single Group Assignment||Treatment||None (Open Label)||||||
1488584|NCT01133145||Single Group Assignment||Treatment||None (Open Label)||||||
1488585|NCT01133132|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1488586|NCT01133119|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1488587|NCT01133106|Randomized|Parallel Assignment||Treatment||Single||||||t
1488588|NCT01133093|||||Cross-Sectional|||||||
1488589|NCT01133080|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488590|NCT01133067|||Cohort||Prospective|||||||
1488591|NCT01133054|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488592|NCT01133041|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1488593|NCT01133028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488594|NCT01133015||Single Group Assignment||Diagnostic||None (Open Label)||||||
1488595|NCT01133002|||Cohort||Prospective|||||||
1488596|NCT01132989||Single Group Assignment||Treatment||None (Open Label)||||||
1488597|NCT01132976|Randomized|Parallel Assignment||Treatment||Single|||||t|
1488598|NCT01132963|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1488599|NCT01132950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488600|NCT01132937|||||Prospective|||||||
1488601|NCT01132924|||Cohort||Retrospective|||||||
1488602|NCT01132911|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488603|NCT01132898|||Cohort||Prospective|||||||
1488604|NCT01132885|||||Prospective|||||||
1488605|NCT01132872|||||Prospective|||||||
1488606|NCT01132859|||Other||Prospective|||||||
1488607|NCT01132846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488608|NCT01132833|||||Prospective|||||||
1488609|NCT01132820||Single Group Assignment||Treatment||None (Open Label)||||||
1488610|NCT01132807||Single Group Assignment||Treatment||None (Open Label)||||||
1488611|NCT01132794||||||||||||
1488612|NCT01132781|Randomized|Crossover Assignment||Treatment||Single|||t|||
1488613|NCT01132768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488614|NCT01132755||Single Group Assignment||Diagnostic||None (Open Label)||||||
1488615|NCT01132742|||Cohort||Prospective|||||||
1488616|NCT01132729|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488617|NCT01132716|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488618|NCT01132703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488619|NCT01132690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488620|NCT01132677|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1488621|NCT01132664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488622|NCT01132651|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1488623|NCT01132638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488624|NCT01132625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488625|NCT01132612|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488626|NCT01132599||||Diagnostic||None (Open Label)||||||
1488627|NCT01132586||Single Group Assignment||Treatment||None (Open Label)||||||
1488628|NCT01132573||Single Group Assignment||Treatment||None (Open Label)||||||
1488629|NCT01132560|||Other||Retrospective|||||||
1488630|NCT01132547|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1488631|NCT01132534|||Case-Crossover||Prospective|||||||
1488632|NCT01132521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488633|NCT01132508|||Case-Only||Prospective|||||||
1488634|NCT01132495|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1488635|NCT01132482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488636|NCT01132469||Single Group Assignment||Treatment||None (Open Label)||||||
1488637|NCT01132456|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488638|NCT01132443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488639|NCT01132430|Randomized|Parallel Assignment||Treatment||Single||||||t
1488640|NCT01132417|||Case Control||Cross-Sectional|||||||
1488641|NCT01132404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488642|NCT01132391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488643|NCT01132378|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488644|NCT01132365|||Cohort||Prospective|||||||
1488645|NCT01132352|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488646|NCT01132339|||Cohort||Prospective|||||||
1488647|NCT01132326||Single Group Assignment||Treatment||None (Open Label)||||||
1488648|NCT01132313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488649|NCT01132300||Single Group Assignment||Treatment||None (Open Label)||||||
1488650|NCT01132287|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1488651|NCT01132274|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488652|NCT01132261|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1488653|NCT01132248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488654|NCT01132235||Single Group Assignment||Treatment||None (Open Label)||||||
1488655|NCT01132222|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488656|NCT01132209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488657|NCT01132196|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488658|NCT01132183|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488659|NCT01132170|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488660|NCT01132157|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1488661|NCT01132144|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488662|NCT01132131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488663|NCT01132118|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1488664|NCT01132105|||||Prospective|||||||
1488665|NCT01132092|||Cohort||Prospective|||||||
1488666|NCT01132079|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1488667|NCT01132066|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1488668|NCT01132053|||Case-Control||Prospective|||||||
1488669|NCT01132040|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488670|NCT01132027|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488671|NCT01132014||||Treatment||||||||
1488672|NCT01132001|||Case-Only||Cross-Sectional|||||||
1488673|NCT01131988|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488674|NCT01131975|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488675|NCT01131962|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488676|NCT01131949|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488677|NCT01131936|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488678|NCT01131923|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488679|NCT01131910||Single Group Assignment||Prevention||None (Open Label)||||||
1488680|NCT01131897|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488681|NCT01131884|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1488682|NCT01131871|Randomized|Parallel Assignment||Treatment||Single||||||t
1488683|NCT01131858|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1488684|NCT01131845|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488685|NCT01131832|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1488686|NCT01131819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488687|NCT01131806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488688|NCT01131793||Single Group Assignment||Treatment||None (Open Label)||||||
1488689|NCT01131780|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488690|NCT01131767|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488691|NCT01131754|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489467|NCT01121549|||||Prospective|||||||
1488692|NCT01131741|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1488693|NCT01131728|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488694|NCT01131715||||||||||||
1488695|NCT01131702|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488696|NCT01131689|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488697|NCT01131676|Randomized|Parallel Assignment||Treatment||Double||||||
1488698|NCT01131663|||Case-Only||Prospective|||||||
1488699|NCT01131650|||Ecologic or Community||Cross-Sectional|||||||
1488700|NCT01131637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488701|NCT01131624|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488702|NCT01131611|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1488703|NCT01131598|||||Prospective|||||||
1488704|NCT01131585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488705|NCT01131572||Single Group Assignment||Treatment||None (Open Label)||||||
1488706|NCT01131559|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488707|NCT01131546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488708|NCT01131533|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1488709|NCT01131520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488710|NCT01131507||Single Group Assignment||Treatment||None (Open Label)||||||
1488711|NCT01131494||Single Group Assignment||Treatment||Single||||||t
1488712|NCT01131481|Randomized|Parallel Assignment||||Single|||t|||
1488713|NCT01131468|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488714|NCT01131455|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488715|NCT01131442|||Case Control||Cross-Sectional|||||||
1488716|NCT01131429|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488717|NCT01131416|Randomized|Parallel Assignment||Treatment||Single||||||t
1488718|NCT01131403|||Case Control||Prospective|||||||
1488719|NCT01131390||Single Group Assignment||Supportive Care||None (Open Label)||||||
1488720|NCT01131377|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488721|NCT01131364||Single Group Assignment||Treatment||None (Open Label)||||||
1488722|NCT01131351||Single Group Assignment||Treatment||None (Open Label)||||||
1488723|NCT01131325||Single Group Assignment||Treatment||None (Open Label)||||||
1488724|NCT01131312|Randomized|Parallel Assignment||Screening||Single|Computer random assignment to HPV testing (HC2), cytology (ThinPrep), or immediate colposcopy.||t|||
1488725|NCT01131299|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488726|NCT01131273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488727|NCT01131260|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488728|NCT01131247|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488729|NCT01131234||Single Group Assignment||Treatment||None (Open Label)||||||
1488730|NCT01131221|||||Retrospective|||||||
1488731|NCT01131208|||Other||Retrospective|||||||
1488732|NCT01131195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488733|NCT01131182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488734|NCT01131169|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488735|NCT01131156|Randomized|Single Group Assignment||Prevention||Single||||||t
1488736|NCT01131143|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1488737|NCT01131130|Randomized|Crossover Assignment||||Single|||t|||
1488738|NCT01131117|||Cohort||Prospective|||||||
1488739|NCT01131104|||Case-Crossover||Prospective|||||||
1488740|NCT01131091|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1488741|NCT01131078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488742|NCT01131065||Single Group Assignment||Prevention||None (Open Label)||||||
1488743|NCT01131052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488744|NCT01131039||Single Group Assignment||Treatment||None (Open Label)||||||
1488745|NCT01131026||Single Group Assignment||Treatment||None (Open Label)||||||
1488746|NCT01131013|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1488747|NCT01131000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488748|NCT01130987||Single Group Assignment||Health Services Research||None (Open Label)||||||
1488749|NCT01130974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488750|NCT01130961|||Cohort||Retrospective|||||||
1488751|NCT01130948|Randomized|Crossover Assignment||||Single||||||t
1488752|NCT01130935|||Cohort||Prospective|||||||
1488753|NCT01130922|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1488754|NCT01130909|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1488755|NCT01130896|||Cohort||Prospective|||||||
1488756|NCT01130883|||||Prospective|||||||
1488757|NCT01130870|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488758|NCT01130857|||Case-Only|||||||||
1488759|NCT01130844|Randomized|Parallel Assignment||||None (Open Label)||||||
1488760|NCT01130831|||Case-Only||Prospective|||||||
1488761|NCT01130818|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1488762|NCT01130805||Single Group Assignment||Treatment||None (Open Label)||||||
1488763|NCT01130792|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1488764|NCT01130779||Single Group Assignment||Treatment||None (Open Label)||||||
1488765|NCT01130766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488766|NCT01130753|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488767|NCT01130740|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1488768|NCT01130727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488769|NCT01130714|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1488770|NCT01130701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488771|NCT01130688||Single Group Assignment||Treatment||None (Open Label)||||||
1488772|NCT01130675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488773|NCT01130662||Single Group Assignment||Treatment||None (Open Label)||||||
1488774|NCT01130649|||Other||Other|||||||
1488775|NCT01130636||Single Group Assignment||Basic Science||None (Open Label)||||||
1488776|NCT01130623|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488777|NCT01130610|||Cohort||Prospective|||||||
1488778|NCT01130597||Single Group Assignment||Prevention||None (Open Label)||||||
1488779|NCT01130584|||Cohort||Prospective|||||||
1488780|NCT01130571|||Cohort||Prospective|||||||
1488781|NCT01130558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488782|NCT01130545|||||Prospective|||||||
1488783|NCT01130532|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488784|NCT01130519|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488785|NCT01130506||Single Group Assignment||Treatment||None (Open Label)||||||
1488786|NCT01130493|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1488787|NCT01130480||Single Group Assignment||Diagnostic||None (Open Label)||||||
1488788|NCT01130467|||Case Control||Prospective|||||||
1488789|NCT01130454|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488790|NCT01130441|||Cohort||Cross-Sectional|||||||
1488791|NCT01130428|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1488792|NCT01130415|||Cohort||Retrospective|||||||
1488793|NCT01130402|||||Retrospective|||||||
1488794|NCT01130389|||Case Control||Retrospective|||||||
1488795|NCT01130376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488796|NCT01130363|||Case Control||Prospective|||||||
1488797|NCT01130337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488798|NCT01130324|||Cohort||Prospective|||||||
1488799|NCT01130311|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1488800|NCT01130298||Single Group Assignment||Treatment||None (Open Label)||||||
1488801|NCT01130285|||Cohort||Prospective|||||||
1488802|NCT01130272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488803|NCT01130259||||||||||||
1488804|NCT01130246|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488805|NCT01130233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488806|NCT01130220|||||Prospective|||||||
1488807|NCT01130207|||Case-Only||Prospective|||||||
1488808|NCT01130194||Single Group Assignment||Treatment||None (Open Label)||||||
1488809|NCT01130181|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488810|NCT01130168|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488811|NCT01130155|||Ecologic or Community||Cross-Sectional|||||||
1488812|NCT01130142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488813|NCT01130129||Single Group Assignment||Basic Science||None (Open Label)||||||
1488814|NCT01130103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488815|NCT01130090||Single Group Assignment||Supportive Care||Single||||||t
1488816|NCT01130077||Single Group Assignment||Treatment||None (Open Label)||||||
1488817|NCT01130064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488818|NCT01130051|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1488819|NCT01130038||||||||||||
1488820|NCT01130025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488821|NCT01130012|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488822|NCT01129999|Randomized|Parallel Assignment||Treatment||Single||||||t
1488823|NCT01129986||Single Group Assignment||Treatment||None (Open Label)||||||
1488824|NCT01129973|||||Prospective|||||||
1488825|NCT01129960|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488826|NCT01129947|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488827|NCT01129934|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1488828|NCT01129921|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1488829|NCT01129908|||Cohort||Prospective|||||||
1488830|NCT01129895|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488831|NCT01129882||Single Group Assignment||Treatment||None (Open Label)||||||
1488832|NCT01129869|||||Prospective|||||||
1488833|NCT01129856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488834|NCT01129843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488835|NCT01129830|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488836|NCT01129817|Randomized|Parallel Assignment||Treatment||Single||||||t
1488837|NCT01129804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488838|NCT01129791|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1488839|NCT01129778||Single Group Assignment||Treatment||None (Open Label)||||||
1488840|NCT01129765|||Case Control||Prospective|||||||
1488841|NCT01129752|||Case Control||Prospective|||||||
1488842|NCT01129739|Randomized|Parallel Assignment||Treatment||Single||||||t
1488843|NCT01129726|Randomized|Parallel Assignment||||Triple|||t||t|t
1488844|NCT01129713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488845|NCT01129700||Single Group Assignment||Treatment||None (Open Label)||||||
1488846|NCT01129687|||Cohort||Prospective|||||||
1488847|NCT01129674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488848|NCT01129661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488849|NCT01129648|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1488850|NCT01129635||Single Group Assignment||Treatment||None (Open Label)||||||
1488851|NCT01129622||Single Group Assignment||Diagnostic||None (Open Label)||||||
1488852|NCT01129609|||Cohort||Other|||||||
1488853|NCT01129596|||Cohort||Prospective|||||||
1488854|NCT01129583|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1488855|NCT01129570|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488856|NCT01129557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488857|NCT01129544||Single Group Assignment||Treatment||None (Open Label)||||||
1488858|NCT01129531|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488859|NCT01129518|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488860|NCT01129505||Single Group Assignment||Prevention||None (Open Label)||||||
1488861|NCT01129492|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1488862|NCT01129479|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1488863|NCT01129466|Randomized|Crossover Assignment||||None (Open Label)||||||
1488864|NCT01129453|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1488865|NCT01129440|Randomized|Parallel Assignment||Prevention||Single|||||t|
1488866|NCT01129427|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1488867|NCT01129414|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1488868|NCT01129401||Single Group Assignment||Treatment||None (Open Label)||||||
1488869|NCT01129388|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1488870|NCT01129375|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1488871|NCT01129362|||Cohort||Cross-Sectional|||||||
1488872|NCT01129349||Single Group Assignment||Treatment||None (Open Label)||||||
1488873|NCT01129336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488874|NCT01129323||Single Group Assignment||Treatment||None (Open Label)||||||
1488875|NCT01129310|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488876|NCT01129297|||Cohort||Prospective|||||||
1488877|NCT01129284||Single Group Assignment||Treatment||None (Open Label)||||||
1488878|NCT01129271|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1488879|NCT01129258|Randomized|Parallel Assignment||||Double|||t||t|
1488880|NCT01129245|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1488881|NCT01129232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488882|NCT01129219|Randomized|Single Group Assignment||Treatment||Single||||||t
1488883|NCT01129206||Single Group Assignment||Treatment||None (Open Label)||||||
1488884|NCT01129193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488885|NCT01129180||Single Group Assignment||Treatment||None (Open Label)||||||
1488886|NCT01129167|||Cohort||Retrospective|||||||
1488887|NCT01129154||Single Group Assignment||Treatment||None (Open Label)||||||
1488888|NCT01129141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488889|NCT01129128|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1488890|NCT01129115|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488891|NCT01129102|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1488892|NCT01129089|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1488893|NCT01129076|||||Prospective|||||||
1488894|NCT01129063||Crossover Assignment||Basic Science||None (Open Label)||||||
1488895|NCT01129050|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1488896|NCT01129037|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1488897|NCT01129024||Single Group Assignment||Treatment||None (Open Label)||||||
1488898|NCT01129011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488899|NCT01128998||Single Group Assignment||Treatment||None (Open Label)||||||
1488900|NCT01128985|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488901|NCT01128972|Randomized|Crossover Assignment||Treatment||Single|||||t|
1488902|NCT01128959||Single Group Assignment||Treatment||None (Open Label)||||||
1488903|NCT01128946|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1488904|NCT01128933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488905|NCT01128920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488906|NCT01128907|||Case Control||Prospective|||||||
1488907|NCT01128894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488908|NCT01128881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488909|NCT01128868|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488910|NCT01128855|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488911|NCT01128842||Single Group Assignment||Treatment||None (Open Label)||||||
1488912|NCT01128829|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1488913|NCT01128816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488914|NCT01128803||Single Group Assignment||Treatment||None (Open Label)||||||
1488915|NCT01128790|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1488916|NCT01128777|Randomized|Parallel Assignment||Treatment||Single||||||t
1488917|NCT01128764|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488918|NCT01128751|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1488919|NCT01128738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488920|NCT01128725||Single Group Assignment||Basic Science||None (Open Label)||||||
1488921|NCT01128712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488922|NCT01128699|Randomized|Parallel Assignment||Treatment||Single||||||t
1488923|NCT01128686|||Cohort||Retrospective|||||||
1488924|NCT01128673|||Case-Only||Prospective|||||||
1488925|NCT01128660|||Cohort||Retrospective|||||||
1488926|NCT01128647||||||||||||
1488927|NCT01128634|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1488928|NCT01128621|Randomized|Single Group Assignment||Treatment||Single|||||t|
1488929|NCT01128608|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1488930|NCT01128595|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488931|NCT01128582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488932|NCT01128569|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1488933|NCT01128556|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1488934|NCT01128543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1488935|NCT01128530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488936|NCT01128517|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1488937|NCT01128478|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1488938|NCT01128465|||Case-Only||Prospective|||||||
1488939|NCT01128452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488940|NCT01128439|||Case-Only||Prospective|||||||
1488941|NCT01128426|||Case-Only||Prospective|||||||
1488942|NCT01128413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488943|NCT01128400|||Case-Control||Cross-Sectional|||||||
1488944|NCT01128387|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||Dose escalation study||||
1488945|NCT01128374|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488946|NCT01128361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488947|NCT01128348|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1488948|NCT01128335|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1488949|NCT01128322|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1488950|NCT01128309|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488951|NCT01128296||Single Group Assignment||Treatment||None (Open Label)||||||
1488952|NCT01128283|||Case Control||Prospective|||||||
1488953|NCT01128270|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1488954|NCT01128257|||Cohort||Prospective|||||||
1488955|NCT01128244||Single Group Assignment||Treatment||None (Open Label)||||||
1488956|NCT01128218||Single Group Assignment||Treatment||None (Open Label)||||||
1488957|NCT01128205|||Cohort||Cross-Sectional|||||||
1488958|NCT01128192|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1488959|NCT01128179|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488960|NCT01128166|||Case-Only||Prospective|||||||
1488961|NCT01128153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1488962|NCT01128140|Randomized|Parallel Assignment||Treatment||Single||||||t
1488963|NCT01128127|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1488964|NCT01128114||Single Group Assignment||Treatment||None (Open Label)||||||
1488965|NCT01128101|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488966|NCT01128088|||Cohort||Prospective|||||||
1488967|NCT01128075|||Cohort||Prospective|||||||
1488968|NCT01128062|||Case-Only||Prospective|||||||
1488969|NCT01128049|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1488970|NCT01128036|||Case Control||Prospective|||||||
1488971|NCT01128023|||Cohort||Prospective|||||||
1488972|NCT01128010|||Case Control||Prospective|||||||
1488973|NCT01127997|||Case Control||Cross-Sectional|||||||
1488974|NCT01127984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488975|NCT01127971|||||Prospective|||||||
1488976|NCT01127958|Randomized|Parallel Assignment||Treatment||Single|||t|||
1488977|NCT01127945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488978|NCT01127932|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1488979|NCT01127919|||Cohort||Prospective|||||||
1488980|NCT01127906|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1488981|NCT01127893|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488982|NCT01127880|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1488983|NCT01127867||Single Group Assignment||Basic Science||None (Open Label)||||||
1488984|NCT01127854|||Case-Control||Cross-Sectional|||||||
1488985|NCT01127841||Single Group Assignment||Treatment||None (Open Label)||||||
1488986|NCT01127828|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1488987|NCT01127815|||Case Control|||||||||
1488988|NCT01127802|||Cohort||Prospective|||||||
1488989|NCT01127789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1488990|NCT01127776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488991|NCT01127763||Single Group Assignment||Treatment||None (Open Label)||||||
1488992|NCT01127750||Single Group Assignment||Treatment||None (Open Label)||||||
1488993|NCT01127737|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1488994|NCT01127724|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1488995|NCT01127711|||Cohort||Prospective|||||||
1488996|NCT01127698|||Cohort||Prospective|||||||
1488997|NCT01127685|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1488998|NCT01127672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1488999|NCT01127659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489000|NCT01127646|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489001|NCT01127633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489002|NCT01127620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489003|NCT01127607|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489004|NCT01127594||Single Group Assignment||Treatment||None (Open Label)||||||
1489005|NCT01127581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489006|NCT01127568|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1489007|NCT01127555||Single Group Assignment||Treatment||None (Open Label)||||||
1489008|NCT01127542||Single Group Assignment||Treatment||None (Open Label)||||||
1489009|NCT01127529|||Cohort||Prospective|||||||
1489010|NCT01127516|||Ecologic or Community||Cross-Sectional|||||||
1489011|NCT01127503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489012|NCT01127490|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489013|NCT01127477||Single Group Assignment||Treatment||None (Open Label)||||||
1489014|NCT01127464|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1489015|NCT01127451||Single Group Assignment||Treatment||None (Open Label)||||||
1489016|NCT01127438|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489017|NCT01127425|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489018|NCT01127412|Randomized|Parallel Assignment||Prevention||Single||||||t
1489019|NCT01127399|||Cohort||Cross-Sectional|||||||
1489020|NCT01127386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489021|NCT01127373||Single Group Assignment||Treatment||None (Open Label)||||||
1489022|NCT01127360|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489023|NCT01127347||||||||||||
1489024|NCT01127334|||||Prospective|||||||
1489025|NCT01127321|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489026|NCT01127308||Single Group Assignment||Basic Science||None (Open Label)||||||
1489027|NCT01127295||Single Group Assignment||Treatment||None (Open Label)||||||
1489028|NCT01127282|Randomized|Parallel Assignment||Treatment||Single|||||t|
1489029|NCT01127269||Single Group Assignment||Treatment||None (Open Label)||||||
1489030|NCT01127256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489031|NCT01127243|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489032|NCT01127230||||||||||||
1489033|NCT01127217|Randomized|Parallel Assignment||Treatment||Double||||||
1489034|NCT01127204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489035|NCT01127191|||Cohort||Prospective|||||||
1489036|NCT01127178||Single Group Assignment||Treatment||None (Open Label)||||||
1489037|NCT01127165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489038|NCT01127152|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1489039|NCT01127139|||||Prospective|||||||
1489040|NCT01127126|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489041|NCT01127113|Randomized|Parallel Assignment||Basic Science||Single||||||t
1489042|NCT01127100|Randomized|Parallel Assignment||Treatment||Single||||||t
1489043|NCT01127087|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489044|NCT01127074|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489045|NCT01127061|Randomized|Parallel Assignment||Supportive Care||Triple|Investigator who randomized participants was blinded to participant PHI. Investigators who interpreted all data and assessed outcomes were masked to randomization status.|||t|t|t
1489046|NCT01127048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489047|NCT01127035|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489048|NCT01127022|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1489049|NCT01127009||Single Group Assignment||Treatment||None (Open Label)||||||
1489050|NCT01126996|||Cohort||Prospective|||||||
1489051|NCT01126983|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1489052|NCT01126970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489053|NCT01126957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489054|NCT01126944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489055|NCT01126931|||||Prospective|||||||
1489056|NCT01126918|Randomized|Parallel Assignment||Prevention||Single||||||t
1489057|NCT01126905|||Cohort||Prospective|||||||
1489058|NCT01126892||Single Group Assignment||Treatment||None (Open Label)||||||
1489059|NCT01126879|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489060|NCT01126866||Single Group Assignment||Treatment||None (Open Label)||||||
1489061|NCT01126853|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1489062|NCT01126840|||Case-Only||Prospective|||||||
1489063|NCT01126827|Randomized|Parallel Assignment||Treatment||Single||||||t
1489064|NCT01126814||Single Group Assignment||Treatment||None (Open Label)||||||
1489065|NCT01126801|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1489066|NCT01126788|||Cohort||Prospective|||||||
1489067|NCT01126775|||Cohort||Prospective|||||||
1489068|NCT01126762|Randomized|Parallel Assignment||Prevention||Single|||t|||
1489069|NCT01126749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489070|NCT01126736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489071|NCT01126723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489072|NCT01126710|||Case-Only||Retrospective|||||||
1489073|NCT01126697|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1489074|NCT01126684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489075|NCT01126671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489076|NCT01126658|||Case-Only||Prospective|||||||
1489077|NCT01126645|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489078|NCT01126632|||||Prospective|||||||
1489079|NCT01126619|||||Prospective|||||||
1489080|NCT01126606|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489081|NCT01126593|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1489082|NCT01126580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489083|NCT01126567|||Cohort||Prospective|||||||
1489084|NCT01126554|||Cohort||Prospective|||||||
1489085|NCT01126541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489086|NCT01126528|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1489087|NCT01126515|||Cohort||Prospective|||||||
1489088|NCT01126502||Single Group Assignment||Treatment||None (Open Label)||||||
1489089|NCT01126476|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1489090|NCT01126463||Single Group Assignment||Treatment||None (Open Label)||||||
1489091|NCT01126450||Single Group Assignment||Treatment||None (Open Label)||||||
1489092|NCT01126437|Randomized|Parallel Assignment||Treatment||Double||||||
1489093|NCT01126424|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1489094|NCT01126411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489095|NCT01126398|||Case-Only||Prospective|||||||
1489096|NCT01126385|||Case-Only||Prospective|||||||
1489097|NCT01126372|||Cohort||Prospective|||||||
1489098|NCT01126359|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1489099|NCT01126346||Single Group Assignment||Supportive Care||None (Open Label)||||||
1489100|NCT01126333|||Cohort||Prospective|||||||
1489101|NCT01126320|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489102|NCT01126307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489103|NCT01126294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489104|NCT01126281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489105|NCT01126268||Single Group Assignment||Treatment||None (Open Label)||||||
1489106|NCT01126255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489107|NCT01126242|Randomized|Parallel Assignment||Treatment||Single||||||t
1489108|NCT01126229|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1489109|NCT01126216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489110|NCT01126203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489111|NCT01126190|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1489112|NCT01126177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489113|NCT01126164|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1489114|NCT01126151|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1489115|NCT01126138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489116|NCT01126125|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1489117|NCT01126112||Single Group Assignment||Treatment||None (Open Label)||||||
1489118|NCT01126099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489119|NCT01126086|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489120|NCT01126073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489121|NCT01126060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489122|NCT01126047||Single Group Assignment||Diagnostic||None (Open Label)||||||
1489123|NCT01126034|Randomized|Parallel Assignment||||None (Open Label)||||||
1489124|NCT01126021|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489125|NCT01126008||Single Group Assignment||Treatment||None (Open Label)||||||
1489126|NCT01125995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489127|NCT01125982|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1489128|NCT01125969|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1489129|NCT01125956|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489130|NCT01125943|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1489131|NCT01125930|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489132|NCT01125917||Single Group Assignment||Treatment||None (Open Label)||||||
1489133|NCT01125904|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1489134|NCT01125891||Single Group Assignment||Treatment||None (Open Label)||||||
1489135|NCT01125878|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1489136|NCT01125865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489137|NCT01125852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489138|NCT01125839|||Cohort||Prospective|||||||
1489139|NCT01125826|||Case-Only||Prospective|||||||
1489140|NCT01125813||Single Group Assignment||Prevention||None (Open Label)||||||
1489141|NCT01125800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489142|NCT01125787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489143|NCT01125774|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489144|NCT01125761|Randomized|Parallel Assignment||Treatment||Single|||||t|
1489145|NCT01125748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489146|NCT01125735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489147|NCT01125722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489148|NCT01125709|||Case-Crossover||Prospective|||||||
1489149|NCT01125696|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489150|NCT01125683|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1489151|NCT01125670|Randomized|Crossover Assignment||||None (Open Label)||||||
1489152|NCT01125657|Randomized|Crossover Assignment||||None (Open Label)||||||
1489153|NCT01125644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489154|NCT01125631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489155|NCT01125618|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1489156|NCT01125605|||Cohort||Prospective|||||||
1489157|NCT01125592||Single Group Assignment||||None (Open Label)||||||
1489158|NCT01125579|||Cohort||Prospective|||||||
1489159|NCT01125566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489160|NCT01125553|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1489161|NCT01125540|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1489162|NCT01125527|Randomized|Parallel Assignment||Prevention||Single||||||t
1489163|NCT01125514|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1489164|NCT01125501|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1489165|NCT01125488|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489166|NCT01125475|||Cohort||Prospective|||||||
1489167|NCT01125462|||Case-Only||Prospective|||||||
1489168|NCT01125449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489169|NCT01125436|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489170|NCT01125423|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489171|NCT01125410|Randomized|Parallel Assignment||Treatment||Single|||||t|
1489172|NCT01125397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489173|NCT01125384|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1489174|NCT01125371|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1489175|NCT01125358|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489176|NCT01125345|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1489177|NCT01125332|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489178|NCT01125319|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1489179|NCT01125306||Single Group Assignment||Supportive Care||None (Open Label)||||||
1489180|NCT01125293||Single Group Assignment||Treatment||None (Open Label)||||||
1489181|NCT01125280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489182|NCT01125267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489183|NCT01125254|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1489184|NCT01125241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489185|NCT01125228|||Cohort||Prospective|||||||
1489186|NCT01125215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489187|NCT01125202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489188|NCT01125189|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489189|NCT01125176||Single Group Assignment||Treatment||None (Open Label)||||||
1489190|NCT01125163|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1489191|NCT01125150|||Case Control||Prospective|||||||
1489192|NCT01125137||Single Group Assignment||Basic Science||None (Open Label)||||||
1489193|NCT01125124|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489194|NCT01125111|||Case Control||Retrospective|||||||
1489195|NCT01125098||||||||||||
1489196|NCT01125085|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489197|NCT01125072|||Cohort||Retrospective|||||||
1489198|NCT01125059|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1489199|NCT01125046||Single Group Assignment||Treatment||None (Open Label)||||||
1489200|NCT01125033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489201|NCT01125020|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1489202|NCT01125007|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1489203|NCT01124994||Single Group Assignment||Treatment||None (Open Label)||||||
1489204|NCT01124981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489205|NCT01124968|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1489206|NCT01124955|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489207|NCT01124942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489208|NCT01124929|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1489209|NCT01124916|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489210|NCT01124903|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1489211|NCT01124890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489212|NCT01124877|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489213|NCT01124864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489214|NCT01124851|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489215|NCT01124838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489216|NCT01124825|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1489217|NCT01124812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489218|NCT01124799|Randomized|Parallel Assignment||Treatment||Double||||||
1489219|NCT01124786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489220|NCT01124773|||Cohort||Prospective|||||||
1489221|NCT01124760|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489222|NCT01124747|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1489223|NCT01124734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489224|NCT01124721|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489225|NCT01124708|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489226|NCT01124695||||Treatment||None (Open Label)||||||
1489227|NCT01124682||||Treatment||None (Open Label)||||||
1489228|NCT01124669|||Other||Retrospective|||||||
1489229|NCT01124656||Single Group Assignment||Treatment||None (Open Label)||||||
1489230|NCT01124643||Single Group Assignment||Treatment||None (Open Label)||||||
1489231|NCT01124630||Single Group Assignment||Treatment||None (Open Label)||||||
1489232|NCT01124617|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489233|NCT01124604|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489234|NCT01124591|Randomized|Factorial Assignment||Treatment||Single||||||t
1489235|NCT01124578|||Case Control||Cross-Sectional|||||||
1489236|NCT01124565||Single Group Assignment||Treatment||None (Open Label)||||||
1489237|NCT01124552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489238|NCT01124539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489239|NCT01124526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489240|NCT01124513|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1489241|NCT01124500|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1489242|NCT01124487|Randomized|Crossover Assignment||Prevention||Single|||t|||
1489243|NCT01124474|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489244|NCT01124461|||Cohort||Prospective|||||||
1489245|NCT01124448|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1489246|NCT01124435||Single Group Assignment||Treatment||None (Open Label)||||||
1489247|NCT01124422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489248|NCT01124409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489249|NCT01124396|||Cohort||Prospective|||||||
1489250|NCT01124383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489251|NCT01124370||Single Group Assignment||Treatment||None (Open Label)||||||
1489252|NCT01124357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489253|NCT01124344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489254|NCT01124331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489255|NCT01124318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489256|NCT01124305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489257|NCT01124292|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1489258|NCT01124279|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1489259|NCT01124266|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1489260|NCT01124253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489261|NCT01124240|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489262|NCT01124227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489263|NCT01124214|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1489264|NCT01124201|Randomized|Parallel Assignment||Treatment||Single|||||t|
1489265|NCT01124188|Randomized|Parallel Assignment||Treatment||Single||||||t
1489266|NCT01124175|Randomized|Crossover Assignment||||None (Open Label)||||||
1489267|NCT01124162|Randomized|Crossover Assignment||||None (Open Label)||||||
1489268|NCT01124149||Single Group Assignment||Treatment||None (Open Label)||||||
1489269|NCT01124136|Randomized|Crossover Assignment||Treatment||Double||Heart failure treatment standard of care (SOC) consists of medication management to support heart and manage symptoms. In this study, patients will receive the neurostimulator + SOC or SOC only.|t||t|
1489270|NCT01124123|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1489271|NCT01124110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489272|NCT01124097|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489273|NCT01124084|||Cohort||Prospective|||||||
1489274|NCT01124071|Randomized|Parallel Assignment||||None (Open Label)||||||
1489275|NCT01124058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489276|NCT01124045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489277|NCT01124032|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1489278|NCT01124019|||Cohort||Prospective|||||||
1489279|NCT01124006|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489280|NCT01123993|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489281|NCT01123980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489282|NCT01123967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489283|NCT01123954|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1489284|NCT01123941|Randomized|Parallel Assignment||Prevention||Single|||t|||
1489285|NCT01123928|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489286|NCT01123915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489287|NCT01123902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489288|NCT01123889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489289|NCT01123876||Single Group Assignment||Treatment||None (Open Label)||||||
1489290|NCT01123863|||Cohort||Prospective|||||||
1489291|NCT01123850||Single Group Assignment||Treatment||None (Open Label)||||||
1489292|NCT01123837|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1489293|NCT01123824|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1489294|NCT01123811|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489295|NCT01123798|||Cohort||Prospective|||||||
1489296|NCT01123785|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489297|NCT01123772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489298|NCT01123759|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489299|NCT01123746|||Cohort||Prospective|||||||
1489300|NCT01123733|||Cohort||Prospective|||||||
1489301|NCT01123720|||Ecologic or Community||Retrospective|||||||
1489302|NCT01123707||Single Group Assignment||Treatment||None (Open Label)||||||
1489303|NCT01123694|||Case-Only||Cross-Sectional|||||||
1489304|NCT01123681|||Case Control||Prospective|||||||
1489305|NCT01123668|||Case-Control||Prospective|||||||
1489306|NCT01123655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489307|NCT01123642|||Cohort||Prospective|||||||
1489308|NCT01123616|Randomized|Parallel Assignment||Prevention||Double||||t||t
1489309|NCT01123603|||Case Control||Prospective|||||||
1489310|NCT01123590|||Case Control||Retrospective|||||||
1489311|NCT01123577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489312|NCT01123564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489313|NCT01123551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489314|NCT01123538|Randomized|Parallel Assignment||||None (Open Label)||||||
1489315|NCT01123525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489316|NCT01123512|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489317|NCT01123499|||||Prospective|||||||
1489318|NCT01123486||Single Group Assignment||Treatment||None (Open Label)||||||
1489319|NCT01123473|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489320|NCT01123460|||Other||Retrospective|||||||
1489321|NCT01123447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489322|NCT01123434|||Case-Only||Prospective|||||||
1489323|NCT01123421|||Case Control||Retrospective|||||||
1489324|NCT01123408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489325|NCT01123395|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1489326|NCT01123382|Randomized|Parallel Assignment||Treatment||Single||||||t
1489327|NCT01123369|||Case Control||Prospective|||||||
1489328|NCT01123356||Single Group Assignment||Treatment||None (Open Label)||||||
1489329|NCT01123343|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489330|NCT01123330|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1489331|NCT01123317||Parallel Assignment||Basic Science||Single|||t|||
1489332|NCT01123304||Single Group Assignment||Treatment||None (Open Label)||||||
1489333|NCT01123291|Randomized|Parallel Assignment||Prevention||Single||||||t
1489334|NCT01123278|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1489335|NCT01123265|||Case Control||Prospective|||||||
1489336|NCT01123252|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1489337|NCT01123239|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1489338|NCT01123226|Randomized|Parallel Assignment||Treatment||Single||||||t
1489339|NCT01123213|||Case-Only||Retrospective|||||||
1489340|NCT01123200||Single Group Assignment||Supportive Care||None (Open Label)||||||
1489341|NCT01123187||Single Group Assignment||Treatment||None (Open Label)||Islet transplantation||||
1489342|NCT01123174|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1489343|NCT01123161|Randomized|Factorial Assignment||Treatment||Single||Randomized to normothermia or hypothermia||||t
1489344|NCT01123148||Single Group Assignment||Supportive Care||None (Open Label)||||||
1489345|NCT01123135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489346|NCT01123122|Randomized|Parallel Assignment||Treatment||Single||||||t
1489347|NCT01123109||Single Group Assignment||Other||None (Open Label)||||||
1489348|NCT01123096|||Cohort||Prospective|||||||
1489349|NCT01123083|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489350|NCT01123070|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489351|NCT01123057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489352|NCT01123044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489353|NCT01123031|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489354|NCT01123018|||Ecologic or Community||Other|||||||
1489355|NCT01123005|Non-Randomized|Sequential Assignment||Diagnostic||None (Open Label)||||||
1489356|NCT01122992|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489357|NCT01122979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489358|NCT01122966|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1489359|NCT01122953|Randomized|Crossover Assignment||||None (Open Label)||||||
1489360|NCT01122940|Randomized|Crossover Assignment||||None (Open Label)||||||
1489361|NCT01122927||Single Group Assignment||Treatment||None (Open Label)||||||
1489362|NCT01122914|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489363|NCT01122901|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489364|NCT01122888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489365|NCT01122875|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489366|NCT01122862|Randomized|Crossover Assignment||Prevention||Single||||||t
1489367|NCT01122849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489368|NCT01122836|Randomized|Parallel Assignment||Treatment||Single||||||t
1489369|NCT01122823||Single Group Assignment||Supportive Care||None (Open Label)||||||
1489370|NCT01122810|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1489371|NCT01122797|||Case Control||Cross-Sectional|||||||
1489372|NCT01122784|Randomized|Parallel Assignment||||Single|||t|||
1489373|NCT01122771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489374|NCT01122758|||Cohort||Prospective|||||||
1489375|NCT01122745|||||Prospective|||||||
1489376|NCT01122732|||||Prospective|||||||
1489377|NCT01122719|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489378|NCT01122706|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489379|NCT01122693|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1489380|NCT01122680|Randomized|Crossover Assignment||Treatment||Double||||||
1489381|NCT01122667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489382|NCT01122654|||Cohort||Prospective|||||||
1489383|NCT01122641|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1489384|NCT01122628|||Cohort||Retrospective|||||||
1489385|NCT01122615||Single Group Assignment||Treatment||None (Open Label)||||||
1489386|NCT01122602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489387|NCT01122589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489388|NCT01122576|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489389|NCT01122563|||Case-Only||Prospective|||||||
1489390|NCT01122550|||Case-Only||Prospective|||||||
1489391|NCT01122537|||Cohort||Prospective|||||||
1489392|NCT01122524|||Case Control||Prospective|||||||
1489393|NCT01122511|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489394|NCT01122498|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489395|NCT01122485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489396|NCT01122472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489397|NCT01122459|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1489398|NCT01122446|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1489399|NCT01122433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489400|NCT01122420|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489401|NCT01122407|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1489402|NCT01122394|Randomized|Parallel Assignment||Prevention||Single||||||t
1489403|NCT01122381|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1489404|NCT01122368|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1489405|NCT01122355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489406|NCT01122342||Single Group Assignment||Treatment||None (Open Label)||||||
1489407|NCT01122329|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1489408|NCT01122316||Single Group Assignment||Treatment||None (Open Label)||||||
1489409|NCT01122303|||||Cross-Sectional|||||||
1489410|NCT01122290|||Ecologic or Community||Cross-Sectional|||||||
1489411|NCT01122277|||Cohort||Prospective|||||||
1489412|NCT01122264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489413|NCT01122251|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1489414|NCT01122238|Randomized|Factorial Assignment||Treatment||Single||||||t
1489415|NCT01122225|||Cohort||Prospective|||||||
1489416|NCT01122212|||Case-Only||Prospective|||||||
1489417|NCT01122199||Single Group Assignment||Treatment||None (Open Label)||||||
1489418|NCT01122186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489419|NCT01122173||Single Group Assignment||Treatment||None (Open Label)||||||
1489420|NCT01122160|Randomized|Crossover Assignment||||Triple|||t||t|t
1489421|NCT01122147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489422|NCT01122134|||||Prospective|||||||
1489423|NCT01122121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489424|NCT01122108|Randomized|Crossover Assignment||Treatment||Single|||t|||
1489425|NCT01122095|||Case Control||Cross-Sectional|||||||
1489426|NCT01122082|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1489427|NCT01122069|||Case-Only||Prospective|||||||
1489428|NCT01122056|Randomized|Single Group Assignment||Other||Single|||t|||
1489429|NCT01122043|||Cohort||Prospective|||||||
1489430|NCT01122030|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1489431|NCT01122017|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489432|NCT01122004||||Treatment||||||||
1489433|NCT01121991||Single Group Assignment||Treatment||None (Open Label)||||||
1489434|NCT01121978|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489435|NCT01121965|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489436|NCT01121952|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489437|NCT01121939||Single Group Assignment||Treatment||None (Open Label)||||||
1489438|NCT01121926|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489439|NCT01121913|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489440|NCT01121900|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489441|NCT01121887|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489442|NCT01121874|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489443|NCT01121861|Randomized|Parallel Assignment||Treatment||Single||||||
1489444|NCT01121848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489445|NCT01121835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489446|NCT01121822|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489447|NCT01121809|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489448|NCT01121796|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1489449|NCT01121783|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1489450|NCT01121770|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489451|NCT01121757|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489452|NCT01121744|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489453|NCT01121731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489454|NCT01121718||Single Group Assignment||Diagnostic||None (Open Label)|This study does not involve any masking.|This is an experimental study. All study subjects will receive the same intervention.||||
1489455|NCT01121705|Randomized|Parallel Assignment||Treatment||Single|||||t|
1489456|NCT01121692|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1489457|NCT01121679|||Cohort||Prospective|||||||
1489458|NCT01121666|Randomized|Parallel Assignment||Treatment||Single||||||t
1489459|NCT01121653|Randomized|||Treatment||Double|||t|t||
1489460|NCT01121640|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1489461|NCT01121627||Single Group Assignment||Treatment||None (Open Label)||||||
1489462|NCT01121614|Randomized|Single Group Assignment||Basic Science||Single||||||t
1489463|NCT01121601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489464|NCT01121588|Non-Randomized|||Treatment||None (Open Label)||||||
1489465|NCT01121575|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489466|NCT01121562||Single Group Assignment||Treatment||None (Open Label)||||||
1489468|NCT01121536||Single Group Assignment||Treatment||None (Open Label)||||||
1489469|NCT01121523|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489470|NCT01121510|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1489471|NCT01121497|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1489472|NCT01121484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489473|NCT01121471|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1489474|NCT01121458||Single Group Assignment||Diagnostic||None (Open Label)||||||
1489475|NCT01121445|Randomized|Crossover Assignment||Treatment||Single|||||t|
1489476|NCT01121432|||Cohort||Prospective|||||||
1489477|NCT01121419|||Cohort||Retrospective|||||||
1489478|NCT01121406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489479|NCT01121393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489480|NCT01121380|Randomized|Parallel Assignment||||Double|||t||t|
1489481|NCT01121367|||Case Control||Cross-Sectional|||||||
1489482|NCT01121354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489483|NCT01121341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489484|NCT01121328|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1489485|NCT01121315|||||Retrospective|||||||
1489486|NCT01121302|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1489487|NCT01121289|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1489488|NCT01121276|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1489489|NCT01121263|||Cohort||Prospective|||||||
1489490|NCT01121250|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1489491|NCT01121237|||Cohort||Prospective|||||||
1489492|NCT01121224|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1489493|NCT01121211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489494|NCT01121198|Randomized|Parallel Assignment||||Single|||t|||
1489495|NCT01121185|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1489496|NCT01121172|||Case Control||Prospective|||||||
1489497|NCT01121159|||Cohort||Prospective|||||||
1489498|NCT01121146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489499|NCT01121133|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489500|NCT01121120|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1489501|NCT01121107|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1489502|NCT01121094|||Cohort||Prospective|||||||
1489503|NCT01121081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489504|NCT01121068|||Cohort||Prospective|||||||
1489505|NCT01121055|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1489506|NCT01121042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489507|NCT01121029||Single Group Assignment||Treatment||None (Open Label)||||||
1489508|NCT01121016|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489509|NCT01121003|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1489510|NCT01120990|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1489511|NCT01120977|||||Cross-Sectional|||||||
1489512|NCT01120964|Randomized|Parallel Assignment||Prevention||Single|||||t|
1489513|NCT01120951|||Cohort||Prospective|||||||
1489514|NCT01120938|||Case-Crossover||Prospective|||||||
1489515|NCT01120925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489516|NCT01120912|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1489517|NCT01120899||Single Group Assignment||Treatment||None (Open Label)||||||
1489518|NCT01120886|||Cohort||Prospective|||||||
1489519|NCT01120873|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489520|NCT01120860|||Cohort||Prospective|||||||
1489521|NCT01120847|||Case-Control||Prospective|||||||
1489522|NCT01120834||Single Group Assignment||Treatment||None (Open Label)||||||
1489523|NCT01120821||Single Group Assignment||Treatment||None (Open Label)||||||
1489524|NCT01120808||Single Group Assignment||Prevention||None (Open Label)||||||
1489525|NCT01120795|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489526|NCT01120782|Randomized|Crossover Assignment||Treatment||Single|||t|||
1489527|NCT01120769|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1489528|NCT01120756|Randomized|Crossover Assignment||Treatment||Single||||||t
1489529|NCT01120743|||Cohort||Prospective|||||||
1489530|NCT01120730|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1489531|NCT01120717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489532|NCT01120704|Randomized|Factorial Assignment||Treatment||Single||||||t
1489533|NCT01120691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489534|NCT01120678|||Cohort||Prospective|||||||
1489535|NCT01120665|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1489536|NCT01120652|Randomized|Parallel Assignment||Treatment||Single||||||t
1489537|NCT01120639|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489538|NCT01120626|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489539|NCT01120613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489540|NCT01120600|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489541|NCT01120587|||Cohort||Prospective|||||||
1489542|NCT01120574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489543|NCT01120561||||||||||||
1489544|NCT01120548|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489545|NCT01120535||Single Group Assignment||Treatment||None (Open Label)||||||
1489546|NCT01120522||Single Group Assignment||Treatment||None (Open Label)||||||
1489547|NCT01120509||Single Group Assignment||Treatment||None (Open Label)||||||
1489548|NCT01120496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489549|NCT01120483|||Cohort||Prospective|||||||
1489550|NCT01120470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489551|NCT01120457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489552|NCT01120444|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1489553|NCT01120431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489554|NCT01120418|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1489555|NCT01120405|Randomized|Parallel Assignment||Screening||Single|||t|||
1489556|NCT01120392|Randomized|Parallel Assignment||Treatment||Single||||||t
1489557|NCT01120379|||Cohort||Prospective|||||||
1489558|NCT01120366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489559|NCT01120353|||Cohort||Retrospective|||||||
1489560|NCT01120340|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1489561|NCT01120327|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489562|NCT01120314|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1489563|NCT01120301|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489564|NCT01120288|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489565|NCT01120275||Single Group Assignment||Treatment||None (Open Label)||||||
1489566|NCT01120262|||Cohort||Retrospective|||||||
1489567|NCT01120249|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489568|NCT01120236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489569|NCT01120223||Single Group Assignment||Treatment||None (Open Label)||||||
1489570|NCT01120210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489571|NCT01120197|Randomized|Parallel Assignment||Treatment||Single||||||t
1489572|NCT01120184|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489573|NCT01120171||Single Group Assignment||Treatment||None (Open Label)||||||
1489574|NCT01120158||Single Group Assignment||Treatment||None (Open Label)||||||
1489575|NCT01120145|||Cohort|||||||||
1489576|NCT01120132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489577|NCT01120119||||||||||||
1489578|NCT01120106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489579|NCT01120093|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1489580|NCT01120080|Randomized|Single Group Assignment||Treatment||Single|||t|||
1489581|NCT01120067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489582|NCT01120054|||Cohort||Cross-Sectional|||||||
1489583|NCT01120041|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1489584|NCT01120028|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1489585|NCT01120015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489586|NCT01120002|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1489587|NCT01119989|Randomized|Single Group Assignment||Basic Science||Triple|||t|t|t|
1489588|NCT01119976|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489589|NCT01119963|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1489590|NCT01119950|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1489591|NCT01119937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489592|NCT01119924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489593|NCT01119911|||||Prospective|||||||
1489594|NCT01119898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489595|NCT01119885|||Cohort||Prospective|||||||
1489596|NCT01119872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489597|NCT01119859|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489598|NCT01119846|Randomized|Crossover Assignment||Other||Double|||t||t|
1489599|NCT01119833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489600|NCT01119820||Single Group Assignment||Basic Science||None (Open Label)||||||
1489601|NCT01119807|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489602|NCT01119794||Single Group Assignment||Treatment||None (Open Label)||||||
1489603|NCT01119781|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1489604|NCT01119768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489605|NCT01119755|||Case-Only||Prospective|||||||
1489606|NCT01119742|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489607|NCT01119729|||Cohort||Prospective|||||||
1489608|NCT01119716|||Cohort||Prospective|||||||
1489609|NCT01119703|||Cohort||Prospective|||||||
1489610|NCT01119690|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1489611|NCT01119677|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489612|NCT01119664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489613|NCT01119651|Randomized|Parallel Assignment||Basic Science||Single||||||t
1489614|NCT01119638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489615|NCT01119625|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489616|NCT01119612|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1489617|NCT01119599||Single Group Assignment||Treatment||None (Open Label)||||||
1489618|NCT01119586|||Case-Only||Prospective|||||||
1489619|NCT01119573||||||||||||
1489620|NCT01119560||||||||||||
1489621|NCT01119547|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1489622|NCT01119534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489623|NCT01119521|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489624|NCT01119508||Single Group Assignment||Treatment||None (Open Label)||||||
1489625|NCT01119482||Single Group Assignment||Prevention||None (Open Label)||||||
1489626|NCT01119469|Randomized|Parallel Assignment||Treatment||Single||||||t
1489627|NCT01119456||Single Group Assignment||Treatment||None (Open Label)||||||
1489628|NCT01119443|Randomized|Crossover Assignment||||None (Open Label)||||||
1489629|NCT01119430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489630|NCT01119417|Randomized|Crossover Assignment||Other||Single|||t|||
1489631|NCT01119404|||||Cross-Sectional|||||||
1489632|NCT01119391|||Cohort||Prospective|||||||
1489633|NCT01119378|Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1489634|NCT01119365|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1489635|NCT01119352|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1489636|NCT01119339|Randomized|Factorial Assignment||Treatment||Single|||t|||
1489637|NCT01119326|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489638|NCT01119313|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1489639|NCT01119300|Randomized|Parallel Assignment||||Single|||t|||
1489640|NCT01119287|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1489641|NCT01119274|Randomized|Parallel Assignment||||Single|||t|||
1489642|NCT01119261|Randomized|Parallel Assignment||||Single|||t|||
1489643|NCT01119248|||Case-Only||Prospective|||||||
1489644|NCT01119235|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489645|NCT01119222|Randomized|Crossover Assignment||||Double|||t||t|
1489646|NCT01119209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489647|NCT01119196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489648|NCT01119183|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1489649|NCT01119170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489650|NCT01119157|Randomized|Parallel Assignment||Prevention||Single|||t|||
1489651|NCT01119144|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489652|NCT01119131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489653|NCT01119118||Single Group Assignment||Treatment||None (Open Label)||||||
1489654|NCT01119105|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489655|NCT01119092|Randomized|Parallel Assignment||Treatment||Single||||||t
1489656|NCT01119079|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489657|NCT01119066|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489658|NCT01119053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489659|NCT01119040||Single Group Assignment||Treatment||None (Open Label)||||||
1489660|NCT01119027|||Cohort||Prospective|||||||
1489661|NCT01119014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489662|NCT01119001||Single Group Assignment||Supportive Care||None (Open Label)||||||
1489663|NCT01118988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489664|NCT01118975|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489665|NCT01118962||Single Group Assignment||Treatment||None (Open Label)||||||
1489666|NCT01118949||Single Group Assignment||Treatment||None (Open Label)||||||
1489667|NCT01118936|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1489668|NCT01118923|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1489669|NCT01118910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489670|NCT01118897||Single Group Assignment||Treatment||None (Open Label)||||||
1489671|NCT01118884|Randomized|Crossover Assignment||Health Services Research||Single||||||t
1489672|NCT01118871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489673|NCT01118858|||Case-Control||Prospective|||||||
1489674|NCT01118845|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489675|NCT01118832|||Case-Only|||||||||
1489676|NCT01118819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489677|NCT01118806|||Case Control||Cross-Sectional|||||||
1489678|NCT01118793|||Case-Only||Prospective|||||||
1489679|NCT01118780|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489680|NCT01118767|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1489681|NCT01118754|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489682|NCT01118741||Single Group Assignment||Treatment||None (Open Label)||||||
1489683|NCT01118728||Single Group Assignment||Treatment||None (Open Label)||||||
1489684|NCT01118715|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489685|NCT01118702|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1489686|NCT01118689||Single Group Assignment||Treatment||None (Open Label)||||||
1489687|NCT01118676||Single Group Assignment||Treatment||None (Open Label)||||||
1489688|NCT01118663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489689|NCT01118650|||Case-Only||Cross-Sectional|||||||
1489690|NCT01118637|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489691|NCT01118624||Single Group Assignment||Treatment||None (Open Label)||||||
1489692|NCT01118611||||Treatment||||||||
1489693|NCT01118598|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489694|NCT01118585||Single Group Assignment||Treatment||None (Open Label)||||||
1489695|NCT01118572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489696|NCT01118559|Randomized|Crossover Assignment||||None (Open Label)||||||
1489697|NCT01118546|||Case Control||Prospective|||||||
1489698|NCT01118533|Randomized|Parallel Assignment||||Single|||t|||
1489699|NCT01118520|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1489700|NCT01118507|||Case Control||Prospective|||||||
1489701|NCT01118494|||Case-Only||Prospective|||||||
1489702|NCT01118481|||Other||Prospective|||||||
1489703|NCT01118468|||Other||Prospective|||||||
1489704|NCT01118455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489705|NCT01118442|||Other||Prospective|||||||
1489706|NCT01118429||Single Group Assignment||Treatment||None (Open Label)||||||
1489707|NCT01118416|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489708|NCT01118403|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1489709|NCT01118390|Randomized|Parallel Assignment||Treatment||Single||||||t
1489710|NCT01118377|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489711|NCT01118364|Randomized|Crossover Assignment||Health Services Research||Triple|||t||t|t
1489712|NCT01118351||Single Group Assignment||Treatment||None (Open Label)||||||
1489713|NCT01118338||||||||||||
1489714|NCT01118325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489715|NCT01118312|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1489716|NCT01118299|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489717|NCT01118286|||Cohort||Prospective|||||||
1489718|NCT01118273|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489719|NCT01118260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489720|NCT01118247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489721|NCT01118234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489722|NCT01118221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489723|NCT01118208|Randomized|Parallel Assignment||Prevention||Single||||||t
1489724|NCT01118195|||Cohort||Cross-Sectional|||||||
1489725|NCT01118182|||Cohort||Cross-Sectional|||||||
1489726|NCT01118169|||Cohort||Cross-Sectional|||||||
1489727|NCT01118156|||Cohort||Prospective|||||||
1489728|NCT01118143|Randomized|Parallel Assignment||Prevention||Single|||t|||
1489729|NCT01118130|||Case-Control||Retrospective|||||||
1489730|NCT01118117||Single Group Assignment||Treatment||None (Open Label)||||||
1489731|NCT01118104||Single Group Assignment||||None (Open Label)||||||
1489732|NCT01118091|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489733|NCT01118078|||Case-Only||Prospective|||||||
1489734|NCT01118065||||Treatment||None (Open Label)||||||
1489735|NCT01118052||Single Group Assignment||Treatment||None (Open Label)||||||
1489736|NCT01118039||||Treatment||None (Open Label)||||||
1489737|NCT01118026||Single Group Assignment||Treatment||None (Open Label)||||||
1489738|NCT01118013||Single Group Assignment||Treatment||None (Open Label)||||||
1489739|NCT01118000|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489740|NCT01117987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489741|NCT01117974||Single Group Assignment||Treatment||None (Open Label)||||||
1489742|NCT01117961|Randomized|Factorial Assignment||Treatment||Single||||||t
1489743|NCT01117948|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489744|NCT01117935||Single Group Assignment||Treatment||None (Open Label)||||||
1489745|NCT01117922|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489746|NCT01117909|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489747|NCT01117896|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1489748|NCT01117883||Single Group Assignment||Diagnostic||None (Open Label)||||||
1489749|NCT01117870|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489750|NCT01117857||Single Group Assignment||Treatment||None (Open Label)||||||
1489751|NCT01117844||Parallel Assignment||Treatment||None (Open Label)||||||
1489752|NCT01117831|||Cohort||Prospective|||||||
1489753|NCT01117818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489754|NCT01117805|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1489755|NCT01117792||Single Group Assignment||Treatment||None (Open Label)||||||
1489756|NCT01117779|||Case-Only||Prospective|||||||
1489757|NCT01117766|Randomized|Crossover Assignment||||Double|||t||t|
1489758|NCT01117753|Randomized|Parallel Assignment||Treatment||Single||||||t
1489759|NCT01117740|||Case-Only||Prospective|||||||
1489760|NCT01117727||Single Group Assignment||Health Services Research||None (Open Label)||||||
1489761|NCT01117714|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1489762|NCT01117701|Randomized|Parallel Assignment||||None (Open Label)||||||
1489763|NCT01117688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489764|NCT01117675|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1489765|NCT01117662|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489766|NCT01117649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489767|NCT01117636|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1489768|NCT01117623|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1489769|NCT01117610|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489770|NCT01117597|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1489771|NCT01117584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489772|NCT01117571|||Cohort||Prospective|||||||
1489773|NCT01117558|||Cohort||Prospective|||||||
1489774|NCT01117545|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1489775|NCT01117532|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1489776|NCT01117519|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489777|NCT01117506|||Cohort||Prospective|||||||
1489778|NCT01117493|Randomized|Parallel Assignment||Treatment||Single||||||t
1489779|NCT01117480|||Cohort||Prospective|||||||
1489780|NCT01117467|Randomized|Parallel Assignment||||None (Open Label)||||||
1489781|NCT01117454|Randomized|Crossover Assignment||Treatment||Single|||t|||
1489782|NCT01117441|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1489783|NCT01117428||Single Group Assignment||Treatment||None (Open Label)||||||
1489784|NCT01117415|||Case-Only||Prospective|||||||
1489785|NCT01117402|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489786|NCT01117389|||Case Control||Cross-Sectional|||||||
1489787|NCT01117376|Randomized|Parallel Assignment||Treatment||Single||||||t
1489788|NCT01117363|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1489789|NCT01117350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489790|NCT01117337|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1489791|NCT01117324|||Case Control||Prospective|||||||
1489792|NCT01117311|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1489793|NCT01117298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489794|NCT01117285|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1489795|NCT01117272|||Cohort||Retrospective|||||||
1489796|NCT01117246||Single Group Assignment||Supportive Care||None (Open Label)||||||
1489797|NCT01117233|Randomized|Parallel Assignment||||Double|||t||t|
1489798|NCT01117220|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489799|NCT01117194|Randomized|Parallel Assignment||Prevention||Single|||t|||
1489800|NCT01117181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489801|NCT01117168|||Cohort||Prospective|||||||
1489802|NCT01117155|||||Prospective|||||||
1489803|NCT01117142|||Cohort||Prospective|||||||
1489804|NCT01117129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489805|NCT01117116|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489806|NCT01117103|||Cohort||Prospective|||||||
1489807|NCT01117090|||Cohort||Prospective|||||||
1489808|NCT01117077|||Case Control||Prospective|||||||
1489809|NCT01117064|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489810|NCT01117051|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489811|NCT01117038|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1489812|NCT01117025|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1489813|NCT01117012||Single Group Assignment||Treatment||None (Open Label)||||||
1489814|NCT01116999|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1489815|NCT01116986|Randomized|Factorial Assignment||Treatment||Single||||||t
1489816|NCT01116973|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1489817|NCT01116960|||Other||Prospective|||||||
1489818|NCT01116947|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1489819|NCT01116934|||Case Control||Cross-Sectional|||||||
1489820|NCT01116921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489821|NCT01116908|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489822|NCT01116895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489823|NCT01116882|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1489824|NCT01116869|||Case Control||Prospective|||||||
1489825|NCT01116856|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489826|NCT01116843|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489827|NCT01116830|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489828|NCT01116817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489829|NCT01116804||Single Group Assignment||Diagnostic||None (Open Label)||||||
1489830|NCT01116791||Single Group Assignment||Treatment||None (Open Label)||||||
1489831|NCT01116778|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489832|NCT01116765|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489833|NCT01116752|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1489834|NCT01116739|Randomized|Parallel Assignment||Prevention||Single||||||t
1489835|NCT01116726|Randomized|Parallel Assignment||Prevention||Single||||||t
1489836|NCT01116713|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1489837|NCT01116700||Single Group Assignment||||None (Open Label)||||||
1489838|NCT01116687||Single Group Assignment||Treatment||None (Open Label)||||||
1489839|NCT01116674|||Case-Only|||||||||
1489840|NCT01116661||Single Group Assignment||Treatment||None (Open Label)||||||
1489841|NCT01116648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489842|NCT01116635|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489843|NCT01116622||Single Group Assignment||Treatment||None (Open Label)||||||
1489844|NCT01116609|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1489845|NCT01116596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489846|NCT01116583|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1489847|NCT01116570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489848|NCT01116557|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1489849|NCT01116544|Randomized|Parallel Assignment||Treatment||Single||||||t
1489850|NCT01116531|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489851|NCT01116518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489852|NCT01116505|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1489853|NCT01116492|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1489854|NCT01116479|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1489855|NCT01116466||Single Group Assignment||Treatment||None (Open Label)||||||
1489856|NCT01116453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489857|NCT01116440|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489858|NCT01116427|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1489859|NCT01116414|||Cohort||Prospective|||||||
1489860|NCT01116401||Single Group Assignment||Basic Science||None (Open Label)||||||
1489861|NCT01116388|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1489862|NCT01116375|||Cohort||Prospective|||||||
1489863|NCT01116362|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1489864|NCT01116349|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1489865|NCT01116336||Single Group Assignment||Prevention||None (Open Label)||||||
1489866|NCT01116323|||Cohort||Prospective|||||||
1489867|NCT01116310|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489868|NCT01116297|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1489869|NCT01116284||Single Group Assignment||Treatment||None (Open Label)||||||
1489870|NCT01116271||Single Group Assignment||Treatment||None (Open Label)||||||
1489871|NCT01116258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489872|NCT01116245|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489873|NCT01116232||Single Group Assignment||Supportive Care||None (Open Label)||||||
1489874|NCT01116219|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489875|NCT01116206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489876|NCT01116193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489877|NCT01116180|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1489878|NCT01116167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489879|NCT01116154|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489880|NCT01116141|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489881|NCT01116128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489882|NCT01116115|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1489883|NCT01116102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489884|NCT01116089|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489885|NCT01116076|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1489886|NCT01116063||Single Group Assignment||Treatment||None (Open Label)||||||
1489887|NCT01116050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489888|NCT01116037||Single Group Assignment||Treatment||None (Open Label)||||||
1489889|NCT01116024||Single Group Assignment||Treatment||None (Open Label)||||||
1489890|NCT01116011|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1489891|NCT01115998|Randomized|Parallel Assignment||Treatment||Single||||||t
1489892|NCT01115985|Randomized|Crossover Assignment||||None (Open Label)||||||
1489893|NCT01115972|Randomized|Crossover Assignment||||None (Open Label)||||||
1489894|NCT01115959|Randomized|Parallel Assignment||Prevention||Double||||||
1489895|NCT01115946|Randomized|Crossover Assignment||||None (Open Label)||||||
1489896|NCT01115933||Single Group Assignment||Treatment||None (Open Label)||||||
1489897|NCT01115920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489898|NCT01115907||Single Group Assignment||Treatment||None (Open Label)||||||
1489899|NCT01115894|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1489900|NCT01115881|||Cohort||Prospective|||||||
1489901|NCT01115868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489902|NCT01115855|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489903|NCT01115842|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1489904|NCT01115803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489905|NCT01115790||Single Group Assignment||Treatment||None (Open Label)||||||
1489906|NCT01115777|||Cohort||Prospective|||||||
1489907|NCT01115764|||||Prospective|||||||
1489908|NCT01115751||Single Group Assignment||Treatment||None (Open Label)||||||
1489909|NCT01115738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489910|NCT01115725|||Cohort||Prospective|||||||
1489911|NCT01115712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489912|NCT01115699||Single Group Assignment||Treatment||None (Open Label)||||||
1489913|NCT01115686|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489914|NCT01115673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489915|NCT01115660|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489916|NCT01115647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489917|NCT01115634||Single Group Assignment||Treatment||None (Open Label)||||||
1489918|NCT01115621|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489919|NCT01115608|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1489920|NCT01115595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489921|NCT01115582||Single Group Assignment||Treatment||None (Open Label)||||||
1489922|NCT01115569||Single Group Assignment||Treatment||None (Open Label)||||||
1489923|NCT01115556|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489924|NCT01115543|Randomized|Crossover Assignment||Treatment||Single|||||t|
1489925|NCT01115530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489926|NCT01115517|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489927|NCT01115504|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1489928|NCT01115491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489929|NCT01115478|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1489930|NCT01115465||Single Group Assignment||Treatment||None (Open Label)||||||
1489931|NCT01115452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489932|NCT01115439|||Case-Only||Prospective|||||||
1489933|NCT01115426|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489934|NCT01115413|||Cohort||Retrospective|||||||
1489935|NCT01115400|||Case-Only||Prospective|||||||
1489936|NCT01115387|||Case-Control||Prospective|||||||
1489937|NCT01115374|Randomized|Crossover Assignment||Treatment||Single|||||t|
1489938|NCT01115361|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1489939|NCT01115348|||Cohort||Prospective|||||||
1489940|NCT01115335|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1489941|NCT01115322|Randomized|Parallel Assignment||Basic Science||Single||||||t
1489942|NCT01115309||Single Group Assignment||Treatment||None (Open Label)||||||
1489943|NCT01115296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489944|NCT01115283|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1489945|NCT01115270|||Case Control||Prospective|||||||
1489946|NCT01115257|Randomized|Parallel Assignment||Treatment||Single|||t|||
1489947|NCT01115244|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489948|NCT01115231|||Cohort||Prospective|||||||
1489949|NCT01115218|||Case-Only||Prospective|||||||
1489950|NCT01115205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489951|NCT01115192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489952|NCT01115179|Randomized|Parallel Assignment||||Triple|||t||t|t
1489953|NCT01115166|||Cohort||Prospective|||||||
1489954|NCT01115153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489955|NCT01115140|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1489956|NCT01115127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489957|NCT01115114|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1489958|NCT01115101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489959|NCT01115088|Randomized|Single Group Assignment||||Single|||t|||
1489960|NCT01115075||Single Group Assignment||Treatment||None (Open Label)||||||
1489961|NCT01115062|Randomized|Parallel Assignment||Treatment||Single||||||t
1489962|NCT01115049|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1489963|NCT01115036|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1489964|NCT01115023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489965|NCT01115010|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1489966|NCT01114997|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1489967|NCT01114984|||||Prospective|||||||
1489968|NCT01114971|Randomized|Factorial Assignment||Prevention||Double|||t|t||
1489969|NCT01114958||Single Group Assignment||Treatment||None (Open Label)||||||
1489970|NCT01114945|Randomized|Parallel Assignment||||Single|||t|||
1489971|NCT01114932|||||Prospective|||||||
1489972|NCT01114919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489973|NCT01114906|||||Retrospective|||||||
1489974|NCT01114893|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489975|NCT01114880|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1489976|NCT01114867|||Case Control||Prospective|||||||
1489977|NCT01114854||Single Group Assignment||Treatment||None (Open Label)|It was a open-label study|||||
1489978|NCT01114841|Randomized|Parallel Assignment||Basic Science||Single||||||t
1489979|NCT01114828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489980|NCT01114815|||Case-Only||Retrospective|||||||
1489981|NCT01114802|Randomized|Parallel Assignment||Treatment||Single||||||t
1489982|NCT01114789|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1489983|NCT01114776|||Case Control||Prospective|||||||
1489984|NCT01114763|||Case Control||Cross-Sectional|||||||
1489985|NCT01114750|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1489986|NCT01114737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1489987|NCT01114724||Single Group Assignment||Treatment||None (Open Label)||||||
1489988|NCT01114711|||Cohort||Other|||||||
1489989|NCT01114698|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489990|NCT01114685|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1489991|NCT01114672|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1489992|NCT01114659|||Cohort||Prospective|||||||
1489993|NCT01114646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1489994|NCT01114633|||Case-Only||Prospective|||||||
1489995|NCT01114620||Single Group Assignment||Prevention||None (Open Label)||||||
1489996|NCT01114607|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1489997|NCT01114594|||Other||Prospective|||||||
1489998|NCT01114581|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1489999|NCT01114568|Randomized|Crossover Assignment||||None (Open Label)||||||
1490000|NCT01114555||Single Group Assignment||Treatment||None (Open Label)||||||
1490001|NCT01114542|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490002|NCT01114529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490003|NCT01114516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490004|NCT01114503|Randomized|Parallel Assignment||Treatment||Single||||||t
1490005|NCT01114490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490006|NCT01114477|||Case-Only||Prospective|||||||
1490007|NCT01114464|||Case-Only||Prospective|||||||
1490008|NCT01114451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490009|NCT01114438||Single Group Assignment||Treatment||None (Open Label)||||||
1490010|NCT01114425||Crossover Assignment||Treatment||None (Open Label)||||||
1490011|NCT01114412|||Other||Prospective|||||||
1490012|NCT01114399|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490013|NCT01114386|||Cohort||Prospective|||||||
1490014|NCT01114373|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490015|NCT01114360|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490016|NCT01114347|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490017|NCT01114334|Randomized|Parallel Assignment||Health Services Research||Double||Cluster Randomized Clinical Trial|t|||t
1490018|NCT01114321|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1490019|NCT01114308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490020|NCT01114295||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490021|NCT01114282||Single Group Assignment||Treatment||None (Open Label)||||||
1490022|NCT01114269|||Cohort||Prospective|||||||
1490023|NCT01114256|||Cohort||Prospective|||||||
1490024|NCT01114243|||Case-Only||Prospective|||||||
1490025|NCT01114230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490026|NCT01114217||Single Group Assignment||Treatment||None (Open Label)||||||
1490027|NCT01114204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490028|NCT01114191|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1490029|NCT01114178|||Cohort||Prospective|||||||
1490030|NCT01114165|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490031|NCT01114152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490032|NCT01114139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490033|NCT01114126|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490034|NCT01114113|Non-Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1490035|NCT01114100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490036|NCT01114087||Single Group Assignment||Treatment||None (Open Label)||||||
1490037|NCT01114074|||||Cross-Sectional|||||||
1490038|NCT01114061|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1490039|NCT01114048||Single Group Assignment||Treatment||None (Open Label)||||||
1490040|NCT01114035|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490041|NCT01114022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490042|NCT01114009|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490043|NCT01113996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490044|NCT01113983||Single Group Assignment||Treatment||None (Open Label)||||||
1490045|NCT01113970||Single Group Assignment||Treatment||None (Open Label)||||||
1490046|NCT01113957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490047|NCT01113944|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1490048|NCT01113931|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490049|NCT01113918|||Cohort||Retrospective|||||||
1490050|NCT01113905|||Case Control||Prospective|||||||
1490051|NCT01113892|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490052|NCT01113879|Randomized|Parallel Assignment||Treatment||Single||||||t
1490053|NCT01113866|||Cohort||Prospective|||||||
1490054|NCT01113853|||Case-Only||Cross-Sectional|||||||
1490055|NCT01113840|Randomized|Parallel Assignment||Treatment||Single||||||t
1490056|NCT01113827|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1490057|NCT01113814||||Diagnostic||||||||
1490058|NCT01113801|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490059|NCT01113788|||Cohort||Prospective|||||||
1490060|NCT01113775|||Cohort||Prospective|||||||
1490061|NCT01113762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490062|NCT01113749|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1490063|NCT01113736||Single Group Assignment||Prevention||None (Open Label)||||||
1490064|NCT01113723|Randomized|Parallel Assignment||||Single|||t|||
1490065|NCT01113710|||Cohort||Prospective|||||||
1490066|NCT01113697|||Cohort||Prospective|||||||
1490067|NCT01113684|||Cohort||Prospective|||||||
1490068|NCT01113671|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1490069|NCT01113658||Single Group Assignment||Treatment||None (Open Label)||||||
1490070|NCT01113645|||Cohort||Prospective|||||||
1490071|NCT01113632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490072|NCT01113619|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490073|NCT01113606||||||||||||
1490074|NCT01113593|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1490075|NCT01113580|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490076|NCT01113567|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490077|NCT01113554||Single Group Assignment||Treatment||None (Open Label)||||||
1490078|NCT01113541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490079|NCT01113528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490080|NCT01113515|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490081|NCT01113502||||Treatment||||||||
1490082|NCT01113489|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490083|NCT01113476||Single Group Assignment||Treatment||None (Open Label)||||||
1490084|NCT01113463||Single Group Assignment||Treatment||None (Open Label)||||||
1490085|NCT01113450|||||Retrospective|||||||
1490086|NCT01113437|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490087|NCT01113424|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490088|NCT01113411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490089|NCT01113398||Single Group Assignment||Treatment||None (Open Label)||||||
1490090|NCT01113385||Single Group Assignment||Treatment||None (Open Label)||||||
1490091|NCT01113372|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1490092|NCT01113359|||Case Control||Cross-Sectional|||||||
1490093|NCT01113346|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490094|NCT01113333|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490095|NCT01113320|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1490096|NCT01113307|||Cohort||Prospective|||||||
1490097|NCT01113294|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490098|NCT01113281|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490099|NCT01113268||Single Group Assignment||Other||None (Open Label)||||||
1490100|NCT01113255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490101|NCT01113242|||Case Control||Prospective|||||||
1490102|NCT01113229|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490103|NCT01113216|||Family-Based||Prospective|||||||
1490104|NCT01113203|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490105|NCT01113190|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1490106|NCT01113177|||Case-Only||Retrospective|||||||
1490107|NCT01113164|Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1490108|NCT01113151|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1490109|NCT01113138|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1490110|NCT01113125|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490111|NCT01113112|||Case-Only||Prospective|||||||
1490112|NCT01113099|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1490113|NCT01113086|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1490114|NCT01113073||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490115|NCT01113060|||Cohort||Prospective|||||||
1490116|NCT01113047|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490117|NCT01113034|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1490118|NCT01113021||||||||||||
1490119|NCT01113008|Randomized|Parallel Assignment||||Single|||||t|
1490120|NCT01112995|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490121|NCT01112982|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1490122|NCT01112969|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1490123|NCT01112956|||Cohort||Prospective|||||||
1490124|NCT01112943|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1490125|NCT01112930|||Cohort||Cross-Sectional|||||||
1490126|NCT01112917||Single Group Assignment||Prevention||None (Open Label)||||||
1490127|NCT01112904|||Cohort||Prospective|||||||
1490128|NCT01112891|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490129|NCT01112878|Randomized|Factorial Assignment||Prevention||Double|||t|t||
1490130|NCT01112865|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490131|NCT01112852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490132|NCT01112839|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490133|NCT01112826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490134|NCT01112813||Single Group Assignment||Treatment||None (Open Label)||||||
1490135|NCT01112800|||Cohort||Prospective|||||||
1490136|NCT01112787|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1490137|NCT01112774|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1490138|NCT01112761|Non-Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1490139|NCT01112748||Single Group Assignment||Treatment||None (Open Label)||||||
1490140|NCT01112735|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490141|NCT01112722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490142|NCT01112709|Randomized|Parallel Assignment||Prevention||Single|||t|||
1490143|NCT01112696||Single Group Assignment||Other||None (Open Label)||||||
1490144|NCT01112683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490145|NCT01112670|Randomized|Crossover Assignment||||None (Open Label)||||||
1490146|NCT01112657|||Cohort||Prospective|||||||
1490147|NCT01112644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490148|NCT01112631|||Case Control||Prospective|||||||
1490149|NCT01112618|||Cohort||Prospective|||||||
1490150|NCT01112605|||||Cross-Sectional|||||||
1490151|NCT01112592|||Case Control||Cross-Sectional|||||||
1490152|NCT01112579|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490153|NCT01112566|||Case-Only||Prospective|||||||
1490154|NCT01112553|||Cohort|||||||||
1490155|NCT01112540||||||||||||
1490156|NCT01112527|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490157|NCT01112514||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490158|NCT01112501|||Case Control||Prospective|||||||
1490159|NCT01112488|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1490160|NCT01112475||||||||||||
1490161|NCT01112462|Randomized|Crossover Assignment||Basic Science||Single||||||t
1490162|NCT01112449|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1490163|NCT01112436|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1490164|NCT01112423|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490165|NCT01112410|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490166|NCT01112397|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490167|NCT01112384||Single Group Assignment||Treatment||None (Open Label)||||||
1490168|NCT01112371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490169|NCT01112358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490170|NCT01112345|||Cohort||Prospective|||||||
1490171|NCT01112332||||||||||||
1490172|NCT01112319|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1490173|NCT01112306||Single Group Assignment||Treatment||None (Open Label)||||||
1490174|NCT01112293||||Treatment||||||||
1490175|NCT01112280|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490176|NCT01112267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490177|NCT01112254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490178|NCT01112241||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490179|NCT01112228|||Cohort||Prospective|||||||
1490180|NCT01112215|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490181|NCT01112202|||Cohort||Retrospective|||||||
1490182|NCT01112189|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490183|NCT01112176||Single Group Assignment||Basic Science||None (Open Label)||||||
1490184|NCT01112163||Single Group Assignment||Treatment||None (Open Label)||||||
1490185|NCT01112150|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1490186|NCT01112137|Randomized|Parallel Assignment||Treatment||Single||||||t
1490187|NCT01112124|||Cohort||Prospective|||||||
1490188|NCT01112111|||Cohort||Prospective|||||||
1490189|NCT01112098|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1490190|NCT01112085|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490191|NCT01112072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490192|NCT01112059|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490193|NCT01112046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490194|NCT01112033|||Case Control||Prospective|||||||
1490195|NCT01112020|Randomized|Parallel Assignment||||Single||||||t
1490196|NCT01112007|||Cohort||Cross-Sectional|||||||
1490197|NCT01111994|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1490198|NCT01111981||Single Group Assignment||Treatment||None (Open Label)||||||
1490199|NCT01111968|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490200|NCT01111955|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490201|NCT01111942|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490202|NCT01111929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490203|NCT01111916|||Case-Only||Prospective|||||||
1490204|NCT01111903||Single Group Assignment||Treatment||None (Open Label)||||||
1490205|NCT01111890|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490206|NCT01111877||||||||||||
1490207|NCT01111864|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1490208|NCT01111851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490209|NCT01111838||Single Group Assignment||Treatment||None (Open Label)||||||
1490210|NCT01111825||Single Group Assignment||Treatment||None (Open Label)||||||
1490211|NCT01111812|||Cohort||Prospective|||||||
1490212|NCT01111799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490213|NCT01111786|||Case Control||Cross-Sectional|||||||
1490214|NCT01111773||Single Group Assignment||Treatment||None (Open Label)||||||
1490215|NCT01111760|||Case-Only|||||||||
1490216|NCT01111747|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1490217|NCT01111734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490218|NCT01111721|Randomized|Parallel Assignment||Prevention||Single||||||t
1490219|NCT01111708|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490220|NCT01111695||Single Group Assignment||Treatment||None (Open Label)||||||
1490221|NCT01111682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490222|NCT01111669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490223|NCT01111656|Randomized|Parallel Assignment||Treatment||Single||||||t
1490224|NCT01111643|||Cohort||Prospective|||||||
1490225|NCT01111630|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490226|NCT01111617|Non-Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1490227|NCT01111604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490228|NCT01111591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490229|NCT01111578|||Cohort||Prospective|||||||
1490230|NCT01111565|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490231|NCT01111552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490232|NCT01111539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490233|NCT01111526||Single Group Assignment||Treatment||None (Open Label)||||||
1490234|NCT01111513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490235|NCT01111500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490236|NCT01111487|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490237|NCT01111474|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490238|NCT01111461||Single Group Assignment||Treatment||None (Open Label)||||||
1490239|NCT01111448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490240|NCT01111435|||Cohort||Prospective|||||||
1490241|NCT01111422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490242|NCT01111409||Single Group Assignment||Treatment||None (Open Label)||||||
1490243|NCT01111396|||Case-Only||Prospective|||||||
1490244|NCT01111383||Single Group Assignment||Treatment||None (Open Label)||||||
1490245|NCT01111370||Single Group Assignment||Other||None (Open Label)||||||
1490246|NCT01111357|||Case Control||Prospective|||||||
1490247|NCT01111344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490248|NCT01111331|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490249|NCT01111318|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490250|NCT01111305|Randomized|Parallel Assignment||Treatment||Triple|Drug assignment (reslizumab vs. placebo) and eosinophil count||t|t|t|
1490251|NCT01111292|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490252|NCT01111279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490253|NCT01111266||Single Group Assignment||Basic Science||None (Open Label)||||||
1490254|NCT01111253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490255|NCT01111240|||Case-Only||Prospective|||||||
1490256|NCT01111227|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1490257|NCT01111214|||||Retrospective|||||||
1490258|NCT01111201|||Cohort||Retrospective|||||||
1490259|NCT01111188||Single Group Assignment||Treatment||None (Open Label)||||||
1490260|NCT01111175|||Cohort||Prospective|||||||
1490261|NCT01111162||Single Group Assignment||Treatment||None (Open Label)||||||
1490262|NCT01111149|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1490263|NCT01111136||Single Group Assignment||Treatment||||||||
1490264|NCT01111123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490265|NCT01111110|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1490266|NCT01111097|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490267|NCT01111084|||Cohort||Prospective|||||||
1490268|NCT01111071|||||Prospective|||||||
1490269|NCT01111058|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490270|NCT01111045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490271|NCT01111032|||Cohort||Prospective|||||||
1490272|NCT01111019|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490273|NCT01111006||Single Group Assignment||Supportive Care||None (Open Label)||||||
1490274|NCT01110993|||Cohort||Prospective|||||||
1490275|NCT01110980|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1490276|NCT01110967|||Cohort||Retrospective|||||||
1490277|NCT01110954|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1490278|NCT01110941||Single Group Assignment||Treatment||None (Open Label)||||||
1490279|NCT01110928|||Cohort||Prospective|||||||
1490280|NCT01110915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490281|NCT01110902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490282|NCT01110889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490283|NCT01110876|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490284|NCT01110863|||Cohort||Prospective|||||||
1490285|NCT01110850|||Cohort||Prospective|||||||
1490286|NCT01110837|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1490287|NCT01110824|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490288|NCT01110811|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490289|NCT01110798|Randomized|||Treatment||None (Open Label)||||||
1490290|NCT01110785||||Treatment||None (Open Label)||||||
1490291|NCT01110772|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490292|NCT01110759|||Case Control||Retrospective|||||||
1490293|NCT01110746|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490294|NCT01110733|||Case-Only||Prospective|||||||
1490295|NCT01110720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490296|NCT01110707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490297|NCT01110694|||Cohort||Prospective|||||||
1490298|NCT01110681||Single Group Assignment||Treatment||None (Open Label)||||||
1490299|NCT01110668||Single Group Assignment||Treatment||None (Open Label)||||||
1490300|NCT01110655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490301|NCT01110642||Single Group Assignment||Treatment||None (Open Label)||||||
1490302|NCT01110629|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490303|NCT01110616|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490304|NCT01110603|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490305|NCT01110590|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1490306|NCT01110577|||Cohort||Cross-Sectional|||||||
1490307|NCT01110564|||||Cross-Sectional|||||||
1490308|NCT01110551|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490309|NCT01110538|||Case-Only||Prospective|||||||
1490310|NCT01110525|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1490311|NCT01110512|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490312|NCT01110499|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490313|NCT01110486|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490314|NCT01110473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490315|NCT01110460|||Cohort||Prospective|||||||
1490316|NCT01110447|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490317|NCT01110434|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1490318|NCT01110421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490319|NCT01110408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490320|NCT01110395|||Case-Only||Cross-Sectional|||||||
1490321|NCT01110382|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490322|NCT01110369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490323|NCT01110356|Randomized|Single Group Assignment||Treatment||Single|||t|||
1490324|NCT01110343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490325|NCT01110330|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490326|NCT01110317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490327|NCT01110304|Randomized|Parallel Assignment||Treatment||Single||||||t
1490328|NCT01110291|||Case-Only||Prospective|||||||
1490329|NCT01110278|||Case-Control||Cross-Sectional|||||||
1490330|NCT01110265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490331|NCT01110252|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490804|NCT01104090|Randomized|Parallel Assignment||||Double|||t|t||
1490332|NCT01110239||Single Group Assignment||Treatment||None (Open Label)||||||
1490333|NCT01110226||Single Group Assignment||Treatment||None (Open Label)||||||
1490334|NCT01110213|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490335|NCT01110200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490336|NCT01110187|Randomized|Parallel Assignment||Prevention||Single||||||t
1490337|NCT01110174||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490338|NCT01110161|||Cohort||Cross-Sectional|||||||
1490339|NCT01110148|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1490340|NCT01110135||Single Group Assignment||Treatment||None (Open Label)||||||
1490341|NCT01110122|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1490342|NCT01110109|||Case-Only||Prospective|||||||
1490343|NCT01110096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490344|NCT01110083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490345|NCT01110070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490346|NCT01110057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490347|NCT01110044|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490348|NCT01110031|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1490349|NCT01110018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490350|NCT01110005|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490351|NCT01109992|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490352|NCT01109979|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1490353|NCT01109966|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1490354|NCT01109953|||Cohort||Prospective|||||||
1490355|NCT01109940||Single Group Assignment||Treatment||None (Open Label)||||||
1490356|NCT01109927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490357|NCT01109914|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490358|NCT01109901|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1490359|NCT01109888||||||||||||
1490360|NCT01109875||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490361|NCT01109862|Randomized|Parallel Assignment||Treatment||Single||||||t
1490362|NCT01109849|Randomized|Parallel Assignment||Treatment||None (Open Label)||"initial randomization to behavior or extended release stimulant (ER stimulant) arms.~Participants in either arm meting criteria for a weight recovery intervention (based on change in zBMI) will be adaptively randomized to one of three weight recovery arms (Monitoring, Drug Holiday, Caloric Supplementation)"||||
1490363|NCT01109836|Randomized|Parallel Assignment||Prevention||Single||||||t
1490364|NCT01109823|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490365|NCT01109810|||Cohort||Prospective|||||||
1490366|NCT01109797|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490367|NCT01109784|Randomized|Crossover Assignment||Treatment||Single||||||t
1490368|NCT01109771|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490369|NCT01109758||Single Group Assignment||Basic Science||None (Open Label)||||||
1490370|NCT01109745|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1490371|NCT01109732|Randomized|Parallel Assignment||Treatment||Single||||||t
1490372|NCT01109719|||Ecologic or Community||Prospective|||||||
1490373|NCT01109706|||||Prospective|||||||
1490374|NCT01109693|Randomized|Parallel Assignment||Treatment||Single||||||t
1490375|NCT01109680||Single Group Assignment||Basic Science||None (Open Label)||||||
1490376|NCT01109667|||Cohort||Prospective|||||||
1490377|NCT01109654|||Case-Only||Prospective|||||||
1490378|NCT01109641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490379|NCT01109628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490380|NCT01109615||Factorial Assignment||Treatment||None (Open Label)||||||
1490381|NCT01109602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490382|NCT01109589|||Cohort||Retrospective|||||||
1490383|NCT01109576||Single Group Assignment||Supportive Care||None (Open Label)||||||
1490384|NCT01109563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490385|NCT01109550|||Case Control||Prospective|||||||
1490386|NCT01109537|||Case Control||Prospective|||||||
1490387|NCT01109524||Single Group Assignment||Treatment||None (Open Label)||||||
1490388|NCT01109511|Randomized|Parallel Assignment||Prevention||||||||
1490389|NCT01109498|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490390|NCT01109485||Single Group Assignment||Treatment||None (Open Label)||||||
1490391|NCT01109472|Randomized|Parallel Assignment||Prevention||Single|||t|||
1490392|NCT01109459|Randomized|Parallel Assignment||||Single|||t|||
1490393|NCT01109446|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1490394|NCT01109433|||Case-Control||Prospective|||||||
1490395|NCT01109420|||Cohort||Prospective|||||||
1490396|NCT01109407|||Cohort||Prospective|||||||
1490397|NCT01109394|||Cohort||Cross-Sectional|||||||
1490398|NCT01109381||Single Group Assignment||Treatment||None (Open Label)||||||
1490399|NCT01109368|||Cohort||Prospective|||||||
1490400|NCT01109355|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490401|NCT01109342|||Case Control||Prospective|||||||
1490402|NCT01109329||Single Group Assignment||Prevention||None (Open Label)||||||
1490403|NCT01109316|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490404|NCT01109303|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1490405|NCT01109290|||Cohort||Prospective|||||||
1490406|NCT01109277|||Cohort|||||||||
1490407|NCT01109264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490805|NCT01104077|||Case-Only||Retrospective|||||||
1490408|NCT01109251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490409|NCT01109238|||Case-Only||Prospective|||||||
1490410|NCT01109225||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490411|NCT01109212|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490412|NCT01109199|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490413|NCT01109186|||Cohort||Prospective|||||||
1490414|NCT01109173|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490415|NCT01109160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490416|NCT01109147|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1490417|NCT01109134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490418|NCT01109121|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490419|NCT01109108|||Other||Prospective|||||||
1490420|NCT01109095||Single Group Assignment||Treatment||None (Open Label)||||||
1490421|NCT01109082|||Cohort||Prospective|||||||
1490422|NCT01109069||Single Group Assignment||Treatment||None (Open Label)||||||
1490423|NCT01109056|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490424|NCT01109043|||Cohort||Prospective|||||||
1490425|NCT01109030|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1490426|NCT01109017|||Cohort||Prospective|||||||
1490427|NCT01109004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490428|NCT01108991|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1490429|NCT01108978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490430|NCT01108965|||Cohort||Cross-Sectional|||||||
1490431|NCT01108952|||Cohort||Prospective|||||||
1490432|NCT01108939||Crossover Assignment||Treatment||None (Open Label)||||||
1490433|NCT01108926||Single Group Assignment||Treatment||None (Open Label)||||||
1490434|NCT01108913|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1490435|NCT01108900|||Case-Only||Prospective|||||||
1490436|NCT01108887|||Cohort||Prospective|||||||
1490437|NCT01108874|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1490438|NCT01108861|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490439|NCT01108848|||Cohort||Prospective|||||||
1490440|NCT01108835|Randomized|Parallel Assignment||Treatment||Single||||||t
1490441|NCT01108822||||||||||||
1490442|NCT01108809|||Cohort||Prospective|||||||
1490443|NCT01108796|||Cohort||Prospective|||||||
1490444|NCT01108783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490445|NCT01108770||||||||||||
1490446|NCT01108757|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1490447|NCT01108744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490448|NCT01108731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490449|NCT01108718|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1490450|NCT01108705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490451|NCT01108692|Randomized|Parallel Assignment||Prevention||Single|||t|||
1490452|NCT01108679|||Cohort||Prospective|||||||
1490453|NCT01108666||||Treatment||||||||
1490454|NCT01108653|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1490455|NCT01108640|||Cohort||Prospective|||||||
1490456|NCT01108627|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1490457|NCT01108614|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490458|NCT01108601|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1490459|NCT01108588|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490460|NCT01108575|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490461|NCT01108562|Randomized|||Treatment||Quadruple|||t|t|t|t
1490462|NCT01108549||Single Group Assignment||Treatment||None (Open Label)||||||
1490463|NCT01108536||Single Group Assignment||Basic Science||None (Open Label)||||||
1490464|NCT01108523||Single Group Assignment||Treatment||None (Open Label)||||||
1490465|NCT01108510|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490466|NCT01108497|||Cohort||Prospective|||||||
1490467|NCT01108484|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1490468|NCT01108471|||Cohort||Prospective|||||||
1490469|NCT01108458||Single Group Assignment||Treatment||None (Open Label)||||||
1490470|NCT01108445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490471|NCT01108432|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490472|NCT01108419|Randomized|Parallel Assignment||||Double|||t||t|
1490473|NCT01108406||Single Group Assignment||Treatment||None (Open Label)||||||
1490474|NCT01108393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490475|NCT01108380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490476|NCT01108367|||Cohort||Retrospective|||||||
1490477|NCT01108354|||Case Control||Cross-Sectional|||||||
1490478|NCT01108341||Single Group Assignment||Treatment||None (Open Label)||||||
1490479|NCT01108328|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1490480|NCT01108315|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1490481|NCT01108302|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490482|NCT01108289|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490483|NCT01108276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490484|NCT01108263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490485|NCT01108250|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1490486|NCT01108237|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490487|NCT01108224|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1490488|NCT01108211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490489|NCT01108198|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1490490|NCT01108185|||||Prospective|||||||
1490491|NCT01108172|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1490492|NCT01108159|||Cohort||Prospective|||||||
1490493|NCT01108146|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1490494|NCT01108133|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1490495|NCT01108120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490496|NCT01108107|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1490497|NCT01108094|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490498|NCT01108081|Randomized|Factorial Assignment||||Single||||||t
1490499|NCT01108068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490500|NCT01108055||Single Group Assignment||Treatment||None (Open Label)||||||
1490501|NCT01108042||Single Group Assignment||Treatment||None (Open Label)||||||
1490502|NCT01108029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490503|NCT01108016|Randomized|Crossover Assignment||||None (Open Label)||||||
1490504|NCT01108003|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490505|NCT01107990|||Case Control||Prospective|||||||
1490506|NCT01107977|Randomized|Parallel Assignment||Treatment||Single||||||t
1490507|NCT01107964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490508|NCT01107951||Single Group Assignment||Treatment||None (Open Label)||||||
1490509|NCT01107938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490510|NCT01107925|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1490511|NCT01107912|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1490512|NCT01107899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490513|NCT01107886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490514|NCT01107873|||||Prospective|||||||
1490515|NCT01107860|||Cohort||Prospective|||||||
1490516|NCT01107847||Parallel Assignment||Diagnostic||None (Open Label)||||||
1490517|NCT01107834|||Case Control||Cross-Sectional|||||||
1490518|NCT01107821||Single Group Assignment||Treatment||None (Open Label)||||||
1490519|NCT01107808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490520|NCT01107795|||Case-Only||Prospective|||||||
1490521|NCT01107782|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490522|NCT01107769|||Cohort||Prospective|||||||
1490523|NCT01107756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490524|NCT01107743|||Case-Only||Prospective|||||||
1490525|NCT01107730|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490526|NCT01107717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490527|NCT01107704|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1490528|NCT01107691|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490529|NCT01107678|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490530|NCT01107665||Single Group Assignment||Treatment||None (Open Label)||||||
1490531|NCT01107639|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1490532|NCT01107626|Randomized|||Treatment||None (Open Label)||||||
1490533|NCT01107613|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1490534|NCT01107600||Single Group Assignment||Treatment||None (Open Label)||Immediate loading||||
1490535|NCT01107587|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490536|NCT01107574|Randomized|Single Group Assignment||Treatment||Triple||||t|t|t
1490537|NCT01107561|Randomized|Parallel Assignment||Treatment||Single||||||t
1490538|NCT01107548|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1490539|NCT01107535|||Cohort||Prospective|||||||
1490540|NCT01107522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490541|NCT01107509||Single Group Assignment||Treatment||None (Open Label)||||||
1490542|NCT01107496|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1490543|NCT01107483|||Cohort||Prospective|||||||
1490544|NCT01107470|||Cohort||Prospective|||||||
1490545|NCT01107457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490546|NCT01107444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490547|NCT01107431|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1490548|NCT01107418|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490549|NCT01107405|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490550|NCT01107392|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490551|NCT01107379|||Cohort||Prospective|||||||
1490552|NCT01107366|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490553|NCT01107353|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490554|NCT01107340||Single Group Assignment||Treatment||None (Open Label)||||||
1490555|NCT01107327|||Case-Only||Prospective|||||||
1490556|NCT01107314|||Other||Prospective|||||||
1490557|NCT01107301|||Case Control||Cross-Sectional|||||||
1490558|NCT01107288|Randomized|Crossover Assignment||Prevention||Single||||||t
1490559|NCT01107275|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490560|NCT01107262|||Case Control||Cross-Sectional|||||||
1490561|NCT01107249||Single Group Assignment||Treatment||None (Open Label)||||||
1490562|NCT01107236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490563|NCT01107223|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1490564|NCT01107210|||Cohort||Prospective|||||||
1490565|NCT01107197|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1490566|NCT01107184|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1490567|NCT01107171|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1490568|NCT01107158|||Case Control||Cross-Sectional|||||||
1490569|NCT01107145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490570|NCT01107132|||Cohort|||||||||
1490571|NCT01107119|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1490572|NCT01107106|||Case-Only||Prospective|||||||
1490573|NCT01107093|Randomized|Crossover Assignment||||Double||||||
1490574|NCT01107080|||Cohort||Prospective|||||||
1490575|NCT01107067||Single Group Assignment||Screening||None (Open Label)||||||
1490576|NCT01107054|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490577|NCT01107041||Single Group Assignment||Other||None (Open Label)||This study is collecting phone sensor data and ecological momentary assessment data to try to develop algorithms that can passively detect behavioral patterns in participants||||
1490578|NCT01107028|||Case-Only||Prospective|||||||
1490579|NCT01107015|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490580|NCT01107002|Randomized|Single Group Assignment||Treatment||Single||||||t
1490581|NCT01106989||Single Group Assignment||Treatment||None (Open Label)||||||
1490582|NCT01106976|||Cohort||Prospective|||||||
1490583|NCT01106963|||Cohort||Prospective|||||||
1490584|NCT01106950||Single Group Assignment||Treatment||None (Open Label)||||||
1490585|NCT01106937|||Cohort||Prospective|||||||
1490586|NCT01106924|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490587|NCT01106911||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490588|NCT01106898||Single Group Assignment||Treatment||None (Open Label)||||||
1490589|NCT01106885|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490590|NCT01106872||Single Group Assignment||Treatment||None (Open Label)||||||
1490591|NCT01106859|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1490592|NCT01106846|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490593|NCT01106833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490594|NCT01106820|Randomized|Parallel Assignment||Treatment||Single||||||t
1490595|NCT01106807|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490596|NCT01106794|||Cohort||Prospective|||||||
1490597|NCT01106781|||Case-Only||Prospective|||||||
1490598|NCT01106768|||Cohort||Prospective|||||||
1490599|NCT01106755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490600|NCT01106742|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490601|NCT01106729||Single Group Assignment||Basic Science||None (Open Label)||||||
1490602|NCT01106716|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490603|NCT01106703|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490604|NCT01106690|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490605|NCT01106677|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490606|NCT01106664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490607|NCT01106651|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490608|NCT01106638|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490609|NCT01106625|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490610|NCT01106612|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490611|NCT01106599|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490612|NCT01106586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490613|NCT01106573|||Cohort||Prospective|||||||
1490614|NCT01106560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490615|NCT01106547|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490616|NCT01106534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490617|NCT01106521||Single Group Assignment||Treatment||None (Open Label)||||||
1490618|NCT01106508||Single Group Assignment||Treatment||None (Open Label)||||||
1490619|NCT01106495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490620|NCT01106482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490621|NCT01106469|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1490622|NCT01106456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490623|NCT01106443|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490624|NCT01106430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490625|NCT01106417|Randomized|Parallel Assignment||Treatment||Single||||||t
1490626|NCT01106404|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490627|NCT01106391||Single Group Assignment||Treatment||None (Open Label)||||||
1490628|NCT01106378|||||Prospective|||||||
1490629|NCT01106365|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490630|NCT01106352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490631|NCT01106339|||Cohort||Prospective|||||||
1490632|NCT01106326||Single Group Assignment||Health Services Research||None (Open Label)||||||
1490633|NCT01106313|||Case-Control||Cross-Sectional|||||||
1490634|NCT01106300|||Cohort||Prospective|||||||
1490635|NCT01106287|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490636|NCT01106274||Single Group Assignment||Treatment||None (Open Label)||||||
1490637|NCT01106261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490638|NCT01106248|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490639|NCT01106235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490640|NCT01106222||||||||||||
1490641|NCT01106209|||Cohort||Prospective|||||||
1490642|NCT01106196|||||Retrospective|||||||
1490643|NCT01106183|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490644|NCT01106170|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1490645|NCT01106157|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490646|NCT01106144|||Case-Only||Retrospective|||||||
1490647|NCT01106131|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490648|NCT01106118|||Cohort||Prospective|||||||
1490649|NCT01106105|||Case-Crossover||Cross-Sectional|||||||
1490650|NCT01106092|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490651|NCT01106079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490652|NCT01106066|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490653|NCT01106053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490654|NCT01106040||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490655|NCT01106027||Single Group Assignment||Prevention||None (Open Label)||||||
1490656|NCT01106014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490657|NCT01106001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490658|NCT01105988|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1490659|NCT01105975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490660|NCT01105962|||Cohort||Prospective|||||||
1490661|NCT01105949|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490662|NCT01105936|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1490663|NCT01105923|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490664|NCT01105910|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1490665|NCT01105897|||Cohort||Prospective|||||||
1490666|NCT01105884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490667|NCT01105871|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1490668|NCT01105858|||Cohort||Other|||||||
1490669|NCT01105845|||||Prospective|||||||
1490670|NCT01105832|Randomized|Parallel Assignment||Treatment||Single||||||t
1490671|NCT01105819|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490672|NCT01105806|||Cohort||Prospective|||||||
1490673|NCT01105793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490674|NCT01105780|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1490675|NCT01105767|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1490676|NCT01105754|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1490677|NCT01105741|||Cohort||Prospective|||||||
1490678|NCT01105728||Single Group Assignment||Treatment||None (Open Label)||||||
1490679|NCT01105715|||Case Control||Prospective|||||||
1490680|NCT01105702||Single Group Assignment||Treatment||None (Open Label)||||||
1490681|NCT01105689|||Cohort||Cross-Sectional|||||||
1490682|NCT01105676||Single Group Assignment||Basic Science||None (Open Label)||||||
1490683|NCT01105663|||Cohort||Prospective|||||||
1490684|NCT01105650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490685|NCT01105637||Single Group Assignment||Prevention||None (Open Label)||||||
1490686|NCT01105624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490687|NCT01105611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490688|NCT01105598|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490689|NCT01105585|Randomized|Single Group Assignment||Treatment||Single|||t|||
1490690|NCT01105572|Randomized|Parallel Assignment||||None (Open Label)||||||
1490691|NCT01105559|||Cohort||Prospective|||||||
1490692|NCT01105546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490693|NCT01105533|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490694|NCT01105520|||Cohort||Prospective|||||||
1490695|NCT01105507||Single Group Assignment||Treatment||None (Open Label)||||||
1490696|NCT01105494|||Cohort||Prospective|||||||
1490697|NCT01105481|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490698|NCT01105468|||Case Control||Prospective|||||||
1490699|NCT01105455|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490700|NCT01105442|||Cohort|||||||||
1490701|NCT01105429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490702|NCT01105416|Randomized|Parallel Assignment||Prevention||Single||||||t
1490703|NCT01105403||Single Group Assignment||Treatment||None (Open Label)||||||
1490704|NCT01105390||Single Group Assignment||Treatment||None (Open Label)||||||
1490705|NCT01105377||Single Group Assignment||Treatment||None (Open Label)||||||
1490706|NCT01105364||||Diagnostic||||||||
1490707|NCT01105351|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1490708|NCT01105338|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1490709|NCT01105325|||Cohort||Prospective|||||||
1490710|NCT01105312||Single Group Assignment||Treatment||None (Open Label)||||||
1490711|NCT01105299|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490712|NCT01105286|Randomized|Single Group Assignment||Treatment||Single|||||t|
1490713|NCT01105273|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490714|NCT01105260|||Cohort||Prospective|||||||
1490715|NCT01105247|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490716|NCT01105234|Randomized|Single Group Assignment||||Single|||||t|
1490717|NCT01105221|Randomized|Parallel Assignment||Treatment||Single||||||t
1490718|NCT01105208|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490719|NCT01105195|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490720|NCT01105182|||Case-Only||Prospective|||||||
1490721|NCT01105169|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1490722|NCT01105156|||Case-Only||Retrospective|||||||
1490723|NCT01105143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490724|NCT01105130|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1490725|NCT01105117|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490726|NCT01105104|Randomized|Parallel Assignment||Prevention||Single||||||t
1490727|NCT01105091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490728|NCT01105078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490729|NCT01105065||Single Group Assignment||Treatment||None (Open Label)||||||
1490730|NCT01105052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490731|NCT01105039|||Cohort||Prospective|||||||
1490732|NCT01105026||Single Group Assignment||Treatment||None (Open Label)||||||
1490733|NCT01105013|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490734|NCT01105000|||Cohort||Cross-Sectional|||||||
1490735|NCT01104987|||Cohort||Prospective|||||||
1490736|NCT01104974|||Cohort||Cross-Sectional|||||||
1490737|NCT01104961|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1490738|NCT01104948|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490739|NCT01104935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490740|NCT01104922||Single Group Assignment||Treatment||None (Open Label)||||||
1490741|NCT01104909|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1490742|NCT01104896|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1490743|NCT01104883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490744|NCT01104870|Randomized|Parallel Assignment||Treatment||Single||||||t
1490745|NCT01104857|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1490746|NCT01104844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490747|NCT01104831|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1490748|NCT01104818|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1490749|NCT01104805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490750|NCT01104792|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490751|NCT01104779|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490752|NCT01104766|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490753|NCT01104753|||||Prospective|||||||
1490754|NCT01104740|||Cohort||Prospective|||||||
1490755|NCT01104727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490756|NCT01104714|||Cohort||Prospective|||||||
1490757|NCT01104701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490758|NCT01104688|||||Cross-Sectional|||||||
1490759|NCT01104675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490760|NCT01104662|Randomized|Parallel Assignment||Treatment||Single||||||t
1490761|NCT01104649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490762|NCT01104636|||Cohort||Prospective|||||||
1490763|NCT01104623|||Cohort||Prospective|||||||
1490764|NCT01104610|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1490765|NCT01104597||Single Group Assignment||Health Services Research||None (Open Label)||||||
1490766|NCT01104584||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490767|NCT01104571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490768|NCT01104558||Single Group Assignment||Treatment||None (Open Label)||||||
1490769|NCT01104545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490770|NCT01104532|Randomized|Crossover Assignment||||None (Open Label)||||||
1490771|NCT01104519|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490772|NCT01104506|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490773|NCT01104493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490774|NCT01104480||Single Group Assignment||Treatment||None (Open Label)||||||
1490775|NCT01104467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490776|NCT01104454|||Cohort||Cross-Sectional|||||||
1490777|NCT01104441|||Case-Only||Prospective|||||||
1490778|NCT01104428|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1490779|NCT01104415||Single Group Assignment||Treatment||None (Open Label)||||||
1490780|NCT01104402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490781|NCT01104389|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1490782|NCT01104376||Single Group Assignment||Screening||None (Open Label)||||||
1490783|NCT01104363|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1490784|NCT01104350||Single Group Assignment||Treatment||None (Open Label)||||||
1490785|NCT01104337|Randomized|Parallel Assignment||Screening||Triple|||t|t|t|
1490786|NCT01104324|||Cohort||Prospective|||||||
1490787|NCT01104311|Randomized|Parallel Assignment||Treatment||Single||||||t
1490788|NCT01104298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490789|NCT01104285|||||Retrospective|||||||
1490790|NCT01104272|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1490791|NCT01104259||Single Group Assignment||Treatment||None (Open Label)||||||
1490792|NCT01104246||Single Group Assignment||Treatment||None (Open Label)||||||
1490793|NCT01104233|||||Prospective|||||||
1490794|NCT01104220|||Case-Control||Cross-Sectional|||||||
1490795|NCT01104207|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1490796|NCT01104194|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490797|NCT01104181|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1490798|NCT01104168|||Cohort||Retrospective|||||||
1490799|NCT01104155|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490800|NCT01104142|||Cohort||Prospective|||||||
1490801|NCT01104129|||Case-Control||Prospective|||||||
1490802|NCT01104116||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490803|NCT01104103|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1490806|NCT01104064|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490807|NCT01104051|||Case-Crossover||Prospective|||||||
1490808|NCT01104038|Randomized|Single Group Assignment||Prevention||Triple|||t|t||t
1490809|NCT01104025||Single Group Assignment||Treatment||None (Open Label)||||||
1490810|NCT01104012|||Cohort||Cross-Sectional|||||||
1490811|NCT01103999|||Cohort||Prospective|||||||
1490812|NCT01103986|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1490813|NCT01103973|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490814|NCT01103960|Randomized|Parallel Assignment||Treatment||Double||||||
1490815|NCT01103947|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1490816|NCT01103934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490817|NCT01103921|Non-Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1490818|NCT01103908|||||Prospective|||||||
1490819|NCT01103895|||||Prospective|||||||
1490820|NCT01103882|||Cohort||Prospective|||||||
1490821|NCT01103869||||||||||||
1490822|NCT01103856|Randomized|Parallel Assignment||Treatment||Single||||||t
1490823|NCT01103843|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490824|NCT01103830|Randomized|Parallel Assignment||Treatment||Single||||||t
1490825|NCT01103817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490826|NCT01103804|||Cohort||Prospective|||||||
1490827|NCT01103791|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490828|NCT01103778||Single Group Assignment||Treatment||None (Open Label)||||||
1490829|NCT01103765|Randomized|Parallel Assignment||Treatment||Single||||||t
1490830|NCT01103752|||||Prospective|||||||
1490831|NCT01103739|Randomized|Parallel Assignment||||None (Open Label)||||||
1490832|NCT01103726|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1490833|NCT01103713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490834|NCT01103700|||Cohort||Prospective|||||||
1490835|NCT01103687|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1490836|NCT01103674||Single Group Assignment||Treatment||None (Open Label)||||||
1490837|NCT01103661||Single Group Assignment||Treatment||None (Open Label)||||||
1490838|NCT01103648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490839|NCT01103635||Single Group Assignment||Treatment||None (Open Label)||||||
1490840|NCT01103622|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490841|NCT01103609|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490842|NCT01103596|||||Retrospective|||||||
1490843|NCT01103583|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490844|NCT01103570|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490845|NCT01103557||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490846|NCT01103544|||Cohort||Prospective|||||||
1490847|NCT01103531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490848|NCT01103518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490849|NCT01103505|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490850|NCT01103492||Single Group Assignment||Treatment||None (Open Label)||||||
1490851|NCT01103479|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1490852|NCT01103466|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490853|NCT01103453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490854|NCT01103440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490855|NCT01103427|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490856|NCT01103414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490857|NCT01103401|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490858|NCT01103388|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490859|NCT01103375||Single Group Assignment||Treatment||None (Open Label)||||||
1490860|NCT01103362||Single Group Assignment||Treatment||None (Open Label)||||||
1490861|NCT01103349|Randomized|Parallel Assignment||Treatment||Double||||||
1490862|NCT01103336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490863|NCT01103323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490864|NCT01103310|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1490865|NCT01103297||Single Group Assignment||Treatment||None (Open Label)||||||
1490866|NCT01103284|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490867|NCT01103271|Randomized|Single Group Assignment||Treatment||Single|||||t|
1490868|NCT01103258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490869|NCT01103245|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490870|NCT01103232|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1490871|NCT01103219|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1490872|NCT01103206|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1490873|NCT01103193|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1490874|NCT01103180|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1490875|NCT01103167||Single Group Assignment||Treatment||None (Open Label)||||||
1490876|NCT01103154|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490877|NCT01103141|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1490878|NCT01103128|||Cohort||Retrospective|||||||
1490879|NCT01103115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490880|NCT01103102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490881|NCT01103089|||Case-Only||Retrospective|||||||
1490882|NCT01103076|Randomized|Crossover Assignment||Treatment||Single|||t|||
1490883|NCT01103063|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490884|NCT01103050|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1490885|NCT01103037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490886|NCT01103024|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490887|NCT01103011|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490888|NCT01102998|||Cohort||Prospective|||||||
1490889|NCT01102985|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1490890|NCT01102972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490891|NCT01102959|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1490892|NCT01102946|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490893|NCT01102933|||Case-Only||Prospective|||||||
1490894|NCT01102920|Randomized|Parallel Assignment||Treatment||Single||||||t
1490895|NCT01102907|||Case Control||Cross-Sectional|||||||
1490896|NCT01102894||Single Group Assignment||||Single|||t|||
1490897|NCT01102881|Randomized|Crossover Assignment||||Double|||t||t|
1490898|NCT01102868|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1490899|NCT01102855|||||Prospective|||||||
1490900|NCT01102842|||||Cross-Sectional|||||||
1490901|NCT01102829|||Cohort||Prospective|||||||
1490902|NCT01102816|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1490903|NCT01102803|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490904|NCT01102790|||Cohort||Prospective|||||||
1490905|NCT01102777|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1490906|NCT01102764|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1490907|NCT01102751|||Case Control||Prospective|||||||
1490908|NCT01102738|||Ecologic or Community||Prospective|||||||
1490909|NCT01102725|||Case-Only||Prospective|||||||
1490910|NCT01102712||Single Group Assignment||Treatment||None (Open Label)||||||
1490911|NCT01102699||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490912|NCT01102686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490913|NCT01102673|Randomized|Crossover Assignment||||Double|||t||t|
1490914|NCT01102660|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490915|NCT01102647|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1490916|NCT01102634|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1490917|NCT01102621|||Case Control||Prospective|||||||
1490918|NCT01102608||Single Group Assignment||Treatment||None (Open Label)||||||
1490919|NCT01102595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490920|NCT01102582|||Cohort||Prospective|||||||
1490921|NCT01102569|||Cohort||Prospective|||||||
1490922|NCT01102556|||Cohort||Prospective|||||||
1490923|NCT01102543|||Cohort||Prospective|||||||
1490924|NCT01102530|||Cohort||Retrospective|||||||
1490925|NCT01102517|Randomized|Parallel Assignment||Treatment||Single||||||t
1490926|NCT01102504|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1490927|NCT01102491|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1490928|NCT01102478|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490929|NCT01102465|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1490930|NCT01102452|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1490931|NCT01102439|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1490932|NCT01102426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490933|NCT01102413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490934|NCT01102400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490935|NCT01102387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490936|NCT01102374|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1490937|NCT01102361||Single Group Assignment||Diagnostic||None (Open Label)||||||
1490938|NCT01102348||Single Group Assignment||Supportive Care||None (Open Label)||||||
1490939|NCT01102335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490940|NCT01102322|||Cohort||Prospective|||||||
1490941|NCT01102309|Randomized|Parallel Assignment||Treatment||Single||||||t
1490942|NCT01102296|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1490943|NCT01102283|||Cohort||Prospective|||||||
1490944|NCT01102270|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1490945|NCT01102257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1490946|NCT01102244|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490947|NCT01102231||Single Group Assignment||Treatment||None (Open Label)||||||
1490948|NCT01102218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490949|NCT01102205|||Cohort||Prospective|||||||
1490950|NCT01102192|||Case-Control||Prospective|||||||
1490951|NCT01102179|||||Cross-Sectional|||||||
1490952|NCT01102166||Crossover Assignment||Treatment||None (Open Label)||||||
1490953|NCT01102153|||Cohort||Prospective|||||||
1490954|NCT01102140|Randomized|Parallel Assignment||Treatment||Single|The participant will either receive POMx or matching placebo (sugar pill)||t|||
1490955|NCT01102127|||Case Control||Cross-Sectional|||||||
1490956|NCT01102114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490957|NCT01102101||Single Group Assignment||Basic Science||None (Open Label)||||||
1490958|NCT01102088||Single Group Assignment||Treatment||None (Open Label)||||||
1490959|NCT01102075|Randomized|Parallel Assignment||Treatment||Single|||t|||
1490960|NCT01102062||Single Group Assignment||Basic Science||None (Open Label)||||||
1490961|NCT01102049||Single Group Assignment||Basic Science||None (Open Label)||||||
1490962|NCT01102036|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1490963|NCT01102023||||||||||||
1490964|NCT01102010|Randomized|Single Group Assignment||Treatment||Single||||||t
1490965|NCT01101997|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1490966|NCT01101984|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490967|NCT01101971||Single Group Assignment||Other||None (Open Label)||||||
1490968|NCT01101958||Single Group Assignment||Treatment||None (Open Label)||||||
1490969|NCT01101945||Single Group Assignment||Treatment||None (Open Label)||||||
1490970|NCT01101932|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1490971|NCT01101919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1490972|NCT01101906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490973|NCT01101893|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1490974|NCT01101880||Single Group Assignment||Treatment||None (Open Label)||||||
1490975|NCT01101867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490976|NCT01101854|||Cohort||Prospective|||||||
1490977|NCT01101841|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1490978|NCT01101828|||||Cross-Sectional|||||||
1490979|NCT01101815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490980|NCT01101802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1490981|NCT01101789|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490982|NCT01101776|||Cohort||Prospective|||||||
1490983|NCT01101763|||Case-Only||Prospective|||||||
1490984|NCT01101750|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1490985|NCT01101737|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1490986|NCT01101724|Randomized|Parallel Assignment||Treatment||Single|||||t|
1490987|NCT01101711|||Cohort||Prospective|||||||
1490988|NCT01101698|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1490989|NCT01101685|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1490990|NCT01101672|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1490991|NCT01101659|Randomized|Crossover Assignment||Basic Science||Double||||||
1490992|NCT01101646|Randomized|Crossover Assignment||||None (Open Label)||||||
1490993|NCT01101633|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1490994|NCT01101620|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1490995|NCT01101607|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1490996|NCT01101594||Single Group Assignment||Treatment||None (Open Label)||||||
1490997|NCT01101581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1490998|NCT01101568|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1490999|NCT01101555|Randomized|Single Group Assignment||Treatment||Single|||t|||
1491000|NCT01101542|||Cohort||Prospective|||||||
1491001|NCT01101529|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491002|NCT01101503|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491003|NCT01101490|||Case Control||Prospective|||||||
1491004|NCT01101477|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1491005|NCT01101464|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1491006|NCT01101451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491007|NCT01101438|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491008|NCT01101425|||Case-Only||Prospective|||||||
1491009|NCT01101412|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1491010|NCT01101399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491011|NCT01101386|||Case-Only||Prospective|||||||
1491012|NCT01101373|||Cohort||Retrospective|||||||
1491013|NCT01101360||Single Group Assignment||Treatment||Single|||t|||
1491014|NCT01101347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491015|NCT01101334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491016|NCT01101321|Randomized|Crossover Assignment||||None (Open Label)||||||
1491017|NCT01101308|Randomized|Crossover Assignment||||None (Open Label)||||||
1491018|NCT01101295|||Cohort||Prospective|||||||
1491019|NCT01101282|Randomized|Parallel Assignment||Treatment||Single||||||t
1491020|NCT01101269|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491021|NCT01101256|||Cohort||Prospective|||||||
1491022|NCT01101243|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1491023|NCT01101230|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1491024|NCT01101217|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491025|NCT01101204|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1491026|NCT01101191|Randomized|Crossover Assignment||||None (Open Label)||||||
1491027|NCT01101178|Randomized|Crossover Assignment||||None (Open Label)||||||
1491028|NCT01101165|Randomized|Crossover Assignment||||None (Open Label)||||||
1491029|NCT01101152|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1491030|NCT01101139|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491031|NCT01101126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491032|NCT01101113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491033|NCT01101100||Single Group Assignment||Treatment||None (Open Label)||||||
1491034|NCT01101087|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1491035|NCT01101074|||Cohort||Prospective|||||||
1491036|NCT01101061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491037|NCT01101048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491038|NCT01101035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491039|NCT01101022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491040|NCT01101009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491041|NCT01100996|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491042|NCT01100983||||||||||||
1491043|NCT01100970|||Cohort||Prospective|||||||
1491044|NCT01100957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491045|NCT01100944||Single Group Assignment||Treatment||None (Open Label)||||||
1491046|NCT01100931||Single Group Assignment||Treatment||None (Open Label)||||||
1491047|NCT01100918|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491048|NCT01100905||||||||||||
1491049|NCT01100892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491050|NCT01100879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491051|NCT01100866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491052|NCT01100853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491053|NCT01100840|||Case-Crossover||Cross-Sectional|||||||
1491054|NCT01100827|||Cohort||Retrospective|||||||
1491055|NCT01100814|||Case Control||Cross-Sectional|||||||
1491056|NCT01100801|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491057|NCT01100788|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1491058|NCT01100775|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1491059|NCT01100762||Single Group Assignment||Treatment||None (Open Label)||||||
1491060|NCT01100749|||Case-Only||Prospective|||||||
1491061|NCT01100736|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1491062|NCT01100723||Single Group Assignment||Treatment||None (Open Label)||||||
1491063|NCT01100710|||Case-Only||Cross-Sectional|||||||
1491064|NCT01100697|||Cohort||Retrospective|||||||
1491065|NCT01100684|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491066|NCT01100671|||Cohort||Cross-Sectional|||||||
1491067|NCT01100658|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491068|NCT01100645|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491069|NCT01100632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491070|NCT01100619||Single Group Assignment||Treatment||None (Open Label)||||||
1491071|NCT01100606|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491072|NCT01100593|Randomized|Single Group Assignment||||None (Open Label)||||||
1491073|NCT01100580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491074|NCT01100567|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491075|NCT01100554||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491076|NCT01100541||Single Group Assignment||||None (Open Label)||||||
1491077|NCT01100528||Single Group Assignment||Treatment||None (Open Label)||||||
1491078|NCT01100515|Randomized|Parallel Assignment||Treatment||Single||||||t
1491079|NCT01100502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491080|NCT01100489||Single Group Assignment||Treatment||None (Open Label)||||||
1491081|NCT01100476||Single Group Assignment||Treatment||None (Open Label)||||||
1491082|NCT01100463|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1491083|NCT01100450||Single Group Assignment||Health Services Research||None (Open Label)||||||
1491084|NCT01100437|Randomized|Crossover Assignment||||Triple|||t||t|t
1491085|NCT01100424|Non-Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1491086|NCT01100411|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491087|NCT01100398|||Cohort||Prospective|||||||
1491088|NCT01100385|Randomized|Parallel Assignment||||Double|||t||t|
1491089|NCT01100372|Randomized|||Treatment||||||||
1491090|NCT01100359||||Treatment||None (Open Label)||||||
1491091|NCT01100346|||Cohort||Prospective|||||||
1491092|NCT01100333|||Cohort||Prospective|||||||
1491093|NCT01100320|Randomized|Crossover Assignment||||None (Open Label)||||||
1491094|NCT01100307|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491095|NCT01100294|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1491096|NCT01100281|||Case Control||Prospective|||||||
1491097|NCT01100268||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491098|NCT01100255|Randomized|Crossover Assignment||||Double|||t||t|
1491099|NCT01100242||Single Group Assignment||Treatment||None (Open Label)||||||
1491100|NCT01100216|Randomized|Crossover Assignment||||None (Open Label)||||||
1491101|NCT01100203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491102|NCT01100190||Single Group Assignment||Treatment||None (Open Label)||||||
1491103|NCT01100177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491104|NCT01100164|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491105|NCT01100151|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1491106|NCT01100125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491107|NCT01100112||Single Group Assignment||Treatment||None (Open Label)||||||
1491108|NCT01100099|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1491109|NCT01100086|Randomized|Crossover Assignment||||None (Open Label)||||||
1491110|NCT01100073|||Cohort||Prospective|||||||
1491111|NCT01100060|Randomized|Parallel Assignment||||None (Open Label)||||||
1491112|NCT01100047|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1491113|NCT01100034|||Cohort||Prospective|||||||
1491114|NCT01100021|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491115|NCT01100008||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491116|NCT01099995|Randomized|Parallel Assignment||Treatment||Single||||||t
1491117|NCT01099982|||Cohort||Prospective|||||||
1491118|NCT01099969|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491119|NCT01099956|||Case Control||Prospective|||||||
1491120|NCT01099943|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1491121|NCT01099930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491122|NCT01099917||Single Group Assignment||Treatment||None (Open Label)||||||
1491123|NCT01099904|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1491124|NCT01099891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491125|NCT01099878|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491126|NCT01099865|||Cohort||Cross-Sectional|||||||
1491127|NCT01099852|||Cohort||Prospective|||||||
1491128|NCT01099839|Randomized|Crossover Assignment||||None (Open Label)||||||
1491129|NCT01099826|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1491130|NCT01099813|||Cohort||Prospective|||||||
1491131|NCT01099800|||Family-Based||Prospective|||||||
1491132|NCT01099787|||Case-Only||Prospective|||||||
1491133|NCT01099774|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491134|NCT01099761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491135|NCT01099748|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491136|NCT01099735|||Case-Only||Prospective|||||||
1491137|NCT01099722|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491138|NCT01099709|Randomized|Crossover Assignment||||None (Open Label)||||||
1491139|NCT01099696|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491140|NCT01099683|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491141|NCT01099670|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491142|NCT01099657|Randomized|Parallel Assignment||Treatment||Single||||t||
1491143|NCT01099644||Single Group Assignment||Treatment||None (Open Label)||||||
1491144|NCT01099631||Single Group Assignment||Treatment||None (Open Label)||||||
1491145|NCT01099618|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491146|NCT01099605|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491147|NCT01099592||Single Group Assignment||Treatment||None (Open Label)||||||
1491148|NCT01099579|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491149|NCT01099566|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491150|NCT01099553|Randomized|Parallel Assignment||Treatment||Single||||||t
1491151|NCT01099540||Single Group Assignment||Treatment||None (Open Label)||||||
1491152|NCT01099527||Single Group Assignment||Treatment||None (Open Label)||||||
1491153|NCT01099514||Single Group Assignment||Treatment||None (Open Label)||||||
1491154|NCT01099501|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491155|NCT01099488||Single Group Assignment||Other||None (Open Label)||||||
1491156|NCT01099475|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1491157|NCT01099462|||Cohort||Prospective|||||||
1491158|NCT01099449|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1491159|NCT01099436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491160|NCT01099423|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491161|NCT01099410|||Case-Only||Prospective|||||||
1491162|NCT01099397|||Cohort||Prospective|||||||
1491163|NCT01099384|Randomized|Parallel Assignment||Treatment||Single||||||t
1491164|NCT01099371|Randomized|Parallel Assignment||Treatment||Single||||||t
1491165|NCT01099358|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1491166|NCT01099345|||Case Control||Prospective|||||||
1491167|NCT01099332|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491168|NCT01099319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491169|NCT01099306|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1491170|NCT01099293|||Case Control||Cross-Sectional|||||||
1491171|NCT01099280|Randomized|Parallel Assignment||||None (Open Label)||||||
1491172|NCT01099267|||||Retrospective|||||||
1491173|NCT01099254|||||Prospective|||||||
1491174|NCT01099241|||||Prospective|||||||
1491175|NCT01099228|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491176|NCT01099215||Single Group Assignment||Treatment||None (Open Label)||||||
1491177|NCT01099202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491178|NCT01099189|||Cohort||Prospective|||||||
1491179|NCT01099176|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1491180|NCT01099163|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1491181|NCT01099150|Randomized|Crossover Assignment||Prevention||Single|||||t|
1491182|NCT01099137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491183|NCT01099124|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491184|NCT01099111|||Case Control||Cross-Sectional|||||||
1491185|NCT01099098|||Case Control||Prospective|||||||
1491186|NCT01099085|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491187|NCT01099072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491188|NCT01099059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491189|NCT01099046|Randomized|Crossover Assignment||Treatment||Single||||||t
1491190|NCT01099033|||Case-Control||Prospective|||||||
1491191|NCT01099020|||Case-Only||Prospective|||||||
1491192|NCT01099007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491193|NCT01098994|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1491194|NCT01098981|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491195|NCT01098968|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491196|NCT01098955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491197|NCT01098942|||Cohort||Prospective|||||||
1491198|NCT01098929|||Case-Only||Prospective|||||||
1491199|NCT01098916|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1491200|NCT01098903|||Cohort||Prospective|||||||
1491201|NCT01098890|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1491202|NCT01098877|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491203|NCT01098864||Single Group Assignment||||None (Open Label)||||||
1491204|NCT01098851|||Case Control||Prospective|||||||
1491205|NCT01098838|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491206|NCT01098825|||Case-Only||Retrospective|||||||
1491207|NCT01098812|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1491208|NCT01098799|||||Prospective|||||||
1491209|NCT01098786|||Cohort||Prospective|||||||
1491210|NCT01098773|||||Cross-Sectional|||||||
1491211|NCT01098760||Single Group Assignment||Treatment||None (Open Label)||||||
1491212|NCT01098747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491213|NCT01098734|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1491214|NCT01098721|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491215|NCT01098708|||Cohort||Prospective|||||||
1491216|NCT01098695|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491217|NCT01098682||||||||||||
1491218|NCT01098669|||Cohort||Cross-Sectional|||||||
1491219|NCT01098656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491220|NCT01098643||Single Group Assignment||Health Services Research||||||||
1491221|NCT01098630|||Cohort||Prospective|||||||
1491222|NCT01098617|||Case Control||Prospective|||||||
1491223|NCT01098604|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1491224|NCT01098591|||Case-Only||Retrospective|||||||
1491225|NCT01098578||Single Group Assignment||Treatment||None (Open Label)||||||
1491226|NCT01098565|Randomized|Single Group Assignment||||Double|||t||t|
1491227|NCT01098552|||Cohort||Prospective|||||||
1491228|NCT01098539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491229|NCT01098526||Single Group Assignment||Treatment||None (Open Label)||||||
1491230|NCT01098513|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491231|NCT01098500|||Cohort||Retrospective|||||||
1491232|NCT01098487||Single Group Assignment||Treatment||None (Open Label)||||||
1491233|NCT01098474|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491234|NCT01098461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491235|NCT01098448|Randomized|Factorial Assignment||Treatment||Single||||||t
1491236|NCT01098435|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491237|NCT01098422||Single Group Assignment||Treatment||None (Open Label)||||||
1491238|NCT01098409|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1491239|NCT01098396|||Case-Only|||||||||
1491240|NCT01098383|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491241|NCT01098357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491242|NCT01098344|Non-Randomized|||Treatment||None (Open Label)||||||
1491243|NCT01098331|Randomized|||||None (Open Label)||||||
1491244|NCT01098318|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491245|NCT01098305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491246|NCT01098292|||Cohort||Prospective|||||||
1491247|NCT01098279|||Cohort||Prospective|||||||
1491248|NCT01098266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491249|NCT01098253|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491250|NCT01098240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491251|NCT01098227|||Case Control||Prospective|||||||
1491252|NCT01098214|||Cohort||Prospective|||||||
1491253|NCT01098201|||Cohort||Prospective|||||||
1491254|NCT01098188||Single Group Assignment||Treatment||None (Open Label)||||||
1491255|NCT01098175|||Case Control||Prospective|||||||
1491256|NCT01098162|||Cohort||Prospective|||||||
1491257|NCT01098149|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491258|NCT01098136|Randomized|Factorial Assignment||Treatment||Single||||||t
1491259|NCT01098123|||Case Control||Retrospective|||||||
1491260|NCT01098110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491261|NCT01098097|||Cohort||Prospective|||||||
1491262|NCT01098084||Single Group Assignment||||||||||
1491263|NCT01098071||Single Group Assignment||Treatment||None (Open Label)||||||
1491264|NCT01098058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491265|NCT01098045|||Case Control||Cross-Sectional|||||||
1491266|NCT01098032|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491267|NCT01098019|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491268|NCT01098006|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1491269|NCT01097993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491270|NCT01097980|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1491271|NCT01097967|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491272|NCT01097954|||Case-Only||Prospective|||||||
1491273|NCT01097941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491274|NCT01097928|||Other||Prospective|||||||
1491275|NCT01097915|||Cohort||Prospective|||||||
1491276|NCT01097902|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1491277|NCT01097889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491278|NCT01097876|Randomized|Crossover Assignment||||Double|||t||t|
1491279|NCT01097863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491280|NCT01097850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491281|NCT01097837|||Ecologic or Community||Prospective|||||||
1491282|NCT01097824||||||||||||
1491283|NCT01097811|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1491284|NCT01097798|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491285|NCT01097785|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1491286|NCT01097772||Single Group Assignment||Treatment||None (Open Label)||||||
1491287|NCT01097759|||||Prospective|||||||
1491288|NCT01097746||Single Group Assignment||Treatment||None (Open Label)||||||
1491289|NCT01097733|||Cohort||Prospective|||||||
1491290|NCT01097720|||Cohort||Prospective|||||||
1491291|NCT01097707|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491292|NCT01097694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491293|NCT01097681|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1491294|NCT01097668|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491295|NCT01097655|||Cohort||Prospective|||||||
1491296|NCT01097642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491297|NCT01097629|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491298|NCT01097616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491299|NCT01097603|||Case-Only||Cross-Sectional|||||||
1491300|NCT01097590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491301|NCT01097577|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491302|NCT01097564|||Case Control||Cross-Sectional|||||||
1491303|NCT01097551|||Case Control||Prospective|||||||
1491304|NCT01097538|Randomized|Parallel Assignment||||None (Open Label)||||||
1491305|NCT01097525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491306|NCT01097512|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491307|NCT01097499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491308|NCT01097486|Randomized|Parallel Assignment||Treatment||Single||||||t
1491309|NCT01097473|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1491310|NCT01097460||Single Group Assignment||Treatment||None (Open Label)||||||
1491311|NCT01097447|||Cohort||Prospective|||||||
1491312|NCT01097434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491313|NCT01097421|||||Prospective|||||||
1491314|NCT01097408|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491315|NCT01097395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491316|NCT01097382||Single Group Assignment||Treatment||None (Open Label)||||||
1491317|NCT01097369|||Cohort||Prospective|||||||
1491318|NCT01097356|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491319|NCT01097343|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1491320|NCT01097330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491321|NCT01097317|Randomized|||Supportive Care||None (Open Label)||||||
1491322|NCT01097304||Single Group Assignment||Prevention||None (Open Label)||||||
1491323|NCT01097278|Randomized|Parallel Assignment||Prevention||Double||Randomized Phase 2 study|t||t|
1491324|NCT01097265|Randomized|||Diagnostic||None (Open Label)||||||
1491325|NCT01097252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491326|NCT01097239||Single Group Assignment||Supportive Care||None (Open Label)||||||
1491327|NCT01097226|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1491328|NCT01097213|||Cohort||Prospective|||||||
1491329|NCT01097200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491330|NCT01097174|||Case-Only||Other|||||||
1491331|NCT01097161||Single Group Assignment||Treatment||None (Open Label)||||||
1491332|NCT01097148|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1491333|NCT01097135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491334|NCT01097122||Single Group Assignment||Basic Science||Double|||t|||t
1491335|NCT01097109|||Cohort||Cross-Sectional|||||||
1491336|NCT01097096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491337|NCT01097083|Randomized|||Treatment||||||||
1491338|NCT01097070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491339|NCT01097057||Single Group Assignment||Treatment||None (Open Label)||||||
1491340|NCT01097044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491341|NCT01097031|||||Prospective|||||||
1491342|NCT01097018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491343|NCT01097005|||Cohort||Prospective|||||||
1491344|NCT01096992|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491345|NCT01096979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491346|NCT01096966|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491347|NCT01096953|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1491348|NCT01096940|Randomized|Single Group Assignment||||None (Open Label)||||||
1491349|NCT01096927||Single Group Assignment||Treatment||None (Open Label)||||||
1491350|NCT01096914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491351|NCT01096901|Randomized|Parallel Assignment||Prevention||Single|||t|||
1491352|NCT01096888|Randomized|Parallel Assignment||Prevention||Single|||t|||
1491353|NCT01096875|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491354|NCT01096862|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1491355|NCT01096849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491356|NCT01096836|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491357|NCT01096823|Randomized|Parallel Assignment||Treatment||Single||||||t
1491358|NCT01096810||Single Group Assignment||Treatment||None (Open Label)||||||
1491359|NCT01096797||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491360|NCT01096784|Randomized|Parallel Assignment||Prevention||Single||||||t
1491361|NCT01096771|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491362|NCT01096758|||Case Control||Cross-Sectional|||||||
1491363|NCT01096745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491364|NCT01096732||Single Group Assignment||Treatment||None (Open Label)||||||
1491365|NCT01096719|Randomized|Parallel Assignment||Treatment||Single||||||t
1491366|NCT01096706|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1491367|NCT01096693|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1491368|NCT01096680|Randomized|Parallel Assignment||||Triple|||t||t|t
1491369|NCT01096667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491370|NCT01096654|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1491371|NCT01096641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491372|NCT01096628|Randomized|Parallel Assignment||Treatment||Single||||||t
1491373|NCT01096615|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1491374|NCT01096602||Single Group Assignment||Treatment||None (Open Label)||||||
1491375|NCT01096589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491376|NCT01096576||Parallel Assignment||Treatment||Double|||t||t|
1491377|NCT01096563|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1491378|NCT01096550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491379|NCT01096537|||Cohort||Retrospective|||||||
1491380|NCT01096524|Randomized|Parallel Assignment||Treatment||Single||||||t
1491381|NCT01096511|||Cohort||Prospective|||||||
1491382|NCT01096498|Randomized|Crossover Assignment||||None (Open Label)||||||
1491383|NCT01096485|Randomized|Crossover Assignment||||None (Open Label)||||||
1491384|NCT01096472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491385|NCT01096459||Single Group Assignment||Treatment||None (Open Label)||||||
1491386|NCT01096446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491387|NCT01096433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491388|NCT01096420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491389|NCT01096407|||Cohort||Prospective|||||||
1491390|NCT01096394|||Cohort||Prospective|||||||
1491391|NCT01096381|||Cohort||Prospective|||||||
1491392|NCT01096368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491393|NCT01096355|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491394|NCT01096342||Single Group Assignment||Treatment||None (Open Label)||||||
1491395|NCT01096329|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1491396|NCT01096316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491397|NCT01096303|||Case-Control||Cross-Sectional|||||||
1491398|NCT01096290|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491399|NCT01096277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491400|NCT01096264|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1491401|NCT01096251|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491402|NCT01096238||||||||||||
1491403|NCT01096225|||Cohort||Prospective|||||||
1491404|NCT01096212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491405|NCT01096199||||||||||||
1491406|NCT01096186||Single Group Assignment||Treatment||None (Open Label)||||||
1491407|NCT01096173||||||||||||
1491408|NCT01096160|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491409|NCT01096147||Single Group Assignment||Treatment||None (Open Label)||||||
1491410|NCT01096134||Single Group Assignment||Prevention||None (Open Label)||||||
1491411|NCT01096121|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491412|NCT01096108|Randomized|Single Group Assignment||||None (Open Label)||||||
1491413|NCT01096095|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491414|NCT01096082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491415|NCT01096069|||Cohort||Prospective|||||||
1491416|NCT01096056|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491417|NCT01096043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491418|NCT01096030|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491419|NCT01096017|Randomized|Crossover Assignment||Treatment||Single|||t|||
1491420|NCT01096004|Randomized|Parallel Assignment||||Single|||t|||
1491421|NCT01095991|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491422|NCT01095978|||||Prospective|||||||
1491423|NCT01095965|Randomized|Parallel Assignment||||None (Open Label)||||||
1491424|NCT01095952||Single Group Assignment||Treatment||None (Open Label)||||||
1491425|NCT01095939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491426|NCT01095926||Single Group Assignment||Treatment||None (Open Label)||||||
1491427|NCT01095913||Single Group Assignment||Treatment||None (Open Label)||||||
1491428|NCT01095900|||Case Control||Prospective|||||||
1491429|NCT01095887||Single Group Assignment||Treatment||None (Open Label)||||||
1491430|NCT01095874|||Cohort||Prospective|||||||
1491431|NCT01095861|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1491432|NCT01095848|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491433|NCT01095835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491434|NCT01095822|Randomized|Parallel Assignment||Treatment||Single|||||t|
1491435|NCT01095809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491436|NCT01095796|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491437|NCT01095783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491438|NCT01095770|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491439|NCT01095757||Single Group Assignment||Treatment||None (Open Label)||||||
1491440|NCT01095744|||Case Control||Prospective|||||||
1491441|NCT01095731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491442|NCT01095718|Randomized|Single Group Assignment||Prevention||Double|||||t|t
1491443|NCT01095705|Randomized|Parallel Assignment||Treatment||Single|||||t|
1491444|NCT01095692|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491445|NCT01095679|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491446|NCT01095666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491447|NCT01095653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491448|NCT01095640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491449|NCT01095627||Single Group Assignment||Basic Science||None (Open Label)||||||
1491450|NCT01095614||||||||||||
1491451|NCT01095601|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1491452|NCT01095588|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491453|NCT01095575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491454|NCT01095562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491455|NCT01095549|Randomized|Parallel Assignment||Treatment||Single||||||t
1491456|NCT01095536|||Cohort||Prospective|||||||
1491457|NCT01095523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491458|NCT01095510|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491459|NCT01095497|Randomized|Crossover Assignment||||None (Open Label)||||||
1491460|NCT01095484|||Case-Only||Prospective|||||||
1491461|NCT01095471|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491462|NCT01095458|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491463|NCT01095445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491464|NCT01095432|||Cohort||Prospective|||||||
1491465|NCT01095419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491466|NCT01095406|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491467|NCT01095393|||Cohort||Prospective|||||||
1491468|NCT01095380|Randomized|Parallel Assignment||Treatment||Single||||||t
1491469|NCT01095367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491470|NCT01095354|||Cohort||Prospective|||||||
1491471|NCT01095341|||Case Control||Prospective|||||||
1491472|NCT01095328|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1491473|NCT01095315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491474|NCT01095302||Single Group Assignment||Treatment||None (Open Label)||||||
1491475|NCT01095289|||Case-Only||Cross-Sectional|||||||
1491476|NCT01095276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491477|NCT01095263|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491478|NCT01095250|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491479|NCT01095237|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491480|NCT01095224|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1491481|NCT01095211|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1491482|NCT01095198|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491483|NCT01095185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491484|NCT01095172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491485|NCT01095159|Randomized|Parallel Assignment||Treatment||Single||||||t
1491486|NCT01095146|||Case-Only||Retrospective|||||||
1491487|NCT01095133|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491488|NCT01095120||Single Group Assignment||Treatment||None (Open Label)||||||
1491489|NCT01095107|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1491490|NCT01095094||Single Group Assignment||Treatment||None (Open Label)||||||
1491491|NCT01095081|||Cohort||Prospective|||||||
1491492|NCT01095068||Single Group Assignment||Prevention||None (Open Label)||||||
1491493|NCT01095055|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491494|NCT01095042|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1491495|NCT01095029|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1491496|NCT01095016|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491497|NCT01095003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491498|NCT01094990|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1491499|NCT01094977|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1491500|NCT01094964|Randomized|||Treatment||None (Open Label)||||||
1491501|NCT01094951||Single Group Assignment||Other||None (Open Label)||||||
1491502|NCT01094938||||||||||||
1491503|NCT01094925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491504|NCT01094912||Single Group Assignment||Supportive Care||None (Open Label)||||||
1491505|NCT01094899|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1491506|NCT01094886|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1491507|NCT01094873|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491508|NCT01094860||Single Group Assignment||Treatment||None (Open Label)||||||
1491509|NCT01094847|Randomized|Crossover Assignment||||None (Open Label)||||||
1491510|NCT01094834|Randomized|Single Group Assignment||||Double|||t||t|
1491511|NCT01094821|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491512|NCT01094808|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1491513|NCT01094795|||Cohort||Prospective|||||||
1491514|NCT01094782|Randomized|Factorial Assignment||Diagnostic||Triple|||t|t|t|
1491515|NCT01094769|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491516|NCT01094756|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491517|NCT01094743|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491518|NCT01094730|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491519|NCT01094717|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1491520|NCT01094704|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1491521|NCT01094691||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491522|NCT01094678||Single Group Assignment||Treatment||None (Open Label)||||||
1491523|NCT01094665||Single Group Assignment||Treatment||None (Open Label)||||||
1491524|NCT01094652|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1491525|NCT01094639|Randomized|Parallel Assignment||Treatment||Single||||||t
1491526|NCT01094626|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1491527|NCT01094613|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491528|NCT01094600|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1491529|NCT01094587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491530|NCT01094574|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1491531|NCT01094561||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491532|NCT01094548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491533|NCT01094535||Single Group Assignment||Screening||None (Open Label)||||||
1491534|NCT01094522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491535|NCT01094509|Randomized|Parallel Assignment||Prevention||Single||||||t
1491536|NCT01094496||Single Group Assignment||Treatment||None (Open Label)||||||
1491537|NCT01094483|Randomized|Parallel Assignment||||Double|||t||t|
1491538|NCT01094470||Single Group Assignment||Treatment||None (Open Label)||||||
1491539|NCT01094457|Randomized|Parallel Assignment||Treatment||Single||||||t
1491540|NCT01094444|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491541|NCT01094431|||Cohort|||||||||
1491542|NCT01094418|||Case Control||Cross-Sectional|||||||
1491543|NCT01094405||Single Group Assignment||Treatment||None (Open Label)||||||
1491544|NCT01094392|||Case-Only||Prospective|||||||
1491545|NCT01094379|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491546|NCT01094366|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1491547|NCT01094353|Randomized|Parallel Assignment||Treatment||Triple|The participants were randomly allocated to a single-incision mini-sling or a transobturator midurethral tape by a simple randomization procedure using a random number generator computer program. Randomization was performed at the moment of inclusion by a nurse blinded to women's histories. Group assign- ment was concealed in consecutively numbered, sealed, opaque envelopes that were opened in the operating room just before the procedure.|Clinical, prospective, single-center, randomized controlled trial comparing the efficacy and safety of a single-incision mini-sling and a transobturator midurethral sling for female stress urinary incontinence (SUI) treatment.|t||t|t
1491548|NCT01094340|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491549|NCT01094327|||Other||Retrospective|||||||
1491550|NCT01094314|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1491551|NCT01094301||Single Group Assignment||Treatment||Single|||t|||
1491552|NCT01094288||Single Group Assignment||Treatment||None (Open Label)||||||
1491553|NCT01094275|||Case-Crossover||Prospective|||||||
1491554|NCT01094262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491555|NCT01094249||Single Group Assignment||||None (Open Label)||||||
1491556|NCT01094236|Randomized|Parallel Assignment||||None (Open Label)||||||
1491557|NCT01094223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491558|NCT01094210|||Case-Crossover||Prospective|||||||
1491559|NCT01094197|||Case-Only||Cross-Sectional|||||||
1491560|NCT01094184|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491561|NCT01094171||Single Group Assignment||Prevention||None (Open Label)||||||
1491562|NCT01094158|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491563|NCT01094145|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1491564|NCT01094132||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491565|NCT01094119|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1491566|NCT01094106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491567|NCT01094093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491568|NCT01094080|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1491569|NCT01094067|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1491570|NCT01094054|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1491571|NCT01094041|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491572|NCT01094028|Randomized|||Prevention||Quadruple|||t|t|t|t
1491573|NCT01094015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491574|NCT01094002|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1491575|NCT01093989|Randomized|Parallel Assignment||||None (Open Label)||||||
1491576|NCT01093976||Single Group Assignment||Treatment||None (Open Label)||||||
1491577|NCT01093963|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491578|NCT01093950|||Case-Only||Prospective|||||||
1491579|NCT01093937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491580|NCT01093924|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491581|NCT01093911|Randomized|Parallel Assignment||||Double|||t||t|
1491582|NCT01093898|||Family-Based||Prospective|||||||
1491583|NCT01093885||Single Group Assignment||Treatment||None (Open Label)||Single arm open label study.||||
1491584|NCT01093872||Single Group Assignment||Treatment||None (Open Label)||||||
1491585|NCT01093859||Single Group Assignment||||None (Open Label)||||||
1491586|NCT01093846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491587|NCT01093833||Single Group Assignment||Basic Science||None (Open Label)||||||
1491588|NCT01093820||Single Group Assignment||Treatment||None (Open Label)||||||
1491589|NCT01093807|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1491590|NCT01093794|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491591|NCT01093781||Single Group Assignment||Treatment||None (Open Label)||||||
1491592|NCT01093768|Randomized|Crossover Assignment||Diagnostic||||||||
1491593|NCT01093755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491594|NCT01093742|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1491595|NCT01093729|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1491596|NCT01093716|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1491597|NCT01093703|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1491598|NCT01093690|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491599|NCT01093677|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491600|NCT01093664||Single Group Assignment||Treatment||None (Open Label)||||||
1491601|NCT01093651|Randomized|Parallel Assignment||||Double|||t||t|
1491602|NCT01093638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491603|NCT01093625|Randomized|Parallel Assignment||Treatment||Single|||||t|
1491604|NCT01093612||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491605|NCT01093599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491606|NCT01093586||Single Group Assignment||Treatment||None (Open Label)||||||
1491607|NCT01093573||Single Group Assignment||Treatment||None (Open Label)||||||
1491608|NCT01093560|Randomized|Crossover Assignment||||Triple|||t||t|t
1491609|NCT01093547|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1491610|NCT01093534|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1491611|NCT01093521|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1491612|NCT01093508|Randomized|||Treatment||Quadruple|||t|t|t|t
1491613|NCT01093495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491614|NCT01093482|||Cohort||Prospective|||||||
1491615|NCT01093469|Randomized|Parallel Assignment||Treatment||Single|||||t|
1491616|NCT01093456|||Case Control||Cross-Sectional|||||||
1491617|NCT01093443|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491618|NCT01093430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491619|NCT01093417|Randomized|Single Group Assignment||||Triple|||t|t|t|
1491620|NCT01093404|Randomized|Parallel Assignment||Treatment||Single||||||t
1491621|NCT01093391|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491622|NCT01093378|||Case Control||Cross-Sectional|||||||
1491623|NCT01093365|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491624|NCT01093352|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1491625|NCT01093339|||Case Control||Prospective|||||||
1491626|NCT01093326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491627|NCT01093313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491628|NCT01093300|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491629|NCT01093287|||Case-Only||Prospective|||||||
1491630|NCT01093274|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1491631|NCT01093261|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491632|NCT01093248|||Case-Only||Prospective|||||||
1491633|NCT01093235|Randomized|||Treatment||None (Open Label)||||||
1491634|NCT01093222||Single Group Assignment||Treatment||None (Open Label)||||||
1491635|NCT01093209|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1491636|NCT01093196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491637|NCT01093183||Single Group Assignment||Treatment||None (Open Label)||||||
1491638|NCT01093170|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491639|NCT01093157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491640|NCT01093144|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1491641|NCT01093131|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1491642|NCT01093118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491643|NCT01093105|||Cohort||Prospective|||||||
1491644|NCT01093092||Single Group Assignment||Treatment||None (Open Label)||||||
1491645|NCT01093079|||Cohort||Prospective|||||||
1491646|NCT01093066||Single Group Assignment||Treatment||None (Open Label)||||||
1491647|NCT01093053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491648|NCT01093040|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491649|NCT01093027|Randomized|Crossover Assignment||Treatment||Single|||||t|
1491650|NCT01093014|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491651|NCT01093001|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491652|NCT01092988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491653|NCT01092975|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1491654|NCT01092962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491655|NCT01092949|||Case-Only||Prospective|||||||
1491656|NCT01092936|||||Prospective|||||||
1491657|NCT01092923|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491658|NCT01092910||Single Group Assignment||Treatment||None (Open Label)||||||
1491659|NCT01092897|||Cohort||Prospective|||||||
1491660|NCT01092884|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491661|NCT01092871||||||||||||
1491662|NCT01092858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491663|NCT01092845|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1491664|NCT01092832|Non-Randomized|||Treatment||None (Open Label)||||||
1491665|NCT01092819|||Cohort||Prospective|||||||
1491666|NCT01092806|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1491667|NCT01092793|Randomized|||||None (Open Label)||||||
1491668|NCT01092780|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491669|NCT01092767||Single Group Assignment||Treatment||None (Open Label)||||||
1491670|NCT01092754|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1491671|NCT01092741||Single Group Assignment||Treatment||None (Open Label)||||||
1491672|NCT01092728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491673|NCT01092715|Randomized|Parallel Assignment||Treatment||Single||||||t
1491674|NCT01092702||Single Group Assignment||Treatment||None (Open Label)||||||
1491675|NCT01092689|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1491676|NCT01092676|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1491677|NCT01092663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491678|NCT01092650|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1491679|NCT01092637|||Cohort||Cross-Sectional|||||||
1491680|NCT01092624|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491681|NCT01092611|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1491682|NCT01092598|||||Cross-Sectional|||||||
1491683|NCT01092585||Single Group Assignment||Treatment||None (Open Label)||||||
1491684|NCT01092572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491685|NCT01092559||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491686|NCT01092546||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491687|NCT01092533|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1491688|NCT01092520||Single Group Assignment||Treatment||None (Open Label)||||||
1491689|NCT01092507|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1491690|NCT01092494|||Cohort||Retrospective|||||||
1491691|NCT01092481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491692|NCT01092468|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491693|NCT01092455|||Cohort||Prospective|||||||
1491694|NCT01092442|||Cohort||Prospective|||||||
1491695|NCT01092429|||Cohort||Prospective|||||||
1491696|NCT01092416||Single Group Assignment||Treatment||None (Open Label)||||||
1491697|NCT01092403|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491698|NCT01092390|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1491699|NCT01092377|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1491700|NCT01092364|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491701|NCT01092351||Single Group Assignment||Treatment||None (Open Label)||||||
1491702|NCT01092338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491703|NCT01092325|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1491704|NCT01092312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491705|NCT01092299|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1491706|NCT01092286|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491707|NCT01092273|||||Prospective|||||||
1491708|NCT01092260|||Cohort||Cross-Sectional|||||||
1491709|NCT01092247|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1491710|NCT01092234|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1491711|NCT01092221|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491712|NCT01092208|||||Retrospective|||||||
1491713|NCT01092195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491714|NCT01092182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491715|NCT01092169|||Cohort||Cross-Sectional|||||||
1491716|NCT01092156|Randomized|Parallel Assignment||Prevention||Single||||||t
1491717|NCT01092143|Randomized|Parallel Assignment||Treatment||Double||||||
1491718|NCT01092130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491719|NCT01092117||Single Group Assignment||Treatment||None (Open Label)||||||
1491720|NCT01092104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491721|NCT01092091||Single Group Assignment||Treatment||None (Open Label)||||||
1491722|NCT01092078|Randomized|Parallel Assignment||||None (Open Label)||||||
1491723|NCT01092065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491724|NCT01092052||Single Group Assignment||Treatment||None (Open Label)||||||
1491725|NCT01092039|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491726|NCT01092026||Single Group Assignment||Treatment||None (Open Label)||||||
1491727|NCT01092013|Randomized|Parallel Assignment||||Single||||||t
1491728|NCT01092000|||Cohort||Prospective|||||||
1491729|NCT01091987||Single Group Assignment||Treatment||None (Open Label)||||||
1491730|NCT01091974|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1491731|NCT01091961|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1491732|NCT01091948|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1491733|NCT01091935|||Cohort||Prospective|||||||
1491734|NCT01091922|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1491735|NCT01091909||Single Group Assignment||Treatment||Single|||t|||
1491736|NCT01091896|Randomized|Parallel Assignment||Prevention||Single||||||t
1491737|NCT01091883|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491738|NCT01091870|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1491739|NCT01091857|Randomized|Factorial Assignment||||Single|||||t|
1491740|NCT01091844|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1491741|NCT01091831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491742|NCT01091818|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1491743|NCT01091805|||Case-Only||Prospective|||||||
1491744|NCT01091792||Single Group Assignment||Basic Science||None (Open Label)||||||
1491745|NCT01091779|||Case-Only||Prospective|||||||
1491746|NCT01091766|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1491747|NCT01091753|Randomized|||Treatment||None (Open Label)||||||
1491748|NCT01091740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491749|NCT01091727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491750|NCT01091714|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491751|NCT01091701|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491752|NCT01091688|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491753|NCT01091675||Single Group Assignment||Treatment||None (Open Label)||||||
1491754|NCT01091662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491755|NCT01091649|Randomized|Crossover Assignment||||None (Open Label)||||||
1491756|NCT01091636|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491757|NCT01091623|Randomized|Parallel Assignment||||None (Open Label)||||||
1491758|NCT01091610|||Ecologic or Community||Retrospective|||||||
1491759|NCT01091597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491760|NCT01091584|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1491761|NCT01091571|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1491762|NCT01091558|||Case-Control||Prospective|||||||
1491763|NCT01091545||Single Group Assignment||Prevention||None (Open Label)||||||
1491764|NCT01091532|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1491765|NCT01091519|||||Prospective|||||||
1491766|NCT01091506|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1491767|NCT01091493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491768|NCT01091480|||Cohort||Other|||||||
1491769|NCT01091467|||Cohort||Prospective|||||||
1491770|NCT01091454||Single Group Assignment||Treatment||None (Open Label)||||||
1491771|NCT01091441|||Cohort||Prospective|||||||
1491772|NCT01091428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491773|NCT01091415|Randomized|Parallel Assignment||Treatment||Single||||||t
1491774|NCT01091402|||Case Control||Prospective|||||||
1491775|NCT01091389|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491776|NCT01091376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491777|NCT01091363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491778|NCT01091350|Randomized|Parallel Assignment||||Single|||t|||
1491779|NCT01091337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491780|NCT01091324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491781|NCT01091311||Single Group Assignment||Treatment||None (Open Label)||||||
1491782|NCT01091298|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1491783|NCT01091285|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1491784|NCT01091272|Randomized|Crossover Assignment||||Double|||t||t|
1491785|NCT01091259||Single Group Assignment||Treatment||None (Open Label)||||||
1491786|NCT01091246|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1491787|NCT01091233|||Cohort||Prospective|||||||
1491788|NCT01091220|Randomized|Parallel Assignment||||Double|||t||t|
1491789|NCT01091207|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491790|NCT01091194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491791|NCT01091181|Randomized|Parallel Assignment||Other||Double|the surgeon who performed the operation knew what technique to use. Participant were not informed in what group they were. Six months postpartum patients came to ultrasound department and underwent ultrasound examination of uterus and uterine cesarean scar. Sonographer was blinded to the surgery technique.|women aimed for emergency cesarean section were randomized into two groups according to surgery technique of opening the uterus: 1 Group - high level of hysterotomy incision; 2 Group - low level of hysterotomy incision. Opening and closing of abdomen performed in the same manner in both groups|t||t|
1491792|NCT01091168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491793|NCT01091155||Single Group Assignment||||None (Open Label)||||||
1491794|NCT01091142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491795|NCT01091129||Single Group Assignment||Treatment||None (Open Label)||||||
1491796|NCT01091116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491797|NCT01091103||Parallel Assignment||Treatment||None (Open Label)||||||
1491798|NCT01091090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491799|NCT01091077|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491800|NCT01091064|Randomized|Crossover Assignment||||None (Open Label)||||||
1491801|NCT01091051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491802|NCT01091038|Randomized|Parallel Assignment||Health Services Research||Triple||||t|t|t
1491803|NCT01091025||Single Group Assignment||Screening||None (Open Label)||||||
1491804|NCT01091012|Randomized|Parallel Assignment||||None (Open Label)||||||
1491805|NCT01090999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491806|NCT01090986|||Case-Only||Prospective|||||||
1491807|NCT01090973||Single Group Assignment||Treatment||None (Open Label)||||||
1491808|NCT01090960|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491809|NCT01090947|||Case-Only||Cross-Sectional|||||||
1491810|NCT01090934|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1491811|NCT01090921||Single Group Assignment||Treatment||None (Open Label)||||||
1491812|NCT01090908|||Case-Only||Prospective|||||||
1491813|NCT01090895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491814|NCT01090882|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1491815|NCT01090869|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491816|NCT01090856|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1492052|NCT01087775||Single Group Assignment||Treatment||Triple|||t||t|t
1491817|NCT01090843|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1491818|NCT01090830||Single Group Assignment||Other||None (Open Label)||||||
1491819|NCT01090817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491820|NCT01090804|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1491821|NCT01090791|||Case-Crossover||Prospective|||||||
1491822|NCT01090778|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491823|NCT01090765|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491824|NCT01090752|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491825|NCT01090739||Single Group Assignment||Treatment||None (Open Label)||||||
1491826|NCT01090726|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491827|NCT01090713|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491828|NCT01090700|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491829|NCT01090687|||Cohort||Prospective|||||||
1491830|NCT01090674|||Cohort||Prospective|||||||
1491831|NCT01090661|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491832|NCT01090648|Non-Randomized|Single Group Assignment||||Single|||t|||
1491833|NCT01090635|||Case-Only||Prospective|||||||
1491834|NCT01090622|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491835|NCT01090609||Single Group Assignment||Treatment||None (Open Label)||||||
1491836|NCT01090596|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1491837|NCT01090583|||Cohort||Prospective|||||||
1491838|NCT01090570|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491839|NCT01090557|||Case Control||Prospective|||||||
1491840|NCT01090544||Single Group Assignment||Treatment||None (Open Label)||||||
1491841|NCT01090531|||Cohort||Prospective|||||||
1491842|NCT01090518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491843|NCT01090505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491844|NCT01090492|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491845|NCT01090479|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1491846|NCT01090466||Single Group Assignment||Treatment||None (Open Label)||||||
1491847|NCT01090453|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491848|NCT01090440|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1491849|NCT01090427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491850|NCT01090414||Single Group Assignment||Treatment||None (Open Label)||||||
1491851|NCT01090401||Single Group Assignment||Treatment||None (Open Label)||||||
1491852|NCT01090388|||Cohort||Cross-Sectional|||||||
1491853|NCT01090375||Parallel Assignment||Basic Science||||||||
1491854|NCT01090362|||Cohort||Prospective|||||||
1491855|NCT01090349|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1491856|NCT01090336|||||Prospective|||||||
1491857|NCT01090323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491858|NCT01090310|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491859|NCT01090297|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1491860|NCT01090284|||Cohort||Prospective|||||||
1491861|NCT01090271|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1491862|NCT01090258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491863|NCT01090245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491864|NCT01090232|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1491865|NCT01090219|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1491866|NCT01090206||Single Group Assignment||Screening||None (Open Label)||||||
1491867|NCT01090193|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1491868|NCT01090180|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491869|NCT01090167||Single Group Assignment||Treatment||None (Open Label)||||||
1491870|NCT01090154||Single Group Assignment||Treatment||None (Open Label)||||||
1491871|NCT01090141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491872|NCT01090128||Single Group Assignment||Treatment||None (Open Label)||||||
1491873|NCT01090102|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1491874|NCT01090089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491875|NCT01090076|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1491876|NCT01090063||Single Group Assignment||Treatment||None (Open Label)||||||
1491877|NCT01090050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491878|NCT01090037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491879|NCT01090024|Randomized|Crossover Assignment||Treatment||Double||||||
1491880|NCT01090011|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491881|NCT01089998|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1491882|NCT01089985||Single Group Assignment||Treatment||None (Open Label)||||||
1491883|NCT01089972|||Case Control||Prospective|||||||
1491884|NCT01089959||Single Group Assignment||Treatment||None (Open Label)||||||
1491885|NCT01089946|||Cohort||Prospective|||||||
1491886|NCT01089933|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1491887|NCT01089920|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1491888|NCT01089907|||Case-Only||Retrospective|||||||
1491889|NCT01089894|||Case-Only||Prospective|||||||
1491890|NCT01089881|||Case-Only||Prospective|||||||
1491891|NCT01089868|||Cohort||Prospective|||||||
1491892|NCT01089855||Single Group Assignment||Treatment||None (Open Label)||||||
1491893|NCT01089842|Randomized|Parallel Assignment||Prevention||Single|||||t|
1491894|NCT01089829|||Cohort||Prospective|||||||
1491895|NCT01089816|||Cohort||Prospective|||||||
1491896|NCT01089803|||Cohort||Prospective|||||||
1491897|NCT01089790|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1491898|NCT01089777|||Case-Only||Prospective|||||||
1491899|NCT01089764|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1491900|NCT01089751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491901|NCT01089738|Randomized|Sequential Assignment||Other||Double|||t||t|
1491902|NCT01089725|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491903|NCT01089712|||Case-Only||Prospective|||||||
1491904|NCT01089699|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1491905|NCT01089686|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1491906|NCT01089673|||Case-Only||Retrospective|||||||
1491907|NCT01089660|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491908|NCT01089647|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1491909|NCT01089634|||Other||Prospective|||||||
1491910|NCT01089621||Single Group Assignment||Treatment||None (Open Label)||||||
1491911|NCT01089608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491912|NCT01089595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491913|NCT01089582|||||Prospective|||||||
1491914|NCT01089569|Randomized|Parallel Assignment||Treatment||None (Open Label)|Subjects were randomized and then told the medications they were randomized to. Since the medications were already on the market, there was no need for masking for any involved individuals.|||||
1491915|NCT01089556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491916|NCT01089543|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491917|NCT01089530|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1491918|NCT01089517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491919|NCT01089504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491920|NCT01089491|||Case-Only||Prospective|||||||
1491921|NCT01089478|||Case-Only||Prospective|||||||
1491922|NCT01089465||Single Group Assignment||Prevention||None (Open Label)||||||
1491923|NCT01089452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491924|NCT01089439|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491925|NCT01089426|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491926|NCT01089413|||Cohort||Prospective|||||||
1491927|NCT01089400|||Case Control||Prospective|||||||
1491928|NCT01089387||Single Group Assignment||Treatment||None (Open Label)||||||
1491929|NCT01089374||Single Group Assignment||Treatment||None (Open Label)||||||
1491930|NCT01089361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491931|NCT01089348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491932|NCT01089335|||Cohort||Prospective|||||||
1491933|NCT01089322||Single Group Assignment||Treatment||None (Open Label)|Open label study. All subjects received the same treatment|Retrospective analysis after treatment outcome (controlled vs. non controlled) based on the primary outcome; and post hoc analysis after oral steroid treatment based on pulmonary function reversibility||||
1491934|NCT01089309|Randomized|Parallel Assignment||Treatment||Single|||t|||
1491935|NCT01089296|Randomized|Parallel Assignment||Treatment||Single||||||t
1491936|NCT01089283|||Cohort||Prospective|||||||
1491937|NCT01089270|||Cohort||Prospective|||||||
1491938|NCT01089257|||Case Control||Prospective|||||||
1491939|NCT01089244|||Cohort||Prospective|||||||
1491940|NCT01089231|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1491941|NCT01089218|Randomized|Parallel Assignment||Prevention||Single|||||t|
1491942|NCT01089205||||||||||||
1491943|NCT01089192||||||||||||
1491944|NCT01089179||||||||||||
1491945|NCT01089166||||||||||||
1491946|NCT01089153|||Case-Only||Prospective|||||||
1491947|NCT01089140|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1491948|NCT01089127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1491949|NCT01089114|||||Other|||||||
1491950|NCT01089101||Single Group Assignment||Treatment||None (Open Label)||||||
1491951|NCT01089088||Single Group Assignment||Treatment||None (Open Label)||||||
1491952|NCT01089075|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491953|NCT01089062|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491954|NCT01089049|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1491955|NCT01089036|||Cohort||Prospective|||||||
1491956|NCT01089023|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491957|NCT01089010|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1491958|NCT01088997|Randomized|Parallel Assignment||Treatment||Single||||||t
1491959|NCT01088984||Single Group Assignment||Treatment||None (Open Label)||||||
1491960|NCT01088971|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491961|NCT01088958|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491962|NCT01088945|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491963|NCT01088932|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1491964|NCT01088919|Randomized|Crossover Assignment||||None (Open Label)||||||
1491965|NCT01088906||Single Group Assignment||Treatment||None (Open Label)||||||
1491966|NCT01088893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491967|NCT01088880||Single Group Assignment||Treatment||None (Open Label)||||||
1491968|NCT01088867||Single Group Assignment||||None (Open Label)||||||
1491969|NCT01088854|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1491970|NCT01088841|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1491971|NCT01088828|||Case Control||Cross-Sectional|||||||
1491972|NCT01088815||Single Group Assignment||Treatment||None (Open Label)||||||
1491973|NCT01088802||Single Group Assignment||Diagnostic||None (Open Label)||||||
1491974|NCT01088789|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491975|NCT01088776|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1491976|NCT01088763||Single Group Assignment||Treatment||None (Open Label)||||||
1491977|NCT01088750|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491978|NCT01088737|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1491979|NCT01088724||Single Group Assignment||Treatment||||||||
1491980|NCT01088711|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491981|NCT01088698|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491982|NCT01088685|Randomized|Parallel Assignment||Treatment||Single|||||t|
1491983|NCT01088672||Single Group Assignment||Treatment||None (Open Label)||||||
1491984|NCT01088659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491985|NCT01088646||Single Group Assignment||Diagnostic||Single|||||t|
1491986|NCT01088633||Single Group Assignment||Basic Science||None (Open Label)||||||
1491987|NCT01088620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491988|NCT01088607||Single Group Assignment||Treatment||None (Open Label)||||||
1491989|NCT01088594|Randomized|Crossover Assignment||||None (Open Label)||||||
1491990|NCT01088581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1491991|NCT01088568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491992|NCT01088555|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1491993|NCT01088542|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1491994|NCT01088529|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1491995|NCT01088516||Single Group Assignment||Prevention||None (Open Label)||||||
1491996|NCT01088503|||Cohort||Prospective|||||||
1491997|NCT01088490|||Cohort||Prospective|||||||
1491998|NCT01088477|||Case-Only||Prospective|||||||
1491999|NCT01088464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492000|NCT01088451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492001|NCT01088438|Randomized|Parallel Assignment||||Single||||||t
1492002|NCT01088425|||Case-Control||Retrospective|||||||
1492003|NCT01088412|||Cohort||Prospective|||||||
1492004|NCT01088399|||Cohort||Prospective|||||||
1492005|NCT01088386|||Cohort||Prospective|||||||
1492006|NCT01088373||Single Group Assignment||Treatment||None (Open Label)||||||
1492007|NCT01088360|||Cohort||Prospective|||||||
1492008|NCT01088347||Single Group Assignment||Treatment||None (Open Label)||||||
1492009|NCT01088334|||||Prospective|||||||
1492010|NCT01088321|||Cohort||Prospective|||||||
1492011|NCT01088308||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492012|NCT01088295||Single Group Assignment||Treatment||None (Open Label)||||||
1492013|NCT01088282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492014|NCT01088269|||Case-Control||Cross-Sectional|||||||
1492015|NCT01088256|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492016|NCT01088243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492017|NCT01088230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492018|NCT01088217|||Family-Based||Cross-Sectional|||||||
1492019|NCT01088204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492020|NCT01088191|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1492021|NCT01088178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492022|NCT01088165|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1492023|NCT01088152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492024|NCT01088139|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1492025|NCT01088126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492026|NCT01088113|||Cohort||Prospective|||||||
1492027|NCT01088100|||Case Control||Retrospective|||||||
1492028|NCT01088087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492029|NCT01088074|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492030|NCT01088061|||Case Control||Cross-Sectional|||||||
1492031|NCT01088048|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492032|NCT01088035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492033|NCT01088022|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1492034|NCT01088009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492035|NCT01087996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492036|NCT01087983|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492037|NCT01087970||Single Group Assignment||Treatment||None (Open Label)||||||
1492038|NCT01087957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492039|NCT01087944|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492040|NCT01087931|Randomized|Parallel Assignment||Prevention||Single|||t|||
1492041|NCT01087918|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1492042|NCT01087905|Randomized|Factorial Assignment||Treatment||Single||||||t
1492043|NCT01087892|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1492044|NCT01087879|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492045|NCT01087866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492046|NCT01087853|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1492047|NCT01087840||Single Group Assignment||Treatment||None (Open Label)||||||
1492048|NCT01087827|||Case-Only||Prospective|||||||
1492049|NCT01087814|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1492050|NCT01087801|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1492051|NCT01087788|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492053|NCT01087762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492054|NCT01087749|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1492055|NCT01087736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492056|NCT01087723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492057|NCT01087710|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492058|NCT01087697||Single Group Assignment||Treatment||None (Open Label)||||||
1492059|NCT01087684|Randomized|Single Group Assignment||Treatment||Single|||||t|
1492060|NCT01087671||Single Group Assignment||Treatment||None (Open Label)||||||
1492061|NCT01087658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492062|NCT01087645|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492063|NCT01087632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492064|NCT01087619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492065|NCT01087593|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1492066|NCT01087580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492067|NCT01087567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492068|NCT01087554|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492069|NCT01087541|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1492070|NCT01087528||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492071|NCT01087515||Single Group Assignment||Basic Science||None (Open Label)||||||
1492072|NCT01087502|Randomized|Parallel Assignment||Treatment||Double||||||
1492073|NCT01087489|Randomized|Crossover Assignment||Treatment||Single|||||t|
1492074|NCT01087476|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1492075|NCT01087463||Single Group Assignment||Treatment||None (Open Label)||||||
1492076|NCT01087450|||Other||Prospective|||||||
1492077|NCT01087437|Non-Randomized|Single Group Assignment||Treatment||||||||
1492078|NCT01087424||Single Group Assignment||Treatment||None (Open Label)||||||
1492079|NCT01087411|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492080|NCT01087398|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492081|NCT01087385|||Cohort||Retrospective|||||||
1492082|NCT01087372|||Case-Only||Prospective|||||||
1492083|NCT01087359|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1492084|NCT01087346|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1492085|NCT01087333|||Case-Control||Prospective|||||||
1492086|NCT01087320|||Cohort||Prospective|||||||
1492087|NCT01087307|||Case-Control||Prospective|||||||
1492088|NCT01087294|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1492089|NCT01087281|||||Prospective|||||||
1492090|NCT01087268|Randomized|||Supportive Care||Double||||||
1492091|NCT01087255|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1492092|NCT01087242|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492093|NCT01087229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492094|NCT01087216|Randomized|Parallel Assignment||Treatment||Single|||||t|
1492095|NCT01087203|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492096|NCT01087190|Randomized|Parallel Assignment||Treatment||Single||||||t
1492097|NCT01087177|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1492098|NCT01087164|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1492099|NCT01087151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492100|NCT01087138|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492101|NCT01087125|||Cohort||Prospective|||||||
1492102|NCT01087112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492103|NCT01087099||Single Group Assignment||Treatment||None (Open Label)||||||
1492104|NCT01087086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492105|NCT01087073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492106|NCT01087060|||Case Control||Retrospective|||||||
1492107|NCT01087047|||Cohort||Prospective|||||||
1492108|NCT01087034|||Cohort||Prospective|||||||
1492109|NCT01087021||Single Group Assignment||Treatment||None (Open Label)||||||
1492110|NCT01087008|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492111|NCT01086995|||Cohort||Prospective|||||||
1492112|NCT01086982|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492113|NCT01086969|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492114|NCT01086956|Randomized|||Diagnostic||||||||
1492115|NCT01086943||Single Group Assignment||||None (Open Label)||||||
1492116|NCT01086930|Randomized|Parallel Assignment||Treatment||Single||||||t
1492117|NCT01086917|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1492118|NCT01086904||Single Group Assignment||Prevention||None (Open Label)||||||
1492119|NCT01086891|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492120|NCT01086878|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1492121|NCT01086865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492122|NCT01086852||Single Group Assignment||Treatment||None (Open Label)||||||
1492123|NCT01086839|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1492124|NCT01086826|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1492125|NCT01086813|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1492126|NCT01086800|Randomized|Parallel Assignment||Treatment||Single|||||t|
1492127|NCT01086787|||Cohort||Prospective|||||||
1492128|NCT01086774||Single Group Assignment||Treatment||None (Open Label)||||||
1492129|NCT01086761|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492130|NCT01086748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492131|NCT01086735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492132|NCT01086722||Single Group Assignment||Basic Science||None (Open Label)||||||
1492133|NCT01086709|||||Prospective|||||||
1492134|NCT01086696||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492135|NCT01086683|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1492136|NCT01086670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492137|NCT01086657|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492138|NCT01086631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492139|NCT01086618|Randomized|||Treatment||||||||
1492140|NCT01086605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492141|NCT01086592|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1492142|NCT01086579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492143|NCT01086566|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1492144|NCT01086553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492145|NCT01086540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492146|NCT01086527||Single Group Assignment||Basic Science||None (Open Label)||||||
1492147|NCT01086514||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492148|NCT01086501|||||Prospective|||||||
1492149|NCT01086488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492150|NCT01086475|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492151|NCT01086462||Single Group Assignment||Other||None (Open Label)||||||
1492152|NCT01086449||Single Group Assignment||Prevention||None (Open Label)||||||
1492153|NCT01086436|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1492154|NCT01086423|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492155|NCT01086410|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492156|NCT01086397|||||Prospective|||||||
1492157|NCT01086384|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492158|NCT01086371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492159|NCT01086358|Randomized|Crossover Assignment||Other||None (Open Label)||This was a randomized, open-label, 6-attack (3-attacks per arm) crossover design in which subjects were randomized to threat their first 3 workplace migraines with sumatriptan/naproxen sodium or with their usual triptan monotherapy before treating their subsequent 3 workplace migraines with the opposite medication.||||
1492160|NCT01086345||Single Group Assignment||Treatment||None (Open Label)||||||
1492161|NCT01086332||Single Group Assignment||Treatment||None (Open Label)||||||
1492162|NCT01086319|||Cohort|||||||||
1492163|NCT01086306|||Cohort|||||||||
1492164|NCT01086293|||Cohort|||||||||
1492165|NCT01086280|||Cohort|||||||||
1492166|NCT01086267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492167|NCT01086254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492168|NCT01086241|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1492169|NCT01086228|||Cohort||Prospective|||||||
1492170|NCT01086215|||Case-Only||Prospective|||||||
1492171|NCT01086202|||Case-Only||Prospective|||||||
1492172|NCT01086189|||Case-Crossover||Cross-Sectional|||||||
1492173|NCT01086176|||Case Control||Prospective|||||||
1492174|NCT01086163|||Case Control||Prospective|||||||
1492175|NCT01086150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492176|NCT01086137|||Case-Only||Cross-Sectional|||||||
1492177|NCT01086124|||Cohort||Prospective|||||||
1492178|NCT01086111|||Case Control||Prospective|||||||
1492179|NCT01086098|||Ecologic or Community||Retrospective|||||||
1492180|NCT01086085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492181|NCT01086072|||Ecologic or Community||Retrospective|||||||
1492182|NCT01086059|||Cohort||Prospective|||||||
1492183|NCT01086046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492184|NCT01086033|||||Prospective|||||||
1492185|NCT01086020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492186|NCT01086007||||||||||||
1492187|NCT01085994||||||||||||
1492188|NCT01085981|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1492189|NCT01085968|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1492190|NCT01085955|||Case Control||Prospective|||||||
1492191|NCT01085942|||Case-Only||Prospective|||||||
1492192|NCT01085929|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492193|NCT01085916|||Case-Only||Cross-Sectional|||||||
1492194|NCT01085903|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1492195|NCT01085890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492196|NCT01085877|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492197|NCT01085864|||Other||Prospective|||||||
1492198|NCT01085851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492199|NCT01085838|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492200|NCT01085825|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1492201|NCT01085812|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1492202|NCT01085799|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492203|NCT01085786|Randomized|Parallel Assignment||Treatment||Single||||||t
1492204|NCT01085773|Randomized|Parallel Assignment||Treatment||Single|||||t|
1492205|NCT01085760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492206|NCT01085747|||Case Control||Prospective|||||||
1492207|NCT01085734|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492208|NCT01085721|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492209|NCT01085708|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492210|NCT01085695|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492211|NCT01085682|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492212|NCT01085669|||Cohort||Prospective|||||||
1492213|NCT01085656||Single Group Assignment||Treatment||None (Open Label)||||||
1492214|NCT01085643|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1492215|NCT01085630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492216|NCT01085617|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomised phase III trial of standard treatment +/- rituximab for patients with precursor B-cell ALL or nelarabine for patients with T-cell ALL. A further randomisation investigated two schedules of palifermin administration in patients undergoing myeloablative transplant.||||
1492217|NCT01085604|||Cohort||Prospective|||||||
1492218|NCT01085591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492219|NCT01085578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492220|NCT01085565|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492221|NCT01085552|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1492222|NCT01085539|||Case-Only||Prospective|||||||
1492223|NCT01085526|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1492224|NCT01085513|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1492225|NCT01085500|Randomized|Parallel Assignment||||Single||||||t
1492226|NCT01085487|||Case Control||Prospective|||||||
1492227|NCT01085474|||||Prospective|||||||
1492228|NCT01085461|||Case-Only||Cross-Sectional|||||||
1492229|NCT01085448||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492230|NCT01085435|||Cohort||Prospective|||||||
1492231|NCT01085422|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492232|NCT01085409|||||Prospective|||||||
1492233|NCT01085396|||||Prospective|||||||
1492234|NCT01085383||Single Group Assignment||Treatment||None (Open Label)||||||
1492235|NCT01085370|Randomized|Parallel Assignment||Prevention||Single||||||t
1492236|NCT01085357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492237|NCT01085344||Single Group Assignment||Treatment||None (Open Label)||||||
1492238|NCT01085331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492239|NCT01085318|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1492240|NCT01085305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492241|NCT01085292|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1492242|NCT01085279|Randomized|Parallel Assignment||Treatment||Single|||||t|
1492243|NCT01085266||Single Group Assignment||Treatment||None (Open Label)||||||
1492244|NCT01085253|||||Prospective|||||||
1492245|NCT01085240|Randomized|Crossover Assignment||Other||Double|||t|||t
1492246|NCT01085227|||Family-Based||Prospective|||||||
1492247|NCT01085214||Single Group Assignment||Treatment||None (Open Label)||||||
1492248|NCT01085201|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492249|NCT01085188|Randomized|Factorial Assignment||Treatment||||||||
1492250|NCT01085175|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1492251|NCT01085162|||||Prospective|||||||
1492252|NCT01085149|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1492253|NCT01085136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492254|NCT01085123|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1492255|NCT01085110|||Case-Only|||||||||
1492256|NCT01085097|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1492257|NCT01085084|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1492258|NCT01085071|Randomized|Parallel Assignment||Treatment||Single||||||t
1492259|NCT01085058||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492260|NCT01085045|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1492261|NCT01085032|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1492262|NCT01085019|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1492263|NCT01085006|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1492264|NCT01084993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492265|NCT01084980||Single Group Assignment||Treatment||None (Open Label)||||||
1492266|NCT01084967|||Cohort||Cross-Sectional|||||||
1492267|NCT01084954|||Case-Only||Cross-Sectional|||||||
1492268|NCT01084941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492269|NCT01084928||Single Group Assignment||Prevention||Single||||||t
1492270|NCT01084915|||Case-Only||Retrospective|||||||
1492271|NCT01084902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492272|NCT01084889|||Other||Prospective|||||||
1492273|NCT01084876|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492274|NCT01084863|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492275|NCT01084850|||Case Control||Cross-Sectional|||||||
1492276|NCT01084837|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492277|NCT01084824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492278|NCT01084811|||Case Control||Prospective|||||||
1492279|NCT01084798|||Cohort||Retrospective|||||||
1492280|NCT01084785|||Cohort||Prospective|||||||
1492281|NCT01084772|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1492282|NCT01084759||Single Group Assignment||Treatment||None (Open Label)||||||
1492283|NCT01084746|Randomized|Parallel Assignment||Prevention||Single||||t||
1492284|NCT01084733|||Case-Only||Prospective|||||||
1492285|NCT01084720|Randomized|Single Group Assignment||Treatment||Double||||||
1492286|NCT01084707|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492287|NCT01084694|||Other||Prospective|||||||
1492288|NCT01084681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492289|NCT01084668|||Cohort||Prospective|||||||
1492290|NCT01084655||Single Group Assignment||Treatment||None (Open Label)||||||
1492291|NCT01084642|||Cohort||Prospective|||||||
1492292|NCT01084629|||Cohort||Prospective|||||||
1492293|NCT01084616|||Case Control||Prospective|||||||
1492294|NCT01084603|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492295|NCT01084590|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492296|NCT01084577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492297|NCT01084564|||Cohort||Retrospective|||||||
1492298|NCT01084551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492299|NCT01084538|||||Prospective|||||||
1492300|NCT01084525|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1492301|NCT01084512|||Case Control||Cross-Sectional|||||||
1492302|NCT01084499|Randomized|Crossover Assignment||||None (Open Label)||||||
1492303|NCT01084486||||||||||||
1492304|NCT01084473|Randomized|Crossover Assignment||||Single|||t|||
1492305|NCT01084460|||Cohort||Retrospective|||||||
1492306|NCT01084447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492307|NCT01084434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492308|NCT01084421|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1492309|NCT01084408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492310|NCT01084395|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492311|NCT01084382|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1492312|NCT01084369||Single Group Assignment||Treatment||None (Open Label)||||||
1492313|NCT01084356|||Cohort||Prospective|||||||
1492314|NCT01084343|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1492315|NCT01084330|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492316|NCT01084317|||Cohort||Retrospective|||||||
1492317|NCT01084304|||Cohort||Prospective|||||||
1492318|NCT01084291|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1492319|NCT01084278|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1492320|NCT01084265||Single Group Assignment||Treatment||None (Open Label)||||||
1492321|NCT01084252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492322|NCT01084239|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1492323|NCT01084226||Parallel Assignment||||Triple|||t|t|t|
1492324|NCT01084213|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1492325|NCT01084200|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1492326|NCT01084187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492327|NCT01084174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492328|NCT01084161|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492329|NCT01084148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492330|NCT01084135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492331|NCT01084122|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1492332|NCT01084109|Randomized|Parallel Assignment||||None (Open Label)||||||
1492333|NCT01084096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492334|NCT01084083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492335|NCT01084070|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492336|NCT01084057|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492337|NCT01084044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492338|NCT01084031|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1492339|NCT01084018|Randomized|Parallel Assignment||||Single||||||t
1492340|NCT01084005|Randomized|Parallel Assignment||Treatment||Double||||||
1492341|NCT01083992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492342|NCT01083979||Single Group Assignment||Treatment||None (Open Label)||||||
1492343|NCT01083966||Single Group Assignment||Treatment||None (Open Label)||||||
1492344|NCT01083953|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1492345|NCT01083940|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1492346|NCT01083927|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492347|NCT01083914|||Case Control||Prospective|||||||
1492348|NCT01083901|Randomized|Parallel Assignment||||Triple|||t||t|t
1492349|NCT01083888|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1492350|NCT01083875|Randomized|Parallel Assignment||Treatment||Double||||||
1492351|NCT01083862|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1492352|NCT01083849|||Cohort||Prospective|||||||
1492353|NCT01083823|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1492354|NCT01083810|||Case-Only||Prospective|||||||
1492355|NCT01083797||Single Group Assignment||Treatment||Single|||||t|
1492356|NCT01083784|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492357|NCT01083771||Single Group Assignment||Prevention||None (Open Label)||||||
1492358|NCT01083758||Single Group Assignment||Treatment||None (Open Label)||||||
1492359|NCT01083745|||Cohort||Prospective|||||||
1492360|NCT01083732||Single Group Assignment||||None (Open Label)||||||
1492361|NCT01083719||Single Group Assignment||Treatment||None (Open Label)||||||
1492362|NCT01083706||Single Group Assignment||Treatment||None (Open Label)||||||
1492363|NCT01083693|||Cohort||Prospective|||||||
1492364|NCT01083680|||Case-Only||Prospective|||||||
1492365|NCT01083667||Single Group Assignment||Treatment||None (Open Label)||||||
1492680|NCT01079546|||Cohort||Retrospective|||||||
1492366|NCT01083654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492367|NCT01083641||Single Group Assignment||Treatment||None (Open Label)||||||
1492368|NCT01083628|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492369|NCT01083615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492370|NCT01083602||Single Group Assignment||Treatment||None (Open Label)||||||
1492371|NCT01083589||Single Group Assignment||Treatment||None (Open Label)||||||
1492372|NCT01083576|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492373|NCT01083563|||Cohort||Prospective|||||||
1492374|NCT01083550|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1492375|NCT01083537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492376|NCT01083524|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492377|NCT01083511|||Case-Only||Prospective|||||||
1492378|NCT01083498|Randomized|Parallel Assignment||Treatment||Single|||||t|
1492379|NCT01083485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492380|NCT01083472|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492381|NCT01083459|||Family-Based||Cross-Sectional|||||||
1492382|NCT01083446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492383|NCT01083433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492384|NCT01083420|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1492385|NCT01083407|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1492386|NCT01083394|Randomized|Parallel Assignment||Treatment||Single||||||t
1492387|NCT01083381|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492388|NCT01083368||Single Group Assignment||Treatment||None (Open Label)||||||
1492389|NCT01083355|||Case Control||Prospective|||||||
1492390|NCT01083342||Single Group Assignment||Treatment||None (Open Label)||||||
1492391|NCT01083329|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1492392|NCT01083316||Single Group Assignment||Treatment||None (Open Label)||||||
1492393|NCT01083303|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1492394|NCT01083290|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1492395|NCT01083277|Randomized|Crossover Assignment||Device Feasibility||None (Open Label)||||||
1492396|NCT01083264|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492397|NCT01083251|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492398|NCT01083238|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1492399|NCT01083225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492400|NCT01083212|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492401|NCT01083199||Single Group Assignment||Treatment||None (Open Label)||||||
1492402|NCT01083186|||||Prospective|||||||
1492403|NCT01083173|||Case-Only||Prospective|||||||
1492404|NCT01083160|||Case-Only||Prospective|||||||
1492405|NCT01083147|||Cohort||Prospective|||||||
1492406|NCT01083134|||Cohort||Prospective|||||||
1492407|NCT01083121|||Case-Only||Prospective|||||||
1492408|NCT01083108|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1492409|NCT01083095|Randomized|Parallel Assignment||||None (Open Label)||||||
1492410|NCT01083082|||||Cross-Sectional|||||||
1492411|NCT01083069|||Case Control||Prospective|||||||
1492412|NCT01083056|||Cohort||Prospective|||||||
1492413|NCT01083043|||Case-Only||Prospective|||||||
1492414|NCT01083030|Randomized|Parallel Assignment||Treatment||Single||||||t
1492415|NCT01083017|||Cohort||Prospective|||||||
1492416|NCT01083004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492417|NCT01082991|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1492418|NCT01082978|Randomized|Parallel Assignment||Health Services Research||Double|Primary outcomes, death and overnight hospitalisations, are obtained through record linkage and are masked outcomes. Outcome assessor, however, is not masked to patient-reported outcomes. Chief Investigator and statistical analyses are masked to randomisation/intervention group.||||t|t
1492419|NCT01082965|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1492420|NCT01082952|||Case Control|||||||||
1492421|NCT01082939||Single Group Assignment||Treatment||None (Open Label)||||||
1492422|NCT01082926|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492423|NCT01082913|Randomized|Parallel Assignment||Treatment||Single|||||t|
1492424|NCT01082900|Randomized|Single Group Assignment||Prevention||Single||||t||
1492425|NCT01082887||Single Group Assignment||Treatment||None (Open Label)||||||
1492426|NCT01082874|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1492427|NCT01082861|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492428|NCT01082848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492429|NCT01082835|||Case Control||Prospective|||||||
1492430|NCT01082822|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492431|NCT01082809|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492432|NCT01082796|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1492433|NCT01082783|||Case-Control||Prospective|||||||
1492434|NCT01082770|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492435|NCT01082757|||Cohort||Prospective|||||||
1492436|NCT01082744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492437|NCT01082731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492438|NCT01082718|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492439|NCT01082705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492440|NCT01082692||Single Group Assignment||Treatment||None (Open Label)||||||
1493246|NCT01072110|||||Prospective|||||||
1492441|NCT01082679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492442|NCT01082666|Randomized|Parallel Assignment||Treatment||Single||||||t
1492443|NCT01082653||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492444|NCT01082640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492445|NCT01082627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492446|NCT01082614|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492447|NCT01082601|||Cohort||Prospective|||||||
1492448|NCT01082588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492449|NCT01082575|||Case-Only||Prospective|||||||
1492450|NCT01082562|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1492451|NCT01082549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492452|NCT01082536|||Cohort||Prospective|||||||
1492453|NCT01082523|Randomized|Parallel Assignment||||Single|||||t|
1492454|NCT01082510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492455|NCT01082497|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1492456|NCT01082484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492457|NCT01082471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492458|NCT01082458||||Prevention||||||||
1492459|NCT01082445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492460|NCT01082432|||Case-Only||Cross-Sectional|||||||
1492461|NCT01082419|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1492462|NCT01082406|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1492463|NCT01082393|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1492464|NCT01082380|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1492465|NCT01082367|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1492466|NCT01082354|||Cohort||Prospective|||||||
1492467|NCT01082341|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492468|NCT01082328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492469|NCT01082315|||Case-Only||Prospective|||||||
1492470|NCT01082302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492471|NCT01082289||Single Group Assignment||||||||||
1492472|NCT01082276|Randomized|Single Group Assignment||||None (Open Label)||||||
1492473|NCT01082263|Randomized|Single Group Assignment||||None (Open Label)||||||
1492474|NCT01082250|Randomized|Crossover Assignment||||None (Open Label)||||||
1492475|NCT01082237||Single Group Assignment||Treatment||None (Open Label)||||||
1492476|NCT01082224||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492477|NCT01082211||Single Group Assignment||Treatment||None (Open Label)||||||
1492478|NCT01082198||||Treatment||None (Open Label)||||||
1492479|NCT01082185||Single Group Assignment||Treatment||None (Open Label)||||||
1492480|NCT01082172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492481|NCT01082159||Single Group Assignment||Treatment||None (Open Label)||||||
1492482|NCT01082146||Single Group Assignment||||None (Open Label)||||||
1492483|NCT01082133||Single Group Assignment||Treatment||None (Open Label)||||||
1492484|NCT01082120|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492485|NCT01082107||Single Group Assignment||Prevention||None (Open Label)||||||
1492486|NCT01082094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492487|NCT01082081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492488|NCT01082068|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492489|NCT01082055|||Ecologic or Community||Retrospective|||||||
1492490|NCT01082042|||Case Control||Prospective|||||||
1492491|NCT01082029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492492|NCT01082016||Single Group Assignment||||None (Open Label)||||||
1492493|NCT01082003|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1492494|NCT01081990|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492495|NCT01081977|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1492496|NCT01081964|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492497|NCT01081951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492498|NCT01081938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492499|NCT01081925|||Case-Only||Cross-Sectional|||||||
1492500|NCT01081912|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1492501|NCT01081899|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1492502|NCT01081886|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492503|NCT01081873|||Case-Only||Prospective|||||||
1492504|NCT01081860|||Case Control||Cross-Sectional|||||||
1492505|NCT01081847|Randomized|Factorial Assignment||||Quadruple|||t|t|t|t
1492506|NCT01081834|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492507|NCT01081821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492508|NCT01081808||Single Group Assignment||Treatment||None (Open Label)||||||
1492509|NCT01081795|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492510|NCT01081782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492511|NCT01081769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492512|NCT01081756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492513|NCT01081743|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1492514|NCT01081730|||Cohort||Prospective|||||||
1492515|NCT01081717|||Cohort||Prospective|||||||
1492516|NCT01081704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492517|NCT01081691|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1492518|NCT01081678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492519|NCT01081665|||||Prospective|||||||
1492520|NCT01081652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492521|NCT01081639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492522|NCT01081626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492523|NCT01081613|||Cohort||Prospective|||||||
1492524|NCT01081600|||Cohort||Prospective|||||||
1492525|NCT01081587|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492526|NCT01081574||Single Group Assignment||Treatment||None (Open Label)||||||
1492527|NCT01081561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492528|NCT01081548||Parallel Assignment||||None (Open Label)||||||
1492529|NCT01081535|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1492530|NCT01081522|||Case-Only||Prospective|||||||
1492531|NCT01081509|||Cohort||Prospective|||||||
1492532|NCT01081496|||Cohort||Cross-Sectional|||||||
1492533|NCT01081483|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1492534|NCT01081457|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1492535|NCT01081444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492536|NCT01081431||Single Group Assignment||Treatment||None (Open Label)||||||
1492537|NCT01081418|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492538|NCT01081405||Single Group Assignment||Treatment||None (Open Label)||||||
1492539|NCT01081392|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1492540|NCT01081379|||Case Control||Cross-Sectional|||||||
1492541|NCT01081366|||Cohort||Prospective|||||||
1492542|NCT01081353|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492543|NCT01081340|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492544|NCT01081327|||Ecologic or Community||Retrospective|||||||
1492545|NCT01081314|Randomized|Parallel Assignment||Treatment||Single||||||t
1492546|NCT01081301||Single Group Assignment||Supportive Care||None (Open Label)||||||
1492547|NCT01081288|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492548|NCT01081275|Randomized|Parallel Assignment||Treatment||Single||||||t
1492549|NCT01081262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492550|NCT01081249|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1492551|NCT01081236|||Cohort||Prospective|||||||
1492552|NCT01081223||Single Group Assignment||Treatment||None (Open Label)||||||
1492553|NCT01081210|||||Prospective|||||||
1492554|NCT01081197|||Cohort|||||||||
1492555|NCT01081184|||Case Control||Prospective|||||||
1492556|NCT01081158|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492557|NCT01081145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492558|NCT01081132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492559|NCT01081119|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492560|NCT01081106|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1492561|NCT01081093||Single Group Assignment||Treatment||None (Open Label)||||||
1492562|NCT01081080|||Cohort||Prospective|||||||
1492563|NCT01081067|||Cohort||Prospective|||||||
1492564|NCT01081054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492565|NCT01081041|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492566|NCT01081028|||Cohort||Prospective|||||||
1492567|NCT01081015|||Cohort||Prospective|||||||
1492568|NCT01081002|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1492569|NCT01080989||Single Group Assignment||Screening||None (Open Label)||||||
1492570|NCT01080976|||Cohort||Prospective|||||||
1492571|NCT01080963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492572|NCT01080950|||Case Control||Prospective|||||||
1492573|NCT01080937|||Cohort||Prospective|||||||
1492574|NCT01080924||Single Group Assignment||Basic Science||None (Open Label)||||||
1492575|NCT01080911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492576|NCT01080898|||Cohort||Cross-Sectional|||||||
1492577|NCT01080885|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492578|NCT01080872|||Case Control||Prospective|||||||
1492579|NCT01080859|||Case Control||Prospective|||||||
1492580|NCT01080846||Single Group Assignment||Treatment||None (Open Label)||||||
1492581|NCT01080833|Randomized|Parallel Assignment||Treatment||Single||||||t
1492582|NCT01080820|Randomized|Parallel Assignment||||Double|||t||t|
1492583|NCT01080807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492584|NCT01080794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492585|NCT01080781|||||Prospective|||||||
1492586|NCT01080768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492587|NCT01080755|||Cohort||Prospective|||||||
1492588|NCT01080742|||Cohort||Prospective|||||||
1492589|NCT01080729|||Cohort||Prospective|||||||
1492590|NCT01080716|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1492591|NCT01080703||Single Group Assignment||Treatment||None (Open Label)||||||
1492592|NCT01080690|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1492593|NCT01080677|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1492594|NCT01080664|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492595|NCT01080651|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1492596|NCT01080638|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492597|NCT01080625|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1492598|NCT01080612|Randomized|Crossover Assignment||||None (Open Label)||||||
1492599|NCT01080599|Randomized|Parallel Assignment||||||||||
1492600|NCT01080586|Randomized|Crossover Assignment||||None (Open Label)||||||
1492601|NCT01080573|||Cohort||Prospective|||||||
1492602|NCT01080560|Randomized|Crossover Assignment||||None (Open Label)||||||
1492603|NCT01080547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492604|NCT01080534|Randomized|Crossover Assignment||||None (Open Label)||||||
1492605|NCT01080521|||Cohort||Prospective|||||||
1492606|NCT01080508|||Case Control||Prospective|||||||
1492607|NCT01080495|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1492608|NCT01080482|Randomized|Crossover Assignment||||None (Open Label)||||||
1492609|NCT01080469|Randomized|Crossover Assignment||||None (Open Label)||||||
1492610|NCT01080456|Randomized|Crossover Assignment||||None (Open Label)||||||
1492611|NCT01080443|Randomized|Crossover Assignment||||None (Open Label)||||||
1492612|NCT01080430|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1492613|NCT01080417|Randomized|Crossover Assignment||||None (Open Label)||||||
1492614|NCT01080404|Randomized|Parallel Assignment||Treatment||Single|||||t|
1492615|NCT01080391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492616|NCT01080378|Randomized|Parallel Assignment||||None (Open Label)||||||
1492617|NCT01080365|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492618|NCT01080352||Single Group Assignment||Treatment||None (Open Label)||||||
1492619|NCT01080339|||Case Control||Prospective|||||||
1492620|NCT01080326||Single Group Assignment||||None (Open Label)||||||
1492621|NCT01080313|||||Prospective|||||||
1492622|NCT01080300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492623|NCT01080287|||Cohort||Prospective|||||||
1492624|NCT01080274|||Case Control||Cross-Sectional|||||||
1492625|NCT01080261||Single Group Assignment||Treatment||None (Open Label)||||||
1492626|NCT01080248||Single Group Assignment||Treatment||None (Open Label)||||||
1492627|NCT01080235|Randomized|Parallel Assignment||||Single|||||t|
1492628|NCT01080222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492629|NCT01080209|Non-Randomized|Single Group Assignment||||Single|||t|||
1492630|NCT01080196|Randomized|Parallel Assignment||Prevention||Single||||||t
1492631|NCT01080183|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1492632|NCT01080170|||Cohort||Prospective|||||||
1492633|NCT01080157|||Cohort||Prospective|||||||
1492634|NCT01080144||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492635|NCT01080131|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492636|NCT01080118|Randomized|Parallel Assignment||||Double|||t||t|
1492637|NCT01080105|Randomized|Parallel Assignment||Prevention||Single||||||t
1492638|NCT01080092|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492639|NCT01080079|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492640|NCT01080066|||Cohort||Prospective|||||||
1492641|NCT01080053|||Cohort||Prospective|||||||
1492642|NCT01080040|||Cohort||Prospective|||||||
1492643|NCT01080027|||Cohort||Prospective|||||||
1492644|NCT01080014|||Cohort||Prospective|||||||
1492645|NCT01080001|||Cohort||Prospective|||||||
1492646|NCT01079988|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492647|NCT01079975|||Cohort||Prospective|||||||
1492648|NCT01079962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492649|NCT01079949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492650|NCT01079936||Single Group Assignment||Treatment||None (Open Label)||||||
1492651|NCT01079923|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1492652|NCT01079910|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1492653|NCT01079897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492654|NCT01079884|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1492655|NCT01079871|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492656|NCT01079858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492657|NCT01079845|Randomized|Parallel Assignment||Treatment||Single||||||t
1492658|NCT01079832||Single Group Assignment||Treatment||None (Open Label)||||||
1492659|NCT01079819|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1492660|NCT01079806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492661|NCT01079793||||Treatment||None (Open Label)||||||
1492662|NCT01079780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492663|NCT01079767|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492664|NCT01079754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492665|NCT01079741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492666|NCT01079728|||Case-Only||Prospective|||||||
1492667|NCT01079715|Randomized|Parallel Assignment||Treatment||Single|||||t|
1492668|NCT01079702|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492669|NCT01079689|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1492670|NCT01079676|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492671|NCT01079663||||Treatment||||||||
1492672|NCT01079650|||Case-Only||Prospective|||||||
1492673|NCT01079637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492674|NCT01079624|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1492675|NCT01079611|||Cohort||Prospective|||||||
1492676|NCT01079598||Single Group Assignment||Treatment||None (Open Label)||||||
1492677|NCT01079585|Randomized|Crossover Assignment||||Single||||||
1492678|NCT01079572|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1492679|NCT01079559|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1492681|NCT01079533|Randomized|Factorial Assignment||Screening||Single|||t|||
1492682|NCT01079520||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492683|NCT01079507|||Case-Only||Retrospective|||||||
1492684|NCT01079494|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1492685|NCT01079481||Single Group Assignment||Treatment||None (Open Label)||||||
1492686|NCT01079468|||Cohort||Prospective|||||||
1492687|NCT01079455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492688|NCT01079442|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1492689|NCT01079429|||Cohort||Prospective|||||||
1492690|NCT01079416|||Cohort||Prospective|||||||
1492691|NCT01079390|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1492692|NCT01079377|||Case-Control||Prospective|||||||
1492693|NCT01079364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492694|NCT01079351||Single Group Assignment||Treatment||None (Open Label)||||||
1492695|NCT01079338||||Basic Science||||||||
1492696|NCT01079325|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492697|NCT01079312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492698|NCT01079299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492699|NCT01079286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492700|NCT01079273||Single Group Assignment||||None (Open Label)||||||
1492701|NCT01079260|Randomized|Crossover Assignment||Treatment||Single|||t|||
1492702|NCT01079247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492703|NCT01079234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492704|NCT01079221||Single Group Assignment||Basic Science||None (Open Label)||||||
1492705|NCT01079208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492706|NCT01079195||||||||||||
1492707|NCT01079182|||Case-Only||Prospective|||||||
1492708|NCT01079169|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1492709|NCT01079143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492710|NCT01079130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492711|NCT01079117|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492712|NCT01079104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492713|NCT01079091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492714|NCT01079078|Randomized|Crossover Assignment||||None (Open Label)||||||
1492715|NCT01079065|Randomized|Crossover Assignment||||None (Open Label)||||||
1492716|NCT01079052|Randomized|Crossover Assignment||||None (Open Label)||||||
1492717|NCT01079026|||Cohort||Prospective|||||||
1492718|NCT01079013||Single Group Assignment||Treatment||None (Open Label)||||||
1492719|NCT01079000|Randomized|Parallel Assignment||Treatment||Single||||||t
1492720|NCT01078987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492721|NCT01078974||Single Group Assignment||Treatment||None (Open Label)||||||
1492722|NCT01078961||Single Group Assignment||Treatment||None (Open Label)||||||
1492723|NCT01078948|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1492724|NCT01078935|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1492725|NCT01078922|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492726|NCT01078909|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1492727|NCT01078883|||Cohort||Prospective|||||||
1492728|NCT01078870|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1492729|NCT01078857||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492730|NCT01078844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492731|NCT01078831|||Case-Only||Prospective|||||||
1492732|NCT01078818|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1492733|NCT01078805|||Cohort||Prospective|||||||
1492734|NCT01078792|||Cohort||Prospective|||||||
1492735|NCT01078779|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1492736|NCT01078766||Single Group Assignment||Treatment||None (Open Label)||||||
1492737|NCT01078753|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492738|NCT01078740|||Cohort||Prospective|||||||
1492739|NCT01078727|Randomized|Parallel Assignment||Treatment||Single||||||t
1492740|NCT01078714|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492741|NCT01078701|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1492742|NCT01078688|||Cohort||Cross-Sectional|||||||
1492743|NCT01078675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492744|NCT01078662||Single Group Assignment||Treatment||None (Open Label)||||||
1492745|NCT01078649||Single Group Assignment||Treatment||None (Open Label)||||||
1492746|NCT01078636|||Case Control||Prospective|||||||
1492747|NCT01078623|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1492748|NCT01078610|||Case-Only||Prospective|||||||
1492749|NCT01078597|||Cohort||Prospective|||||||
1492750|NCT01078584|||Cohort||Prospective|||||||
1492751|NCT01078571|||Cohort||Prospective|||||||
1492752|NCT01078558|||Case-Only||Prospective|||||||
1492753|NCT01078545|||Case-Only||Prospective|||||||
1492754|NCT01078532|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1492755|NCT01078519|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492756|NCT01078506|||Ecologic or Community||Prospective|||||||
1492757|NCT01078493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492758|NCT01078480|Randomized|Parallel Assignment||Treatment||Single||||||t
1492759|NCT01078467|||||Prospective|||||||
1492760|NCT01078454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492761|NCT01078441||Single Group Assignment||Treatment||None (Open Label)||||||
1492762|NCT01078428|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1492763|NCT01078415||Single Group Assignment||Treatment||None (Open Label)||||||
1492764|NCT01078402|||Case-Only||Prospective|||||||
1492765|NCT01078389|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492766|NCT01078376|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1492767|NCT01078363|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1492768|NCT01078350|||Cohort||Prospective|||||||
1492769|NCT01078337|||Cohort||Prospective|||||||
1492770|NCT01078324|||Cohort||Prospective|||||||
1492771|NCT01078311|||Cohort||Prospective|||||||
1492772|NCT01078298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492773|NCT01078285|||Cohort||Prospective|||||||
1492774|NCT01078272|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1492775|NCT01078246|||Cohort||Retrospective|||||||
1492776|NCT01078233|||Cohort||Other|||||||
1492777|NCT01078220|||Cohort||Prospective|||||||
1492778|NCT01078207|||Case Control||Prospective|||||||
1492779|NCT01078194|||Case-Only||Prospective|||||||
1492780|NCT01078181|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492781|NCT01078168|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492782|NCT01078155|||||Prospective|||||||
1492783|NCT01078142||Single Group Assignment||Treatment||None (Open Label)||||||
1492784|NCT01078129|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1492785|NCT01078116|||Cohort||Prospective|||||||
1492786|NCT01078103|||Case Control||Prospective|||||||
1492787|NCT01078090|||Case-Only||Prospective|||||||
1492788|NCT01078077|||Case Control||Prospective|||||||
1492789|NCT01078064|||Case-Only||Cross-Sectional|||||||
1492790|NCT01078051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492791|NCT01078038|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492792|NCT01078025|||Cohort||Prospective|||||||
1492793|NCT01078012||Single Group Assignment||Treatment||Double|||t||t|
1492794|NCT01077999|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492795|NCT01077986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492796|NCT01077973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492797|NCT01077960|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492798|NCT01077947|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1492799|NCT01077934|||Cohort||Prospective|||||||
1492800|NCT01077921|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1492801|NCT01077908|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492802|NCT01077895|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492803|NCT01077882|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1492804|NCT01077869|||Cohort||Prospective|||||||
1492805|NCT01077856|||Ecologic or Community||Other|||||||
1492806|NCT01077843|||Cohort||Retrospective|||||||
1492807|NCT01077830|||Cohort||Retrospective|||||||
1492808|NCT01077817|||Cohort||Retrospective|||||||
1492809|NCT01077804|||Cohort||Prospective|||||||
1492810|NCT01077791|Randomized|Single Group Assignment||Treatment||Single|||||t|
1492811|NCT01077778|||Cohort||Prospective|||||||
1492812|NCT01077765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492813|NCT01077752|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492814|NCT01077739|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492815|NCT01077726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492816|NCT01077713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492817|NCT01077700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492818|NCT01077687|||Family-Based||Prospective|||||||
1492819|NCT01077674|||Case-Only||Prospective|||||||
1492820|NCT01077661|||Other||Prospective|||||||
1492821|NCT01077648|||Cohort||Retrospective|||||||
1492822|NCT01077635|||Cohort||Prospective|||||||
1492823|NCT01077622||Single Group Assignment||Treatment||None (Open Label)||||||
1492824|NCT01077609|||Cohort||Retrospective|||||||
1492825|NCT01077596|||Case-Control||Retrospective|||||||
1492826|NCT01077583|||Case-Only||Prospective|||||||
1492827|NCT01077570|||Cohort||Prospective|||||||
1492828|NCT01077557|||Case-Control||Retrospective|||||||
1492829|NCT01077544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492830|NCT01077531|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492831|NCT01077518|Randomized|||Treatment||None (Open Label)||||||
1492832|NCT01077505|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1492833|NCT01077492|||Case-Only||Prospective|||||||
1492834|NCT01077479|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1492835|NCT01077466||Single Group Assignment||Treatment||None (Open Label)||||||
1492836|NCT01077453|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1492837|NCT01077440|||Case-Only||Prospective|||||||
1492838|NCT01077427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492839|NCT01077414|||||Prospective|||||||
1492840|NCT01077401|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492841|NCT01077388|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1492842|NCT01077375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492843|NCT01077362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492844|NCT01077349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492845|NCT01077336|||Cohort||Retrospective|||||||
1492846|NCT01077323|||Cohort||Retrospective|||||||
1492847|NCT01077310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492848|NCT01077297||Single Group Assignment||Treatment||None (Open Label)||||||
1492849|NCT01077284|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492850|NCT01077271|||Cohort||Prospective|||||||
1492851|NCT01077258|||Case-Only||Prospective|||||||
1492852|NCT01077245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492853|NCT01077232|||Case-Only||Prospective|||||||
1492854|NCT01077219|||Case Control||Cross-Sectional|||||||
1492855|NCT01077206|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1492856|NCT01077193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492857|NCT01077180|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492858|NCT01077167||Single Group Assignment||Basic Science||None (Open Label)||||||
1492859|NCT01077154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492860|NCT01077141||||||||||||
1492861|NCT01077128|||||Prospective|||||||
1492862|NCT01077115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492863|NCT01077102|Randomized|Parallel Assignment||Treatment||Single||||||t
1492864|NCT01077089|||Ecologic or Community||Prospective|||||||
1492865|NCT01077076|Randomized|Crossover Assignment||||None (Open Label)||||||
1492866|NCT01077063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492867|NCT01077050||Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1492868|NCT01077037|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1492869|NCT01077024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492870|NCT01077011|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1492871|NCT01076998|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1492872|NCT01076985|||Cohort||Prospective|||||||
1492873|NCT01076972|||Cohort||Prospective|||||||
1492874|NCT01076959|||Cohort||Prospective|||||||
1492875|NCT01076946|||Cohort||Prospective|||||||
1492876|NCT01076933|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492877|NCT01076920||Single Group Assignment||Treatment||None (Open Label)||||||
1492878|NCT01076907|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1492879|NCT01076894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492880|NCT01076881|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1492881|NCT01076868||Single Group Assignment||Prevention||None (Open Label)||||||
1492882|NCT01076855|||Cohort||Prospective|||||||
1492883|NCT01076842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492884|NCT01076829|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1492885|NCT01076816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492886|NCT01076803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492887|NCT01076790|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1492888|NCT01076777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492889|NCT01076764|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1492890|NCT01076751|||Cohort||Prospective|||||||
1492891|NCT01076738|||Cohort||Prospective|||||||
1492892|NCT01076725|Randomized|Parallel Assignment||||Single||||t||
1492893|NCT01076712|Randomized|Parallel Assignment||Treatment||Single||||||t
1492894|NCT01076699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492895|NCT01076686|||Cohort||Prospective|||||||
1492896|NCT01076673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492897|NCT01076660|||Cohort||Prospective|||||||
1492898|NCT01076647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492899|NCT01076634|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1492900|NCT01076621|||Cohort||Prospective|||||||
1492901|NCT01076608|||Ecologic or Community||Prospective|||||||
1492902|NCT01076595|||Cohort||Prospective|||||||
1492903|NCT01076582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492904|NCT01076569|||Case Control||Retrospective|||||||
1492905|NCT01076556||Single Group Assignment||Treatment||None (Open Label)||||||
1492906|NCT01076543||Single Group Assignment||Treatment||None (Open Label)||||||
1492907|NCT01076530||Single Group Assignment||Treatment||None (Open Label)||||||
1492908|NCT01076517||||||||||||
1492909|NCT01076504||Single Group Assignment||Treatment||None (Open Label)||||||
1492910|NCT01076491|Randomized|Single Group Assignment||||None (Open Label)||||||
1492911|NCT01076478|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492912|NCT01076465|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1492913|NCT01076452|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492914|NCT01076439|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492915|NCT01076426|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1492916|NCT01076413|Randomized|Parallel Assignment||Treatment||Single||||||t
1492917|NCT01076400|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492918|NCT01076387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492919|NCT01076374|||Cohort||Prospective|||||||
1492920|NCT01076361|||Cohort||Prospective|||||||
1492921|NCT01076348|||Cohort||Other|||||||
1492922|NCT01076335||Single Group Assignment||Treatment||None (Open Label)||||||
1492923|NCT01076322|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492924|NCT01076309|||Case Control||Prospective|||||||
1492925|NCT01076296|||Case-Only||Prospective|||||||
1492926|NCT01076283|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492927|NCT01076270||Single Group Assignment||Treatment||None (Open Label)||||||
1492928|NCT01076257|Randomized|Parallel Assignment||Treatment||Single||||||t
1492929|NCT01076244||Single Group Assignment||Treatment||None (Open Label)||||||
1492930|NCT01076231||Single Group Assignment||Treatment||None (Open Label)||||||
1492931|NCT01076218|||Cohort||Prospective|||||||
1492932|NCT01076205|||Case-Only||Prospective|||||||
1492933|NCT01076192|||Cohort||Prospective|||||||
1492934|NCT01076179|||Cohort||Prospective|||||||
1492935|NCT01076166|||Cohort||Prospective|||||||
1492936|NCT01076153|||Cohort||Prospective|||||||
1492937|NCT01076140|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492938|NCT01076127|Randomized|Factorial Assignment||Prevention||Single||||||t
1492939|NCT01076114|||Cohort||Prospective|||||||
1492940|NCT01076101|||Family-Based||Prospective|||||||
1492941|NCT01076088|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492942|NCT01076075|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492943|NCT01076062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492944|NCT01076049|Randomized|Parallel Assignment||||Single||||||t
1492945|NCT01076036||Single Group Assignment||Treatment||None (Open Label)||||||
1492946|NCT01076023|||Cohort||Prospective|||||||
1492947|NCT01076010|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492948|NCT01075997|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1492949|NCT01075984|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1492950|NCT01075971||Single Group Assignment||Treatment||None (Open Label)||||||
1492951|NCT01075958|||||Cross-Sectional|||||||
1492952|NCT01075945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492953|NCT01075932|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1492954|NCT01075919|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1492955|NCT01075906|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1492956|NCT01075893|||Case-Control||Prospective|||||||
1492957|NCT01075880|||Cohort||Prospective|||||||
1492958|NCT01075867|||Cohort||Prospective|||||||
1492959|NCT01075854|||Case-Only||Prospective|||||||
1492960|NCT01075841|||Case-Only||Prospective|||||||
1492961|NCT01075828|||Case-Only||Prospective|||||||
1492962|NCT01075815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492963|NCT01075802||Single Group Assignment||Diagnostic||None (Open Label)||||||
1492964|NCT01075789|Randomized|Parallel Assignment||Prevention||Single|||||t|
1492965|NCT01075776|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1492966|NCT01075763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492967|NCT01075750|||Cohort||Prospective|||||||
1492968|NCT01075737|||Case Control||Prospective|||||||
1492969|NCT01075724|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492970|NCT01075711|||Cohort||Prospective|||||||
1492971|NCT01075698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492972|NCT01075685|Randomized|Parallel Assignment||||Single|||t|||
1492973|NCT01075672|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492974|NCT01075659|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1492975|NCT01075646|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1492976|NCT01075633|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1492977|NCT01075620|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1492978|NCT01075607|||Case-Only||Prospective|||||||
1492979|NCT01075594|||||Prospective|||||||
1492980|NCT01075581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492981|NCT01075568|Randomized|Crossover Assignment||||Single||||||
1492982|NCT01075555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492983|NCT01075542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1492984|NCT01075529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492985|NCT01075516|||Cohort||Prospective|||||||
1492986|NCT01075503|Randomized|Parallel Assignment||||Double|||||t|t
1492987|NCT01075490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1492988|NCT01075477|||Cohort||Prospective|||||||
1492989|NCT01075464|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1492990|NCT01075451|||Ecologic or Community||Retrospective|||||||
1492991|NCT01075438|||Case-Only||Prospective|||||||
1492992|NCT01075425||Single Group Assignment||Treatment||None (Open Label)||||||
1492993|NCT01075412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1492994|NCT01075399||Single Group Assignment||||None (Open Label)||||||
1492995|NCT01075386|||Case-Control||Prospective|||||||
1492996|NCT01075373|||Case-Only||Prospective|||||||
1492997|NCT01075360|||Cohort||Retrospective|||||||
1492998|NCT01075347|Randomized|Parallel Assignment||Treatment||Single|||t|||
1492999|NCT01075334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493000|NCT01075321||Single Group Assignment||Treatment||None (Open Label)||||||
1493001|NCT01075308||Single Group Assignment||Treatment||None (Open Label)||||||
1493002|NCT01075295|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493003|NCT01075282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493004|NCT01075269|||Case Control||Prospective|||||||
1493005|NCT01075256|Randomized|Parallel Assignment||Treatment||Single||||||t
1493006|NCT01075243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493007|NCT01075230|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493008|NCT01075217|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1493009|NCT01075204|||Cohort||Prospective|||||||
1493010|NCT01075191|||Cohort||Prospective|||||||
1493011|NCT01075178|||Cohort||Retrospective|||||||
1493012|NCT01075165|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1493013|NCT01075152|Randomized|Parallel Assignment||Treatment||Single||||||t
1493014|NCT01075139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493015|NCT01075126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493016|NCT01075113|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493017|NCT01075100||Single Group Assignment||Treatment||None (Open Label)||||||
1493018|NCT01075087|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1493019|NCT01075074|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1493020|NCT01075061|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1493021|NCT01075048|Randomized|Parallel Assignment||Treatment||Double||Phase 1 is single group open label with one arm. Phase 2 is parallel, double-blind design with two arms.|t||t|
1493022|NCT01075035|||Case Control||Prospective|||||||
1493023|NCT01075022|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493024|NCT01075009|||Ecologic or Community||Retrospective|||||||
1493025|NCT01074996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493026|NCT01074983|||Cohort||Prospective|||||||
1493027|NCT01074970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493028|NCT01074957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493029|NCT01074944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493030|NCT01074931|||||Prospective|||||||
1493031|NCT01074918|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1493032|NCT01074905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493033|NCT01074892|Randomized|Parallel Assignment||Treatment||Single||||||t
1493034|NCT01074879|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1493035|NCT01074866|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1493036|NCT01074853|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1493037|NCT01074840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493038|NCT01074827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493039|NCT01074814|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493040|NCT01074801|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493041|NCT01074788|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1493042|NCT01074775||Single Group Assignment||Basic Science||None (Open Label)||||||
1493043|NCT01074762|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1493044|NCT01074749|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493045|NCT01074736|||Family-Based||Cross-Sectional|||||||
1493046|NCT01074723|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1493047|NCT01074710|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1493048|NCT01074697|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1493049|NCT01074684|||Cohort||Prospective|||||||
1493050|NCT01074671||Single Group Assignment||Treatment||None (Open Label)||||||
1493051|NCT01074658|||Cohort||Prospective|||||||
1493052|NCT01074645|Randomized|Parallel Assignment||Treatment||Double||||||
1493053|NCT01074632||||||||||||
1493054|NCT01074619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493055|NCT01074606|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493056|NCT01074593|Randomized|Crossover Assignment||||None (Open Label)||||||
1493057|NCT01074580|||Cohort||Prospective|||||||
1493058|NCT01074567||Single Group Assignment||Treatment||None (Open Label)||||||
1493059|NCT01074554|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1493060|NCT01074541|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1493061|NCT01074528|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1493062|NCT01074515|||Cohort||Prospective|||||||
1493063|NCT01074502||Single Group Assignment||Treatment||None (Open Label)||||||
1493064|NCT01074489|||Cohort||Prospective|||||||
1493065|NCT01074476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493066|NCT01074463|Randomized|Crossover Assignment||||None (Open Label)||||||
1493067|NCT01074450|Randomized|Crossover Assignment||||None (Open Label)||||||
1493068|NCT01074437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493069|NCT01074424||||||||||||
1493070|NCT01074411||Single Group Assignment||Treatment||None (Open Label)||||||
1493071|NCT01074398||||||||||||
1493072|NCT01074385|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1493073|NCT01074372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493074|NCT01074359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493075|NCT01074346|||Cohort||Prospective|||||||
1493076|NCT01074333|||Cohort||Prospective|||||||
1493077|NCT01074320|||Cohort||Prospective|||||||
1493078|NCT01074307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493079|NCT01074294|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1493080|NCT01074281|||Cohort||Prospective|||||||
1493081|NCT01074268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493082|NCT01074255|||Case-Only||Prospective|||||||
1493083|NCT01074242|||Other||Prospective|||||||
1493084|NCT01074229|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1493085|NCT01074216||Single Group Assignment||Treatment||None (Open Label)||||||
1493086|NCT01074203||Single Group Assignment||Prevention||None (Open Label)||||||
1493087|NCT01074190|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493088|NCT01074177||Single Group Assignment||Treatment||None (Open Label)||||||
1493089|NCT01074164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493090|NCT01074151|||Other||Prospective|||||||
1493091|NCT01074138||Single Group Assignment||Treatment||None (Open Label)||||||
1493092|NCT01074125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493093|NCT01074112|||Cohort||Cross-Sectional|||||||
1493094|NCT01074099|Randomized|Single Group Assignment||Treatment||Single|||t|||
1493095|NCT01074086||Factorial Assignment||Treatment||None (Open Label)||||||
1493096|NCT01074073|Randomized|Single Group Assignment||||None (Open Label)||||||
1493097|NCT01074060||Single Group Assignment||Treatment||None (Open Label)||||||
1493098|NCT01074047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493099|NCT01074034||Single Group Assignment||Treatment||None (Open Label)||||||
1493100|NCT01074021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493101|NCT01074008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493102|NCT01073995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493103|NCT01073982|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493104|NCT01073969|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1493105|NCT01073956|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1493106|NCT01073943|Randomized|Parallel Assignment||Treatment||Single||||||t
1493107|NCT01073930|Randomized|Parallel Assignment||Treatment||Single||||||t
1493108|NCT01073917|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1493109|NCT01073904|Randomized|Crossover Assignment||||None (Open Label)||||||
1493110|NCT01073891|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1493111|NCT01073878||Single Group Assignment||||None (Open Label)||||||
1493112|NCT01073865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493113|NCT01073852|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493114|NCT01073839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493115|NCT01073826|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493116|NCT01073813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493117|NCT01073800|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493118|NCT01073787|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493119|NCT01073774|Randomized|Crossover Assignment||||None (Open Label)||||||
1493120|NCT01073761||Single Group Assignment||Treatment||None (Open Label)||||||
1493121|NCT01073748|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1493122|NCT01073735|||Cohort||Prospective|||||||
1493123|NCT01073722|Randomized|Parallel Assignment||Treatment||Single||||t||
1493124|NCT01073709|Randomized|Crossover Assignment||||None (Open Label)||||||
1493125|NCT01073696|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493126|NCT01073683||Single Group Assignment||Treatment||None (Open Label)||||||
1493127|NCT01073670|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1493128|NCT01073657|Randomized|Single Group Assignment||Treatment||Single|||t|||
1493129|NCT01073644|||Cohort||Prospective|||||||
1493130|NCT01073631|||Case-Only||Prospective|||||||
1493131|NCT01073618|||Case-Only||Prospective|||||||
1493132|NCT01073605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493133|NCT01073592|||Cohort||Prospective|||||||
1493134|NCT01073579|||||Prospective|||||||
1493135|NCT01073566|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493136|NCT01073553|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493137|NCT01073540|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493138|NCT01073527|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493139|NCT01073514|||Case-Only||Prospective|||||||
1493140|NCT01073501|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1493141|NCT01073488|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493142|NCT01073475|||Cohort||Prospective|||||||
1493143|NCT01073462|||Cohort||Prospective|||||||
1493144|NCT01073449|||Cohort||Prospective|||||||
1493145|NCT01073436|||Case-Only||Prospective|||||||
1493146|NCT01073423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493147|NCT01073410|||Case-Control||Prospective|||||||
1493148|NCT01073397|Randomized|Parallel Assignment||Other||Single||||||t
1493149|NCT01073384|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1493150|NCT01073371|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1493151|NCT01073358|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1493152|NCT01073345|||Cohort||Prospective|||||||
1493153|NCT01073332|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1493154|NCT01073319|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1493155|NCT01073306|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493156|NCT01073293|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493157|NCT01073280|||Case-Crossover||Cross-Sectional|||||||
1493158|NCT01073267||Single Group Assignment||Treatment||None (Open Label)||||||
1493159|NCT01073241|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1493160|NCT01073228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493161|NCT01073215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493162|NCT01073202|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1493163|NCT01073189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493164|NCT01073176||Single Group Assignment||Treatment||None (Open Label)||||||
1493165|NCT01073163||Single Group Assignment||Treatment||None (Open Label)||||||
1493166|NCT01073150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493167|NCT01073137|||Cohort||Prospective|||||||
1493168|NCT01073124|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1493169|NCT01073111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493170|NCT01073098||Single Group Assignment||||None (Open Label)||||||
1493171|NCT01073085|Randomized|Parallel Assignment||Prevention||Single|||t|||
1493172|NCT01073072|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493173|NCT01073059|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1493174|NCT01073046|||Case Control||Prospective|||||||
1493175|NCT01073033|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493176|NCT01073020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493177|NCT01073007|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493178|NCT01072994|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493179|NCT01072981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493180|NCT01072968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493181|NCT01072955|Randomized|Parallel Assignment||Prevention||Single|||||t|
1493182|NCT01072942|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493183|NCT01072929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493184|NCT01072916|||Case Control||Prospective|||||||
1493185|NCT01072903|||Case Control||Prospective|||||||
1493186|NCT01072890||Single Group Assignment||Treatment||None (Open Label)||||||
1493187|NCT01072877|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1493188|NCT01072864|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1493189|NCT01072851|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1493190|NCT01072838||Single Group Assignment||Treatment||None (Open Label)||||||
1493191|NCT01072825|||Cohort||Prospective|||||||
1493192|NCT01072812||Single Group Assignment||Treatment||None (Open Label)||||||
1493193|NCT01072799|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493194|NCT01072786|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1493195|NCT01072773||Single Group Assignment||Treatment||None (Open Label)||||||
1493196|NCT01072760|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1493197|NCT01072747|Randomized|Parallel Assignment||Treatment||Single|||||t|
1493198|NCT01072734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493199|NCT01072721||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493200|NCT01072708||Single Group Assignment||||None (Open Label)||||||
1493201|NCT01072695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493202|NCT01072682||Single Group Assignment||Treatment||None (Open Label)||||||
1493203|NCT01072669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493204|NCT01072656|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1493205|NCT01072643||Single Group Assignment||Treatment||None (Open Label)||||||
1493206|NCT01072630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493207|NCT01072617||Single Group Assignment||Treatment||None (Open Label)||||||
1493208|NCT01072604|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493209|NCT01072591|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493210|NCT01072578|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1493211|NCT01072565|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1493212|NCT01072552|||Case Control||Prospective|||||||
1493213|NCT01072539|||Case-Only||Prospective|||||||
1493214|NCT01072526|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493215|NCT01072513||Single Group Assignment||||None (Open Label)||||||
1493216|NCT01072500|Randomized|Parallel Assignment||Prevention||Single||||||t
1493217|NCT01072487|Randomized|Parallel Assignment||Prevention||Single|||t|||
1493218|NCT01072474|Randomized|Parallel Assignment||Prevention||Single|||t|||
1493219|NCT01072461|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1493220|NCT01072448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493221|NCT01072435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493222|NCT01072422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493223|NCT01072409||Single Group Assignment||Treatment||None (Open Label)||||||
1493224|NCT01072396|Randomized|Crossover Assignment||Treatment||Double||||||
1493225|NCT01072383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493226|NCT01072370|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1493227|NCT01072357|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493228|NCT01072344|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493229|NCT01072331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493230|NCT01072318||Single Group Assignment||Treatment||None (Open Label)||||||
1493231|NCT01072305|Randomized|Parallel Assignment||Treatment||Single|||||t|
1493232|NCT01072292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493233|NCT01072279|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493234|NCT01072266||Single Group Assignment||Treatment||None (Open Label)||||||
1493235|NCT01072253|||Cohort||Retrospective|||||||
1493236|NCT01072240|||Cohort||Prospective|||||||
1493237|NCT01072227|||Case-Only||Prospective|||||||
1493238|NCT01072214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493239|NCT01072201|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493240|NCT01072188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493241|NCT01072175|Non-Randomized|||Treatment||None (Open Label)||||||
1493242|NCT01072162|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1493243|NCT01072149|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1493244|NCT01072136|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493245|NCT01072123||Single Group Assignment||||Double||||t|t|
1493247|NCT01072097|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1493248|NCT01072084|||Case Control||Prospective|||||||
1493249|NCT01072071|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493250|NCT01072058||Single Group Assignment||Screening||None (Open Label)||||||
1493251|NCT01072045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493252|NCT01072032|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1493253|NCT01072019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493254|NCT01072006|||Case-Control||Prospective|||||||
1493255|NCT01071993|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1493256|NCT01071980|Randomized|Factorial Assignment||Prevention||Single|||||t|
1493257|NCT01071967|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493258|NCT01071954|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1493259|NCT01071941||Single Group Assignment||Treatment||None (Open Label)||||||
1493260|NCT01071928||Single Group Assignment||Treatment||None (Open Label)||||||
1493261|NCT01071915||Single Group Assignment||Treatment||None (Open Label)||||||
1493262|NCT01071902|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493263|NCT01071889|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1493264|NCT01071876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493265|NCT01071863|||Cohort||Prospective|||||||
1493266|NCT01071850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493267|NCT01071837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493268|NCT01071824|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493269|NCT01071811|Randomized|Parallel Assignment||Prevention||Single||||||t
1493270|NCT01071798|||Cohort||Prospective|||||||
1493271|NCT01071785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493272|NCT01071772|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493273|NCT01071759|||Case-Crossover||Prospective|||||||
1493274|NCT01071746|||Cohort||Prospective|||||||
1493275|NCT01071733|||Cohort||Prospective|||||||
1493276|NCT01071720|Randomized|Crossover Assignment||||None (Open Label)||||||
1493277|NCT01071707|||Case-Only||Prospective|||||||
1493278|NCT01071694|||Cohort||Prospective|||||||
1493279|NCT01071681|||Cohort||Prospective|||||||
1493280|NCT01071668|||Cohort||Prospective|||||||
1493281|NCT01071655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493282|NCT01071642|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1493283|NCT01071629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493284|NCT01071616|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1493285|NCT01071603|||||Prospective|||||||
1493286|NCT01071590|||||Prospective|||||||
1493287|NCT01071577|||Other||Prospective|||||||
1493288|NCT01071564||Single Group Assignment||Treatment||None (Open Label)||||||
1493289|NCT01071551|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493290|NCT01071538||Single Group Assignment||Treatment||None (Open Label)||||||
1493291|NCT01071525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493292|NCT01071512||Single Group Assignment||Treatment||None (Open Label)||||||
1493293|NCT01071499|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1493294|NCT01071486||Single Group Assignment||Treatment||None (Open Label)||||||
1493295|NCT01071473||Single Group Assignment||Supportive Care||None (Open Label)||||||
1493296|NCT01071460||Single Group Assignment||Treatment||None (Open Label)||||||
1493297|NCT01071447|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1493298|NCT01071434|||Cohort||Prospective|||||||
1493299|NCT01071421|||Case Control||Prospective|||||||
1493300|NCT01071408|Randomized|Single Group Assignment||Prevention||Double|||||t|t
1493301|NCT01071395|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1493302|NCT01071382|||Cohort||Retrospective|||||||
1493303|NCT01071369|Randomized|Parallel Assignment||Treatment||Double|Randomly assigned to groups||t||t|
1493304|NCT01071356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493305|NCT01071343|Randomized|Single Group Assignment||Prevention||Single||||||t
1493306|NCT01071317|Randomized|Parallel Assignment||Prevention||Single||||||t
1493307|NCT01071304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493308|NCT01071291|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1493309|NCT01071278|||||Prospective|||||||
1493310|NCT01071265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493311|NCT01071252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493312|NCT01071239||Single Group Assignment||Treatment||None (Open Label)||||||
1493313|NCT01071226|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493314|NCT01071200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493315|NCT01071187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493316|NCT01071174|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1493317|NCT01071161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493318|NCT01071148|||Cohort||Prospective|||||||
1493319|NCT01071135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493320|NCT01071122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493321|NCT01071109|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1493322|NCT01071096|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1493323|NCT01071083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493324|NCT01071070|Randomized|Single Group Assignment||Treatment||Single|||t|||
1493325|NCT01071057|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1493326|NCT01071044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493327|NCT01071031|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1493328|NCT01071018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493329|NCT01071005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493330|NCT01070992||||||||||||
1493331|NCT01070979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493332|NCT01070966|||||Prospective|||||||
1493333|NCT01070953|||||Prospective|||||||
1493334|NCT01070940|Randomized|Crossover Assignment||||Single|||t|||
1493335|NCT01070927|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493336|NCT01070914|||Case-Only||Cross-Sectional|||||||
1493337|NCT01070901|||Cohort||Prospective|||||||
1493338|NCT01070888|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1493339|NCT01070875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493340|NCT01070862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493341|NCT01070849|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1493342|NCT01070836||||||||||||
1493343|NCT01070823|||||Prospective|||||||
1493344|NCT01070810|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493345|NCT01070797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493346|NCT01070784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493347|NCT01070771||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493348|NCT01070758||Single Group Assignment||Treatment||None (Open Label)||||||
1493349|NCT01070745|Randomized|Parallel Assignment||Treatment||Single||||||t
1493350|NCT01070732|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1493351|NCT01070719|||Cohort||Cross-Sectional|||||||
1493352|NCT01070706||Single Group Assignment||Treatment||None (Open Label)||||||
1493353|NCT01070693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493354|NCT01070680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493355|NCT01070667|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1493356|NCT01070654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493357|NCT01070641|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493358|NCT01070628|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493359|NCT01070615||Single Group Assignment||Treatment||None (Open Label)||||||
1493360|NCT01070602||Single Group Assignment||Treatment||None (Open Label)||||||
1493361|NCT01070589|||Case Control||Prospective|||||||
1493362|NCT01070576|||||Prospective|||||||
1493363|NCT01070563|||Case Control||Prospective|||||||
1493364|NCT01070550|||Cohort||Prospective|||||||
1493365|NCT01070537||Single Group Assignment||||||||||
1493366|NCT01070524|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1493367|NCT01070511|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1493368|NCT01070498||Single Group Assignment||Treatment||None (Open Label)||||||
1493369|NCT01070485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493370|NCT01070472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493371|NCT01070459|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493372|NCT01070446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493373|NCT01070433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493374|NCT01070420|Non-Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1493375|NCT01070407|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493376|NCT01070394||Single Group Assignment||Treatment||None (Open Label)||||||
1493377|NCT01070381|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493378|NCT01070368||Parallel Assignment||Diagnostic||None (Open Label)||||||
1493379|NCT01070355|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493380|NCT01070342|||Cohort||Prospective|||||||
1493381|NCT01070329|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493382|NCT01070316||Single Group Assignment||Treatment||None (Open Label)||||||
1493383|NCT01070303||Single Group Assignment||Treatment||None (Open Label)||||||
1493384|NCT01070290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493385|NCT01070277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493386|NCT01070264||Single Group Assignment||||||||||
1493387|NCT01070251|Randomized|Parallel Assignment||Prevention||Single||||||t
1493388|NCT01070238|Randomized|Crossover Assignment||||Double|||t||t|
1493389|NCT01070225|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1493390|NCT01070212|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1493391|NCT01070199|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1493392|NCT01070186||Single Group Assignment||Treatment||None (Open Label)||||||
1493393|NCT01070173|||Cohort||Prospective|||||||
1493394|NCT01070160|||Cohort||Prospective|||||||
1493395|NCT01070147||Single Group Assignment||Supportive Care||None (Open Label)||||||
1493396|NCT01070134|Randomized|Parallel Assignment||Treatment||Single||||||t
1493397|NCT01070121|||Cohort||Prospective|||||||
1493398|NCT01070108|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493399|NCT01070095||Single Group Assignment||Supportive Care||None (Open Label)||||||
1493400|NCT01070082|||Cohort||Prospective|||||||
1493401|NCT01070069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493402|NCT01070056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493403|NCT01070043|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493404|NCT01070030|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493405|NCT01070017|Randomized|Parallel Assignment||Health Services Research||Single||Cluster randomization of sites assign individuals starting antiretroviral therapy to receive community-based directly observed therapy plus home visits / social support versus home visits / social support alone.||||t
1493406|NCT01070004|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1493407|NCT01069991|Randomized|Parallel Assignment||Prevention||Single||||||t
1493408|NCT01069965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493409|NCT01069952||Single Group Assignment||Treatment||None (Open Label)||||||
1493410|NCT01069939|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493411|NCT01069926||Single Group Assignment||||None (Open Label)||||||
1493412|NCT01069913|Randomized|Crossover Assignment||||None (Open Label)||||||
1493413|NCT01069900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493414|NCT01069887|||Cohort||Prospective|||||||
1493415|NCT01069874|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493416|NCT01069861||Single Group Assignment||Treatment||None (Open Label)||||||
1493417|NCT01069848||||||||||||
1493418|NCT01069835|||Cohort||Prospective|||||||
1493419|NCT01069822|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1493420|NCT01069809|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493421|NCT01069796||Single Group Assignment||Treatment||None (Open Label)||||||
1493422|NCT01069783|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493423|NCT01069770||Single Group Assignment||Treatment||None (Open Label)||||||
1493424|NCT01069757||Single Group Assignment||Treatment||None (Open Label)||||||
1493425|NCT01069744|||Cohort||Prospective|||||||
1493426|NCT01069731|||Cohort||Prospective|||||||
1493427|NCT01069718|||Cohort||Prospective|||||||
1493428|NCT01069705||Single Group Assignment||Treatment||None (Open Label)||||||
1493429|NCT01069692|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493430|NCT01069666|||||Prospective|||||||
1493431|NCT01069653|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493432|NCT01069640|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493433|NCT01069627||Single Group Assignment||Treatment||None (Open Label)||||||
1493434|NCT01069614|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493435|NCT01069601|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493436|NCT01069588|||Cohort||Prospective|||||||
1493437|NCT01069575|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493438|NCT01069562|Randomized|Parallel Assignment||||Single|||t|||
1493439|NCT01069549|||Case Control||Cross-Sectional|||||||
1493440|NCT01069536|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1493441|NCT01069523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493442|NCT01069510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493443|NCT01069497|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493444|NCT01069484|Randomized|Parallel Assignment||Prevention||Single||||||t
1493445|NCT01069471|Randomized|Parallel Assignment||Prevention||Single|||t|||
1493446|NCT01069458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493447|NCT01069445|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493448|NCT01069432|||Cohort||Prospective|||||||
1493449|NCT01069419|||Cohort||Prospective|||||||
1493450|NCT01069406|||Cohort||Prospective|||||||
1493451|NCT01069393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493452|NCT01069380|||Cohort||Cross-Sectional|||||||
1493453|NCT01069367|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1493454|NCT01069354|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493455|NCT01069341||Single Group Assignment||Treatment||None (Open Label)||||||
1493456|NCT01069328|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1493457|NCT01069315|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1493458|NCT01069302|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1493459|NCT01069289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493460|NCT01069276|||Case-Only||Prospective|||||||
1493461|NCT01069263|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493462|NCT01069250|||Case-Only||Prospective|||||||
1493463|NCT01069237|||||Prospective|||||||
1493464|NCT01069224|||Cohort||Prospective|||||||
1493465|NCT01069211|||Case Control||Prospective|||||||
1493466|NCT01069198|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493467|NCT01069185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493468|NCT01069172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493469|NCT01069159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493470|NCT01069146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493471|NCT01069133|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493472|NCT01069120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493473|NCT01069107|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1493474|NCT01069094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493475|NCT01069081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493476|NCT01069068|||Case-Only||Prospective|||||||
1493477|NCT01069055|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493478|NCT01069042|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493479|NCT01069029|||Cohort||Retrospective|||||||
1493480|NCT01069016|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1493481|NCT01069003|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493482|NCT01068990|||Cohort||Prospective|||||||
1493483|NCT01068977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493484|NCT01068964|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493485|NCT01068951|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493486|NCT01068938|||Cohort||Prospective|||||||
1493487|NCT01068925|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1493488|NCT01068912|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1493489|NCT01068899|||Ecologic or Community||Cross-Sectional|||||||
1493490|NCT01068886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493491|NCT01068873||Single Group Assignment||Treatment||None (Open Label)||||||
1493492|NCT01068860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493493|NCT01068847||Single Group Assignment||Basic Science||Double|||t||t|
1493494|NCT01068834|||Cohort||Prospective|||||||
1493495|NCT01068821|Randomized|Single Group Assignment||Prevention||Single|||t|||
1493496|NCT01068808|||Case-Only||Cross-Sectional|||||||
1493497|NCT01068795|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493498|NCT01068782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493499|NCT01068769||Single Group Assignment||Treatment||None (Open Label)||||||
1493500|NCT01068756||Single Group Assignment||||None (Open Label)||||||
1493501|NCT01068743|Randomized|Crossover Assignment||||None (Open Label)||||||
1493502|NCT01068730|Randomized|Crossover Assignment||||None (Open Label)||||||
1493503|NCT01068717|Randomized|Crossover Assignment||||None (Open Label)||||||
1493504|NCT01068704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493505|NCT01068691|||Case-Only||Prospective|||||||
1493506|NCT01068678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493507|NCT01068665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493508|NCT01068652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493509|NCT01068639|||Case-Only||Cross-Sectional|||||||
1493510|NCT01068626|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493511|NCT01068613|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1493512|NCT01068600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493513|NCT01068587|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493514|NCT01068574|||Cohort||Prospective|||||||
1493515|NCT01068561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493516|NCT01068548|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1493517|NCT01068535|||Case Control||Prospective|||||||
1493518|NCT01068522|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1493519|NCT01068509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493520|NCT01068496|||Cohort||Prospective|||||||
1493521|NCT01068483||Single Group Assignment||Treatment||None (Open Label)||||||
1493522|NCT01068470|||Cohort||Prospective|||||||
1493523|NCT01068457|||Cohort||Retrospective|||||||
1493524|NCT01068444|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493525|NCT01068431|Randomized|Single Group Assignment||Treatment||Single|||||t|
1493526|NCT01068418||Single Group Assignment||Other||None (Open Label)||||||
1493527|NCT01068405|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493528|NCT01068392||Single Group Assignment||Treatment||None (Open Label)||||||
1493529|NCT01068379|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493530|NCT01068366|||Case Control||Prospective|||||||
1493531|NCT01068353|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1493532|NCT01068340|||Cohort||Retrospective|||||||
1493533|NCT01068327||Single Group Assignment||Treatment||None (Open Label)||||||
1493534|NCT01068314|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1493535|NCT01068301||Single Group Assignment||Treatment||None (Open Label)||||||
1493536|NCT01068288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493537|NCT01068275|Randomized|Parallel Assignment||Treatment||Single||||||t
1493538|NCT01068262|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493539|NCT01068249||Single Group Assignment||Treatment||None (Open Label)||||||
1493540|NCT01068236|Randomized|Parallel Assignment||Treatment||Single||||||t
1493541|NCT01068223|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1493542|NCT01068210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493543|NCT01068197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493544|NCT01068184|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1493545|NCT01068171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493546|NCT01068158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493547|NCT01068145|Randomized|Crossover Assignment||||Double|||t||t|
1493548|NCT01068132||Single Group Assignment||Treatment||None (Open Label)||||||
1493549|NCT01068119||Single Group Assignment||Treatment||None (Open Label)||||||
1493550|NCT01068106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493551|NCT01068093|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493552|NCT01068080|||Cohort||Prospective|||||||
1493553|NCT01068067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493554|NCT01068054|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493555|NCT01068041|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493556|NCT01068028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493557|NCT01068015|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493558|NCT01068002|||Cohort||Prospective|||||||
1493559|NCT01067989||Single Group Assignment||Treatment||None (Open Label)||||||
1493560|NCT01067976|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1493561|NCT01067963|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493562|NCT01067950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493563|NCT01067937||||||None (Open Label)||||||
1493564|NCT01067924|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1493565|NCT01067911|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1493566|NCT01067898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493567|NCT01067885||Single Group Assignment||Treatment||None (Open Label)||||||
1493568|NCT01067859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493569|NCT01067846|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493570|NCT01067833|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493571|NCT01067820|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493572|NCT01067807|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493573|NCT01067794|||Case-Only||Prospective|||||||
1493574|NCT01067781|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493575|NCT01067768|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493576|NCT01067755|||Case-Only||Prospective|||||||
1493577|NCT01067742|||Cohort||Prospective|||||||
1493578|NCT01067729|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493579|NCT01067716|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493580|NCT01067703|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493581|NCT01067690||Single Group Assignment||Treatment||None (Open Label)||||||
1493582|NCT01067677|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493583|NCT01067664|||Cohort||Prospective|||||||
1493584|NCT01067651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493585|NCT01067638|Randomized|||Treatment||Double||||||
1493586|NCT01067625||Single Group Assignment||Treatment||None (Open Label)||||||
1493587|NCT01067599|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493588|NCT01067586|||Case-Only||Cross-Sectional|||||||
1493589|NCT01067573|||Case-Crossover||Prospective|||||||
1493590|NCT01067560|||||Prospective|||||||
1493591|NCT01067547|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493592|NCT01067534|Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1493593|NCT01067521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493594|NCT01067508|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1493595|NCT01067495||Single Group Assignment||Treatment||None (Open Label)||||||
1493596|NCT01067482|||||Prospective|||||||
1493597|NCT01067469|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493598|NCT01067456|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Randomized diagnostic trial, two arms||||
1493599|NCT01067443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493600|NCT01067430|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493601|NCT01067417|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493602|NCT01067404|||Cohort||Prospective|||||||
1493603|NCT01067391|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1493604|NCT01067378|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1493605|NCT01067365|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493606|NCT01067352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493607|NCT01067339|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493608|NCT01067326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493609|NCT01067313|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493610|NCT01067300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493611|NCT01067287|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493612|NCT01067274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493613|NCT01067261|Randomized|Parallel Assignment||Treatment||Single||||||t
1493614|NCT01067248|||Cohort||Cross-Sectional|||||||
1493615|NCT01067235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493616|NCT01067222|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493617|NCT01067209|||Case-Only||Prospective|||||||
1493618|NCT01067196|||Cohort||Prospective|||||||
1493619|NCT01067183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493620|NCT01067170|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1493621|NCT01067157||Single Group Assignment||Treatment||None (Open Label)||||||
1493622|NCT01067144|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1493623|NCT01067131|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493624|NCT01067118|Randomized|Crossover Assignment||Other||Double|||t||t|
1493625|NCT01067105||Single Group Assignment||Treatment||None (Open Label)||||||
1493626|NCT01067092|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493627|NCT01067079|||Cohort||Retrospective|||||||
1493628|NCT01067066||Single Group Assignment||Treatment||None (Open Label)||||||
1493629|NCT01067053||Single Group Assignment||Treatment||None (Open Label)||||||
1493630|NCT01067040||||||||||||
1493631|NCT01067027|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1493632|NCT01067014|||Case-Only||Prospective|||||||
1493633|NCT01067001||||||||||||
1493634|NCT01066988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493635|NCT01066975|||Case-Only||Prospective|||||||
1493636|NCT01066962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493637|NCT01066949|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1493638|NCT01066936|||Cohort||Prospective|||||||
1493639|NCT01066923|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1493640|NCT01066910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493641|NCT01066897||Single Group Assignment||Treatment||None (Open Label)||||||
1493642|NCT01066884||Single Group Assignment||Treatment||None (Open Label)||||||
1493643|NCT01066871|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493644|NCT01066858|||Cohort||Prospective|||||||
1493645|NCT01066845|||Cohort||Prospective|||||||
1493646|NCT01066832||Single Group Assignment||Treatment||None (Open Label)||||||
1493647|NCT01066819|||Cohort||Prospective|||||||
1493648|NCT01066806|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493649|NCT01066793|||Cohort||Prospective|||||||
1493650|NCT01066780|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493651|NCT01066767|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493652|NCT01066754|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493653|NCT01066741|Randomized|Parallel Assignment||Prevention||Single|||||t|
1493654|NCT01066728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493655|NCT01066715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493656|NCT01066702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493657|NCT01066689|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493658|NCT01066676|Randomized|Parallel Assignment||Treatment||Single||||||t
1493659|NCT01066663||Single Group Assignment||Treatment||None (Open Label)||||||
1493660|NCT01066650|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493661|NCT01066637|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1493662|NCT01066624|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493663|NCT01066611|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1493664|NCT01066598||Single Group Assignment||Treatment||None (Open Label)||||||
1493665|NCT01066585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493666|NCT01066572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493667|NCT01066559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493668|NCT01066546|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493669|NCT01066533|Randomized|Parallel Assignment||Treatment||Double||||t||t
1493670|NCT01066520|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493671|NCT01066507|||Case Control||Retrospective|||||||
1493672|NCT01066494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493673|NCT01066481|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493674|NCT01066468|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1493675|NCT01066455|||Case-Only||Cross-Sectional|||||||
1493676|NCT01066442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493677|NCT01066429||Single Group Assignment||Treatment||None (Open Label)||||||
1493678|NCT01066416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493679|NCT01066403|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1493680|NCT01066390||Single Group Assignment||Treatment||None (Open Label)||||||
1493681|NCT01066377|Randomized|Parallel Assignment||||Triple|||t||t|t
1493682|NCT01066364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493683|NCT01066351|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1493684|NCT01066338|||Case-Only||Retrospective|||||||
1493685|NCT01066325|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493686|NCT01066312|||Other||Other|||||||
1493687|NCT01066299|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1493688|NCT01066286|||Case-Only||Retrospective|||||||
1493689|NCT01066273||Single Group Assignment||Treatment||None (Open Label)||||||
1493690|NCT01066260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493691|NCT01066247|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1493692|NCT01066234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493693|NCT01066221|||||Prospective|||||||
1493694|NCT01066208|||Case Control||Prospective|||||||
1493695|NCT01066195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493696|NCT01066182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493697|NCT01066169|||Cohort||Prospective|||||||
1493698|NCT01066156||Single Group Assignment||Treatment||None (Open Label)||||||
1493699|NCT01066143||Single Group Assignment||Treatment||None (Open Label)||||||
1493700|NCT01066130|Randomized|Parallel Assignment||Treatment||Single|||t|||
1493701|NCT01066117||Single Group Assignment||Supportive Care||None (Open Label)||||||
1493702|NCT01066104|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1493703|NCT01066091|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1493704|NCT01066078|||Cohort||Prospective|||||||
1493705|NCT01066065|||Cohort||Prospective|||||||
1493706|NCT01066052|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493707|NCT01066039||Single Group Assignment||Treatment||None (Open Label)||||||
1493708|NCT01066026|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1493709|NCT01066013|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493710|NCT01066000||Single Group Assignment||Treatment||None (Open Label)||||||
1493711|NCT01065987|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493712|NCT01065974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493713|NCT01065961|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493714|NCT01065948||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493715|NCT01065935|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493716|NCT01065909|||Cohort||Prospective|||||||
1493717|NCT01065896|||Case Control||Prospective|||||||
1493718|NCT01065883|Randomized|Parallel Assignment||Treatment||Single||||||t
1493719|NCT01065870|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493720|NCT01065857|Randomized|Parallel Assignment||||Single||||||t
1493721|NCT01065844||Single Group Assignment||Treatment||None (Open Label)||||||
1493722|NCT01065831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493723|NCT01065818||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493724|NCT01065805||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493725|NCT01065792|||||Prospective|||||||
1493726|NCT01065779|||||Prospective|||||||
1493727|NCT01065766|||||Prospective|||||||
1493728|NCT01065753|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493729|NCT01065740|Randomized|Parallel Assignment||Treatment||Single||||||t
1493730|NCT01065727|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1493731|NCT01065714|Randomized|Parallel Assignment||Treatment||Single|||||t|
1493732|NCT01065701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493733|NCT01065688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493734|NCT01065675||Single Group Assignment||Health Services Research||Single||||t||
1493735|NCT01065662||Single Group Assignment||Treatment||None (Open Label)||||||
1493736|NCT01065649|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1493737|NCT01065636|Randomized|Parallel Assignment||Treatment||Single||||||t
1493738|NCT01065623|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493739|NCT01065610||||||||||||
1493740|NCT01065597||Single Group Assignment||Treatment||None (Open Label)||||||
1493741|NCT01065584|||Cohort||Prospective|||||||
1493742|NCT01065571|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1493743|NCT01065558||Single Group Assignment||Treatment||None (Open Label)||||||
1493744|NCT01065545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493745|NCT01065532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493746|NCT01065519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493747|NCT01065506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493748|NCT01065493|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493749|NCT01065480|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1493750|NCT01065467||Single Group Assignment||Treatment||None (Open Label)||||||
1493751|NCT01065454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493752|NCT01065441||Single Group Assignment||Treatment||None (Open Label)||||||
1493753|NCT01065428|||Cohort||Prospective|||||||
1493754|NCT01065415|||Case Control||Prospective|||||||
1493755|NCT01065402|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1493756|NCT01065389|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1493757|NCT01065376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493758|NCT01065363|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493759|NCT01065350|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493760|NCT01065337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493761|NCT01065324|||Cohort||Prospective|||||||
1493762|NCT01065311|Randomized|Parallel Assignment||Treatment||Single||||||t
1493763|NCT01065298|||Case Control||Prospective|||||||
1493764|NCT01065285||Single Group Assignment||Treatment||None (Open Label)||||||
1493765|NCT01065272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493766|NCT01065259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493767|NCT01065246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493768|NCT01065233|||Case Control||Prospective|||||||
1493769|NCT01065220|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1493770|NCT01065207||Single Group Assignment||||None (Open Label)||||||
1493771|NCT01065194|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493772|NCT01065181|||Cohort||Cross-Sectional|||||||
1493773|NCT01065168|||Case-Only||Prospective|||||||
1493774|NCT01065155|||||Prospective|||||||
1493775|NCT01065142|Randomized|Parallel Assignment||||Single|||t|||
1493776|NCT01065129|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493777|NCT01065116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493778|NCT01065103||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493779|NCT01065090|||Case Control||Prospective|||||||
1493780|NCT01065077|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493781|NCT01065064|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1493782|NCT01065051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493783|NCT01065038||||||||||||
1493784|NCT01065025||Single Group Assignment||Treatment||None (Open Label)||||||
1493785|NCT01065012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493786|NCT01064999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493787|NCT01064986|Randomized|Parallel Assignment||||Double|||t||t|
1493788|NCT01064973||Single Group Assignment||Treatment||None (Open Label)||||||
1493789|NCT01064960||Single Group Assignment||Treatment||None (Open Label)||||||
1493790|NCT01064947||Single Group Assignment||Treatment||None (Open Label)||||||
1493791|NCT01064934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493792|NCT01064921||Single Group Assignment||Treatment||None (Open Label)||||||
1493793|NCT01064908|||Case-Only||Cross-Sectional|||||||
1493794|NCT01064895|||Case-Only||Prospective|||||||
1493795|NCT01064882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493796|NCT01064869|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1493797|NCT01064856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493798|NCT01064843|||||Prospective|||||||
1493799|NCT01064830|Randomized|Parallel Assignment||Treatment||Single|||||t|
1493800|NCT01064817|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493801|NCT01064804|||Cohort||Prospective|||||||
1493802|NCT01064791|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493803|NCT01064778|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1493804|NCT01064765|||||Prospective|||||||
1493805|NCT01064752|||Case-Only||Prospective|||||||
1493806|NCT01064739||Single Group Assignment||||None (Open Label)||||||
1493807|NCT01064726|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1493808|NCT01064713||Single Group Assignment||Treatment||None (Open Label)||||||
1493809|NCT01064700|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493810|NCT01064687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493811|NCT01064674|||Cohort||Prospective|||||||
1493812|NCT01064661|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1493813|NCT01064648|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493814|NCT01064635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493815|NCT01064622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493816|NCT01064609|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1493817|NCT01064596|||Cohort||Prospective|||||||
1493818|NCT01064583|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1493819|NCT01064570||Single Group Assignment||Treatment||None (Open Label)||||||
1493820|NCT01064557||Single Group Assignment||Treatment||None (Open Label)||||||
1493821|NCT01064544|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493822|NCT01064531|||Cohort||Prospective|||||||
1493823|NCT01064518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493824|NCT01064505||Single Group Assignment||||None (Open Label)||||||
1493825|NCT01064492|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493826|NCT01064479|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493827|NCT01064466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493828|NCT01064453|||Cohort||Prospective|||||||
1493829|NCT01064440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493830|NCT01064427|||Cohort||Prospective|||||||
1493831|NCT01064414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493832|NCT01064401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493833|NCT01064388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493834|NCT01064375|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493835|NCT01064362|||Cohort||Retrospective|||||||
1493836|NCT01064349|||Cohort||Retrospective|||||||
1493837|NCT01064336|||Cohort||Prospective|||||||
1493838|NCT01064323||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493839|NCT01064310|Randomized|||Treatment||Quadruple|||t|t|t|t
1493840|NCT01064297|||Cohort||Prospective|||||||
1493841|NCT01064284|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1493842|NCT01064271|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493843|NCT01064258|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1493844|NCT01064245|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1493845|NCT01064232|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493846|NCT01064219|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1493847|NCT01064206|||Case Control||Prospective|||||||
1493848|NCT01064193|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1493849|NCT01064180|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493850|NCT01064167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493851|NCT01064154|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493852|NCT01064141|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493853|NCT01064128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493854|NCT01064115|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493855|NCT01064102|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493856|NCT01064089|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493857|NCT01064076||Single Group Assignment||Treatment||None (Open Label)||||||
1493858|NCT01064063|Randomized|Parallel Assignment||Treatment||Single||Patients will be randomised into two arms, one receiving the AGC CR cement knee system (control group), and the other receiving Vanguard CR cement knee system (trial group).||||t
1493859|NCT01064050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493860|NCT01064037|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493861|NCT01064024|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493862|NCT01064011|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493863|NCT01063998|||||Prospective|||||||
1493864|NCT01063985|||||Prospective|||||||
1493865|NCT01063972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493866|NCT01063959|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1493867|NCT01063946||Single Group Assignment||Treatment||None (Open Label)||||||
1493868|NCT01063933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493869|NCT01063920|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1493870|NCT01063907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493871|NCT01063894|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1493872|NCT01063881||Single Group Assignment||Treatment||None (Open Label)||||||
1493873|NCT01063868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493874|NCT01063855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493875|NCT01063842|Randomized|Parallel Assignment||Treatment||Double||||||
1493876|NCT01063829|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493877|NCT01063816||Single Group Assignment||Treatment||None (Open Label)||||||
1493878|NCT01063803|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493879|NCT01063790|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1493880|NCT01063777|Randomized|Parallel Assignment||Treatment||Single|||||t|
1493881|NCT01063764||Single Group Assignment||Treatment||None (Open Label)||||||
1493882|NCT01063751||Single Group Assignment||Treatment||None (Open Label)||||||
1493883|NCT01063738|Randomized|Parallel Assignment||Treatment||Single||||||t
1493884|NCT01063725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493885|NCT01063712||Single Group Assignment||Treatment||None (Open Label)||||||
1493886|NCT01063699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493887|NCT01063686||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493888|NCT01063673|||Cohort||Prospective|||||||
1493889|NCT01063660||Single Group Assignment||Supportive Care||None (Open Label)||||||
1493890|NCT01063647|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493891|NCT01063634|||||Prospective|||||||
1493892|NCT01063621||Single Group Assignment||Treatment||None (Open Label)||||||
1493893|NCT01063608||Single Group Assignment||Basic Science||None (Open Label)||||||
1493894|NCT01063595|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493895|NCT01063582|||Cohort||Cross-Sectional|||||||
1493896|NCT01063569|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493897|NCT01063556|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1493898|NCT01063543|||Cohort||Prospective|||||||
1493899|NCT01063530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493900|NCT01063517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493901|NCT01063504|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493902|NCT01063491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493903|NCT01063478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493904|NCT01063465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493905|NCT01063452|Randomized|Parallel Assignment||||None (Open Label)||||||
1493906|NCT01063439|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493907|NCT01063426|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493908|NCT01063413|||Case-Control||Prospective|||||||
1493909|NCT01063400|||Cohort||Prospective|||||||
1493910|NCT01063387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493911|NCT01063374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493912|NCT01063361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493913|NCT01063348|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493914|NCT01063335|||||Prospective|||||||
1493915|NCT01063322|||||Prospective|||||||
1493916|NCT01063309|||Cohort||Cross-Sectional|||||||
1493917|NCT01063296|||Case-Only||Prospective|||||||
1493918|NCT01063283|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493919|NCT01063270|Randomized|Parallel Assignment||Treatment||Single||||||t
1493920|NCT01063257|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493921|NCT01063244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493922|NCT01063231||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493923|NCT01063218|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1493924|NCT01063205|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1493925|NCT01063192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493926|NCT01063179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493927|NCT01063166|||Cohort||Prospective|||||||
1493928|NCT01063153|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1493929|NCT01063140|||||Prospective|||||||
1493930|NCT01063127|||||Prospective|||||||
1493931|NCT01063114||Single Group Assignment||Treatment||None (Open Label)||||||
1493932|NCT01063101|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1493933|NCT01063088|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1493934|NCT01063075|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1493935|NCT01063062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493936|NCT01063049|Randomized|Parallel Assignment||Treatment||Single|||||t|
1493937|NCT01063036||Single Group Assignment||Treatment||None (Open Label)||||||
1493938|NCT01063023|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1493939|NCT01063010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493940|NCT01062997|||Case Control||Prospective|||||||
1493941|NCT01062984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493942|NCT01062971|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1493943|NCT01062958|||Case Control||Retrospective|||||||
1493944|NCT01062945|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1493945|NCT01062932|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1493946|NCT01062919|Randomized|Parallel Assignment||||Double|||t|||t
1493947|NCT01062906|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1493948|NCT01062893|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493949|NCT01062880|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1493950|NCT01062867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493951|NCT01062854|Randomized|Parallel Assignment||||Single||||||t
1493952|NCT01062841|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1493953|NCT01062828|||Cohort||Prospective|||||||
1493954|NCT01062815|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1493955|NCT01062802|Randomized|Parallel Assignment||||Triple|||t|t|t|
1493956|NCT01062789|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1493957|NCT01062776|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1493958|NCT01062763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493959|NCT01062750||Single Group Assignment||Treatment||None (Open Label)||||||
1493960|NCT01062737||||||||||||
1493961|NCT01062724|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1493962|NCT01062711|Randomized|Parallel Assignment||Prevention||Single|||t|||
1493963|NCT01062698|Randomized|Parallel Assignment||Treatment||Single|||||t|
1493964|NCT01062685|||Cohort||Prospective|||||||
1493965|NCT01062672|||Case Control||Prospective|||||||
1493966|NCT01062659|||Cohort||Prospective|||||||
1493967|NCT01062646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493968|NCT01062633|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1493969|NCT01062620||Single Group Assignment||Treatment||None (Open Label)||||||
1493970|NCT01062607|||Cohort|||||||||
1493971|NCT01062594|Randomized|Parallel Assignment||||None (Open Label)||||||
1493972|NCT01062581|||Cohort||Prospective|||||||
1493973|NCT01062568|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1493974|NCT01062555|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493975|NCT01062542|||Cohort||Prospective|||||||
1493976|NCT01062529|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1493977|NCT01062516|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1493978|NCT01062503|||Case-Only||Prospective|||||||
1493979|NCT01062490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1493980|NCT01062477|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1493981|NCT01062464||||||||||||
1493982|NCT01062451|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1493983|NCT01062438|||Cohort||Retrospective|||||||
1493984|NCT01062425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1493985|NCT01062412||||||||||||
1493986|NCT01062399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1493987|NCT01062386|||Cohort||Cross-Sectional|||||||
1493988|NCT01062373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493989|NCT01062360|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1493990|NCT01062347||||||||||||
1493991|NCT01062334||Single Group Assignment||Diagnostic||None (Open Label)||||||
1493992|NCT01062321|||Case Control||Prospective|||||||
1493993|NCT01062308|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1493994|NCT01062295||Crossover Assignment||Supportive Care||||||||
1493995|NCT01062282|||||Prospective|||||||
1493996|NCT01062269|Randomized|Crossover Assignment||Treatment||Single|||t|||
1493997|NCT01062256|Randomized|Parallel Assignment||Treatment||Single|||||t|
1493998|NCT01062243|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1493999|NCT01062230||Single Group Assignment||Treatment||None (Open Label)||||||
1494000|NCT01062217||||||||||||
1494001|NCT01062204|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494002|NCT01062191|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494003|NCT01062178|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1494004|NCT01062165||Single Group Assignment||||None (Open Label)||||||
1494005|NCT01062152|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494006|NCT01062139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494007|NCT01062126|||Cohort||Prospective|||||||
1494008|NCT01062113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494009|NCT01062100||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494010|NCT01062087|||Cohort||Retrospective|||||||
1494011|NCT01062074|||Other||Prospective|||||||
1494012|NCT01062061|||||Prospective|||||||
1494013|NCT01062048|||Case-Only||Prospective|||||||
1494014|NCT01062035|||Case Control||Prospective|||||||
1494015|NCT01062022|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1494016|NCT01062009|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1494017|NCT01061996||Single Group Assignment||Treatment||None (Open Label)||||||
1494018|NCT01061983||Single Group Assignment||Treatment||None (Open Label)||||||
1494019|NCT01061970|Randomized|Parallel Assignment||Treatment||Double||||||
1494020|NCT01061957|||Cohort||Prospective|||||||
1494021|NCT01061944|||Cohort||Prospective|||||||
1494022|NCT01061931|Randomized|Parallel Assignment||Treatment||Single|||||t|
1494023|NCT01061918|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1494024|NCT01061905|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1494025|NCT01061879||||||||||||
1494026|NCT01061866|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494027|NCT01061853|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494028|NCT01061840|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494029|NCT01061827|||Case-Only||Prospective|||||||
1494030|NCT01061814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494031|NCT01061801|Randomized|||Basic Science||None (Open Label)||||||
1494032|NCT01061788||Single Group Assignment||Treatment||None (Open Label)||||||
1494033|NCT01061775||Single Group Assignment||Treatment||None (Open Label)||||||
1494034|NCT01061762|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1494035|NCT01061749||Single Group Assignment||Treatment||None (Open Label)||||||
1494036|NCT01061736|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494037|NCT01061723|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494038|NCT01061710|||Case-Only||Retrospective|||||||
1494039|NCT01061697||Single Group Assignment||Treatment||None (Open Label)||||||
1494040|NCT01061684|||Cohort||Prospective|||||||
1494041|NCT01061671|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494042|NCT01061658|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1494043|NCT01061645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494044|NCT01061632|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494045|NCT01061619|||Case-Only||Retrospective|||||||
1494046|NCT01061606||Single Group Assignment||Treatment||None (Open Label)||||||
1494047|NCT01061593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494048|NCT01061580|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494049|NCT01061567|||Cohort||Prospective|||||||
1494050|NCT01061554|Randomized|Parallel Assignment||Basic Science||Single||||||t
1494051|NCT01061541|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1494052|NCT01061528|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494053|NCT01061515|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494054|NCT01061502|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1494055|NCT01061489|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1494056|NCT01061476||Single Group Assignment||||None (Open Label)||||||
1494057|NCT01061463|||Case Control||Cross-Sectional|||||||
1494058|NCT01061450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494059|NCT01061437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494060|NCT01061424|Randomized|Parallel Assignment||Treatment||Single||||||t
1494061|NCT01061411||Single Group Assignment||Treatment||None (Open Label)||||||
1494062|NCT01061398|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1494063|NCT01061385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494064|NCT01061372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494065|NCT01061359|||||Prospective|||||||
1494066|NCT01061346|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1494067|NCT01061333|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1494068|NCT01061320|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1494069|NCT01061307|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494070|NCT01061294||Single Group Assignment||Treatment||None (Open Label)||||||
1494071|NCT01061281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494072|NCT01061268|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494073|NCT01061255|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1494074|NCT01061242|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494075|NCT01061229|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1494076|NCT01061216|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1494077|NCT01061203|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494078|NCT01061190|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494079|NCT01061177||Single Group Assignment||Treatment||None (Open Label)||||||
1494080|NCT01061164|||Cohort||Prospective|||||||
1494081|NCT01061151|Randomized|Parallel Assignment||Prevention||Double|The investigators and outcomes assessor did not receive by-arm tabulations while the study was ongoing.||||t|t
1494082|NCT01061138|||Cohort||Prospective|||||||
1494083|NCT01061125|||Case-Control||Prospective|||||||
1494084|NCT01061112|||Case-Crossover||Prospective|||||||
1494085|NCT01061099|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494086|NCT01061086|||Case-Only||Prospective|||||||
1494087|NCT01061073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494088|NCT01061060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494089|NCT01061047||||||||||||
1494090|NCT01061034||Single Group Assignment||||None (Open Label)||||||
1494091|NCT01061021|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1494092|NCT01061008|Randomized|Parallel Assignment||Basic Science||Single||||||t
1494093|NCT01060995|||Case-Control||Cross-Sectional|||||||
1494094|NCT01060982||Single Group Assignment||Basic Science||None (Open Label)||||||
1494095|NCT01060969|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494096|NCT01060956|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1494097|NCT01060943|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494098|NCT01060930|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1494099|NCT01060917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494100|NCT01060904|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494101|NCT01060891||||||||||||
1494102|NCT01060878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494103|NCT01060865||Single Group Assignment||Treatment||None (Open Label)||||||
1494104|NCT01060852|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494105|NCT01060839|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494106|NCT01060826|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494107|NCT01060813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494108|NCT01060800|||Family-Based||Cross-Sectional|||||||
1494109|NCT01060787|||Cohort||Prospective|||||||
1494110|NCT01060774|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1494111|NCT01060761|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1494112|NCT01060748|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1494113|NCT01060735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494114|NCT01060722|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1494115|NCT01060709|||Cohort||Prospective|||||||
1494116|NCT01060696|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1494117|NCT01060683|||Cohort||Prospective|||||||
1494118|NCT01060670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494119|NCT01060657|||Case Control||Prospective|||||||
1494120|NCT01060644|||||Prospective|||||||
1494121|NCT01060631|||Case Control||Prospective|||||||
1494122|NCT01060618|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1494123|NCT01060605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494124|NCT01060592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494125|NCT01060579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494126|NCT01060566|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494127|NCT01060553|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494128|NCT01060540|Randomized|Parallel Assignment||Prevention||Single||||||t
1494129|NCT01060527|||Case Control|||||||||
1494130|NCT01060514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494131|NCT01060501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494132|NCT01060488|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1494133|NCT01060475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494134|NCT01060462|||Case-Only||Prospective|||||||
1494135|NCT01060449|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1494136|NCT01060436|||Cohort||Prospective|||||||
1494137|NCT01060423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494138|NCT01060410|||Case-Only||Prospective|||||||
1494139|NCT01060397|Randomized|Single Group Assignment||Treatment||Single||||||t
1494140|NCT01060384||Single Group Assignment||Treatment||None (Open Label)||||||
1494141|NCT01060371|||Cohort||Prospective|||||||
1494142|NCT01060358|||Case-Only||Cross-Sectional|||||||
1494143|NCT01060345||Single Group Assignment||Prevention||None (Open Label)||||||
1494144|NCT01060332|||Cohort||Cross-Sectional|||||||
1494145|NCT01060319|||Cohort||Prospective|||||||
1494146|NCT01060306|||Case Control||Prospective|||||||
1494147|NCT01060293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494148|NCT01060280|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1494149|NCT01060267|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1494150|NCT01060254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494151|NCT01060241|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494152|NCT01060228||Single Group Assignment||||None (Open Label)||||||
1494153|NCT01060215|Randomized|Parallel Assignment||||Single|||||t|
1494154|NCT01060202|||Case-Only||Prospective|||||||
1494155|NCT01060189|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494156|NCT01060176|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494157|NCT01060163|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1494158|NCT01060150||Single Group Assignment||Treatment||None (Open Label)||||||
1494159|NCT01060137||Single Group Assignment||Treatment||None (Open Label)||||||
1494160|NCT01060124||Single Group Assignment||Treatment||None (Open Label)||||||
1494161|NCT01060111|Randomized|Parallel Assignment||Treatment||Single|||||t|
1494162|NCT01060098|||Case Control||Prospective|||||||
1494163|NCT01060085|||Cohort||Prospective|||||||
1494164|NCT01060072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494165|NCT01060059|||Cohort||Prospective|||||||
1494166|NCT01060046|||Case-Control||Prospective|||||||
1494167|NCT01060033||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1494168|NCT01060020||Single Group Assignment||Treatment||None (Open Label)||||||
1494169|NCT01060007||Single Group Assignment||Treatment||None (Open Label)||||||
1494170|NCT01059994|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494171|NCT01059981|||||Retrospective|||||||
1494172|NCT01059968|||||Prospective|||||||
1494173|NCT01059955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494174|NCT01059942|||Cohort||Cross-Sectional|||||||
1494175|NCT01059929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494176|NCT01059903|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1494177|NCT01059890||||||||||||
1494178|NCT01059877|Randomized|Parallel Assignment||Treatment||Triple||Small placebo controlled randomized trial.|t|t||t
1494179|NCT01059864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494180|NCT01059851|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494181|NCT01059838|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1494182|NCT01059825|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494183|NCT01059812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494184|NCT01059799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494185|NCT01059786|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494186|NCT01059773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494187|NCT01059760|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494188|NCT01059747|||Case-Only||Cross-Sectional|||||||
1494189|NCT01059734|||||Retrospective|||||||
1494190|NCT01059721|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494191|NCT01059708|||Cohort||Prospective|||||||
1494192|NCT01059695|||Cohort||Retrospective|||||||
1494193|NCT01059682|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494194|NCT01059669|||Case Control||Prospective|||||||
1494195|NCT01059656||Single Group Assignment||Treatment||None (Open Label)||||||
1494196|NCT01059643||Single Group Assignment||Treatment||None (Open Label)||||||
1494197|NCT01059630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494198|NCT01059617|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1494199|NCT01059604|||Cohort||Prospective|||||||
1494200|NCT01059591|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1494201|NCT01059578|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1494202|NCT01059565|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1494203|NCT01059552||Single Group Assignment||Treatment||None (Open Label)||||||
1494204|NCT01059539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494205|NCT01059526|||Cohort||Prospective|||||||
1494206|NCT01059513|||Other||Other|||||||
1494207|NCT01059500|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1494208|NCT01059487||Single Group Assignment||Treatment||None (Open Label)||||||
1494209|NCT01059474|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1494210|NCT01059461||Single Group Assignment||Prevention||None (Open Label)||||||
1494211|NCT01059448||Single Group Assignment||Treatment||None (Open Label)||||||
1494212|NCT01059435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494213|NCT01059422||Single Group Assignment||Treatment||None (Open Label)||||||
1494214|NCT01059409||Single Group Assignment||Treatment||None (Open Label)||||||
1494215|NCT01059396|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1494216|NCT01059383|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494217|NCT01059370|Randomized|Single Group Assignment||Prevention||Single|||t|||
1494218|NCT01059357||Single Group Assignment||Treatment||None (Open Label)||||||
1494219|NCT01059344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494220|NCT01059331|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494221|NCT01059318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494222|NCT01059305||Single Group Assignment||Treatment||None (Open Label)||||||
1494223|NCT01059292||||||||||||
1494224|NCT01059279|||Case-Only||Prospective|||||||
1494225|NCT01059266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494226|NCT01059253||Single Group Assignment||Treatment||None (Open Label)||||||
1494227|NCT01059240|||||Prospective|||||||
1494228|NCT01059227|||Case-Crossover||Prospective|||||||
1494229|NCT01059214|||||Prospective|||||||
1494230|NCT01059201|||Cohort||Other|||||||
1494231|NCT01059188||Single Group Assignment||Treatment||None (Open Label)||||||
1494232|NCT01059175|Randomized|Parallel Assignment||Treatment||Single||||||t
1494233|NCT01059162||Single Group Assignment||Treatment||None (Open Label)||||||
1494234|NCT01059149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494235|NCT01059136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494236|NCT01059123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494237|NCT01059110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494238|NCT01059097|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494239|NCT01059084||Single Group Assignment||Basic Science||None (Open Label)||||||
1494240|NCT01059071||Single Group Assignment||Treatment||None (Open Label)||||||
1494241|NCT01059058|Randomized|Parallel Assignment||Treatment||Single||||||t
1494242|NCT01059045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494243|NCT01059032|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1494244|NCT01059019|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1494245|NCT01059006||Single Group Assignment||Treatment||None (Open Label)||||||
1494246|NCT01058993||Single Group Assignment||Treatment||None (Open Label)||||||
1494247|NCT01058980|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494248|NCT01058967|||Case-Only||Prospective|||||||
1494249|NCT01058941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494250|NCT01058928|||Case Control||Prospective|||||||
1494251|NCT01058915|Randomized|Parallel Assignment||Treatment||Single|||||t|
1494252|NCT01058902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494253|NCT01058889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494254|NCT01058876|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1494255|NCT01058863|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1494256|NCT01058850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494257|NCT01058837|||Case Control||Cross-Sectional|||||||
1494258|NCT01058824|Randomized|Crossover Assignment||||None (Open Label)||||||
1494259|NCT01058811|||Case-Only||Prospective|||||||
1494260|NCT01058798|||Cohort||Retrospective|||||||
1494261|NCT01058785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494262|NCT01058772|Randomized|Parallel Assignment||||None (Open Label)||||||
1494263|NCT01058759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494264|NCT01058746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494265|NCT01058733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494266|NCT01058720||Single Group Assignment||Treatment||None (Open Label)||||||
1494267|NCT01058707||Single Group Assignment||Treatment||None (Open Label)||||||
1494268|NCT01058694|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1494503|NCT01055626|||Cohort||Cross-Sectional|||||||
1494269|NCT01058681|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1494270|NCT01058668|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494271|NCT01058655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494272|NCT01058642|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1494273|NCT01058629|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494274|NCT01058616||Single Group Assignment||Treatment||None (Open Label)||||||
1494275|NCT01058603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494276|NCT01058590|||Cohort||Prospective|||||||
1494277|NCT01058577|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494278|NCT01058564||Single Group Assignment||Treatment||None (Open Label)||||||
1494279|NCT01058551||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494280|NCT01058538||Single Group Assignment||Treatment||None (Open Label)||||||
1494281|NCT01058525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494282|NCT01058512||Single Group Assignment||Treatment||None (Open Label)||||||
1494283|NCT01058499||Single Group Assignment||Treatment||None (Open Label)||||||
1494284|NCT01058486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494285|NCT01058473|||Cohort||Prospective|||||||
1494286|NCT01058460|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1494287|NCT01058447||Single Group Assignment||Basic Science||None (Open Label)||||||
1494288|NCT01058434|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494289|NCT01058421|Randomized|Parallel Assignment||Treatment||Single||||||t
1494290|NCT01058408|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494291|NCT01058395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494292|NCT01058382|||Cohort||Prospective|||||||
1494293|NCT01058369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494294|NCT01058356|||Case Control||Prospective|||||||
1494295|NCT01058343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494296|NCT01058330|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494297|NCT01058317||Single Group Assignment||Treatment||None (Open Label)||||||
1494298|NCT01058304|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1494299|NCT01058291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494300|NCT01058278|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494301|NCT01058265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494302|NCT01058252|||Cohort||Prospective|||||||
1494303|NCT01058239||Single Group Assignment||Treatment||None (Open Label)||||||
1494304|NCT01058226||||||None (Open Label)||||||
1494305|NCT01058213|Randomized|Parallel Assignment||Treatment||Single|||||t|
1494306|NCT01058200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494307|NCT01058187|||Cohort||Prospective|||||||
1494308|NCT01058174|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494309|NCT01058161|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1494310|NCT01058148|||||Prospective|||||||
1494311|NCT01058135|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1494312|NCT01058122|||Cohort||Prospective|||||||
1494313|NCT01058109|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494314|NCT01058096|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494315|NCT01058083|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494316|NCT01058070||Single Group Assignment||Treatment||None (Open Label)||||||
1494317|NCT01058057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494318|NCT01058044||Single Group Assignment||||None (Open Label)||||||
1494319|NCT01058031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494320|NCT01058018|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494321|NCT01058005|Randomized|Parallel Assignment||||None (Open Label)||||||
1494322|NCT01057992||Single Group Assignment||Treatment||None (Open Label)||||||
1494323|NCT01057979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494324|NCT01057966|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1494325|NCT01057953||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494326|NCT01057940|||Cohort||Prospective|||||||
1494327|NCT01057927|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494328|NCT01057914|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1494329|NCT01057901|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494330|NCT01057888|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1494331|NCT01057875|Randomized|Crossover Assignment||Treatment||Single|||t|||
1494332|NCT01057862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494333|NCT01057849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494334|NCT01057836|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1494335|NCT01057823|||Cohort||Cross-Sectional|||||||
1494336|NCT01057810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494337|NCT01057797|Randomized|Parallel Assignment||Treatment||Single|||||t|
1494338|NCT01057784|||Cohort||Prospective|||||||
1494339|NCT01057771|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494340|NCT01057758|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494341|NCT01057745|||Cohort||Prospective|||||||
1494342|NCT01057732|||Case Control||Prospective|||||||
1494343|NCT01057719|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494344|NCT01057706|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1494345|NCT01057693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494346|NCT01057680|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1494347|NCT01057667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494348|NCT01057654|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1494349|NCT01057641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494350|NCT01057628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494351|NCT01057615|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494352|NCT01057602|||Cohort||Cross-Sectional|||||||
1494353|NCT01057589||Single Group Assignment||Treatment||None (Open Label)||||||
1494354|NCT01057576|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494355|NCT01057563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494356|NCT01057550|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1494357|NCT01057537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494358|NCT01057524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494359|NCT01057511|Randomized|Parallel Assignment||Treatment||Single||||||t
1494360|NCT01057498|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494361|NCT01057485|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494362|NCT01057472|||Cohort||Prospective|||||||
1494363|NCT01057459|||Cohort||Retrospective|||||||
1494364|NCT01057446|||Case Control||Prospective|||||||
1494365|NCT01057433|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1494366|NCT01057420|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1494367|NCT01057407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494368|NCT01057394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494369|NCT01057381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494370|NCT01057368|Randomized|Factorial Assignment||Basic Science||Single|||||t|
1494371|NCT01057355||Single Group Assignment||Treatment||None (Open Label)||||||
1494372|NCT01057342||Single Group Assignment||Treatment||None (Open Label)||||||
1494373|NCT01057329|||Case-Only||Prospective|||||||
1494374|NCT01057316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494375|NCT01057303|||Case-Only||Retrospective|||||||
1494376|NCT01057290|||Case Control||Retrospective|||||||
1494377|NCT01057277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494378|NCT01057264||Single Group Assignment||Treatment||None (Open Label)||||||
1494379|NCT01057251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494380|NCT01057238|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494381|NCT01057225||Single Group Assignment||Treatment||None (Open Label)||||||
1494382|NCT01057212||Single Group Assignment||Treatment||None (Open Label)||||||
1494383|NCT01057199|||Case-Only||Retrospective|||||||
1494384|NCT01057186|||Cohort|||||||||
1494385|NCT01057173|Randomized|Parallel Assignment||Treatment||Single||||||t
1494386|NCT01057160|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494387|NCT01057147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494388|NCT01057134||||||||||||
1494389|NCT01057121||Single Group Assignment||Treatment||None (Open Label)||||||
1494390|NCT01057108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494391|NCT01057095|||Case-Only||Retrospective|||||||
1494392|NCT01057082|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494393|NCT01057069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494394|NCT01057056||||Supportive Care||||||||
1494395|NCT01057043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494396|NCT01057030|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1494397|NCT01057017||Single Group Assignment||Treatment||None (Open Label)||||||
1494398|NCT01057004|||Cohort||Prospective|||||||
1494399|NCT01056991|Randomized|Parallel Assignment||Prevention||Single|||||t|
1494400|NCT01056978|||Cohort||Prospective|||||||
1494401|NCT01056965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494402|NCT01056952|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494403|NCT01056939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494404|NCT01056926|Randomized|Factorial Assignment||Health Services Research||Double|||t||t|
1494405|NCT01056913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494406|NCT01056900|||Case-Only||Retrospective|||||||
1494407|NCT01056887|||Cohort||Prospective|||||||
1494408|NCT01056874|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494409|NCT01056861|||Case Control||Prospective|||||||
1494410|NCT01056848|||Cohort||Cross-Sectional|||||||
1494411|NCT01056835|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494412|NCT01056822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494413|NCT01056809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494414|NCT01056796|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494415|NCT01056783|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494416|NCT01056770||Single Group Assignment||Prevention||None (Open Label)||||||
1494417|NCT01056757||Single Group Assignment||Treatment||None (Open Label)||||||
1494418|NCT01056744|Randomized|Parallel Assignment||Treatment||Single||||||t
1494419|NCT01056731||Single Group Assignment||Treatment||None (Open Label)||||||
1494420|NCT01056718||Single Group Assignment||Treatment||None (Open Label)||||||
1494421|NCT01056705|Randomized|Parallel Assignment||Prevention||Single||||||t
1494422|NCT01056692|Randomized|Crossover Assignment||Treatment||Double||||||
1494423|NCT01056679||Single Group Assignment||Treatment||None (Open Label)||||||
1494966|NCT01049542||Single Group Assignment||Basic Science||Single|||t|||
1494424|NCT01056666|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494425|NCT01056653|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1494426|NCT01056640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494427|NCT01056627|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494428|NCT01056614||Single Group Assignment||Treatment||None (Open Label)||||||
1494429|NCT01056601||Single Group Assignment||Treatment||None (Open Label)||||||
1494430|NCT01056588|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494431|NCT01056575||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494432|NCT01056562|||Case-Only||Prospective|||||||
1494433|NCT01056549|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1494434|NCT01056536|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494435|NCT01056523||Single Group Assignment||Treatment||None (Open Label)||||||
1494436|NCT01056510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494437|NCT01056497|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1494438|NCT01056484|Randomized|Parallel Assignment||Treatment||Single||||||t
1494439|NCT01056471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494440|NCT01056458|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1494441|NCT01056445||Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1494442|NCT01056432|||Case-Only||Retrospective|||||||
1494443|NCT01056419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494444|NCT01056406|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494445|NCT01056393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494446|NCT01056380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494447|NCT01056367|||||Prospective|||||||
1494448|NCT01056354|||Cohort||Prospective|||||||
1494449|NCT01056341|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494450|NCT01056328|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494451|NCT01056315|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494452|NCT01056302|||Case-Only||Retrospective|||||||
1494453|NCT01056289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494454|NCT01056276||Single Group Assignment||Treatment||None (Open Label)||||||
1494455|NCT01056263|||||Retrospective|||||||
1494456|NCT01056250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494457|NCT01056237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494458|NCT01056224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494459|NCT01056211|Randomized|Parallel Assignment||Treatment||Single|||||t|
1494460|NCT01056198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494461|NCT01056185|||Cohort||Prospective|||||||
1494462|NCT01056172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494463|NCT01056159|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1494464|NCT01056146|Randomized|Parallel Assignment||Treatment||Single||||||t
1494465|NCT01056133||Single Group Assignment||Treatment||None (Open Label)||||||
1494466|NCT01056120|||Cohort||Prospective|||||||
1494467|NCT01056107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494468|NCT01056094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494469|NCT01056081|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1494470|NCT01056055|||Case Control||Prospective|||||||
1494471|NCT01056042|Randomized|Parallel Assignment||Treatment||Single||||||t
1494472|NCT01056029|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494473|NCT01056016|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1494474|NCT01056003|||Cohort||Prospective|||||||
1494475|NCT01055990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494476|NCT01055977|||||Retrospective|||||||
1494477|NCT01055964|Randomized|Crossover Assignment||||None (Open Label)||||||
1494478|NCT01055951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494479|NCT01055938|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494480|NCT01055925||||Treatment||||||||
1494481|NCT01055912|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494482|NCT01055899|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1494483|NCT01055886|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494484|NCT01055873||||||||||||
1494485|NCT01055860|||Case-Only||Retrospective|||||||
1494486|NCT01055847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494487|NCT01055834|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494488|NCT01055821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494489|NCT01055808|||||Prospective|||||||
1494490|NCT01055795|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494491|NCT01055782|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1494492|NCT01055769|Randomized|Crossover Assignment||||None (Open Label)||||||
1494493|NCT01055756|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494494|NCT01055743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494495|NCT01055730|||Cohort||Prospective|||||||
1494496|NCT01055717|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1494497|NCT01055704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494498|NCT01055691|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1494499|NCT01055678||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494500|NCT01055665|||||Retrospective|||||||
1494501|NCT01055652||Single Group Assignment||||None (Open Label)||||||
1494502|NCT01055639|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1494504|NCT01055613|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494505|NCT01055600||Single Group Assignment||||None (Open Label)||||||
1494506|NCT01055587|||Cohort||Prospective|||||||
1494507|NCT01055574|||Cohort||Prospective|||||||
1494508|NCT01055561|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494509|NCT01055548|||Cohort||Retrospective|||||||
1494510|NCT01055535|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494511|NCT01055522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494512|NCT01055509|Randomized|Parallel Assignment||Treatment||Single||||||t
1494513|NCT01055496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494514|NCT01055483||Single Group Assignment||Treatment||None (Open Label)||||||
1494515|NCT01055470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494516|NCT01055457|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494517|NCT01055444||Single Group Assignment||Treatment||None (Open Label)||||||
1494518|NCT01055431|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1494519|NCT01055418|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1494520|NCT01055405|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494521|NCT01055392|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494522|NCT01055379|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494523|NCT01055366||Single Group Assignment||Treatment||None (Open Label)||||||
1494524|NCT01055353|||Cohort||Cross-Sectional|||||||
1494525|NCT01055340|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1494526|NCT01055327|||Case Control||Retrospective|||||||
1494527|NCT01055314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494528|NCT01055301||Single Group Assignment||Treatment||None (Open Label)||||||
1494529|NCT01055275|||Cohort||Prospective|||||||
1494530|NCT01055262|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1494531|NCT01055249|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1494532|NCT01055236|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494533|NCT01055223|||Case-Control||Retrospective|||||||
1494534|NCT01055210|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1494535|NCT01055197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494536|NCT01055184||Single Group Assignment||Prevention||None (Open Label)||||||
1494537|NCT01055171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494538|NCT01055158|Randomized|Parallel Assignment||Treatment||Single||||||t
1494539|NCT01055145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494540|NCT01055132|Randomized|Crossover Assignment||Treatment||Single|||t|||
1494541|NCT01055119|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1494542|NCT01055106|Randomized|Parallel Assignment||Treatment||Single|||||t|
1494543|NCT01055093|||Cohort||Prospective|||||||
1494544|NCT01055080|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494545|NCT01055067||Single Group Assignment||Treatment||None (Open Label)||||||
1494546|NCT01055054|||Cohort||Prospective|||||||
1494547|NCT01055041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494548|NCT01055028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494549|NCT01055015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494550|NCT01055002|Randomized|Parallel Assignment||||None (Open Label)||||||
1494551|NCT01054989|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1494552|NCT01054976||Single Group Assignment||Treatment||None (Open Label)||||||
1494553|NCT01054963||Single Group Assignment||Supportive Care||||||||
1494554|NCT01054950|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1494555|NCT01054937|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1494556|NCT01054924|||Cohort||Prospective|||||||
1494557|NCT01054911||Single Group Assignment||Treatment||None (Open Label)||||||
1494558|NCT01054898|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1494559|NCT01054885|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494560|NCT01054872|Non-Randomized|Single Group Assignment||Prevention||Single||||||t
1494561|NCT01054859|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1494562|NCT01054846|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494563|NCT01054833||Single Group Assignment||Treatment||None (Open Label)||||||
1494564|NCT01054820||Single Group Assignment||Treatment||None (Open Label)||||||
1494565|NCT01054807|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1494566|NCT01054794|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1494567|NCT01054781||Single Group Assignment||Treatment||None (Open Label)||||||
1494568|NCT01054768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494569|NCT01054742|||Cohort||Prospective|||||||
1494570|NCT01054729|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1494571|NCT01054716|||Case Control||Prospective|||||||
1494572|NCT01054703||Single Group Assignment||Treatment||None (Open Label)||||||
1494573|NCT01054690|Randomized|Parallel Assignment||Prevention||Single||||||t
1494574|NCT01054677||||Health Services Research||||||||
1494575|NCT01054664|||Cohort||Prospective|||||||
1494576|NCT01054651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494577|NCT01054638|||Cohort||Retrospective|||||||
1494578|NCT01054625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494579|NCT01054612||||||||||||
1494580|NCT01054599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494581|NCT01054586|||Cohort||Prospective|||||||
1494582|NCT01054573||Single Group Assignment||Treatment||None (Open Label)||||||
1494583|NCT01054560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494584|NCT01054547|Randomized|Crossover Assignment||Health Services Research||Triple|||t|t|t|
1494585|NCT01054534||Single Group Assignment||Supportive Care||None (Open Label)||||||
1494586|NCT01054521|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1494587|NCT01054508|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1494588|NCT01054495|Randomized|Parallel Assignment||||Single|||t|||
1494589|NCT01054482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494590|NCT01054469|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1494591|NCT01054456|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1494592|NCT01054443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494593|NCT01054430|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494594|NCT01054417|||Cohort||Prospective|||||||
1494595|NCT01054404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494596|NCT01054391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494597|NCT01054378||||Treatment||||||||
1494598|NCT01054365|||Cohort||Prospective|||||||
1494599|NCT01054352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494600|NCT01054339|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494601|NCT01054326|Randomized|Parallel Assignment||Treatment||Single|||||t|
1494602|NCT01054313||Single Group Assignment||Treatment||None (Open Label)||||||
1494603|NCT01054300|Randomized|Crossover Assignment||Other||Double|||t||t|
1494604|NCT01054287||||||||||||
1494605|NCT01054274|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494606|NCT01054261|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494607|NCT01054248|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494608|NCT01054235|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1494609|NCT01054222|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494610|NCT01054209|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494611|NCT01054196||Single Group Assignment||Treatment||None (Open Label)||||||
1494612|NCT01054183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494613|NCT01054170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494614|NCT01054157|||Case-Only||Prospective|||||||
1494615|NCT01054144||Single Group Assignment||Treatment||None (Open Label)||||||
1494616|NCT01054131||Single Group Assignment||Supportive Care||||||||
1494617|NCT01054118|Randomized|Crossover Assignment||Treatment||Double||||||
1494618|NCT01054105|||Case-Control||Prospective|||||||
1494619|NCT01054092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494620|NCT01054079||Single Group Assignment||Treatment||None (Open Label)||||||
1494621|NCT01054066|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1494622|NCT01054053|||Cohort||Prospective|||||||
1494623|NCT01054040|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494624|NCT01054027|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1494625|NCT01054014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494626|NCT01054001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494627|NCT01053988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494628|NCT01053975|||Cohort||Prospective|||||||
1494629|NCT01053962|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1494630|NCT01053949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494631|NCT01053936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494632|NCT01053923|||Case-Only||Prospective|||||||
1494633|NCT01053910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494634|NCT01053897|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1494635|NCT01053884||Single Group Assignment||Prevention||None (Open Label)||||||
1494636|NCT01053871|Randomized|Parallel Assignment||||Double|||t||t|
1494637|NCT01053858|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494638|NCT01053845|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1494639|NCT01053832|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1494640|NCT01053819||Single Group Assignment||Treatment||None (Open Label)||||||
1494641|NCT01053806||Single Group Assignment||Treatment||None (Open Label)||||||
1494642|NCT01053793|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1494643|NCT01053780|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494644|NCT01053767|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1494645|NCT01053754||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494646|NCT01053741|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1494647|NCT01053728|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1494648|NCT01053715|||Cohort||Prospective|||||||
1494649|NCT01053702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494650|NCT01053689|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494651|NCT01053676|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494652|NCT01053663||Single Group Assignment||Treatment||None (Open Label)||||||
1494653|NCT01053650|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1494654|NCT01053637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494655|NCT01053624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494656|NCT01053611|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1494657|NCT01053598|||Cohort||Prospective|||||||
1494658|NCT01053585|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1494659|NCT01053572|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1494660|NCT01053559||Single Group Assignment||Treatment||None (Open Label)||||||
1494661|NCT01053546|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494662|NCT01053533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494663|NCT01053520|Randomized|Crossover Assignment||||None (Open Label)||||||
1494664|NCT01053507|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1494665|NCT01053494|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494666|NCT01053481||Single Group Assignment||Prevention||Single|||t|||
1494667|NCT01053468|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494668|NCT01053455|||Case-Crossover||Prospective|||||||
1494669|NCT01053442|Randomized|Crossover Assignment||Prevention||Single|||t|||
1494670|NCT01053429|||Case-Only||Prospective|||||||
1494671|NCT01053416|Randomized|Parallel Assignment||Prevention||Single|||||t|
1494672|NCT01053403|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1494673|NCT01053390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494674|NCT01053377|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1494675|NCT01053364||Single Group Assignment||Treatment||None (Open Label)||||||
1494676|NCT01053338|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494677|NCT01053325|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494678|NCT01053312||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494679|NCT01053299||Single Group Assignment||Basic Science||Single||||||t
1494680|NCT01053286|||Cohort||Cross-Sectional|||||||
1494681|NCT01053273|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1494682|NCT01053260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494683|NCT01053247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494684|NCT01053234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494685|NCT01053221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494686|NCT01053208|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494687|NCT01053195|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494688|NCT01053182|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494689|NCT01053169|||Cohort||Cross-Sectional|||||||
1494690|NCT01053156|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1494691|NCT01053143|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1494692|NCT01053130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494693|NCT01053117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494694|NCT01053104|||Cohort||Prospective|||||||
1494695|NCT01053091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494696|NCT01053078|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1494697|NCT01053065|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1494698|NCT01053052||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494699|NCT01053039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494700|NCT01053026|||Case Control||Prospective|||||||
1494701|NCT01053013||Single Group Assignment||Treatment||None (Open Label)||||||
1494702|NCT01053000|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494703|NCT01052987|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1494704|NCT01052974|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494705|NCT01052961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494706|NCT01052948|||Cohort||Retrospective|||||||
1494707|NCT01052935||Single Group Assignment||Prevention||None (Open Label)||||||
1494708|NCT01052922|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1494709|NCT01052909|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494710|NCT01052896|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494711|NCT01052883|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494712|NCT01052870|Randomized|Single Group Assignment||Treatment||Single||||||
1494713|NCT01052857|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494714|NCT01052844|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494715|NCT01052831|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1494716|NCT01052818|||Cohort||Prospective|||||||
1494717|NCT01052805|||Case-Only||Prospective|||||||
1494718|NCT01052792|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494719|NCT01052779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494720|NCT01052766||Single Group Assignment||Treatment||None (Open Label)||||||
1494721|NCT01052753||||||||||||
1494722|NCT01052740|||||Prospective|||||||
1494723|NCT01052727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494724|NCT01052714|Randomized|Crossover Assignment||Treatment||Single|||||t|
1494725|NCT01052701|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1494726|NCT01052688|||Case-Only||Cross-Sectional|||||||
1494727|NCT01052675|||||Prospective|||||||
1494728|NCT01052662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494729|NCT01052649|||Cohort||Prospective|||||||
1494730|NCT01052636|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1494731|NCT01052623|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1494732|NCT01052610|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494733|NCT01052597|Randomized|Parallel Assignment||Treatment||Single|||||t|
1494734|NCT01052584|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494735|NCT01052571|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1494736|NCT01052558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494737|NCT01052545|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1494738|NCT01052532|||Case-Only||Prospective|||||||
1494739|NCT01052519|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494740|NCT01052506|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1494741|NCT01052493|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1494742|NCT01052480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494743|NCT01052467|||Cohort||Prospective|||||||
1494744|NCT01052454|Randomized|Parallel Assignment||Treatment||Single||||||t
1494745|NCT01052441|||||Prospective|||||||
1494746|NCT01052428|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494747|NCT01052415|Randomized|Parallel Assignment||Prevention||Single||||t||
1494748|NCT01052402|Randomized|Parallel Assignment||Prevention||Single|||t|||
1494749|NCT01052389|Randomized|Parallel Assignment||Treatment||Single||||||t
1494750|NCT01052376||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494751|NCT01052363|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494752|NCT01052350|||Case-Control||Prospective|||||||
1494753|NCT01052337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494754|NCT01052324||||Prevention||||||||
1494755|NCT01052311|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494756|NCT01052298|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494757|NCT01052285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494758|NCT01052272|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1494759|NCT01052259||Single Group Assignment||Treatment||None (Open Label)||||||
1494760|NCT01052246|Randomized|Parallel Assignment||Treatment||Single||||||t
1494761|NCT01052233|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1494762|NCT01052220|Randomized|Parallel Assignment||Treatment||None (Open Label)||Participants were randomized to intervention group of standard care.||||
1494763|NCT01052207|||Cohort||Prospective|||||||
1494764|NCT01052194|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494765|NCT01052181|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1494766|NCT01052168|Randomized|Parallel Assignment||Basic Science||Single||||||t
1494767|NCT01052155|||||Retrospective|||||||
1494768|NCT01052142||Single Group Assignment||Treatment||None (Open Label)||||||
1494769|NCT01052129|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494770|NCT01052116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494771|NCT01052103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494772|NCT01052090|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1494773|NCT01052077|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494774|NCT01052064|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494775|NCT01052051|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494776|NCT01052038|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1494777|NCT01052025|Randomized|Parallel Assignment||Prevention||Single|||||t|
1494778|NCT01052012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494779|NCT01051999|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494780|NCT01051986|Randomized|Parallel Assignment||Treatment||Single||||||t
1494781|NCT01051973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494782|NCT01051960||Single Group Assignment||Treatment||None (Open Label)||||||
1494783|NCT01051947|Randomized|Crossover Assignment||Treatment||Single|||||t|
1494784|NCT01051934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494785|NCT01051921||Single Group Assignment||Treatment||None (Open Label)||||||
1494786|NCT01051895|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1494787|NCT01051882|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494788|NCT01051869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494789|NCT01051856|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494790|NCT01051843|||||Cross-Sectional|||||||
1494791|NCT01051830|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1494792|NCT01051817|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494793|NCT01051804|Randomized|Parallel Assignment||Treatment||Single||||t||
1494794|NCT01051791||Single Group Assignment||Treatment||None (Open Label)||||||
1494795|NCT01051778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494796|NCT01051765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494797|NCT01051752|||Cohort||Prospective|||||||
1494798|NCT01051739|||Case-Control||Prospective|||||||
1494799|NCT01051726|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1494800|NCT01051713|Randomized|Factorial Assignment||Treatment||Single|||t|||
1494801|NCT01051700|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1494802|NCT01051687|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494803|NCT01051674|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1494804|NCT01051661|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1494805|NCT01051648||Single Group Assignment||Treatment||None (Open Label)||||||
1494806|NCT01051635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494807|NCT01051622|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1494808|NCT01051609|||||Prospective|||||||
1494809|NCT01051596||Single Group Assignment||Treatment||None (Open Label)||||||
1494810|NCT01051583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494811|NCT01051570||Single Group Assignment||Treatment||None (Open Label)||||||
1494812|NCT01051557||Single Group Assignment||Treatment||None (Open Label)||||||
1494813|NCT01051544|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494814|NCT01051531||Single Group Assignment||Treatment||None (Open Label)||||||
1494815|NCT01051518||Single Group Assignment||Treatment||None (Open Label)||||||
1494816|NCT01051505|Randomized|Parallel Assignment||||Double|||t||t|
1494817|NCT01051492|||Case-Crossover||Cross-Sectional|||||||
1494818|NCT01051479||Single Group Assignment||Diagnostic||None (Open Label)||||||
1494819|NCT01051466|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1494820|NCT01051440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494821|NCT01051427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494822|NCT01051414||Single Group Assignment||Treatment||None (Open Label)||||||
1494823|NCT01051401|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494824|NCT01051388|Randomized|Parallel Assignment||Prevention||Single||||||t
1494825|NCT01051375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494826|NCT01051362||Single Group Assignment||Treatment||None (Open Label)||||||
1494827|NCT01051349||Single Group Assignment||Treatment||None (Open Label)||||||
1494828|NCT01051336|Randomized|Parallel Assignment||Treatment||Single|||t|||
1494829|NCT01051323|||Cohort||Prospective|||||||
1494830|NCT01051310||Single Group Assignment||Treatment||None (Open Label)||||||
1494831|NCT01051297|||Cohort||Prospective|||||||
1494832|NCT01051284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494833|NCT01051271|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1494834|NCT01051258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494835|NCT01051245|Randomized|Parallel Assignment||Treatment||Single||||||t
1494836|NCT01051232|Randomized|Parallel Assignment||||Triple|||t|t|t|
1494837|NCT01051219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494838|NCT01051206||||Prevention||||||||
1494839|NCT01051193||Single Group Assignment||Treatment||None (Open Label)||||||
1494840|NCT01051180|||Case-Control||Prospective|||||||
1494841|NCT01051167||Single Group Assignment||Treatment||None (Open Label)||||||
1494842|NCT01051154|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494843|NCT01051141|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1494844|NCT01051128||Single Group Assignment||Treatment||None (Open Label)||||||
1494845|NCT01051115||Single Group Assignment||Treatment||None (Open Label)||||||
1494846|NCT01051102|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1494847|NCT01051089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494848|NCT01051076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494849|NCT01051063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494850|NCT01051050|Randomized|Parallel Assignment||||None (Open Label)||||||
1494851|NCT01051037||Single Group Assignment||Treatment||None (Open Label)||||||
1494852|NCT01051024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494853|NCT01051011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494854|NCT01050998|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494855|NCT01050985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494856|NCT01050972|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494857|NCT01050959|||Case-Only||Prospective|||||||
1494858|NCT01050946||Single Group Assignment||Treatment||None (Open Label)||||||
1494859|NCT01050933||Single Group Assignment||Treatment||None (Open Label)||||||
1494860|NCT01050920|||Cohort||Cross-Sectional|||||||
1494861|NCT01050907||Single Group Assignment||Treatment||None (Open Label)||||||
1494862|NCT01050894|||Case-Only||Prospective|||||||
1494863|NCT01050881|||Case-Only||Retrospective|||||||
1494864|NCT01050868|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1494865|NCT01050855|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494866|NCT01050842||Single Group Assignment||Treatment||None (Open Label)||||||
1494867|NCT01050829|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1494868|NCT01050816||Single Group Assignment||Treatment||None (Open Label)||||||
1494869|NCT01050803|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1494870|NCT01050790||Single Group Assignment||Treatment||None (Open Label)||||||
1494871|NCT01050777|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1494872|NCT01050764||Single Group Assignment||Treatment||None (Open Label)||||||
1494873|NCT01050751|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494874|NCT01050738|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494875|NCT01050725|||Case-Only||Prospective|||||||
1494876|NCT01050712|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1494877|NCT01050699|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1494878|NCT01050686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494879|NCT01050673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494880|NCT01050660|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494881|NCT01050647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494882|NCT01050634|||Case-Only||Prospective|||||||
1494883|NCT01050621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494884|NCT01050608|||Cohort||Prospective|||||||
1494885|NCT01050595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494886|NCT01050582||Parallel Assignment||Treatment||None (Open Label)||||||
1494887|NCT01050569|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1494888|NCT01050556|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494889|NCT01050543|Randomized|Parallel Assignment||Treatment||Single||||||t
1494890|NCT01050530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494891|NCT01050517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494892|NCT01050504|||Case-Control||Prospective|||||||
1494893|NCT01050491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494894|NCT01050478||Single Group Assignment||Treatment||None (Open Label)||||||
1494895|NCT01050465|Randomized|Parallel Assignment||||None (Open Label)||||||
1494896|NCT01050452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494897|NCT01050439||Single Group Assignment||Treatment||None (Open Label)||||||
1494898|NCT01050426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494899|NCT01050413|||Cohort||Prospective|||||||
1494900|NCT01050400|||Other||Prospective|||||||
1494901|NCT01050387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494902|NCT01050374|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494903|NCT01050361|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1494904|NCT01050348|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494905|NCT01050335|||Cohort||Prospective|||||||
1494906|NCT01050322|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494907|NCT01050309|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1494908|NCT01050296|||Cohort||Prospective|||||||
1494909|NCT01050283|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1494910|NCT01050270|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1494911|NCT01050257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494912|NCT01050244|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1494913|NCT01050231|Randomized|Parallel Assignment||Treatment||Single||||||t
1494914|NCT01050218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494915|NCT01050205|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494916|NCT01050192|||Cohort||Prospective|||||||
1494917|NCT01050179|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1494918|NCT01050166|||Cohort||Prospective|||||||
1494919|NCT01050153|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494920|NCT01050140|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1494921|NCT01050127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494922|NCT01050114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494923|NCT01050101|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1494924|NCT01050088|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1494925|NCT01050075|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494926|NCT01050062|||Case-Only||Prospective|||||||
1494927|NCT01050049|||Cohort||Retrospective|||||||
1494928|NCT01050036||Single Group Assignment||Treatment||None (Open Label)||||||
1494929|NCT01050023|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494930|NCT01050010||Single Group Assignment||Screening||None (Open Label)||||||
1494931|NCT01049997|||Cohort||Prospective|||||||
1494932|NCT01049984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494933|NCT01049971|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494934|NCT01049958|||Ecologic or Community||Prospective|||||||
1494935|NCT01049945||Single Group Assignment||Treatment||None (Open Label)||||||
1494936|NCT01049932||Single Group Assignment||Prevention||None (Open Label)||||||
1494937|NCT01049919|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1494938|NCT01049906|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1494939|NCT01049893||Single Group Assignment||Treatment||None (Open Label)||||||
1494940|NCT01049880||Single Group Assignment||Treatment||None (Open Label)||||||
1494941|NCT01049867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1494942|NCT01049854|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494943|NCT01049841||Single Group Assignment||Treatment||None (Open Label)||||||
1494944|NCT01049828|||Case-Only||Cross-Sectional|||||||
1494945|NCT01049815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494946|NCT01049802|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1494947|NCT01049789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494948|NCT01049776||Single Group Assignment||Treatment||None (Open Label)||||||
1494949|NCT01049763|Randomized|Crossover Assignment||||None (Open Label)||||||
1494950|NCT01049750|||Cohort||Cross-Sectional|||||||
1494951|NCT01049737|||Cohort||Prospective|||||||
1494952|NCT01049724|||Cohort||Prospective|||||||
1494953|NCT01049711|||||Prospective|||||||
1494954|NCT01049698|Randomized|Parallel Assignment||Treatment||Single||||||t
1494955|NCT01049685|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494956|NCT01049672|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1494957|NCT01049659|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494958|NCT01049646|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1494959|NCT01049633||||||||||||
1494960|NCT01049620||Single Group Assignment||Treatment||None (Open Label)||||||
1494961|NCT01049607|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1494962|NCT01049594|||Cohort||Prospective|||||||
1494963|NCT01049581|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1494964|NCT01049568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494965|NCT01049555|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1494967|NCT01049529|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1494968|NCT01049516|Randomized|Parallel Assignment||Treatment||Single||||||t
1494969|NCT01049503|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1494970|NCT01049490|Randomized|Parallel Assignment||Prevention||Single||||||t
1494971|NCT01049477|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1494972|NCT01049464|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494973|NCT01049451|Randomized|Parallel Assignment||Treatment||Single||||||t
1494974|NCT01049438|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1494975|NCT01049425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1494976|NCT01049412|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1494977|NCT01049399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494978|NCT01049386|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1494979|NCT01049373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494980|NCT01049360|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1494981|NCT01049347|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494982|NCT01049334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1494983|NCT01049321|Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1494984|NCT01049308|||Cohort||Prospective|||||||
1494985|NCT01049295|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1494986|NCT01049282|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1494987|NCT01049269||||||||||||
1494988|NCT01049256||Single Group Assignment||Basic Science||None (Open Label)||||||
1494989|NCT01049243||Single Group Assignment||Treatment||None (Open Label)||||||
1494990|NCT01049230||Single Group Assignment||Treatment||None (Open Label)||||||
1494991|NCT01049217|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1494992|NCT01049204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1494993|NCT01049191|||||Cross-Sectional|||||||
1494994|NCT01049178|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1494995|NCT01049165|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1494996|NCT01049152|||Case Control||Cross-Sectional|||||||
1494997|NCT01049139|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1494998|NCT01049126|||Case-Only||Retrospective|||||||
1494999|NCT01049113||Single Group Assignment||Treatment||None (Open Label)||||||
1495000|NCT01049100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495001|NCT01049087|Non-Randomized|Single Group Assignment||Basic Science||Single||||||t
1495002|NCT01049074|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495003|NCT01049061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495004|NCT01049048|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1495005|NCT01049035|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495006|NCT01049022||Single Group Assignment||Basic Science||None (Open Label)||||||
1495007|NCT01049009|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1495008|NCT01048996|||Case Control||Prospective|||||||
1495009|NCT01048983|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1495010|NCT01048970|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1495011|NCT01048957|Randomized|Single Group Assignment||Other||||||||
1495012|NCT01048944|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1495013|NCT01048931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495014|NCT01048918|||Cohort||Prospective|||||||
1495015|NCT01048905|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1495016|NCT01048892||Single Group Assignment||Treatment||None (Open Label)||||||
1495017|NCT01048879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495018|NCT01048866|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495019|NCT01048853||Single Group Assignment||Treatment||None (Open Label)||||||
1495020|NCT01048840|||Case Control||Retrospective|||||||
1495021|NCT01048827||Single Group Assignment||Treatment||None (Open Label)||||||
1495022|NCT01048814|||Case-Only||Retrospective|||||||
1495023|NCT01048801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495024|NCT01048788||Single Group Assignment||Treatment||None (Open Label)||||||
1495025|NCT01048775|||Cohort||Prospective|||||||
1495026|NCT01048762|Randomized|Parallel Assignment||Treatment||Single||||||t
1495027|NCT01048749|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1495028|NCT01048736|Randomized|Parallel Assignment||Treatment||Single||||||t
1495029|NCT01048723||Single Group Assignment||Treatment||None (Open Label)||||||
1495030|NCT01048710|||Cohort||Prospective|||||||
1495031|NCT01048697||Single Group Assignment||||None (Open Label)||||||
1495032|NCT01048684|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1495033|NCT01048671|||Cohort||Prospective|||||||
1495034|NCT01048658|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1495035|NCT01048645|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495036|NCT01048632||Single Group Assignment||Treatment||None (Open Label)||||||
1495037|NCT01048619||Single Group Assignment||Treatment||None (Open Label)||||||
1495038|NCT01048606|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1495039|NCT01048593|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495040|NCT01048580||Single Group Assignment||Treatment||None (Open Label)||||||
1495041|NCT01048567|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495042|NCT01048554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495043|NCT01048541|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1495354|NCT01044472|||Cohort||Prospective|||||||
1495044|NCT01048528|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495045|NCT01048515|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1495046|NCT01048502|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1495047|NCT01048489|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495048|NCT01048476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495049|NCT01048463|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1495050|NCT01048450|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1495051|NCT01048437|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1495052|NCT01048424|Randomized|Parallel Assignment||Treatment||Single||||||t
1495053|NCT01048411|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495054|NCT01048398|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1495055|NCT01048385|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1495056|NCT01048372|||Cohort||Prospective|||||||
1495057|NCT01048359|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1495058|NCT01048346|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1495059|NCT01048333|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1495060|NCT01048320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495061|NCT01048307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495062|NCT01048294|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495063|NCT01048281|||Cohort||Prospective|||||||
1495064|NCT01048268|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1495065|NCT01048255|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1495066|NCT01048242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495067|NCT01048229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495068|NCT01048216||||Treatment||||||||
1495069|NCT01048203||Single Group Assignment||||None (Open Label)||||||
1495070|NCT01048190|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1495071|NCT01048177||Single Group Assignment||Treatment||None (Open Label)||||||
1495072|NCT01048164|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495073|NCT01048151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495074|NCT01048138|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495075|NCT01048125|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1495076|NCT01048112|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495077|NCT01048099||Single Group Assignment||Treatment||None (Open Label)||||||
1495078|NCT01048086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495079|NCT01048073|||||Cross-Sectional|||||||
1495080|NCT01048060|||Cohort||Prospective|||||||
1495081|NCT01048047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495082|NCT01048034||Single Group Assignment||Treatment||None (Open Label)||||||
1495083|NCT01048021|||Cohort||Prospective|||||||
1495084|NCT01048008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495085|NCT01047995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495086|NCT01047982|Randomized|Parallel Assignment||Prevention||Single|||t|||
1495087|NCT01047969||Single Group Assignment||Treatment||None (Open Label)||||||
1495088|NCT01047956|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1495089|NCT01047943|Randomized|Single Group Assignment||Treatment||Single||||||t
1495090|NCT01047930|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1495091|NCT01047917||Single Group Assignment||Prevention||None (Open Label)||||||
1495092|NCT01047904||Single Group Assignment||Treatment||None (Open Label)||||||
1495093|NCT01047891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495094|NCT01047878|||Case-Only||Prospective|||||||
1495095|NCT01047865|||Cohort||Other|||||||
1495096|NCT01047852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495097|NCT01047839|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495098|NCT01047826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495099|NCT01047813|||Case Control||Cross-Sectional|||||||
1495100|NCT01047800|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1495101|NCT01047787|||Case-Crossover||Prospective|||||||
1495102|NCT01047774|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495103|NCT01047761||Single Group Assignment||Treatment||None (Open Label)||||||
1495104|NCT01047748|Randomized|Parallel Assignment||||None (Open Label)||||||
1495105|NCT01047735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495106|NCT01047722|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1495107|NCT01047709|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495108|NCT01047696|Randomized|Parallel Assignment||Prevention||Single||||||t
1495109|NCT01047683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495110|NCT01047670|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495111|NCT01047657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495112|NCT01047644||Single Group Assignment||Health Services Research||None (Open Label)||||||
1495113|NCT01047631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495114|NCT01047618|||Cohort||Prospective|||||||
1495115|NCT01047605|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1495116|NCT01047592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495117|NCT01047579||Single Group Assignment||Other||None (Open Label)||||||
1495118|NCT01047566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495119|NCT01047553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495120|NCT01047540|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495121|NCT01047527|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495122|NCT01047514|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1495123|NCT01047501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495124|NCT01047488|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1495125|NCT01047475|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495126|NCT01047462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495127|NCT01047449|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1495128|NCT01047436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495129|NCT01047423|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1495130|NCT01047410|Randomized|Parallel Assignment||Treatment||None (Open Label)|Outcomes assessors are blinded if possible.|3-arm randomized controlled trial||||
1495131|NCT01047397|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495132|NCT01047384|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495133|NCT01047371|||Case-Only||Prospective|||||||
1495134|NCT01047358|||Case-Only||Prospective|||||||
1495135|NCT01047345|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1495136|NCT01047332|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1495137|NCT01047319||Single Group Assignment||Treatment||None (Open Label)||||||
1495138|NCT01047306|||Cohort||Prospective|||||||
1495139|NCT01047293||Single Group Assignment||Treatment||None (Open Label)||||||
1495140|NCT01047280|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1495141|NCT01047267|||Case-Only||Prospective|||||||
1495142|NCT01047254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495143|NCT01047241||Single Group Assignment||Treatment||None (Open Label)||||||
1495144|NCT01047215|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1495145|NCT01047202|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1495146|NCT01047189|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495147|NCT01047176|||Case-Only||Prospective|||||||
1495148|NCT01047163|||Cohort||Cross-Sectional|||||||
1495149|NCT01047150|||Case Control||Cross-Sectional|||||||
1495150|NCT01047137|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495151|NCT01047124|Randomized|Parallel Assignment||Treatment||Single||||||t
1495152|NCT01047111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495153|NCT01047098|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1495154|NCT01047085|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1495155|NCT01047072|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495156|NCT01047059||Single Group Assignment||Treatment||None (Open Label)||||||
1495157|NCT01047046|||Cohort||Retrospective|||||||
1495158|NCT01047033|Randomized|Parallel Assignment||||None (Open Label)||||||
1495159|NCT01047020|||Case Control||Cross-Sectional|||||||
1495160|NCT01047007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495161|NCT01046994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495162|NCT01046981|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1495163|NCT01046968|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1495164|NCT01046955|Randomized|Parallel Assignment||||None (Open Label)||||||
1495165|NCT01046942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495166|NCT01046929||Single Group Assignment||Prevention||None (Open Label)||||||
1495167|NCT01046916||Single Group Assignment||Treatment||None (Open Label)||||||
1495168|NCT01046903|||Cohort||Prospective|||||||
1495169|NCT01046890|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495170|NCT01046877||Single Group Assignment||Treatment||None (Open Label)||||||
1495171|NCT01046864|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1495172|NCT01046851|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1495173|NCT01046838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495174|NCT01046825|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495175|NCT01046812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495176|NCT01046799||Single Group Assignment||Treatment||None (Open Label)||||||
1495177|NCT01046786|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495178|NCT01046773|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1495179|NCT01046760|||Cohort||Retrospective|||||||
1495180|NCT01046747|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495181|NCT01046734|||Case-Only||Prospective|||||||
1495182|NCT01046721|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1495183|NCT01046708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495184|NCT01046695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495185|NCT01046682|Randomized|Parallel Assignment||Treatment||Single||||||t
1495186|NCT01046669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495187|NCT01046656|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495188|NCT01046643|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1495189|NCT01046630|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1495190|NCT01046617|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495191|NCT01046604|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1495192|NCT01046591|||Case Control||Cross-Sectional|||||||
1495193|NCT01046578|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1495194|NCT01046565|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495195|NCT01046552|Randomized|Single Group Assignment||Treatment||Single|||t|||
1495196|NCT01046539|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1495197|NCT01046526|||||Other|||||||
1495198|NCT01046513|||||Other|||||||
1495199|NCT01046500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495200|NCT01046487||Single Group Assignment||Treatment||None (Open Label)||||||
1495201|NCT01046474|Randomized|Parallel Assignment||Prevention||Single||||||t
1495202|NCT01046461||Single Group Assignment||Prevention||None (Open Label)||||||
1495203|NCT01046448|||Cohort||Prospective|||||||
1495204|NCT01046435|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495205|NCT01046422|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495206|NCT01046409|||Case-Only||Cross-Sectional|||||||
1495207|NCT01046396|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495208|NCT01046383|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495209|NCT01046370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495210|NCT01046357|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1495211|NCT01046331|||Cohort|||||||||
1495212|NCT01046318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495213|NCT01046305|||Case-Control||Prospective|||||||
1495214|NCT01046292|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495215|NCT01046279|||||Prospective|||||||
1495216|NCT01046266|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495217|NCT01046253|Randomized|Crossover Assignment||||None (Open Label)||||||
1495218|NCT01046240|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1495219|NCT01046227|||Cohort||Prospective|||||||
1495220|NCT01046214|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1495221|NCT01046201|||Cohort||Prospective|||||||
1495222|NCT01046188|Randomized|Parallel Assignment||||Triple||||t|t|t
1495223|NCT01046175|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495224|NCT01046162|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1495225|NCT01046149|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495226|NCT01046136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495227|NCT01046123||Single Group Assignment||Treatment||None (Open Label)||||||
1495228|NCT01046110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495229|NCT01046097|||||Prospective|||||||
1495230|NCT01046084|Randomized|Crossover Assignment||||None (Open Label)||||||
1495231|NCT01046071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495232|NCT01046058|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495233|NCT01046045|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495234|NCT01046032|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495235|NCT01046019|||Cohort||Prospective|||||||
1495236|NCT01046006||Single Group Assignment||Treatment||None (Open Label)||||||
1495237|NCT01045993|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495238|NCT01045980|Randomized|Factorial Assignment||Treatment||Single||||||t
1495239|NCT01045967|Randomized|Crossover Assignment||||None (Open Label)||||||
1495240|NCT01045954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495241|NCT01045941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495242|NCT01045928||Single Group Assignment||Treatment||None (Open Label)||||||
1495243|NCT01045915||Single Group Assignment||Treatment||None (Open Label)||||||
1495244|NCT01045902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495245|NCT01045889||Single Group Assignment||Treatment||None (Open Label)||||||
1495246|NCT01045876|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1495247|NCT01045863|Randomized|Crossover Assignment||||Double|||t||t|
1495248|NCT01045850|||Cohort||Prospective|||||||
1495249|NCT01045837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495250|NCT01045824|||Family-Based|||||||||
1495251|NCT01045811|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495252|NCT01045798|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495253|NCT01045785|||Cohort||Cross-Sectional|||||||
1495254|NCT01045772||Single Group Assignment||Treatment||None (Open Label)||||||
1495255|NCT01045759|||||Prospective|||||||
1495256|NCT01045746|Randomized|Crossover Assignment||Treatment||Single|||t|||
1495257|NCT01045733|Randomized|Single Group Assignment||Treatment||Single|||t|||
1495258|NCT01045720|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495259|NCT01045707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495260|NCT01045694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495261|NCT01045681|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495262|NCT01045668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495263|NCT01045655|Randomized|Parallel Assignment||Treatment||Single||||||t
1495264|NCT01045642|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495265|NCT01045629|||Cohort||Cross-Sectional|||||||
1495266|NCT01045616|||Cohort||Retrospective|||||||
1495267|NCT01045603|||Cohort||Prospective|||||||
1495268|NCT01045590|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495269|NCT01045577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495270|NCT01045564|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495271|NCT01045551||Single Group Assignment||Treatment||None (Open Label)||||||
1495272|NCT01045538||Single Group Assignment||Treatment||None (Open Label)||||||
1495273|NCT01045525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495588|NCT01041365|||Cohort||Cross-Sectional|||||||
1495274|NCT01045512|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495275|NCT01045499||Single Group Assignment||Treatment||None (Open Label)||||||
1495276|NCT01045486|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1495277|NCT01045473|||||Prospective|||||||
1495278|NCT01045460|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495279|NCT01045447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495280|NCT01045434|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495281|NCT01045421|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495282|NCT01045408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495283|NCT01045395|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1495284|NCT01045382|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1495285|NCT01045369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495286|NCT01045356|||Cohort||Prospective|||||||
1495287|NCT01045343|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1495288|NCT01045330|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1495289|NCT01045317|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1495290|NCT01045304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495291|NCT01045291|Randomized|Crossover Assignment||Treatment||Single|||t|||
1495292|NCT01045278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495293|NCT01045265|||Cohort||Prospective|||||||
1495294|NCT01045252|||Case Control||Cross-Sectional|||||||
1495295|NCT01045239|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495296|NCT01045226||Single Group Assignment||Treatment||None (Open Label)||||||
1495297|NCT01045213|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495298|NCT01045200|||Cohort||Prospective|||||||
1495299|NCT01045187|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495300|NCT01045174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495301|NCT01045161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495302|NCT01045148||Single Group Assignment||Treatment||None (Open Label)||||||
1495303|NCT01045135|||Cohort||Prospective|||||||
1495304|NCT01045122|Randomized|Crossover Assignment||||Double|||t||t|
1495305|NCT01045109||Single Group Assignment||Treatment||None (Open Label)||||||
1495306|NCT01045096|Randomized|Parallel Assignment||||None (Open Label)||||||
1495307|NCT01045083|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1495308|NCT01045070|||||Prospective|||||||
1495309|NCT01045057||Single Group Assignment||Treatment||None (Open Label)||||||
1495310|NCT01045044|||Cohort||Prospective|||||||
1495311|NCT01045031|||Cohort||Prospective|||||||
1495312|NCT01045018|Randomized|Parallel Assignment||||||||||
1495313|NCT01045005|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495314|NCT01044992|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1495315|NCT01044979|||Cohort||Prospective|||||||
1495316|NCT01044966||Single Group Assignment||Treatment||None (Open Label)||||||
1495317|NCT01044953|||Cohort||Prospective|||||||
1495318|NCT01044940|||Cohort||Prospective|||||||
1495319|NCT01044927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495320|NCT01044914|||Cohort||Prospective|||||||
1495321|NCT01044901|||Case Control||Prospective|||||||
1495322|NCT01044888||Single Group Assignment||Supportive Care||Single||||||t
1495323|NCT01044875|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495324|NCT01044862|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495325|NCT01044849|||Case Control||Cross-Sectional|||||||
1495326|NCT01044836|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1495327|NCT01044823|||Cohort||Prospective|||||||
1495328|NCT01044810|||Cohort||Retrospective|||||||
1495329|NCT01044797|||Case-Only||Prospective|||||||
1495330|NCT01044784|||Cohort||Prospective|||||||
1495331|NCT01044771||Single Group Assignment||Treatment||None (Open Label)||||||
1495332|NCT01044758|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1495333|NCT01044745||Single Group Assignment||Treatment||None (Open Label)||||||
1495334|NCT01044732|Randomized|Crossover Assignment||Diagnostic||None (Open Label)|Open Label|||||
1495335|NCT01044719|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1495336|NCT01044706|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495337|NCT01044693|Randomized|Crossover Assignment||||Double|||t||t|
1495338|NCT01044680|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1495339|NCT01044667||Single Group Assignment||Other||None (Open Label)||||||
1495340|NCT01044654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495341|NCT01044641|||Cohort||Prospective|||||||
1495342|NCT01044628|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1495343|NCT01044615|||Cohort||Cross-Sectional|||||||
1495344|NCT01044602|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1495345|NCT01044589|Randomized|Parallel Assignment||Treatment||Single||||||t
1495346|NCT01044576|||Cohort||Prospective|||||||
1495347|NCT01044563|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495348|NCT01044550|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1495349|NCT01044537|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1495350|NCT01044524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495351|NCT01044511|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1495352|NCT01044498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495353|NCT01044485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495355|NCT01044459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495356|NCT01044446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495357|NCT01044433||Single Group Assignment||Treatment||None (Open Label)||||||
1495358|NCT01044420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495359|NCT01044407|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1495360|NCT01044394||Single Group Assignment||Treatment||None (Open Label)||||||
1495361|NCT01044381||Single Group Assignment||Treatment||None (Open Label)||||||
1495362|NCT01044368|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1495363|NCT01044355|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1495364|NCT01044342|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1495365|NCT01044329|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495366|NCT01044316|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495367|NCT01044303||Single Group Assignment||Treatment||None (Open Label)||||||
1495368|NCT01044290|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1495369|NCT01044277|Randomized|Parallel Assignment||Basic Science||Double|Double-Blind - GSH 500 mg/GSH 125 mg/Placebo||t||t|
1495370|NCT01044264|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495371|NCT01044251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495372|NCT01044238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495373|NCT01044225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495374|NCT01044212|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495375|NCT01044199|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495376|NCT01044186||Single Group Assignment||Treatment||None (Open Label)||||||
1495377|NCT01044173|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1495378|NCT01044160|||Case-Control||Prospective|||||||
1495379|NCT01044147|Randomized|Parallel Assignment||Treatment||Single||||||t
1495380|NCT01044134|Randomized|Parallel Assignment||Treatment||Single||||||t
1495381|NCT01044121||Crossover Assignment||Supportive Care||Single|||t|||
1495382|NCT01044108|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1495383|NCT01044095|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1495384|NCT01044082|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495385|NCT01044069||Single Group Assignment||Treatment||None (Open Label)||||||
1495386|NCT01044056|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1495387|NCT01044043|||||Prospective|||||||
1495388|NCT01044030|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495389|NCT01044017|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1495390|NCT01044004|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1495391|NCT01043991|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495392|NCT01043978|Randomized|Single Group Assignment||Prevention||Single||||||t
1495393|NCT01043965|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1495394|NCT01043952|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495395|NCT01043939|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495396|NCT01043926|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495397|NCT01043913|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1495398|NCT01043900|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1495399|NCT01043887|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495400|NCT01043874||Single Group Assignment||Treatment||None (Open Label)||||||
1495401|NCT01043848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495402|NCT01043835|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1495403|NCT01043822|||Case Control||Retrospective|||||||
1495404|NCT01043809|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495405|NCT01043796|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495406|NCT01043783|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495407|NCT01043770|Randomized|Parallel Assignment||Prevention||Single||||||t
1495408|NCT01043757|Randomized|Parallel Assignment||Treatment||Double||||t||t
1495409|NCT01043744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495410|NCT01043731|||Cohort||Prospective|||||||
1495411|NCT01043718|Randomized|Parallel Assignment||Treatment||Single||||||t
1495412|NCT01043705|||Case Control||Prospective|||||||
1495413|NCT01043692|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495414|NCT01043679|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495415|NCT01043666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495416|NCT01043653|||Cohort||Prospective|||||||
1495417|NCT01043640||Single Group Assignment||Treatment||None (Open Label)||||||
1495418|NCT01043627|||Case-Only|||||||||
1495419|NCT01043614|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495420|NCT01043601|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1495421|NCT01043588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495422|NCT01043575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495423|NCT01043562|||Cohort||Prospective|||||||
1495424|NCT01043549|Non-Randomized|Crossover Assignment||Treatment||Double|||t|||t
1495425|NCT01043536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495426|NCT01043523|||Cohort||Retrospective|||||||
1495427|NCT01043510|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1495428|NCT01043497||||||||||||
1495429|NCT01043484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495430|NCT01043471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495431|NCT01043458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495432|NCT01043445|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1495433|NCT01043432|||Cohort||Cross-Sectional|||||||
1495434|NCT01043419||Single Group Assignment||Treatment||None (Open Label)||||||
1495435|NCT01043406||Single Group Assignment||Treatment||None (Open Label)||||||
1495436|NCT01043393|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495437|NCT01043380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495438|NCT01043367|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495439|NCT01043354|Randomized|Parallel Assignment||Prevention||Single||||||t
1495440|NCT01043341|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1495441|NCT01043328|||Case Control||Retrospective|||||||
1495442|NCT01043315|||Case-Only||Prospective|||||||
1495443|NCT01043302|||Case Control||Cross-Sectional|||||||
1495444|NCT01043289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495445|NCT01043276|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1495446|NCT01043263|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495447|NCT01043250|||Case-Only||Retrospective|||||||
1495448|NCT01043237|||Case-Only||Prospective|||||||
1495449|NCT01043224|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1495450|NCT01043211|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1495451|NCT01043198||Single Group Assignment||Diagnostic||None (Open Label)||||||
1495452|NCT01043185|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1495453|NCT01043172||Single Group Assignment||Treatment||None (Open Label)||||||
1495454|NCT01043146|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1495455|NCT01043133|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1495456|NCT01043120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495457|NCT01043107|||Cohort||Retrospective|||||||
1495458|NCT01043094|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1495459|NCT01043081|||Case-Only||Cross-Sectional|||||||
1495460|NCT01043068||Single Group Assignment||Supportive Care||None (Open Label)||||||
1495461|NCT01043055|||Cohort||Prospective|||||||
1495462|NCT01043042|||Cohort||Retrospective|||||||
1495463|NCT01043029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495464|NCT01043016||Single Group Assignment||Treatment||None (Open Label)||||||
1495465|NCT01043003|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1495466|NCT01042990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495467|NCT01042977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495468|NCT01042964|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495469|NCT01042951|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1495470|NCT01042938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495471|NCT01042925|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495472|NCT01042912|||Case-Only||Prospective|||||||
1495473|NCT01042899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495474|NCT01042886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495475|NCT01042873||Single Group Assignment||Other||None (Open Label)||||||
1495476|NCT01042860|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1495477|NCT01042847|||Case-Only||Prospective|||||||
1495478|NCT01042834|||Cohort||Prospective|||||||
1495479|NCT01042821|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495480|NCT01042808|||||Prospective|||||||
1495481|NCT01042795||Single Group Assignment||Treatment||None (Open Label)||||||
1495482|NCT01042782||Single Group Assignment||Treatment||None (Open Label)||||||
1495483|NCT01042769|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495484|NCT01042743|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495485|NCT01042730|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495486|NCT01042717||Single Group Assignment||Treatment||None (Open Label)||||||
1495487|NCT01042704||Single Group Assignment||Treatment||None (Open Label)||||||
1495488|NCT01042691||Single Group Assignment||Treatment||None (Open Label)||||||
1495489|NCT01042678|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495490|NCT01042665|||Case-Crossover||Prospective|||||||
1495491|NCT01042652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495492|NCT01042639|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1495493|NCT01042626||Parallel Assignment||Basic Science||None (Open Label)||||||
1495494|NCT01042613|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1495495|NCT01042600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495496|NCT01042587|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1495497|NCT01042574||Single Group Assignment||Treatment||None (Open Label)||||||
1495498|NCT01042561|Randomized|Parallel Assignment||Diagnostic||Double||||t|t|
1495499|NCT01042548|||Case-Control||Prospective|||||||
1495500|NCT01042535||Single Group Assignment||Treatment||None (Open Label)||||||
1495501|NCT01042522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495502|NCT01042509||Single Group Assignment||Treatment||None (Open Label)||||||
1495503|NCT01042496|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495504|NCT01042483|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1495505|NCT01042470|||Case-Control||Prospective|||||||
1495506|NCT01042457||Single Group Assignment||Treatment||None (Open Label)||||||
1495507|NCT01042444||Single Group Assignment||Treatment||None (Open Label)||||||
1495508|NCT01042431|||Cohort||Prospective|||||||
1495509|NCT01042418|Randomized|Crossover Assignment||Prevention||Single|||t|||
1495510|NCT01042405|||Case-Only||Prospective|||||||
1495511|NCT01042392|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495512|NCT01042379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495513|NCT01042366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495514|NCT01042353|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1495515|NCT01042340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495516|NCT01042327||Single Group Assignment||Treatment||None (Open Label)||||||
1495517|NCT01042314|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1495518|NCT01042301|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1495519|NCT01042288||Single Group Assignment||Treatment||None (Open Label)||||||
1495520|NCT01042275|||Case Control||Retrospective|||||||
1495521|NCT01042262|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1495522|NCT01042249|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495523|NCT01042236|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1495524|NCT01042223|||Case Control||Prospective|||||||
1495525|NCT01042210|||Case Control||Cross-Sectional|||||||
1495526|NCT01042197|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1495527|NCT01042184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495528|NCT01042171|||||Prospective|||||||
1495529|NCT01042158||Single Group Assignment||Treatment||None (Open Label)||||||
1495530|NCT01042145|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495531|NCT01042132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495532|NCT01042119|||Case-Only||Retrospective|||||||
1495533|NCT01042106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495534|NCT01042093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495535|NCT01042080|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1495536|NCT01042067|||Cohort||Prospective|||||||
1495537|NCT01042054|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495538|NCT01042041||Single Group Assignment||Treatment||None (Open Label)||||||
1495539|NCT01042028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495540|NCT01042015|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495541|NCT01042002|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495542|NCT01041989|Randomized|Parallel Assignment||Prevention||Single||||||t
1495543|NCT01041976|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495544|NCT01041963|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495545|NCT01041950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495546|NCT01041937|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1495547|NCT01041924||Single Group Assignment||Treatment||Single|||t|||
1495548|NCT01041911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495549|NCT01041898|||Cohort||Cross-Sectional|||||||
1495550|NCT01041885||Single Group Assignment||Treatment||None (Open Label)||||||
1495551|NCT01041872|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495552|NCT01041859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495553|NCT01041846|||Case-Only||Prospective|||||||
1495554|NCT01041833|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1495555|NCT01041820|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495556|NCT01041807|||||Prospective|||||||
1495557|NCT01041794|||Cohort|||||||||
1495558|NCT01041781|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495559|NCT01041768|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495560|NCT01041755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495561|NCT01041742||Single Group Assignment||Prevention||None (Open Label)||||||
1495562|NCT01041729|Randomized|Parallel Assignment||Basic Science||Single||||||t
1495563|NCT01041716|||Case-Only||Prospective|||||||
1495564|NCT01041690|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495565|NCT01041677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495566|NCT01041664|||Cohort||Cross-Sectional|||||||
1495567|NCT01041638||Single Group Assignment||Treatment||None (Open Label)||||||
1495568|NCT01041625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495569|NCT01041612|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1495570|NCT01041599|||Case Control||Cross-Sectional|||||||
1495571|NCT01041586||Single Group Assignment||Treatment||None (Open Label)||||||
1495572|NCT01041573|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495573|NCT01041560|||Case-Only||Prospective|||||||
1495574|NCT01041547|||Cohort||Cross-Sectional|||||||
1495575|NCT01041534|||Cohort||Prospective|||||||
1495576|NCT01041521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495577|NCT01041508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495578|NCT01041495|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495579|NCT01041482|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495580|NCT01041469|||Case Control||Cross-Sectional|||||||
1495581|NCT01041456|||Cohort||Retrospective|||||||
1495582|NCT01041443||Single Group Assignment||Treatment||None (Open Label)||||||
1495583|NCT01041430|Randomized|Parallel Assignment||Treatment||Single||||t||
1495584|NCT01041417|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495585|NCT01041404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495586|NCT01041391|||Case-Control||Prospective|||||||
1495587|NCT01041378|Randomized|Parallel Assignment||||Double|||t||t|
1495589|NCT01041352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495590|NCT01041339|||Case Control||Prospective|||||||
1495591|NCT01041326|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495592|NCT01041313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495593|NCT01041300||Single Group Assignment||||None (Open Label)||||||
1495594|NCT01041287|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1495595|NCT01041274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495596|NCT01041261|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1495597|NCT01041248||Single Group Assignment||Treatment||None (Open Label)||||||
1495598|NCT01041235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495599|NCT01041222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495600|NCT01041209|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1495601|NCT01041196|||Cohort||Retrospective|||||||
1495602|NCT01041183|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1495603|NCT01041170|Randomized|Parallel Assignment||Other||Double||||||
1495604|NCT01041157|Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1495605|NCT01041144||||Supportive Care||||||||
1495606|NCT01041131|||Cohort||Retrospective|||||||
1495607|NCT01041105|||Cohort||Retrospective|||||||
1495608|NCT01041092|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495609|NCT01041079|||Cohort||Retrospective|||||||
1495610|NCT01041066|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1495611|NCT01041040|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495612|NCT01041027||Single Group Assignment||Treatment||None (Open Label)||||||
1495613|NCT01041014|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1495614|NCT01041001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495615|NCT01040988|||Other||Cross-Sectional|||||||
1495616|NCT01040975|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1495617|NCT01040962|||Cohort||Cross-Sectional|||||||
1495618|NCT01040949|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495619|NCT01040936|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495620|NCT01040923|||Case-Only||Cross-Sectional|||||||
1495621|NCT01040910|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495622|NCT01040897|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1495623|NCT01040884||Single Group Assignment||Treatment||None (Open Label)||||||
1495624|NCT01040871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495625|NCT01040858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495626|NCT01040845|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1495627|NCT01040832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495628|NCT01040819|Randomized|Parallel Assignment||Treatment||Single||||||t
1495629|NCT01040806|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1495630|NCT01040793|Randomized|Crossover Assignment||Treatment||Double||||||
1495631|NCT01040780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495632|NCT01040767|Randomized|Parallel Assignment||||None (Open Label)||||||
1495633|NCT01040754|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1495634|NCT01040741|||Cohort||Prospective|||||||
1495635|NCT01040728|Randomized|Crossover Assignment||Treatment||Double||||||
1495636|NCT01040715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495637|NCT01040702|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1495638|NCT01040689|Randomized|Crossover Assignment||Treatment||Double||||||
1495639|NCT01040676|Randomized|Parallel Assignment||Treatment||Single||||||t
1495640|NCT01040663|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1495641|NCT01040650|||Cohort||Prospective|||||||
1495642|NCT01040637|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495643|NCT01040624|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495644|NCT01040611|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1495645|NCT01040598||Single Group Assignment||Basic Science||None (Open Label)||||||
1495646|NCT01040585|||Cohort||Prospective|||||||
1495647|NCT01040572|||Cohort||Retrospective|||||||
1495648|NCT01040559||Single Group Assignment||Treatment||None (Open Label)||||||
1495649|NCT01040546|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1495650|NCT01040533|||Cohort||Retrospective|||||||
1495651|NCT01040520|||Cohort||Prospective|||||||
1495652|NCT01040507|||Cohort||Retrospective|||||||
1495653|NCT01040494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495654|NCT01040481|||Cohort||Retrospective|||||||
1495655|NCT01040468|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495656|NCT01040455|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495657|NCT01040442||Parallel Assignment||Treatment||Single|||||t|
1495658|NCT01040429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495659|NCT01040416|||Cohort||Retrospective|||||||
1495660|NCT01040403|Randomized|Crossover Assignment||Treatment||Double||||||
1495661|NCT01040390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495662|NCT01040377|||Cohort||Retrospective|||||||
1495663|NCT01040364|||Cohort||Retrospective|||||||
1495664|NCT01040351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495665|NCT01040338|||Case-Crossover||Prospective|||||||
1495666|NCT01040325|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495667|NCT01040312|||Cohort||Prospective|||||||
1495668|NCT01040299|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1495669|NCT01040286|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495670|NCT01040273|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1495671|NCT01040260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495672|NCT01040247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495673|NCT01040234|||Cohort||Prospective|||||||
1495674|NCT01040221|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1495675|NCT01040208|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495676|NCT01040195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495677|NCT01040182|||Case Control||Retrospective|||||||
1495678|NCT01040169|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495679|NCT01040156|||Cohort||Retrospective|||||||
1495680|NCT01040143|||Case-Control||Cross-Sectional|||||||
1495681|NCT01040130|Randomized|Crossover Assignment||Treatment||Double||||||
1495682|NCT01040117|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1495683|NCT01040104|||||Prospective|||||||
1495684|NCT01040091|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495685|NCT01040078|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1495686|NCT01040065|||Case Control||Prospective|||||||
1495687|NCT01040052||Single Group Assignment||Prevention||None (Open Label)||||||
1495688|NCT01040039|||Cohort||Prospective|||||||
1495689|NCT01040026||Single Group Assignment||Treatment||None (Open Label)||||||
1495690|NCT01040013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495691|NCT01040000||Single Group Assignment||Treatment||None (Open Label)||||||
1495692|NCT01039987|||Cohort||Prospective|||||||
1495693|NCT01039974|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495694|NCT01039961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495695|NCT01039948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495696|NCT01039935|||||Prospective|||||||
1495697|NCT01039922|||Cohort||Prospective|||||||
1495698|NCT01039909|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1495699|NCT01039896|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1495700|NCT01039883|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1495701|NCT01039870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495702|NCT01039857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495703|NCT01039844||Single Group Assignment||Treatment||None (Open Label)||||||
1495704|NCT01039831|||Case Control|||||||||
1495705|NCT01039818|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495706|NCT01039805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495707|NCT01039792|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495708|NCT01039779|Randomized|Parallel Assignment||Prevention||Single|||t|||
1495709|NCT01039766|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495710|NCT01039753|||Cohort||Prospective|||||||
1495711|NCT01039740|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1495712|NCT01039727|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1495713|NCT01039714|||Cohort||Prospective|||||||
1495714|NCT01039701|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495715|NCT01039688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495716|NCT01039675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495717|NCT01039662|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1495718|NCT01039649|||Case-Only||Prospective|||||||
1495719|NCT01039636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495720|NCT01039623|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495721|NCT01039610|Randomized|Single Group Assignment||Treatment||Single|||t|||
1495722|NCT01039597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495723|NCT01039584|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1495724|NCT01039571|||Case Control||Prospective|||||||
1495725|NCT01039558|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495726|NCT01039545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495727|NCT01039532|||Case Control||Prospective|||||||
1495728|NCT01039519||Single Group Assignment||Treatment||None (Open Label)||||||
1495729|NCT01039506|||Cohort||Prospective|||||||
1495730|NCT01039493|||||Cross-Sectional|||||||
1495731|NCT01039480|||Cohort||Cross-Sectional|||||||
1495732|NCT01039467|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495733|NCT01039454|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1495734|NCT01039441|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1495735|NCT01039428|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495736|NCT01039415|||Case-Only||Prospective|||||||
1495737|NCT01039402|||Cohort||Cross-Sectional|||||||
1495738|NCT01039389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495739|NCT01039376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495740|NCT01039363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495741|NCT01039350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495742|NCT01039337|Randomized|Parallel Assignment||Treatment||Single||||||t
1495743|NCT01039324|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1495744|NCT01039311|||Case-Only||Prospective|||||||
1495745|NCT01039298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495746|NCT01039285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495747|NCT01039272|||Case Control||Cross-Sectional|||||||
1495748|NCT01039259|||Case Control||Prospective|||||||
1495749|NCT01039233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495750|NCT01039220||Single Group Assignment||Other||None (Open Label)||||||
1495751|NCT01039207||Single Group Assignment||Treatment||None (Open Label)||||||
1495752|NCT01039194|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1495753|NCT01039181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495754|NCT01039168|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1495755|NCT01039155||Single Group Assignment||Treatment||None (Open Label)||||||
1495756|NCT01039142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495757|NCT01039129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495758|NCT01039116|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1495759|NCT01039103|Randomized|Parallel Assignment||||Single|||||t|
1495760|NCT01039090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495761|NCT01039077|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495762|NCT01039064||||||||||||
1495763|NCT01039051|Randomized|Parallel Assignment||Prevention||Single||||||t
1495764|NCT01039038||Single Group Assignment||Treatment||None (Open Label)||||||
1495765|NCT01039025||Single Group Assignment||Treatment||None (Open Label)||||||
1495766|NCT01039012|Randomized|Parallel Assignment||Treatment||Single||||||t
1495767|NCT01038999|||Case Control||Prospective|||||||
1495768|NCT01038986|||||Prospective|||||||
1495769|NCT01038960|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495770|NCT01038947||Single Group Assignment||Treatment||None (Open Label)||||||
1495771|NCT01038934||Single Group Assignment||Diagnostic||None (Open Label)||||||
1495772|NCT01038921|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1495773|NCT01038908|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1495774|NCT01038895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495775|NCT01038882|Randomized|Parallel Assignment||||Double|||||t|t
1495776|NCT01038869||Single Group Assignment||Treatment||None (Open Label)||||||
1495777|NCT01038856||Single Group Assignment||Treatment||None (Open Label)||||||
1495778|NCT01038843|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495779|NCT01038830|||Cohort||Prospective|||||||
1495780|NCT01038817|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1495781|NCT01038804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495782|NCT01038791|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1495783|NCT01038778||Single Group Assignment||Treatment||None (Open Label)||||||
1495784|NCT01038765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495785|NCT01038752|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495786|NCT01038739|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495787|NCT01038726|Randomized|Parallel Assignment||Prevention||Single||||||t
1495788|NCT01038713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495789|NCT01038700|||Cohort||Prospective|||||||
1495790|NCT01038687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495791|NCT01038674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495792|NCT01038661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495793|NCT01038648|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1495794|NCT01038635||Single Group Assignment||Treatment||None (Open Label)||||||
1495795|NCT01038622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495796|NCT01038609|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495797|NCT01038596|||Case-Control||Prospective|||||||
1495798|NCT01038583|||Cohort||Prospective|||||||
1495799|NCT01038570|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495800|NCT01038557|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1495801|NCT01038544||Single Group Assignment||Diagnostic||None (Open Label)||||||
1495802|NCT01038531|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495803|NCT01038518|||Cohort||Cross-Sectional|||||||
1495804|NCT01038505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495805|NCT01038492||Single Group Assignment||Diagnostic||None (Open Label)||||||
1495806|NCT01038479|Randomized|Parallel Assignment||Prevention||Single|||||t|
1495807|NCT01038466|||Cohort||Retrospective|||||||
1495808|NCT01038453|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495809|NCT01038440|Randomized|Parallel Assignment||Prevention||Single|||t|||
1495810|NCT01038427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495811|NCT01038414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495812|NCT01038401|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495813|NCT01038388||Single Group Assignment||Treatment||None (Open Label)||||||
1495814|NCT01038375|||Case Control||Prospective|||||||
1495815|NCT01038362|Randomized|Crossover Assignment||||None (Open Label)||||||
1495816|NCT01038349|||Case-Only||Prospective|||||||
1495817|NCT01038336|Randomized|Parallel Assignment||Prevention||Single|||t|||
1495818|NCT01038323|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1495819|NCT01038310|||Case-Only||Prospective|||||||
1495820|NCT01038297|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495821|NCT01038284|Randomized|Parallel Assignment||||Single||||||t
1495822|NCT01038271|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1495823|NCT01038258||Single Group Assignment||Diagnostic||None (Open Label)||||||
1495824|NCT01038245||||||||||||
1495825|NCT01038232|||||Other|||||||
1495826|NCT01038219|||Case-Only||Prospective|||||||
1495827|NCT01038206|Randomized|Parallel Assignment||Prevention||Single||||||t
1495828|NCT01038193|||Case-Only||Prospective|||||||
1495829|NCT01038180|||Cohort||Prospective|||||||
1495830|NCT01038167|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1495831|NCT01038154|Randomized|Parallel Assignment||Treatment||Single||||||t
1495832|NCT01038141|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495833|NCT01038128||Single Group Assignment||Treatment||None (Open Label)||||||
1495834|NCT01038115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495835|NCT01038102|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495836|NCT01038089|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1495837|NCT01038076|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1495838|NCT01038063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495839|NCT01038050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495840|NCT01038037|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1495841|NCT01038024||Single Group Assignment||Prevention||None (Open Label)||||||
1495842|NCT01038011|Randomized|Parallel Assignment||Treatment||Double||||||
1495843|NCT01037998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495844|NCT01037985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495845|NCT01037972|||Case Control||Prospective|||||||
1495846|NCT01037959|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1495847|NCT01037946|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1495848|NCT01037933|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495849|NCT01037920|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1495850|NCT01037907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495851|NCT01037894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495852|NCT01037881|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495853|NCT01037868|Randomized|Parallel Assignment||Treatment||Single||||||t
1495854|NCT01037855|||Cohort||Prospective|||||||
1495855|NCT01037842|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495856|NCT01037829|||Cohort||Prospective|||||||
1495857|NCT01037816|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495858|NCT01037803|||Case-Only||Prospective|||||||
1495859|NCT01037790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495860|NCT01037777|||Family-Based||Prospective|||||||
1495861|NCT01037764||Single Group Assignment||Treatment||None (Open Label)||||||
1495862|NCT01037751|||Case-Only||Prospective|||||||
1495863|NCT01037738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495864|NCT01037725|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1495865|NCT01037712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495866|NCT01037699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495867|NCT01037686|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1495868|NCT01037673|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1495869|NCT01037660||Single Group Assignment||Basic Science||None (Open Label)||||||
1495870|NCT01037647|||Case Control||Prospective|||||||
1495871|NCT01037634||Single Group Assignment||Treatment||None (Open Label)||||||
1495872|NCT01037621|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1495873|NCT01037608|Randomized|Parallel Assignment||Other||Double||||||
1495874|NCT01037595|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495875|NCT01037582|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495876|NCT01037569|||||Prospective|||||||
1495877|NCT01037556||Single Group Assignment||Treatment||None (Open Label)||||||
1495878|NCT01037543|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1495879|NCT01037530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495880|NCT01037517|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495881|NCT01037504|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1495882|NCT01037491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495883|NCT01037478||Single Group Assignment||Treatment||None (Open Label)||||||
1495884|NCT01037465|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1495885|NCT01037452|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1495886|NCT01037439||||||||||||
1495887|NCT01037426||Single Group Assignment||Prevention||None (Open Label)||Patients were their own control and number of falls was compared in the year before and after Pacemaker implant||||
1495888|NCT01037413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495889|NCT01037400|||Cohort||Prospective|||||||
1495890|NCT01037387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495891|NCT01037374|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1495892|NCT01037361|||||Prospective|||||||
1495893|NCT01037348||Single Group Assignment||Treatment||None (Open Label)||||||
1495894|NCT01037335|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1495895|NCT01037322|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495896|NCT01037309|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495897|NCT01037296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495898|NCT01037283||Single Group Assignment||Treatment||None (Open Label)||||||
1495899|NCT01037270|||Cohort||Prospective|||||||
1495900|NCT01037244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495901|NCT01037231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495902|NCT01037218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495903|NCT01037205|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1495904|NCT01037192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495905|NCT01037179||Single Group Assignment||Treatment||None (Open Label)||||||
1495906|NCT01037166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495907|NCT01037153||||||||||||
1495908|NCT01037140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1495909|NCT01037127|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495910|NCT01037114|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1495911|NCT01037101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495912|NCT01037088|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1495913|NCT01037075||||||||||||
1495914|NCT01037062||Parallel Assignment||Treatment||None (Open Label)||||||
1495915|NCT01037049|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1495916|NCT01037036||Single Group Assignment||Treatment||None (Open Label)||||||
1495917|NCT01037023||||||||||||
1495918|NCT01036971|||||Other|||||||
1495919|NCT01036958|||Case-Only||Cross-Sectional|||||||
1495920|NCT01036932|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495921|NCT01036893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495922|NCT01036854|Randomized|Parallel Assignment||Treatment||Single||||||t
1495923|NCT01036841|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495924|NCT01036802|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495925|NCT01036763|||||Prospective|||||||
1495926|NCT01036724|||Case-Only||Prospective|||||||
1495927|NCT01036711|||||Other|||||||
1495928|NCT01036685||||||||||||
1495929|NCT01036659|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495930|NCT01036646|||Cohort||Prospective|||||||
1495931|NCT01036633|||Case Control||Prospective|||||||
1495932|NCT01036594|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1495933|NCT01036581||||||||||||
1495934|NCT01036568||||||||||||
1495935|NCT01036529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495936|NCT01036516|||||Prospective|||||||
1495937|NCT01036490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495938|NCT01036438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495939|NCT01036412||Single Group Assignment||Supportive Care||None (Open Label)||||||
1495940|NCT01036399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495941|NCT01036360|||||Prospective|||||||
1495942|NCT01036321|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495943|NCT01036308|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1495944|NCT01036282|Randomized|Parallel Assignment||Treatment||Single|Raters were blind to the type of interventions|Two arm, parallel group, randomized, blinded 12 -week intervention study of two forms of cognitive remediation in patients with chronic schizophrenia||||t
1495945|NCT01036243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495946|NCT01036230|||||Other|||||||
1495947|NCT01036217|||||Prospective|||||||
1495948|NCT01036165||Single Group Assignment||Supportive Care||None (Open Label)||||||
1495949|NCT01036139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495950|NCT01036126||||||||||||
1495951|NCT01036113|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495952|NCT01036087||Single Group Assignment||Treatment||None (Open Label)||||||
1495953|NCT01036074||||||||||||
1495954|NCT01036061|Randomized|Single Group Assignment||Other||Double|||t||t|
1495955|NCT01036048|||||Retrospective|||||||
1495956|NCT01036035|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1495957|NCT01036022|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495958|NCT01036009|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495959|NCT01035996||||||||||||
1495960|NCT01035983||Single Group Assignment||Treatment||None (Open Label)||||||
1495961|NCT01035944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495962|NCT01035905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495963|NCT01035879|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1495964|NCT01035853||Single Group Assignment||Treatment||None (Open Label)||||||
1495965|NCT01035801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495966|NCT01035788|Randomized|Parallel Assignment||Treatment||Single||||||t
1495967|NCT01035775|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1495968|NCT01035749|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1495969|NCT01035723|||||Other|||||||
1495970|NCT01035697|||Cohort||Prospective|||||||
1495971|NCT01035671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495972|NCT01035658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1495973|NCT01035645|Randomized|Parallel Assignment||Treatment||Single|||t|||
1495974|NCT01035632|||||Prospective|||||||
1495975|NCT01035619||Single Group Assignment||Treatment||None (Open Label)||||||
1495976|NCT01035606|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The design for Arms 1 and 2 was a cross-over design. Half the participants completed Arm 1 first and then crossed-over to Arm 2; the remaining half completed Arm 2 first and then crossed-over to Arm 1. Thus, all participants completed both Arm 1 and 2.~Arm 3 represented a parallel study. Participants enrolled in this arm did not cross-over to any other condition."||||
1495977|NCT01035593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495978|NCT01035580||Single Group Assignment||Treatment||None (Open Label)||||||
1495979|NCT01035567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495980|NCT01035554|Randomized|Parallel Assignment||Treatment||Single||||||t
1495981|NCT01035541|||||Prospective|||||||
1495982|NCT01035528|Randomized|Parallel Assignment||Treatment||Single|||||t|
1495983|NCT01035515|Randomized|Crossover Assignment||||Double|||t||t|
1495984|NCT01035502||Single Group Assignment||Treatment||None (Open Label)||||||
1495985|NCT01035489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495986|NCT01035476|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1495987|NCT01035463||Single Group Assignment||Treatment||None (Open Label)||||||
1495988|NCT01035450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495989|NCT01035437||Single Group Assignment||Treatment||None (Open Label)||||||
1495990|NCT01035424|||Case-Only||Prospective|||||||
1495991|NCT01035411|Randomized|Single Group Assignment||||None (Open Label)||||||
1495992|NCT01035398|||Case-Control||Retrospective|||||||
1495993|NCT01035385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495994|NCT01035372||Single Group Assignment||||None (Open Label)||||||
1495995|NCT01035359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1495996|NCT01035346|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1495997|NCT01035333||Single Group Assignment||Treatment||None (Open Label)||||||
1495998|NCT01035320|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1495999|NCT01035307|||Cohort||Retrospective|||||||
1496000|NCT01035294|Randomized|Parallel Assignment||Treatment||Single||||||t
1496001|NCT01035281|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496002|NCT01035268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496003|NCT01035255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496004|NCT01035242|Randomized|Parallel Assignment||Treatment||Single||||||t
1496005|NCT01035229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496006|NCT01035216||Single Group Assignment||Treatment||None (Open Label)||||||
1496007|NCT01035203|Randomized|Parallel Assignment||Treatment||Single||||t||
1496008|NCT01035190|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496009|NCT01035177|||Case Control||Prospective|||||||
1496010|NCT01035164|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1496011|NCT01035151|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496012|NCT01035138||Single Group Assignment||Treatment||None (Open Label)||||||
1496013|NCT01035125|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1496014|NCT01035112|||Cohort||Prospective|||||||
1496015|NCT01035099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496016|NCT01035086|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1496017|NCT01035073||Single Group Assignment||Treatment||None (Open Label)||||||
1496018|NCT01035060|||Case Control||Cross-Sectional|||||||
1496019|NCT01035047|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1496020|NCT01035034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496021|NCT01035021|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496022|NCT01035008|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1496023|NCT01034995|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496024|NCT01034982|Randomized|Single Group Assignment||||None (Open Label)||||||
1496025|NCT01034969|||Cohort||Prospective|||||||
1496026|NCT01034956|||Cohort||Cross-Sectional|||||||
1496027|NCT01034943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496028|NCT01034930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496029|NCT01034917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496030|NCT01034904|||Cohort||Prospective|||||||
1496031|NCT01034891|||Cohort||Retrospective|||||||
1496032|NCT01034878||Single Group Assignment||Treatment||None (Open Label)||||||
1496033|NCT01034865|||Case-Control||Cross-Sectional|||||||
1496034|NCT01034852|||Case-Only||Retrospective|||||||
1496035|NCT01034839|||Cohort||Retrospective|||||||
1496036|NCT01034826|||Case-Only||Prospective|||||||
1496037|NCT01034813|||||Prospective|||||||
1496038|NCT01034800||||||||||||
1496039|NCT01034787||Single Group Assignment||Treatment||None (Open Label)||||||
1496040|NCT01034774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496041|NCT01034761|Randomized|Parallel Assignment||Prevention||Single||||||t
1496042|NCT01034748|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1496043|NCT01034735|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1496044|NCT01034722|||Ecologic or Community|||||||||
1496045|NCT01034709|||Cohort||Prospective|||||||
1496046|NCT01034696|||Cohort||Prospective|||||||
1496047|NCT01034683||Single Group Assignment||Treatment||None (Open Label)||||||
1496048|NCT01034670||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496049|NCT01034657|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496050|NCT01034644|||||Retrospective|||||||
1496051|NCT01034631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496052|NCT01034618||Crossover Assignment||Basic Science||Double|||t||t|
1496053|NCT01034605|Randomized|Crossover Assignment||||Double|||t||t|
1496054|NCT01034592||Single Group Assignment||Treatment||None (Open Label)||||||
1496055|NCT01034579|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1496056|NCT01034566||||Treatment||None (Open Label)||||||
1496057|NCT01034553||Single Group Assignment||Treatment||None (Open Label)||||||
1496058|NCT01034540|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1496059|NCT01034527|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496060|NCT01034514||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496061|NCT01034501|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496062|NCT01034488|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1496063|NCT01034475||Single Group Assignment||Treatment||None (Open Label)||||||
1496064|NCT01034462|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496065|NCT01034449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496066|NCT01034436|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1496067|NCT01034423|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1496068|NCT01034410|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496069|NCT01034397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496070|NCT01034384|||||Prospective|||||||
1496071|NCT01034371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496072|NCT01034358||Single Group Assignment||Prevention||None (Open Label)||||||
1496073|NCT01034345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496074|NCT01034332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496075|NCT01034319|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496076|NCT01034306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496077|NCT01034293|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1496078|NCT01034280|||Case-Only||Cross-Sectional|||||||
1496079|NCT01034267||Single Group Assignment||Treatment||None (Open Label)||||||
1496080|NCT01034254|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1496081|NCT01034241|Randomized|Crossover Assignment||Prevention||Single|||t|||
1496082|NCT01034228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496083|NCT01034215|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1496084|NCT01034202|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496085|NCT01034189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496086|NCT01034176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496087|NCT01034163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496088|NCT01034150|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1496089|NCT01034137|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496090|NCT01034124|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1496091|NCT01034111|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496092|NCT01034098|||Cohort||Cross-Sectional|||||||
1496093|NCT01034085|||||Other|||||||
1496094|NCT01034072|||Other||Cross-Sectional|||||||
1496095|NCT01034059|||Cohort||Prospective|||||||
1496096|NCT01034046|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496097|NCT01034033|||Cohort||Prospective|||||||
1496098|NCT01034020||||Treatment||||||||
1496099|NCT01034007||Single Group Assignment||Treatment||None (Open Label)||||||
1496100|NCT01033994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496101|NCT01033981|||Cohort||Prospective|||||||
1496102|NCT01033968|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496103|NCT01033955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496104|NCT01033942|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1496105|NCT01033929|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1496106|NCT01033916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496107|NCT01033903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496108|NCT01033890|||Case-Only||Prospective|||||||
1496109|NCT01033877|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496110|NCT01033864|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496111|NCT01033851|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496112|NCT01033838|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496113|NCT01033825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496114|NCT01033812|||Cohort||Cross-Sectional|||||||
1496115|NCT01033799|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1496116|NCT01033786|||Cohort||Retrospective|||||||
1496117|NCT01033773||Single Group Assignment||Treatment||None (Open Label)||||||
1496118|NCT01033760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496119|NCT01033747|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496120|NCT01033734||Single Group Assignment||Treatment||None (Open Label)||||||
1496121|NCT01033721||Single Group Assignment||Treatment||None (Open Label)||||||
1496122|NCT01033708|Randomized|Parallel Assignment||Treatment||Single||||||t
1496123|NCT01033695|||||Prospective|||||||
1496124|NCT01033682|||Cohort||Prospective|||||||
1496125|NCT01033669|||Cohort||Prospective|||||||
1496126|NCT01033656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496127|NCT01033643|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496128|NCT01033630|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496129|NCT01033617|Randomized|Parallel Assignment||Treatment||Quadruple|double blind|Stem cell or placebo|t|t|t|t
1496130|NCT01033604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496131|NCT01033591|Randomized|Parallel Assignment||Treatment||Single||||||t
1496132|NCT01033578|Randomized|Parallel Assignment||Treatment||Single||||||t
1496133|NCT01033565||Single Group Assignment||Treatment||None (Open Label)||||||
1496134|NCT01033552||Single Group Assignment||Treatment||None (Open Label)||||||
1496135|NCT01033539|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1496136|NCT01033526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496137|NCT01033513|||Case-Control||Prospective|||||||
1496138|NCT01033500|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496139|NCT01033487|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1496140|NCT01033474|||Case-Only||Prospective|||||||
1496141|NCT01033461|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1496142|NCT01033448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496143|NCT01033435|||Case Control||Prospective|||||||
1496144|NCT01033422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496145|NCT01033409|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1496146|NCT01033396|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1496147|NCT01033383|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1496148|NCT01033370||Single Group Assignment||Treatment||None (Open Label)||||||
1496149|NCT01033357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496150|NCT01033344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496151|NCT01033331|||Cohort||Prospective|||||||
1496152|NCT01033318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496153|NCT01033305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496154|NCT01033292||Single Group Assignment||Treatment||None (Open Label)||||||
1496155|NCT01033279|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1496156|NCT01033266||Single Group Assignment||Treatment||None (Open Label)||||||
1496157|NCT01033253|Randomized|Parallel Assignment||Prevention||Single|||t|||
1496158|NCT01033240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496159|NCT01033227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496160|NCT01033214||Single Group Assignment||Treatment||None (Open Label)||||||
1496161|NCT01033201|||Case-Only||Prospective|||||||
1496162|NCT01033188|Randomized|Parallel Assignment||Treatment||Single|||||t|
1496163|NCT01033175|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1496164|NCT01033162|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1496165|NCT01033149||Single Group Assignment||Treatment||None (Open Label)||||||
1496166|NCT01033136|Randomized|Single Group Assignment||Treatment||Single|Post-treatment and follow-up assessments are conducted by an assessor masked to treatment condition.|Multiple Channel Exposure Therapy is a behavioral treatment that simultaneously targets panic disorder and PTSD.||||t
1496167|NCT01033123||Single Group Assignment||Treatment||None (Open Label)||||||
1496168|NCT01033110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496169|NCT01033097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496170|NCT01033084|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1496171|NCT01033071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496172|NCT01033058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496173|NCT01033045|||||Prospective|||||||
1496174|NCT01033032||Single Group Assignment||Treatment||None (Open Label)||||||
1496175|NCT01033019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496176|NCT01033006|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1496177|NCT01032993|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1496178|NCT01032980|||Cohort||Prospective|||||||
1496179|NCT01032967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496180|NCT01032954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496181|NCT01032941|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1496182|NCT01032928||Single Group Assignment||Treatment||None (Open Label)||||||
1496183|NCT01032915|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496184|NCT01032902|||Cohort||Prospective|||||||
1496185|NCT01032889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496186|NCT01032876|Randomized|Parallel Assignment||Prevention||Single||||||t
1496187|NCT01032863|||Case-Only||Cross-Sectional|||||||
1496188|NCT01032850||Single Group Assignment||Treatment||None (Open Label)||||||
1496189|NCT01032837|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496190|NCT01032824|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1496191|NCT01032811|||Case-Only||Prospective|||||||
1496192|NCT01032798|Randomized|Crossover Assignment||Health Services Research||Triple|||t|t|t|
1496193|NCT01032785|||Case-Only||Prospective|||||||
1496194|NCT01032772|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1496195|NCT01032759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496196|NCT01032746|Randomized|||Screening||||||||
1496197|NCT01032733|Randomized|Parallel Assignment||Treatment||Single||||||t
1496198|NCT01032720|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496199|NCT01032694|||Case Control||Prospective|||||||
1496200|NCT01032681|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496201|NCT01032668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496202|NCT01032655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496203|NCT01032642|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1496204|NCT01032629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496205|NCT01032616|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1496206|NCT01032603|Randomized|Parallel Assignment||Treatment||Single||||||t
1496207|NCT01032590|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1496208|NCT01032577|||Cohort||Prospective|||||||
1496209|NCT01032564||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496210|NCT01032551|Randomized|Parallel Assignment||||None (Open Label)||||||
1496211|NCT01032538|||Cohort||Prospective|||||||
1496212|NCT01032525|||Cohort||Retrospective|||||||
1496213|NCT01032512|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496214|NCT01032499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496215|NCT01032486|||Cohort||Prospective|||||||
1496216|NCT01032473|||Case Control||Prospective|||||||
1496217|NCT01032460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496218|NCT01032447|||Case-Only||Prospective|||||||
1496219|NCT01032434||Single Group Assignment||Treatment||None (Open Label)||||||
1496220|NCT01032421|||Cohort||Prospective|||||||
1496221|NCT01032408|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496222|NCT01032395|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496223|NCT01032382|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1496224|NCT01032369|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1496225|NCT01032356||Single Group Assignment||Treatment||None (Open Label)||||||
1496226|NCT01032343|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1496227|NCT01032330|Randomized|Parallel Assignment||Treatment||Single||||||t
1496228|NCT01032317||Single Group Assignment||Treatment||None (Open Label)||||||
1496229|NCT01032304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496230|NCT01032291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496231|NCT01032278||Single Group Assignment||Supportive Care||None (Open Label)||||||
1496232|NCT01032265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496233|NCT01032252|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1496234|NCT01032239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496235|NCT01032226|||Cohort||Prospective|||||||
1496236|NCT01032213|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496237|NCT01032200|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1496238|NCT01032187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496239|NCT01032174|||Case-Only||Prospective|||||||
1496240|NCT01032161|||Cohort||Prospective|||||||
1496241|NCT01032148||Single Group Assignment||Treatment||None (Open Label)||||||
1496242|NCT01032135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496243|NCT01032122||Single Group Assignment||Treatment||None (Open Label)||||||
1496244|NCT01032109||Single Group Assignment||Treatment||None (Open Label)||||||
1496245|NCT01032096|||Cohort||Prospective|||||||
1496246|NCT01032083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496247|NCT01032070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496248|NCT01032057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496249|NCT01032044|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1496250|NCT01032031|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1496251|NCT01032018|Randomized|Parallel Assignment||Other||Single||||||t
1496252|NCT01032005|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1496253|NCT01031992|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1496254|NCT01031979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496255|NCT01031966|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1496256|NCT01031953||Single Group Assignment||Supportive Care||None (Open Label)||||||
1496257|NCT01031940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496258|NCT01031927|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496259|NCT01031914||Single Group Assignment||||None (Open Label)||||||
1496260|NCT01031901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496261|NCT01031888|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496262|NCT01031875|Non-Randomized|||Treatment||None (Open Label)||||||
1496263|NCT01031862||Single Group Assignment||Basic Science||None (Open Label)||||||
1496264|NCT01031849||Single Group Assignment||||None (Open Label)||||||
1496265|NCT01031836|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496266|NCT01031823||Single Group Assignment||Treatment||None (Open Label)||||||
1496267|NCT01031810||Single Group Assignment||Treatment||None (Open Label)||||||
1496268|NCT01031797|||Case Control||Prospective|||||||
1496269|NCT01031784|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496270|NCT01031771|||Case-Crossover||Cross-Sectional|||||||
1496271|NCT01031758|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1496272|NCT01031745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496273|NCT01031732|Randomized|Parallel Assignment||Treatment||Single||||||t
1496274|NCT01031719|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496275|NCT01031706|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496276|NCT01031693|Randomized|Parallel Assignment||Treatment||||||||
1496277|NCT01031680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496278|NCT01031667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496279|NCT01031654|||Cohort||Cross-Sectional|||||||
1496280|NCT01031641|||Case-Only||Prospective|||||||
1496281|NCT01031628|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496282|NCT01031615|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496283|NCT01031602|||Case-Only||Prospective|||||||
1496284|NCT01031589|Randomized|Parallel Assignment||Prevention||Double||||||
1496285|NCT01031576|||Case Control||Prospective|||||||
1496286|NCT01031563|||||Other|||||||
1496287|NCT01031550|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496288|NCT01031537||Single Group Assignment||Prevention||None (Open Label)||||||
1496289|NCT01031524|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496290|NCT01031511|Randomized|Parallel Assignment||Treatment||Single||||||t
1496291|NCT01031498|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1496292|NCT01031485|Randomized|Parallel Assignment||||Double||||||
1496293|NCT01031472|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496294|NCT01031459|||Cohort||Cross-Sectional|||||||
1496295|NCT01031446||Single Group Assignment||Treatment||None (Open Label)||||||
1496296|NCT01031433|||||Prospective|||||||
1496297|NCT01031420||Single Group Assignment||Treatment||None (Open Label)||||||
1496298|NCT01031407|||||Other|||||||
1496299|NCT01031394|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496300|NCT01031381||Single Group Assignment||Treatment||None (Open Label)||||||
1496301|NCT01031368||Single Group Assignment||Treatment||None (Open Label)||||||
1496302|NCT01031355|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496303|NCT01031342|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1496304|NCT01031329|||Case-Only||Prospective|||||||
1496305|NCT01031316|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1496306|NCT01031303|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1496307|NCT01031290|Randomized|Parallel Assignment||Treatment||Double||||||
1496308|NCT01031277|||Case-Only||Cross-Sectional|||||||
1496309|NCT01031264|||Cohort||Prospective|||||||
1496310|NCT01031238|||Case-Only||Prospective|||||||
1496311|NCT01031225|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496312|NCT01031212||Single Group Assignment||Treatment||None (Open Label)||||||
1496313|NCT01031199|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1496314|NCT01031186|Randomized|Crossover Assignment||Treatment||Single|||t|||
1496315|NCT01031173||||||||||||
1496316|NCT01031160|||||Other|||||||
1496317|NCT01031147|||Cohort||Prospective|||||||
1496318|NCT01031134|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1496319|NCT01031121|||||Other|||||||
1496320|NCT01031108|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1496321|NCT01031095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496322|NCT01031082|||Cohort||Prospective|||||||
1496323|NCT01031069|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1496324|NCT01031056|||||Prospective|||||||
1496325|NCT01031043||Single Group Assignment||Treatment||None (Open Label)||||||
1496326|NCT01031030|Randomized|||Treatment||None (Open Label)||||||
1496327|NCT01031017|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496328|NCT01031004|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496329|NCT01030991|||Cohort||Prospective|||||||
1496330|NCT01030978|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496331|NCT01030965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496332|NCT01030952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496333|NCT01030939|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496334|NCT01030926|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1496335|NCT01030913|||Case-Control||Cross-Sectional|||||||
1496336|NCT01030900||Single Group Assignment||Treatment||None (Open Label)||||||
1496337|NCT01030887|Randomized|Parallel Assignment||Treatment||Single||||||t
1496338|NCT01030874|Randomized|Single Group Assignment||Treatment||Single||||||t
1496339|NCT01030861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496340|NCT01030848|||Cohort||Prospective|||||||
1496341|NCT01030835|||||Other|||||||
1496342|NCT01030822|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496343|NCT01030809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496344|NCT01030796||Single Group Assignment||Treatment||None (Open Label)||||||
1496345|NCT01030783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496346|NCT01030770|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1496347|NCT01030757||Single Group Assignment||Treatment||None (Open Label)||||||
1496348|NCT01030744|||Cohort||Prospective|||||||
1496349|NCT01030731||Parallel Assignment||Basic Science||None (Open Label)||||||
1496350|NCT01030718||Parallel Assignment||Treatment||None (Open Label)||||||
1496351|NCT01030705|||||Retrospective|||||||
1496352|NCT01030692|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1496353|NCT01030679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496354|NCT01030666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496355|NCT01030653|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1496356|NCT01030640|Non-Randomized|Parallel Assignment||Treatment||Double|||t|t||
1496357|NCT01030627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496358|NCT01030614|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496359|NCT01030601|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496360|NCT01030588||||||||||||
1496361|NCT01030575|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496362|NCT01030562|||Cohort||Other|||||||
1496363|NCT01030549|||Cohort||Cross-Sectional|||||||
1496364|NCT01030536|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496365|NCT01030523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496366|NCT01030510|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1496367|NCT01030497|||Case-Only||Prospective|||||||
1496368|NCT01030484|||Cohort||Prospective|||||||
1496369|NCT01030471|Randomized|Crossover Assignment||Treatment||Single||||||t
1496370|NCT01030458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496371|NCT01030445|||Cohort||Prospective|||||||
1496372|NCT01030432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496373|NCT01030419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496374|NCT01030406|Randomized|Crossover Assignment||Treatment||Double|Matching white tablets||t||t|
1496375|NCT01030393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496376|NCT01030380|Randomized|Parallel Assignment||Treatment||Single||||||t
1496377|NCT01030367|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1496378|NCT01030354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496379|NCT01030341||Single Group Assignment||Treatment||None (Open Label)||||||
1496380|NCT01030328|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1496381|NCT01030315|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1496382|NCT01030302|||Case-Only||Prospective|||||||
1496383|NCT01030289|Randomized|Crossover Assignment||Other||Single|||t|||
1496384|NCT01030276|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496385|NCT01030263|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1496386|NCT01030250|||Cohort||Prospective|||||||
1496387|NCT01030237|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496388|NCT01030224|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1496389|NCT01030211|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496390|NCT01030198|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1496391|NCT01030185||Single Group Assignment||Treatment||None (Open Label)||||||
1496392|NCT01030159|||Cohort||Prospective|||||||
1496393|NCT01030146|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496394|NCT01030133|Randomized|Parallel Assignment||Other||Single|||t|||
1496395|NCT01030120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496396|NCT01030107|||Case-Only||Prospective|||||||
1496397|NCT01030094|||Cohort||Cross-Sectional|||||||
1496398|NCT01030081|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496399|NCT01030068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496400|NCT01030055|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496401|NCT01030042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496402|NCT01030029|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496403|NCT01030016|Non-Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1496404|NCT01030003|||Cohort||Prospective|||||||
1496405|NCT01029990|Randomized|Parallel Assignment||Screening||Single||||t||
1496406|NCT01029977|||Case-Only||Cross-Sectional|||||||
1496407|NCT01029964|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496408|NCT01029951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496409|NCT01029938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496410|NCT01029925||Single Group Assignment||Treatment||None (Open Label)||||||
1496411|NCT01029912|Randomized|Parallel Assignment||Treatment||Single||||||t
1496412|NCT01029899|||Case-Only||Prospective|||||||
1496413|NCT01029886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496414|NCT01029873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496415|NCT01029860|||Case-Crossover||Prospective|||||||
1496416|NCT01029847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496417|NCT01029834|Randomized|Parallel Assignment||Prevention||Single||||t||
1496418|NCT01029821|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496419|NCT01029808|||Cohort||Cross-Sectional|||||||
1496420|NCT01029795|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496421|NCT01029782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496422|NCT01029769|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1496423|NCT01029756|Randomized|Parallel Assignment||||None (Open Label)||||||
1496424|NCT01029743|||Cohort||Prospective|||||||
1496425|NCT01029730||Single Group Assignment||Treatment||None (Open Label)||||||
1496426|NCT01029717|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1496427|NCT01029704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496428|NCT01029691|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496429|NCT01029678||Single Group Assignment||Treatment||None (Open Label)||||||
1496430|NCT01029665|||Cohort||Prospective|||||||
1496431|NCT01029652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496432|NCT01029639|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1496433|NCT01029626||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496434|NCT01029613|||Cohort||Prospective|||||||
1496435|NCT01029600|Randomized|Parallel Assignment||Treatment||Single||||||t
1496436|NCT01029587||Single Group Assignment||Prevention||None (Open Label)||||||
1496437|NCT01029574|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496438|NCT01029561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496439|NCT01029548|||Cohort||Prospective|||||||
1496440|NCT01029535||Single Group Assignment||Treatment||None (Open Label)||||||
1496441|NCT01029522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496442|NCT01029509||Single Group Assignment||Treatment||None (Open Label)||||||
1496443|NCT01029496|Randomized|Single Group Assignment||Prevention||Single|||t|||
1496444|NCT01029483|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1496445|NCT01029470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496446|NCT01029444||Single Group Assignment||Treatment||None (Open Label)||||||
1496447|NCT01029431|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496448|NCT01029418||Single Group Assignment||Treatment||None (Open Label)||||||
1496449|NCT01029405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496450|NCT01029392|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||Patients with clinically significantly low Vitamin D levels (<30 ng/mL) were supplemented with Vitamin D and compared to patients with normal vitamin D levels (50-80 nG/mL).||||
1496451|NCT01029379|||Cohort||Prospective|||||||
1496452|NCT01029366|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496453|NCT01029353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496454|NCT01029340|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496455|NCT01029327|||Case-Crossover||Cross-Sectional|||||||
1496456|NCT01029314|||Cohort||Prospective|||||||
1496457|NCT01029301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496458|NCT01029288|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1496459|NCT01029275|Randomized|Parallel Assignment||||None (Open Label)||||||
1496460|NCT01029262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496461|NCT01029249|||Cohort||Prospective|||||||
1496462|NCT01029236||Single Group Assignment||Basic Science||None (Open Label)||||||
1496463|NCT01029223|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1496464|NCT01029210|||Case-Crossover||Cross-Sectional|||||||
1496465|NCT01029197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496466|NCT01029184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496467|NCT01029171|Randomized|Single Group Assignment||Treatment||Single|||t|||
1496468|NCT01029158|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1496469|NCT01029145|||Cohort||Prospective|||||||
1496470|NCT01029132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496471|NCT01029119|||Case Control||Cross-Sectional|||||||
1496472|NCT01029106|||||Prospective|||||||
1496473|NCT01029093|||||Prospective|||||||
1496474|NCT01029080|||Case-Only||Prospective|||||||
1496475|NCT01029067|Randomized|Parallel Assignment||Treatment||Single||||||t
1496476|NCT01029054||Single Group Assignment||Health Services Research||None (Open Label)||||||
1496477|NCT01029041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496478|NCT01029028||||||||||||
1496479|NCT01029015|||Case Control||Prospective|||||||
1496480|NCT01029002|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496481|NCT01028989|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1496482|NCT01028976|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496483|NCT01028963|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1496484|NCT01028950||Single Group Assignment||Prevention||None (Open Label)||||||
1496485|NCT01028937||Single Group Assignment||Treatment||None (Open Label)||||||
1496486|NCT01028924|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1496487|NCT01028911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496488|NCT01028898|||Case Control||Prospective|||||||
1496489|NCT01028885||Single Group Assignment||Treatment||None (Open Label)||||||
1496490|NCT01028872||||||||||||
1496491|NCT01028859||Single Group Assignment||Treatment||None (Open Label)||||||
1496492|NCT01028846|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496493|NCT01028833|Randomized|Parallel Assignment||Treatment||Single||||||t
1496494|NCT01028820||Single Group Assignment||Treatment||None (Open Label)||||||
1496495|NCT01028807|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496496|NCT01028794|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496497|NCT01028781||Single Group Assignment||Treatment||None (Open Label)||||||
1496498|NCT01028768|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1496499|NCT01028755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496500|NCT01028742|||Cohort||Prospective|||||||
1496501|NCT01028729||Single Group Assignment||Treatment||None (Open Label)||||||
1496502|NCT01028716||Single Group Assignment||Treatment||None (Open Label)||||||
1496503|NCT01028703|||Case Control||Prospective|||||||
1496504|NCT01028690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496505|NCT01028677|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1496506|NCT01028664||Single Group Assignment||Supportive Care||None (Open Label)||||||
1496507|NCT01028651|||Cohort||Prospective|||||||
1496508|NCT01028638|||Cohort||Prospective|||||||
1496509|NCT01028625|Randomized|Parallel Assignment||Treatment||Single|||||t|
1496510|NCT01028612||Single Group Assignment||Treatment||None (Open Label)||||||
1496511|NCT01028599|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496512|NCT01028586|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1496513|NCT01028573|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1496514|NCT01028560|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496515|NCT01028547|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496516|NCT01028534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496517|NCT01028521|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1496518|NCT01028508|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496519|NCT01028495|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496520|NCT01028482|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496521|NCT01028469||Single Group Assignment||Treatment||None (Open Label)||||||
1496522|NCT01028456|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496523|NCT01028443||||||||||||
1496524|NCT01028430|||Case-Control||Cross-Sectional|||||||
1496525|NCT01028417|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496526|NCT01028404|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496527|NCT01028391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496528|NCT01028378||Single Group Assignment||Treatment||None (Open Label)||||||
1496529|NCT01028365|||Cohort||Prospective|||||||
1496530|NCT01028352||Single Group Assignment||Treatment||None (Open Label)||||||
1496531|NCT01028339|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496532|NCT01028326|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1496533|NCT01028313||Single Group Assignment||Treatment||None (Open Label)||||||
1496534|NCT01028300||Single Group Assignment||Treatment||None (Open Label)||||||
1496535|NCT01028287|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496536|NCT01028274|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496537|NCT01028261|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496538|NCT01028248|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496539|NCT01028235|||||Prospective|||||||
1496540|NCT01028222|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1496541|NCT01028209||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496542|NCT01028196|||Case-Only||Cross-Sectional|||||||
1496543|NCT01028183|||Cohort||Prospective|||||||
1496544|NCT01028170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496545|NCT01028157|Randomized|Parallel Assignment||Prevention||Single|||t|||
1496546|NCT01028144|Randomized|Parallel Assignment||Prevention||Single||||||t
1496547|NCT01028131|Randomized|Factorial Assignment||Treatment||Single|||t|||
1496548|NCT01028118|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496549|NCT01028105|Randomized|Parallel Assignment||||None (Open Label)||||||
1496550|NCT01028092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496551|NCT01028079|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496552|NCT01028066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496553|NCT01028053||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496554|NCT01028040|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1496555|NCT01028027|Randomized|Parallel Assignment||Treatment||Single|||||t|
1496556|NCT01028014|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1496557|NCT01027988|||Cohort||Prospective|||||||
1496558|NCT01027975||||Treatment||||||||
1496559|NCT01027962|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496560|NCT01027949||Single Group Assignment||Treatment||None (Open Label)||||||
1496561|NCT01027936|||Case Control||Prospective|||||||
1496562|NCT01027923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496563|NCT01027910|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496564|NCT01027897||Single Group Assignment||Treatment||None (Open Label)||||||
1496565|NCT01027884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496566|NCT01027871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496567|NCT01027858|Randomized|Single Group Assignment||Treatment||Single|||t|||
1496568|NCT01027845|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496569|NCT01027832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496570|NCT01027819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496571|NCT01027806|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1496572|NCT01027793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496573|NCT01027780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496574|NCT01027767|||Cohort|||||||||
1496575|NCT01027754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496576|NCT01027741|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1496577|NCT01027728|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1496578|NCT01027715|Randomized|Parallel Assignment||Treatment||Single||||||t
1496579|NCT01027702||Single Group Assignment||Treatment||None (Open Label)||||||
1496580|NCT01027689|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1496581|NCT01027676||Single Group Assignment||Treatment||None (Open Label)||||||
1496582|NCT01027663|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1496583|NCT01027650|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496584|NCT01027637||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496585|NCT01027624|||Cohort||Prospective|||||||
1496586|NCT01027611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496587|NCT01027598|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1496588|NCT01027585|||Case-Crossover||Cross-Sectional|||||||
1496589|NCT01027572|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496590|NCT01027559|Randomized|Parallel Assignment||Other||Single||||||t
1496591|NCT01027546|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496592|NCT01027533|||||Prospective|||||||
1496593|NCT01027520||Single Group Assignment||Treatment||None (Open Label)||||||
1496594|NCT01027507|||Case-Only|||||||||
1496595|NCT01027494|||Case Control||Prospective|||||||
1496596|NCT01027481|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496597|NCT01027468||Single Group Assignment||Treatment||None (Open Label)||||||
1496598|NCT01027455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496599|NCT01027442|Non-Randomized|Parallel Assignment||Supportive Care||Single||||||t
1496600|NCT01027429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496601|NCT01027416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496602|NCT01027403|||||Prospective|||||||
1496603|NCT01027390|Randomized|Parallel Assignment||Prevention||Single|||||t|
1496604|NCT01027377|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496605|NCT01027364|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496606|NCT01027351|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496607|NCT01027338||||||||||||
1496608|NCT01027325|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1496609|NCT01027312|||Cohort||Prospective|||||||
1496610|NCT01027299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496611|NCT01027286|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496612|NCT01027273|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1496613|NCT01027260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496614|NCT01027247||||||||||||
1496615|NCT01027234|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1496616|NCT01027221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496617|NCT01027208||Single Group Assignment||Treatment||None (Open Label)||||||
1496618|NCT01027195|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496619|NCT01027182||Single Group Assignment||||None (Open Label)||||||
1496620|NCT01027169|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1496621|NCT01027156||||Prevention||||||||
1496622|NCT01027143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496623|NCT01027130|||Case Control||Prospective|||||||
1496624|NCT01027117|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1496625|NCT01027104||Parallel Assignment||||None (Open Label)||||||
1496626|NCT01027091|||Cohort||Prospective|||||||
1496627|NCT01027078|||Cohort||Prospective|||||||
1496628|NCT01027065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496629|NCT01027052|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1496630|NCT01027039|||Cohort||Prospective|||||||
1496631|NCT01027026|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1496632|NCT01027013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496633|NCT01027000||Single Group Assignment||Treatment||None (Open Label)||||||
1496634|NCT01026987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496635|NCT01026974|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496636|NCT01026961|Randomized|Crossover Assignment||||Triple|||t|t|t|
1496637|NCT01026948|||Cohort||Prospective|||||||
1496638|NCT01026935|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496639|NCT01026922|||Case-Only||Prospective|||||||
1496640|NCT01026909|Randomized|Parallel Assignment||Treatment||Single||||||t
1496641|NCT01026896|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1496642|NCT01026883|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1496643|NCT01026870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496644|NCT01026857|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1496645|NCT01026844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496646|NCT01026831|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496647|NCT01026818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496648|NCT01026805|||Cohort||Retrospective|||||||
1496649|NCT01026792||Single Group Assignment||Treatment||None (Open Label)||||||
1496650|NCT01026779|||Case-Control||Retrospective|||||||
1496651|NCT01026766|||Case Control||Prospective|||||||
1496652|NCT01026753|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1496653|NCT01026740||Single Group Assignment||Basic Science||None (Open Label)||||||
1496654|NCT01026727|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496655|NCT01026714|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1496656|NCT01026701|||Case-Only||Prospective|||||||
1496657|NCT01026688|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1496658|NCT01026675|||Cohort||Prospective|||||||
1496659|NCT01026662|||Case-Only||Prospective|||||||
1496660|NCT01026649|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496661|NCT01026636||Single Group Assignment||Basic Science||None (Open Label)||||||
1496662|NCT01026623||Single Group Assignment||Treatment||None (Open Label)||||||
1496663|NCT01026610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496664|NCT01026597|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496665|NCT01026584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496666|NCT01026571|||Cohort||Prospective|||||||
1496667|NCT01026558|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1496668|NCT01026545|Randomized|Parallel Assignment||||Double|||t||t|
1496669|NCT01026532||Single Group Assignment||Basic Science||None (Open Label)||||||
1496670|NCT01026519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496671|NCT01026506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496672|NCT01026493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496673|NCT01026480|||Cohort||Prospective|||||||
1496674|NCT01026467|||Case-Only||Prospective|||||||
1496675|NCT01026454|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496676|NCT01026441||Single Group Assignment||Treatment||None (Open Label)||||||
1496677|NCT01026428|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1496678|NCT01026415|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496679|NCT01026402||Single Group Assignment||Treatment||None (Open Label)||||||
1496680|NCT01026389|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1496681|NCT01026376||||||||||||
1496682|NCT01026363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496683|NCT01026350|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1496684|NCT01026337||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496685|NCT01026324||Single Group Assignment||Treatment||None (Open Label)||||||
1496686|NCT01026311|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1496687|NCT01026298|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1496688|NCT01026285|||||Prospective|||||||
1496689|NCT01026272|||Cohort||Prospective|||||||
1496690|NCT01026259|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1496691|NCT01026246|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1496692|NCT01026233|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496693|NCT01026220|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496694|NCT01026207|||Cohort||Prospective|||||||
1496695|NCT01026194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496696|NCT01026181|||Cohort||Prospective|||||||
1496697|NCT01026155|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1496698|NCT01026142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496699|NCT01026129|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1496700|NCT01026116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496701|NCT01026103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496702|NCT01026090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496703|NCT01026077|||Cohort||Prospective|||||||
1496704|NCT01026064|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1496705|NCT01026051||Single Group Assignment||Treatment||None (Open Label)||||||
1496706|NCT01026038|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1496707|NCT01026025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496708|NCT01026012||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496709|NCT01025999|||Cohort||Prospective|||||||
1496710|NCT01025986|||Cohort||Prospective|||||||
1496711|NCT01025973|||Cohort||Prospective|||||||
1496712|NCT01025960|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1496713|NCT01025947|||Cohort||Prospective|||||||
1496714|NCT01025934||||Treatment||||||||
1496715|NCT01025921|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496716|NCT01025908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496717|NCT01025895|Randomized|Parallel Assignment||Treatment||||||||
1496718|NCT01025882||||Treatment||||||||
1496719|NCT01025869||Single Group Assignment||Treatment||None (Open Label)||||||
1496720|NCT01025856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496721|NCT01025843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496722|NCT01025830|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496723|NCT01025817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496724|NCT01025804|||Case-Only||Prospective|||||||
1496725|NCT01025791|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1496726|NCT01025778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496727|NCT01025765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496728|NCT01025752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496729|NCT01025739||Single Group Assignment||Treatment||None (Open Label)||||||
1496730|NCT01025726|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1496731|NCT01025713|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1496732|NCT01025700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496733|NCT01025687|Randomized|Crossover Assignment||Prevention||Single|||t|||
1496734|NCT01025674|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496735|NCT01025661|Non-Randomized|Parallel Assignment||Treatment||||||||
1496736|NCT01025648|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1496737|NCT01025635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496738|NCT01025622||Single Group Assignment||Treatment||None (Open Label)||||||
1496739|NCT01025609|||Case Control||Cross-Sectional|||||||
1496740|NCT01025596||Single Group Assignment||Treatment||None (Open Label)||||||
1496741|NCT01025583|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1496742|NCT01025570||Single Group Assignment||Treatment||None (Open Label)||||||
1496743|NCT01025557|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1496744|NCT01025544|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496745|NCT01025531|||Cohort||Prospective|||||||
1496746|NCT01025518|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1496747|NCT01025505||Single Group Assignment||Treatment||None (Open Label)||||||
1496748|NCT01025492|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496749|NCT01025479|||Case-Only||Retrospective|||||||
1496750|NCT01025466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496751|NCT01025453||Single Group Assignment||Treatment||None (Open Label)||||||
1496752|NCT01025440|Randomized|Crossover Assignment||Treatment||Single|||t|||
1496753|NCT01025427|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496754|NCT01025414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496755|NCT01025401||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496756|NCT01025388|||Case-Only||Cross-Sectional|||||||
1496757|NCT01025375|Randomized|Crossover Assignment||||Double|||t||t|
1496758|NCT01025362|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1496759|NCT01025349||Single Group Assignment||Treatment||None (Open Label)||||||
1496760|NCT01025336|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1496761|NCT01025323|Randomized|Parallel Assignment||Prevention||Single|||t|||
1496762|NCT01025310|||Cohort||Cross-Sectional|||||||
1496763|NCT01025297|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496764|NCT01025284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496765|NCT01025271||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496766|NCT01025258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496767|NCT01025245||Parallel Assignment||Prevention||None (Open Label)||||||
1496768|NCT01025232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496769|NCT01025219||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496770|NCT01025206||Single Group Assignment||Treatment||None (Open Label)||||||
1496771|NCT01025193||Single Group Assignment||Treatment||None (Open Label)|There was no masking in this single group trial. The patients, providers and investigators were all aware that the patient were on belimumab therapy.|There was only one group in this trial. All participants received belimumab.||||
1496772|NCT01025180|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1496773|NCT01025167|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1496774|NCT01025154||Single Group Assignment||Treatment||None (Open Label)||||||
1496775|NCT01025141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496776|NCT01025128|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1496777|NCT01025115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496778|NCT01025102|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1496779|NCT01025089||Single Group Assignment||Treatment||None (Open Label)||||||
1496780|NCT01025076||Single Group Assignment||Treatment||None (Open Label)||||||
1496781|NCT01025063|||Cohort||Prospective|||||||
1496782|NCT01025050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496783|NCT01025037||Single Group Assignment||Treatment||None (Open Label)||||||
1496784|NCT01025024|||Case Control||Prospective|||||||
1496785|NCT01025011||||||||||||
1496786|NCT01024998|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496787|NCT01024985|||Cohort||Prospective|||||||
1496788|NCT01024972|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496789|NCT01024959||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496790|NCT01024946|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496791|NCT01024933|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496792|NCT01024920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496793|NCT01024907||Single Group Assignment||Treatment||None (Open Label)||||||
1496794|NCT01024894||Single Group Assignment||Treatment||None (Open Label)||||||
1496795|NCT01024881|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496796|NCT01024868|||Case-Only||Prospective|||||||
1496797|NCT01024855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496798|NCT01024842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496799|NCT01024829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496800|NCT01024816|Randomized|Parallel Assignment||Treatment||Single|||||t|
1496801|NCT01024803|Randomized|Single Group Assignment||Treatment||Single|||t|||
1496802|NCT01024790|Randomized|Parallel Assignment||Treatment||Single||||||t
1496803|NCT01024777|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496804|NCT01024764|||||Prospective|||||||
1496805|NCT01024751|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1496806|NCT01024738|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1496807|NCT01024725|||||Prospective|||||||
1496808|NCT01024712|Non-Randomized|||Treatment||None (Open Label)||||||
1496809|NCT01024699|||Cohort||Prospective|||||||
1496810|NCT01024686|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1496811|NCT01024673|||Cohort||Prospective|||||||
1496812|NCT01024660|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1496813|NCT01024647|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496814|NCT01024634|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1496815|NCT01024621|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1496816|NCT01024608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496817|NCT01024595|||||Prospective|||||||
1496818|NCT01024582||Single Group Assignment||Treatment||None (Open Label)||||||
1496819|NCT01024569|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1496820|NCT01024556|||||Prospective|||||||
1496821|NCT01024543|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1496822|NCT01024517|Randomized|Crossover Assignment||||None (Open Label)||||||
1496823|NCT01024504|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496824|NCT01024491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496825|NCT01024478|||Cohort||Prospective|||||||
1496826|NCT01024465||Single Group Assignment||Treatment||None (Open Label)||||||
1496827|NCT01024452|Randomized|Parallel Assignment||Treatment||Single|||t|||
1496828|NCT01024439|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1496829|NCT01024426|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1496830|NCT01024413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496831|NCT01024400||Single Group Assignment||Prevention||None (Open Label)||||||
1496832|NCT01024387||Single Group Assignment||Treatment||None (Open Label)||||||
1496833|NCT01024374|||Case-Only||Prospective|||||||
1496834|NCT01024361|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496835|NCT01024348|Randomized|Parallel Assignment||Treatment||Single||||||t
1496836|NCT01024335|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496837|NCT01024322|||Cohort||Prospective|||||||
1496838|NCT01024309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496839|NCT01024296||Single Group Assignment||Treatment||None (Open Label)||||||
1496840|NCT01024283|||Cohort||Prospective|||||||
1496841|NCT01024270|Randomized|||||Single||||t||
1496842|NCT01024257||||||||||||
1496843|NCT01024244|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496844|NCT01024231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496845|NCT01024218|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496846|NCT01024205||||Treatment||None (Open Label)||||||
1496847|NCT01024192||Single Group Assignment||Treatment||None (Open Label)||||||
1496848|NCT01024179|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496849|NCT01024166|||||Prospective|||||||
1496850|NCT01024153|Randomized|Parallel Assignment||Prevention||Single|||t|||
1496851|NCT01024140||Single Group Assignment||Treatment||None (Open Label)||||||
1496852|NCT01024127|||Cohort||Cross-Sectional|||||||
1496853|NCT01024114|||Case-Only||Prospective|||||||
1496854|NCT01024101||Single Group Assignment||Treatment||None (Open Label)||||||
1496855|NCT01024088|||||Prospective|||||||
1496856|NCT01024075|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1496857|NCT01024062||Single Group Assignment||Treatment||None (Open Label)||||||
1496858|NCT01024049|||Case Control|||||||||
1496859|NCT01024036|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496860|NCT01024023|Randomized|Parallel Assignment||||None (Open Label)||||||
1496861|NCT01024010|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496862|NCT01023997|||Cohort||Prospective|||||||
1496863|NCT01023984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496864|NCT01023971|||Cohort||Prospective|||||||
1496865|NCT01023958||Single Group Assignment||Treatment||None (Open Label)||||||
1496866|NCT01023945|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496867|NCT01023932|||Cohort||Prospective|||||||
1496868|NCT01023919|Randomized|Single Group Assignment||Treatment||Single||||||t
1496869|NCT01023906|||Cohort||Cross-Sectional|||||||
1496870|NCT01023893|||Case-Only||Prospective|||||||
1496871|NCT01023880||Single Group Assignment||Treatment||None (Open Label)||||||
1496872|NCT01023867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496873|NCT01023854|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1496874|NCT01023841|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496875|NCT01023828|||||Retrospective|||||||
1496876|NCT01023815|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496877|NCT01023802|||Case-Only||Prospective|||||||
1496878|NCT01023789||Single Group Assignment||Treatment||None (Open Label)||||||
1496879|NCT01023776||Single Group Assignment||Prevention||None (Open Label)||||||
1496880|NCT01023763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496881|NCT01023750|||||Prospective|||||||
1496882|NCT01023737||Single Group Assignment||Treatment||None (Open Label)||||||
1496883|NCT01023724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496884|NCT01023711||Single Group Assignment||Prevention||None (Open Label)||||||
1496885|NCT01023698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496886|NCT01023685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496887|NCT01023672||Single Group Assignment||Treatment||None (Open Label)||||||
1496888|NCT01023659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496889|NCT01023646|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1496890|NCT01023633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496891|NCT01023620|Randomized|Parallel Assignment||||None (Open Label)||||||
1496892|NCT01023607|Randomized|Single Group Assignment||Treatment||Single||||||t
1496893|NCT01023594|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496894|NCT01023581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496895|NCT01023568|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1496896|NCT01023555|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1496897|NCT01023542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496898|NCT01023529|||Case-Only||Prospective|||||||
1496899|NCT01023516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496900|NCT01023503|||||Retrospective|||||||
1496901|NCT01023490|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496902|NCT01023477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496903|NCT01023464|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1496904|NCT01023451|||Cohort||Cross-Sectional|||||||
1496905|NCT01023438|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1496906|NCT01023425|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496907|NCT01023412|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496908|NCT01023399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496909|NCT01023386|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1496910|NCT01023373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496911|NCT01023360||Crossover Assignment||Screening||None (Open Label)||||||
1496912|NCT01023347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496913|NCT01023334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496914|NCT01023321|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1496915|NCT01023308|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1496916|NCT01023295|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496917|NCT01023282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496918|NCT01023269|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496919|NCT01023256|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1496920|NCT01023243|Randomized|Single Group Assignment||Health Services Research||Single||||t||
1496921|NCT01023230||Single Group Assignment||Treatment||None (Open Label)||||||
1496922|NCT01023217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496923|NCT01023204||Single Group Assignment||Treatment||None (Open Label)||||||
1496924|NCT01023191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496925|NCT01023178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496926|NCT01023165|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496927|NCT01023152||Parallel Assignment||Prevention||||||||
1496928|NCT01023139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496929|NCT01023126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496930|NCT01023113|Randomized|Parallel Assignment||Treatment||Single||||||t
1496931|NCT01023100|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1496932|NCT01023087|||Cohort||Prospective|||||||
1496933|NCT01023074|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1496934|NCT01023061||Single Group Assignment||Treatment||None (Open Label)||||||
1496935|NCT01023048||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496936|NCT01023035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496937|NCT01023022|||Cohort||Prospective|||||||
1496938|NCT01023009|||Case-Only||Prospective|||||||
1496939|NCT01022996||Single Group Assignment||Treatment||None (Open Label)||||||
1496940|NCT01022983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496941|NCT01022970|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1496942|NCT01022957||Single Group Assignment||Diagnostic||None (Open Label)||||||
1496943|NCT01022944|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1496944|NCT01022931|||Cohort||Prospective|||||||
1496945|NCT01022918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496946|NCT01022905|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1496947|NCT01022892|||Case Control||Prospective|||||||
1496948|NCT01022879||Single Group Assignment||Treatment||||||||
1496949|NCT01022866|||Cohort||Prospective|||||||
1496950|NCT01022853||Single Group Assignment||Treatment||None (Open Label)||||||
1496951|NCT01022840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496952|NCT01022827|Randomized|Parallel Assignment||Treatment||Single||||||t
1496953|NCT01022814|||Case Control||Cross-Sectional|||||||
1496954|NCT01022801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1496955|NCT01022788|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1496956|NCT01022775|Randomized|Parallel Assignment||Treatment||Single||||||t
1496957|NCT01022762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496958|NCT01022749|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496959|NCT01022736||Single Group Assignment||Treatment||None (Open Label)||||||
1496960|NCT01022723|||Cohort||Prospective|||||||
1496961|NCT01022710|||Case-Only||Cross-Sectional|||||||
1496962|NCT01022697|Randomized|Parallel Assignment||||None (Open Label)||||||
1496963|NCT01022684|||Cohort||Cross-Sectional|||||||
1496964|NCT01022671||Single Group Assignment||Treatment||None (Open Label)||||||
1496965|NCT01022658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496966|NCT01022645|||Cohort||Prospective|||||||
1496967|NCT01022632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496968|NCT01022619|||Case Control||Prospective|||||||
1496969|NCT01022606||Single Group Assignment||Diagnostic||Single|||||t|
1496970|NCT01022580|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1496971|NCT01022567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496972|NCT01022554||||||||||||
1496973|NCT01022541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1496974|NCT01022528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496975|NCT01022515|||Case Control||Prospective|||||||
1496976|NCT01022502|Randomized|Single Group Assignment||Treatment||Single||||||t
1496977|NCT01022489|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1496978|NCT01022476||Single Group Assignment||Treatment||None (Open Label)||||||
1496979|NCT01022463|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1496980|NCT01022450|||Case-Only||Retrospective|||||||
1496981|NCT01022437||Single Group Assignment||Supportive Care||None (Open Label)||||||
1496982|NCT01022424||Single Group Assignment||Treatment||None (Open Label)||||||
1496983|NCT01022411|Randomized|Parallel Assignment||Treatment||Single||||||t
1496984|NCT01022398|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1496985|NCT01022385||||Diagnostic||||||||
1496986|NCT01022372|||Case Control||Prospective|||||||
1496987|NCT01022359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496988|NCT01022346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496989|NCT01022333|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1496990|NCT01022320||Single Group Assignment||Treatment||None (Open Label)||||||
1496991|NCT01022307|||Case Control||Retrospective|||||||
1496992|NCT01022294|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1496993|NCT01022281|||Cohort||Prospective|||||||
1496994|NCT01022268|||Case Control||Prospective|||||||
1496995|NCT01022255||Single Group Assignment||Treatment||None (Open Label)||||||
1496996|NCT01022242|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1496997|NCT01022229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1496998|NCT01022216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1496999|NCT01022203|Randomized|Parallel Assignment||Treatment||Single||||||t
1497000|NCT01022190||Single Group Assignment||Prevention||None (Open Label)||||||
1497001|NCT01022177|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497002|NCT01022164|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1497003|NCT01022151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497004|NCT01022138||Single Group Assignment||Treatment||None (Open Label)||||||
1497005|NCT01022125|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497006|NCT01022112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497007|NCT01022099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497008|NCT01022086|||Other||Prospective|||||||
1497009|NCT01022073|||Cohort||Prospective|||||||
1497010|NCT01022060|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497011|NCT01022047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497012|NCT01022034|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497013|NCT01022021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497014|NCT01022008||Single Group Assignment||||None (Open Label)||||||
1497015|NCT01021995|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1497016|NCT01021982|||Case Control||Prospective|||||||
1497017|NCT01021969|Randomized|Crossover Assignment||Prevention||Single|||t|||
1497018|NCT01021956||Single Group Assignment||Treatment||None (Open Label)||||||
1497019|NCT01021943|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497020|NCT01021930|Randomized|Single Group Assignment||Treatment||Single||||||t
1497021|NCT01021917|||Case-Control||Prospective|||||||
1497022|NCT01021904|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1497023|NCT01021891|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497024|NCT01021878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497025|NCT01021865|||Case Control||Prospective|||||||
1497026|NCT01021852|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497027|NCT01021839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497028|NCT01021826|||Cohort||Prospective|||||||
1497029|NCT01021813|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497030|NCT01021800||Single Group Assignment||Treatment||None (Open Label)||||||
1497031|NCT01021787|Randomized|Single Group Assignment||||None (Open Label)||||||
1497032|NCT01021774|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497033|NCT01021761|Randomized|Parallel Assignment||Treatment||Single||||||t
1497034|NCT01021748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497035|NCT01021735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497036|NCT01021722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497037|NCT01021709||Single Group Assignment||Treatment||None (Open Label)||||||
1497038|NCT01021696|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1497039|NCT01021683|||Case-Only||Prospective|||||||
1497040|NCT01021670|||Cohort||Prospective|||||||
1497041|NCT01021657|||Cohort||Prospective|||||||
1497042|NCT01021644|Randomized|Parallel Assignment||Treatment||Single||||||t
1497043|NCT01021631|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1497044|NCT01021618|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1497045|NCT01021605||||||||||||
1497046|NCT01021592|||Case-Only||Prospective|||||||
1497047|NCT01021579|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1497048|NCT01021566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497049|NCT01021553|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497050|NCT01021540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497051|NCT01021527|Randomized|Crossover Assignment||Treatment||Single|||t|||
1497052|NCT01021514|||Case Control||Cross-Sectional|||||||
1497053|NCT01021501||Single Group Assignment||||None (Open Label)||||||
1497054|NCT01021488|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497055|NCT01021475|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497056|NCT01021462|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497057|NCT01021449|||Case Control||Prospective|||||||
1497058|NCT01021436||Single Group Assignment||Treatment||None (Open Label)||||||
1497059|NCT01021423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497060|NCT01021410|||Cohort||Prospective|||||||
1497061|NCT01021397|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1497062|NCT01021384|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1497063|NCT01021371|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1497064|NCT01021358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497065|NCT01021332||Single Group Assignment||Treatment||None (Open Label)||||||
1497066|NCT01021319|||Cohort||Cross-Sectional|||||||
1497067|NCT01021306|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497068|NCT01021293|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497069|NCT01021280|||Case Control||Prospective|||||||
1497070|NCT01021267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497071|NCT01021241||Single Group Assignment||Treatment||None (Open Label)||||||
1497072|NCT01021228|||Cohort||Retrospective|||||||
1497073|NCT01021215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497074|NCT01021202|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1497075|NCT01021189|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1497076|NCT01021176|Randomized|Single Group Assignment||Treatment||Single|||t|||
1497077|NCT01021163||Parallel Assignment||Treatment||||||||
1497078|NCT01021150||Single Group Assignment||Treatment||None (Open Label)||||||
1497079|NCT01021137|||Cohort||Cross-Sectional|||||||
1497080|NCT01021124|||Cohort||Prospective|||||||
1497081|NCT01021111||Single Group Assignment||Prevention||None (Open Label)||||||
1497082|NCT01021098|||Cohort||Prospective|||||||
1497083|NCT01021085|||Case Control||Cross-Sectional|||||||
1497084|NCT01021072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497085|NCT01021059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497086|NCT01021046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497087|NCT01021033|||Case-Only||Other|||||||
1497088|NCT01021020|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1497089|NCT01021007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497090|NCT01020994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497091|NCT01020981|||Cohort||Cross-Sectional|||||||
1497092|NCT01020968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497093|NCT01020955|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1497094|NCT01020942|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1497095|NCT01020929|||Cohort||Prospective|||||||
1497096|NCT01020916|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1497097|NCT01020903|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1497098|NCT01020890|||||Cross-Sectional|||||||
1497099|NCT01020877|Randomized|Crossover Assignment||||None (Open Label)||||||
1497100|NCT01020864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497101|NCT01020851|Randomized|Parallel Assignment||Prevention||Single||||||t
1497102|NCT01020838||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497103|NCT01020825|||||Prospective|||||||
1497104|NCT01020812||Single Group Assignment||Treatment||None (Open Label)||||||
1497105|NCT01020799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497106|NCT01020786||Single Group Assignment||Treatment||None (Open Label)||||||
1497107|NCT01020773|Randomized|Parallel Assignment||Treatment||||||||
1497108|NCT01020760|Randomized|Parallel Assignment||Treatment||Single||||||t
1497109|NCT01020747||Single Group Assignment||Treatment||None (Open Label)||||||
1497110|NCT01020734||Single Group Assignment||Treatment||None (Open Label)||||||
1497111|NCT01020721|||Family-Based||Prospective|||||||
1497112|NCT01020695|||Case Control||Retrospective|||||||
1497113|NCT01020682|||Cohort||Prospective|||||||
1497114|NCT01020669|||||Other|||||||
1497115|NCT01020656|||Cohort||Retrospective|||||||
1497116|NCT01020643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497117|NCT01020630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497118|NCT01020617|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1497119|NCT01020604|||Cohort||Prospective|||||||
1497120|NCT01020591|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1497121|NCT01020578|||Case Control||Cross-Sectional|||||||
1497122|NCT01020565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497123|NCT01020552|||||Cross-Sectional|||||||
1497124|NCT01020539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497125|NCT01020526|Non-Randomized|||Treatment||None (Open Label)||||||
1497126|NCT01020513|||Case-Only||Prospective|||||||
1497127|NCT01020500|||Cohort||Prospective|||||||
1497128|NCT01020474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497129|NCT01020461|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497130|NCT01020448||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497131|NCT01020435|Randomized|Parallel Assignment||Treatment||Single||||||t
1497132|NCT01020422|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1497133|NCT01020409|||Cohort||Prospective|||||||
1497134|NCT01020396|Randomized|Parallel Assignment||||Double||||||
1497135|NCT01020370|||Cohort||Prospective|||||||
1497136|NCT01020357|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497137|NCT01020344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497138|NCT01020331|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497139|NCT01020318|||||Prospective|||||||
1497140|NCT01020305||Single Group Assignment||Treatment||None (Open Label)||||||
1497141|NCT01020279|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497142|NCT01020266|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1497143|NCT01020253|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497144|NCT01020240|Randomized|Parallel Assignment||Prevention||Single|||t|||
1497145|NCT01020227|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1497146|NCT01020214|Randomized|Crossover Assignment||||None (Open Label)||||||
1497147|NCT01020201|||Cohort||Prospective|||||||
1497148|NCT01020188|||Case-Only||Prospective|||||||
1497149|NCT01020175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497150|NCT01020162|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497151|NCT01020149|||Cohort||Prospective|||||||
1497152|NCT01020136|Randomized|Crossover Assignment||||None (Open Label)||||||
1497153|NCT01020123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497154|NCT01020110|||Case Control||Prospective|||||||
1497155|NCT01020084|||||Cross-Sectional|||||||
1497156|NCT01020071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497157|NCT01020058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497158|NCT01020045|||Cohort||Cross-Sectional|||||||
1497159|NCT01020032|Randomized|Parallel Assignment||Treatment||Single||||||t
1497160|NCT01020019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497161|NCT01020006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497162|NCT01019993|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497163|NCT01019980|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497164|NCT01019967|||||Prospective|||||||
1497165|NCT01019941|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497166|NCT01019928|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1497167|NCT01019915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497168|NCT01019902|||Case-Only||Cross-Sectional|||||||
1497169|NCT01019889|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497170|NCT01019876|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497171|NCT01019863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497172|NCT01019850||Single Group Assignment||Treatment||None (Open Label)||||||
1497173|NCT01019837||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497174|NCT01019824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497175|NCT01019811||Single Group Assignment||Treatment||None (Open Label)||||||
1497176|NCT01019798||Single Group Assignment||Treatment||None (Open Label)||||||
1497177|NCT01019785|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497178|NCT01019772|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497179|NCT01019759|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497180|NCT01019746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497181|NCT01019733||Single Group Assignment||Treatment||None (Open Label)||||||
1497182|NCT01019707|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1497183|NCT01019694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497184|NCT01019681||Single Group Assignment||Treatment||None (Open Label)||||||
1497185|NCT01019668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497186|NCT01019655|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497187|NCT01019642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497188|NCT01019629|||Cohort||Other|||||||
1497189|NCT01019616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497190|NCT01019603|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1497191|NCT01019590|Randomized|Crossover Assignment||||None (Open Label)||||||
1497192|NCT01019577||Single Group Assignment||Treatment||None (Open Label)||||||
1497193|NCT01019564|Randomized|Parallel Assignment||Other||Double|||t||t|
1497194|NCT01019551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497195|NCT01019538|||Case-Only||Prospective|||||||
1497196|NCT01019525|||||Cross-Sectional|||||||
1497197|NCT01019499|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1497198|NCT01019486|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1497199|NCT01019473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497200|NCT01019460||Single Group Assignment||Diagnostic||Double|||t|t||
1497201|NCT01019447|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1497202|NCT01019434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497203|NCT01019421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497204|NCT01019408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497205|NCT01019395|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1497206|NCT01019382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497207|NCT01019369|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497208|NCT01019356|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1497209|NCT01019343|||||Prospective|||||||
1497210|NCT01019330|||Cohort||Prospective|||||||
1497211|NCT01019317||Single Group Assignment||Treatment||None (Open Label)||||||
1497212|NCT01019291|Randomized|||||Double|||t||t|
1497213|NCT01019265|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1497214|NCT01019252|Randomized|Crossover Assignment||Treatment||Single||||||t
1497215|NCT01019239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497216|NCT01019226|||Cohort||Retrospective|||||||
1497217|NCT01019213|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497218|NCT01019200|||Case Control||Cross-Sectional|||||||
1497219|NCT01019174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497220|NCT01019161|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497221|NCT01019148|||Case-Only||Prospective|||||||
1497222|NCT01019135|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1497223|NCT01019109|||Case-Only||Prospective|||||||
1497224|NCT01019096|||Case-Only||Prospective|||||||
1497225|NCT01019083|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1497226|NCT01019070|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1497227|NCT01019057|||Cohort||Prospective|||||||
1497228|NCT01019044|||Cohort||Prospective|||||||
1497229|NCT01019018|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1497230|NCT01019005|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1497231|NCT01018992|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1497232|NCT01018979|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497233|NCT01018966||Single Group Assignment||Treatment||None (Open Label)||||||
1497234|NCT01018953|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497235|NCT01018940|||Case-Crossover||Prospective|||||||
1497236|NCT01018927|||Other||Prospective|||||||
1497237|NCT01018914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497238|NCT01018888||Single Group Assignment||Treatment||None (Open Label)||||||
1497239|NCT01018862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497240|NCT01018849|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1497241|NCT01018836||Single Group Assignment||Treatment||None (Open Label)||||||
1497242|NCT01018823|Randomized|Parallel Assignment||Other||Double|||t||t|
1497243|NCT01018810|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1497244|NCT01018797||Single Group Assignment||Treatment||Single|||||t|
1497245|NCT01018784||Single Group Assignment||Treatment||None (Open Label)||||||
1497246|NCT01018771|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497247|NCT01018758||Single Group Assignment||Prevention||None (Open Label)||||||
1497248|NCT01018745||Single Group Assignment||Treatment||None (Open Label)||||||
1497249|NCT01018732|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497250|NCT01018719|||Case Control||Cross-Sectional|||||||
1497251|NCT01018706|||Cohort||Prospective|||||||
1497252|NCT01018693|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497253|NCT01018680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497254|NCT01018667|||Case Control||Prospective|||||||
1497255|NCT01018654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497256|NCT01020708|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497257|NCT01020487|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497258|NCT01020383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497259|NCT01020292||||||||||||
1497260|NCT01020097||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497261|NCT01019954||||Treatment||||||||
1497262|NCT01019512|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1497263|NCT01019278||Single Group Assignment||Treatment||None (Open Label)||||||
1497264|NCT01019187|Randomized|Factorial Assignment||Supportive Care||Double|||t||t|
1497265|NCT01019122|||Cohort||Prospective|||||||
1497266|NCT01018901||Single Group Assignment||||None (Open Label)||||||
1497267|NCT01018875|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497268|NCT01018641|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1497269|NCT01018628|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1497270|NCT01018615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497271|NCT01018602|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497272|NCT01018589||Single Group Assignment||Treatment||None (Open Label)||||||
1497273|NCT01018576||Single Group Assignment||Prevention||None (Open Label)||||||
1497274|NCT01018563||Single Group Assignment||Treatment||None (Open Label)||||||
1497275|NCT01018550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497276|NCT01018537|||Other||Prospective|||||||
1497277|NCT01018524|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1497278|NCT01018511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497279|NCT01018498||Single Group Assignment||Treatment||None (Open Label)||||||
1497280|NCT01018485|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1497281|NCT01018472|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1497282|NCT01018459|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1497283|NCT01018446||Single Group Assignment||Treatment||None (Open Label)||||||
1497284|NCT01018433|Randomized|Parallel Assignment||Treatment||Single||||||t
1497285|NCT01018420|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1497286|NCT01018407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497287|NCT01018394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497288|NCT01018381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497289|NCT01018368|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497290|NCT01018355|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497291|NCT01018342|Randomized|Crossover Assignment||||None (Open Label)||||||
1497292|NCT01018329||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497293|NCT01018316|||Cohort||Cross-Sectional|||||||
1497294|NCT01018303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497295|NCT01018290|||Case-Only||Prospective|||||||
1497296|NCT01018277|||Cohort||Prospective|||||||
1497297|NCT01018264|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497298|NCT01018251||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497299|NCT01018238|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1497300|NCT01018225||||||||||||
1497301|NCT01018212||Single Group Assignment||Treatment||None (Open Label)||||||
1497302|NCT01018199|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1497303|NCT01018186|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497304|NCT01018173|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497305|NCT01018160|||Case-Only||Prospective|||||||
1497306|NCT01018147||Single Group Assignment||||None (Open Label)||||||
1497307|NCT01018134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497308|NCT01018121|Randomized|Parallel Assignment||Treatment||Single||||||t
1497309|NCT01018108||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497310|NCT01018095|Randomized|Parallel Assignment||Treatment||Single|||||t|
1497311|NCT01018082|||Cohort||Prospective|||||||
1497312|NCT01018069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497313|NCT01018056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497314|NCT01018043|||Cohort||Prospective|||||||
1497315|NCT01018030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497316|NCT01018017|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1497317|NCT01018004||||||||||||
1497318|NCT01017991|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1497319|NCT01017978||Single Group Assignment||||None (Open Label)||||||
1497320|NCT01017965|||Case-Only||Prospective|||||||
1497321|NCT01017952|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497322|NCT01017939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497323|NCT01017926|Randomized|Crossover Assignment||||None (Open Label)||||||
1497324|NCT01017913|Randomized|Parallel Assignment||Treatment||Single||||||t
1497325|NCT01017900|Randomized|Parallel Assignment||Treatment||Single||||||t
1497326|NCT01017887|||Case Control||Prospective|||||||
1497327|NCT01017874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497328|NCT01017861|||Cohort||Prospective|||||||
1497329|NCT01017848|||Case-Only||Retrospective|||||||
1497330|NCT01017835|||Case Control||Prospective|||||||
1497331|NCT01017822||||Treatment||None (Open Label)||||||
1497332|NCT01017809||Single Group Assignment||Prevention||None (Open Label)||||||
1497333|NCT01017796|Randomized|Parallel Assignment||Prevention||Single|||||t|
1497334|NCT01017783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497335|NCT01017770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497336|NCT01017757|||Cohort||Prospective|||||||
1497337|NCT01017744|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1497338|NCT01017731||Single Group Assignment||||None (Open Label)||||||
1497339|NCT01017718|||Cohort||Prospective|||||||
1497340|NCT01017692|||Cohort||Prospective|||||||
1497341|NCT01017679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497342|NCT01017666|Randomized|Crossover Assignment||||Double|||t||t|
1497343|NCT01017653||Single Group Assignment||Treatment||None (Open Label)||||||
1497344|NCT01017640|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497345|NCT01017627|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1497346|NCT01017614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497347|NCT01017601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497348|NCT01017588|Randomized|Parallel Assignment||Prevention||Single||||||t
1497349|NCT01017575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497350|NCT01017562|||Case Control||Prospective|||||||
1497351|NCT01017549||Single Group Assignment||Treatment||None (Open Label)||||||
1497352|NCT01017536|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497353|NCT01017523|Randomized|Factorial Assignment||Treatment||Single||||||t
1497354|NCT01017510||Parallel Assignment||||None (Open Label)||||||
1497355|NCT01017497|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497356|NCT01017484|Randomized|Parallel Assignment||||Double|||t|||t
1497357|NCT01017471|Randomized|Parallel Assignment||Treatment||Single||||||t
1497358|NCT01017458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497359|NCT01017445|Randomized|Parallel Assignment||Treatment||Single||||||t
1497360|NCT01017432|||Ecologic or Community||Prospective|||||||
1497361|NCT01017419|||Cohort||Prospective|||||||
1497362|NCT01017406|Randomized|Parallel Assignment||Treatment||Single||||||t
1497363|NCT01017393|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1497364|NCT01017380|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1497365|NCT01017367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497366|NCT01017354|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497367|NCT01017341|Randomized|Parallel Assignment||Prevention||Single|||||t|
1497368|NCT01017328|||Case-Only||Prospective|||||||
1497369|NCT01017315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497370|NCT01017302|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497371|NCT01017289||Single Group Assignment||Treatment||None (Open Label)||||||
1497372|NCT01017276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497373|NCT01017263||Single Group Assignment||Treatment||None (Open Label)||||||
1497374|NCT01017250||Single Group Assignment||Treatment||None (Open Label)||||||
1497375|NCT01017237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497376|NCT01017224|||Cohort||Prospective|||||||
1497377|NCT01017211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497378|NCT01017198|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497379|NCT01017185||Single Group Assignment||Treatment||None (Open Label)||||||
1497380|NCT01017172|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1497381|NCT01017159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497382|NCT01017146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497383|NCT01017133||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497384|NCT01017120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497385|NCT01017107|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1497386|NCT01017094|Randomized|Parallel Assignment||Treatment||Single||||||t
1497387|NCT01017081|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1497388|NCT01017068|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497389|NCT01017055|||Cohort||Prospective|||||||
1497390|NCT01017042|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1497391|NCT01017029|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497392|NCT01017003|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1497393|NCT01016990||||Treatment||None (Open Label)||||||
1497394|NCT01016977|Randomized|Parallel Assignment||Treatment||Single|||||t|
1497395|NCT01016964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497396|NCT01016951|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1497397|NCT01016938|||||Prospective|||||||
1497398|NCT01016925|Randomized|Parallel Assignment||Prevention||Single||||||t
1497399|NCT01016912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497400|NCT01016899|||Cohort||Prospective|||||||
1497401|NCT01016886|Randomized|Single Group Assignment||Diagnostic||Double||||t|t|
1497402|NCT01016873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497403|NCT01016860||Single Group Assignment||Treatment||None (Open Label)||||||
1497404|NCT01016847|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1497405|NCT01016834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497406|NCT01016821||Single Group Assignment||Treatment||None (Open Label)||||||
1497407|NCT01016808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497408|NCT01016795|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497409|NCT01016782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497410|NCT01016769||Single Group Assignment||Treatment||None (Open Label)||||||
1497411|NCT01016756|||Family-Based||Prospective|||||||
1497412|NCT01016743|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497413|NCT01016730||Single Group Assignment||Treatment||None (Open Label)||||||
1497414|NCT01016717|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497415|NCT01016704|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1497416|NCT01016691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497417|NCT01016678|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1497418|NCT01016665|Randomized|||Basic Science||Double||||||
1497419|NCT01016652|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497420|NCT01016639|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497421|NCT01016626|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497422|NCT01016613|||Cohort||Prospective|||||||
1497423|NCT01016600|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497424|NCT01016587|||Cohort||Prospective|||||||
1497425|NCT01016574|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497426|NCT01016561||Single Group Assignment||Treatment||None (Open Label)||||||
1497427|NCT01016548|Randomized|Single Group Assignment||||None (Open Label)||||||
1497428|NCT01016535|||Case-Crossover||Cross-Sectional|||||||
1497429|NCT01016522||Single Group Assignment||Treatment||None (Open Label)||||||
1497430|NCT01016509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497431|NCT01016496|Randomized|Parallel Assignment||Treatment||Double||||t||t
1497432|NCT01016483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497433|NCT01016470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497434|NCT01016457|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1497435|NCT01016444|||Case Control||Prospective|||||||
1497436|NCT01016431|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497437|NCT01016418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497438|NCT01016405|||Case-Only||Prospective|||||||
1497439|NCT01016392|||Cohort||Prospective|||||||
1497440|NCT01016379|||Case-Only||Retrospective|||||||
1497441|NCT01016366|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497442|NCT01016353|||Case-Control||Prospective|||||||
1497443|NCT01016340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497444|NCT01016327||Single Group Assignment||Treatment||None (Open Label)||||||
1497445|NCT01016314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497446|NCT01016301|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1497447|NCT01016288|||Case Control||Prospective|||||||
1497448|NCT01016275|||Cohort||Prospective|||||||
1497449|NCT01016262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497450|NCT01016249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497451|NCT01016236||||||||||||
1497452|NCT01016223|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1497453|NCT01016210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497454|NCT01016197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497455|NCT01016184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497456|NCT01016158|Randomized|Parallel Assignment||Treatment||Single||||||t
1497457|NCT01016145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497458|NCT01016132||Single Group Assignment||Treatment||Double|||t||t|
1497459|NCT01016119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497460|NCT01016106|Non-Randomized|Single Group Assignment||Diagnostic||Double|||t|||t
1497461|NCT01016093|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497462|NCT01016080|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1497463|NCT01016067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497464|NCT01016054|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497465|NCT01016041|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497466|NCT01016028|||Case-Only||Prospective|||||||
1497467|NCT01016015||Single Group Assignment||Treatment||None (Open Label)||||||
1497468|NCT01016002||Single Group Assignment||Treatment||None (Open Label)||||||
1497469|NCT01015989|Randomized|Parallel Assignment||Health Services Research||Single|The CARE Kenya counseling tool software randomizes the participant automatically to the control or intervention arms when the user first logs into the program, using a quasi-random number algorithm.||t|||
1497470|NCT01015976|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1497471|NCT01015963|||Case-Only||Retrospective|||||||
1497472|NCT01015950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497473|NCT01015937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497474|NCT01015924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497475|NCT01015911||Single Group Assignment||Treatment||None (Open Label)||||||
1497476|NCT01015898|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497477|NCT01015872||Single Group Assignment||Treatment||None (Open Label)||||||
1497478|NCT01015859|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497479|NCT01015846|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1497480|NCT01015833|Randomized|Parallel Assignment||Treatment||Single|||||t|
1497481|NCT01015820|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1497482|NCT01015807|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1497483|NCT01015794|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1497484|NCT01015781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497485|NCT01015768|Randomized|Single Group Assignment||Diagnostic||Triple|||t||t|t
1497486|NCT01015755|Randomized|Single Group Assignment||Treatment||Single|||||t|
1497487|NCT01015742||Single Group Assignment||Treatment||None (Open Label)||||||
1497488|NCT01015729|Randomized|Crossover Assignment||||None (Open Label)||||||
1497489|NCT01015716|Randomized|Parallel Assignment||Prevention||Single||||||t
1497490|NCT01015703||Single Group Assignment||Basic Science||None (Open Label)||||||
1497491|NCT01015690|||Case Control||Prospective|||||||
1497492|NCT01015677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497493|NCT01015664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497494|NCT01015651|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1497495|NCT01015638|Randomized|Parallel Assignment||Treatment||Single|||||t|
1497496|NCT01015625|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497497|NCT01015612||Single Group Assignment||Treatment||None (Open Label)||||||
1497498|NCT01015599|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497499|NCT01015586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497500|NCT01015573||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497501|NCT01015560||Single Group Assignment||Treatment||None (Open Label)||||||
1497502|NCT01015547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497503|NCT01015534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497504|NCT01015521|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497505|NCT01015508|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1497506|NCT01015495||Single Group Assignment||Treatment||None (Open Label)||||||
1497507|NCT01015482|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1497508|NCT01015469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497509|NCT01015456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497510|NCT01015443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497511|NCT01015430|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497512|NCT01015417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497513|NCT01015404|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497514|NCT01015391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497515|NCT01015378|||Cohort||Prospective|||||||
1497516|NCT01015365||Single Group Assignment||Treatment||None (Open Label)||||||
1497517|NCT01015352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497518|NCT01015339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497519|NCT01015326|||Cohort||Prospective|||||||
1497520|NCT01015313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497521|NCT01015300||Single Group Assignment||Treatment||None (Open Label)||||||
1497522|NCT01015287|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497523|NCT01015274|||Cohort||Prospective|||||||
1497524|NCT01015261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497525|NCT01015248||Single Group Assignment||Treatment||None (Open Label)||||||
1497526|NCT01015235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497527|NCT01015222||Single Group Assignment||Treatment||None (Open Label)||||||
1497528|NCT01015209|Randomized|Single Group Assignment||Basic Science||Single|||||t|
1497529|NCT01015196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497530|NCT01015183|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497531|NCT01015170||Single Group Assignment||Treatment||None (Open Label)||||||
1497532|NCT01015157|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497533|NCT01015144|||Cohort||Prospective|||||||
1497534|NCT01015131||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497535|NCT01015118|Randomized|Parallel Assignment||Treatment||Double||||||
1497536|NCT01015105|||Case-Only||Prospective|||||||
1497537|NCT01015092|||Cohort||Cross-Sectional|||||||
1497538|NCT01015079|||Cohort||Retrospective|||||||
1497539|NCT01015066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497540|NCT01015053|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1497541|NCT01015040|Randomized|Crossover Assignment||||None (Open Label)||||||
1497542|NCT01015027|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1497543|NCT01015014|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497544|NCT01015001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497545|NCT01014988||Single Group Assignment||Treatment||None (Open Label)||||||
1497546|NCT01014975|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497547|NCT01014962|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1497548|NCT01014949||Parallel Assignment||Diagnostic||None (Open Label)||||||
1497549|NCT01014936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497550|NCT01014923|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1497551|NCT01014910|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1497552|NCT01014897|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1497553|NCT01014884||||||||||||
1497554|NCT01014871|Randomized|Single Group Assignment||Treatment||Single||||||t
1497555|NCT01014858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497556|NCT01014845|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497557|NCT01014832||Single Group Assignment||Treatment||None (Open Label)||||||
1497558|NCT01014819|||Cohort||Cross-Sectional|||||||
1497559|NCT01014806|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497560|NCT01014793|||Case-Only||Prospective|||||||
1497561|NCT01014780|||||Cross-Sectional|||||||
1497562|NCT01014767|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497563|NCT01014754|||Case Control|||||||||
1497564|NCT01014741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497565|NCT01014728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497566|NCT01014715||Single Group Assignment||Prevention||None (Open Label)||||||
1497567|NCT01014702|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497568|NCT01014689|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1497569|NCT01014676||||||||||||
1497570|NCT01014663|Randomized|Parallel Assignment||Treatment||Single||||||t
1497571|NCT01014650|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1497572|NCT01014637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497573|NCT01014624|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1497574|NCT01014611|||Cohort||Prospective|||||||
1497575|NCT01014598||Single Group Assignment||Treatment||None (Open Label)||||||
1497576|NCT01014585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497577|NCT01014572|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497578|NCT01014559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497579|NCT01014546||Single Group Assignment||Treatment||None (Open Label)||||||
1497580|NCT01014533|Randomized|Parallel Assignment||Other||Double|||t||t|
1497581|NCT01014520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497582|NCT01014507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497583|NCT01014494|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1497584|NCT01014481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497585|NCT01014468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497586|NCT01014455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497587|NCT01014442|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497588|NCT01014429||Single Group Assignment||Treatment||None (Open Label)||||||
1497589|NCT01014416|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1497590|NCT01014403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497591|NCT01014390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497592|NCT01014377||Single Group Assignment||Treatment||None (Open Label)||||||
1497593|NCT01014364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497594|NCT01014351||Single Group Assignment||Treatment||None (Open Label)||||||
1497595|NCT01014338|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497596|NCT01014325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497597|NCT01014312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497598|NCT01014299|Randomized|Parallel Assignment||||Single|||t|||
1497599|NCT01014286|||Other||Retrospective|||||||
1497600|NCT01014273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497601|NCT01014260|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1497602|NCT01014247|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1497603|NCT01014234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497604|NCT01014221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497605|NCT01014208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497606|NCT01014195|||Case-Only||Prospective|||||||
1497607|NCT01014182||||||||||||
1497608|NCT01014169|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1497609|NCT01014156|Randomized|Parallel Assignment||Treatment||Single||||||t
1497610|NCT01014143|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497611|NCT01014130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497612|NCT01014117|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1497613|NCT01014104|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497614|NCT01014091|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1497615|NCT01014078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497616|NCT01014065|||Cohort||Prospective|||||||
1497617|NCT01014052||Single Group Assignment||Treatment||None (Open Label)||||||
1497618|NCT01014039|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497619|NCT01014026|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1497620|NCT01014013|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497621|NCT01014000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497622|NCT01013987||Single Group Assignment||Treatment||None (Open Label)||||||
1497623|NCT01013974|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1497698|NCT01012986|||Cohort||Cross-Sectional|||||||
1497624|NCT01013961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497625|NCT01013948|||||Cross-Sectional|||||||
1497626|NCT01013935|Randomized|Crossover Assignment||Prevention||Single|||t|||
1497627|NCT01013922||||||||||||
1497628|NCT01013909|Randomized|Parallel Assignment||Treatment||Single|||||t|
1497629|NCT01013896|Randomized|Parallel Assignment||||Single|||t|||
1497630|NCT01013883|||Cohort||Retrospective|||||||
1497631|NCT01013870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497632|NCT01013857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497633|NCT01013844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497634|NCT01013831||Single Group Assignment||Prevention||None (Open Label)||||||
1497635|NCT01013818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497636|NCT01013805||Single Group Assignment||Treatment||None (Open Label)||||||
1497637|NCT01013792|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497638|NCT01013779||Single Group Assignment||Treatment||None (Open Label)||||||
1497639|NCT01013766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497640|NCT01013753|Randomized|Crossover Assignment||Treatment||Double||||||
1497641|NCT01013740|Randomized|Crossover Assignment||Treatment||None (Open Label)||After disease progression in the Randomized Phase (in which participants received lapatinib plus vinorelbine), participants were given the option of crossing over to the alternative treatment arm (lapatinib plus capecitabine), and continuing in a post-progression Cross-over Phase.||||
1497642|NCT01013727|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1497643|NCT01013714|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497644|NCT01013701|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497645|NCT01013688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497646|NCT01013675|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497647|NCT01013662|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1497648|NCT01013649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497649|NCT01013636|||Case-Only||Prospective|||||||
1497650|NCT01013623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497651|NCT01013610|Randomized|Parallel Assignment||||Double|||t||t|
1497652|NCT01013597||Single Group Assignment||Treatment||None (Open Label)||||||
1497653|NCT01013584|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497654|NCT01013571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497655|NCT01013558|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1497656|NCT01013545|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1497657|NCT01013532|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1497658|NCT01013506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497659|NCT01013493|||Case Control||Retrospective|||||||
1497660|NCT01013480||Single Group Assignment||Treatment||None (Open Label)||||||
1497661|NCT01013467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497662|NCT01013454|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1497663|NCT01013441||Single Group Assignment||Treatment||None (Open Label)||||||
1497664|NCT01013428|||Cohort||Prospective|||||||
1497665|NCT01013415|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497666|NCT01013402||Single Group Assignment||Health Services Research||None (Open Label)||||||
1497667|NCT01013389|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497668|NCT01013376|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497669|NCT01013363|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497670|NCT01013350|||Other||Prospective|||||||
1497671|NCT01013337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497672|NCT01013324||Single Group Assignment||Treatment||None (Open Label)||||||
1497673|NCT01013311|||Cohort||Retrospective|||||||
1497674|NCT01013298||Single Group Assignment||Supportive Care||Single||||||t
1497675|NCT01013285||Single Group Assignment||Treatment||None (Open Label)||||||
1497676|NCT01013272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497677|NCT01013259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497678|NCT01013246|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1497679|NCT01013233|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497680|NCT01013220|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1497681|NCT01013207|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497682|NCT01013194|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497683|NCT01013181|||Cohort||Retrospective|||||||
1497684|NCT01013168||Single Group Assignment||Treatment||None (Open Label)||||||
1497685|NCT01013155|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497686|NCT01013142|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1497687|NCT01013129|||Case Control||Prospective|||||||
1497688|NCT01013116|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497689|NCT01013103|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1497690|NCT01013090|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1497691|NCT01013077|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1497692|NCT01013064|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1497693|NCT01013051|||Case Control||Prospective|||||||
1497694|NCT01013038|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497695|NCT01013025|||Cohort||Cross-Sectional|||||||
1497696|NCT01013012|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497697|NCT01012999||Single Group Assignment||Treatment||None (Open Label)||||||
1497699|NCT01012973|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1497700|NCT01012960|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1497701|NCT01012947|Randomized|Parallel Assignment||Prevention||Single|||t|||
1497702|NCT01012934|Randomized|Crossover Assignment||||None (Open Label)||||||
1497703|NCT01012921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497704|NCT01012908|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497705|NCT01012895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497706|NCT01012882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497707|NCT01012869||Single Group Assignment||Treatment||None (Open Label)||||||
1497708|NCT01012856|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497709|NCT01012843|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1497710|NCT01012830||Single Group Assignment||Treatment||None (Open Label)||||||
1497711|NCT01012817||Single Group Assignment||Treatment||None (Open Label)||||||
1497712|NCT01012804|||Case-Only||Prospective|||||||
1497713|NCT01012791|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497714|NCT01012778||Single Group Assignment||Treatment||None (Open Label)||||||
1497715|NCT01012765|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1497716|NCT01012752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497717|NCT01012739|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497718|NCT01012726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497719|NCT01012713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497720|NCT01012700|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1497721|NCT01012687|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497722|NCT01012674||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497723|NCT01012661|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497724|NCT01012648|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1497725|NCT01012635|||Cohort||Prospective|||||||
1497726|NCT01012622||Single Group Assignment||Treatment||None (Open Label)||||||
1497727|NCT01012609|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497728|NCT01012596|||Cohort||Prospective|||||||
1497729|NCT01012583|||Case Control||Prospective|||||||
1497730|NCT01012570|||Case Control||Prospective|||||||
1497731|NCT01012557|Randomized|Parallel Assignment||Prevention||Single|||t|||
1497732|NCT01012544|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1497733|NCT01012531|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497734|NCT01012518|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1497735|NCT01012505|||Cohort||Prospective|||||||
1497736|NCT01012492||Single Group Assignment||Treatment||None (Open Label)||||||
1497737|NCT01012479||Single Group Assignment||Treatment||None (Open Label)||||||
1497738|NCT01012466|||Cohort||Prospective|||||||
1497739|NCT01012453|Randomized|Parallel Assignment||Prevention||Single||||||t
1497740|NCT01012440||Single Group Assignment||Treatment||None (Open Label)||||||
1497741|NCT01012427||Single Group Assignment||Treatment||None (Open Label)||||||
1497742|NCT01012414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497743|NCT01012401|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1497744|NCT01012388||Single Group Assignment||Treatment||None (Open Label)||||||
1497745|NCT01012375|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497746|NCT01012362|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1497747|NCT01012349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497748|NCT01012336||Single Group Assignment||Treatment||None (Open Label)||||||
1497749|NCT01012323||Single Group Assignment||Treatment||None (Open Label)||||||
1497750|NCT01012310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497751|NCT01012297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497752|NCT01012284|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497753|NCT01012271|||Case-Only||Prospective|||||||
1497754|NCT01012258||Single Group Assignment||Treatment||None (Open Label)||||||
1497755|NCT01012245|||Cohort||Prospective|||||||
1497756|NCT01012232|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1497757|NCT01012219|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1497758|NCT01012206|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497759|NCT01012193|Randomized|Parallel Assignment||Treatment||Single|||||t|
1497760|NCT01012180|||||Other|||||||
1497761|NCT01012167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497762|NCT01012154||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497763|NCT01012141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497764|NCT01012128|||||Prospective|||||||
1497765|NCT01012115|||Cohort||Prospective|||||||
1497766|NCT01012102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497767|NCT01012089||Single Group Assignment||Other||None (Open Label)||||||
1497768|NCT01012076|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1497769|NCT01012063|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497770|NCT01012050|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1497771|NCT01012037|Randomized|Parallel Assignment||Treatment||Double||||||
1497772|NCT01012011|||Cohort||Prospective|||||||
1497773|NCT01011998||Single Group Assignment||Treatment||None (Open Label)||||||
1497774|NCT01011985|||Cohort||Prospective|||||||
1497775|NCT01011972||Single Group Assignment||Treatment||None (Open Label)||||||
1497776|NCT01011959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497777|NCT01011946||Single Group Assignment||||None (Open Label)||||||
1497778|NCT01011933||Single Group Assignment||Treatment||None (Open Label)||||||
1497779|NCT01011920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497780|NCT01011907|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1497781|NCT01011894||Single Group Assignment||Treatment||None (Open Label)||||||
1497782|NCT01011881|||Cohort||Prospective|||||||
1497783|NCT01011868|Randomized|Parallel Assignment||Treatment||Double||||||
1497784|NCT01011855|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1497785|NCT01011842||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497786|NCT01011829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497787|NCT01011816|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1497788|NCT01011803||Single Group Assignment||Screening||Double||||t||t
1497789|NCT01011790||Single Group Assignment||Treatment||None (Open Label)||||||
1497790|NCT01011777||Single Group Assignment||Treatment||None (Open Label)||||||
1497791|NCT01011764|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1497792|NCT01011751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497793|NCT01011738|||Cohort||Prospective|||||||
1497794|NCT01011725|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497795|NCT01011712|||Case-Only||Prospective|||||||
1497796|NCT01011699|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1497797|NCT01011686||||||||||||
1497798|NCT01011673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497799|NCT01011660|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1497800|NCT01011647|||Cohort||Prospective|||||||
1497801|NCT01011634|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497802|NCT01011621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497803|NCT01011608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497804|NCT01011595||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497805|NCT01011582|||Cohort||Prospective|||||||
1497806|NCT01011569|||Cohort||Prospective|||||||
1497807|NCT01011556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497808|NCT01011543|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1497809|NCT01011530||Single Group Assignment||Treatment||None (Open Label)||||||
1497810|NCT01011517|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1497811|NCT01011504|||Case-Only||Prospective|||||||
1497812|NCT01011491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497813|NCT01011478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497814|NCT01011465|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1497815|NCT01011452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497816|NCT01011439||Single Group Assignment||Treatment||None (Open Label)||||||
1497817|NCT01011426|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497818|NCT01011413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497819|NCT01011400|||Case-Only||Prospective|||||||
1497820|NCT01011387||Single Group Assignment||Treatment||None (Open Label)||||||
1497821|NCT01011374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497822|NCT01011361|||Cohort||Prospective|||||||
1497823|NCT01011348|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1497824|NCT01011335|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497825|NCT01011322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497826|NCT01011309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497827|NCT01011296|Randomized|Parallel Assignment||Other||Double|||t||t|
1497828|NCT01011283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497829|NCT01011270|||Case Control||Retrospective|||||||
1497830|NCT01011257|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497831|NCT01011244||Single Group Assignment||Treatment||None (Open Label)||||||
1497832|NCT01011231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497833|NCT01011218|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1497834|NCT01011205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497835|NCT01011192|||Cohort||Prospective|||||||
1497836|NCT01011179|Randomized|Parallel Assignment||Treatment||Single||||||t
1497837|NCT01011166|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1497838|NCT01011153|||Cohort||Cross-Sectional|||||||
1497839|NCT01011140|||Other||Prospective|||||||
1497840|NCT01011127|||Case Control||Prospective|||||||
1497841|NCT01011114|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497842|NCT01011101|||Case-Control||Prospective|||||||
1497843|NCT01011088|||Case-Only||Prospective|||||||
1497844|NCT01011075||Single Group Assignment||Treatment||None (Open Label)||||||
1497845|NCT01011062|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1497846|NCT01011049|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497847|NCT01011036|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1497848|NCT01011023|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497849|NCT01011010||Single Group Assignment||Treatment||None (Open Label)||||||
1497850|NCT01010997|||Cohort||Prospective|||||||
1497851|NCT01010984||Single Group Assignment||Treatment||None (Open Label)||||||
1497852|NCT01010971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497853|NCT01010958||Single Group Assignment||Treatment||None (Open Label)||||||
1497854|NCT01010945||Single Group Assignment||Treatment||None (Open Label)||||||
1497855|NCT01010932||Single Group Assignment||Diagnostic||None (Open Label)||||||
1497856|NCT01010919||||||||||||
1497857|NCT01010906|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497858|NCT01010893|Randomized|Parallel Assignment||Prevention||Single|||t|||
1497859|NCT01010880||Single Group Assignment||Treatment||None (Open Label)||||||
1497860|NCT01010867||Single Group Assignment||Supportive Care||None (Open Label)||||||
1497861|NCT01010854||Single Group Assignment||Treatment||None (Open Label)||||||
1497862|NCT01010841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497863|NCT01010828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497864|NCT01010815|||Case Control||Prospective|||||||
1497865|NCT01010802||Single Group Assignment||Prevention||None (Open Label)||||||
1497866|NCT01010789|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1497867|NCT01010776||Single Group Assignment||Treatment||None (Open Label)||||||
1497868|NCT01010763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497869|NCT01010750|Randomized|Crossover Assignment||||Triple|||t||t|t
1497870|NCT01010737|Randomized|Parallel Assignment||Prevention||Single|||t|||
1497871|NCT01010724||||||||||||
1497872|NCT01010711||Single Group Assignment||Treatment||None (Open Label)||||||
1497873|NCT01010698|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1497874|NCT01010685||Single Group Assignment||Treatment||None (Open Label)||||||
1497875|NCT01010672||Single Group Assignment||Treatment||None (Open Label)||||||
1497876|NCT01010659||Single Group Assignment||Treatment||None (Open Label)||||||
1497877|NCT01010646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497878|NCT01010633|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497879|NCT01010620|||Other||Prospective|||||||
1497880|NCT01010607|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1497881|NCT01010594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497882|NCT01010581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497883|NCT01010568||Single Group Assignment||Treatment||None (Open Label)||||||
1497884|NCT01010555|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1497885|NCT01010542|Randomized|Single Group Assignment||Treatment||Single|||t|||
1497886|NCT01010529|Randomized|Parallel Assignment||Treatment||Single||||||t
1497887|NCT01010516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497888|NCT01010503||Single Group Assignment||Treatment||None (Open Label)||||||
1497889|NCT01010490|Randomized|Parallel Assignment||Treatment||Single||||||t
1497890|NCT01010477|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497891|NCT01010464|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497892|NCT01010451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497893|NCT01010438|||||Retrospective|||||||
1497894|NCT01010425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497895|NCT01010412|Randomized|Single Group Assignment||Treatment||Single|||||t|
1497896|NCT01010399||Single Group Assignment||Treatment||None (Open Label)||||||
1497897|NCT01010386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497898|NCT01010373||Single Group Assignment||Treatment||None (Open Label)||||||
1497899|NCT01010360||||||||||||
1497900|NCT01010347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497901|NCT01010334|Randomized|Single Group Assignment||||None (Open Label)||||||
1497902|NCT01010321|||Case-Only||Prospective|||||||
1497903|NCT01010308|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497904|NCT01010295||Single Group Assignment||Treatment||None (Open Label)||||||
1497905|NCT01010282|Randomized|Parallel Assignment||||Double|||t||t|
1497906|NCT01010269|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497907|NCT01010256|||Case-Control||Prospective|||||||
1497908|NCT01010243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497909|NCT01010230|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497910|NCT01010217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497911|NCT01010204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497912|NCT01010191|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497913|NCT01010178||Single Group Assignment||Treatment||Single||||||t
1497914|NCT01010165|||Cohort||Prospective|||||||
1497915|NCT01010152|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497916|NCT01010139|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497917|NCT01010126||Single Group Assignment||Treatment||None (Open Label)||||||
1497918|NCT01010113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497919|NCT01010100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497920|NCT01010087|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1497921|NCT01010074|||Case Control||Cross-Sectional|||||||
1497922|NCT01010061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497923|NCT01010048|Randomized|Parallel Assignment||Treatment||Single||||||t
1497924|NCT01010035|||Case Control||Cross-Sectional|||||||
1497925|NCT01010022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497926|NCT01010009|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1497927|NCT01009996|||Cohort||Prospective|||||||
1497928|NCT01009983||Single Group Assignment||Treatment||None (Open Label)||||||
1497929|NCT01009970||Single Group Assignment||Treatment||None (Open Label)||||||
1497930|NCT01009957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497931|NCT01009944||Single Group Assignment||Treatment||None (Open Label)||||||
1497932|NCT01009931||Single Group Assignment||Treatment||None (Open Label)||||||
1497933|NCT01009918|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1497934|NCT01009905|||Case-Only||Prospective|||||||
1497935|NCT01009892|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497936|NCT01009879||Single Group Assignment||Basic Science||None (Open Label)||||||
1497937|NCT01009866||Single Group Assignment||Treatment||None (Open Label)||||||
1497938|NCT01009853||Single Group Assignment||Treatment||None (Open Label)||||||
1497939|NCT01009840||Single Group Assignment||Treatment||None (Open Label)||||||
1497940|NCT01009827|||Cohort||Cross-Sectional|||||||
1497941|NCT01009814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497942|NCT01009801|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497943|NCT01009788||Single Group Assignment||Treatment||None (Open Label)||||||
1497944|NCT01009775||Single Group Assignment||Treatment||None (Open Label)||||||
1497945|NCT01009762|Randomized|Parallel Assignment||Treatment||Single|||t|||
1497946|NCT01009749|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1497947|NCT01009736||Single Group Assignment||Treatment||None (Open Label)||||||
1497948|NCT01009723|||Case Control||Prospective|||||||
1497949|NCT01009710|||Case-Only||Prospective|||||||
1497950|NCT01009697|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1497951|NCT01009684|||Cohort||Prospective|||||||
1497952|NCT01009671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497953|NCT01009658|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1497954|NCT01009645|Randomized|Parallel Assignment||Prevention||Single|||t|||
1497955|NCT01009632|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1497956|NCT01009619|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1497957|NCT01009606|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497958|NCT01009593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497959|NCT01009580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497960|NCT01009567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1497961|NCT01009554|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1497962|NCT01009541|Randomized|Crossover Assignment||||None (Open Label)||||||
1497963|NCT01009528|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1497964|NCT01009515||Single Group Assignment||Treatment||None (Open Label)||||||
1497965|NCT01009502||Single Group Assignment||Treatment||None (Open Label)||||||
1497966|NCT01009476|||||Prospective|||||||
1497967|NCT01009463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497968|NCT01009450|Randomized|Single Group Assignment||Treatment||Single|||t|||
1497969|NCT01009437|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1497970|NCT01009424|Randomized|Crossover Assignment||Treatment||Double||||||
1497971|NCT01009411|||Cohort||Cross-Sectional|||||||
1497972|NCT01009398|||Case-Only||Prospective|||||||
1497973|NCT01009385|Randomized|Parallel Assignment||||None (Open Label)||||||
1497974|NCT01009372|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1497975|NCT01009359|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1497976|NCT01009346||Single Group Assignment||Treatment||None (Open Label)||||||
1497977|NCT01009333|Randomized|Crossover Assignment||||Single|||t|||
1497978|NCT01009320|||Cohort||Cross-Sectional|||||||
1497979|NCT01009307||||||||||||
1497980|NCT01009294||Single Group Assignment||Treatment||None (Open Label)||||||
1497981|NCT01009281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497982|NCT01009268|Randomized|Parallel Assignment||Treatment||Single||||||t
1497983|NCT01009255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497984|NCT01009242|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1497985|NCT01009229||Single Group Assignment||Treatment||None (Open Label)||||||
1497986|NCT01009216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1497987|NCT01009203||Single Group Assignment||Treatment||None (Open Label)||||||
1497988|NCT01009190|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497989|NCT01009177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497990|NCT01009151||Single Group Assignment||Prevention||None (Open Label)||||||
1497991|NCT01009138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497992|NCT01009125|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1497993|NCT01009112|Randomized|Parallel Assignment||Treatment||Single||||||t
1497994|NCT01009099|Randomized|Parallel Assignment||Treatment||Single||||||t
1497995|NCT01009086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1497996|NCT01009073|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1497997|NCT01009060|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1497998|NCT01009047|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1497999|NCT01009034|||Cohort||Prospective|||||||
1498000|NCT01009021|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1498001|NCT01009008||Single Group Assignment||Treatment||None (Open Label)||||||
1498002|NCT01008995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498003|NCT01008982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498004|NCT01008969||Single Group Assignment||Diagnostic||None (Open Label)||||||
1498005|NCT01008956|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498006|NCT01008943||Single Group Assignment||Treatment||None (Open Label)||||||
1498007|NCT01008930||Single Group Assignment||Screening||None (Open Label)||||||
1498008|NCT01008917||Single Group Assignment||Treatment||None (Open Label)||||||
1498009|NCT01008904||Single Group Assignment||Supportive Care||None (Open Label)||||||
1498010|NCT01008878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498011|NCT01008865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498012|NCT01008852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498013|NCT01008839||||||||||||
1498014|NCT01008826|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1498015|NCT01008813|Randomized|Parallel Assignment||Prevention||Single|||t|||
1498016|NCT01008800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498017|NCT01008787|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1498018|NCT01008774|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498019|NCT01008761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498020|NCT01008748||Single Group Assignment||Treatment||None (Open Label)||||||
1498021|NCT01008735|||Cohort||Retrospective|||||||
1498022|NCT01008722|||Cohort||Prospective|||||||
1498023|NCT01008709|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1498024|NCT01008696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498025|NCT01008683|||||Prospective|||||||
1498026|NCT01008670|||Case-Only||Prospective|||||||
1498027|NCT01008657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498028|NCT01008644|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1498029|NCT01008631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498030|NCT01008618|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498031|NCT01008605|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1498032|NCT01008592|||Case-Crossover||Cross-Sectional|||||||
1498033|NCT01008579|||Cohort||Prospective|||||||
1498034|NCT01008566||Single Group Assignment||Treatment||None (Open Label)||||||
1498035|NCT01008553|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498036|NCT01008540||Single Group Assignment||Prevention||None (Open Label)||||||
1498037|NCT01008527||Single Group Assignment||Treatment||None (Open Label)||||||
1498038|NCT01008514||Single Group Assignment||Treatment||None (Open Label)||||||
1498039|NCT01008501|||Other||Prospective|||||||
1498040|NCT01008488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498041|NCT01008475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498042|NCT01008462||Single Group Assignment||Treatment||None (Open Label)||||||
1498043|NCT01008449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498044|NCT01008436|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498045|NCT01008423|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498046|NCT01008410|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498047|NCT01008397||Single Group Assignment||Treatment||None (Open Label)||||||
1498048|NCT01008384|Randomized|Single Group Assignment||||Double|||t||t|
1498049|NCT01008371|||Case Control||Cross-Sectional|||||||
1498050|NCT01008345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498051|NCT01008332|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498052|NCT01008319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498053|NCT01008306|||Cohort||Cross-Sectional|||||||
1498054|NCT01008293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498055|NCT01008280|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498056|NCT01008267|||Case Control||Prospective|||||||
1498057|NCT01008254|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1498058|NCT01008241|||||Cross-Sectional|||||||
1498059|NCT01008228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498060|NCT01008215|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498061|NCT01008202||||||||||||
1498062|NCT01008176||Parallel Assignment||Treatment||Single|||t|||
1498063|NCT01008150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498064|NCT01008137|Randomized|Parallel Assignment||Prevention||Single||||t||
1498065|NCT01008124|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1498066|NCT01008111|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1498067|NCT01008098||Single Group Assignment||Treatment||None (Open Label)||||||
1498068|NCT01008085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498069|NCT01008072|||Case Control||Retrospective|||||||
1498070|NCT01008059|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1498071|NCT01008046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498072|NCT01008033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498073|NCT01008020|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1498074|NCT01008007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498075|NCT01007994|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498076|NCT01007981|||Cohort||Prospective|||||||
1498077|NCT01007968||Single Group Assignment||||None (Open Label)||||||
1498078|NCT01007955|||Cohort||Prospective|||||||
1498079|NCT01007929||Single Group Assignment||Treatment||None (Open Label)||||||
1498080|NCT01007916|Randomized|Crossover Assignment||Treatment||Single|||t|||
1498081|NCT01007903|Randomized|Parallel Assignment||Treatment||Single||||||t
1498082|NCT01007890|||Cohort||Prospective|||||||
1498083|NCT01008358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498084|NCT01008189|Randomized|Parallel Assignment||Prevention||Single||||||t
1498085|NCT01008163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498086|NCT01007942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498087|NCT01007877|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1498088|NCT01007864|Randomized|Parallel Assignment||Treatment||Single||||||t
1498089|NCT01007851||||||||||||
1498090|NCT01007838|Randomized|Parallel Assignment||Treatment||Single||||||t
1498091|NCT01007812|Randomized|Crossover Assignment||Treatment||Single|||t|||
1498092|NCT01007799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498093|NCT01007786|||Cohort||Prospective|||||||
1498094|NCT01007773|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1498095|NCT01007760|Non-Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1498096|NCT01007747|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498097|NCT01007734|||Cohort||Cross-Sectional|||||||
1498098|NCT01007721|Randomized|Crossover Assignment||Treatment||Double||||||
1498099|NCT01007708|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498100|NCT01007695||Single Group Assignment||Treatment||None (Open Label)||||||
1498101|NCT01007682|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1498102|NCT01007669|Randomized|Parallel Assignment||Basic Science||Single||||||t
1498103|NCT01007656||Single Group Assignment||||None (Open Label)||||||
1498104|NCT01007643|Randomized|Parallel Assignment||Treatment||Single|||||t|
1498105|NCT01007630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498106|NCT01007617|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1498107|NCT01007604|Randomized|Parallel Assignment||Treatment||Single||||||t
1498108|NCT01007591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498109|NCT01007578||Single Group Assignment||Treatment||None (Open Label)||||||
1498110|NCT01007565|Randomized|Parallel Assignment||Treatment||Double||||||
1498111|NCT01007552||Single Group Assignment||Treatment||None (Open Label)||||||
1498112|NCT01007539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498113|NCT01007526||Single Group Assignment||Treatment||None (Open Label)||||||
1498114|NCT01007513|||Cohort||Prospective|||||||
1498115|NCT01007500|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1498116|NCT01007487|||||Prospective|||||||
1498117|NCT01007474|||Cohort||Prospective|||||||
1498118|NCT01007461|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1498119|NCT01007448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498120|NCT01007435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498121|NCT01007422|||Cohort||Prospective|||||||
1498122|NCT01007409|Randomized|Crossover Assignment||||None (Open Label)||||||
1498123|NCT01007396||Single Group Assignment||Screening||None (Open Label)||||||
1498124|NCT01007383|Randomized|Single Group Assignment||||Double|||t||t|
1498125|NCT01007370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498126|NCT01007357|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1498127|NCT01007344|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498128|NCT01007331|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1498129|NCT01007318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498130|NCT01007305|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1498131|NCT01007292||Single Group Assignment||Treatment||None (Open Label)||||||
1498132|NCT01007279|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498133|NCT01007266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498134|NCT01007253|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1498135|NCT01007240|Non-Randomized|Single Group Assignment||Prevention||Single|||t|||
1498136|NCT01007227|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498137|NCT01007214||Single Group Assignment||Diagnostic||None (Open Label)||||||
1498138|NCT01007201|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498139|NCT01007188|Randomized|Crossover Assignment||||Double|||t||t|
1498140|NCT01007175|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1498141|NCT01007162|||Cohort||Cross-Sectional|||||||
1498142|NCT01007149|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1498143|NCT01007136|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498144|NCT01007123|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498145|NCT01007110|Randomized|Parallel Assignment||||Double|||t||t|
1498146|NCT01007097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498147|NCT01007084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498148|NCT01007071|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498149|NCT01007058|||Case-Only||Prospective|||||||
1498150|NCT01007045|||Cohort||Prospective|||||||
1498151|NCT01007032||Single Group Assignment||Treatment||None (Open Label)||||||
1498152|NCT01007019|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1498153|NCT01007006|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498154|NCT01006993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498155|NCT01006980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498156|NCT01006967|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498157|NCT01006954|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498158|NCT01006941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498159|NCT01006928|||Case-Only||Cross-Sectional|||||||
1498160|NCT01006915|Randomized|Parallel Assignment||Treatment||Single||||||t
1498161|NCT01006902|||Cohort||Prospective|||||||
1498162|NCT01006889||Single Group Assignment||Treatment||None (Open Label)||||||
1498163|NCT01006876|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498164|NCT01006863|Randomized|Parallel Assignment||Prevention||Double||||t||t
1498165|NCT01006837|||Cohort||Prospective|||||||
1498166|NCT01006824|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1498167|NCT01006811|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498168|NCT01006798|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1498169|NCT01006785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498170|NCT01006772|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1498171|NCT01006759|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1498172|NCT01006746|||Cohort||Prospective|||||||
1498173|NCT01006733|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1498174|NCT01006720|||||Prospective|||||||
1498175|NCT01006707|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1498176|NCT01006694|Randomized|Parallel Assignment||Treatment||Single||||||t
1498177|NCT01006681|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1498178|NCT01006668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498179|NCT01006655|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1498180|NCT01006642|||Case Control||Prospective|||||||
1498181|NCT01006629|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1498182|NCT01006616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498183|NCT01006603|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498184|NCT01006590|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498185|NCT01006577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498186|NCT01006564||Single Group Assignment||Diagnostic||||||||
1498187|NCT01006551||Single Group Assignment||Treatment||None (Open Label)||||||
1498188|NCT01006538|Randomized|Single Group Assignment||Treatment||Single||||||t
1498189|NCT01006525|||Cohort||Prospective|||||||
1498190|NCT01006499|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1498191|NCT01006486|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1498192|NCT01006473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498193|NCT01006460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498194|NCT01006447|Randomized|Parallel Assignment||||None (Open Label)||||||
1498195|NCT01006434|||Cohort||Prospective|||||||
1498196|NCT01006421|||Case Control||Prospective|||||||
1498197|NCT01006408|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1498198|NCT01006395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498199|NCT01006382|||||Cross-Sectional|||||||
1498200|NCT01006369|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498201|NCT01006356||Single Group Assignment||Treatment||None (Open Label)||||||
1498202|NCT01006343|Randomized|Parallel Assignment||Prevention||||||||
1498203|NCT01006330|||Cohort||Prospective|||||||
1498204|NCT01006317|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498205|NCT01006304|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1498206|NCT01006291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498207|NCT01006278|||Cohort||Prospective|||||||
1498208|NCT01006265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498209|NCT01006252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498210|NCT01006239|||Cohort||Prospective|||||||
1498211|NCT01006226||Single Group Assignment||Treatment||None (Open Label)||||||
1498212|NCT01006213|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498213|NCT01006200|||Cohort||Retrospective|||||||
1498214|NCT01006187|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498215|NCT01006174|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1498216|NCT01006161|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498217|NCT01006148||Single Group Assignment||Treatment||None (Open Label)||||||
1498218|NCT01006135|||||Prospective|||||||
1498219|NCT01006122|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498220|NCT01006109|||Case-Only||Cross-Sectional|||||||
1498221|NCT01006096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498222|NCT01006083|||Cohort||Prospective|||||||
1498223|NCT01006070|||Case-Only||Prospective|||||||
1498224|NCT01006057|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498225|NCT01006044||Single Group Assignment||Treatment||None (Open Label)||||||
1498226|NCT01006031||Single Group Assignment||Treatment||None (Open Label)||||||
1498227|NCT01006018|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1498228|NCT01006005|||Cohort||Prospective|||||||
1498229|NCT01005992|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498230|NCT01005979||Single Group Assignment||Treatment||None (Open Label)||||||
1498231|NCT01005966|Randomized|Crossover Assignment||Treatment||Single|||||t|
1498232|NCT01005953|||Case-Only||Prospective|||||||
1498233|NCT01005940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498234|NCT01005927|Randomized|Crossover Assignment||Prevention||Single|||t|||
1498235|NCT01005914||Single Group Assignment||Treatment||None (Open Label)||||||
1498236|NCT01005901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498237|NCT01005888|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1498238|NCT01005875||Single Group Assignment||Treatment||None (Open Label)||||||
1498239|NCT01005862|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498240|NCT01005849|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1498241|NCT01005836|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1498242|NCT01005823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498243|NCT01005810|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498244|NCT01005797|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498245|NCT01005784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498246|NCT01005771|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498247|NCT01005758|Non-Randomized|||Treatment||None (Open Label)||||||
1498248|NCT01005745||Single Group Assignment||Treatment||None (Open Label)||||||
1498249|NCT01005732|Randomized|Single Group Assignment||Treatment||Single|||||t|
1498250|NCT01005719|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498251|NCT01005706|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498252|NCT01005693||||Supportive Care||||||||
1498253|NCT01005680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498254|NCT01005667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498255|NCT01005654|||Cohort||Prospective|||||||
1498256|NCT01005641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498257|NCT01005628|||Case-Only||Prospective|||||||
1498258|NCT01005615|Randomized|Crossover Assignment||Treatment||Single||||||t
1498259|NCT01005602|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498260|NCT01005589|||Cohort||Retrospective|||||||
1498261|NCT01005576||Single Group Assignment||Treatment||None (Open Label)||||||
1498262|NCT01005563|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498263|NCT01005550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498264|NCT01005537||||||||||||
1498265|NCT01005524|||Cohort||Prospective|||||||
1498266|NCT01005511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498267|NCT01005498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498268|NCT01005485|||Cohort||Other|||||||
1498269|NCT01005472||Single Group Assignment||Treatment||None (Open Label)||||||
1498270|NCT01005459|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498271|NCT01005446|||Cohort||Prospective|||||||
1498272|NCT01005433|Randomized|Parallel Assignment||Prevention||Double||||t||t
1498273|NCT01005420|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1498274|NCT01005407|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1498275|NCT01005394|||Case-Only||Prospective|||||||
1498276|NCT01005381|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1498277|NCT01005368|||Case-Only||Retrospective|||||||
1498278|NCT01005355||Single Group Assignment||Treatment||None (Open Label)||||||
1498279|NCT01005342|Randomized|Factorial Assignment||||Single|||t|||
1498280|NCT01005329||Single Group Assignment||Treatment||None (Open Label)||||||
1498281|NCT01005316|||Cohort||Prospective|||||||
1498282|NCT01005303|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498283|NCT01005290|Randomized|Crossover Assignment||||None (Open Label)||||||
1498284|NCT01005277|||Case-Only||Retrospective|||||||
1498285|NCT01005264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498286|NCT01005251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498287|NCT01005238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498288|NCT01005225|||Cohort|||||||||
1498289|NCT01005212|||Case-Only||Prospective|||||||
1498290|NCT01005199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498291|NCT01005186|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498292|NCT01005173|||Case-Control||Prospective|||||||
1498293|NCT01005160|Randomized|Crossover Assignment||||None (Open Label)||||||
1498294|NCT01005147|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498295|NCT01005121||Single Group Assignment||Treatment||None (Open Label)||||||
1498296|NCT01005108||||Treatment||||||||
1498297|NCT01005095|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1498298|NCT01005082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498299|NCT01005069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498300|NCT01005056|||Ecologic or Community||Prospective|||||||
1498301|NCT01005043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498302|NCT01005030|||Cohort||Prospective|||||||
1498303|NCT01005017|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498304|NCT01005004||Single Group Assignment||||None (Open Label)||||||
1498305|NCT01004991||Single Group Assignment||Treatment||None (Open Label)||||||
1498306|NCT01004978|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498307|NCT01004965|||Cohort||Prospective|||||||
1498308|NCT01004952|||Cohort||Prospective|||||||
1498309|NCT01004939|||Cohort||Retrospective|||||||
1498310|NCT01004926||Single Group Assignment||Treatment||None (Open Label)||||||
1498311|NCT01004913|||Cohort||Prospective|||||||
1498312|NCT01004900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498313|NCT01004887|||Case-Only||Retrospective|||||||
1498314|NCT01004874||Single Group Assignment||Treatment||None (Open Label)||||||
1498315|NCT01004861||Single Group Assignment||Treatment||None (Open Label)||||||
1498316|NCT01004848|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1498317|NCT01004835|||Family-Based|||||||||
1498318|NCT01004822|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498319|NCT01004809|||Other||Prospective|||||||
1498320|NCT01004796||||||||||||
1498321|NCT01004783|||Cohort||Prospective|||||||
1498322|NCT01004770|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1498323|NCT01004757|Randomized|Crossover Assignment||Treatment||Single|||||t|
1498324|NCT01004744|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498325|NCT01004731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498326|NCT01004718|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1498327|NCT01004705|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1498328|NCT01004692|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498329|NCT01004666|||Cohort||Prospective|||||||
1498330|NCT01004653||Single Group Assignment||Prevention||None (Open Label)||||||
1498331|NCT01004640|||Case-Only||Prospective|||||||
1498332|NCT01004627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498333|NCT01004614|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498334|NCT01004601|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498335|NCT01004588|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1498336|NCT01004575|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498337|NCT01004562|||||Retrospective|||||||
1498338|NCT01004549|||Case-Only||Cross-Sectional|||||||
1498339|NCT01004536|Randomized|Parallel Assignment||Prevention||Single||||||t
1498340|NCT01004523|||Case-Only||Retrospective|||||||
1498341|NCT01004510||Single Group Assignment||Treatment||None (Open Label)||||||
1498342|NCT01004497||Single Group Assignment||Treatment||None (Open Label)||||||
1498343|NCT01004484|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1498344|NCT01004458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498345|NCT01004445|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498346|NCT01004432|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498347|NCT01004419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498348|NCT01004406|Randomized|Parallel Assignment||Prevention||Single||||||t
1498349|NCT01004393||Single Group Assignment||Supportive Care||None (Open Label)||||||
1498350|NCT01004380||Single Group Assignment||||None (Open Label)||||||
1498351|NCT01004367|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1498352|NCT01004354||Single Group Assignment||Treatment||None (Open Label)||||||
1498353|NCT01004341||Single Group Assignment||Treatment||None (Open Label)||||||
1498354|NCT01004328||Single Group Assignment||Health Services Research||None (Open Label)||||||
1498355|NCT01004315|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498356|NCT01004302|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498357|NCT01004289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498358|NCT01004276|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498359|NCT01004263||Single Group Assignment||Treatment||None (Open Label)||||||
1498360|NCT01004250||Single Group Assignment||Treatment||None (Open Label)||||||
1498361|NCT01004237|Randomized|Crossover Assignment||Treatment||Single|||t|||
1498362|NCT01004224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498363|NCT01004211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498364|NCT01004198|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498365|NCT01004185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498366|NCT01004172||Single Group Assignment||Treatment||None (Open Label)||||||
1498367|NCT01004159||Single Group Assignment||Treatment||None (Open Label)||||||
1498368|NCT01004146|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1498369|NCT01004133|||Other||Other|||||||
1498370|NCT01004120|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1498371|NCT01004107|Randomized|Crossover Assignment||Treatment||Single||||||t
1498372|NCT01004094|Randomized|Parallel Assignment||Prevention||Single||||||t
1498373|NCT01004081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498374|NCT01004068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498375|NCT01004055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498376|NCT01004042|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498377|NCT01004029|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1498378|NCT01004016|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1498379|NCT01004003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498380|NCT01003990|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1498381|NCT01003977|||Cohort||Retrospective|||||||
1498382|NCT01003964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498383|NCT01003951||Single Group Assignment||Treatment||None (Open Label)||||||
1498384|NCT01003938||Single Group Assignment||Treatment||None (Open Label)||||||
1498385|NCT01003925||||||||||||
1498386|NCT01003912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498387|NCT01003899|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498388|NCT01003886|||Cohort||Prospective|||||||
1498389|NCT01003873|||Case-Control||Prospective|||||||
1498390|NCT01003860|||Cohort||Prospective|||||||
1498391|NCT01003847|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498392|NCT01003834|Randomized|Single Group Assignment||Treatment||Single||||||t
1498393|NCT01003808||Single Group Assignment||Treatment||None (Open Label)||||||
1498394|NCT01003795|||Cohort||Retrospective|||||||
1498395|NCT01003782|||Cohort||Prospective|||||||
1498396|NCT01003769||Single Group Assignment||Treatment||None (Open Label)||||||
1498397|NCT01003756|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1498398|NCT01003743||||||||||||
1498399|NCT01003730|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498400|NCT01003717|||Cohort||Retrospective|||||||
1498401|NCT01003704|||Case-Only||Retrospective|||||||
1498402|NCT01003691|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1498403|NCT01003678||Single Group Assignment||Treatment||None (Open Label)||||||
1498404|NCT01003665|||Case Control||Prospective|||||||
1498405|NCT01003652|||Cohort||Prospective|||||||
1498406|NCT01003639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498407|NCT01003626||Single Group Assignment||Treatment||None (Open Label)||||||
1498408|NCT01003613|Randomized|Parallel Assignment||Treatment||Single||||||t
1498409|NCT01003600|||Cohort||Prospective|||||||
1498410|NCT01003587|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1498411|NCT01003574|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1498412|NCT01003561|Randomized|Parallel Assignment||||Single|||||t|
1498413|NCT01003548|Randomized|Single Group Assignment||||None (Open Label)||||||
1498414|NCT01003535|||Cohort||Prospective|||||||
1498415|NCT01003522|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498416|NCT01003509|Randomized|Parallel Assignment||Treatment||Single|||||t|
1498417|NCT01003496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498418|NCT01003483|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498419|NCT01003470|Randomized|Parallel Assignment||Treatment||Single||||||t
1498420|NCT01003457|||Cohort||Prospective|||||||
1498421|NCT01003444||Single Group Assignment||Basic Science||None (Open Label)||||||
1498422|NCT01003431|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498423|NCT01003418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498424|NCT01003405||Single Group Assignment||Treatment||None (Open Label)||||||
1498425|NCT01003392|||||Prospective|||||||
1498426|NCT01003379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498427|NCT01003366|Randomized|Parallel Assignment||||None (Open Label)||||||
1498428|NCT01003353||Single Group Assignment||Treatment||None (Open Label)||||||
1498429|NCT01003340||Single Group Assignment||Prevention||None (Open Label)||||||
1498430|NCT01003327|Randomized|Crossover Assignment||Treatment||Single|||t|||
1498431|NCT01003314|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498432|NCT01003301|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1498433|NCT01003288||Single Group Assignment||Prevention||None (Open Label)||||||
1498434|NCT01003275|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498435|NCT01003262|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498436|NCT01003249|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1498437|NCT01003236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498438|NCT01003223||Single Group Assignment||Treatment||None (Open Label)||||||
1498439|NCT01003210|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1498440|NCT01003197|||Cohort||Retrospective|||||||
1498441|NCT01003184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498442|NCT01003171||Single Group Assignment||Treatment||None (Open Label)||||||
1498443|NCT01003158|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498444|NCT01003145|Randomized|||Prevention||None (Open Label)||||||
1498445|NCT01003132|Randomized|Parallel Assignment||Treatment||Single||||||t
1498446|NCT01003119|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498447|NCT01003106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498448|NCT01003093|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498449|NCT01003080|Randomized|Single Group Assignment||Other||Single|||t|||
1498450|NCT01003067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498451|NCT01003054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498452|NCT01003041|||Case-Crossover||Prospective|||||||
1498453|NCT01003028|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1498454|NCT01003015||Single Group Assignment||Treatment||None (Open Label)||||||
1498455|NCT01003002|||Cohort||Prospective|||||||
1498456|NCT01002989|||Case-Only||Cross-Sectional|||||||
1498457|NCT01002976|||Case Control||Prospective|||||||
1498458|NCT01002963|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1498459|NCT01002950|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498460|NCT01002937|||Cohort||Retrospective|||||||
1498461|NCT01002924||Single Group Assignment||Treatment||None (Open Label)||||||
1498462|NCT01002911|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498463|NCT01002898|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498464|NCT01002885|||||Prospective|||||||
1498465|NCT01002872|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1498466|NCT01002859|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1498467|NCT01002846|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498468|NCT01002833|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1498469|NCT01002820||Single Group Assignment||Treatment||None (Open Label)||||||
1498470|NCT01002807|Randomized|Crossover Assignment||||None (Open Label)||||||
1498471|NCT01002794|Randomized|Parallel Assignment||Treatment||Single||||||t
1498472|NCT01002781||Single Group Assignment||Treatment||None (Open Label)||||||
1498473|NCT01002768|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1498474|NCT01002755||Single Group Assignment||Treatment||None (Open Label)||||||
1498475|NCT01002742|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498476|NCT01002729|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498477|NCT01002716|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1498478|NCT01002703|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498479|NCT01002690|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1498480|NCT01002677|Randomized|Parallel Assignment||||Single||||||t
1498481|NCT01002664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498482|NCT01002651|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1498483|NCT01002638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498484|NCT01002625|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1498485|NCT01002612|||Cohort||Cross-Sectional|||||||
1498486|NCT01002599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498487|NCT01002586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498488|NCT01002573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498489|NCT01002560|||Case Control||Retrospective|||||||
1498490|NCT01002547|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498491|NCT01002534|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1498492|NCT01002521|||Case Control||Cross-Sectional|||||||
1498493|NCT01002508|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1498494|NCT01002495|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498495|NCT01002482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498496|NCT01002469||Single Group Assignment||Diagnostic||None (Open Label)||||||
1498497|NCT01002456|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498498|NCT01002443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498499|NCT01002430|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498500|NCT01002417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498501|NCT01002404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498502|NCT01002391|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1498503|NCT01002378|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1498504|NCT01002365||||||||||||
1498505|NCT01002352|||Cohort||Prospective|||||||
1498506|NCT01002339|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498507|NCT01002326||Single Group Assignment||Treatment||None (Open Label)||||||
1498508|NCT01002313|||Case Control||Prospective|||||||
1498509|NCT01002300|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498510|NCT01002287|Randomized|Parallel Assignment||Prevention||Single|||t|||
1498511|NCT01002274||Single Group Assignment||Treatment||None (Open Label)||||||
1498512|NCT01002261|||Cohort||Prospective|||||||
1498513|NCT01002248|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498514|NCT01002235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498515|NCT01002222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498516|NCT01002209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498517|NCT01002196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498518|NCT01002183|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498519|NCT01002170|||Case-Only||Prospective|||||||
1498520|NCT01002157|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498521|NCT01002144|||Case-Only||Prospective|||||||
1498522|NCT01002131|||Case-Only||Cross-Sectional|||||||
1498523|NCT01002118|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1498524|NCT01002105|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1498525|NCT01002092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498526|NCT01002079|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1498527|NCT01002066|||Cohort|||||||||
1498528|NCT01002053|||Other||Prospective|||||||
1498529|NCT01002040|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498530|NCT01002027|Randomized|Parallel Assignment||Treatment||Single||||||t
1498531|NCT01002014||Single Group Assignment||Treatment||None (Open Label)||||||
1498532|NCT01002001|||Case-Only||Prospective|||||||
1498533|NCT01001988||Single Group Assignment||Prevention||None (Open Label)||||||
1498534|NCT01001975|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1498535|NCT01001962|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1498536|NCT01001949|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1498537|NCT01001936|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498538|NCT01001923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498539|NCT01001910||Single Group Assignment||Treatment||None (Open Label)||||||
1498540|NCT01001897|Randomized|Parallel Assignment||Health Services Research||Double|||t|t||
1498541|NCT01001884|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1498542|NCT01001871|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498543|NCT01001858|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1498544|NCT01001845|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498545|NCT01001832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498546|NCT01001819|||Cohort||Prospective|||||||
1498547|NCT01001806|Randomized|Parallel Assignment||Treatment||Single||||||t
1498548|NCT01001793||Single Group Assignment||Treatment||None (Open Label)||||||
1498549|NCT01001780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498550|NCT01001767|Randomized|Parallel Assignment||||Triple|||t|t|t|
1498551|NCT01001754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498552|NCT01001741|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1498553|NCT01001728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498554|NCT01001715|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498555|NCT01001702||Parallel Assignment||Treatment||None (Open Label)||||||
1498556|NCT01001689|Randomized|Parallel Assignment||Prevention||Single|||||t|
1498557|NCT01001676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498558|NCT01001663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498559|NCT01001650|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1498560|NCT01001637|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1498561|NCT01001624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498562|NCT01001611|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498563|NCT01001598||Single Group Assignment||Treatment||None (Open Label)||||||
1498564|NCT01001585||Single Group Assignment||Supportive Care||Double||||t|t|
1498565|NCT01001572|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498566|NCT01001559|||Case Control||Retrospective|||||||
1498567|NCT01001546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498568|NCT01001533|||Cohort||Prospective|||||||
1498569|NCT01001520|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1498570|NCT01001507|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498571|NCT01001494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498572|NCT01001481|||Cohort||Prospective|||||||
1498573|NCT01001468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498574|NCT01001455|||||Prospective|||||||
1498575|NCT01001442||Single Group Assignment||Treatment||None (Open Label)||||||
1498576|NCT01001429|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1498577|NCT01001403|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1498578|NCT01001390|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1498579|NCT01001377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498580|NCT01001364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498581|NCT01001351|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1498582|NCT01001338|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1498583|NCT01001325|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1498584|NCT01001312|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498585|NCT01001299||Parallel Assignment||Treatment||None (Open Label)||||||
1498586|NCT01001286|Randomized|Parallel Assignment||Prevention||Single||||||t
1498587|NCT01001273|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498588|NCT01001260|||Case-Only||Cross-Sectional|||||||
1498589|NCT01001247|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498590|NCT01001234|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498591|NCT01001221||Single Group Assignment||Treatment||None (Open Label)||||||
1498592|NCT01001208|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498593|NCT01001195|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498594|NCT01001182|||Cohort||Prospective|||||||
1498595|NCT01001169|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498596|NCT01001156|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498597|NCT01001143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498598|NCT01001130|||||Prospective|||||||
1498599|NCT01001117|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498600|NCT01001104|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498601|NCT01001091|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498602|NCT01001078|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1498603|NCT01001065|||Cohort||Prospective|||||||
1498604|NCT01001052|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1498605|NCT01001039|||Cohort||Prospective|||||||
1498606|NCT01001026|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498607|NCT01001013|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498608|NCT01001000|||Cohort||Prospective|||||||
1498609|NCT01000987|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498610|NCT01000974|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1498611|NCT01000961|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498612|NCT01000948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498613|NCT01000935|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1498614|NCT01000922|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498615|NCT01000909|||Cohort||Prospective|||||||
1498616|NCT01000896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498617|NCT01000883|||Case-Only||Prospective|||||||
1498618|NCT01000870||Single Group Assignment||Diagnostic||None (Open Label)||||||
1498619|NCT01000857|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1498620|NCT01000844|||Cohort||Prospective|||||||
1498621|NCT01000831||Single Group Assignment||Prevention||None (Open Label)||||||
1498622|NCT01000818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498623|NCT01000805|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498624|NCT01000792||Single Group Assignment||Treatment||None (Open Label)||||||
1498625|NCT01000779|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498626|NCT01000766|||Cohort||Prospective|||||||
1498627|NCT01000753||||||||||||
1498628|NCT01000740|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498629|NCT01000727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498630|NCT01000714||||||||||||
1498631|NCT01000701|||Cohort||Prospective|||||||
1498632|NCT01000688|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1498633|NCT01000675|||||Prospective|||||||
1498634|NCT01000662|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498635|NCT01000649|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498797|NCT00998530|||Case-Control||Cross-Sectional|||||||
1498636|NCT01000636||Single Group Assignment||Prevention||None (Open Label)||||||
1498637|NCT01000623|Randomized|Parallel Assignment||Supportive Care||Double||||||
1498638|NCT01000610||Single Group Assignment||Treatment||None (Open Label)||||||
1498639|NCT01000597|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1498640|NCT01000584|Randomized|Parallel Assignment||Prevention||Single||||||t
1498641|NCT01000571|||Case-Only||Prospective|||||||
1498642|NCT01000558||||||||||||
1498643|NCT01000545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498644|NCT01000532|||Cohort||Prospective|||||||
1498645|NCT01000519|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1498646|NCT01000506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498647|NCT01000493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498648|NCT01000480||Single Group Assignment||Treatment||None (Open Label)||||||
1498649|NCT01000467|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498650|NCT01000454||||||||||||
1498651|NCT01000441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498652|NCT01000428|||Cohort||Prospective|||||||
1498653|NCT01000415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498654|NCT01000402||Single Group Assignment||||None (Open Label)||||||
1498655|NCT01000389|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498656|NCT01000376|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498657|NCT01000363|||Cohort||Prospective|||||||
1498658|NCT01000350|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498659|NCT01000337|Randomized|Parallel Assignment||Other||Single||||||t
1498660|NCT01000324||Single Group Assignment||Prevention||None (Open Label)||||||
1498661|NCT01000311|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498662|NCT01000298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498663|NCT01000285||Single Group Assignment||Treatment||None (Open Label)||||||
1498664|NCT01000272|||Case Control||Prospective|||||||
1498665|NCT01000259||||||||||||
1498666|NCT01000246|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498667|NCT01000233|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1498668|NCT01000220|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498669|NCT01000207|Randomized|Parallel Assignment||Prevention||Single|||t|||
1498670|NCT01000194|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1498671|NCT01000181|||Case-Only||Prospective|||||||
1498672|NCT01000168|Randomized|Parallel Assignment||Treatment||Single|||||t|
1498673|NCT01000155||Single Group Assignment||Treatment||None (Open Label)||||||
1498674|NCT01000142|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498675|NCT01000129||Single Group Assignment||Treatment||||||||
1498676|NCT01000116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498677|NCT01000103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498678|NCT01000090|||Cohort||Retrospective|||||||
1498679|NCT01000077|||Other||Other|||||||
1498680|NCT01000064|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1498681|NCT01000051|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1498682|NCT01000038|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1498683|NCT01000025|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498684|NCT01000012||||||||||||
1498685|NCT00999999|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498686|NCT00999986|Randomized|Parallel Assignment||Treatment||Single|||||t|
1498687|NCT00999973||||||||||||
1498688|NCT00999960|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1498689|NCT00999947|||Cohort||Prospective|||||||
1498690|NCT00999934|||Cohort||Prospective|||||||
1498691|NCT00999921|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498692|NCT00999908|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498693|NCT00999895|||Case-Only||Prospective|||||||
1498694|NCT00999882|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498695|NCT00999869|Randomized|Single Group Assignment||Treatment||Single|||t|||
1498696|NCT00999856|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1498697|NCT00999843|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498698|NCT00999830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498699|NCT00999817|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1498700|NCT00999804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498701|NCT00999791||Parallel Assignment||Treatment||||||||
1498702|NCT00999778|Randomized|Parallel Assignment||Treatment||Single||||t||
1498703|NCT00999765|||Cohort||Prospective|||||||
1498704|NCT00999752|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1498705|NCT00999739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498706|NCT00999713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498707|NCT00999700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498708|NCT00999687|Randomized|Single Group Assignment||Treatment||Single||||||t
1498709|NCT00999674|Randomized|||Health Services Research||||||||
1498710|NCT00999661|||Cohort|||||||||
1498711|NCT00999648|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1498712|NCT00999635|Randomized|Parallel Assignment||Prevention||Single|||t|||
1498713|NCT00999622|||Case Control||Prospective|||||||
1498714|NCT00999609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498715|NCT00999596|||||Prospective|||||||
1498716|NCT00999583|Randomized|Parallel Assignment||Treatment||Single||||||t
1498717|NCT00999570|||Case Control||Prospective|||||||
1498718|NCT00999557|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1498719|NCT00999544|Randomized|Crossover Assignment||Basic Science||Triple||Within subject crossover designed that examined 15 experimental conditions within a single group of participants|t||t|t
1498720|NCT00999531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498721|NCT00999518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498722|NCT00999505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498723|NCT00999492|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498724|NCT00999479|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498725|NCT00999466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498726|NCT00999453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498727|NCT00999440||Single Group Assignment||Diagnostic||None (Open Label)||||||
1498728|NCT00999427|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498729|NCT00999414||||||||||||
1498730|NCT00999401||Single Group Assignment||Treatment||None (Open Label)||||||
1498731|NCT00999388|||Cohort||Prospective|||||||
1498732|NCT00999375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498733|NCT00999362|||||Prospective|||||||
1498734|NCT00999349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498735|NCT00999336|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498736|NCT00999323|||Cohort||Prospective|||||||
1498737|NCT00999310|||Case Control||Cross-Sectional|||||||
1498738|NCT00999297|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1498739|NCT00999284|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498740|NCT00999271|||Case Control|||||||||
1498741|NCT00999258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498742|NCT00999245|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1498743|NCT00999232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498744|NCT00999219|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498745|NCT00999206|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1498746|NCT00999193|Randomized|Parallel Assignment||Treatment||Single||||||t
1498747|NCT00999180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498748|NCT00999167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498749|NCT00999154|||||Prospective|||||||
1498750|NCT00999141|Randomized|Single Group Assignment||Treatment||Single|||t|||
1498751|NCT00999128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498752|NCT00999115||Single Group Assignment||Treatment||None (Open Label)||||||
1498753|NCT00999102|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498754|NCT00999089|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498755|NCT00999076|||Case-Only||Prospective|||||||
1498756|NCT00999063|||||Prospective|||||||
1498757|NCT00999050|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498758|NCT00999037|Randomized|Parallel Assignment||Prevention||Single|||t|||
1498759|NCT00999024|||Cohort||Prospective|||||||
1498760|NCT00999011|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1498761|NCT00998998|Randomized|Parallel Assignment||Treatment||Single||||||t
1498762|NCT00998985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498763|NCT00998972|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498764|NCT00998959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498765|NCT00998946||Single Group Assignment||Treatment||None (Open Label)||||||
1498766|NCT00998933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498767|NCT00998920|Randomized|Single Group Assignment||||Double|||t||t|
1498768|NCT00998907|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498769|NCT00998894|||Cohort||Prospective|||||||
1498770|NCT00998881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498771|NCT00998868|||Case-Only||Cross-Sectional|||||||
1498772|NCT00998855|||Cohort||Prospective|||||||
1498773|NCT00998842|||Cohort||Prospective|||||||
1498774|NCT00998829|||Case-Only||Cross-Sectional|||||||
1498775|NCT00998816|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1498776|NCT00998803|||Cohort||Prospective|||||||
1498777|NCT00998790||Single Group Assignment||Treatment||None (Open Label)||||||
1498778|NCT00998777|Randomized|Parallel Assignment||Prevention||Single||||||t
1498779|NCT00998764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498780|NCT00998751||Single Group Assignment||Treatment||None (Open Label)||||||
1498781|NCT00998738|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1498782|NCT00998725|||Cohort||Prospective|||||||
1498783|NCT00998712|||Case Control||Prospective|||||||
1498784|NCT00998699|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498785|NCT00998686|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498786|NCT00998673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498787|NCT00998660||Single Group Assignment||||None (Open Label)||||||
1498788|NCT00998647|||Cohort||Prospective|||||||
1498789|NCT00998634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498790|NCT00998621|||||Prospective|||||||
1498791|NCT00998608|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498792|NCT00998595|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498793|NCT00998582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498794|NCT00998569|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1498795|NCT00998556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498796|NCT00998543|||Cohort||Prospective|||||||
1498798|NCT00998517|Randomized|Parallel Assignment||Treatment||Single|||||t|
1498799|NCT00998504|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1498800|NCT00998478|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498801|NCT00998465|||Case Control||Cross-Sectional|||||||
1498802|NCT00998452|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498803|NCT00998439|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498804|NCT00998426||Single Group Assignment||Supportive Care||None (Open Label)||||||
1498805|NCT00998413|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498806|NCT00998400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498807|NCT00998387|||Cohort||Prospective|||||||
1498808|NCT00998374|||Case-Only||Prospective|||||||
1498809|NCT00998361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498810|NCT00998348|Randomized|Parallel Assignment||Prevention||Single||||||t
1498811|NCT00998335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498812|NCT00998322|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498813|NCT00998309|||Case-Only||Prospective|||||||
1498814|NCT00998296||Single Group Assignment||Treatment||None (Open Label)||||||
1498815|NCT00998283|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498816|NCT00998270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498817|NCT00998257|||Cohort||Prospective|||||||
1498818|NCT00998244|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1498819|NCT00998231|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1498820|NCT00998218|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498821|NCT00998205||Single Group Assignment||Prevention||None (Open Label)||||||
1498822|NCT00998192||Single Group Assignment||Treatment||None (Open Label)||||||
1498823|NCT00998179|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1498824|NCT00998166|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498825|NCT00998153|Randomized|Parallel Assignment||Treatment||Single||||||t
1498826|NCT00998140|||Cohort||Other|||||||
1498827|NCT00998127|||Cohort||Prospective|||||||
1498828|NCT00998114||Single Group Assignment||Prevention||None (Open Label)||||||
1498829|NCT00998101||Single Group Assignment||Treatment||None (Open Label)||||||
1498830|NCT00998088|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1498831|NCT00998075|Randomized|Crossover Assignment||||None (Open Label)||||||
1498832|NCT00998062|||||Retrospective|||||||
1498833|NCT00998049||Single Group Assignment||Treatment||None (Open Label)||||||
1498834|NCT00998036||Single Group Assignment||Treatment||None (Open Label)||||||
1498835|NCT00998023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498836|NCT00998010||Single Group Assignment||Treatment||None (Open Label)||||||
1498837|NCT00997997|||Cohort||Prospective|||||||
1498838|NCT00997984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498839|NCT00997971|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1498840|NCT00997958||Single Group Assignment||Treatment||None (Open Label)||||||
1498841|NCT00997945|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1498842|NCT00997932||Single Group Assignment||Prevention||None (Open Label)||||||
1498843|NCT00997919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498844|NCT00997906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498845|NCT00997893|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498846|NCT00997880|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1498847|NCT00997867|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498848|NCT00997854|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498849|NCT00997841|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1498850|NCT00997828|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498851|NCT00997815|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1498852|NCT00997802||Single Group Assignment||Diagnostic||None (Open Label)||||||
1498853|NCT00997789|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498854|NCT00997776|Randomized|Parallel Assignment||Treatment||Single||||||t
1498855|NCT00997763|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498856|NCT00997750|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498857|NCT00997737|Randomized|Crossover Assignment||Treatment||Single|||||t|
1498858|NCT00997724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498859|NCT00997711||Single Group Assignment||Treatment||None (Open Label)||||||
1498860|NCT00997698|||Cohort||Prospective|||||||
1498861|NCT00997685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498862|NCT00997672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498863|NCT00997659|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1498864|NCT00997646|||Cohort||Prospective|||||||
1498865|NCT00997633|||Case-Only|||||||||
1498866|NCT00997620|Randomized|Parallel Assignment||Other||Double|||t||t|
1498867|NCT00997607|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1498868|NCT00997594|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498869|NCT00997581|Randomized|Parallel Assignment||Treatment||Single|||||t|
1498870|NCT00997568|||Case-Only||Prospective|||||||
1498871|NCT00997555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498872|NCT00997542|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1498873|NCT00997529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498874|NCT00997516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498875|NCT00997503|||Cohort||Prospective|||||||
1498876|NCT00997490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498877|NCT00997477||Single Group Assignment||Treatment||None (Open Label)||||||
1498878|NCT00997464|||Cohort||Prospective|||||||
1498879|NCT00997451|Randomized|Parallel Assignment||Treatment||Single|||||t|
1498880|NCT00997438|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498881|NCT00997425||Single Group Assignment||Treatment||Single||||||t
1498882|NCT00997412|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1498883|NCT00997399|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1498884|NCT00997386||Single Group Assignment||Treatment||None (Open Label)||||||
1498885|NCT00997373|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498886|NCT00997360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498887|NCT00997347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498888|NCT00997334||Single Group Assignment||Treatment||None (Open Label)||||||
1498889|NCT00997321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498890|NCT00997308|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1498891|NCT00997295|||Case Control||Prospective|||||||
1498892|NCT00997282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498893|NCT00997269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498894|NCT00997256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498895|NCT00997243||Single Group Assignment||Treatment||None (Open Label)||||||
1498896|NCT00997230|||Case-Only||Prospective|||||||
1498897|NCT00997217|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1498898|NCT00997204|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498899|NCT00997191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498900|NCT00997178|Randomized|Parallel Assignment||Treatment||Single||||||t
1498901|NCT00997165|||Cohort||Prospective|||||||
1498902|NCT00997152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498903|NCT00997139||Single Group Assignment||Treatment||None (Open Label)||||||
1498904|NCT00997126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498905|NCT00997113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498906|NCT00997100|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1498907|NCT00997087|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498908|NCT00997074|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498909|NCT00997061|||||Prospective|||||||
1498910|NCT00997048|Randomized|Parallel Assignment||Treatment||Single||||||t
1498911|NCT00997035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498912|NCT00997022||Single Group Assignment||Treatment||None (Open Label)||||||
1498913|NCT00997009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498914|NCT00996996||Single Group Assignment||Treatment||None (Open Label)||||||
1498915|NCT00996983|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498916|NCT00996970|||Cohort||Prospective|||||||
1498917|NCT00996957||Single Group Assignment||Treatment||None (Open Label)||||||
1498918|NCT00996944|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498919|NCT00996931||Single Group Assignment||Treatment||None (Open Label)||||||
1498920|NCT00996918|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498921|NCT00996905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498922|NCT00996892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498923|NCT00996879||Single Group Assignment||||None (Open Label)||||||
1498924|NCT00996866|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498925|NCT00996853|||Cohort||Prospective|||||||
1498926|NCT00996840|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498927|NCT00996827|||Case-Only||Prospective|||||||
1498928|NCT00996814|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1498929|NCT00996801|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498930|NCT00996788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498931|NCT00996775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498932|NCT00996762|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498933|NCT00996749||Single Group Assignment||Treatment||None (Open Label)||||||
1498934|NCT00996736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498935|NCT00996723||Single Group Assignment||Treatment||None (Open Label)||||||
1498936|NCT00996710|||Family-Based||Other|||||||
1498937|NCT00996697|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1498938|NCT00996684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498939|NCT00996671|Randomized|Single Group Assignment||Treatment||Single|||t|||
1498940|NCT00996658|Randomized|Parallel Assignment||Treatment||Double||||||
1498941|NCT00996645|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1498942|NCT00996632|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498943|NCT00996619|||Ecologic or Community||Cross-Sectional|||||||
1498944|NCT00996606||Single Group Assignment||Treatment||None (Open Label)||||||
1498945|NCT00996593||Single Group Assignment||Treatment||None (Open Label)||||||
1498946|NCT00996580||Single Group Assignment||Prevention||None (Open Label)||||||
1498947|NCT00996567||Single Group Assignment||Treatment||None (Open Label)||||||
1498948|NCT00996554|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1498949|NCT00996541|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498950|NCT00996528|Randomized|Parallel Assignment||Treatment||Single||||||t
1500182|NCT00980304||||||||||||
1498951|NCT00996515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498952|NCT00996502||Single Group Assignment||Treatment||None (Open Label)||||||
1498953|NCT00996489||Single Group Assignment||Treatment||None (Open Label)||||||
1498954|NCT00996476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498955|NCT00996463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498956|NCT00996450|||Family-Based||Retrospective|||||||
1498957|NCT00996437|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1498958|NCT00996424|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498959|NCT00996411||Single Group Assignment||Basic Science||Triple|||t||t|t
1498960|NCT00996398|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498961|NCT00996385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498962|NCT00996372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498963|NCT00996359||Single Group Assignment||Treatment||None (Open Label)||||||
1498964|NCT00996346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498965|NCT00996333||Single Group Assignment||Treatment||None (Open Label)||||||
1498966|NCT00996320|Randomized|Crossover Assignment||Prevention||Single||||||t
1498967|NCT00996307|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1498968|NCT00996294|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498969|NCT00996281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498970|NCT00996268|Randomized|Parallel Assignment||Treatment||Single|||t|||
1498971|NCT00996255||Single Group Assignment||Treatment||None (Open Label)||||||
1498972|NCT00996242|Randomized|Crossover Assignment||Treatment||Single|||t|||
1498973|NCT00996229|Randomized|Parallel Assignment||Prevention||Single|||||t|
1498974|NCT00996216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498975|NCT00996203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1498976|NCT00996190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1498977|NCT00996177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498978|NCT00996164|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1498979|NCT00996151||Single Group Assignment||||None (Open Label)||||||
1498980|NCT00996138|Randomized|Parallel Assignment||Prevention||Single|||t|||
1498981|NCT00996125|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1498982|NCT00996112|||Cohort||Prospective|||||||
1498983|NCT00996099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1498984|NCT00996086|||Case-Only||Prospective|||||||
1498985|NCT00996073|Randomized|Parallel Assignment||Treatment||Single||||||t
1498986|NCT00996060||Single Group Assignment||Treatment||None (Open Label)||||||
1498987|NCT00996047||||||||||||
1498988|NCT00996034||Single Group Assignment||Health Services Research||None (Open Label)||||||
1498989|NCT00996021|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1498990|NCT00996008|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498991|NCT00995995|||Other||Retrospective|||||||
1498992|NCT00995982|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1498993|NCT00995969|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498994|NCT00995956|||Cohort||Prospective|||||||
1498995|NCT00995930|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1498996|NCT00995917|Randomized|Crossover Assignment||Treatment||Single|||t|||
1498997|NCT00995904|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1498998|NCT00995891|||Cohort||Prospective|||||||
1498999|NCT00995878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499000|NCT00995865|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499001|NCT00995852|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499002|NCT00995839|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499003|NCT00995826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499004|NCT00995813||Single Group Assignment||Prevention||None (Open Label)||||||
1499005|NCT00995800|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499006|NCT00995787|Randomized|Single Group Assignment||Treatment||Single|||t|||
1499007|NCT00995774|Randomized|Crossover Assignment||Treatment||Single||||||t
1499008|NCT00995761||Single Group Assignment||Treatment||None (Open Label)||||||
1499009|NCT00995748|||Cohort||Prospective|||||||
1499010|NCT00995735|||Cohort||Prospective|||||||
1499011|NCT00995722|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499012|NCT00995709|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499013|NCT00995696|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1499014|NCT00995683|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499015|NCT00995670|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499016|NCT00995657|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1499017|NCT00995644|||Ecologic or Community||Prospective|||||||
1499018|NCT00995631|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1499019|NCT00995618|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1499020|NCT00995605|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1499021|NCT00995592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499022|NCT00995579|||Cohort||Cross-Sectional|||||||
1499023|NCT00995566|||Cohort||Prospective|||||||
1499024|NCT00995553|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1499025|NCT00995540|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499026|NCT00995527|||||Prospective|||||||
1499027|NCT00995514|||Cohort||Prospective|||||||
1499028|NCT00995501|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1499029|NCT00995488||Single Group Assignment||Treatment||None (Open Label)||||||
1499030|NCT00995475|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1499031|NCT00995462|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499032|NCT00995449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499033|NCT00995436|Randomized|Parallel Assignment||Treatment||Single|||||t|
1499034|NCT00995423|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499035|NCT00995410||Single Group Assignment||Treatment||None (Open Label)||||||
1499036|NCT00995397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499037|NCT00995384||Single Group Assignment||Diagnostic||Single||||||t
1499038|NCT00995371|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1499039|NCT00995358||Single Group Assignment||Treatment||None (Open Label)||||||
1499040|NCT00995345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499041|NCT00995332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499042|NCT00995319|||Cohort||Prospective|||||||
1499043|NCT00995306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499044|NCT00995293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499045|NCT00995280|Randomized|Parallel Assignment||||Single|||t|||
1499046|NCT00995267|Randomized|Parallel Assignment||Prevention||Single||||||t
1499047|NCT00995254|Randomized|Single Group Assignment||Prevention||Single||||||t
1499048|NCT00995241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499049|NCT00995228|||||Prospective|||||||
1499050|NCT00995215||Single Group Assignment||Treatment||None (Open Label)||||||
1499051|NCT00995202|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1499052|NCT00995189|Non-Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1499053|NCT00995176|||Cohort||Prospective|||||||
1499054|NCT00995163|||Cohort||Prospective|||||||
1499055|NCT00995150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499056|NCT00995137||Single Group Assignment||Treatment||None (Open Label)||||||
1499057|NCT00995124|Randomized|Parallel Assignment||Treatment||Single||||||t
1499058|NCT00995098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499059|NCT00995085||Single Group Assignment||Treatment||None (Open Label)||||||
1499060|NCT00995072|Non-Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499061|NCT00995059||Single Group Assignment||Treatment||None (Open Label)||||||
1499062|NCT00995046|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1499063|NCT00995033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499064|NCT00995020|Randomized|Parallel Assignment||Treatment||Single||||||t
1499065|NCT00995007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499066|NCT00994994|Randomized|Parallel Assignment||Treatment||Single||||t||
1499067|NCT00994981|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499068|NCT00994968||||Treatment||None (Open Label)||||||
1499069|NCT00994955||Single Group Assignment||Treatment||Single||||||t
1499070|NCT00994942|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499071|NCT00994929||Single Group Assignment||Treatment||None (Open Label)||||||
1499072|NCT00994916||||||||||||
1499073|NCT00994903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499074|NCT00994890|Randomized|Parallel Assignment||||Double|||t||t|
1499075|NCT00994877|||Cohort||Prospective|||||||
1499076|NCT00994864||Single Group Assignment||Treatment||None (Open Label)||||||
1499077|NCT00994851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499078|NCT00994838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499079|NCT00994825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499080|NCT00994812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499081|NCT00994799|||Cohort||Prospective|||||||
1499082|NCT00994786|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1499083|NCT00994773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499084|NCT00994760|||Cohort||Prospective|||||||
1499085|NCT00994747|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1499086|NCT00994734|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499087|NCT00994721|||Case Control||Prospective|||||||
1499088|NCT00994708||||||||||||
1499089|NCT00994695||Parallel Assignment||Prevention||None (Open Label)||||||
1499090|NCT00994682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499091|NCT00994669|||Case Control||Prospective|||||||
1499092|NCT00994656|||Cohort||Prospective|||||||
1499093|NCT00994643||Single Group Assignment||Treatment||None (Open Label)||||||
1499094|NCT00994630|||||Prospective|||||||
1499095|NCT00994617|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499096|NCT00994604||Single Group Assignment||Basic Science||None (Open Label)||||||
1499097|NCT00994591||Single Group Assignment||Basic Science||None (Open Label)||||||
1499098|NCT00994578|Randomized|Factorial Assignment||||None (Open Label)||||||
1499099|NCT00994565|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499100|NCT00994552|Randomized|Crossover Assignment||Treatment||Single|||t|||
1499101|NCT00994539|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499102|NCT00994526|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1499103|NCT00994513|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1499104|NCT00994500||Single Group Assignment||Treatment||None (Open Label)||||||
1499105|NCT00994487|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1499106|NCT00994474|Randomized|Single Group Assignment||Diagnostic||Triple|||t||t|t
1499107|NCT00994461|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499108|NCT00994448|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499109|NCT00994435|||Case-Only||Prospective|||||||
1499110|NCT00994422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499111|NCT00994409|||Cohort||Prospective|||||||
1499112|NCT00994396|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499113|NCT00994383|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499114|NCT00994370|||Case-Only||Prospective|||||||
1499115|NCT00994357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499116|NCT00994344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499117|NCT00994331|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499118|NCT00994318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499119|NCT00994305|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1499120|NCT00994292|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1499121|NCT00994279|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499122|NCT00994266|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499123|NCT00994253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499124|NCT00994240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499125|NCT00994227||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499126|NCT00994214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499127|NCT00994201|||Case-Only||Prospective|||||||
1499128|NCT00994188||Single Group Assignment||Treatment||None (Open Label)||||||
1499129|NCT00994175|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1499130|NCT00994162|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499131|NCT00994149|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499132|NCT00994136|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499133|NCT00994123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499134|NCT00994110|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499135|NCT00994097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499136|NCT00994084|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1499137|NCT00994071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499138|NCT00994058|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1499139|NCT00994045|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499140|NCT00994032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499141|NCT00994019|||Cohort||Prospective|||||||
1499142|NCT00994006|Randomized|Crossover Assignment||Treatment||Single|||t|||
1499143|NCT00993993|||Case-Only||Prospective|||||||
1499144|NCT00993980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499145|NCT00993967||Single Group Assignment||Treatment||None (Open Label)||||||
1499146|NCT00993954|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499147|NCT00993941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499148|NCT00993928|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499149|NCT00993915|||Case-Only||Prospective|||||||
1499150|NCT00993902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499151|NCT00993889|Randomized|Parallel Assignment||Treatment||Single||||t||
1499152|NCT00993876|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1499153|NCT00993863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499154|NCT00993850|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499155|NCT00993837|Randomized|Parallel Assignment||Treatment||Single||||||t
1499156|NCT00993824|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1499157|NCT00993811||Single Group Assignment||Prevention||None (Open Label)||||||
1499158|NCT00993798|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499159|NCT00993785||||||||||||
1499160|NCT00993772||||||||||||
1499161|NCT00993759|Randomized|Parallel Assignment||Prevention||Single||||||t
1499162|NCT00993746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499163|NCT00993733|Randomized|Parallel Assignment||||None (Open Label)||||||
1499164|NCT00993720|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499165|NCT00993707|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1499166|NCT00993694||||||||||||
1499167|NCT00993681|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499168|NCT00993668|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499169|NCT00993655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499170|NCT00993642||Single Group Assignment||Basic Science||None (Open Label)||||||
1499171|NCT00993629|Randomized|Parallel Assignment||Treatment||Double||||||
1499172|NCT00993616||Single Group Assignment||Treatment||None (Open Label)||||||
1499173|NCT00993603||Single Group Assignment||Prevention||None (Open Label)||||||
1499174|NCT00993590|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499175|NCT00993577|Randomized|Parallel Assignment||Treatment||Single|||||t|
1499176|NCT00993564|||Case-Only||Prospective|||||||
1499177|NCT00993551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499178|NCT00993538||Single Group Assignment||Basic Science||None (Open Label)||||||
1499179|NCT00993525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499180|NCT00993512||Single Group Assignment||Treatment||None (Open Label)||||||
1499181|NCT00993499||Single Group Assignment||Treatment||None (Open Label)||||||
1499182|NCT00993486|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499183|NCT00993473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499184|NCT00993460|||Cohort||Prospective|||||||
1499185|NCT00993447|Randomized|Parallel Assignment||Prevention||Single||||||t
1499186|NCT00993434|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499187|NCT00993421|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499188|NCT00993408|Randomized|Parallel Assignment||||||||||
1499189|NCT00993395||Single Group Assignment||Supportive Care||None (Open Label)||||||
1499190|NCT00993382|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1499191|NCT00993369|||Case Control||Prospective|||||||
1499192|NCT00993356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499193|NCT00993343|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499194|NCT00993330|||Case-Only||Prospective|||||||
1499195|NCT00993317|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499196|NCT00993304|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1499197|NCT00993291||Single Group Assignment||Treatment||Double|||t||t|
1499198|NCT00993278|Randomized|Parallel Assignment||Treatment||Single|||||t|
1499199|NCT00993265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499200|NCT00993252||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499201|NCT00993239||Single Group Assignment||Treatment||None (Open Label)||||||
1499202|NCT00993226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499203|NCT00993213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499204|NCT00993200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499205|NCT00993187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499206|NCT00993174|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1499207|NCT00993161|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1499208|NCT00993148||Single Group Assignment||Treatment||None (Open Label)||||||
1499209|NCT00993135|||Cohort||Retrospective|||||||
1499210|NCT00993122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499211|NCT00993109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499212|NCT00993096|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1499213|NCT00993083|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499214|NCT00993070|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1499215|NCT00993057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499216|NCT00993044||Single Group Assignment||Treatment||None (Open Label)||||||
1499217|NCT00993031|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499218|NCT00993018|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499219|NCT00993005|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499220|NCT00992992||Single Group Assignment||Treatment||None (Open Label)||||||
1499221|NCT00992979|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1499222|NCT00992966|||Cohort||Prospective|||||||
1499223|NCT00992953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499224|NCT00992940|Randomized|Parallel Assignment||Treatment||Single||||||t
1499225|NCT00992927|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1499226|NCT00992914|Randomized|Parallel Assignment||Treatment||Single||||t||
1499227|NCT00992901|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1499228|NCT00992888|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1499229|NCT00992875|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1499230|NCT00992862|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499231|NCT00992849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499232|NCT00992836||Single Group Assignment||Prevention||None (Open Label)||||||
1499233|NCT00992823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499234|NCT00992810|Randomized|Parallel Assignment||Treatment||Single||||||t
1499235|NCT00992797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499236|NCT00992784|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499237|NCT00992771|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499238|NCT00992758||Single Group Assignment||Treatment||None (Open Label)||||||
1499239|NCT00992745|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1499240|NCT00992732||Single Group Assignment||Treatment||None (Open Label)||||||
1499241|NCT00992719|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499242|NCT00992706|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1499243|NCT00992693||Single Group Assignment||Treatment||None (Open Label)||||||
1499244|NCT00992680|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499245|NCT00992667|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499246|NCT00992654||||||||||||
1499247|NCT00992641|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499248|NCT00992628|Randomized|Parallel Assignment||Prevention||Single||||||t
1499249|NCT00992615||||||||||||
1499250|NCT00992602||Single Group Assignment||Treatment||None (Open Label)||||||
1499251|NCT00992589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499252|NCT00992576|Randomized|Parallel Assignment||Treatment||Double||||||
1499253|NCT00992563|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1499254|NCT00992550|Randomized|Crossover Assignment||||None (Open Label)||||||
1499255|NCT00992537|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499256|NCT00992524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499257|NCT00992511|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1499258|NCT00992498|||Cohort||Prospective|||||||
1499259|NCT00992485||Single Group Assignment||Treatment||None (Open Label)||||||
1499260|NCT00992472|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499261|NCT00992459|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499262|NCT00992446||Single Group Assignment||Treatment||None (Open Label)||||||
1499263|NCT00992433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499264|NCT00992420|||Cohort||Prospective|||||||
1499265|NCT00992407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499266|NCT00992394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499267|NCT00992381|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1499268|NCT00992368|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499269|NCT00992355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499270|NCT00992342|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1499271|NCT00992329|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1499272|NCT00992316|||Cohort||Prospective|||||||
1499273|NCT00992303|||Case-Only||Cross-Sectional|||||||
1499274|NCT00992290|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499275|NCT00992277||Single Group Assignment||Treatment||Single||||||t
1499276|NCT00992264|Randomized|Factorial Assignment||Treatment||Single|||t|||
1499277|NCT00992251|||Case-Only||Prospective|||||||
1499278|NCT00992238|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499279|NCT00992225||Single Group Assignment||Treatment||None (Open Label)||||||
1499280|NCT00992212|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499281|NCT00992199|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499282|NCT00992186||Single Group Assignment||Treatment||None (Open Label)||||||
1499283|NCT00992173||Single Group Assignment||Treatment||None (Open Label)||||||
1499284|NCT00992160|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499285|NCT00992147||Single Group Assignment||Treatment||None (Open Label)||||||
1499286|NCT00992134|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499287|NCT00992121|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1499288|NCT00992108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499289|NCT00992095|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499290|NCT00992082|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499291|NCT00992069||Crossover Assignment||Treatment||None (Open Label)||||||
1499292|NCT00992056|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499293|NCT00992043|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499294|NCT00992030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499295|NCT00992017|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1499296|NCT00992004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499297|NCT00991991|||||Prospective|||||||
1499298|NCT00991978||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499299|NCT00991965|||Cohort||Prospective|||||||
1499300|NCT00991952|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499301|NCT00991939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499302|NCT00991926|||Case Control||Cross-Sectional|||||||
1499303|NCT00991913|||Cohort||Prospective|||||||
1499304|NCT00991900|||Other||Prospective|||||||
1499305|NCT00991887|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499306|NCT00991874|||Cohort||Prospective|||||||
1499307|NCT00991861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499308|NCT00991848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499309|NCT00991835|||Cohort||Prospective|||||||
1499310|NCT00991822|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1499311|NCT00991809|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1499312|NCT00991796|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499313|NCT00991783||Single Group Assignment||||None (Open Label)||||||
1499314|NCT00991770|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1499315|NCT00991757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499316|NCT00991744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499317|NCT00991731|Randomized|Factorial Assignment||||None (Open Label)||||||
1499318|NCT00991718|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1499319|NCT00991705|Randomized|Crossover Assignment||||None (Open Label)||||||
1499320|NCT00991692|Randomized|Factorial Assignment||Treatment||Single||||||t
1499321|NCT00991679|||Case Control||Prospective|||||||
1499322|NCT00991666|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499323|NCT00991653|||Cohort||Cross-Sectional|||||||
1499324|NCT00991640|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1499325|NCT00991627|Randomized|Parallel Assignment||Treatment||Single||||||t
1499326|NCT00991614|||Case-Only||Prospective|||||||
1499327|NCT00991601|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1499328|NCT00991588|||Cohort||Prospective|||||||
1499329|NCT00991575|||Cohort||Prospective|||||||
1499330|NCT00991562||Single Group Assignment||Treatment||None (Open Label)||||||
1499331|NCT00991549|Randomized|Parallel Assignment||Prevention||Single||||||t
1499332|NCT00991536|||Case-Only||Retrospective|||||||
1499333|NCT00991523|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1499334|NCT00991510|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499335|NCT00991497|Randomized|Parallel Assignment||Treatment||Single||||||t
1499336|NCT00991484|||Family-Based||Prospective|||||||
1499337|NCT00991471|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499338|NCT00991458|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499339|NCT00991445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499340|NCT00991432|||Cohort||Prospective|||||||
1499341|NCT00991419|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1499342|NCT00991406||Single Group Assignment||Treatment||None (Open Label)||||||
1499343|NCT00991393|||Cohort||Prospective|||||||
1499344|NCT00991380|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499345|NCT00991367|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499346|NCT00991354|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1499347|NCT00991341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499348|NCT00991328|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1499349|NCT00991315|||Case-Only||Prospective|||||||
1499350|NCT00991302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499351|NCT00991289||Single Group Assignment||Treatment||None (Open Label)||||||
1499352|NCT00991276|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1499353|NCT00991263|||Case-Only||Retrospective|||||||
1499354|NCT00991250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499355|NCT00991237||Single Group Assignment||Treatment||Single|||||t|
1499356|NCT00991224|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1499357|NCT00991211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499358|NCT00991198|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499359|NCT00991185|||Case-Only||Cross-Sectional|||||||
1499360|NCT00991172|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499361|NCT00991159|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1499362|NCT00991146||Single Group Assignment||Treatment||None (Open Label)||||||
1499363|NCT00991133||Single Group Assignment||Treatment||None (Open Label)||||||
1499364|NCT00991120|||Other||Other|||||||
1499365|NCT00991107|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499366|NCT00991094|||Case-Only||Prospective|||||||
1499367|NCT00991081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499368|NCT00991068||Single Group Assignment||Treatment||None (Open Label)||||||
1499369|NCT00991055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499370|NCT00991042||Single Group Assignment||Health Services Research||None (Open Label)||||||
1499371|NCT00991029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499372|NCT00991016|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1499373|NCT00991003||Single Group Assignment||Prevention||Single|||||t|
1499374|NCT00990990|Randomized|Parallel Assignment||||Double|||t||t|
1499375|NCT00990977|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499376|NCT00990964|||||Prospective|||||||
1499377|NCT00990951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499378|NCT00990938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499379|NCT00990925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499380|NCT00990912|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499381|NCT00990899|||||Cross-Sectional|||||||
1499382|NCT00990886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499383|NCT00990873|||Case-Only||Retrospective|||||||
1499384|NCT00990860|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1499385|NCT00990847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499386|NCT00990834||Single Group Assignment||Basic Science||None (Open Label)||||||
1499387|NCT00990821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499388|NCT00990808|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499389|NCT00990795|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1499390|NCT00990782||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499391|NCT00990769|Randomized|Parallel Assignment||||Double|||t|||t
1499392|NCT00990756|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1499393|NCT00990743||Single Group Assignment||Treatment||Single|||||t|
1499394|NCT00990730|||Cohort||Cross-Sectional|||||||
1499395|NCT00990717||Single Group Assignment||Treatment||None (Open Label)||||||
1499396|NCT00990704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499397|NCT00990691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499398|NCT00990678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499399|NCT00990665||Single Group Assignment||Treatment||None (Open Label)||||||
1499400|NCT00990652||Single Group Assignment||Treatment||None (Open Label)||||||
1499401|NCT00990639|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499402|NCT00990626|||Cohort||Prospective|||||||
1499403|NCT00990613|Randomized|Crossover Assignment||||Double|||t||t|
1499404|NCT00990600||Single Group Assignment||Treatment||None (Open Label)||||||
1499405|NCT00990587|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499406|NCT00990574|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1499407|NCT00990561|Randomized|Parallel Assignment||Treatment||Single|||||t|
1499408|NCT00990548|||Cohort||Prospective|||||||
1499409|NCT00990535|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499410|NCT00990522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499411|NCT00990509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499412|NCT00990496||Single Group Assignment||Treatment||None (Open Label)||||||
1499413|NCT00990483||||||||||||
1499414|NCT00990470|||Cohort||Prospective|||||||
1499415|NCT00990457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499416|NCT00990444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499417|NCT00990431|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1499418|NCT00990418|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499419|NCT00990405|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499420|NCT00990392|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499421|NCT00990379|||Cohort|||||||||
1499422|NCT00990366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499423|NCT00990353|||Other||Prospective|||||||
1499424|NCT00990340|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499425|NCT00990327|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1499426|NCT00990314|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499427|NCT00990301|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499428|NCT00990288|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1499429|NCT00990275|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499430|NCT00990262|||Cohort||Prospective|||||||
1499431|NCT00990249||Single Group Assignment||Treatment||None (Open Label)||||||
1499432|NCT00990236|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1499433|NCT00990223|Randomized|Single Group Assignment||||Double|||t||t|
1499434|NCT00990210||||||||||||
1499435|NCT00990197|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499436|NCT00990184||Single Group Assignment||Treatment||Single|||t|||
1499437|NCT00990171|||Cohort||Prospective|||||||
1499438|NCT00990158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499439|NCT00990145|Randomized|||||Triple|||t||t|t
1499440|NCT00990132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499441|NCT00990119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499442|NCT00990106|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499443|NCT00990093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499444|NCT00990080|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499445|NCT00990067|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1499446|NCT00990054||Single Group Assignment||Treatment||None (Open Label)||||||
1499447|NCT00990041|||Case Control||Cross-Sectional|||||||
1499448|NCT00990028|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1499449|NCT00990015|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1499450|NCT00990002|||Cohort||Prospective|||||||
1499451|NCT00989989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499452|NCT00989976|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1499453|NCT00989963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499454|NCT00989950|Randomized|Crossover Assignment||Treatment||Single|||t|||
1499455|NCT00989937|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1499456|NCT00989924|||Case-Only||Cross-Sectional|||||||
1499457|NCT00989911||Single Group Assignment||Supportive Care||None (Open Label)||||||
1499458|NCT00989898|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499459|NCT00989885|||Ecologic or Community||Retrospective|||||||
1499460|NCT00989872|Randomized|||Treatment||Triple|||t||t|t
1499461|NCT00989859|||Case-Only||Prospective|||||||
1499462|NCT00989846|||Cohort||Prospective|||||||
1499463|NCT00989833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499464|NCT00989820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499465|NCT00989807||||||||||||
1499466|NCT00989794||Single Group Assignment||Treatment||None (Open Label)||||||
1499467|NCT00989781|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1499468|NCT00989768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499469|NCT00989755|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1499470|NCT00989742|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499471|NCT00989729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499472|NCT00989716|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499473|NCT00989703|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1499474|NCT00989690|Randomized|||Treatment||None (Open Label)||||||
1499475|NCT00989677|||Case-Only||Cross-Sectional|||||||
1499476|NCT00989664||Single Group Assignment||Treatment||None (Open Label)||||||
1499477|NCT00989651|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499478|NCT00989638|||Case-Only||Prospective|||||||
1499479|NCT00989625|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1499480|NCT00989612||Single Group Assignment||Prevention||None (Open Label)||||||
1499481|NCT00989599|Randomized|Parallel Assignment||Treatment||Single||||||t
1499482|NCT00989586|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499483|NCT00989573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499484|NCT00989560|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499485|NCT00989547|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499486|NCT00989534|Randomized|Parallel Assignment||||None (Open Label)||||||
1499487|NCT00989521|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499488|NCT00989508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499489|NCT00989495|Randomized|Parallel Assignment||Treatment||Single||||||t
1499490|NCT00989482|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1499491|NCT00989469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499492|NCT00989456|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499493|NCT00989443||Single Group Assignment||Treatment||None (Open Label)||||||
1499494|NCT00989430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499495|NCT00989417|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499496|NCT00989404|Randomized|Crossover Assignment||Other||Triple|||t|t|t|
1499497|NCT00989391|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1499498|NCT00989378|||Cohort|||||||||
1499499|NCT00989365|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499500|NCT00989352|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499501|NCT00989339|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1499502|NCT00989326|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499503|NCT00989313|||Case-Only||Prospective|||||||
1499504|NCT00989300|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499505|NCT00989287|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1499506|NCT00989274|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499507|NCT00989261|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499508|NCT00989248|Randomized|Single Group Assignment||Treatment||Single|||||t|
1499509|NCT00989235|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499510|NCT00989222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499511|NCT00989209|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499512|NCT00989196|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499513|NCT00989183|||Other||Prospective|||||||
1499514|NCT00989170|Randomized|Parallel Assignment||Prevention||Single|||t|||
1499515|NCT00989157||Single Group Assignment||Basic Science||None (Open Label)||||||
1499516|NCT00989144|||Cohort||Prospective|||||||
1499517|NCT00989131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499518|NCT00989118||Parallel Assignment||||||||||
1499519|NCT00989105||||Diagnostic||None (Open Label)||||||
1499520|NCT00989092|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499521|NCT00989079|Randomized|Crossover Assignment||||Double|||t||t|
1499522|NCT00989066|||Cohort||Prospective|||||||
1499523|NCT00989053|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499524|NCT00989040|||Case Control||Cross-Sectional|||||||
1499525|NCT00989027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499526|NCT00989014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499527|NCT00989001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499528|NCT00988988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499529|NCT00988975|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1499530|NCT00988962|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499531|NCT00988949|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1499532|NCT00988936|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1499533|NCT00988923|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1499534|NCT00988910|||Cohort||Prospective|||||||
1499535|NCT00988897|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499536|NCT00988884|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499537|NCT00988871|||Case-Only||Prospective|||||||
1499538|NCT00988858||Single Group Assignment||Treatment||None (Open Label)||||||
1499539|NCT00988845||Single Group Assignment||Prevention||None (Open Label)||||||
1499540|NCT00988832|||Case-Only||Retrospective|||||||
1499541|NCT00988819|||Case Control||Prospective|||||||
1499542|NCT00988806|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499543|NCT00988793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499544|NCT00988780|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1499545|NCT00988767||Single Group Assignment||Treatment||None (Open Label)||||||
1499546|NCT00988754|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499547|NCT00988741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499548|NCT00988728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499549|NCT00988715||Single Group Assignment||Treatment||None (Open Label)||||||
1499550|NCT00988702|Randomized|Parallel Assignment||Basic Science||Single||||||t
1499551|NCT00988689|Randomized|Crossover Assignment||Prevention||Single|||t|||
1499552|NCT00988676|||Cohort||Prospective|||||||
1499553|NCT00988663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499554|NCT00988650|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1499555|NCT00988637|Randomized|Parallel Assignment||Treatment||Single||||||t
1499556|NCT00988624|Randomized|Crossover Assignment||||None (Open Label)||||||
1499557|NCT00988611|||Other||Prospective|||||||
1499558|NCT00988598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499559|NCT00988585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499560|NCT00988572|Randomized|Parallel Assignment||Treatment||Single||||||t
1499561|NCT00988559|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499562|NCT00988546|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499563|NCT00988533||Single Group Assignment||Treatment||None (Open Label)||||||
1499564|NCT00988520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499565|NCT00988507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499566|NCT00988494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499567|NCT00988481||Single Group Assignment||Treatment||None (Open Label)||||||
1499568|NCT00988468|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1499569|NCT00988455|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499570|NCT00988442|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1499571|NCT00988429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499572|NCT00988416|||Case-Only||Prospective|||||||
1499573|NCT00988403|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1499574|NCT00988390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499575|NCT00988377|Randomized|Crossover Assignment||Prevention||Single|||t|||
1499576|NCT00988364|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1499577|NCT00988351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499578|NCT00988338||Single Group Assignment||Treatment||None (Open Label)||||||
1499579|NCT00988325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499580|NCT00988312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499581|NCT00988299|Randomized|Crossover Assignment||||None (Open Label)||||||
1499582|NCT00988286||Single Group Assignment||Basic Science||None (Open Label)||||||
1499583|NCT00988273|||Case-Control||Prospective|||||||
1499584|NCT00988260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499585|NCT00988247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499586|NCT00988234|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1499587|NCT00988221|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499588|NCT00988208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499589|NCT00988195||Single Group Assignment||Treatment||None (Open Label)||||||
1499590|NCT00988182|Randomized|Crossover Assignment||Prevention||Single|||t|||
1499591|NCT00988169||Single Group Assignment||Treatment||None (Open Label)||||||
1499592|NCT00988156|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499593|NCT00988143|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499594|NCT00988130||||Treatment||None (Open Label)||||||
1499595|NCT00988117||Single Group Assignment||Treatment||None (Open Label)||||||
1499596|NCT00988104|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1499597|NCT00988091|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499598|NCT00988078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499599|NCT00988065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499600|NCT00988052||Single Group Assignment||Treatment||None (Open Label)||||||
1499601|NCT00988039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499602|NCT00988026|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1499603|NCT00988013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499604|NCT00988000|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499605|NCT00987987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499606|NCT00987974|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499607|NCT00987961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499608|NCT00987948||Single Group Assignment||Treatment||None (Open Label)||||||
1499609|NCT00987935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499610|NCT00987922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499611|NCT00987909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499612|NCT00987896||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499613|NCT00987883|||Cohort||Prospective|||||||
1499614|NCT00987870|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1499615|NCT00987857|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1499616|NCT00987844||Single Group Assignment||Treatment||None (Open Label)||||||
1499617|NCT00987831|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499618|NCT00987818|Randomized|Single Group Assignment||Treatment||Single|||t|||
1499619|NCT00987805|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499620|NCT00987792|||Cohort||Prospective|||||||
1499621|NCT00987779|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499622|NCT00987766||Single Group Assignment||Treatment||None (Open Label)||||||
1499623|NCT00987753|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499624|NCT00987740||Single Group Assignment||Treatment||None (Open Label)||||||
1499625|NCT00987727|Randomized|Parallel Assignment||Treatment||Single|||||t|
1499626|NCT00987714|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499627|NCT00987701|Randomized|Parallel Assignment||Treatment||Single||||||t
1499628|NCT00987688|Randomized|Parallel Assignment||Treatment||Single||||||t
1499629|NCT00987675||||Treatment||||||||
1499630|NCT00987662|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1499631|NCT00987649|||Case-Only||Prospective|||||||
1499632|NCT00987636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499633|NCT00987623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499634|NCT00987610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499635|NCT00987597|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499636|NCT00987584|||Cohort||Prospective|||||||
1499637|NCT00987571|||Case Control||Prospective|||||||
1499638|NCT00987558|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499639|NCT00987545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499640|NCT00987532|Randomized|Parallel Assignment||Prevention||Single||||||t
1499641|NCT00987519|||Case Control||Prospective|||||||
1499642|NCT00987506|||Cohort||Prospective|||||||
1499643|NCT00987493||Single Group Assignment||Treatment||None (Open Label)||||||
1499644|NCT00987480||Single Group Assignment||Treatment||None (Open Label)||||||
1499645|NCT00987467||Single Group Assignment||Treatment||None (Open Label)||||||
1499646|NCT00987454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499647|NCT00987441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499648|NCT00987428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499649|NCT00987415|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499650|NCT00987402|Randomized|Crossover Assignment||Prevention||Single||||||t
1499651|NCT00987389|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1499652|NCT00987376||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499653|NCT00987363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499654|NCT00987350|Randomized|Parallel Assignment||Device Feasibility||Quadruple|||t|t|t|t
1499655|NCT00987337|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499656|NCT00987324|Randomized|Parallel Assignment||Treatment||Single||||||t
1499657|NCT00987311|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1499658|NCT00987298|||Cohort||Cross-Sectional|||||||
1499659|NCT00987285|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499660|NCT00987272|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499661|NCT00987259|||Cohort||Retrospective|||||||
1499662|NCT00987246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499663|NCT00987233|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499664|NCT00987220|||Case Control||Cross-Sectional|||||||
1499665|NCT00987207|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499666|NCT00987194|||||Prospective|||||||
1499667|NCT00987181|||Case Control||Cross-Sectional|||||||
1499668|NCT00987168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499669|NCT00987155||Single Group Assignment||Basic Science||None (Open Label)||||||
1499670|NCT00987142|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499671|NCT00987129|||Cohort||Prospective|||||||
1499672|NCT00987116|Randomized|Parallel Assignment||Treatment||Single||||||t
1499673|NCT00987103|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499674|NCT00987090|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1499675|NCT00987077|Randomized|Crossover Assignment||Treatment||Single|||||t|
1499676|NCT00987064|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499677|NCT00987051||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499678|NCT00987038|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499679|NCT00987025|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499680|NCT00987012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499681|NCT00986999||Single Group Assignment||Treatment||None (Open Label)||||||
1499682|NCT00986986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499683|NCT00986973||Single Group Assignment||Treatment||Single||||||t
1499684|NCT00986960|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1499685|NCT00986947||Single Group Assignment||Treatment||None (Open Label)||||||
1499686|NCT00986921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499687|NCT00986908||||||||||||
1499688|NCT00986895||||Treatment||None (Open Label)||||||
1499689|NCT00986882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499690|NCT00986869|||Case-Only||Prospective|||||||
1499691|NCT00986856|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499692|NCT00986843|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499693|NCT00986830|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499694|NCT00986817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499695|NCT00986804|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499696|NCT00986791|Randomized|Parallel Assignment||Prevention||Single||||||t
1499697|NCT00986778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499698|NCT00986765|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499699|NCT00986752|Randomized|Parallel Assignment||Treatment||Single||||||t
1499700|NCT00986739|||Cohort||Prospective|||||||
1499701|NCT00986713|Randomized|Parallel Assignment||Prevention||Single|||t|||
1499702|NCT00986700||Single Group Assignment||Treatment||None (Open Label)||||||
1499703|NCT00986687|||Cohort||Prospective|||||||
1499704|NCT00986674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499705|NCT00986661||Single Group Assignment||Treatment||None (Open Label)||||||
1499706|NCT00986648|||Cohort||Prospective|||||||
1499707|NCT00986635|||Cohort||Retrospective|||||||
1499708|NCT00986609||Single Group Assignment||Other||None (Open Label)||||||
1499709|NCT00986596|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499710|NCT00986583|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1499711|NCT00986570||Single Group Assignment||Treatment||None (Open Label)||||||
1499712|NCT00986557|Randomized|||Supportive Care||None (Open Label)||||||
1499713|NCT00986544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499714|NCT00986531|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1499715|NCT00986518||Single Group Assignment||Treatment||None (Open Label)||||||
1499716|NCT00986505|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499717|NCT00986492|||||Prospective|||||||
1499718|NCT00986479|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499719|NCT00986466|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1499720|NCT00986453|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499721|NCT00986440|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499722|NCT00986427|Randomized|Parallel Assignment||Treatment||Single|||||t|
1499723|NCT00986414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499724|NCT00986401|Randomized|Crossover Assignment||||None (Open Label)||||||
1499725|NCT00986375|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1499726|NCT00986362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499727|NCT00986349||Single Group Assignment||Treatment||None (Open Label)||||||
1499728|NCT00986336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499729|NCT00986323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499730|NCT00986310|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1499731|NCT00986297||Single Group Assignment||Treatment||None (Open Label)||||||
1499732|NCT00986284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499733|NCT00986271||Parallel Assignment||Diagnostic||None (Open Label)||||||
1499734|NCT00986258||Single Group Assignment||Treatment||None (Open Label)||||||
1499735|NCT00986245|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499736|NCT00986232|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1499737|NCT00986219|||Case-Only||Cross-Sectional|||||||
1499738|NCT00986206|||Cohort||Prospective|||||||
1499739|NCT00986193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499740|NCT00986180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499741|NCT00986167||Single Group Assignment||Treatment||None (Open Label)||||||
1499742|NCT00986154|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499743|NCT00986141|||||Prospective|||||||
1499744|NCT00986128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499745|NCT00986115|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1499746|NCT00986102||Single Group Assignment||Treatment||None (Open Label)||||||
1499747|NCT00986089|||||Prospective|||||||
1499748|NCT00986076|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1499749|NCT00986063|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499750|NCT00986050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499751|NCT00986037|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1499752|NCT00986024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499753|NCT00986011||||||||||||
1499754|NCT00985998|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499755|NCT00985985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499756|NCT00985972|||||Retrospective|||||||
1499757|NCT00985959|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499758|NCT00985946||Single Group Assignment||Treatment||None (Open Label)||||||
1499759|NCT00985933|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1499760|NCT00985920|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499761|NCT00985907||Single Group Assignment||Treatment||None (Open Label)||||||
1499762|NCT00985894|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499763|NCT00985881|Randomized|Factorial Assignment||Treatment||Single|||t|||
1499764|NCT00985868||||Treatment||None (Open Label)||||||
1499765|NCT00985855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499766|NCT00985842|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499767|NCT00985829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499768|NCT00985816|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499769|NCT00985803|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499770|NCT00985790|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1499771|NCT00985777||Single Group Assignment||Treatment||None (Open Label)||||||
1499772|NCT00985764|||Case-Only||Prospective|||||||
1499773|NCT00985751|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1499774|NCT00985738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499775|NCT00985725|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499776|NCT00985712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499777|NCT00985699|||||Retrospective|||||||
1499778|NCT00985686|Randomized|Parallel Assignment||Treatment||Single||||||t
1499779|NCT00985673|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1499780|NCT00985660|Randomized|Crossover Assignment||||None (Open Label)||||||
1499781|NCT00985647|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1499782|NCT00985634|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499783|NCT00985621|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499784|NCT00985608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499785|NCT00985595|||Case Control||Prospective|||||||
1499786|NCT00985582|||Case-Only||Prospective|||||||
1499787|NCT00985569|||Cohort||Prospective|||||||
1499788|NCT00985556|Randomized|||Treatment||None (Open Label)||||||
1499789|NCT00985543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499790|NCT00985530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499791|NCT00985517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499792|NCT00985504|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499793|NCT00985491||Single Group Assignment||Treatment||None (Open Label)||||||
1499794|NCT00985478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499795|NCT00985465|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499796|NCT00985452|Randomized|Factorial Assignment||||None (Open Label)||||||
1499797|NCT00985439|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499798|NCT00985426|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1499799|NCT00985413|||Cohort|||||||||
1499800|NCT00985400|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499801|NCT00985387|||Cohort||Prospective|||||||
1499802|NCT00985374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499803|NCT00985361|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499804|NCT00985348|Randomized|Crossover Assignment||||None (Open Label)||||||
1499805|NCT00985335||Single Group Assignment||Treatment||None (Open Label)||||||
1499806|NCT00985322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499807|NCT00985309|||Cohort||Retrospective|||||||
1499808|NCT00985296|||Case Control||Prospective|||||||
1499809|NCT00985283|Randomized|Parallel Assignment||Prevention||Single||||||t
1499810|NCT00985270|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1499811|NCT00985257||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499812|NCT00985244|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499813|NCT00985231|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499814|NCT00985218|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499815|NCT00985205|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1499816|NCT00985192||Single Group Assignment||Treatment||None (Open Label)||||||
1499817|NCT00985179|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499818|NCT00985166|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1499819|NCT00985153|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1499820|NCT00985140|||Cohort||Prospective|||||||
1499821|NCT00985127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499822|NCT00985114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499823|NCT00985101|||Case Control|||||||||
1499824|NCT00985088|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1499825|NCT00985075|||Case-Only||Prospective|||||||
1499826|NCT00985062|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1499827|NCT00985049|||Cohort||Prospective|||||||
1499828|NCT00985036|||Case Control||Prospective|||||||
1499829|NCT00985023|Randomized|Parallel Assignment||Treatment||Single||||||t
1499830|NCT00985010|||Case-Only||Prospective|||||||
1499831|NCT00984997||Single Group Assignment||Treatment||None (Open Label)||||||
1499832|NCT00984984|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499833|NCT00984971|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1499834|NCT00984958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499835|NCT00984945|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1499836|NCT00984932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499837|NCT00984919|||Case Control||Prospective|||||||
1499838|NCT00984906|Randomized|Crossover Assignment||||None (Open Label)||||||
1499839|NCT00984893|||Cohort||Prospective|||||||
1499840|NCT00984880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499841|NCT00984867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499842|NCT00984854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499843|NCT00984841|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499844|NCT00984828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499845|NCT00984815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499846|NCT00984802|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1499847|NCT00984789|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499848|NCT00984776||||Diagnostic||||||||
1499849|NCT00984763|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499850|NCT00984750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499851|NCT00984737||||Diagnostic||||||||
1499852|NCT00984724|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1499853|NCT00984711|||Cohort||Prospective|||||||
1499854|NCT00984698|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1499855|NCT00984685|||Cohort||Retrospective|||||||
1499856|NCT00984672|||Case Control||Prospective|||||||
1499857|NCT00984659|Randomized|Parallel Assignment||Other||Double|||t||t|
1499858|NCT00984646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499859|NCT00984633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499860|NCT00984620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499861|NCT00984607||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499862|NCT00984594|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1499863|NCT00984581|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1499864|NCT00984568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499865|NCT00984555|||Case Control||Prospective|||||||
1499866|NCT00984542||Single Group Assignment||Treatment||None (Open Label)||||||
1499867|NCT00984529|||Case Control||Cross-Sectional|||||||
1499868|NCT00984516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499869|NCT00984503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499870|NCT00984490||Single Group Assignment||Treatment||None (Open Label)||||||
1499871|NCT00984477|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1499872|NCT00984464||Single Group Assignment||Treatment||None (Open Label)||||||
1499873|NCT00984451|||Cohort||Prospective|||||||
1499874|NCT00984438|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499875|NCT00984425|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499876|NCT00984412||Single Group Assignment||Treatment||None (Open Label)||||||
1499877|NCT00984399||Parallel Assignment||Treatment||Double|||t||t|
1499878|NCT00984386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499879|NCT00984373|||||Prospective|||||||
1499880|NCT00984360|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499881|NCT00984347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499882|NCT00984334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499883|NCT00984321|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499884|NCT00984308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499885|NCT00984295|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1499886|NCT00984282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499887|NCT00984269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499888|NCT00984256|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1499889|NCT00984243||Single Group Assignment||Prevention||None (Open Label)||||||
1499890|NCT00984230|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1499891|NCT00984217||Single Group Assignment||Treatment||None (Open Label)||||||
1499892|NCT00984204|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499893|NCT00984191|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1499894|NCT00984178|Randomized|Parallel Assignment||Treatment||Single||||||t
1499895|NCT00984165|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499896|NCT00984152|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499897|NCT00984139||Single Group Assignment||Prevention||None (Open Label)||||||
1499898|NCT00984126|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499899|NCT00984113|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499900|NCT00984100||Single Group Assignment||Treatment||None (Open Label)||||||
1499901|NCT00984087||Single Group Assignment||Treatment||None (Open Label)||||||
1499902|NCT00984074||||||||||||
1499903|NCT00984061|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499904|NCT00984048|||Case-Only||Prospective|||||||
1499905|NCT00984035|||Case-Only||Prospective|||||||
1499906|NCT00984022|Randomized|Parallel Assignment||Treatment||None (Open Label)||Aquacel vs. Iodoform Gauze||||
1499907|NCT00984009|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499908|NCT00983996|Randomized|Crossover Assignment||||None (Open Label)||||||
1499909|NCT00983983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499910|NCT00983970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499911|NCT00983957||Single Group Assignment||||None (Open Label)||||||
1499912|NCT00983944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499913|NCT00983931|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499914|NCT00983918|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1499915|NCT00983905|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499916|NCT00983892|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1499917|NCT00983879|||Case-Only||Prospective|||||||
1499918|NCT00983866|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499919|NCT00983853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499920|NCT00983840|Randomized|Single Group Assignment||Prevention||Single|||t|||
1499921|NCT00983827||Single Group Assignment||Supportive Care||None (Open Label)||||||
1499922|NCT00983814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499923|NCT00983801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499924|NCT00983788|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499925|NCT00983775|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1499926|NCT00983762|||Case Control||Prospective|||||||
1499927|NCT00983749|Randomized|Parallel Assignment||Treatment||Single|||t|||
1499928|NCT00983736|Randomized|Parallel Assignment||||Double|||t||t|
1499929|NCT00983723|||Cohort||Prospective|||||||
1499930|NCT00983710|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1499931|NCT00983697||Single Group Assignment||Diagnostic||None (Open Label)||||||
1499932|NCT00983684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499933|NCT00983671|||Case Control||Cross-Sectional|||||||
1499934|NCT00983658|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499935|NCT00983645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499936|NCT00983632||Single Group Assignment||Basic Science||None (Open Label)||||||
1499937|NCT00983619||Single Group Assignment||Treatment||None (Open Label)||||||
1499938|NCT00983606|||Cohort||Prospective|||||||
1499939|NCT00983593|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499940|NCT00983580|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1499941|NCT00983567|Randomized|Parallel Assignment||Prevention||Single|||t|||
1499942|NCT00983554|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499943|NCT00983541||Single Group Assignment||Treatment||None (Open Label)||||||
1499944|NCT00983528||Single Group Assignment||Treatment||None (Open Label)||||||
1499945|NCT00983515|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499946|NCT00983502|||Cohort||Prospective|||||||
1499947|NCT00983489|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499948|NCT00983476|Randomized|Parallel Assignment||Treatment||Single||||||t
1499949|NCT00983463|||Case-Control||Prospective|||||||
1499950|NCT00983450|Randomized|Parallel Assignment||Treatment||Single||||||t
1499951|NCT00983437|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499952|NCT00983424|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499953|NCT00983411|||Other||Prospective|||||||
1499954|NCT00983398||Single Group Assignment||Treatment||None (Open Label)||||||
1499955|NCT00983385||Single Group Assignment||Treatment||None (Open Label)||||||
1499956|NCT00983372|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499957|NCT00983359||Single Group Assignment||Treatment||None (Open Label)||||||
1499958|NCT00983346||Single Group Assignment||Prevention||None (Open Label)||||||
1499959|NCT00983333|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1499960|NCT00983320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499961|NCT00983307||Single Group Assignment||Treatment||None (Open Label)||||||
1499962|NCT00983294|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1499963|NCT00983281|||Cohort||Retrospective|||||||
1499964|NCT00983268||Single Group Assignment||Treatment||None (Open Label)||||||
1499965|NCT00983255|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1499966|NCT00983242|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499967|NCT00983229|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1499968|NCT00983216|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1499969|NCT00983203|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1499970|NCT00983190||Single Group Assignment||Treatment||None (Open Label)||||||
1499971|NCT00983177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1499972|NCT00983164|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1499973|NCT00983151|Randomized|Parallel Assignment||||Double|||t||t|
1499974|NCT00983138||Single Group Assignment||Treatment||None (Open Label)||||||
1499975|NCT00983125|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1499976|NCT00983112|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1499977|NCT00983099|Randomized|Parallel Assignment||||Double|||t||t|
1499978|NCT00983086|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1499979|NCT00983073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499980|NCT00983060|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1499981|NCT00983047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499982|NCT00983034|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1499983|NCT00983021|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1499984|NCT00983008|Non-Randomized|Single Group Assignment||Health Services Research||Single||||||t
1499985|NCT00982995||Single Group Assignment||Prevention||None (Open Label)||||||
1499986|NCT00982982|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1499987|NCT00982969|||Case-Only||Prospective|||||||
1499988|NCT00982956|||Case Control||Prospective|||||||
1499989|NCT00982943|||Case-Only||Retrospective|||||||
1499990|NCT00982930||Single Group Assignment||Treatment||None (Open Label)||||||
1499991|NCT00982917|Randomized|Parallel Assignment||Prevention||Single|||t|||
1499992|NCT00982904|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1499993|NCT00982891|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1499994|NCT00982878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1499995|NCT00982865|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499996|NCT00982852|||Case Control||Prospective|||||||
1499997|NCT00982839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1499998|NCT00982826|Randomized|Parallel Assignment||||Double|||t||t|
1499999|NCT00982813||Single Group Assignment||Prevention||None (Open Label)||||||
1500000|NCT00982800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500001|NCT00982787|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1500002|NCT00982774|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500003|NCT00982761|||Case Control||Retrospective|||||||
1500004|NCT00982748|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1500005|NCT00982735|||Cohort||Prospective|||||||
1500006|NCT00982722|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1500007|NCT00982709|Randomized|Parallel Assignment||Treatment||Single||||||t
1500008|NCT00982696||Single Group Assignment||Treatment||None (Open Label)||||||
1500009|NCT00982683|||Ecologic or Community||Retrospective|||||||
1500010|NCT00982670|||Case Control||Prospective|||||||
1500011|NCT00982657|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500012|NCT00982644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500013|NCT00982631||Single Group Assignment||Treatment||None (Open Label)||||||
1500014|NCT00982618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500015|NCT00982605|||Case Control||Prospective|||||||
1500016|NCT00982592|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500017|NCT00982579|Randomized|Parallel Assignment||Prevention||Single||||||t
1500018|NCT00982566|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500019|NCT00982553||Single Group Assignment||Treatment||None (Open Label)||||||
1500020|NCT00982540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500021|NCT00982527|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1500022|NCT00982514|||Cohort||Prospective|||||||
1500023|NCT00982501|Randomized|Parallel Assignment||||Double|||t||t|
1500024|NCT00982488|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500025|NCT00982475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500026|NCT00982462|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500027|NCT00982449|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1500028|NCT00982436||Single Group Assignment||Treatment||None (Open Label)||||||
1500029|NCT00982423||Single Group Assignment||Treatment||None (Open Label)||||||
1500030|NCT00982410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500031|NCT00982397|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500032|NCT00982384|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500033|NCT00982371|||Case Control||Prospective|||||||
1500034|NCT00982358|Randomized|Parallel Assignment||Treatment||Double||||||
1500035|NCT00982345||Single Group Assignment||Treatment||None (Open Label)||||||
1500036|NCT00982332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500037|NCT00982319|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1500038|NCT00982306|Randomized|Single Group Assignment||Health Services Research||Single|||||t|
1500039|NCT00982293|Randomized|Parallel Assignment||||Double|||t|||t
1500040|NCT00982280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500041|NCT00982267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500042|NCT00982254|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500043|NCT00982241|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1500044|NCT00982228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500045|NCT00982215|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1500046|NCT00982202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500047|NCT00982189|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1500048|NCT00982176|||Cohort||Prospective|||||||
1500049|NCT00982163|||Cohort||Prospective|||||||
1500050|NCT00982150||Single Group Assignment||Treatment||None (Open Label)||||||
1500051|NCT00982137|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500052|NCT00982124||Single Group Assignment||Supportive Care||None (Open Label)||||||
1500053|NCT00982111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500054|NCT00982098|Randomized|Parallel Assignment||Treatment||Single||||||t
1500055|NCT00982085|||Ecologic or Community||Prospective|||||||
1500056|NCT00982072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500057|NCT00982059|||Case-Only||Retrospective|||||||
1500058|NCT00982046|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1500059|NCT00982033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500060|NCT00982020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500061|NCT00982007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500062|NCT00981994|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500063|NCT00981981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500064|NCT00981968|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500065|NCT00981955|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1500066|NCT00981942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500067|NCT00981929|Non-Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1500068|NCT00981916|||Cohort||Prospective|||||||
1500069|NCT00981903|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1500070|NCT00981890||Single Group Assignment||Treatment||None (Open Label)||||||
1500071|NCT00981877|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1500072|NCT00981864||Single Group Assignment||Treatment||None (Open Label)||||||
1500073|NCT00981851|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1500074|NCT00981838||Single Group Assignment||Treatment||None (Open Label)||||||
1500075|NCT00981825|Randomized|Crossover Assignment||Treatment||Single|||t|||
1500076|NCT00981812||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500077|NCT00981799||Single Group Assignment||Treatment||None (Open Label)||||||
1500078|NCT00981786|Randomized|Crossover Assignment||Treatment||Single|||||t|
1500079|NCT00981773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500080|NCT00981747||Single Group Assignment||Treatment||Double||Participants will receive sildenafil for three months then losartan for three months, then sildenafil and losartan for three months and then placebo for three months in a random order.|t||t|
1500081|NCT00981734|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500082|NCT00981721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500083|NCT00981708||Single Group Assignment||Treatment||None (Open Label)||||||
1500084|NCT00981695|Randomized|Parallel Assignment||||Single||||||t
1500085|NCT00981682||Single Group Assignment||Treatment||None (Open Label)||||||
1500086|NCT00981669|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500087|NCT00981656||Single Group Assignment||Treatment||None (Open Label)||||||
1500088|NCT00981643|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1500089|NCT00981630|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500090|NCT00981617|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500091|NCT00981604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500092|NCT00981591|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500093|NCT00981578||Single Group Assignment||Treatment||None (Open Label)||||||
1500094|NCT00981565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500095|NCT00981552||Single Group Assignment||Treatment||None (Open Label)||||||
1500096|NCT00981539|Randomized|Parallel Assignment||Prevention||Single||||t||
1500097|NCT00981526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500098|NCT00981513|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500099|NCT00981500|||Cohort||Prospective|||||||
1500100|NCT00981487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500101|NCT00981474|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1500102|NCT00981461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500103|NCT00981448|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1500104|NCT00981435|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500105|NCT00981422|||Case Control||Retrospective|||||||
1500106|NCT00981409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500107|NCT00981396|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500108|NCT00981383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500109|NCT00981370||Single Group Assignment||Treatment||None (Open Label)||||||
1500110|NCT00981357|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1500111|NCT00981344||Single Group Assignment||||None (Open Label)||||||
1500112|NCT00981331|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1500113|NCT00981318||Single Group Assignment||Treatment||None (Open Label)||||||
1500114|NCT00981305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500115|NCT00981292|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1500116|NCT00981279|||||Retrospective|||||||
1500117|NCT00981266|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500118|NCT00981253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500119|NCT00981240|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500120|NCT00981227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500121|NCT00981214||Single Group Assignment||Treatment||None (Open Label)||||||
1500122|NCT00981201|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1500123|NCT00981188||||||||||||
1500124|NCT00981175|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1500125|NCT00981162||Single Group Assignment||Treatment||None (Open Label)||||||
1500126|NCT00981149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500127|NCT00981136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500128|NCT00981123|||Case-Only||Prospective|||||||
1500129|NCT00981110|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1500130|NCT00981097|||Cohort||Prospective|||||||
1500131|NCT00981084|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1500132|NCT00981071|||Cohort||Prospective|||||||
1500133|NCT00981058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500134|NCT00981045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500135|NCT00981032|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1500136|NCT00981019|||Ecologic or Community||Prospective|||||||
1500137|NCT00981006||Single Group Assignment||Treatment||None (Open Label)||||||
1500138|NCT00980993|||Case-Only||Prospective|||||||
1500139|NCT00980980|Randomized|||Prevention||||||||
1500140|NCT00980967||Single Group Assignment||||None (Open Label)||||||
1500141|NCT00980954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500142|NCT00980941|Randomized|Crossover Assignment||Prevention||Single|||t|||
1500143|NCT00980915|||Cohort||Prospective|||||||
1500144|NCT00980889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500145|NCT00980876|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500146|NCT00980863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500147|NCT00980850|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500148|NCT00980824|Randomized|Factorial Assignment||Treatment||Single||||||t
1500149|NCT00980798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500150|NCT00980785|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1500151|NCT00980759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500152|NCT00980746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500153|NCT00980733|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500154|NCT00980707|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1500155|NCT00980694||Single Group Assignment||||None (Open Label)||||||
1500156|NCT00980681|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1500157|NCT00980655|Non-Randomized|||Prevention||None (Open Label)||||||
1500158|NCT00980642|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1500159|NCT00980629|Randomized|||||Double||||||
1500160|NCT00980616|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500161|NCT00980603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500162|NCT00980590|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1500163|NCT00980577|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500164|NCT00980551||Single Group Assignment||Treatment||None (Open Label)||||||
1500165|NCT00980538||Single Group Assignment||Treatment||None (Open Label)||||||
1500166|NCT00980525|||Cohort||Prospective|||||||
1500167|NCT00980512|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1500168|NCT00980486|||Cohort||Prospective|||||||
1500169|NCT00980473|Randomized|Parallel Assignment||Treatment||||||||
1500170|NCT00980460|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500171|NCT00980447|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1500172|NCT00980434|||Cohort||Prospective|||||||
1500173|NCT00980421|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500174|NCT00980408|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1500175|NCT00980395||Single Group Assignment||Treatment||None (Open Label)||||||
1500176|NCT00980382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500177|NCT00980369|||Case Control||Prospective|||||||
1500178|NCT00980356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500179|NCT00980343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500180|NCT00980330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500181|NCT00980317||Single Group Assignment||Treatment||None (Open Label)||||||
1500183|NCT00980278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500184|NCT00980252|Randomized|Parallel Assignment||||Triple|||t||t|t
1500185|NCT00980239|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500186|NCT00980213|||Cohort||Prospective|||||||
1500187|NCT00980200|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1500188|NCT00980187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500189|NCT00980174|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1500190|NCT00980161|||Case Control||Cross-Sectional|||||||
1500191|NCT00980148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500192|NCT00980135|Randomized|Parallel Assignment||Treatment||Single|||||t|
1500193|NCT00980122|||Cohort||Cross-Sectional|||||||
1500194|NCT00980109|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500195|NCT00980083|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1500196|NCT00980070|Randomized|Single Group Assignment||||None (Open Label)||||||
1500197|NCT00980057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500198|NCT00980044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500199|NCT00980031|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1500200|NCT00980018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500201|NCT00980005|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1500202|NCT00979992||Single Group Assignment||Treatment||None (Open Label)||||||
1500203|NCT00979979|||Case-Only||Cross-Sectional|||||||
1500204|NCT00979966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500205|NCT00979953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500206|NCT00979940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500207|NCT00979927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500208|NCT00979914|Randomized|Parallel Assignment||Treatment||Single||||||t
1500209|NCT00979901|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500210|NCT00979888||||Supportive Care||None (Open Label)||||||
1500211|NCT00979875|Randomized|Crossover Assignment||||Double|||t||t|
1500212|NCT00979862||Single Group Assignment||Treatment||None (Open Label)||||||
1500213|NCT00979849|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1500214|NCT00979836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500215|NCT00979823|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500216|NCT00979810||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500217|NCT00979797|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500218|NCT00979784|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500219|NCT00979771|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500220|NCT00979758|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1500221|NCT00979745|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500222|NCT00979732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500223|NCT00979719|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500224|NCT00979706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500225|NCT00979693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500226|NCT00979680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500227|NCT00979667|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500228|NCT00979654||Single Group Assignment||Treatment||None (Open Label)||||||
1500229|NCT00979641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500230|NCT00979628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500231|NCT00979615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500232|NCT00979602|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1500233|NCT00979589|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500234|NCT00979576|Randomized|Parallel Assignment||Treatment||Double||||||
1500235|NCT00979563|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500236|NCT00979550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500237|NCT00979537|Randomized|Crossover Assignment||||None (Open Label)||||||
1500238|NCT00979524|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500239|NCT00979511|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1500240|NCT00979498||||||||||||
1500241|NCT00979485|||Case Control||Cross-Sectional|||||||
1500242|NCT00979472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500243|NCT00979459|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500244|NCT00979446|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1500245|NCT00979433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500246|NCT00979420|||||Retrospective|||||||
1500247|NCT00979407|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1500248|NCT00979394|||Cohort||Prospective|||||||
1500249|NCT00979381|||Cohort||Prospective|||||||
1500250|NCT00979368|Randomized|Parallel Assignment||||Triple|||t||t|t
1500251|NCT00979355||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500252|NCT00979342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500253|NCT00979329|||Case-Only||Prospective|||||||
1500254|NCT00979316|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1500255|NCT00979303|Randomized|Parallel Assignment||Treatment||None (Open Label)||Intent to treat use of non fluoroscopic mapping system with traditional fluoroscopic mapping system during elective catheter ablation in children 8-17 with normal cardiac anatomy||||
1500256|NCT00979290|||Case Control||Prospective|||||||
1500257|NCT00979277|||Cohort||Prospective|||||||
1500258|NCT00979264|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500259|NCT00979251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500260|NCT00979238||Single Group Assignment||Other||None (Open Label)||||||
1500261|NCT00979225|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500262|NCT00979212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500263|NCT00979199||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500264|NCT00979186||Single Group Assignment||Treatment||None (Open Label)||||||
1500265|NCT00979173||Single Group Assignment||Treatment||None (Open Label)||||||
1500266|NCT00979160||Single Group Assignment||Treatment||None (Open Label)||||||
1500267|NCT00979147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500268|NCT00979134|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500269|NCT00979121|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500270|NCT00979108|Randomized|Parallel Assignment||Treatment||Single|||||t|
1500271|NCT00979095|||Case Control||Prospective|||||||
1500272|NCT00979069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500273|NCT00979056|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1500274|NCT00979043|Randomized|Parallel Assignment||Treatment||Single||||||t
1500275|NCT00979030||||||||||||
1500276|NCT00979017||Single Group Assignment||Treatment||None (Open Label)||||||
1500277|NCT00979004|Randomized|Crossover Assignment||Treatment||Single|||t|||
1500278|NCT00978991|||Cohort|||||||||
1500279|NCT00978978|Randomized|Parallel Assignment||||Double||||t|t|
1500280|NCT00978965|||Cohort||Prospective|||||||
1500281|NCT00978952||Single Group Assignment||Treatment||None (Open Label)||||||
1500282|NCT00978939|Randomized|Parallel Assignment||Treatment||Single||||||t
1500283|NCT00978926|||Cohort||Prospective|||||||
1500284|NCT00978913||Single Group Assignment||Treatment||None (Open Label)||||||
1500285|NCT00978900|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1500286|NCT00978887|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500287|NCT00978874||||Diagnostic||None (Open Label)||||||
1500288|NCT00978861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500289|NCT00978848|||Case-Only||Cross-Sectional|||||||
1500290|NCT00978835|Randomized|Parallel Assignment||Treatment||Single||||||t
1500291|NCT00978822||Single Group Assignment||Treatment||None (Open Label)||||||
1500292|NCT00978809|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1500293|NCT00978796|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1500294|NCT00978783|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1500295|NCT00978770||||Diagnostic||||||||
1500296|NCT00978757|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500297|NCT00978744||||||||||||
1500298|NCT00978731||Single Group Assignment||Treatment||None (Open Label)||||||
1500299|NCT00978718|Randomized|||Prevention||Double||||||
1500300|NCT00978705||Single Group Assignment||Treatment||None (Open Label)||||||
1500301|NCT00978692|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1500302|NCT00978679|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500303|NCT00978666|||Case Control||Cross-Sectional|||||||
1500304|NCT00978653||Single Group Assignment||Screening||None (Open Label)||||||
1500305|NCT00978640|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1500306|NCT00978627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500307|NCT00978614||Parallel Assignment||||Double|||t|t||
1500308|NCT00978601|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1500309|NCT00978588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500310|NCT00978575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500311|NCT00978562||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500312|NCT00978549|Randomized|||Treatment||None (Open Label)||||||
1500313|NCT00978536|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1500314|NCT00978523||Single Group Assignment||Treatment||None (Open Label)||||||
1500315|NCT00978510|||Case-Crossover||Cross-Sectional|||||||
1500316|NCT00978497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500317|NCT00978484|Randomized|Parallel Assignment||Treatment||Single||||||t
1500318|NCT00978471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500319|NCT00978458|Randomized|Parallel Assignment||Treatment||||||||
1500320|NCT00978445|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500321|NCT00978432|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500322|NCT00978419|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1500323|NCT00978406|||Other||Cross-Sectional|||||||
1500324|NCT00978393|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1500325|NCT00978380||Single Group Assignment||Prevention||None (Open Label)||||||
1500326|NCT00978367|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500327|NCT00978354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500328|NCT00978341|Randomized|Crossover Assignment||||Double|||t||t|
1500329|NCT00978328|||Cohort||Prospective|||||||
1500330|NCT00978315|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500331|NCT00978302|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500332|NCT00978289|||Cohort||Prospective|||||||
1500333|NCT00978276|||Case Control||Retrospective|||||||
1500334|NCT00978263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500335|NCT00978250||Single Group Assignment||Treatment||None (Open Label)||||||
1500336|NCT00978237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500337|NCT00978224|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500338|NCT00978211||Single Group Assignment||Treatment||None (Open Label)||||||
1500339|NCT00978198|Randomized|Parallel Assignment||||Single|||t|||
1500340|NCT00978185|Randomized|||Supportive Care||||||||
1500341|NCT00978172||Single Group Assignment||Treatment||None (Open Label)||||||
1500342|NCT00978159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500343|NCT00978146||Single Group Assignment||Treatment||None (Open Label)||||||
1500344|NCT00978133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500345|NCT00978120|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500346|NCT00978107|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500347|NCT00978094||||||||||||
1500348|NCT00978081|Randomized|||Treatment||||||||
1500349|NCT00978068|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500350|NCT00978055|Randomized|Crossover Assignment||||None (Open Label)||||||
1500351|NCT00978042|Randomized|Parallel Assignment||||Single||||||t
1500352|NCT00978029|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500353|NCT00978016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500354|NCT00978003|||||Prospective|||||||
1500355|NCT00977990|||||Other|||||||
1500356|NCT00977977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500357|NCT00977964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500358|NCT00977951|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500359|NCT00977938|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500360|NCT00977925|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500361|NCT00977912|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500362|NCT00977899|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500363|NCT00977886|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500364|NCT00977873|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500365|NCT00977860||Single Group Assignment||Treatment||None (Open Label)||||||
1500366|NCT00977847|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500367|NCT00977834|||Cohort||Cross-Sectional|||||||
1500368|NCT00977821|Randomized|Parallel Assignment||||None (Open Label)||||||
1500369|NCT00977808|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500370|NCT00977795||Single Group Assignment||Treatment||None (Open Label)||||||
1500371|NCT00977769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500372|NCT00977756|||Cohort||Prospective|||||||
1500373|NCT00977730|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500374|NCT00977717|||Cohort||Prospective|||||||
1500375|NCT00977704||Single Group Assignment||Treatment||None (Open Label)||||||
1500376|NCT00977691|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500377|NCT00977678|||Case Control||Prospective|||||||
1500378|NCT00977665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500379|NCT00977652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500380|NCT00977639|||Cohort||Prospective|||||||
1500381|NCT00977626|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1500382|NCT00977613||Single Group Assignment||||||||||
1500383|NCT00977600|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500384|NCT00977587|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1500385|NCT00977574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500386|NCT00977561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500387|NCT00977548||Single Group Assignment||Treatment||None (Open Label)||||||
1500388|NCT00977522|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500389|NCT00977509|||Case-Only||Prospective|||||||
1500390|NCT00977496|||Cohort||Prospective|||||||
1500391|NCT00977483|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1500392|NCT00977470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500393|NCT00977457||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500394|NCT00977444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500395|NCT00977431|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500396|NCT00977418|Randomized|Parallel Assignment||Prevention||Single|||||t|
1500397|NCT00977405|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1500398|NCT00977392||||||||||||
1500399|NCT00977379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500400|NCT00977366|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1500401|NCT00977353|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500402|NCT00977340|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500403|NCT00977327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500404|NCT00977314||Single Group Assignment||Treatment||None (Open Label)||||||
1500405|NCT00977301|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500406|NCT00977288|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500407|NCT00977275|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500408|NCT00977262|Randomized|Crossover Assignment||||Double|||t||t|
1500409|NCT00977249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500410|NCT00977236|Randomized|Parallel Assignment||Treatment||Single|||||t|
1500411|NCT00977223|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1500412|NCT00977210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500413|NCT00977197|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500414|NCT00977184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500415|NCT00977171||Single Group Assignment||Treatment||None (Open Label)||||||
1500416|NCT00977158|||Cohort||Prospective|||||||
1500417|NCT00977145||Single Group Assignment||Treatment||None (Open Label)||||||
1500418|NCT00977132||Single Group Assignment||Treatment||None (Open Label)||||||
1500419|NCT00977119|||Cohort||Prospective|||||||
1500420|NCT00977106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500421|NCT00977093||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500422|NCT00977080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500423|NCT00977067||Single Group Assignment||Treatment||None (Open Label)||||||
1500424|NCT00977054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500425|NCT00977041||Single Group Assignment||Treatment||None (Open Label)||||||
1500426|NCT00977028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500427|NCT00977015|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1500428|NCT00977002|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500429|NCT00976989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500430|NCT00976976|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500431|NCT00976963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500432|NCT00976950|||Cohort||Prospective|||||||
1500433|NCT00976937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500434|NCT00976924|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1500435|NCT00976911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500436|NCT00976898||Single Group Assignment||Treatment||None (Open Label)||||||
1500437|NCT00976885|||Case Control||Cross-Sectional|||||||
1500438|NCT00976872|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1500439|NCT00976859|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500440|NCT00976846||Single Group Assignment||Treatment||None (Open Label)||||||
1500441|NCT00976833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500442|NCT00976820|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1500443|NCT00976807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500444|NCT00976794|Randomized|Parallel Assignment||Treatment||Single||||||t
1500445|NCT00976781|||||Retrospective|||||||
1500446|NCT00976768||Single Group Assignment||Treatment||None (Open Label)||||||
1500447|NCT00976755||Single Group Assignment||Treatment||None (Open Label)||||||
1500448|NCT00976742||Single Group Assignment||Prevention||||||||
1500449|NCT00976729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500450|NCT00976716|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500451|NCT00976703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500452|NCT00976690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500453|NCT00976677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500454|NCT00976664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500455|NCT00976651|Randomized|Parallel Assignment||Treatment||Single|||||t|
1500456|NCT00976638|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1500457|NCT00976625|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500458|NCT00976612|||Cohort||Prospective|||||||
1500459|NCT00976599|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1500460|NCT00976586|||Cohort||Prospective|||||||
1500461|NCT00976573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500462|NCT00976560|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500463|NCT00976547|||||Prospective|||||||
1500464|NCT00976534|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500465|NCT00976521|Randomized|Factorial Assignment||Treatment||Single|||t|||
1500466|NCT00976508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500467|NCT00976495|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1500468|NCT00976482|||Cohort||Prospective|||||||
1500469|NCT00976469|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500470|NCT00976456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500471|NCT00976443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500472|NCT00976430||Single Group Assignment||Treatment||None (Open Label)||||||
1500473|NCT00976417|||||Prospective|||||||
1500474|NCT00976404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500475|NCT00976391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500476|NCT00976378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500477|NCT00976365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500478|NCT00976352|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)|Open label study|||||
1500479|NCT00976339|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500480|NCT00976326|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500481|NCT00976313|||Cohort||Prospective|||||||
1500482|NCT00976300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500483|NCT00976287|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500484|NCT00976274|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500485|NCT00976261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500486|NCT00976248||Single Group Assignment||Treatment||None (Open Label)||||||
1500487|NCT00976235||Single Group Assignment||Other||None (Open Label)||||||
1500488|NCT00976222||Single Group Assignment||Treatment||None (Open Label)||||||
1500489|NCT00976209|Randomized|Crossover Assignment||Treatment||Single|||t|||
1500490|NCT00976196|||Cohort||Prospective|||||||
1500491|NCT00976183||Single Group Assignment||Treatment||None (Open Label)||||||
1500492|NCT00976170|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500493|NCT00976157|||Case-Only||Prospective|||||||
1500494|NCT00976144|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1500495|NCT00976131|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1500496|NCT00976118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500497|NCT00976105|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500498|NCT00976092|Randomized|Parallel Assignment||Treatment||Single||||||t
1500499|NCT00976079|Randomized|Parallel Assignment||Treatment||Single||||||t
1500500|NCT00976066|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1500501|NCT00976053|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1500502|NCT00976040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500503|NCT00976027|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500504|NCT00976014|||Case Control||Prospective|||||||
1500505|NCT00976001|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500506|NCT00975988|||||Prospective|||||||
1500507|NCT00975975||Single Group Assignment||Treatment||None (Open Label)||||||
1500508|NCT00975962|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1500509|NCT00975949|||||Prospective|||||||
1500510|NCT00975936|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1500511|NCT00975923|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500512|NCT00975910|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1500513|NCT00975897|Randomized|||Diagnostic||None (Open Label)||||||
1500514|NCT00975884|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1500515|NCT00975871|||Case-Only||Prospective|||||||
1500516|NCT00975858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500517|NCT00975845|||Cohort||Prospective|||||||
1500518|NCT00975832|||Case Control||Cross-Sectional|||||||
1500519|NCT00975819||Single Group Assignment||Treatment||None (Open Label)||||||
1500520|NCT00975806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500521|NCT00975793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500522|NCT00975780|Randomized|Parallel Assignment||Prevention||Single||||||t
1500523|NCT00975767|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500524|NCT00975754|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1500525|NCT00975741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500526|NCT00975728|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1500527|NCT00975715|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500528|NCT00975702|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500529|NCT00975689|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1500530|NCT00975676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500531|NCT00975663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500532|NCT00975650|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500533|NCT00975637|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500534|NCT00975611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500535|NCT00975585|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500536|NCT00975572|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500537|NCT00975559|||Case Control||Prospective|||||||
1500538|NCT00975546||||||||||||
1500539|NCT00975533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500540|NCT00975520|Randomized|Parallel Assignment||Treatment||Single||||||t
1500541|NCT00975507|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1500542|NCT00975494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500543|NCT00975481|Randomized|Crossover Assignment||||Double|||t||t|
1500544|NCT00975468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500545|NCT00975455|||Case-Only||Prospective|||||||
1500546|NCT00975442|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500547|NCT00975429|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500548|NCT00975416|Randomized|Parallel Assignment||Treatment||Double||||||
1500549|NCT00975403|Randomized|Crossover Assignment||||Triple|||t||t|t
1500550|NCT00975390|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1500551|NCT00975377|Randomized|Parallel Assignment||Prevention||Single||||||t
1500552|NCT00975364||||||||||||
1500553|NCT00975351||Single Group Assignment||Basic Science||None (Open Label)||||||
1500554|NCT00975338|||Cohort||Prospective|||||||
1500555|NCT00975325|Randomized|Crossover Assignment||||None (Open Label)||||||
1500556|NCT00975312|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500557|NCT00975299|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1500558|NCT00975286|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500559|NCT00975273|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1500560|NCT00975247|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1500561|NCT00975234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500562|NCT00975221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500563|NCT00975208|||Case Control||Prospective|||||||
1500564|NCT00975195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500565|NCT00975182|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500566|NCT00975169|||Case Control||Retrospective|||||||
1500567|NCT00975156|Randomized|Parallel Assignment||Treatment||Single||||||t
1500568|NCT00975143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500569|NCT00975130|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500570|NCT00975117|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500571|NCT00975104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500572|NCT00975091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500573|NCT00975078||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500574|NCT00975065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500575|NCT00975052|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1500576|NCT00975039||Single Group Assignment||Treatment||None (Open Label)||||||
1500577|NCT00975026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500578|NCT00975013|||Case-Only||Prospective|||||||
1500579|NCT00975000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500580|NCT00974987||Single Group Assignment||Treatment||None (Open Label)||||||
1500581|NCT00974974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500582|NCT00974961|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500583|NCT00974948|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1500584|NCT00974935|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500585|NCT00974922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500586|NCT00974909|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500587|NCT00974896|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500588|NCT00974883|||Cohort||Prospective|||||||
1500589|NCT00974870|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500590|NCT00974857|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1500591|NCT00974844|||Case-Only||Prospective|||||||
1500592|NCT00974831|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1500593|NCT00974818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500594|NCT00974805|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1500595|NCT00974792||||Treatment||None (Open Label)||||||
1500596|NCT00974779|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1500597|NCT00974766|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500598|NCT00974753|Randomized|Parallel Assignment||Prevention||Single|||t|||
1500599|NCT00974740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500600|NCT00974727|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500601|NCT00974714|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500602|NCT00974701|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1500603|NCT00974688|Randomized|Crossover Assignment||Treatment||Single||||t||
1500604|NCT00974675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500605|NCT00974662||Single Group Assignment||Treatment||None (Open Label)||||||
1500606|NCT00974649||Single Group Assignment||Supportive Care||None (Open Label)||||||
1500607|NCT00974636|Randomized|Crossover Assignment||||None (Open Label)||||||
1500608|NCT00974623|||Cohort||Prospective|||||||
1500609|NCT00974610|||Other||Prospective|||||||
1500610|NCT00974597|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500611|NCT00974584|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500612|NCT00974571|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500613|NCT00974558||Single Group Assignment||Treatment||None (Open Label)||||||
1500614|NCT00974532|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1500615|NCT00974519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500616|NCT00974506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500617|NCT00974493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500618|NCT00974480|Randomized|Parallel Assignment||Treatment||Single||||||t
1500619|NCT00974467|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500620|NCT00974454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500621|NCT00974441|Randomized|Crossover Assignment||||None (Open Label)||||||
1500622|NCT00974428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500623|NCT00974415|Randomized|Single Group Assignment||Treatment||Single|||t|||
1500624|NCT00974402||Single Group Assignment||Treatment||None (Open Label)||||||
1500625|NCT00974389||||Treatment||None (Open Label)||||||
1500626|NCT00974376|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500627|NCT00974363|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500628|NCT00974350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500629|NCT00974337|||||Cross-Sectional|||||||
1500630|NCT00974324|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500631|NCT00974311|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500632|NCT00974298|||||Prospective|||||||
1500633|NCT00974285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500634|NCT00974272|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1500635|NCT00974259|Randomized|Parallel Assignment||Treatment||Single||||||t
1500636|NCT00974246||Single Group Assignment||Treatment||None (Open Label)||||||
1500637|NCT00974233||Single Group Assignment||Treatment||None (Open Label)||||||
1500638|NCT00974220|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1500639|NCT00974194|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500640|NCT00974181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500641|NCT00974168|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500642|NCT00974155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500643|NCT00974142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500644|NCT00974129|||Cohort||Prospective|||||||
1500645|NCT00974116|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500646|NCT00974103|Randomized|Parallel Assignment||Treatment||Single||||||t
1500647|NCT00974090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500648|NCT00974077|Randomized|Factorial Assignment||Treatment||Single||||||t
1500649|NCT00974064|||Case-Control||Prospective|||||||
1500650|NCT00974051|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500651|NCT00974038||Single Group Assignment||Treatment||None (Open Label)||||||
1500652|NCT00974025|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500653|NCT00974012|Randomized|Crossover Assignment||||None (Open Label)||||||
1500654|NCT00973999|Randomized|Single Group Assignment||Treatment||Single|||t|||
1500655|NCT00973986|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1500656|NCT00973973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500657|NCT00973960|||Cohort||Prospective|||||||
1500658|NCT00973947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500659|NCT00973934|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1500660|NCT00973921|||Case-Only||Retrospective|||||||
1500661|NCT00973908|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500662|NCT00973895|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1500663|NCT00973882||Single Group Assignment||Treatment||None (Open Label)||||||
1500664|NCT00973869||||Prevention||||||||
1500665|NCT00973856|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1500666|NCT00973830|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500667|NCT00973817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500668|NCT00973804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500669|NCT00973791|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1500670|NCT00973778||Single Group Assignment||Treatment||None (Open Label)||||||
1500671|NCT00973765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500672|NCT00973752||Single Group Assignment||Treatment||None (Open Label)||||||
1500673|NCT00973739||Single Group Assignment||Treatment||None (Open Label)||||||
1500674|NCT00973726|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1500675|NCT00973713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500676|NCT00973700|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500677|NCT00973687|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1500678|NCT00973674|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500679|NCT00973661|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500680|NCT00973648|||Cohort||Cross-Sectional|||||||
1500681|NCT00973635|Randomized|Crossover Assignment||||None (Open Label)||||||
1500682|NCT00973622|Non-Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1500683|NCT00973609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500684|NCT00973596|||Cohort||Prospective|||||||
1500685|NCT00973583|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500686|NCT00973570|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500687|NCT00973557|||Cohort||Cross-Sectional|||||||
1500688|NCT00973544|||Cohort||Prospective|||||||
1500689|NCT00973531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500690|NCT00973518|||Cohort||Prospective|||||||
1500691|NCT00973505|||Case-Only||Prospective|||||||
1500692|NCT00973492|||Case-Only||Prospective|||||||
1500693|NCT00973479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500694|NCT00973466|||Cohort||Prospective|||||||
1500695|NCT00973453|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1500696|NCT00973440|||Case-Only||Prospective|||||||
1500697|NCT00973427|||Cohort||Prospective|||||||
1500698|NCT00973414|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1500699|NCT00973401|||||Prospective|||||||
1500700|NCT00973388|Randomized|Crossover Assignment||Treatment||Double||||||
1500701|NCT00973375|||Case Control||Cross-Sectional|||||||
1500702|NCT00973362|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1500703|NCT00973349|Randomized|Parallel Assignment||Prevention||Single|||t|||
1500704|NCT00973336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500705|NCT00973323|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500706|NCT00973310|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500707|NCT00973297|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500708|NCT00973284|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500709|NCT00973271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500710|NCT00973258|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500711|NCT00973245|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500712|NCT00973232|Randomized|Crossover Assignment||||None (Open Label)||||||
1500713|NCT00973219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500714|NCT00973206|||Cohort||Prospective|||||||
1500715|NCT00973193||Single Group Assignment||Treatment||None (Open Label)||||||
1500716|NCT00973180|Randomized|Parallel Assignment||||None (Open Label)||||||
1500717|NCT00973167|Randomized|Parallel Assignment||Treatment||Single||||||t
1500718|NCT00973154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500719|NCT00973141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500720|NCT00973128|Randomized|Parallel Assignment||Treatment||Single|||||t|
1500721|NCT00973115|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500722|NCT00973102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500723|NCT00973089|Randomized|Parallel Assignment||Treatment||Single|||||t|
1500724|NCT00973076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500725|NCT00973063|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1500726|NCT00973050|Randomized|Parallel Assignment||||None (Open Label)||||||
1500727|NCT00973037|||Case-Only||Prospective|||||||
1500728|NCT00973024|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500729|NCT00973011||Single Group Assignment||Treatment||None (Open Label)||||||
1500730|NCT00972998||Single Group Assignment||||None (Open Label)||||||
1500731|NCT00972985|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1500732|NCT00972972|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1500733|NCT00972959||Single Group Assignment||Treatment||None (Open Label)||||||
1500734|NCT00972946|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1500735|NCT00972933||Single Group Assignment||Treatment||None (Open Label)||||||
1500736|NCT00972920|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500737|NCT00972907||Single Group Assignment||Treatment||None (Open Label)||||||
1500738|NCT00972894|||||Prospective|||||||
1500739|NCT00972881||Single Group Assignment||Treatment||None (Open Label)||||||
1500740|NCT00972868||Single Group Assignment||Treatment||None (Open Label)||||||
1500741|NCT00972855|Randomized|Parallel Assignment||||None (Open Label)||||||
1500742|NCT00972842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500743|NCT00972829|Randomized|Parallel Assignment||Treatment||||||||
1500744|NCT00972816|Randomized|Parallel Assignment||Prevention||Single|||t|||
1500745|NCT00972803|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1500746|NCT00972790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500747|NCT00972777|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500748|NCT00972764|||Case Control||Prospective|||||||
1500749|NCT00972751|||Cohort||Retrospective|||||||
1500750|NCT00972738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500751|NCT00972725|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500752|NCT00972712||Single Group Assignment||Treatment||None (Open Label)||||||
1500753|NCT00972699|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500754|NCT00972686|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500755|NCT00972673|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1500756|NCT00972660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500757|NCT00972647|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1500758|NCT00972634|||Cohort||Cross-Sectional|||||||
1500759|NCT00972621|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1500760|NCT00972608|||Case-Only||Prospective|||||||
1500761|NCT00972595|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500762|NCT00972582|Non-Randomized|Single Group Assignment||||Single|||t|||
1500763|NCT00972569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500764|NCT00972556|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1500765|NCT00972543|Randomized|Parallel Assignment||Treatment||||||||
1500766|NCT00972530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500767|NCT00972517||Single Group Assignment||Prevention||None (Open Label)||||||
1500768|NCT00972504|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1500769|NCT00972491|Randomized|Parallel Assignment||Treatment||Single||||||t
1500770|NCT00972478||Single Group Assignment||Treatment||None (Open Label)||||||
1500771|NCT00972465|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500772|NCT00972452||Single Group Assignment||Prevention||None (Open Label)||||||
1500773|NCT00972439|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1500774|NCT00972426|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500775|NCT00972413|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1500776|NCT00972400||||||||||||
1500777|NCT00972387|Randomized|Factorial Assignment||Other||Single|||t|||
1500778|NCT00972374|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1500779|NCT00972361|||Case-Only||Retrospective|||||||
1500780|NCT00972348|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500781|NCT00972335||Single Group Assignment||Treatment||None (Open Label)||||||
1500782|NCT00972322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500783|NCT00972309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500784|NCT00972296|||Case-Only||Cross-Sectional|||||||
1500785|NCT00972283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500786|NCT00972270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500787|NCT00972257|Randomized|Crossover Assignment||Treatment||Single|||||t|
1500788|NCT00972244|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500789|NCT00972231|||Cohort||Retrospective|||||||
1500790|NCT00972218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500791|NCT00972205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500792|NCT00972192|Randomized|Parallel Assignment||||Single||||||t
1500793|NCT00972179|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500794|NCT00972153|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1500795|NCT00972140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500796|NCT00972127||Crossover Assignment||Treatment||None (Open Label)||||||
1500797|NCT00972114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500798|NCT00972101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500799|NCT00972088||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500800|NCT00972075|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500801|NCT00972062|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1500802|NCT00972049|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1500803|NCT00972036||Single Group Assignment||Treatment||None (Open Label)||||||
1500804|NCT00972023||Single Group Assignment||Treatment||None (Open Label)||||||
1500805|NCT00972010|||||Prospective|||||||
1500806|NCT00971997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500807|NCT00971984|||Case-Only||Retrospective|||||||
1500808|NCT00971971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500809|NCT00971958|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500810|NCT00971945||Single Group Assignment||Treatment||None (Open Label)||||||
1500811|NCT00971932||Single Group Assignment||Treatment||None (Open Label)||||||
1500812|NCT00971919||||||||||||
1500813|NCT00971906|Randomized|Parallel Assignment||Prevention||Single|||||t|
1500814|NCT00971893|||Cohort||Prospective|||||||
1500815|NCT00971880|||Case-Only||Retrospective|||||||
1500816|NCT00971867||Single Group Assignment||Treatment||None (Open Label)||||||
1500817|NCT00971854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500818|NCT00971841||Single Group Assignment||Treatment||None (Open Label)||||||
1500819|NCT00971828|||Case Control||Prospective|||||||
1500820|NCT00971815|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1500821|NCT00971802|Randomized|Parallel Assignment||||Double|||t||t|
1500822|NCT00971789||Single Group Assignment||Treatment||None (Open Label)||||||
1500823|NCT00971776|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1500824|NCT00971763||Single Group Assignment||Treatment||None (Open Label)||||||
1500825|NCT00971750|||Case-Only||Prospective|||||||
1500826|NCT00971737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500827|NCT00971724|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500828|NCT00971711||Single Group Assignment||Treatment||None (Open Label)||||||
1500829|NCT00971698|||Cohort||Retrospective|||||||
1500830|NCT00971685||Single Group Assignment||Treatment||None (Open Label)||||||
1500831|NCT00971672|||Cohort||Prospective|||||||
1500832|NCT00971659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500833|NCT00971646|||Cohort||Prospective|||||||
1500834|NCT00971633|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500835|NCT00971620|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1500836|NCT00971607|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500837|NCT00971594|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1500838|NCT00971581|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500839|NCT00971568|||Case Control||Retrospective|||||||
1500840|NCT00971555|||Cohort||Prospective|||||||
1500841|NCT00971542|Randomized|Parallel Assignment||Prevention||Single|||||t|
1500842|NCT00971529|||Case Control|||||||||
1500843|NCT00971516|Randomized|Parallel Assignment||Treatment||Single||||||t
1500844|NCT00971503|Randomized|Parallel Assignment||Treatment||Single||||||t
1500845|NCT00971490|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1500846|NCT00971477|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1500847|NCT00971464|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1500848|NCT00971451|Randomized|Parallel Assignment||Treatment||Single||||||t
1500849|NCT00971438|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1500850|NCT00971425|Randomized|Parallel Assignment||Prevention||Single|||t|||
1500851|NCT00971399|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1500852|NCT00971386|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500853|NCT00971373|Randomized|Crossover Assignment||||Single|||t|||
1500854|NCT00971360|||Cohort||Prospective|||||||
1500855|NCT00971347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500856|NCT00971334|||||Prospective|||||||
1500857|NCT00971321|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500858|NCT00971308|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500859|NCT00971295|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500860|NCT00971282|Randomized|Single Group Assignment||Prevention||Single|||||t|
1500861|NCT00971269||Single Group Assignment||Treatment||None (Open Label)||||||
1500862|NCT00971256|||Case Control||Retrospective|||||||
1500863|NCT00971243|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500864|NCT00971230|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500865|NCT00971217|Randomized|Factorial Assignment||||None (Open Label)||||||
1500866|NCT00971204||Single Group Assignment||Treatment||None (Open Label)||||||
1500867|NCT00971191|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1500868|NCT00971178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500869|NCT00971165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500870|NCT00971152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500871|NCT00971139|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1500872|NCT00971126||Single Group Assignment||Treatment||None (Open Label)||||||
1500873|NCT00971113|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1500874|NCT00971100|Randomized|Parallel Assignment||Prevention||Single|||t|||
1500875|NCT00971087|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500876|NCT00971074|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1500877|NCT00971061|Randomized|Parallel Assignment||Treatment||Single||||||t
1500878|NCT00971048|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1500879|NCT00971035|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500880|NCT00971022|||Case-Only||Prospective|||||||
1500881|NCT00971009|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1500882|NCT00970996||Single Group Assignment||Treatment||None (Open Label)||||||
1500883|NCT00970983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500884|NCT00970970|||Cohort||Prospective|||||||
1500885|NCT00970957|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1500886|NCT00970944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500887|NCT00970931|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500888|NCT00970918||Single Group Assignment||Screening||||||||
1500889|NCT00970905||Single Group Assignment||Treatment||None (Open Label)||||||
1500890|NCT00970892|||Cohort||Prospective|||||||
1500891|NCT00970879|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500892|NCT00970866|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1500893|NCT00970853|Randomized|Parallel Assignment||Prevention||Single||||||t
1500894|NCT00970840||Single Group Assignment||Other||None (Open Label)||||||
1500895|NCT00970827|Randomized|Parallel Assignment||Prevention||Double||||t||t
1500896|NCT00970814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500897|NCT00970801|||Cohort||Prospective|||||||
1500898|NCT00970788|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1500899|NCT00970775|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1500900|NCT00970762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500901|NCT00970749|||Case-Only||Cross-Sectional|||||||
1500902|NCT00970736|||Cohort||Prospective|||||||
1500903|NCT00970723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500904|NCT00970710||Single Group Assignment||Prevention||None (Open Label)||Pragmatic controlled trial||||
1500905|NCT00970697|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500906|NCT00970684||Single Group Assignment||Treatment||None (Open Label)||||||
1500907|NCT00970671|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1500908|NCT00970658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500909|NCT00970645|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1500910|NCT00970632|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500911|NCT00970619|Randomized|Single Group Assignment||Treatment||Single||||||t
1500912|NCT00970606|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1500913|NCT00970593|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1500914|NCT00970580||Single Group Assignment||Treatment||None (Open Label)||||||
1500915|NCT00970567|Randomized|Crossover Assignment||||None (Open Label)||||||
1500916|NCT00970554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500917|NCT00970541|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1500918|NCT00970528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500919|NCT00970515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500920|NCT00970502||Single Group Assignment||Treatment||None (Open Label)||||||
1500921|NCT00970489|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1500922|NCT00970476|||Case-Only||Prospective|||||||
1500923|NCT00970463|||Cohort||Prospective|||||||
1500924|NCT00970450|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1500925|NCT00970437|Randomized|Parallel Assignment||Treatment||Single||||||t
1500926|NCT00970424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500927|NCT00970411|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500928|NCT00970398|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1500929|NCT00970385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500930|NCT00970372|||||Prospective|||||||
1500931|NCT00970359||Single Group Assignment||Treatment||None (Open Label)||||||
1500932|NCT00970346|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1500933|NCT00970333||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500934|NCT00970320|Randomized|Parallel Assignment||||None (Open Label)||||||
1500935|NCT00970307|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500936|NCT00970294||Single Group Assignment||||None (Open Label)||||||
1500937|NCT00970281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500938|NCT00970268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500939|NCT00970255|Randomized|Crossover Assignment||Treatment||Single||||||t
1500940|NCT00970242|||||Prospective|||||||
1500941|NCT00970229||Single Group Assignment||Diagnostic||None (Open Label)||||||
1500942|NCT00970216|||||Prospective|||||||
1500943|NCT00970203|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1500944|NCT00970190|||Cohort||Prospective|||||||
1500945|NCT00970177|Randomized|Parallel Assignment||Prevention||Single|||||t|
1500946|NCT00970151|||Cohort||Prospective|||||||
1500947|NCT00970138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500948|NCT00970125||Single Group Assignment||Health Services Research||None (Open Label)||||||
1500949|NCT00970112|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1500950|NCT00970099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500951|NCT00970086||Single Group Assignment||Treatment||Double|||t|t||
1500952|NCT00970073|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1500953|NCT00970060||Single Group Assignment||||None (Open Label)||||||
1500954|NCT00970047|||Case-Only||Prospective|||||||
1500955|NCT00970034|||Cohort||Prospective|||||||
1500956|NCT00970021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500957|NCT00970008|Randomized|Parallel Assignment||Treatment||Single||||||t
1500958|NCT00969995|||Case Control||Prospective|||||||
1500959|NCT00969982|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1500960|NCT00969969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500961|NCT00969956|||Case-Only||Prospective|||||||
1500962|NCT00969943|||Case-Control||Prospective|||||||
1500963|NCT00969930|||Case Control||Prospective|||||||
1500964|NCT00969917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500965|NCT00969904|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1500966|NCT00969891|||Cohort||Prospective|||||||
1500967|NCT00969878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500968|NCT00969865|||Case-Control||Prospective|||||||
1500969|NCT00969852|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500970|NCT00969839||Single Group Assignment||Treatment||None (Open Label)||||||
1500971|NCT00969826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1500972|NCT00969813|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1500973|NCT00969800|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1500974|NCT00969787|Randomized|Single Group Assignment||||Double|||t||t|
1500975|NCT00969774|||Cohort||Cross-Sectional|||||||
1500976|NCT00969761|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500977|NCT00969748||||||||||||
1500978|NCT00969735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500979|NCT00969722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500980|NCT00969709|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1500981|NCT00969696|Non-Randomized|Parallel Assignment||Screening||Double|||t||t|
1500982|NCT00969683|Randomized|Parallel Assignment||Treatment||Single|||t|||
1500983|NCT00969670|||Ecologic or Community||Cross-Sectional|||||||
1500984|NCT00969657|||Case-Only||Prospective|||||||
1500985|NCT00969644|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1500986|NCT00969631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1500987|NCT00969618||Single Group Assignment||Treatment||None (Open Label)||||||
1500988|NCT00969605|Randomized|Parallel Assignment||Screening||Single|||t|||
1500989|NCT00969592|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1500990|NCT00969579|||||Prospective|||||||
1500991|NCT00969566|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500992|NCT00969553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500993|NCT00969540|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1500994|NCT00969527|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1500995|NCT00969514|||Case-Only||Retrospective|||||||
1500996|NCT00969501|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1500997|NCT00969488|Randomized|Parallel Assignment||||Single|||t|||
1500998|NCT00969475|Randomized|Crossover Assignment||Treatment||Single||||||t
1500999|NCT00969462||Single Group Assignment||Treatment||None (Open Label)||||||
1501000|NCT00969449|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501001|NCT00969436|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501002|NCT00969423|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501003|NCT00969410||Single Group Assignment||Treatment||None (Open Label)||||||
1501004|NCT00969397|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501005|NCT00969384|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1501006|NCT00969371|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1501007|NCT00969358|||Cohort||Prospective|||||||
1501008|NCT00969345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501009|NCT00969332||Single Group Assignment||Treatment||None (Open Label)||||||
1501010|NCT00969319|||Cohort||Prospective|||||||
1501011|NCT00969306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501012|NCT00969293||Single Group Assignment||Treatment||None (Open Label)||||||
1501013|NCT00969280|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1501014|NCT00969267|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501015|NCT00969254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501016|NCT00969241|||Case Control||Prospective|||||||
1501017|NCT00969228|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501018|NCT00969215|Randomized|Crossover Assignment||Treatment||Single||||||t
1501019|NCT00969202||Single Group Assignment||Treatment||None (Open Label)||||||
1501020|NCT00969189|||Cohort||Prospective|||||||
1501021|NCT00969176||Single Group Assignment||Treatment||None (Open Label)||||||
1501022|NCT00969163|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1501023|NCT00969150|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1501024|NCT00969137|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1501025|NCT00969124||Single Group Assignment||Diagnostic||None (Open Label)|Open Label|||||
1501026|NCT00969111|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501027|NCT00969098|||Cohort||Retrospective|||||||
1501028|NCT00969085||Single Group Assignment||Treatment||None (Open Label)||||||
1501029|NCT00969072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501030|NCT00969059|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501031|NCT00969046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501032|NCT00969033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501033|NCT00969020|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1501034|NCT00969007||Single Group Assignment||Treatment||None (Open Label)||||||
1501035|NCT00968994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501036|NCT00968981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501037|NCT00968968|Randomized|||Treatment||None (Open Label)||||||
1501038|NCT00968955|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1501039|NCT00968942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501040|NCT00968929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501041|NCT00968916|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501042|NCT00968903|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1501043|NCT00968890|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1501044|NCT00968877|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501045|NCT00968864||Single Group Assignment||Treatment||None (Open Label)||||||
1501046|NCT00968851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501047|NCT00968838|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1501048|NCT00968825|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501049|NCT00968812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501050|NCT00968799||Single Group Assignment||Treatment||None (Open Label)||||||
1501051|NCT00968786|Randomized|Parallel Assignment||Prevention||Single|||t|||
1501052|NCT00968773|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501053|NCT00968760|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501054|NCT00968747|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1501055|NCT00968734|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501056|NCT00968721|||Case-Only||Cross-Sectional|||||||
1501057|NCT00968708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501058|NCT00968695||Single Group Assignment||Treatment||None (Open Label)||||||
1501059|NCT00968682|||Cohort||Prospective|||||||
1501060|NCT00968669|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501061|NCT00968656|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1501062|NCT00968643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501063|NCT00968630||Single Group Assignment||Treatment||None (Open Label)||||||
1501064|NCT00968617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501065|NCT00968604||Single Group Assignment||Treatment||None (Open Label)||||||
1501066|NCT00968591||Single Group Assignment||||None (Open Label)||||||
1501067|NCT00968578|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1501068|NCT00968565||Single Group Assignment||Treatment||None (Open Label)||||||
1501069|NCT00968552|||Case-Only||Prospective|||||||
1501070|NCT00968539|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1501071|NCT00968526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501072|NCT00968513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501073|NCT00968500|||Cohort||Cross-Sectional|||||||
1501074|NCT00968487|Randomized|Crossover Assignment||Treatment||Single|||||t|
1501075|NCT00968474||||||||||||
1501076|NCT00968461||Single Group Assignment||Treatment||None (Open Label)||||||
1501077|NCT00968448|Randomized|Parallel Assignment||||Single|||t|||
1501078|NCT00968435||Single Group Assignment||Treatment||None (Open Label)||||||
1501079|NCT00968422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501080|NCT00968409||Single Group Assignment||Diagnostic||None (Open Label)||||||
1501081|NCT00968396||Single Group Assignment||Treatment||None (Open Label)||||||
1501082|NCT00968383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501083|NCT00968370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501084|NCT00968357|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1501085|NCT00968344|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1501086|NCT00968331||Single Group Assignment||Treatment||None (Open Label)||||||
1501087|NCT00968318||Single Group Assignment||Prevention||None (Open Label)||||||
1501088|NCT00968305|||Case-Only||Cross-Sectional|||||||
1501089|NCT00968292|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501090|NCT00968279|||Cohort||Prospective|||||||
1501091|NCT00968266|Randomized|Parallel Assignment||Prevention||Single|||||t|
1501092|NCT00968253|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501093|NCT00968240|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501094|NCT00968227||Single Group Assignment||Treatment||None (Open Label)||||||
1501095|NCT00968214|||Case-Control||Prospective|||||||
1501096|NCT00968201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501097|NCT00968188|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1501098|NCT00968175|Randomized|Parallel Assignment||||Single|||||t|
1501099|NCT00968162||Single Group Assignment||Treatment||None (Open Label)||||||
1501100|NCT00968149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501101|NCT00968136|||Cohort||Prospective|||||||
1501102|NCT00968123|||Case-Only||Retrospective|||||||
1501103|NCT00968110||Single Group Assignment||Treatment||None (Open Label)||||||
1501104|NCT00968097||Single Group Assignment||Diagnostic||Single||||||t
1501105|NCT00968084|||||Other|||||||
1501106|NCT00968071||Single Group Assignment||Treatment||None (Open Label)||||||
1501107|NCT00968058|||Case-Only||Prospective|||||||
1501108|NCT00968045|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501109|NCT00968032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501110|NCT00968019|||Cohort||Prospective|||||||
1502119|NCT00954655|||Case-Only||Prospective|||||||
1501111|NCT00968006|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1501112|NCT00967993|||||Retrospective|||||||
1501113|NCT00967980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501114|NCT00967967||Single Group Assignment||Treatment||None (Open Label)||||||
1501115|NCT00967954|Non-Randomized|||Treatment||||||||
1501116|NCT00967941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501117|NCT00967928||Single Group Assignment||Treatment||None (Open Label)||||||
1501118|NCT00967915|Randomized|Parallel Assignment||Treatment||Single||||||
1501119|NCT00967902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501120|NCT00967889||||||||||||
1501121|NCT00967876|||Cohort||Prospective|||||||
1501122|NCT00967863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501123|NCT00967850|Randomized|Parallel Assignment||Treatment||Single||||||t
1501124|NCT00967837||Single Group Assignment||Treatment||None (Open Label)||||||
1501125|NCT00967824|Randomized|||||||||||
1501126|NCT00967811|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501127|NCT00967798|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1501128|NCT00967785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501129|NCT00967772||Parallel Assignment||Basic Science||Single||||||t
1501130|NCT00967759|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501131|NCT00967746|Randomized|Parallel Assignment||Prevention||Single|||t|||
1501132|NCT00967733|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1501133|NCT00967720|||Other||Retrospective|||||||
1501134|NCT00967707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501135|NCT00967694||Single Group Assignment||Diagnostic||Single|||||t|
1501136|NCT00967681|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1501137|NCT00967668|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501138|NCT00967655||||Treatment||None (Open Label)||||||
1501139|NCT00967642|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501140|NCT00967629|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501141|NCT00967616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501142|NCT00967603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501143|NCT00967590|Randomized|Parallel Assignment||Treatment||Double||||||
1501144|NCT00967577||Single Group Assignment||Treatment||None (Open Label)||||||
1501145|NCT00967564|||Cohort||Prospective|||||||
1501146|NCT00967551|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1501147|NCT00967538||Single Group Assignment||Treatment||None (Open Label)||||||
1501148|NCT00967525||Single Group Assignment||Treatment||None (Open Label)||||||
1501149|NCT00967512|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501150|NCT00967499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501151|NCT00967486|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1501152|NCT00967473||Single Group Assignment||Treatment||None (Open Label)||||||
1501153|NCT00967460|Randomized|Parallel Assignment||Prevention||Single|||||t|
1501154|NCT00967447|||Cohort||Prospective|||||||
1501155|NCT00967434|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1501156|NCT00967421|Non-Randomized|Crossover Assignment||Other||Single|||t|||
1501157|NCT00967408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501158|NCT00967395|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1501159|NCT00967382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501160|NCT00967369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501161|NCT00967356|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1501162|NCT00967343||Single Group Assignment||Prevention||None (Open Label)||||||
1501163|NCT00967330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501164|NCT00967317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501165|NCT00967304|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1501166|NCT00967291||Single Group Assignment||Treatment||None (Open Label)||||||
1501167|NCT00967278|||Cohort||Cross-Sectional|||||||
1501168|NCT00967265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501169|NCT00967252|||Case-Only||Prospective|||||||
1501170|NCT00967239|||Case Control||Retrospective|||||||
1501171|NCT00967226|Randomized|Parallel Assignment||Treatment||Single||||||t
1501172|NCT00967213||Single Group Assignment||||None (Open Label)||||||
1501173|NCT00967200|||Cohort||Retrospective|||||||
1501174|NCT00967187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501175|NCT00967174|Randomized|Single Group Assignment||Screening||Double|||t||t|
1501176|NCT00967161|Randomized|Parallel Assignment||||None (Open Label)||||||
1501177|NCT00967148|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501178|NCT00967135|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1501179|NCT00967122|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1501180|NCT00967109|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1501181|NCT00967096|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501182|NCT00967083|||Cohort||Prospective|||||||
1501183|NCT00967070|Randomized|Single Group Assignment||Screening||Double|||t||t|
1501184|NCT00967057|Randomized|||Treatment||||||||
1501185|NCT00967044||Single Group Assignment||Treatment||None (Open Label)||||||
1501186|NCT00967031|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501187|NCT00967018||Single Group Assignment||Treatment||None (Open Label)||||||
1501188|NCT00967005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501189|NCT00966992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501190|NCT00966979||Single Group Assignment||Treatment||None (Open Label)||||||
1501191|NCT00966966|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501192|NCT00966953|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1501193|NCT00966940|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1501194|NCT00966927|||Cohort||Cross-Sectional|||||||
1501195|NCT00966914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501196|NCT00966901|Randomized|Single Group Assignment||Screening||Double|||t||t|
1501197|NCT00966888|Randomized|||Treatment||||||||
1501198|NCT00966875|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501199|NCT00966862||||||||||||
1501200|NCT00966849|Randomized|Parallel Assignment||||None (Open Label)||||||
1501201|NCT00966836|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501202|NCT00966823||Single Group Assignment||Treatment||None (Open Label)||||||
1501203|NCT00966810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501204|NCT00966784||||||||||||
1501205|NCT00966771|||Other||Prospective|||||||
1501206|NCT00966758||Single Group Assignment||Diagnostic||None (Open Label)||||||
1501207|NCT00966745|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501208|NCT00966732|Randomized|Parallel Assignment||Treatment||Single||||||t
1501209|NCT00966719|Randomized|Parallel Assignment||||Single|||||t|
1501210|NCT00966706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501211|NCT00966693||Single Group Assignment||Treatment||None (Open Label)||||||
1501212|NCT00966680|||||Prospective|||||||
1501213|NCT00966667|||Ecologic or Community||Prospective|||||||
1501214|NCT00966654|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501215|NCT00966641|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1501216|NCT00966628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501217|NCT00966615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501218|NCT00966602|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501219|NCT00966589|Randomized|Single Group Assignment||Treatment||Single|||t|||
1501220|NCT00966576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501221|NCT00966563|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501222|NCT00966550|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1501223|NCT00966537|||Cohort||Prospective|||||||
1501224|NCT00966524|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1501225|NCT00966511|||Cohort||Prospective|||||||
1501226|NCT00966498|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501227|NCT00966485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501228|NCT00966472||Single Group Assignment||Treatment||None (Open Label)||||||
1501229|NCT00966459||Single Group Assignment||Diagnostic||None (Open Label)||||||
1501230|NCT00966446|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501231|NCT00966433|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1501232|NCT00966420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501233|NCT00966407|||Cohort||Cross-Sectional|||||||
1501234|NCT00966394|||Cohort||Cross-Sectional|||||||
1501235|NCT00966381|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501236|NCT00966368|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1501237|NCT00966355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501238|NCT00966342|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1501239|NCT00966329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501240|NCT00966316|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501241|NCT00966303|Randomized|Single Group Assignment||Treatment||Single|||t|||
1501242|NCT00966290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501243|NCT00966277|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501244|NCT00966264|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1501245|NCT00966251|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501246|NCT00966238||Single Group Assignment||Prevention||None (Open Label)||||||
1501247|NCT00966225|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501248|NCT00966212|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501249|NCT00966199|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1501250|NCT00966186|Randomized|Parallel Assignment||||Single|||t|||
1501251|NCT00966173|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1501252|NCT00966160|Randomized|Parallel Assignment||Treatment||Single|||||t|
1501253|NCT00966147|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1501254|NCT00966134|||Cohort||Prospective|||||||
1501255|NCT00966121|Randomized|Parallel Assignment||Prevention||None (Open Label)||Endoscopic Band Ligation (EBL) Versus Endoscopic Band Ligation and Propranolol||||
1501256|NCT00966108|||Cohort||Prospective|||||||
1501257|NCT00966095|||Case Control||Prospective|||||||
1501258|NCT00966082|Randomized|Parallel Assignment||Prevention||None (Open Label)||Endoscopic Band Ligation (EBL) Versus Endoscopic Band Ligation and Propranolol||||
1501259|NCT00966069|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1501260|NCT00966056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501261|NCT00966043|||Cohort||Prospective|||||||
1501262|NCT00966030|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501263|NCT00966017|||Case Control||Retrospective|||||||
1501264|NCT00966004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501265|NCT00965991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501266|NCT00965978|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501267|NCT00965965|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1501268|NCT00965952|||Case-Only||Prospective|||||||
1501269|NCT00965939|||Cohort||Prospective|||||||
1501270|NCT00965926|Randomized|Crossover Assignment||||None (Open Label)||||||
1501271|NCT00965913|Randomized|Single Group Assignment||Screening||Double|||t||t|
1501272|NCT00965900|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501273|NCT00965887|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501274|NCT00965874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501275|NCT00965861|||Cohort|||||||||
1501276|NCT00965848|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501277|NCT00965835|||Case Control||Prospective|||||||
1501278|NCT00965822|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501279|NCT00965809|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501280|NCT00965796|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501281|NCT00965783|Randomized|Crossover Assignment||||None (Open Label)||||||
1501282|NCT00965770|||Cohort||Retrospective|||||||
1501283|NCT00965757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501284|NCT00965744|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1501285|NCT00965731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501286|NCT00965718||Single Group Assignment||Treatment||None (Open Label)||||||
1501287|NCT00965705|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501288|NCT00965679|||||Prospective|||||||
1501289|NCT00965666|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1501290|NCT00965653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501291|NCT00965640||||Screening||||||||
1501292|NCT00965627|||Cohort||Retrospective|||||||
1501293|NCT00965614||||||||||||
1501294|NCT00965601|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1501295|NCT00965588||Single Group Assignment||Treatment||None (Open Label)||||||
1501296|NCT00965575|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1501297|NCT00965562|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501298|NCT00965549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501299|NCT00965536|||Case Control||Retrospective|||||||
1501300|NCT00965523|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501301|NCT00965510|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1501302|NCT00965497|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501303|NCT00965484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501304|NCT00965471|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1501305|NCT00965458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501306|NCT00965445|||Case Control||Prospective|||||||
1501307|NCT00965432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501308|NCT00965419||Single Group Assignment||Treatment||None (Open Label)||||||
1501309|NCT00965406|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501310|NCT00965393|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1501311|NCT00965380|||Case-Only||Prospective|||||||
1501312|NCT00965367|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1501313|NCT00965354|||Cohort||Prospective|||||||
1501314|NCT00965341|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1501315|NCT00965328|Randomized|Crossover Assignment||Treatment||Single||||||t
1501316|NCT00965315||||||||||||
1501317|NCT00965302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501318|NCT00965289|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501319|NCT00965276||||||||||||
1501320|NCT00965263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501321|NCT00965250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501322|NCT00965237|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501323|NCT00965224||||Treatment||||||||
1501324|NCT00965211||Single Group Assignment||Treatment||None (Open Label)||||||
1501325|NCT00965198|||Case-Crossover||Prospective|||||||
1501326|NCT00965185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501327|NCT00965172|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501328|NCT00965146||Single Group Assignment||Treatment||None (Open Label)||||||
1501329|NCT00965133|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501330|NCT00965120|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1501331|NCT00965107|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501332|NCT00965094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501333|NCT00965081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501334|NCT00965068|Randomized|Parallel Assignment||Treatment||||||||
1501335|NCT00965055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501336|NCT00965042||Single Group Assignment||Basic Science||None (Open Label)||||||
1501337|NCT00965029|||Cohort||Prospective|||||||
1501338|NCT00965016|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1501339|NCT00965003||Single Group Assignment||Diagnostic||None (Open Label)||||||
1501340|NCT00964990|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501341|NCT00964977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501342|NCT00964964|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1501343|NCT00964951|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1501344|NCT00964938|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1501345|NCT00964912|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501346|NCT00964886|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501347|NCT00964873||Single Group Assignment||Treatment||None (Open Label)||||||
1501348|NCT00964860|Randomized|Parallel Assignment||Treatment||Single||||||t
1501349|NCT00964847|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501350|NCT00964834|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501351|NCT00964821|||Case-Control||Prospective|||||||
1501352|NCT00964808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501353|NCT00964795||Single Group Assignment||Treatment||None (Open Label)||||||
1501354|NCT00964782|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1501355|NCT00964769||Parallel Assignment||||None (Open Label)||||||
1501356|NCT00964756||Single Group Assignment||Treatment||None (Open Label)||||||
1501357|NCT00964743||Single Group Assignment||Treatment||None (Open Label)||||||
1501358|NCT00964730|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501359|NCT00964717|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1501360|NCT00964704|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501361|NCT00964691|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501362|NCT00964678||Single Group Assignment||Treatment||None (Open Label)||||||
1501363|NCT00964665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501364|NCT00964652||Single Group Assignment||Treatment||None (Open Label)||||||
1501365|NCT00964639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501366|NCT00964626||||Treatment||None (Open Label)||||||
1501367|NCT00964613|||Case-Only||Prospective|||||||
1501368|NCT00964600|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501369|NCT00964587|Randomized|Parallel Assignment||Treatment||Single||||||t
1501370|NCT00964574|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501371|NCT00964561|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501372|NCT00964548|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501373|NCT00964535|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1501374|NCT00964522|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1501375|NCT00964496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501376|NCT00964483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501377|NCT00964470|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501378|NCT00964457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501379|NCT00964444|||||Prospective|||||||
1501380|NCT00964431|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501381|NCT00964418|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1501382|NCT00964405|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1501383|NCT00964392|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501384|NCT00964379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501385|NCT00964366|Randomized|Parallel Assignment||Treatment||Single||||||t
1501386|NCT00964353|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1501387|NCT00964340|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1501388|NCT00964327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501389|NCT00964314|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1501390|NCT00964301|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501391|NCT00964288|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1501392|NCT00964275|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1501393|NCT00964262|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1501394|NCT00964249|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501395|NCT00964236|||Case-Control||Prospective|||||||
1501396|NCT00964223|Randomized|Parallel Assignment||Treatment||Single||||||t
1501397|NCT00964210||Single Group Assignment||Prevention||None (Open Label)||||||
1501398|NCT00964197||Single Group Assignment||Other||None (Open Label)||||||
1501399|NCT00964184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501400|NCT00964171||||Treatment||None (Open Label)||||||
1501401|NCT00964158||Single Group Assignment||Prevention||None (Open Label)||||||
1501402|NCT00964145|||||Cross-Sectional|||||||
1501403|NCT00964132||Single Group Assignment||Treatment||None (Open Label)||||||
1501404|NCT00964119|||Case-Only||Prospective|||||||
1501405|NCT00964106|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1501406|NCT00964093|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501407|NCT00964080||Single Group Assignment||Treatment||None (Open Label)||||||
1501408|NCT00964067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501409|NCT00964054|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1501410|NCT00964041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501411|NCT00964028|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501412|NCT00964015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501413|NCT00964002||||Treatment||None (Open Label)||||||
1501414|NCT00963989||Single Group Assignment||Treatment||None (Open Label)||||||
1501415|NCT00963976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501416|NCT00963963|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501417|NCT00963950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501418|NCT00963937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501419|NCT00963924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501420|NCT00963911|Non-Randomized|||Screening||None (Open Label)||||||
1501421|NCT00963898|Randomized|Single Group Assignment||Supportive Care||Single|||||t|
1501422|NCT00963885|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501423|NCT00963872|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501424|NCT00963859||Single Group Assignment||Treatment||None (Open Label)||||||
1501425|NCT00963846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501426|NCT00963833|||Cohort||Prospective|||||||
1501427|NCT00963820|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501428|NCT00963807||Single Group Assignment||Treatment||None (Open Label)||||||
1501429|NCT00963794||Single Group Assignment||Diagnostic||Single|||t|||
1501430|NCT00963781||Single Group Assignment||Treatment||None (Open Label)||||||
1501431|NCT00963768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501432|NCT00963755|||Cohort||Prospective|||||||
1501433|NCT00963742||Single Group Assignment||Treatment||None (Open Label)||||||
1501434|NCT00963729|Randomized|||Treatment||None (Open Label)||||||
1501435|NCT00963716|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1501436|NCT00963703||Single Group Assignment||Treatment||None (Open Label)||||||
1501437|NCT00963690|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1501438|NCT00963677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501439|NCT00963664||Single Group Assignment||Treatment||None (Open Label)||||||
1501440|NCT00963651|||Case-Only||Cross-Sectional|||||||
1501441|NCT00963638|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501442|NCT00963625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501443|NCT00963612||Single Group Assignment||Diagnostic||None (Open Label)||||||
1501444|NCT00963599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501445|NCT00963586|||Cohort||Cross-Sectional|||||||
1501446|NCT00963573||Single Group Assignment||Treatment||None (Open Label)||||||
1501447|NCT00963560|Randomized|Single Group Assignment||Treatment||Single|||t|||
1501448|NCT00963547|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501449|NCT00963534||Single Group Assignment||Treatment||None (Open Label)||||||
1501450|NCT00963521|Non-Randomized|||Treatment||||||||
1501451|NCT00963508|Randomized|Parallel Assignment||Treatment||Single||||||t
1501452|NCT00963495|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501453|NCT00963482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501454|NCT00963469|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501455|NCT00963443|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501456|NCT00963430|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1501457|NCT00963417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501458|NCT00963404||Single Group Assignment||Treatment||None (Open Label)||||||
1501459|NCT00963391|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501460|NCT00963365|Randomized|Crossover Assignment||||Single|||t|||
1501461|NCT00963352|||Case Control||Prospective|||||||
1501462|NCT00963339|||Cohort||Prospective|||||||
1501463|NCT00963326||||||||||||
1501464|NCT00963313|||Case-Only||Prospective|||||||
1501465|NCT00963300||Single Group Assignment||Diagnostic||None (Open Label)||||||
1501466|NCT00963287|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1501467|NCT00963274||Single Group Assignment||Treatment||None (Open Label)||||||
1501468|NCT00963261|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1501469|NCT00963248|||Cohort||Prospective|||||||
1501470|NCT00963235||Single Group Assignment||Prevention||None (Open Label)||||||
1501471|NCT00963222|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501472|NCT00963209||Single Group Assignment||Treatment||None (Open Label)||||||
1501473|NCT00963196|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1501474|NCT00963183|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1501475|NCT00963157|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1501476|NCT00963144|||Cohort||Prospective|||||||
1501477|NCT00963131|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501478|NCT00963118|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1501479|NCT00963105|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501480|NCT00963092||||||||||||
1501481|NCT00963079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501482|NCT00963066|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1501483|NCT00963053|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1501484|NCT00963040|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501485|NCT00963027||Crossover Assignment||Treatment||None (Open Label)||||||
1501486|NCT00963001|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501487|NCT00962988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501488|NCT00962975|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501489|NCT00962962|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1501490|NCT00962949|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1501491|NCT00962936||Single Group Assignment||Treatment||None (Open Label)||||||
1501492|NCT00962923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501493|NCT00962910|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1501494|NCT00962897|||Case Control||Retrospective|||||||
1501495|NCT00962884|Randomized|Crossover Assignment||Treatment||Single|||t|||
1502191|NCT00953693|||Case-Only||Prospective|||||||
1501496|NCT00962871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501497|NCT00962845||Single Group Assignment||Treatment||None (Open Label)||||||
1501498|NCT00962832|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501499|NCT00962819|||||Cross-Sectional|||||||
1501500|NCT00962806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501501|NCT00962793|||||Prospective|||||||
1501502|NCT00962780||Single Group Assignment||Prevention||None (Open Label)||||||
1501503|NCT00962767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501504|NCT00962754|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1501505|NCT00962741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501506|NCT00962728|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1501507|NCT00962715|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501508|NCT00962702|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1501509|NCT00962689|||Cohort||Prospective|||||||
1501510|NCT00962676||||||||||||
1501511|NCT00962663|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1501512|NCT00962650||Single Group Assignment||Diagnostic||None (Open Label)||||||
1501513|NCT00962637|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501514|NCT00962624||Single Group Assignment||Prevention||None (Open Label)||||||
1501515|NCT00962611||Single Group Assignment||Treatment||None (Open Label)||||||
1501516|NCT00962598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501517|NCT00962585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501518|NCT00962572|||Case Control||Retrospective|||||||
1501519|NCT00962559|||Cohort||Prospective|||||||
1501520|NCT00962546|||Cohort||Prospective|||||||
1501521|NCT00962533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501522|NCT00962520||Single Group Assignment||Treatment||None (Open Label)||||||
1501523|NCT00962507||Single Group Assignment||Treatment||None (Open Label)||||||
1501524|NCT00962494|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1501525|NCT00962481|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1501526|NCT00962468|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1501527|NCT00962455|Randomized|Parallel Assignment||||Single||||||t
1501528|NCT00962442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501529|NCT00962429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501530|NCT00962416|Randomized|Parallel Assignment||Treatment||Single||||||t
1501531|NCT00962403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501532|NCT00962390|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501533|NCT00962377|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1501534|NCT00962364|||Case-Only||Prospective|||||||
1501535|NCT00962351|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501536|NCT00962338|||||Prospective|||||||
1501537|NCT00962325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501538|NCT00962312||Single Group Assignment||Treatment||None (Open Label)||||||
1501539|NCT00962299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501540|NCT00962286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501541|NCT00962273|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1501542|NCT00962260||||||||||||
1501543|NCT00962247||Sequential Assignment||Other||None (Open Label)||||||
1501544|NCT00962234|||Case-Only||Cross-Sectional|||||||
1501545|NCT00962221|||Case-Only||Cross-Sectional|||||||
1501546|NCT00962208|Randomized|Parallel Assignment||Treatment||Single|||||t|
1501547|NCT00962195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501548|NCT00962182|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1501549|NCT00962169|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1501550|NCT00962156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501551|NCT00962143|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1501552|NCT00962130||Single Group Assignment||Diagnostic||None (Open Label)||||||
1501553|NCT00962117|||||Cross-Sectional|||||||
1501554|NCT00962104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501555|NCT00962091|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501556|NCT00962078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501557|NCT00962065|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501558|NCT00962052|||Cohort||Prospective|||||||
1501559|NCT00962039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501560|NCT00962026||Single Group Assignment||Treatment||None (Open Label)||||||
1501561|NCT00962013||Single Group Assignment||Treatment||None (Open Label)||||||
1501562|NCT00962000|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501563|NCT00961987|Randomized|Parallel Assignment||Treatment||Single||||||t
1501564|NCT00961974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501565|NCT00961961|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501566|NCT00961948|||Case-Only||Prospective|||||||
1501567|NCT00961935|||||Cross-Sectional|||||||
1501568|NCT00961922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501569|NCT00961909||Parallel Assignment||Treatment||Double|||t||t|
1501570|NCT00961896|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501571|NCT00961883|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1501572|NCT00961870|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1501573|NCT00961857|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502579|NCT00948597|||Case-Only||Prospective|||||||
1501574|NCT00961844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501575|NCT00961831|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1501576|NCT00961818|||Case Control||Prospective|||||||
1501577|NCT00961805|Randomized|Parallel Assignment||Treatment||Single||||||t
1501578|NCT00961792|Randomized|Parallel Assignment||Screening||Double|||t||t|
1501579|NCT00961779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501580|NCT00961766|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501581|NCT00961753|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1501582|NCT00961740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501583|NCT00961727|||Case-Crossover||Prospective|||||||
1501584|NCT00961714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501585|NCT00961701|||Case-Only||Cross-Sectional|||||||
1501586|NCT00961688||||||||||||
1501587|NCT00961675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501588|NCT00961662|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501589|NCT00961649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501590|NCT00961636|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501591|NCT00961623|||Case-Only||Prospective|||||||
1501592|NCT00961610|||Case Control||Prospective|||||||
1501593|NCT00961597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501594|NCT00961571||Single Group Assignment||Treatment||None (Open Label)||||||
1501595|NCT00961558|Randomized|Parallel Assignment||Treatment||Single||||||t
1501596|NCT00961532||Single Group Assignment||Treatment||None (Open Label)||||||
1501597|NCT00961519||||||||||||
1501598|NCT00961506|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501599|NCT00961493|Randomized|Parallel Assignment||Treatment||Single||||||t
1501600|NCT00961480|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501601|NCT00961467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501602|NCT00961454|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501603|NCT00961441|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501604|NCT00961428|||||Prospective|||||||
1501605|NCT00961415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501606|NCT00961402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501607|NCT00961389|||Cohort||Prospective|||||||
1501608|NCT00961376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501609|NCT00961363|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501610|NCT00961350|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501611|NCT00961337|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501612|NCT00961324|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501613|NCT00961311|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501614|NCT00961298||Single Group Assignment||Treatment||Single|||t|||
1501615|NCT00961285|||||Prospective|||||||
1501616|NCT00961272|||Cohort||Prospective|||||||
1501617|NCT00961259|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1501618|NCT00961246|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1501619|NCT00961233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501620|NCT00961220||Single Group Assignment||Treatment||None (Open Label)||||||
1501621|NCT00961207|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501622|NCT00961194|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1501623|NCT00961181||Single Group Assignment||Treatment||None (Open Label)||||||
1501624|NCT00961168|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1501625|NCT00961155|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1501626|NCT00961142||Single Group Assignment||Treatment||None (Open Label)||||||
1501627|NCT00961129|||Cohort||Prospective|||||||
1501628|NCT00961116|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1501629|NCT00961103|||Cohort||Retrospective|||||||
1501630|NCT00961090||Single Group Assignment||Treatment||None (Open Label)||||||
1501631|NCT00961077||Single Group Assignment||Treatment||None (Open Label)||||||
1501632|NCT00961064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501633|NCT00961051|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1501634|NCT00961038|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501635|NCT00961025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501636|NCT00961012|Randomized|Single Group Assignment||Prevention||Single|||||t|
1501637|NCT00960999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501638|NCT00960986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501639|NCT00960973|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1501640|NCT00960960|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501641|NCT00960947||||||||||||
1501642|NCT00960934|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501643|NCT00960921|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501644|NCT00960908|||Case Control||Prospective|||||||
1501645|NCT00960895|||Case-Only||Retrospective|||||||
1501646|NCT00960882||Single Group Assignment||Treatment||None (Open Label)||||||
1501647|NCT00960869|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501648|NCT00960856|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1501649|NCT00960843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501650|NCT00960830|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1501651|NCT00960817||||||||||||
1501652|NCT00960804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501653|NCT00960791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501654|NCT00960778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501655|NCT00960765|||Cohort||Prospective|||||||
1501656|NCT00960752|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1501657|NCT00960739||Single Group Assignment||Treatment||None (Open Label)||||||
1501658|NCT00960726||Single Group Assignment||Treatment||None (Open Label)||||||
1501659|NCT00960713|||Cohort||Prospective|||||||
1501660|NCT00960700|||Cohort||Prospective|||||||
1501661|NCT00960687|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1501662|NCT00960674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501663|NCT00960661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501664|NCT00960648|||Case Control||Prospective|||||||
1501665|NCT00960635||||Prevention||||||||
1501666|NCT00960622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501667|NCT00960609|||Cohort||Prospective|||||||
1501668|NCT00960596|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1501669|NCT00960583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501670|NCT00960570|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1501671|NCT00960557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501672|NCT00960544||Single Group Assignment||Treatment||None (Open Label)||||||
1501673|NCT00960531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501674|NCT00960518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501675|NCT00960505|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501676|NCT00960492|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501677|NCT00960479|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501678|NCT00960466|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1501679|NCT00960453|Randomized|Crossover Assignment||||None (Open Label)||||||
1501680|NCT00960440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501681|NCT00960427||||Treatment||None (Open Label)||||||
1501682|NCT00960414|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1501683|NCT00960401|||||Retrospective|||||||
1501684|NCT00960375|Randomized|Parallel Assignment||Treatment||Single||||||t
1501685|NCT00960362|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1501686|NCT00960349|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501687|NCT00960336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501688|NCT00960323|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1501689|NCT00960310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501690|NCT00960297||Single Group Assignment||Treatment||None (Open Label)||||||
1501691|NCT00960284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501692|NCT00960271|||Case-Only||Prospective|||||||
1501693|NCT00960258||Single Group Assignment||Treatment||None (Open Label)||||||
1501694|NCT00960245|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501695|NCT00960232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501696|NCT00960219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501697|NCT00960206|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501698|NCT00960193|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1501699|NCT00960180|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1501700|NCT00960167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501701|NCT00960154|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501702|NCT00960141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501703|NCT00960128|||Cohort||Prospective|||||||
1501704|NCT00960115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501705|NCT00960102|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501706|NCT00960089||Single Group Assignment||Treatment||None (Open Label)||||||
1501707|NCT00960076|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501708|NCT00960063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501709|NCT00960037|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1501710|NCT00960024|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1501711|NCT00960011|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501712|NCT00959998|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501713|NCT00959985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501714|NCT00959972|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501715|NCT00959959|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501716|NCT00959946|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501717|NCT00959933|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501718|NCT00959920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501719|NCT00959907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501720|NCT00959894||Single Group Assignment||Treatment||None (Open Label)||||||
1501721|NCT00959881|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1501722|NCT00959868||Single Group Assignment||Treatment||None (Open Label)||||||
1501723|NCT00959855|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1501724|NCT00959842||Single Group Assignment||Treatment||None (Open Label)||||||
1501725|NCT00959829|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1501726|NCT00959816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501727|NCT00959803|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1501728|NCT00959790|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1501729|NCT00959777||||||||||||
1501730|NCT00959764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501731|NCT00959751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501732|NCT00959738|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501733|NCT00959725||Single Group Assignment||Treatment||None (Open Label)||||||
1501734|NCT00959712|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501735|NCT00959699|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501736|NCT00959686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501737|NCT00959660|Randomized|Factorial Assignment||Treatment||Single||||||t
1501738|NCT00959647||Single Group Assignment||Treatment||None (Open Label)||||||
1501739|NCT00959634|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1501740|NCT00959621|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501741|NCT00959608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501742|NCT00959595|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501743|NCT00959582|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1501744|NCT00959569|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501745|NCT00959556||||||||||||
1501746|NCT00959543|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1501747|NCT00959530|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501748|NCT00959517|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1501749|NCT00959504|||Case-Only||Retrospective|||||||
1501750|NCT00959491|||||Prospective|||||||
1501751|NCT00959478|Randomized|Single Group Assignment||Prevention||Single|||t|||
1501752|NCT00959465|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501753|NCT00959452||Single Group Assignment||Treatment||None (Open Label)||||||
1501754|NCT00959439|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501755|NCT00959426|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501756|NCT00959413|||Case-Only||Cross-Sectional|||||||
1501757|NCT00959400||Single Group Assignment||Treatment||None (Open Label)||||||
1501758|NCT00959387||Single Group Assignment||Treatment||None (Open Label)||||||
1501759|NCT00959374||Single Group Assignment||Treatment||Single|||t|||
1501760|NCT00959361|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1501761|NCT00959348|||Case Control||Cross-Sectional|||||||
1501762|NCT00959335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501763|NCT00959322||Single Group Assignment||Treatment||None (Open Label)||||||
1501764|NCT00959309|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1501765|NCT00959296|||Cohort||Prospective|||||||
1501766|NCT00959283||||||||||||
1501767|NCT00959270|||Cohort||Cross-Sectional|||||||
1501768|NCT00959257|||Case Control||Cross-Sectional|||||||
1501769|NCT00959244|||Cohort||Prospective|||||||
1501770|NCT00959231|Non-Randomized|||Treatment||None (Open Label)||||||
1501771|NCT00959218|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501772|NCT00959205|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501773|NCT00959192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501774|NCT00959179|||Case-Only||Prospective|||||||
1501775|NCT00959166|||Case Control||Prospective|||||||
1501776|NCT00959153|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501777|NCT00959140||Single Group Assignment||Treatment||None (Open Label)||||||
1501778|NCT00959127||Single Group Assignment||Treatment||None (Open Label)||||||
1501779|NCT00959114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501780|NCT00959101|Randomized|Crossover Assignment||Treatment||Single|||||t|
1501781|NCT00959088|||Case-Only||Cross-Sectional|||||||
1501782|NCT00959075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501783|NCT00959062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501784|NCT00959049|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501785|NCT00959036|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501786|NCT00959023||||||||||||
1501787|NCT00959010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501788|NCT00958997|||Case Control||Prospective|||||||
1501789|NCT00958984|||Cohort||Prospective|||||||
1501790|NCT00958971||Parallel Assignment||Treatment||None (Open Label)||||||
1501791|NCT00958958|Randomized|Parallel Assignment||||Single||||||t
1501792|NCT00958945|||||Retrospective|||||||
1501793|NCT00958932|Randomized|Parallel Assignment||Treatment||Single|||||t|
1501794|NCT00958919|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1501795|NCT00958906||Single Group Assignment||Treatment||None (Open Label)||||||
1501796|NCT00958893||Single Group Assignment||Treatment||None (Open Label)||||||
1501797|NCT00958880|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501798|NCT00958867|Randomized|Single Group Assignment||Prevention||Single|||t|||
1501799|NCT00958854||||Treatment||None (Open Label)||||||
1501800|NCT00958841||Single Group Assignment||Treatment||None (Open Label)||||||
1501801|NCT00958828|Randomized|Crossover Assignment||Treatment||Single|||t|||
1501802|NCT00958815|||Cohort||Cross-Sectional|||||||
1501803|NCT00958802|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501804|NCT00958789||Single Group Assignment||Treatment||None (Open Label)||||||
1501805|NCT00958776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501806|NCT00958763|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1501807|NCT00958750|Randomized|Parallel Assignment||Treatment||Single|||||t|
1501808|NCT00958737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501809|NCT00958724||Single Group Assignment||Treatment||None (Open Label)||||||
1501810|NCT00958711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501811|NCT00958698|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1501812|NCT00958685|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1501813|NCT00958672|||Cohort||Prospective|||||||
1501814|NCT00958659|||Case Control||Retrospective|||||||
1501815|NCT00958646|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1501816|NCT00958633|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1501817|NCT00958620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501818|NCT00958607|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1501819|NCT00958581|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501820|NCT00958568|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501821|NCT00958555|||Case-Crossover||Cross-Sectional|||||||
1501822|NCT00958542|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1501823|NCT00958529||Single Group Assignment||Other||None (Open Label)||||||
1501824|NCT00958516||Single Group Assignment||||Double|||t||t|
1501825|NCT00958503|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1501826|NCT00958490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501827|NCT00958477||Single Group Assignment||Treatment||None (Open Label)||||||
1501828|NCT00958464|||Case-Only||Cross-Sectional|||||||
1501829|NCT00958451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501830|NCT00958438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501831|NCT00958425|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501832|NCT00958412||Single Group Assignment||Treatment||None (Open Label)||||||
1501833|NCT00958399|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1501834|NCT00958386||Single Group Assignment||Treatment||None (Open Label)||||||
1501835|NCT00958373|||Cohort||Prospective|||||||
1501836|NCT00958360|Randomized|Parallel Assignment||Treatment||Single||||||t
1501837|NCT00958347||Single Group Assignment||Treatment||None (Open Label)||||||
1501838|NCT00958334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501839|NCT00958321||Single Group Assignment||Diagnostic||None (Open Label)||||||
1501840|NCT00958308|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1501841|NCT00958295|||Case-Only||Prospective|||||||
1501842|NCT00958282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501843|NCT00958269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501844|NCT00958256||Single Group Assignment||Treatment||None (Open Label)||||||
1501845|NCT00958243|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501846|NCT00958230||Single Group Assignment||Treatment||None (Open Label)||||||
1501847|NCT00958217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501848|NCT00958204|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1501849|NCT00958191||Single Group Assignment||Treatment||None (Open Label)||||||
1501850|NCT00958178|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1501851|NCT00958165||Single Group Assignment||Treatment||None (Open Label)||||||
1501852|NCT00958152|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1501853|NCT00958139|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501854|NCT00958126|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501855|NCT00958113|||Case Control||Cross-Sectional|||||||
1501856|NCT00958100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501857|NCT00958087|||Cohort||Prospective|||||||
1501858|NCT00958074|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501859|NCT00958061|||Cohort||Cross-Sectional|||||||
1501860|NCT00958048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501861|NCT00958035|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501862|NCT00958022||Single Group Assignment||Treatment||None (Open Label)||||||
1501863|NCT00958009||Single Group Assignment||||None (Open Label)||||||
1501864|NCT00957996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501865|NCT00957983|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1501866|NCT00957970|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501867|NCT00957957|||Cohort||Prospective|||||||
1501868|NCT00957944|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1501869|NCT00957931||Single Group Assignment||Treatment||None (Open Label)||||||
1501870|NCT00957918|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501871|NCT00957905|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501872|NCT00957892|||Case-Crossover||Cross-Sectional|||||||
1501873|NCT00957879|Randomized|Parallel Assignment||||None (Open Label)||||||
1501874|NCT00957866|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1501875|NCT00957853|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501876|NCT00957840||Single Group Assignment||Treatment||None (Open Label)||||||
1501877|NCT00957827|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1501878|NCT00957814|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1501879|NCT00957801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501880|NCT00957788|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501881|NCT00957775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501882|NCT00957762|||||Prospective|||||||
1501883|NCT00957749|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501884|NCT00957736|||Case-Only||Retrospective|||||||
1501885|NCT00957723||Single Group Assignment||Treatment||None (Open Label)||||||
1501886|NCT00957710||Single Group Assignment||||None (Open Label)||||||
1501887|NCT00957697|||Cohort||Retrospective|||||||
1501888|NCT00957684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501889|NCT00957671||Single Group Assignment||Treatment||None (Open Label)||||||
1501890|NCT00957658||Single Group Assignment||Treatment||None (Open Label)||||||
1501891|NCT00957645|||Cohort||Prospective|||||||
1501892|NCT00957632||||||||||||
1501893|NCT00957619|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1501894|NCT00957606|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1501895|NCT00957593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501896|NCT00957580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501897|NCT00957567|||Case Control||Retrospective|||||||
1501898|NCT00957554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501899|NCT00957541|Non-Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1501900|NCT00957528|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1501901|NCT00957502|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501902|NCT00957489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501903|NCT00957476|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1501904|NCT00957463|||Case Control||Cross-Sectional|||||||
1501905|NCT00957450|||Cohort||Prospective|||||||
1501906|NCT00957437|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1501907|NCT00957424||Single Group Assignment||||None (Open Label)||||||
1501908|NCT00957411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501909|NCT00957398||||||||||||
1501910|NCT00957385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501911|NCT00957372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501912|NCT00957359|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1501913|NCT00957346|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501914|NCT00957333|||Case-Only||Cross-Sectional|||||||
1501915|NCT00957320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501916|NCT00957307|||Case-Only||Prospective|||||||
1501917|NCT00957294|||Cohort||Prospective|||||||
1501918|NCT00957281|||Case-Only||Cross-Sectional|||||||
1501919|NCT00957268|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1501920|NCT00957255|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501921|NCT00957242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501922|NCT00957229|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1501923|NCT00957216|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1501924|NCT00957203||Single Group Assignment||Treatment||None (Open Label)||||||
1501925|NCT00957190||Single Group Assignment||Other||None (Open Label)||||||
1501926|NCT00957177|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501927|NCT00957164|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1501928|NCT00957151|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1501929|NCT00957138||||||||||||
1501930|NCT00957125||Single Group Assignment||Treatment||None (Open Label)||||||
1501931|NCT00957112|Randomized|||Supportive Care||None (Open Label)||||||
1501932|NCT00957099|||Cohort||Prospective|||||||
1501933|NCT00957086|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1501934|NCT00957073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501935|NCT00957060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501936|NCT00957047|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1501937|NCT00957034|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501938|NCT00957021||Single Group Assignment||Treatment||None (Open Label)||||||
1501939|NCT00957008|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1501940|NCT00956982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501941|NCT00956969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501942|NCT00956956|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1501943|NCT00956943|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1501944|NCT00956930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501945|NCT00956917|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1501946|NCT00956904||Single Group Assignment||Treatment||None (Open Label)||||||
1501947|NCT00956891|||Case Control||Retrospective|||||||
1501948|NCT00956878|||Case-Only||Prospective|||||||
1501949|NCT00956865|Randomized|Parallel Assignment||Screening||Double|||t|t||
1501950|NCT00956852|||Case-Only||Prospective|||||||
1501951|NCT00956839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501952|NCT00956826|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1501953|NCT00956813|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1501954|NCT00956800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501955|NCT00956787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501956|NCT00956774|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1501957|NCT00956761||Single Group Assignment||Prevention||None (Open Label)||||||
1501958|NCT00956748|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1501959|NCT00956735|Randomized|Crossover Assignment||Basic Science||Single||||||t
1501960|NCT00956722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501961|NCT00956709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501962|NCT00956696|||Case-Only||Prospective|||||||
1503122|NCT00941512|||Case-Only||Cross-Sectional|||||||
1501963|NCT00956683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501964|NCT00956670||Single Group Assignment||Supportive Care||None (Open Label)||||||
1501965|NCT00956657|Randomized|Parallel Assignment||Health Services Research||||||||
1501966|NCT00956644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501967|NCT00956631||Single Group Assignment||Treatment||None (Open Label)||||||
1501968|NCT00956618||||||||||||
1501969|NCT00956605|Randomized|Crossover Assignment||Treatment||||||||
1501970|NCT00956592|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1501971|NCT00956579|||Case Control||Prospective|||||||
1501972|NCT00956566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501973|NCT00956553|Randomized|Parallel Assignment||Prevention||Single|||t|||
1501974|NCT00956540|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1501975|NCT00956527||Single Group Assignment||Treatment||None (Open Label)||||||
1501976|NCT00956514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501977|NCT00956501|||||Prospective|||||||
1501978|NCT00956488||Single Group Assignment||Prevention||None (Open Label)||||||
1501979|NCT00956475|||Case-Only||Cross-Sectional|||||||
1501980|NCT00956462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501981|NCT00956449|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1501982|NCT00956436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501983|NCT00956423|Randomized|Parallel Assignment||Treatment||Single||||||t
1501984|NCT00956410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501985|NCT00956397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1501986|NCT00956384|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501987|NCT00956371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1501988|NCT00956358|||Case Control||Prospective|||||||
1501989|NCT00956345|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501990|NCT00956332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501991|NCT00956319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501992|NCT00956306|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1501993|NCT00956293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501994|NCT00956280|||Case-Only||Prospective|||||||
1501995|NCT00956267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1501996|NCT00956254||Single Group Assignment||Supportive Care||None (Open Label)||||||
1501997|NCT00956241|Randomized|Parallel Assignment||Treatment||Single|||t|||
1501998|NCT00956228|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1501999|NCT00956215|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1502000|NCT00956202|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502001|NCT00956189|Randomized|Parallel Assignment||Treatment||Single||||||t
1502002|NCT00956176||Single Group Assignment||Treatment||None (Open Label)||||||
1502003|NCT00956163||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502004|NCT00956150|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502005|NCT00956137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502006|NCT00956124|||Case-Control||Prospective|||||||
1502007|NCT00956111|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502008|NCT00956098|Randomized|Parallel Assignment||Treatment||Double||||||
1502009|NCT00956085||Single Group Assignment||Treatment||None (Open Label)||||||
1502010|NCT00956072|Randomized|||Treatment||||||||
1502011|NCT00956059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502012|NCT00956046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502013|NCT00956033|||Case-Only||Prospective|||||||
1502014|NCT00956020||Single Group Assignment||Treatment||None (Open Label)||||||
1502015|NCT00956007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502016|NCT00955994|Randomized|Parallel Assignment||Treatment||Double||||||
1502017|NCT00955981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502018|NCT00955968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502019|NCT00955955|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1502020|NCT00955942|Randomized|||Treatment||Double||||||
1502021|NCT00955929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502022|NCT00955916||Single Group Assignment||Treatment||None (Open Label)||||||
1502023|NCT00955903|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1502024|NCT00955890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502025|NCT00955877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502026|NCT00955864||||||||||||
1502027|NCT00955851|||Cohort||Prospective|||||||
1502028|NCT00955838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502029|NCT00955825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502030|NCT00955812||Single Group Assignment||Treatment||None (Open Label)||||||
1502031|NCT00955799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502032|NCT00955786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502033|NCT00955773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502034|NCT00955760||||||None (Open Label)||||||
1502035|NCT00955747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502036|NCT00955734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502037|NCT00955721|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502038|NCT00955708|||Cohort||Prospective|||||||
1502039|NCT00955695|Randomized|||Prevention||||||||
1502040|NCT00955682|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502041|NCT00955669|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502042|NCT00955656|||Cohort||Prospective|||||||
1502043|NCT00955643|Randomized|Parallel Assignment||Treatment||Single||||||t
1502044|NCT00955630|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502045|NCT00955617|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1502046|NCT00955604|||Cohort||Retrospective|||||||
1502047|NCT00955591||Single Group Assignment||Screening||None (Open Label)||||||
1502048|NCT00955578|||Case-Only||Prospective|||||||
1502049|NCT00955565|Randomized|Parallel Assignment||Treatment||Single||||||t
1502050|NCT00955552|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502051|NCT00955539|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1502052|NCT00955526|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502053|NCT00955513|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502054|NCT00955500|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1502055|NCT00955487|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1502056|NCT00955474|Randomized|Parallel Assignment||Treatment||Single||||||t
1502057|NCT00955461||Single Group Assignment||Treatment||Single||||||t
1502058|NCT00955448|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1502059|NCT00955435|||Cohort||Prospective|||||||
1502060|NCT00955422|||||Prospective|||||||
1502061|NCT00955409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502062|NCT00955396|Randomized|Crossover Assignment||Other||Double|||t||t|
1502063|NCT00955383|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1502064|NCT00955370|||||Retrospective|||||||
1502065|NCT00955357|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502066|NCT00955344|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502067|NCT00955331||||||||||||
1502068|NCT00955318||Single Group Assignment||Treatment||None (Open Label)||||||
1502069|NCT00955305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502070|NCT00955292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502071|NCT00955279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502072|NCT00955266|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502073|NCT00955253|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1502074|NCT00955240|Non-Randomized|||Treatment||||||||
1502075|NCT00955227|Randomized|Parallel Assignment||||None (Open Label)||||||
1502076|NCT00955214||Single Group Assignment||Treatment||None (Open Label)||||||
1502077|NCT00955201|Randomized|Factorial Assignment||Treatment||Single|||||t|
1502078|NCT00955188|||Case-Only||Prospective|||||||
1502079|NCT00955175|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502080|NCT00955162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502081|NCT00955149|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1502082|NCT00955136|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1502083|NCT00955123|||Case-Crossover||Prospective|||||||
1502084|NCT00955110|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1502085|NCT00955097||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502086|NCT00955084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502087|NCT00955071|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502088|NCT00955058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502089|NCT00955045||||||||||||
1502090|NCT00955032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502091|NCT00955019|||Cohort||Prospective|||||||
1502092|NCT00955006|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1502093|NCT00954993||Single Group Assignment||Treatment||None (Open Label)||||||
1502094|NCT00954980|||Cohort||Prospective|||||||
1502095|NCT00954967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502096|NCT00954954|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502097|NCT00954941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502098|NCT00954928|||Case Control||Prospective|||||||
1502099|NCT00954915||Single Group Assignment||Treatment||None (Open Label)||||||
1502100|NCT00954902|Randomized|Crossover Assignment||Prevention||Single||||||t
1502101|NCT00954889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502102|NCT00954876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502103|NCT00954863|||Case-Only||Prospective|||||||
1502104|NCT00954850|||Case Control||Prospective|||||||
1502105|NCT00954837||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502106|NCT00954824||Single Group Assignment||Health Services Research||None (Open Label)||||||
1502107|NCT00954811|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502108|NCT00954798|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502109|NCT00954785|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502110|NCT00954772|||Cohort||Prospective|||||||
1502111|NCT00954759|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502112|NCT00954746|||Cohort||Prospective|||||||
1502113|NCT00954733|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1502114|NCT00954720|||Cohort||Prospective|||||||
1502115|NCT00954707|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502116|NCT00954694|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1502117|NCT00954681||Single Group Assignment||Treatment||None (Open Label)||||||
1502118|NCT00954668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502120|NCT00954642|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502121|NCT00954629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502122|NCT00954616|||Case-Only||Prospective|||||||
1502123|NCT00954603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502124|NCT00954590|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502125|NCT00954577|||Case-Crossover||Prospective|||||||
1502126|NCT00954564|||Cohort||Prospective|||||||
1502127|NCT00954551|||Cohort||Prospective|||||||
1502128|NCT00954538|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1502129|NCT00954525||Single Group Assignment||Treatment||None (Open Label)||||||
1502130|NCT00954512|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502131|NCT00954499|Randomized|Parallel Assignment||Treatment||Single||||t||
1502132|NCT00954486|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502133|NCT00954473|||Case Control||Retrospective|||||||
1502134|NCT00954460||||||||||||
1502135|NCT00954447|Randomized|Parallel Assignment||Treatment||Double||||||
1502136|NCT00954434|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1502137|NCT00954421||Single Group Assignment||Treatment||None (Open Label)||||||
1502138|NCT00954408|||Case-Only||Cross-Sectional|||||||
1502139|NCT00954395|||Cohort||Prospective|||||||
1502140|NCT00954382|||||Retrospective|||||||
1502141|NCT00954369|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1502142|NCT00954356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502143|NCT00954343|Randomized|Parallel Assignment||Treatment||Single||||||t
1502144|NCT00954330|Randomized|||Treatment||Single||||||t
1502145|NCT00954317|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502146|NCT00954304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502147|NCT00954291|||Case-Only|||||||||
1502148|NCT00954278||Single Group Assignment||Treatment||None (Open Label)||||||
1502149|NCT00954265|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502150|NCT00954252|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1502151|NCT00954226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502152|NCT00954213||Single Group Assignment||Treatment||None (Open Label)||||||
1502153|NCT00954200|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502154|NCT00954187|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1502155|NCT00954174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502156|NCT00954161|Randomized|Parallel Assignment||||Single|||||t|
1502157|NCT00954148|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1502158|NCT00954135|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502159|NCT00954122||Single Group Assignment||Treatment||None (Open Label)||||||
1502160|NCT00954109||Single Group Assignment||Treatment||None (Open Label)||||||
1502161|NCT00954096|Randomized|Single Group Assignment||||Double|||t||t|
1502162|NCT00954083|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502163|NCT00954070|||Case Control||Prospective|||||||
1502164|NCT00954057|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502165|NCT00954044|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1502166|NCT00954031|||Case Control||Prospective|||||||
1502167|NCT00954018|||Other||Prospective|||||||
1502168|NCT00954005||Single Group Assignment||Treatment||None (Open Label)||||||
1502169|NCT00953992|||Cohort||Prospective|||||||
1502170|NCT00953979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502171|NCT00953966|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1502172|NCT00953953|||Case-Only||Prospective|||||||
1502173|NCT00953940|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502174|NCT00953927|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502175|NCT00953914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502176|NCT00953901|Randomized|Parallel Assignment||Prevention||Double||||||
1502177|NCT00953888|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1502178|NCT00953862||Single Group Assignment||Treatment||None (Open Label)||||||
1502179|NCT00953849|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1502180|NCT00953836|||||Prospective|||||||
1502181|NCT00953823|||Case-Only||Cross-Sectional|||||||
1502182|NCT00953810|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502183|NCT00953797||Single Group Assignment||Treatment||None (Open Label)||||||
1502184|NCT00953784|Randomized|Parallel Assignment||Prevention||Single||||||t
1502185|NCT00953771||Single Group Assignment||Treatment||None (Open Label)||||||
1502186|NCT00953758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502187|NCT00953745|Non-Randomized|Parallel Assignment||Other||Single||This study is designed to help understand the mechanism of action of aripiprazole in MDD augmentation. Subjects will undergo exposure to en an existing antidepressant (Lexapro 10-20mg) for 10 weeks; subjects failing to completely respond to the monotherapy antidepressant treatment will receive augmentation with aripiprazole for six weeks. We have included two placebo phases to the study in which the subjects received one placebo along with the Lexapro for the first 6 weeks and a second placebo along with Lexapro for the next two weeks (weeks 7 and 8). This double placebo design is to ensure that subjects receiving aripiprazole augmentation have a legitimate response (non-placebo) to the aripiprazole augmentation. Since the N of this study is small and a small % of patients with placebo response could skew the imaging data significantly, the use of a double placebo prior to the start of the true aripiprazole augmentation should reduce or eliminate a placebo response.|t|||
1502188|NCT00953732|||||Prospective|||||||
1502189|NCT00953719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502190|NCT00953706|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502192|NCT00953680|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502193|NCT00953667||Single Group Assignment||Basic Science||None (Open Label)||||||
1502194|NCT00953654|Randomized|Parallel Assignment||Treatment||Single||||||t
1502195|NCT00953641|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502196|NCT00953628|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502197|NCT00953615||Single Group Assignment||Treatment||None (Open Label)||||||
1502198|NCT00953602|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1502199|NCT00953589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502200|NCT00953576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||The Phase I dose escalation schedule was to evaluate up to 4 dose levels of lapatinib as well as one step down dose for ketoconazole (-1). This is not a 'parallel assignment' since this dose escalation design proceeds in sequence not in parallel.||||
1502201|NCT00953563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502202|NCT00953550|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502203|NCT00953537|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502204|NCT00953524|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502205|NCT00953511||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502206|NCT00953498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502207|NCT00953485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502208|NCT00953472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502209|NCT00953459|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502210|NCT00953446||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502211|NCT00953433|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1502212|NCT00953420||Single Group Assignment||Treatment||None (Open Label)||||||
1502213|NCT00953407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502214|NCT00953394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502215|NCT00953381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502216|NCT00953368|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502217|NCT00953355|Non-Randomized|Parallel Assignment||Prevention||Double|||t||t|
1502218|NCT00953342|Randomized|Parallel Assignment||Treatment||Single||||||t
1502219|NCT00953329||Single Group Assignment||Treatment||None (Open Label)||||||
1502220|NCT00953316|||Case-Only||Prospective|||||||
1502221|NCT00953303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502222|NCT00953290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502223|NCT00953277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502224|NCT00953264||Single Group Assignment||Treatment||None (Open Label)||||||
1502225|NCT00953251|||Cohort||Prospective|||||||
1502226|NCT00953225|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502227|NCT00953212|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1502228|NCT00953199|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1502229|NCT00953186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502230|NCT00953173|||Cohort||Prospective|||||||
1502231|NCT00953160||Single Group Assignment||Treatment||None (Open Label)||||||
1502232|NCT00953147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502233|NCT00953134|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1502234|NCT00953121|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502235|NCT00953108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502236|NCT00953095|Randomized|Parallel Assignment||Treatment||Single||||t||
1502237|NCT00953056|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1502238|NCT00953043|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502239|NCT00953030|Randomized|||||None (Open Label)||||||
1502240|NCT00953017|Randomized|Parallel Assignment||Treatment||Single||||t||
1502241|NCT00953004|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1502242|NCT00952991|Randomized|Crossover Assignment||Treatment||Double||||||
1502243|NCT00952978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502244|NCT00952965|||||Prospective|||||||
1502245|NCT00952952|Randomized|Parallel Assignment||Treatment||Double||||||
1502246|NCT00952939|||Case-Only||Prospective|||||||
1502247|NCT00952926|||Case-Only||Prospective|||||||
1502248|NCT00952913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502249|NCT00952900|Randomized|Parallel Assignment||Prevention||Single||||||t
1502250|NCT00952887|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502251|NCT00952874|||Case Control||Cross-Sectional|||||||
1502252|NCT00952861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502253|NCT00952848||Single Group Assignment||Supportive Care||None (Open Label)||||||
1502254|NCT00952835|||Case-Only||Cross-Sectional|||||||
1502255|NCT00952822|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1502256|NCT00952796|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502257|NCT00952783|||Case-Only||Prospective|||||||
1502258|NCT00952770|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502259|NCT00952757|||Case-Only||Prospective|||||||
1502260|NCT00952744|||Cohort||Prospective|||||||
1502261|NCT00952731|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502262|NCT00952718|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502263|NCT00952705|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502264|NCT00952692||Single Group Assignment||||None (Open Label)||||||
1502265|NCT00952679||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502266|NCT00952666||Single Group Assignment||Treatment||None (Open Label)||||||
1502267|NCT00952653|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502268|NCT00952640|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1502269|NCT00952627|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1502270|NCT00952614||Single Group Assignment||Treatment||None (Open Label)||||||
1502271|NCT00952601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502272|NCT00952588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502273|NCT00952575|Randomized|Parallel Assignment||||None (Open Label)||||||
1502274|NCT00952562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502275|NCT00952549||Single Group Assignment||Treatment||None (Open Label)||||||
1502276|NCT00952536|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502277|NCT00952523|Randomized|Single Group Assignment||Treatment||Single|||||t|
1502278|NCT00952510|||Cohort||Prospective|||||||
1502279|NCT00952497||Single Group Assignment||Treatment||None (Open Label)||||||
1502280|NCT00952484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502281|NCT00952471|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1502282|NCT00952458|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1502283|NCT00952445|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502284|NCT00952432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502285|NCT00952419|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502286|NCT00952406|||Cohort||Prospective|||||||
1502287|NCT00952393||Single Group Assignment||Treatment||None (Open Label)||||||
1502288|NCT00952380||Single Group Assignment||Treatment||None (Open Label)||||||
1502289|NCT00952367|||||Prospective|||||||
1502290|NCT00952354|||Cohort||Cross-Sectional|||||||
1502291|NCT00952341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502292|NCT00952328|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502293|NCT00952315|Randomized|Factorial Assignment||Treatment||Single|||t|||
1502294|NCT00952302|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1502295|NCT00952289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502296|NCT00952276|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502297|NCT00952263|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502298|NCT00952250|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1502299|NCT00952237||Single Group Assignment||Treatment||None (Open Label)||||||
1502300|NCT00952224|||Cohort||Prospective|||||||
1502301|NCT00952211|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1502302|NCT00952198|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1502303|NCT00952185||Single Group Assignment||Supportive Care||None (Open Label)||||||
1502304|NCT00952172|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502305|NCT00952159|||Cohort||Prospective|||||||
1502306|NCT00952146||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502307|NCT00952133|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1502308|NCT00952120|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502309|NCT00952107|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1502310|NCT00952094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502311|NCT00952081||Single Group Assignment||Treatment||None (Open Label)||||||
1502312|NCT00952068||Single Group Assignment||Treatment||None (Open Label)||||||
1502313|NCT00952055|||Cohort||Prospective|||||||
1502314|NCT00952042|Randomized|Parallel Assignment||Treatment||Single||||||t
1502315|NCT00952029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502316|NCT00952016|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502317|NCT00952003||Single Group Assignment||Treatment||None (Open Label)||||||
1502318|NCT00951990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502319|NCT00951977|||Case-Control||Cross-Sectional|||||||
1502320|NCT00951964|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1502321|NCT00951951|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502322|NCT00951938|||Case-Only||Prospective|||||||
1502323|NCT00951925|||Cohort||Other|||||||
1502324|NCT00951912|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502325|NCT00951899|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1502326|NCT00951886|||Cohort||Retrospective|||||||
1502327|NCT00951873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502328|NCT00951860|||Cohort||Prospective|||||||
1502329|NCT00951847|Randomized|Crossover Assignment||||None (Open Label)||||||
1502330|NCT00951834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502331|NCT00951821|Randomized|Parallel Assignment||Treatment||Single||||||t
1502332|NCT00951808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502333|NCT00951795|||Cohort||Prospective|||||||
1502334|NCT00951782|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502335|NCT00951769|||Case Control||Prospective|||||||
1502336|NCT00951756|Randomized|Parallel Assignment||Basic Science||Single||||||t
1502337|NCT00951743|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1502338|NCT00951730|||Case-Only||Prospective|||||||
1502339|NCT00951717|Randomized|Parallel Assignment||Prevention||Single||||||t
1502340|NCT00951704|||Cohort||Prospective|||||||
1502341|NCT00951691|Randomized|Parallel Assignment||Treatment||Single||||||t
1502342|NCT00951678|||Case-Only||Prospective|||||||
1502343|NCT00951665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502344|NCT00951652|Randomized|Parallel Assignment||Treatment||Single||||||t
1502345|NCT00951639|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1502346|NCT00951626|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1502347|NCT00951613|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502348|NCT00951600|Randomized|Crossover Assignment||||None (Open Label)||||||
1502349|NCT00951587||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502350|NCT00951574|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1502351|NCT00951561|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502352|NCT00951548|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1502353|NCT00951535|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502354|NCT00951522|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1502355|NCT00951509|||Cohort||Prospective|||||||
1502356|NCT00951496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502357|NCT00951483|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502358|NCT00951470|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502359|NCT00951457||Single Group Assignment||Treatment||None (Open Label)||||||
1502360|NCT00951444|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502361|NCT00951431|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502362|NCT00951418|||||Cross-Sectional|||||||
1502363|NCT00951405|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1502364|NCT00951392|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1502365|NCT00951379|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502366|NCT00951366|||Case-Only||Prospective|||||||
1502367|NCT00951353|||Cohort||Prospective|||||||
1502368|NCT00951340|Randomized|Parallel Assignment||Treatment||Single||||||t
1502369|NCT00951327|||Cohort||Prospective|||||||
1502370|NCT00951314|||||Prospective|||||||
1502371|NCT00951301|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502372|NCT00951288|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1502373|NCT00951275|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502374|NCT00951262|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502375|NCT00951249|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1502376|NCT00951236||Parallel Assignment||Treatment||||||||
1502377|NCT00951223|||Case-Only||Prospective|||||||
1502378|NCT00951210|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1502379|NCT00951197|||Ecologic or Community||Prospective|||||||
1502380|NCT00951184|||Cohort||Prospective|||||||
1502381|NCT00951171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502382|NCT00951158||Single Group Assignment||Basic Science||None (Open Label)||||||
1502383|NCT00951145|||Case-Only|||||||||
1502384|NCT00951132|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502385|NCT00951119|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502386|NCT00951106|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502387|NCT00951093|||Cohort||Prospective|||||||
1502388|NCT00951080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502389|NCT00951067|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502390|NCT00951054|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502391|NCT00951041|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1502392|NCT00951028|Randomized|Parallel Assignment||Treatment||Single||||||t
1502393|NCT00951015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502394|NCT00951002|||Case-Only||Prospective|||||||
1502395|NCT00950989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502396|NCT00950976|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1502397|NCT00950963|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1502398|NCT00950950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502399|NCT00950937|||Case Control||Prospective|||||||
1502400|NCT00950924|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502401|NCT00950911||Single Group Assignment||Supportive Care||None (Open Label)||||||
1502402|NCT00950898|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1502403|NCT00950885|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1502404|NCT00950872||Single Group Assignment||Treatment||None (Open Label)||||||
1502405|NCT00950859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502406|NCT00950846||Single Group Assignment||Treatment||None (Open Label)||||||
1502407|NCT00950833|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502408|NCT00950820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502409|NCT00950807|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1502410|NCT00950794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502411|NCT00950781|||Other||Prospective|||||||
1502412|NCT00950768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502413|NCT00950755||Single Group Assignment||Treatment||None (Open Label)||||||
1502414|NCT00950742||Single Group Assignment||Treatment||None (Open Label)||||||
1502415|NCT00950729|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1502416|NCT00950716|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502417|NCT00950703|||||Prospective|||||||
1502418|NCT00950690|||||Prospective|||||||
1502419|NCT00950677|Randomized|Single Group Assignment||Treatment||Single|||t|||
1502420|NCT00950664|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1503197|NCT00940537|||Cohort||Cross-Sectional|||||||
1502421|NCT00950651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502422|NCT00950638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502423|NCT00950625|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1502424|NCT00950612|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1502425|NCT00950599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502426|NCT00950586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502427|NCT00950573|||Cohort||Prospective|||||||
1502428|NCT00950560|||Case Control||Cross-Sectional|||||||
1502429|NCT00950547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502430|NCT00950534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502431|NCT00950521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502432|NCT00950508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502433|NCT00950495|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502434|NCT00950482|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502435|NCT00950469|||Cohort||Prospective|||||||
1502436|NCT00950456|||Ecologic or Community||Prospective|||||||
1502437|NCT00950443|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1502438|NCT00950430||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502439|NCT00950417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502440|NCT00950404|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1502441|NCT00950391|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1502442|NCT00950378|||Case Control||Prospective|||||||
1502443|NCT00950365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502444|NCT00950352|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502445|NCT00950339|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502446|NCT00950326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502447|NCT00950313|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1502448|NCT00950300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502449|NCT00950287|||Cohort||Prospective|||||||
1502450|NCT00950274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502451|NCT00950261||Single Group Assignment||Treatment||None (Open Label)||||||
1502452|NCT00950248|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502453|NCT00950235|Randomized|Parallel Assignment||Prevention||Single||||||t
1502454|NCT00950222||Single Group Assignment||Treatment||None (Open Label)||||||
1502455|NCT00950209|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1502456|NCT00950196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502457|NCT00950183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502458|NCT00950170||Single Group Assignment||||None (Open Label)||||||
1502459|NCT00950157|Randomized|Parallel Assignment||||Single|||||t|
1502460|NCT00950144|||Case-Only||Prospective|||||||
1502461|NCT00950131|Randomized|Parallel Assignment||||Single|||||t|
1502462|NCT00950118|||Case-Only||Prospective|||||||
1502463|NCT00950105|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1502464|NCT00950092||Single Group Assignment||Treatment||None (Open Label)||||||
1502465|NCT00950079|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502466|NCT00950066|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502467|NCT00950053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502468|NCT00950040|Randomized|Parallel Assignment||Treatment||Single||||||t
1502469|NCT00950027|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502470|NCT00950014|Randomized|Parallel Assignment||||Single|||||t|
1502471|NCT00950001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502472|NCT00949988|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502473|NCT00949975|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1502474|NCT00949962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502475|NCT00949949|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502476|NCT00949936||||Treatment||||||||
1502477|NCT00949923|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502478|NCT00949910||Single Group Assignment||Treatment||None (Open Label)||||||
1502479|NCT00949897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502480|NCT00949884|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502481|NCT00949871||||||None (Open Label)||||||
1502482|NCT00949858|||Cohort||Prospective|||||||
1502483|NCT00949845||||Basic Science||||||||
1502484|NCT00949832|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502485|NCT00949819|||Ecologic or Community||Prospective|||||||
1502486|NCT00949806||Single Group Assignment||Treatment||None (Open Label)||||||
1502487|NCT00949793||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502488|NCT00949780||Single Group Assignment||||None (Open Label)||||||
1502489|NCT00949767|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1502490|NCT00949754|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1502491|NCT00949741|||Cohort||Retrospective|||||||
1502492|NCT00949728||Single Group Assignment||Treatment||None (Open Label)||||||
1502493|NCT00949715|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502494|NCT00949702||Single Group Assignment||Treatment||None (Open Label)||||||
1502495|NCT00949689|Randomized|Parallel Assignment||Treatment||Single||||||t
1502496|NCT00949676|||Cohort||Prospective|||||||
1502497|NCT00949663|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1502498|NCT00949650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502499|NCT00949637|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502500|NCT00949624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502501|NCT00949611|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1502502|NCT00949598|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1502503|NCT00949585|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1502504|NCT00949572|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1502505|NCT00949559||Single Group Assignment||Treatment||None (Open Label)||||||
1502506|NCT00949546|||Cohort||Prospective|||||||
1502507|NCT00949533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502508|NCT00949520||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502509|NCT00949507|||Cohort||Prospective|||||||
1502510|NCT00949494|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1502511|NCT00949481|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1502512|NCT00949468|||Case Control||Cross-Sectional|||||||
1502513|NCT00949455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502514|NCT00949442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502515|NCT00949429|||Cohort||Prospective|||||||
1502516|NCT00949416|||Cohort||Prospective|||||||
1502517|NCT00949403|||Case-Only||Prospective|||||||
1502518|NCT00949390|||Cohort||Prospective|||||||
1502519|NCT00949377|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1502520|NCT00949364||Single Group Assignment||Treatment||None (Open Label)||||||
1502521|NCT00949351|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502522|NCT00949338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502523|NCT00949325||Single Group Assignment||Treatment||None (Open Label)||||||
1502524|NCT00949312|||Cohort||Prospective|||||||
1502525|NCT00949299|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1502526|NCT00949286|||Cohort||Prospective|||||||
1502527|NCT00949273|||Case Control||Prospective|||||||
1502528|NCT00949260|||Cohort||Prospective|||||||
1502529|NCT00949247||Single Group Assignment||Treatment||None (Open Label)||||||
1502530|NCT00949234||Single Group Assignment||Prevention||None (Open Label)||||||
1502531|NCT00949221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502532|NCT00949208|||Cohort||Prospective|||||||
1502533|NCT00949195|||Cohort||Cross-Sectional|||||||
1502534|NCT00949182||Single Group Assignment||Treatment||None (Open Label)||||||
1502535|NCT00949169|||Case-Only||Cross-Sectional|||||||
1502536|NCT00949156|||Cohort||Cross-Sectional|||||||
1502537|NCT00949143|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1502538|NCT00949130|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502539|NCT00949117|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502540|NCT00949104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502541|NCT00949091|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1502542|NCT00949078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502543|NCT00949065|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1502544|NCT00949052|||Other||Other|||||||
1502545|NCT00949039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502546|NCT00949026||Single Group Assignment||Basic Science||None (Open Label)||||||
1502547|NCT00949013|||||Retrospective|||||||
1502548|NCT00949000||Single Group Assignment||Diagnostic||None (Open Label)||||||
1502549|NCT00948987||Single Group Assignment||Treatment||None (Open Label)||||||
1502550|NCT00948974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502551|NCT00948961||Single Group Assignment||Treatment||None (Open Label)||||||
1502552|NCT00948948||||||||||||
1502553|NCT00948935||Single Group Assignment||Treatment||None (Open Label)||||||
1502554|NCT00948922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502555|NCT00948909|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502556|NCT00948896|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502557|NCT00948883|||Case Control||Prospective|||||||
1502558|NCT00948870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502559|NCT00948857|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1502560|NCT00948844|||Case Control||Cross-Sectional|||||||
1502561|NCT00948831|||Cohort||Prospective|||||||
1502562|NCT00948818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502563|NCT00948805|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502564|NCT00948792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502565|NCT00948779|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1502566|NCT00948766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502567|NCT00948753|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502568|NCT00948740||Single Group Assignment||Treatment||None (Open Label)||||||
1502569|NCT00948727||Single Group Assignment||Prevention||None (Open Label)||||||
1502570|NCT00948714|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1502571|NCT00948701|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1502572|NCT00948688||Single Group Assignment||Treatment||None (Open Label)||||||
1502573|NCT00948675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502574|NCT00948662|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502575|NCT00948649|Randomized|Crossover Assignment||Screening||Triple|||t|t|t|
1502576|NCT00948636|||Cohort||Prospective|||||||
1502577|NCT00948623|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502578|NCT00948610|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1502580|NCT00948584|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502581|NCT00948571|||Cohort||Prospective|||||||
1502582|NCT00948558|||Case Control||Prospective|||||||
1502583|NCT00948545|||Case-Only||Prospective|||||||
1502584|NCT00948532|||Cohort||Prospective|||||||
1502585|NCT00948519|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1502586|NCT00948506|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1502587|NCT00948493||||||||||||
1502588|NCT00948480||Single Group Assignment||Treatment||None (Open Label)||||||
1502589|NCT00948467||Single Group Assignment||Treatment||None (Open Label)||||||
1502590|NCT00948454|||Case Control||Cross-Sectional|||||||
1502591|NCT00948441|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1502592|NCT00948428|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502593|NCT00948415|Randomized|Factorial Assignment||Treatment||Single||||||t
1502594|NCT00948402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502595|NCT00948389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502596|NCT00948376|||Cohort||Prospective|||||||
1502597|NCT00948363|Randomized|Parallel Assignment||Treatment||Single||||||t
1502598|NCT00948350|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502599|NCT00948337|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1502600|NCT00948324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502601|NCT00948311|||Cohort||Prospective|||||||
1502602|NCT00948298|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1502603|NCT00948285|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1502604|NCT00948272|Randomized|Parallel Assignment||Prevention||Single||||||t
1502605|NCT00948259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502606|NCT00948246|||Case-Only||Prospective|||||||
1502607|NCT00948233|||Case-Only||Prospective|||||||
1502608|NCT00948220|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1502609|NCT00948207|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1502610|NCT00948194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502611|NCT00948181|||Cohort||Prospective|||||||
1502612|NCT00948168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502613|NCT00948155|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1502614|NCT00948142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502615|NCT00948129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502616|NCT00948116|||Cohort||Prospective|||||||
1502617|NCT00948103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502618|NCT00948090||Single Group Assignment||Treatment||None (Open Label)||||||
1502619|NCT00948077|Randomized|Crossover Assignment||||None (Open Label)||||||
1502620|NCT00948064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502621|NCT00948051|Randomized|Parallel Assignment||||Triple|||t|t|t|
1502622|NCT00948038|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1502623|NCT00948025|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1502624|NCT00948012|||Cohort||Cross-Sectional|||||||
1502625|NCT00947999|||Case Control||Cross-Sectional|||||||
1502626|NCT00947986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502627|NCT00947973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502628|NCT00947960|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1502629|NCT00947947|Randomized|Single Group Assignment||Prevention||Single|||||t|
1502630|NCT00947934||Single Group Assignment||Treatment||None (Open Label)||||||
1502631|NCT00947921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502632|NCT00947908||Single Group Assignment||Basic Science||None (Open Label)||||||
1502633|NCT00947895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502634|NCT00947882|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502635|NCT00947869|||Cohort||Prospective|||||||
1502636|NCT00947856|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502637|NCT00947843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502638|NCT00947830|||Cohort||Prospective|||||||
1502639|NCT00947817|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502640|NCT00947804|||Cohort||Cross-Sectional|||||||
1502641|NCT00947791|Randomized|Crossover Assignment||Treatment||Double|Patient, doctor and rater are masked (triple masked). Only the research pharmacist is unblinded.||t||t|
1502642|NCT00947778|Randomized|Parallel Assignment||||None (Open Label)||||||
1502643|NCT00947765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502644|NCT00947752|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502645|NCT00947739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502646|NCT00947726||Single Group Assignment||Treatment||None (Open Label)||||||
1502647|NCT00947713|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1502648|NCT00947700|Randomized|Parallel Assignment||Other||Single||||||t
1502649|NCT00947687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502650|NCT00947674|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502651|NCT00947661|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1502652|NCT00947648|Randomized|Parallel Assignment||||None (Open Label)||||||
1502653|NCT00947635||Single Group Assignment||Treatment||None (Open Label)||||||
1502654|NCT00947622|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1502655|NCT00947609|||Cohort||Prospective|||||||
1502656|NCT00947596|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502657|NCT00947583|||Cohort||Prospective|||||||
1502658|NCT00947570||Single Group Assignment||Basic Science||None (Open Label)||||||
1502659|NCT00947557|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502660|NCT00947544||Single Group Assignment||Treatment||None (Open Label)||||||
1502661|NCT00947531|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502662|NCT00947518|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1502663|NCT00947505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502664|NCT00947492|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1502665|NCT00947479|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1502666|NCT00947466||Single Group Assignment||Treatment||None (Open Label)||||||
1502667|NCT00947453||Single Group Assignment||Treatment||None (Open Label)||||||
1502668|NCT00947440|Randomized|Crossover Assignment||||None (Open Label)||||||
1502669|NCT00947427|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502670|NCT00947414|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502671|NCT00947401|||Cohort||Prospective|||||||
1502672|NCT00947388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502673|NCT00947375|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502674|NCT00947362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502675|NCT00947349|Randomized|Parallel Assignment||Treatment||Double||||||
1502676|NCT00947336|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1502677|NCT00947323|Randomized|Single Group Assignment||Treatment||Double||||||
1502678|NCT00947310|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502679|NCT00947297||Single Group Assignment||Treatment||None (Open Label)||||||
1502680|NCT00947284|Non-Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1502681|NCT00947271|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1502682|NCT00947258|Randomized|||Prevention||Single||||||t
1502683|NCT00947245|Randomized|Parallel Assignment||||Triple|||t||t|t
1502684|NCT00947232|Randomized|Parallel Assignment||Treatment||Single||||||t
1502685|NCT00947219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502686|NCT00947206|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502687|NCT00947193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502688|NCT00947180|Randomized|Parallel Assignment||Treatment||Single||||||t
1502689|NCT00947167||Single Group Assignment||Treatment||None (Open Label)||||||
1502690|NCT00947154||Single Group Assignment||Treatment||None (Open Label)||||||
1502691|NCT00947141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502692|NCT00947128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502693|NCT00947115|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502694|NCT00947102|||Cohort||Prospective|||||||
1502695|NCT00947089|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502696|NCT00947076|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502697|NCT00947063|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502698|NCT00947050|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1502699|NCT00947037||Single Group Assignment||Treatment||None (Open Label)||||||
1502700|NCT00947024|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502701|NCT00947011|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1502702|NCT00946998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502703|NCT00946985|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502704|NCT00946972|Randomized|Single Group Assignment||Treatment||Double||||||
1502705|NCT00946959|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1502706|NCT00946946|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502707|NCT00946933|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1502708|NCT00946920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502709|NCT00946907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502710|NCT00946894|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502711|NCT00946881||Single Group Assignment||Treatment||None (Open Label)||||||
1502712|NCT00946868|||Case-Only||Prospective|||||||
1502713|NCT00946855|||Cohort||Prospective|||||||
1502714|NCT00946842|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502715|NCT00946829|||Cohort||Prospective|||||||
1502716|NCT00946816|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502717|NCT00946803|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502718|NCT00946790|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502719|NCT00946777||Single Group Assignment||Treatment||None (Open Label)||||||
1502720|NCT00946764|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502721|NCT00946751|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502722|NCT00946738|Randomized|Parallel Assignment||Treatment||||||||
1502723|NCT00946725|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502724|NCT00946712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502725|NCT00946699|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1502726|NCT00946686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502727|NCT00946673||Single Group Assignment||Treatment||None (Open Label)||||||
1502728|NCT00946660|||Case-Only||Prospective|||||||
1502729|NCT00946647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502730|NCT00946634|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502731|NCT00946621|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502732|NCT00946608|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502733|NCT00946595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502734|NCT00946582||Single Group Assignment||Treatment||None (Open Label)||||||
1502735|NCT00946569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502736|NCT00946556|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1502737|NCT00946543||||Treatment||||||||
1502738|NCT00946530|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1502739|NCT00946517|||Family-Based||Prospective|||||||
1502740|NCT00946504|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502741|NCT00946491|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502742|NCT00946478|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502743|NCT00946465|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502744|NCT00946452|||Case-Only||Prospective|||||||
1502745|NCT00946439|Non-Randomized|Parallel Assignment||Treatment||Single||||t||
1502746|NCT00946426|||Case-Only||Prospective|||||||
1502747|NCT00946413|Non-Randomized|Parallel Assignment||Prevention||Double|||t|t||
1502748|NCT00946400|||Cohort||Prospective|||||||
1502749|NCT00946387|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502750|NCT00946374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502751|NCT00946361|||Case-Only||Prospective|||||||
1502752|NCT00946348|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1502753|NCT00946335||Single Group Assignment||Treatment||None (Open Label)||||||
1502754|NCT00946322||Single Group Assignment||Treatment||None (Open Label)||||||
1502755|NCT00946309|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1502756|NCT00946296|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502757|NCT00946283||Single Group Assignment||Supportive Care||None (Open Label)||||||
1502758|NCT00946270||Single Group Assignment||Treatment||None (Open Label)||||||
1502759|NCT00946257|Randomized|Single Group Assignment||Treatment||Single|||t|||
1502760|NCT00946244|||Cohort||Prospective|||||||
1502761|NCT00946231|||Case-Only||Prospective|||||||
1502762|NCT00946218|||Case-Only||Retrospective|||||||
1502763|NCT00946205|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1502764|NCT00946192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502765|NCT00946179|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502766|NCT00946166|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1502767|NCT00946153|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502768|NCT00946140|||Cohort||Prospective|||||||
1502769|NCT00946127|||Cohort||Prospective|||||||
1502770|NCT00946114|||||Prospective|||||||
1502771|NCT00946101|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502772|NCT00946088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502773|NCT00946075||||||||||||
1502774|NCT00946062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502775|NCT00946049||||Treatment||||||||
1502776|NCT00946036||||||||||||
1502777|NCT00946023||Single Group Assignment||Treatment||None (Open Label)||||||
1502778|NCT00946010|||Case-Only||Cross-Sectional|||||||
1502779|NCT00945997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502780|NCT00945984|||Case Control||Retrospective|||||||
1502781|NCT00945971||Single Group Assignment||Treatment||None (Open Label)||||||
1502782|NCT00945958||Single Group Assignment||Treatment||None (Open Label)||||||
1502783|NCT00945945|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502784|NCT00945932|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1502785|NCT00945919||Single Group Assignment||Supportive Care||None (Open Label)||||||
1502786|NCT00945906||Single Group Assignment||||None (Open Label)||||||
1502787|NCT00945893|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502788|NCT00945880||Single Group Assignment||Treatment||None (Open Label)||||||
1502789|NCT00945867|||Case-Only||Prospective|||||||
1502790|NCT00945854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502791|NCT00945841|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1502792|NCT00945828|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502793|NCT00945815||Single Group Assignment||Treatment||None (Open Label)||||||
1502794|NCT00945802|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502795|NCT00945789|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502796|NCT00945776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502797|NCT00945763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502798|NCT00945750|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502799|NCT00945737|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1502800|NCT00945724||Single Group Assignment||Treatment||None (Open Label)||||||
1502801|NCT00945711|||Case Control||Retrospective|||||||
1502802|NCT00945698|Randomized|Parallel Assignment||Prevention||Single||||||t
1502803|NCT00945685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502804|NCT00945672|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502805|NCT00945659|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||3 group (Standard Care: Continuous Glucose Monitor; Continuous Glucose Monitor + Behavior Therapy) X 4 time points (0, 3, 6, and 9 months) Repeated measures randomized treatments design.||||
1502806|NCT00945646|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502807|NCT00945633|||Cohort||Prospective|||||||
1502808|NCT00945620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502809|NCT00945607|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1502810|NCT00945594|Randomized|Parallel Assignment||||None (Open Label)||||||
1502811|NCT00945581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502812|NCT00945568|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1502813|NCT00945555|||Cohort||Prospective|||||||
1502814|NCT00945542|Randomized|Parallel Assignment||Treatment||Single||||||t
1502815|NCT00945529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502816|NCT00945516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502817|NCT00945503|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502818|NCT00945490|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502819|NCT00945477||Single Group Assignment||Treatment||None (Open Label)||||||
1502820|NCT00945464|||Cohort|||||||||
1502821|NCT00945451||Single Group Assignment||Treatment||None (Open Label)||||||
1502822|NCT00945438|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502823|NCT00945425|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1502824|NCT00945412|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1502825|NCT00945399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502826|NCT00945386|||Cohort||Prospective|||||||
1502827|NCT00945373||Single Group Assignment||Treatment||Single|||||t|
1502828|NCT00945360||Single Group Assignment||Treatment||None (Open Label)||||||
1502829|NCT00945347|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1502830|NCT00945334|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502831|NCT00945321|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502832|NCT00945308|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502833|NCT00945295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502834|NCT00945282|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502835|NCT00945269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502836|NCT00945256|Randomized|Factorial Assignment||||None (Open Label)||||||
1502837|NCT00945243||Single Group Assignment||Treatment||None (Open Label)||||||
1502838|NCT00945230||Single Group Assignment||Health Services Research||None (Open Label)||||||
1502839|NCT00945217|||Cohort||Cross-Sectional|||||||
1502840|NCT00945204|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1502841|NCT00945191||Single Group Assignment||Treatment||None (Open Label)||||||
1502842|NCT00945178|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1502843|NCT00945165|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502844|NCT00945152|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502845|NCT00945139||Single Group Assignment||Treatment||None (Open Label)||||||
1502846|NCT00945126||Single Group Assignment||Treatment||None (Open Label)||||||
1502847|NCT00945113|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1502848|NCT00945100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502849|NCT00945087||||||||||||
1502850|NCT00945074|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1502851|NCT00945061|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502852|NCT00945048|||Cohort||Prospective|||||||
1502853|NCT00945035|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502854|NCT00945022||Single Group Assignment||Supportive Care||None (Open Label)||||||
1502855|NCT00945009|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502856|NCT00944996|Non-Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1502857|NCT00944983||||||||||||
1502858|NCT00944970|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1502859|NCT00944957|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1502860|NCT00944944|||Cohort||Prospective|||||||
1502861|NCT00944931|Randomized|Parallel Assignment||Treatment||Single||||||
1502862|NCT00944918|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502863|NCT00944905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502864|NCT00944892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502865|NCT00944879|||Cohort||Prospective|||||||
1502866|NCT00944866|||Case Control||Cross-Sectional|||||||
1502867|NCT00944853|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502868|NCT00944840|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1502869|NCT00944827|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1502870|NCT00944814|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502871|NCT00944801||Single Group Assignment||Treatment||None (Open Label)||||||
1502872|NCT00944788|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1502873|NCT00944775|Randomized|Parallel Assignment||Screening||Triple||||t|t|t
1502874|NCT00944762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502875|NCT00944749||Single Group Assignment||Treatment||None (Open Label)||||||
1502876|NCT00944736|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502877|NCT00944723|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502878|NCT00944710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502879|NCT00944697|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1502880|NCT00944684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502881|NCT00944671|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502882|NCT00944658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502883|NCT00944645|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502884|NCT00944632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502885|NCT00944619|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502886|NCT00944606|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1502887|NCT00944593|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1502888|NCT00944580||Single Group Assignment||Treatment||None (Open Label)||||||
1502889|NCT00944567|||Cohort||Prospective|||||||
1502890|NCT00944554|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1502891|NCT00944541|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502892|NCT00944528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502893|NCT00944515|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502894|NCT00944502|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502895|NCT00944489|||Cohort||Prospective|||||||
1502896|NCT00944476|||Cohort||Prospective|||||||
1502897|NCT00944463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502898|NCT00944450|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1502899|NCT00944437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502900|NCT00944424|Randomized|Parallel Assignment||Treatment||Single|||||t|
1502901|NCT00944411||||||||||||
1502902|NCT00944398|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502903|NCT00944385||||||||||||
1502904|NCT00944372|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1502905|NCT00944359|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502906|NCT00944346||||||||||||
1502907|NCT00944333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502908|NCT00944320|||Case Control||Cross-Sectional|||||||
1502909|NCT00944307|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1502910|NCT00944294|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1502911|NCT00944281|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502912|NCT00944268|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1502913|NCT00944255|||Case Control||Cross-Sectional|||||||
1502914|NCT00944242||||||||||||
1502915|NCT00944229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502916|NCT00944216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502917|NCT00944203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502918|NCT00944190|Randomized|Parallel Assignment||Treatment||Single||||||t
1502919|NCT00944177||||||||||||
1502920|NCT00944164|Randomized|Parallel Assignment||Prevention||Single||||t||
1502921|NCT00944151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502922|NCT00944138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502923|NCT00944125|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1502924|NCT00944112|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502925|NCT00944099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502926|NCT00944086|||Case-Only||Prospective|||||||
1502927|NCT00944073|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1502928|NCT00944060||||Prevention||||||||
1502929|NCT00944047||Single Group Assignment||Treatment||None (Open Label)||||||
1502930|NCT00944034|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502931|NCT00944021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502932|NCT00944008|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1502933|NCT00943995|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502934|NCT00943982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502935|NCT00943969||Single Group Assignment||||None (Open Label)||||||
1502936|NCT00943956||Single Group Assignment||Treatment||None (Open Label)||||||
1502937|NCT00943943||Single Group Assignment||Treatment||None (Open Label)||||||
1502938|NCT00943930|||Case-Only||Prospective|||||||
1502939|NCT00943917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502940|NCT00943904|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1502941|NCT00943891|||Case-Crossover||Cross-Sectional|||||||
1502942|NCT00943878|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1502943|NCT00943865|Randomized|Parallel Assignment||Treatment||Single||||||t
1502944|NCT00943852|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1502945|NCT00943839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502946|NCT00943826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502947|NCT00943813|||Cohort||Prospective|||||||
1502948|NCT00943800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502949|NCT00943787||Single Group Assignment||||None (Open Label)||||||
1502950|NCT00943774|||Cohort||Prospective|||||||
1502951|NCT00943761|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502952|NCT00943748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502953|NCT00943735|||Other||Prospective|||||||
1502954|NCT00943722|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502955|NCT00943709|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1502956|NCT00943696|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1502957|NCT00943683|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502958|NCT00943670||Single Group Assignment||Treatment||None (Open Label)||||||
1502959|NCT00943657|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1502960|NCT00943644|||Case-Only||Prospective|||||||
1502961|NCT00943631|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1502962|NCT00943618|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1502963|NCT00943605|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502964|NCT00943592||Single Group Assignment||Treatment||None (Open Label)||||||
1502965|NCT00943579||Single Group Assignment||Treatment||None (Open Label)||||||
1502966|NCT00943566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502967|NCT00943553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502968|NCT00943540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1502969|NCT00943527|||Case-Only||Cross-Sectional|||||||
1502970|NCT00943514|||Other||Prospective|||||||
1502971|NCT00943501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502972|NCT00943488|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1502973|NCT00943475|Randomized|Parallel Assignment||Treatment||Single||||||t
1502974|NCT00943462|||Case-Only||Prospective|||||||
1502975|NCT00943449|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502976|NCT00943436|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1502977|NCT00943423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502978|NCT00943410|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502979|NCT00943397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1502980|NCT00943384||Single Group Assignment||Treatment||None (Open Label)||||||
1502981|NCT00943371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1502982|NCT00943358|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1502983|NCT00943345|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t||t
1502984|NCT00943332|||Cohort||Prospective|||||||
1502985|NCT00943319||Single Group Assignment||Treatment||None (Open Label)||||||
1502986|NCT00943306||Single Group Assignment||Treatment||None (Open Label)||||||
1502987|NCT00943293||Single Group Assignment||Treatment||None (Open Label)||||||
1502988|NCT00943280|||Cohort||Prospective|||||||
1502989|NCT00943267|Randomized|Parallel Assignment||||Single|||t|||
1502990|NCT00943254|Randomized|Parallel Assignment||Prevention||Single|||t|||
1502991|NCT00943241|||Case-Only||Prospective|||||||
1502992|NCT00943228||Single Group Assignment||||None (Open Label)||||||
1502993|NCT00943215|||Case-Only|||||||||
1502994|NCT00943202|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1502995|NCT00943189|||Cohort||Prospective|||||||
1502996|NCT00943176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1502997|NCT00943163|||Cohort||Retrospective|||||||
1502998|NCT00943150|Randomized|Parallel Assignment||Treatment||Single|||t|||
1502999|NCT00943137|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503000|NCT00943124|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503001|NCT00943111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503002|NCT00943098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503003|NCT00943085|Randomized|Parallel Assignment||Prevention||Single||||||t
1503004|NCT00943072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503005|NCT00943059|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1503006|NCT00943046||Single Group Assignment||Treatment||None (Open Label)||||||
1503007|NCT00943033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503008|NCT00943020|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1503009|NCT00943007|Randomized|Parallel Assignment||Treatment||Single||||||t
1503010|NCT00942994|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503011|NCT00942981|||||Other|||||||
1503012|NCT00942968||Single Group Assignment||Treatment||None (Open Label)||||||
1503013|NCT00942955|||Case Control||Prospective|||||||
1503014|NCT00942942||||||||||||
1503015|NCT00942929|||Cohort||Prospective|||||||
1503016|NCT00942916|||Case Control||Prospective|||||||
1503017|NCT00942903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503018|NCT00942890|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1503019|NCT00942877||Single Group Assignment||Treatment||None (Open Label)||||||
1503020|NCT00942864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503021|NCT00942851|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503022|NCT00942838||Single Group Assignment||Treatment||None (Open Label)||||||
1503023|NCT00942825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503024|NCT00942812|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503025|NCT00942799|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503026|NCT00942786|||Cohort||Prospective|||||||
1503027|NCT00942773|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1503028|NCT00942760|||||Cross-Sectional|||||||
1503029|NCT00942747||Single Group Assignment||Treatment||None (Open Label)||||||
1503030|NCT00942734||Single Group Assignment||Treatment||None (Open Label)||||||
1503031|NCT00942721|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503032|NCT00942708|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503033|NCT00942695|Randomized|Crossover Assignment||||None (Open Label)||||||
1503034|NCT00942682||Single Group Assignment||Treatment||None (Open Label)||||||
1503035|NCT00942669|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1503036|NCT00942656|Randomized|Crossover Assignment||||Triple|||t||t|t
1503037|NCT00942643|Randomized|Parallel Assignment||Treatment||Single|||||t|
1503038|NCT00942630|||Cohort||Prospective|||||||
1503039|NCT00942617||Single Group Assignment||Basic Science||None (Open Label)||||||
1503040|NCT00942604|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503041|NCT00942591|Randomized|Parallel Assignment||Treatment||Single||||||t
1503042|NCT00942578||Single Group Assignment||Treatment||None (Open Label)||||||
1503043|NCT00942565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503044|NCT00942539|Randomized|Parallel Assignment||Treatment||Single||||||t
1503045|NCT00942526|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1503046|NCT00942513|Randomized|Crossover Assignment||||Triple|||t||t|t
1503047|NCT00942500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503048|NCT00942487|Randomized|Parallel Assignment||Treatment||Single||||||t
1503049|NCT00942474||Single Group Assignment||Basic Science||None (Open Label)||||||
1503050|NCT00942461|Randomized|Parallel Assignment||||Double|||t|||t
1503051|NCT00942448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503052|NCT00942435|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503053|NCT00942422||Single Group Assignment||Treatment||None (Open Label)||||||
1503054|NCT00942409||Single Group Assignment||Treatment||None (Open Label)||||||
1503055|NCT00942396|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1503056|NCT00942383||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503057|NCT00942370|||||Prospective|||||||
1503058|NCT00942357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503059|NCT00942344|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1503060|NCT00942331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503061|NCT00942318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503062|NCT00942305|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1503063|NCT00942292|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1503064|NCT00942266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503065|NCT00942253|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1503066|NCT00942240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503067|NCT00942227|Randomized|Parallel Assignment||Treatment||Single|||||t|
1503068|NCT00942214||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503069|NCT00942201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503070|NCT00942188|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503071|NCT00942175|Randomized|Crossover Assignment||||None (Open Label)||||||
1503072|NCT00942162||Single Group Assignment||Treatment||None (Open Label)||||||
1503073|NCT00942149|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503074|NCT00942136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503075|NCT00942123|||Case-Only||Prospective|||||||
1503076|NCT00942110|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503077|NCT00942097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503078|NCT00942084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503079|NCT00942071|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503080|NCT00942058|||Cohort||Prospective|||||||
1503081|NCT00942045|||Cohort||Prospective|||||||
1503082|NCT00942032|||Case-Only||Retrospective|||||||
1503083|NCT00942019|||Cohort||Cross-Sectional|||||||
1503084|NCT00942006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503085|NCT00941993||Single Group Assignment||||None (Open Label)||||||
1503086|NCT00941980|||Cohort||Prospective|||||||
1503087|NCT00941967|Randomized|||Treatment||||||||
1503088|NCT00941954|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503089|NCT00941941|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1503090|NCT00941928||Single Group Assignment||Treatment||None (Open Label)||||||
1503091|NCT00941915||Single Group Assignment||Treatment||None (Open Label)||||||
1503092|NCT00941902|||Case Control||Cross-Sectional|||||||
1503093|NCT00941889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503094|NCT00941876||Single Group Assignment||Health Services Research||None (Open Label)||||||
1503095|NCT00941863|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503096|NCT00941850|Randomized|Parallel Assignment||Treatment||Single||||||t
1503097|NCT00941837|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1503098|NCT00941824||Single Group Assignment||Treatment||None (Open Label)||||||
1503099|NCT00941811|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1503100|NCT00941798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503101|NCT00941785|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503102|NCT00941772||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503103|NCT00941759|||Cohort||Prospective|||||||
1503104|NCT00941746|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1503105|NCT00941733|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1503106|NCT00941720||Single Group Assignment||Treatment||None (Open Label)||||||
1503107|NCT00941707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503108|NCT00941694|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1503109|NCT00941681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503110|NCT00941668|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503111|NCT00941655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503112|NCT00941642|Randomized|Single Group Assignment||Treatment||Single|||t|||
1503113|NCT00941629|Randomized|Parallel Assignment||Treatment||Single||||||t
1503114|NCT00941616|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503115|NCT00941603|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503116|NCT00941590|||Case Control||Prospective|||||||
1503117|NCT00941577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503118|NCT00941564|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1503119|NCT00941551|||Case Control||Prospective|||||||
1503120|NCT00941538|||Cohort||Prospective|||||||
1503121|NCT00941525||Single Group Assignment||Basic Science||None (Open Label)||||||
1503123|NCT00941499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503124|NCT00941486|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503125|NCT00941473||Single Group Assignment||Basic Science||None (Open Label)||||||
1503126|NCT00941460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503127|NCT00941447|Randomized|Parallel Assignment||Treatment||Single||||||t
1503128|NCT00941434|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503129|NCT00941421|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1503130|NCT00941408|||Case-Only||Cross-Sectional|||||||
1503131|NCT00941395|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503132|NCT00941382|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503133|NCT00941369|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503134|NCT00941356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503135|NCT00941343||Single Group Assignment||Treatment||None (Open Label)||||||
1503136|NCT00941330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503137|NCT00941317|Randomized|Single Group Assignment||||None (Open Label)||||||
1503138|NCT00941304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503139|NCT00941291|||Cohort||Retrospective|||||||
1503140|NCT00941278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503141|NCT00941265|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1503142|NCT00941252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503143|NCT00941239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503144|NCT00941226|||Cohort||Prospective|||||||
1503145|NCT00941213|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1503146|NCT00941200|||Case-Crossover||Cross-Sectional|||||||
1503147|NCT00941187|||Cohort||Prospective|||||||
1503148|NCT00941174||Single Group Assignment||Treatment||None (Open Label)||||||
1503149|NCT00941161|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1503150|NCT00941148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503151|NCT00941135||Single Group Assignment||Treatment||None (Open Label)||||||
1503152|NCT00941122|||||Prospective|||||||
1503153|NCT00941109|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503154|NCT00941096||Single Group Assignment||Treatment||Single||||||t
1503155|NCT00941083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503156|NCT00941070||Single Group Assignment||Treatment||None (Open Label)||||||
1503157|NCT00941057|Randomized|Crossover Assignment||||None (Open Label)||||||
1503158|NCT00941044||Single Group Assignment||Treatment||None (Open Label)||||||
1503159|NCT00941031|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503160|NCT00941018|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1503161|NCT00941005|Randomized|Parallel Assignment||Prevention||Single|||t|||
1503162|NCT00940992|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503163|NCT00940979|Randomized|Parallel Assignment||Prevention||Single|||t|||
1503164|NCT00940966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503165|NCT00940953|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1503166|NCT00940940|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1503167|NCT00940927||Single Group Assignment||Treatment||None (Open Label)||||||
1503168|NCT00940914|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1503169|NCT00940901|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503170|NCT00940888|||Case-Only||Prospective|||||||
1503171|NCT00940875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503172|NCT00940862|Randomized|Parallel Assignment||Prevention||Single||||||t
1503173|NCT00940849|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1503174|NCT00940836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503175|NCT00940823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503176|NCT00940810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503177|NCT00940797|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503178|NCT00940784|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1503179|NCT00940771||Single Group Assignment||Treatment||None (Open Label)||||||
1503180|NCT00940758||Single Group Assignment||Treatment||None (Open Label)||||||
1503181|NCT00940745|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1503182|NCT00940732|Randomized|Parallel Assignment||||None (Open Label)||||||
1503183|NCT00940719||Single Group Assignment||Basic Science||None (Open Label)||||||
1503184|NCT00940706|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1503185|NCT00940693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503186|NCT00940680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503187|NCT00940667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503188|NCT00940654|||Case Control||Prospective|||||||
1503189|NCT00940641|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1503190|NCT00940628|Non-Randomized|||Treatment||None (Open Label)||||||
1503191|NCT00940615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503192|NCT00940602|Randomized|Parallel Assignment||Treatment||Double|Patients, investigator staff, persons performing the assessments, and data analysts remained blind to the identity of the study treatment from the time of randomization until database lock.||t||t|
1503193|NCT00940589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503194|NCT00940576|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1503195|NCT00940563||Single Group Assignment||Treatment||None (Open Label)||||||
1503196|NCT00940550|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1503198|NCT00940524||Single Group Assignment||Treatment||None (Open Label)||||||
1503199|NCT00940511|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1503200|NCT00940498||||Treatment||None (Open Label)||||||
1503201|NCT00940485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503202|NCT00940472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503203|NCT00940459|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1503204|NCT00940446|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1503205|NCT00940433|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1503206|NCT00940420|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503207|NCT00940407||Single Group Assignment||Treatment||None (Open Label)||||||
1503208|NCT00940394|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1503209|NCT00940381||Single Group Assignment||Treatment||None (Open Label)||||||
1503210|NCT00940368|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1503211|NCT00940355|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1503212|NCT00940342|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503213|NCT00940329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503214|NCT00940316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503215|NCT00940303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503216|NCT00940290|Randomized|Parallel Assignment||||None (Open Label)||||||
1503217|NCT00940277|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1503218|NCT00940264|||Cohort||Prospective|||||||
1503219|NCT00940251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503220|NCT00940238||||||||||||
1503221|NCT00940225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503222|NCT00940212|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1503223|NCT00940199|||Cohort||Prospective|||||||
1503224|NCT00940186|||Case Control||Prospective|||||||
1503225|NCT00940173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503226|NCT00940160|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503227|NCT00940147|||Cohort||Prospective|||||||
1503228|NCT00940134|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1503229|NCT00940121|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1503230|NCT00940108|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503231|NCT00940095|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503232|NCT00940082|||Cohort||Prospective|||||||
1503233|NCT00940069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503234|NCT00940056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503235|NCT00940043|||Cohort||Prospective|||||||
1503236|NCT00940030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503237|NCT00940017|Randomized|Single Group Assignment||||None (Open Label)||||||
1503238|NCT00940004|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503239|NCT00939991|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503240|NCT00939978||||||||||||
1503241|NCT00939965||||Treatment||None (Open Label)||||||
1503242|NCT00939952|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1503243|NCT00939939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503244|NCT00939926||||||||||||
1503245|NCT00939913|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1503246|NCT00939900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503247|NCT00939887|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1503248|NCT00939874||Single Group Assignment||Treatment||None (Open Label)||||||
1503249|NCT00939861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503250|NCT00939848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503251|NCT00939835||||||||||||
1503252|NCT00939822|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1503253|NCT00939809||Single Group Assignment||Treatment||None (Open Label)||||||
1503254|NCT00939796||Single Group Assignment||Treatment||None (Open Label)||||||
1503255|NCT00939783|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503256|NCT00939770||Single Group Assignment||Treatment||None (Open Label)||||||
1503257|NCT00939757|Randomized|Crossover Assignment||||None (Open Label)||||||
1503258|NCT00939744|||Case-Only||Prospective|||||||
1503259|NCT00939731|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1503260|NCT00939718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503261|NCT00939705|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1503262|NCT00939692|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1503263|NCT00939679|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1503264|NCT00939666||Single Group Assignment||Treatment||None (Open Label)||||||
1503265|NCT00939653||Single Group Assignment||Treatment||None (Open Label)||||||
1503266|NCT00939640||Single Group Assignment||Treatment||None (Open Label)||||||
1503267|NCT00939627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503268|NCT00939614||||||||||||
1503269|NCT00939601|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1503270|NCT00939588|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1503271|NCT00939575|||Case Control||Prospective|||||||
1503272|NCT00939562|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1503273|NCT00939549||Single Group Assignment||Treatment||None (Open Label)||||||
1503274|NCT00939536|Randomized|Crossover Assignment||Treatment||||||||
1503275|NCT00939523||Single Group Assignment||Treatment||None (Open Label)||||||
1503276|NCT00939510||Single Group Assignment||Treatment||None (Open Label)||||||
1503277|NCT00939497||||||||||||
1503278|NCT00939484||Single Group Assignment||Treatment||None (Open Label)||||||
1503279|NCT00939471||Single Group Assignment||Treatment||None (Open Label)||||||
1503280|NCT00939458||||||||||||
1503281|NCT00939445|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503282|NCT00939432|||Ecologic or Community||Cross-Sectional|||||||
1503283|NCT00939419|Randomized|Parallel Assignment||Treatment||Single|||||t|
1503284|NCT00939406|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1503285|NCT00939393|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1503286|NCT00939380|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1503287|NCT00939367|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503288|NCT00939354|||Case-Only||Prospective|||||||
1503289|NCT00939341||Single Group Assignment||Treatment||None (Open Label)||||||
1503290|NCT00939328||||Treatment||None (Open Label)||||||
1503291|NCT00939315|||Cohort||Prospective|||||||
1503292|NCT00939289|||Cohort||Prospective|||||||
1503293|NCT00939276|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503294|NCT00939263|||Cohort||Prospective|||||||
1503295|NCT00939250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503296|NCT00939237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503297|NCT00939224|||Cohort||Prospective|||||||
1503298|NCT00939211|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1503299|NCT00939198||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503300|NCT00939185|||||Prospective|||||||
1503301|NCT00939172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503302|NCT00939159||Single Group Assignment||Treatment||None (Open Label)||||||
1503303|NCT00939146|Randomized|Parallel Assignment||||None (Open Label)||||||
1503304|NCT00939133|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1503305|NCT00939120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503306|NCT00939107|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1503307|NCT00939094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503308|NCT00939081|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503309|NCT00939068|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503310|NCT00939055|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503311|NCT00939042|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503312|NCT00939029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503313|NCT00939016|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1503314|NCT00939003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503315|NCT00938990|Randomized|Parallel Assignment||||Double||||||
1503316|NCT00938977||Single Group Assignment||Treatment||None (Open Label)||||||
1503317|NCT00938964|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503318|NCT00938951||Single Group Assignment||Supportive Care||None (Open Label)||||||
1503319|NCT00938938|Randomized|Parallel Assignment||||Single|||||t|
1503320|NCT00938925|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1503321|NCT00938912||Single Group Assignment||Treatment||None (Open Label)||||||
1503322|NCT00938899||||||||||||
1503323|NCT00938886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503324|NCT00938873|||Case-Only||Retrospective|||||||
1503325|NCT00938860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503326|NCT00938847|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1503327|NCT00938834||Single Group Assignment||Treatment||None (Open Label)||||||
1503328|NCT00938821|||Case-Only||Retrospective|||||||
1503329|NCT00938808|Randomized|Parallel Assignment||Treatment||Single||||||t
1503330|NCT00938795|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1503331|NCT00938782|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1503332|NCT00938769|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1503333|NCT00938756||||Diagnostic||None (Open Label)||||||
1503334|NCT00938743|Randomized|Parallel Assignment||Treatment||Single||||||t
1503335|NCT00938730|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503336|NCT00938717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503337|NCT00938704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503338|NCT00938691|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1503339|NCT00938678|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1503340|NCT00938665|||Case Control||Cross-Sectional|||||||
1503341|NCT00938652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503342|NCT00938639|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503343|NCT00938626||Single Group Assignment||Treatment||None (Open Label)||||||
1503344|NCT00938613|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1503345|NCT00938600|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503346|NCT00938587|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503347|NCT00938574||Single Group Assignment||Treatment||None (Open Label)||||||
1503348|NCT00938561|||Cohort|||||||||
1503349|NCT00938548|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503350|NCT00938535|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503351|NCT00938522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503352|NCT00938509|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503353|NCT00938496|||||Prospective|||||||
1503354|NCT00938483|Randomized|Parallel Assignment||||Single||||t||
1503355|NCT00938470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503356|NCT00938457||Single Group Assignment||Treatment||None (Open Label)||||||
1503357|NCT00938444|||Cohort||Prospective|||||||
1503358|NCT00938431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503359|NCT00938418||Single Group Assignment||Treatment||None (Open Label)||||||
1503360|NCT00938405|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503361|NCT00938392|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1503362|NCT00938379|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1503363|NCT00938366|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503364|NCT00938353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503365|NCT00938340|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1503366|NCT00938327|||Cohort||Prospective|||||||
1503367|NCT00938314|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503368|NCT00938301|Non-Randomized|Crossover Assignment||Treatment||Double|||t||t|
1503369|NCT00938288|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1503370|NCT00938275|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1503371|NCT00938262|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1503372|NCT00938249|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1503373|NCT00938236||Single Group Assignment||Prevention||None (Open Label)||||||
1503374|NCT00938223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503375|NCT00938210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503376|NCT00938197|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1503377|NCT00938184|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1503378|NCT00938171|Randomized|Parallel Assignment||Treatment||Single||||||t
1503379|NCT00938158|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503380|NCT00938145|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1503381|NCT00938132|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1503382|NCT00938119|||Case Control||Prospective|||||||
1503383|NCT00938106||Single Group Assignment||Treatment||None (Open Label)||||||
1503384|NCT00938093|Randomized|Parallel Assignment||Treatment||Single||||||t
1503385|NCT00938080|Non-Randomized|Parallel Assignment||||Single|||t|||
1503386|NCT00938067|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1503387|NCT00938054|||||Other|||||||
1503388|NCT00938041||Single Group Assignment||Treatment||None (Open Label)||||||
1503389|NCT00938028|||||Prospective|||||||
1503390|NCT00938015|||Cohort||Retrospective|||||||
1503391|NCT00938002|||Case-Control||Prospective|||||||
1503392|NCT00937989||Single Group Assignment||Health Services Research||None (Open Label)||||||
1503393|NCT00937976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503394|NCT00937963|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503395|NCT00937950||Single Group Assignment||Prevention||None (Open Label)||||||
1503396|NCT00937937||Single Group Assignment||Treatment||None (Open Label)||||||
1503397|NCT00937924|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1503398|NCT00937911|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1503399|NCT00937898|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1503400|NCT00937885||Parallel Assignment||Supportive Care||None (Open Label)||||||
1503401|NCT00937872||Crossover Assignment||Basic Science||None (Open Label)||||||
1503402|NCT00937859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503403|NCT00937846||Single Group Assignment||Supportive Care||None (Open Label)||||||
1503404|NCT00937833|Randomized|Parallel Assignment||Prevention||Single|||t|||
1503405|NCT00937820|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1503406|NCT00937807|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503407|NCT00937794|||Cohort||Prospective|||||||
1503408|NCT00937781|||Other||Retrospective|||||||
1503409|NCT00937768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503410|NCT00937755|||Case-Only||Prospective|||||||
1503411|NCT00937742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503412|NCT00937729|||Cohort||Prospective|||||||
1503413|NCT00937716|||Case-Control||Prospective|||||||
1503414|NCT00937703|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1503415|NCT00937690|||Case Control||Prospective|||||||
1503416|NCT00937677|||Case Control||Prospective|||||||
1503417|NCT00937664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503418|NCT00937651|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503419|NCT00937638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503420|NCT00937625||Single Group Assignment||Treatment||None (Open Label)||||||
1503421|NCT00937612||Single Group Assignment||Treatment||None (Open Label)||Prospective cohort||||
1503422|NCT00937599|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503423|NCT00937586|||Cohort||Prospective|||||||
1503424|NCT00937573|||Cohort||Prospective|||||||
1503425|NCT00937560||Single Group Assignment||Treatment||None (Open Label)||||||
1503426|NCT00937547|||||Prospective|||||||
1503427|NCT00937534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503428|NCT00937521|Randomized|Parallel Assignment||Prevention||Single|||t|||
1503429|NCT00937508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503430|NCT00937495||Single Group Assignment||Treatment||None (Open Label)||||||
1503431|NCT00937482||Single Group Assignment||Treatment||None (Open Label)||||||
1503509|NCT00936455|||Cohort||Retrospective|||||||
1503432|NCT00937469|Randomized|Parallel Assignment||Treatment||Single||||||t
1503433|NCT00937456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503434|NCT00937443|||Cohort||Prospective|||||||
1503435|NCT00937430|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1503436|NCT00937417||Single Group Assignment||Treatment||None (Open Label)||||||
1503437|NCT00937404||Single Group Assignment||Prevention||None (Open Label)||||||
1503438|NCT00937391|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1503439|NCT00937378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503440|NCT00937365|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503441|NCT00937352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503442|NCT00937339|Randomized|Parallel Assignment||Treatment||Single||||||t
1503443|NCT00937326|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503444|NCT00937313||||||||||||
1503445|NCT00937300|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503446|NCT00937287|||||Prospective|||||||
1503447|NCT00937274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503448|NCT00937261|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503449|NCT00937248|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503450|NCT00937235|Randomized|Parallel Assignment||Treatment||Single||||||t
1503451|NCT00937222|Randomized|Parallel Assignment||Treatment||Single||||||t
1503452|NCT00937196|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1503453|NCT00937183||||Treatment||None (Open Label)||||||
1503454|NCT00937170|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503455|NCT00937157|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1503456|NCT00937144|Randomized|Crossover Assignment||Treatment||Double||||t|t|
1503457|NCT00937131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503458|NCT00937118|||Cohort||Retrospective|||||||
1503459|NCT00937105|Randomized|Parallel Assignment||Treatment||Single|||||t|
1503460|NCT00937092|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503461|NCT00937079|||Case-Only||Prospective|||||||
1503462|NCT00937066|||Cohort|||||||||
1503463|NCT00937053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503464|NCT00937040|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503465|NCT00937027|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503466|NCT00937014|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1503467|NCT00937001||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503468|NCT00936988||Single Group Assignment||Treatment||None (Open Label)||||||
1503469|NCT00936975||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503470|NCT00936962|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1503471|NCT00936949|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503472|NCT00936936|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503473|NCT00936923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503474|NCT00936910||Single Group Assignment||Treatment||None (Open Label)||||||
1503475|NCT00936897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503476|NCT00936884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503477|NCT00936871|Randomized|Crossover Assignment||Treatment||Single|||t|||
1503478|NCT00936858||Single Group Assignment||Treatment||None (Open Label)||||||
1503479|NCT00936845|||Cohort||Retrospective|||||||
1503480|NCT00936832|Non-Randomized|||Treatment||None (Open Label)||||||
1503481|NCT00936819|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503482|NCT00936806|||Case Control||Prospective|||||||
1503483|NCT00936793|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1503484|NCT00936780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503485|NCT00936767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503486|NCT00936754|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1503487|NCT00936741||Single Group Assignment||Treatment||None (Open Label)||||||
1503488|NCT00936728|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1503489|NCT00936715||Single Group Assignment||Treatment||None (Open Label)||||||
1503490|NCT00936702||Single Group Assignment||Treatment||None (Open Label)||||||
1503491|NCT00936689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503492|NCT00936676|||Cohort||Prospective|||||||
1503493|NCT00936663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503494|NCT00936650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503495|NCT00936637|Randomized|Single Group Assignment||||Single||||t||
1503496|NCT00936624|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503497|NCT00936611||Single Group Assignment||Treatment||None (Open Label)||||||
1503498|NCT00936598|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1503499|NCT00936585||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503500|NCT00936572|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503501|NCT00936559|Randomized|Single Group Assignment||Treatment||Single|||t|||
1503502|NCT00936546||Single Group Assignment||Treatment||None (Open Label)||||||
1503503|NCT00936533||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1503504|NCT00936520|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503505|NCT00936507|Non-Randomized|Crossover Assignment||Other||Single|||t|||
1503506|NCT00936494|Randomized|Parallel Assignment||Treatment||Single|||||t|
1503507|NCT00936481|||Case Control||Prospective|||||||
1503508|NCT00936468|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1503510|NCT00936442|||Cohort||Prospective|||||||
1503511|NCT00936429|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503512|NCT00936416||Single Group Assignment||Screening||None (Open Label)||||||
1503513|NCT00936403|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503514|NCT00936390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503515|NCT00936377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503516|NCT00936364|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1503517|NCT00936351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503518|NCT00936338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503519|NCT00936325|||Case-Only||Prospective|||||||
1503520|NCT00936312|||Cohort||Retrospective|||||||
1503521|NCT00936299|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1503522|NCT00936286||Single Group Assignment||Treatment||None (Open Label)||||||
1503523|NCT00936273|||Cohort||Cross-Sectional|||||||
1503524|NCT00936260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503525|NCT00936247|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503526|NCT00936234|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1503527|NCT00936221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503528|NCT00936208|||Cohort||Prospective|||||||
1503529|NCT00936195|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503530|NCT00936182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503531|NCT00936169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503532|NCT00936156||Single Group Assignment||Treatment||None (Open Label)||||||
1503533|NCT00936143||Single Group Assignment||Treatment||None (Open Label)||||||
1503534|NCT00936130|||Cohort||Prospective|||||||
1503535|NCT00936117||Single Group Assignment||Treatment||None (Open Label)||||||
1503536|NCT00936104|||Cohort||Prospective|||||||
1503537|NCT00936091|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1503538|NCT00936078|||Cohort||Prospective|||||||
1503539|NCT00936065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503540|NCT00936052||Single Group Assignment||Treatment||None (Open Label)||||||
1503541|NCT00936039||Single Group Assignment||Basic Science||None (Open Label)||||||
1503542|NCT00936026||||||None (Open Label)||||||
1503543|NCT00936013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503544|NCT00936000|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1503545|NCT00935987||Single Group Assignment||Treatment||None (Open Label)||||||
1503546|NCT00935974||||||||||||
1503547|NCT00935961||Single Group Assignment||Treatment||None (Open Label)||||||
1503548|NCT00935948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503549|NCT00935935|||Cohort||Cross-Sectional|||||||
1503550|NCT00935922|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1503551|NCT00935909|||Case Control||Prospective|||||||
1503552|NCT00935896|Randomized|||Supportive Care||None (Open Label)||||||
1503553|NCT00935883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503554|NCT00935870|||Cohort||Cross-Sectional|||||||
1503555|NCT00935857|Randomized|Crossover Assignment||Treatment||Single|||t|||
1503556|NCT00935844||Single Group Assignment||Treatment||None (Open Label)||||||
1503557|NCT00935831|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1503558|NCT00935818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503559|NCT00935805|||Cohort||Prospective|||||||
1503560|NCT00935792||Single Group Assignment||Treatment||None (Open Label)||||||
1503561|NCT00935779|||Case Control||Prospective|||||||
1503562|NCT00935766|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1503563|NCT00935753|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503564|NCT00935740|||Case Control||Prospective|||||||
1503565|NCT00935727||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503566|NCT00935714|Randomized|Factorial Assignment||Treatment||Single||||||t
1503567|NCT00935701||Single Group Assignment||Treatment||None (Open Label)||||||
1503568|NCT00935688|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1503569|NCT00935675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503570|NCT00935662|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1503571|NCT00935649|Randomized|Single Group Assignment||Treatment||Single||||||t
1503572|NCT00935636|||Cohort||Prospective|||||||
1503573|NCT00935623|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1503574|NCT00935610|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1503575|NCT00935597|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503576|NCT00935584||Single Group Assignment||Health Services Research||None (Open Label)||||||
1503577|NCT00935571|||Case Control||Prospective|||||||
1503578|NCT00935558|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503579|NCT00935545||Single Group Assignment||Treatment||None (Open Label)||||||
1503580|NCT00935532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503581|NCT00935519||Single Group Assignment||Treatment||None (Open Label)||||||
1503582|NCT00935506|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1503583|NCT00935493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503584|NCT00935480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503585|NCT00935467||Single Group Assignment||||None (Open Label)||||||
1503586|NCT00935454|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503587|NCT00935441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503588|NCT00935428|||Cohort||Retrospective|||||||
1503589|NCT00935415|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1503590|NCT00935402|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1503591|NCT00935389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503592|NCT00935376|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503593|NCT00935363|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1503594|NCT00935350|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503595|NCT00935337|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503596|NCT00935324|||Cohort||Prospective|||||||
1503597|NCT00935311|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503598|NCT00935298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503599|NCT00935285|||Cohort||Prospective|||||||
1503600|NCT00935272|Randomized|Parallel Assignment||Treatment||Single||||||t
1503601|NCT00935259|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1503602|NCT00935246|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503603|NCT00935233||||||||||||
1503604|NCT00935220|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503605|NCT00935207|||||Prospective|||||||
1503606|NCT00935194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503607|NCT00935181|Randomized|Parallel Assignment||Treatment||Single||||||t
1503608|NCT00935168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503609|NCT00935155|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1503610|NCT00935142||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503611|NCT00935129|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503612|NCT00935116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503613|NCT00935103|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1503614|NCT00935090||Single Group Assignment||Diagnostic||None (Open Label)||PET scans will be performed to show the distribution throughout the body of substances containing a small amount of radioactive material.||||
1503615|NCT00935077|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1503616|NCT00935064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503617|NCT00935051||Single Group Assignment||Basic Science||None (Open Label)||||||
1503618|NCT00935025|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1503619|NCT00935012||||Treatment||None (Open Label)||||||
1503620|NCT00934999|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503621|NCT00934986||Single Group Assignment||Basic Science||None (Open Label)||||||
1503622|NCT00934973|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1503623|NCT00934960|||Case-Only||Retrospective|||||||
1503624|NCT00934947|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503625|NCT00934934|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1503626|NCT00934921|Randomized|Crossover Assignment||||None (Open Label)||||||
1503627|NCT00934908|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1503628|NCT00934895||Single Group Assignment||Treatment||None (Open Label)||||||
1503629|NCT00934882|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503630|NCT00934869|||Cohort||Prospective|||||||
1503631|NCT00934856|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503632|NCT00934843|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1503633|NCT00934830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503634|NCT00934817|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1503635|NCT00934804|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1503636|NCT00934791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503637|NCT00934778||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503638|NCT00934765|||Case-Only||Prospective|||||||
1503639|NCT00934752||Single Group Assignment||Treatment||None (Open Label)||||||
1503640|NCT00934739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503641|NCT00934726|||Cohort||Prospective|||||||
1503642|NCT00934713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503643|NCT00934700|Randomized|Parallel Assignment||Treatment||Single||||||t
1503644|NCT00934687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503645|NCT00934674|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503646|NCT00934661|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503647|NCT00934648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503648|NCT00934635|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503649|NCT00934622|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503650|NCT00934609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503651|NCT00934596|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503652|NCT00934583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503653|NCT00934570|Randomized|Parallel Assignment||Prevention||Single|||t|||
1503654|NCT00934557|Randomized|||Prevention||None (Open Label)||||||
1503655|NCT00934544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503656|NCT00934531|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1503657|NCT00934518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503658|NCT00934505|||||Prospective|||||||
1503659|NCT00934492|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1503660|NCT00934479|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1503661|NCT00934466|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1503662|NCT00934453|Randomized|Parallel Assignment||||Triple|||t|t|t|
1503663|NCT00934440||Sequential Assignment||Treatment||None (Open Label)||||||
1503664|NCT00934427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503665|NCT00934414|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503666|NCT00934401|||Cohort||Prospective|||||||
1503667|NCT00934388|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1503668|NCT00934375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503669|NCT00934362|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1503670|NCT00934349|||Case Control||Prospective|||||||
1503671|NCT00934336|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1503672|NCT00934323|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1503673|NCT00934310|||Case-Control||Prospective|||||||
1503674|NCT00934297|||Cohort||Prospective|||||||
1503675|NCT00934284|Randomized|Parallel Assignment||Treatment||Single|||||t|
1503676|NCT00934271|||Cohort||Retrospective|||||||
1503677|NCT00934258||||||||||||
1503678|NCT00934245|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503679|NCT00934232||Single Group Assignment||Treatment||None (Open Label)||||||
1503680|NCT00934219||Single Group Assignment||Treatment||None (Open Label)||||||
1503681|NCT00934206||Single Group Assignment||Prevention||None (Open Label)||||||
1503682|NCT00934193|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503683|NCT00934180|Randomized|Crossover Assignment||||None (Open Label)||||||
1503684|NCT00934167|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503685|NCT00934154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503686|NCT00934141|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1503687|NCT00934128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503688|NCT00934115|||Cohort|||||||||
1503689|NCT00934102|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503690|NCT00934089|Randomized|Crossover Assignment||Treatment||Single|||t|||
1503691|NCT00934076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503692|NCT00934063|||Cohort||Prospective|||||||
1503693|NCT00934050||Single Group Assignment||Treatment||None (Open Label)||||||
1503694|NCT00934037||Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1503695|NCT00934024|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503696|NCT00934011|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503697|NCT00933998|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503698|NCT00933985||Single Group Assignment||Treatment||None (Open Label)||||||
1503699|NCT00933972|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503700|NCT00933959|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503701|NCT00933946|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503702|NCT00933933|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1503703|NCT00933920|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1503704|NCT00933907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503705|NCT00933894|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503706|NCT00933881|||Case Control||Cross-Sectional|||||||
1503707|NCT00933868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503708|NCT00933855|||Cohort||Prospective|||||||
1503709|NCT00933842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503710|NCT00933829|Randomized|Parallel Assignment||Treatment||Single||||||t
1503711|NCT00933816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503712|NCT00933790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503713|NCT00933777||Single Group Assignment||Treatment||None (Open Label)||||||
1503714|NCT00933764|||Case-Only||Prospective|||||||
1503715|NCT00933751|||Case-Only||Prospective|||||||
1503716|NCT00933738|||Case-Only||Prospective|||||||
1503717|NCT00933725|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1503718|NCT00933712|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503719|NCT00933699|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1503720|NCT00933686|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1503721|NCT00933673||Single Group Assignment||Treatment||None (Open Label)||||||
1503722|NCT00933660|Randomized|Parallel Assignment||||Single|||||t|
1503723|NCT00933647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503724|NCT00933634|Randomized|Parallel Assignment||Treatment||Single|||||t|
1503725|NCT00933621||Single Group Assignment||Treatment||None (Open Label)||||||
1503726|NCT00933608|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1503727|NCT00933595||Single Group Assignment||||None (Open Label)||||||
1503728|NCT00933582|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1503729|NCT00933569|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1503730|NCT00933556|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503731|NCT00933543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503732|NCT00933530|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1503733|NCT00933517||Single Group Assignment||Treatment||None (Open Label)||||||
1503734|NCT00933504|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503735|NCT00933491|||Cohort||Prospective|||||||
1503736|NCT00933478|||Cohort||Retrospective|||||||
1503737|NCT00933465|Randomized|Crossover Assignment||Treatment||Single||||||t
1503738|NCT00933452||Parallel Assignment||||None (Open Label)||||||
1503739|NCT00933439||Single Group Assignment||Treatment||None (Open Label)||||||
1503740|NCT00933426||Single Group Assignment||Treatment||None (Open Label)||||||
1503741|NCT00933413|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1503742|NCT00933400|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1503743|NCT00933387||Single Group Assignment||Treatment||None (Open Label)||||||
1503744|NCT00933374||Single Group Assignment||Treatment||None (Open Label)||||||
1503745|NCT00933361||Single Group Assignment||Treatment||None (Open Label)||||||
1503746|NCT00933348|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503747|NCT00933335||Single Group Assignment||Treatment||None (Open Label)||||||
1503748|NCT00933322|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1503749|NCT00933309|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503750|NCT00933296|||Case-Control||Prospective|||||||
1503751|NCT00933283||Single Group Assignment||Treatment||None (Open Label)||||||
1503752|NCT00933270||Single Group Assignment||Treatment||None (Open Label)||||||
1503753|NCT00933257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503754|NCT00933244|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503755|NCT00933231|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1503756|NCT00933218|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503757|NCT00933205||||||||||||
1503758|NCT00933192|||Cohort||Prospective|||||||
1503759|NCT00933179|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1503760|NCT00933166||Single Group Assignment||Treatment||None (Open Label)||||||
1503761|NCT00933153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503762|NCT00933140|||Cohort||Prospective|||||||
1503763|NCT00933127|||||Retrospective|||||||
1503764|NCT00933114|||Case-Only||Prospective|||||||
1503765|NCT00933101|||Case-Only||Prospective|||||||
1503766|NCT00933088|||Case-Only||Cross-Sectional|||||||
1503767|NCT00933075|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503768|NCT00933062|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1503769|NCT00933049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503770|NCT00933036||Single Group Assignment||Treatment||None (Open Label)||||||
1503771|NCT00933023|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503772|NCT00933010|||Ecologic or Community||Cross-Sectional|||||||
1503773|NCT00932997|Randomized|Single Group Assignment||||None (Open Label)||||||
1503774|NCT00932984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503775|NCT00932971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503776|NCT00932958|||Cohort||Prospective|||||||
1503777|NCT00932945|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1503778|NCT00932932|||Case Control||Prospective|||||||
1503779|NCT00932919|Randomized|Single Group Assignment||Treatment||Single||||||t
1503780|NCT00932906|Randomized|Parallel Assignment||||Single||||||t
1503781|NCT00932893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503782|NCT00932880||||||||||||
1503783|NCT00932867|||Cohort||Prospective|||||||
1503784|NCT00932854||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503785|NCT00932841|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503786|NCT00932828||Single Group Assignment||Treatment||None (Open Label)|For exploratory analysis, subjects will be randomized 1:1 to high (3000mg) and low dose (300mg) OIT to potentially look for a dose response. Low dose will be masked by adding oat flour to provide a dose equal to high dose with respect to flour but with lower peanut protein content|For the purposes of the primary outcome, all subjects will receive peanut OIT and represent a single group. For exploratory analysis, subjects will be randomized to high and low dose OIT to potentially look for a dose response.||||
1503787|NCT00932802|||Cohort||Prospective|||||||
1503788|NCT00932789||||||||||||
1503789|NCT00932776||||||||||||
1503790|NCT00932763||||||||||||
1503791|NCT00932750|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503792|NCT00932737|Randomized|Parallel Assignment||Treatment||Double||||||
1503793|NCT00932724|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503794|NCT00932711|Randomized|Parallel Assignment||Treatment||Single||||||t
1503795|NCT00932698||Single Group Assignment||Treatment||None (Open Label)||||||
1503796|NCT00932685|Randomized|Parallel Assignment||Prevention||Single||||||t
1503797|NCT00932672|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503798|NCT00932659|||Cohort||Prospective|||||||
1503799|NCT00932646|Randomized|Crossover Assignment||Treatment||Double||||||
1503800|NCT00932633|||Cohort||Prospective|||||||
1503801|NCT00932620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503802|NCT00932607|Randomized|Parallel Assignment||Treatment||Single||||||t
1503803|NCT00932594|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503804|NCT00932581|||Case Control||Prospective|||||||
1503805|NCT00932555|||Cohort||Prospective|||||||
1503806|NCT00932542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503807|NCT00932529|Randomized|Parallel Assignment||Treatment||Single|||||t|
1503808|NCT00932516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503809|NCT00932503|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1503810|NCT00932490|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1503811|NCT00932477|Randomized|Crossover Assignment||||Double|||t||t|
1503812|NCT00932464|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1503813|NCT00932451|Non-Randomized|||Treatment||None (Open Label)||||||
1503814|NCT00932438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503815|NCT00932425|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1503816|NCT00932412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503817|NCT00932399|||Cohort||Retrospective|||||||
1503818|NCT00932386|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503819|NCT00932373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503820|NCT00932360|Randomized|Crossover Assignment||||Double|||t||t|
1503821|NCT00932347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503822|NCT00932334|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1503823|NCT00932321|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503824|NCT00932308|Randomized|Crossover Assignment||Prevention||Single|||||t|
1503825|NCT00932295|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1503826|NCT00932282|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503827|NCT00932269|||Cohort||Cross-Sectional|||||||
1503828|NCT00932256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503829|NCT00932243|||Cohort||Prospective|||||||
1503830|NCT00932230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503831|NCT00932217|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503832|NCT00932204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503833|NCT00932191|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503834|NCT00932178||Single Group Assignment||Treatment||None (Open Label)||||||
1503835|NCT00932165|||Case-Only||Prospective|||||||
1503836|NCT00932152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503837|NCT00932139|Randomized|Parallel Assignment||Treatment||Triple|The care provider or acupuncturist does not know the outcome of the treatment. The investigator does not know the participants and the outcome of the study. The outcome assessor does not know the participants.|Two different formulated sets of acupoints will be used as EA intervention in the treatment of hypertension.||t|t|t
1503838|NCT00932126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503839|NCT00932113|Randomized|Parallel Assignment||Basic Science||Single||||||t
1503840|NCT00932100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503841|NCT00932087|||Case Control||Prospective|||||||
1503842|NCT00932074|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503843|NCT00932061|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1503844|NCT00932048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503845|NCT00932035|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1503846|NCT00932022|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503847|NCT00932009|||Ecologic or Community||Cross-Sectional|||||||
1503848|NCT00931996||Single Group Assignment||Basic Science||None (Open Label)||||||
1503849|NCT00931983|||Case-Only||Prospective|||||||
1503850|NCT00931970|||Cohort||Prospective|||||||
1503851|NCT00931957|Randomized|Parallel Assignment||Treatment||Single|||||t|
1503852|NCT00931944||Single Group Assignment||Treatment||None (Open Label)||||||
1503853|NCT00931931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503854|NCT00931918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503855|NCT00931905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503856|NCT00931892|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1503857|NCT00931879|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503858|NCT00931866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503859|NCT00931853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503860|NCT00931840|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503861|NCT00931827|||Cohort||Prospective|||||||
1503862|NCT00931814|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503863|NCT00931801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503864|NCT00931788|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1503865|NCT00931775|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503866|NCT00931762||Single Group Assignment||Treatment||None (Open Label)||||||
1503867|NCT00931749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503868|NCT00931736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503869|NCT00931723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503870|NCT00931710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503871|NCT00931697|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503872|NCT00931671|Randomized|Single Group Assignment||Treatment||Single|||t|||
1503873|NCT00931645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503874|NCT00931632|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1503875|NCT00931619|||||Prospective|||||||
1503876|NCT00931606|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503877|NCT00931593||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503878|NCT00931580|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1503879|NCT00931567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503880|NCT00931554|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503881|NCT00931541|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1503882|NCT00931528|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1503883|NCT00931515|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503884|NCT00931502|||Case-Only||Other|||||||
1503885|NCT00931489|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503886|NCT00931476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503887|NCT00931463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503888|NCT00931450|Randomized|||Treatment||Double||||||
1503889|NCT00931437||Single Group Assignment||Treatment||None (Open Label)||||||
1503890|NCT00931424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503891|NCT00931411|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1503892|NCT00931398|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1503893|NCT00931385|Randomized|Crossover Assignment||Treatment||Double||||||
1503894|NCT00931372|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1503895|NCT00931359|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1503896|NCT00931346|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503897|NCT00931333||Single Group Assignment||Treatment||None (Open Label)||||||
1503898|NCT00931320|||Cohort||Retrospective|||||||
1503899|NCT00931307||Single Group Assignment||Treatment||None (Open Label)||||||
1503900|NCT00931294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503901|NCT00931281|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503902|NCT00931268||Single Group Assignment||Treatment||None (Open Label)||||||
1503903|NCT00931255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503904|NCT00931242||Single Group Assignment||Treatment||None (Open Label)||||||
1503905|NCT00931229||Single Group Assignment||Prevention||None (Open Label)||||||
1503906|NCT00931216|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1503907|NCT00931203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503908|NCT00931190|||Cohort||Prospective|||||||
1503909|NCT00931177|||Cohort||Prospective|||||||
1503910|NCT00931164||Single Group Assignment||Treatment||None (Open Label)||||||
1503911|NCT00931151|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1503912|NCT00931138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503913|NCT00931125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503914|NCT00931112|Randomized|Single Group Assignment||Treatment||Single|||t|||
1503915|NCT00931099|||Cohort||Prospective|||||||
1503916|NCT00931086||||||||||||
1503917|NCT00931073|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1503918|NCT00931060|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1503919|NCT00931034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503920|NCT00931021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503921|NCT00931008|Randomized|Crossover Assignment||||Double|||t||t|
1503922|NCT00930995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503923|NCT00930982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503924|NCT00930969|||Cohort||Prospective|||||||
1503925|NCT00930956|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1503926|NCT00930943|Randomized|Crossover Assignment||Treatment||Single||||||t
1503927|NCT00930930|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503928|NCT00930917|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1503929|NCT00930904|||Other||Prospective|||||||
1503930|NCT00930891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503931|NCT00930878|||Cohort||Prospective|||||||
1503932|NCT00930865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503933|NCT00930852|||Case-Only||Cross-Sectional|||||||
1503934|NCT00930839|||Cohort||Prospective|||||||
1503935|NCT00930826|||Case Control||Prospective|||||||
1503936|NCT00930813|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503937|NCT00930800|Randomized|Parallel Assignment||Treatment||Single|||t|||
1503938|NCT00930787|Randomized|Parallel Assignment||Treatment||Single||||||t
1503939|NCT00930774|Randomized|Factorial Assignment||||None (Open Label)||||||
1503940|NCT00930761|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503941|NCT00930748|||Cohort||Prospective|||||||
1503942|NCT00930735|||Cohort||Prospective|||||||
1503943|NCT00930722|||Case-Only||Prospective|||||||
1503944|NCT00930709|Randomized|Parallel Assignment||Treatment||Single||||||t
1503945|NCT00930696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503946|NCT00930683|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503947|NCT00930670|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1503948|NCT00930657|||Cohort||Prospective|||||||
1503949|NCT00930644||Single Group Assignment||Treatment||None (Open Label)||||||
1503950|NCT00930631||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503951|NCT00930618|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503952|NCT00930605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503953|NCT00930592|||Case Control||Cross-Sectional|||||||
1503954|NCT00930579||Single Group Assignment||Treatment||None (Open Label)||||||
1503955|NCT00930566||Single Group Assignment||Prevention||None (Open Label)||||||
1503956|NCT00930553|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1503957|NCT00930527|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1503958|NCT00930514||Parallel Assignment||Treatment||None (Open Label)||||||
1503959|NCT00930501|||Case-Only||Prospective|||||||
1503960|NCT00930488|||Cohort||Prospective|||||||
1503961|NCT00930475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503962|NCT00930462|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1503963|NCT00930449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503964|NCT00930436|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1503965|NCT00930423|||Case Control||Prospective|||||||
1503966|NCT00930410||Single Group Assignment||Diagnostic||None (Open Label)||||||
1503967|NCT00930397|||Cohort||Prospective|||||||
1503968|NCT00930384|||Case Control||Cross-Sectional|||||||
1503969|NCT00930371||Single Group Assignment||Basic Science||Single|||t|||
1503970|NCT00930358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503971|NCT00930345|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1503972|NCT00930332|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1503973|NCT00930319|||Case-Only||Prospective|||||||
1503974|NCT00930306|Randomized|Single Group Assignment||||None (Open Label)||||||
1503975|NCT00930293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503976|NCT00930280|||Case-Control||Prospective|||||||
1503977|NCT00930267|||Cohort||Prospective|||||||
1503978|NCT00930254|Randomized|Parallel Assignment||||None (Open Label)||||||
1503979|NCT00930241|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1503980|NCT00930228|Randomized|Crossover Assignment||Other||Quadruple||Randomized, placebo-controlled, crossover study|t|t|t|t
1503981|NCT00930215|Randomized|Single Group Assignment||||None (Open Label)||||||
1503982|NCT00930202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503983|NCT00930189|Randomized|Parallel Assignment||Treatment||Double||||||
1503984|NCT00930176||Single Group Assignment||Treatment||None (Open Label)||||||
1503985|NCT00930163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1503986|NCT00930150|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1503987|NCT00930137|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1503988|NCT00930124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503989|NCT00930111|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1503990|NCT00930098||Single Group Assignment||Treatment||None (Open Label)||||||
1503991|NCT00930085||Single Group Assignment||||None (Open Label)||||||
1503992|NCT00930072|Randomized|Parallel Assignment||Treatment||Double||||t||t
1503993|NCT00930059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503994|NCT00930046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1503995|NCT00930033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1503996|NCT00930020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1503997|NCT00930007|||Cohort||Cross-Sectional|||||||
1503998|NCT00929994|||Cohort||Prospective|||||||
1503999|NCT00929981|||Cohort||Prospective|||||||
1504000|NCT00929968|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1504001|NCT00929955|Randomized|Parallel Assignment||Treatment||Single|||||t|
1504002|NCT00929942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504003|NCT00929929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504004|NCT00929916|||Cohort||Prospective|||||||
1504005|NCT00929903||Single Group Assignment||Treatment||None (Open Label)||||||
1504006|NCT00929890|Randomized|Parallel Assignment||||None (Open Label)||||||
1504007|NCT00929877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504008|NCT00929864|Randomized|Parallel Assignment||Treatment||Single|||||t|
1504009|NCT00929851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504010|NCT00929838|Randomized|Factorial Assignment||Treatment||Single||||||t
1504011|NCT00929825|Randomized|Single Group Assignment||Prevention||Single|||||t|
1504012|NCT00929812|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1504013|NCT00929799||Single Group Assignment||Basic Science||None (Open Label)||||||
1504014|NCT00929786|||Case Control||Prospective|||||||
1504015|NCT00929773|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504016|NCT00929760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504017|NCT00929747|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504018|NCT00929734|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504019|NCT00929721||Single Group Assignment||||None (Open Label)||||||
1504020|NCT00929708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504021|NCT00929695|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1504022|NCT00929682|Randomized|Parallel Assignment||||Double|||t||t|
1504023|NCT00929669||Single Group Assignment||Treatment||None (Open Label)||||||
1504024|NCT00929656|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1504025|NCT00929643|||||Prospective|||||||
1504026|NCT00929630|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504027|NCT00929617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504028|NCT00929604|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1504029|NCT00929591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504030|NCT00929578|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504031|NCT00929565|||Case Control||Prospective|||||||
1504032|NCT00929552|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1504033|NCT00929539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504034|NCT00929526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504035|NCT00929500|Randomized|Parallel Assignment||Other||Single||||||t
1504036|NCT00929487|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1504037|NCT00929474|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504038|NCT00929461||||Treatment||||||||
1504039|NCT00929448|||Cohort||Prospective|||||||
1504040|NCT00929435|||Case-Only||Prospective|||||||
1504041|NCT00929422|||Case Control||Prospective|||||||
1504042|NCT00929409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504043|NCT00929396|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504044|NCT00929383|||Cohort||Prospective|||||||
1504045|NCT00929370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504046|NCT00929357|||Cohort||Retrospective|||||||
1504047|NCT00929344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504048|NCT00929331|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504049|NCT00929318|Randomized|||Basic Science||None (Open Label)||||||
1504050|NCT00929305|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504051|NCT00929292|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1504052|NCT00929279|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504053|NCT00929266||Single Group Assignment||Health Services Research||None (Open Label)||||||
1504054|NCT00929253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504055|NCT00929240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504056|NCT00929227|||||Prospective|||||||
1504057|NCT00929214||Single Group Assignment||Treatment||None (Open Label)||||||
1504058|NCT00929201|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504059|NCT00929188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504060|NCT00929175|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504061|NCT00929162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504062|NCT00929136|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1504063|NCT00929123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504064|NCT00929110|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504065|NCT00929097|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1504066|NCT00929084|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1504067|NCT00929071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504068|NCT00929058||Single Group Assignment||||None (Open Label)||||||
1504069|NCT00929045|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504070|NCT00929032|||Cohort||Prospective|||||||
1504071|NCT00929019|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504072|NCT00929006|Randomized|Crossover Assignment||Basic Science||Quadruple||Randomized, placebo-controlled, crossover study|t|t|t|t
1504073|NCT00928993|||Cohort||Prospective|||||||
1504074|NCT00928980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504075|NCT00928967|||Cohort||Prospective|||||||
1504076|NCT00928954|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1504077|NCT00928941|Randomized|Parallel Assignment||Treatment||Single||||||t
1504078|NCT00928928|Randomized|Parallel Assignment||||Double|||t|||t
1504079|NCT00928915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504080|NCT00928902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504081|NCT00928889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504082|NCT00928876|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504083|NCT00928863|||Case-Only||Prospective|||||||
1504084|NCT00928850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504085|NCT00928837|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504086|NCT00928824|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504087|NCT00928811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504088|NCT00928798|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1504089|NCT00928785|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504090|NCT00928772|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1504091|NCT00928759|||Case-Only||Prospective|||||||
1504092|NCT00928746||||Treatment||||||||
1504093|NCT00928733|Randomized|Crossover Assignment||||Single|||||t|
1504094|NCT00928720|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1504095|NCT00928707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504096|NCT00928694|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504097|NCT00928681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504098|NCT00928668|Randomized|Crossover Assignment||Treatment||Double||||||
1504099|NCT00928655|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504100|NCT00928642|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504101|NCT00928629||Single Group Assignment||Screening||None (Open Label)||||||
1504102|NCT00928616|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504103|NCT00928603||Single Group Assignment||Treatment||None (Open Label)||||||
1504104|NCT00928590||Single Group Assignment||Treatment||None (Open Label)||||||
1504105|NCT00928577|||Cohort||Prospective|||||||
1504106|NCT00928564|Randomized|Crossover Assignment||Health Services Research||Double|||t|||t
1504107|NCT00928551|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504108|NCT00928538|Randomized|Parallel Assignment||Prevention||Single||||||t
1504109|NCT00928525||Single Group Assignment||Treatment||None (Open Label)||||||
1504110|NCT00928512|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504111|NCT00928499|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504112|NCT00928486||Single Group Assignment||Treatment||None (Open Label)||||||
1504113|NCT00928473||Single Group Assignment||Health Services Research||None (Open Label)||||||
1504114|NCT00928460|||||Prospective|||||||
1504115|NCT00928447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504116|NCT00928434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504117|NCT00928421||Single Group Assignment||Treatment||None (Open Label)||||||
1504118|NCT00928408|||Other||Prospective|||||||
1504119|NCT00928395||Single Group Assignment||Treatment||None (Open Label)||||||
1504120|NCT00928382|||||Prospective|||||||
1504121|NCT00928369|||Case-Only||Retrospective|||||||
1504122|NCT00928356|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504123|NCT00928343|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1504124|NCT00928330|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504125|NCT00928317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504126|NCT00928304||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504127|NCT00928291|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1504128|NCT00928278|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504129|NCT00928265|||Case-Only||Prospective|||||||
1504130|NCT00928252||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504131|NCT00928239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504132|NCT00928226|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504133|NCT00928213|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1504134|NCT00928200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504135|NCT00928187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504136|NCT00928174||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504137|NCT00928161|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504138|NCT00928148|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1504139|NCT00928135|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1504140|NCT00928122||Single Group Assignment||Treatment||None (Open Label)||||||
1504141|NCT00928109|Randomized|Parallel Assignment||Treatment||Single||||||t
1504142|NCT00928096|||Cohort||Prospective|||||||
1504143|NCT00928083|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504144|NCT00928070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504145|NCT00928057|Randomized|Crossover Assignment||||None (Open Label)||||||
1504146|NCT00928044|||Case Control||Prospective|||||||
1504147|NCT00928031|||Cohort||Retrospective|||||||
1504148|NCT00928018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504149|NCT00928005|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504150|NCT00927992|||Cohort||Cross-Sectional|||||||
1504151|NCT00927979|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504152|NCT00927966||Single Group Assignment||Treatment||None (Open Label)||||||
1504153|NCT00927953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504154|NCT00927940||Single Group Assignment||Treatment||None (Open Label)||||||
1504155|NCT00927927|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1504156|NCT00927914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504157|NCT00927901|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504158|NCT00927888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504159|NCT00927875||Single Group Assignment||Treatment||None (Open Label)||||||
1504160|NCT00927862|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504161|NCT00927849|Randomized|Single Group Assignment||Treatment||Single|||t|||
1504162|NCT00927836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504163|NCT00927823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504164|NCT00927810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504165|NCT00927797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504166|NCT00927784|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504167|NCT00927771|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1504168|NCT00927758|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504169|NCT00927745|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1504170|NCT00927732|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504171|NCT00927719|||Cohort||Retrospective|||||||
1504172|NCT00927706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504173|NCT00927693|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504174|NCT00927680|||Family-Based||Prospective|||||||
1504175|NCT00927667|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1504176|NCT00927654|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504177|NCT00927641|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504178|NCT00927628|||Cohort||Retrospective|||||||
1504179|NCT00927615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504180|NCT00927602||Single Group Assignment||Prevention||None (Open Label)||||||
1504181|NCT00927589||Single Group Assignment||Treatment||None (Open Label)||||||
1504182|NCT00927576|||Ecologic or Community||Cross-Sectional|||||||
1504183|NCT00927563||Single Group Assignment||Treatment||None (Open Label)||||||
1504184|NCT00927550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504185|NCT00927537|||Cohort||Prospective|||||||
1504186|NCT00927524|Randomized|Crossover Assignment||Treatment||Single|||t|||
1504187|NCT00927511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504188|NCT00927498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504189|NCT00927485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504190|NCT00927472|Randomized|Parallel Assignment||Treatment||Single||||||t
1504191|NCT00927459|Randomized|Single Group Assignment||Treatment||Single|||t|||
1504192|NCT00927446|||Cohort||Cross-Sectional|||||||
1504193|NCT00927433|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1504194|NCT00927420|||||Cross-Sectional|||||||
1504195|NCT00927407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504196|NCT00927394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504197|NCT00927381|||Cohort||Retrospective|||||||
1504582|NCT00922168|||Cohort||Prospective|||||||
1504198|NCT00927368|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1504199|NCT00927355|Randomized|Parallel Assignment||||Double|||t|||t
1504200|NCT00927342|Randomized|Parallel Assignment||Prevention||Single|||t|||
1504201|NCT00927329||Single Group Assignment||Other||None (Open Label)||||||
1504202|NCT00927316|Randomized|Crossover Assignment||Prevention||Double|||t|t||
1504203|NCT00927303|||Cohort||Prospective|||||||
1504204|NCT00927290|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504205|NCT00927277|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504206|NCT00927264|Randomized|Factorial Assignment||Prevention||Single|For masking we were unable to mask the caregiver and child participant since they knew if they were receiving intervention component. The investigator was masked, but outcome assessor may have known group assignment.||||t|
1504207|NCT00927251|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504208|NCT00927238|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504209|NCT00927225|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504210|NCT00927212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504211|NCT00927199|Randomized|Crossover Assignment||Prevention||Single|||t|||
1504212|NCT00927186|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504213|NCT00927173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504214|NCT00927160|||Cohort||Prospective|||||||
1504215|NCT00927147||Single Group Assignment||Treatment||None (Open Label)||||||
1504216|NCT00927134|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504217|NCT00927121|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504218|NCT00927108||Single Group Assignment||Basic Science||None (Open Label)||||||
1504219|NCT00927095|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504220|NCT00927082|Randomized|Parallel Assignment||||None (Open Label)||||||
1504221|NCT00927069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504222|NCT00927056|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504223|NCT00927043|||Cohort||Prospective|||||||
1504224|NCT00927030|Randomized|Single Group Assignment||Treatment||Single||||t||
1504225|NCT00927017|Randomized|Parallel Assignment||||None (Open Label)||||||
1504226|NCT00927004|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504227|NCT00926991|||Cohort||Prospective|||||||
1504228|NCT00926978||Single Group Assignment||Other||None (Open Label)||||||
1504229|NCT00926965|Randomized|Parallel Assignment||Treatment||Single|||||t|
1504230|NCT00926952||Single Group Assignment||Treatment||None (Open Label)||||||
1504231|NCT00926939|Randomized|Parallel Assignment||Treatment||Single||||t||
1504232|NCT00926926|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1504233|NCT00926913|||Cohort||Cross-Sectional|||||||
1504234|NCT00926900|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1504235|NCT00926887|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504236|NCT00926874|||Cohort||Prospective|||||||
1504237|NCT00926861|||Cohort||Prospective|||||||
1504238|NCT00926848|Randomized|Parallel Assignment||Treatment||Single|The research personnel who were collecting outcomes data were unaware of the subjects' group assignment.|Patients and partners in the PaTH intervention group formally joined and participated in the full cardiac rehabilitation (CR) program consisting of 18-36 exercise and 18 educational sessions. In the usual care group, only patients received the exercise and educational sessions; partners received the educational sessions only.||||t
1504239|NCT00926835|Randomized|Parallel Assignment||Treatment||Single||||||t
1504240|NCT00926809|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504241|NCT00926796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504242|NCT00926783|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504243|NCT00926770|||Case Control||Prospective|||||||
1504244|NCT00926757|Randomized|Parallel Assignment||Prevention||Single||||||t
1504245|NCT00926744|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1504246|NCT00926731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504247|NCT00926718|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1504248|NCT00926705|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1504249|NCT00926692|||Case-Only||Prospective|||||||
1504250|NCT00926666|Non-Randomized|Single Group Assignment||||Triple|||t|t|t|
1504251|NCT00926653|||Cohort||Prospective|||||||
1504252|NCT00926640|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504253|NCT00926627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504254|NCT00926614||Single Group Assignment||Treatment||None (Open Label)||||||
1504255|NCT00926601|||Cohort||Prospective|||||||
1504256|NCT00926588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504257|NCT00926575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504258|NCT00926562|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1504259|NCT00926549||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504260|NCT00926536|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1504261|NCT00926523|||Case Control||Prospective|||||||
1504262|NCT00926510|Randomized|Parallel Assignment||Treatment||Single|||||t|
1504263|NCT00926497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504264|NCT00926484|||Case-Only||Retrospective|||||||
1504265|NCT00926471|Randomized|Parallel Assignment||Treatment||Single||||||t
1504266|NCT00926458|||Cohort||Prospective|||||||
1504267|NCT00926445|||Cohort||Prospective|||||||
1504268|NCT00926432|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1504269|NCT00926419|Randomized|Parallel Assignment||Prevention||Single||||||t
1506447|NCT00897299||||||||||||
1504270|NCT00926406|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504271|NCT00926393|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1504272|NCT00926380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504273|NCT00926367|Randomized|Parallel Assignment||Treatment||Single||||||t
1504274|NCT00926354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504275|NCT00926341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504276|NCT00926328|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504277|NCT00926315||Single Group Assignment||||None (Open Label)||||||
1504278|NCT00926302|Randomized|Crossover Assignment||||None (Open Label)||||||
1504279|NCT00926289|Randomized|Parallel Assignment||Treatment||Double||||||
1504280|NCT00926276|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504281|NCT00926263|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1504282|NCT00926250|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1504283|NCT00926237|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1504284|NCT00926224||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504285|NCT00926211|Randomized|Parallel Assignment||Treatment||Single||||||t
1504286|NCT00926198|||Cohort||Cross-Sectional|||||||
1504287|NCT00926185|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504288|NCT00926172|||Ecologic or Community||Prospective|||||||
1504289|NCT00926159|||Case-Only|||||||||
1504290|NCT00926146|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504291|NCT00926133|||Cohort||Prospective|||||||
1504292|NCT00926120||Single Group Assignment||Treatment||None (Open Label)||||||
1504293|NCT00926107||Single Group Assignment||Treatment||None (Open Label)||||||
1504294|NCT00926094|||Case-Crossover||Cross-Sectional|||||||
1504295|NCT00926081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504296|NCT00926068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504297|NCT00926055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504298|NCT00926042|||Cohort||Prospective|||||||
1504299|NCT00926029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504300|NCT00926016|Randomized|Parallel Assignment||||None (Open Label)||||||
1504301|NCT00926003|Randomized|Factorial Assignment||Treatment||Single|||t|||
1504302|NCT00925990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504303|NCT00925977|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504304|NCT00925964|||||Prospective|||||||
1504305|NCT00925951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504306|NCT00925938|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504307|NCT00925925|||Case Control||Prospective|||||||
1504308|NCT00925912|Randomized|Parallel Assignment||Treatment||Single||||||t
1504309|NCT00925899|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504310|NCT00925886||Single Group Assignment||Treatment||None (Open Label)||||||
1504311|NCT00925873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504312|NCT00925860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504313|NCT00925847|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504314|NCT00925834|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1504315|NCT00925821|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504316|NCT00925808|||Case-Only||Prospective|||||||
1504317|NCT00925795|Randomized|Crossover Assignment||Prevention||Single|||t|||
1504318|NCT00925782|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504319|NCT00925769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504320|NCT00925756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504321|NCT00925743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504322|NCT00925730||Single Group Assignment||Treatment||None (Open Label)||||||
1504323|NCT00925717|||Cohort||Retrospective|||||||
1504324|NCT00925704|Randomized|Crossover Assignment||||None (Open Label)||||||
1504325|NCT00925691|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504326|NCT00925678|Randomized|||||Double||||||
1504327|NCT00925665|||Cohort||Prospective|||||||
1504328|NCT00925652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504329|NCT00925639|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504330|NCT00925626|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504331|NCT00925613|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1504332|NCT00925600|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1504333|NCT00925587|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504334|NCT00925574|Randomized|Single Group Assignment||Treatment||Double||||||
1504335|NCT00925561|||Cohort||Cross-Sectional|||||||
1504336|NCT00925548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504337|NCT00925535|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504338|NCT00925522||Single Group Assignment||Treatment||None (Open Label)||||||
1504339|NCT00925509||Single Group Assignment||Supportive Care||None (Open Label)||||||
1504340|NCT00925496|||Cohort||Prospective|||||||
1504341|NCT00925483|Randomized|Parallel Assignment||Treatment||Single||||||t
1504342|NCT00925470|||Cohort||Cross-Sectional|||||||
1504343|NCT00925457|||Case Control||Retrospective|||||||
1504344|NCT00925444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504345|NCT00925431|Randomized|Parallel Assignment||Treatment||Single||||||t
1504346|NCT00925418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504347|NCT00925405|||Case-Only||Prospective|||||||
1504348|NCT00925392|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1504349|NCT00925379|||Cohort|||||||||
1504350|NCT00925366|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1504351|NCT00925353||Single Group Assignment||Treatment||None (Open Label)||||||
1504352|NCT00925340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504353|NCT00925327||Single Group Assignment||Treatment||None (Open Label)||||||
1504354|NCT00925314||Single Group Assignment||Treatment||None (Open Label)||||||
1504355|NCT00925301|Randomized|Parallel Assignment||Treatment||Double|Sponsor and Assessor were also blinded||t||t|
1504356|NCT00925288|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504357|NCT00925275|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1504358|NCT00925262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504359|NCT00925249|||||Prospective|||||||
1504360|NCT00925236|||Cohort|||||||||
1504361|NCT00925223|||Case Control|||||||||
1504362|NCT00925210|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1504363|NCT00925197|Randomized|||||None (Open Label)||||||
1504364|NCT00925184|||Ecologic or Community||Prospective|||||||
1504365|NCT00925171|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1504366|NCT00925158|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1504367|NCT00925145|||Cohort||Prospective|||||||
1504368|NCT00925132||Single Group Assignment||Treatment||None (Open Label)||||||
1504369|NCT00925119||Single Group Assignment||Treatment||None (Open Label)||||||
1504370|NCT00925106|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504371|NCT00925093|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504372|NCT00925080|||Cohort||Prospective|||||||
1504373|NCT00925067|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1504374|NCT00925054||Single Group Assignment||Treatment||None (Open Label)||||||
1504375|NCT00925041||||||||||||
1504376|NCT00925028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504377|NCT00925015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504378|NCT00925002||Single Group Assignment||Treatment||None (Open Label)||||||
1504379|NCT00924989|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504380|NCT00924976|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1504381|NCT00924963|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1504382|NCT00924950|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504383|NCT00924937|Randomized|Parallel Assignment||Prevention||Single|||||t|
1504384|NCT00924924|Randomized|Factorial Assignment||Prevention||Single||||||t
1504385|NCT00924911|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504386|NCT00924898||Single Group Assignment||Treatment||None (Open Label)||||||
1504387|NCT00924885|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1504388|NCT00924872|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1504389|NCT00924859|||Case-Only||Prospective|||||||
1504390|NCT00924846|Randomized|Crossover Assignment||Treatment||Single|||t|||
1504391|NCT00924833|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504392|NCT00924820||Single Group Assignment||Treatment||None (Open Label)||||||
1504393|NCT00924807||Single Group Assignment||Treatment||None (Open Label)||||||
1504394|NCT00924794|||Case-Only||Retrospective|||||||
1504395|NCT00924781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504396|NCT00924768||Single Group Assignment||Basic Science||None (Open Label)||||||
1504397|NCT00924755||Single Group Assignment||Treatment||None (Open Label)||||||
1504398|NCT00924742|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1504399|NCT00924729|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1504400|NCT00924716||||||||||||
1504401|NCT00924703||Single Group Assignment||Treatment||None (Open Label)||||||
1504402|NCT00924690|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1504403|NCT00924677|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504404|NCT00924664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504405|NCT00924651|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1504406|NCT00924638|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1504407|NCT00924625|Randomized|Parallel Assignment||Treatment||Single||||||t
1504408|NCT00924612|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504409|NCT00924599|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504410|NCT00924586|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1504411|NCT00924573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504412|NCT00924560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504413|NCT00924547|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504414|NCT00924534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504415|NCT00924521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504416|NCT00924508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504417|NCT00924495|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1504418|NCT00924482|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1504419|NCT00924469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504420|NCT00924456|Randomized|Crossover Assignment||Prevention||Single|||||t|
1504421|NCT00924443||Single Group Assignment||Treatment||None (Open Label)||||||
1504422|NCT00924430|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504423|NCT00924417|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1504424|NCT00924404|Randomized|Parallel Assignment||Treatment||Single||||||t
1504425|NCT00924391|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504426|NCT00924365||||||||||||
1504427|NCT00924352||Single Group Assignment||Treatment||None (Open Label)||||||
1504428|NCT00924339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504429|NCT00924326|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1504430|NCT00924313||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504431|NCT00924300|||Case-Control||Other|||||||
1504432|NCT00924287||Single Group Assignment||Treatment||None (Open Label)||||||
1504433|NCT00924274|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504434|NCT00924261|Randomized|Parallel Assignment||||Single||||||t
1504435|NCT00924248|||Cohort||Prospective|||||||
1504436|NCT00924222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504437|NCT00924209||Single Group Assignment||Treatment||None (Open Label)||||||
1504438|NCT00924196|||Cohort||Prospective|||||||
1504439|NCT00924183|||Case-Only||Prospective|||||||
1504440|NCT00924170||Single Group Assignment||Treatment||None (Open Label)||||||
1504441|NCT00924157|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1504442|NCT00924131|||||Other|||||||
1504443|NCT00924118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504444|NCT00924105|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504445|NCT00924092|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504446|NCT00924079|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1504447|NCT00924066||Single Group Assignment||Treatment||None (Open Label)||||||
1504448|NCT00924053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504449|NCT00924040||Single Group Assignment||Treatment||None (Open Label)||||||
1504450|NCT00924027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504451|NCT00924014|Randomized|Crossover Assignment||||None (Open Label)||||||
1504452|NCT00924001||Single Group Assignment||Treatment||None (Open Label)||||||
1504453|NCT00923988||Single Group Assignment||Prevention||None (Open Label)||||||
1504454|NCT00923975||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504455|NCT00923962|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1504456|NCT00923949|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504457|NCT00923936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504458|NCT00923923|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1504459|NCT00923910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504460|NCT00923897||Single Group Assignment||Supportive Care||None (Open Label)||||||
1504461|NCT00923884|||Cohort||Prospective|||||||
1504462|NCT00923871||Single Group Assignment||Treatment||None (Open Label)||||||
1504463|NCT00923858|||Case-Control||Prospective|||||||
1504464|NCT00923845|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504465|NCT00923832|||||Prospective|||||||
1504466|NCT00923819|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504467|NCT00923806||Single Group Assignment||Treatment||None (Open Label)||||||
1504468|NCT00923793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504469|NCT00923780|||||Prospective|||||||
1504470|NCT00923741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504471|NCT00923728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504472|NCT00923702|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504473|NCT00923676|Randomized|Parallel Assignment||Treatment||Single||||||t
1504474|NCT00923663||Single Group Assignment||Treatment||None (Open Label)||||||
1504475|NCT00923650|||||Prospective|||||||
1504476|NCT00923637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504477|NCT00923624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504478|NCT00923611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504479|NCT00923598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504480|NCT00923572|||Cohort||Prospective|||||||
1504481|NCT00923559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504482|NCT00923533|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1504483|NCT00923520||Single Group Assignment||Treatment||None (Open Label)||||||
1504484|NCT00923507|||Case-Only||Other|||||||
1504485|NCT00923494|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504486|NCT00923481||Single Group Assignment||Treatment||None (Open Label)||||||
1504487|NCT00923468|||||Prospective|||||||
1504488|NCT00923442|||Cohort||Prospective|||||||
1504489|NCT00923429|Randomized|Parallel Assignment||Treatment||Single||||||t
1504490|NCT00923416|||Cohort||Prospective|||||||
1504491|NCT00923403|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504492|NCT00923390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504493|NCT00923377|||||Prospective|||||||
1504494|NCT00923364||Single Group Assignment||Treatment||None (Open Label)||||||
1504495|NCT00923351|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504496|NCT00923338||Single Group Assignment||Treatment||None (Open Label)||||||
1504497|NCT00923325|||Case-Only||Prospective|||||||
1504498|NCT00923312||Single Group Assignment||Treatment||None (Open Label)||||||
1504499|NCT00923299|Non-Randomized|||Treatment||None (Open Label)||||||
1504500|NCT00923273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504501|NCT00923260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504502|NCT00923247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504503|NCT00923234||Single Group Assignment||Treatment||None (Open Label)||||||
1504504|NCT00923221|||Case-Only||Cross-Sectional|||||||
1504505|NCT00923195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504506|NCT00923182||Single Group Assignment||Treatment||None (Open Label)||||||
1504507|NCT00923169||||Treatment||||||||
1504508|NCT00923156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504509|NCT00923130||Single Group Assignment||Treatment||None (Open Label)||||||
1504510|NCT00923117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504511|NCT00923104|||Cohort||Prospective|||||||
1504512|NCT00923091|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504513|NCT00923078|Randomized|Crossover Assignment||Treatment||Single||||||t
1504514|NCT00923065|||Cohort||Prospective|||||||
1504515|NCT00923052|||Case-Control||Prospective|||||||
1504516|NCT00923039|||Cohort||Retrospective|||||||
1504517|NCT00923026|||Cohort||Prospective|||||||
1504518|NCT00923013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504519|NCT00923000|Randomized|Crossover Assignment||||None (Open Label)||||||
1504520|NCT00922987|||Cohort||Prospective|||||||
1504521|NCT00922974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504522|NCT00922961||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504523|NCT00922948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504524|NCT00922935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504525|NCT00922922|||Case-Only||Cross-Sectional|||||||
1504526|NCT00922909|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504527|NCT00922896||Single Group Assignment||Treatment||None (Open Label)||||||
1504528|NCT00922883||Single Group Assignment||Treatment||None (Open Label)||||||
1504529|NCT00922870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504530|NCT00922857||Parallel Assignment||Basic Science||None (Open Label)||||||
1504531|NCT00922844|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1504532|NCT00922831|||Cohort||Prospective|||||||
1504533|NCT00922818|||Cohort||Prospective|||||||
1504534|NCT00922805|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1504535|NCT00922792|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504536|NCT00922779||Single Group Assignment||Treatment||None (Open Label)||||||
1504537|NCT00922766|||Case-Only||Prospective|||||||
1504538|NCT00922753|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1504539|NCT00922740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504540|NCT00922727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504541|NCT00922714|Randomized|Single Group Assignment||Treatment||Double||||||
1504542|NCT00922701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504543|NCT00922688|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1504544|NCT00922675|Randomized|Parallel Assignment||Treatment||Single||||||t
1504545|NCT00922662|||Cohort|||||||||
1504546|NCT00922649|Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1504547|NCT00922636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504548|NCT00922623|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504549|NCT00922610|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504550|NCT00922597|||Cohort||Prospective|||||||
1504551|NCT00922584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504552|NCT00922571||Single Group Assignment||||None (Open Label)||||||
1504553|NCT00922558|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1504554|NCT00922545|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504555|NCT00922532|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1504556|NCT00922519|||Cohort||Prospective|||||||
1504557|NCT00922506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504558|NCT00922493|Randomized|Parallel Assignment||||||||||
1504559|NCT00922480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504560|NCT00922467|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504561|NCT00922454||Crossover Assignment||||None (Open Label)||||||
1504562|NCT00922441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504563|NCT00922428|||Cohort||Prospective|||||||
1504564|NCT00922415|||Case-Only||Prospective|||||||
1504565|NCT00922402|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504566|NCT00922389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504567|NCT00922376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504568|NCT00922363|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504569|NCT00922350|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1504570|NCT00922337|||Case-Only||Prospective|||||||
1504571|NCT00922324|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1504572|NCT00922311||Single Group Assignment||Treatment||None (Open Label)||||||
1504573|NCT00922285||Single Group Assignment||Supportive Care||None (Open Label)||||||
1504574|NCT00922272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504575|NCT00922259||Single Group Assignment||Prevention||None (Open Label)||||||
1504576|NCT00922246|Randomized|Parallel Assignment||Prevention||||||||
1504577|NCT00922233||Single Group Assignment||Prevention||None (Open Label)||||||
1504578|NCT00922220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504579|NCT00922207|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504580|NCT00922194|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504581|NCT00922181|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504583|NCT00922155|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1504584|NCT00922142|||Case Control||Prospective|||||||
1504585|NCT00922129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504586|NCT00922116||Single Group Assignment||Treatment||None (Open Label)||||||
1504587|NCT00922103|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504588|NCT00922090|||Case-Only||Prospective|||||||
1504589|NCT00922077||Single Group Assignment||Treatment||||||||
1504590|NCT00922064||Single Group Assignment||Basic Science||None (Open Label)||||||
1504591|NCT00922051|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1504592|NCT00922038|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504593|NCT00922025|||||Prospective|||||||
1504594|NCT00922012||Single Group Assignment||Treatment||None (Open Label)||||||
1504595|NCT00921999|||||Prospective|||||||
1504596|NCT00921986|||Case-Control||Prospective|||||||
1504597|NCT00921973|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1504598|NCT00921960|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504599|NCT00921947|Randomized|Parallel Assignment||Prevention||Single||||||t
1504600|NCT00921934|||Cohort||Prospective|||||||
1504601|NCT00921921|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1504602|NCT00921908|||Case-Only||Prospective|||||||
1504603|NCT00921895||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504604|NCT00921882|||Cohort||Prospective|||||||
1504605|NCT00921869|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504606|NCT00921856|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1504607|NCT00921843||Single Group Assignment||Treatment||None (Open Label)||||||
1504608|NCT00921830|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504609|NCT00921817|||Ecologic or Community||Prospective|||||||
1504610|NCT00921804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504611|NCT00921791|Randomized|Factorial Assignment||Treatment||Single||||||t
1504612|NCT00921778|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504613|NCT00921765|Randomized|Parallel Assignment||Basic Science||Quadruple|Double blind (one making drug solutions) another administrating the drugs|Parallell Group design should be used when final dose had been found|t|t|t|t
1504614|NCT00921752|||Cohort||Prospective|||||||
1504615|NCT00921739||Single Group Assignment||Treatment||None (Open Label)||||||
1504616|NCT00921726|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504617|NCT00921713|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1504618|NCT00921700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504619|NCT00921687|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1504620|NCT00921674|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504621|NCT00921661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504622|NCT00921648|||Case-Only||Retrospective|||||||
1504623|NCT00921635|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1504624|NCT00921622|Randomized|Parallel Assignment||Treatment||Double||vitamin C compared with vitamin D in prospective clinical trial|t||t|
1504625|NCT00921609|||Case-Only||Prospective|||||||
1504626|NCT00921596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504627|NCT00921583|||Cohort||Retrospective|||||||
1504628|NCT00921570|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504629|NCT00921557|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1504630|NCT00921544|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1504631|NCT00921531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504632|NCT00921518|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1504633|NCT00921505|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504634|NCT00921492|Randomized|Parallel Assignment||Treatment||Single||||||t
1504635|NCT00921479|||Cohort||Prospective|||||||
1504636|NCT00921466|||||Prospective|||||||
1504637|NCT00921453|||Case Control||Cross-Sectional|||||||
1504638|NCT00921440|||Cohort||Prospective|||||||
1504639|NCT00921427|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1504640|NCT00921414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504641|NCT00921401|Randomized|Parallel Assignment||||Double|||t||t|
1504642|NCT00921388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504643|NCT00921375||Single Group Assignment||Prevention||None (Open Label)||||||
1504644|NCT00921362|||Cohort||Prospective|||||||
1504645|NCT00921349|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504646|NCT00921336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504647|NCT00921323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504648|NCT00921310|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504649|NCT00921297|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1504650|NCT00921284|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504651|NCT00921271|||Cohort||Prospective|||||||
1504652|NCT00921258|||Cohort||Prospective|||||||
1504653|NCT00921245|||Cohort||Prospective|||||||
1504654|NCT00921232||Single Group Assignment||||None (Open Label)||||||
1504655|NCT00921219|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504656|NCT00921206|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504657|NCT00921193||Single Group Assignment||Supportive Care||None (Open Label)||||||
1504658|NCT00921180|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504659|NCT00921167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504660|NCT00921154|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504661|NCT00921141|||Case-Only||Prospective|||||||
1504662|NCT00921128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504663|NCT00921115||Single Group Assignment||Treatment||None (Open Label)||||||
1504664|NCT00921102|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504665|NCT00921089|||||Cross-Sectional|||||||
1504666|NCT00921076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504667|NCT00921063|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504668|NCT00921050|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1504669|NCT00921037||Single Group Assignment||Treatment||None (Open Label)||||||
1504670|NCT00921024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504671|NCT00921011|||Cohort||Prospective|||||||
1504672|NCT00920998|Randomized|Crossover Assignment||||None (Open Label)||||||
1504673|NCT00920985|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1504674|NCT00920972|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504675|NCT00920959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504676|NCT00920946|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504677|NCT00920933|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1504678|NCT00920920|||Cohort||Prospective|||||||
1504679|NCT00920907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504680|NCT00920894|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504681|NCT00920881|||Cohort||Prospective|||||||
1504682|NCT00920868||Single Group Assignment||Treatment||None (Open Label)||||||
1504683|NCT00920855|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504684|NCT00920842|||Case Control||Cross-Sectional|||||||
1504685|NCT00920829|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1504686|NCT00920816|Randomized|||Treatment||None (Open Label)||||||
1504687|NCT00920803|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1504688|NCT00920790||Single Group Assignment||Treatment||None (Open Label)||||||
1504689|NCT00920777|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1504690|NCT00920764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504691|NCT00920751|Non-Randomized|Single Group Assignment||Screening||Single|||t|||
1504692|NCT00920738|||Cohort||Prospective|||||||
1504693|NCT00920725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504694|NCT00920712|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1504695|NCT00920699|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504696|NCT00920686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504697|NCT00920673||Single Group Assignment||Basic Science||None (Open Label)||||||
1504698|NCT00920660|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1504699|NCT00920647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504700|NCT00920634|||||Prospective|||||||
1504701|NCT00920621|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1504702|NCT00920608|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1504703|NCT00920595||Single Group Assignment||Treatment||None (Open Label)||||||
1504704|NCT00920582|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504705|NCT00920569|||||Prospective|||||||
1504706|NCT00920556||Single Group Assignment||Treatment||None (Open Label)||||||
1504707|NCT00920543|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504708|NCT00920530|||Cohort||Prospective|||||||
1504709|NCT00920517|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1504710|NCT00920504|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1504711|NCT00920491|||Cohort||Cross-Sectional|||||||
1504712|NCT00920478|Randomized|Parallel Assignment||Treatment||Single||||||t
1504713|NCT00920465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504714|NCT00920452|||||Prospective|||||||
1504715|NCT00920439||Single Group Assignment||Prevention||None (Open Label)||||||
1504716|NCT00920426|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504717|NCT00920413|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504718|NCT00920400|||||Prospective|||||||
1504719|NCT00920387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504720|NCT00920374|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504721|NCT00920361|||||Prospective|||||||
1504722|NCT00920348|||Cohort||Prospective|||||||
1504723|NCT00920335||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504724|NCT00920322|Randomized|Parallel Assignment||Treatment||Single||||||t
1504725|NCT00920309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504726|NCT00920296||Single Group Assignment||Basic Science||None (Open Label)||||||
1504727|NCT00920283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504728|NCT00920270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504729|NCT00920257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504730|NCT00920244|||Cohort||Prospective|||||||
1504731|NCT00920231|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1504732|NCT00920218|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1504733|NCT00920205||Single Group Assignment||||None (Open Label)||||||
1504734|NCT00920192|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504735|NCT00920179|||Case Control||Prospective|||||||
1504736|NCT00920166|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1504737|NCT00920153|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504738|NCT00920140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504739|NCT00920127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504740|NCT00920114|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1504741|NCT00920101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504742|NCT00920088|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1504743|NCT00920075|||Other||Other|||||||
1504744|NCT00920062|||||Prospective|||||||
1504745|NCT00920049|Randomized|Parallel Assignment||Prevention||Single||||||
1504746|NCT00920036|Randomized|Parallel Assignment||Treatment||Single||||||t
1504747|NCT00920023||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504748|NCT00920010|||Cohort||Prospective|||||||
1504749|NCT00919997|||Case-Only||Prospective|||||||
1504750|NCT00919984||Single Group Assignment||Treatment||None (Open Label)||||||
1504751|NCT00919971|||Cohort||Retrospective|||||||
1504752|NCT00919958|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1504753|NCT00919945|Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1504754|NCT00919932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504755|NCT00919919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504756|NCT00919906|Randomized|Parallel Assignment||Treatment||Single||||||t
1504757|NCT00919893|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1504758|NCT00919880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504759|NCT00919867|Randomized|Crossover Assignment||||None (Open Label)||||||
1504760|NCT00919854||Single Group Assignment||Treatment||None (Open Label)||||||
1504761|NCT00919841|||Cohort||Prospective|||||||
1504762|NCT00919828|||Case-Only||Prospective|||||||
1504763|NCT00919815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504764|NCT00919802|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1504765|NCT00919776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504766|NCT00919763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504767|NCT00919750||||||||||||
1504768|NCT00919737|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504769|NCT00919724|||Case Control||Prospective|||||||
1504770|NCT00919711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504771|NCT00919698|||Cohort||Prospective|||||||
1504772|NCT00919685||Single Group Assignment||Prevention||None (Open Label)||||||
1504773|NCT00919672|Randomized|Crossover Assignment||Treatment||Triple||||t|t|t
1504774|NCT00919659|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1504775|NCT00919646|||Case-Only||Prospective|||||||
1504776|NCT00919633|Randomized|Parallel Assignment||Treatment||Single|||||t|
1504777|NCT00919620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504778|NCT00919607|Randomized|Single Group Assignment||||None (Open Label)||||||
1504779|NCT00919594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504780|NCT00919581|||Cohort||Prospective|||||||
1504781|NCT00919568|||Case Control||Prospective|||||||
1504782|NCT00919555|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504783|NCT00919542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504784|NCT00919516||Single Group Assignment||Treatment||None (Open Label)||||||
1504785|NCT00919503|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504786|NCT00919490|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1504787|NCT00919477|||Cohort||Prospective|||||||
1504788|NCT00919464||Single Group Assignment||Basic Science||None (Open Label)||||||
1504789|NCT00919451||Single Group Assignment||Treatment||None (Open Label)||||||
1504790|NCT00919438|||Case-Only||Prospective|||||||
1504791|NCT00919425||||||||||||
1504792|NCT00919412|||Cohort||Prospective|||||||
1504793|NCT00919399||Single Group Assignment||Treatment||None (Open Label)||||||
1504794|NCT00919386|||Case-Only||Prospective|||||||
1504795|NCT00919373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504796|NCT00919360|||Case Control||Prospective|||||||
1504797|NCT00919347|||Case Control||Prospective|||||||
1504798|NCT00919334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504799|NCT00919321|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1504800|NCT00919308|||Case Control||Prospective|||||||
1504801|NCT00919295|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1504802|NCT00919282|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504803|NCT00919269||||||||||||
1504804|NCT00919243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504805|NCT00919230|Randomized|Single Group Assignment||Treatment||Single||||||t
1504806|NCT00919217|||Other||Prospective|||||||
1504807|NCT00919204|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1504808|NCT00919191|Randomized|Single Group Assignment||Treatment||Single|||||t|
1504809|NCT00919178|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1504810|NCT00919165|||Case Control||Prospective|||||||
1504811|NCT00919152|||Case-Only||Retrospective|||||||
1504812|NCT00919139||||||||||||
1504813|NCT00919126|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504814|NCT00919113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504815|NCT00919100|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1504816|NCT00919087|||Case-Only||Prospective|||||||
1504817|NCT00919074|Randomized|Single Group Assignment||Treatment||Single|||t|||
1504818|NCT00919061||Single Group Assignment||Treatment||None (Open Label)||||||
1504819|NCT00919048|||Cohort||Retrospective|||||||
1504820|NCT00919035||Single Group Assignment||Treatment||None (Open Label)||||||
1504821|NCT00919022|||Cohort||Prospective|||||||
1504822|NCT00919009|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1504823|NCT00918996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504824|NCT00918983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504825|NCT00918970|||Case-Only||Prospective|||||||
1504826|NCT00918957|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504827|NCT00918944|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1504828|NCT00918931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504829|NCT00918918|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504830|NCT00918905|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504831|NCT00918892|||Other||Retrospective|||||||
1504832|NCT00918879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504833|NCT00918866|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1504834|NCT00918853||Single Group Assignment||Treatment||None (Open Label)||||||
1504835|NCT00918840|||Cohort||Prospective|||||||
1504836|NCT00918827|||Cohort||Prospective|||||||
1504837|NCT00918814|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504838|NCT00918801|||Case Control||Prospective|||||||
1504839|NCT00918788|||Case-Only||Cross-Sectional|||||||
1504840|NCT00918775|||Case-Only||Prospective|||||||
1504841|NCT00918762||Single Group Assignment||Treatment||None (Open Label)||||||
1504842|NCT00918749|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504843|NCT00918736||Single Group Assignment||Treatment||Single||||||t
1504844|NCT00918723||Single Group Assignment||Treatment||None (Open Label)||||||
1504845|NCT00918710|||Cohort||Prospective|||||||
1504846|NCT00918697|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1504847|NCT00918684||Single Group Assignment||Treatment||None (Open Label)||||||
1504848|NCT00918671|||Cohort||Prospective|||||||
1504849|NCT00918658|||Case Control||Prospective|||||||
1504850|NCT00918645||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504851|NCT00918632|Randomized|Crossover Assignment||||None (Open Label)||||||
1504852|NCT00918619|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504853|NCT00918606||Single Group Assignment||Treatment||None (Open Label)||||||
1504854|NCT00918593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504855|NCT00918580|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1504856|NCT00918567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504857|NCT00918554|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504858|NCT00918541|||Cohort||Prospective|||||||
1504859|NCT00918528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504860|NCT00918515|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504861|NCT00918502|||Case-Only||Prospective|||||||
1504862|NCT00918489||Single Group Assignment||Treatment||None (Open Label)||||||
1504863|NCT00918476||Crossover Assignment||||None (Open Label)||||||
1504864|NCT00918463||Single Group Assignment||Treatment||None (Open Label)||||||
1504865|NCT00918450|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504866|NCT00918437|||Cohort||Prospective|||||||
1504867|NCT00918424||||||||||||
1504868|NCT00918411|Randomized|Parallel Assignment||||Single|||t|||
1504869|NCT00918398|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1504870|NCT00918385|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504871|NCT00918372|||Case Control||Cross-Sectional|||||||
1504872|NCT00918359|||Case-Only||Prospective|||||||
1504873|NCT00918346|Randomized|Crossover Assignment||Treatment||Single|||||t|
1504874|NCT00918333||Single Group Assignment||Treatment||None (Open Label)||||||
1504875|NCT00918320||Single Group Assignment||Treatment||None (Open Label)||||||
1504876|NCT00918307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504877|NCT00918294||Single Group Assignment||Treatment||None (Open Label)||||||
1504878|NCT00918281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504879|NCT00918268|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1504880|NCT00918255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504881|NCT00918242|||Cohort||Prospective|||||||
1504882|NCT00918229||Single Group Assignment||Prevention||None (Open Label)||||||
1504883|NCT00918216|||Case-Only||Cross-Sectional|||||||
1504884|NCT00918203|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504885|NCT00918190|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1504886|NCT00918177|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1504887|NCT00918164|Randomized|Crossover Assignment||||None (Open Label)||||||
1504888|NCT00918151|||Ecologic or Community||Cross-Sectional|||||||
1504889|NCT00918138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504890|NCT00918125|||Cohort||Prospective|||||||
1504891|NCT00918112|||Case Control||Prospective|||||||
1504892|NCT00918099|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1504893|NCT00918086|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1504894|NCT00918073|||Cohort||Prospective|||||||
1504895|NCT00918060|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504896|NCT00918047|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504897|NCT00918034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504898|NCT00918021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504899|NCT00918008|||Cohort||Prospective|||||||
1504900|NCT00917995|Randomized|Parallel Assignment||Prevention||Single|||t|||
1504901|NCT00917982||||||||||||
1504902|NCT00917956|||Cohort||Prospective|||||||
1504903|NCT00917943|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504904|NCT00917930|||Case Control||Prospective|||||||
1504905|NCT00917917|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504906|NCT00917904|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1504907|NCT00917891|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1504908|NCT00917878|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1504909|NCT00917865||Single Group Assignment||Diagnostic||None (Open Label)||||||
1504910|NCT00917852||Single Group Assignment||Treatment||None (Open Label)||||||
1504911|NCT00917839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504912|NCT00917826||Single Group Assignment||Treatment||None (Open Label)||||||
1504913|NCT00917813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504914|NCT00917800|||Case-Only||Prospective|||||||
1504915|NCT00917787|||Cohort||Cross-Sectional|||||||
1504916|NCT00917774|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504917|NCT00917761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504918|NCT00917748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504919|NCT00917735|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1504920|NCT00917722|||Cohort||Prospective|||||||
1504921|NCT00917709|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1504922|NCT00917696|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1504923|NCT00917683|||Case Control||Prospective|||||||
1504924|NCT00917670|||Case-Only||Prospective|||||||
1504925|NCT00917657||Single Group Assignment||Treatment||None (Open Label)||||||
1504926|NCT00917644|Randomized|Crossover Assignment||||None (Open Label)||||||
1504927|NCT00917631|Randomized|Parallel Assignment||Treatment||Single||||||t
1504928|NCT00917618||Parallel Assignment||Treatment||None (Open Label)||||||
1504929|NCT00917605|Randomized|Parallel Assignment||Treatment||Single||||||t
1504930|NCT00917592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504931|NCT00917579|Randomized|Crossover Assignment||||None (Open Label)||||||
1504932|NCT00917566|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504933|NCT00917553|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504934|NCT00917540|||Cohort||Prospective|||||||
1504935|NCT00917527|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1504936|NCT00917514|||Case-Only||Prospective|||||||
1504937|NCT00917501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504938|NCT00917488|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1504939|NCT00917475|||Cohort||Prospective|||||||
1504940|NCT00917462||Single Group Assignment||Treatment||None (Open Label)||||||
1504941|NCT00917449|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1504942|NCT00917436||||Treatment||||||||
1504943|NCT00917423|||Case Control||Prospective|||||||
1504944|NCT00917410|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1504945|NCT00917397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504946|NCT00917384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504947|NCT00917371||||||||||||
1504948|NCT00917358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504949|NCT00917345|||Case Control||Prospective|||||||
1504950|NCT00917332|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1504951|NCT00917319|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1504952|NCT00917306||Single Group Assignment||Treatment||None (Open Label)||||||
1504953|NCT00917293|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504954|NCT00917280|||Case Control||Cross-Sectional|||||||
1504955|NCT00917267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504956|NCT00917254|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1504957|NCT00917241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504958|NCT00917228|||Cohort||Cross-Sectional|||||||
1504959|NCT00917215|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1504960|NCT00917202||||||||||||
1504961|NCT00917189||Single Group Assignment||Treatment||None (Open Label)||||||
1504962|NCT00917176||Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1504963|NCT00917163|Randomized|Parallel Assignment||Treatment||Single|||t|||
1504964|NCT00917150|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1504965|NCT00917137|||Cohort||Prospective|||||||
1504966|NCT00917124|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1504967|NCT00917111|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504968|NCT00917098|Randomized|Parallel Assignment||Treatment||Single||||||t
1504969|NCT00917085|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1504970|NCT00917072|Randomized|Single Group Assignment||||Single||||||t
1504971|NCT00917059|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504972|NCT00917046|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1504973|NCT00917033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1504974|NCT00917020|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504975|NCT00917007|||Cohort||Prospective|||||||
1504976|NCT00916994|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504977|NCT00916981||Single Group Assignment||Treatment||None (Open Label)||||||
1504978|NCT00916968|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1504979|NCT00916955|||Cohort||Prospective|||||||
1504980|NCT00916942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504981|NCT00916929|Non-Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1504982|NCT00916916||||||||||||
1504983|NCT00916903|||Family-Based||Retrospective|||||||
1504984|NCT00916890|Randomized|Parallel Assignment||Treatment||Single||||||t
1504985|NCT00916877|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1504986|NCT00916864|||Case-Only||Prospective|||||||
1504987|NCT00916851|||Case Control|||||||||
1504988|NCT00916838|||Case-Control||Prospective|||||||
1504989|NCT00916825||Single Group Assignment||Treatment||None (Open Label)||||||
1504990|NCT00916812|||||Prospective|||||||
1504991|NCT00916799|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1504992|NCT00916786|||Case Control|||||||||
1504993|NCT00916773||Single Group Assignment||Treatment||None (Open Label)||||||
1504994|NCT00916760|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1504995|NCT00916747||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1504996|NCT00916734|Randomized|Crossover Assignment||Treatment||Single||||||t
1504997|NCT00916721|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1504998|NCT00916708|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1504999|NCT00916695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505000|NCT00916682|||Case Control||Prospective|||||||
1505001|NCT00916669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505002|NCT00916656|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505003|NCT00916643||Single Group Assignment||Treatment||None (Open Label)||||||
1505004|NCT00916630||Single Group Assignment||Treatment||None (Open Label)||||||
1505005|NCT00916617|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505006|NCT00916604|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505007|NCT00916591|||Cohort||Prospective|||||||
1505008|NCT00916578||Single Group Assignment||Treatment||None (Open Label)||||||
1505009|NCT00916565|||Cohort||Prospective|||||||
1505010|NCT00916552|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1505011|NCT00916539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505012|NCT00916526||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505013|NCT00916513|||||Cross-Sectional|||||||
1505014|NCT00916500||Single Group Assignment||Treatment||None (Open Label)||||||
1505015|NCT00916487|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1505016|NCT00916474|||Cohort||Prospective|||||||
1505017|NCT00916461|Randomized|||Treatment||Double||||||
1505018|NCT00916448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505019|NCT00916435|||Cohort||Prospective|||||||
1505020|NCT00916422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505021|NCT00916409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505022|NCT00916396|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505023|NCT00916383|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1505024|NCT00916370|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505025|NCT00916357|Randomized|Crossover Assignment||||Double|||t||t|
1505026|NCT00916344|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505027|NCT00916331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505028|NCT00916318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505029|NCT00916305|Randomized|Single Group Assignment||Prevention||Single||||||t
1505030|NCT00916292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505031|NCT00916279||Single Group Assignment||Treatment||None (Open Label)||||||
1505032|NCT00916266||Single Group Assignment||Treatment||None (Open Label)||||||
1505033|NCT00916253|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1505034|NCT00916240|Randomized|Parallel Assignment||Treatment||Single||||||t
1505035|NCT00916227||Single Group Assignment||Treatment||None (Open Label)||||||
1505036|NCT00916214|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1505037|NCT00916201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505038|NCT00916188|Randomized|Parallel Assignment||||None (Open Label)||||||
1505039|NCT00916175|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1505040|NCT00916162|||Case-Only||Prospective|||||||
1505041|NCT00916149|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505042|NCT00916136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505043|NCT00916123|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1505044|NCT00916110|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505045|NCT00916097|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505046|NCT00916084|Randomized|Parallel Assignment||Treatment||Single|||||t|
1505047|NCT00916071|||Case-Only||Cross-Sectional|||||||
1505048|NCT00916058|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505049|NCT00916045|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505050|NCT00916032|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505051|NCT00916019||Single Group Assignment||Basic Science||None (Open Label)||||||
1505052|NCT00916006|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505053|NCT00915993||||Diagnostic||None (Open Label)||||||
1505054|NCT00915980|||Case-Only||Prospective|||||||
1505055|NCT00915967|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505056|NCT00915954||||||Single|||t|||
1505057|NCT00915941|||Case-Only||Prospective|||||||
1505058|NCT00915928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505059|NCT00915915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505060|NCT00915902|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1505061|NCT00915889|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1505062|NCT00915876|Randomized|Single Group Assignment||||Single|||t|||
1505063|NCT00915863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505064|NCT00915850||Single Group Assignment||Treatment||None (Open Label)||||||
1505065|NCT00915837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505066|NCT00915824|Randomized|Parallel Assignment||||None (Open Label)||||||
1505067|NCT00915811||Single Group Assignment||Treatment||None (Open Label)||||||
1505068|NCT00915798||||||||||||
1505069|NCT00915785||Single Group Assignment||Treatment||None (Open Label)||||||
1505070|NCT00915772|Randomized|Single Group Assignment||Treatment||Double||||||
1505071|NCT00915759|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505072|NCT00915746|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1505073|NCT00915733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505074|NCT00915720|||Case-Only||Prospective|||||||
1505075|NCT00915707|Randomized|Crossover Assignment||||Single|||t|||
1505076|NCT00915694||Single Group Assignment||Treatment||None (Open Label)||||||
1505077|NCT00915681||Single Group Assignment||Treatment||None (Open Label)||||||
1505078|NCT00915668|Randomized|Crossover Assignment||||None (Open Label)||||||
1505079|NCT00915655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505080|NCT00915642|||Cohort||Prospective|||||||
1505081|NCT00915629|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1505082|NCT00915616||||Treatment||||||||
1505083|NCT00915603|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505084|NCT00915590|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1505085|NCT00915577||Crossover Assignment||||None (Open Label)||||||
1505086|NCT00915564||Single Group Assignment||Treatment||None (Open Label)||||||
1505087|NCT00915551|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505088|NCT00915538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505089|NCT00915525|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505090|NCT00915512||Single Group Assignment||Treatment||None (Open Label)||||||
1505091|NCT00915499|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1505092|NCT00915486|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505093|NCT00915473|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505094|NCT00915460|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1505095|NCT00915447|||Cohort||Prospective|||||||
1505096|NCT00915434|Randomized|Crossover Assignment||||None (Open Label)||||||
1505097|NCT00915421|||Case Control||Prospective|||||||
1505098|NCT00915408||Single Group Assignment||Treatment||None (Open Label)||||||
1505099|NCT00915382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505100|NCT00915369||Single Group Assignment||Treatment||None (Open Label)||||||
1505101|NCT00915356|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505102|NCT00915343|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505103|NCT00915330|Randomized|||Diagnostic||None (Open Label)||||||
1505104|NCT00915317|||Cohort||Prospective|||||||
1505105|NCT00915304|Randomized|Single Group Assignment||Health Services Research||Double|||t||t|
1505106|NCT00915291|Randomized|Parallel Assignment||||Single||||t||
1505107|NCT00915278||Single Group Assignment||Treatment||None (Open Label)||||||
1505108|NCT00915265|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505109|NCT00915252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505110|NCT00915239|Randomized|Parallel Assignment||Basic Science||Double||||||
1505111|NCT00915226|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1505112|NCT00915213|||Cohort||Prospective|||||||
1505113|NCT00915200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505114|NCT00915187|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1505115|NCT00915174|Randomized|Crossover Assignment||||Double|||t||t|
1505116|NCT00915161|||Cohort||Prospective|||||||
1505117|NCT00915148|||Case-Only||Prospective|||||||
1505118|NCT00915135|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1505119|NCT00915122||Single Group Assignment||Treatment||None (Open Label)||||||
1505120|NCT00915109|||Case Control||Prospective|||||||
1505121|NCT00915096|||Case-Only||Prospective|||||||
1505122|NCT00915083||Single Group Assignment||Treatment||None (Open Label)||||||
1505123|NCT00915070|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1505124|NCT00915057|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1505125|NCT00915044|||Case-Only||Cross-Sectional|||||||
1505126|NCT00915031|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505127|NCT00915018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505128|NCT00915005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505129|NCT00914992|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1505130|NCT00914979|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505131|NCT00914966||Single Group Assignment||Prevention||None (Open Label)||||||
1505132|NCT00914953|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1505133|NCT00914940||Single Group Assignment||Treatment||None (Open Label)||||||
1505134|NCT00914927|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505135|NCT00914914||Single Group Assignment||Treatment||None (Open Label)||||||
1505136|NCT00914901|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1505137|NCT00914888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505138|NCT00914875|||Case-Only||Prospective|||||||
1505139|NCT00914862|Randomized|Parallel Assignment||||None (Open Label)||||||
1505140|NCT00914849|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505141|NCT00914836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505142|NCT00914823||Single Group Assignment||Other||None (Open Label)||||||
1505143|NCT00914810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505144|NCT00914797|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1505145|NCT00914784|||Case Control||Prospective|||||||
1505146|NCT00914771|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1505147|NCT00914758|||Case Control||Prospective|||||||
1505148|NCT00914745|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1505149|NCT00914732|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1505150|NCT00914719||Factorial Assignment||Prevention||||||||
1505151|NCT00914706|||Cohort||Prospective|||||||
1505152|NCT00914693|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1505153|NCT00914680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505154|NCT00914667|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505155|NCT00914654|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1505156|NCT00914641|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1505157|NCT00914628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505158|NCT00914615||Single Group Assignment||Treatment||None (Open Label)||||||
1505159|NCT00914602||Single Group Assignment||Treatment||None (Open Label)||||||
1505160|NCT00914589|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1505161|NCT00914576|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1505162|NCT00914563|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505163|NCT00914550|||Case Control||Prospective|||||||
1505164|NCT00914537|||Cohort||Prospective|||||||
1505165|NCT00914524||Single Group Assignment||Treatment||None (Open Label)||||||
1505166|NCT00914511|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1505167|NCT00914498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505168|NCT00914485|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1505169|NCT00914472|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505170|NCT00914459||Single Group Assignment||Treatment||None (Open Label)||||||
1505171|NCT00914446||Single Group Assignment||Screening||None (Open Label)||||||
1505172|NCT00914433||Single Group Assignment||Treatment||Triple|||t|t|t|
1505173|NCT00914420|Randomized|Crossover Assignment||Treatment||Single|||t|||
1505174|NCT00914407||Single Group Assignment||Basic Science||None (Open Label)||||||
1505175|NCT00914394|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1505176|NCT00914381|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1505177|NCT00914368|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1505178|NCT00914355||Single Group Assignment||Treatment||None (Open Label)||||||
1505179|NCT00914342|||Case-Only||Cross-Sectional|||||||
1505180|NCT00914329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505181|NCT00914316|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1505182|NCT00914303|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1505183|NCT00914290|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1505184|NCT00914277|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1505185|NCT00914264|||Cohort||Prospective|||||||
1505186|NCT00914251|Randomized|Crossover Assignment||Treatment||Single|||t|||
1505187|NCT00914238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505188|NCT00914225|||Cohort||Prospective|||||||
1505189|NCT00914212|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1505190|NCT00914199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505191|NCT00914186|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505192|NCT00914173||Single Group Assignment||Diagnostic||Single|||t|||
1505193|NCT00914160|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505194|NCT00914147||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505195|NCT00914134||Single Group Assignment||Treatment||None (Open Label)||||||
1505196|NCT00914121|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1505197|NCT00914108|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1505198|NCT00914095|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505199|NCT00914082|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1505200|NCT00914069|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1505201|NCT00914056||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505202|NCT00914043||||||||||||
1505203|NCT00914030|||Case Control||Cross-Sectional|||||||
1505204|NCT00914017|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1505205|NCT00914004|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505206|NCT00913991|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1505207|NCT00913978|Randomized|Parallel Assignment||Treatment||Single||||||t
1505208|NCT00913965|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505209|NCT00913952|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505210|NCT00913939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505211|NCT00913926|||Cohort||Prospective|||||||
1505212|NCT00913913||Single Group Assignment||Treatment||None (Open Label)||||||
1505213|NCT00913900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505214|NCT00913887|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505215|NCT00913874|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505216|NCT00913861|Randomized|Parallel Assignment||Treatment||Single||||||t
1505217|NCT00913848|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505218|NCT00913835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505219|NCT00913822|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505220|NCT00913809|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505221|NCT00913796|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505222|NCT00913783|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505223|NCT00913770|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505224|NCT00913757|||Case-Control||Prospective|||||||
1505225|NCT00913744|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505226|NCT00913731|||||Prospective|||||||
1505227|NCT00913718|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505228|NCT00913705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505229|NCT00913692|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1505230|NCT00913679|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505231|NCT00913666|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1505232|NCT00913653|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505233|NCT00913640|||Case Control||Cross-Sectional|||||||
1505234|NCT00913627|Randomized|Parallel Assignment||Treatment||Double||||||
1505235|NCT00913614|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505236|NCT00913601|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1505237|NCT00913588|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505238|NCT00913575|Randomized|Parallel Assignment||Treatment||Single||||||t
1505239|NCT00913562|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1505240|NCT00913549|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505241|NCT00913536||Single Group Assignment||Treatment||None (Open Label)||||||
1505242|NCT00913523|Randomized|Parallel Assignment||||Single||||||t
1505243|NCT00913510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505244|NCT00913497|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505245|NCT00913484|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1505246|NCT00913471|||Cohort||Prospective|||||||
1505247|NCT00913458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505248|NCT00913445|Randomized|Parallel Assignment||Treatment||Single||||||t
1505249|NCT00913432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505250|NCT00913419|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505251|NCT00913406|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1505252|NCT00913393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505253|NCT00913380|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1505254|NCT00913367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505255|NCT00913354|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505256|NCT00913341|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505257|NCT00913328|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505258|NCT00913315|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505259|NCT00913302|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1505260|NCT00913289||Single Group Assignment||Treatment||None (Open Label)||||||
1505261|NCT00913276|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505262|NCT00913263||Single Group Assignment||Treatment||None (Open Label)||||||
1505263|NCT00913250|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1505264|NCT00913237|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505265|NCT00913224|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505266|NCT00913211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505267|NCT00913198||Single Group Assignment||Treatment||None (Open Label)||||||
1505268|NCT00913185|Randomized|Parallel Assignment||Treatment||Double||||||
1505269|NCT00913172|||||Prospective|||||||
1505270|NCT00913159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505271|NCT00913146|||||Prospective|||||||
1505272|NCT00913133||Single Group Assignment||Treatment||None (Open Label)||||||
1505273|NCT00913120|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1505274|NCT00913107|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1505275|NCT00913094|||Cohort||Prospective|||||||
1505276|NCT00913081|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1505277|NCT00913068|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1505278|NCT00913055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505279|NCT00913042|||Case-Only||Prospective|||||||
1505280|NCT00913029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505281|NCT00913016|||Cohort||Prospective|||||||
1505282|NCT00913003|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1505283|NCT00912990|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505284|NCT00912977|||Case-Crossover||Prospective|||||||
1505285|NCT00912964|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505286|NCT00912938||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505287|NCT00912925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505288|NCT00912912||Single Group Assignment||Treatment||None (Open Label)||||||
1505289|NCT00912899||Single Group Assignment||Treatment||None (Open Label)||||||
1505290|NCT00912886|||Case Control||Prospective|||||||
1505291|NCT00912873|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1505292|NCT00912860||Single Group Assignment||Basic Science||None (Open Label)||||||
1505293|NCT00912847|||||Prospective|||||||
1505294|NCT00912834|||Case Control||Retrospective|||||||
1505295|NCT00912821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505296|NCT00912808|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1505297|NCT00912795|Randomized|Parallel Assignment||||None (Open Label)||||||
1505298|NCT00912782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505299|NCT00912769|||Cohort||Retrospective|||||||
1505300|NCT00912756|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505301|NCT00912743||Single Group Assignment||Treatment||None (Open Label)||||||
1505302|NCT00912730|||Case Control||Prospective|||||||
1505303|NCT00912717|||Case-Control||Prospective|||||||
1505304|NCT00912704|||Case-Only||Retrospective|||||||
1505305|NCT00912691||Single Group Assignment||Treatment||None (Open Label)||||||
1505306|NCT00912678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505307|NCT00912665||Single Group Assignment||Basic Science||None (Open Label)||||||
1505308|NCT00912652|Randomized|Parallel Assignment||Treatment||Single||||||t
1505309|NCT00912639||Single Group Assignment||Treatment||None (Open Label)||||||
1505310|NCT00912626|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1505311|NCT00912613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505312|NCT00912600|||Cohort||Prospective|||||||
1505313|NCT00912587|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1505314|NCT00912574|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505315|NCT00912561|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505316|NCT00912548|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1505317|NCT00912535|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505318|NCT00912522|Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1505319|NCT00912509|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1505320|NCT00912496|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1505321|NCT00912483|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505322|NCT00912470|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1505323|NCT00912457|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505324|NCT00912444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505325|NCT00912431|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1505326|NCT00912418||Parallel Assignment||Treatment||None (Open Label)||||||
1505327|NCT00912405||Single Group Assignment||Supportive Care||None (Open Label)||||||
1505328|NCT00912392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505329|NCT00912379|||Cohort||Prospective|||||||
1505330|NCT00912366|||Cohort||Prospective|||||||
1505331|NCT00912353|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1505332|NCT00912340|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505333|NCT00912327|||Cohort||Prospective|||||||
1505334|NCT00912314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505335|NCT00912301|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505336|NCT00912288|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505337|NCT00912275||Single Group Assignment||Treatment||None (Open Label)||||||
1505338|NCT00912262|Randomized|Single Group Assignment||Treatment||Single||||||
1505339|NCT00912249|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1505340|NCT00912236|||Cohort||Cross-Sectional|||||||
1505341|NCT00912223||Single Group Assignment||Treatment||None (Open Label)||||||
1505342|NCT00912210|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1505343|NCT00912197|Randomized|Parallel Assignment||||Single|||t|||
1505344|NCT00912184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505345|NCT00912171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505346|NCT00912158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505347|NCT00912145|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505348|NCT00912132|||Cohort||Prospective|||||||
1505349|NCT00912119|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505350|NCT00912106|||Case Control||Prospective|||||||
1505351|NCT00912093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505352|NCT00912080|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1505353|NCT00912067|||Cohort||Cross-Sectional|||||||
1505354|NCT00912054|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505355|NCT00912041||Single Group Assignment||Other||None (Open Label)||||||
1505356|NCT00912028|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505357|NCT00912015|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505358|NCT00912002||Single Group Assignment||Treatment||None (Open Label)||||||
1505359|NCT00911989||Single Group Assignment||Treatment||None (Open Label)||||||
1505360|NCT00911976||Single Group Assignment||Treatment||None (Open Label)||||||
1505361|NCT00911963|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1505362|NCT00911937|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1505363|NCT00911924||Single Group Assignment||Treatment||None (Open Label)||||||
1505364|NCT00911911|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1505365|NCT00911898||Single Group Assignment||Treatment||None (Open Label)||||||
1505366|NCT00911885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505367|NCT00911872|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505368|NCT00911859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505369|NCT00911846|||Case Control||Cross-Sectional|||||||
1505370|NCT00911833|||||Prospective|||||||
1505371|NCT00911820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505372|NCT00911807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505373|NCT00911794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505374|NCT00911781|||Cohort||Retrospective|||||||
1505375|NCT00911768|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505376|NCT00911755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505377|NCT00911742|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505378|NCT00911729|||Case-Only||Cross-Sectional|||||||
1505379|NCT00911716|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505380|NCT00911703|||Cohort||Prospective|||||||
1505381|NCT00911690|||Case Control||Prospective|||||||
1505382|NCT00911677|||Cohort||Prospective|||||||
1505383|NCT00911664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505384|NCT00911651|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505385|NCT00911638|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1505386|NCT00911625|Randomized|Parallel Assignment||Treatment||None (Open Label)||Eligible participants are randomized to one of the two dosing groups using a 1:1 allocation||||
1505387|NCT00911612|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505388|NCT00911599|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505389|NCT00911586||Single Group Assignment||Treatment||None (Open Label)||||||
1505390|NCT00911573|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505391|NCT00911560||Single Group Assignment||Treatment||None (Open Label)||||||
1505392|NCT00911547|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505393|NCT00911534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505394|NCT00911521||Parallel Assignment||Prevention||None (Open Label)||||||
1505395|NCT00911508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505396|NCT00911495||Single Group Assignment||Treatment||None (Open Label)||||||
1505397|NCT00911482|||||Cross-Sectional|||||||
1505398|NCT00911469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505399|NCT00911456||Single Group Assignment||Treatment||None (Open Label)||||||
1505400|NCT00911443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505401|NCT00911430|||||Prospective|||||||
1505402|NCT00911417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505403|NCT00911404|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505404|NCT00911391|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505405|NCT00911378|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1505406|NCT00911365|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505407|NCT00911352|Randomized|Parallel Assignment||Prevention||Single||||||t
1505408|NCT00911339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505409|NCT00911326||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505410|NCT00911313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505411|NCT00911300|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505412|NCT00911287||Single Group Assignment||Treatment||None (Open Label)||||||
1505413|NCT00911274|Randomized|Crossover Assignment||||None (Open Label)||||||
1505414|NCT00911261||Single Group Assignment||Treatment||None (Open Label)||||||
1505415|NCT00911248||Single Group Assignment||Treatment||None (Open Label)||||||
1505416|NCT00911235|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505417|NCT00911222|||Cohort||Prospective|||||||
1505418|NCT00911209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505419|NCT00911196|||Case-Only||Retrospective|||||||
1505420|NCT00911183|Randomized|||Treatment||||||||
1505421|NCT00911170|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1505422|NCT00911157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505423|NCT00911144|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1505424|NCT00911131|Non-Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1505425|NCT00911118||Single Group Assignment||Treatment||None (Open Label)||||||
1505426|NCT00911105|||Cohort||Prospective|||||||
1505427|NCT00911092|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1505428|NCT00911079||Single Group Assignment||Treatment||None (Open Label)||||||
1505429|NCT00911066|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505430|NCT00911053|Non-Randomized|Factorial Assignment||Treatment||Single|||t|||
1505431|NCT00911040||||||||||||
1505432|NCT00911027|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1505433|NCT00911014|||||Prospective|||||||
1505434|NCT00911001|||Cohort||Prospective|||||||
1505435|NCT00910988|Randomized|Crossover Assignment||Prevention||Single|||t|||
1505436|NCT00910975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505437|NCT00910962|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505438|NCT00910949|||Cohort|||||||||
1505439|NCT00910936|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1505440|NCT00910923|Randomized|Crossover Assignment||Treatment||Double||||||
1505441|NCT00910910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505442|NCT00910897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505443|NCT00910884|||Case-Only||Retrospective|||||||
1505444|NCT00910871||Single Group Assignment||Treatment||None (Open Label)||||||
1505445|NCT00910858||Parallel Assignment||Treatment||None (Open Label)||||||
1505446|NCT00910845|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505447|NCT00910832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505448|NCT00910819|||Cohort||Prospective|||||||
1505449|NCT00910806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505450|NCT00910793||Single Group Assignment||Treatment||None (Open Label)||||||
1505451|NCT00910780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505452|NCT00910767|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505453|NCT00910754||Single Group Assignment||Treatment||None (Open Label)||||||
1505454|NCT00910741||Single Group Assignment||Treatment||None (Open Label)||||||
1505455|NCT00910728||Single Group Assignment||Other||None (Open Label)||||||
1505456|NCT00910715|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1505457|NCT00910702||Single Group Assignment||Treatment||None (Open Label)||||||
1505458|NCT00910689|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505459|NCT00910676||Single Group Assignment||Prevention||None (Open Label)||||||
1505460|NCT00910663|Randomized|Crossover Assignment||||None (Open Label)||||||
1505461|NCT00910650||Single Group Assignment||Treatment||None (Open Label)||||||
1505462|NCT00910637|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1505463|NCT00910624||Single Group Assignment||Treatment||None (Open Label)||||||
1505464|NCT00910611|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1505465|NCT00910598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505466|NCT00910585|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505467|NCT00910572||Single Group Assignment||Treatment||None (Open Label)||||||
1505468|NCT00910559|||Family-Based||Cross-Sectional|||||||
1505469|NCT00910546||Single Group Assignment||Basic Science||None (Open Label)||||||
1505470|NCT00910533|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1505471|NCT00910520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505472|NCT00910507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505473|NCT00910494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505474|NCT00910481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505475|NCT00910468|||Case Control||Retrospective|||||||
1505476|NCT00910455|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1505477|NCT00910442|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1505478|NCT00910429||Single Group Assignment||Treatment||None (Open Label)||||||
1505479|NCT00910416|||Cohort||Prospective|||||||
1505480|NCT00910403||Single Group Assignment||Treatment||None (Open Label)||||||
1505481|NCT00910390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505482|NCT00910377|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1505483|NCT00910364||Single Group Assignment||Prevention||None (Open Label)||||||
1505484|NCT00910351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505485|NCT00910338||Single Group Assignment||Treatment||None (Open Label)||||||
1505486|NCT00910325||Single Group Assignment||Treatment||None (Open Label)||||||
1505487|NCT00910312||Single Group Assignment||Treatment||None (Open Label)||||||
1505488|NCT00910299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505489|NCT00910286||Crossover Assignment||||Single|||t|||
1505490|NCT00910273|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505491|NCT00910260|||Cohort||Prospective|||||||
1505492|NCT00910247||Single Group Assignment||Treatment||None (Open Label)|open label|||||
1505493|NCT00910234|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1505494|NCT00910221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505495|NCT00910208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505496|NCT00910195|Randomized|Crossover Assignment||Treatment||Single|||||t|
1505497|NCT00910182|||Cohort||Retrospective|||||||
1505498|NCT00910169|||Cohort||Prospective|||||||
1505499|NCT00910156||||||||||||
1505500|NCT00910143|||Cohort||Retrospective|||||||
1505501|NCT00910130|||Case Control||Cross-Sectional|||||||
1505502|NCT00910117||Single Group Assignment||Treatment||None (Open Label)||||||
1505503|NCT00910104||Single Group Assignment||Treatment||None (Open Label)||||||
1505504|NCT00910091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505505|NCT00910078|||Cohort||Retrospective|||||||
1505506|NCT00910065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505507|NCT00910052|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1505508|NCT00910039||Single Group Assignment||Treatment||None (Open Label)||||||
1505509|NCT00910026|Randomized|Parallel Assignment||Prevention||Single|||||t|
1505510|NCT00910013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505511|NCT00910000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505512|NCT00909987||Single Group Assignment||Treatment||None (Open Label)||||||
1505513|NCT00909974|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505514|NCT00909961||Single Group Assignment||Treatment||None (Open Label)||||||
1505515|NCT00909948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505516|NCT00909935|||Cohort||Prospective|||||||
1505517|NCT00909922|||Cohort||Cross-Sectional|||||||
1505518|NCT00909909|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505519|NCT00909896|||Cohort||Prospective|||||||
1505520|NCT00909883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505521|NCT00909870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505522|NCT00909857|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505523|NCT00909844||Single Group Assignment||Treatment||None (Open Label)||||||
1505524|NCT00909831||||Treatment||||||||
1505525|NCT00909818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505526|NCT00909805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505527|NCT00909792|Randomized|Crossover Assignment||Treatment||Single|||t|||
1505528|NCT00909779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505529|NCT00909766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505530|NCT00909753|Randomized|Crossover Assignment||||None (Open Label)||||||
1505531|NCT00909740||Single Group Assignment||Treatment||None (Open Label)||||||
1505532|NCT00909727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505533|NCT00909714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505534|NCT00909701|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1505535|NCT00909688|Randomized|Single Group Assignment||Other||Triple|||t|t|t|
1505536|NCT00909662|||Case Control||Prospective|||||||
1505537|NCT00909649|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1505538|NCT00909636|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1505539|NCT00909610|Randomized|Crossover Assignment||||None (Open Label)||||||
1505540|NCT00909597|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505541|NCT00909584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505542|NCT00909571|Randomized|Parallel Assignment||||None (Open Label)||||||
1505543|NCT00909558||Single Group Assignment||Treatment||None (Open Label)||||||
1505544|NCT00909545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505545|NCT00909532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505546|NCT00909519|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1505547|NCT00909506|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1505548|NCT00909493|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1505549|NCT00909480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505550|NCT00909467|||Cohort||Prospective|||||||
1505551|NCT00909454|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1505552|NCT00909441||Single Group Assignment||Treatment||None (Open Label)||||||
1505553|NCT00909428||Single Group Assignment||Treatment||None (Open Label)||||||
1505554|NCT00909415|||||Retrospective|||||||
1505555|NCT00909402||Single Group Assignment||Treatment||None (Open Label)||||||
1505556|NCT00909389|||Cohort||Prospective|||||||
1505557|NCT00909376|||Cohort||Prospective|||||||
1505558|NCT00909363||Single Group Assignment||Treatment||None (Open Label)||||||
1505559|NCT00909350|||Case-Only||Prospective|||||||
1505560|NCT00909337||Single Group Assignment||Treatment||None (Open Label)||||||
1505561|NCT00909324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505562|NCT00909311|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505563|NCT00909298|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1505564|NCT00909285|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505565|NCT00909272|||||Prospective|||||||
1505566|NCT00909259||Single Group Assignment||Treatment||None (Open Label)||||||
1505567|NCT00909233|||Cohort||Prospective|||||||
1505568|NCT00909220|||Case-Control||Prospective|||||||
1505569|NCT00909207|||Case-Only||Prospective|||||||
1505570|NCT00909194|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505571|NCT00909181|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505572|NCT00909168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505573|NCT00909155|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1505574|NCT00909142|||Cohort||Prospective|||||||
1505575|NCT00909129||Single Group Assignment||Basic Science||None (Open Label)||||||
1505576|NCT00909116|||Cohort||Prospective|||||||
1505577|NCT00909103|||Case Control||Prospective|||||||
1505578|NCT00909090|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1505579|NCT00909077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505580|NCT00909064||Single Group Assignment||Treatment||None (Open Label)||||||
1505581|NCT00909051|||Cohort||Prospective|||||||
1505582|NCT00909038|||Cohort||Retrospective|||||||
1505583|NCT00909025||Single Group Assignment||Other||None (Open Label)||||||
1505584|NCT00909012|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1505585|NCT00908999|||Case Control||Prospective|||||||
1505586|NCT00908986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505587|NCT00908973|||Case Control||Prospective|||||||
1505588|NCT00908960|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505589|NCT00908947||Single Group Assignment||Treatment||None (Open Label)||||||
1505590|NCT00908934|Randomized|Crossover Assignment||||None (Open Label)||||||
1505591|NCT00908921||Single Group Assignment||Treatment||None (Open Label)||||||
1505592|NCT00908908|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505593|NCT00908895|Randomized|Parallel Assignment||Treatment||Single||||||t
1505594|NCT00908882|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1505595|NCT00908869||Single Group Assignment||Treatment||None (Open Label)||||||
1505596|NCT00908856|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505597|NCT00908843|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505598|NCT00908830|||Other||Prospective|||||||
1505599|NCT00908817|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1505600|NCT00908804||||||||||||
1505601|NCT00908791||Single Group Assignment||Basic Science||None (Open Label)||||||
1505602|NCT00908778|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1505603|NCT00908765|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1505604|NCT00908752|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505605|NCT00908739|||Case Control||Prospective|||||||
1505606|NCT00908726|Randomized|Crossover Assignment||Treatment||Single|||t|||
1505607|NCT00908713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505608|NCT00908700|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505609|NCT00908687|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1505610|NCT00908674|||Cohort||Prospective|||||||
1505611|NCT00908661|Randomized|Parallel Assignment||Prevention||Single||||||t
1505612|NCT00908648|Randomized|Parallel Assignment||Diagnostic||Single||||||
1505613|NCT00908635|||Cohort||Prospective|||||||
1505614|NCT00908622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505615|NCT00908609|||Cohort||Prospective|||||||
1505616|NCT00908596||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505617|NCT00908583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505618|NCT00908570|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1505619|NCT00908557|Randomized|Parallel Assignment||||Single|||t|||
1505620|NCT00908544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505621|NCT00908531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505622|NCT00908518|||Cohort||Prospective|||||||
1505623|NCT00908505||Crossover Assignment||Treatment||None (Open Label)||||||
1505624|NCT00908492|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1505625|NCT00908479|Randomized|Parallel Assignment||Other||Single|||t|||
1505626|NCT00908466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505627|NCT00908453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505628|NCT00908440|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1505629|NCT00908427|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505630|NCT00908414|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1505631|NCT00908401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505632|NCT00908388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505633|NCT00908375|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505634|NCT00908362|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1505635|NCT00908349||Single Group Assignment||Treatment||None (Open Label)||||||
1505636|NCT00908336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505637|NCT00908323|||Case-Only||Prospective|||||||
1505638|NCT00908310||Single Group Assignment||||None (Open Label)||||||
1505639|NCT00908297||Single Group Assignment||Prevention||None (Open Label)||||||
1505640|NCT00908284|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505641|NCT00908271||Single Group Assignment||||None (Open Label)||||||
1505642|NCT00908245|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505643|NCT00908232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505644|NCT00908219||Single Group Assignment||Prevention||None (Open Label)||||||
1505645|NCT00908206|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1505646|NCT00908193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505647|NCT00908180||||Treatment||None (Open Label)||||||
1505648|NCT00908167||Single Group Assignment||Treatment||None (Open Label)||||||
1505649|NCT00908154|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1505650|NCT00908141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505651|NCT00908128|Randomized|Crossover Assignment||||None (Open Label)||||||
1505652|NCT00908115|||Cohort||Retrospective|||||||
1505653|NCT00908102|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1505654|NCT00908089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505655|NCT00908076|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505656|NCT00908063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505657|NCT00908050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505658|NCT00908037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505659|NCT00908024||Single Group Assignment||Treatment||None (Open Label)||||||
1505660|NCT00908011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505661|NCT00907998|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1505662|NCT00907985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505663|NCT00907972|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505664|NCT00907959|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505665|NCT00907946|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505666|NCT00907933|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1505667|NCT00907920|||Cohort||Retrospective|||||||
1505668|NCT00907907|Randomized|Crossover Assignment||||None (Open Label)||||||
1505669|NCT00907894|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1505670|NCT00907881|||Cohort||Prospective|||||||
1505671|NCT00907868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505672|NCT00907855|||Cohort||Prospective|||||||
1505673|NCT00907842||Single Group Assignment||Prevention||None (Open Label)||||||
1505674|NCT00907829|Randomized|Parallel Assignment||Treatment||Single||||||
1505675|NCT00907816|||Case Control||Prospective|||||||
1505676|NCT00907803|Randomized|Parallel Assignment||||Double|||t||t|
1505677|NCT00907790|Randomized|Parallel Assignment||Treatment||Single||||||t
1505678|NCT00907777|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505679|NCT00907764|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1505680|NCT00907751||Single Group Assignment||Treatment||None (Open Label)||||||
1505681|NCT00907738|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505682|NCT00907725|Randomized|Parallel Assignment||||None (Open Label)||||||
1505683|NCT00907712||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505684|NCT00907699|||Case-Only||Cross-Sectional|||||||
1505685|NCT00907686|||Cohort||Prospective|||||||
1505686|NCT00907673||Single Group Assignment||Treatment||None (Open Label)||||||
1505687|NCT00907660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505688|NCT00907634|||||Prospective|||||||
1505689|NCT00907621|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505690|NCT00907608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505691|NCT00907595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505692|NCT00907582||Single Group Assignment||Treatment||None (Open Label)||||||
1505693|NCT00907569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505694|NCT00907543|Randomized|Parallel Assignment||Treatment||Single||||||t
1505695|NCT00907530|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1505696|NCT00907517|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505697|NCT00907504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505698|NCT00907491|||Case-Only||Retrospective|||||||
1505699|NCT00907478||Single Group Assignment||Treatment||None (Open Label)||||||
1505700|NCT00907465|||Cohort||Prospective|||||||
1505701|NCT00907452|Randomized|Parallel Assignment||||None (Open Label)||||||
1505702|NCT00907439|||Cohort||Prospective|||||||
1505703|NCT00907426|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1505704|NCT00907413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505705|NCT00907400|Randomized|Crossover Assignment||||None (Open Label)||||||
1505706|NCT00907387|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505707|NCT00907374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505708|NCT00907361|||Cohort||Prospective|||||||
1505709|NCT00907348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505710|NCT00907335|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505711|NCT00907322|Randomized|Crossover Assignment||||Double|||t||t|
1505712|NCT00907309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505713|NCT00907296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505714|NCT00907283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505715|NCT00907270|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505716|NCT00907257|Randomized|Parallel Assignment||Treatment||Single|||||t|
1505717|NCT00907244|||Case-Only||Prospective|||||||
1505718|NCT00907231|||Cohort||Prospective|||||||
1505719|NCT00907218||Single Group Assignment||Treatment||None (Open Label)||||||
1505720|NCT00907205||Single Group Assignment||Treatment||None (Open Label)||||||
1505721|NCT00907192|||Case-Only||Prospective|||||||
1505722|NCT00907179||Single Group Assignment||Treatment||None (Open Label)||||||
1505723|NCT00907166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505724|NCT00907153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505725|NCT00907140||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505726|NCT00907127||Single Group Assignment||Prevention||None (Open Label)||||||
1505727|NCT00907114|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1505728|NCT00907101||Single Group Assignment||||None (Open Label)||||||
1505729|NCT00907088|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1505730|NCT00907075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505731|NCT00907062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505732|NCT00907049|||||Prospective|||||||
1505733|NCT00907036||||Treatment||None (Open Label)||||||
1505734|NCT00907023|||Cohort||Prospective|||||||
1505735|NCT00907010||||||||||||
1505736|NCT00906997|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1505737|NCT00906984||Single Group Assignment||Treatment||None (Open Label)||||||
1505738|NCT00906971|Randomized|Parallel Assignment||Treatment||Single||||||t
1505739|NCT00906958||||||||||||
1505740|NCT00906945|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505741|NCT00906932|||||Prospective|||||||
1505742|NCT00906919|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1505743|NCT00906906|||Cohort||Prospective|||||||
1505744|NCT00906893||Single Group Assignment||Health Services Research||None (Open Label)||||||
1505745|NCT00906880||Single Group Assignment||Treatment||None (Open Label)||||||
1505746|NCT00906867|||Case-Only||Cross-Sectional|||||||
1505747|NCT00906854|||Cohort|||||||||
1505748|NCT00906841||Single Group Assignment||Treatment||None (Open Label)||||||
1505749|NCT00906828|Randomized|Crossover Assignment||Treatment||Single||||||t
1505750|NCT00906815||||||||||||
1505751|NCT00906802|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505752|NCT00906789||||||||||||
1505753|NCT00906776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505754|NCT00906763|Randomized|Crossover Assignment||Treatment||Single|||||t|
1505755|NCT00906750|Randomized|Parallel Assignment||||None (Open Label)||||||
1505756|NCT00906737|Randomized|Parallel Assignment||Treatment||Single||||||t
1505757|NCT00906724|||Case-Only||Prospective|||||||
1505758|NCT00906711||||||||||||
1505759|NCT00906698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505760|NCT00906685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505761|NCT00906672|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505762|NCT00906659|||Case-Only||Prospective|||||||
1505763|NCT00906646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505764|NCT00906633|||Case-Only||Prospective|||||||
1505765|NCT00906620|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505766|NCT00906607|||Cohort|||||||||
1505767|NCT00906594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505768|NCT00906581|Randomized|Single Group Assignment||Treatment||Single||||||t
1505769|NCT00906568|||Case-Only||Cross-Sectional|||||||
1505770|NCT00906555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505771|NCT00906542|||Cohort||Prospective|||||||
1505772|NCT00906529|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505773|NCT00906516||Single Group Assignment||Treatment||None (Open Label)||||||
1505774|NCT00906503||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505775|NCT00906490|||Cohort||Prospective|||||||
1505776|NCT00906477|Randomized|Parallel Assignment||Treatment||Single||||||t
1505777|NCT00906451|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505778|NCT00906438|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1505779|NCT00906425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505780|NCT00906412|||Case Control||Cross-Sectional|||||||
1505781|NCT00906399|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1505782|NCT00906386|Randomized|Parallel Assignment||Treatment||Double||||||
1505783|NCT00906373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505784|NCT00906360||Single Group Assignment||Treatment||None (Open Label)||||||
1505785|NCT00906347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505786|NCT00906334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505787|NCT00906321|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1505788|NCT00906308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505789|NCT00906295|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1505790|NCT00906282||Single Group Assignment||Treatment||None (Open Label)||||||
1505791|NCT00906269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505792|NCT00906256|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1505793|NCT00906243||Single Group Assignment||Treatment||None (Open Label)||||||
1505794|NCT00906217|||Cohort||Prospective|||||||
1505795|NCT00906204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505796|NCT00906191|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1505797|NCT00906178|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505798|NCT00906165|Randomized|Parallel Assignment||Treatment||Single|||||t|
1505799|NCT00906152|||||Prospective|||||||
1505800|NCT00906139|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505801|NCT00906126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505802|NCT00906113||Single Group Assignment||Treatment||None (Open Label)||||||
1505803|NCT00906100|||Case-Only||Prospective|||||||
1505804|NCT00906087||Single Group Assignment||Basic Science||None (Open Label)||||||
1505805|NCT00906074|||Case Control||Prospective|||||||
1505806|NCT00906061||Single Group Assignment||Treatment||None (Open Label)||||||
1505807|NCT00906048|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505808|NCT00906035|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505809|NCT00906022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505810|NCT00906009||||||||||||
1505811|NCT00905996|Randomized|Single Group Assignment||Prevention||Single|||t|||
1505812|NCT00905983||Single Group Assignment||Treatment||None (Open Label)||||||
1505813|NCT00905970|||Cohort||Prospective|||||||
1505814|NCT00905957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505815|NCT00905944|Randomized|Crossover Assignment||Treatment||Single|||||t|
1505816|NCT00905931|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1505817|NCT00905918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505818|NCT00905905|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1505819|NCT00905892||Single Group Assignment||Basic Science||None (Open Label)||||||
1505820|NCT00905879|||Cohort||Prospective|||||||
1505821|NCT00905866|||Case-Only||Prospective|||||||
1505822|NCT00905853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505823|NCT00905840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505824|NCT00905827|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1505825|NCT00905814|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1505826|NCT00905801|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1505827|NCT00905788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505828|NCT00905775|||Case Control||Prospective|||||||
1505829|NCT00905762|Randomized|Parallel Assignment||Screening||Double|||t||t|
1505830|NCT00905749||||||||||||
1505831|NCT00905736|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505832|NCT00905723|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505833|NCT00905710|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505834|NCT00905697|||Cohort||Prospective|||||||
1505835|NCT00905684|||Cohort||Prospective|||||||
1505836|NCT00905671|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1505837|NCT00905658|Randomized|||Supportive Care||||||||
1505838|NCT00905645|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505839|NCT00905632|Randomized|Parallel Assignment||Treatment||Double||||||
1505840|NCT00905619|||Case-Crossover||Cross-Sectional|||||||
1505841|NCT00905606|Randomized|Crossover Assignment||||None (Open Label)||||||
1505842|NCT00905593||||||||||||
1505843|NCT00905580|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505844|NCT00905567|Randomized|Crossover Assignment||||None (Open Label)||||||
1505845|NCT00905554|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1505846|NCT00905541||Crossover Assignment||Basic Science||None (Open Label)||||||
1505847|NCT00905528|||Cohort||Prospective|||||||
1505848|NCT00905515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505849|NCT00905502|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1505850|NCT00905489|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505851|NCT00905476|||Cohort||Prospective|||||||
1505852|NCT00905463|||Cohort||Prospective|||||||
1505853|NCT00905450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505854|NCT00905437|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1505855|NCT00905424|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1505856|NCT00905411|Randomized|Single Group Assignment||||Single|||t|||
1505857|NCT00905398|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505858|NCT00905385|Randomized|Parallel Assignment||||Double|||t||t|
1505859|NCT00905372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505860|NCT00905359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505861|NCT00905346|Randomized|Crossover Assignment||||None (Open Label)||||||
1505862|NCT00905333||Crossover Assignment||||None (Open Label)||||||
1505863|NCT00905320|Randomized|Single Group Assignment||Treatment||Single|||t|||
1505864|NCT00905307|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505865|NCT00905294|||Cohort||Prospective|||||||
1505866|NCT00905281|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1505867|NCT00905268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505868|NCT00905255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505869|NCT00905242|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1505870|NCT00905229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505871|NCT00905216|Randomized|Parallel Assignment||Prevention||Single|||t|||
1505872|NCT00905203|Randomized|Parallel Assignment||Treatment||Single|||t|||
1505873|NCT00905190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505874|NCT00905177|||Cohort||Prospective|||||||
1505875|NCT00905164|Randomized|Crossover Assignment||||None (Open Label)||||||
1505876|NCT00905151|||Cohort||Other|||||||
1505877|NCT00905138|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1505878|NCT00905125|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1505879|NCT00905112|Randomized|Parallel Assignment||Treatment||Single||||||t
1505880|NCT00905086|||Cohort||Prospective|||||||
1505881|NCT00905073|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505882|NCT00905060||Single Group Assignment||Treatment||None (Open Label)||||||
1505883|NCT00905047|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505884|NCT00905034||Single Group Assignment||Treatment||None (Open Label)||||||
1505885|NCT00905021||Single Group Assignment||Treatment||None (Open Label)||||||
1505886|NCT00905008|||Case Control||Retrospective|||||||
1505887|NCT00904995|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505888|NCT00904982|Randomized|Parallel Assignment||Other||Single|||||t|
1505889|NCT00904969||Single Group Assignment||Treatment||None (Open Label)||||||
1505890|NCT00904956|||Case-Only||Prospective|||||||
1505891|NCT00904943|Randomized|Crossover Assignment||||None (Open Label)||||||
1505892|NCT00904930|||Cohort||Cross-Sectional|||||||
1505893|NCT00904917|Randomized|Parallel Assignment||Prevention||Single||||||t
1505894|NCT00904904|Randomized|Parallel Assignment||Prevention||Single|||||t|
1505895|NCT00904891|Randomized|Parallel Assignment||Prevention||Single||||||t
1505896|NCT00904878|||Other||Prospective|||||||
1505897|NCT00904865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505898|NCT00904852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505899|NCT00904839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505900|NCT00904826||Single Group Assignment||Treatment||None (Open Label)||||||
1505901|NCT00904813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505902|NCT00904800|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1505903|NCT00904787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505904|NCT00904774|||Cohort||Prospective|||||||
1505905|NCT00904761|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1505906|NCT00904748|Randomized|Crossover Assignment||||None (Open Label)||||||
1505907|NCT00904735|Randomized|||Treatment||None (Open Label)||||||
1505908|NCT00904722||Single Group Assignment||Treatment||None (Open Label)||||||
1505909|NCT00904709||Single Group Assignment||Treatment||None (Open Label)||||||
1505910|NCT00904696|||Case-Only||Prospective|||||||
1505911|NCT00904683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505912|NCT00904670|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1505913|NCT00904657|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1505914|NCT00904644|||Cohort||Other|||||||
1505915|NCT00904631||Single Group Assignment||Treatment||None (Open Label)||||||
1505916|NCT00904618|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505917|NCT00904605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505918|NCT00904592|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1505919|NCT00904579|||Cohort||Retrospective|||||||
1505920|NCT00904566|||Cohort||Retrospective|||||||
1505921|NCT00904553|||Case-Only||Prospective|||||||
1505922|NCT00904540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506448|NCT00897286|||Case-Only||Prospective|||||||
1505923|NCT00904527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505924|NCT00904514||||||||||||
1505925|NCT00904501|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505926|NCT00904488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505927|NCT00904475|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505928|NCT00904462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505929|NCT00904449||Single Group Assignment||Treatment||None (Open Label)||||||
1505930|NCT00904436||Factorial Assignment||||None (Open Label)||||||
1505931|NCT00904423||Single Group Assignment||Treatment||None (Open Label)||||||
1505932|NCT00904410|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1505933|NCT00904397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505934|NCT00904384|||Case-Only||Cross-Sectional|||||||
1505935|NCT00904371|||Cohort||Prospective|||||||
1505936|NCT00904358|||Cohort||Prospective|||||||
1505937|NCT00904345||Single Group Assignment||Treatment||None (Open Label)||||||
1505938|NCT00904332|||||Prospective|||||||
1505939|NCT00904319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505940|NCT00904306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505941|NCT00904293|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1505942|NCT00904280||Single Group Assignment||Treatment||None (Open Label)||||||
1505943|NCT00904254|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1505944|NCT00904241||||||||||||
1505945|NCT00904228|Randomized|Single Group Assignment||Prevention||Single|||t|||
1505946|NCT00904215|||||Prospective|||||||
1505947|NCT00904202|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505948|NCT00904189||Single Group Assignment||Diagnostic||None (Open Label)||||||
1505949|NCT00904176|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1505950|NCT00904163|||Case-Only||Prospective|||||||
1505951|NCT00904150|||Case Control||Cross-Sectional|||||||
1505952|NCT00904137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505953|NCT00904124|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1505954|NCT00904111|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505955|NCT00904098|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505956|NCT00904085|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1505957|NCT00904072|||Case Control||Retrospective|||||||
1505958|NCT00904059|Randomized|Crossover Assignment||||None (Open Label)||||||
1505959|NCT00904046|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1505960|NCT00904033|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1505961|NCT00904020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505962|NCT00904007|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1505963|NCT00903994|Non-Randomized|Single Group Assignment||Treatment||||||||
1505964|NCT00903981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505965|NCT00903968|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505966|NCT00903955|||Cohort||Cross-Sectional|||||||
1505967|NCT00903942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505968|NCT00903929||Single Group Assignment||Treatment||None (Open Label)||||||
1505969|NCT00903916|||Case-Only||Prospective|||||||
1505970|NCT00903903|||Case-Only||Cross-Sectional|||||||
1505971|NCT00903890|||Case-Only||Retrospective|||||||
1505972|NCT00903877||Single Group Assignment||Treatment||None (Open Label)||||||
1505973|NCT00903864|||||Prospective|||||||
1505974|NCT00903851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505975|NCT00903838|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1505976|NCT00903825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505977|NCT00903812|||Other||Other|||||||
1505978|NCT00903799|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1505979|NCT00903786||Single Group Assignment||Treatment||None (Open Label)||||||
1505980|NCT00903773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505981|NCT00903760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1505982|NCT00903747|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505983|NCT00903734||Single Group Assignment||Treatment||None (Open Label)||||||
1505984|NCT00903721|||Cohort||Prospective|||||||
1505985|NCT00903708|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505986|NCT00903695|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1505987|NCT00903682|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1505988|NCT00903669|||Case-Only||Prospective|||||||
1505989|NCT00903656|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505990|NCT00903643|||Case Control||Prospective|||||||
1505991|NCT00903630|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1505992|NCT00903617|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1505993|NCT00903604|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1505994|NCT00903591|||Case-Control||Prospective|||||||
1505995|NCT00903578|||||Prospective|||||||
1505996|NCT00903565|||Case-Only||Prospective|||||||
1505997|NCT00903552|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1505998|NCT00903539|||Cohort||Prospective|||||||
1505999|NCT00903526|||Cohort||Retrospective|||||||
1506000|NCT00903500|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1506001|NCT00903474|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1506002|NCT00903461||Single Group Assignment||Treatment||None (Open Label)||||||
1506003|NCT00903448|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1506004|NCT00903435|||Case Control||Prospective|||||||
1506005|NCT00903422|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506006|NCT00903409|Randomized|Single Group Assignment||Treatment||||||||
1506007|NCT00903396|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1506008|NCT00903383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506009|NCT00903370|Randomized|Parallel Assignment||Treatment||Single||||||t
1506010|NCT00903357|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1506011|NCT00903344|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506012|NCT00903331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506013|NCT00903318|||Case-Only||Prospective|||||||
1506014|NCT00903305||Parallel Assignment||Health Services Research||None (Open Label)||||||
1506015|NCT00903292||Parallel Assignment||Screening||None (Open Label)||||||
1506016|NCT00903279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506017|NCT00903266|Randomized|Parallel Assignment||Treatment||Single||||||t
1506018|NCT00903253|Randomized|||||Double||||||
1506019|NCT00903240|||Cohort||Prospective|||||||
1506020|NCT00903227|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1506021|NCT00903214||Single Group Assignment||Treatment||None (Open Label)||||||
1506022|NCT00903201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506023|NCT00903188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506024|NCT00903175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506025|NCT00903162||Single Group Assignment||Treatment||None (Open Label)||||||
1506026|NCT00903149|||Cohort|||||||||
1506027|NCT00903136||||Screening||None (Open Label)||||||
1506028|NCT00903110|||Case-Only||Other|||||||
1506029|NCT00903084|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1506030|NCT00903071|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1506031|NCT00903058||||||||||||
1506032|NCT00903045|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506033|NCT00903032|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1506034|NCT00903019|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1506035|NCT00903006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506036|NCT00902993|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1506037|NCT00902980|||Case Control||Retrospective|||||||
1506038|NCT00902967|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506039|NCT00902954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506040|NCT00902941|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1506041|NCT00902928|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506042|NCT00902915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506043|NCT00902902|||Case Control||Prospective|||||||
1506044|NCT00902889|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506045|NCT00902876|Randomized|Parallel Assignment||Treatment||Single||||||t
1506046|NCT00902863||Single Group Assignment||Supportive Care||None (Open Label)||||||
1506047|NCT00902850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506048|NCT00902837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506049|NCT00902824|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506050|NCT00902811|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506051|NCT00902798|Randomized|Parallel Assignment||Treatment||Single||||||t
1506052|NCT00902785|||Case Control||Prospective|||||||
1506053|NCT00902772|Randomized|Crossover Assignment||||Double|||t||t|
1506054|NCT00902759|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1506055|NCT00902746||Single Group Assignment||Treatment||None (Open Label)||||||
1506056|NCT00902733||||Health Services Research||||||||
1506057|NCT00902720||Single Group Assignment||Supportive Care||None (Open Label)||||||
1506058|NCT00902707|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1506059|NCT00902694|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1506060|NCT00902681|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1506061|NCT00902668||Single Group Assignment||Supportive Care||None (Open Label)||||||
1506062|NCT00902655||Single Group Assignment||Treatment||None (Open Label)||||||
1506063|NCT00902642|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506064|NCT00902629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506065|NCT00902616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506066|NCT00902603|||Cohort||Prospective|||||||
1506067|NCT00902590|||Case-Control||Prospective|||||||
1506068|NCT00902577||Single Group Assignment||Diagnostic||None (Open Label)||||||
1506069|NCT00902564||Single Group Assignment||Treatment||None (Open Label)||||||
1506070|NCT00902551|||Case Control||Prospective|||||||
1506071|NCT00902538|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506072|NCT00902525||Single Group Assignment||Treatment||None (Open Label)||||||
1506073|NCT00902512|Randomized|Crossover Assignment||||None (Open Label)||||||
1506074|NCT00902499|||Case Control||Cross-Sectional|||||||
1506075|NCT00902486|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506076|NCT00902473|Randomized|Crossover Assignment||||None (Open Label)||||||
1506077|NCT00902460|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506078|NCT00902447|||Case-Control||Cross-Sectional|||||||
1506079|NCT00902434|||Case-Only||Retrospective|||||||
1506080|NCT00902421|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506081|NCT00902408|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506082|NCT00902395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506083|NCT00902382|||Cohort||Prospective|||||||
1506084|NCT00902369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506085|NCT00902356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506086|NCT00902343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506087|NCT00902330|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1506088|NCT00902317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506089|NCT00902304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506090|NCT00902291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506091|NCT00902278|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1506092|NCT00902265|||Case-Only||Prospective|||||||
1506093|NCT00902252|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506094|NCT00902226||Single Group Assignment||Treatment||None (Open Label)||||||
1506095|NCT00902213|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1506096|NCT00902200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506097|NCT00902187|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1506098|NCT00902174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506099|NCT00902161|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1506100|NCT00902148|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506101|NCT00902135|||Cohort||Prospective|||||||
1506102|NCT00902122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506103|NCT00902109|||Cohort||Prospective|||||||
1506104|NCT00902096|||Cohort||Prospective|||||||
1506105|NCT00902083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506106|NCT00902070|||||Prospective|||||||
1506107|NCT00902057|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1506108|NCT00902044|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506109|NCT00902031|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506110|NCT00902018||Single Group Assignment||Treatment||None (Open Label)||||||
1506111|NCT00902005|||Cohort||Prospective|||||||
1506112|NCT00901992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506113|NCT00901979|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506114|NCT00901966|||Cohort||Prospective|||||||
1506115|NCT00901953|||Case Control||Prospective|||||||
1506116|NCT00901940|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506117|NCT00901927||Single Group Assignment||Treatment||None (Open Label)||||||
1506118|NCT00901914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506119|NCT00901901|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506120|NCT00901888|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1506121|NCT00901875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506122|NCT00901862|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1506123|NCT00901849||Single Group Assignment||Treatment||None (Open Label)||||||
1506124|NCT00901836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506125|NCT00901823|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506126|NCT00901810|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1506127|NCT00901797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506128|NCT00901784|Randomized|Crossover Assignment||||None (Open Label)||||||
1506129|NCT00901771|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506130|NCT00901758|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1506131|NCT00901745|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1506132|NCT00901732|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1506133|NCT00901719|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1506134|NCT00901706|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1506135|NCT00901693|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506136|NCT00901680|||||Prospective|||||||
1506137|NCT00901667||||||||||||
1506138|NCT00901654|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506139|NCT00901641||Parallel Assignment||Treatment||None (Open Label)||||||
1506140|NCT00901628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506141|NCT00901615||Single Group Assignment||Treatment||None (Open Label)||||||
1506142|NCT00901602|||Case-Only||Prospective|||||||
1506143|NCT00901589|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1506144|NCT00901576|Randomized|Crossover Assignment||||None (Open Label)||||||
1506145|NCT00901563|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1506146|NCT00901550|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506147|NCT00901537||Single Group Assignment||Treatment||None (Open Label)||||||
1506148|NCT00901524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506149|NCT00901511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506150|NCT00901498|Randomized|Crossover Assignment||||None (Open Label)||||||
1506151|NCT00901485|Randomized|Crossover Assignment||Treatment||Single||||||t
1506152|NCT00901472|||Cohort||Cross-Sectional|||||||
1506153|NCT00901459|Randomized|Crossover Assignment||Treatment||Single|||t|||
1506154|NCT00901446|||Case-Only||Cross-Sectional|||||||
1506155|NCT00901433|||Case-Only||Prospective|||||||
1506156|NCT00901420|||Case Control||Prospective|||||||
1506157|NCT00901407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506158|NCT00901394|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506159|NCT00901381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506160|NCT00901368|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506161|NCT00901355|||Cohort||Prospective|||||||
1506162|NCT00901342||Single Group Assignment||Treatment||None (Open Label)||||||
1506163|NCT00901329|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1506164|NCT00901316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506165|NCT00901303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506166|NCT00901290|Randomized|Crossover Assignment||||Double|||t||t|
1506167|NCT00901277|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1506168|NCT00901264|||Case Control||Prospective|||||||
1506169|NCT00901251|||Case-Only||Prospective|||||||
1506170|NCT00901238||Single Group Assignment||Treatment||None (Open Label)||||||
1506171|NCT00901225||Single Group Assignment||Treatment||None (Open Label)||||||
1506172|NCT00901212|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1506173|NCT00901199|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506174|NCT00901186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506175|NCT00901173|||Case-Control||Prospective|||||||
1506176|NCT00901160|||Cohort||Prospective|||||||
1506177|NCT00901147|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506178|NCT00901134|||Cohort|||||||||
1506179|NCT00901121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506180|NCT00901108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506181|NCT00901095|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1506182|NCT00901082|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1506183|NCT00901069||Single Group Assignment||Treatment||None (Open Label)||||||
1506184|NCT00901056|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506185|NCT00901043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506186|NCT00901030|||Cohort||Prospective|||||||
1506187|NCT00901017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506188|NCT00901004|||Cohort||Cross-Sectional|||||||
1506189|NCT00900991|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506190|NCT00900978|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1506191|NCT00900965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506192|NCT00900952|||Cohort||Prospective|||||||
1506193|NCT00900939|Randomized|Parallel Assignment||Treatment||Single||||||t
1506194|NCT00900913|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1506195|NCT00900900|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1506196|NCT00900887|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1506197|NCT00900874|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506198|NCT00900861|||Cohort||Prospective|||||||
1506199|NCT00900848|||Cohort||Retrospective|||||||
1506200|NCT00900835||Single Group Assignment||||None (Open Label)||||||
1506201|NCT00900822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506202|NCT00900809||Single Group Assignment||Treatment||None (Open Label)||||||
1506203|NCT00900796|||Cohort||Prospective|||||||
1506204|NCT00900783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506205|NCT00900770|||Cohort||Cross-Sectional|||||||
1506206|NCT00900757||Single Group Assignment||Prevention||None (Open Label)||||||
1506207|NCT00900744|||Cohort||Prospective|||||||
1506208|NCT00900731|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1506209|NCT00900718|Randomized|Parallel Assignment||Treatment||Single|||||t|
1506210|NCT00900705||||||||||||
1506211|NCT00900692|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506212|NCT00900679||||||||||||
1506213|NCT00900666|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506214|NCT00900653|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506215|NCT00900640|||Case-Only||Prospective|||||||
1506216|NCT00900627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506217|NCT00900614|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1506218|NCT00900601||Single Group Assignment||Treatment||None (Open Label)||||||
1506219|NCT00900588|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506220|NCT00900575||Single Group Assignment||Diagnostic||None (Open Label)||||||
1506221|NCT00900562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506222|NCT00900549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506223|NCT00900536||||||||||||
1506224|NCT00900523|||Case-Only||Prospective|||||||
1506225|NCT00900510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506226|NCT00900497||Single Group Assignment||Treatment||None (Open Label)||||||
1506227|NCT00900484||||||||||||
1506228|NCT00900471|||Case-Only||Other|||||||
1506229|NCT00900458|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1506230|NCT00900445||||||||||||
1506231|NCT00900432|||Case-Only||Prospective|||||||
1506232|NCT00900419|||Other||Prospective|||||||
1506233|NCT00900406|||Cohort||Prospective|||||||
1506234|NCT00900380|||Other||Retrospective|||||||
1506235|NCT00900367|||Cohort|||||||||
1506236|NCT00900354||||||||||||
1506237|NCT00900341|||Case-Only||Prospective|||||||
1506238|NCT00900328|||Cohort||Retrospective|||||||
1506239|NCT00900302|||Cohort||Retrospective|||||||
1506240|NCT00900289|||Case-Only||Prospective|||||||
1506241|NCT00900276|||Other||Prospective|||||||
1506242|NCT00900263|||Cohort||Prospective|||||||
1506243|NCT00900250||||||||||||
1506449|NCT00897273|||Cohort||Prospective|||||||
1506244|NCT00900237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506245|NCT00900224|||Cohort||Retrospective|||||||
1506246|NCT00900211||||||||||||
1506247|NCT00900198|||Case-Only||Other|||||||
1506248|NCT00900185||||||||||||
1506249|NCT00900172|||Other||Retrospective|||||||
1506250|NCT00900159|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1506251|NCT00900146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506252|NCT00900133|||Case-Only||Cross-Sectional|||||||
1506253|NCT00900120|||Case-Only||Prospective|||||||
1506254|NCT00900107||Single Group Assignment||Basic Science||None (Open Label)||||||
1506255|NCT00900094|||Cohort||Prospective|||||||
1506256|NCT00900081|||Cohort||Prospective|||||||
1506257|NCT00900068|||Cohort||Retrospective|||||||
1506258|NCT00900055|||Cohort||Prospective|||||||
1506259|NCT00900042|||||Prospective|||||||
1506260|NCT00900029|||Cohort||Prospective|||||||
1506261|NCT00900016|||Cohort||Prospective|||||||
1506262|NCT00900003|||Case-Only||Prospective|||||||
1506263|NCT00899990|||Cohort||Prospective|||||||
1506264|NCT00899977|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1506265|NCT00899964|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506266|NCT00899951|||Cohort||Prospective|||||||
1506267|NCT00899912|||Case-Only||Prospective|||||||
1506268|NCT00899899|||Case-Only||Retrospective|||||||
1506269|NCT00899873|||Other||Retrospective|||||||
1506270|NCT00899860|||Other||Prospective|||||||
1506271|NCT00899847||Single Group Assignment||Treatment||None (Open Label)||||||
1506272|NCT00899834|||Case-Only||Prospective|||||||
1506273|NCT00899821||||||||||||
1506274|NCT00899808|||Case Control||Retrospective|||||||
1506275|NCT00899795|||Case-Control||Prospective|||||||
1506276|NCT00899782|||Case-Only||Prospective|||||||
1506277|NCT00899769||||||||||||
1506278|NCT00899756||||||||||||
1506279|NCT00899743|||||Retrospective|||||||
1506280|NCT00899717|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1506281|NCT00899704|||Case-Only||Retrospective|||||||
1506282|NCT00899691||||||||||||
1506283|NCT00899678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506284|NCT00899665||||||||||||
1506285|NCT00899652|||Cohort||Prospective|||||||
1506286|NCT00899639|||Cohort||Retrospective|||||||
1506287|NCT00899626|||Case Control||Prospective|||||||
1506288|NCT00899613||||||||||||
1506289|NCT00899600|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1506290|NCT00899587||||||||||||
1506291|NCT00899574||Single Group Assignment||Treatment||None (Open Label)||||||
1506292|NCT00899561|||Cohort||Prospective|||||||
1506293|NCT00899548|||Cohort||Prospective|||||||
1506294|NCT00899535|||Cohort||Prospective|||||||
1506295|NCT00899522|||Case-Control||Retrospective|||||||
1506296|NCT00899509|||Case-Only||Retrospective|||||||
1506297|NCT00899496|||Other||Prospective|||||||
1506298|NCT00899483|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1506299|NCT00899470|Randomized|Crossover Assignment||||None (Open Label)||||||
1506300|NCT00899457|||Cohort||Prospective|||||||
1506301|NCT00899431|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506302|NCT00899418|||||Retrospective|||||||
1506303|NCT00899405|||Cohort||Prospective|||||||
1506304|NCT00899392|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1506305|NCT00899379|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506306|NCT00899366|||Other||Retrospective|||||||
1506307|NCT00899353||Single Group Assignment||Treatment||None (Open Label)||||||
1506308|NCT00899340|||Case-Only||Retrospective|||||||
1506309|NCT00899327||||||||||||
1506310|NCT00899301|||Cohort||Prospective|||||||
1506311|NCT00899288|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506312|NCT00899275|||Other||Retrospective|||||||
1506313|NCT00899262||||||||||||
1506314|NCT00899223|||Other||Prospective|||||||
1506315|NCT00899210||||||||||||
1506316|NCT00899197|||Cohort||Prospective|||||||
1506317|NCT00899184|||Other||Retrospective|||||||
1506318|NCT00899171|||||Retrospective|||||||
1506319|NCT00899158|||Case-Only||Cross-Sectional|||||||
1506320|NCT00899145||||||||||||
1506321|NCT00899132|||Case-Only||Cross-Sectional|||||||
1506322|NCT00899119||||||||||||
1506323|NCT00899093|||Cohort||Prospective|||||||
1506324|NCT00899080|||Other||Retrospective|||||||
1506325|NCT00899054||Single Group Assignment||Treatment||None (Open Label)||||||
1506326|NCT00899041|Randomized|Parallel Assignment||||Triple|||t||t|t
1506327|NCT00899028||||||||||||
1506328|NCT00899015||||||||||||
1506329|NCT00899002|||Case-Only||Retrospective|||||||
1506330|NCT00898989|||Case Control||Prospective|||||||
1506331|NCT00898976|||Case-Only||Prospective|||||||
1506332|NCT00898963|||Other||Retrospective|||||||
1506333|NCT00898950|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1506334|NCT00898937|||Cohort||Prospective|||||||
1506335|NCT00898924|||Cohort||Prospective|||||||
1506336|NCT00898911|||Other||Retrospective|||||||
1506337|NCT00898898|||Cohort||Retrospective|||||||
1506338|NCT00898885|||Cohort||Prospective|||||||
1506339|NCT00898872|||||Retrospective|||||||
1506340|NCT00898859|||Case Control||Prospective|||||||
1506341|NCT00898846|||Cohort||Prospective|||||||
1506342|NCT00898833|||Case-Control||Retrospective|||||||
1506343|NCT00898820||||||||||||
1506344|NCT00898807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506345|NCT00898794||||||||||||
1506346|NCT00898781|||Cohort||Prospective|||||||
1506347|NCT00898768||Single Group Assignment||Screening||None (Open Label)||||||
1506348|NCT00898755||||||||||||
1506349|NCT00898742|||Case-Only||Retrospective|||||||
1506350|NCT00898716||Single Group Assignment||Treatment||None (Open Label)||||||
1506351|NCT00898703|||Case-Only||Prospective|||||||
1506352|NCT00898690||||||||||||
1506353|NCT00898677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506354|NCT00898664|||Case-Only||Prospective|||||||
1506355|NCT00898638|||Cohort||Cross-Sectional|||||||
1506356|NCT00898612|||Cohort||Prospective|||||||
1506357|NCT00898599|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1506358|NCT00898573|||Case-Only||Cross-Sectional|||||||
1506359|NCT00898560|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506360|NCT00898547|||Case-Only||Prospective|||||||
1506361|NCT00898534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506362|NCT00898521||Single Group Assignment||Treatment||None (Open Label)||||||
1506363|NCT00898508|||Case-Control||Prospective|||||||
1506364|NCT00898495|||Other||Retrospective|||||||
1506365|NCT00898482|||Case-Only|||||||||
1506366|NCT00898469|||Cohort||Retrospective|||||||
1506367|NCT00898456|||Cohort||Retrospective|||||||
1506368|NCT00898443|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1506369|NCT00898430|||Case-Only||Prospective|||||||
1506370|NCT00898417|||Other||Retrospective|||||||
1506371|NCT00898404|||||Prospective|||||||
1506372|NCT00898391|||Case-Only||Retrospective|||||||
1506373|NCT00898378|||Case Control||Prospective|||||||
1506374|NCT00898365|||Case-Only||Prospective|||||||
1506375|NCT00898352|Randomized|||Treatment||||||||
1506376|NCT00898326|||Cohort||Prospective|||||||
1506377|NCT00898313|||Cohort||Prospective|||||||
1506378|NCT00898300|||Cohort||Prospective|||||||
1506379|NCT00898287||Single Group Assignment||Treatment||None (Open Label)||||||
1506380|NCT00898274|||Case Control||Prospective|||||||
1506381|NCT00898261|||Other||Retrospective|||||||
1506382|NCT00898235|||Other||Prospective|||||||
1506383|NCT00898222||Single Group Assignment||Basic Science||None (Open Label)||||||
1506384|NCT00898209|||Cohort||Prospective|||||||
1506385|NCT00898183|||Cohort||Prospective|||||||
1506386|NCT00898170|Non-Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1506387|NCT00898157|||Other||Retrospective|||||||
1506388|NCT00898144||||||||||||
1506389|NCT00898131|||Cohort||Prospective|||||||
1506390|NCT00898118||||||||||||
1506391|NCT00898092|||Case-Only||Retrospective|||||||
1506392|NCT00898079||||||||||||
1506393|NCT00898066||||||||||||
1506394|NCT00898053|||Cohort||Prospective|||||||
1506395|NCT00898040|||Other||Retrospective|||||||
1506396|NCT00898027|||Case-Only||Prospective|||||||
1506397|NCT00898014||||||||||||
1506398|NCT00897988||||||||||||
1506399|NCT00897975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506400|NCT00897962|||Other||Other|||||||
1506401|NCT00897949|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506402|NCT00897936|||Other||Retrospective|||||||
1506403|NCT00897923|||Cohort||Prospective|||||||
1506404|NCT00897910|||Case-Only||Prospective|||||||
1506405|NCT00897897||Single Group Assignment||Treatment||None (Open Label)||||||
1506406|NCT00897884||Single Group Assignment||Treatment||None (Open Label)||||||
1506407|NCT00897871||||||||||||
1506408|NCT00897858|||Cohort||Prospective|||||||
1506409|NCT00897845|||Other||Retrospective|||||||
1506410|NCT00897832|||Case-Only||Prospective|||||||
1506411|NCT00897819|||Other||Retrospective|||||||
1506412|NCT00897806|||Case-Only||Prospective|||||||
1506413|NCT00897793|||Cohort||Prospective|||||||
1506414|NCT00897780|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1506415|NCT00897767||||||||||||
1506416|NCT00897754|||Other||Retrospective|||||||
1506417|NCT00897741|||Case-Only||Prospective|||||||
1506418|NCT00897728||||||||||||
1506419|NCT00897715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506420|NCT00897702|||Case-Only||Prospective|||||||
1506421|NCT00897676|Randomized|Crossover Assignment||Treatment||None (Open Label)||In a random crossover design, subjects were assigned to either intervention (6 hour infusion of exendin( 9-39) at a dose range of 100-500pmol/kg/min) or vehicle (6hr infusion of 0.9%NaCl)||||
1506422|NCT00897663|||Cohort||Cross-Sectional|||||||
1506423|NCT00897650|||Cohort||Prospective|||||||
1506424|NCT00897637|||Cohort||Retrospective|||||||
1506425|NCT00897624||||||||||||
1506426|NCT00897611||Single Group Assignment||||None (Open Label)||||||
1506427|NCT00897559|||Cohort||Retrospective|||||||
1506428|NCT00897546|||Other||Retrospective|||||||
1506429|NCT00897533|||Other||Retrospective|||||||
1506430|NCT00897520|||Other||Retrospective|||||||
1506431|NCT00897507|||Case-Only||Retrospective|||||||
1506432|NCT00897494|||Case-Only||Prospective|||||||
1506433|NCT00897481||||||||||||
1506434|NCT00897468|||Case-Only||Prospective|||||||
1506435|NCT00897455||||||||||||
1506436|NCT00897442|||Cohort||Prospective|||||||
1506437|NCT00897429|||Case-Control||Retrospective|||||||
1506438|NCT00897416|||||Prospective|||||||
1506439|NCT00897403|||||Prospective|||||||
1506440|NCT00897390|Randomized|Crossover Assignment||||None (Open Label)||||||
1506441|NCT00897377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506442|NCT00897364|||Other||Prospective|||||||
1506443|NCT00897351|||Other||Retrospective|||||||
1506444|NCT00897338|||Cohort||Prospective|||||||
1506445|NCT00897325||||||||||||
1506446|NCT00897312|||Case-Only||Prospective|||||||
1506450|NCT00897260||Single Group Assignment||Treatment||None (Open Label)||||||
1506451|NCT00897247|||Case Control||Prospective|||||||
1506452|NCT00897234|||Cohort||Prospective|||||||
1506453|NCT00897221|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506454|NCT00897208|||Cohort||Prospective|||||||
1506455|NCT00897182|||Cohort||Retrospective|||||||
1506456|NCT00897169|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506457|NCT00897143|||||Retrospective|||||||
1506458|NCT00897130|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506459|NCT00897117|||Cohort||Prospective|||||||
1506460|NCT00897104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506461|NCT00897091|||||Retrospective|||||||
1506462|NCT00897078|||Case-Only||Prospective|||||||
1506463|NCT00897065||||||||||||
1506464|NCT00897052|||Case-Only||Retrospective|||||||
1506465|NCT00897039||||||||||||
1506466|NCT00897026|||Case-Only||Prospective|||||||
1506467|NCT00896987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506468|NCT00896974||Single Group Assignment||Treatment||None (Open Label)||||||
1506469|NCT00896961||Single Group Assignment||||None (Open Label)||||||
1506470|NCT00896948||||||||||||
1506471|NCT00896935|||Other||Other|||||||
1506472|NCT00896922|||Other||Retrospective|||||||
1506473|NCT00896909|||Other||Retrospective|||||||
1506474|NCT00896896|||Cohort||Retrospective|||||||
1506475|NCT00896883||Single Group Assignment||Prevention||None (Open Label)||||||
1506476|NCT00896857|||Cohort||Prospective|||||||
1506477|NCT00896844|Randomized|Parallel Assignment||Treatment||Single|||||t|
1506478|NCT00896831|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506479|NCT00896818||||||||||||
1506480|NCT00896792||Single Group Assignment||Other||||||||
1506481|NCT00896779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506482|NCT00896766|||Case-Only||Retrospective|||||||
1506483|NCT00896753|||Cohort||Retrospective|||||||
1506484|NCT00896740|||Case-Control||Prospective|||||||
1506485|NCT00896727|||||Retrospective|||||||
1506486|NCT00896714||Single Group Assignment||Treatment||None (Open Label)||||||
1506487|NCT00896701|||Case-Only||Prospective|||||||
1506488|NCT00896688|||Other||Prospective|||||||
1506489|NCT00896675|||Case-Only||Retrospective|||||||
1506490|NCT00896662|||Case-Only||Prospective|||||||
1506491|NCT00896649||Single Group Assignment||Screening||None (Open Label)||PEM||||
1506492|NCT00896636|||Cohort||Prospective|||||||
1506493|NCT00896623|||Other||Retrospective|||||||
1506494|NCT00896610|||||Prospective|||||||
1506495|NCT00896597|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1506496|NCT00896584|||Case-Only||Prospective|||||||
1506497|NCT00896571|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1506498|NCT00896558|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1506499|NCT00896545|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506500|NCT00896532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506501|NCT00896519|Non-Randomized|||Treatment||None (Open Label)||||||
1506502|NCT00896493||Single Group Assignment||Treatment||None (Open Label)||||||
1506503|NCT00896480||Single Group Assignment||Treatment||None (Open Label)||||||
1506504|NCT00896467||||||||||||
1506505|NCT00896454||Single Group Assignment||Treatment||None (Open Label)||||||
1506506|NCT00896441|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506507|NCT00896428|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506508|NCT00896415|||Ecologic or Community|||||||||
1506509|NCT00896402|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1506510|NCT00896389||Single Group Assignment||Treatment||None (Open Label)||||||
1506511|NCT00896376||Single Group Assignment||Treatment||None (Open Label)||||||
1506512|NCT00896363|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506513|NCT00896350||||Diagnostic||None (Open Label)||||||
1506514|NCT00896337||Single Group Assignment||Treatment||None (Open Label)||||||
1506515|NCT00896324|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1506516|NCT00896311|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1506517|NCT00896298|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1506518|NCT00896285|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1506519|NCT00896272|||||Retrospective|||||||
1506520|NCT00896259|||Case Control||Prospective|||||||
1506521|NCT00896246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506522|NCT00896233|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1506523|NCT00896220|||Cohort||Prospective|||||||
1506524|NCT00896207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506525|NCT00896194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506526|NCT00896181||Single Group Assignment||Treatment||None (Open Label)||||||
1506527|NCT00896168|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506528|NCT00896155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506529|NCT00896142|||Cohort||Prospective|||||||
1506530|NCT00896129|||Case-Only||Cross-Sectional|||||||
1506531|NCT00896090||||||||||||
1506532|NCT00896077|Randomized|Crossover Assignment||||None (Open Label)||||||
1506533|NCT00896064|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1506534|NCT00896051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506535|NCT00896038|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506536|NCT00896025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506537|NCT00896012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506538|NCT00895999|Randomized|Parallel Assignment||Treatment||Single||||||t
1506539|NCT00895986|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1506540|NCT00895973|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506541|NCT00895960||Single Group Assignment||Treatment||None (Open Label)||||||
1506542|NCT00895947|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506543|NCT00895934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506544|NCT00895921|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1506545|NCT00895908|Randomized|Parallel Assignment||Prevention||Double||Comparison of social skill training intervention with active attention control group (academic tutoring)|t|||t
1506546|NCT00895895|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506547|NCT00895882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506548|NCT00895869|||||Prospective|||||||
1506549|NCT00895856|||||Prospective|||||||
1506550|NCT00895843|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1506551|NCT00895830|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506552|NCT00895817|Randomized|Parallel Assignment||Treatment||Single|||||t|
1506553|NCT00895804|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1506554|NCT00895791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506555|NCT00895778|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1506556|NCT00895765|||Case-Only||Prospective|||||||
1506557|NCT00895752||Single Group Assignment||Treatment||None (Open Label)||||||
1506558|NCT00895739|Non-Randomized|||Treatment||None (Open Label)||||||
1506559|NCT00895726||Single Group Assignment||Treatment||None (Open Label)||||||
1506560|NCT00895713|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1506561|NCT00895700|Randomized|Parallel Assignment||||None (Open Label)||||||
1506562|NCT00895687||Single Group Assignment||Treatment||None (Open Label)||||||
1506563|NCT00895674|||Cohort||Prospective|||||||
1506564|NCT00895661||Single Group Assignment||Treatment||None (Open Label)||||||
1506565|NCT00895648||Single Group Assignment||Treatment||None (Open Label)||||||
1506566|NCT00895635|Randomized|Parallel Assignment||Treatment||Single||||||t
1506567|NCT00895622|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506568|NCT00895609|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1506569|NCT00895596|Non-Randomized|||Treatment||None (Open Label)||||||
1506570|NCT00895583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506571|NCT00895570|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506572|NCT00895557|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1506573|NCT00895544|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506574|NCT00895531|Randomized|Parallel Assignment||Treatment||Single|||||t|
1506575|NCT00895518|Randomized|Parallel Assignment||Prevention||Single||||||t
1506576|NCT00895505|Randomized|Parallel Assignment||||None (Open Label)||||||
1506577|NCT00895492|||Case-Only||Prospective|||||||
1506578|NCT00895479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506579|NCT00895466||||||||||||
1506580|NCT00895453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506581|NCT00895440|||||Cross-Sectional|||||||
1506582|NCT00895427|||Cohort||Cross-Sectional|||||||
1506583|NCT00895414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506584|NCT00895401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506585|NCT00895388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506586|NCT00895375|||Case-Control||Cross-Sectional|||||||
1506587|NCT00895362||Single Group Assignment||Treatment||None (Open Label)||||||
1506588|NCT00895349|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1506589|NCT00895336||Single Group Assignment||Treatment||None (Open Label)||||||
1506590|NCT00895323||||Diagnostic||None (Open Label)||||||
1506591|NCT00895310||Single Group Assignment||Treatment||None (Open Label)||||||
1506592|NCT00895297|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506593|NCT00895284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506594|NCT00895271|||Cohort||Prospective|||||||
1506595|NCT00895258|Randomized|Parallel Assignment||Treatment||Single||||||t
1506596|NCT00895245||Single Group Assignment||Supportive Care||None (Open Label)||||||
1506597|NCT00895232|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506598|NCT00895219|Randomized|Parallel Assignment||Treatment||Single||||||t
1506599|NCT00895206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506600|NCT00895193|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1506601|NCT00895180|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506602|NCT00895167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506603|NCT00895154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506604|NCT00895141|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1506605|NCT00895128||Single Group Assignment||Treatment||None (Open Label)||||||
1506606|NCT00895115|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506607|NCT00895102|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1506608|NCT00895089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506609|NCT00895076|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506610|NCT00895063|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506611|NCT00895050|||Cohort||Prospective|||||||
1506612|NCT00895037|||Cohort||Prospective|||||||
1506613|NCT00895024|||Other||Prospective|||||||
1506614|NCT00895011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506615|NCT00894998|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506616|NCT00894985|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506617|NCT00894972|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1506618|NCT00894959|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506619|NCT00894946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506620|NCT00894933||Single Group Assignment||Treatment||None (Open Label)||||||
1506621|NCT00894920|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1506622|NCT00894907|Randomized|Parallel Assignment||Treatment||Single||||||t
1506623|NCT00894894||Single Group Assignment||Treatment||None (Open Label)||||||
1506624|NCT00894881|||Cohort||Prospective|||||||
1506625|NCT00894868|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506626|NCT00894855|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1506627|NCT00894842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506628|NCT00894829|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506629|NCT00894816|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506630|NCT00894803|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506631|NCT00894790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506632|NCT00894777|||Case-Only||Retrospective|||||||
1506633|NCT00894764|||Cohort||Prospective|||||||
1506634|NCT00894751|Randomized|Parallel Assignment||||None (Open Label)||||||
1506635|NCT00894738|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1506636|NCT00894725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506637|NCT00894712|||Cohort||Prospective|||||||
1506638|NCT00894699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506639|NCT00894686|Non-Randomized|||Prevention||None (Open Label)||||||
1506640|NCT00894673|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506641|NCT00894660|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1506642|NCT00894647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506643|NCT00894634|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506644|NCT00894621|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506645|NCT00894608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506646|NCT00894595|Randomized|Parallel Assignment||Prevention||Single||||||t
1506647|NCT00894582|||Cohort||Prospective|||||||
1506648|NCT00894569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506649|NCT00894556|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1506650|NCT00894543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506651|NCT00894530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506652|NCT00894517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506653|NCT00894504||Single Group Assignment||Treatment||None (Open Label)||||||
1506654|NCT00894491|||Cohort||Retrospective|||||||
1506655|NCT00894478|||Cohort||Cross-Sectional|||||||
1506656|NCT00894465|Randomized|Parallel Assignment||||Triple|||t|t|t|
1506657|NCT00894452|||Case-Only||Cross-Sectional|||||||
1506658|NCT00894439|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506659|NCT00894426|||Cohort||Prospective|||||||
1506660|NCT00894413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506661|NCT00894400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506662|NCT00894387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506663|NCT00894374|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1506664|NCT00894361|Randomized|Parallel Assignment||Treatment||Single|||t|||
1506665|NCT00894348|||Other||Prospective|||||||
1506666|NCT00894335|||Cohort||Prospective|||||||
1506667|NCT00894322|Randomized|Parallel Assignment||Treatment||Single|||t|||
1506668|NCT00894309|||Cohort||Prospective|||||||
1506669|NCT00894296|||Case Control||Prospective|||||||
1506670|NCT00894283|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1506671|NCT00894270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506672|NCT00894257|||Cohort||Retrospective|||||||
1506673|NCT00894244||Single Group Assignment||Treatment||Single||||||t
1506674|NCT00894231|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1506675|NCT00894218|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1506676|NCT00894205||Single Group Assignment||Prevention||None (Open Label)||||||
1506677|NCT00894192|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506678|NCT00894179|||Case-Only||Prospective|||||||
1506679|NCT00894166|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506680|NCT00894153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506681|NCT00894140||Single Group Assignment||Treatment||None (Open Label)||||||
1506682|NCT00894127||Single Group Assignment||Diagnostic||Single|||||t|
1506683|NCT00894114|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1506684|NCT00894101|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1506685|NCT00894088|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506686|NCT00894075||Single Group Assignment||Treatment||None (Open Label)||||||
1506687|NCT00894062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506688|NCT00894049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506689|NCT00894036|||Ecologic or Community||Prospective|||||||
1506690|NCT00894023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506691|NCT00894010|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1506692|NCT00893997||Single Group Assignment||Treatment||None (Open Label)||||||
1506693|NCT00893984||Single Group Assignment||Treatment||None (Open Label)||||||
1506694|NCT00893971|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1506695|NCT00893958|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506696|NCT00893945||Single Group Assignment||Prevention||None (Open Label)||||||
1506697|NCT00893932|||Cohort||Prospective|||||||
1506698|NCT00893919|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506699|NCT00893906|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1506700|NCT00893893|||Cohort||Prospective|||||||
1506701|NCT00893880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506702|NCT00893867|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506703|NCT00893854|Randomized|Parallel Assignment||Treatment||Double||||||
1506704|NCT00893841|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506705|NCT00893828|||Cohort||Prospective|||||||
1506706|NCT00893815|||Case-Control||Cross-Sectional|||||||
1506707|NCT00893802|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1506708|NCT00893789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506709|NCT00893776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506710|NCT00893763|Randomized|Parallel Assignment||Prevention||Single||||||t
1506711|NCT00893750|Randomized|Parallel Assignment||Treatment||Single||||||t
1506712|NCT00893737||Single Group Assignment||Treatment||None (Open Label)||||||
1506713|NCT00893724|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506714|NCT00893711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506715|NCT00893698||Single Group Assignment||Treatment||None (Open Label)||||||
1506716|NCT00893685|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1506717|NCT00893672|||Case-Crossover||Prospective|||||||
1506718|NCT00893659|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1506719|NCT00893646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506720|NCT00893633|||Case-Only||Prospective|||||||
1506721|NCT00893620||Single Group Assignment||Treatment||None (Open Label)||||||
1506722|NCT00893607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506723|NCT00893594|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506724|NCT00893581|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1506725|NCT00893568|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1506726|NCT00893555|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506727|NCT00893542|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506728|NCT00893529|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1506729|NCT00893516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506730|NCT00893503|||Cohort||Prospective|||||||
1506731|NCT00893490||||Treatment||||||||
1506732|NCT00893477|Non-Randomized|||Treatment||None (Open Label)||||||
1506733|NCT00893464||Single Group Assignment||Treatment||None (Open Label)||||||
1506734|NCT00893451|Randomized|Crossover Assignment||Treatment||Single|||t|||
1506735|NCT00893438|Randomized|Parallel Assignment||Treatment||Single||||||t
1506736|NCT00893425||Single Group Assignment||Treatment||Single||||||
1506737|NCT00893412|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506738|NCT00893399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506739|NCT00893386|||Cohort||Prospective|||||||
1506740|NCT00893373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506741|NCT00893360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506742|NCT00893347|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506743|NCT00893334|||Case Control||Prospective|||||||
1506744|NCT00893321|Randomized|Parallel Assignment||Treatment||Single|||t|||
1506745|NCT00893308|||Cohort||Prospective|||||||
1506746|NCT00893295|Randomized|||Screening||None (Open Label)||||||
1506747|NCT00893282|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1506748|NCT00893269|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1506749|NCT00893256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506750|NCT00893243|||Cohort||Prospective|||||||
1506751|NCT00893230|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506752|NCT00893217|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506753|NCT00893191|||Case Control||Prospective|||||||
1506754|NCT00893178|||Case-Control||Prospective|||||||
1506755|NCT00893165|||Case-Crossover||Prospective|||||||
1506756|NCT00893152||||||||||||
1506757|NCT00893139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506758|NCT00893126|||Case Control||Prospective|||||||
1506759|NCT00893113|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1506760|NCT00893100|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1506761|NCT00893087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506762|NCT00893074|Randomized|Crossover Assignment||Basic Science||Double|Dronbinol doses were double blind and placebo controlled|Within-subjects cross-over evaluation of 0, 30, 60, and 120mg dronabinol per day on withdrawal, cognitive performance, and response to acute cannabis exposure|t|||t
1506763|NCT00893061|Randomized|||Treatment||None (Open Label)||||||
1506764|NCT00893048|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1506765|NCT00893035|||Cohort||Prospective|||||||
1506766|NCT00893009|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1506767|NCT00892996|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506768|NCT00892983|Randomized|Parallel Assignment||Prevention||Single||||||t
1506769|NCT00892970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506770|NCT00892957|Randomized|Parallel Assignment||Treatment||Single|||t|||
1506771|NCT00892944||Single Group Assignment||Basic Science||None (Open Label)||||||
1506772|NCT00892931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506773|NCT00892918|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506774|NCT00892905|||||Prospective|||||||
1506775|NCT00892892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506776|NCT00892879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506777|NCT00892866||||||||||||
1506778|NCT00892853|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1506779|NCT00892840|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506780|NCT00892827||Single Group Assignment||Treatment||None (Open Label)||||||
1506781|NCT00892814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506782|NCT00892801||Single Group Assignment||Treatment||None (Open Label)||||||
1506783|NCT00892788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506784|NCT00892775|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506785|NCT00892762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506786|NCT00892749||Single Group Assignment||Treatment||None (Open Label)||||||
1506787|NCT00892736||Single Group Assignment||Treatment||None (Open Label)||||||
1506788|NCT00892723|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1506789|NCT00892710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506790|NCT00892697||Single Group Assignment||Treatment||None (Open Label)||||||
1506791|NCT00892684|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506792|NCT00892671||||||||||||
1506793|NCT00892658||Single Group Assignment||Treatment||None (Open Label)||||||
1506794|NCT00892632||Single Group Assignment||Diagnostic||None (Open Label)||||||
1506795|NCT00892619|Randomized|Parallel Assignment||||Single|||t|||
1506796|NCT00892606|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1506797|NCT00892593|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1506798|NCT00892580|||Cohort||Prospective|||||||
1506799|NCT00892567||Single Group Assignment||Treatment||None (Open Label)||||||
1506800|NCT00892554|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506801|NCT00892541|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506802|NCT00892515|Randomized|||||Single||||||
1506803|NCT00892502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506804|NCT00892489|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506805|NCT00892476|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506806|NCT00892463||Single Group Assignment||Treatment||None (Open Label)||||||
1506807|NCT00892450|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1506808|NCT00892437|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506809|NCT00892424||Single Group Assignment||Treatment||None (Open Label)||||||
1506810|NCT00892411|||Cohort||Prospective|||||||
1506811|NCT00892398|Randomized|Parallel Assignment||Treatment||Single|||t|||
1506812|NCT00892385||Single Group Assignment||Treatment||None (Open Label)||||||
1506813|NCT00892372|||Case-Only||Retrospective|||||||
1506814|NCT00892359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506815|NCT00892346||Single Group Assignment||Treatment||None (Open Label)||||||
1506816|NCT00892333|||Case-Only||Prospective|||||||
1506817|NCT00892320|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506818|NCT00892307|||||Prospective|||||||
1506819|NCT00892281|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506820|NCT00892268|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1506821|NCT00892255|||Case-Only||Prospective|||||||
1506822|NCT00892242||Single Group Assignment||Treatment||None (Open Label)||||||
1506823|NCT00892229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506824|NCT00892216|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1506825|NCT00892203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506826|NCT00892190||Single Group Assignment||Treatment||None (Open Label)||||||
1506827|NCT00892177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506828|NCT00892164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506829|NCT00892151||Single Group Assignment||Diagnostic||None (Open Label)||||||
1506830|NCT00892138|Randomized|Parallel Assignment||Prevention||Single||||||t
1506831|NCT00892125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506832|NCT00892112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506833|NCT00892099|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506834|NCT00892086|||Cohort||Prospective|||||||
1506835|NCT00892073||Single Group Assignment||Treatment||None (Open Label)||||||
1506836|NCT00892047|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1506837|NCT00892021|Randomized|Parallel Assignment||||Double||||||
1506838|NCT00892008|||Cohort||Prospective|||||||
1506839|NCT00891995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506840|NCT00891982|Randomized|Parallel Assignment||Treatment||Single||||||t
1506841|NCT00891969|||Cohort||Prospective|||||||
1506842|NCT00891956|||||Prospective|||||||
1506843|NCT00891943|Randomized|Parallel Assignment||Treatment||Single||||||t
1506844|NCT00891930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506845|NCT00891917|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1506846|NCT00891904||Single Group Assignment||Treatment||None (Open Label)||||||
1506847|NCT00891891|||Cohort||Prospective|||||||
1506848|NCT00891878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506849|NCT00891865|||Case-Only||Prospective|||||||
1506850|NCT00891852|||Case-Only||Cross-Sectional|||||||
1506851|NCT00891839||Single Group Assignment||Treatment||None (Open Label)||||||
1506852|NCT00891826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506853|NCT00891813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506854|NCT00891800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506855|NCT00891787|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1506856|NCT00891774||Single Group Assignment||Treatment||None (Open Label)||||||
1506857|NCT00891761|Randomized|Parallel Assignment||Supportive Care||Double||||||
1506858|NCT00891748||Single Group Assignment||Treatment||None (Open Label)||||||
1506859|NCT00891735|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1506860|NCT00891722||||||||||||
1506861|NCT00891709|Randomized|Parallel Assignment||||Triple|||t||t|t
1506862|NCT00891696|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1506863|NCT00891683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506864|NCT00891670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506865|NCT00891657|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506866|NCT00891644|||Case-Control||Prospective|||||||
1506867|NCT00891631|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1506868|NCT00891618||Single Group Assignment||Treatment||None (Open Label)||||||
1506869|NCT00891605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506870|NCT00891592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506871|NCT00891579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506872|NCT00891566|||Case Control||Prospective|||||||
1506873|NCT00891553|||||Prospective|||||||
1506874|NCT00891540|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1506875|NCT00891527||Single Group Assignment||Treatment||None (Open Label)||||||
1506876|NCT00891514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506877|NCT00891501||Single Group Assignment||Treatment||None (Open Label)||||||
1506878|NCT00891488|||Case Control||Prospective|||||||
1506879|NCT00891475|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506880|NCT00891462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506881|NCT00891449|||Cohort||Prospective|||||||
1506882|NCT00891436|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1506883|NCT00891423|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1506884|NCT00891397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506885|NCT00891384|Randomized|Parallel Assignment||Treatment||Single|||t|||
1506886|NCT00891371||Single Group Assignment||Treatment||None (Open Label)||||||
1506887|NCT00891358||Single Group Assignment||Prevention||None (Open Label)||||||
1506888|NCT00891345||Single Group Assignment||Treatment||None (Open Label)||||||
1506889|NCT00891332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506890|NCT00891319|Randomized|Parallel Assignment||Treatment||Single||||||t
1506891|NCT00891306||Single Group Assignment||Treatment||None (Open Label)||||||
1506892|NCT00891293||Single Group Assignment||Treatment||None (Open Label)||||||
1506893|NCT00891280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506894|NCT00891267|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1506895|NCT00891254|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1506896|NCT00891241|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1506897|NCT00891228|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1506898|NCT00891202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506899|NCT00891189|||Case Control||Prospective|||||||
1506900|NCT00891176|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506901|NCT00891163|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1506902|NCT00891150|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1506903|NCT00891137|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1506904|NCT00891124|||Cohort||Prospective|||||||
1506905|NCT00891111|Randomized|Parallel Assignment||Other||Single|||t|||
1506906|NCT00891098|Randomized|Parallel Assignment||Treatment||Single||||||t
1506907|NCT00891085|||||Prospective|||||||
1506908|NCT00891072||Single Group Assignment||Treatment||None (Open Label)||||||
1506909|NCT00891059|||Case-Only||Cross-Sectional|||||||
1506910|NCT00891046||Single Group Assignment||Treatment||None (Open Label)||||||
1506911|NCT00891033|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506912|NCT00891020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506913|NCT00891007|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506914|NCT00890994|||Case-Only||Cross-Sectional|||||||
1506915|NCT00890981||Single Group Assignment||Supportive Care||None (Open Label)||||||
1506916|NCT00890968|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506917|NCT00890955||Single Group Assignment||Treatment||None (Open Label)||||||
1506918|NCT00890942|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1506919|NCT00890929||Single Group Assignment||Treatment||None (Open Label)||||||
1506920|NCT00890916||Single Group Assignment||Treatment||None (Open Label)||||||
1506921|NCT00890903|||Cohort||Prospective|||||||
1506922|NCT00890890|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506923|NCT00890877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506924|NCT00890864|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506925|NCT00890851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506926|NCT00890838|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1506927|NCT00890825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506928|NCT00890812|||Case Control||Retrospective|||||||
1506929|NCT00890799||Single Group Assignment||Treatment||Single|||t|||
1506930|NCT00890786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506931|NCT00890760|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506932|NCT00890747||Single Group Assignment||Treatment||None (Open Label)||||||
1506933|NCT00890734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506934|NCT00890721|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1506935|NCT00890708|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1506936|NCT00890695|Randomized|Parallel Assignment||Treatment||None (Open Label)||Open label randomised trial of nutrition products||||
1506937|NCT00890682|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1506938|NCT00890669||Single Group Assignment||Treatment||None (Open Label)||||||
1506939|NCT00890656||Single Group Assignment||Treatment||None (Open Label)||||||
1506940|NCT00890643|Randomized|Parallel Assignment||Basic Science||Double||||||
1506941|NCT00890630|Randomized|Parallel Assignment||Treatment||Single||||||t
1506942|NCT00890617||Single Group Assignment||Treatment||None (Open Label)||||||
1506943|NCT00890604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506944|NCT00890591||Single Group Assignment||Treatment||None (Open Label)||||||
1506945|NCT00890578|||Cohort||Prospective|||||||
1506946|NCT00890565|Randomized|Parallel Assignment||||Single|||t|||
1506947|NCT00890552||Single Group Assignment||Treatment||None (Open Label)||||||
1506948|NCT00890539|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1506949|NCT00890526|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1506950|NCT00890513|||Cohort||Prospective|||||||
1506951|NCT00890500|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1506952|NCT00890487|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1506953|NCT00890474|Randomized|Parallel Assignment||Treatment||Single||||t||
1506954|NCT00890461|||Cohort||Prospective|||||||
1506955|NCT00890448|||Case Control|||||||||
1506956|NCT00890435|||Cohort||Prospective|||||||
1506957|NCT00890422|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1506958|NCT00890409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506959|NCT00890396|||Cohort|||||||||
1506960|NCT00890383|Randomized|Parallel Assignment||Treatment||Single||||||t
1506961|NCT00890370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506962|NCT00890357|||Cohort||Prospective|||||||
1506963|NCT00890344|||||Prospective|||||||
1506964|NCT00890331|Randomized|Parallel Assignment||Prevention||Single|||t|||
1506965|NCT00890318|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1506966|NCT00890305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506967|NCT00890292|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1506968|NCT00890279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506969|NCT00890266||Single Group Assignment||Prevention||None (Open Label)||||||
1506970|NCT00890253||Single Group Assignment||Treatment||None (Open Label)||||||
1506971|NCT00890240|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1506972|NCT00890227|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1506973|NCT00890214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506974|NCT00890201|||Case Control||Prospective|||||||
1506975|NCT00890188||Single Group Assignment||Treatment||None (Open Label)||||||
1506976|NCT00890175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1506977|NCT00890162|Randomized|Parallel Assignment||Treatment||||||||
1506978|NCT00890149|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1506979|NCT00890136|||Case-Only||Prospective|||||||
1506980|NCT00890123|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1506981|NCT00890110|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506982|NCT00890097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506983|NCT00890084|||||Prospective|||||||
1506984|NCT00890071|||Case-Only||Prospective|||||||
1506985|NCT00890058|||Case Control||Cross-Sectional|||||||
1506986|NCT00890045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506987|NCT00890032||Single Group Assignment||Treatment||None (Open Label)||||||
1506988|NCT00890019|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1506989|NCT00890006||Single Group Assignment||Diagnostic||None (Open Label)||||||
1506990|NCT00889993|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1506991|NCT00889980|||Case-Only||Cross-Sectional|||||||
1506992|NCT00889967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1506993|NCT00889954||Single Group Assignment||Treatment||None (Open Label)||||||
1506994|NCT00889941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1506995|NCT00889928||Single Group Assignment||Treatment||None (Open Label)||||||
1506996|NCT00889915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1506997|NCT00889902|||Case Control||Prospective|||||||
1506998|NCT00889889|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1506999|NCT00889876|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1507000|NCT00889863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507001|NCT00889850|Randomized|Crossover Assignment||||None (Open Label)||||||
1507002|NCT00889837|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1507003|NCT00889824||Single Group Assignment||Treatment||None (Open Label)||||||
1507004|NCT00889811|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1507005|NCT00889798|||Cohort||Prospective|||||||
1507006|NCT00889785|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1507007|NCT00889772|||Cohort|||||||||
1507008|NCT00889759|||Cohort||Prospective|||||||
1507009|NCT00889746||||||||||||
1507010|NCT00889733||Single Group Assignment||Treatment||None (Open Label)||||||
1507011|NCT00889720|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507012|NCT00889707|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507013|NCT00889694|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507014|NCT00889681||Single Group Assignment||Treatment||None (Open Label)||||||
1507015|NCT00889668||Single Group Assignment||Screening||None (Open Label)||||||
1507016|NCT00889655|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1507017|NCT00889642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507018|NCT00889629|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1507019|NCT00889616|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507020|NCT00889603|||Case-Only||Prospective|||||||
1507021|NCT00889590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507022|NCT00889577|||Cohort||Cross-Sectional|||||||
1507023|NCT00889564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507024|NCT00889551||||||||||||
1507025|NCT00889538|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1507026|NCT00889525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507027|NCT00889512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507028|NCT00889499|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1507029|NCT00889486|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507030|NCT00889473|Randomized|Parallel Assignment||Treatment||Double|double-blind|randomized, double-blind, placebo-controlled, dose ranging, multicenter|t||t|
1507031|NCT00889460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507032|NCT00889447|||Case-Only||Cross-Sectional|||||||
1507033|NCT00889434|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507034|NCT00889421||Single Group Assignment||Treatment||None (Open Label)||||||
1507035|NCT00889408||Single Group Assignment||Treatment||None (Open Label)||||||
1507036|NCT00889395|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507037|NCT00889382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507038|NCT00889369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507039|NCT00889356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507040|NCT00889343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507041|NCT00889330|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507042|NCT00889317|||Cohort||Prospective|||||||
1507043|NCT00889304|||Cohort||Prospective|||||||
1507044|NCT00889291|||Cohort||Other|||||||
1507045|NCT00889278|||Cohort||Prospective|||||||
1507046|NCT00889265||Single Group Assignment||Treatment||None (Open Label)||||||
1507047|NCT00889252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507048|NCT00889239||Single Group Assignment||Treatment||None (Open Label)||||||
1507049|NCT00889226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507050|NCT00889213|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1507051|NCT00889200||Single Group Assignment||Basic Science||None (Open Label)||||||
1507052|NCT00889187|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507053|NCT00889174|||Cohort||Other|||||||
1507054|NCT00889161||Single Group Assignment||Treatment||None (Open Label)||||||
1507055|NCT00889148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507056|NCT00889135||||||||||||
1507057|NCT00889122|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507058|NCT00889109|||Case Control||Prospective|||||||
1507059|NCT00889096|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1507060|NCT00889083|||Case Control||Prospective|||||||
1507061|NCT00889070|||Cohort||Prospective|||||||
1507062|NCT00889057||Single Group Assignment||Treatment||None (Open Label)||||||
1507063|NCT00889044|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1507064|NCT00889031|||Cohort||Prospective|||||||
1507065|NCT00889018|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1507066|NCT00889005|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507067|NCT00888992|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1507068|NCT00888979||Single Group Assignment||Treatment||None (Open Label)||||||
1507069|NCT00888966|||Cohort||Prospective|||||||
1507070|NCT00888953|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507071|NCT00888940|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1507072|NCT00888927||Single Group Assignment||Treatment||None (Open Label)||||||
1507073|NCT00888914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507074|NCT00888901|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1507075|NCT00888888|||Cohort||Retrospective|||||||
1507076|NCT00888875|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507077|NCT00888862|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507309|NCT00885807|||Case-Only||Cross-Sectional|||||||
1507078|NCT00888849|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507079|NCT00888836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507080|NCT00888823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507081|NCT00888810||Single Group Assignment||Treatment||None (Open Label)||||||
1507082|NCT00888797|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1507083|NCT00888784|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1507084|NCT00888771|||Cohort||Prospective|||||||
1507085|NCT00888758|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1507086|NCT00888745|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507087|NCT00888732|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507088|NCT00888719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507089|NCT00888706|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1507090|NCT00888693|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1507091|NCT00888680|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1507092|NCT00888667|||||Prospective|||||||
1507093|NCT00888654||Single Group Assignment||Treatment||None (Open Label)||||||
1507094|NCT00888641|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507095|NCT00888628||Single Group Assignment||Treatment||None (Open Label)||||||
1507096|NCT00888615||Single Group Assignment||Treatment||None (Open Label)||||||
1507097|NCT00888602|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1507098|NCT00888589|||Case-Only||Prospective|||||||
1507099|NCT00888576|||Cohort||Prospective|||||||
1507100|NCT00888563|||Cohort||Prospective|||||||
1507101|NCT00888550|Randomized|Parallel Assignment||Treatment||Single||||||t
1507102|NCT00888537|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507103|NCT00888524|Randomized|Parallel Assignment||Treatment||Double||||t||t
1507104|NCT00888511||Single Group Assignment||Treatment||None (Open Label)||||||
1507105|NCT00888498|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1507106|NCT00888485|Randomized|Parallel Assignment||Prevention||Single||||||t
1507107|NCT00888472||Single Group Assignment||Treatment||None (Open Label)||||||
1507108|NCT00888459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507109|NCT00888446|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1507110|NCT00888433|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507111|NCT00888420|||Case-Only||Prospective|||||||
1507112|NCT00888407|Randomized|Parallel Assignment||Prevention||Single|||t|||
1507113|NCT00888394|Randomized|Parallel Assignment||Treatment||Double||||t||t
1507114|NCT00888381|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507115|NCT00888368|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507116|NCT00888355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507117|NCT00888342|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1507118|NCT00888329|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1507119|NCT00888316|||Cohort||Prospective|||||||
1507120|NCT00888303|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507121|NCT00888290|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1507122|NCT00888277|||Case-Only||Prospective|||||||
1507123|NCT00888264|||Cohort||Prospective|||||||
1507124|NCT00888251|||Cohort||Retrospective|||||||
1507125|NCT00888238|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1507126|NCT00888225|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507127|NCT00888212||Single Group Assignment||Diagnostic||None (Open Label)||||||
1507128|NCT00888199|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507129|NCT00888186|Non-Randomized|Single Group Assignment||Treatment||Double|||t|||t
1507130|NCT00888173||Single Group Assignment||Treatment||None (Open Label)||||||
1507131|NCT00888160|||Other||Prospective|||||||
1507132|NCT00888147|||Case-Only||Prospective|||||||
1507133|NCT00888134||Single Group Assignment||Treatment||None (Open Label)||||||
1507134|NCT00888108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507135|NCT00888095|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507136|NCT00888082|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507137|NCT00888069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507138|NCT00888056||Single Group Assignment||Treatment||None (Open Label)||||||
1507139|NCT00888043||Single Group Assignment||||None (Open Label)||||||
1507140|NCT00888030|||Cohort||Prospective|||||||
1507141|NCT00888017|||Case Control|||||||||
1507142|NCT00888004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507143|NCT00887991|||Case Control||Prospective|||||||
1507144|NCT00887978|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507145|NCT00887965||Single Group Assignment||Supportive Care||None (Open Label)||||||
1507146|NCT00887952|Randomized|Parallel Assignment||Treatment||Single||||||t
1507147|NCT00887939|||||Prospective|||||||
1507148|NCT00887926||Single Group Assignment||Treatment||None (Open Label)||||||
1507149|NCT00887913||Single Group Assignment||Treatment||None (Open Label)||||||
1507150|NCT00887900|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507151|NCT00887887|||Cohort||Prospective|||||||
1507152|NCT00887874|||Ecologic or Community||Cross-Sectional|||||||
1507153|NCT00887861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507154|NCT00887848|Randomized|Parallel Assignment||Treatment||Single|||||t|
1507155|NCT00887835|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507156|NCT00887822|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507157|NCT00887809||Single Group Assignment||Treatment||None (Open Label)||||||
1507158|NCT00887783|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507159|NCT00887770|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1507160|NCT00887757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507161|NCT00887744||Single Group Assignment||Treatment||None (Open Label)||||||
1507162|NCT00887731|||Case-Crossover||Prospective|||||||
1507163|NCT00887718|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1507164|NCT00887705|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1507165|NCT00887692||Single Group Assignment||Treatment||None (Open Label)||||||
1507166|NCT00887679||Single Group Assignment||Treatment||None (Open Label)||||||
1507167|NCT00887666|||Cohort||Prospective|||||||
1507168|NCT00887653||Single Group Assignment||Treatment||None (Open Label)||||||
1507169|NCT00887640||Single Group Assignment||Treatment||None (Open Label)||||||
1507170|NCT00887627|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1507171|NCT00887614||Single Group Assignment||Treatment||None (Open Label)||||||
1507172|NCT00887601|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1507173|NCT00887588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507174|NCT00887575|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507175|NCT00887562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507176|NCT00887549||Single Group Assignment||Treatment||None (Open Label)||||||
1507177|NCT00887536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507178|NCT00887523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507179|NCT00887510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507180|NCT00887497|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507181|NCT00887484|Randomized|Parallel Assignment||Treatment||Single|||||t|
1507182|NCT00887471|||Cohort||Prospective|||||||
1507183|NCT00887458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507184|NCT00887445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507185|NCT00887432|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1507186|NCT00887419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507187|NCT00887406|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1507188|NCT00887393|Randomized|Parallel Assignment||Treatment||Single|||||t|
1507189|NCT00887380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507190|NCT00887367|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1507191|NCT00887354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507192|NCT00887341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507193|NCT00887328|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507194|NCT00887315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507195|NCT00887302|||Cohort|||||||||
1507196|NCT00887289|||||Prospective|||||||
1507197|NCT00887276|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1507198|NCT00887263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507199|NCT00887250|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507200|NCT00887237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507201|NCT00887224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507202|NCT00887211|Randomized|Parallel Assignment||Treatment||Single||||||t
1507203|NCT00887198|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507204|NCT00887185|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1507205|NCT00887172|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507206|NCT00887159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507207|NCT00887146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507208|NCT00887133|||Cohort||Prospective|||||||
1507209|NCT00887120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507210|NCT00887107||Single Group Assignment||Treatment||None (Open Label)||||||
1507211|NCT00887094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507212|NCT00887081|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1507213|NCT00887068|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507214|NCT00887055|||Cohort||Prospective|||||||
1507215|NCT00887042||Single Group Assignment||Treatment||None (Open Label)||||||
1507216|NCT00887029|Randomized|Crossover Assignment||Treatment||Single|||||t|
1507217|NCT00887003|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1507218|NCT00886990|||Cohort||Retrospective|||||||
1507219|NCT00886977||Single Group Assignment||Treatment||None (Open Label)||||||
1507220|NCT00886964|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507221|NCT00886951||Single Group Assignment||Diagnostic||None (Open Label)||||||
1507222|NCT00886938||Single Group Assignment||Treatment||None (Open Label)||||||
1507223|NCT00886925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507224|NCT00886912|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1507225|NCT00886899|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507226|NCT00886886|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1507227|NCT00886873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507228|NCT00886860|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507229|NCT00886847||Single Group Assignment||Diagnostic||None (Open Label)||||||
1507230|NCT00886834|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507231|NCT00886821|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1507232|NCT00886808|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507233|NCT00886795||Single Group Assignment||Treatment||None (Open Label)||||||
1507234|NCT00886782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507235|NCT00886769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507236|NCT00886756|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1507237|NCT00886743||Single Group Assignment||Treatment||None (Open Label)||||||
1507238|NCT00886730|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1507239|NCT00886717|Non-Randomized|||Treatment||None (Open Label)||||||
1507240|NCT00886704|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1507241|NCT00886691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507242|NCT00886678||Single Group Assignment||Treatment||None (Open Label)||||||
1507243|NCT00886665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507244|NCT00886652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507245|NCT00886639|Randomized|Crossover Assignment||Screening||Single|||t|||
1507246|NCT00886626|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507247|NCT00886613|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1507248|NCT00886600|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507249|NCT00886587|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1507250|NCT00886574|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507251|NCT00886561|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507252|NCT00886548|||Case-Only||Prospective|||||||
1507253|NCT00886535|||Cohort||Prospective|||||||
1507254|NCT00886522||Single Group Assignment||Treatment||None (Open Label)||||||
1507255|NCT00886509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507256|NCT00886496|Non-Randomized|||Supportive Care||None (Open Label)||||||
1507257|NCT00886483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507258|NCT00886470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507259|NCT00886457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507260|NCT00886444||Single Group Assignment||Diagnostic||None (Open Label)||||||
1507261|NCT00886431|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1507262|NCT00886418|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507263|NCT00886405|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507264|NCT00886392|||Ecologic or Community||Prospective|||||||
1507265|NCT00886379|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1507266|NCT00886366|Randomized|Single Group Assignment||Treatment||Single|||t|||
1507267|NCT00886353|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1507268|NCT00886340|Randomized|Parallel Assignment||Prevention||Single||||||t
1507269|NCT00886327|||Cohort||Prospective|||||||
1507270|NCT00886314|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507271|NCT00886301||Single Group Assignment||Diagnostic||None (Open Label)||||||
1507272|NCT00886288|||Case-Only||Prospective|||||||
1507273|NCT00886275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507274|NCT00886262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507275|NCT00886249|||Case-Only||Retrospective|||||||
1507276|NCT00886236|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1507277|NCT00886223||Single Group Assignment||Treatment||None (Open Label)||||||
1507278|NCT00886210|Randomized|Single Group Assignment||Prevention||Single|||t|||
1507279|NCT00886197|||Case-Only||Prospective|||||||
1507280|NCT00886184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507281|NCT00886171|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507282|NCT00886158|||Cohort||Prospective|||||||
1507283|NCT00886145||Single Group Assignment||Prevention||None (Open Label)||||||
1507284|NCT00886132||Single Group Assignment||Treatment||None (Open Label)||||||
1507285|NCT00886119|Randomized|Crossover Assignment||Treatment||Single|||t|||
1507286|NCT00886106|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1507287|NCT00886093|Randomized|Crossover Assignment||||None (Open Label)||||||
1507288|NCT00886080|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507289|NCT00886067|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1507290|NCT00886054|||Cohort||Prospective|||||||
1507291|NCT00886041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507292|NCT00886028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507293|NCT00886015|Randomized|Parallel Assignment||Treatment||Single||||||t
1507294|NCT00886002|Randomized|Crossover Assignment||Treatment||Double||||||
1507295|NCT00885989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507296|NCT00885976|||Cohort||Prospective|||||||
1507297|NCT00885963|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507298|NCT00885950|||Cohort||Retrospective|||||||
1507299|NCT00885937|Randomized|Single Group Assignment||Treatment||Single|||||t|
1507300|NCT00885924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507301|NCT00885911|||Cohort||Prospective|||||||
1507302|NCT00885898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507303|NCT00885885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507304|NCT00885872||Single Group Assignment||Treatment||None (Open Label)||||||
1507305|NCT00885859|||Cohort||Prospective|||||||
1507306|NCT00885846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507307|NCT00885833||Single Group Assignment||Treatment||None (Open Label)||||||
1507308|NCT00885820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507310|NCT00885794|Randomized|Single Group Assignment||Treatment||Single|||||t|
1507311|NCT00885781|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507312|NCT00885768|||Case-Only||Prospective|||||||
1507313|NCT00885755||Single Group Assignment||Treatment||None (Open Label)||||||
1507314|NCT00885742||Single Group Assignment||||None (Open Label)||||||
1507315|NCT00885729|Randomized|Parallel Assignment||Treatment||Single||||||t
1507316|NCT00885716|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1507317|NCT00885703|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 1 was the dose escalation phase which used a sequential model. Phase 2 was the dose validation phase which used a parallel model. Analyses combine arms from Phase 1 and Phase 2, as appropriate, for validation.||||
1507318|NCT00885690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507319|NCT00885677|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507320|NCT00885664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507321|NCT00885651|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1507322|NCT00885638|Non-Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1507323|NCT00885625|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507324|NCT00885612|||Case-Only||Cross-Sectional|||||||
1507325|NCT00885599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507326|NCT00885586|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1507327|NCT00885573||Single Group Assignment||Diagnostic||Triple|||t||t|t
1507328|NCT00885560|||Case-Only||Cross-Sectional|||||||
1507329|NCT00885547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507330|NCT00885534||Single Group Assignment||Treatment||None (Open Label)||||||
1507331|NCT00885521|Randomized|Parallel Assignment||Treatment||Single||||||t
1507332|NCT00885508||Single Group Assignment||Treatment||None (Open Label)||||||
1507333|NCT00885495|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507334|NCT00885482||Single Group Assignment||Treatment||None (Open Label)||||||
1507335|NCT00885469|||Cohort||Prospective|||||||
1507336|NCT00885456|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1507337|NCT00885443|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1507338|NCT00885430||Single Group Assignment||Diagnostic||None (Open Label)||||||
1507339|NCT00885417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507340|NCT00885404|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507341|NCT00885391|||Cohort||Prospective|||||||
1507342|NCT00885378|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507343|NCT00885365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507344|NCT00885352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507345|NCT00885339|||Cohort||Prospective|||||||
1507346|NCT00885326||Single Group Assignment||Treatment||None (Open Label)||||||
1507347|NCT00885313|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507348|NCT00885300|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1507349|NCT00885287|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507350|NCT00885274|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1507351|NCT00885261|||Cohort||Prospective|||||||
1507352|NCT00885248|||Case-Only||Prospective|||||||
1507353|NCT00885235|||Cohort||Prospective|||||||
1507354|NCT00885222||Parallel Assignment||Treatment||None (Open Label)||||||
1507355|NCT00885209|||Cohort||Prospective|||||||
1507356|NCT00885196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507357|NCT00885183|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507358|NCT00885170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507359|NCT00885157|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507360|NCT00885144|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1507361|NCT00885131|||||Prospective|||||||
1507362|NCT00885118|Randomized|Parallel Assignment||Treatment||Double||||||
1507363|NCT00885105|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507364|NCT00885092|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1507365|NCT00885079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507366|NCT00885066|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507367|NCT00885053|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1507368|NCT00885040|||||Prospective|||||||
1507369|NCT00885027|||||Prospective|||||||
1507370|NCT00885014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507371|NCT00885001|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507372|NCT00884988|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507373|NCT00884975|||Cohort||Prospective|||||||
1507374|NCT00884962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507375|NCT00884949|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507376|NCT00884936|||Case Control||Prospective|||||||
1507377|NCT00884910||Single Group Assignment||Supportive Care||None (Open Label)||||||
1507378|NCT00884897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507379|NCT00884884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507380|NCT00884871|||Cohort||Prospective|||||||
1507381|NCT00884858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507382|NCT00884845|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507383|NCT00884832|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507384|NCT00884819|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508082|NCT00875628|Randomized|Parallel Assignment||||Double|||t||t|
1507385|NCT00884806|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1507386|NCT00884793||Single Group Assignment||||None (Open Label)||||||
1507387|NCT00884780|||Cohort||Prospective|||||||
1507388|NCT00884767|Non-Randomized|||Treatment||||||||
1507389|NCT00884754|Randomized|Parallel Assignment||||Double|||t|||t
1507390|NCT00884741|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507391|NCT00884728|||Ecologic or Community||Prospective|||||||
1507392|NCT00884715|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507393|NCT00884702|||Cohort||Prospective|||||||
1507394|NCT00884689|||Case-Only|||||||||
1507395|NCT00884676|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507396|NCT00884663|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1507397|NCT00884650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507398|NCT00884637|||Cohort||Prospective|||||||
1507399|NCT00884624|||Cohort||Prospective|||||||
1507400|NCT00884611||Single Group Assignment||Treatment||None (Open Label)||||||
1507401|NCT00884598||||Treatment||None (Open Label)||||||
1507402|NCT00884585|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507403|NCT00884559|Randomized|Parallel Assignment||||Double|||t|||t
1507404|NCT00884546|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507405|NCT00884533|Randomized|Parallel Assignment||Treatment||Double||||||
1507406|NCT00884520|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1507407|NCT00884507||Parallel Assignment||Treatment||Double|||t||t|
1507408|NCT00884494|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1507409|NCT00884481|||Cohort||Prospective|||||||
1507410|NCT00884468|||Cohort||Cross-Sectional|||||||
1507411|NCT00884455|||Other||Prospective|||||||
1507412|NCT00884442|Randomized|Crossover Assignment||||None (Open Label)||||||
1507413|NCT00884429|Randomized|Parallel Assignment||Treatment||Single|||||t|
1507414|NCT00884416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507415|NCT00884403|||Cohort||Retrospective|||||||
1507416|NCT00884390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507417|NCT00884377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507418|NCT00884364|Randomized|Parallel Assignment||||Single|||||t|
1507419|NCT00884351|||||Prospective|||||||
1507420|NCT00884338|Randomized|Parallel Assignment||Treatment||Single|||||t|
1507421|NCT00884325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507422|NCT00884312||Single Group Assignment||Treatment||None (Open Label)||||||
1507423|NCT00884299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507424|NCT00884286||Single Group Assignment||Treatment||None (Open Label)||||||
1507425|NCT00884273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507426|NCT00884260|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507427|NCT00884247|||Case-Only||Prospective|||||||
1507428|NCT00884234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507429|NCT00884221|Randomized|Parallel Assignment||Treatment||Single||||||t
1507430|NCT00884208|||Cohort||Prospective|||||||
1507431|NCT00884195|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507432|NCT00884182|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507433|NCT00884169|Randomized|||||Double||||||
1507434|NCT00884143|||Case-Only||Retrospective|||||||
1507435|NCT00884130|||Cohort||Prospective|||||||
1507436|NCT00884117|||Case-Only||Prospective|||||||
1507437|NCT00884104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507438|NCT00884091|||Cohort||Cross-Sectional|||||||
1507439|NCT00884078|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507440|NCT00884065|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507441|NCT00884052||Single Group Assignment||Treatment||None (Open Label)||||||
1507442|NCT00884039|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1507443|NCT00884026|Non-Randomized|Parallel Assignment||Prevention||Double|||t||t|
1507444|NCT00884013|||Case Control||Prospective|||||||
1507445|NCT00884000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507446|NCT00883987|||Cohort||Prospective|||||||
1507447|NCT00883974|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1507448|NCT00883961|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1507449|NCT00883948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507450|NCT00883935|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1507451|NCT00883922|||Cohort||Prospective|||||||
1507452|NCT00883909|||Other||Prospective|||||||
1507453|NCT00883896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507454|NCT00883883|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507455|NCT00883870|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507456|NCT00883857|||Cohort||Prospective|||||||
1507457|NCT00883844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507458|NCT00883831||Single Group Assignment||Treatment||None (Open Label)||||||
1507459|NCT00883818||Single Group Assignment||Treatment||None (Open Label)||||||
1507460|NCT00883805|||Cohort||Prospective|||||||
1507461|NCT00883792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507462|NCT00883779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507463|NCT00883766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507464|NCT00883753|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507465|NCT00883740|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1507466|NCT00883727|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507467|NCT00883714|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1507468|NCT00883701|||Case Control||Prospective|||||||
1507469|NCT00883688||Single Group Assignment||Treatment||None (Open Label)||||||
1507470|NCT00883675||Single Group Assignment||Treatment||None (Open Label)||||||
1507471|NCT00883662|||Cohort||Prospective|||||||
1507472|NCT00883649|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507473|NCT00883636|||Cohort||Prospective|||||||
1507474|NCT00883623||Single Group Assignment||Treatment||None (Open Label)||||||
1507475|NCT00883610|||Cohort||Prospective|||||||
1507476|NCT00883597|||Cohort||Prospective|||||||
1507477|NCT00883584|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507478|NCT00883571|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1507479|NCT00883558|Randomized|Crossover Assignment||||None (Open Label)||||||
1507480|NCT00883545|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1507481|NCT00883532|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1507482|NCT00883519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507483|NCT00883506|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507484|NCT00883493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507485|NCT00883480||Parallel Assignment||Health Services Research||None (Open Label)||||||
1507486|NCT00883467|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1507487|NCT00883454|||Cohort||Retrospective|||||||
1507488|NCT00883441|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1507489|NCT00883428|||||Cross-Sectional|||||||
1507490|NCT00883415|||Case-Crossover||Prospective|||||||
1507491|NCT00883402|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507492|NCT00883389|||Cohort||Prospective|||||||
1507493|NCT00883376|||Ecologic or Community||Cross-Sectional|||||||
1507494|NCT00883363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507495|NCT00883350|Randomized|Parallel Assignment||Treatment||Single|||||t|
1507496|NCT00883337|Randomized|Parallel Assignment||Treatment||Single||||||t
1507497|NCT00883324|||Case Control||Prospective|||||||
1507498|NCT00883311||Single Group Assignment||Treatment||None (Open Label)||||||
1507499|NCT00883298||Single Group Assignment||Treatment||None (Open Label)||||||
1507500|NCT00883285|||Cohort||Prospective|||||||
1507501|NCT00883272|||Case Control||Prospective|||||||
1507502|NCT00883259|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1507503|NCT00883246||Single Group Assignment||Treatment||None (Open Label)||||||
1507504|NCT00883233|Randomized|Parallel Assignment||Treatment||Single|||||t|
1507505|NCT00883220|Randomized|Parallel Assignment||Prevention||Single|||||t|
1507506|NCT00883207|Randomized|Single Group Assignment||Treatment||Single|||||t|
1507507|NCT00883194|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1507508|NCT00883181|||Other||Prospective|||||||
1507509|NCT00883168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507510|NCT00883155|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507511|NCT00883142|||Cohort||Prospective|||||||
1507512|NCT00883129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507513|NCT00883116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507514|NCT00883103|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1507515|NCT00883090||Single Group Assignment||||None (Open Label)||||||
1507516|NCT00883077|||Case Control||Prospective|||||||
1507517|NCT00883064|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507518|NCT00883051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507519|NCT00883038|Randomized|Parallel Assignment||Treatment||||||||
1507520|NCT00883025|||Ecologic or Community||Cross-Sectional|||||||
1507521|NCT00883012|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1507522|NCT00882999|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507523|NCT00882986|||Case Control||Cross-Sectional|||||||
1507524|NCT00882973|Non-Randomized|Parallel Assignment||Treatment||||||||
1507525|NCT00882960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507526|NCT00882947|||Cohort||Prospective|||||||
1507527|NCT00882934|Randomized|Parallel Assignment||Treatment||Single|||||t|
1507528|NCT00882921|||Cohort||Prospective|||||||
1507529|NCT00882908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507530|NCT00882895||Single Group Assignment||Treatment||None (Open Label)||||||
1507531|NCT00882882|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507532|NCT00882869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507533|NCT00882856|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1507534|NCT00882843|||Case Control||Cross-Sectional|||||||
1507535|NCT00882830|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507536|NCT00882817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507537|NCT00882804|Randomized|Parallel Assignment||||Triple|||t||t|t
1507538|NCT00882791|||Cohort||Prospective|||||||
1507539|NCT00882778|||Case-Only||Retrospective|||||||
1507540|NCT00882765|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507541|NCT00882752|||Case-Only||Retrospective|||||||
1507542|NCT00882739|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1507543|NCT00882726|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1507544|NCT00882713||Single Group Assignment||Treatment||None (Open Label)||||||
1507545|NCT00882700|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507546|NCT00882687|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1507547|NCT00882674|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1507548|NCT00882661|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507549|NCT00882648|||||Retrospective|||||||
1507550|NCT00882635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507551|NCT00882622|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507552|NCT00882609|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1507553|NCT00882596||Single Group Assignment||Treatment||None (Open Label)||||||
1507554|NCT00882583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507555|NCT00882570|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507556|NCT00882557|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507557|NCT00882544|||Cohort||Prospective|||||||
1507558|NCT00882531|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507559|NCT00882518|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507560|NCT00882505|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507561|NCT00882492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507562|NCT00882479|||||Cross-Sectional|||||||
1507563|NCT00882466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507564|NCT00882453|||Cohort||Prospective|||||||
1507565|NCT00882440|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507566|NCT00882427||Single Group Assignment||Treatment||None (Open Label)||||||
1507567|NCT00882414|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507568|NCT00882401|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507569|NCT00882388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507570|NCT00882375|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507571|NCT00882362||Single Group Assignment||Treatment||None (Open Label)||||||
1507572|NCT00882336|||||Cross-Sectional|||||||
1507573|NCT00882323||Parallel Assignment||Treatment||None (Open Label)||||||
1507574|NCT00882310||Single Group Assignment||Treatment||None (Open Label)||||||
1507575|NCT00882297|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1507576|NCT00882284|||Cohort||Prospective|||||||
1507577|NCT00882271|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507578|NCT00882258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507579|NCT00882245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507580|NCT00882232||Single Group Assignment||Treatment||None (Open Label)||||||
1507581|NCT00882219|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507582|NCT00882206||Single Group Assignment||Treatment||None (Open Label)||||||
1507583|NCT00882193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507584|NCT00882180|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507585|NCT00882167|||Cohort||Prospective|||||||
1507586|NCT00882154|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507587|NCT00882141|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507588|NCT00882128|||Cohort||Cross-Sectional|||||||
1507589|NCT00882115||Single Group Assignment||Basic Science||None (Open Label)||||||
1507590|NCT00882102||Single Group Assignment||Treatment||None (Open Label)||||||
1507591|NCT00882089||Single Group Assignment||Treatment||None (Open Label)||||||
1507592|NCT00882076|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1507593|NCT00882063||Single Group Assignment||Treatment||None (Open Label)||||||
1507594|NCT00882050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507595|NCT00882037|||Other||Prospective|||||||
1507596|NCT00882024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507597|NCT00882011|||Case-Only||Prospective|||||||
1507598|NCT00881998|Randomized|||Treatment||||||||
1507599|NCT00881985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507600|NCT00881972||Single Group Assignment||Prevention||None (Open Label)||||||
1507601|NCT00881959|Randomized|Parallel Assignment||Treatment||Single||||||t
1507602|NCT00881946||Single Group Assignment||Basic Science||None (Open Label)||||||
1507603|NCT00881933||Parallel Assignment||Treatment||None (Open Label)||||||
1507604|NCT00881920|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507605|NCT00881907|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507606|NCT00881894|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1507607|NCT00881881|||Cohort||Retrospective|||||||
1507608|NCT00881868|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507609|NCT00881855|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507610|NCT00881842|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1507611|NCT00881829|||Case-Only||Prospective|||||||
1507612|NCT00881816||Single Group Assignment||Treatment||None (Open Label)||||||
1507613|NCT00881803|||Cohort||Prospective|||||||
1507614|NCT00881790|||Cohort||Cross-Sectional|||||||
1507615|NCT00881777|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507616|NCT00881764|||Other||Other|||||||
1507617|NCT00881751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507618|NCT00881738|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507619|NCT00881725||Single Group Assignment||Treatment||None (Open Label)||||||
1507620|NCT00881712|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507621|NCT00881699|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1507622|NCT00881686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507623|NCT00881673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507624|NCT00881660||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1507625|NCT00881647|Randomized|Parallel Assignment||Treatment||Single||||||t
1507626|NCT00881634|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507627|NCT00881621||Single Group Assignment||Treatment||None (Open Label)||||||
1507628|NCT00881608|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507629|NCT00881595|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507630|NCT00881582||Single Group Assignment||Treatment||None (Open Label)||||||
1507631|NCT00881569||Single Group Assignment||Treatment||None (Open Label)||||||
1507632|NCT00881556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507633|NCT00881543|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507634|NCT00881530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507635|NCT00881517|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1507636|NCT00881504||Single Group Assignment||Treatment||None (Open Label)||||||
1507637|NCT00881491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507638|NCT00881478|Randomized|Parallel Assignment||Treatment||Single||||||t
1507639|NCT00881465|Randomized|Parallel Assignment||Treatment||Single||||||t
1507640|NCT00881452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507641|NCT00881439|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507642|NCT00881426|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507643|NCT00881413|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1507644|NCT00881400|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507645|NCT00881387|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507646|NCT00881374|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1507647|NCT00881361||Single Group Assignment||Diagnostic||None (Open Label)||||||
1507648|NCT00881348|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1507649|NCT00881335|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1507650|NCT00881322|Randomized|Parallel Assignment||||Double|||t||t|
1507651|NCT00881309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507652|NCT00881296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507653|NCT00881283|||Case-Control||Cross-Sectional|||||||
1507654|NCT00881270|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1507655|NCT00881257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507656|NCT00881244|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507657|NCT00881231|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507658|NCT00881218|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1507659|NCT00881205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507660|NCT00881192|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507661|NCT00881179|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507662|NCT00881166|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507663|NCT00881153|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507664|NCT00881140||Single Group Assignment||Treatment||None (Open Label)||||||
1507665|NCT00881127|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507666|NCT00881114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507667|NCT00881101||Single Group Assignment||Treatment||None (Open Label)||||||
1507668|NCT00881088|Randomized|Parallel Assignment||Prevention||Single||||||t
1507669|NCT00881075||Single Group Assignment||Diagnostic||None (Open Label)||||||
1507670|NCT00881062||Single Group Assignment||||None (Open Label)||||||
1507671|NCT00881049||Single Group Assignment||Treatment||None (Open Label)||||||
1507672|NCT00881036|||Cohort||Prospective|||||||
1507673|NCT00881023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507674|NCT00881010|||Case-Control||Prospective|||||||
1507675|NCT00880997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507676|NCT00880984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507677|NCT00880971|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507678|NCT00880958|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1507679|NCT00880945|||Case Control||Prospective|||||||
1507680|NCT00880932|Randomized|Parallel Assignment||||Single||||t||
1507681|NCT00880919|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507682|NCT00880906|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507683|NCT00880893|Randomized|Parallel Assignment||Prevention||Single||||||t
1507684|NCT00880880|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1507685|NCT00880867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507686|NCT00880854||Single Group Assignment||Treatment||None (Open Label)||||||
1507687|NCT00880841|||Other||Prospective|||||||
1507688|NCT00880828|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507689|NCT00880815||Single Group Assignment||Treatment||None (Open Label)||||||
1507690|NCT00880802|||Cohort||Prospective|||||||
1507691|NCT00880789||Single Group Assignment||Treatment||None (Open Label)||||||
1507692|NCT00880763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507693|NCT00880750|Randomized|Crossover Assignment||||None (Open Label)||||||
1507694|NCT00880737|||Cohort||Prospective|||||||
1507695|NCT00880724|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507696|NCT00880711|||Case-Only||Prospective|||||||
1507697|NCT00880698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507698|NCT00880685||Single Group Assignment||Treatment||None (Open Label)||||||
1507699|NCT00880672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507700|NCT00880659|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507701|NCT00880646|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1507702|NCT00880633|||||Retrospective|||||||
1507703|NCT00880620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507704|NCT00880607|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507705|NCT00880594||Single Group Assignment||Treatment||None (Open Label)||||||
1507706|NCT00880581||Single Group Assignment||Treatment||None (Open Label)||||||
1507707|NCT00880568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507708|NCT00880555|||||Prospective|||||||
1507709|NCT00880542||Single Group Assignment||Treatment||None (Open Label)||||||
1507710|NCT00880529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507711|NCT00880516|||Case Control||Prospective|||||||
1507712|NCT00880503|||Cohort||Prospective|||||||
1507713|NCT00880490|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1507714|NCT00880477|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507715|NCT00880464||Single Group Assignment||Treatment||None (Open Label)||||||
1507716|NCT00880451|||||Retrospective|||||||
1507717|NCT00880425|||Case-Only||Retrospective|||||||
1507718|NCT00880412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507719|NCT00880399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507720|NCT00880386||Single Group Assignment||Supportive Care||None (Open Label)||||||
1507721|NCT00880373|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507722|NCT00880360||Single Group Assignment||Treatment||None (Open Label)||||||
1507723|NCT00880347||Single Group Assignment||Diagnostic||Single||||||t
1507724|NCT00880334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507725|NCT00880321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507726|NCT00880308||Single Group Assignment||Treatment||None (Open Label)||||||
1507727|NCT00880295|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507728|NCT00880282||Single Group Assignment||Treatment||None (Open Label)||||||
1507729|NCT00880269|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507730|NCT00880256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507731|NCT00880243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507732|NCT00880230||Single Group Assignment||Treatment||None (Open Label)||||||
1507733|NCT00880217|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507734|NCT00880204|Randomized|Parallel Assignment||||Double|||t|||t
1507735|NCT00880191|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1507736|NCT00880178|||Cohort||Prospective|||||||
1507737|NCT00880165|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1507738|NCT00880152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507739|NCT00880139|||Cohort||Cross-Sectional|||||||
1507740|NCT00880126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507741|NCT00880113|||Cohort||Prospective|||||||
1507742|NCT00880100||Single Group Assignment||Treatment||None (Open Label)||||||
1507743|NCT00880087|Randomized|Parallel Assignment||Treatment||Single||||||t
1507744|NCT00880074||Single Group Assignment||Diagnostic||None (Open Label)||||||
1507745|NCT00880061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507746|NCT00880048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507747|NCT00880035|Randomized|Crossover Assignment||Treatment||Single|||||t|
1507748|NCT00880022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507749|NCT00880009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507750|NCT00879996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507751|NCT00879983|Randomized|Crossover Assignment||||None (Open Label)||||||
1507752|NCT00879970|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1507753|NCT00879957|Non-Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1507754|NCT00879944|||||Prospective|||||||
1507755|NCT00879931|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507756|NCT00879918||Single Group Assignment||Basic Science||None (Open Label)||||||
1507757|NCT00879905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507758|NCT00879892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507759|NCT00879879||Single Group Assignment||Treatment||None (Open Label)||||||
1507760|NCT00879866||Single Group Assignment||Treatment||None (Open Label)||||||
1507761|NCT00879853||||||||||||
1507762|NCT00879840|||Case-Only||Retrospective|||||||
1507763|NCT00879827||Single Group Assignment||Prevention||None (Open Label)||||||
1507764|NCT00879814|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507765|NCT00879801|||Cohort||Prospective|||||||
1507766|NCT00879788|Randomized|Crossover Assignment||||None (Open Label)||||||
1507767|NCT00879775|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1507768|NCT00879762|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1507769|NCT00879749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507770|NCT00879736|Randomized|Parallel Assignment||Prevention||Single|||||t|
1507771|NCT00879723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507772|NCT00879710|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1507773|NCT00879697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507774|NCT00879684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507775|NCT00879671|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1507776|NCT00879658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507777|NCT00879645|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507778|NCT00879632|||Cohort||Prospective|||||||
1507779|NCT00879619||Single Group Assignment||Treatment||None (Open Label)||||||
1507780|NCT00879606|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507781|NCT00879593||Single Group Assignment||Prevention||None (Open Label)||||||
1507782|NCT00879580|||Cohort||Prospective|||||||
1507783|NCT00879554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507784|NCT00879541|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1507785|NCT00879528|||Cohort||Prospective|||||||
1507786|NCT00879515|||Case-Control||Cross-Sectional|||||||
1507787|NCT00879502|||Case-Control||Cross-Sectional|||||||
1507788|NCT00879489||Single Group Assignment||Treatment||None (Open Label)||||||
1507789|NCT00879476|Randomized|Crossover Assignment||||None (Open Label)||||||
1507790|NCT00879463|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1507791|NCT00879450|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1507792|NCT00879437||Single Group Assignment||Treatment||None (Open Label)||||||
1507793|NCT00879424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507794|NCT00879411|||Case-Only||Prospective|||||||
1507795|NCT00879398|||Case-Only||Prospective|||||||
1507796|NCT00879385||Single Group Assignment||Treatment||None (Open Label)||||||
1507797|NCT00879372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507798|NCT00879359||Single Group Assignment||Treatment||None (Open Label)||||||
1507799|NCT00879346||Crossover Assignment||Basic Science||None (Open Label)||||||
1507800|NCT00879333|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507801|NCT00879320|||Case Control||Cross-Sectional|||||||
1507802|NCT00879307||Single Group Assignment||Treatment||None (Open Label)||||||
1507803|NCT00879294|Randomized|Single Group Assignment||Supportive Care||Single|||||t|
1507804|NCT00879281|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507805|NCT00879268|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507806|NCT00879255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507807|NCT00879242||Single Group Assignment||Treatment||None (Open Label)||||||
1507808|NCT00879229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507809|NCT00879216|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1507810|NCT00879203|||Case Control||Prospective|||||||
1507811|NCT00879190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507812|NCT00879177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507813|NCT00879164||||Supportive Care||||||||
1507814|NCT00879151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507815|NCT00879138|Randomized|Crossover Assignment||||Double|||t||t|
1507816|NCT00879125|||Case-Only||Retrospective|||||||
1507817|NCT00879112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507818|NCT00879099|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1507819|NCT00879086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507820|NCT00879073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507821|NCT00879060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507822|NCT00879047|Non-Randomized|Crossover Assignment||||Double|||t||t|
1507823|NCT00879034||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1507824|NCT00879021|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1507825|NCT00879008|||Cohort||Prospective|||||||
1507826|NCT00878995|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1507827|NCT00878982||||||||||||
1507828|NCT00878969|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1507829|NCT00878956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507830|NCT00878943||||||||||||
1507831|NCT00878930|||Cohort||Prospective|||||||
1507832|NCT00878917|Randomized|Crossover Assignment||Treatment||Single||||||t
1507833|NCT00878904||Single Group Assignment||Treatment||None (Open Label)||||||
1507834|NCT00878891|Randomized|Parallel Assignment||Prevention||Single|||t|||
1507835|NCT00878878|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1507836|NCT00878865|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1507837|NCT00878852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507838|NCT00878839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507839|NCT00878826|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507840|NCT00878813|||Cohort||Prospective|||||||
1507841|NCT00878800||Single Group Assignment||Treatment||None (Open Label)||||||
1507842|NCT00878787|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1507843|NCT00878774|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507844|NCT00878761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507845|NCT00878748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507846|NCT00878735|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1507847|NCT00878722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507848|NCT00878709|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507849|NCT00878696|||Case-Only||Retrospective|||||||
1507850|NCT00878683|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507851|NCT00878670||Single Group Assignment||Treatment||None (Open Label)||||||
1507852|NCT00878657||Single Group Assignment||Treatment||None (Open Label)||||||
1509241|NCT00860327|||Cohort||Prospective|||||||
1507853|NCT00878644|Randomized|Parallel Assignment||Treatment||Single||||||t
1507854|NCT00878631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507855|NCT00878618|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1507856|NCT00878605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507857|NCT00878592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507858|NCT00878579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507859|NCT00878566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507860|NCT00878553|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1507861|NCT00878540||Single Group Assignment||Basic Science||None (Open Label)||||||
1507862|NCT00878527||Single Group Assignment||Treatment||None (Open Label)||||||
1507863|NCT00878514|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1507864|NCT00878501|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507865|NCT00878475|||Cohort||Prospective|||||||
1507866|NCT00878462|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1507867|NCT00878449||Single Group Assignment||Treatment||None (Open Label)||||||
1507868|NCT00878436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507869|NCT00878423||Single Group Assignment||Basic Science||None (Open Label)||||||
1507870|NCT00878397|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1507871|NCT00878384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507872|NCT00878371||Single Group Assignment||Treatment||None (Open Label)||||||
1507873|NCT00878358|Randomized|Parallel Assignment||Treatment||Single||||||t
1507874|NCT00878345|Randomized|Parallel Assignment||Other||Single|||t|||
1507875|NCT00878332|||Cohort||Prospective|||||||
1507876|NCT00878319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507877|NCT00878306|Randomized|Single Group Assignment||||None (Open Label)||||||
1507878|NCT00878293|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1507879|NCT00878280|||Case Control||Prospective|||||||
1507880|NCT00878267|||Case-Only||Prospective|||||||
1507881|NCT00878254||Single Group Assignment||Treatment||None (Open Label)||||||
1507882|NCT00878241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507883|NCT00878228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507884|NCT00878215|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507885|NCT00878202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507886|NCT00878189|Non-Randomized|||Treatment||None (Open Label)||||||
1507887|NCT00878176||Crossover Assignment||Screening||None (Open Label)||||||
1507888|NCT00878163||Single Group Assignment||Treatment||None (Open Label)||||||
1507889|NCT00878150|Randomized|Parallel Assignment||Treatment||Single||||||t
1507890|NCT00878137|||Case Control||Prospective|||||||
1507891|NCT00878124|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1507892|NCT00878111||Single Group Assignment||Treatment||None (Open Label)||||||
1507893|NCT00878098|||||Prospective|||||||
1507894|NCT00878085|Randomized|Parallel Assignment||Treatment||Single||||||t
1507895|NCT00878072||Single Group Assignment||Treatment||None (Open Label)||||||
1507896|NCT00878059|||||Cross-Sectional|||||||
1507897|NCT00878046||Single Group Assignment||Treatment||None (Open Label)||||||
1507898|NCT00878033|||Cohort||Cross-Sectional|||||||
1507899|NCT00878020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507900|NCT00878007|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1507901|NCT00877994|Randomized|Parallel Assignment||Treatment||Single||||||t
1507902|NCT00877981|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507903|NCT00877968|Randomized|Crossover Assignment||Treatment||Single|||t|||
1507904|NCT00877955|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1507905|NCT00877942|||Case Control||Prospective|||||||
1507906|NCT00877929|Randomized|Parallel Assignment||Treatment||Double||||||
1507907|NCT00877916||||||||||||
1507908|NCT00877903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507909|NCT00877890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507910|NCT00877877||Single Group Assignment||Prevention||None (Open Label)||||||
1507911|NCT00877864|Randomized|Factorial Assignment||Treatment||Single||||t||
1507912|NCT00877851|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507913|NCT00877838|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1507914|NCT00877825|Randomized|Crossover Assignment||Treatment||Single||||||
1507915|NCT00877812|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1507916|NCT00877799|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507917|NCT00877786|Randomized|Parallel Assignment||Treatment||Single||||||t
1507918|NCT00877773||Single Group Assignment||Treatment||None (Open Label)||||||
1507919|NCT00877760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507920|NCT00877747|||Cohort||Retrospective|||||||
1507921|NCT00877734|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507922|NCT00877721|Randomized|Crossover Assignment||Treatment||Single||||||t
1507923|NCT00877708|||Case-Control||Prospective|||||||
1507924|NCT00877695|Randomized|Single Group Assignment||Prevention||Single|||t|||
1507925|NCT00877682||Single Group Assignment||Treatment||None (Open Label)||||||
1507926|NCT00877669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507927|NCT00877656|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507928|NCT00877643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507929|NCT00877630|||Cohort||Prospective|||||||
1507930|NCT00877617|||Case-Only||Prospective|||||||
1507931|NCT00877604|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1507932|NCT00877591|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507933|NCT00877578|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1507934|NCT00877565|||Cohort||Prospective|||||||
1507935|NCT00877552|||Case-Control||Prospective|||||||
1507936|NCT00877539|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1507937|NCT00877526|||Ecologic or Community||Cross-Sectional|||||||
1507938|NCT00877513||Single Group Assignment||Basic Science||None (Open Label)||||||
1507939|NCT00877500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507940|NCT00877487|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507941|NCT00877474|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507942|NCT00877461|||Case-Only||Cross-Sectional|||||||
1507943|NCT00877448|Randomized|Parallel Assignment||Prevention||Single|||t|||
1507944|NCT00877435|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507945|NCT00877422|Randomized|Parallel Assignment||Prevention||Single|||||t|
1507946|NCT00877409|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507947|NCT00877396|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1507948|NCT00877383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507949|NCT00877370||Single Group Assignment||||None (Open Label)||||||
1507950|NCT00877357|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507951|NCT00877344|Randomized|Parallel Assignment||Prevention||Single|The assessment of outcomes (pregnancy conceived within one year) will be assessed through documentation of pregnancy in health administrative data.|"This study uses a drug, but as the study is conducted in Canada the FDA approval is not required. We have approval (a Letter of No Objection) from the Canadian Equivalent Institution: Health Canada"||||t
1507952|NCT00877331|Randomized|Parallel Assignment||Treatment||Single||||||t
1507953|NCT00877318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507954|NCT00877305|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507955|NCT00877292|||Cohort||Cross-Sectional|||||||
1507956|NCT00877279|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1507957|NCT00877266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507958|NCT00877253|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507959|NCT00877240|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1507960|NCT00877227|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1507961|NCT00877214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507962|NCT00877201|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1507963|NCT00877188|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1507964|NCT00877175|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1507965|NCT00877162||Single Group Assignment||Treatment||Single||||||t
1507966|NCT00877149||Single Group Assignment||Treatment||None (Open Label)||||||
1507967|NCT00877136|||Case-Only||Prospective|||||||
1507968|NCT00877123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507969|NCT00877110||Single Group Assignment||Treatment||None (Open Label)||||||
1507970|NCT00877097|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1507971|NCT00877084|Randomized|Parallel Assignment||Treatment||Single||||||t
1507972|NCT00877071||Single Group Assignment||Treatment||None (Open Label)||||||
1507973|NCT00877058|Randomized|Parallel Assignment||Prevention||Single|||||t|
1507974|NCT00877045|||Case-Only||Retrospective|||||||
1507975|NCT00877032|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1507976|NCT00877019|Randomized|||Treatment||Single|||||t|
1507977|NCT00877006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507978|NCT00876993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1507979|NCT00876980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507980|NCT00876967|Randomized|Parallel Assignment||||None (Open Label)||||||
1507981|NCT00876954|Randomized|Parallel Assignment||Treatment||Single|||t|||
1507982|NCT00876941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507983|NCT00876928|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1507984|NCT00876915|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507985|NCT00876902|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1507986|NCT00876889|||Other||Prospective|||||||
1507987|NCT00876876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507988|NCT00876863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507989|NCT00876850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1507990|NCT00876837|||Cohort||Prospective|||||||
1507991|NCT00876824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507992|NCT00876811|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1507993|NCT00876798|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1507994|NCT00876785|Randomized|Crossover Assignment||Prevention||Single|||t|||
1507995|NCT00876772|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1507996|NCT00876759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507997|NCT00876746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1507998|NCT00876733|||Cohort||Prospective|||||||
1507999|NCT00876720|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508000|NCT00876707||Parallel Assignment||Treatment||Single|||||t|
1508001|NCT00876694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508002|NCT00876681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508003|NCT00876668|||Case Control||Prospective|||||||
1510243|NCT00847041||||||||||||
1508004|NCT00876655|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1508005|NCT00876642|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508006|NCT00876629||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508007|NCT00876616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508008|NCT00876603|||Cohort||Prospective|||||||
1508009|NCT00876590|||Case-Only||Cross-Sectional|||||||
1508010|NCT00876577|||Cohort||Prospective|||||||
1508011|NCT00876564||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508012|NCT00876551|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508013|NCT00876538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508014|NCT00876525||Single Group Assignment||Treatment||None (Open Label)||||||
1508015|NCT00876512|||Case Control||Prospective|||||||
1508016|NCT00876499|||Cohort||Prospective|||||||
1508017|NCT00876486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508018|NCT00876473|||Cohort||Prospective|||||||
1508019|NCT00876460|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508020|NCT00876447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508021|NCT00876434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508022|NCT00876421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508023|NCT00876408|||Case-Only||Retrospective|||||||
1508024|NCT00876395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508025|NCT00876382|||Case-Only||Retrospective|||||||
1508026|NCT00876369|||Ecologic or Community||Cross-Sectional|||||||
1508027|NCT00876356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508028|NCT00876343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508029|NCT00876330|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1508030|NCT00876317|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1508031|NCT00876304|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1508032|NCT00876291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508033|NCT00876278|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1508034|NCT00876265|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1508035|NCT00876252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508036|NCT00876226||Single Group Assignment||Health Services Research||None (Open Label)||||||
1508037|NCT00876213|||Case Control|||||||||
1508038|NCT00876200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508039|NCT00876187|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1508040|NCT00876174|||Cohort||Prospective|||||||
1508041|NCT00876161|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1508042|NCT00876148|||Cohort||Retrospective|||||||
1508043|NCT00876135||Single Group Assignment||Diagnostic||Triple|||t|t|t|
1508044|NCT00876122|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508045|NCT00876109|Non-Randomized|||Treatment||None (Open Label)||||||
1508046|NCT00876096||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508047|NCT00876083|||Cohort||Prospective|||||||
1508048|NCT00876070|||Case-Only||Retrospective|||||||
1508049|NCT00876057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508050|NCT00876044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508051|NCT00876031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508052|NCT00876018|Randomized|Parallel Assignment||Other||Double|||t||t|
1508053|NCT00876005|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1508054|NCT00875992|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508055|NCT00875979|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508056|NCT00875966|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508057|NCT00875953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508058|NCT00875940|||Case-Only||Retrospective|||||||
1508059|NCT00875927|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508060|NCT00875914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508061|NCT00875901|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508062|NCT00875888|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508063|NCT00875875|Randomized|Parallel Assignment||Treatment||Single||||||t
1508064|NCT00875862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508065|NCT00875849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508066|NCT00875836|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1508067|NCT00875823|||Cohort||Retrospective|||||||
1508068|NCT00875810|||||Prospective|||||||
1508069|NCT00875797|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508070|NCT00875784|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508071|NCT00875771||Single Group Assignment||Treatment||None (Open Label)||||||
1508072|NCT00875758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508073|NCT00875745||Single Group Assignment||Treatment||None (Open Label)||||||
1508074|NCT00875732|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1508075|NCT00875719|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508076|NCT00875706|Non-Randomized|||Health Services Research||None (Open Label)||||||
1508077|NCT00875693|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508078|NCT00875680||Single Group Assignment||Treatment||None (Open Label)||||||
1508079|NCT00875667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508080|NCT00875654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508081|NCT00875641|||Cohort||Other|||||||
1508083|NCT00875615||Single Group Assignment||Treatment||None (Open Label)||||||
1508084|NCT00875602|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508085|NCT00875589|||Case Control||Prospective|||||||
1508086|NCT00875576||||||||||||
1508087|NCT00875563||Single Group Assignment||Treatment||None (Open Label)||||||
1508088|NCT00875550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508089|NCT00875537|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1508090|NCT00875524|Randomized|Crossover Assignment||Prevention||Single||||||t
1508091|NCT00875511||||||||||||
1508092|NCT00875498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508093|NCT00875485|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508094|NCT00875472||||||||||||
1508095|NCT00875459||Single Group Assignment||Treatment||None (Open Label)||||||
1508096|NCT00875446|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1508097|NCT00875433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508098|NCT00875420|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508099|NCT00875407||Single Group Assignment||Treatment||None (Open Label)||||||
1508100|NCT00875394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508101|NCT00875381|||Case-Only||Prospective|||||||
1508102|NCT00875368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508103|NCT00875355|Randomized|||Treatment||||||||
1508104|NCT00875342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508105|NCT00875329|||Cohort||Cross-Sectional|||||||
1508106|NCT00875316|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1508107|NCT00875303|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1508108|NCT00875290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508109|NCT00875277|Randomized|Parallel Assignment||||Single|||||t|
1508110|NCT00875264||Single Group Assignment||Treatment||None (Open Label)||||||
1508111|NCT00875251|||Cohort||Prospective|||||||
1508112|NCT00875238|||Cohort||Prospective|||||||
1508113|NCT00875225|Randomized|Parallel Assignment||Prevention||Single|||t|||
1508114|NCT00875212|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1508115|NCT00875199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508116|NCT00875186|||Case Control||Prospective|||||||
1508117|NCT00875173|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508118|NCT00875160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508119|NCT00875147|||Cohort||Retrospective|||||||
1508120|NCT00875134||Single Group Assignment||Prevention||None (Open Label)||||||
1508121|NCT00875121||||||||||||
1508122|NCT00875108||Single Group Assignment||Treatment||None (Open Label)||||||
1508123|NCT00875095|||Case-Only||Cross-Sectional|||||||
1508124|NCT00875082|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1508125|NCT00875069|Randomized|Parallel Assignment||||Double|||t||t|
1508126|NCT00875056|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508127|NCT00875043|||Case-Crossover||Prospective|||||||
1508128|NCT00875030|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1508129|NCT00875017|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1508130|NCT00875004|Non-Randomized|||Supportive Care||||||||
1508131|NCT00874991|||Cohort||Retrospective|||||||
1508132|NCT00874978||Single Group Assignment||Treatment||None (Open Label)||||||
1508133|NCT00874965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508134|NCT00874952|||Ecologic or Community||Cross-Sectional|||||||
1508135|NCT00874939|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1508136|NCT00874926|||Cohort||Prospective|||||||
1508137|NCT00874913||Single Group Assignment||Basic Science||Single|||t|||
1508138|NCT00874900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508139|NCT00874887|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1508140|NCT00874874|Non-Randomized|||Treatment||||||||
1508141|NCT00874861||Single Group Assignment||Treatment||None (Open Label)||||||
1508142|NCT00874848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508143|NCT00874835||Single Group Assignment||Treatment||None (Open Label)||||||
1508144|NCT00874822|||||Retrospective|||||||
1508145|NCT00874809|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508146|NCT00874796|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508147|NCT00874783|||Case-Control||Prospective|||||||
1508148|NCT00874770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508149|NCT00874757|||Cohort||Prospective|||||||
1508150|NCT00874744|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508151|NCT00874731|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1508152|NCT00874718|Randomized|Parallel Assignment||Prevention||Single||||||t
1508153|NCT00874692|Randomized|Parallel Assignment||||None (Open Label)||||||
1508154|NCT00874679|||Cohort||Prospective|||||||
1508155|NCT00874666|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1508156|NCT00874653|||Cohort||Prospective|||||||
1508157|NCT00874640|||Cohort||Prospective|||||||
1508158|NCT00874627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508159|NCT00874614||Single Group Assignment||Treatment||None (Open Label)||||||
1508160|NCT00874601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508161|NCT00874588||Single Group Assignment||Treatment||None (Open Label)||||||
1508162|NCT00874575|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1508163|NCT00874562|Randomized|Parallel Assignment||||None (Open Label)||||||
1508164|NCT00874549|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508165|NCT00874536|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508166|NCT00874523|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508167|NCT00874510|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1508168|NCT00874497|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508169|NCT00874484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508170|NCT00874471|||Case Control||Prospective|||||||
1508171|NCT00874458||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508172|NCT00874445|||Cohort||Prospective|||||||
1508173|NCT00874432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508174|NCT00874419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508175|NCT00874406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508176|NCT00874393|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1508177|NCT00874380|||Cohort||Prospective|||||||
1508178|NCT00874367|||Cohort||Prospective|||||||
1508179|NCT00874354||Single Group Assignment||Treatment||None (Open Label)||||||
1508180|NCT00874341|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508181|NCT00874328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508182|NCT00874315|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508183|NCT00874302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508184|NCT00874289|||Cohort||Prospective|||||||
1508185|NCT00874276|Randomized|Parallel Assignment||||None (Open Label)||||||
1508186|NCT00874263|||Case-Only||Cross-Sectional|||||||
1508187|NCT00874250||Single Group Assignment||Treatment||None (Open Label)||||||
1508188|NCT00874237|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1508189|NCT00874224|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1508190|NCT00874211|||Cohort||Prospective|||||||
1508191|NCT00874198||Single Group Assignment||Diagnostic||Single|||||t|
1508192|NCT00874185|||Cohort||Prospective|||||||
1508193|NCT00874172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508194|NCT00874159|||Ecologic or Community||Cross-Sectional|||||||
1508195|NCT00874146|||Cohort||Retrospective|||||||
1508196|NCT00874133|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508197|NCT00874120|Randomized|Crossover Assignment||||Double|||t||t|
1508198|NCT00874107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508199|NCT00874094||Single Group Assignment||Treatment||None (Open Label)||||||
1508200|NCT00874068|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1508201|NCT00874055||||||||||||
1508202|NCT00874042|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508203|NCT00874029||Single Group Assignment||Treatment||None (Open Label)||||||
1508204|NCT00874016|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508205|NCT00874003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508206|NCT00873990|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1508207|NCT00873977|Randomized|Crossover Assignment||Treatment||Single|||t|||
1508208|NCT00873964|||||Prospective|||||||
1508209|NCT00873951|Randomized|Parallel Assignment||||||||||
1508210|NCT00873938|||Cohort||Prospective|||||||
1508211|NCT00873925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508212|NCT00873912|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508213|NCT00873899|||Cohort||Prospective|||||||
1508214|NCT00873886|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1508215|NCT00873873|||Cohort||Prospective|||||||
1508216|NCT00873860|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508217|NCT00873847|||Cohort||Prospective|||||||
1508218|NCT00873834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508219|NCT00873821|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508220|NCT00873808||||||||||||
1508221|NCT00873795|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508222|NCT00873782||Single Group Assignment||Treatment||None (Open Label)||||||
1508223|NCT00873769|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)|Single-center, single-dose, single-treatment, open label study|||||
1508224|NCT00873756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508225|NCT00873743|||||Prospective|||||||
1508226|NCT00873730|Randomized|Parallel Assignment||Treatment||Double||||||
1508227|NCT00873717|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1508228|NCT00873704|Randomized|Parallel Assignment||Treatment||Single|||||t|
1508229|NCT00873691|||Cohort||Prospective|||||||
1508230|NCT00873678|||Family-Based||Cross-Sectional|||||||
1508231|NCT00873665|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508232|NCT00873652|||Cohort||Other|||||||
1508233|NCT00873639|||Cohort||Prospective|||||||
1508234|NCT00873626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508235|NCT00873613|Non-Randomized|Crossover Assignment||Screening||Single||||||t
1508236|NCT00873600|||Case Control||Prospective|||||||
1508237|NCT00873587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508238|NCT00873574|||Case Control||Cross-Sectional|||||||
1508239|NCT00873561|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1508240|NCT00873548|||Case-Only||Prospective|||||||
1508241|NCT00873535|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508242|NCT00873522|||Cohort||Retrospective|||||||
1508243|NCT00873509|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508244|NCT00873496|||Case Control||Prospective|||||||
1508245|NCT00873483|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1508246|NCT00873470||Single Group Assignment||||None (Open Label)||||||
1508247|NCT00873457||Single Group Assignment||Treatment||None (Open Label)||||||
1508248|NCT00873444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508249|NCT00873431|Randomized|Parallel Assignment||||None (Open Label)||||||
1508250|NCT00873418|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1508251|NCT00873405|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508252|NCT00873392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508253|NCT00873379|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508254|NCT00873366|||Case-Only||Prospective|||||||
1508255|NCT00873353||Single Group Assignment||Treatment||None (Open Label)||||||
1508256|NCT00873340|||Cohort||Prospective|||||||
1508257|NCT00873327||Single Group Assignment||Other||None (Open Label)||||||
1508258|NCT00873314|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508259|NCT00873301||Single Group Assignment||Treatment||None (Open Label)||||||
1508260|NCT00873288|Randomized|||Health Services Research||||||||
1508261|NCT00873275||Single Group Assignment||Treatment||None (Open Label)||||||
1508262|NCT00873262|Randomized|Factorial Assignment||Treatment||Single|||t|||
1508263|NCT00873249|||||Prospective|||||||
1508264|NCT00873236|Randomized|||Diagnostic||None (Open Label)||||||
1508265|NCT00873223|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508266|NCT00873210|||Cohort||Prospective|||||||
1508267|NCT00873197||Single Group Assignment||||None (Open Label)||||||
1508268|NCT00873184||Single Group Assignment||Treatment||None (Open Label)||||||
1508269|NCT00873171|||Case Control||Prospective|||||||
1508270|NCT00873158|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508271|NCT00873145|||Cohort||Retrospective|||||||
1508272|NCT00873132|||Cohort|||||||||
1508273|NCT00873119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508274|NCT00873106|||Cohort||Cross-Sectional|||||||
1508275|NCT00873093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508276|NCT00873080|||||Cross-Sectional|||||||
1508277|NCT00873067|Randomized|Parallel Assignment||Treatment||Single||||||t
1508278|NCT00873054|||Case-Only||Prospective|||||||
1508279|NCT00873041|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508280|NCT00873028|Randomized|Parallel Assignment||Treatment||Single|||||t|
1508281|NCT00873015|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508282|NCT00873002||Single Group Assignment||Treatment||None (Open Label)||||||
1508283|NCT00872989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508284|NCT00872976|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508285|NCT00872963|||Cohort||Prospective|||||||
1508286|NCT00872950||Single Group Assignment||Treatment||None (Open Label)||||||
1508287|NCT00872937|||Case Control||Retrospective|||||||
1508288|NCT00872924|Randomized|Crossover Assignment||||None (Open Label)||||||
1508289|NCT00872911|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1508290|NCT00872898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508291|NCT00872885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508292|NCT00872872|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508293|NCT00872859|Randomized|Parallel Assignment||Treatment||Single|||||t|
1508294|NCT00872846|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508295|NCT00872833|||Cohort||Prospective|||||||
1508296|NCT00872820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508297|NCT00872807|Randomized|Parallel Assignment||Treatment||Single||||||t
1508298|NCT00872794||Single Group Assignment||Treatment||None (Open Label)||||||
1508299|NCT00872781|Randomized|Crossover Assignment||||None (Open Label)||||||
1508300|NCT00872755|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1508301|NCT00872742|Randomized|Parallel Assignment||Treatment||Single||||||t
1508302|NCT00872729|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508303|NCT00872716|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1508304|NCT00872703|||Case Control||Retrospective|||||||
1508305|NCT00872690||||||||||||
1508306|NCT00872677|||Case Control||Prospective|||||||
1508307|NCT00872664|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1508308|NCT00872651|Randomized|Parallel Assignment||Treatment||Single||||||t
1508309|NCT00872638|Randomized|Parallel Assignment||||None (Open Label)||||||
1508310|NCT00872625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508311|NCT00872612|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1508312|NCT00872599|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1508313|NCT00872586|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508314|NCT00872573||Single Group Assignment||Treatment||None (Open Label)||||||
1508315|NCT00872560|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508316|NCT00872547|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508317|NCT00872534|Randomized|Parallel Assignment||Prevention||Single|||||t|
1508318|NCT00872521||Single Group Assignment||Treatment||None (Open Label)||||||
1508319|NCT00872495|||Case-Control||Prospective|||||||
1508320|NCT00872482|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508321|NCT00872469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508322|NCT00872456|||Cohort||Prospective|||||||
1508323|NCT00872443|||Cohort||Retrospective|||||||
1508324|NCT00872430|Randomized|Crossover Assignment||Treatment||Single|||t|||
1508325|NCT00872417|Randomized|Parallel Assignment||Treatment||Single|||||t|
1508326|NCT00872404||Single Group Assignment||Treatment||None (Open Label)||||||
1508327|NCT00872391||Single Group Assignment||Treatment||None (Open Label)||||||
1508328|NCT00872378|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508329|NCT00872365|Randomized|Factorial Assignment||Basic Science||Double|||||t|t
1508330|NCT00872352||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508331|NCT00872339|||Cohort||Prospective|||||||
1508332|NCT00872326||Single Group Assignment||Treatment||None (Open Label)||||||
1508333|NCT00872313|||Case-Only||Prospective|||||||
1508334|NCT00872300||Single Group Assignment||Supportive Care||None (Open Label)||||||
1508335|NCT00872287|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1508336|NCT00872274|Randomized|Crossover Assignment||||None (Open Label)||||||
1508337|NCT00872261|||Cohort||Prospective|||||||
1508338|NCT00872248|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508339|NCT00872235|Randomized|Crossover Assignment||||None (Open Label)||||||
1508340|NCT00872222||Single Group Assignment||Treatment||None (Open Label)||||||
1508341|NCT00872209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508342|NCT00872196||Single Group Assignment||||None (Open Label)||||||
1508343|NCT00872183|||||Prospective|||||||
1508344|NCT00872170|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508345|NCT00872157||Single Group Assignment||Treatment||None (Open Label)||||||
1508346|NCT00872144||Crossover Assignment||Treatment||Double|||t||t|
1508347|NCT00872131|||Case Control||Prospective|||||||
1508348|NCT00872118|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508349|NCT00872105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508350|NCT00872092||||||||||||
1508351|NCT00872079||Single Group Assignment||Health Services Research||None (Open Label)||||||
1508352|NCT00872066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508353|NCT00872053|Randomized|Parallel Assignment||Treatment||Single||||||t
1508354|NCT00872040|||Cohort||Prospective|||||||
1508355|NCT00872027|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508356|NCT00872014|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508357|NCT00872001|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508358|NCT00871975||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508359|NCT00871962|||Cohort||Prospective|||||||
1508360|NCT00871949|Randomized|Crossover Assignment||||Double|||t||t|
1508361|NCT00871936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508362|NCT00871923||Single Group Assignment||Treatment||None (Open Label)||||||
1508363|NCT00871910|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508364|NCT00871897|||Case Control||Prospective|||||||
1508365|NCT00871884|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508366|NCT00871871|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1508367|NCT00871858|Randomized|||Treatment||None (Open Label)||||||
1508368|NCT00871845|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)|Participants were divided into arms based upon BMI. Weight loss instruction/management provided only to overweight arm.|Both groups followed for same period of time||||
1508369|NCT00871832|||Cohort||Prospective|||||||
1508370|NCT00871819||Single Group Assignment||Supportive Care||Double|||t||t|
1508371|NCT00871806|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1508372|NCT00871793|Randomized|Crossover Assignment||Treatment||Single||||||t
1508373|NCT00871780||Single Group Assignment||Treatment||None (Open Label)||||||
1508374|NCT00871767|Randomized|Crossover Assignment||||None (Open Label)||||||
1508375|NCT00871754|||Cohort||Prospective|||||||
1508376|NCT00871741|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508377|NCT00871728||Single Group Assignment||Treatment||None (Open Label)||||||
1508378|NCT00871715|Randomized|Parallel Assignment||Treatment||Single||||||t
1508379|NCT00871702||Single Group Assignment||Treatment||None (Open Label)||||||
1508380|NCT00871689||Single Group Assignment||Treatment||None (Open Label)||||||
1508381|NCT00871676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508382|NCT00871663|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508383|NCT00871650|||Case Control||Cross-Sectional|||||||
1508384|NCT00871637|||Case-Control||Prospective|||||||
1508385|NCT00871624|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508386|NCT00871611|||Cohort||Prospective|||||||
1508387|NCT00871598|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1508388|NCT00871585|||Case-Only||Prospective|||||||
1508389|NCT00871572|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508390|NCT00871559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508391|NCT00871546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508392|NCT00871533|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1508393|NCT00871520|||Cohort||Prospective|||||||
1508394|NCT00871507|Randomized|Crossover Assignment||Treatment||Double||||||
1508395|NCT00871494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508396|NCT00871481||Single Group Assignment||Treatment||Single||||||
1508397|NCT00871468|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508398|NCT00871455|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508399|NCT00871442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508400|NCT00871429||Single Group Assignment||Supportive Care||None (Open Label)||||||
1508401|NCT00871416|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508402|NCT00871403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508403|NCT00871390|||Cohort||Prospective|||||||
1508404|NCT00871377|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1508405|NCT00871364|Randomized|Crossover Assignment||||None (Open Label)||||||
1508406|NCT00871351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508407|NCT00871338|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508408|NCT00871325|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1508409|NCT00871312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508410|NCT00871299|Randomized|Parallel Assignment||Treatment||Single||||||t
1508411|NCT00871286|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1508412|NCT00871273||Single Group Assignment||Basic Science||None (Open Label)||||||
1508413|NCT00871260||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508414|NCT00871247|Randomized|Crossover Assignment||||None (Open Label)||||||
1508415|NCT00871234|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1508416|NCT00871208|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508417|NCT00871195|||Cohort||Prospective|||||||
1508418|NCT00871182|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1508419|NCT00871169||Single Group Assignment||Treatment||None (Open Label)||||||
1508420|NCT00871156|Randomized|Parallel Assignment||Other||Double|||t||t|
1508421|NCT00871143|Randomized|Parallel Assignment||Treatment||Single||||||t
1508422|NCT00871130|||Cohort||Retrospective|||||||
1508423|NCT00871117|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508424|NCT00871104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508425|NCT00871091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508426|NCT00871078|||Case Control||Prospective|||||||
1508427|NCT00871065||Single Group Assignment||Prevention||None (Open Label)||||||
1508428|NCT00871052|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1508429|NCT00871039|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1508430|NCT00871026|Randomized|Parallel Assignment||Treatment||Single||||t||
1508431|NCT00871013||Single Group Assignment||Treatment||None (Open Label)||||||
1508432|NCT00871000|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508433|NCT00870987|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1508434|NCT00870974||Single Group Assignment||||None (Open Label)||||||
1508435|NCT00870961|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1508436|NCT00870948|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1508437|NCT00870935|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1508438|NCT00870922||Single Group Assignment||Treatment||None (Open Label)||||||
1508439|NCT00870909|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508440|NCT00870896||Single Group Assignment||Treatment||None (Open Label)||||||
1508441|NCT00870883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508442|NCT00870870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508443|NCT00870857|||Cohort||Prospective|||||||
1508444|NCT00870844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508445|NCT00870831|||Cohort|||||||||
1508446|NCT00870818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508447|NCT00870805|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508448|NCT00870792|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1508449|NCT00870779||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508450|NCT00870766|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1508451|NCT00870753|Randomized|Parallel Assignment||Treatment||Single||||||t
1508452|NCT00870740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508453|NCT00870727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508454|NCT00870714||Single Group Assignment||Treatment||None (Open Label)||||||
1508455|NCT00870701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508456|NCT00870688|||||Prospective|||||||
1508457|NCT00870675|||Case-Only||Prospective|||||||
1508458|NCT00870662||Single Group Assignment||Treatment||None (Open Label)||||||
1508459|NCT00870649|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508460|NCT00870636||||||||||||
1508461|NCT00870623|||Cohort||Prospective|||||||
1508462|NCT00870610|||Case-Only||Prospective|||||||
1508463|NCT00870597|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508464|NCT00870584|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508465|NCT00870571|Randomized|Crossover Assignment||||None (Open Label)||||||
1508466|NCT00870558|Randomized|||Treatment||||||||
1508467|NCT00870545||Single Group Assignment||Treatment||None (Open Label)||||||
1508468|NCT00870532|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508469|NCT00870519|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1508470|NCT00870506|Randomized|Parallel Assignment||||None (Open Label)||||||
1508471|NCT00870493|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1508472|NCT00870480|Randomized|Crossover Assignment||||None (Open Label)||||||
1508473|NCT00870467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508474|NCT00870454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508475|NCT00870441|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1508476|NCT00870428|||Case-Only||Prospective|||||||
1508477|NCT00870415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508478|NCT00870402|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508479|NCT00870376|||Cohort||Prospective|||||||
1508480|NCT00870363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508481|NCT00870350|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1508482|NCT00870337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508483|NCT00870324|||Cohort||Prospective|||||||
1508484|NCT00870311|Non-Randomized|Single Group Assignment||Basic Science||Single|||t|||
1508485|NCT00870298|Randomized|Parallel Assignment||||Single|||t|||
1508486|NCT00870285|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508487|NCT00870272|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508488|NCT00870259||Single Group Assignment||Basic Science||None (Open Label)||||||
1508489|NCT00870246||||||||||||
1508490|NCT00870233|||Cohort||Prospective|||||||
1508491|NCT00870220||Single Group Assignment||Treatment||Single|||t|||
1508492|NCT00870207|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1508493|NCT00870194|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508494|NCT00870181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508495|NCT00870168||||Treatment||||||||
1508496|NCT00870155||Single Group Assignment||Treatment||None (Open Label)||||||
1508497|NCT00870142|Randomized|Crossover Assignment||||None (Open Label)||||||
1508498|NCT00870129||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508499|NCT00870116|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508500|NCT00870103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508501|NCT00870077||Single Group Assignment||Treatment||None (Open Label)||||||
1508502|NCT00870064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508503|NCT00870051|||Cohort||Prospective|||||||
1508504|NCT00870038|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1508505|NCT00870025|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508506|NCT00870012|Randomized|Parallel Assignment||||Single||||||t
1508507|NCT00869999|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508508|NCT00869986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508509|NCT00869973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508510|NCT00869960|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1508511|NCT00869947|Non-Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1508512|NCT00869934|Randomized|Parallel Assignment||Treatment||Single||||||t
1508513|NCT00869921|||Other||Prospective|||||||
1508514|NCT00869908|||Cohort||Prospective|||||||
1508515|NCT00869895||Single Group Assignment||Treatment||None (Open Label)||||||
1508516|NCT00869882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508517|NCT00869869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508518|NCT00869856|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508519|NCT00869843||Single Group Assignment||Treatment||None (Open Label)||||||
1508520|NCT00869830||Single Group Assignment||Treatment||None (Open Label)||||||
1508521|NCT00869817|||Cohort||Prospective|||||||
1508522|NCT00869804|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1508523|NCT00869791|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508524|NCT00869778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508525|NCT00869765||Single Group Assignment||Treatment||None (Open Label)||||||
1508526|NCT00869752|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508527|NCT00869739|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1508528|NCT00869726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508529|NCT00869713||Single Group Assignment||Prevention||None (Open Label)||||||
1508530|NCT00869700||Single Group Assignment||Treatment||None (Open Label)||||||
1508531|NCT00869687|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1508532|NCT00869674|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1508533|NCT00869661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508534|NCT00869648|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1508535|NCT00869635|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508536|NCT00869622|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508537|NCT00869609|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508538|NCT00869596|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1508539|NCT00869583|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1508540|NCT00869570||Single Group Assignment||Treatment||None (Open Label)||||||
1508541|NCT00869557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508542|NCT00869544|||Cohort||Prospective|||||||
1508543|NCT00869531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508544|NCT00869518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508545|NCT00869505|||Case Control||Retrospective|||||||
1508546|NCT00869492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508547|NCT00869479|||||Cross-Sectional|||||||
1508548|NCT00869466||||||||||||
1508549|NCT00869453|||||Prospective|||||||
1508550|NCT00869440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508551|NCT00869427|Randomized|Parallel Assignment||Prevention||Single|||||t|
1508552|NCT00869414|Randomized|Crossover Assignment||Treatment||Single|||||t|
1508553|NCT00869401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508554|NCT00869388|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508555|NCT00869375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508556|NCT00869362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508557|NCT00869349|Randomized|Parallel Assignment||Other||Single|||||t|
1508558|NCT00869336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508559|NCT00869323||Single Group Assignment||Treatment||None (Open Label)||||||
1508560|NCT00869310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508561|NCT00869297|Randomized|Single Group Assignment||Treatment||Single||||||
1508562|NCT00869284||Single Group Assignment||Treatment||None (Open Label)||||||
1508563|NCT00869271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508564|NCT00869258||Single Group Assignment||Treatment||None (Open Label)||||||
1508565|NCT00869245|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1508566|NCT00869232||Single Group Assignment||Treatment||None (Open Label)||||||
1508567|NCT00869219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508568|NCT00869206|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1508569|NCT00869193|Randomized|Parallel Assignment||||Triple|||t||t|t
1508570|NCT00869180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508571|NCT00869167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508572|NCT00869154|Randomized|Parallel Assignment||Treatment||Single|The baseline data were collected before randomization. The data collection at 12 months was conducted by postal self-report questionnaires, and for GOSE, an assistant who was blinded to the group allocation performed a telephone interview. Two independent persons, who were blinded for the groups and were unfamiliar with the aim and content of the study, entered the data into the SPSS database. A statistician, who did not participate in the treatment program and was blinded to the group allocation when the data were analyzed, controlled the data and performed the statistical analyses for RTW and the secondary outcomes.|Randomized controlled trial. Multidisciplinary outpatient rehabilitation with individual contacts and a psycho-educational group intervention at two outpatient rehabilitation clinics compared to follow-up by a general practitioner after a multidisciplinary examination.|||t|
1508573|NCT00869141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508574|NCT00869128|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1508575|NCT00869115|Randomized|||Treatment||Quadruple|||t|t|t|t
1508576|NCT00869102||Single Group Assignment||Basic Science||None (Open Label)||||||
1508577|NCT00869089||Single Group Assignment||Treatment||None (Open Label)||||||
1508578|NCT00869076|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1508579|NCT00869063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508580|NCT00869050||Single Group Assignment||Treatment||None (Open Label)||||||
1508581|NCT00869037|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508582|NCT00869024|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1508583|NCT00869011|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1508584|NCT00868998||Single Group Assignment||Treatment||None (Open Label)||||||
1508585|NCT00868985|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1508586|NCT00868972|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1508587|NCT00868959||Single Group Assignment||Treatment||None (Open Label)||||||
1508588|NCT00868946||Single Group Assignment||Treatment||None (Open Label)||||||
1508589|NCT00868933|Randomized|Parallel Assignment||||None (Open Label)||||||
1508590|NCT00868920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508591|NCT00868907|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508592|NCT00868894|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508593|NCT00868881|||||Retrospective|||||||
1508594|NCT00868868|||Cohort||Prospective|||||||
1508595|NCT00868855||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508596|NCT00868842|||Case-Only||Cross-Sectional|||||||
1508597|NCT00868829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508598|NCT00868816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508599|NCT00868803|||Other||Prospective|||||||
1508600|NCT00868790|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1508601|NCT00868777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508602|NCT00868764||Single Group Assignment||||None (Open Label)||||||
1508603|NCT00868751||Single Group Assignment||Treatment||None (Open Label)||||||
1508604|NCT00868738|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1508605|NCT00868725|||Case-Only||Cross-Sectional|||||||
1508606|NCT00868712|||Cohort||Prospective|||||||
1508607|NCT00868699|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508608|NCT00868686|Randomized|Parallel Assignment||Treatment||Single||||||t
1508609|NCT00868673|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1508610|NCT00868660|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1508611|NCT00868647||Single Group Assignment||Treatment||None (Open Label)||||||
1508612|NCT00868634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508613|NCT00868621|||||Prospective|||||||
1508614|NCT00868608||||Treatment||None (Open Label)||||||
1508615|NCT00868595||Single Group Assignment||Treatment||None (Open Label)||||||
1508616|NCT00868582|||||Prospective|||||||
1508617|NCT00868569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508618|NCT00868556|||Case Control||Prospective|||||||
1508619|NCT00868543|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508620|NCT00868530||Single Group Assignment||Treatment||None (Open Label)||||||
1508621|NCT00868517|Randomized|Parallel Assignment||Treatment||Single||||||
1508622|NCT00868504|||Case-Only||Cross-Sectional|||||||
1508623|NCT00868491||Single Group Assignment||Treatment||None (Open Label)||||||
1508624|NCT00868478||Single Group Assignment||Treatment||None (Open Label)||||||
1508625|NCT00868465|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1508626|NCT00868452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508627|NCT00868439|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508628|NCT00868426|Randomized|Crossover Assignment||||None (Open Label)||||||
1508629|NCT00868413|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508630|NCT00868400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508631|NCT00868387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508632|NCT00868374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508633|NCT00868361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508634|NCT00868348|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508635|NCT00868335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508636|NCT00868309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508637|NCT00868296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508638|NCT00868283|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508639|NCT00868270|||Cohort||Prospective|||||||
1508640|NCT00868257|||Cohort||Prospective|||||||
1508641|NCT00868244|||Case-Only|||||||||
1508642|NCT00868231|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1508643|NCT00868218|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1508644|NCT00868205|Randomized|Parallel Assignment||Prevention||Single|||||t|
1508645|NCT00868192||Single Group Assignment||Treatment||None (Open Label)||||||
1508646|NCT00868179||Single Group Assignment||Treatment||None (Open Label)||||||
1508647|NCT00868166|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1508648|NCT00868153|||Cohort||Prospective|||||||
1508649|NCT00868140|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1508650|NCT00868127||Single Group Assignment||Treatment||None (Open Label)||||||
1508651|NCT00868114|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508652|NCT00868101|Randomized|Parallel Assignment||Treatment||Single||||t||
1508653|NCT00868088|Randomized|Parallel Assignment||Treatment||Single||||||t
1508654|NCT00868075|Randomized|Parallel Assignment||Treatment||Single||||||t
1508655|NCT00868062|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1508656|NCT00868049|||||Cross-Sectional|||||||
1508657|NCT00868036||Single Group Assignment||Other||None (Open Label)||||||
1508658|NCT00868023|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1508659|NCT00868010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508660|NCT00867997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508661|NCT00867984|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508662|NCT00867971|||Cohort||Cross-Sectional|||||||
1508663|NCT00867958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508664|NCT00867945|||Case Control||Prospective|||||||
1508665|NCT00867932||Single Group Assignment||Treatment||None (Open Label)||||||
1508666|NCT00867919|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508667|NCT00867906|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508668|NCT00867893|||Case Control||Prospective|||||||
1508669|NCT00867880|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1508670|NCT00867867|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1508671|NCT00867854|||Case-Control||Prospective|||||||
1508672|NCT00867841|||Ecologic or Community||Prospective|||||||
1508673|NCT00867828|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508674|NCT00867815||Single Group Assignment||Other||None (Open Label)||||||
1508675|NCT00867802|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1508676|NCT00867789|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1508677|NCT00867776||Single Group Assignment||Health Services Research||None (Open Label)||||||
1508678|NCT00867763|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1508679|NCT00867750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508680|NCT00867737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508681|NCT00867724||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508682|NCT00867711|||Cohort||Retrospective|||||||
1508683|NCT00867698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508684|NCT00867685|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1508685|NCT00867672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508686|NCT00867659|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1508687|NCT00867646|||Case-Only||Prospective|||||||
1508688|NCT00867633|||Case Control||Cross-Sectional|||||||
1508689|NCT00867620|||Case Control||Cross-Sectional|||||||
1508690|NCT00867607|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1508691|NCT00867594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508692|NCT00867581|||Case Control||Cross-Sectional|||||||
1508693|NCT00867568||Single Group Assignment||Treatment||None (Open Label)||||||
1508694|NCT00867555|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1508695|NCT00867542|||||Retrospective|||||||
1508696|NCT00867529||Single Group Assignment||Treatment||None (Open Label)||||||
1508697|NCT00867516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508698|NCT00867503||Single Group Assignment||Treatment||None (Open Label)||||||
1508699|NCT00867490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508700|NCT00867477|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1508701|NCT00867464|||Cohort||Prospective|||||||
1508702|NCT00867451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508703|NCT00867438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508704|NCT00867425||Single Group Assignment||Prevention||None (Open Label)||||||
1508705|NCT00867412|||||Prospective|||||||
1508706|NCT00867399|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1508707|NCT00867386|||Cohort||Prospective|||||||
1508708|NCT00867373|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1508709|NCT00867360|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1508710|NCT00867347|Randomized|||Treatment||||||||
1508711|NCT00867334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508712|NCT00867321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508713|NCT00867308|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508714|NCT00867295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508715|NCT00867282|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1508716|NCT00867269|||||Prospective|||||||
1508717|NCT00867256||Single Group Assignment||Treatment||None (Open Label)||||||
1508718|NCT00867243|||Cohort||Prospective|||||||
1508719|NCT00867230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508720|NCT00867217|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1508721|NCT00867204|||Case Control||Prospective|||||||
1508722|NCT00867191|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1508723|NCT00867178||Single Group Assignment||Treatment||None (Open Label)||||||
1508724|NCT00867165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508725|NCT00867152|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1508726|NCT00867139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508727|NCT00867126||Single Group Assignment||Treatment||None (Open Label)||||||
1508728|NCT00867113||Single Group Assignment||Treatment||None (Open Label)||||||
1508729|NCT00867100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508730|NCT00867087|Non-Randomized|||Treatment||None (Open Label)||||||
1508731|NCT00867061||Single Group Assignment||Treatment||None (Open Label)||||||
1508732|NCT00867048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508733|NCT00867035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508734|NCT00867022|||Case Control||Prospective|||||||
1508735|NCT00867009|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508736|NCT00866996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508737|NCT00866983||||||||||||
1508738|NCT00866970|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1508739|NCT00866957|||Cohort||Prospective|||||||
1508740|NCT00866944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508741|NCT00866918|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508742|NCT00866905||Single Group Assignment||Treatment||None (Open Label)||||||
1508743|NCT00866892|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508744|NCT00866879|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508745|NCT00866866|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508746|NCT00866853|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508747|NCT00866840||Single Group Assignment||Treatment||None (Open Label)||||||
1508748|NCT00866827|||Other||Retrospective|||||||
1508749|NCT00866814|||Case-Only||Prospective|||||||
1508750|NCT00866801|||||Prospective|||||||
1508751|NCT00866788|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508752|NCT00866775|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508753|NCT00866762|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508754|NCT00866749||Single Group Assignment||Treatment||None (Open Label)||||||
1508755|NCT00866736|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508756|NCT00866723||Single Group Assignment||Treatment||None (Open Label)||||||
1508757|NCT00866710||Single Group Assignment||Treatment||None (Open Label)||||||
1508758|NCT00866697|Randomized|||Treatment||Double|||t||t|
1508759|NCT00866684|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508760|NCT00866671|||Cohort||Prospective|||||||
1508761|NCT00866658|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508762|NCT00866645|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508763|NCT00866632|Randomized|Parallel Assignment||Treatment||Single||||||t
1508764|NCT00866619|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508765|NCT00866606|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508766|NCT00866593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508767|NCT00866580|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1508768|NCT00866567|||Cohort||Prospective|||||||
1508769|NCT00866554|Randomized|Parallel Assignment||Treatment||Single|||||t|
1508770|NCT00866541||Single Group Assignment||Basic Science||Double|||t||t|
1508771|NCT00866528||Single Group Assignment||Treatment||None (Open Label)||||||
1508772|NCT00866515|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1508773|NCT00866502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508774|NCT00866489|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508775|NCT00866476|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508776|NCT00866463|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1508777|NCT00866450|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1508778|NCT00866437|Randomized|Factorial Assignment||Diagnostic||Single||||t||
1508779|NCT00866424|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508780|NCT00866411|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508781|NCT00866398|||Cohort||Prospective|||||||
1508782|NCT00866385|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1508783|NCT00866359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508784|NCT00866346||Single Group Assignment||Treatment||None (Open Label)||||||
1508785|NCT00866333||Single Group Assignment||Treatment||None (Open Label)||||||
1508786|NCT00866320||Single Group Assignment||Treatment||None (Open Label)||||||
1508787|NCT00866307|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508788|NCT00866294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508789|NCT00866281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508790|NCT00866268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508791|NCT00866255||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508792|NCT00866242||Single Group Assignment||Prevention||None (Open Label)||||||
1508793|NCT00866229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508794|NCT00866216|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508795|NCT00866203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508796|NCT00866190|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508797|NCT00866177||Single Group Assignment||Treatment||None (Open Label)||||||
1508798|NCT00866164||||||||||||
1508799|NCT00866151|||Cohort||Prospective|||||||
1508800|NCT00866138||Single Group Assignment||Treatment||None (Open Label)||||||
1508801|NCT00866125|||Case-Only||Cross-Sectional|||||||
1508802|NCT00866112|Randomized|Parallel Assignment||||None (Open Label)||||||
1508803|NCT00866099|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1508804|NCT00866086||||Diagnostic||None (Open Label)||||||
1508805|NCT00866073||Single Group Assignment||Treatment||None (Open Label)||||||
1508806|NCT00866060|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1508807|NCT00866047||Single Group Assignment||Treatment||None (Open Label)||||||
1508808|NCT00866034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508809|NCT00866021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508810|NCT00866008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508811|NCT00865995|||Case Control||Prospective|||||||
1508812|NCT00865982||Single Group Assignment||Treatment||None (Open Label)||||||
1508813|NCT00865969||Single Group Assignment||Treatment||None (Open Label)||||||
1508814|NCT00865956|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1508815|NCT00865943|Randomized|Crossover Assignment||||None (Open Label)||||||
1508816|NCT00865930||||||||||||
1508817|NCT00865917|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1508818|NCT00865904|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508819|NCT00865891|Randomized|Crossover Assignment||||None (Open Label)||||||
1508820|NCT00865878|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508821|NCT00865865|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508822|NCT00865852|Randomized|Crossover Assignment||||None (Open Label)||||||
1508823|NCT00865839|Randomized|Crossover Assignment||||None (Open Label)||||||
1508824|NCT00865826|||Cohort||Prospective|||||||
1508825|NCT00865813|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1508826|NCT00865787|||Case Control||Prospective|||||||
1508827|NCT00865774|Randomized|Parallel Assignment||Prevention||Single|||t|||
1508828|NCT00865761|Randomized|Crossover Assignment||||None (Open Label)||||||
1508829|NCT00865748|Randomized|Crossover Assignment||||None (Open Label)||||||
1508830|NCT00865735||||||||||||
1508831|NCT00865722|Randomized|Parallel Assignment||Treatment||Single||||||t
1508832|NCT00865709|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508833|NCT00865696|Randomized|Crossover Assignment||||None (Open Label)||||||
1508834|NCT00865683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508835|NCT00865670|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508836|NCT00865657|Randomized|Crossover Assignment||||None (Open Label)||||||
1508837|NCT00865644||Single Group Assignment||Treatment||None (Open Label)||||||
1508838|NCT00865631|Randomized|Crossover Assignment||||None (Open Label)||||||
1508839|NCT00865618|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508840|NCT00865605|Randomized|Crossover Assignment||||Single|||t|||
1508841|NCT00865592||Single Group Assignment||Treatment||None (Open Label)||||||
1508842|NCT00865579||Single Group Assignment||Treatment||None (Open Label)||||||
1508843|NCT00865566|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1508844|NCT00865553||||Health Services Research||||||||
1508845|NCT00865540|Randomized|Single Group Assignment||Treatment||Single|||||t|
1508846|NCT00865527|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1508847|NCT00865514||Single Group Assignment||Basic Science||None (Open Label)||||||
1508848|NCT00865501|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1508849|NCT00865488|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1508850|NCT00865475|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508851|NCT00865462|Randomized|Crossover Assignment||||None (Open Label)||||||
1508852|NCT00865449|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508853|NCT00865436|Randomized|Crossover Assignment||||None (Open Label)||||||
1508854|NCT00865423|Randomized|Crossover Assignment||||None (Open Label)||||||
1508855|NCT00865410|Randomized|Crossover Assignment||||None (Open Label)||||||
1508856|NCT00865397|||Case Control||Prospective|||||||
1508857|NCT00865384|Randomized|Crossover Assignment||||None (Open Label)||||||
1508858|NCT00865371|Randomized|Crossover Assignment||||None (Open Label)||||||
1508859|NCT00865358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508860|NCT00865345||Single Group Assignment||Treatment||None (Open Label)||||||
1508861|NCT00865332||||||||||||
1508862|NCT00865319|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1508863|NCT00865306|Randomized|Parallel Assignment||Treatment||Single||||||t
1508864|NCT00865293|||Case Control||Cross-Sectional|||||||
1508865|NCT00865280|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508866|NCT00865267||Single Group Assignment||||Single|||t|||
1508867|NCT00865254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508868|NCT00865241|Randomized|Crossover Assignment||||None (Open Label)||||||
1508869|NCT00865228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508870|NCT00865215|Randomized|Crossover Assignment||||None (Open Label)||||||
1508871|NCT00865202|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1508872|NCT00865189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508873|NCT00865176|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508874|NCT00865163|||Cohort||Prospective|||||||
1508875|NCT00865150|||Cohort||Prospective|||||||
1508876|NCT00865137||Single Group Assignment||Treatment||None (Open Label)||||||
1508877|NCT00865124|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508878|NCT00865111|Randomized|Crossover Assignment||||None (Open Label)||||||
1508879|NCT00865098||Single Group Assignment||Treatment||None (Open Label)||||||
1508880|NCT00865085|Randomized|Crossover Assignment||||None (Open Label)||||||
1508881|NCT00865072|Randomized|Crossover Assignment||||None (Open Label)||||||
1508882|NCT00865059|Randomized|Crossover Assignment||||None (Open Label)||||||
1508883|NCT00865046|Randomized|Parallel Assignment||Treatment||Single||||||
1508884|NCT00865033|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508885|NCT00865020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508886|NCT00865007|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508887|NCT00864994|||Case Control||Prospective|||||||
1508888|NCT00864981|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508889|NCT00864968|Randomized|Crossover Assignment||||None (Open Label)||||||
1508890|NCT00864955|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1508891|NCT00864942|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508892|NCT00864929|||Cohort||Retrospective|||||||
1508893|NCT00864916|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508894|NCT00864903|||Case-Only||Prospective|||||||
1508895|NCT00864890|Randomized|Crossover Assignment||||None (Open Label)||||||
1508896|NCT00864877||||Treatment||||||||
1508897|NCT00864864||Single Group Assignment||Treatment||None (Open Label)||||||
1508898|NCT00864851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508899|NCT00864838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508900|NCT00864825|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1508901|NCT00864812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508902|NCT00864799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508903|NCT00864786|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1508904|NCT00864773|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1508905|NCT00864760|Randomized|Crossover Assignment||||None (Open Label)||||||
1508906|NCT00864747|Randomized|Crossover Assignment||||None (Open Label)||||||
1508907|NCT00864734|Randomized|Crossover Assignment||||None (Open Label)||||||
1508908|NCT00864721||Single Group Assignment||Treatment||None (Open Label)||||||
1508909|NCT00864708||Single Group Assignment||Treatment||None (Open Label)||||||
1508910|NCT00864695|||Cohort||Prospective|||||||
1508911|NCT00864682|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508912|NCT00864669|Randomized|Crossover Assignment||||None (Open Label)||||||
1508913|NCT00864656|||Cohort||Prospective|||||||
1508914|NCT00864643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508915|NCT00864630|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1508916|NCT00864617|Randomized|Crossover Assignment||||None (Open Label)||||||
1508917|NCT00864604|Randomized|Crossover Assignment||||None (Open Label)||||||
1508918|NCT00864591|||Cohort||Prospective|||||||
1508919|NCT00864578|||Case-Only||Prospective|||||||
1508920|NCT00864565|Randomized|Crossover Assignment||||None (Open Label)||||||
1508921|NCT00864552|||Cohort||Prospective|||||||
1508922|NCT00864539|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1508923|NCT00864526|Randomized|Crossover Assignment||||None (Open Label)||||||
1508924|NCT00864513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508925|NCT00864500|Randomized|Crossover Assignment||||None (Open Label)||||||
1508926|NCT00864487|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508927|NCT00864474|||Case-Only||Retrospective|||||||
1508928|NCT00864461|||Case-Control||Cross-Sectional|||||||
1508929|NCT00864448|Randomized|Crossover Assignment||||None (Open Label)||||||
1508930|NCT00864435|Randomized|Crossover Assignment||||None (Open Label)||||||
1508931|NCT00864422|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1508932|NCT00864409|Randomized|||Treatment||Triple|||t||t|t
1508933|NCT00864396||Single Group Assignment||Treatment||None (Open Label)||||||
1508934|NCT00864383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508935|NCT00864370|||Cohort||Prospective|||||||
1508936|NCT00864357|Randomized|Crossover Assignment||||None (Open Label)||||||
1508937|NCT00864344|Randomized|Crossover Assignment||||None (Open Label)||||||
1508938|NCT00864331|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508939|NCT00864318||Single Group Assignment||Treatment||None (Open Label)||||||
1508940|NCT00864305|Randomized|Crossover Assignment||||None (Open Label)||||||
1508941|NCT00864292|||Case Control||Prospective|||||||
1508942|NCT00864279|Randomized|Crossover Assignment||||None (Open Label)||||||
1508943|NCT00864266||Single Group Assignment||Diagnostic||None (Open Label)||||||
1508944|NCT00864253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508945|NCT00864240|Randomized|Single Group Assignment||||None (Open Label)||||||
1508946|NCT00864227||Single Group Assignment||Treatment||None (Open Label)||||||
1508947|NCT00864214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508948|NCT00864201||Single Group Assignment||Treatment||None (Open Label)||||||
1508949|NCT00864188|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1508950|NCT00864175|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1508951|NCT00864162|Randomized|Crossover Assignment||||None (Open Label)||||||
1508952|NCT00864149|Randomized|Crossover Assignment||||None (Open Label)||||||
1508953|NCT00864136|||Cohort||Prospective|||||||
1508954|NCT00864123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508955|NCT00864110|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1508956|NCT00864097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508957|NCT00864084||Single Group Assignment||Treatment||None (Open Label)||||||
1508958|NCT00864071|Randomized|Crossover Assignment||||None (Open Label)||||||
1508959|NCT00864058|Randomized|Crossover Assignment||||None (Open Label)||||||
1508960|NCT00864045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508961|NCT00864032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508962|NCT00864019|Randomized|Crossover Assignment||||None (Open Label)||||||
1508963|NCT00864006|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508964|NCT00863993|||Cohort||Prospective|||||||
1508965|NCT00863980|Randomized|Parallel Assignment||Prevention||Single||||||t
1508966|NCT00863967|||Cohort||Prospective|||||||
1508967|NCT00863954|Randomized|Parallel Assignment||||Double|||t|||t
1508968|NCT00863941|Randomized|Crossover Assignment||||None (Open Label)||||||
1508969|NCT00863928||Single Group Assignment||Treatment||||||||
1508970|NCT00863915|Randomized|Crossover Assignment||||None (Open Label)||||||
1508971|NCT00863902|Randomized|Crossover Assignment||||None (Open Label)||||||
1508972|NCT00863889|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508973|NCT00863876|||Cohort||Cross-Sectional|||||||
1508974|NCT00863863|Randomized|Crossover Assignment||||None (Open Label)||||||
1508975|NCT00863850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508976|NCT00863837|Randomized|Parallel Assignment||Treatment||Single||||||t
1508977|NCT00863824|||Case-Only||Prospective|||||||
1508978|NCT00863811|||Case-Only||Prospective|||||||
1508979|NCT00863798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508980|NCT00863785|Randomized|Parallel Assignment||Treatment||Single|||t|||
1508981|NCT00863772|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508982|NCT00863759|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1508983|NCT00863746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508984|NCT00863733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1508985|NCT00863707|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1508986|NCT00863694|||Cohort||Prospective|||||||
1508987|NCT00863681||Single Group Assignment||Treatment||None (Open Label)||||||
1508988|NCT00863668|Randomized|Parallel Assignment||Basic Science||Single||||||t
1508989|NCT00863655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1508990|NCT00863642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508991|NCT00863629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1508992|NCT00863616|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1508993|NCT00863603|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1508994|NCT00863590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1508995|NCT00863577||Parallel Assignment||||None (Open Label)||||||
1508996|NCT00863564|Randomized|Crossover Assignment||Prevention||Single|||t|||
1508997|NCT00863551||Single Group Assignment||Treatment||None (Open Label)||||||
1508998|NCT00863538||Single Group Assignment||Treatment||None (Open Label)||||||
1508999|NCT00863525|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509000|NCT00863512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509001|NCT00863499|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1509002|NCT00863486||||||||||||
1509003|NCT00863473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509004|NCT00863460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509005|NCT00863447||||||||||||
1509006|NCT00863434||Single Group Assignment||Treatment||None (Open Label)||||||
1509007|NCT00863421|||Cohort||Prospective|||||||
1509008|NCT00863408|||||Prospective|||||||
1509009|NCT00863395|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1509010|NCT00863382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509011|NCT00863369||Single Group Assignment||Treatment||None (Open Label)||||||
1509012|NCT00863356||Single Group Assignment||Treatment||None (Open Label)||||||
1509013|NCT00863343|||Cohort||Prospective|||||||
1509014|NCT00863330||Single Group Assignment||Treatment||None (Open Label)||||||
1509015|NCT00863317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509016|NCT00863304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509017|NCT00863291|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1509018|NCT00863278|Randomized|Parallel Assignment||Treatment||Single||||||t
1509019|NCT00863265|Randomized|Crossover Assignment||Basic Science||Quadruple|Phytosterols solutions were provided as food oil only (placebo) or food oil containing 2000 mg/day phytosterols (Phytosterols). Active and placebo ezetimibe tablets were provided by Merck.|This is a randomized, crossover design. There are three periods of 21 days separated by two 7 day washouts. All subjects eat a controlled low-phytosterol diet for each of the three periods. During period B placebo phytosterols and placebo ezetimibe are given. During period C phytosterol placebo and active ezetimibe are given. During period A active phytosterols and active ezetimibe are given. Periods are assigned in random order as described in Arms below.|t|t|t|t
1509020|NCT00863252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509021|NCT00863239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509022|NCT00863226|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509023|NCT00863213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509024|NCT00863200|||Case-Only||Prospective|||||||
1509025|NCT00863187|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1509026|NCT00863174|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1509027|NCT00863161|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1509028|NCT00863148||Single Group Assignment||Treatment||None (Open Label)||||||
1509029|NCT00863135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509030|NCT00863122|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1509031|NCT00863109|||Cohort||Prospective|||||||
1509032|NCT00863096|||Cohort||Prospective|||||||
1509033|NCT00863083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509034|NCT00863070|||Cohort||Prospective|||||||
1509035|NCT00863057|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1509036|NCT00863044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509037|NCT00863031|Randomized|Parallel Assignment||Treatment||Single||||||t
1509038|NCT00863018|||Case Control||Prospective|||||||
1509039|NCT00863005||Parallel Assignment||||||||||
1509040|NCT00862992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509041|NCT00862979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509042|NCT00862966|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1509043|NCT00862953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509044|NCT00862940|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509045|NCT00862927|||Case-Only||Prospective|||||||
1509046|NCT00862914|||Case Control||Prospective|||||||
1509047|NCT00862901|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509048|NCT00862888|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509049|NCT00862875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509050|NCT00862862|||||Prospective|||||||
1509051|NCT00862849||Crossover Assignment||||Double|||t||t|
1509052|NCT00862836||Single Group Assignment||Treatment||None (Open Label)||||||
1509053|NCT00862823|Randomized|Crossover Assignment||||None (Open Label)||||||
1509054|NCT00862810|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509055|NCT00862797|||Cohort||Prospective|||||||
1509056|NCT00862784||Single Group Assignment||Treatment||None (Open Label)||||||
1509057|NCT00862758||||||||||||
1509058|NCT00862745|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509059|NCT00862732|Randomized|Parallel Assignment||Prevention||Single||||||t
1509060|NCT00862719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509061|NCT00862706||Single Group Assignment||Treatment||None (Open Label)||||||
1509062|NCT00862693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509063|NCT00862680||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509064|NCT00862667|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1509065|NCT00862654|Randomized|Parallel Assignment||Treatment||Single|||||t|
1509066|NCT00862641|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1509067|NCT00862628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509068|NCT00862615|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1509069|NCT00862602|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509070|NCT00862589|Randomized|Parallel Assignment||||Single|||t|||
1509071|NCT00862576|||Case Control|||||||||
1509072|NCT00862563|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509073|NCT00862550|Randomized|Single Group Assignment||Treatment||Single|||t|||
1509074|NCT00862537||||||||||||
1509075|NCT00862524||Single Group Assignment||Treatment||None (Open Label)||||||
1509076|NCT00862511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509077|NCT00862498|Randomized|Parallel Assignment||Treatment||Single||||||t
1509078|NCT00862485|||Case-Only|||||||||
1509079|NCT00862472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509080|NCT00862459|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1509081|NCT00862446||Single Group Assignment||Treatment||None (Open Label)||||||
1509082|NCT00862433|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1509083|NCT00862420|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509084|NCT00862407|||Cohort||Retrospective|||||||
1509085|NCT00862394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509086|NCT00862381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509087|NCT00862368|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509088|NCT00862355|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1509089|NCT00862342||Single Group Assignment||Treatment||None (Open Label)||||||
1509090|NCT00862329|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1509091|NCT00862316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509092|NCT00862303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509093|NCT00862290|||Case Control||Prospective|||||||
1509094|NCT00862277|||Case Control||Retrospective|||||||
1509095|NCT00862264|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509096|NCT00862251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509097|NCT00862238|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509098|NCT00862225|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509099|NCT00862212|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509100|NCT00862186||Single Group Assignment||Supportive Care||None (Open Label)||||||
1509101|NCT00862173|||Cohort||Prospective|||||||
1509102|NCT00862160|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509103|NCT00862147|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1509104|NCT00862134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509105|NCT00862121|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509106|NCT00862108||Single Group Assignment||Treatment||None (Open Label)||||||
1509107|NCT00862095|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1509108|NCT00862082||Single Group Assignment||Treatment||None (Open Label)||||||
1509109|NCT00862056|||Cohort||Prospective|||||||
1509110|NCT00862043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509111|NCT00862030|||Cohort||Cross-Sectional|||||||
1509112|NCT00862017|Randomized|Crossover Assignment||Basic Science||||||||
1509113|NCT00862004|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509114|NCT00861991|Randomized|Parallel Assignment||||Single|||t|||
1509115|NCT00861978|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509116|NCT00861965||Single Group Assignment||Treatment||None (Open Label)||||||
1509117|NCT00861952|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509118|NCT00861939|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509119|NCT00861926|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509120|NCT00861913||Single Group Assignment||Treatment||None (Open Label)||||||
1509121|NCT00861900|||Cohort||Prospective|||||||
1509122|NCT00861887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509123|NCT00861874|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509124|NCT00861861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509125|NCT00861848|||||Prospective|||||||
1509126|NCT00861835||||Diagnostic||||||||
1509127|NCT00861822|Randomized|Parallel Assignment||Prevention||Single||||||t
1509128|NCT00861809|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1509129|NCT00861796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509130|NCT00861783|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509131|NCT00861770|Randomized|Parallel Assignment||Treatment||Single|||||t|
1509132|NCT00861757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509133|NCT00861744|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1509134|NCT00861731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509135|NCT00861718|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1509136|NCT00861705|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1509137|NCT00861692||Single Group Assignment||Treatment||None (Open Label)||||||
1509138|NCT00861679||Single Group Assignment||Treatment||None (Open Label)||||||
1509139|NCT00861666|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1509140|NCT00861653|||Ecologic or Community||Prospective|||||||
1509141|NCT00861640|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509142|NCT00861627||Single Group Assignment||Treatment||None (Open Label)||||||
1509143|NCT00861614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509144|NCT00861601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509145|NCT00861588|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509146|NCT00861575|||Cohort||Prospective|||||||
1509147|NCT00861562|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1509148|NCT00861549|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1509149|NCT00861536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509150|NCT00861523|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509151|NCT00861510|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509152|NCT00861497||Single Group Assignment||Treatment||None (Open Label)||||||
1509153|NCT00861484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509154|NCT00861471||Single Group Assignment||Treatment||None (Open Label)||||||
1509155|NCT00861458|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1509156|NCT00861445|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509157|NCT00861432|Randomized|Parallel Assignment||Treatment||Single||||||t
1509158|NCT00861419|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509159|NCT00861406|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509160|NCT00861393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509161|NCT00861380|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1509162|NCT00861367|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1509163|NCT00861354|||Case-Only||Prospective|||||||
1509164|NCT00861341||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509165|NCT00861328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509166|NCT00861315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509167|NCT00861302||Single Group Assignment||Treatment||None (Open Label)||||||
1509168|NCT00861276|Randomized|Parallel Assignment||Treatment||Single|||t|||
1509169|NCT00861263||Single Group Assignment||||None (Open Label)||||||
1509170|NCT00861250||Single Group Assignment||Treatment||None (Open Label)||||||
1509171|NCT00861237|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509172|NCT00861224|||Cohort||Prospective|||||||
1509173|NCT00861211|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509174|NCT00861198|||||Prospective|||||||
1509175|NCT00861185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509176|NCT00861172||Single Group Assignment||||None (Open Label)||||||
1509177|NCT00861159|||Case-Only||Prospective|||||||
1509178|NCT00861146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509179|NCT00861133|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1509180|NCT00861120|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1509181|NCT00861107||Single Group Assignment||Treatment||None (Open Label)||||||
1509182|NCT00861094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509183|NCT00861081|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1509184|NCT00861068|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509185|NCT00861055|||Cohort||Prospective|||||||
1509186|NCT00861042||Single Group Assignment||Treatment||None (Open Label)||||||
1509187|NCT00861029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509188|NCT00861016||Single Group Assignment||Treatment||None (Open Label)||||||
1509189|NCT00861003|||Case-Only||Prospective|||||||
1509190|NCT00860990|||||Prospective|||||||
1509191|NCT00860977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509192|NCT00860964|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509193|NCT00860951||Single Group Assignment||Health Services Research||None (Open Label)||||||
1509194|NCT00860938|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509195|NCT00860925|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1509196|NCT00860912|Randomized|Sequential Assignment||Treatment||Single||collagen graft reinforcement|t|||
1509197|NCT00860899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509198|NCT00860886|||Case-Control||Cross-Sectional|||||||
1509199|NCT00860873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509200|NCT00860860||Single Group Assignment||Treatment||None (Open Label)||||||
1509201|NCT00860847|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509202|NCT00860834|Randomized|Parallel Assignment||Treatment||Single||||||t
1509203|NCT00860821|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1509204|NCT00860808|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509205|NCT00860795|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1509206|NCT00860782|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509207|NCT00860769|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509208|NCT00860756|Randomized|Parallel Assignment||||None (Open Label)||||||
1509209|NCT00860743|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1509210|NCT00860730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509211|NCT00860717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509212|NCT00860704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509213|NCT00860691|Randomized|Parallel Assignment||Treatment||Double||||t||t
1509214|NCT00860678|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509215|NCT00860665|||Cohort||Prospective|||||||
1509216|NCT00860652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509217|NCT00860639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509218|NCT00860626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509219|NCT00860613|Randomized|Parallel Assignment||Treatment||Single|||t|||
1509220|NCT00860600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509221|NCT00860587|||Case-Only||Prospective|||||||
1509222|NCT00860574||Single Group Assignment||Treatment||None (Open Label)||||||
1509223|NCT00860561|||||Prospective|||||||
1509224|NCT00860548|||Cohort||Prospective|||||||
1509225|NCT00860535|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1509226|NCT00860522|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509227|NCT00860509|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1509228|NCT00860496||Parallel Assignment||Prevention||None (Open Label)||||||
1509229|NCT00860483||Single Group Assignment||Health Services Research||None (Open Label)||||||
1509230|NCT00860470|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509231|NCT00860457||Single Group Assignment||Treatment||None (Open Label)||||||
1509232|NCT00860444|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1509233|NCT00860431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509234|NCT00860418|Randomized|Parallel Assignment||Prevention||Single|||t|||
1509235|NCT00860405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509236|NCT00860392|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1509237|NCT00860379|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509238|NCT00860366|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509239|NCT00860353|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1509240|NCT00860340||Single Group Assignment||Treatment||None (Open Label)||||||
1509242|NCT00860314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509243|NCT00860301|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1509244|NCT00860288|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509245|NCT00860275|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1509246|NCT00860262|Randomized|Parallel Assignment||Treatment||Double||||||
1509247|NCT00860249|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1509248|NCT00860236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509249|NCT00860223|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509250|NCT00860210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509251|NCT00860197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509252|NCT00860184|||Cohort||Prospective|||||||
1509253|NCT00860171||Single Group Assignment||Treatment||None (Open Label)||A single site, open label clinical trial.||||
1509254|NCT00860158||Single Group Assignment||Treatment||None (Open Label)||||||
1509255|NCT00860145|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509256|NCT00860132|||Cohort||Retrospective|||||||
1509257|NCT00860119|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1509258|NCT00860106|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1509259|NCT00860093|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509260|NCT00860080|Randomized|Parallel Assignment||||Single|||t|||
1509261|NCT00860067|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509262|NCT00860054|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1509263|NCT00860041|||Cohort||Prospective|||||||
1509264|NCT00860028|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509265|NCT00860015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509266|NCT00860002|||Case Control||Prospective|||||||
1509267|NCT00859989|Randomized|||||||||||
1509268|NCT00859976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509269|NCT00859963|||Cohort||Prospective|||||||
1509270|NCT00859950|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1509271|NCT00859937||Single Group Assignment||Treatment||None (Open Label)||||||
1509272|NCT00859911|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509273|NCT00859898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509274|NCT00859885|||Cohort||Prospective|||||||
1509275|NCT00859872|Randomized|Parallel Assignment||Treatment||Single||||||t
1509276|NCT00859859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509277|NCT00859846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509278|NCT00859833||Single Group Assignment||Diagnostic||Single|||t|||
1509279|NCT00859807|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509280|NCT00859794|||Case-Only||Prospective|||||||
1509281|NCT00859781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509282|NCT00859768|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509283|NCT00859755|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1509284|NCT00859742||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509285|NCT00859729|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509286|NCT00859716|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509287|NCT00859703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509288|NCT00859690|||Case Control|||||||||
1509289|NCT00859677|||Cohort||Cross-Sectional|||||||
1509290|NCT00859664|||Cohort||Prospective|||||||
1509291|NCT00859651|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509292|NCT00859638|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509293|NCT00859625|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1509294|NCT00859612|||Other||Prospective|||||||
1509295|NCT00859599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509296|NCT00859586||Single Group Assignment||Treatment||None (Open Label)||||||
1509297|NCT00859573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509298|NCT00859560|||Cohort||Retrospective|||||||
1509299|NCT00859547||Single Group Assignment||Treatment||None (Open Label)||||||
1509300|NCT00859534||Single Group Assignment||Treatment||None (Open Label)||||||
1509301|NCT00859521|Randomized|Crossover Assignment||||None (Open Label)||||||
1509302|NCT00859508|Randomized|Parallel Assignment||Treatment||Single|||t|||
1509303|NCT00859495|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509304|NCT00859482|||Cohort||Prospective|||||||
1509305|NCT00859469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509306|NCT00859456|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509307|NCT00859430|Randomized|Crossover Assignment||||None (Open Label)||||||
1509308|NCT00859417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509309|NCT00859404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509310|NCT00859391|||Cohort||Prospective|||||||
1509311|NCT00859378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509312|NCT00859365|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509313|NCT00859352|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1509314|NCT00859339||Single Group Assignment||Treatment||None (Open Label)||||||
1509315|NCT00859313||Single Group Assignment||Treatment||None (Open Label)||||||
1509316|NCT00859300|||Case Control||Prospective|||||||
1509317|NCT00859287|||Cohort||Prospective|||||||
1509318|NCT00859274||Single Group Assignment||Basic Science||None (Open Label)||||||
1509319|NCT00859261||Single Group Assignment||Diagnostic||Single||||||t
1509320|NCT00859235|Randomized|Parallel Assignment||Prevention||Single|||t|||
1509321|NCT00859222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509322|NCT00859209|||Cohort||Prospective|||||||
1509323|NCT00859196|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1509324|NCT00859183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509325|NCT00859170|Randomized|Parallel Assignment||Treatment||Single|||t|||
1509326|NCT00859157|||Case-Control||Prospective|||||||
1509327|NCT00859144|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1509328|NCT00859131|Randomized|Parallel Assignment||||None (Open Label)||||||
1509329|NCT00859118|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509330|NCT00859105|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509331|NCT00859092|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509332|NCT00859079|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509333|NCT00859066|||Case Control||Prospective|||||||
1509334|NCT00859053|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1509335|NCT00859040||Single Group Assignment||Treatment||None (Open Label)||||||
1509336|NCT00859027|Randomized|Parallel Assignment||Treatment||Double||Randomized, placebo controlled trial.|t||t|
1509337|NCT00859014||Single Group Assignment||Treatment||None (Open Label)||||||
1509338|NCT00859001|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509339|NCT00858988|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1509340|NCT00858975||Parallel Assignment||Treatment||None (Open Label)||||||
1509341|NCT00858962||Single Group Assignment||Treatment||None (Open Label)||||||
1509342|NCT00858949|||Cohort||Prospective|||||||
1509343|NCT00858936|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1509344|NCT00858923||Single Group Assignment||Treatment||None (Open Label)||||||
1509345|NCT00858910|Randomized|Parallel Assignment||Treatment||Single||||||t
1509346|NCT00858897|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1509347|NCT00858884||Single Group Assignment||Diagnostic||Single||||||t
1509348|NCT00858871|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509349|NCT00858858|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1509350|NCT00858845|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1509351|NCT00858832|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509352|NCT00858819|||Case-Crossover||Cross-Sectional|||||||
1509353|NCT00858806||Single Group Assignment||Treatment||None (Open Label)||||||
1509354|NCT00858793||Single Group Assignment||Treatment||None (Open Label)||||||
1509355|NCT00858780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509356|NCT00858767|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509357|NCT00858754|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509358|NCT00858741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509359|NCT00858728|Randomized|Parallel Assignment||Prevention||Single||||||t
1509360|NCT00858715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509361|NCT00858702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509362|NCT00858689||Single Group Assignment||Treatment||None (Open Label)||||||
1509363|NCT00858676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509364|NCT00858663||Single Group Assignment||Treatment||None (Open Label)||||||
1509365|NCT00858650|||Cohort||Prospective|||||||
1509366|NCT00858637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509367|NCT00858624|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1509368|NCT00858611|Randomized|Parallel Assignment||Prevention||Double||||||
1509369|NCT00858598|||Cohort||Prospective|||||||
1509370|NCT00858585|||Other||Prospective|||||||
1509371|NCT00858572||Single Group Assignment||Treatment||None (Open Label)||||||
1509372|NCT00858559|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509373|NCT00858546||Single Group Assignment||Treatment||None (Open Label)||||||
1509374|NCT00858533|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1509375|NCT00858520|||Case Control||Prospective|||||||
1509376|NCT00858507|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1509377|NCT00858494||Single Group Assignment||Treatment||None (Open Label)||||||
1509378|NCT00858481|Randomized|Parallel Assignment||Treatment||Single||||||t
1509379|NCT00858468|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509380|NCT00858455|Randomized|Crossover Assignment||||None (Open Label)||||||
1509381|NCT00858442|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1509382|NCT00858429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509383|NCT00858416|Randomized|Crossover Assignment||Treatment||Single|||t|||
1509384|NCT00858403||Single Group Assignment||Treatment||None (Open Label)||||||
1509385|NCT00858390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509386|NCT00858377||Single Group Assignment||Treatment||None (Open Label)||||||
1509387|NCT00858364|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1509388|NCT00858351|Randomized|Parallel Assignment||Treatment||Single|||t|||
1509389|NCT00858338||Single Group Assignment||Treatment||None (Open Label)||||||
1509390|NCT00858325|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509391|NCT00858312|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1509392|NCT00858299||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509393|NCT00858286|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509394|NCT00858273|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1509395|NCT00858260|||Cohort||Prospective|||||||
1509396|NCT00858247|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509397|NCT00858234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509398|NCT00858221|||Cohort||Retrospective|||||||
1509399|NCT00858208|||Case-Only||Prospective|||||||
1509400|NCT00858195|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509401|NCT00858182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509402|NCT00858169|||Cohort||Prospective|||||||
1509403|NCT00858156|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1509404|NCT00858143|||Case-Only||Prospective|||||||
1509405|NCT00858130||Single Group Assignment||Treatment||None (Open Label)||Patients were told to use different voltages and numbers of treatment periods, and experiment with pad placement, to find intensity, frequency of use, and pad position for optimal PTS symptom relief. Assessments (Villalta score, QOL questionnaire, calf circumference) were obtained at study entry and after 8 weeks of device use.||||
1509406|NCT00858117||Single Group Assignment||Treatment||None (Open Label)||||||
1509407|NCT00858104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509408|NCT00858091||||||||||||
1509409|NCT00858078|||Family-Based||Other|||||||
1509410|NCT00858065|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509411|NCT00858052||Single Group Assignment||Treatment||None (Open Label)||||||
1509412|NCT00858039|||Cohort||Prospective|||||||
1509413|NCT00858026|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1509414|NCT00858013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509415|NCT00858000|||Case-Only||Retrospective|||||||
1509416|NCT00857987|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509417|NCT00857974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509418|NCT00857961|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509419|NCT00857948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509420|NCT00857935|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1509421|NCT00857922|||Other||Prospective|||||||
1509422|NCT00857909|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509423|NCT00857896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509424|NCT00857883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509425|NCT00857870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509426|NCT00857857|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509427|NCT00857844|||Cohort||Cross-Sectional|||||||
1509428|NCT00857831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509429|NCT00857818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509430|NCT00857805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509431|NCT00857792||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509432|NCT00857779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509433|NCT00857766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509434|NCT00857753|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509435|NCT00857740|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509436|NCT00857727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509437|NCT00857714||Single Group Assignment||Basic Science||None (Open Label)||||||
1509438|NCT00857701|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509439|NCT00857688|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509440|NCT00857675|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509441|NCT00857662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509442|NCT00857649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509443|NCT00857636|Randomized|Parallel Assignment||Prevention||Single|||t|||
1509444|NCT00857623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509445|NCT00857610|||Cohort||Prospective|||||||
1509446|NCT00857597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509447|NCT00857584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509448|NCT00857571|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1509449|NCT00857558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509450|NCT00857545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509451|NCT00857532|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1509452|NCT00857519||Single Group Assignment||Treatment||None (Open Label)||||||
1509453|NCT00857506||Single Group Assignment||Diagnostic||Single||||||t
1509454|NCT00857493|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1509455|NCT00857480|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1509456|NCT00857467|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1509457|NCT00857454||Parallel Assignment||Treatment||None (Open Label)||||||
1509458|NCT00857441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509459|NCT00857428|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509460|NCT00857415|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1509461|NCT00857402|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1509462|NCT00857389||Single Group Assignment||Treatment||None (Open Label)||||||
1509463|NCT00857376|Randomized|Parallel Assignment||||Triple|||t||t|t
1509464|NCT00857363|||Case Control||Prospective|||||||
1509465|NCT00857350|||Ecologic or Community||Cross-Sectional|||||||
1509466|NCT00857324||Single Group Assignment||Treatment||None (Open Label)||||||
1509467|NCT00857311|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509468|NCT00857298|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1509469|NCT00857285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509470|NCT00857272|Randomized|Parallel Assignment||Treatment||Single||||||t
1509471|NCT00857259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509472|NCT00857246||Single Group Assignment||Treatment||None (Open Label)||||||
1509473|NCT00857233||Single Group Assignment||Treatment||None (Open Label)||||||
1509474|NCT00857220||Single Group Assignment||Treatment||None (Open Label)||||||
1509475|NCT00857207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509476|NCT00857194|||Case-Control||Prospective|||||||
1509477|NCT00857181|||Cohort||Prospective|||||||
1509478|NCT00857168|Randomized|Parallel Assignment||||None (Open Label)||||||
1509479|NCT00857155|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1509480|NCT00857142|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509481|NCT00857129|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1509482|NCT00857116|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1509483|NCT00857103|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1509484|NCT00857090|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509485|NCT00857077|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509486|NCT00857064|||Case-Only||Cross-Sectional|||||||
1509487|NCT00857051|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509488|NCT00857038|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509489|NCT00857025||Single Group Assignment||Treatment||None (Open Label)||||||
1509490|NCT00857012|||Case-Only||Prospective|||||||
1509491|NCT00856999||||Treatment||||||||
1509492|NCT00856986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509493|NCT00856973|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509494|NCT00856960|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509495|NCT00856947|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509496|NCT00856934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509497|NCT00856921|||Case-Only||Retrospective|||||||
1509498|NCT00856908|Randomized|Parallel Assignment||Treatment||Single|||t|||
1509499|NCT00856895|||Other||Cross-Sectional|||||||
1509500|NCT00856882||||||||||||
1509501|NCT00856869|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1509502|NCT00856856||Single Group Assignment||Treatment||None (Open Label)||||||
1509503|NCT00856843|Randomized|Parallel Assignment||Treatment||Single||||||t
1509504|NCT00856830||Single Group Assignment||Treatment||None (Open Label)||This is a single arm, open-label, Phase I - II trial with an initial dose escalation component and an expansion cohort of patients treated at the recommended Phase II dose.||||
1509505|NCT00856817|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1509506|NCT00856804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509507|NCT00856791||Single Group Assignment||Treatment||None (Open Label)||||||
1509508|NCT00856778||Single Group Assignment||Treatment||None (Open Label)||||||
1509509|NCT00856765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509510|NCT00856752|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1509511|NCT00856739|||Ecologic or Community|||||||||
1509512|NCT00856726||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509513|NCT00856713|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1509514|NCT00856700|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1509515|NCT00856687|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509516|NCT00856674||Single Group Assignment||Treatment||None (Open Label)||||||
1509517|NCT00856661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509518|NCT00856648|||Case Control||Prospective|||||||
1509519|NCT00856635|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509520|NCT00856622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509521|NCT00856609|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509522|NCT00856596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509523|NCT00856583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509524|NCT00856570|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1509525|NCT00856557|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1509526|NCT00856544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509527|NCT00856531|||||Cross-Sectional|||||||
1509528|NCT00856518|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509529|NCT00856505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509530|NCT00856492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509531|NCT00856479|Randomized|Parallel Assignment||Treatment||Single|||t|||
1509532|NCT00856453|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509533|NCT00856440|||||Prospective|||||||
1509534|NCT00856427||Single Group Assignment||Treatment||None (Open Label)||||||
1509535|NCT00856414||Single Group Assignment||Treatment||None (Open Label)||||||
1509536|NCT00856401||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509537|NCT00856388||Single Group Assignment||Treatment||None (Open Label)||||||
1509538|NCT00856375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509539|NCT00856362|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509540|NCT00856349|||Cohort||Prospective|||||||
1509541|NCT00856336|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509542|NCT00856323||Single Group Assignment||Prevention||None (Open Label)||||||
1509543|NCT00856310|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1509544|NCT00856297|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509545|NCT00856284|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509546|NCT00856271|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509547|NCT00856258|Randomized|Single Group Assignment||||Double|||t||t|
1509548|NCT00856245||Single Group Assignment||Treatment||None (Open Label)||||||
1509549|NCT00856232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509550|NCT00856219|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1509551|NCT00856206|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509552|NCT00856193|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509553|NCT00856180||Single Group Assignment||Treatment||None (Open Label)||||||
1509554|NCT00856167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509555|NCT00856154||Single Group Assignment||Treatment||None (Open Label)||||||
1509556|NCT00856141|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1509557|NCT00856115|||Case Control||Retrospective|||||||
1509558|NCT00856102|Randomized|Parallel Assignment||Treatment||Single||||||t
1509559|NCT00856089||Single Group Assignment||Treatment||None (Open Label)||||||
1509560|NCT00856076|||Case Control||Retrospective|||||||
1509561|NCT00856063|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1509562|NCT00856050||Single Group Assignment||Treatment||None (Open Label)||||||
1509563|NCT00856037||Single Group Assignment||Treatment||None (Open Label)||||||
1509564|NCT00856024|||Cohort||Retrospective|||||||
1509565|NCT00856011|||Case Control||Prospective|||||||
1509566|NCT00855998|||Family-Based||Prospective|||||||
1509567|NCT00855985|Randomized|Parallel Assignment||Treatment||Single|||t|||
1509568|NCT00855972|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509569|NCT00855959|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509570|NCT00855946|||Cohort||Prospective|||||||
1509571|NCT00855933|Randomized|Parallel Assignment||Treatment||Single||||||t
1509572|NCT00855920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509573|NCT00855907|||||Cross-Sectional|||||||
1509574|NCT00855894|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509575|NCT00855881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509576|NCT00855868||Single Group Assignment||Diagnostic||Single||||||t
1509577|NCT00855855|||Cohort||Cross-Sectional|||||||
1509578|NCT00855842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509579|NCT00855829|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1509580|NCT00855816|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1509581|NCT00855803|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509582|NCT00855790|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1509583|NCT00855777|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509584|NCT00855764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509585|NCT00855738||Single Group Assignment||Treatment||None (Open Label)||||||
1509586|NCT00855725|||Case Control||Cross-Sectional|||||||
1509587|NCT00855712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509588|NCT00855699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509589|NCT00855686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509590|NCT00855673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509591|NCT00855660|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1509592|NCT00855647|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509593|NCT00855634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509594|NCT00855621|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509595|NCT00855608||Single Group Assignment||Treatment||None (Open Label)||||||
1509596|NCT00855595|Randomized|Parallel Assignment||Treatment||Single|||||t|
1509597|NCT00855582|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509598|NCT00855569|||Case-Control||Prospective|||||||
1509599|NCT00855556|||Cohort||Prospective|||||||
1509600|NCT00855543|||Cohort||Prospective|||||||
1509601|NCT00855530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509602|NCT00855517|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509603|NCT00855504|||Cohort||Prospective|||||||
1509604|NCT00855491|Non-Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1509605|NCT00855478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509606|NCT00855465|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509607|NCT00855452||Single Group Assignment||Treatment||None (Open Label)||||||
1509608|NCT00855439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509609|NCT00855426|||Cohort||Prospective|||||||
1509610|NCT00855413||Single Group Assignment||Treatment||None (Open Label)||||||
1509611|NCT00855400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509612|NCT00855387|||Cohort||Retrospective|||||||
1509613|NCT00855374|||Case-Control||Prospective|||||||
1509614|NCT00855361||Single Group Assignment||Treatment||None (Open Label)||||||
1509615|NCT00855348|||Cohort||Prospective|||||||
1509616|NCT00855335|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509617|NCT00855322|Randomized|Parallel Assignment||Treatment||Single||||||t
1509618|NCT00855309|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509619|NCT00855296|||Case-Control||Prospective|||||||
1509620|NCT00855283||Single Group Assignment||Treatment||None (Open Label)||||||
1511172|NCT00834782|||Cohort||Prospective|||||||
1509621|NCT00855270|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509622|NCT00855257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509623|NCT00855244||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509624|NCT00855231|||Cohort||Prospective|||||||
1509625|NCT00855218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509626|NCT00855205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509627|NCT00855192|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509628|NCT00855179|Randomized|Parallel Assignment||Treatment||Double||||||
1509629|NCT00855166|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509630|NCT00855153||Single Group Assignment||Treatment||None (Open Label)||||||
1509631|NCT00855140|Randomized|Parallel Assignment||Treatment||Triple|Subjects were unaware of whether they were receiving verum or sham treatment.||t||t|t
1509632|NCT00855127|||Cohort||Prospective|||||||
1509633|NCT00855114||Single Group Assignment||Treatment||None (Open Label)||||||
1509634|NCT00855101|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1509635|NCT00855088|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1509636|NCT00855075|||Case-Only||Prospective|||||||
1509637|NCT00855062|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1509638|NCT00855049|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1509639|NCT00855036|||Case-Control||Prospective|||||||
1509640|NCT00855023|||Case-Only||Cross-Sectional|||||||
1509641|NCT00855010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509642|NCT00854997|||Cohort||Prospective|||||||
1509643|NCT00854984|Randomized|Parallel Assignment||Treatment||Single||||||t
1509644|NCT00854971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509645|NCT00854958|||Cohort|||||||||
1509646|NCT00854945||Single Group Assignment||Treatment||None (Open Label)||||||
1509647|NCT00854932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509648|NCT00854919||||||||||||
1509649|NCT00854906|||Case-Only||Prospective|||||||
1509650|NCT00854893|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1509651|NCT00854880|Randomized|Parallel Assignment||Treatment||Double||||||
1509652|NCT00854867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509653|NCT00854854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509654|NCT00854841||||||||||||
1509655|NCT00854828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509656|NCT00854815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509657|NCT00854802|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509658|NCT00854789|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509659|NCT00854776|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509660|NCT00854763|||Cohort||Prospective|||||||
1509661|NCT00854750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509662|NCT00854737|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509663|NCT00854724|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1509664|NCT00854711|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509665|NCT00854698|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1509666|NCT00854685|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1509667|NCT00854672|||Case Control||Prospective|||||||
1509668|NCT00854659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509669|NCT00854646||Single Group Assignment||Treatment||None (Open Label)||||||
1509670|NCT00854633|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1509671|NCT00854620||Single Group Assignment||Treatment||None (Open Label)||||||
1509672|NCT00854607|||Cohort||Prospective|||||||
1509673|NCT00854594|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509674|NCT00854581|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1509675|NCT00854568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509676|NCT00854555|Randomized|Parallel Assignment||Treatment||Single||||||t
1509677|NCT00854542|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509678|NCT00854529|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509679|NCT00854516|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509680|NCT00854503|Randomized|Crossover Assignment||Treatment||Single|||t|||
1509681|NCT00854490|||Cohort||Prospective|||||||
1509682|NCT00854477||Single Group Assignment||Basic Science||None (Open Label)||||||
1509683|NCT00854464|||Case Control||Retrospective|||||||
1509684|NCT00854451|Randomized|Parallel Assignment||Treatment||Single|||||t|
1509685|NCT00854438|Randomized|Parallel Assignment||Prevention||Single|||||t|
1509686|NCT00854425||Single Group Assignment||Treatment||None (Open Label)||||||
1509687|NCT00854412||Single Group Assignment||Prevention||None (Open Label)||||||
1509688|NCT00854399||Parallel Assignment||Basic Science||None (Open Label)||||||
1509689|NCT00854386|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1509690|NCT00854373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509691|NCT00854360|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509692|NCT00854347|||Cohort||Prospective|||||||
1509693|NCT00854334|||Cohort||Cross-Sectional|||||||
1509694|NCT00854321|||Case-Only||Retrospective|||||||
1509695|NCT00854308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509696|NCT00854295|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509697|NCT00854282||Single Group Assignment||Basic Science||None (Open Label)||||||
1509698|NCT00854269||Single Group Assignment||Basic Science||None (Open Label)||||||
1509699|NCT00854256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509700|NCT00854243|||||Prospective|||||||
1509701|NCT00854230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509702|NCT00854217|Randomized|Single Group Assignment||Treatment||Single|||t|||
1509703|NCT00854204|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509704|NCT00854191|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1509705|NCT00854178|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1509706|NCT00854165|||Case Control||Retrospective|||||||
1509707|NCT00854152|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509708|NCT00854139||Single Group Assignment||Treatment||None (Open Label)||||||
1509709|NCT00854126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509710|NCT00854113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509711|NCT00854100|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509712|NCT00854087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509713|NCT00854074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509714|NCT00854061|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1509715|NCT00854048|||Case-Crossover||Prospective|||||||
1509716|NCT00854035|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509717|NCT00854022|||Cohort||Prospective|||||||
1509718|NCT00854009|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1509719|NCT00853996||Single Group Assignment||Prevention||None (Open Label)||||||
1509720|NCT00853983||Single Group Assignment||Basic Science||None (Open Label)||||||
1509721|NCT00853970|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509722|NCT00853957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509723|NCT00853944|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1509724|NCT00853931||Single Group Assignment||||None (Open Label)||||||
1509725|NCT00853918|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1509726|NCT00853905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509727|NCT00853892|Randomized|Crossover Assignment||||None (Open Label)||||||
1509728|NCT00853879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509729|NCT00853866|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1509730|NCT00853853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509731|NCT00853840|Randomized|Crossover Assignment||Treatment||Single|||t|||
1509732|NCT00853827|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509733|NCT00853814|Randomized|Factorial Assignment||Treatment||Single|||t|||
1509734|NCT00853801|Randomized|Parallel Assignment||Prevention||Single||||t||
1509735|NCT00853788|||Case Control||Prospective|||||||
1509736|NCT00853775|||Family-Based||Cross-Sectional|||||||
1509737|NCT00853762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509738|NCT00853749|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1509739|NCT00853736|Randomized|Crossover Assignment||||None (Open Label)||||||
1509740|NCT00853723|Randomized|Factorial Assignment||Treatment||Single|||t|||
1509741|NCT00853710||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509742|NCT00853697||Single Group Assignment||Treatment||None (Open Label)||||||
1509743|NCT00853684||Single Group Assignment||Treatment||None (Open Label)||||||
1509744|NCT00853671||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509745|NCT00853658|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509746|NCT00853645||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1509747|NCT00853632||Single Group Assignment||Treatment||None (Open Label)||||||
1509748|NCT00853619|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1509749|NCT00853606||Single Group Assignment||Treatment||None (Open Label)||||||
1509750|NCT00853593|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509751|NCT00853580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509752|NCT00853567|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509753|NCT00853554|Randomized|Crossover Assignment||||None (Open Label)||||||
1509754|NCT00853541|||Cohort||Prospective|||||||
1509755|NCT00853528|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||This is a Phase I study with 2 parallel groups of dose escalation using a 3 +3 design to determine the maximum tolerated dose of the radiation with the FDA approved device. There are three dose cohorts in each group, thus 6 arms.||||
1509756|NCT00853515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509757|NCT00853502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509758|NCT00853489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509759|NCT00853476|||Cohort||Cross-Sectional|||||||
1509760|NCT00853463|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509761|NCT00853450|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509762|NCT00853437|||Case-Only||Prospective|||||||
1509763|NCT00853424|Randomized|Single Group Assignment||Treatment||Single||||||t
1509764|NCT00853411|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509765|NCT00853398||||||||||||
1509766|NCT00853385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509767|NCT00853372|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509768|NCT00853346|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509769|NCT00853333|Randomized|Parallel Assignment||||None (Open Label)||||||
1509770|NCT00853320|Randomized|Crossover Assignment||||None (Open Label)||||||
1509771|NCT00853307||Single Group Assignment||Treatment||None (Open Label)||||||
1509772|NCT00853294|Randomized|Crossover Assignment||||None (Open Label)||||||
1509773|NCT00853281|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509774|NCT00853268|Randomized|Parallel Assignment||||None (Open Label)||||||
1509775|NCT00853255|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1509776|NCT00853242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509777|NCT00853229|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1509778|NCT00853216|Randomized|Crossover Assignment||||None (Open Label)||||||
1509779|NCT00853203|||Cohort||Prospective|||||||
1509780|NCT00853190|Randomized|Crossover Assignment||||None (Open Label)||||||
1509781|NCT00853177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509782|NCT00853164|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1509783|NCT00853151|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509784|NCT00853138|Randomized|Parallel Assignment||Treatment||Single||||||t
1509785|NCT00853125||Single Group Assignment||Treatment||None (Open Label)||||||
1509786|NCT00853112|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509787|NCT00853099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509788|NCT00853086|||Cohort|||||||||
1509789|NCT00853073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509790|NCT00853060|||||Cross-Sectional|||||||
1509791|NCT00853047|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509792|NCT00853034|Randomized|Crossover Assignment||Treatment||Single|||t|||
1509793|NCT00853021||Single Group Assignment||Treatment||None (Open Label)||||||
1509794|NCT00853008||Single Group Assignment||Treatment||None (Open Label)||||||
1509795|NCT00852995|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509796|NCT00852982|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509797|NCT00852969|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509798|NCT00852956|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1509799|NCT00852943|||||Other|||||||
1509800|NCT00852930|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1509801|NCT00852917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509802|NCT00852904|||Cohort||Prospective|||||||
1509803|NCT00852891|||||Prospective|||||||
1509804|NCT00852878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509805|NCT00852865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509806|NCT00852852|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509807|NCT00852839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509808|NCT00852826|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1509809|NCT00852813|Randomized|Crossover Assignment||Treatment||Single|||t|||
1509810|NCT00852800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509811|NCT00852787|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1509812|NCT00852774|||Cohort||Prospective|||||||
1509813|NCT00852761|Randomized|Parallel Assignment||Treatment||Single|||||t|
1509814|NCT00852748|||Cohort||Prospective|||||||
1509815|NCT00852735|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1509816|NCT00852722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509817|NCT00852709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509818|NCT00852696|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1509819|NCT00852683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509820|NCT00852670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509821|NCT00852657|Randomized|Parallel Assignment||Treatment||Single||||||t
1509822|NCT00852644|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Participants to receive Cyberknife radiation therapy in 4 doses over two weeks. Dose will be determined using a dose-escalation plan.||||
1509823|NCT00852631||Single Group Assignment||Treatment||None (Open Label)||||||
1509824|NCT00852618|||Case-Only||Prospective|||||||
1509825|NCT00852605|Randomized|||||None (Open Label)||||||
1509826|NCT00852592|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509827|NCT00852579|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509828|NCT00852566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509829|NCT00852553|||Case-Only||Prospective|||||||
1509830|NCT00852540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509831|NCT00852527|||Cohort||Prospective|||||||
1509832|NCT00852514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509833|NCT00852501|||Cohort||Prospective|||||||
1509834|NCT00852488||Single Group Assignment||Treatment||None (Open Label)||||||
1509835|NCT00852475|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509836|NCT00852462|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509837|NCT00852449|Randomized|||||Triple|||t||t|t
1509838|NCT00852436|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509839|NCT00852423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509840|NCT00852410|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1509841|NCT00852397|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509842|NCT00852384|Non-Randomized|Parallel Assignment||||Double|||t||t|
1509843|NCT00852371|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509844|NCT00852358|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509845|NCT00852345||||||||||||
1509846|NCT00852332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509847|NCT00852319|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1509848|NCT00852306|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1509849|NCT00852293|||Cohort||Prospective|||||||
1509850|NCT00852280|Randomized|Single Group Assignment||Treatment||Single||||||t
1509851|NCT00852267|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1509852|NCT00852254|||Case-Only||Prospective|||||||
1509853|NCT00852241||Single Group Assignment||Treatment||None (Open Label)||||||
1509854|NCT00852228|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509855|NCT00852215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509856|NCT00852202|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509857|NCT00852189||Single Group Assignment||Treatment||None (Open Label)||||||
1509858|NCT00852176|||Cohort||Retrospective|||||||
1509859|NCT00852163||Single Group Assignment||Treatment||None (Open Label)||||||
1509860|NCT00852150|||||Prospective|||||||
1509861|NCT00852137|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509862|NCT00852124|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509863|NCT00852111|||Cohort||Prospective|||||||
1509864|NCT00852098|Randomized|Parallel Assignment||Treatment||Double||||||
1509865|NCT00852085|Randomized|Parallel Assignment||Prevention||Single||||||t
1509866|NCT00852072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509867|NCT00852059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509868|NCT00852046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509869|NCT00852033|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1509870|NCT00852020|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1509871|NCT00852007||Single Group Assignment||||None (Open Label)||||||
1509872|NCT00851994|||Case Control||Prospective|||||||
1509873|NCT00851981|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509874|NCT00851968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509875|NCT00851955|||Case-Only||Prospective|||||||
1509876|NCT00851942||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509877|NCT00851929||Single Group Assignment||Treatment||None (Open Label)||||||
1509878|NCT00851916||Single Group Assignment||Treatment||None (Open Label)||||||
1509879|NCT00851903||Single Group Assignment||Treatment||None (Open Label)||||||
1509880|NCT00851890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509881|NCT00851877||Single Group Assignment||Treatment||None (Open Label)||||||
1509882|NCT00851864||Single Group Assignment||||None (Open Label)||||||
1509883|NCT00851851|||Case-Only||Prospective|||||||
1509884|NCT00851838||Single Group Assignment||Treatment||None (Open Label)||||||
1509885|NCT00851825|||||Cross-Sectional|||||||
1509886|NCT00851812|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1509887|NCT00851799|||Cohort||Prospective|||||||
1509888|NCT00851786|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1509889|NCT00851773|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509890|NCT00851760|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509891|NCT00851747|Randomized|Parallel Assignment||Treatment||Triple|double-blind||t|t|t|
1509892|NCT00851734|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1509893|NCT00851721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509894|NCT00851708|Randomized|Parallel Assignment||Prevention||||||||
1509895|NCT00851695|||Cohort||Retrospective|||||||
1509896|NCT00851682|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1509897|NCT00851669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509898|NCT00851656|||Case-Only||Prospective|||||||
1509899|NCT00851643|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1509900|NCT00851630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509901|NCT00851617|Randomized|Parallel Assignment||||None (Open Label)||||||
1509902|NCT00851604|||Cohort||Prospective|||||||
1509903|NCT00851591|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1509904|NCT00851578||Single Group Assignment||||None (Open Label)||||||
1509905|NCT00851565|Randomized|Parallel Assignment||Treatment||Single|||t|||
1509906|NCT00851552||Single Group Assignment||Treatment||None (Open Label)||||||
1509907|NCT00851539|Randomized|Parallel Assignment||Prevention||Single||||t||
1509908|NCT00851526|||Cohort||Retrospective|||||||
1509909|NCT00851513|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1509910|NCT00851500|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509911|NCT00851487|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1509912|NCT00851474|||Case-Only||Prospective|||||||
1509913|NCT00851461|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509914|NCT00851448|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1509915|NCT00851435|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509916|NCT00851422|||Case-Only||Prospective|||||||
1509917|NCT00851409||Single Group Assignment||Treatment||None (Open Label)||||||
1509918|NCT00851396|||Case Control||Prospective|||||||
1509919|NCT00851383|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1509920|NCT00851370|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1509921|NCT00851357|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1509922|NCT00851344|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1509923|NCT00851331||||||||||||
1509924|NCT00851318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509925|NCT00851305|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1509926|NCT00851292|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1509927|NCT00851279||Single Group Assignment||Treatment||None (Open Label)||||||
1509928|NCT00851266|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1511173|NCT00834769|||Cohort||Retrospective|||||||
1509929|NCT00851253|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509930|NCT00851240|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509931|NCT00851227|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1509932|NCT00851214|||Cohort||Prospective|||||||
1509933|NCT00851201|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509934|NCT00851188|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1509935|NCT00851175|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1509936|NCT00851162|Randomized|Single Group Assignment||Treatment||Single|||t|||
1509937|NCT00851149|||Case Control||Prospective|||||||
1509938|NCT00851136||Single Group Assignment||Treatment||None (Open Label)||||||
1509939|NCT00851123|Randomized|Parallel Assignment||Treatment||Single||||||t
1509940|NCT00851110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509941|NCT00851084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509942|NCT00851071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509943|NCT00851058|Randomized|Parallel Assignment||Prevention||Single||||||t
1509944|NCT00851045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509945|NCT00851032|||Case-Only||Retrospective|||||||
1509946|NCT00851019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509947|NCT00851006||Single Group Assignment||Treatment||None (Open Label)||||||
1509948|NCT00850993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509949|NCT00850980|||Other||Prospective|||||||
1509950|NCT00850954|||Cohort||Prospective|||||||
1509951|NCT00850941|||Cohort||Retrospective|||||||
1509952|NCT00850928|||Cohort||Prospective|||||||
1509953|NCT00850915|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509954|NCT00850902|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509955|NCT00850889|Randomized|Parallel Assignment||||Single|||||t|
1509956|NCT00850876|||Case-Crossover||Cross-Sectional|||||||
1509957|NCT00850863|||Case Control||Prospective|||||||
1509958|NCT00850850|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1509959|NCT00850837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509960|NCT00850824|Randomized|Parallel Assignment||Treatment||Single||||t||
1509961|NCT00850811||Single Group Assignment||Treatment||None (Open Label)||||||
1509962|NCT00850798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509963|NCT00850785||Single Group Assignment||Treatment||None (Open Label)||||||
1509964|NCT00850772|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509965|NCT00850759|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509966|NCT00850746|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1509967|NCT00850733||||||||||||
1509968|NCT00850720|||Case-Only||Prospective|||||||
1509969|NCT00850707|||Case Control||Prospective|||||||
1509970|NCT00850694|||Cohort||Prospective|||||||
1509971|NCT00850681||Single Group Assignment||Treatment||None (Open Label)||||||
1509972|NCT00850668|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509973|NCT00850655|||Ecologic or Community||Cross-Sectional|||||||
1509974|NCT00850642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509975|NCT00850629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509976|NCT00850616|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1509977|NCT00850603|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1509978|NCT00850590|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1509979|NCT00850577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1509980|NCT00850564||Single Group Assignment||Treatment||None (Open Label)||||||
1509981|NCT00850551|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1509982|NCT00850538|||Cohort||Prospective|||||||
1509983|NCT00850512|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509984|NCT00850499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509985|NCT00850486||Single Group Assignment||Diagnostic||Double|||||t|t
1509986|NCT00850473||Single Group Assignment||Diagnostic||None (Open Label)||||||
1509987|NCT00850460|Randomized|Parallel Assignment||||Triple|||t|t|t|
1509988|NCT00850447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509989|NCT00850434||||||||||||
1509990|NCT00850421||Single Group Assignment||Treatment||None (Open Label)||||||
1509991|NCT00850408|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1509992|NCT00850395|||||Prospective|||||||
1509993|NCT00850382||Single Group Assignment||Treatment||None (Open Label)||||||
1509994|NCT00850369||Single Group Assignment||Treatment||None (Open Label)||||||
1509995|NCT00850356|||||Prospective|||||||
1509996|NCT00850343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1509997|NCT00850330|||Cohort||Prospective|||||||
1509998|NCT00850304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1509999|NCT00850291|||Cohort||Prospective|||||||
1510000|NCT00850278||Single Group Assignment||Diagnostic||None (Open Label)||||||
1510001|NCT00850265|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510002|NCT00850252||Single Group Assignment||Treatment||None (Open Label)||||||
1510003|NCT00850239|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1510004|NCT00850226|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510005|NCT00850213|||Cohort||Prospective|||||||
1510006|NCT00850200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510007|NCT00850187||Single Group Assignment||Treatment||None (Open Label)||||||
1510008|NCT00850174|Randomized|Crossover Assignment||||None (Open Label)||||||
1510009|NCT00850161|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1510010|NCT00850148||||||||||||
1510011|NCT00850135||Single Group Assignment||Diagnostic||None (Open Label)||||||
1510012|NCT00850122||Single Group Assignment||Treatment||None (Open Label)||||||
1510013|NCT00850109||||||||||||
1510014|NCT00850096|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510015|NCT00850083|||Cohort||Prospective|||||||
1510016|NCT00850070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510017|NCT00850057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510018|NCT00850044|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1510019|NCT00850031||Single Group Assignment||Treatment||None (Open Label)||||||
1510020|NCT00850018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510021|NCT00850005|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1510022|NCT00849992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510023|NCT00849979|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1510024|NCT00849966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510025|NCT00849953|||Cohort||Prospective|||||||
1510026|NCT00849940||Single Group Assignment||Diagnostic||None (Open Label)||||||
1510027|NCT00849927|||Cohort||Prospective|||||||
1510028|NCT00849914|||Case Control||Prospective|||||||
1510029|NCT00849901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510030|NCT00849888|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510031|NCT00849875||Single Group Assignment||Treatment||None (Open Label)||||||
1510032|NCT00849862|Randomized|Crossover Assignment||||None (Open Label)||||||
1510033|NCT00849849|||Case-Only||Prospective|||||||
1510034|NCT00849836|||Case Control||Prospective|||||||
1510035|NCT00849823|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510036|NCT00849810||Single Group Assignment||Treatment||None (Open Label)||||||
1510037|NCT00849797|Randomized|Crossover Assignment||||None (Open Label)||||||
1510038|NCT00849771|||Cohort||Prospective|||||||
1510039|NCT00849758|||Case Control||Prospective|||||||
1510040|NCT00849745|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510041|NCT00849732|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1510042|NCT00849719|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1510043|NCT00849706|||Cohort||Prospective|||||||
1510044|NCT00849693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510045|NCT00849680|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1510046|NCT00849667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510047|NCT00849654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510048|NCT00849641|||Case Control||Prospective|||||||
1510049|NCT00849628|||Case-Only||Cross-Sectional|||||||
1510050|NCT00849615||Single Group Assignment||Treatment||None (Open Label)||||||
1510051|NCT00849602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510052|NCT00849589|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1510053|NCT00849576|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510054|NCT00849563|Randomized|Parallel Assignment||Prevention||Single|||t|||
1510055|NCT00849550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510056|NCT00849537|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510057|NCT00849524||Single Group Assignment||Treatment||None (Open Label)||||||
1510058|NCT00849511|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1510059|NCT00849485|Randomized|Crossover Assignment||||None (Open Label)||||||
1510060|NCT00849472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510061|NCT00849459||Single Group Assignment||Treatment||None (Open Label)||||||
1510062|NCT00849446|||Case Control||Cross-Sectional|||||||
1510063|NCT00849433|||Cohort||Prospective|||||||
1510064|NCT00849407|||Case-Control||Prospective|||||||
1510065|NCT00849394|||Cohort||Prospective|||||||
1510066|NCT00849381|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1510067|NCT00849368||Single Group Assignment||Treatment||None (Open Label)||||||
1510068|NCT00849355||Single Group Assignment||Treatment||None (Open Label)||||||
1510069|NCT00849342|||Case-Only||Prospective|||||||
1510070|NCT00849329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510071|NCT00849316|||Cohort||Prospective|||||||
1510072|NCT00849303|Randomized|Parallel Assignment||Treatment||Double||||t||t
1510073|NCT00849290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510074|NCT00849277|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1510075|NCT00849264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510076|NCT00849251||Single Group Assignment||Treatment||None (Open Label)||||||
1510077|NCT00849238|Randomized|Parallel Assignment||||None (Open Label)||||||
1510078|NCT00849212|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510079|NCT00849199|||Cohort||Prospective|||||||
1510080|NCT00849186||Single Group Assignment||Treatment||None (Open Label)||||||
1510081|NCT00849173|||||Prospective|||||||
1510082|NCT00849160||Single Group Assignment||Treatment||None (Open Label)||||||
1510083|NCT00849147||Single Group Assignment||Treatment||None (Open Label)||||||
1510084|NCT00849134|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510085|NCT00849121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510086|NCT00849108|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1510087|NCT00849095|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510088|NCT00849082||||Treatment||||||||
1510089|NCT00849069|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1510090|NCT00849056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510091|NCT00849043||||||||||||
1510092|NCT00849030|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510093|NCT00849017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510094|NCT00849004|Randomized|Factorial Assignment||Prevention||Single||||||t
1510095|NCT00848991|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1510096|NCT00848978|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1510097|NCT00848965|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1510098|NCT00848952||Single Group Assignment||Diagnostic||None (Open Label)||||||
1510099|NCT00848939|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510100|NCT00848926||Single Group Assignment||Treatment||None (Open Label)||||||
1510101|NCT00848913|Randomized|Parallel Assignment||Treatment||Single||||||t
1510102|NCT00848900|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1510103|NCT00848887|Randomized|Factorial Assignment||Prevention||Single|||t|||
1510104|NCT00848874||Single Group Assignment||Treatment||None (Open Label)||||||
1510105|NCT00848861|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1510106|NCT00848848|Randomized|Factorial Assignment||Prevention||Single|||t|||
1510107|NCT00848835|||||Prospective|||||||
1510108|NCT00848822|||Cohort||Prospective|||||||
1510109|NCT00848809|||Case-Only||Prospective|||||||
1510110|NCT00848796|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1510111|NCT00848783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510112|NCT00848770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510113|NCT00848757|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1510114|NCT00848744|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1510115|NCT00848731|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1510116|NCT00848718|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510117|NCT00848705|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1510118|NCT00848692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510119|NCT00848679|Randomized|Parallel Assignment||Treatment||Single||||||t
1510120|NCT00848666||Single Group Assignment||Treatment||None (Open Label)||||||
1510121|NCT00848653|||||Prospective|||||||
1510122|NCT00848640|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510123|NCT00848627|||Cohort||Prospective|||||||
1510124|NCT00848601|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1510125|NCT00848588|||Cohort||Prospective|||||||
1510126|NCT00848575||||||||||||
1510127|NCT00848562|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1510128|NCT00848549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510129|NCT00848536|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510130|NCT00848523||Single Group Assignment||||None (Open Label)||||||
1510131|NCT00848510||Single Group Assignment||Treatment||None (Open Label)||||||
1510132|NCT00848497|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510133|NCT00848484|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1510134|NCT00848471|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1510135|NCT00848458|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510136|NCT00848445|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1510137|NCT00848432|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510138|NCT00848419|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1510139|NCT00848406|||Cohort||Prospective|||||||
1510140|NCT00848393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510141|NCT00848380|||Case Control||Retrospective|||||||
1510142|NCT00848367|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510143|NCT00848354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510144|NCT00848341|||||Prospective|||||||
1510145|NCT00848328||Single Group Assignment||Treatment||None (Open Label)||||||
1510146|NCT00848315|Randomized|Parallel Assignment||||Single||||||t
1510147|NCT00848302||Single Group Assignment||Treatment||None (Open Label)||||||
1510148|NCT00848289|||Other||Prospective|||||||
1510149|NCT00848276|||Cohort||Prospective|||||||
1510150|NCT00848263|Randomized|Parallel Assignment||Treatment||Single||||||t
1510151|NCT00848250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510152|NCT00848237||Single Group Assignment||Treatment||None (Open Label)||||||
1510153|NCT00848224|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510154|NCT00848211|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1510155|NCT00848198|||Case Control||Prospective|||||||
1510156|NCT00848185|||Cohort||Prospective|||||||
1510157|NCT00848172|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1510158|NCT00848159||||||||||||
1510159|NCT00848146||Single Group Assignment||Treatment||None (Open Label)||||||
1510160|NCT00848133|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510161|NCT00848120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510162|NCT00848107||Single Group Assignment||Treatment||None (Open Label)||||||
1510163|NCT00848094||Single Group Assignment||Treatment||None (Open Label)||||||
1510164|NCT00848081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510165|NCT00848068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510166|NCT00848055|Non-Randomized|||Treatment||None (Open Label)||||||
1510167|NCT00848042|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510168|NCT00848029|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1510169|NCT00848016||Single Group Assignment||Treatment||None (Open Label)||||||
1510170|NCT00848003|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1510171|NCT00847990|||Case-Only||Cross-Sectional|||||||
1510172|NCT00847977|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1510173|NCT00847964||Single Group Assignment||Treatment||None (Open Label)||||||
1510174|NCT00847951||Single Group Assignment||Diagnostic||None (Open Label)||||||
1510175|NCT00847938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510176|NCT00847925|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1510177|NCT00847912|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1510178|NCT00847899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510179|NCT00847886|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1510180|NCT00847873|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1510181|NCT00847860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510182|NCT00847847|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1510183|NCT00847834||Parallel Assignment||Treatment||None (Open Label)||||||
1510184|NCT00847821|||Cohort||Retrospective|||||||
1510185|NCT00847808|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1510186|NCT00847795|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1510187|NCT00847782|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1510188|NCT00847769|Randomized|Parallel Assignment||Basic Science||Single||||||t
1510189|NCT00847756|||Cohort||Prospective|||||||
1510190|NCT00847743|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1510191|NCT00847730||Single Group Assignment||Supportive Care||None (Open Label)||||||
1510192|NCT00847717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510193|NCT00847704||Single Group Assignment||Treatment||None (Open Label)||||||
1510194|NCT00847691|||Case-Only|||||||||
1510195|NCT00847678|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510196|NCT00847665|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510197|NCT00847639||Single Group Assignment||Treatment||None (Open Label)||||||
1510198|NCT00847626|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1510199|NCT00847613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510200|NCT00847600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510201|NCT00847587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510202|NCT00847574|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510203|NCT00847561|Randomized|Parallel Assignment||Prevention||Single||||||t
1510204|NCT00847548|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1510205|NCT00847535|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510206|NCT00847522||Single Group Assignment||Prevention||None (Open Label)||10 patients were enrolled in the Phase 1 portion of the trial. 80 patients were enrolled in the Phase 2 portion of the trial. 90 patients were enrolled total for the Phase 1 and 2 portions. Results are reported for the 80 patients on the Phase 2 portion.||||
1510207|NCT00847509||Single Group Assignment||Diagnostic||None (Open Label)||||||
1510208|NCT00847496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510209|NCT00847483|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510210|NCT00847470|||||Cross-Sectional|||||||
1510211|NCT00847457|Randomized|Parallel Assignment||Treatment||Single||||||t
1510212|NCT00847444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510213|NCT00847431|||Case Control||Prospective|||||||
1510214|NCT00847418||||||||||||
1510215|NCT00847405|Randomized|Crossover Assignment||||None (Open Label)||||||
1510216|NCT00847392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510217|NCT00847379||Single Group Assignment||Treatment||None (Open Label)||||||
1510218|NCT00847366|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510219|NCT00847353|||||Prospective|||||||
1510220|NCT00847340|||Case-Only||Cross-Sectional|||||||
1510221|NCT00847327|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1510222|NCT00847314|||Cohort||Prospective|||||||
1510223|NCT00847301|||Cohort||Prospective|||||||
1510224|NCT00847288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510225|NCT00847275|Randomized|Parallel Assignment||||None (Open Label)||||||
1510226|NCT00847262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510227|NCT00847249|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1510228|NCT00847236|||Case-Control||Prospective|||||||
1510229|NCT00847223||Single Group Assignment||Treatment||None (Open Label)||||||
1510230|NCT00847210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510231|NCT00847197|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510232|NCT00847184|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510233|NCT00847171||Single Group Assignment||Treatment||None (Open Label)||||||
1510234|NCT00847158|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510235|NCT00847145|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510236|NCT00847132|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1510237|NCT00847119||Single Group Assignment||Treatment||None (Open Label)||||||
1510238|NCT00847106|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510239|NCT00847093|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1510240|NCT00847080|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510241|NCT00847067|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1510242|NCT00847054||Single Group Assignment||Treatment||None (Open Label)||||||
1510244|NCT00847028|Randomized|Factorial Assignment||Supportive Care||Triple|||t|t|t|
1510245|NCT00847015||Single Group Assignment||Treatment||None (Open Label)||||||
1510246|NCT00847002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510247|NCT00846989|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510248|NCT00846976||Single Group Assignment||Treatment||None (Open Label)||||||
1510249|NCT00846963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510250|NCT00846950|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1510251|NCT00846937|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1510252|NCT00846924|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1510253|NCT00846911|||Cohort||Prospective|||||||
1510254|NCT00846898|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1510255|NCT00846885|Randomized|Crossover Assignment||||None (Open Label)||||||
1510256|NCT00846872|Non-Randomized|Crossover Assignment||||Single|||t|||
1510257|NCT00846859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510258|NCT00846846||Single Group Assignment||Treatment||None (Open Label)||||||
1510259|NCT00846833||Single Group Assignment||Treatment||None (Open Label)||||||
1510260|NCT00846820||||||||||||
1510261|NCT00846807|||Cohort||Prospective|||||||
1510262|NCT00846794|||Case Control||Cross-Sectional|||||||
1510263|NCT00846781||Single Group Assignment||Treatment||None (Open Label)||||||
1510264|NCT00846768||Crossover Assignment||Treatment||||||||
1510265|NCT00846755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510266|NCT00846742||Single Group Assignment||Treatment||None (Open Label)||||||
1510267|NCT00846729|||Cohort||Prospective|||||||
1510268|NCT00846716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510269|NCT00846703|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1510270|NCT00846690|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1510271|NCT00846677|Randomized|Crossover Assignment||||None (Open Label)||||||
1510272|NCT00846664||Single Group Assignment||Treatment||None (Open Label)||||||
1510273|NCT00846651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510274|NCT00846638|Randomized|Parallel Assignment||Prevention||Single|||t|||
1510275|NCT00846625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510276|NCT00846612||Single Group Assignment||Treatment||None (Open Label)||||||
1510277|NCT00846599|||Case-Control||Cross-Sectional|||||||
1510278|NCT00846586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510279|NCT00846573|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1510280|NCT00846560|||Other||Other|||||||
1510281|NCT00846547||Single Group Assignment||Treatment||None (Open Label)||||||
1510282|NCT00846534|||Cohort||Prospective|||||||
1510283|NCT00846521||Single Group Assignment||Treatment||None (Open Label)||||||
1510284|NCT00846508|Randomized|Parallel Assignment||Treatment||Single||||||t
1510285|NCT00846495|Randomized|Parallel Assignment||Prevention||Single|||||t|
1510286|NCT00846482|||||Prospective|||||||
1510287|NCT00846469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510288|NCT00846456||Single Group Assignment||Treatment||None (Open Label)||||||
1510289|NCT00846443||Single Group Assignment||Treatment||None (Open Label)||||||
1510290|NCT00846430|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510291|NCT00846417|||Case Control||Prospective|||||||
1510292|NCT00846404|||Case Control||Prospective|||||||
1510293|NCT00846391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510294|NCT00846378|Randomized|Parallel Assignment||Treatment||Single||||||t
1510295|NCT00846365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510296|NCT00846352|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1510297|NCT00846339|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510298|NCT00846326|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1510299|NCT00846313|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1510300|NCT00846300|Non-Randomized|Factorial Assignment||Treatment||Single||||t||
1510301|NCT00846287|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1510302|NCT00846274|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510303|NCT00846261|Randomized|Single Group Assignment||Treatment||Single|||t|||
1510304|NCT00846248|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1510305|NCT00846235|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1510306|NCT00846222||Single Group Assignment||Treatment||None (Open Label)||||||
1510307|NCT00846209|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1510308|NCT00846196|Randomized|Crossover Assignment||||Double|||t||t|
1510309|NCT00846183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510310|NCT00846170|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1510311|NCT00846157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510312|NCT00846144||Single Group Assignment||Prevention||None (Open Label)||||||
1510313|NCT00846131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510314|NCT00846118|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510315|NCT00846105|Randomized|Crossover Assignment||Prevention||Single||||||t
1510316|NCT00846092|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510317|NCT00846079|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1510318|NCT00846066|Randomized|Parallel Assignment||||Single|||t|||
1510395|NCT00845065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510396|NCT00845052|||Cohort||Prospective|||||||
1511332|NCT00832676||||||||||||
1510319|NCT00846053|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||In this pilot study, we examined the value of FDG-PET scans as a noninvasive measure of neutrophilic inflammation in adolescents and young adults with cystic fibrosis. All subjects underwent scans.||||
1510320|NCT00846040|||||Prospective|||||||
1510321|NCT00846027||Single Group Assignment||Treatment||None (Open Label)||||||
1510322|NCT00846014||Single Group Assignment||Diagnostic||None (Open Label)||||||
1510323|NCT00846001|Randomized|Parallel Assignment||Treatment||Single||||||t
1510324|NCT00845988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510325|NCT00845975|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1510326|NCT00845962|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510327|NCT00845949|||Case Control||Prospective|||||||
1510328|NCT00845936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510329|NCT00845923||Single Group Assignment||Treatment||None (Open Label)||||||
1510330|NCT00845910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510331|NCT00845897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510332|NCT00845884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510333|NCT00845871||Single Group Assignment||Treatment||None (Open Label)||||||
1510334|NCT00845858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510335|NCT00845845|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510336|NCT00845832|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510337|NCT00845819|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1510338|NCT00845806|||Case-Only|||||||||
1510339|NCT00845793||Single Group Assignment||Health Services Research||None (Open Label)||||||
1510340|NCT00845780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510341|NCT00845767|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1510342|NCT00845754|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1510343|NCT00845741|||Cohort||Prospective|||||||
1510344|NCT00845728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510345|NCT00845715|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510346|NCT00845702|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1510347|NCT00845689||||||||||||
1510348|NCT00845676||Single Group Assignment||Treatment||None (Open Label)||||||
1510349|NCT00845663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510350|NCT00845650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510351|NCT00845637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510352|NCT00845624|||Cohort||Prospective|||||||
1510353|NCT00845611||Single Group Assignment||Treatment||None (Open Label)||||||
1510354|NCT00845598|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1510355|NCT00845585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510356|NCT00845572||Single Group Assignment||Treatment||None (Open Label)||||||
1510357|NCT00845559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510358|NCT00845546|Randomized|Crossover Assignment||||None (Open Label)||||||
1510359|NCT00845533||Single Group Assignment||||None (Open Label)||||||
1510360|NCT00845520|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 2 medical device study||||
1510361|NCT00845507|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510362|NCT00845494|Randomized|Parallel Assignment||||None (Open Label)||||||
1510363|NCT00845481|Randomized|Single Group Assignment||||Single|||||t|
1510364|NCT00845468|||Cohort||Prospective|||||||
1510365|NCT00845455|||Cohort||Prospective|||||||
1510366|NCT00845442|Non-Randomized|Single Group Assignment||Treatment||Double||||t|t|
1510367|NCT00845429|Randomized|Parallel Assignment||Prevention||Single||||||t
1510368|NCT00845416|||Cohort||Prospective|||||||
1510369|NCT00845403|||||Prospective|||||||
1510370|NCT00845390|||Case Control|||||||||
1510371|NCT00845377|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510372|NCT00845364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510373|NCT00845351||Single Group Assignment||||None (Open Label)||||||
1510374|NCT00845338|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510375|NCT00845325|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1510376|NCT00845312|||Cohort||Retrospective|||||||
1510377|NCT00845299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510378|NCT00845286|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1510379|NCT00845273|||Case-Only||Prospective|||||||
1510380|NCT00845260|Randomized|Parallel Assignment||Treatment||Single||||||t
1510381|NCT00845247|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1510382|NCT00845234|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510383|NCT00845221||Single Group Assignment||||None (Open Label)||||||
1510384|NCT00845208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510385|NCT00845195|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510386|NCT00845182|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510387|NCT00845169|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1510388|NCT00845156|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510389|NCT00845143|||Case Control||Prospective|||||||
1510390|NCT00845130|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1510391|NCT00845117||Single Group Assignment||Treatment||None (Open Label)||||||
1510392|NCT00845104||Single Group Assignment||Treatment||None (Open Label)||||||
1510393|NCT00845091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510394|NCT00845078|||Cohort||Prospective|||||||
1510397|NCT00845039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510398|NCT00845026|Randomized|Parallel Assignment||Treatment||Single||||||t
1510399|NCT00845013|||Cohort||Prospective|||||||
1510400|NCT00845000|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1510401|NCT00844987|||Cohort||Prospective|||||||
1510402|NCT00844974||Single Group Assignment||||None (Open Label)||||||
1510403|NCT00844961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510404|NCT00844948|||Cohort||Prospective|||||||
1510405|NCT00844935|||Cohort|||||||||
1510406|NCT00844922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510407|NCT00844909|Randomized|Single Group Assignment||Treatment||Double||||||
1510408|NCT00844896|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1510409|NCT00844883||Single Group Assignment||Treatment||None (Open Label)||||||
1510410|NCT00844870|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1510411|NCT00844857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510412|NCT00844844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510413|NCT00844831||Single Group Assignment||Treatment||None (Open Label)||||||
1510414|NCT00844818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510415|NCT00844805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510416|NCT00844792|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510417|NCT00844779|||Case Control||Prospective|||||||
1510418|NCT00844766|||Cohort||Prospective|||||||
1510419|NCT00844753|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510420|NCT00844740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510421|NCT00844727|Randomized|Parallel Assignment||Treatment||Double||||||
1510422|NCT00844714||Single Group Assignment||Treatment||None (Open Label)||||||
1510423|NCT00844701|||Case Control||Prospective|||||||
1510424|NCT00844688||Single Group Assignment||Treatment||None (Open Label)||||||
1510425|NCT00844675|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1510426|NCT00844662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510427|NCT00844649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510428|NCT00844636|Randomized|Parallel Assignment||Prevention||Single||||||t
1510429|NCT00844623||Single Group Assignment||Treatment||None (Open Label)||||||
1510430|NCT00844597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510431|NCT00844584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510432|NCT00844571|||Cohort||Prospective|||||||
1510433|NCT00844558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510434|NCT00844545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510435|NCT00844532|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510436|NCT00844519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510437|NCT00844506||Single Group Assignment||Treatment||None (Open Label)||||||
1510438|NCT00844493|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1510439|NCT00844480|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1510440|NCT00844467|||Case-Only||Prospective|||||||
1510441|NCT00844454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510442|NCT00844441||||Health Services Research||||||||
1510443|NCT00844428|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510444|NCT00844415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510445|NCT00844402|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510446|NCT00844389|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510447|NCT00844376|Randomized|Crossover Assignment||||None (Open Label)||||||
1510448|NCT00844363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510449|NCT00844350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510450|NCT00844337|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1510451|NCT00844324|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1510452|NCT00844311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510453|NCT00844298||Single Group Assignment||Treatment||None (Open Label)||||||
1510454|NCT00844285|||Cohort||Prospective|||||||
1510455|NCT00844272|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510456|NCT00844259|||Case-Crossover||Cross-Sectional|||||||
1510457|NCT00844246|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1510458|NCT00844233||Single Group Assignment||Treatment||None (Open Label)||||||
1510459|NCT00844220|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1510460|NCT00844207|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1510461|NCT00844194|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510462|NCT00844181|||Cohort||Cross-Sectional|||||||
1510463|NCT00844168||Single Group Assignment||Treatment||None (Open Label)||||||
1510464|NCT00844155|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1510465|NCT00844142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510466|NCT00844129|||Cohort||Prospective|||||||
1510467|NCT00844116|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1510468|NCT00844103|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1510469|NCT00844090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510470|NCT00844077|||Case-Only||Prospective|||||||
1510471|NCT00844064||Single Group Assignment||Treatment||None (Open Label)||||||
1510472|NCT00844051|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1510473|NCT00844038|||Case-Only||Prospective|||||||
1510474|NCT00844025|Randomized|Parallel Assignment||Treatment||Double||||t||t
1510475|NCT00844012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510476|NCT00843986|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510477|NCT00843973|||Cohort||Prospective|||||||
1510478|NCT00843960|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1510479|NCT00843947||Single Group Assignment||Treatment||None (Open Label)||||||
1510480|NCT00843934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510481|NCT00843921||Single Group Assignment||Treatment||None (Open Label)||||||
1510482|NCT00843908|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510483|NCT00843895|Non-Randomized|Single Group Assignment||Screening||Single|||t|||
1510484|NCT00843882|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510485|NCT00843869|||Case-Only||Prospective|||||||
1510486|NCT00843856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510487|NCT00843843|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1510488|NCT00843830||Single Group Assignment||Treatment||None (Open Label)||||||
1510489|NCT00843817||Single Group Assignment||Basic Science||None (Open Label)||||||
1510490|NCT00843804|||Cohort||Prospective|||||||
1510491|NCT00843791|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1510492|NCT00843778||Single Group Assignment||Treatment||None (Open Label)||||||
1510493|NCT00843765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510494|NCT00843752||||||||||||
1510495|NCT00843739|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510496|NCT00843726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510497|NCT00843713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510498|NCT00843700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510499|NCT00843687|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510500|NCT00843661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510501|NCT00843648|||Cohort||Prospective|||||||
1510502|NCT00843635|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510503|NCT00843622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510504|NCT00843609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510505|NCT00843596||Single Group Assignment||Treatment||None (Open Label)||||||
1510506|NCT00843583|||Case-Only||Cross-Sectional|||||||
1510507|NCT00843570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510508|NCT00843557|||Cohort||Prospective|||||||
1510509|NCT00843544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510510|NCT00843531||Single Group Assignment||Treatment||None (Open Label)||||||
1510511|NCT00843518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510512|NCT00843505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510513|NCT00843492|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510514|NCT00843479|||Case Control||Cross-Sectional|||||||
1510515|NCT00843466|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510516|NCT00843453|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1510517|NCT00843440|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510518|NCT00843427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510519|NCT00843414|||Cohort||Prospective|||||||
1510520|NCT00843401|||Cohort||Prospective|||||||
1510521|NCT00843388|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1510522|NCT00843375|||Case Control||Cross-Sectional|||||||
1510523|NCT00843362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510524|NCT00843349|Randomized|Factorial Assignment||Prevention||Single|||t|||
1510525|NCT00843336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510526|NCT00843323||Single Group Assignment||Treatment||None (Open Label)||||||
1510527|NCT00843310||Single Group Assignment||Treatment||None (Open Label)||||||
1510528|NCT00843297|Randomized|Single Group Assignment||Treatment||Single|||t|||
1510529|NCT00843284|||||Prospective|||||||
1510530|NCT00843271|||Cohort||Prospective|||||||
1510531|NCT00843258|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1510532|NCT00843245|||Cohort||Prospective|||||||
1510533|NCT00843232|||Case Control||Cross-Sectional|||||||
1510534|NCT00843219|||Case-Only||Prospective|||||||
1510535|NCT00843193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510536|NCT00843180|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1510537|NCT00843167|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1510538|NCT00843154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510539|NCT00843141|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1510540|NCT00843128|Randomized|Single Group Assignment||Treatment||Single||||||t
1510541|NCT00843115|||Ecologic or Community||Prospective|||||||
1510542|NCT00843102|||Case-Crossover||Prospective|||||||
1510543|NCT00843089|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510544|NCT00843076|||Cohort||Prospective|||||||
1510545|NCT00843063|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1510546|NCT00843050||Single Group Assignment||Treatment||None (Open Label)||||||
1510547|NCT00843037||Single Group Assignment||Treatment||None (Open Label)||||||
1510548|NCT00843024|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510549|NCT00843011|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510550|NCT00842998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510551|NCT00842985||Sequential Assignment||Treatment||None (Open Label)||||||
1510552|NCT00842972|||Cohort||Prospective|||||||
1510553|NCT00842959|Randomized|Single Group Assignment||||None (Open Label)||||||
1510554|NCT00842946|Randomized|Parallel Assignment||Treatment||Single||||||t
1510555|NCT00842933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510556|NCT00842920|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1510557|NCT00842907|Randomized|Parallel Assignment||Treatment||Single||||||t
1510558|NCT00842894|||Cohort||Prospective|||||||
1510559|NCT00842881|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510560|NCT00842868|||Cohort||Prospective|||||||
1510561|NCT00842855|||Cohort||Prospective|||||||
1510562|NCT00842842|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510563|NCT00842829|Randomized|Parallel Assignment||||None (Open Label)||||||
1510564|NCT00842816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510565|NCT00842803|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1510566|NCT00842790|||Cohort||Prospective|||||||
1510567|NCT00842777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510568|NCT00842764||Single Group Assignment||Treatment||None (Open Label)||||||
1510569|NCT00842751|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510570|NCT00842738|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510571|NCT00842712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510572|NCT00842699|||Cohort||Prospective|||||||
1510573|NCT00842686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510574|NCT00842673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510575|NCT00842660|Randomized|Parallel Assignment||Treatment||Single||||||t
1510576|NCT00842647|||Case-Only||Prospective|||||||
1510577|NCT00842634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510578|NCT00842621|||Cohort||Prospective|||||||
1510579|NCT00842608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510580|NCT00842595||Single Group Assignment||Treatment||None (Open Label)||||||
1510581|NCT00842582||Single Group Assignment||Treatment||None (Open Label)||||||
1510582|NCT00842569|||Case Control|||||||||
1510583|NCT00842556|Randomized|Crossover Assignment||||None (Open Label)||||||
1510584|NCT00842543|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1510585|NCT00842530|Randomized|Parallel Assignment||Prevention||Single||||||t
1510586|NCT00842517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510587|NCT00842504|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1510588|NCT00842491||Single Group Assignment||Treatment||None (Open Label)||||||
1510589|NCT00842478|Randomized|Parallel Assignment||Prevention||Single|||||t|
1510590|NCT00842465|||||Cross-Sectional|||||||
1510591|NCT00842452||Single Group Assignment||Treatment||None (Open Label)||||||
1510592|NCT00842439|Randomized|Factorial Assignment||Prevention||Single||||||t
1510593|NCT00842426|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1510594|NCT00842413|||Cohort||Prospective|||||||
1510595|NCT00842400|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1510596|NCT00842387|||Cohort||Prospective|||||||
1510597|NCT00842374|||Cohort||Prospective|||||||
1510598|NCT00842361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510599|NCT00842348||Single Group Assignment||Treatment||None (Open Label)||||||
1510600|NCT00842335||Single Group Assignment||Treatment||None (Open Label)||||||
1510601|NCT00842322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510602|NCT00842309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510603|NCT00842296||Single Group Assignment||Treatment||None (Open Label)||||||
1510604|NCT00842283|||Other||Other|||||||
1510605|NCT00842270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510606|NCT00842257||Single Group Assignment||Treatment||None (Open Label)||||||
1510607|NCT00842244|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510608|NCT00842231|||Cohort||Prospective|||||||
1510609|NCT00842218|||Cohort||Prospective|||||||
1510610|NCT00842205||Parallel Assignment||Basic Science||None (Open Label)||||||
1510611|NCT00842192|||Case-Only||Prospective|||||||
1510612|NCT00842179|||Cohort||Retrospective|||||||
1510613|NCT00842166||Single Group Assignment||Prevention||None (Open Label)||||||
1510614|NCT00842153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510615|NCT00842140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510616|NCT00842127|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510617|NCT00842114||Single Group Assignment||Treatment||None (Open Label)||||||
1510618|NCT00842101|||Cohort||Prospective|||||||
1510619|NCT00842088|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510620|NCT00842075|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1510621|NCT00842062||Single Group Assignment||Treatment||None (Open Label)||||||
1510622|NCT00842049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510623|NCT00842036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510624|NCT00842023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510625|NCT00842010|||Case Control||Cross-Sectional|||||||
1510626|NCT00841984|||||Prospective|||||||
1510627|NCT00841971|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1510628|NCT00841958|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510629|NCT00841945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510630|NCT00841932|||Case-Only||Retrospective|||||||
1510631|NCT00841919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511014|NCT00836862|||Other||Prospective|||||||
1510632|NCT00841906|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1510633|NCT00841893|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1510634|NCT00841880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510635|NCT00841867|||Case Control||Cross-Sectional|||||||
1510636|NCT00841854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510637|NCT00841841|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510638|NCT00841828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510639|NCT00841815|Randomized|Crossover Assignment||||None (Open Label)||||||
1510640|NCT00841802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510641|NCT00841789|Randomized|Parallel Assignment||Treatment||Quadruple||Approximately 200 subjects will be randomized in a 1:1 ratio to receive Etanercept or Placebo. Subjects are randomized after hospital admission and diagnosis of Kawasaki Disease at eight participating sites. The primary analysis time-point is visit 5 (day 44). Sample size calculation is based on initial IVIG refractory rate at Seattle Children's. Assuming a 17.4% refractory rate in the control group and a 4.3% refractory rate in the Etanercept group, 200 subjects will provide 80% power at a 5% 2-sided type I error rate. Analyses will be based on a modified intention to treat population, including all subjects who were randomized and received at least 1 dose of study drug. Efficacy analyses will be based on randomization assignment, and safety analyses will be based on the treatment actually received. The statistical analysis plan will be finalized prior to database lock and study unblinding.|t|t|t|t
1510642|NCT00841776|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510643|NCT00841763|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1510644|NCT00841750|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510645|NCT00841737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510646|NCT00841724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510647|NCT00841711||Single Group Assignment||Supportive Care||None (Open Label)||||||
1510648|NCT00841698|Randomized|Crossover Assignment||||None (Open Label)||||||
1510649|NCT00841685|Randomized|Parallel Assignment||||None (Open Label)||||||
1510650|NCT00841672|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510651|NCT00841659|Randomized|Crossover Assignment||||None (Open Label)||||||
1510652|NCT00841646|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1510653|NCT00841633|Randomized|Parallel Assignment||Treatment||Single||||||t
1510654|NCT00841620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510655|NCT00841607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510656|NCT00841594|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510657|NCT00841581|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510658|NCT00841568||Single Group Assignment||Treatment||None (Open Label)||||||
1510659|NCT00841555||Single Group Assignment||Treatment||None (Open Label)||||||
1510660|NCT00841542|Randomized|Crossover Assignment||||None (Open Label)||||||
1510661|NCT00841529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510662|NCT00841516|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1510663|NCT00841503|||Cohort||Prospective|||||||
1510664|NCT00841490|||Case-Control||Prospective|||||||
1510665|NCT00841477|Randomized|Factorial Assignment||Prevention||Single||||||t
1510666|NCT00841464|||Cohort||Prospective|||||||
1510667|NCT00841451||||||||||||
1510668|NCT00841438|Randomized|Parallel Assignment||Treatment||Single||||||t
1510669|NCT00841425|||Cohort||Prospective|||||||
1510670|NCT00841412|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510671|NCT00841399|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510672|NCT00841386|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1510673|NCT00841373|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510674|NCT00841360|||Case-Control||Cross-Sectional|||||||
1510675|NCT00841347|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1510676|NCT00841334|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510677|NCT00841321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510678|NCT00841308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510679|NCT00841295|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1510680|NCT00841282|Randomized|Single Group Assignment||Treatment||Single|||t|||
1510681|NCT00841269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510682|NCT00841256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510683|NCT00841243|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510684|NCT00841230|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1510685|NCT00841217|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1510686|NCT00841204|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1510687|NCT00841191|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510688|NCT00841178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510689|NCT00841165|Randomized|Parallel Assignment||Treatment||Single||||||t
1510690|NCT00841152|||Case-Control||Prospective|||||||
1510691|NCT00841139|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510692|NCT00841126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510693|NCT00841113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510694|NCT00841100||Single Group Assignment||Treatment||None (Open Label)||||||
1510695|NCT00841087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510696|NCT00841074|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1510697|NCT00841061|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1510698|NCT00841048|Randomized|Single Group Assignment||||Single|||t|||
1510699|NCT00841035||Single Group Assignment||Treatment||None (Open Label)||||||
1510700|NCT00841022|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1510701|NCT00841009|||Case-Crossover||Prospective|||||||
1510702|NCT00840996|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1510703|NCT00840983|Randomized|Single Group Assignment||Prevention||Single||||||t
1510704|NCT00840970||||||||||||
1510705|NCT00840957|||Cohort||Prospective|||||||
1510706|NCT00840944||Single Group Assignment||Treatment||None (Open Label)||||||
1510707|NCT00840931||Single Group Assignment||Treatment||None (Open Label)||||||
1510708|NCT00840918|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1510709|NCT00840905|||Cohort||Retrospective|||||||
1510710|NCT00840892|Randomized|Parallel Assignment||Treatment||Single||||||t
1510711|NCT00840879|Randomized|Crossover Assignment||||None (Open Label)||||||
1510712|NCT00840866|Randomized|Crossover Assignment||||None (Open Label)||||||
1510713|NCT00840853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510714|NCT00840840|Randomized|Crossover Assignment||||None (Open Label)||||||
1510715|NCT00840827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510716|NCT00840814|||Cohort||Cross-Sectional|||||||
1510717|NCT00840801|Randomized|Parallel Assignment||Prevention||Single|||t|||
1510718|NCT00840788|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510719|NCT00840775||Single Group Assignment||Other||None (Open Label)||||||
1510720|NCT00840762|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1510721|NCT00840749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510722|NCT00840736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510723|NCT00840723|||Case Control||Cross-Sectional|||||||
1510724|NCT00840710|||Cohort||Cross-Sectional|||||||
1510725|NCT00840697|Randomized|Parallel Assignment||Treatment||Single||||||t
1510726|NCT00840684|Non-Randomized|||Treatment||None (Open Label)||||||
1510727|NCT00840671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510728|NCT00840658|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1510729|NCT00840645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510730|NCT00840632|Randomized|Crossover Assignment||||None (Open Label)||||||
1510731|NCT00840619||||||||||||
1510732|NCT00840606|Randomized|Crossover Assignment||||None (Open Label)||||||
1510733|NCT00840593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510734|NCT00840580|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510735|NCT00840567|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1510736|NCT00840554|Randomized|Single Group Assignment||Treatment||Single|||||t|
1510737|NCT00840541|||Cohort||Retrospective|||||||
1510738|NCT00840528||Single Group Assignment||Basic Science||None (Open Label)||||||
1510739|NCT00840515|||Case Control||Prospective|||||||
1510740|NCT00840502|||Cohort||Prospective|||||||
1510741|NCT00840489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510742|NCT00840476|Randomized|Crossover Assignment||||None (Open Label)||||||
1510743|NCT00840463|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1510744|NCT00840450||Single Group Assignment||Treatment||None (Open Label)||||||
1510745|NCT00840437|||Cohort||Prospective|||||||
1510746|NCT00840411|Randomized|Crossover Assignment||||None (Open Label)||||||
1510747|NCT00840398|Randomized|Crossover Assignment||||None (Open Label)||||||
1510748|NCT00840385||Single Group Assignment||Treatment||None (Open Label)||||||
1510749|NCT00840372|||Cohort||Prospective|||||||
1510750|NCT00840359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510751|NCT00840346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510752|NCT00840333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510753|NCT00840320|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1510754|NCT00840307|||Case-Only||Prospective|||||||
1510755|NCT00840294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510756|NCT00840281|Randomized|Crossover Assignment||||None (Open Label)||||||
1510757|NCT00840268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510758|NCT00840255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510759|NCT00840242|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510760|NCT00840229|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1510761|NCT00840216|Randomized|Crossover Assignment||||None (Open Label)||||||
1510762|NCT00840203|Randomized|Crossover Assignment||||None (Open Label)||||||
1510763|NCT00840190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510764|NCT00840177||Single Group Assignment||Treatment||None (Open Label)||||||
1510765|NCT00840164|||||Prospective|||||||
1510766|NCT00840151|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1510767|NCT00840138|||Cohort||Prospective|||||||
1510768|NCT00840125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510769|NCT00840112||Single Group Assignment||Treatment||None (Open Label)||||||
1510770|NCT00840099|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1510771|NCT00840086|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510772|NCT00840073|Randomized|Crossover Assignment||||None (Open Label)||||||
1510773|NCT00840060|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510774|NCT00840047||Single Group Assignment||Diagnostic||None (Open Label)||||||
1510775|NCT00840034|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510776|NCT00840008|Randomized|Parallel Assignment||||None (Open Label)||||||
1510777|NCT00839995|||Case-Only||Prospective|||||||
1510778|NCT00839982||Single Group Assignment||Treatment||None (Open Label)||||||
1510779|NCT00839969|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510780|NCT00839956||Single Group Assignment||Treatment||None (Open Label)||||||
1510781|NCT00839943|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1510782|NCT00839930|Randomized|Crossover Assignment||||None (Open Label)||||||
1510783|NCT00839917|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510784|NCT00839904|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510785|NCT00839891|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1510786|NCT00839878|||Ecologic or Community||Cross-Sectional|||||||
1510787|NCT00839865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510788|NCT00839852||Single Group Assignment||Treatment||None (Open Label)||||||
1510789|NCT00839839||Single Group Assignment||Treatment||None (Open Label)||||||
1510790|NCT00839826|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510791|NCT00839813|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1510792|NCT00839800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510793|NCT00839787|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510794|NCT00839774|Randomized|Crossover Assignment||Prevention||Single|||t|||
1510795|NCT00839761|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1510796|NCT00839748|||Cohort||Prospective|||||||
1510797|NCT00839735|||Cohort||Prospective|||||||
1510798|NCT00839722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510799|NCT00839709|||Case Control||Prospective|||||||
1510800|NCT00839696|||Cohort||Prospective|||||||
1510801|NCT00839683|Randomized|Crossover Assignment||||None (Open Label)||||||
1510802|NCT00839670|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510803|NCT00839657|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510804|NCT00839644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510805|NCT00839631||Single Group Assignment||Treatment||None (Open Label)||||||
1510806|NCT00839605|||Case-Only||Cross-Sectional|||||||
1510807|NCT00839592|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510808|NCT00839579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510809|NCT00839566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510810|NCT00839553|Randomized|Parallel Assignment||Prevention||Single||||||
1510811|NCT00839540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510812|NCT00839527|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510813|NCT00839514|||Cohort||Cross-Sectional|||||||
1510814|NCT00839501||Single Group Assignment||Treatment||Double|||t|||t
1510815|NCT00839488|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510816|NCT00839475|||Case-Only||Cross-Sectional|||||||
1510817|NCT00839462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510818|NCT00839449|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510819|NCT00839436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510820|NCT00839423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510821|NCT00839410|||Cohort||Prospective|||||||
1510822|NCT00839397|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510823|NCT00839384||Single Group Assignment||Treatment||None (Open Label)||||||
1510824|NCT00839371|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1510825|NCT00839358|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1510826|NCT00839345||||||||||||
1510827|NCT00839332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510828|NCT00839319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510829|NCT00839306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510830|NCT00839293|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510831|NCT00839280|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510832|NCT00839267|||Case Control||Prospective|||||||
1510833|NCT00839254|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1510834|NCT00839241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510835|NCT00839228|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510836|NCT00839202||Single Group Assignment||Basic Science||None (Open Label)||||||
1510837|NCT00839189||Single Group Assignment||Basic Science||None (Open Label)||||||
1510838|NCT00839176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510839|NCT00839163|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1510840|NCT00839150|||Case Control||Cross-Sectional|||||||
1510841|NCT00839137|||Case Control||Prospective|||||||
1510842|NCT00839124|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1510843|NCT00839111|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510844|NCT00839098|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1510845|NCT00839085|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1510846|NCT00839072|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510847|NCT00839059||Single Group Assignment||Treatment||None (Open Label)||||||
1510848|NCT00839046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510849|NCT00839033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510850|NCT00839020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510851|NCT00839007|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510852|NCT00838994|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510853|NCT00838981|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510854|NCT00838968|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510855|NCT00838955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510856|NCT00838942|||Case-Only||Prospective|||||||
1510857|NCT00838929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510858|NCT00838916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510859|NCT00838903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510860|NCT00838890|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510861|NCT00838877|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1510862|NCT00838864|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510863|NCT00838851|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1510864|NCT00838838|||Cohort||Prospective|||||||
1510865|NCT00838825|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1510866|NCT00838812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510867|NCT00838799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510868|NCT00838773|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1510869|NCT00838760|Randomized|Parallel Assignment||Treatment||Double||||||
1510870|NCT00838747|||Cohort||Prospective|||||||
1510871|NCT00838734|||Cohort||Prospective|||||||
1510872|NCT00838721||Single Group Assignment||Treatment||None (Open Label)||||||
1510873|NCT00838708|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1510874|NCT00838695|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1510875|NCT00838682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510876|NCT00838669|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510877|NCT00838656|Randomized|||Treatment||None (Open Label)||||||
1510878|NCT00838643|||Cohort||Prospective|||||||
1510879|NCT00838630|Randomized|Crossover Assignment||||None (Open Label)||||||
1510880|NCT00838617|||Case-Only||Prospective|||||||
1510881|NCT00838591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510882|NCT00838578||Single Group Assignment||Treatment||None (Open Label)||||||
1510883|NCT00838565|Randomized|Parallel Assignment||Other||Double|||t||t|
1510884|NCT00838552|||Case Control||Prospective|||||||
1510885|NCT00838539|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1510886|NCT00838526|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510887|NCT00838513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510888|NCT00838500|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510889|NCT00838487|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510890|NCT00838474|Randomized|Crossover Assignment||Treatment||||||||
1510891|NCT00838461|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1510892|NCT00838448|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1510893|NCT00838435||Single Group Assignment||Treatment||None (Open Label)||||||
1510894|NCT00838422|||Cohort||Prospective|||||||
1510895|NCT00838409|||||Cross-Sectional|||||||
1510896|NCT00838396|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1510897|NCT00838383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510898|NCT00838370||Single Group Assignment||Prevention||None (Open Label)||||||
1510899|NCT00838357||Single Group Assignment||Treatment||None (Open Label)||||||
1510900|NCT00838344|Randomized|Single Group Assignment||Health Services Research||Single||||t||
1510901|NCT00838331||Single Group Assignment||Treatment||None (Open Label)||||||
1510902|NCT00838318|||Case-Only||Prospective|||||||
1510903|NCT00838305|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1510904|NCT00838292|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1510905|NCT00838279|Randomized|Crossover Assignment||||None (Open Label)||||||
1510906|NCT00838266|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1510907|NCT00838253|Randomized|||Treatment||Quadruple|||t|t|t|t
1510908|NCT00838240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510909|NCT00838227||Single Group Assignment||Treatment||None (Open Label)||||||
1510910|NCT00838214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510911|NCT00838201||Single Group Assignment||Treatment||None (Open Label)||||||
1510912|NCT00838188|||Case-Crossover||Prospective|||||||
1510913|NCT00838175|||Cohort||Retrospective|||||||
1510914|NCT00838162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510915|NCT00838149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510916|NCT00838136|Randomized|Crossover Assignment||||None (Open Label)||||||
1510917|NCT00838123|||Case Control||Prospective|||||||
1510918|NCT00838110|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1510919|NCT00838097|||||Prospective|||||||
1510920|NCT00838084|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1510921|NCT00838071||Single Group Assignment||Prevention||None (Open Label)||||||
1510922|NCT00838058|Randomized|Crossover Assignment||||None (Open Label)||||||
1510923|NCT00838045||Single Group Assignment||Treatment||None (Open Label)||||||
1510924|NCT00838032|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510925|NCT00838019||Single Group Assignment||Treatment||None (Open Label)||||||
1510926|NCT00838006|Randomized|Parallel Assignment||Prevention||Single||||||t
1510927|NCT00837993|||Case-Only||Prospective|||||||
1510928|NCT00837980|||Cohort||Prospective|||||||
1510929|NCT00837967|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1510930|NCT00837954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510931|NCT00837941|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1510932|NCT00837928||Single Group Assignment||Treatment||None (Open Label)||||||
1510933|NCT00837915|Randomized|Crossover Assignment||||None (Open Label)||||||
1510934|NCT00837902||Single Group Assignment||Other||None (Open Label)||||||
1510935|NCT00837889|||Case Control||Prospective|||||||
1510936|NCT00837876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510937|NCT00837863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510938|NCT00837850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510939|NCT00837837|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510940|NCT00837824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510941|NCT00837811||Single Group Assignment||Treatment||None (Open Label)||||||
1510942|NCT00837798|||Case-Only||Prospective|||||||
1510943|NCT00837785|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1510944|NCT00837772|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1510945|NCT00837759||Single Group Assignment||Treatment||None (Open Label)||||||
1510946|NCT00837746||||||||||||
1510947|NCT00837733|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510948|NCT00837720|||||Prospective|||||||
1510949|NCT00837707||Single Group Assignment||Treatment||None (Open Label)||||||
1510950|NCT00837694|||||Prospective|||||||
1510951|NCT00837681|||Cohort||Prospective|||||||
1510952|NCT00837668|||Cohort||Prospective|||||||
1510953|NCT00837655|Randomized|Parallel Assignment||Treatment||Single|||t|||
1510954|NCT00837642||||||||||||
1510955|NCT00837629|||||Prospective|||||||
1510956|NCT00837616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510957|NCT00837603|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1510958|NCT00837590|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510959|NCT00837577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510960|NCT00837564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510961|NCT00837551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510962|NCT00837538|||Case-Only||Cross-Sectional|||||||
1510963|NCT00837525||Single Group Assignment||Treatment||None (Open Label)||||||
1510964|NCT00837512|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1510965|NCT00837499|||Case-Control||Prospective|||||||
1510966|NCT00837486|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510967|NCT00837473||Single Group Assignment||Treatment||None (Open Label)||||||
1510968|NCT00837460||Crossover Assignment||Supportive Care||Single||||||t
1510969|NCT00837447|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1510970|NCT00837434|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510971|NCT00837421|||Cohort||Prospective|||||||
1510972|NCT00837408|||Case-Control||Cross-Sectional|||||||
1510973|NCT00837395|||Cohort||Prospective|||||||
1510974|NCT00837382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510975|NCT00837369||Single Group Assignment||Diagnostic||Single||||||t
1510976|NCT00837356||Single Group Assignment||Treatment||None (Open Label)||||||
1510977|NCT00837343||Single Group Assignment||Treatment||None (Open Label)||||||
1510978|NCT00837330|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510979|NCT00837317|Randomized|Crossover Assignment||Basic Science||Double|||t|t||
1510980|NCT00837304|||Case Control||Prospective|||||||
1510981|NCT00837291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1510982|NCT00837278|||Cohort||Prospective|||||||
1510983|NCT00837265|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1510984|NCT00837252||Single Group Assignment||Treatment||None (Open Label)||||||
1510985|NCT00837239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1510986|NCT00837226|||||Prospective|||||||
1510987|NCT00837213|Randomized|Parallel Assignment||Treatment||Single|||||t|
1510988|NCT00837200||Single Group Assignment||Treatment||None (Open Label)||||||
1510989|NCT00837187|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1510990|NCT00837174|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510991|NCT00837161||Single Group Assignment||Treatment||None (Open Label)||||||
1510992|NCT00837148||Single Group Assignment||Treatment||None (Open Label)||||||
1510993|NCT00837135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1510994|NCT00837122|||Case-Control||Prospective|||||||
1510995|NCT00837109|Randomized|Parallel Assignment||Treatment||Single||||||t
1510996|NCT00837096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1510997|NCT00837083|||||Prospective|||||||
1510998|NCT00837070||Single Group Assignment||Treatment||None (Open Label)||||||
1510999|NCT00837057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511000|NCT00837044|Randomized|Crossover Assignment||||Double|||t||t|
1511001|NCT00837031||Single Group Assignment||Treatment||None (Open Label)||||||
1511002|NCT00837018|Randomized|Factorial Assignment||||Single|||t|||
1511003|NCT00837005|||Cohort||Prospective|||||||
1511004|NCT00836992|||Case-Control||Prospective|||||||
1511005|NCT00836979|||Cohort||Cross-Sectional|||||||
1511006|NCT00836966|||Cohort||Prospective|||||||
1511007|NCT00836953|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1511008|NCT00836940|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511009|NCT00836927|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511010|NCT00836914|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1511011|NCT00836901|Randomized|Crossover Assignment||||None (Open Label)||||||
1511012|NCT00836888||Single Group Assignment||Treatment||None (Open Label)||||||
1511013|NCT00836875|Non-Randomized|||Treatment||None (Open Label)||||||
1511015|NCT00836849|Randomized|Crossover Assignment||||None (Open Label)||||||
1511016|NCT00836836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511017|NCT00836823||Single Group Assignment||Treatment||None (Open Label)||||||
1511018|NCT00836810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511019|NCT00836797|||Case Control||Prospective|||||||
1511020|NCT00836784|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1511021|NCT00836771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511022|NCT00836758|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1511023|NCT00836745|||Case-Only||Prospective|||||||
1511024|NCT00836732||Single Group Assignment||||None (Open Label)||||||
1511025|NCT00836719||Single Group Assignment||Treatment||None (Open Label)||||||
1511026|NCT00836706|Randomized|Crossover Assignment||||None (Open Label)||||||
1511027|NCT00836693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511028|NCT00836680||Single Group Assignment||Treatment||None (Open Label)||||||
1511029|NCT00836667|Randomized|Crossover Assignment||||None (Open Label)||||||
1511030|NCT00836654|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511031|NCT00836641|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511032|NCT00836628|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511033|NCT00836602|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1511034|NCT00836589|||Cohort||Prospective|||||||
1511035|NCT00836576|Randomized|Crossover Assignment||||None (Open Label)||||||
1511036|NCT00836563|||Case-Only||Prospective|||||||
1511037|NCT00836550|Randomized|Parallel Assignment||Prevention||Single||||t||
1511038|NCT00836537|Randomized|Crossover Assignment||||None (Open Label)||||||
1511039|NCT00836524|||Cohort||Prospective|||||||
1511040|NCT00836498|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1511041|NCT00836485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511042|NCT00836472|Randomized|Crossover Assignment||||None (Open Label)||||||
1511043|NCT00836459|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1511044|NCT00836446|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511045|NCT00836433|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1511046|NCT00836420|||Case-Only||Prospective|||||||
1511047|NCT00836407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511048|NCT00836394|Randomized|Parallel Assignment||Treatment||Single||||||t
1511049|NCT00836381|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511050|NCT00836368||Single Group Assignment||Treatment||None (Open Label)||||||
1511051|NCT00836355|Randomized|Parallel Assignment||Treatment||Single||||||t
1511052|NCT00836342|||Case Control||Cross-Sectional|||||||
1511053|NCT00836329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511054|NCT00836316|Randomized|Parallel Assignment||Treatment||Double||||||
1511055|NCT00836303|Randomized|Parallel Assignment||Prevention||Single||||||t
1511056|NCT00836290|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1511057|NCT00836277||Single Group Assignment||Treatment||None (Open Label)||||||
1511058|NCT00836264|||Cohort||Prospective|||||||
1511059|NCT00836251|||Cohort||Prospective|||||||
1511060|NCT00836238|||Cohort||Prospective|||||||
1511061|NCT00836225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511062|NCT00836212|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511063|NCT00836199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511064|NCT00836186||Single Group Assignment||Prevention||None (Open Label)||||||
1511065|NCT00836173||Single Group Assignment||Treatment||None (Open Label)||||||
1511066|NCT00836160|||||Prospective|||||||
1511067|NCT00836147|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1511068|NCT00836134|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511069|NCT00836121|||Case-Only|||||||||
1511070|NCT00836108|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1511071|NCT00836095|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1511072|NCT00836082|Randomized|Parallel Assignment||||Double|||t||t|
1511073|NCT00836069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511074|NCT00836056|Randomized|Crossover Assignment||||None (Open Label)||||||
1511075|NCT00836043|||Cohort||Prospective|||||||
1511076|NCT00836030|||Ecologic or Community||Cross-Sectional|||||||
1511077|NCT00836017|||Case-Only||Prospective|||||||
1511078|NCT00836004|Randomized|Crossover Assignment||||None (Open Label)||||||
1511079|NCT00835991|Randomized|Crossover Assignment||||None (Open Label)||||||
1511080|NCT00835978|Randomized|||Treatment||Quadruple|||t|t|t|t
1511081|NCT00835965|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1511082|NCT00835952|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1511083|NCT00835939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511084|NCT00835926|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511085|NCT00835913|||Cohort||Prospective|||||||
1511086|NCT00835900|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511087|NCT00835887|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511088|NCT00835874|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511089|NCT00835861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511090|NCT00835848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511091|NCT00835835|Randomized|Parallel Assignment||Treatment||Single||||||t
1511092|NCT00835822|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511093|NCT00835809|||Cohort||Prospective|||||||
1511094|NCT00835796|Randomized|Crossover Assignment||||None (Open Label)||||||
1511095|NCT00835783|||Case-Only||Prospective|||||||
1511096|NCT00835770|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1511097|NCT00835757|||Case Control||Prospective|||||||
1511098|NCT00835744|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511099|NCT00835731|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1511100|NCT00835718|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511101|NCT00835705|Randomized|Crossover Assignment||||None (Open Label)||||||
1511102|NCT00835692|Randomized|Crossover Assignment||||None (Open Label)||||||
1511103|NCT00835679|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1511104|NCT00835666|Randomized|Crossover Assignment||||None (Open Label)||||||
1511105|NCT00835653|||Cohort||Prospective|||||||
1511106|NCT00835640|Randomized|Crossover Assignment||||None (Open Label)||||||
1511107|NCT00835627|Randomized|Single Group Assignment||Treatment||Single||||||t
1511108|NCT00835614|Randomized|Crossover Assignment||||None (Open Label)||||||
1511109|NCT00835601|||Case-Only||Prospective|||||||
1511110|NCT00835588|Randomized|Crossover Assignment||||None (Open Label)||||||
1511111|NCT00835575|Randomized|Crossover Assignment||||None (Open Label)||||||
1511112|NCT00835562|Randomized|Parallel Assignment||Treatment||Single||||||t
1511113|NCT00835549|Randomized|Crossover Assignment||||None (Open Label)||||||
1511114|NCT00835536|Randomized|Crossover Assignment||||None (Open Label)||||||
1511115|NCT00835523|||Cohort||Prospective|||||||
1511116|NCT00835510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511117|NCT00835497|Randomized|Crossover Assignment||||None (Open Label)||||||
1511118|NCT00835484|Randomized|Crossover Assignment||||None (Open Label)||||||
1511119|NCT00835471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511120|NCT00835458||Single Group Assignment||Treatment||None (Open Label)||||||
1511121|NCT00835445|||Case Control||Prospective|||||||
1511122|NCT00835432|Randomized|Parallel Assignment||Treatment||Single||||||t
1511123|NCT00835419||Single Group Assignment||Treatment||None (Open Label)||||||
1511124|NCT00835406|Randomized|Crossover Assignment||||None (Open Label)||||||
1511125|NCT00835393|Randomized|Crossover Assignment||||None (Open Label)||||||
1511126|NCT00835380|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1511127|NCT00835367|Randomized|Crossover Assignment||||None (Open Label)||||||
1511128|NCT00835354|Randomized|Crossover Assignment||||None (Open Label)||||||
1511129|NCT00835341|||Cohort||Prospective|||||||
1511130|NCT00835328|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511131|NCT00835315|||||Prospective|||||||
1511132|NCT00835302||Single Group Assignment||Treatment||None (Open Label)||||||
1511133|NCT00835289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511134|NCT00835276|Randomized|Crossover Assignment||||None (Open Label)||||||
1511135|NCT00835263|Randomized|Crossover Assignment||||None (Open Label)||||||
1511136|NCT00835250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511137|NCT00835237|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511138|NCT00835224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511139|NCT00835211|Randomized|Crossover Assignment||||None (Open Label)||||||
1511140|NCT00835198|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511141|NCT00835185||Single Group Assignment||Treatment||None (Open Label)||||||
1511142|NCT00835172|Randomized|Crossover Assignment||||None (Open Label)||||||
1511143|NCT00835159|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511144|NCT00835146|Randomized|Crossover Assignment||||None (Open Label)||||||
1511145|NCT00835133|||Family-Based||Prospective|||||||
1511146|NCT00835120||Single Group Assignment||Treatment||None (Open Label)||||||
1511147|NCT00835107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511148|NCT00835094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511149|NCT00835081|Randomized|Crossover Assignment||||None (Open Label)||||||
1511150|NCT00835068|||Cohort||Prospective|||||||
1511151|NCT00835055|||Case-Only||Prospective|||||||
1511152|NCT00835042|Randomized|Crossover Assignment||||None (Open Label)||||||
1511153|NCT00835029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511154|NCT00835016|Randomized|Parallel Assignment||Treatment||Single||||||t
1511155|NCT00835003|Randomized|Parallel Assignment||Prevention||Single||||||t
1511156|NCT00834990|Randomized|Crossover Assignment||||None (Open Label)||||||
1511157|NCT00834977|Randomized|Crossover Assignment||||None (Open Label)||||||
1511158|NCT00834964|Randomized|Crossover Assignment||||None (Open Label)||||||
1511159|NCT00834951||Single Group Assignment||Treatment||None (Open Label)||||||
1511160|NCT00834938|||Case Control||Cross-Sectional|||||||
1511161|NCT00834925|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511162|NCT00834912|Randomized|Crossover Assignment||||None (Open Label)||||||
1511163|NCT00834899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511164|NCT00834886|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511165|NCT00834873|Randomized|Crossover Assignment||||None (Open Label)||||||
1511166|NCT00834860|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511167|NCT00834847|Randomized|Crossover Assignment||||None (Open Label)||||||
1511168|NCT00834834|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511169|NCT00834821|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1511170|NCT00834808|Randomized|Crossover Assignment||||None (Open Label)||||||
1511171|NCT00834795|Randomized|Crossover Assignment||||None (Open Label)||||||
1511174|NCT00834756|Randomized|Crossover Assignment||||None (Open Label)||||||
1511175|NCT00834743|Randomized|Crossover Assignment||||None (Open Label)||||||
1511176|NCT00834730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511177|NCT00834717|Randomized|Crossover Assignment||||None (Open Label)||||||
1511178|NCT00834704|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1511179|NCT00834691|||Case Control||Cross-Sectional|||||||
1511180|NCT00834678||Single Group Assignment||Treatment||None (Open Label)||||||
1511181|NCT00834665|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511182|NCT00834652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511183|NCT00834639|Randomized|Crossover Assignment||||None (Open Label)||||||
1511184|NCT00834626||Single Group Assignment||Treatment||None (Open Label)||||||
1511185|NCT00834613|Randomized|Crossover Assignment||||None (Open Label)||||||
1511186|NCT00834600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511187|NCT00834587|Randomized|Crossover Assignment||||None (Open Label)||||||
1511188|NCT00834574|Randomized|Crossover Assignment||||None (Open Label)||||||
1511189|NCT00834561|Randomized|Crossover Assignment||||None (Open Label)||||||
1511190|NCT00834548|||Cohort||Prospective|||||||
1511191|NCT00834535|Randomized|Crossover Assignment||||None (Open Label)||||||
1511192|NCT00834522|Randomized|Crossover Assignment||||None (Open Label)||||||
1511193|NCT00834509|||Case-Control||Prospective|||||||
1511194|NCT00834496|||Cohort||Prospective|||||||
1511195|NCT00834483|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1511196|NCT00834470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511197|NCT00834457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511198|NCT00834444|Randomized|Crossover Assignment||||None (Open Label)||||||
1511199|NCT00834431|Randomized|Crossover Assignment||||None (Open Label)||||||
1511200|NCT00834418|Randomized|Parallel Assignment||||None (Open Label)||||||
1511201|NCT00834405|Randomized|Parallel Assignment||||None (Open Label)||||||
1511202|NCT00834392|Randomized|Parallel Assignment||Treatment||Single||||||t
1511203|NCT00834379|Randomized|Crossover Assignment||||None (Open Label)||||||
1511204|NCT00834366|Randomized|Crossover Assignment||||None (Open Label)||||||
1511205|NCT00834353|||Case Control||Prospective|||||||
1511206|NCT00834340|Randomized|Crossover Assignment||||None (Open Label)||||||
1511207|NCT00834327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511208|NCT00834314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511209|NCT00834301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511210|NCT00834288|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511211|NCT00834275|Randomized|Crossover Assignment||||None (Open Label)||||||
1511212|NCT00834262|||Case-Only||Prospective|||||||
1511213|NCT00834249|Randomized|Crossover Assignment||||None (Open Label)||||||
1511214|NCT00834236|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1511215|NCT00834223|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511216|NCT00834210|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511217|NCT00834197|Randomized|Crossover Assignment||||None (Open Label)||||||
1511218|NCT00834184|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511219|NCT00834171|||Case-Only||Retrospective|||||||
1511220|NCT00834158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511221|NCT00834145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511222|NCT00834132|Randomized|Crossover Assignment||||None (Open Label)||||||
1511223|NCT00834119|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511224|NCT00834106|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1511225|NCT00834093||Single Group Assignment||Treatment||None (Open Label)||||||
1511226|NCT00834080||Single Group Assignment||Treatment||None (Open Label)||||||
1511227|NCT00834067|Randomized|Crossover Assignment||||None (Open Label)||||||
1511228|NCT00834054|||Cohort||Prospective|||||||
1511229|NCT00834041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511230|NCT00834028|||Case-Only||Prospective|||||||
1511231|NCT00834015|Randomized|Parallel Assignment||||Single||||||t
1511232|NCT00834002||Single Group Assignment||Treatment||None (Open Label)||||||
1511233|NCT00833989|Randomized|Parallel Assignment||Other||Single|||t|||
1511234|NCT00833976||Single Group Assignment||Treatment||None (Open Label)||||||
1511235|NCT00833963|||Cohort||Prospective|||||||
1511236|NCT00833950||Parallel Assignment||Treatment||None (Open Label)||||||
1511237|NCT00833937|Randomized|Crossover Assignment||||None (Open Label)||||||
1511238|NCT00833924||Single Group Assignment||Treatment||None (Open Label)||||||
1511239|NCT00833911||Single Group Assignment||Treatment||None (Open Label)||||||
1511240|NCT00833898|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511241|NCT00833885|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511242|NCT00833872|Randomized|Parallel Assignment||||Double|||t||t|
1511243|NCT00833859||Single Group Assignment||Treatment||None (Open Label)||||||
1511244|NCT00833846|||||Prospective|||||||
1511245|NCT00833833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511246|NCT00833820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511247|NCT00833807||Single Group Assignment||Treatment||None (Open Label)||||||
1511248|NCT00833794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511249|NCT00833781|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511250|NCT00833768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512414|NCT00818454||Crossover Assignment||Treatment||||||||
1511251|NCT00833755|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1511252|NCT00833742|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511253|NCT00833729|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511254|NCT00833716|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511255|NCT00833703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511256|NCT00833690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511257|NCT00833677||Single Group Assignment||Supportive Care||None (Open Label)||||||
1511258|NCT00833664|Randomized|Crossover Assignment||||None (Open Label)||||||
1511259|NCT00833651|||Cohort||Prospective|||||||
1511260|NCT00833638|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511261|NCT00833625||Single Group Assignment||Diagnostic||None (Open Label)||||||
1511262|NCT00833612|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511263|NCT00833599|||Case-Control||Cross-Sectional|||||||
1511264|NCT00833586|Randomized|Crossover Assignment||||None (Open Label)||||||
1511265|NCT00833573|||Cohort||Cross-Sectional|||||||
1511266|NCT00833560||Single Group Assignment||Treatment||None (Open Label)||||||
1511267|NCT00833547|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1511268|NCT00833534||||Treatment||None (Open Label)||||||
1511269|NCT00833521|Randomized|Crossover Assignment||||None (Open Label)||||||
1511270|NCT00833508||Single Group Assignment||Diagnostic||None (Open Label)||||||
1511271|NCT00833495|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1511272|NCT00833482|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1511273|NCT00833469||Single Group Assignment||Treatment||None (Open Label)||||||
1511274|NCT00833456|||Case Control||Prospective|||||||
1511275|NCT00833443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511276|NCT00833430||||||||||||
1511277|NCT00833417||Single Group Assignment||Treatment||None (Open Label)||||||
1511278|NCT00833404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511279|NCT00833391|Randomized|Crossover Assignment||||None (Open Label)||||||
1511280|NCT00833378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511281|NCT00833365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511282|NCT00833352|Randomized|Parallel Assignment||Treatment||Single||||||t
1511283|NCT00833339|Randomized|Parallel Assignment||||Triple|||t||t|t
1511284|NCT00833326||Single Group Assignment||Treatment||None (Open Label)||||||
1511285|NCT00833313|||Cohort||Prospective|||||||
1511286|NCT00833300|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511287|NCT00833287|||Case-Only||Prospective|||||||
1511288|NCT00833274||Parallel Assignment||Diagnostic||None (Open Label)||||||
1511289|NCT00833261||Single Group Assignment||Treatment||None (Open Label)||||||
1511290|NCT00833248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511291|NCT00833235|||Case-Control||Prospective|||||||
1511292|NCT00833222|||Cohort||Prospective|||||||
1511293|NCT00833209|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1511294|NCT00833196|||Cohort||Prospective|||||||
1511295|NCT00833183|Randomized|Parallel Assignment||Treatment||Single||||||t
1511296|NCT00833170|||Cohort||Prospective|||||||
1511297|NCT00833157|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1511298|NCT00833144|||Case Control||Prospective|||||||
1511299|NCT00833131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511300|NCT00833118|||||Prospective|||||||
1511301|NCT00833105||Single Group Assignment||Treatment||None (Open Label)||||||
1511302|NCT00833092|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511303|NCT00833079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511304|NCT00833066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511305|NCT00833053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511306|NCT00833040|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1511307|NCT00833027|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511308|NCT00833014|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511309|NCT00833001|||Cohort||Prospective|||||||
1511310|NCT00832988|||Case-Crossover||Prospective|||||||
1511311|NCT00832975|||Case-Only||Prospective|||||||
1511312|NCT00832962|||||Prospective|||||||
1511313|NCT00832949||||||||||||
1511314|NCT00832923|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1511315|NCT00832910|||Case Control|||||||||
1511316|NCT00832897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511317|NCT00832884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511318|NCT00832871||Single Group Assignment||Prevention||None (Open Label)||||||
1511319|NCT00832845|Randomized|Parallel Assignment||Treatment||Single||||||t
1511320|NCT00832832|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511321|NCT00832819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511322|NCT00832806|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511323|NCT00832793||||||||||||
1511324|NCT00832780||Single Group Assignment||Treatment||None (Open Label)||||||
1511325|NCT00832767|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511326|NCT00832754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511327|NCT00832741||||||||||||
1511328|NCT00832728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511329|NCT00832715||Single Group Assignment||Treatment||None (Open Label)||||||
1511330|NCT00832702|||Other||Prospective|||||||
1511331|NCT00832689||||Treatment||||||||
1511333|NCT00832663|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1511334|NCT00832650|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511335|NCT00832637||Single Group Assignment||Treatment||None (Open Label)||||||
1511336|NCT00832624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511337|NCT00832611||Single Group Assignment||Treatment||None (Open Label)||||||
1511338|NCT00832598||Single Group Assignment||Treatment||None (Open Label)||||||
1511339|NCT00832585||Single Group Assignment||Treatment||None (Open Label)||||||
1511340|NCT00832572|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1511341|NCT00832559||Single Group Assignment||Treatment||None (Open Label)||||||
1511342|NCT00832546|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1511343|NCT00832533|||Ecologic or Community||Prospective|||||||
1511344|NCT00832520||Single Group Assignment||Prevention||None (Open Label)||||||
1511345|NCT00832507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511346|NCT00832494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511347|NCT00832481|Randomized|Parallel Assignment||||None (Open Label)||||||
1511348|NCT00832468|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1511349|NCT00832455|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511350|NCT00832442||||||||||||
1511351|NCT00832429||Single Group Assignment||Diagnostic||None (Open Label)||||||
1511352|NCT00832416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511353|NCT00832403|||Case-Only||Retrospective|||||||
1511354|NCT00832390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511355|NCT00832377|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511356|NCT00832364|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511357|NCT00832351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511358|NCT00832338||Single Group Assignment||Treatment||None (Open Label)||||||
1511359|NCT00832325|||Cohort||Prospective|||||||
1511360|NCT00832312|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1511361|NCT00832299||Single Group Assignment||Treatment||None (Open Label)||||||
1511362|NCT00832286|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1511363|NCT00832273||||||||||||
1511364|NCT00832260|||Case-Only||Prospective|||||||
1511365|NCT00832247||Single Group Assignment||Treatment||None (Open Label)||||||
1511366|NCT00832234||Single Group Assignment||Treatment||None (Open Label)||||||
1511367|NCT00832221|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1511368|NCT00832208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511369|NCT00832195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511370|NCT00832182|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511371|NCT00832169||Single Group Assignment||||None (Open Label)||||||
1511372|NCT00832156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511373|NCT00832143|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1511374|NCT00832130|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511375|NCT00832117||Single Group Assignment||Treatment||None (Open Label)||||||
1511376|NCT00832091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511377|NCT00832078|Randomized|Crossover Assignment||Treatment||Single|||t|||
1511378|NCT00832065|||Case-Only||Prospective|||||||
1511379|NCT00832052|Randomized|Parallel Assignment||||Double|||t||t|
1511380|NCT00832039|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1511381|NCT00832026|||Case-Only||Cross-Sectional|||||||
1511382|NCT00832013|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511383|NCT00832000|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1511384|NCT00831987|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511385|NCT00831974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511386|NCT00831961|||Cohort||Prospective|||||||
1511387|NCT00831948|||Case-Only||Cross-Sectional|||||||
1511388|NCT00831935|||Cohort||Prospective|||||||
1511389|NCT00831922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511390|NCT00831909|||Cohort||Prospective|||||||
1511391|NCT00831896||Single Group Assignment||Treatment||None (Open Label)||||||
1511392|NCT00831883|Randomized|Parallel Assignment||Prevention||Single||||||t
1511393|NCT00831870|||Case-Only||Prospective|||||||
1511394|NCT00831857|||Cohort||Prospective|||||||
1511395|NCT00831844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511396|NCT00831831|Randomized|Parallel Assignment||Prevention||Single|||t|||
1511397|NCT00831818|||Case Control||Prospective|||||||
1511398|NCT00831805|||Ecologic or Community||Prospective|||||||
1511399|NCT00831792||Single Group Assignment||Treatment||None (Open Label)||||||
1511400|NCT00831779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511401|NCT00831766|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511402|NCT00831753|Randomized|Parallel Assignment||Prevention||Single||||||t
1511403|NCT00831740|Randomized|Parallel Assignment||Treatment||Single||||||t
1511404|NCT00831727|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511405|NCT00831714|||Cohort||Prospective|||||||
1511406|NCT00831701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511407|NCT00831688|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511408|NCT00831675|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511409|NCT00831662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511410|NCT00831649||Single Group Assignment||Treatment||None (Open Label)||||||
1511411|NCT00831636||Single Group Assignment||Treatment||None (Open Label)||||||
1511412|NCT00831623||Single Group Assignment||Treatment||None (Open Label)||||||
1511413|NCT00831610|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1511414|NCT00831597||Single Group Assignment||Treatment||None (Open Label)||||||
1511415|NCT00831571|||Case-Only||Prospective|||||||
1511416|NCT00831545|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511417|NCT00831532|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511418|NCT00831519|||Case-Control||Prospective|||||||
1511419|NCT00831506|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1511420|NCT00831493||Single Group Assignment||Treatment||None (Open Label)||||||
1511421|NCT00831480||Single Group Assignment||Prevention||None (Open Label)||||||
1511422|NCT00831467||Single Group Assignment||Treatment||None (Open Label)||||||
1511423|NCT00831454|||Cohort||Retrospective|||||||
1511424|NCT00831441|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1511425|NCT00831428|||Other||Cross-Sectional|||||||
1511426|NCT00831415||Single Group Assignment||Treatment||None (Open Label)||||||
1511427|NCT00831402|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511428|NCT00831389|Non-Randomized|Crossover Assignment||Other||None (Open Label)||||||
1511429|NCT00831376|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1511430|NCT00831363|||Cohort||Prospective|||||||
1511431|NCT00831350||Parallel Assignment||Treatment||None (Open Label)||BRVO and CRVO will be enrolled in this trial.||||
1511432|NCT00831337|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511433|NCT00831311|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511434|NCT00831298|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1511435|NCT00831285|Randomized|Parallel Assignment||||Triple|||t|t|t|
1511436|NCT00831272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511437|NCT00831259|||Cohort||Prospective|||||||
1511438|NCT00831246|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1511439|NCT00831233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511440|NCT00831220|||Case Control||Prospective|||||||
1511441|NCT00831207|||||Cross-Sectional|||||||
1511442|NCT00831194||Single Group Assignment||Health Services Research||Single||||||t
1511443|NCT00831181||Single Group Assignment||Treatment||None (Open Label)||||||
1511444|NCT00831168|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1511445|NCT00831155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511446|NCT00831142|||Case-Only||Prospective|||||||
1511447|NCT00831129|Randomized|Parallel Assignment||||Double|||t||t|
1511448|NCT00831116|||Cohort||Prospective|||||||
1511449|NCT00831103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511450|NCT00831090|||Cohort||Prospective|||||||
1511451|NCT00831077|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1511452|NCT00831064|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1511453|NCT00831051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511454|NCT00831038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1511455|NCT00831025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511456|NCT00831012|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1511457|NCT00830999|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1511458|NCT00830986|||Case Control||Prospective|||||||
1511459|NCT00830973|||Cohort||Prospective|||||||
1511460|NCT00830960|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511461|NCT00830947|Randomized|Parallel Assignment||Treatment||Single||||||t
1511462|NCT00830934|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511463|NCT00830921||||||||||||
1511464|NCT00830908||Single Group Assignment||Treatment||None (Open Label)||||||
1511465|NCT00830895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511466|NCT00830882|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1511467|NCT00830869||Single Group Assignment||Treatment||None (Open Label)||||||
1511468|NCT00830856|Randomized|Parallel Assignment||Treatment||Single||||t||
1511469|NCT00830843|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511470|NCT00830830|Randomized|Parallel Assignment||Treatment||Double||||||
1511471|NCT00830817|||Case Control||Prospective|||||||
1511472|NCT00830804||Single Group Assignment||Treatment||None (Open Label)||||||
1511473|NCT00830791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511474|NCT00830778|Randomized|||Treatment||||||||
1511475|NCT00830765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511476|NCT00830752|||Case-Only||Prospective|||||||
1511477|NCT00830739|||||Other|||||||
1511478|NCT00830726|||Case Control||Prospective|||||||
1511479|NCT00830713||Single Group Assignment||Treatment||None (Open Label)||||||
1511480|NCT00830700|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1511481|NCT00830687||Single Group Assignment||Treatment||None (Open Label)||||||
1511482|NCT00830674|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511483|NCT00830661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511484|NCT00830648||Single Group Assignment||Prevention||None (Open Label)||||||
1511485|NCT00830635||Single Group Assignment||||None (Open Label)||||||
1511486|NCT00830622|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1511487|NCT00830609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511488|NCT00830596|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1513184|NCT00808353|||Cohort||Prospective|||||||
1511489|NCT00830583||Single Group Assignment||Diagnostic||None (Open Label)||||||
1511490|NCT00830570|||Cohort||Prospective|||||||
1511491|NCT00830557|||Case-Only||Prospective|||||||
1511492|NCT00830544||Single Group Assignment||Treatment||None (Open Label)||||||
1511493|NCT00830531|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511494|NCT00830518||Single Group Assignment||Treatment||None (Open Label)||||||
1511495|NCT00830505|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1511496|NCT00830492|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511497|NCT00830479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511498|NCT00830466||Single Group Assignment||Treatment||None (Open Label)||||||
1511499|NCT00830453||Single Group Assignment||Treatment||None (Open Label)||||||
1511500|NCT00830440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511501|NCT00830427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511502|NCT00830414|Randomized|Parallel Assignment||||None (Open Label)||||||
1511503|NCT00830401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511504|NCT00830388||Single Group Assignment||Treatment||None (Open Label)||||||
1511505|NCT00830375||Single Group Assignment||Treatment||None (Open Label)||||||
1511506|NCT00830362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511507|NCT00830349|Randomized|Crossover Assignment||||None (Open Label)||||||
1511508|NCT00830336|Randomized|Crossover Assignment||||None (Open Label)||||||
1511509|NCT00830323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511510|NCT00830310||Single Group Assignment||Treatment||None (Open Label)||||||
1511511|NCT00830297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511512|NCT00830284||Single Group Assignment||Treatment||None (Open Label)||||||
1511513|NCT00830271|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1511514|NCT00830258|Randomized|Crossover Assignment||||None (Open Label)||||||
1511515|NCT00830245|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511516|NCT00830232|Randomized|Parallel Assignment||Prevention||Single||||||t
1511517|NCT00830219|Randomized|Crossover Assignment||||None (Open Label)||||||
1511518|NCT00830206|Randomized|Crossover Assignment||||None (Open Label)||||||
1511519|NCT00830193|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511520|NCT00830180||Single Group Assignment||Treatment||None (Open Label)||||||
1511521|NCT00830167|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511522|NCT00830154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511523|NCT00830141|||Case Control||Prospective|||||||
1511524|NCT00830128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511525|NCT00830115|||Case-Only||Prospective|||||||
1511526|NCT00830102|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1511527|NCT00830089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511528|NCT00830076|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1511529|NCT00830063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511530|NCT00830050|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1511531|NCT00830037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511532|NCT00830024|Randomized|Crossover Assignment||||None (Open Label)||||||
1511533|NCT00830011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511534|NCT00829998|Randomized|Crossover Assignment||||None (Open Label)||||||
1511535|NCT00829985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511536|NCT00829972|||Case Control||Prospective|||||||
1511537|NCT00829959|||Cohort||Prospective|||||||
1511538|NCT00829946|Randomized|Parallel Assignment||Treatment||Single||||||
1511539|NCT00829933|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511540|NCT00829920|||Cohort||Prospective|||||||
1511541|NCT00829907|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1511542|NCT00829894|Randomized|Crossover Assignment||||None (Open Label)||||||
1511543|NCT00829881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511544|NCT00829868|Randomized|Crossover Assignment||||None (Open Label)||||||
1511545|NCT00829855|||Case-Crossover||Prospective|||||||
1511546|NCT00829842|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511547|NCT00829829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511548|NCT00829816|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511549|NCT00829803|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1511550|NCT00829790|Randomized|Crossover Assignment||||None (Open Label)||||||
1511551|NCT00829777|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1511552|NCT00829764|Randomized|Crossover Assignment||||None (Open Label)||||||
1511553|NCT00829751|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1511554|NCT00829738|||Cohort||Prospective|||||||
1511555|NCT00829725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511556|NCT00829712|Randomized|Crossover Assignment||||None (Open Label)||||||
1511557|NCT00829699|Randomized|Factorial Assignment||Prevention||Single|||t|||
1511558|NCT00829686|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1511559|NCT00829673|Randomized|Crossover Assignment||||None (Open Label)||||||
1511560|NCT00829660|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511561|NCT00829647||Single Group Assignment||Treatment||None (Open Label)||||||
1511562|NCT00829634||Single Group Assignment||Basic Science||None (Open Label)||||||
1511563|NCT00829621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511564|NCT00829608||Single Group Assignment||Treatment||None (Open Label)||||||
1511565|NCT00829595||Single Group Assignment||Prevention||None (Open Label)||||||
1511566|NCT00829582|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511567|NCT00829569|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1511568|NCT00829556|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1511569|NCT00829543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511570|NCT00829530|Randomized|Crossover Assignment||||None (Open Label)||||||
1511571|NCT00829517|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1511572|NCT00829504|Randomized|Crossover Assignment||||None (Open Label)||||||
1511573|NCT00829491||Single Group Assignment||Prevention||None (Open Label)||||||
1511574|NCT00829478|Randomized|Parallel Assignment||||Single||||||t
1511575|NCT00829465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511576|NCT00829452|Randomized|Crossover Assignment||||None (Open Label)||||||
1511577|NCT00829439||Single Group Assignment||Treatment||None (Open Label)||||||
1511578|NCT00829426|Randomized|Crossover Assignment||||None (Open Label)||||||
1511579|NCT00829413||Single Group Assignment||Diagnostic||None (Open Label)||||||
1511580|NCT00829400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511581|NCT00829387|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511582|NCT00829374|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511583|NCT00829361||Single Group Assignment||Treatment||None (Open Label)||||||
1511584|NCT00829348|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1511585|NCT00829335|||Cohort||Prospective|||||||
1511586|NCT00829322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511587|NCT00829309|Randomized|Crossover Assignment||||None (Open Label)||||||
1511588|NCT00829296|Randomized|Parallel Assignment||Prevention||Single||||||t
1511589|NCT00829283|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1511590|NCT00829270|||Case-Only||Cross-Sectional|||||||
1511591|NCT00829257|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511592|NCT00829244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511593|NCT00829231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511594|NCT00829218|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1511595|NCT00829205|Non-Randomized|||Treatment||None (Open Label)||||||
1511596|NCT00829192|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1511597|NCT00829179||Single Group Assignment||Basic Science||None (Open Label)||||||
1511598|NCT00829166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511599|NCT00829153|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1511600|NCT00829140|Randomized|Parallel Assignment||||Double|||t||t|
1511601|NCT00829127|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1511602|NCT00829114|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511603|NCT00829101|||Cohort||Prospective|||||||
1511604|NCT00829088||Single Group Assignment||||None (Open Label)||||||
1511605|NCT00829075||||||||||||
1511606|NCT00829062|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1511607|NCT00829049|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511608|NCT00829036||Single Group Assignment||||None (Open Label)||||||
1511609|NCT00829023|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1511610|NCT00829010|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511611|NCT00828997||Single Group Assignment||Prevention||None (Open Label)||||||
1511612|NCT00828984|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1511613|NCT00828971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511614|NCT00828958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511615|NCT00828945|||Case-Only||Prospective|||||||
1511616|NCT00828932||Single Group Assignment||||None (Open Label)||||||
1511617|NCT00828919||||Treatment||None (Open Label)||||||
1511618|NCT00828906||Single Group Assignment||Treatment||None (Open Label)||||||
1511619|NCT00828893|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1511620|NCT00828880|||Cohort||Retrospective|||||||
1511621|NCT00828867|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1511622|NCT00828854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511623|NCT00828841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511624|NCT00828828|||Case Control||Prospective|||||||
1511625|NCT00828815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511626|NCT00828802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511627|NCT00828789|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511628|NCT00828776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511629|NCT00828763||Single Group Assignment||Treatment||None (Open Label)||||||
1511630|NCT00828750|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511631|NCT00828737||Single Group Assignment||Treatment||None (Open Label)||||||
1511632|NCT00828724||Crossover Assignment||||None (Open Label)||||||
1511633|NCT00828711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511634|NCT00828698|||Cohort||Prospective|||||||
1511635|NCT00828685||||||||||||
1511636|NCT00828672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511637|NCT00828659|Randomized|Crossover Assignment||||Double|||t||t|
1511638|NCT00828646|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511639|NCT00828633|||Ecologic or Community||Cross-Sectional|||||||
1511640|NCT00828620|||Cohort||Prospective|||||||
1511641|NCT00828607|||Cohort||Prospective|||||||
1511642|NCT00828594||Single Group Assignment||Treatment||None (Open Label)||||||
1511643|NCT00828581||Single Group Assignment||||None (Open Label)||||||
1511644|NCT00828568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511645|NCT00828555||||||||||||
1511646|NCT00828542|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1511647|NCT00828529|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511648|NCT00828516||Single Group Assignment||Supportive Care||None (Open Label)||||||
1511649|NCT00828503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511650|NCT00828490|||||Retrospective|||||||
1511651|NCT00828477|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511652|NCT00828464||Single Group Assignment||Treatment||None (Open Label)||||||
1511653|NCT00828451||Single Group Assignment||Basic Science||None (Open Label)||||||
1511654|NCT00828438||Single Group Assignment||||None (Open Label)||||||
1511655|NCT00828425|||||Retrospective|||||||
1511656|NCT00828412|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511657|NCT00828399|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511658|NCT00828386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511659|NCT00828373|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1511660|NCT00828360|||Cohort||Prospective|||||||
1511661|NCT00828347|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511662|NCT00828334||Single Group Assignment||Treatment||None (Open Label)||||||
1511663|NCT00828321|Randomized|Crossover Assignment||||None (Open Label)||||||
1511664|NCT00828308||Single Group Assignment||Treatment||None (Open Label)||||||
1511665|NCT00828295|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511666|NCT00828282|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511667|NCT00828269|Non-Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1511668|NCT00828256|||Cohort||Cross-Sectional|||||||
1511669|NCT00828243|||Case-Control||Cross-Sectional|||||||
1511670|NCT00828230|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511671|NCT00828217|Randomized|Parallel Assignment||||None (Open Label)||||||
1511672|NCT00828204||Single Group Assignment||||None (Open Label)||||||
1511673|NCT00828191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511674|NCT00828178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511675|NCT00828165|Randomized|Crossover Assignment||||Triple|||t|t|t|
1511676|NCT00828152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511677|NCT00828139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511678|NCT00828126|||Case-Only||Prospective|||||||
1511679|NCT00828113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511680|NCT00828100|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1511681|NCT00828087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511682|NCT00828074||Single Group Assignment||Treatment||None (Open Label)||||||
1511683|NCT00828061|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1511684|NCT00828048|||Case-Control||Prospective|||||||
1511685|NCT00828035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511686|NCT00828022|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511687|NCT00828009|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511688|NCT00827996||Single Group Assignment||Treatment||None (Open Label)||||||
1511689|NCT00827983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511690|NCT00827970|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1511691|NCT00827957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511692|NCT00827944|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511693|NCT00827931|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511694|NCT00827918|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511695|NCT00827905|||Case-Only||Cross-Sectional|||||||
1511696|NCT00827892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511697|NCT00827879|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1511698|NCT00827866|Randomized|Parallel Assignment||||None (Open Label)||||||
1511699|NCT00827853|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511700|NCT00827840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511701|NCT00827827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511702|NCT00827814||Single Group Assignment||Treatment||None (Open Label)||||||
1511703|NCT00827801|||Case-Only||Prospective|||||||
1511704|NCT00827788|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1511705|NCT00827775|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511706|NCT00827762|||Case-Only||Prospective|||||||
1511707|NCT00827749|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1511708|NCT00827736|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511709|NCT00827723|||Case-Only||Prospective|||||||
1511710|NCT00827710|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1511711|NCT00827697|||Cohort||Cross-Sectional|||||||
1511712|NCT00827684||||Treatment||||||||
1511713|NCT00827671|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511714|NCT00827658|Randomized|Single Group Assignment||Treatment||Single|||||t|
1511715|NCT00827645|||Case-Only||Prospective|||||||
1511716|NCT00827632|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511717|NCT00827619||Single Group Assignment||Treatment||None (Open Label)||||||
1511718|NCT00827606||Single Group Assignment||Treatment||None (Open Label)||||||
1511719|NCT00827593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511720|NCT00827580||Single Group Assignment||Treatment||Double||||||
1511721|NCT00827567||Single Group Assignment||Treatment||None (Open Label)||||||
1511722|NCT00827554|Randomized|Parallel Assignment||Treatment||Single||||||t
1511723|NCT00827541|||Cohort||Prospective|||||||
1511724|NCT00827528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511725|NCT00827515|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1511726|NCT00827502|||||Prospective|||||||
1511727|NCT00827489|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511728|NCT00827476||Single Group Assignment||Treatment||None (Open Label)||||||
1511729|NCT00827463|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1511730|NCT00827450|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1511731|NCT00827437||Single Group Assignment||Supportive Care||None (Open Label)||||||
1511732|NCT00827424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511733|NCT00827411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511734|NCT00827398||Single Group Assignment||Treatment||None (Open Label)||||||
1511735|NCT00827385|||Case Control||Prospective|||||||
1511736|NCT00827372|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1511737|NCT00827359||Single Group Assignment||Treatment||None (Open Label)||||||
1511738|NCT00827346|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1511739|NCT00827333|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1511740|NCT00827320|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511741|NCT00827307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511742|NCT00827294||Single Group Assignment||Treatment||None (Open Label)||||||
1511743|NCT00827281|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511744|NCT00827268||Single Group Assignment||Treatment||None (Open Label)||This is a repeated probe design study.||||
1511745|NCT00827255|||Case-Only||Retrospective|||||||
1511746|NCT00827242|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511747|NCT00827229||Single Group Assignment||||None (Open Label)||||||
1511748|NCT00827216|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1511749|NCT00827203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511750|NCT00827190|Randomized|Single Group Assignment||Treatment||Double||||||
1511751|NCT00827177||Single Group Assignment||Treatment||None (Open Label)||||||
1511752|NCT00827164|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1511753|NCT00827151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511754|NCT00827138||Single Group Assignment||Treatment||None (Open Label)||||||
1511755|NCT00827125|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1511756|NCT00827112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511757|NCT00827099||Single Group Assignment||Treatment||None (Open Label)||||||
1511758|NCT00827086|||Cohort||Prospective|||||||
1511759|NCT00827073|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1511760|NCT00827060|||Case-Only||Prospective|||||||
1511761|NCT00827047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511762|NCT00827034|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511763|NCT00827021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511764|NCT00827008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511765|NCT00826995|Randomized|Parallel Assignment||||Single||||||t
1511766|NCT00826982|||Case-Only||Prospective|||||||
1511767|NCT00826969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511768|NCT00826956||||||||||||
1511769|NCT00826943|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1511770|NCT00826930|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1511771|NCT00826917|||Case Control|||||||||
1511772|NCT00826904|||Cohort||Prospective|||||||
1511773|NCT00826891|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511774|NCT00826878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511775|NCT00826865|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511776|NCT00826852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511777|NCT00826839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511778|NCT00826826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511779|NCT00826813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511780|NCT00826800||Single Group Assignment||Treatment||None (Open Label)||||||
1511781|NCT00826787|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511782|NCT00826774|Randomized|Parallel Assignment||Treatment||Single||||||t
1511783|NCT00826761|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1511784|NCT00826748|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1511785|NCT00826735||||Prevention||||||||
1511786|NCT00826722|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511787|NCT00826709|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1511788|NCT00826696|||Case Control||Retrospective|||||||
1511789|NCT00826683|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1511790|NCT00826670|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511791|NCT00826657|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1511792|NCT00826644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511793|NCT00826631|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1511794|NCT00826618||Single Group Assignment||Treatment||None (Open Label)||||||
1511795|NCT00826605|||Cohort||Retrospective|||||||
1511796|NCT00826592|Randomized|Parallel Assignment||||Single|||||t|
1511797|NCT00826579|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1511798|NCT00826566|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1511799|NCT00826553|Randomized|Parallel Assignment||Other||Single||||||t
1511800|NCT00826540||Single Group Assignment||Treatment||None (Open Label)||||||
1511801|NCT00826527|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511802|NCT00826514|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511803|NCT00826501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511804|NCT00826488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1511805|NCT00826475|Randomized|Parallel Assignment||Treatment||Single||||||t
1511806|NCT00826462|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1511807|NCT00826449||Single Group Assignment||Treatment||None (Open Label)||||||
1511808|NCT00826436|||Cohort||Prospective|||||||
1511809|NCT00826423|||Case-Only||Prospective|||||||
1511810|NCT00826410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511811|NCT00826397|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1511812|NCT00826384|Randomized|Parallel Assignment||Treatment||Single||||||t
1511813|NCT00826371||Single Group Assignment||Treatment||None (Open Label)||||||
1511814|NCT00826358|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511815|NCT00826345|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511816|NCT00826332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511817|NCT00826319|||Cohort||Prospective|||||||
1511818|NCT00826306|Randomized|Parallel Assignment||||Single||||||t
1511819|NCT00826293|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1511820|NCT00826280|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1511821|NCT00826267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511822|NCT00826254|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511823|NCT00826241||Single Group Assignment||Treatment||None (Open Label)||||||
1511824|NCT00826228||Single Group Assignment||Treatment||None (Open Label)||||||
1511825|NCT00826215|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511826|NCT00826202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511827|NCT00826189|||Cohort||Prospective|||||||
1511828|NCT00826176|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511829|NCT00826163|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511830|NCT00826150||Single Group Assignment||Treatment||None (Open Label)||||||
1511831|NCT00826137|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511832|NCT00826124|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511833|NCT00826111|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511834|NCT00826098|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511835|NCT00826085||Single Group Assignment||Treatment||None (Open Label)||||||
1511836|NCT00826072|||Case Control||Prospective|||||||
1511837|NCT00826059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511838|NCT00826046||||||||||||
1511839|NCT00826033|||||Prospective|||||||
1511840|NCT00826020||Single Group Assignment||Treatment||None (Open Label)||||||
1511841|NCT00826007|||||Retrospective|||||||
1511842|NCT00825994||Single Group Assignment||Treatment||None (Open Label)||||||
1511843|NCT00825981|||Cohort||Prospective|||||||
1511844|NCT00825968|||Cohort||Prospective|||||||
1511845|NCT00825955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511846|NCT00825942||Single Group Assignment||Treatment||None (Open Label)||||||
1511847|NCT00825929|||Case-Crossover||Prospective|||||||
1511848|NCT00825916|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1511849|NCT00825903|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1511850|NCT00825890|||Cohort||Prospective|||||||
1511851|NCT00825877|||||Other|||||||
1511852|NCT00825864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511853|NCT00825851|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1511854|NCT00825838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511855|NCT00825825|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1511856|NCT00825812|Randomized|Parallel Assignment||Treatment||Single||||||t
1511857|NCT00825799|||Case Control||Cross-Sectional|||||||
1511858|NCT00825786|Randomized|Parallel Assignment||Treatment||Single||||||t
1511859|NCT00825773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511860|NCT00825760|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1511861|NCT00825747|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511862|NCT00825734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511863|NCT00825721|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511864|NCT00825708|Randomized|Crossover Assignment||||Double|||t|||t
1511865|NCT00825695|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1511866|NCT00825682|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511867|NCT00825669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511868|NCT00825656|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1511869|NCT00825643|||Case-Only||Prospective|||||||
1511870|NCT00825630|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1511871|NCT00825617|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511872|NCT00825604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511873|NCT00825591|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1511874|NCT00825578|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511875|NCT00825565||Single Group Assignment||Treatment||None (Open Label)||||||
1511876|NCT00825552||Single Group Assignment||Treatment||Single|||t|||
1511877|NCT00825539|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1511878|NCT00825526|Randomized|Crossover Assignment||Treatment||Single|||||t|
1511879|NCT00825513|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511880|NCT00825500|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511881|NCT00825487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511882|NCT00825474||Single Group Assignment||Treatment||None (Open Label)||||||
1511883|NCT00825461|||Case-Control||Prospective|||||||
1511884|NCT00825448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511885|NCT00825435|Randomized|Single Group Assignment||||None (Open Label)||||||
1511886|NCT00825422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511887|NCT00825396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511888|NCT00825383|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511889|NCT00825370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511890|NCT00825357|||Case Control||Prospective|||||||
1511891|NCT00825344|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1511892|NCT00825331|||Ecologic or Community||Prospective|||||||
1511893|NCT00825318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511894|NCT00825305|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511895|NCT00825292|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1511896|NCT00825279|Randomized|Parallel Assignment||Treatment||Single|||||t|
1511897|NCT00825266|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1511898|NCT00825253|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511899|NCT00825240|||Case-Crossover||Prospective|||||||
1511900|NCT00825227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511901|NCT00825214|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1511902|NCT00825201||Single Group Assignment||Treatment||None (Open Label)||||||
1511903|NCT00825188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511904|NCT00825175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511905|NCT00825162|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1511906|NCT00825149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511907|NCT00825136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511908|NCT00825123|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1511909|NCT00825110|||Cohort||Prospective|||||||
1511910|NCT00825097|Randomized|Parallel Assignment||Treatment||Single||||||t
1511911|NCT00825084|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511912|NCT00825071|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1511913|NCT00825058|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511914|NCT00825045||Single Group Assignment||Treatment||None (Open Label)||||||
1511915|NCT00825032|Randomized|Parallel Assignment||Treatment||Single||||||t
1511916|NCT00825019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511917|NCT00825006||Crossover Assignment||Treatment||None (Open Label)||||||
1511918|NCT00824993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511919|NCT00824980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511920|NCT00824967|Randomized|Parallel Assignment||||None (Open Label)||||||
1511921|NCT00824954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511922|NCT00824941|||Case-Control||Prospective|||||||
1511923|NCT00824928|||Case-Only||Prospective|||||||
1511924|NCT00824915|||Cohort||Prospective|||||||
1511925|NCT00824902||Single Group Assignment||Treatment||None (Open Label)||||||
1511926|NCT00824889|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1511927|NCT00824876|||||Prospective|||||||
1511928|NCT00824863||Single Group Assignment||Treatment||None (Open Label)||||||
1511929|NCT00824850|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1511930|NCT00824837|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1511931|NCT00824824|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1511932|NCT00824811|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511933|NCT00824798|||Cohort||Retrospective|||||||
1511934|NCT00824785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511935|NCT00824772|||Case-Only||Prospective|||||||
1511936|NCT00824759|Randomized|Parallel Assignment||Treatment||Single|||t|||
1511937|NCT00824746||Single Group Assignment||Treatment||None (Open Label)||||||
1511938|NCT00824733||Single Group Assignment||Treatment||None (Open Label)||||||
1511939|NCT00824720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511940|NCT00824707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511941|NCT00824694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511942|NCT00824681|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1511943|NCT00824668|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511944|NCT00824655|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511945|NCT00824642|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1511946|NCT00824629|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511947|NCT00824616|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511948|NCT00824603|||Cohort||Cross-Sectional|||||||
1511949|NCT00824590|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511950|NCT00824577|||Cohort||Cross-Sectional|||||||
1511951|NCT00824564|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1511952|NCT00824551|Randomized|Parallel Assignment||Treatment||Single||||||t
1511953|NCT00824538||Single Group Assignment||Treatment||None (Open Label)||||||
1511954|NCT00824512|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1511955|NCT00824499||Parallel Assignment||Health Services Research||None (Open Label)||||||
1511956|NCT00824486|Randomized|Single Group Assignment||||||||||
1511957|NCT00824473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511958|NCT00824460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511959|NCT00824447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511960|NCT00824434||Single Group Assignment||Treatment||None (Open Label)||||||
1511961|NCT00824421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511962|NCT00824408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511963|NCT00824395|||Case Control||Cross-Sectional|||||||
1511964|NCT00824382|Randomized|Parallel Assignment||Treatment||Double||||||
1511965|NCT00824369|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1511966|NCT00824356|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1511967|NCT00824343||Single Group Assignment||Treatment||None (Open Label)||||||
1511968|NCT00824330||Single Group Assignment||Other||None (Open Label)||||||
1511969|NCT00824317||Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1511970|NCT00824304|||Case Control||Cross-Sectional|||||||
1511971|NCT00824291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511972|NCT00824278|||||Prospective|||||||
1511973|NCT00824265|Randomized|||Treatment||None (Open Label)||||||
1511974|NCT00824252|||Cohort||Prospective|||||||
1511975|NCT00824239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1511976|NCT00824226||Single Group Assignment||Treatment||None (Open Label)||||||
1511977|NCT00824213|||Case-Only||Prospective|||||||
1511978|NCT00824200|Randomized|Single Group Assignment||Treatment||Single||||||t
1511979|NCT00824187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511980|NCT00824174|||Cohort||Retrospective|||||||
1511981|NCT00824161|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1511982|NCT00824148|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1511983|NCT00824135||Single Group Assignment||Treatment||None (Open Label)||||||
1511984|NCT00824122|||Case Control||Prospective|||||||
1511985|NCT00824109||Single Group Assignment||Treatment||None (Open Label)||||||
1511986|NCT00824096|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1511987|NCT00824083|||Cohort||Prospective|||||||
1511988|NCT00824070|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1511989|NCT00824057|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1511990|NCT00824044|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1511991|NCT00824031|||||Cross-Sectional|||||||
1511992|NCT00824018||||||||||||
1511993|NCT00824005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511994|NCT00823992|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511995|NCT00823979|Randomized|Parallel Assignment||Treatment||Double||||||
1511996|NCT00823966|||Case-Only||Prospective|||||||
1511997|NCT00823953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1511998|NCT00823940|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1511999|NCT00823927|||Case Control||Prospective|||||||
1512000|NCT00823914|||Cohort||Prospective|||||||
1512001|NCT00823901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512002|NCT00823888||Crossover Assignment||Treatment||None (Open Label)||||||
1512003|NCT00823875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512004|NCT00823862|Randomized|Single Group Assignment||Treatment||Single|||||t|
1512005|NCT00823849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512006|NCT00823836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512007|NCT00823823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512008|NCT00823810||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512009|NCT00823797||Single Group Assignment||Treatment||None (Open Label)||||||
1512010|NCT00823784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512011|NCT00823771|||Case-Control||Prospective|||||||
1512012|NCT00823758|||Case-Only||Prospective|||||||
1512013|NCT00823745|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1512014|NCT00823732|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512015|NCT00823719||Single Group Assignment||Treatment||None (Open Label)||||||
1512016|NCT00823706|||Cohort||Prospective|||||||
1512017|NCT00823693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512018|NCT00823680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512019|NCT00823667|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512020|NCT00823654|||Cohort||Prospective|||||||
1512021|NCT00823641||Single Group Assignment||Treatment||None (Open Label)||||||
1512022|NCT00823628|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512023|NCT00823615|Randomized|Crossover Assignment||Treatment||Single|||t|||
1512024|NCT00823602|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512025|NCT00823589|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1512026|NCT00823576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512027|NCT00823563|||Case-Only||Prospective|||||||
1512028|NCT00823550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512029|NCT00823537|Randomized|Parallel Assignment||Treatment||Single||||||t
1512030|NCT00823524||Single Group Assignment||Treatment||None (Open Label)||||||
1512031|NCT00823511|||Cohort||Prospective|||||||
1512032|NCT00823498|||Cohort||Prospective|||||||
1512033|NCT00823485|Randomized|Factorial Assignment||Treatment||Single|||t|||
1512034|NCT00823472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512035|NCT00823459||Single Group Assignment||Treatment||None (Open Label)||||||
1512036|NCT00823446|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512037|NCT00823433||Single Group Assignment||Prevention||None (Open Label)||||||
1512038|NCT00823420|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1512039|NCT00823407|Randomized|Single Group Assignment||Basic Science||Double|||t|t||
1512040|NCT00823394|||Case-Control||Prospective|||||||
1512041|NCT00823381|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1512042|NCT00823368|||Cohort||Prospective|||||||
1512043|NCT00823355||Single Group Assignment||Treatment||None (Open Label)||||||
1512044|NCT00823342|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512045|NCT00823329||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512046|NCT00823316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512047|NCT00823303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512048|NCT00823290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512049|NCT00823277|||Case-Only||Prospective|||||||
1512050|NCT00823264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512051|NCT00823251||Single Group Assignment||Treatment||None (Open Label)||||||
1512052|NCT00823238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512053|NCT00823225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512054|NCT00823212|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512055|NCT00823199||Single Group Assignment||Treatment||None (Open Label)||||||
1512056|NCT00823186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512057|NCT00823173||Single Group Assignment||Treatment||None (Open Label)||||||
1512058|NCT00823160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512059|NCT00823147|||Case Control||Prospective|||||||
1512060|NCT00823134|||Cohort||Cross-Sectional|||||||
1512061|NCT00823121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512062|NCT00823108|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512063|NCT00823095||Single Group Assignment||Treatment||None (Open Label)||||||
1512064|NCT00823082|Randomized|Parallel Assignment||Prevention||Single|||t|||
1512065|NCT00823069|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512066|NCT00823056|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512067|NCT00823043|||Cohort||Prospective|||||||
1512068|NCT00823030|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1512069|NCT00823017|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1512070|NCT00823004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512071|NCT00822991|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1512072|NCT00822978|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1512073|NCT00822965|||Case-Only||Retrospective|||||||
1512074|NCT00822952|||Case-Only||Prospective|||||||
1512075|NCT00822926|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512076|NCT00822913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512077|NCT00822900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512078|NCT00822887||Single Group Assignment||Treatment||None (Open Label)||||||
1512079|NCT00822874|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1512080|NCT00822861|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512081|NCT00822848||Single Group Assignment||Treatment||None (Open Label)||||||
1512082|NCT00822835|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1512083|NCT00822822|||||Prospective|||||||
1512084|NCT00822809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512085|NCT00822796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512086|NCT00822783||||||||||||
1512087|NCT00822770|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512088|NCT00822757|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512089|NCT00822744|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512090|NCT00822731||Single Group Assignment||||None (Open Label)||||||
1512091|NCT00822718|||||Prospective|||||||
1512092|NCT00822705|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1512093|NCT00822692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512094|NCT00822679|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1512095|NCT00822666|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512096|NCT00822653||Single Group Assignment||Prevention||None (Open Label)||||||
1512097|NCT00822640|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1512098|NCT00822627|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1512099|NCT00822614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512100|NCT00822601|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1512101|NCT00822588|Randomized|Parallel Assignment||Treatment||Single||||||t
1512102|NCT00822575|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512103|NCT00822562|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512104|NCT00822549|||||Cross-Sectional|||||||
1512105|NCT00822536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512106|NCT00822523|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1512107|NCT00822510|Randomized|Single Group Assignment||Treatment||Single||||||t
1512108|NCT00822497|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1512109|NCT00822484|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1512110|NCT00822471|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1512111|NCT00822458||Single Group Assignment||Treatment||None (Open Label)||||||
1512112|NCT00822445|||Cohort||Cross-Sectional|||||||
1512113|NCT00822432|||||Cross-Sectional|||||||
1512114|NCT00822419|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512115|NCT00822406|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512116|NCT00822393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512117|NCT00822380|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512118|NCT00822367||Single Group Assignment||||None (Open Label)||||||
1512119|NCT00822354|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512120|NCT00822341|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1512121|NCT00822328|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1512122|NCT00822315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512123|NCT00822302|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1512124|NCT00822289|||Cohort||Prospective|||||||
1512125|NCT00822276|||Case Control||Prospective|||||||
1512126|NCT00822263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512127|NCT00822250||Single Group Assignment||Basic Science||None (Open Label)||||||
1512128|NCT00822237|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1512129|NCT00822224||Single Group Assignment||Treatment||None (Open Label)||||||
1512130|NCT00822211|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512131|NCT00822198|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512132|NCT00822185|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512133|NCT00822172|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1512134|NCT00822159|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1512135|NCT00822146||Single Group Assignment||Other||None (Open Label)||||||
1512136|NCT00822133|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512137|NCT00822120|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512138|NCT00822107||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512139|NCT00822094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512140|NCT00822081|Randomized|Parallel Assignment||Treatment||Single||||||
1512141|NCT00822068|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1512142|NCT00822055|Randomized|Parallel Assignment||Treatment||Single|||||t|
1512143|NCT00822042|||Cohort||Prospective|||||||
1512144|NCT00822029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512145|NCT00822016|||||Prospective|||||||
1512146|NCT00822003|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1512147|NCT00821990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512148|NCT00821977|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512149|NCT00821964||Single Group Assignment||Treatment||None (Open Label)||||||
1512150|NCT00821951||Single Group Assignment||Treatment||None (Open Label)||||||
1512151|NCT00821938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512152|NCT00821925||Single Group Assignment||Screening||None (Open Label)||||||
1512153|NCT00821912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512154|NCT00821899||Single Group Assignment||Treatment||None (Open Label)||||||
1512155|NCT00821886||Single Group Assignment||Treatment||None (Open Label)||||||
1512156|NCT00821873||Single Group Assignment||Treatment||None (Open Label)||||||
1512157|NCT00821860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512158|NCT00821847|||Cohort||Cross-Sectional|||||||
1512159|NCT00821834|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1512160|NCT00821821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512161|NCT00821808|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512162|NCT00821795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512163|NCT00821782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512164|NCT00821769||||||||||||
1512165|NCT00821756|Randomized|Parallel Assignment||Prevention||Single||||||t
1512166|NCT00821743|Non-Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512167|NCT00821730||||||||||||
1512168|NCT00821717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512169|NCT00821691|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512170|NCT00821678|Randomized|Parallel Assignment||Treatment||Single||||||t
1512171|NCT00821665|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1512172|NCT00821652|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1512173|NCT00821639|Randomized|Factorial Assignment||Prevention||Single||||||t
1512174|NCT00821626|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1512175|NCT00821613|||Case-Only|||||||||
1512176|NCT00821600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512177|NCT00821587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512178|NCT00821574|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1512179|NCT00821561|Randomized|Parallel Assignment||Treatment||Double||||||
1512180|NCT00821548||Single Group Assignment||Treatment||None (Open Label)||||||
1512181|NCT00821535||Single Group Assignment||||None (Open Label)||||||
1512182|NCT00821522|Randomized|Parallel Assignment||Prevention||Single||||||t
1512183|NCT00821509|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1512184|NCT00821496|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512185|NCT00821483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512186|NCT00821470|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512187|NCT00821457|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1512188|NCT00821444|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1512189|NCT00821431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512190|NCT00821418|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512191|NCT00821405|||Cohort||Cross-Sectional|||||||
1512192|NCT00821392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512193|NCT00821379|||Cohort||Prospective|||||||
1512194|NCT00821366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512195|NCT00821353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512196|NCT00821340||Single Group Assignment||Treatment||None (Open Label)||||||
1512197|NCT00821327||Single Group Assignment||Treatment||None (Open Label)||||||
1512198|NCT00821314|||Cohort||Prospective|||||||
1512199|NCT00821301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512200|NCT00821288|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1512201|NCT00821275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512202|NCT00821262|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1512203|NCT00821249|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512204|NCT00821236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512205|NCT00821223|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512206|NCT00821210|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512207|NCT00821197|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1512208|NCT00821184|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512209|NCT00821158|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1512210|NCT00821145|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512211|NCT00821132|||Family-Based||Other|||||||
1512212|NCT00821119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512213|NCT00821106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512214|NCT00821093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512215|NCT00821080|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512216|NCT00821067|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512217|NCT00019539||||Treatment||||||||
1512218|NCT00821054|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1512219|NCT00821041|Randomized|Parallel Assignment||Treatment||Single|||||t|
1512220|NCT00821028||Single Group Assignment||Treatment||None (Open Label)||||||
1512221|NCT00821015||Single Group Assignment||Treatment||None (Open Label)||||||
1512222|NCT00821002|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512223|NCT00820989|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1512224|NCT00820976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512225|NCT00820963|Randomized|||Treatment||||||||
1512226|NCT00820950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512227|NCT00820937||Single Group Assignment||Diagnostic||||||||
1512228|NCT00820924||Single Group Assignment||Treatment||None (Open Label)||||||
1512229|NCT00820911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512230|NCT00820898||Single Group Assignment||Treatment||None (Open Label)||||||
1512231|NCT00820885|Randomized|Single Group Assignment||||Triple|||t||t|t
1512232|NCT00820872||Single Group Assignment||Treatment||None (Open Label)||||||
1512233|NCT00820859|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512234|NCT00820846|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1512235|NCT00820833|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1512236|NCT00820820|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1512237|NCT00820807|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1512238|NCT00820794|Randomized|Crossover Assignment||||None (Open Label)||||||
1512239|NCT00820781|Randomized|Parallel Assignment||Treatment||Single|||||t|
1512240|NCT00820768||Single Group Assignment||Treatment||None (Open Label)||||||
1512241|NCT00820755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512242|NCT00820742|||||Prospective|||||||
1512243|NCT00820729|||Cohort||Cross-Sectional|||||||
1512244|NCT00820716|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512245|NCT00820703|Randomized|Parallel Assignment||Treatment||Double||||||
1512246|NCT00820690|||Cohort||Prospective|||||||
1512247|NCT00820677|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1512248|NCT00820664|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1512249|NCT00820651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512250|NCT00820638||Single Group Assignment||Supportive Care||None (Open Label)||||||
1512251|NCT00820625|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512252|NCT00820612|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1512253|NCT00820599||Single Group Assignment||Treatment||None (Open Label)||||||
1512254|NCT00820586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512255|NCT00820573|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512256|NCT00820560|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512257|NCT00820547||Single Group Assignment||Treatment||None (Open Label)||||||
1512258|NCT00820534|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512259|NCT00820521|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1512260|NCT00820508||Single Group Assignment||Treatment||None (Open Label)||||||
1512261|NCT00820495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512262|NCT00820482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512263|NCT00820469|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1512264|NCT00820456|||Case-Only||Prospective|||||||
1512265|NCT00820443||Single Group Assignment||Treatment||None (Open Label)||||||
1512266|NCT00820430|||Case Control||Prospective|||||||
1512267|NCT00820417|Non-Randomized|||||None (Open Label)||||||
1512268|NCT00820404|Randomized|Single Group Assignment||Treatment||Double||||||
1512269|NCT00820391|Randomized|||Treatment||Single||||||t
1512270|NCT00820378|||Case-Crossover||Cross-Sectional|||||||
1512271|NCT00820365||Single Group Assignment||Treatment||None (Open Label)||||||
1512272|NCT00820352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512273|NCT00820339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512274|NCT00820326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512275|NCT00820313|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1512276|NCT00820300|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512277|NCT00820287||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512278|NCT00820274||Single Group Assignment||Treatment||None (Open Label)||||||
1512279|NCT00820261|||Cohort||Prospective|||||||
1512280|NCT00820248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512281|NCT00820235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512282|NCT00820222|Randomized|||Treatment||None (Open Label)||||||
1512283|NCT00820196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512284|NCT00820183|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1512285|NCT00820170||Single Group Assignment||Treatment||None (Open Label)||||||
1512286|NCT00820157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512287|NCT00820144|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1512288|NCT00820131|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1512289|NCT00820118||Single Group Assignment||Treatment||None (Open Label)||||||
1512290|NCT00820105|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512291|NCT00820092|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512292|NCT00820079|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512293|NCT00820053|Randomized|Parallel Assignment||Prevention||Single||||||t
1512294|NCT00820040||||||||||||
1512295|NCT00820027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512296|NCT00820014|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1512297|NCT00820001|Randomized|Parallel Assignment||Treatment||Single||||||t
1512298|NCT00819988|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1512299|NCT00819975|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1512300|NCT00819962|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1512301|NCT00819949||Single Group Assignment||Basic Science||Single||||||t
1512302|NCT00819936|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1512303|NCT00819923|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512304|NCT00819910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512305|NCT00819897|||||Prospective|||||||
1512306|NCT00819884|Randomized|Crossover Assignment||Treatment||Single|||t|||
1512307|NCT00819871|||Case Control||Prospective|||||||
1512308|NCT00819858|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512309|NCT00819845|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512310|NCT00819832|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512311|NCT00819819|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1512312|NCT00819806|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1512313|NCT00819793||Single Group Assignment||Treatment||None (Open Label)||||||
1512314|NCT00819780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512315|NCT00819767|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512316|NCT00819754||Single Group Assignment||Treatment||None (Open Label)||||||
1512317|NCT00819741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512318|NCT00819728||Single Group Assignment||Treatment||None (Open Label)||||||
1512319|NCT00819715|||Cohort||Prospective|||||||
1512320|NCT00819702|Randomized|Parallel Assignment||Prevention||Single|||t|||
1512321|NCT00819676|||Case Control||Cross-Sectional|||||||
1512322|NCT00819663|||Cohort||Retrospective|||||||
1512323|NCT00819650|Randomized|Parallel Assignment||Treatment||Single||||||t
1512324|NCT00819637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512325|NCT00819624|Randomized|Crossover Assignment||||None (Open Label)||||||
1512326|NCT00819611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512327|NCT00819598|||Case-Only||Prospective|||||||
1512328|NCT00819585|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512329|NCT00819572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512330|NCT00819559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512331|NCT00819546||Single Group Assignment||Treatment||None (Open Label)||||||
1512332|NCT00819533|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1512333|NCT00819520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512334|NCT00819507||Single Group Assignment||Treatment||None (Open Label)||||||
1512335|NCT00819494||Parallel Assignment||Diagnostic||None (Open Label)||||||
1512336|NCT00819481|||Cohort||Prospective|||||||
1512337|NCT00819468|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1512338|NCT00819455|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512339|NCT00819442||Parallel Assignment||Diagnostic||None (Open Label)||||||
1512340|NCT00819429|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1512341|NCT00819416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512342|NCT00819403|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1512343|NCT00819390|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1512344|NCT00819377|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512345|NCT00819364|Randomized|Parallel Assignment||Treatment||Single||||||t
1512346|NCT00819351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512347|NCT00819338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512348|NCT00819325|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512349|NCT00819312|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1512350|NCT00819299||Single Group Assignment||Treatment||None (Open Label)||||||
1512351|NCT00819286|Randomized|Parallel Assignment||Treatment||Single|Participant blinded to treatment assignment until completion of study.||t|||
1512352|NCT00819273|||Cohort||Retrospective|||||||
1512353|NCT00819260|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512354|NCT00819247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512355|NCT00819234|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512356|NCT00819221||Single Group Assignment||Treatment||None (Open Label)||||||
1512357|NCT00819208|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1512358|NCT00819195|||Cohort||Prospective|||||||
1512359|NCT00819182|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1512360|NCT00819169|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512361|NCT00819156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512362|NCT00819143|||||Prospective|||||||
1512363|NCT00819130||||||||||||
1512364|NCT00819117|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512365|NCT00819104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512366|NCT00819091|Randomized|Parallel Assignment||Treatment||Double||||||
1512367|NCT00819078|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1512368|NCT00819065|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1512369|NCT00819052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512370|NCT00819039|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512371|NCT00819026|||||Cross-Sectional|||||||
1512372|NCT00819013|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1512373|NCT00819000|||Cohort||Prospective|||||||
1512374|NCT00818987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512375|NCT00818961||Single Group Assignment||Treatment||None (Open Label)||||||
1512376|NCT00818948|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1512377|NCT00818935|Randomized|Parallel Assignment||Treatment||Single|||||t|
1512378|NCT00818922||||||||||||
1512379|NCT00818909||Single Group Assignment||Treatment||None (Open Label)||||||
1512380|NCT00818896|||Case-Only||Prospective|||||||
1512381|NCT00818883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512382|NCT00818870|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512383|NCT00818857|Randomized|Crossover Assignment||Prevention||Single||||||t
1512384|NCT00818844|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512385|NCT00818831||Single Group Assignment||||None (Open Label)||||||
1512386|NCT00818818||Single Group Assignment||Treatment||None (Open Label)||||||
1512387|NCT00818805|Randomized|Crossover Assignment||Treatment||Single|||t|||
1512388|NCT00818792|Randomized|Parallel Assignment||Treatment||Single||||||t
1512389|NCT00818779|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1512390|NCT00818766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512391|NCT00818753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512392|NCT00818740|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1512393|NCT00818727|||Case Control||Prospective|||||||
1512394|NCT00818714|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512395|NCT00818701|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1512396|NCT00818688|||Cohort||Cross-Sectional|||||||
1512397|NCT00818675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512398|NCT00818662|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512399|NCT00818649||Single Group Assignment||Treatment||None (Open Label)||||||
1512400|NCT00818636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512401|NCT00818623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512402|NCT00818610|Randomized|Parallel Assignment||Treatment||Single||||||t
1512403|NCT00818597||Single Group Assignment||Treatment||None (Open Label)||||||
1512404|NCT00818584|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1512405|NCT00818571|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512406|NCT00818558|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512407|NCT00818545|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1512408|NCT00818532|||||Prospective|||||||
1512409|NCT00818519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512410|NCT00818506|||Case Control||Cross-Sectional|||||||
1512411|NCT00818493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512412|NCT00818480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512413|NCT00818467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512415|NCT00818441|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512416|NCT00818428|Randomized|Factorial Assignment||Prevention||Single||||||t
1512417|NCT00818415|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512418|NCT00818402|||Case-Only||Prospective|||||||
1512419|NCT00818389|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1512420|NCT00818376|Randomized|Crossover Assignment||Prevention||Single|||||t|
1512421|NCT00818363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512422|NCT00818350|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1512423|NCT00818337||Single Group Assignment||Prevention||None (Open Label)||||||
1512424|NCT00818324||Single Group Assignment||Treatment||None (Open Label)||||||
1512425|NCT00818311|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1512426|NCT00818298|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512427|NCT00818285|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512428|NCT00818272|||Cohort||Prospective|||||||
1512429|NCT00818259|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512430|NCT00818246||Single Group Assignment||Treatment||Single||||||t
1512431|NCT00818233|||Case-Only||Prospective|||||||
1512432|NCT00818220|Randomized|Parallel Assignment||Prevention||Single||||||t
1512433|NCT00818207|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1512434|NCT00818194|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1512435|NCT00818181||Single Group Assignment||Treatment||None (Open Label)||||||
1512436|NCT00818168|||Cohort||Prospective|||||||
1512437|NCT00818155|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1512438|NCT00818142|||Cohort||Prospective|||||||
1512439|NCT00818129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512440|NCT00818116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512441|NCT00818103|Randomized|Crossover Assignment||||None (Open Label)||||||
1512442|NCT00818090|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512443|NCT00818077|||Cohort||Prospective|||||||
1512444|NCT00818064|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1512445|NCT00818051|Randomized|||Treatment||||||||
1512446|NCT00818038|||Cohort||Prospective|||||||
1512447|NCT00818025|Randomized|Parallel Assignment||Prevention||Single||||||t
1512448|NCT00818012|||Cohort||Prospective|||||||
1512449|NCT00817999|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1512450|NCT00817986|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512451|NCT00817973|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1512452|NCT00817960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512453|NCT00817947|Randomized|Crossover Assignment||Treatment||Single||||||t
1512454|NCT00817934|||Case-Only||Prospective|||||||
1512455|NCT00817921|||Cohort||Prospective|||||||
1512456|NCT00817908|||Cohort||Prospective|||||||
1512457|NCT00817895|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512458|NCT00817882|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1512459|NCT00817869|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512460|NCT00817843|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1512461|NCT00817830|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1512462|NCT00817817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512463|NCT00817804|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512464|NCT00817791|Randomized|Parallel Assignment||Prevention||Single||||t||
1512465|NCT00817778|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512466|NCT00817765|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512467|NCT00817752|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1512468|NCT00817739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512469|NCT00817726|||Case-Control||Prospective|||||||
1512470|NCT00817713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512471|NCT00817700|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1512472|NCT00817687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512473|NCT00817674|||Case Control||Prospective|||||||
1512474|NCT00817661|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1512475|NCT00817648|Randomized|Parallel Assignment||Treatment||Single||||||t
1512476|NCT00817635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512477|NCT00817622|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1512478|NCT00817609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512479|NCT00817596||Single Group Assignment||Treatment||None (Open Label)||||||
1512480|NCT00817583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512481|NCT00817570|||Cohort||Prospective|||||||
1512482|NCT00817557|Randomized|Crossover Assignment||Treatment||Single|||||t|
1512483|NCT00817544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512484|NCT00817531||Single Group Assignment||Treatment||None (Open Label)||||||
1512485|NCT00817518|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512486|NCT00817505|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512487|NCT00817492|||Case Control||Prospective|||||||
1512488|NCT00817479|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1512489|NCT00817466|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512490|NCT00817453|||Cohort||Cross-Sectional|||||||
1512491|NCT00817440|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1512492|NCT00817427|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1512493|NCT00817414|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512494|NCT00817401|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1512495|NCT00817388||||||||||||
1512496|NCT00817375|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512497|NCT00817362||Single Group Assignment||Treatment||None (Open Label)||||||
1512498|NCT00817349|||Case-Only||Prospective|||||||
1512499|NCT00817336|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1512500|NCT00817323|Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1512501|NCT00817310|||Case Control||Prospective|||||||
1512502|NCT00817297|Randomized|Crossover Assignment||Treatment||Single|Subject was blinded to device identity||t|||
1512503|NCT00817284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512504|NCT00817271|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512505|NCT00817258||Single Group Assignment||Treatment||None (Open Label)||||||
1512506|NCT00817245|Randomized|Parallel Assignment||Treatment||Single|||||t|
1512507|NCT00817232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512508|NCT00817219|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512509|NCT00817206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512510|NCT00817193|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512511|NCT00817180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512512|NCT00817167|Randomized|Parallel Assignment||||None (Open Label)||||||
1512513|NCT00817154||Single Group Assignment||Health Services Research||None (Open Label)||||||
1512514|NCT00817141|||Cohort||Prospective|||||||
1512515|NCT00817128|Randomized|Parallel Assignment||Treatment||Single||||||t
1512516|NCT00817115|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1512517|NCT00817102||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512518|NCT00817089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512519|NCT00817076||Single Group Assignment||Treatment||None (Open Label)||||||
1512520|NCT00817063|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512521|NCT00817050|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1512522|NCT00817037|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1512523|NCT00817024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512524|NCT00817011|Non-Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512525|NCT00816998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512526|NCT00816985||Single Group Assignment||Supportive Care||None (Open Label)||||||
1512527|NCT00816972|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512528|NCT00816959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512529|NCT00816946|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1512530|NCT00816933|Randomized|Parallel Assignment||Treatment||Single|||||t|
1512531|NCT00816920|||Cohort||Prospective|||||||
1512532|NCT00816907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512533|NCT00816894|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512534|NCT00816881|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1512535|NCT00816868||Single Group Assignment||Treatment||None (Open Label)||||||
1512536|NCT00816855||Single Group Assignment||Treatment||None (Open Label)||||||
1512537|NCT00816842||||||||||||
1512538|NCT00816829|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512539|NCT00816816||Single Group Assignment||Treatment||None (Open Label)||||||
1512540|NCT00816803||Parallel Assignment||Treatment||Single||||||t
1512541|NCT00816790|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1512542|NCT00816777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512543|NCT00816764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512544|NCT00816751|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512545|NCT00816738|||Cohort||Retrospective|||||||
1512546|NCT00816725|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1512547|NCT00816712|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512548|NCT00816699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512549|NCT00816686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512550|NCT00816673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512551|NCT00816660|Randomized|Crossover Assignment||Other||Single|||t|||
1512552|NCT00816647|Randomized|Parallel Assignment||Treatment||Single||||||t
1512553|NCT00816634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512554|NCT00816621|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1512555|NCT00816608|||Case-Only||Prospective|||||||
1512556|NCT00816595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512557|NCT00816582||Single Group Assignment||Other||None (Open Label)||||||
1512558|NCT00816569||Single Group Assignment||Treatment||None (Open Label)||||||
1512559|NCT00816556|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512560|NCT00816543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512561|NCT00816530|||||Prospective|||||||
1512562|NCT00816517||Single Group Assignment||Treatment||None (Open Label)||||||
1512563|NCT00816504||Single Group Assignment||Treatment||None (Open Label)||||||
1512564|NCT00816491|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1512565|NCT00816478||Single Group Assignment||Treatment||None (Open Label)||||||
1512566|NCT00816465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512567|NCT00816452|||Cohort||Prospective|||||||
1512568|NCT00816439|||||Prospective|||||||
1512569|NCT00816426|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1512570|NCT00816413|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512571|NCT00816400||Single Group Assignment||Treatment||None (Open Label)||||||
1512572|NCT00816387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512573|NCT00816374|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512574|NCT00816361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512575|NCT00816348||Single Group Assignment||Treatment||None (Open Label)||||||
1512576|NCT00816335||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512577|NCT00816322|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1512578|NCT00816309|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512579|NCT00816296|||Case Control||Prospective|||||||
1512580|NCT00816283||Single Group Assignment||Treatment||None (Open Label)||||||
1512581|NCT00816270|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1512582|NCT00816257|||||Prospective|||||||
1512583|NCT00816244|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512584|NCT00816231|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512585|NCT00816218|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1512586|NCT00816205||Single Group Assignment||||||||||
1512587|NCT00816192|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512588|NCT00816179||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512589|NCT00816166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512590|NCT00816153|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1512591|NCT00816140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512592|NCT00816127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512593|NCT00816114|||Case-Control||Retrospective|||||||
1512594|NCT00816101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512595|NCT00816088|||Cohort||Prospective|||||||
1512596|NCT00816075|Randomized|Single Group Assignment||Prevention||Single||||t||
1512597|NCT00816062||Single Group Assignment||Treatment||None (Open Label)||||||
1512598|NCT00816049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512599|NCT00816036|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1512600|NCT00816023|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1512601|NCT00816010|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512602|NCT00815997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512603|NCT00815984|||Cohort||Retrospective|||||||
1512604|NCT00815971|||Case-Only||Prospective|||||||
1512605|NCT00815958|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1512606|NCT00815945||Single Group Assignment||Treatment||None (Open Label)||||||
1512607|NCT00815932|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512608|NCT00815919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512609|NCT00815906|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512610|NCT00815893|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1512611|NCT00815880||Single Group Assignment||Treatment||None (Open Label)||||||
1512612|NCT00815867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512613|NCT00815854|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1512614|NCT00815841|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1512615|NCT00815828|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512616|NCT00815815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512617|NCT00815802|||Cohort||Prospective|||||||
1512618|NCT00815789|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1512619|NCT00815776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512620|NCT00815763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512621|NCT00815750|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1512622|NCT00815737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512623|NCT00815724|Randomized|Parallel Assignment||||Single|||t|||
1512624|NCT00815711|||Cohort||Prospective|||||||
1512625|NCT00815698|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1512626|NCT00815685||Single Group Assignment||Treatment||None (Open Label)||||||
1512627|NCT00815672|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1512628|NCT00815659||Single Group Assignment||Treatment||None (Open Label)||||||
1512629|NCT00815646||Single Group Assignment||Prevention||None (Open Label)||||||
1512630|NCT00815633||Single Group Assignment||Treatment||None (Open Label)||||||
1512631|NCT00815620|||Cohort||Prospective|||||||
1512632|NCT00815607||Single Group Assignment||Treatment||None (Open Label)||||||
1512633|NCT00815594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512634|NCT00815581|Randomized|Parallel Assignment||||Double||||||
1512635|NCT00815568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512636|NCT00815555|||||Retrospective|||||||
1512637|NCT00815542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512638|NCT00815529||||||||||||
1512639|NCT00815516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512640|NCT00815503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512641|NCT00815490||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512642|NCT00815477|Randomized|Parallel Assignment||Prevention||Single||||||t
1512643|NCT00815464||Single Group Assignment||Treatment||None (Open Label)||||||
1512644|NCT00815451|Randomized|Crossover Assignment||Prevention||Single|||t|||
1512645|NCT00815438||Single Group Assignment||Treatment||None (Open Label)||||||
1512646|NCT00815425|||Case Control||Cross-Sectional|||||||
1512647|NCT00815412|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1512648|NCT00815399|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512649|NCT00815386||Single Group Assignment||Treatment||None (Open Label)||||||
1512650|NCT00815373|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1512651|NCT00815360|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512652|NCT00815347|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1512653|NCT00815334||Parallel Assignment||Treatment||None (Open Label)||||||
1512654|NCT00815321||Single Group Assignment||Treatment||None (Open Label)||||||
1512655|NCT00815308||Single Group Assignment||Treatment||None (Open Label)||||||
1512656|NCT00815295||Single Group Assignment||Treatment||None (Open Label)||||||
1512657|NCT00815282||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512658|NCT00815269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512659|NCT00815256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512660|NCT00815243|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512661|NCT00815230|||Case-Only||Prospective|||||||
1512662|NCT00815217|Randomized|Single Group Assignment||Treatment||Single||||||t
1512663|NCT00815204|||Case Control||Prospective|||||||
1512664|NCT00815191|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1512665|NCT00815178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512666|NCT00815165|||Case Control||Prospective|||||||
1512667|NCT00815152|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512668|NCT00815139|||Case-Only||Prospective|||||||
1512669|NCT00815126||Parallel Assignment||Diagnostic||None (Open Label)||||||
1512670|NCT00815113|||Cohort||Prospective|||||||
1512671|NCT00815100|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512672|NCT00815087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512673|NCT00815074|||||Retrospective|||||||
1512674|NCT00815061|||Cohort||Retrospective|||||||
1512675|NCT00815048|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1512676|NCT00815035|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1512677|NCT00815022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512678|NCT00815009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512679|NCT00814996|||Case Control||Prospective|||||||
1512680|NCT00814983|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512681|NCT00814970||Single Group Assignment||Treatment||None (Open Label)||||||
1512682|NCT00814957|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512683|NCT00814944|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512684|NCT00814931|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512685|NCT00814918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512686|NCT00814905|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1512687|NCT00814892||Single Group Assignment||Treatment||None (Open Label)||||||
1512688|NCT00814879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512689|NCT00814866||Single Group Assignment||Basic Science||None (Open Label)||||||
1512690|NCT00814853|||Case Control||Prospective|||||||
1512691|NCT00814840|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512692|NCT00814827|||||Prospective|||||||
1512693|NCT00814814|||Cohort||Other|||||||
1512694|NCT00814801|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1512695|NCT00814788||Single Group Assignment||Treatment||None (Open Label)||||||
1512696|NCT00814775|Randomized|Parallel Assignment||||None (Open Label)||||||
1512697|NCT00814762|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1512698|NCT00814749|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1512699|NCT00814736|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1512700|NCT00814723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512701|NCT00814710|Randomized|Parallel Assignment||Prevention||Single|||t|||
1512702|NCT00814697||Single Group Assignment||Treatment||None (Open Label)||||||
1512703|NCT00814671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512704|NCT00814658|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512705|NCT00814645|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512706|NCT00814632||Single Group Assignment||Treatment||None (Open Label)||||||
1512707|NCT00814619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512708|NCT00814606||Single Group Assignment||Treatment||None (Open Label)||||||
1512709|NCT00814593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512710|NCT00814580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512711|NCT00814567|Randomized|||Treatment||||||||
1512712|NCT00814554|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1512713|NCT00814541|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512714|NCT00814528|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512715|NCT00814515|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512716|NCT00814502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512717|NCT00814489|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1512718|NCT00814476|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512719|NCT00814463||Single Group Assignment||Treatment||None (Open Label)||||||
1512720|NCT00814450|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1512721|NCT00814437||||||||||||
1512722|NCT00814424|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512723|NCT00814411|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512724|NCT00814398|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512725|NCT00814385|Randomized|Single Group Assignment||||Double|||||t|t
1512726|NCT00814372|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512727|NCT00814359|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512728|NCT00814346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512729|NCT00814333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512730|NCT00814320|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512731|NCT00814307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512732|NCT00814294|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512733|NCT00814281|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1512734|NCT00814268|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512735|NCT00814255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512736|NCT00814242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512737|NCT00814229|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1512738|NCT00814216|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1512739|NCT00814203|||Cohort||Prospective|||||||
1512740|NCT00814190|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1512741|NCT00814177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512742|NCT00814164||Single Group Assignment||Treatment||None (Open Label)||||||
1512743|NCT00814151|||Case Control||Prospective|||||||
1512744|NCT00814138|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512745|NCT00814125|Randomized|Parallel Assignment||||Double|||t||t|
1512746|NCT00814112|||Case Control||Prospective|||||||
1512747|NCT00814099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512748|NCT00814086||Single Group Assignment||Treatment||None (Open Label)||||||
1512749|NCT00814073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512750|NCT00814060|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512751|NCT00814047|Randomized|Crossover Assignment||Treatment||Double||||||
1512752|NCT00814034|||Cohort||Prospective|||||||
1512753|NCT00814021||Single Group Assignment||Treatment||None (Open Label)||||||
1512754|NCT00814008|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1512755|NCT00813995|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512756|NCT00813982|Randomized|Single Group Assignment||Treatment||Single|||t|||
1512757|NCT00813969||Single Group Assignment||Treatment||None (Open Label)||||||
1512758|NCT00813956||Single Group Assignment||Treatment||None (Open Label)||||||
1512759|NCT00813943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512760|NCT00813930|Randomized|Parallel Assignment||Supportive Care||||||||
1512761|NCT00813917|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1512762|NCT00813904||Single Group Assignment||Treatment||None (Open Label)||||||
1512763|NCT00813891|Randomized|Parallel Assignment||Treatment||Single||||||t
1512764|NCT00813878|||Case-Only||Prospective|||||||
1512765|NCT00813865||Single Group Assignment||Treatment||None (Open Label)||||||
1512766|NCT00813852|Randomized|Parallel Assignment||Treatment||Single||||||t
1512767|NCT00813839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512768|NCT00813826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512769|NCT00813813||Single Group Assignment||Treatment||None (Open Label)||||||
1512770|NCT00813800||Single Group Assignment||Treatment||None (Open Label)||||||
1512771|NCT00813787|||Cohort||Prospective|||||||
1512772|NCT00813774|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1512773|NCT00813761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512774|NCT00813748|||Other||Other|||||||
1512775|NCT00813735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512776|NCT00813722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512777|NCT00813709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512778|NCT00813696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512779|NCT00813683|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512780|NCT00813670|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512781|NCT00813657|Randomized|||Prevention||||||||
1512782|NCT00813644|||Cohort||Prospective|||||||
1512783|NCT00813631|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1512784|NCT00813618|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512785|NCT00813605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512786|NCT00813592||Single Group Assignment||Treatment||None (Open Label)||||||
1512787|NCT00813579|||Case-Only||Prospective|||||||
1512788|NCT00813566|||Case-Only||Prospective|||||||
1512789|NCT00813553|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1512790|NCT00813540|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1512791|NCT00813527|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512792|NCT00813514||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512793|NCT00813501|||Cohort||Prospective|||||||
1512794|NCT00813488|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1512795|NCT00813475|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1512796|NCT00813449|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512797|NCT00813436|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512798|NCT00813423||Single Group Assignment||Treatment||None (Open Label)||||||
1512799|NCT00813410||Single Group Assignment||Basic Science||None (Open Label)||||||
1512800|NCT00813397|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512801|NCT00813384||Single Group Assignment||Treatment||None (Open Label)||||||
1512802|NCT00813371|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512803|NCT00813358||Single Group Assignment||Treatment||None (Open Label)||||||
1512804|NCT00813345|Randomized|Parallel Assignment||Prevention||Single|||t|||
1512805|NCT00813332|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512806|NCT00813319|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512807|NCT00813306|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1512808|NCT00813293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512809|NCT00813280|||Cohort||Retrospective|||||||
1512810|NCT00813267||Single Group Assignment||Treatment||None (Open Label)||||||
1512811|NCT00813254|||Cohort||Retrospective|||||||
1512812|NCT00813241|Randomized|Crossover Assignment||||None (Open Label)||||||
1512813|NCT00813228|Randomized|Parallel Assignment||Treatment||||||||
1512814|NCT00813215|Randomized|Crossover Assignment||||Single|||t|||
1512815|NCT00813202|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512816|NCT00813189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512817|NCT00813176|Randomized|Parallel Assignment||Treatment||Double||prospective randomized study|t|||t
1512818|NCT00813163||Single Group Assignment||Treatment||None (Open Label)||||||
1512819|NCT00813150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512820|NCT00813137||Single Group Assignment||Treatment||None (Open Label)||||||
1512821|NCT00813124||Single Group Assignment||Treatment||None (Open Label)||||||
1512822|NCT00813111|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1512823|NCT00813098|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512824|NCT00813085|Randomized|Parallel Assignment||Prevention||Single||||||t
1512825|NCT00813072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512826|NCT00813059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512827|NCT00813046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512828|NCT00813033||Single Group Assignment||||None (Open Label)||||||
1512829|NCT00813020|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512830|NCT00813007|||Case-Only||Prospective|||||||
1512831|NCT00812994||||Basic Science||Double|||t|||t
1512832|NCT00812981|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1512833|NCT00812968||Single Group Assignment||Treatment||None (Open Label)||||||
1512834|NCT00812955|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512835|NCT00812942|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512836|NCT00812929|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512837|NCT00812916|||Cohort||Prospective|||||||
1512838|NCT00812903|Randomized|Parallel Assignment||Prevention||Single||||||t
1512839|NCT00812890|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1512840|NCT00812877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512841|NCT00812864|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1512842|NCT00812851|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1512843|NCT00812838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512844|NCT00812825|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1512845|NCT00812812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512846|NCT00812799|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512847|NCT00812786|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1512848|NCT00812773|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512849|NCT00812760|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1512850|NCT00812747|||Cohort||Prospective|||||||
1512851|NCT00812734||||||||||||
1512852|NCT00812721|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1512853|NCT00812708||Single Group Assignment||Treatment||None (Open Label)||||||
1512854|NCT00812695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512855|NCT00812682|||Case-Only||Prospective|||||||
1512856|NCT00812669|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512857|NCT00812656|||Cohort||Prospective|||||||
1512858|NCT00812643||Single Group Assignment||||None (Open Label)||||||
1512859|NCT00812630|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1512860|NCT00812617|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1512861|NCT00812604|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1512862|NCT00812591||Single Group Assignment||Basic Science||None (Open Label)||||||
1512863|NCT00812578|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1512864|NCT00812565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512865|NCT00812552|||Case Control||Retrospective|||||||
1512866|NCT00812539|Randomized|Parallel Assignment||||None (Open Label)||||||
1512867|NCT00812526|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1512868|NCT00812513||Single Group Assignment||Treatment||None (Open Label)||||||
1512869|NCT00812500|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512870|NCT00812487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512871|NCT00812474|||Case Control||Prospective|||||||
1512872|NCT00812461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512873|NCT00812448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512874|NCT00812435|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512875|NCT00812422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512876|NCT00812409|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512877|NCT00812396|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1512878|NCT00812383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512879|NCT00812370||Single Group Assignment||Treatment||None (Open Label)||||||
1512880|NCT00812357|||Cohort||Prospective|||||||
1512881|NCT00812344|Randomized|Crossover Assignment||||None (Open Label)||||||
1512882|NCT00812331|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512883|NCT00812318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512884|NCT00812305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512885|NCT00812292|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1512886|NCT00812279|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1512887|NCT00812266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512888|NCT00812253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512889|NCT00812240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512890|NCT00812227||Single Group Assignment||Treatment||None (Open Label)||||||
1512891|NCT00812214|Randomized|Parallel Assignment||||Double|||t||t|
1512892|NCT00812201|||Case-Only||Prospective|||||||
1512893|NCT00812188|Randomized|Parallel Assignment||Treatment||Single|||||t|
1512894|NCT00812175|||Cohort||Prospective|||||||
1512895|NCT00812162|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512896|NCT00812149|||||Prospective|||||||
1512897|NCT00812136||||Prevention||||||||
1512898|NCT00812123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512899|NCT00812110||Single Group Assignment||Prevention||None (Open Label)||||||
1512900|NCT00812097|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512901|NCT00812084|||||Prospective|||||||
1512902|NCT00812071|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1512903|NCT00812058|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512904|NCT00812045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512905|NCT00812032|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1512906|NCT00812019|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512907|NCT00812006|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512908|NCT00811993|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512909|NCT00811980|||||Prospective|||||||
1512910|NCT00811967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512911|NCT00811954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512912|NCT00811941|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512913|NCT00811928|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1512914|NCT00811915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512915|NCT00811902|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512916|NCT00811889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512917|NCT00811876|||Cohort||Retrospective|||||||
1512918|NCT00811863|||Cohort||Prospective|||||||
1512919|NCT00811850|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1512920|NCT00811837|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1512921|NCT00811824|Randomized|Crossover Assignment||Prevention||Single||||||t
1512922|NCT00811811|Randomized|Parallel Assignment||Prevention||Single|||t|||
1512923|NCT00811798||Single Group Assignment||Prevention||None (Open Label)||||||
1512924|NCT00811785||Single Group Assignment||Treatment||None (Open Label)||||||
1512925|NCT00811772|Randomized|Parallel Assignment||Treatment||Single||||||t
1512926|NCT00811759||||Treatment||None (Open Label)||||||
1512927|NCT00811746|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1512928|NCT00811733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512929|NCT00811720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512930|NCT00811707|||Case Control||Cross-Sectional|||||||
1512931|NCT00811694||||||||||||
1512932|NCT00811681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512933|NCT00811668|Randomized|Crossover Assignment||Treatment||Single|||||t|
1512934|NCT00811655||Single Group Assignment||Treatment||None (Open Label)||||||
1512935|NCT00811642|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512936|NCT00811629|||||Prospective|||||||
1512937|NCT00811616||Single Group Assignment||Treatment||None (Open Label)||||||
1512938|NCT00811603|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1512939|NCT00811590||Single Group Assignment||Treatment||None (Open Label)||||||
1512940|NCT00811577|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512941|NCT00811564|Randomized|Parallel Assignment||Treatment||Single|||||t|
1512942|NCT00811551|||Cohort||Prospective|||||||
1512943|NCT00811538|||Cohort||Prospective|||||||
1512944|NCT00811525||||||||||||
1512945|NCT00811512|||Case-Only||Retrospective|||||||
1512946|NCT00811499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512947|NCT00811486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512948|NCT00811473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512949|NCT00811460|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512950|NCT00811447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512951|NCT00811434|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1512952|NCT00811421|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1512953|NCT00811408||||Treatment||||||||
1512954|NCT00811395|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513341|NCT00806247|Randomized|Parallel Assignment||Treatment||Double||||||
1512955|NCT00811382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512956|NCT00811369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512957|NCT00811356|Randomized|Crossover Assignment||Treatment||Single|||t|||
1512958|NCT00811343||Single Group Assignment||Diagnostic||None (Open Label)||||||
1512959|NCT00811330|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512960|NCT00811317||Single Group Assignment||Treatment||None (Open Label)||||||
1512961|NCT00811304|||Cohort||Prospective|||||||
1512962|NCT00811291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512963|NCT00811278|||Cohort||Prospective|||||||
1512964|NCT00811265|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512965|NCT00811252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512966|NCT00811239||Parallel Assignment||Treatment||None (Open Label)||||||
1512967|NCT00811226|||Cohort||Prospective|||||||
1512968|NCT00811213|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1512969|NCT00811200|Randomized|Parallel Assignment||Treatment||Single|||t|||
1512970|NCT00811187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512971|NCT00811174||Single Group Assignment||Treatment||None (Open Label)||||||
1512972|NCT00811161||Single Group Assignment||Treatment||None (Open Label)||||||
1512973|NCT00811148|||Case-Only||Prospective|||||||
1512974|NCT00811135||Single Group Assignment||Treatment||None (Open Label)||||||
1512975|NCT00811122||Single Group Assignment||Basic Science||None (Open Label)||||||
1512976|NCT00811109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512977|NCT00811096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512978|NCT00811083|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1512979|NCT00811070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512980|NCT00811057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512981|NCT00811044|||Other||Cross-Sectional|||||||
1512982|NCT00811031||Single Group Assignment||Treatment||None (Open Label)||||||
1512983|NCT00811018|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1512984|NCT00811005|Randomized|Parallel Assignment||Treatment||Single|||||t|
1512985|NCT00810992|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512986|NCT00810979|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1512987|NCT00810953|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1512988|NCT00810940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1512989|NCT00810927|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1512990|NCT00810914|Randomized|Parallel Assignment||||Double|||t|t||
1512991|NCT00810901|Randomized|Parallel Assignment||Prevention||Single|||||t|
1512992|NCT00810888|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512993|NCT00810875|||Case Control||Prospective|||||||
1512994|NCT00810862|Randomized|Single Group Assignment||Treatment||Single|||||t|
1512995|NCT00810849|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1512996|NCT00810836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1512997|NCT00810823|||Cohort||Prospective|||||||
1512998|NCT00810810|Randomized|Parallel Assignment||Prevention||Double|Clinical teams caring for patients were not masked. Laboratory personnel were masked until all testing completed.|Individuals who consented for study were scheduled for cardiac surgery. They were randomized to one of three arms to receive blood components prepared by different, but clinically acceptable processes. If they required transfusion from 2 days prior to surgery until 30 days post surgery they received study product. Blood samples were collected prior to surgery and at two points after surgery.|||t|t
1512999|NCT00810797||Single Group Assignment||Treatment||None (Open Label)||||||
1513000|NCT00810784|||Case Control||Retrospective|||||||
1513001|NCT00810771|Randomized|Parallel Assignment||Health Services Research||Single||||||
1513002|NCT00810758|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1513003|NCT00810745|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513004|NCT00810732|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513005|NCT00810719||Single Group Assignment||Treatment||None (Open Label)||||||
1513006|NCT00810706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513007|NCT00810693|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513008|NCT00810680||Single Group Assignment||Treatment||None (Open Label)||||||
1513009|NCT00810667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513010|NCT00810654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513011|NCT00810641|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513012|NCT00810628||Single Group Assignment||Supportive Care||None (Open Label)||||||
1513013|NCT00810615|Randomized|Parallel Assignment||Treatment||Single|||t|||
1513014|NCT00810602||Single Group Assignment||Treatment||None (Open Label)||||||
1513015|NCT00810589|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513016|NCT00810576||Single Group Assignment||Treatment||None (Open Label)||||||
1513017|NCT00810563|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1513018|NCT00810550||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513019|NCT00810524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513020|NCT00810511|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513021|NCT00810498||||||||||||
1513022|NCT00810485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513023|NCT00810472|Randomized|Parallel Assignment||Prevention||Single|||t|||
1513024|NCT00810459||||||||||||
1513025|NCT00810446|||Case-Only||Prospective|||||||
1513026|NCT00810433||Single Group Assignment||Treatment||None (Open Label)||||||
1513027|NCT00810420||||||||||||
1513028|NCT00810407|||Case-Only||Prospective|||||||
1513029|NCT00810394||Single Group Assignment||Treatment||None (Open Label)||||||
1513030|NCT00810381|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1513031|NCT00810368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513032|NCT00810355|Randomized|Parallel Assignment||Treatment||Single||||||t
1513033|NCT00810342|Randomized|Parallel Assignment||Prevention||Single|||||t|
1513034|NCT00810329|||Cohort||Prospective|||||||
1513035|NCT00810316|Randomized|Parallel Assignment||||Single|||t|||
1513036|NCT00810303|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1513037|NCT00810290|Randomized|Single Group Assignment||Prevention||Single||||||t
1513038|NCT00810277||Single Group Assignment||Treatment||None (Open Label)||||||
1513039|NCT00810264|||Cohort||Prospective|||||||
1513040|NCT00810251|||Cohort||Prospective|||||||
1513041|NCT00810238|Randomized|Parallel Assignment||Treatment||Single||||||t
1513042|NCT00810225|||Case-Control||Cross-Sectional|||||||
1513043|NCT00810212|Randomized|Parallel Assignment||Treatment||Single||||||t
1513044|NCT00810199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513045|NCT00810186|||Case Control||Prospective|||||||
1513046|NCT00810173|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513047|NCT00810160|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513048|NCT00810147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513049|NCT00810134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513050|NCT00810121|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513051|NCT00810108|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513052|NCT00810095||Single Group Assignment||Treatment||None (Open Label)||||||
1513053|NCT00810082|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513054|NCT00810069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513055|NCT00810056|Randomized|Single Group Assignment||Prevention||Single||||||t
1513056|NCT00810043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513057|NCT00810030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513058|NCT00810017|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513059|NCT00810004|Randomized|Parallel Assignment||Treatment||Single|||t|||
1513060|NCT00809991||Single Group Assignment||Treatment||None (Open Label)||||||
1513061|NCT00809965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513062|NCT00809952||||||||||||
1513063|NCT00809939|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513064|NCT00809926|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1513065|NCT00809913|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513066|NCT00809900|||Cohort|||||||||
1513067|NCT00809887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513068|NCT00809874|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1513069|NCT00809861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513070|NCT00809848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513071|NCT00809835|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1513072|NCT00809822|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513073|NCT00809809|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513074|NCT00809796||Single Group Assignment||Treatment||None (Open Label)||||||
1513075|NCT00809783|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513076|NCT00809770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513077|NCT00809757|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513078|NCT00809744|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1513079|NCT00809731|||Case-Only||Prospective|||||||
1513080|NCT00809718||Single Group Assignment||||None (Open Label)||||||
1513081|NCT00809705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513082|NCT00809692|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1513083|NCT00809679|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513084|NCT00809666|Randomized|Single Group Assignment||Diagnostic||Single||||||t
1513085|NCT00809653|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1513086|NCT00809640|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1513087|NCT00809627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513088|NCT00809614|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513089|NCT00809601|Randomized|Parallel Assignment||Treatment||Single|||t|||
1513090|NCT00809588||Single Group Assignment||Treatment||None (Open Label)||||||
1513091|NCT00809575|||Cohort||Prospective|||||||
1513092|NCT00809562|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513093|NCT00809549|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513094|NCT00809536|Randomized|Crossover Assignment||||None (Open Label)||||||
1513095|NCT00809523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513096|NCT00809510|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513097|NCT00809497|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513098|NCT00809484|||Case-Only||Prospective|||||||
1513099|NCT00809471|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513100|NCT00809458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513101|NCT00809445|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513102|NCT00809432|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1513103|NCT00809419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513104|NCT00809406||||||||||||
1513105|NCT00809393|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513106|NCT00809380|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513107|NCT00809367||Single Group Assignment||||None (Open Label)||||||
1513108|NCT00809354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513109|NCT00809341|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513110|NCT00809328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513111|NCT00809315|Randomized|Single Group Assignment||Prevention||Single||||||t
1513112|NCT00809302|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513113|NCT00809289|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1513114|NCT00809276||Single Group Assignment||Treatment||None (Open Label)||||||
1513115|NCT00809263|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1513116|NCT00809250||Single Group Assignment||Treatment||None (Open Label)||||||
1513117|NCT00809237||Single Group Assignment||Treatment||None (Open Label)||||||
1513118|NCT00809224|||Case Control|||||||||
1513119|NCT00809211|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513120|NCT00809198|Randomized|Parallel Assignment||Treatment||Single|||||t|
1513121|NCT00809185||Single Group Assignment||Treatment||None (Open Label)||||||
1513122|NCT00809172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513123|NCT00809159|Randomized|Parallel Assignment||||Double|||t||t|
1513124|NCT00809146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513125|NCT00809133|Non-Randomized|||Treatment||None (Open Label)||||||
1513126|NCT00809120||Single Group Assignment||Screening||None (Open Label)||||||
1513127|NCT00809107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513128|NCT00809094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513129|NCT00809081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513130|NCT00809068|Randomized|Crossover Assignment||Prevention||Single||||||t
1513131|NCT00809055|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513132|NCT00809042|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1513133|NCT00809029|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1513134|NCT00809016|Non-Randomized|||Diagnostic||None (Open Label)||||||
1513135|NCT00809003|||Cohort||Prospective|||||||
1513136|NCT00808990|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1513137|NCT00808977|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513138|NCT00808964|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1513139|NCT00808951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513140|NCT00808938||Single Group Assignment||Treatment||None (Open Label)||||||
1513141|NCT00808925||Single Group Assignment||Basic Science||Single|||||t|
1513142|NCT00808912|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1513143|NCT00808899||Single Group Assignment||Treatment||None (Open Label)||||||
1513144|NCT00808886|||Case-Only||Prospective|||||||
1513145|NCT00808873|Randomized|Parallel Assignment||||Single|||||t|
1513146|NCT00808860|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513147|NCT00808834|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513148|NCT00808821||||||||||||
1513149|NCT00808808|||||Prospective|||||||
1513150|NCT00808795|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513151|NCT00808782|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513152|NCT00808769|Randomized|Crossover Assignment||||Single|||||t|
1513153|NCT00808756|Randomized|Parallel Assignment||||Double||||t|t|
1513154|NCT00808743|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1513155|NCT00808730||Single Group Assignment||Health Services Research||None (Open Label)||||||
1513156|NCT00808717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513157|NCT00808704|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1513158|NCT00808691|||Cohort||Prospective|||||||
1513159|NCT00808678|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513160|NCT00808665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513161|NCT00808652|||Cohort||Prospective|||||||
1513162|NCT00808639||Single Group Assignment||Treatment||None (Open Label)||||||
1513163|NCT00808626||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513164|NCT00808613|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513165|NCT00808600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513166|NCT00808587|||Other||Prospective|||||||
1513167|NCT00808574|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1513168|NCT00808561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513169|NCT00808548|||Case-Only||Retrospective|||||||
1513170|NCT00808535|||Case Control||Prospective|||||||
1513171|NCT00808522|Randomized|Parallel Assignment||Prevention||Single||||||t
1513172|NCT00808509|Randomized|Parallel Assignment||||None (Open Label)||||||
1513173|NCT00808496|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1513174|NCT00808483|Randomized|Parallel Assignment||Treatment||Single||||||t
1513175|NCT00808470|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513176|NCT00808457|||||Prospective|||||||
1513177|NCT00808444|Randomized|Parallel Assignment||Prevention||Double||||t||t
1513178|NCT00808431|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1513179|NCT00808418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513180|NCT00808405|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513181|NCT00808392|Randomized|Parallel Assignment||Prevention||Single|||t|||
1513182|NCT00808379|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513183|NCT00808366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513185|NCT00808340|Randomized|Crossover Assignment||Treatment||Single|||t|||
1513186|NCT00808327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513187|NCT00808314|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1513188|NCT00808301|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1513189|NCT00808288|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513190|NCT00808275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513191|NCT00808262|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513192|NCT00808249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513193|NCT00808236|Randomized|Parallel Assignment||Treatment||Single||||||t
1513194|NCT00808223|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513195|NCT00808210||Parallel Assignment||Treatment||Double|||t||t|
1513196|NCT00808197||Single Group Assignment||Basic Science||None (Open Label)||||||
1513197|NCT00808184|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513198|NCT00808171|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1513199|NCT00808158|||Cohort||Prospective|||||||
1513200|NCT00808145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513201|NCT00808132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513202|NCT00808119|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1513203|NCT00808106|||Cohort||Prospective|||||||
1513204|NCT00808093|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1513205|NCT00808080||Single Group Assignment||Treatment||None (Open Label)||||||
1513206|NCT00808067|Randomized|Parallel Assignment||Treatment||Double||||||
1513207|NCT00808054|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1513208|NCT00808041|||Case-Only||Prospective|||||||
1513209|NCT00808028|Randomized|Parallel Assignment||Prevention||Single||||||
1513210|NCT00808015|||Case-Only||Prospective|||||||
1513211|NCT00808002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513212|NCT00807989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513213|NCT00807976|||||Cross-Sectional|||||||
1513214|NCT00807963|Randomized|Single Group Assignment||Other||Single|||t|||
1513215|NCT00807950||||Treatment||||||||
1513216|NCT00807937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513217|NCT00807924|||Case-Only||Prospective|||||||
1513218|NCT00807911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513219|NCT00807898|||Case-Only||Cross-Sectional|||||||
1513220|NCT00807885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513221|NCT00807872||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513222|NCT00807859|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513223|NCT00807846|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513224|NCT00807833|||Cohort||Prospective|||||||
1513225|NCT00807820|||Case-Only||Prospective|||||||
1513226|NCT00807807|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1513227|NCT00807794|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513228|NCT00807781||Single Group Assignment||Treatment||None (Open Label)||||||
1513229|NCT00807768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513230|NCT00807755||Single Group Assignment||Treatment||None (Open Label)||||||
1513231|NCT00807742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513232|NCT00807729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513233|NCT00807716|Randomized|Single Group Assignment||Treatment||Single||||||t
1513234|NCT00807703||Single Group Assignment||Treatment||None (Open Label)||||||
1513235|NCT00807690|Randomized|Parallel Assignment||Treatment||Double||||||
1513236|NCT00807677||Single Group Assignment||Treatment||None (Open Label)||||||
1513237|NCT00807664|Randomized|Parallel Assignment||Treatment||Single|||t|||
1513238|NCT00807651|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513239|NCT00807625|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513240|NCT00807612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513241|NCT00807599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513242|NCT00807586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513243|NCT00807573||Single Group Assignment||Treatment||None (Open Label)||||||
1513244|NCT00807560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513245|NCT00807547|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513246|NCT00807534|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1513247|NCT00807521|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1513248|NCT00807508|Randomized|Parallel Assignment||Treatment||Double||||||
1513249|NCT00807495||Single Group Assignment||Treatment||None (Open Label)||||||
1513250|NCT00807482|||Cohort||Prospective|||||||
1513251|NCT00807469|||Case Control||Prospective|||||||
1513252|NCT00807456||Single Group Assignment||Treatment||None (Open Label)||||||
1513253|NCT00807443||Single Group Assignment||Basic Science||None (Open Label)||||||
1513254|NCT00807430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513255|NCT00807404||||Diagnostic||None (Open Label)||||||
1513256|NCT00807391||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513257|NCT00807378|||Case-Only||Prospective|||||||
1513258|NCT00807365||Single Group Assignment||Treatment||None (Open Label)||||||
1513259|NCT00807352|||Cohort||Prospective|||||||
1513260|NCT00807339||Single Group Assignment||Treatment||None (Open Label)||||||
1513261|NCT00807326|Randomized|Parallel Assignment||Treatment||Single|||||t|
1513262|NCT00807313|||Cohort||Prospective|||||||
1513263|NCT00807300|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513264|NCT00807287|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513265|NCT00807274|||Cohort||Prospective|||||||
1513266|NCT00807261|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1513267|NCT00807248|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513268|NCT00807235|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513269|NCT00807222|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513270|NCT00807209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513271|NCT00807196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513272|NCT00807183|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1513273|NCT00807170||Single Group Assignment||Treatment||None (Open Label)||||||
1513274|NCT00807157|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1513275|NCT00807144|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513276|NCT00807131|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1513277|NCT00807118|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513278|NCT00807105||Single Group Assignment||Treatment||None (Open Label)||||||
1513279|NCT00807092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513280|NCT00807079||Single Group Assignment||Treatment||None (Open Label)||||||
1513281|NCT00807066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513282|NCT00807053|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513283|NCT00807040|Randomized|Parallel Assignment||Treatment||Single||||||t
1513284|NCT00807027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513285|NCT00807014|Randomized|Parallel Assignment||Treatment||Single|||||t|
1513286|NCT00807001|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513287|NCT00806988|Randomized|Parallel Assignment||Treatment||Single||||||t
1513288|NCT00806975|Randomized|Crossover Assignment||Treatment||Single||||||t
1513289|NCT00806962|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513290|NCT00806936|||Case-Only||Prospective|||||||
1513291|NCT00806923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513292|NCT00806910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513293|NCT00806897|||Case-Only||Prospective|||||||
1513294|NCT00806884|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1513295|NCT00806871|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513296|NCT00806858|||||Prospective|||||||
1513297|NCT00806845|||Cohort||Cross-Sectional|||||||
1513298|NCT00806832|||Case Control||Prospective|||||||
1513299|NCT00806819|Randomized|Parallel Assignment||Treatment||Double||||||
1513300|NCT00806806|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1513301|NCT00806780|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1513302|NCT00806767|Non-Randomized|||Treatment||None (Open Label)||||||
1513303|NCT00806754|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513304|NCT00806741|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1513305|NCT00806728|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513306|NCT00806715|||Cohort||Prospective|||||||
1513307|NCT00806689|||Cohort|||||||||
1513308|NCT00806676|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1513309|NCT00806663||Single Group Assignment||Treatment||None (Open Label)||||||
1513310|NCT00806650|||Case-Only||Retrospective|||||||
1513311|NCT00806637|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1513312|NCT00806624|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513313|NCT00806611|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1513314|NCT00806598||Single Group Assignment||Treatment||None (Open Label)||||||
1513315|NCT00806585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513316|NCT00806572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513317|NCT00806559|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1513318|NCT00806546|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513319|NCT00806533|||Cohort||Prospective|||||||
1513320|NCT00806520|||Cohort||Prospective|||||||
1513321|NCT00806507|||Case-Only||Prospective|||||||
1513322|NCT00806494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513323|NCT00806481|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513324|NCT00806468|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513325|NCT00806455|||Case-Only||Prospective|||||||
1513326|NCT00806442|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1513327|NCT00806429|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513328|NCT00806416|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513329|NCT00806403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513330|NCT00806390|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513331|NCT00806377|||Cohort||Prospective|||||||
1513332|NCT00806364|||Case-Control||Prospective|||||||
1513333|NCT00806351|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513334|NCT00806338|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1513335|NCT00806325|||Cohort||Prospective|||||||
1513336|NCT00806312|||Case Control||Prospective|||||||
1513337|NCT00806299|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1513338|NCT00806286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513339|NCT00806273|Randomized|Parallel Assignment||Treatment||Single||||||t
1513340|NCT00806260|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513342|NCT00806234|Randomized|Factorial Assignment||Treatment||Single||||||t
1513343|NCT00806221||Single Group Assignment||Prevention||None (Open Label)||||||
1513344|NCT00806208|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513345|NCT00806195|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513346|NCT00806182|||Case-Control||Other|||||||
1513347|NCT00806169|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513348|NCT00806156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513349|NCT00806143|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513350|NCT00806130|||Other||Cross-Sectional|||||||
1513351|NCT00806117|Randomized|Parallel Assignment||Treatment||Single||"After radical surgery, eligible patients with risk pathological factors were randomize to three groups.~Radiotherapy: Group A underwent 50 GY pelvic RT alone. Radiotherapy and drugs: Group B received concurrent weekly cisplatin and RT (CCRT).~Radiotherapy and drugs: Group C received paclitaxel and bolus cisplatin every three weeks for two cycles before RT, followed by two cycles of chemotherapy (SCRT)."||||t
1513352|NCT00806104|Randomized|Parallel Assignment||||Double|||t||t|
1513353|NCT00806091|||Cohort||Prospective|||||||
1513354|NCT00806078|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1513355|NCT00806065|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513356|NCT00806052||||||||||||
1513357|NCT00806039|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513358|NCT00806026|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513359|NCT00806013|||Case Control||Prospective|||||||
1513360|NCT00806000|||Cohort||Prospective|||||||
1513361|NCT00805974||Single Group Assignment||Screening||None (Open Label)||||||
1513362|NCT00805961||Single Group Assignment||Treatment||None (Open Label)||||||
1513363|NCT00805948||Single Group Assignment||Treatment||None (Open Label)||||||
1513364|NCT00805935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513365|NCT00805922|||Ecologic or Community||Cross-Sectional|||||||
1513366|NCT00805909||Single Group Assignment||Treatment||None (Open Label)||||||
1513367|NCT00805896|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513368|NCT00805883||Single Group Assignment||Treatment||None (Open Label)||||||
1513369|NCT00805870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513370|NCT00805857||||||||||||
1513371|NCT00805844|||Cohort||Prospective|||||||
1513372|NCT00805831||Single Group Assignment||Treatment||None (Open Label)||||||
1513373|NCT00805818|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1513374|NCT00805805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513375|NCT00805792||Single Group Assignment||Treatment||None (Open Label)||||||
1513376|NCT00805779||Single Group Assignment||Treatment||None (Open Label)||||||
1513377|NCT00805766||Single Group Assignment||Treatment||None (Open Label)||||||
1513378|NCT00805753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513379|NCT00805740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513380|NCT00805714|||||Prospective|||||||
1513381|NCT00805701|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1513382|NCT00805688|||Cohort||Prospective|||||||
1513383|NCT00805675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513384|NCT00805662|Randomized|Parallel Assignment||Treatment||Double||||||
1513385|NCT00805649|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513386|NCT00805636||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513387|NCT00805623|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513388|NCT00805610||Single Group Assignment||Treatment||None (Open Label)||||||
1513389|NCT00805597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513390|NCT00805584||Single Group Assignment||Treatment||None (Open Label)||||||
1513391|NCT00805571|||Cohort||Prospective|||||||
1513392|NCT00805558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513393|NCT00805545|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513394|NCT00805532|Randomized|Parallel Assignment||Treatment||Single||||||t
1513395|NCT00805519|Randomized|Parallel Assignment||Treatment||Single|||||t|
1513396|NCT00805506|||Cohort||Prospective|||||||
1513397|NCT00805493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513398|NCT00805480|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513399|NCT00805467|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513400|NCT00805454||||Basic Science||None (Open Label)||||||
1513401|NCT00805441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513402|NCT00805428|||Case Control|||||||||
1513403|NCT00805415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513404|NCT00805402|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1513405|NCT00805389|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1513406|NCT00805376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513407|NCT00805350|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513408|NCT00805337||||||||||||
1513409|NCT00805324||Single Group Assignment||Treatment||None (Open Label)||||||
1513410|NCT00805311|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513411|NCT00805298|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1513412|NCT00805285||Single Group Assignment||Treatment||None (Open Label)||||||
1513413|NCT00805272||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513414|NCT00805259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513415|NCT00805246|||Cohort|||||||||
1513416|NCT00805233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513417|NCT00805220|Randomized|Parallel Assignment||Treatment||Single||||||t
1513418|NCT00805207|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1513419|NCT00805194|Randomized|Parallel Assignment||Treatment||Double||||||
1513420|NCT00805181|||Cohort||Prospective|||||||
1513421|NCT00805155|||Cohort||Prospective|||||||
1513422|NCT00805142|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513423|NCT00805129||Single Group Assignment||Treatment||None (Open Label)||||||
1513424|NCT00805116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513425|NCT00805103||Single Group Assignment||Treatment||None (Open Label)||||||
1513426|NCT00805090||Crossover Assignment||||None (Open Label)||||||
1513427|NCT00805077|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1513428|NCT00805064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513429|NCT00805051|||Cohort||Prospective|||||||
1513430|NCT00805038|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1513431|NCT00805025||Single Group Assignment||Treatment||None (Open Label)||||||
1513432|NCT00805012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513433|NCT00804999|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1513434|NCT00804986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513435|NCT00804973|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513436|NCT00804960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513437|NCT00804947||Single Group Assignment||Treatment||None (Open Label)||||||
1513438|NCT00804934||||||||||||
1513439|NCT00804921||||||||||||
1513440|NCT00804908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513441|NCT00804895|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513442|NCT00804882|||Case-Only||Cross-Sectional|||||||
1513443|NCT00804869|||Cohort||Retrospective|||||||
1513444|NCT00804856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513445|NCT00804843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513446|NCT00804830||Single Group Assignment||Treatment||None (Open Label)||||||
1513447|NCT00804817|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1513448|NCT00804804|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1513449|NCT00804791|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513450|NCT00804778||||||||||||
1513451|NCT00804765|Randomized|Parallel Assignment||Prevention||Single|||t|||
1513452|NCT00804752||||||||||||
1513453|NCT00804739||Single Group Assignment||Health Services Research||None (Open Label)||||||
1513454|NCT00804726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513455|NCT00804713||Single Group Assignment||Screening||Double|||t|||t
1513456|NCT00804700|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513457|NCT00804687|Randomized|Crossover Assignment||Treatment||Single|||t|||
1513458|NCT00804674|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1513459|NCT00804661|||Cohort||Cross-Sectional|||||||
1513460|NCT00804648|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1513461|NCT00804622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513462|NCT00804609|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1513463|NCT00804596||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513464|NCT00804583|||Cohort||Prospective|||||||
1513465|NCT00804570|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513466|NCT00804557|||Case-Crossover||Prospective|||||||
1513467|NCT00804544||Single Group Assignment||Treatment||None (Open Label)||||||
1513468|NCT00804531|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513469|NCT00804518||Single Group Assignment||Prevention||None (Open Label)||||||
1513470|NCT00804505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513471|NCT00804492|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513472|NCT00804479|||Cohort||Prospective|||||||
1513473|NCT00804466||Single Group Assignment||Screening||None (Open Label)||||||
1513474|NCT00804453|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513475|NCT00804440|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513476|NCT00804427|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513477|NCT00804414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513478|NCT00804401|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513479|NCT00804388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513480|NCT00804375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513481|NCT00804362|||Cohort||Prospective|||||||
1513482|NCT00804349|Randomized|Parallel Assignment||Treatment||Single||||||t
1513483|NCT00804336||Single Group Assignment||Treatment||None (Open Label)||||||
1513484|NCT00804323||Single Group Assignment||Treatment||None (Open Label)||||||
1513485|NCT00804310||Single Group Assignment||Treatment||None (Open Label)||||||
1513486|NCT00804297|Randomized|Factorial Assignment||Treatment||Double||||||
1513487|NCT00804284|||Cohort|||||||||
1513488|NCT00804271|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1513489|NCT00804258|||Case-Only||Prospective|||||||
1513490|NCT00804245||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513491|NCT00804232|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513492|NCT00804219|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1513493|NCT00804206|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513494|NCT00804193|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513495|NCT00804180||Single Group Assignment||Treatment||None (Open Label)||||||
1513496|NCT00804167|||Cohort||Cross-Sectional|||||||
1513497|NCT00804154|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513498|NCT00804141||Single Group Assignment||Treatment||None (Open Label)||||||
1513499|NCT00804128|||Cohort||Prospective|||||||
1513500|NCT00804115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513501|NCT00804102|Randomized|Parallel Assignment||Treatment||Single|||t|||
1513502|NCT00804089|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513503|NCT00804076||Single Group Assignment||Treatment||None (Open Label)||||||
1513504|NCT00804063|||Case Control||Prospective|||||||
1513505|NCT00804050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513506|NCT00804037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513507|NCT00804024|||Cohort||Prospective|||||||
1513508|NCT00804011|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513509|NCT00803998||||||||||||
1513510|NCT00803985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513511|NCT00803972|Randomized|Parallel Assignment||Other||Single|||t|||
1513512|NCT00803959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513513|NCT00803946|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513514|NCT00803933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513515|NCT00803920|||Cohort||Prospective|||||||
1513516|NCT00803907||Single Group Assignment||Treatment||None (Open Label)||||||
1513517|NCT00803894|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1513518|NCT00803881|||Cohort||Prospective|||||||
1513519|NCT00803868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513520|NCT00803855|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1513521|NCT00803842|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1513522|NCT00803829|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1513523|NCT00803816||Single Group Assignment||Treatment||None (Open Label)||||||
1513524|NCT00803803|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513525|NCT00803790|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513526|NCT00803777||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513527|NCT00803764|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513528|NCT00803751|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1513529|NCT00803738|Randomized|Parallel Assignment||Treatment||Single|||||t|
1513530|NCT00803725|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513531|NCT00803712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513532|NCT00803699|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513533|NCT00803686|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1513534|NCT00803673|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513535|NCT00803660|||||Cross-Sectional|||||||
1513536|NCT00803647||Single Group Assignment||Treatment||None (Open Label)||||||
1513537|NCT00803634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513538|NCT00803621|||Cohort||Prospective|||||||
1513539|NCT00803608|Randomized|Parallel Assignment||Prevention||Single|||t|||
1513540|NCT00803595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513541|NCT00803582|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1513542|NCT00803569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513543|NCT00803556|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513544|NCT00803543|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513545|NCT00803530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513546|NCT00803517|||Case Control||Prospective|||||||
1513547|NCT00803504||||||||||||
1513548|NCT00803491|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513549|NCT00803478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513550|NCT00803465|||Cohort||Prospective|||||||
1513551|NCT00803452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513552|NCT00803439|||Cohort||Prospective|||||||
1513553|NCT00803426|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513554|NCT00803413|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1513555|NCT00803400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513556|NCT00803387|||Cohort||Prospective|||||||
1513557|NCT00803374|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513558|NCT00803361|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513559|NCT00803348|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1513560|NCT00803335|Randomized|Parallel Assignment||Treatment||Single||||||t
1513561|NCT00803322|||Cohort||Prospective|||||||
1513562|NCT00803309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513563|NCT00803296|||Case Control||Cross-Sectional|||||||
1513564|NCT00803283|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513565|NCT00803270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513566|NCT00803257|Randomized|Factorial Assignment||Treatment||Single||||||t
1513567|NCT00803244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513568|NCT00803231|||Cohort|||||||||
1513569|NCT00803218|||Case-Only||Prospective|||||||
1513570|NCT00803205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513571|NCT00803192|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513572|NCT00803179||Single Group Assignment||Treatment||None (Open Label)||||||
1513573|NCT00803166|||Cohort||Prospective|||||||
1513574|NCT00803153|||Cohort||Retrospective|||||||
1513575|NCT00803140|Randomized|Parallel Assignment||Treatment||Single|||t|||
1513576|NCT00803127|||Case-Only||Prospective|||||||
1513577|NCT00803114|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513578|NCT00803101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513579|NCT00803088|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513580|NCT00803075|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513581|NCT00803062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513582|NCT00803049|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513583|NCT00803036|||Cohort||Prospective|||||||
1513584|NCT00803023|Randomized|Single Group Assignment||Treatment||Single|||t|||
1513585|NCT00803010|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513586|NCT00802997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513587|NCT00802984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513588|NCT00802971|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513589|NCT00802958|||Cohort||Prospective|||||||
1513590|NCT00802945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513591|NCT00802932|||Cohort||Prospective|||||||
1513592|NCT00802919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513593|NCT00802906|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513594|NCT00802893|Randomized|Parallel Assignment||Treatment||Double||||||
1513595|NCT00802880||Single Group Assignment||Treatment||None (Open Label)||||||
1513596|NCT00802867|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1513597|NCT00802854|||Case-Only||Other|||||||
1513598|NCT00802841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513599|NCT00802828|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513600|NCT00802815|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1513601|NCT00802802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513602|NCT00802789|||Cohort||Prospective|||||||
1513603|NCT00802776|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513604|NCT00802763|||Case-Only||Retrospective|||||||
1513605|NCT00802750||||||||||||
1513606|NCT00802737||Single Group Assignment||Treatment||None (Open Label)||||||
1513607|NCT00802724|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1513608|NCT00802711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513609|NCT00802698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513610|NCT00802685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513611|NCT00802672|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513612|NCT00802659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513613|NCT00802646|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1513614|NCT00802633|Randomized|Parallel Assignment||Treatment||Single|||t|||
1513615|NCT00802620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513616|NCT00802607|||||Other|||||||
1513617|NCT00802594||Single Group Assignment||Treatment||None (Open Label)||||||
1513618|NCT00802581|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1513619|NCT00802568|Non-Randomized|||Treatment||None (Open Label)||||||
1513620|NCT00802555||Single Group Assignment||Treatment||None (Open Label)||||||
1513621|NCT00802542|||Case-Only||Prospective|||||||
1513622|NCT00802529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513623|NCT00802516|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1513624|NCT00802503|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513625|NCT00802490|Randomized|Parallel Assignment||Treatment||Single||||||t
1513626|NCT00802477|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1513627|NCT00802464|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1513628|NCT00802451|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513629|NCT00802438||Single Group Assignment||Basic Science||None (Open Label)||||||
1513630|NCT00802425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513631|NCT00802412|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513632|NCT00802399|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513633|NCT00802386|||Cohort||Prospective|||||||
1513634|NCT00802373|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513635|NCT00802360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513636|NCT00802347|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1513637|NCT00802334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513638|NCT00802321|Randomized|Single Group Assignment||||Double|||t|t||
1513639|NCT00802308|Randomized|Crossover Assignment||||Single|||t|||
1513640|NCT00802295|Non-Randomized|Crossover Assignment||Prevention||Single|||t|||
1513641|NCT00802282|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1513642|NCT00802269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513643|NCT00802256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513644|NCT00802243||Single Group Assignment||Treatment||None (Open Label)||||||
1513645|NCT00802230|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513646|NCT00802217|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1513647|NCT00802204|Non-Randomized|Sequential Assignment||Other||None (Open Label)||"Lean who are age and sex similar to obese will complete baseline outcome measurements only.~Obese will complete baseline outcome measurements then the VLCD intervention with post outcome measurements ."||||
1513648|NCT00802191|||Case Control||Cross-Sectional|||||||
1513649|NCT00802178|||Cohort||Prospective|||||||
1513650|NCT00802165|Randomized|Parallel Assignment||Treatment||Single|||t|||
1513651|NCT00802152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513652|NCT00802139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513653|NCT00802126||Single Group Assignment||Treatment||None (Open Label)||||||
1513654|NCT00802113|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513655|NCT00802100|Randomized|Parallel Assignment||Treatment||Single||||||t
1513656|NCT00802087|Randomized|Crossover Assignment||||None (Open Label)||||||
1513657|NCT00802074|Randomized|Factorial Assignment||||None (Open Label)||||||
1513658|NCT00802061||||||||||||
1513659|NCT00802048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513660|NCT00802035|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513661|NCT00802022||Single Group Assignment||Treatment||None (Open Label)||||||
1513662|NCT00802009|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513663|NCT00801996|||Case Control||Cross-Sectional|||||||
1513664|NCT00801983|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1513665|NCT00801970|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1513666|NCT00801957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513667|NCT00801944|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513668|NCT00801931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513669|NCT00801918|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513670|NCT00801905|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1513671|NCT00801892|Randomized|Crossover Assignment||Health Services Research||Triple|The mask and equipment appeared similar to actual CPAP but does not give pressure required to prevent OSA. Only CPAP naive persons eligible.|Participants on sham-CPAP were allowed to try actual CPAP.|t||t|t
1513672|NCT00801879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513673|NCT00801866||||Treatment||||||||
1513674|NCT00801853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513675|NCT00801827||Single Group Assignment||Basic Science||None (Open Label)||||||
1513676|NCT00801814|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1513677|NCT00801801||Single Group Assignment||Treatment||None (Open Label)||||||
1513678|NCT00801788|Randomized|Crossover Assignment||||None (Open Label)||||||
1513679|NCT00801775|||Cohort||Prospective|||||||
1513680|NCT00801762|||||Prospective|||||||
1513681|NCT00801749||||||||||||
1513682|NCT00801736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513683|NCT00801723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513684|NCT00801710||Single Group Assignment||Treatment||None (Open Label)||||||
1513685|NCT00801697|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1513686|NCT00801684|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1513687|NCT00801671|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513688|NCT00801658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513689|NCT00801645|Randomized|Parallel Assignment||Treatment||Single||||||t
1513690|NCT00801632||Single Group Assignment||Treatment||None (Open Label)||||||
1513691|NCT00801619|||Cohort||Prospective|||||||
1513692|NCT00801606|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1513693|NCT00801593|||Cohort||Prospective|||||||
1513694|NCT00801580||Single Group Assignment||Treatment||None (Open Label)||||||
1513695|NCT00801567||Single Group Assignment||||None (Open Label)||||||
1513696|NCT00801554|||Case Control||Cross-Sectional|||||||
1513697|NCT00801541|||Cohort||Prospective|||||||
1513698|NCT00801528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513699|NCT00801515||||||||||||
1513700|NCT00801502|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1513701|NCT00801489||Single Group Assignment||Treatment||None (Open Label)||||||
1513702|NCT00801476|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1513703|NCT00801463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513704|NCT00801450|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1513705|NCT00801437|||Case-Only||Prospective|||||||
1513706|NCT00801424|Randomized|Factorial Assignment||Treatment||Single|||t|||
1513707|NCT00801411|Randomized|||Treatment||None (Open Label)||||||
1513708|NCT00801398||Single Group Assignment||Treatment||None (Open Label)||||||
1513709|NCT00801385||||Treatment||None (Open Label)||||||
1513710|NCT00801372|||Case-Control||Prospective|||||||
1513711|NCT00801359|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513712|NCT00801346||||||||||||
1513713|NCT00801333|||Other||Prospective|||||||
1513714|NCT00801320|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1513715|NCT00801307|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1513716|NCT00801294||Parallel Assignment||Treatment||||||||
1513717|NCT00801281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513718|NCT00801268|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1513719|NCT00801255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513720|NCT00801242||Single Group Assignment||Treatment||None (Open Label)||||||
1513721|NCT00801229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513722|NCT00801216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513723|NCT00801203|Randomized|Parallel Assignment||||Single||||||t
1513724|NCT00801190|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1513725|NCT00801177|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1513726|NCT00801164|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1513727|NCT00801151||Single Group Assignment||Treatment||None (Open Label)||||||
1513728|NCT00801138|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1513729|NCT00801125||Single Group Assignment||Treatment||None (Open Label)||||||
1513730|NCT00801112|||Cohort||Prospective|||||||
1513731|NCT00801099|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1513732|NCT00801086|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513733|NCT00801073|Randomized|Parallel Assignment||Treatment||Single|||t|||
1513734|NCT00801060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513735|NCT00801047|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513736|NCT00801034|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513737|NCT00801021||Single Group Assignment||Prevention||None (Open Label)||||||
1513738|NCT00801008|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513739|NCT00800995|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513740|NCT00800982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513741|NCT00800969|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1513742|NCT00800956|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1513743|NCT00800943|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513744|NCT00800930|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1513745|NCT00800917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513746|NCT00800904|||||Retrospective|||||||
1513747|NCT00800891||||||||||||
1513748|NCT00800878|||||Cross-Sectional|||||||
1513749|NCT00800865|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1513750|NCT00800852||||||||||||
1513751|NCT00800839||Single Group Assignment||Treatment||None (Open Label)||||||
1513752|NCT00800826|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1513753|NCT00800813|||Cohort||Prospective|||||||
1513754|NCT00800800|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513755|NCT00800787||Single Group Assignment||Treatment||None (Open Label)||||||
1513756|NCT00800774||Single Group Assignment||Treatment||None (Open Label)||||||
1513757|NCT00800761|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513758|NCT00800748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513759|NCT00800735||Single Group Assignment||Treatment||None (Open Label)||||||
1513760|NCT00800722||Single Group Assignment||Treatment||None (Open Label)||||||
1513761|NCT00800709|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513762|NCT00800696|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513763|NCT00800683|Randomized|Parallel Assignment||Treatment||Double||||||
1513764|NCT00800670|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1513765|NCT00800657||Single Group Assignment||Treatment||Single|||||t|
1513766|NCT00800644|||Case-Only||Prospective|||||||
1513767|NCT00800631|||Cohort||Prospective|||||||
1513768|NCT00800618|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1513769|NCT00800605|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1513770|NCT00800592||Single Group Assignment||Treatment||None (Open Label)||||||
1513771|NCT00800579|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1513772|NCT00800566|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513773|NCT00800553|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1513774|NCT00800540|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513775|NCT00800527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513776|NCT00800514||Crossover Assignment||Basic Science||Single|||t|||
1513777|NCT00800501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513778|NCT00800488|||Case Control||Prospective|||||||
1513779|NCT00800475|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1513780|NCT00800462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513781|NCT00800449|||Cohort||Prospective|||||||
1513782|NCT00800436|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513783|NCT00800423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513784|NCT00800410|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513785|NCT00800397|||Case-Only||Prospective|||||||
1513786|NCT00800384|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1513787|NCT00800371|||Cohort||Prospective|||||||
1513788|NCT00800358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513789|NCT00800345||Single Group Assignment||Treatment||None (Open Label)||||||
1513790|NCT00800332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513791|NCT00800319|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1513792|NCT00800306|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513793|NCT00800293|||Cohort||Prospective|||||||
1513794|NCT00800280|Randomized|Crossover Assignment||||None (Open Label)||||||
1513795|NCT00800267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513796|NCT00800254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513797|NCT00800241|||||Retrospective|||||||
1513798|NCT00800228|||Cohort||Prospective|||||||
1513799|NCT00800215|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513800|NCT00800202|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513801|NCT00800189||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513802|NCT00800176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513803|NCT00800163||Single Group Assignment||||None (Open Label)||||||
1513804|NCT00800150||||Treatment||||||||
1513805|NCT00800137|Randomized|Parallel Assignment||Treatment||Single||||||t
1513806|NCT00800124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513807|NCT00800111||Single Group Assignment||Treatment||None (Open Label)||||||
1513808|NCT00800098|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513809|NCT00800085||Single Group Assignment||||None (Open Label)||||||
1513810|NCT00800072||Single Group Assignment||||None (Open Label)||||||
1513811|NCT00800059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513812|NCT00800046||Single Group Assignment||Treatment||None (Open Label)||||||
1513813|NCT00800033|Randomized|Factorial Assignment||Prevention||Double|||||t|t
1513814|NCT00800007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513815|NCT00799994|||Case-Only||Prospective|||||||
1513816|NCT00799981||||||||||||
1513817|NCT00799968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513818|NCT00799955|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513819|NCT00799942||Single Group Assignment||Treatment||None (Open Label)||||||
1513820|NCT00799929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513821|NCT00799916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513822|NCT00799903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513823|NCT00799890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513824|NCT00799877|||Other||Prospective|||||||
1513825|NCT00799864||Single Group Assignment||Treatment||None (Open Label)||||||
1513826|NCT00799851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513827|NCT00799838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513828|NCT00799825||Single Group Assignment||Prevention||None (Open Label)||||||
1513829|NCT00799812|Randomized|Single Group Assignment||||Single||||||t
1513830|NCT00799799||Single Group Assignment||Treatment||None (Open Label)||||||
1513831|NCT00799786|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1513832|NCT00799773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513833|NCT00799760|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513834|NCT00799747|Randomized|Single Group Assignment||||Single|||t|||
1513835|NCT00799734|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513836|NCT00799721|||Cohort||Prospective|||||||
1513837|NCT00799708|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1513838|NCT00799695|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1513839|NCT00799682|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1513840|NCT00799669|||Case-Control||Prospective|||||||
1513841|NCT00799656|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513842|NCT00799643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513843|NCT00799630|Randomized|Crossover Assignment||||Triple|||t|t|t|
1513844|NCT00799617|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513845|NCT00799604||Single Group Assignment||Treatment||None (Open Label)||||||
1513846|NCT00799591|||||Prospective|||||||
1513847|NCT00799578||Single Group Assignment||Treatment||None (Open Label)||||||
1513848|NCT00799565|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1513849|NCT00799552|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513850|NCT00799539||||||||||||
1513851|NCT00799526|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513852|NCT00799513||Single Group Assignment||Treatment||None (Open Label)||||||
1513853|NCT00799500|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1513854|NCT00799487|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513855|NCT00799474|||Cohort||Cross-Sectional|||||||
1513856|NCT00799461|Randomized|Factorial Assignment||Supportive Care||Single||||||
1513857|NCT00799448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513858|NCT00799435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513859|NCT00799422|Randomized|Crossover Assignment||||Double|||t||t|
1513860|NCT00799409|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513861|NCT00799396||Single Group Assignment||Treatment||None (Open Label)||||||
1513862|NCT00799383|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513863|NCT00799370|Randomized|Parallel Assignment||||None (Open Label)||||||
1513864|NCT00799357|||||Cross-Sectional|||||||
1513865|NCT00799344|||Cohort||Prospective|||||||
1513866|NCT00799331|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1513867|NCT00799305|||Case-Only||Prospective|||||||
1513868|NCT00799292|Randomized|Parallel Assignment||Treatment||Single||||||t
1513869|NCT00799279|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513870|NCT00799266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513871|NCT00799240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513872|NCT00799227||Single Group Assignment||Treatment||None (Open Label)||||||
1513873|NCT00799214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513874|NCT00799201|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513875|NCT00799188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513876|NCT00799175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513877|NCT00799162|||Cohort||Prospective|||||||
1513878|NCT00799149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513879|NCT00799136|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513880|NCT00799123|||Cohort||Prospective|||||||
1513881|NCT00799110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513882|NCT00799097|||Cohort||Prospective|||||||
1513883|NCT00799084|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513884|NCT00799071||Single Group Assignment||Prevention||None (Open Label)||||||
1513885|NCT00799058|Randomized|Parallel Assignment||Prevention||Double|Potential participants who provide inform concent will be invited to screen for the trail. All participants who consent to participate in the trail and meet specified inclusion /exclusion criteria will be invited to enroll.. At enrollment women will be randomly assigned in a1:1: 1 ratio to one of three groups.|All enrolled participants will apply gel on a daily basis for 12 weeks, with clinical follow-up visits at weeks 2, 4,8 and 12 to monitor safety and acceptability, and a final visit 4 weeks post gel discontinuation (Visit 6, week 16) Dapivirine concentration will be measured in blood and vaginal fluid and cervical tissue.|t||t|
1513886|NCT00799045|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513887|NCT00799032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513888|NCT00799019|||Cohort||Prospective|||||||
1513889|NCT00799006|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1513890|NCT00798993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513891|NCT00798980|||Cohort||Prospective|||||||
1513892|NCT00798967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513893|NCT00798954|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513894|NCT00798941|Randomized|Parallel Assignment||Treatment||Single||||||t
1513895|NCT00798915|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1513896|NCT00798902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513897|NCT00798889||Single Group Assignment||Treatment||None (Open Label)||||||
1513898|NCT00798876|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1513899|NCT00798863||Single Group Assignment||Treatment||None (Open Label)||||||
1513900|NCT00798850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513901|NCT00798837||Single Group Assignment||Treatment||None (Open Label)||||||
1513902|NCT00798824|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513903|NCT00798811|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513904|NCT00798798||Single Group Assignment||Treatment||Single||||||t
1513905|NCT00798785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513906|NCT00798772|Randomized|Parallel Assignment||Treatment||Quadruple||Treatment group (Group A): Will receive micronutrients and antioxidants. Control group (Group B): Will receive identical appearing RDA multivitamins and minerals|t|t|t|t
1513907|NCT00798759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513908|NCT00798746|||Case-Only||Prospective|||||||
1513909|NCT00798733|||Cohort||Prospective|||||||
1513910|NCT00798720||Single Group Assignment||Treatment||None (Open Label)||||||
1513911|NCT00798707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513912|NCT00798694|Non-Randomized|Parallel Assignment||Treatment||Single|Doctors assessing patients were masked to treatment. Patients used open label Xalantan in the right eye and Travatan Z in the left eye.||||t|
1513913|NCT00798681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513914|NCT00798668|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513915|NCT00798655||Single Group Assignment||Treatment||None (Open Label)||||||
1513916|NCT00798642|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513917|NCT00798629||Single Group Assignment||Treatment||None (Open Label)||||||
1513918|NCT00798616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513919|NCT00798603||Single Group Assignment||Treatment||None (Open Label)||||||
1513920|NCT00798590|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513921|NCT00798577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513922|NCT00798564|||||Cross-Sectional|||||||
1513923|NCT00798551||Single Group Assignment||Prevention||None (Open Label)||||||
1513924|NCT00798538|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1513925|NCT00798525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513926|NCT00798512||Single Group Assignment||Prevention||None (Open Label)||||||
1513927|NCT00798499|||Case-Only|||||||||
1513928|NCT00798486||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513929|NCT00798473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513930|NCT00798460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513931|NCT00798447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513932|NCT00798434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513933|NCT00798421|||Cohort||Prospective|||||||
1513934|NCT00798408|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1513935|NCT00798395|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1513936|NCT00798382|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513937|NCT00798369|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513938|NCT00798356|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1513939|NCT00798343|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1513940|NCT00798330|||Cohort||Prospective|||||||
1513941|NCT00798317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513942|NCT00798304|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513943|NCT00798291|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1513944|NCT00798278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513945|NCT00798265|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513946|NCT00798252|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513947|NCT00798239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513948|NCT00798226|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1513949|NCT00798213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513950|NCT00798200||Single Group Assignment||Supportive Care||Single||||||t
1513951|NCT00798187|||Case-Control||Retrospective|||||||
1513952|NCT00798174||Single Group Assignment||Treatment||None (Open Label)||Single group undergoing crossover in therapy (defibrillation testing with two different device configurations).||||
1513953|NCT00798161|Randomized|Parallel Assignment||Treatment||Double||||||
1513954|NCT00798148|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513955|NCT00798135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513956|NCT00798122||Single Group Assignment||Diagnostic||None (Open Label)||||||
1513957|NCT00798109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513958|NCT00798096||Single Group Assignment||Treatment||None (Open Label)||||||
1513959|NCT00798083||Single Group Assignment||Treatment||None (Open Label)||||||
1513960|NCT00798070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513961|NCT00798057|||Cohort||Prospective|||||||
1513962|NCT00798044|Randomized|Parallel Assignment||||None (Open Label)||||||
1513963|NCT00798031||Single Group Assignment||Supportive Care||None (Open Label)||||||
1513964|NCT00798018|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1513965|NCT00798005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513966|NCT00797992||Single Group Assignment||Treatment||None (Open Label)||||||
1513967|NCT00797979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513968|NCT00797966|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1513969|NCT00797953|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1513970|NCT00797940|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513971|NCT00797927|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513972|NCT00797914|||Case-Only||Prospective|||||||
1513973|NCT00797901|Randomized|Parallel Assignment||Treatment||Single|||||t|
1513974|NCT00797888|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1513975|NCT00797875|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1513976|NCT00797862|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1513977|NCT00797849|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1513978|NCT00797836|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1513979|NCT00797823|Randomized|Crossover Assignment||Treatment||Single|||t|||
1513980|NCT00797810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513981|NCT00797797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513982|NCT00797784||Single Group Assignment||Treatment||None (Open Label)||||||
1513983|NCT00797771||Single Group Assignment||Treatment||None (Open Label)||||||
1513984|NCT00797758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1513985|NCT00797745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513986|NCT00797732|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1513987|NCT00797719||Single Group Assignment||Treatment||None (Open Label)||||||
1513988|NCT00797706|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1513989|NCT00797693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513990|NCT00797680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1513991|NCT00797667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1513992|NCT00797654|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513993|NCT00797641|||Cohort||Retrospective|||||||
1513994|NCT00797628|Randomized|Factorial Assignment||Health Services Research||Double|||t||t|
1513995|NCT00797615|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1513996|NCT00797602|||Cohort||Prospective|||||||
1513997|NCT00797589|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1513998|NCT00797576|||Case Control||Prospective|||||||
1513999|NCT00797563||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514000|NCT00797550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514001|NCT00797537|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1514002|NCT00797524|||Cohort||Prospective|||||||
1514003|NCT00797511||Single Group Assignment||Prevention||None (Open Label)||||||
1514004|NCT00797498|||Cohort||Prospective|||||||
1514005|NCT00797485|Randomized|||Treatment||None (Open Label)||||||
1514006|NCT00797472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514007|NCT00797459|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1514008|NCT00797446|||Cohort||Prospective|||||||
1514009|NCT00797433|||Case-Only||Prospective|||||||
1514010|NCT00797420|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514011|NCT00797407||Single Group Assignment||Supportive Care||None (Open Label)||||||
1514012|NCT00797394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514013|NCT00797381|||Case Control||Prospective|||||||
1514014|NCT00797368|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514015|NCT00797342|Randomized|Crossover Assignment||||Double|||t||t|
1514016|NCT00797329|||||Retrospective|||||||
1514017|NCT00797316|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514018|NCT00797303||Single Group Assignment||Treatment||Single|||||t|
1514019|NCT00797290|||Cohort||Prospective|||||||
1514020|NCT00797277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514021|NCT00797264|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514022|NCT00797251|||Cohort||Prospective|||||||
1514023|NCT00797238|||Case Control||Prospective|||||||
1514024|NCT00797225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514025|NCT00797212||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514026|NCT00797199|||Cohort||Prospective|||||||
1514027|NCT00797186|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1514028|NCT00797160|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1514029|NCT00797134|||Cohort|||||||||
1514030|NCT00797121|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514031|NCT00797108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514032|NCT00797095|||||Retrospective|||||||
1514033|NCT00797082||Single Group Assignment||Diagnostic||Single||||||t
1514034|NCT00797069|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1514035|NCT00797056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514036|NCT00797043|||Cohort||Prospective|||||||
1514037|NCT00797030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514038|NCT00797017|||Cohort||Prospective|||||||
1514039|NCT00797004|||Cohort||Prospective|||||||
1514040|NCT00796991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514041|NCT00796978||Single Group Assignment||Treatment||None (Open Label)||||||
1514042|NCT00796965|Randomized|Single Group Assignment||||Triple|||t||t|t
1514043|NCT00796952|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1514044|NCT00796939|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514045|NCT00796926|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514046|NCT00796913|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514047|NCT00796900|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514048|NCT00796887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514049|NCT00796874||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514050|NCT00796861||Single Group Assignment||Treatment||None (Open Label)||||||
1514051|NCT00796848|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514052|NCT00796835|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514053|NCT00796822|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514054|NCT00796809|||Cohort||Retrospective|||||||
1514055|NCT00796796|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514056|NCT00796783|||Case-Only||Prospective|||||||
1514057|NCT00796770||Single Group Assignment||Treatment||None (Open Label)||||||
1514058|NCT00796757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514059|NCT00796744|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514060|NCT00796731||Single Group Assignment||Treatment||None (Open Label)||||||
1514061|NCT00796718||Single Group Assignment||Treatment||None (Open Label)||||||
1514062|NCT00796705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514063|NCT00796692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514064|NCT00796679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514065|NCT00796666|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514066|NCT00796653|Randomized|Parallel Assignment||Treatment||Double||||||
1514067|NCT00796640|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514068|NCT00796627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1514069|NCT00796614|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514070|NCT00796601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514071|NCT00796588|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1514072|NCT00796575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514073|NCT00796562|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1514074|NCT00796549||Single Group Assignment||Treatment||None (Open Label)||||||
1514075|NCT00796536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514076|NCT00796523|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1514077|NCT00796510|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514078|NCT00796497|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1514079|NCT00796484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514080|NCT00796471|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514081|NCT00796458|Randomized|||Treatment||None (Open Label)||||||
1514082|NCT00796445|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514083|NCT00796432|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514084|NCT00796419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514085|NCT00796393|Randomized|Parallel Assignment||||Double|||t||t|
1514086|NCT00796380|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1514087|NCT00796367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514088|NCT00796354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514089|NCT00796341|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514090|NCT00796328||Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1514091|NCT00796315||Single Group Assignment||||None (Open Label)||||||
1514092|NCT00796302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514093|NCT00796289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514094|NCT00796276|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514095|NCT00796263||Single Group Assignment||Treatment||None (Open Label)||||||
1514096|NCT00796250|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514097|NCT00796237|Randomized|Parallel Assignment||Treatment||Single||||||t
1514098|NCT00796224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514099|NCT00796211|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514100|NCT00796198|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514101|NCT00796185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514411|NCT00792025|Non-Randomized|||Treatment||None (Open Label)||||||
1514102|NCT00796172|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514103|NCT00796159|||Case-Only||Cross-Sectional|||||||
1514104|NCT00796146|||Cohort||Prospective|||||||
1514105|NCT00796133|Randomized|Crossover Assignment||Treatment||Single|||t|||
1514106|NCT00796120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514107|NCT00796107||Single Group Assignment||Treatment||None (Open Label)||||||
1514108|NCT00796094|||Cohort||Prospective|||||||
1514109|NCT00796081|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514110|NCT00796068|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514111|NCT00796055|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514112|NCT00796042|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1514113|NCT00796029|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514114|NCT00796003|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514115|NCT00795990|||Cohort||Retrospective|||||||
1514116|NCT00795977||Single Group Assignment||Treatment||None (Open Label)||||||
1514117|NCT00795964|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1514118|NCT00795951||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514119|NCT00795938|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1514120|NCT00795925||||||None (Open Label)||||||
1514121|NCT00795912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514122|NCT00795899|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514123|NCT00795886||Single Group Assignment||Treatment||None (Open Label)||||||
1514124|NCT00795873|||Cohort||Prospective|||||||
1514125|NCT00795860|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1514126|NCT00795847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514127|NCT00795834|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1514128|NCT00795821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514129|NCT00795808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514130|NCT00795795|Randomized|Parallel Assignment||||None (Open Label)||||||
1514131|NCT00795782|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1514132|NCT00795769||Single Group Assignment||Supportive Care||None (Open Label)||||||
1514133|NCT00795756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514134|NCT00795743|||Cohort||Prospective|||||||
1514135|NCT00795730|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514136|NCT00795717|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1514137|NCT00795704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514138|NCT00795691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514139|NCT00795678|||Case-Only||Prospective|||||||
1514140|NCT00795665||Single Group Assignment||Treatment||None (Open Label)||||||
1514141|NCT00795652|Randomized|Parallel Assignment||Treatment||Single||||||t
1514142|NCT00795639|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514143|NCT00795626|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514144|NCT00795613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514145|NCT00795600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514146|NCT00795587|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514147|NCT00795574|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1514148|NCT00795561|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514149|NCT00795548|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514150|NCT00795535|||Cohort||Prospective|||||||
1514151|NCT00795522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514152|NCT00795509|||Case-Only||Prospective|||||||
1514153|NCT00795496|||Cohort|||||||||
1514154|NCT00795483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514155|NCT00795470|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1514156|NCT00795457|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514157|NCT00795444||Single Group Assignment||Basic Science||None (Open Label)||||||
1514158|NCT00795418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514159|NCT00795405|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1514160|NCT00795392|||Case Control||Prospective|||||||
1514161|NCT00795379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514162|NCT00795366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514163|NCT00795353|||Case-Only||Prospective|||||||
1514164|NCT00795340|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514165|NCT00795327|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514166|NCT00795314|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514167|NCT00795301|Randomized|||Treatment||||||||
1514168|NCT00795288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514169|NCT00795275|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514170|NCT00795262|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1514171|NCT00795249|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1514172|NCT00795236|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514173|NCT00795223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514174|NCT00795210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514175|NCT00795197||||||||||||
1514176|NCT00795184|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1514177|NCT00795171|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1514178|NCT00795158||Single Group Assignment||Treatment||None (Open Label)||||||
1514179|NCT00795145|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1514180|NCT00795132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514181|NCT00795119||Single Group Assignment||Screening||None (Open Label)||||||
1514182|NCT00795106|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1514183|NCT00795093|||Cohort|||||||||
1514184|NCT00795080|||Case-Control||Prospective|||||||
1514185|NCT00795067|||Case-Only||Prospective|||||||
1514186|NCT00795054|||Cohort||Prospective|||||||
1514187|NCT00795041|||Case-Only||Prospective|||||||
1514188|NCT00795028|Randomized|Single Group Assignment||||||||||
1514189|NCT00795015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514190|NCT00795002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514191|NCT00794989|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514192|NCT00794976|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514193|NCT00794963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514194|NCT00794950||Single Group Assignment||Treatment||None (Open Label)||||||
1514195|NCT00794924|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514196|NCT00794911|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1514197|NCT00794898||Single Group Assignment||Treatment||None (Open Label)||||||
1514198|NCT00794885|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514199|NCT00794872|||Cohort||Prospective|||||||
1514200|NCT00794859||Single Group Assignment||Treatment||None (Open Label)||||||
1514201|NCT00794846|Randomized|Crossover Assignment||||None (Open Label)||||||
1514202|NCT00794820||Single Group Assignment||Treatment||None (Open Label)||||||
1514203|NCT00794807||Single Group Assignment||Treatment||None (Open Label)||||||
1514204|NCT00794794|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1514205|NCT00794781|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514206|NCT00794768|Randomized|Crossover Assignment||||None (Open Label)||||||
1514207|NCT00794755|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514208|NCT00794742|||Case Control||Prospective|||||||
1514209|NCT00794729|||||Prospective|||||||
1514210|NCT00794716||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514211|NCT00794703|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514212|NCT00794690|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514213|NCT00794677|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1514214|NCT00794664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514215|NCT00794651|||||Prospective|||||||
1514216|NCT00794638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514217|NCT00794625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514218|NCT00794612|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1514219|NCT00794599|Randomized|Crossover Assignment||||None (Open Label)||||||
1514220|NCT00794586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514221|NCT00794573|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514222|NCT00794560|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1514223|NCT00794547|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514224|NCT00794534||||||||||||
1514225|NCT00794508||Single Group Assignment||Treatment||None (Open Label)||||||
1514226|NCT00794495|Randomized|Crossover Assignment||||None (Open Label)||||||
1514227|NCT00794482|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1514228|NCT00794469|||Cohort||Prospective|||||||
1514229|NCT00794456|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514230|NCT00794443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514231|NCT00794430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514232|NCT00794417||Single Group Assignment||Treatment||None (Open Label)||||||
1514233|NCT00794404|||Cohort||Prospective|||||||
1514234|NCT00794391|Randomized|Parallel Assignment||Prevention||Single||||||t
1514235|NCT00794378|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1514236|NCT00794365|||Cohort||Prospective|||||||
1514237|NCT00794352|||Case-Control||Prospective|||||||
1514238|NCT00794339||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514239|NCT00794326|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514240|NCT00794313|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1514241|NCT00794300|||Cohort||Prospective|||||||
1514242|NCT00794287|||Cohort||Retrospective|||||||
1514243|NCT00794274||Single Group Assignment||Treatment||None (Open Label)||||||
1514244|NCT00794261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514245|NCT00794248|Randomized|Crossover Assignment||||None (Open Label)||||||
1514246|NCT00794235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514247|NCT00794222|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1514248|NCT00794209||Crossover Assignment||||None (Open Label)||||||
1514249|NCT00794196|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1514250|NCT00794183|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514251|NCT00794170|Randomized|Parallel Assignment||||None (Open Label)||||||
1514252|NCT00794157|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514253|NCT00794144|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1514254|NCT00794131||Single Group Assignment||Treatment||None (Open Label)||||||
1514255|NCT00794118|||Cohort||Prospective|||||||
1514256|NCT00794105|||Case Control||Prospective|||||||
1514257|NCT00794092||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514258|NCT00794079|Randomized|Parallel Assignment||Prevention||Single|||t|||
1514259|NCT00794066|||Cohort||Prospective|||||||
1514260|NCT00794053||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514261|NCT00794040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514262|NCT00794027||Single Group Assignment||Treatment||None (Open Label)||||||
1514263|NCT00794014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514264|NCT00794001||Single Group Assignment||Health Services Research||None (Open Label)||||||
1514265|NCT00793988|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514266|NCT00793975|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1514267|NCT00793962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514268|NCT00793936|||Case Control||Prospective|||||||
1514269|NCT00793923|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1514270|NCT00793910|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1514271|NCT00793897|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514272|NCT00793884|||Cohort||Prospective|||||||
1514273|NCT00793871||Single Group Assignment||Treatment||None (Open Label)||||||
1514274|NCT00793858|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1514275|NCT00793845||Single Group Assignment||Treatment||None (Open Label)||||||
1514276|NCT00793832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514277|NCT00793819|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514278|NCT00793806|||Case-Only||Prospective|||||||
1514279|NCT00793793|Randomized|Parallel Assignment||Treatment||Double||||||
1514280|NCT00793780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514281|NCT00793767|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1514282|NCT00793754|Randomized|Parallel Assignment||Treatment||Single||||||t
1514283|NCT00793741|||Case-Control||Prospective|||||||
1514284|NCT00793728|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514285|NCT00793715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514286|NCT00793702|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1514287|NCT00793689|||Cohort||Prospective|||||||
1514288|NCT00793676|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1514289|NCT00793663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514290|NCT00793650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514291|NCT00793637|||Case-Only||Prospective|||||||
1514292|NCT00793624|Randomized|Parallel Assignment||Treatment||Double||||||
1514293|NCT00793611|Randomized|Parallel Assignment||Treatment||Single||||||t
1514294|NCT00793598|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514295|NCT00793585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514296|NCT00793572||Single Group Assignment||Treatment||None (Open Label)||||||
1514297|NCT00793559|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1514298|NCT00793546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514299|NCT00793520|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1514300|NCT00793507|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514301|NCT00793494|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1514302|NCT00793481|||Case-Only||Prospective|||||||
1514303|NCT00793468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514304|NCT00793455|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1514305|NCT00793442|||Cohort||Prospective|||||||
1514306|NCT00793429||||||||||||
1514307|NCT00793416||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514308|NCT00793403|||Cohort||Prospective|||||||
1514309|NCT00793390|||Case-Control||Retrospective|||||||
1514310|NCT00793377|Randomized|Parallel Assignment||||None (Open Label)||||||
1514311|NCT00793364|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1514312|NCT00793351||Single Group Assignment||Treatment||None (Open Label)||||||
1514313|NCT00793338|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514314|NCT00793325|||Case-Only||Prospective|||||||
1514315|NCT00793312|||Cohort||Prospective|||||||
1514316|NCT00793299||Single Group Assignment||Supportive Care||None (Open Label)||||||
1514317|NCT00793286|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514318|NCT00793273|||Cohort||Prospective|||||||
1514319|NCT00793260|Randomized|Parallel Assignment||||Single|||t|||
1514320|NCT00793247||||||||||||
1514321|NCT00793234|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514322|NCT00793221|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1514323|NCT00793208|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514324|NCT00793195|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514325|NCT00793182|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1514326|NCT00793169|||Cohort||Prospective|||||||
1514327|NCT00793156|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1514328|NCT00793143|||Cohort||Prospective|||||||
1514329|NCT00793130||Single Group Assignment||Treatment||None (Open Label)||||||
1514330|NCT00793117|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1514331|NCT00793104||Single Group Assignment||Treatment||None (Open Label)||||||
1514332|NCT00793091|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514333|NCT00793078|||Case Control||Prospective|||||||
1514334|NCT00793065|||Cohort||Prospective|||||||
1514335|NCT00793052||Single Group Assignment||Treatment||Triple|||t|t|t|
1514336|NCT00793026|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1514337|NCT00793013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514338|NCT00793000|Randomized|Parallel Assignment||||Double|||t||t|
1514339|NCT00792974|||Case Control||Prospective|||||||
1514340|NCT00792961||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514341|NCT00792948||Single Group Assignment||Treatment||None (Open Label)||||||
1514342|NCT00792935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514343|NCT00792922|Randomized|Factorial Assignment||Treatment||Single||"The study was a factorial study model to begin with in all 3 countries (Niger,Tanzania and Gambia) but because we never stopped treatment in Tanzania and Niger site.Hence the study design was collapsed to a simple design in Tanzania and Niger.The study model was kept as a factorial design for the Gambia site.~Protocol Enrollment refers to the number of communities, not the number of participants enrolled."||||t
1514344|NCT00792909|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514345|NCT00792896||Parallel Assignment||Health Services Research||None (Open Label)||||||
1514346|NCT00792883|||Cohort||Prospective|||||||
1514347|NCT00792870|Randomized|Factorial Assignment||Treatment||Single||||||t
1514348|NCT00792857|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514349|NCT00792844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514350|NCT00792831||Single Group Assignment||Treatment||None (Open Label)||||||
1514351|NCT00792818|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1514352|NCT00792805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514353|NCT00792792|||Case-Only||Prospective|||||||
1514354|NCT00792779|Randomized|Parallel Assignment||Treatment||Single||||||t
1514355|NCT00792766||Single Group Assignment||Treatment||None (Open Label)||||||
1514356|NCT00792753|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514357|NCT00792740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514358|NCT00792727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514359|NCT00792714|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514360|NCT00792701||Single Group Assignment||Treatment||None (Open Label)||||||
1514361|NCT00792688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514362|NCT00792675||Single Group Assignment||Treatment||None (Open Label)||||||
1514363|NCT00792662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514364|NCT00792649|||Case Control||Prospective|||||||
1514365|NCT00792636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514366|NCT00792623|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1514367|NCT00792610||Single Group Assignment||Prevention||None (Open Label)||||||
1514368|NCT00792597|||Cohort||Prospective|||||||
1514369|NCT00792584|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1514370|NCT00792571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514371|NCT00792558||Single Group Assignment||Treatment||None (Open Label)||||||
1514372|NCT00792532||Single Group Assignment||Treatment||None (Open Label)||||||
1514373|NCT00792519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514374|NCT00792506|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514375|NCT00792493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514376|NCT00792480|Randomized|Parallel Assignment||Prevention||Single|||t|||
1514377|NCT00792467||Single Group Assignment||Treatment||None (Open Label)||||||
1514378|NCT00792454|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514379|NCT00792441||Single Group Assignment||Treatment||Single|||t|||
1514380|NCT00792428|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1514381|NCT00792415|||Cohort||Prospective|||||||
1514382|NCT00792402|||Case Control||Prospective|||||||
1514383|NCT00792389|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514384|NCT00792376|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514385|NCT00792363|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1514386|NCT00792350|||Cohort||Prospective|||||||
1514387|NCT00792337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514388|NCT00792324|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1514389|NCT00792311||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514390|NCT00792298|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1514391|NCT00792285|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514392|NCT00792272|||Case Control||Cross-Sectional|||||||
1514393|NCT00792259|||Cohort||Prospective|||||||
1514394|NCT00792246|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514395|NCT00792233||Single Group Assignment||Treatment||None (Open Label)||||||
1514396|NCT00792220|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1514397|NCT00792207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514398|NCT00792194|Randomized|Parallel Assignment||||None (Open Label)||||||
1514399|NCT00792181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514400|NCT00792168|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1514401|NCT00792155|||Cohort||Prospective|||||||
1514402|NCT00792142||Single Group Assignment||Treatment||None (Open Label)||||||
1514403|NCT00792129|||Cohort||Prospective|||||||
1514404|NCT00792116|Randomized|Parallel Assignment||Treatment||Single||||||t
1514405|NCT00792103||Single Group Assignment||Treatment||None (Open Label)||||||
1514406|NCT00792090|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514407|NCT00792077||Single Group Assignment||Treatment||None (Open Label)||||||
1514408|NCT00792064|||Cohort||Prospective|||||||
1514409|NCT00792051|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1514410|NCT00792038|||Case Control||Prospective|||||||
1514412|NCT00792012||Single Group Assignment||Treatment||None (Open Label)||||||
1514413|NCT00791999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514414|NCT00791986|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1514415|NCT00791973|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1514416|NCT00791960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514417|NCT00791947|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514418|NCT00791934||Single Group Assignment||Treatment||None (Open Label)||||||
1514419|NCT00791921|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514420|NCT00791908|Randomized|Single Group Assignment||Treatment||Single||||||t
1514421|NCT00791895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514422|NCT00791882|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514423|NCT00791869|||Case-Only||Cross-Sectional|||||||
1514424|NCT00791856|Randomized|Crossover Assignment||||None (Open Label)||||||
1514425|NCT00791843|Randomized|Crossover Assignment||Treatment||Single|||t|||
1514426|NCT00791830|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514427|NCT00791817|Randomized|Crossover Assignment||||None (Open Label)||||||
1514428|NCT00791804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514429|NCT00791791|Randomized|||Diagnostic||||||||
1514430|NCT00791778|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514431|NCT00791765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514432|NCT00791752|Randomized|Single Group Assignment||||Single|||t|||
1514433|NCT00791739||Single Group Assignment||Treatment||None (Open Label)||||||
1514434|NCT00791726|||Cohort||Cross-Sectional|||||||
1514435|NCT00791713|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514436|NCT00791700||Parallel Assignment||Treatment||None (Open Label)||||||
1514437|NCT00791687|||Case Control||Prospective|||||||
1514438|NCT00791674|||Cohort||Prospective|||||||
1514439|NCT00791661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514440|NCT00791648|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514441|NCT00791635|||Cohort||Prospective|||||||
1514442|NCT00791622|Randomized|Parallel Assignment||Treatment||Double||||||
1514443|NCT00791609|||Case-Only||Cross-Sectional|||||||
1514444|NCT00791596|Non-Randomized|Crossover Assignment||Prevention||Single|||||t|
1514445|NCT00791583|||Cohort||Prospective|||||||
1514446|NCT00791570||Single Group Assignment||Treatment||None (Open Label)||||||
1514447|NCT00791557||Single Group Assignment||Treatment||None (Open Label)||||||
1514448|NCT00791544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514449|NCT00791531||Single Group Assignment||Treatment||None (Open Label)||||||
1514450|NCT00791518|||||Prospective|||||||
1514451|NCT00791505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514452|NCT00791492||Single Group Assignment||Treatment||None (Open Label)||||||
1514453|NCT00791479|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514454|NCT00791466|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514455|NCT00791453|||Case-Only||Prospective|||||||
1514456|NCT00791440|Randomized|Parallel Assignment||Treatment||Single||||||t
1514457|NCT00791427|||Case-Only||Prospective|||||||
1514458|NCT00791414||||||||||||
1514459|NCT00791401|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514460|NCT00791388|Randomized|Parallel Assignment||||Double|||t||t|
1514461|NCT00791375|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1514462|NCT00791362|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1514463|NCT00791349|Randomized|Parallel Assignment||Treatment||Double||||||
1514464|NCT00791336||Single Group Assignment||Treatment||None (Open Label)||||||
1514465|NCT00791323|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1514466|NCT00791310|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514467|NCT00791297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514468|NCT00791284|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514469|NCT00791271||Single Group Assignment||Treatment||None (Open Label)||||||
1514470|NCT00791258||Single Group Assignment||Treatment||None (Open Label)||||||
1514471|NCT00791245|||Case-Only||Prospective|||||||
1514472|NCT00791232|Randomized|Parallel Assignment||Treatment||Double||||||
1514473|NCT00791219|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1514474|NCT00791206|Randomized|Crossover Assignment||||Single|||t|||
1514475|NCT00791193|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514476|NCT00791180|||Cohort||Prospective|||||||
1514477|NCT00791167|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514478|NCT00791154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514479|NCT00791141||Single Group Assignment||Treatment||None (Open Label)||||||
1514480|NCT00791128||Single Group Assignment||Treatment||None (Open Label)||||||
1514481|NCT00791115||Single Group Assignment||Treatment||None (Open Label)||||||
1514482|NCT00791102|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1514483|NCT00791089|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514484|NCT00791076|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514485|NCT00791063||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514486|NCT00791050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514487|NCT00791037||Single Group Assignment||Treatment||None (Open Label)||||||
1514488|NCT00791024|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1514489|NCT00791011|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514490|NCT00790998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514491|NCT00790985|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514492|NCT00790972|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514493|NCT00790959|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1514494|NCT00790946|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514495|NCT00790933||Single Group Assignment||Other||None (Open Label)||||||
1514496|NCT00790920|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514497|NCT00790907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514498|NCT00790894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514499|NCT00790881||Parallel Assignment||Treatment||None (Open Label)||||||
1514500|NCT00790868|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514501|NCT00790855||Single Group Assignment||Treatment||None (Open Label)||||||
1514502|NCT00790842|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514503|NCT00790829|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1514504|NCT00790816|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514505|NCT00790803||Single Group Assignment||Treatment||None (Open Label)||||||
1514506|NCT00790790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514507|NCT00790777|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514508|NCT00790764|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514509|NCT00790751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514510|NCT00790738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514511|NCT00790725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514512|NCT00790699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514513|NCT00790686||Single Group Assignment||Treatment||None (Open Label)||||||
1514514|NCT00790673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514515|NCT00790660|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514516|NCT00790647||Single Group Assignment||Treatment||None (Open Label)||||||
1514517|NCT00790634|||Case Control||Prospective|||||||
1514518|NCT00790621||||||||||||
1514519|NCT00790608||Single Group Assignment||Treatment||None (Open Label)||||||
1514520|NCT00790595|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514521|NCT00790582||Single Group Assignment||Treatment||None (Open Label)||||||
1514522|NCT00790569|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1514523|NCT00790556|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1514524|NCT00790543|||Cohort||Prospective|||||||
1514525|NCT00790530|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1514526|NCT00790517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514527|NCT00790504|||Cohort||Prospective|||||||
1514528|NCT00790491|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1514529|NCT00790478|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1514530|NCT00790465|Randomized|Crossover Assignment||Treatment||Single||||||t
1514531|NCT00790452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514532|NCT00790439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514533|NCT00790426|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514534|NCT00790413||Single Group Assignment||Treatment||None (Open Label)||||||
1514535|NCT00790400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514536|NCT00790387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514537|NCT00790374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514538|NCT00790361|||Cohort||Prospective|||||||
1514539|NCT00790348|||||Cross-Sectional|||||||
1514540|NCT00790335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514541|NCT00790322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514542|NCT00790309|||Case-Control||Prospective|||||||
1514543|NCT00790296|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1514544|NCT00790283|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514545|NCT00790270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514546|NCT00790257||Single Group Assignment||Treatment||None (Open Label)||||||
1514547|NCT00790244|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514548|NCT00790231|||Cohort||Prospective|||||||
1514549|NCT00790218||Single Group Assignment||Treatment||None (Open Label)||||||
1514550|NCT00790205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514551|NCT00790192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514552|NCT00790179|Randomized|Crossover Assignment||Treatment||Single|||t|||
1514553|NCT00790166|Randomized|Crossover Assignment||Treatment||Single|||t|||
1514554|NCT00790153|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514555|NCT00790140|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1514556|NCT00790127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514557|NCT00790114|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1514558|NCT00790101|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1514559|NCT00790088|||Cohort||Prospective|||||||
1514560|NCT00790075||Single Group Assignment||Treatment||None (Open Label)||||||
1514561|NCT00790062|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514562|NCT00790049|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1514563|NCT00790036|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514564|NCT00790023|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514565|NCT00790010|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514566|NCT00789997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514567|NCT00789984|||||Prospective|||||||
1514568|NCT00789971|Randomized|Single Group Assignment||Treatment||Single||||||t
1514569|NCT00789958||Single Group Assignment||Treatment||None (Open Label)||||||
1514570|NCT00789945|Randomized|Factorial Assignment||Diagnostic||Double|||||t|t
1514571|NCT00789932|Randomized|Parallel Assignment||Treatment||Single||||||t
1514572|NCT00789919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514573|NCT00789906|||||Prospective|||||||
1514574|NCT00789893|||Cohort||Prospective|||||||
1514575|NCT00789880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514576|NCT00789867||Single Group Assignment||Treatment||None (Open Label)||||||
1514577|NCT00789854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514578|NCT00789841||||||||||||
1514579|NCT00789828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514580|NCT00789815|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1514581|NCT00789802|Randomized|Parallel Assignment||Prevention||Single||||||t
1514582|NCT00789789|||Cohort||Prospective|||||||
1514583|NCT00789776||Single Group Assignment||Treatment||None (Open Label)||||||
1514584|NCT00789763||Single Group Assignment||Treatment||None (Open Label)||||||
1514585|NCT00789750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514586|NCT00789737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514587|NCT00789724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514588|NCT00789711|||Cohort||Prospective|||||||
1514589|NCT00789698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514590|NCT00789685||Single Group Assignment||Treatment||None (Open Label)||||||
1514591|NCT00789672|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514592|NCT00789659|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514593|NCT00789646|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1514594|NCT00789633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514595|NCT00789620|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1514596|NCT00789607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514597|NCT00789594|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1514598|NCT00789581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514599|NCT00789568|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1514600|NCT00789555|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514601|NCT00789542|Randomized|Parallel Assignment||Prevention||Single||||||t
1514602|NCT00789529|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1514603|NCT00789516|||Case Control||Cross-Sectional|||||||
1514604|NCT00789503||Single Group Assignment||Treatment||None (Open Label)||||||
1514605|NCT00789490|Randomized|Crossover Assignment||||None (Open Label)||||||
1514606|NCT00789477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514607|NCT00789464|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514608|NCT00789451|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1514609|NCT00789438|||Case Control||Prospective|||||||
1514610|NCT00789425|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514611|NCT00789412|||Case Control||Cross-Sectional|||||||
1514612|NCT00789399|Randomized|Parallel Assignment||Treatment||Single|||||t|
1514613|NCT00789386|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1514614|NCT00789373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514615|NCT00789360|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1514616|NCT00789347|||Case Control||Cross-Sectional|||||||
1514617|NCT00789334||||||||||||
1514618|NCT00789321|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1514619|NCT00789308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514620|NCT00789295|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1514621|NCT00789282|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1514622|NCT00789269|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514623|NCT00789256||Single Group Assignment||Treatment||None (Open Label)||||||
1514624|NCT00789243|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1514625|NCT00789230|Randomized|Parallel Assignment||Treatment||Triple||Suture versus mesh repair in umbilical hernia patients|t||t|t
1514626|NCT00789217|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1514627|NCT00789204|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1514628|NCT00789191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514629|NCT00789178|||Cohort||Prospective|||||||
1514630|NCT00789165|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514631|NCT00789152|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1514632|NCT00789139||Single Group Assignment||Supportive Care||None (Open Label)||||||
1514633|NCT00789126|Randomized|||||Double||||||
1514634|NCT00789113||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514635|NCT00789100|||Cohort||Prospective|||||||
1514636|NCT00789087|Randomized|Parallel Assignment||Treatment||Single||||||t
1514637|NCT00789074|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514638|NCT00789061|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1514639|NCT00789048|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1514640|NCT00789035||Parallel Assignment||Treatment||||||||
1514641|NCT00789022|||||Prospective|||||||
1514642|NCT00789009|||||Prospective|||||||
1514643|NCT00788996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514644|NCT00788983|||||Prospective|||||||
1514645|NCT00788970|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1514646|NCT00788957|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514647|NCT00788944|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1514648|NCT00788931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514649|NCT00788918|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1514650|NCT00788905|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514651|NCT00788892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514652|NCT00788879|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514653|NCT00788866|Randomized|Single Group Assignment||Prevention||Double||||t|t|
1514654|NCT00788853|||Ecologic or Community||Cross-Sectional|||||||
1514655|NCT00788840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514656|NCT00788827||Single Group Assignment||Treatment||None (Open Label)||||||
1514657|NCT00788814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514658|NCT00788801|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1514659|NCT00788788|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1514660|NCT00788775||Single Group Assignment||Treatment||None (Open Label)||||||
1514661|NCT00788762|||Cohort||Prospective|||||||
1514662|NCT00788749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514663|NCT00788736|||Cohort||Prospective|||||||
1514664|NCT00788723|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1514665|NCT00788710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514666|NCT00788697||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514667|NCT00788684||Single Group Assignment||Treatment||None (Open Label)||||||
1514668|NCT00788671||Single Group Assignment||Treatment||None (Open Label)||||||
1514669|NCT00788658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514670|NCT00788645|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514671|NCT00788632|Randomized|Parallel Assignment||Prevention||Single|||t|||
1514672|NCT00788619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514673|NCT00788606|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514674|NCT00788593|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1514675|NCT00788580||||Treatment||||||||
1514676|NCT00788567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514677|NCT00788554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514678|NCT00788541|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1514679|NCT00788528||Single Group Assignment||Treatment||None (Open Label)||||||
1514680|NCT00788515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514681|NCT00788502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514682|NCT00788489|||Cohort||Prospective|||||||
1514683|NCT00788476|||Case-Only||Prospective|||||||
1514684|NCT00788463|Randomized|Parallel Assignment||Treatment||Single|||||t|
1514685|NCT00788450||||||||||||
1514686|NCT00788437||||||||||||
1514687|NCT00788424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514688|NCT00788398|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1514689|NCT00788385||Single Group Assignment||Diagnostic||Double|||t||t|
1514690|NCT00788372||Single Group Assignment||Treatment||None (Open Label)||||||
1514691|NCT00788359|||Case-Only||Prospective|||||||
1514692|NCT00788346|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1514693|NCT00788333||Single Group Assignment||Treatment||None (Open Label)||||||
1514694|NCT00788320|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1514695|NCT00788307||Single Group Assignment||Treatment||None (Open Label)||||||
1514696|NCT00788294|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514697|NCT00788281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514698|NCT00788255|||Case-Only||Prospective|||||||
1514699|NCT00788242|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514700|NCT00788229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514701|NCT00788216|||||Prospective|||||||
1514702|NCT00788203|||Case Control||Prospective|||||||
1514703|NCT00788190|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1514704|NCT00788177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514705|NCT00788164|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514706|NCT00788151|Randomized|Crossover Assignment||Prevention||Single||||||t
1514707|NCT00788138|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1514708|NCT00788125||Single Group Assignment||Treatment||None (Open Label)||||||
1514709|NCT00788112||Single Group Assignment||Other||None (Open Label)||||||
1514710|NCT00788099|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514711|NCT00788073|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1514712|NCT00788060||Single Group Assignment||Treatment||None (Open Label)||||||
1514713|NCT00788047|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1514714|NCT00788034|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514715|NCT00788021|||Cohort||Prospective|||||||
1514716|NCT00788008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514717|NCT00787995|||Case-Only|||||||||
1514718|NCT00787982||Single Group Assignment||Treatment||None (Open Label)||||||
1514719|NCT00787969||Single Group Assignment||Treatment||None (Open Label)||||||
1514720|NCT00787956|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1514721|NCT00787943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514722|NCT00787930|||Case Control||Prospective|||||||
1514723|NCT00787917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514724|NCT00787904|||Case Control||Prospective|||||||
1514725|NCT00787891|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514726|NCT00787878|||Cohort|||||||||
1514727|NCT00787865|||Case-Control||Prospective|||||||
1514728|NCT00787852|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514729|NCT00787839|||Cohort||Cross-Sectional|||||||
1514730|NCT00787826||Single Group Assignment||Prevention||None (Open Label)||||||
1514731|NCT00787813|Randomized|Parallel Assignment||Prevention||Single|||t|||
1514732|NCT00787800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514733|NCT00787787||Single Group Assignment||Treatment||None (Open Label)||||||
1514734|NCT00787774||Single Group Assignment||Screening||None (Open Label)||||||
1514735|NCT00787761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514736|NCT00787748|||||Cross-Sectional|||||||
1514737|NCT00787735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514738|NCT00787722||Single Group Assignment||Treatment||None (Open Label)||||||
1514739|NCT00787709|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514740|NCT00787696|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514741|NCT00787683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514742|NCT00787670|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1514743|NCT00787657|||Cohort||Prospective|||||||
1514744|NCT00787644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514745|NCT00787631|||Case-Only||Prospective|||||||
1514746|NCT00787618|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1514747|NCT00787605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514748|NCT00787592|||Cohort||Prospective|||||||
1514749|NCT00787579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514750|NCT00787566|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1514751|NCT00787553|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514752|NCT00787540|||Case Control||Prospective|||||||
1514753|NCT00787527||Single Group Assignment||Treatment||None (Open Label)||||||
1514754|NCT00787514||||||||||||
1514755|NCT00787501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514756|NCT00787488||Single Group Assignment||Treatment||None (Open Label)||||||
1514757|NCT00787475|Randomized|Parallel Assignment||Prevention||Single|||||t|
1514758|NCT00787462|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1514759|NCT00787436|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514760|NCT00787423|||||Prospective|||||||
1514761|NCT00787410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514762|NCT00787397||Single Group Assignment||Treatment||None (Open Label)||||||
1514763|NCT00787384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514764|NCT00787371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514765|NCT00787358|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514766|NCT00787345|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1514767|NCT00787332|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514768|NCT00787319|||Case-Control||Cross-Sectional|||||||
1514769|NCT00787306|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514770|NCT00787293||Single Group Assignment||Treatment||None (Open Label)||||||
1514771|NCT00787280|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1514772|NCT00787267||Single Group Assignment||Treatment||None (Open Label)||||||
1514773|NCT00787254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514774|NCT00787241|||Cohort||Retrospective|||||||
1514775|NCT00787215|||Case-Only||Prospective|||||||
1514776|NCT00787202|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514777|NCT00787189|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1514778|NCT00787176|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1514779|NCT00787163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514780|NCT00787150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514781|NCT00787137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514782|NCT00787124|||Cohort||Prospective|||||||
1514783|NCT00787111||Single Group Assignment||Treatment||None (Open Label)||||||
1514784|NCT00787098|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514785|NCT00787085|||Case Control||Prospective|||||||
1514786|NCT00787072|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1514787|NCT00787059|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514788|NCT00787033||Single Group Assignment||Treatment||None (Open Label)||||||
1514789|NCT00787020|||Case Control||Prospective|||||||
1514790|NCT00787007|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1514791|NCT00786994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514792|NCT00786981|Randomized|Parallel Assignment||Treatment||Single||||||t
1514793|NCT00786968||Single Group Assignment||Treatment||None (Open Label)||||||
1514794|NCT00786942|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1514795|NCT00786929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514796|NCT00786916|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1514797|NCT00786903|||Case Control||Prospective|||||||
1514798|NCT00786890|||Case-Only||Prospective|||||||
1514799|NCT00786877|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1514800|NCT00786864|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1514801|NCT00786851||Single Group Assignment||Treatment||None (Open Label)||||||
1514802|NCT00786838||Single Group Assignment||Treatment||Single|||t|||
1514803|NCT00786825|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1514804|NCT00786812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514805|NCT00786799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514806|NCT00786786|||Case-Only||Cross-Sectional|||||||
1514807|NCT00786773|||||Prospective|||||||
1514808|NCT00786760|||Ecologic or Community||Prospective|||||||
1514809|NCT00786747|Randomized|Parallel Assignment||Screening||Triple|||t||t|t
1514810|NCT00786734|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514811|NCT00786721|||Cohort||Prospective|||||||
1514812|NCT00786708|||Cohort||Prospective|||||||
1514813|NCT00786695|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1514814|NCT00786682||Single Group Assignment||Treatment||None (Open Label)||||||
1514815|NCT00786669||Single Group Assignment||Treatment||None (Open Label)||||||
1514816|NCT00786656|||Other||Cross-Sectional|||||||
1514817|NCT00786643|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514818|NCT00786630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514819|NCT00786617|||Cohort||Prospective|||||||
1514820|NCT00786604|||Case Control||Prospective|||||||
1514821|NCT00786591|||Case Control||Prospective|||||||
1514822|NCT00786578|||Case Control||Prospective|||||||
1514823|NCT00786565|Randomized|Parallel Assignment||||Single|||t|||
1514824|NCT00786552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514825|NCT00786539|||Case-Control||Prospective|||||||
1514826|NCT00786526|||Case-Only||Prospective|||||||
1514827|NCT00786513|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514828|NCT00786500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514829|NCT00786487|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1514830|NCT00786474|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1514831|NCT00786461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514832|NCT00786448|||Cohort||Prospective|||||||
1514833|NCT00786435|||Case Control||Prospective|||||||
1514834|NCT00786422||Single Group Assignment||Treatment||None (Open Label)||||||
1514835|NCT00786409||Single Group Assignment||Prevention||None (Open Label)||||||
1514836|NCT00786396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514837|NCT00786383|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514838|NCT00786370|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514839|NCT00786357||Single Group Assignment||Treatment||Double|||t|||t
1514840|NCT00786344|Randomized|Crossover Assignment||||Triple|||t|t||t
1514841|NCT00786331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514842|NCT00786318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514843|NCT00786305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514844|NCT00786292||||Treatment||||||||
1514845|NCT00786279|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1514846|NCT00786266|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1514847|NCT00786253|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514848|NCT00786240|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514849|NCT00786227|||Cohort||Prospective|||||||
1514850|NCT00786214|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514851|NCT00786201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514852|NCT00786188|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514853|NCT00786175|||Case-Only||Retrospective|||||||
1514854|NCT00786162|Randomized|Parallel Assignment||||None (Open Label)||||||
1514855|NCT00786149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514856|NCT00786136|Randomized|Parallel Assignment||Prevention||Single||||||t
1514857|NCT00786123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514858|NCT00786110|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514859|NCT00786097|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1514860|NCT00786084|||Case Control||Retrospective|||||||
1514861|NCT00786071|||||Cross-Sectional|||||||
1514862|NCT00786058||||||||||||
1514863|NCT00786045|Randomized|Parallel Assignment||||Single||||||t
1514864|NCT00786032|||Cohort||Prospective|||||||
1514865|NCT00786019||Single Group Assignment||Health Services Research||None (Open Label)||||||
1514866|NCT00786006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514867|NCT00785993|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1514868|NCT00785980|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1514869|NCT00785967|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1514870|NCT00785954|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514871|NCT00785941||Single Group Assignment||||None (Open Label)||||||
1514872|NCT00785928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514873|NCT00785915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514874|NCT00785902||||||||||||
1514875|NCT00785889|Randomized|Single Group Assignment||Screening||Single|||t|||
1514876|NCT00785876|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1514877|NCT00785863|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1514878|NCT00785850|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1514879|NCT00785837||Parallel Assignment||Supportive Care||Single||||||t
1514880|NCT00785824|||Cohort||Prospective|||||||
1514881|NCT00785811|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1514882|NCT00785798||Single Group Assignment||Treatment||None (Open Label)||||||
1514883|NCT00785785|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514884|NCT00785772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514885|NCT00785759||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514886|NCT00785746|Randomized|Parallel Assignment||||Single||||||t
1514887|NCT00785733|||Cohort||Prospective|||||||
1514888|NCT00785720|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1514889|NCT00785707|||Cohort||Prospective|||||||
1514890|NCT00785694|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1514891|NCT00785681|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1514892|NCT00785668||Single Group Assignment||Treatment||||||||
1514893|NCT00785655|Non-Randomized|Single Group Assignment||Supportive Care||||||||
1514894|NCT00785642|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1514895|NCT00785629|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514896|NCT00785616||Single Group Assignment||Treatment||None (Open Label)||||||
1514897|NCT00785603|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1514898|NCT00785590|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1514899|NCT00785577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514900|NCT00785564|||Cohort||Prospective|||||||
1514901|NCT00785551|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1514902|NCT00785538||Single Group Assignment||Treatment||None (Open Label)||||||
1514903|NCT00785525||Single Group Assignment||Other||None (Open Label)||||||
1514904|NCT00785512|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514905|NCT00785499|Randomized|Factorial Assignment||Prevention||Triple||||t|t|t
1514906|NCT00785486|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1514907|NCT00785473|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514908|NCT00785460|Randomized|Crossover Assignment||Prevention||Single||||||
1514909|NCT00785447||Single Group Assignment||Treatment||None (Open Label)||||||
1514910|NCT00785434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514911|NCT00785421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514912|NCT00785408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514913|NCT00785395||Single Group Assignment||Prevention||Double|||t|t||
1514914|NCT00785382|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514915|NCT00785369|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1514916|NCT00785356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514917|NCT00785343|Randomized|Parallel Assignment||Treatment||Single||||||t
1514918|NCT00785330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514919|NCT00785317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514920|NCT00785304|||Case Control||Prospective|||||||
1514921|NCT00785291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514922|NCT00785278|||Case Control||Prospective|||||||
1514923|NCT00785265|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1514924|NCT00785252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514925|NCT00785239|||Case-Only||Prospective|||||||
1514926|NCT00785226||Single Group Assignment||Treatment||None (Open Label)||||||
1514927|NCT00785213|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1514928|NCT00785200|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1514929|NCT00785187|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1514930|NCT00785174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514931|NCT00785161|||Cohort||Prospective|||||||
1514932|NCT00785148|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1514933|NCT00785135|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1514934|NCT00785122||Single Group Assignment||Treatment||None (Open Label)||||||
1514935|NCT00785109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514936|NCT00785096|||Cohort||Prospective|||||||
1514937|NCT00785083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514938|NCT00785070|||||Prospective|||||||
1514939|NCT00785057|||Cohort||Retrospective|||||||
1514940|NCT00785044|||Other||Prospective|||||||
1514941|NCT00785031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514942|NCT00785018|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1514943|NCT00785005|||Cohort||Prospective|||||||
1514944|NCT00784992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514945|NCT00784979||Single Group Assignment||Treatment||None (Open Label)||||||
1514946|NCT00784966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514947|NCT00784953|||||Prospective|||||||
1514948|NCT00784940|Randomized|Parallel Assignment||||Double|||t||t|
1514949|NCT00784927||Single Group Assignment||Treatment||None (Open Label)||||||
1514950|NCT00784914|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514951|NCT00784901|||Case-Only||Retrospective|||||||
1514952|NCT00784888|||Cohort||Prospective|||||||
1514953|NCT00784875|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1514954|NCT00784862|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514955|NCT00784849||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514956|NCT00784836||Single Group Assignment||Treatment||None (Open Label)||||||
1514957|NCT00784823||Parallel Assignment||Treatment||None (Open Label)||||||
1514958|NCT00784810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514959|NCT00784797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514960|NCT00784784|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514961|NCT00784771||Single Group Assignment||Treatment||None (Open Label)||||||
1514962|NCT00784758|Randomized|Parallel Assignment||Treatment||Single||||||t
1514963|NCT00784745|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1514964|NCT00784732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514965|NCT00784719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514966|NCT00784706|Randomized|Parallel Assignment||Treatment||Single||||||t
1514967|NCT00784693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514968|NCT00784680|Randomized|Parallel Assignment||||Double|||t||t|
1514969|NCT00784667|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514970|NCT00784654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514971|NCT00784641||||||||||||
1514972|NCT00784615|||Cohort||Cross-Sectional|||||||
1514973|NCT00784602|||Other||Other|||||||
1514974|NCT00784589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514975|NCT00784576|||Cohort||Prospective|||||||
1514976|NCT00784563|Randomized|Parallel Assignment||Treatment||Single||||||t
1514977|NCT00784550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1514978|NCT00784537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514979|NCT00784524||Single Group Assignment||Treatment||None (Open Label)||||||
1514980|NCT00784511|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1514981|NCT00784498|Randomized|Parallel Assignment||Treatment||Single|||t|||
1514982|NCT00784485||Single Group Assignment||Treatment||None (Open Label)||||||
1514983|NCT00784472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514984|NCT00784459|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1514985|NCT00784446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514986|NCT00784433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514987|NCT00784420|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1514988|NCT00784407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514989|NCT00784394|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1514990|NCT00784381|||||Prospective|||||||
1514991|NCT00784368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514992|NCT00784355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1514993|NCT00784342|||Cohort||Prospective|||||||
1514994|NCT00784329||Single Group Assignment||Diagnostic||None (Open Label)||||||
1514995|NCT00784316|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1514996|NCT00784303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514997|NCT00784290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1514998|NCT00784277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1514999|NCT00784264|||||Prospective|||||||
1515000|NCT00784251|||Case-Only||Prospective|||||||
1515001|NCT00784238||Single Group Assignment||Treatment||None (Open Label)||||||
1515002|NCT00784225|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1515003|NCT00784212|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1515004|NCT00784199|||Case-Only||Prospective|||||||
1515005|NCT00784186|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515006|NCT00784173|||Case-Only||Prospective|||||||
1515007|NCT00784160|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1515008|NCT00784147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515009|NCT00784134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515010|NCT00784121|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1515011|NCT00784108|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1515012|NCT00784095|Randomized|Parallel Assignment||||None (Open Label)||||||
1515013|NCT00784082||||||||||||
1515014|NCT00784069|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1515015|NCT00784056|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1515016|NCT00784043|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515017|NCT00784030|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1515018|NCT00784017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515019|NCT00784004|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1515020|NCT00783991|||||Cross-Sectional|||||||
1515021|NCT00783978|||Family-Based||Cross-Sectional|||||||
1515022|NCT00783965|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515023|NCT00783952||Single Group Assignment||Other||None (Open Label)||||||
1515024|NCT00783939|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1515025|NCT00783926|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1515026|NCT00783913|Randomized|Factorial Assignment||Treatment||Double||||||
1515027|NCT00783900|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515028|NCT00783887|||Family-Based||Cross-Sectional|||||||
1515029|NCT00783861|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1515030|NCT00783848|||Cohort||Prospective|||||||
1515031|NCT00783835||Single Group Assignment||Treatment||None (Open Label)||||||
1515032|NCT00783822|Randomized|Parallel Assignment||||None (Open Label)||||||
1515033|NCT00783809|||Cohort||Prospective|||||||
1515034|NCT00783796|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515035|NCT00783783|||Cohort||Prospective|||||||
1515036|NCT00783770|||Cohort||Cross-Sectional|||||||
1515037|NCT00783757||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1515038|NCT00783744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515039|NCT00783731||||Treatment||||||||
1515040|NCT00783718|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515041|NCT00783705|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1515042|NCT00783692|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1515043|NCT00783679||Single Group Assignment||||None (Open Label)||||||
1515044|NCT00783666|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1515045|NCT00783653||Single Group Assignment||Treatment||None (Open Label)||||||
1515046|NCT00783640|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1515047|NCT00783627|||Case Control||Prospective|||||||
1515048|NCT00783614|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1515049|NCT00783601|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1515050|NCT00783588|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515051|NCT00783575|||Family-Based||Prospective|||||||
1515052|NCT00783562|Randomized|Parallel Assignment||Prevention||Single|||||t|
1515053|NCT00783549|Randomized|Single Group Assignment||Treatment||Single|||||t|
1515054|NCT00783536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515055|NCT00783523|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1515056|NCT00783510|||Cohort||Prospective|||||||
1515057|NCT00783497|||Case Control||Cross-Sectional|||||||
1515058|NCT00783484|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1515059|NCT00783471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515060|NCT00783458|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515061|NCT00783445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515062|NCT00783432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515063|NCT00783419|||Case Control||Retrospective|||||||
1515064|NCT00783406|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1515065|NCT00783393||Single Group Assignment||Treatment||None (Open Label)||||||
1515066|NCT00783380|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1515067|NCT00783367||Single Group Assignment||Treatment||None (Open Label)||||||
1515068|NCT00783354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515069|NCT00783341|Randomized|Single Group Assignment||Treatment||Double||||||
1515070|NCT00783328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515071|NCT00783315|Randomized|Parallel Assignment||Treatment||Single|Persons who measured weight and other outcomes were masked to randomized assignment.|"Three Group:~advice only comparison group~remotely delivered behavioral weight loss group~in-person behavioral weight loss group"||||t
1515072|NCT00783302|||Case-Only||Prospective|||||||
1515073|NCT00783289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515074|NCT00783276|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1515075|NCT00783263|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515076|NCT00783250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515077|NCT00783237|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515078|NCT00783224|Randomized|Parallel Assignment||Treatment||Single|||||t|
1515079|NCT00783211|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515080|NCT00783198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515081|NCT00783185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515082|NCT00783172||Single Group Assignment||Treatment||None (Open Label)||||||
1515083|NCT00783159|Randomized|Parallel Assignment||Treatment||Single||||||t
1515084|NCT00783146|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515085|NCT00783133|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1515086|NCT00783120|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1515087|NCT00783107|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515088|NCT00783094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515089|NCT00783081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515090|NCT00783068|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1515091|NCT00783055|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1515092|NCT00783042|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1515093|NCT00783029|||Case-Only||Prospective|||||||
1515094|NCT00783016|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1515095|NCT00783003|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1515096|NCT00782990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515097|NCT00782977|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1515098|NCT00782964|||Cohort||Prospective|||||||
1515099|NCT00782951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515100|NCT00782938|||Case Control||Prospective|||||||
1515101|NCT00782925|Randomized|Parallel Assignment||Prevention||Single|||||t|
1515102|NCT00782912|||Case Control||Prospective|||||||
1515103|NCT00782899|||Cohort||Prospective|||||||
1515104|NCT00782886|||Case-Only||Prospective|||||||
1515105|NCT00782873|||Case Control||Prospective|||||||
1515106|NCT00782860|||||Prospective|||||||
1515107|NCT00782847|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1515108|NCT00782834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515109|NCT00782821|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515110|NCT00782808|||Cohort||Prospective|||||||
1515111|NCT00782795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515112|NCT00782782|||Case Control||Prospective|||||||
1515113|NCT00782769|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515114|NCT00782756||Single Group Assignment||Treatment||None (Open Label)||||||
1515115|NCT00782743|||Cohort||Prospective|||||||
1515116|NCT00782730|||||Prospective|||||||
1515117|NCT00782717|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1515118|NCT00782704|||||Prospective|||||||
1515119|NCT00782691||||||||||||
1515120|NCT00782665||Parallel Assignment||Treatment||None (Open Label)||||||
1515121|NCT00782652|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515122|NCT00782639|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1515123|NCT00782626||Single Group Assignment||Treatment||None (Open Label)||||||
1515124|NCT00782613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515125|NCT00782600|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1515126|NCT00782587||Single Group Assignment||Treatment||None (Open Label)||||||
1515127|NCT00782574||Single Group Assignment||Treatment||None (Open Label)||||||
1515128|NCT00782561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515129|NCT00782548|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1515130|NCT00782535|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515131|NCT00782522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515132|NCT00782509|Randomized|Parallel Assignment||Treatment||Double||||||
1515133|NCT00782496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515134|NCT00782483||Single Group Assignment||Treatment||None (Open Label)||||||
1515135|NCT00782470|||Cohort|||||||||
1515136|NCT00782457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515137|NCT00782444|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1515138|NCT00782431|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1515139|NCT00782418|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1515140|NCT00782405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515141|NCT00782392|||Cohort||Cross-Sectional|||||||
1515142|NCT00782379||Single Group Assignment||Treatment||None (Open Label)||||||
1515143|NCT00782366|||Cohort||Prospective|||||||
1515144|NCT00782353|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515145|NCT00782340|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515146|NCT00782327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515147|NCT00782314|||Case Control||Prospective|||||||
1515148|NCT00782301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515149|NCT00782288|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515150|NCT00782275||Single Group Assignment||Treatment||None (Open Label)||||||
1515151|NCT00782262|Randomized|Parallel Assignment||Treatment||Single||||||t
1515152|NCT00782249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515153|NCT00782236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515154|NCT00782223|||Cohort||Prospective|||||||
1515155|NCT00782210|Randomized|Parallel Assignment||Treatment||Double||||||
1515156|NCT00782197|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515157|NCT00782184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515158|NCT00782171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515159|NCT00782158|||||Other|||||||
1515160|NCT00782145|Randomized|Parallel Assignment||Supportive Care||||||||
1515161|NCT00782132|||Cohort||Cross-Sectional|||||||
1515162|NCT00782119||||||||||||
1515163|NCT00782106||Parallel Assignment||Treatment||None (Open Label)||||||
1515164|NCT00782093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515165|NCT00782080|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515166|NCT00782067||Single Group Assignment||Treatment||None (Open Label)||||||
1515167|NCT00782054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515168|NCT00782041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515169|NCT00782028|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1515170|NCT00782015|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1515171|NCT00782002|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515172|NCT00781989|||Cohort||Prospective|||||||
1515173|NCT00781976|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515174|NCT00781963|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1515175|NCT00781950|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1515176|NCT00781937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515177|NCT00781924|||Cohort||Prospective|||||||
1515178|NCT00781911|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515179|NCT00781898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515180|NCT00781885|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515181|NCT00781872||Single Group Assignment||Treatment||None (Open Label)||||||
1515182|NCT00781859|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515183|NCT00781846|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515184|NCT00781833||Single Group Assignment||Treatment||None (Open Label)||||||
1515185|NCT00781820|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515186|NCT00781807||Single Group Assignment||Prevention||None (Open Label)||||||
1515187|NCT00781794|Randomized|Crossover Assignment||||Triple|||t|t|t|
1515188|NCT00781781|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515189|NCT00781768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515190|NCT00781755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515191|NCT00781742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515192|NCT00781729|Randomized|Parallel Assignment||Treatment||Single||||||
1515193|NCT00781716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515194|NCT00781703||Single Group Assignment||Health Services Research||Single|||t|||
1515195|NCT00781690||Single Group Assignment||Treatment||None (Open Label)||||||
1515196|NCT00781677|||Case-Only||Prospective|||||||
1515197|NCT00781664|Randomized|Parallel Assignment||||Double|||t|||t
1515198|NCT00781651||||||||||||
1515199|NCT00781638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515200|NCT00781625|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1515201|NCT00781612||Single Group Assignment||Treatment||None (Open Label)||||||
1515202|NCT00781599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515203|NCT00781586|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1515204|NCT00781573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515205|NCT00781560|||||Prospective|||||||
1515206|NCT00781547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515207|NCT00781534|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1515208|NCT00781521|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515209|NCT00781508|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1515210|NCT00781495|||Cohort||Prospective|||||||
1515211|NCT00781482|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1515212|NCT00781469|||Cohort||Cross-Sectional|||||||
1515213|NCT00781456|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1515214|NCT00781443|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1515215|NCT00781430|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1515216|NCT00781417|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1515217|NCT00781404|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515218|NCT00781391|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515219|NCT00781378|Randomized|Parallel Assignment||Treatment||Single||||||t
1515220|NCT00781365|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515221|NCT00781352|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1515222|NCT00781339||Single Group Assignment||Treatment||None (Open Label)||||||
1515223|NCT00781326||Single Group Assignment||Treatment||None (Open Label)||||||
1515224|NCT00781313|||Case-Crossover||Cross-Sectional|||||||
1515225|NCT00781300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515226|NCT00781287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515227|NCT00781274||Single Group Assignment||Treatment||None (Open Label)||||||
1515228|NCT00781261|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515229|NCT00781248|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1515230|NCT00781222||||||||||||
1515231|NCT00781209||Single Group Assignment||Treatment||None (Open Label)||||||
1515232|NCT00781196|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515233|NCT00781183||Single Group Assignment||||None (Open Label)||||||
1515234|NCT00781170||Single Group Assignment||Treatment||None (Open Label)||||||
1515235|NCT00781157||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1515236|NCT00781144|||Case-Only||Prospective|||||||
1515237|NCT00781131|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515238|NCT00781118|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1515239|NCT00781105||Single Group Assignment||Treatment||None (Open Label)||||||
1515240|NCT00781092|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515241|NCT00781079|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1515242|NCT00781066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515243|NCT00781053||Single Group Assignment||Treatment||None (Open Label)||||||
1515244|NCT00781040|||Case-Only||Prospective|||||||
1515245|NCT00781027|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1515246|NCT00781001|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1515247|NCT00780988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515248|NCT00780975||Single Group Assignment||Treatment||None (Open Label)||||||
1515249|NCT00780962|Randomized|Parallel Assignment||Prevention||Quadruple|The study medication (or placebo) will come premixed from the pharmacy. There will be no external marks on the medication (or placebo) that suggests its identity.|"Subjects will be randomized to receive either of two interventions: N-acetylcysteine (Treatment group) or Normal Saline (Placebo group).~Patients in the treatment group will receive 3 g of Nacetylcysteine in 500mL normal saline (0.9% Sodium Chloride) solution during 30 minutes before contrast administration. After contrast administration, patients will receive a continuous infusion of 200mg of N-acetylcysteine per hour, administered as an infusion of 67 mL per hour of a solution of 3 g of N-acetylcysteine diluted to a total volume of 1,000 mL with normal saline solution.~Patients in the placebo group will receive 500 mL of normal saline solution during 30 minutes before contrast administration and a continuous infusion of 67 mL per hour of normal saline solution after contrast administration.~Patients in both arms will receive the postcontrast infusion (N-acetylcysteine or saline solution) for a minimum of 2 hours."|t|t|t|t
1515250|NCT00780949||Single Group Assignment||Basic Science||None (Open Label)||||||
1515251|NCT00780936|Randomized|Crossover Assignment||Prevention||Double||||||
1515252|NCT00780923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515253|NCT00780910||Single Group Assignment||Treatment||None (Open Label)||||||
1515254|NCT00780897|||||Cross-Sectional|||||||
1515255|NCT00780884||Single Group Assignment||Treatment||None (Open Label)||||||
1515256|NCT00780858|||Case Control||Prospective|||||||
1515257|NCT00780845|||Cohort||Prospective|||||||
1515258|NCT00780832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515259|NCT00780819||Single Group Assignment||Diagnostic||None (Open Label)||||||
1515260|NCT00780806|Randomized|Single Group Assignment||||None (Open Label)||||||
1515261|NCT00780793|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515262|NCT00780780|Randomized|Parallel Assignment||Treatment||Single|||||t|
1515263|NCT00780767|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515264|NCT00780754|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515265|NCT00780741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515266|NCT00780728||||||||||||
1515267|NCT00780715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515268|NCT00780702|Randomized|Parallel Assignment||Treatment||||||||
1515269|NCT00780676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515270|NCT00780663|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515271|NCT00780650|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1515272|NCT00780637|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1515273|NCT00780624|Randomized|Parallel Assignment||Treatment||Single|||||t|
1515274|NCT00780611|||Case-Only||Prospective|||||||
1515275|NCT00780598||Single Group Assignment||Treatment||None (Open Label)||||||
1515276|NCT00780585|||Cohort||Prospective|||||||
1515277|NCT00780572|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1515278|NCT00780559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515279|NCT00780546|||Ecologic or Community||Retrospective|||||||
1515280|NCT00780533|||Cohort||Cross-Sectional|||||||
1515281|NCT00780520|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1515282|NCT00780507|||Cohort||Prospective|||||||
1515283|NCT00780494||Single Group Assignment||Treatment||None (Open Label)||||||
1515284|NCT00780481||Single Group Assignment||Basic Science||None (Open Label)||||||
1515285|NCT00780468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515286|NCT00780455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515287|NCT00780442|Randomized|Parallel Assignment||Other||Double|||t||t|
1515288|NCT00780429||||||||||||
1515289|NCT00780416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515290|NCT00780403|Randomized|Crossover Assignment||||None (Open Label)||||||
1515291|NCT00780390|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515292|NCT00780377||Single Group Assignment||Basic Science||None (Open Label)||||||
1515293|NCT00780364|||Cohort||Prospective|||||||
1515294|NCT00780351|||Case-Only||Prospective|||||||
1515295|NCT00780338|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515296|NCT00780325|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515297|NCT00780312|Randomized|Parallel Assignment||Prevention||Single|||||t|
1515298|NCT00780299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515299|NCT00780286||||||||||||
1515300|NCT00780273|Randomized|Single Group Assignment||||None (Open Label)||||||
1515301|NCT00780260|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1515302|NCT00780247|||Cohort||Cross-Sectional|||||||
1515303|NCT00780234|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515304|NCT00780221|||Case Control||Prospective|||||||
1515305|NCT00780208||Single Group Assignment||Treatment||None (Open Label)||||||
1515306|NCT00780195|Randomized|Factorial Assignment||||Single|||t|||
1515307|NCT00780182|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1515308|NCT00780169||Single Group Assignment||Treatment||None (Open Label)||||||
1515309|NCT00780156|||||Prospective|||||||
1515310|NCT00780143||Single Group Assignment||Treatment||None (Open Label)||||||
1515311|NCT00780130|||Case-Only|||||||||
1515312|NCT00780117|||Cohort||Prospective|||||||
1515313|NCT00780104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515314|NCT00780091|||Case Control||Prospective|||||||
1515315|NCT00780078|||Case-Only||Prospective|||||||
1515316|NCT00780065||||||||||||
1515317|NCT00780052||Single Group Assignment||Treatment||None (Open Label)||||||
1515318|NCT00780039||Single Group Assignment||Treatment||None (Open Label)||||||
1515319|NCT00780026|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1515320|NCT00780013|Randomized|Crossover Assignment||||None (Open Label)||||||
1515321|NCT00780000||Single Group Assignment||Treatment||None (Open Label)||||||
1515322|NCT00779987|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515323|NCT00779974|||Case-Only||Prospective|||||||
1515324|NCT00779961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515325|NCT00779948|||Cohort||Prospective|||||||
1515326|NCT00779935||Single Group Assignment||Treatment||None (Open Label)||||||
1515327|NCT00779922||||||||||||
1515328|NCT00779909|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515329|NCT00779896||Single Group Assignment||Treatment||None (Open Label)||||||
1515330|NCT00779883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515331|NCT00779870|||Cohort||Cross-Sectional|||||||
1515332|NCT00779857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515333|NCT00779844|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515334|NCT00779831|Randomized|Crossover Assignment||||None (Open Label)||||||
1515335|NCT00779818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515336|NCT00779805|Randomized|Crossover Assignment||||None (Open Label)||||||
1515337|NCT00779792||Single Group Assignment||Treatment||Triple|||t||t|t
1515338|NCT00779779||||||||||||
1515339|NCT00779766|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515340|NCT00779753|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1515341|NCT00779740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515342|NCT00779727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515343|NCT00779714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515344|NCT00779701||Single Group Assignment||Treatment||None (Open Label)||||||
1515345|NCT00779688|||||Prospective|||||||
1515346|NCT00779675|||Cohort||Prospective|||||||
1515347|NCT00779662|||Ecologic or Community||Cross-Sectional|||||||
1515348|NCT00779649|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1515349|NCT00779636|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515350|NCT00779623||||||||||||
1515351|NCT00779610|Randomized|Parallel Assignment||Treatment||Single|||||t|
1515352|NCT00779597|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1515353|NCT00779584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515354|NCT00779571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515355|NCT00779558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515356|NCT00779545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515357|NCT00779532|Randomized|Parallel Assignment||||Triple|||t||t|t
1515358|NCT00779519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515359|NCT00779506||Single Group Assignment||Treatment||None (Open Label)||||||
1515360|NCT00779493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515361|NCT00779480||Single Group Assignment||Treatment||None (Open Label)||||||
1515362|NCT00779467|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1515363|NCT00779454|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1515364|NCT00779441|Randomized|Crossover Assignment||||None (Open Label)||||||
1515365|NCT00779428||Single Group Assignment||Treatment||None (Open Label)||||||
1515366|NCT00779415|||Case-Only||Retrospective|||||||
1515367|NCT00779402|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515368|NCT00779389|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515369|NCT00779376|Randomized|Crossover Assignment||||None (Open Label)||||||
1515370|NCT00779363||Single Group Assignment||Treatment||None (Open Label)||||||
1515371|NCT00779350|Randomized|Crossover Assignment||||None (Open Label)||||||
1515372|NCT00779337||Single Group Assignment||Treatment||None (Open Label)||||||
1515373|NCT00779324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515374|NCT00779311||Single Group Assignment||Treatment||None (Open Label)||||||
1515375|NCT00779298||||||||||||
1515376|NCT00779285||Single Group Assignment||Treatment||None (Open Label)||||||
1515377|NCT00779272|||Cohort||Retrospective|||||||
1515378|NCT00779259|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1515379|NCT00779246|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515380|NCT00779233|Randomized|Crossover Assignment||||None (Open Label)||||||
1515381|NCT00779220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515382|NCT00779207|Randomized|Parallel Assignment||Treatment||Single||||||t
1515383|NCT00779194|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515384|NCT00779181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515385|NCT00779168||Single Group Assignment||Treatment||None (Open Label)||||||
1515386|NCT00779155|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1515387|NCT00779142||Single Group Assignment||Treatment||None (Open Label)||||||
1515388|NCT00779129||Single Group Assignment||Treatment||None (Open Label)||||||
1515389|NCT00779116|Randomized|Crossover Assignment||||None (Open Label)||||||
1515390|NCT00779103||Single Group Assignment||Treatment||None (Open Label)||||||
1515391|NCT00779090|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1515392|NCT00779077|||Cohort|||||||||
1515393|NCT00779064|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515394|NCT00779051|Randomized|Crossover Assignment||||None (Open Label)||||||
1515395|NCT00779038||Single Group Assignment||Treatment||None (Open Label)||||||
1515396|NCT00779025|Randomized|Parallel Assignment||||None (Open Label)||||||
1515397|NCT00779012||Single Group Assignment||Treatment||None (Open Label)||||||
1515398|NCT00778999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515399|NCT00778986|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1515400|NCT00778973|Randomized|Crossover Assignment||||None (Open Label)||||||
1515401|NCT00778960|Randomized|Parallel Assignment||Treatment||Single|||||t|
1515402|NCT00778947|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1515403|NCT00778934||Single Group Assignment||||Single|||t|||
1515404|NCT00778921|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515405|NCT00778908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515406|NCT00778895|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515407|NCT00778882||Single Group Assignment||Treatment||None (Open Label)||||||
1515408|NCT00778869||Single Group Assignment||Treatment||None (Open Label)||||||
1515409|NCT00778856||Single Group Assignment||Treatment||None (Open Label)||||||
1515410|NCT00778843|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515411|NCT00778830|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515412|NCT00778817||Single Group Assignment||Treatment||None (Open Label)||||||
1515413|NCT00778804|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515414|NCT00778791|Randomized|Crossover Assignment||||None (Open Label)||||||
1515415|NCT00778778|Randomized|Crossover Assignment||||Double||||||
1515416|NCT00778765|Randomized|Crossover Assignment||||None (Open Label)||||||
1515417|NCT00778752||Single Group Assignment||Treatment||None (Open Label)||||||
1515418|NCT00778739|Randomized|Crossover Assignment||||None (Open Label)||||||
1515419|NCT00778726|Randomized|Crossover Assignment||||None (Open Label)||||||
1515420|NCT00778713|Randomized|Crossover Assignment||||None (Open Label)||||||
1515421|NCT00778700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515422|NCT00778687|||Cohort||Prospective|||||||
1515423|NCT00778674|Randomized|Crossover Assignment||||None (Open Label)||||||
1515424|NCT00778661|Randomized|Crossover Assignment||||None (Open Label)||||||
1515425|NCT00778648|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515426|NCT00778622|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515427|NCT00778609|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1515428|NCT00778596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515429|NCT00778583|Randomized|Crossover Assignment||||None (Open Label)||||||
1515430|NCT00778570||||||||||||
1515431|NCT00778557|Randomized|Crossover Assignment||||Double||||||
1515432|NCT00778544|Randomized|Crossover Assignment||||None (Open Label)||||||
1515433|NCT00778531|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1515434|NCT00778518|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515435|NCT00778505|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515436|NCT00778492|||Cohort||Prospective|||||||
1515437|NCT00778479|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515438|NCT00778466|Randomized|Crossover Assignment||||None (Open Label)||||||
1515439|NCT00778453|Randomized|Parallel Assignment||Treatment||Single||||||t
1515440|NCT00778440|||Ecologic or Community||Cross-Sectional|||||||
1515441|NCT00778427|Randomized|Crossover Assignment||||None (Open Label)||||||
1515442|NCT00778414|Randomized|Crossover Assignment||||None (Open Label)||||||
1515443|NCT00778401|Randomized|Crossover Assignment||||None (Open Label)||||||
1515444|NCT00778388|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1515445|NCT00778375||Single Group Assignment||Treatment||None (Open Label)||||||
1515446|NCT00778362|||Case-Only||Retrospective|||||||
1515447|NCT00778349|Randomized|Crossover Assignment||||None (Open Label)||||||
1515448|NCT00778336|||Case-Only||Prospective|||||||
1515449|NCT00778323|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1515450|NCT00778310|Randomized|Crossover Assignment||||Triple|||t|t||t
1515451|NCT00778297|Randomized|Parallel Assignment||Prevention||Single|||t|||
1515452|NCT00778284|Randomized|Crossover Assignment||||None (Open Label)||||||
1515453|NCT00778271|Randomized|Crossover Assignment||||None (Open Label)||||||
1515454|NCT00778258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515455|NCT00778245|Randomized|Crossover Assignment||||None (Open Label)||||||
1515456|NCT00778232|Randomized|Crossover Assignment||||None (Open Label)||||||
1515457|NCT00778219|||Case Control||Prospective|||||||
1515458|NCT00778206|||Case-Only||Prospective|||||||
1515459|NCT00778193||||||||||||
1515460|NCT00778180|Randomized|Crossover Assignment||||None (Open Label)||||||
1515461|NCT00778167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515462|NCT00778154|||Cohort||Prospective|||||||
1515463|NCT00778141|Randomized|Crossover Assignment||||None (Open Label)||||||
1515464|NCT00778128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515465|NCT00778115|Randomized|Crossover Assignment||||None (Open Label)||||||
1515466|NCT00778102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515467|NCT00778089|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1515468|NCT00778076|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515469|NCT00778063|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515470|NCT00778050|Randomized|Crossover Assignment||||None (Open Label)||||||
1515471|NCT00778037|Randomized|Crossover Assignment||||None (Open Label)||||||
1515472|NCT00778024|Randomized|Crossover Assignment||||None (Open Label)||||||
1515473|NCT00778011|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1515474|NCT00777998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515475|NCT00777985|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1515476|NCT00777972|Randomized|Crossover Assignment||||None (Open Label)||||||
1515477|NCT00777959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515478|NCT00777946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515479|NCT00777933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515480|NCT00777920||Single Group Assignment||Treatment||None (Open Label)||||||
1515481|NCT00777907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515482|NCT00777894||Single Group Assignment||Treatment||None (Open Label)||||||
1515483|NCT00777868|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515484|NCT00777855|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1515485|NCT00777842||Single Group Assignment||Treatment||None (Open Label)||||||
1515486|NCT00777829|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1515487|NCT00777816|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1515488|NCT00777803|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1515489|NCT00777790|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515490|NCT00777777||Single Group Assignment||Treatment||None (Open Label)||||||
1515491|NCT00777764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515492|NCT00777751|||Case-Only||Prospective|||||||
1515493|NCT00777738||Single Group Assignment||Treatment||None (Open Label)||||||
1515494|NCT00777725|||Cohort||Prospective|||||||
1515495|NCT00777712|||Cohort||Prospective|||||||
1515496|NCT00777699||Single Group Assignment||Treatment||None (Open Label)||||||
1515497|NCT00777686|||Case-Only||Prospective|||||||
1515498|NCT00777673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515499|NCT00777647|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1515500|NCT00777634|||Cohort||Cross-Sectional|||||||
1515501|NCT00777621|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515502|NCT00777608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515503|NCT00777595|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515504|NCT00777582|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1515505|NCT00777569|Randomized|Parallel Assignment||Treatment||Double||||||
1515506|NCT00777556||Single Group Assignment||Treatment||None (Open Label)||||||
1515507|NCT00777543|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1515508|NCT00777530|Randomized|Single Group Assignment||||Double|||t||t|
1515509|NCT00777517|Randomized|Crossover Assignment||||None (Open Label)||||||
1515510|NCT00777504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515511|NCT00777491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515512|NCT00777478||Single Group Assignment||Treatment||None (Open Label)||||||
1515513|NCT00777465|||Cohort||Prospective|||||||
1515514|NCT00777452|||Cohort||Prospective|||||||
1515515|NCT00777439||Single Group Assignment||Treatment||None (Open Label)||||||
1515516|NCT00777426|||Cohort||Prospective|||||||
1515517|NCT00777413|Randomized|Crossover Assignment||||None (Open Label)||||||
1515518|NCT00777400|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1515519|NCT00777387|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515520|NCT00777374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515521|NCT00777361|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1515522|NCT00777348|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515523|NCT00777335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515524|NCT00777322|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515525|NCT00777309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515526|NCT00777296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515527|NCT00777283||||||||||||
1515528|NCT00777270|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515529|NCT00777257|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1515530|NCT00777244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515531|NCT00777231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||No control group used, single group for each of four different disease groups||||
1515532|NCT00777218|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1515533|NCT00777205|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1515534|NCT00777192|||Cohort||Prospective|||||||
1515535|NCT00777179|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515536|NCT00777166|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1515537|NCT00777153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515538|NCT00777140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515539|NCT00777127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515540|NCT00777114||Single Group Assignment||Treatment||None (Open Label)||||||
1515541|NCT00777101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515542|NCT00777088||Single Group Assignment||Treatment||None (Open Label)||||||
1515543|NCT00777075|Randomized|Crossover Assignment||Treatment||Double||||||
1515544|NCT00777062|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515545|NCT00777049|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515546|NCT00777036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515547|NCT00777023|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1515548|NCT00777010|Randomized|Parallel Assignment||Prevention||None (Open Label)||Parallel groups, randomized controlled nutritional intervention.||||
1515549|NCT00776997||Single Group Assignment||Treatment||None (Open Label)||||||
1515550|NCT00776984|Randomized|Parallel Assignment||Treatment||Double||||||
1515551|NCT00776971||Crossover Assignment||||None (Open Label)||||||
1515552|NCT00776958|||Case Control||Prospective|||||||
1515553|NCT00776945|||Case-Only||Prospective|||||||
1515554|NCT00776932|||Cohort||Cross-Sectional|||||||
1515555|NCT00776919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515556|NCT00776906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515557|NCT00776893||||||||||||
1515558|NCT00776880|||Case Control||Prospective|||||||
1515559|NCT00776867||Single Group Assignment||Treatment||None (Open Label)||||||
1515560|NCT00776854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515561|NCT00776841|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1515562|NCT00776828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515563|NCT00776815||||||||||||
1515564|NCT00776802||Single Group Assignment||Treatment||None (Open Label)||||||
1515565|NCT00776789|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1515566|NCT00776776|||Cohort|||||||||
1515567|NCT00776763|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1515568|NCT00776750||Parallel Assignment||Treatment||None (Open Label)||||||
1515569|NCT00776737|||||Prospective|||||||
1515570|NCT00776724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515571|NCT00776711|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515572|NCT00776698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515573|NCT00776685|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1515574|NCT00776672|Randomized|Crossover Assignment||||None (Open Label)||||||
1515575|NCT00776659|||Case-Only||Prospective|||||||
1515576|NCT00776646|Randomized|Crossover Assignment||||None (Open Label)||||||
1515577|NCT00776633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515578|NCT00776620|Randomized|Crossover Assignment||||None (Open Label)||||||
1515579|NCT00776607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515580|NCT00776594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515581|NCT00776581|||||Retrospective|||||||
1515582|NCT00776568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515583|NCT00776555|Randomized|Crossover Assignment||||Single|||t|||
1515584|NCT00776542|Randomized|Crossover Assignment||||None (Open Label)||||||
1515585|NCT00776529|Randomized|Parallel Assignment||Treatment||Single||||||t
1515586|NCT00776516|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1515587|NCT00776503|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515588|NCT00776490|Randomized|Crossover Assignment||||None (Open Label)||||||
1515589|NCT00776477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515590|NCT00776464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515591|NCT00776451|||Case Control||Prospective|||||||
1515592|NCT00776438|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515593|NCT00776425|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515594|NCT00776412|||Cohort||Prospective|||||||
1515595|NCT00776399||Single Group Assignment||Treatment||None (Open Label)||||||
1515596|NCT00776386|||Cohort||Cross-Sectional|||||||
1515597|NCT00776373||Single Group Assignment||Treatment||None (Open Label)||||||
1515598|NCT00776360|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1515599|NCT00776347||Single Group Assignment||Supportive Care||None (Open Label)||||||
1515600|NCT00776334|Randomized|Crossover Assignment||||None (Open Label)||||||
1515601|NCT00776321|Randomized|Parallel Assignment||Prevention||Double||||||
1515602|NCT00776308|||Case-Only||Prospective|||||||
1515603|NCT00776295||Single Group Assignment||Treatment||None (Open Label)||||||
1515604|NCT00776282|Randomized|Crossover Assignment||||None (Open Label)||||||
1515605|NCT00776269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515606|NCT00776256|Randomized|Crossover Assignment||||Triple|||t||t|t
1515607|NCT00776243|||Case Control||Prospective|||||||
1515608|NCT00776230|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1515609|NCT00776217|Randomized|Crossover Assignment||||None (Open Label)||||||
1515610|NCT00776204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515611|NCT00776191|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1515612|NCT00776178|||Cohort||Retrospective|||||||
1515613|NCT00776165|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515614|NCT00776152||||||||||||
1515615|NCT00776139|Randomized|Crossover Assignment||||None (Open Label)||||||
1515616|NCT00776126|||Case-Only||Prospective|||||||
1515617|NCT00776113|Randomized|Crossover Assignment||||None (Open Label)||||||
1515618|NCT00776100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515619|NCT00776087|Randomized|Parallel Assignment||Treatment||None (Open Label)|HM ON vs. HM OFF|Randomized prospective multicenter international clinical trial||||
1515620|NCT00776074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515621|NCT00776048|||Case Control||Prospective|||||||
1515622|NCT00776035|||Other||Prospective|||||||
1515623|NCT00776022|Randomized|Crossover Assignment||||None (Open Label)||||||
1515624|NCT00776009|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515625|NCT00775996|Randomized|Crossover Assignment||||None (Open Label)||||||
1515626|NCT00775983|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1515627|NCT00775970|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1515628|NCT00775957|||Case Control||Prospective|||||||
1515629|NCT00775944|Randomized|Factorial Assignment||Treatment||Single|||||t|
1515630|NCT00775931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515631|NCT00775918|Randomized|Crossover Assignment||||None (Open Label)||||||
1515632|NCT00775905|Randomized|Crossover Assignment||||None (Open Label)||||||
1515633|NCT00775892||Single Group Assignment||Treatment||None (Open Label)||||||
1515634|NCT00775879|Randomized|Parallel Assignment||Prevention||Single|||t|||
1515635|NCT00775866||Single Group Assignment||Diagnostic||None (Open Label)||||||
1515636|NCT00775853|||||Prospective|||||||
1515637|NCT00775840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515638|NCT00775827|Randomized|Crossover Assignment||||None (Open Label)||||||
1515639|NCT00775814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515640|NCT00775801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515641|NCT00775788||Single Group Assignment||Treatment||None (Open Label)||||||
1515642|NCT00775775|||Case-Only||Prospective|||||||
1515643|NCT00775762|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1515644|NCT00775749|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1515645|NCT00775736|||Cohort||Prospective|||||||
1515646|NCT00775723|||Cohort||Prospective|||||||
1515647|NCT00775710|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1515648|NCT00775697||Single Group Assignment||Treatment||None (Open Label)||||||
1516116|NCT00769509|Randomized|Crossover Assignment||||Triple||||t|t|t
1515649|NCT00775684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515650|NCT00775671|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1515651|NCT00775658|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1515652|NCT00775645|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1515653|NCT00775632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515654|NCT00775619|Randomized|Crossover Assignment||||None (Open Label)||||||
1515655|NCT00775606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515656|NCT00775593|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515657|NCT00775580|Randomized|Crossover Assignment||||None (Open Label)||||||
1515658|NCT00775567|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1515659|NCT00775554||||||||||||
1515660|NCT00775541|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1515661|NCT00775528||Single Group Assignment||Treatment||None (Open Label)||||||
1515662|NCT00775515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515663|NCT00775502||Single Group Assignment||Treatment||None (Open Label)||||||
1515664|NCT00775489|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1515665|NCT00775476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515666|NCT00775463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515667|NCT00775450|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515668|NCT00775437||Single Group Assignment||Treatment||None (Open Label)||||||
1515669|NCT00775424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515670|NCT00775411||Single Group Assignment||Treatment||None (Open Label)||||||
1515671|NCT00775398|||Cohort||Prospective|||||||
1515672|NCT00775385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515673|NCT00775372|Randomized|Crossover Assignment||||None (Open Label)||||||
1515674|NCT00775359|Randomized|Crossover Assignment||||None (Open Label)||||||
1515675|NCT00775346|||Cohort||Prospective|||||||
1515676|NCT00775333|||Case Control||Prospective|||||||
1515677|NCT00775320|||Case Control||Prospective|||||||
1515678|NCT00775307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515679|NCT00775294|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1515680|NCT00775281|||Case Control||Cross-Sectional|||||||
1515681|NCT00775268|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1515682|NCT00775255|Randomized|Crossover Assignment||||None (Open Label)||||||
1515683|NCT00775242|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515684|NCT00775229|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1515685|NCT00775216|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515686|NCT00775203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515687|NCT00775190|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1515688|NCT00775177|Randomized|Crossover Assignment||||None (Open Label)||||||
1515689|NCT00775164|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515690|NCT00775151|Randomized|Crossover Assignment||||None (Open Label)||||||
1515691|NCT00775138|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515692|NCT00775125|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1515693|NCT00775112|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1515694|NCT00775099|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1515695|NCT00775086|Randomized|Crossover Assignment||Health Services Research||Double||||||
1515696|NCT00775073||Single Group Assignment||Treatment||None (Open Label)||||||
1515697|NCT00775060|||Cohort||Prospective|||||||
1515698|NCT00775047|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515699|NCT00775034|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1515700|NCT00775021|Randomized|Crossover Assignment||Treatment||Single|||t|||
1515701|NCT00775008|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1515702|NCT00774995|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515703|NCT00774982|Randomized|Crossover Assignment||||Single||||||t
1515704|NCT00774969||Single Group Assignment||Basic Science||||||||
1515705|NCT00774956|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515706|NCT00774943|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1515707|NCT00774930|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515708|NCT00774917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515709|NCT00774904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515710|NCT00774891|||Cohort||Prospective|||||||
1515711|NCT00774878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515712|NCT00774865|||Cohort||Prospective|||||||
1515713|NCT00774852|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515714|NCT00774839|||Cohort||Prospective|||||||
1515715|NCT00774826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515716|NCT00774813|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515717|NCT00774800||Crossover Assignment||Treatment||Single|||t|||
1515718|NCT00774787|Randomized|Single Group Assignment||Treatment||Single||||||t
1515719|NCT00774774|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515720|NCT00774761|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1515721|NCT00774748||Single Group Assignment||Supportive Care||None (Open Label)||||||
1515722|NCT00774735|Randomized|Parallel Assignment||||None (Open Label)||||||
1515723|NCT00774722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515724|NCT00774709|||Case-Only||Prospective|||||||
1515725|NCT00774696|Randomized|Crossover Assignment||||None (Open Label)||||||
1515726|NCT00774683|||Cohort||Prospective|||||||
1515727|NCT00774657|||Cohort||Prospective|||||||
1515728|NCT00774644|Randomized|Crossover Assignment||||None (Open Label)||||||
1515729|NCT00774631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515730|NCT00774618|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1515731|NCT00774605|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1515732|NCT00774592|Randomized|Parallel Assignment||Prevention||Single||||||t
1515733|NCT00774579|||Cohort||Prospective|||||||
1515734|NCT00774566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515735|NCT00774553|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515736|NCT00774540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515737|NCT00774527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515738|NCT00774514|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1515739|NCT00774501||Single Group Assignment||Treatment||None (Open Label)||||||
1515740|NCT00774488|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1515741|NCT00774475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515742|NCT00774462||Single Group Assignment||Treatment||None (Open Label)||||||
1515743|NCT00774449|||Cohort||Prospective|||||||
1515744|NCT00774436||Single Group Assignment||Treatment||None (Open Label)||||||
1515745|NCT00774423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515746|NCT00774397|Randomized|Parallel Assignment||Treatment||Double||||||
1515747|NCT00774384|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515748|NCT00774371|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515749|NCT00774358||Single Group Assignment||Treatment||None (Open Label)||||||
1515750|NCT00774345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515751|NCT00774332||Single Group Assignment||Treatment||None (Open Label)||||||
1515752|NCT00774319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515753|NCT00774306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515754|NCT00774293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515755|NCT00774280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515756|NCT00774267|||Cohort||Retrospective|||||||
1515757|NCT00774254|||Other||Prospective|||||||
1515758|NCT00774241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515759|NCT00774228||||||||||||
1515760|NCT00774215|||Cohort||Retrospective|||||||
1515761|NCT00774202|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515762|NCT00774189|Randomized|Crossover Assignment||||None (Open Label)||||||
1515763|NCT00774176|||Other||Other|||||||
1515764|NCT00774163|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515765|NCT00774150|Randomized|Parallel Assignment||Treatment||Single||||||t
1515766|NCT00774137|||Cohort||Prospective|||||||
1515767|NCT00774124|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1515768|NCT00774111|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1515769|NCT00774098|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1515770|NCT00774085|||Case-Only|||||||||
1515771|NCT00774072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515772|NCT00774059||Parallel Assignment||Prevention||None (Open Label)||||||
1515773|NCT00774046||Single Group Assignment||Treatment||None (Open Label)||||||
1515774|NCT00774033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515775|NCT00774020||Single Group Assignment||Treatment||None (Open Label)||||||
1515776|NCT00774007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515777|NCT00773994||Single Group Assignment||Treatment||None (Open Label)||||||
1515778|NCT00773981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515779|NCT00773968||Single Group Assignment||Treatment||None (Open Label)||||||
1515780|NCT00773955||Single Group Assignment||Treatment||None (Open Label)||||||
1515781|NCT00773942|Randomized|Parallel Assignment||Treatment||Single||||||t
1515782|NCT00773929||Single Group Assignment||Treatment||None (Open Label)||||||
1515783|NCT00773916||Single Group Assignment||||None (Open Label)||||||
1515784|NCT00773903||||||||||||
1515785|NCT00773890|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515786|NCT00773877|||||Prospective|||||||
1515787|NCT00773864|||Case-Only||Prospective|||||||
1515788|NCT00773851|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515789|NCT00773838|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515790|NCT00773825|||||Prospective|||||||
1515791|NCT00773812|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1515792|NCT00773799|||Case-Only||Retrospective|||||||
1515793|NCT00773786|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515794|NCT00773773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1515795|NCT00773760|||Cohort||Prospective|||||||
1515796|NCT00773747|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1515797|NCT00773734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515798|NCT00773721||||||||||||
1515799|NCT00773708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515800|NCT00773695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515801|NCT00773682|Randomized|Parallel Assignment||Treatment||Single|||||t|
1515802|NCT00773669|||Ecologic or Community||Retrospective|||||||
1515803|NCT00773656|||Case-Only||Cross-Sectional|||||||
1515804|NCT00773643||Single Group Assignment||Diagnostic||None (Open Label)||||||
1515805|NCT00773630|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1515806|NCT00773617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515807|NCT00773604|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515808|NCT00773591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515809|NCT00773578|||Cohort||Prospective|||||||
1515810|NCT00773565||Single Group Assignment||Basic Science||None (Open Label)||||||
1515811|NCT00773552|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1515812|NCT00773539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515813|NCT00773526|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515814|NCT00773513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515815|NCT00773500|||Cohort||Prospective|||||||
1515816|NCT00773487||Single Group Assignment||Basic Science||None (Open Label)||||||
1515817|NCT00773474||Single Group Assignment||Treatment||None (Open Label)||||||
1515818|NCT00773461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515819|NCT00773448|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1515820|NCT00773435|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1515821|NCT00773422|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1515822|NCT00773409|||Case Control||Prospective|||||||
1515823|NCT00773383|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515824|NCT00773370|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515825|NCT00773357|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1515826|NCT00773344||Single Group Assignment||Treatment||None (Open Label)||||||
1515827|NCT00773331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515828|NCT00773318||Single Group Assignment||Diagnostic||None (Open Label)||||||
1515829|NCT00773305|||Ecologic or Community||Retrospective|||||||
1515830|NCT00773292||Single Group Assignment||Treatment||None (Open Label)||||||
1515831|NCT00773279|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1515832|NCT00773266|||Case-Only||Retrospective|||||||
1515833|NCT00773253|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1515834|NCT00773240|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515835|NCT00773227||Single Group Assignment||Treatment||None (Open Label)||||||
1515836|NCT00773214||Single Group Assignment||Basic Science||None (Open Label)||||||
1515837|NCT00773201||Single Group Assignment||Treatment||None (Open Label)||||||
1515838|NCT00773188|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515839|NCT00773175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515840|NCT00773162|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515841|NCT00773149|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515842|NCT00773136||Single Group Assignment||Treatment||Triple|||t||t|t
1515843|NCT00773123|||||Prospective|||||||
1515844|NCT00773110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515845|NCT00773097||Single Group Assignment||Prevention||None (Open Label)||||||
1515846|NCT00773084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515847|NCT00773071||Single Group Assignment||Diagnostic||None (Open Label)||||||
1515848|NCT00773058|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515849|NCT00773045|||||Prospective|||||||
1515850|NCT00773032||||||||||||
1515851|NCT00773019|||Cohort||Prospective|||||||
1515852|NCT00773006|||Cohort||Prospective|||||||
1515853|NCT00772993|||||Prospective|||||||
1515854|NCT00772980|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1515855|NCT00772967|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1515856|NCT00772954|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515857|NCT00772941|||Case-Only||Prospective|||||||
1515858|NCT00772928|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515859|NCT00772915||Single Group Assignment||Treatment||None (Open Label)||||||
1515860|NCT00772902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515861|NCT00772889|Non-Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1515862|NCT00772876||Single Group Assignment||Treatment||None (Open Label)||||||
1515863|NCT00772863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515864|NCT00772850|||Cohort||Retrospective|||||||
1515865|NCT00772837|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515866|NCT00772824|Randomized|Parallel Assignment||Prevention||Single||Case Control|t|||
1515867|NCT00772811|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515868|NCT00772798|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515869|NCT00772785||Single Group Assignment||Treatment||None (Open Label)||||||
1515870|NCT00772772||Single Group Assignment||Treatment||None (Open Label)||||||
1515871|NCT00772759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515872|NCT00772746|||Case Control||Prospective|||||||
1515873|NCT00772733|||||Prospective|||||||
1515874|NCT00772720|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515875|NCT00772707||Single Group Assignment||Treatment||None (Open Label)||||||
1515876|NCT00772694||Single Group Assignment||Treatment||None (Open Label)||||||
1515877|NCT00772681|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515878|NCT00772668||Single Group Assignment||Treatment||None (Open Label)||||||
1515879|NCT00772655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515880|NCT00772642|||||Other|||||||
1515881|NCT00772629|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515882|NCT00772616|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1515883|NCT00772603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515884|NCT00772590|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1515885|NCT00772577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515886|NCT00772564|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515887|NCT00772551|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1515888|NCT00772538|Randomized|Parallel Assignment||Treatment||Double||||||
1515889|NCT00772525|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1515890|NCT00772512|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1515891|NCT00772499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515892|NCT00772486|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515893|NCT00772473|||Case-Only||Prospective|||||||
1515894|NCT00772460|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515895|NCT00772447|Randomized|Parallel Assignment||Treatment||Single|||||t|
1515896|NCT00772434|||Case-Only||Prospective|||||||
1515897|NCT00772421|||||Cross-Sectional|||||||
1515898|NCT00772408|||Case Control||Prospective|||||||
1515899|NCT00772395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515900|NCT00772382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515901|NCT00772369|||Cohort||Retrospective|||||||
1515902|NCT00772356|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1515903|NCT00772343|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1515904|NCT00772330||Single Group Assignment||Treatment||None (Open Label)||||||
1515905|NCT00772317||Single Group Assignment||Treatment||None (Open Label)||||||
1515906|NCT00772304|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1515907|NCT00772291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515908|NCT00772278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515909|NCT00772265|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1515910|NCT00772252|||Cohort||Prospective|||||||
1515911|NCT00772239|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1515912|NCT00772226|Randomized|Single Group Assignment||Treatment||Single|||||t|
1515913|NCT00772213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515914|NCT00772200||||||||||||
1515915|NCT00772187|Randomized|Parallel Assignment||Treatment||Single||||||t
1515916|NCT00772174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515917|NCT00772161|Randomized|Crossover Assignment||Treatment||Single||||||t
1515918|NCT00772148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515919|NCT00772135|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1515920|NCT00772122|Randomized|Parallel Assignment||Treatment||Single|||t|||
1515921|NCT00772109|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515922|NCT00772096|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1515923|NCT00772083|Randomized|Parallel Assignment||||None (Open Label)||||||
1515924|NCT00772070|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515925|NCT00772057|Randomized|Single Group Assignment||Prevention||Single|||t|||
1515926|NCT00772044|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515927|NCT00772031|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515928|NCT00772018|||Ecologic or Community||Cross-Sectional|||||||
1515929|NCT00772005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515930|NCT00771992||Single Group Assignment||Basic Science||None (Open Label)||||||
1515931|NCT00771979|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1515932|NCT00771966|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1515933|NCT00771953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515934|NCT00771940|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1515935|NCT00771927|||Cohort||Prospective|||||||
1515936|NCT00771914|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1515937|NCT00771901|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1515938|NCT00771888||Single Group Assignment||Treatment||None (Open Label)||||||
1515939|NCT00771875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515940|NCT00771862|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515941|NCT00771849|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1515942|NCT00771836|||Cohort||Prospective|||||||
1515943|NCT00771823|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1515944|NCT00771810|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1515945|NCT00771797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515946|NCT00771784|||Case Control||Prospective|||||||
1515947|NCT00771771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515948|NCT00771758|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515949|NCT00771745|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515950|NCT00771732|Randomized|Single Group Assignment||Treatment||Single|||t|||
1515951|NCT00771719||Single Group Assignment||Treatment||None (Open Label)||||||
1515952|NCT00771706|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1515953|NCT00771693|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1515954|NCT00771680|||Cohort||Prospective|||||||
1515955|NCT00771667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515956|NCT00771654|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515957|NCT00771641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515958|NCT00771628|Randomized|Parallel Assignment||Treatment||Single|||||t|
1515959|NCT00771615|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1515960|NCT00771602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515961|NCT00771589||Single Group Assignment||Diagnostic||None (Open Label)||||||
1515962|NCT00771576|||Other||Retrospective|||||||
1515963|NCT00771563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515964|NCT00771537|Randomized|Factorial Assignment||Health Services Research||Triple||||t|t|t
1515965|NCT00771524|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1515966|NCT00771511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515967|NCT00771498||Single Group Assignment||||None (Open Label)||||||
1515968|NCT00771485|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1515969|NCT00771472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1515970|NCT00771459|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1515971|NCT00771446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515972|NCT00771433|Non-Randomized|||Supportive Care||||||||
1515973|NCT00771420|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515974|NCT00771407|Randomized|Parallel Assignment||||Triple|||t|t||t
1515975|NCT00771394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515976|NCT00771381||Single Group Assignment||Diagnostic||None (Open Label)||||||
1515977|NCT00771368||Single Group Assignment||Treatment||None (Open Label)||||||
1515978|NCT00771355|||Case-Only||Prospective|||||||
1515979|NCT00771342|Randomized|Crossover Assignment||Treatment||Single|||t|||
1515980|NCT00771329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515981|NCT00771316|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515982|NCT00771303|||Cohort||Prospective|||||||
1515983|NCT00771290|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1515984|NCT00771277|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1515985|NCT00771264|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1515986|NCT00771251|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1515987|NCT00771238|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1515988|NCT00771225|Randomized|Parallel Assignment||Treatment||Single||||t||
1515989|NCT00771212|||Cohort||Prospective|||||||
1515990|NCT00771199||Single Group Assignment||Treatment||None (Open Label)||||||
1515991|NCT00771186|||Cohort||Prospective|||||||
1515992|NCT00771173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1515993|NCT00771160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1515994|NCT00771147|||Cohort||Prospective|||||||
1515995|NCT00771134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1515996|NCT00771121||||||||||||
1515997|NCT00771108|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1515998|NCT00771095||Parallel Assignment||Treatment||None (Open Label)||||||
1515999|NCT00771082|||Case Control||Retrospective|||||||
1516000|NCT00771069|||Cohort||Retrospective|||||||
1516001|NCT00771056||Single Group Assignment||Treatment||None (Open Label)||||||
1516002|NCT00771043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516003|NCT00771030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516004|NCT00771017|Randomized|||Treatment||None (Open Label)||||||
1516005|NCT00771004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516006|NCT00770991|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516007|NCT00770978|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516008|NCT00770965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516009|NCT00770952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516010|NCT00770939||Single Group Assignment||Treatment||None (Open Label)||||||
1516011|NCT00770926|Randomized|Parallel Assignment||Prevention||Single|||||t|
1516012|NCT00770913|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516013|NCT00770900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516014|NCT00770887|||||Prospective|||||||
1516015|NCT00770874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516016|NCT00770861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516017|NCT00770848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516018|NCT00770835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516019|NCT00770822|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516020|NCT00770809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516021|NCT00770796|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1516022|NCT00770783|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1516023|NCT00770770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516024|NCT00770757||Single Group Assignment||Treatment||None (Open Label)||||||
1516025|NCT00770744|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516026|NCT00770731|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516027|NCT00770718|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516028|NCT00770705|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516029|NCT00770692|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516030|NCT00770679||Single Group Assignment||Diagnostic||None (Open Label)||||||
1516031|NCT00770666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516032|NCT00770653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516033|NCT00770640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516034|NCT00770627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516035|NCT00770614|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516036|NCT00770601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516037|NCT00770588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516038|NCT00770575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516039|NCT00770562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516040|NCT00770536|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516041|NCT00770523|||Case-Only||Prospective|||||||
1516042|NCT00770510|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516043|NCT00770497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516044|NCT00770484|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516045|NCT00770471||Single Group Assignment||Treatment||None (Open Label)||||||
1516046|NCT00770458|||Cohort||Cross-Sectional|||||||
1516047|NCT00770445|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516048|NCT00770432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516049|NCT00770419|||Cohort||Prospective|||||||
1516050|NCT00770406|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516051|NCT00770393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516052|NCT00770380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516053|NCT00770367|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1516054|NCT00770354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516055|NCT00770341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516056|NCT00770328|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516057|NCT00770315|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516058|NCT00770302||Single Group Assignment||Basic Science||None (Open Label)||||||
1516059|NCT00770289|||Cohort|||||||||
1516060|NCT00770276|||Case-Control||Prospective|||||||
1516061|NCT00770263|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516062|NCT00770250|||Cohort||Cross-Sectional|||||||
1516063|NCT00770237||Crossover Assignment||Diagnostic||Single|||t|||
1516064|NCT00770224||Single Group Assignment||Treatment||None (Open Label)||||||
1516065|NCT00770211|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516066|NCT00770198|||Case Control||Prospective|||||||
1516067|NCT00770185||Single Group Assignment||Treatment||None (Open Label)||||||
1516068|NCT00770172|Randomized|||Supportive Care||None (Open Label)||||||
1516069|NCT00770159|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516070|NCT00770146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516071|NCT00770133|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516072|NCT00770120||Single Group Assignment||Treatment||None (Open Label)||||||
1516073|NCT00770107|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1516074|NCT00770094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516075|NCT00770081|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516076|NCT00770068|||Cohort||Prospective|||||||
1516077|NCT00770055||||Health Services Research||||||||
1516078|NCT00770042|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1516079|NCT00770029|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516080|NCT00770016||Single Group Assignment||Basic Science||None (Open Label)||||||
1516081|NCT00770003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516082|NCT00769990||Single Group Assignment||Treatment||None (Open Label)||||||
1516083|NCT00769964||||Treatment||||||||
1516084|NCT00769951|||Cohort||Prospective|||||||
1516085|NCT00769938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516086|NCT00769925|Randomized|Parallel Assignment||Treatment||Single||||||t
1516087|NCT00769912|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516088|NCT00769899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516089|NCT00769886|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516090|NCT00769873|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516091|NCT00769860|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516092|NCT00769847|||Cohort||Prospective|||||||
1516093|NCT00769834|||Cohort||Cross-Sectional|||||||
1516094|NCT00769821|||Cohort||Prospective|||||||
1516095|NCT00769808||||||||||||
1516096|NCT00769795||Single Group Assignment||Treatment||None (Open Label)||||||
1516097|NCT00769782||Single Group Assignment||Treatment||None (Open Label)||||||
1516098|NCT00769769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516099|NCT00769756|||Family-Based||Prospective|||||||
1516100|NCT00769730|||Case Control||Prospective|||||||
1516101|NCT00769717|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516102|NCT00769704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516103|NCT00769691|||Cohort||Prospective|||||||
1516104|NCT00769678|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1516105|NCT00769665|||Cohort||Prospective|||||||
1516106|NCT00769652|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1516107|NCT00769626|Randomized|Parallel Assignment||Treatment||Single||||||t
1516108|NCT00769613||||Supportive Care||None (Open Label)||||||
1516109|NCT00769600|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516110|NCT00769587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516111|NCT00769574|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1516112|NCT00769561|Randomized|Parallel Assignment||Treatment||Single||||||t
1516113|NCT00769548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516114|NCT00769535||Single Group Assignment||Basic Science||None (Open Label)||||||
1516115|NCT00769522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516117|NCT00769496|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516118|NCT00769483|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516119|NCT00769470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516120|NCT00769457|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516121|NCT00769431||Single Group Assignment||Health Services Research||None (Open Label)||||||
1516122|NCT00769418|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516123|NCT00769405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516124|NCT00769392|Randomized|Crossover Assignment||Treatment||Single|||t|||
1516125|NCT00769379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516126|NCT00769366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516127|NCT00769353|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1516128|NCT00769340||||||||||||
1516129|NCT00769327|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516130|NCT00769314|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516131|NCT00769301|||Cohort||Prospective|||||||
1516132|NCT00769288||Single Group Assignment||Treatment||None (Open Label)||||||
1516133|NCT00769275|||Cohort||Prospective|||||||
1516134|NCT00769262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516135|NCT00769249|||Cohort||Cross-Sectional|||||||
1516136|NCT00769236|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1516137|NCT00769223|||Cohort||Other|||||||
1516138|NCT00769210||Single Group Assignment||Basic Science||None (Open Label)||||||
1516139|NCT00769197|||Cohort||Cross-Sectional|||||||
1516140|NCT00769184|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1516141|NCT00769171|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516142|NCT00769158|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1516143|NCT00769145||Single Group Assignment||Treatment||None (Open Label)||||||
1516144|NCT00769132|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516145|NCT00769119|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1516146|NCT00769106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516147|NCT00769093|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1516148|NCT00769080|||||Prospective|||||||
1516149|NCT00769067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516150|NCT00769054|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1516151|NCT00769041|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1516152|NCT00769028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516153|NCT00769015|Randomized|Parallel Assignment||Prevention||Single||||||t
1516154|NCT00769002|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1516155|NCT00768989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516156|NCT00768976|||Ecologic or Community||Prospective|||||||
1516157|NCT00768963|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516158|NCT00768950|||Cohort||Prospective|||||||
1516159|NCT00768937|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516160|NCT00768924|||Cohort||Prospective|||||||
1516161|NCT00768911|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516162|NCT00768898|||Cohort||Prospective|||||||
1516163|NCT00768885|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1516164|NCT00768872|||Case-Only||Prospective|||||||
1516165|NCT00768859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516166|NCT00768846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516167|NCT00768833|||Cohort||Prospective|||||||
1516168|NCT00768820||Single Group Assignment||Diagnostic||None (Open Label)||||||
1516169|NCT00768807|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1516170|NCT00768794||Single Group Assignment||Treatment||None (Open Label)||||||
1516171|NCT00768781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516172|NCT00768768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516173|NCT00768755|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516174|NCT00768742||Single Group Assignment||Treatment||None (Open Label)||||||
1516175|NCT00768729|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1516176|NCT00768716|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1516177|NCT00768703||Single Group Assignment||Treatment||None (Open Label)||||||
1516178|NCT00768690|Randomized|Single Group Assignment||||Triple|||t|t|t|
1516179|NCT00768677||Single Group Assignment||Treatment||||||||
1516180|NCT00768664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516181|NCT00768651||Single Group Assignment||Treatment||None (Open Label)||||||
1516182|NCT00768638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516183|NCT00768625|||Cohort||Prospective|||||||
1516184|NCT00768612|Randomized|Parallel Assignment||Treatment||Double||||||
1516185|NCT00768599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516186|NCT00768586|||Cohort||Prospective|||||||
1516187|NCT00768573|||||Prospective|||||||
1516188|NCT00768560|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1516189|NCT00768547|||Cohort||Prospective|||||||
1516190|NCT00768534|||Cohort||Prospective|||||||
1516191|NCT00768521|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516192|NCT00768508|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1516193|NCT00768495|||Cohort||Prospective|||||||
1516194|NCT00768482||Crossover Assignment||Treatment||None (Open Label)||||||
1516195|NCT00768469|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516196|NCT00768456|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1516197|NCT00768443|||||Prospective|||||||
1516198|NCT00768430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516199|NCT00768417|||Case-Crossover||Cross-Sectional|||||||
1516200|NCT00768404|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516201|NCT00768391||Single Group Assignment||||None (Open Label)||||||
1516202|NCT00768378|Randomized|Parallel Assignment||Treatment||Single||||||t
1516203|NCT00768365|||||Prospective|||||||
1516204|NCT00768352||Single Group Assignment||||None (Open Label)||||||
1516205|NCT00768339||Single Group Assignment||Treatment||None (Open Label)||||||
1516206|NCT00768326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516207|NCT00768313|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516208|NCT00768300|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516209|NCT00768287|Randomized|Crossover Assignment||Supportive Care||Quadruple|Study Part 1 only|Study Part 1: Randomized, double-blind, cross-over study of pharmacokinetics; Study Part 2: Non-randomized, open-label study of safety and efficacy; Surgical sub-study: Non-randomized, open-label study of safety and efficacy during major surgery|t|t|t|t
1516210|NCT00768274|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516211|NCT00768261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516212|NCT00768248|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1516213|NCT00768235|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516214|NCT00768222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516215|NCT00768209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516216|NCT00768196|||Case-Only||Prospective|||||||
1516217|NCT00768183|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1516218|NCT00768170|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516219|NCT00768157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516220|NCT00768144||Single Group Assignment||Treatment||None (Open Label)||||||
1516221|NCT00768131|Randomized|Parallel Assignment||||None (Open Label)||||||
1516222|NCT00768118||Single Group Assignment||Prevention||None (Open Label)||||||
1516223|NCT00768105|Randomized|Factorial Assignment||Treatment||Single|||t|||
1516224|NCT00768079|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516225|NCT00768066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516226|NCT00768053||Single Group Assignment||Treatment||None (Open Label)||||||
1516227|NCT00768040|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516228|NCT00768027|||Cohort||Prospective|||||||
1516229|NCT00768014|||Case Control||Prospective|||||||
1516230|NCT00768001|||Cohort||Prospective|||||||
1516231|NCT00767988|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516232|NCT00767975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516233|NCT00767962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516234|NCT00767949||Single Group Assignment||Treatment||None (Open Label)||||||
1516235|NCT00767936|||Cohort||Prospective|||||||
1516236|NCT00767923|||Cohort||Prospective|||||||
1516237|NCT00767910||||||||||||
1516238|NCT00767897|||Other||Prospective|||||||
1516239|NCT00767884||||||||||||
1516240|NCT00767871||Single Group Assignment||Basic Science||None (Open Label)||||||
1516241|NCT00767858|||Case-Only||Prospective|||||||
1516242|NCT00767845||||||||||||
1516243|NCT00767832|||Cohort||Prospective|||||||
1516244|NCT00767819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516245|NCT00767806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516246|NCT00767793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516247|NCT00767780|||Cohort||Retrospective|||||||
1516248|NCT00767767|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1516249|NCT00767754||Single Group Assignment||Treatment||None (Open Label)||||||
1516250|NCT00767741|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1516251|NCT00767728|Randomized|Parallel Assignment||Prevention||Double||||||
1516252|NCT00767715|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516253|NCT00767702|||||Prospective|||||||
1516254|NCT00767689|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1516255|NCT00767676|Non-Randomized|Single Group Assignment||||Single||||||t
1516256|NCT00767663|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1516257|NCT00767650|||||Prospective|||||||
1516258|NCT00767637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516259|NCT00767624|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516260|NCT00767611|||||Prospective|||||||
1516261|NCT00767598|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1516262|NCT00767585|||Case Control||Cross-Sectional|||||||
1516263|NCT00767572|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1516264|NCT00767559|Randomized|Parallel Assignment||Treatment||Single||||||t
1516265|NCT00767546||Single Group Assignment||Treatment||None (Open Label)||||||
1516266|NCT00767533|||Cohort||Prospective|||||||
1516267|NCT00767520|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516268|NCT00767507|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516269|NCT00767494|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516270|NCT00767481|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516271|NCT00767468|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516272|NCT00767455|Randomized|Single Group Assignment||||Single||||||t
1516273|NCT00767442|||Case Control||Prospective|||||||
1516274|NCT00767429||Single Group Assignment||Prevention||None (Open Label)||||||
1516275|NCT00767416|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1516276|NCT00767403|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1516277|NCT00767390|||Case-Only||Prospective|||||||
1516278|NCT00767377||Single Group Assignment||Treatment||None (Open Label)||||||
1516279|NCT00767364|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516280|NCT00767351|||Case-Only||Prospective|||||||
1516281|NCT00767338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516282|NCT00767325|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1516283|NCT00767312|||Cohort||Prospective|||||||
1516284|NCT00767299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516285|NCT00767286||||Treatment||||||||
1516286|NCT00767273|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1516287|NCT00767260|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1516288|NCT00767247|||Case Control||Prospective|||||||
1516289|NCT00767234|||Cohort||Prospective|||||||
1516290|NCT00767221||Single Group Assignment||Treatment||None (Open Label)||||||
1516291|NCT00767208||Parallel Assignment||||Single|||t|||
1516292|NCT00767195|||Case Control||Prospective|||||||
1516293|NCT00767182|||Cohort||Prospective|||||||
1516294|NCT00767169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516295|NCT00767156|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1516296|NCT00767130|||Cohort||Retrospective|||||||
1516297|NCT00767117|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1516298|NCT00767104|Randomized|Parallel Assignment||Treatment||Single|||||t|
1516299|NCT00767091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516300|NCT00767065|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1516301|NCT00767052|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1516302|NCT00767039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516303|NCT00767026|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1516304|NCT00767013||Single Group Assignment||Diagnostic||None (Open Label)||||||
1516305|NCT00767000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516306|NCT00766987|||Cohort||Prospective|||||||
1516307|NCT00766974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516308|NCT00766961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516309|NCT00766948|||Cohort||Prospective|||||||
1516310|NCT00766935|||Case Control||Cross-Sectional|||||||
1516311|NCT00766909|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1516312|NCT00766896|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1516313|NCT00766883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516314|NCT00766870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516315|NCT00766857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516316|NCT00766844||Single Group Assignment||Prevention||None (Open Label)||||||
1516317|NCT00766831||Single Group Assignment||Treatment||None (Open Label)||||||
1516318|NCT00766818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516319|NCT00766805|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1516320|NCT00766792|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516321|NCT00766779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516322|NCT00766766|Randomized|Parallel Assignment||||None (Open Label)||||||
1516323|NCT00766753||Single Group Assignment||Treatment||None (Open Label)||||||
1516324|NCT00766740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516325|NCT00766727||||||||||||
1516326|NCT00766714|Randomized|Parallel Assignment||||None (Open Label)||||||
1516327|NCT00766701|||Cohort||Retrospective|||||||
1516328|NCT00766688|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516329|NCT00766675||Single Group Assignment||Treatment||None (Open Label)||||||
1516330|NCT00766662|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1516331|NCT00766649||Single Group Assignment||Treatment||None (Open Label)||||||
1516332|NCT00766636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516333|NCT00766623|Randomized|Crossover Assignment||||Double|||t||t|
1516334|NCT00766597||Single Group Assignment||Treatment||None (Open Label)||||||
1516335|NCT00766584|||Cohort||Prospective|||||||
1516336|NCT00766571|||||Other|||||||
1516337|NCT00766558|||Cohort||Prospective|||||||
1516338|NCT00766545|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1516339|NCT00766532||Single Group Assignment||Diagnostic||None (Open Label)||||||
1516340|NCT00766519|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516341|NCT00766506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516342|NCT00766493||Single Group Assignment||Treatment||None (Open Label)||||||
1516343|NCT00766480||||Treatment||None (Open Label)||||||
1516344|NCT00766467|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1516345|NCT00766454|||Other||Prospective|||||||
1516346|NCT00766441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516347|NCT00766415|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516348|NCT00766402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516349|NCT00766389|||Case Control||Retrospective|||||||
1516350|NCT00766376||Single Group Assignment||Treatment||None (Open Label)||||||
1516351|NCT00766363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516352|NCT00766350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516353|NCT00766337|Randomized|Parallel Assignment||Treatment||Single||||||t
1516354|NCT00766324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516355|NCT00766311||Single Group Assignment||Supportive Care||None (Open Label)||||||
1516356|NCT00766298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516357|NCT00766285|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1516358|NCT00766272|Randomized|Parallel Assignment||Treatment||Single||||||t
1516359|NCT00766259|||Case Control||Prospective|||||||
1516360|NCT00766246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516361|NCT00766233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516362|NCT00766220|Randomized|Single Group Assignment||Treatment||Single|||t|||
1516363|NCT00766207|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1516364|NCT00766194|||Cohort||Prospective|||||||
1516365|NCT00766181|||Cohort||Cross-Sectional|||||||
1516366|NCT00766168|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1516367|NCT00766155|Randomized|||Treatment||None (Open Label)||||||
1516368|NCT00766142|Non-Randomized|||Treatment||||||||
1516369|NCT00766129|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516370|NCT00766116||Single Group Assignment||Treatment||None (Open Label)||||||
1516371|NCT00766103||Single Group Assignment||Diagnostic||None (Open Label)||||||
1516372|NCT00766090|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516373|NCT00766077|||Cohort||Prospective|||||||
1516374|NCT00766064||Single Group Assignment||Treatment||None (Open Label)||||||
1516375|NCT00766051|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516376|NCT00766038|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516377|NCT00766025|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1516378|NCT00766012|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1516379|NCT00765999|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516380|NCT00765986|||Cohort||Prospective|||||||
1516381|NCT00765973|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516382|NCT00765960|||Other||Retrospective|||||||
1516383|NCT00765947|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516384|NCT00765934|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1516385|NCT00765921|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516386|NCT00765908|Randomized|Parallel Assignment||Basic Science||Triple|||t|t||t
1516387|NCT00765895|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516388|NCT00765882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516389|NCT00765869|Randomized|Parallel Assignment||Prevention||Single|||t|||
1516390|NCT00765856||Single Group Assignment||Treatment||None (Open Label)||||||
1516391|NCT00765843|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1516392|NCT00765830|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516393|NCT00765817|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516394|NCT00765804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516395|NCT00765791|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1516396|NCT00765778|||Case-Only||Prospective|||||||
1516397|NCT00765765||Single Group Assignment||Treatment||None (Open Label)||||||
1516398|NCT00765752|||Case Control||Cross-Sectional|||||||
1516399|NCT00765739|Randomized|Parallel Assignment||Treatment||Single||||||t
1516400|NCT00765726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516401|NCT00765713|Randomized|Parallel Assignment||Treatment||Single|||||t|
1516402|NCT00765700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516403|NCT00765687||Single Group Assignment||Prevention||None (Open Label)||||||
1516404|NCT00765674|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516405|NCT00765661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516406|NCT00765648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516407|NCT00765635|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516408|NCT00765622|||Case-Crossover||Cross-Sectional|||||||
1516409|NCT00765609|||Case-Only||Prospective|||||||
1516410|NCT00765596|||Case Control||Prospective|||||||
1516411|NCT00765583|Randomized|Single Group Assignment||Treatment||Single||||||t
1516412|NCT00765570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516413|NCT00765557|Randomized|Single Group Assignment||Treatment||Double|The Investigational Drug Pharmacist will be blinded to all patient data, and physicians and nurses evaluating patients will be blinded to randomization of these patients to laxative versus placebo arms.|Only patients of investigators and sub-investigators will be recruited for this study. Children with urinary incontinence, urinary frequency, diurnal incontinence, UTIs and/or reflux validated by bladder/bowel symptom questionnaire to have Urge Syndrome (US) are eligible for this study. Standardized questionnaire of bowel/bladder activity will be given and a KUB obtained, standard of care, at entry to the study. A standard 1-day voiding diary will be completed at home before beginning therapy. Only subjects 4 years of age and older will be studied. Exclusion criteria also includes known neurological disorders, a diagnosis of attention deficit disorder, bladder symptoms less than 6 months in duration at presentation, other bladder dysfunctions besides US, history of anorectal malformation, pregnancy and encopresis. Those accepted into the study will be randomized to receive either laxative or placebo once daily for one month.||t|t|
1516414|NCT00765544|Randomized|Parallel Assignment||Treatment||Single||||||t
1516415|NCT00765531||||||||||||
1516416|NCT00765518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516417|NCT00765505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516418|NCT00765492|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1516419|NCT00765479|Randomized|||Treatment||Double||||||
1516420|NCT00765466||Single Group Assignment||Treatment||None (Open Label)||||||
1516421|NCT00765453|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516422|NCT00765440|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1516423|NCT00765427||Single Group Assignment||||None (Open Label)||||||
1516424|NCT00765414||Single Group Assignment||Treatment||None (Open Label)||||||
1516425|NCT00765401|||Case-Control||Prospective|||||||
1516426|NCT00765388|Randomized|Crossover Assignment||||None (Open Label)||||||
1516427|NCT00765375||Single Group Assignment||Treatment||Double|||t|||t
1516428|NCT00765362|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516429|NCT00765349|||Cohort||Prospective|||||||
1516430|NCT00765336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516431|NCT00765323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516432|NCT00765310|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1516433|NCT00765297|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1516434|NCT00765284|||Cohort||Prospective|||||||
1516435|NCT00765271|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1516436|NCT00765258|||Case-Only||Prospective|||||||
1516437|NCT00765245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516438|NCT00765232|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516439|NCT00765219|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516440|NCT00765206|Randomized|Crossover Assignment||||None (Open Label)||||||
1516441|NCT00765193|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1516442|NCT00765180|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1516443|NCT00765167|Randomized|Crossover Assignment||Treatment||Single|||t|||
1516444|NCT00765154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516445|NCT00765141|||Cohort||Prospective|||||||
1516446|NCT00765128|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516447|NCT00765115|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1516448|NCT00765102||Single Group Assignment||Treatment||None (Open Label)||||||
1516449|NCT00765089|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516450|NCT00765076|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1516451|NCT00765063|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516452|NCT00765050|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516453|NCT00765037|||Cohort||Retrospective|||||||
1516454|NCT00765024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516455|NCT00765011|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1516456|NCT00764998|Randomized|Parallel Assignment||Prevention||Single|||t|||
1516457|NCT00764985|||Cohort||Prospective|||||||
1516458|NCT00764972||Single Group Assignment||Treatment||None (Open Label)||||||
1516459|NCT00764959|||Cohort||Retrospective|||||||
1516460|NCT00764946|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516461|NCT00764933|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1516462|NCT00764920|||Other||Other|||||||
1516463|NCT00764907|Randomized|||Treatment||||||||
1516464|NCT00764894|||Cohort||Retrospective|||||||
1516465|NCT00764881|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516466|NCT00764868|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1516467|NCT00764855|||Cohort||Prospective|||||||
1516468|NCT00764842|||Cohort||Retrospective|||||||
1516469|NCT00764829|||Case-Only||Prospective|||||||
1516470|NCT00764816|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1516471|NCT00764803|||Cohort||Retrospective|||||||
1516472|NCT00764790|Randomized|Parallel Assignment||Prevention||Double||||t||t
1516473|NCT00764777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516474|NCT00764764|Randomized|Parallel Assignment||Treatment||Single||||||t
1516475|NCT00764751|Randomized|Parallel Assignment||Treatment||Single|||||t|
1516476|NCT00764738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516477|NCT00764725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516478|NCT00764712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516479|NCT00764699||Single Group Assignment||Treatment||None (Open Label)||||||
1516480|NCT00764686|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516481|NCT00764673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516482|NCT00764660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516483|NCT00764647||Single Group Assignment||Treatment||None (Open Label)||||||
1516484|NCT00764634|Randomized|Parallel Assignment||||Triple|||t|t|t|
1516485|NCT00764621|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1516486|NCT00764608|||Case-Only||Prospective|||||||
1516487|NCT00764595||Single Group Assignment||Treatment||None (Open Label)||||||
1516488|NCT00764582|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1516489|NCT00764569|||Other||Other|||||||
1516490|NCT00764556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516491|NCT00764543||||||||||||
1516492|NCT00764530|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516493|NCT00764517|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516494|NCT00764504|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516495|NCT00764491||||||||||||
1516496|NCT00764478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516497|NCT00764465|Randomized|Factorial Assignment||||None (Open Label)||||||
1516498|NCT00764452||||||||||||
1516499|NCT00764439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516500|NCT00764426|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1516501|NCT00764413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516502|NCT00764400|Randomized|Parallel Assignment||Treatment||Single|||||t|
1516503|NCT00764387|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1516504|NCT00764374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516505|NCT00764361|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516506|NCT00764348|||||Prospective|||||||
1516507|NCT00764335|||Case-Control||Prospective|||||||
1516508|NCT00764322|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516509|NCT00764309||Single Group Assignment||Treatment||None (Open Label)||||||
1516510|NCT00764296|||Cohort||Prospective|||||||
1516511|NCT00764283|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516512|NCT00764270|Randomized|Crossover Assignment||Treatment||Quadruple||Crossover study in which participants are randomly assigned to the sequence of receiving R-Alpha Lipoic Acid and Placebo|t|t|t|t
1516513|NCT00764257||||||||||||
1516514|NCT00764244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516515|NCT00764231|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1516516|NCT00764218||Factorial Assignment||Health Services Research||None (Open Label)||||||
1516517|NCT00764205|||Case Control||Prospective|||||||
1516518|NCT00764192||Single Group Assignment||Basic Science||None (Open Label)||||||
1516519|NCT00764179|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1516520|NCT00764166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516521|NCT00764153|Randomized|Parallel Assignment||Treatment||Single||||||t
1516522|NCT00764140|||Case Control||Cross-Sectional|||||||
1516523|NCT00764127|||Case Control||Prospective|||||||
1516524|NCT00764114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516525|NCT00764101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516526|NCT00764088|||Case Control||Retrospective|||||||
1516527|NCT00764075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516528|NCT00764062|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516529|NCT00764049||Single Group Assignment||Treatment||None (Open Label)||||||
1516530|NCT00764036||Sequential Assignment||Treatment||None (Open Label)||dose escalation||||
1516531|NCT00764023|||Case-Only||Prospective|||||||
1516532|NCT00764010|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1516533|NCT00763997|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1516534|NCT00763984|Randomized|Parallel Assignment||Prevention||Single||||t||
1516535|NCT00763971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516536|NCT00763958|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1516537|NCT00763945|||||Prospective|||||||
1516538|NCT00763932||Single Group Assignment||Treatment||None (Open Label)||||||
1516539|NCT00763919||Single Group Assignment||Treatment||None (Open Label)||||||
1516540|NCT00763906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516541|NCT00763893|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516542|NCT00763880|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1516543|NCT00763867|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516544|NCT00763841|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1516545|NCT00763828||Single Group Assignment||Treatment||None (Open Label)||||||
1516546|NCT00763815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516547|NCT00763802|||Cohort||Prospective|||||||
1516548|NCT00763789|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1516549|NCT00763776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516550|NCT00763763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516551|NCT00763750||Single Group Assignment||Treatment||None (Open Label)||||||
1516552|NCT00763737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516553|NCT00763724|||Cohort||Retrospective|||||||
1516554|NCT00763711||Single Group Assignment||Treatment||None (Open Label)||||||
1516555|NCT00763698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516556|NCT00763685|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1516557|NCT00763672|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516558|NCT00763659|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1516559|NCT00763646||Single Group Assignment||Treatment||None (Open Label)||||||
1516560|NCT00763633|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1516561|NCT00763620|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1516562|NCT00763607|||Cohort||Retrospective|||||||
1516563|NCT00763594|Randomized|Parallel Assignment||Treatment||Single||||||t
1516564|NCT00763581|||Case-Only||Cross-Sectional|||||||
1516565|NCT00763568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516566|NCT00763555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516567|NCT00763542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516568|NCT00763529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516569|NCT00763516||Single Group Assignment||Treatment||None (Open Label)||||||
1516570|NCT00763503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516571|NCT00763490||Single Group Assignment||Treatment||None (Open Label)||||||
1516572|NCT00763477|Randomized|Crossover Assignment||Health Services Research||Triple|||t|t|t|
1516573|NCT00763464||Single Group Assignment||Diagnostic||None (Open Label)||||||
1516574|NCT00763451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516575|NCT00763438||Single Group Assignment||Treatment||None (Open Label)||||||
1516576|NCT00763425|Randomized|Parallel Assignment||Treatment||Single||||||t
1516577|NCT00763412|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1516578|NCT00763399|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1516579|NCT00763386|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516580|NCT00763373||||||||||||
1516581|NCT00763360|Randomized|Parallel Assignment||||Single||||||t
1516582|NCT00763347|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516583|NCT00763321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516584|NCT00763308|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516585|NCT00763295|||Case Control||Prospective|||||||
1516586|NCT00763282|Randomized|Parallel Assignment||Prevention||Single|||||t|
1516587|NCT00763269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516588|NCT00763256|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516589|NCT00763243||Single Group Assignment||Treatment||None (Open Label)||||||
1516590|NCT00763230|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1516591|NCT00763217|||Cohort||Prospective|||||||
1516592|NCT00763204|Randomized|||Treatment||Double|||t|||t
1516593|NCT00763191|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1516594|NCT00763178||Single Group Assignment||Basic Science||None (Open Label)||||||
1516595|NCT00763165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516596|NCT00763152|||Cohort||Prospective|||||||
1516597|NCT00763139|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1516598|NCT00763126|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1516599|NCT00763113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516600|NCT00763100|||Case-Crossover||Prospective|||||||
1516601|NCT00763087|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516602|NCT00763074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516603|NCT00763061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516604|NCT00763048|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516605|NCT00763035|Randomized|Crossover Assignment||Diagnostic||Single||||||t
1516606|NCT00763022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516607|NCT00763009||Single Group Assignment||Diagnostic||None (Open Label)||||||
1516608|NCT00762996|Randomized|Crossover Assignment||Treatment||Single|||t|||
1516609|NCT00762983|||Ecologic or Community||Prospective|||||||
1516610|NCT00762970|Randomized|Parallel Assignment||Treatment||Single|||||t|
1516611|NCT00762957|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516612|NCT00762944|||Cohort||Prospective|||||||
1516613|NCT00762931||Single Group Assignment||Treatment||None (Open Label)||||||
1516614|NCT00762918||Single Group Assignment||Treatment||None (Open Label)||||||
1516615|NCT00762905|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1516616|NCT00762892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516617|NCT00762879|||Case-Control||Cross-Sectional|||||||
1516618|NCT00762866|||Cohort||Cross-Sectional|||||||
1516619|NCT00762853|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516620|NCT00762840|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1516621|NCT00762814||Single Group Assignment||Treatment||None (Open Label)||||||
1516622|NCT00762801|||||Prospective|||||||
1516623|NCT00762788|Randomized|Parallel Assignment||||Single|||||t|
1516624|NCT00762775|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1516625|NCT00762762|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516626|NCT00762749|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1516627|NCT00762736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516628|NCT00762723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516629|NCT00762710|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1516630|NCT00762697|||Case Control||Prospective|||||||
1516631|NCT00762684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516632|NCT00762671|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1516633|NCT00762658|Randomized|||Treatment||Double|||t|||t
1516634|NCT00762645|Randomized|Parallel Assignment||Treatment||Double||||||
1516635|NCT00762632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516636|NCT00762619|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516637|NCT00762606|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516638|NCT00762593|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516639|NCT00762580|||Cohort||Prospective|||||||
1516640|NCT00762567|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1516641|NCT00762554|Randomized|Parallel Assignment||Treatment||Single||||||t
1516642|NCT00762541||Single Group Assignment||Treatment||None (Open Label)||||||
1516643|NCT00762528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516644|NCT00762515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516645|NCT00762502|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1516646|NCT00762489|Non-Randomized|Single Group Assignment||||||||||
1516647|NCT00762476|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1516648|NCT00762463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516649|NCT00762450|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516650|NCT00762437||Single Group Assignment||Treatment||None (Open Label)||||||
1516651|NCT00762424|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1516652|NCT00762411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516653|NCT00762398|||Case-Only||Prospective|||||||
1516654|NCT00762385|Randomized|Crossover Assignment||Treatment||Single|||t|||
1516655|NCT00762372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516656|NCT00762359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516657|NCT00762346||Single Group Assignment||Treatment||None (Open Label)||||||
1516658|NCT00762333|||Case-Control||Prospective|||||||
1516659|NCT00762320||Single Group Assignment||Treatment||None (Open Label)||||||
1516660|NCT00762307||Single Group Assignment||Treatment||None (Open Label)||||||
1516661|NCT00762294|||Case-Only||Prospective|||||||
1516662|NCT00762281||Single Group Assignment||Treatment||None (Open Label)||||||
1516663|NCT00762268|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516664|NCT00762255|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516665|NCT00762242|||Case Control||Prospective|||||||
1516666|NCT00762229|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1516667|NCT00762216|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516668|NCT00762190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516669|NCT00762177|Randomized|Crossover Assignment||Treatment||Single|||t|||
1516670|NCT00762164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516671|NCT00762151||Crossover Assignment||Prevention||None (Open Label)||||||
1516672|NCT00762138||Single Group Assignment||||None (Open Label)||||||
1516673|NCT00762125|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516674|NCT00762112|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516675|NCT00762099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516676|NCT00762086|Randomized|Parallel Assignment||Treatment||Single||||t||
1516677|NCT00762073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516678|NCT00762060|||Cohort||Prospective|||||||
1516679|NCT00762047|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516680|NCT00762034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516681|NCT00762021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516682|NCT00762008|||Case-Control||Prospective|||||||
1516683|NCT00761995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516684|NCT00761982|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1516685|NCT00761969|||Cohort||Prospective|||||||
1516686|NCT00761956|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516687|NCT00761943|||Case-Only||Prospective|||||||
1516688|NCT00761930|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516689|NCT00761917|||Case Control||Cross-Sectional|||||||
1516690|NCT00761904|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1516691|NCT00761891|Randomized|Parallel Assignment||||Single|||||t|
1516692|NCT00761878||Single Group Assignment||Treatment||None (Open Label)||||||
1516693|NCT00761865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516694|NCT00761852|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1516695|NCT00761839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516696|NCT00761826||Single Group Assignment||Treatment||None (Open Label)||||||
1516697|NCT00761813|Randomized|Parallel Assignment||Treatment||Single||||||t
1516698|NCT00761800|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1516699|NCT00761787|||Cohort||Prospective|||||||
1516700|NCT00761774||Single Group Assignment||Treatment||None (Open Label)||||||
1516701|NCT00761761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516702|NCT00761748|Randomized|Crossover Assignment||||None (Open Label)||||||
1516703|NCT00761735||Single Group Assignment||Treatment||None (Open Label)||||||
1516704|NCT00761722|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516705|NCT00761709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516706|NCT00761696||Single Group Assignment||Treatment||None (Open Label)||||||
1516707|NCT00761683|||Cohort||Prospective|||||||
1516708|NCT00761670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516709|NCT00761657|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516710|NCT00761644||Single Group Assignment||Treatment||None (Open Label)||||||
1516711|NCT00761631|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1516712|NCT00761618|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516713|NCT00761605||Single Group Assignment||Treatment||None (Open Label)||||||
1516714|NCT00761592|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516715|NCT00761579||Single Group Assignment||Treatment||None (Open Label)||||||
1516716|NCT00761566|Randomized|Crossover Assignment||||Double|||t||t|
1516717|NCT00761553|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516718|NCT00761540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516719|NCT00761527|||Ecologic or Community||Prospective|||||||
1516720|NCT00761514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516721|NCT00761501|Randomized|Crossover Assignment||||None (Open Label)||||||
1516722|NCT00761488|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516723|NCT00761475|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1516724|NCT00761462|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516725|NCT00761449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516726|NCT00761436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516727|NCT00761423|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1516728|NCT00761410||Single Group Assignment||Treatment||None (Open Label)||||||
1516729|NCT00761397|||Cohort||Prospective|||||||
1516730|NCT00761384||Single Group Assignment||Treatment||None (Open Label)||||||
1516731|NCT00761371||Single Group Assignment||Treatment||None (Open Label)||||||
1516732|NCT00761358|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516733|NCT00761345||Single Group Assignment||Treatment||None (Open Label)||||||
1516734|NCT00761332|||Cohort||Prospective|||||||
1516735|NCT00761319|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516736|NCT00761306||Single Group Assignment||Treatment||None (Open Label)||||||
1516737|NCT00761280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516738|NCT00761267||Single Group Assignment||Treatment||None (Open Label)||||||
1516739|NCT00761254||Single Group Assignment||Treatment||None (Open Label)||||||
1516740|NCT00761241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516741|NCT00761228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516742|NCT00761215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516743|NCT00761202|Randomized|Parallel Assignment||Treatment||Single|||||t|
1516744|NCT00761189||Single Group Assignment||Treatment||None (Open Label)||||||
1516745|NCT00761176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516746|NCT00761163|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516747|NCT00761150|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516748|NCT00761137|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1516749|NCT00761124|Randomized|Parallel Assignment||Prevention||Single|||t|||
1516750|NCT00761111|Randomized|Single Group Assignment||||Double|||t||t|
1516751|NCT00761098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516752|NCT00761085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516753|NCT00761072|||Cohort||Retrospective|||||||
1516754|NCT00761059|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1516755|NCT00761046|||Cohort||Retrospective|||||||
1516756|NCT00761033|Randomized|Parallel Assignment||Treatment||Single||||||t
1516757|NCT00761020|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1516758|NCT00761007|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516759|NCT00760994|Randomized|Parallel Assignment||Treatment||Single||||||t
1516760|NCT00760981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516761|NCT00760968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516762|NCT00760955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516763|NCT00760942|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1516764|NCT00760929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516765|NCT00760916|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516766|NCT00760903|||Case Control|||||||||
1516767|NCT00760890|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516768|NCT00760877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516769|NCT00760864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516770|NCT00760851|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1516771|NCT00760838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516772|NCT00760825||Single Group Assignment||Prevention||None (Open Label)||||||
1516773|NCT00760812|Randomized|Crossover Assignment||Treatment||Single||||||t
1516774|NCT00760799|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516775|NCT00760786|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1516776|NCT00760773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516777|NCT00760760|Randomized|Parallel Assignment||Basic Science||Single||||||t
1516778|NCT00760747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516779|NCT00760734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516780|NCT00760721|Randomized|Parallel Assignment||Screening||Single|||t|||
1516781|NCT00760708|||Case Control||Prospective|||||||
1516782|NCT00760695|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1516783|NCT00760682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516784|NCT00760669|||Cohort||Prospective|||||||
1516785|NCT00760656|||Cohort||Prospective|||||||
1516786|NCT00760643||||||||||||
1516787|NCT00760630|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1516788|NCT00760617|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1516789|NCT00760604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516790|NCT00760591|||Cohort||Prospective|||||||
1516791|NCT00760578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516792|NCT00760565|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1516793|NCT00760552|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1516794|NCT00760539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516795|NCT00760526|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1516796|NCT00760513|Randomized|Parallel Assignment||Treatment||Single|||||t|
1516797|NCT00760500|||Ecologic or Community||Prospective|||||||
1516798|NCT00760487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516799|NCT00760474|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1516800|NCT00760461||Single Group Assignment||Treatment||None (Open Label)||||||
1516801|NCT00760448|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516802|NCT00760435|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516803|NCT00760422|||Case Control||Retrospective|||||||
1516804|NCT00760409|||Other||Prospective|||||||
1516805|NCT00760396|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1516806|NCT00760383|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516807|NCT00760370||Single Group Assignment||Treatment||None (Open Label)||||||
1516808|NCT00760357|||||Retrospective|||||||
1516809|NCT00760344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516810|NCT00760331|||Cohort||Prospective|||||||
1516811|NCT00760318|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516812|NCT00760305|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1516813|NCT00760292|||Case Control||Cross-Sectional|||||||
1516814|NCT00760279|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516815|NCT00760266|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516816|NCT00760253|||Case Control||Prospective|||||||
1516817|NCT00760240|||||Cross-Sectional|||||||
1516818|NCT00760227|Randomized|Single Group Assignment||||None (Open Label)||||||
1516819|NCT00760214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516820|NCT00760201||||||||||||
1516821|NCT00760188|||Cohort||Prospective|||||||
1516822|NCT00760175|Randomized|Parallel Assignment||Prevention||Single|||||t|
1516823|NCT00760162|||Cohort||Prospective|||||||
1516824|NCT00760149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516825|NCT00760136|||Case-Only||Retrospective|||||||
1516826|NCT00760123|Randomized|Parallel Assignment||Prevention||Single||||||t
1516827|NCT00760110|||Cohort||Prospective|||||||
1516828|NCT00760097|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1516829|NCT00760084|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516830|NCT00760071|||Case-Crossover||Prospective|||||||
1516831|NCT00760058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516832|NCT00760045|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1516833|NCT00760032|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1516834|NCT00760019|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1516835|NCT00760006|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516836|NCT00759993|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1516837|NCT00759980|||||Prospective|||||||
1516838|NCT00759967|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1516839|NCT00759954|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1516840|NCT00759941|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516841|NCT00759928||Single Group Assignment||Treatment||None (Open Label)||||||
1516842|NCT00759915|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1516843|NCT00759902|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1516844|NCT00759889|||Other||Prospective|||||||
1516845|NCT00759876||Single Group Assignment||Treatment||None (Open Label)||||||
1516846|NCT00759863|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1516847|NCT00759850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516848|NCT00759837|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1516849|NCT00759824|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516850|NCT00759811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516851|NCT00759798||Single Group Assignment||Treatment||None (Open Label)||||||
1516852|NCT00759785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516853|NCT00759772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516854|NCT00759759|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1516855|NCT00759746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516856|NCT00759733|||Case Control||Prospective|||||||
1516857|NCT00759720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516858|NCT00759707||Single Group Assignment||Basic Science||Single|Investigators who analyzed the results of vascular function testing were blinded to the participant identity.|||||t
1516859|NCT00759694||||||||||||
1516860|NCT00759681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516861|NCT00759668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516862|NCT00759655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516863|NCT00759642||Single Group Assignment||Treatment||None (Open Label)||||||
1516864|NCT00759629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516865|NCT00759616||Single Group Assignment||Treatment||None (Open Label)||||||
1516866|NCT00759603||Single Group Assignment||Treatment||None (Open Label)||||||
1516867|NCT00759590|||Cohort||Prospective|||||||
1516868|NCT00759577||Single Group Assignment||Treatment||None (Open Label)||||||
1516869|NCT00759564|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1516870|NCT00759551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516871|NCT00759538|||Cohort||Prospective|||||||
1516872|NCT00759525|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1516873|NCT00759512|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1516874|NCT00759499|||Other||Prospective|||||||
1516875|NCT00759486|||Other||Prospective|||||||
1516876|NCT00759473|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1516877|NCT00759460|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516878|NCT00759447||||||||||||
1516879|NCT00759434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516880|NCT00759421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516881|NCT00759408||Single Group Assignment||Treatment||None (Open Label)||||||
1516882|NCT00759395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516883|NCT00759382|||Cohort||Prospective|||||||
1516884|NCT00759369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516885|NCT00759356|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1516886|NCT00759343|||Case Control|||||||||
1516887|NCT00759330|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516888|NCT00759317|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1516889|NCT00759304|||Cohort||Prospective|||||||
1516890|NCT00759291|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1516891|NCT00759278|||Case Control||Prospective|||||||
1516892|NCT00759265|Randomized|Parallel Assignment||Treatment||Single||||||t
1516893|NCT00759252|||Cohort||Cross-Sectional|||||||
1516894|NCT00759239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516895|NCT00759226||Single Group Assignment||Treatment||None (Open Label)||||||
1516896|NCT00759213|||Cohort||Prospective|||||||
1516897|NCT00759200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516898|NCT00759187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516899|NCT00759174|||Case-Crossover||Retrospective|||||||
1516900|NCT00759161|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1516901|NCT00759148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516902|NCT00759135|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516903|NCT00759122|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516904|NCT00759109|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516905|NCT00759096|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516906|NCT00759083|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1516907|NCT00759070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516908|NCT00759057|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516909|NCT00759044|||Cohort||Prospective|||||||
1516910|NCT00759031|Randomized|Crossover Assignment||Treatment||Single|||t|||
1516911|NCT00759018||||||||||||
1516912|NCT00759005||||||||||||
1516913|NCT00758992|||Case-Only||Prospective|||||||
1516914|NCT00758979||||||||||||
1516915|NCT00758966|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516916|NCT00758953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516917|NCT00758940|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516918|NCT00758927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516919|NCT00758914||||||||||||
1516920|NCT00758901|||Cohort||Prospective|||||||
1516921|NCT00758888|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516922|NCT00758875||||||||||||
1516923|NCT00758862||Single Group Assignment||Treatment||None (Open Label)||||||
1516924|NCT00758849|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1516925|NCT00758836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516926|NCT00758823|Randomized|Single Group Assignment||Treatment||Single|||||t|
1516927|NCT00758810|||Cohort||Prospective|||||||
1516928|NCT00758797||Single Group Assignment||Treatment||None (Open Label)||||||
1516929|NCT00758784||Single Group Assignment||Treatment||None (Open Label)||||||
1516930|NCT00758771|||Case Control||Prospective|||||||
1516931|NCT00758758|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516932|NCT00758745|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516933|NCT00758732|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516934|NCT00758719|||||Prospective|||||||
1516935|NCT00758706|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516936|NCT00758693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516937|NCT00758680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516938|NCT00758667|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1516939|NCT00758654|||Cohort||Prospective|||||||
1516940|NCT00758641|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516941|NCT00758628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516942|NCT00758615|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516943|NCT00758602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516944|NCT00758589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516945|NCT00758576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516946|NCT00758563|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516947|NCT00758550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516948|NCT00758537|||||Prospective|||||||
1516949|NCT00758524|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516950|NCT00758511|Randomized|Parallel Assignment||Treatment||Single||||||t
1516951|NCT00758498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516952|NCT00758485|Randomized|Parallel Assignment||Treatment||Single||||||t
1516953|NCT00758472|||Cohort||Prospective|||||||
1516954|NCT00758459|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516955|NCT00758446|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1516956|NCT00758433|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1516957|NCT00758420|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516958|NCT00758407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516959|NCT00758394|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516960|NCT00758381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516961|NCT00758368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516962|NCT00758355|||Cohort||Prospective|||||||
1516963|NCT00758342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516964|NCT00758329|||Cohort||Retrospective|||||||
1516965|NCT00758316|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516966|NCT00758303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516967|NCT00758290|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1516968|NCT00758277|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1516969|NCT00758264|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1516970|NCT00758251|||Case-Only||Prospective|||||||
1516971|NCT00758238|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1516972|NCT00758225||Single Group Assignment||Treatment||None (Open Label)||||||
1516973|NCT00758212|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1516974|NCT00758199|Randomized|Parallel Assignment||Treatment||Single|||||t|
1516975|NCT00758186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516976|NCT00758173||||||||||||
1516977|NCT00758160||Single Group Assignment||Treatment||None (Open Label)||||||
1516978|NCT00758147|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1516979|NCT00758134||Single Group Assignment||Treatment||None (Open Label)||||||
1516980|NCT00758121|||Cohort||Prospective|||||||
1516981|NCT00758108|||||Other|||||||
1516982|NCT00758095||||||||||||
1516983|NCT00758082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516984|NCT00758069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1516985|NCT00758056||||||||||||
1516986|NCT00758043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1516987|NCT00758030|Randomized|Parallel Assignment||Treatment||Double||||||
1516988|NCT00758017|Randomized|Parallel Assignment||Treatment||Single|||t|||
1516989|NCT00758004|Randomized|Crossover Assignment||||None (Open Label)||||||
1516990|NCT00757991||||||||||||
1516991|NCT00757978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1516992|NCT00757965||||||||||||
1516993|NCT00757952|||Case Control||Prospective|||||||
1516994|NCT00757939|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1516995|NCT00757926|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1516996|NCT00757913|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1516997|NCT00757900|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1516998|NCT00757887|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1516999|NCT00757874|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517000|NCT00757848|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1517001|NCT00757835|Randomized|Crossover Assignment||Treatment||Single|||||t|
1517002|NCT00757822|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517003|NCT00757809|Randomized|Parallel Assignment||Treatment||Double||||||
1517004|NCT00757796|||Cohort||Prospective|||||||
1517005|NCT00757783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517006|NCT00757770|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1517007|NCT00757757||Single Group Assignment||Treatment||None (Open Label)||||||
1517008|NCT00757744|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1517009|NCT00757731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517010|NCT00757718|Randomized|Parallel Assignment||Treatment||Single||||||t
1517011|NCT00757705||Single Group Assignment||Treatment||None (Open Label)||||||
1517012|NCT00757692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517013|NCT00757679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517014|NCT00757666|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517015|NCT00757653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517016|NCT00757640|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1517017|NCT00757627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517018|NCT00757614||||||||||||
1517019|NCT00757601|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517020|NCT00757588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517021|NCT00757575|||Cohort||Prospective|||||||
1517022|NCT00757562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517023|NCT00757549||||Diagnostic||||||||
1517024|NCT00757536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517025|NCT00757523|Randomized|Parallel Assignment||Treatment||Single||||||t
1517026|NCT00757510|||Cohort||Prospective|||||||
1517027|NCT00757497|Randomized|Parallel Assignment||Treatment||||||||
1517028|NCT00757484|||Cohort||Retrospective|||||||
1517029|NCT00757471|Randomized|Parallel Assignment||Treatment||Single||||||t
1517030|NCT00757458|Randomized|Single Group Assignment||||Double|||t||t|
1517031|NCT00757445|||Case-Only||Retrospective|||||||
1517032|NCT00757432|||Cohort||Retrospective|||||||
1517033|NCT00757419|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1517034|NCT00757406|||Case Control||Cross-Sectional|||||||
1517035|NCT00757393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517036|NCT00757380|Randomized|Parallel Assignment||Treatment||Single||||||t
1517037|NCT00757367|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517038|NCT00757354||Single Group Assignment||Treatment||None (Open Label)||||||
1517039|NCT00757341|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517040|NCT00757328|||Case-Only||Retrospective|||||||
1517041|NCT00757315|Randomized|Parallel Assignment||Treatment||Single||||||t
1517042|NCT00757302|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517043|NCT00757289|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517044|NCT00757276|||Cohort||Prospective|||||||
1517045|NCT00757263||||||||||||
1517352|NCT00753194|||Case Control||Cross-Sectional|||||||
1517046|NCT00757250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517047|NCT00757237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517048|NCT00757224|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517049|NCT00757211||||||||||||
1517050|NCT00757198|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517051|NCT00757185|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1517052|NCT00757172||Single Group Assignment||Treatment||None (Open Label)||||||
1517053|NCT00757159|Randomized|Parallel Assignment||Treatment||Single|||||t|
1517054|NCT00757146|||||Retrospective|||||||
1517055|NCT00757133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517056|NCT00757120|||Cohort||Cross-Sectional|||||||
1517057|NCT00757107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517058|NCT00757094|||Case-Crossover||Prospective|||||||
1517059|NCT00757081||Single Group Assignment||Treatment||None (Open Label)||||||
1517060|NCT00757068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517061|NCT00757055|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517062|NCT00757042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517063|NCT00757029|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517064|NCT00757016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517065|NCT00757003||Single Group Assignment||Treatment||None (Open Label)||||||
1517066|NCT00756990||Single Group Assignment||Treatment||None (Open Label)||||||
1517067|NCT00756977|Randomized|Parallel Assignment||Treatment||Single||||||t
1517068|NCT00756964|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517069|NCT00756951|Randomized|Single Group Assignment||Health Services Research||Double|||t||t|
1517070|NCT00756938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517071|NCT00756925|||Case-Control||Prospective|||||||
1517072|NCT00756912|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1517073|NCT00756899|||Case Control||Prospective|||||||
1517074|NCT00756886|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1517075|NCT00756873|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517076|NCT00756860|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517077|NCT00756847||Single Group Assignment||Treatment||None (Open Label)||||||
1517078|NCT00756834||||||||||||
1517079|NCT00756821|||Cohort||Cross-Sectional|||||||
1517080|NCT00756808|||||Prospective|||||||
1517081|NCT00756795|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1517082|NCT00756782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517083|NCT00756769|||Cohort||Prospective|||||||
1517084|NCT00756756|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1517085|NCT00756743|Randomized|Crossover Assignment||||Triple|||t||t|t
1517086|NCT00756730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517087|NCT00756717|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1517088|NCT00756704|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1517089|NCT00756691|||Cohort||Prospective|||||||
1517090|NCT00756678|Randomized|Crossover Assignment||Treatment||Single|||||t|
1517091|NCT00756665|||Cohort||Prospective|||||||
1517092|NCT00756652|||Cohort||Prospective|||||||
1517093|NCT00756639||Single Group Assignment||Treatment||None (Open Label)||||||
1517094|NCT00756626|Randomized|Parallel Assignment||Prevention||Single||||||t
1517095|NCT00756613|||Cohort||Prospective|||||||
1517096|NCT00756600|Randomized|Parallel Assignment||Treatment||Single||||||t
1517097|NCT00756587|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1517098|NCT00756574|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517099|NCT00756561|||Case-Only||Retrospective|||||||
1517100|NCT00756548|Randomized|Parallel Assignment||Treatment||Single||||||t
1517101|NCT00756535|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1517102|NCT00756522|||Other||Cross-Sectional|||||||
1517103|NCT00756509|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517104|NCT00756496||||||||||||
1517105|NCT00756483|||Case Control||Prospective|||||||
1517106|NCT00756470||Single Group Assignment||Treatment||None (Open Label)||||||
1517107|NCT00756457|Randomized|Parallel Assignment||Treatment||Single|||t|||
1517108|NCT00756444|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517109|NCT00756431|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517110|NCT00756418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517111|NCT00756405|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517112|NCT00756392|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1517113|NCT00756379|Randomized|Parallel Assignment||Prevention||Single||"Study Intervention: PET diagnostic imaging offered in addition to current standard of care for the detection of coronary atherosclerosis.~Comprehensive program of atherosclerotic risk factor modification, involving treatment to target lipid levels, blood pressure and diabetes control, smoking cessation, very low fat diet and aerobic exercise program.~This is addition to standard current medical therapy as provided by primary referring physician. No experimental medication or procedure will be used. Clinic visits for patients education and consulting in the comprehensive program will be performed five times during the first year and semiannually thereafter."||||t
1517114|NCT00756366|Randomized|Parallel Assignment||Treatment||Single|||||t|
1517115|NCT00756353|||||Cross-Sectional|||||||
1517116|NCT00756340||Single Group Assignment||Treatment||None (Open Label)||||||
1517117|NCT00756327|||Case Control||Cross-Sectional|||||||
1517118|NCT00756314|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1517119|NCT00756301|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1517120|NCT00756288|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1517121|NCT00756275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517122|NCT00756262|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517123|NCT00756249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517124|NCT00756236|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1517125|NCT00756223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517126|NCT00756210||||||||||||
1517127|NCT00756197|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517128|NCT00756184|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1517129|NCT00756171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517130|NCT00756158|||Family-Based|||||||||
1517131|NCT00756145|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517132|NCT00756132|||Case-Control||Prospective|||||||
1517133|NCT00756119|||Case-Only||Prospective|||||||
1517134|NCT00756106|||Cohort||Prospective|||||||
1517135|NCT00756093|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517136|NCT00756080|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1517137|NCT00756067|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1517138|NCT00756041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517139|NCT00756028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517140|NCT00756015|Randomized|Parallel Assignment||Treatment||Single|||||t|
1517141|NCT00756002|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517142|NCT00755989|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517143|NCT00755976|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517144|NCT00755963|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1517145|NCT00755950|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1517146|NCT00755937|||Cohort||Prospective|||||||
1517147|NCT00755924|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1517148|NCT00755911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517149|NCT00755898|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1517150|NCT00755885|Non-Randomized|||Treatment||None (Open Label)||||||
1517151|NCT00755872|Randomized|Crossover Assignment||||None (Open Label)||||||
1517152|NCT00755859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517153|NCT00755846|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517154|NCT00755833|||Cohort||Prospective|||||||
1517155|NCT00755820|||||Prospective|||||||
1517156|NCT00755807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517157|NCT00755794|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517158|NCT00755781|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517159|NCT00755768|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1517160|NCT00755755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517161|NCT00755742|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517162|NCT00755729|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1517163|NCT00755716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517164|NCT00755703|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1517165|NCT00755690|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517166|NCT00755677|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1517167|NCT00755664|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517168|NCT00755651|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1517169|NCT00755638|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1517170|NCT00755599|Randomized|Parallel Assignment||||Single||||||t
1517171|NCT00755586|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517172|NCT00755573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517173|NCT00755560|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517174|NCT00755547|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517175|NCT00755534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517176|NCT00755521|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517177|NCT00755508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517178|NCT00755495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517179|NCT00755482|Randomized|Parallel Assignment||Treatment||Double||||||
1517180|NCT00755469|Randomized|Parallel Assignment||Treatment||Single|||t|||
1517181|NCT00755456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517182|NCT00755443|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1517183|NCT00755430|||Cohort|||||||||
1517184|NCT00755417|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517185|NCT00755404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517186|NCT00755391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517187|NCT00755378|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1517188|NCT00755365|||Case-Only||Retrospective|||||||
1517189|NCT00755352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517190|NCT00755339|||||Prospective|||||||
1517191|NCT00755326|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517192|NCT00755313|||Case-Control||Prospective|||||||
1517193|NCT00755300|||Cohort||Prospective|||||||
1517194|NCT00755287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517195|NCT00755274|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517196|NCT00755261||Single Group Assignment||Treatment||None (Open Label)||||||
1517197|NCT00755248|||Case-Only||Prospective|||||||
1517198|NCT00755235|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1517199|NCT00755222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517200|NCT00755209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517201|NCT00755196|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517202|NCT00755183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517203|NCT00755170||Single Group Assignment||Treatment||None (Open Label)||||||
1517204|NCT00755157||Single Group Assignment||Treatment||None (Open Label)||||||
1517205|NCT00755144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517206|NCT00755131|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1517207|NCT00755118||Single Group Assignment||Treatment||None (Open Label)||||||
1517208|NCT00755105|||Other||Prospective|||||||
1517209|NCT00755092|Non-Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1517210|NCT00755079|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517211|NCT00755066|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1517212|NCT00755053|Randomized|Parallel Assignment||Treatment||Single|||||t|
1517213|NCT00755040|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517214|NCT00755027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517215|NCT00755014|Randomized|Parallel Assignment||Treatment||Single||||||
1517216|NCT00755001|||Cohort||Prospective|||||||
1517217|NCT00754988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517218|NCT00754975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517219|NCT00754962|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517220|NCT00754949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517221|NCT00754936||Single Group Assignment||Treatment||None (Open Label)||||||
1517222|NCT00754923||Single Group Assignment||Treatment||None (Open Label)||||||
1517223|NCT00754910|||Case-Control||Retrospective|||||||
1517224|NCT00754897|||Case-Only||Retrospective|||||||
1517225|NCT00754884|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1517226|NCT00754871|Randomized|Parallel Assignment||||Double|||t||t|
1517227|NCT00754858||Single Group Assignment||Treatment||None (Open Label)||||||
1517228|NCT00754845|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517229|NCT00754832|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1517230|NCT00754819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517231|NCT00754806|||||Prospective|||||||
1517232|NCT00754793|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1517233|NCT00754780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517234|NCT00754767|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1517235|NCT00754754||Single Group Assignment||Prevention||None (Open Label)||||||
1517236|NCT00754741|Randomized|Parallel Assignment||Treatment||Single||||||t
1517237|NCT00754728||Single Group Assignment||Treatment||None (Open Label)||||||
1517238|NCT00754715|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1517239|NCT00754702||Single Group Assignment||Treatment||None (Open Label)||||||
1517240|NCT00754689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517241|NCT00754676|||Case Control||Prospective|||||||
1517242|NCT00754663|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1517243|NCT00754650||Single Group Assignment||Treatment||None (Open Label)||||||
1517244|NCT00754637|||Cohort||Prospective|||||||
1517245|NCT00754624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517246|NCT00754611|||Case-Only||Prospective|||||||
1517247|NCT00754598||||||||||||
1517248|NCT00754585||||||||||||
1517249|NCT00754572|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517250|NCT00754559||Single Group Assignment||Treatment||None (Open Label)||||||
1517251|NCT00754546|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1517252|NCT00754533|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517253|NCT00754520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517254|NCT00754507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517255|NCT00754494|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1517256|NCT00754481|Randomized|Parallel Assignment||Treatment||Single||||||t
1517257|NCT00754468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517258|NCT00754455|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1517259|NCT00754442|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1517260|NCT00754429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517261|NCT00754416|||Cohort||Prospective|||||||
1517262|NCT00754403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517263|NCT00754390|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1517264|NCT00754377|||Cohort||Retrospective|||||||
1517265|NCT00754364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517266|NCT00754351||Single Group Assignment||Treatment||None (Open Label)||||||
1517267|NCT00754338|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1517268|NCT00754325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517269|NCT00754312|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1517270|NCT00754299|||Case-Only||Prospective|||||||
1517271|NCT00754286|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1517272|NCT00754273|||Case-Only||Prospective|||||||
1517273|NCT00754260|Randomized|Parallel Assignment||Treatment||Single|||||t|
1517274|NCT00754247|Randomized|Parallel Assignment||Treatment||Single|||||t|
1517275|NCT00754234|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1517276|NCT00754221|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517277|NCT00754208||Single Group Assignment||Treatment||None (Open Label)||||||
1517278|NCT00754195|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517279|NCT00754182|Randomized|Parallel Assignment||||Single||||||t
1517280|NCT00754169|||||Other|||||||
1517281|NCT00754156|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517282|NCT00754143|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517283|NCT00754130|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517284|NCT00754117|||Cohort||Prospective|||||||
1517285|NCT00754104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517286|NCT00754091||||||||||||
1517287|NCT00754078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517288|NCT00754065|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517289|NCT00754052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517290|NCT00754039|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517291|NCT00754026|Randomized|Parallel Assignment||Treatment||Single|||t|||
1517292|NCT00754013|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517293|NCT00754000|||Cohort||Prospective|||||||
1517294|NCT00753987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517295|NCT00753974|||Case-Only||Prospective|||||||
1517296|NCT00753961|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1517297|NCT00753948|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1517298|NCT00753935|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1517299|NCT00753922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517300|NCT00753909||Single Group Assignment||Treatment||None (Open Label)||||||
1517301|NCT00753896||Single Group Assignment||Treatment||None (Open Label)||||||
1517302|NCT00753883|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517303|NCT00753870|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1517304|NCT00753857|Randomized|Single Group Assignment||Treatment||Single|||||t|
1517305|NCT00753844||Single Group Assignment||Treatment||None (Open Label)||||||
1517306|NCT00753831||Single Group Assignment||Treatment||None (Open Label)||||||
1517307|NCT00753818||||||||||||
1517308|NCT00753805|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1517309|NCT00753792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517310|NCT00753779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517311|NCT00753766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517312|NCT00753753|||Cohort||Prospective|||||||
1517313|NCT00753740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517314|NCT00753727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517315|NCT00753714|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517316|NCT00753688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517317|NCT00753675|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517318|NCT00753662|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517319|NCT00753649|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517320|NCT00753636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517321|NCT00753623|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1517322|NCT00753610|||Case-Control||Prospective|||||||
1517323|NCT00753597||Single Group Assignment||Prevention||None (Open Label)||||||
1517324|NCT00753571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517325|NCT00753558||||||||||||
1517326|NCT00753545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517327|NCT00753532|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517328|NCT00753519|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517329|NCT00753506|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517330|NCT00753493||Single Group Assignment||Treatment||None (Open Label)||||||
1517331|NCT00753480||Single Group Assignment||Treatment||None (Open Label)||||||
1517332|NCT00753467|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517333|NCT00753454||Single Group Assignment||Treatment||None (Open Label)||||||
1517334|NCT00753441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517335|NCT00753428|||Cohort||Cross-Sectional|||||||
1517336|NCT00753415|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517337|NCT00753402|Randomized|Parallel Assignment||||Double|||t||t|
1517338|NCT00753389|||||Prospective|||||||
1517339|NCT00753363|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1517340|NCT00753350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517341|NCT00753337||Single Group Assignment||Treatment||None (Open Label)||||||
1517342|NCT00753324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517343|NCT00753311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517344|NCT00753298|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517345|NCT00753285||Single Group Assignment||Treatment||None (Open Label)||||||
1517346|NCT00753272|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517347|NCT00753259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517348|NCT00753246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517349|NCT00753233|||||Retrospective|||||||
1517350|NCT00753220||Single Group Assignment||Treatment||None (Open Label)||||||
1517351|NCT00753207||Single Group Assignment||Treatment||None (Open Label)||||||
1517353|NCT00753181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517354|NCT00753168|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1517355|NCT00753155|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1517356|NCT00753142|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517357|NCT00753129|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1517358|NCT00753116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517359|NCT00753103|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517360|NCT00753090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517361|NCT00753077|||Case Control||Prospective|||||||
1517362|NCT00753064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517363|NCT00753051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517364|NCT00753038||Single Group Assignment||Treatment||None (Open Label)||||||
1517365|NCT00753025|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517366|NCT00753012||Single Group Assignment||||None (Open Label)||||||
1517367|NCT00752999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517368|NCT00752986|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517369|NCT00752973|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517370|NCT00752960|||Cohort||Retrospective|||||||
1517371|NCT00752947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517372|NCT00752934|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1517373|NCT00752921|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1517374|NCT00752908|||Case Control||Prospective|||||||
1517375|NCT00752895|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517376|NCT00752882|Randomized|Single Group Assignment||Treatment||Single||||||
1517377|NCT00752869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517378|NCT00752856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517379|NCT00752843||Single Group Assignment||Basic Science||None (Open Label)||||||
1517380|NCT00752830|Randomized|Crossover Assignment||||None (Open Label)||||||
1517381|NCT00752817|Randomized|Parallel Assignment||||Single||||||t
1517382|NCT00752804|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517383|NCT00752791||Single Group Assignment||Treatment||None (Open Label)||||||
1517384|NCT00752778||Single Group Assignment||Treatment||None (Open Label)||||||
1517385|NCT00752765|||Case-Only||Prospective|||||||
1517386|NCT00752752|||Cohort||Prospective|||||||
1517387|NCT00752739|Randomized|||Treatment||||||||
1517388|NCT00752726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517389|NCT00752713|||Case Control||Prospective|||||||
1517390|NCT00752700|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1517391|NCT00752687|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1517392|NCT00752674|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517393|NCT00752661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517394|NCT00752648|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517395|NCT00752635|Randomized|Parallel Assignment||Treatment||Double||||||
1517396|NCT00752622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517397|NCT00752609|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517398|NCT00752596||Single Group Assignment||Treatment||None (Open Label)||||||
1517399|NCT00752583|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517400|NCT00752570|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517401|NCT00752557|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517402|NCT00752544|Randomized|Single Group Assignment||Treatment||Double||||||
1517403|NCT00752531|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1517404|NCT00752518|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1517405|NCT00752505|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1517406|NCT00752492|Randomized|Single Group Assignment||Treatment||Single|||t|||
1517407|NCT00752479|Randomized|Parallel Assignment||||None (Open Label)||||||
1517408|NCT00752466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517409|NCT00752453|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517410|NCT00752440|Randomized|Single Group Assignment||Treatment||Single|||t|||
1517411|NCT00752427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517412|NCT00752414|Randomized|Parallel Assignment||Prevention||Single|||t|||
1517413|NCT00752401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517414|NCT00752388|||Cohort||Prospective|||||||
1517415|NCT00752375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517416|NCT00752362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517417|NCT00752349||||||||||||
1517418|NCT00752336|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1517419|NCT00752323|Randomized|Parallel Assignment||Diagnostic||Single|Neurosurgeons and investigators responsible for determining pathologic characteristics, for quantifying fluorescence images, for extracting chemical PpIX, for co-localizing fluorescence images with MR images will be blinded to the ALA dose and administration time. In case of emergency, such as toxicity or allergic reaction attributable to the drug, the research pharmacist on call will break the blind and inform the physician responsible for clinical management.|||||t
1517420|NCT00752310|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517421|NCT00752297|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517422|NCT00752284|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517423|NCT00752271|||Case Control||Prospective|||||||
1517424|NCT00752258||Single Group Assignment||Treatment||None (Open Label)||||||
1517425|NCT00752245|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517426|NCT00752232|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1517427|NCT00752219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517428|NCT00752206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517429|NCT00752193|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1517430|NCT00752180|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1517431|NCT00752167|||Case Control||Cross-Sectional|||||||
1517432|NCT00752154|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517433|NCT00752141|Randomized|Parallel Assignment||||Triple|||t||t|t
1517434|NCT00752128|||Cohort||Prospective|||||||
1517435|NCT00752115|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517436|NCT00752102|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517437|NCT00752089|Randomized|Crossover Assignment||Treatment||Single|||t|||
1517438|NCT00752076||Single Group Assignment||Basic Science||None (Open Label)||||||
1517439|NCT00752063||Single Group Assignment||Treatment||None (Open Label)||||||
1517440|NCT00752050|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517441|NCT00752037|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517442|NCT00752024|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1517443|NCT00752011||Single Group Assignment||Treatment||None (Open Label)||||||
1517444|NCT00751998||Single Group Assignment||Treatment||None (Open Label)||||||
1517445|NCT00751985|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517446|NCT00751972||Single Group Assignment||Supportive Care||None (Open Label)||||||
1517447|NCT00751959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517448|NCT00751946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517449|NCT00751933|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1517450|NCT00751920||Single Group Assignment||Diagnostic||None (Open Label)||||||
1517451|NCT00751907|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517452|NCT00751894|Non-Randomized|||Treatment||None (Open Label)||||||
1517453|NCT00751881|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517454|NCT00751868||Single Group Assignment||Treatment||None (Open Label)||||||
1517455|NCT00751855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517456|NCT00751842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517457|NCT00751829|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517458|NCT00751816|||Cohort||Prospective|||||||
1517459|NCT00751803|Randomized|Parallel Assignment||Treatment||||||||
1517460|NCT00751790||Single Group Assignment||Treatment||None (Open Label)||||||
1517461|NCT00751777|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517462|NCT00751764|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1517463|NCT00751751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517464|NCT00751738||Single Group Assignment||Treatment||None (Open Label)||||||
1517465|NCT00751712|||Cohort||Prospective|||||||
1517466|NCT00751699|Randomized|Parallel Assignment||||None (Open Label)||||||
1517467|NCT00751686|||Cohort||Prospective|||||||
1517468|NCT00751673|||Cohort||Prospective|||||||
1517469|NCT00751660||Single Group Assignment||Screening||None (Open Label)||||||
1517470|NCT00751647||Single Group Assignment||Supportive Care||None (Open Label)||||||
1517471|NCT00751634||Single Group Assignment||Treatment||None (Open Label)||||||
1517472|NCT00751621||Single Group Assignment||Treatment||None (Open Label)||||||
1517473|NCT00751608|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1517474|NCT00751595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517475|NCT00751582|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1517476|NCT00751569||||||||||||
1517477|NCT00751556|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517478|NCT00751543|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517479|NCT00751530|||Cohort||Retrospective|||||||
1517480|NCT00751517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517481|NCT00751504|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517482|NCT00751491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517483|NCT00751478|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1517484|NCT00751465|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1517485|NCT00751452|||||Prospective|||||||
1517486|NCT00751439|||Case Control||Prospective|||||||
1517487|NCT00751426||||||||||||
1517488|NCT00751413|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517489|NCT00751400|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1517490|NCT00751387|||||Cross-Sectional|||||||
1517491|NCT00751374|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517492|NCT00751361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517493|NCT00751348|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517494|NCT00751335|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517495|NCT00751322|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1517496|NCT00751309|||Cohort||Prospective|||||||
1517497|NCT00751296||Single Group Assignment||Treatment||None (Open Label)||||||
1517498|NCT00751283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517499|NCT00751270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517500|NCT00751257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518040|NCT00744120|||Cohort||Retrospective|||||||
1517501|NCT00751244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517502|NCT00751231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517503|NCT00751218|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517504|NCT00751205|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517505|NCT00751192|Randomized|Single Group Assignment||Screening||||||||
1517506|NCT00751179|Randomized|Parallel Assignment||Treatment||Single||||||t
1517507|NCT00751166|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517508|NCT00751153||Single Group Assignment||Treatment||None (Open Label)||||||
1517509|NCT00751140||Single Group Assignment||Diagnostic||None (Open Label)||||||
1517510|NCT00751127|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517511|NCT00751114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517512|NCT00751101|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1517513|NCT00751088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517514|NCT00751075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517515|NCT00751062|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517516|NCT00751049|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517517|NCT00751036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517518|NCT00751023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517519|NCT00751010|||Case Control||Prospective|||||||
1517520|NCT00750997|||Case-Control||Prospective|||||||
1517521|NCT00750984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517522|NCT00750971|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517523|NCT00750958||Single Group Assignment||Diagnostic||None (Open Label)||||||
1517524|NCT00750945|Randomized|Factorial Assignment||Treatment||Single||||||t
1517525|NCT00750932|||Case-Control||Prospective|||||||
1517526|NCT00750919||Single Group Assignment||Treatment||None (Open Label)||||||
1517527|NCT00750906|||Case-Only||Prospective|||||||
1517528|NCT00750893|||Cohort||Prospective|||||||
1517529|NCT00750880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517530|NCT00750867||Single Group Assignment||Treatment||None (Open Label)||||||
1517531|NCT00750854|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1517532|NCT00750841||Single Group Assignment||Treatment||None (Open Label)||||||
1517533|NCT00750828|||Case Control||Cross-Sectional|||||||
1517534|NCT00750815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517535|NCT00750802|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1517536|NCT00750789|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1517537|NCT00750776|||||Prospective|||||||
1517538|NCT00750763|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1517539|NCT00750750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517540|NCT00750737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517541|NCT00750724|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517542|NCT00750711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517543|NCT00750698|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517544|NCT00750685||Single Group Assignment||Treatment||None (Open Label)||||||
1517545|NCT00750672|||Ecologic or Community||Retrospective|||||||
1517546|NCT00750659||Single Group Assignment||Treatment||None (Open Label)||||||
1517547|NCT00750646|||Cohort||Prospective|||||||
1517548|NCT00750633|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517549|NCT00750620|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1517550|NCT00750594|||Case-Control||Cross-Sectional|||||||
1517551|NCT00750581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517552|NCT00750568|||Cohort||Prospective|||||||
1517553|NCT00750555|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517554|NCT00750529|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517555|NCT00750516|||Case Control||Prospective|||||||
1517556|NCT00750503||Single Group Assignment||Treatment||None (Open Label)||||||
1517557|NCT00750477|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1517558|NCT00750464|||Case-Only||Cross-Sectional|||||||
1517559|NCT00750451|Randomized|Parallel Assignment||Treatment||Single||||||t
1517560|NCT00750438|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1517561|NCT00750425||Single Group Assignment||Treatment||None (Open Label)||||||
1517562|NCT00750412|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517563|NCT00750399||Single Group Assignment||Treatment||None (Open Label)||||||
1517564|NCT00750386|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517565|NCT00750373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517566|NCT00750360|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517567|NCT00750347|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517568|NCT00750334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517569|NCT00750308|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1517570|NCT00750295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517571|NCT00750282||Single Group Assignment||Diagnostic||None (Open Label)||||||
1517572|NCT00750269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517573|NCT00750256|Randomized|Single Group Assignment||Treatment||Single|||t|||
1517574|NCT00750243|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1517575|NCT00750230||Single Group Assignment||Supportive Care||None (Open Label)||||||
1517576|NCT00750217||Single Group Assignment||Treatment||None (Open Label)||||||
1517577|NCT00750204|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517578|NCT00750191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517579|NCT00750178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517580|NCT00750165||Single Group Assignment||Treatment||None (Open Label)||||||
1517581|NCT00750152|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517582|NCT00750139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517583|NCT00750126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517584|NCT00750113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517585|NCT00750100|Randomized|Parallel Assignment||Treatment||Single|||||t|
1517586|NCT00750087|||Cohort||Prospective|||||||
1517587|NCT00750074|||Cohort||Prospective|||||||
1517588|NCT00750061|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517589|NCT00750048|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517590|NCT00750035|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517591|NCT00750022|Randomized|Parallel Assignment||Treatment||Single|||t|||
1517592|NCT00750009|Randomized|Parallel Assignment||||Double|||t||t|
1517593|NCT00749996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517594|NCT00749983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517595|NCT00749970|||||Prospective|||||||
1517596|NCT00749957|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517597|NCT00749944|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517598|NCT00749931|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1517599|NCT00749918|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1517600|NCT00749905|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1517601|NCT00749892||Single Group Assignment||Treatment||None (Open Label)||||||
1517602|NCT00749879|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1517603|NCT00749866|Randomized|Parallel Assignment||Treatment||Single||||||t
1517604|NCT00749853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517605|NCT00749840|||Cohort||Prospective|||||||
1517606|NCT00749827|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517607|NCT00749814|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517608|NCT00749801|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1517609|NCT00749788|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517610|NCT00749775|||Case-Only||Prospective|||||||
1517611|NCT00749762|||Cohort||Retrospective|||||||
1517612|NCT00749749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517613|NCT00749736|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1517614|NCT00749723|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517615|NCT00749710|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517616|NCT00749697||Single Group Assignment||Diagnostic||None (Open Label)||||||
1517617|NCT00749684|||Cohort||Prospective|||||||
1517618|NCT00749671|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1517619|NCT00749658|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517620|NCT00749645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517621|NCT00749632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517622|NCT00749619||||Prevention||||||||
1517623|NCT00749606|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517624|NCT00749593|||Cohort||Cross-Sectional|||||||
1517625|NCT00749580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517626|NCT00749567||Single Group Assignment||Treatment||None (Open Label)||||||
1517627|NCT00749554|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1517628|NCT00749541|||Case Control||Prospective|||||||
1517629|NCT00749528|||Case Control||Prospective|||||||
1517630|NCT00749515||Single Group Assignment||Treatment||None (Open Label)||||||
1517631|NCT00749502|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517632|NCT00749489|Randomized|Single Group Assignment||Treatment||Single||||||t
1517633|NCT00749476|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1517634|NCT00749463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517635|NCT00749450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517636|NCT00749437||Single Group Assignment||Treatment||None (Open Label)||||||
1517637|NCT00749424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517638|NCT00749411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517639|NCT00749398|||Cohort||Prospective|||||||
1517640|NCT00749385|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1517641|NCT00749372||Single Group Assignment||Screening||None (Open Label)||||||
1517642|NCT00749359|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1517643|NCT00749346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517644|NCT00749333|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1517645|NCT00749320||Single Group Assignment||Diagnostic||None (Open Label)||||||
1517646|NCT00749307|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517647|NCT00749294|||Cohort||Prospective|||||||
1517648|NCT00749281|||Case Control||Prospective|||||||
1517649|NCT00749268|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517650|NCT00749255|||Case-Only||Prospective|||||||
1517651|NCT00749242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517652|NCT00749229||Single Group Assignment||Prevention||None (Open Label)||||||
1517653|NCT00749216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517654|NCT00749203|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1517655|NCT00749190||Parallel Assignment||Treatment||||||||
1517656|NCT00749177|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1517657|NCT00749164|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517658|NCT00749151|Randomized|Parallel Assignment||||Single||||||t
1517659|NCT00749138||Single Group Assignment||Treatment||None (Open Label)||||||
1517660|NCT00749125|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1517661|NCT00749112||Single Group Assignment||Treatment||None (Open Label)||||||
1517662|NCT00749099|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1517663|NCT00749086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517664|NCT00749073||Single Group Assignment||Treatment||None (Open Label)||||||
1517665|NCT00749060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517666|NCT00749047||Single Group Assignment||Basic Science||None (Open Label)||||||
1517667|NCT00749034|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517668|NCT00749021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517669|NCT00749008|||Cohort||Prospective|||||||
1517670|NCT00748995|||Cohort||Other|||||||
1517671|NCT00748982|Randomized|Parallel Assignment||Treatment||Single|||t|||
1517672|NCT00748969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517673|NCT00748956|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1517674|NCT00748943|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1517675|NCT00748930|||Cohort||Retrospective|||||||
1517676|NCT00748917||||||||||||
1517677|NCT00748904|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517678|NCT00748891||Single Group Assignment||||None (Open Label)||||||
1517679|NCT00748878|||Cohort||Prospective|||||||
1517680|NCT00748865|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517681|NCT00748852||Single Group Assignment||Treatment||None (Open Label)||||||
1517682|NCT00748839|||Cohort||Prospective|||||||
1517683|NCT00748826|||Cohort||Prospective|||||||
1517684|NCT00748813|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1517685|NCT00748800|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517686|NCT00748787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517687|NCT00748774|||Case Control||Prospective|||||||
1517688|NCT00748761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517689|NCT00748748|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1517690|NCT00748735|||||Retrospective|||||||
1517691|NCT00748722|||Case-Only||Prospective|||||||
1517692|NCT00748709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517693|NCT00748696|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1517694|NCT00748683||Single Group Assignment||Health Services Research||None (Open Label)||||||
1517695|NCT00748670||Single Group Assignment||Treatment||None (Open Label)||||||
1517696|NCT00748657||Single Group Assignment||Treatment||None (Open Label)||||||
1517697|NCT00748644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517698|NCT00748631||Single Group Assignment||Treatment||None (Open Label)||||||
1517699|NCT00748618|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517700|NCT00748605|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517701|NCT00748592|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517702|NCT00748579|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517703|NCT00748566|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517704|NCT00748553||Single Group Assignment||Treatment||None (Open Label)||||||
1517705|NCT00748540||Single Group Assignment||Treatment||None (Open Label)||||||
1517706|NCT00748527|Randomized|||Treatment||None (Open Label)||||||
1517707|NCT00748514|||Cohort||Retrospective|||||||
1517708|NCT00748501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517709|NCT00748488|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517710|NCT00748475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517711|NCT00748462||Single Group Assignment||Treatment||None (Open Label)||||||
1517712|NCT00748449|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1517713|NCT00748436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517714|NCT00748423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517715|NCT00748410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517716|NCT00748397||Single Group Assignment||Treatment||None (Open Label)||||||
1517717|NCT00748384|||Cohort||Prospective|||||||
1517718|NCT00748371|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1517719|NCT00748358||Single Group Assignment||Treatment||None (Open Label)||||||
1517720|NCT00748345|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517721|NCT00748332|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517722|NCT00748319|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1517723|NCT00748306|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1517724|NCT00748293|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1517725|NCT00748280|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1517726|NCT00748267||Single Group Assignment||Supportive Care||None (Open Label)||||||
1517727|NCT00748254|||Cohort||Prospective|||||||
1517728|NCT00748241||Single Group Assignment||Treatment||None (Open Label)||||||
1517729|NCT00748228|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1517730|NCT00748215|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1517731|NCT00748202|Randomized|Crossover Assignment||||None (Open Label)||||||
1517732|NCT00748189|Randomized|||Treatment||None (Open Label)||||||
1517733|NCT00748176|||||Prospective|||||||
1517734|NCT00748163||Single Group Assignment||Treatment||None (Open Label)||||||
1517735|NCT00748150|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1517736|NCT00748137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517737|NCT00748124|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517738|NCT00748111|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1517739|NCT00748098|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1517740|NCT00748085||Single Group Assignment||Treatment||None (Open Label)||||||
1517741|NCT00748072|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1517742|NCT00748059||Single Group Assignment||Screening||None (Open Label)||||||
1517743|NCT00748046||Single Group Assignment||Basic Science||None (Open Label)||||||
1517744|NCT00748033||||||||||||
1517745|NCT00748020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517746|NCT00748007|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1517747|NCT00747994|||Family-Based||Retrospective|||||||
1517748|NCT00747981|Non-Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1517749|NCT00747968|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1517750|NCT00747955|||Cohort||Prospective|||||||
1517751|NCT00747942|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1517752|NCT00747929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517753|NCT00747916||Single Group Assignment||Treatment||None (Open Label)||||||
1517754|NCT00747903||||Treatment||None (Open Label)||||||
1517755|NCT00747890|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1517756|NCT00747877|Randomized|||Treatment||None (Open Label)||||||
1517757|NCT00747864|||Cohort||Retrospective|||||||
1517758|NCT00747851|||Other||Prospective|||||||
1517759|NCT00747838|||Cohort||Prospective|||||||
1517760|NCT00747825|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1517761|NCT00747812|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517762|NCT00747799||Single Group Assignment||Treatment||None (Open Label)||||||
1517763|NCT00747786|||Case Control||Prospective|||||||
1517764|NCT00747773||Single Group Assignment||Treatment||None (Open Label)||||||
1517765|NCT00747760|||Cohort||Prospective|||||||
1517766|NCT00747747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517767|NCT00747734||Single Group Assignment||Treatment||None (Open Label)||||||
1517768|NCT00747721|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1517769|NCT00747708|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1517770|NCT00747695|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517771|NCT00747682|||Cohort||Retrospective|||||||
1517772|NCT00747669||Single Group Assignment||Basic Science||None (Open Label)||||||
1517773|NCT00747656|||Cohort||Prospective|||||||
1517774|NCT00747643|Randomized|Parallel Assignment||||Triple|||t|t|t|
1517775|NCT00747630|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517776|NCT00747617|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1517777|NCT00747604|||Case-Only|||||||||
1517778|NCT00747591|||Case-Only||Retrospective|||||||
1517779|NCT00747578|||Cohort||Prospective|||||||
1517780|NCT00747565|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1517781|NCT00747552|||Cohort||Prospective|||||||
1517782|NCT00747539|||Case Control||Prospective|||||||
1517783|NCT00747526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517784|NCT00747513|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517785|NCT00747500|||Case Control||Prospective|||||||
1517786|NCT00747487|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517787|NCT00747474||Single Group Assignment||Treatment||None (Open Label)||||||
1517788|NCT00747461||Single Group Assignment||Treatment||None (Open Label)||||||
1517789|NCT00747448|||Case-Only|||||||||
1517790|NCT00747435|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517791|NCT00747422||Single Group Assignment||Other||None (Open Label)||||||
1517792|NCT00747409|Randomized|Parallel Assignment||Treatment||Single|||||t|
1517793|NCT00747396|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1517794|NCT00747383|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1517795|NCT00747370|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1517796|NCT00747357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1517797|NCT00747344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517798|NCT00747331|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517799|NCT00747318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517800|NCT00747305||Single Group Assignment||Treatment||None (Open Label)||||||
1517801|NCT00747292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517802|NCT00747279|Randomized|||Treatment||None (Open Label)||||||
1517803|NCT00747266||||||||||||
1517804|NCT00747253||Single Group Assignment||Treatment||None (Open Label)||||||
1517805|NCT00747240|||Cohort||Prospective|||||||
1517806|NCT00747227|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517807|NCT00747214|Randomized|Parallel Assignment||Treatment||Single|||t|||
1517808|NCT00747201|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1517809|NCT00747188||||Health Services Research||||||||
1517810|NCT00747175|Randomized|Factorial Assignment||Treatment||Single|||t|||
1518581|NCT00737009|||||Prospective|||||||
1517811|NCT00747162|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1517812|NCT00747149|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517813|NCT00747136|||Case-Only||Prospective|||||||
1517814|NCT00747123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517815|NCT00747110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517816|NCT00747097|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517817|NCT00747084|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1517818|NCT00747071|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1517819|NCT00747058|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517820|NCT00747045|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1517821|NCT00747032|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517822|NCT00747019|Randomized|Single Group Assignment||Prevention||Single||||||t
1517823|NCT00747006|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517824|NCT00746993|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517825|NCT00746980||Single Group Assignment||Treatment||None (Open Label)||||||
1517826|NCT00746967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517827|NCT00746954|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1517828|NCT00746941|Randomized|Parallel Assignment||Treatment||Single||||||t
1517829|NCT00746928||Single Group Assignment||Basic Science||None (Open Label)||||||
1517830|NCT00746915||Single Group Assignment||Treatment||None (Open Label)||||||
1517831|NCT00746902|Randomized|Parallel Assignment||Treatment||Single|||t|||
1517832|NCT00746889|Randomized|Parallel Assignment||Treatment||Double||||||
1517833|NCT00746876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517834|NCT00746863|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517835|NCT00746850|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1517836|NCT00746837|Randomized|Single Group Assignment||Basic Science||Double|||t||t|
1517837|NCT00746824|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517838|NCT00746811|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517839|NCT00746798|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517840|NCT00746785|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517841|NCT00746772|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1517842|NCT00746759|||Cohort||Prospective|||||||
1517843|NCT00746746|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517844|NCT00746733|Randomized|Crossover Assignment||||None (Open Label)||||||
1517845|NCT00746720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517846|NCT00746707|Randomized|Parallel Assignment||Treatment||Single||||||t
1517847|NCT00746694|||Case-Only||Cross-Sectional|||||||
1517848|NCT00746681|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1517849|NCT00746668|Randomized|Crossover Assignment||||Single||||||t
1517850|NCT00746655||Single Group Assignment||Treatment||None (Open Label)||||||
1517851|NCT00746642|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1517852|NCT00746629|Randomized|Parallel Assignment||Treatment||Single|||t|||
1517853|NCT00746616||Single Group Assignment||Treatment||None (Open Label)||||||
1517854|NCT00746603|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1517855|NCT00746590||Single Group Assignment||Treatment||None (Open Label)||||||
1517856|NCT00746577|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1517857|NCT00746564||Single Group Assignment||Diagnostic||None (Open Label)||||||
1517858|NCT00746551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517859|NCT00746538|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1517860|NCT00746525||Single Group Assignment||Other||None (Open Label)||||||
1517861|NCT00746512|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517862|NCT00746499||Single Group Assignment||||None (Open Label)||||||
1517863|NCT00746486|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517864|NCT00746473|||Cohort||Prospective|||||||
1517865|NCT00746460||Single Group Assignment||Prevention||None (Open Label)||||||
1517866|NCT00746447|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517867|NCT00746434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517868|NCT00746421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517869|NCT00746408|||Case Control||Cross-Sectional|||||||
1517870|NCT00746395|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1517871|NCT00746382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517872|NCT00746369|Randomized|Parallel Assignment||Prevention||Single||||||t
1517873|NCT00746356|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517874|NCT00746343|Randomized|Parallel Assignment||Treatment||Single||||||t
1517875|NCT00746330|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1517876|NCT00746317|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517877|NCT00746304|||Cohort||Retrospective|||||||
1517878|NCT00746291|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517879|NCT00746278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517880|NCT00746265|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1517881|NCT00746252|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1517882|NCT00746239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517883|NCT00746226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517884|NCT00746213|||Cohort||Retrospective|||||||
1517885|NCT00746200|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518740|NCT00734890||||Treatment||||||||
1517886|NCT00746187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517887|NCT00746174|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1517888|NCT00746161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517889|NCT00746148|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1517890|NCT00746135|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1517891|NCT00746122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517892|NCT00746109|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1517893|NCT00746096|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517894|NCT00746083|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517895|NCT00746070|||Case Control||Prospective|||||||
1517896|NCT00746057||Single Group Assignment||||None (Open Label)||||||
1517897|NCT00746044|||Cohort||Prospective|||||||
1517898|NCT00746031|Randomized|Single Group Assignment||||None (Open Label)||||||
1517899|NCT00746018||Single Group Assignment||Treatment||None (Open Label)||||||
1517900|NCT00746005|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1517901|NCT00745992|||Cohort||Prospective|||||||
1517902|NCT00745966||||||||||||
1517903|NCT00745953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517904|NCT00745940|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517905|NCT00745927|Randomized|Parallel Assignment||Screening||Triple|||t|t||t
1517906|NCT00745914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517907|NCT00745901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517908|NCT00745888|||||Prospective|||||||
1517909|NCT00745875|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517910|NCT00745862|||Cohort||Prospective|||||||
1517911|NCT00745849|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1517912|NCT00745836||Parallel Assignment||Treatment||||||||
1517913|NCT00745823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517914|NCT00745810|||Case-Only||Prospective|||||||
1517915|NCT00745797|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1517916|NCT00745784|||Cohort||Prospective|||||||
1517917|NCT00745771||||Treatment||||||||
1517918|NCT00745758|||Cohort||Prospective|||||||
1517919|NCT00745745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517920|NCT00745732||Single Group Assignment||Treatment||None (Open Label)||||||
1517921|NCT00745719||Single Group Assignment||Treatment||None (Open Label)||||||
1517922|NCT00745706||Single Group Assignment||Diagnostic||None (Open Label)||||||
1517923|NCT00745693|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1517924|NCT00745680|||Case-Only||Prospective|||||||
1517925|NCT00745667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517926|NCT00745654|||Cohort||Retrospective|||||||
1517927|NCT00745641|||Case Control||Prospective|||||||
1517928|NCT00745628|||Cohort||Prospective|||||||
1517929|NCT00745615|Randomized|Parallel Assignment||Treatment||None (Open Label)|Blinding performed by interactive voice response system (IVRS) and relevant only to the first period of the extension. General medical evaluations will be assessed separately from neurological assessment evaluations by two different neurologists/ physicians. MRI scan evaluation will be performed at a central reading center by staff that does not have access to the clinical data.|||||
1517930|NCT00745602||Single Group Assignment||Diagnostic||None (Open Label)||||||
1517931|NCT00745589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517932|NCT00745576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517933|NCT00745563||Crossover Assignment||Treatment||None (Open Label)||||||
1517934|NCT00745550||Single Group Assignment||Treatment||None (Open Label)||||||
1517935|NCT00745537|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1517936|NCT00745524|||Case Control|||||||||
1517937|NCT00745511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517938|NCT00745498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517939|NCT00745485|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517940|NCT00745472|||||Prospective|||||||
1517941|NCT00745459||Single Group Assignment||Treatment||None (Open Label)||||||
1517942|NCT00745446|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1517943|NCT00745433|||||Prospective|||||||
1517944|NCT00745420||Single Group Assignment||Treatment||None (Open Label)||||||
1517945|NCT00745407||Crossover Assignment||Treatment||||||||
1517946|NCT00745394|||Cohort||Prospective|||||||
1517947|NCT00745381|||Cohort||Prospective|||||||
1517948|NCT00745368||Single Group Assignment||||None (Open Label)||||||
1517949|NCT00745355|||Cohort||Prospective|||||||
1517950|NCT00745342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517951|NCT00745329|||Case Control||Prospective|||||||
1517952|NCT00745316|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517953|NCT00745303|||Case Control||Prospective|||||||
1517954|NCT00745290|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1517955|NCT00745264|Randomized|Parallel Assignment||||None (Open Label)||||||
1517956|NCT00745251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517957|NCT00745238||Single Group Assignment||Supportive Care||None (Open Label)||||||
1517958|NCT00745225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517959|NCT00745212|||Cohort||Prospective|||||||
1517960|NCT00745199|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517961|NCT00745186|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517962|NCT00745173|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517963|NCT00745160|||Cohort||Prospective|||||||
1517964|NCT00745147|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1517965|NCT00745134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517966|NCT00745121|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517967|NCT00745108|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1517968|NCT00745095|Randomized|Factorial Assignment||Diagnostic||Single||||||t
1517969|NCT00745069|Randomized|Parallel Assignment||Treatment||Double||||||
1517970|NCT00745056|||Cohort||Prospective|||||||
1517971|NCT00745043|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1517972|NCT00745030|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517973|NCT00745017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517974|NCT00745004|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1517975|NCT00744991||Single Group Assignment||Treatment||None (Open Label)||||||
1517976|NCT00744978|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1517977|NCT00744965|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1517978|NCT00744952|||Cohort||Prospective|||||||
1517979|NCT00744939|||Cohort||Prospective|||||||
1517980|NCT00744926|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1517981|NCT00744913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517982|NCT00744900|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517983|NCT00744887|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1517984|NCT00744874||Single Group Assignment||Treatment||None (Open Label)||||||
1517985|NCT00744861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1517986|NCT00744848|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1517987|NCT00744835|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517988|NCT00744822|||||Prospective|||||||
1517989|NCT00744809|Randomized|Crossover Assignment||Diagnostic||Double||||||
1517990|NCT00744796|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517991|NCT00744770|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517992|NCT00744757||Single Group Assignment||Treatment||None (Open Label)||||||
1517993|NCT00744744|||Ecologic or Community||Cross-Sectional|||||||
1517994|NCT00744731|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1517995|NCT00744718||Factorial Assignment||Treatment||None (Open Label)||||||
1517996|NCT00744705|||Case-Only||Retrospective|||||||
1517997|NCT00744692|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1517998|NCT00744679|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1517999|NCT00744666|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1518000|NCT00744653||Single Group Assignment||Treatment||None (Open Label)||||||
1518001|NCT00744640||Single Group Assignment||Treatment||None (Open Label)||||||
1518002|NCT00744627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518003|NCT00744614|||Cohort||Prospective|||||||
1518004|NCT00744601|||Case Control||Cross-Sectional|||||||
1518005|NCT00744588|||Case-Only||Cross-Sectional|||||||
1518006|NCT00744575|||Case Control||Prospective|||||||
1518007|NCT00744562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518008|NCT00744549|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1518009|NCT00744536||Single Group Assignment||Treatment||None (Open Label)||||||
1518010|NCT00744523||Single Group Assignment||Prevention||None (Open Label)||||||
1518011|NCT00744510|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1518012|NCT00744497|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518013|NCT00744484|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518014|NCT00744471|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518015|NCT00744458|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1518016|NCT00744445|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518017|NCT00744419||Single Group Assignment||Treatment||None (Open Label)||||||
1518018|NCT00744406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518019|NCT00744393|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1518020|NCT00744380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518021|NCT00744367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518022|NCT00744354||Single Group Assignment||Treatment||None (Open Label)||||||
1518023|NCT00744341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518024|NCT00744328|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518025|NCT00744315||Single Group Assignment||Treatment||None (Open Label)||||||
1518026|NCT00744302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518027|NCT00744289|Randomized|Parallel Assignment||Prevention||Single||||t||
1518028|NCT00744276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518029|NCT00744263|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518030|NCT00744250||Single Group Assignment||Supportive Care||None (Open Label)||||||
1518031|NCT00744237|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518032|NCT00744224|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1518033|NCT00744211|Randomized|Parallel Assignment||Other||Double|||t||t|
1518034|NCT00744198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518035|NCT00744185|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518036|NCT00744172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518037|NCT00744159|||Case Control||Prospective|||||||
1518038|NCT00744146|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1518039|NCT00744133|Randomized|Parallel Assignment||||None (Open Label)||||||
1518041|NCT00744107|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518042|NCT00744094|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1518043|NCT00744081|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518044|NCT00744068|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1518045|NCT00744055|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518046|NCT00744042||Single Group Assignment||Treatment||None (Open Label)||||||
1518047|NCT00744029|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1518048|NCT00744016|Randomized|Parallel Assignment||Prevention||Double||||||
1518049|NCT00744003|||Cohort||Prospective|||||||
1518050|NCT00743990|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518051|NCT00743977|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1518052|NCT00743964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518053|NCT00743951|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1518054|NCT00743938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518055|NCT00743925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518056|NCT00743912||Single Group Assignment||||None (Open Label)||||||
1518057|NCT00743899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518058|NCT00743886|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518059|NCT00743873|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518060|NCT00743860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518061|NCT00743847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518062|NCT00743834|Randomized|Factorial Assignment||Treatment||Single|||t|||
1518063|NCT00743821|||Case Control||Cross-Sectional|||||||
1518064|NCT00743808|||Cohort||Prospective|||||||
1518065|NCT00743795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518066|NCT00743782|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518067|NCT00743769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518068|NCT00743756|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1518069|NCT00743743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518070|NCT00743730|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1518071|NCT00743717|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518072|NCT00743704|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1518073|NCT00743691|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1518074|NCT00743678|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518075|NCT00743665|||Cohort||Prospective|||||||
1518076|NCT00743652|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518077|NCT00743639|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518078|NCT00743626||Single Group Assignment||Diagnostic||None (Open Label)||||||
1518079|NCT00743613|||Cohort||Prospective|||||||
1518080|NCT00743600|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1518081|NCT00743587|Randomized|Crossover Assignment||Other||Double|||t||t|
1518082|NCT00743574||Single Group Assignment||Treatment||None (Open Label)||||||
1518083|NCT00743561||Single Group Assignment||Diagnostic||Single||||||t
1518084|NCT00743548|Randomized|Single Group Assignment||Prevention||Single|||||t|
1518085|NCT00743535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518086|NCT00743522|||Cohort||Prospective|||||||
1518087|NCT00743509|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518088|NCT00743496||Single Group Assignment||Treatment||None (Open Label)||||||
1518089|NCT00743483||Single Group Assignment||Treatment||None (Open Label)||||||
1518090|NCT00743470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518091|NCT00743457|||Cohort||Prospective|||||||
1518092|NCT00743444|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1518093|NCT00743431|||Case-Only||Prospective|||||||
1518094|NCT00743418|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1518095|NCT00743405|Randomized|Crossover Assignment||Treatment||Single|||t|||
1518096|NCT00743392|||Cohort||Prospective|||||||
1518097|NCT00743379|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518098|NCT00743366|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1518099|NCT00743353|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1518100|NCT00743340||Single Group Assignment||Other||None (Open Label)||||||
1518101|NCT00743327|||Cohort||Prospective|||||||
1518102|NCT00743314||||Diagnostic||None (Open Label)||||||
1518103|NCT00743301|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1518104|NCT00743288||Single Group Assignment||Treatment||None (Open Label)||||||
1518105|NCT00743275||Single Group Assignment||Prevention||None (Open Label)||||||
1518106|NCT00743262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518107|NCT00743249|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1518108|NCT00743236|Randomized|Parallel Assignment||Treatment||Single||||||
1518109|NCT00743223|||Case Control||Prospective|||||||
1518110|NCT00743210|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1518111|NCT00743197|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518112|NCT00743184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518113|NCT00743171|||Case Control||Prospective|||||||
1518114|NCT00743158|||Case-Only||Prospective|||||||
1518115|NCT00743145|Randomized|Crossover Assignment||Basic Science||Double|Double-blind, placebo-controlled||t||t|
1518116|NCT00743132|||Cohort||Retrospective|||||||
1518117|NCT00743119|Randomized|Crossover Assignment||Other||Double|Placebo-controlled, double-blind||t||t|
1518118|NCT00743106|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1518119|NCT00743093|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1518120|NCT00743080|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518121|NCT00743067|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1518122|NCT00743054|||Case-Only||Cross-Sectional|||||||
1518123|NCT00743041|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1518124|NCT00743028|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518125|NCT00743015||Crossover Assignment||Treatment||||||||
1518126|NCT00743002|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1518127|NCT00742989|Randomized|Crossover Assignment||||None (Open Label)||||||
1518128|NCT00742976|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1518129|NCT00742963||Single Group Assignment||Treatment||None (Open Label)||||||
1518130|NCT00742950|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518131|NCT00742937|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518132|NCT00742924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518133|NCT00742911||Single Group Assignment||Treatment||None (Open Label)||||||
1518134|NCT00742898|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1518135|NCT00742885|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518136|NCT00742872|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518137|NCT00742859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518138|NCT00742846|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1518139|NCT00742833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518140|NCT00742820|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518141|NCT00742807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518142|NCT00742794|||Cohort||Retrospective|||||||
1518143|NCT00742781||Single Group Assignment||Supportive Care||None (Open Label)||||||
1518144|NCT00742768|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1518145|NCT00742755||Single Group Assignment||Screening||None (Open Label)||||||
1518146|NCT00742742|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518147|NCT00742729|Randomized|Parallel Assignment||Screening||Single|||t|||
1518148|NCT00742716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518149|NCT00742703|Randomized|Crossover Assignment||||Double|||t||t|
1518150|NCT00742690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518151|NCT00742677|Randomized|||Supportive Care||||||||
1518152|NCT00742664|Randomized|Parallel Assignment||Treatment||Single||||||t
1518153|NCT00742638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518154|NCT00742625||Parallel Assignment||Treatment||None (Open Label)||||||
1518155|NCT00742612|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518156|NCT00742599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518157|NCT00742586||||||||||||
1518158|NCT00742573|Randomized|Parallel Assignment||Treatment||Single||||||t
1518159|NCT00742560|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518160|NCT00742547|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518161|NCT00742534||Single Group Assignment||Treatment||None (Open Label)||||||
1518162|NCT00742521|Randomized|Crossover Assignment||||Single|||t|||
1518163|NCT00742508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518164|NCT00742495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518165|NCT00742482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518166|NCT00742469|Randomized|Parallel Assignment||Prevention||Double||||||
1518167|NCT00742456|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1518168|NCT00742443|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518169|NCT00742430|||Cohort||Prospective|||||||
1518170|NCT00742417|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1518171|NCT00742404||||Treatment||None (Open Label)||||||
1518172|NCT00742391|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518173|NCT00742378|||Case Control||Cross-Sectional|||||||
1518174|NCT00742365|||Cohort||Prospective|||||||
1518175|NCT00742352|||Cohort||Prospective|||||||
1518176|NCT00742339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518177|NCT00742326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518178|NCT00742313|Randomized|Parallel Assignment||Treatment||Single||||||t
1518179|NCT00742300||Single Group Assignment||Treatment||None (Open Label)||||||
1518180|NCT00742287|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1518181|NCT00742274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518182|NCT00742261|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518183|NCT00742248|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1518184|NCT00742235|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518185|NCT00742222||Single Group Assignment||Treatment||None (Open Label)||||||
1518186|NCT00742209|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518187|NCT00742196|||Case Control||Retrospective|||||||
1518188|NCT00742183|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1518189|NCT00742170|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518190|NCT00742157|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518191|NCT00742144||Single Group Assignment||Treatment||None (Open Label)||||||
1518192|NCT00742131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518193|NCT00742118|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1518194|NCT00742105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518195|NCT00742092|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1518196|NCT00742079|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1518197|NCT00742066|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1518198|NCT00742053||Single Group Assignment||Basic Science||None (Open Label)||||||
1518199|NCT00742040|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518200|NCT00742027||Single Group Assignment||Treatment||None (Open Label)||||||
1518201|NCT00742014||Single Group Assignment||Treatment||None (Open Label)||||||
1518202|NCT00742001|Non-Randomized|Parallel Assignment||||Single|||t|||
1518203|NCT00741988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518204|NCT00741975|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518205|NCT00741962|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1518206|NCT00741949|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1518207|NCT00741936|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1518208|NCT00741923||Single Group Assignment||Prevention||None (Open Label)||||||
1518209|NCT00741910||Single Group Assignment||Treatment||None (Open Label)||||||
1518210|NCT00741897||Single Group Assignment||Treatment||None (Open Label)||||||
1518211|NCT00741884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518212|NCT00741871||Single Group Assignment||Treatment||None (Open Label)||||||
1518213|NCT00741858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518214|NCT00741845|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518215|NCT00741832|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1518216|NCT00741819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518217|NCT00741806|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518218|NCT00741793|||Cohort||Prospective|||||||
1518219|NCT00741780|||||Prospective|||||||
1518220|NCT00741767|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1518221|NCT00741754|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518222|NCT00741741|Randomized|Parallel Assignment||Treatment||Double||||||
1518223|NCT00741728|||Cohort||Prospective|||||||
1518224|NCT00741715|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1518225|NCT00741702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518226|NCT00741689|Randomized|Factorial Assignment||Treatment||Single|||t|||
1518227|NCT00741676|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518228|NCT00741663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518229|NCT00741650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518230|NCT00741637|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518231|NCT00741624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518232|NCT00741611|Randomized|Parallel Assignment||Treatment||Single||||||t
1518233|NCT00741598|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518234|NCT00741585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518235|NCT00741572|||Case-Only||Prospective|||||||
1518236|NCT00741559||Single Group Assignment||Diagnostic||None (Open Label)||||||
1518237|NCT00741546|||Case Control||Prospective|||||||
1518238|NCT00741533|||Case-Only||Prospective|||||||
1518239|NCT00741520|Randomized|Parallel Assignment||Treatment||Single|||||t|
1518240|NCT00741507|Non-Randomized|Parallel Assignment||Screening||Single||||||t
1518241|NCT00741494|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1518242|NCT00741481|||||Prospective|||||||
1518243|NCT00741468||Single Group Assignment||Treatment||None (Open Label)||||||
1518244|NCT00741455||Single Group Assignment||Treatment||None (Open Label)||||||
1518245|NCT00741442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518246|NCT00741429|||Cohort||Prospective|||||||
1518247|NCT00741416|||Case Control||Prospective|||||||
1518248|NCT00741403||Single Group Assignment||Treatment||None (Open Label)||||||
1518249|NCT00741390|Randomized|Parallel Assignment||||Single|||t|||
1518250|NCT00741377||Single Group Assignment||Treatment||None (Open Label)||||||
1518251|NCT00741364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518252|NCT00741351|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518253|NCT00741338|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518254|NCT00741325|||||Prospective|||||||
1518255|NCT00741312|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1518256|NCT00741299|||||Retrospective|||||||
1518257|NCT00741286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518258|NCT00741273|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1518259|NCT00741260|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1518260|NCT00741247||Single Group Assignment||Diagnostic||None (Open Label)||||||
1518261|NCT00741234|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518262|NCT00741221||Single Group Assignment||Treatment||None (Open Label)||||||
1518263|NCT00741208|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1518264|NCT00741195||Single Group Assignment||Treatment||None (Open Label)||||||
1518265|NCT00741182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518266|NCT00741169|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518267|NCT00741156||Single Group Assignment||Treatment||None (Open Label)||||||
1518268|NCT00741143|Randomized|Parallel Assignment||||Triple|||t|t|t|
1518269|NCT00741130|||Case-Only||Cross-Sectional|||||||
1518270|NCT00741117|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1518271|NCT00741104|||Cohort||Prospective|||||||
1518272|NCT00741091||Single Group Assignment||Treatment||None (Open Label)||||||
1518273|NCT00741078||Crossover Assignment||Treatment||||||||
1518274|NCT00741065||Single Group Assignment||Treatment||None (Open Label)||||||
1518275|NCT00741052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518276|NCT00741039|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518277|NCT00741026|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1518278|NCT00741013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518279|NCT00741000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518280|NCT00740987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518281|NCT00740974||||||||||||
1518282|NCT00740961|||Case Control||Prospective|||||||
1518283|NCT00740948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518284|NCT00740935||Single Group Assignment||Prevention||None (Open Label)||||||
1518285|NCT00740922|||Cohort||Retrospective|||||||
1518286|NCT00740909|Randomized|Parallel Assignment||Treatment||Single||||||t
1518287|NCT00740896|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1518288|NCT00740883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518289|NCT00740870||Single Group Assignment||Treatment||None (Open Label)||||||
1518290|NCT00740857|Randomized|Parallel Assignment||Treatment||Double||||||
1518291|NCT00740844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518292|NCT00740831|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518293|NCT00740818|Randomized|Parallel Assignment||Prevention||Single||||||t
1518294|NCT00740805||Single Group Assignment||Treatment||None (Open Label)||||||
1518295|NCT00740792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518296|NCT00740779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518297|NCT00740766|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518298|NCT00740753||Single Group Assignment||Treatment||None (Open Label)||||||
1518299|NCT00740740|||Case Control||Prospective|||||||
1518300|NCT00740727||Single Group Assignment||Treatment||None (Open Label)||||||
1518301|NCT00740714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518302|NCT00740701|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1518303|NCT00740688|Non-Randomized|Single Group Assignment||Treatment||Double|||t|||t
1518304|NCT00740675|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1518305|NCT00740662|||Cohort||Prospective|||||||
1518306|NCT00740649|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1518307|NCT00740636|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518308|NCT00740623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518309|NCT00740610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518310|NCT00740597||Single Group Assignment||Treatment||None (Open Label)||||||
1518311|NCT00740584||Single Group Assignment||Treatment||None (Open Label)||||||
1518312|NCT00740571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518313|NCT00740558|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1518314|NCT00740545|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518315|NCT00740532|||Cohort||Retrospective|||||||
1518316|NCT00740519|||Cohort||Prospective|||||||
1518317|NCT00740506|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518318|NCT00740493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518319|NCT00740480|||Case-Only||Prospective|||||||
1518320|NCT00740467|Non-Randomized|||Treatment||None (Open Label)||||||
1518321|NCT00740454|||Cohort||Prospective|||||||
1518322|NCT00740441||Single Group Assignment||Treatment||None (Open Label)||||||
1518323|NCT00740428|Randomized|Parallel Assignment||Prevention||Single|||t|||
1518324|NCT00740415||Single Group Assignment||Treatment||None (Open Label)||||||
1518325|NCT00740402|||Case Control||Cross-Sectional|||||||
1518326|NCT00740389|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518327|NCT00740376|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518328|NCT00740363|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518329|NCT00740350|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518330|NCT00740337|||Cohort||Cross-Sectional|||||||
1518331|NCT00740324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518332|NCT00740311||||||||||||
1518333|NCT00740298|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1518334|NCT00740285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518335|NCT00740272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518336|NCT00740259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518337|NCT00740246|Randomized|Crossover Assignment||Treatment||Double||||||
1518338|NCT00740233|||Cohort||Prospective|||||||
1518339|NCT00740220|||Cohort||Prospective|||||||
1518340|NCT00740207|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1518341|NCT00740194|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518342|NCT00740181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518343|NCT00740168|||Cohort||Prospective|||||||
1518344|NCT00740155|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518345|NCT00740142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518346|NCT00740129||Single Group Assignment||Treatment||None (Open Label)||||||
1518347|NCT00740116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518348|NCT00740103||Single Group Assignment||Treatment||None (Open Label)||||||
1518349|NCT00740090|Randomized|Parallel Assignment||Prevention||Double||||||
1518350|NCT00740077||Single Group Assignment||Basic Science||None (Open Label)||||||
1518351|NCT00740064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518352|NCT00740051|Randomized|Parallel Assignment||Treatment||Double||||||
1518353|NCT00740038|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1518354|NCT00740025|||Case Control||Prospective|||||||
1518355|NCT00740012|Randomized|Parallel Assignment||||None (Open Label)||||||
1518356|NCT00739999||Parallel Assignment||||None (Open Label)||||||
1518357|NCT00739986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518358|NCT00739973|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1518359|NCT00739960||Single Group Assignment||Treatment||None (Open Label)||||||
1518360|NCT00739947|||Cohort||Prospective|||||||
1518361|NCT00739934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518362|NCT00739921||Parallel Assignment||Diagnostic||None (Open Label)||||||
1518363|NCT00739908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518364|NCT00739895|||Case Control||Prospective|||||||
1518365|NCT00739882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518366|NCT00739869|||Case Control||Cross-Sectional|||||||
1518367|NCT00739856|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518368|NCT00739843|||Cohort||Prospective|||||||
1518369|NCT00739830|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518370|NCT00739817|||||Prospective|||||||
1518371|NCT00739791||||Treatment||||||||
1518372|NCT00739778|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1518373|NCT00739765|Randomized|Parallel Assignment||Treatment||Single||Randomized controlled trial of three time-limited (14 week) psychotherapies for unmedicated patients with chronic posttraumatic stress disorder (PTSD)||||t
1518374|NCT00739752|Randomized|Factorial Assignment||Prevention||Triple||2 X 3 Factorial Design|t||t|t
1518375|NCT00739739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518376|NCT00739713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518377|NCT00739700|||Cohort||Prospective|||||||
1518378|NCT00739687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518379|NCT00739674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518380|NCT00739661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518381|NCT00739648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518382|NCT00739635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518383|NCT00739622|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518384|NCT00739609||Single Group Assignment||Treatment||None (Open Label)||||||
1518385|NCT00739596|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518386|NCT00739583|Randomized|Parallel Assignment||||None (Open Label)||||||
1518387|NCT00739570|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1518388|NCT00739557|||||Prospective|||||||
1518389|NCT00739544||Single Group Assignment||Prevention||Single|||t|||
1518390|NCT00739531|||Case-Only||Cross-Sectional|||||||
1518391|NCT00739518||Single Group Assignment||Diagnostic||None (Open Label)||||||
1518392|NCT00739505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518393|NCT00739492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518394|NCT00739479|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518395|NCT00739466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518396|NCT00739453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518397|NCT00739440|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518398|NCT00739414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518399|NCT00739401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518400|NCT00739388||Single Group Assignment||Treatment||None (Open Label)||||||
1518401|NCT00739375||Single Group Assignment||Basic Science||None (Open Label)||||||
1518402|NCT00739362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518403|NCT00739349|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518404|NCT00739336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518405|NCT00739323|||Case-Control||Prospective|||||||
1518406|NCT00739310||Single Group Assignment||Prevention||None (Open Label)||||||
1518407|NCT00739297|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1518408|NCT00739284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518409|NCT00739271|Randomized|Single Group Assignment||Treatment||Single||||||t
1518410|NCT00739258|||Cohort|||||||||
1518411|NCT00739245||||||||||||
1518412|NCT00739232|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1518413|NCT00739219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518414|NCT00739206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518415|NCT00739193|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518416|NCT00739180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518417|NCT00739167|||Cohort||Prospective|||||||
1518418|NCT00739154|||Cohort||Cross-Sectional|||||||
1518419|NCT00739141||Single Group Assignment||Treatment||None (Open Label)||||||
1518420|NCT00739128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518421|NCT00739115|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518422|NCT00739102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518423|NCT00739089|||Case-Control||Prospective|||||||
1518424|NCT00739076|Randomized|Parallel Assignment||Treatment||Single||||t||
1518425|NCT00739063||Single Group Assignment||Treatment||None (Open Label)||||||
1518426|NCT00739050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518427|NCT00739037|Randomized|Single Group Assignment||||Triple|||t|t|t|
1518428|NCT00739024|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1518429|NCT00739011||Single Group Assignment||Treatment||None (Open Label)||||||
1518430|NCT00738998||Single Group Assignment||Supportive Care||None (Open Label)||||||
1518431|NCT00738985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518432|NCT00738972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518433|NCT00738959|Randomized|Parallel Assignment||||Double|||t||t|
1518434|NCT00738946|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518435|NCT00738933|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1518436|NCT00738920|Randomized|Parallel Assignment||Treatment||Single||||||t
1518437|NCT00738907|||Case Control||Cross-Sectional|||||||
1518438|NCT00738894|Randomized|Parallel Assignment||Treatment||Single||||||t
1518439|NCT00738881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518440|NCT00738868|Non-Randomized|||Treatment||||||||
1518441|NCT00738855|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518442|NCT00738842|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1518443|NCT00738829||Single Group Assignment||Treatment||None (Open Label)||||||
1518444|NCT00738816|Randomized|Parallel Assignment||Prevention||Single||||||t
1518445|NCT00738803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518446|NCT00738790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518447|NCT00738777|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1518448|NCT00738764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518449|NCT00738751||Single Group Assignment||Treatment||None (Open Label)||||||
1518450|NCT00738738|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518451|NCT00738725|||Cohort||Prospective|||||||
1518452|NCT00738712||Single Group Assignment||Diagnostic||None (Open Label)||||||
1518453|NCT00738699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518454|NCT00738686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518455|NCT00738673||Single Group Assignment||Treatment||None (Open Label)||||||
1518456|NCT00738660||Crossover Assignment||Treatment||None (Open Label)||||||
1518457|NCT00738647|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518458|NCT00738634|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518459|NCT00738621|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1518460|NCT00738608|||Case Control||Prospective|||||||
1518461|NCT00738595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518462|NCT00738582||Single Group Assignment||Treatment||None (Open Label)||||||
1518463|NCT00738569||Single Group Assignment||Supportive Care||None (Open Label)||||||
1518464|NCT00738556|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1518465|NCT00738543||Single Group Assignment||Prevention||Single||||||t
1518466|NCT00738530|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518467|NCT00738517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518468|NCT00738504|||Case Control||Retrospective|||||||
1518469|NCT00738491|||Case-Crossover||Prospective|||||||
1518470|NCT00738478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518471|NCT00738452||Single Group Assignment||Treatment||None (Open Label)||||||
1518472|NCT00738439|||Case-Control||Prospective|||||||
1518473|NCT00738426|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1518474|NCT00738413|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518475|NCT00738400|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518476|NCT00738387|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518477|NCT00738374||Single Group Assignment||Treatment||None (Open Label)||||||
1518478|NCT00738361||Single Group Assignment||Treatment||None (Open Label)||||||
1518479|NCT00738348|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1518480|NCT00738335||Single Group Assignment||Treatment||None (Open Label)||||||
1518481|NCT00738322|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518482|NCT00738309|||Case Control||Prospective|||||||
1518483|NCT00738296|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518484|NCT00738283|||Cohort||Prospective|||||||
1518485|NCT00738257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518486|NCT00738244|||Case-Crossover||Prospective|||||||
1518487|NCT00738231|Randomized|Parallel Assignment||Prevention||Single|||t|||
1518488|NCT00738218||Single Group Assignment||Diagnostic||Single|||||t|
1518489|NCT00738205|||Cohort||Prospective|||||||
1518490|NCT00738192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518491|NCT00738179|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518492|NCT00738166|Randomized|Crossover Assignment||||Double|||t||t|
1518493|NCT00738153|||||Prospective|||||||
1518494|NCT00738140|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518495|NCT00738127|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1518496|NCT00738114|||Cohort||Retrospective|||||||
1518497|NCT00738101||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1518498|NCT00738088||Single Group Assignment||Treatment||None (Open Label)||||||
1518499|NCT00738075|||Case Control|||||||||
1518500|NCT00738062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518501|NCT00738049|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1518502|NCT00738036|||Cohort||Prospective|||||||
1518503|NCT00738023|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518504|NCT00738010|Randomized|Single Group Assignment||Treatment||Single||||||t
1518505|NCT00737997|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518506|NCT00737984|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518507|NCT00737971|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518508|NCT00737958|||Case-Crossover||Prospective|||||||
1518509|NCT00737945|||Cohort||Prospective|||||||
1518510|NCT00737932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518511|NCT00737919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518512|NCT00737906||Single Group Assignment||Treatment||Single||||||t
1518513|NCT00737893|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1518514|NCT00737880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518515|NCT00737867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518516|NCT00737854||Single Group Assignment||Treatment||Single|||||t|
1518517|NCT00737841|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1518518|NCT00737828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518519|NCT00737815|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1518520|NCT00737802|||Case-Control||Prospective|||||||
1518521|NCT00737789|Randomized|Parallel Assignment||Treatment||Single|||||t|
1518522|NCT00737776|||Cohort||Prospective|||||||
1518523|NCT00737763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518524|NCT00737750|Randomized|Single Group Assignment||Treatment||Single||||||t
1518525|NCT00737737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518526|NCT00737724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518527|NCT00737711||Single Group Assignment||Treatment||None (Open Label)||||||
1518528|NCT00737698|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1518529|NCT00737685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518530|NCT00737672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518531|NCT00737659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518532|NCT00737646|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1518533|NCT00737633|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518534|NCT00737620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518535|NCT00737607|||Case-Only||Prospective|||||||
1518536|NCT00737594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518537|NCT00737581|||Other||Prospective|||||||
1518538|NCT00737568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518539|NCT00737555||Single Group Assignment||Treatment||None (Open Label)||||||
1518540|NCT00737542||||||||||||
1518541|NCT00737529||Single Group Assignment||Treatment||None (Open Label)||||||
1518542|NCT00737516||Single Group Assignment||||None (Open Label)||||||
1518543|NCT00737503|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518544|NCT00737490|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1518545|NCT00737477||Single Group Assignment||Treatment||None (Open Label)||||||
1518546|NCT00737464||Single Group Assignment||Treatment||None (Open Label)||||||
1518547|NCT00737451|||Case Control||Prospective|||||||
1518548|NCT00737438||Single Group Assignment||Treatment||None (Open Label)||||||
1518549|NCT00737425|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518550|NCT00737412|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1518551|NCT00737399||Single Group Assignment||Supportive Care||None (Open Label)||||||
1518552|NCT00737386|||Ecologic or Community||Cross-Sectional|||||||
1518553|NCT00737373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518554|NCT00737360||Single Group Assignment||Treatment||None (Open Label)||||||
1518555|NCT00737347|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518556|NCT00737334||Single Group Assignment||Diagnostic||None (Open Label)||||||
1518557|NCT00737321|||Case-Only||Prospective|||||||
1518558|NCT00737308||Parallel Assignment||Treatment||None (Open Label)||||||
1518559|NCT00737295|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1518560|NCT00737282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518561|NCT00737269|||||Prospective|||||||
1518562|NCT00737256|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518563|NCT00737243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518564|NCT00737230|Randomized|||Health Services Research||||||||
1518565|NCT00737217|||Case Control||Prospective|||||||
1518566|NCT00737204|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1518567|NCT00737191|Randomized|||Supportive Care||Double||||||
1518568|NCT00737178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518569|NCT00737165|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518570|NCT00737152|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518571|NCT00737139|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518572|NCT00737126|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518573|NCT00737113||Single Group Assignment||||None (Open Label)||||||
1518574|NCT00737100|Randomized|Parallel Assignment||Treatment||Double||||||
1518575|NCT00737087||Single Group Assignment||Treatment||None (Open Label)||||||
1518576|NCT00737074|||Cohort||Retrospective|||||||
1518577|NCT00737061||Single Group Assignment||Basic Science||None (Open Label)||||||
1518578|NCT00737048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518579|NCT00737035|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1518580|NCT00737022|||Cohort||Retrospective|||||||
1518582|NCT00736996|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518583|NCT00736983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518584|NCT00736970|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518585|NCT00736957||Single Group Assignment||Treatment||None (Open Label)||||||
1518586|NCT00736944|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518587|NCT00736931|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1518588|NCT00736918|Randomized|Parallel Assignment||Prevention||Single||||||t
1518589|NCT00736905|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1518590|NCT00736892|||Cohort||Prospective|||||||
1518591|NCT00736879|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518592|NCT00736866|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518593|NCT00736853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518594|NCT00736840||Single Group Assignment||Diagnostic||Single|||||t|
1518595|NCT00736827|||Cohort||Prospective|||||||
1518596|NCT00736814|Randomized|||Treatment||None (Open Label)||||||
1518597|NCT00736801||Single Group Assignment||Basic Science||None (Open Label)||||||
1518598|NCT00736788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518599|NCT00736775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518600|NCT00736762|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1518601|NCT00736749||||||||||||
1518602|NCT00736736|Randomized|Parallel Assignment||Treatment||Single||||||t
1518603|NCT00736723|||Cohort||Prospective|||||||
1518604|NCT00736710|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518605|NCT00736697|Randomized|Parallel Assignment||||None (Open Label)||||||
1518606|NCT00736684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518607|NCT00736671|||Case Control||Prospective|||||||
1518608|NCT00736658|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518609|NCT00736645|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518610|NCT00736632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518611|NCT00736619||Single Group Assignment||Treatment||None (Open Label)||||||
1518612|NCT00736606|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1518613|NCT00736593|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1518614|NCT00736580|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518615|NCT00736567|||||Cross-Sectional|||||||
1518616|NCT00736554|||Cohort||Prospective|||||||
1518617|NCT00736541|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518618|NCT00736528|Randomized|Parallel Assignment||||Double|||t||t|
1518619|NCT00736515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518620|NCT00736502|||Cohort||Prospective|||||||
1518621|NCT00736489|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1518622|NCT00736476|Randomized|Single Group Assignment||Prevention||Single|||t|||
1518623|NCT00736463|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1518624|NCT00736450||Single Group Assignment||Treatment||None (Open Label)||||||
1518625|NCT00736437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518626|NCT00736424|||Case-Only|||||||||
1518627|NCT00736411|Randomized|Parallel Assignment||Treatment||Single||||||t
1518628|NCT00736398|||Cohort||Prospective|||||||
1518629|NCT00736385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518630|NCT00736372|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518631|NCT00736346|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518632|NCT00736333|||Case-Only||Prospective|||||||
1518633|NCT00736320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518634|NCT00736307||Single Group Assignment||Treatment||None (Open Label)||||||
1518635|NCT00736294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518636|NCT00736281|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1518637|NCT00736268|Randomized|Parallel Assignment||Treatment||Single||||||t
1518638|NCT00736255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518639|NCT00736242|||Case-Only||Prospective|||||||
1518640|NCT00736229||Single Group Assignment||Treatment||None (Open Label)||||||
1518641|NCT00736216|||Ecologic or Community||Cross-Sectional|||||||
1518642|NCT00736203|||Cohort||Prospective|||||||
1518643|NCT00736190||Single Group Assignment||Treatment||None (Open Label)||||||
1518644|NCT00736177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518645|NCT00736164|Randomized|||Treatment||Double||||||
1518646|NCT00736151|Randomized|Parallel Assignment||Basic Science||Double||||||
1518647|NCT00736138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518648|NCT00736125|Randomized|Parallel Assignment||Prevention||Single|||t|||
1518649|NCT00736112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518650|NCT00736099|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518651|NCT00736086|||||Prospective|||||||
1518652|NCT00736073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518653|NCT00736060|||||Retrospective|||||||
1518654|NCT00736047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518655|NCT00736034||Single Group Assignment||Treatment||None (Open Label)||||||
1518656|NCT00736021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518657|NCT00736008|||Cohort||Retrospective|||||||
1518658|NCT00735995|Randomized|Parallel Assignment||Treatment||Single||||||t
1518659|NCT00735969|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518660|NCT00735956|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518661|NCT00735943|||Case-Only||Prospective|||||||
1518662|NCT00735930||Single Group Assignment||Treatment||None (Open Label)||||||
1518663|NCT00735917||Single Group Assignment||Treatment||None (Open Label)||||||
1518664|NCT00735904||Single Group Assignment||Treatment||None (Open Label)||||||
1518665|NCT00735878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518666|NCT00735865||Parallel Assignment||Treatment||None (Open Label)||||||
1518667|NCT00735852||Single Group Assignment||Treatment||None (Open Label)||||||
1518668|NCT00735839|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1518669|NCT00735826||Single Group Assignment||Basic Science||None (Open Label)||||||
1518670|NCT00735813|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518671|NCT00735800|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1518672|NCT00735787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518673|NCT00735774|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1518674|NCT00735761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518675|NCT00735748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518676|NCT00735735||Parallel Assignment||Diagnostic||Single|||||t|
1518677|NCT00735722|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518678|NCT00735709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518679|NCT00735696||Single Group Assignment||Treatment||None (Open Label)||||||
1518680|NCT00735683|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518681|NCT00735670|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1518682|NCT00735657|Randomized|Parallel Assignment||Treatment||Single|||||t|
1518683|NCT00735644|Randomized|Parallel Assignment||Prevention||Single||||||t
1518684|NCT00735631||Single Group Assignment||Treatment||None (Open Label)||||||
1518685|NCT00735618||Single Group Assignment||Treatment||None (Open Label)||||||
1518686|NCT00735605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518687|NCT00735592|||Cohort||Retrospective|||||||
1518688|NCT00735579|||Cohort||Prospective|||||||
1518689|NCT00735566|||Cohort||Prospective|||||||
1518690|NCT00735553|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518691|NCT00735540|||Case-Only||Retrospective|||||||
1518692|NCT00735527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518693|NCT00735514|||Case Control||Prospective|||||||
1518694|NCT00735501|||Cohort||Prospective|||||||
1518695|NCT00735488|||Cohort||Retrospective|||||||
1518696|NCT00735475|Randomized|Parallel Assignment||Prevention||Single|||||t|
1518697|NCT00735462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518698|NCT00735449|Randomized|Parallel Assignment||Treatment||Single|||||t|
1518699|NCT00735436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518700|NCT00735423|||Cohort||Cross-Sectional|||||||
1518701|NCT00735410|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518702|NCT00735397||Single Group Assignment||Treatment||None (Open Label)||||||
1518703|NCT00735384|||Case-Control||Prospective|||||||
1518704|NCT00735371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518705|NCT00735358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518706|NCT00735345||Single Group Assignment||Treatment||None (Open Label)||||||
1518707|NCT00735332||Single Group Assignment||Treatment||None (Open Label)||||||
1518708|NCT00735319|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1518709|NCT00735306||Single Group Assignment||Treatment||None (Open Label)||||||
1518710|NCT00735293||Single Group Assignment||Treatment||None (Open Label)||||||
1518711|NCT00735280||Single Group Assignment||Treatment||None (Open Label)||||||
1518712|NCT00735267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518713|NCT00735254|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1518714|NCT00735241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518715|NCT00735228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518716|NCT00735215|||Case-Only||Prospective|||||||
1518717|NCT00735189|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1518718|NCT00735176|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518719|NCT00735163||Single Group Assignment||Treatment||None (Open Label)||||||
1518720|NCT00735150|||Cohort||Prospective|||||||
1518721|NCT00735137|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518722|NCT00735124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518723|NCT00735111||Single Group Assignment||||None (Open Label)||||||
1518724|NCT00735098|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518725|NCT00735085|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518726|NCT00735072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518727|NCT00735059|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518728|NCT00735046|||||Prospective|||||||
1518729|NCT00735033||||Treatment||||||||
1518730|NCT00735020|Randomized|Parallel Assignment||Prevention||Single|||t|||
1518731|NCT00735007||Single Group Assignment||Treatment||None (Open Label)||||||
1518732|NCT00734994||Single Group Assignment||Treatment||None (Open Label)||||||
1518733|NCT00734981|||Case-Crossover||Prospective|||||||
1518734|NCT00734968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518735|NCT00734955|Non-Randomized|Single Group Assignment||Device Feasibility||None (Open Label)||||||
1518736|NCT00734942|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1518737|NCT00734929|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518738|NCT00734916|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1518739|NCT00734903|Randomized|Parallel Assignment||Treatment||Single||||||t
1518741|NCT00734877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518742|NCT00734864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518743|NCT00734851||Single Group Assignment||Treatment||None (Open Label)||||||
1518744|NCT00734838|Non-Randomized|Parallel Assignment||Device Feasibility||None (Open Label)||||||
1518745|NCT00734825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518746|NCT00734812|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518747|NCT00734799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518748|NCT00734786|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1518749|NCT00734773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518750|NCT00734760|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518751|NCT00734747||Single Group Assignment||Treatment||None (Open Label)||||||
1518752|NCT00734734||Single Group Assignment||Prevention||None (Open Label)||||||
1518753|NCT00734721|Randomized|Factorial Assignment||Other||Triple||||t|t|t
1518754|NCT00734708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518755|NCT00734695|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518756|NCT00734682||Single Group Assignment||Treatment||None (Open Label)||||||
1518757|NCT00734669|||Cohort||Prospective|||||||
1518758|NCT00734656|Randomized|Factorial Assignment||||Quadruple|||t|t|t|t
1518759|NCT00734643|||Case-Only||Prospective|||||||
1518760|NCT00734630|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518761|NCT00734617|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1518762|NCT00734604|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518763|NCT00734591|||Cohort|||||||||
1518764|NCT00734578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518765|NCT00734565|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518766|NCT00734552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518767|NCT00734539|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518768|NCT00734526|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518769|NCT00734513|Randomized|Parallel Assignment||Treatment||Single||||||t
1518770|NCT00734500||Single Group Assignment||Treatment||None (Open Label)||||||
1518771|NCT00734487|||Case-Control||Prospective|||||||
1518772|NCT00734474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518773|NCT00734461|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1518774|NCT00734448||Single Group Assignment||Supportive Care||None (Open Label)||||||
1518775|NCT00734435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518776|NCT00734422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518777|NCT00734409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518778|NCT00734396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518779|NCT00734383|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518780|NCT00734370|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1518781|NCT00734357|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1518782|NCT00734344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518783|NCT00734331|||Case Control||Prospective|||||||
1518784|NCT00734318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518785|NCT00734305||Single Group Assignment||Treatment||None (Open Label)||||||
1518786|NCT00734292|Randomized|Crossover Assignment||||Double|||t||t|
1518787|NCT00734279|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1518788|NCT00734266|||Case Control||Prospective|||||||
1518789|NCT00734253|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518790|NCT00734240|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1518791|NCT00734227|Randomized|Parallel Assignment||Treatment||Single|||||t|
1518792|NCT00734214|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518793|NCT00734201|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1518794|NCT00734188|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518795|NCT00734175|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518796|NCT00734162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518797|NCT00734149||Single Group Assignment||Treatment||None (Open Label)||||||
1518798|NCT00734136|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1518799|NCT00734123|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518800|NCT00734110|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518801|NCT00734097|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518802|NCT00734084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518803|NCT00734071|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518804|NCT00734058||Single Group Assignment||Treatment||None (Open Label)||||||
1518805|NCT00734045|||||Prospective|||||||
1518806|NCT00734032|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518807|NCT00734019||Single Group Assignment||Treatment||None (Open Label)||||||
1518808|NCT00734006|||Case Control||Prospective|||||||
1518809|NCT00733993|Non-Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1518810|NCT00733980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518811|NCT00733967|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1518812|NCT00733954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518813|NCT00733941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518814|NCT00733928|Randomized|Parallel Assignment||Treatment||Single||||||t
1518815|NCT00733915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518816|NCT00733902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518817|NCT00733889||Single Group Assignment||Treatment||None (Open Label)||||||
1518818|NCT00733876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518819|NCT00733863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518820|NCT00733850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518821|NCT00733837||Single Group Assignment||Treatment||None (Open Label)||||||
1518822|NCT00733824|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518823|NCT00733811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518824|NCT00733798|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518825|NCT00733785|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518826|NCT00733772|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518827|NCT00733759|||||Prospective|||||||
1518828|NCT00733746||Single Group Assignment||Treatment||None (Open Label)||||||
1518829|NCT00733733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518830|NCT00733720|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1518831|NCT00733707|Randomized|Parallel Assignment||||Single|||||t|
1518832|NCT00733694||Single Group Assignment||Treatment||None (Open Label)||||||
1518833|NCT00733681||Single Group Assignment||Treatment||None (Open Label)||||||
1518834|NCT00733668||Single Group Assignment||Treatment||None (Open Label)||||||
1518835|NCT00733655|||Cohort||Prospective|||||||
1518836|NCT00733642||Parallel Assignment||Treatment||None (Open Label)||||||
1518837|NCT00733629|||||Prospective|||||||
1518838|NCT00733616||Single Group Assignment||Treatment||None (Open Label)||||||
1518839|NCT00733603|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518840|NCT00733590|||Cohort||Prospective|||||||
1518841|NCT00733577|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518842|NCT00733564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518843|NCT00733551|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1518844|NCT00733538|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1518845|NCT00733525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518846|NCT00733512|||Cohort||Retrospective|||||||
1518847|NCT00733499|Randomized|Parallel Assignment||Treatment||Single||||||t
1518848|NCT00733486|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518849|NCT00733473|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1518850|NCT00733460|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1518851|NCT00733447||||||||||||
1518852|NCT00733434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518853|NCT00733421|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1518854|NCT00733408||Single Group Assignment||Treatment||None (Open Label)||||||
1518855|NCT00733395|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1518856|NCT00733382|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1518857|NCT00733369|Randomized|Parallel Assignment||Treatment||Single||||||t
1518858|NCT00733356||Single Group Assignment||Basic Science||Single||||||
1518859|NCT00733343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518860|NCT00733330|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518861|NCT00733317|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1518862|NCT00733304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518863|NCT00733291|Randomized|Crossover Assignment||||Double|||t||t|
1518864|NCT00733278||Single Group Assignment||Treatment||None (Open Label)||||||
1518865|NCT00733265|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1518866|NCT00733252|||Case-Only||Retrospective|||||||
1518867|NCT00733239||Single Group Assignment||Basic Science||Double|||t||t|
1518868|NCT00733226|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1518869|NCT00733213|||Case-Only||Retrospective|||||||
1518870|NCT00733200||||||||||||
1518871|NCT00733187||Single Group Assignment||Basic Science||None (Open Label)||||||
1518872|NCT00733174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518873|NCT00733161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518874|NCT00733148|||Case-Only||Retrospective|||||||
1518875|NCT00733135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518876|NCT00733122|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1518877|NCT00733109|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518878|NCT00733096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518879|NCT00733083|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518880|NCT00733070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518881|NCT00733057|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1518882|NCT00733044|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1518883|NCT00733031|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518884|NCT00733018|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1518885|NCT00733005|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518886|NCT00732992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518887|NCT00732979|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518888|NCT00732966||Single Group Assignment||||None (Open Label)||||||
1518889|NCT00732953|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518890|NCT00732940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518891|NCT00732927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518892|NCT00732914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518893|NCT00732901|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1518894|NCT00732888|Randomized|Crossover Assignment||||None (Open Label)||||||
1518895|NCT00732875||Single Group Assignment||Treatment||None (Open Label)||||||
1518896|NCT00732862||Single Group Assignment||Treatment||None (Open Label)||||||
1518897|NCT00732849|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518898|NCT00732836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518899|NCT00732823|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1518900|NCT00732810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518901|NCT00732797|Randomized|Parallel Assignment||Treatment||Single|||||t|
1518902|NCT00732784|Randomized|Crossover Assignment||||None (Open Label)||||||
1518903|NCT00732771|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1518904|NCT00732758|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1518905|NCT00732745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518906|NCT00732732|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518907|NCT00732719|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1518908|NCT00732706|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1518909|NCT00732693|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1518910|NCT00732680||Single Group Assignment||Treatment||None (Open Label)||||||
1518911|NCT00732654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518912|NCT00732641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518913|NCT00732628|||Case-Only||Prospective|||||||
1518914|NCT00732615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518915|NCT00732602|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1518916|NCT00732589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518917|NCT00732576|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1518918|NCT00732563||Single Group Assignment||Diagnostic||None (Open Label)||||||
1518919|NCT00732550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518920|NCT00732537|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1518921|NCT00732524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518922|NCT00732511|Randomized|Parallel Assignment||||None (Open Label)||||||
1518923|NCT00732498||Single Group Assignment||Treatment||None (Open Label)||||||
1518924|NCT00732485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518925|NCT00732472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518926|NCT00732459|||Cohort||Prospective|||||||
1518927|NCT00732446|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518928|NCT00732433||Single Group Assignment||Diagnostic||None (Open Label)||||||
1518929|NCT00732420|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1518930|NCT00732407|Randomized|Crossover Assignment||||None (Open Label)||||||
1518931|NCT00732394|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1518932|NCT00732381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518933|NCT00732368||Single Group Assignment||Treatment||None (Open Label)||||||
1518934|NCT00732355|||Case Control||Prospective|||||||
1518935|NCT00732342|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1518936|NCT00732329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518937|NCT00732316||Single Group Assignment||Treatment||None (Open Label)||||||
1518938|NCT00732303||Single Group Assignment||Treatment||None (Open Label)||||||
1518939|NCT00732290|Randomized|Crossover Assignment||||Single||||||t
1518940|NCT00732277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518941|NCT00732264||||||||||||
1518942|NCT00732251||Single Group Assignment||Prevention||None (Open Label)||||||
1518943|NCT00732238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518944|NCT00732225|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1518945|NCT00732212|Randomized|Parallel Assignment||Treatment||Single|||t|||
1518946|NCT00732199|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1518947|NCT00732186|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518948|NCT00732173|Randomized|Parallel Assignment||||None (Open Label)||||||
1518949|NCT00732160|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1518950|NCT00732147|Randomized|Factorial Assignment||Treatment||Single|||t|||
1518951|NCT00732134||||||||||||
1518952|NCT00732121|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1518953|NCT00732108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518954|NCT00732095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518955|NCT00732082|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518956|NCT00732069|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1518957|NCT00732056||Single Group Assignment||Treatment||None (Open Label)||||||
1518958|NCT00732043|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518959|NCT00732030|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518960|NCT00732017|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1518961|NCT00732004|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1518962|NCT00731991|Randomized|Parallel Assignment||Treatment||Single||||||t
1518963|NCT00731978|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1518964|NCT00731965|Randomized|Parallel Assignment||||None (Open Label)||||||
1518965|NCT00731952||Single Group Assignment||Other||None (Open Label)||||||
1518966|NCT00731939||Single Group Assignment||Treatment||None (Open Label)||||||
1518967|NCT00731926|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1518968|NCT00731913|||Case Control||Prospective|||||||
1518969|NCT00731900|||Case-Only||Prospective|||||||
1518970|NCT00731887|||Case-Only||Cross-Sectional|||||||
1518971|NCT00731874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518972|NCT00731861||Single Group Assignment||Treatment||None (Open Label)||||||
1518973|NCT00731848||Single Group Assignment||Treatment||None (Open Label)||||||
1518974|NCT00731835|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518975|NCT00731822|Randomized|Parallel Assignment||Treatment||Double||||||
1518976|NCT00731809|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1518977|NCT00731796|||Cohort||Prospective|||||||
1518978|NCT00731783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518979|NCT00731770|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1518980|NCT00731757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1518981|NCT00731744||Single Group Assignment||Basic Science||None (Open Label)||||||
1518982|NCT00731731||Single Group Assignment||Treatment||None (Open Label)||||||
1518983|NCT00731718||Single Group Assignment||Treatment||None (Open Label)||||||
1518984|NCT00731705|||Case-Only||Prospective|||||||
1518985|NCT00731692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518986|NCT00731679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1518987|NCT00731666||Single Group Assignment||Treatment||None (Open Label)||||||
1518988|NCT00731653||Parallel Assignment||Treatment||None (Open Label)||||||
1518989|NCT00731640|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1518990|NCT00731627|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1518991|NCT00731614|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1518992|NCT00731601|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1518993|NCT00731588|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1518994|NCT00731575|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1518995|NCT00731562|Randomized|Crossover Assignment||||None (Open Label)||||||
1518996|NCT00731549||Single Group Assignment||Treatment||None (Open Label)||||||
1518997|NCT00731536|||Case-Only||Retrospective|||||||
1518998|NCT00731523||Single Group Assignment||||None (Open Label)||||||
1518999|NCT00731510|Randomized|Factorial Assignment||Other||Triple|||t||t|t
1519000|NCT00731497|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519001|NCT00731484|||Case Control||Cross-Sectional|||||||
1519002|NCT00731471|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1519003|NCT00731458||Single Group Assignment||Health Services Research||None (Open Label)||||||
1519004|NCT00731445||Single Group Assignment||Treatment||None (Open Label)||||||
1519005|NCT00731432|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519006|NCT00731419|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519007|NCT00731393|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1519008|NCT00731380||Single Group Assignment||Treatment||None (Open Label)||||||
1519009|NCT00731367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519010|NCT00731354|Randomized|Crossover Assignment||||Single|||t|||
1519011|NCT00731341||Single Group Assignment||Treatment||None (Open Label)||||||
1519012|NCT00731328||Single Group Assignment||Treatment||None (Open Label)||||||
1519013|NCT00731315|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1519014|NCT00731302||Single Group Assignment||Other||None (Open Label)||||||
1519015|NCT00731289|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519016|NCT00731276||Single Group Assignment||Treatment||None (Open Label)||||||
1519017|NCT00731263|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519018|NCT00731250|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1519019|NCT00731237|||Cohort||Prospective|||||||
1519020|NCT00731224||Single Group Assignment||Treatment||None (Open Label)||||||
1519021|NCT00731211||Single Group Assignment||Treatment||None (Open Label)||||||
1519022|NCT00731198|Randomized|Parallel Assignment||Prevention||Single||||||t
1519023|NCT00731185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519024|NCT00731172|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519025|NCT00731159|||||Prospective|||||||
1519026|NCT00731146|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1519027|NCT00731133||Single Group Assignment||Treatment||None (Open Label)||||||
1519028|NCT00731120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519029|NCT00731107|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519030|NCT00731094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519031|NCT00731081|||Cohort||Prospective|||||||
1519032|NCT00731068|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1519033|NCT00731055|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1519034|NCT00731042|Randomized|Crossover Assignment||||Double|||t|||t
1519035|NCT00731029|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1519036|NCT00731016||Single Group Assignment||Treatment||None (Open Label)||||||
1519037|NCT00731003|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1519038|NCT00730990|Randomized|Single Group Assignment||||Single|||t|||
1519039|NCT00730977||Single Group Assignment||||None (Open Label)||||||
1519040|NCT00730964||Single Group Assignment||||None (Open Label)||||||
1519041|NCT00730951|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1519042|NCT00730938|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1519043|NCT00730925|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519044|NCT00730912|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519045|NCT00730899|||Cohort||Prospective|||||||
1519046|NCT00730886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519047|NCT00730873||||Treatment||||||||
1519048|NCT00730860|Randomized|Parallel Assignment||Treatment||Single||||||t
1519049|NCT00730847||Single Group Assignment||Prevention||None (Open Label)||||||
1519050|NCT00730834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519051|NCT00730821||||Treatment||||||||
1519052|NCT00730808|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1519053|NCT00730795|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519054|NCT00730782|Randomized|Parallel Assignment||Prevention||Single|||t|||
1519055|NCT00730769||Single Group Assignment||Treatment||None (Open Label)||||||
1519056|NCT00730756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519057|NCT00730743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519058|NCT00730730||Single Group Assignment||Treatment||None (Open Label)||||||
1519059|NCT00730717|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519060|NCT00730704|||Case-Only||Prospective|||||||
1519061|NCT00730691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519062|NCT00730678|||Cohort||Prospective|||||||
1519063|NCT00730665|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519064|NCT00730652||Single Group Assignment||Treatment||None (Open Label)||||||
1519065|NCT00730639|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519066|NCT00730626|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1519067|NCT00730613||Single Group Assignment||Treatment||None (Open Label)||||||
1519068|NCT00730600||Single Group Assignment||||None (Open Label)||||||
1519069|NCT00730587|||Cohort||Cross-Sectional|||||||
1519070|NCT00730574|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1519071|NCT00730561|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1519072|NCT00730548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519073|NCT00730535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519074|NCT00730522|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519075|NCT00730509||Single Group Assignment||||None (Open Label)||||||
1519076|NCT00730496|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519077|NCT00730483||Single Group Assignment||Treatment||None (Open Label)||||||
1519078|NCT00730470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519079|NCT00730457|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1519080|NCT00730444||||||||||||
1519081|NCT00730431|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519082|NCT00730418|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1519083|NCT00730405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519084|NCT00730392|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519085|NCT00730379|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519086|NCT00730366|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519087|NCT00730353||Single Group Assignment||Treatment||None (Open Label)||||||
1519088|NCT00730340|Randomized|Parallel Assignment||Treatment||Single||||||t
1519089|NCT00730327|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1519090|NCT00730314|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519091|NCT00730301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519092|NCT00730288|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519093|NCT00730275|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519094|NCT00730262||Single Group Assignment||Treatment||None (Open Label)||||||
1519095|NCT00730249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519096|NCT00730236|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519097|NCT00730223|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1519098|NCT00730210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519099|NCT00730197|Randomized|Crossover Assignment||||None (Open Label)||||||
1519100|NCT00730184|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1519101|NCT00730171||Single Group Assignment||Treatment||None (Open Label)||||||
1519102|NCT00730158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519103|NCT00730145|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1519104|NCT00730132|||Cohort||Prospective|||||||
1519105|NCT00730119|||Case-Only||Prospective|||||||
1519106|NCT00730106|||Cohort||Cross-Sectional|||||||
1519107|NCT00730093|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1519108|NCT00730080|||Case-Control||Prospective|||||||
1519109|NCT00730067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519110|NCT00730054|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1519111|NCT00730041|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519112|NCT00730028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519113|NCT00730015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519114|NCT00730002|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1519115|NCT00729989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519116|NCT00729976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519117|NCT00729963|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519118|NCT00729950|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519119|NCT00729937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519120|NCT00729924||Single Group Assignment||Basic Science||None (Open Label)||||||
1519121|NCT00729911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519122|NCT00729898|||Cohort||Prospective|||||||
1519123|NCT00729885|Randomized|Crossover Assignment||Treatment||Single|||t|||
1519124|NCT00729872|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1519125|NCT00729859|Randomized|Parallel Assignment||Prevention||Single|||t|||
1519126|NCT00729846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519127|NCT00729833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519128|NCT00729820||||||||||||
1519129|NCT00729807||Single Group Assignment||Treatment||None (Open Label)||||||
1519130|NCT00729794|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519131|NCT00729781|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519132|NCT00729768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519133|NCT00729755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519134|NCT00729742|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519135|NCT00729729|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1519136|NCT00729716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519137|NCT00729703|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519138|NCT00729690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519139|NCT00729677|||Case-Only||Prospective|||||||
1519140|NCT00729664|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519141|NCT00729651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519142|NCT00729638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519143|NCT00729625|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1519144|NCT00729612||Single Group Assignment||Treatment||None (Open Label)||||||
1519145|NCT00729599||Single Group Assignment||Treatment||None (Open Label)||||||
1519146|NCT00729586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519147|NCT00729573|||Cohort||Prospective|||||||
1519148|NCT00729560|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1519149|NCT00729547|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1519150|NCT00729534|||||Prospective|||||||
1519151|NCT00729521|Randomized|Parallel Assignment||Prevention||Single|||t|||
1519152|NCT00729508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519153|NCT00729495|Randomized|Single Group Assignment||||None (Open Label)||||||
1519154|NCT00729482||Single Group Assignment||Treatment||None (Open Label)||||||
1519155|NCT00729469|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519156|NCT00729456|Randomized|Parallel Assignment||Prevention||Single||||||t
1519157|NCT00729443|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1519158|NCT00729430|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519159|NCT00729417|||||Retrospective|||||||
1519160|NCT00729404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519161|NCT00729391|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519162|NCT00729378|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1519163|NCT00729365|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1519164|NCT00729352|||Case-Crossover||Prospective|||||||
1519165|NCT00729339|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1519166|NCT00729326|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1519167|NCT00729313|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519168|NCT00729300|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1519169|NCT00729287|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519170|NCT00729274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519171|NCT00729261|Randomized|Single Group Assignment||Treatment||Single||||||t
1519172|NCT00729248|||||Cross-Sectional|||||||
1519173|NCT00729235|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519174|NCT00729222|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519175|NCT00729209|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1519176|NCT00729196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519177|NCT00729183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519178|NCT00729170|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519179|NCT00729157||Single Group Assignment||Treatment||None (Open Label)||||||
1519180|NCT00729144|||Cohort||Prospective|||||||
1519181|NCT00729131|||Case Control||Prospective|||||||
1519182|NCT00729118||Single Group Assignment||Treatment||None (Open Label)||||||
1519183|NCT00729092|||Cohort||Prospective|||||||
1519184|NCT00729079|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519185|NCT00729053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519186|NCT00729040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519187|NCT00729027|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519188|NCT00729014|||||Retrospective|||||||
1519189|NCT00729001|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1519190|NCT00728988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519191|NCT00728975|||Cohort||Retrospective|||||||
1519192|NCT00728962|||Cohort||Prospective|||||||
1519193|NCT00728949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519194|NCT00728936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519195|NCT00728923||Single Group Assignment||Treatment||None (Open Label)||||||
1519196|NCT00728910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519197|NCT00728897|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519198|NCT00728884|||Cohort||Prospective|||||||
1519199|NCT00728871||Single Group Assignment||Basic Science||None (Open Label)||||||
1519200|NCT00728858|||Case Control||Prospective|||||||
1519201|NCT00728845|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519202|NCT00728832|Randomized|Parallel Assignment||||None (Open Label)||||||
1519203|NCT00728819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519204|NCT00728806|||Case Control|||||||||
1519205|NCT00728793||Single Group Assignment||Treatment||None (Open Label)||||||
1519206|NCT00728780|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519207|NCT00728767|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519208|NCT00728754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519209|NCT00728741|||||Prospective|||||||
1519210|NCT00728728|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519211|NCT00728715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519212|NCT00728702||||||||||||
1519213|NCT00728689|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1519214|NCT00728676|||Case Control||Prospective|||||||
1519215|NCT00728663||Single Group Assignment||Treatment||None (Open Label)||||||
1519216|NCT00728650|||||Retrospective|||||||
1519217|NCT00728637|Randomized|Parallel Assignment||Prevention||Single||||||t
1519218|NCT00728624|||Other||Prospective|||||||
1519219|NCT00728611|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1519220|NCT00728598|||Case Control||Prospective|||||||
1519221|NCT00728585|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1519222|NCT00728572|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519223|NCT00728559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519224|NCT00728546||Single Group Assignment||Treatment||None (Open Label)||||||
1519225|NCT00728533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519226|NCT00728520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519227|NCT00728507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519228|NCT00728494|||Cohort||Prospective|||||||
1519229|NCT00728481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519230|NCT00728468||||||None (Open Label)||||||
1519231|NCT00728455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519232|NCT00728442|Randomized|Parallel Assignment||||None (Open Label)||||||
1519233|NCT00728429|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1519234|NCT00728416|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519235|NCT00728403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519236|NCT00728390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519237|NCT00728377|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519238|NCT00728364|||Cohort||Cross-Sectional|||||||
1519239|NCT00728351|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519240|NCT00728338|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519241|NCT00728325|Randomized|Parallel Assignment||||None (Open Label)||||||
1519242|NCT00728312|Randomized|Parallel Assignment||Treatment||Double||||||
1519243|NCT00728299|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1519244|NCT00728286|||Cohort||Prospective|||||||
1519245|NCT00728273|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1519246|NCT00728260|||Cohort|||||||||
1519247|NCT00728247||Single Group Assignment||Basic Science||None (Open Label)||||||
1519248|NCT00728234|||Cohort||Prospective|||||||
1519249|NCT00728221|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1519250|NCT00728208|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519251|NCT00728195|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519252|NCT00728182|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519253|NCT00728169|||Ecologic or Community||Cross-Sectional|||||||
1519254|NCT00728156|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519255|NCT00728143|Randomized|Parallel Assignment||Prevention||Single|||t|||
1519256|NCT00728130||Single Group Assignment||Treatment||None (Open Label)||||||
1519257|NCT00728117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519258|NCT00728104|||Family-Based||Prospective|||||||
1519259|NCT00728091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519260|NCT00728078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519261|NCT00728065|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1519262|NCT00728052|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1519263|NCT00728039|||Cohort||Prospective|||||||
1519264|NCT00728026|||Case-Only||Retrospective|||||||
1519265|NCT00728013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519266|NCT00728000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519267|NCT00727987|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519268|NCT00727974|||Other||Prospective|||||||
1519269|NCT00727961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519270|NCT00727948||Single Group Assignment||Treatment||None (Open Label)||||||
1519271|NCT00727935|Randomized|Parallel Assignment||Prevention||Double||||||
1519272|NCT00727922|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519273|NCT00727909||Single Group Assignment||Treatment||None (Open Label)||||||
1519274|NCT00727896|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1519275|NCT00727883|||Cohort||Retrospective|||||||
1519276|NCT00727870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519277|NCT00727857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519278|NCT00727844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519279|NCT00727831||Single Group Assignment||Treatment||None (Open Label)||||||
1519280|NCT00727818|Randomized|Parallel Assignment||Treatment||Double||||||
1519281|NCT00727805||||||||||||
1519282|NCT00727792|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1519283|NCT00727779|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519284|NCT00727766|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519285|NCT00727753|||Cohort||Prospective|||||||
1519286|NCT00727740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519287|NCT00727727|||||Prospective|||||||
1519288|NCT00727714|||Cohort||Prospective|||||||
1519289|NCT00727701|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519290|NCT00727688||||||||||||
1519291|NCT00727675||Single Group Assignment||Treatment||None (Open Label)||||||
1519292|NCT00727662|Randomized|Parallel Assignment||Treatment||Single||||||t
1519293|NCT00727649|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519294|NCT00727636|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1519295|NCT00727623|||Cohort||Prospective|||||||
1519296|NCT00727610|||Cohort||Prospective|||||||
1519297|NCT00727597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519298|NCT00727584|Randomized|||Treatment||||||||
1519299|NCT00727571|||||Prospective|||||||
1519300|NCT00727558|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519301|NCT00727545|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519302|NCT00727532||Single Group Assignment||Treatment||None (Open Label)||||||
1519303|NCT00727519||||Prevention||||||||
1519304|NCT00727506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519305|NCT00727493|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519306|NCT00727480|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519307|NCT00727467|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519308|NCT00727454|Randomized|Parallel Assignment||Treatment||Single|||||t|
1519309|NCT00727441|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519310|NCT00727428||Single Group Assignment||Prevention||None (Open Label)||||||
1519311|NCT00727415||Single Group Assignment||Treatment||None (Open Label)||||||
1519312|NCT00727402|||Cohort||Prospective|||||||
1519313|NCT00727389||Single Group Assignment||Prevention||None (Open Label)||||||
1519314|NCT00727376|||Cohort||Prospective|||||||
1519315|NCT00727363|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1519316|NCT00727350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519317|NCT00727337|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519318|NCT00727324||Single Group Assignment||Treatment||None (Open Label)||||||
1519319|NCT00727311|||Case-Only||Prospective|||||||
1519320|NCT00727298|||Cohort||Prospective|||||||
1519321|NCT00727285|||Cohort||Prospective|||||||
1519322|NCT00727272|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1519323|NCT00727259|||Cohort||Prospective|||||||
1519324|NCT00727246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519325|NCT00727233|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519326|NCT00727220|||Cohort||Prospective|||||||
1519327|NCT00727207|Non-Randomized|||Treatment||||||||
1519328|NCT00727194|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519329|NCT00727181||Single Group Assignment||Treatment||None (Open Label)||||||
1519330|NCT00727168|||Cohort||Cross-Sectional|||||||
1519331|NCT00727155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519332|NCT00727142|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1519333|NCT00727129|Randomized|Parallel Assignment||Treatment||Double||||||
1519334|NCT00727116|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519335|NCT00727103|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519336|NCT00727090|Randomized|Parallel Assignment||Treatment||Single||||||t
1519337|NCT00727077|||Case-Only||Prospective|||||||
1519338|NCT00727064|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1519339|NCT00727051|||Case-Only||Cross-Sectional|||||||
1519340|NCT00727038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519341|NCT00727025|Randomized|Single Group Assignment||||None (Open Label)||||||
1519342|NCT00727012||Single Group Assignment||Treatment||None (Open Label)||||||
1519343|NCT00726999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519344|NCT00726986||Single Group Assignment||Treatment||None (Open Label)||||||
1519345|NCT00726973|Randomized|Parallel Assignment||Treatment||Single||||t||
1519346|NCT00726960|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1519347|NCT00726947|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519348|NCT00726934|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1519349|NCT00726921|||Other||Prospective|||||||
1519350|NCT00726908|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1519351|NCT00726895|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1519352|NCT00726882||Single Group Assignment||||None (Open Label)||||||
1519353|NCT00726869|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519354|NCT00726856|||Cohort||Retrospective|||||||
1519355|NCT00726843|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519356|NCT00726830|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1519357|NCT00726817|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1519599|NCT00723645|||Cohort||Prospective|||||||
1519358|NCT00726804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519359|NCT00726791||Single Group Assignment||Treatment||None (Open Label)||||||
1519360|NCT00726778|||Cohort||Cross-Sectional|||||||
1519361|NCT00726765|||Cohort||Prospective|||||||
1519362|NCT00726752|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519363|NCT00726739|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519364|NCT00726726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519365|NCT00726713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519366|NCT00726700|Randomized|||Treatment||||||||
1519367|NCT00726687||Single Group Assignment||Treatment||None (Open Label)||||||
1519368|NCT00726674|||Cohort||Prospective|||||||
1519369|NCT00726661|||Cohort||Prospective|||||||
1519370|NCT00726648|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1519371|NCT00726635|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1519372|NCT00726622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519373|NCT00726609|||Case-Only||Prospective|||||||
1519374|NCT00726596||Single Group Assignment||Treatment||None (Open Label)||||||
1519375|NCT00726583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519376|NCT00726570|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1519377|NCT00726557|||Case-Only||Prospective|||||||
1519378|NCT00726544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519379|NCT00726531|Randomized|Parallel Assignment||Prevention||Single||||||t
1519380|NCT00726505|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1519381|NCT00726492|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1519382|NCT00726479||Parallel Assignment||Treatment||||||||
1519383|NCT00726466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519384|NCT00726453||Single Group Assignment||Treatment||None (Open Label)||||||
1519385|NCT00726440|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1519386|NCT00726427|Randomized|Factorial Assignment||Treatment||Single|||t|||
1519387|NCT00726414|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1519388|NCT00726401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519389|NCT00726388||Single Group Assignment||Treatment||None (Open Label)||||||
1519390|NCT00726375||Single Group Assignment||Treatment||None (Open Label)||||||
1519391|NCT00726362|||Cohort||Prospective|||||||
1519392|NCT00726349|||Cohort||Prospective|||||||
1519393|NCT00726336|Non-Randomized|||Treatment||||||||
1519394|NCT00726323|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519395|NCT00726310|||Case-Only||Prospective|||||||
1519396|NCT00726297||||||||||||
1519397|NCT00726284|||Cohort||Prospective|||||||
1519398|NCT00726271||Single Group Assignment||Treatment||None (Open Label)||||||
1519399|NCT00726258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519400|NCT00726245|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1519401|NCT00726232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519402|NCT00726219|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519403|NCT00726206||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519404|NCT00726193|||Case-Only||Prospective|||||||
1519405|NCT00726180||Single Group Assignment||Treatment||None (Open Label)||||||
1519406|NCT00726167|||Case Control||Prospective|||||||
1519407|NCT00726154|Randomized|Parallel Assignment||||None (Open Label)||||||
1519408|NCT00726141|Randomized|Single Group Assignment||Treatment||Single|||t|||
1519409|NCT00726128|||Case-Only||Prospective|||||||
1519410|NCT00726115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519411|NCT00726102|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519412|NCT00726076|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1519413|NCT00726063|Randomized|Parallel Assignment||Treatment||None (Open Label)||implant types were randomized- 2 different surface treatments||||
1519414|NCT00726050|||||Prospective|||||||
1519415|NCT00726037||Single Group Assignment||Treatment||None (Open Label)||||||
1519416|NCT00726024||||||||||||
1519417|NCT00726011||Single Group Assignment||Treatment||None (Open Label)||||||
1519418|NCT00725998|||Other||Other|||||||
1519419|NCT00725985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519420|NCT00725972|Randomized|Parallel Assignment||Prevention||Double|Participants undergo anesthesia and are unaware of the arm they are in. Outcomes Assessors are only given data on results and are kept unaware of the peri-operative management.|A protocol group receiving augmented Oxygen Delivery will be compared to a usual care group.|t|||t
1519421|NCT00725959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519422|NCT00725946||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519423|NCT00725933||Single Group Assignment||Treatment||None (Open Label)||||||
1519424|NCT00725920|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519425|NCT00725907|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1519426|NCT00725894|||Cohort||Prospective|||||||
1519427|NCT00725881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519428|NCT00725868||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519429|NCT00725855|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1519430|NCT00725842|||Cohort||Prospective|||||||
1519431|NCT00725829|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1519432|NCT00725816||||||||||||
1519433|NCT00725803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519434|NCT00725790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519435|NCT00725777||Single Group Assignment||Treatment||None (Open Label)||||||
1519436|NCT00725764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519437|NCT00725751|||Cohort||Prospective|||||||
1519438|NCT00725738|Randomized|Parallel Assignment||Treatment||Single||||||t
1519439|NCT00725725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519440|NCT00725712|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519441|NCT00725699||||||||||||
1519442|NCT00725686||Single Group Assignment||Treatment||None (Open Label)||||||
1519443|NCT00725673|||Case Control||Cross-Sectional|||||||
1519444|NCT00725660|||Cohort||Prospective|||||||
1519445|NCT00725647|||Cohort||Prospective|||||||
1519446|NCT00725634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519447|NCT00725621|||Cohort||Prospective|||||||
1519448|NCT00725608|||Cohort||Prospective|||||||
1519449|NCT00725595|||Case-Only|||||||||
1519450|NCT00725582|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519451|NCT00725569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519452|NCT00725556|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1519453|NCT00725543|||Cohort||Prospective|||||||
1519454|NCT00725530|Randomized|Crossover Assignment||||Single|||t|||
1519455|NCT00725517|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519456|NCT00725504||Single Group Assignment||Treatment||None (Open Label)||||||
1519457|NCT00725491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519458|NCT00725478|||||Prospective|||||||
1519459|NCT00725465|||Cohort||Prospective|||||||
1519460|NCT00725452|||Cohort||Prospective|||||||
1519461|NCT00725439|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519462|NCT00725426|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1519463|NCT00725413||Single Group Assignment||Treatment||None (Open Label)||||||
1519464|NCT00725400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519465|NCT00725387|||Cohort||Prospective|||||||
1519466|NCT00725374|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519467|NCT00725361||Single Group Assignment||Treatment||None (Open Label)||||||
1519468|NCT00725348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519469|NCT00725335|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1519470|NCT00725322|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519471|NCT00725309|||Case-Only||Cross-Sectional|||||||
1519472|NCT00725296|||Cohort||Prospective|||||||
1519473|NCT00725283||Single Group Assignment||Treatment||None (Open Label)||||||
1519474|NCT00725270|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519475|NCT00725257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519476|NCT00725244|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519477|NCT00725231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519478|NCT00725218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519479|NCT00725205|||Cohort||Prospective|||||||
1519480|NCT00725192|Randomized|Parallel Assignment||Treatment||Single||||||t
1519481|NCT00725179|||Case-Only||Retrospective|||||||
1519482|NCT00725166|||Case Control||Prospective|||||||
1519483|NCT00725153|Randomized|Crossover Assignment||||Single|||t|||
1519484|NCT00725140|||Cohort||Prospective|||||||
1519485|NCT00725127|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519486|NCT00725114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519487|NCT00725101|||Cohort||Prospective|||||||
1519488|NCT00725088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519489|NCT00725075|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519490|NCT00725062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519491|NCT00725049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519492|NCT00725036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519493|NCT00725023|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1519494|NCT00725010|||Cohort||Prospective|||||||
1519495|NCT00724997|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1519496|NCT00724984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519497|NCT00724971||Single Group Assignment||Treatment||None (Open Label)||||||
1519498|NCT00724958|||Cohort||Prospective|||||||
1519499|NCT00724945|Randomized|Crossover Assignment||Treatment||Single|||t|||
1519500|NCT00724932|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1519501|NCT00724919|||Cohort||Prospective|||||||
1519502|NCT00724906|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519503|NCT00724893|||Cohort||Prospective|||||||
1519504|NCT00724880|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519505|NCT00724867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519506|NCT00724854|||Case Control||Prospective|||||||
1519507|NCT00724841|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519508|NCT00724828|||Cohort||Prospective|||||||
1519509|NCT00724815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519510|NCT00724802||Single Group Assignment||Treatment||None (Open Label)||||||
1519511|NCT00724789|||Cohort||Prospective|||||||
1519512|NCT00724776||Single Group Assignment||Treatment||None (Open Label)||||||
1519513|NCT00724763|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1519514|NCT00724750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519515|NCT00724737|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519516|NCT00724724|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1519517|NCT00724711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519518|NCT00724698|||Cohort||Prospective|||||||
1519519|NCT00724685|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519520|NCT00724672|||||Prospective|||||||
1519521|NCT00724659|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519522|NCT00724646|||Cohort||Retrospective|||||||
1519523|NCT00724633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519524|NCT00724620|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519525|NCT00724607|||Case-Control||Prospective|||||||
1519526|NCT00724594|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519527|NCT00724581|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1519528|NCT00724568||Single Group Assignment||Treatment||None (Open Label)||||||
1519529|NCT00724555|||Ecologic or Community||Prospective|||||||
1519530|NCT00724542|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1519531|NCT00724529|||Cohort||Prospective|||||||
1519532|NCT00724516||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1519533|NCT00724503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519534|NCT00724490||Single Group Assignment||Treatment||None (Open Label)||||||
1519535|NCT00724477|||Cohort||Retrospective|||||||
1519536|NCT00724464|||Case-Only||Retrospective|||||||
1519537|NCT00724451|||Case-Only||Prospective|||||||
1519538|NCT00724438|||Cohort||Prospective|||||||
1519539|NCT00724425||Single Group Assignment||Treatment||None (Open Label)||||||
1519540|NCT00724412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519541|NCT00724399|||Case-Only||Prospective|||||||
1519542|NCT00724386|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519543|NCT00724373|||Cohort||Retrospective|||||||
1519544|NCT00724360||Single Group Assignment||Treatment||None (Open Label)||||||
1519545|NCT00724347||Single Group Assignment||Basic Science||None (Open Label)||||||
1519546|NCT00724334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519547|NCT00724321||Single Group Assignment||Basic Science||Triple|||t||t|t
1519548|NCT00724308|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1519549|NCT00724295|||||Prospective|||||||
1519550|NCT00724282|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519551|NCT00724269|Randomized|Crossover Assignment||Screening||Single|||||t|
1519552|NCT00724256|Randomized|Parallel Assignment||Treatment||Single||||||t
1519553|NCT00724243|||Cohort||Prospective|||||||
1519554|NCT00724230|||||Prospective|||||||
1519555|NCT00724217|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519556|NCT00724204|Randomized|Parallel Assignment||||Double|||t||t|
1519557|NCT00724191|||Case-Only||Prospective|||||||
1519558|NCT00724178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519559|NCT00724165|Randomized|Parallel Assignment||||None (Open Label)||||||
1519560|NCT00724152|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519561|NCT00724139|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519562|NCT00724126|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519563|NCT00724113|Randomized|Parallel Assignment||Treatment||Single|||||t|
1519564|NCT00724100||Single Group Assignment||Treatment||None (Open Label)||||||
1519565|NCT00724087|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1519566|NCT00724074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519567|NCT00724061||Single Group Assignment||Treatment||None (Open Label)||||||
1519568|NCT00724048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519569|NCT00724035|Randomized|Parallel Assignment||Treatment||Single||||||t
1519570|NCT00724022|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519571|NCT00724009||Single Group Assignment||Treatment||None (Open Label)||||||
1519572|NCT00723996|||||Prospective|||||||
1519573|NCT00723983|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1519574|NCT00723970|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1519575|NCT00723957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519576|NCT00723944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519577|NCT00723931|||Cohort||Retrospective|||||||
1519578|NCT00723918|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519579|NCT00723905|||Cohort||Prospective|||||||
1519580|NCT00723892|||Cohort||Prospective|||||||
1519581|NCT00723879|||Cohort||Prospective|||||||
1519582|NCT00723866|Randomized|Parallel Assignment||Treatment||Single||||||t
1519583|NCT00723853|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519584|NCT00723840|||Cohort||Prospective|||||||
1519585|NCT00723827|||Cohort||Prospective|||||||
1519586|NCT00723814||||||||||||
1519587|NCT00723801|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519588|NCT00723788||Single Group Assignment||Diagnostic||Single|||||t|
1519589|NCT00723775|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519590|NCT00723762|||Case Control|||||||||
1519591|NCT00723749|||Cohort||Prospective|||||||
1519592|NCT00723736|||Cohort||Prospective|||||||
1519593|NCT00723723|||Cohort||Prospective|||||||
1519594|NCT00723710|||Case-Only||Prospective|||||||
1519595|NCT00723697|||Cohort||Prospective|||||||
1519596|NCT00723684|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519597|NCT00723671||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519598|NCT00723658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519600|NCT00723632|||Case-Only||Prospective|||||||
1519601|NCT00723619|||Cohort||Prospective|||||||
1519602|NCT00723606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519603|NCT00723593|||||Prospective|||||||
1519604|NCT00723580||Single Group Assignment||Health Services Research||None (Open Label)||||||
1519605|NCT00723567|||Cohort||Prospective|||||||
1519606|NCT00723554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519607|NCT00723541||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519608|NCT00723528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519609|NCT00723515|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519610|NCT00723502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519611|NCT00723489|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1519612|NCT00723476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519613|NCT00723463||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519614|NCT00723450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519615|NCT00723437||Single Group Assignment||||None (Open Label)||||||
1519616|NCT00723424|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1519617|NCT00723411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519618|NCT00723398|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519619|NCT00723385|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1519620|NCT00723359||Single Group Assignment||Treatment||None (Open Label)||||||
1519621|NCT00723346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519622|NCT00723333|||Cohort||Retrospective|||||||
1519623|NCT00723320|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1519624|NCT00723307|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519625|NCT00723294||Single Group Assignment||Treatment||None (Open Label)||||||
1519626|NCT00723281|||Case-Only||Prospective|||||||
1519627|NCT00723268|Randomized|Parallel Assignment||Treatment||Single|||||t|
1519628|NCT00723255||Single Group Assignment||Treatment||None (Open Label)||||||
1519629|NCT00723242||||Basic Science||||||||
1519630|NCT00723229|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519631|NCT00723216||Parallel Assignment||Prevention||None (Open Label)||||||
1519632|NCT00723203||Single Group Assignment||Treatment||None (Open Label)||||||
1519633|NCT00723190||Single Group Assignment||Treatment||None (Open Label)||||||
1519634|NCT00723177|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1519635|NCT00723164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519636|NCT00723151|Randomized|Parallel Assignment||Treatment||Single||||||t
1519637|NCT00723125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519638|NCT00723112|||Case Control||Prospective|||||||
1519639|NCT00723099||Single Group Assignment||Treatment||None (Open Label)||||||
1519640|NCT00723086|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519641|NCT00723073|||Cohort||Retrospective|||||||
1519642|NCT00723060|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519643|NCT00723047|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519644|NCT00723021|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519645|NCT00723008|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1519646|NCT00722995|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519647|NCT00722982|||Case Control||Prospective|||||||
1519648|NCT00722969||Single Group Assignment||Treatment||None (Open Label)||||||
1519649|NCT00722956|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1519650|NCT00722943|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1519651|NCT00722930||Single Group Assignment||Treatment||None (Open Label)||||||
1519652|NCT00722917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519653|NCT00722904|||Case Control||Cross-Sectional|||||||
1519654|NCT00722891|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1519655|NCT00722878|||Cohort||Prospective|||||||
1519656|NCT00722865||Single Group Assignment||Treatment||None (Open Label)||||||
1519657|NCT00722852|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519658|NCT00722839|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519659|NCT00722826|||Cohort||Cross-Sectional|||||||
1519660|NCT00722813|||Case Control||Prospective|||||||
1519661|NCT00722800|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519662|NCT00722774|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1519663|NCT00722761|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519664|NCT00722748|||Case-Only||Cross-Sectional|||||||
1519665|NCT00722735|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519666|NCT00722722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519667|NCT00722709|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1519668|NCT00722696||Single Group Assignment||||None (Open Label)||||||
1519669|NCT00722683||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519670|NCT00722670|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519671|NCT00722657|||Ecologic or Community||Retrospective|||||||
1519672|NCT00722644|Randomized|Parallel Assignment||Treatment||Single||||||
1519673|NCT00722631|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519674|NCT00722618|Randomized|Parallel Assignment||||Single|||t|||
1519675|NCT00722605||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519676|NCT00722592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519677|NCT00722579|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519678|NCT00722566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519679|NCT00722553||Single Group Assignment||Treatment||None (Open Label)||||||
1519680|NCT00722540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519681|NCT00722527|||Cohort||Prospective|||||||
1519682|NCT00722514||||||||||||
1519683|NCT00722501|Randomized|Single Group Assignment||Treatment||Double||||||
1519684|NCT00722488|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519685|NCT00722475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519686|NCT00722462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519687|NCT00722436|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519688|NCT00722423|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1519689|NCT00722410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519690|NCT00722397|||Case-Only||Cross-Sectional|||||||
1519691|NCT00722384|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519692|NCT00722371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519693|NCT00722358|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519694|NCT00722345|Randomized|Parallel Assignment||Treatment||Single||||||t
1519695|NCT00722332||Single Group Assignment||Prevention||None (Open Label)||||||
1519696|NCT00722319|||Cohort||Prospective|||||||
1519697|NCT00722306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519698|NCT00722293|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519699|NCT00722280||Single Group Assignment||Treatment||None (Open Label)||||||
1519700|NCT00722267|||Case-Only||Cross-Sectional|||||||
1519701|NCT00722254|||Cohort||Prospective|||||||
1519702|NCT00722241|||Case-Only||Prospective|||||||
1519703|NCT00722228||Single Group Assignment||Prevention||None (Open Label)||||||
1519704|NCT00722215|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1519705|NCT00722202|Randomized|Single Group Assignment||Treatment||Double||||||
1519706|NCT00722189|||||Prospective|||||||
1519707|NCT00722176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519708|NCT00722163|Randomized|Single Group Assignment||||Single||||||t
1519709|NCT00722150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519710|NCT00722137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519711|NCT00722124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519712|NCT00722111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519713|NCT00722098|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1519714|NCT00722085|||Cohort||Retrospective|||||||
1519715|NCT00722072||Single Group Assignment||Treatment||None (Open Label)||||||
1519716|NCT00722059|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519717|NCT00722046|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519718|NCT00722033|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519719|NCT00722020|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1519720|NCT00722007||Single Group Assignment||Treatment||None (Open Label)||||||
1519721|NCT00721994|||Cohort||Prospective|||||||
1519722|NCT00721981|||Case-Only||Prospective|||||||
1519723|NCT00721968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519724|NCT00721955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519725|NCT00721929||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519726|NCT00721916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519727|NCT00721903|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1519728|NCT00721890|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1519729|NCT00721877||Single Group Assignment||Prevention||None (Open Label)||||||
1519730|NCT00721864|||Cohort||Prospective|||||||
1519731|NCT00721851|||||Prospective|||||||
1519732|NCT00721838|||Case Control||Prospective|||||||
1519733|NCT00721825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519734|NCT00721812|Randomized|Crossover Assignment||Treatment||Single|||t|||
1519735|NCT00721799||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519736|NCT00721786||Single Group Assignment||Treatment||None (Open Label)||||||
1519737|NCT00721773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519738|NCT00721760|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1519739|NCT00721747||Single Group Assignment||Treatment||None (Open Label)||||||
1519740|NCT00721734||Single Group Assignment||Treatment||None (Open Label)||||||
1519741|NCT00721721||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519742|NCT00721708||Crossover Assignment||||None (Open Label)||||||
1519743|NCT00721695|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519744|NCT00721682|||Case Control||Prospective|||||||
1519745|NCT00721669||Single Group Assignment||Treatment||None (Open Label)||||||
1519746|NCT00721656|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519747|NCT00721643|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1519748|NCT00721630||Single Group Assignment||Treatment||None (Open Label)||||||
1519749|NCT00721617|Randomized|Parallel Assignment||Basic Science||Single||||||t
1519750|NCT00721604|||Case-Only||Prospective|||||||
1519751|NCT00721591|||Cohort||Prospective|||||||
1519752|NCT00721578|||||Prospective|||||||
1519753|NCT00721565|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519754|NCT00721552|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1519755|NCT00721539||Single Group Assignment||Health Services Research||None (Open Label)||||||
1519756|NCT00721526||Single Group Assignment||Treatment||None (Open Label)||||||
1519757|NCT00721513||Single Group Assignment||Treatment||None (Open Label)||||||
1519758|NCT00721500|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1519759|NCT00721487|||Case-Only||Retrospective|||||||
1519760|NCT00721474|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519761|NCT00721461|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519762|NCT00721448||Single Group Assignment||Basic Science||None (Open Label)||||||
1519763|NCT00721435|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519764|NCT00721422|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1519765|NCT00721409|Randomized|||Treatment||None (Open Label)||||||
1519766|NCT00721396|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519767|NCT00721383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519768|NCT00721370|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1519769|NCT00721357|||Cohort||Cross-Sectional|||||||
1519770|NCT00721344|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519771|NCT00721331|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1519772|NCT00721318|||Case Control||Cross-Sectional|||||||
1519773|NCT00721305|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519774|NCT00721279|||||Prospective|||||||
1519775|NCT00721266|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519776|NCT00721253|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519777|NCT00721240|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519778|NCT00721227|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519779|NCT00721214||Single Group Assignment||Treatment||None (Open Label)||||||
1519780|NCT00721201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519781|NCT00721188|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519782|NCT00721175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519783|NCT00721162||Single Group Assignment||Treatment||None (Open Label)||||||
1519784|NCT00721149|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1519785|NCT00721136|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519786|NCT00721123||Single Group Assignment||Treatment||None (Open Label)||||||
1519787|NCT00721110|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1519788|NCT00721097|||Case-Only||Prospective|||||||
1519789|NCT00721084|||Case Control||Cross-Sectional|||||||
1519790|NCT00721071|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519791|NCT00721058||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519792|NCT00721045|Randomized|Factorial Assignment||Treatment||Single|||t|||
1519793|NCT00721032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519794|NCT00721019|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1519795|NCT00721006|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1519796|NCT00720993|||Case Control||Prospective|||||||
1519797|NCT00720980|||Case-Only||Retrospective|||||||
1519798|NCT00720967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519799|NCT00720954|Randomized|||Diagnostic||||||||
1519800|NCT00720941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519801|NCT00720928||Single Group Assignment||Treatment||None (Open Label)||||||
1519802|NCT00720915|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519803|NCT00720902|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1519804|NCT00720889|||Case Control||Cross-Sectional|||||||
1519805|NCT00720876||Single Group Assignment||Treatment||None (Open Label)||||||
1519806|NCT00720850||Single Group Assignment||Treatment||None (Open Label)||||||
1519807|NCT00720837||Single Group Assignment||Treatment||None (Open Label)||||||
1519808|NCT00720824|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1519809|NCT00720811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519810|NCT00720798||Single Group Assignment||Treatment||None (Open Label)||||||
1519811|NCT00720785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519812|NCT00720772|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1519813|NCT00720759|Randomized|Parallel Assignment||Treatment||Single||||||t
1519814|NCT00720733|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519815|NCT00720720|Randomized|Parallel Assignment||||Double|||t||t|
1519816|NCT00720707|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519817|NCT00720694|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1519818|NCT00720681|||Cohort||Cross-Sectional|||||||
1519819|NCT00720668|||Case-Only||Prospective|||||||
1519820|NCT00720655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519821|NCT00720642|||Case-Only||Prospective|||||||
1519822|NCT00720629|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519823|NCT00720616|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519824|NCT00720603||||||||||||
1519825|NCT00720590|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1519826|NCT00720577|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1519827|NCT00720564||||Treatment||||||||
1519828|NCT00720551|Randomized|Crossover Assignment||||Single|||t|||
1519829|NCT00720538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519830|NCT00720525|||Case Control||Prospective|||||||
1519831|NCT00720512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519832|NCT00720499|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1519833|NCT00720486|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519986|NCT00718458|||Case-Control||Cross-Sectional|||||||
1519834|NCT00720473|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1519835|NCT00720460|||Case-Only||Prospective|||||||
1519836|NCT00720447|Non-Randomized|||Treatment||||||||
1519837|NCT00720434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519838|NCT00720421|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1519839|NCT00720408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519840|NCT00720395|||Cohort||Prospective|||||||
1519841|NCT00720382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519842|NCT00720369|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1519843|NCT00720356||Single Group Assignment||Treatment||None (Open Label)||||||
1519844|NCT00720343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519845|NCT00720330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519846|NCT00720317|||Case-Only||Prospective|||||||
1519847|NCT00720304||Single Group Assignment||Treatment||None (Open Label)||||||
1519848|NCT00720291|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519849|NCT00720278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519850|NCT00720265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519851|NCT00720252|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519852|NCT00720239|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519853|NCT00720226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519854|NCT00720213||||||||||||
1519855|NCT00720200|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1519856|NCT00720174||Single Group Assignment||Treatment||None (Open Label)||||||
1519857|NCT00720161|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519858|NCT00720148||Single Group Assignment||Treatment||None (Open Label)||||||
1519859|NCT00720135||Single Group Assignment||Treatment||None (Open Label)||||||
1519860|NCT00720122||Single Group Assignment||Treatment||None (Open Label)||||||
1519861|NCT00720109||Single Group Assignment||Treatment||None (Open Label)||||||
1519862|NCT00720096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519863|NCT00720083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519864|NCT00720070|Randomized|||Diagnostic||||||||
1519865|NCT00720057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519866|NCT00720031||Single Group Assignment||Treatment||None (Open Label)||||||
1519867|NCT00720018|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519868|NCT00720005|||Case Control||Retrospective|||||||
1519869|NCT00719992|Non-Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1519870|NCT00719979|Randomized|Parallel Assignment||Treatment||Single||||||t
1519871|NCT00719966|||Cohort||Prospective|||||||
1519872|NCT00719953||Single Group Assignment||Treatment||None (Open Label)||||||
1519873|NCT00719940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519874|NCT00719927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519875|NCT00719914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519876|NCT00719901||Single Group Assignment||Treatment||None (Open Label)||||||
1519877|NCT00719888|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519878|NCT00719875||Single Group Assignment||Treatment||None (Open Label)||||||
1519879|NCT00719862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519880|NCT00719849|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519881|NCT00719836||Single Group Assignment||Treatment||None (Open Label)||||||
1519882|NCT00719823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519883|NCT00719810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519884|NCT00719797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519885|NCT00719784||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519886|NCT00719771||Single Group Assignment||Treatment||None (Open Label)||||||
1519887|NCT00719758|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519888|NCT00719745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519889|NCT00719732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519890|NCT00719719|||Case-Only||Prospective|||||||
1519891|NCT00719706|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519892|NCT00719693|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1519893|NCT00719680||Single Group Assignment||Treatment||None (Open Label)||||||
1519894|NCT00719667|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519895|NCT00719654|||Case-Control||Prospective|||||||
1519896|NCT00719641|Randomized|Single Group Assignment||Treatment||||||||
1519897|NCT00719628|||Cohort||Prospective|||||||
1519898|NCT00719615|||Case Control||Prospective|||||||
1519899|NCT00719602|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1519900|NCT00719589|||Case Control||Prospective|||||||
1519901|NCT00719576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519902|NCT00719563|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1519903|NCT00719550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519904|NCT00719537|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1519905|NCT00719524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519906|NCT00719511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519907|NCT00719498|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519908|NCT00719485|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1519909|NCT00719472||Single Group Assignment||Treatment||None (Open Label)||||||
1519910|NCT00719459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519911|NCT00719446|||Cohort||Prospective|||||||
1519912|NCT00719433|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1519913|NCT00719420|Randomized|Parallel Assignment||Treatment||Single||||||t
1519914|NCT00719407|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519915|NCT00719394|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1519916|NCT00719381|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519917|NCT00719368|||Cohort|||||||||
1519918|NCT00719355|Randomized|Parallel Assignment||Treatment||Single||||||t
1519919|NCT00719342|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1519920|NCT00719329|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519921|NCT00719316|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519922|NCT00719303|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519923|NCT00719290|Randomized|Parallel Assignment||Treatment||Single|||||t|
1519924|NCT00719277|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1519925|NCT00719264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519926|NCT00719251|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1519927|NCT00719238|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519928|NCT00719225||||||||||||
1519929|NCT00719212||Single Group Assignment||Treatment||None (Open Label)||||||
1519930|NCT00719199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519931|NCT00719186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519932|NCT00719173|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519933|NCT00719160|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1519934|NCT00719147||||||||||||
1519935|NCT00719134|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1519936|NCT00719121|Randomized|Single Group Assignment||||Single|||||t|
1519937|NCT00719108|Randomized|Crossover Assignment||Health Services Research||Quadruple|||t|t|t|t
1519938|NCT00719095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519939|NCT00719082|||Ecologic or Community||Prospective|||||||
1519940|NCT00719069|Randomized|Crossover Assignment||Treatment||Double||||||
1519941|NCT00719056|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519942|NCT00719043|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1519943|NCT00719030|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519944|NCT00719017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519945|NCT00719004||Single Group Assignment||Diagnostic||None (Open Label)||||||
1519946|NCT00718991||Single Group Assignment||Treatment||None (Open Label)||||||
1519947|NCT00718978||Single Group Assignment||Treatment||None (Open Label)||||||
1519948|NCT00718965|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1519949|NCT00718952|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519950|NCT00718939|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519951|NCT00718926|||Case Control|||||||||
1519952|NCT00718913|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519953|NCT00718887|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519954|NCT00718874|Randomized|Parallel Assignment||Prevention||Single|||t|||
1519955|NCT00718861|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519956|NCT00718848|||Cohort||Prospective|||||||
1519957|NCT00718835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519958|NCT00718822|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519959|NCT00718809||Single Group Assignment||Treatment||None (Open Label)||||||
1519960|NCT00718796|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519961|NCT00718783|||Case-Only||Prospective|||||||
1519962|NCT00718770||Single Group Assignment||Treatment||None (Open Label)||||||
1519963|NCT00718757||Single Group Assignment||Treatment||None (Open Label)||||||
1519964|NCT00718744||Single Group Assignment||||None (Open Label)||||||
1519965|NCT00718731|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519966|NCT00718718|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1519967|NCT00718705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519968|NCT00718692||Single Group Assignment||Treatment||None (Open Label)||||||
1519969|NCT00718679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519970|NCT00718666|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1519971|NCT00718653|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1519972|NCT00718640||Single Group Assignment||Treatment||None (Open Label)||||||
1519973|NCT00718627||Single Group Assignment||Treatment||None (Open Label)||||||
1519974|NCT00718614|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1519975|NCT00718601|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1519976|NCT00718588|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1519977|NCT00718575|Randomized|Parallel Assignment||Treatment||Single|||t|||
1519978|NCT00718562||Single Group Assignment||Treatment||None (Open Label)||||||
1519979|NCT00718549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519980|NCT00718536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519981|NCT00718523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519982|NCT00718510|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519983|NCT00718497|||Case-Only||Cross-Sectional|||||||
1519984|NCT00718484|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1519985|NCT00718471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519988|NCT00718432|Randomized|Factorial Assignment||Prevention||Single||||||t
1519989|NCT00718419||Single Group Assignment||Treatment||None (Open Label)||||||
1519990|NCT00718406||||||||||||
1519991|NCT00718393|||Case-Only||Cross-Sectional|||||||
1519992|NCT00718380|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1519993|NCT00718367|||Cohort||Retrospective|||||||
1519994|NCT00718354|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1519995|NCT00718341|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1519996|NCT00718328|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1519997|NCT00718315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519998|NCT00718302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1519999|NCT00718289|Randomized|Crossover Assignment||Treatment||Single|||t|||
1520000|NCT00718276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520001|NCT00718250|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1520002|NCT00718237|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1520003|NCT00718224|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520004|NCT00718211||||||||||||
1520005|NCT00718198|||Cohort||Cross-Sectional|||||||
1520006|NCT00718185|||Cohort||Prospective|||||||
1520007|NCT00718172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520008|NCT00718159||Single Group Assignment||Treatment||None (Open Label)||||||
1520009|NCT00718146|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520010|NCT00718133|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1520011|NCT00718120|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520012|NCT00718107|||Case-Only||Cross-Sectional|||||||
1520013|NCT00718094|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1520014|NCT00718081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520015|NCT00718068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520016|NCT00718055|||Cohort||Prospective|||||||
1520017|NCT00718042|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1520018|NCT00718029|||Cohort||Prospective|||||||
1520019|NCT00718016|||Cohort||Cross-Sectional|||||||
1520020|NCT00718003|||Case-Only||Cross-Sectional|||||||
1520021|NCT00717990||Single Group Assignment||Treatment||None (Open Label)||||||
1520022|NCT00717977|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1520023|NCT00717951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520024|NCT00717938|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520025|NCT00717925||Single Group Assignment||Treatment||None (Open Label)||||||
1520026|NCT00717912|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1520027|NCT00717899|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1520028|NCT00717886||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520029|NCT00717873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520030|NCT00717860|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520031|NCT00717847|||Case-Only||Cross-Sectional|||||||
1520032|NCT00717834|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520033|NCT00717821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520034|NCT00717808|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520035|NCT00717795|||Cohort||Prospective|||||||
1520036|NCT00717782|Randomized|Parallel Assignment||Treatment||Single|||||t|
1520037|NCT00717769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520038|NCT00717756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520039|NCT00717743|||Case-Only||Prospective|||||||
1520040|NCT00717730|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1520041|NCT00717717|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520042|NCT00717704|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520043|NCT00717691|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520044|NCT00717678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520045|NCT00717665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520046|NCT00717652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520047|NCT00717639||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520048|NCT00717626|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520049|NCT00717613|||Cohort||Cross-Sectional|||||||
1520050|NCT00717600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520051|NCT00717587||||Treatment||||||||
1520052|NCT00717574|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1520053|NCT00717561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520054|NCT00717548||Single Group Assignment||Treatment||None (Open Label)||||||
1520055|NCT00717535|||||Prospective|||||||
1520056|NCT00717522||Single Group Assignment||Treatment||None (Open Label)||||||
1520057|NCT00717509|||Cohort||Cross-Sectional|||||||
1520058|NCT00717496|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1520059|NCT00717483|||Cohort||Retrospective|||||||
1520060|NCT00717470|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520061|NCT00717457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520062|NCT00717444|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1520063|NCT00717431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520064|NCT00717418|||Cohort||Prospective|||||||
1520065|NCT00717405||Single Group Assignment||Treatment||None (Open Label)||||||
1520067|NCT00717379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520068|NCT00717366|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520069|NCT00717353|||Case-Only||Cross-Sectional|||||||
1520070|NCT00717340|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520071|NCT00717327|||||Cross-Sectional|||||||
1520072|NCT00717314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520073|NCT00717301|||Cohort||Prospective|||||||
1520074|NCT00717288|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520075|NCT00717275||Single Group Assignment||Treatment||None (Open Label)||||||
1520076|NCT00717262|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520077|NCT00717249|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1520078|NCT00717236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520079|NCT00717223|||Case-Only||Cross-Sectional|||||||
1520080|NCT00717210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520081|NCT00717197||Single Group Assignment||Treatment||None (Open Label)||||||
1520082|NCT00717184|Non-Randomized|||Treatment||None (Open Label)||||||
1520083|NCT00717171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520084|NCT00717158|Randomized|Parallel Assignment||Prevention||Single|||||t|
1520085|NCT00717145|Randomized|Crossover Assignment||||None (Open Label)||||||
1520086|NCT00717132|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520087|NCT00717119|||Cohort||Retrospective|||||||
1520088|NCT00717106|||Cohort||Prospective|||||||
1520089|NCT00717093|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520090|NCT00717080|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520091|NCT00717067|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520092|NCT00717054|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520093|NCT00717041|||Cohort||Prospective|||||||
1520094|NCT00717028|||||Cross-Sectional|||||||
1520095|NCT00717015|||Case-Crossover||Cross-Sectional|||||||
1520096|NCT00717002|||Case-Only||Cross-Sectional|||||||
1520097|NCT00716989|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1520098|NCT00716976|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520099|NCT00716963|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1520100|NCT00716950|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520101|NCT00716937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520102|NCT00716924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520103|NCT00716911||||Supportive Care||||||||
1520104|NCT00716898|||Case Control||Prospective|||||||
1520105|NCT00716885|||Cohort||Prospective|||||||
1520106|NCT00716872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520107|NCT00716859|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520108|NCT00716846|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520109|NCT00716833|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1520110|NCT00716820|||Case-Only||Prospective|||||||
1520111|NCT00716807|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1520112|NCT00716794||Single Group Assignment||Treatment||None (Open Label)||||||
1520113|NCT00716781|||Ecologic or Community||Prospective|||||||
1520114|NCT00716768|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520115|NCT00716755||Single Group Assignment||Treatment||None (Open Label)||||||
1520116|NCT00716742|||Cohort||Prospective|||||||
1520117|NCT00716729|||||Prospective|||||||
1520118|NCT00716716||Single Group Assignment||Treatment||None (Open Label)||||||
1520119|NCT00716703|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1520120|NCT00716690||Single Group Assignment||Treatment||None (Open Label)||||||
1520121|NCT00716677|||Case Control||Cross-Sectional|||||||
1520122|NCT00716664|Randomized|Parallel Assignment||Treatment||Single|||||t|
1520123|NCT00716651||Single Group Assignment||Treatment||None (Open Label)||||||
1520124|NCT00716638|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1520125|NCT00716625|||Case-Only||Prospective|||||||
1520126|NCT00716612|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520127|NCT00716599|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1520128|NCT00716586||Single Group Assignment||Treatment||None (Open Label)||||||
1520129|NCT00716573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520130|NCT00716560|||Case-Only|||||||||
1520131|NCT00716547|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1520132|NCT00716534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520133|NCT00716521|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1520134|NCT00716508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520135|NCT00716495|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1520136|NCT00716482|||Case-Only||Cross-Sectional|||||||
1520137|NCT00716469||Single Group Assignment||Treatment||None (Open Label)||||||
1520138|NCT00716456||Parallel Assignment||Treatment||None (Open Label)||||||
1520139|NCT00716443|Randomized|Single Group Assignment||Treatment||Single||||||t
1520140|NCT00716430|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1520141|NCT00716417|Non-Randomized|||Treatment||None (Open Label)||||||
1520142|NCT00716404|||Case-Only||Prospective|||||||
1520143|NCT00716391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520144|NCT00716378|Randomized|Parallel Assignment||Prevention||Single||||||
1520145|NCT00716365|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520220|NCT00715390|||Cohort||Retrospective|||||||
1520146|NCT00716352|Randomized|Parallel Assignment||Health Services Research||||||||
1520147|NCT00716339|Randomized|Parallel Assignment||Treatment||||||||
1520148|NCT00716326|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520149|NCT00716313||||||||||||
1520150|NCT00716300|||Case Control||Cross-Sectional|||||||
1520151|NCT00716287|||Case-Only||Cross-Sectional|||||||
1520152|NCT00716274|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520153|NCT00716261||Single Group Assignment||Treatment||||||||
1520154|NCT00716248|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520155|NCT00716235|||Case Control||Prospective|||||||
1520156|NCT00716222|||Cohort||Cross-Sectional|||||||
1520157|NCT00716209|||Case-Only||Prospective|||||||
1520158|NCT00716196|||||Prospective|||||||
1520159|NCT00716183|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520160|NCT00716170|||Case-Only||Cross-Sectional|||||||
1520161|NCT00716157|||Case-Only||Prospective|||||||
1520162|NCT00716144|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1520163|NCT00716131|||Case Control||Cross-Sectional|||||||
1520164|NCT00716118|||Cohort||Prospective|||||||
1520165|NCT00716105|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1520166|NCT00716092|Randomized|Parallel Assignment||Treatment||Double||||||
1520167|NCT00716079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520168|NCT00716066||Single Group Assignment||Treatment||None (Open Label)||||||
1520169|NCT00716053|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1520170|NCT00716040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520171|NCT00716027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520172|NCT00716014|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520173|NCT00716001|Randomized|Parallel Assignment||||None (Open Label)||||||
1520174|NCT00715988|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1520175|NCT00715975|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520176|NCT00715962|Randomized|Parallel Assignment||Treatment||Single||||||t
1520177|NCT00715949|||Case-Only||Prospective|||||||
1520178|NCT00715936|Randomized|Factorial Assignment||Prevention||Single||||||t
1520179|NCT00715923|Randomized|Parallel Assignment||||Single|||t|||
1520180|NCT00715910|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520181|NCT00715897|Randomized|Crossover Assignment||Treatment||Single||||||t
1520182|NCT00715884|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520183|NCT00715871||Single Group Assignment||Treatment||None (Open Label)||||||
1520184|NCT00715858|Non-Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1520185|NCT00715845|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520186|NCT00715832|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520187|NCT00715819|||||Prospective|||||||
1520188|NCT00715806|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1520189|NCT00715793||Single Group Assignment||Treatment||None (Open Label)||||||
1520190|NCT00715780|||Cohort||Prospective|||||||
1520191|NCT00715767|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1520192|NCT00715754|||Cohort||Prospective|||||||
1520193|NCT00715741|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1520194|NCT00715728|||Cohort||Prospective|||||||
1520195|NCT00715715|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520196|NCT00715702|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1520197|NCT00715689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520198|NCT00715676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520199|NCT00715663|||Cohort||Prospective|||||||
1520200|NCT00715650|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520201|NCT00715637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520202|NCT00715624|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520203|NCT00715611||Single Group Assignment||Treatment||None (Open Label)||||||
1520204|NCT00715598|||Case Control||Cross-Sectional|||||||
1520205|NCT00715585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520206|NCT00715572|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520207|NCT00715559||Single Group Assignment||Treatment||None (Open Label)||||||
1520208|NCT00715546||Single Group Assignment||Treatment||None (Open Label)||||||
1520209|NCT00715533|||Cohort||Prospective|||||||
1520210|NCT00715520|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1520211|NCT00715507|||||Prospective|||||||
1520212|NCT00715494|Randomized|Parallel Assignment||Treatment||Single||This was a single-site, feasibility, pilot, randomized trial of 21 general medical/surgical intensive care unit survivors (8 controls and 13 intervention patients) with either cognitive or functional impairment at hospital discharge. After discharge, study controls received usual care (sporadic rehabilitation), whereas intervention patients received a combination of in-home cognitive, physical, and functional rehabilitation over a 3-month period via a social worker or master's level psychology technician utilizing telemedicine to allow specialized multidisciplinary treatment. Interventions over 12 wks included six in-person visits for cognitive rehabilitation and six televisits for physical/functional rehabilitation.||||t
1520213|NCT00715481|||Cohort||Prospective|||||||
1520214|NCT00715468|||Case-Crossover||Prospective|||||||
1520215|NCT00715455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520216|NCT00715442||Single Group Assignment||Treatment||None (Open Label)||||||
1520217|NCT00715429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520218|NCT00715416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520219|NCT00715403||||Treatment||||||||
1520221|NCT00715377||Single Group Assignment||Treatment||None (Open Label)||||||
1520222|NCT00715364|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520223|NCT00715351|||||Prospective|||||||
1520224|NCT00715338|||Case-Only||Prospective|||||||
1520225|NCT00715325||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520226|NCT00715312|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1520227|NCT00715299||Single Group Assignment||Treatment||None (Open Label)||||||
1520228|NCT00715286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520229|NCT00715273|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1520230|NCT00715260|||Cohort||Prospective|||||||
1520231|NCT00715247|||Case-Control||Prospective|||||||
1520232|NCT00715234|Randomized|Parallel Assignment||Prevention||Single|||t|||
1520233|NCT00715221|||Case-Control||Prospective|||||||
1520234|NCT00715208|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520235|NCT00715195|Randomized|Parallel Assignment||||None (Open Label)||||||
1520236|NCT00715182||Single Group Assignment||Treatment||None (Open Label)||||||
1520237|NCT00715169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520238|NCT00715156|||Case-Only||Cross-Sectional|||||||
1520239|NCT00715143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520240|NCT00715130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520241|NCT00715117|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520242|NCT00715104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520243|NCT00715091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520244|NCT00715078|Randomized|Parallel Assignment||Treatment||Single|||||t|
1520245|NCT00715065|||Case Control||Prospective|||||||
1520246|NCT00715052|Randomized|Crossover Assignment||Treatment||Single||||||t
1520247|NCT00715039|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1520248|NCT00715026||Single Group Assignment||Treatment||None (Open Label)||||||
1520249|NCT00715013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520250|NCT00715000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520251|NCT00714987|||Case Control||Prospective|||||||
1520252|NCT00714974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520253|NCT00714961|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520254|NCT00714948||Single Group Assignment||Treatment||None (Open Label)||||||
1520255|NCT00714935|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520256|NCT00714922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520257|NCT00714909|||Cohort||Prospective|||||||
1520258|NCT00714896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520259|NCT00714883||Single Group Assignment||Treatment||None (Open Label)||||||
1520260|NCT00714870|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520261|NCT00714857|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1520262|NCT00714844|||Case-Only||Retrospective|||||||
1520263|NCT00714831|Randomized|Parallel Assignment||Prevention||Single||||||t
1520264|NCT00714818|Randomized|Parallel Assignment||||Single|||t|||
1520265|NCT00714805|||Case Control||Cross-Sectional|||||||
1520266|NCT00714792|||Cohort||Prospective|||||||
1520267|NCT00714779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520268|NCT00714766||Single Group Assignment||Basic Science||None (Open Label)||||||
1520269|NCT00714753||Single Group Assignment||Treatment||None (Open Label)||||||
1520270|NCT00714740|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520271|NCT00714727||Single Group Assignment||Treatment||None (Open Label)||||||
1520272|NCT00714714|Randomized|Single Group Assignment||Treatment||Single|||||t|
1520273|NCT00714701|||Cohort||Prospective|||||||
1520274|NCT00714688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520275|NCT00714675|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520276|NCT00714662|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520277|NCT00714649||Parallel Assignment||Treatment||None (Open Label)||||||
1520278|NCT00714636|||Case-Control||Cross-Sectional|||||||
1520279|NCT00714623|||||Prospective|||||||
1520280|NCT00714610|||Case-Only||Cross-Sectional|||||||
1520281|NCT00714597|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520282|NCT00714584|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520283|NCT00714571|Randomized|Parallel Assignment||Treatment||Single||||||
1520284|NCT00714558|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520285|NCT00714545||Single Group Assignment||Treatment||None (Open Label)||||||
1520286|NCT00714532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520287|NCT00714519|Randomized|Single Group Assignment||Treatment||Triple||||t|t|t
1520288|NCT00714506|Randomized|Single Group Assignment||Prevention||Single||||||t
1520289|NCT00714493|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520290|NCT00714480|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1520291|NCT00714467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520292|NCT00714454||||||||||||
1520293|NCT00714441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520294|NCT00714428|||Cohort||Cross-Sectional|||||||
1520295|NCT00714415|||Cohort||Prospective|||||||
1520296|NCT00714402|||Case-Only||Prospective|||||||
1520297|NCT00714389|||Cohort||Prospective|||||||
1520298|NCT00714376||Single Group Assignment||Treatment||None (Open Label)||||||
1520299|NCT00714363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520300|NCT00714350|||||Prospective|||||||
1520301|NCT00714337|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1520302|NCT00714324||||||||||||
1520303|NCT00714311|Randomized|Parallel Assignment||Treatment||Single||||||t
1520304|NCT00714298||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520305|NCT00714285|Randomized|Parallel Assignment||Prevention||Single|||t|||
1520306|NCT00714272||||||||||||
1520307|NCT00714259||Single Group Assignment||Treatment||None (Open Label)||||||
1520308|NCT00714246|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1520309|NCT00714233|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520310|NCT00714220|||Case Control||Cross-Sectional|||||||
1520311|NCT00714207|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520312|NCT00714194|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520313|NCT00714181||||Treatment||None (Open Label)||||||
1520314|NCT00714168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520315|NCT00714155|||Cohort|||||||||
1520316|NCT00714142|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1520317|NCT00714129|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1520318|NCT00714116||Sequential Assignment||Treatment||None (Open Label)||||||
1520319|NCT00714103||Single Group Assignment||Treatment||None (Open Label)||||||
1520320|NCT00714090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520321|NCT00714077|||Cohort||Prospective|||||||
1520322|NCT00714064|Randomized|Parallel Assignment||Prevention||Single||||||t
1520323|NCT00714051|Randomized|Parallel Assignment||Prevention||Single||||||t
1520324|NCT00714038|||||Prospective|||||||
1520325|NCT00714025||Single Group Assignment||Treatment||None (Open Label)||||||
1520326|NCT00714012|||||Prospective|||||||
1520327|NCT00713999||Single Group Assignment||||None (Open Label)||||||
1520328|NCT00713986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520329|NCT00713973|||Cohort||Prospective|||||||
1520330|NCT00713960|||||Prospective|||||||
1520331|NCT00713947|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520332|NCT00713934|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520333|NCT00713921||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520334|NCT00713908|||Cohort||Prospective|||||||
1520335|NCT00713895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520336|NCT00713882|||Cohort||Cross-Sectional|||||||
1520337|NCT00713869|||Case Control||Prospective|||||||
1520338|NCT00713856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520339|NCT00713843|Randomized|Parallel Assignment||Treatment||Single||||||t
1520340|NCT00713830|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520341|NCT00713817|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1520342|NCT00713804|Randomized|Single Group Assignment||||Single|||t|||
1520343|NCT00713791|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1520344|NCT00713778|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520345|NCT00713765|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1520346|NCT00713752|||Cohort||Prospective|||||||
1520347|NCT00713739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520348|NCT00713726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520349|NCT00713713|Randomized|Crossover Assignment||||Single||||||t
1520350|NCT00713700||Single Group Assignment||Treatment||None (Open Label)||||||
1520351|NCT00713687|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520352|NCT00713674|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520353|NCT00713661||Single Group Assignment||Treatment||None (Open Label)||||||
1520354|NCT00713648|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1520355|NCT00713635|||Cohort||Prospective|||||||
1520356|NCT00713622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520357|NCT00713609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520358|NCT00713596|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1520359|NCT00713583|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520360|NCT00713570|||Cohort||Retrospective|||||||
1520361|NCT00713557|||Cohort||Prospective|||||||
1520362|NCT00713544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520363|NCT00713531|||Cohort||Prospective|||||||
1520364|NCT00713518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520365|NCT00713505|Randomized|||||||||||
1520366|NCT00713492|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520367|NCT00713479|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520368|NCT00713466|||Cohort||Prospective|||||||
1520369|NCT00713453|||Case-Only|||||||||
1520370|NCT00713440|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1520371|NCT00713427||Single Group Assignment||Treatment||None (Open Label)||||||
1520372|NCT00713414|||Cohort||Prospective|||||||
1520373|NCT00713401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520374|NCT00713375|||Cohort||Prospective|||||||
1520375|NCT00713362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520376|NCT00713349|Randomized|Single Group Assignment||Treatment||Single|||||t|
1520377|NCT00713336|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1520378|NCT00713323||Single Group Assignment||Supportive Care||None (Open Label)||||||
1520379|NCT00713310|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520380|NCT00713297|||Ecologic or Community||Prospective|||||||
1520381|NCT00713284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520382|NCT00713271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520383|NCT00713258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520384|NCT00713245|||Case-Only||Prospective|||||||
1520385|NCT00713232|||Cohort||Cross-Sectional|||||||
1520386|NCT00713219||Single Group Assignment||Treatment||None (Open Label)||||||
1520387|NCT00713206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520388|NCT00713193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520389|NCT00713180|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1520390|NCT00713167|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520391|NCT00713154|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1520392|NCT00713141|||Case Control||Cross-Sectional|||||||
1520393|NCT00713128|||Case-Only||Prospective|||||||
1520394|NCT00713115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520395|NCT00713102|||Case-Only||Retrospective|||||||
1520396|NCT00713089|||Ecologic or Community||Prospective|||||||
1520397|NCT00713076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520398|NCT00713063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520399|NCT00713050|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1520400|NCT00713037||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520401|NCT00713024|||Cohort||Cross-Sectional|||||||
1520402|NCT00713011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520403|NCT00712998|||Case Control||Prospective|||||||
1520404|NCT00712985||Single Group Assignment||Prevention||None (Open Label)||||||
1520405|NCT00712972|||Cohort||Prospective|||||||
1520406|NCT00712959|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520407|NCT00712946|||Case Control||Prospective|||||||
1520408|NCT00712933|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520409|NCT00712920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520410|NCT00712907|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1520411|NCT00712894|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1520412|NCT00712881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520413|NCT00712868||Single Group Assignment||Treatment||None (Open Label)||||||
1520414|NCT00712855||Single Group Assignment||Treatment||None (Open Label)||||||
1520415|NCT00712842|||Cohort||Prospective|||||||
1520416|NCT00712829|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1520417|NCT00712816|Randomized|Parallel Assignment||Treatment||Single||||||t
1520418|NCT00712803|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1520419|NCT00712790||Single Group Assignment||Treatment||None (Open Label)||||||
1520420|NCT00712777||Parallel Assignment||Diagnostic||None (Open Label)||||||
1520421|NCT00712764|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1520422|NCT00712751|||Cohort||Prospective|||||||
1520423|NCT00712738|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520424|NCT00712725|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520425|NCT00712712|Non-Randomized|||Supportive Care||||||||
1520426|NCT00712699|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1520427|NCT00712686|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520428|NCT00712673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520429|NCT00712660|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520430|NCT00712647|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520431|NCT00712634|Randomized|||Treatment||Double||||||
1520432|NCT00712621|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520433|NCT00712608|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1520434|NCT00712595|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520435|NCT00712582|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520436|NCT00712569|||Case-Crossover||Prospective|||||||
1520437|NCT00712556|||Cohort||Retrospective|||||||
1520438|NCT00712543|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520439|NCT00712530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520440|NCT00712517|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520441|NCT00712504|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520442|NCT00712491|Randomized|Parallel Assignment||Treatment||Single||||||t
1520443|NCT00712478|||Cohort||Prospective|||||||
1520444|NCT00712465|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520445|NCT00712452|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1520446|NCT00712439|Randomized|Parallel Assignment||Treatment||Double||||||
1520447|NCT00712426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520448|NCT00712413||Single Group Assignment||Treatment||None (Open Label)||||||
1520449|NCT00712400|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1520450|NCT00712387|Randomized|Parallel Assignment||||Single||||||t
1520451|NCT00712374|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1520452|NCT00712361||Single Group Assignment||Screening||Single|||||t|
1520453|NCT00712348||Single Group Assignment||Treatment||None (Open Label)||||||
1520454|NCT00712335|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1520455|NCT00712322|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520456|NCT00712309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520457|NCT00712296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520458|NCT00712283|Randomized|Parallel Assignment||||Triple|||t||t|t
1520459|NCT00712270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520460|NCT00712257||Single Group Assignment||Treatment||None (Open Label)||||||
1520461|NCT00712244|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520462|NCT00712231|||Cohort||Prospective|||||||
1520463|NCT00712218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520464|NCT00712205|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520465|NCT00712192||Single Group Assignment||Basic Science||None (Open Label)||||||
1520466|NCT00712179|||||Cross-Sectional|||||||
1520467|NCT00712166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520468|NCT00712153|||Case-Only||Prospective|||||||
1520469|NCT00712140|Randomized|||Treatment||||||||
1520470|NCT00712127|Randomized|Parallel Assignment||Treatment||Single||||||t
1520471|NCT00712114|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520472|NCT00712101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520473|NCT00712088|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520474|NCT00712075|Randomized|Parallel Assignment||Treatment||Single||||||t
1520475|NCT00712062||Single Group Assignment||Treatment||None (Open Label)||||||
1520476|NCT00712049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520477|NCT00712036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520478|NCT00712023|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520479|NCT00712010|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1520480|NCT00711997||Single Group Assignment||Treatment||None (Open Label)||||||
1520481|NCT00711984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520482|NCT00711971|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1520483|NCT00711958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520484|NCT00711945|||Cohort||Prospective|||||||
1520485|NCT00711932|||Cohort||Cross-Sectional|||||||
1520486|NCT00711919|Randomized|Parallel Assignment||Treatment||Single||||||t
1520487|NCT00711906|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520488|NCT00711893|||Cohort||Prospective|||||||
1520489|NCT00711880|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1520490|NCT00711867|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520491|NCT00711854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520492|NCT00711841|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520493|NCT00711828||Single Group Assignment||Treatment||None (Open Label)||||||
1520494|NCT00711815|||Cohort||Prospective|||||||
1520495|NCT00711802|Randomized|Parallel Assignment||Treatment||Single||||||t
1520496|NCT00711789|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520497|NCT00711776|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520498|NCT00711763|||||Prospective|||||||
1520499|NCT00711750|||Case-Only||Retrospective|||||||
1520500|NCT00711737|||Case-Only||Prospective|||||||
1520501|NCT00711724|||Case-Only||Cross-Sectional|||||||
1520502|NCT00711711|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1520503|NCT00711698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520504|NCT00711685|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520505|NCT00711672|||Cohort||Prospective|||||||
1520506|NCT00711659|||Cohort||Prospective|||||||
1520507|NCT00711646|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1520508|NCT00711633|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1520509|NCT00711620|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1520510|NCT00711607|Randomized|Parallel Assignment||||Double|||t||t|
1520511|NCT00711594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520512|NCT00711581||Single Group Assignment||Treatment||None (Open Label)||||||
1520513|NCT00711568|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1520514|NCT00711555|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1520515|NCT00711542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520516|NCT00711529|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520517|NCT00711516|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520518|NCT00711503|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520519|NCT00711490||Single Group Assignment||Treatment||None (Open Label)||||||
1520520|NCT00711477|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1520521|NCT00711464|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1520522|NCT00711451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520523|NCT00711438|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1520524|NCT00711425|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520525|NCT00711412||Single Group Assignment||Treatment||None (Open Label)||||||
1520526|NCT00711399|||Case Control||Prospective|||||||
1520527|NCT00711386|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1520528|NCT00711373||Single Group Assignment||Treatment||None (Open Label)||||||
1520529|NCT00711360||Single Group Assignment||Supportive Care||None (Open Label)||||||
1520530|NCT00711347|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520531|NCT00711321|||||Prospective|||||||
1520532|NCT00711308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520533|NCT00711295|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520534|NCT00711282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520535|NCT00711269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520536|NCT00711256|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1520537|NCT00711243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520538|NCT00711230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520539|NCT00711217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520540|NCT00711204|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1520541|NCT00711191|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520542|NCT00711178|Randomized|Parallel Assignment||Treatment||Single||||||t
1520543|NCT00711165|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520544|NCT00711152|Randomized|Parallel Assignment||||None (Open Label)||||||
1520545|NCT00711139|||||Prospective|||||||
1520546|NCT00711126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520547|NCT00711113|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520548|NCT00711100|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)|Open label trial|||||
1520549|NCT00711087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520550|NCT00711074||Single Group Assignment||Basic Science||None (Open Label)||||||
1520551|NCT00711061|||Case Control||Prospective|||||||
1520552|NCT00711048|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1520553|NCT00711035||Single Group Assignment||Treatment||None (Open Label)||||||
1520554|NCT00711022||Single Group Assignment||Treatment||None (Open Label)||||||
1520555|NCT00711009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520556|NCT00710996|||Cohort||Cross-Sectional|||||||
1520557|NCT00710983|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520558|NCT00710970||Single Group Assignment||Treatment||None (Open Label)||||||
1520559|NCT00710957|||Cohort||Prospective|||||||
1520560|NCT00710944|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520561|NCT00710931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520562|NCT00710905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520563|NCT00710892||Single Group Assignment||Treatment||None (Open Label)||||||
1520564|NCT00710879|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520565|NCT00710866|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1520566|NCT00710853|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1520567|NCT00710840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520568|NCT00710827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520569|NCT00710814|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1520570|NCT00710801|||Cohort||Prospective|||||||
1520571|NCT00710788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520572|NCT00710775|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1520573|NCT00710762||Parallel Assignment||Prevention||||||||
1520574|NCT00710749|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1520575|NCT00710736||Single Group Assignment||Treatment||None (Open Label)||||||
1520576|NCT00710723|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520577|NCT00710710||Parallel Assignment||Treatment||||||||
1520578|NCT00710697||Single Group Assignment||Treatment||None (Open Label)||||||
1520579|NCT00710684|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520580|NCT00710671|||Case-Only||Cross-Sectional|||||||
1520581|NCT00710658|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520582|NCT00710645|||Cohort||Prospective|||||||
1520583|NCT00710632||||Supportive Care||||||||
1520584|NCT00710619|||Case-Only||Prospective|||||||
1520585|NCT00710606|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1520586|NCT00710593|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520587|NCT00710580|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520588|NCT00710567||Single Group Assignment||Treatment||None (Open Label)||||||
1520589|NCT00710554|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1520590|NCT00710541|Randomized|Parallel Assignment||Treatment||Single||||||t
1520591|NCT00710528||Single Group Assignment||Treatment||None (Open Label)||||||
1520592|NCT00710515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520593|NCT00710502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520594|NCT00710489|||Other||Other|||||||
1520595|NCT00710476|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520596|NCT00710463|||Cohort|||||||||
1520597|NCT00710450|||Case-Only||Prospective|||||||
1520598|NCT00710437|||Case-Control||Retrospective|||||||
1520599|NCT00710424|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1520600|NCT00710411|||Case Control||Prospective|||||||
1520601|NCT00710398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520602|NCT00710385|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1520603|NCT00710372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520604|NCT00710359|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1520605|NCT00710346|||||Prospective|||||||
1520606|NCT00710333|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1520607|NCT00710320|||Cohort||Prospective|||||||
1520608|NCT00710307|||Cohort||Cross-Sectional|||||||
1520609|NCT00710294|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520610|NCT00710281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520611|NCT00710268|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520612|NCT00710255|||Cohort||Prospective|||||||
1520613|NCT00710242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520614|NCT00710229|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1520615|NCT00710216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520616|NCT00710203|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1520617|NCT00710190||Single Group Assignment||Treatment||None (Open Label)||||||
1520618|NCT00710177|||Case-Control||Prospective|||||||
1520619|NCT00710164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520620|NCT00710151|||Cohort||Prospective|||||||
1520621|NCT00710138|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1520622|NCT00710125||Single Group Assignment||Treatment||None (Open Label)||||||
1520623|NCT00710112|||Cohort||Prospective|||||||
1520624|NCT00710099|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520625|NCT00710086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520626|NCT00710073||Single Group Assignment||Treatment||None (Open Label)||||||
1520627|NCT00710060|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1520628|NCT00710047|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1520629|NCT00710034|Randomized|Parallel Assignment||Treatment||None (Open Label)|This was an open label trial.|||||
1520630|NCT00710021|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520631|NCT00710008|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1520632|NCT00709995|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520633|NCT00709982|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520634|NCT00709969||Single Group Assignment||Treatment||None (Open Label)||||||
1520635|NCT00709956|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520636|NCT00709930|Randomized|Parallel Assignment||||Double|||t||t|
1520637|NCT00709917|||||Prospective|||||||
1520638|NCT00709904|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520639|NCT00709891||Single Group Assignment||Diagnostic||Triple|||t||t|t
1520640|NCT00709878|||Cohort||Retrospective|||||||
1520641|NCT00709865|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520642|NCT00709852|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1520643|NCT00709839|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1520644|NCT00709826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520645|NCT00709813|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1520646|NCT00709800|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1520647|NCT00709787|||Case-Only||Prospective|||||||
1520648|NCT00709774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520649|NCT00709761||Single Group Assignment||Treatment||None (Open Label)||||||
1520650|NCT00709748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520651|NCT00709735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520652|NCT00709722||Single Group Assignment||Treatment||None (Open Label)||||||
1520653|NCT00709709||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520654|NCT00709696|Randomized|Parallel Assignment||Other||Double|||t||t|
1520655|NCT00709683|||Cohort||Prospective|||||||
1520656|NCT00709670||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520657|NCT00709657|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1520658|NCT00709644|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1520659|NCT00709631|||Cohort||Prospective|||||||
1520660|NCT00709618|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520661|NCT00709605|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520662|NCT00709592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520663|NCT00709579|Randomized|Parallel Assignment||||Double|||t||t|
1520664|NCT00709566|Randomized|Parallel Assignment||Treatment||Single|||||t|
1520665|NCT00709553|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1520666|NCT00709540|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1520667|NCT00709527|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520668|NCT00709514|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520669|NCT00709501|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1520670|NCT00709488||Single Group Assignment||Treatment||None (Open Label)||||||
1520671|NCT00709475|||Cohort||Prospective|||||||
1520672|NCT00709462|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520673|NCT00709449|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520674|NCT00709436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520675|NCT00709423|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520676|NCT00709410||Single Group Assignment||Prevention||None (Open Label)||||||
1520677|NCT00709397|||Cohort||Prospective|||||||
1520678|NCT00709384||Single Group Assignment||Treatment||None (Open Label)||||||
1520679|NCT00709371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520680|NCT00709358|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1520681|NCT00709345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520682|NCT00709332|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520683|NCT00709319|||Cohort||Prospective|||||||
1520684|NCT00709306|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1520685|NCT00709293|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520686|NCT00709280|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520687|NCT00709267|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1520688|NCT00709254|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520689|NCT00709241|||Cohort||Prospective|||||||
1520690|NCT00709228|||Cohort||Prospective|||||||
1520691|NCT00709215||Single Group Assignment||Treatment||None (Open Label)||||||
1520692|NCT00709202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520693|NCT00709189|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1520694|NCT00709176|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520695|NCT00709163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520696|NCT00709150|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1520697|NCT00709137|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520698|NCT00709124|Randomized|Parallel Assignment||Prevention||Single||||||t
1520699|NCT00709111||Single Group Assignment||Treatment||None (Open Label)||||||
1520700|NCT00709098|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520701|NCT00709085|||Case Control||Retrospective|||||||
1520702|NCT00709072|Randomized|Parallel Assignment||Prevention||Single||||||t
1520703|NCT00709059|||Case-Only||Prospective|||||||
1520704|NCT00709046|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520705|NCT00709033||Single Group Assignment||Treatment||None (Open Label)||||||
1520706|NCT00709020||Single Group Assignment||Treatment||None (Open Label)||||||
1520707|NCT00709007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520708|NCT00708994|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1520709|NCT00708981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520710|NCT00708968|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520711|NCT00708955|||||Other|||||||
1520712|NCT00708942|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520713|NCT00708929|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1520714|NCT00708916||Single Group Assignment||Treatment||None (Open Label)||||||
1520715|NCT00708903|Randomized|Crossover Assignment||Treatment||Double||||||
1520716|NCT00708890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520717|NCT00708877||Single Group Assignment||Treatment||None (Open Label)||||||
1520718|NCT00708851|Randomized|Single Group Assignment||Treatment||Single|||||t|
1520719|NCT00708838|||Case-Only||Prospective|||||||
1520720|NCT00708825|||Cohort||Retrospective|||||||
1520721|NCT00708812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520722|NCT00708799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520723|NCT00708786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520724|NCT00708773||Single Group Assignment||Treatment||None (Open Label)||||||
1520725|NCT00708760|||Case-Crossover||Prospective|||||||
1520726|NCT00708747|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520727|NCT00708734||Single Group Assignment||Treatment||None (Open Label)||||||
1520728|NCT00708721||Single Group Assignment||Treatment||None (Open Label)||||||
1520729|NCT00708708|||Cohort||Prospective|||||||
1520730|NCT00708695|||Cohort||Retrospective|||||||
1520731|NCT00708682|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1520732|NCT00708669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520733|NCT00708656|Randomized|Parallel Assignment||Treatment||Single||||||t
1520734|NCT00708643|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520735|NCT00708630|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1520736|NCT00708617|||Case-Only||Prospective|||||||
1520737|NCT00708604|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520738|NCT00708591||Single Group Assignment||Treatment||None (Open Label)||||||
1520739|NCT00708578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520740|NCT00708565|Randomized|Crossover Assignment||Basic Science||Double|||||t|t
1520741|NCT00708552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520742|NCT00708539|Randomized|Parallel Assignment||Treatment||Single||||||t
1520743|NCT00708526|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1520744|NCT00708513|||Case-Only||Prospective|||||||
1520745|NCT00708500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520746|NCT00708487|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1520747|NCT00708474|Randomized|Parallel Assignment||Treatment||Single||||||t
1520748|NCT00708461|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520749|NCT00708448||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520750|NCT00708435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520751|NCT00708422|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1520752|NCT00708409|||||Prospective|||||||
1520753|NCT00708396||Single Group Assignment||Treatment||None (Open Label)||||||
1520754|NCT00708383|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1520755|NCT00708370|Randomized|Parallel Assignment||||None (Open Label)||||||
1520756|NCT00708357|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1520757|NCT00708344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520758|NCT00708331||Single Group Assignment||Treatment||None (Open Label)||||||
1520759|NCT00708318|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520760|NCT00708305|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1520761|NCT00708292|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520762|NCT00708279||Single Group Assignment||Treatment||None (Open Label)||||||
1520763|NCT00708266|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1520764|NCT00708253|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1520765|NCT00708240||Single Group Assignment||Treatment||None (Open Label)||||||
1520766|NCT00708227|||Case-Crossover||Prospective|||||||
1520767|NCT00708214|Non-Randomized|||Treatment||None (Open Label)||||||
1520768|NCT00708201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522103|NCT00690469||||||||||||
1520769|NCT00708188||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520770|NCT00708175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520771|NCT00708162|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520772|NCT00708149|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1520773|NCT00708136|Randomized|Parallel Assignment||Prevention||Single||||||t
1520774|NCT00708123|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1520775|NCT00708110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520776|NCT00708097|Randomized|Crossover Assignment||Treatment||Single|||||t|
1520777|NCT00708084|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520778|NCT00708071|Randomized|Single Group Assignment||Treatment||Single||||||t
1520779|NCT00708058|||||Prospective|||||||
1520780|NCT00708045||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520781|NCT00708032|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520782|NCT00708019|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520783|NCT00708006||Single Group Assignment||Treatment||None (Open Label)||||||
1520784|NCT00707993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520785|NCT00707980||Single Group Assignment||Treatment||None (Open Label)||||||
1520786|NCT00707967|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1520787|NCT00707954|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520788|NCT00707941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520789|NCT00707928|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1520790|NCT00707915||Single Group Assignment||Treatment||None (Open Label)||||||
1520791|NCT00707902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520792|NCT00707889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520793|NCT00707876|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1520794|NCT00707863|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520795|NCT00707850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520796|NCT00707837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520797|NCT00707824|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1520798|NCT00707811|||Cohort||Prospective|||||||
1520799|NCT00707798|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1520800|NCT00707785|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520801|NCT00707772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520802|NCT00707759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520803|NCT00707746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520804|NCT00707720|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520805|NCT00707707||Single Group Assignment||Treatment||None (Open Label)||||||
1520806|NCT00707694|||Case Control||Prospective|||||||
1520807|NCT00707681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520808|NCT00707668|||Cohort||Prospective|||||||
1520809|NCT00707655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520810|NCT00707642|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1520811|NCT00707629|||Cohort||Cross-Sectional|||||||
1520812|NCT00707616|||Cohort||Cross-Sectional|||||||
1520813|NCT00707603|||Case Control||Cross-Sectional|||||||
1520814|NCT00707590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520815|NCT00707577|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520816|NCT00707564||Single Group Assignment||Treatment||None (Open Label)||||||
1520817|NCT00707551|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520818|NCT00707538||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520819|NCT00707525|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1520820|NCT00707512|||Cohort||Prospective|||||||
1520821|NCT00707499||Single Group Assignment||Diagnostic||Single|||t|||
1520822|NCT00707486|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520823|NCT00707473||Single Group Assignment||Treatment||None (Open Label)||||||
1520824|NCT00707460|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520825|NCT00707447|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520826|NCT00707434||Single Group Assignment||Supportive Care||None (Open Label)||||||
1520827|NCT00707421|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1520828|NCT00707408||Single Group Assignment||Treatment||None (Open Label)||||||
1520829|NCT00707382|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1520830|NCT00707369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520831|NCT00707356||Single Group Assignment||Treatment||None (Open Label)||||||
1520832|NCT00707343||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520833|NCT00707330|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1520834|NCT00707317|||Cohort||Prospective|||||||
1520835|NCT00707304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520836|NCT00707291|||Case-Only||Prospective|||||||
1520837|NCT00707278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520838|NCT00707265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520839|NCT00707252||Single Group Assignment||Treatment||None (Open Label)||||||
1520840|NCT00707239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520841|NCT00707226|||Case Control||Prospective|||||||
1520842|NCT00707213||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520843|NCT00707200|||Case Control||Prospective|||||||
1520844|NCT00707187|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1520845|NCT00707174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520846|NCT00707161||Single Group Assignment||Treatment||None (Open Label)||||||
1520847|NCT00707148|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1520848|NCT00707135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520849|NCT00707122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520850|NCT00707083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520851|NCT00707070|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520852|NCT00707057|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520853|NCT00707044|Randomized|Single Group Assignment||Treatment||Single|||t|||
1520854|NCT00707031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520855|NCT00707018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520856|NCT00707005|||||Prospective|||||||
1520857|NCT00706992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520858|NCT00706979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520859|NCT00706966||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520860|NCT00706953|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520861|NCT00706940|||Case-Only||Prospective|||||||
1520862|NCT00706927|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1520863|NCT00706914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520864|NCT00706901|Randomized|Parallel Assignment||Treatment||Single||||||t
1520865|NCT00706888|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1520866|NCT00706875|||Cohort||Retrospective|||||||
1520867|NCT00706862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520868|NCT00706849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520869|NCT00706836|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1520870|NCT00706823|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520871|NCT00706810||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1520872|NCT00706797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520873|NCT00706784||Single Group Assignment||Treatment||None (Open Label)||||||
1520874|NCT00706771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520875|NCT00706758|Randomized|Parallel Assignment||Treatment||Single||||||t
1520876|NCT00706745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520877|NCT00706732|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520878|NCT00706719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520879|NCT00706706|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520880|NCT00706693|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520881|NCT00706680||Single Group Assignment||Prevention||None (Open Label)||||||
1520882|NCT00706667|Randomized|Parallel Assignment||Treatment||Single|||t|||
1520883|NCT00706654|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520884|NCT00706641||Single Group Assignment||Treatment||None (Open Label)||||||
1520885|NCT00706628||Parallel Assignment||Treatment||||||||
1520886|NCT00706615|Non-Randomized|||Treatment||None (Open Label)||||||
1520887|NCT00706602|||Cohort||Prospective|||||||
1520888|NCT00706589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520889|NCT00706576||Single Group Assignment||Treatment||None (Open Label)||||||
1520890|NCT00706563|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520891|NCT00706550|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1520892|NCT00706537|Randomized|Single Group Assignment||Basic Science||Triple|||t|t|t|
1520893|NCT00706511|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520894|NCT00706498||Single Group Assignment||Treatment||||||||
1520895|NCT00706485||Single Group Assignment||Treatment||None (Open Label)||||||
1520896|NCT00706459|||Case Control||Prospective|||||||
1520897|NCT00706446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520898|NCT00706433|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1520899|NCT00706420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520900|NCT00706407||Single Group Assignment||Diagnostic||None (Open Label)||||||
1520901|NCT00706394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520902|NCT00706381|Randomized|Crossover Assignment||Other||||||||
1520903|NCT00706368|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1520904|NCT00706355||Single Group Assignment||Treatment||None (Open Label)||||||
1520905|NCT00706342||Single Group Assignment||Treatment||None (Open Label)||||||
1520906|NCT00706329||Single Group Assignment||Treatment||None (Open Label)||||||
1520907|NCT00706316||Single Group Assignment||||None (Open Label)||||||
1520908|NCT00706303|Randomized|Parallel Assignment||Treatment||Single||||||t
1520909|NCT00706290|Randomized|Parallel Assignment||Treatment||Single||||||t
1520910|NCT00706277|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1520911|NCT00706264|Randomized|Parallel Assignment||Prevention||Single||||||t
1520912|NCT00706251|||Cohort||Retrospective|||||||
1520913|NCT00706238||Single Group Assignment||Treatment||None (Open Label)||||||
1520914|NCT00706225|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1520915|NCT00706212|||Cohort||Prospective|||||||
1520916|NCT00706199||||||||||||
1520917|NCT00706186||Single Group Assignment||Treatment||None (Open Label)||||||
1520918|NCT00706173|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1520919|NCT00706160|||||Prospective|||||||
1520920|NCT00706147|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520921|NCT00706134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520922|NCT00706121|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520923|NCT00706108||||||||||||
1520924|NCT00706095|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520925|NCT00706082|||Cohort||Prospective|||||||
1520926|NCT00706069|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520927|NCT00706056|||Cohort||Prospective|||||||
1520928|NCT00706043|||Cohort||Prospective|||||||
1520929|NCT00706030|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1520930|NCT00706017|||Cohort||Prospective|||||||
1520931|NCT00706004|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520932|NCT00705991|||||Prospective|||||||
1520933|NCT00705978|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520934|NCT00705965|Randomized|Parallel Assignment||Treatment||Single||||||t
1520935|NCT00705952||Single Group Assignment||Treatment||None (Open Label)||||||
1520936|NCT00705939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520937|NCT00705926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520938|NCT00705913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520939|NCT00705900|Randomized|Parallel Assignment||Treatment||Single|||||t|
1520940|NCT00705887|Randomized|Parallel Assignment||Prevention||Single|||t|||
1520941|NCT00705874|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520942|NCT00705861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520943|NCT00705848|||Case-Control||Prospective|||||||
1520944|NCT00705835|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520945|NCT00705822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520946|NCT00705809|||||Prospective|||||||
1520947|NCT00705796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520948|NCT00705783|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520949|NCT00705770|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1520950|NCT00705757|Randomized|Parallel Assignment||Treatment||Single||||||t
1520951|NCT00705744||Single Group Assignment||Supportive Care||None (Open Label)||||||
1520952|NCT00705731|||Cohort||Prospective|||||||
1520953|NCT00705718|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520954|NCT00705705|Randomized|Parallel Assignment||||None (Open Label)||||||
1520955|NCT00705692|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1520956|NCT00705679|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1520957|NCT00705666|||Cohort||Prospective|||||||
1520958|NCT00705653||Single Group Assignment||Treatment||None (Open Label)||||||
1520959|NCT00705640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520960|NCT00705627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520961|NCT00705614|||Cohort||Prospective|||||||
1520962|NCT00705601|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1520963|NCT00705588|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520964|NCT00705575|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1520965|NCT00705562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520966|NCT00705549|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520967|NCT00705536|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1520968|NCT00705523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520969|NCT00705510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520970|NCT00705497||Single Group Assignment||Treatment||None (Open Label)||||||
1520971|NCT00705484|||Cohort||Prospective|||||||
1520972|NCT00705471|||Cohort||Retrospective|||||||
1520973|NCT00705458|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1520974|NCT00705445|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1520975|NCT00705432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520976|NCT00705419|||Cohort||Prospective|||||||
1520977|NCT00705406|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520978|NCT00705380|Randomized|Parallel Assignment||Treatment||Single||||||t
1520979|NCT00705367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1520980|NCT00705354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1520981|NCT00705341|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1520982|NCT00705328|Randomized|Factorial Assignment||Health Services Research||Single|||||t|
1520983|NCT00705315|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520984|NCT00705302|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1520985|NCT00705289|||Cohort||Prospective|||||||
1520986|NCT00705276||Single Group Assignment||Supportive Care||None (Open Label)||||||
1520987|NCT00705263|||Cohort||Prospective|||||||
1520988|NCT00705250||Single Group Assignment||Treatment||None (Open Label)||||||
1520989|NCT00705237|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1520990|NCT00705224|||Cohort||Prospective|||||||
1520991|NCT00705211|||||Prospective|||||||
1520992|NCT00705198|||Cohort||Prospective|||||||
1520993|NCT00705185|||Case Control||Prospective|||||||
1520994|NCT00705172|||||Retrospective|||||||
1520995|NCT00705159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1520996|NCT00705146|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1520997|NCT00705133||Single Group Assignment||Treatment||None (Open Label)||||||
1520998|NCT00705120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1520999|NCT00705107|||Case-Only||Prospective|||||||
1521000|NCT00705094|||Case Control||Prospective|||||||
1521001|NCT00705081|||Cohort||Prospective|||||||
1521002|NCT00705055|||Cohort||Prospective|||||||
1521003|NCT00705042|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1521004|NCT00705016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521005|NCT00705003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521006|NCT00704990||Single Group Assignment||Treatment||None (Open Label)||||||
1521007|NCT00704977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521008|NCT00704964|||Case-Only||Prospective|||||||
1521009|NCT00704951|||Cohort||Prospective|||||||
1521010|NCT00704938|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521011|NCT00704925||||||||||||
1521012|NCT00704912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521013|NCT00704899|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521014|NCT00704886|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1521015|NCT00704860||Single Group Assignment||Treatment||None (Open Label)||||||
1521016|NCT00704847|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521017|NCT00704834|||Cohort||Prospective|||||||
1521018|NCT00704821|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521019|NCT00704808|||Cohort||Prospective|||||||
1521020|NCT00704795|||Case Control|||||||||
1521021|NCT00704782||Single Group Assignment||Treatment||None (Open Label)||||||
1521022|NCT00704769|||Cohort||Prospective|||||||
1521023|NCT00704756|||Case-Only|||||||||
1521024|NCT00704743|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521025|NCT00704730|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521026|NCT00704717|||Case-Only||Prospective|||||||
1521027|NCT00704704||Single Group Assignment||Treatment||None (Open Label)||||||
1521028|NCT00704691||Single Group Assignment||Treatment||None (Open Label)||||||
1521029|NCT00704678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521030|NCT00704665|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521031|NCT00704652|||Case Control||Prospective|||||||
1521032|NCT00704639||Single Group Assignment||Treatment||None (Open Label)||||||
1521033|NCT00704626|||Cohort||Prospective|||||||
1521034|NCT00704613|||Case-Only||Prospective|||||||
1521035|NCT00704600||Single Group Assignment||Treatment||None (Open Label)||||||
1521036|NCT00704587|||Case Control||Prospective|||||||
1521037|NCT00704574|||Case-Only||Prospective|||||||
1521038|NCT00704561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521039|NCT00704548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521040|NCT00704535|||Cohort||Prospective|||||||
1521041|NCT00704522|||Cohort||Prospective|||||||
1521042|NCT00704509|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521043|NCT00704496|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521044|NCT00704483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521045|NCT00704470|Randomized|Parallel Assignment||||Single|||t|||
1521046|NCT00704457|||Case Control||Prospective|||||||
1521047|NCT00704444|||||Prospective|||||||
1521048|NCT00704431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521049|NCT00704418|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521050|NCT00704405|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521051|NCT00704392||Single Group Assignment||Treatment||None (Open Label)||||||
1521052|NCT00704379|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1521053|NCT00704366||Single Group Assignment||Treatment||None (Open Label)||||||
1521054|NCT00704353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521055|NCT00704340|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521056|NCT00704327|||Case-Only||Cross-Sectional|||||||
1521057|NCT00704314|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1521058|NCT00704301|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521059|NCT00704288||Single Group Assignment||Treatment||None (Open Label)||||||
1521060|NCT00704275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521061|NCT00704262||Single Group Assignment||Treatment||None (Open Label)||||||
1521062|NCT00704249|Randomized|Parallel Assignment||||None (Open Label)||||||
1521063|NCT00704236|Randomized|Parallel Assignment||Treatment||Double||||||
1521064|NCT00704223|||Cohort||Prospective|||||||
1521065|NCT00704210|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1521066|NCT00704197|||Case Control||Cross-Sectional|||||||
1521067|NCT00704184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521068|NCT00704171|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521069|NCT00704158||Single Group Assignment||Treatment||None (Open Label)||||||
1521070|NCT00704145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521071|NCT00704132|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521072|NCT00704119||Single Group Assignment||||None (Open Label)||||||
1521073|NCT00704106|||Cohort|||||||||
1521074|NCT00704093||Single Group Assignment||Basic Science||Single|||||t|
1521075|NCT00704080||Single Group Assignment||Treatment||None (Open Label)||||||
1521076|NCT00704067|Randomized|Parallel Assignment||Treatment||Single||||||t
1521077|NCT00704054||Single Group Assignment||Treatment||None (Open Label)||||||
1521078|NCT00704028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521079|NCT00704015|Randomized|Parallel Assignment||Prevention||Single||||||t
1521080|NCT00704002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521081|NCT00703989|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521082|NCT00703976|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1521083|NCT00703963|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1521084|NCT00703950|Randomized|Single Group Assignment||Supportive Care||Single||||t||
1521085|NCT00703937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521086|NCT00703924|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521087|NCT00703911|||||Prospective|||||||
1521088|NCT00703898|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521089|NCT00703885|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1521090|NCT00703872|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521091|NCT00703859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521092|NCT00703846||Single Group Assignment||Treatment||None (Open Label)||||||
1521093|NCT00703833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521094|NCT00703820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521095|NCT00703807||Single Group Assignment||Treatment||None (Open Label)||||||
1521096|NCT00703794|||Other||Prospective|||||||
1521097|NCT00703781|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521098|NCT00703768|||Case-Only||Prospective|||||||
1521099|NCT00703755|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1521100|NCT00703742|Non-Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1521101|NCT00703729|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521102|NCT00703716|||Cohort||Prospective|||||||
1521103|NCT00703703|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521104|NCT00703690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521105|NCT00703677|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521106|NCT00703664||Single Group Assignment||Treatment||None (Open Label)||||||
1521107|NCT00703651|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521108|NCT00703638||Single Group Assignment||Treatment||None (Open Label)||||||
1521109|NCT00703625|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521110|NCT00703612||Single Group Assignment||Treatment||None (Open Label)||||||
1521111|NCT00703599||Single Group Assignment||Treatment||None (Open Label)||||||
1521112|NCT00703586|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521113|NCT00703573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521114|NCT00703560|||Cohort||Prospective|||||||
1521115|NCT00703547|Randomized|Crossover Assignment||Prevention||||||||
1521116|NCT00703534|Randomized|Parallel Assignment||||Double|||t||t|
1521117|NCT00703521|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521118|NCT00703508||Single Group Assignment||Treatment||None (Open Label)||||||
1521119|NCT00703495|||Case-Crossover||Cross-Sectional|||||||
1521120|NCT00703482|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521121|NCT00703469|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1521122|NCT00703456|Randomized|Parallel Assignment||||Single|||t|||
1521123|NCT00703443|||Family-Based||Retrospective|||||||
1521124|NCT00703430||Single Group Assignment||Treatment||Single||||||t
1521125|NCT00703417|||Case Control||Prospective|||||||
1521126|NCT00703404|||||Prospective|||||||
1521127|NCT00703391|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1521128|NCT00703378|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521129|NCT00703365|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521130|NCT00703352|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521131|NCT00703339||Single Group Assignment||Treatment||None (Open Label)||||||
1521132|NCT00703326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521133|NCT00703313|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1521134|NCT00703300||Single Group Assignment||Treatment||None (Open Label)||||||
1521135|NCT00703287|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1521136|NCT00703274|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521137|NCT00703261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521138|NCT00703248||||Supportive Care||||||||
1521139|NCT00703235||||||||||||
1521140|NCT00703222||Single Group Assignment||Treatment||None (Open Label)||||||
1521141|NCT00703209|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1521142|NCT00703196|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521143|NCT00703183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521144|NCT00703170|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521145|NCT00703157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521146|NCT00703144||Single Group Assignment||Treatment||None (Open Label)||||||
1521147|NCT00703131|||Cohort||Prospective|||||||
1521148|NCT00703118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521149|NCT00703105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521150|NCT00703092||Single Group Assignment||Treatment||None (Open Label)||||||
1521151|NCT00703079|||Cohort||Prospective|||||||
1521152|NCT00703066|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1521153|NCT00703053|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521154|NCT00703040|||Other||Prospective|||||||
1521155|NCT00703027|||||Retrospective|||||||
1521156|NCT00703014|||Other||Prospective|||||||
1521157|NCT00703001|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1521158|NCT00702988|||Other||Prospective|||||||
1521159|NCT00702975||Single Group Assignment||Treatment||None (Open Label)||||||
1521160|NCT00702962||Sequential Assignment||Treatment||None (Open Label)||||||
1521161|NCT00702949|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1521162|NCT00702936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521163|NCT00702923||Single Group Assignment||Treatment||None (Open Label)||||||
1521164|NCT00702910|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521165|NCT00702897|||Case-Only||Retrospective|||||||
1521166|NCT00702884||Single Group Assignment||Treatment||None (Open Label)||||||
1521167|NCT00702871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521168|NCT00702858|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1521169|NCT00702845|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521170|NCT00702832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521171|NCT00702819||Single Group Assignment||Treatment||None (Open Label)||||||
1521172|NCT00702806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521173|NCT00702793||Single Group Assignment||Treatment||None (Open Label)||||||
1521174|NCT00702780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521175|NCT00702767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521176|NCT00702754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521177|NCT00702741|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521178|NCT00702728|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521179|NCT00702715|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521180|NCT00702702|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521181|NCT00702689||Single Group Assignment||Treatment||None (Open Label)||||||
1521182|NCT00702676|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521183|NCT00702663|||||Cross-Sectional|||||||
1521184|NCT00702650||Single Group Assignment||Treatment||None (Open Label)||||||
1521185|NCT00702637|Randomized|Crossover Assignment||Treatment||Double||||||
1521186|NCT00702624|||Other||Prospective|||||||
1521187|NCT00702611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521188|NCT00702598|Randomized|Parallel Assignment||Treatment||Single||||||t
1521189|NCT00702585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521190|NCT00702572|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521191|NCT00702559|||Case-Only||Prospective|||||||
1521192|NCT00702546|||||Prospective|||||||
1521193|NCT00702533|||Case-Control||Prospective|||||||
1521194|NCT00702520|||Other||Prospective|||||||
1521195|NCT00702507|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521196|NCT00702494||Single Group Assignment||Treatment||None (Open Label)||||||
1521197|NCT00702481||Single Group Assignment||Treatment||None (Open Label)||||||
1521198|NCT00702468|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1521199|NCT00702455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521200|NCT00702442|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1521201|NCT00702429|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521202|NCT00702416|Randomized|Parallel Assignment||Treatment||Single||||||t
1521203|NCT00702403||Single Group Assignment||Treatment||None (Open Label)||||||
1521204|NCT00702377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521205|NCT00702364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521206|NCT00702351|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521207|NCT00702338|||Other||Prospective|||||||
1521208|NCT00702325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521209|NCT00702312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521210|NCT00702299||Single Group Assignment||Treatment||None (Open Label)||||||
1521211|NCT00702286|||Ecologic or Community||Prospective|||||||
1521212|NCT00702273|||Other||Prospective|||||||
1521213|NCT00702260|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521214|NCT00702247||Single Group Assignment||Treatment||||||||
1521215|NCT00702234|||Other||Prospective|||||||
1521216|NCT00702221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521217|NCT00702208||Single Group Assignment||Screening||None (Open Label)||||||
1521218|NCT00702195|||Other||Prospective|||||||
1521219|NCT00702182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521220|NCT00702169|||Case Control||Prospective|||||||
1521221|NCT00702156|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1521222|NCT00702143|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1521223|NCT00702130|Randomized|Parallel Assignment||Prevention||Single|||||t|
1521224|NCT00702117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521225|NCT00702104|||Ecologic or Community||Prospective|||||||
1521226|NCT00702091|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521227|NCT00702078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521228|NCT00702065|||||Prospective|||||||
1521229|NCT00702052||Single Group Assignment||Treatment||None (Open Label)||||||
1521230|NCT00702039|||Case-Control||Prospective|||||||
1521231|NCT00702026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521232|NCT00702013|||||Cross-Sectional|||||||
1521233|NCT00702000|||Case-Only||Prospective|||||||
1521234|NCT00701987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521235|NCT00701974|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521236|NCT00701961||Single Group Assignment||Treatment||None (Open Label)||||||
1521237|NCT00701948|||Cohort||Prospective|||||||
1521238|NCT00701935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521239|NCT00701922|||Cohort||Prospective|||||||
1521240|NCT00701909|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1521241|NCT00701896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521242|NCT00701883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521243|NCT00701870|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521244|NCT00701857||Single Group Assignment||Treatment||None (Open Label)||||||
1521245|NCT00701844|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1521246|NCT00701831||Single Group Assignment||Treatment||None (Open Label)||||||
1521247|NCT00701818|||Cohort||Prospective|||||||
1521248|NCT00701805|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521249|NCT00701792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521250|NCT00701779||Single Group Assignment||Treatment||None (Open Label)||||||
1521251|NCT00701766||Parallel Assignment||Treatment||||||||
1521252|NCT00701753|||Case-Only|||||||||
1521253|NCT00701740|Randomized|Parallel Assignment||Treatment||Single||||||t
1521254|NCT00701727|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521255|NCT00701714|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521256|NCT00701701|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521257|NCT00701688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521258|NCT00701675|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1521259|NCT00701662||Single Group Assignment||Treatment||None (Open Label)||||||
1521260|NCT00701649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521261|NCT00701636|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1521262|NCT00701623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521263|NCT00701610|||Cohort||Prospective|||||||
1521264|NCT00701597|Randomized|Crossover Assignment||Treatment||Single|||||t|
1521265|NCT00701584|||Cohort||Prospective|||||||
1521266|NCT00701571|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1521267|NCT00701558||Single Group Assignment||Treatment||None (Open Label)||||||
1521268|NCT00701545|||Case-Only||Prospective|||||||
1521269|NCT00701532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521270|NCT00701519|||Case-Only||Retrospective|||||||
1521271|NCT00701506|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521272|NCT00701493|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521273|NCT00701480|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1521274|NCT00701467|||Cohort||Prospective|||||||
1521275|NCT00701454|||Ecologic or Community||Cross-Sectional|||||||
1521276|NCT00701441|||Case Control||Prospective|||||||
1521277|NCT00701428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521278|NCT00701415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521279|NCT00701402|||Cohort||Cross-Sectional|||||||
1521280|NCT00701389|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521281|NCT00701376||Single Group Assignment||Supportive Care||None (Open Label)||||||
1521282|NCT00701363||Single Group Assignment||Treatment||None (Open Label)||||||
1521283|NCT00701350|||Case-Only||Prospective|||||||
1521284|NCT00701337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521285|NCT00701324|Randomized|||Treatment||None (Open Label)||||||
1521286|NCT00701311||Single Group Assignment||Treatment||None (Open Label)||||||
1521287|NCT00701298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521288|NCT00701285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521289|NCT00701272|||Case Control||Prospective|||||||
1521290|NCT00701259|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521291|NCT00701246|Randomized|Parallel Assignment||||Triple|||t|t||t
1521292|NCT00701233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521293|NCT00701220|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521294|NCT00701207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521295|NCT00701194|Randomized|Parallel Assignment||Prevention||Single||||||t
1521296|NCT00701181|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521297|NCT00701168||||||||||||
1521298|NCT00701155|||||Prospective|||||||
1521299|NCT00701142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521300|NCT00701129||Single Group Assignment||Treatment||None (Open Label)||||||
1521301|NCT00701103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521302|NCT00701090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521303|NCT00701077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521304|NCT00701064|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521305|NCT00701051|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521306|NCT00701038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521307|NCT00701025|||Cohort||Prospective|||||||
1521308|NCT00701012|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1521309|NCT00700999|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1521310|NCT00700986|Randomized|Crossover Assignment||||Double|||t||t|
1521311|NCT00700973|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1521312|NCT00700960|||Cohort||Prospective|||||||
1521313|NCT00700947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521314|NCT00700934|||Cohort||Prospective|||||||
1521315|NCT00700921|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521316|NCT00700908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521317|NCT00700895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521318|NCT00700882||Single Group Assignment||Treatment||None (Open Label)||||||
1521319|NCT00700869|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521320|NCT00700856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521321|NCT00700843|||Case-Only||Prospective|||||||
1521322|NCT00700830|||Case-Only||Prospective|||||||
1521323|NCT00700817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521324|NCT00700804|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1521325|NCT00700791|Randomized|Parallel Assignment||Other||Double|||t||t|
1521326|NCT00700778||Single Group Assignment||Prevention||None (Open Label)||||||
1521327|NCT00700765|||Cohort||Prospective|||||||
1521328|NCT00700752|Randomized|Crossover Assignment||Treatment||Single|||t|||
1521329|NCT00700739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521330|NCT00700726|||Cohort||Prospective|||||||
1521331|NCT00700713|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521332|NCT00700700|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521333|NCT00700687|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1521334|NCT00700674|||Case Control||Prospective|||||||
1521335|NCT00700661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521336|NCT00700648|||Case-Only||Prospective|||||||
1521337|NCT00700635|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521338|NCT00700622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521339|NCT00700609|Randomized|Parallel Assignment||Treatment||Single||||||t
1521340|NCT00700596|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1521341|NCT00700583||Single Group Assignment||Treatment||None (Open Label)||||||
1521342|NCT00700570|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521343|NCT00700557|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521344|NCT00700544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521345|NCT00700531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521346|NCT00700518|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1521347|NCT00700505||Single Group Assignment||Treatment||None (Open Label)||||||
1521348|NCT00700492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521349|NCT00700479|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1521350|NCT00700466|||Cohort||Prospective|||||||
1521351|NCT00700453|Randomized|Parallel Assignment||||None (Open Label)||||||
1521352|NCT00700440|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521353|NCT00700427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521354|NCT00700414|||Other||Prospective|||||||
1521355|NCT00700401|||Cohort||Prospective|||||||
1521356|NCT00700388|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521357|NCT00700375|Randomized|Parallel Assignment||Prevention||Single|||t|||
1521358|NCT00700362||||||||||||
1521359|NCT00700349|Randomized|Parallel Assignment||||Single||||||t
1521360|NCT00700336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521361|NCT00700323|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521362|NCT00700310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521363|NCT00700297|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1521364|NCT00700284|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1521365|NCT00700271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521366|NCT00700258|||Cohort||Prospective|||||||
1521367|NCT00700245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521368|NCT00700232|||Cohort||Prospective|||||||
1521369|NCT00700219|||Case-Only||Prospective|||||||
1521370|NCT00700206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521371|NCT00700193|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521372|NCT00700180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521373|NCT00700167||Single Group Assignment||Treatment||None (Open Label)||||||
1521374|NCT00700154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521375|NCT00700141|||Cohort||Prospective|||||||
1521376|NCT00700128|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521377|NCT00700115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521378|NCT00700102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521379|NCT00700089|Randomized|Parallel Assignment||Treatment||Single|||||t|
1521380|NCT00700076|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1521381|NCT00700063|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521382|NCT00700050|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521383|NCT00700037|Randomized|Parallel Assignment||Treatment||Single||||||t
1521384|NCT00700024|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521385|NCT00700011|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521386|NCT00699998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521387|NCT00699985|||Case Control||Cross-Sectional|||||||
1521388|NCT00699972|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521389|NCT00699959|||Cohort||Cross-Sectional|||||||
1521390|NCT00699946|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1521391|NCT00699933|||Cohort||Prospective|||||||
1521392|NCT00699920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521393|NCT00699907|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521394|NCT00699894|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521395|NCT00699881||Single Group Assignment||Treatment||None (Open Label)||||||
1521396|NCT00699868||Parallel Assignment||||None (Open Label)||||||
1521397|NCT00699855||||||||||||
1521398|NCT00699842||Single Group Assignment||Treatment||None (Open Label)||||||
1521399|NCT00699829|||Cohort||Prospective|||||||
1521400|NCT00699816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521401|NCT00699803|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1521402|NCT00699790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521403|NCT00699777|Randomized|Crossover Assignment||||None (Open Label)||||||
1521404|NCT00699764|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521405|NCT00699751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521406|NCT00699738|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1521407|NCT00699725|||||Prospective|||||||
1521408|NCT00699712||Single Group Assignment||Treatment||None (Open Label)||||||
1521409|NCT00699699|||||Prospective|||||||
1521410|NCT00699686|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521411|NCT00699673|||Case-Only||Prospective|||||||
1521412|NCT00699660|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1521413|NCT00699634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521414|NCT00699621|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1521415|NCT00699608|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521416|NCT00699595|||Cohort||Prospective|||||||
1521417|NCT00699582|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521418|NCT00699569|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1521419|NCT00699556|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1521420|NCT00699543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521421|NCT00699530|||Cohort||Prospective|||||||
1521422|NCT00699517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521423|NCT00699504|Randomized|Crossover Assignment||||Triple|||t|t|t|
1521424|NCT00699491||Single Group Assignment||Treatment||None (Open Label)||||||
1521425|NCT00699478||Single Group Assignment||Treatment||None (Open Label)||||||
1521426|NCT00699465|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521427|NCT00699452|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521428|NCT00699439|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1521429|NCT00699426|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1521430|NCT00699413|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521431|NCT00699400|||Cohort||Prospective|||||||
1521432|NCT00699387||Single Group Assignment||Basic Science||None (Open Label)||||||
1521433|NCT00699374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521434|NCT00699361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521435|NCT00699348||Single Group Assignment||Treatment||None (Open Label)||||||
1521436|NCT00699335|||Cohort||Prospective|||||||
1521437|NCT00699322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521438|NCT00699309|||Cohort||Prospective|||||||
1521439|NCT00699296||Single Group Assignment||Treatment||None (Open Label)||||||
1521440|NCT00699283|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521441|NCT00699270|||Cohort||Prospective|||||||
1521442|NCT00699257|||Cohort||Prospective|||||||
1521443|NCT00699244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521444|NCT00699231|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521445|NCT00699218||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1521446|NCT00699192|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1521447|NCT00699179|||Cohort||Prospective|||||||
1521448|NCT00699166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521449|NCT00699153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521450|NCT00699140||Single Group Assignment||Treatment||None (Open Label)||||||
1521451|NCT00699127|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521452|NCT00699114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521453|NCT00699101||Single Group Assignment||Treatment||None (Open Label)||||||
1521454|NCT00699088|||Cohort||Prospective|||||||
1521455|NCT00699062|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521456|NCT00699049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521457|NCT00699036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521458|NCT00699023|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521459|NCT00699010|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521460|NCT00698997|Randomized|Parallel Assignment||Treatment||Single||||||t
1521461|NCT00698984|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521462|NCT00698958|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521463|NCT00698945|Randomized|Parallel Assignment||Treatment||Single|||||t|
1521464|NCT00698932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521465|NCT00698919|||||Prospective|||||||
1521466|NCT00698906|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521467|NCT00698893|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521468|NCT00698880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521469|NCT00698867|||Cohort||Prospective|||||||
1521470|NCT00698854|||Cohort||Prospective|||||||
1521471|NCT00698841||Single Group Assignment||Treatment||None (Open Label)||||||
1521472|NCT00698828|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521473|NCT00698815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521474|NCT00698802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521475|NCT00698789|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521476|NCT00698776||Single Group Assignment||Treatment||None (Open Label)||||||
1521477|NCT00698763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521478|NCT00698750|||Cohort||Prospective|||||||
1521479|NCT00698737|||Case-Only||Prospective|||||||
1521480|NCT00698724|Randomized|Parallel Assignment||Treatment||Single|||||t|
1521481|NCT00698711||Single Group Assignment||Treatment||None (Open Label)||||||
1521482|NCT00698698|||Case Control||Cross-Sectional|||||||
1521483|NCT00698685||Single Group Assignment||Treatment||None (Open Label)||||||
1521484|NCT00698672|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521485|NCT00698659|||||Prospective|||||||
1521486|NCT00698646|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521487|NCT00698633|||Cohort||Prospective|||||||
1521488|NCT00698607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521489|NCT00698594|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521490|NCT00698581|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521491|NCT00698568|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521492|NCT00698555|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521493|NCT00698542|||Cohort||Prospective|||||||
1521494|NCT00698529|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521495|NCT00698516|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521496|NCT00698503|||Cohort||Prospective|||||||
1521497|NCT00698490|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521498|NCT00698477||||||||||||
1521499|NCT00698464||Single Group Assignment||||None (Open Label)||||||
1521500|NCT00698451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521501|NCT00698438|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521502|NCT00698425|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521503|NCT00698412|Randomized|Parallel Assignment||Treatment||Single||||||t
1521504|NCT00698399|||Case-Control||Prospective|||||||
1521505|NCT00698386|Randomized|Parallel Assignment||Treatment||Double||||||
1521506|NCT00698373|||||Prospective|||||||
1521507|NCT00698360|||Case-Only||Prospective|||||||
1521508|NCT00698347|||Cohort||Prospective|||||||
1521509|NCT00698334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521510|NCT00698321|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521511|NCT00698295|||Case Control||Prospective|||||||
1521512|NCT00698282|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1521513|NCT00698269|||||Prospective|||||||
1521514|NCT00698256|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1521515|NCT00698243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521516|NCT00698230|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521517|NCT00698204|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1521518|NCT00698191|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521519|NCT00698178|||Cohort||Cross-Sectional|||||||
1521520|NCT00698165|||Case-Only||Cross-Sectional|||||||
1521521|NCT00698152|||Cohort||Prospective|||||||
1521522|NCT00698139|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521523|NCT00698126|||||Prospective|||||||
1521524|NCT00698113|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1521525|NCT00698100|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521526|NCT00698087|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1521527|NCT00698074|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521528|NCT00698061|Randomized|Parallel Assignment||Prevention||Single|||t|||
1521529|NCT00698048|||Cohort||Prospective|||||||
1521530|NCT00698035|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521531|NCT00698022|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1521532|NCT00698009||Single Group Assignment||Treatment||None (Open Label)||||||
1521533|NCT00697996|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521534|NCT00697983|||Cohort||Cross-Sectional|||||||
1521535|NCT00697970|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1521536|NCT00697957|Randomized|Parallel Assignment||Prevention||Single||||||t
1521537|NCT00697944||Single Group Assignment||Prevention||None (Open Label)||||||
1521538|NCT00697931|Randomized|Parallel Assignment||Prevention||Single|||t|||
1521539|NCT00697918|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521540|NCT00697905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521541|NCT00697892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521542|NCT00697879||Single Group Assignment||Treatment||None (Open Label)||||||
1521543|NCT00697866|Randomized|Parallel Assignment||Prevention||Single|||t|||
1521544|NCT00697853|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521545|NCT00697840|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1521546|NCT00697827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521547|NCT00697814|Non-Randomized|Single Group Assignment||Treatment||||||||
1521548|NCT00697801|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521549|NCT00697788||Single Group Assignment||Treatment||None (Open Label)||||||
1521550|NCT00697775|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521551|NCT00697762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521552|NCT00697749|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521553|NCT00697736||Single Group Assignment||Diagnostic||None (Open Label)||||||
1521554|NCT00697723||Single Group Assignment||Supportive Care||None (Open Label)||||||
1521555|NCT00697710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521556|NCT00697697|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521557|NCT00697684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521558|NCT00697671|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521559|NCT00697658|||||Prospective|||||||
1521560|NCT00697645|Randomized|Parallel Assignment||Treatment||Quadruple|patients in the placebo group received sham TMS|Patietns were recruited into placebo or active treatment groups|t|t|t|t
1521561|NCT00697632||Single Group Assignment||Treatment||None (Open Label)||||||
1521562|NCT00697619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521563|NCT00697606|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521564|NCT00697593||Single Group Assignment||Treatment||None (Open Label)||||||
1521565|NCT00697580|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1521566|NCT00697567|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521567|NCT00697554|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521568|NCT00697541|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1521569|NCT00697528|||Case Control||Prospective|||||||
1521570|NCT00697515|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1521571|NCT00697502|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521572|NCT00697489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521573|NCT00697476||Single Group Assignment||Treatment||None (Open Label)||||||
1521574|NCT00697463||Single Group Assignment||Treatment||None (Open Label)||||||
1521575|NCT00697450|||Cohort||Prospective|||||||
1521576|NCT00697437|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521577|NCT00697424||Single Group Assignment||Treatment||None (Open Label)||||||
1521578|NCT00697411|||Other||Prospective|||||||
1521579|NCT00697398|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521580|NCT00697385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521581|NCT00697372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521582|NCT00697359||Single Group Assignment||Diagnostic||None (Open Label)||||||
1521583|NCT00697346|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521584|NCT00697333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521585|NCT00697320|||||Prospective|||||||
1521586|NCT00697307|||||Prospective|||||||
1521587|NCT00697294||Parallel Assignment||Diagnostic||None (Open Label)||||||
1521588|NCT00697281|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1521589|NCT00697268||||||||||||
1521590|NCT00697255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521591|NCT00697242|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1521592|NCT00697229|Randomized|Parallel Assignment||Prevention||Double||||||
1521593|NCT00697216|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521594|NCT00697203|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521595|NCT00697190|Randomized|Crossover Assignment||Treatment||Single|||t|||
1521596|NCT00697177|||Cohort||Prospective|||||||
1521597|NCT00697164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521598|NCT00697151|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521599|NCT00697138||Crossover Assignment||Basic Science||Double|||t|t||
1521600|NCT00697125|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1521601|NCT00697112|||Cohort||Prospective|||||||
1521602|NCT00697099|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521603|NCT00697086|Randomized|Parallel Assignment||Treatment||Double||||||
1521604|NCT00697073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521605|NCT00697060|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521606|NCT00697047|Randomized|Parallel Assignment||Screening||Single||||||t
1521607|NCT00697034||Single Group Assignment||Treatment||None (Open Label)||||||
1521608|NCT00697021||Parallel Assignment||Prevention||None (Open Label)||||||
1521609|NCT00697008|||Cohort||Prospective|||||||
1521610|NCT00696995|||Cohort||Prospective|||||||
1521611|NCT00696982|Randomized|Crossover Assignment||||None (Open Label)||||||
1521612|NCT00696969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521613|NCT00696956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521614|NCT00696943||Single Group Assignment||Diagnostic||None (Open Label)||||||
1521615|NCT00696930||||Treatment||||||||
1521616|NCT00696917|Randomized|Parallel Assignment||Prevention||Single|||t|||
1521617|NCT00696904|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1521618|NCT00696891|Randomized|Parallel Assignment||Prevention||Single|||t|||
1521619|NCT00696878||Single Group Assignment||Treatment||None (Open Label)||||||
1521620|NCT00696865|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1521621|NCT00696852|Randomized|Parallel Assignment||Treatment||Single||||||t
1521622|NCT00696839|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521623|NCT00696826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521624|NCT00696813|||Cohort||Prospective|||||||
1521625|NCT00696800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521626|NCT00696787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521627|NCT00696774||Parallel Assignment||Treatment||None (Open Label)||||||
1521628|NCT00696761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521629|NCT00696748|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521630|NCT00696735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521631|NCT00696722|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1521632|NCT00696709|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521633|NCT00696696||Single Group Assignment||Treatment||None (Open Label)||||||
1521634|NCT00696683|||Case-Only||Retrospective|||||||
1521635|NCT00696657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521636|NCT00696644|||Cohort||Prospective|||||||
1521637|NCT00696631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521638|NCT00696618|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1521639|NCT00696605|||Other||Prospective|||||||
1521640|NCT00696592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521641|NCT00696579|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521642|NCT00696566||Single Group Assignment||Basic Science||None (Open Label)||||||
1521643|NCT00696553|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1521644|NCT00696540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521645|NCT00696527|||Cohort||Prospective|||||||
1521646|NCT00696514|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521647|NCT00696501|||Cohort||Prospective|||||||
1521648|NCT00696488||Single Group Assignment||Treatment||None (Open Label)||||||
1521649|NCT00696475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521650|NCT00696462|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1521651|NCT00696449|Randomized|Parallel Assignment||Treatment||Single|||||t|
1521652|NCT00696436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521653|NCT00696423|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521654|NCT00696410|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521655|NCT00696397|||Case-Control||Prospective|||||||
1521656|NCT00696384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521657|NCT00696371|||||Prospective|||||||
1521658|NCT00696358||||||||||||
1521659|NCT00696345|||Case Control||Prospective|||||||
1521660|NCT00696332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521661|NCT00696319|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521662|NCT00696306|||Case-Only||Prospective|||||||
1521663|NCT00696293||Single Group Assignment||Treatment||None (Open Label)||||||
1521664|NCT00696280|||||Prospective|||||||
1521665|NCT00696254|||Case Control||Prospective|||||||
1521666|NCT00696241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521667|NCT00696228|Randomized|Parallel Assignment||Treatment||Single|||||t|
1521668|NCT00696215|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521669|NCT00696202|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521670|NCT00696189|||Cohort||Prospective|||||||
1521671|NCT00696176||Single Group Assignment||Basic Science||None (Open Label)||||||
1521672|NCT00696163|||Case-Only||Prospective|||||||
1521673|NCT00696150|Randomized|Parallel Assignment||Treatment||Double||||t||t
1521674|NCT00696137||Single Group Assignment||Treatment||None (Open Label)||||||
1521675|NCT00696124|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521676|NCT00696111|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1521677|NCT00696098|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1521678|NCT00696085|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1521679|NCT00696072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521680|NCT00696059||Single Group Assignment||Treatment||None (Open Label)||||||
1521681|NCT00696046||Single Group Assignment||Treatment||None (Open Label)||||||
1521682|NCT00696033|Randomized|Crossover Assignment||||Double|||t||t|
1521683|NCT00696020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521684|NCT00696007|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521685|NCT00695994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521686|NCT00695981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521687|NCT00695968|||Cohort||Prospective|||||||
1521688|NCT00695955|Non-Randomized|||Treatment||None (Open Label)||||||
1521689|NCT00695942|||Cohort||Prospective|||||||
1521690|NCT00695929|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521691|NCT00695916|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1521692|NCT00695903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521693|NCT00695890|||Cohort||Prospective|||||||
1521694|NCT00695877|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1521695|NCT00695864|Non-Randomized|Single Group Assignment||Treatment||Double|||t|||t
1521696|NCT00695851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521697|NCT00695838|||Cohort||Prospective|||||||
1521698|NCT00695825|Randomized|Crossover Assignment||Prevention||Single|||t|||
1521699|NCT00695812|||Cohort||Prospective|||||||
1521700|NCT00695799|||Cohort||Prospective|||||||
1521701|NCT00695786|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521702|NCT00695773|||Case-Only|||||||||
1521703|NCT00695747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521704|NCT00695734|||Case-Only||Cross-Sectional|||||||
1521705|NCT00695708|Randomized|Parallel Assignment||||Single|||t|||
1521706|NCT00695695|||||Prospective|||||||
1521707|NCT00695682|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521708|NCT00695669|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521709|NCT00695656|||Cohort||Prospective|||||||
1521710|NCT00695643|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521711|NCT00695630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521712|NCT00695617|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521713|NCT00695604|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521714|NCT00695591|||Case-Only||Prospective|||||||
1521715|NCT00695578|Randomized|Crossover Assignment||Treatment||Single|||||t|
1521716|NCT00695565|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521717|NCT00695552|Randomized|Parallel Assignment||Treatment||Single||||||t
1521718|NCT00695539|||Case-Only||Prospective|||||||
1521719|NCT00695526|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521720|NCT00695513||Single Group Assignment||Treatment||None (Open Label)||||||
1521721|NCT00695500|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521722|NCT00695487|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521723|NCT00695474|||Cohort||Cross-Sectional|||||||
1521724|NCT00695461|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521725|NCT00695448|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521726|NCT00695435|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1521727|NCT00695422|||Cohort||Prospective|||||||
1521728|NCT00695409||Single Group Assignment||Treatment||None (Open Label)||||||
1521729|NCT00695396|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521730|NCT00695383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521731|NCT00695370|Non-Randomized|||Treatment||None (Open Label)||||||
1521732|NCT00695357|||Case-Only||Cross-Sectional|||||||
1521733|NCT00695344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521734|NCT00695331|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521735|NCT00695318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521736|NCT00695305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521737|NCT00695292||Single Group Assignment||Treatment||None (Open Label)||||||
1521738|NCT00695279|||Cohort||Prospective|||||||
1521739|NCT00695266|||Cohort||Prospective|||||||
1521740|NCT00695253||Single Group Assignment||Treatment||None (Open Label)||||||
1521741|NCT00695240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521742|NCT00695227||Single Group Assignment||Diagnostic||None (Open Label)||||||
1521743|NCT00695214||Single Group Assignment||Treatment||None (Open Label)||||||
1521744|NCT00695201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521745|NCT00695188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521746|NCT00695175|||Cohort||Prospective|||||||
1521747|NCT00695162|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1521748|NCT00695149|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521749|NCT00695136||Single Group Assignment||||None (Open Label)||||||
1521750|NCT00695123|||Other||Prospective|||||||
1521751|NCT00695110|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521752|NCT00695097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521753|NCT00695084||Single Group Assignment||Treatment||None (Open Label)||||||
1521754|NCT00695071||Single Group Assignment||||None (Open Label)||||||
1521755|NCT00695058|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521756|NCT00695045|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1521757|NCT00695032|Non-Randomized|Parallel Assignment||Treatment||||||||
1521758|NCT00695019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521759|NCT00695006|Randomized|Parallel Assignment||Treatment||Single||||||t
1521760|NCT00694993|Randomized|Sequential Assignment||Treatment||||||||
1521761|NCT00694980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521762|NCT00694967|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521763|NCT00694954|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1521764|NCT00694941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521765|NCT00694928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521766|NCT00694915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521767|NCT00694902|Randomized|Crossover Assignment||Treatment||||||||
1521768|NCT00694889|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1521769|NCT00694876|||Cohort||Prospective|||||||
1521770|NCT00694863||Single Group Assignment||Treatment||None (Open Label)||||||
1521771|NCT00694850||Single Group Assignment||Treatment||None (Open Label)||||||
1521772|NCT00694837||Single Group Assignment||Treatment||None (Open Label)||||||
1521773|NCT00694824|||Cohort||Cross-Sectional|||||||
1521774|NCT00694811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521775|NCT00694798||Single Group Assignment||Treatment||None (Open Label)||||||
1521776|NCT00694785|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521777|NCT00694772|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1521778|NCT00694759|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1521779|NCT00694746|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521780|NCT00694733|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1521781|NCT00694720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521782|NCT00694707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521783|NCT00694694|Randomized|Parallel Assignment||Treatment||Single||||||t
1521784|NCT00694681|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1521785|NCT00694668|Randomized|Parallel Assignment||Treatment||Single||||||t
1521786|NCT00694655||Single Group Assignment||Basic Science||None (Open Label)||||||
1521787|NCT00694642|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521788|NCT00694629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521789|NCT00694616|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1521790|NCT00694603||Single Group Assignment||Treatment||None (Open Label)||||||
1521791|NCT00694590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521792|NCT00694577|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521793|NCT00694564||Single Group Assignment||Treatment||None (Open Label)||||||
1521794|NCT00694551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521795|NCT00694538|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1521796|NCT00694525|||Case Control||Cross-Sectional|||||||
1521797|NCT00694512|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1521798|NCT00694499|||Cohort||Retrospective|||||||
1521799|NCT00694486|||Cohort||Prospective|||||||
1521800|NCT00694473||Single Group Assignment||Diagnostic||None (Open Label)||||||
1521801|NCT00694460|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521802|NCT00694447||||||||||||
1521803|NCT00694434|||Cohort||Retrospective|||||||
1521804|NCT00694421|||Cohort||Cross-Sectional|||||||
1521805|NCT00694408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521806|NCT00694395|||||Retrospective|||||||
1521807|NCT00694382|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521808|NCT00694369|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521809|NCT00694356|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521810|NCT00694343|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521811|NCT00694330||Single Group Assignment||Treatment||None (Open Label)||||||
1521812|NCT00694317|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521813|NCT00694304||Single Group Assignment||Treatment||None (Open Label)||||||
1521814|NCT00694291|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521815|NCT00694278|||Case-Only||Cross-Sectional|||||||
1521816|NCT00694265|||Cohort||Prospective|||||||
1521817|NCT00694252||Single Group Assignment||Treatment||None (Open Label)||||||
1521818|NCT00694239|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1521819|NCT00694226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521820|NCT00694213|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1521821|NCT00694200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521822|NCT00694187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521823|NCT00694174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521824|NCT00694161||Single Group Assignment||Treatment||None (Open Label)||||||
1521825|NCT00694148|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521826|NCT00694135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521827|NCT00694122|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521828|NCT00694109||Single Group Assignment||Treatment||None (Open Label)||||||
1521829|NCT00694096||Single Group Assignment||Diagnostic||None (Open Label)||||||
1521830|NCT00694083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521831|NCT00694070|||Case-Only||Cross-Sectional|||||||
1521832|NCT00694057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521833|NCT00694044|Randomized|Parallel Assignment||||Double|||t||t|
1521834|NCT00694031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521835|NCT00694018|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521836|NCT00694005|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521837|NCT00693992|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521838|NCT00693979||||||||||||
1521839|NCT00693966|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521840|NCT00693953|||Case Control|||||||||
1521841|NCT00693940|Randomized|Parallel Assignment||Treatment||Single||||||t
1521842|NCT00693927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521843|NCT00693914|||Case-Control||Cross-Sectional|||||||
1521844|NCT00693901|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521845|NCT00693888|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1521846|NCT00693875|||Cohort||Prospective|||||||
1521847|NCT00693862|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521848|NCT00693849|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1521849|NCT00693836||||||||||||
1521850|NCT00693823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521851|NCT00693797|||Case Control||Prospective|||||||
1521852|NCT00693784||Single Group Assignment||Treatment||None (Open Label)||||||
1521853|NCT00693771|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521854|NCT00693758|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1521855|NCT00693745|||Cohort||Prospective|||||||
1521856|NCT00693732|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1521857|NCT00693719||Single Group Assignment||Treatment||None (Open Label)||||||
1521858|NCT00693706|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1521859|NCT00693693|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521860|NCT00693680|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1521861|NCT00693667|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521862|NCT00693654|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521863|NCT00693641|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1521864|NCT00693628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521865|NCT00693615|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521866|NCT00693602||Single Group Assignment||Supportive Care||None (Open Label)||||||
1521867|NCT00693589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521868|NCT00693576||Single Group Assignment||Treatment||None (Open Label)||||||
1521869|NCT00693563|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1521870|NCT00693550|||Cohort||Prospective|||||||
1521871|NCT00693537|Randomized|||||||||||
1521872|NCT00693524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521873|NCT00693511|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521874|NCT00693498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521875|NCT00693485|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1521876|NCT00693472|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1521877|NCT00693459||Single Group Assignment||Treatment||None (Open Label)||||||
1521878|NCT00693446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521879|NCT00693433||Single Group Assignment||Treatment||None (Open Label)||||||
1521880|NCT00693420|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521881|NCT00693407|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1521882|NCT00693381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521883|NCT00693355|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1521884|NCT00693342|Randomized|||Treatment||||||||
1521885|NCT00693329|||Cohort||Prospective|||||||
1521886|NCT00693316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521887|NCT00693303||Single Group Assignment||Treatment||None (Open Label)||||||
1521888|NCT00693290|Randomized|Parallel Assignment||Diagnostic||Double|||||t|t
1521889|NCT00693277||||||||||||
1521890|NCT00693264|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1521891|NCT00693251|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521892|NCT00693238|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521893|NCT00693225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521894|NCT00693212|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1521895|NCT00693199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521896|NCT00693186|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521897|NCT00693173|||Case-Only||Retrospective|||||||
1521898|NCT00693160|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1521899|NCT00693147|Randomized|Parallel Assignment||Treatment||Single||||||t
1521900|NCT00693134|||Case Control||Prospective|||||||
1521901|NCT00693121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521902|NCT00693108||||||||||||
1521903|NCT00693095|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521904|NCT00693082||Single Group Assignment||Treatment||None (Open Label)||||||
1521905|NCT00693069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521906|NCT00693056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521907|NCT00693043|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521908|NCT00693030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521909|NCT00693017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521910|NCT00693004||||Treatment||||||||
1521911|NCT00692991|||Cohort||Prospective|||||||
1521912|NCT00692978|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1521913|NCT00692965|||Case-Only||Prospective|||||||
1521914|NCT00692952|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521915|NCT00692939||Single Group Assignment||Treatment||None (Open Label)||||||
1521916|NCT00692926|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521917|NCT00692913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521918|NCT00692900|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521919|NCT00692887|||Case Control||Prospective|||||||
1521920|NCT00692874|||Cohort||Prospective|||||||
1521921|NCT00692861|||||Prospective|||||||
1521922|NCT00692848|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1521923|NCT00692835|Randomized|Parallel Assignment||Treatment||Single||||||t
1521924|NCT00692822|||Case Control||Prospective|||||||
1521925|NCT00692809|||||Prospective|||||||
1521926|NCT00692796||Single Group Assignment||Treatment||||||||
1521927|NCT00692783|||||Prospective|||||||
1521928|NCT00692770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521929|NCT00692757|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1521930|NCT00692744|||Cohort||Prospective|||||||
1521931|NCT00692731|||Cohort||Prospective|||||||
1521932|NCT00692718|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521933|NCT00692705|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1521934|NCT00692692|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1521935|NCT00692666|||||Retrospective|||||||
1521936|NCT00692653|Randomized|Parallel Assignment||||None (Open Label)||||||
1521937|NCT00692640||Single Group Assignment||Treatment||None (Open Label)||||||
1521938|NCT00692627|||Case-Only||Prospective|||||||
1521939|NCT00692614|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521940|NCT00692601|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1521941|NCT00692588|||Case Control||Prospective|||||||
1521942|NCT00692575|Randomized|Parallel Assignment||Treatment||Single||||||t
1521943|NCT00692562||Single Group Assignment||Treatment||None (Open Label)||||||
1521944|NCT00692549|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521945|NCT00692536|Randomized|Parallel Assignment||||None (Open Label)||||||
1521946|NCT00692523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521947|NCT00692510|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1521948|NCT00692497|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1521949|NCT00692484|Randomized|Parallel Assignment||||None (Open Label)||||||
1521950|NCT00692471|||Case-Control||Prospective|||||||
1521951|NCT00692458|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521952|NCT00692445|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1521953|NCT00692432|||Cohort||Prospective|||||||
1521954|NCT00692419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521955|NCT00692406|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1521956|NCT00692393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521957|NCT00692380||Single Group Assignment||Treatment||None (Open Label)||||||
1521958|NCT00692367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521959|NCT00692354||Single Group Assignment||Treatment||None (Open Label)||||||
1521960|NCT00692341|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521961|NCT00692328|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1521962|NCT00692315|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521963|NCT00692302|Randomized|Parallel Assignment||Treatment||Single||||||t
1521964|NCT00692289|||Cohort||Prospective|||||||
1521965|NCT00692276|Randomized|Parallel Assignment||Treatment||Single|||t|||
1521966|NCT00692263|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1521967|NCT00692250|Randomized|Parallel Assignment||||None (Open Label)||||||
1521968|NCT00692237|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1521969|NCT00692224|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1521970|NCT00692211|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1521971|NCT00692198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521972|NCT00692185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1521973|NCT00692172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521974|NCT00692159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1521975|NCT00692146|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1521976|NCT00692133|||||Prospective|||||||
1521977|NCT00692120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521978|NCT00692107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521979|NCT00692094|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1521980|NCT00692081|Randomized|Parallel Assignment||Treatment||Single||||||t
1521981|NCT00692068|||Case Control||Prospective|||||||
1521982|NCT00692055|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1521983|NCT00692042|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1521984|NCT00692029|||Cohort||Prospective|||||||
1521985|NCT00692016|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1521986|NCT00692003|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521987|NCT00691990|Randomized|Parallel Assignment||Treatment||Single||||||t
1521988|NCT00691977|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1521989|NCT00691964|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1521990|NCT00691951||||||||||||
1521991|NCT00691938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1521992|NCT00691925|||Cohort||Prospective|||||||
1521993|NCT00691912||Single Group Assignment||Treatment||None (Open Label)||||||
1521994|NCT00691899|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1521995|NCT00691886|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1521996|NCT00691873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1521997|NCT00691860|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1521998|NCT00691847|||Cohort||Prospective|||||||
1521999|NCT00691834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522000|NCT00691821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522001|NCT00691808|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522002|NCT00691795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522003|NCT00691782|||Case-Only||Retrospective|||||||
1522004|NCT00691769|||Case-Control||Prospective|||||||
1522005|NCT00691756|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522006|NCT00691743|||Case-Only||Cross-Sectional|||||||
1522007|NCT00691730||Single Group Assignment||Diagnostic||None (Open Label)||||||
1522008|NCT00691717|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522009|NCT00691704||Single Group Assignment||Treatment||None (Open Label)||||||
1522010|NCT00691691|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522011|NCT00691678||Single Group Assignment||Supportive Care||None (Open Label)||||||
1522012|NCT00691665|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522013|NCT00691652||Single Group Assignment||Treatment||None (Open Label)||||||
1522014|NCT00691639|||Case-Only||Retrospective|||||||
1522015|NCT00691626|Randomized|Parallel Assignment||Treatment||Single||This is a randomized controlled trial comparing two forms of psychotherapy.||||t
1522016|NCT00691613|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1522017|NCT00691600|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1522018|NCT00691587|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1522019|NCT00691574|Non-Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1522020|NCT00691561|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522021|NCT00691548||Single Group Assignment||Diagnostic||None (Open Label)||||||
1522022|NCT00691535||||||||||||
1522023|NCT00691522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522024|NCT00691509||||||||||||
1522025|NCT00691496|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522026|NCT00691483|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522027|NCT00691470|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522028|NCT00691457|Randomized|Parallel Assignment||Treatment||Single|||||t|
1522029|NCT00691444|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1522030|NCT00691431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522031|NCT00691418|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1522032|NCT00691405|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522033|NCT00691392|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522034|NCT00691379||Single Group Assignment||Treatment||None (Open Label)||||||
1522035|NCT00691366|||Case-Only||Cross-Sectional|||||||
1522036|NCT00691353|||Case-Only||Cross-Sectional|||||||
1522037|NCT00691340|||Case-Only||Prospective|||||||
1522038|NCT00691327|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1522039|NCT00691314|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522040|NCT00691301||Single Group Assignment||Treatment||None (Open Label)||||||
1522041|NCT00691288|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522042|NCT00691275|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522043|NCT00691262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522044|NCT00691249|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1522045|NCT00691236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522046|NCT00691223|||Other||Prospective|||||||
1522047|NCT00691210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522048|NCT00691197|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522049|NCT00691184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522050|NCT00691171|||Case Control||Prospective|||||||
1522051|NCT00691158|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1522052|NCT00691145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522053|NCT00691132|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1522054|NCT00691119|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1522055|NCT00691093|||Case-Only||Prospective|||||||
1522056|NCT00691080|||Case Control||Cross-Sectional|||||||
1522057|NCT00691067|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1522058|NCT00691054||Single Group Assignment||Treatment||None (Open Label)||||||
1522059|NCT00691041|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522060|NCT00691028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522061|NCT00691015||Single Group Assignment||Supportive Care||None (Open Label)||||||
1522062|NCT00691002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522063|NCT00690989|||||Retrospective|||||||
1522064|NCT00690976|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522065|NCT00690963|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522066|NCT00690950|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522067|NCT00690937|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522068|NCT00690924||Single Group Assignment||Prevention||None (Open Label)||||||
1522069|NCT00690911||Single Group Assignment||Treatment||None (Open Label)||||||
1522070|NCT00690898||Single Group Assignment||Treatment||None (Open Label)||||||
1522071|NCT00690885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522072|NCT00690872|Non-Randomized|||Treatment||None (Open Label)||||||
1522073|NCT00690859|||Case Control||Prospective|||||||
1522074|NCT00690846||Single Group Assignment||Treatment||None (Open Label)||||||
1522075|NCT00690833||Single Group Assignment||Treatment||None (Open Label)||||||
1522076|NCT00690820|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522077|NCT00690807||Single Group Assignment||Treatment||None (Open Label)||||||
1522078|NCT00690794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522079|NCT00690781|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1522080|NCT00690768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522081|NCT00690755|||Cohort||Cross-Sectional|||||||
1522082|NCT00690742||||||||||||
1522083|NCT00690729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522084|NCT00690716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522085|NCT00690703||Single Group Assignment||Treatment||None (Open Label)||||||
1522086|NCT00690690|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522087|NCT00690677||Single Group Assignment||Treatment||None (Open Label)||||||
1522088|NCT00690664|||Case-Control||Prospective|||||||
1522089|NCT00690651|Randomized|Parallel Assignment||Treatment||Single||||t||
1522090|NCT00690638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522091|NCT00690625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522092|NCT00690612||Single Group Assignment||Treatment||None (Open Label)||||||
1522093|NCT00690599|||||Retrospective|||||||
1522094|NCT00690586|||Case-Only||Prospective|||||||
1522095|NCT00690573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522096|NCT00690560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522097|NCT00690547|||||Prospective|||||||
1522098|NCT00690534|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1522099|NCT00690521|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1522100|NCT00690508|Randomized|Single Group Assignment||Treatment||Single||||||t
1522101|NCT00690495|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1522102|NCT00690482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522104|NCT00690456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522105|NCT00690443|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522106|NCT00690430|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522107|NCT00690417|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1522108|NCT00690404|Randomized|Crossover Assignment||||None (Open Label)||||||
1522109|NCT00690391|||Cohort||Prospective|||||||
1522110|NCT00690378|Randomized|Parallel Assignment||Treatment||Single|||||t|
1522111|NCT00690365|||Case-Only||Prospective|||||||
1522112|NCT00690352|||Case Control||Retrospective|||||||
1522113|NCT00690339|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1522114|NCT00690326|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1522115|NCT00690313|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522116|NCT00690300|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522117|NCT00690287|Randomized|Crossover Assignment||Treatment||Single|||t|||
1522118|NCT00690274|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522119|NCT00690261|||Case Control||Prospective|||||||
1522120|NCT00690248|||Case-Crossover||Cross-Sectional|||||||
1522121|NCT00690235|Randomized|Parallel Assignment||Other||Double|||t||t|
1522122|NCT00690222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522123|NCT00690209|Randomized|Parallel Assignment||||Single|||t|||
1522124|NCT00690196|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522125|NCT00690183|||Cohort||Cross-Sectional|||||||
1522126|NCT00690170|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1522127|NCT00690157|||Cohort||Prospective|||||||
1522128|NCT00690144|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1522129|NCT00690131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522130|NCT00690118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522131|NCT00690105|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522132|NCT00690092|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1522133|NCT00690079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522134|NCT00690066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522135|NCT00690053||Single Group Assignment||Diagnostic||Single|||t|||
1522136|NCT00690040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522137|NCT00690027|Randomized|Parallel Assignment||Treatment||Single|||||t|
1522138|NCT00690014||Single Group Assignment||Treatment||None (Open Label)||||||
1522139|NCT00690001|||Cohort||Cross-Sectional|||||||
1522140|NCT00689988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522141|NCT00689975|Randomized|||||||||||
1522142|NCT00689962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522143|NCT00689949||Single Group Assignment||Diagnostic||None (Open Label)||||||
1522144|NCT00689936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522145|NCT00689923|||Case-Only||Prospective|||||||
1522146|NCT00689910|||Cohort||Prospective|||||||
1522147|NCT00689897|Randomized|Parallel Assignment||Treatment||Single||||||t
1522148|NCT00689884||Single Group Assignment||Treatment||None (Open Label)||||||
1522149|NCT00689871|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1522150|NCT00689858|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1522151|NCT00689845|Non-Randomized|||Treatment||||||||
1522152|NCT00689832|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522153|NCT00689819|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522154|NCT00689806|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522155|NCT00689793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522156|NCT00689780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522157|NCT00689767|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522158|NCT00689754|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1522159|NCT00689741|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1522160|NCT00689728|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522161|NCT00689715||Single Group Assignment||Treatment||None (Open Label)||||||
1522162|NCT00689702||Single Group Assignment||Treatment||None (Open Label)||||||
1522163|NCT00689689|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522164|NCT00689676|||Case Control||Prospective|||||||
1522165|NCT00689663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522166|NCT00689650||||||||||||
1522167|NCT00689637|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1522168|NCT00689624||Single Group Assignment||Treatment||None (Open Label)||||||
1522169|NCT00689611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522170|NCT00689598|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522171|NCT00689585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522172|NCT00689572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522173|NCT00689559|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1522174|NCT00689546|||Case Control||Prospective|||||||
1522175|NCT00689533|||Cohort||Prospective|||||||
1522176|NCT00689520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522177|NCT00689507|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522178|NCT00689494|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1522179|NCT00689481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522180|NCT00689468|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1522181|NCT00689455|||||Cross-Sectional|||||||
1522182|NCT00689442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522183|NCT00689429|||Case-Only||Retrospective|||||||
1522184|NCT00689416|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1522185|NCT00689403|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522186|NCT00689390|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1522187|NCT00689377|||Case-Only||Cross-Sectional|||||||
1522188|NCT00689364|||Cohort||Prospective|||||||
1522189|NCT00689351|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1522190|NCT00689338|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522191|NCT00689325|||||Prospective|||||||
1522192|NCT00689312|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1522193|NCT00689299|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522194|NCT00689286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522195|NCT00689273|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522196|NCT00689260|Randomized|Single Group Assignment||||Single|||t|||
1522197|NCT00689247|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522198|NCT00689234|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522199|NCT00689221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522200|NCT00689208|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1522201|NCT00689195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522202|NCT00689182||Single Group Assignment||Treatment||None (Open Label)||||||
1522203|NCT00689169||Single Group Assignment||Treatment||None (Open Label)||||||
1522204|NCT00689156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522205|NCT00689143||Single Group Assignment||Treatment||None (Open Label)||||||
1522206|NCT00689130|||Cohort||Prospective|||||||
1522207|NCT00689117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522208|NCT00689104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522209|NCT00689091|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1522210|NCT00689078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522211|NCT00689065||Single Group Assignment||Treatment||None (Open Label)||||||
1522212|NCT00689052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522213|NCT00689039|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522214|NCT00689026|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1522215|NCT00689013|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1522216|NCT00689000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522217|NCT00688987|Randomized|Parallel Assignment||Treatment||Single|||||t|
1522218|NCT00688974|||Cohort||Prospective|||||||
1522219|NCT00688961|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1522220|NCT00688948||Single Group Assignment||Treatment||None (Open Label)||||||
1522221|NCT00688935|Non-Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1522222|NCT00688922|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522223|NCT00688909||Single Group Assignment||Prevention||None (Open Label)||||||
1522224|NCT00688896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522225|NCT00688883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522226|NCT00688870|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1522227|NCT00688857|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522228|NCT00688844|||Cohort||Prospective|||||||
1522229|NCT00688831|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522230|NCT00688818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522231|NCT00688805|Randomized|Parallel Assignment||Basic Science||||||||
1522232|NCT00688792|||Cohort||Prospective|||||||
1522233|NCT00688779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522234|NCT00688766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522235|NCT00688753||Single Group Assignment||Treatment||None (Open Label)||||||
1522236|NCT00688740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522237|NCT00688727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522238|NCT00688714|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1522239|NCT00688701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522240|NCT00688688|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522241|NCT00688675|||||Retrospective|||||||
1522242|NCT00688662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522243|NCT00688649|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522244|NCT00688636|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1522245|NCT00688623||Single Group Assignment||Treatment||None (Open Label)||||||
1522246|NCT00688610|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522247|NCT00688597|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522248|NCT00688584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522249|NCT00688571||Single Group Assignment||Treatment||None (Open Label)||||||
1522250|NCT00688558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522251|NCT00688545|||Cohort||Prospective|||||||
1522252|NCT00688532|||Cohort||Retrospective|||||||
1522253|NCT00688519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522254|NCT00688506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522255|NCT00688493|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1522256|NCT00688480|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522257|NCT00688467|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522258|NCT00688454|||||Prospective|||||||
1522259|NCT00688441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522260|NCT00688428|Randomized|Crossover Assignment||||None (Open Label)||||||
1522261|NCT00688415|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1522262|NCT00688402|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1522263|NCT00688389|||Case-Control||Other|||||||
1522264|NCT00688376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522265|NCT00688363|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1522266|NCT00688350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522267|NCT00688337|||Cohort||Prospective|||||||
1522268|NCT00688324||Single Group Assignment||Treatment||None (Open Label)||||||
1522269|NCT00688311|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1522270|NCT00688298|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522271|NCT00688285|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1522272|NCT00688272|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1522273|NCT00688259|Randomized|Parallel Assignment||Treatment||Single||||||t
1522274|NCT00688246|||Cohort||Prospective|||||||
1522275|NCT00688233||Single Group Assignment||Treatment||None (Open Label)||||||
1522276|NCT00688220|||Case Control||Prospective|||||||
1522277|NCT00688207|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522278|NCT00688194|Randomized|||Treatment||Double||||||
1522279|NCT00688181|||Case-Only||Prospective|||||||
1522280|NCT00688168|||Case-Only||Prospective|||||||
1522281|NCT00688155|Randomized|Factorial Assignment||Prevention||Single|Data collection related to study outcomes was performed by staff who were masked to intervention assignment.|Participants were randomly assigned, with equal probability to one of four conditions: an educational control condition, moderate-intensity physical activity training, repetition lag cognitive training, or both physical activity and repetitive lag training.||||t
1522282|NCT00688142|||||Prospective|||||||
1522283|NCT00688129|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1522284|NCT00688116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522285|NCT00688103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522286|NCT00688090|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522287|NCT00688077|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1522288|NCT00688064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522289|NCT00688051||Single Group Assignment||Treatment||None (Open Label)||||||
1522290|NCT00688038||Single Group Assignment||Treatment||None (Open Label)||||||
1522291|NCT00688025|||||Cross-Sectional|||||||
1522292|NCT00688012|Randomized|||Treatment||Quadruple|||t|t|t|t
1522293|NCT00687999|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522294|NCT00687986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522295|NCT00687973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522296|NCT00687960|Randomized|Crossover Assignment||Supportive Care||Double|||t|||t
1522297|NCT00687947|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1522298|NCT00687934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522299|NCT00687921|||Cohort||Prospective|||||||
1522300|NCT00687908|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522301|NCT00687895|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1522302|NCT00687882|Randomized|Parallel Assignment||Treatment||Single||||||t
1522303|NCT00687869|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1522304|NCT00687856|||Case-Only||Prospective|||||||
1522305|NCT00687843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522306|NCT00687830|Randomized|Parallel Assignment||Treatment||Single||||t||
1522307|NCT00687817||Single Group Assignment||Treatment||None (Open Label)||||||
1522308|NCT00687804|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522309|NCT00687791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522310|NCT00687778|||Cohort||Prospective|||||||
1522311|NCT00687765||Single Group Assignment||Treatment||None (Open Label)||||||
1522312|NCT00687752|||Case Control||Prospective|||||||
1522313|NCT00687739|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522314|NCT00687726|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522315|NCT00687713|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522316|NCT00687700|Randomized|Crossover Assignment||Treatment||||||||
1522317|NCT00687687||Single Group Assignment||Treatment||None (Open Label)||||||
1522318|NCT00687674||Single Group Assignment||Treatment||None (Open Label)||||||
1522319|NCT00687661|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1522320|NCT00687648|Randomized|||Treatment||None (Open Label)||||||
1522321|NCT00687622|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522322|NCT00687609||Single Group Assignment||Treatment||None (Open Label)||||||
1522323|NCT00687596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522324|NCT00687583|||Cohort||Prospective|||||||
1522325|NCT00687570|Randomized|Crossover Assignment||||None (Open Label)||||||
1522326|NCT00687544||Single Group Assignment||Treatment||None (Open Label)||||||
1522327|NCT00687531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522328|NCT00687518|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1522329|NCT00687505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522330|NCT00687492|||Case-Only||Prospective|||||||
1522331|NCT00687479|||Case-Only||Prospective|||||||
1522332|NCT00687466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522333|NCT00687453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522334|NCT00687440||Single Group Assignment||Treatment||None (Open Label)||||||
1522335|NCT00687427|||Cohort|||||||||
1522336|NCT00687414|||||Prospective|||||||
1522337|NCT00687401||Single Group Assignment||Treatment||None (Open Label)||||||
1522338|NCT00687388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522339|NCT00687375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522340|NCT00687362||Single Group Assignment||Treatment||None (Open Label)||||||
1522341|NCT00687349|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1522342|NCT00687336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522343|NCT00687323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522344|NCT00687310|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1522345|NCT00687297|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522346|NCT00687284|||Cohort||Retrospective|||||||
1522347|NCT00687271|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1522348|NCT00687258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522349|NCT00687245|Randomized|Parallel Assignment||||None (Open Label)||||||
1522350|NCT00687232|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522351|NCT00687219||Single Group Assignment||Treatment||None (Open Label)||||||
1522352|NCT00687206||Single Group Assignment||Treatment||None (Open Label)||||||
1522353|NCT00687193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522354|NCT00687180||||Treatment||||||||
1522355|NCT00687167|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1522356|NCT00687154|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522357|NCT00687141|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1522358|NCT00687128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522359|NCT00687115|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522360|NCT00687102|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1522361|NCT00687089|||Case-Only||Prospective|||||||
1522362|NCT00687076|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1522363|NCT00687063|||||Prospective|||||||
1522364|NCT00687050|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522365|NCT00687037||Single Group Assignment||Supportive Care||None (Open Label)||||||
1522366|NCT00687024|||Cohort||Prospective|||||||
1522367|NCT00687011||Single Group Assignment||Prevention||None (Open Label)||||||
1522368|NCT00686998|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522369|NCT00686985||Single Group Assignment||Treatment||None (Open Label)||||||
1522370|NCT00686972||Single Group Assignment||Other||None (Open Label)||||||
1522371|NCT00686959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522372|NCT00686946|||Cohort||Prospective|||||||
1522373|NCT00686933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522374|NCT00686920|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1522375|NCT00686907|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1522376|NCT00686894||Single Group Assignment||Diagnostic||None (Open Label)||||||
1522377|NCT00686881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522378|NCT00686868|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522379|NCT00686855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522380|NCT00686842||Single Group Assignment||Treatment||None (Open Label)||||||
1522381|NCT00686829||Single Group Assignment||Treatment||None (Open Label)||||||
1522382|NCT00686816|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522383|NCT00686803|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522384|NCT00686790||Single Group Assignment||Treatment||None (Open Label)||||||
1522385|NCT00686777||Single Group Assignment||Treatment||None (Open Label)||||||
1522386|NCT00686764|||Case-Only||Cross-Sectional|||||||
1522387|NCT00686751||Single Group Assignment||Prevention||None (Open Label)||||||
1522388|NCT00686738|||Case-Only||Prospective|||||||
1522389|NCT00686725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522390|NCT00686712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522391|NCT00686699|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1522392|NCT00686686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522393|NCT00686673|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1522394|NCT00686660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522395|NCT00686647||Single Group Assignment||Treatment||None (Open Label)||||||
1522396|NCT00686634||Single Group Assignment||Treatment||None (Open Label)||||||
1522397|NCT00686621||||||||||||
1522398|NCT00686608|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1522399|NCT00686595||Single Group Assignment||Treatment||None (Open Label)||||||
1522400|NCT00686582|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522401|NCT00686569|||Case Control||Prospective|||||||
1522402|NCT00686556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522403|NCT00686543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522404|NCT00686530|||Case Control||Prospective|||||||
1522405|NCT00686517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522406|NCT00686504|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1522407|NCT00686491|||Case Control||Prospective|||||||
1522408|NCT00686478|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522409|NCT00686465||Single Group Assignment||Treatment||None (Open Label)||||||
1522410|NCT00686452|||Case Control||Prospective|||||||
1522411|NCT00686439|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522412|NCT00686426|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522413|NCT00686413|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522414|NCT00686400|||Case Control||Prospective|||||||
1522415|NCT00686387|||Case-Only||Prospective|||||||
1522416|NCT00686374||Single Group Assignment||Treatment||None (Open Label)||||||
1522417|NCT00686361|Randomized|Single Group Assignment||Treatment||Single|||t|||
1522418|NCT00686348|||||Prospective|||||||
1522419|NCT00686335|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522420|NCT00686322||Single Group Assignment||Treatment||None (Open Label)||||||
1522421|NCT00686309|||Case-Crossover||Prospective|||||||
1522422|NCT00686296|Randomized|Parallel Assignment||Treatment||Single||||||t
1522423|NCT00686283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522424|NCT00686270||Single Group Assignment||Treatment||None (Open Label)||||||
1522425|NCT00686257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522426|NCT00686244|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522427|NCT00686231|Randomized|Parallel Assignment||||Single|||t|||
1522428|NCT00686218||Single Group Assignment||Treatment||None (Open Label)||||||
1522429|NCT00686205|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1522430|NCT00686192||Single Group Assignment||Prevention||None (Open Label)||||||
1522431|NCT00686179|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1522432|NCT00686166||Single Group Assignment||Treatment||None (Open Label)||||||
1522433|NCT00686140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522434|NCT00686127|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1522435|NCT00686114|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1522436|NCT00686101|||Case Control|||||||||
1522437|NCT00686088||Single Group Assignment||Treatment||None (Open Label)||||||
1522438|NCT00686075|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522439|NCT00686062|Randomized|Parallel Assignment||||Single|||||t|
1522440|NCT00686049|||Cohort||Prospective|||||||
1522441|NCT00686036|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522442|NCT00686023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522443|NCT00686010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522444|NCT00685997|||Cohort||Cross-Sectional|||||||
1522445|NCT00685984|||Case Control||Prospective|||||||
1522446|NCT00685971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522447|NCT00685958||Single Group Assignment||Treatment||None (Open Label)||||||
1522448|NCT00685945|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1522449|NCT00685932|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522450|NCT00685919|Randomized|Crossover Assignment||Other||Single|||t|||
1522451|NCT00685906|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1522452|NCT00685893|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1522453|NCT00685880|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1522454|NCT00685867|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1522455|NCT00685854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522456|NCT00685841|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522457|NCT00685828|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522458|NCT00685815|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1522459|NCT00685802|Randomized|Crossover Assignment||||None (Open Label)||||||
1522460|NCT00685789|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1522461|NCT00685776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522462|NCT00685763||Single Group Assignment||Treatment||None (Open Label)||||||
1522463|NCT00685750|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1522464|NCT00685737|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522465|NCT00685724|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1522466|NCT00685711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522467|NCT00685698||Single Group Assignment||Treatment||None (Open Label)||||||
1522468|NCT00685685|Randomized|Crossover Assignment||||Single||||||t
1522469|NCT00685672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522470|NCT00685659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522471|NCT00685646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522472|NCT00685633|Randomized|||Treatment||||||||
1522473|NCT00685620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522474|NCT00685607|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522475|NCT00685594|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1522476|NCT00685581|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1522477|NCT00685568|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1522478|NCT00685555|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522479|NCT00685542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522480|NCT00685529|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522481|NCT00685516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522482|NCT00685503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522483|NCT00685490|||Case-Only||Retrospective|||||||
1522484|NCT00685477|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1522485|NCT00685464|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1522486|NCT00685451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522487|NCT00685438|||Ecologic or Community||Prospective|||||||
1522488|NCT00685425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522489|NCT00685412|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522490|NCT00685399|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522491|NCT00685386|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1522492|NCT00685373||Single Group Assignment||Treatment||None (Open Label)||||||
1522493|NCT00685360|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522494|NCT00685347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522495|NCT00685334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522496|NCT00685321|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522497|NCT00685308|||Cohort||Prospective|||||||
1522498|NCT00685295|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1522499|NCT00685282|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1522500|NCT00685269|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522501|NCT00685256|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1522502|NCT00685243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522503|NCT00685230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522504|NCT00685217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522505|NCT00685204||Single Group Assignment||Treatment||||||||
1522506|NCT00685191|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522507|NCT00685178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522508|NCT00685165|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1522509|NCT00685152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522510|NCT00685139|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1522511|NCT00685126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522512|NCT00685113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522513|NCT00685100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522514|NCT00685087|||Case-Only||Prospective|||||||
1522515|NCT00685074|Randomized|Parallel Assignment||Treatment||Single||||||t
1522516|NCT00685061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522517|NCT00685048|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1522518|NCT00685035|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1522519|NCT00685022|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522520|NCT00685009|||Case Control||Prospective|||||||
1522521|NCT00684996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522522|NCT00684983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522523|NCT00684970|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522524|NCT00684957|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1522525|NCT00684944|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522526|NCT00684931|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1522527|NCT00684918||Parallel Assignment||Treatment||None (Open Label)||||||
1522528|NCT00684905||||Treatment||||||||
1522529|NCT00684892||Single Group Assignment||Diagnostic||None (Open Label)||||||
1522530|NCT00684879|||||Prospective|||||||
1522531|NCT00684866|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522532|NCT00684853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522533|NCT00684840|||Case-Only||Prospective|||||||
1522534|NCT00684827|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522535|NCT00684814|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1522536|NCT00684801|||Cohort||Retrospective|||||||
1522537|NCT00684788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522538|NCT00684775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522539|NCT00684762|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1522540|NCT00684749|||||Prospective|||||||
1522541|NCT00684736|||Cohort||Prospective|||||||
1522542|NCT00684723|Randomized|Crossover Assignment||||Single||||||t
1522543|NCT00684710|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522544|NCT00684697|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1522545|NCT00684684||Single Group Assignment||Diagnostic||None (Open Label)||||||
1522546|NCT00684671|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522547|NCT00684658|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1522548|NCT00684645|||Case-Only||Prospective|||||||
1522549|NCT00684632|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1522550|NCT00684619||Single Group Assignment||Treatment||None (Open Label)||||||
1522551|NCT00684606|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522552|NCT00684593|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522553|NCT00684580|||Cohort||Prospective|||||||
1522554|NCT00684567||Single Group Assignment||Treatment||None (Open Label)||||||
1522555|NCT00684554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522556|NCT00684541|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1522557|NCT00684528|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522558|NCT00684515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522559|NCT00684502|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1522560|NCT00684489|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522561|NCT00684476|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522562|NCT00684463||Single Group Assignment||Prevention||None (Open Label)||||||
1522563|NCT00684450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522564|NCT00684437|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1522565|NCT00684424|||Case Control||Cross-Sectional|||||||
1522566|NCT00684411||Single Group Assignment||Treatment||None (Open Label)||||||
1522567|NCT00684398|||||Prospective|||||||
1522568|NCT00684385||Single Group Assignment||Treatment||None (Open Label)||||||
1522569|NCT00684372|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522570|NCT00684359|||||Retrospective|||||||
1522571|NCT00684346||Single Group Assignment||Diagnostic||None (Open Label)||||||
1522572|NCT00684333||Single Group Assignment||||Single|||t|||
1522573|NCT00684320|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1522574|NCT00684307|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1522575|NCT00684294|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522576|NCT00684281|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1522577|NCT00684268|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522578|NCT00684255|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522579|NCT00684242||Single Group Assignment||Treatment||None (Open Label)||||||
1522580|NCT00684229|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1522581|NCT00684216|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522582|NCT00684203|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522583|NCT00684190|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1522584|NCT00684177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522585|NCT00684164|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1522586|NCT00684151|||Cohort||Retrospective|||||||
1522587|NCT00684138|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522588|NCT00684125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522589|NCT00684112|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522590|NCT00684099|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522591|NCT00684086|Randomized|Single Group Assignment||||None (Open Label)||||||
1522592|NCT00684073||Single Group Assignment||Treatment||None (Open Label)||||||
1522593|NCT00684060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522594|NCT00684047|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522595|NCT00684034|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1522596|NCT00684021|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522597|NCT00684008||Single Group Assignment||Treatment||None (Open Label)||||||
1522598|NCT00683995||Single Group Assignment||Treatment||None (Open Label)||||||
1522599|NCT00683982|Randomized|Parallel Assignment||Treatment||Single||||t||
1522600|NCT00683969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522601|NCT00683956|Randomized|Single Group Assignment||||Single||||||
1522602|NCT00683943|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522603|NCT00683930|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522604|NCT00683917|Randomized|Parallel Assignment||Prevention||Single|||t|||
1522605|NCT00683904|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522606|NCT00683891|||Case-Only||Prospective|||||||
1522607|NCT00683878|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522608|NCT00683865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522609|NCT00683852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522610|NCT00683839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522611|NCT00683826|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1522612|NCT00683813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522613|NCT00683800|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522614|NCT00683787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522615|NCT00683774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522616|NCT00683761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522617|NCT00683748|||Case-Only||Prospective|||||||
1522618|NCT00683735|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1522619|NCT00683722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522620|NCT00683709|||Cohort||Prospective|||||||
1522621|NCT00683696|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522622|NCT00683683||Single Group Assignment||Treatment||None (Open Label)||||||
1522623|NCT00683670|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522624|NCT00683657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522625|NCT00683644|Randomized|Crossover Assignment||Treatment||Double|placebo pill||t||t|
1522626|NCT00683631||Single Group Assignment||Treatment||None (Open Label)||||||
1522627|NCT00683618|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522628|NCT00683592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522629|NCT00683579|||Cohort||Prospective|||||||
1522630|NCT00683566||Single Group Assignment||||None (Open Label)||||||
1522631|NCT00683553|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1522632|NCT00683540|||Other||Prospective|||||||
1522633|NCT00683527|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522634|NCT00683514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522635|NCT00683501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522636|NCT00683488|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522637|NCT00683475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522638|NCT00683462|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1522639|NCT00683449|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522640|NCT00683436|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1522641|NCT00683423|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522642|NCT00683410|||Case-Only||Prospective|||||||
1522643|NCT00683397|||Cohort||Prospective|||||||
1522644|NCT00683384|||Case-Only||Prospective|||||||
1522645|NCT00683371|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1522646|NCT00683358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522647|NCT00683345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522648|NCT00683332|||Case-Only||Prospective|||||||
1522649|NCT00683319||||||||||||
1522650|NCT00683306||||||||||||
1522651|NCT00683293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522652|NCT00683280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522653|NCT00683267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522654|NCT00683254|||Cohort||Cross-Sectional|||||||
1522655|NCT00683241||Single Group Assignment||Treatment||None (Open Label)||||||
1522656|NCT00683228||Single Group Assignment||Prevention||None (Open Label)||||||
1522657|NCT00683202|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1522658|NCT00683189||Single Group Assignment||Treatment||None (Open Label)||||||
1522659|NCT00683176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522660|NCT00683163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522661|NCT00683150|||Case-Only||Prospective|||||||
1522662|NCT00683137|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522663|NCT00683124|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1522664|NCT00683111|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1522665|NCT00683098|||Case-Only||Prospective|||||||
1522666|NCT00683085|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522667|NCT00683072|||Case-Only||Prospective|||||||
1522668|NCT00683059||Single Group Assignment||Treatment||None (Open Label)||||||
1522669|NCT00683046||Single Group Assignment||Treatment||None (Open Label)||||||
1522670|NCT00683033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522671|NCT00683020|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1522672|NCT00683007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522673|NCT00682994||Single Group Assignment||||None (Open Label)||||||
1522674|NCT00682981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522675|NCT00682968|||Other||Other|||||||
1522676|NCT00682955|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522677|NCT00682942|||Cohort||Prospective|||||||
1522678|NCT00682929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522679|NCT00682916|Randomized|Crossover Assignment||Treatment||Single|||t|||
1522680|NCT00682903|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1522681|NCT00682890|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1522682|NCT00682877|||Case Control||Prospective|||||||
1522683|NCT00682851|||Cohort||Cross-Sectional|||||||
1522684|NCT00682838|Randomized|Parallel Assignment||Treatment||Single||||t||
1522685|NCT00682825|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1522686|NCT00682812|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1522687|NCT00682799|||||Prospective|||||||
1522688|NCT00682786|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522689|NCT00682773|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1522690|NCT00682760|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1522691|NCT00682747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522692|NCT00682734|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522693|NCT00682721|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1522694|NCT00682708||||Prevention||||||||
1522695|NCT00682695|||Ecologic or Community||Prospective|||||||
1522696|NCT00682682|Randomized|Crossover Assignment||Treatment||Single|||t|||
1522697|NCT00682669|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522698|NCT00682656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522699|NCT00682643|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522700|NCT00682630|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522701|NCT00682617|Randomized|Crossover Assignment||Treatment||Single|||t|||
1522702|NCT00682604|||Ecologic or Community||Cross-Sectional|||||||
1522703|NCT00682591|||Cohort||Prospective|||||||
1522704|NCT00682578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522705|NCT00682565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522706|NCT00682552||Single Group Assignment||Diagnostic||None (Open Label)||||||
1522707|NCT00682539|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522708|NCT00682526|||Case Control|||||||||
1522709|NCT00682513|||Family-Based||Prospective|||||||
1522710|NCT00682500|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522711|NCT00682487|||Case Control||Prospective|||||||
1522712|NCT00682474|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522713|NCT00682461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522714|NCT00682448|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1522715|NCT00682435||Single Group Assignment||Treatment||None (Open Label)||||||
1522716|NCT00682422|||Family-Based||Retrospective|||||||
1522717|NCT00682409||Single Group Assignment||Diagnostic||None (Open Label)||||||
1522718|NCT00682383||Single Group Assignment||Prevention||None (Open Label)||||||
1522719|NCT00682370|Randomized|Crossover Assignment||Treatment||Single||||||t
1522874|NCT00680329|||Cohort||Prospective|||||||
1522720|NCT00682357|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1522721|NCT00682344|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1522722|NCT00682318|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522723|NCT00682305||Single Group Assignment||Treatment||None (Open Label)||||||
1522724|NCT00682292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522725|NCT00682279|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522726|NCT00682266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522727|NCT00682253|||Cohort||Prospective|||||||
1522728|NCT00682240|Randomized|Crossover Assignment||||None (Open Label)||||||
1522729|NCT00682227||Single Group Assignment||Treatment||None (Open Label)||||||
1522730|NCT00682214|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1522731|NCT00682201|||Cohort||Prospective|||||||
1522732|NCT00682188|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522733|NCT00682175|||Case-Only||Prospective|||||||
1522734|NCT00682162|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1522735|NCT00682149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522736|NCT00682136|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1522737|NCT00682123|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1522738|NCT00682110|||Case Control||Prospective|||||||
1522739|NCT00682097|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522740|NCT00682084|||Cohort||Prospective|||||||
1522741|NCT00682071|||Case Control||Prospective|||||||
1522742|NCT00682058|||Cohort||Prospective|||||||
1522743|NCT00682045|||Cohort||Prospective|||||||
1522744|NCT00682032|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1522745|NCT00682019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522746|NCT00682006|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1522747|NCT00681993|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522748|NCT00681980|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522749|NCT00681967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522750|NCT00681954|||Cohort||Prospective|||||||
1522751|NCT00681941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522752|NCT00681928|||Case Control||Prospective|||||||
1522753|NCT00681915|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1522754|NCT00681902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522755|NCT00681889||Single Group Assignment||Treatment||None (Open Label)||||||
1522756|NCT00681876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522757|NCT00681863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522758|NCT00681850|||Cohort||Prospective|||||||
1522759|NCT00681837|||Cohort||Cross-Sectional|||||||
1522760|NCT00681824|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1522761|NCT00681811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522762|NCT00681798|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522763|NCT00681785|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1522764|NCT00681772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522765|NCT00681759|||||Prospective|||||||
1522766|NCT00681746|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1522767|NCT00681733|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1522768|NCT00681720|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1522769|NCT00681707|||Cohort||Retrospective|||||||
1522770|NCT00681694|||Cohort||Prospective|||||||
1522771|NCT00681681|||Cohort||Prospective|||||||
1522772|NCT00681668||Single Group Assignment||Treatment||None (Open Label)||||||
1522773|NCT00681655||Single Group Assignment||Other||None (Open Label)||Two session, within subjects, single blind||||
1522774|NCT00681642|||Case Control||Prospective|||||||
1522775|NCT00681629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522776|NCT00681616|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1522777|NCT00681603|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522778|NCT00681590|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1522779|NCT00681577||Single Group Assignment||Treatment||None (Open Label)||||||
1522780|NCT00681564|Randomized|Parallel Assignment||Basic Science||Double|||||t|t
1522781|NCT00681551|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1522782|NCT00681538|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1522783|NCT00681525|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522784|NCT00681512||Single Group Assignment||Basic Science||None (Open Label)||||||
1522785|NCT00681499|||Cohort||Prospective|||||||
1522786|NCT00681486|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522787|NCT00681473||Single Group Assignment||Treatment||None (Open Label)||||||
1522788|NCT00681460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522789|NCT00681447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522790|NCT00681434|Randomized|Parallel Assignment||Treatment||Single||||||t
1522791|NCT00681421||Single Group Assignment||Treatment||None (Open Label)||||||
1522792|NCT00681408|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522793|NCT00681395|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522794|NCT00681382|||Case-Only||Cross-Sectional|||||||
1522795|NCT00681369|||Cohort||Retrospective|||||||
1522796|NCT00681356|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1522797|NCT00681343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522798|NCT00681330||Single Group Assignment||Treatment||None (Open Label)||||||
1522799|NCT00681317|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1522800|NCT00681304|||Case-Only||Prospective|||||||
1522801|NCT00681291|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1522802|NCT00681278|||Cohort||Retrospective|||||||
1522803|NCT00681265|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1522804|NCT00681252||Single Group Assignment||Treatment||None (Open Label)||||||
1522805|NCT00681239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522806|NCT00681226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522807|NCT00681213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522808|NCT00681200|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1522809|NCT00681187|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522810|NCT00681174|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1522811|NCT00681161||Single Group Assignment||Basic Science||None (Open Label)||||||
1522812|NCT00681148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522813|NCT00681135|Randomized|Parallel Assignment||Prevention||Single|||||t|
1522814|NCT00681122|||Cohort||Prospective|||||||
1522815|NCT00681109|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522816|NCT00681096|||Cohort||Prospective|||||||
1522817|NCT00681083|Randomized|Crossover Assignment||Treatment||Single|||||t|
1522818|NCT00681070|Randomized|Parallel Assignment||Treatment||Single||||||t
1522819|NCT00681057||||||||||||
1522820|NCT00681044||Single Group Assignment||Treatment||None (Open Label)||||||
1522821|NCT00681031||Single Group Assignment||Prevention||None (Open Label)||||||
1522822|NCT00681018|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1522823|NCT00681005|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1522824|NCT00680992||Single Group Assignment||Treatment||None (Open Label)||||||
1522825|NCT00680979|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522826|NCT00680966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522827|NCT00680953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522828|NCT00680940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522829|NCT00680927|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1522830|NCT00680914|Randomized|Parallel Assignment||Prevention||Single|||t|||
1522831|NCT00680901|Randomized|||Treatment||Quadruple|||t|t|t|t
1522832|NCT00680888|||Case-Only||Retrospective|||||||
1522833|NCT00680875|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522834|NCT00680862|||Cohort||Cross-Sectional|||||||
1522835|NCT00680849|||Cohort||Prospective|||||||
1522836|NCT00680836|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522837|NCT00680823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522838|NCT00680797|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1522839|NCT00680784|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1522840|NCT00680771|||Cohort||Prospective|||||||
1522841|NCT00680758||Single Group Assignment||Treatment||None (Open Label)||||||
1522842|NCT00680745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522843|NCT00680732|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1522844|NCT00680719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522845|NCT00680706|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522846|NCT00680693|Randomized|Parallel Assignment||Treatment||Single||||||t
1522847|NCT00680680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522848|NCT00680667||Single Group Assignment||Treatment||None (Open Label)||||||
1522849|NCT00680654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522850|NCT00680641|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522851|NCT00680628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522852|NCT00680615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522853|NCT00680602|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1522854|NCT00680589||Single Group Assignment||Treatment||None (Open Label)||||||
1522855|NCT00680576|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1522856|NCT00680563|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522857|NCT00680550|||||Prospective|||||||
1522858|NCT00680537|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1522859|NCT00680524|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1522860|NCT00680511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522861|NCT00680498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522862|NCT00680485|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522863|NCT00680472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522864|NCT00680459|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1522865|NCT00680446||Single Group Assignment||Treatment||None (Open Label)||||||
1522866|NCT00680433|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1522867|NCT00680420|||Cohort||Prospective|||||||
1522868|NCT00680407|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522869|NCT00680394|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522870|NCT00680381|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1522871|NCT00680368|||Case-Only||Prospective|||||||
1522872|NCT00680355|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1522873|NCT00680342|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522875|NCT00680316|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522876|NCT00680303|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1522877|NCT00680290||Single Group Assignment||Treatment||None (Open Label)||||||
1522878|NCT00680277|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1522879|NCT00680264|||Case-Control||Prospective|||||||
1522880|NCT00680251||||||||||||
1522881|NCT00680238|Randomized|Parallel Assignment||||Single|||t|||
1522882|NCT00680225|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522883|NCT00680212|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1522884|NCT00680199|||Cohort||Prospective|||||||
1522885|NCT00680186|Randomized|Parallel Assignment||Treatment||Double||||||
1522886|NCT00680173|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1522887|NCT00680160||||Treatment||None (Open Label)||||||
1522888|NCT00680147||Single Group Assignment||Prevention||None (Open Label)||||||
1522889|NCT00680134|Randomized|||Treatment||None (Open Label)||||||
1522890|NCT00680121|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522891|NCT00680108|Randomized|Parallel Assignment||Treatment||Double||||||
1522892|NCT00680095||||Other||None (Open Label)||||||
1522893|NCT00680082|||Cohort||Cross-Sectional|||||||
1522894|NCT00680069|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1522895|NCT00680056|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1522896|NCT00680043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522897|NCT00680030|||Case-Only||Prospective|||||||
1522898|NCT00680017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522899|NCT00680004|||Cohort||Prospective|||||||
1522900|NCT00679991|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1522901|NCT00679978|||Cohort||Prospective|||||||
1522902|NCT00679965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522903|NCT00679952|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522904|NCT00679939|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522905|NCT00679926|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522906|NCT00679913|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522907|NCT00679900|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522908|NCT00679887|Randomized|Crossover Assignment||Treatment||Single|||t|||
1522909|NCT00679874|||Cohort||Prospective|||||||
1522910|NCT00679861|Randomized|Factorial Assignment||Health Services Research||Double||||t||t
1522911|NCT00679848||Single Group Assignment||Treatment||None (Open Label)||||||
1522912|NCT00679835|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1522913|NCT00679822|||Case-Only|||||||||
1522914|NCT00679809|||Cohort||Prospective|||||||
1522915|NCT00679796|||Case Control||Prospective|||||||
1522916|NCT00679783|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522917|NCT00679770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522918|NCT00679757|||||Cross-Sectional|||||||
1522919|NCT00679744|Randomized|Factorial Assignment||||Quadruple|||t|t|t|t
1522920|NCT00679731|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522921|NCT00679718|Randomized|Parallel Assignment||Treatment||Double||||||
1522922|NCT00679705|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1522923|NCT00679692|||||Prospective|||||||
1522924|NCT00679679|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522925|NCT00679666|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1522926|NCT00679653|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522927|NCT00679640|||Cohort||Prospective|||||||
1522928|NCT00679627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522929|NCT00679614|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522930|NCT00679601||||Treatment||None (Open Label)||||||
1522931|NCT00679588|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1522932|NCT00679575|||Case Control||Prospective|||||||
1522933|NCT00679562|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1522934|NCT00679549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522935|NCT00679536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522936|NCT00679523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522937|NCT00679510|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1522938|NCT00679497|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1522939|NCT00679484|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522940|NCT00679471|||Cohort||Prospective|||||||
1522941|NCT00679458|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1522942|NCT00679445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522943|NCT00679432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522944|NCT00679419|||Cohort||Prospective|||||||
1522945|NCT00679406||Single Group Assignment||Treatment||None (Open Label)||||||
1522946|NCT00679393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522947|NCT00679380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522948|NCT00679367||Single Group Assignment||Treatment||None (Open Label)||||||
1522949|NCT00679354||Single Group Assignment||Treatment||None (Open Label)||||||
1522950|NCT00679341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522951|NCT00679328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522952|NCT00679315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1522953|NCT00679302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523185|NCT00676247|||Cohort||Cross-Sectional|||||||
1522954|NCT00679289|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Dose-escalation cohorts||||
1522955|NCT00679276|||Case Control||Retrospective|||||||
1522956|NCT00679263|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522957|NCT00679250|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1522958|NCT00679237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522959|NCT00679224|||Other||Prospective|||||||
1522960|NCT00679211||Single Group Assignment||Treatment||None (Open Label)||||||
1522961|NCT00679198|Randomized|Single Group Assignment||Supportive Care||Double|||t|t||
1522962|NCT00679185|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1522963|NCT00679172|Randomized|Sequential Assignment||Prevention||Triple|||t||t|t
1522964|NCT00679159|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1522965|NCT00679146|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522966|NCT00679133||Single Group Assignment||Treatment||None (Open Label)||||||
1522967|NCT00679120|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522968|NCT00679107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522969|NCT00679094|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1522970|NCT00679081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522971|NCT00679068|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1522972|NCT00679055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522973|NCT00679042||Single Group Assignment||Treatment||None (Open Label)||||||
1522974|NCT00679029||Single Group Assignment||Treatment||None (Open Label)||||||
1522975|NCT00679003|Randomized|Parallel Assignment||Treatment||Single|||t|||
1522976|NCT00678990||Single Group Assignment||Treatment||None (Open Label)||||||
1522977|NCT00678977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522978|NCT00678964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522979|NCT00678938|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1522980|NCT00678925|Randomized|Parallel Assignment||||Triple|||t||t|t
1522981|NCT00678912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522982|NCT00678899||Single Group Assignment||Treatment||None (Open Label)||||||
1522983|NCT00678886|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522984|NCT00678873||Single Group Assignment||Treatment||None (Open Label)||||||
1522985|NCT00678860|||||Prospective|||||||
1522986|NCT00678847|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1522987|NCT00678834|Randomized|Parallel Assignment||||Single|||t|||
1522988|NCT00678821|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1522989|NCT00678808||||||||||||
1522990|NCT00678795|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1522991|NCT00678782|Randomized|Crossover Assignment||Treatment||Single|||t|||
1522992|NCT00678769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1522993|NCT00678756|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1522994|NCT00678743||Single Group Assignment||Treatment||None (Open Label)||||||
1522995|NCT00678730|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1522996|NCT00678717|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1522997|NCT00678704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522998|NCT00678691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1522999|NCT00678678||||||||||||
1523000|NCT00678665|||Case Control||Prospective|||||||
1523001|NCT00678652|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1523002|NCT00678639|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1523003|NCT00678626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523004|NCT00678613|Randomized|||Prevention||Double||||||
1523005|NCT00678600|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1523006|NCT00678587|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523007|NCT00678574|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523008|NCT00678561|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523009|NCT00678548|Randomized|Parallel Assignment||Treatment||Single|||t|||
1523010|NCT00678535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523011|NCT00678522|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1523012|NCT00678509||Single Group Assignment||Treatment||None (Open Label)||||||
1523013|NCT00678496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523014|NCT00678483|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523015|NCT00678470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523016|NCT00678457|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1523017|NCT00678444|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523018|NCT00678431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523019|NCT00678418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523020|NCT00678405|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1523021|NCT00678392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523022|NCT00678379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523023|NCT00678366|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1523024|NCT00678353|||Case-Only||Prospective|||||||
1523025|NCT00678340|Randomized|Parallel Assignment||Treatment||Single|||t|||
1523026|NCT00678327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523027|NCT00678314|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1523028|NCT00678301|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523029|NCT00678288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523030|NCT00678275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523031|NCT00678262|||Case Control||Prospective|||||||
1523032|NCT00678249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523033|NCT00678236|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1523034|NCT00678210|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523035|NCT00678197||||Health Services Research||||||||
1523036|NCT00678184|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1523037|NCT00678171|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1523038|NCT00678158|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523039|NCT00678145|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1523040|NCT00678132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523041|NCT00678119|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523042|NCT00678106|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1523043|NCT00678093|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1523044|NCT00678080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523045|NCT00678067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523046|NCT00678054||Single Group Assignment||Treatment||None (Open Label)||||||
1523047|NCT00678041|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523048|NCT00678028|||Case Control||Prospective|||||||
1523049|NCT00678015||Single Group Assignment||Treatment||None (Open Label)||||||
1523050|NCT00678002|||Cohort||Prospective|||||||
1523051|NCT00677989|||Case Control||Prospective|||||||
1523052|NCT00677976|||Case-Control||Prospective|||||||
1523053|NCT00677963||Single Group Assignment||Diagnostic||None (Open Label)||||||
1523054|NCT00677950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523055|NCT00677937|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523056|NCT00677924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523057|NCT00677911|Non-Randomized|Single Group Assignment||||||||||
1523058|NCT00677898|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523059|NCT00677885|||||Prospective|||||||
1523060|NCT00677872||Single Group Assignment||Treatment||None (Open Label)||||||
1523061|NCT00677859|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1523062|NCT00677846|||Case-Only||Prospective|||||||
1523063|NCT00677833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523064|NCT00677820|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523065|NCT00677807|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523066|NCT00677794|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1523067|NCT00677781|||Cohort||Prospective|||||||
1523068|NCT00677768|||Case Control||Prospective|||||||
1523069|NCT00677755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523070|NCT00677742|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523071|NCT00677729|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523072|NCT00677716||Single Group Assignment||Treatment||None (Open Label)||||||
1523073|NCT00677703|Randomized|Single Group Assignment||||None (Open Label)||||||
1523074|NCT00677690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523075|NCT00677677||Single Group Assignment||Prevention||None (Open Label)||||||
1523076|NCT00677664|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523077|NCT00677651|||Case-Only||Prospective|||||||
1523078|NCT00677638||Single Group Assignment||Treatment||None (Open Label)||||||
1523079|NCT00677625|||Cohort||Prospective|||||||
1523080|NCT00677612||Single Group Assignment||Treatment||None (Open Label)||||||
1523081|NCT00677599|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1523082|NCT00677586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523083|NCT00677573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523084|NCT00677560|||Cohort||Cross-Sectional|||||||
1523085|NCT00677547|||Case Control||Prospective|||||||
1523086|NCT00677534||Single Group Assignment||Treatment||None (Open Label)||||||
1523087|NCT00677521||Single Group Assignment||Treatment||None (Open Label)||||||
1523088|NCT00677508|||Case-Only||Prospective|||||||
1523089|NCT00677495||Single Group Assignment||Diagnostic||None (Open Label)||||||
1523090|NCT00677482|||Cohort||Prospective|||||||
1523091|NCT00677469|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523092|NCT00677456|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1523093|NCT00677443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523094|NCT00677430|||Case-Only||Prospective|||||||
1523095|NCT00677417|||Case-Only||Retrospective|||||||
1523096|NCT00677404||Single Group Assignment||Treatment||None (Open Label)||||||
1523097|NCT00677391|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523098|NCT00677378|||Case Control||Prospective|||||||
1523099|NCT00677365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523100|NCT00677352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523101|NCT00677339|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1523102|NCT00677326||Single Group Assignment||Treatment||None (Open Label)||||||
1523103|NCT00677313||Single Group Assignment||Treatment||None (Open Label)||||||
1523104|NCT00677300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523105|NCT00677287||Single Group Assignment||Treatment||None (Open Label)||||||
1523106|NCT00677274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523107|NCT00677261|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1523108|NCT00677248|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523109|NCT00677235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523110|NCT00677222|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523111|NCT00677209||Single Group Assignment||Treatment||None (Open Label)||||||
1523112|NCT00677196|Randomized|Parallel Assignment||Treatment||Single|||t|||
1523113|NCT00677183|||Family-Based||Prospective|||||||
1523114|NCT00677170|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523115|NCT00677157|||||Prospective|||||||
1523116|NCT00677144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523117|NCT00677131|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523118|NCT00677118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523119|NCT00677105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523120|NCT00677092||Single Group Assignment||Treatment||None (Open Label)||||||
1523121|NCT00677079||Single Group Assignment||Treatment||None (Open Label)||||||
1523122|NCT00677066|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1523123|NCT00677053|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523124|NCT00677040|||Case-Only||Prospective|||||||
1523125|NCT00677027|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1523126|NCT00677014|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1523127|NCT00677001|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523128|NCT00676988|||Case-Only||Cross-Sectional|||||||
1523129|NCT00676975|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523130|NCT00676962|Randomized|Parallel Assignment||||None (Open Label)||||||
1523131|NCT00676949||Single Group Assignment||Treatment||None (Open Label)||||||
1523132|NCT00676936|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1523133|NCT00676923|||Cohort||Prospective|||||||
1523134|NCT00676910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523135|NCT00676897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523136|NCT00676884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523137|NCT00676871|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523138|NCT00676858|||Cohort||Prospective|||||||
1523139|NCT00676845|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523140|NCT00676832|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523141|NCT00676819|Randomized|Crossover Assignment||Treatment||Double||||||
1523142|NCT00676806|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523143|NCT00676793||Single Group Assignment||Basic Science||None (Open Label)||||||
1523144|NCT00676780||Single Group Assignment||Basic Science||None (Open Label)||||||
1523145|NCT00676767|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1523146|NCT00676754|||Cohort||Prospective|||||||
1523147|NCT00676741|||Cohort||Prospective|||||||
1523148|NCT00676728||Single Group Assignment||Treatment||None (Open Label)||||||
1523149|NCT00676715|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523150|NCT00676702||Crossover Assignment||||||||||
1523151|NCT00676689||Single Group Assignment||Treatment||None (Open Label)||||||
1523152|NCT00676676||Single Group Assignment||Treatment||None (Open Label)||||||
1523153|NCT00676663|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523154|NCT00676650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523155|NCT00676637|||Cohort||Prospective|||||||
1523156|NCT00676624|||Cohort||Prospective|||||||
1523157|NCT00676611|||Case-Only||Retrospective|||||||
1523158|NCT00676598|||Cohort||Retrospective|||||||
1523159|NCT00676585|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523160|NCT00676572|||||Prospective|||||||
1523161|NCT00676559|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1523162|NCT00676546||||||||||||
1523163|NCT00676533|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523164|NCT00676520|||Cohort||Prospective|||||||
1523165|NCT00676507|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523166|NCT00676494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523167|NCT00676481|Randomized|Parallel Assignment||Screening||Single|||t|||
1523168|NCT00676468|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523169|NCT00676455|||Cohort||Prospective|||||||
1523170|NCT00676442|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1523171|NCT00676429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523172|NCT00676416|||Case Control||Prospective|||||||
1523173|NCT00676403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523174|NCT00676390||Single Group Assignment||Prevention||None (Open Label)||||||
1523175|NCT00676377|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1523176|NCT00676364|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523177|NCT00676351||Single Group Assignment||Diagnostic||None (Open Label)||||||
1523178|NCT00676338|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523179|NCT00676325|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1523180|NCT00676312|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1523181|NCT00676299|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523182|NCT00676286|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1523183|NCT00676273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523184|NCT00676260|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523186|NCT00676234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523187|NCT00676221|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523188|NCT00676208|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523189|NCT00676195||Single Group Assignment||Treatment||None (Open Label)||||||
1523190|NCT00676182|||Case-Only||Prospective|||||||
1523191|NCT00676169|||Cohort||Prospective|||||||
1523192|NCT00676156|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523193|NCT00676143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523194|NCT00676130|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523195|NCT00676117|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523196|NCT00676104|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1523197|NCT00676091|Randomized|Parallel Assignment||Prevention||Double||||||
1523198|NCT00676078||||||||||||
1523199|NCT00676065|||Cohort||Prospective|||||||
1523200|NCT00676052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523201|NCT00676039|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523202|NCT00676026|Non-Randomized|Single Group Assignment||Other||Single|||t|||
1523203|NCT00676013|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1523204|NCT00676000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523205|NCT00675987|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1523206|NCT00675974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523207|NCT00675961|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1523208|NCT00675948|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523209|NCT00675935|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523210|NCT00675922||Single Group Assignment||Treatment||None (Open Label)||||||
1523211|NCT00675909|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1523212|NCT00675896|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523213|NCT00675883||||||||||||
1523214|NCT00675870||Single Group Assignment||Treatment||None (Open Label)||||||
1523215|NCT00675857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523216|NCT00675844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523217|NCT00675831||Single Group Assignment||Treatment||None (Open Label)||||||
1523218|NCT00675818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523219|NCT00675805|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523220|NCT00675792|Randomized|Parallel Assignment||Treatment||Single||||||t
1523221|NCT00675779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523222|NCT00675766|||Case Control||Prospective|||||||
1523223|NCT00675753|||Case Control||Retrospective|||||||
1523224|NCT00675740|Randomized|Parallel Assignment||Treatment||Single||||||t
1523225|NCT00675727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523226|NCT00675714|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523227|NCT00675701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523228|NCT00675688|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523229|NCT00675675|Randomized|Parallel Assignment||Basic Science||Single||||||t
1523230|NCT00675662|Randomized|Factorial Assignment||Prevention||Single|||||t|
1523231|NCT00675649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523232|NCT00675636|||Other||Prospective|||||||
1523233|NCT00675623|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523234|NCT00675610|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523235|NCT00675597||Single Group Assignment||Treatment||None (Open Label)||||||
1523236|NCT00675584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523237|NCT00675558|||Case Control||Prospective|||||||
1523238|NCT00675545||Single Group Assignment||Treatment||None (Open Label)||||||
1523239|NCT00675532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523240|NCT00675519|Randomized|Parallel Assignment||Treatment||Single||||||t
1523241|NCT00675506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523242|NCT00675493|||Cohort||Prospective|||||||
1523243|NCT00675480|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1523244|NCT00675467|||Cohort||Prospective|||||||
1523245|NCT00675454|||Cohort||Prospective|||||||
1523246|NCT00675441||Single Group Assignment||Treatment||None (Open Label)||||||
1523247|NCT00675428|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523248|NCT00675415|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1523249|NCT00675402|||Cohort||Prospective|||||||
1523250|NCT00675389|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1523251|NCT00675376|||Cohort||Prospective|||||||
1523252|NCT00675363|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1523253|NCT00675350||Single Group Assignment||||None (Open Label)||||||
1523254|NCT00675337|Randomized|Parallel Assignment||Prevention||Single||||t||
1523255|NCT00675324|Randomized|Parallel Assignment||Basic Science||Single||||t||
1523256|NCT00675311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523257|NCT00675298|||Family-Based||Prospective|||||||
1523258|NCT00675285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523259|NCT00675272|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1523260|NCT00675259||Single Group Assignment||Treatment||None (Open Label)||||||
1523261|NCT00675246|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523262|NCT00675233||Single Group Assignment||Treatment||None (Open Label)||||||
1523263|NCT00675220|||Cohort||Prospective|||||||
1523264|NCT00675207|Randomized|Parallel Assignment||Treatment||Single|||||t|
1523265|NCT00675194|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523266|NCT00675181|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1523267|NCT00675168|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1523268|NCT00675155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523269|NCT00675142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523270|NCT00675129|Randomized|Parallel Assignment||Treatment||Single||||||t
1523271|NCT00675116|Randomized|Parallel Assignment||Treatment||Single||||||
1523272|NCT00675103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523273|NCT00675090|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1523274|NCT00675077|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523275|NCT00675064|Randomized|Parallel Assignment||Other||Single|||t|||
1523276|NCT00675051|||Case-Only||Prospective|||||||
1523277|NCT00675038|||Case-Only||Prospective|||||||
1523278|NCT00675025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523279|NCT00675012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523280|NCT00674999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523281|NCT00674986|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1523282|NCT00674973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523283|NCT00674960|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523284|NCT00674947|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523285|NCT00674934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523286|NCT00674921|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1523287|NCT00674908|Randomized|Parallel Assignment||Prevention||Single|||t|||
1523288|NCT00674895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523289|NCT00674882|||Other||Other|||||||
1523290|NCT00674869|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523291|NCT00674856|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523292|NCT00674843|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523293|NCT00674830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523294|NCT00674817|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1523295|NCT00674804|||||Other|||||||
1523296|NCT00674791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523297|NCT00674778|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523298|NCT00674765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523299|NCT00674752|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523300|NCT00674739|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523301|NCT00674726|||Case Control||Prospective|||||||
1523302|NCT00674713|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1523303|NCT00674700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523304|NCT00674687|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1523305|NCT00674674|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523306|NCT00674661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523307|NCT00674648||Single Group Assignment||Treatment||None (Open Label)||||||
1523308|NCT00674635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523309|NCT00674622|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523310|NCT00674609|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1523311|NCT00674596|Randomized|Crossover Assignment||Prevention||Single||||||
1523312|NCT00674583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523313|NCT00674570|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1523314|NCT00674557|Randomized|||Treatment||None (Open Label)||||||
1523315|NCT00674544|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1523316|NCT00674531||Single Group Assignment||Basic Science||None (Open Label)||||||
1523317|NCT00674518|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1523318|NCT00674505||Single Group Assignment||||None (Open Label)||||||
1523319|NCT00674492|||||Retrospective|||||||
1523320|NCT00674479||Single Group Assignment||Treatment||None (Open Label)||||||
1523321|NCT00674466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523322|NCT00674453|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1523323|NCT00674440|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1523324|NCT00674427|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523325|NCT00674414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523326|NCT00674401|Randomized|Parallel Assignment||Treatment||Single|||t|||
1523327|NCT00674388|||Other||Prospective|||||||
1523328|NCT00674375|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1523329|NCT00674362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523330|NCT00674349||Parallel Assignment||Basic Science||None (Open Label)||||||
1523331|NCT00674336||Single Group Assignment||Prevention||Triple|||t|t|t|
1523332|NCT00674323|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1523333|NCT00674310|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523334|NCT00674297||Single Group Assignment||Basic Science||None (Open Label)||||||
1523335|NCT00674284|||Cohort||Retrospective|||||||
1523336|NCT00674271||||||||||||
1523337|NCT00674258||Single Group Assignment||Treatment||None (Open Label)||||||
1523338|NCT00674245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523339|NCT00674232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523340|NCT00674219||Single Group Assignment||Treatment||None (Open Label)||||||
1523341|NCT00674206||Single Group Assignment||Treatment||None (Open Label)||||||
1523342|NCT00674193|||Cohort||Prospective|||||||
1523343|NCT00674180|||Other||Other|||||||
1523344|NCT00674167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523345|NCT00674154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523346|NCT00674141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523347|NCT00674128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523348|NCT00674115|Randomized|Crossover Assignment||||None (Open Label)||||||
1523349|NCT00674102||Single Group Assignment||Treatment||None (Open Label)||||||
1523350|NCT00674089|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1523351|NCT00674076|||Case Control||Prospective|||||||
1523352|NCT00674063|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523353|NCT00674050|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523354|NCT00674037|Randomized|Parallel Assignment||||Single|||t|||
1523355|NCT00674024|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523356|NCT00674011|||Case-Only||Prospective|||||||
1523357|NCT00673998|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1523358|NCT00673985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523359|NCT00673972||Parallel Assignment||Diagnostic||None (Open Label)||||||
1523360|NCT00673959|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523361|NCT00673946|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1523362|NCT00673933|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523363|NCT00673920|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523364|NCT00673907|Randomized|Crossover Assignment||||Double|||t||t|
1523365|NCT00673894|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523366|NCT00673881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523367|NCT00673868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523368|NCT00673855|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523369|NCT00673842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523370|NCT00673829|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523371|NCT00673816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523372|NCT00673803|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523373|NCT00673790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523374|NCT00673777||Single Group Assignment||Treatment||None (Open Label)||||||
1523375|NCT00673764|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523376|NCT00673751||Single Group Assignment||Basic Science||Single|||t|||
1523377|NCT00673738||Single Group Assignment||Treatment||None (Open Label)||||||
1523378|NCT00673725|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523379|NCT00673712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523380|NCT00673699|||Case Control||Prospective|||||||
1523381|NCT00673686|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523382|NCT00673673||Single Group Assignment||Treatment||None (Open Label)||||||
1523383|NCT00673660|||Cohort||Prospective|||||||
1523384|NCT00673647|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523385|NCT00673634|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1523386|NCT00673621|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523387|NCT00673608||Single Group Assignment||Treatment||None (Open Label)||||||
1523388|NCT00673595|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1523389|NCT00673582|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523390|NCT00673569||||Treatment||None (Open Label)||||||
1523391|NCT00673556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523392|NCT00673543|||Case-Control||Prospective|||||||
1523393|NCT00673530|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523394|NCT00673517|||Cohort||Prospective|||||||
1523395|NCT00673504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523396|NCT00673491|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523397|NCT00673478||Crossover Assignment||Treatment||||||||
1523398|NCT00673465|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1523399|NCT00673452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523400|NCT00673439||Single Group Assignment||Treatment||None (Open Label)||||||
1523401|NCT00673426|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1523402|NCT00673413|||Case-Only||Cross-Sectional|||||||
1523403|NCT00673400||Single Group Assignment||Treatment||None (Open Label)||||||
1523404|NCT00673387|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1523405|NCT00673374|||Cohort||Prospective|||||||
1523406|NCT00673361||Single Group Assignment||Treatment||None (Open Label)||||||
1523407|NCT00673348|||Case-Only||Prospective|||||||
1523408|NCT00673335|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523409|NCT00673322||Single Group Assignment||Treatment||None (Open Label)||||||
1523410|NCT00673309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523411|NCT00673296||Single Group Assignment||Treatment||None (Open Label)||||||
1523412|NCT00673283||Single Group Assignment||Diagnostic||None (Open Label)||||||
1523413|NCT00673270|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1523414|NCT00673257||Single Group Assignment||Treatment||None (Open Label)||||||
1523415|NCT00673244||Single Group Assignment||Prevention||None (Open Label)||||||
1523416|NCT00673231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523417|NCT00673218|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1523418|NCT00673205|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523419|NCT00673192||Single Group Assignment||Basic Science||None (Open Label)||||||
1523420|NCT00673179|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523421|NCT00673166||Single Group Assignment||Health Services Research||None (Open Label)||||||
1523422|NCT00673153||Single Group Assignment||Treatment||None (Open Label)||||||
1523423|NCT00673140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523424|NCT00673127||Single Group Assignment||Treatment||None (Open Label)||||||
1523425|NCT00673114||Single Group Assignment||Treatment||None (Open Label)||||||
1523426|NCT00673101|||Cohort||Prospective|||||||
1523427|NCT00673088|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523428|NCT00673075|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523429|NCT00673062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523430|NCT00673049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523431|NCT00673036|||Cohort||Prospective|||||||
1523432|NCT00673023|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1523433|NCT00673010||Single Group Assignment||Treatment||None (Open Label)||||||
1523434|NCT00672997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523435|NCT00672984|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1523436|NCT00672971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523437|NCT00672958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523438|NCT00672945||||Treatment||||||||
1523439|NCT00672932|Randomized|Parallel Assignment||||None (Open Label)||||||
1523440|NCT00672919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523441|NCT00672906|Randomized|Parallel Assignment||Treatment||Single||||||t
1523442|NCT00672893|||||Prospective|||||||
1523443|NCT00672880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523444|NCT00672867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523445|NCT00672854|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523446|NCT00672841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523447|NCT00672828|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523448|NCT00672815|||Ecologic or Community||Prospective|||||||
1523449|NCT00672802|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523450|NCT00672789|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523451|NCT00672776|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1523452|NCT00672763|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523453|NCT00672750|||Case-Crossover||Retrospective|||||||
1523454|NCT00672737|||Cohort||Cross-Sectional|||||||
1523455|NCT00672724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523456|NCT00672711|||Case-Control||Prospective|||||||
1523457|NCT00672698|||Case-Only||Retrospective|||||||
1523458|NCT00672685|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1523459|NCT00672672||Single Group Assignment||Prevention||None (Open Label)||||||
1523460|NCT00672659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523461|NCT00672646|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523462|NCT00672633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523463|NCT00672620|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523464|NCT00672607|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523465|NCT00672594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523466|NCT00672581|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523467|NCT00672568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523468|NCT00672555||Single Group Assignment||Treatment||None (Open Label)||||||
1523469|NCT00672542|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523470|NCT00672529|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523471|NCT00672516|||Case-Only||Prospective|||||||
1523472|NCT00672503|||Case Control||Retrospective|||||||
1523473|NCT00672490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523474|NCT00672477|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523475|NCT00672464|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1523476|NCT00672451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523477|NCT00672438|Randomized|Crossover Assignment||||Double|||t||t|
1523478|NCT00672412|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523479|NCT00672399|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1523480|NCT00672386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523481|NCT00672373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523482|NCT00672360|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1523483|NCT00672347|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523484|NCT00672334|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523485|NCT00672321||||||||||||
1523486|NCT00672308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523487|NCT00672295||Single Group Assignment||Treatment||None (Open Label)||||||
1523488|NCT00672282|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523489|NCT00672269|||Case Control||Prospective|||||||
1523490|NCT00672256|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1523491|NCT00672243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524719|NCT00656136|Randomized|Parallel Assignment||Treatment||Double||||||
1523492|NCT00672230|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1523493|NCT00672217|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1523494|NCT00672204||Single Group Assignment||Treatment||None (Open Label)||||||
1523495|NCT00672191||Single Group Assignment||Treatment||None (Open Label)||||||
1523496|NCT00672178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523497|NCT00672165||Single Group Assignment||Treatment||None (Open Label)||||||
1523498|NCT00672152||Single Group Assignment||Treatment||None (Open Label)||||||
1523499|NCT00672139||Single Group Assignment||Treatment||None (Open Label)||||||
1523500|NCT00672113|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1523501|NCT00672100|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523502|NCT00672087|||Cohort||Prospective|||||||
1523503|NCT00672074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523504|NCT00672061|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523505|NCT00672048|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1523506|NCT00672035|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523507|NCT00672022|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523508|NCT00672009||Single Group Assignment||Treatment||None (Open Label)||||||
1523509|NCT00671996|Randomized|Parallel Assignment||Treatment||Single|||t|||
1523510|NCT00671983||Single Group Assignment||Prevention||None (Open Label)||||||
1523511|NCT00671970||Single Group Assignment||Treatment||None (Open Label)||||||
1523512|NCT00671957|||Case-Only||Prospective|||||||
1523513|NCT00671944||Single Group Assignment||Treatment||None (Open Label)||||||
1523514|NCT00671931|Randomized|Factorial Assignment||||None (Open Label)||||||
1523515|NCT00671918||Single Group Assignment||Treatment||None (Open Label)||||||
1523516|NCT00671905|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1523517|NCT00671892||Single Group Assignment||Basic Science||None (Open Label)||||||
1523518|NCT00671879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523519|NCT00671866|||Cohort||Cross-Sectional|||||||
1523520|NCT00671853|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523521|NCT00671827|||Case-Only||Other|||||||
1523522|NCT00671814|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1523523|NCT00671801||Single Group Assignment||Treatment||None (Open Label)||||||
1523524|NCT00671788||Single Group Assignment||Treatment||None (Open Label)||||||
1523525|NCT00671775|||Case-Control||Prospective|||||||
1523526|NCT00671749||Single Group Assignment||Treatment||None (Open Label)||||||
1523527|NCT00671736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523528|NCT00671723|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523529|NCT00671710||Single Group Assignment||Diagnostic||None (Open Label)||||||
1523530|NCT00671697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523531|NCT00671684||Single Group Assignment||Diagnostic||None (Open Label)||||||
1523532|NCT00671671|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523533|NCT00671658||Single Group Assignment||Treatment||None (Open Label)||||||
1523534|NCT00671645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523535|NCT00671632|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523536|NCT00671619|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1523537|NCT00671606||Single Group Assignment||Diagnostic||None (Open Label)||||||
1523538|NCT00671593||Single Group Assignment||Basic Science||None (Open Label)||||||
1523539|NCT00671580|Randomized|Parallel Assignment||Treatment||Single||||||t
1523540|NCT00671567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523541|NCT00671554||Single Group Assignment||Treatment||None (Open Label)||||||
1523542|NCT00671541|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1523543|NCT00671528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523544|NCT00671515||Single Group Assignment||Treatment||None (Open Label)||||||
1523545|NCT00671502|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523546|NCT00671489||Single Group Assignment||Prevention||None (Open Label)||||||
1523547|NCT00671476|Randomized|||Treatment||Single||||||
1523548|NCT00671463|Randomized|Parallel Assignment||Prevention||Single||||||t
1523549|NCT00671450|||Case Control||Prospective|||||||
1523550|NCT00671437||Single Group Assignment||Treatment||None (Open Label)||||||
1523551|NCT00671424|Randomized|Parallel Assignment||Treatment||Double||||||
1523552|NCT00671411||Single Group Assignment||Diagnostic||None (Open Label)||||||
1523553|NCT00671398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523554|NCT00671385|||Cohort||Prospective|||||||
1523555|NCT00671372|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523556|NCT00671359|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1523557|NCT00671346|||Cohort||Prospective|||||||
1523558|NCT00671333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523559|NCT00671320|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523560|NCT00671307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523561|NCT00671294|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523562|NCT00671281|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523563|NCT00671268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523564|NCT00671255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523565|NCT00671242||||||||||||
1523566|NCT00671229|||Cohort||Prospective|||||||
1523567|NCT00671216|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1523568|NCT00671203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523569|NCT00671190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523570|NCT00671177|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1523571|NCT00671151|Randomized|Single Group Assignment||Basic Science||Single||||||t
1523572|NCT00671138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523573|NCT00671125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523574|NCT00671112||Single Group Assignment||Treatment||None (Open Label)||||||
1523575|NCT00671099|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523576|NCT00671086|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523577|NCT00671073|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523578|NCT00671060|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523579|NCT00671047|||Cohort||Prospective|||||||
1523580|NCT00671034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523581|NCT00671021|||Cohort||Prospective|||||||
1523582|NCT00671008|||Cohort||Prospective|||||||
1523583|NCT00670995|Randomized|Parallel Assignment||Prevention||Single|||t|||
1523584|NCT00670982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523585|NCT00670969|||Cohort||Prospective|||||||
1523586|NCT00670956|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523587|NCT00670943|||Cohort||Prospective|||||||
1523588|NCT00670930|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523589|NCT00670917|Randomized|Parallel Assignment||Supportive Care||Double||||||
1523590|NCT00670904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523591|NCT00670891|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523592|NCT00670878|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1523593|NCT00670865|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523594|NCT00670852|||Case Control||Retrospective|||||||
1523595|NCT00670839|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523596|NCT00670826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523597|NCT00670813|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1523598|NCT00670800|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523599|NCT00670787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523600|NCT00670774||Single Group Assignment||Treatment||None (Open Label)||||||
1523601|NCT00670761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523602|NCT00670748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523603|NCT00670735|||Cohort||Prospective|||||||
1523604|NCT00670722|||Cohort||Prospective|||||||
1523605|NCT00670709|||Case Control||Cross-Sectional|||||||
1523606|NCT00670696|Randomized|Crossover Assignment||Treatment||Single|||t|||
1523607|NCT00670683|||||Prospective|||||||
1523608|NCT00670670|Randomized|Parallel Assignment||Treatment||Single|||t|||
1523609|NCT00670657||Single Group Assignment||Treatment||None (Open Label)||||||
1523610|NCT00670644|||Cohort||Prospective|||||||
1523611|NCT00670631||Single Group Assignment||Treatment||None (Open Label)||Induction- Tandem Transplants with VTD-MEL and gemcitabine, BCNU, melphalan, velcade and dexamethasone- Maintenance therapy||||
1523612|NCT00670618|Randomized|Parallel Assignment||Treatment||Single|||t|||
1523613|NCT00670605|||Cohort||Prospective|||||||
1523614|NCT00670592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523615|NCT00670579|||Cohort||Prospective|||||||
1523616|NCT00670566|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523617|NCT00670553||Single Group Assignment||Treatment||None (Open Label)||||||
1523618|NCT00670540|||Cohort||Prospective|||||||
1523619|NCT00670527|Non-Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1523620|NCT00670514|Randomized|Parallel Assignment||||Single||||||
1523621|NCT00670501|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523622|NCT00670488|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523623|NCT00670475|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523624|NCT00670462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523625|NCT00670449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523626|NCT00670436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523627|NCT00670423||Single Group Assignment||Treatment||None (Open Label)||||||
1523628|NCT00670410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523629|NCT00670397||Single Group Assignment||Treatment||None (Open Label)||||||
1523630|NCT00670384|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523631|NCT00670371|||||Cross-Sectional|||||||
1523632|NCT00670358||Single Group Assignment||Treatment||None (Open Label)||||||
1523633|NCT00670345|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523634|NCT00670332|||||Retrospective|||||||
1523635|NCT00670319|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523636|NCT00670306||Single Group Assignment||Treatment||None (Open Label)||||||
1523637|NCT00670293|||Case Control||Cross-Sectional|||||||
1523638|NCT00670280|Randomized|Parallel Assignment||||Triple|||t|t||t
1523639|NCT00670267||Single Group Assignment||Treatment||None (Open Label)||||||
1523640|NCT00670254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523641|NCT00670241|Randomized|Parallel Assignment||Treatment||Single|||||t|
1523642|NCT00670228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523643|NCT00670215|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1523644|NCT00670202|Randomized|Parallel Assignment||Other||Quadruple||Randomized, placebo controlled, parallel arm design|t|t|t|t
1524720|NCT00656123||||Treatment||None (Open Label)||||||
1523645|NCT00670189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523646|NCT00670176|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1523647|NCT00670163|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1523648|NCT00670150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523649|NCT00670137||||||||||||
1523650|NCT00670124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523651|NCT00670111|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523652|NCT00670098|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1523653|NCT00670059|Randomized|Parallel Assignment||||None (Open Label)||||||
1523654|NCT00670046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523655|NCT00670033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523656|NCT00670020|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523657|NCT00670007||Single Group Assignment||Treatment||None (Open Label)||||||
1523658|NCT00669994|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523659|NCT00669981|Randomized|Parallel Assignment||Treatment||Single||||||t
1523660|NCT00669968|||Case-Only||Prospective|||||||
1523661|NCT00669955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523662|NCT00669942|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1523663|NCT00669929|||Cohort||Retrospective|||||||
1523664|NCT00669916|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1523665|NCT00669903|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523666|NCT00669890||Single Group Assignment||Treatment||None (Open Label)||||||
1523667|NCT00669877||Single Group Assignment||Treatment||None (Open Label)||||||
1523668|NCT00669864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523669|NCT00669851|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1523670|NCT00669838|||Case Control||Prospective|||||||
1523671|NCT00669825|Non-Randomized|Crossover Assignment||Basic Science||Single|||t|||
1523672|NCT00669812||||Treatment||None (Open Label)||||||
1523673|NCT00669799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523674|NCT00669786||||||||||||
1523675|NCT00669773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523676|NCT00669760|||Case-Only||Prospective|||||||
1523677|NCT00669747|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523678|NCT00669734||Single Group Assignment||Treatment||None (Open Label)||||||
1523679|NCT00669721|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1523680|NCT00669708|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1523681|NCT00669695|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523682|NCT00669682|||Cohort||Prospective|||||||
1523683|NCT00669669||Single Group Assignment||Treatment||None (Open Label)||||||
1523684|NCT00669656||Single Group Assignment||Treatment||None (Open Label)||||||
1523685|NCT00669643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523686|NCT00669630|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523687|NCT00669617|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1523688|NCT00669604|||Cohort||Prospective|||||||
1523689|NCT00669591||Single Group Assignment||Treatment||None (Open Label)||||||
1523690|NCT00669578||Single Group Assignment||Treatment||None (Open Label)||||||
1523691|NCT00669565|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523692|NCT00669552|||Cohort||Prospective|||||||
1523693|NCT00669539|||Cohort||Prospective|||||||
1523694|NCT00669526|Randomized|Parallel Assignment||Treatment||Single||||||t
1523695|NCT00669513|Randomized|Crossover Assignment||||None (Open Label)||||||
1523696|NCT00669500||Single Group Assignment||Prevention||None (Open Label)||||||
1523697|NCT00669487|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1523698|NCT00669474|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523699|NCT00669461|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523700|NCT00669448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523701|NCT00669435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523702|NCT00669422|||Case-Only||Prospective|||||||
1523703|NCT00669409|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523704|NCT00669396|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523705|NCT00669383|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523706|NCT00669370||Single Group Assignment||Treatment||None (Open Label)||||||
1523707|NCT00669357||||||||||||
1523708|NCT00669344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523709|NCT00669331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523710|NCT00669318||Single Group Assignment||Treatment||None (Open Label)||||||
1523711|NCT00669305|||Cohort||Prospective|||||||
1523712|NCT00669292||Single Group Assignment||Treatment||None (Open Label)||||||
1523713|NCT00669279|Randomized|Parallel Assignment||Treatment||Single||||||t
1523714|NCT00669266|||Case-Control||Other|||||||
1523715|NCT00669253|Randomized|Parallel Assignment||Treatment||Single|||t|||
1523716|NCT00669240|||Case-Only||Prospective|||||||
1523717|NCT00669227|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523718|NCT00669214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523719|NCT00669201|||Cohort||Cross-Sectional|||||||
1523720|NCT00669188|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1523721|NCT00669175|||Case-Only||Prospective|||||||
1523722|NCT00669162||Single Group Assignment||Treatment||None (Open Label)||||||
1523723|NCT00669149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523724|NCT00669136||Single Group Assignment||Treatment||None (Open Label)||||||
1523725|NCT00669123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523726|NCT00669110|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523727|NCT00669097||Single Group Assignment||Treatment||None (Open Label)||||||
1523728|NCT00669084|||||Prospective|||||||
1523729|NCT00669071|Randomized|Single Group Assignment||Treatment||Single||||||t
1523730|NCT00669058|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523731|NCT00669045|||Cohort||Prospective|||||||
1523732|NCT00669032|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523733|NCT00669019||Single Group Assignment||Treatment||None (Open Label)||||||
1523734|NCT00669006|||Case-Only||Prospective|||||||
1523735|NCT00668993|Randomized|Single Group Assignment||Treatment||Single||||t||
1523736|NCT00668980|||Case Control||Prospective|||||||
1523737|NCT00668967|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523738|NCT00668954|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1523739|NCT00668941|Randomized|Parallel Assignment||Treatment||Single||||||t
1523740|NCT00668928|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1523741|NCT00668915|||Cohort||Prospective|||||||
1523742|NCT00668902|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1523743|NCT00668889|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523744|NCT00668876|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523745|NCT00668863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523746|NCT00668850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523747|NCT00668837|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523748|NCT00668824||||Diagnostic||||||||
1523749|NCT00668811||Single Group Assignment||Treatment||None (Open Label)||||||
1523750|NCT00668798|||||Prospective|||||||
1523751|NCT00668785||Single Group Assignment||Treatment||None (Open Label)||||||
1523752|NCT00668772|Randomized|Parallel Assignment||Treatment||Double||||||
1523753|NCT00668759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523754|NCT00668746|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1523755|NCT00668733|||Cohort||Prospective|||||||
1523756|NCT00668720|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1523757|NCT00668707|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523758|NCT00668694|Randomized|Single Group Assignment||Treatment||Single||||||t
1523759|NCT00668681||Single Group Assignment||Treatment||None (Open Label)||||||
1523760|NCT00668668|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523761|NCT00668655|||Case-Only||Prospective|||||||
1523762|NCT00668642|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1523763|NCT00668629|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523764|NCT00668616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523765|NCT00668603|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523766|NCT00668590|Randomized|Parallel Assignment||||Single||||t||
1523767|NCT00668577|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523768|NCT00668564||Single Group Assignment||Treatment||None (Open Label)||||||
1523769|NCT00668551|||Cohort||Prospective|||||||
1523770|NCT00668538||Single Group Assignment||Basic Science||None (Open Label)||||||
1523771|NCT00668525|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523772|NCT00668512||Single Group Assignment||||None (Open Label)||||||
1523773|NCT00668499|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523774|NCT00668486|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523775|NCT00668473|||Case Control||Cross-Sectional|||||||
1523776|NCT00668460|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523777|NCT00668447|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1523778|NCT00668434|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523779|NCT00668421||Single Group Assignment||Treatment||None (Open Label)||||||
1523780|NCT00668408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523781|NCT00668395|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1523782|NCT00668382||Single Group Assignment||||None (Open Label)||||||
1523783|NCT00668369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523784|NCT00668356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523785|NCT00668343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523786|NCT00668330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523787|NCT00668317||Single Group Assignment||Health Services Research||None (Open Label)||||||
1523788|NCT00668304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523789|NCT00668291|||Cohort|||||||||
1523790|NCT00668278|Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1523791|NCT00668265|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1523792|NCT00668252|||||Cross-Sectional|||||||
1523793|NCT00668239|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523794|NCT00668226|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1523795|NCT00668213|||Case-Only||Prospective|||||||
1523796|NCT00668200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523797|NCT00668187|||Cohort||Prospective|||||||
1523798|NCT00668174|Randomized|Single Group Assignment||Prevention||Single|||||t|
1523799|NCT00668161|Randomized|Single Group Assignment||Prevention||Single|||||t|
1524798|NCT00655096|||||Retrospective|||||||
1523800|NCT00668148||Single Group Assignment||Treatment||None (Open Label)||||||
1523801|NCT00668135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523802|NCT00668122|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523803|NCT00668109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523804|NCT00668096|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523805|NCT00668083|||Case-Only||Retrospective|||||||
1523806|NCT00668070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523807|NCT00668057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523808|NCT00668044|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523809|NCT00668031|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1523810|NCT00668018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523811|NCT00668005|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523812|NCT00667992|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523813|NCT00667979|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523814|NCT00667966|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1523815|NCT00667953|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523816|NCT00667940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523817|NCT00667927|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523818|NCT00667914|Randomized|Parallel Assignment||Treatment||Single||||||t
1523819|NCT00667901||||Treatment||None (Open Label)||||||
1523820|NCT00667888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523821|NCT00667875|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1523822|NCT00667862||Single Group Assignment||Prevention||None (Open Label)||||||
1523823|NCT00667849|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523824|NCT00667836|||Cohort||Prospective|||||||
1523825|NCT00667823||Single Group Assignment||Treatment||None (Open Label)||||||
1523826|NCT00667810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523827|NCT00667797|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523828|NCT00667784|||Case Control||Prospective|||||||
1523829|NCT00667771|Randomized|Parallel Assignment||Treatment||Double||||||
1523830|NCT00667758|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523831|NCT00667745|Randomized|Parallel Assignment||Treatment||Single||||||t
1523832|NCT00667732|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1523833|NCT00667719||Single Group Assignment||Treatment||None (Open Label)||||||
1523834|NCT00667706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523835|NCT00667693|Randomized|Parallel Assignment||Other||Single||||||t
1523836|NCT00667680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523837|NCT00667667|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523838|NCT00667654|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523839|NCT00667641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523840|NCT00667628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523841|NCT00667615||Single Group Assignment||Treatment||None (Open Label)||||||
1523842|NCT00667602|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523843|NCT00667589|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523844|NCT00667576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523845|NCT00667563||Single Group Assignment||Prevention||None (Open Label)||||||
1523846|NCT00667550|||Cohort||Prospective|||||||
1523847|NCT00667537||Single Group Assignment||Basic Science||None (Open Label)||||||
1523848|NCT00667524|||Cohort||Retrospective|||||||
1523849|NCT00667511|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523850|NCT00667498|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523851|NCT00667485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523852|NCT00667472|Randomized|Single Group Assignment||Treatment||Single||||||t
1523853|NCT00667459|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523854|NCT00667446|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523855|NCT00667433||Single Group Assignment||Treatment||None (Open Label)||||||
1523856|NCT00667420||Single Group Assignment||Treatment||None (Open Label)||||||
1523857|NCT00667407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523858|NCT00667394|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523859|NCT00667381|Randomized|Parallel Assignment||Treatment||Single||||||t
1523860|NCT00667368|Randomized|Parallel Assignment||Treatment||Single||||||t
1523861|NCT00667355||Single Group Assignment||Treatment||None (Open Label)||||||
1523862|NCT00667342|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523863|NCT00667329||Single Group Assignment||Treatment||None (Open Label)||||||
1523864|NCT00667316|||||Prospective|||||||
1523865|NCT00667303|||||Prospective|||||||
1523866|NCT00667290|Randomized|Parallel Assignment||Treatment||Single||||||
1523867|NCT00667277||Single Group Assignment||Treatment||None (Open Label)||||||
1523868|NCT00667264|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523869|NCT00667251|Randomized|||Treatment||None (Open Label)||||||
1523870|NCT00667238|||||Retrospective|||||||
1523871|NCT00667225|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523872|NCT00667212|Randomized|Factorial Assignment||Treatment||Single|||t|||
1523873|NCT00667199|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523874|NCT00667186|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1523875|NCT00667173|Randomized|Parallel Assignment||Treatment||Single||||||t
1523876|NCT00667160|Randomized|Parallel Assignment||Treatment||Single|||||t|
1523877|NCT00667147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523878|NCT00667134|||Case Control||Cross-Sectional|||||||
1523879|NCT00667121|||Case-Control||Cross-Sectional|||||||
1523880|NCT00667108|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523881|NCT00667095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523882|NCT00667082||Single Group Assignment||Other||None (Open Label)||||||
1523883|NCT00667069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523884|NCT00667056|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523885|NCT00667043|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1523886|NCT00667030|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1523887|NCT00667017||Single Group Assignment||Treatment||None (Open Label)||||||
1523888|NCT00667004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523889|NCT00666991|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523890|NCT00666978|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523891|NCT00666965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523892|NCT00666952|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1523893|NCT00666939|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523894|NCT00666926|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523895|NCT00666913|||Case-Only||Prospective|||||||
1523896|NCT00666900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523897|NCT00666887|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1523898|NCT00666874|Randomized|Parallel Assignment||Treatment||Single||||||t
1523899|NCT00666861|||Cohort||Cross-Sectional|||||||
1523900|NCT00666848|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1523901|NCT00666835|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523902|NCT00666822|||Case-Only||Prospective|||||||
1523903|NCT00666809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523904|NCT00666796|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1523905|NCT00666783|Randomized|Parallel Assignment||Supportive Care||Double||||||
1523906|NCT00666770|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523907|NCT00666757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523908|NCT00666744|Randomized|Single Group Assignment||Treatment||Single||||||t
1523909|NCT00666731|||Other||Prospective|||||||
1523910|NCT00666718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523911|NCT00666705|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1523912|NCT00666692||Single Group Assignment||Treatment||None (Open Label)||||||
1523913|NCT00666679|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1523914|NCT00666666||Single Group Assignment||Treatment||None (Open Label)||||||
1523915|NCT00666653|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1523916|NCT00666640|||Case Control||Prospective|||||||
1523917|NCT00666627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523918|NCT00666614|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1523919|NCT00666601|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1523920|NCT00666588|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523921|NCT00666575|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523922|NCT00666562|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1523923|NCT00666549|||Other||Other|||||||
1523924|NCT00666536|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523925|NCT00666523|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523926|NCT00666510|||Case Control||Retrospective|||||||
1523927|NCT00666497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523928|NCT00666484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523929|NCT00666471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523930|NCT00666458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523931|NCT00666445|||Case Control||Cross-Sectional|||||||
1523932|NCT00666432|||Family-Based||Other|||||||
1523933|NCT00666419|||||Cross-Sectional|||||||
1523934|NCT00666406|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523935|NCT00666393||Single Group Assignment||Treatment||None (Open Label)||||||
1523936|NCT00666380|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523937|NCT00666367|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523938|NCT00666354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523939|NCT00666341|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1523940|NCT00666328||Single Group Assignment||Treatment||None (Open Label)||||||
1523941|NCT00666315|||Case Control||Prospective|||||||
1523942|NCT00666302|Randomized|Parallel Assignment||Treatment||Single|||||t|
1523943|NCT00666289|||Family-Based||Other|||||||
1523944|NCT00666276|||Case-Only||Prospective|||||||
1523945|NCT00666263|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1523946|NCT00666250|Non-Randomized|Crossover Assignment||Prevention||Single|||||t|
1523947|NCT00666237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523948|NCT00666224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523949|NCT00666211|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1523950|NCT00666198|||Case-Only||Prospective|||||||
1523951|NCT00666185|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523952|NCT00666172|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523953|NCT00666159|Randomized|Parallel Assignment||Treatment||Single|||||t|
1523954|NCT00666146|||Family-Based||Other|||||||
1523955|NCT00666133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523956|NCT00666120|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1523957|NCT00666107||Single Group Assignment||Prevention||None (Open Label)||||||
1523958|NCT00666094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523959|NCT00666081|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1523960|NCT00666068|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1523961|NCT00666055|||Case Control||Prospective|||||||
1523962|NCT00666042|Randomized|Parallel Assignment||||Single||||||t
1523963|NCT00666029|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1523964|NCT00666016||Single Group Assignment||Treatment||None (Open Label)||||||
1523965|NCT00666003|||Cohort||Prospective|||||||
1523966|NCT00665990||Single Group Assignment||Treatment||None (Open Label)||||||
1523967|NCT00665977|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1523968|NCT00665964|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523969|NCT00665951|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523970|NCT00665938|Randomized|Parallel Assignment||||Triple|||t|t|t|
1523971|NCT00665925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523972|NCT00665912|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1523973|NCT00665899|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1523974|NCT00665886|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1523975|NCT00665873|Randomized|Parallel Assignment||Treatment||Double||||||
1523976|NCT00665860|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1523977|NCT00665847||Single Group Assignment||Treatment||None (Open Label)||||||
1523978|NCT00665834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523979|NCT00665821|Randomized|Parallel Assignment||||Double|||t|||t
1523980|NCT00665808|||||Prospective|||||||
1523981|NCT00665795|||Cohort||Prospective|||||||
1523982|NCT00665782|||Other||Prospective|||||||
1523983|NCT00665769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523984|NCT00665756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1523985|NCT00665743|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1523986|NCT00665730|Randomized|Parallel Assignment||Prevention||Single|||t|||
1523987|NCT00665717|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1523988|NCT00665704||Single Group Assignment||Health Services Research||None (Open Label)||||||
1523989|NCT00665691|||Other||Other|||||||
1523990|NCT00665678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523991|NCT00665665|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523992|NCT00665652||Single Group Assignment||Supportive Care||None (Open Label)||||||
1523993|NCT00665639|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523994|NCT00665626|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1523995|NCT00665613|||Case-Only||Retrospective|||||||
1523996|NCT00665600|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1523997|NCT00665587|||Cohort||Prospective|||||||
1523998|NCT00665574|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1523999|NCT00665561|||Cohort||Prospective|||||||
1524000|NCT00665548|||Case Control||Cross-Sectional|||||||
1524001|NCT00665535|Randomized|Parallel Assignment||Prevention||Single||||||t
1524002|NCT00665522|||Cohort||Prospective|||||||
1524003|NCT00665509|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1524004|NCT00665496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524005|NCT00665483||||||||||||
1524006|NCT00665470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524007|NCT00665457||Single Group Assignment||Treatment||None (Open Label)||||||
1524008|NCT00665444||Single Group Assignment||Treatment||None (Open Label)||||||
1524009|NCT00665431|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524010|NCT00665418||Single Group Assignment||Prevention||None (Open Label)||||||
1524011|NCT00665405|||Case Control||Prospective|||||||
1524012|NCT00665392||Single Group Assignment||Treatment||None (Open Label)||||||
1524013|NCT00665379||Parallel Assignment||Treatment||None (Open Label)||||||
1524014|NCT00665366|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524015|NCT00665353||Single Group Assignment||Treatment||None (Open Label)||||||
1524016|NCT00665340|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524017|NCT00665327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524018|NCT00665314|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524019|NCT00665301|||Case-Only||Prospective|||||||
1524020|NCT00665288|||Cohort||Prospective|||||||
1524021|NCT00665275|||Cohort||Cross-Sectional|||||||
1524022|NCT00665262||Single Group Assignment||Treatment||None (Open Label)||||||
1524023|NCT00665249|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524024|NCT00665236|Randomized|Parallel Assignment||Treatment||Single||||||t
1524025|NCT00665223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524026|NCT00665210|||Case-Only||Prospective|||||||
1524027|NCT00665197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524028|NCT00665184|Randomized|Factorial Assignment||Treatment||Single||||||t
1524029|NCT00665171|||Family-Based||Prospective|||||||
1524030|NCT00665158|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524031|NCT00665145|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524032|NCT00665132||Single Group Assignment||Treatment||None (Open Label)||||||
1524033|NCT00665119|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1524034|NCT00665106|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1524035|NCT00665093|||Cohort||Prospective|||||||
1524036|NCT00665067|||Other||Other|||||||
1524037|NCT00665054|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524038|NCT00665041|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524039|NCT00665028|||Cohort||Prospective|||||||
1524040|NCT00665015|||Cohort||Retrospective|||||||
1524041|NCT00665002||Single Group Assignment||Treatment||None (Open Label)||||||
1524042|NCT00664989|||||Prospective|||||||
1524043|NCT00664976|Randomized|Parallel Assignment||Treatment||Single|||||t|
1524044|NCT00664963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524045|NCT00664950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524046|NCT00664937|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1524047|NCT00664924|||Cohort||Prospective|||||||
1524048|NCT00664911||Single Group Assignment||||None (Open Label)||||||
1524049|NCT00664898||Single Group Assignment||Treatment||None (Open Label)||||||
1524050|NCT00664885|Randomized|Parallel Assignment||Treatment||Single||||||t
1524051|NCT00664872|Randomized|Parallel Assignment||Treatment||Single||||||t
1524052|NCT00664859||Single Group Assignment||Treatment||None (Open Label)||||||
1524053|NCT00664846|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524054|NCT00664833|Randomized|Factorial Assignment||||None (Open Label)||||||
1524055|NCT00664820|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1524056|NCT00664807|||Case Control||Prospective|||||||
1524057|NCT00664794|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524058|NCT00664781||||Treatment||None (Open Label)||||||
1524059|NCT00664768|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524060|NCT00664755|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524061|NCT00664742||Single Group Assignment||Treatment||None (Open Label)||||||
1524062|NCT00664729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524063|NCT00664716|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1524064|NCT00664703|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1524065|NCT00664690|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524066|NCT00664677||Single Group Assignment||Treatment||None (Open Label)||||||
1524067|NCT00664664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524068|NCT00664651|||Case Control||Retrospective|||||||
1524069|NCT00664638||Single Group Assignment||Treatment||None (Open Label)||||||
1524070|NCT00664625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524071|NCT00664612|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1524072|NCT00664599|Randomized|Parallel Assignment||Treatment||Single||||||t
1524073|NCT00664586||Single Group Assignment||Treatment||None (Open Label)||||||
1524074|NCT00664573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524075|NCT00664560|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524076|NCT00664547||Parallel Assignment||Treatment||||||||
1524077|NCT00664534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524078|NCT00664521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524079|NCT00664508|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Comparative study with a control group||||
1524080|NCT00664495|Randomized|Parallel Assignment||Treatment||||||||
1524081|NCT00664482|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524082|NCT00664469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524083|NCT00664456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524084|NCT00664443|||Cohort||Prospective|||||||
1524085|NCT00664430|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524086|NCT00664417|Randomized|Parallel Assignment||Prevention||Single||||||t
1524087|NCT00664404||Single Group Assignment||Basic Science||None (Open Label)||||||
1524088|NCT00664391|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1524089|NCT00664378||Single Group Assignment||Treatment||None (Open Label)||||||
1524090|NCT00664365|Randomized|Crossover Assignment||Treatment||||||||
1524091|NCT00664352|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524092|NCT00664339|Randomized|Parallel Assignment||Prevention||Single|||t|||
1524093|NCT00664326||Single Group Assignment||Treatment||None (Open Label)||||||
1524094|NCT00664313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524095|NCT00664300||||||||||||
1524096|NCT00664287|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524097|NCT00664274||Single Group Assignment||Basic Science||None (Open Label)||||||
1524098|NCT00664261|Randomized|||Health Services Research||None (Open Label)||||||
1524099|NCT00664248|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524100|NCT00664235|||||Prospective|||||||
1524101|NCT00664222|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1524102|NCT00664209|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524103|NCT00664196||Single Group Assignment||Treatment||None (Open Label)||||||
1524104|NCT00664183|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1524105|NCT00664170|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524106|NCT00664157|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1524107|NCT00664144|Non-Randomized|||Treatment||None (Open Label)||||||
1524108|NCT00664131|||||Prospective|||||||
1524109|NCT00664118|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524110|NCT00664105||Single Group Assignment||Treatment||None (Open Label)||||||
1524111|NCT00664092|Randomized|Factorial Assignment||Prevention||Single||||t||
1524112|NCT00664079|||Cohort||Prospective|||||||
1524113|NCT00664066|||Cohort||Prospective|||||||
1524114|NCT00664053|Randomized|Factorial Assignment||Treatment||Double||||||
1524115|NCT00664040||Single Group Assignment||Basic Science||None (Open Label)||||||
1524116|NCT00664027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524117|NCT00664014|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524118|NCT00664001|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524119|NCT00663988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524120|NCT00663975||Single Group Assignment||Treatment||None (Open Label)||||||
1524121|NCT00663962|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524122|NCT00663949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524123|NCT00663936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524124|NCT00663923|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524125|NCT00663910||Single Group Assignment||Diagnostic||None (Open Label)||||||
1524126|NCT00663897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524127|NCT00663884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524128|NCT00663871|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1524129|NCT00663858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524130|NCT00663845|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524131|NCT00663832||Single Group Assignment||Treatment||None (Open Label)||||||
1524132|NCT00663819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524133|NCT00663806|Randomized|Parallel Assignment||||None (Open Label)||||||
1524134|NCT00663793|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524135|NCT00663780|||Case-Only||Prospective|||||||
1524136|NCT00663767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524137|NCT00663754|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1524138|NCT00663741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524139|NCT00663728|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1524140|NCT00663715|||Case-Only||Prospective|||||||
1524141|NCT00663702|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524142|NCT00663689|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524143|NCT00663663|Randomized|Parallel Assignment||Treatment||Single||||||t
1524144|NCT00663650|Randomized|Parallel Assignment||Treatment||Single|||||t|
1524145|NCT00663637||Single Group Assignment||Treatment||None (Open Label)||||||
1524146|NCT00663624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524147|NCT00663611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524148|NCT00663598|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524149|NCT00663585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524150|NCT00663572|||||Prospective|||||||
1524151|NCT00663559|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524152|NCT00663546|||||Prospective|||||||
1524153|NCT00663533||Single Group Assignment||Prevention||None (Open Label)||||||
1524154|NCT00663520|||Case-Control||Prospective|||||||
1524155|NCT00663507|||||Prospective|||||||
1524156|NCT00663494|||Case Control||Prospective|||||||
1524157|NCT00663481|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524158|NCT00663468|||Case-Only||Prospective|||||||
1524159|NCT00663455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524160|NCT00663442|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1524161|NCT00663429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524162|NCT00663416|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524163|NCT00663403|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1524164|NCT00663390|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1524165|NCT00663377|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1524166|NCT00663364|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1524167|NCT00663351|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524168|NCT00663338||Single Group Assignment||Treatment||Double|||t||t|
1524169|NCT00663325|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1524170|NCT00663312|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1524171|NCT00663299||Single Group Assignment||Basic Science||None (Open Label)||||||
1524172|NCT00663286|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524173|NCT00663273|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1524174|NCT00663260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524175|NCT00663247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524176|NCT00663234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524177|NCT00663221|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1524178|NCT00663208|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524179|NCT00663195|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1524180|NCT00663182|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524181|NCT00663169|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524182|NCT00663156|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1524183|NCT00663143|||Case-Only||Prospective|||||||
1524184|NCT00663130|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524185|NCT00663117|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525104|NCT00651079|Randomized|Parallel Assignment||Treatment||Double||||||
1524186|NCT00663104|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1524187|NCT00663091|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1524188|NCT00663078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524189|NCT00663065|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1524190|NCT00663052|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1524191|NCT00663039|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1524192|NCT00663026|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524193|NCT00663013|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524194|NCT00663000|||Case-Only||Cross-Sectional|||||||
1524195|NCT00662987|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524196|NCT00662974|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1524197|NCT00662961|Randomized|Single Group Assignment||Treatment||Single||||||t
1524198|NCT00662948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524199|NCT00662935|Randomized|Crossover Assignment||Treatment||Double||||||
1524200|NCT00662922|||Case Control||Cross-Sectional|||||||
1524201|NCT00662909|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524202|NCT00662896|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524203|NCT00662883||Single Group Assignment||||None (Open Label)||||||
1524204|NCT00662870|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524205|NCT00662857|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524206|NCT00662844|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1524207|NCT00662831|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524208|NCT00662818|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1524209|NCT00662805|||||Prospective|||||||
1524210|NCT00662792||Crossover Assignment||Treatment||||||||
1524211|NCT00662779|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1524212|NCT00662766||Crossover Assignment||Supportive Care||Single|||||t|
1524213|NCT00662753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524214|NCT00662740|Randomized|Parallel Assignment||Treatment||Double||||||
1524215|NCT00662727|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1524216|NCT00662714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524217|NCT00662701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524218|NCT00662688|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524219|NCT00662675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524220|NCT00662662|||Cohort||Prospective|||||||
1524221|NCT00662649|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524222|NCT00662636||Single Group Assignment||Treatment||None (Open Label)||||||
1524223|NCT00662623|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1524224|NCT00662610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524225|NCT00662597|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524226|NCT00662584||Single Group Assignment||Treatment||None (Open Label)||||||
1524227|NCT00662571|||Case Control||Retrospective|||||||
1524228|NCT00662558|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524229|NCT00662545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524230|NCT00662532|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1524231|NCT00662519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524232|NCT00662506||Single Group Assignment||Treatment||None (Open Label)||||||
1524233|NCT00662493|Randomized|Parallel Assignment||Treatment||Single||||||t
1524234|NCT00662480|Randomized|Parallel Assignment||Screening||Single|||||t|
1524235|NCT00662467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524236|NCT00662454||Single Group Assignment||Diagnostic||None (Open Label)||||||
1524237|NCT00662441|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524238|NCT00662428|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1524239|NCT00662415|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1524240|NCT00662402|Randomized|Parallel Assignment||Other||Single||||||t
1524241|NCT00662389|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524242|NCT00662376|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1524243|NCT00662363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524244|NCT00662350|||Case-Only||Prospective|||||||
1524245|NCT00662337|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1524246|NCT00662324|||Cohort||Prospective|||||||
1524247|NCT00662311||Single Group Assignment||Treatment||None (Open Label)||||||
1524248|NCT00662298|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1524249|NCT00662285|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524250|NCT00662272|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1524251|NCT00662259|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1524252|NCT00662246||Single Group Assignment||Treatment||None (Open Label)||||||
1524253|NCT00662233||Single Group Assignment||Treatment||||||||
1524254|NCT00662220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524255|NCT00662207||Single Group Assignment||Basic Science||None (Open Label)||||||
1524256|NCT00662194|||Cohort||Cross-Sectional|||||||
1524257|NCT00662181||||||||||||
1524258|NCT00662168|||Case-Only||Retrospective|||||||
1524259|NCT00662155|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524260|NCT00662142|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524261|NCT00662129||Single Group Assignment||Treatment||None (Open Label)||||||
1524262|NCT00662116|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524263|NCT00662103|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1524264|NCT00662090|||Other||Prospective|||||||
1524265|NCT00662077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524266|NCT00662064|||||Prospective|||||||
1524267|NCT00662051|||Cohort||Prospective|||||||
1524268|NCT00662038||Single Group Assignment||Treatment||None (Open Label)||||||
1524269|NCT00662025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524270|NCT00662012||Single Group Assignment||Treatment||None (Open Label)||||||
1524271|NCT00661999|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1524272|NCT00661986|Randomized|Parallel Assignment||Treatment||Single||||||t
1524273|NCT00661973||Single Group Assignment||Basic Science||None (Open Label)||||||
1524274|NCT00661960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524275|NCT00661947|||||Prospective|||||||
1524276|NCT00661934|||Cohort||Cross-Sectional|||||||
1524277|NCT00661921|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524278|NCT00661908|||Cohort||Cross-Sectional|||||||
1524279|NCT00661895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524280|NCT00661882|||Other||Prospective|||||||
1524281|NCT00661869||Single Group Assignment||Supportive Care||None (Open Label)||||||
1524282|NCT00661856|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524283|NCT00661843|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524284|NCT00661830|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524285|NCT00661817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524286|NCT00661804|||||Prospective|||||||
1524287|NCT00661791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524288|NCT00661778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524289|NCT00661765|Randomized|Crossover Assignment||||None (Open Label)||||||
1524290|NCT00661752|||Case Control||Retrospective|||||||
1524291|NCT00661739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524292|NCT00661726||Single Group Assignment||Treatment||None (Open Label)||||||
1524293|NCT00661713|Randomized|Parallel Assignment||Prevention||Single|||t|||
1524294|NCT00661700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524295|NCT00661687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524296|NCT00661674|Randomized|Crossover Assignment||Treatment||Triple||"There were three treatment arms to the study: Placebo, Palonosetron, and Palonosetron + Hydroxyzine (Combo). Participants were not randomized in between these arms, all participants completed each arm of the study in a cross-over study methodology (Placebo, Palonosetron, Palonosetron + Hydroxyzene (combo). Participants were individually randomized into the order in which they participated in each arm.~Per sequence each individual participant underwent the following randomization schedule:~Participant 1: Placebo, Combo, Palonosetron Participant 2: Palonosetron, Combo, Placebo Participant 3: Palonosetron, Combo, Placebo Participant 4: Combo, Placebo, Palonosetron Participant 5: Placebo, Palonosetron, Combo Participant 6: Combo, Palonosetron, Placebo Participant 7: Combo, Placebo, Palonosetron Participant 8: Combo, Palonosetron, Placebo Participant 9: Palonosetron, Placebo, Combo Participant 10: Placebo, Combo, Palonosetron"|t|t||t
1524297|NCT00661661||Single Group Assignment||Treatment||None (Open Label)||||||
1524298|NCT00661648|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1524299|NCT00661635|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524300|NCT00661622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524301|NCT00661609||Single Group Assignment||Treatment||None (Open Label)||||||
1524302|NCT00661596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524303|NCT00661583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524304|NCT00661570||Single Group Assignment||Treatment||None (Open Label)||||||
1524305|NCT00661557|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524306|NCT00661544||Single Group Assignment||Treatment||None (Open Label)||||||
1524307|NCT00661531||Single Group Assignment||Treatment||None (Open Label)||||||
1524308|NCT00661518|||Case Control||Prospective|||||||
1524309|NCT00661505||Single Group Assignment||Treatment||None (Open Label)||||||
1524310|NCT00661492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524311|NCT00661479|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1524312|NCT00661466|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524313|NCT00661453||Single Group Assignment||Treatment||None (Open Label)||||||
1524314|NCT00661440|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1524315|NCT00661427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524316|NCT00661414||Single Group Assignment||Treatment||None (Open Label)||||||
1524317|NCT00661401||Single Group Assignment||Treatment||None (Open Label)||||||
1524318|NCT00661388||Single Group Assignment||Treatment||None (Open Label)||||||
1524319|NCT00661375|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524320|NCT00661362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524321|NCT00661349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524322|NCT00661336||||Treatment||None (Open Label)||||||
1524323|NCT00661323|||Case Control||Prospective|||||||
1524324|NCT00661310|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1524325|NCT00661297|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524326|NCT00661284|||Case-Only||Prospective|||||||
1524327|NCT00661271|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1524328|NCT00661258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524329|NCT00661245|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524330|NCT00661232|||Cohort||Prospective|||||||
1524331|NCT00661219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524332|NCT00661206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524333|NCT00661193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524334|NCT00661180|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524335|NCT00661167||Single Group Assignment||Treatment||None (Open Label)||||||
1524336|NCT00661154|||Cohort||Prospective|||||||
1524337|NCT00661141|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524338|NCT00661128|||Case-Control||Other|||||||
1524339|NCT00661115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524340|NCT00661102||Parallel Assignment||Treatment||None (Open Label)||||||
1524341|NCT00661089|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1524342|NCT00661076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524343|NCT00661063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524344|NCT00661050|||Cohort||Prospective|||||||
1524345|NCT00661037|||Cohort||Prospective|||||||
1524346|NCT00661024|Randomized|Parallel Assignment||Prevention||Single|||t|||
1524347|NCT00661011|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524348|NCT00660998|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524349|NCT00660985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524350|NCT00660972||Single Group Assignment||Treatment||None (Open Label)||||||
1524351|NCT00660959|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524352|NCT00660946|||Cohort||Prospective|||||||
1524353|NCT00660933|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524354|NCT00660920||Single Group Assignment||Treatment||None (Open Label)||||||
1524355|NCT00660907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524356|NCT00660894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524357|NCT00660881||Single Group Assignment||Treatment||None (Open Label)||||||
1524358|NCT00660868|||||Prospective|||||||
1524359|NCT00660855|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524360|NCT00660842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524361|NCT00660829|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524362|NCT00660816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524363|NCT00660803|||||Retrospective|||||||
1524364|NCT00660790|||Cohort||Prospective|||||||
1524365|NCT00660777|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524366|NCT00660764|||Cohort||Prospective|||||||
1524367|NCT00660751|Randomized|Single Group Assignment||Basic Science||Triple|||t||t|t
1524368|NCT00660738|||Case-Crossover||Prospective|||||||
1524369|NCT00660725||Single Group Assignment||Treatment||None (Open Label)||||||
1524370|NCT00660712|||Cohort||Prospective|||||||
1524371|NCT00660699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524372|NCT00660686|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1524373|NCT00660673||Single Group Assignment||Treatment||None (Open Label)||||||
1524374|NCT00660660|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524375|NCT00660647|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524376|NCT00660634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524377|NCT00660621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524378|NCT00660608|||Case Control||Prospective|||||||
1524379|NCT00660595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524380|NCT00660582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524381|NCT00660569|||Cohort||Prospective|||||||
1524382|NCT00660556||||||||||||
1524383|NCT00660543|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1524384|NCT00660530|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524385|NCT00660517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524386|NCT00660504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524387|NCT00660491|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1524388|NCT00660478|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1524389|NCT00660465|||Case-Only||Cross-Sectional|||||||
1524390|NCT00660452|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524391|NCT00660439|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524392|NCT00660426|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524393|NCT00660413|Randomized|||Treatment||Single||||||
1524394|NCT00660400||Single Group Assignment||Treatment||None (Open Label)||||||
1524395|NCT00660387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524396|NCT00660374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524397|NCT00660361|||Cohort||Prospective|||||||
1524398|NCT00660348|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524399|NCT00660335||Single Group Assignment||Diagnostic||None (Open Label)||||||
1524400|NCT00660322|Randomized|Parallel Assignment||Supportive Care||Triple||||t|t|t
1524401|NCT00660309|Randomized|Parallel Assignment||||None (Open Label)||||||
1524402|NCT00660296|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1524403|NCT00660283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524404|NCT00660270||Single Group Assignment||Treatment||None (Open Label)||||||
1524405|NCT00660257|Non-Randomized|Parallel Assignment||Prevention||Double|||t|||t
1524406|NCT00660244|||Case-Only||Prospective|||||||
1524407|NCT00660231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524408|NCT00660218||Single Group Assignment||Treatment||None (Open Label)||||||
1524409|NCT00660205|||Cohort||Prospective|||||||
1524410|NCT00660192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524411|NCT00660179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524412|NCT00660166|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524413|NCT00660153||Single Group Assignment||Treatment||None (Open Label)||||||
1524414|NCT00660140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524415|NCT00660127|||Case-Only||Prospective|||||||
1524416|NCT00660114|||||Prospective|||||||
1524417|NCT00660101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524418|NCT00660088|||Cohort||Prospective|||||||
1524419|NCT00660075|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1524420|NCT00660062|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524421|NCT00660049||Single Group Assignment||Treatment||None (Open Label)||||||
1524422|NCT00660036||Single Group Assignment||Treatment||None (Open Label)||||||
1524423|NCT00660023||Single Group Assignment||Treatment||None (Open Label)||||||
1524424|NCT00660010|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524425|NCT00659997|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524426|NCT00659984||Single Group Assignment||Treatment||None (Open Label)||Ultratrace™ Iobenguane I 131||||
1524427|NCT00659971|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1524428|NCT00659958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524429|NCT00659945|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1524430|NCT00659932|Randomized|Parallel Assignment||Treatment||||||||
1524431|NCT00659919|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1524432|NCT00659906|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1524433|NCT00659893|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1524434|NCT00659880|||Cohort||Prospective|||||||
1524435|NCT00659867|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1524436|NCT00659854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524437|NCT00659841|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524438|NCT00659828||Single Group Assignment||Treatment||None (Open Label)||||||
1524439|NCT00659815|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1524440|NCT00659802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524441|NCT00659789|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524442|NCT00659776|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1524443|NCT00659763|||Cohort||Prospective|||||||
1524444|NCT00659750|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524445|NCT00659737|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1524446|NCT00659724|||Other||Prospective|||||||
1524447|NCT00659711|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524448|NCT00659698|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1524449|NCT00659685|Randomized|Crossover Assignment||||None (Open Label)||||||
1524450|NCT00659672|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1524451|NCT00659659|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1524452|NCT00659646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524453|NCT00659633||Single Group Assignment||Treatment||None (Open Label)||||||
1524454|NCT00659620||Single Group Assignment||Treatment||None (Open Label)||||||
1524455|NCT00659607|||||Prospective|||||||
1524456|NCT00659594|Randomized|||Treatment||Double|||t||t|
1524457|NCT00659581|||Case-Only||Prospective|||||||
1524458|NCT00659568|Non-Randomized|||Treatment||None (Open Label)||||||
1524459|NCT00659555|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524460|NCT00659542|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524461|NCT00659529||Single Group Assignment||Treatment||None (Open Label)||||||
1524462|NCT00659516|||Case-Only||Prospective|||||||
1524463|NCT00659503|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524464|NCT00659490|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524465|NCT00659477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524466|NCT00659464|||Case-Only||Prospective|||||||
1524467|NCT00659451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524468|NCT00659438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524469|NCT00659425||Single Group Assignment||Treatment||None (Open Label)||||||
1524470|NCT00659412|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524471|NCT00659399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524472|NCT00659386|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1524473|NCT00659373|Randomized|Parallel Assignment||||None (Open Label)||||||
1524474|NCT00659360||Single Group Assignment||Treatment||None (Open Label)||||||
1524475|NCT00659347|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524476|NCT00659334|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1524477|NCT00659321|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524478|NCT00659308|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524479|NCT00659295|||Cohort||Prospective|||||||
1524480|NCT00659282|||Cohort||Prospective|||||||
1524481|NCT00659269|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1524482|NCT00659256|||||Other|||||||
1524483|NCT00659243|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1524484|NCT00659230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524485|NCT00659217||Single Group Assignment||Treatment||None (Open Label)||||||
1524486|NCT00659204|Randomized|Factorial Assignment||Screening||Quadruple|||t|t|t|t
1524487|NCT00659191|Randomized|Parallel Assignment||Treatment||Double||||||
1524488|NCT00659178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524489|NCT00659165|Randomized|Crossover Assignment||Other||Triple|||t||t|t
1524490|NCT00659152|||Cohort||Prospective|||||||
1524491|NCT00659139||||||||||||
1524492|NCT00659126||Single Group Assignment||Diagnostic||None (Open Label)||||||
1524493|NCT00659113||||Treatment||None (Open Label)||||||
1524494|NCT00659100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524495|NCT00659087|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1524496|NCT00659074|Randomized|Factorial Assignment||||None (Open Label)||||||
1524497|NCT00659061|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1524498|NCT00659048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524499|NCT00659035|||Case-Control||Cross-Sectional|||||||
1524500|NCT00659022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524501|NCT00659009|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1524502|NCT00658996|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1524503|NCT00658983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524504|NCT00658970||Single Group Assignment||Treatment||None (Open Label)||||||
1524505|NCT00658957|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1524506|NCT00658944|||||Prospective|||||||
1524507|NCT00658931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524508|NCT00658918|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524509|NCT00658905|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1524510|NCT00658892||Single Group Assignment||Treatment||None (Open Label)||||||
1524511|NCT00658879|||Case-Only||Prospective|||||||
1524512|NCT00658866||Single Group Assignment||||None (Open Label)||||||
1524513|NCT00658853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524514|NCT00658840||Single Group Assignment||Treatment||None (Open Label)||||||
1524515|NCT00658827|||Cohort||Prospective|||||||
1524516|NCT00658814||Single Group Assignment||Treatment||None (Open Label)||||||
1524517|NCT00658801||Single Group Assignment||Treatment||None (Open Label)||||||
1524518|NCT00658788||Single Group Assignment||Treatment||None (Open Label)||||||
1524519|NCT00658775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524520|NCT00658762|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524521|NCT00658749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524522|NCT00658736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524523|NCT00658723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524524|NCT00658710|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524525|NCT00658697||Single Group Assignment||Treatment||None (Open Label)||||||
1524526|NCT00658684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524527|NCT00658671|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524528|NCT00658658||Single Group Assignment||Treatment||None (Open Label)||||||
1524529|NCT00658645|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524530|NCT00658632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524531|NCT00658619|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1524532|NCT00658606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524533|NCT00658593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524534|NCT00658580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524535|NCT00658567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524536|NCT00658554|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1524537|NCT00658541|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1524538|NCT00658528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524539|NCT00658515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524540|NCT00658502|||Cohort||Prospective|||||||
1524541|NCT00658489|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524542|NCT00658476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524543|NCT00658463|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1524544|NCT00658450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524545|NCT00658437||Single Group Assignment||Treatment||None (Open Label)||||||
1524546|NCT00658411||Single Group Assignment||Prevention||None (Open Label)||||||
1524547|NCT00658398|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524548|NCT00658385||Single Group Assignment||Treatment||None (Open Label)||||||
1524549|NCT00658372|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524550|NCT00658359|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524551|NCT00658346|||Case Control||Prospective|||||||
1524552|NCT00658333|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524553|NCT00658320|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524554|NCT00658307|Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1524555|NCT00658294|||Cohort||Prospective|||||||
1524556|NCT00658281|||Case-Only||Prospective|||||||
1524557|NCT00658268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524558|NCT00658255|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524559|NCT00658242|||||Prospective|||||||
1524560|NCT00658229|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524561|NCT00658216|||Cohort||Prospective|||||||
1524562|NCT00658203|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524563|NCT00658190|||Case-Only||Prospective|||||||
1524564|NCT00658177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524565|NCT00658164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524566|NCT00658151|||Case Control||Prospective|||||||
1524567|NCT00658138|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524568|NCT00658125||Single Group Assignment||Treatment||None (Open Label)||||||
1524569|NCT00658112||Single Group Assignment||Treatment||None (Open Label)||||||
1524570|NCT00658099|||Cohort||Prospective|||||||
1524571|NCT00658086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524572|NCT00658073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524573|NCT00658060|||Cohort||Cross-Sectional|||||||
1524574|NCT00658047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524575|NCT00658034|Randomized|Crossover Assignment||Treatment||Single|||t|||
1524576|NCT00658021|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524577|NCT00658008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524578|NCT00657995|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524579|NCT00657982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524580|NCT00657969|||Case Control|||||||||
1524581|NCT00657956|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524582|NCT00657943|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1524583|NCT00657930|||Case Control||Prospective|||||||
1524584|NCT00657917||Single Group Assignment||Treatment||None (Open Label)||||||
1524585|NCT00657904|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524586|NCT00657891|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1524587|NCT00657878|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524588|NCT00657865|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1524589|NCT00657852|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524590|NCT00657839|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524591|NCT00657826||Single Group Assignment||Treatment||None (Open Label)||||||
1524592|NCT00657813|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1524593|NCT00657800|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524594|NCT00657787|||Case Control||Prospective|||||||
1524595|NCT00657774|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524596|NCT00657761|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1524597|NCT00657748||Single Group Assignment||Treatment||None (Open Label)||||||
1524598|NCT00657735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524599|NCT00657722||Single Group Assignment||Diagnostic||Single||||||t
1524600|NCT00657709|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524601|NCT00657696|||Other||Cross-Sectional|||||||
1524602|NCT00657683|Randomized|Parallel Assignment||Prevention||Single|||t|||
1524603|NCT00657670|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524604|NCT00657657|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1524605|NCT00657644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524606|NCT00657631|Randomized|Single Group Assignment||Treatment||Single|||||t|
1524607|NCT00657618||Single Group Assignment||Treatment||None (Open Label)||||||
1524608|NCT00657605||Single Group Assignment||Treatment||None (Open Label)||||||
1524609|NCT00657579||||||||||||
1524610|NCT00657566|Randomized|Parallel Assignment||Treatment||Single||||||t
1524611|NCT00657553|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524612|NCT00657540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524613|NCT00657527|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524614|NCT00657514|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1524615|NCT00657501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524616|NCT00657488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524617|NCT00657475|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1524618|NCT00657462|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1524619|NCT00657449|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524620|NCT00657436|||Cohort||Prospective|||||||
1524621|NCT00657423|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1524622|NCT00657410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524623|NCT00657397|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524624|NCT00657384|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1524625|NCT00657371||Single Group Assignment||Screening||None (Open Label)||||||
1524626|NCT00657358||Single Group Assignment||Treatment||None (Open Label)||||||
1524627|NCT00657345|||Case-Only||Prospective|||||||
1524628|NCT00657332|||Cohort||Prospective|||||||
1524629|NCT00657319|||Cohort||Retrospective|||||||
1524630|NCT00657306|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524631|NCT00657293|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1524632|NCT00657280||Single Group Assignment||Treatment||None (Open Label)||||||
1524633|NCT00657267||Single Group Assignment||Treatment||None (Open Label)||||||
1524634|NCT00657254|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524635|NCT00657241|Randomized|Crossover Assignment||Treatment||Single|||t|||
1524636|NCT00657228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524637|NCT00657202||Single Group Assignment||Treatment||None (Open Label)||||||
1524638|NCT00657189|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524639|NCT00657176|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524640|NCT00657163|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524641|NCT00657150|Randomized|Parallel Assignment||Prevention||Double||||||
1524642|NCT00657137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524643|NCT00657124|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1524644|NCT00657111|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524645|NCT00657098|||Cohort||Prospective|||||||
1524646|NCT00657085|||Case-Only||Prospective|||||||
1524647|NCT00657072|||Case-Only||Prospective|||||||
1524648|NCT00657059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524649|NCT00657046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524650|NCT00657033|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524651|NCT00657020|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1524652|NCT00657007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524653|NCT00656994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524654|NCT00656981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524655|NCT00656968|Randomized|Parallel Assignment||Treatment||Single|||||t|
1524656|NCT00656955|||Case-Only||Prospective|||||||
1524657|NCT00656942|||Case-Control||Cross-Sectional|||||||
1524658|NCT00656929|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1524659|NCT00656916|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524660|NCT00656903|||||Prospective|||||||
1524661|NCT00656890|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524662|NCT00656877|||Case-Only|||||||||
1524663|NCT00656864|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1524664|NCT00656851|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1524665|NCT00656838|Randomized|Parallel Assignment||Screening||Single|||t|||
1524666|NCT00656825|Randomized|Parallel Assignment||||Double|||t||t|
1524667|NCT00656812||Single Group Assignment||Treatment||None (Open Label)||||||
1524668|NCT00656799||Single Group Assignment||Treatment||None (Open Label)||||||
1524669|NCT00656786|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1524670|NCT00656773|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524671|NCT00656760||Single Group Assignment||Diagnostic||Single||||t||
1524672|NCT00656747|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524673|NCT00656734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524674|NCT00656721|Randomized|Crossover Assignment||Treatment||Single||||||t
1524675|NCT00656708||Single Group Assignment||Prevention||None (Open Label)||||||
1524676|NCT00656695|Randomized|Parallel Assignment||Treatment||Double||||t||t
1524677|NCT00656682|Randomized|Parallel Assignment||Prevention||Single||||||t
1524678|NCT00656669||Single Group Assignment||Treatment||None (Open Label)||||||
1524679|NCT00656656||Single Group Assignment||Treatment||None (Open Label)||||||
1524680|NCT00656643|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1524681|NCT00656630|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1524682|NCT00656617||Single Group Assignment||Treatment||None (Open Label)||||||
1524683|NCT00656604|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1524684|NCT00656591|||Ecologic or Community||Prospective|||||||
1524685|NCT00656578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524686|NCT00656565||||||||||||
1524687|NCT00656552|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1524688|NCT00656539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524689|NCT00656526|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1524690|NCT00656513|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||One arm Phase II followed by a two-arm Phase III||||
1524691|NCT00656500|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1524692|NCT00656487|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1524693|NCT00656474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524694|NCT00656461|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524695|NCT00656448|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524696|NCT00656435|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524697|NCT00656422|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524698|NCT00656409||||Basic Science||||||||
1524699|NCT00656396|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1524700|NCT00656383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524701|NCT00656370|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524702|NCT00656357|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524703|NCT00656344||Single Group Assignment||Treatment||None (Open Label)||||||
1524704|NCT00656331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524705|NCT00656318|||Cohort||Prospective|||||||
1524706|NCT00656305|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524707|NCT00656292|Randomized|Parallel Assignment||Treatment||Single||||t||
1524708|NCT00656279|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524709|NCT00656266|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524710|NCT00656253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524711|NCT00656240||||||||||||
1524712|NCT00656227|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1524713|NCT00656214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524714|NCT00656201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524715|NCT00656188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524716|NCT00656175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524717|NCT00656162|||Cohort||Prospective|||||||
1524718|NCT00656149|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1524721|NCT00656110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524722|NCT00656097|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524723|NCT00656084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524724|NCT00656071|||Case Control||Retrospective|||||||
1524725|NCT00656058||Single Group Assignment||Treatment||None (Open Label)||||||
1524726|NCT00656045|Randomized|Parallel Assignment||Treatment||Single||||||t
1524727|NCT00656032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524728|NCT00656019|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524729|NCT00656006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524730|NCT00655993|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1524731|NCT00655980|Randomized|Factorial Assignment||Diagnostic||Quadruple|||t|t|t|t
1524732|NCT00655967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524733|NCT00655954|||||Prospective|||||||
1524734|NCT00655941|Randomized|Parallel Assignment||Treatment||Single||||||t
1524735|NCT00655928|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524736|NCT00655915|||Cohort||Prospective|||||||
1524737|NCT00655902|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524738|NCT00655889||Single Group Assignment||Treatment||None (Open Label)||||||
1524739|NCT00655876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524740|NCT00655863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524741|NCT00655850||Single Group Assignment||Treatment||None (Open Label)||||||
1524742|NCT00655837||Single Group Assignment||Treatment||None (Open Label)||||||
1524743|NCT00655824||Single Group Assignment||Treatment||None (Open Label)||||||
1524744|NCT00655811|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1524745|NCT00655798|Randomized|Crossover Assignment||Prevention||Double||||||
1524746|NCT00655785||Single Group Assignment||Treatment||None (Open Label)||||||
1524747|NCT00655772|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1524748|NCT00655746|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1524749|NCT00655733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524750|NCT00655720|Randomized|Parallel Assignment||||Triple|||t|t|t|
1524751|NCT00655707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524752|NCT00655694|||Cohort||Prospective|||||||
1524753|NCT00655681|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524754|NCT00655668||Single Group Assignment||Treatment||None (Open Label)||||||
1524755|NCT00655655||Single Group Assignment||Treatment||None (Open Label)||||||
1524756|NCT00655642|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1524757|NCT00655629|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524758|NCT00655616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524759|NCT00655603|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1524760|NCT00655590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524761|NCT00655577|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1524762|NCT00655564||Single Group Assignment||Treatment||None (Open Label)||||||
1524763|NCT00655551|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524764|NCT00655538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524765|NCT00655525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524766|NCT00655512|Randomized|Parallel Assignment||Treatment||Single|||||t|
1524767|NCT00655499||||Treatment||None (Open Label)||||||
1524768|NCT00655486||Single Group Assignment||Treatment||None (Open Label)||||||
1524769|NCT00655473|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524770|NCT00655460|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524771|NCT00655447|||Cohort||Prospective|||||||
1524772|NCT00655434|||Case-Only||Prospective|||||||
1524773|NCT00655421|Non-Randomized|Parallel Assignment||Screening||Single|||||t|
1524774|NCT00655408|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524775|NCT00655395|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524776|NCT00655382|||Cohort||Prospective|||||||
1524777|NCT00655369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524778|NCT00655356|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524779|NCT00655343|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524780|NCT00655330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524781|NCT00655317|Randomized|Parallel Assignment||Prevention||Single|||t|||
1524782|NCT00655304|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524783|NCT00655291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524784|NCT00655278||Single Group Assignment||Treatment||None (Open Label)||||||
1524785|NCT00655265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524786|NCT00655252||||||||||||
1524787|NCT00655239|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1524788|NCT00655226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524789|NCT00655213|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524790|NCT00655200|||Cohort||Prospective|||||||
1524791|NCT00655187|||Case-Control||Prospective|||||||
1524792|NCT00655174|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524793|NCT00655161||Single Group Assignment||Treatment||None (Open Label)||||||
1524794|NCT00655148|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524795|NCT00655135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524796|NCT00655122|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1524797|NCT00655109|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524799|NCT00655083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524800|NCT00655070||Single Group Assignment||Diagnostic||None (Open Label)||||||
1524801|NCT00655057|Randomized|Parallel Assignment||||None (Open Label)||||||
1524802|NCT00655044|||Case Control|||||||||
1524803|NCT00655031|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524804|NCT00655018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524805|NCT00655005|||Case-Only||Prospective|||||||
1524806|NCT00654992|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1524807|NCT00654979||Single Group Assignment||Prevention||None (Open Label)||||||
1524808|NCT00654966|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1524809|NCT00654953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524810|NCT00654940|Randomized|Crossover Assignment||||Double|||t||t|
1524811|NCT00654927||Single Group Assignment||Treatment||None (Open Label)||||||
1524812|NCT00654914|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524813|NCT00654901|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524814|NCT00654888|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524815|NCT00654875|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524816|NCT00654862|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1524817|NCT00654849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524818|NCT00654836||Single Group Assignment||Treatment||None (Open Label)||||||
1524819|NCT00654823|||Cohort||Prospective|||||||
1524820|NCT00654810|Randomized|Parallel Assignment||Treatment||Single||||||t
1524821|NCT00654797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524822|NCT00654784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524823|NCT00654771|||Case-Only||Prospective|||||||
1524824|NCT00654758||Single Group Assignment||Treatment||None (Open Label)||||||
1524825|NCT00654745|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524826|NCT00654732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524827|NCT00654719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524828|NCT00654706|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524829|NCT00654693|||Cohort||Prospective|||||||
1524830|NCT00654680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524831|NCT00654667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524832|NCT00654654||Single Group Assignment||Treatment||None (Open Label)||||||
1524833|NCT00654641|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524834|NCT00654628|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524835|NCT00654615|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study was a prospective clinical trial comparing two different types of hardware to fix a specific type of distal radius fracture.||||
1524836|NCT00654602||Single Group Assignment||Treatment||None (Open Label)||||||
1524837|NCT00654589||Single Group Assignment||Treatment||None (Open Label)||||||
1524838|NCT00654576|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1524839|NCT00654563|||Case-Only||Prospective|||||||
1524840|NCT00654550|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524841|NCT00654537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524842|NCT00654524|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524843|NCT00654511|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1524844|NCT00654498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524845|NCT00654485|Randomized|Parallel Assignment||Treatment||Double||||||
1524846|NCT00654472|||Case-Only||Prospective|||||||
1524847|NCT00654459|||Case Control||Prospective|||||||
1524848|NCT00654446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524849|NCT00654433||Single Group Assignment||Treatment||None (Open Label)||||||
1524850|NCT00654420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524851|NCT00654407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524852|NCT00654394|Randomized|Parallel Assignment||Treatment||Double||||||
1524853|NCT00654381|Randomized|Parallel Assignment||Treatment||Double||||||
1524854|NCT00654368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524855|NCT00654355||Single Group Assignment||Treatment||None (Open Label)||||||
1524856|NCT00654342|Randomized|Parallel Assignment||||Single|||t|||
1524857|NCT00654329|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1524858|NCT00654316|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1524859|NCT00654303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524860|NCT00654290|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524861|NCT00654277|Randomized|Crossover Assignment||||None (Open Label)||||||
1524862|NCT00654264|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524863|NCT00654251|||Cohort||Prospective|||||||
1524864|NCT00654238||Single Group Assignment||Treatment||None (Open Label)||||||
1524865|NCT00654225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524866|NCT00654212|Randomized|Parallel Assignment||Treatment||Double||||t||t
1524867|NCT00654199|||Case-Only||Prospective|||||||
1524868|NCT00654186||Single Group Assignment||Treatment||None (Open Label)||||||
1524869|NCT00654173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524870|NCT00654160|Randomized|Single Group Assignment||Treatment||||||||
1524871|NCT00654147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524872|NCT00654134||Single Group Assignment||Basic Science||None (Open Label)||||||
1524873|NCT00654121||Parallel Assignment||Prevention||None (Open Label)||||||
1524874|NCT00654108|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1524875|NCT00654095|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524876|NCT00654082|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1524877|NCT00654069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524878|NCT00654056|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1524879|NCT00654043|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1524880|NCT00654030||Single Group Assignment||Treatment||None (Open Label)||||||
1524881|NCT00654017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524882|NCT00654004|||Case Control||Prospective|||||||
1524883|NCT00653991|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524884|NCT00653978|Randomized|Parallel Assignment||Treatment||Single||||||t
1524885|NCT00653965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524886|NCT00653952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524887|NCT00653939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524888|NCT00653926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524889|NCT00653913|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524890|NCT00653900|||Cohort||Prospective|||||||
1524891|NCT00653887|Randomized|Parallel Assignment||||Single||||t||
1524892|NCT00653874|Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1524893|NCT00653861|Randomized|Parallel Assignment||||Double|||t||t|
1524894|NCT00653848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524895|NCT00653835|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524896|NCT00653822|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1524897|NCT00653809|||Case Control||Cross-Sectional|||||||
1524898|NCT00653796|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524899|NCT00653783|||Case Control||Prospective|||||||
1524900|NCT00653770|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524901|NCT00653757||||Treatment||None (Open Label)||||||
1524902|NCT00653744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524903|NCT00653731|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524904|NCT00653718|||Case-Only||Prospective|||||||
1524905|NCT00653705|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1524906|NCT00653692|||Cohort||Prospective|||||||
1524907|NCT00653679|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1524908|NCT00653666|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1524909|NCT00653653|||Cohort||Prospective|||||||
1524910|NCT00653640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524911|NCT00653627|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1524912|NCT00653614|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1524913|NCT00653601|||Case Control||Prospective|||||||
1524914|NCT00653588||Parallel Assignment||Treatment||Double||||||
1524915|NCT00653575|||Case Control||Retrospective|||||||
1524916|NCT00653562|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1524917|NCT00653549|Randomized|Crossover Assignment||||None (Open Label)||||||
1524918|NCT00653536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524919|NCT00653523|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524920|NCT00653510|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1524921|NCT00653497|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1524922|NCT00653484|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524923|NCT00653471|Randomized|Crossover Assignment||||Triple|||t||t|t
1524924|NCT00653458|Randomized|Crossover Assignment||||None (Open Label)||||||
1524925|NCT00653445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524926|NCT00653432|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1524927|NCT00653419|Randomized|Crossover Assignment||||None (Open Label)||||||
1524928|NCT00653406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524929|NCT00653393|Randomized|Crossover Assignment||||None (Open Label)||||||
1524930|NCT00653380|Randomized|Crossover Assignment||||None (Open Label)||||||
1524931|NCT00653367|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1524932|NCT00653354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524933|NCT00653341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524934|NCT00653328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524935|NCT00653315|Randomized|Crossover Assignment||||None (Open Label)||||||
1524936|NCT00653302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524937|NCT00653276|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524938|NCT00653263|||Case-Only||Prospective|||||||
1524939|NCT00653250||Single Group Assignment||Treatment||None (Open Label)||||||
1524940|NCT00653237||Single Group Assignment||Treatment||Single|||t|||
1524941|NCT00653224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524942|NCT00653211||||||||||||
1524943|NCT00653198|||Case-Control||Prospective|||||||
1524944|NCT00653185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524945|NCT00653172|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524946|NCT00653159|Randomized|Parallel Assignment||Treatment||Single|||t|||
1524947|NCT00653146|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1524948|NCT00653133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524949|NCT00653120|Randomized|Crossover Assignment||||None (Open Label)||||||
1525789|NCT00642096|Randomized|Parallel Assignment||Treatment||Double||||||
1524950|NCT00653107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524951|NCT00653094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524952|NCT00653081|Randomized|Parallel Assignment||Treatment||Single||||||t
1524953|NCT00653068||Single Group Assignment||Treatment||None (Open Label)||||||
1524954|NCT00653055|Randomized|Crossover Assignment||||None (Open Label)||||||
1524955|NCT00653042|Randomized|Parallel Assignment||Prevention||Double||||||
1524956|NCT00653029|||Case Control||Cross-Sectional|||||||
1524957|NCT00653016|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524958|NCT00653003|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1524959|NCT00652977|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524960|NCT00652964|||Family-Based||Cross-Sectional|||||||
1524961|NCT00652951|Randomized|Parallel Assignment||Prevention||Single|||t|||
1524962|NCT00652938|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524963|NCT00652925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1524964|NCT00652912|Randomized|Crossover Assignment||||None (Open Label)||||||
1524965|NCT00652899|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1524966|NCT00652886|Randomized|Crossover Assignment||||None (Open Label)||||||
1524967|NCT00652873|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1524968|NCT00652860||||Treatment||None (Open Label)||||||
1524969|NCT00652847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524970|NCT00652834||Single Group Assignment||Treatment||None (Open Label)||||||
1524971|NCT00652821|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1524972|NCT00652808|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1524973|NCT00652795|Randomized|Crossover Assignment||||None (Open Label)||||||
1524974|NCT00652782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524975|NCT00652769|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1524976|NCT00652756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524977|NCT00652743|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1524978|NCT00652730|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1524979|NCT00652717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524980|NCT00652704|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1524981|NCT00652691||||Treatment||||||||
1524982|NCT00652678|||Case-Only||Cross-Sectional|||||||
1524983|NCT00652665|Randomized|Crossover Assignment||||None (Open Label)||||||
1524984|NCT00652652|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1524985|NCT00652639|Randomized|Crossover Assignment||||None (Open Label)||||||
1524986|NCT00652626|Randomized|Parallel Assignment||||None (Open Label)||||||
1524987|NCT00652613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524988|NCT00652600|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1524989|NCT00652587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524990|NCT00652574||Single Group Assignment||Treatment||None (Open Label)||||||
1524991|NCT00652561||Single Group Assignment||Treatment||None (Open Label)||||||
1524992|NCT00652548|||Other||Prospective|||||||
1524993|NCT00652522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524994|NCT00652509|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1524995|NCT00652496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524996|NCT00652483|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1524997|NCT00652470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1524998|NCT00652457|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1524999|NCT00652444|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525000|NCT00652431|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525001|NCT00652418|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1525002|NCT00652405|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1525003|NCT00652392|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525004|NCT00652379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525005|NCT00652366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525006|NCT00652353|Randomized|Parallel Assignment||||Double|||||t|t
1525007|NCT00652340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525008|NCT00652327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525009|NCT00652314|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1525010|NCT00652301|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1525011|NCT00652288|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525012|NCT00652275|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1525013|NCT00652262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525014|NCT00652249|||Cohort||Cross-Sectional|||||||
1525015|NCT00652236|||Case Control||Retrospective|||||||
1525016|NCT00652223||Single Group Assignment||Treatment||None (Open Label)||||||
1525017|NCT00652210||Single Group Assignment||Diagnostic||None (Open Label)||||||
1525018|NCT00652197|||Cohort||Cross-Sectional|||||||
1525019|NCT00652184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525020|NCT00652171|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525021|NCT00652158||Single Group Assignment||Treatment||None (Open Label)||||||
1525022|NCT00652145|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525023|NCT00652132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525024|NCT00652119||Single Group Assignment||Treatment||None (Open Label)||||||
1525025|NCT00652106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525026|NCT00652093|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1525027|NCT00652080||Single Group Assignment||Treatment||None (Open Label)||||||
1525028|NCT00652067||||||||||||
1525029|NCT00652054||Single Group Assignment||Treatment||None (Open Label)||||||
1525030|NCT00652041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525031|NCT00652028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525032|NCT00652015|||Cohort||Prospective|||||||
1525033|NCT00652002|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525034|NCT00651989|||Cohort||Cross-Sectional|||||||
1525035|NCT00651976||Single Group Assignment||Treatment||None (Open Label)||||||
1525036|NCT00651963|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525037|NCT00651950|||Cohort||Cross-Sectional|||||||
1525038|NCT00651937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525039|NCT00651924||Single Group Assignment||||None (Open Label)||||||
1525040|NCT00651911|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525041|NCT00651898|||Cohort|||||||||
1525042|NCT00651885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525043|NCT00651872|||Cohort||Cross-Sectional|||||||
1525044|NCT00651859|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525045|NCT00651846|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525046|NCT00651833||Single Group Assignment||Treatment||None (Open Label)||||||
1525047|NCT00651820|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1525048|NCT00651807|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525049|NCT00651794|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1525050|NCT00651781||Single Group Assignment||Treatment||None (Open Label)||||||
1525051|NCT00651768|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525052|NCT00651755|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525053|NCT00651742||Single Group Assignment||Treatment||None (Open Label)||||||
1525054|NCT00651729||Single Group Assignment||Treatment||None (Open Label)||||||
1525055|NCT00651716|||Cohort||Prospective|||||||
1525056|NCT00651703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525057|NCT00651690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525058|NCT00651677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525059|NCT00651664|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525060|NCT00651651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525061|NCT00651638|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1525062|NCT00651625|Randomized|Parallel Assignment||Treatment||Single||||||t
1525063|NCT00651612|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525064|NCT00651599|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525065|NCT00651586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525066|NCT00651573|Randomized|Parallel Assignment||Other||Double|||t|||t
1525067|NCT00651560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525068|NCT00651547|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525069|NCT00651534||||||||||||
1525070|NCT00651521|||Cohort||Retrospective|||||||
1525071|NCT00651508||Single Group Assignment||Treatment||None (Open Label)||||||
1525072|NCT00651495|Randomized|Parallel Assignment||||Single|||t|||
1525073|NCT00651482||Single Group Assignment||Treatment||None (Open Label)||||||
1525074|NCT00651469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525075|NCT00651456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525076|NCT00651443||Single Group Assignment||Treatment||None (Open Label)||||||
1525077|NCT00651430|||Cohort||Prospective|||||||
1525078|NCT00651417|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1525079|NCT00651404|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525080|NCT00651391|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1525081|NCT00651378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525082|NCT00651365|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525083|NCT00651352|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525084|NCT00651339|||Case-Only||Prospective|||||||
1525085|NCT00651326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525086|NCT00651313|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1525087|NCT00651300|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525088|NCT00651287||Parallel Assignment||Treatment||None (Open Label)||||||
1525089|NCT00651274|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525090|NCT00651261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525091|NCT00651248|||Cohort|||||||||
1525092|NCT00651235|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1525093|NCT00651222|||Cohort||Retrospective|||||||
1525094|NCT00651209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525095|NCT00651196|||Case Control||Cross-Sectional|||||||
1525096|NCT00651183|||||Prospective|||||||
1525097|NCT00651170|||Cohort||Prospective|||||||
1525098|NCT00651157||Single Group Assignment||Treatment||None (Open Label)||||||
1525099|NCT00651144|Randomized|Parallel Assignment||Treatment||Single|||||t|
1525100|NCT00651131|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525101|NCT00651118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525102|NCT00651105|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525103|NCT00651092|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525105|NCT00651066|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525106|NCT00651053||Crossover Assignment||Diagnostic||None (Open Label)||||||
1525107|NCT00651040|Randomized|Parallel Assignment||Treatment||Single|||||t|
1525108|NCT00651027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525109|NCT00651014|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525110|NCT00651001|||Ecologic or Community||Cross-Sectional|||||||
1525111|NCT00650988|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525112|NCT00650975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525113|NCT00650962|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1525114|NCT00650949||Single Group Assignment||Treatment||None (Open Label)||||||
1525115|NCT00650936||Single Group Assignment||Treatment||None (Open Label)||||||
1525116|NCT00650923||Single Group Assignment||Treatment||None (Open Label)||||||
1525117|NCT00650910||Single Group Assignment||Treatment||None (Open Label)||||||
1525118|NCT00650897||Single Group Assignment||Treatment||None (Open Label)||||||
1525119|NCT00650884|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525120|NCT00650871|Randomized|Crossover Assignment||Diagnostic||||||||
1525121|NCT00650858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525122|NCT00650845|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1525123|NCT00650832|Randomized|Parallel Assignment||Treatment||Single||||||
1525124|NCT00650819|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525125|NCT00650806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525126|NCT00650793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525127|NCT00650780|||Cohort||Cross-Sectional|||||||
1525128|NCT00650767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525129|NCT00650754|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1525130|NCT00650741|||||Cross-Sectional|||||||
1525131|NCT00650728||Single Group Assignment||Diagnostic||None (Open Label)||||||
1525132|NCT00650715|Randomized|Parallel Assignment||Treatment||Single|||t|||
1525133|NCT00650702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525134|NCT00650689|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525135|NCT00650676|||Case Control||Cross-Sectional|||||||
1525136|NCT00650663|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525137|NCT00650650|||Cohort||Prospective|||||||
1525138|NCT00650637|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525139|NCT00650624|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525140|NCT00650611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525141|NCT00650598|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525142|NCT00650585|Randomized|Parallel Assignment||Prevention||Single|||t|||
1525143|NCT00650572||Single Group Assignment||Treatment||None (Open Label)||||||
1525144|NCT00650559||Single Group Assignment||Treatment||None (Open Label)||||||
1525145|NCT00650546||Single Group Assignment||Other||None (Open Label)||||||
1525146|NCT00650533|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1525147|NCT00650520|Randomized|Crossover Assignment||||None (Open Label)||||||
1525148|NCT00650507|Randomized|Parallel Assignment||||Triple|||t||t|t
1525149|NCT00650494|Randomized|Crossover Assignment||||None (Open Label)||||||
1525150|NCT00650481|Randomized|Crossover Assignment||||None (Open Label)||||||
1525151|NCT00650468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525152|NCT00650455||Parallel Assignment||Treatment||Double|||t||t|
1525153|NCT00650442|Randomized|Crossover Assignment||||Single||||||t
1525154|NCT00650429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525155|NCT00650416|Randomized|Crossover Assignment||||None (Open Label)||||||
1525156|NCT00650403|Randomized|Crossover Assignment||||None (Open Label)||||||
1525157|NCT00650390||||||||||||
1525158|NCT00650377|Randomized|Crossover Assignment||||None (Open Label)||||||
1525159|NCT00650364|Randomized|Crossover Assignment||||None (Open Label)||||||
1525160|NCT00650351|Randomized|Crossover Assignment||||None (Open Label)||||||
1525161|NCT00650338|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525162|NCT00650325|Randomized|Crossover Assignment||||None (Open Label)||||||
1525163|NCT00650312|Randomized|Crossover Assignment||||None (Open Label)||||||
1525164|NCT00650299|Randomized|Crossover Assignment||||None (Open Label)||||||
1525165|NCT00650286|Randomized|Crossover Assignment||||None (Open Label)||||||
1525166|NCT00650273|Randomized|Crossover Assignment||||None (Open Label)||||||
1525167|NCT00650260|Randomized|Parallel Assignment||Prevention||Single||||||t
1525168|NCT00650247|Randomized|Crossover Assignment||||None (Open Label)||||||
1525169|NCT00650234|Randomized|Crossover Assignment||||None (Open Label)||||||
1525170|NCT00650221|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525171|NCT00650208|Randomized|Crossover Assignment||||None (Open Label)||||||
1525172|NCT00650195|Randomized|Crossover Assignment||||None (Open Label)||||||
1525173|NCT00650182|Randomized|Parallel Assignment||Treatment||Double||||||
1525174|NCT00650169|Randomized|Crossover Assignment||||None (Open Label)||||||
1525175|NCT00650156|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525176|NCT00650143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525177|NCT00650130|||Case Control|||||||||
1525178|NCT00650117|Randomized|Parallel Assignment||||None (Open Label)||||||
1525179|NCT00650104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525180|NCT00650091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525181|NCT00650078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525182|NCT00650065|Randomized|Crossover Assignment||||None (Open Label)||||||
1525183|NCT00650052|Randomized|Parallel Assignment||||None (Open Label)||||||
1525184|NCT00650039|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525185|NCT00650026||||||||||||
1525186|NCT00650013|Randomized|Crossover Assignment||||None (Open Label)||||||
1525187|NCT00650000|Randomized|Crossover Assignment||||None (Open Label)||||||
1525188|NCT00649987|Randomized|Crossover Assignment||||None (Open Label)||||||
1525189|NCT00649974|Randomized|Crossover Assignment||||None (Open Label)||||||
1525190|NCT00649961||Single Group Assignment||||None (Open Label)||||||
1525191|NCT00649948|Randomized|Crossover Assignment||||None (Open Label)||||||
1525192|NCT00649935|Randomized|Crossover Assignment||||None (Open Label)||||||
1525193|NCT00649922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525194|NCT00649909|||Cohort||Prospective|||||||
1525195|NCT00649896|Randomized|Single Group Assignment||||Single||||||t
1525196|NCT00649883|Randomized|Parallel Assignment||Prevention||Single|||t|||
1525197|NCT00649870|Randomized|Crossover Assignment||||None (Open Label)||||||
1525198|NCT00649857|Randomized|Crossover Assignment||||None (Open Label)||||||
1525199|NCT00649844|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525200|NCT00649831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525201|NCT00649818|Randomized|Crossover Assignment||||None (Open Label)||||||
1525202|NCT00649805|Randomized|Crossover Assignment||||None (Open Label)||||||
1525203|NCT00649792||Single Group Assignment||Treatment||None (Open Label)||||||
1525204|NCT00649779|Randomized|Crossover Assignment||||None (Open Label)||||||
1525205|NCT00649766|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1525206|NCT00649753|Randomized|Parallel Assignment||Treatment||Single||||||t
1525207|NCT00649740|Randomized|Crossover Assignment||||None (Open Label)||||||
1525208|NCT00649727|Randomized|Crossover Assignment||||None (Open Label)||||||
1525209|NCT00649714|Randomized|Parallel Assignment||||None (Open Label)||||||
1525210|NCT00649701|Randomized|Parallel Assignment||Prevention||Single|||t|||
1525211|NCT00649688|Randomized|Crossover Assignment||||None (Open Label)||||||
1525212|NCT00649675|Randomized|Crossover Assignment||||None (Open Label)||||||
1525213|NCT00649662|Randomized|Crossover Assignment||||None (Open Label)||||||
1525214|NCT00649649|Randomized|Crossover Assignment||||None (Open Label)||||||
1525215|NCT00649636|Randomized|Crossover Assignment||||None (Open Label)||||||
1525216|NCT00649623|Randomized|Crossover Assignment||||None (Open Label)||||||
1525217|NCT00649610|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525218|NCT00649597|Randomized|Crossover Assignment||||None (Open Label)||||||
1525219|NCT00649584||Single Group Assignment||Treatment||None (Open Label)||||||
1525220|NCT00649571|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1525221|NCT00649558|Randomized|Crossover Assignment||||None (Open Label)||||||
1525222|NCT00649545||||||||||||
1525223|NCT00649532|Randomized|Crossover Assignment||||None (Open Label)||||||
1525224|NCT00649519|Randomized|Crossover Assignment||||None (Open Label)||||||
1525225|NCT00649506|Randomized|Crossover Assignment||||None (Open Label)||||||
1525226|NCT00649493|Randomized|Crossover Assignment||||None (Open Label)||||||
1525227|NCT00649480|Randomized|Crossover Assignment||||None (Open Label)||||||
1525228|NCT00649467|Randomized|Crossover Assignment||||None (Open Label)||||||
1525229|NCT00649454|Randomized|Crossover Assignment||||None (Open Label)||||||
1525230|NCT00649441|Randomized|Crossover Assignment||||None (Open Label)||||||
1525231|NCT00649428|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525232|NCT00649415|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1525233|NCT00649402|Randomized|Crossover Assignment||||None (Open Label)||||||
1525234|NCT00649389|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525235|NCT00649376|Randomized|Crossover Assignment||||None (Open Label)||||||
1525236|NCT00649363|Randomized|Crossover Assignment||||None (Open Label)||||||
1525237|NCT00649350|Randomized|Crossover Assignment||||None (Open Label)||||||
1525238|NCT00649337||Single Group Assignment||Screening||None (Open Label)||||||
1525239|NCT00649324|Randomized|Crossover Assignment||||None (Open Label)||||||
1525240|NCT00649311|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525241|NCT00649298|Randomized|Parallel Assignment||Treatment||Single||||||t
1525242|NCT00649285|Randomized|Crossover Assignment||||None (Open Label)||||||
1525243|NCT00649272|Randomized|Crossover Assignment||||None (Open Label)||||||
1525244|NCT00649259|Randomized|Crossover Assignment||||None (Open Label)||||||
1525245|NCT00649246|||Cohort||Prospective|||||||
1525246|NCT00649233|Randomized|Crossover Assignment||||None (Open Label)||||||
1525247|NCT00649220||Single Group Assignment||Treatment||None (Open Label)||||||
1525248|NCT00649207|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525249|NCT00649194|Randomized|Crossover Assignment||||None (Open Label)||||||
1525250|NCT00649181|Randomized|Crossover Assignment||||None (Open Label)||||||
1525251|NCT00649168|Randomized|Crossover Assignment||||None (Open Label)||||||
1525252|NCT00649155|Randomized|Crossover Assignment||||None (Open Label)||||||
1525253|NCT00649142|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525254|NCT00649129|Randomized|Crossover Assignment||||None (Open Label)||||||
1525255|NCT00649116|Randomized|Crossover Assignment||||None (Open Label)||||||
1525256|NCT00649103|Randomized|Crossover Assignment||||None (Open Label)||||||
1525257|NCT00649090|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525258|NCT00649077|Randomized|Crossover Assignment||||None (Open Label)||||||
1525259|NCT00649064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525260|NCT00649051|Randomized|Crossover Assignment||||None (Open Label)||||||
1525261|NCT00649038|Randomized|Crossover Assignment||||None (Open Label)||||||
1525262|NCT00649025|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525263|NCT00649012|Randomized|Crossover Assignment||||None (Open Label)||||||
1525264|NCT00648999|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525265|NCT00648986||Single Group Assignment||Treatment||None (Open Label)||||||
1525266|NCT00648973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525267|NCT00648960|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525268|NCT00648947|Randomized|Crossover Assignment||||None (Open Label)||||||
1525269|NCT00648934|Randomized|Crossover Assignment||||None (Open Label)||||||
1525270|NCT00648921|Randomized|Crossover Assignment||||None (Open Label)||||||
1525271|NCT00648908||Single Group Assignment||Treatment||None (Open Label)||||||
1525272|NCT00648895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525273|NCT00648882|Randomized|Crossover Assignment||||None (Open Label)||||||
1525274|NCT00648869|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525275|NCT00648856|Randomized|Crossover Assignment||||None (Open Label)||||||
1525276|NCT00648843|Randomized|Crossover Assignment||||None (Open Label)||||||
1525277|NCT00648830|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525278|NCT00648817|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1525279|NCT00648804|Randomized|Crossover Assignment||||None (Open Label)||||||
1525280|NCT00648791|Randomized|Crossover Assignment||||None (Open Label)||||||
1525281|NCT00648778|Randomized|Crossover Assignment||||None (Open Label)||||||
1525282|NCT00648765|Randomized|Crossover Assignment||||None (Open Label)||||||
1525283|NCT00648739||Single Group Assignment||Treatment||None (Open Label)||||||
1525284|NCT00648726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525285|NCT00648713|Randomized|Crossover Assignment||||None (Open Label)||||||
1525286|NCT00648700|Randomized|Crossover Assignment||||None (Open Label)||||||
1525287|NCT00648687|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1525288|NCT00648674||Single Group Assignment||Treatment||None (Open Label)||||||
1525289|NCT00648661|Randomized|Crossover Assignment||||None (Open Label)||||||
1525290|NCT00648648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525291|NCT00648635|||Case-Only||Prospective|||||||
1525292|NCT00648622|Randomized|Crossover Assignment||||None (Open Label)||||||
1525293|NCT00648609|||Cohort||Prospective|||||||
1525294|NCT00648596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525295|NCT00648583|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1525296|NCT00648570|Randomized|Crossover Assignment||||None (Open Label)||||||
1525297|NCT00648557|Randomized|Crossover Assignment||||None (Open Label)||||||
1525298|NCT00648544|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525299|NCT00648531|Randomized|Crossover Assignment||||None (Open Label)||||||
1525300|NCT00648518|Randomized|Crossover Assignment||||None (Open Label)||||||
1525301|NCT00648505|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1525302|NCT00648492|Randomized|Crossover Assignment||||None (Open Label)||||||
1525303|NCT00648479|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1525304|NCT00648466|Randomized|Crossover Assignment||||None (Open Label)||||||
1525305|NCT00648453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525306|NCT00648440|Randomized|Crossover Assignment||||None (Open Label)||||||
1525307|NCT00648427|Randomized|Crossover Assignment||||None (Open Label)||||||
1525308|NCT00648414|Randomized|Factorial Assignment||||None (Open Label)||||||
1525309|NCT00648401|Randomized|Crossover Assignment||||None (Open Label)||||||
1525310|NCT00648388|Randomized|Crossover Assignment||||None (Open Label)||||||
1525311|NCT00648375|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525312|NCT00648362|Randomized|Crossover Assignment||||None (Open Label)||||||
1525313|NCT00648349|Randomized|Crossover Assignment||||None (Open Label)||||||
1525314|NCT00648336|Randomized|Crossover Assignment||||None (Open Label)||||||
1525315|NCT00648323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525316|NCT00648310||||||||||||
1525317|NCT00648297|Randomized|Crossover Assignment||||None (Open Label)||||||
1525318|NCT00648284|||||Prospective|||||||
1525319|NCT00648271|Randomized|Crossover Assignment||||None (Open Label)||||||
1525320|NCT00648258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525321|NCT00648245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525322|NCT00648232|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1525323|NCT00648219|Randomized|Crossover Assignment||||None (Open Label)||||||
1525324|NCT00648206|||Case-Crossover|||||||||
1525325|NCT00648193|Randomized|Crossover Assignment||||None (Open Label)||||||
1525326|NCT00648180|Randomized|Crossover Assignment||||None (Open Label)||||||
1525327|NCT00648167||Single Group Assignment||Treatment||None (Open Label)||||||
1525328|NCT00648154|Randomized|Crossover Assignment||||None (Open Label)||||||
1525329|NCT00648141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525330|NCT00648128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525331|NCT00648115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525332|NCT00648102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525790|NCT00642083||Single Group Assignment||Treatment||||||||
1525333|NCT00648089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525334|NCT00648076|Randomized|Crossover Assignment||||None (Open Label)||||||
1525335|NCT00648063|Randomized|Crossover Assignment||||None (Open Label)||||||
1525336|NCT00648050|Randomized|Crossover Assignment||||None (Open Label)||||||
1525337|NCT00648037||Single Group Assignment||Treatment||None (Open Label)||||||
1525338|NCT00648024|Randomized|Crossover Assignment||||None (Open Label)||||||
1525339|NCT00648011|Randomized|Crossover Assignment||||None (Open Label)||||||
1525340|NCT00647998|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525341|NCT00647985|Randomized|Crossover Assignment||||None (Open Label)||||||
1525342|NCT00647972|Randomized|Crossover Assignment||||None (Open Label)||||||
1525343|NCT00647959|Randomized|Crossover Assignment||||None (Open Label)||||||
1525344|NCT00647946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525345|NCT00647933|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525346|NCT00647920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525347|NCT00647907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525348|NCT00647894|Randomized|Crossover Assignment||||None (Open Label)||||||
1525349|NCT00647881|Randomized|Crossover Assignment||||None (Open Label)||||||
1525350|NCT00647868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525351|NCT00647855|Randomized|Crossover Assignment||||None (Open Label)||||||
1525352|NCT00647842|Randomized|Crossover Assignment||||None (Open Label)||||||
1525353|NCT00647829|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525354|NCT00647816|Randomized|Crossover Assignment||||None (Open Label)||||||
1525355|NCT00647790|||Cohort||Prospective|||||||
1525356|NCT00647777|Randomized|Crossover Assignment||||None (Open Label)||||||
1525357|NCT00647764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525358|NCT00647751|Randomized|Crossover Assignment||||None (Open Label)||||||
1525359|NCT00647738|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525360|NCT00647725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525361|NCT00647712|Randomized|Crossover Assignment||||None (Open Label)||||||
1525362|NCT00647699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525363|NCT00647686|Randomized|Crossover Assignment||||None (Open Label)||||||
1525364|NCT00647673|Randomized|Crossover Assignment||||None (Open Label)||||||
1525365|NCT00647660|Randomized|Crossover Assignment||||None (Open Label)||||||
1525366|NCT00647647|Randomized|Crossover Assignment||||None (Open Label)||||||
1525367|NCT00647634|Randomized|Crossover Assignment||||None (Open Label)||||||
1525368|NCT00647621|Randomized|Crossover Assignment||||None (Open Label)||||||
1525369|NCT00647608|Randomized|Crossover Assignment||||None (Open Label)||||||
1525370|NCT00647595|Randomized|Parallel Assignment||Prevention||Single|||||t|
1525371|NCT00647582||||Treatment||None (Open Label)||||||
1525372|NCT00647569|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1525373|NCT00647556|Randomized|Parallel Assignment||Treatment||Single||||||t
1525374|NCT00647543|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525375|NCT00647530|Randomized|Parallel Assignment||Treatment||None (Open Label)||Pre- plus Post-operative chemotherapy (+/- Panitumumab) vs standard post-operative chemotherapy.||||
1525376|NCT00647517|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1525377|NCT00647504|||Case Control||Prospective|||||||
1525378|NCT00647491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525379|NCT00647478|||Cohort||Prospective|||||||
1525380|NCT00647465|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1525381|NCT00647452|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1525382|NCT00647439|||Case-Control||Other|||||||
1525383|NCT00647426||Single Group Assignment||Treatment||None (Open Label)||||||
1525384|NCT00647413|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1525385|NCT00647400|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525386|NCT00647387||Single Group Assignment||Treatment||None (Open Label)||||||
1525387|NCT00647374|||Cohort||Prospective|||||||
1525388|NCT00647361||Single Group Assignment||Treatment||None (Open Label)||||||
1525389|NCT00647348|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525390|NCT00647335|||Case-Only||Prospective|||||||
1525391|NCT00647322|Non-Randomized|Single Group Assignment||||Single|||||t|
1525392|NCT00647309|||Cohort||Prospective|||||||
1525393|NCT00647296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525394|NCT00647283|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1525395|NCT00647270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525396|NCT00647257|Randomized|Parallel Assignment||Treatment||Single|||t|||
1525397|NCT00647244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525398|NCT00647231|Randomized|Factorial Assignment||||Quadruple|||t|t|t|t
1525399|NCT00647218||Single Group Assignment||Treatment||None (Open Label)||||||
1525400|NCT00647205|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1525401|NCT00647192|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1525402|NCT00647179|||Cohort||Prospective|||||||
1525403|NCT00647166|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525404|NCT00647153||Single Group Assignment||Diagnostic||None (Open Label)||||||
1525405|NCT00647140||Single Group Assignment||Diagnostic||None (Open Label)||||||
1525406|NCT00647127|Randomized|Crossover Assignment||||Double|||t||t|
1525407|NCT00647114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525408|NCT00647101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525409|NCT00647088|||Case-Control||Prospective|||||||
1525410|NCT00647075|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525411|NCT00647049|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525412|NCT00647036|Randomized|Single Group Assignment||||Double|||t||t|
1525413|NCT00647023||||Basic Science||||||||
1525414|NCT00646997|||Case-Crossover||Prospective|||||||
1525415|NCT00646984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525416|NCT00646971|Randomized|Parallel Assignment||Treatment||Single|||t|||
1525417|NCT00646958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525418|NCT00646945|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1525419|NCT00646932|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1525420|NCT00646919|||Case-Only||Prospective|||||||
1525421|NCT00646906|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525422|NCT00646893|Randomized|Parallel Assignment||Screening||Quadruple|||t|t|t|t
1525423|NCT00646880|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1525424|NCT00646867|Randomized|Single Group Assignment||Treatment||Single|||||t|
1525425|NCT00646854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525426|NCT00646841|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525427|NCT00646828|||Family-Based||Cross-Sectional|||||||
1525428|NCT00646815|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1525429|NCT00646802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525430|NCT00646789|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525431|NCT00646776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525432|NCT00646763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525433|NCT00646750||Single Group Assignment||Treatment||None (Open Label)||||||
1525434|NCT00646737||Single Group Assignment||Treatment||None (Open Label)||||||
1525435|NCT00646724||Single Group Assignment||Treatment||None (Open Label)||||||
1525436|NCT00646711|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525437|NCT00646698|||Case Control||Cross-Sectional|||||||
1525438|NCT00646685|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525439|NCT00646672|||||Retrospective|||||||
1525440|NCT00646659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525441|NCT00646646|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1525442|NCT00646633|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1525443|NCT00646620|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1525444|NCT00646607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525445|NCT00646594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525446|NCT00646581|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525447|NCT00646568||Single Group Assignment||Diagnostic||None (Open Label)||||||
1525448|NCT00646555||||||||||||
1525449|NCT00646542|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525450|NCT00646529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525451|NCT00646516|Randomized|Parallel Assignment||Treatment||Double||||||
1525452|NCT00646503||Single Group Assignment||Treatment||None (Open Label)||||||
1525453|NCT00646490|||Cohort||Prospective|||||||
1525454|NCT00646477|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525455|NCT00646464|||Cohort||Prospective|||||||
1525456|NCT00646451|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525457|NCT00646438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525458|NCT00646425|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525459|NCT00646412|Randomized|Parallel Assignment||Prevention||Single|||t|||
1525460|NCT00646399|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525461|NCT00646386|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525462|NCT00646373|Randomized|Parallel Assignment||Prevention||Single||||||t
1525463|NCT00646360|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1525464|NCT00646347|Randomized|Parallel Assignment||Treatment||Single||||||t
1525465|NCT00646334|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525466|NCT00646321|Randomized|Parallel Assignment||Treatment||Double||||||
1525467|NCT00646308|||Case Control||Cross-Sectional|||||||
1525468|NCT00646295||Single Group Assignment||Diagnostic||None (Open Label)||||||
1525469|NCT00646282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525470|NCT00646269|Randomized|Parallel Assignment||Treatment||Single||||||t
1525471|NCT00646256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525472|NCT00646243|||Cohort||Prospective|||||||
1525473|NCT00646230||Single Group Assignment||Treatment||None (Open Label)||||||
1525474|NCT00646217|Randomized|Parallel Assignment||||None (Open Label)||||||
1525475|NCT00646204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525476|NCT00646191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525477|NCT00646178|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525478|NCT00646165|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525479|NCT00646152|Randomized|Single Group Assignment||Treatment||||||||
1525480|NCT00646139||Single Group Assignment||Treatment||None (Open Label)||||||
1525481|NCT00646126|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525482|NCT00646113||Single Group Assignment||Treatment||None (Open Label)||||||
1525483|NCT00646100|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525484|NCT00646087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525485|NCT00646074|Randomized|Parallel Assignment||||None (Open Label)||||||
1525486|NCT00646061|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1525487|NCT00646048|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525488|NCT00646035|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525489|NCT00646022|||Family-Based||Prospective|||||||
1525490|NCT00646009|Randomized|Crossover Assignment||Treatment||Double||||||
1525491|NCT00645996|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1525492|NCT00645983|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525493|NCT00645970|||Cohort||Prospective|||||||
1525494|NCT00645957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525495|NCT00645944|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525496|NCT00645931|||Case Control||Prospective|||||||
1525497|NCT00645918|Randomized|Parallel Assignment||||Triple|||t|t|t|
1525498|NCT00645905|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525499|NCT00645892|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525500|NCT00645879||Single Group Assignment||Treatment||None (Open Label)||||||
1525501|NCT00645866||||Treatment||None (Open Label)||||||
1525502|NCT00645853|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525503|NCT00645840||Single Group Assignment||Treatment||None (Open Label)||||||
1525504|NCT00645827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525505|NCT00645814|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525506|NCT00645801|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525507|NCT00645788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525508|NCT00645775|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525509|NCT00645762||Single Group Assignment||Treatment||None (Open Label)||||||
1525510|NCT00645749||Single Group Assignment||Treatment||None (Open Label)||||||
1525511|NCT00645736|||Cohort||Cross-Sectional|||||||
1525512|NCT00645723|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525513|NCT00645710||Single Group Assignment||Treatment||None (Open Label)||||||
1525514|NCT00645697|||Cohort||Retrospective|||||||
1525515|NCT00645684|Randomized|Parallel Assignment||Treatment||Single|||t|||
1525516|NCT00645671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525517|NCT00645658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525518|NCT00645645|||Cohort||Prospective|||||||
1525519|NCT00645632||||Treatment||||||||
1525520|NCT00645619|||Case-Control||Cross-Sectional|||||||
1525521|NCT00645606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525522|NCT00645593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525523|NCT00645580||Single Group Assignment||Treatment||None (Open Label)||||||
1525524|NCT00645567|||Case-Crossover||Cross-Sectional|||||||
1525525|NCT00645554|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525526|NCT00645541|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1525527|NCT00645528||Single Group Assignment||Health Services Research||None (Open Label)||||||
1525528|NCT00645515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525529|NCT00645502|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525530|NCT00645489|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1525531|NCT00645463|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525532|NCT00645450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525533|NCT00645437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525534|NCT00645424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525535|NCT00645411|Randomized|Parallel Assignment||Prevention||Single|||t|||
1525536|NCT00645398|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525537|NCT00645385|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1525538|NCT00645372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525539|NCT00645359|||Cohort||Prospective|||||||
1525540|NCT00645346|Randomized|Parallel Assignment||Prevention||Single|||t|||
1525541|NCT00645333||Single Group Assignment||Treatment||None (Open Label)||||||
1525542|NCT00645320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525543|NCT00645307|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525544|NCT00645294|Randomized|Crossover Assignment||||None (Open Label)||||||
1525545|NCT00645281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525546|NCT00645268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525547|NCT00645255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525548|NCT00645242||Single Group Assignment||Treatment||None (Open Label)||||||
1525549|NCT00645229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525550|NCT00645216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525551|NCT00645203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525552|NCT00645190|Randomized|Parallel Assignment||Treatment||Double||||||
1525553|NCT00645177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525554|NCT00645164||Single Group Assignment||||Quadruple|||t|t|t|t
1525555|NCT00645151|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525556|NCT00645138|Randomized|Parallel Assignment||Treatment||Single||||||t
1525557|NCT00645125|Randomized|Crossover Assignment||||Single|||t|||
1525558|NCT00645112|Randomized|Parallel Assignment||Treatment||Single|||||t|
1525559|NCT00645099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525560|NCT00645086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525561|NCT00645073|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525562|NCT00645060||Single Group Assignment||Treatment||None (Open Label)||||||
1525563|NCT00645047|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1525564|NCT00645034|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1525565|NCT00645021|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525566|NCT00645008|||Other||Other|||||||
1525567|NCT00644995|Randomized|Parallel Assignment||Treatment||Single||||||t
1525568|NCT00644982|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525569|NCT00644969|Randomized|Parallel Assignment||||Double|||t||t|
1525570|NCT00644956|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525571|NCT00644943|Randomized|||Treatment||Single|||||t|
1525572|NCT00644930|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525573|NCT00644917|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1525574|NCT00644904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525575|NCT00644891|Randomized|Crossover Assignment||||Single|||t|||
1525576|NCT00644878||Single Group Assignment||Treatment||None (Open Label)||||||
1525577|NCT00644852|||Cohort||Retrospective|||||||
1525578|NCT00644839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525579|NCT00644826|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1525580|NCT00644813|||Cohort||Prospective|||||||
1525581|NCT00644800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525582|NCT00644787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525583|NCT00644774|Randomized|Crossover Assignment||||Single|||t|||
1525584|NCT00644761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525585|NCT00644748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525586|NCT00644735|Randomized|Parallel Assignment||Treatment||Double||||||
1525587|NCT00644722|Randomized|Parallel Assignment||Treatment||Single|||t|||
1525588|NCT00644709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525589|NCT00644696||Single Group Assignment||Treatment||None (Open Label)||||||
1525590|NCT00644683|||Case Control||Retrospective|||||||
1525591|NCT00644670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525592|NCT00644657||Single Group Assignment||Basic Science||None (Open Label)||||||
1525593|NCT00644644|||Cohort||Prospective|||||||
1525594|NCT00644631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525595|NCT00644618|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1525596|NCT00644605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525597|NCT00644592|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1525598|NCT00644579|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525599|NCT00644566|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1525600|NCT00644553|Randomized|Parallel Assignment||Treatment||Single|||||t|
1525601|NCT00644540|Randomized|Parallel Assignment||Prevention||Single|||t|||
1525602|NCT00644527|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1525603|NCT00644514||Single Group Assignment||Basic Science||None (Open Label)||||||
1525604|NCT00644501||Single Group Assignment||Treatment||None (Open Label)||||||
1525605|NCT00644488|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525606|NCT00644475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525607|NCT00644462|||Case Control||Retrospective|||||||
1525608|NCT00644449|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525609|NCT00644436|Randomized|Single Group Assignment||||Single|||||t|
1525610|NCT00644423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525611|NCT00644410|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525612|NCT00644397|||Case-Only||Prospective|||||||
1525613|NCT00644384|Randomized|||Prevention||Double||||||
1525614|NCT00644371||Single Group Assignment||Treatment||None (Open Label)||||||
1525615|NCT00644358||Single Group Assignment||Treatment||None (Open Label)||||||
1525616|NCT00644345|||Case Control||Prospective|||||||
1525617|NCT00644332|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1525618|NCT00644319|Randomized|||Supportive Care||||||||
1525619|NCT00644306|Randomized|Parallel Assignment||Treatment||Double||||||
1525620|NCT00644293|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525621|NCT00644280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525622|NCT00644267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525623|NCT00644254|||Cohort||Retrospective|||||||
1525624|NCT00644241||Single Group Assignment||Treatment||None (Open Label)||||||
1525625|NCT00644228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525626|NCT00644215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525627|NCT00644202|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1525628|NCT00644189||Single Group Assignment||Treatment||None (Open Label)||||||
1525629|NCT00644176|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1525630|NCT00644163|Randomized|Parallel Assignment||Prevention||||||||
1525631|NCT00644150|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525632|NCT00644137|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1525633|NCT00644124|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525634|NCT00644111|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1525635|NCT00644098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525636|NCT00644085|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525637|NCT00644072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525638|NCT00644059|Randomized|Parallel Assignment||Prevention||Single|||t|||
1525639|NCT00644046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525640|NCT00644033|Randomized|Crossover Assignment||Prevention||Double||||||
1525641|NCT00644020|||Case Control||Prospective|||||||
1525642|NCT00644007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525643|NCT00643994||Single Group Assignment||Treatment||None (Open Label)||||||
1525644|NCT00643981|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525645|NCT00643968|Randomized|Parallel Assignment||||None (Open Label)||||||
1525646|NCT00643955|||Cohort||Cross-Sectional|||||||
1525647|NCT00643942|||Case-Only||Prospective|||||||
1525648|NCT00643929|||Cohort||Prospective|||||||
1525649|NCT00643916|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525650|NCT00643903|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1525651|NCT00643890|Randomized|||Treatment||Quadruple|||t|t|t|t
1525652|NCT00643877|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525653|NCT00643864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525654|NCT00643851|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525655|NCT00643838|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525656|NCT00643825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525657|NCT00643812|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525658|NCT00643799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525659|NCT00643786|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525660|NCT00643773|Randomized|Factorial Assignment||||Double|||t|t||
1525661|NCT00643760|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525662|NCT00643747||Single Group Assignment||Treatment||None (Open Label)||||||
1525663|NCT00643734|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525664|NCT00643721|||Cohort||Prospective|||||||
1525665|NCT00643708|||Case-Only||Prospective|||||||
1525666|NCT00643695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525667|NCT00643682|Randomized|Parallel Assignment||Treatment||Single||||||t
1525668|NCT00643669|Randomized|Single Group Assignment||Treatment||Single||||||t
1525669|NCT00643656|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525670|NCT00643643|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1525671|NCT00643630|Randomized|Single Group Assignment||Prevention||Single|||||t|
1525672|NCT00643617||Single Group Assignment||Treatment||None (Open Label)||||||
1525673|NCT00643604|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525674|NCT00643591|||Case-Only||Prospective|||||||
1525675|NCT00643578|Randomized|Crossover Assignment||||None (Open Label)||||||
1525676|NCT00643565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525677|NCT00643552|||Cohort||Cross-Sectional|||||||
1525678|NCT00643539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525679|NCT00643526|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525680|NCT00643513|||Case-Only||Prospective|||||||
1525681|NCT00643500|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525682|NCT00643487|||Case-Only||Prospective|||||||
1525683|NCT00643474|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1525684|NCT00643461|||Cohort||Prospective|||||||
1525685|NCT00643448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525686|NCT00643435|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1525687|NCT00643422|||Cohort||Prospective|||||||
1525688|NCT00643409|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525689|NCT00643396||||Treatment||||||||
1525690|NCT00643383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525691|NCT00643370|||Case-Only||Retrospective|||||||
1525692|NCT00643357|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525693|NCT00643344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525694|NCT00643331|Randomized|Parallel Assignment||Treatment||Single||||||t
1525695|NCT00643318||Single Group Assignment||Treatment||None (Open Label)||||||
1525696|NCT00643305|Randomized|Parallel Assignment||Prevention||Single||||||t
1525697|NCT00643292|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525698|NCT00643279|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1525699|NCT00643266|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1525700|NCT00643253|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1525701|NCT00643240||Single Group Assignment||Treatment||None (Open Label)||||||
1525702|NCT00643227|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525703|NCT00643214|Randomized|Single Group Assignment||||Single|||||t|
1525704|NCT00643201|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525705|NCT00643188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525706|NCT00643175|||Case-Only||Prospective|||||||
1525707|NCT00643162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525708|NCT00643149|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525709|NCT00643136|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525710|NCT00643123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525711|NCT00643110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525712|NCT00643097|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525713|NCT00643084|Randomized|Single Group Assignment||Treatment||Triple||||t|t|t
1525791|NCT00642070|||Case-Only||Prospective|||||||
1525714|NCT00643071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525715|NCT00643058||Single Group Assignment||Basic Science||None (Open Label)||||||
1525716|NCT00643045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525717|NCT00643032|Randomized|||Treatment||||||||
1525718|NCT00643019|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525719|NCT00643006|Randomized|Parallel Assignment||Treatment||Single||||||t
1525720|NCT00642993|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525721|NCT00642980|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1525722|NCT00642967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525723|NCT00642954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525724|NCT00642941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525725|NCT00642928|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525726|NCT00642915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525727|NCT00642902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525728|NCT00642889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525729|NCT00642876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525730|NCT00642863|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1525731|NCT00642850||Single Group Assignment||Treatment||None (Open Label)||||||
1525732|NCT00642837|||||Prospective|||||||
1525733|NCT00642824|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525734|NCT00642811|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525735|NCT00642798|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525736|NCT00642785|||Case-Only||Prospective|||||||
1525737|NCT00642772||Single Group Assignment||Health Services Research||None (Open Label)||||||
1525738|NCT00642759||Single Group Assignment||Treatment||None (Open Label)||||||
1525739|NCT00642746|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525740|NCT00642733||Single Group Assignment||Treatment||None (Open Label)||||||
1525741|NCT00642720|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1525742|NCT00642707|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525743|NCT00642694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525744|NCT00642681|||Cohort||Prospective|||||||
1525745|NCT00642668||Single Group Assignment||Treatment||None (Open Label)||||||
1525746|NCT00642655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525747|NCT00642642|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525748|NCT00642629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525749|NCT00642616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525750|NCT00642603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525751|NCT00642590|||Cohort||Prospective|||||||
1525752|NCT00642577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525753|NCT00642564|||Cohort||Prospective|||||||
1525754|NCT00642551|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1525755|NCT00642538|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1525756|NCT00642525|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1525757|NCT00642512|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1525758|NCT00642499|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525759|NCT00642486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525760|NCT00642473|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525761|NCT00642460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525762|NCT00642447|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1525763|NCT00642434|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1525764|NCT00642421|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525765|NCT00642408|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1525766|NCT00642395||Single Group Assignment||Treatment||None (Open Label)||||||
1525767|NCT00642382|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525768|NCT00642369|Randomized|Parallel Assignment||Treatment||Single||||||t
1525769|NCT00642356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525770|NCT00642343|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525771|NCT00642330|Randomized|Crossover Assignment||Treatment||Single||||||t
1525772|NCT00642317|||Ecologic or Community||Prospective|||||||
1525773|NCT00642304||Single Group Assignment||Treatment||None (Open Label)||||||
1525774|NCT00642291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525775|NCT00642278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525776|NCT00642265|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525777|NCT00642252|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1525778|NCT00642239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525779|NCT00642226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525780|NCT00642213|||Cohort||Prospective|||||||
1525781|NCT00642200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525782|NCT00642187|Randomized|Parallel Assignment||Treatment||Single||||||
1525783|NCT00642174|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525784|NCT00642161|Randomized|Parallel Assignment||Treatment||Double||||||
1525785|NCT00642148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525786|NCT00642135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525787|NCT00642122|Randomized|Parallel Assignment||Treatment||Single||||||
1525788|NCT00642109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525793|NCT00642044|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1525794|NCT00642031||Single Group Assignment||Treatment||None (Open Label)||||||
1525795|NCT00642018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525796|NCT00642005|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1525797|NCT00641992|||Case Control||Prospective|||||||
1525798|NCT00641979|Randomized|Parallel Assignment||Treatment||Double||||||
1525799|NCT00641953|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525800|NCT00641940|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525801|NCT00641927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525802|NCT00641914|Randomized|Parallel Assignment||Treatment||Double||||||
1525803|NCT00641901|||Case-Only||Prospective|||||||
1525804|NCT00641888|||Cohort||Prospective|||||||
1525805|NCT00641875|||Cohort||Prospective|||||||
1525806|NCT00641862|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525807|NCT00641849|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1525808|NCT00641836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525809|NCT00641823|||Cohort||Cross-Sectional|||||||
1525810|NCT00641810||Single Group Assignment||Treatment||None (Open Label)||||||
1525811|NCT00641797|Randomized|Parallel Assignment||Treatment||Single||||t||
1525812|NCT00641784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525813|NCT00641771|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1525814|NCT00641758|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525815|NCT00641745|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525816|NCT00641732|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1525817|NCT00641719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525818|NCT00641706|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525819|NCT00641693|Randomized|Parallel Assignment||Treatment||Double||||||
1525820|NCT00641680|Randomized|Parallel Assignment||Treatment||Double||||||
1525821|NCT00641667||Single Group Assignment||Treatment||None (Open Label)||||||
1525822|NCT00641654|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525823|NCT00641641||Single Group Assignment||Treatment||None (Open Label)||||||
1525824|NCT00641628|||Case Control||Prospective|||||||
1525825|NCT00641615||Single Group Assignment||Treatment||None (Open Label)||||||
1525826|NCT00641602|Randomized|Parallel Assignment||Treatment||Double||||||
1525827|NCT00641589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525828|NCT00641576|||Case-Only||Prospective|||||||
1525829|NCT00641563|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1525830|NCT00641550|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525831|NCT00641537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525832|NCT00641524||Single Group Assignment||Treatment||None (Open Label)||||||
1525833|NCT00641511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525834|NCT00641498|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1525835|NCT00641472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525836|NCT00641459|||Cohort||Prospective|||||||
1525837|NCT00641446|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525838|NCT00641433|Randomized|Parallel Assignment||Treatment||Single||||||t
1525839|NCT00641420|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525840|NCT00641407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525841|NCT00641394|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1525842|NCT00641381||Single Group Assignment||Treatment||None (Open Label)||||||
1525843|NCT00641368|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525844|NCT00641355|||Case-Only||Prospective|||||||
1525845|NCT00641342|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1525846|NCT00641329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525847|NCT00641316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525848|NCT00641303|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1525849|NCT00641290||||||||||||
1525850|NCT00641277|||Case-Only||Prospective|||||||
1525851|NCT00641264||Single Group Assignment||Diagnostic||None (Open Label)||||||
1525852|NCT00641251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525853|NCT00641238|||Case-Only||Prospective|||||||
1525854|NCT00641225||Single Group Assignment||Treatment||None (Open Label)||||||
1525855|NCT00641212|Randomized|Parallel Assignment||Treatment||Double||||||
1525856|NCT00641199|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1525857|NCT00641186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525858|NCT00641173|Randomized|Parallel Assignment||Treatment||Double||||||
1525859|NCT00641160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525860|NCT00641147|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525861|NCT00641134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525862|NCT00641121|||Case-Only||Prospective|||||||
1525863|NCT00641108|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1525864|NCT00641095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525865|NCT00641082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525866|NCT00641069|||Cohort||Prospective|||||||
1525867|NCT00641056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525868|NCT00641043|Randomized|Parallel Assignment||Treatment||Double||||||
1525869|NCT00641030||Single Group Assignment||Treatment||None (Open Label)||||||
1525870|NCT00641017|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1525871|NCT00641004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525872|NCT00640991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525873|NCT00640978||Single Group Assignment||Treatment||None (Open Label)||||||
1525874|NCT00640965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525875|NCT00640952||Single Group Assignment||Treatment||None (Open Label)||||||
1525876|NCT00640939|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525877|NCT00640926|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525878|NCT00640913|||Case-Only||Prospective|||||||
1525879|NCT00640900|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525880|NCT00640887|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525881|NCT00640874|||Cohort||Prospective|||||||
1525882|NCT00640861|Randomized|||Treatment||||||||
1525883|NCT00640848|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525884|NCT00640835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525885|NCT00640822|Randomized|Parallel Assignment||Treatment||Single|||||t|
1525886|NCT00640809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525887|NCT00640796||Single Group Assignment||Treatment||None (Open Label)||||||
1525888|NCT00640783|Randomized|Parallel Assignment||Treatment||Single||||||t
1525889|NCT00640770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525890|NCT00640757|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525891|NCT00640744|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525892|NCT00640731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525893|NCT00640718|||Case-Only||Prospective|||||||
1525894|NCT00640705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525895|NCT00640692|||Case Control||Prospective|||||||
1525896|NCT00640679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525897|NCT00640666|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1525898|NCT00640653|Randomized|Parallel Assignment||Prevention||Single||||||t
1525899|NCT00640640||Single Group Assignment||||None (Open Label)||||||
1525900|NCT00640627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525901|NCT00640614|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1525902|NCT00640601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525903|NCT00640588|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1525904|NCT00640575|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1525905|NCT00640562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525906|NCT00640549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525907|NCT00640536|||Case Control||Prospective|||||||
1525908|NCT00640523|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525909|NCT00640510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525910|NCT00640497||Single Group Assignment||Treatment||None (Open Label)||||||
1525911|NCT00640484|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1525912|NCT00640471|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525913|NCT00640458|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1525914|NCT00640445|Randomized|Factorial Assignment||Treatment||Single|||||t|
1525915|NCT00640432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525916|NCT00640419|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525917|NCT00640406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525918|NCT00640393|Randomized|Parallel Assignment||Treatment||Single||||||t
1525919|NCT00640380|Randomized|Single Group Assignment||||Single||||||t
1525920|NCT00640367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525921|NCT00640354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525922|NCT00640341|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1525923|NCT00640328|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1525924|NCT00640315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525925|NCT00640302|||Cohort||Prospective|||||||
1525926|NCT00640289||Single Group Assignment||Treatment||None (Open Label)||||||
1525927|NCT00640276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525928|NCT00640263|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1525929|NCT00640250||Single Group Assignment||Diagnostic||None (Open Label)||||||
1525930|NCT00640237|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525931|NCT00640224|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525932|NCT00640211|||Cohort||Prospective|||||||
1525933|NCT00640198|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525934|NCT00640185|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525935|NCT00640172|||Cohort||Prospective|||||||
1525936|NCT00640159||Single Group Assignment||Treatment||None (Open Label)||||||
1525937|NCT00640146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525938|NCT00640133|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1525939|NCT00640120|||Case Control||Prospective|||||||
1525940|NCT00640107|||Case-Only||Prospective|||||||
1525941|NCT00640094|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1525942|NCT00640081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525943|NCT00640068|||Cohort||Prospective|||||||
1525944|NCT00640055|Non-Randomized|Single Group Assignment||Diagnostic||Double|||t|t||
1525945|NCT00640042||Single Group Assignment||Treatment||None (Open Label)||||||
1525946|NCT00640029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525947|NCT00640016|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525948|NCT00640003|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1525949|NCT00639990|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1525950|NCT00639977|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525951|NCT00639964|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1525952|NCT00639951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525953|NCT00639938|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1525954|NCT00639925||Single Group Assignment||Treatment||None (Open Label)||||||
1525955|NCT00639912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525956|NCT00639899|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525957|NCT00639873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525958|NCT00639860||Single Group Assignment||Treatment||None (Open Label)||||||
1525959|NCT00639847|Randomized|Parallel Assignment||Treatment||Single||||t||
1525960|NCT00639834||Single Group Assignment||Treatment||None (Open Label)||||||
1525961|NCT00639821|||Cohort||Prospective|||||||
1525962|NCT00639808|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1525963|NCT00639795|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1525964|NCT00639782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525965|NCT00639769||Single Group Assignment||Treatment||None (Open Label)||||||
1525966|NCT00639756|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525967|NCT00639743|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525968|NCT00639730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525969|NCT00639717||Single Group Assignment||Prevention||None (Open Label)||||||
1525970|NCT00639704|||Case-Only||Prospective|||||||
1525971|NCT00639691||Single Group Assignment||Treatment||None (Open Label)||||||
1525972|NCT00639678|Randomized|Parallel Assignment||Treatment||Single|||||t|
1525973|NCT00639665|||Cohort||Prospective|||||||
1525974|NCT00639652|||Cohort||Prospective|||||||
1525975|NCT00639639|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525976|NCT00639626||Single Group Assignment||Treatment||None (Open Label)||||||
1525977|NCT00639613|||Case Control||Prospective|||||||
1525978|NCT00639600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525979|NCT00639587|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1525980|NCT00639574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525981|NCT00639561|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1525982|NCT00639548|||Case-Only||Prospective|||||||
1525983|NCT00639535|||Case-Only||Prospective|||||||
1525984|NCT00639522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1525985|NCT00639509||Single Group Assignment||Treatment||None (Open Label)||||||
1525986|NCT00639496|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1525987|NCT00639483|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1525988|NCT00639470|Randomized|Parallel Assignment||||None (Open Label)||||||
1525989|NCT00639457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1525990|NCT00639444|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1525991|NCT00639431|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1525992|NCT00639418|||||Prospective|||||||
1525993|NCT00639405|||Case-Only||Prospective|||||||
1525994|NCT00639392|Randomized|Parallel Assignment||||Triple|||t|t|t|
1525995|NCT00639379|Randomized|Crossover Assignment||Treatment||Single|||t|||
1525996|NCT00639366|Randomized|||Prevention||||||||
1525997|NCT00639353|Randomized|Crossover Assignment||Treatment||Single|||t|||
1525998|NCT00639340||||||||||||
1525999|NCT00639327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526000|NCT00639314|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526001|NCT00639301|||Cohort||Retrospective|||||||
1526002|NCT00639288||Single Group Assignment||Treatment||None (Open Label)||||||
1526003|NCT00639275|||||Prospective|||||||
1526004|NCT00639262|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526005|NCT00639249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526006|NCT00639236|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526007|NCT00639223|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526008|NCT00639210|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1526009|NCT00639197|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526010|NCT00639184|Randomized|Single Group Assignment||Treatment||Single||||t||
1526011|NCT00639171|||Case-Only||Prospective|||||||
1526012|NCT00639158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526013|NCT00639145|||Cohort||Prospective|||||||
1526014|NCT00639132|||Case-Only||Prospective|||||||
1526015|NCT00639119|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1526016|NCT00639106|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526017|NCT00639093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526018|NCT00639080|||Case Control|||||||||
1526019|NCT00639067|||Cohort||Prospective|||||||
1526020|NCT00639054|||Cohort||Prospective|||||||
1526021|NCT00639041|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1526022|NCT00639028|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1526023|NCT00639015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526024|NCT00639002||Single Group Assignment||Treatment||None (Open Label)||||||
1526025|NCT00638989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526026|NCT00638976|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1526027|NCT00638963|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526028|NCT00638950|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1526029|NCT00638937||Single Group Assignment||Treatment||None (Open Label)||||||
1526030|NCT00638924|||||Prospective|||||||
1526031|NCT00638911|||Cohort||Prospective|||||||
1526032|NCT00638898||Single Group Assignment||Treatment||None (Open Label)||||||
1526033|NCT00638885|||Cohort||Prospective|||||||
1526034|NCT00638872|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526035|NCT00638859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526036|NCT00638846|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526037|NCT00638833|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1526038|NCT00638820||Single Group Assignment||Treatment||None (Open Label)||||||
1526039|NCT00638807|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526040|NCT00638794|||||Prospective|||||||
1526041|NCT00638781|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526042|NCT00638768|Randomized|Parallel Assignment||Treatment||Single||||||t
1526043|NCT00638755|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1526044|NCT00638742|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1526045|NCT00638729|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1526046|NCT00638716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526047|NCT00638703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526048|NCT00638690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526049|NCT00638677|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1526050|NCT00638664|||||Prospective|||||||
1526051|NCT00638651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526052|NCT00638638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526053|NCT00638625|||Cohort||Prospective|||||||
1526054|NCT00638612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526055|NCT00638599|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1526056|NCT00638586|||Case Control||Prospective|||||||
1526057|NCT00638573|||Case Control||Cross-Sectional|||||||
1526058|NCT00638560|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1526059|NCT00638547||Single Group Assignment||Treatment||None (Open Label)||||||
1526060|NCT00638534|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526061|NCT00638521|||Cohort||Prospective|||||||
1526062|NCT00638508|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526063|NCT00638495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526064|NCT00638482|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526065|NCT00638469|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526066|NCT00638456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526067|NCT00638443|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1526068|NCT00638430|||Case-Only||Prospective|||||||
1526069|NCT00638417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526070|NCT00638404|||Other||Prospective|||||||
1526071|NCT00638391|||Case-Only||Prospective|||||||
1526072|NCT00638378||Single Group Assignment||Treatment||None (Open Label)||||||
1526073|NCT00638365|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526074|NCT00638352|||Cohort||Retrospective|||||||
1526075|NCT00638339|||Case-Control||Prospective|||||||
1526076|NCT00638326|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526077|NCT00638313|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1526078|NCT00638300|Randomized|Crossover Assignment||||None (Open Label)||||||
1526079|NCT00638287|||Cohort||Prospective|||||||
1526080|NCT00638274|Randomized|Parallel Assignment||Other||Single|||t|||
1526081|NCT00638261|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526082|NCT00638248|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526083|NCT00638235|||Cohort||Prospective|||||||
1526084|NCT00638222|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1526085|NCT00638209|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1526086|NCT00638196||Crossover Assignment||Treatment||Single|||t|||
1526087|NCT00638183|||Cohort||Prospective|||||||
1526088|NCT00638170|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1526089|NCT00638157|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526090|NCT00638144|||Cohort||Prospective|||||||
1526091|NCT00638131|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526092|NCT00638118|Randomized|Crossover Assignment||Treatment||Double||||||
1526093|NCT00638092|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1526094|NCT00638079|Randomized|Crossover Assignment||||None (Open Label)||||||
1526095|NCT00638066|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1526096|NCT00638053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526097|NCT00638040|||Cohort||Cross-Sectional|||||||
1526098|NCT00638027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526099|NCT00638014|Randomized|Parallel Assignment||Prevention||Single|||t|||
1526100|NCT00638001|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526101|NCT00637988|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526102|NCT00637975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526103|NCT00637962|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1526104|NCT00637949|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526105|NCT00637936|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1526106|NCT00637923|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526107|NCT00637910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526108|NCT00637897||Single Group Assignment||Treatment||None (Open Label)||||||
1526109|NCT00637884|Randomized|Crossover Assignment||Treatment||Double||||||
1526110|NCT00637871|Randomized|Parallel Assignment||Treatment||Double||||||
1526111|NCT00637858|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526112|NCT00637845|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526113|NCT00637832|Non-Randomized|||Treatment||None (Open Label)||||||
1526114|NCT00637819|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526115|NCT00637806|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526116|NCT00637793|Randomized|Crossover Assignment||Treatment||Double||||||
1526117|NCT00637780||Single Group Assignment||Treatment||None (Open Label)||||||
1526118|NCT00637767|Randomized|||Treatment||None (Open Label)||||||
1526119|NCT00637754|||Cohort||Prospective|||||||
1526120|NCT00637741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526121|NCT00637728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526122|NCT00637715|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526123|NCT00637702||Single Group Assignment||Treatment||None (Open Label)||||||
1526124|NCT00637689|||Cohort||Prospective|||||||
1526125|NCT00637676|Randomized|Single Group Assignment||Treatment||Single|||||t|
1526126|NCT00637663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526127|NCT00637650|Randomized|Parallel Assignment||||None (Open Label)||||||
1526128|NCT00637637|Randomized|||Treatment||||||||
1526129|NCT00637624|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1526130|NCT00637611|Randomized|Parallel Assignment||Treatment||Double||||||
1526131|NCT00637598||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1526132|NCT00637585|Randomized|Crossover Assignment||Treatment||Double||||||
1526133|NCT00637572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526134|NCT00637559|Randomized|Crossover Assignment||Treatment||Double||||||
1526135|NCT00637546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526136|NCT00637533|Randomized|Crossover Assignment||Treatment||Double||||||
1526137|NCT00637520|||Case-Control||Cross-Sectional|||||||
1526138|NCT00637507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526139|NCT00637494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526140|NCT00637481|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526141|NCT00637468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526142|NCT00637455|Randomized|Crossover Assignment||Treatment||Double||||||
1526143|NCT00637442||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526144|NCT00637429|||Cohort||Prospective|||||||
1526145|NCT00637416|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526146|NCT00637403|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1526147|NCT00637390||Single Group Assignment||Treatment||None (Open Label)||||||
1526148|NCT00637377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526149|NCT00637364||Single Group Assignment||Treatment||None (Open Label)||||||
1526150|NCT00637351|||Case-Only||Prospective|||||||
1526151|NCT00637338|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1526152|NCT00637325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526153|NCT00637312|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526154|NCT00637299|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1526155|NCT00637286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526156|NCT00637273|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526157|NCT00637260|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t||t
1526158|NCT00637247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526159|NCT00637234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526160|NCT00637221|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1526161|NCT00637208||Single Group Assignment||Treatment||None (Open Label)||||||
1526162|NCT00637195|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526163|NCT00637182|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526164|NCT00637169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526165|NCT00637156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526166|NCT00637143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526167|NCT00637130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526168|NCT00637117||Single Group Assignment||Treatment||None (Open Label)||||||
1526169|NCT00637104|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526170|NCT00637091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526171|NCT00637078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526172|NCT00637065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526173|NCT00637052|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526174|NCT00637039|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526175|NCT00637026||Single Group Assignment||Treatment||None (Open Label)||||||
1526176|NCT00637013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526177|NCT00637000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526178|NCT00636987||Single Group Assignment||Treatment||None (Open Label)||||||
1526179|NCT00636974|Randomized|Parallel Assignment||Treatment||Double||||||
1526180|NCT00636961|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1526182|NCT00636935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526183|NCT00636922||Single Group Assignment||Treatment||None (Open Label)||||||
1526184|NCT00636909|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526185|NCT00636896|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1526186|NCT00636883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526187|NCT00636870|Randomized|Crossover Assignment||Treatment||Double||||||
1526188|NCT00636857|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526189|NCT00636844|||Cohort||Prospective|||||||
1526190|NCT00636831|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1526191|NCT00636818||Single Group Assignment||Treatment||None (Open Label)||||||
1526192|NCT00636805||Single Group Assignment||Supportive Care||None (Open Label)||||||
1526193|NCT00636792||Single Group Assignment||Treatment||None (Open Label)||||||
1526194|NCT00636779|||Cohort||Cross-Sectional|||||||
1526195|NCT00636766|Randomized|Factorial Assignment||||None (Open Label)||||||
1526196|NCT00636753|||Cohort||Prospective|||||||
1526197|NCT00636740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526198|NCT00636727|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526199|NCT00636714|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526200|NCT00636701|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526201|NCT00636688|Randomized|Parallel Assignment||Treatment||Single||||||t
1526202|NCT00636675|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1526203|NCT00636662|||Cohort||Prospective|||||||
1526204|NCT00636649|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526205|NCT00636636|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526206|NCT00636623|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526207|NCT00636610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526208|NCT00636597|||Cohort||Prospective|||||||
1526209|NCT00636584|Randomized|Parallel Assignment||Screening||Single|||||t|
1526210|NCT00636571||Single Group Assignment||Supportive Care||None (Open Label)||||||
1526211|NCT00636558||Single Group Assignment||Treatment||None (Open Label)||||||
1526212|NCT00636545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526213|NCT00636519|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1526214|NCT00636506|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526215|NCT00636493||Single Group Assignment||Treatment||None (Open Label)||||||
1526216|NCT00636480|Randomized|Parallel Assignment||||Single||||||t
1526217|NCT00636467||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526218|NCT00636454|Randomized|Parallel Assignment||Treatment||Single||||||t
1526219|NCT00636441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526220|NCT00636428|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1526221|NCT00636415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526222|NCT00636402|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526223|NCT00636389|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526224|NCT00636376|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1526225|NCT00636363|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1526226|NCT00636350|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1526227|NCT00636337|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1526228|NCT00636324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526229|NCT00636311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526230|NCT00636298||Single Group Assignment||Treatment||None (Open Label)||||||
1526231|NCT00636285|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526232|NCT00636272|||Cohort||Prospective|||||||
1526233|NCT00636259||||||||||||
1526234|NCT00636246|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526235|NCT00636233|||Family-Based||Cross-Sectional|||||||
1526236|NCT00636220|||Case-Only||Cross-Sectional|||||||
1526237|NCT00636207|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526238|NCT00636194|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1526239|NCT00636181|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526240|NCT00636168|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526241|NCT00636155||Single Group Assignment||Treatment||None (Open Label)||||||
1526242|NCT00636142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526243|NCT00636129|||Case-Only||Prospective|||||||
1526244|NCT00636116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526245|NCT00636103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526246|NCT00636090|||Cohort||Prospective|||||||
1526247|NCT00636077|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526248|NCT00636064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526249|NCT00636051|||||Prospective|||||||
1526250|NCT00636038|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1526251|NCT00636025|||Case-Only||Prospective|||||||
1526252|NCT00636012|Randomized|Parallel Assignment||||Single|||t|||
1526253|NCT00635999|Randomized|Parallel Assignment||Treatment||Single||||||t
1526254|NCT00635986|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526255|NCT00635973||Single Group Assignment||Treatment||None (Open Label)||||||
1526256|NCT00635960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526257|NCT00635947|Randomized|Factorial Assignment||Treatment||Single|||||t|
1526258|NCT00635934||Single Group Assignment||Treatment||None (Open Label)||||||
1526259|NCT00635921|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526260|NCT00635895|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526261|NCT00635882|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526262|NCT00635869|||||Prospective|||||||
1526263|NCT00635856||Single Group Assignment||||None (Open Label)||||||
1526264|NCT00635843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526265|NCT00635830|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1526266|NCT00635817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526267|NCT00635804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526268|NCT00635791||Single Group Assignment||Treatment||None (Open Label)||||||
1526269|NCT00635778|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526270|NCT00635765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526271|NCT00635752|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1526272|NCT00635739|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526273|NCT00635726||Single Group Assignment||Treatment||None (Open Label)||||||
1526274|NCT00635713|Randomized|Parallel Assignment||Treatment||Double||||||
1526275|NCT00635700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526276|NCT00635687||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526277|NCT00635674||Parallel Assignment||Treatment||None (Open Label)||||||
1526278|NCT00635661|||Cohort||Prospective|||||||
1526279|NCT00635648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526280|NCT00635635|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1526281|NCT00635622|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1526282|NCT00635609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526283|NCT00635596||Single Group Assignment||Treatment||None (Open Label)||||||
1526284|NCT00635583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526285|NCT00635570|Randomized|Parallel Assignment||||None (Open Label)||||||
1526286|NCT00635557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526287|NCT00635544|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1526288|NCT00635531|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526289|NCT00635518|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1526290|NCT00635505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526291|NCT00635492|||Cohort||Prospective|||||||
1526292|NCT00635479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526293|NCT00635466||Single Group Assignment||Treatment||None (Open Label)||||||
1526294|NCT00635453|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1526295|NCT00635440|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1526296|NCT00635427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526297|NCT00635414|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526298|NCT00635401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526299|NCT00635388|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1526300|NCT00635375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526301|NCT00635362|Randomized|Parallel Assignment||Treatment||Single|||||t|
1526302|NCT00635349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526303|NCT00635336||Single Group Assignment||Treatment||None (Open Label)||||||
1526304|NCT00635323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526305|NCT00635310|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1526306|NCT00635297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526307|NCT00635284||Single Group Assignment||Treatment||None (Open Label)||||||
1526308|NCT00635271|||||Prospective|||||||
1526309|NCT00635258|||Case Control||Prospective|||||||
1526310|NCT00635245||||Treatment||None (Open Label)||||||
1526311|NCT00635232|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526312|NCT00635219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526313|NCT00635206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526314|NCT00635193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526315|NCT00635180|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1526316|NCT00635167||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526317|NCT00635154||Single Group Assignment||Treatment||None (Open Label)||||||
1526318|NCT00635141|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1526319|NCT00635128|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526320|NCT00635115|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1526321|NCT00635102|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1526322|NCT00635089||Single Group Assignment||Treatment||None (Open Label)||||||
1526323|NCT00635076|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526324|NCT00635063|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1526325|NCT00635050||Single Group Assignment||Treatment||None (Open Label)||||||
1526326|NCT00635037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526327|NCT00635024||Single Group Assignment||Treatment||None (Open Label)||||||
1526328|NCT00635011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526329|NCT00634998|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1526330|NCT00634985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526331|NCT00634972|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1526332|NCT00634959|Randomized|Parallel Assignment||Treatment||Double||||||
1526486|NCT00632918|||Case-Only||Retrospective|||||||
1526333|NCT00634946|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526334|NCT00634933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526335|NCT00634920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526336|NCT00634907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526337|NCT00634894|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526338|NCT00634881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526339|NCT00634868|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1526340|NCT00634855|||Case-Control||Prospective|||||||
1526341|NCT00634842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526342|NCT00634829|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1526343|NCT00634816|||Case-Only||Cross-Sectional|||||||
1526344|NCT00634803|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1526345|NCT00634790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526346|NCT00634777||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526347|NCT00634764|||Cohort||Prospective|||||||
1526348|NCT00634751|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526349|NCT00634738|Randomized|Crossover Assignment||Treatment||Single|||t|||
1526350|NCT00634725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526351|NCT00634712|Randomized|Parallel Assignment||Treatment||Double||||||
1526352|NCT00634699|Randomized|Crossover Assignment||Treatment||Single|||t|||
1526353|NCT00634686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526354|NCT00634673|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1526355|NCT00634660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526356|NCT00634647||Single Group Assignment||Treatment||None (Open Label)||||||
1526357|NCT00634634||Single Group Assignment||Treatment||None (Open Label)||||||
1526358|NCT00634621|||Case-Only||Prospective|||||||
1526359|NCT00634608|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1526360|NCT00634595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526361|NCT00634582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526362|NCT00634569||Single Group Assignment||Treatment||None (Open Label)||||||
1526363|NCT00634556|Randomized|Factorial Assignment||Other||Quadruple|||t|t|t|t
1526364|NCT00634543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526365|NCT00634530|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1526366|NCT00634517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526367|NCT00634504|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526368|NCT00634491|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1526369|NCT00634478|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526370|NCT00634465|||Case-Only||Prospective|||||||
1526371|NCT00634452||Single Group Assignment||Treatment||None (Open Label)||||||
1526372|NCT00634439|||Cohort||Retrospective|||||||
1526373|NCT00634426|||Cohort||Prospective|||||||
1526374|NCT00634413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526375|NCT00634400|Randomized|Parallel Assignment||Treatment||Double||||||
1526376|NCT00634387|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1526377|NCT00634374|Randomized|Parallel Assignment||||None (Open Label)||||||
1526378|NCT00634361||Single Group Assignment||Treatment||None (Open Label)||||||
1526379|NCT00634348|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526380|NCT00634335|||Cohort||Cross-Sectional|||||||
1526381|NCT00634322|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1526382|NCT00634309|Randomized|Parallel Assignment||Treatment||Double||||||
1526383|NCT00634296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526384|NCT00634283|Non-Randomized|Single Group Assignment||||Double|||t|t||
1526385|NCT00634270||Single Group Assignment||Treatment||None (Open Label)||||||
1526386|NCT00634257|||Case-Control||Prospective|||||||
1526387|NCT00634244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526388|NCT00634231||Single Group Assignment||Treatment||None (Open Label)||||||
1526389|NCT00634218|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1526390|NCT00634205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526391|NCT00634192||Crossover Assignment||Treatment||None (Open Label)||||||
1526392|NCT00634179||Single Group Assignment||Treatment||None (Open Label)||||||
1526393|NCT00634166|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526394|NCT00634153|||Cohort||Other|||||||
1526395|NCT00634140|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1526396|NCT00634114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526397|NCT00634101|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526398|NCT00634088|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526399|NCT00634075|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526400|NCT00634062|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526401|NCT00634049||Single Group Assignment||Treatment||None (Open Label)||||||
1526402|NCT00634036|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526403|NCT00634023|||||Cross-Sectional|||||||
1526404|NCT00634010|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526405|NCT00633997|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1526406|NCT00633984|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526407|NCT00633971|Randomized|Parallel Assignment||Treatment||Single||||||t
1526408|NCT00633958||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526487|NCT00632905|||Cohort||Prospective|||||||
1526409|NCT00633945||Single Group Assignment||Treatment||None (Open Label)||||||
1526410|NCT00633932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526411|NCT00633919|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526412|NCT00633906|Randomized|Parallel Assignment||Prevention||Single||||||t
1526413|NCT00633893|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526414|NCT00633880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526415|NCT00633867|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526416|NCT00633854|||Cohort||Cross-Sectional|||||||
1526417|NCT00633841|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526418|NCT00633828|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1526419|NCT00633815|||Case-Control||Prospective|||||||
1526420|NCT00633802|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526421|NCT00633789|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1526422|NCT00633776|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1526423|NCT00633763|||Case Control||Prospective|||||||
1526424|NCT00633750||Single Group Assignment||Treatment||None (Open Label)||||||
1526425|NCT00633737|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1526426|NCT00633724||Single Group Assignment||Treatment||None (Open Label)||||||
1526427|NCT00633711|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526428|NCT00633698|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526429|NCT00633685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526430|NCT00633672||Parallel Assignment||Treatment||Double||||||
1526431|NCT00633659|Randomized|Single Group Assignment||Treatment||Single|||t|||
1526432|NCT00633646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526433|NCT00633633|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1526434|NCT00633620|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1526435|NCT00633607|||Family-Based||Other|||||||
1526436|NCT00633594||Single Group Assignment||Treatment||None (Open Label)||||||
1526437|NCT00633581|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1526438|NCT00633568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526439|NCT00633555|||Case-Control||Prospective|||||||
1526440|NCT00633542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526441|NCT00633529|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1526442|NCT00633516|||Case-Control||Prospective|||||||
1526443|NCT00633503|||Cohort||Prospective|||||||
1526444|NCT00633490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526445|NCT00633477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526446|NCT00633464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526447|NCT00633451|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1526448|NCT00633438|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1526449|NCT00633425|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526450|NCT00633412|Randomized|Parallel Assignment||Treatment||Double||||||
1526451|NCT00633399|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526452|NCT00633386|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1526453|NCT00633373||||||||||||
1526454|NCT00633360|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526455|NCT00633347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526456|NCT00633334|||Cohort||Cross-Sectional|||||||
1526457|NCT00633321|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526458|NCT00633308|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526459|NCT00633295||Single Group Assignment||Treatment||None (Open Label)||||||
1526460|NCT00633282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526461|NCT00633269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526462|NCT00633256|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1526463|NCT00633243|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1526464|NCT00633230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526465|NCT00633217|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526466|NCT00633204||Single Group Assignment||Prevention||Double|||t||t|
1526467|NCT00633191||Single Group Assignment||Prevention||None (Open Label)||||||
1526468|NCT00633178|Randomized|Parallel Assignment||Prevention||Single||||||t
1526469|NCT00633165||Single Group Assignment||Treatment||None (Open Label)||||||
1526470|NCT00633152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526471|NCT00633139|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526472|NCT00633126||Single Group Assignment||Other||None (Open Label)||||||
1526473|NCT00633113|Randomized|Single Group Assignment||Treatment||Single|||t|||
1526474|NCT00633087||Single Group Assignment||Treatment||None (Open Label)||||||
1526475|NCT00633074|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1526476|NCT00633061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526477|NCT00633048|Randomized|Parallel Assignment||||Double|||t||t|
1526478|NCT00633035|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526479|NCT00633022|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526480|NCT00633009|Randomized|Parallel Assignment||Screening||Double|||t||t|
1526481|NCT00632996||Single Group Assignment||Treatment||None (Open Label)||||||
1526482|NCT00632970|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open Label|||||
1526483|NCT00632957|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526484|NCT00632944||||||||||||
1526485|NCT00632931|Randomized|Crossover Assignment||Treatment||Single|||t|||
1526488|NCT00632892|||Case-Only||Prospective|||||||
1526489|NCT00632879|||Cohort||Prospective|||||||
1526490|NCT00632866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526491|NCT00632853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526492|NCT00632840|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1526493|NCT00632827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526494|NCT00632814|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526495|NCT00632801||Single Group Assignment||||None (Open Label)||||||
1526496|NCT00632788|||Cohort||Retrospective|||||||
1526497|NCT00632775|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526498|NCT00632762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526499|NCT00632749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526500|NCT00632736|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526501|NCT00632723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526502|NCT00632710|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1526503|NCT00632697|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526504|NCT00632684|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526505|NCT00632671|||Case-Only||Prospective|||||||
1526506|NCT00632658|||Case-Only||Prospective|||||||
1526507|NCT00632645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526508|NCT00632632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526509|NCT00632619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526510|NCT00632606|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1526511|NCT00632593|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526512|NCT00632580|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526513|NCT00632567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526514|NCT00632554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526515|NCT00632541||Single Group Assignment||Treatment||None (Open Label)||||||
1526516|NCT00632528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526517|NCT00632515|||Family-Based||Cross-Sectional|||||||
1526518|NCT00632502|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526519|NCT00632489|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526520|NCT00632476|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1526521|NCT00632463|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526522|NCT00632450|||||Prospective|||||||
1526523|NCT00632437|||Case-Only||Prospective|||||||
1526524|NCT00632424|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526525|NCT00632411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526526|NCT00632398|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1526527|NCT00632385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526528|NCT00632372||Single Group Assignment||Treatment||None (Open Label)||||||
1526529|NCT00632359||Single Group Assignment||Treatment||None (Open Label)||||||
1526530|NCT00632346|||Ecologic or Community||Retrospective|||||||
1526531|NCT00632333||Single Group Assignment||Treatment||None (Open Label)||||||
1526532|NCT00632320|||||Prospective|||||||
1526533|NCT00632307|||Other||Prospective|||||||
1526534|NCT00632294|||Case-Only||Retrospective|||||||
1526535|NCT00632281||Single Group Assignment||Treatment||None (Open Label)||||||
1526536|NCT00632268||Single Group Assignment||Treatment||None (Open Label)||||||
1526537|NCT00632255|||Cohort||Prospective|||||||
1526538|NCT00632242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526539|NCT00632229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526540|NCT00632216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526541|NCT00632203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526542|NCT00632190||||Diagnostic||None (Open Label)||||||
1526543|NCT00632164|||Case-Only||Cross-Sectional|||||||
1526544|NCT00632138|Randomized|||Supportive Care||||||||
1526545|NCT00632125||Single Group Assignment||Treatment||None (Open Label)||||||
1526546|NCT00632112|||||Prospective|||||||
1526547|NCT00632099|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526548|NCT00632086|Randomized|Crossover Assignment||||None (Open Label)||||||
1526549|NCT00632073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526550|NCT00632060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526551|NCT00632047|Randomized|||Screening||||||||
1526552|NCT00632034||Single Group Assignment||Treatment||None (Open Label)||||||
1526553|NCT00632021|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1526554|NCT00632008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526555|NCT00631995|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1526556|NCT00631982||Single Group Assignment||Treatment||None (Open Label)||||||
1526557|NCT00631969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526558|NCT00631956|||Family-Based||Retrospective|||||||
1526559|NCT00631943|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526560|NCT00631917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526561|NCT00631904|||Cohort||Prospective|||||||
1526562|NCT00631878|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1526563|NCT00631865||Single Group Assignment||Treatment||None (Open Label)||||||
1526564|NCT00631852||Single Group Assignment||Treatment||None (Open Label)||||||
1526565|NCT00631839|||Cohort||Prospective|||||||
1526566|NCT00631826|||Case-Only||Prospective|||||||
1526567|NCT00631813|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526568|NCT00631800|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1526569|NCT00631787|||||Prospective|||||||
1526570|NCT00631774|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1526571|NCT00631761|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526572|NCT00631748|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526573|NCT00631735||||||||||||
1526574|NCT00631722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526575|NCT00631709||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526576|NCT00631696|Randomized|Parallel Assignment||||Double|||t|t||
1526577|NCT00631683|||Cohort||Prospective|||||||
1526578|NCT00631670|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526579|NCT00631657|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526580|NCT00631644|||||Prospective|||||||
1526581|NCT00631631|||Cohort||Prospective|||||||
1526582|NCT00631618||Single Group Assignment||Treatment||None (Open Label)||||||
1526583|NCT00631605|||Case Control||Cross-Sectional|||||||
1526584|NCT00631592||Single Group Assignment||Treatment||Double||||||
1526585|NCT00631579|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526586|NCT00631566|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526587|NCT00631553||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526588|NCT00631540||Single Group Assignment||Treatment||None (Open Label)||||||
1526589|NCT00631527||Single Group Assignment||Treatment||None (Open Label)||||||
1526590|NCT00631514|Randomized|Factorial Assignment||Treatment||Single||||||t
1526591|NCT00631501|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526592|NCT00631488|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526593|NCT00631475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526594|NCT00631462|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526595|NCT00631449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526596|NCT00631436|||Case Control||Prospective|||||||
1526597|NCT00631423|||Case Control||Prospective|||||||
1526598|NCT00631410|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526599|NCT00631397|||Case-Only||Prospective|||||||
1526600|NCT00631384|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1526601|NCT00631371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526602|NCT00631358|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526603|NCT00631345|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526604|NCT00631332|||Other||Other|||||||
1526605|NCT00631319|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526606|NCT00631306|||Case Control||Prospective|||||||
1526607|NCT00631293|Randomized|Crossover Assignment||Health Services Research||Double|||t||t|
1526608|NCT00631280|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526609|NCT00631267|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1526610|NCT00631254||Parallel Assignment||Basic Science||None (Open Label)||||||
1526611|NCT00631241||Single Group Assignment||Treatment||None (Open Label)||||||
1526612|NCT00631228|||Cohort||Prospective|||||||
1526613|NCT00631215||Single Group Assignment||Supportive Care||None (Open Label)||||||
1526614|NCT00631202|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526615|NCT00631189|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526616|NCT00631176|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1526617|NCT00631163||Single Group Assignment||Treatment||None (Open Label)||||||
1526618|NCT00631150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526619|NCT00631137|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1526620|NCT00631124|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1526621|NCT00631111|Randomized|Parallel Assignment||Treatment||Double||||||
1526622|NCT00631098|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526623|NCT00631085|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1526624|NCT00631072||Single Group Assignment||Treatment||None (Open Label)||||||
1526625|NCT00631059||Single Group Assignment||Treatment||None (Open Label)||||||
1526626|NCT00631046|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1526627|NCT00631033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526628|NCT00631020||Single Group Assignment||Treatment||None (Open Label)||||||
1526629|NCT00631007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526630|NCT00630994||Single Group Assignment||Treatment||None (Open Label)||||||
1526631|NCT00630981|||||Prospective|||||||
1526632|NCT00630968|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526633|NCT00630955|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1526634|NCT00630942||Single Group Assignment||Treatment||||||||
1526635|NCT00630929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526636|NCT00630916|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526637|NCT00630903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526638|NCT00630890||Single Group Assignment||Treatment||None (Open Label)||||||
1526639|NCT00630877|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526640|NCT00630864||Single Group Assignment||Treatment||None (Open Label)||||||
1526641|NCT00630851|Randomized|Parallel Assignment||Treatment||Double||||||
1526642|NCT00630838|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1526643|NCT00630825|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526644|NCT00630812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526645|NCT00630799|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1526646|NCT00630786||Single Group Assignment||Treatment||None (Open Label)||||||
1526647|NCT00630773|||Case-Only||Prospective|||||||
1526648|NCT00630760|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526649|NCT00630747||Single Group Assignment||Treatment||None (Open Label)||||||
1526650|NCT00630734|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526651|NCT00630721||Single Group Assignment||Basic Science||None (Open Label)||||||
1526652|NCT00630708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526653|NCT00630695|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1526654|NCT00630682|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1526655|NCT00630669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526656|NCT00630656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526657|NCT00630643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526658|NCT00630630|Randomized|Parallel Assignment||Treatment||Double||||||
1526659|NCT00630617||Single Group Assignment||Prevention||None (Open Label)||||||
1526660|NCT00630604||||||||||||
1526661|NCT00630591|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526662|NCT00630578|Randomized|Crossover Assignment||Treatment||Single||||||t
1526663|NCT00630565|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526664|NCT00630552|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1526665|NCT00630539|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526666|NCT00630526||||||||||||
1526667|NCT00630513|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1526668|NCT00630500|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526669|NCT00630487|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526670|NCT00630474|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1526671|NCT00630461||Single Group Assignment||Basic Science||None (Open Label)||||||
1526672|NCT00630448|||Case-Control||Cross-Sectional|||||||
1526673|NCT00630435|Randomized|Crossover Assignment||||None (Open Label)||||||
1526674|NCT00630422|||Ecologic or Community||Cross-Sectional|||||||
1526675|NCT00630409||Single Group Assignment||Treatment||None (Open Label)||||||
1526676|NCT00630396||Single Group Assignment||Treatment||None (Open Label)||||||
1526677|NCT00630383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526678|NCT00630370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526679|NCT00630357|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526680|NCT00630344||Single Group Assignment||Treatment||None (Open Label)||||||
1526681|NCT00630331|Randomized|Parallel Assignment||Prevention||Single|||t|||
1526682|NCT00630318||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526683|NCT00630305|Randomized|Crossover Assignment||Treatment||Single|||t|||
1526684|NCT00630292||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526685|NCT00630279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526686|NCT00630266|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1526687|NCT00630253||Single Group Assignment||Treatment||None (Open Label)||||||
1526688|NCT00630240|||||Prospective|||||||
1526689|NCT00630227||Single Group Assignment||Treatment||None (Open Label)||||||
1526690|NCT00630214|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1526691|NCT00630201||Single Group Assignment||Treatment||None (Open Label)||||||
1526692|NCT00630188|Randomized|Parallel Assignment||Prevention||Single||||||t
1526693|NCT00630175|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1526694|NCT00630162||||||||||||
1526695|NCT00630149||Single Group Assignment||Treatment||None (Open Label)||||||
1526696|NCT00630136|||Ecologic or Community||Prospective|||||||
1526697|NCT00630123|||Cohort||Prospective|||||||
1526698|NCT00630110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526699|NCT00630097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526700|NCT00630084|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526701|NCT00630071|||Cohort||Prospective|||||||
1526702|NCT00630058|Randomized|Parallel Assignment||||None (Open Label)||||||
1526703|NCT00630045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526704|NCT00630032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526705|NCT00630019|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1526706|NCT00630006|Randomized|Factorial Assignment||||None (Open Label)||||||
1526707|NCT00629993|Randomized|Parallel Assignment||Screening||Triple|||t|t||t
1526708|NCT00629980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526709|NCT00629967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526710|NCT00629954|||Cohort||Prospective|||||||
1526711|NCT00629941||Single Group Assignment||Treatment||None (Open Label)||||||
1526712|NCT00629928|Randomized|Parallel Assignment||Prevention||Double||||||
1526713|NCT00629915|||Cohort||Prospective|||||||
1526714|NCT00629902|||Case-Only||Prospective|||||||
1526715|NCT00629889|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1526716|NCT00629876||Single Group Assignment||Treatment||None (Open Label)||||||
1526717|NCT00629863|Randomized|||Diagnostic||||||||
1526718|NCT00629850|Randomized|Parallel Assignment||Treatment||Single|||||t|
1526719|NCT00629837|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1526720|NCT00629824|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526721|NCT00629811|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526722|NCT00629798||Single Group Assignment||Treatment||None (Open Label)||||||
1526723|NCT00629785|||||Retrospective|||||||
1526724|NCT00629772|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1526725|NCT00629759|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526726|NCT00629746|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1526727|NCT00629733|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526728|NCT00629720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526729|NCT00629707|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526730|NCT00629694|Randomized|Parallel Assignment||Treatment||Single||||||t
1526731|NCT00629681|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526732|NCT00629668|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1526733|NCT00629655|||||Cross-Sectional|||||||
1526734|NCT00629642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526735|NCT00629629|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1526736|NCT00629616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526737|NCT00629603||Single Group Assignment||Basic Science||None (Open Label)||||||
1526738|NCT00629590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526739|NCT00629577||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526740|NCT00629564|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526741|NCT00629551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526742|NCT00629538||Single Group Assignment||Treatment||None (Open Label)||||||
1526743|NCT00629525||Single Group Assignment||Treatment||None (Open Label)||||||
1526744|NCT00629512|Randomized|Parallel Assignment||Prevention||Double||||||
1526745|NCT00629499||Single Group Assignment||Treatment||None (Open Label)||||||
1526746|NCT00629486||Single Group Assignment||Basic Science||None (Open Label)||||||
1526747|NCT00629473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526748|NCT00629460|||Cohort||Cross-Sectional|||||||
1526749|NCT00629447||Single Group Assignment||Prevention||None (Open Label)||||||
1526750|NCT00629434|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526751|NCT00629421|||Case-Only||Prospective|||||||
1526752|NCT00629395||Single Group Assignment||Supportive Care||None (Open Label)||||||
1526753|NCT00629382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526754|NCT00629369|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1526755|NCT00629356|||Case Control||Retrospective|||||||
1526756|NCT00629343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526757|NCT00629330|Randomized|Parallel Assignment||Screening||Triple|||t|t||t
1526758|NCT00629317|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1526759|NCT00629304|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526760|NCT00629291|||Case Control||Prospective|||||||
1526761|NCT00629278|Randomized|||Treatment||||||||
1526762|NCT00629265|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526763|NCT00629252|Non-Randomized|Parallel Assignment||Basic Science||Single|||||t|
1526764|NCT00629239|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526765|NCT00629226||||Treatment||||||||
1526766|NCT00629213|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1526767|NCT00629200||Single Group Assignment||Treatment||None (Open Label)||||||
1526768|NCT00629187||Single Group Assignment||Treatment||None (Open Label)||||||
1526769|NCT00629174|Randomized|Parallel Assignment||Prevention||Single||||||t
1526770|NCT00629161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526771|NCT00629148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526772|NCT00629135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526773|NCT00629122|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1526774|NCT00629096|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526775|NCT00629083|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526776|NCT00629070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526777|NCT00629057|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526778|NCT00629044|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1526779|NCT00629031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526780|NCT00629018|Randomized|Parallel Assignment||Treatment||Single||||||t
1526781|NCT00629005|Randomized|Parallel Assignment||Treatment||Single||||||t
1526782|NCT00628992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526783|NCT00628979||Single Group Assignment||Treatment||None (Open Label)||||||
1526784|NCT00628966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526785|NCT00628953|Randomized|Parallel Assignment||Treatment||Double||||||
1526786|NCT00628940||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526787|NCT00628927|||Case Control||Cross-Sectional|||||||
1526788|NCT00628914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526789|NCT00628901|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526790|NCT00628888|Randomized|Parallel Assignment||Treatment||Single||||||t
1526791|NCT00628875|||Case-Only||Prospective|||||||
1526792|NCT00628862|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526793|NCT00628849|||Cohort||Prospective|||||||
1526794|NCT00628836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526795|NCT00628823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526796|NCT00628810||Single Group Assignment||Treatment||None (Open Label)||||||
1526797|NCT00628797|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526798|NCT00628784|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526799|NCT00628771|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526800|NCT00628758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526801|NCT00628745|||Other||Prospective|||||||
1526802|NCT00628732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526803|NCT00628719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526804|NCT00628706|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1526805|NCT00628693|||Cohort||Prospective|||||||
1526806|NCT00628680|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526807|NCT00628667|Randomized|Parallel Assignment||Treatment||Double||||||
1526808|NCT00628654|||Case-Control||Prospective|||||||
1526809|NCT00628628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526810|NCT00628615|||||Prospective|||||||
1526811|NCT00628602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526812|NCT00628589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526813|NCT00628576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526814|NCT00628563|||||Retrospective|||||||
1526815|NCT00628550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526816|NCT00628537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526817|NCT00628524|||Cohort||Prospective|||||||
1526818|NCT00628511||||||||||||
1526819|NCT00628498||Single Group Assignment||Treatment||None (Open Label)||||||
1526820|NCT00628485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526821|NCT00628472|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1526822|NCT00628459|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1526823|NCT00628446|||||Cross-Sectional|||||||
1526824|NCT00628433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526825|NCT00628420|Randomized|Parallel Assignment||||Double|||t||t|
1526826|NCT00628407|||Case-Only||Prospective|||||||
1526827|NCT00628394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526828|NCT00628381|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526829|NCT00628368|Non-Randomized|||Diagnostic||||||||
1526830|NCT00628355|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1526831|NCT00628342|Randomized|Parallel Assignment||Treatment||Double||||||
1526832|NCT00628329|||Cohort||Cross-Sectional|||||||
1526833|NCT00628316||Single Group Assignment||Treatment||None (Open Label)||||||
1526834|NCT00628303|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1526835|NCT00628290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526836|NCT00628277|Randomized|Parallel Assignment||Treatment||Single|||||t|
1526837|NCT00628264|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1526838|NCT00628251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526839|NCT00628238|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526840|NCT00628225|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526841|NCT00628212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526842|NCT00628199|||||Prospective|||||||
1526843|NCT00628186|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526844|NCT00628173||Parallel Assignment||Treatment||Single||||||
1526845|NCT00628160|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526846|NCT00628147|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1526847|NCT00628134|Randomized|Crossover Assignment||Basic Science||Single||||||t
1526848|NCT00628121|Randomized|Parallel Assignment||Treatment||Single|||t|||
1526849|NCT00628108|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526850|NCT00628095|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526851|NCT00628082|||Cohort|||||||||
1526852|NCT00628069|||Case Control||Prospective|||||||
1526853|NCT00628056|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1526854|NCT00628043|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526855|NCT00628030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526856|NCT00628017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526857|NCT00628004|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1526858|NCT00627991|Randomized|Single Group Assignment||Treatment||Double||||||
1526859|NCT00627978|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526860|NCT00627965|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1526861|NCT00627952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526862|NCT00627926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526863|NCT00627913|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526864|NCT00627900|Non-Randomized|||||||||||
1526865|NCT00627887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526866|NCT00627874|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526867|NCT00627861||Single Group Assignment||Treatment||None (Open Label)||||||
1526868|NCT00627848|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1526869|NCT00627835|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1526870|NCT00627822|||||Cross-Sectional|||||||
1526871|NCT00627809|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1526872|NCT00627796||Single Group Assignment||Treatment||None (Open Label)||||||
1526873|NCT00627783|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1526874|NCT00627770||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526875|NCT00627757|||Case Control||Cross-Sectional|||||||
1526876|NCT00627744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526877|NCT00627731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526878|NCT00627718||Single Group Assignment||Diagnostic||Single||||||t
1526879|NCT00627705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526880|NCT00627692|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526881|NCT00627679|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1526882|NCT00627666||||Treatment||None (Open Label)||||||
1526883|NCT00627653|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1526884|NCT00627640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526885|NCT00627627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526886|NCT00627614||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526887|NCT00627588|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526888|NCT00627575|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526889|NCT00627562||Single Group Assignment||Treatment||None (Open Label)||||||
1526890|NCT00627549||||||||||||
1526891|NCT00627536|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1526892|NCT00627523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526893|NCT00627510|||Case-Only||Prospective|||||||
1526894|NCT00627497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526895|NCT00627484|||Case-Control||Prospective|||||||
1526896|NCT00627471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526897|NCT00627458|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526898|NCT00627445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526899|NCT00627432|Randomized|||Treatment||||||||
1526900|NCT00627419||Single Group Assignment||Treatment||None (Open Label)||||||
1526901|NCT00627406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526902|NCT00627393|Randomized|Parallel Assignment||Treatment||Single||||||t
1526903|NCT00627380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526904|NCT00627367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526905|NCT00627354|Randomized|||Treatment||||||||
1526906|NCT00627341|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1526907|NCT00627328|||Cohort||Prospective|||||||
1526908|NCT00627315|||Cohort||Prospective|||||||
1526909|NCT00627302|Randomized|Parallel Assignment||||Double|||t||t|
1526910|NCT00627289|||Cohort||Prospective|||||||
1526911|NCT00627276|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526912|NCT00627263|Randomized|Parallel Assignment||Prevention||Single||||||t
1526913|NCT00627250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526914|NCT00627237|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526915|NCT00627211|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1526916|NCT00627185|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526917|NCT00627172|||Cohort||Prospective|||||||
1526918|NCT00627159|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1526919|NCT00627146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526920|NCT00627133||Single Group Assignment||Treatment||None (Open Label)||||||
1526921|NCT00627120|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1526922|NCT00627107||Single Group Assignment||Supportive Care||None (Open Label)||||||
1526923|NCT00627094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526924|NCT00627081|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526925|NCT00627068|||Cohort||Prospective|||||||
1526926|NCT00627055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526927|NCT00627042||Single Group Assignment||Treatment||None (Open Label)||||||
1526928|NCT00627029|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1526929|NCT00627016|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526930|NCT00627003|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1526931|NCT00626990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526932|NCT00626977|||Cohort||Prospective|||||||
1526933|NCT00626964|||Other||Prospective|||||||
1526934|NCT00626951|Randomized|Crossover Assignment||Treatment||Single||||t||
1526935|NCT00626938|||Case Control||Cross-Sectional|||||||
1526936|NCT00626925|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526937|NCT00626912|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526938|NCT00626899|||Case-Only||Prospective|||||||
1526939|NCT00626886|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526940|NCT00626873||Single Group Assignment||Diagnostic||None (Open Label)||||||
1526941|NCT00626860||Single Group Assignment||Treatment||None (Open Label)||||||
1526942|NCT00626847|||Cohort||Prospective|||||||
1526943|NCT00626834|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1526944|NCT00626821|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526945|NCT00626808|||Cohort||Retrospective|||||||
1526946|NCT00626795|Randomized|Parallel Assignment||Treatment||Single|||||t|
1526947|NCT00626782|Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients requiring trabeculectomy were randomly assigned to either MMC or Ranibizumab during surgery.||||
1526948|NCT00626769|||Cohort||Prospective|||||||
1526949|NCT00626756|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1526950|NCT00626743|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1526951|NCT00626730|Non-Randomized|||Treatment||||||||
1526952|NCT00626717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526953|NCT00626704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526954|NCT00626691|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1526955|NCT00626678|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1526956|NCT00626665|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1526957|NCT00626652|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1526958|NCT00626639|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1526959|NCT00626626|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526960|NCT00626613||Single Group Assignment||||Double|||t|t||
1526961|NCT00626600|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526962|NCT00626587|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1526963|NCT00626574|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1526964|NCT00626561||Single Group Assignment||Treatment||None (Open Label)||||||
1526965|NCT00626548|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526966|NCT00626535|Randomized|Parallel Assignment||Treatment||Double||||||
1526967|NCT00626522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526968|NCT00626509|Randomized|||Treatment||||||||
1526969|NCT00626496|||Family-Based||Prospective|||||||
1526970|NCT00626483||Single Group Assignment||Treatment||None (Open Label)||||||
1526971|NCT00626470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526972|NCT00626457|Randomized|Factorial Assignment||Treatment||Single||||||t
1526973|NCT00626444||Single Group Assignment||Treatment||None (Open Label)||||||
1526974|NCT00626431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526975|NCT00626418|Randomized|Crossover Assignment||Treatment||Single|||t|||
1526976|NCT00626405|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526977|NCT00626392|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1526978|NCT00626379|||Cohort||Cross-Sectional|||||||
1526979|NCT00626366|Non-Randomized|Single Group Assignment||Other||Single||||||t
1526980|NCT00626353|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1526981|NCT00626340|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1526982|NCT00626327|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1526983|NCT00626314|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1526984|NCT00626301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526985|NCT00626288|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1526986|NCT00626275|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1526987|NCT00626262|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1526988|NCT00626249|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526989|NCT00626236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526990|NCT00626223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526991|NCT00626210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1526992|NCT00626197|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1526993|NCT00626184|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1526994|NCT00626171|Randomized|Parallel Assignment||Basic Science||Single||||||t
1526995|NCT00626158||Single Group Assignment||Treatment||None (Open Label)||||||
1526996|NCT00626145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1526997|NCT00626132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1526998|NCT00626119|||Cohort||Cross-Sectional|||||||
1526999|NCT00626106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527000|NCT00626093||Single Group Assignment||Treatment||None (Open Label)||||||
1527001|NCT00626080|Randomized|Crossover Assignment||||None (Open Label)||||||
1527002|NCT00626067|Randomized|Single Group Assignment||Supportive Care||Double|||t||t|
1527003|NCT00626054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527004|NCT00626041|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1527005|NCT00626028|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1527006|NCT00626015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527007|NCT00626002|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527008|NCT00625989|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1527009|NCT00625976|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527010|NCT00625963|||Cohort||Retrospective|||||||
1527011|NCT00625950|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1527012|NCT00625937||||Treatment||None (Open Label)||||||
1527013|NCT00625924|||Case-Crossover||Retrospective|||||||
1527014|NCT00625911|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527015|NCT00625898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527016|NCT00625885|||Cohort||Prospective|||||||
1527017|NCT00625872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527018|NCT00625859|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1527019|NCT00625846||Single Group Assignment||Treatment||None (Open Label)||||||
1527020|NCT00625833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527021|NCT00625820||Single Group Assignment||Treatment||None (Open Label)||||||
1527022|NCT00625807|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527023|NCT00625794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527024|NCT00625781|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1527025|NCT00625768|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527026|NCT00625755||Single Group Assignment||Treatment||None (Open Label)||||||
1527027|NCT00625742||Single Group Assignment||Treatment||None (Open Label)||||||
1527028|NCT00625729||Single Group Assignment||Treatment||None (Open Label)||||||
1528410|NCT00607204|||Cohort||Prospective|||||||
1527029|NCT00625703|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1527030|NCT00625690|||Cohort||Prospective|||||||
1527031|NCT00625677|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527032|NCT00625664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527033|NCT00625651|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527034|NCT00625638|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1527035|NCT00625625||||Diagnostic||||||||
1527036|NCT00625612|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527037|NCT00625599|||Ecologic or Community||Prospective|||||||
1527038|NCT00625586||Single Group Assignment||Treatment||None (Open Label)||||||
1527039|NCT00625573||Single Group Assignment||Treatment||None (Open Label)||||||
1527040|NCT00625560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527041|NCT00625547|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1527042|NCT00625534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527043|NCT00625521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527044|NCT00625495|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527045|NCT00625482||||Prevention||||||||
1527046|NCT00625469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527047|NCT00625456|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527048|NCT00625443|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527049|NCT00625430||Single Group Assignment||Treatment||None (Open Label)||||||
1527050|NCT00625417||Single Group Assignment||Diagnostic||None (Open Label)||Optical spectroscopy is applied to evaluate tumor margins in consenting patients who undergo surgery for breast tumors||||
1527051|NCT00625404|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527052|NCT00625391|Randomized|Factorial Assignment||Prevention||Single||||||t
1527053|NCT00625378||Single Group Assignment||Treatment||None (Open Label)||||||
1527054|NCT00625365||Single Group Assignment||||None (Open Label)||||||
1527055|NCT00625352||Single Group Assignment||Treatment||None (Open Label)||||||
1527056|NCT00625339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527057|NCT00625326|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527058|NCT00625313||Single Group Assignment||Treatment||None (Open Label)||||||
1527059|NCT00625300|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527060|NCT00625274|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527061|NCT00625261|Randomized|Parallel Assignment||Prevention||Single|||||t|
1527062|NCT00625248|||||Prospective|||||||
1527063|NCT00625235|Randomized|Parallel Assignment||Treatment||||||||
1527064|NCT00625222||Single Group Assignment||Diagnostic||None (Open Label)||||||
1527065|NCT00625209|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1527066|NCT00625196|Randomized|Crossover Assignment||Treatment||||||||
1527067|NCT00625183||Single Group Assignment||Treatment||None (Open Label)||||||
1527068|NCT00625170|Randomized|Parallel Assignment||||Single|||t|||
1527069|NCT00625157||||Treatment||||||||
1527070|NCT00625131|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527071|NCT00625118|||Cohort||Prospective|||||||
1527072|NCT00625105|Randomized|Factorial Assignment||Treatment||Single||||||t
1527073|NCT00625092||Single Group Assignment||Treatment||None (Open Label)||||||
1527074|NCT00625079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527075|NCT00625066|||Cohort||Prospective|||||||
1527076|NCT00625053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527077|NCT00625040|||Case-Only||Prospective|||||||
1527078|NCT00625027|||Case-Only||Prospective|||||||
1527079|NCT00625014||Single Group Assignment||||None (Open Label)||||||
1527080|NCT00625001|||Cohort||Prospective|||||||
1527081|NCT00624988||Single Group Assignment||Treatment||None (Open Label)||||||
1527082|NCT00624975|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527083|NCT00624962||Single Group Assignment||Supportive Care||None (Open Label)||||||
1527084|NCT00624949|||Cohort||Prospective|||||||
1527085|NCT00624936||Single Group Assignment||Treatment||None (Open Label)||||||
1527086|NCT00624923|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527087|NCT00624910|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527088|NCT00624884|||Case Control||Prospective|||||||
1527089|NCT00624871|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527090|NCT00624858||Single Group Assignment||Treatment||None (Open Label)||||||
1527091|NCT00624845|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527092|NCT00624832|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527093|NCT00624819|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527094|NCT00624806|Randomized|Parallel Assignment||Prevention||Single|||||t|
1527095|NCT00624793|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527096|NCT00624780|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527097|NCT00624767|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527098|NCT00624754|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1527099|NCT00624741||||||||||||
1527100|NCT00624728|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1527101|NCT00624715|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1527102|NCT00624702|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1527103|NCT00624689|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527104|NCT00624676|Randomized|Parallel Assignment||Treatment||Single||||||t
1527105|NCT00624663|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1528411|NCT00607191|||Family-Based||Prospective|||||||
1527106|NCT00624650|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527107|NCT00624637|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1527108|NCT00624624|||Cohort||Prospective|||||||
1527109|NCT00624611|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527110|NCT00624598|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527111|NCT00624585||Single Group Assignment||Treatment||None (Open Label)||||||
1527112|NCT00624572|Randomized|Single Group Assignment||Treatment||Single|||t|||
1527113|NCT00624559|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1527114|NCT00624546|||Cohort||Prospective|||||||
1527115|NCT00624533|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1527116|NCT00624520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527117|NCT00624494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527118|NCT00624481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527119|NCT00624468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527120|NCT00624455|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1527121|NCT00624442|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1527122|NCT00624429||Single Group Assignment||Treatment||None (Open Label)||||||
1527123|NCT00624416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527124|NCT00624403|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527125|NCT00624390|Randomized|Parallel Assignment||Prevention||Single|||t|||
1527126|NCT00624377|||Cohort||Prospective|||||||
1527127|NCT00624364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527128|NCT00624351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527129|NCT00624338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527130|NCT00624325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527131|NCT00624312|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1527132|NCT00624299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527133|NCT00624286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527134|NCT00624273||Single Group Assignment||Treatment||None (Open Label)||||||
1527135|NCT00624260|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1527136|NCT00624247|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1527137|NCT00624234|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527138|NCT00624221|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527139|NCT00624208|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1527140|NCT00624195|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527141|NCT00624182||Single Group Assignment||Treatment||None (Open Label)||||||
1527142|NCT00624169||Single Group Assignment||Treatment||None (Open Label)||||||
1527143|NCT00624156|||Cohort||Prospective|||||||
1527144|NCT00624143|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527145|NCT00624130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527146|NCT00624117|Randomized|Parallel Assignment||Treatment||Single||||||t
1527147|NCT00624104||||||||||||
1527148|NCT00624091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527149|NCT00624078||Single Group Assignment||Treatment||None (Open Label)||||||
1527150|NCT00624065|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527151|NCT00624052||||Treatment||||||||
1527152|NCT00624039||Single Group Assignment||Basic Science||Double|||||t|t
1527153|NCT00624026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527154|NCT00624013|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527155|NCT00624000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527156|NCT00623987|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527157|NCT00623974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527158|NCT00623961|||Cohort||Prospective|||||||
1527159|NCT00623948|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1527160|NCT00623935|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527161|NCT00623922|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1527162|NCT00623909||Single Group Assignment||Treatment||None (Open Label)|Not applicable, study terminated prior to enrollment and closed.|||||
1527163|NCT00623896|||Case-Only||Prospective|||||||
1527164|NCT00623883|Randomized|Parallel Assignment||Prevention||Single||||||t
1527165|NCT00623870||Parallel Assignment||Treatment||None (Open Label)||||||
1527166|NCT00623857|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1527167|NCT00623844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527168|NCT00623831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527169|NCT00623818|||||Prospective|||||||
1527170|NCT00623805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527171|NCT00623792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527172|NCT00623779|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527173|NCT00623766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527174|NCT00623753||Single Group Assignment||Prevention||None (Open Label)||||||
1527175|NCT00623740|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527176|NCT00623727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527177|NCT00623714|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1527178|NCT00623701|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527179|NCT00623688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527180|NCT00623675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527181|NCT00623662|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527182|NCT00623649|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1527183|NCT00623636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527184|NCT00623623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527185|NCT00623610||Single Group Assignment||Treatment||None (Open Label)||||||
1527186|NCT00623597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527187|NCT00623584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527188|NCT00623571|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1527189|NCT00623558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527190|NCT00623545||Single Group Assignment||Treatment||None (Open Label)||||||
1527191|NCT00623532|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1527192|NCT00623519|||||Prospective|||||||
1527193|NCT00623506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527194|NCT00623493|||||Prospective|||||||
1527195|NCT00623480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527196|NCT00623467|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1527197|NCT00623454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527198|NCT00623441|||Cohort||Prospective|||||||
1527199|NCT00623428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527200|NCT00623415|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527201|NCT00623402||Single Group Assignment||Treatment||None (Open Label)||||||
1527202|NCT00623389||Single Group Assignment||Treatment||None (Open Label)||||||
1527203|NCT00623376||||||||||||
1527204|NCT00623363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527205|NCT00623350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527206|NCT00623337|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527207|NCT00623324|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1527208|NCT00623298|Non-Randomized|||Treatment||Single||||||t
1527209|NCT00623285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527210|NCT00623272||Single Group Assignment||Supportive Care||None (Open Label)||||||
1527211|NCT00623259||||Diagnostic||||||||
1527212|NCT00623246|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527213|NCT00623233||Single Group Assignment||Treatment||None (Open Label)||||||
1527214|NCT00623220|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527215|NCT00623207|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1527216|NCT00623194|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527217|NCT00623181|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527218|NCT00623168||Single Group Assignment||Treatment||None (Open Label)||||||
1527219|NCT00623155|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1527220|NCT00623142|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1527221|NCT00623129|Randomized|||Supportive Care||Single||||||
1527222|NCT00623116||Single Group Assignment||Treatment||None (Open Label)||||||
1527223|NCT00623103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527224|NCT00623090|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1527225|NCT00623077||Single Group Assignment||Treatment||None (Open Label)||||||
1527226|NCT00623064||Single Group Assignment||Treatment||None (Open Label)||||||
1527227|NCT00623051||Single Group Assignment||Prevention||None (Open Label)||||||
1527228|NCT00623038|||Cohort||Prospective|||||||
1527229|NCT00623025|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1527230|NCT00623012||Single Group Assignment||Treatment||None (Open Label)||||||
1527231|NCT00622999|||Cohort||Prospective|||||||
1527232|NCT00622986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527233|NCT00622973|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1527234|NCT00622960|Randomized|Parallel Assignment||Treatment||Single||||||t
1527235|NCT00622947|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527236|NCT00622934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527237|NCT00622921|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527238|NCT00622908|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527239|NCT00622895||Single Group Assignment||Treatment||None (Open Label)||||||
1527240|NCT00622882|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1527241|NCT00622869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527242|NCT00622856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527243|NCT00622843|Randomized|Parallel Assignment||||None (Open Label)||||||
1527244|NCT00622830|Randomized|Parallel Assignment||Treatment||Double||||||
1527245|NCT00622817|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1527246|NCT00622804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527247|NCT00622791|||Cohort||Prospective|||||||
1527248|NCT00622778|||Cohort||Prospective|||||||
1527249|NCT00622765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527250|NCT00622752|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1527251|NCT00622739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527252|NCT00622726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527253|NCT00622713||Single Group Assignment||Treatment||None (Open Label)||||||
1527254|NCT00622700|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527255|NCT00622687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527256|NCT00622674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527257|NCT00622661|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1527258|NCT00622648|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527259|NCT00622635|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1527260|NCT00622622||Single Group Assignment||Treatment||None (Open Label)||||||
1527261|NCT00622609|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527262|NCT00622596||Single Group Assignment||Treatment||None (Open Label)||||||
1527263|NCT00622583|||Other||Prospective|||||||
1527264|NCT00622570|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527265|NCT00622557|||Case-Only||Prospective|||||||
1527266|NCT00622544|||Other||Prospective|||||||
1527267|NCT00622531|||Case Control||Prospective|||||||
1527268|NCT00622518|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1527269|NCT00622505||Single Group Assignment||Prevention||None (Open Label)||||||
1527270|NCT00622492|||Cohort||Prospective|||||||
1527271|NCT00622479|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1527272|NCT00622466||Single Group Assignment||Treatment||None (Open Label)||||||
1527273|NCT00622453|||Other||Other|||||||
1527274|NCT00622440|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527275|NCT00622427|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1527276|NCT00622414||Single Group Assignment||Treatment||None (Open Label)||||||
1527277|NCT00622401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527278|NCT00622388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527279|NCT00622375||Single Group Assignment||Basic Science||None (Open Label)||||||
1527280|NCT00622362|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527281|NCT00622349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527282|NCT00622336||Single Group Assignment||Treatment||None (Open Label)||||||
1527283|NCT00622323|||Cohort||Prospective|||||||
1527284|NCT00622310|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1527285|NCT00622284|Randomized|Parallel Assignment||Treatment||Double||||||
1527286|NCT00622271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527287|NCT00622258||Single Group Assignment||Treatment||None (Open Label)||||||
1527288|NCT00622245|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527289|NCT00622232|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527290|NCT00622219|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1527291|NCT00622206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527292|NCT00622193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527293|NCT00622180|Randomized|Single Group Assignment||Treatment||Single|||||t|
1527294|NCT00622167||Single Group Assignment||Diagnostic||None (Open Label)||||||
1527295|NCT00622141|Randomized|Crossover Assignment||||None (Open Label)||||||
1527296|NCT00622128|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1527297|NCT00622115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527298|NCT00622102|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1527299|NCT00622089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527300|NCT00622076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527301|NCT00622063||Single Group Assignment||Treatment||None (Open Label)||||||
1527302|NCT00622050|Randomized|Parallel Assignment||Treatment||Single|||||t|
1527303|NCT00622037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527304|NCT00622024|||||Prospective|||||||
1527305|NCT00622011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527306|NCT00621998|Randomized|Parallel Assignment||Treatment||Single||||||t
1527307|NCT00621985|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527308|NCT00621972|||Cohort||Prospective|||||||
1527309|NCT00621959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527310|NCT00621946|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527311|NCT00621933|||Cohort||Prospective|||||||
1527312|NCT00621920|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527313|NCT00621907|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527314|NCT00621894|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527315|NCT00621881|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1527316|NCT00621868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527317|NCT00621855|Randomized|Parallel Assignment||Treatment||Double||||||
1527318|NCT00621842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527319|NCT00621829|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1527320|NCT00621816|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1527321|NCT00621803|Randomized|Parallel Assignment||Treatment||Double||||||
1527322|NCT00621790|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527323|NCT00621777|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527324|NCT00621764|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1527325|NCT00621751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527326|NCT00621738|||||Prospective|||||||
1527327|NCT00621725|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527328|NCT00621712|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1527329|NCT00621699|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1527330|NCT00621686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527331|NCT00621673|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1527332|NCT00621660|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527333|NCT00621647|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1527334|NCT00621634|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527335|NCT00621621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527336|NCT00621608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527337|NCT00621595|Randomized|Parallel Assignment||Treatment||Single||||||t
1527338|NCT00621582|||||Prospective|||||||
1527339|NCT00621569|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527340|NCT00621556|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1527341|NCT00621543||Single Group Assignment||Treatment||None (Open Label)||||||
1527342|NCT00621530|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527343|NCT00621517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527344|NCT00621504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527345|NCT00621491|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1527346|NCT00621478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527347|NCT00621465|Randomized|Parallel Assignment||Prevention||Single||||||t
1527348|NCT00621452|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527349|NCT00621439|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1527350|NCT00621426|||Cohort||Prospective|||||||
1527351|NCT00621413|||Cohort||Prospective|||||||
1527352|NCT00621400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527353|NCT00621387|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527354|NCT00621374|Randomized|Single Group Assignment||Treatment||Single||||||t
1527355|NCT00621361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527356|NCT00621348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527357|NCT00621335|||||Prospective|||||||
1527358|NCT00621322|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1527359|NCT00621309|Randomized|Crossover Assignment||||None (Open Label)||||||
1527360|NCT00621296||Single Group Assignment||Treatment||None (Open Label)||||||
1527361|NCT00621283|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1527362|NCT00621270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527363|NCT00621257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527364|NCT00621244|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527365|NCT00621231||Parallel Assignment||Basic Science||||||||
1527366|NCT00621218|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527367|NCT00621205|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1527368|NCT00621192||Single Group Assignment||Treatment||None (Open Label)||||||
1527369|NCT00621179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527370|NCT00621166|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527371|NCT00621153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527372|NCT00621140|Randomized|Parallel Assignment||Treatment||Double||||||
1527373|NCT00621114|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527374|NCT00621101|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1527375|NCT00621088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527376|NCT00621075|||Cohort||Retrospective|||||||
1527377|NCT00621062|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527378|NCT00621049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527379|NCT00621036||Single Group Assignment||Treatment||None (Open Label)||||||
1527380|NCT00621023||Single Group Assignment||Treatment||None (Open Label)||||||
1527381|NCT00621010||||Treatment||||||||
1527382|NCT00620997|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1527383|NCT00620984|||Cohort||Prospective|||||||
1527384|NCT00620971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527385|NCT00620958|Randomized|Parallel Assignment||Treatment||Single||||||t
1527386|NCT00620945||Single Group Assignment||Treatment||None (Open Label)||||||
1527387|NCT00620932|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1527388|NCT00620919|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1527389|NCT00620906||Single Group Assignment||Treatment||None (Open Label)||||||
1527390|NCT00620893|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527391|NCT00620880|||||Prospective|||||||
1527392|NCT00620867|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527393|NCT00620854|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1527394|NCT00620841|||Cohort||Retrospective|||||||
1527395|NCT00620828|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1527396|NCT00620815|Randomized|Parallel Assignment||Prevention||Single|||||t|
1527397|NCT00620802|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527398|NCT00620789|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527399|NCT00620776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527400|NCT00620763|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1527401|NCT00620750||Single Group Assignment||Treatment||None (Open Label)||||||
1527402|NCT00620737|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1527403|NCT00620724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527404|NCT00620711||Single Group Assignment||Treatment||None (Open Label)||||||
1527405|NCT00620698|||Cohort||Prospective|||||||
1527406|NCT00620685|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527407|NCT00620672|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1527408|NCT00620659|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1527409|NCT00620646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527410|NCT00620633||Single Group Assignment||Treatment||None (Open Label)||||||
1527411|NCT00620620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527412|NCT00620607||Single Group Assignment||Treatment||None (Open Label)||||||
1527413|NCT00620594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527414|NCT00620581||||||||||||
1527415|NCT00620568|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1527416|NCT00620555|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527417|NCT00620542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527418|NCT00620529|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1527419|NCT00620516|||||Prospective|||||||
1527420|NCT00620503|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527421|NCT00620490|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1527422|NCT00620477|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527423|NCT00620464|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527424|NCT00620451|Randomized|Parallel Assignment||Treatment||Double|double-blind|randomized, parallel- group, double-blind, multicenter|t||t|
1527425|NCT00620438|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527426|NCT00620425||Single Group Assignment||Treatment||None (Open Label)||||||
1527427|NCT00620412|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527428|NCT00620399||||Treatment||||||||
1527429|NCT00620386|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527430|NCT00620373||Single Group Assignment||Diagnostic||Single|||||t|
1527431|NCT00620360|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1527432|NCT00620347||Single Group Assignment||Treatment||None (Open Label)||||||
1527433|NCT00620334|||Cohort||Prospective|||||||
1527434|NCT00620321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527435|NCT00620308|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1527436|NCT00620295||Single Group Assignment||Treatment||None (Open Label)||||||
1527437|NCT00620282|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527438|NCT00620269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527439|NCT00620256|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527440|NCT00620243||Single Group Assignment||Diagnostic||None (Open Label)||||||
1527441|NCT00620230|Randomized|Parallel Assignment||||Double|||t||t|
1527442|NCT00620217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527443|NCT00620204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527444|NCT00620191|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527445|NCT00620178|||Cohort||Retrospective|||||||
1527446|NCT00620165|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1527447|NCT00620152|Randomized|Parallel Assignment||Treatment||Single||||||t
1527448|NCT00620139|||Cohort||Prospective|||||||
1527449|NCT00620126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527450|NCT00620113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527451|NCT00620100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527452|NCT00620087|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1527453|NCT00620074|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527454|NCT00620061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527455|NCT00620048|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527456|NCT00620035||Single Group Assignment||Prevention||None (Open Label)||||||
1527457|NCT00620022|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1527458|NCT00620009|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527459|NCT00619996||Single Group Assignment||Treatment||None (Open Label)||||||
1527460|NCT00619983|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527461|NCT00619970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527462|NCT00619957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527463|NCT00619944|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1527464|NCT00619931|||Cohort||Prospective|||||||
1527465|NCT00619918|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527466|NCT00619905|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527467|NCT00619892|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527468|NCT00619879|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527469|NCT00619866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527470|NCT00619853|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1527471|NCT00619840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527472|NCT00619827|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527473|NCT00619814||Single Group Assignment||Diagnostic||Single|||||t|
1527474|NCT00619801|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527475|NCT00619788||Single Group Assignment||Treatment||None (Open Label)||||||
1527476|NCT00619775||Single Group Assignment||Treatment||None (Open Label)||||||
1527477|NCT00619762|||Cohort||Prospective|||||||
1527478|NCT00619749|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1527479|NCT00619736|Randomized|Parallel Assignment||||Double||||||
1527480|NCT00619723|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1527481|NCT00619710|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527482|NCT00619697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527483|NCT00619684||Single Group Assignment||Treatment||None (Open Label)||||||
1527484|NCT00619671|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527485|NCT00619658||Single Group Assignment||Treatment||None (Open Label)||||||
1527486|NCT00619645||Single Group Assignment||Treatment||None (Open Label)||||||
1527487|NCT00619632|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1527488|NCT00619619|Randomized|Single Group Assignment||||None (Open Label)||||||
1527489|NCT00619606|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1527490|NCT00619593|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527491|NCT00619580|||Cohort||Retrospective|||||||
1527492|NCT00619567|Randomized|Parallel Assignment||Treatment||Single||||||t
1527493|NCT00619554|||||Prospective|||||||
1527494|NCT00619541||Single Group Assignment||Treatment||None (Open Label)||||||
1527495|NCT00619528|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1527496|NCT00619515||Single Group Assignment||Treatment||None (Open Label)||||||
1527497|NCT00619502|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527498|NCT00619489|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527499|NCT00619476|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527500|NCT00619463|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527501|NCT00619450|||Case-Only||Prospective|||||||
1527502|NCT00619437|||Family-Based||Prospective|||||||
1527503|NCT00619424|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527504|NCT00619411|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527505|NCT00619398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527506|NCT00619385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527507|NCT00619372|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527508|NCT00619359|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1527509|NCT00619346|Randomized|Parallel Assignment||||Double|||t||t|
1527510|NCT00619333||Single Group Assignment||||None (Open Label)||||||
1527511|NCT00619320|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527512|NCT00619307|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1527513|NCT00619294|||Cohort||Prospective|||||||
1527514|NCT00619281|||Case Control||Prospective|||||||
1527515|NCT00619268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527516|NCT00619255|Randomized|Parallel Assignment||Treatment||Single||||||t
1527517|NCT00619242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527518|NCT00619229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527519|NCT00619216|||Case-Only||Prospective|||||||
1527520|NCT00619203|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1527521|NCT00619190|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527522|NCT00619177|||Cohort||Prospective|||||||
1527523|NCT00619164|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527524|NCT00619151|Randomized|Parallel Assignment||||None (Open Label)||||||
1527525|NCT00619138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527526|NCT00619125|||Cohort||Retrospective|||||||
1527527|NCT00619112||Single Group Assignment||Treatment||None (Open Label)||||||
1527528|NCT00619099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527529|NCT00619086|Randomized|Parallel Assignment||||Triple|||t|t|t|
1527530|NCT00619073|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1527531|NCT00619060|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527532|NCT00619047|||Cohort||Prospective|||||||
1527533|NCT00619034|Randomized|Crossover Assignment||Prevention||Single|||||t|
1527534|NCT00619021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527535|NCT00619008|Randomized|Parallel Assignment||Basic Science||Single||||||t
1527536|NCT00618995|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1527537|NCT00618982||Single Group Assignment||Treatment||None (Open Label)||||||
1527538|NCT00618969||Single Group Assignment||Treatment||None (Open Label)||||||
1527539|NCT00618956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527540|NCT00618943|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527541|NCT00618930|Randomized|Parallel Assignment||Treatment||Single|||||t|
1527542|NCT00618917||Single Group Assignment||Treatment||None (Open Label)||||||
1527543|NCT00618904|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1527544|NCT00618878|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527545|NCT00618865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527546|NCT00618852|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527547|NCT00618839|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527548|NCT00618826||Single Group Assignment||Treatment||None (Open Label)||||||
1527549|NCT00618813||Single Group Assignment||Treatment||None (Open Label)||||||
1527550|NCT00618800|Randomized|Parallel Assignment||Prevention||Single||||||t
1527551|NCT00618787|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527552|NCT00618774||Parallel Assignment||Treatment||||||||
1527553|NCT00618761|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1527554|NCT00618748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527555|NCT00618735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527556|NCT00618722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527557|NCT00618709|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1527558|NCT00618696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527559|NCT00618683||Single Group Assignment||Diagnostic||None (Open Label)||||||
1527560|NCT00618670|Randomized|Parallel Assignment||Treatment||Single||||||t
1527561|NCT00618657|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527562|NCT00618644||Single Group Assignment||Treatment||Double|||t||t|
1527563|NCT00618631|Randomized|Parallel Assignment||Screening||||||||
1527564|NCT00618618|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527565|NCT00618605|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1527566|NCT00618592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527567|NCT00618579|Randomized|Parallel Assignment||||Double|||t||t|
1527568|NCT00618566|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527569|NCT00618553||Single Group Assignment||Treatment||None (Open Label)||||||
1527570|NCT00618540||Single Group Assignment||Treatment||None (Open Label)||||||
1527571|NCT00618527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527572|NCT00618514|Randomized|Parallel Assignment||||None (Open Label)||||||
1527573|NCT00618501||||Treatment||None (Open Label)||||||
1527574|NCT00618488|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527575|NCT00618475|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527576|NCT00618462|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1527577|NCT00618449|Randomized|Parallel Assignment||Treatment||Single|||||t|
1527578|NCT00618436|Randomized|Parallel Assignment||Treatment||Single||||||t
1527579|NCT00618423|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1527580|NCT00618410|Randomized|Crossover Assignment||||Double|||t||t|
1527581|NCT00618397||Single Group Assignment||||None (Open Label)||||||
1527582|NCT00618384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527583|NCT00618371||Single Group Assignment||||None (Open Label)||||||
1527584|NCT00618358|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527585|NCT00618345||||Treatment||None (Open Label)||||||
1527586|NCT00618332|Randomized|Parallel Assignment||||Double|||t||t|
1527587|NCT00618319||Single Group Assignment||Treatment||None (Open Label)||||||
1527588|NCT00618293|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527589|NCT00618280|Randomized|Factorial Assignment||Basic Science||Triple|||t|t|t|
1527590|NCT00618267|||Cohort||Prospective|||||||
1527591|NCT00618254|Randomized|||Treatment||None (Open Label)||||||
1527592|NCT00618241|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527593|NCT00618228|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527594|NCT00618215|Randomized|Factorial Assignment||Health Services Research||Single||||t||
1527595|NCT00618202|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527596|NCT00618176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527597|NCT00618163|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527598|NCT00618150|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1527599|NCT00618137|||Cohort||Prospective|||||||
1527600|NCT00618124|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527601|NCT00618111|Randomized|||Treatment||None (Open Label)||||||
1527602|NCT00618098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527603|NCT00618085|Randomized|Parallel Assignment||Treatment||Single||||||t
1527604|NCT00618072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527605|NCT00618059|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527606|NCT00618046|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527607|NCT00618033|Randomized|Crossover Assignment||Treatment||Single|||t|||
1527608|NCT00618020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527609|NCT00618007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527610|NCT00617994|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527611|NCT00617981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527612|NCT00617968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527613|NCT00617955|||Cohort||Retrospective|||||||
1527614|NCT00617942|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527615|NCT00617929||Single Group Assignment||Treatment||None (Open Label)||||||
1527616|NCT00617916|||Cohort||Prospective|||||||
1527617|NCT00617903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527618|NCT00617890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527619|NCT00617877|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527620|NCT00617864|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1527621|NCT00617851|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1527622|NCT00617838|Randomized|Parallel Assignment||Prevention||Single|||t|||
1527623|NCT00617825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527624|NCT00617812||Single Group Assignment||Prevention||None (Open Label)||||||
1527625|NCT00617799|||Cohort||Prospective|||||||
1527626|NCT00617786|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1527627|NCT00617773||Single Group Assignment||Treatment||None (Open Label)||||||
1527628|NCT00617760|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527629|NCT00617747|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527630|NCT00617734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527631|NCT00617721|||Family-Based||Prospective|||||||
1527632|NCT00617708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527633|NCT00617695|Randomized|Crossover Assignment||Treatment||Single||||||
1527634|NCT00617682|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527635|NCT00617669|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527636|NCT00617656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527637|NCT00617643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527638|NCT00617630||||||||||||
1527639|NCT00617617|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1527640|NCT00617604|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527641|NCT00617591||Single Group Assignment||Treatment||None (Open Label)||||||
1527642|NCT00617578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527643|NCT00617565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527644|NCT00617552|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527645|NCT00617539||Single Group Assignment||Treatment||None (Open Label)||||||
1527646|NCT00617526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527647|NCT00617513|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527648|NCT00617500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527649|NCT00617487|||Cohort||Prospective|||||||
1527650|NCT00617474|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527651|NCT00617461|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1527652|NCT00617448|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527653|NCT00617435|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1527654|NCT00617409|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1527655|NCT00617396||Single Group Assignment||Treatment||None (Open Label)||||||
1527656|NCT00617383|||Cohort||Prospective|||||||
1527657|NCT00617370||Single Group Assignment||Treatment||None (Open Label)||||||
1527658|NCT00617357||Single Group Assignment||Treatment||None (Open Label)||||||
1527659|NCT00617344|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527660|NCT00617331|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1527661|NCT00617318|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1527662|NCT00617305|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527663|NCT00617292|||Case Control||Prospective|||||||
1527664|NCT00617279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527665|NCT00617266|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527666|NCT00617253|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527667|NCT00617240|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527668|NCT00617227|||Case-Only||Prospective|||||||
1527669|NCT00617214|||Case-Only||Prospective|||||||
1527670|NCT00617201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527671|NCT00617188||Single Group Assignment||Treatment||None (Open Label)||||||
1527672|NCT00617175|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527673|NCT00617162||||||||||||
1527674|NCT00617149|Randomized|Parallel Assignment||Treatment||Single|||||t|
1527675|NCT00617136|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527676|NCT00617123|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1527677|NCT00617110|Randomized|Parallel Assignment||||Double|||t||t|
1527678|NCT00617097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527679|NCT00617084|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1527680|NCT00617071|Randomized|||Health Services Research||Single||||||
1527681|NCT00617058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527682|NCT00617045||Single Group Assignment||Treatment||None (Open Label)||||||
1527683|NCT00617032|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527684|NCT00617019|||Ecologic or Community||Cross-Sectional|||||||
1527685|NCT00617006|||Ecologic or Community||Prospective|||||||
1527686|NCT00616993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527687|NCT00616980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527688|NCT00616967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527689|NCT00616954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527690|NCT00616941|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1527691|NCT00616928|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1527692|NCT00616915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527693|NCT00616902|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527694|NCT00616889|||Cohort||Prospective|||||||
1527695|NCT00616876|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1527696|NCT00616863|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527697|NCT00616850|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1527698|NCT00616837|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1527699|NCT00616824|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527700|NCT00616811|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527701|NCT00616798|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527702|NCT00616785||||Treatment||None (Open Label)||||||
1527703|NCT00616772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527704|NCT00616759|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527705|NCT00616746||Single Group Assignment||||Triple|||t||t|t
1527706|NCT00616733|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527707|NCT00616720|Randomized|||Treatment||||||||
1527708|NCT00616707|||Other||Cross-Sectional|||||||
1527709|NCT00616694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527710|NCT00616681|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1527711|NCT00616668|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1527712|NCT00616655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527713|NCT00616642|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527714|NCT00616629|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1527715|NCT00616616||Single Group Assignment||Treatment||None (Open Label)||||||
1527716|NCT00616603|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1527717|NCT00616590|||Cohort||Prospective|||||||
1527718|NCT00616577|Randomized|Factorial Assignment||Treatment||Double|||t|t||
1527719|NCT00616564||Single Group Assignment||Treatment||None (Open Label)||||||
1527720|NCT00616551|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527721|NCT00616538|Randomized|Parallel Assignment||Treatment||Single|||||t|
1527722|NCT00616512|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527723|NCT00616499||||Treatment||None (Open Label)||||||
1527724|NCT00616486|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527725|NCT00616473|||Case-Only||Cross-Sectional|||||||
1527726|NCT00616460|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527727|NCT00616447|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527728|NCT00616434|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1527729|NCT00616421|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1527730|NCT00616408|||Cohort||Retrospective|||||||
1527731|NCT00616395|||Cohort||Prospective|||||||
1527732|NCT00616382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527733|NCT00616369|||Cohort||Prospective|||||||
1527734|NCT00616356|||Case-Only||Cross-Sectional|||||||
1527735|NCT00616343||Single Group Assignment||Treatment||Single||||||t
1527736|NCT00616330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527737|NCT00616317|||Cohort||Retrospective|||||||
1527738|NCT00616304|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1527739|NCT00616291||Parallel Assignment||Treatment||None (Open Label)||||||
1527740|NCT00616278|||Cohort||Prospective|||||||
1527741|NCT00616265|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1527742|NCT00616252|||Cohort||Prospective|||||||
1527743|NCT00616239|Randomized|Single Group Assignment||Treatment||Single|||||t|
1527744|NCT00616226||||||||||||
1527745|NCT00616213|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527746|NCT00616200||Single Group Assignment||Treatment||None (Open Label)||||||
1527747|NCT00616187|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527748|NCT00616174|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527749|NCT00616161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527750|NCT00616148|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527751|NCT00616135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527752|NCT00616122||Single Group Assignment||Treatment||None (Open Label)||||||
1527753|NCT00616109||Single Group Assignment||Treatment||None (Open Label)||||||
1527754|NCT00616096||Single Group Assignment||Treatment||None (Open Label)||||||
1527755|NCT00616083|||Cohort||Prospective|||||||
1527756|NCT00616070|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527757|NCT00616057|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527758|NCT00616044|Randomized|Crossover Assignment||Treatment||Single|||t|||
1527759|NCT00616031|Randomized|||Treatment||||||||
1527760|NCT00616018|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1527761|NCT00616005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527762|NCT00615992|||Cohort|||||||||
1527763|NCT00615979|||Other||Cross-Sectional|||||||
1527764|NCT00615966|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527765|NCT00615940|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527766|NCT00615927|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527767|NCT00615914|||Cohort||Prospective|||||||
1527768|NCT00615901||Single Group Assignment||Treatment||None (Open Label)||||||
1527769|NCT00615888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527770|NCT00615875|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527771|NCT00615862|||Cohort||Prospective|||||||
1527772|NCT00615849|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1527773|NCT00615836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527774|NCT00615823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527775|NCT00615810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527776|NCT00615797|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527777|NCT00615784||Single Group Assignment||Treatment||None (Open Label)||||||
1527778|NCT00615771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527779|NCT00615758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527780|NCT00615745||Single Group Assignment||Treatment||None (Open Label)||||||
1527781|NCT00615732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527782|NCT00615719|||Cohort||Prospective|||||||
1527783|NCT00615706|||||Cross-Sectional|||||||
1527784|NCT00615693||Single Group Assignment||Treatment||None (Open Label)||||||
1527785|NCT00615667||Single Group Assignment||Treatment||None (Open Label)||||||
1527786|NCT00615654|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1527787|NCT00615641|||Cohort||Prospective|||||||
1527788|NCT00615628|||Family-Based||Prospective|||||||
1527789|NCT00615615|Randomized|Parallel Assignment||Treatment||Double||||||
1527790|NCT00615602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527791|NCT00615589||Single Group Assignment||Treatment||None (Open Label)||||||
1527792|NCT00615576|Randomized|Single Group Assignment||Treatment||||||||
1527793|NCT00615563|||Cohort||Prospective|||||||
1528713|NCT00603200|||Case-Only||Prospective|||||||
1527794|NCT00615550|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527795|NCT00615537||Single Group Assignment||Treatment||None (Open Label)||||||
1527796|NCT00615524|Randomized|Parallel Assignment||Treatment||Double||||||
1527797|NCT00615511|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527798|NCT00615498|||Cohort||Prospective|||||||
1527799|NCT00615485||||||||||||
1527800|NCT00615472|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1527801|NCT00615459|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1527802|NCT00615446|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527803|NCT00615433|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527804|NCT00615420|Randomized|Parallel Assignment||Supportive Care||Double||||||
1527805|NCT00615407|||||Cross-Sectional|||||||
1527806|NCT00615394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527807|NCT00615381|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527808|NCT00615368|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1527809|NCT00615355|Randomized|Single Group Assignment||Treatment||Single||||||t
1527810|NCT00615342||||||||||||
1527811|NCT00615329|||Case-Only||Prospective|||||||
1527812|NCT00615316|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1527813|NCT00615303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527814|NCT00615290|||Case-Only||Prospective|||||||
1527815|NCT00615277|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1527816|NCT00615264|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527817|NCT00615251|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527818|NCT00615238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527819|NCT00615225||||||||||||
1527820|NCT00615212|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527821|NCT00615199|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1527822|NCT00615186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527823|NCT00615173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527824|NCT00615160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527825|NCT00615147|||Cohort||Prospective|||||||
1527826|NCT00615134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527827|NCT00615121|||Case Control||Cross-Sectional|||||||
1527828|NCT00615108|||Cohort||Prospective|||||||
1527829|NCT00615095|||Cohort||Prospective|||||||
1527830|NCT00615082|Randomized|Parallel Assignment||Supportive Care||Double|||||t|t
1527831|NCT00615069||Single Group Assignment||Treatment||None (Open Label)||||||
1527832|NCT00615056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527833|NCT00615043|||Case-Only||Prospective|||||||
1527834|NCT00615030|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1527835|NCT00615017|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1527836|NCT00615004|||Cohort||Retrospective|||||||
1527837|NCT00614991|Randomized|Factorial Assignment||||None (Open Label)||||||
1527838|NCT00614978||Single Group Assignment||Treatment||None (Open Label)||||||
1527839|NCT00614965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527840|NCT00614952|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1527841|NCT00614939|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527842|NCT00614926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527843|NCT00614913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527844|NCT00614900|||||Cross-Sectional|||||||
1527845|NCT00614887|||Case Control||Prospective|||||||
1527846|NCT00614874|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527847|NCT00614861|||Cohort||Cross-Sectional|||||||
1527848|NCT00614848|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1527849|NCT00614835||Single Group Assignment||Treatment||None (Open Label)||||||
1527850|NCT00614822||Single Group Assignment||Treatment||None (Open Label)||||||
1527851|NCT00614809|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527852|NCT00614796|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1527853|NCT00614783|||Cohort||Prospective|||||||
1527854|NCT00614770|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1527855|NCT00614757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527856|NCT00614744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527857|NCT00614731|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1527858|NCT00614718|||Case Control||Retrospective|||||||
1527859|NCT00614705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527860|NCT00614679|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527861|NCT00614666|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527862|NCT00614653||Single Group Assignment||Treatment||None (Open Label)||||||
1527863|NCT00614640|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527864|NCT00614614|Randomized|Parallel Assignment||Prevention||Single||||t||
1527865|NCT00614601|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527866|NCT00614588|||Case-Only||Prospective|||||||
1527867|NCT00614575|||Cohort||Prospective|||||||
1527868|NCT00614562||Single Group Assignment||Treatment||None (Open Label)||||||
1527869|NCT00614549|||Cohort||Prospective|||||||
1527870|NCT00614536|||Case-Only||Prospective|||||||
1527871|NCT00614523|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1527872|NCT00614510|||Cohort|||||||||
1527873|NCT00614484||Single Group Assignment||Treatment||None (Open Label)||||||
1529099|NCT00597974|||Case Control||Prospective|||||||
1527874|NCT00614471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527875|NCT00614458|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527876|NCT00614445|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1527877|NCT00614432|||Cohort||Prospective|||||||
1527878|NCT00614419|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1527879|NCT00614406|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1527880|NCT00614393|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527881|NCT00614380||||Treatment||||||||
1527882|NCT00614367|||||Prospective|||||||
1527883|NCT00614354||Single Group Assignment||Diagnostic||None (Open Label)||||||
1527884|NCT00614341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527885|NCT00614328|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1527886|NCT00614315||Single Group Assignment||Treatment||None (Open Label)||||||
1527887|NCT00614302|||Cohort||Prospective|||||||
1527888|NCT00614289|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527889|NCT00614276|||Case-Only||Prospective|||||||
1527890|NCT00614263||||||||||||
1527891|NCT00614250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527892|NCT00614224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527893|NCT00614211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527894|NCT00614198|Randomized|Parallel Assignment||Treatment||Single|||||t|
1527895|NCT00614172||Single Group Assignment||Treatment||None (Open Label)||||||
1527896|NCT00614159|||Cohort||Prospective|||||||
1527897|NCT00614146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527898|NCT00614133|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1527899|NCT00614120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527900|NCT00614107|||Cohort||Prospective|||||||
1527901|NCT00614094|||Cohort||Retrospective|||||||
1527902|NCT00614081||Parallel Assignment||Diagnostic||Single||||||t
1527903|NCT00614068|Randomized|Parallel Assignment||Treatment||Single||||||t
1527904|NCT00614055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527905|NCT00614042||Single Group Assignment||Treatment||None (Open Label)||||||
1527906|NCT00614029|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1527907|NCT00614016|Randomized|Single Group Assignment||||Double|||t||t|
1527908|NCT00614003|Randomized|Parallel Assignment||||Single|||t|||
1527909|NCT00613977|||Cohort||Prospective|||||||
1527910|NCT00613964|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527911|NCT00613951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527912|NCT00613938|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527913|NCT00613925|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1527914|NCT00613912|||Case-Only||Prospective|||||||
1527915|NCT00613899||Single Group Assignment||Treatment||None (Open Label)||||||
1527916|NCT00613886||Single Group Assignment||Diagnostic||None (Open Label)||||||
1527917|NCT00613873|||Cohort||Prospective|||||||
1527918|NCT00613860||Single Group Assignment||Treatment||None (Open Label)||||||
1527919|NCT00613847|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1527920|NCT00613834|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1527921|NCT00613821|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1527922|NCT00613808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527923|NCT00613795|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1527924|NCT00613782|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1527925|NCT00613769|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1527926|NCT00613756|||Cohort||Prospective|||||||
1527927|NCT00613743|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1527928|NCT00613730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527929|NCT00613717|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1527930|NCT00613691||Single Group Assignment||Treatment||None (Open Label)||||||
1527931|NCT00613678|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1527932|NCT00613665|Randomized|Parallel Assignment||Prevention||Single|||t|||
1527933|NCT00613652|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527934|NCT00613626|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1527935|NCT00613613|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1527936|NCT00613600|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527937|NCT00613587|||||Prospective|||||||
1527938|NCT00613574|||Cohort||Prospective|||||||
1527939|NCT00613561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527940|NCT00613548|Randomized|Parallel Assignment||Treatment||Single||||||t
1527941|NCT00613535|Randomized|Parallel Assignment||Treatment||Single|||t|||
1527942|NCT00613522|||Case Control||Prospective|||||||
1527943|NCT00613509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527944|NCT00613496|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1527945|NCT00613470||Single Group Assignment||Basic Science||None (Open Label)||||||
1527946|NCT00613457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527947|NCT00613444||Single Group Assignment||Treatment||Single||||||t
1527948|NCT00613431|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527949|NCT00613418||Single Group Assignment||Treatment||None (Open Label)||||||
1527950|NCT00613405|Randomized|Parallel Assignment||||None (Open Label)||||||
1527951|NCT00613392|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527952|NCT00613379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527953|NCT00613366|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1527954|NCT00613353|||Case-Only||Prospective|||||||
1527955|NCT00613340|Randomized|Parallel Assignment||Treatment||Single||||||t
1527956|NCT00613327||Single Group Assignment||Treatment||None (Open Label)||||||
1527957|NCT00613314|||Cohort||Prospective|||||||
1527958|NCT00613301|||Cohort||Prospective|||||||
1527959|NCT00613288|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1527960|NCT00613275|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1527961|NCT00613262||Single Group Assignment||Prevention||Single|||||t|
1527962|NCT00613249|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1527963|NCT00613223||Single Group Assignment||Treatment||None (Open Label)||||||
1527964|NCT00613210|||Case Control||Prospective|||||||
1527965|NCT00613197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527966|NCT00613184|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1527967|NCT00613171||Single Group Assignment||Treatment||None (Open Label)||||||
1527968|NCT00613158|||Case Control||Cross-Sectional|||||||
1527969|NCT00613145|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527970|NCT00613132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527971|NCT00613119|||||Prospective|||||||
1527972|NCT00613106|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1527973|NCT00613093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527974|NCT00613080||Single Group Assignment||Treatment||None (Open Label)||||||
1527975|NCT00613067||Single Group Assignment||Treatment||None (Open Label)||||||
1527976|NCT00613054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527977|NCT00613041|||Cohort||Prospective|||||||
1527978|NCT00613028|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527979|NCT00613015|Randomized|Parallel Assignment||Other||Double|||t||t|
1527980|NCT00613002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527981|NCT00612989|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1527982|NCT00612976|||Cohort||Prospective|||||||
1527983|NCT00612963|||Case-Only||Prospective|||||||
1527984|NCT00612950|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1527985|NCT00612937|||||Prospective|||||||
1527986|NCT00612924||Single Group Assignment||Treatment||None (Open Label)||||||
1527987|NCT00612911|||Case-Only||Prospective|||||||
1527988|NCT00612898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1527989|NCT00612885||||||||||||
1527990|NCT00612872|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1527991|NCT00612859|Randomized|Parallel Assignment||Treatment||Double||||||
1527992|NCT00612846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1527993|NCT00612833|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1527994|NCT00612820|Randomized|Crossover Assignment||Treatment||Double||||||
1527995|NCT00612807|Randomized|Parallel Assignment||Treatment||Single||||||t
1527996|NCT00612794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527997|NCT00612781|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1527998|NCT00612768||Single Group Assignment||Diagnostic||None (Open Label)||||||
1527999|NCT00612755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528000|NCT00612742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528001|NCT00612729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528002|NCT00612716||Single Group Assignment||Treatment||None (Open Label)||||||
1528003|NCT00612703|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528004|NCT00612690|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1528005|NCT00612677||Single Group Assignment||Treatment||None (Open Label)||||||
1528006|NCT00612664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528007|NCT00612651|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528008|NCT00612638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528009|NCT00612625|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1528010|NCT00612612||Single Group Assignment||Treatment||None (Open Label)||||||
1528011|NCT00612599|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528012|NCT00612586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528013|NCT00612573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528014|NCT00612560|Randomized|Factorial Assignment||Basic Science||Quadruple|||t|t|t|t
1528015|NCT00612547|||Cohort||Prospective|||||||
1528016|NCT00612534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528017|NCT00612521|Non-Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528018|NCT00612508|Randomized|Parallel Assignment||||None (Open Label)||||||
1528019|NCT00612495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528020|NCT00612482|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1528021|NCT00612469|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1528022|NCT00612456|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528023|NCT00612443|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1528024|NCT00612430||Single Group Assignment||Treatment||None (Open Label)||||||
1528025|NCT00612417|Randomized|Parallel Assignment||||Double|||t||t|
1528026|NCT00612404|||Cohort||Prospective|||||||
1528027|NCT00612391|Randomized|Parallel Assignment||Treatment||Single||||||t
1528028|NCT00612378||Single Group Assignment||Treatment||None (Open Label)||||||
1528029|NCT00612365|||Cohort||Retrospective|||||||
1528030|NCT00612352|Non-Randomized|Parallel Assignment||||Double|||t|||t
1528031|NCT00612339||Single Group Assignment||Treatment||None (Open Label)||||||
1528032|NCT00612326|||Cohort||Prospective|||||||
1528033|NCT00612313|Randomized|Parallel Assignment||Treatment||Single||||||t
1528034|NCT00612300|Randomized|Crossover Assignment||Treatment||Single||||||t
1528035|NCT00612287||Single Group Assignment||Treatment||None (Open Label)||||||
1528036|NCT00612274||Single Group Assignment||Treatment||None (Open Label)||||||
1528037|NCT00612261|Randomized|Parallel Assignment||Treatment||Single||||||t
1528038|NCT00612248|Randomized|Parallel Assignment||Treatment||Single||||||t
1528039|NCT00612235|||Cohort||Prospective|||||||
1528040|NCT00612222||Single Group Assignment||Treatment||None (Open Label)||||||
1528041|NCT00612209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528042|NCT00612196|Randomized|Parallel Assignment||||Double|||t||t|
1528043|NCT00612183||Single Group Assignment||Treatment||None (Open Label)||||||
1528044|NCT00612170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528045|NCT00612157|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1528046|NCT00612144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528047|NCT00612131|||Cohort||Prospective|||||||
1528048|NCT00612118|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528049|NCT00612105|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528050|NCT00612092|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1528051|NCT00612079|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1528052|NCT00612066||Single Group Assignment||Treatment||None (Open Label)||||||
1528053|NCT00612053|||Cohort||Prospective|||||||
1528054|NCT00612040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528055|NCT00612027|||Cohort||Prospective|||||||
1528056|NCT00612014|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528057|NCT00612001||Single Group Assignment||Treatment||None (Open Label)||||||
1528058|NCT00611988|Randomized|Parallel Assignment||Treatment||Single||||||t
1528059|NCT00611975|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1528060|NCT00611962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528061|NCT00611949|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528062|NCT00611936|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528063|NCT00611923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528064|NCT00611910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528065|NCT00611897|Randomized|Crossover Assignment||||Triple|||t||t|t
1528066|NCT00611884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528067|NCT00611871|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528068|NCT00611858||Single Group Assignment||Treatment||None (Open Label)||||||
1528069|NCT00611845||||||||||||
1528070|NCT00611832|Randomized|Parallel Assignment||Prevention||Single||||||t
1528071|NCT00611819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528072|NCT00611806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528073|NCT00611793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528074|NCT00611780|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1528075|NCT00611767|Randomized|Crossover Assignment||Health Services Research||Double|||t|||t
1528076|NCT00611754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528077|NCT00611741||Single Group Assignment||||None (Open Label)||||||
1528078|NCT00611728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528079|NCT00611715|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528080|NCT00611702|||Cohort||Prospective|||||||
1528081|NCT00611689||Single Group Assignment||Treatment||None (Open Label)||||||
1528082|NCT00611676|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1528083|NCT00611663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528084|NCT00611650|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1528085|NCT00611637||Single Group Assignment||||None (Open Label)||||||
1528086|NCT00611624||Single Group Assignment||Treatment||None (Open Label)||||||
1528087|NCT00611611|||Case Control||Prospective|||||||
1528088|NCT00611598|||Cohort||Prospective|||||||
1528089|NCT00611585||Single Group Assignment||Treatment||None (Open Label)||||||
1528090|NCT00611572|Randomized|Single Group Assignment||Other||Triple|||t||t|t
1528091|NCT00611559|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528092|NCT00611546|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528093|NCT00611533|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1528094|NCT00611520|||Cohort||Prospective|||||||
1528095|NCT00611507||Single Group Assignment||Treatment||None (Open Label)||||||
1528096|NCT00611494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528097|NCT00611481|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1528098|NCT00611468||Single Group Assignment||Treatment||None (Open Label)||||||
1528099|NCT00611455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528100|NCT00611442|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1528101|NCT00611429|Randomized|Factorial Assignment||Health Services Research||Single||||||t
1528102|NCT00611416|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1528103|NCT00611403|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528104|NCT00611390|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528105|NCT00611377|||Cohort||Prospective|||||||
1528106|NCT00611364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528107|NCT00611351||Single Group Assignment||Treatment||None (Open Label)||||||
1528108|NCT00611338|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528109|NCT00611325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528110|NCT00611312|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1528111|NCT00611299|Randomized|Parallel Assignment||||Double||||||
1528112|NCT00611286|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1528113|NCT00611273||Single Group Assignment||Treatment||None (Open Label)||||||
1528114|NCT00611260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528115|NCT00611247|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528116|NCT00611221|Randomized|Parallel Assignment||Treatment||Single|||t|||
1528117|NCT00611208||Single Group Assignment||Treatment||None (Open Label)||||||
1528118|NCT00611195||Single Group Assignment||Prevention||None (Open Label)||||||
1528119|NCT00611182|||Cohort||Prospective|||||||
1528120|NCT00611169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528121|NCT00611156|Randomized|Crossover Assignment||Prevention||Single|||||t|
1528122|NCT00611143|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528123|NCT00611130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528124|NCT00611117|Randomized|Crossover Assignment||Basic Science||Single||||t||
1528125|NCT00611104|||Case-Control||Prospective|||||||
1528126|NCT00611091|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1528127|NCT00611078|||Case Control||Prospective|||||||
1528128|NCT00611065||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528129|NCT00611052|Non-Randomized|Parallel Assignment||Prevention||Single|||||t|
1528130|NCT00611039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528131|NCT00611026|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528132|NCT00611013||Single Group Assignment||Basic Science||None (Open Label)||||||
1528133|NCT00611000||||Prevention||Single||||||
1528134|NCT00610987|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528135|NCT00610974|Randomized|Parallel Assignment||Treatment||Single||||t||
1528136|NCT00610961|||Case Control|||||||||
1528137|NCT00610948|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528138|NCT00610935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528139|NCT00610922|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1528140|NCT00610909|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528141|NCT00610896|||Cohort||Prospective|||||||
1528142|NCT00610883||Single Group Assignment||Treatment||None (Open Label)||||||
1528143|NCT00610870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528144|NCT00610857||Single Group Assignment||Other||None (Open Label)||||||
1528145|NCT00610844||Single Group Assignment||Treatment||None (Open Label)||||||
1528146|NCT00610831||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528147|NCT00610818|||||Prospective|||||||
1528148|NCT00610805|Randomized|Parallel Assignment||Prevention||Single|||||t|
1528149|NCT00610792|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528150|NCT00610779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528151|NCT00610766|||Case-Only||Prospective|||||||
1528152|NCT00610753|Randomized|Parallel Assignment||Treatment||Single||||||t
1528153|NCT00610740||Single Group Assignment||Treatment||None (Open Label)||||||
1528154|NCT00610727|Randomized|Parallel Assignment||Treatment||Quadruple|Stage 2 was a double-blind, placebo-controlled, 4 step dose-escalation trial|Stage 1: open-label, single-dose stage with 3 treatment periods divided into 2 phases Stage 2: double-blind, placebo-controlled, dose-escalation treatment period|t|t|t|t
1528155|NCT00610714|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528156|NCT00610701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528157|NCT00610688|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1528158|NCT00610675||Single Group Assignment||Treatment||None (Open Label)||||||
1528159|NCT00610662||||||||||||
1528160|NCT00610649|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528161|NCT00610636|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1528162|NCT00610623|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528163|NCT00610610|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528164|NCT00610597|||Case Control||Prospective|||||||
1528165|NCT00610584|Randomized|Parallel Assignment||Treatment||Single|||t|||
1528166|NCT00610571||Single Group Assignment||Treatment||None (Open Label)||||||
1528167|NCT00610558||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528168|NCT00610545|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528169|NCT00610532|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1528170|NCT00610519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528171|NCT00610506||Single Group Assignment||Treatment||Single||||||t
1528172|NCT00610493||Single Group Assignment||Treatment||None (Open Label)||||||
1528173|NCT00610480|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528174|NCT00610467||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528175|NCT00610454|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528176|NCT00610441|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528177|NCT00610428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528178|NCT00610415|||Cohort||Prospective|||||||
1528179|NCT00610402|||Case-Only||Prospective|||||||
1528180|NCT00610389|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528181|NCT00610376|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528182|NCT00610363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528183|NCT00610350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528184|NCT00610337|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528185|NCT00610324|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528186|NCT00610311||Single Group Assignment||Treatment||None (Open Label)||||||
1528187|NCT00610298|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528188|NCT00610285|||Cohort||Prospective|||||||
1528189|NCT00610272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528190|NCT00610259|Randomized|Parallel Assignment||Treatment||Single||||||t
1528191|NCT00610246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528192|NCT00610233|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1528193|NCT00610220|Randomized|Parallel Assignment||Treatment||Single||||||t
1528194|NCT00610207||Single Group Assignment||Treatment||None (Open Label)||||||
1528195|NCT00610194||Single Group Assignment||Treatment||None (Open Label)||||||
1528196|NCT00610181|||Case-Only||Prospective|||||||
1528197|NCT00610168|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528198|NCT00610155|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1528199|NCT00610142|Randomized|Parallel Assignment||Treatment||Single|||||t|
1528200|NCT00610129||Single Group Assignment||Treatment||None (Open Label)||||||
1528201|NCT00610116||Single Group Assignment||Treatment||None (Open Label)||||||
1528202|NCT00610103|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528203|NCT00610090||Single Group Assignment||Treatment||None (Open Label)||||||
1528204|NCT00610077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528205|NCT00610064|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1528206|NCT00610051|Randomized|Single Group Assignment||Treatment||Single|The party or parties involved in the study trials who are prevented from having knowledge of the interventions assigned to individual participants||||t|
1528207|NCT00610038||Single Group Assignment||Treatment||None (Open Label)||||||
1528208|NCT00610025|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1528209|NCT00610012|||Cohort||Prospective|||||||
1528210|NCT00609999|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528211|NCT00609986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528212|NCT00609973|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1528213|NCT00609960|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1528214|NCT00609947||Single Group Assignment||Treatment||None (Open Label)||||||
1528215|NCT00609934||Single Group Assignment||||None (Open Label)||||||
1528216|NCT00609921||Single Group Assignment||Treatment||None (Open Label)||||||
1528217|NCT00609908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528218|NCT00609895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528219|NCT00609882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528220|NCT00609869||Single Group Assignment||Treatment||None (Open Label)||||||
1528221|NCT00609856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528222|NCT00609843||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528223|NCT00609830|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1528224|NCT00609817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528225|NCT00609804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528226|NCT00609791||Single Group Assignment||Treatment||None (Open Label)||||||
1528227|NCT00609778|Randomized|Parallel Assignment||Treatment||Single|||t|||
1528228|NCT00609765||Single Group Assignment||Treatment||None (Open Label)||||||
1528229|NCT00609752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528230|NCT00609739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528231|NCT00609726|||Case Control||Prospective|||||||
1528232|NCT00609713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528233|NCT00609700|||Cohort|||||||||
1528234|NCT00609687||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528235|NCT00609674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528236|NCT00609661|||Case Control||Prospective|||||||
1528237|NCT00609648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528238|NCT00609635|||Cohort||Prospective|||||||
1528239|NCT00609622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528240|NCT00609609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528241|NCT00609596|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528242|NCT00609570|Randomized|Factorial Assignment||Treatment||Single|||||t|
1528243|NCT00609557|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1528244|NCT00609544|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528245|NCT00609531|Randomized|Parallel Assignment||||Triple|||t|t|t|
1528246|NCT00609518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528247|NCT00609505|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1528248|NCT00609492|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528249|NCT00609479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528250|NCT00609466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528251|NCT00609453|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1528252|NCT00609440||Single Group Assignment||Treatment||None (Open Label)||||||
1528253|NCT00609427|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1528254|NCT00609414|||||Prospective|||||||
1528255|NCT00609401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529100|NCT00597961|||Case-Only||Prospective|||||||
1528256|NCT00609388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528257|NCT00609375|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528258|NCT00609362|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1528259|NCT00609349||Single Group Assignment||Screening||None (Open Label)||||||
1528260|NCT00609336||Single Group Assignment||Treatment||None (Open Label)||||||
1528261|NCT00609323|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1528262|NCT00609310|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1528263|NCT00609297|||Cohort||Prospective|||||||
1528264|NCT00609284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528265|NCT00609271|Randomized|Parallel Assignment||Prevention||Single||||||t
1528266|NCT00609245||Single Group Assignment||Treatment||None (Open Label)||||||
1528267|NCT00609219||Single Group Assignment||Treatment||None (Open Label)||||||
1528268|NCT00609193|||Cohort||Prospective|||||||
1528269|NCT00609180|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1528270|NCT00609167||Single Group Assignment||Treatment||None (Open Label)||||||
1528271|NCT00609154|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1528272|NCT00609141||Single Group Assignment||Treatment||None (Open Label)||||||
1528273|NCT00609128||Single Group Assignment||Basic Science||None (Open Label)||||||
1528274|NCT00609115|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1528275|NCT00609102|Randomized|Single Group Assignment||Treatment||Single|||t|||
1528276|NCT00609089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528277|NCT00609063|Randomized|Parallel Assignment||||Double|||t||t|
1528278|NCT00609050|Randomized|Crossover Assignment||Treatment||Single||||||t
1528279|NCT00609037|||Case Control||Prospective|||||||
1528280|NCT00609011|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528281|NCT00608998|||Case-Only||Cross-Sectional|||||||
1528282|NCT00608985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528283|NCT00608972||Single Group Assignment||Treatment||None (Open Label)||||||
1528284|NCT00608959|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528285|NCT00608946|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528286|NCT00608933|Randomized|Single Group Assignment||Other||Single|||t|||
1528287|NCT00608920||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528288|NCT00608907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528289|NCT00608894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528290|NCT00608881|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528291|NCT00608868|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528292|NCT00608855||||Treatment||None (Open Label)||||||
1528293|NCT00608842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528294|NCT00608829||Single Group Assignment||Treatment||None (Open Label)||||||
1528295|NCT00608816|Randomized|Crossover Assignment||||Single|||t|||
1528296|NCT00608803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528297|NCT00608790|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1528298|NCT00608777||Single Group Assignment||Treatment||None (Open Label)||||||
1528299|NCT00608764|||Cohort||Cross-Sectional|||||||
1528300|NCT00608751||Single Group Assignment||Treatment||None (Open Label)||||||
1528301|NCT00608738||||Health Services Research||None (Open Label)||||||
1528302|NCT00608725|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1528303|NCT00608712|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1528304|NCT00608699|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1528305|NCT00608686|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1528306|NCT00608673|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1528307|NCT00608660|Randomized|Parallel Assignment||Treatment||Single||||||t
1528308|NCT00608647||||||||||||
1528309|NCT00608634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528310|NCT00608621|||||Prospective|||||||
1528311|NCT00608595||Single Group Assignment||Treatment||None (Open Label)||||||
1528312|NCT00608582|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1528313|NCT00608569|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528314|NCT00608556|||||Prospective|||||||
1528315|NCT00608543||Single Group Assignment||Treatment||None (Open Label)||||||
1528316|NCT00608530|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528317|NCT00608517|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528318|NCT00608504|||Case-Only||Prospective|||||||
1528319|NCT00608491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528320|NCT00608465|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1528321|NCT00608452|||Case-Only||Prospective|||||||
1528322|NCT00608439|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1528323|NCT00608426|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1528324|NCT00608400|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1528325|NCT00608387|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1528326|NCT00608374|Randomized|||Treatment||None (Open Label)||||||
1528327|NCT00608361||Single Group Assignment||Treatment||None (Open Label)||||||
1528328|NCT00608348|Randomized|Factorial Assignment||||None (Open Label)||||||
1528329|NCT00608335|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1528330|NCT00608322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528331|NCT00608296|||Cohort||Prospective|||||||
1528332|NCT00608283|||Cohort||Retrospective|||||||
1528333|NCT00608244||Single Group Assignment||Treatment||None (Open Label)||||||
1528334|NCT00608231|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528335|NCT00608218|||Case-Only||Prospective|||||||
1528336|NCT00608205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528337|NCT00608192|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1528338|NCT00608179|Randomized|Factorial Assignment||||Single|||t|||
1528339|NCT00608153|||Cohort||Prospective|||||||
1528340|NCT00608140|Randomized|Parallel Assignment||Treatment||Single||||||t
1528341|NCT00608127||Single Group Assignment||Treatment||None (Open Label)||||||
1528342|NCT00608101|Randomized|Factorial Assignment||||Single|||t|||
1528343|NCT00608088|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1528344|NCT00608075|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1528345|NCT00608062|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1528346|NCT00608049|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1528347|NCT00608036|||Ecologic or Community||Prospective|||||||
1528348|NCT00608023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528349|NCT00608010|Randomized|Parallel Assignment||Treatment||Single||||||t
1528350|NCT00607997||Single Group Assignment||Treatment||None (Open Label)||||||
1528351|NCT00607984||Single Group Assignment||Treatment||None (Open Label)||||||
1528352|NCT00607971||Single Group Assignment||||None (Open Label)||||||
1528353|NCT00607958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528354|NCT00607945|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528355|NCT00607932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528356|NCT00607919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528357|NCT00607906|Randomized|Parallel Assignment||Treatment||||||||
1528358|NCT00607893|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1528359|NCT00607880|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1528360|NCT00607867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528361|NCT00607854||Single Group Assignment||Treatment||None (Open Label)||||||
1528362|NCT00607841|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528363|NCT00607828||Single Group Assignment||Treatment||None (Open Label)||||||
1528364|NCT00607815|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1528365|NCT00607802||||Treatment||||||||
1528366|NCT00607789|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528367|NCT00607776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528368|NCT00607763|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1528369|NCT00607750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528370|NCT00607737|Randomized|Factorial Assignment||Diagnostic||Quadruple|||t|t|t|t
1528371|NCT00607724|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528372|NCT00607711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528373|NCT00607685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528374|NCT00607672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528375|NCT00607659|||Case Control||Prospective|||||||
1528376|NCT00607646|Randomized|Crossover Assignment||Other||Single|||t|||
1528377|NCT00607633|||Cohort||Prospective|||||||
1528378|NCT00607620|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1528379|NCT00607607|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528380|NCT00607594||Single Group Assignment||Treatment||None (Open Label)||||||
1528381|NCT00607581||Single Group Assignment||Treatment||None (Open Label)||||||
1528382|NCT00607568|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528383|NCT00607555|||Case-Crossover||Prospective|||||||
1528384|NCT00607542||Single Group Assignment||Treatment||None (Open Label)||||||
1528385|NCT00607529|||Cohort||Prospective|||||||
1528386|NCT00607516|Randomized|Parallel Assignment||Treatment||Single||||||t
1528387|NCT00607503||Single Group Assignment||Prevention||None (Open Label)||||||
1528388|NCT00607490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528389|NCT00607477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528390|NCT00607464|Randomized|Parallel Assignment||Treatment||Single||||||t
1528391|NCT00607451|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528392|NCT00607438|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528393|NCT00607425|||Case Control|||||||||
1528394|NCT00607412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528395|NCT00607399||Single Group Assignment||Treatment||None (Open Label)||||||
1528396|NCT00607386||Single Group Assignment||Treatment||None (Open Label)||||||
1528397|NCT00607373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528398|NCT00607360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528399|NCT00607347||Single Group Assignment||Prevention||None (Open Label)||||||
1528400|NCT00607334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528401|NCT00607321||Single Group Assignment||Treatment||None (Open Label)||||||
1528402|NCT00607308|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528403|NCT00607295|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1528404|NCT00607282|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528405|NCT00607269|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528406|NCT00607256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528407|NCT00607243|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528408|NCT00607230|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1528409|NCT00607217|Randomized|Parallel Assignment||Prevention||Single|||t|||
1528412|NCT00607178|Randomized|Parallel Assignment||Prevention||Single|||t|||
1528413|NCT00607152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528414|NCT00607139|||Cohort||Prospective|||||||
1528415|NCT00607126|Randomized|Parallel Assignment||Treatment||Single||||||t
1528416|NCT00607113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528417|NCT00607100|||Cohort||Prospective|||||||
1528418|NCT00607087|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528419|NCT00607074|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1528420|NCT00607061|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1528421|NCT00607048|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528422|NCT00607035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528423|NCT00607022|Non-Randomized|Parallel Assignment||Health Services Research||Double||This is a phase IV Post-Market evaluation of three 510K cleared implant products. One type of dental implant was used but clinically loaded with a dental crown at one of three time points, immediate at implant placement, at 6weeks or 12 weeks following implant placement. There are therefore 3 interventions being evaluated.|t|||t
1528424|NCT00607009|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528425|NCT00606996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528426|NCT00606983|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528427|NCT00606970|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1528428|NCT00606957||Single Group Assignment||Treatment||None (Open Label)||||||
1528429|NCT00606944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528430|NCT00606931||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528431|NCT00606918|||Case Control||Cross-Sectional|||||||
1528432|NCT00606905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528433|NCT00606892|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528434|NCT00606879||Single Group Assignment||Treatment||None (Open Label)||||||
1528435|NCT00606866|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528436|NCT00606853|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1528437|NCT00606840|Randomized|Parallel Assignment||Prevention||Single||||||t
1528438|NCT00606827|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1528439|NCT00606814|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528440|NCT00606801|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528441|NCT00606788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528442|NCT00606775|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528443|NCT00606762|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t||t
1528444|NCT00606749||Single Group Assignment||Treatment||None (Open Label)||||||
1528445|NCT00606736|||Case Control||Prospective|||||||
1528446|NCT00606723||Single Group Assignment||Treatment||None (Open Label)||||||
1528447|NCT00606710|||Cohort||Prospective|||||||
1528448|NCT00606697|Randomized|Crossover Assignment||Treatment||||||||
1528449|NCT00606684|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528450|NCT00606671|||Case Control||Cross-Sectional|||||||
1528451|NCT00606658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528452|NCT00606645||Single Group Assignment||Treatment||None (Open Label)||||||
1528453|NCT00606632||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528454|NCT00606619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528455|NCT00606606|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1528456|NCT00606593|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1528457|NCT00606580|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528458|NCT00606567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528459|NCT00606554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528460|NCT00606541|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528461|NCT00606528|||Cohort||Prospective|||||||
1528462|NCT00606515|Randomized|Parallel Assignment||||None (Open Label)||||||
1528463|NCT00606502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528464|NCT00606489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528465|NCT00606476|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1528466|NCT00606463||Single Group Assignment||Treatment||None (Open Label)||||||
1528467|NCT00606450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528468|NCT00606437||Single Group Assignment||Treatment||None (Open Label)||||||
1528469|NCT00606424|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1528470|NCT00606411|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528471|NCT00606398|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528472|NCT00606385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528473|NCT00606372|||Cohort||Prospective|||||||
1528474|NCT00606359|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528475|NCT00606346|||Cohort||Prospective|||||||
1528476|NCT00606333|Randomized|Parallel Assignment||Treatment||Single|||t|||
1528477|NCT00606320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528478|NCT00606307||Single Group Assignment||Treatment||None (Open Label)||||||
1528479|NCT00606294|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1528480|NCT00606281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528481|NCT00606268|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528482|NCT00606255|||Case Control||Prospective|||||||
1528483|NCT00606242|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1528484|NCT00606229|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528485|NCT00606216|||Cohort||Prospective|||||||
1528486|NCT00606203|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1528487|NCT00606190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528488|NCT00606177|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528489|NCT00606164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528490|NCT00606151|||Case Control||Prospective|||||||
1528491|NCT00606138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528492|NCT00606125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528493|NCT00606112|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1528494|NCT00606099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528495|NCT00606086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528496|NCT00606073||Parallel Assignment||Treatment||None (Open Label)||||||
1528497|NCT00606060|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528498|NCT00606047|||Cohort||Prospective|||||||
1528499|NCT00606034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528500|NCT00606021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528501|NCT00606008||Single Group Assignment||Treatment||None (Open Label)||||||
1528502|NCT00605995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528503|NCT00605982||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528504|NCT00605969|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1528505|NCT00605956|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1528506|NCT00605943|||||Prospective|||||||
1528507|NCT00605930|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528508|NCT00605917|||Case-Only||Prospective|||||||
1528509|NCT00605904|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528510|NCT00605891|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528511|NCT00605878|||Cohort||Prospective|||||||
1528512|NCT00605865|||Case-Only||Prospective|||||||
1528513|NCT00605852|Randomized|Crossover Assignment||Treatment||||||||
1528514|NCT00605839|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1528515|NCT00605826|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1528516|NCT00605813|||Case-Only||Prospective|||||||
1528517|NCT00605800|||Case Control||Prospective|||||||
1528518|NCT00605787||Single Group Assignment||Treatment||None (Open Label)||||||
1528519|NCT00605774|Randomized|Crossover Assignment||||None (Open Label)||||||
1528520|NCT00605761|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1528521|NCT00605748|Randomized|Parallel Assignment||Treatment||Single|||t|||
1528522|NCT00605735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528523|NCT00605722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528524|NCT00605709|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528525|NCT00605696|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528526|NCT00605683|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528527|NCT00605670|||Cohort||Prospective|||||||
1528528|NCT00605657||Single Group Assignment||Treatment||None (Open Label)||||||
1528529|NCT00605644|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528530|NCT00605631|Randomized|Parallel Assignment||Treatment||Single||||||t
1528531|NCT00605618|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528532|NCT00605605|Randomized|Parallel Assignment||Treatment||Single||||||t
1528533|NCT00605592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528534|NCT00605566||Single Group Assignment||Supportive Care||None (Open Label)||||||
1528535|NCT00605553|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1528536|NCT00605540|||Cohort||Prospective|||||||
1528537|NCT00605527|||Cohort||Prospective|||||||
1528538|NCT00605514|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528539|NCT00605488||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528540|NCT00605475|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528541|NCT00605449|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528542|NCT00605436|Randomized|Parallel Assignment||Treatment||Single||||||t
1528543|NCT00605423|Randomized|Parallel Assignment||Treatment||Single|||t|||
1528544|NCT00605410|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1528545|NCT00605397|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1528546|NCT00605384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528547|NCT00605371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528548|NCT00605358|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1528549|NCT00605345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528550|NCT00605332|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1528551|NCT00605319||Single Group Assignment||Treatment||None (Open Label)||||||
1528552|NCT00605306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528553|NCT00605293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528554|NCT00605280|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528555|NCT00605267|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528556|NCT00605254|||Case-Crossover||Prospective|||||||
1528557|NCT00605241|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528558|NCT00605228|Randomized|Parallel Assignment||Treatment||Single|||||t|
1528559|NCT00605215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529556|NCT00591903|||||Prospective|||||||
1528560|NCT00605202|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528561|NCT00605189|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1528562|NCT00605176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528563|NCT00605163|||Cohort|||||||||
1528564|NCT00605150|||Case-Only||Other|||||||
1528565|NCT00605137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528566|NCT00605124|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1528567|NCT00605111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528568|NCT00605098|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528569|NCT00605085|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1528570|NCT00605072|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528571|NCT00605059|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1528572|NCT00605046|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1528573|NCT00605033|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528574|NCT00605020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528575|NCT00605007|||||Retrospective|||||||
1528576|NCT00604994|||Case Control||Prospective|||||||
1528577|NCT00604981|Randomized|Parallel Assignment||Treatment||Single|||||t|
1528578|NCT00604968|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528579|NCT00604955||Single Group Assignment||Treatment||None (Open Label)||||||
1528580|NCT00604942|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1528581|NCT00604929|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1528582|NCT00604916|Randomized|Parallel Assignment||Prevention||Single|||||t|
1528583|NCT00604903||Single Group Assignment||Device Feasibility||None (Open Label)|No masking|||||
1528584|NCT00604890|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528585|NCT00604877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528586|NCT00604864|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528587|NCT00604838||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528588|NCT00604825|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528589|NCT00604812|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528590|NCT00604799|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528591|NCT00604786|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1528592|NCT00604773|||Cohort||Prospective|||||||
1528593|NCT00604760|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528594|NCT00604747||Single Group Assignment||Treatment||None (Open Label)||||||
1528595|NCT00604734||Single Group Assignment||Treatment||None (Open Label)||||||
1528596|NCT00604721||Single Group Assignment||Treatment||None (Open Label)||||||
1528597|NCT00604708|Randomized|Parallel Assignment||Prevention||Single|||t|||
1528598|NCT00604695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528599|NCT00604682||Single Group Assignment||Treatment||None (Open Label)||||||
1528600|NCT00604669|||||Retrospective|||||||
1528601|NCT00604656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528602|NCT00604643||||||||||||
1528603|NCT00604630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528604|NCT00604617|||Ecologic or Community||Prospective|||||||
1528605|NCT00604604|Randomized|Parallel Assignment||Prevention||Single|||||t|
1528606|NCT00604591|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1528607|NCT00604578|Randomized|Parallel Assignment||Treatment||Double||||||
1528608|NCT00604565|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1528609|NCT00604552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528610|NCT00604539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528611|NCT00604526||Single Group Assignment||Treatment||None (Open Label)||||||
1528612|NCT00604513|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528613|NCT00604500||Single Group Assignment||Treatment||None (Open Label)||||||
1528614|NCT00604487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528615|NCT00604474||Single Group Assignment||Treatment||None (Open Label)||||||
1528616|NCT00604461||Single Group Assignment||Treatment||None (Open Label)||||||
1528617|NCT00604448|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528618|NCT00604435|Randomized|Parallel Assignment||Treatment||Single|||t|||
1528619|NCT00604422|||Cohort||Prospective|||||||
1528620|NCT00604409||Single Group Assignment||Treatment||None (Open Label)||||||
1528621|NCT00604396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528622|NCT00604383|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528623|NCT00604370|||Case Control||Retrospective|||||||
1528624|NCT00604357|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528625|NCT00604344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528626|NCT00604331||Single Group Assignment||Treatment||None (Open Label)||||||
1528627|NCT00604318|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1528628|NCT00604305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528629|NCT00604292|||Cohort||Prospective|||||||
1528630|NCT00604279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528631|NCT00604266|||Case-Only||Prospective|||||||
1528632|NCT00604253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528633|NCT00604240|||Cohort||Prospective|||||||
1528634|NCT00604227||Single Group Assignment||||None (Open Label)||||||
1528635|NCT00604214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528636|NCT00604201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528637|NCT00604188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528638|NCT00604175|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528639|NCT00604162|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1528640|NCT00604149|||Case Control||Prospective|||||||
1528641|NCT00604136||Single Group Assignment||Treatment||None (Open Label)||||||
1528642|NCT00604123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528643|NCT00604110|Randomized|Crossover Assignment||Treatment||Single|||t|||
1528644|NCT00604097|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1528645|NCT00604084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528646|NCT00604071|||Cohort||Prospective|||||||
1528647|NCT00604058|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528648|NCT00604045|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1528649|NCT00604032|Randomized|Single Group Assignment||||Single||||||t
1528650|NCT00604019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528651|NCT00604006|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1528652|NCT00603993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528653|NCT00603980|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1528654|NCT00603967||Single Group Assignment||Supportive Care||None (Open Label)||||||
1528655|NCT00603954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528656|NCT00603941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528657|NCT00603928|||Case-Only||Prospective|||||||
1528658|NCT00603915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528659|NCT00603902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528660|NCT00603889||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528661|NCT00603876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528662|NCT00603863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528663|NCT00603850|||Cohort||Prospective|||||||
1528664|NCT00603837|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1528665|NCT00603824|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528666|NCT00603811|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528667|NCT00603798|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528668|NCT00603785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528669|NCT00603772|Randomized|Single Group Assignment||||Single||||||t
1528670|NCT00603759|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1528671|NCT00603746|Randomized|Parallel Assignment||Treatment||||||||
1528672|NCT00603733|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528673|NCT00603720|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1528674|NCT00603707|||Case Control||Prospective|||||||
1528675|NCT00603694|||Case Control||Prospective|||||||
1528676|NCT00603681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528677|NCT00603668||Single Group Assignment||Treatment||None (Open Label)||||||
1528678|NCT00603655|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1528679|NCT00603642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528680|NCT00603629|||Case-Only||Prospective|||||||
1528681|NCT00603616|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1528682|NCT00603603|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528683|NCT00603590|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528684|NCT00603577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528685|NCT00603564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528686|NCT00603551|||Case-Only||Cross-Sectional|||||||
1528687|NCT00603538|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528688|NCT00603525|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528689|NCT00603512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528690|NCT00603499|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528691|NCT00603486|||Case-Only||Prospective|||||||
1528692|NCT00603473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528693|NCT00603460|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1528694|NCT00603447||Single Group Assignment||Treatment||None (Open Label)||||||
1528695|NCT00603434|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1528696|NCT00603421|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1528697|NCT00603408||Single Group Assignment||Treatment||None (Open Label)||||||
1528698|NCT00603395||Single Group Assignment||Treatment||None (Open Label)||||||
1528699|NCT00603382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528700|NCT00603369|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528701|NCT00603356|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528702|NCT00603343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528703|NCT00603330|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528704|NCT00603317|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1528705|NCT00603304|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528706|NCT00603291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528707|NCT00603278|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528708|NCT00603265|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528709|NCT00603252|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528710|NCT00603239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528711|NCT00603226|||Cohort||Prospective|||||||
1528712|NCT00603213|||Case-Only||Prospective|||||||
1528714|NCT00603187||Single Group Assignment||Treatment||None (Open Label)||||||
1528715|NCT00603174||Single Group Assignment||Treatment||None (Open Label)||||||
1528716|NCT00603148|||Cohort||Prospective|||||||
1528717|NCT00603135||Single Group Assignment||Treatment||None (Open Label)||||||
1528718|NCT00603122|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528719|NCT00603109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528720|NCT00603096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528721|NCT00603083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528722|NCT00603070|||Cohort||Prospective|||||||
1528723|NCT00603057|||Case-Only||Prospective|||||||
1528724|NCT00603044|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1528725|NCT00603031|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1528726|NCT00603018||Single Group Assignment||Basic Science||None (Open Label)||||||
1528727|NCT00603005|Randomized|Factorial Assignment||Supportive Care||Single||||t||
1528728|NCT00602992|||Cohort||Cross-Sectional|||||||
1528729|NCT00602979|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1528730|NCT00602966|||Case Control||Prospective|||||||
1528731|NCT00602953|||Other||Cross-Sectional|||||||
1528732|NCT00602940|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528733|NCT00602927|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1528734|NCT00602914|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1528735|NCT00602901|Randomized|Parallel Assignment||Treatment||Single||||||t
1528736|NCT00602862|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1528737|NCT00602849|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528738|NCT00602836||Single Group Assignment||Treatment||None (Open Label)||||||
1528739|NCT00602823||||||||||||
1528740|NCT00602797||Single Group Assignment||Treatment||None (Open Label)||||||
1528741|NCT00602784|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528742|NCT00602771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528743|NCT00602758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528744|NCT00602745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528745|NCT00602732|Randomized|Parallel Assignment||Prevention||Single||||||t
1528746|NCT00602719|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528747|NCT00602706||||Treatment||||||||
1528748|NCT00602693||Single Group Assignment||Treatment||None (Open Label)||||||
1528749|NCT00602680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528750|NCT00602667|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528751|NCT00602641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528752|NCT00602628||||Diagnostic||None (Open Label)||||||
1528753|NCT00602615|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528754|NCT00602602|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528755|NCT00602589|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528756|NCT00602576|Randomized|||Treatment||None (Open Label)||||||
1528757|NCT00602563|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1528758|NCT00602550|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528759|NCT00602537|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528760|NCT00602524|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528761|NCT00602511|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528762|NCT00602498|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528763|NCT00602485|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1528764|NCT00602472|Randomized|Parallel Assignment||Treatment||Double||||||
1528765|NCT00602459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528766|NCT00602446|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1528767|NCT00602433|||Case-Only||Prospective|||||||
1528768|NCT00602420|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1528769|NCT00602407|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528770|NCT00602394|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528771|NCT00602381|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528772|NCT00602368||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528773|NCT00602355|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528774|NCT00602342|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528775|NCT00602329|Randomized|||Diagnostic||||||||
1528776|NCT00602316||||Diagnostic||||||||
1528777|NCT00602303|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528778|NCT00602290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528779|NCT00602277||Single Group Assignment||Treatment||None (Open Label)||||||
1528780|NCT00602264|||Case Control||Prospective|||||||
1528781|NCT00602251|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528782|NCT00602225||Single Group Assignment||Treatment||None (Open Label)||||||
1528783|NCT00602212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528784|NCT00602199||||Treatment||None (Open Label)||||||
1528785|NCT00602186|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1528786|NCT00602173|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528787|NCT00602160|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1528788|NCT00602147|||Cohort||Prospective|||||||
1528789|NCT00602134|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528790|NCT00602108||||Treatment||None (Open Label)||||||
1529713|NCT00589810|||Case-Control||Retrospective|||||||
1528791|NCT00602095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528792|NCT00602082|Randomized|||Treatment||||||||
1528793|NCT00602069|Randomized|Parallel Assignment||Treatment||Single|||||t|
1528794|NCT00602056|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1528795|NCT00602043||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528796|NCT00602030|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528797|NCT00602017|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528798|NCT00602004|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528799|NCT00601991||||Treatment||None (Open Label)||||||
1528800|NCT00601978|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528801|NCT00601965|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528802|NCT00601952|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1528803|NCT00601939|Randomized|Parallel Assignment||Treatment||Single|||||t|
1528804|NCT00601926||Single Group Assignment||Treatment||None (Open Label)||||||
1528805|NCT00601913||Single Group Assignment||Treatment||None (Open Label)||||||
1528806|NCT00601900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528807|NCT00601887|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528808|NCT00601874|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528809|NCT00601861|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528810|NCT00601848||Single Group Assignment||Treatment||None (Open Label)||||||
1528811|NCT00601835|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528812|NCT00601822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528813|NCT00601809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528814|NCT00601796||Single Group Assignment||Treatment||None (Open Label)||||||
1528815|NCT00601770||Single Group Assignment||Treatment||None (Open Label)||||||
1528816|NCT00601757|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528817|NCT00601744|||Family-Based||Prospective|||||||
1528818|NCT00601731|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528819|NCT00601718||Single Group Assignment||Treatment||None (Open Label)||||||
1528820|NCT00601705||Single Group Assignment||Treatment||None (Open Label)||||||
1528821|NCT00601692|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528822|NCT00601679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528823|NCT00601666|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528824|NCT00601653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528825|NCT00601640|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528826|NCT00601627||Single Group Assignment||Treatment||None (Open Label)||||||
1528827|NCT00601614||||Treatment||||||||
1528828|NCT00601601||||||||||||
1528829|NCT00601588|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528830|NCT00601575|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528831|NCT00601562|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528832|NCT00601549|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1528833|NCT00601536|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528834|NCT00601523|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528835|NCT00601510||Single Group Assignment||Treatment||None (Open Label)||||||
1528836|NCT00601497|Randomized|Parallel Assignment||Treatment||Single|||t|||
1528837|NCT00601484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528838|NCT00601471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528839|NCT00601458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528840|NCT00601445|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1528841|NCT00601432|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528842|NCT00601419|||Case-Only||Prospective|||||||
1528843|NCT00601406||||Treatment||None (Open Label)||||||
1528844|NCT00601393|Randomized|Parallel Assignment||Treatment||Single||||||t
1528845|NCT00601367||Single Group Assignment||Treatment||None (Open Label)||||||
1528846|NCT00601354|Randomized|Parallel Assignment||Treatment||Single||||||t
1528847|NCT00601341|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528848|NCT00601328|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528849|NCT00601315|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528850|NCT00601302|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528851|NCT00601289||Single Group Assignment||Treatment||None (Open Label)||||||
1528852|NCT00601276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528853|NCT00601263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528854|NCT00601250|Randomized|Parallel Assignment||Treatment||Double||||||
1528855|NCT00601237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528856|NCT00601224|Randomized|Parallel Assignment||Treatment||Single||||||t
1528857|NCT00601211|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528858|NCT00601198|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528859|NCT00601185|||Cohort||Prospective|||||||
1528860|NCT00601172|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1528861|NCT00601159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528862|NCT00601146||Single Group Assignment||Screening||None (Open Label)||Single arm study of low-dose Chest CT screening for long-term Hodgkin lymphoma survivors||||
1528863|NCT00601133|||Case-Only||Prospective|||||||
1528864|NCT00601120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528865|NCT00601107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528866|NCT00601094||Single Group Assignment||Treatment||None (Open Label)||||||
1528867|NCT00601081|||Cohort||Prospective|||||||
1528868|NCT00601068|||Case-Only||Retrospective|||||||
1528869|NCT00601055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528870|NCT00601042|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1528871|NCT00601029|||Cohort||Prospective|||||||
1528872|NCT00601016||Single Group Assignment||Treatment||None (Open Label)||||||
1528873|NCT00601003||Single Group Assignment||Treatment||None (Open Label)||||||
1528874|NCT00600990|Randomized|Parallel Assignment||Prevention||Double||||||
1528875|NCT00600977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528876|NCT00600964|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528877|NCT00600951|||Cohort||Prospective|||||||
1528878|NCT00600938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528879|NCT00600925|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1528880|NCT00600912|Randomized|Parallel Assignment||Treatment||Double||||||
1528881|NCT00600899|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528882|NCT00600886|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528883|NCT00600873|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1528884|NCT00600860|||Cohort||Prospective|||||||
1528885|NCT00600847|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1528886|NCT00600834|||Cohort||Prospective|||||||
1528887|NCT00600821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528888|NCT00600808|Randomized|Parallel Assignment||Treatment||Single||||||
1528889|NCT00600795|||Case-Only||Prospective|||||||
1528890|NCT00600782|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1528891|NCT00600769||Single Group Assignment||Treatment||None (Open Label)||||||
1528892|NCT00600756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528893|NCT00600743|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1528894|NCT00600730|Randomized|Parallel Assignment||||None (Open Label)||||||
1528895|NCT00600717|||Other||Prospective|||||||
1528896|NCT00600704|Randomized|Parallel Assignment||Supportive Care||Double||||t|t|
1528897|NCT00600691|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1528898|NCT00600678||Single Group Assignment||Supportive Care||None (Open Label)||||||
1528899|NCT00600665|Randomized|Factorial Assignment||Supportive Care||Single|||||t|
1528900|NCT00600652|||||Prospective|||||||
1528901|NCT00600639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528902|NCT00600626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528903|NCT00600613||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528904|NCT00600600||Single Group Assignment||Treatment||None (Open Label)||||||
1528905|NCT00600587|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1528906|NCT00600574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528907|NCT00600561|Randomized|Parallel Assignment||Treatment||Single||||||t
1528908|NCT00600548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528909|NCT00600535|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528910|NCT00600522|||Cohort||Prospective|||||||
1528911|NCT00600509|Randomized|Parallel Assignment||Treatment||Double||||||
1528912|NCT00600496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528913|NCT00600483|Randomized|Parallel Assignment||Prevention||Single||||||t
1528914|NCT00600470|Randomized|Parallel Assignment||Treatment||Single||||||t
1528915|NCT00600457||||||||||||
1528916|NCT00600444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528917|NCT00600431|||Case Control||Prospective|||||||
1528918|NCT00600418|||Family-Based||Cross-Sectional|||||||
1528919|NCT00600405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528920|NCT00600392|||Cohort||Prospective|||||||
1528921|NCT00600379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528922|NCT00600366|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528923|NCT00600353||Single Group Assignment||Supportive Care||None (Open Label)||||||
1528924|NCT00600340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528925|NCT00600327|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528926|NCT00600314|||Cohort||Prospective|||||||
1528927|NCT00600301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528928|NCT00600288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528929|NCT00600275||Single Group Assignment||Treatment||None (Open Label)||||||
1528930|NCT00600262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528931|NCT00600249||Single Group Assignment||Treatment||None (Open Label)||||||
1528932|NCT00600236|Non-Randomized|Parallel Assignment||Prevention||Single||||||
1528933|NCT00600223|||Cohort||Prospective|||||||
1528934|NCT00600210||Single Group Assignment||Treatment||None (Open Label)||||||
1528935|NCT00600197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528936|NCT00600184||Single Group Assignment||Treatment||None (Open Label)||||||
1528937|NCT00600171|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528938|NCT00600158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528939|NCT00600145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528940|NCT00600119|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528941|NCT00600106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528942|NCT00600093||Single Group Assignment||Treatment||None (Open Label)||||||
1528943|NCT00600080|Randomized|Crossover Assignment||Treatment||Single|||t|||
1528944|NCT00600067|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528945|NCT00600054||Single Group Assignment||Treatment||None (Open Label)||||||
1528946|NCT00600041|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1528947|NCT00600028|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1528948|NCT00600015|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1528949|NCT00600002||Single Group Assignment||Treatment||None (Open Label)||||||
1528950|NCT00599989||||Treatment||None (Open Label)||||||
1528951|NCT00599976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528952|NCT00599963|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528953|NCT00599950|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1528954|NCT00599937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528955|NCT00599924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528956|NCT00599911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528957|NCT00599898|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1528958|NCT00599885|Randomized|Parallel Assignment||Treatment||Single|||t|||
1528959|NCT00599872|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528960|NCT00599859||Parallel Assignment||Basic Science||None (Open Label)||||||
1528961|NCT00599846|||Case-Only||Prospective|||||||
1528962|NCT00599833||||Treatment||None (Open Label)||||||
1528963|NCT00599820|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528964|NCT00599807|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528965|NCT00599794|||Cohort||Prospective|||||||
1528966|NCT00599781|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528967|NCT00599768|||Case-Only||Prospective|||||||
1528968|NCT00599755||Single Group Assignment||Diagnostic||None (Open Label)||||||
1528969|NCT00599742|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1528970|NCT00599729|||Cohort||Prospective|||||||
1528971|NCT00599716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528972|NCT00599703|||Cohort||Prospective|||||||
1528973|NCT00599690||Single Group Assignment||Screening||None (Open Label)||||||
1528974|NCT00599677|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528975|NCT00599664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528976|NCT00599651|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528977|NCT00599638|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1528978|NCT00599625||Single Group Assignment||Treatment||None (Open Label)||||||
1528979|NCT00599612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528980|NCT00599599|Randomized|Parallel Assignment||Treatment||Single||||||t
1528981|NCT00599586|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1528982|NCT00599573||Single Group Assignment||Treatment||None (Open Label)||||||
1528983|NCT00599560|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1528984|NCT00599547||Single Group Assignment||Treatment||None (Open Label)||||||
1528985|NCT00599534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528986|NCT00599521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1528987|NCT00599508|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1528988|NCT00599495||Single Group Assignment||Treatment||None (Open Label)||||||
1528989|NCT00599482|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1528990|NCT00599469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528991|NCT00599456|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528992|NCT00599443|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1528993|NCT00599430|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1528994|NCT00599417|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1528995|NCT00599404||Single Group Assignment||Basic Science||None (Open Label)||||||
1528996|NCT00599391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1528997|NCT00599378|Randomized|Parallel Assignment||Prevention||Single|||t|||
1528998|NCT00599365|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1528999|NCT00599352||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529000|NCT00599339|||Cohort||Prospective|||||||
1529001|NCT00599326||Single Group Assignment||Treatment||None (Open Label)||||||
1529002|NCT00599313||Single Group Assignment||Treatment||None (Open Label)||||||
1529003|NCT00599287|Randomized|Parallel Assignment||Treatment||Single|||||t|
1529004|NCT00599274|||Case-Only|||||||||
1529005|NCT00599261|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529006|NCT00599248|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529007|NCT00599235|Randomized|Crossover Assignment||||Double|||t||t|
1529008|NCT00599222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529009|NCT00599209|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1529010|NCT00599196||Single Group Assignment||Treatment||None (Open Label)||||||
1529011|NCT00599183|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1529012|NCT00599170||Single Group Assignment||Treatment||None (Open Label)||||||
1529013|NCT00599144|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529014|NCT00599131||Single Group Assignment||Treatment||None (Open Label)||||||
1529015|NCT00599118|||Case-Control||Prospective|||||||
1529016|NCT00599105||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529017|NCT00599092|||||Prospective|||||||
1529018|NCT00599079||Single Group Assignment||Treatment||None (Open Label)||||||
1529019|NCT00599066|||Case-Only||Prospective|||||||
1529020|NCT00599053|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529021|NCT00599040|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1529022|NCT00599027|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529023|NCT00599014|||Cohort||Prospective|||||||
1529024|NCT00599001|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529025|NCT00598988|Randomized|Parallel Assignment||Treatment||Single|||||t|
1529026|NCT00598975||Single Group Assignment||Treatment||None (Open Label)||||||
1529027|NCT00598962||Single Group Assignment||Treatment||None (Open Label)||||||
1529028|NCT00598949|||Case Control||Prospective|||||||
1529029|NCT00598936|||Case-Only||Prospective|||||||
1529030|NCT00598923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529031|NCT00598910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529032|NCT00598897||Single Group Assignment||Treatment||None (Open Label)||||||
1529033|NCT00598884|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529034|NCT00598871|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529035|NCT00598858||Single Group Assignment||Treatment||None (Open Label)||||||
1529036|NCT00598845|||Cohort||Prospective|||||||
1529037|NCT00598832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529038|NCT00598819||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529039|NCT00598806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529040|NCT00598793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529041|NCT00598780|||Cohort||Prospective|||||||
1529042|NCT00598767|||Cohort||Prospective|||||||
1529043|NCT00598754|||Cohort||Prospective|||||||
1529044|NCT00598741||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529045|NCT00598728|||Cohort||Retrospective|||||||
1529046|NCT00598715|Randomized|Parallel Assignment||Treatment||Single||||||t
1529047|NCT00598702||Single Group Assignment||Treatment||None (Open Label)||||||
1529048|NCT00598689|Randomized|Parallel Assignment||Treatment||Single|||||t|
1529049|NCT00598676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529050|NCT00598663|Randomized|Crossover Assignment||||None (Open Label)||||||
1529051|NCT00598650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529052|NCT00598637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529053|NCT00598624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529054|NCT00598611|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529055|NCT00598598|||Cohort||Prospective|||||||
1529056|NCT00598585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529057|NCT00598572||Single Group Assignment||Other||None (Open Label)||||||
1529058|NCT00598559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529059|NCT00598546|||Cohort||Prospective|||||||
1529060|NCT00598533|Randomized|Parallel Assignment||Treatment||Single||||||t
1529061|NCT00598507||Single Group Assignment||Treatment||None (Open Label)||||||
1529062|NCT00598494|||Case-Only||Prospective|||||||
1529063|NCT00598481||Single Group Assignment||Treatment||None (Open Label)||||||
1529064|NCT00598455|||Cohort||Prospective|||||||
1529065|NCT00598442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529066|NCT00598429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529067|NCT00598416|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1529068|NCT00598403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529069|NCT00598390|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1529070|NCT00598377|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1529071|NCT00598364|||Cohort||Prospective|||||||
1529072|NCT00598351|||||Prospective|||||||
1529073|NCT00598338|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529074|NCT00598325|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529075|NCT00598312|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529076|NCT00598299|||Case Control||Prospective|||||||
1529077|NCT00598286|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1529078|NCT00598273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529079|NCT00598260|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529080|NCT00598247|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529081|NCT00598234|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529082|NCT00598208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529083|NCT00598195||Single Group Assignment||Supportive Care||None (Open Label)||||||
1529084|NCT00598182|||Case-Only|||||||||
1529085|NCT00598169|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529086|NCT00598156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529087|NCT00598143|||Cohort||Prospective|||||||
1529088|NCT00598130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529089|NCT00598117|||Cohort||Prospective|||||||
1529090|NCT00598104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529091|NCT00598091|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1529092|NCT00598078|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1529093|NCT00598065||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529094|NCT00598052|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1529095|NCT00598026|Randomized|Parallel Assignment||||None (Open Label)||||||
1529096|NCT00598013|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529097|NCT00598000|||Cohort||Prospective|||||||
1529098|NCT00597987|||Case Control||Prospective|||||||
1529101|NCT00597948|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529102|NCT00597935|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1529103|NCT00597922|||Cohort||Prospective|||||||
1529104|NCT00597909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529105|NCT00597896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529106|NCT00597883|||Case Control||Prospective|||||||
1529107|NCT00597870||Single Group Assignment||Treatment||None (Open Label)||||||
1529108|NCT00597857|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1529109|NCT00597844|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1529110|NCT00597831|||Cohort||Prospective|||||||
1529111|NCT00597818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529112|NCT00597805|||Case-Only||Prospective|||||||
1529113|NCT00597792|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529114|NCT00597779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529115|NCT00597766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529116|NCT00597753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529117|NCT00597740|||||Prospective|||||||
1529118|NCT00597727|Randomized|Crossover Assignment||Treatment||Triple||"For the initial 12 months of the study, subjects were blinded to receive either peanut SLIT or placebo. After unblinding, subjects on placebo are crossed over to receive open-label peanut SLIT. They underwent an identical dosing protocol as those that were initially randomized to active treatment.~After 12 months of peanut SLIT dosing, whether initially randomized to active or crossed over from placebo, all subjects remained part of an open-label extended maintenance phase for the duration of the study (total peanut SLIT dosing 36-60 months)~2 additional cohorts were included in the protocol. One cohort, called the Early Unblinded Peanut SLIT cohort, was unblinded prior to the scheduled 12 month time point for pharmacy safety concerns. The second cohort, called the Pilot Peanut SLIT Rollover cohort involved subjects from the prior pilot study (NCT00429429) who were added to the study through an amendment and received open-label peanut SLIT."|t|t|t|
1529119|NCT00597714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529120|NCT00597701|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529121|NCT00597688|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1529122|NCT00597675|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1529123|NCT00597662|Randomized|Parallel Assignment||Prevention||Single|||t|||
1529124|NCT00597649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529125|NCT00597636|||Case-Control||Prospective|||||||
1529126|NCT00597623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529127|NCT00597610||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529128|NCT00597597||Single Group Assignment||Treatment||None (Open Label)||||||
1529129|NCT00597584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529130|NCT00597571||||||||||||
1529131|NCT00597558||Single Group Assignment||Treatment||None (Open Label)||||||
1529132|NCT00597545|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1529133|NCT00597532|Randomized|Parallel Assignment||Prevention||Single|||t|||
1529134|NCT00597519||Single Group Assignment||Treatment||None (Open Label)||||||
1529135|NCT00597506|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529136|NCT00597493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529137|NCT00597480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529138|NCT00597467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529139|NCT00597454||Single Group Assignment||Health Services Research||None (Open Label)||||||
1529140|NCT00597441||Single Group Assignment||Treatment||None (Open Label)||||||
1529141|NCT00597428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529142|NCT00597415|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1529143|NCT00597402|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529144|NCT00597389|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529145|NCT00597376|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529146|NCT00597363|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529147|NCT00597350|||Case-Only||Prospective|||||||
1529148|NCT00597337|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529149|NCT00597324|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529150|NCT00597311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529151|NCT00597298|Randomized|Single Group Assignment||||Single||||||t
1529152|NCT00597285|||||Prospective|||||||
1529153|NCT00597272||Single Group Assignment||Treatment||None (Open Label)||||||
1529154|NCT00597259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529155|NCT00597246||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529156|NCT00597233|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1529157|NCT00597220|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529158|NCT00597207|Randomized|Parallel Assignment||Treatment||Single||||||t
1529159|NCT00597194|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529160|NCT00597181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529161|NCT00597168|||Case-Only||Prospective|||||||
1529162|NCT00597142||Single Group Assignment||Treatment||None (Open Label)||||||
1529163|NCT00597129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529164|NCT00597116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529165|NCT00597103|||Case Control||Prospective|||||||
1529166|NCT00597090|||Case Control||Prospective|||||||
1529167|NCT00597077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529168|NCT00597064|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1529169|NCT00597051|Randomized|Crossover Assignment||Treatment||Double||||||
1529170|NCT00597038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529171|NCT00597025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529172|NCT00597012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529173|NCT00596999|||Case-Only||Prospective|||||||
1529174|NCT00596986|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529175|NCT00596973||Single Group Assignment||Treatment||None (Open Label)||||||
1529176|NCT00596960|Randomized|Parallel Assignment||Treatment||Single||||||t
1529177|NCT00596947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529178|NCT00596934||Single Group Assignment||Treatment||None (Open Label)||||||
1529179|NCT00596921|||Case-Only||Cross-Sectional|||||||
1529180|NCT00596908|||Cohort||Prospective|||||||
1529181|NCT00596895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529182|NCT00596882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529183|NCT00596856|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1529184|NCT00596843|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529185|NCT00596830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529186|NCT00596817|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529187|NCT00596804||Single Group Assignment||Treatment||None (Open Label)||||||
1529188|NCT00596791||Single Group Assignment||Treatment||None (Open Label)||||||
1529189|NCT00596778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529190|NCT00596765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529191|NCT00596752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529192|NCT00596739|||Cohort||Prospective|||||||
1529193|NCT00596726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529194|NCT00596713|||Cohort||Cross-Sectional|||||||
1529195|NCT00596700|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1529196|NCT00596687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529197|NCT00596674|Randomized|Parallel Assignment||Treatment||Single||||||t
1529198|NCT00596661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529199|NCT00596648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529200|NCT00596635|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1529201|NCT00596622|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1529202|NCT00596609|||Case Control||Prospective|||||||
1529203|NCT00596596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529204|NCT00596583|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529205|NCT00596570|||Cohort||Prospective|||||||
1529206|NCT00596557|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529207|NCT00596544|||Cohort||Prospective|||||||
1529208|NCT00596531|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1529209|NCT00596518||Single Group Assignment||Treatment||None (Open Label)||||||
1529210|NCT00596505|||Case Control||Prospective|||||||
1529211|NCT00596492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529212|NCT00596479|Randomized|Parallel Assignment||Treatment||Double||||||
1529213|NCT00596466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529214|NCT00596453|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1529215|NCT00596440|||Case Control||Prospective|||||||
1529216|NCT00596427|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1529217|NCT00596414|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1529218|NCT00596401|||Cohort||Prospective|||||||
1529219|NCT00596388|||Cohort||Prospective|||||||
1529220|NCT00596375|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1529221|NCT00596362||Single Group Assignment||Treatment||None (Open Label)||||||
1529222|NCT00596349|||Cohort||Prospective|||||||
1529223|NCT00596336|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1529224|NCT00596323|||Cohort||Cross-Sectional|||||||
1529225|NCT00596310||Single Group Assignment||Screening||None (Open Label)||||||
1529226|NCT00596297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529227|NCT00596284|Randomized|Parallel Assignment||Treatment||Single||||||t
1529228|NCT00596271|Randomized|Parallel Assignment||Prevention||Single|||t|||
1529229|NCT00596258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529230|NCT00596245|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529231|NCT00596232|||Case Control||Cross-Sectional|||||||
1529232|NCT00596219||Single Group Assignment||Treatment||None (Open Label)||||||
1529233|NCT00596206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529234|NCT00596193|||Case Control||Prospective|||||||
1529235|NCT00596180|||Other||Retrospective|||||||
1529236|NCT00596167||Single Group Assignment||||None (Open Label)||||||
1529237|NCT00596154||Single Group Assignment||Treatment||None (Open Label)||||||
1529238|NCT00596141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529239|NCT00596128||Single Group Assignment||Treatment||None (Open Label)||||||
1529240|NCT00596115||||||||||||
1529241|NCT00596102|||Cohort|||||||||
1529242|NCT00596089|||Cohort||Cross-Sectional|||||||
1529243|NCT00596076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529244|NCT00596063|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1529245|NCT00596050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529246|NCT00596037|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529247|NCT00596024|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1529248|NCT00596011|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529249|NCT00595998|||Cohort||Retrospective|||||||
1529250|NCT00595985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529251|NCT00595972|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529252|NCT00595959|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529253|NCT00595946|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529254|NCT00595933|Randomized|Single Group Assignment||Treatment||Single|||t|||
1529255|NCT00595920||Single Group Assignment||Treatment||None (Open Label)||||||
1529256|NCT00595907|||||Prospective|||||||
1529257|NCT00595894|||Cohort||Prospective|||||||
1529258|NCT00595881|||||Cross-Sectional|||||||
1529259|NCT00595868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529260|NCT00595855|Randomized|Parallel Assignment||Treatment||Single||||||t
1529261|NCT00595842|||Case-Only||Retrospective|||||||
1529262|NCT00595829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529263|NCT00595816|Randomized|Parallel Assignment||Prevention||Single||||||t
1529264|NCT00595790|Randomized|Parallel Assignment||Prevention||Single|||t|||
1529265|NCT00595777|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1529266|NCT00595764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529267|NCT00595751|||Cohort||Prospective|||||||
1529268|NCT00595738|||Cohort||Prospective|||||||
1529269|NCT00595725||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529270|NCT00595712|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1529271|NCT00595699|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529272|NCT00595686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529273|NCT00595673||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529274|NCT00595660|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1529275|NCT00595647|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529276|NCT00595634|||Cohort||Prospective|||||||
1529277|NCT00595621|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1529278|NCT00595608|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1529279|NCT00595595|||Case Control||Cross-Sectional|||||||
1529280|NCT00595582||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529281|NCT00595569|||Cohort||Prospective|||||||
1529282|NCT00595556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529283|NCT00595543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529284|NCT00595530||Single Group Assignment||Treatment||None (Open Label)||||||
1529285|NCT00595517|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1529286|NCT00595504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529287|NCT00595491||Single Group Assignment||Basic Science||None (Open Label)||||||
1529288|NCT00595478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529289|NCT00595465|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1529290|NCT00595439|||||Prospective|||||||
1529291|NCT00595426|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1529292|NCT00595413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529293|NCT00595387|Randomized|Parallel Assignment||Treatment||Single||||||t
1529294|NCT00595374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529295|NCT00595361|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529296|NCT00595348|||Cohort||Prospective|||||||
1529297|NCT00595335|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529298|NCT00595322||Single Group Assignment||Treatment||None (Open Label)||||||
1529299|NCT00595309||Single Group Assignment||Prevention||None (Open Label)||||||
1529300|NCT00595296|||Case-Only||Prospective|||||||
1529301|NCT00595283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529302|NCT00595270||Single Group Assignment||Prevention||None (Open Label)||||||
1529303|NCT00595257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529304|NCT00595244||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529305|NCT00595231|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529306|NCT00595218|Randomized|Parallel Assignment||Other||Single|||t|||
1529307|NCT00595205|||||Prospective|||||||
1529308|NCT00595179|||||Retrospective|||||||
1529309|NCT00595166|||Cohort||Prospective|||||||
1529310|NCT00595153|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529311|NCT00595140|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1529312|NCT00595127||Single Group Assignment||Treatment||None (Open Label)||||||
1529313|NCT00595114|||Cohort||Retrospective|||||||
1529314|NCT00595101|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529315|NCT00595088||Single Group Assignment||Treatment||None (Open Label)||||||
1529316|NCT00595075|Randomized|Crossover Assignment||Basic Science||Triple|||t||t|t
1529317|NCT00595062||Single Group Assignment||Treatment||None (Open Label)||||||
1529318|NCT00595049|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529319|NCT00595023|||Case-Only||Prospective|||||||
1529320|NCT00595010||Single Group Assignment||Health Services Research||None (Open Label)||||||
1529321|NCT00594997|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529322|NCT00594984|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529323|NCT00594971|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1529324|NCT00594958|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1530277|NCT00582270|||Cohort||Prospective|||||||
1529325|NCT00594945|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1529326|NCT00594932|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1529327|NCT00594919|||||Prospective|||||||
1529328|NCT00594906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529329|NCT00594893|Randomized|Parallel Assignment||||None (Open Label)||||||
1529330|NCT00594880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529331|NCT00594867|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1529332|NCT00594854|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529333|NCT00594841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529334|NCT00594828|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1529335|NCT00594815||Single Group Assignment||Treatment||None (Open Label)||||||
1529336|NCT00594802|||||Retrospective|||||||
1529337|NCT00594789|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1529338|NCT00594776|||Cohort||Prospective|||||||
1529339|NCT00594763|||Case-Only||Cross-Sectional|||||||
1529340|NCT00594750|||Cohort||Cross-Sectional|||||||
1529341|NCT00594737||Single Group Assignment||Treatment||None (Open Label)||||||
1529342|NCT00594724||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529343|NCT00594711|||Case Control||Prospective|||||||
1529344|NCT00594698||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529345|NCT00594685|||Case-Only||Prospective|||||||
1529346|NCT00594672|||Cohort||Prospective|||||||
1529347|NCT00594659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529348|NCT00594646||Single Group Assignment||Prevention||None (Open Label)||||||
1529349|NCT00594633||Single Group Assignment||Treatment||None (Open Label)||||||
1529350|NCT00594620|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1529351|NCT00594607|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1529352|NCT00594594|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1529353|NCT00594581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529354|NCT00594568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529355|NCT00594555|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529356|NCT00594542|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1529357|NCT00594529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529358|NCT00594516|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1529359|NCT00594503||Single Group Assignment||Treatment||None (Open Label)||||||
1529360|NCT00594490|||Other||Prospective|||||||
1529361|NCT00594477||Single Group Assignment||Treatment||None (Open Label)||||||
1529362|NCT00594464||Single Group Assignment||Treatment||None (Open Label)||||||
1529363|NCT00594451|||Cohort||Cross-Sectional|||||||
1529364|NCT00594438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529365|NCT00594425|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529366|NCT00594412|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1529367|NCT00594399|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529368|NCT00594386||Single Group Assignment||Treatment||None (Open Label)||||||
1529369|NCT00594373|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1529370|NCT00594360|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529371|NCT00594347|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529372|NCT00594334|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1529373|NCT00594321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529374|NCT00594308|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529375|NCT00594295|||Cohort||Prospective|||||||
1529376|NCT00594282|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1529377|NCT00594269|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529378|NCT00594256||Single Group Assignment||Treatment||None (Open Label)||||||
1529379|NCT00594243|Randomized|Crossover Assignment||Treatment||Single||||||t
1529380|NCT00594230|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529381|NCT00594217|Randomized|Crossover Assignment||Other||Triple||Randomized, placebo-controlled, crossover study|t|t|t|
1529382|NCT00594204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529383|NCT00594191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529384|NCT00594178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529385|NCT00594165||Single Group Assignment||Treatment||None (Open Label)||||||
1529386|NCT00594152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529387|NCT00594139||Single Group Assignment||Treatment||None (Open Label)||||||
1529388|NCT00594126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529389|NCT00594113|Randomized|Parallel Assignment||||None (Open Label)||||||
1529390|NCT00594100||Single Group Assignment||Treatment||None (Open Label)||||||
1529391|NCT00594087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529392|NCT00594074|Randomized|Parallel Assignment||||None (Open Label)||||||
1529393|NCT00594061||Single Group Assignment||Treatment||None (Open Label)||||||
1529394|NCT00594048|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529395|NCT00594035|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529396|NCT00594022|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1529397|NCT00594009||Single Group Assignment||Treatment||None (Open Label)||||||
1529398|NCT00593996|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529399|NCT00593983|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1529400|NCT00593970|||Cohort||Cross-Sectional|||||||
1529401|NCT00593957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529402|NCT00593944|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529403|NCT00593931||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529404|NCT00593918|||Case Control||Prospective|||||||
1529405|NCT00593905|||Cohort|||||||||
1529406|NCT00593892|||Case-Only||Prospective|||||||
1529407|NCT00593879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529408|NCT00593866||Single Group Assignment||Treatment||None (Open Label)||||||
1529409|NCT00593853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529410|NCT00593840||Single Group Assignment||Treatment||None (Open Label)||||||
1529411|NCT00593827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529412|NCT00593814||Single Group Assignment||Treatment||None (Open Label)||||||
1529413|NCT00593801|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529414|NCT00593788|||Case-Only||Prospective|||||||
1529415|NCT00593775|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529416|NCT00593762|||Cohort||Prospective|||||||
1529417|NCT00593749|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529418|NCT00593736|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529419|NCT00593723||Single Group Assignment||Treatment||None (Open Label)||||||
1529420|NCT00593710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529421|NCT00593697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529422|NCT00593684|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529423|NCT00593671|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529424|NCT00593658||Single Group Assignment||Treatment||None (Open Label)||||||
1529425|NCT00593645||Single Group Assignment||Treatment||None (Open Label)||||||
1529426|NCT00593632||Single Group Assignment||Treatment||None (Open Label)||||||
1529427|NCT00593619|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1529428|NCT00593606|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529429|NCT00593593|||||Prospective|||||||
1529430|NCT00593580|Randomized|Parallel Assignment||Prevention||Single|||t|||
1529431|NCT00593567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529432|NCT00593554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529433|NCT00593541|||Case-Control||Prospective|||||||
1529434|NCT00593528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529435|NCT00593515|Randomized|Parallel Assignment||Treatment||Single||||||t
1529436|NCT00593502|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529437|NCT00593489|Randomized|Parallel Assignment||||None (Open Label)||||||
1529438|NCT00593476|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1529439|NCT00593463||Single Group Assignment||||Double|||t||t|
1529440|NCT00593450|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1529441|NCT00593437|||||Retrospective|||||||
1529442|NCT00593424|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1529443|NCT00593411|||Cohort||Prospective|||||||
1529444|NCT00593398|||Case-Only||Prospective|||||||
1529445|NCT00593385||Single Group Assignment||Treatment||None (Open Label)||||||
1529446|NCT00593372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529447|NCT00593359|||Cohort||Prospective|||||||
1529448|NCT00593346||Single Group Assignment||Treatment||None (Open Label)||||||
1529449|NCT00593333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529450|NCT00593320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529451|NCT00593307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529452|NCT00593294|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529453|NCT00593281|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1529454|NCT00593268|||Other||Other|||||||
1529455|NCT00593255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529456|NCT00593242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529457|NCT00593229|||Case-Only||Prospective|||||||
1529458|NCT00593216|||Case Control||Retrospective|||||||
1529459|NCT00593203|||Other||Prospective|||||||
1529460|NCT00593190||Single Group Assignment||Treatment||None (Open Label)||||||
1529461|NCT00593177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529462|NCT00593164|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529463|NCT00593151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529464|NCT00593138|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529465|NCT00593125||Single Group Assignment||Treatment||None (Open Label)||||||
1529466|NCT00593112|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1529467|NCT00593099|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529468|NCT00593086|Randomized|Crossover Assignment||Treatment||Single|||t|||
1529469|NCT00593073|Randomized|Parallel Assignment||Prevention||Single|||t|||
1529470|NCT00593060|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529471|NCT00593047|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1529472|NCT00593034|||Case-Only||Cross-Sectional|||||||
1529473|NCT00593021|||Case-Only||Prospective|||||||
1529474|NCT00593008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529475|NCT00592995|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529476|NCT00592982|||Cohort||Prospective|||||||
1529477|NCT00592969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529478|NCT00592943|Randomized|Parallel Assignment||||None (Open Label)||||||
1530278|NCT00582257|||Cohort||Prospective|||||||
1529479|NCT00592930|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529480|NCT00592917|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529481|NCT00592904||Single Group Assignment||Treatment||None (Open Label)||||||
1529482|NCT00592891||Single Group Assignment||Treatment||None (Open Label)||||||
1529483|NCT00592865|||Other||Other|||||||
1529484|NCT00592852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529485|NCT00592839|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529486|NCT00592826|||Case Control||Prospective|||||||
1529487|NCT00592813|Randomized|Parallel Assignment||Treatment||Single||||||t
1529488|NCT00592800|||||Prospective|||||||
1529489|NCT00592774|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529490|NCT00592761|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529491|NCT00592748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529492|NCT00592735|||Cohort||Prospective|||||||
1529493|NCT00592722|||Cohort||Prospective|||||||
1529494|NCT00592709|||Other||Retrospective|||||||
1529495|NCT00592696|||Cohort||Cross-Sectional|||||||
1529496|NCT00592683|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1529497|NCT00592670|Randomized|Parallel Assignment||||Double|||t||t|
1529498|NCT00592657|||Case Control||Retrospective|||||||
1529499|NCT00592644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529500|NCT00592631|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529501|NCT00592618||Single Group Assignment||Treatment||None (Open Label)||||||
1529502|NCT00592605|||Cohort||Prospective|||||||
1529503|NCT00592592||Single Group Assignment||Treatment||None (Open Label)||||||
1529504|NCT00592579|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529505|NCT00592566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529506|NCT00592553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529507|NCT00592540||Single Group Assignment||Treatment||None (Open Label)||||||
1529508|NCT00592527|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529509|NCT00592514|||Cohort||Prospective|||||||
1529510|NCT00592501||Single Group Assignment||Treatment||None (Open Label)||||||
1529511|NCT00592488|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1529512|NCT00592475|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529513|NCT00592462|||Case-Only||Prospective|||||||
1529514|NCT00592449|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1529515|NCT00592436|||Case-Only||Prospective|||||||
1529516|NCT00592423||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529517|NCT00592410||Single Group Assignment||Treatment||None (Open Label)||||||
1529518|NCT00592397||Single Group Assignment||Basic Science||None (Open Label)||||||
1529519|NCT00592384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529520|NCT00592371|||Cohort||Prospective|||||||
1529521|NCT00592358||Single Group Assignment||Treatment||None (Open Label)||||||
1529522|NCT00592345|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529523|NCT00592332|Randomized|Crossover Assignment||||Single|||t|||
1529524|NCT00592319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529525|NCT00592306|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1529526|NCT00592293||Single Group Assignment||Treatment||None (Open Label)||||||
1529527|NCT00592280||Single Group Assignment||Prevention||None (Open Label)||||||
1529528|NCT00592267|||Case-Only||Prospective|||||||
1529529|NCT00592254|||Case-Only||Prospective|||||||
1529530|NCT00592241|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1529531|NCT00592228|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1529532|NCT00592215||Single Group Assignment||Treatment||None (Open Label)||||||
1529533|NCT00592202||Single Group Assignment||Treatment||None (Open Label)||||||
1529534|NCT00592189||Single Group Assignment||Basic Science||None (Open Label)||||||
1529535|NCT00592176||Single Group Assignment||Treatment||None (Open Label)||||||
1529536|NCT00592163|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529537|NCT00592150|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1529538|NCT00592137|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1529539|NCT00592124|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1529540|NCT00592111|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529541|NCT00592098|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1529542|NCT00592085|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529543|NCT00592072|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1529544|NCT00592059|||Case-Only||Prospective|||||||
1529545|NCT00592046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529546|NCT00592033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529547|NCT00592020|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529548|NCT00592007||Single Group Assignment||Treatment||None (Open Label)||||||
1529549|NCT00591994|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1529550|NCT00591981|||Cohort||Prospective|||||||
1529551|NCT00591968|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1529552|NCT00591955|||Case-Only||Prospective|||||||
1529553|NCT00591942|Randomized|Crossover Assignment||Basic Science||Single|Subject unaware of the dental cement used on which crown or retainer|2 crowns per subject or one dental bridge with two retainer crowns for a total of 72 Teeth.|t|||
1529554|NCT00591929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529555|NCT00591916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529557|NCT00591890|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529558|NCT00591877|Randomized|Crossover Assignment||Treatment||Single|||||t|
1529559|NCT00591864||Single Group Assignment||Diagnostic||Single|||||t|
1529560|NCT00591851||Single Group Assignment||Treatment||None (Open Label)||||||
1529561|NCT00591838|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529562|NCT00591825|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529563|NCT00591812||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529564|NCT00591799||Single Group Assignment||Treatment||None (Open Label)||||||
1529565|NCT00591786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529566|NCT00591773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529567|NCT00591760|Randomized|Parallel Assignment||Treatment||Single|||||t|
1529568|NCT00591747|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1529569|NCT00591734||Single Group Assignment||Treatment||None (Open Label)||||||
1529570|NCT00591721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529571|NCT00591708|Randomized|Crossover Assignment||Prevention||Triple|||t|t||t
1529572|NCT00591695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529573|NCT00591682|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529574|NCT00591669|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1529575|NCT00591656|||Case-Only||Prospective|||||||
1529576|NCT00591643||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529577|NCT00591630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529578|NCT00591617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529579|NCT00591604||Single Group Assignment||Treatment||None (Open Label)||||||
1529580|NCT00591591|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1529581|NCT00591578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529582|NCT00591565||Single Group Assignment||Treatment||None (Open Label)||||||
1529583|NCT00591552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529584|NCT00591539|||Cohort||Prospective|||||||
1529585|NCT00591526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529586|NCT00591513|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529587|NCT00591500|||Case-Control||Prospective|||||||
1529588|NCT00591487|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1529589|NCT00591474|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1529590|NCT00591461|||Case-Only||Prospective|||||||
1529591|NCT00591448|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1529592|NCT00591435|||Cohort||Retrospective|||||||
1529593|NCT00591422||Single Group Assignment||Treatment||None (Open Label)||||||
1529594|NCT00591409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529595|NCT00591396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529596|NCT00591383|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529597|NCT00591370||Single Group Assignment||Treatment||None (Open Label)||||||
1529598|NCT00591357|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529599|NCT00591344|Randomized|Parallel Assignment||Treatment||Single||||||t
1529600|NCT00591331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529601|NCT00591318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529602|NCT00591305|Randomized|Parallel Assignment||Prevention||Single|treatment to be selected based on a randomized number table, blinded to participants|laser only vs laser+ a dietary agent (DIM)|t|||
1529603|NCT00591292||Single Group Assignment||Treatment||None (Open Label)||||||
1529604|NCT00591279|||Cohort||Prospective|||||||
1529605|NCT00591266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529606|NCT00591253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529607|NCT00591240|||Cohort||Prospective|||||||
1529608|NCT00591227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529609|NCT00591214||Single Group Assignment||||None (Open Label)||||||
1529610|NCT00591201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529611|NCT00591188|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529612|NCT00591175|||Cohort||Prospective|||||||
1529613|NCT00591162||Single Group Assignment||Treatment||None (Open Label)||||||
1529614|NCT00591149||Single Group Assignment||Treatment||None (Open Label)||||||
1529615|NCT00591136|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529616|NCT00591123||Single Group Assignment||Treatment||None (Open Label)||||||
1529617|NCT00591110|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529618|NCT00591097|||Case-Only||Prospective|||||||
1529619|NCT00591084|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529620|NCT00591071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529621|NCT00591058|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529622|NCT00591045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529623|NCT00591032|||Cohort||Prospective|||||||
1529624|NCT00591019|Randomized|||Treatment||Single|||t|||
1529625|NCT00591006||Single Group Assignment||Treatment||Double|||t||t|
1529626|NCT00590993|||Cohort||Prospective|||||||
1529627|NCT00590980|||Cohort||Prospective|||||||
1529628|NCT00590967|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529629|NCT00590954||Single Group Assignment||Treatment||None (Open Label)||||||
1529630|NCT00590941|Randomized|Single Group Assignment||||None (Open Label)||||||
1529631|NCT00590928|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529632|NCT00590915||||||||||||
1529633|NCT00590902||Single Group Assignment||Treatment||None (Open Label)||||||
1529634|NCT00590889|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529635|NCT00590876|||Cohort||Prospective|||||||
1529636|NCT00590863|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529637|NCT00590850|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529638|NCT00590837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529639|NCT00590824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529640|NCT00590811|||Cohort|||||||||
1529641|NCT00590798||Single Group Assignment||Supportive Care||None (Open Label)||||||
1529642|NCT00590785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529643|NCT00590772|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1529644|NCT00590759||Single Group Assignment||Treatment||None (Open Label)||||||
1529645|NCT00590746|||Case-Only||Prospective|||||||
1529646|NCT00590720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529647|NCT00590707|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1529648|NCT00590694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529649|NCT00590681|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529650|NCT00590668|||Cohort||Prospective|||||||
1529651|NCT00590655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529652|NCT00590642|||Case-Only||Prospective|||||||
1529653|NCT00590629|Randomized|Parallel Assignment||Prevention||Double||||||
1529654|NCT00590616|||Cohort||Prospective|||||||
1529655|NCT00590603||Single Group Assignment||Treatment||None (Open Label)||||||
1529656|NCT00590590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529657|NCT00590577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529658|NCT00590564||Single Group Assignment||Treatment||None (Open Label)||||||
1529659|NCT00590551|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529660|NCT00590538|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1529661|NCT00590525|||Cohort||Prospective|||||||
1529662|NCT00590512|Randomized|Crossover Assignment||Diagnostic||Double||||t||t
1529663|NCT00590499|||Cohort||Prospective|||||||
1529664|NCT00590473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529665|NCT00590460||Single Group Assignment||Treatment||None (Open Label)||||||
1529666|NCT00590447|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529667|NCT00590434|||Case Control||Retrospective|||||||
1529668|NCT00590421|||Cohort||Retrospective|||||||
1529669|NCT00590408|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529670|NCT00590395||Single Group Assignment||Other||None (Open Label)||||||
1529671|NCT00590382||||||||||||
1529672|NCT00590369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529673|NCT00590356|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529674|NCT00590343||Single Group Assignment||Treatment||None (Open Label)||||||
1529675|NCT00590330|||Family-Based||Prospective|||||||
1529676|NCT00590317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529677|NCT00590304|||Ecologic or Community||Cross-Sectional|||||||
1529678|NCT00590291|||Family-Based||Retrospective|||||||
1529679|NCT00590278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529680|NCT00590265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529681|NCT00590252|||Case-Only||Prospective|||||||
1529682|NCT00590239|||Cohort||Prospective|||||||
1529683|NCT00590226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529684|NCT00590213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529685|NCT00590200|||Other||Prospective|||||||
1529686|NCT00590187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529687|NCT00590174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529688|NCT00590161|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529689|NCT00590148|||Cohort||Prospective|||||||
1529690|NCT00590135||Single Group Assignment||Treatment||None (Open Label)||||||
1529691|NCT00590122|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1529692|NCT00590109|||Cohort||Prospective|||||||
1529693|NCT00590096|||Case-Only|||||||||
1529694|NCT00590083||Single Group Assignment||Treatment||None (Open Label)||||||
1529695|NCT00590070|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529696|NCT00590044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529697|NCT00590031||Single Group Assignment||Treatment||None (Open Label)||||||
1529698|NCT00590018|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1529699|NCT00590005|||Cohort||Prospective|||||||
1529700|NCT00589992||Single Group Assignment||Basic Science||None (Open Label)||||||
1529701|NCT00589979|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1529702|NCT00589966|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1529703|NCT00589953|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529704|NCT00589927|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529705|NCT00589914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529706|NCT00589901|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529707|NCT00589888|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1529708|NCT00589875||Single Group Assignment||Treatment||None (Open Label)||||||
1529709|NCT00589862|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529710|NCT00589849|||Cohort||Prospective|||||||
1529711|NCT00589836|||Case-Control||Cross-Sectional|||||||
1529712|NCT00589823|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1529714|NCT00589797|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529715|NCT00589784||Single Group Assignment||Treatment||None (Open Label)||||||
1529716|NCT00589771|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529717|NCT00589758|||Cohort||Prospective|||||||
1529718|NCT00589745||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529719|NCT00589732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529720|NCT00589719|||Ecologic or Community||Cross-Sectional|||||||
1529721|NCT00589706||Single Group Assignment||Treatment||None (Open Label)||||||
1529722|NCT00589693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529723|NCT00589680|||||Retrospective|||||||
1529724|NCT00589667||Single Group Assignment||Treatment||None (Open Label)||||||
1529725|NCT00589654|||Cohort||Prospective|||||||
1529726|NCT00589641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529727|NCT00589628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529728|NCT00589615|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529729|NCT00589602||Single Group Assignment||Treatment||None (Open Label)||Allogeneic Hematopoietic Stem Cell Transplantation||||
1529730|NCT00589589|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1529731|NCT00589563|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1529732|NCT00589550||Single Group Assignment||Treatment||None (Open Label)||||||
1529733|NCT00589537|Randomized|||Diagnostic||||||||
1529734|NCT00589524||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529735|NCT00589511|||Case-Only|||||||||
1529736|NCT00589498|Randomized|Parallel Assignment||Prevention||Single||||||t
1529737|NCT00589485|||Cohort||Prospective|||||||
1529738|NCT00589472||Single Group Assignment||Treatment||None (Open Label)||||||
1529739|NCT00589459|||Case-Only||Cross-Sectional|||||||
1529740|NCT00589446||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529741|NCT00589433|||Case-Crossover||Cross-Sectional|||||||
1529742|NCT00589420||||Treatment||None (Open Label)||||||
1529743|NCT00589407|||Case Control||Cross-Sectional|||||||
1529744|NCT00589394||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529745|NCT00589381|Non-Randomized|||Treatment||None (Open Label)||||||
1529746|NCT00589368|||Case Control||Cross-Sectional|||||||
1529747|NCT00589355|||Case Control||Cross-Sectional|||||||
1529748|NCT00589329|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529749|NCT00589316||Single Group Assignment||Treatment||None (Open Label)||||||
1529750|NCT00589303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529751|NCT00589290||Single Group Assignment||Treatment||None (Open Label)||||||
1529752|NCT00589277|Randomized|Single Group Assignment||Treatment||Single|||t|||
1529753|NCT00589264|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529754|NCT00589251||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529755|NCT00589238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529756|NCT00589225|||Cohort||Retrospective|||||||
1529757|NCT00589212|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529758|NCT00589199||Single Group Assignment||Treatment||None (Open Label)||||||
1529759|NCT00589186|Non-Randomized|||Treatment||None (Open Label)||||||
1529760|NCT00589173|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1529761|NCT00589147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529762|NCT00589134|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529763|NCT00589121|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529764|NCT00589108|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529765|NCT00589095|||Case-Only||Prospective|||||||
1529766|NCT00589082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529767|NCT00589069||||||||||||
1529768|NCT00589056||||Treatment||None (Open Label)||||||
1529769|NCT00589043||||||||||||
1529770|NCT00589030||||||||||||
1529771|NCT00588991||Single Group Assignment||Treatment||None (Open Label)||||||
1529772|NCT00588978|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529773|NCT00588965|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1529774|NCT00588952|Randomized|Parallel Assignment||||Double|||t|||t
1529775|NCT00588939|||Cohort||Prospective|||||||
1529776|NCT00588926||Single Group Assignment||Basic Science||None (Open Label)||||||
1529777|NCT00588913|Non-Randomized|||Treatment||None (Open Label)||||||
1529778|NCT00588900||Single Group Assignment||Treatment||None (Open Label)||||||
1529779|NCT00588887|||Cohort||Prospective|||||||
1529780|NCT00588874|||Case-Only||Cross-Sectional|||||||
1529781|NCT00588861|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529782|NCT00588848|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529783|NCT00588835|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1529784|NCT00588822||Single Group Assignment||Treatment||None (Open Label)||||||
1529785|NCT00588809||Single Group Assignment||Treatment||None (Open Label)||||||
1529786|NCT00588796|||Case Control||Prospective|||||||
1529787|NCT00588783|||Cohort||Prospective|||||||
1529788|NCT00588770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529789|NCT00588757|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529790|NCT00588731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529791|NCT00588718|||Case-Control||Cross-Sectional|||||||
1529792|NCT00588705|||Family-Based||Prospective|||||||
1529793|NCT00588692|Randomized|Parallel Assignment||Treatment||Single|||||t|
1529794|NCT00588679||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529795|NCT00588666||Single Group Assignment||Treatment||None (Open Label)||||||
1529796|NCT00588653|Non-Randomized|Single Group Assignment||Diagnostic||Triple||||t|t|t
1529797|NCT00588640|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1529798|NCT00588627|||Case Control||Prospective|||||||
1529799|NCT00588614|||Cohort||Prospective|||||||
1529800|NCT00588601||||||||||||
1529801|NCT00588588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529802|NCT00588575|||Cohort||Prospective|||||||
1529803|NCT00588562|||Cohort||Other|||||||
1529804|NCT00588549|||Cohort||Prospective|||||||
1529805|NCT00588536||Single Group Assignment||Treatment||None (Open Label)||||||
1529806|NCT00588523||Single Group Assignment||Treatment||None (Open Label)||||||
1529807|NCT00588510|||Cohort||Prospective|||||||
1529808|NCT00588497|||||Prospective|||||||
1529809|NCT00588484|||Cohort||Prospective|||||||
1529810|NCT00588471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529811|NCT00588458||Single Group Assignment||||None (Open Label)||||||
1529812|NCT00588445||Single Group Assignment||Treatment||None (Open Label)||||||
1529813|NCT00588432|||Case Control||Cross-Sectional|||||||
1529814|NCT00588419|||Case-Only||Cross-Sectional|||||||
1529815|NCT00588406|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529816|NCT00588393|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1529817|NCT00588380||Single Group Assignment||Basic Science||None (Open Label)||||||
1529818|NCT00588367|||Cohort||Prospective|||||||
1529819|NCT00588354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529820|NCT00588341||Single Group Assignment||Treatment||None (Open Label)||||||
1529821|NCT00588328||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529822|NCT00588315|||Case-Control||Prospective|||||||
1529823|NCT00588302||Single Group Assignment||Treatment||None (Open Label)||||||
1529824|NCT00588289|||||Prospective|||||||
1529825|NCT00588276||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529826|NCT00588263|||Cohort||Prospective|||||||
1529827|NCT00588250|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1529828|NCT00588237||Single Group Assignment||Treatment||None (Open Label)||||||
1529829|NCT00588224|||||Prospective|||||||
1529830|NCT00588211|||Other||Prospective|||||||
1529831|NCT00588198|||Cohort||Prospective|||||||
1529832|NCT00588185||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529833|NCT00588172|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529834|NCT00588159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529835|NCT00588146|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1529836|NCT00588133|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529837|NCT00588120||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529838|NCT00588107|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1529839|NCT00588094||Single Group Assignment||Treatment||None (Open Label)||||||
1529840|NCT00588081||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529841|NCT00588068|||Cohort||Prospective|||||||
1529842|NCT00588042|Randomized|Parallel Assignment||Treatment||Single|||||t|
1529843|NCT00588029|||Case-Control||Prospective|||||||
1529844|NCT00588016||Single Group Assignment||Treatment||None (Open Label)||||||
1529845|NCT00588003|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1529846|NCT00587990|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529847|NCT00587977|||Cohort||Prospective|||||||
1529848|NCT00587964||Single Group Assignment||Treatment||None (Open Label)||||||
1529849|NCT00587951|||Case-Only||Prospective|||||||
1529850|NCT00587938|||Cohort||Prospective|||||||
1529851|NCT00587925||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529852|NCT00587912|||Case-Only||Prospective|||||||
1529853|NCT00587899|Randomized|Parallel Assignment||Prevention||Single||||||t
1529854|NCT00587886|||Case-Control||Prospective|||||||
1529855|NCT00587873||Single Group Assignment||Treatment||None (Open Label)||||||
1529856|NCT00587860|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529857|NCT00587847||Single Group Assignment||Treatment||None (Open Label)||||||
1529858|NCT00587834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529859|NCT00587821|||Case-Only||Prospective|||||||
1529860|NCT00587808|||Case Control||Prospective|||||||
1529861|NCT00587795|Randomized|Parallel Assignment||Treatment||Single|||t|||
1529862|NCT00587769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529863|NCT00587756|||Cohort||Prospective|||||||
1529864|NCT00587730|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1529865|NCT00587717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529866|NCT00587704|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1529867|NCT00587691|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529868|NCT00587678|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529869|NCT00587665|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1529870|NCT00587652|||Cohort||Prospective|||||||
1529871|NCT00587639||Single Group Assignment||Treatment||None (Open Label)||||||
1529872|NCT00587626|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1529873|NCT00587613||||||||||||
1529874|NCT00587600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529875|NCT00587587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529876|NCT00587574|||Cohort||Prospective|||||||
1529877|NCT00587561|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1529878|NCT00587548||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529879|NCT00587535|||Cohort||Prospective|||||||
1529880|NCT00587522||Single Group Assignment||Treatment||None (Open Label)||||||
1529881|NCT00587509||||||||||||
1529882|NCT00587496|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1529883|NCT00587483|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529884|NCT00587470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529885|NCT00587457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529886|NCT00587444|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1529887|NCT00587431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529888|NCT00587418|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1529889|NCT00587405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529890|NCT00587392|||Cohort||Prospective|||||||
1529891|NCT00587379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529892|NCT00587353|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529893|NCT00587340|||Cohort||Prospective|||||||
1529894|NCT00587327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529895|NCT00587314|||Cohort||Prospective|||||||
1529896|NCT00587301||Single Group Assignment||Treatment||None (Open Label)||||||
1529897|NCT00587288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529898|NCT00587275|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1529899|NCT00587262|||Cohort||Prospective|||||||
1529900|NCT00587249|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529901|NCT00587236|||Cohort||Prospective|||||||
1529902|NCT00587223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529903|NCT00587210|||Cohort||Prospective|||||||
1529904|NCT00587197|||Case-Only||Prospective|||||||
1529905|NCT00587184|||Cohort||Retrospective|||||||
1529906|NCT00587171|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1529907|NCT00587158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529908|NCT00587145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529909|NCT00587132|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1529910|NCT00587119||Single Group Assignment||Treatment||None (Open Label)||||||
1529911|NCT00587106|||Cohort||Prospective|||||||
1529912|NCT00587093||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529913|NCT00587080|||Cohort||Prospective|||||||
1529914|NCT00587067||Single Group Assignment||Treatment||None (Open Label)||||||
1529915|NCT00587054||Single Group Assignment||Treatment||None (Open Label)||||||
1529916|NCT00587041|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529917|NCT00587028|||Cohort||Prospective|||||||
1529918|NCT00587015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529919|NCT00587002|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1529920|NCT00586989|||Cohort||Prospective|||||||
1529921|NCT00586976|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529922|NCT00586963|||Cohort||Prospective|||||||
1529923|NCT00586950|||Cohort||Prospective|||||||
1529924|NCT00586937|||Case-Only||Prospective|||||||
1529925|NCT00586924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529926|NCT00586911|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529927|NCT00586898||Single Group Assignment||Treatment||None (Open Label)||||||
1529928|NCT00586885||Single Group Assignment||Treatment||None (Open Label)||||||
1529929|NCT00586872|||Cohort||Retrospective|||||||
1529930|NCT00586859||Single Group Assignment||Treatment||None (Open Label)||||||
1529931|NCT00586846||Single Group Assignment||Treatment||None (Open Label)||||||
1529932|NCT00586833|||Case Control||Cross-Sectional|||||||
1529933|NCT00586820|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529934|NCT00586807||Single Group Assignment||Basic Science||None (Open Label)||||||
1529935|NCT00586794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529936|NCT00586781|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529937|NCT00586755||Single Group Assignment||Treatment||None (Open Label)||||||
1529938|NCT00586742|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1529939|NCT00586729|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529940|NCT00586716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529941|NCT00586703||Single Group Assignment||Treatment||None (Open Label)||||||
1529942|NCT00586690|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529943|NCT00586677|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529944|NCT00586664|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529945|NCT00586651||Single Group Assignment||Treatment||None (Open Label)||||||
1529946|NCT00586638|Randomized|Parallel Assignment||||Single|||t|||
1529947|NCT00586625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1529948|NCT00586612|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529949|NCT00586599|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1529950|NCT00586586|Randomized|Parallel Assignment||Treatment||Single||||||t
1529951|NCT00586573||Single Group Assignment||Treatment||None (Open Label)||||||
1529952|NCT00586560|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529953|NCT00586547|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529954|NCT00586534|Randomized|Parallel Assignment||Treatment||Single||||||t
1529955|NCT00586521|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530442|NCT00580099|Randomized|Parallel Assignment||||Double|||t||t|
1529956|NCT00586508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529957|NCT00586495|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529958|NCT00586482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529959|NCT00586469|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1529960|NCT00586456||||||||||||
1529961|NCT00586443||Single Group Assignment||||None (Open Label)||||||
1529962|NCT00586430|Randomized|Crossover Assignment||Screening||Triple|||t|t|t|
1529963|NCT00586417||Single Group Assignment||Basic Science||None (Open Label)||||||
1529964|NCT00586404|||Cohort||Prospective|||||||
1529965|NCT00586391||Single Group Assignment||Treatment||None (Open Label)||||||
1529966|NCT00586378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529967|NCT00586365|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1529968|NCT00586352|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529969|NCT00586339|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1529970|NCT00586326||Single Group Assignment||Treatment||None (Open Label)||||||
1529971|NCT00586313||Single Group Assignment||Diagnostic||None (Open Label)||||||
1529972|NCT00586300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529973|NCT00586287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529974|NCT00586274||Single Group Assignment||Treatment||None (Open Label)||||||
1529975|NCT00586261|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529976|NCT00586248|||||Prospective|||||||
1529977|NCT00586235|||Case Control||Prospective|||||||
1529978|NCT00586222|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1529979|NCT00586209|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1529980|NCT00586196|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1529981|NCT00586183||Single Group Assignment||||None (Open Label)||||||
1529982|NCT00586170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529983|NCT00586157|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1529984|NCT00586131|Randomized|Crossover Assignment||Other||None (Open Label)||Treatment with sodium citrate/citric acid or ammonium chloride chloride in each phase to achieve the desired arterial pH||||
1529985|NCT00586118|||Case Control||Prospective|||||||
1529986|NCT00586105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529987|NCT00586092||Single Group Assignment||||None (Open Label)||||||
1529988|NCT00586079|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1529989|NCT00586066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1529990|NCT00586053|||Cohort||Prospective|||||||
1529991|NCT00586040|Randomized|Parallel Assignment||Treatment||Single||||||t
1529992|NCT00586027|||Case Control||Prospective|||||||
1529993|NCT00586014||Single Group Assignment||Treatment||None (Open Label)||||||
1529994|NCT00586001|Randomized|Parallel Assignment||Treatment||Single||Treatment with the Unified Protocol (Arm 1) compared to a 16-week wait list control condition (Arm 2).||||t
1529995|NCT00585988|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1529996|NCT00585975|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1529997|NCT00585962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1529998|NCT00585949|||Case-Control||Prospective|||||||
1529999|NCT00585936|||Cohort||Prospective|||||||
1530000|NCT00585923|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530001|NCT00585910||Single Group Assignment||Treatment||None (Open Label)||||||
1530002|NCT00585897||Single Group Assignment||||None (Open Label)||||||
1530003|NCT00585884|||Other||Prospective|||||||
1530004|NCT00585871|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530005|NCT00585858|||Cohort||Prospective|||||||
1530006|NCT00585845||Single Group Assignment||Treatment||None (Open Label)||||||
1530007|NCT00585832|Randomized|Single Group Assignment||Treatment||Single|||||t|
1530008|NCT00585819|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1530009|NCT00585806|||Case Control||Prospective|||||||
1530010|NCT00585793|||Cohort||Prospective|||||||
1530011|NCT00585780|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530012|NCT00585767|||Case-Control||Prospective|||||||
1530013|NCT00585754|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530014|NCT00585741|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530015|NCT00585728||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530016|NCT00585715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530017|NCT00585702|||Cohort||Prospective|||||||
1530018|NCT00585689||Single Group Assignment||Treatment||None (Open Label)||||||
1530019|NCT00585676|||Cohort||Prospective|||||||
1530020|NCT00585650|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530021|NCT00585637|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1530022|NCT00585624|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530023|NCT00585611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530024|NCT00585598|||||Prospective|||||||
1530025|NCT00585585||Single Group Assignment||Treatment||None (Open Label)||||||
1530026|NCT00585572|||Other||Other|||||||
1530027|NCT00585559|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1530028|NCT00585546||Single Group Assignment||Treatment||None (Open Label)||||||
1530029|NCT00585533||Single Group Assignment||Treatment||None (Open Label)||||||
1530030|NCT00585520|Randomized|Parallel Assignment||||Triple|||t|t|t|
1530031|NCT00585507||Single Group Assignment||Treatment||None (Open Label)||||||
1530032|NCT00585494|||Cohort||Prospective|||||||
1530033|NCT00585481|||||Prospective|||||||
1530034|NCT00585468|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1530035|NCT00585455|||Cohort||Prospective|||||||
1530036|NCT00585442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530037|NCT00585429|||Cohort||Prospective|||||||
1530038|NCT00585416||Single Group Assignment||Treatment||None (Open Label)||||||
1530039|NCT00585403|||Cohort||Cross-Sectional|||||||
1530040|NCT00585390|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530041|NCT00585377||Single Group Assignment||Treatment||None (Open Label)||||||
1530042|NCT00585364|||Case Control||Prospective|||||||
1530043|NCT00585351|Randomized|Factorial Assignment||||Double|||t||t|
1530044|NCT00585338||Single Group Assignment||Treatment||None (Open Label)||||||
1530045|NCT00585325|Randomized|Single Group Assignment||Treatment||Single|||||t|
1530046|NCT00585312|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1530047|NCT00585299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530048|NCT00585286||Single Group Assignment||Treatment||None (Open Label)||||||
1530049|NCT00585273|||Cohort||Prospective|||||||
1530050|NCT00585260|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1530051|NCT00585247|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1530052|NCT00585234|||Cohort||Prospective|||||||
1530053|NCT00585221||Single Group Assignment||Treatment||None (Open Label)||||||
1530054|NCT00585208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530055|NCT00585195||||Treatment||None (Open Label)||||||
1530056|NCT00585182||Single Group Assignment||Prevention||None (Open Label)||||||
1530057|NCT00585169||Single Group Assignment||Treatment||None (Open Label)||||||
1530058|NCT00585156||Single Group Assignment||Basic Science||Single||||||t
1530059|NCT00585143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530060|NCT00585117|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1530061|NCT00585104||Single Group Assignment||Treatment||None (Open Label)||||||
1530062|NCT00585091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530063|NCT00585078||Single Group Assignment||Treatment||None (Open Label)||||||
1530064|NCT00585065|||||Prospective|||||||
1530065|NCT00585052||Single Group Assignment||Treatment||None (Open Label)||||||
1530066|NCT00585039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530067|NCT00585026|Randomized|Parallel Assignment||Treatment||Single||||||
1530068|NCT00585013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530069|NCT00585000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530070|NCT00584987|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530071|NCT00584974|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530072|NCT00584961|||Cohort||Prospective|||||||
1530073|NCT00584948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530074|NCT00584935||Single Group Assignment||Treatment||None (Open Label)||||||
1530075|NCT00584922|||Cohort||Prospective|||||||
1530076|NCT00584909||Single Group Assignment||Treatment||None (Open Label)||||||
1530077|NCT00584896||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530078|NCT00584883||Single Group Assignment||Treatment||None (Open Label)||||||
1530079|NCT00584870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530080|NCT00584857||Single Group Assignment||Treatment||None (Open Label)||||||
1530081|NCT00584844||Single Group Assignment||Prevention||None (Open Label)||||||
1530082|NCT00584831|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530083|NCT00584818||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530084|NCT00584805||Single Group Assignment||Prevention||None (Open Label)||||||
1530085|NCT00584792|||Case Control||Prospective|||||||
1530086|NCT00584779||Parallel Assignment||Treatment||None (Open Label)||||||
1530087|NCT00584766||Single Group Assignment||Treatment||None (Open Label)||||||
1530088|NCT00584753|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1530089|NCT00584740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530090|NCT00584727|Randomized|Crossover Assignment||Treatment||Single|||t|||
1530091|NCT00584714|||Case-Only||Prospective|||||||
1530092|NCT00584701||Single Group Assignment||Treatment||None (Open Label)||||||
1530093|NCT00584688|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1530094|NCT00584675||Single Group Assignment||||None (Open Label)||||||
1530095|NCT00584662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530096|NCT00584649||Single Group Assignment||Treatment||None (Open Label)||||||
1530097|NCT00584636|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1530098|NCT00584623|||Case-Only||Cross-Sectional|||||||
1530099|NCT00584610|Randomized|Parallel Assignment||Prevention||Single|||t|||
1530100|NCT00584597|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530101|NCT00584584|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530102|NCT00584571|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530103|NCT00584558|||Cohort||Prospective|||||||
1530104|NCT00584545|||Case-Only||Retrospective|||||||
1530105|NCT00584532|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1530106|NCT00584519|||Cohort||Prospective|||||||
1530107|NCT00584506|||||Retrospective|||||||
1530108|NCT00584493||||||||||||
1530109|NCT00584480||Single Group Assignment||Treatment||None (Open Label)||||||
1530110|NCT00584467|||Cohort||Prospective|||||||
1530111|NCT00584454||Single Group Assignment||Prevention||None (Open Label)||||||
1530112|NCT00584441|||Case Control||Prospective|||||||
1530113|NCT00584428||Single Group Assignment||Treatment||None (Open Label)||||||
1530114|NCT00584415||Single Group Assignment||Treatment||None (Open Label)||||||
1530115|NCT00584402||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530116|NCT00584389|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1530117|NCT00584376|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1530118|NCT00584363|||Other||Cross-Sectional|||||||
1530119|NCT00584350|Randomized|Parallel Assignment||Prevention||Single||||||t
1530120|NCT00584337|||Cohort||Prospective|||||||
1530121|NCT00584324|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1530122|NCT00584311||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530123|NCT00584298|Randomized|Crossover Assignment||||Double|||t||t|
1530124|NCT00584285|||Case-Only||Prospective|||||||
1530125|NCT00584272|||Case-Only||Retrospective|||||||
1530126|NCT00584259||Single Group Assignment||Supportive Care||None (Open Label)||||||
1530127|NCT00584246|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530128|NCT00584233||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530129|NCT00584220|Randomized|Crossover Assignment||Treatment||Single|||t|||
1530130|NCT00584207|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530131|NCT00584194||Single Group Assignment||Prevention||None (Open Label)||||||
1530132|NCT00584181|||Cohort||Prospective|||||||
1530133|NCT00584168|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530134|NCT00584155|Randomized|Single Group Assignment||Treatment||Single|||t|||
1530135|NCT00584142|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530136|NCT00584129|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530137|NCT00584116|||Cohort||Cross-Sectional|||||||
1530138|NCT00584103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530139|NCT00584090|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530140|NCT00584077|||Cohort||Cross-Sectional|||||||
1530141|NCT00584064||||||||||||
1530142|NCT00584051|||Cohort||Prospective|||||||
1530143|NCT00584038|Randomized|Factorial Assignment||Prevention||Single||||||t
1530144|NCT00584025|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1530145|NCT00584012||Single Group Assignment||Treatment||None (Open Label)||||||
1530146|NCT00583999|||Cohort||Retrospective|||||||
1530147|NCT00583986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530148|NCT00583973|||Cohort||Prospective|||||||
1530149|NCT00583960|||Case-Only||Retrospective|||||||
1530150|NCT00583947|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1530151|NCT00583934|||Case-Only||Cross-Sectional|||||||
1530152|NCT00583921|||Cohort||Prospective|||||||
1530153|NCT00583908|Randomized|Crossover Assignment||Treatment||Single|||t|||
1530154|NCT00583895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530155|NCT00583882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530156|NCT00583869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530157|NCT00583856|||Case Control||Retrospective|||||||
1530158|NCT00583843|||Case-Only||Prospective|||||||
1530159|NCT00583830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530160|NCT00583817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530161|NCT00583804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530162|NCT00583791||Single Group Assignment||Treatment||None (Open Label)||||||
1530163|NCT00583778|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530164|NCT00583765|||Cohort||Prospective|||||||
1530165|NCT00583752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530166|NCT00583739|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530167|NCT00583726|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530168|NCT00583713|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530169|NCT00583700|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530170|NCT00583687||Single Group Assignment||Treatment||None (Open Label)||||||
1530171|NCT00583674|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530172|NCT00583661||Single Group Assignment||Treatment||None (Open Label)||||||
1530173|NCT00583648|Randomized|Single Group Assignment||||None (Open Label)||||||
1530174|NCT00583635|||Case Control||Prospective|||||||
1530175|NCT00583622||Single Group Assignment||Treatment||None (Open Label)||||||
1530176|NCT00583609||Single Group Assignment||Treatment||None (Open Label)||||||
1530177|NCT00583596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530178|NCT00583583||||||||||||
1530179|NCT00583570|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1530180|NCT00583557||Single Group Assignment||Treatment||None (Open Label)||||||
1530181|NCT00583544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530182|NCT00583531||Single Group Assignment||Treatment||None (Open Label)||||||
1530183|NCT00583518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530184|NCT00583505||||||||||||
1530185|NCT00583492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530186|NCT00583479|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530187|NCT00583466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530188|NCT00583453|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1530189|NCT00583440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530190|NCT00583427||Single Group Assignment||Prevention||Single|||t|||
1530191|NCT00583414||Single Group Assignment||Treatment||None (Open Label)||||||
1530192|NCT00583401||||||||||||
1530193|NCT00583388|||Case-Crossover||Cross-Sectional|||||||
1530194|NCT00583375|Randomized|Parallel Assignment||Treatment||Single||||||t
1530195|NCT00583362||Single Group Assignment||Treatment||None (Open Label)||||||
1530196|NCT00583349||Single Group Assignment||Treatment||None (Open Label)||||||
1530197|NCT00583336||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530198|NCT00583323|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1530199|NCT00583310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530200|NCT00583297|||Cohort||Prospective|||||||
1530201|NCT00583284|||Case-Only||Prospective|||||||
1530202|NCT00583271|||Cohort||Prospective|||||||
1530203|NCT00583258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530204|NCT00583245||Single Group Assignment||Treatment||None (Open Label)||||||
1530205|NCT00583232|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1530206|NCT00583219||Single Group Assignment||Treatment||None (Open Label)||||||
1530207|NCT00583206|||Case-Only||Prospective|||||||
1530208|NCT00583193||Single Group Assignment||Treatment||None (Open Label)||||||
1530209|NCT00583180|||Cohort||Prospective|||||||
1530210|NCT00583167|||Cohort||Prospective|||||||
1530211|NCT00583154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530212|NCT00583128|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530213|NCT00583115||Single Group Assignment||Treatment||None (Open Label)||||||
1530214|NCT00583102||Single Group Assignment||Treatment||None (Open Label)||||||
1530215|NCT00583089|||Cohort||Prospective|||||||
1530216|NCT00583076||Single Group Assignment||Treatment||None (Open Label)||||||
1530217|NCT00583063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530218|NCT00583050||Single Group Assignment||Treatment||None (Open Label)||||||
1530219|NCT00583037||Single Group Assignment||Supportive Care||None (Open Label)||||||
1530220|NCT00583024||Single Group Assignment||Treatment||None (Open Label)||||||
1530221|NCT00583011|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1530222|NCT00582998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530223|NCT00582985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530224|NCT00582972|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1530225|NCT00582959||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530226|NCT00582946||Single Group Assignment||Basic Science||None (Open Label)||||||
1530227|NCT00582933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530228|NCT00582920|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1530229|NCT00582907|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1530230|NCT00582894||Single Group Assignment||Treatment||None (Open Label)||||||
1530231|NCT00582881|||Cohort||Prospective|||||||
1530232|NCT00582868|||Case-Only||Prospective|||||||
1530233|NCT00582855|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530234|NCT00582842|||Cohort||Prospective|||||||
1530235|NCT00582829||||||||||||
1530236|NCT00582816||Single Group Assignment||Treatment||None (Open Label)||||||
1530237|NCT00582803|||Case-Only||Prospective|||||||
1530238|NCT00582790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530239|NCT00582777|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1530240|NCT00582764|||Case-Only||Prospective|||||||
1530241|NCT00582751|||Cohort||Prospective|||||||
1530242|NCT00582738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530243|NCT00582725||Single Group Assignment||Treatment||None (Open Label)||||||
1530244|NCT00582712||Single Group Assignment||Treatment||None (Open Label)||||||
1530245|NCT00582699|||Case-Only||Prospective|||||||
1530246|NCT00582686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530247|NCT00582673|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530248|NCT00582660|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530249|NCT00582647|||Cohort||Prospective|||||||
1530250|NCT00582634||Single Group Assignment||Treatment||None (Open Label)||||||
1530251|NCT00582621|||Family-Based||Prospective|||||||
1530252|NCT00582608||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530253|NCT00582582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530254|NCT00582569|||Case-Only||Prospective|||||||
1530255|NCT00582556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530256|NCT00582543|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1530257|NCT00582530|||Case-Control||Prospective|||||||
1530258|NCT00582517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530259|NCT00582504||Single Group Assignment||Prevention||None (Open Label)||||||
1530260|NCT00582491|Randomized|Parallel Assignment||||Triple|||t||t|t
1530261|NCT00582478|||Case-Only||Prospective|||||||
1530262|NCT00582465|||Cohort||Prospective|||||||
1530263|NCT00582452|||Family-Based||Cross-Sectional|||||||
1530264|NCT00582439||Single Group Assignment||Treatment||None (Open Label)||||||
1530265|NCT00582426|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530266|NCT00582413|||Case-Crossover||Prospective|||||||
1530267|NCT00582400||Single Group Assignment||Treatment||None (Open Label)||||||
1530268|NCT00582387|||Cohort||Prospective|||||||
1530269|NCT00582374|||Cohort||Prospective|||||||
1530270|NCT00582361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530271|NCT00582348|||Case-Only||Retrospective|||||||
1530272|NCT00582335|||Family-Based||Prospective|||||||
1530273|NCT00582322|||Case-Only||Prospective|||||||
1530274|NCT00582309|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1530275|NCT00582296|||Cohort||Prospective|||||||
1530276|NCT00582283||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530279|NCT00582244|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1530280|NCT00582231|||Case-Only||Prospective|||||||
1530281|NCT00582218|||Case-Only||Prospective|||||||
1530282|NCT00582205||Single Group Assignment||Treatment||None (Open Label)||||||
1530283|NCT00582192|||Case-Only||Prospective|||||||
1530284|NCT00582179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530285|NCT00582166||Single Group Assignment||Treatment||None (Open Label)||||||
1530286|NCT00582140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530287|NCT00582127|||Case Control||Cross-Sectional|||||||
1530288|NCT00582114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530289|NCT00582101|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530290|NCT00582088||Single Group Assignment||Prevention||None (Open Label)||||||
1530291|NCT00582075||Single Group Assignment||Treatment||None (Open Label)||||||
1530292|NCT00582062|||Case-Crossover||Prospective|||||||
1530293|NCT00582049|||Case Control||Prospective|||||||
1530294|NCT00582036|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530295|NCT00582023|||Cohort|||||||||
1530296|NCT00582010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530297|NCT00581997|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530298|NCT00581984|||Case-Only||Prospective|||||||
1530299|NCT00581971||Single Group Assignment||Treatment||None (Open Label)||||||
1530300|NCT00581958|||Cohort||Prospective|||||||
1530301|NCT00581945|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1530302|NCT00581932|||Cohort||Prospective|||||||
1530303|NCT00581919||Single Group Assignment||Treatment||None (Open Label)||||||
1530304|NCT00581906|||Case-Only||Prospective|||||||
1530305|NCT00581893|Randomized|Crossover Assignment||Other||Double|||t||t|
1530306|NCT00581880|||Case-Only||Prospective|||||||
1530307|NCT00581867|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1530308|NCT00581854||Single Group Assignment||Treatment||None (Open Label)||||||
1530309|NCT00581841|||Cohort||Prospective|||||||
1530310|NCT00581828||Single Group Assignment||Treatment||None (Open Label)||||||
1530311|NCT00581815||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530312|NCT00581802|||Cohort||Prospective|||||||
1530313|NCT00581789||Single Group Assignment||Treatment||None (Open Label)||||||
1530314|NCT00581776||Single Group Assignment||Treatment||None (Open Label)||||||
1530315|NCT00581763|||Cohort||Prospective|||||||
1530316|NCT00581750|||Cohort||Prospective|||||||
1530317|NCT00581737|||Cohort||Prospective|||||||
1530318|NCT00581724|||Case-Only||Prospective|||||||
1530319|NCT00581711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530320|NCT00581698|||Case-Only||Prospective|||||||
1530321|NCT00581685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530322|NCT00581672|||Cohort||Prospective|||||||
1530323|NCT00581659|||Cohort||Cross-Sectional|||||||
1530324|NCT00581646|||Case-Only||Prospective|||||||
1530325|NCT00581633||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530326|NCT00581620|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530327|NCT00581607|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530328|NCT00581594|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530329|NCT00581581|||Case Control||Prospective|||||||
1530330|NCT00581568||Single Group Assignment||Treatment||None (Open Label)||||||
1530331|NCT00581555|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530332|NCT00581542|Randomized|Parallel Assignment||Treatment||Single|||||t|
1530333|NCT00581529||Single Group Assignment||Treatment||None (Open Label)||||||
1530334|NCT00581516|||Cohort||Prospective|||||||
1530335|NCT00581503|||Case-Only||Prospective|||||||
1530336|NCT00581490|||Case-Control||Prospective|||||||
1530337|NCT00581477|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1530338|NCT00581464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530339|NCT00581451|Randomized|Single Group Assignment||||Triple|||t|t|t|
1530340|NCT00581438|||Case-Only||Retrospective|||||||
1530341|NCT00581425||Single Group Assignment||Treatment||None (Open Label)||||||
1530342|NCT00581412|||Case-Only||Retrospective|||||||
1530343|NCT00581399|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530344|NCT00581386|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530345|NCT00581373||Single Group Assignment||Treatment||None (Open Label)||||||
1530346|NCT00581360||Single Group Assignment||Treatment||None (Open Label)||||||
1530347|NCT00581347|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1530348|NCT00581334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530349|NCT00581321||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530350|NCT00581308||Single Group Assignment||Treatment||None (Open Label)||||||
1530351|NCT00581295|||Case-Only||Prospective|||||||
1530352|NCT00581282|||Cohort||Prospective|||||||
1530353|NCT00581269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530354|NCT00581256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530355|NCT00581243|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1530356|NCT00581230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530357|NCT00581217|||Cohort||Prospective|||||||
1530358|NCT00581204|||Case-Only||Prospective|||||||
1530359|NCT00581191|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1530360|NCT00581178|||Cohort||Prospective|||||||
1530361|NCT00581165|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530362|NCT00581152|||Case-Only|||||||||
1530363|NCT00581139|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1530364|NCT00581126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530365|NCT00581113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530366|NCT00581100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530367|NCT00581087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530368|NCT00581074|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1530369|NCT00581061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530370|NCT00581048||Single Group Assignment||Basic Science||None (Open Label)||||||
1530371|NCT00581035|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530372|NCT00581022|||Cohort||Prospective|||||||
1530373|NCT00581009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530374|NCT00580996|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1530375|NCT00580983||Single Group Assignment||Treatment||None (Open Label)||||||
1530376|NCT00580970||Single Group Assignment||Supportive Care||None (Open Label)||||||
1530377|NCT00580957|Randomized|Parallel Assignment||||Single|||t|||
1530378|NCT00580944||Single Group Assignment||Treatment||None (Open Label)||||||
1530379|NCT00580931|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530380|NCT00580918|||Cohort||Prospective|||||||
1530381|NCT00580905|Non-Randomized|Single Group Assignment||Other||Single|||t|||
1530382|NCT00580892|||Case-Only||Prospective|||||||
1530383|NCT00580879|||Cohort||Prospective|||||||
1530384|NCT00580866|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1530385|NCT00580853|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530386|NCT00580840|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530387|NCT00580827|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1530388|NCT00580814||Single Group Assignment||Basic Science||None (Open Label)||||||
1530389|NCT00580801|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530390|NCT00580788|Non-Randomized|Single Group Assignment||||Single|||t|||
1530391|NCT00580775|||Cohort||Prospective|||||||
1530392|NCT00580762|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530393|NCT00580749|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530394|NCT00580736||Single Group Assignment||Treatment||None (Open Label)||||||
1530395|NCT00580723||Single Group Assignment||Treatment||None (Open Label)||||||
1530396|NCT00580710|||Case-Control||Cross-Sectional|||||||
1530397|NCT00580697|||Cohort||Prospective|||||||
1530398|NCT00580684|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530399|NCT00580671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530400|NCT00580658||||||||||||
1530401|NCT00580645|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530402|NCT00580632|||Case-Only||Retrospective|||||||
1530403|NCT00580619|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1530404|NCT00580606|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1530405|NCT00580593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530406|NCT00580580|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1530407|NCT00580567|||Case Control||Cross-Sectional|||||||
1530408|NCT00580541|Randomized|Crossover Assignment||||None (Open Label)||||||
1530409|NCT00580528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530410|NCT00580515|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530411|NCT00580502||Single Group Assignment||Treatment||None (Open Label)||||||
1530412|NCT00580489|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1530413|NCT00580476|||Case-Only||Prospective|||||||
1530414|NCT00580463|||Case-Only||Prospective|||||||
1530415|NCT00580450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530416|NCT00580437||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530417|NCT00580424||Single Group Assignment||Prevention||None (Open Label)||||||
1530418|NCT00580411|||Cohort||Retrospective|||||||
1530419|NCT00580398|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530420|NCT00580385||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530421|NCT00580372||Single Group Assignment||Treatment||None (Open Label)||||||
1530422|NCT00580359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530423|NCT00580346||Single Group Assignment||Prevention||Double||||t|t|
1530424|NCT00580333||Single Group Assignment||Treatment||None (Open Label)||||||
1530425|NCT00580320||Single Group Assignment||Treatment||None (Open Label)||||||
1530426|NCT00580307|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1530427|NCT00580294||Single Group Assignment||Treatment||None (Open Label)||||||
1530428|NCT00580281||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530429|NCT00580268|||Cohort||Prospective|||||||
1530430|NCT00580255|||Cohort||Prospective|||||||
1530431|NCT00580242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530432|NCT00580229||Single Group Assignment||Treatment||None (Open Label)||||||
1530433|NCT00580216|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1530434|NCT00580203|||Case-Only||Prospective|||||||
1530435|NCT00580190|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530436|NCT00580177|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530437|NCT00580164|||Cohort||Prospective|||||||
1530438|NCT00580151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530439|NCT00580138|||Case-Only||Prospective|||||||
1530440|NCT00580125|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530441|NCT00580112|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530443|NCT00580086|||Case-Only||Retrospective|||||||
1530444|NCT00580073||Single Group Assignment||Treatment||None (Open Label)||||||
1530445|NCT00580060||Single Group Assignment||Treatment||None (Open Label)||||||
1530446|NCT00580047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530447|NCT00580034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530448|NCT00580021|||Cohort||Retrospective|||||||
1530449|NCT00580008|||Case-Only||Retrospective|||||||
1530450|NCT00579995|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1530451|NCT00579982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530452|NCT00579969|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1530453|NCT00579956|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530454|NCT00579943|||Cohort||Prospective|||||||
1530455|NCT00579930|||Case-Only||Prospective|||||||
1530456|NCT00579917|||Cohort||Prospective|||||||
1530457|NCT00579904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530458|NCT00579891|||Case-Only||Prospective|||||||
1530459|NCT00579878|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530460|NCT00579865|||Cohort||Prospective|||||||
1530461|NCT00579852|||Case-Only||Prospective|||||||
1530462|NCT00579839|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530463|NCT00579826|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1530464|NCT00579813|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1530465|NCT00579800||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530466|NCT00579787|||Case Control||Prospective|||||||
1530467|NCT00579774|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1530468|NCT00579761|||Case-Only||Retrospective|||||||
1530469|NCT00579748|||Case-Only||Prospective|||||||
1530470|NCT00579735|||Case-Only||Retrospective|||||||
1530471|NCT00579709||Single Group Assignment||Treatment||None (Open Label)||||||
1530472|NCT00579696|||Ecologic or Community||Prospective|||||||
1530473|NCT00579683|||Case-Only||Prospective|||||||
1530474|NCT00579670|||Cohort||Prospective|||||||
1530475|NCT00579657|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1530476|NCT00579644|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530477|NCT00579631|||Case-Only||Cross-Sectional|||||||
1530478|NCT00579618|||Cohort||Prospective|||||||
1530479|NCT00579605||Single Group Assignment||Prevention||None (Open Label)||||||
1530480|NCT00579592||Single Group Assignment||Treatment||None (Open Label)||||||
1530481|NCT00579579|||Case-Only||Prospective|||||||
1530482|NCT00579566|||Case-Control||Prospective|||||||
1530483|NCT00579553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530484|NCT00579540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530485|NCT00579527|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530486|NCT00579514|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1530487|NCT00579501||Single Group Assignment||Treatment||None (Open Label)||||||
1530488|NCT00579488|||Case-Only||Prospective|||||||
1530489|NCT00579475|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530490|NCT00579462|||Case Control||Prospective|||||||
1530491|NCT00579449|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530492|NCT00579436|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1530493|NCT00579423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530494|NCT00579410|||Cohort||Prospective|||||||
1530495|NCT00579397|||Cohort||Prospective|||||||
1530496|NCT00579384|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1530497|NCT00579371||Single Group Assignment||Treatment||None (Open Label)||||||
1530498|NCT00579358|||Case Control||Prospective|||||||
1530499|NCT00579345|Randomized|Parallel Assignment||Prevention||Single|||t|||
1530500|NCT00579332|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1530501|NCT00579319|||Case-Only||Retrospective|||||||
1530502|NCT00579306|||Cohort||Prospective|||||||
1530503|NCT00579293|||Case-Only||Prospective|||||||
1530504|NCT00579280|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530505|NCT00579267|||Case-Only||Cross-Sectional|||||||
1530506|NCT00579254|||Cohort||Prospective|||||||
1530507|NCT00579241|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1530508|NCT00579228|||Cohort||Prospective|||||||
1530509|NCT00579215|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530510|NCT00579202|||Other||Other|||||||
1530511|NCT00579189|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530512|NCT00579176||||||||||||
1530513|NCT00579163|||Case-Only||Prospective|||||||
1530514|NCT00579150|||Cohort||Prospective|||||||
1530515|NCT00579137||Single Group Assignment||Treatment||None (Open Label)||||||
1530516|NCT00579124|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530517|NCT00579111|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530518|NCT00579098|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530519|NCT00579085|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530520|NCT00579072|||Case-Control||Prospective|||||||
1530521|NCT00579059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530522|NCT00579046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530523|NCT00579033|Randomized|Parallel Assignment||Treatment||Single||||||t
1530524|NCT00579020|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530525|NCT00579007|||Cohort||Prospective|||||||
1530526|NCT00578994|||Cohort||Prospective|||||||
1530527|NCT00578981|Randomized|Factorial Assignment||||Single|||t|||
1530528|NCT00578968|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530529|NCT00578955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530530|NCT00578942||Single Group Assignment||Treatment||None (Open Label)||||||
1530531|NCT00578929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530532|NCT00578916|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530533|NCT00578903||Single Group Assignment||Treatment||None (Open Label)||||||
1530534|NCT00578890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530535|NCT00578877|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1530536|NCT00578864|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530537|NCT00578851|||Cohort||Prospective|||||||
1530538|NCT00578838|||Case Control||Prospective|||||||
1530539|NCT00578825|Randomized|Parallel Assignment||Treatment||Double||||||
1530540|NCT00578812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530541|NCT00578799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530542|NCT00578786|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530543|NCT00578773|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530544|NCT00578760|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1530545|NCT00578747|||||Prospective|||||||
1530546|NCT00578734|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530547|NCT00578721||Single Group Assignment||Prevention||None (Open Label)||||||
1530548|NCT00578708||Single Group Assignment||Treatment||None (Open Label)||||||
1530549|NCT00578695|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530550|NCT00578682|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1530551|NCT00578669|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530552|NCT00578656|Non-Randomized|||Diagnostic||None (Open Label)||||||
1530553|NCT00578643||Single Group Assignment||Treatment||None (Open Label)||||||
1530554|NCT00578630|||Case-Only||Prospective|||||||
1530555|NCT00578617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530556|NCT00578604|||Cohort||Prospective|||||||
1530557|NCT00578591|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530558|NCT00578578|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530559|NCT00578565||Single Group Assignment||Treatment||None (Open Label)||||||
1530560|NCT00578552|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1530561|NCT00578539||Single Group Assignment||Treatment||None (Open Label)||||||
1530562|NCT00578526|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530563|NCT00578513||||||||||||
1530564|NCT00578500||Single Group Assignment||Treatment||None (Open Label)||||||
1530565|NCT00578487||||||||||||
1530566|NCT00578474|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530567|NCT00578461||Single Group Assignment||Treatment||None (Open Label)||||||
1530568|NCT00578448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530569|NCT00578435||Single Group Assignment||Treatment||None (Open Label)||||||
1530570|NCT00578422|||Case-Control||Prospective|||||||
1530571|NCT00578409|||Cohort||Retrospective|||||||
1530572|NCT00578396|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530573|NCT00578383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530574|NCT00578370|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530575|NCT00578357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530576|NCT00578344||Single Group Assignment||Treatment||None (Open Label)||||||
1530577|NCT00578331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530578|NCT00578318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530579|NCT00578305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530580|NCT00578292||Single Group Assignment||Treatment||None (Open Label)||||||
1530581|NCT00578279|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1530582|NCT00578266||Single Group Assignment||Treatment||None (Open Label)||||||
1530583|NCT00578240|||Case-Only||Other|||||||
1530584|NCT00578227|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530585|NCT00578214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530586|NCT00578201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530587|NCT00578188|||Case Control||Prospective|||||||
1530588|NCT00578175|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1530589|NCT00578162|||||Prospective|||||||
1530590|NCT00578149|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530591|NCT00578136|Randomized|Single Group Assignment||Treatment||Single||||||t
1530592|NCT00578123||Single Group Assignment||Supportive Care||None (Open Label)||||||
1530593|NCT00578110|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1530594|NCT00578097|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530595|NCT00578084|||Cohort||Prospective|||||||
1530596|NCT00578071||Single Group Assignment||Treatment||None (Open Label)||||||
1530597|NCT00578058|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530598|NCT00578045|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1530599|NCT00578032|||Case-Only||Prospective|||||||
1530600|NCT00578019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530601|NCT00578006|Randomized|Parallel Assignment||||None (Open Label)||||||
1530602|NCT00577993|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530603|NCT00577980||Single Group Assignment||Treatment||None (Open Label)||||||
1530604|NCT00577967|Randomized|Parallel Assignment||Treatment||Double||||||
1530605|NCT00577954|||Cohort||Prospective|||||||
1530606|NCT00577928|||Case Control||Retrospective|||||||
1530607|NCT00577915||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530608|NCT00577902|||||Prospective|||||||
1530609|NCT00577889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530610|NCT00577876||Single Group Assignment||Treatment||None (Open Label)||||||
1530611|NCT00577863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530612|NCT00577850|Randomized|Parallel Assignment||||None (Open Label)||||||
1530613|NCT00577837|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530614|NCT00577824|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530615|NCT00577811|||Case Control||Prospective|||||||
1530616|NCT00577798||Single Group Assignment||Diagnostic||Single|||||t|
1530617|NCT00577785|||Case-Only||Prospective|||||||
1530618|NCT00577772|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1530619|NCT00577759|Randomized|Factorial Assignment||Prevention||Single|||t|||
1530620|NCT00577746|||Cohort||Prospective|||||||
1530621|NCT00577733|||||Prospective|||||||
1530622|NCT00577720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530623|NCT00577707||Single Group Assignment||Treatment||None (Open Label)||||||
1530624|NCT00577694||Single Group Assignment||Treatment||None (Open Label)||||||
1530625|NCT00577681|||Case Control||Retrospective|||||||
1530626|NCT00577668|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1530627|NCT00577655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530628|NCT00577642||Single Group Assignment||Treatment||None (Open Label)||||||
1530629|NCT00577629||Single Group Assignment||Treatment||None (Open Label)||||||
1530630|NCT00577616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530631|NCT00577603|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530632|NCT00577590|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530633|NCT00577577|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1530634|NCT00577564|||Case-Only||Retrospective|||||||
1530635|NCT00577538|||Case Control||Retrospective|||||||
1530636|NCT00577525|||Case Control||Prospective|||||||
1530637|NCT00577512||Single Group Assignment||Treatment||None (Open Label)||||||
1530638|NCT00577499|||Case-Only||Prospective|||||||
1530639|NCT00577473|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530640|NCT00577460|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530641|NCT00577447|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530642|NCT00577434|||Cohort||Prospective|||||||
1530643|NCT00577421||Single Group Assignment||Treatment||None (Open Label)||||||
1530644|NCT00577408|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530645|NCT00577395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530646|NCT00577382||Single Group Assignment||Treatment||None (Open Label)||||||
1530647|NCT00577369||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530648|NCT00577356||Single Group Assignment||Treatment||None (Open Label)||||||
1530649|NCT00577343|||Cohort||Prospective|||||||
1530650|NCT00577330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530651|NCT00577317|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1530652|NCT00577304|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1530653|NCT00577278||Single Group Assignment||Treatment||None (Open Label)||||||
1530654|NCT00577265|||||Prospective|||||||
1530655|NCT00577252|||Cohort||Cross-Sectional|||||||
1530656|NCT00577226|||||Prospective|||||||
1530657|NCT00577213|||Cohort||Cross-Sectional|||||||
1530658|NCT00577200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530659|NCT00577187||Single Group Assignment||Treatment||None (Open Label)||||||
1530660|NCT00577174|||Case Control|||||||||
1530661|NCT00577161|Randomized|Parallel Assignment||Treatment||Single||||||t
1530662|NCT00577148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530663|NCT00577135|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1530664|NCT00577122|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530665|NCT00577109||Single Group Assignment||Treatment||None (Open Label)||||||
1530666|NCT00577096|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530667|NCT00577083|Randomized|Crossover Assignment||Screening||None (Open Label)||||||
1530668|NCT00577070|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530669|NCT00577057|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1530670|NCT00577044||||||||||||
1530671|NCT00577031||Single Group Assignment||Treatment||None (Open Label)||||||
1530672|NCT00577018|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530673|NCT00577005|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530674|NCT00576992|||Cohort||Prospective|||||||
1530675|NCT00576979||Single Group Assignment||Treatment||None (Open Label)||||||
1530676|NCT00576953||||||||||||
1530677|NCT00576940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530678|NCT00576927|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1530679|NCT00576914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530680|NCT00576901|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530681|NCT00576888|||Other||Other|||||||
1530682|NCT00576875|||Cohort||Cross-Sectional|||||||
1530683|NCT00576862|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530684|NCT00576849|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530685|NCT00576836|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530686|NCT00576823|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530687|NCT00576810||Parallel Assignment||Treatment||||||||
1530688|NCT00576797|||||Prospective|||||||
1530689|NCT00576784||Single Group Assignment||Treatment||None (Open Label)||||||
1530690|NCT00576771||Single Group Assignment||Treatment||None (Open Label)||||||
1530691|NCT00576758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530692|NCT00576745|Randomized|Parallel Assignment||Treatment||Single||||||t
1530693|NCT00576732|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530694|NCT00576719|Randomized|Parallel Assignment||Treatment||Single||||||t
1530695|NCT00576706|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1530696|NCT00576693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530697|NCT00576680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530698|NCT00576667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530699|NCT00576654|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530700|NCT00576641||Single Group Assignment||Treatment||None (Open Label)||||||
1530701|NCT00576628||Single Group Assignment||Treatment||None (Open Label)||||||
1530702|NCT00576615|||Case Control||Prospective|||||||
1530703|NCT00576602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530704|NCT00576589|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1530705|NCT00576576||Single Group Assignment||Treatment||None (Open Label)||||||
1530706|NCT00576563||Single Group Assignment||Treatment||None (Open Label)||||||
1530707|NCT00576550|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530708|NCT00576537|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530709|NCT00576524|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1530710|NCT00576511|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530711|NCT00576498|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1530712|NCT00576485|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530713|NCT00576472||Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1530714|NCT00576459|Randomized|Parallel Assignment||Treatment||Single||||||t
1530715|NCT00576446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530716|NCT00576433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530717|NCT00576420|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530718|NCT00576407||Single Group Assignment||Treatment||None (Open Label)||||||
1530719|NCT00576394|Randomized|Parallel Assignment||Treatment||Single||||||t
1530720|NCT00576381||Single Group Assignment||Treatment||None (Open Label)||||||
1530721|NCT00576368|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530722|NCT00576355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530723|NCT00576342|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1530724|NCT00576329|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1530725|NCT00576316|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530726|NCT00576303||Single Group Assignment||Treatment||None (Open Label)||||||
1530727|NCT00576277|Randomized|Parallel Assignment||Treatment||Double||||||
1530728|NCT00576264|||Cohort||Prospective|||||||
1530729|NCT00576251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530730|NCT00576238|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530731|NCT00576225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530732|NCT00576212|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530733|NCT00576199||Single Group Assignment||Treatment||None (Open Label)||||||
1530734|NCT00576186|||Case-Only||Prospective|||||||
1530735|NCT00576173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530736|NCT00576160|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1530737|NCT00576147||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530738|NCT00576134|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530739|NCT00576121|||Case Control||Prospective|||||||
1530740|NCT00576108|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1530741|NCT00576095|||||Prospective|||||||
1530742|NCT00576082|||Case-Only||Prospective|||||||
1530743|NCT00576069|||Case-Control||Prospective|||||||
1530744|NCT00576056||Single Group Assignment||Treatment||None (Open Label)||||||
1530745|NCT00576043|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1530746|NCT00576030|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1530747|NCT00576017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530748|NCT00576004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530749|NCT00575991|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1530750|NCT00575978||Single Group Assignment||Health Services Research||None (Open Label)||||||
1530751|NCT00575965||Single Group Assignment||Treatment||None (Open Label)||||||
1530752|NCT00575952||Single Group Assignment||Treatment||None (Open Label)||||||
1530753|NCT00575939|||Case Control||Prospective|||||||
1530754|NCT00575926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530755|NCT00575913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530756|NCT00575900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530757|NCT00575887|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530758|NCT00575874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530759|NCT00575861|Non-Randomized|Crossover Assignment||Treatment||Single||||||t
1530760|NCT00575848|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1530761|NCT00575835|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530841|NCT00574743|Randomized|Parallel Assignment||Treatment||Single||||||
1530762|NCT00575822|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1530763|NCT00575809|||Other||Prospective|||||||
1530764|NCT00575796||Single Group Assignment||Treatment||None (Open Label)||||||
1530765|NCT00575783|||Case Control||Cross-Sectional|||||||
1530766|NCT00575757|||Cohort||Prospective|||||||
1530767|NCT00575744|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530768|NCT00575731|Randomized|Factorial Assignment||Treatment||Single||||||t
1530769|NCT00575718|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530770|NCT00575692||||||||||||
1530771|NCT00575679|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1530772|NCT00575666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530773|NCT00575653|||Cohort||Retrospective|||||||
1530774|NCT00575640||Single Group Assignment||Health Services Research||None (Open Label)||||||
1530775|NCT00575627|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530776|NCT00575614|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530777|NCT00575601|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1530778|NCT00575588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530779|NCT00575575|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530780|NCT00575562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530781|NCT00575549||||||||||||
1530782|NCT00575536|||Case-Only||Retrospective|||||||
1530783|NCT00575523|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1530784|NCT00575510|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1530785|NCT00575497|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1530786|NCT00575484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530787|NCT00575471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530788|NCT00575458|||Cohort||Prospective|||||||
1530789|NCT00575445|||Case-Only||Cross-Sectional|||||||
1530790|NCT00575432|||Cohort||Prospective|||||||
1530791|NCT00575419|Randomized|Parallel Assignment||Prevention||Single|||t|||
1530792|NCT00575406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530793|NCT00575393||||Treatment||||||||
1530794|NCT00575380|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530795|NCT00575367|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530796|NCT00575354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530797|NCT00575341|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530798|NCT00575328|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1530799|NCT00575315|||Cohort||Prospective|||||||
1530800|NCT00575302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530801|NCT00575276|||Case Control||Cross-Sectional|||||||
1530802|NCT00575263|||Case Control||Cross-Sectional|||||||
1530803|NCT00575250|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1530804|NCT00575237|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1530805|NCT00575224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530806|NCT00575211|||Cohort||Prospective|||||||
1530807|NCT00575198|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1530808|NCT00575185|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530809|NCT00575172|||Cohort||Prospective|||||||
1530810|NCT00575159|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1530811|NCT00575146||Single Group Assignment||Treatment||None (Open Label)||||||
1530812|NCT00575133|||Cohort||Prospective|||||||
1530813|NCT00575120||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530814|NCT00575107|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530815|NCT00575094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530816|NCT00575081|||Case-Only||Cross-Sectional|||||||
1530817|NCT00575068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530818|NCT00575055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530819|NCT00575042||Single Group Assignment||Treatment||None (Open Label)||||||
1530820|NCT00575029||Single Group Assignment||Health Services Research||None (Open Label)||||||
1530821|NCT00575016|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530822|NCT00575003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530823|NCT00574990|||||Prospective|||||||
1530824|NCT00574977|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530825|NCT00574964|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530826|NCT00574951||Single Group Assignment||Treatment||None (Open Label)||||||
1530827|NCT00574925|Randomized|Parallel Assignment||Treatment||Double||||||
1530828|NCT00574912||Single Group Assignment||Treatment||None (Open Label)||||||
1530829|NCT00574899|||Case Control||Prospective|||||||
1530830|NCT00574886|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530831|NCT00574873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530832|NCT00574860|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1530833|NCT00574847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530834|NCT00574834|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1530835|NCT00574821|||Cohort||Prospective|||||||
1530836|NCT00574808|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1530837|NCT00574795|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1530838|NCT00574782|||||Prospective|||||||
1530839|NCT00574769||Single Group Assignment||Treatment||None (Open Label)||||||
1530840|NCT00574756|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1530842|NCT00574730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530843|NCT00574717||Single Group Assignment||Treatment||None (Open Label)||||||
1530844|NCT00574704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530845|NCT00574691||Single Group Assignment||Treatment||None (Open Label)||||||
1530846|NCT00574678|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1530847|NCT00574665|Randomized|Factorial Assignment||Prevention||Single|||t|||
1530848|NCT00574652|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530849|NCT00574639|Randomized|Factorial Assignment||Treatment||Single|||t|||
1530850|NCT00574626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530851|NCT00574613|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530852|NCT00574600|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1530853|NCT00574587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530854|NCT00574574|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1530855|NCT00574561|||Case Control||Prospective|||||||
1530856|NCT00574548|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1530857|NCT00574535|||Cohort||Retrospective|||||||
1530858|NCT00574522||Single Group Assignment||Treatment||None (Open Label)||||||
1530859|NCT00574509||Single Group Assignment||Treatment||None (Open Label)||||||
1530860|NCT00574496||Single Group Assignment||Treatment||None (Open Label)||||||
1530861|NCT00574483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530862|NCT00574470||Single Group Assignment||Treatment||None (Open Label)||||||
1530863|NCT00574457||Single Group Assignment||Prevention||None (Open Label)||||||
1530864|NCT00574444||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530865|NCT00574431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530866|NCT00574418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530867|NCT00574405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530868|NCT00574392|||Cohort||Prospective|||||||
1530869|NCT00574379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530870|NCT00574366||Single Group Assignment||Treatment||None (Open Label)||||||
1530871|NCT00574353||Single Group Assignment||Screening||None (Open Label)||||||
1530872|NCT00574340|Randomized|Crossover Assignment||Prevention||Single|||t|||
1530873|NCT00574327|||Case-Control||Prospective|||||||
1530874|NCT00574314|||Cohort||Other|||||||
1530875|NCT00574301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530876|NCT00574288|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530877|NCT00574275|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530878|NCT00574262|||Case-Only||Prospective|||||||
1530879|NCT00574249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530880|NCT00574236||Single Group Assignment||Treatment||None (Open Label)||||||
1530881|NCT00574223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530882|NCT00574210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530883|NCT00574197|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530884|NCT00574184|||Cohort||Cross-Sectional|||||||
1530885|NCT00574171||Single Group Assignment||Treatment||None (Open Label)||||||
1530886|NCT00574158|||Cohort||Prospective|||||||
1530887|NCT00574145|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1530888|NCT00574132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530889|NCT00574119||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530890|NCT00574106|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530891|NCT00574093||Single Group Assignment||Treatment||None (Open Label)||||||
1530892|NCT00574080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530893|NCT00574067|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1530894|NCT00574054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530895|NCT00574041|Randomized|Parallel Assignment||Treatment||Single|||t|||
1530896|NCT00574028|||Case Control||Prospective|||||||
1530897|NCT00574015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530898|NCT00574002|||Cohort||Prospective|||||||
1530899|NCT00573989||Single Group Assignment||Treatment||None (Open Label)||||||
1530900|NCT00573976|||Case Control||Prospective|||||||
1530901|NCT00573963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530902|NCT00573950|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1530903|NCT00573937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530904|NCT00573924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530905|NCT00573911|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1530906|NCT00573898|||||Prospective|||||||
1530907|NCT00573885|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530908|NCT00573872||Single Group Assignment||Treatment||None (Open Label)||||||
1530909|NCT00573859|Randomized|Factorial Assignment||Basic Science||Double|||t||t|
1530910|NCT00573846|||Case Control||Retrospective|||||||
1530911|NCT00573833||Single Group Assignment||Treatment||None (Open Label)||||||
1530912|NCT00573820|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530913|NCT00573807|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530914|NCT00573794||Single Group Assignment||Treatment||None (Open Label)||||||
1530915|NCT00573781|Randomized|Parallel Assignment||Treatment||Single||||||t
1530916|NCT00573768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530917|NCT00573755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530918|NCT00573742|||Case-Only||Prospective|||||||
1530919|NCT00573729|Randomized|Single Group Assignment||Treatment||Single||||||t
1530920|NCT00573716|||Case Control||Retrospective|||||||
1530921|NCT00573703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530922|NCT00573690|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530923|NCT00573664|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530924|NCT00573651|Non-Randomized|Single Group Assignment||Treatment||Single|The geometric mean titers are analyzed in a de-identified manner at Merck Contract laboratories.|Open label vaccination study.||||t
1530925|NCT00573638||Single Group Assignment||Treatment||None (Open Label)||||||
1530926|NCT00573612|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1530927|NCT00573599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530928|NCT00573586|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530929|NCT00573573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530930|NCT00573560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530931|NCT00573547||Single Group Assignment||Treatment||None (Open Label)||||||
1530932|NCT00573534||Single Group Assignment||Treatment||None (Open Label)||||||
1530933|NCT00573521|||Other||Retrospective|||||||
1530934|NCT00573508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530935|NCT00573495||Single Group Assignment||Treatment||None (Open Label)||||||
1530936|NCT00573482|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1530937|NCT00573469|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530938|NCT00573456|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530939|NCT00573443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530940|NCT00573430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530941|NCT00573417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530942|NCT00573404||Single Group Assignment||Treatment||None (Open Label)||||||
1530943|NCT00573391|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530944|NCT00573378||Single Group Assignment||Treatment||None (Open Label)||||||
1530945|NCT00573365|Randomized|Parallel Assignment||Device Feasibility||Single||The enrollment goal of 40 includes 20 for each arm.||||t
1530946|NCT00573352|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530947|NCT00573339|||Cohort||Prospective|||||||
1530948|NCT00573326|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530949|NCT00573313|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530950|NCT00573300|||Case-Only||Prospective|||||||
1530951|NCT00573287|Randomized|Parallel Assignment||Treatment||Single||||||t
1530952|NCT00573274|||Case-Only||Prospective|||||||
1530953|NCT00573261|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530954|NCT00573248|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1530955|NCT00573235|||Other||Retrospective|||||||
1530956|NCT00573222|||||Prospective|||||||
1530957|NCT00573209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530958|NCT00573196|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530959|NCT00573183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530960|NCT00573170|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1530961|NCT00573157|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1530962|NCT00573144|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1530963|NCT00573131|Randomized|Parallel Assignment||Treatment||Single||||||t
1530964|NCT00573118|||Case Control||Retrospective|||||||
1530965|NCT00573105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530966|NCT00573092||||||||||||
1530967|NCT00573079|||||Prospective|||||||
1530968|NCT00573066||Single Group Assignment||Treatment||None (Open Label)||||||
1530969|NCT00573053|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1530970|NCT00573040|||Cohort||Prospective|||||||
1530971|NCT00573027||Single Group Assignment||Treatment||None (Open Label)||||||
1530972|NCT00573014|||Cohort||Prospective|||||||
1530973|NCT00573001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530974|NCT00572988|||||Prospective|||||||
1530975|NCT00572975|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1530976|NCT00572962||Single Group Assignment||Treatment||None (Open Label)||||||
1530977|NCT00572949|||Cohort||Prospective|||||||
1530978|NCT00572936|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1530979|NCT00572923|||Cohort||Prospective|||||||
1530980|NCT00572910|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1530981|NCT00572897||Single Group Assignment||Treatment||None (Open Label)||||||
1530982|NCT00572884||Single Group Assignment||Basic Science||None (Open Label)||||||
1530983|NCT00572871|||Case-Only||Cross-Sectional|||||||
1530984|NCT00572858|||Cohort||Prospective|||||||
1530985|NCT00572845||Single Group Assignment||||None (Open Label)||||||
1530986|NCT00572832|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1530987|NCT00572819|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1530988|NCT00572806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1530989|NCT00572793|||Case Control||Prospective|||||||
1530990|NCT00572780|||Cohort||Retrospective|||||||
1530991|NCT00572767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1530992|NCT00572754||Single Group Assignment||Prevention||None (Open Label)||||||
1530993|NCT00572741|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1530994|NCT00572728||Single Group Assignment||Diagnostic||None (Open Label)||||||
1530995|NCT00572715|||||Prospective|||||||
1530996|NCT00572702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1530997|NCT00572689|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1530998|NCT00572663|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1530999|NCT00572650||Single Group Assignment||Treatment||None (Open Label)||||||
1531000|NCT00572637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531001|NCT00572624|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1531002|NCT00572611||Single Group Assignment||Basic Science||None (Open Label)||||||
1531003|NCT00572598||Single Group Assignment||||None (Open Label)||||||
1531004|NCT00572585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531005|NCT00572572|Randomized|Crossover Assignment||Supportive Care||Double|||t|t||
1531006|NCT00572559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531007|NCT00572533|Randomized|Parallel Assignment||Other||Double|||t|t||
1531008|NCT00572520|Randomized|Parallel Assignment||Treatment||Single||||||t
1531009|NCT00572507|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531010|NCT00572494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531011|NCT00572481|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||During surgery, the technetium-99m sulfur colloid will be injected into the breast and the blue dye injected (if the patient is not allergic and it is not required to locate the SLN) in the patient's ipsilateral upper arm. The lymph node biopsy and/or dissection will be performed by the surgeon, according to standard practice.||||
1531012|NCT00572468|Randomized|Parallel Assignment||Screening||Double|||t||t|
1531013|NCT00572455|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531014|NCT00572442||||||||||||
1531015|NCT00572429|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1531016|NCT00572416|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1531017|NCT00572403|||Cohort||Prospective|||||||
1531018|NCT00572390|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1531019|NCT00572377|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1531020|NCT00572364|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531021|NCT00572351|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1531022|NCT00572338|||Case-Only||Prospective|||||||
1531023|NCT00572325|||Cohort||Prospective|||||||
1531024|NCT00572312|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531025|NCT00572299|||Case Control||Prospective|||||||
1531026|NCT00572286|||Cohort||Prospective|||||||
1531027|NCT00572260||Single Group Assignment||||None (Open Label)||||||
1531028|NCT00572247|Randomized|Parallel Assignment||||None (Open Label)||||||
1531029|NCT00572234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531030|NCT00572221|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1531031|NCT00572208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531032|NCT00572195||Single Group Assignment||Treatment||None (Open Label)||||||
1531033|NCT00572182||Single Group Assignment||Treatment||None (Open Label)||||||
1531034|NCT00572169||Single Group Assignment||Treatment||None (Open Label)||||||
1531035|NCT00572156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531036|NCT00572143|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1531037|NCT00572130|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531038|NCT00572117|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531039|NCT00572104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531040|NCT00572091||Single Group Assignment||Treatment||None (Open Label)||||||
1531041|NCT00572078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531042|NCT00572065||Single Group Assignment||Treatment||None (Open Label)||||||
1531043|NCT00572052|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531044|NCT00572039|Randomized|Parallel Assignment||Treatment||Single||||||t
1531045|NCT00572026|Randomized|Crossover Assignment||||None (Open Label)||||||
1531046|NCT00572013||Single Group Assignment||Treatment||None (Open Label)||||||
1531047|NCT00572000|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1531048|NCT00571987||Single Group Assignment||Treatment||None (Open Label)||||||
1531049|NCT00571974|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531050|NCT00571961||Single Group Assignment||Basic Science||None (Open Label)||||||
1531051|NCT00571948|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1531052|NCT00571935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531053|NCT00571922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531054|NCT00571909||Single Group Assignment||Treatment||None (Open Label)||||||
1531055|NCT00571896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531056|NCT00571883|Randomized|||Treatment||||||||
1531057|NCT00571870|Randomized|Parallel Assignment||Treatment||Single||||t||
1531058|NCT00571844|Randomized|Parallel Assignment||Treatment||Single||||||t
1531059|NCT00571831|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531060|NCT00571818|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1531061|NCT00571805|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1531062|NCT00571792|||Cohort||Prospective|||||||
1531063|NCT00571779||||||||||||
1531064|NCT00571766|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531065|NCT00571753|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531066|NCT00571740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531067|NCT00571727||Single Group Assignment||Treatment||None (Open Label)||||||
1531901|NCT00560625|||Case-Only||Prospective|||||||
1531068|NCT00571714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531069|NCT00571701|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531070|NCT00571688|Randomized|Parallel Assignment||Treatment||Single||||||t
1531071|NCT00571675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531072|NCT00571662||Single Group Assignment||Treatment||None (Open Label)||||||
1531073|NCT00571649|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1531074|NCT00571636|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1531075|NCT00571623|||Case-Crossover||Prospective|||||||
1531076|NCT00571610||Single Group Assignment||Treatment||None (Open Label)||||||
1531077|NCT00571597|||Case-Only||Prospective|||||||
1531078|NCT00571584|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531079|NCT00571571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531080|NCT00571558||Single Group Assignment||Treatment||None (Open Label)||||||
1531081|NCT00571545|Randomized|Parallel Assignment||Treatment||Single||||||t
1531082|NCT00571519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531083|NCT00571506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531084|NCT00571493||Single Group Assignment||Treatment||None (Open Label)||||||
1531085|NCT00571480|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1531086|NCT00571467||Single Group Assignment||Treatment||None (Open Label)||||||
1531087|NCT00571454|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1531088|NCT00571441|||Case Control||Prospective|||||||
1531089|NCT00571428|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1531090|NCT00571415|||Cohort||Prospective|||||||
1531091|NCT00571402|Randomized|Parallel Assignment||Treatment||Single||||||t
1531092|NCT00571389|||Case-Only||Prospective|||||||
1531093|NCT00571376|||Cohort||Prospective|||||||
1531094|NCT00571363|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1531095|NCT00571350|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1531096|NCT00571337||Parallel Assignment||Treatment||None (Open Label)||||||
1531097|NCT00571324|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1531098|NCT00571311|||||Prospective|||||||
1531099|NCT00571298|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531100|NCT00571285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531101|NCT00571272|||Cohort||Prospective|||||||
1531102|NCT00571259|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1531103|NCT00571246|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1531104|NCT00571233|||Case Control||Cross-Sectional|||||||
1531105|NCT00571220|||Case-Control||Prospective|||||||
1531106|NCT00571207||||||||||||
1531107|NCT00571194||Single Group Assignment||Other||None (Open Label)||||||
1531108|NCT00571181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531109|NCT00571168|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531110|NCT00571155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531111|NCT00571142|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531112|NCT00571129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531113|NCT00571116||Single Group Assignment||Treatment||None (Open Label)||||||
1531114|NCT00571103||Single Group Assignment||Treatment||None (Open Label)||||||
1531115|NCT00571090|||Case-Only||Cross-Sectional|||||||
1531116|NCT00571077|||||Prospective|||||||
1531117|NCT00571064||Single Group Assignment||Treatment||None (Open Label)||||||
1531118|NCT00571051|Randomized|Parallel Assignment||Basic Science||Single||||||t
1531119|NCT00571038|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1531120|NCT00571025|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1531121|NCT00571012|||Case-Only||Prospective|||||||
1531122|NCT00570999|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531123|NCT00570986|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531124|NCT00570973|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531125|NCT00570960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531126|NCT00570947|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531127|NCT00570934|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531128|NCT00570921||Single Group Assignment||Treatment||None (Open Label)||||||
1531129|NCT00570908||Single Group Assignment||Treatment||None (Open Label)||||||
1531130|NCT00570895|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1531131|NCT00570882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531132|NCT00570869|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1531133|NCT00570856|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1531134|NCT00570843|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531135|NCT00570830||Single Group Assignment||Treatment||None (Open Label)||||||
1531136|NCT00570817|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1531137|NCT00570804|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531138|NCT00570791|||||Prospective|||||||
1531139|NCT00570778|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1531140|NCT00570765|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531141|NCT00570752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531142|NCT00570739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531143|NCT00570726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531144|NCT00570713|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531145|NCT00570700||Single Group Assignment||Treatment||None (Open Label)||||||
1531146|NCT00570687|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531147|NCT00570674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531148|NCT00570661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531149|NCT00570648|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1531150|NCT00570635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531151|NCT00570622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531152|NCT00570609||Single Group Assignment||Prevention||None (Open Label)||||||
1531153|NCT00570583|||Case-Control||Prospective|||||||
1531154|NCT00570570|Randomized|Single Group Assignment||Treatment||Single||||||t
1531155|NCT00570557|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531156|NCT00570544|||Case-Crossover||Retrospective|||||||
1531157|NCT00570531||Single Group Assignment||Treatment||None (Open Label)||||||
1531158|NCT00570518|||Case Control|||||||||
1531159|NCT00570505||Single Group Assignment||Treatment||None (Open Label)||||||
1531160|NCT00570492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531161|NCT00570479|Randomized|Parallel Assignment||Prevention||Single||||||t
1531162|NCT00570466|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531163|NCT00570440|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531164|NCT00570427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531165|NCT00570414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531166|NCT00570401||Single Group Assignment||Treatment||None (Open Label)||||||
1531167|NCT00570388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531168|NCT00570375|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531169|NCT00570362|||Case Control||Cross-Sectional|||||||
1531170|NCT00570349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531171|NCT00570336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531172|NCT00570323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531173|NCT00570310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531174|NCT00570297|||Case-Only||Prospective|||||||
1531175|NCT00570284||Single Group Assignment||Treatment||None (Open Label)||||||
1531176|NCT00570271|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1531177|NCT00570258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531178|NCT00570245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531179|NCT00570232||Single Group Assignment||Prevention||None (Open Label)||||||
1531180|NCT00570219|Randomized|Parallel Assignment||Treatment||Single||||||t
1531181|NCT00570206|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1531182|NCT00570193|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531183|NCT00570180||Single Group Assignment||Treatment||None (Open Label)||||||
1531184|NCT00570167|Randomized|Parallel Assignment||Treatment||Single||||||t
1531185|NCT00570154|||||Prospective|||||||
1531186|NCT00570141|Randomized|Single Group Assignment||||None (Open Label)||||||
1531187|NCT00570128|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531188|NCT00570115|||Cohort||Prospective|||||||
1531189|NCT00570102|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1531190|NCT00570089|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1531191|NCT00570063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531192|NCT00570050|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531193|NCT00570037|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531194|NCT00570024|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531195|NCT00570011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531196|NCT00569998|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531197|NCT00569985||Single Group Assignment||Treatment||None (Open Label)||||||
1531198|NCT00569972|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531199|NCT00569959||Crossover Assignment||Diagnostic||None (Open Label)||||||
1531200|NCT00569946||Single Group Assignment||Treatment||None (Open Label)||||||
1531201|NCT00569933|Randomized|Parallel Assignment||||Single|||t|||
1531202|NCT00569920|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531203|NCT00569907|||Case-Crossover||Prospective|||||||
1531204|NCT00569894|||Cohort||Prospective|||||||
1531205|NCT00569881|||Case Control||Retrospective|||||||
1531206|NCT00569868|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1531207|NCT00569855||Single Group Assignment||Treatment||None (Open Label)||||||
1531208|NCT00569842|||Case-Only||Prospective|||||||
1531209|NCT00569829|Randomized|Parallel Assignment||Treatment||Single||||||t
1531210|NCT00569816|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531211|NCT00569803|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1531212|NCT00569790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531213|NCT00569777|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1531214|NCT00569764|||Case-Only||Prospective|||||||
1531215|NCT00569751|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531216|NCT00569738|||Cohort||Prospective|||||||
1531217|NCT00569712|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531218|NCT00569699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531219|NCT00569686|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531220|NCT00569673||||Treatment||None (Open Label)||||||
1531221|NCT00569660|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531222|NCT00569647|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1531223|NCT00569634||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531224|NCT00569621|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531225|NCT00569608|Randomized|Single Group Assignment||Supportive Care||Single||||||t
1531226|NCT00569595|Randomized|Parallel Assignment||Prevention||Single||||||t
1531227|NCT00569582||Single Group Assignment||Treatment||None (Open Label)||||||
1531228|NCT00569569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531229|NCT00569556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531230|NCT00569543|||Cohort||Prospective|||||||
1531231|NCT00569530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531232|NCT00569517|Randomized|Parallel Assignment||Treatment||Single||||||t
1531233|NCT00569504|||Case-Only||Cross-Sectional|||||||
1531234|NCT00569491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531235|NCT00569478|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1531236|NCT00569465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531237|NCT00569452|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1531238|NCT00569439|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1531239|NCT00569426|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531240|NCT00569413|||Cohort||Cross-Sectional|||||||
1531241|NCT00569400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531242|NCT00569387|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531243|NCT00569374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531244|NCT00569361||Single Group Assignment||Screening||None (Open Label)||||||
1531245|NCT00569335|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531246|NCT00569322|||||Prospective|||||||
1531247|NCT00569309||Single Group Assignment||Treatment||None (Open Label)||||||
1531248|NCT00569296||Single Group Assignment||Treatment||None (Open Label)||||||
1531249|NCT00569283||||Treatment||||||||
1531250|NCT00569270|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531251|NCT00569257||Single Group Assignment||Treatment||None (Open Label)||||||
1531252|NCT00569244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531253|NCT00569231|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1531254|NCT00569192|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531255|NCT00569179||Single Group Assignment||Treatment||None (Open Label)||||||
1531256|NCT00569166|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1531257|NCT00569153|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531258|NCT00569140||Single Group Assignment||Treatment||None (Open Label)||||||
1531259|NCT00569127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531260|NCT00569114|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1531261|NCT00569101||Single Group Assignment||Treatment||None (Open Label)||||||
1531262|NCT00569088|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1531263|NCT00569075|||Cohort||Prospective|||||||
1531264|NCT00569062|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531265|NCT00569049|||Cohort||Prospective|||||||
1531266|NCT00569036|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531267|NCT00569023||Single Group Assignment||Treatment||None (Open Label)||||||
1531268|NCT00569010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531269|NCT00568997|||Case-Control||Prospective|||||||
1531270|NCT00568984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531271|NCT00568971|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531272|NCT00568958|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531273|NCT00568945|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531274|NCT00568906|||Case Control||Prospective|||||||
1531275|NCT00568893||Single Group Assignment||Treatment||None (Open Label)||||||
1531276|NCT00568880||||Treatment||None (Open Label)||||||
1531277|NCT00568867|||Cohort||Prospective|||||||
1531278|NCT00568854|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1531279|NCT00568841||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531280|NCT00568828|||Case-Only||Prospective|||||||
1531281|NCT00568815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531282|NCT00568802|Randomized|Single Group Assignment||Treatment||Double||||||
1531283|NCT00568789|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531284|NCT00568776|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531285|NCT00568763|Randomized|||Treatment||||||||
1531286|NCT00568750||Single Group Assignment||Treatment||None (Open Label)||||||
1531287|NCT00568737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531288|NCT00568724|||Case Control||Prospective|||||||
1531289|NCT00568711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531290|NCT00568698|Randomized|Single Group Assignment||Treatment||Double||||||
1531291|NCT00568685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531292|NCT00568672|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531293|NCT00568659|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531294|NCT00568646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531295|NCT00568633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531296|NCT00568620|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1531297|NCT00568607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531298|NCT00568594|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1531299|NCT00568568|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1531300|NCT00568555|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1531301|NCT00568542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531302|NCT00568529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531303|NCT00568516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531304|NCT00568503|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1531305|NCT00568490|||Cohort||Prospective|||||||
1531306|NCT00568477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531307|NCT00568464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531308|NCT00568451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531309|NCT00568438|||Cohort||Retrospective|||||||
1531310|NCT00568425|||Cohort||Prospective|||||||
1531311|NCT00568412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531312|NCT00568399||Single Group Assignment||Treatment||None (Open Label)||||||
1531313|NCT00568386|Randomized|Crossover Assignment||Treatment||Double||||||
1531314|NCT00568373||Single Group Assignment||Treatment||None (Open Label)||All patients who have severe symptoms and have been identified by the PI and Sub I to qualify for the treatment will be under one single group||||
1531315|NCT00568360|||Cohort||Prospective|||||||
1531316|NCT00568347|||Ecologic or Community||Prospective|||||||
1531317|NCT00568334|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1531318|NCT00568321|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531319|NCT00568308|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531320|NCT00568295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531321|NCT00568282|||Cohort||Prospective|||||||
1531322|NCT00568269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531323|NCT00568256|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1531324|NCT00568243|||Case-Only||Prospective|||||||
1531325|NCT00568230||Single Group Assignment||Treatment||None (Open Label)||||||
1531326|NCT00568217|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1531327|NCT00568204||Single Group Assignment||Treatment||None (Open Label)||||||
1531328|NCT00568191|||Case-Only||Prospective|||||||
1531329|NCT00568178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531330|NCT00568165|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1531331|NCT00568152|Randomized|Crossover Assignment||Prevention||Single|||t|||
1531332|NCT00568139|||Case-Control||Prospective|||||||
1531333|NCT00568126|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531334|NCT00568113|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531335|NCT00568100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531336|NCT00568087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531337|NCT00568074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531338|NCT00568061|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1531339|NCT00568048||Single Group Assignment||Treatment||None (Open Label)||||||
1531340|NCT00568035|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531341|NCT00568022|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531342|NCT00568009|||Cohort||Prospective|||||||
1531343|NCT00567996|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531344|NCT00567983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531345|NCT00567970||||Treatment||||||||
1531346|NCT00567957|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1531347|NCT00567944||Single Group Assignment||Treatment||None (Open Label)||||||
1531348|NCT00567931||Single Group Assignment||Treatment||None (Open Label)||||||
1531349|NCT00567918||Single Group Assignment||Treatment||None (Open Label)||||||
1531350|NCT00567905|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531351|NCT00567892|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531352|NCT00567879||Single Group Assignment||Treatment||None (Open Label)||||||
1531353|NCT00567866|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1531354|NCT00567853||Single Group Assignment||Treatment||None (Open Label)||||||
1531355|NCT00567840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531356|NCT00567827|||Cohort||Prospective|||||||
1531357|NCT00567814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531358|NCT00567801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531359|NCT00567788|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531360|NCT00567775|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531361|NCT00567762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531362|NCT00567749|||Case-Only||Prospective|||||||
1531363|NCT00567736|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1531364|NCT00567723|||Cohort||Prospective|||||||
1531365|NCT00567710|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531366|NCT00567697|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1531367|NCT00567684||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531368|NCT00567671|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531369|NCT00567658|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1531370|NCT00567645|||Case Control||Retrospective|||||||
1531371|NCT00567632|||Cohort||Prospective|||||||
1531372|NCT00567619|||||Prospective|||||||
1531373|NCT00567606|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531374|NCT00567593||Single Group Assignment||Basic Science||None (Open Label)||||||
1531375|NCT00567580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532748|NCT00549250|||||Prospective|||||||
1531376|NCT00567567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531377|NCT00567554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531378|NCT00567541|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531379|NCT00567528|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531380|NCT00567515||Single Group Assignment||Treatment||None (Open Label)||||||
1531381|NCT00567502|||Cohort||Prospective|||||||
1531382|NCT00567489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531383|NCT00567476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531384|NCT00567463|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1531385|NCT00567450|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1531386|NCT00567437||Parallel Assignment||Diagnostic||None (Open Label)||||||
1531387|NCT00567424|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531388|NCT00567411|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1531389|NCT00567398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531390|NCT00567385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531391|NCT00567372||Single Group Assignment||Treatment||None (Open Label)||||||
1531392|NCT00567359||Single Group Assignment||Treatment||None (Open Label)||||||
1531393|NCT00567346|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531394|NCT00567333|Randomized|Parallel Assignment||Treatment||Single||||||t
1531395|NCT00567320|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1531396|NCT00567307|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531397|NCT00567294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531398|NCT00567281|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1531399|NCT00567268|||Case-Only||Prospective|||||||
1531400|NCT00567255|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531401|NCT00567242|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531402|NCT00567229||Single Group Assignment||Treatment||None (Open Label)||||||
1531403|NCT00567216|Randomized|Parallel Assignment||Prevention||Single||||||t
1531404|NCT00567203|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1531405|NCT00567190|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531406|NCT00567177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531407|NCT00567164|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531408|NCT00567151|||Cohort||Prospective|||||||
1531409|NCT00567125|||||Prospective|||||||
1531410|NCT00567112|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531411|NCT00567099|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531412|NCT00567086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531413|NCT00567073|||Other||Other|||||||
1531414|NCT00567060|Randomized|Parallel Assignment||Treatment||Double||||||
1531415|NCT00567047||Single Group Assignment||Treatment||None (Open Label)||||||
1531416|NCT00567034|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1531417|NCT00567021|||||Prospective|||||||
1531418|NCT00567008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531419|NCT00566995||Single Group Assignment||Treatment||None (Open Label)||||||
1531420|NCT00566982|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531421|NCT00566969|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1531422|NCT00566956|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531423|NCT00566943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531424|NCT00566930|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1531425|NCT00566917|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531426|NCT00566904|Randomized|Crossover Assignment||Treatment||Single|||||t|
1531427|NCT00566891|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531428|NCT00566878|||Other||Prospective|||||||
1531429|NCT00566865|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531430|NCT00566852|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1531431|NCT00566839|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531432|NCT00566826|Randomized|Parallel Assignment||Treatment||Double||||t||t
1531433|NCT00566813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531434|NCT00566800||||Treatment||None (Open Label)||||||
1531435|NCT00566787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531436|NCT00566774|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1531437|NCT00566761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531438|NCT00566735|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531439|NCT00566722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531440|NCT00566709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531441|NCT00566696||Single Group Assignment||Treatment||None (Open Label)||||||
1531442|NCT00566683|Randomized|Single Group Assignment||Treatment||Single||||||t
1531443|NCT00566670|||Cohort||Prospective|||||||
1531444|NCT00566657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531445|NCT00566644|Randomized|||Prevention||None (Open Label)||||||
1531446|NCT00566631||Single Group Assignment||Treatment||None (Open Label)||||||
1531447|NCT00566618||Single Group Assignment||Treatment||None (Open Label)||||||
1531448|NCT00566605|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531449|NCT00566592|Randomized|Crossover Assignment||||Single|||t|||
1531450|NCT00566579|Randomized|Parallel Assignment||Treatment||Single||||||t
1531451|NCT00566566|||Cohort|||||||||
1532972|NCT00546195|||||Prospective|||||||
1531452|NCT00566553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531453|NCT00566540||Single Group Assignment||Treatment||None (Open Label)||||||
1531454|NCT00566527|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531455|NCT00566514|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1531456|NCT00566501|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531457|NCT00566488||Single Group Assignment||Treatment||None (Open Label)||||||
1531458|NCT00566475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531459|NCT00566462|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531460|NCT00566449|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531461|NCT00566436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531462|NCT00566423||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531463|NCT00566410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531464|NCT00566397|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531465|NCT00566384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531466|NCT00566371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531467|NCT00566358||Single Group Assignment||Treatment||None (Open Label)||||||
1531468|NCT00566345|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1531469|NCT00566332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531470|NCT00566319|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1531471|NCT00566306||Parallel Assignment||Prevention||None (Open Label)||||||
1531472|NCT00566280||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531473|NCT00566267|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1531474|NCT00566254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531475|NCT00566241|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531476|NCT00566228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531477|NCT00566215|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531478|NCT00566202|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531479|NCT00566189||Single Group Assignment||Treatment||None (Open Label)||||||
1531480|NCT00566176|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531481|NCT00566150|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531482|NCT00566137|||Cohort||Retrospective|||||||
1531483|NCT00566124|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531484|NCT00566111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531485|NCT00566098||Single Group Assignment||Treatment||None (Open Label)||||||
1531486|NCT00566085||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531487|NCT00566072|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1531488|NCT00566059|||Cohort||Prospective|||||||
1531489|NCT00566046|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1531490|NCT00566033|Randomized|Parallel Assignment||Treatment||Single||||t||
1531491|NCT00566020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531492|NCT00566007|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1531493|NCT00565994|||Case Control||Cross-Sectional|||||||
1531494|NCT00565981||Single Group Assignment||Treatment||None (Open Label)||||||
1531495|NCT00565968||Single Group Assignment||Treatment||None (Open Label)||||||
1531496|NCT00565955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531497|NCT00565942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531498|NCT00565929|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1531499|NCT00565916|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1531500|NCT00565903|||Family-Based||Prospective|||||||
1531501|NCT00565890|Randomized|Parallel Assignment||Treatment||Single||||||t
1531502|NCT00565877|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1531503|NCT00565864|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531504|NCT00565851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531505|NCT00565838|||Case-Only||Prospective|||||||
1531506|NCT00565812|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531507|NCT00565799|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531508|NCT00565786|||||Prospective|||||||
1531509|NCT00565773|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531510|NCT00565760|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531511|NCT00565747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531512|NCT00565734|||Cohort||Prospective|||||||
1531513|NCT00565721||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531514|NCT00565708|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531515|NCT00565695|||Case Control||Retrospective|||||||
1531516|NCT00565682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531517|NCT00565669|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1531518|NCT00565656||Single Group Assignment||Treatment||None (Open Label)||||||
1531519|NCT00565643|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531520|NCT00565630|Randomized|Parallel Assignment||||Single||||||t
1531521|NCT00565617||Single Group Assignment||Treatment||None (Open Label)|Open Label|We are currently monitoring participants that were implanted with Epidural Cortical Stimulators starting back in 2008. Primary investigation is completed, but they have implanted devices for investigational treatment of depression. We will keep the study open while they are monitored.||||
1531522|NCT00565604||Single Group Assignment||Treatment||None (Open Label)||||||
1531523|NCT00565591|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1531524|NCT00565565|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531525|NCT00565552|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531526|NCT00565539||Single Group Assignment||Treatment||None (Open Label)||||||
1531527|NCT00565526|||||Prospective|||||||
1531528|NCT00565513||Parallel Assignment||Prevention||None (Open Label)||||||
1531529|NCT00565500|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1531530|NCT00565487||Single Group Assignment||Treatment||None (Open Label)||||||
1531531|NCT00565474|Randomized|Parallel Assignment||Prevention||Double||||||
1531532|NCT00565461|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531533|NCT00565448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531534|NCT00565435|||Case Control||Prospective|||||||
1531535|NCT00565422||Single Group Assignment||Treatment||None (Open Label)||||||
1531536|NCT00565409|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1531537|NCT00565396|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531538|NCT00565383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531539|NCT00565370|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531540|NCT00565357|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1531541|NCT00565344|||Cohort||Retrospective|||||||
1531542|NCT00565331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531543|NCT00565318|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531544|NCT00565305|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1531545|NCT00565292|Randomized|Parallel Assignment||Treatment||Double||||||
1531546|NCT00565279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531547|NCT00565266|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531548|NCT00565253|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1531549|NCT00565240|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1531550|NCT00565227||Single Group Assignment||Treatment||None (Open Label)||||||
1531551|NCT00565214|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1531552|NCT00565201|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1531553|NCT00565188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531554|NCT00565175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531555|NCT00565162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531556|NCT00565149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531557|NCT00565136||Single Group Assignment||Treatment||None (Open Label)||||||
1531558|NCT00565123|Randomized|Parallel Assignment||Treatment||Single|||||t|
1531559|NCT00565110|Randomized|Parallel Assignment||Treatment||Single||||||t
1531560|NCT00565097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531561|NCT00565084|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1531562|NCT00565071|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1531563|NCT00565058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531564|NCT00565045|Randomized|Parallel Assignment||Treatment||Single||||||t
1531565|NCT00565032|||Cohort||Prospective|||||||
1531566|NCT00565019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531567|NCT00565006||||||||||||
1531568|NCT00564993|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1531569|NCT00564980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531570|NCT00564967|Randomized|Parallel Assignment||Treatment||Single||||||t
1531571|NCT00564954|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1531572|NCT00564941||Single Group Assignment||Treatment||None (Open Label)||||||
1531573|NCT00564928|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531574|NCT00564915|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1531575|NCT00564902|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1531576|NCT00564889||Single Group Assignment||Treatment||None (Open Label)||||||
1531577|NCT00564876||Single Group Assignment||Treatment||None (Open Label)||||||
1531578|NCT00564863||Single Group Assignment||Other||None (Open Label)||This is a phase 1, open-label, strain and dose-finding study designed to establish a human challenge model for CS19-ETEC that causes a > 80% attack rate without causing high output diarrhea. This will be a strain and dose-finding study in which CS19-ETEC strain WS0115A will be administered at a starting inoculum of 5 x 108 colony forming units (cfu) to 5 subjects as the initial step to establish a human disease model. If an 80% attack rate (AR) for predefined diarrheal disease is achieved without high output diarrhea, the same inoculum will be given to 5 - 10 more subjects for confirmation of AR. If an 80% AR is not achieved, AR and severity of disease will be evaluated to determine if the dose should be increased. The same sequence may be conducted with DS26-1 as necessary.||||
1531579|NCT00564850||Single Group Assignment||Treatment||None (Open Label)||||||
1531580|NCT00564837|Randomized|Parallel Assignment||Treatment||Single||||||t
1531581|NCT00564824|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1531582|NCT00564811|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531583|NCT00564798|||Case Control||Prospective|||||||
1531584|NCT00564785|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1531585|NCT00564772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531586|NCT00564759|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1531587|NCT00564746|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1531588|NCT00564733||Single Group Assignment||Treatment||None (Open Label)||||||
1531589|NCT00564720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531590|NCT00564707|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531591|NCT00564694||||||||||||
1531592|NCT00564681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531593|NCT00564668|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531594|NCT00564655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531595|NCT00564642|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1531596|NCT00564629|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531597|NCT00564616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531598|NCT00564603|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531599|NCT00564590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531600|NCT00564577||Single Group Assignment||Screening||None (Open Label)||||||
1531601|NCT00564564|Randomized|Parallel Assignment||Treatment||Single||||||t
1531602|NCT00564551|Randomized|Parallel Assignment||Treatment||Single||||||t
1531603|NCT00564538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531604|NCT00564525|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531605|NCT00564512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531606|NCT00564499|||Case-Crossover||Prospective|||||||
1531607|NCT00564486|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531608|NCT00564473|||||Prospective|||||||
1531609|NCT00564460|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531610|NCT00564447|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1531611|NCT00564434|||Cohort||Prospective|||||||
1531612|NCT00564421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531613|NCT00564408|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1531614|NCT00564395|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531615|NCT00564382||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531616|NCT00564369|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1531617|NCT00564356||Single Group Assignment||Treatment||None (Open Label)||||||
1531618|NCT00564343|||Cohort||Prospective|||||||
1531619|NCT00564330|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1531620|NCT00564317|Randomized|Parallel Assignment||Treatment||Single|||||t|
1531621|NCT00564304|||Case-Only||Prospective|||||||
1531622|NCT00564291|||Case-Only||Prospective|||||||
1531623|NCT00564278|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1531624|NCT00564265|||Case-Only||Retrospective|||||||
1531625|NCT00564252||Single Group Assignment||Treatment||Single|||t|||
1531626|NCT00564239|Randomized|Factorial Assignment||Prevention||Single||||||t
1531627|NCT00564226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531628|NCT00564213|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531629|NCT00564200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531630|NCT00564187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531631|NCT00564174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531632|NCT00564161|||||Prospective|||||||
1531633|NCT00564148|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531634|NCT00564135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531635|NCT00564122|||Case-Crossover||Prospective|||||||
1531636|NCT00564109|||Cohort||Retrospective|||||||
1531637|NCT00564096|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1531638|NCT00564083|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1531639|NCT00564070|Randomized|Parallel Assignment||Treatment||Single||||||t
1531640|NCT00564057|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531641|NCT00564044|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1531642|NCT00564031|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1531643|NCT00564018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531644|NCT00564005|Randomized|Parallel Assignment||Treatment||Single||||||t
1531645|NCT00563992|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531646|NCT00563979|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531647|NCT00563966|||Family-Based||Prospective|||||||
1531648|NCT00563953||Single Group Assignment||Treatment||None (Open Label)||||||
1531649|NCT00563940|||Case-Only||Prospective|||||||
1531650|NCT00563927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531651|NCT00563914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531652|NCT00563901|||Cohort||Retrospective|||||||
1531653|NCT00563888|Randomized|Parallel Assignment||Treatment||Single||||||t
1531654|NCT00563875|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1531655|NCT00563862|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1531656|NCT00563849||Single Group Assignment||Treatment||None (Open Label)||||||
1531657|NCT00563836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531658|NCT00563823||||Treatment||None (Open Label)||||||
1531659|NCT00563810|Randomized|Single Group Assignment||Health Services Research||Double||||||
1531660|NCT00563797|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531661|NCT00563784||Single Group Assignment||Treatment||None (Open Label)||||||
1531662|NCT00563771||Single Group Assignment||Treatment||None (Open Label)||||||
1531663|NCT00563758|Randomized|Parallel Assignment||Treatment||Double||||||
1531664|NCT00563745|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1531665|NCT00563732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531666|NCT00563706|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531667|NCT00563693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531668|NCT00563680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532973|NCT00546182|||Case Control||Prospective|||||||
1531669|NCT00563667|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531670|NCT00563654|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531671|NCT00563641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531672|NCT00563628|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531673|NCT00563615|Randomized|Parallel Assignment||Treatment||Double||||||
1531674|NCT00563602|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531675|NCT00563589|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531676|NCT00563576|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531677|NCT00563563||Single Group Assignment||Treatment||None (Open Label)||||||
1531678|NCT00563537|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1531679|NCT00563524|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1531680|NCT00563511|Randomized|Single Group Assignment||||Single||||||
1531681|NCT00563498|Randomized|Parallel Assignment||Prevention||Double||||||
1531682|NCT00563485|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531683|NCT00563472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531684|NCT00563459|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531685|NCT00563446|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531686|NCT00563433|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531687|NCT00563420|Non-Randomized|||Diagnostic||||||||
1531688|NCT00563407|||Cohort||Prospective|||||||
1531689|NCT00563394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531690|NCT00563381|Randomized|Parallel Assignment||Treatment||Double||||||
1531691|NCT00563368|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531692|NCT00563355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531693|NCT00563342||Single Group Assignment||Treatment||||||||
1531694|NCT00563329|Randomized|Single Group Assignment||||Single||||||
1531695|NCT00563316||Single Group Assignment||Treatment||None (Open Label)||||||
1531696|NCT00563303|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1531697|NCT00563290|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531698|NCT00563277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531699|NCT00563264|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531700|NCT00563251|Randomized|Parallel Assignment||Treatment||Double||||||
1531701|NCT00563238|Randomized|Parallel Assignment||Prevention||Single||||||t
1531702|NCT00563225|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531703|NCT00563212||Single Group Assignment||Treatment||None (Open Label)||||||
1531704|NCT00563199|Randomized|Parallel Assignment||||Double||||||
1531705|NCT00563186|Randomized|Parallel Assignment||Prevention||Single|||||t|
1531706|NCT00563173|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531707|NCT00563160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531708|NCT00563147|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531709|NCT00563134|Randomized|Parallel Assignment||Treatment||Double||||||
1531710|NCT00563121||Single Group Assignment||Basic Science||None (Open Label)||||||
1531711|NCT00563108|Randomized|Parallel Assignment||Treatment||Double||||||
1531712|NCT00563095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531713|NCT00563082|||Case Control||Retrospective|||||||
1531714|NCT00563069|Randomized|Single Group Assignment||Prevention||Double||||||
1531715|NCT00563056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531716|NCT00563043|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531717|NCT00563030|||Case Control||Prospective|||||||
1531718|NCT00563017|Non-Randomized|||Treatment||||||||
1531719|NCT00563004|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1531720|NCT00562991|||||Prospective|||||||
1531721|NCT00562978||Single Group Assignment||Treatment||None (Open Label)||||||
1531722|NCT00562965|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1531723|NCT00562952|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531724|NCT00562939|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1531725|NCT00562926|||||Prospective|||||||
1531726|NCT00562913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531727|NCT00562900|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531728|NCT00562887|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531729|NCT00562874|Randomized|Parallel Assignment||Prevention||Single|||t|||
1531730|NCT00562861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531731|NCT00562848|Randomized|Crossover Assignment||Treatment||||||||
1531732|NCT00562835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531733|NCT00562822|Randomized|Parallel Assignment||Treatment||Single|||||t|
1531734|NCT00562809||Single Group Assignment||Treatment||None (Open Label)||||||
1531735|NCT00562796|||Case Control||Cross-Sectional|||||||
1531736|NCT00562783|Randomized|Single Group Assignment||Treatment||Double||||||
1531737|NCT00562770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531738|NCT00562757|||Case Control||Prospective|||||||
1531739|NCT00562744|Randomized|Parallel Assignment||||None (Open Label)||||||
1531740|NCT00562731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531741|NCT00562718|Non-Randomized|||Treatment||None (Open Label)||||||
1531742|NCT00562705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531743|NCT00562692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531744|NCT00562679|||Cohort||Prospective|||||||
1531745|NCT00562666|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531746|NCT00562653|||Case Control||Prospective|||||||
1531747|NCT00562640||Single Group Assignment||Treatment||None (Open Label)||||||
1531748|NCT00562627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531749|NCT00562614|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1531750|NCT00562601||||||||||||
1531751|NCT00562588||Parallel Assignment||Treatment||||||||
1531752|NCT00562575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531753|NCT00562562||Single Group Assignment||Basic Science||None (Open Label)||||||
1531754|NCT00562549|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1531755|NCT00562536|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531756|NCT00562523|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531757|NCT00562510|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1531758|NCT00562497|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531759|NCT00562484|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1531760|NCT00562471|Randomized|Parallel Assignment||Prevention||Single|||t|||
1531761|NCT00562458|||||Prospective|||||||
1531762|NCT00562445|||Case-Only||Prospective|||||||
1531763|NCT00562432|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531764|NCT00562419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531765|NCT00562406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531766|NCT00562393||Single Group Assignment||Basic Science||Single||||||t
1531767|NCT00562380|Randomized|||Treatment||None (Open Label)||||||
1531768|NCT00562367|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1531769|NCT00562354|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531770|NCT00562341|||Case-Only||Prospective|||||||
1531771|NCT00562328||Single Group Assignment||Treatment||None (Open Label)||||||
1531772|NCT00562315||Single Group Assignment||Diagnostic||Single|||||t|
1531773|NCT00562302|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531774|NCT00562289|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531775|NCT00562276|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1531776|NCT00562263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531777|NCT00562250|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531778|NCT00562237|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1531779|NCT00562224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531780|NCT00562211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531781|NCT00562198|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531782|NCT00562185||Single Group Assignment||Treatment||None (Open Label)||||||
1531783|NCT00562172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531784|NCT00562159|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531785|NCT00562146|||Case Control||Prospective|||||||
1531786|NCT00562133|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531787|NCT00562120|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1531788|NCT00562107|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531789|NCT00562094|||Cohort||Prospective|||||||
1531790|NCT00562081|Randomized|Parallel Assignment||Prevention||Single|||t|||
1531791|NCT00562068||||Treatment||None (Open Label)||||||
1531792|NCT00562055|Randomized|Parallel Assignment||Treatment||Double||||||
1531793|NCT00562042|||Cohort||Prospective|||||||
1531794|NCT00562029|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531795|NCT00562016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531796|NCT00562003|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531797|NCT00561990||||||||||||
1531798|NCT00561977|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531799|NCT00561964|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531800|NCT00561951|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531801|NCT00561938|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1531802|NCT00561925|Randomized|Parallel Assignment||Treatment||Double||||||
1531803|NCT00561912||Single Group Assignment||Treatment||None (Open Label)||||||
1531804|NCT00561899|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531805|NCT00561886||Single Group Assignment||Treatment||None (Open Label)||||||
1531806|NCT00561873|||Case-Only||Prospective|||||||
1531807|NCT00561860|Randomized|Single Group Assignment||Treatment||Single|||||t|
1531808|NCT00561847||||||||||||
1531809|NCT00561834||Single Group Assignment||Treatment||None (Open Label)||||||
1531810|NCT00561821|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1531811|NCT00561808||Single Group Assignment||Treatment||None (Open Label)||||||
1531812|NCT00561795|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531813|NCT00561782|||Case Control||Prospective|||||||
1531814|NCT00561769|||Case Control||Prospective|||||||
1531815|NCT00561756||Single Group Assignment||Treatment||None (Open Label)||||||
1531816|NCT00561743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531817|NCT00561730|||Case-Only||Prospective|||||||
1531818|NCT00561717|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1531819|NCT00561704||Parallel Assignment||Treatment||None (Open Label)||||||
1531820|NCT00561691|||Case-Only||Prospective|||||||
1531821|NCT00561678|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531822|NCT00561652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531823|NCT00561639|||Cohort||Prospective|||||||
1531824|NCT00561626|Randomized|Crossover Assignment||Prevention||Single||||||t
1531825|NCT00561613|Randomized|Crossover Assignment||Treatment||Single||||||t
1531826|NCT00561600|Randomized|Parallel Assignment||Treatment||Single|||t|||
1531827|NCT00561587|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531828|NCT00561574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531829|NCT00561561|||Cohort||Cross-Sectional|||||||
1531830|NCT00561548|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1531831|NCT00561535|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531832|NCT00561522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531833|NCT00561509|||Cohort||Prospective|||||||
1531834|NCT00561496||Single Group Assignment||Basic Science||None (Open Label)||||||
1531835|NCT00561483|||Cohort||Prospective|||||||
1531836|NCT00561470|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531837|NCT00561457||Single Group Assignment||Treatment||None (Open Label)||||||
1531838|NCT00561444|||Case-Only||Prospective|||||||
1531839|NCT00561431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531840|NCT00561418||Single Group Assignment||Treatment||None (Open Label)||||||
1531841|NCT00561405|Randomized|Parallel Assignment||Treatment||Single||||||t
1531842|NCT00561392|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531843|NCT00561379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531844|NCT00561366|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531845|NCT00561353|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531846|NCT00561340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531847|NCT00561327|||||Retrospective|||||||
1531848|NCT00561314||||Treatment||||||||
1531849|NCT00561301||Single Group Assignment||Treatment||None (Open Label)||||||
1531850|NCT00561288|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1531851|NCT00561275||Single Group Assignment||Treatment||None (Open Label)||||||
1531852|NCT00561262||||Treatment||||||||
1531853|NCT00561249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531854|NCT00561236|||Case-Only||Prospective|||||||
1531855|NCT00561223||Single Group Assignment||Treatment||None (Open Label)||||||
1531856|NCT00561210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531857|NCT00561197||Single Group Assignment||Treatment||None (Open Label)||||||
1531858|NCT00561184|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1531859|NCT00561171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531860|NCT00561158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531861|NCT00561145|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1531862|NCT00561132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531863|NCT00561119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531864|NCT00561106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531865|NCT00561093|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1531866|NCT00561080|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531867|NCT00561067|Randomized|Parallel Assignment||Treatment||Single||||||t
1531868|NCT00561054||Single Group Assignment||Treatment||None (Open Label)||||||
1531869|NCT00561041|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1531870|NCT00561028|||Case Control||Prospective|||||||
1531871|NCT00561015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531872|NCT00561002|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531873|NCT00560989|||Case Control||Retrospective|||||||
1531874|NCT00560976||Single Group Assignment||Treatment||None (Open Label)||||||
1531875|NCT00560963||Single Group Assignment||Treatment||None (Open Label)||||||
1531876|NCT00560950|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531877|NCT00560937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531878|NCT00560924|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531879|NCT00560911|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1531880|NCT00560898|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1531881|NCT00560885||Single Group Assignment||Treatment||None (Open Label)||||||
1531882|NCT00560872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531883|NCT00560859|Randomized|Parallel Assignment||Treatment||Single|||||t|
1531884|NCT00560846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531885|NCT00560833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531886|NCT00560820||Single Group Assignment||Treatment||None (Open Label)||||||
1531887|NCT00560807|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1531888|NCT00560794||Single Group Assignment||Treatment||None (Open Label)||||||
1531889|NCT00560781|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531890|NCT00560768|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1531891|NCT00560755||Single Group Assignment||Prevention||None (Open Label)||||||
1531892|NCT00560742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531893|NCT00560729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531894|NCT00560716||Single Group Assignment||Treatment||None (Open Label)||||||
1531895|NCT00560703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531896|NCT00560690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531897|NCT00560677|||Case-Only||Cross-Sectional|||||||
1531898|NCT00560664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531899|NCT00560651|||Other||Prospective|||||||
1531900|NCT00560638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531902|NCT00560612|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1531903|NCT00560599|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1531904|NCT00560586|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1531905|NCT00560573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531906|NCT00560560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531907|NCT00560547|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531908|NCT00560534|||Case Control||Prospective|||||||
1531909|NCT00560521|Randomized|Parallel Assignment||Treatment||Single||||||t
1531910|NCT00560508|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531911|NCT00560495||||Treatment||None (Open Label)||||||
1531912|NCT00560482|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531913|NCT00560469|||Case Control||Cross-Sectional|||||||
1531914|NCT00560456|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1531915|NCT00560443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531916|NCT00560430|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1531917|NCT00560417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531918|NCT00560404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531919|NCT00560391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531920|NCT00560378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531921|NCT00560365||||||||||||
1531922|NCT00560352||Single Group Assignment||Treatment||None (Open Label)||||||
1531923|NCT00560339|||Cohort||Prospective|||||||
1531924|NCT00560326||Single Group Assignment||Treatment||None (Open Label)||||||
1531925|NCT00560313|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1531926|NCT00560300|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1531927|NCT00560287|Randomized|Parallel Assignment||Supportive Care||Double||||t||t
1531928|NCT00560274|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531929|NCT00560261|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1531930|NCT00560248|||Case-Only||Retrospective|||||||
1531931|NCT00560235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531932|NCT00560222|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1531933|NCT00560209|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1531934|NCT00560196|||Case Control||Prospective|||||||
1531935|NCT00560183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531936|NCT00560170|Randomized|Parallel Assignment||Basic Science||Single||||||t
1531937|NCT00560157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531938|NCT00560144|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531939|NCT00560131|||Case Control||Prospective|||||||
1531940|NCT00560118|Non-Randomized|||Treatment||||||||
1531941|NCT00560105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531942|NCT00560092|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1531943|NCT00560079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531944|NCT00560066|Randomized|Single Group Assignment||Prevention||Single|||t|||
1531945|NCT00560053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531946|NCT00560040|||||Prospective|||||||
1531947|NCT00560027|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1531948|NCT00560014|Randomized|Factorial Assignment||Basic Science||None (Open Label)||||||
1531949|NCT00560001|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1531950|NCT00559988|Randomized|Parallel Assignment||Prevention||Single|||||t|
1531951|NCT00559975|Randomized|Parallel Assignment||Prevention||Single|||t|||
1531952|NCT00559962|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1531953|NCT00559949||Single Group Assignment||Treatment||None (Open Label)||||||
1531954|NCT00559936||Single Group Assignment||Treatment||None (Open Label)||||||
1531955|NCT00559910|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531956|NCT00559897||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531957|NCT00559884|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531958|NCT00559871|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531959|NCT00559858|Randomized|||Supportive Care||Double||||||
1531960|NCT00559845||Single Group Assignment||Treatment||None (Open Label)||||||
1531961|NCT00559832|Randomized|Parallel Assignment||Prevention||Double||||||
1531962|NCT00559819|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t||t
1531963|NCT00559806|Non-Randomized|Parallel Assignment||Basic Science||Single||||||t
1531964|NCT00559780|Randomized|Parallel Assignment||Treatment||Single||||||t
1531965|NCT00559767||||||||||||
1531966|NCT00559754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531967|NCT00559741|Non-Randomized|||Treatment||None (Open Label)||||||
1531968|NCT00559728|||||Prospective|||||||
1531969|NCT00559715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531970|NCT00559702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531971|NCT00559689|||Case-Crossover||Cross-Sectional|||||||
1531972|NCT00559676|Non-Randomized|||Treatment||||||||
1531973|NCT00559663|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1531974|NCT00559650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531975|NCT00559637||Single Group Assignment||Treatment||None (Open Label)||||||
1531976|NCT00559624||Single Group Assignment||Treatment||None (Open Label)||||||
1531977|NCT00559611||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531978|NCT00559598||||||||||||
1531979|NCT00559585|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531980|NCT00559572|Randomized|Parallel Assignment||Treatment||Single|||||t|
1531981|NCT00559559|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1531982|NCT00559546|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1531983|NCT00559533|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531984|NCT00559520|Randomized|Factorial Assignment||Screening||Double|||t||t|
1531985|NCT00559507||Single Group Assignment||Treatment||None (Open Label)||||||
1531986|NCT00559494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531987|NCT00559481|Randomized|||Treatment||None (Open Label)||||||
1531988|NCT00559468|Randomized|Parallel Assignment||Treatment||Single||||||t
1531989|NCT00559455||Single Group Assignment||Treatment||None (Open Label)||||||
1531990|NCT00559442||Single Group Assignment||Basic Science||None (Open Label)||||||
1531991|NCT00559429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531992|NCT00559416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1531993|NCT00559403|Randomized|Parallel Assignment||Prevention||Single||||||t
1531994|NCT00559390|||Family-Based||Prospective|||||||
1531995|NCT00559377||Single Group Assignment||Diagnostic||None (Open Label)||||||
1531996|NCT00559364|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1531997|NCT00559351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1531998|NCT00559338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1531999|NCT00559312|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532000|NCT00559299|Randomized|Crossover Assignment||Treatment||Single||||||
1532001|NCT00559286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532002|NCT00559273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532003|NCT00559260|||||Prospective|||||||
1532004|NCT00559247|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532005|NCT00559234|||||Prospective|||||||
1532006|NCT00559221||Single Group Assignment||Treatment||None (Open Label)||||||
1532007|NCT00559208|||Case Control||Prospective|||||||
1532008|NCT00559195|Non-Randomized|||Supportive Care||||||||
1532009|NCT00559182|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532010|NCT00559169||Crossover Assignment||Treatment||None (Open Label)||||||
1532011|NCT00559156|Non-Randomized|||Treatment||||||||
1532012|NCT00559143|Randomized|Crossover Assignment||Treatment||Single|||t|||
1532013|NCT00559130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532014|NCT00559117||Single Group Assignment||Treatment||None (Open Label)||||||
1532015|NCT00559104|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532016|NCT00559091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532017|NCT00559078|||||Cross-Sectional|||||||
1532018|NCT00559065|||Cohort||Retrospective|||||||
1532019|NCT00559052|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1532020|NCT00559039||||||||||||
1532021|NCT00559026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532022|NCT00559013||Single Group Assignment||Prevention||None (Open Label)||||||
1532023|NCT00559000|Randomized|Parallel Assignment||Treatment||Single|||||t|
1532024|NCT00558987|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1532025|NCT00558961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532026|NCT00558948|||Case-Only||Cross-Sectional|||||||
1532027|NCT00558935|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1532028|NCT00558922||Single Group Assignment||Treatment||None (Open Label)||||||
1532029|NCT00558909||||Treatment||||||||
1532030|NCT00558896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532031|NCT00558883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532032|NCT00558870|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532033|NCT00558857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532034|NCT00558844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532035|NCT00558831|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532036|NCT00558818||Single Group Assignment||Treatment||None (Open Label)||||||
1532037|NCT00558805|Randomized|Parallel Assignment||Prevention||Single||||||t
1532038|NCT00558792|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1532039|NCT00558779|Randomized|Parallel Assignment||Treatment||Single||||||t
1532040|NCT00558766|||||Prospective|||||||
1532041|NCT00558753|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532042|NCT00558740|||||Prospective|||||||
1532043|NCT00558727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532044|NCT00558701|Randomized|Parallel Assignment||Treatment||Single||||||t
1532045|NCT00558688|Randomized|Single Group Assignment||Treatment||Single||||||t
1532046|NCT00558675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532047|NCT00558662|Randomized|Parallel Assignment||Treatment||Single||||||t
1532048|NCT00558649|Randomized|Parallel Assignment||Prevention||Single||||||t
1532049|NCT00558636|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1532050|NCT00558623|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1532051|NCT00558597|||Case Control||Prospective|||||||
1532052|NCT00558584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532053|NCT00558571|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532054|NCT00558558||Single Group Assignment||Treatment||None (Open Label)||||||
1532055|NCT00558545||Single Group Assignment||Treatment||None (Open Label)||||||
1532056|NCT00558532|||Case Control||Prospective|||||||
1532057|NCT00558519||Single Group Assignment||Treatment||None (Open Label)||||||
1532058|NCT00558506|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532059|NCT00558493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532060|NCT00558480|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1532061|NCT00558467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532062|NCT00558454|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532063|NCT00558441||Single Group Assignment||Diagnostic||None (Open Label)||||||
1532064|NCT00558428||Parallel Assignment||Treatment||||||||
1532065|NCT00558402|Randomized|Parallel Assignment||Treatment||Single||||||t
1532066|NCT00558376|Randomized|Parallel Assignment||Treatment||Single|||||t|
1532067|NCT00558363|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1532068|NCT00558350|||Cohort||Prospective|||||||
1532069|NCT00558337|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1532070|NCT00558324|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1532071|NCT00558311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532072|NCT00558298|Non-Randomized|||Treatment||None (Open Label)||||||
1532073|NCT00558285|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532074|NCT00558272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532075|NCT00558259|Randomized|Parallel Assignment||Prevention||Double||||||
1532076|NCT00558246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532077|NCT00558233|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1532078|NCT00558220|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532079|NCT00558207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532080|NCT00558194|Randomized|Parallel Assignment||Treatment||Single||||||t
1532081|NCT00558181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532082|NCT00558168|||||Prospective|||||||
1532083|NCT00558155|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532084|NCT00558142|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1532085|NCT00558129|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532086|NCT00558116|Randomized|Crossover Assignment||Treatment||Single|||||t|
1532087|NCT00558103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532088|NCT00558090|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532089|NCT00558077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532090|NCT00558064||Parallel Assignment||Treatment||||||||
1532091|NCT00558051|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1532092|NCT00558038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532093|NCT00558025|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532094|NCT00558012|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532095|NCT00557999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532096|NCT00557986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532097|NCT00557973|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532098|NCT00557960|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532099|NCT00557947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532100|NCT00557934||Single Group Assignment||Diagnostic||None (Open Label)||||||
1532101|NCT00557921|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532102|NCT00557908|||Cohort||Other|||||||
1532103|NCT00557895|||Cohort||Prospective|||||||
1532104|NCT00557882|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1532105|NCT00557869||||||||||||
1532106|NCT00557856||Single Group Assignment||Treatment||None (Open Label)||||||
1532107|NCT00557843|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532108|NCT00557830|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532109|NCT00557817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532110|NCT00557804|||Case-Only|||||||||
1532111|NCT00557791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532112|NCT00557778|||Cohort||Prospective|||||||
1532113|NCT00557765|||Case-Only||Prospective|||||||
1532114|NCT00557752|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532115|NCT00557739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532116|NCT00557726|||Other||Prospective|||||||
1532117|NCT00557713||Single Group Assignment||Treatment||None (Open Label)||||||
1532118|NCT00557700|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1532119|NCT00557687|||Cohort||Prospective|||||||
1532120|NCT00557661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532121|NCT00557648|Randomized|Parallel Assignment||Treatment||Single||||||t
1532122|NCT00557635|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532123|NCT00557622|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532124|NCT00557609||Single Group Assignment||Treatment||None (Open Label)||||||
1532125|NCT00557596||Single Group Assignment||Treatment||None (Open Label)||||||
1532126|NCT00557583|Randomized|Single Group Assignment||||Triple|||t|t|t|
1532127|NCT00557570||||||||||||
1532128|NCT00557557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532129|NCT00557544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532130|NCT00557531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532131|NCT00557518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532132|NCT00557505||Single Group Assignment||Treatment||None (Open Label)||||||
1532133|NCT00557492||Single Group Assignment||Treatment||None (Open Label)||||||
1532134|NCT00557466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532135|NCT00557453|||Case Control||Prospective|||||||
1532136|NCT00557440|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532137|NCT00557427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532138|NCT00557414|||Cohort||Prospective|||||||
1532139|NCT00557401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532140|NCT00557388|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1532141|NCT00557375|||Case-Only||Cross-Sectional|||||||
1532142|NCT00557362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532143|NCT00557349|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1532144|NCT00557336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532145|NCT00557323|||Cohort||Prospective|||||||
1532146|NCT00557310||Single Group Assignment||Treatment||None (Open Label)||||||
1532147|NCT00557297|||||Cross-Sectional|||||||
1532148|NCT00557284|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532149|NCT00557258||||||||||||
1532150|NCT00557245|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532151|NCT00557232||Single Group Assignment||Treatment||None (Open Label)||||||
1532152|NCT00557219|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1532153|NCT00557206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532154|NCT00557193|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532155|NCT00557180|||Cohort||Prospective|||||||
1532156|NCT00557154|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532157|NCT00557141|||Cohort||Prospective|||||||
1532158|NCT00557128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532159|NCT00557115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532160|NCT00557102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532161|NCT00557089|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532162|NCT00557076|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532163|NCT00557050|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532164|NCT00557037||Single Group Assignment||Treatment||None (Open Label)||||||
1532165|NCT00557024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532166|NCT00557011|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532167|NCT00556998|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1532168|NCT00556972||Single Group Assignment||Supportive Care||None (Open Label)||||||
1532169|NCT00556959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532170|NCT00556946||Single Group Assignment||Treatment||None (Open Label)||||||
1532171|NCT00556933|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1532172|NCT00556920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532173|NCT00556907||Single Group Assignment||Treatment||None (Open Label)||||||
1532174|NCT00556894|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532175|NCT00556868|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1532176|NCT00556855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532177|NCT00556842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532178|NCT00556816|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1532179|NCT00556803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532180|NCT00556790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532181|NCT00556777|Non-Randomized|||Treatment||None (Open Label)||||||
1532182|NCT00556764||Single Group Assignment||Screening||None (Open Label)||||||
1532183|NCT00556751|||Cohort||Retrospective|||||||
1532184|NCT00556738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532185|NCT00556712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532186|NCT00556699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532187|NCT00556686|||Case Control||Prospective|||||||
1532188|NCT00556673|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532189|NCT00556660|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1532190|NCT00556647|||Cohort||Prospective|||||||
1532191|NCT00556634|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532192|NCT00556621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532193|NCT00556608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532194|NCT00556595|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532195|NCT00556569|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1532196|NCT00556543||Single Group Assignment||Treatment||None (Open Label)||||||
1532197|NCT00556530|||Family-Based||Prospective|||||||
1532198|NCT00556517|||Case-Only||Prospective|||||||
1532199|NCT00556504|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532200|NCT00556491|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1532201|NCT00556478|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532202|NCT00556465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532203|NCT00556452||Single Group Assignment||Treatment||None (Open Label)||||||
1532204|NCT00556439|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532205|NCT00556426||Single Group Assignment||Treatment||None (Open Label)||||||
1532206|NCT00556413|Non-Randomized|||Treatment||||||||
1532207|NCT00556400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532208|NCT00556387|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532209|NCT00556374|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1532210|NCT00556361|Non-Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1532211|NCT00556348||Single Group Assignment||Treatment||None (Open Label)||||||
1532212|NCT00556335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532213|NCT00556322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532214|NCT00556309|||Case-Only||Prospective|||||||
1532215|NCT00556296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532216|NCT00556283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532217|NCT00556270|||Case-Only||Prospective|||||||
1532218|NCT00556257|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532219|NCT00556244|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1532220|NCT00556231|||Case Control||Prospective|||||||
1532221|NCT00556218|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1532222|NCT00556205|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532223|NCT00556192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532224|NCT00556179||Single Group Assignment||Prevention||None (Open Label)||||||
1532225|NCT00556166||Single Group Assignment||Treatment||None (Open Label)||||||
1532226|NCT00556153|||Case-Only||Prospective|||||||
1532227|NCT00556140||Single Group Assignment||Treatment||None (Open Label)||||||
1532228|NCT00556127||Single Group Assignment||Treatment||None (Open Label)||||||
1532229|NCT00556114|||Case-Control||Prospective|||||||
1532230|NCT00556101|||||Prospective|||||||
1532231|NCT00556088|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532232|NCT00556075|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532233|NCT00556062|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1532234|NCT00556049||Single Group Assignment||Treatment||None (Open Label)||||||
1532235|NCT00556036|||Case Control||Cross-Sectional|||||||
1532236|NCT00556023|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532237|NCT00556010|||Cohort||Prospective|||||||
1532238|NCT00555997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532239|NCT00555984|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1532240|NCT00555971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532241|NCT00555958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532242|NCT00555945|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1532243|NCT00555932|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1532244|NCT00555919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532245|NCT00555906|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532246|NCT00555893|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532247|NCT00555880|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532248|NCT00555867|||Cohort||Prospective|||||||
1532249|NCT00555854|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532250|NCT00555841|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532251|NCT00555828|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532252|NCT00555815|||Cohort||Prospective|||||||
1532253|NCT00555802|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1532254|NCT00555789|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532255|NCT00555776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532256|NCT00555763|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1532257|NCT00555750|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1532258|NCT00555737|||Cohort||Prospective|||||||
1532259|NCT00555724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532260|NCT00555711|||Case-Only||Cross-Sectional|||||||
1532261|NCT00555698||Single Group Assignment||Treatment||None (Open Label)||||||
1532262|NCT00555685|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532263|NCT00555672|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532264|NCT00555659|||Case-Only||Prospective|||||||
1532265|NCT00555646||Single Group Assignment||Treatment||None (Open Label)||||||
1532266|NCT00555633||||||||||||
1532267|NCT00555620|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532268|NCT00555607|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1532269|NCT00555594|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532270|NCT00555581||Single Group Assignment||Treatment||None (Open Label)||||||
1532271|NCT00555568|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1532272|NCT00555555||Single Group Assignment||Treatment||None (Open Label)||||||
1532273|NCT00555542||Single Group Assignment||Treatment||None (Open Label)||||||
1532274|NCT00555529||||||||||||
1532275|NCT00555516|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1532276|NCT00555503|||Cohort||Prospective|||||||
1532277|NCT00555490|Randomized|Parallel Assignment||Treatment||Single||||||t
1532278|NCT00555477||Single Group Assignment||Treatment||None (Open Label)||||||
1532279|NCT00555464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532280|NCT00555451|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1532281|NCT00555438|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1532282|NCT00555425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532283|NCT00555412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532284|NCT00555399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532285|NCT00555386|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1532286|NCT00555373||Single Group Assignment||Prevention||None (Open Label)||||||
1532287|NCT00555360|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532288|NCT00555347|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532289|NCT00555334|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532290|NCT00555321|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532291|NCT00555308||Single Group Assignment||Diagnostic||None (Open Label)||||||
1532292|NCT00555295|||Case-Only||Retrospective|||||||
1532293|NCT00555282|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532294|NCT00555269|||||Prospective|||||||
1532295|NCT00555256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532296|NCT00555243|Randomized|Parallel Assignment||||Single||||||t
1532297|NCT00555230|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532298|NCT00555217|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1532299|NCT00555204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532300|NCT00555191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532301|NCT00555178|||Cohort||Prospective|||||||
1532302|NCT00555165||Single Group Assignment||Treatment||None (Open Label)||||||
1532303|NCT00555152|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532304|NCT00555139|Randomized|Crossover Assignment||Treatment||||||||
1532305|NCT00555126|Randomized|Factorial Assignment||Treatment||Single||||||t
1532306|NCT00555113|||Cohort||Retrospective|||||||
1532307|NCT00555100||Single Group Assignment||Treatment||None (Open Label)||||||
1532308|NCT00555087|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532309|NCT00555074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532310|NCT00555061||Single Group Assignment||Treatment||None (Open Label)||||||
1532311|NCT00555048||||Treatment||||||||
1532312|NCT00555035|Randomized|Parallel Assignment||Treatment||Double||||||
1532313|NCT00555022|Randomized|Crossover Assignment||Treatment||||||||
1532314|NCT00555009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532315|NCT00554996|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1532316|NCT00554983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532317|NCT00554970|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532318|NCT00554957|||Cohort||Cross-Sectional|||||||
1532319|NCT00554944|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532320|NCT00554918|Randomized|||Treatment||||||||
1532321|NCT00554905|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532322|NCT00554892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532323|NCT00554879|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1532324|NCT00554866||Single Group Assignment||||None (Open Label)||||||
1532325|NCT00554853|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1532326|NCT00554840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532327|NCT00554827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532328|NCT00554814|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532329|NCT00554801|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1532330|NCT00554788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532331|NCT00554775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532332|NCT00554762|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1532333|NCT00554749|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532334|NCT00554736|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532335|NCT00554723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532336|NCT00554710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532337|NCT00554697|||Cohort||Prospective|||||||
1532338|NCT00554684|||Cohort||Prospective|||||||
1532339|NCT00554671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532340|NCT00554658||Single Group Assignment||||None (Open Label)||||||
1532341|NCT00554645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532342|NCT00554632|Randomized|Crossover Assignment||Treatment||Single|||||t|
1532343|NCT00554619|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532344|NCT00554606|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532345|NCT00554580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532346|NCT00554567|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1532347|NCT00554541|||Cohort||Prospective|||||||
1532348|NCT00554528|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1532349|NCT00554515||Single Group Assignment||Treatment||None (Open Label)||||||
1532350|NCT00554502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532351|NCT00554489||Single Group Assignment||Supportive Care||None (Open Label)||||||
1532352|NCT00554476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532353|NCT00554463||Single Group Assignment||Supportive Care||None (Open Label)||||||
1532354|NCT00554450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532355|NCT00554437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532356|NCT00554424|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1532357|NCT00554411|||Cohort||Prospective|||||||
1532358|NCT00554398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532359|NCT00554385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532360|NCT00554372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532361|NCT00554359|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1532362|NCT00554346|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532363|NCT00554333|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532364|NCT00554320|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532365|NCT00554307|||Cohort||Prospective|||||||
1532366|NCT00554294|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532367|NCT00554281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532368|NCT00554268||Single Group Assignment||Treatment||None (Open Label)||||||
1532369|NCT00554255|Randomized|Crossover Assignment||Treatment||Single|||t|||
1532370|NCT00554242|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1532371|NCT00554229|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532372|NCT00554216|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532373|NCT00554203|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1532374|NCT00554190|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532375|NCT00554177|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532376|NCT00554164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532377|NCT00554151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532378|NCT00554138|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1532379|NCT00554125|Randomized|Parallel Assignment||Prevention||Single|||||t|
1532380|NCT00554112|Randomized|Parallel Assignment||Treatment||Single||||||t
1532381|NCT00554099|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532382|NCT00554086|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532383|NCT00554073|||||Prospective|||||||
1532384|NCT00554047|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1532385|NCT00554034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532386|NCT00554021|||Cohort||Prospective|||||||
1532387|NCT00554008|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532388|NCT00553995|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1532389|NCT00553982|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1532390|NCT00553969|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1532391|NCT00553956|Randomized|Crossover Assignment||Treatment||Single||||||t
1532392|NCT00553943||Single Group Assignment||Treatment||None (Open Label)||||||
1532393|NCT00553930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532394|NCT00553917|||Case-Only||Prospective|||||||
1532395|NCT00553904|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1532396|NCT00553891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532397|NCT00553878|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1532398|NCT00553865|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532399|NCT00553852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532400|NCT00553839||Single Group Assignment||Basic Science||None (Open Label)||||||
1532401|NCT00553813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532402|NCT00553800||Single Group Assignment||Treatment||None (Open Label)||||||
1532403|NCT00553787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532404|NCT00553774|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1532405|NCT00553761|||Cohort||Prospective|||||||
1532406|NCT00553748||Single Group Assignment||Diagnostic||None (Open Label)||||||
1532407|NCT00553735|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1532408|NCT00553722|Randomized|Crossover Assignment||Diagnostic||Triple|||t|t|t|
1532409|NCT00553709|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532410|NCT00553696||Single Group Assignment||Treatment||None (Open Label)||||||
1532411|NCT00553683||Single Group Assignment||Treatment||None (Open Label)||||||
1532412|NCT00553670|||Case-Only||Prospective|||||||
1532413|NCT00553657|Randomized|Parallel Assignment||Diagnostic||Double||||||
1532414|NCT00553644||Single Group Assignment||Treatment||None (Open Label)||||||
1532415|NCT00553631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532416|NCT00553618||Single Group Assignment||Treatment||None (Open Label)||||||
1532417|NCT00553605|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532418|NCT00553592|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532419|NCT00553579|||Case-Only||Prospective|||||||
1532420|NCT00553566||||||||||||
1532421|NCT00553553|Randomized|Parallel Assignment||Treatment||Single||||||t
1532422|NCT00553540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532423|NCT00553527|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1532424|NCT00553514|Randomized|Parallel Assignment||Treatment||Single||||||t
1532425|NCT00553501||Single Group Assignment||Treatment||None (Open Label)||||||
1532426|NCT00553488|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532427|NCT00553475|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532428|NCT00553462||Single Group Assignment||Treatment||None (Open Label)||||||
1532429|NCT00553449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532430|NCT00553436||Single Group Assignment||Treatment||None (Open Label)||||||
1532431|NCT00553423|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532432|NCT00553410|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532433|NCT00553397|||Case-Only||Retrospective|||||||
1532434|NCT00553384|||||Prospective|||||||
1532435|NCT00553371||||||||||||
1532436|NCT00553358|Randomized|||Treatment||None (Open Label)||||||
1532437|NCT00553345|Randomized|||Prevention||Double||||||
1532438|NCT00553332||Single Group Assignment||Treatment||None (Open Label)||||||
1532439|NCT00553319|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532440|NCT00553306||Single Group Assignment||Treatment||None (Open Label)||||||
1532441|NCT00553293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532442|NCT00553280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532443|NCT00553267||Parallel Assignment||Treatment||||||||
1532444|NCT00553254|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532445|NCT00553241|||Cohort||Prospective|||||||
1532446|NCT00553228|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532447|NCT00553215||||||||||||
1532448|NCT00553202||Single Group Assignment||Treatment||None (Open Label)||||||
1532449|NCT00553189|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1532450|NCT00553176|||Case-Only||Prospective|||||||
1532451|NCT00553163|Randomized|Single Group Assignment||Treatment||Single|||||t|
1532452|NCT00553150||Single Group Assignment||Treatment||None (Open Label)||||||
1532453|NCT00553137|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532454|NCT00553124||||Prevention||||||||
1532455|NCT00553111|Randomized|Factorial Assignment||Prevention||Single|||||t|
1532456|NCT00553098||Single Group Assignment||Treatment||None (Open Label)||||||
1532457|NCT00553085|||Case Control||Cross-Sectional|||||||
1532458|NCT00553072|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1532459|NCT00553059|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1532460|NCT00553046|||Cohort||Retrospective|||||||
1532461|NCT00553033|||Cohort||Prospective|||||||
1532462|NCT00553020|Randomized|Crossover Assignment||Treatment||Single|||t|||
1532463|NCT00553007||Single Group Assignment||Treatment||None (Open Label)||||||
1532464|NCT00552994|Randomized|Single Group Assignment||Treatment||Single||||||t
1532465|NCT00552981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532466|NCT00552968|||Cohort||Prospective|||||||
1532467|NCT00552955|||||Other|||||||
1532468|NCT00552942|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532469|NCT00552929|Randomized|Parallel Assignment||Treatment||Single||||||t
1532470|NCT00552916|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532471|NCT00552903|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532472|NCT00552890|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532473|NCT00552877|Randomized|Single Group Assignment||Treatment||Single||||||t
1532474|NCT00552864|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1532475|NCT00552851||Single Group Assignment||Treatment||None (Open Label)||||||
1532476|NCT00552838|Randomized|Parallel Assignment||||Single||||||t
1532477|NCT00552825|||Cohort||Retrospective|||||||
1532478|NCT00552812||Single Group Assignment||Treatment||None (Open Label)||||||
1532479|NCT00552799|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532480|NCT00552786|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1532481|NCT00552773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532482|NCT00552760|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532483|NCT00552747|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1532484|NCT00552734|||||Prospective|||||||
1532485|NCT00552721|Randomized|Parallel Assignment||Treatment||Single||||||t
1532486|NCT00552708|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1532487|NCT00552695|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1532488|NCT00552682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532489|NCT00552669|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1532490|NCT00552656|||Cohort||Prospective|||||||
1532491|NCT00552643|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532492|NCT00552630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532493|NCT00552617|Randomized|Parallel Assignment||Treatment||Single||||||t
1532494|NCT00552604|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532495|NCT00552591|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532496|NCT00552578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532497|NCT00552565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532498|NCT00552552|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1532499|NCT00552539|Randomized|Factorial Assignment||Prevention||Single|||||t|
1532500|NCT00552526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532501|NCT00552513|Randomized|Parallel Assignment||Treatment||Single||||||t
1532502|NCT00552500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532503|NCT00552487||Parallel Assignment||Diagnostic||None (Open Label)||||||
1532504|NCT00552474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532505|NCT00552461|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532506|NCT00552448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532507|NCT00552435|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532508|NCT00552422||Single Group Assignment||Treatment||None (Open Label)||||||
1532509|NCT00552409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532510|NCT00552396||Single Group Assignment||Treatment||None (Open Label)||||||
1532511|NCT00552383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532512|NCT00552370|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532513|NCT00552357|||Case-Only||Prospective|||||||
1532514|NCT00552344||Single Group Assignment||Treatment||None (Open Label)||||||
1532515|NCT00552331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532516|NCT00552305||Single Group Assignment||Treatment||None (Open Label)||||||
1532517|NCT00552292|||Cohort||Prospective|||||||
1532518|NCT00552279|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532519|NCT00552266|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532520|NCT00552253|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532521|NCT00552240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532522|NCT00552227|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532523|NCT00552214|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1532524|NCT00552201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532525|NCT00552188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532526|NCT00552175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532527|NCT00552162|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532528|NCT00552149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532529|NCT00552136|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532530|NCT00552110|Randomized|Parallel Assignment||Treatment||Single|||||t|
1532531|NCT00552097|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1532532|NCT00552084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532533|NCT00552071|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532534|NCT00552058|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532535|NCT00552045|||Case-Control||Prospective|||||||
1532536|NCT00552032|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532537|NCT00552019|||Cohort||Prospective|||||||
1532538|NCT00552006|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1532539|NCT00551993|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1532540|NCT00551980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532541|NCT00551967||Single Group Assignment||Treatment||None (Open Label)||||||
1532542|NCT00551954|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532543|NCT00551941|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1532544|NCT00551928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532545|NCT00551915|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1532546|NCT00551902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532547|NCT00551889||||Treatment||||||||
1532548|NCT00551876|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532549|NCT00551863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532550|NCT00551850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532551|NCT00551837|||Cohort||Prospective|||||||
1532552|NCT00551824|Randomized|Crossover Assignment||Treatment||Single|||t|||
1532553|NCT00551811|Randomized|Crossover Assignment||Treatment||||||||
1532554|NCT00551798||Single Group Assignment||Diagnostic||None (Open Label)||||||
1532555|NCT00551785|||Cohort||Prospective|||||||
1532556|NCT00551772|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532557|NCT00551759||Single Group Assignment||Treatment||None (Open Label)||||||
1532558|NCT00551746|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1532559|NCT00551733|Randomized|||Treatment||None (Open Label)||||||
1532560|NCT00551720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532561|NCT00551707|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532562|NCT00551694|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1532563|NCT00551681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532564|NCT00551668|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532565|NCT00551655|||Cohort||Retrospective|||||||
1532566|NCT00551642|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1532567|NCT00551629|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1532568|NCT00551616|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532569|NCT00551603|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532570|NCT00551590|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1532571|NCT00551577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532572|NCT00551564|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1532573|NCT00551551|Randomized|Parallel Assignment||Prevention||Single|||||t|
1532574|NCT00551538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532575|NCT00551525||Single Group Assignment||Treatment||None (Open Label)||||||
1532576|NCT00551512||Single Group Assignment||Treatment||None (Open Label)||||||
1532577|NCT00551499|Randomized|Crossover Assignment||Treatment||Single||Comparing effect of CRT in patients with and without CSA + comparing effect of AOP in combination with CRT in patients with CSA|t|||
1532578|NCT00551486|||||Prospective|||||||
1532579|NCT00551473|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1532580|NCT00551460||Single Group Assignment||Treatment||None (Open Label)||||||
1532581|NCT00551447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532582|NCT00551434|Randomized|Factorial Assignment||Basic Science||Triple|||t||t|t
1532583|NCT00551421||Single Group Assignment||Treatment||None (Open Label)||||||
1532584|NCT00551408|||Case-Control||Prospective|||||||
1532585|NCT00551395|Randomized|Parallel Assignment||Treatment||Single||||||t
1532586|NCT00551382|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1532587|NCT00551369||Single Group Assignment||Treatment||None (Open Label)||||||
1532588|NCT00551356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532589|NCT00551343|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1532590|NCT00551330|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532591|NCT00551317|Randomized|Crossover Assignment||Treatment||Double||||||
1532592|NCT00551304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532593|NCT00551291||Single Group Assignment||Treatment||None (Open Label)||||||
1532594|NCT00551278|||Case-Only||Prospective|||||||
1532595|NCT00551265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532596|NCT00551252|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532597|NCT00551239|Randomized|||Treatment||||||||
1532598|NCT00551226|||Cohort||Prospective|||||||
1532599|NCT00551213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532600|NCT00551200||Single Group Assignment||Treatment||None (Open Label)||||||
1532601|NCT00551187|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1532602|NCT00551174|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532603|NCT00551161||Single Group Assignment||Treatment||None (Open Label)||||||
1532604|NCT00551148|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532605|NCT00551135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532606|NCT00551122|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532607|NCT00551109|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532608|NCT00551096||Single Group Assignment||Treatment||None (Open Label)||||||
1532609|NCT00551083|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532610|NCT00551070||Single Group Assignment||Treatment||None (Open Label)||||||
1532611|NCT00551057|||Cohort||Prospective|||||||
1532612|NCT00551044||Single Group Assignment||Treatment||None (Open Label)||||||
1532613|NCT00551031|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532614|NCT00551018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532615|NCT00551005||||Treatment||||||||
1532616|NCT00550992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532617|NCT00550979|||Case Control||Cross-Sectional|||||||
1532618|NCT00550966||Parallel Assignment||Supportive Care||Single||||||t
1532619|NCT00550953||Parallel Assignment||Treatment||||||||
1532620|NCT00550940|||Case Control||Prospective|||||||
1532621|NCT00550927|Non-Randomized|||Treatment||None (Open Label)||||||
1532622|NCT00550914|||||Prospective|||||||
1532623|NCT00550901||||Treatment||||||||
1532624|NCT00550888|Randomized|Parallel Assignment||||Single|||t|||
1532625|NCT00550875|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532626|NCT00550862|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532627|NCT00550849|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1532628|NCT00550836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532629|NCT00550823||Single Group Assignment||Diagnostic||None (Open Label)||||||
1532630|NCT00550810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532631|NCT00550797|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532632|NCT00550784|Non-Randomized|||Treatment||||||||
1532633|NCT00550771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532634|NCT00550758|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1532635|NCT00550745|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1532636|NCT00550732||Single Group Assignment||Treatment||None (Open Label)||||||
1532637|NCT00550706|||Case-Only||Prospective|||||||
1532638|NCT00550693|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532639|NCT00550680||Single Group Assignment||Treatment||None (Open Label)||||||
1532640|NCT00550667|||Case Control|||||||||
1532641|NCT00550654||Single Group Assignment||Treatment||None (Open Label)||||||
1532642|NCT00550641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532643|NCT00550628|||Cohort||Prospective|||||||
1532644|NCT00550615|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532645|NCT00550602|||Other||Prospective|||||||
1532646|NCT00550589||Single Group Assignment||Treatment||None (Open Label)||||||
1532647|NCT00550576||Single Group Assignment||Treatment||Single|||t|||
1532648|NCT00550563||Single Group Assignment||Supportive Care||None (Open Label)||||||
1532649|NCT00550550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532650|NCT00550537||Single Group Assignment||Treatment||None (Open Label)||||||
1532651|NCT00550524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532652|NCT00550511|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1532653|NCT00550498||Single Group Assignment||Treatment||None (Open Label)||||||
1532654|NCT00550485|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1532655|NCT00550472|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1532656|NCT00550459|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532657|NCT00550446|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532658|NCT00550433|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532659|NCT00550420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532660|NCT00550407|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532661|NCT00550394|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532662|NCT00550381|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1532663|NCT00550368|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1532664|NCT00550355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532665|NCT00550342||Single Group Assignment||Treatment||None (Open Label)||||||
1532666|NCT00550329|||||Prospective|||||||
1532667|NCT00550303|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532668|NCT00550290|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1532669|NCT00550277||Single Group Assignment||Treatment||None (Open Label)||||||
1532670|NCT00550264|Randomized|Single Group Assignment||||None (Open Label)||||||
1532671|NCT00550251|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1532672|NCT00550238||Single Group Assignment||Treatment||None (Open Label)||||||
1532673|NCT00550225|Randomized|Crossover Assignment||Treatment||||||||
1532674|NCT00550212|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532675|NCT00550199||Single Group Assignment||Treatment||None (Open Label)||||||
1532676|NCT00550186|Randomized|Parallel Assignment||||Triple||||t|t|t
1532677|NCT00550173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532678|NCT00550160|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1532679|NCT00550147||Single Group Assignment||Treatment||None (Open Label)||||||
1532680|NCT00550134|||Case-Control||Prospective|||||||
1532681|NCT00550121|Randomized|Crossover Assignment||||Double|||t||t|
1532682|NCT00550108|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532683|NCT00550095||Single Group Assignment||Treatment||None (Open Label)||||||
1532684|NCT00550082|||Cohort||Prospective|||||||
1532685|NCT00550069|||Case Control||Prospective|||||||
1532686|NCT00550056|Randomized|Parallel Assignment||Treatment||Single||||||t
1532687|NCT00550043|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532688|NCT00550030|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532689|NCT00550017|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532690|NCT00550004|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1532691|NCT00549991|||Case-Only||Retrospective|||||||
1532692|NCT00549978||Crossover Assignment||Treatment||None (Open Label)||||||
1532693|NCT00549965|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532694|NCT00549952|||||Prospective|||||||
1532695|NCT00549939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532696|NCT00549926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532697|NCT00549913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532698|NCT00549900|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1532699|NCT00549887|||Cohort||Prospective|||||||
1532700|NCT00549874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532701|NCT00549861||Single Group Assignment||Diagnostic||None (Open Label)||||||
1532702|NCT00549848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532703|NCT00549835|Randomized|Parallel Assignment||Supportive Care||Double|||t|||t
1532704|NCT00549822||Single Group Assignment||Treatment||None (Open Label)||||||
1532705|NCT00549809||Parallel Assignment||Treatment||Single|||t|||
1532706|NCT00549796|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1532707|NCT00549783|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532708|NCT00549770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532709|NCT00549757|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532710|NCT00549744|Randomized|Crossover Assignment||Treatment||||||||
1532711|NCT00549731|||Case Control||Prospective|||||||
1532712|NCT00549718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532713|NCT00549705|||Cohort||Retrospective|||||||
1532714|NCT00549692|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532715|NCT00549679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532716|NCT00549666|Randomized|Crossover Assignment||||Double|||t||t|
1532717|NCT00549653|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532718|NCT00549640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532719|NCT00549627|Randomized|Parallel Assignment||||None (Open Label)||||||
1532720|NCT00549614|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532721|NCT00549601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532722|NCT00549588|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1532723|NCT00549575|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532724|NCT00549562||Sequential Assignment||Treatment||None (Open Label)||||||
1532725|NCT00549549|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532726|NCT00549536|Randomized|Parallel Assignment||Treatment||Single||||||t
1532727|NCT00549523|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1532728|NCT00549510|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532729|NCT00549497||Single Group Assignment||Treatment||Double||||||
1532730|NCT00549484|||||Prospective|||||||
1532731|NCT00549471|Randomized|Parallel Assignment||Treatment||Single||||||t
1532732|NCT00549458|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1532733|NCT00549445|||Cohort||Retrospective|||||||
1532734|NCT00549432||Single Group Assignment||Treatment||None (Open Label)||||||
1532735|NCT00549419|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532736|NCT00549406|Randomized|Parallel Assignment||Treatment||Single||||||t
1532737|NCT00549393|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1532738|NCT00549380||Single Group Assignment||Treatment||None (Open Label)||||||
1532739|NCT00549367||Single Group Assignment||Supportive Care||None (Open Label)||||||
1532740|NCT00549354|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532741|NCT00549341|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1532742|NCT00549328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532743|NCT00549315||Single Group Assignment||Treatment||None (Open Label)||||||
1532744|NCT00549302|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532745|NCT00549289||Single Group Assignment||||None (Open Label)||||||
1532746|NCT00549276|||Cohort||Prospective|||||||
1532747|NCT00549263|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532749|NCT00549237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532750|NCT00549211|Randomized|Crossover Assignment||Treatment||Single||||||
1532751|NCT00549198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532752|NCT00549185|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532753|NCT00549172|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532754|NCT00549159|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532755|NCT00549146|Randomized|Parallel Assignment||Treatment||Double||||||
1532756|NCT00549133|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532757|NCT00549120|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1532758|NCT00549107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532759|NCT00549081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532760|NCT00549068|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532761|NCT00549055|||Cohort||Other|||||||
1532762|NCT00549042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532763|NCT00549029|||Case Control||Retrospective|||||||
1532764|NCT00549016||Single Group Assignment||Treatment||None (Open Label)||||||
1532765|NCT00549003|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1532766|NCT00548990|Randomized|Parallel Assignment||Treatment||Single||||||
1532767|NCT00548977|||Case Control||Prospective|||||||
1532768|NCT00548964|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532769|NCT00548951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532770|NCT00548938||Single Group Assignment||Treatment||None (Open Label)||||||
1532771|NCT00548925|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532772|NCT00548912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532773|NCT00548899||Single Group Assignment||Treatment||None (Open Label)||||||
1532774|NCT00548886||Single Group Assignment||Health Services Research||None (Open Label)||||||
1532775|NCT00548860|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532776|NCT00548847||Single Group Assignment||Treatment||None (Open Label)||||||
1532777|NCT00548834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532778|NCT00548821|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532779|NCT00548808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532780|NCT00548795|||Cohort||Prospective|||||||
1532781|NCT00548782|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1532782|NCT00548769|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532783|NCT00548756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532784|NCT00548743|Randomized|Parallel Assignment||Screening||Double|||t|||t
1532785|NCT00548730|||Cohort||Prospective|||||||
1532786|NCT00548717|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1532787|NCT00548704|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532788|NCT00548691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532789|NCT00548678|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532790|NCT00548665|Randomized|Parallel Assignment||Screening||Double||||t||t
1532791|NCT00548652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532792|NCT00548639|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532793|NCT00548626|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1532794|NCT00548613|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532795|NCT00548600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532796|NCT00548587|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532797|NCT00548574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532798|NCT00548561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532799|NCT00548548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532800|NCT00548535|||||Prospective|||||||
1532801|NCT00548522|||Case-Only||Cross-Sectional|||||||
1532802|NCT00548509|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532803|NCT00548496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532804|NCT00548483|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1532805|NCT00548470||Single Group Assignment||Treatment||None (Open Label)||||||
1532806|NCT00548457|||Case Control||Prospective|||||||
1532807|NCT00548444|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532808|NCT00548431||Single Group Assignment||Treatment||None (Open Label)||||||
1532809|NCT00548418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532810|NCT00548405|Randomized|Parallel Assignment||Treatment||Single||||||t
1532811|NCT00548392|||Case-Only||Prospective|||||||
1532812|NCT00548379|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532813|NCT00548366|Randomized|Single Group Assignment||Treatment||Single|||||t|
1532814|NCT00548353|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532815|NCT00548340|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532816|NCT00548327|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532817|NCT00548314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532818|NCT00548301|Randomized|Parallel Assignment||||Double||||||
1532819|NCT00548288|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532820|NCT00548275|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1532821|NCT00548262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532822|NCT00548249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532823|NCT00548236|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1532824|NCT00548223|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532825|NCT00548210|||||Prospective|||||||
1532826|NCT00548197|Randomized|Parallel Assignment||Treatment||Single||||||t
1532827|NCT00548184||Single Group Assignment||Treatment||None (Open Label)||||||
1532828|NCT00548171|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532829|NCT00548158|||Cohort||Prospective|||||||
1532830|NCT00548145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532831|NCT00548132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532832|NCT00548119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532833|NCT00548106|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532834|NCT00548093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532835|NCT00548080|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532836|NCT00548067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532837|NCT00548054|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1532838|NCT00548041||Single Group Assignment||Diagnostic||None (Open Label)||||||
1532839|NCT00548015|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532840|NCT00548002|||Cohort||Prospective|||||||
1532841|NCT00547989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532842|NCT00547976|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1532843|NCT00547963|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1532844|NCT00547950|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532845|NCT00547937|Randomized|Crossover Assignment||||Triple|||t|t|t|
1532846|NCT00547924|||Case-Only||Prospective|||||||
1532847|NCT00547911|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532848|NCT00547898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532849|NCT00547885|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532850|NCT00547872|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532851|NCT00547859|||Cohort||Prospective|||||||
1532852|NCT00547846|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1532853|NCT00547833|||Case Control||Prospective|||||||
1532854|NCT00547820|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1532855|NCT00547807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532856|NCT00547794|||Cohort||Prospective|||||||
1532857|NCT00547781|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1532858|NCT00547768|Randomized|Crossover Assignment||Treatment||Double||||||
1532859|NCT00547742|||Cohort||Prospective|||||||
1532860|NCT00547729||Single Group Assignment||Diagnostic||None (Open Label)||||||
1532861|NCT00547716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532862|NCT00547703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532863|NCT00547690|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532864|NCT00547677|Non-Randomized|||Treatment||||||||
1532865|NCT00547664|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1532866|NCT00547651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532867|NCT00547638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532868|NCT00547625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532869|NCT00547612|Non-Randomized|||Diagnostic||||||||
1532870|NCT00547599|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532871|NCT00547586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532872|NCT00547573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532873|NCT00547560|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1532874|NCT00547547||Single Group Assignment||Treatment||None (Open Label)||||||
1532875|NCT00547534||Single Group Assignment||Treatment||None (Open Label)||||||
1532876|NCT00547521|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532877|NCT00547508|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532878|NCT00547495|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532879|NCT00547482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532880|NCT00547469|Randomized|Parallel Assignment||Treatment||Double||||||
1532881|NCT00547456||Single Group Assignment||Supportive Care||None (Open Label)||||||
1532882|NCT00547443|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532883|NCT00547417||Single Group Assignment||Treatment||None (Open Label)||||||
1532884|NCT00547404||Single Group Assignment||Treatment||None (Open Label)||||||
1532885|NCT00547391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532886|NCT00547378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532887|NCT00547365||Single Group Assignment||Treatment||None (Open Label)||||||
1532888|NCT00547352||Crossover Assignment||||None (Open Label)||||||
1532889|NCT00547339||Single Group Assignment||Treatment||None (Open Label)||||||
1532890|NCT00547326|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1532891|NCT00547300|Randomized|Parallel Assignment||Treatment||Double||||||
1532892|NCT00547287||Crossover Assignment||Treatment||None (Open Label)||||||
1532893|NCT00547274|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532894|NCT00547261|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532895|NCT00547248|Randomized|Parallel Assignment||Prevention||Double||||t||t
1532896|NCT00547235||||||||||||
1532897|NCT00547209|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532898|NCT00547196|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532899|NCT00547183|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532974|NCT00546169|||Case Control||Prospective|||||||
1532900|NCT00547170|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1532901|NCT00547157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532902|NCT00547144|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532903|NCT00547131||||Treatment||||||||
1532904|NCT00547118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532905|NCT00547105||Single Group Assignment||Treatment||None (Open Label)||This study is a single arm phase II pilot trial. Patients enrolled on the trial will have been receiving or will begin to receive erlotinib at standard doses (150 mg po per day). SBRT will commence within 4 weeks of the initiation of erlotinib. Maintenance erlotinib will continue until disease progression uncontrollable by SBRT, intolerable toxicity, or death.||||
1532906|NCT00547092|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532907|NCT00547066||Single Group Assignment||Treatment||None (Open Label)||||||
1532908|NCT00547053||Single Group Assignment||Treatment||None (Open Label)||||||
1532909|NCT00547040|||Cohort||Prospective|||||||
1532910|NCT00547027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532911|NCT00547014|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1532912|NCT00547001|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532913|NCT00546988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532914|NCT00546975|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1532915|NCT00546962|||||Prospective|||||||
1532916|NCT00546949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532917|NCT00546936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532918|NCT00546923|Randomized|Parallel Assignment||Treatment||Double||||||
1532919|NCT00546910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532920|NCT00546897|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532921|NCT00546884|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1532922|NCT00546871|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532923|NCT00546858|||Case-Only||Prospective|||||||
1532924|NCT00546845|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532925|NCT00546832|Randomized|Parallel Assignment||Treatment||Double||||||
1532926|NCT00546819|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1532927|NCT00546806|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1532928|NCT00546793||Single Group Assignment||Treatment||None (Open Label)||||||
1532929|NCT00546780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532930|NCT00546767|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1532931|NCT00546754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532932|NCT00546741|Randomized|Crossover Assignment||||None (Open Label)||||||
1532933|NCT00546728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532934|NCT00546715|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532935|NCT00546702|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532936|NCT00546689|||Case-Only||Prospective|||||||
1532937|NCT00546676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532938|NCT00546663||Single Group Assignment||Treatment||None (Open Label)||||||
1532939|NCT00546650|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532940|NCT00546637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532941|NCT00546624|Randomized|Parallel Assignment||Treatment||Double||||||
1532942|NCT00546611||Single Group Assignment||Treatment||None (Open Label)||||||
1532943|NCT00546598||Single Group Assignment||Treatment||None (Open Label)||||||
1532944|NCT00546585|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1532945|NCT00546572|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1532946|NCT00546559|||Case Control||Prospective|||||||
1532947|NCT00546546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532948|NCT00546533|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532949|NCT00546520|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1532950|NCT00546507|Randomized|Parallel Assignment||Treatment||Double||||||
1532951|NCT00546494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532952|NCT00546481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532953|NCT00546468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532954|NCT00546455|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532955|NCT00546442|Randomized|Parallel Assignment||Treatment||Single|||||t|
1532956|NCT00546429||Single Group Assignment||Treatment||None (Open Label)||||||
1532957|NCT00546403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532958|NCT00546390|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1532959|NCT00546377||Single Group Assignment||Treatment||None (Open Label)||||||
1532960|NCT00546364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532961|NCT00546351||Single Group Assignment||Treatment||None (Open Label)||||||
1532962|NCT00546325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1532963|NCT00546312||Single Group Assignment||Treatment||None (Open Label)||||||
1532964|NCT00546299|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1532965|NCT00546286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532966|NCT00546273|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1532967|NCT00546260|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1532968|NCT00546247|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532969|NCT00546234|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1532970|NCT00546221|Randomized|Parallel Assignment||Treatment||Single|||t|||
1532971|NCT00546208|||||Prospective|||||||
1532975|NCT00546156|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532976|NCT00546143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532977|NCT00546130||Single Group Assignment||Treatment||None (Open Label)||||||
1532978|NCT00546117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532979|NCT00546104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532980|NCT00546091|||||Prospective|||||||
1532981|NCT00546078|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532982|NCT00546065|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1532983|NCT00546052|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1532984|NCT00546039|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1532985|NCT00546026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532986|NCT00546013|||Cohort||Prospective|||||||
1532987|NCT00546000||Single Group Assignment||Treatment||None (Open Label)||||||
1532988|NCT00545987|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1532989|NCT00545974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532990|NCT00545961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532991|NCT00545948|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532992|NCT00545935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532993|NCT00545922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532994|NCT00545909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1532995|NCT00545896||Single Group Assignment||Treatment||None (Open Label)||||||
1532996|NCT00545883|||Cohort||Prospective|||||||
1532997|NCT00545870|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1532998|NCT00545857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1532999|NCT00545844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533000|NCT00545831|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533001|NCT00545818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533002|NCT00545805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533003|NCT00545792||Single Group Assignment||Treatment||None (Open Label)||||||
1533004|NCT00545779||Single Group Assignment||Treatment||None (Open Label)||||||
1533005|NCT00545766||Single Group Assignment||Treatment||None (Open Label)||||||
1533006|NCT00545753|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1533007|NCT00545740|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533008|NCT00545727||Crossover Assignment||Treatment||None (Open Label)||||||
1533009|NCT00545714||Single Group Assignment||Treatment||None (Open Label)||||||
1533010|NCT00545701|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1533011|NCT00545688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533012|NCT00545675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533013|NCT00545662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533014|NCT00545649|Randomized|Parallel Assignment||Treatment||Single|||||t|
1533015|NCT00545636||Single Group Assignment||Prevention||Single||||t||
1533016|NCT00545623|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1533017|NCT00545610|||Case-Control||Prospective|||||||
1533018|NCT00545597|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533019|NCT00545584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533020|NCT00545571||Single Group Assignment||Treatment||None (Open Label)||||||
1533021|NCT00545558||Single Group Assignment||Treatment||None (Open Label)||||||
1533022|NCT00545545|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533023|NCT00545532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533024|NCT00545519|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533025|NCT00545506|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1533026|NCT00545493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533027|NCT00545480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533028|NCT00545467|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533029|NCT00545454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533030|NCT00545441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533031|NCT00545428|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1533032|NCT00545415|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1533033|NCT00545402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533034|NCT00545389|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533035|NCT00545376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533036|NCT00545363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533037|NCT00545350|Randomized|Parallel Assignment||Prevention||Single|||||t|
1533038|NCT00545337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533039|NCT00545324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533040|NCT00545311|Randomized|Parallel Assignment||Treatment||Double||||||
1533041|NCT00545298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533042|NCT00545285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533043|NCT00545272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533044|NCT00545259|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1533045|NCT00545246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533046|NCT00545233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533047|NCT00545220|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533048|NCT00545207|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533049|NCT00545194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533050|NCT00545181|Randomized|Parallel Assignment||Treatment||Single||||||t
1533051|NCT00545168|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1533052|NCT00545155|||Cohort||Prospective|||||||
1533053|NCT00545142|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533054|NCT00545129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533055|NCT00545116|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533056|NCT00545103|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533057|NCT00545090||Single Group Assignment||Treatment||None (Open Label)||||||
1533058|NCT00545077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533059|NCT00545064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533060|NCT00545051|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533061|NCT00545025|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533062|NCT00545012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533063|NCT00544999||||Treatment||||||||
1533064|NCT00544986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533065|NCT00544960|Non-Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533066|NCT00544947|||Cohort||Prospective|||||||
1533067|NCT00544934|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533068|NCT00544921|Randomized|Parallel Assignment||||None (Open Label)||||||
1533069|NCT00544908||Single Group Assignment||Treatment||None (Open Label)||||||
1533070|NCT00544895|||Cohort||Prospective|||||||
1533071|NCT00544882|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533072|NCT00544869||Single Group Assignment||Treatment||None (Open Label)||||||
1533073|NCT00544856|Randomized|Crossover Assignment||Treatment||Single|||t|||
1533074|NCT00544830||Single Group Assignment||Treatment||None (Open Label)||||||
1533075|NCT00544817||Single Group Assignment||Treatment||None (Open Label)||||||
1533076|NCT00544804||Single Group Assignment||Treatment||None (Open Label)||||||
1533077|NCT00544791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533078|NCT00544778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533079|NCT00544765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533080|NCT00544752|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1533081|NCT00544739|||Case Control||Prospective|||||||
1533082|NCT00544726|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533083|NCT00544713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533084|NCT00544700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533085|NCT00544687|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533086|NCT00544674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533087|NCT00544648||Single Group Assignment||Treatment||None (Open Label)||||||
1533088|NCT00544635|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533089|NCT00544622|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1533090|NCT00544609||Single Group Assignment||Treatment||None (Open Label)||||||
1533091|NCT00544596||Single Group Assignment||Treatment||None (Open Label)||||||
1533092|NCT00544583|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1533093|NCT00544570||||Treatment||||||||
1533094|NCT00544557|||Cohort||Prospective|||||||
1533095|NCT00544544||Single Group Assignment||Treatment||None (Open Label)||||||
1533096|NCT00544531|||||Prospective|||||||
1533097|NCT00544518|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533098|NCT00544505||Single Group Assignment||Treatment||None (Open Label)||||||
1533099|NCT00544492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533100|NCT00544479|||Cohort||Prospective|||||||
1533101|NCT00544466||Single Group Assignment||Treatment||None (Open Label)||||||
1533102|NCT00544453|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1533103|NCT00544440||Single Group Assignment||Treatment||None (Open Label)||||||
1533104|NCT00544427|||Case-Only||Prospective|||||||
1533105|NCT00544414||Single Group Assignment||Treatment||None (Open Label)||||||
1533106|NCT00544401|Randomized|Parallel Assignment||Treatment||Single||||||t
1533107|NCT00544388|Randomized|Parallel Assignment||Treatment||Double||||||
1533108|NCT00544375|||Case-Only||Prospective|||||||
1533109|NCT00544362||Single Group Assignment||Treatment||None (Open Label)||||||
1533110|NCT00544349|Non-Randomized|||Treatment||None (Open Label)||||||
1533111|NCT00544336|||Cohort||Prospective|||||||
1533112|NCT00544323|Randomized|Single Group Assignment||Treatment||Single|||t|||
1533113|NCT00544310|Randomized|Single Group Assignment||Prevention||Double||||||
1533114|NCT00544297||Single Group Assignment||Treatment||None (Open Label)||||||
1533115|NCT00544284||Single Group Assignment||Treatment||None (Open Label)||||||
1533116|NCT00544271|Randomized|Parallel Assignment||Prevention||Single||||||
1533117|NCT00544258||Single Group Assignment||Treatment||None (Open Label)||||||
1533118|NCT00544245|Randomized|Parallel Assignment||||None (Open Label)||||||
1533119|NCT00544232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533120|NCT00544219||Single Group Assignment||Treatment||None (Open Label)||||||
1533121|NCT00544206|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533122|NCT00544193||||Treatment||||||||
1533123|NCT00544180|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533124|NCT00544167||Single Group Assignment||Treatment||None (Open Label)||||||
1533125|NCT00544154|Randomized|Parallel Assignment||Treatment||Double||||||
1533126|NCT00544141||||||||||||
1533127|NCT00544128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533128|NCT00544115|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533129|NCT00544102|||Cohort||Cross-Sectional|||||||
1533130|NCT00544089|||||Prospective|||||||
1533131|NCT00544076|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1533132|NCT00544063|Non-Randomized|||Treatment||||||||
1533133|NCT00544050|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533134|NCT00544037|||Cohort||Prospective|||||||
1533135|NCT00544024|||Cohort||Prospective|||||||
1533136|NCT00544011|Non-Randomized|||Treatment||||||||
1533137|NCT00543998|||Case-Only||Prospective|||||||
1533138|NCT00543985||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533139|NCT00543972|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533140|NCT00543959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533141|NCT00543946|Randomized|Single Group Assignment||Prevention||Single||||||t
1533142|NCT00543933||Single Group Assignment||Treatment||None (Open Label)||||||
1533143|NCT00543920|Randomized|Parallel Assignment||Treatment||Double||||||
1533144|NCT00543907|||Cohort||Retrospective|||||||
1533145|NCT00543894|||||Prospective|||||||
1533146|NCT00543881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533147|NCT00543868|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533148|NCT00543855|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533149|NCT00543842||Single Group Assignment||Treatment||None (Open Label)||||||
1533150|NCT00543829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533151|NCT00543816|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533152|NCT00543803|||Cohort||Prospective|||||||
1533153|NCT00543790|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1533154|NCT00543777||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533155|NCT00543764|||Cohort||Retrospective|||||||
1533156|NCT00543751|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533157|NCT00543738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533158|NCT00543725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533159|NCT00543712||Single Group Assignment||Treatment||||||||
1533160|NCT00543686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533161|NCT00543673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533162|NCT00543660||Single Group Assignment||Treatment||None (Open Label)||||||
1533163|NCT00543647|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1533164|NCT00543634|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1533165|NCT00543621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533166|NCT00543608|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533167|NCT00543595|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533168|NCT00543582||Single Group Assignment||Treatment||None (Open Label)||||||
1533169|NCT00543569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533170|NCT00543556|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533171|NCT00543543|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533172|NCT00543530|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533173|NCT00543517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533174|NCT00543504|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533175|NCT00543491|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1533176|NCT00543478|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533177|NCT00543465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533178|NCT00543452|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1533179|NCT00543439|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533180|NCT00543426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533181|NCT00543413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533182|NCT00543400|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533183|NCT00543387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533184|NCT00543374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533185|NCT00543361|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1533186|NCT00543348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533187|NCT00543335||Single Group Assignment||Treatment||None (Open Label)||||||
1533188|NCT00543322|||||Prospective|||||||
1533189|NCT00543309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533190|NCT00543296||Single Group Assignment||Treatment||None (Open Label)||||||
1533191|NCT00543270|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533192|NCT00543257|||Cohort||Cross-Sectional|||||||
1533193|NCT00543244|||Case-Only||Cross-Sectional|||||||
1533194|NCT00543231|Randomized|Crossover Assignment||Treatment||Single||||||
1533195|NCT00543218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533196|NCT00543205||Parallel Assignment||Treatment||None (Open Label)||||||
1533197|NCT00543192|||Case-Only||Cross-Sectional|||||||
1533198|NCT00543179||Single Group Assignment||Treatment||None (Open Label)||||||
1533199|NCT00543166|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1533200|NCT00543153|||Case-Only||Prospective|||||||
1533201|NCT00543140||Single Group Assignment||Treatment||None (Open Label)||||||
1533202|NCT00543127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533203|NCT00543114||Single Group Assignment||Treatment||None (Open Label)||||||
1533204|NCT00543101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533205|NCT00543088|||||Prospective|||||||
1533206|NCT00543075|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1533207|NCT00543062|Randomized|Crossover Assignment||Treatment||Quadruple|This was a double-blind randomized 4-period crossover study to assess the effects of single doses of 5 and 10 mg of Staccato Prochlorperazine on QT intervals.|Female and male subjects in approximately equal numbers were randomly assigned (1:1:1:1) to receive the 4 treatment sequences|t|t|t|t
1533208|NCT00543049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533209|NCT00543036|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533210|NCT00543023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533211|NCT00543010|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533212|NCT00542997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533213|NCT00542984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533214|NCT00542971||Single Group Assignment||Treatment||None (Open Label)||||||
1533215|NCT00542958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533216|NCT00542945|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533217|NCT00542932|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533218|NCT00542919|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533219|NCT00542906||Single Group Assignment||Treatment||None (Open Label)||||||
1533220|NCT00542893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533221|NCT00542880|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1533222|NCT00542867|||||Prospective|||||||
1533223|NCT00542854|||Case-Crossover||Prospective|||||||
1533224|NCT00542841||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533225|NCT00542828|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533226|NCT00542815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533227|NCT00542802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533228|NCT00542789|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533229|NCT00542776|||Cohort||Prospective|||||||
1533230|NCT00542763||Single Group Assignment||Treatment||None (Open Label)||||||
1533231|NCT00542750||Single Group Assignment||Treatment||None (Open Label)||||||
1533232|NCT00542737|Randomized|Parallel Assignment||||None (Open Label)||||||
1533233|NCT00542724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533234|NCT00542711|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533235|NCT00542698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533236|NCT00542685|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533237|NCT00542672|||Cohort||Prospective|||||||
1533238|NCT00542659|||Cohort||Prospective|||||||
1533239|NCT00542646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533240|NCT00542633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533241|NCT00542620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533242|NCT00542607|Randomized|Crossover Assignment||Treatment||Double||||||
1533243|NCT00542594|||Cohort||Prospective|||||||
1533244|NCT00542581||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1533245|NCT00542568|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533246|NCT00542555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533247|NCT00542542|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1533248|NCT00542529|Randomized|Parallel Assignment||||Triple|||t||t|t
1533249|NCT00542516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533250|NCT00542503|||Cohort||Prospective|||||||
1533251|NCT00542490||Single Group Assignment||Treatment||None (Open Label)||||||
1533252|NCT00542477||||||||||||
1533253|NCT00542464|Randomized|Parallel Assignment||||Triple|||t||t|t
1533254|NCT00542451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533255|NCT00542438|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533256|NCT00542425|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533257|NCT00542412||Parallel Assignment||Treatment||None (Open Label)||||||
1533258|NCT00542399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533259|NCT00542386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533260|NCT00542373||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533261|NCT00542360|Randomized|Parallel Assignment||Prevention||Single||||||t
1533262|NCT00542347|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533263|NCT00542334|||Case-Only||Cross-Sectional|||||||
1533264|NCT00542321|Randomized|Parallel Assignment||Treatment||Single||||||t
1533265|NCT00542308||Single Group Assignment||||None (Open Label)||||||
1533266|NCT00542295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533267|NCT00542282|||Cohort||Prospective|||||||
1533268|NCT00542269|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533269|NCT00542256|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1533270|NCT00542243|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1533271|NCT00542230|||||Prospective|||||||
1533272|NCT00542217|Randomized|Parallel Assignment||||Triple|||t||t|t
1533273|NCT00542204|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1533274|NCT00542191||Single Group Assignment||Treatment||None (Open Label)||||||
1533275|NCT00542178|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1533276|NCT00542165||Single Group Assignment||Treatment||None (Open Label)||||||
1533277|NCT00542152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533278|NCT00542139|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533279|NCT00542126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533280|NCT00542113|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533281|NCT00542100|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1533282|NCT00542087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533283|NCT00542074|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1533284|NCT00542061|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1533285|NCT00542048|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1533286|NCT00542035|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1533287|NCT00542022|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533288|NCT00542009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533289|NCT00541996|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1533290|NCT00541983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533291|NCT00541970|Randomized|Parallel Assignment||Prevention||Single|||t|||
1533292|NCT00541957|Randomized|Parallel Assignment||Treatment||Single||||||t
1533293|NCT00541944|||Cohort||Prospective|||||||
1533294|NCT00541931|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1533295|NCT00541918|Randomized|Crossover Assignment||Prevention||Double|||t|||t
1533296|NCT00541905||Single Group Assignment||Treatment||None (Open Label)||||||
1533297|NCT00541892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533298|NCT00541879|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533299|NCT00541866||Single Group Assignment||Treatment||None (Open Label)||||||
1533300|NCT00541853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533301|NCT00541840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533302|NCT00541827|||Cohort||Prospective|||||||
1533303|NCT00541814|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533304|NCT00541801||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533305|NCT00541788||Single Group Assignment||Treatment||None (Open Label)||||||
1533306|NCT00541775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533307|NCT00541762|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1533308|NCT00541749|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533309|NCT00541736|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1533310|NCT00541723|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533311|NCT00541710|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533312|NCT00541697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533313|NCT00541684|Randomized|Parallel Assignment||Treatment||Double||||||
1533314|NCT00541671|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1533315|NCT00541658|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533316|NCT00541645|||||Prospective|||||||
1533317|NCT00541632|||||Prospective|||||||
1533318|NCT00541619|||Cohort||Prospective|||||||
1533319|NCT00541606|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1533320|NCT00541593||Single Group Assignment||Treatment||None (Open Label)||||||
1533321|NCT00541580|||Cohort||Prospective|||||||
1533322|NCT00541567|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533323|NCT00541554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533324|NCT00541541||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533325|NCT00541515||Single Group Assignment||Treatment||None (Open Label)||||||
1533326|NCT00541502|||||Prospective|||||||
1533327|NCT00541489|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533328|NCT00541476|||||Prospective|||||||
1533329|NCT00541463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533330|NCT00541450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533331|NCT00541437|||||Prospective|||||||
1533332|NCT00541424|||Case-Only||Prospective|||||||
1533333|NCT00541411||Single Group Assignment||Treatment||None (Open Label)||||||
1533334|NCT00541398|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1533335|NCT00541385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533336|NCT00541372|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1533337|NCT00541359||Single Group Assignment||Treatment||None (Open Label)||||||
1533338|NCT00541346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533339|NCT00541333|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1533340|NCT00541320|Randomized|Parallel Assignment||Prevention||Double||||||
1533341|NCT00541307||Single Group Assignment||Treatment||None (Open Label)||||||
1533342|NCT00541294|||||Prospective|||||||
1533343|NCT00541281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533344|NCT00541268|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533345|NCT00541255|||Cohort||Prospective|||||||
1533346|NCT00541242|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533347|NCT00541229|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1533348|NCT00541216|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533349|NCT00541203|||Cohort||Prospective|||||||
1533350|NCT00541190|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1533351|NCT00541177|Randomized|Parallel Assignment||Prevention||Single||||||t
1533352|NCT00541164|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1533353|NCT00541151|||Cohort||Prospective|||||||
1533354|NCT00541138||Single Group Assignment||Treatment||None (Open Label)||||||
1533355|NCT00541125||Single Group Assignment||Supportive Care||None (Open Label)||||||
1533356|NCT00541112|Non-Randomized|||Treatment||||||||
1533357|NCT00541099||Single Group Assignment||Treatment||None (Open Label)||||||
1533358|NCT00541086|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1533359|NCT00541073|Non-Randomized|||Treatment||||||||
1533360|NCT00541060|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1533361|NCT00541047|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1533362|NCT00541034||Single Group Assignment||Treatment||None (Open Label)||||||
1533363|NCT00541021|Randomized|||Treatment||Double||||||
1533364|NCT00541008||||Treatment||None (Open Label)||||||
1533365|NCT00540995||Single Group Assignment||Treatment||None (Open Label)||||||
1533366|NCT00540982|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533367|NCT00540969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533368|NCT00540956||||Treatment||None (Open Label)||||||
1533369|NCT00540943||Single Group Assignment||Treatment||None (Open Label)||||||
1533370|NCT00540930|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533371|NCT00540917||Single Group Assignment||Treatment||None (Open Label)||||||
1533372|NCT00540904|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533373|NCT00540891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533374|NCT00540878|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533375|NCT00540865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533376|NCT00540852||Single Group Assignment||Device Feasibility||||||||
1533377|NCT00540839|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533378|NCT00540826|||Cohort||Prospective|||||||
1533379|NCT00540813||Single Group Assignment||Treatment||None (Open Label)||||||
1533380|NCT00540800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533381|NCT00540787|Randomized|Parallel Assignment||||None (Open Label)||||||
1533382|NCT00540774|||Case-Only||Prospective|||||||
1533383|NCT00540761|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1533384|NCT00540748|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533385|NCT00540735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533386|NCT00540722||Single Group Assignment||Treatment||None (Open Label)||||||
1533387|NCT00540709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533388|NCT00540696|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533389|NCT00540683|||Case-Only||Prospective|||||||
1533390|NCT00540670|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533391|NCT00540657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533392|NCT00540644||Single Group Assignment||Treatment||None (Open Label)||||||
1533393|NCT00540631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533394|NCT00540618|Randomized|Single Group Assignment||Treatment||Double||||||
1533395|NCT00540605|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1533396|NCT00540592|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533397|NCT00540579||Single Group Assignment||Treatment||None (Open Label)||||||
1533398|NCT00540566|||Case-Only||Prospective|||||||
1533399|NCT00540553|Randomized|Single Group Assignment||Treatment||Double||||||
1533400|NCT00540540|||Case-Only||Prospective|||||||
1533401|NCT00540527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533402|NCT00540514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533403|NCT00540501|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533404|NCT00540488|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533405|NCT00540475|||Case-Control||Prospective|||||||
1533406|NCT00540462|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1533407|NCT00540449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533408|NCT00540436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533409|NCT00540423|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533410|NCT00540410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533411|NCT00540397|Randomized|Parallel Assignment||Treatment||Double||||||
1533412|NCT00540384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533413|NCT00540371|||Case-Only||Retrospective|||||||
1533414|NCT00540358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533415|NCT00540345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533416|NCT00540332|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1533417|NCT00540319|Randomized|Parallel Assignment||Prevention||Single|||t|||
1533418|NCT00540306|||Case-Only||Prospective|||||||
1533419|NCT00540293|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533420|NCT00540280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533421|NCT00540267|||Case Control|||||||||
1533422|NCT00540254|Randomized|Parallel Assignment||Treatment||Single||||t||
1533423|NCT00540241|||Case-Only||Prospective|||||||
1533424|NCT00540228|Randomized|Parallel Assignment||Prevention||Single|||t|||
1533425|NCT00540215||Single Group Assignment||Basic Science||Single|||t|||
1533426|NCT00540202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533427|NCT00540189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533428|NCT00540176|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533429|NCT00540163|||||Prospective|||||||
1533430|NCT00540150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533431|NCT00540137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533432|NCT00540124|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533433|NCT00540111||Single Group Assignment||Treatment||None (Open Label)||||||
1533434|NCT00540098|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1533435|NCT00540085|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1533436|NCT00540072|Randomized|Parallel Assignment||||Double||||||
1533437|NCT00540059|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1533438|NCT00540046|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1533439|NCT00540033|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1533440|NCT00540020|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1533441|NCT00540007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533442|NCT00539994|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1533443|NCT00539981|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1533444|NCT00539968|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533445|NCT00539955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533446|NCT00539942|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533447|NCT00539929|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533448|NCT00539916|Randomized|Crossover Assignment||Prevention||Single||||||t
1533449|NCT00539903|Randomized|Parallel Assignment||||Single|||||t|
1533450|NCT00539890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533451|NCT00539877|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533452|NCT00539864|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1533453|NCT00539851|||Cohort||Prospective|||||||
1533454|NCT00539838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533455|NCT00539825|Randomized|Crossover Assignment||Treatment||Double||||||
1533456|NCT00539812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533457|NCT00539799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533458|NCT00539786||Parallel Assignment||Diagnostic||None (Open Label)||||||
1533459|NCT00539773||Single Group Assignment||Treatment||None (Open Label)||||||
1533460|NCT00539760|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533461|NCT00539747|||||Retrospective|||||||
1533462|NCT00539734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533463|NCT00539721|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533464|NCT00539708|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533465|NCT00539695||Single Group Assignment||Treatment||None (Open Label)||||||
1533466|NCT00539669|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533467|NCT00539656||Single Group Assignment||Treatment||None (Open Label)||||||
1533468|NCT00539643|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533469|NCT00539630|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533470|NCT00539617||Single Group Assignment||Treatment||None (Open Label)||||||
1533471|NCT00539604|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1533472|NCT00539591|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533473|NCT00539578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533474|NCT00539565|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533475|NCT00539539|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533476|NCT00539526|Randomized|Parallel Assignment||Treatment||Single|||||t|
1533477|NCT00539513|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533478|NCT00539500||Single Group Assignment||Treatment||None (Open Label)||||||
1533479|NCT00539487|||||Prospective|||||||
1533480|NCT00539474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533481|NCT00539461|||||Prospective|||||||
1533482|NCT00539448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533483|NCT00539435|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533484|NCT00539422|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1533485|NCT00539409|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533486|NCT00539396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533487|NCT00539383||Single Group Assignment||||None (Open Label)||||||
1533488|NCT00539370|||||Prospective|||||||
1533489|NCT00539357||Single Group Assignment||Treatment||None (Open Label)||||||
1533490|NCT00539344||Single Group Assignment||||None (Open Label)||||||
1533491|NCT00539331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533492|NCT00539318|||||Prospective|||||||
1533493|NCT00539305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533494|NCT00539292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533495|NCT00539279|Randomized|Parallel Assignment||Treatment||Single||||||t
1533496|NCT00539266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533497|NCT00539253||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533498|NCT00539240|Randomized|Parallel Assignment||Treatment||Double||||||
1533499|NCT00539227|||Case Control||Prospective|||||||
1533500|NCT00539214|||||Prospective|||||||
1533501|NCT00539201|Randomized|Single Group Assignment||Treatment||Double||||||
1533502|NCT00539188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533503|NCT00539175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533504|NCT00539162||Single Group Assignment||Screening||None (Open Label)||||||
1533505|NCT00539149|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533506|NCT00539136|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1533507|NCT00539123|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1533508|NCT00539110|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533509|NCT00539097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533510|NCT00539084|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533511|NCT00539071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533512|NCT00539045|||Cohort||Prospective|||||||
1533513|NCT00539032|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533514|NCT00539019|||||Prospective|||||||
1533515|NCT00539006|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1533516|NCT00538993|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1533517|NCT00538980||Single Group Assignment||Treatment||None (Open Label)||||||
1533518|NCT00538967|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1533519|NCT00538954|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1533520|NCT00538941|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533521|NCT00538928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533522|NCT00538915||Single Group Assignment||Treatment||None (Open Label)||||||
1533523|NCT00538902|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533524|NCT00538889|Randomized|Parallel Assignment||Treatment||Double||||||
1533525|NCT00538876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533526|NCT00538863|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1533527|NCT00538850||Crossover Assignment||Treatment||Triple|||t||t|t
1533528|NCT00538824||Single Group Assignment||Treatment||None (Open Label)||||||
1533529|NCT00538811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533530|NCT00538798||||Treatment||||||||
1533531|NCT00538785|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533532|NCT00538772|||||Prospective|||||||
1533533|NCT00538759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533534|NCT00538746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533535|NCT00538733||Single Group Assignment||Treatment||None (Open Label)||||||
1533536|NCT00538720||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533537|NCT00538707||Parallel Assignment||Prevention||None (Open Label)||||||
1533538|NCT00538694|Randomized|Parallel Assignment||||Double||||||
1533539|NCT00538681|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533540|NCT00538668|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533541|NCT00538655||Crossover Assignment||Treatment||None (Open Label)||||||
1533542|NCT00538642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533543|NCT00538629|||||Prospective|||||||
1533544|NCT00538616|Randomized|Crossover Assignment||Treatment||Single|||t|||
1533545|NCT00538603||Single Group Assignment||Treatment||None (Open Label)||||||
1533546|NCT00538590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533547|NCT00538577|||Case Control||Prospective|||||||
1533548|NCT00538564|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533549|NCT00538551|||Cohort||Prospective|||||||
1533550|NCT00538538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533551|NCT00538525||Single Group Assignment||Treatment||None (Open Label)||||||
1533552|NCT00538512|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1533553|NCT00538499|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533554|NCT00538486|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533555|NCT00538473|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533556|NCT00538460|||Cohort||Prospective|||||||
1533557|NCT00538447||Single Group Assignment||Health Services Research||None (Open Label)||||||
1533558|NCT00538434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533559|NCT00538421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533560|NCT00538408|||||Prospective|||||||
1533561|NCT00538395||Single Group Assignment||Treatment||None (Open Label)||||||
1533562|NCT00538382|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1533563|NCT00538369|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533564|NCT00538356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533565|NCT00538343||Single Group Assignment||Treatment||None (Open Label)||||||
1533566|NCT00538330||Single Group Assignment||Health Services Research||None (Open Label)||||||
1533567|NCT00538317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533568|NCT00538304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533569|NCT00538291||Single Group Assignment||Treatment||None (Open Label)||||||
1533570|NCT00538278|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1533571|NCT00538265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533572|NCT00538252|||Family-Based||Prospective|||||||
1533573|NCT00538239|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533574|NCT00538226||Single Group Assignment||||None (Open Label)||||||
1533575|NCT00538213|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533576|NCT00538200|Randomized|Parallel Assignment||||None (Open Label)||||||
1533577|NCT00538187||Single Group Assignment||Treatment||None (Open Label)||||||
1533578|NCT00538174|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1533579|NCT00538161|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533580|NCT00538148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533581|NCT00538135|Randomized|Parallel Assignment||Treatment||Single||||||t
1533582|NCT00538122|||||Prospective|||||||
1533583|NCT00538109|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533584|NCT00538096|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533585|NCT00538083|Randomized|Crossover Assignment||Prevention||Single|||||t|
1533586|NCT00538070|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1533587|NCT00538057|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1533588|NCT00538044|Randomized|Parallel Assignment||Treatment||Single|||||t|
1533589|NCT00538031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533590|NCT00538018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533591|NCT00538005||||Treatment||||||||
1533592|NCT00537992|Randomized|Parallel Assignment||Treatment||Single||||||t
1533593|NCT00537979|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533594|NCT00537966|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533595|NCT00537953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533596|NCT00537940|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533597|NCT00537927|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533598|NCT00537914||Single Group Assignment||Treatment||None (Open Label)||||||
1533599|NCT00537901|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533600|NCT00537888|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1533601|NCT00537875|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1533602|NCT00537862|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533603|NCT00537849||Single Group Assignment||Treatment||None (Open Label)||||||
1533604|NCT00537836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533605|NCT00537823|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533606|NCT00537810|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1533607|NCT00537797||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533608|NCT00537784|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533609|NCT00537771|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1533610|NCT00537758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533611|NCT00537745||Single Group Assignment||Treatment||None (Open Label)||||||
1533612|NCT00537732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533613|NCT00537719|Randomized|Parallel Assignment||Treatment||Single|||||t|
1533614|NCT00537706|||||Prospective|||||||
1533615|NCT00537693|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533616|NCT00537680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533617|NCT00537667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533618|NCT00537654|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533619|NCT00537641|||Cohort||Prospective|||||||
1533620|NCT00537628|||Cohort||Prospective|||||||
1533621|NCT00537615|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1533622|NCT00537602|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533623|NCT00537589|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1533624|NCT00537576|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1533625|NCT00537563|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533626|NCT00537550||Single Group Assignment||Treatment||None (Open Label)||||||
1533627|NCT00537537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533628|NCT00537524|Randomized|Parallel Assignment||Prevention||Single||||||t
1533629|NCT00537511||Single Group Assignment||Treatment||None (Open Label)||||||
1533630|NCT00537498||Single Group Assignment||Treatment||None (Open Label)||||||
1533631|NCT00537485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533632|NCT00537472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533633|NCT00537459|Randomized|Crossover Assignment||Treatment||Double||||||
1533634|NCT00537446|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1533635|NCT00537433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533636|NCT00537420|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1533637|NCT00537407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533638|NCT00537394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533639|NCT00537381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533640|NCT00537368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533641|NCT00537355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533642|NCT00537342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533643|NCT00537329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533644|NCT00537316|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533645|NCT00537303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533646|NCT00537290||Single Group Assignment||Treatment||None (Open Label)||||||
1533647|NCT00537277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533648|NCT00537264|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1533649|NCT00537251|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533650|NCT00537238|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533651|NCT00537225|Randomized|Parallel Assignment||Treatment||Single||Home-based exercise|t|||
1533652|NCT00537212|Randomized|Parallel Assignment||Treatment||Single|||||t|
1533653|NCT00537199||Single Group Assignment||Treatment||None (Open Label)||||||
1533654|NCT00537186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533655|NCT00537173|||Other||Prospective|||||||
1533656|NCT00537160||Single Group Assignment||Treatment||None (Open Label)||||||
1533657|NCT00537147|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1533658|NCT00537134|Randomized|Parallel Assignment||Treatment||Single||||||t
1533659|NCT00537121||Single Group Assignment||Treatment||None (Open Label)||||||
1533660|NCT00537108|Randomized|Single Group Assignment||Prevention||Single||||||t
1533661|NCT00537095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533662|NCT00537082|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533663|NCT00537056||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533664|NCT00537043|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533665|NCT00537030||Single Group Assignment||Treatment||None (Open Label)||||||
1533666|NCT00537017||Single Group Assignment||Treatment||None (Open Label)||||||
1533667|NCT00537004|||Cohort||Prospective|||||||
1533668|NCT00536991||Single Group Assignment||Treatment||None (Open Label)||||||
1533669|NCT00536978||Single Group Assignment||Treatment||None (Open Label)||||||
1533670|NCT00536965|||Cohort||Prospective|||||||
1533671|NCT00536952|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1533672|NCT00536939|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533673|NCT00536926|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533674|NCT00536913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533675|NCT00536900|Randomized|Parallel Assignment||Treatment||Single||||||t
1533676|NCT00536887|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533677|NCT00536874||Single Group Assignment||Treatment||None (Open Label)||||||
1533678|NCT00536861||Single Group Assignment||Treatment||None (Open Label)||||||
1533679|NCT00536848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533680|NCT00536835|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533681|NCT00536822|||||Prospective|||||||
1533682|NCT00536809|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533683|NCT00536796|||Cohort||Prospective|||||||
1533684|NCT00536783|||||Prospective|||||||
1533685|NCT00536770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533686|NCT00536744|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533687|NCT00536731|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533688|NCT00536718||||||||||||
1533689|NCT00536705|||Case Control||Prospective|||||||
1533690|NCT00536692|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533691|NCT00536679|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533692|NCT00536666|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533693|NCT00536653|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533694|NCT00536640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533695|NCT00536627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533696|NCT00536614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533697|NCT00536601|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533698|NCT00536588|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533699|NCT00536575||Single Group Assignment||Treatment||None (Open Label)||||||
1533700|NCT00536562|Randomized|Parallel Assignment||Treatment||Single||||||t
1533701|NCT00536549|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1533702|NCT00536536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533703|NCT00536523|||Cohort||Prospective|||||||
1533704|NCT00536510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533705|NCT00536497|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533706|NCT00536484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533707|NCT00536471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533708|NCT00536458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533709|NCT00536445||Single Group Assignment||Basic Science||None (Open Label)||||||
1533710|NCT00536432|||Cohort||Prospective|||||||
1533711|NCT00536419|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533712|NCT00536406|Randomized|Parallel Assignment||Treatment||Single||||||t
1533713|NCT00536393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533714|NCT00536380|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533715|NCT00536367|||||Prospective|||||||
1533716|NCT00536354||Single Group Assignment||Prevention||None (Open Label)||||||
1533717|NCT00536341||Single Group Assignment||Treatment||None (Open Label)||||||
1533718|NCT00536328|||||Prospective|||||||
1533719|NCT00536315|||Cohort||Prospective|||||||
1533720|NCT00536302|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533721|NCT00536289|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1533722|NCT00536276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533723|NCT00536263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533724|NCT00536250|||Cohort||Prospective|||||||
1533725|NCT00536237|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1533726|NCT00536224|Randomized|Parallel Assignment||Prevention||Single||||||t
1533727|NCT00536211|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1533728|NCT00536198|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533729|NCT00536185|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1533730|NCT00536172|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533731|NCT00536159|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533732|NCT00536146|||||Prospective|||||||
1533733|NCT00536133|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533734|NCT00536120|Randomized|Parallel Assignment||||None (Open Label)||||||
1533735|NCT00536107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533736|NCT00536094|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1533737|NCT00536081|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533738|NCT00536068|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533739|NCT00536055|||Defined Population||Longitudinal, Prospective|||||||
1533740|NCT00536042||Single Group Assignment||Treatment||None (Open Label)||||||
1533741|NCT00536029|||Defined Population|Screening|Longitudinal, Prospective|||||||
1533742|NCT00536016||Single Group Assignment||Treatment||None (Open Label)||||||
1533743|NCT00536003|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1533744|NCT00535990|||Case-Only||Prospective|||||||
1533745|NCT00535977|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1533746|NCT00535964|||Cohort||Prospective|||||||
1533747|NCT00535951||Single Group Assignment||Treatment||None (Open Label)||||||
1533748|NCT00535938|||||Prospective|||||||
1533749|NCT00535925|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533750|NCT00535912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533751|NCT00535899|||||Prospective|||||||
1533752|NCT00535886|Randomized|Parallel Assignment||Prevention||Single|||t|||
1533753|NCT00535873||Single Group Assignment||Treatment||None (Open Label)||||||
1533754|NCT00535860|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533755|NCT00535847|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533756|NCT00535834||||||||||||
1533757|NCT00535821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533758|NCT00535808|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533759|NCT00535795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533760|NCT00535782|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533761|NCT00535769|Randomized|Parallel Assignment||||Single||||||t
1533762|NCT00535756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533763|NCT00535743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533764|NCT00535730|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533765|NCT00535717|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533766|NCT00535704|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533767|NCT00535691|Randomized|Parallel Assignment||Treatment||Double||||||
1533768|NCT00535678|||Cohort||Prospective|||||||
1533769|NCT00535665|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533770|NCT00535652||Single Group Assignment||Treatment||None (Open Label)||||||
1533771|NCT00535639|Randomized|Parallel Assignment||||Double||||||
1533772|NCT00535626||Single Group Assignment||Treatment||None (Open Label)||||||
1533773|NCT00535613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533774|NCT00535600|||||Prospective|||||||
1533775|NCT00535587|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533776|NCT00535574|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1533777|NCT00535561|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1533778|NCT00535548||Single Group Assignment||Basic Science||Single|||t|||
1533779|NCT00535535|Randomized|Crossover Assignment||Prevention||Single||||||
1533780|NCT00535522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533781|NCT00535509||Single Group Assignment||Treatment||None (Open Label)||||||
1533782|NCT00535496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533783|NCT00535483|||||Prospective|||||||
1533784|NCT00535470||Single Group Assignment||Treatment||None (Open Label)||||||
1533785|NCT00535457|Randomized|Parallel Assignment||Prevention||Single|||||t|
1533786|NCT00535444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533787|NCT00535431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533788|NCT00535418||Single Group Assignment||Treatment||None (Open Label)||||||
1533789|NCT00535405|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533790|NCT00535392||Single Group Assignment||Treatment||None (Open Label)||||||
1533791|NCT00535379||Single Group Assignment||Treatment||None (Open Label)||||||
1533792|NCT00535366|Randomized|Crossover Assignment||Treatment||Double||||||
1533793|NCT00535353||Single Group Assignment||Treatment||None (Open Label)||||||
1533794|NCT00535340|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533795|NCT00535327|||Cohort||Prospective|||||||
1533796|NCT00535314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533797|NCT00535301|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1533798|NCT00535288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533799|NCT00535275|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533800|NCT00535262||Single Group Assignment||Treatment||None (Open Label)||||||
1533801|NCT00535236|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533802|NCT00535223|Randomized|Parallel Assignment||Treatment||Single||||||t
1533803|NCT00535210|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533804|NCT00535197|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1533805|NCT00535184|||Cohort||Prospective|||||||
1533806|NCT00535171|||Case-Only||Prospective|||||||
1533807|NCT00535158|||Other||Cross-Sectional|||||||
1533808|NCT00535145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533809|NCT00535132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533810|NCT00535119||Single Group Assignment||Treatment||None (Open Label)||||||
1533811|NCT00535106|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1533812|NCT00535093||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533813|NCT00535080||||||||||||
1533814|NCT00535067|||Case-Only||Prospective|||||||
1533815|NCT00535054||Single Group Assignment||Treatment||None (Open Label)||||||
1533816|NCT00535041||Single Group Assignment||Treatment||None (Open Label)||||||
1533817|NCT00535028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533818|NCT00535015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533819|NCT00535002|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1533820|NCT00534989||Single Group Assignment||Treatment||None (Open Label)||||||
1533821|NCT00534976|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1533822|NCT00534963|Randomized|Single Group Assignment||Treatment||Single|||t|||
1533823|NCT00534950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533824|NCT00534937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533825|NCT00534924|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533826|NCT00534911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533827|NCT00534898|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533828|NCT00534885|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1533829|NCT00534872|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533830|NCT00534859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533831|NCT00534846|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533832|NCT00534833|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533833|NCT00534820||Single Group Assignment||Basic Science||None (Open Label)||||||
1533834|NCT00534807|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533835|NCT00534794|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533836|NCT00534781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533837|NCT00534768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533838|NCT00534755||Single Group Assignment||||None (Open Label)||||||
1533839|NCT00534742|||Family-Based||Cross-Sectional|||||||
1533840|NCT00534729||Single Group Assignment||Treatment||None (Open Label)||||||
1533841|NCT00534716|||||Prospective|||||||
1533842|NCT00534703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533843|NCT00534690|Randomized|Crossover Assignment||Supportive Care||Single|||t|||
1533844|NCT00534677|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533845|NCT00534664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533846|NCT00534651|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1533847|NCT00534638|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533848|NCT00534625|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533849|NCT00534612||Single Group Assignment||Diagnostic||Double|||||t|t
1533850|NCT00534599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533851|NCT00534586|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1533852|NCT00534573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533853|NCT00534560|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1533854|NCT00534547||Single Group Assignment||Treatment||None (Open Label)||||||
1533855|NCT00534534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533856|NCT00534521|Randomized|Parallel Assignment||||Single|||t|||
1533857|NCT00534508||Single Group Assignment||Treatment||None (Open Label)||||||
1533858|NCT00534495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533859|NCT00534482|Randomized|Factorial Assignment||||None (Open Label)||||||
1533860|NCT00534469|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533861|NCT00534456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533862|NCT00534443|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1533863|NCT00534430||Single Group Assignment||Treatment||None (Open Label)||||||
1533864|NCT00534417||Single Group Assignment||Treatment||None (Open Label)||||||
1533865|NCT00534404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533866|NCT00534391|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533867|NCT00534378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533868|NCT00534365|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1533869|NCT00534352|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533870|NCT00534339|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533871|NCT00534326|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533872|NCT00534313|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533873|NCT00534300|Randomized|Crossover Assignment||||Triple|||t||t|t
1533874|NCT00534287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533875|NCT00534274||Single Group Assignment||Diagnostic||None (Open Label)||||||
1533876|NCT00534261|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533877|NCT00534248|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533878|NCT00534235|Randomized|Parallel Assignment||Treatment||Single|||t|||
1533879|NCT00534222|||Cohort||Prospective|||||||
1533880|NCT00534209|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533881|NCT00534196|||Cohort||Prospective|||||||
1533882|NCT00534183|Randomized|Parallel Assignment||Screening||Double|||t||t|
1533883|NCT00534170|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1533884|NCT00534157|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1533885|NCT00534144|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1533886|NCT00534131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533887|NCT00534118||Single Group Assignment||Treatment||None (Open Label)||||||
1533888|NCT00534105|||Cohort||Prospective|||||||
1533889|NCT00534092|||Cohort||Other|||||||
1533890|NCT00534079|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533891|NCT00534066|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1533892|NCT00534053|Randomized|Single Group Assignment||Screening||Triple|||t||t|t
1533893|NCT00534027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533894|NCT00534014|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1533895|NCT00534001|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1533896|NCT00533988|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1533897|NCT00533975|||Defined Population|Screening|Longitudinal, Prospective|||||||
1533898|NCT00533962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533899|NCT00533949|Randomized|Crossover Assignment||Treatment||None (Open Label)||This study was revised 06/18/08 to a 2x2 factorial design to evaluate the addition of cetuximab to the radiation therapy regimens.||||
1533900|NCT00533936|Randomized|||Treatment||None (Open Label)||||||
1533901|NCT00533923||Single Group Assignment||Treatment||None (Open Label)||||||
1533902|NCT00533910|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1533903|NCT00533897|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533904|NCT00533884|||Cohort||Prospective|||||||
1533905|NCT00533871|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1533906|NCT00533858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533907|NCT00533845|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533908|NCT00533832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533909|NCT00533819|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533910|NCT00533806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533911|NCT00533793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533912|NCT00533780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533913|NCT00533767|||Case-Only||Prospective|||||||
1533914|NCT00533754||Single Group Assignment||Basic Science||Single||||||t
1533915|NCT00533741|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1533916|NCT00533728||Single Group Assignment||Treatment||None (Open Label)||||||
1533917|NCT00533715||||Screening|Cross-Sectional, Retrospective/Prospective|||||||
1533918|NCT00533702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533919|NCT00533689|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1533920|NCT00533676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533921|NCT00533663|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1533922|NCT00533650|Randomized|Parallel Assignment||Treatment||Double||||||
1533923|NCT00533637|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533924|NCT00533624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533925|NCT00533611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533926|NCT00533598|Randomized|Parallel Assignment||Treatment||Double||||||
1533927|NCT00533585||Single Group Assignment||Treatment||None (Open Label)||||||
1533928|NCT00533572|||Cohort||Cross-Sectional|||||||
1533929|NCT00533559|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1533930|NCT00533546||Single Group Assignment||Treatment||None (Open Label)||||||
1533931|NCT00533533|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533932|NCT00533520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533933|NCT00533507|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1533934|NCT00533494|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1533935|NCT00533481|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1533936|NCT00533468|Randomized|Single Group Assignment||Supportive Care||Quadruple|||t|t|t|t
1533937|NCT00533455|Randomized|Parallel Assignment||||Double||||||
1533938|NCT00533442|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1533939|NCT00533429|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533940|NCT00533416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533941|NCT00533403|Randomized|Parallel Assignment||Treatment||Double||||||
1533942|NCT00533390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533943|NCT00533377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533944|NCT00533364||Single Group Assignment||Treatment||None (Open Label)||||||
1533945|NCT00533351|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1533946|NCT00533338|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1533947|NCT00533312|Randomized|Parallel Assignment||Treatment||Double||||||
1533948|NCT00533299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533949|NCT00533286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533950|NCT00533273|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533951|NCT00533260|||Case-Only||Prospective|||||||
1533952|NCT00533247|Randomized|Parallel Assignment||Treatment||Double||||||
1533953|NCT00533234|||Other||Prospective|||||||
1533954|NCT00533221|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533955|NCT00533208|Randomized|Parallel Assignment||Treatment||Double||||||
1533956|NCT00533195|Randomized|Crossover Assignment||Treatment||Single||||||t
1533957|NCT00533182|||Cohort||Prospective|||||||
1533958|NCT00533169||Single Group Assignment||Treatment||None (Open Label)||||||
1533959|NCT00533156|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533960|NCT00533143|Randomized|Parallel Assignment||Supportive Care||Single|||||t|
1533961|NCT00533130|||Defined Population|Screening|Longitudinal, Prospective|||||||
1533962|NCT00533117|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533963|NCT00533104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533964|NCT00533091|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1533965|NCT00533078||Single Group Assignment||Prevention||None (Open Label)||||||
1533966|NCT00533065|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1533967|NCT00533052||Single Group Assignment||Treatment||None (Open Label)||||||
1533968|NCT00533039|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1533969|NCT00533026|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1533970|NCT00533013|Randomized|Parallel Assignment||Treatment||Single||||||t
1533971|NCT00533000|Randomized|Parallel Assignment||Prevention||Single||||||t
1533972|NCT00532987|||Cohort||Prospective|||||||
1533973|NCT00532974|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533974|NCT00532961|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533975|NCT00532948||Single Group Assignment||Treatment||None (Open Label)||||||
1533976|NCT00532935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533977|NCT00532922|||Cohort||Prospective|||||||
1533978|NCT00532909|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533979|NCT00532896|||Cohort||Prospective|||||||
1533980|NCT00532883|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533981|NCT00532870||Parallel Assignment||Treatment||None (Open Label)||||||
1533982|NCT00532857||Single Group Assignment||Treatment||None (Open Label)||||||
1533983|NCT00532844|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533984|NCT00532831|||Case Control||Cross-Sectional|||||||
1533985|NCT00532818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1533986|NCT00532805|||Cohort||Prospective|||||||
1533987|NCT00532792|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1533988|NCT00532779|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1533989|NCT00532766|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1533990|NCT00532753|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1533991|NCT00532740|||Cohort||Prospective|||||||
1533992|NCT00532727|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1533993|NCT00532714|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533994|NCT00532701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1533995|NCT00532688|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1533996|NCT00532675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1533997|NCT00532662|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1533998|NCT00532636|Randomized|Crossover Assignment||Treatment||Single|||t|||
1533999|NCT00532623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534000|NCT00532610|Randomized|Crossover Assignment||Treatment||Double||||||
1534001|NCT00532597|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534002|NCT00532584|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1534003|NCT00532571|Randomized|Crossover Assignment||Treatment||Double||||||
1534004|NCT00532558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534005|NCT00532545|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534006|NCT00532532|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534007|NCT00532519||Single Group Assignment||||None (Open Label)||||||
1534008|NCT00532506|Randomized|Parallel Assignment||||Double||||||
1534009|NCT00532493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534010|NCT00532480||Single Group Assignment||Treatment||None (Open Label)||||||
1534011|NCT00532467|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1534012|NCT00532454|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534013|NCT00532441|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534014|NCT00532428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534015|NCT00532415||Single Group Assignment||Treatment||Single||||||t
1534016|NCT00532402|||Cohort||Prospective|||||||
1534017|NCT00532389||Single Group Assignment||Treatment||None (Open Label)||||||
1534018|NCT00532376|||||Prospective|||||||
1534019|NCT00532363|||Case Control||Cross-Sectional|||||||
1534020|NCT00532350|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1534021|NCT00532337|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534022|NCT00532324||Single Group Assignment||Prevention||None (Open Label)||||||
1534023|NCT00532311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534024|NCT00532298|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1534025|NCT00532285|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534026|NCT00532272|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534027|NCT00532259||Single Group Assignment||Treatment||None (Open Label)||||||
1534028|NCT00532246|Randomized|Parallel Assignment||Treatment||Double||||||
1534029|NCT00532233|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1534030|NCT00532220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534031|NCT00532207||Single Group Assignment||Treatment||None (Open Label)||||||
1534032|NCT00532194|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534033|NCT00532181|Randomized|Parallel Assignment||Prevention||Single|||t|||
1534034|NCT00532168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534035|NCT00532155|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534036|NCT00532142|Randomized|Parallel Assignment||Treatment||Single|||t|||
1534037|NCT00532129||Single Group Assignment||Treatment||None (Open Label)||||||
1534038|NCT00532116||Crossover Assignment||Diagnostic||None (Open Label)||||||
1534039|NCT00532103|||Cohort||Prospective|||||||
1534192|NCT00530049|||Cohort||Prospective|||||||
1534040|NCT00532090|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534041|NCT00532077|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534042|NCT00532064|||Cohort||Prospective|||||||
1534043|NCT00532051|||Case-Only||Prospective|||||||
1534044|NCT00532038||Single Group Assignment||Treatment||None (Open Label)||||||
1534045|NCT00532025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534046|NCT00532012|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1534047|NCT00531999|Randomized|Parallel Assignment||||None (Open Label)||||||
1534048|NCT00531986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534049|NCT00531973|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534050|NCT00531960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534051|NCT00531947|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534052|NCT00531934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534053|NCT00531921|||Case-Only||Prospective|||||||
1534054|NCT00531908|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534055|NCT00531895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534056|NCT00531882|Randomized|Parallel Assignment||Other||None (Open Label)|No person associated with the study was masked|||||
1534057|NCT00531869|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1534058|NCT00531856|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1534059|NCT00531843|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534060|NCT00531830|||Defined Population||Longitudinal, Retrospective|||||||
1534061|NCT00531817|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534062|NCT00531804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534063|NCT00531791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534064|NCT00531778|||Cohort||Prospective|||||||
1534065|NCT00531765|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534066|NCT00531752|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1534067|NCT00531739|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534068|NCT00531726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534069|NCT00531713|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1534070|NCT00531700|Randomized|Factorial Assignment||Prevention||Single|||t|||
1534071|NCT00531687||Single Group Assignment||Treatment||None (Open Label)||||||
1534072|NCT00531674|Randomized|Parallel Assignment||||Single|||||t|
1534073|NCT00531661|Randomized|Parallel Assignment||Treatment||Single|||t|||
1534074|NCT00531648|||Case Control||Cross-Sectional, Retrospective|||||||
1534075|NCT00531635||Single Group Assignment||Treatment||None (Open Label)||||||
1534076|NCT00531622|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534077|NCT00531596|Randomized|Single Group Assignment||||None (Open Label)||||||
1534078|NCT00531583||Single Group Assignment||Treatment||None (Open Label)||||||
1534079|NCT00531570|||Case-Only||Prospective|||||||
1534080|NCT00531557||Single Group Assignment||||None (Open Label)||||||
1534081|NCT00531544||Single Group Assignment||Treatment||None (Open Label)||||||
1534082|NCT00531531|||Cohort||Cross-Sectional|||||||
1534083|NCT00531518|Non-Randomized|Parallel Assignment||Prevention||Single||||||t
1534084|NCT00531505|||Cohort||Prospective|||||||
1534085|NCT00531492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534086|NCT00531479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534087|NCT00531466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534088|NCT00531453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534089|NCT00531440|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534090|NCT00531427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534091|NCT00531414|||||Prospective|||||||
1534092|NCT00531401|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1534093|NCT00531375|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1534094|NCT00531362|||Cohort||Prospective|||||||
1534095|NCT00531349|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1534096|NCT00531336|Randomized|Parallel Assignment||Treatment||Single||||||t
1534097|NCT00531323|Randomized|Parallel Assignment||||None (Open Label)||||||
1534098|NCT00531310|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534099|NCT00531297||Single Group Assignment||Treatment||None (Open Label)||||||
1534100|NCT00531284|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534101|NCT00531271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534102|NCT00531258|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1534103|NCT00531245|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534104|NCT00531232|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534105|NCT00531219|||Cohort||Prospective|||||||
1534106|NCT00531206|||||Prospective|||||||
1534107|NCT00531193|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1534108|NCT00531180||Single Group Assignment||Diagnostic||None (Open Label)||||||
1534109|NCT00531167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534110|NCT00531154|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1534111|NCT00531141|||Cohort||Prospective|||||||
1534112|NCT00531128|Randomized|Crossover Assignment||Prevention||||||||
1534113|NCT00531115||Single Group Assignment||Treatment||None (Open Label)||||||
1534114|NCT00531102|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1534115|NCT00531089||Single Group Assignment||Treatment||None (Open Label)||||||
1534269|NCT00529048|||Case Control||Cross-Sectional|||||||
1534116|NCT00531076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534117|NCT00531063|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534118|NCT00531050|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1534119|NCT00531037|||Cohort||Prospective|||||||
1534120|NCT00531024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534121|NCT00531011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534122|NCT00530998|||Cohort||Prospective|||||||
1534123|NCT00530985|Randomized|Parallel Assignment||Treatment||Single||||||t
1534124|NCT00530972||Single Group Assignment||Treatment||None (Open Label)||||||
1534125|NCT00530946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534126|NCT00530933|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1534127|NCT00530920||Parallel Assignment||Treatment||||||||
1534128|NCT00530907||Single Group Assignment||Treatment||None (Open Label)||||||
1534129|NCT00530894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534130|NCT00530881|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534131|NCT00530868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534132|NCT00530855||Single Group Assignment||Treatment||None (Open Label)||||||
1534133|NCT00530842||Crossover Assignment||Treatment||||||||
1534134|NCT00530829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534135|NCT00530816||Single Group Assignment||Treatment||None (Open Label)||||||
1534136|NCT00530803|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1534137|NCT00530790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534138|NCT00530777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534139|NCT00530764|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1534140|NCT00530751|||Family-Based||Prospective|||||||
1534141|NCT00530738|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1534142|NCT00530725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534143|NCT00530712|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534144|NCT00530699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534145|NCT00530686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534146|NCT00530660||Single Group Assignment||Prevention||None (Open Label)||||||
1534147|NCT00530647|||Defined Population||Longitudinal, Prospective|||||||
1534148|NCT00530634||Single Group Assignment||Treatment||None (Open Label)||||||
1534149|NCT00530621|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534150|NCT00530608|||Cohort||Prospective|||||||
1534151|NCT00530595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534152|NCT00530582|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1534153|NCT00530569|||||Prospective|||||||
1534154|NCT00530556|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534155|NCT00530543|Randomized|Parallel Assignment||||None (Open Label)||||||
1534156|NCT00530530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534157|NCT00530517||Single Group Assignment||||None (Open Label)||||||
1534158|NCT00530504||Single Group Assignment||Treatment||None (Open Label)||||||
1534159|NCT00530491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534160|NCT00530478|Randomized|Parallel Assignment||||None (Open Label)||||||
1534161|NCT00530452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534162|NCT00530439|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534163|NCT00530426|||||Retrospective|||||||
1534164|NCT00530413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534165|NCT00530400|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1534166|NCT00530387|Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1534167|NCT00530374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534168|NCT00530361|Randomized|Parallel Assignment||Treatment||Double||||||
1534169|NCT00530348|Randomized|Parallel Assignment||Treatment||Single||||||t
1534170|NCT00530335||Factorial Assignment||Treatment||None (Open Label)||||||
1534171|NCT00530322|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1534172|NCT00530309|Randomized|Parallel Assignment||Treatment||||||||
1534173|NCT00530296|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1534174|NCT00530283|||Cohort||Prospective|||||||
1534175|NCT00530270|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534176|NCT00530257|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534177|NCT00530244|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1534178|NCT00530231|||Defined Population|Screening|Longitudinal, Prospective|||||||
1534179|NCT00530218||Single Group Assignment||Supportive Care||None (Open Label)||||||
1534180|NCT00530205|||Cohort||Prospective|||||||
1534181|NCT00530192||Single Group Assignment||Treatment||None (Open Label)||||||
1534182|NCT00530179|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534183|NCT00530166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534184|NCT00530153|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534185|NCT00530140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534186|NCT00530127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534187|NCT00530114|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534188|NCT00530101||Single Group Assignment||Treatment||None (Open Label)||||||
1534189|NCT00530088||Single Group Assignment||Treatment||None (Open Label)||||||
1534190|NCT00530075||Single Group Assignment||Treatment||None (Open Label)||||||
1534191|NCT00530062|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534193|NCT00530036|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1534194|NCT00530023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534195|NCT00530010|||Cohort||Prospective|||||||
1534196|NCT00529997|Randomized|Parallel Assignment||Treatment||Single|||t|||
1534197|NCT00529984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534198|NCT00529971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534199|NCT00529958|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1534200|NCT00529945|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534201|NCT00529932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534202|NCT00529919|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1534203|NCT00529906|||Family-Based|||||||||
1534204|NCT00529893|||Case-Only|||||||||
1534205|NCT00529880||Single Group Assignment||Treatment||None (Open Label)||||||
1534206|NCT00529867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534207|NCT00529854|||||Prospective|||||||
1534208|NCT00529841||Single Group Assignment||Treatment||None (Open Label)||||||
1534209|NCT00529828|Randomized|Crossover Assignment||Prevention||Double||||||
1534210|NCT00529815|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534211|NCT00529802||Single Group Assignment||Treatment||None (Open Label)||||||
1534212|NCT00529789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534213|NCT00529776|Randomized|Parallel Assignment||Prevention||Single||||||t
1534214|NCT00529763||Single Group Assignment||Treatment||None (Open Label)||||||
1534215|NCT00529750|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534216|NCT00529737|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1534217|NCT00529724|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1534218|NCT00529711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534219|NCT00529698|Randomized|Parallel Assignment||Prevention||Double||||||
1534220|NCT00529685||||||||||||
1534221|NCT00529672|Randomized|Parallel Assignment||Treatment||Single||||||t
1534222|NCT00529659|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534223|NCT00529646|Randomized|||||Quadruple|||t|t|t|t
1534224|NCT00529633|Randomized|Single Group Assignment||Treatment||Single|||t|||
1534225|NCT00529620|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534226|NCT00529607|||Cohort||Prospective|||||||
1534227|NCT00529594|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1534228|NCT00529581|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534229|NCT00529568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534230|NCT00529555|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534231|NCT00529542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534232|NCT00529529|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534233|NCT00529516|Non-Randomized|Parallel Assignment||Prevention||Double|||t||t|
1534234|NCT00529503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534235|NCT00529490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534236|NCT00529477|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1534237|NCT00529464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534238|NCT00529451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534239|NCT00529438||Single Group Assignment||Treatment||None (Open Label)||||||
1534240|NCT00529425|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534241|NCT00529412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534242|NCT00529399|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534243|NCT00529386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534244|NCT00529373|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534245|NCT00529360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534246|NCT00529347||Single Group Assignment||Basic Science||None (Open Label)||||||
1534247|NCT00529334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534248|NCT00529321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534249|NCT00529308|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1534250|NCT00529295|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1534251|NCT00529282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534252|NCT00529269|Non-Randomized|Crossover Assignment||Treatment||Single||||||
1534253|NCT00529256|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1534254|NCT00529243||Single Group Assignment||Treatment||None (Open Label)||||||
1534255|NCT00529230|||Case-Control||Prospective|||||||
1534256|NCT00529217||Single Group Assignment||Treatment||None (Open Label)||||||
1534257|NCT00529204||Single Group Assignment||Treatment||None (Open Label)||||||
1534258|NCT00529191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534259|NCT00529178|Randomized|Parallel Assignment||Treatment||Double||||||
1534260|NCT00529165|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534261|NCT00529152|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534262|NCT00529139|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534263|NCT00529126|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534264|NCT00529113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534265|NCT00529100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534266|NCT00529087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534267|NCT00529074|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534268|NCT00529061|||Cohort|||||||||
1534270|NCT00529035||Single Group Assignment||Treatment||None (Open Label)||||||
1534271|NCT00529022||Single Group Assignment||Treatment||None (Open Label)||||||
1534272|NCT00529009|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1534273|NCT00528996||Parallel Assignment||Treatment||||||||
1534274|NCT00528983|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534275|NCT00528970|Randomized|Factorial Assignment||Treatment||Double||||||
1534276|NCT00528957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534277|NCT00528944|||Cohort||Prospective|||||||
1534278|NCT00528931||Single Group Assignment||Other||None (Open Label)||||||
1534279|NCT00528918|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1534280|NCT00528905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534281|NCT00528892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534282|NCT00528879|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534283|NCT00528866||Single Group Assignment||Treatment||None (Open Label)||||||
1534284|NCT00528853|||Case-Only||Prospective|||||||
1534285|NCT00528840||Single Group Assignment||Treatment||None (Open Label)||||||
1534286|NCT00528827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534287|NCT00528814|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1534288|NCT00528801|||Case-Control||Cross-Sectional|||||||
1534289|NCT00528788||Single Group Assignment||Treatment||None (Open Label)||||||
1534290|NCT00528775||Single Group Assignment||Treatment||None (Open Label)||||||
1534291|NCT00528762|||Case Control||Prospective|||||||
1534292|NCT00528749||Single Group Assignment||||None (Open Label)||||||
1534293|NCT00528736|||Defined Population|Screening|Longitudinal, Prospective|||||||
1534294|NCT00528723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534295|NCT00528710|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534296|NCT00528697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534297|NCT00528684||Single Group Assignment||Treatment||None (Open Label)||||||
1534298|NCT00528671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534299|NCT00528658|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1534300|NCT00528645||Single Group Assignment||Treatment||None (Open Label)||||||
1534301|NCT00528632|||Case Control||Retrospective|||||||
1534302|NCT00528619|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534303|NCT00528606|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534304|NCT00528593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534305|NCT00528580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534306|NCT00528567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534307|NCT00528554|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1534308|NCT00528541|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534309|NCT00528528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534310|NCT00528515|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1534311|NCT00528502|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534312|NCT00528489|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1534313|NCT00528476|||Case Control, Natural History||Longitudinal, Prospective|||||||
1534314|NCT00528463||Single Group Assignment||Prevention||None (Open Label)||||||
1534315|NCT00528450||Single Group Assignment||Treatment||None (Open Label)||||||
1534316|NCT00528437||Single Group Assignment||Treatment||None (Open Label)||||||
1534317|NCT00528424||Single Group Assignment||Treatment||None (Open Label)||||||
1534318|NCT00528411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534319|NCT00528398||Single Group Assignment||Treatment||None (Open Label)||||||
1534320|NCT00528385|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534321|NCT00528372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534322|NCT00528359|||||Prospective|||||||
1534323|NCT00528346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534324|NCT00528333|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534325|NCT00528320||||||||||||
1534326|NCT00528307|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534327|NCT00528294||Single Group Assignment||Treatment||None (Open Label)||||||
1534328|NCT00528281||Single Group Assignment||Treatment||None (Open Label)||||||
1534329|NCT00528268|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534330|NCT00528255|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534331|NCT00528242|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1534332|NCT00528229|||||Longitudinal, Retrospective/Prospective|||||||
1534333|NCT00528216|Randomized|Single Group Assignment||Treatment||Single||||||
1534334|NCT00528203|||Cohort||Prospective|||||||
1534335|NCT00528190|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1534336|NCT00528177|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534337|NCT00528164|Randomized|Parallel Assignment||Treatment||Single||||||t
1534338|NCT00528151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534339|NCT00528138|||Cohort||Prospective|||||||
1534340|NCT00528125|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1534341|NCT00528112|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534342|NCT00528099|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1534343|NCT00528086|||Case Control||Prospective|||||||
1534344|NCT00528073|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534345|NCT00528060|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534346|NCT00528047|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534347|NCT00528034|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1534348|NCT00528021|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534349|NCT00528008|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534350|NCT00527995|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1534351|NCT00527982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534352|NCT00527969|Randomized|Crossover Assignment||Treatment||Double||||||
1534353|NCT00527956|||||Prospective|||||||
1534354|NCT00527943|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1534355|NCT00527930||Single Group Assignment||Treatment||None (Open Label)||||||
1534356|NCT00527917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534357|NCT00527904|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534358|NCT00527891|||Cohort||Prospective|||||||
1534359|NCT00527878|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534360|NCT00527865|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1534361|NCT00527852||Single Group Assignment||Diagnostic||Single||||||t
1534362|NCT00527839|||Cohort||Other|||||||
1534363|NCT00527826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534364|NCT00527813|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1534365|NCT00527800|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1534366|NCT00527787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534367|NCT00527774|||Cohort||Prospective|||||||
1534368|NCT00527761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534369|NCT00527748|Randomized|Parallel Assignment||Treatment||Single||||||t
1534370|NCT00527735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534371|NCT00527722|Randomized|Parallel Assignment||||None (Open Label)||||||
1534372|NCT00527709|||||Retrospective|||||||
1534373|NCT00527696|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1534374|NCT00527683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534375|NCT00527670|||Case Control||Prospective|||||||
1534376|NCT00527657||Single Group Assignment||Treatment||None (Open Label)||||||
1534377|NCT00527644||Single Group Assignment||Prevention||None (Open Label)||||||
1534378|NCT00527631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534379|NCT00527618|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534380|NCT00527605|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534381|NCT00527592|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1534382|NCT00527579|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1534383|NCT00527566||Single Group Assignment||Treatment||None (Open Label)||||||
1534384|NCT00527553|Randomized|Parallel Assignment||Prevention||Single|||||t|
1534385|NCT00527540||Single Group Assignment||Treatment||None (Open Label)||||||
1534386|NCT00527527|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1534387|NCT00527514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534388|NCT00527501|Randomized|Parallel Assignment||Treatment||Double||||||
1534389|NCT00527488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534390|NCT00527475|Randomized|Parallel Assignment||Treatment||Single||||||t
1534391|NCT00527462|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1534392|NCT00527449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534393|NCT00527436|Randomized|Parallel Assignment||||Triple|||t||t|t
1534394|NCT00527423||Single Group Assignment||Treatment||Single|||t|||
1534395|NCT00527410||Single Group Assignment||Treatment||None (Open Label)||||||
1534396|NCT00527397|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534397|NCT00527384|||||Prospective|||||||
1534398|NCT00527371|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534399|NCT00527358|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534400|NCT00527345|||||Prospective|||||||
1534401|NCT00527332|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1534402|NCT00527319|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1534403|NCT00527306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534404|NCT00527293|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1534405|NCT00527280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534406|NCT00527267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534407|NCT00527254|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1534408|NCT00527241|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534409|NCT00527228|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534410|NCT00527215|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534411|NCT00527202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534412|NCT00527189||Single Group Assignment||Treatment||None (Open Label)||||||
1534413|NCT00527176|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1534414|NCT00527163|||||Prospective|||||||
1534415|NCT00527150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534416|NCT00527137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534417|NCT00527124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534418|NCT00527111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534419|NCT00527098|||Case Control||Prospective|||||||
1534420|NCT00527085|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534421|NCT00527072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534498|NCT00526032|||Case-Only||Prospective|||||||
1534422|NCT00527059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534423|NCT00527046|Randomized|Parallel Assignment||Treatment||Double||||||
1534424|NCT00527033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534425|NCT00527020|Randomized|Crossover Assignment||Treatment||||||||
1534426|NCT00527007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534427|NCT00526994|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534428|NCT00526981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534429|NCT00526968|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1534430|NCT00526955|||||Prospective|||||||
1534431|NCT00526942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534432|NCT00526929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534433|NCT00526916|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1534434|NCT00526903|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1534435|NCT00526890||Single Group Assignment||Treatment||None (Open Label)||||||
1534436|NCT00526877||Single Group Assignment||Treatment||None (Open Label)||||||
1534437|NCT00526864|||Cohort||Prospective|||||||
1534438|NCT00526851|||||Prospective|||||||
1534439|NCT00526838|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534440|NCT00526812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534441|NCT00526799|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534442|NCT00526786||Single Group Assignment||Treatment||None (Open Label)||||||
1534443|NCT00526773|Randomized|Parallel Assignment||Treatment||Single|||t|||
1534444|NCT00526760||Single Group Assignment||Treatment||None (Open Label)||||||
1534445|NCT00526747||||||||||||
1534446|NCT00526734|Randomized|||Treatment||None (Open Label)||||||
1534447|NCT00526721|||Case Control||Prospective|||||||
1534448|NCT00526708|||Case-Only||Prospective|||||||
1534449|NCT00526695|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534450|NCT00526682|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534451|NCT00526669|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534452|NCT00526656||Single Group Assignment||Treatment||None (Open Label)||||||
1534453|NCT00526643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534454|NCT00526630|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534455|NCT00526617|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534456|NCT00526604|Randomized|Parallel Assignment||Treatment||Single||||||t
1534457|NCT00526591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534458|NCT00526578|||Case-Control||Prospective|||||||
1534459|NCT00526565|Randomized|Parallel Assignment||Prevention||Single||||||t
1534460|NCT00526552|||Case-Only||Prospective|||||||
1534461|NCT00526539|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1534462|NCT00526513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534463|NCT00526500|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534464|NCT00526487||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1534465|NCT00526474|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1534466|NCT00526461||Single Group Assignment||Treatment||None (Open Label)||||||
1534467|NCT00526448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534468|NCT00526435|Non-Randomized|Parallel Assignment||Treatment||Double|||||t|t
1534469|NCT00526422|||Cohort||Cross-Sectional|||||||
1534470|NCT00526409|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534471|NCT00526396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534472|NCT00526383|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534473|NCT00526370|||Case-Only||Cross-Sectional|||||||
1534474|NCT00526357|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1534475|NCT00526344|||Case Control||Cross-Sectional|||||||
1534476|NCT00526331|Randomized|Parallel Assignment||Treatment||Single|||t|||
1534477|NCT00526318|Randomized|||Treatment||||||||
1534478|NCT00526305|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534479|NCT00526292||Single Group Assignment||Treatment||None (Open Label)||||||
1534480|NCT00526279|||Cohort||Prospective|||||||
1534481|NCT00526266|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1534482|NCT00526253|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534483|NCT00526227||Single Group Assignment||Treatment||None (Open Label)||||||
1534484|NCT00526214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534485|NCT00526201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534486|NCT00526188|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1534487|NCT00526175|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534488|NCT00526162|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534489|NCT00526149|Non-Randomized|||Treatment||None (Open Label)||||||
1534490|NCT00526136|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1534491|NCT00526123|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534492|NCT00526110||Single Group Assignment||Treatment||None (Open Label)||||||
1534493|NCT00526097|Randomized|Parallel Assignment||Treatment||Double||||||
1534494|NCT00526084|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1534495|NCT00526071||Single Group Assignment||Treatment||None (Open Label)||||||
1534496|NCT00526058|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1534497|NCT00526045|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534499|NCT00526019|||Case Control||Prospective|||||||
1534500|NCT00526006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534501|NCT00525993|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1534502|NCT00525980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534503|NCT00525967|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1534504|NCT00525954|Randomized|Parallel Assignment||Prevention||Double||||||
1534505|NCT00525941|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1534506|NCT00525928||Single Group Assignment||Treatment||None (Open Label)||||||
1534507|NCT00525915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534508|NCT00525902||Single Group Assignment||Treatment||None (Open Label)||||||
1534509|NCT00525889||Single Group Assignment||Treatment||None (Open Label)||||||
1534510|NCT00525876|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534511|NCT00525863|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534512|NCT00525850|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534513|NCT00525837||Single Group Assignment||Treatment||None (Open Label)||||||
1534514|NCT00525824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534515|NCT00525811|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1534516|NCT00525798|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534517|NCT00525785||Single Group Assignment||Treatment||None (Open Label)||||||
1534518|NCT00525772|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534519|NCT00525759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534520|NCT00525746|||Case-Control||Prospective|||||||
1534521|NCT00525733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534522|NCT00525720|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534523|NCT00525707|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534524|NCT00525694|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1534525|NCT00525681|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534526|NCT00525668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534527|NCT00525655||Single Group Assignment||Supportive Care||None (Open Label)||||||
1534528|NCT00525642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534529|NCT00525629|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1534530|NCT00525616|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534531|NCT00525603||Single Group Assignment||Treatment||None (Open Label)||||||
1534532|NCT00525590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534533|NCT00525577|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534534|NCT00525564|Randomized|Crossover Assignment||Treatment||Double||||||
1534535|NCT00525551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534536|NCT00525538||Parallel Assignment||||None (Open Label)||||||
1534537|NCT00525525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534538|NCT00525512|Randomized|Parallel Assignment||Treatment||Double||||||
1534539|NCT00525499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534540|NCT00525486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534541|NCT00525473|||||Retrospective|||||||
1534542|NCT00525460|||Case-Only||Prospective|||||||
1534543|NCT00525447||Single Group Assignment||Treatment||None (Open Label)||||||
1534544|NCT00525434||Single Group Assignment||Treatment||None (Open Label)||||||
1534545|NCT00525421|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534546|NCT00525408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534547|NCT00525395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534548|NCT00525382|Randomized|Parallel Assignment||Treatment||Single||||||
1534549|NCT00525369|||Defined Population||Cross-Sectional, Prospective|||||||
1534550|NCT00525356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534551|NCT00525343|||Cohort||Retrospective|||||||
1534552|NCT00525330|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534553|NCT00525317|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534554|NCT00525304|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1534555|NCT00525291|Randomized|Parallel Assignment||Treatment||Single||||||t
1534556|NCT00525278|Randomized|Parallel Assignment||Treatment||Single||||||
1534557|NCT00525265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534558|NCT00525252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534559|NCT00525239||Single Group Assignment||||None (Open Label)||||||
1534560|NCT00525226|||Cohort||Prospective|||||||
1534561|NCT00525213|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534562|NCT00525200|Randomized|Parallel Assignment||||None (Open Label)||||||
1534563|NCT00525187|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1534564|NCT00525174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534565|NCT00525161||Single Group Assignment||Treatment||None (Open Label)||||||
1534566|NCT00525148||Single Group Assignment||Treatment||None (Open Label)||||||
1534567|NCT00525135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534568|NCT00525122|||Cohort||Prospective|||||||
1534569|NCT00525109|||Family-Based||Cross-Sectional|||||||
1534570|NCT00525096|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534571|NCT00525083|||Case-Only||Cross-Sectional|||||||
1534572|NCT00525057||Single Group Assignment||Prevention||None (Open Label)||||||
1534573|NCT00525044|Randomized|Parallel Assignment||Treatment||Double||||||
1534574|NCT00525031|Randomized|Parallel Assignment||Treatment||Single|||t|||
1534575|NCT00525018|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1534576|NCT00525005||Single Group Assignment||Treatment||None (Open Label)||||||
1534577|NCT00524992|||||Prospective|||||||
1534578|NCT00524979|||Case Control||Prospective|||||||
1534579|NCT00524966|Randomized|Parallel Assignment||Treatment||Single|||t|||
1534580|NCT00524953||Single Group Assignment||Prevention||None (Open Label)||||||
1534581|NCT00524940|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1534582|NCT00524927|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534583|NCT00524914|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1534584|NCT00524901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534585|NCT00524888|Randomized|Parallel Assignment||Treatment||Single||||||t
1534586|NCT00524875|Randomized|Parallel Assignment||Prevention||Double||||||
1534587|NCT00524862|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534588|NCT00524849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534589|NCT00524836|Randomized|Parallel Assignment||Treatment||Single||||||
1534590|NCT00524823|||Defined Population||Longitudinal, Prospective|||||||
1534591|NCT00524810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534592|NCT00524797||Single Group Assignment||Prevention||None (Open Label)||||||
1534593|NCT00524784|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1534594|NCT00524771|||Cohort||Prospective|||||||
1534595|NCT00524758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534596|NCT00524745|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534597|NCT00524732|||||Cross-Sectional|||||||
1534598|NCT00524719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534599|NCT00524706||Single Group Assignment||Treatment||None (Open Label)||||||
1534600|NCT00524693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534601|NCT00524680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534602|NCT00524667|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534603|NCT00524654|Randomized|Parallel Assignment||||Single||||||t
1534604|NCT00524641|||||Prospective|||||||
1534605|NCT00524615|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534606|NCT00524602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534607|NCT00524589||Single Group Assignment||Treatment||None (Open Label)||||||
1534608|NCT00524576|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1534609|NCT00524563|||Cohort||Retrospective|||||||
1534610|NCT00524550|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1534611|NCT00524537|||Cohort||Prospective|||||||
1534612|NCT00524524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534613|NCT00524511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534614|NCT00524498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534615|NCT00524485|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534616|NCT00524472|Randomized|Parallel Assignment||Prevention||Single|||t|||
1534617|NCT00524459|Non-Randomized|Single Group Assignment||Treatment||||||||
1534618|NCT00524446|Randomized|Parallel Assignment||Prevention||Single||||||t
1534619|NCT00524433|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534620|NCT00524420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534621|NCT00524407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534622|NCT00524394|||Cohort||Prospective|||||||
1534623|NCT00524381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534624|NCT00524368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534625|NCT00524355|||||Prospective|||||||
1534626|NCT00524342||Single Group Assignment||Prevention||None (Open Label)||||||
1534627|NCT00524329|||||Prospective|||||||
1534628|NCT00524316||Single Group Assignment||Treatment||None (Open Label)||||||
1534629|NCT00524303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534630|NCT00524290|||Cohort||Retrospective|||||||
1534631|NCT00524277|Randomized|Parallel Assignment||Prevention||Single|||t|||
1534632|NCT00524264|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534633|NCT00524251|||||Prospective|||||||
1534634|NCT00524238||Single Group Assignment||Basic Science||None (Open Label)||||||
1534635|NCT00524225||Single Group Assignment||Prevention||None (Open Label)||||||
1534636|NCT00524212|||||Prospective|||||||
1534637|NCT00524199|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534638|NCT00524186||Single Group Assignment||Treatment||None (Open Label)||||||
1534639|NCT00524173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534640|NCT00524160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534641|NCT00524147|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534642|NCT00524134||Single Group Assignment||Treatment||None (Open Label)||||||
1534643|NCT00524121||Single Group Assignment||Treatment||None (Open Label)||||||
1534644|NCT00524108|||Cohort||Retrospective|||||||
1534645|NCT00524095|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1534646|NCT00524069||||Treatment||None (Open Label)||||||
1534647|NCT00524056|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534648|NCT00524043|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534649|NCT00524030|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534650|NCT00524017|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1534651|NCT00524004|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1534652|NCT00523991|Randomized|Parallel Assignment||Treatment||Double||||||
1534653|NCT00523978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534654|NCT00523965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534655|NCT00523952||Single Group Assignment||Treatment||None (Open Label)||||||
1534656|NCT00523939|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534657|NCT00523926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534658|NCT00523913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534659|NCT00523900||Single Group Assignment||Treatment||None (Open Label)||||||
1534660|NCT00523887|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534661|NCT00523874|||Defined Population|Screening|Longitudinal, Prospective|||||||
1534662|NCT00523861|Randomized|Crossover Assignment||||None (Open Label)||||||
1534663|NCT00523848||Single Group Assignment||Treatment||None (Open Label)||||||
1534664|NCT00523835|||Natural History||Cross-Sectional, Prospective|||||||
1534665|NCT00523822|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1534666|NCT00523809||Single Group Assignment||Treatment||None (Open Label)||||||
1534667|NCT00523796|||Case-Only||Retrospective|||||||
1534668|NCT00523783|||||Prospective|||||||
1534669|NCT00523770|||Cohort||Prospective|||||||
1534670|NCT00523757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534671|NCT00523744|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534672|NCT00523731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534673|NCT00523718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534674|NCT00523705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534675|NCT00523692|Randomized|Parallel Assignment||Treatment||Single||||||t
1534676|NCT00523679|||Case-Only||Prospective|||||||
1534677|NCT00523666|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534678|NCT00523653|||Family-Based||Prospective|||||||
1534679|NCT00523640|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534680|NCT00523627|||||Prospective|||||||
1534681|NCT00523614|||Case Control|||||||||
1534682|NCT00523601|||||Prospective|||||||
1534683|NCT00523588|Randomized|Single Group Assignment||Treatment||Single||||||t
1534684|NCT00523575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534685|NCT00523562|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1534686|NCT00523549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534687|NCT00523536|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1534688|NCT00523523|Randomized|Parallel Assignment||Treatment||Single||||||t
1534689|NCT00523510|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1534690|NCT00523497|Randomized|Parallel Assignment||||None (Open Label)||||||
1534691|NCT00523484|||Cohort||Prospective|||||||
1534692|NCT00523471|||Case-Only||Prospective|||||||
1534693|NCT00523458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534694|NCT00523445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534695|NCT00523432|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1534696|NCT00523419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534697|NCT00523406|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534698|NCT00523393|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1534699|NCT00523380|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534700|NCT00523367||Single Group Assignment||Treatment||None (Open Label)||||||
1534701|NCT00523354||Single Group Assignment||Treatment||None (Open Label)||||||
1534702|NCT00523341||Single Group Assignment||Treatment||None (Open Label)||||||
1534703|NCT00523328||Single Group Assignment||Treatment||None (Open Label)||||||
1534704|NCT00523315|||Cohort||Prospective|||||||
1534705|NCT00523302|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534706|NCT00523289|Randomized|Parallel Assignment||||Triple|||t|t|t|
1534707|NCT00523276|||Family-Based||Cross-Sectional|||||||
1534708|NCT00523263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534709|NCT00523250|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534710|NCT00523237|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534711|NCT00523224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534712|NCT00523211|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534713|NCT00523198|||Cohort||Prospective|||||||
1534714|NCT00523185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534715|NCT00523172|Randomized|Parallel Assignment||Treatment||Single||||||t
1534716|NCT00523159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534717|NCT00523146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534718|NCT00523133|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534719|NCT00523120|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1534720|NCT00523107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534721|NCT00523094|||Cohort||Prospective|||||||
1534722|NCT00523081|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1534723|NCT00523068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534724|NCT00523055|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1534725|NCT00523042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534726|NCT00523029||Single Group Assignment||Treatment||None (Open Label)||||||
1534727|NCT00523016|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1534728|NCT00523003|Randomized|Parallel Assignment||Treatment||Single|||t|||
1534729|NCT00522990||Single Group Assignment||Treatment||None (Open Label)||||||
1534731|NCT00522964|Randomized|Factorial Assignment||Prevention||Single|||t|||
1534732|NCT00522951|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1534733|NCT00522938||Single Group Assignment||Supportive Care||None (Open Label)||||||
1534734|NCT00522925|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534735|NCT00522912|Randomized|Parallel Assignment||Treatment||Single||||||t
1534736|NCT00522899|Randomized|Factorial Assignment||Prevention||Double|||t|||t
1534737|NCT00522886||Single Group Assignment||Treatment||None (Open Label)||||||
1534738|NCT00522873|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534739|NCT00522860|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534740|NCT00522847|||Cohort||Prospective|||||||
1534741|NCT00522834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534742|NCT00522821|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1534743|NCT00522808|Randomized|Parallel Assignment||Treatment||Double||||||
1534744|NCT00522795|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534745|NCT00522782||Single Group Assignment||Treatment||None (Open Label)||||||
1534746|NCT00522769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534747|NCT00522756|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1534748|NCT00522743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534749|NCT00522730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534750|NCT00522717|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1534751|NCT00522704|||Cohort||Prospective|||||||
1534752|NCT00522691|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1534753|NCT00522678|Randomized|Parallel Assignment||Treatment||||||||
1534754|NCT00522665|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534755|NCT00522652|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534756|NCT00522639||Single Group Assignment||Diagnostic||None (Open Label)||||||
1534757|NCT00522626|||Cohort||Prospective|||||||
1534758|NCT00522613|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1534759|NCT00522600|||||Prospective|||||||
1534760|NCT00522587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534761|NCT00522574|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534762|NCT00522561||Single Group Assignment||Basic Science||None (Open Label)||||||
1534763|NCT00522548|Randomized|Parallel Assignment||Treatment||None (Open Label)|Masking description is not applicable since no masking was used in this study.|This study consisted of 2 parallel active comparator arms.||||
1534764|NCT00522535|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534765|NCT00522522|||||Retrospective|||||||
1534766|NCT00522509|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1534767|NCT00522496|||Cohort||Prospective|||||||
1534768|NCT00522470|Randomized|Parallel Assignment||||None (Open Label)||||||
1534769|NCT00522457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534770|NCT00522444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534771|NCT00522431||Single Group Assignment||Treatment||None (Open Label)||||||
1534772|NCT00522418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534773|NCT00522405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534774|NCT00522392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534775|NCT00522379|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534776|NCT00522353|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1534777|NCT00522340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534778|NCT00522327|Randomized|Single Group Assignment||||None (Open Label)||||||
1534779|NCT00522314|Randomized|Parallel Assignment||Treatment||Single||||||t
1534780|NCT00522301||Single Group Assignment||Treatment||None (Open Label)||||||
1534781|NCT00522288|Randomized|Parallel Assignment||||Single||||||t
1534782|NCT00522275||Single Group Assignment||Treatment||None (Open Label)||||||
1534783|NCT00522262|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534784|NCT00522249||Single Group Assignment||Treatment||None (Open Label)||||||
1534785|NCT00522236|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1534786|NCT00522223|||Case-Only||Prospective|||||||
1534787|NCT00522210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534788|NCT00522197|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1534789|NCT00522184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534790|NCT00522171||||||||||||
1534791|NCT00522158|Randomized|Parallel Assignment||||None (Open Label)||||||
1534792|NCT00522145||Single Group Assignment||Treatment||None (Open Label)||||||
1534793|NCT00522132|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534794|NCT00522119|||||Retrospective|||||||
1534795|NCT00522106|Randomized|Parallel Assignment||Treatment||Single||||||t
1534796|NCT00522093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534797|NCT00522080|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1534798|NCT00522067|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1534799|NCT00522054||Single Group Assignment||Treatment||None (Open Label)||||||
1534800|NCT00522041|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534801|NCT00522028|||Cohort||Prospective|||||||
1534802|NCT00522015||Single Group Assignment||Treatment||None (Open Label)||||||
1534803|NCT00522002|||Cohort||Prospective|||||||
1534804|NCT00521989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534805|NCT00521976|||Cohort||Prospective|||||||
1534806|NCT00521963|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534807|NCT00521950|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1534808|NCT00521937|Randomized|Parallel Assignment||Treatment||Single||||||t
1534809|NCT00521924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534810|NCT00521911|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1534811|NCT00521898||Single Group Assignment||Treatment||None (Open Label)||||||
1534812|NCT00521885|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1534813|NCT00521872|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1534814|NCT00521859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534815|NCT00521846|||Cohort||Other|||||||
1534816|NCT00521833||Parallel Assignment||Treatment||None (Open Label)||||||
1534817|NCT00521820|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534818|NCT00521807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534819|NCT00521794|||Cohort||Prospective|||||||
1534820|NCT00521781||Single Group Assignment||Treatment||None (Open Label)||||||
1534821|NCT00521768||Single Group Assignment||Diagnostic||None (Open Label)||||||
1534822|NCT00521755||Single Group Assignment||Treatment||None (Open Label)||||||
1534823|NCT00521742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534824|NCT00521729|Randomized|Crossover Assignment||Other||||||||
1534825|NCT00521716||Single Group Assignment||Treatment||None (Open Label)||||||
1534826|NCT00521703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534827|NCT00521690|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534828|NCT00521677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534829|NCT00521664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534830|NCT00521651|||Cohort||Prospective|||||||
1534831|NCT00521638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534832|NCT00521625|||||Prospective|||||||
1534833|NCT00521612|Randomized|Parallel Assignment||||Double|||t||t|
1534834|NCT00521599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534835|NCT00521586|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1534836|NCT00521573|Randomized|Parallel Assignment||||Double||||||
1534837|NCT00521560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534838|NCT00521547|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1534839|NCT00521534|||Case Control||Prospective|||||||
1534840|NCT00521521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534841|NCT00521508|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1534842|NCT00521495|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1534843|NCT00521482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534844|NCT00521469|Randomized|Parallel Assignment||||Single|||t|||
1534845|NCT00521456|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534846|NCT00521443|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1534847|NCT00521430||||Treatment||None (Open Label)||||||
1534848|NCT00521417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534849|NCT00521404|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534850|NCT00521391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534851|NCT00521378|||||Prospective|||||||
1534852|NCT00521365|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534853|NCT00521352|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1534854|NCT00521339||Single Group Assignment||Treatment||None (Open Label)||||||
1534855|NCT00521326|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1534856|NCT00521300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534857|NCT00521287|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1534858|NCT00521274|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534859|NCT00521261||Single Group Assignment||Treatment||None (Open Label)||||||
1534860|NCT00521248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534861|NCT00521235|||Cohort||Prospective|||||||
1534862|NCT00521222|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534863|NCT00521209|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1534864|NCT00521196|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1534865|NCT00521183||Single Group Assignment||Treatment||None (Open Label)||||||
1534866|NCT00521170|Randomized|Crossover Assignment||Treatment||Double||||||
1534867|NCT00521157|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534868|NCT00521144||Single Group Assignment||Treatment||None (Open Label)||||||
1534869|NCT00521131|Randomized|Parallel Assignment||Treatment||Double||||||
1534870|NCT00521118||Single Group Assignment||Treatment||None (Open Label)||||||
1534871|NCT00521105|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1534872|NCT00521092||Single Group Assignment||Treatment||None (Open Label)||||||
1534873|NCT00521079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534874|NCT00521066|||Cohort||Prospective|||||||
1534875|NCT00521053||Single Group Assignment||Treatment||None (Open Label)||||||
1534876|NCT00521040|Randomized|Parallel Assignment||Treatment||Double||||||
1534877|NCT00521027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534878|NCT00521014||Single Group Assignment||Treatment||None (Open Label)||||||
1534879|NCT00521001||Single Group Assignment||Treatment||None (Open Label)||||||
1534880|NCT00520988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534881|NCT00520975|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534882|NCT00520962|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1534883|NCT00520949|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534884|NCT00520936|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534885|NCT00520923|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534886|NCT00520910|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1534887|NCT00520897|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1534888|NCT00520884|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1534889|NCT00520871|Randomized|Parallel Assignment||Prevention||Single||||||
1534890|NCT00520858||Parallel Assignment||Treatment||Single|||||t|
1534891|NCT00520845||Single Group Assignment||Treatment||None (Open Label)||||||
1534892|NCT00520832|Randomized|Parallel Assignment||||Double|||t||t|
1534893|NCT00520819|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534894|NCT00520806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534895|NCT00520780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534896|NCT00520767||Single Group Assignment||Treatment||None (Open Label)||||||
1534897|NCT00520754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534898|NCT00520741|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534899|NCT00520728|Randomized|Parallel Assignment||Treatment||Single||||||t
1534900|NCT00520715|||Cohort||Prospective|||||||
1534901|NCT00520702|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1534902|NCT00520689|Randomized|Crossover Assignment||Treatment||Single|||||t|
1534903|NCT00520676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534904|NCT00520663||Single Group Assignment||Treatment||None (Open Label)||||||
1534905|NCT00520650||Single Group Assignment||Treatment||None (Open Label)||||||
1534906|NCT00520637|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1534907|NCT00520624|Randomized|Parallel Assignment||Treatment||Single|||||t|
1534908|NCT00520611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534909|NCT00520598|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1534910|NCT00520585|Non-Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1534911|NCT00520572|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534912|NCT00520559|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1534913|NCT00520546||Single Group Assignment||Diagnostic||None (Open Label)||||||
1534914|NCT00520533||Single Group Assignment||Treatment||None (Open Label)||||||
1534915|NCT00520520|||Case Control||Prospective|||||||
1534916|NCT00520507|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534917|NCT00520494||Single Group Assignment||Treatment||None (Open Label)||||||
1534918|NCT00520481||Single Group Assignment||Treatment||None (Open Label)||||||
1534919|NCT00520468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534920|NCT00520455|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534921|NCT00520442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534922|NCT00520429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534923|NCT00520416|||||Prospective|||||||
1534924|NCT00520403|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534925|NCT00520390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534926|NCT00520377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534927|NCT00520364|||Case Control||Retrospective|||||||
1534928|NCT00520351|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1534929|NCT00520338|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1534930|NCT00520325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534931|NCT00520312|||Cohort||Prospective|||||||
1534932|NCT00520299|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1534933|NCT00520286|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534934|NCT00520273|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1534935|NCT00520260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534936|NCT00520247|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534937|NCT00520234|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1534938|NCT00520221|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1534939|NCT00520208|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534940|NCT00520195|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534941|NCT00520182|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1534942|NCT00520169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534943|NCT00520156|||Defined Population||Longitudinal, Prospective|||||||
1534944|NCT00520143||||||||||||
1534945|NCT00520130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534946|NCT00520117|||Case Control||Cross-Sectional|||||||
1534947|NCT00520104|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1534948|NCT00520091|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534949|NCT00520078||||Screening|Cross-Sectional, Prospective|||||||
1534950|NCT00520065|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1534951|NCT00520052|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534952|NCT00520039|Randomized|Parallel Assignment||Treatment||Double||||t||t
1534953|NCT00520026|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1534954|NCT00520013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534955|NCT00520000|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534956|NCT00519987||Single Group Assignment||||None (Open Label)||||||
1534957|NCT00519974|||Cohort||Prospective|||||||
1534958|NCT00519961|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1534959|NCT00519948||Crossover Assignment||||None (Open Label)||||||
1534960|NCT00519935|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534961|NCT00519922|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1534962|NCT00519909|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1534963|NCT00519896||Single Group Assignment||Treatment||None (Open Label)||||||
1534964|NCT00519883|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534965|NCT00519870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534966|NCT00519857|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1534967|NCT00519844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534968|NCT00519831||Single Group Assignment||Treatment||None (Open Label)||||||
1534969|NCT00519818||Single Group Assignment||Treatment||None (Open Label)||||||
1534970|NCT00519805|Randomized|||Supportive Care||None (Open Label)||||||
1534971|NCT00519792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534972|NCT00519779|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1534973|NCT00519766|||Cohort||Retrospective|||||||
1534974|NCT00519753||Single Group Assignment||Treatment||None (Open Label)||||||
1534975|NCT00519740|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1534976|NCT00519727|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1534977|NCT00519714|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534978|NCT00519701|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1534979|NCT00519688||Single Group Assignment||Treatment||None (Open Label)||||||
1534980|NCT00519675||Single Group Assignment||Treatment||None (Open Label)||||||
1534981|NCT00519662||Single Group Assignment||Treatment||None (Open Label)||||||
1534982|NCT00519649|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1534983|NCT00519636|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1534984|NCT00519623|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1534985|NCT00519610||||||||||||
1534986|NCT00519597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534987|NCT00519584|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1534988|NCT00519571||Single Group Assignment||Treatment||None (Open Label)||||||
1534989|NCT00519558|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534990|NCT00519545|Randomized|Single Group Assignment||Supportive Care||Single|||t|||
1534991|NCT00519532||Single Group Assignment||Treatment||None (Open Label)||||||
1534992|NCT00519519|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1534993|NCT00519506||Single Group Assignment||Diagnostic||None (Open Label)||||||
1534994|NCT00519493|Randomized|Parallel Assignment||Treatment||Single|||||t|
1534995|NCT00519480|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1534996|NCT00519467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1534997|NCT00519454|||Cohort||Prospective|||||||
1534998|NCT00519441||Single Group Assignment||Diagnostic||None (Open Label)||||||
1534999|NCT00519428|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535000|NCT00519415|Randomized|Parallel Assignment||Treatment||Single|||||t|
1535001|NCT00519402|||Cohort||Other|||||||
1535002|NCT00519389|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535003|NCT00519376|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535004|NCT00519363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535005|NCT00519350|||Cohort||Prospective|||||||
1535006|NCT00519337|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535007|NCT00519324||Single Group Assignment||Treatment||None (Open Label)||||||
1535008|NCT00519311|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1535009|NCT00519298|Randomized|Crossover Assignment||||Double|||t||t|
1535010|NCT00519285|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535011|NCT00519272|||Case-Only||Prospective|||||||
1535012|NCT00519259|Randomized|Single Group Assignment||Treatment||Double||||||
1535013|NCT00519246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535014|NCT00519233|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535015|NCT00519220||||||||||||
1535016|NCT00519207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535017|NCT00519194||Single Group Assignment||Treatment||None (Open Label)||||||
1535018|NCT00519181||Single Group Assignment||Treatment||None (Open Label)||||||
1535019|NCT00519168|||Case-Control||Prospective|||||||
1535020|NCT00519155|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535021|NCT00519142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535022|NCT00519129|Randomized|Parallel Assignment||||None (Open Label)||||||
1535023|NCT00519116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535024|NCT00519103||Single Group Assignment||Basic Science||None (Open Label)||||||
1535025|NCT00519090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535026|NCT00519077||Single Group Assignment||Treatment||None (Open Label)||||||
1535027|NCT00519064|Randomized|Parallel Assignment||Prevention||Single||||||
1535028|NCT00519051|Randomized|Parallel Assignment||Treatment||Single||||||t
1535029|NCT00519038|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1535030|NCT00519025|||Cohort||Retrospective|||||||
1535031|NCT00519012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535032|NCT00518999|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1535033|NCT00518986|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535034|NCT00518973|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1535035|NCT00518960|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535036|NCT00518947|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1535037|NCT00518934||Single Group Assignment||Supportive Care||None (Open Label)||||||
1535038|NCT00518921|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535039|NCT00518908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535040|NCT00518895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535041|NCT00518882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535042|NCT00518869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535043|NCT00518856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535044|NCT00518843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535045|NCT00518830|Randomized|Parallel Assignment||Treatment||Single||||||t
1535046|NCT00518817|||Defined Population|Screening|Longitudinal, Prospective|||||||
1535047|NCT00518804|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1535048|NCT00518791|Non-Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1535049|NCT00518778|||Cohort||Retrospective|||||||
1535050|NCT00518765|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1535051|NCT00518752|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1535052|NCT00518739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535053|NCT00518726|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1535054|NCT00518713|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535055|NCT00518700|Randomized|Crossover Assignment||||Single|||||t|
1535056|NCT00518687|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1535057|NCT00518674|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535058|NCT00518661|||Cohort||Retrospective|||||||
1535059|NCT00518648|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1535060|NCT00518635|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1535061|NCT00518622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535062|NCT00518609|||||Prospective|||||||
1535063|NCT00518596|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1535064|NCT00518583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535065|NCT00518570|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535066|NCT00518557|Randomized|Parallel Assignment||Treatment||Single|||t|||
1535067|NCT00518544|Randomized|Parallel Assignment||Prevention||Double||||||
1535068|NCT00518531|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535069|NCT00518518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535070|NCT00518505||Single Group Assignment||Health Services Research||None (Open Label)||||||
1535071|NCT00518492||Single Group Assignment||Basic Science||None (Open Label)||||||
1535072|NCT00518479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535073|NCT00518466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535074|NCT00518453|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1535075|NCT00518440|||Other||Prospective|||||||
1535076|NCT00518427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535077|NCT00518414|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1535078|NCT00518401|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535079|NCT00518388|||Ecologic or Community||Prospective|||||||
1535080|NCT00518375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535081|NCT00518362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535082|NCT00518349|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1535083|NCT00518336|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1535084|NCT00518323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535085|NCT00518310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535086|NCT00518297|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535087|NCT00518284|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535088|NCT00518271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535089|NCT00518258|||Case Control||Prospective|||||||
1535090|NCT00518245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535091|NCT00518232|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535092|NCT00518219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535093|NCT00518206|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Cohort 1 was enrolled first, in which subjects received the NY-ESO-1 ISCOM vaccine. Enrollment then proceeded to Cohort 2, in which subjects received the NY-ESO-1 ISCOM vaccine and low-dose cyclophosphamide.||||
1535094|NCT00518193||Single Group Assignment||Treatment||None (Open Label)||||||
1535095|NCT00518180|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535096|NCT00518167|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535097|NCT00518154||Single Group Assignment||||None (Open Label)||||||
1535098|NCT00518141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535099|NCT00518128|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535100|NCT00518115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535101|NCT00518102|||Cohort||Retrospective|||||||
1535102|NCT00518089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535103|NCT00518076|||Defined Population||Longitudinal, Prospective|||||||
1535104|NCT00518050|||Cohort||Retrospective|||||||
1535105|NCT00518037|||||Prospective|||||||
1535106|NCT00518024|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1535107|NCT00518011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535108|NCT00517998||Single Group Assignment||Treatment||None (Open Label)||||||
1535109|NCT00517985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535110|NCT00517972|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535111|NCT00517959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535112|NCT00517946||||||||||||
1535113|NCT00517933|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1535114|NCT00517920|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535115|NCT00517907||Single Group Assignment||Treatment||None (Open Label)||||||
1535116|NCT00517894||||||||||||
1535117|NCT00517881||Single Group Assignment||Treatment||None (Open Label)||||||
1535118|NCT00517868|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535119|NCT00517855|Randomized|Single Group Assignment||Treatment||Double||||||
1535120|NCT00517842|Randomized|Parallel Assignment||Treatment||Double||||||
1535121|NCT00517829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535122|NCT00517816|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535123|NCT00517803|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1535124|NCT00517790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535125|NCT00517777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535126|NCT00517764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535127|NCT00517751||Single Group Assignment||Treatment||None (Open Label)||||||
1535128|NCT00517738|Randomized|Parallel Assignment||||None (Open Label)||||||
1535129|NCT00517725|Randomized|Crossover Assignment||Treatment||Single|||||t|
1535130|NCT00517712|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535131|NCT00517699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535132|NCT00517686|Randomized|Parallel Assignment||||Single|||t|||
1535133|NCT00517673|Randomized|Parallel Assignment||||Single|||t|||
1535134|NCT00517660|||Case Control||Prospective|||||||
1535135|NCT00517647|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535136|NCT00517634|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535137|NCT00517621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535138|NCT00517608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535139|NCT00517595||Single Group Assignment||Treatment||None (Open Label)||||||
1535140|NCT00517582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535141|NCT00517569||Single Group Assignment||Treatment||None (Open Label)||||||
1535142|NCT00517556|Randomized|Parallel Assignment||Treatment||Single|||t|||
1535143|NCT00517543|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535144|NCT00517530|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535145|NCT00517517|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535146|NCT00517504|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1535147|NCT00517491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535148|NCT00517478|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1535149|NCT00517465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535150|NCT00517452|||Cohort||Prospective|||||||
1535151|NCT00517439|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535152|NCT00517426||Single Group Assignment||||None (Open Label)||||||
1535153|NCT00517413||Single Group Assignment||Treatment||None (Open Label)||||||
1535154|NCT00517400|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1535155|NCT00517387|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535156|NCT00517374|||Cohort||Prospective|||||||
1535157|NCT00517361||Single Group Assignment||Treatment||None (Open Label)||||||
1535158|NCT00517348|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535159|NCT00517335|||Case Control||Prospective|||||||
1535160|NCT00517322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535161|NCT00517309|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1535162|NCT00517296|Randomized|Parallel Assignment||Treatment||Single|Surgeon did not have access to EUS data for the control group prior to exam under anesthesia (EUA) and surgical intervention.|||t||
1535163|NCT00517283|Randomized|Crossover Assignment||Treatment||Single|||t|||
1535164|NCT00517270|Randomized|Parallel Assignment||Treatment||Double||||||
1535165|NCT00517257|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535166|NCT00517244|||Case Control||Prospective|||||||
1535167|NCT00517231|||||Prospective|||||||
1535168|NCT00517218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535169|NCT00517205|||Case-Only||Prospective|||||||
1535170|NCT00517192||Parallel Assignment||Treatment||||||||
1535171|NCT00517179|Randomized|Crossover Assignment||Treatment||Double||||||
1535172|NCT00517166|||Case-Only||Retrospective|||||||
1535173|NCT00517153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535174|NCT00517140|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535175|NCT00517127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535176|NCT00517114|Randomized|Parallel Assignment||Treatment||Double||||||
1535177|NCT00517101|||Defined Population|Screening|Longitudinal, Prospective|||||||
1535178|NCT00517088||Single Group Assignment||||Single|||t|||
1535179|NCT00517075|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1535180|NCT00517062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535181|NCT00517049||Single Group Assignment||Treatment||None (Open Label)||||||
1535182|NCT00517036|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535183|NCT00517023|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1535184|NCT00517010||Single Group Assignment||Treatment||None (Open Label)||||||
1535185|NCT00516984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535186|NCT00516971|Randomized|Parallel Assignment||Treatment||Double||||||
1535187|NCT00516958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535188|NCT00516945|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535189|NCT00516932|||Case Control||Prospective|||||||
1535190|NCT00516919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535191|NCT00516906|Randomized|Parallel Assignment||Treatment||Single|||t|||
1535192|NCT00516893||Single Group Assignment||||None (Open Label)||||||
1535193|NCT00516880|Randomized|Parallel Assignment||Treatment||Double||||||
1535194|NCT00516867|Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1535195|NCT00516854|Randomized|Parallel Assignment||Treatment||Double||||||
1535196|NCT00516841||Single Group Assignment||Treatment||None (Open Label)||||||
1535197|NCT00516828|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535198|NCT00516802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535199|NCT00516776|||Case-Control||Cross-Sectional|||||||
1535200|NCT00516750||||Treatment||None (Open Label)||||||
1535201|NCT00516737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535202|NCT00516724||Single Group Assignment||Treatment||None (Open Label)||||||
1535203|NCT00516711|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535204|NCT00516698|||Case-Only||Prospective|||||||
1535205|NCT00516685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535206|NCT00516672|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535207|NCT00516659|Randomized|Factorial Assignment||||Double|||t||t|
1535208|NCT00516646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535209|NCT00516633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535210|NCT00516620|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1535211|NCT00516607|Non-Randomized|||Treatment||None (Open Label)||||||
1535212|NCT00516594|Randomized|Crossover Assignment||Treatment||Single||||||
1535213|NCT00516581|||Case Control||Retrospective|||||||
1535214|NCT00516555|||Cohort||Prospective|||||||
1535215|NCT00516542||Single Group Assignment||Treatment||None (Open Label)||||||
1535216|NCT00516516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535217|NCT00516503|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1535218|NCT00516490|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1535219|NCT00516477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535220|NCT00516464|Randomized|Single Group Assignment||Treatment||Single|||t|||
1535221|NCT00516451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535222|NCT00516438|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535223|NCT00516425|Randomized|||Treatment||||||||
1535224|NCT00516412||Single Group Assignment||Treatment||None (Open Label)||||||
1535225|NCT00516399|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1535226|NCT00516386||Single Group Assignment||||None (Open Label)||||||
1535227|NCT00516373||Single Group Assignment||Treatment||None (Open Label)||||||
1535228|NCT00516360|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535229|NCT00516347||||||||||||
1535230|NCT00516334|||Cohort||Prospective|||||||
1535231|NCT00516321|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535232|NCT00516308|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535233|NCT00516295|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535234|NCT00516282||Single Group Assignment||Treatment||None (Open Label)||||||
1535235|NCT00516269|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535236|NCT00516256|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1535237|NCT00516243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535238|NCT00516230|||Defined Population|Screening|Longitudinal, Prospective|||||||
1535239|NCT00516217||Single Group Assignment||Treatment||None (Open Label)||||||
1535240|NCT00516204|||Cohort||Prospective|||||||
1535241|NCT00516191||Single Group Assignment||Treatment||None (Open Label)||||||
1535242|NCT00516178|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1535243|NCT00516165||Single Group Assignment||Treatment||None (Open Label)||||||
1535244|NCT00516152||Single Group Assignment||Treatment||None (Open Label)||||||
1535245|NCT00516139|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535246|NCT00516126|||Cohort||Prospective|||||||
1535247|NCT00516113|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1535248|NCT00516100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535249|NCT00516087||Single Group Assignment||Treatment||None (Open Label)||||||
1535250|NCT00516074|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535251|NCT00516061|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1535252|NCT00516048|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535253|NCT00516035|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1535254|NCT00516022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535255|NCT00516009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535256|NCT00515996|||Case Control||Longitudinal, Prospective|||||||
1535257|NCT00515983||Single Group Assignment||Treatment||Single|||t|||
1535258|NCT00515970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535259|NCT00515957|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535260|NCT00515944|Randomized|Single Group Assignment||||Double||||||
1535261|NCT00515931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535262|NCT00515918|||Defined Population||Longitudinal, Prospective|||||||
1535263|NCT00515905|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535264|NCT00515892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535265|NCT00515879|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535266|NCT00515866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535267|NCT00515853|Randomized|Parallel Assignment||Prevention||Single||||||t
1535268|NCT00515840|Randomized|Parallel Assignment||Treatment||Single||||||t
1535269|NCT00515827|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1535270|NCT00515814||Single Group Assignment||Treatment||None (Open Label)||||||
1535271|NCT00515801|Randomized|Crossover Assignment||Prevention||Single|||t|||
1535272|NCT00515788||Single Group Assignment||Treatment||None (Open Label)||||||
1535273|NCT00515775|||Case-Crossover||Prospective|||||||
1535274|NCT00515762||Single Group Assignment||Prevention||None (Open Label)||||||
1535275|NCT00515736|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1535276|NCT00515723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535277|NCT00515710|||Case-Only||Prospective|||||||
1535278|NCT00515697||Single Group Assignment||Treatment||None (Open Label)||||||
1535279|NCT00515684|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1535280|NCT00515671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535281|NCT00515658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535282|NCT00515645|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1535283|NCT00515632|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535284|NCT00515619||Single Group Assignment||Treatment||None (Open Label)||||||
1535285|NCT00515606|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1535286|NCT00515593|||Case-Only||Prospective|||||||
1535287|NCT00515580||Single Group Assignment||Treatment||None (Open Label)||||||
1535288|NCT00515567|||Case-Only||Prospective|||||||
1535289|NCT00515554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535290|NCT00515541|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535291|NCT00515528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535292|NCT00515502|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535293|NCT00515489|||Cohort||Prospective|||||||
1535294|NCT00515476|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1535295|NCT00515463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535296|NCT00515450|Randomized|Parallel Assignment||Treatment||Single|||||t|
1535297|NCT00515437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535298|NCT00515424|Randomized|Parallel Assignment||Treatment||Double||||||
1535299|NCT00515411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535300|NCT00515398|||Case-Only||Cross-Sectional|||||||
1535301|NCT00515385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535302|NCT00515372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535303|NCT00515359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535304|NCT00515346||Single Group Assignment||Treatment||None (Open Label)||||||
1535305|NCT00515333|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535306|NCT00515320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535307|NCT00515307|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535308|NCT00515294|Randomized|Factorial Assignment||Other||Triple|||t|t|t|
1535309|NCT00515281|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535310|NCT00515268|Randomized|Parallel Assignment||Diagnostic||||||||
1535311|NCT00515255|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535312|NCT00515242|Randomized|Parallel Assignment||Treatment||Single||||||t
1535313|NCT00515229|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1535314|NCT00515216||Single Group Assignment||Treatment||None (Open Label)||||||
1535315|NCT00515203|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1535316|NCT00515190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535317|NCT00515177|Randomized|Parallel Assignment||Treatment||Single||||||t
1535318|NCT00515164|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535319|NCT00515151|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535320|NCT00515138||Single Group Assignment||Treatment||None (Open Label)||||||
1535321|NCT00515125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535322|NCT00515112|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535323|NCT00515099|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1535324|NCT00515086|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535325|NCT00515073||Single Group Assignment||Treatment||None (Open Label)||||||
1535326|NCT00515060|||Case-Only||Prospective|||||||
1535327|NCT00515047|||||Cross-Sectional|||||||
1535328|NCT00515034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535329|NCT00515021|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1535330|NCT00515008|Randomized|Parallel Assignment||Treatment||Single||||||t
1535331|NCT00514995|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535332|NCT00514982||Single Group Assignment||Treatment||None (Open Label)||||||
1535333|NCT00514969|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535334|NCT00514956|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1535335|NCT00514943|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535336|NCT00514930|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535337|NCT00514917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535338|NCT00514904|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535339|NCT00514891|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535340|NCT00514878|||Cohort||Prospective|||||||
1535341|NCT00514865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535342|NCT00514852|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535343|NCT00514839|Randomized|Parallel Assignment||Treatment||Single||||||t
1535344|NCT00514826|Randomized|Crossover Assignment||||Single||||||t
1535345|NCT00514813|Randomized|Single Group Assignment||||None (Open Label)||||||
1535346|NCT00514800|Randomized|Parallel Assignment||Prevention||Single||||||t
1535347|NCT00514787|||Case-Only||Prospective|||||||
1535348|NCT00514774|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535349|NCT00514761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535350|NCT00514748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535351|NCT00514735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535352|NCT00514722||Single Group Assignment||Treatment||None (Open Label)||||||
1535353|NCT00514709|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535354|NCT00514696||Single Group Assignment||Treatment||None (Open Label)||||||
1535355|NCT00514683|Randomized|Parallel Assignment||Treatment||Double||||||
1535356|NCT00514670|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535357|NCT00514657|Randomized|Parallel Assignment||Treatment||Double||||||
1535358|NCT00514644|Non-Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1535359|NCT00514618|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535360|NCT00514605|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1535361|NCT00514592|||||Prospective|||||||
1535362|NCT00514579||Single Group Assignment||Treatment||None (Open Label)||||||
1535363|NCT00514566|Randomized|Parallel Assignment||Treatment||Single|||t|||
1535364|NCT00514553|||||Prospective|||||||
1535365|NCT00514540||Single Group Assignment||Treatment||None (Open Label)||||||
1535366|NCT00514527|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535367|NCT00514514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535368|NCT00514501||Single Group Assignment||Treatment||None (Open Label)||||||
1535369|NCT00514488|Randomized|Parallel Assignment||||None (Open Label)||||||
1535370|NCT00514475|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535371|NCT00514462|Randomized|Single Group Assignment||Treatment||Single|||t|||
1535372|NCT00514449|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535373|NCT00514436|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535374|NCT00514423|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535375|NCT00514410|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535376|NCT00514397|Non-Randomized|||Treatment||||||||
1535377|NCT00514384|||Cohort||Prospective|||||||
1535378|NCT00514371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535379|NCT00514358|||Cohort||Prospective|||||||
1535380|NCT00514345||||||||||||
1535381|NCT00514332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535382|NCT00514306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535383|NCT00514293||||Treatment||None (Open Label)||||||
1535384|NCT00514280|||||Other|||||||
1535385|NCT00514267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535386|NCT00514254|||Case-Control||Prospective|||||||
1535387|NCT00514241|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1535388|NCT00514228||Single Group Assignment||Treatment||None (Open Label)||||||
1535389|NCT00514215||Single Group Assignment||Treatment||None (Open Label)||||||
1535390|NCT00514202|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535391|NCT00514189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535392|NCT00514163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535393|NCT00514150|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535394|NCT00514137||Single Group Assignment||Treatment||None (Open Label)||||||
1535395|NCT00514111|||Cohort||Retrospective|||||||
1535396|NCT00514098|||Case-Control||Prospective|||||||
1535397|NCT00514085||Single Group Assignment||Treatment||None (Open Label)||||||
1535398|NCT00514072|Randomized|||Treatment||Double|||t||t|
1535399|NCT00514059||Single Group Assignment||Prevention||None (Open Label)||||||
1535400|NCT00514046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535401|NCT00514033|||Cohort||Prospective|||||||
1535402|NCT00514020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535403|NCT00514007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535404|NCT00513994||Crossover Assignment||Treatment||None (Open Label)||||||
1535405|NCT00513981||||Treatment||None (Open Label)||||||
1535406|NCT00513968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535407|NCT00513955||Single Group Assignment||Treatment||None (Open Label)||||||
1535408|NCT00513942|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1535409|NCT00513929|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535410|NCT00513916|Randomized|||Prevention||||||||
1535411|NCT00513903|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535412|NCT00513890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535413|NCT00513877|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535414|NCT00513864|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1535415|NCT00513851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535416|NCT00513825|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535417|NCT00513799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535418|NCT00513786||Single Group Assignment||Treatment||None (Open Label)||||||
1535419|NCT00513773|||Cohort||Prospective|||||||
1535420|NCT00513760|Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1535421|NCT00513747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535422|NCT00513734|Randomized|Parallel Assignment||Prevention||Single||||||
1535423|NCT00513721|||Case Control||Retrospective|||||||
1535424|NCT00513708|Randomized|Parallel Assignment||Treatment||Single|||||t|
1535425|NCT00513695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535426|NCT00513682||Single Group Assignment||Treatment||None (Open Label)||||||
1535427|NCT00513669|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535428|NCT00513656|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535429|NCT00513643|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535430|NCT00513630|Randomized|Parallel Assignment||Treatment||Double||||||
1535431|NCT00513617|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535432|NCT00513604|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535433|NCT00513591|||Cohort||Prospective|||||||
1535434|NCT00513578||||Treatment||None (Open Label)||||||
1535435|NCT00513565|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1535436|NCT00513552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535437|NCT00513539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535438|NCT00513526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535439|NCT00513513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535440|NCT00513500|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1535441|NCT00513487|Randomized|Parallel Assignment||||None (Open Label)||||||
1535442|NCT00513474|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1535443|NCT00513461|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1535444|NCT00513448|Randomized|Parallel Assignment||Health Services Research||Single||||||
1535445|NCT00513435||Single Group Assignment||Treatment||None (Open Label)||||||
1535446|NCT00513422|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1535447|NCT00513409|Non-Randomized|Parallel Assignment||Prevention||Double||||t|t|
1535448|NCT00513396|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535449|NCT00513383|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535450|NCT00513370|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535451|NCT00513357|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1535452|NCT00513344|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1535453|NCT00513331|||||Prospective|||||||
1535454|NCT00513318|||Case-Only||Prospective|||||||
1535455|NCT00513305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535456|NCT00513292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535457|NCT00513279|Randomized|Crossover Assignment||Treatment||||||||
1535458|NCT00513266||||Treatment||None (Open Label)||||||
1535459|NCT00513253|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535460|NCT00513240|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1535461|NCT00513214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535462|NCT00513201|Randomized|Crossover Assignment||||Double||||||
1535463|NCT00513188||||Treatment||||||||
1535464|NCT00513175|||Cohort||Prospective|||||||
1535465|NCT00513162||Single Group Assignment||Treatment||None (Open Label)||||||
1535466|NCT00513149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535467|NCT00513136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535468|NCT00513123|||Case-Only||Prospective|||||||
1535469|NCT00513110|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1535470|NCT00513097||Single Group Assignment||Prevention||None (Open Label)||||||
1535471|NCT00513084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535472|NCT00513071||Single Group Assignment||Treatment||None (Open Label)||||||
1535473|NCT00513058||Single Group Assignment||Treatment||None (Open Label)||||||
1535474|NCT00513045|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535475|NCT00513032|||Case Control, Natural History||Longitudinal, Prospective|||||||
1535476|NCT00513019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535477|NCT00512993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535478|NCT00512980|Randomized|Parallel Assignment||Treatment||Single||||||
1535479|NCT00512967|||Case-Only||Cross-Sectional|||||||
1535480|NCT00512954|||Case-Only||Prospective|||||||
1535481|NCT00512941|||Cohort||Retrospective|||||||
1535482|NCT00512928||Single Group Assignment||Treatment||None (Open Label)||||||
1535483|NCT00512915|Randomized|Parallel Assignment||Prevention||Single|||t|||
1535484|NCT00512902||Single Group Assignment||Treatment||None (Open Label)||||||
1535485|NCT00512889|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535486|NCT00512876||Single Group Assignment||Treatment||None (Open Label)||||||
1535487|NCT00512863|Randomized|Parallel Assignment||Treatment||Double||||||
1535794|NCT00508846|||Case-Only||Prospective|||||||
1535488|NCT00512850|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1535489|NCT00512837||Parallel Assignment||Supportive Care||Single|||||t|
1535490|NCT00512824|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535491|NCT00512811|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1535492|NCT00512798|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535493|NCT00512785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535494|NCT00512772|||Cohort||Prospective|||||||
1535495|NCT00512759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535496|NCT00512746|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1535497|NCT00512733|||||Prospective|||||||
1535498|NCT00512720|||Case Control||Retrospective|||||||
1535499|NCT00512707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535500|NCT00512694|||Cohort||Prospective|||||||
1535501|NCT00512681||Single Group Assignment||Treatment||None (Open Label)||||||
1535502|NCT00512668||Single Group Assignment||Treatment||None (Open Label)||||||
1535503|NCT00512655|Randomized|Parallel Assignment||Prevention||Single||||||t
1535504|NCT00512642||||||||||||
1535505|NCT00512629|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1535506|NCT00512616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535507|NCT00512603|||Cohort||Prospective|||||||
1535508|NCT00512590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535509|NCT00512577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535510|NCT00512564|||Cohort||Prospective|||||||
1535511|NCT00512551|||Case-Only||Prospective|||||||
1535512|NCT00512538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535513|NCT00512525|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1535514|NCT00512512|||Cohort||Prospective|||||||
1535515|NCT00512499|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1535516|NCT00512486|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1535517|NCT00512473|Randomized|Crossover Assignment||Basic Science||Single||||||
1535518|NCT00512460||Single Group Assignment||Treatment||None (Open Label)||||||
1535519|NCT00512447|||Case-Only||Prospective|||||||
1535520|NCT00512434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535521|NCT00512421|||Cohort||Prospective|||||||
1535522|NCT00512408|||||Prospective|||||||
1535523|NCT00512395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535524|NCT00512382|||Case-Only||Prospective|||||||
1535525|NCT00512369|||||Prospective|||||||
1535526|NCT00512356|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1535527|NCT00512343|||Cohort||Prospective|||||||
1535528|NCT00512330|||||Prospective|||||||
1535529|NCT00512317|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535530|NCT00512304|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535531|NCT00512291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535532|NCT00512278|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535533|NCT00512265|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535534|NCT00512252|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535535|NCT00512239|||Cohort||Prospective|||||||
1535536|NCT00512226||Single Group Assignment||Diagnostic||None (Open Label)||||||
1535537|NCT00512213|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535538|NCT00512200|||Cohort||Prospective|||||||
1535539|NCT00512187|Randomized|Parallel Assignment||Treatment||Single||||||
1535540|NCT00512174||Factorial Assignment||Diagnostic||Single|||||t|
1535541|NCT00512161|||||Retrospective|||||||
1535542|NCT00512148||Single Group Assignment||Treatment||None (Open Label)|Note: Tengion no longer exists following Chapter 7 bankruptcy in 2014. No further information is available. No data are available to be reviewed or re-analyzed.|Note: Tengion no longer exists following Chapter 7 bankruptcy in 2014. No further information is available. No data are available to be reviewed or re-analyzed.||||
1535543|NCT00512135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535544|NCT00512122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535545|NCT00512109|||Cohort||Prospective|||||||
1535546|NCT00512096|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535547|NCT00512083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535548|NCT00512070|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535549|NCT00512057|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535550|NCT00512044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535551|NCT00512031|||Cohort||Prospective|||||||
1535552|NCT00512018|Randomized|Single Group Assignment||||Single|||||t|
1535553|NCT00512005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535554|NCT00511992||Single Group Assignment||Treatment||None (Open Label)||||||
1535555|NCT00511979|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535556|NCT00511966|||Cohort||Prospective|||||||
1535557|NCT00511953|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1535558|NCT00511940|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535559|NCT00511927|||Cohort||Prospective|||||||
1535560|NCT00511914||Single Group Assignment||Prevention||None (Open Label)||||||
1535561|NCT00511901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535562|NCT00511888|||||Prospective|||||||
1535563|NCT00511875|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535564|NCT00511862|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536328|NCT00501800|||Case-Control||Prospective|||||||
1535565|NCT00511849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535566|NCT00511836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535567|NCT00511823|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535568|NCT00511810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535569|NCT00511797|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535570|NCT00511784|||Case Control||Retrospective|||||||
1535571|NCT00511771||||||||||||
1535572|NCT00511758|||Case-Only||Prospective|||||||
1535573|NCT00511745|||Cohort||Prospective|||||||
1535574|NCT00511732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535575|NCT00511719|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535576|NCT00511706|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1535577|NCT00511693|Randomized|Parallel Assignment||Screening||Double||||||
1535578|NCT00511680|Randomized|Single Group Assignment||||Single|||||t|
1535579|NCT00511667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535580|NCT00511654|Randomized|Parallel Assignment||Treatment||||||||
1535581|NCT00511641|||Case-Only||Prospective|||||||
1535582|NCT00511628|||Cohort||Prospective|||||||
1535583|NCT00511615|||Case-Only||Prospective|||||||
1535584|NCT00511602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535585|NCT00511589||Parallel Assignment||||None (Open Label)||||||
1535586|NCT00511576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535587|NCT00511563|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535588|NCT00511550|||||Prospective|||||||
1535589|NCT00511537|||Case-Only||Prospective|||||||
1535590|NCT00511524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535591|NCT00511511|||||Prospective|||||||
1535592|NCT00511498|Randomized|Single Group Assignment||||Double|||t||t|
1535593|NCT00511485||Single Group Assignment||Treatment||None (Open Label)||||||
1535594|NCT00511472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535595|NCT00511459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535596|NCT00511446||Single Group Assignment||Treatment||None (Open Label)||||||
1535597|NCT00511433|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535598|NCT00511420|Randomized|Parallel Assignment||Prevention||Double||||||
1535599|NCT00511407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535600|NCT00511394|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1535601|NCT00511381|||||Prospective|||||||
1535602|NCT00511368|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1535603|NCT00511355|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535604|NCT00511342|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535605|NCT00511329||Single Group Assignment||Treatment||None (Open Label)||||||
1535606|NCT00511316|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1535607|NCT00511303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535608|NCT00511290|Random Sample|||Screening|Longitudinal, Retrospective|||||||
1535609|NCT00511277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535610|NCT00511264|||||Prospective|||||||
1535611|NCT00511251|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1535612|NCT00511238|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535613|NCT00511225|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535614|NCT00511212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535615|NCT00511199|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535616|NCT00511186|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535617|NCT00511173|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1535618|NCT00511160|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1535619|NCT00511147||Single Group Assignment||Treatment||None (Open Label)||||||
1535620|NCT00511134|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1535621|NCT00511121|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535622|NCT00511108|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535623|NCT00511095||Single Group Assignment||Prevention||None (Open Label)||||||
1535624|NCT00511082|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535625|NCT00511069|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535626|NCT00511056|||Cohort||Cross-Sectional|||||||
1535627|NCT00511043||Single Group Assignment||Treatment||None (Open Label)||||||
1535628|NCT00511030|||Case-Only||Prospective|||||||
1535629|NCT00511017|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535630|NCT00511004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535631|NCT00510991|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535632|NCT00510978|Randomized|Parallel Assignment||Prevention||Double||||||
1535633|NCT00510965||Single Group Assignment||Treatment||None (Open Label)||||||
1535634|NCT00510952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535635|NCT00510939|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535636|NCT00510926|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535637|NCT00510913|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535638|NCT00510900|||Cohort||Prospective|||||||
1535639|NCT00510887||Single Group Assignment||Treatment||None (Open Label)||||||
1535640|NCT00510874|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1535641|NCT00510861|||||Retrospective|||||||
1535642|NCT00510848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535643|NCT00510835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535644|NCT00510822|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535645|NCT00510809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535646|NCT00510796|||Case-Only||Prospective|||||||
1535647|NCT00510783|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535648|NCT00510770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535649|NCT00510757|||Cohort|||||||||
1535650|NCT00510744||Single Group Assignment||Treatment||None (Open Label)||||||
1535651|NCT00510731|||Cohort||Prospective|||||||
1535652|NCT00510718||||Treatment||None (Open Label)||||||
1535653|NCT00510705|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535654|NCT00510692|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535655|NCT00510679|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1535656|NCT00510666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535657|NCT00510653||Single Group Assignment||Treatment||None (Open Label)||||||
1535658|NCT00510640|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535659|NCT00510627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535660|NCT00510614|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1535661|NCT00510601||Single Group Assignment||Treatment||None (Open Label)||||||
1535662|NCT00510588|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535663|NCT00510575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535664|NCT00510562|Randomized|Parallel Assignment||Treatment||Single||||||
1535665|NCT00510549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535666|NCT00510536|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535667|NCT00510523|Randomized|Crossover Assignment||Treatment||Single||||||
1535668|NCT00510510|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535669|NCT00510497||Single Group Assignment||Treatment||None (Open Label)||||||
1535670|NCT00510484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535671|NCT00510471||Single Group Assignment||||None (Open Label)||||||
1535672|NCT00510458||Single Group Assignment||Treatment||None (Open Label)||||||
1535673|NCT00510445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535674|NCT00510432|||Cohort||Prospective|||||||
1535675|NCT00510419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535676|NCT00510406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535677|NCT00510393|Randomized|Parallel Assignment||Treatment||Single|||t|||
1535678|NCT00510380|||Case Control||Prospective|||||||
1535679|NCT00510367||Single Group Assignment||Treatment||None (Open Label)||||||
1535680|NCT00510354||Single Group Assignment||Treatment||None (Open Label)||||||
1535681|NCT00510341|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1535682|NCT00510328|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1535683|NCT00510315|||Cohort||Prospective|||||||
1535684|NCT00510302|||Family-Based||Prospective|||||||
1535685|NCT00510289||Single Group Assignment||Treatment||None (Open Label)||||||
1535686|NCT00510276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535687|NCT00510263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535688|NCT00510250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535689|NCT00510237|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1535690|NCT00510224||Single Group Assignment||Treatment||None (Open Label)||||||
1535691|NCT00510211|||Cohort||Prospective|||||||
1535692|NCT00510198|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1535693|NCT00510185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535694|NCT00510172|Randomized|Crossover Assignment||Basic Science||Double||||||
1535695|NCT00510159|Randomized|Parallel Assignment||Treatment||Double||||||
1535696|NCT00510146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535697|NCT00510133||Single Group Assignment||Treatment||None (Open Label)||||||
1535698|NCT00510120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535699|NCT00510107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535700|NCT00510094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535701|NCT00510081||Single Group Assignment||Treatment||None (Open Label)||||||
1535702|NCT00510068|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535703|NCT00510055|Randomized|Single Group Assignment||Treatment||Single||||||t
1535704|NCT00510042|||Cohort||Cross-Sectional|||||||
1535705|NCT00510029|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1535706|NCT00510016|Randomized|Parallel Assignment||Treatment||Double||||||
1535707|NCT00510003|Randomized|Parallel Assignment||Treatment||Double||||||
1535708|NCT00509990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535709|NCT00509977|Randomized|Single Group Assignment||Treatment||Single||||||t
1535710|NCT00509964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535711|NCT00509951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535712|NCT00509938|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1535713|NCT00509925|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535714|NCT00509899||Single Group Assignment||Treatment||None (Open Label)||||||
1535715|NCT00509886|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1535716|NCT00509873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535717|NCT00509860||Single Group Assignment||Treatment||None (Open Label)||||||
1535718|NCT00509847|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535719|NCT00509834|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535720|NCT00509821||Single Group Assignment||Treatment||None (Open Label)||||||
1535721|NCT00509808|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1535722|NCT00509795|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535723|NCT00509782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535724|NCT00509769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535725|NCT00509756|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1535726|NCT00509743||Single Group Assignment||||None (Open Label)||||||
1535727|NCT00509730|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1535728|NCT00509717|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1535729|NCT00509704|||Case Control||Prospective|||||||
1535730|NCT00509691||Single Group Assignment||Supportive Care||None (Open Label)||||||
1535731|NCT00509678||Single Group Assignment||Treatment||None (Open Label)||||||
1535732|NCT00509665||Single Group Assignment||Treatment||None (Open Label)||||||
1535733|NCT00509652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535734|NCT00509639|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1535735|NCT00509626|Randomized|||Supportive Care||||||||
1535736|NCT00509613||Single Group Assignment||||None (Open Label)||||||
1535737|NCT00509600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535738|NCT00509587||Single Group Assignment||Treatment||None (Open Label)||||||
1535739|NCT00509574|||Case-Only||Prospective|||||||
1535740|NCT00509561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535741|NCT00509548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535742|NCT00509535|Randomized|Parallel Assignment||Treatment||Double||||||
1535743|NCT00509509|||||Prospective|||||||
1535744|NCT00509496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535745|NCT00509483||Single Group Assignment||Treatment||None (Open Label)||||||
1535746|NCT00509470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535747|NCT00509457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535748|NCT00509444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535749|NCT00509431||Single Group Assignment||Treatment||None (Open Label)||||||
1535750|NCT00509418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535751|NCT00509405|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535752|NCT00509392|Randomized|Parallel Assignment||Treatment||Single|||t|||
1535753|NCT00509379|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535754|NCT00509366|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535755|NCT00509353||Single Group Assignment||Treatment||None (Open Label)||||||
1535756|NCT00509340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535757|NCT00509327|Randomized|Parallel Assignment||Treatment||Double||||||
1535758|NCT00509314|||Natural History||Cross-Sectional, Prospective|||||||
1535759|NCT00509301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535760|NCT00509288|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535761|NCT00509275|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535762|NCT00509262|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1535763|NCT00509249||Single Group Assignment||Treatment||None (Open Label)||||||
1535764|NCT00509236|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535765|NCT00509223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535766|NCT00509210|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1535767|NCT00509197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535768|NCT00509184||Single Group Assignment||Treatment||None (Open Label)||||||
1535769|NCT00509171|Randomized|Parallel Assignment||Treatment||Single|||t|||
1535770|NCT00509158|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535771|NCT00509145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535772|NCT00509132|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1535773|NCT00509119|||Cohort||Prospective|||||||
1535774|NCT00509106|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535775|NCT00509093||Single Group Assignment||Treatment||None (Open Label)||||||
1535776|NCT00509080|||Cohort||Prospective|||||||
1535777|NCT00509067|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535778|NCT00509054|Randomized|Parallel Assignment||Prevention||Double||||||
1535779|NCT00509041||Single Group Assignment||Treatment||None (Open Label)||||||
1535780|NCT00509028|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535781|NCT00509015|Randomized|Parallel Assignment||Prevention||Single|||t|||
1535782|NCT00509002|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535783|NCT00508989|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535784|NCT00508976|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1535785|NCT00508963||||||||||||
1535786|NCT00508950|Non-Randomized|Single Group Assignment||||||||||
1535787|NCT00508937|Randomized|Parallel Assignment||Prevention||Single|||||t|
1535788|NCT00508924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535789|NCT00508911|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1535790|NCT00508898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535791|NCT00508885|Randomized|Parallel Assignment||Treatment||Double||||||
1535792|NCT00508872|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535793|NCT00508859|Randomized|Parallel Assignment||Treatment||Double||||||
1536632|NCT00497770|||||Prospective|||||||
1535795|NCT00508833|Randomized|Parallel Assignment||Prevention||Double||||||
1535796|NCT00508820||Single Group Assignment||Treatment||None (Open Label)||||||
1535797|NCT00508807|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535798|NCT00508794|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1535799|NCT00508781||||Screening|Cross-Sectional, Prospective|||||||
1535800|NCT00508768|Randomized|Parallel Assignment||Treatment||Double||||||
1535801|NCT00508755||Single Group Assignment||Treatment||None (Open Label)||||||
1535802|NCT00508742|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535803|NCT00508729|Randomized|Parallel Assignment||Treatment||Double||||||
1535804|NCT00508716|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1535805|NCT00508703|||Case-Only||Prospective|||||||
1535806|NCT00508690|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535807|NCT00508677|||Cohort||Prospective|||||||
1535808|NCT00508664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535809|NCT00508651|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535810|NCT00508638|||Cohort||Prospective|||||||
1535811|NCT00508625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535812|NCT00508612|Randomized|Parallel Assignment||Prevention||Single|||t|||
1535813|NCT00508599|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1535814|NCT00508586||Single Group Assignment||Treatment||None (Open Label)||||||
1535815|NCT00508573|||Case-Only||Prospective|||||||
1535816|NCT00508560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535817|NCT00508547|||Cohort||Prospective|||||||
1535818|NCT00508534|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535819|NCT00508521|Randomized|Parallel Assignment||Treatment||Single||||||t
1535820|NCT00508508|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1535821|NCT00508495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535822|NCT00508482|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1535823|NCT00508469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535824|NCT00508456||Single Group Assignment||Treatment||None (Open Label)||||||
1535825|NCT00508443||Single Group Assignment||Treatment||None (Open Label)||||||
1535826|NCT00508430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535827|NCT00508417|||||Prospective|||||||
1535828|NCT00508404||Single Group Assignment||Treatment||None (Open Label)||||||
1535829|NCT00508391|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1535830|NCT00508378|||Case-Only||Prospective|||||||
1535831|NCT00508365|Randomized|Crossover Assignment||Treatment||||||||
1535832|NCT00508352||Single Group Assignment||Treatment||None (Open Label)||||||
1535833|NCT00508339|||Case-Only||Prospective|||||||
1535834|NCT00508326|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535835|NCT00508313|||Case Control||Prospective|||||||
1535836|NCT00508300|Randomized|Parallel Assignment||Treatment||Single||||||t
1535837|NCT00508287|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535838|NCT00508274||||Treatment||None (Open Label)||||||
1535839|NCT00508261|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535840|NCT00508248|Randomized|Parallel Assignment||Treatment||Double||||||
1535841|NCT00508235|||Case-Only||Prospective|||||||
1535842|NCT00508222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535843|NCT00508209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535844|NCT00508196|Non-Randomized|Crossover Assignment||Treatment||Double||||||
1535845|NCT00508183|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1535846|NCT00508170|||Cohort||Prospective|||||||
1535847|NCT00508157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535848|NCT00508144||Single Group Assignment||Treatment||None (Open Label)||||||
1535849|NCT00508131|Randomized|Factorial Assignment||Treatment||Double||||||
1535850|NCT00508118|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535851|NCT00508105|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1535852|NCT00508092|Randomized|Parallel Assignment||Treatment||Single||||||
1535853|NCT00508079|||Cohort|||||||||
1535854|NCT00508066|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535855|NCT00508053|Randomized|Parallel Assignment||Prevention||Double||||||
1535856|NCT00508040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535857|NCT00508027||Single Group Assignment||Treatment||None (Open Label)||||||
1535858|NCT00508014|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1535859|NCT00508001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535860|NCT00507988|Randomized|Parallel Assignment||Treatment||Single||||||t
1535861|NCT00507975|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1535862|NCT00507962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535863|NCT00507949|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535864|NCT00507936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535865|NCT00507923|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1535866|NCT00507910|||Cohort||Prospective|||||||
1535867|NCT00507897|||||Prospective|||||||
1535868|NCT00507884|||Case-Only||Prospective|||||||
1535869|NCT00507871|||||Prospective|||||||
1535870|NCT00507858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535871|NCT00507845|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535872|NCT00507832|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1536935|NCT00493714|||Cohort||Prospective|||||||
1535873|NCT00507819|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1535874|NCT00507806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535875|NCT00507793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535876|NCT00507780|Randomized|Single Group Assignment||Prevention||Double||||||
1535877|NCT00507767||Single Group Assignment||Treatment||None (Open Label)||||||
1535878|NCT00507754|||Case-Only||Prospective|||||||
1535879|NCT00507741||Single Group Assignment||Treatment||None (Open Label)||||||
1535880|NCT00507728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535881|NCT00507715|Randomized|Crossover Assignment||Treatment||Double||||||
1535882|NCT00507702|||Cohort||Prospective|||||||
1535883|NCT00507689|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1535884|NCT00507676|||Case Control||Prospective|||||||
1535885|NCT00507663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535886|NCT00507650|Randomized|Single Group Assignment||Treatment||Single||||||
1535887|NCT00507637||Single Group Assignment||Treatment||None (Open Label)||||||
1535888|NCT00507611||Single Group Assignment||Diagnostic||None (Open Label)||||||
1535889|NCT00507598|||||Prospective|||||||
1535890|NCT00507585||Single Group Assignment||Treatment||None (Open Label)||||||
1535891|NCT00507572|||Case-Only||Other|||||||
1535892|NCT00507559||Single Group Assignment||Treatment||None (Open Label)||||||
1535893|NCT00507546|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1535894|NCT00507533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535895|NCT00507520|Randomized|Crossover Assignment||Treatment||Single||||||
1535896|NCT00507507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535897|NCT00507494|Randomized|Crossover Assignment||Treatment||Double||||||
1535898|NCT00507481|||||Prospective|||||||
1535899|NCT00507468|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1535900|NCT00507455|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535901|NCT00507442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535902|NCT00507429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535903|NCT00507416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535904|NCT00507403|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1535905|NCT00507390|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535906|NCT00507377|||Cohort||Prospective|||||||
1535907|NCT00507364|Randomized|Parallel Assignment||Treatment||Double||||||
1535908|NCT00507351|||Case-Only||Prospective|||||||
1535909|NCT00507338|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535910|NCT00507325|||Case-Only||Prospective|||||||
1535911|NCT00507312|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1535912|NCT00507299|Randomized|Single Group Assignment||Prevention||None (Open Label)||Pediatric residents were trained to screen for and help address prevalent psychosocial problems, such as parental depression and substance abuse, that are risk factors for child maltreatment (CM). The SEEK model included a project social worker and use of community resources.||||
1535913|NCT00507286|Randomized|Crossover Assignment||Treatment||Single||||||
1535914|NCT00507273|||Case-Only||Prospective|||||||
1535915|NCT00507260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535916|NCT00507247||Single Group Assignment||Treatment||None (Open Label)||||||
1535917|NCT00507234|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535918|NCT00507221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535919|NCT00507208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535920|NCT00507195||||Screening|Longitudinal, Prospective|||||||
1535921|NCT00507182||Single Group Assignment||Diagnostic||None (Open Label)||||||
1535922|NCT00507169|Randomized|Parallel Assignment||Treatment||Double||||||
1535923|NCT00507156|Randomized|Parallel Assignment||Treatment||Single|||t|||
1535924|NCT00507143||Single Group Assignment||Basic Science||None (Open Label)||||||
1535925|NCT00507130|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1535926|NCT00507117|Randomized|Parallel Assignment||Diagnostic||Double||||||
1535927|NCT00507104|||Defined Population|Screening|Longitudinal, Prospective|||||||
1535928|NCT00507091|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535929|NCT00507078|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1535930|NCT00507065|Randomized|Parallel Assignment||Treatment||Double||||||
1535931|NCT00507052||Single Group Assignment||||None (Open Label)||||||
1535932|NCT00507039|||Cohort||Cross-Sectional|||||||
1535933|NCT00507026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535934|NCT00507013|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1535935|NCT00507000|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1535936|NCT00506987|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535937|NCT00506974|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1535938|NCT00506961|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1535939|NCT00506948||Single Group Assignment||Treatment||None (Open Label)||||||
1535940|NCT00506935|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1535941|NCT00506922|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535942|NCT00506909|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1535943|NCT00506896|Randomized|Parallel Assignment||Treatment||Double||||||
1535944|NCT00506883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535945|NCT00506870|Randomized|Parallel Assignment||||None (Open Label)||||||
1535946|NCT00506857||Single Group Assignment||Treatment||None (Open Label)||||||
1535947|NCT00506844||Single Group Assignment||Treatment||None (Open Label)||||||
1535948|NCT00506831||Single Group Assignment||Treatment||None (Open Label)||||||
1535949|NCT00506818|Randomized|Parallel Assignment||Prevention||Single||||||
1535950|NCT00506805|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535951|NCT00506792|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1535952|NCT00506779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535953|NCT00506766|Randomized|Single Group Assignment||Prevention||Single||||||
1535954|NCT00506753|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1535955|NCT00506740|Randomized|Parallel Assignment||Supportive Care||Single||||||
1535956|NCT00506727|Randomized|Parallel Assignment||Treatment||Double||||||
1535957|NCT00506714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535958|NCT00506701||Single Group Assignment||Treatment||Triple|||t|t|t|
1535959|NCT00506688|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535960|NCT00506675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535961|NCT00506662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535962|NCT00506649|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1535963|NCT00506636|||Natural History||Cross-Sectional, Prospective|||||||
1535964|NCT00506623||Single Group Assignment||Treatment||None (Open Label)||||||
1535965|NCT00506610|Randomized|Parallel Assignment||Treatment||Double||||||
1535966|NCT00506597||Single Group Assignment||Treatment||None (Open Label)||||||
1535967|NCT00506584|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1535968|NCT00506571||Single Group Assignment||Treatment||None (Open Label)||||||
1535969|NCT00506558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535970|NCT00506545|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1535971|NCT00506532|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535972|NCT00506519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535973|NCT00506506|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1535974|NCT00506493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535975|NCT00506480||Parallel Assignment||Diagnostic||None (Open Label)||||||
1535976|NCT00506467|||Case-Only||Prospective|||||||
1535977|NCT00506454|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535978|NCT00506441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1535979|NCT00506428|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1535980|NCT00506415|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1535981|NCT00506402|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1535982|NCT00506389|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535983|NCT00506376|||Case-Only||Prospective|||||||
1535984|NCT00506363|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1535985|NCT00506350|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1535986|NCT00506337|Randomized|Parallel Assignment||Treatment||Double||||||
1535987|NCT00506324|||Cohort||Prospective|||||||
1535988|NCT00506311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535989|NCT00506298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1535990|NCT00506285|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1535991|NCT00506272|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1535992|NCT00506259|Randomized|Crossover Assignment||Treatment||||||||
1535993|NCT00506246|Randomized|Parallel Assignment||Treatment||Double||||||
1535994|NCT00506233|||Cohort||Prospective|||||||
1535995|NCT00506220||||||||||||
1535996|NCT00506207||Single Group Assignment||Treatment||None (Open Label)||||||
1535997|NCT00506194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1535998|NCT00506181|Randomized|Parallel Assignment||Prevention||Double||||||
1535999|NCT00506168||Single Group Assignment||Treatment||None (Open Label)||||||
1536000|NCT00506155||Single Group Assignment||Treatment||None (Open Label)||||||
1536001|NCT00506142|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536002|NCT00506129||Single Group Assignment||Treatment||None (Open Label)||||||
1536003|NCT00506116|Randomized|Factorial Assignment||Prevention||Single||||||
1536004|NCT00506103|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1536005|NCT00506090|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1536006|NCT00506077|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1536007|NCT00506064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536008|NCT00506051|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536009|NCT00506038|Randomized|Parallel Assignment||Treatment||Single||||||
1536010|NCT00506025|Non-Randomized|Factorial Assignment||Other||None (Open Label)||||||
1536011|NCT00506012||Single Group Assignment||Treatment||None (Open Label)||||||
1536012|NCT00505999|||Case-Control||Prospective|||||||
1536013|NCT00505986|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1536014|NCT00505973|Randomized|Single Group Assignment||Treatment||Double||||||
1536015|NCT00505960|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536016|NCT00505947|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1536017|NCT00505934||Single Group Assignment||Treatment||None (Open Label)||||||
1536018|NCT00505921|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1536019|NCT00505908|||||Prospective|||||||
1536020|NCT00505895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536021|NCT00505882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536022|NCT00505869|||Case-Only||Prospective|||||||
1536023|NCT00505856|||||Prospective|||||||
1536024|NCT00505843|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1536025|NCT00505830|||Defined Population|Screening|Longitudinal, Prospective|||||||
1536026|NCT00505817|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1536027|NCT00505804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536028|NCT00505791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536029|NCT00505778|Randomized|Parallel Assignment||Treatment||Single|||||t|
1536030|NCT00505765|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536031|NCT00505752|Randomized|Parallel Assignment||Treatment||Single||||||t
1536032|NCT00505739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536033|NCT00505726|||Case-Only||Prospective|||||||
1536034|NCT00505713|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536035|NCT00505700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536036|NCT00505687||Single Group Assignment||Treatment||None (Open Label)||||||
1536037|NCT00505661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536038|NCT00505648||Single Group Assignment||Treatment||None (Open Label)||||||
1536039|NCT00505635||Single Group Assignment||Treatment||None (Open Label)||||||
1536040|NCT00505622||Single Group Assignment||Treatment||None (Open Label)||||||
1536041|NCT00505609|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1536042|NCT00505596|Randomized|Parallel Assignment||||None (Open Label)||||||
1536043|NCT00505583|Randomized|Crossover Assignment||Treatment||Double||||||
1536044|NCT00505570|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536045|NCT00505557||Parallel Assignment||Treatment||Single||||||
1536046|NCT00505544|||Case-Control||Prospective|||||||
1536047|NCT00505531|||Case-Control||Prospective|||||||
1536048|NCT00505518||Single Group Assignment||Treatment||None (Open Label)||||||
1536049|NCT00505505|Randomized|Parallel Assignment||Treatment||Single||||||
1536050|NCT00505492|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536051|NCT00505479|Random Sample|||Screening|Longitudinal, Prospective|||||||
1536052|NCT00505466|||Case-Control||Prospective|||||||
1536053|NCT00505453|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536054|NCT00505440|Randomized|Parallel Assignment||Screening||Triple|||t|t||t
1536055|NCT00505427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536056|NCT00505414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536057|NCT00505401|Randomized|Parallel Assignment||Treatment||Double||||||
1536058|NCT00505388|||Case-Only||Prospective|||||||
1536059|NCT00505375|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536060|NCT00505362|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536061|NCT00505349|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1536062|NCT00505336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536063|NCT00505323|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1536064|NCT00505310|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536065|NCT00505297|||Case Control, Natural History||Longitudinal, Retrospective/Prospective|||||||
1536066|NCT00505284|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536067|NCT00505271||Single Group Assignment||Treatment||None (Open Label)||||||
1536068|NCT00505258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536069|NCT00505245|||Cohort||Prospective|||||||
1536070|NCT00505232|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536071|NCT00505219|Randomized|Parallel Assignment||Treatment||Single||||||t
1536072|NCT00505180|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1536073|NCT00505167|Randomized|Parallel Assignment||Treatment||Single|||||t|
1536074|NCT00505154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536075|NCT00505141|||Case Control|Screening|Cross-Sectional, Retrospective|||||||
1536076|NCT00505128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536077|NCT00505115|||||Longitudinal, Prospective|||||||
1536078|NCT00505102|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536079|NCT00505089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536080|NCT00505076|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536081|NCT00505063|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536082|NCT00505050|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536083|NCT00505037|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536084|NCT00505024|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536085|NCT00505011|||Case Control, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1536086|NCT00504998|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536087|NCT00504985|||Case-Only||Prospective|||||||
1536088|NCT00504972||Single Group Assignment||Treatment||None (Open Label)||||||
1536089|NCT00504959||Single Group Assignment||Treatment||None (Open Label)||||||
1536090|NCT00504946|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536091|NCT00504933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536092|NCT00504920|||Case-Only||Prospective|||||||
1536093|NCT00504907|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1536094|NCT00504894|Randomized|Parallel Assignment||Other||Single|||t|||
1536095|NCT00504881|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536096|NCT00504855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536097|NCT00504842|Randomized|Parallel Assignment||Treatment||Single||||||
1536098|NCT00504829|Randomized|Parallel Assignment||Treatment||Double||||||
1536099|NCT00504816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536100|NCT00504803|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536101|NCT00504790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536102|NCT00504777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536103|NCT00504764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536104|NCT00504751||Single Group Assignment||Treatment||None (Open Label)||||||
1536105|NCT00504738|||Case-Only||Prospective|||||||
1536106|NCT00504725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536107|NCT00504712|Randomized|Parallel Assignment||Treatment||Double||||||
1536108|NCT00504699|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1536109|NCT00504686|Randomized|Parallel Assignment||Treatment||Single||||||t
1536110|NCT00504673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536111|NCT00504660|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536112|NCT00504647|Randomized|Crossover Assignment||Treatment||Double||||||
1536113|NCT00504634|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536114|NCT00504621|||||Cross-Sectional|||||||
1536115|NCT00504608|Randomized|Parallel Assignment||Treatment||Double||||||
1536116|NCT00504595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536117|NCT00504582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536118|NCT00504556|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536119|NCT00504543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536120|NCT00504530|Randomized|Parallel Assignment||Treatment||Double||||||
1536121|NCT00504517|||Cohort||Prospective|||||||
1536122|NCT00504504||Single Group Assignment||Treatment||None (Open Label)||||||
1536123|NCT00504491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536124|NCT00504478|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536125|NCT00504465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536126|NCT00504452||Single Group Assignment||Treatment||None (Open Label)||||||
1536127|NCT00504439|Randomized|Parallel Assignment||Treatment||||||||
1536128|NCT00504426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536129|NCT00504413||Single Group Assignment||Basic Science||None (Open Label)||||||
1536130|NCT00504400||Single Group Assignment||Treatment||None (Open Label)||||||
1536131|NCT00504387|||||Prospective|||||||
1536132|NCT00504374|||Case-Only||Prospective|||||||
1536133|NCT00504361|||Case Control||Prospective|||||||
1536134|NCT00504348||Single Group Assignment||Treatment||None (Open Label)||||||
1536135|NCT00504335|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536136|NCT00504322|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536137|NCT00504309|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1536138|NCT00504296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536139|NCT00504283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536140|NCT00504270|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536141|NCT00504257||Single Group Assignment||Treatment||None (Open Label)||||||
1536142|NCT00504244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536143|NCT00504231|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536144|NCT00504218|||||Other|||||||
1536145|NCT00504205||||Treatment||||||||
1536146|NCT00504192|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536147|NCT00504179|Randomized|Parallel Assignment||Treatment||Double||||||
1536148|NCT00504166|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536149|NCT00504153||Single Group Assignment||Treatment||None (Open Label)||||||
1536150|NCT00504140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536151|NCT00504127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536152|NCT00504114|||Case Control||Prospective|||||||
1536153|NCT00504101||Single Group Assignment||Treatment||None (Open Label)||||||
1536154|NCT00504088|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536155|NCT00504075||Single Group Assignment||Treatment||None (Open Label)||||||
1536156|NCT00504062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536157|NCT00504049|||Case Control||Prospective|||||||
1536158|NCT00504036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536159|NCT00504023||Single Group Assignment||Treatment||None (Open Label)||||||
1536160|NCT00504010|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1536161|NCT00503997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536162|NCT00503984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536163|NCT00503971||Single Group Assignment||Treatment||None (Open Label)||||||
1536164|NCT00503958||||||||||||
1536165|NCT00503945||Single Group Assignment||Treatment||None (Open Label)||||||
1536166|NCT00503932||Single Group Assignment||Treatment||None (Open Label)||||||
1536167|NCT00503919||Single Group Assignment||Diagnostic||None (Open Label)||||||
1536168|NCT00503906||Single Group Assignment||Treatment||None (Open Label)||||||
1536169|NCT00503893|||Family-Based||Prospective|||||||
1536170|NCT00503880||Single Group Assignment||Treatment||None (Open Label)||||||
1536171|NCT00503867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536172|NCT00503854|||Cohort||Prospective|||||||
1536173|NCT00503841||Single Group Assignment||Treatment||None (Open Label)||||||
1536174|NCT00503828|Randomized|Parallel Assignment||Treatment||Single||||||
1536175|NCT00503815|Randomized|Parallel Assignment||||Single||||||
1536176|NCT00503802|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536177|NCT00503789|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1536178|NCT00503776|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536179|NCT00503763||Single Group Assignment||Treatment||None (Open Label)||||||
1536180|NCT00503750|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536181|NCT00503737|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1536182|NCT00503724||Single Group Assignment||Treatment||None (Open Label)||||||
1536183|NCT00503711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536184|NCT00503698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536185|NCT00503685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536186|NCT00503672|||Cohort||Prospective|||||||
1536187|NCT00503659|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1536188|NCT00503646|Randomized|||||||||||
1536189|NCT00503633|||Cohort||Prospective|||||||
1536190|NCT00503620|||||Prospective|||||||
1536191|NCT00503607|Randomized|Parallel Assignment||||Single||||||
1536192|NCT00503594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536193|NCT00503581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536194|NCT00503568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536195|NCT00503555|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1536196|NCT00503542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536197|NCT00503529|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536198|NCT00503516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536199|NCT00503503|||||Prospective|||||||
1536200|NCT00503490|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536201|NCT00503477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536202|NCT00503464||||||||||||
1536203|NCT00503451||Single Group Assignment||Treatment||None (Open Label)||||||
1536204|NCT00503438||Single Group Assignment||Treatment||None (Open Label)||||||
1536205|NCT00503425||Single Group Assignment||Treatment||None (Open Label)||||||
1536206|NCT00503412|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536207|NCT00503399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536208|NCT00503386|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1536209|NCT00503360|Randomized|Parallel Assignment||Treatment||Double||||||
1536210|NCT00503347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536211|NCT00503334|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1536212|NCT00503321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536213|NCT00503308|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1536214|NCT00503295||Single Group Assignment||Treatment||None (Open Label)||||||
1536215|NCT00503282|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1536216|NCT00503269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536217|NCT00503256|||Case-Control||Prospective|||||||
1536218|NCT00503243|Randomized|Parallel Assignment||Treatment||Double||||||
1536219|NCT00503230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536220|NCT00503217|Randomized|Parallel Assignment||||Single||||||
1536221|NCT00503204|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536222|NCT00503191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536223|NCT00503178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536224|NCT00503165||Single Group Assignment||Prevention||None (Open Label)||||||
1536225|NCT00503152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536226|NCT00503139|||Case-Only||Prospective|||||||
1536227|NCT00503126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536228|NCT00503113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536229|NCT00503100|||Case Control||Prospective|||||||
1536230|NCT00503087|Randomized|Crossover Assignment||Supportive Care||Single||||||
1536231|NCT00503074|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536232|NCT00503061|||Case-Only||Prospective|||||||
1536233|NCT00503048|||Cohort||Retrospective|||||||
1536234|NCT00503035||Single Group Assignment||Treatment||None (Open Label)||||||
1536235|NCT00503022|Randomized|Parallel Assignment||Treatment||Double||||||
1536236|NCT00503009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536237|NCT00502996||Single Group Assignment||Treatment||None (Open Label)||||||
1536238|NCT00502983|||Case-Control||Prospective|||||||
1536239|NCT00502970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536240|NCT00502957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536241|NCT00502944|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1536242|NCT00502931|||Case Control|Screening|Longitudinal, Retrospective|||||||
1536243|NCT00502918|||Cohort||Cross-Sectional|||||||
1536244|NCT00502905||Single Group Assignment||Treatment||None (Open Label)||||||
1536245|NCT00502892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536246|NCT00502879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536247|NCT00502866|||||Cross-Sectional|||||||
1536248|NCT00502853||Single Group Assignment||Treatment||None (Open Label)||||||
1536249|NCT00502840||Single Group Assignment||Treatment||None (Open Label)||||||
1536250|NCT00502827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536251|NCT00502814|||Case-Only||Prospective|||||||
1536252|NCT00502801||Single Group Assignment||Treatment||None (Open Label)||||||
1536253|NCT00502788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536254|NCT00502775|Randomized|Parallel Assignment||Treatment||Double||||||
1536255|NCT00502762|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536256|NCT00502749|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1536257|NCT00502736|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536258|NCT00502723|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536259|NCT00502710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536260|NCT00502697|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536261|NCT00502684|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1536262|NCT00502671|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536263|NCT00502658|Randomized|Parallel Assignment||||Single||||||
1536264|NCT00502645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536265|NCT00502632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536266|NCT00502619||Single Group Assignment||Treatment||None (Open Label)||||||
1536267|NCT00502606|||Case Control||Prospective|||||||
1536268|NCT00502593|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536269|NCT00502580|||Case-Only||Prospective|||||||
1536270|NCT00502567|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536271|NCT00502554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536272|NCT00502541|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536273|NCT00502528|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536274|NCT00502515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536275|NCT00502502|||Case-Only||Prospective|||||||
1536276|NCT00502489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536277|NCT00502476|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1536278|NCT00502463|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536279|NCT00502450|||Case Control||Cross-Sectional|||||||
1536280|NCT00502437||Crossover Assignment||||Double||||||
1536281|NCT00502424|Randomized|Parallel Assignment||Treatment||Single||||||
1536282|NCT00502411||Single Group Assignment||Treatment||None (Open Label)||||||
1536283|NCT00502398|||||Prospective|||||||
1536284|NCT00502385|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536285|NCT00502372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536286|NCT00502359|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1536287|NCT00502346|Randomized|Parallel Assignment||||Double||||||
1536288|NCT00502333|||Cohort||Prospective|||||||
1536289|NCT00502320|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536290|NCT00502307|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536291|NCT00502294|Randomized|Parallel Assignment||Treatment||Double||||||
1536292|NCT00502281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536293|NCT00502268|Randomized|Single Group Assignment||Prevention||Single|||t|||
1536294|NCT00502255|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1536295|NCT00502242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536296|NCT00502229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536297|NCT00502216|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536298|NCT00502203||Single Group Assignment||Treatment||None (Open Label)||||||
1536299|NCT00502190|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536300|NCT00502177|||Case-Control||Prospective|||||||
1536301|NCT00502164|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536302|NCT00502138||Single Group Assignment||Treatment||None (Open Label)||||||
1536303|NCT00502125|||Case-Only||Prospective|||||||
1536304|NCT00502112||Single Group Assignment||Treatment||None (Open Label)||||||
1536305|NCT00502099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536306|NCT00502086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536307|NCT00502073|Randomized|Parallel Assignment||||Double||||||
1536308|NCT00502060|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536309|NCT00502047|Randomized|Parallel Assignment||Treatment||Double||||||
1536310|NCT00502034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536311|NCT00502021|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1536312|NCT00502008|Randomized|Parallel Assignment||Supportive Care||Double||||||
1536313|NCT00501995||Single Group Assignment||Treatment||None (Open Label)||||||
1536314|NCT00501982|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536315|NCT00501969||Single Group Assignment||Treatment||None (Open Label)||||||
1536316|NCT00501956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536317|NCT00501943|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536318|NCT00501930|Randomized|Crossover Assignment||Treatment||Double||||||
1536319|NCT00501917|Randomized|Parallel Assignment||Treatment||Double||||||
1536320|NCT00501904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536321|NCT00501891||Single Group Assignment||Treatment||None (Open Label)||||||
1536322|NCT00501878|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1536323|NCT00501865|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1536324|NCT00501852|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1536325|NCT00501839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536326|NCT00501826||Single Group Assignment||Treatment||None (Open Label)||||||
1536327|NCT00501813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536329|NCT00501787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536330|NCT00501774|||Case Control, Natural History||Cross-Sectional, Retrospective|||||||
1536331|NCT00501761|||Case-Control||Prospective|||||||
1536332|NCT00501748||Single Group Assignment||Treatment||None (Open Label)||||||
1536333|NCT00501735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536334|NCT00501722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536335|NCT00501709||Single Group Assignment||Treatment||None (Open Label)||||||
1536336|NCT00501696|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1536337|NCT00501683|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536338|NCT00501670|||Case-Only||Prospective|||||||
1536339|NCT00501657|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1536340|NCT00501644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536341|NCT00501631|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536342|NCT00501618||Single Group Assignment||Basic Science||None (Open Label)||||||
1536343|NCT00501605|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536344|NCT00501592|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536345|NCT00501579|Randomized|Parallel Assignment||||Double||||||
1536346|NCT00501566|Randomized|Parallel Assignment||Treatment||Double||||||
1536347|NCT00501553|||Cohort||Prospective|||||||
1536348|NCT00501540||Single Group Assignment||Treatment||None (Open Label)||||||
1536349|NCT00501527|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536350|NCT00501514|Randomized|Parallel Assignment||Treatment||Double||||||
1536351|NCT00501501|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1536352|NCT00501488|||Defined Population|Screening|Longitudinal, Prospective|||||||
1536353|NCT00501475|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536354|NCT00501462|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536355|NCT00501449|||Case-Only||Prospective|||||||
1536356|NCT00501423|||Cohort||Prospective|||||||
1536357|NCT00501410||Single Group Assignment||Treatment||None (Open Label)||||||
1536358|NCT00501397|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536359|NCT00501384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536360|NCT00501371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536361|NCT00501358|||Case Control|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1536362|NCT00501345|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536363|NCT00501332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536364|NCT00501319|||Case-Only||Prospective|||||||
1536365|NCT00501306|||Case Control||Prospective|||||||
1536366|NCT00501293||Single Group Assignment||Treatment||None (Open Label)||||||
1536367|NCT00501280|||Case-Only||Prospective|||||||
1536368|NCT00501267|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536369|NCT00501254|Randomized|Parallel Assignment||Prevention||Double||||||
1536370|NCT00501241|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536371|NCT00501228|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536372|NCT00501215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536373|NCT00501202|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1536374|NCT00501189|||Cohort||Prospective|||||||
1536375|NCT00501176|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536376|NCT00501163|||Cohort||Cross-Sectional|||||||
1536377|NCT00501150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536378|NCT00501137|Randomized|Parallel Assignment||Prevention||Single|||t|||
1536379|NCT00501124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536380|NCT00501111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536381|NCT00501098|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536382|NCT00501085|||Case-Only||Prospective|||||||
1536383|NCT00501072|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536384|NCT00501059|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1536385|NCT00501046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536386|NCT00501033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536387|NCT00501020|Randomized|Parallel Assignment||Treatment||Double||||||
1536388|NCT00501007|||Cohort||Prospective|||||||
1536389|NCT00500994|||||Prospective|||||||
1536390|NCT00500981||Single Group Assignment||Diagnostic||Single||||||t
1536391|NCT00500968|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536392|NCT00500955|Randomized|Parallel Assignment||Treatment||Double||||||
1536393|NCT00500942|||Case-Only||Prospective|||||||
1536394|NCT00500929|Randomized|Parallel Assignment||Treatment||Double||||||
1536395|NCT00500916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536396|NCT00500903||Single Group Assignment||Treatment||None (Open Label)||||||
1536397|NCT00500890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536398|NCT00500877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536399|NCT00500864|Randomized|Crossover Assignment||Treatment||Double||||||
1536400|NCT00500851|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536401|NCT00500838||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1536402|NCT00500825|||Cohort||Prospective|||||||
1536403|NCT00500812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536404|NCT00500799|||||Prospective|||||||
1536405|NCT00500786|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536406|NCT00500773|||Cohort||Prospective|||||||
1536407|NCT00500760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536408|NCT00500747|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1536409|NCT00500734|||Case-Only||Prospective|||||||
1536410|NCT00500721|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1536411|NCT00500708|||Cohort||Prospective|||||||
1536412|NCT00500695|Randomized|Parallel Assignment||Treatment||Single||||||t
1536413|NCT00500682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536414|NCT00500669|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1536415|NCT00500656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536416|NCT00500630|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1536417|NCT00500617|||Other||Prospective|||||||
1536418|NCT00500604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536419|NCT00500591|||Case-Only||Prospective|||||||
1536420|NCT00500578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536421|NCT00500565|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536422|NCT00500552|Randomized|Parallel Assignment||Treatment||Double||||||
1536423|NCT00500539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536424|NCT00500526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536425|NCT00500513||Single Group Assignment||Treatment||None (Open Label)||||||
1536426|NCT00500500|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536427|NCT00500487|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536428|NCT00500474|Randomized|Parallel Assignment||Treatment||Single||||||
1536429|NCT00500461|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536430|NCT00500448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536431|NCT00500435|||Case-Only||Prospective|||||||
1536432|NCT00500422||Single Group Assignment||Treatment||None (Open Label)||||||
1536433|NCT00500409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536434|NCT00500396||Single Group Assignment||Basic Science||None (Open Label)||||||
1536435|NCT00500383|||Case Control||Prospective|||||||
1536436|NCT00500370|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536437|NCT00500357|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536438|NCT00500344||Single Group Assignment||Treatment||None (Open Label)||||||
1536439|NCT00500331|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536440|NCT00500318|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536441|NCT00500305|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1536442|NCT00500292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536443|NCT00500279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536444|NCT00500253|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1536445|NCT00500240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536446|NCT00500227|||Cohort||Prospective|||||||
1536447|NCT00500214|Randomized|Parallel Assignment||Prevention||Double||||||
1536448|NCT00500201|Randomized|Crossover Assignment||Treatment||||||||
1536449|NCT00500188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536450|NCT00500175|Randomized|Parallel Assignment||Diagnostic||Single||||||
1536451|NCT00500162|Randomized|Parallel Assignment||Treatment||Single|||||t|
1536452|NCT00500149|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1536453|NCT00500136|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1536454|NCT00500123|||Cohort||Prospective|||||||
1536455|NCT00500110|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536456|NCT00500097|Non-Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1536457|NCT00500084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536458|NCT00500071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536459|NCT00500058|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536460|NCT00500045||Single Group Assignment||Treatment||None (Open Label)||||||
1536461|NCT00500032|Non-Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1536462|NCT00500019|||||Prospective|||||||
1536463|NCT00500006|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536464|NCT00499993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536465|NCT00499980|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1536466|NCT00499967|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536467|NCT00499954|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1536468|NCT00499941|||Other||Other|||||||
1536469|NCT00499928|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536470|NCT00499915|Randomized|Parallel Assignment||Prevention||Single||||||t
1536471|NCT00499902||Single Group Assignment||Treatment||None (Open Label)||||||
1536472|NCT00499889||Single Group Assignment||Treatment||None (Open Label)||||||
1536473|NCT00499876|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1536474|NCT00499863|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536475|NCT00499850|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536476|NCT00499837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536477|NCT00500266||Single Group Assignment||Prevention||None (Open Label)||||||
1536478|NCT00499824|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1536479|NCT00499811||Single Group Assignment||Treatment||None (Open Label)||||||
1536480|NCT00499798|||Cohort||Prospective|||||||
1536481|NCT00499785|||Cohort||Prospective|||||||
1536482|NCT00499759||Single Group Assignment||Supportive Care||None (Open Label)||||||
1536483|NCT00499746|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1536484|NCT00499733||||Treatment||||||||
1536485|NCT00499720||||||||||||
1536486|NCT00499707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536487|NCT00499694||Single Group Assignment||Treatment||None (Open Label)||||||
1536488|NCT00499681|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536489|NCT00499668|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536490|NCT00499655|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536491|NCT00499642|Randomized|Crossover Assignment||Treatment||Double||||||
1536492|NCT00499629|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1536493|NCT00499616|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536494|NCT00499603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536495|NCT00499590|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536496|NCT00499577||||Treatment||||||||
1536497|NCT00499551|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536498|NCT00499538|Randomized|Crossover Assignment||||None (Open Label)||||||
1536499|NCT00499525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536500|NCT00499512|||Case-Only||Prospective|||||||
1536501|NCT00499499|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536502|NCT00499486||Single Group Assignment||Treatment||None (Open Label)||||||
1536503|NCT00499473|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536504|NCT00499460|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1536505|NCT00499447||Single Group Assignment||Treatment||None (Open Label)||||||
1536506|NCT00499434|||Cohort||Prospective|||||||
1536507|NCT00499421|||Case-Only||Prospective|||||||
1536508|NCT00499408||Single Group Assignment||Treatment||None (Open Label)||||||
1536509|NCT00499395||Single Group Assignment||Diagnostic||None (Open Label)||||||
1536510|NCT00499382|||Case-Only||Prospective|||||||
1536511|NCT00499369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536512|NCT00499356|Randomized|Parallel Assignment||Prevention||Single||||||
1536513|NCT00499343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536514|NCT00499330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536515|NCT00499317|||Family-Based||Prospective|||||||
1536516|NCT00499304|||Case Control||Prospective|||||||
1536517|NCT00499291||||Treatment||None (Open Label)||||||
1536518|NCT00499278|||Natural History||Longitudinal, Retrospective|||||||
1536519|NCT00499265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536520|NCT00499252||Single Group Assignment||Treatment||None (Open Label)||||||
1536521|NCT00499239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536522|NCT00499213|||||Prospective|||||||
1536523|NCT00499200|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1536524|NCT00499187|||Case Control||Prospective|||||||
1536525|NCT00499174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536526|NCT00499161|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1536527|NCT00499148|Randomized|Crossover Assignment||Treatment||Double||||||
1536528|NCT00499135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536529|NCT00499122||Single Group Assignment||Treatment||None (Open Label)||||||
1536530|NCT00499109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536531|NCT00499096|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1536532|NCT00499083||Single Group Assignment||Treatment||None (Open Label)||||||
1536533|NCT00499070|||Cohort||Prospective|||||||
1536534|NCT00499057||Single Group Assignment||Treatment||None (Open Label)||||||
1536535|NCT00499044|Randomized|Crossover Assignment||||None (Open Label)||||||
1536536|NCT00499031||Single Group Assignment||Treatment||None (Open Label)||||||
1536537|NCT00499018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536538|NCT00499005|Randomized|Parallel Assignment||||Double|||t||t|
1536539|NCT00498992||||Supportive Care||||||||
1536540|NCT00498979||Single Group Assignment||Treatment||None (Open Label)||||||
1536541|NCT00498966|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||"Two groups with regard to pre-treatment: patients in group A will have previously failed a VEGF receptor inhibitor but not an mTOR inhibitor, while patients in group B will have failed both a VEGF receptor inhibitor and an mTOR inhibitor.~One treatment group: all patients will receive perifosine 100 mg qhs daily orally. Patients are to be instructed that perifosine is to be taken with food."||||
1536542|NCT00498953|Randomized|||Treatment||None (Open Label)||||||
1536543|NCT00498940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536544|NCT00498927||Single Group Assignment||Treatment||None (Open Label)||||||
1536545|NCT00498914|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536546|NCT00498901||||Treatment||None (Open Label)||||||
1536547|NCT00498888|Randomized|Parallel Assignment||Treatment||Single|||||t|
1536548|NCT00498875|||Case-Only||Prospective|||||||
1536549|NCT00498862|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1536550|NCT00498849|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536551|NCT00498836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536552|NCT00498810|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536553|NCT00498797|Randomized|Parallel Assignment||Treatment||Double||||||
1536554|NCT00498784|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536555|NCT00498771|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536556|NCT00498758|Randomized|Parallel Assignment||Treatment||Double||||||
1536557|NCT00498745|Randomized|Crossover Assignment||||None (Open Label)||||||
1536558|NCT00498732|||Cohort||Prospective|||||||
1536559|NCT00498719|||Case-Only||Prospective|||||||
1536560|NCT00498706|Randomized|Parallel Assignment||Treatment||Single||||||t
1536561|NCT00498693|||Case Control||Prospective|||||||
1536562|NCT00498680|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536563|NCT00498667|||Cohort||Retrospective|||||||
1536564|NCT00498654|Randomized|Parallel Assignment||Prevention||Double||||||
1536565|NCT00498641|Randomized|Parallel Assignment||Treatment||Single||||||
1536566|NCT00498628|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536567|NCT00498615|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1536568|NCT00498602|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536569|NCT00498589|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536570|NCT00498576|||Case Control||Prospective|||||||
1536571|NCT00498563|Randomized|Crossover Assignment||Basic Science||Single||||||
1536572|NCT00498550|Randomized|Parallel Assignment||Treatment||Single||||||t
1536573|NCT00498537|Randomized|Crossover Assignment||Treatment||Double||||||
1536574|NCT00498524|||Case Control||Retrospective|||||||
1536575|NCT00498511|||Defined Population|Screening|Longitudinal, Prospective|||||||
1536576|NCT00498498|||Case-Only||Prospective|||||||
1536577|NCT00498485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536578|NCT00498472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536579|NCT00498459|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536580|NCT00498446|||||Prospective|||||||
1536581|NCT00498433|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536582|NCT00498420|||||Prospective|||||||
1536583|NCT00498407|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536584|NCT00498394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536585|NCT00498381|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1536586|NCT00498368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536587|NCT00498355||Single Group Assignment||Treatment||None (Open Label)||||||
1536588|NCT00498342|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1536589|NCT00498329|||||Prospective|||||||
1536590|NCT00498316||Single Group Assignment||Treatment||None (Open Label)||||||
1536591|NCT00498303|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536592|NCT00498290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536593|NCT00498277|||Case-Only||Prospective|||||||
1536594|NCT00498264|Randomized|Parallel Assignment||Treatment||Single||||||
1536595|NCT00498251|Randomized|Crossover Assignment||Treatment||Double||||||
1536596|NCT00498238||Single Group Assignment||||None (Open Label)||||||
1536597|NCT00498225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536598|NCT00498212|Randomized|Parallel Assignment||Prevention||Single|||t|||
1536599|NCT00498199|||Cohort||Prospective|||||||
1536600|NCT00498186||Single Group Assignment||Treatment||None (Open Label)||||||
1536601|NCT00498173|Randomized|Sequential Assignment||Treatment||Triple||"At the end of the 8-week double-blind, placebo-controlled study, participants randomized to placebo who are not responders at the end of 8 weeks will be treated with atomoxetine for 8 weeks during an open-label trial. All participants who are rated much improved or very much improved on the CGI-I following treatment with atomoxetine (i.e., atomoxetine responders) during either the 8-week placebo-controlled trial or the 8-week open-label phase for placebo nonresponders will be eligible to enter the 10-month open-label extension phase of the study."|t|t|t|
1536602|NCT00498160||Single Group Assignment||Treatment||None (Open Label)||||||
1536603|NCT00498147|||Cohort|||||||||
1536604|NCT00498134|Randomized|Parallel Assignment||Prevention||Double||||||
1536605|NCT00498121|||||Prospective|||||||
1536606|NCT00498108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536607|NCT00498095|||Cohort||Prospective|||||||
1536608|NCT00498082|||||Longitudinal, Prospective|||||||
1536609|NCT00498069|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536610|NCT00498056|Randomized|Parallel Assignment||Prevention||Double||||||
1536611|NCT00498043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536612|NCT00498030|||Cohort||Prospective|||||||
1536613|NCT00498017|||Case-Only||Prospective|||||||
1536614|NCT00498004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536615|NCT00497991|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536616|NCT00497978|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1536617|NCT00497965|Randomized|Parallel Assignment||Prevention||Single||||||
1536618|NCT00497952||Single Group Assignment||Treatment||None (Open Label)||||||
1536619|NCT00497939|Randomized|Crossover Assignment||Treatment||Double||||||
1536620|NCT00497926||Single Group Assignment||Treatment||None (Open Label)||||||
1536621|NCT00497913|Randomized|Parallel Assignment||Treatment||Double||||||
1536622|NCT00497900|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536623|NCT00497887|||Cohort||Prospective|||||||
1536624|NCT00497874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536625|NCT00497861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536626|NCT00497848|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1536627|NCT00497835|||||Prospective|||||||
1536628|NCT00497822|Randomized|Parallel Assignment||||Single||||||
1536629|NCT00497809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536630|NCT00497796|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1536631|NCT00497783||Single Group Assignment||Supportive Care||None (Open Label)||||||
1536633|NCT00497757||Single Group Assignment||Treatment||None (Open Label)||Open label||||
1536634|NCT00497744|||Case-Only||Prospective|||||||
1536635|NCT00497731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536636|NCT00497718||Single Group Assignment||Treatment||None (Open Label)||||||
1536637|NCT00497705|||||Prospective|||||||
1536638|NCT00497692||Single Group Assignment||Supportive Care||None (Open Label)||||||
1536639|NCT00497679|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536640|NCT00497666|||Case Control||Cross-Sectional, Retrospective|||||||
1536641|NCT00497653|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1536642|NCT00497640|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1536643|NCT00497627||||||||||||
1536644|NCT00497614|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536645|NCT00497601|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536646|NCT00497588|Randomized|Parallel Assignment||Treatment||Single||||||t
1536647|NCT00497575|||Defined Population|Screening|Longitudinal, Prospective|||||||
1536648|NCT00497562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536649|NCT00497549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536650|NCT00497536|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536651|NCT00497523|Randomized|Parallel Assignment||Treatment||Double||||||
1536652|NCT00497510|Randomized|Parallel Assignment||Prevention||Single||||||
1536653|NCT00497497|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536654|NCT00497484||Single Group Assignment||Treatment||None (Open Label)||||||
1536655|NCT00497471|Randomized|Factorial Assignment||Prevention||Double||||||
1536656|NCT00497458|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536657|NCT00497445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536658|NCT00497432|||Case Control||Prospective|||||||
1536659|NCT00497419||Single Group Assignment||||None (Open Label)||||||
1536660|NCT00497406|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1536661|NCT00497393|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1536662|NCT00497380|Randomized|Parallel Assignment||Other||Double|||t||t|
1536663|NCT00497367|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1536664|NCT00497354|Randomized|Single Group Assignment||Treatment||Double||||||
1536665|NCT00497341|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1536666|NCT00497328|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536667|NCT00497315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536668|NCT00497302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536669|NCT00497289|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536670|NCT00497276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536671|NCT00497263|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1536672|NCT00497250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536673|NCT00497237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536674|NCT00497224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536675|NCT00497211|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536676|NCT00497198|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536677|NCT00497185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536678|NCT00497172|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536679|NCT00497159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536680|NCT00497146|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536681|NCT00497133|||Case Control||Prospective|||||||
1536682|NCT00497120|Randomized|Parallel Assignment||Treatment||Double||||||
1536683|NCT00497107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536684|NCT00497094|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1536685|NCT00497081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536686|NCT00497068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536687|NCT00497055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536688|NCT00497042||Single Group Assignment||Treatment||None (Open Label)||||||
1536689|NCT00497029|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536690|NCT00497016|Randomized|Crossover Assignment||||Double||||||
1536691|NCT00497003|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536692|NCT00496990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536693|NCT00496977|Randomized|Parallel Assignment||Screening||Single||||||
1536694|NCT00496964|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536695|NCT00496951|||Cohort||Prospective|||||||
1536696|NCT00496938|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536697|NCT00496925|||Cohort||Cross-Sectional|||||||
1536698|NCT00496899|||Cohort||Cross-Sectional|||||||
1536699|NCT00496886|||Case Control||Cross-Sectional|||||||
1536700|NCT00496873||Single Group Assignment||Treatment||None (Open Label)||||||
1536701|NCT00496860||Single Group Assignment||Treatment||None (Open Label)||||||
1536702|NCT00496847|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536703|NCT00496834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536704|NCT00496821|Randomized|Parallel Assignment||Treatment||Double||||||
1536705|NCT00496808||Single Group Assignment||Treatment||None (Open Label)||||||
1536706|NCT00496795||Single Group Assignment||Treatment||None (Open Label)||||||
1536707|NCT00496782|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1536708|NCT00496769|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536709|NCT00496756||Single Group Assignment||Treatment||None (Open Label)||||||
1536710|NCT00496743||Single Group Assignment||Treatment||None (Open Label)||||||
1536711|NCT00496730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536712|NCT00496717|||Cohort||Prospective|||||||
1536713|NCT00496704||||Treatment||None (Open Label)||||||
1536714|NCT00496691|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536715|NCT00496678|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1536716|NCT00496665||Single Group Assignment||Treatment||None (Open Label)||||||
1536717|NCT00496652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536718|NCT00496639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536719|NCT00496626|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536720|NCT00496613|||Cohort||Retrospective|||||||
1536721|NCT00496600||Single Group Assignment||Treatment||None (Open Label)||||||
1536722|NCT00496587||Single Group Assignment||Treatment||None (Open Label)||||||
1536723|NCT00496574|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536724|NCT00496561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536725|NCT00496548||Single Group Assignment||Diagnostic||None (Open Label)||||||
1536726|NCT00496535|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536727|NCT00496522||Single Group Assignment||Treatment||None (Open Label)||||||
1536728|NCT00496509|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536729|NCT00496483||Single Group Assignment||Treatment||None (Open Label)||||||
1536730|NCT00496470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536731|NCT00496457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536732|NCT00496444|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536733|NCT00496431||Single Group Assignment||Treatment||None (Open Label)||||||
1536734|NCT00496418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536735|NCT00496405||Parallel Assignment||||None (Open Label)||||||
1536736|NCT00496392|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536737|NCT00496379||Single Group Assignment||Treatment||None (Open Label)||||||
1536738|NCT00496366||Single Group Assignment||Treatment||None (Open Label)||||||
1536739|NCT00496353|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536740|NCT00496340||Single Group Assignment||Treatment||None (Open Label)||||||
1536741|NCT00496327|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536742|NCT00496314|||Case-Only||Prospective|||||||
1536743|NCT00496301||Single Group Assignment||Treatment||None (Open Label)||||||
1536744|NCT00496288|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536745|NCT00496275|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536746|NCT00496262||Single Group Assignment||Treatment||None (Open Label)||||||
1536747|NCT00496249|||Cohort||Prospective|||||||
1536748|NCT00496236|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536749|NCT00496223|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536750|NCT00496210|||||Other|||||||
1536751|NCT00496197|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536752|NCT00496184|Randomized|Parallel Assignment||Treatment||Double||||||
1536753|NCT00496171|||||Prospective|||||||
1536754|NCT00496158|Randomized|||Treatment||Double||||||
1536755|NCT00496145|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536756|NCT00496132||Single Group Assignment||Treatment||None (Open Label)||||||
1536757|NCT00496119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536758|NCT00496106|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1536759|NCT00496093||Single Group Assignment||Prevention||None (Open Label)||||||
1536760|NCT00496080||Single Group Assignment||Treatment||None (Open Label)||||||
1536761|NCT00496067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536762|NCT00496054|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536763|NCT00496041||Single Group Assignment||Diagnostic||None (Open Label)||||||
1536764|NCT00496028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536765|NCT00496015|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536766|NCT00496002|Randomized|||Treatment||Double||||||
1536767|NCT00495989||Single Group Assignment||Diagnostic||None (Open Label)||||||
1536768|NCT00495976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536769|NCT00495963||Single Group Assignment||Diagnostic||None (Open Label)||||||
1536770|NCT00495950|||Case-Only||Prospective|||||||
1536771|NCT00495924|||Cohort||Prospective|||||||
1536772|NCT00495898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536773|NCT00495885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536774|NCT00495872|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536775|NCT00495859|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1536776|NCT00495846|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536777|NCT00495833|Randomized|Factorial Assignment||Screening||Single||||||t
1536778|NCT00495820|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536779|NCT00495807|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1536780|NCT00495794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536781|NCT00495781|Randomized|Parallel Assignment||Diagnostic||Single||||||
1536782|NCT00495768|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536783|NCT00495755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536784|NCT00495729|Randomized|Single Group Assignment||Treatment||||||||
1536785|NCT00495716|Randomized|Parallel Assignment||||None (Open Label)||||||
1536786|NCT00495703|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536787|NCT00495690|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1536788|NCT00495677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536789|NCT00495664|Randomized|Parallel Assignment||Treatment||Single||||||t
1536790|NCT00495651|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1536791|NCT00495638|||||Other|||||||
1536792|NCT00495625||Single Group Assignment||Treatment||None (Open Label)||||||
1536793|NCT00495612|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536794|NCT00495599|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1536795|NCT00495586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536796|NCT00495573|||Case-Only||Prospective|||||||
1536797|NCT00495560|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536798|NCT00495547|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536799|NCT00495521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536800|NCT00495508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536801|NCT00495495|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1536802|NCT00495482|||Cohort||Prospective|||||||
1536803|NCT00495469|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536804|NCT00495456|||Cohort||Prospective|||||||
1536805|NCT00495443|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1536806|NCT00495430|||Cohort||Prospective|||||||
1536807|NCT00495417|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536808|NCT00495404|Randomized|Parallel Assignment||Health Services Research||Single||||||
1536809|NCT00495391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536810|NCT00495378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536811|NCT00495365|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536812|NCT00495352|Randomized|Parallel Assignment||Treatment||Double||||||
1536813|NCT00495339|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536814|NCT00495326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536815|NCT00495313|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1536816|NCT00495300|||Cohort||Prospective|||||||
1536817|NCT00495287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536818|NCT00495274|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536819|NCT00495261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536820|NCT00495248|Randomized|Parallel Assignment||Prevention||Single||||||t
1536821|NCT00495235|||Case Control||Prospective|||||||
1536822|NCT00495222||Single Group Assignment||Treatment||None (Open Label)||||||
1536823|NCT00495209|||Other||Prospective|||||||
1536824|NCT00495196|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1536825|NCT00495183|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536826|NCT00495170||Single Group Assignment||Treatment||None (Open Label)||||||
1536827|NCT00495157|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536828|NCT00495144|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536829|NCT00495131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536830|NCT00495118|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536831|NCT00495105|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536832|NCT00495092|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536833|NCT00495079||Single Group Assignment||Treatment||None (Open Label)||||||
1536834|NCT00495066||||||||||||
1536835|NCT00495053|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536836|NCT00495040||Single Group Assignment||Treatment||None (Open Label)||||||
1536837|NCT00495027|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536838|NCT00495014|Randomized|Parallel Assignment||Diagnostic||Single||||||
1536839|NCT00494988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536840|NCT00494975|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536841|NCT00494962|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1536842|NCT00494949|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536843|NCT00494936|||Cohort||Prospective|||||||
1536844|NCT00494923|||Cohort||Prospective|||||||
1536845|NCT00494910|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536846|NCT00494897|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536847|NCT00494884|Randomized|Parallel Assignment||Treatment||Double||||||
1536848|NCT00494871|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1536849|NCT00494858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536850|NCT00494845|Randomized|Single Group Assignment||Treatment||Single||||||t
1536851|NCT00494832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536852|NCT00494819|||Case Control|||||||||
1536853|NCT00494806|Randomized|Parallel Assignment||Treatment||Single||||t||
1536854|NCT00494793||Single Group Assignment||Treatment||None (Open Label)||||||
1536855|NCT00494780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536856|NCT00494767|Randomized|Parallel Assignment||Treatment||||||||
1536857|NCT00494754|||Family-Based|||||||||
1536858|NCT00494741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536859|NCT00494728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536860|NCT00494715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536861|NCT00494702|Randomized|Parallel Assignment||Treatment||Single|||||t|
1536862|NCT00494689|||Case Control||Longitudinal, Prospective|||||||
1536863|NCT00494676|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1536864|NCT00494663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536865|NCT00494650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536866|NCT00494637|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1536867|NCT00494624|Randomized|Parallel Assignment||Treatment||Double||||||
1536868|NCT00494611|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536869|NCT00494598|||Cohort||Prospective|||||||
1536870|NCT00494585||Single Group Assignment||Treatment||None (Open Label)||||||
1536871|NCT00494572|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536872|NCT00494559|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536873|NCT00494546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536874|NCT00494533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536875|NCT00494520|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536876|NCT00494507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536877|NCT00494494|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536878|NCT00494481|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536879|NCT00494468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536880|NCT00494455|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536881|NCT00494442|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536882|NCT00494429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536883|NCT00494416|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1536884|NCT00494403|||Case Control||Prospective|||||||
1536885|NCT00494390|||||Prospective|||||||
1536886|NCT00494377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536887|NCT00494364|||Cohort||Prospective|||||||
1536888|NCT00494351|Randomized|Single Group Assignment||Treatment||Single|||||t|
1536889|NCT00494338||Single Group Assignment||Treatment||None (Open Label)||||||
1536890|NCT00494325|||Cohort||Prospective|||||||
1536891|NCT00494312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536892|NCT00494299|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1536893|NCT00494286|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1536894|NCT00494273|Randomized|Parallel Assignment||Prevention||Single||||||
1536895|NCT00494260|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536896|NCT00494247|Randomized|Parallel Assignment||Treatment||Single||||||t
1536897|NCT00494234|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536898|NCT00494221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536899|NCT00494208|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536900|NCT00494195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536901|NCT00494182||Single Group Assignment||Treatment||None (Open Label)||||||
1536902|NCT00494169|||Case-Control||Cross-Sectional|||||||
1536903|NCT00494156|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536904|NCT00494143|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1536905|NCT00494117|||Cohort||Prospective|||||||
1536906|NCT00494104|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1536907|NCT00494091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536908|NCT00494078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536909|NCT00494065|Randomized|Parallel Assignment||Treatment||Single||||||t
1536910|NCT00494052|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1536911|NCT00494039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536912|NCT00494026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536913|NCT00494013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536914|NCT00493987|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536915|NCT00493974|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536916|NCT00493961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536917|NCT00493948|||Cohort||Prospective|||||||
1536918|NCT00493935|||||Prospective|||||||
1536919|NCT00493922|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1536920|NCT00493909|Randomized|Parallel Assignment||Treatment||Single||||||
1536921|NCT00493896|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536922|NCT00493883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536923|NCT00493870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536924|NCT00493857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536925|NCT00493844|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1536926|NCT00493831||Single Group Assignment||Diagnostic||None (Open Label)||||||
1536927|NCT00493818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536928|NCT00493805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536929|NCT00493792|Randomized|Parallel Assignment||Treatment||Single|||t|||
1536930|NCT00493779|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1536931|NCT00493766|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536932|NCT00493753|Randomized|Factorial Assignment||||Single||||||
1536933|NCT00493740|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1536934|NCT00493727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536936|NCT00493701|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1536937|NCT00493688|||Cohort||Prospective|||||||
1536938|NCT00493675||Single Group Assignment||Treatment||None (Open Label)||||||
1536939|NCT00493662|Randomized|Crossover Assignment||||Single||||||
1536940|NCT00493649||Single Group Assignment||Treatment||None (Open Label)||||||
1536941|NCT00493636|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536942|NCT00493623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1536943|NCT00493610|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536944|NCT00493597|||Cohort||Prospective|||||||
1536945|NCT00493584|Randomized|Parallel Assignment||||None (Open Label)||||||
1536946|NCT00493571||Single Group Assignment||Treatment||None (Open Label)||||||
1536947|NCT00493558||Single Group Assignment||Treatment||None (Open Label)||||||
1536948|NCT00493545|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1536949|NCT00493532||||||||||||
1536950|NCT00493519|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1536951|NCT00493506|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1536952|NCT00493493||Single Group Assignment||Treatment||None (Open Label)||||||
1536953|NCT00493480|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536954|NCT00493467||Single Group Assignment||Treatment||None (Open Label)||||||
1536955|NCT00493454||Single Group Assignment||Treatment||None (Open Label)||||||
1536956|NCT00493441|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536957|NCT00493428||Single Group Assignment||Treatment||None (Open Label)||||||
1536958|NCT00493415|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536959|NCT00493402|Randomized|Factorial Assignment||Treatment||Single|||t|||
1536960|NCT00493389||Single Group Assignment||Diagnostic||None (Open Label)||||||
1536961|NCT00493376|||Cohort||Prospective|||||||
1536962|NCT00493363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536963|NCT00493350|||Case-Only||Prospective|||||||
1536964|NCT00493337|Randomized|Parallel Assignment||||None (Open Label)||||||
1536965|NCT00493324|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1536966|NCT00493311|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536967|NCT00493298|||Cohort||Prospective|||||||
1536968|NCT00493285|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1536969|NCT00493272|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1536970|NCT00493259|||Cohort||Retrospective|||||||
1536971|NCT00493246|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536972|NCT00493233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1536973|NCT00493220|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1536974|NCT00493194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536975|NCT00493181||Single Group Assignment||Treatment||None (Open Label)||||||
1536976|NCT00493168|||||Prospective|||||||
1536977|NCT00493155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536978|NCT00493142|Randomized|Single Group Assignment||Treatment||Double|||||t|t
1536979|NCT00493129||Single Group Assignment||Treatment||None (Open Label)||||||
1536980|NCT00493116||Single Group Assignment||Treatment||None (Open Label)||||||
1536981|NCT00493103||||Screening|Cross-Sectional, Prospective|||||||
1536982|NCT00493090|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1536983|NCT00493077||Single Group Assignment||Treatment||None (Open Label)||||||
1536984|NCT00493064||Single Group Assignment||Treatment||None (Open Label)||||||
1536985|NCT00493051|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1536986|NCT00493038|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1536987|NCT00493025||Single Group Assignment||Treatment||None (Open Label)||||||
1536988|NCT00493012|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1536989|NCT00492999|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536990|NCT00492986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1536991|NCT00492973|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1536992|NCT00492960|Randomized|Parallel Assignment||Treatment||Double|Double-blind|Randomized, double-blind, placebo Controlled, dose ranging, multicenter Study|t||t|
1536993|NCT00492947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536994|NCT00492934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1536995|NCT00492921|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1536996|NCT00492908|Randomized|Parallel Assignment||Treatment||Single||||||t
1536997|NCT00492895|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1536998|NCT00492882|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1536999|NCT00492869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537000|NCT00492856|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537001|NCT00492843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537002|NCT00492830|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537003|NCT00492817||Single Group Assignment||Treatment||None (Open Label)||||||
1537004|NCT00492804|Randomized|Parallel Assignment||Prevention||Single|||t|||
1537005|NCT00492791|||Cohort||Prospective|||||||
1537006|NCT00492778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537007|NCT00492765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537008|NCT00492752|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1537009|NCT00492739||Single Group Assignment||Treatment||None (Open Label)||||||
1537010|NCT00492726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537011|NCT00492713|Randomized|Crossover Assignment||Basic Science||Single|||||t|
1537012|NCT00492700|Randomized|Parallel Assignment||Treatment||Double||||||
1537013|NCT00492687||||Treatment||None (Open Label)||||||
1537014|NCT00492674|Randomized|Parallel Assignment||Treatment||Double||||||
1537015|NCT00492661||Single Group Assignment||Prevention||None (Open Label)||||||
1537016|NCT00492648|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537017|NCT00492635|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1537018|NCT00492622|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537019|NCT00492609|||Cohort||Prospective|||||||
1537020|NCT00492596|Randomized|Crossover Assignment||Treatment||Single|||t|||
1537021|NCT00492583|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1537022|NCT00492570|||Cohort||Prospective|||||||
1537023|NCT00492557|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1537024|NCT00492544||Single Group Assignment||Prevention||None (Open Label)||||||
1537025|NCT00492531|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537026|NCT00492518|Randomized|Parallel Assignment||Prevention||Double||||||
1537027|NCT00492505||||Treatment||||||||
1537028|NCT00492492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537029|NCT00492479|Randomized|Parallel Assignment||||Single||||||
1537030|NCT00492466||Single Group Assignment||Treatment||None (Open Label)||||||
1537031|NCT00492453|Randomized|Crossover Assignment||Treatment||Single||||||t
1537032|NCT00492440|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537033|NCT00492427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537034|NCT00492414|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1537035|NCT00492401||Single Group Assignment||Treatment||None (Open Label)||||||
1537036|NCT00492388|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1537037|NCT00492362|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1537038|NCT00492349|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537039|NCT00492336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537040|NCT00492323|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1537041|NCT00492310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537042|NCT00492297|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537043|NCT00492284|Randomized|Parallel Assignment||Treatment||Single||||||t
1537044|NCT00492271|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1537045|NCT00492258|Randomized|||Treatment||None (Open Label)||||||
1537046|NCT00492245|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537047|NCT00492232|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537048|NCT00492219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537049|NCT00492206||Single Group Assignment||Treatment||None (Open Label)||||||
1537050|NCT00492193|||Case-Only||Prospective|||||||
1537051|NCT00492167||Single Group Assignment||Treatment||None (Open Label)||||||
1537052|NCT00492154|||Cohort||Prospective|||||||
1537053|NCT00492141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537054|NCT00492128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537055|NCT00492115|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1537056|NCT00492102||Single Group Assignment||Basic Science||None (Open Label)||||||
1537057|NCT00492089|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1537058|NCT00492076|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1537059|NCT00492063|Randomized|Parallel Assignment||Prevention||Single|||t|||
1537060|NCT00492050||Single Group Assignment||Treatment||None (Open Label)||||||
1537061|NCT00492037|Randomized|Parallel Assignment||Treatment||Double||||||
1537062|NCT00492024|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537063|NCT00492011|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537064|NCT00491998|Randomized|Crossover Assignment||Treatment||Double||||||
1537065|NCT00491985|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537066|NCT00491959|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537067|NCT00491946|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537068|NCT00491933|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1537069|NCT00491920|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1537070|NCT00491907|Randomized|Parallel Assignment||Treatment||Double||||||
1537071|NCT00491894|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537072|NCT00491881|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537073|NCT00491868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537074|NCT00491855||Single Group Assignment||Treatment||None (Open Label)||||||
1537075|NCT00491842|||Cohort||Retrospective|||||||
1537076|NCT00491829|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537077|NCT00491816||Single Group Assignment||Treatment||None (Open Label)||||||
1537078|NCT00491803|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1537079|NCT00491790|Randomized|Parallel Assignment||Treatment||Single|||t|||
1537080|NCT00491777|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1537081|NCT00491764|Randomized|Parallel Assignment||Treatment||Single|||||t|
1537082|NCT00491751|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1537083|NCT00491738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537084|NCT00491725|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537085|NCT00491712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537086|NCT00491699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537087|NCT00491686|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1537088|NCT00491673|Randomized|Parallel Assignment||Treatment||Single||||||t
1537089|NCT00491660|Randomized|Parallel Assignment||Supportive Care||Single||||||
1537090|NCT00491647|||Case Control|||||||||
1537091|NCT00491634|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537092|NCT00491621||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537093|NCT00491608|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537094|NCT00491595|Randomized|Parallel Assignment||||Double||||||
1537095|NCT00491582||Single Group Assignment||Basic Science||None (Open Label)||||||
1537096|NCT00491569|Randomized|Parallel Assignment||Treatment||Double||||||
1537097|NCT00491556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537098|NCT00491543|Randomized|Parallel Assignment||Treatment||Double||||||
1537099|NCT00491530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537100|NCT00491517|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537101|NCT00491504|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537102|NCT00491491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537103|NCT00491478|Randomized|Factorial Assignment||Treatment||Double||||||
1537104|NCT00491465|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1537105|NCT00491452|||Case Control||Retrospective|||||||
1537106|NCT00491439|||Case-Only||Prospective|||||||
1537107|NCT00491426|||||Retrospective|||||||
1537108|NCT00491413|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537109|NCT00491400|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1537110|NCT00491387||Single Group Assignment||Treatment||None (Open Label)||||||
1537111|NCT00491374|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537112|NCT00491361||||||||||||
1537113|NCT00491348||Single Group Assignment||Basic Science||None (Open Label)||||||
1537114|NCT00491335|||||Prospective|||||||
1537115|NCT00491322|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1537116|NCT00491309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537117|NCT00491296|||||Prospective|||||||
1537118|NCT00491283|Randomized|Single Group Assignment||Diagnostic||Single||||||
1537119|NCT00491270|Randomized|Parallel Assignment||Diagnostic||Single||||t||
1537120|NCT00491257|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537121|NCT00491244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537122|NCT00491231|||Case-Only||Prospective|||||||
1537123|NCT00491218|Random Sample||Natural History||Longitudinal, Prospective|||||||
1537124|NCT00491192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537125|NCT00491179|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537126|NCT00491166|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537127|NCT00491153|||Cohort||Prospective|||||||
1537128|NCT00491140|||Cohort||Retrospective|||||||
1537129|NCT00491127|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537130|NCT00491114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537131|NCT00491101|||Cohort||Prospective|||||||
1537132|NCT00491088|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1537133|NCT00491075||Single Group Assignment||Treatment||None (Open Label)||||||
1537134|NCT00491062||Parallel Assignment||||||||||
1537135|NCT00491049|Randomized|Parallel Assignment||Prevention||Double||||||
1537136|NCT00491036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537137|NCT00491023|||||Retrospective|||||||
1537138|NCT00491010|Randomized|Parallel Assignment||Treatment||Single||||||
1537139|NCT00490997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537140|NCT00490984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537141|NCT00490971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537142|NCT00490958|Randomized|Parallel Assignment||Treatment||Double||||||
1537143|NCT00490945|Randomized|Parallel Assignment||Treatment||Double||||||
1537144|NCT00490932||Single Group Assignment||Treatment||None (Open Label)||||||
1537145|NCT00490919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537146|NCT00490906|||Cohort|||||||||
1537147|NCT00490893|Randomized|Crossover Assignment||||Single||||||
1537148|NCT00490880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537149|NCT00490867|Randomized|Parallel Assignment||Treatment||Double||||||
1537150|NCT00490854|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537151|NCT00490841|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537152|NCT00490828|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1537153|NCT00490815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537154|NCT00490802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537155|NCT00490789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537156|NCT00490776||Single Group Assignment||Treatment||None (Open Label)||||||
1537157|NCT00490763|||Cohort||Prospective|||||||
1537158|NCT00490750|Randomized|Single Group Assignment||Treatment||Single|||t|||
1537159|NCT00490737|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1537160|NCT00490724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537161|NCT00490711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537162|NCT00490698||Single Group Assignment||Treatment||None (Open Label)||||||
1537163|NCT00490685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537164|NCT00490672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537165|NCT00490659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537166|NCT00490646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537167|NCT00490633|Randomized|Factorial Assignment||Prevention||Single||||||t
1537168|NCT00490620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537169|NCT00490607|||Defined Population||Longitudinal, Prospective|||||||
1537170|NCT00490594||Single Group Assignment||Treatment||None (Open Label)||||||
1537171|NCT00490581|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1537172|NCT00490568||Single Group Assignment||Treatment||None (Open Label)||||||
1537173|NCT00490555|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537174|NCT00490542|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537175|NCT00490529||Single Group Assignment||Treatment||None (Open Label)||||||
1537176|NCT00490516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537177|NCT00490503|||Case-Only||Prospective|||||||
1537178|NCT00490490||Single Group Assignment||Treatment||None (Open Label)||||||
1537179|NCT00490477|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537180|NCT00490464|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1537181|NCT00490451||Single Group Assignment||Treatment||None (Open Label)||||||
1537182|NCT00490438||||Screening|Longitudinal, Prospective|||||||
1537183|NCT00490425|Randomized|Parallel Assignment||Prevention||Double||||||
1537184|NCT00490412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537185|NCT00490399||Single Group Assignment||Treatment||None (Open Label)||||||
1537186|NCT00490386|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1537187|NCT00490373||Single Group Assignment||Treatment||None (Open Label)||||||
1537188|NCT00490360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537189|NCT00490347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537190|NCT00490334|||Cohort||Prospective|||||||
1537191|NCT00490321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537192|NCT00490308|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537193|NCT00490295|||Cohort||Prospective|||||||
1537194|NCT00490282||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537195|NCT00490269|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1537196|NCT00490256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537197|NCT00490243|Randomized|Parallel Assignment||Treatment||Double||||||
1537198|NCT00490230|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1537199|NCT00490217|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1537200|NCT00490204|Randomized|Parallel Assignment||Treatment||||||||
1537201|NCT00490191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537202|NCT00490178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537203|NCT00490165|||Cohort||Retrospective|||||||
1537204|NCT00490152|||Cohort||Prospective|||||||
1537205|NCT00490139|Randomized|||Treatment||None (Open Label)||||||
1537206|NCT00490126|||Other||Other|||||||
1537207|NCT00490113|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1537208|NCT00490100||Single Group Assignment||Treatment||None (Open Label)||||||
1537209|NCT00490087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537210|NCT00490074|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537211|NCT00490061||Single Group Assignment||Treatment||None (Open Label)||||||
1537212|NCT00490048||Single Group Assignment||Screening||None (Open Label)||||||
1537213|NCT00490035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537214|NCT00490022|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537215|NCT00490009||Single Group Assignment||Treatment||None (Open Label)||||||
1537216|NCT00489996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537217|NCT00489983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537218|NCT00489970|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537219|NCT00489957|||Case Control||Prospective|||||||
1537220|NCT00489944||||Treatment||||||||
1537221|NCT00489931|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537222|NCT00489918|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537223|NCT00489905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537224|NCT00489892|Randomized|Parallel Assignment||Treatment||Double||||||
1537225|NCT00489879|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1537226|NCT00489866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537227|NCT00489853|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1537228|NCT00489840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537229|NCT00489827|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1537230|NCT00489814|||Cohort||Prospective|||||||
1537231|NCT00489801|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537232|NCT00489788|||Cohort||Prospective|||||||
1537233|NCT00489775|Randomized|Parallel Assignment||Treatment||Double||||||
1537234|NCT00489762|Randomized|Parallel Assignment||Prevention||Single||||||
1537235|NCT00489749|Randomized|Parallel Assignment||Treatment||Single||||||
1537236|NCT00489736|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1537237|NCT00489723|||Defined Population|Screening|Longitudinal, Prospective|||||||
1537238|NCT00489710||Single Group Assignment||Treatment||None (Open Label)||||||
1537239|NCT00489697|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1537240|NCT00489684|||Case-Crossover||Cross-Sectional|||||||
1537241|NCT00489671|||Case Control||Prospective|||||||
1537242|NCT00489658||Single Group Assignment||||None (Open Label)||||||
1537243|NCT00489645|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1537244|NCT00489632|||Case-Only||Prospective|||||||
1537245|NCT00489619|||||Prospective|||||||
1537246|NCT00489606|Randomized|Crossover Assignment||Treatment||Double||||||
1537247|NCT00489593||Single Group Assignment||Treatment||None (Open Label)||||||
1537248|NCT00489580|Randomized|Parallel Assignment||Treatment||Single||||||
1537249|NCT00489567|||Case-Only||Prospective|||||||
1537250|NCT00489554|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537251|NCT00489541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537252|NCT00489528|Randomized|Parallel Assignment||Prevention||Double||||||
1537253|NCT00489515|||Cohort||Prospective|||||||
1537254|NCT00489502|||Defined Population||Longitudinal, Prospective|||||||
1537255|NCT00489489|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1537256|NCT00489476|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537257|NCT00489463|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||
1537258|NCT00489450|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537259|NCT00489437||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537260|NCT00489424|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537261|NCT00489411|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1537262|NCT00489398|Randomized|Crossover Assignment||Treatment||Single||||||
1537263|NCT00489385|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537264|NCT00489372|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1537265|NCT00489359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537266|NCT00489346|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537267|NCT00489333|Randomized|Parallel Assignment||Treatment||Double||||||
1537268|NCT00489320|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1537269|NCT00489307|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1537270|NCT00489294|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537271|NCT00489281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537272|NCT00489268|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537273|NCT00489255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537274|NCT00489242|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537275|NCT00489229|Randomized|Factorial Assignment||Treatment||Double||||||
1537276|NCT00489216||Single Group Assignment||Supportive Care||None (Open Label)||||||
1537277|NCT00489203|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1537278|NCT00489190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537279|NCT00489177|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1537280|NCT00489164|Randomized|Parallel Assignment||Treatment||Single||||||
1537281|NCT00489151|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537282|NCT00489138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537283|NCT00489125|||Cohort||Prospective|||||||
1537284|NCT00489112|Randomized|Parallel Assignment||||None (Open Label)||||||
1537285|NCT00489099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537286|NCT00489086||Single Group Assignment||Treatment||None (Open Label)||||||
1537287|NCT00489073|Randomized|Parallel Assignment||Treatment||Double||||||
1537288|NCT00489060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537289|NCT00489034|||Cohort||Prospective|||||||
1537290|NCT00489021|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1537291|NCT00489008|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537292|NCT00488995|Randomized|Single Group Assignment||Treatment||Single||||||
1537293|NCT00488982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537294|NCT00488969|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1537295|NCT00488956|||Cohort||Retrospective|||||||
1537296|NCT00488943|||Cohort||Prospective|||||||
1537297|NCT00488930|||Case-Only||Prospective|||||||
1537298|NCT00488917|||Cohort||Prospective|||||||
1537299|NCT00488904|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1537300|NCT00488891|||Cohort||Retrospective|||||||
1537301|NCT00488878|||Cohort||Other|||||||
1537302|NCT00488865|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537303|NCT00488839|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1537304|NCT00488826|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537305|NCT00488813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537306|NCT00488800|||||Prospective|||||||
1537307|NCT00488787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537308|NCT00488774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537309|NCT00488761|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537310|NCT00488748|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1537311|NCT00488735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537312|NCT00488722|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1537313|NCT00488709||Single Group Assignment||Treatment||None (Open Label)||||||
1537314|NCT00488696||Single Group Assignment||Treatment||None (Open Label)||||||
1537315|NCT00488683|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537316|NCT00488670|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537317|NCT00488657|Randomized|Single Group Assignment||Treatment||Single||||||t
1537318|NCT00488644||Single Group Assignment||Treatment||None (Open Label)||||||
1537319|NCT00488631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537320|NCT00488618|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1537321|NCT00488605|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537322|NCT00488592||Single Group Assignment||Treatment||None (Open Label)||||||
1537323|NCT00488579|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1537324|NCT00488566|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1537325|NCT00488553|||Case Control||Prospective|||||||
1537326|NCT00488540|Randomized|Parallel Assignment||Treatment||Double||||||
1537327|NCT00488527|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537328|NCT00488514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537329|NCT00488501|||Case-Only||Prospective|||||||
1537330|NCT00488488|||Cohort||Prospective|||||||
1537331|NCT00488475|||Cohort||Prospective|||||||
1537332|NCT00488462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537333|NCT00488449|Randomized|Parallel Assignment||Diagnostic||Single||||||
1537334|NCT00488436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537335|NCT00488423|Non-Randomized|Single Group Assignment||||Single||||||t
1537336|NCT00488410|Randomized|Single Group Assignment||||Single||||||
1537337|NCT00488397|||Cohort||Prospective|||||||
1537338|NCT00488384|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537339|NCT00488371|||||Prospective|||||||
1537340|NCT00488358|||Case-Only||Prospective|||||||
1537341|NCT00488345||Single Group Assignment||Treatment||None (Open Label)||||||
1537342|NCT00488332|||Case-Only||Prospective|||||||
1537343|NCT00488319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537344|NCT00488306|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537345|NCT00488293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537346|NCT00488280||Single Group Assignment||Treatment||None (Open Label)||||||
1537347|NCT00488267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537348|NCT00488254|||Cohort||Retrospective|||||||
1537349|NCT00488241||Single Group Assignment||Treatment||None (Open Label)||||||
1537350|NCT00488228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537351|NCT00488215|Randomized|Crossover Assignment||||Double|||t||t|
1537352|NCT00488202|||Cohort||Retrospective|||||||
1537353|NCT00488189|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1537354|NCT00488176|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1537355|NCT00488163|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537356|NCT00488137|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537357|NCT00488124||Single Group Assignment||Treatment||None (Open Label)||||||
1537358|NCT00488111|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1537359|NCT00488098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537360|NCT00488085|||Defined Population||Cross-Sectional, Prospective|||||||
1537361|NCT00488072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537362|NCT00488059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537363|NCT00488046|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537364|NCT00488033|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1537365|NCT00488020||Single Group Assignment||Treatment||None (Open Label)||||||
1537366|NCT00488007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537367|NCT00487994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537368|NCT00487981||Single Group Assignment||Treatment||None (Open Label)||||||
1537369|NCT00487968|Randomized|Single Group Assignment||Treatment||Single||||||
1537370|NCT00487955|||Defined Population||Cross-Sectional, Prospective|||||||
1537371|NCT00487942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537372|NCT00487929|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1537373|NCT00487916|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537374|NCT00487903||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537375|NCT00487890||||||||||||
1537376|NCT00487877|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1537377|NCT00487864|||Natural History||Cross-Sectional, Prospective|||||||
1537378|NCT00487851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537379|NCT00487838|||||Prospective|||||||
1537380|NCT00487825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537381|NCT00487812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537382|NCT00487799|Randomized|Parallel Assignment||Treatment||Double||||||
1537383|NCT00487786||Single Group Assignment||Treatment||None (Open Label)||||||
1537384|NCT00487773|Randomized|Parallel Assignment||||Triple|||t|t|t|
1537385|NCT00487760|||||Prospective|||||||
1537386|NCT00487747||Single Group Assignment||Treatment||None (Open Label)||||||
1537387|NCT00487734|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537388|NCT00487721|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1537389|NCT00487708|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537390|NCT00487695|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1537391|NCT00487682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537392|NCT00487669|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537393|NCT00487656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537394|NCT00487643|||Cohort||Prospective|||||||
1537395|NCT00487630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537396|NCT00487617|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1537397|NCT00487604|||Defined Population||Longitudinal, Retrospective|||||||
1537398|NCT00487591|||Cohort||Prospective|||||||
1537399|NCT00487578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537400|NCT00487565|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537401|NCT00487552||Single Group Assignment||Supportive Care||None (Open Label)||||||
1537402|NCT00487539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537403|NCT00487526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537404|NCT00487513|||Cohort||Prospective|||||||
1537405|NCT00487500|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1537406|NCT00487487|Random Sample||||Cross-Sectional, Prospective|||||||
1537407|NCT00487474|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537408|NCT00487461|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1537409|NCT00487448||Single Group Assignment||Treatment||None (Open Label)||||||
1537410|NCT00487435|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537411|NCT00487422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537412|NCT00487409|Randomized|Parallel Assignment||Treatment||Single|||t|||
1537413|NCT00487396|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1537414|NCT00487383|||||Prospective|||||||
1537415|NCT00487370|Randomized|Parallel Assignment||Treatment||Double||||||
1537416|NCT00487357|||Ecologic or Community||Prospective|||||||
1537417|NCT00487344|Randomized|Parallel Assignment||Health Services Research||Single||||||
1537418|NCT00487331||Single Group Assignment||Supportive Care||None (Open Label)||||||
1537419|NCT00487318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537420|NCT00487305||Single Group Assignment||Treatment||None (Open Label)||||||
1537421|NCT00487292|Randomized|Single Group Assignment||Prevention||Double||||||
1537422|NCT00487279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537423|NCT00487266|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1537424|NCT00487253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537425|NCT00487240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537426|NCT00487227|Randomized|Crossover Assignment||Basic Science||Double||||||
1537427|NCT00487214|||Cohort||Prospective|||||||
1537428|NCT00487201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537429|NCT00487188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537430|NCT00487175|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1537431|NCT00487162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537432|NCT00487149|||Case Control||Prospective|||||||
1537433|NCT00487136|Randomized|Parallel Assignment||Treatment||Double||||||
1537434|NCT00487123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537435|NCT00487110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537436|NCT00487097|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537437|NCT00487084|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537438|NCT00487071||Single Group Assignment||Treatment||None (Open Label)||||||
1537439|NCT00487058|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537440|NCT00487045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537441|NCT00487032|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1537442|NCT00487019|||Cohort||Prospective|||||||
1537443|NCT00487006|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537444|NCT00486993|||Cohort||Prospective|||||||
1537445|NCT00486980|Randomized|Parallel Assignment||||Double||||||
1537446|NCT00486967|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1537447|NCT00486954|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537448|NCT00486941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537449|NCT00486928|||Cohort||Retrospective|||||||
1537450|NCT00486915|Randomized|Parallel Assignment||Prevention||Single|||t|||
1537451|NCT00486902|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537452|NCT00486889||Single Group Assignment||Treatment||None (Open Label)||||||
1537453|NCT00486876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537454|NCT00486863|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537455|NCT00486850|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537456|NCT00486837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537457|NCT00486824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537458|NCT00486811|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537459|NCT00486798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537460|NCT00486785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537461|NCT00486772|Randomized|Crossover Assignment||Prevention||Single||||||
1537462|NCT00486759|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537463|NCT00486746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537464|NCT00486733|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1537465|NCT00486720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537466|NCT00486707|||Case-Only||Prospective|||||||
1537467|NCT00486694|Randomized|Parallel Assignment||Treatment||Double||||||
1537468|NCT00486681|||Case-Crossover||Prospective|||||||
1537469|NCT00486668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537470|NCT00486655||Single Group Assignment||Treatment||None (Open Label)||||||
1537471|NCT00486642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537472|NCT00486629|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537473|NCT00486616|||||Prospective|||||||
1537474|NCT00486603||Single Group Assignment||Treatment||None (Open Label)||||||
1537475|NCT00486590|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1537476|NCT00486577|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1537477|NCT00486564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537478|NCT00486551|Randomized|Parallel Assignment||Treatment||Single||||||
1537479|NCT00486538|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537480|NCT00486525|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1537481|NCT00486512|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1537482|NCT00486499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537483|NCT00486486|Randomized|Crossover Assignment||Treatment||Single|||||t|
1537484|NCT00486473|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1537485|NCT00486460|Randomized|Parallel Assignment||||Double||||||
1537486|NCT00486447||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537487|NCT00486434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537488|NCT00486421||Single Group Assignment||Treatment||None (Open Label)||||||
1537489|NCT00486408|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537490|NCT00486395|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537491|NCT00486382|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537492|NCT00486369|Randomized|Parallel Assignment||Treatment||Double||||||
1537493|NCT00486356||Single Group Assignment||Treatment||None (Open Label)||||||
1537494|NCT00486343|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537495|NCT00486330||Single Group Assignment||Basic Science||None (Open Label)||||||
1537496|NCT00486317|Randomized|Parallel Assignment||Treatment||Double||||||
1537497|NCT00486304|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1537498|NCT00486291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537499|NCT00486278|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537500|NCT00486265|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537501|NCT00486252|||Case-Only||Prospective|||||||
1537502|NCT00486239|Non-Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1537503|NCT00486226|||Cohort||Prospective|||||||
1537504|NCT00486213|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1537505|NCT00486200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537506|NCT00486187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537507|NCT00486174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537508|NCT00486161|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1537509|NCT00486148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537510|NCT00486135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537511|NCT00486122|Randomized|Parallel Assignment||Treatment||Double||||||
1537512|NCT00486109|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1537513|NCT00486096|||||Retrospective|||||||
1537514|NCT00486083|Randomized|Parallel Assignment||Treatment||Double||||||
1537515|NCT00486070|||||Retrospective|||||||
1537516|NCT00486057|||||Retrospective|||||||
1537517|NCT00486044|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1537518|NCT00486031||Single Group Assignment||Supportive Care||None (Open Label)||||||
1537519|NCT00486018|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537520|NCT00486005|Randomized|Parallel Assignment||Treatment||Double||||||
1537521|NCT00485992|||||Retrospective|||||||
1537522|NCT00485979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537523|NCT00485966|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537524|NCT00485953|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1537525|NCT00485940|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537526|NCT00485927||Single Group Assignment||Health Services Research||Double||||||
1537527|NCT00485914|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537528|NCT00485901|Randomized|Parallel Assignment||Treatment||Double||||||
1537529|NCT00485888|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1537530|NCT00485875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537531|NCT00485862|Randomized|Parallel Assignment||Treatment||Double||||||
1537532|NCT00485849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537533|NCT00485836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537534|NCT00485823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537535|NCT00485810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537536|NCT00485797|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1537537|NCT00485784|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537538|NCT00485771|Randomized|Parallel Assignment||Treatment||Double||||||
1537539|NCT00485758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537540|NCT00485745|||||Retrospective|||||||
1537541|NCT00485732|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1537542|NCT00485719|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537543|NCT00485706||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537544|NCT00485693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537545|NCT00485680|Randomized|Parallel Assignment||Treatment||Double||||||
1537546|NCT00485667|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1537547|NCT00485654|||||Retrospective|||||||
1537548|NCT00485641|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1537549|NCT00485628|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537550|NCT00485615|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537551|NCT00485602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537552|NCT00485589|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537553|NCT00485576|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1537554|NCT00485563|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537555|NCT00485550|Randomized|Parallel Assignment||Treatment||Double||||||
1537556|NCT00485537|Randomized|Parallel Assignment||Treatment||Double||||||
1537557|NCT00485524|||Cohort||Retrospective|||||||
1537558|NCT00485511|Randomized|Parallel Assignment||||Double||||||
1537559|NCT00485498|Randomized|Parallel Assignment||Treatment||Double||||||
1537560|NCT00485485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537561|NCT00485472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537562|NCT00485459|Randomized|Parallel Assignment||Treatment||Double||||||
1537563|NCT00485446|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1537564|NCT00485433|Randomized|Parallel Assignment||||Triple|||t||t|t
1537565|NCT00485420|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1537566|NCT00485407|Randomized|Parallel Assignment||Treatment||Double||||||
1537567|NCT00485394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537568|NCT00485368|Randomized|Parallel Assignment||Prevention||Double||||||
1537569|NCT00485355|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1537570|NCT00485342|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537571|NCT00485329|Randomized|Parallel Assignment||Treatment||Double||||||
1537572|NCT00485316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537573|NCT00485303||Single Group Assignment||Treatment||None (Open Label)||||||
1537574|NCT00485290||Single Group Assignment||Basic Science||None (Open Label)||||||
1537575|NCT00485277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537576|NCT00485264|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537577|NCT00485251|Randomized|Parallel Assignment||Treatment||Single|||t|||
1537578|NCT00485238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537579|NCT00485225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537580|NCT00485212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537581|NCT00485199|Randomized|Parallel Assignment||Treatment||Single||||||
1537582|NCT00485186|||Family-Based||Prospective|||||||
1537583|NCT00485173||Single Group Assignment||Treatment||None (Open Label)||||||
1537584|NCT00485160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537585|NCT00485147||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537586|NCT00485134|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1537587|NCT00485121||Single Group Assignment||Treatment||None (Open Label)||||||
1537588|NCT00485108|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1537589|NCT00485095|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1537590|NCT00485082|||||Retrospective|||||||
1537591|NCT00485069|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537592|NCT00485056|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1537593|NCT00485043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537594|NCT00485030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537595|NCT00485017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537596|NCT00485004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537597|NCT00484991||||||||||||
1537598|NCT00484978||Single Group Assignment||Treatment||None (Open Label)||||||
1537599|NCT00484965|Randomized|Parallel Assignment||Treatment||Double||||||
1537600|NCT00484952|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1537601|NCT00484939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537602|NCT00484926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537603|NCT00484913|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1537604|NCT00484900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537605|NCT00484887|||Case-Only||Prospective|||||||
1537606|NCT00484874||Single Group Assignment||Treatment||None (Open Label)||||||
1537607|NCT00484861|||||Prospective|||||||
1537608|NCT00484848|Randomized|Parallel Assignment||Supportive Care||Single||||t||
1537609|NCT00484835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537610|NCT00484822|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537611|NCT00484809|||||Prospective|||||||
1537612|NCT00484796|||Cohort||Prospective|||||||
1537613|NCT00484783|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537614|NCT00484770|Randomized|Parallel Assignment||Treatment||Single||||||
1537615|NCT00484757|Randomized|Crossover Assignment||Basic Science||Double||||||
1537616|NCT00484744|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1537617|NCT00484731|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1537618|NCT00484718|Randomized|Crossover Assignment||||Double|||t||t|
1537619|NCT00484705|Randomized|Factorial Assignment||Treatment||Single||||||
1537620|NCT00484692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537621|NCT00484679||Single Group Assignment||Screening||None (Open Label)||||||
1537622|NCT00484666||Single Group Assignment||Treatment||None (Open Label)||||||
1537623|NCT00484653||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537624|NCT00484640|Randomized|Parallel Assignment||Treatment||Double||||||
1537625|NCT00484627|Randomized|Parallel Assignment||Supportive Care||Double||||||
1537626|NCT00484614|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1537627|NCT00484601||Single Group Assignment||Treatment||None (Open Label)||||||
1537628|NCT00484588|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1537629|NCT00484575|Randomized|Parallel Assignment||Treatment||Single|||t|||
1537630|NCT00484562|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537631|NCT00484549|Randomized|Single Group Assignment||Treatment||Single|||t|||
1537632|NCT00484536|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537633|NCT00484523||Single Group Assignment||Basic Science||None (Open Label)||||||
1537634|NCT00484510|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1537635|NCT00484497|Randomized|Parallel Assignment||Treatment||Double||||||
1537636|NCT00484484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537637|NCT00484471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537638|NCT00484458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537639|NCT00484445|||Cohort||Retrospective|||||||
1537640|NCT00484432||Single Group Assignment||Treatment||None (Open Label)||||||
1537641|NCT00484419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537642|NCT00484406|||Defined Population|Screening|Longitudinal, Prospective|||||||
1537643|NCT00484393|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t||t
1537644|NCT00484380|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1537645|NCT00484367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537646|NCT00484354|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537647|NCT00484341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537648|NCT00484328|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537649|NCT00484315|Randomized|Parallel Assignment||Treatment||Single|||t|||
1537650|NCT00484302|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1537651|NCT00484289|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537652|NCT00484276||Single Group Assignment||Treatment||None (Open Label)||||||
1537653|NCT00484263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537654|NCT00484250|Randomized|Parallel Assignment||Treatment||Double||||||
1537655|NCT00484237|Randomized|Parallel Assignment||Treatment||Double||||||
1537656|NCT00484224|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1537657|NCT00484211|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537658|NCT00484198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537659|NCT00484185|||Cohort||Prospective|||||||
1537660|NCT00484172|||Defined Population|Screening|Longitudinal, Prospective|||||||
1537661|NCT00484159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537662|NCT00484146|||Cohort||Prospective|||||||
1537663|NCT00484133|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537664|NCT00484120|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537665|NCT00484107||||||||||||
1537666|NCT00484094|||Cohort||Prospective|||||||
1537667|NCT00484081||Single Group Assignment||Treatment||None (Open Label)||||||
1537668|NCT00484068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537669|NCT00484055|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537670|NCT00484042|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1537671|NCT00484029|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1537672|NCT00484016|||Case-Only||Retrospective|||||||
1537673|NCT00484003|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537674|NCT00483990|Randomized|Parallel Assignment||Treatment||Double||||||
1537675|NCT00483977|Randomized|Parallel Assignment||Treatment||Double||||||
1537676|NCT00483964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537677|NCT00483951|||Case-Only||Prospective|||||||
1537678|NCT00483938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537679|NCT00483925|||Case Control|Screening|Longitudinal, Prospective|||||||
1537680|NCT00483912|Randomized|Crossover Assignment||||Double||||||
1537681|NCT00483899|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1537682|NCT00483886|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537683|NCT00483873|||Case Control||Prospective|||||||
1537684|NCT00483860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537685|NCT00483847|||Cohort||Prospective|||||||
1537686|NCT00483834||Single Group Assignment||Treatment||None (Open Label)||||||
1537687|NCT00483821|||Case Control||Retrospective|||||||
1537688|NCT00483808||Single Group Assignment||||None (Open Label)||||||
1537689|NCT00483795|Randomized|Parallel Assignment||||Single||||||
1537690|NCT00483782|Randomized|||Treatment||None (Open Label)||||||
1537691|NCT00483769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537692|NCT00483756|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537693|NCT00483743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537694|NCT00483730|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537695|NCT00483717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537696|NCT00483704|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537697|NCT00483691|Randomized|Parallel Assignment||Treatment||Single||||t||
1537698|NCT00483678|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1537699|NCT00483665|||Case-Only||Prospective|||||||
1537700|NCT00483652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537701|NCT00483639|||Case Control||Prospective|||||||
1537702|NCT00483626|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537703|NCT00483613|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1537704|NCT00483600|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1537705|NCT00483587|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537706|NCT00483574|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537707|NCT00483561||Single Group Assignment||Treatment||None (Open Label)||||||
1537708|NCT00483548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537709|NCT00483535|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537710|NCT00483522|Randomized|Parallel Assignment||Treatment||Single||||||t
1537711|NCT00483509||Single Group Assignment||Treatment||None (Open Label)||||||
1537712|NCT00483496|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1537713|NCT00483483|Randomized|Parallel Assignment||Prevention||Single||||||t
1537714|NCT00483470|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537715|NCT00483457|||Case-Only||Prospective|||||||
1537716|NCT00483444|Randomized|Parallel Assignment||Treatment||Single||||||t
1537717|NCT00483431|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537718|NCT00483418|||Cohort||Cross-Sectional|||||||
1537719|NCT00483405||Single Group Assignment||Treatment||None (Open Label)||||||
1537720|NCT00483392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537721|NCT00483379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537722|NCT00483366||Single Group Assignment||Treatment||None (Open Label)||||||
1537723|NCT00483353|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537724|NCT00483327||Single Group Assignment||Treatment||None (Open Label)||||||
1537725|NCT00483314|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537726|NCT00483301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537727|NCT00483288||||Health Services Research||||||||
1537728|NCT00483275|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537729|NCT00483262||Single Group Assignment||Treatment||None (Open Label)||||||
1537730|NCT00483249||Single Group Assignment||Treatment||None (Open Label)||||||
1537731|NCT00483236|||Cohort||Prospective|||||||
1537732|NCT00483223||Single Group Assignment||Treatment||None (Open Label)||||||
1537733|NCT00483210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537734|NCT00483197|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537735|NCT00483184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537736|NCT00483171|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537737|NCT00483158|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1537738|NCT00483145|Randomized|Single Group Assignment||||Single||||||
1537739|NCT00483132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537740|NCT00483119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537741|NCT00483106|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1537742|NCT00483093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537743|NCT00483080|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537744|NCT00483067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537745|NCT00483054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537746|NCT00483041|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537747|NCT00483028|Randomized|Parallel Assignment||Treatment||Double||||||
1537748|NCT00483015|||||Retrospective|||||||
1537749|NCT00483002|||Case-Only||Prospective|||||||
1537750|NCT00482989|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1537751|NCT00482976|Randomized|Crossover Assignment||Treatment||Double||||||
1537752|NCT00482963|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537753|NCT00482950|Randomized|Parallel Assignment||Treatment||Double||||||
1537754|NCT00482937|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537755|NCT00482924|||Cohort||Prospective|||||||
1537756|NCT00482911|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537757|NCT00482898|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1537758|NCT00482885|||Cohort||Prospective|||||||
1537759|NCT00482872||||||||||||
1537760|NCT00482859|||Cohort||Prospective|||||||
1537761|NCT00482846||Single Group Assignment||Supportive Care||None (Open Label)||||||
1537762|NCT00482833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537763|NCT00482820|Randomized|Parallel Assignment||Basic Science||Double|||t|t||
1537764|NCT00482807||Single Group Assignment||Treatment||None (Open Label)||||||
1537765|NCT00482794|||Cohort||Other|||||||
1537766|NCT00482781|Randomized|Parallel Assignment||Prevention||Single||||||
1537767|NCT00482768|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1537768|NCT00482755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537769|NCT00482742|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537770|NCT00482729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537771|NCT00482716|Randomized|||Supportive Care||None (Open Label)||||||
1537772|NCT00482703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537773|NCT00482690||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537774|NCT00482677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537775|NCT00482664|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1537776|NCT00482651||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537777|NCT00482638|Randomized|Parallel Assignment||Treatment||Double||||||
1537778|NCT00482625||Single Group Assignment||Treatment||None (Open Label)||||||
1537779|NCT00482612|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537780|NCT00482599|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537781|NCT00482586|||Case Control||Retrospective|||||||
1537782|NCT00482573|Randomized|Parallel Assignment||Treatment||Single|||t|||
1537783|NCT00482560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537784|NCT00482547|Randomized|Parallel Assignment||Treatment||Single||||||t
1537785|NCT00482521||Single Group Assignment||Treatment||None (Open Label)||||||
1537786|NCT00482508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537787|NCT00482495||||Treatment||None (Open Label)||||||
1537788|NCT00482482|Randomized|Crossover Assignment||Treatment||Single||||||t
1537789|NCT00482469|||Cohort||Prospective|||||||
1537790|NCT00482456||Single Group Assignment||Basic Science||None (Open Label)||||||
1537791|NCT00482443|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1537792|NCT00482430|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1537793|NCT00482417|Randomized|Parallel Assignment||Treatment||Double||||||
1537794|NCT00482404|Randomized|Parallel Assignment||Treatment||Single||||||
1537795|NCT00482391||Single Group Assignment||Treatment||None (Open Label)||||||
1537796|NCT00482378||Single Group Assignment||Treatment||None (Open Label)||||||
1537797|NCT00482365|||Case-Only||Cross-Sectional|||||||
1537798|NCT00482352|||Cohort||Prospective|||||||
1537799|NCT00482339|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1537800|NCT00482313|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537801|NCT00482300|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537802|NCT00482287|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537803|NCT00482274||Single Group Assignment||Treatment||None (Open Label)||||||
1537804|NCT00482261||Single Group Assignment||Treatment||None (Open Label)||||||
1537805|NCT00482248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537806|NCT00482235|Randomized|Parallel Assignment||Treatment||Double||||||
1537807|NCT00482222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537808|NCT00482209|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1537809|NCT00482196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537810|NCT00482183|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537811|NCT00482170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537812|NCT00482157|Randomized|Parallel Assignment||Treatment||Double||||||
1537813|NCT00482144|Randomized|Parallel Assignment||Treatment||Single||||||t
1537814|NCT00482118|||Case-Control||Retrospective|||||||
1537815|NCT00482105|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1537816|NCT00482092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537817|NCT00482079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537818|NCT00482066|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1537819|NCT00482053||Single Group Assignment||Treatment||None (Open Label)||||||
1537820|NCT00482040|Randomized|Crossover Assignment||Treatment||Single||||||
1537821|NCT00482027|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1537822|NCT00482014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537823|NCT00482001|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1537824|NCT00481988|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537825|NCT00481975|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537826|NCT00481962|||Cohort||Prospective|||||||
1537827|NCT00481949|||Case Control||Prospective|||||||
1537828|NCT00481936||Single Group Assignment||Health Services Research||None (Open Label)||||||
1537829|NCT00481923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537830|NCT00481897|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537831|NCT00481884|Randomized|Single Group Assignment||Treatment||Single|||||t|
1537832|NCT00481871|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537833|NCT00481858|||Cohort|||||||||
1537834|NCT00481845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537835|NCT00481832||Single Group Assignment||Treatment||None (Open Label)||||||
1537836|NCT00481819|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537837|NCT00481806|||Case-Only||Prospective|||||||
1537838|NCT00481793||||||||||||
1537839|NCT00481780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537840|NCT00481767|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1537841|NCT00481754|||Case-Only||Cross-Sectional|||||||
1537842|NCT00481741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537843|NCT00481728|Randomized|Crossover Assignment||||Double|||t||t|
1537844|NCT00481715|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1537845|NCT00481702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537846|NCT00481689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537847|NCT00481676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537848|NCT00481663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537849|NCT00481650|||||Prospective|||||||
1537850|NCT00481637|||Case-Control||Prospective|||||||
1537851|NCT00481624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537852|NCT00481611|||Other||Cross-Sectional|||||||
1537853|NCT00481598|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1537854|NCT00481585|||Cohort||Prospective|||||||
1537855|NCT00481572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537856|NCT00481559||||||||||||
1537857|NCT00481546||Single Group Assignment||Treatment||None (Open Label)||||||
1537858|NCT00481533|Randomized|Parallel Assignment||Prevention||Double||||||
1537859|NCT00481520|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1537860|NCT00481507|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1537861|NCT00481494|||||Cross-Sectional, Prospective|||||||
1537862|NCT00481481|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537863|NCT00481468|||Cohort||Prospective|||||||
1537864|NCT00481455|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537865|NCT00481442|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537866|NCT00481429||Parallel Assignment||||None (Open Label)||||||
1537867|NCT00481416|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1537868|NCT00481403|||Cohort||Prospective|||||||
1537869|NCT00481390|||Cohort||Prospective|||||||
1537870|NCT00481377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537871|NCT00481364|Randomized|Parallel Assignment||Treatment||Single|||t|||
1537872|NCT00481351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537873|NCT00481338||Single Group Assignment||||None (Open Label)||||||
1537874|NCT00481325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537875|NCT00481312|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537876|NCT00481299|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1537877|NCT00481286|Randomized|Parallel Assignment||Treatment||Single|||t|||
1537878|NCT00481273|||Cohort||Prospective|||||||
1537879|NCT00481260|||Case-Only||Retrospective|||||||
1537880|NCT00481247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537881|NCT00481234|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1537882|NCT00481221|||Other||Retrospective|||||||
1537883|NCT00481208|||Natural History||Cross-Sectional, Prospective|||||||
1537884|NCT00481195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537885|NCT00481182|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537886|NCT00481169|Randomized|Parallel Assignment||Prevention||Double||||||
1537887|NCT00481156|Randomized|Parallel Assignment||Basic Science||Single|Participants were randomized to computer-based cognitive training or active social-skills groups. Healthy controls (n=9) received no treatment.|Randomized, placebo-controlled, single-blind. An untreated healthy control group was also included to examine simple retest effects.|t|||
1537888|NCT00481143||Single Group Assignment||Treatment||None (Open Label)||||||
1537889|NCT00481130|||Family-Based||Other|||||||
1537890|NCT00481117|Randomized|Single Group Assignment||Treatment||Double||||||
1537891|NCT00481104||Single Group Assignment||Treatment||None (Open Label)||||||
1537892|NCT00481091||Single Group Assignment||Treatment||None (Open Label)||||||
1537893|NCT00481078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537894|NCT00481065|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537895|NCT00481052||Single Group Assignment||Treatment||None (Open Label)||||||
1537896|NCT00481039|||Case-Only||Retrospective|||||||
1537897|NCT00481026|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1537898|NCT00481013|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1537899|NCT00481000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537900|NCT00480987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537901|NCT00480974|||Case-Only||Retrospective|||||||
1537902|NCT00480961||Single Group Assignment||Treatment||None (Open Label)||||||
1537903|NCT00480948|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1537904|NCT00480935||Single Group Assignment||Treatment||None (Open Label)||||||
1537905|NCT00480922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537906|NCT00480896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537907|NCT00480883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537908|NCT00480870|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1537909|NCT00480857||Single Group Assignment||Treatment||None (Open Label)||||||
1537910|NCT00480844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537911|NCT00480831|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1537912|NCT00480818|Randomized|Single Group Assignment||Treatment||Double||||||
1537913|NCT00480805|Randomized|Parallel Assignment||Treatment||Double||||||
1537914|NCT00480792|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537915|NCT00480779|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537916|NCT00480766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537917|NCT00480753|Randomized|Crossover Assignment||Treatment||Double||||||
1537918|NCT00480740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537919|NCT00480727|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1537920|NCT00480714||Single Group Assignment||Prevention||None (Open Label)||||||
1537921|NCT00480701||Single Group Assignment||||None (Open Label)||||||
1537922|NCT00480688||Single Group Assignment||Prevention||None (Open Label)||||||
1537923|NCT00480675|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1537924|NCT00480662|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537925|NCT00480649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537926|NCT00480636|||Cohort||Prospective|||||||
1537927|NCT00480623||Single Group Assignment||Treatment||None (Open Label)||||||
1537928|NCT00480610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537929|NCT00480597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537930|NCT00480584||Single Group Assignment||Treatment||None (Open Label)||||||
1537931|NCT00480571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537932|NCT00480558|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537933|NCT00480545|||Case Control||Prospective|||||||
1537934|NCT00480532|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537935|NCT00480519|Randomized|Parallel Assignment||Treatment||Single||||||
1537936|NCT00480506|||||Retrospective|||||||
1537937|NCT00480493|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1537938|NCT00480480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537939|NCT00480467|Randomized|Single Group Assignment||Treatment||Double||||||
1537940|NCT00480454|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537941|NCT00480441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537942|NCT00480428|||||Retrospective|||||||
1537943|NCT00480402|Randomized|Parallel Assignment||Treatment||Double||||||
1537944|NCT00480389||Single Group Assignment||Treatment||None (Open Label)||||||
1537945|NCT00480376|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537946|NCT00480363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537947|NCT00480350|Randomized|Parallel Assignment||Treatment||Double||||||
1537948|NCT00480337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537949|NCT00480324|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1537950|NCT00480311|||||Cross-Sectional|||||||
1537951|NCT00480298|Randomized|Single Group Assignment||Treatment||Double||||||
1537952|NCT00480285|Randomized|Parallel Assignment||Treatment||Double||||||
1537953|NCT00480272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537954|NCT00480259|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1537955|NCT00480246|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1537956|NCT00480233|||Case-Only||Prospective|||||||
1537957|NCT00480220|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1537958|NCT00480207|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1537959|NCT00480194|||Case-Only||Prospective|||||||
1537960|NCT00480181|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537961|NCT00480168|||Cohort||Prospective|||||||
1537962|NCT00480155|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1537963|NCT00480142|Randomized|Parallel Assignment||Treatment||Double||||||
1537964|NCT00480129|Non-Randomized|Parallel Assignment||Supportive Care||Double||||||
1537965|NCT00480116|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537966|NCT00480103|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1537967|NCT00480090|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537968|NCT00480077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537969|NCT00480064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537970|NCT00480051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537971|NCT00480038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1537972|NCT00480025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537973|NCT00480012|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1537974|NCT00479999|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1537975|NCT00479986|Randomized|Parallel Assignment||Treatment||Double||||||
1537976|NCT00479973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537977|NCT00479960|Randomized|Crossover Assignment||Treatment||Double||||||
1537978|NCT00479947|Randomized|Crossover Assignment||Prevention||Double||||||
1537979|NCT00479934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537980|NCT00479921|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1537981|NCT00479908|Randomized|Crossover Assignment||Treatment||Double||||||
1537982|NCT00479895|Randomized|Crossover Assignment||Treatment||Single|||t|||
1537983|NCT00479882|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1537984|NCT00479856||Single Group Assignment||Treatment||None (Open Label)||||||
1537985|NCT00479843|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1537986|NCT00479830|||Ecologic or Community||Prospective|||||||
1537987|NCT00479817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537988|NCT00479804|||Cohort||Prospective|||||||
1537989|NCT00479791|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1537990|NCT00479778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537991|NCT00479765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537992|NCT00479752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1537993|NCT00479739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537994|NCT00479726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1537995|NCT00479713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1537996|NCT00479700|Randomized|Single Group Assignment||Treatment||Double||||||
1537997|NCT00479687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1537998|NCT00479674||Single Group Assignment||Treatment||None (Open Label)||||||
1537999|NCT00479661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538000|NCT00479648|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1538001|NCT00479635||Single Group Assignment||Treatment||None (Open Label)||||||
1538002|NCT00479622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538003|NCT00479609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538004|NCT00479596|Randomized|Parallel Assignment||Treatment||Double||||||
1538005|NCT00479583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538006|NCT00479570|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1538007|NCT00479557|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538008|NCT00479531|Randomized|Parallel Assignment||Treatment||Double||||||
1538009|NCT00479518|||Cohort||Prospective|||||||
1538010|NCT00479505|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538011|NCT00479492|Randomized|Parallel Assignment||Treatment||Double||||||
1538012|NCT00479479|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1538013|NCT00479466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538014|NCT00479440|Randomized|Single Group Assignment||Treatment||Double||||||
1538015|NCT00479427|Randomized|Crossover Assignment||Treatment||||||||
1538016|NCT00479401|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538017|NCT00479388|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538018|NCT00479375|Randomized|Parallel Assignment||Screening||Double||||||
1538019|NCT00479362|Randomized|Parallel Assignment||Treatment||Single||||t||
1538020|NCT00479349|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1538021|NCT00479336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538022|NCT00479323|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1538023|NCT00479310|Randomized|Parallel Assignment||Treatment||Double||||||
1538024|NCT00479297|Randomized|Single Group Assignment||Treatment||Double||||||
1538025|NCT00479284|Non-Randomized|Crossover Assignment||Supportive Care||Single||||||
1538026|NCT00479271|Randomized|Crossover Assignment||Supportive Care||Single||||||
1538027|NCT00479258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538028|NCT00479245||Single Group Assignment||Diagnostic||None (Open Label)||||||
1538029|NCT00479232|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538030|NCT00479219|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1538031|NCT00479206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538032|NCT00479193||Single Group Assignment||Treatment||None (Open Label)||||||
1538033|NCT00479180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538034|NCT00479167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538035|NCT00479154|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1538036|NCT00479141|Randomized|Parallel Assignment||||None (Open Label)||||||
1538037|NCT00479128||Single Group Assignment||Treatment||None (Open Label)||||||
1538038|NCT00479115|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1538039|NCT00479102|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1538040|NCT00479089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538041|NCT00479076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538042|NCT00479063|||Case Control||Cross-Sectional|||||||
1538043|NCT00479050|Randomized|Single Group Assignment||Treatment||Single||||||
1538044|NCT00479037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538045|NCT00479024|||Case-Only||Retrospective|||||||
1538046|NCT00479011|Randomized|Parallel Assignment||Supportive Care||Single||||||
1538047|NCT00478998|Randomized|Parallel Assignment||Treatment||Double||||||
1538048|NCT00478985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538049|NCT00478972|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538050|NCT00478959||Single Group Assignment||Treatment||None (Open Label)||||||
1538051|NCT00478946|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538052|NCT00478933||Single Group Assignment||Diagnostic||Triple|patients and investigators were blinded to the genetic markers during the study. Therefore, no arm is specified as this is not applicable.||t|t|t|
1538053|NCT00478907|Randomized|Parallel Assignment||Prevention||Double||||||
1538054|NCT00478894|||Cohort||Prospective|||||||
1538055|NCT00478881|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538056|NCT00478868|||||Cross-Sectional|||||||
1538057|NCT00478855|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1538058|NCT00478842|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538059|NCT00478829|||||Prospective|||||||
1538060|NCT00478816|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1538061|NCT00478803|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538062|NCT00478790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538063|NCT00478777||Single Group Assignment||Treatment||None (Open Label)||||||
1538064|NCT00478764|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538065|NCT00478751|||Cohort||Prospective|||||||
1538066|NCT00478738||Single Group Assignment||Treatment||Double||||||
1538067|NCT00478725|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538068|NCT00478712|||Family-Based||Prospective|||||||
1538069|NCT00478699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538070|NCT00478686|||Case-Control||Retrospective|||||||
1538071|NCT00478673||Single Group Assignment||Treatment||None (Open Label)||||||
1538072|NCT00478660|Randomized|Single Group Assignment||Treatment||Double||||||
1538073|NCT00478647|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538074|NCT00478634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538075|NCT00478621|Randomized|Parallel Assignment||Prevention||Single|||t|||
1538076|NCT00478608|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1538077|NCT00478595|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538078|NCT00478582||Single Group Assignment||Diagnostic||Double||||||
1538079|NCT00478569|||Case-Only||Prospective|||||||
1538080|NCT00478556|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1538081|NCT00478543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538082|NCT00478530|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538083|NCT00478517|Randomized|Single Group Assignment||Treatment||Double||||||
1538084|NCT00478504|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1538085|NCT00478491|||Case Control||Prospective|||||||
1538086|NCT00478478|||Cohort||Prospective|||||||
1538087|NCT00478465|Randomized|Parallel Assignment||Treatment||Double||||||
1538088|NCT00478452|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538089|NCT00478439|Randomized|Parallel Assignment||||Double|||t||t|
1538090|NCT00478426||Single Group Assignment||Treatment||None (Open Label)||||||
1538091|NCT00478400|||Case-Control||Cross-Sectional|||||||
1538092|NCT00478387|||Cohort||Prospective|||||||
1538093|NCT00478374||Single Group Assignment||Treatment||None (Open Label)||||||
1538094|NCT00478361||Single Group Assignment||Treatment||None (Open Label)||||||
1538095|NCT00478348|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538096|NCT00478335|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1538097|NCT00478322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538098|NCT00478309|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538099|NCT00478296|||||Retrospective|||||||
1538100|NCT00478283||||Health Services Research||||||||
1538101|NCT00478270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538102|NCT00478257|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1538103|NCT00478244||Single Group Assignment||Treatment||None (Open Label)||||||
1538104|NCT00478231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538105|NCT00478218||Single Group Assignment||Treatment||None (Open Label)||||||
1538106|NCT00478205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538107|NCT00478192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538108|NCT00478179|Randomized|Crossover Assignment||Treatment||Double||||||
1538109|NCT00478166|||Cohort||Cross-Sectional|||||||
1538110|NCT00478140||Single Group Assignment||Treatment||None (Open Label)||||||
1538111|NCT00478127|Random Sample||||Cross-Sectional, Retrospective|||||||
1538112|NCT00478114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538113|NCT00478101|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1538114|NCT00478088|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538115|NCT00478075||||Treatment||None (Open Label)||||||
1538116|NCT00478062||Single Group Assignment||Treatment||None (Open Label)||||||
1538117|NCT00478049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538118|NCT00478036|Randomized|Parallel Assignment||Treatment||Single|||||t|
1538119|NCT00478023|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538120|NCT00478010||||Health Services Research||None (Open Label)||||||
1538121|NCT00477997|Randomized|Factorial Assignment||Basic Science||Single|||t|||
1538122|NCT00477984|Randomized|Single Group Assignment||Basic Science||Single|||t|||
1538123|NCT00477971|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538124|NCT00477958||Single Group Assignment||Health Services Research||None (Open Label)||||||
1538125|NCT00477945||Single Group Assignment||Treatment||None (Open Label)||||||
1538126|NCT00477932|||||Prospective|||||||
1538127|NCT00477919||||||||||||
1538128|NCT00477906|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538129|NCT00477893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538130|NCT00477880||Single Group Assignment||Treatment||None (Open Label)||||||
1538131|NCT00477867||||Health Services Research||||||||
1538132|NCT00477854|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538133|NCT00477841|Randomized|Single Group Assignment||Treatment||Single||||||
1538134|NCT00477828|Randomized|Crossover Assignment||Supportive Care||Single||||||
1538135|NCT00477815||Single Group Assignment||Treatment||None (Open Label)||||||
1538136|NCT00477802|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1538137|NCT00477789|Randomized|Parallel Assignment||Treatment||Double||||||
1538138|NCT00477776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538139|NCT00477763|Randomized|Parallel Assignment||||Double|||t||t|
1538140|NCT00477750||Single Group Assignment||Treatment||None (Open Label)||||||
1538141|NCT00477737|Randomized|Parallel Assignment||Treatment||Single||||||
1538142|NCT00477724|Randomized|Parallel Assignment||Treatment||Single|||||t|
1538143|NCT00477711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538144|NCT00477685|||Case-Only||Prospective|||||||
1538145|NCT00477672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538146|NCT00477659|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538147|NCT00477646|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1538148|NCT00477633|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1538149|NCT00477620|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538150|NCT00477607|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1538151|NCT00477594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538152|NCT00477581|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1538153|NCT00477568|||||Cross-Sectional|||||||
1538154|NCT00477555|||Cohort||Prospective|||||||
1538155|NCT00477542||Single Group Assignment||Treatment||None (Open Label)||||||
1538156|NCT00477529||Single Group Assignment||Treatment||None (Open Label)||||||
1538157|NCT00477516||Crossover Assignment||Basic Science||None (Open Label)||||||
1538158|NCT00477503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538159|NCT00477490|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538160|NCT00477477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538161|NCT00477464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538162|NCT00477451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538163|NCT00477425|||||Prospective|||||||
1538164|NCT00477412||Single Group Assignment||Treatment||None (Open Label)||||||
1538165|NCT00477399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538166|NCT00477386||Single Group Assignment||Treatment||None (Open Label)||||||
1538167|NCT00477373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538168|NCT00477360||Single Group Assignment||Treatment||Single||||||t
1538169|NCT00477347|Randomized|Parallel Assignment||Treatment||Single|||t|||
1538170|NCT00477334|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538171|NCT00477321|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538172|NCT00477308|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1538173|NCT00477295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538174|NCT00477282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538175|NCT00477269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538176|NCT00477256|||||Prospective|||||||
1538177|NCT00477243|||Cohort||Prospective|||||||
1538178|NCT00477230|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538179|NCT00477217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538180|NCT00477204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538181|NCT00477191||Single Group Assignment||Prevention||None (Open Label)||||||
1538182|NCT00477178|||Case Control||Cross-Sectional|||||||
1538183|NCT00477165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538184|NCT00477152||Single Group Assignment||Treatment||None (Open Label)||||||
1538185|NCT00477139|||||Retrospective|||||||
1538186|NCT00477126|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1538187|NCT00477113|||Cohort||Prospective|||||||
1538188|NCT00477100|||Case-Control||Prospective|||||||
1538189|NCT00477087||Single Group Assignment||Treatment||None (Open Label)||||||
1538190|NCT00477074|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1538191|NCT00477061|Randomized|Parallel Assignment||Supportive Care||Double||||||
1538192|NCT00477048||Single Group Assignment||Treatment||None (Open Label)||||||
1538193|NCT00477035||Single Group Assignment||Prevention||None (Open Label)||||||
1538194|NCT00477022|Randomized|Single Group Assignment||Treatment||Single||||||
1538195|NCT00477009|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538196|NCT00476996|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538197|NCT00476983|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538198|NCT00476970|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1538199|NCT00476957|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1538200|NCT00476944|Randomized|Parallel Assignment||||None (Open Label)||||||
1538201|NCT00476931|Randomized|Parallel Assignment||Treatment||Single|||||t|
1538202|NCT00476918|Randomized|Single Group Assignment||Treatment||Double||||||
1538203|NCT00476905|||Case-Control||Prospective|||||||
1538204|NCT00476892|Randomized|Parallel Assignment||Treatment||Single|||||t|
1538205|NCT00476879|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1538206|NCT00476866|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538207|NCT00476853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538208|NCT00476827|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538209|NCT00476814|||||Prospective|||||||
1538210|NCT00476801|Randomized|Crossover Assignment||Treatment||Single||||||t
1538211|NCT00476788||Single Group Assignment||Treatment||None (Open Label)||||||
1538212|NCT00476775|Randomized|Parallel Assignment||Prevention||Single||||||t
1538213|NCT00476736|Randomized|Crossover Assignment||Treatment||Single||||||
1538214|NCT00476723|||Case-Only||Prospective|||||||
1538215|NCT00476710|||Case Control||Retrospective|||||||
1538216|NCT00476697||Single Group Assignment||Treatment||None (Open Label)||||||
1538217|NCT00476684|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1538218|NCT00476671|||Cohort||Cross-Sectional|||||||
1538219|NCT00476658|||Cohort||Prospective|||||||
1538220|NCT00476645||Single Group Assignment||Treatment||None (Open Label)||||||
1538221|NCT00476632|||Case-Control||Prospective|||||||
1538222|NCT00476619|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538223|NCT00476606|||Cohort||Prospective|||||||
1538224|NCT00476593|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1538225|NCT00476580|||Ecologic or Community||Prospective|||||||
1538226|NCT00476567|Randomized|Parallel Assignment||Prevention||Single||||||t
1538227|NCT00476554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538228|NCT00476541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538229|NCT00476528|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1538230|NCT00476515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538231|NCT00476502|||Cohort||Cross-Sectional|||||||
1538232|NCT00476489|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1538233|NCT00476476||Single Group Assignment||Treatment||None (Open Label)||||||
1538234|NCT00476463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538235|NCT00476450|||Other||Prospective|||||||
1538236|NCT00476437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538237|NCT00476424|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538238|NCT00476411|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538239|NCT00476398|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1538240|NCT00476385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538241|NCT00476372|||Cohort||Cross-Sectional|||||||
1538242|NCT00476359||Single Group Assignment||Treatment||None (Open Label)||||||
1538243|NCT00476346|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1538244|NCT00476333||Single Group Assignment||Basic Science||None (Open Label)||||||
1538245|NCT00476320|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1538246|NCT00476307|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538247|NCT00476294|||Case Control||Prospective|||||||
1538248|NCT00476281||Single Group Assignment||Basic Science||None (Open Label)||||||
1538249|NCT00476268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538250|NCT00476255|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1538251|NCT00476242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538252|NCT00476229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538253|NCT00476216||Single Group Assignment||Treatment||None (Open Label)||||||
1538254|NCT00476203|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1538255|NCT00476190|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538256|NCT00476177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538257|NCT00476164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538258|NCT00476151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538259|NCT00476138|Randomized|Crossover Assignment||Supportive Care||Double||||||
1538260|NCT00476125|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1538261|NCT00476112|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538262|NCT00476099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538263|NCT00476086||Single Group Assignment||Treatment||None (Open Label)||||||
1538264|NCT00476073|Randomized|Parallel Assignment||||None (Open Label)||||||
1538265|NCT00476060|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1538266|NCT00476047||Single Group Assignment||Treatment||None (Open Label)||||||
1538267|NCT00476034|Randomized|Parallel Assignment||Treatment||Double||||||
1538268|NCT00476021|Randomized|Parallel Assignment||Treatment||Single|||||t|
1538269|NCT00476008|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538270|NCT00475982|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1538271|NCT00475969|Randomized|Parallel Assignment||Treatment||Double||||||
1538272|NCT00475956|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538273|NCT00475943|||||Prospective|||||||
1538274|NCT00475930|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538275|NCT00475917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538276|NCT00475904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538277|NCT00475891|||Cohort||Retrospective|||||||
1538278|NCT00475878|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538279|NCT00475865|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538280|NCT00475852|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538281|NCT00475839|Randomized|Parallel Assignment||Treatment||Single||||||
1538282|NCT00475826|Randomized|Crossover Assignment||||Single||||||
1538283|NCT00475813|Randomized|Parallel Assignment||||None (Open Label)||||||
1538284|NCT00475800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538285|NCT00475787|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1538286|NCT00475774|Randomized|Crossover Assignment||Basic Science||Double||||||
1538287|NCT00475761|||Cohort||Prospective|||||||
1538288|NCT00475748|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538289|NCT00475735|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1538290|NCT00475722|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538291|NCT00475709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538292|NCT00475696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538293|NCT00475683|Randomized|Crossover Assignment||Treatment||Single||||||t
1538294|NCT00475670|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538295|NCT00475657|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538296|NCT00475644||Single Group Assignment||Treatment||None (Open Label)||||||
1538297|NCT00475631|||Case-Only||Retrospective|||||||
1538298|NCT00475618|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538299|NCT00475605|||Cohort||Prospective|||||||
1538300|NCT00475592|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1538301|NCT00475579|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538302|NCT00475566|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538303|NCT00475553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538304|NCT00475540|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1538305|NCT00475527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538306|NCT00475514|Randomized|Parallel Assignment||||Double||||||
1538307|NCT00475501|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1538308|NCT00475488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538309|NCT00475475|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1538310|NCT00475462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538311|NCT00475449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538312|NCT00475436|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538313|NCT00475423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538314|NCT00475410|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1538315|NCT00475397|Randomized|Parallel Assignment||Treatment||Double||||||
1538316|NCT00475384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538317|NCT00475371|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538318|NCT00475358|Randomized|Parallel Assignment||Treatment||Double||||||
1538319|NCT00475345|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1538320|NCT00475332||Single Group Assignment||Treatment||None (Open Label)||||||
1538321|NCT00475319|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538322|NCT00475306|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1538323|NCT00475293||Single Group Assignment||Treatment||None (Open Label)||||||
1538324|NCT00475280||Single Group Assignment||Treatment||None (Open Label)||||||
1538325|NCT00475267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538326|NCT00475254|||Cohort||Prospective|||||||
1538327|NCT00475241|Randomized|Parallel Assignment||Treatment||Single||||||t
1538328|NCT00475228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538329|NCT00475215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538330|NCT00475202|||Defined Population||Longitudinal, Prospective|||||||
1538331|NCT00475189|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538332|NCT00475176||Single Group Assignment||Treatment||None (Open Label)||||||
1538333|NCT00475163|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538334|NCT00475150||Single Group Assignment||Treatment||None (Open Label)||||||
1538335|NCT00475137|Randomized|Parallel Assignment||Treatment||Single|||t|||
1538336|NCT00475124|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1538337|NCT00475111|Randomized|Parallel Assignment||Treatment||Double||||||
1538338|NCT00475098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538339|NCT00475085|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1538340|NCT00475072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538341|NCT00475059||Single Group Assignment||Diagnostic||None (Open Label)||||||
1538342|NCT00475046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538343|NCT00475033|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1538344|NCT00475020||Single Group Assignment||Treatment||None (Open Label)||||||
1538345|NCT00475007|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1538346|NCT00474994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538347|NCT00474981|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1538348|NCT00474968|||Case Control||Prospective|||||||
1538349|NCT00474955||Single Group Assignment||Treatment||None (Open Label)||||||
1538350|NCT00474942|||Cohort||Prospective|||||||
1538351|NCT00474929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538352|NCT00474916|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538353|NCT00474903|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1538354|NCT00474890|Randomized|Crossover Assignment||Treatment||Double||||||
1538355|NCT00474877|Randomized|Parallel Assignment||Health Services Research||Single||||||
1538356|NCT00474864|Randomized|Parallel Assignment||Treatment||Double||||||
1538357|NCT00474851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538358|NCT00474838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538359|NCT00474825|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538360|NCT00474812||Single Group Assignment||Treatment||None (Open Label)||||||
1538361|NCT00474799|Randomized|Crossover Assignment||||None (Open Label)||||||
1538362|NCT00474786|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538363|NCT00474773|||Cohort||Prospective|||||||
1538364|NCT00474760|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538365|NCT00474747||Single Group Assignment||Treatment||None (Open Label)||||||
1538366|NCT00474734|||Defined Population|Screening|Longitudinal, Prospective|||||||
1538367|NCT00474721|Randomized|Parallel Assignment||Treatment||Double||||||
1538368|NCT00474708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538369|NCT00474695|||||Prospective|||||||
1538370|NCT00474682|Randomized|Crossover Assignment||Basic Science||Single||||||
1538371|NCT00474669|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538372|NCT00474656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538373|NCT00474643|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1538374|NCT00474630|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538375|NCT00474617|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538376|NCT00474604|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1538377|NCT00474591|Randomized|Parallel Assignment||Treatment||Double||||||
1538378|NCT00474565|Non-Randomized|Single Group Assignment||Diagnostic||Double|||||t|t
1538379|NCT00474552|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1538380|NCT00474539|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1538381|NCT00474526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538382|NCT00474513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538383|NCT00474500||Crossover Assignment||Basic Science||None (Open Label)||||||
1538384|NCT00474487|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538385|NCT00474474|Randomized|Single Group Assignment||||Double||||||
1538386|NCT00474461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538387|NCT00474448|||Case-Only|||||||||
1538388|NCT00474435||Single Group Assignment||Treatment||None (Open Label)||||||
1538389|NCT00474422|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538390|NCT00474409|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538391|NCT00474396|Randomized|Parallel Assignment||Basic Science||Double||||||
1538392|NCT00474383||Single Group Assignment||Treatment||None (Open Label)||||||
1538393|NCT00474370|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538394|NCT00474357||Parallel Assignment||Supportive Care||None (Open Label)||||||
1538395|NCT00474344|||Cohort||Retrospective|||||||
1538396|NCT00474331|||Case-Only||Retrospective|||||||
1538397|NCT00474318|||Other||Prospective|||||||
1538398|NCT00474305||Single Group Assignment||Treatment||None (Open Label)||||||
1538399|NCT00474292|||||Other|||||||
1538400|NCT00474279|Randomized|Crossover Assignment||Treatment||Double||||||
1538401|NCT00474266|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538402|NCT00474253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538403|NCT00474240|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538404|NCT00474227|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1538405|NCT00474214|Randomized|Parallel Assignment||Health Services Research||Double|||||t|t
1538406|NCT00474201|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1538407|NCT00474188|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538408|NCT00474175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538409|NCT00474162|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538410|NCT00474136|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538411|NCT00474123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538412|NCT00474110|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538413|NCT00474097|||Case-Only||Prospective|||||||
1538414|NCT00474084|Randomized|Parallel Assignment||Treatment||Double||||||
1538415|NCT00474071|Non-Randomized|Crossover Assignment||Treatment||Double|||t||t|
1538416|NCT00474058|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538417|NCT00474045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538418|NCT00474032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538419|NCT00474019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538420|NCT00474006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538421|NCT00473993|||||Retrospective|||||||
1538422|NCT00473980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538423|NCT00473967|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1538424|NCT00473954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538425|NCT00473941|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1538426|NCT00473928|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1538427|NCT00473915|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1538428|NCT00473902|Randomized|Parallel Assignment||Prevention||Double||||||
1538429|NCT00473889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538430|NCT00473876|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538431|NCT00473863|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1538432|NCT00473850|||Case-Only||Retrospective|||||||
1538433|NCT00473837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538434|NCT00473824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538435|NCT00473811|Randomized|Parallel Assignment||Treatment||Single||||||t
1538436|NCT00473798|||Other||Prospective|||||||
1538437|NCT00473785|Randomized|Parallel Assignment||Prevention||Single||||||
1538438|NCT00473772|Randomized|Parallel Assignment||Treatment||Single|||t|||
1538439|NCT00473746|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538440|NCT00473733|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1538441|NCT00473720||Single Group Assignment||Treatment||None (Open Label)||||||
1538442|NCT00473707|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538443|NCT00473694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538444|NCT00473681|Randomized|Parallel Assignment||Treatment||Single||||||
1538445|NCT00473668|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1538446|NCT00473655|Randomized|Parallel Assignment||Treatment||Double||||||
1538447|NCT00473642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538448|NCT00473616|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538449|NCT00473603|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538450|NCT00473590|Randomized|Parallel Assignment||Treatment||Single|||||t|
1538451|NCT00473577|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538452|NCT00473564||Single Group Assignment||Treatment||None (Open Label)||||||
1538453|NCT00473551||Single Group Assignment||Treatment||None (Open Label)||||||
1538454|NCT00473538|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538455|NCT00473525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538456|NCT00473512||Single Group Assignment||Treatment||None (Open Label)||||||
1538457|NCT00473499|Randomized|Parallel Assignment||Treatment||Single|||t|||
1538458|NCT00473486|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538459|NCT00473473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538460|NCT00473460|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538461|NCT00473447|Randomized|Crossover Assignment||Treatment||Single||||||
1538462|NCT00473434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538463|NCT00473421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538464|NCT00473408|||Cohort||Prospective|||||||
1538465|NCT00473382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538466|NCT00473369|||Case Control, Natural History||Cross-Sectional, Retrospective|||||||
1538467|NCT00473356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538468|NCT00473343||Single Group Assignment||Treatment||None (Open Label)||||||
1538469|NCT00473330|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538470|NCT00473317||Single Group Assignment||Treatment||None (Open Label)||||||
1538471|NCT00473304|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1538472|NCT00473291|||Cohort||Prospective|||||||
1538473|NCT00473278|||Cohort||Prospective|||||||
1538474|NCT00473265||Single Group Assignment||Treatment||None (Open Label)||||||
1538475|NCT00473252|||Cohort||Prospective|||||||
1538476|NCT00473239|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538477|NCT00473213|Randomized|Parallel Assignment||Treatment||Single||||||
1538478|NCT00473200|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1538479|NCT00473187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538480|NCT00473174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538481|NCT00473161|||Cohort||Prospective|||||||
1538482|NCT00473148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538483|NCT00473135|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1538484|NCT00473122||Single Group Assignment||Treatment||None (Open Label)||||||
1538485|NCT00473109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538486|NCT00473096||Single Group Assignment||Health Services Research||None (Open Label)||||||
1538487|NCT00473083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538488|NCT00473070|Randomized|Parallel Assignment||Treatment||Double||||||
1538489|NCT00473057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538490|NCT00473044|Randomized|Parallel Assignment||Treatment||Single||||||
1538491|NCT00473031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538492|NCT00473018|Randomized|Single Group Assignment||Basic Science||Double||||||
1538493|NCT00473005|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538494|NCT00472992|||Cohort||Prospective|||||||
1538495|NCT00472966|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538496|NCT00472953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538497|NCT00472940|||||Cross-Sectional|||||||
1538498|NCT00472927|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538499|NCT00472914|||||Prospective|||||||
1538500|NCT00472901|||||Prospective|||||||
1538501|NCT00472888|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1538502|NCT00472875|Randomized|Single Group Assignment||Treatment||Double||||||
1538503|NCT00472862|Randomized|Parallel Assignment||Treatment||Single||||||t
1538504|NCT00472849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538505|NCT00472836|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538506|NCT00472823|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538507|NCT00472810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538508|NCT00472797|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1538509|NCT00472784|||Cohort||Prospective|||||||
1538510|NCT00472771|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538511|NCT00472758|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1538512|NCT00472745|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538513|NCT00472732|||Cohort||Prospective|||||||
1538514|NCT00472719|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1538515|NCT00472706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538516|NCT00472693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538517|NCT00472680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538518|NCT00472667|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1538519|NCT00472654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538520|NCT00472641||Single Group Assignment||Treatment||None (Open Label)||||||
1538521|NCT00472628|||||Prospective|||||||
1538522|NCT00472615|||Cohort||Prospective|||||||
1538523|NCT00472602|||||Prospective|||||||
1538524|NCT00472589|||||Prospective|||||||
1538525|NCT00472576|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1538526|NCT00472563|Randomized|Parallel Assignment||Prevention||Single||||||
1538527|NCT00472550|Randomized|Crossover Assignment||Treatment||Double||||||
1538528|NCT00472537|||Case Control||Prospective|||||||
1538529|NCT00472524|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1538530|NCT00472511|||||Prospective|||||||
1538531|NCT00472498|||Case Control||Prospective|||||||
1538532|NCT00472485|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538533|NCT00472472|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538534|NCT00472459|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538535|NCT00472446|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1538536|NCT00472433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538537|NCT00472420||Single Group Assignment||Treatment||None (Open Label)||||||
1538538|NCT00472407|||Ecologic or Community||Cross-Sectional|||||||
1538539|NCT00472394|||||Cross-Sectional, Prospective|||||||
1538540|NCT00472381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538541|NCT00472368||Single Group Assignment||Treatment||None (Open Label)||||||
1538542|NCT00472355|Randomized|Crossover Assignment||Treatment||Double||||||
1538543|NCT00472342||Single Group Assignment||Prevention||None (Open Label)||||||
1538544|NCT00472329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538545|NCT00472316|||Cohort||Prospective|||||||
1538546|NCT00472303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538547|NCT00472290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538548|NCT00472264|||Case Control||Prospective|||||||
1538549|NCT00472251|||Cohort||Prospective|||||||
1538550|NCT00472238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538551|NCT00472225|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538552|NCT00472212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538553|NCT00472199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538554|NCT00472186|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538555|NCT00472173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538556|NCT00472160|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538557|NCT00472147|Randomized|Parallel Assignment||Treatment||Double||||||
1538558|NCT00472134|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1538559|NCT00472121||||||||||||
1538560|NCT00472108|Randomized|Parallel Assignment||Treatment||Double||||||
1538561|NCT00472095|Randomized|Parallel Assignment||||Single|||||t|
1538562|NCT00472082||Single Group Assignment||Treatment||None (Open Label)||||||
1538563|NCT00472069|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538564|NCT00472056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538565|NCT00472043|Randomized|Parallel Assignment||Treatment||Double||||||
1538566|NCT00472030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538567|NCT00472017||Single Group Assignment||Treatment||None (Open Label)||||||
1538568|NCT00472004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538569|NCT00471991|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538570|NCT00471978|||Cohort||Retrospective|||||||
1538571|NCT00471965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538572|NCT00471952|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1538573|NCT00471939|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538574|NCT00471926|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1538575|NCT00471913|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538576|NCT00471900|Randomized|Crossover Assignment||Treatment||Double||||||
1538577|NCT00471887||Single Group Assignment||Treatment||None (Open Label)||||||
1538578|NCT00471874|||||Retrospective|||||||
1538579|NCT00471861|||Case-Crossover||Prospective|||||||
1538580|NCT00471848||Single Group Assignment||Treatment||None (Open Label)||||||
1538581|NCT00471835||||Treatment||None (Open Label)||||||
1538582|NCT00471822|||Cohort||Prospective|||||||
1538583|NCT00471809|Randomized|Parallel Assignment||Treatment||Double||||||
1538584|NCT00471796||Single Group Assignment||Treatment||None (Open Label)||||||
1538585|NCT00471783|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1538586|NCT00471770|||||Prospective|||||||
1538587|NCT00471757|||Cohort||Retrospective|||||||
1538588|NCT00471744|Randomized|Parallel Assignment||Treatment||Double||||||
1538589|NCT00471731|||||Prospective|||||||
1538590|NCT00471718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538591|NCT00471705|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538592|NCT00471692|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1538593|NCT00471679|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1538594|NCT00471666|||||Prospective|||||||
1538595|NCT00471653|||Other||Prospective|||||||
1538596|NCT00471640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538597|NCT00471627||Single Group Assignment||Treatment||None (Open Label)||||||
1538598|NCT00471614|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538599|NCT00471601||Single Group Assignment||Health Services Research||None (Open Label)||||||
1538600|NCT00471588|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1538601|NCT00471575|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1538602|NCT00471562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538603|NCT00471549|Randomized|Parallel Assignment||Treatment||Double||||||
1538604|NCT00471536||Single Group Assignment||Treatment||None (Open Label)||||||
1538605|NCT00471523|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538606|NCT00471510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538607|NCT00471497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538608|NCT00471484||||Treatment||None (Open Label)||||||
1538609|NCT00471471||Single Group Assignment||Treatment||None (Open Label)||||||
1538610|NCT00471458|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1538611|NCT00471445|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1538612|NCT00471432||||Treatment||None (Open Label)||||||
1538613|NCT00471419|Randomized|Parallel Assignment||Treatment||Double||||||
1538614|NCT00471406|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538615|NCT00471393|Randomized|Parallel Assignment||Treatment||Double||||||
1538616|NCT00471380|Randomized|Crossover Assignment||Treatment||Double||||||
1538617|NCT00471367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538618|NCT00471354||Single Group Assignment||Treatment||None (Open Label)||||||
1538619|NCT00471341|Randomized|Parallel Assignment||Treatment||Double||||||
1538620|NCT00471328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538621|NCT00471315||Single Group Assignment||Treatment||None (Open Label)||||||
1538622|NCT00471302|||Cohort||Cross-Sectional|||||||
1538623|NCT00471289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538624|NCT00471276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538625|NCT00471263|Randomized|Crossover Assignment||Treatment||Double||||||
1538626|NCT00471250|||||Prospective|||||||
1538627|NCT00471237|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538628|NCT00471224|||Case-Only||Prospective|||||||
1538629|NCT00471211|Randomized|Parallel Assignment||Treatment||Double||||||
1538630|NCT00471185|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538631|NCT00471172|Randomized|Parallel Assignment||||None (Open Label)||||||
1538632|NCT00471159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538633|NCT00471146|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538634|NCT00471133||Single Group Assignment||Treatment||None (Open Label)||||||
1538635|NCT00471120||Single Group Assignment||Screening||None (Open Label)||||||
1538636|NCT00471107|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1538637|NCT00471094|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538638|NCT00471081|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538639|NCT00471068|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538640|NCT00471055|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1538641|NCT00471042|||Other||Prospective|||||||
1538642|NCT00471029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538643|NCT00471016|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1538644|NCT00471003|||Cohort||Prospective|||||||
1538645|NCT00470990||Crossover Assignment||||None (Open Label)||||||
1538646|NCT00470977||Single Group Assignment||Treatment||None (Open Label)||||||
1538647|NCT00470964|Randomized|Parallel Assignment||||Double||||||
1538648|NCT00470951|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538649|NCT00470938|Randomized|Parallel Assignment||||None (Open Label)||||||
1538650|NCT00470925|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1538651|NCT00470912|Randomized|Parallel Assignment||Prevention||Double||||||
1538652|NCT00470899|Randomized|Parallel Assignment||Treatment||Double||||||
1538653|NCT00470886|||Cohort||Prospective|||||||
1538654|NCT00470873|||Cohort||Prospective|||||||
1538655|NCT00470860|Randomized|Parallel Assignment||||None (Open Label)||||||
1538656|NCT00470847||Single Group Assignment||Treatment||None (Open Label)||||||
1538657|NCT00470834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538658|NCT00470821|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1538659|NCT00470808|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538660|NCT00470795|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1538661|NCT00470782|||Case-Only|||||||||
1538662|NCT00470769|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1538663|NCT00470756|||Cohort||Prospective|||||||
1538664|NCT00470743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538665|NCT00470717||Single Group Assignment||Prevention||None (Open Label)||||||
1538666|NCT00470704||Single Group Assignment||Treatment||None (Open Label)||||||
1538667|NCT00470691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538668|NCT00470678||Single Group Assignment||Treatment||None (Open Label)||||||
1538669|NCT00470665|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1538670|NCT00470652|||||Prospective|||||||
1538671|NCT00470639|Randomized|Parallel Assignment||Treatment||Double||||||
1538672|NCT00470626||Single Group Assignment||Treatment||None (Open Label)||||||
1538673|NCT00470613||Single Group Assignment||Treatment||None (Open Label)||||||
1538674|NCT00470600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538675|NCT00470587|||Cohort||Prospective|||||||
1538676|NCT00470574||Single Group Assignment||Treatment||None (Open Label)||||||
1538677|NCT00470561|Randomized|Parallel Assignment||||Triple|||t|t|t|
1538678|NCT00470548|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538679|NCT00470535||Single Group Assignment||Treatment||None (Open Label)||||||
1538680|NCT00470522|Randomized|Parallel Assignment||Treatment||Double||||||
1538681|NCT00470509|Randomized|Parallel Assignment||Treatment||Double||||||
1538682|NCT00470496||Single Group Assignment||Treatment||None (Open Label)||||||
1538683|NCT00470483|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538684|NCT00470470||Single Group Assignment||Treatment||None (Open Label)||||||
1538685|NCT00470457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538686|NCT00470444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538687|NCT00470418|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538688|NCT00470405||Single Group Assignment||Treatment||None (Open Label)||||||
1538689|NCT00470392|Non-Randomized|Factorial Assignment||||Single|||t|||
1538690|NCT00470379|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538691|NCT00470366||Single Group Assignment||Treatment||None (Open Label)||||||
1538692|NCT00470353|Randomized|||Treatment||||||||
1538693|NCT00470340|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538694|NCT00470327|||Other||Prospective|||||||
1538695|NCT00470314|Randomized|Parallel Assignment||Treatment||Double||||||
1538696|NCT00470301||Single Group Assignment||Treatment||None (Open Label)||||||
1538697|NCT00470288|Randomized|Parallel Assignment||Treatment||Single||||||
1538698|NCT00470275||Single Group Assignment||Treatment||None (Open Label)||||||
1538699|NCT00470262|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1538700|NCT00470249|Non-Randomized|||Treatment||None (Open Label)||||||
1538701|NCT00470236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538702|NCT00470223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538703|NCT00470210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538704|NCT00470197||Single Group Assignment||Treatment||None (Open Label)||||||
1538705|NCT00470184||Single Group Assignment||Treatment||None (Open Label)||||||
1538706|NCT00470171|Randomized|Parallel Assignment||Treatment||Double||||||
1538707|NCT00470158|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1538708|NCT00470145|Randomized|Crossover Assignment||Treatment||Single||||||
1538709|NCT00470132|||Cohort||Retrospective|||||||
1538710|NCT00470119|Randomized|Parallel Assignment||Prevention||Single|||||t|
1538711|NCT00470106|Randomized|Parallel Assignment||Treatment||Single||||||t
1538712|NCT00470093||Single Group Assignment||Treatment||None (Open Label)||||||
1538713|NCT00470080|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538714|NCT00470067||Single Group Assignment||Treatment||None (Open Label)||||||
1538715|NCT00470054||Single Group Assignment||Treatment||None (Open Label)||||||
1538716|NCT00470041|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538717|NCT00470028|Randomized|Parallel Assignment||Treatment||Double||||||
1538718|NCT00470015||Single Group Assignment||Treatment||None (Open Label)||||||
1538719|NCT00470002|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1538720|NCT00469989|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1538721|NCT00469976||||Treatment||None (Open Label)||||||
1538722|NCT00469963||Single Group Assignment||Treatment||None (Open Label)||||||
1538723|NCT00469950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538724|NCT00469937||Single Group Assignment||Supportive Care||None (Open Label)||||||
1538725|NCT00469924|Randomized|Parallel Assignment||||Single||||||t
1538726|NCT00469911|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||Compare magnetic resonance imaging measurements of triglyceride accumulation in myocardial tissue with ex vivo myocardial tissue collected from heart transplant patients who have had routine clinical heart biopsy.||||
1538727|NCT00469898||Single Group Assignment||Treatment||None (Open Label)||||||
1538728|NCT00469885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538729|NCT00469872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538730|NCT00469859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538731|NCT00469846|Randomized|Parallel Assignment||Prevention||Double||||||
1538732|NCT00469833||Single Group Assignment||Treatment||None (Open Label)||||||
1538733|NCT00469820||||Treatment||None (Open Label)||||||
1538734|NCT00469807|||||Prospective|||||||
1538735|NCT00469794|||Case Control, Natural History||Longitudinal, Retrospective|||||||
1538736|NCT00469781|Randomized|Parallel Assignment||Prevention||Single|||||t|
1538737|NCT00469768|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538738|NCT00469755|Randomized|Factorial Assignment||Treatment||Single||||||t
1538739|NCT00469742|||||Retrospective|||||||
1538740|NCT00469729|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538741|NCT00469716|Randomized|Parallel Assignment||Prevention||Double||||||
1538742|NCT00469703|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538743|NCT00469690|Randomized|Parallel Assignment||Treatment||Single|||||t|
1538744|NCT00469664|Randomized|Parallel Assignment||Treatment||Double||||||
1538745|NCT00469651|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1538746|NCT00469638|Randomized|Parallel Assignment||Treatment||Single|||t|||
1538747|NCT00469625|Randomized|Single Group Assignment||Treatment||Double||||||
1538748|NCT00469612|Randomized|Parallel Assignment||Treatment||Single||||||t
1538749|NCT00469599|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538750|NCT00469586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538751|NCT00469573|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1538752|NCT00469560||Single Group Assignment||Treatment||None (Open Label)||||||
1538753|NCT00469547|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1538754|NCT00469534|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538755|NCT00469521|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1538756|NCT00469508|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538757|NCT00469495|Randomized|Parallel Assignment||Treatment||Double||||||
1538758|NCT00469482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538759|NCT00469469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538760|NCT00469456|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538761|NCT00469443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538762|NCT00469430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538763|NCT00469417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538764|NCT00469404|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538765|NCT00469391|Randomized|Parallel Assignment||Treatment||Single|||t|||
1538766|NCT00469378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538767|NCT00469365|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1538768|NCT00469352|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538769|NCT00469339|||Cohort||Retrospective|||||||
1538770|NCT00469326|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538771|NCT00469313|||||Prospective|||||||
1538772|NCT00469300|Randomized|Parallel Assignment||Treatment||Double||||||
1538773|NCT00469287|||||Prospective|||||||
1538774|NCT00469274|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538775|NCT00469261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538776|NCT00469248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538777|NCT00469235|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538778|NCT00469222||Single Group Assignment||Treatment||None (Open Label)||||||
1538779|NCT00469209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538780|NCT00469196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538781|NCT00469183|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538782|NCT00469170|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1538783|NCT00469157|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1538784|NCT00469144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538785|NCT00469131|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538786|NCT00469118|Randomized|Crossover Assignment||Treatment||Single||||||t
1538787|NCT00469105|Randomized|Single Group Assignment||||None (Open Label)||||||
1538788|NCT00469092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538789|NCT00469079|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538790|NCT00469066|||Case-Only||Prospective|||||||
1538791|NCT00469053|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538792|NCT00469040|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538793|NCT00469027||Single Group Assignment||||None (Open Label)||||||
1538794|NCT00469014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538795|NCT00469001|||Cohort||Prospective|||||||
1538796|NCT00468988|Randomized|Single Group Assignment||Treatment||Single||||||
1538797|NCT00468975|Randomized|Crossover Assignment||Treatment||Double||||||
1538798|NCT00468962|Randomized|Parallel Assignment||||Double||||||
1538799|NCT00468949|||Cohort||Prospective|||||||
1538800|NCT00468936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538801|NCT00468923|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1538802|NCT00468910|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538803|NCT00468897|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538804|NCT00468884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538805|NCT00468871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538806|NCT00468858|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1538807|NCT00468845|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538808|NCT00468832|||Case Control||Prospective|||||||
1538809|NCT00468819|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1538810|NCT00468806|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538811|NCT00468793|Randomized|Parallel Assignment||Treatment||Single||||||t
1538812|NCT00468780|||Case-Only||Prospective|||||||
1538813|NCT00468767|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1538814|NCT00468754|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1538815|NCT00468741|Randomized|Parallel Assignment||||None (Open Label)||||||
1538816|NCT00468728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538817|NCT00468715||Single Group Assignment||Treatment||None (Open Label)||||||
1538818|NCT00468702|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1538819|NCT00468689|Randomized|Single Group Assignment||Treatment||Single||||||
1538820|NCT00468676|Randomized|Parallel Assignment||Treatment||Single||||||t
1538821|NCT00468663|||||Prospective|||||||
1538822|NCT00468650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538823|NCT00468637|||||Prospective|||||||
1538824|NCT00468624|Randomized|Crossover Assignment||||Double||||||
1538825|NCT00468611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538826|NCT00468598|||Cohort||Prospective|||||||
1538827|NCT00468585||Single Group Assignment||Treatment||None (Open Label)||||||
1538828|NCT00468572|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1538829|NCT00468559|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538830|NCT00468546|Randomized|Parallel Assignment||Treatment||Double||||||
1538831|NCT00468533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538832|NCT00468520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538833|NCT00468507|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1538834|NCT00468494|||||Prospective|||||||
1538835|NCT00468481|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1538836|NCT00468468|Randomized|Parallel Assignment||||Single|||t|||
1538837|NCT00468455|||Case-Only||Prospective|||||||
1538838|NCT00468442||Single Group Assignment||Treatment||None (Open Label)||||||
1538839|NCT00468429|Randomized|Parallel Assignment||Treatment||Single||||||
1538840|NCT00468416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538841|NCT00468403||Single Group Assignment||Treatment||None (Open Label)||||||
1538842|NCT00468390|||Case Control||Prospective|||||||
1538843|NCT00468364|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1538844|NCT00468351|Randomized|Parallel Assignment||Treatment||Single||||||
1538845|NCT00468338|||Case-Only||Prospective|||||||
1538846|NCT00468325|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1538847|NCT00468312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538848|NCT00468299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538849|NCT00468286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538850|NCT00468273||Single Group Assignment||Prevention||None (Open Label)||||||
1538851|NCT00468260|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538852|NCT00468247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538853|NCT00468234|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1538854|NCT00468221||Single Group Assignment||Basic Science||None (Open Label)||||||
1538855|NCT00468208||Single Group Assignment||Treatment||None (Open Label)||||||
1538856|NCT00468195|||Cohort||Prospective|||||||
1538857|NCT00468182|||||Prospective|||||||
1538858|NCT00468169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538859|NCT00468156|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538860|NCT00468143|Randomized|Crossover Assignment||Treatment||Single||||||t
1538861|NCT00468130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538862|NCT00468117||Single Group Assignment||Treatment||None (Open Label)||||||
1538863|NCT00468104|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1538864|NCT00468091|Randomized|Crossover Assignment||Diagnostic||Double||||||
1538865|NCT00468078|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1538866|NCT00468065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538867|NCT00468052|Randomized|Parallel Assignment||Prevention||Single|||t|||
1538868|NCT00468039||Single Group Assignment||Treatment||None (Open Label)||||||
1538869|NCT00468026||Single Group Assignment||Treatment||None (Open Label)||||||
1538870|NCT00468013|Randomized|Crossover Assignment||Treatment||Single|||t|||
1538871|NCT00468000|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538872|NCT00467987|Randomized|Parallel Assignment||Treatment||Single|||t|||
1538873|NCT00467974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538874|NCT00467961||Single Group Assignment||Treatment||None (Open Label)||Evaluation of selective depletion of alloreactive T cells to prevent graft vs host disease||||
1538875|NCT00467948|Randomized|Parallel Assignment||Prevention||Double||||||
1538876|NCT00467935|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538877|NCT00467922|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1538878|NCT00467909|Randomized|Factorial Assignment||||Double||||||
1538879|NCT00467896||Single Group Assignment||Treatment||None (Open Label)||||||
1538880|NCT00467883||Single Group Assignment||Treatment||None (Open Label)||||||
1538881|NCT00467870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538882|NCT00467857|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538883|NCT00467844|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1538884|NCT00467831||Single Group Assignment||Treatment||None (Open Label)||||||
1538885|NCT00467818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538886|NCT00467805|Non-Randomized|Crossover Assignment||Basic Science||Single||||||t
1538887|NCT00467792|||Cohort||Prospective|||||||
1538888|NCT00467779|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538889|NCT00467766|Randomized|Single Group Assignment||Treatment||Single||||||
1538890|NCT00467753|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538891|NCT00467740||Parallel Assignment||Treatment||||||||
1538892|NCT00467727||Single Group Assignment||Diagnostic||None (Open Label)||||||
1538893|NCT00467714|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1538894|NCT00467701|||Case-Only||Cross-Sectional|||||||
1538895|NCT00467688|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1538896|NCT00467675|||||Prospective|||||||
1538897|NCT00467662|Randomized|Factorial Assignment||Treatment||Double||||||
1538898|NCT00467649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538899|NCT00467636|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538900|NCT00467623|||||Prospective|||||||
1538901|NCT00467610|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538902|NCT00467597|||Case Control||Prospective|||||||
1538903|NCT00467584|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538904|NCT00467571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538905|NCT00467558|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538906|NCT00467545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538907|NCT00467532|||Cohort||Prospective|||||||
1538908|NCT00467519|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1538909|NCT00467506|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1538910|NCT00467493|Randomized|Parallel Assignment||Treatment||Double||||||
1538911|NCT00467467|Randomized|Single Group Assignment||||Double||||||
1538912|NCT00467454|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1538913|NCT00467441|Randomized|Parallel Assignment||Treatment||Double||||||
1538914|NCT00467428|Randomized|Parallel Assignment||Treatment||Double||||||
1538915|NCT00467415|Randomized|Parallel Assignment||Treatment||Single||||||t
1538916|NCT00467402|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1538917|NCT00467389|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1538918|NCT00467376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538919|NCT00467363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538920|NCT00467350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538921|NCT00467337|Randomized|Parallel Assignment||Treatment||Double||||||
1538922|NCT00467324|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538923|NCT00467311|||||Cross-Sectional|||||||
1538924|NCT00467298|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1538925|NCT00467285|||Case Control||Prospective|||||||
1538926|NCT00467272||Single Group Assignment||Treatment||None (Open Label)||||||
1538927|NCT00467259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538928|NCT00467246|Randomized|Parallel Assignment||Treatment||Double||||||
1538929|NCT00467233|Randomized|Single Group Assignment||Treatment||Single||||||t
1538930|NCT00467220|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1538931|NCT00467207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538932|NCT00467194||Single Group Assignment||Treatment||None (Open Label)||||||
1538933|NCT00467181|Randomized|Parallel Assignment||Treatment||Single||||||
1538934|NCT00467168|Randomized|Parallel Assignment||Prevention||Single||||||
1538935|NCT00467155|||Case-Only||Prospective|||||||
1538936|NCT00467142|Non-Randomized|||Treatment||||||||
1538937|NCT00467129||||||||||||
1538938|NCT00467116||Single Group Assignment||Treatment||None (Open Label)||||||
1538939|NCT00467103|||Cohort||Prospective|||||||
1538940|NCT00467090|||||Prospective|||||||
1538941|NCT00467077||Single Group Assignment||Treatment||None (Open Label)||||||
1538942|NCT00467064|Randomized|Single Group Assignment||||None (Open Label)||||||
1538943|NCT00467051||Single Group Assignment||Treatment||None (Open Label)||||||
1538944|NCT00467038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538945|NCT00467025|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1538946|NCT00467012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538947|NCT00466999|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538948|NCT00466986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538949|NCT00466973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538950|NCT00466960||Single Group Assignment||Treatment||None (Open Label)||||||
1538951|NCT00466947|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1538952|NCT00466934|||||Prospective|||||||
1538953|NCT00466921|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538954|NCT00466908|||Case-Control||Retrospective|||||||
1538955|NCT00466895|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538956|NCT00466882|||Other||Retrospective|||||||
1538957|NCT00466869|Randomized|Parallel Assignment||Treatment||Double||||||
1538958|NCT00466856||Single Group Assignment||Treatment||None (Open Label)||||||
1538959|NCT00466843|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538960|NCT00466830||||||||||||
1538961|NCT00466817|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1538962|NCT00466804|||Case-Only||Prospective|||||||
1538963|NCT00466791|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1538964|NCT00466778|||Case Control|Screening|Longitudinal, Prospective|||||||
1538965|NCT00466765||Single Group Assignment||Treatment||None (Open Label)||||||
1538966|NCT00466752|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1538967|NCT00466739||||||||||||
1538968|NCT00466726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538969|NCT00466713|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1538970|NCT00466700|||Case-Only||Prospective|||||||
1538971|NCT00466687||Single Group Assignment||Treatment||None (Open Label)||||||
1538972|NCT00466674||Single Group Assignment||Treatment||None (Open Label)||||||
1538973|NCT00466661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1538974|NCT00466648|Randomized|Single Group Assignment||Treatment||Single||||||
1538975|NCT00466635|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538976|NCT00466622|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1538977|NCT00466609|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538978|NCT00466596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538979|NCT00466583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538980|NCT00466570|Randomized|Factorial Assignment||Prevention||Single||||||
1538981|NCT00466557|||||Prospective|||||||
1538982|NCT00466544|Randomized|Parallel Assignment||Treatment||Double||||||
1538983|NCT00466531||Single Group Assignment||Treatment||None (Open Label)||||||
1538984|NCT00466518||Single Group Assignment||Treatment||None (Open Label)||||||
1538985|NCT00466505||Single Group Assignment||Treatment||None (Open Label)||||||
1538986|NCT00466492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538987|NCT00466479|Randomized|Parallel Assignment||Treatment||Single||||||
1538988|NCT00466466|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538989|NCT00466453|Randomized|Crossover Assignment||||None (Open Label)||||||
1538990|NCT00466440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1538991|NCT00466414|Randomized|Parallel Assignment||Treatment||Single||||||
1538992|NCT00466401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1538993|NCT00466375|||Family-Based||Other|||||||
1538994|NCT00466362|||Defined Population||Longitudinal, Prospective|||||||
1538995|NCT00466349|||Family-Based||Other|||||||
1538996|NCT00466336|||Case-Only||Cross-Sectional|||||||
1538997|NCT00466323|Randomized|Parallel Assignment||Treatment||Single||||||t
1539227|NCT00463281|||Cohort||Prospective|||||||
1538998|NCT00466310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1538999|NCT00466297|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1539000|NCT00466284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539001|NCT00466271|||Case-Only||Cross-Sectional|||||||
1539002|NCT00466258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539003|NCT00466245|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1539004|NCT00466232|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539005|NCT00466219|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539006|NCT00466206||Single Group Assignment||Treatment||None (Open Label)||||||
1539007|NCT00466193|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539008|NCT00466180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539009|NCT00466167||Parallel Assignment||Treatment||||||||
1539010|NCT00466154|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539011|NCT00466141|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1539012|NCT00466128|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539013|NCT00466102|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539014|NCT00466089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539015|NCT00466076|Randomized|Parallel Assignment||Treatment||Single||||||
1539016|NCT00466063|||Cohort||Prospective|||||||
1539017|NCT00466050|||Case-Only||Prospective|||||||
1539018|NCT00466037|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539019|NCT00466024|Randomized|Parallel Assignment||Prevention||Single|||t|||
1539020|NCT00466011|||||Prospective|||||||
1539021|NCT00465998|||Case-Only||Prospective|||||||
1539022|NCT00465985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539023|NCT00465972|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539024|NCT00465959|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539025|NCT00465946|Randomized|Crossover Assignment||Prevention||Double||||||
1539026|NCT00465933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539027|NCT00465920|Randomized|Parallel Assignment||Treatment||Single||||||
1539028|NCT00465907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539029|NCT00465894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539030|NCT00465881|||||Prospective|||||||
1539031|NCT00465868|||Case-Only||Prospective|||||||
1539032|NCT00465855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539033|NCT00465842|||||Prospective|||||||
1539034|NCT00465829|||Cohort||Prospective|||||||
1539035|NCT00465816|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539036|NCT00465803|Randomized|Parallel Assignment||Treatment||Single||||||t
1539037|NCT00465790||||||||||||
1539038|NCT00465777|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1539039|NCT00465764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539040|NCT00465751|Non-Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1539041|NCT00465738|Randomized|Parallel Assignment||Treatment||Single||||||t
1539042|NCT00465725|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539043|NCT00465712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539044|NCT00465699|Randomized|Single Group Assignment||Treatment||Double||||||
1539045|NCT00465686|Randomized|Crossover Assignment||Supportive Care||Single||||||t
1539046|NCT00465673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539047|NCT00465660|Randomized|Parallel Assignment||Treatment||Single||||||
1539048|NCT00465647|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539049|NCT00465634|||Case-Only||Prospective|||||||
1539050|NCT00465621|Randomized|Single Group Assignment||Treatment||Double||||||
1539051|NCT00465608||Single Group Assignment||Treatment||None (Open Label)||||||
1539052|NCT00465595|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1539053|NCT00465582|||||Prospective|||||||
1539054|NCT00465569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539055|NCT00465556|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539056|NCT00465543|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539057|NCT00465530|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539058|NCT00465517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539059|NCT00465504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539060|NCT00465491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539061|NCT00465478|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539062|NCT00465465|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539063|NCT00465452|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539064|NCT00465439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539065|NCT00465426|||Case Control||Prospective|||||||
1539066|NCT00465413|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539067|NCT00465400|||Case-Only||Prospective|||||||
1539068|NCT00465387|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539069|NCT00465374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539070|NCT00465361|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1539071|NCT00465348|||Case-Only||Prospective|||||||
1539072|NCT00465335|||||Prospective|||||||
1539073|NCT00465322|||||Longitudinal, Prospective|||||||
1539074|NCT00465309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540438|NCT00447135|||||Retrospective|||||||
1539075|NCT00465296|Randomized|Single Group Assignment||Treatment||Double||||||
1539076|NCT00466388|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1539077|NCT00465283|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539078|NCT00465270|Randomized|Parallel Assignment||Prevention||None (Open Label)||AMPLATZER PFO Occluder||||
1539079|NCT00465257|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1539080|NCT00465244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539081|NCT00465231|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1539082|NCT00465218|||Case Control||Prospective|||||||
1539083|NCT00465205|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1539084|NCT00465192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539085|NCT00465179||Single Group Assignment||Treatment||None (Open Label)||||||
1539086|NCT00465166|||Cohort||Retrospective|||||||
1539087|NCT00465153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539088|NCT00465140|Randomized|Parallel Assignment||Prevention||Double||||||
1539089|NCT00465114|||Cohort||Prospective|||||||
1539090|NCT00465101||Single Group Assignment||Treatment||None (Open Label)||||||
1539091|NCT00465088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539092|NCT00465075|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1539093|NCT00465062||||||||||||
1539094|NCT00465049|Randomized|Parallel Assignment||Treatment||Single||||||t
1539095|NCT00465036|Randomized|Crossover Assignment||Prevention||Double||||||
1539096|NCT00465023||Single Group Assignment||Treatment||None (Open Label)||||||
1539097|NCT00465010|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539098|NCT00464997|||Defined Population|Screening|Longitudinal, Prospective|||||||
1539099|NCT00464984|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539100|NCT00464971|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539101|NCT00464958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539102|NCT00464945|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1539103|NCT00464932|Random Sample||||Longitudinal, Prospective|||||||
1539104|NCT00464919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539105|NCT00464893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539106|NCT00464880|Randomized|Crossover Assignment||Treatment||Double||||||
1539107|NCT00464867|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1539108|NCT00464854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539109|NCT00464841|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1539110|NCT00464828|||||Prospective|||||||
1539111|NCT00464815|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539112|NCT00464802|Randomized|Crossover Assignment||Treatment||Double||||||
1539113|NCT00464789|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539114|NCT00464776|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1539115|NCT00464763|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1539116|NCT00464750|||||Prospective|||||||
1539117|NCT00464737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539118|NCT00464724||Single Group Assignment||Diagnostic||None (Open Label)||||||
1539119|NCT00464711||Single Group Assignment||Treatment||None (Open Label)||||||
1539120|NCT00464698||Single Group Assignment||Treatment||None (Open Label)||||||
1539121|NCT00464685|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1539122|NCT00464672|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1539123|NCT00464659|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1539124|NCT00464646|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539125|NCT00464633||Single Group Assignment||Treatment||None (Open Label)||||||
1539126|NCT00464620||Single Group Assignment||Treatment||None (Open Label)||||||
1539127|NCT00464607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539128|NCT00464594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539129|NCT00464581|||Case-Only||Retrospective|||||||
1539130|NCT00464568|Randomized|Crossover Assignment||Treatment||||||||
1539131|NCT00464555||Single Group Assignment||Treatment||None (Open Label)||||||
1539132|NCT00464542||Single Group Assignment||Treatment||None (Open Label)||||||
1539133|NCT00464529|||||Prospective|||||||
1539134|NCT00464516|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539135|NCT00464503|Randomized|Crossover Assignment||Diagnostic||Double||||||
1539136|NCT00464490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539137|NCT00464477|||Case-Only||Retrospective|||||||
1539138|NCT00464464|Randomized|Parallel Assignment||Treatment||Single||||||t
1539139|NCT00464451|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539140|NCT00464438|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539141|NCT00464425|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1539142|NCT00464412|Randomized|Parallel Assignment||||None (Open Label)||||||
1539143|NCT00464399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539144|NCT00464386|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1539145|NCT00464373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539146|NCT00464347|Randomized|Parallel Assignment||Treatment||Single||||||
1539147|NCT00464334|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1539148|NCT00464321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539149|NCT00464308|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539150|NCT00464295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539151|NCT00464282|||Defined Population|Screening|Longitudinal, Prospective|||||||
1539152|NCT00464269|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539153|NCT00464256|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539154|NCT00464243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539155|NCT00464230|Randomized|Parallel Assignment||Treatment||Single||||||
1539156|NCT00464217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539157|NCT00464204|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539158|NCT00464191|Randomized|Parallel Assignment||Treatment||Double||||||
1539159|NCT00464178||Single Group Assignment||Treatment||None (Open Label)||||||
1539160|NCT00464165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539161|NCT00464139|||Cohort||Retrospective|||||||
1539162|NCT00464126|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539163|NCT00464113|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539164|NCT00464100|||Case Control||Prospective|||||||
1539165|NCT00464087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539166|NCT00464074|||Case-Only||Prospective|||||||
1539167|NCT00464061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539168|NCT00464048|Randomized|Parallel Assignment||Treatment||Single||||||
1539169|NCT00464035|Randomized|Crossover Assignment||||None (Open Label)||||||
1539170|NCT00464022|Randomized|Parallel Assignment||Diagnostic||Double||||||
1539171|NCT00464009|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1539172|NCT00463996|||Case Control|Screening|Longitudinal, Prospective|||||||
1539173|NCT00463983|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539174|NCT00463970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539175|NCT00463957|Randomized|Parallel Assignment||Diagnostic||Double||||||
1539176|NCT00463944|||Defined Population||Longitudinal, Prospective|||||||
1539177|NCT00463931|||Case Control, Natural History||Longitudinal, Prospective|||||||
1539178|NCT00463918|Randomized|Parallel Assignment||Treatment||Double||||||
1539179|NCT00463905|Randomized|Parallel Assignment||Screening||Double|||t|||t
1539180|NCT00463892|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1539181|NCT00463879|Randomized|Parallel Assignment||Treatment||Double||||||
1539182|NCT00463866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539183|NCT00463853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539184|NCT00463840||Single Group Assignment||Treatment||None (Open Label)||||||
1539185|NCT00463827|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539186|NCT00463814||Single Group Assignment||Treatment||None (Open Label)||||||
1539187|NCT00463801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539188|NCT00463788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539189|NCT00463775|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1539190|NCT00463762|||||Prospective|||||||
1539191|NCT00463749|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539192|NCT00463736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539193|NCT00463723|Randomized|Parallel Assignment||Prevention||Single||||||
1539194|NCT00463710|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1539195|NCT00463697|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539196|NCT00463684|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539197|NCT00463671|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539198|NCT00463658|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1539199|NCT00463645|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1539200|NCT00463632|||Cohort||Prospective|||||||
1539201|NCT00463619|||Cohort||Prospective|||||||
1539202|NCT00463606|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539203|NCT00463593|||Cohort||Prospective|||||||
1539204|NCT00463580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539205|NCT00463567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539206|NCT00463554|||Cohort||Prospective|||||||
1539207|NCT00463541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539208|NCT00463528||||Screening|Cross-Sectional, Retrospective/Prospective|||||||
1539209|NCT00463515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539210|NCT00463502|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1539211|NCT00463489|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539212|NCT00463476|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539213|NCT00463463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539214|NCT00463450|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539215|NCT00463437|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539216|NCT00463424|Randomized|Parallel Assignment||Treatment||Single||||||
1539217|NCT00463411|Random Sample||Natural History||Longitudinal, Prospective|||||||
1539218|NCT00463398|||Cohort||Prospective|||||||
1539219|NCT00463385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539220|NCT00463372|Randomized|Parallel Assignment||Treatment||Double||||||
1539221|NCT00463359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539222|NCT00463346|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539223|NCT00463333|||Defined Population|Screening|Longitudinal, Prospective|||||||
1539224|NCT00463320|Randomized|Parallel Assignment||Diagnostic||Single||||||
1539225|NCT00463307||||||||||||
1539226|NCT00463294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539228|NCT00463268|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1539229|NCT00463255|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539230|NCT00463242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539231|NCT00463229|Randomized|Parallel Assignment||Treatment||Single||||||t
1539232|NCT00463216|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1539233|NCT00463203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539234|NCT00463190|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539235|NCT00463177|||||Cross-Sectional|||||||
1539236|NCT00463164|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1539237|NCT00463151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539238|NCT00463138|||Case-Only||Cross-Sectional|||||||
1539239|NCT00463125|Randomized|Parallel Assignment||Treatment||Double||||||
1539240|NCT00463112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539241|NCT00463099|||Cohort||Prospective|||||||
1539242|NCT00463086|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1539243|NCT00463073|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1539244|NCT00463060||Single Group Assignment||Treatment||None (Open Label)||||||
1539245|NCT00463047|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539246|NCT00463034||||||||||||
1539247|NCT00463021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539248|NCT00463008|Non-Randomized|||Treatment||||||||
1539249|NCT00462995||Single Group Assignment||Treatment||None (Open Label)||||||
1539250|NCT00462982||Single Group Assignment||Treatment||None (Open Label)||||||
1539251|NCT00462969||Single Group Assignment||Screening||None (Open Label)||||||
1539252|NCT00462956|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539253|NCT00462943||Single Group Assignment||Treatment||None (Open Label)||||||
1539254|NCT00462917|Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1539255|NCT00462904|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539256|NCT00462891|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1539257|NCT00462878|||Case-Only||Prospective|||||||
1539258|NCT00462865||Single Group Assignment||Treatment||None (Open Label)||||||
1539259|NCT00462852|Randomized|||Treatment||||||||
1539260|NCT00462839|Randomized|Crossover Assignment||Health Services Research||Single|||t|||
1539261|NCT00462826||Single Group Assignment||Treatment||None (Open Label)||||||
1539262|NCT00462813|Randomized|||Prevention||Double||||||
1539263|NCT00462787||Single Group Assignment||Treatment||None (Open Label)||||||
1539264|NCT00462774|Randomized|Parallel Assignment||Treatment||Double||||||
1539265|NCT00462761||Single Group Assignment||Treatment||None (Open Label)||||||
1539266|NCT00462748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539267|NCT00462735||Single Group Assignment||Treatment||None (Open Label)||||||
1539268|NCT00462722|Randomized|Parallel Assignment||||Triple|||t||t|t
1539269|NCT00462709||Single Group Assignment||Prevention||None (Open Label)||||||
1539270|NCT00462696|Non-Randomized|||Diagnostic||||||||
1539271|NCT00462683|||||Prospective|||||||
1539272|NCT00462670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539273|NCT00462657||||Diagnostic||||||||
1539274|NCT00462644|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539275|NCT00462631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539276|NCT00462618|Randomized|Parallel Assignment||Treatment||Single||||||t
1539277|NCT00462605||Single Group Assignment||Treatment||None (Open Label)||||||
1539278|NCT00462592|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539279|NCT00462579|||Cohort||Retrospective|||||||
1539280|NCT00462566|Randomized|Crossover Assignment||Treatment||Single|||||t|
1539281|NCT00462553||Single Group Assignment||Treatment||None (Open Label)||||||
1539282|NCT00462540|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539283|NCT00462527|||Cohort||Prospective|||||||
1539284|NCT00462501||Single Group Assignment||Treatment||None (Open Label)||||||
1539285|NCT00462488|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539286|NCT00462475|||Case Control||Prospective|||||||
1539287|NCT00462462|Randomized|Parallel Assignment||||None (Open Label)||||||
1539288|NCT00462449|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1539289|NCT00462436|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539290|NCT00462423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539291|NCT00462410||||Health Services Research||None (Open Label)||||||
1539292|NCT00462397||||Treatment||None (Open Label)||||||
1539293|NCT00462384||Single Group Assignment||Treatment||None (Open Label)||||||
1539294|NCT00462371|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539295|NCT00462358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539296|NCT00462345|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539297|NCT00462332|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539298|NCT00462319|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1539299|NCT00462306|||Cohort||Prospective|||||||
1539300|NCT00462280|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1539301|NCT00462267|Randomized|Parallel Assignment||Treatment||Single||||||t
1539302|NCT00462254|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1539303|NCT00462241|Randomized|Parallel Assignment||Treatment||Single||||||t
1539304|NCT00462228|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1539305|NCT00462215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539306|NCT00462202||Single Group Assignment||Treatment||None (Open Label)||||||
1539307|NCT00462189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539308|NCT00462176|||Cohort||Retrospective|||||||
1539309|NCT00462150|Randomized|Parallel Assignment||Treatment||Double||||||
1539310|NCT00462137|||Case Control||Prospective|||||||
1539311|NCT00462124|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539312|NCT00462111|Randomized|Crossover Assignment||Prevention||Double||||||
1539313|NCT00462098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539314|NCT00462085|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1539315|NCT00462072||Single Group Assignment||Treatment||None (Open Label)||||||
1539316|NCT00462059|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539317|NCT00462046|Randomized|Factorial Assignment||Treatment||Double||||||
1539318|NCT00462020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539319|NCT00462007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539320|NCT00461994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539321|NCT00461981|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539322|NCT00461968|Randomized|Crossover Assignment||Treatment||Double||||||
1539323|NCT00461955||Single Group Assignment||Treatment||None (Open Label)||||||
1539324|NCT00461942|Randomized|Crossover Assignment||Treatment||Double||||||
1539325|NCT00461929|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1539326|NCT00461916|Randomized|Parallel Assignment||Treatment||Double||||||
1539327|NCT00461903|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539328|NCT00461890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539329|NCT00461877|||Cohort||Prospective|||||||
1539330|NCT00461864|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1539331|NCT00461851||Single Group Assignment||Treatment||None (Open Label)||||||
1539332|NCT00461838|||Cohort||Retrospective|||||||
1539333|NCT00461825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539334|NCT00461812|Randomized|Parallel Assignment||Treatment||Single||||||
1539335|NCT00461799|Randomized|Crossover Assignment||Treatment||Double||||||
1539336|NCT00461786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539337|NCT00461773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539338|NCT00461760|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1539339|NCT00461747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539340|NCT00461734|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539341|NCT00461721|||Case Control|||||||||
1539342|NCT00461708|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539343|NCT00461695|Non-Randomized|Single Group Assignment||Prevention||Single||||||t
1539344|NCT00461682|Randomized|Crossover Assignment||Treatment||||||||
1539345|NCT00461669|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1539346|NCT00461656|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1539347|NCT00461643|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539348|NCT00461630|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1539349|NCT00461617|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539350|NCT00461604|||||Prospective|||||||
1539351|NCT00461591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539352|NCT00461578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539353|NCT00461565|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1539354|NCT00461552|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1539355|NCT00461539|Randomized|Parallel Assignment||Treatment||Single||||||t
1539356|NCT00461526|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539357|NCT00461513|||Other||Prospective|||||||
1539358|NCT00461500|Randomized|Parallel Assignment||Treatment||Double||||||
1539359|NCT00461487|Randomized|Parallel Assignment||||Single|||t|||
1539360|NCT00461474|Randomized|Parallel Assignment||Treatment||Single||||||
1539361|NCT00461461|Randomized|Crossover Assignment||||None (Open Label)||||||
1539362|NCT00461448|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1539363|NCT00461435|Randomized|Parallel Assignment||||Single||||||
1539364|NCT00461422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539365|NCT00461409||Single Group Assignment||Treatment||None (Open Label)||||||
1539366|NCT00461396|||Cohort||Prospective|||||||
1539367|NCT00461370|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1539368|NCT00461357|Random Sample||||Longitudinal, Prospective|||||||
1539369|NCT00461344|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539370|NCT00461331|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539371|NCT00461318|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539372|NCT00461305|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539373|NCT00461292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539374|NCT00461279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539375|NCT00461266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539376|NCT00461253|||Case Control|||||||||
1539377|NCT00461240|||Case Control||Prospective|||||||
1539378|NCT00461227|||Case Control||Cross-Sectional|||||||
1539379|NCT00461214||||||||||||
1539380|NCT00461201|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1539381|NCT00461188|||Cohort||Prospective|||||||
1539382|NCT00461175|||Cohort||Prospective|||||||
1539383|NCT00461162|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539384|NCT00461149|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539385|NCT00461136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539386|NCT00461123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539387|NCT00461110|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539388|NCT00461097|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539389|NCT00461084|||Cohort||Prospective|||||||
1539390|NCT00461071|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1539391|NCT00461058|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539392|NCT00461045||Single Group Assignment||Treatment||None (Open Label)||||||
1539393|NCT00461032|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539394|NCT00461019|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539395|NCT00461006|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539396|NCT00460993|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1539397|NCT00460980||Single Group Assignment||||Single||||||t
1539398|NCT00460967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539399|NCT00460954|||||Prospective|||||||
1539400|NCT00460941|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539401|NCT00460928||Single Group Assignment||Prevention||None (Open Label)||||||
1539402|NCT00460915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539403|NCT00460902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539404|NCT00460889|||||Retrospective|||||||
1539405|NCT00460876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539406|NCT00460863|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539407|NCT00460850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539408|NCT00460837|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1539409|NCT00460824|||||Retrospective|||||||
1539410|NCT00460811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539411|NCT00460798|||Cohort||Prospective|||||||
1539412|NCT00460785|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539413|NCT00460759||Single Group Assignment||Treatment||None (Open Label)||||||
1539414|NCT00460746|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539415|NCT00460733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539416|NCT00460720|||Cohort||Prospective|||||||
1539417|NCT00460707|Randomized|Crossover Assignment||Treatment||||||||
1539418|NCT00460694|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539419|NCT00460681|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539420|NCT00460668|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1539421|NCT00460655|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539422|NCT00460642|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539423|NCT00460629|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539424|NCT00460616|||Case Control||Prospective|||||||
1539425|NCT00460603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539426|NCT00460590|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539427|NCT00460577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539428|NCT00460564|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539429|NCT00460551||Single Group Assignment||Treatment||None (Open Label)||||||
1539430|NCT00460538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539431|NCT00460525|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1539432|NCT00460512||Single Group Assignment||Treatment||None (Open Label)||||||
1539433|NCT00460499|Randomized|Factorial Assignment||Treatment||Single||||||t
1539434|NCT00460486|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539435|NCT00460473|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1539436|NCT00460460|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539437|NCT00460447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539438|NCT00460434|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1539439|NCT00460421||Single Group Assignment||Prevention||None (Open Label)||||||
1539440|NCT00460408|||||Prospective|||||||
1539441|NCT00460395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539442|NCT00460382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539443|NCT00460369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539444|NCT00460356||||||||||||
1539445|NCT00460343|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1539446|NCT00460330|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1539447|NCT00460317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539448|NCT00460304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539449|NCT00460291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539450|NCT00460278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539451|NCT00460265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539452|NCT00460252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539453|NCT00460239|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1539454|NCT00460226|||||Prospective|||||||
1539455|NCT00460213|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539456|NCT00460200|||||Prospective|||||||
1539457|NCT00460187|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539458|NCT00460174||Single Group Assignment||Treatment||None (Open Label)||||||
1539459|NCT00460161|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1539460|NCT00460148|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539461|NCT00460135|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539462|NCT00460122|||||Other|||||||
1539463|NCT00460109||Single Group Assignment||Treatment||None (Open Label)||||||
1539464|NCT00460096|Randomized|Crossover Assignment||Treatment||Double||||||
1539465|NCT00460083|Randomized|Parallel Assignment||Treatment||Single|||||t|
1539466|NCT00460070|||Cohort||Cross-Sectional|||||||
1539467|NCT00460057||Single Group Assignment||Treatment||Double|||t||t|
1539468|NCT00460044|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1539469|NCT00460031||Single Group Assignment||Treatment||None (Open Label)||||||
1539470|NCT00460018|Randomized|Parallel Assignment||Prevention||Single||||||t
1539471|NCT00460005|||||Prospective|||||||
1539472|NCT00459992|Randomized|Parallel Assignment||Treatment||||||||
1539473|NCT00459979||Single Group Assignment||Treatment||None (Open Label)||||||
1539474|NCT00459966|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539475|NCT00459953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539476|NCT00459940|Randomized|Parallel Assignment||Treatment||Double||||||
1539477|NCT00459927|Randomized|Parallel Assignment||Treatment||Single||||||
1539478|NCT00459914|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1539479|NCT00459901||Single Group Assignment||Treatment||None (Open Label)||||||
1539480|NCT00459888|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539481|NCT00459875||Single Group Assignment||Treatment||None (Open Label)||||||
1539482|NCT00459862||Single Group Assignment||Treatment||None (Open Label)||||||
1539483|NCT00459849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539484|NCT00459836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539485|NCT00459823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539486|NCT00459810||Single Group Assignment||Treatment||None (Open Label)||||||
1539487|NCT00459797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539488|NCT00459784|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1539489|NCT00459771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539490|NCT00459758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539491|NCT00459745|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1539492|NCT00459732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539493|NCT00459719|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539494|NCT00459706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539495|NCT00459693||||Treatment||||||||
1539496|NCT00459680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539497|NCT00459667|Non-Randomized|Parallel Assignment||Treatment||Double||||||
1539498|NCT00459654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539499|NCT00459641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539500|NCT00459628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539501|NCT00459615|Randomized|Parallel Assignment||Treatment||Single||||||
1539502|NCT00459602|||||Prospective|||||||
1539503|NCT00459589|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539504|NCT00459576|||Cohort||Prospective|||||||
1539505|NCT00459563|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539506|NCT00459550|Randomized|Single Group Assignment||Treatment||Single|||t|||
1539507|NCT00459537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539508|NCT00459524|||Case-Only||Prospective|||||||
1539509|NCT00459511|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1539510|NCT00459498||||Screening|Cross-Sectional, Prospective|||||||
1539511|NCT00459485|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1539512|NCT00459472||Single Group Assignment||||None (Open Label)||||||
1539513|NCT00459459|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1539514|NCT00459446|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1539515|NCT00459433|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539516|NCT00459420|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539517|NCT00459407|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1539518|NCT00459381||Single Group Assignment||Treatment||None (Open Label)||||||
1539519|NCT00459368|Randomized|Parallel Assignment||Treatment||Single||||||t
1539520|NCT00459355|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1539521|NCT00459342||Single Group Assignment||Treatment||None (Open Label)||||||
1539522|NCT00459329|Randomized|Single Group Assignment||Treatment||Single||||||t
1539523|NCT00459316|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539524|NCT00459303||Single Group Assignment||Treatment||Double|||t|||t
1539525|NCT00459290||||Treatment||None (Open Label)||||||
1539526|NCT00459277|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1539527|NCT00459264|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1539528|NCT00459251|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1539529|NCT00459238|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1539530|NCT00459225|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539531|NCT00459212||Single Group Assignment||Treatment||None (Open Label)||||||
1539532|NCT00459186||Single Group Assignment||Treatment||None (Open Label)||||||
1539533|NCT00459173|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539534|NCT00459160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539535|NCT00459134|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t||t
1539536|NCT00459121||Single Group Assignment||Treatment||None (Open Label)||||||
1539537|NCT00459108||Single Group Assignment||Treatment||None (Open Label)||||||
1539538|NCT00459082|Randomized|Parallel Assignment||Treatment||Single||||||
1539539|NCT00459069|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539540|NCT00459056|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1539541|NCT00459043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539542|NCT00459030|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1539543|NCT00459017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539544|NCT00459004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539545|NCT00458991|||Cohort||Prospective|||||||
1539546|NCT00458978||Single Group Assignment||Treatment||None (Open Label)||||||
1539547|NCT00458952||Single Group Assignment||Treatment||None (Open Label)||||||
1539548|NCT00458926|||Case-Control||Prospective|||||||
1539549|NCT00458913||Single Group Assignment||Treatment||None (Open Label)||||||
1539550|NCT00458900||Single Group Assignment||Treatment||None (Open Label)||||||
1539551|NCT00458887|||Cohort||Prospective|||||||
1539552|NCT00458874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539553|NCT00458861|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1539554|NCT00458848||Single Group Assignment||Treatment||None (Open Label)||||||
1539555|NCT00458835|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539556|NCT00458822||Single Group Assignment||Treatment||None (Open Label)||||||
1539557|NCT00458809|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539558|NCT00458796|Randomized|||Supportive Care||None (Open Label)||||||
1539559|NCT00458783|Randomized|Parallel Assignment||Other||Double|||t|||t
1539560|NCT00458770||Single Group Assignment||Basic Science||None (Open Label)||||||
1539561|NCT00458757|||Case-Control||Prospective|||||||
1539562|NCT00458744||||Treatment||||||||
1539563|NCT00458731||Single Group Assignment||Treatment||None (Open Label)||||||
1539564|NCT00458718|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539565|NCT00458705||Single Group Assignment||Treatment||None (Open Label)||||||
1539566|NCT00458679||Single Group Assignment||Treatment||None (Open Label)||||||
1539567|NCT00458666|||||Longitudinal, Prospective|||||||
1539568|NCT00458653|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539569|NCT00458627|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1539570|NCT00458614|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539571|NCT00458601||Single Group Assignment||Treatment||None (Open Label)||||||
1539572|NCT00458588|||Other||Prospective|||||||
1539573|NCT00458575||Single Group Assignment||Treatment||None (Open Label)||||||
1539574|NCT00458562|||Case Control||Prospective|||||||
1539575|NCT00458549|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1539576|NCT00458536||Single Group Assignment||Treatment||None (Open Label)||||||
1539577|NCT00458523||||Treatment||None (Open Label)||||||
1539578|NCT00458510|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1539579|NCT00458497|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539580|NCT00458484||Single Group Assignment||Treatment||None (Open Label)||||||
1539581|NCT00458471|Non-Randomized|||Prevention||||||||
1539582|NCT00458458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539583|NCT00458445|Randomized|Crossover Assignment||Treatment||Double||||||
1539584|NCT00458432|||||Prospective|||||||
1539585|NCT00458419|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1539586|NCT00458406|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539587|NCT00458393|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1539588|NCT00458380|Randomized|Parallel Assignment||Diagnostic||Double||||||
1539589|NCT00458367|||||Prospective|||||||
1539590|NCT00458354|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539591|NCT00458341|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539592|NCT00458328|Randomized|Parallel Assignment||Treatment||Double||||||
1539593|NCT00458315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539594|NCT00458302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539595|NCT00458289|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539596|NCT00458276|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539597|NCT00458263|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539598|NCT00458250|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1539599|NCT00458237|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539600|NCT00458224||Single Group Assignment||Prevention||None (Open Label)||||||
1539601|NCT00458211||Single Group Assignment||Treatment||None (Open Label)||||||
1539602|NCT00458198|Randomized|Parallel Assignment||Treatment||Single||||||t
1539603|NCT00458185|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539604|NCT00458172||||||||||||
1539605|NCT00458159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539606|NCT00458146|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539607|NCT00458133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539608|NCT00458120|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1539609|NCT00458107|Randomized|Single Group Assignment||Treatment||Double||||||
1539610|NCT00458094|Randomized|Parallel Assignment||Treatment||Single||||||t
1539611|NCT00458081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539612|NCT00458068|Randomized|Single Group Assignment||Prevention||Single||||||
1539613|NCT00458055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539614|NCT00458042|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539615|NCT00458029|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539616|NCT00458016|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1539617|NCT00458003|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539618|NCT00457990|Randomized|Single Group Assignment||Prevention||Single||||||
1539619|NCT00457977|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539620|NCT00457964||Single Group Assignment||Treatment||None (Open Label)||||||
1539621|NCT00457951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539622|NCT00457938||Single Group Assignment||Treatment||Double||||||
1539623|NCT00457925|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539624|NCT00457912|||Case-Only||Prospective|||||||
1539625|NCT00457899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539626|NCT00457886|||Other||Prospective|||||||
1539627|NCT00457873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539628|NCT00457860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539629|NCT00457847|||Cohort||Prospective|||||||
1539630|NCT00457834|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1539631|NCT00457821|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1539632|NCT00457808|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539633|NCT00457795|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539634|NCT00457782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539635|NCT00457769|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539636|NCT00457756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539637|NCT00457743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539638|NCT00457730|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1539639|NCT00457717|Randomized|Parallel Assignment||Treatment||Single||||||
1539640|NCT00457704|||Defined Population||Longitudinal, Prospective|||||||
1539641|NCT00457691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539642|NCT00457678|Randomized|Parallel Assignment||Treatment||Single||"Patients with~AMD will be randomly assigned to one of 2 treatments:~Continuation of previous Lucentis monotherapy (50 patients)~V-L-D triple therapy with half fluence (300 mW/cm2 for 83 seconds) Visudyne followed within 2 hours by intravitreal Lucentis 0.5 mg (first injection) and intravitreal dexamethasone 0.5 mg (second injection) (50 patients)"|t|||
1539643|NCT00457665|Randomized|Parallel Assignment||Treatment||Double||||||
1539644|NCT00457652|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1539645|NCT00457639|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1539646|NCT00457626||Single Group Assignment||Treatment||None (Open Label)||||||
1539647|NCT00457613|Randomized|Parallel Assignment||Treatment||Double||||||
1539648|NCT00457600|||Defined Population||Longitudinal, Prospective|||||||
1539649|NCT00457587|||Case-Control||Prospective|||||||
1539650|NCT00457574||Single Group Assignment||Treatment||None (Open Label)||||||
1539651|NCT00457561|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1539652|NCT00457548||||||||||||
1539653|NCT00457535|||Defined Population||Longitudinal, Prospective|||||||
1539654|NCT00457522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539655|NCT00457509|Randomized|Parallel Assignment||Prevention||Single||||||t
1539656|NCT00457496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539657|NCT00457483|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1539658|NCT00457470|Randomized|Parallel Assignment||Treatment||Double||||||
1539659|NCT00457457|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539660|NCT00457444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539661|NCT00457431|Randomized|Parallel Assignment||Treatment||Single||||||t
1539662|NCT00457418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539663|NCT00457405|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1539664|NCT00457392|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1539665|NCT00457379|Randomized|Single Group Assignment||||None (Open Label)||||||
1539666|NCT00457366|Randomized|Parallel Assignment||Treatment||Single||||||t
1539667|NCT00457353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539668|NCT00457340|Randomized|Parallel Assignment||Treatment||Double||||||
1539669|NCT00457327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539670|NCT00457314|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539671|NCT00457301|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1539672|NCT00457288|Randomized|Single Group Assignment||Treatment||Double||||||
1539673|NCT00457275|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539674|NCT00457262|Randomized|Parallel Assignment||Prevention||Double||||||
1539675|NCT00457249|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1539676|NCT00457236|||Defined Population|Screening|Longitudinal, Prospective|||||||
1539677|NCT00457223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539678|NCT00457210|||Defined Population||Cross-Sectional, Prospective|||||||
1539679|NCT00457197|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539680|NCT00457184|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1539681|NCT00457171|Randomized|Single Group Assignment||Treatment||Double||||||
1539682|NCT00457158|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539683|NCT00457145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539684|NCT00457132|Randomized|Parallel Assignment||Treatment||Double||||||
1539685|NCT00457119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539686|NCT00457106|Randomized|Parallel Assignment||Treatment||Single||||||
1539687|NCT00457093|Randomized|Parallel Assignment||Treatment||Double||||||
1539688|NCT00457080|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1539689|NCT00457067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539690|NCT00457054|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539691|NCT00457041|||||Prospective|||||||
1539692|NCT00457028|||Cohort||Retrospective|||||||
1539693|NCT00457015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539694|NCT00457002|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1539695|NCT00456989||Single Group Assignment||Treatment||None (Open Label)||||||
1539696|NCT00456976|Randomized|Parallel Assignment||Treatment||Double||||||
1539697|NCT00456963|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1539698|NCT00456950|||Cohort||Prospective|||||||
1539699|NCT00456937|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1539700|NCT00456924|Randomized|Parallel Assignment||Treatment||Double||||||
1539701|NCT00456911|Randomized|Parallel Assignment||||Single||||||
1539702|NCT00456898|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539703|NCT00456885|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539704|NCT00456872|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539705|NCT00456859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539706|NCT00456846||Single Group Assignment||Treatment||None (Open Label)||||||
1539707|NCT00456833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539708|NCT00456820|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539709|NCT00456807|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1539710|NCT00456794|Randomized|Parallel Assignment||Treatment||Double||||||
1539711|NCT00456781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539712|NCT00456768|||Cohort|||||||||
1539713|NCT00456755|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539714|NCT00456742|||Cohort||Retrospective|||||||
1539715|NCT00456729|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1539716|NCT00456716|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539717|NCT00456703|Randomized|Parallel Assignment||Prevention||Single||||||t
1539718|NCT00456690|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1539719|NCT00456677|Randomized|Crossover Assignment||Treatment||Double||Double blind, placebo-controlled. crossover study|t|t||
1539720|NCT00456664||||||||||||
1539721|NCT00456651|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539722|NCT00456638|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1539723|NCT00456625||Single Group Assignment||Prevention||None (Open Label)||||||
1539724|NCT00456612||Single Group Assignment||Treatment||None (Open Label)||||||
1539725|NCT00456599||Single Group Assignment||Treatment||None (Open Label)||||||
1539726|NCT00456586|Randomized|Parallel Assignment||Treatment||Double||||||
1539727|NCT00456573||Parallel Assignment||||None (Open Label)||||||
1539728|NCT00456560|Randomized|Parallel Assignment||||None (Open Label)||||||
1539729|NCT00456547|||Case Control||Prospective|||||||
1539730|NCT00456534|||Defined Population||Cross-Sectional, Prospective|||||||
1539731|NCT00456521|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1539732|NCT00456508||Single Group Assignment||Treatment||None (Open Label)||||||
1539733|NCT00456495||Single Group Assignment||Treatment||None (Open Label)||||||
1539734|NCT00456482|Randomized|Parallel Assignment||Treatment||Double||||||
1539735|NCT00456469|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1539736|NCT00456456|||Defined Population||Cross-Sectional, Retrospective/Prospective|||||||
1539737|NCT00456443|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1539738|NCT00456430|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539739|NCT00456417|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1539740|NCT00456404|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539741|NCT00456391|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1539742|NCT00456378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539743|NCT00456365|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539744|NCT00456352|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539745|NCT00456339|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539746|NCT00456326|||||Retrospective|||||||
1539747|NCT00456313|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539748|NCT00456300|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539749|NCT00456287|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539750|NCT00456274||Single Group Assignment||Diagnostic||None (Open Label)||||||
1539751|NCT00456261|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539752|NCT00456248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539753|NCT00456235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539754|NCT00456222|||||Prospective|||||||
1539755|NCT00456209|||Cohort||Prospective|||||||
1539756|NCT00456196|||Cohort||Retrospective|||||||
1539757|NCT00456183|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539758|NCT00456170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539759|NCT00456157|Randomized|Single Group Assignment||Treatment||Double||||||
1539760|NCT00456144|||Case-Only||Prospective|||||||
1539761|NCT00456131|Randomized|Parallel Assignment||Prevention||Single||||||t
1539762|NCT00456118|||Cohort||Prospective|||||||
1539763|NCT00456105|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539764|NCT00456092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539765|NCT00456066|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539766|NCT00456053|Randomized|Factorial Assignment||Treatment||Single||||||
1539767|NCT00456040|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1539768|NCT00456027||Single Group Assignment||Treatment||None (Open Label)||||||
1539769|NCT00456014||Single Group Assignment||Treatment||None (Open Label)||||||
1539770|NCT00456001|||Cohort||Retrospective|||||||
1539771|NCT00455988|Random Sample||||Cross-Sectional, Prospective|||||||
1539772|NCT00455975|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539773|NCT00455962|Non-Randomized|Parallel Assignment||Other||None (Open Label)|No masking.|Comparisons will be made between response to estradiol and progesterone infusion in young African-American and Caucasian women.||||
1539774|NCT00455949|||Defined Population||Longitudinal, Prospective|||||||
1539775|NCT00455936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539776|NCT00455923|Randomized|Parallel Assignment||Treatment||||||||
1539777|NCT00455910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539778|NCT00455897|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539779|NCT00455884|||Cohort||Prospective|||||||
1539780|NCT00455871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539781|NCT00455858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539782|NCT00455845|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1539783|NCT00455832|||Cohort||Prospective|||||||
1539784|NCT00455819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539785|NCT00455806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539786|NCT00455793|||||Cross-Sectional|||||||
1539787|NCT00455780|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1539788|NCT00455767|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539789|NCT00455754|Randomized|Parallel Assignment||Treatment||Double||||||
1539790|NCT00455741|Non-Randomized|Parallel Assignment||Other||None (Open Label)||Estradiol and progesterone infusion to assess negative and positive feedback on the hypothalamus and pituitary in young and older postmenopausal women.||||
1539791|NCT00455728|||Cohort||Prospective|||||||
1539792|NCT00455715|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1539793|NCT00455702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539794|NCT00455689|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1539795|NCT00455676|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1539796|NCT00455663|Randomized|Parallel Assignment||Treatment||Single||||||t
1539797|NCT00455650|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539798|NCT00455637|Randomized|Single Group Assignment||Treatment||Double||||||
1539799|NCT00455624|||Case-Only||Prospective|||||||
1539800|NCT00455611|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1539801|NCT00455598|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539802|NCT00455585|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539803|NCT00455572|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539804|NCT00455559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539805|NCT00455546|Randomized|Parallel Assignment||Prevention||Double||||||
1539806|NCT00455533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539807|NCT00455520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539808|NCT00455507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539809|NCT00455494|Randomized|Crossover Assignment||Treatment||Single||||||
1539810|NCT00455468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539811|NCT00455455|Randomized|Crossover Assignment||Treatment||Single|||||t|
1539812|NCT00455442|Randomized|Parallel Assignment||||Double||||||
1539813|NCT00455429|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1539814|NCT00455416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539815|NCT00455403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539816|NCT00455390|Randomized|Parallel Assignment||Prevention||Single||||||
1539817|NCT00455377|||Case Control||Cross-Sectional|||||||
1539818|NCT00455364|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539819|NCT00455351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539820|NCT00455338|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539821|NCT00455325|Randomized|Crossover Assignment||Treatment||Single|||t|||
1539822|NCT00455312|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539823|NCT00455299|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1539824|NCT00455286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539825|NCT00455273|||Case-Only||Prospective|||||||
1539826|NCT00455260|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539827|NCT00455247|Randomized|Parallel Assignment||Prevention||Double||||||
1539828|NCT00455234|Randomized|Parallel Assignment||Treatment||Single||||||
1539829|NCT00455221|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539830|NCT00455208|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539831|NCT00455195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539832|NCT00455182|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539833|NCT00455169|||Cohort||Prospective|||||||
1539834|NCT00455156||Single Group Assignment||Prevention||None (Open Label)||||||
1539835|NCT00455143|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1539836|NCT00455130|Randomized|Crossover Assignment||Treatment||Double||||||
1539837|NCT00455117|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1539838|NCT00455104|||Other||Other|||||||
1539839|NCT00455091|||Case-Control||Prospective|||||||
1539840|NCT00455078|||Cohort||Prospective|||||||
1539841|NCT00455065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539842|NCT00455052||Single Group Assignment||Treatment||None (Open Label)||||||
1539843|NCT00455039||Single Group Assignment||Treatment||None (Open Label)||||||
1539844|NCT00455026|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1539845|NCT00455013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539846|NCT00455000|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539847|NCT00454987|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539848|NCT00454974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539849|NCT00454961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539850|NCT00454948|Randomized|Parallel Assignment||Prevention||Single||||||
1539851|NCT00454935|||Cohort||Prospective|||||||
1539852|NCT00454922|Randomized|Parallel Assignment||Prevention||Single||||||t
1539853|NCT00454909|Randomized|Parallel Assignment||Prevention||Single|||t|||
1539854|NCT00454896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539855|NCT00454883|||Cohort||Prospective|||||||
1539856|NCT00454870|Randomized|Parallel Assignment||Treatment||Double||||||
1539857|NCT00454857|||Cohort|||||||||
1539858|NCT00454831|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1539859|NCT00454818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539860|NCT00454805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539861|NCT00454792|Randomized|Parallel Assignment||Treatment||Single||||||t
1539862|NCT00454779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539863|NCT00454766|||Case-Only||Prospective|||||||
1539864|NCT00454753||||||||||||
1539865|NCT00454740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539866|NCT00454714|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539867|NCT00454701|||Cohort||Prospective|||||||
1539868|NCT00454688|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539869|NCT00454675|||Ecologic or Community||Prospective|||||||
1539870|NCT00454662|Randomized|Parallel Assignment||Prevention||Single||||||t
1539871|NCT00454649|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539872|NCT00454636|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539873|NCT00454623|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1539874|NCT00454610|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539875|NCT00454597|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1539876|NCT00454584|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1539877|NCT00454571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539878|NCT00454558||Single Group Assignment||Treatment||None (Open Label)||||||
1539879|NCT00454545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539880|NCT00454532|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539881|NCT00454519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539882|NCT00454506|||Cohort||Prospective|||||||
1539883|NCT00454493|Randomized|Parallel Assignment||Treatment||Double||||||
1539884|NCT00454480|Randomized|||Treatment||||||||
1539885|NCT00454467|||Cohort||Prospective|||||||
1539886|NCT00454454|||Cohort||Prospective|||||||
1539887|NCT00454441|Randomized|Single Group Assignment||Treatment||Double||||||
1539888|NCT00454428|Randomized|Parallel Assignment||||None (Open Label)||||||
1539889|NCT00454415|||Cohort||Prospective|||||||
1539890|NCT00454402|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539891|NCT00454389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539892|NCT00454376||||||||||||
1539893|NCT00454363||Single Group Assignment||Treatment||None (Open Label)||||||
1539894|NCT00454350|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539895|NCT00454337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539896|NCT00454324|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539897|NCT00454311|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1539898|NCT00454298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539899|NCT00454285|Randomized|Parallel Assignment||Prevention||Double||||||
1539900|NCT00454272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539901|NCT00454259|Randomized|Crossover Assignment||Health Services Research||Triple|||t||t|t
1539902|NCT00454246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539903|NCT00454233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539904|NCT00454220|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539905|NCT00454207|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539906|NCT00454194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539907|NCT00454181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539908|NCT00454168|Randomized|||Treatment||||||||
1539909|NCT00454155|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1539910|NCT00454142||Single Group Assignment||Treatment||None (Open Label)||||||
1539911|NCT00454129|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1539912|NCT00454116|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539913|NCT00454103|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1539914|NCT00454090|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539915|NCT00454077|Random Sample||Natural History||Longitudinal, Prospective|||||||
1539916|NCT00454064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539917|NCT00454051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539918|NCT00454038|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539919|NCT00454025|||Cohort||Prospective|||||||
1539920|NCT00454012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539921|NCT00453999|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539922|NCT00453986|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1539923|NCT00453973|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539924|NCT00453960|Randomized|Parallel Assignment||Treatment||Single|||t|||
1539925|NCT00453947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539926|NCT00453934|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539927|NCT00453921|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1539928|NCT00453908|Randomized|Parallel Assignment||Treatment||Double||||||
1539929|NCT00453895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539930|NCT00453882||Single Group Assignment||||None (Open Label)||||||
1539931|NCT00453869|||Cohort||Prospective|||||||
1539932|NCT00453856|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539933|NCT00453843|Randomized|Parallel Assignment||Treatment||Single||||||t
1539934|NCT00453830|Randomized|Single Group Assignment||Treatment||Single|||t|||
1539935|NCT00453817|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1539936|NCT00453804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539937|NCT00453791|Randomized|Crossover Assignment||Treatment||||||||
1539938|NCT00453778|Randomized|Crossover Assignment||Treatment||Double||||||
1539939|NCT00453765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1539940|NCT00453752|||Defined Population|Screening|Longitudinal, Prospective|||||||
1539941|NCT00453739|||Cohort||Prospective|||||||
1539942|NCT00453726|||Cohort||Prospective|||||||
1539943|NCT00453713|||Cohort||Prospective|||||||
1539944|NCT00453700|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1539945|NCT00453687|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1539946|NCT00453674|||Cohort||Prospective|||||||
1539947|NCT00453661|||Case-Control||Prospective|||||||
1539948|NCT00453648|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1539949|NCT00453635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539950|NCT00453622|||Cohort||Prospective|||||||
1539951|NCT00453609|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539952|NCT00453596|||Case Control||Longitudinal, Prospective|||||||
1539953|NCT00453583|||||Retrospective|||||||
1539954|NCT00453570|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539955|NCT00453557|Randomized|Parallel Assignment||Treatment||Double||||||
1539956|NCT00453544|Randomized|Parallel Assignment||||Single||||||t
1539957|NCT00453531|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1539958|NCT00453518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539959|NCT00453505|||||Prospective|||||||
1539960|NCT00453492|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1539961|NCT00453479|Randomized|Parallel Assignment||Diagnostic||||||||
1539962|NCT00453466|Randomized|Parallel Assignment||Prevention||Single||||||
1539963|NCT00453453|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539964|NCT00453440||||||||||||
1539965|NCT00453427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539966|NCT00453414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539967|NCT00453401|Randomized|Parallel Assignment||Treatment||Double||||||
1539968|NCT00453388|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539969|NCT00453375|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539970|NCT00453362||Single Group Assignment||Treatment||None (Open Label)||||||
1539971|NCT00453349|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539972|NCT00453336||Single Group Assignment||Treatment||None (Open Label)||||||
1539973|NCT00453323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539974|NCT00453310||Single Group Assignment||Treatment||None (Open Label)||||||
1539975|NCT00453297|Randomized|Single Group Assignment||Treatment||Double||||||
1539976|NCT00453271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539977|NCT00453258|||Cohort||Prospective|||||||
1539978|NCT00453245|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1539979|NCT00453232|Non-Randomized|||Treatment||||||||
1539980|NCT00453219|||||Prospective|||||||
1539981|NCT00453206||Single Group Assignment||Treatment||None (Open Label)||||||
1539982|NCT00453193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539983|NCT00453180|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1539984|NCT00453167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539985|NCT00453154|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1539986|NCT00453141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539987|NCT00453128|||Case Control, Natural History||Longitudinal, Prospective|||||||
1539988|NCT00453115|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539989|NCT00453102||Single Group Assignment||Treatment||None (Open Label)||||||
1539990|NCT00453089|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1539991|NCT00453076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539992|NCT00453063|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1539993|NCT00453050||||Treatment||None (Open Label)||||||
1539994|NCT00453037|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1539995|NCT00453024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1539996|NCT00453011|Randomized|Parallel Assignment||Treatment||Single||||||
1539997|NCT00452998|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1539998|NCT00452985|||Case-Only||Prospective|||||||
1539999|NCT00452972|Randomized|Parallel Assignment||Treatment||Single||||||
1540000|NCT00452920|Non-Randomized|||Treatment||None (Open Label)||||||
1540001|NCT00452907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540002|NCT00452894|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540003|NCT00452881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540004|NCT00452868||Single Group Assignment||Supportive Care||None (Open Label)||||||
1540005|NCT00452855|Randomized|Parallel Assignment||Prevention||Double||||||
1540006|NCT00452842||||||||||||
1540007|NCT00452829|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1540008|NCT00452816|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540009|NCT00452803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540010|NCT00452790|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540011|NCT00452777|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540012|NCT00452764|||||Prospective|||||||
1540013|NCT00452751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540014|NCT00452738|Randomized|Single Group Assignment||Treatment||Single||||||
1540015|NCT00452725|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540016|NCT00452712|||Defined Population|Screening|Longitudinal, Prospective|||||||
1540017|NCT00452699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540018|NCT00452686|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540019|NCT00452673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540020|NCT00452660||Single Group Assignment||Treatment||None (Open Label)||||||
1540021|NCT00452647|||Cohort||Retrospective|||||||
1540022|NCT00452634|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540023|NCT00452621|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540024|NCT00452608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540025|NCT00452595|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540026|NCT00452582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540027|NCT00452569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540028|NCT00452556|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540029|NCT00452543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540030|NCT00452530|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540031|NCT00452517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540032|NCT00452504|Randomized|Single Group Assignment||Treatment||Double||||||
1540033|NCT00452491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540034|NCT00452478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540035|NCT00452465|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1540036|NCT00452452|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540037|NCT00452439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540038|NCT00452426|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1540039|NCT00452413||Single Group Assignment||Treatment||None (Open Label)||||||
1540040|NCT00452400||Parallel Assignment||Treatment||||||||
1540041|NCT00452387|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540042|NCT00452374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540043|NCT00452361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540044|NCT00452348|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540045|NCT00452335|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540046|NCT00452322|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540047|NCT00452309|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1540048|NCT00452296||Single Group Assignment||Diagnostic||None (Open Label)||||||
1540049|NCT00452283|||Case-Only||Prospective|||||||
1540050|NCT00452270|Randomized|Parallel Assignment||Treatment||Double||||||
1540051|NCT00452257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540052|NCT00452244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540053|NCT00452231|Randomized|Single Group Assignment||Treatment||Double||||||
1540054|NCT00452218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540055|NCT00452205|||Cohort||Prospective|||||||
1540056|NCT00452192|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1540057|NCT00452179|Randomized|Crossover Assignment||Treatment||Double||||||
1540058|NCT00452166|Randomized|Parallel Assignment||Treatment||Double||||||
1540059|NCT00452153||Single Group Assignment||Diagnostic||None (Open Label)||||||
1540060|NCT00452140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540061|NCT00452127||Single Group Assignment||Treatment||None (Open Label)||||||
1540062|NCT00452114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540063|NCT00452101|Randomized|Parallel Assignment||Treatment||Double||||||
1540064|NCT00452088|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540065|NCT00452075|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540066|NCT00452062|Randomized|Parallel Assignment||Prevention||Double||||||
1540067|NCT00452049|||Cohort||Prospective|||||||
1540068|NCT00452036|||Cohort||Retrospective|||||||
1540069|NCT00452023||Single Group Assignment||Treatment||None (Open Label)||||||
1540070|NCT00452010|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540071|NCT00451997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540072|NCT00451984|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540073|NCT00451971|Randomized|Single Group Assignment||Treatment||Single||||||
1540074|NCT00451958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540075|NCT00451945|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1540076|NCT00451932|Randomized|Parallel Assignment||Treatment||Double||||||
1540077|NCT00451919||||||||||||
1540078|NCT00451906||Single Group Assignment||Treatment||None (Open Label)||||||
1540079|NCT00451893|Randomized|Parallel Assignment||Treatment||Single||||||t
1540080|NCT00451880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540081|NCT00451867|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540082|NCT00451854|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540083|NCT00451841|||Cohort||Prospective|||||||
1540084|NCT00451828|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540085|NCT00451815|Randomized|Parallel Assignment||Treatment||Double||||||
1540086|NCT00451802|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1540087|NCT00451789|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1540088|NCT00451776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540089|NCT00451763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540090|NCT00451750|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540091|NCT00451737|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1540092|NCT00451724|Randomized|Parallel Assignment||Treatment||Double||||||
1540093|NCT00451711|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540094|NCT00451698|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1540095|NCT00451672|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540096|NCT00451659|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1540097|NCT00451646|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540098|NCT00451633|Randomized|Crossover Assignment||Treatment||Double||||||
1540099|NCT00451620|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540100|NCT00451607|||Case-Only||Prospective|||||||
1540101|NCT00451594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540102|NCT00451581|Randomized|Parallel Assignment||Treatment||Double||||||
1540103|NCT00451568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540104|NCT00451555|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540105|NCT00451542|||Other||Retrospective|||||||
1540106|NCT00451529|||Cohort||Prospective|||||||
1540107|NCT00451516|Randomized|Crossover Assignment||Treatment||Double||||||
1540108|NCT00451503||Single Group Assignment||Treatment||None (Open Label)||||||
1540109|NCT00451490|Randomized|Parallel Assignment||Health Services Research||Double||||||
1540110|NCT00451464|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1540111|NCT00451451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540112|NCT00451438|||Case Control||Cross-Sectional, Prospective|||||||
1540113|NCT00451425|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540114|NCT00451412|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1540115|NCT00451399|Randomized|Factorial Assignment||Treatment||Double||||||
1540116|NCT00451386|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540117|NCT00451373|Randomized|Single Group Assignment||Treatment||Single||||||
1540118|NCT00451360|Randomized|Parallel Assignment||Treatment||Double||||||
1540119|NCT00451347|Randomized|Crossover Assignment||Treatment||Single||||||
1540120|NCT00451334|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1540121|NCT00451321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540122|NCT00451308|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540123|NCT00451295|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540124|NCT00451282|Randomized|Parallel Assignment||Prevention||Single||||||t
1540125|NCT00451269|||Case Control||Prospective|||||||
1540126|NCT00451256|Randomized|Single Group Assignment||Treatment||Double||||||
1540127|NCT00451243|||Case Control||Cross-Sectional, Retrospective/Prospective|||||||
1540128|NCT00451230|Randomized|Single Group Assignment||||Double||||||
1540129|NCT00451217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540130|NCT00451204|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540131|NCT00451191|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540132|NCT00451178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540133|NCT00451165|||Case Control||Prospective|||||||
1540134|NCT00451152|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540135|NCT00451139|Randomized|Parallel Assignment||||None (Open Label)||||||
1540136|NCT00451126|||Natural History||Cross-Sectional, Prospective|||||||
1540137|NCT00451113|Randomized|Crossover Assignment||Treatment||Single|||t|||
1540138|NCT00451100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540139|NCT00451087|Randomized|Parallel Assignment||Treatment||Single|||t|||
1540140|NCT00451074||Single Group Assignment||Treatment||None (Open Label)||||||
1540141|NCT00451061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540142|NCT00451048||Single Group Assignment||Treatment||None (Open Label)||||||
1540143|NCT00451035||Single Group Assignment||Treatment||None (Open Label)||||||
1540144|NCT00451022||||||||||||
1540145|NCT00451009|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540146|NCT00450996|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540147|NCT00450983||||Treatment||None (Open Label)||||||
1540148|NCT00450970|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540149|NCT00450957|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540150|NCT00450944||||Treatment||||||||
1540151|NCT00450931|Randomized|||||||||||
1540152|NCT00450918|||Cohort||Prospective|||||||
1540153|NCT00450905|Randomized|Parallel Assignment||Treatment||Double||||||
1540154|NCT00450892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540155|NCT00450879||Single Group Assignment||Treatment||None (Open Label)||||||
1540156|NCT00450866||Single Group Assignment||Treatment||None (Open Label)||||||
1540157|NCT00450853||Single Group Assignment||Supportive Care||None (Open Label)||||||
1540158|NCT00450840|Randomized|Parallel Assignment||Treatment||Double||||||
1540159|NCT00450827||Single Group Assignment||Treatment||None (Open Label)||||||
1540160|NCT00450814|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540161|NCT00450801||Single Group Assignment||Treatment||None (Open Label)||||||
1540162|NCT00450788|||Cohort||Prospective|||||||
1540163|NCT00450775|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540164|NCT00450762|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540165|NCT00450749|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540166|NCT00450736||Single Group Assignment||Treatment||None (Open Label)||||||
1540167|NCT00450723||Single Group Assignment||Diagnostic||None (Open Label)||||||
1540168|NCT00450710|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1540169|NCT00450697|||Cohort||Prospective|||||||
1540170|NCT00450684|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1540171|NCT00450671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540172|NCT00450658|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540173|NCT00450645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540174|NCT00450632|||||Prospective|||||||
1540175|NCT00450619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540176|NCT00450606|Randomized|Parallel Assignment||Treatment||Single||||||
1540177|NCT00450593||||||||||||
1540178|NCT00450580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540179|NCT00450567|||Case-Only||Prospective|||||||
1540180|NCT00450554|||||Prospective|||||||
1540181|NCT00450541|||Case-Only||Prospective|||||||
1540182|NCT00450528|||||Prospective|||||||
1540183|NCT00450515||Single Group Assignment||Treatment||None (Open Label)||||||
1540184|NCT00450502||||Treatment||||||||
1540185|NCT00450489|||Cohort||Retrospective|||||||
1540186|NCT00450476|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1540187|NCT00450463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540188|NCT00450450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540189|NCT00450437|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1540190|NCT00450424|Randomized|Parallel Assignment||||None (Open Label)||||||
1540191|NCT00450411||Single Group Assignment||Treatment||None (Open Label)||||||
1540192|NCT00450398|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540193|NCT00450385||Single Group Assignment||Treatment||None (Open Label)||||||
1540194|NCT00450372||Single Group Assignment||Treatment||None (Open Label)||||||
1540195|NCT00450359|Randomized|||Screening||||||||
1540196|NCT00450333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540197|NCT00450320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540198|NCT00450307||Single Group Assignment||Treatment||None (Open Label)||||||
1540199|NCT00450294|||||Prospective|||||||
1540200|NCT00450281|||Case-Only||Prospective|||||||
1540201|NCT00450268|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1540202|NCT00450255||Single Group Assignment||Treatment||None (Open Label)||||||
1540203|NCT00450242|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1540204|NCT00450229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540205|NCT00450216|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540206|NCT00450203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540207|NCT00450190||Single Group Assignment||Treatment||None (Open Label)||||||
1540208|NCT00450177|Randomized|Single Group Assignment||Treatment||Double||||||
1540209|NCT00450164|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540210|NCT00450151|||Case-Only||Prospective|||||||
1540211|NCT00450138|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540212|NCT00450125|||Case-Only||Prospective|||||||
1540213|NCT00450112|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540214|NCT00450099|Randomized|Single Group Assignment||Treatment||Single|||t|||
1540215|NCT00450086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540216|NCT00450073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540217|NCT00450060|Randomized|Parallel Assignment||Prevention||Double||||||
1540218|NCT00450047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540219|NCT00450034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540220|NCT00450021|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1540221|NCT00450008||Single Group Assignment||Treatment||None (Open Label)||||||
1540222|NCT00449995|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1540223|NCT00449982|Randomized|Parallel Assignment||Treatment||Double||||||
1540224|NCT00449969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540225|NCT00449956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540226|NCT00449943|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1540227|NCT00449930|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540228|NCT00449917|Randomized|Parallel Assignment||Prevention||Double||||||
1540229|NCT00449904|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540230|NCT00449891|||||Cross-Sectional|||||||
1540231|NCT00449878|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540232|NCT00449865|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540233|NCT00449852|Randomized|Factorial Assignment||||None (Open Label)||||||
1540234|NCT00449839|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540235|NCT00449826|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||t
1540236|NCT00449813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540237|NCT00449800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540238|NCT00449787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540239|NCT00449774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540240|NCT00449761||Single Group Assignment||Treatment||None (Open Label)||||||
1540241|NCT00449748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540242|NCT00449735|||Cohort||Retrospective|||||||
1540243|NCT00449722|Randomized|Parallel Assignment||Treatment||Double||||||
1540244|NCT00449709|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540245|NCT00449696|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540246|NCT00449683||Single Group Assignment||Treatment||None (Open Label)||||||
1540247|NCT00449670|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540248|NCT00449657||Single Group Assignment||Treatment||None (Open Label)||||||
1540249|NCT00449644|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540250|NCT00449631||||Screening|Cross-Sectional, Prospective|||||||
1540251|NCT00449618|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1540252|NCT00449605|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540253|NCT00449592|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540254|NCT00449579|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1540255|NCT00449566|||Case Control, Natural History||Longitudinal, Prospective|||||||
1540256|NCT00449553|||Cohort||Prospective|||||||
1540257|NCT00449540|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1540258|NCT00449527|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540259|NCT00449514|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540260|NCT00449501|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540261|NCT00449488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540262|NCT00449462|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540263|NCT00449449|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540264|NCT00449436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540265|NCT00449423|Randomized|Parallel Assignment||Treatment||Double||||||
1540266|NCT00449410|Randomized|Parallel Assignment||Prevention||Double||||||
1540267|NCT00449397|Randomized|Single Group Assignment||Treatment||Double||||||
1540268|NCT00449384|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1540269|NCT00449358|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1540270|NCT00449345|||Defined Population|Screening|Longitudinal, Prospective|||||||
1540271|NCT00449332|||Cohort||Prospective|||||||
1540272|NCT00449319|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1540273|NCT00449306|||Case Control||Cross-Sectional|||||||
1540274|NCT00449293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540275|NCT00449280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540276|NCT00449267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540277|NCT00449254|Randomized|Parallel Assignment||Treatment||Double||||||
1540278|NCT00449241|Randomized|Parallel Assignment||Treatment||Double||||||
1540279|NCT00449228|Randomized|Parallel Assignment||Treatment||Single|||||t|
1540280|NCT00449215|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1540281|NCT00449202|Randomized|Parallel Assignment||Treatment||Double||||||
1540282|NCT00449176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540283|NCT00449163||Single Group Assignment||Treatment||None (Open Label)||||||
1540284|NCT00449150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540285|NCT00449137||Single Group Assignment||Treatment||None (Open Label)||||||
1540286|NCT00449124|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1540287|NCT00449111|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540288|NCT00449098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540289|NCT00449085||Single Group Assignment||Diagnostic||None (Open Label)||||||
1540290|NCT00449072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540291|NCT00449059|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540292|NCT00449046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540293|NCT00449033|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540294|NCT00449020||Single Group Assignment||Treatment||None (Open Label)||||||
1540295|NCT00449007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540296|NCT00448994|||Case-Only|||||||||
1540297|NCT00448981|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1540298|NCT00448968|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1540299|NCT00448955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540300|NCT00448942|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1540301|NCT00448929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540302|NCT00448916|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540303|NCT00448903|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540304|NCT00448890|Randomized|Crossover Assignment||Treatment||Single|||||t|
1540305|NCT00448877|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1540306|NCT00448864|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540307|NCT00448851|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1540308|NCT00448838|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540309|NCT00448825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540310|NCT00448812||||||||||||
1540311|NCT00448799|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1540312|NCT00448786|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540313|NCT00448773|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540314|NCT00448760||Single Group Assignment||Treatment||None (Open Label)||||||
1540315|NCT00448747|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||Multi-center, randomized, open-label, cross-over trial to compare AEZS-130 to an established GH stimulation test, L-ARG+GHRH, in the diagnosis of GH deficiency and in terms of safety. Following Amendment no. 3 (version 27 May 2010) , no cross-over was performed anymore due to unavailability of L-ARG+GHRH) with resulting single arm testing of AEZS-130. Thus, two treatment arms was applicable as long as GHRH as substance was available.||||
1540316|NCT00448734|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540317|NCT00448721||Single Group Assignment||Treatment||None (Open Label)||||||
1540318|NCT00448708|Randomized|Parallel Assignment||Treatment||Single|||t|||
1540319|NCT00448695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540320|NCT00448682||Single Group Assignment||Treatment||None (Open Label)||||||
1540321|NCT00448669|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1540322|NCT00448656||Single Group Assignment||Treatment||None (Open Label)||||||
1540323|NCT00448643||Single Group Assignment||Treatment||None (Open Label)||||||
1540324|NCT00448630|||Cohort||Prospective|||||||
1540325|NCT00448617|||Cohort||Prospective|||||||
1540326|NCT00448604|||Cohort||Prospective|||||||
1540327|NCT00448591||Single Group Assignment||Treatment||None (Open Label)||||||
1540328|NCT00448578|Randomized|Parallel Assignment||Treatment||Double||||||
1540329|NCT00448565|||Case-Only||Prospective|||||||
1540330|NCT00448552||||Treatment||None (Open Label)||||||
1540331|NCT00448539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540332|NCT00448526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540333|NCT00448513|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540334|NCT00448500|||Case Control||Prospective|||||||
1540335|NCT00448487|||Cohort||Prospective|||||||
1540336|NCT00448474|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1540337|NCT00448461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540338|NCT00448448|Randomized|Parallel Assignment||Treatment||Single|The outcomes assessor(s) are blinded to the treatment assignment.|||||t
1540339|NCT00448435|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540340|NCT00448422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540341|NCT00448409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540342|NCT00448396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540343|NCT00448383|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540344|NCT00448370|||Cohort||Prospective|||||||
1540345|NCT00448357||Single Group Assignment||Treatment||None (Open Label)||||||
1540346|NCT00448344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540347|NCT00448331|||Cohort||Prospective|||||||
1540348|NCT00448318|Randomized|Parallel Assignment||Treatment||Single||||||
1540349|NCT00448305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540350|NCT00448292|Randomized|Parallel Assignment||Treatment||Double||||||
1540351|NCT00448279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540352|NCT00448266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540353|NCT00448253|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540354|NCT00448240|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540355|NCT00448227|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540356|NCT00448214|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540357|NCT00448201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540358|NCT00448188|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540359|NCT00448175|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540360|NCT00448162|||Cohort||Cross-Sectional|||||||
1540361|NCT00448149||Single Group Assignment||Treatment||None (Open Label)||||||
1540513|NCT00446160|||Case-Only||Retrospective|||||||
1540362|NCT00448136|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540363|NCT00448123|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540364|NCT00448110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540365|NCT00448097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540366|NCT00448084||||||||||||
1540367|NCT00448071|Randomized|Parallel Assignment||Treatment||Double||||||
1540368|NCT00448058|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540369|NCT00448045|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1540370|NCT00448032|Randomized|Single Group Assignment||Diagnostic||Double||||||
1540371|NCT00448019||Single Group Assignment||Treatment||None (Open Label)||||||
1540372|NCT00448006|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540373|NCT00447993|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1540374|NCT00447980|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1540375|NCT00447967|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540376|NCT00447954|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1540377|NCT00447941|Randomized|Crossover Assignment||Treatment||Double||||||
1540378|NCT00447928|Randomized|Parallel Assignment||Treatment||Double||||||
1540379|NCT00447915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540380|NCT00447902||Parallel Assignment||Treatment||||||||
1540381|NCT00447889|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1540382|NCT00447876|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540383|NCT00447863|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540384|NCT00447850||||||||||||
1540385|NCT00447837|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540386|NCT00447824|Randomized|Parallel Assignment||Treatment||Single||||||
1540387|NCT00447811|Randomized|Crossover Assignment||Diagnostic||Double||||||
1540388|NCT00447798|Randomized|Single Group Assignment||||Double|||t|||t
1540389|NCT00447785|||Case Control, Natural History||Longitudinal, Prospective|||||||
1540390|NCT00447772||Single Group Assignment||Treatment||None (Open Label)||||||
1540391|NCT00447759|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540392|NCT00447746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540393|NCT00447733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540394|NCT00447720|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540395|NCT00447707|Randomized|Parallel Assignment||||Single||||||
1540396|NCT00447694||Single Group Assignment||Treatment||None (Open Label)||||||
1540397|NCT00447681|Randomized|Single Group Assignment||Treatment||Double||||||
1540398|NCT00447668|Randomized|Parallel Assignment||Treatment||Single||||||t
1540399|NCT00447655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540400|NCT00447642|Randomized|Parallel Assignment||Prevention||Single|||t|||
1540401|NCT00447629|Randomized|Crossover Assignment||Diagnostic||Double||||||
1540402|NCT00447616|||Other||Prospective|||||||
1540403|NCT00447603|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540404|NCT00447590||Single Group Assignment||Treatment||None (Open Label)||||||
1540405|NCT00447577|Randomized|Parallel Assignment||Treatment||Single|||t|||
1540406|NCT00447564|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540407|NCT00447551|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540408|NCT00447538|||||Retrospective|||||||
1540409|NCT00447525|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540410|NCT00447512|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1540411|NCT00447499|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540412|NCT00447486|Randomized|Single Group Assignment||Treatment||Double||||||
1540413|NCT00447473||Single Group Assignment||Treatment||None (Open Label)||||||
1540414|NCT00447460|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540415|NCT00447434|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540416|NCT00447421|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540417|NCT00447408|Randomized|Parallel Assignment||||None (Open Label)||||||
1540418|NCT00447395|||||Prospective|||||||
1540419|NCT00447382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540420|NCT00447369|Randomized|Crossover Assignment||Treatment||Double||||||
1540421|NCT00447356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540422|NCT00447343|||Case-Control||Prospective|||||||
1540423|NCT00447330|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540424|NCT00447317|Randomized|Parallel Assignment||||None (Open Label)||||||
1540425|NCT00447304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540426|NCT00447291|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1540427|NCT00447278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540428|NCT00447265|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1540429|NCT00447252|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1540430|NCT00447239|Randomized|Parallel Assignment||Prevention||Double||||||
1540431|NCT00447226|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1540432|NCT00447213|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540433|NCT00447200|||||Prospective|||||||
1540434|NCT00447187|Randomized|Parallel Assignment||Prevention||Single|||t|||
1540435|NCT00447174|Randomized|Parallel Assignment||Treatment||Single||||||t
1540436|NCT00447161|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540437|NCT00447148|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1540439|NCT00447122||Single Group Assignment||Treatment||None (Open Label)||||||
1540440|NCT00447109|Randomized|Parallel Assignment||Treatment||Single||||||
1540441|NCT00447096|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1540442|NCT00447083|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1540443|NCT00447070|Randomized|Parallel Assignment||Treatment||Single||||||
1540444|NCT00447057|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540445|NCT00447044|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1540446|NCT00447031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540447|NCT00447018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540448|NCT00447005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540449|NCT00446992|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540450|NCT00446979|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540451|NCT00446966|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540452|NCT00446953|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540453|NCT00446940|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540454|NCT00446927|||Case-Only||Prospective|||||||
1540455|NCT00446914|Randomized|Parallel Assignment||||None (Open Label)||||||
1540456|NCT00446901|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540457|NCT00446888|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1540458|NCT00446875|Randomized|Parallel Assignment||Treatment||Double||||||
1540459|NCT00446862|||Case Control||Prospective|||||||
1540460|NCT00446849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540461|NCT00446836||Single Group Assignment||Treatment||None (Open Label)||||||
1540462|NCT00446823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540463|NCT00446810|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1540464|NCT00446797|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540465|NCT00446784|Randomized|Parallel Assignment||Treatment||Double||||||
1540466|NCT00446771|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540467|NCT00446758|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540468|NCT00446745|||Cohort||Prospective|||||||
1540469|NCT00446732|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540470|NCT00446719|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540471|NCT00446706|||Case-Only||Prospective|||||||
1540472|NCT00446693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540473|NCT00446680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540474|NCT00446667|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540475|NCT00446654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540476|NCT00446641|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540477|NCT00446628|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540478|NCT00446615|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1540479|NCT00446602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540480|NCT00446589|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540481|NCT00446576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540482|NCT00446563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540483|NCT00446550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540484|NCT00446537|Randomized|Crossover Assignment||||Double||||||
1540485|NCT00446524|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540486|NCT00446511|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540487|NCT00446498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540488|NCT00446485|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540489|NCT00446472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540490|NCT00446459|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540491|NCT00446446||Single Group Assignment||Treatment||None (Open Label)||||||
1540492|NCT00446433|Randomized|Parallel Assignment||Treatment||Double||||||
1540493|NCT00446420|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1540494|NCT00446407|Randomized|Parallel Assignment||Treatment||Single||||||t
1540495|NCT00446394|Randomized|Parallel Assignment||Treatment||Single||||||t
1540496|NCT00446381|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1540497|NCT00446368||Single Group Assignment||Treatment||None (Open Label)||||||
1540498|NCT00446355|||Case Control||Retrospective|||||||
1540499|NCT00446342||Single Group Assignment||Treatment||None (Open Label)||||||
1540500|NCT00446329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540501|NCT00446316|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540502|NCT00446303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540503|NCT00446290||Single Group Assignment||Treatment||None (Open Label)||||||
1540504|NCT00446277|||Case-Only||Prospective|||||||
1540505|NCT00446264||Single Group Assignment||Treatment||None (Open Label)||||||
1540506|NCT00446251|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540507|NCT00446238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540508|NCT00446225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540509|NCT00446212|Randomized|Parallel Assignment||Diagnostic||Double|||t|||t
1540510|NCT00446199|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540511|NCT00446186|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540512|NCT00446173||Single Group Assignment||Treatment||None (Open Label)||||||
1540514|NCT00446147|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1540515|NCT00446134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540516|NCT00446121|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1540517|NCT00446108|||Case Control||Retrospective|||||||
1540518|NCT00446095||Single Group Assignment||Treatment||None (Open Label)||||||
1540519|NCT00446082||Single Group Assignment||Treatment||None (Open Label)||||||
1540520|NCT00446069|Randomized|Crossover Assignment||Supportive Care||Triple|||t||t|t
1540521|NCT00446056|Randomized|Parallel Assignment||Treatment||Double||||||
1540522|NCT00446043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540523|NCT00446030|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540524|NCT00446017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540525|NCT00446004|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540526|NCT00445978|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540527|NCT00445965||Single Group Assignment||Treatment||None (Open Label)||||||
1540528|NCT00445952||||||||||||
1540529|NCT00445939|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540530|NCT00445926|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540531|NCT00445913|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1540532|NCT00445900||||Treatment||None (Open Label)||||||
1540533|NCT00445887|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1540534|NCT00445874|Randomized|Parallel Assignment||||Double||||||
1540535|NCT00445861||Single Group Assignment||Treatment||None (Open Label)||||||
1540536|NCT00445848||Single Group Assignment||Treatment||None (Open Label)||||||
1540537|NCT00445835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540538|NCT00445822|||Cohort||Prospective|||||||
1540539|NCT00445809|||Cohort||Prospective|||||||
1540540|NCT00445796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540541|NCT00445783||||||||||||
1540542|NCT00445770|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540543|NCT00445757||Single Group Assignment||Treatment||None (Open Label)||||||
1540544|NCT00445744||Single Group Assignment||Treatment||None (Open Label)||||||
1540545|NCT00445731|Randomized|||Supportive Care||||||||
1540546|NCT00445718|||Case-Only||Prospective|||||||
1540547|NCT00445705|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540548|NCT00445692||Single Group Assignment||Treatment||None (Open Label)||||||
1540549|NCT00445679|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540550|NCT00445653|||Case Control||Prospective|||||||
1540551|NCT00445627|||Cohort||Prospective|||||||
1540552|NCT00445614|Randomized|Parallel Assignment||Prevention||Single||||||
1540553|NCT00445601|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540554|NCT00445588||Single Group Assignment||Treatment||None (Open Label)||||||
1540555|NCT00445575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540556|NCT00445562||||||||||||
1540557|NCT00445549|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540558|NCT00445523|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540559|NCT00445510|Randomized|Crossover Assignment||Treatment||Double||||||
1540560|NCT00445497|Randomized|||Supportive Care||||||||
1540561|NCT00445484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540562|NCT00445471|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540563|NCT00445458|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540564|NCT00445445|||Case-Control||Other|||||||
1540565|NCT00445432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540566|NCT00445419|Randomized|Parallel Assignment||Treatment||Single||||||
1540567|NCT00445406||Single Group Assignment||Treatment||None (Open Label)||||||
1540568|NCT00445393|||Cohort||Prospective|||||||
1540569|NCT00445367|||Case-Control||Other|||||||
1540570|NCT00445354|Randomized|Parallel Assignment||Treatment||Single||||||
1540571|NCT00445341||Single Group Assignment||Treatment||None (Open Label)||||||
1540572|NCT00445328|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540573|NCT00445315|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1540574|NCT00445302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540575|NCT00445289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540576|NCT00445276|Randomized|Parallel Assignment||Treatment||Double||||||
1540577|NCT00445263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540578|NCT00445250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540579|NCT00445237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540580|NCT00445224|Randomized|Crossover Assignment||Treatment||Single|||t|||
1540581|NCT00445211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540582|NCT00445198|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540583|NCT00445185|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540584|NCT00445172||Single Group Assignment||Treatment||None (Open Label)||||||
1540585|NCT00445159|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1540586|NCT00445146||Single Group Assignment||Treatment||None (Open Label)||||||
1540587|NCT00445133|Randomized|Parallel Assignment||Treatment||Double||||||
1540588|NCT00445120|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1540589|NCT00445107|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540590|NCT00445094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540591|NCT00445081|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540592|NCT00445068||Single Group Assignment||Treatment||None (Open Label)||||||
1540593|NCT00445055|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1540594|NCT00445042||Single Group Assignment||Treatment||None (Open Label)||||||
1540595|NCT00445029|||Defined Population||Longitudinal, Prospective|||||||
1540596|NCT00445016|||||Prospective|||||||
1540597|NCT00445003|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1540598|NCT00444990|Randomized|Parallel Assignment||Treatment||Double||||||
1540599|NCT00444977|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540600|NCT00444964|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1540601|NCT00444951|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540602|NCT00444938|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540603|NCT00444925|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540604|NCT00444912|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540605|NCT00444899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540606|NCT00444886|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540607|NCT00444873|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540608|NCT00444860|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540609|NCT00444847|Non-Randomized|Crossover Assignment||Treatment||Single||||||
1540610|NCT00444834|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1540611|NCT00444821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540612|NCT00444808|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540613|NCT00444795|||Case-Only||Prospective|||||||
1540614|NCT00444782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540615|NCT00444769|Randomized|Parallel Assignment||Treatment||Double||||||
1540616|NCT00444756|Randomized|Single Group Assignment||Treatment||Single||||||
1540617|NCT00444743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540618|NCT00444730|||Case Control||Prospective|||||||
1540619|NCT00444717|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540620|NCT00444704|Randomized|Parallel Assignment||Treatment||Double||||||
1540621|NCT00444691|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1540622|NCT00444678||Single Group Assignment||Treatment||None (Open Label)||||||
1540623|NCT00444665|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540624|NCT00444652|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540625|NCT00444639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540626|NCT00444626|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1540627|NCT00444613|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540628|NCT00444600|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1540629|NCT00444587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540630|NCT00444574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540631|NCT00444561|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540632|NCT00444548|Randomized|Crossover Assignment||Treatment||Double||||||
1540633|NCT00444535||||Treatment||None (Open Label)||||||
1540634|NCT00444522|Randomized|Parallel Assignment||Treatment||Double||||||
1540635|NCT00444509|Randomized|Crossover Assignment||Treatment||||||||
1540636|NCT00444496|||||Retrospective|||||||
1540637|NCT00444483|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1540638|NCT00444470|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540639|NCT00444457|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1540640|NCT00444444|||Case Control|Screening|Longitudinal, Prospective|||||||
1540641|NCT00444431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540642|NCT00444418|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1540643|NCT00444405|||Other||Prospective|||||||
1540644|NCT00444392|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540645|NCT00444379|Randomized|Parallel Assignment||Treatment||Single||||||t
1540646|NCT00444353|Randomized|Parallel Assignment||Treatment||Single||||||
1540647|NCT00444340|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540648|NCT00444327|||Cohort||Prospective|||||||
1540649|NCT00444314|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540650|NCT00444301|||Cohort||Prospective|||||||
1540651|NCT00444288|||||Other|||||||
1540652|NCT00444275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540653|NCT00444262|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540654|NCT00444249|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1540655|NCT00444236|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540656|NCT00444223||Single Group Assignment||Diagnostic||None (Open Label)||||||
1540657|NCT00444210|Randomized|Parallel Assignment||Treatment||Single||||||
1540658|NCT00444197|Randomized|Parallel Assignment||Prevention||Single||||||
1540659|NCT00444184|Randomized|Crossover Assignment||Treatment||Single|||||t|
1540660|NCT00444171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540661|NCT00444158|Randomized|Crossover Assignment||Treatment||Double||||||
1540662|NCT00444145||Single Group Assignment||Treatment||None (Open Label)||||||
1540663|NCT00444132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540664|NCT00444119|||Defined Population||Cross-Sectional, Retrospective/Prospective|||||||
1540665|NCT00444106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540742|NCT00443170|Randomized|Single Group Assignment||Treatment||Single||||||
1540743|NCT00443157|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540666|NCT00444093|Randomized|Parallel Assignment||Treatment||None (Open Label)||Comparision between treatment with Tinctura Opii normata and Loperamid in patients with therapy-associated diarrhea during radiaton therapy of small pelvis||||
1540667|NCT00444080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540668|NCT00444067|Randomized|Parallel Assignment||Treatment||Single|||t|||
1540669|NCT00444054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540670|NCT00444041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540671|NCT00444028|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540672|NCT00444015||Single Group Assignment||Treatment||None (Open Label)||||||
1540673|NCT00444002|||Case-Only||Cross-Sectional|||||||
1540674|NCT00443989|||Cohort||Prospective|||||||
1540675|NCT00443976||Single Group Assignment||Treatment||None (Open Label)||||||
1540676|NCT00443963|Randomized|Parallel Assignment||Treatment||Single||||||
1540677|NCT00443950|Randomized|Parallel Assignment||Treatment||Double||||||
1540678|NCT00443937|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540679|NCT00443924|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540680|NCT00443911|||Case-Only||Prospective|||||||
1540681|NCT00443898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540682|NCT00443885|||Cohort||Prospective|||||||
1540683|NCT00443872||Single Group Assignment||Treatment||None (Open Label)||||||
1540684|NCT00443859|||Cohort||Prospective|||||||
1540685|NCT00443846|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540686|NCT00443833|||Case Control|Screening|Cross-Sectional, Retrospective|||||||
1540687|NCT00443820|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540688|NCT00443807|Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1540689|NCT00443794|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540690|NCT00443781||Single Group Assignment||Diagnostic||None (Open Label)||||||
1540691|NCT00443768|||Case Control||Prospective|||||||
1540692|NCT00443755|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1540693|NCT00443742||||||||||||
1540694|NCT00443729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540695|NCT00443716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540696|NCT00443703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540697|NCT00443690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540698|NCT00443677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540699|NCT00443664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540700|NCT00443651|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540701|NCT00443638|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1540702|NCT00443625|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540703|NCT00443612|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540704|NCT00443599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540705|NCT00443586|Randomized|Parallel Assignment||Prevention||Single|Assessors were masked to original treatment assignments.|||||t
1540706|NCT00443573|Non-Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540707|NCT00443560|||Case Control||Retrospective|||||||
1540708|NCT00443547|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540709|NCT00443534||Single Group Assignment||Treatment||None (Open Label)||||||
1540710|NCT00443521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540711|NCT00443508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540712|NCT00443495|Randomized|Parallel Assignment||Treatment||Double||||||
1540713|NCT00443482|Randomized|Crossover Assignment||Treatment||Double||||||
1540714|NCT00443469|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1540715|NCT00443456|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540716|NCT00443443|||Cohort||Prospective|||||||
1540717|NCT00443430|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540718|NCT00443417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540719|NCT00443404|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1540720|NCT00443391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540721|NCT00443378|Randomized|Parallel Assignment||||None (Open Label)||||||
1540722|NCT00443365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540723|NCT00443352||Single Group Assignment||Prevention||None (Open Label)||||||
1540724|NCT00443339|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540725|NCT00020475||||Treatment||||||||
1540726|NCT00020371||||Treatment||||||||
1540727|NCT00020345||||Treatment||||||||
1540728|NCT00020267||||Treatment||||||||
1540729|NCT00019643|||||Prospective|||||||
1540730|NCT00443326|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1540731|NCT00443313|||||Other|||||||
1540732|NCT00443300|||Case Control||Prospective|||||||
1540733|NCT00443287|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540734|NCT00443274|||Cohort||Prospective|||||||
1540735|NCT00443261||Single Group Assignment||Treatment||None (Open Label)||||||
1540736|NCT00443248|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1540737|NCT00443235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540738|NCT00443222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540739|NCT00443209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540740|NCT00443196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540741|NCT00443183|Randomized|Parallel Assignment||Treatment||Single|||t|||
1540744|NCT00443144||||||||||||
1540745|NCT00443131|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1540746|NCT00443118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540747|NCT00443105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540748|NCT00443092|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1540749|NCT00443079|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1540750|NCT00443066|||Case-Only||Prospective|||||||
1540751|NCT00443053|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540752|NCT00443040|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540753|NCT00443027|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1540754|NCT00443014|Randomized|Factorial Assignment||Treatment||Double|||||t|t
1540755|NCT00443001|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1540756|NCT00442988|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1540757|NCT00442975|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1540758|NCT00442962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540759|NCT00442949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540760|NCT00442936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540761|NCT00442923|Randomized|Parallel Assignment||||Double||||||
1540762|NCT00442910|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540763|NCT00442897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540764|NCT00442884|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1540765|NCT00442871|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540766|NCT00442858|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1540767|NCT00020202||||Treatment||||||||
1540768|NCT00020046||||Treatment||||||||
1540769|NCT00019968||||Treatment||||||||
1540770|NCT00019890||||Treatment||||||||
1540771|NCT00019760||||Treatment||||||||
1540772|NCT00019695||||Treatment||||||||
1540773|NCT00019630||||Treatment||||||||
1540774|NCT00019448||||Treatment||||||||
1540775|NCT00019396||||Treatment||||||||
1540776|NCT00019188||||Treatment||||||||
1540777|NCT00019097||||Treatment||||||||
1540778|NCT00003552||||Treatment||||||||
1540779|NCT00442845|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540780|NCT00442832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540781|NCT00442819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540782|NCT00442806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540783|NCT00442793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540784|NCT00442780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540785|NCT00442767|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540786|NCT00442754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540787|NCT00442741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540788|NCT00442728|Randomized|Parallel Assignment||Prevention||Double||||||
1540789|NCT00442715|Random Sample|||Screening|Cross-Sectional, Retrospective|||||||
1540790|NCT00442702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540791|NCT00442689|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1540792|NCT00442676|Randomized|Parallel Assignment||Treatment||Single|||t|||
1540793|NCT00442663|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540794|NCT00442650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540795|NCT00442637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540796|NCT00442624|||Case Control||Prospective|||||||
1540797|NCT00442611|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540798|NCT00442598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540799|NCT00442585|Randomized|Parallel Assignment||Treatment||Double||||||
1540800|NCT00442572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540801|NCT00442559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540802|NCT00442546|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540803|NCT00442533||Single Group Assignment||Treatment||None (Open Label)||||||
1540804|NCT00442520|||Cohort||Prospective|||||||
1540805|NCT00442507|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540806|NCT00442494|Randomized|Parallel Assignment||||None (Open Label)||||||
1540807|NCT00442481|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540808|NCT00442468|||||Prospective|||||||
1540809|NCT00442455||Single Group Assignment||Treatment||None (Open Label)||||||
1540810|NCT00442442|Randomized|Crossover Assignment||Prevention||Single||||||t
1540811|NCT00442429|||Defined Population||Longitudinal, Prospective|||||||
1540812|NCT00442416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540813|NCT00019578||||Treatment||||||||
1540814|NCT00019006||||Treatment||||||||
1540815|NCT00442403|Randomized|Parallel Assignment||Treatment||Double||||||
1540816|NCT00442390|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540817|NCT00442377|Randomized|Parallel Assignment||Prevention||Double||||||
1540818|NCT00442364|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540819|NCT00442351|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540820|NCT00442338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540821|NCT00442325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540822|NCT00442312|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1540823|NCT00442299|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540824|NCT00442286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540825|NCT00442273|Non-Randomized|Parallel Assignment||Treatment||Double||||||
1540826|NCT00442260||Single Group Assignment||Treatment||None (Open Label)||||||
1540827|NCT00442247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540828|NCT00442234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540829|NCT00442221|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540830|NCT00442208|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540831|NCT00442195|||||Prospective|||||||
1540832|NCT00442182|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540833|NCT00442169|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540834|NCT00442156|||Cohort||Prospective|||||||
1540835|NCT00442143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540836|NCT00442130||Single Group Assignment||Treatment||None (Open Label)||||||
1540837|NCT00442117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540838|NCT00442104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540839|NCT00442091||Single Group Assignment||Treatment||None (Open Label)||||||
1540840|NCT00442078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540841|NCT00442065||Single Group Assignment||Treatment||None (Open Label)||||||
1540842|NCT00442052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540843|NCT00442039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540844|NCT00442026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540845|NCT00442013|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540846|NCT00442000|||||Retrospective|||||||
1540847|NCT00441987|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1540848|NCT00441974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540849|NCT00441961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540850|NCT00441948|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1540851|NCT00441935|||Other||Prospective|||||||
1540852|NCT00441922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540853|NCT00441909|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1540854|NCT00441896|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1540855|NCT00441883|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540856|NCT00441870|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540857|NCT00441857|Randomized|Parallel Assignment||Treatment||Double||||||
1540858|NCT00441844|Randomized|Parallel Assignment||Treatment||Double||||||
1540859|NCT00441831|||Case Control||Retrospective|||||||
1540860|NCT00441818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540861|NCT00441805|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540862|NCT00441792|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540863|NCT00441779|||Cohort||Retrospective|||||||
1540864|NCT00441766|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1540865|NCT00441753|||Cohort||Prospective|||||||
1540866|NCT00441740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540867|NCT00441727|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540868|NCT00441714|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1540869|NCT00441701|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540870|NCT00441688||||Other||None (Open Label)||||||
1540871|NCT00441675|||Case-Only|||||||||
1540872|NCT00441662|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540873|NCT00441649|Non-Randomized|Single Group Assignment||Treatment||Double||||||
1540874|NCT00441636|Randomized|Parallel Assignment||Treatment||Single||||||t
1540875|NCT00441623|||Cohort||Prospective|||||||
1540876|NCT00441610||Single Group Assignment||Treatment||None (Open Label)||||||
1540877|NCT00441597|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1540878|NCT00441584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540879|NCT00441571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540880|NCT00441558||Single Group Assignment||Treatment||None (Open Label)||||||
1540881|NCT00441545|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540882|NCT00441532|Randomized|Parallel Assignment||Treatment||Double||||||
1540883|NCT00441519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540884|NCT00441506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540885|NCT00441493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540886|NCT00441480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540887|NCT00441467||Single Group Assignment||Treatment||None (Open Label)||||||
1540888|NCT00441454|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540889|NCT00441441|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540890|NCT00441428||||||||||||
1540891|NCT00441415|Randomized|Parallel Assignment||Treatment||Single||||||
1540892|NCT00441402|||||Prospective|||||||
1540893|NCT00441389|||Natural History||Longitudinal, Prospective|||||||
1540894|NCT00441376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540895|NCT00441363|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540896|NCT00441350|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540897|NCT00441337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540898|NCT00441324|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540899|NCT00441311|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1540900|NCT00441298|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1540901|NCT00441285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540902|NCT00441272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540903|NCT00441259|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540904|NCT00441246|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540905|NCT00441233|Randomized|Parallel Assignment||Treatment||Single||||||
1540906|NCT00441220|||Case-Only|||||||||
1540907|NCT00441207||Single Group Assignment||Treatment||None (Open Label)||||||
1540908|NCT00441194|||Cohort||Prospective|||||||
1540909|NCT00441181|Randomized|Parallel Assignment||Treatment||Double||||||
1540910|NCT00441168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540911|NCT00441155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540912|NCT00441142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540913|NCT00441129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540914|NCT00441116|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540915|NCT00441103|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1540916|NCT00441090|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540917|NCT00441077|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1540918|NCT00441064|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540919|NCT00441051|Randomized|Single Group Assignment||Treatment||Double||||||
1540920|NCT00441038|Randomized|Parallel Assignment||||Double|||t||t|
1540921|NCT00441025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540922|NCT00441012|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1540923|NCT00440999|Randomized|Parallel Assignment||Treatment||Double||||||
1540924|NCT00440986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540925|NCT00440973||Single Group Assignment||Treatment||None (Open Label)||||||
1540926|NCT00440960|Randomized|Factorial Assignment||Treatment||Single||||||
1540927|NCT00440947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540928|NCT00440934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540929|NCT00440921|Randomized|Parallel Assignment||Supportive Care||Single||||||
1540930|NCT00440908|||||Prospective|||||||
1540931|NCT00440895|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540932|NCT00440882|||Cohort||Prospective|||||||
1540933|NCT00440869|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540934|NCT00440856|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1540935|NCT00440843|Randomized|Parallel Assignment||Treatment||Single|||||t|
1540936|NCT00440830|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540937|NCT00440817|||||Retrospective|||||||
1540938|NCT00440804|Randomized|Parallel Assignment||Treatment||Double||||||
1540939|NCT00440791|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1540940|NCT00440778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540941|NCT00440765|||Case-Only|||||||||
1540942|NCT00440752|||Cohort||Prospective|||||||
1540943|NCT00440739|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1540944|NCT00440726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540945|NCT00440713|Randomized|Single Group Assignment||Treatment||Single||||||
1540946|NCT00440700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540947|NCT00440687|Randomized|Parallel Assignment||Treatment||Double||||||
1540948|NCT00440674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540949|NCT00440661|Randomized|Parallel Assignment||Treatment||Double||||||
1540950|NCT00440648|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1540951|NCT00440635|||||Prospective|||||||
1540952|NCT00440622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540953|NCT00440609|Randomized|Parallel Assignment||Treatment||Single|||t|||
1540954|NCT00440596|Randomized|Factorial Assignment||Treatment||Single||||||t
1540955|NCT00440583||Single Group Assignment||Treatment||None (Open Label)||||||
1540956|NCT00440570|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1540957|NCT00440557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540958|NCT00440544|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540959|NCT00440531|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1540960|NCT00440518|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1540961|NCT00440505|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1540962|NCT00440492|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540963|NCT00440479|||Case-Only|||||||||
1540964|NCT00440466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540965|NCT00440453|Randomized|Single Group Assignment||Treatment||Single|||||t|
1540966|NCT00440440|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1540967|NCT00440427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540968|NCT00440414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540969|NCT00440401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540970|NCT00440388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540971|NCT00440375|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540972|NCT00440362|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1540973|NCT00440349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540974|NCT00440336|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1540975|NCT00440323|Randomized|Crossover Assignment||Treatment||||||||
1540976|NCT00440310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540977|NCT00440297|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1540978|NCT00440284|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540979|NCT00440271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540980|NCT00440258|Randomized|Parallel Assignment||Prevention||Double||||||
1540981|NCT00440245||Single Group Assignment||Treatment||None (Open Label)||||||
1540982|NCT00440232|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1540983|NCT00440219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540984|NCT00440206|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1540985|NCT00440193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540986|NCT00440180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540987|NCT00440167|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540988|NCT00440154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1540989|NCT00440141|Randomized|Parallel Assignment||Treatment||Single|||||t|
1540990|NCT00440128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1540991|NCT00440115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540992|NCT00440102|Randomized|Parallel Assignment||Treatment||Single||||t||
1540993|NCT00440089|Randomized|Factorial Assignment||Treatment||Single|||t|||
1540994|NCT00440076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1540995|NCT00440063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1540996|NCT00440050|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1540997|NCT00440037||Single Group Assignment||Treatment||None (Open Label)||||||
1540998|NCT00440024|Randomized|Single Group Assignment||Treatment||Single||||||t
1540999|NCT00440011|Randomized|Parallel Assignment||Treatment||Single|||||t|
1541000|NCT00439998|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541001|NCT00439985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541002|NCT00439972|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541003|NCT00439959|Randomized|Single Group Assignment||Diagnostic||Double||||||
1541004|NCT00439946||Single Group Assignment||Treatment||None (Open Label)||||||
1541005|NCT00439933|Randomized|Parallel Assignment||Prevention||Single||||||
1541006|NCT00439920||Single Group Assignment||Treatment||None (Open Label)||||||
1541007|NCT00439907|Randomized|Parallel Assignment||Treatment||Single||||||t
1541008|NCT00439894||||||||||||
1541009|NCT00439881|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541010|NCT00439868|Non-Randomized|Crossover Assignment||Diagnostic||||||||
1541011|NCT00439855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541012|NCT00439842|Randomized|Parallel Assignment||Prevention||Single|||t|||
1541013|NCT00439829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541014|NCT00439816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541015|NCT00439803|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1541016|NCT00439790|||Cohort||Prospective|||||||
1541017|NCT00439777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541018|NCT00439764|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541019|NCT00439751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541020|NCT00439738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541021|NCT00439725|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541022|NCT00439712|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541023|NCT00439699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541024|NCT00439686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541025|NCT00439673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541026|NCT00439660|Randomized|Parallel Assignment||Prevention||Double||||||
1541027|NCT00439647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541028|NCT00439634|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541029|NCT00439621|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541030|NCT00439608||Single Group Assignment||Treatment||None (Open Label)||||||
1541031|NCT00439595|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541032|NCT00439582|Randomized|Crossover Assignment||Prevention||Double||||||
1541033|NCT00439569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541034|NCT00439556||Single Group Assignment||Treatment||None (Open Label)||||||
1541035|NCT00439543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541036|NCT00439530|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1541037|NCT00439517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541038|NCT00439504|Randomized|Parallel Assignment||Treatment||Double||||||
1541039|NCT00439491|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541040|NCT00439478||||||||||||
1541041|NCT00439465||Single Group Assignment||Treatment||None (Open Label)||||||
1541042|NCT00439452|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1541043|NCT00439439|Randomized|Factorial Assignment||Treatment||Single||||||
1541044|NCT00439426|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541045|NCT00439413|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541046|NCT00439400|Randomized|Parallel Assignment||||Double|||t||t|
1541047|NCT00439387||||||||||||
1541048|NCT00439374|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1541049|NCT00439361||Single Group Assignment||Treatment||None (Open Label)||||||
1541050|NCT00439348|Randomized|Single Group Assignment||Treatment||Single|||t|||
1541051|NCT00439335|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1541052|NCT00439322|||||Prospective|||||||
1541053|NCT00439309|Randomized|Parallel Assignment||Treatment||Single|||t|||
1541054|NCT00439296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541055|NCT00439283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541056|NCT00439270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541057|NCT00439257|||||Prospective|||||||
1541058|NCT00439244|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541059|NCT00439231||Single Group Assignment||Treatment||None (Open Label)||||||
1541060|NCT00439218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541061|NCT00439205|||Case-Only||Prospective|||||||
1541062|NCT00439192|Randomized|Parallel Assignment||Treatment||Double||||||
1541063|NCT00439179|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541064|NCT00439166|Non-Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1541065|NCT00439153|Randomized|Parallel Assignment||Treatment||Single|||||t|
1541066|NCT00439140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541067|NCT00439127|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1541068|NCT00439114|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1541069|NCT00439101|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541070|NCT00439088|||Defined Population||Cross-Sectional, Prospective|||||||
1541071|NCT00439075|Randomized|Parallel Assignment||Treatment||Single|||||t|
1541072|NCT00439062|Randomized|Parallel Assignment||Treatment||Double||||||
1541073|NCT00439049|||Other||Prospective|||||||
1541074|NCT00439036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541075|NCT00439023|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541076|NCT00439010|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1541077|NCT00438984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541078|NCT00438971||Single Group Assignment||Treatment||None (Open Label)||||||
1541079|NCT00438958|Randomized|||Treatment||||||||
1541080|NCT00438945|Randomized|Crossover Assignment||||Double||||||
1541081|NCT00438932|Randomized|Factorial Assignment||Prevention||Single|||t|||
1541082|NCT00438919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541083|NCT00438906|||Cohort||Prospective|||||||
1541084|NCT00438893||Single Group Assignment||Treatment||None (Open Label)||||||
1541085|NCT00438880||Single Group Assignment||Treatment||None (Open Label)||||||
1541086|NCT00438867|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541087|NCT00438854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541088|NCT00438841||||Treatment||None (Open Label)||||||
1541089|NCT00438828||Single Group Assignment||Treatment||None (Open Label)||||||
1541090|NCT00438815||Single Group Assignment||Treatment||None (Open Label)||||||
1541091|NCT00438802||Single Group Assignment||Treatment||None (Open Label)||||||
1541092|NCT00438789||||||||||||
1541093|NCT00438776|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541094|NCT00438763|||Cohort||Prospective|||||||
1541095|NCT00438750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541096|NCT00438737|Randomized|||Treatment||None (Open Label)||||||
1541097|NCT00438724|Randomized|Parallel Assignment||||None (Open Label)||||||
1541098|NCT00438711|||Cohort||Cross-Sectional|||||||
1541099|NCT00438698|Randomized|Parallel Assignment||Treatment||Single||||||t
1541100|NCT00438685|Randomized|Factorial Assignment||Treatment||Single||||||t
1541101|NCT00438672|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1541102|NCT00438659|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1541103|NCT00438646|||||Prospective|||||||
1541104|NCT00438633|||Cohort||Prospective|||||||
1541105|NCT00438620|||Case-Only||Prospective|||||||
1541106|NCT00438607|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541107|NCT00438594|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1541108|NCT00438581|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541109|NCT00438568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541110|NCT00438555|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541111|NCT00438542|||Case Control, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1541112|NCT00438516|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1541113|NCT00438503|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541114|NCT00438490|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541115|NCT00438477|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541116|NCT00438464|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541117|NCT00438451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541118|NCT00438438|Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1541119|NCT00438425|Randomized|Parallel Assignment||Treatment||Single||||||t
1541120|NCT00438412|||Case Control||Prospective|||||||
1541121|NCT00438399|Randomized|Crossover Assignment||Treatment||Single|||||t|
1541122|NCT00438386|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541123|NCT00438373|||Cohort||Prospective|||||||
1541124|NCT00438360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541125|NCT00438347|||||Prospective|||||||
1541126|NCT00438334|Randomized|Crossover Assignment||Treatment||Double||||||
1541127|NCT00438321|Randomized|Parallel Assignment||Treatment||Double||||||
1541128|NCT00438308|||Cohort||Prospective|||||||
1541129|NCT00438295|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541130|NCT00438282|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1541131|NCT00438269|Randomized|Parallel Assignment||Treatment||Double||||||
1541132|NCT00438256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541133|NCT00438243|Randomized|Parallel Assignment||||Double|||t||t|
1541134|NCT00438230|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541135|NCT00438217|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541136|NCT00438204||Single Group Assignment||Treatment||None (Open Label)||||||
1541137|NCT00438191|||Cohort||Prospective|||||||
1541138|NCT00438178|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541139|NCT00438165|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1541140|NCT00438152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541141|NCT00438139|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541142|NCT00438126|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541143|NCT00438113|Randomized|Parallel Assignment||Prevention||None (Open Label)|Open Label|||||
1541144|NCT00438100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541145|NCT00438087|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1541146|NCT00438074|||Case-Only||Prospective|||||||
1541147|NCT00438061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541148|NCT00438048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541149|NCT00438035||Single Group Assignment||Diagnostic||None (Open Label)||||||
1541150|NCT00438022|||Case Control||Prospective|||||||
1541151|NCT00438009||Single Group Assignment||Treatment||None (Open Label)||||||
1541152|NCT00437996|Randomized|Parallel Assignment||Prevention||Double||||||
1541153|NCT00437983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541154|NCT00437970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541155|NCT00437957||Single Group Assignment||Treatment||None (Open Label)||||||
1541156|NCT00437944|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1541157|NCT00437931|||Case Control||Prospective|||||||
1541158|NCT00437918|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541159|NCT00437905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541160|NCT00437892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541161|NCT00437879|||Case-Only||Prospective|||||||
1541162|NCT00437866|||Cohort||Prospective|||||||
1541163|NCT00437853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541164|NCT00437840|Randomized|Single Group Assignment||Treatment||||||||
1541165|NCT00437827|Randomized|Parallel Assignment||Treatment||Single|||t|||
1541166|NCT00437814|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541167|NCT00437788|Random Sample|||Screening|Longitudinal, Prospective|||||||
1541168|NCT00437775|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1541169|NCT00437762|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541170|NCT00437749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541171|NCT00437736||Single Group Assignment||Treatment||None (Open Label)||||||
1541172|NCT00437723|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541173|NCT00437710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541174|NCT00437697|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541175|NCT00437684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541176|NCT00437671|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541177|NCT00437658|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541178|NCT00437645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541179|NCT00437632|Randomized|Parallel Assignment||Treatment||||||||
1541180|NCT00437619|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541181|NCT00437606|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541182|NCT00437593|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1541183|NCT00437580|Randomized|Parallel Assignment||||Double|||t|t||
1541184|NCT00437567|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1541185|NCT00437554|Randomized|Parallel Assignment||Treatment||Double||||||
1541186|NCT00437541|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541187|NCT00437528|Random Sample|||Screening|Longitudinal, Prospective|||||||
1541188|NCT00437502||Single Group Assignment||Treatment||None (Open Label)||||||
1541189|NCT00437489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541190|NCT00437476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541191|NCT00437463|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541192|NCT00437450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541193|NCT00437437|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541194|NCT00437424|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541195|NCT00437411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541196|NCT00437398||Single Group Assignment||Treatment||None (Open Label)||||||
1541197|NCT00437385|Randomized|Parallel Assignment||Treatment||Single||||||t
1541198|NCT00437372||Single Group Assignment||Treatment||None (Open Label)||||||
1541199|NCT00437359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541200|NCT00437346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541201|NCT00437333|Randomized|Parallel Assignment||Treatment||Double||||||
1541202|NCT00437320|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1541203|NCT00437307|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541204|NCT00437294|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541205|NCT00437281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541206|NCT00437268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541207|NCT00437255|Randomized|Parallel Assignment||Treatment||Single||||||t
1541208|NCT00437242|Randomized|Crossover Assignment||Treatment||Double||||||
1541209|NCT00437229|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541210|NCT00437216|||Case-Only|||||||||
1541211|NCT00437203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541212|NCT00437190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541213|NCT00437177|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1541214|NCT00437164|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541215|NCT00437151|Randomized|Parallel Assignment||Treatment||Single||||||t
1541216|NCT00437138|Randomized|Crossover Assignment||Prevention||Double||||||
1541217|NCT00437125||Single Group Assignment||Treatment||None (Open Label)||||||
1541218|NCT00437112|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541219|NCT00437099|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541220|NCT00437086||Parallel Assignment||Treatment||None (Open Label)||||||
1541221|NCT00437073|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541222|NCT00437060|||Cohort||Prospective|||||||
1541223|NCT00437034||Single Group Assignment||Treatment||None (Open Label)||||||
1541224|NCT00437021|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1541225|NCT00437008|Randomized|Crossover Assignment||Prevention||Single||||||
1541226|NCT00436995|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541227|NCT00436982|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1541228|NCT00436969|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1541229|NCT00436956||Single Group Assignment||Treatment||None (Open Label)||||||
1541230|NCT00436943|||Ecologic or Community||Prospective|||||||
1541231|NCT00436930|Randomized|||Treatment||||||||
1541232|NCT00436917||Single Group Assignment||Supportive Care||None (Open Label)||||||
1541233|NCT00436904|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541234|NCT00436891|||||Prospective|||||||
1541235|NCT00436878|Randomized|Crossover Assignment||Basic Science||Single|||t|||
1541236|NCT00436865|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541237|NCT00436852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541238|NCT00436839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541239|NCT00436826|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541240|NCT00436800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541241|NCT00436787|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1541242|NCT00436774||||||||||||
1541243|NCT00436761||||Treatment||None (Open Label)||||||
1541244|NCT00436748|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541245|NCT00436722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541246|NCT00436709|Non-Randomized|||Treatment||||||||
1541247|NCT00436696|||Case-Only||Cross-Sectional|||||||
1541248|NCT00436683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541249|NCT00436670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541250|NCT00436657||Single Group Assignment||Treatment||None (Open Label)||||||
1541251|NCT00436644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541252|NCT00436631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541253|NCT00436618|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541254|NCT00436605||Single Group Assignment||Treatment||None (Open Label)||||||
1541255|NCT00436592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541256|NCT00436579|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541257|NCT00436566|Randomized|||Treatment||||||||
1541258|NCT00436553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541259|NCT00436540|Randomized|Parallel Assignment||Treatment||Single||||||t
1541260|NCT00436527|Randomized|Single Group Assignment||Treatment||Single||||||t
1541261|NCT00436514|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1541262|NCT00436501|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541263|NCT00436488|||Defined Population|Screening|Longitudinal, Prospective|||||||
1541264|NCT00436475|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1541265|NCT00436462|||Cohort||Prospective|||||||
1541266|NCT00436449|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541267|NCT00436436||Single Group Assignment||Treatment||None (Open Label)||||||
1541268|NCT00436423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541269|NCT00436410||||Treatment||||||||
1541270|NCT00436397||||Treatment||||||||
1541271|NCT00436384||||||||||||
1541272|NCT00436371|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541273|NCT00436358|||||Prospective|||||||
1541274|NCT00436345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541275|NCT00436332||Single Group Assignment||Treatment||None (Open Label)||||||
1541276|NCT00436319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541277|NCT00436306|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541278|NCT00436293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541279|NCT00436280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541280|NCT00436267||||Treatment||None (Open Label)||||||
1541281|NCT00436254||Single Group Assignment||Treatment||None (Open Label)||||||
1541282|NCT00436241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541283|NCT00436228|||||Prospective|||||||
1541284|NCT00436215||Single Group Assignment||Treatment||None (Open Label)||||||
1541285|NCT00436202|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541286|NCT00436189|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541287|NCT00436176|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1541288|NCT00436163||Single Group Assignment||Treatment||None (Open Label)||||||
1541289|NCT00436150|Randomized|Parallel Assignment||Prevention||Single|||t|||
1541290|NCT00436137|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1541291|NCT00436124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541292|NCT00436111|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1541293|NCT00436098|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541294|NCT00436085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541295|NCT00436072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541296|NCT00436059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541297|NCT00436046|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1541298|NCT00436033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541299|NCT00436020|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1541300|NCT00436007|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541301|NCT00435994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541302|NCT00435981|Randomized|Parallel Assignment||Treatment||Double||||||
1541303|NCT00435968|Randomized|Parallel Assignment||Treatment||Double||||||
1541304|NCT00435955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541305|NCT00435942|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541306|NCT00435929|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541307|NCT00435916||Single Group Assignment||Treatment||None (Open Label)||||||
1541308|NCT00435903|Randomized|Crossover Assignment||||None (Open Label)||||||
1541309|NCT00435890|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1541310|NCT00435877|||||Prospective|||||||
1541311|NCT00435864|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1541312|NCT00435851|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1541313|NCT00435838|||||Retrospective|||||||
1541314|NCT00435825|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541315|NCT00435812|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1541316|NCT00435799|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541317|NCT00435786|||Case Control, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1541318|NCT00435773|Randomized|Parallel Assignment||Treatment||Single||||||
1541319|NCT00435760|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1541320|NCT00435747|Randomized|Parallel Assignment||Treatment||Double||||||
1541321|NCT00435734|||Cohort||Prospective|||||||
1541322|NCT00435721|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1541323|NCT00435708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541324|NCT00435695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541325|NCT00435682|Randomized|Crossover Assignment||Health Services Research||Double||||||
1541326|NCT00435669|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541327|NCT00435656|||Cohort||Cross-Sectional|||||||
1541328|NCT00435643|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1541329|NCT00435630|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1541330|NCT00435617|Randomized|Parallel Assignment||Treatment||Single||||||t
1541331|NCT00435604|Randomized|Crossover Assignment||Health Services Research||Double||||||
1541332|NCT00435591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541333|NCT00435578|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541334|NCT00435565|||Defined Population||Longitudinal, Prospective|||||||
1541335|NCT00435552|Randomized|Single Group Assignment||Treatment||Double||||||
1541336|NCT00435539|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541337|NCT00435526|Randomized|Single Group Assignment||Prevention||Double||||||
1541338|NCT00435513|||Case Control||Retrospective|||||||
1541339|NCT00435500|Randomized|Parallel Assignment||Prevention||Single||||||
1541340|NCT00435487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541341|NCT00435474|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1541342|NCT00435461|Randomized|Parallel Assignment||Treatment||||||||
1541343|NCT00435448|Randomized|Factorial Assignment||Treatment||Double||||||
1541344|NCT00435435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541345|NCT00435422||Single Group Assignment||Treatment||None (Open Label)||||||
1541346|NCT00435409|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541347|NCT00435396|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541348|NCT00435383|||Cohort||Prospective|||||||
1541349|NCT00435370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541350|NCT00435357|Randomized|Parallel Assignment||Treatment||Single|||t|||
1541351|NCT00435344|Randomized|Parallel Assignment||Treatment||Single||||||
1541352|NCT00435331|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541353|NCT00435318|Randomized|Parallel Assignment||Treatment||Double||||||
1541354|NCT00435305|||||Prospective|||||||
1541355|NCT00435292|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541356|NCT00435279|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541357|NCT00435266|Randomized|Parallel Assignment||Treatment||Single||||||t
1541358|NCT00435253|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541359|NCT00435240|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541360|NCT00435227|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1541361|NCT00435214|||Cohort||Other|||||||
1541362|NCT00435201|||Case-Only||Prospective|||||||
1541363|NCT00435188|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541364|NCT00435175|Randomized|Crossover Assignment||Treatment||Single||||||
1541365|NCT00435162|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541366|NCT00435149|Randomized|Parallel Assignment||Treatment||Single||||||t
1541367|NCT00435123|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1541368|NCT00435110|||Cohort||Prospective|||||||
1541369|NCT00435097|||Defined Population|Screening|Longitudinal, Prospective|||||||
1541370|NCT00435084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541371|NCT00435071|Randomized|Parallel Assignment||Treatment||Single||||||t
1541372|NCT00435058|Randomized|Parallel Assignment||Treatment||Single||||||
1541373|NCT00435045|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541374|NCT00435032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541375|NCT00435019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541376|NCT00435006|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1541377|NCT00434993|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1541378|NCT00434980||Single Group Assignment||Treatment||None (Open Label)||||||
1541379|NCT00434967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541380|NCT00434954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541381|NCT00434941||Single Group Assignment||Treatment||None (Open Label)||||||
1541382|NCT00434928|||Defined Population|Screening|Longitudinal, Prospective|||||||
1541383|NCT00434915|Randomized|Crossover Assignment||Treatment||Double||||||
1541384|NCT00434902|||Cohort||Prospective|||||||
1541385|NCT00434889|||Cohort||Prospective|||||||
1541386|NCT00434876|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541387|NCT00434863|Randomized|Single Group Assignment||Treatment||Double||||||
1541388|NCT00434850||Single Group Assignment||Treatment||None (Open Label)||||||
1541389|NCT00434837|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541390|NCT00434824|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541391|NCT00434811||Single Group Assignment||Treatment||None (Open Label)||||||
1541392|NCT00434798|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541393|NCT00434785|Randomized|Single Group Assignment||Treatment||Double||||||
1541394|NCT00434772|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541395|NCT00434759|Randomized|Parallel Assignment||Treatment||Single||||||t
1541396|NCT00434746|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1541397|NCT00434733|Randomized|Parallel Assignment||Prevention||Single||||||
1541398|NCT00434720|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1541399|NCT00434707|||Case Control, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1541400|NCT00434694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541401|NCT00434681|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1541402|NCT00434668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541403|NCT00434655|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541404|NCT00434642|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541405|NCT00434629|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541406|NCT00434616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541407|NCT00434603|||Case Control||Prospective|||||||
1541408|NCT00434590|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541409|NCT00434577|Randomized|Parallel Assignment||Prevention||Single|||t|||
1541410|NCT00434564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541411|NCT00434551|||Cohort||Prospective|||||||
1541412|NCT00434538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541413|NCT00434525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541414|NCT00434512|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541415|NCT00434499|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1541416|NCT00434486|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541417|NCT00434473|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541418|NCT00434460|||Cohort||Prospective|||||||
1541419|NCT00434447|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541420|NCT00434434|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541421|NCT00434421||Single Group Assignment||Treatment||None (Open Label)||||||
1541422|NCT00434408|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1541423|NCT00434395|Randomized|Crossover Assignment||Treatment||Double||||||
1541424|NCT00434382|Randomized|Parallel Assignment||Supportive Care||Single||||||
1541425|NCT00434369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541426|NCT00434356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541427|NCT00434343|Randomized|Parallel Assignment||Treatment||Single||||||
1541428|NCT00434330|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541429|NCT00434317||Single Group Assignment||Treatment||None (Open Label)||||||
1541430|NCT00434304||Single Group Assignment||Treatment||None (Open Label)||||||
1541431|NCT00434291|Randomized|Parallel Assignment||Treatment||Double||||||
1541432|NCT00434278|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541433|NCT00434265|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541434|NCT00434252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541435|NCT00434239||Single Group Assignment||Treatment||None (Open Label)||||||
1541436|NCT00434226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541437|NCT00434213||Single Group Assignment||Treatment||None (Open Label)||||||
1541438|NCT00434200|Randomized|Parallel Assignment||Treatment||Single||||||
1541439|NCT00434187|Randomized|Single Group Assignment||Treatment||Double||||||
1541440|NCT00434174|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541441|NCT00434161|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1541442|NCT00434148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541443|NCT00434135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541444|NCT00434122|Randomized|Parallel Assignment||Prevention||Single|||||t|
1541445|NCT00434109||Single Group Assignment||Treatment||None (Open Label)||||||
1541446|NCT00434096|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541447|NCT00434083|Randomized|Parallel Assignment||Treatment||Double||||||
1541448|NCT00434070|||||Prospective|||||||
1541449|NCT00434057|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541450|NCT00434044|Randomized|Parallel Assignment||Treatment||Double||||||
1541451|NCT00434031|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541452|NCT00434018|Randomized|Parallel Assignment||||None (Open Label)||||||
1541453|NCT00434005|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1541454|NCT00433992|||Cohort||Prospective|||||||
1541455|NCT00433979|||||Prospective|||||||
1541456|NCT00433966|Randomized|Factorial Assignment||Treatment||Single|||t|||
1541457|NCT00433953|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541458|NCT00433940|||Cohort||Prospective|||||||
1541459|NCT00433927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541460|NCT00433914|Randomized|Parallel Assignment||Prevention||Single|||t|||
1541461|NCT00433901|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541462|NCT00433888|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541463|NCT00433875|Randomized|Parallel Assignment||Treatment||Double||||||
1541464|NCT00433862|||||Prospective|||||||
1541465|NCT00433849|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541466|NCT00433836|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541467|NCT00433823|Randomized|Crossover Assignment||||None (Open Label)||||||
1541468|NCT00433810|||Cohort||Prospective|||||||
1541469|NCT00433797|Randomized|Parallel Assignment||Treatment||Single||||||t
1541470|NCT00433784|Randomized|Parallel Assignment||Diagnostic||Double||||||
1541471|NCT00433771|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541472|NCT00433758|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1541473|NCT00433745||Single Group Assignment||Treatment||None (Open Label)||||||
1541474|NCT00433732|Randomized|Parallel Assignment||Treatment||Double||||||
1541475|NCT00433719|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541476|NCT00433706|Randomized|Parallel Assignment||||None (Open Label)||||||
1541477|NCT00433693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541478|NCT00433680|Randomized|Parallel Assignment||Prevention||Single|||||t|
1541479|NCT00433667|Randomized|Parallel Assignment||Treatment||Double||||||
1541480|NCT00433654|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1541481|NCT00433641|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541482|NCT00433628|||||Prospective|||||||
1541483|NCT00433615|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541484|NCT00433602||||||||||||
1541485|NCT00433589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541486|NCT00433576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541487|NCT00433563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541488|NCT00433550|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541489|NCT00433537|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541490|NCT00433524||||Diagnostic||||||||
1541491|NCT00433511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541492|NCT00433498|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541493|NCT00433485||||Prevention||None (Open Label)||||||
1541494|NCT00433472||||Diagnostic||||||||
1541495|NCT00433459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541496|NCT00433446||Single Group Assignment||Treatment||None (Open Label)||||||
1541497|NCT00433433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541498|NCT00433420|Randomized|||Treatment||||||||
1541499|NCT00433407||Single Group Assignment||Treatment||None (Open Label)||||||
1541500|NCT00433394||Single Group Assignment||||None (Open Label)||||||
1541501|NCT00433381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541502|NCT00433368|Randomized|Parallel Assignment||Treatment||Double||||||
1541503|NCT00433355|||Case Control||Prospective|||||||
1542327|NCT00422331|Randomized|Parallel Assignment||Treatment||Double||||||
1541504|NCT00433342|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541505|NCT00433329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541506|NCT00433316|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541507|NCT00433303|||Defined Population|Screening|Longitudinal, Prospective|||||||
1541508|NCT00433290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541509|NCT00433277|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1541510|NCT00433264|||Case-Only||Prospective|||||||
1541511|NCT00433238|Randomized|Parallel Assignment||Screening||Single||||||
1541512|NCT00433225|Randomized|Parallel Assignment||||Single||||||
1541513|NCT00433212|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541514|NCT00433199|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541515|NCT00433186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541516|NCT00433173|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541517|NCT00433160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541518|NCT00433147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541519|NCT00433134|||Cohort||Retrospective|||||||
1541520|NCT00433121|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541521|NCT00433108|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1541522|NCT00433095|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541523|NCT00433082|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541524|NCT00433069||Single Group Assignment||Treatment||None (Open Label)||||||
1541525|NCT00433056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541526|NCT00433043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541527|NCT00433030|||Cohort||Prospective|||||||
1541528|NCT00433017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541529|NCT00433004|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1541530|NCT00432991|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1541531|NCT00432978|Randomized|Crossover Assignment||Treatment||Double||||||
1541532|NCT00432965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541533|NCT00432952|Randomized|Crossover Assignment||Prevention||Single||||||
1541534|NCT00432939|||Cohort||Prospective|||||||
1541535|NCT00432926|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541536|NCT00432913|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541537|NCT00432900||Single Group Assignment||Basic Science||None (Open Label)||||||
1541538|NCT00432887|Randomized|Crossover Assignment||Treatment||Double||||||
1541539|NCT00432874|Randomized|Parallel Assignment||||Single|||t|||
1541540|NCT00432861|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1541541|NCT00432835|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1541542|NCT00432822|Randomized|Parallel Assignment||Treatment||Double||||||
1541543|NCT00432809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541544|NCT00432796|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541545|NCT00432783|||Cohort||Prospective|||||||
1541546|NCT00432770|Randomized|Parallel Assignment||Treatment||Double||||||
1541547|NCT00432757|Randomized|Parallel Assignment||Treatment||Double||||||
1541548|NCT00432744|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1541549|NCT00432731|Randomized|Crossover Assignment||||Double||||||
1541550|NCT00432718|Randomized|Factorial Assignment||Prevention||Single||||||
1541551|NCT00432705|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541552|NCT00432692|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541553|NCT00432679|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541554|NCT00432666|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541555|NCT00432653|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541556|NCT00432640|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541557|NCT00432627|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541558|NCT00432614|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541559|NCT00432601|Randomized|Parallel Assignment||||None (Open Label)||||||
1541560|NCT00432588|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541561|NCT00432575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541562|NCT00432562|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541563|NCT00432549|Randomized|Parallel Assignment||Prevention||Double||||||
1541564|NCT00432536|||Cohort||Prospective|||||||
1541565|NCT00432523|Randomized|Parallel Assignment||||None (Open Label)||||||
1541566|NCT00432510|Randomized|Parallel Assignment||||None (Open Label)||||||
1541567|NCT00432484|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541568|NCT00432471||Single Group Assignment||Diagnostic||None (Open Label)||||||
1541569|NCT00432458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541570|NCT00432445||Single Group Assignment||Treatment||None (Open Label)||||||
1541571|NCT00432432|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541572|NCT00432419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541573|NCT00432406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541574|NCT00432393|Randomized|Parallel Assignment||Treatment||Double||||||
1541575|NCT00432380|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1541576|NCT00432367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541577|NCT00432354|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541578|NCT00432341|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541579|NCT00432328|Randomized|Single Group Assignment||Prevention||Double||||||
1541580|NCT00432315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541581|NCT00432302||Single Group Assignment||Treatment||None (Open Label)||||||
1541582|NCT00432289|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541583|NCT00432276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541584|NCT00432263|Randomized|Parallel Assignment||Treatment||Double||||||
1541585|NCT00432250|Randomized|Parallel Assignment||Health Services Research||Single||||||
1541586|NCT00432237|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541587|NCT00432224|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541588|NCT00432211|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541589|NCT00432198|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541590|NCT00432185|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541591|NCT00432172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541592|NCT00432159|Randomized|Parallel Assignment||Treatment||Single|Participant was masked to which treatment they would receive until AFTER the surgery/treatment procedure. At that point, they were unmasked.||t|||
1541593|NCT00432146|||||Prospective|||||||
1541594|NCT00432133|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1541595|NCT00432120|Randomized|Parallel Assignment||||None (Open Label)||||||
1541596|NCT00432107||Single Group Assignment||Treatment||None (Open Label)||||||
1541597|NCT00432094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541598|NCT00432081|Randomized|Parallel Assignment||Treatment||Double||||||
1541599|NCT00432068||Single Group Assignment||Treatment||None (Open Label)||||||
1541600|NCT00432055|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541601|NCT00432042|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541602|NCT00432029|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1541603|NCT00432016|Randomized|Single Group Assignment||Treatment||Double||||||
1541604|NCT00432003|||||Prospective|||||||
1541605|NCT00431990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541606|NCT00431977|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1541607|NCT00431964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541608|NCT00431951|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1541609|NCT00431925|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1541610|NCT00431912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541611|NCT00431899|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1541612|NCT00431886|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1541613|NCT00431873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541614|NCT00431860|||Case Control, Natural History||Longitudinal, Retrospective/Prospective|||||||
1541615|NCT00431847|||Cohort||Prospective|||||||
1541616|NCT00431834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541617|NCT00431821|Randomized|Parallel Assignment||||None (Open Label)||||||
1541618|NCT00431808|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541619|NCT00431795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541620|NCT00431782||Single Group Assignment||Treatment||None (Open Label)||||||
1541621|NCT00431769||Single Group Assignment||Treatment||None (Open Label)||||||
1541622|NCT00431756|||Cohort||Prospective|||||||
1541623|NCT00431743|Randomized|Parallel Assignment||Treatment||Double||||||
1541624|NCT00431730|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1541625|NCT00431717|||Cohort||Prospective|||||||
1541626|NCT00431704|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541627|NCT00431691|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541628|NCT00431678|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541629|NCT00431665|Randomized|Crossover Assignment||Treatment||Double||||||
1541630|NCT00431639|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1541631|NCT00431626|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541632|NCT00431613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541633|NCT00431600|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541634|NCT00431587|||||Prospective|||||||
1541635|NCT00431574|Randomized|Parallel Assignment||Treatment||Double||||||
1541636|NCT00431561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541637|NCT00431548|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541638|NCT00431535|||||Prospective|||||||
1541639|NCT00431522|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1541640|NCT00431509|Randomized|Parallel Assignment||Treatment||Single||||||
1541641|NCT00431496||Single Group Assignment||Treatment||None (Open Label)||||||
1541642|NCT00431483|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1541643|NCT00431470|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1541644|NCT00431457|Randomized|Single Group Assignment||Treatment||Single|||t|||
1541645|NCT00431444|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541646|NCT00431431|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541647|NCT00431418|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541648|NCT00431405|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1541649|NCT00431392|Randomized|Crossover Assignment||Treatment||Double||||||
1541650|NCT00431379|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541651|NCT00431366||||||||||||
1541652|NCT00431353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541653|NCT00431340|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541654|NCT00431327|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541655|NCT00431314|||Cohort||Cross-Sectional|||||||
1541656|NCT00431301|||Case-Control||Prospective|||||||
1541657|NCT00431288|Randomized|Single Group Assignment||Treatment||Single||||||
1541658|NCT00431275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541659|NCT00431262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541660|NCT00431249|Randomized|Single Group Assignment||Treatment||Single|||t|||
1541661|NCT00431236|Randomized|Parallel Assignment||Prevention||||||||
1541662|NCT00431223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541663|NCT00431210||Single Group Assignment||Treatment||None (Open Label)||||||
1541664|NCT00431197|Randomized|Single Group Assignment||||Double||||||
1541665|NCT00431184|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1541666|NCT00431171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541667|NCT00431158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541668|NCT00431145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541669|NCT00431132|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541670|NCT00431119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541671|NCT00431106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541672|NCT00431093|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541673|NCT00431080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541674|NCT00431067|Non-Randomized|||Treatment||None (Open Label)||||||
1541675|NCT00431054||Single Group Assignment||Treatment||None (Open Label)||||||
1541676|NCT00431041|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541677|NCT00431028|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1541678|NCT00431015||Single Group Assignment||Treatment||None (Open Label)||||||
1541679|NCT00431002|Randomized|Single Group Assignment||Treatment||Single|||t|||
1541680|NCT00430989|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1541681|NCT00430976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541682|NCT00430963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541683|NCT00430950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541684|NCT00430937|Randomized|Parallel Assignment||Treatment||Single||||||t
1541685|NCT00430924|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1541686|NCT00430911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541687|NCT00430898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541688|NCT00430885|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541689|NCT00430872|||Case-Only||Prospective|||||||
1541690|NCT00430859|Randomized|Single Group Assignment||Treatment||Double||||t|t|
1541691|NCT00430846||Single Group Assignment||Treatment||None (Open Label)||||||
1541692|NCT00430833|Randomized|Parallel Assignment||||Double||||||
1541693|NCT00430820|||||Prospective|||||||
1541694|NCT00430807|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541695|NCT00430794|Randomized|Parallel Assignment||Treatment||Double||||||
1541696|NCT00430781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541697|NCT00430768|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541698|NCT00430755||Single Group Assignment||Health Services Research||None (Open Label)||||||
1541699|NCT00430742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541700|NCT00430729|Randomized|Parallel Assignment||Treatment||Double||||||
1541701|NCT00430716|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541702|NCT00430703|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541703|NCT00430690|||Cohort||Prospective|||||||
1541704|NCT00430677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541705|NCT00430664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541706|NCT00430651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541707|NCT00430638|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541708|NCT00430625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541709|NCT00430612|||||Prospective|||||||
1541710|NCT00430599|||Case-Crossover||Cross-Sectional|||||||
1541711|NCT00430586|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541712|NCT00430573|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541713|NCT00430560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541714|NCT00430547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541715|NCT00430534|Randomized|Parallel Assignment||Prevention||Double||||||
1541716|NCT00430521|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541717|NCT00430508|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541718|NCT00430495|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541719|NCT00430482|Randomized|Parallel Assignment||Treatment||Single||||||t
1541720|NCT00430469||Single Group Assignment||Prevention||None (Open Label)||||||
1541721|NCT00430456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541722|NCT00430443|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541723|NCT00430430|Randomized|Parallel Assignment||Treatment||Single||||||t
1541724|NCT00430417|||Cohort||Prospective|||||||
1541725|NCT00430404|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1541726|NCT00430391|Randomized|Parallel Assignment||||None (Open Label)||||||
1541727|NCT00430378|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1541728|NCT00430365|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541729|NCT00430352||Single Group Assignment||Treatment||None (Open Label)||||||
1541730|NCT00430326|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1541731|NCT00430313|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1541732|NCT00430300|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541733|NCT00430287|||Cohort||Prospective|||||||
1541734|NCT00430274|||Case-Only||Prospective|||||||
1541735|NCT00430261|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541736|NCT00430248|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1541737|NCT00430235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541738|NCT00430209|||Case-Only||Cross-Sectional|||||||
1541739|NCT00430196|Randomized|Parallel Assignment||Treatment||Double||||||
1541740|NCT00430183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541741|NCT00430170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541742|NCT00430157|Randomized|Crossover Assignment||Treatment||Double||||||
1541743|NCT00430144||Single Group Assignment||Treatment||None (Open Label)||||||
1541744|NCT00430131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541745|NCT00430118|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1541746|NCT00430105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541747|NCT00430092|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541748|NCT00430079||Single Group Assignment||Diagnostic||None (Open Label)||||||
1541749|NCT00430066||Single Group Assignment||Treatment||None (Open Label)||||||
1541750|NCT00430053||||||||||||
1541751|NCT00430040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541752|NCT00430027||Single Group Assignment||Treatment||None (Open Label)||||||
1541753|NCT00430014||Single Group Assignment||Treatment||None (Open Label)||||||
1541754|NCT00430001|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1541755|NCT00429988|||Cohort||Prospective|||||||
1541756|NCT00429975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541757|NCT00429962|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1541758|NCT00429949|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541759|NCT00429936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541760|NCT00429923|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541761|NCT00429910|||Cohort||Prospective|||||||
1541762|NCT00429897|Randomized|Crossover Assignment||Treatment||Double||||||
1541763|NCT00429884|||||Prospective|||||||
1541764|NCT00429871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541765|NCT00429858||Single Group Assignment||Treatment||None (Open Label)||||||
1541766|NCT00429845|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541767|NCT00429832|Randomized|Parallel Assignment||Treatment||Double||||||
1541768|NCT00429819|||Case Control||Prospective|||||||
1541769|NCT00429806|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541770|NCT00429793||Single Group Assignment||Treatment||None (Open Label)||||||
1541771|NCT00429780|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541772|NCT00429767|||Case-Only||Prospective|||||||
1541773|NCT00429754|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541774|NCT00429728|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1541775|NCT00429715|Randomized|Parallel Assignment||Prevention||Double||||||
1541776|NCT00429702|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1541777|NCT00429689|||Cohort||Prospective|||||||
1541778|NCT00429676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541779|NCT00429663|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541780|NCT00429650|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541781|NCT00429637||||||||||||
1541782|NCT00429624|Randomized|Parallel Assignment||Treatment||Single||||||
1541783|NCT00429611|Randomized|Parallel Assignment||Treatment||Single|||t|||
1541784|NCT00429585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541785|NCT00429572|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541786|NCT00429559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541787|NCT00429546|Randomized|Single Group Assignment||||Single||||||t
1541788|NCT00429533|Randomized|Crossover Assignment||Treatment||Double||||||
1541789|NCT00429520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541790|NCT00429507||Single Group Assignment||Treatment||None (Open Label)||||||
1541791|NCT00429494||Single Group Assignment||Treatment||None (Open Label)||||||
1541792|NCT00429481|Randomized|Parallel Assignment||Prevention||Double||||||
1541793|NCT00429468|Randomized|Single Group Assignment||Treatment||Double||||||
1541794|NCT00429455|||Case-Only||Retrospective|||||||
1541795|NCT00429442|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1541796|NCT00429429||Single Group Assignment||Treatment||None (Open Label)||||||
1541797|NCT00429416||Single Group Assignment||Treatment||None (Open Label)||||||
1541798|NCT00429403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541799|NCT00429390|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541800|NCT00429377|Randomized|Parallel Assignment||Treatment||Double||||||
1541801|NCT00429364|Randomized|Parallel Assignment||Treatment||Single||||||t
1541802|NCT00429351|||Case-Crossover||Prospective|||||||
1541803|NCT00429338|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541804|NCT00429325|Random Sample|||Screening|Longitudinal, Prospective|||||||
1541805|NCT00429312||Single Group Assignment||Treatment||None (Open Label)||||||
1541806|NCT00429299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541807|NCT00429286|||Cohort||Prospective|||||||
1541808|NCT00429273|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541809|NCT00429260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541810|NCT00429247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541811|NCT00429234||Single Group Assignment||Treatment||None (Open Label)||||||
1541812|NCT00429221|Randomized|Parallel Assignment||||None (Open Label)||||||
1541813|NCT00429208|Non-Randomized|Single Group Assignment||Diagnostic||Double||||||
1541814|NCT00429195|Randomized|Single Group Assignment||Treatment||Single||||||
1541815|NCT00429182||Single Group Assignment||Treatment||None (Open Label)||||||
1541816|NCT00429169|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541817|NCT00429156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541818|NCT00429143||Single Group Assignment||Treatment||None (Open Label)||||||
1541819|NCT00429117|||Case-Only||Prospective|||||||
1541820|NCT00429104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541821|NCT00429091|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1541822|NCT00429078||Single Group Assignment||Treatment||None (Open Label)||||||
1541823|NCT00429065|||Defined Population|Screening|Longitudinal, Prospective|||||||
1541824|NCT00429052|||Cohort||Prospective|||||||
1541825|NCT00429039|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541826|NCT00429026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541827|NCT00429013|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541828|NCT00429000|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541829|NCT00428987|||Cohort||Prospective|||||||
1541830|NCT00428974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541831|NCT00428961|||Cohort||Cross-Sectional|||||||
1541832|NCT00428948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541833|NCT00428935|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1541834|NCT00428922||Single Group Assignment||Treatment||None (Open Label)||||||
1541835|NCT00428909|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541836|NCT00428896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541837|NCT00428883|Randomized|Single Group Assignment||Treatment||Double||||||
1541838|NCT00428870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541839|NCT00428857|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541840|NCT00428844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541841|NCT00428831|||Case-Only||Prospective|||||||
1541842|NCT00428818|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541843|NCT00428805|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1541844|NCT00428792|Randomized|Crossover Assignment||Treatment||Single||||||t
1541845|NCT00428779|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1541846|NCT00428766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541847|NCT00428753||||||||||||
1541848|NCT00428740|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1541849|NCT00428727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541850|NCT00428714|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541851|NCT00428701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541852|NCT00428688|||Case-Only||Prospective|||||||
1541853|NCT00428675|||||Prospective|||||||
1541854|NCT00428662|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541855|NCT00428649|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541856|NCT00428636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541857|NCT00428623|Random Sample||||Longitudinal, Prospective|||||||
1541858|NCT00428610||Single Group Assignment||Treatment||None (Open Label)||||||
1541859|NCT00428597|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541860|NCT00428584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541861|NCT00428571|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541862|NCT00428558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541863|NCT00428545||Single Group Assignment||Treatment||None (Open Label)||||||
1541864|NCT00428532|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541865|NCT00428519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541866|NCT00428506|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541867|NCT00428493|||||Prospective|||||||
1541868|NCT00428480|Randomized|Parallel Assignment||Treatment||Single||||||t
1541869|NCT00428467|Randomized|Parallel Assignment||Treatment||Single||||||
1541870|NCT00428454|Randomized|Parallel Assignment||Treatment||Single|||t|||
1541871|NCT00428441|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541872|NCT00428428|Randomized|Single Group Assignment||Treatment||Triple|||t|t||t
1541873|NCT00428415|Randomized|Parallel Assignment||Treatment||Double||||||
1541874|NCT00428402|||||Prospective|||||||
1541875|NCT00428389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541876|NCT00428376|Randomized|Single Group Assignment||||Single||||||
1541877|NCT00428363|Randomized|Parallel Assignment||Prevention||Double||||||
1541878|NCT00428350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541879|NCT00428337|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1541880|NCT00428311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541881|NCT00428298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541882|NCT00428285||Single Group Assignment||Treatment||None (Open Label)||||||
1541883|NCT00428272|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541884|NCT00428246|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1541885|NCT00428233||Single Group Assignment||Treatment||None (Open Label)||||||
1541886|NCT00428220||Single Group Assignment||Treatment||None (Open Label)||||||
1541887|NCT00428207|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541888|NCT00428194|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541889|NCT00428181|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541890|NCT00428168|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541891|NCT00428155|Randomized|Single Group Assignment||Treatment||Single||||||
1541892|NCT00428142||Single Group Assignment||Treatment||None (Open Label)||||||
1541893|NCT00428129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541894|NCT00428116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541895|NCT00428103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541896|NCT00428090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541897|NCT00428077||Single Group Assignment||Treatment||None (Open Label)||||||
1541898|NCT00428064|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541899|NCT00428051|||||Prospective|||||||
1541900|NCT00428038|||Case Control||Prospective|||||||
1541901|NCT00428025|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541902|NCT00428012|Randomized|Parallel Assignment||||None (Open Label)||||||
1541903|NCT00427999||Single Group Assignment||Treatment||None (Open Label)||||||
1541904|NCT00427986|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541905|NCT00427973||Single Group Assignment||Treatment||None (Open Label)||||||
1541906|NCT00427960|Randomized|Parallel Assignment||Treatment||Double||||||
1541907|NCT00427947|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1541908|NCT00427934|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541909|NCT00427921|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541910|NCT00427908|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1541911|NCT00427895|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1541912|NCT00427882|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541913|NCT00427856|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541914|NCT00427843|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541915|NCT00427830|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541916|NCT00427817|||Case Control||Prospective|||||||
1541917|NCT00427804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541918|NCT00427791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541919|NCT00427778|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541920|NCT00427765||Single Group Assignment||Treatment||None (Open Label)||||||
1541921|NCT00427752||Single Group Assignment||Diagnostic||Single|||||t|
1541922|NCT00427739|||Cohort||Prospective|||||||
1541923|NCT00427726||||||||||||
1541924|NCT00427713|Randomized|||Treatment||None (Open Label)||||||
1541925|NCT00427700|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541926|NCT00427687|Randomized|Parallel Assignment||Treatment||Double||||||
1541927|NCT00427674|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1541928|NCT00427661||Single Group Assignment||Treatment||None (Open Label)||||||
1541929|NCT00427648|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541930|NCT00427635|Randomized|Parallel Assignment||Treatment||Double||||||
1541931|NCT00427622||||Diagnostic||None (Open Label)||||||
1541932|NCT00427609|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541933|NCT00427596|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541934|NCT00427583||Single Group Assignment||Treatment||None (Open Label)||||||
1541935|NCT00427570||||Treatment||||||||
1541936|NCT00427557||Single Group Assignment||Treatment||None (Open Label)||||||
1541937|NCT00427544|Randomized|Parallel Assignment||Treatment||Single||||||
1541938|NCT00427531||||Diagnostic||||||||
1541939|NCT00427505|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541940|NCT00427492|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1541941|NCT00427479|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1541942|NCT00427466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541943|NCT00427453|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1541944|NCT00427440|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541945|NCT00427427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541946|NCT00427414||Single Group Assignment||Treatment||None (Open Label)||||||
1541947|NCT00427401|Randomized|Parallel Assignment||Treatment||Double||||||
1541948|NCT00427388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541949|NCT00427375|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1541950|NCT00427362|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541951|NCT00427349||Single Group Assignment||Treatment||None (Open Label)||||||
1541952|NCT00427336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541953|NCT00427323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541954|NCT00427310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541955|NCT00427297|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541956|NCT00427284|||Case Control||Prospective|||||||
1541957|NCT00427271|Randomized|Crossover Assignment||Treatment||Double||||||
1541958|NCT00427258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541959|NCT00427245|Randomized|||Supportive Care||None (Open Label)||||||
1541960|NCT00427232|Randomized|Parallel Assignment||Diagnostic||Double||||||
1541961|NCT00427219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541962|NCT00427206|Randomized|Single Group Assignment||||Double|||t||t|
1541963|NCT00427193|Randomized|Parallel Assignment||Prevention||Single|all lab based assays were masked due to de-identified person and time interval measured. All physical measures were masked to intervention group status.|||||t
1541964|NCT00427180|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541965|NCT00427167|Randomized|Factorial Assignment||Prevention||Double||||||
1541966|NCT00427154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541967|NCT00427141|Randomized|Crossover Assignment||Treatment||Single||||||
1541968|NCT00427128|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541969|NCT00427115|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1541970|NCT00427102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541971|NCT00427089|Randomized|Parallel Assignment||Treatment||Single||||||t
1541972|NCT00427076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541973|NCT00427063|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1541974|NCT00427050|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541975|NCT00427037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541976|NCT00427024|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1541977|NCT00427011|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541978|NCT00426998|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1541979|NCT00426985|Randomized|Parallel Assignment||Treatment||Double||||||
1541980|NCT00426972|Randomized|Parallel Assignment||Treatment||Double||||||
1541981|NCT00426959|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1541982|NCT00426946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541983|NCT00426933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541984|NCT00426920|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1541985|NCT00426907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541986|NCT00426894|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1541987|NCT00426881|Randomized|Single Group Assignment||Prevention||Single|||t|||
1541988|NCT00426868|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1541989|NCT00426855||Single Group Assignment||Treatment||None (Open Label)||||||
1541990|NCT00426842||Single Group Assignment||Treatment||None (Open Label)||||||
1541991|NCT00426829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1541992|NCT00426816|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1541993|NCT00426803|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1541994|NCT00426790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541995|NCT00426777|Randomized|Parallel Assignment||Prevention||Single|||t|||
1541996|NCT00426764||Single Group Assignment||Treatment||None (Open Label)||||||
1541997|NCT00426751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1541998|NCT00426725|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1541999|NCT00426712|Randomized|Parallel Assignment||Prevention||Single||||||t
1542000|NCT00426699|||Case-Only||Prospective|||||||
1542001|NCT00426686|||Case-Only|||||||||
1542002|NCT00426673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542003|NCT00426660|Non-Randomized|||Treatment||||||||
1542004|NCT00426647|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542005|NCT00426634|||||Prospective|||||||
1542006|NCT00426621|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542007|NCT00426608|Randomized|Crossover Assignment||Diagnostic||||||||
1542008|NCT00426595|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542009|NCT00426582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542010|NCT00426569|||Case-Only||Prospective|||||||
1542011|NCT00426556|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542012|NCT00426543|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542013|NCT00426530|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542014|NCT00426517||Factorial Assignment||Treatment||None (Open Label)||||||
1542015|NCT00426504||Single Group Assignment||Treatment||None (Open Label)||||||
1542016|NCT00426491|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1542017|NCT00426478|Randomized|Parallel Assignment||Treatment||Double||||||
1542018|NCT00426465||||||||||||
1542019|NCT00426452|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542020|NCT00426439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542021|NCT00426426|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1542022|NCT00426413|||Cohort||Prospective|||||||
1542023|NCT00426400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542024|NCT00426374|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1542025|NCT00426361|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542026|NCT00426348|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542027|NCT00426335|||||Prospective|||||||
1542028|NCT00426322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542029|NCT00426296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542030|NCT00426283|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542031|NCT00426270||Single Group Assignment||Treatment||None (Open Label)||||||
1542032|NCT00426257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542033|NCT00426244|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1542034|NCT00426231|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542035|NCT00426218|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542036|NCT00426205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542037|NCT00426192|Randomized|Parallel Assignment||Prevention||Single||||||
1542038|NCT00426179|Randomized|Parallel Assignment||Treatment||Double||||||
1542039|NCT00426166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542040|NCT00426153|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542041|NCT00426140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542042|NCT00426127||Single Group Assignment||Treatment||None (Open Label)||||||
1542043|NCT00426114|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1542044|NCT00426101||Single Group Assignment||Treatment||None (Open Label)||||||
1542045|NCT00426075|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542046|NCT00426062|||Defined Population||Longitudinal, Prospective|||||||
1542047|NCT00426049|Randomized|Parallel Assignment||Treatment||Double||||||
1542048|NCT00426036|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542049|NCT00426023|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1542050|NCT00426010|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1542051|NCT00425997|Randomized|Parallel Assignment||Treatment||Double||||||
1542052|NCT00425984|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542053|NCT00425971|Randomized|Parallel Assignment||Treatment||Double||||||
1542054|NCT00425958||||Screening|Cross-Sectional, Prospective|||||||
1542055|NCT00425945|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1542056|NCT00425932|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1542057|NCT00425919|Randomized|Parallel Assignment||Treatment||Double||||||
1542058|NCT00425906|Randomized|||Supportive Care||Double||||||
1542059|NCT00425893|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1542060|NCT00425880|||Cohort||Prospective|||||||
1542061|NCT00425867|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1542062|NCT00425854|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1542063|NCT00425841||||Treatment||None (Open Label)||||||
1542064|NCT00425815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542065|NCT00425802||Single Group Assignment||Treatment||None (Open Label)||||||
1542066|NCT00425789|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542067|NCT00425776|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1542068|NCT00425763||Single Group Assignment||Prevention||None (Open Label)||||||
1542069|NCT00425750|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542070|NCT00425737|Randomized|Parallel Assignment||Prevention||Double||||||
1542071|NCT00425724|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542072|NCT00425711||Single Group Assignment||Treatment||None (Open Label)||||||
1542073|NCT00425698|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1542074|NCT00425685|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1542075|NCT00425672||Single Group Assignment||Treatment||None (Open Label)||||||
1542076|NCT00425659|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1542077|NCT00425646||||Treatment||None (Open Label)||||||
1542078|NCT00425633|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1542079|NCT00425620|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542080|NCT00425607||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1542081|NCT00425594|Randomized|Parallel Assignment||Treatment||Single||||||
1542082|NCT00425581|||||Prospective|||||||
1542083|NCT00425568|||||Prospective|||||||
1542084|NCT00425555|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542085|NCT00425542|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1542086|NCT00425529|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1542087|NCT00425516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542088|NCT00425503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542089|NCT00425490|Randomized|Parallel Assignment||Treatment||Double||||||
1542090|NCT00425477||Single Group Assignment||Treatment||None (Open Label)||||||
1542091|NCT00425464|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542092|NCT00425451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542093|NCT00425438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542094|NCT00425425||||Treatment||None (Open Label)||||||
1542095|NCT00425399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542096|NCT00425386||Single Group Assignment||Treatment||None (Open Label)||||||
1542097|NCT00425373|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1542098|NCT00425360|Randomized|||Treatment||None (Open Label)||||||
1542099|NCT00425347|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542100|NCT00425334|Randomized|Single Group Assignment||Treatment||Single|||t|||
1542101|NCT00425321|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542102|NCT00425308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542103|NCT00425295|Randomized|Crossover Assignment||||Single||||||t
1542104|NCT00425282|Randomized|Parallel Assignment||Treatment||Double||||||
1542105|NCT00425269|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542106|NCT00425256|Randomized|Parallel Assignment||||Double||||||
1542107|NCT00425243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542108|NCT00425230|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1542109|NCT00425217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542110|NCT00425204|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542111|NCT00425191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542112|NCT00425178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542113|NCT00425165|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1542114|NCT00425152||||Treatment||||||||
1542115|NCT00425139|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1542116|NCT00425126|Randomized|Single Group Assignment||Treatment||Double||||||
1542117|NCT00425113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542118|NCT00425100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542119|NCT00425074|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1542120|NCT00425061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542121|NCT00425048|||||Prospective|||||||
1542122|NCT00425035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542123|NCT00425022|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542124|NCT00425009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542125|NCT00424996|||Cohort||Prospective|||||||
1542126|NCT00424983|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542127|NCT00424970|Randomized|Parallel Assignment||Treatment||Double||||||
1542128|NCT00424957|||Case Control||Cross-Sectional|||||||
1542129|NCT00424944|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1542130|NCT00424931|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542131|NCT00424918|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1542132|NCT00424905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542133|NCT00424892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542134|NCT00424866|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542135|NCT00424853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542136|NCT00424840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542137|NCT00424827||Single Group Assignment||Treatment||None (Open Label)||||||
1542138|NCT00424814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542139|NCT00424801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542140|NCT00424788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542141|NCT00424775|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542142|NCT00424762|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542143|NCT00424749|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542144|NCT00424736|||Defined Population|Screening|Longitudinal, Prospective|||||||
1542145|NCT00424723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542146|NCT00424710||Single Group Assignment||Treatment||None (Open Label)||||||
1542147|NCT00424697|Randomized|Crossover Assignment||Diagnostic||Double||||||
1542148|NCT00424684|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1542149|NCT00424671|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542150|NCT00424658|Randomized|Crossover Assignment||Diagnostic||Double||||||
1542151|NCT00424645|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1542152|NCT00424632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542153|NCT00424619|Randomized|Parallel Assignment||Treatment||Single|||t|||
1542154|NCT00424606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542155|NCT00424593|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1542156|NCT00424580|Randomized|Crossover Assignment||Treatment||Double||||||
1542157|NCT00424567|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542158|NCT00424554|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542159|NCT00424541|Randomized|Parallel Assignment||Treatment||Double||||||
1542160|NCT00424528|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542161|NCT00424515||Single Group Assignment||Treatment||None (Open Label)||||||
1542162|NCT00424502||Single Group Assignment||Treatment||None (Open Label)||||||
1542163|NCT00424489||Single Group Assignment||Treatment||None (Open Label)||||||
1542164|NCT00424476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542165|NCT00424463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542166|NCT00424450|||Cohort||Prospective|||||||
1542167|NCT00424437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542168|NCT00424424|Randomized|Single Group Assignment||Prevention||Double||||||
1542169|NCT00424411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542170|NCT00424398|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542171|NCT00424385||Single Group Assignment||Treatment||None (Open Label)||||||
1542172|NCT00424372|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542173|NCT00424359|||Cohort||Prospective|||||||
1542174|NCT00424346|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542175|NCT00424333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542176|NCT00424320|Randomized|Parallel Assignment||Prevention||Double||||||
1542177|NCT00424307|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542178|NCT00424294|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542179|NCT00424281|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1542180|NCT00424268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542181|NCT00424255|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542182|NCT00424242||Single Group Assignment||Treatment||None (Open Label)||||||
1542183|NCT00424229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542184|NCT00424216||||Treatment||||||||
1542185|NCT00424203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542186|NCT00424190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542187|NCT00424177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542188|NCT00424164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542189|NCT00424151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542190|NCT00424138|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1542191|NCT00424125|Randomized|Single Group Assignment||Treatment||Single||||||t
1542192|NCT00424112|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1542193|NCT00424099|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1542194|NCT00424086|Randomized|Parallel Assignment||Prevention||Single||||||
1542195|NCT00424060|Non-Randomized|||Treatment||None (Open Label)||||||
1542196|NCT00424047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542197|NCT00424034|Randomized|Parallel Assignment||Treatment||Double||||||
1542198|NCT00424021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542199|NCT00424008|Randomized|Parallel Assignment||Treatment||Single|||||t|
1542200|NCT00423995|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542201|NCT00423982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542202|NCT00423969|Randomized|Parallel Assignment||Treatment||Single||||||
1542203|NCT00423956|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1542204|NCT00423943|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542205|NCT00423930||Single Group Assignment||Treatment||None (Open Label)||||||
1542206|NCT00423917||Single Group Assignment||Treatment||None (Open Label)||||||
1542207|NCT00423904|Randomized|Factorial Assignment||Educational/Counseling/Training||Single||||||
1542208|NCT00423891||Single Group Assignment||Treatment||None (Open Label)||||||
1542209|NCT00423878|Randomized|Parallel Assignment||Treatment||Single||||||t
1542210|NCT00423865||Single Group Assignment||Treatment||None (Open Label)||||||
1542211|NCT00423852||Single Group Assignment||Treatment||None (Open Label)||||||
1542212|NCT00423839|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1542213|NCT00423826||||||||||||
1542214|NCT00423813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542215|NCT00423800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542216|NCT00423787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542217|NCT00423774|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1542218|NCT00423761|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1542219|NCT00423748|Randomized|Parallel Assignment||Treatment||Double||||||
1542220|NCT00423735||Single Group Assignment||Treatment||None (Open Label)||||||
1542221|NCT00423722|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1542222|NCT00423709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542223|NCT00423696|Randomized|||Treatment||None (Open Label)||||||
1542224|NCT00423683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542225|NCT00423670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542226|NCT00423657|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542227|NCT00423644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542228|NCT00423631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542229|NCT00423618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542230|NCT00423605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542231|NCT00423592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542232|NCT00423579|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542233|NCT00423566|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1542234|NCT00423553||||||||||||
1542235|NCT00423540|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542236|NCT00423527|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1542237|NCT00423514||Single Group Assignment||Treatment||None (Open Label)||||||
1542238|NCT00423501|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542239|NCT00423488|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542240|NCT00423475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542241|NCT00423462|Randomized|Parallel Assignment||Treatment||Single||||||
1542242|NCT00423449|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542243|NCT00423436|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1542244|NCT00423410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542245|NCT00423397||||Treatment||None (Open Label)||||||
1542246|NCT00423384|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542247|NCT00423371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542248|NCT00423358|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542249|NCT00423345|||Cohort||Prospective|||||||
1542250|NCT00423332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542251|NCT00423319|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1542252|NCT00423306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542253|NCT00423293||Single Group Assignment||Treatment||None (Open Label)||||||
1542254|NCT00423280|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542255|NCT00423267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542256|NCT00423254|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542257|NCT00423241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542258|NCT00423228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542259|NCT00423215|||Cohort||Prospective|||||||
1542260|NCT00423202|Randomized|Single Group Assignment||Treatment||Double||||||
1542261|NCT00423189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542262|NCT00423176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542263|NCT00423163|Randomized|Parallel Assignment||Treatment||Double||||||
1542264|NCT00423150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542265|NCT00423137||Parallel Assignment||Treatment||||||||
1542266|NCT00423124|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542267|NCT00423111|||Natural History||Longitudinal, Retrospective/Prospective|||||||
1542268|NCT00423098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542269|NCT00423085|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542270|NCT00423072|||Cohort||Prospective|||||||
1542271|NCT00423059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542272|NCT00423046|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1542273|NCT00423033|||||Prospective|||||||
1542274|NCT00423020|Randomized|Parallel Assignment||Treatment||Double||||||
1542275|NCT00423007|Randomized|Parallel Assignment||Treatment||Double||||||
1542276|NCT00422994|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1542277|NCT00422981|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542278|NCT00422968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542279|NCT00422955|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1542280|NCT00422942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542281|NCT00422929|||Cohort||Prospective|||||||
1542282|NCT00422916|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1542283|NCT00422903|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542284|NCT00422890|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542285|NCT00422877|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542286|NCT00422864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542287|NCT00422851|||Cohort||Cross-Sectional|||||||
1542288|NCT00422838|||Cohort||Prospective|||||||
1542289|NCT00422825|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542290|NCT00422812|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542291|NCT00422799||Single Group Assignment||Treatment||None (Open Label)||||||
1542292|NCT00422786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542293|NCT00422773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542294|NCT00422760|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1542295|NCT00422747|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1542296|NCT00422734|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542297|NCT00422721|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1542298|NCT00422708|Randomized|Parallel Assignment||Treatment||Single||||||
1542299|NCT00422695|||Cohort||Prospective|||||||
1542300|NCT00422682|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542301|NCT00422669|Randomized|Parallel Assignment||Treatment||Single|||t|||
1542302|NCT00422656||Single Group Assignment||Treatment||None (Open Label)||||||
1542303|NCT00422643|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1542304|NCT00422630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542305|NCT00422617|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1542306|NCT00422604|Randomized|Crossover Assignment||Treatment||Single|||t|||
1542307|NCT00422591||Single Group Assignment||Treatment||None (Open Label)||||||
1542308|NCT00422578|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542309|NCT00422565|Randomized|Parallel Assignment||Treatment||Single|||t|||
1542310|NCT00422552|Randomized|Crossover Assignment||Treatment||Double||||||
1542311|NCT00422539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542312|NCT00422526|Randomized|Factorial Assignment||Prevention||Double||||||
1542313|NCT00422513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542314|NCT00422500|||Cohort||Prospective|||||||
1542315|NCT00422487|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1542316|NCT00422474|||||Prospective|||||||
1542317|NCT00422461|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542318|NCT00422448|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1542319|NCT00422435|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542320|NCT00422422||Single Group Assignment||Treatment||None (Open Label)||||||
1542321|NCT00422409|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542322|NCT00422396|Randomized|Parallel Assignment||Treatment||Double||||||
1542323|NCT00422383|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542324|NCT00422370|Randomized|Parallel Assignment||||Double||||||
1542325|NCT00422357|Randomized|Factorial Assignment||Treatment||Double||||||
1542326|NCT00422344|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542328|NCT00422318|Randomized|Crossover Assignment||Treatment||Double||||||
1542329|NCT00422305|||Case-Control||Cross-Sectional|||||||
1542330|NCT00422292|Randomized|Parallel Assignment||Prevention||Single|||||t|
1542331|NCT00422279|Randomized|Parallel Assignment||||Double|||t||t|
1542332|NCT00422266|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1542333|NCT00422253|Randomized|Crossover Assignment||Prevention||Single||||||
1542334|NCT00422240|Randomized|Parallel Assignment||Treatment||Double||||||
1542335|NCT00422227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542336|NCT00422214|Randomized|Parallel Assignment||Treatment||Double||||||
1542337|NCT00422201||Single Group Assignment||Treatment||None (Open Label)||||||
1542338|NCT00422188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542339|NCT00422175|Randomized|Parallel Assignment||Treatment||Double||||||
1542340|NCT00422162|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542341|NCT00422149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542342|NCT00422136|||Family-Based||Cross-Sectional|||||||
1542343|NCT00422123|Randomized|Parallel Assignment||Treatment||Double||||||
1542344|NCT00422110|Randomized|Parallel Assignment||Treatment||Double||||||
1542345|NCT00422097|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542346|NCT00422084|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542347|NCT00422071||||||||||||
1542348|NCT00422058|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542349|NCT00422045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542350|NCT00422032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542351|NCT00422019|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542352|NCT00422006|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1542353|NCT00421993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542354|NCT00421980|Randomized|Parallel Assignment||Treatment||Double||||||
1542355|NCT00421967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542356|NCT00421954||Single Group Assignment||Treatment||None (Open Label)||||||
1542357|NCT00421941|Randomized|Parallel Assignment||Treatment||Double||||||
1542358|NCT00421928|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542359|NCT00421915|Randomized|Parallel Assignment||Treatment||Double||||||
1542360|NCT00421902||Single Group Assignment||Treatment||None (Open Label)||Acupuncture to pevent hot flushes||||
1542361|NCT00421889||Single Group Assignment||Treatment||None (Open Label)||||||
1542362|NCT00421876|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1542363|NCT00421863|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542364|NCT00421850|Randomized|Single Group Assignment||||None (Open Label)||||||
1542365|NCT00421837|||Case Control||Prospective|||||||
1542366|NCT00421824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542367|NCT00421811|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542368|NCT00421798|||Case Control||Prospective|||||||
1542369|NCT00421785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542370|NCT00421772|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1542371|NCT00421759|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1542372|NCT00421746|Randomized|Parallel Assignment||Treatment||Double||||||
1542373|NCT00421733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542374|NCT00421720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542375|NCT00421707|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1542376|NCT00421694|Randomized|Parallel Assignment||||Single||||||
1542377|NCT00421681|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542378|NCT00421668|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1542379|NCT00421655|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542380|NCT00421642||Single Group Assignment||Treatment||None (Open Label)||||||
1542381|NCT00421629|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1542382|NCT00421616|Randomized|Parallel Assignment||Treatment||Single||||||
1542383|NCT00421603|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542384|NCT00421590|Randomized|Crossover Assignment||Treatment||Double||||||
1542385|NCT00421577||||Screening|Cross-Sectional, Prospective|||||||
1542386|NCT00421564|Randomized|Parallel Assignment||Treatment||Double||||||
1542387|NCT00421551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542388|NCT00421538|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542389|NCT00421525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542390|NCT00421512|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542391|NCT00421499|Randomized|Parallel Assignment||Treatment||Single||||||
1542392|NCT00421486|||Case Control||Prospective|||||||
1542393|NCT00421473|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542394|NCT00421460||Single Group Assignment||Treatment||None (Open Label)||||||
1542395|NCT00421447|||Case Control||Prospective|||||||
1542396|NCT00421434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542397|NCT00421421|Randomized|Parallel Assignment||Treatment||Double||||||
1542398|NCT00421408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542399|NCT00421395|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542400|NCT00421369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542401|NCT00421356|||||Prospective|||||||
1542402|NCT00421343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542403|NCT00421330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542404|NCT00421317||Single Group Assignment||Treatment||None (Open Label)||||||
1542405|NCT00421304|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542406|NCT00421291|Randomized|Single Group Assignment||Health Services Research||Single||||||
1542407|NCT00421278|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1542408|NCT00421265|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1542409|NCT00421252|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1542410|NCT00421239|||Case Control||Retrospective|||||||
1542411|NCT00421226|Randomized|Parallel Assignment||Treatment||Double||||||
1542412|NCT00421213|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542413|NCT00421200|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542414|NCT00421187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542415|NCT00421174|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542416|NCT00421161|Randomized|Single Group Assignment||Treatment||Double||||||
1542417|NCT00421148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542418|NCT00421135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542419|NCT00421122|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542420|NCT00421109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542421|NCT00421096|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542422|NCT00421083|Randomized|Parallel Assignment||Treatment||Double||||||
1542423|NCT00421070|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542424|NCT00421057|||Case-Only||Prospective|||||||
1542425|NCT00421044|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542426|NCT00421031|Randomized|Single Group Assignment||Treatment||Double||||||
1542427|NCT00421018|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542428|NCT00421005|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542429|NCT00420992|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542430|NCT00420966|||Other||Prospective|||||||
1542431|NCT00420953|Randomized|Crossover Assignment||Treatment||Double||||||
1542432|NCT00420940|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542433|NCT00420927|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542434|NCT00420914|Randomized|Parallel Assignment||Health Services Research||Double||||||
1542435|NCT00420901|Randomized|Parallel Assignment||Treatment||Double||||||
1542436|NCT00420888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542437|NCT00420875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542438|NCT00420862|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1542439|NCT00420849||Single Group Assignment||Treatment||None (Open Label)||||||
1542440|NCT00420836|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542441|NCT00420823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542442|NCT00420810|Randomized|Crossover Assignment||Treatment||Double||||||
1542443|NCT00420797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542444|NCT00420784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542445|NCT00420771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542446|NCT00420758|Randomized|Parallel Assignment||Treatment||Single||||||t
1542447|NCT00420745|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1542448|NCT00420732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542449|NCT00420719||Single Group Assignment||Treatment||None (Open Label)||||||
1542450|NCT00420706|Randomized|Parallel Assignment||Treatment||Double||||||
1542451|NCT00420693||Parallel Assignment||Treatment||None (Open Label)||||||
1542452|NCT00420680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542453|NCT00420667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542454|NCT00420654|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542455|NCT00420641|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542456|NCT00420628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542457|NCT00420615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542458|NCT00420602||Single Group Assignment||Prevention||None (Open Label)||||||
1542459|NCT00420589|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1542460|NCT00420576|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542461|NCT00420563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542462|NCT00420550|Randomized|Parallel Assignment||Treatment||Single||||||
1542463|NCT00420537|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542464|NCT00420524|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542465|NCT00420511|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542466|NCT00420498|Randomized|Parallel Assignment||Treatment||Double||||||
1542467|NCT00420485|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542468|NCT00420472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542469|NCT00420459||Single Group Assignment||Treatment||None (Open Label)||||||
1542470|NCT00420446|Randomized|Parallel Assignment||||Double||||||
1542471|NCT00420433|||Case-Only||Prospective|||||||
1542472|NCT00420420|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542473|NCT00420407|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542474|NCT00420394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542475|NCT00420381||Single Group Assignment||Treatment||None (Open Label)||||||
1542476|NCT00420368|Randomized|Parallel Assignment||Treatment||Single||||||
1542477|NCT00420355|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542478|NCT00420342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542479|NCT00420316|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542480|NCT00420303|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542481|NCT00420290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542482|NCT00420277|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542483|NCT00420264||Single Group Assignment||||None (Open Label)||||||
1542484|NCT00420251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542485|NCT00420238|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542486|NCT00420225|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542487|NCT00420212|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542488|NCT00420199|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542489|NCT00420186||Single Group Assignment||Treatment||None (Open Label)||||||
1542490|NCT00420173|||Cohort||Prospective|||||||
1542491|NCT00420160|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542492|NCT00420147|Randomized|Parallel Assignment||Treatment||Single|||t|||
1542493|NCT00420134|Randomized|Single Group Assignment||Treatment||Single||||||
1542494|NCT00420121|||Cohort||Retrospective|||||||
1542495|NCT00420108|||Cohort||Prospective|||||||
1542496|NCT00420095|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542497|NCT00420082|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1542498|NCT00420069||||||||||||
1542499|NCT00420056|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542500|NCT00420043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542501|NCT00420030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542502|NCT00420017|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542503|NCT00420004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542504|NCT00419991||Single Group Assignment||Treatment||None (Open Label)||||||
1542505|NCT00419978|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542506|NCT00419965|||Cohort||Prospective|||||||
1542507|NCT00419952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542508|NCT00419939|||||Prospective|||||||
1542509|NCT00419926|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542510|NCT00419913|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542511|NCT00419900|Randomized|Single Group Assignment||Screening||Single||||||
1542512|NCT00419887|Randomized|Parallel Assignment||Treatment||Double||||||
1542513|NCT00419874|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1542514|NCT00419861|||Case-Only||Prospective|||||||
1542515|NCT00419848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542516|NCT00419835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542517|NCT00419822|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1542518|NCT00419809|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542519|NCT00419796|Randomized|Parallel Assignment||Treatment||Double||||||
1542520|NCT00419783|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1542521|NCT00419770|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542522|NCT00419757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542523|NCT00419744|Randomized|Parallel Assignment||Treatment||Double||||||
1542524|NCT00419731|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542525|NCT00419718|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542526|NCT00419705|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542527|NCT00419692|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542528|NCT00419679|Randomized|Single Group Assignment||Diagnostic||Single||||||
1542529|NCT00419666|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542530|NCT00419653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542531|NCT00419640|Randomized|Parallel Assignment||Treatment||Single|||t|||
1542532|NCT00419627|||Natural History||Longitudinal, Prospective|||||||
1542533|NCT00419614|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1542534|NCT00419601|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542535|NCT00419588|||Case-Control||Prospective|||||||
1542536|NCT00419575|||Case-Only||Prospective|||||||
1542537|NCT00419562|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1542538|NCT00419549|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1542539|NCT00419536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542540|NCT00419510|Randomized|Single Group Assignment||||None (Open Label)||||||
1542541|NCT00419497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542542|NCT00419484|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1542543|NCT00419471|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542544|NCT00419458|Randomized|Single Group Assignment||Treatment||Single||||||
1542545|NCT00419445|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1542546|NCT00419432|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1542547|NCT00419419|Randomized|Crossover Assignment||Treatment||Double||||||
1542548|NCT00419406|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1542549|NCT00419393||Single Group Assignment||Treatment||None (Open Label)||||||
1542550|NCT00419380|Randomized|Parallel Assignment||Treatment||Single|||||t|
1542551|NCT00419367||||||||||||
1542552|NCT00419354|||Cohort||Prospective|||||||
1542553|NCT00419341||Single Group Assignment||Treatment||None (Open Label)||||||
1542554|NCT00419328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542555|NCT00419315|Randomized|Parallel Assignment||Treatment||Single||||||t
1542556|NCT00419302|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542557|NCT00419289|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542558|NCT00419276|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542559|NCT00419263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542560|NCT00419250|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542561|NCT00419237|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542562|NCT00419224|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542563|NCT00419211|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542564|NCT00419198|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1542565|NCT00419185|Randomized|Parallel Assignment||Treatment||Single||||||
1542566|NCT00419172|Non-Randomized|Crossover Assignment||Treatment||Single||||||
1542567|NCT00419159|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542568|NCT00419146|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1542569|NCT00419133|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1542570|NCT00419120||Single Group Assignment||Treatment||None (Open Label)||||||
1542571|NCT00419107|||Case Control||Prospective|||||||
1542572|NCT00419094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542573|NCT00419081|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542574|NCT00419068|Randomized|Parallel Assignment||Treatment||Double||||||
1542575|NCT00419055|||Case Control||Prospective|||||||
1542576|NCT00419042|||Case-Only||Prospective|||||||
1542577|NCT00419029|Randomized|Parallel Assignment||Screening||Single|||t|||
1542578|NCT00419016|||Defined Population||Cross-Sectional, Retrospective|||||||
1542579|NCT00419003|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1542580|NCT00418990|Randomized|Parallel Assignment||Treatment||Double||||||
1542581|NCT00418977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542582|NCT00418964|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542583|NCT00418951|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542584|NCT00418938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542585|NCT00418925|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1542586|NCT00418912|||Family-Based||Prospective|||||||
1542587|NCT00418899|||Family-Based||Prospective|||||||
1542588|NCT00418886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542589|NCT00418873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542590|NCT00418860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542591|NCT00418847||Single Group Assignment||Treatment||None (Open Label)||||||
1542592|NCT00418834|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542593|NCT00418821|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542594|NCT00418808|||Case Control|Screening|Longitudinal, Retrospective/Prospective|||||||
1542595|NCT00418795|Randomized|Parallel Assignment||Treatment||Double||||||
1542596|NCT00418782|Randomized|Parallel Assignment||Treatment||Double||||||
1542597|NCT00418769|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542598|NCT00418756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542599|NCT00418743|||Case-Only||Prospective|||||||
1542600|NCT00418730|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542601|NCT00418717|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542602|NCT00418704|||Case-Only||Prospective|||||||
1542603|NCT00418691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542604|NCT00418678|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542605|NCT00418665|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1542606|NCT00418652|Randomized|Single Group Assignment||Diagnostic||Single|||t|||
1542607|NCT00418639|Randomized|Parallel Assignment||Treatment||Double||||||
1542608|NCT00418626||Single Group Assignment||Treatment||None (Open Label)||||||
1542609|NCT00418613|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542610|NCT00418600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542611|NCT00418587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542612|NCT00418574|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542613|NCT00418561|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1542614|NCT00418548|Randomized|Parallel Assignment||Treatment||Double||||||
1542615|NCT00418535|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542616|NCT00418522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542617|NCT00418509|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542618|NCT00418496||Single Group Assignment||Treatment||None (Open Label)||||||
1542619|NCT00418483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542620|NCT00418470|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542621|NCT00418457|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542622|NCT00418444|Randomized|Parallel Assignment||||None (Open Label)||||||
1542623|NCT00418431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542624|NCT00418418|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1542625|NCT00418405|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1542626|NCT00418392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542627|NCT00418379|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542628|NCT00418366|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542629|NCT00418353|Randomized|Parallel Assignment||Treatment||Double||||||
1542630|NCT00418340|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542631|NCT00418327|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542632|NCT00418314|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1542633|NCT00418301|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1542634|NCT00418288|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1542635|NCT00418275|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542636|NCT00418262||Single Group Assignment||Treatment||None (Open Label)||open label||||
1542637|NCT00418249|Randomized|Parallel Assignment||Treatment||Double||||||
1542638|NCT00418236|||||Retrospective|||||||
1542639|NCT00418223|||Case Control||Prospective|||||||
1542640|NCT00418210||Single Group Assignment||Treatment||None (Open Label)||||||
1542641|NCT00418197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542642|NCT00418184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542643|NCT00418171|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542644|NCT00418158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542645|NCT00418145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542646|NCT00418132|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1542647|NCT00418119|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542648|NCT00418106|||Cohort||Prospective|||||||
1542649|NCT00418093||Single Group Assignment||Treatment||None (Open Label)||||||
1542650|NCT00418080|Randomized|Parallel Assignment||Treatment||Single||||||
1542651|NCT00418067|Randomized|Parallel Assignment||Treatment||Single|||t|||
1542652|NCT00418054|Randomized|Parallel Assignment||Treatment||Double||||||
1542653|NCT00418041|||Cohort||Prospective|||||||
1542654|NCT00418028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542655|NCT00418015|||Cohort||Prospective|||||||
1542656|NCT00418002|Randomized|Parallel Assignment||Treatment||Double||||||
1542657|NCT00417989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542658|NCT00417976||Single Group Assignment||Treatment||None (Open Label)||||||
1542659|NCT00417963||Single Group Assignment||Treatment||None (Open Label)||||||
1542660|NCT00417950|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542661|NCT00417937|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542662|NCT00417924|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1542663|NCT00417911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542664|NCT00417898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542665|NCT00417885|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542666|NCT00417872|Randomized|Parallel Assignment||Treatment||Double||||||
1542667|NCT00417859|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542668|NCT00417846|||Cohort||Prospective|||||||
1542669|NCT00417833|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1542670|NCT00417820|Randomized|Parallel Assignment||Treatment||Double||||||
1542671|NCT00417807|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542672|NCT00417794|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1542673|NCT00417781|||Case Control|||||||||
1542674|NCT00417768|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1542675|NCT00417755|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1542676|NCT00417742|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542677|NCT00417729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542678|NCT00417716|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542679|NCT00417703|||||Prospective|||||||
1542680|NCT00417690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542681|NCT00417677|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542682|NCT00417664|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542683|NCT00417651|||Case-Only||Prospective|||||||
1542684|NCT00417638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542685|NCT00417625|||||Prospective|||||||
1542686|NCT00417612|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542687|NCT00417599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542688|NCT00417586|||Cohort||Prospective|||||||
1542689|NCT00417573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542690|NCT00417560||Single Group Assignment||Prevention||None (Open Label)||||||
1542691|NCT00417547||||||||||||
1542692|NCT00417534|||Defined Population||Longitudinal, Prospective|||||||
1542693|NCT00417521||Single Group Assignment||Treatment||None (Open Label)||||||
1542694|NCT00417508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542695|NCT00417495|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1542696|NCT00417482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542697|NCT00417469|Randomized|Single Group Assignment||Treatment||Single|||t|||
1542698|NCT00417456|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1542699|NCT00417443|Randomized|Parallel Assignment||Treatment||Double||||||
1542700|NCT00417430|Randomized|Single Group Assignment||Treatment||Double||||||
1542701|NCT00417417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542702|NCT00417404|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1542703|NCT00417391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542704|NCT00417378|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1543158|NCT00411255||Crossover Assignment||Supportive Care||Single|||t|||
1542705|NCT00417365|Randomized|Parallel Assignment||Treatment||Single|||||t|
1542706|NCT00417352|Randomized|Single Group Assignment||||None (Open Label)||||||
1542707|NCT00417339|||Cohort||Prospective|||||||
1542708|NCT00417326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542709|NCT00417313|Randomized|Parallel Assignment||Treatment||Single||||||
1542710|NCT00417287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542711|NCT00417274||Single Group Assignment||Treatment||None (Open Label)||||||
1542712|NCT00417261|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1542713|NCT00417248||Single Group Assignment||Treatment||None (Open Label)||||||
1542714|NCT00417235|Randomized|Factorial Assignment||Prevention||Single||||||t
1542715|NCT00417222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542716|NCT00417209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542717|NCT00417196|Randomized|Parallel Assignment||Treatment||Double||||||
1542718|NCT00417183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542719|NCT00417170|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542720|NCT00417157|||Cohort||Prospective|||||||
1542721|NCT00417144|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542722|NCT00417131|||Cohort||Prospective|||||||
1542723|NCT00417118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542724|NCT00417105|||Case-Only||Prospective|||||||
1542725|NCT00417092|Randomized|Parallel Assignment||Treatment||Single||||||
1542726|NCT00417079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542727|NCT00417066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542728|NCT00417053|Non-Randomized|||Treatment||None (Open Label)||||||
1542729|NCT00417040||Single Group Assignment||Other||None (Open Label)||||||
1542730|NCT00417027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542731|NCT00417014||||Treatment||None (Open Label)||||||
1542732|NCT00417001|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1542733|NCT00416988|Randomized|||Prevention||||||||
1542734|NCT00416975||Single Group Assignment||Screening||None (Open Label)||||||
1542735|NCT00416962|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542736|NCT00416949||Single Group Assignment||Basic Science||None (Open Label)||||||
1542737|NCT00416936|||||Prospective|||||||
1542738|NCT00416923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542739|NCT00416910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542740|NCT00416897|Randomized|||Treatment||None (Open Label)||||||
1542741|NCT00416884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542742|NCT00416871|Randomized|||Treatment||None (Open Label)||||||
1542743|NCT00416858|Randomized|||Treatment||||||||
1542744|NCT00416845|Randomized|Parallel Assignment||Treatment||Double||||||
1542745|NCT00416832||||Treatment||||||||
1542746|NCT00416819||Single Group Assignment||Treatment||None (Open Label)||||||
1542747|NCT00416793||Single Group Assignment||Treatment||None (Open Label)||||||
1542748|NCT00416780|Randomized|||Supportive Care||||||||
1542749|NCT00416767||Single Group Assignment||Treatment||None (Open Label)||||||
1542750|NCT00416754|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1542751|NCT00416741|||Cohort||Prospective|||||||
1542752|NCT00416728|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542753|NCT00416715||Single Group Assignment||Supportive Care||None (Open Label)||||||
1542754|NCT00416702|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542755|NCT00416689|||Case-Only||Prospective|||||||
1542756|NCT00416676||||Treatment||None (Open Label)||||||
1542757|NCT00416663|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542758|NCT00416650||Single Group Assignment||Treatment||None (Open Label)||||||
1542759|NCT00416637||Single Group Assignment||Treatment||None (Open Label)||||||
1542760|NCT00416624|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1542761|NCT00416611|||Cohort||Prospective|||||||
1542762|NCT00416598||Single Group Assignment||Treatment||None (Open Label)||||||
1542763|NCT00416585|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542764|NCT00416572|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1542765|NCT00416559|Non-Randomized|||Supportive Care||||||||
1542766|NCT00416546|Randomized|Parallel Assignment||Treatment||Double||||||
1542767|NCT00416533||||Treatment||None (Open Label)||||||
1542768|NCT00416520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542769|NCT00416507|Randomized|||Treatment||||||||
1542770|NCT00416494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542771|NCT00416481|||Case-Only||Prospective|||||||
1542772|NCT00416468|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542773|NCT00416455||Single Group Assignment||Diagnostic||None (Open Label)||||||
1542774|NCT00416442|Randomized|Parallel Assignment||Treatment||Double||||||
1542775|NCT00416429|Randomized|||Treatment||None (Open Label)||||||
1542776|NCT00416403|Randomized|Parallel Assignment||Treatment||Single||||||t
1542777|NCT00416390|Randomized|||Treatment||Double||||||
1542778|NCT00416377||||Treatment||None (Open Label)||||||
1542779|NCT00416364|||Case Control||Prospective|||||||
1542780|NCT00416351||Single Group Assignment||Treatment||None (Open Label)||||||
1542781|NCT00416338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542782|NCT00416325||||Prevention||||||||
1542783|NCT00416312|||Cohort||Prospective|||||||
1542784|NCT00416299|||||Prospective|||||||
1542785|NCT00416286|||Defined Population|Screening|Longitudinal, Prospective|||||||
1542786|NCT00416273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542787|NCT00416260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542788|NCT00416247|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1542789|NCT00416234|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542790|NCT00416221|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542791|NCT00416208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542792|NCT00416195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542793|NCT00416182|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542794|NCT00416169|Randomized|Parallel Assignment||Treatment||Double||||||
1542795|NCT00416156|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1542796|NCT00416143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542797|NCT00416130||Single Group Assignment||Treatment||None (Open Label)||||||
1542798|NCT00416117|Randomized|Parallel Assignment||Treatment||Single||||||
1542799|NCT00416104|||Defined Population||Cross-Sectional, Retrospective|||||||
1542800|NCT00416091|||Case Control|||||||||
1542801|NCT00416078|Randomized|Parallel Assignment||Treatment||Single||||||t
1542802|NCT00416065|Randomized|Single Group Assignment||||None (Open Label)||||||
1542803|NCT00416052|||Case-Only|||||||||
1542804|NCT00416039|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542805|NCT00416026|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1542806|NCT00416013|||Case-Only||Prospective|||||||
1542807|NCT00416000|||Cohort||Prospective|||||||
1542808|NCT00415987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542809|NCT00415974|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542810|NCT00415961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542811|NCT00415948|||Cohort||Prospective|||||||
1542812|NCT00415935|||Defined Population||Longitudinal, Prospective|||||||
1542813|NCT00415922|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542814|NCT00415909||Single Group Assignment||Treatment||None (Open Label)||||||
1542815|NCT00415896|Randomized|Crossover Assignment||Treatment||Single||||||
1542816|NCT00415883|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542817|NCT00415870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542818|NCT00415857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542819|NCT00415844|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542820|NCT00415831|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542821|NCT00415818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542822|NCT00415805|Randomized|Crossover Assignment||Diagnostic||Double|||t|||t
1542823|NCT00415792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542824|NCT00415779|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542825|NCT00415766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542826|NCT00415753|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1542827|NCT00415740|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542828|NCT00415727|Randomized|Single Group Assignment||||Single||||||
1542829|NCT00415714|Randomized|Parallel Assignment||Treatment||Single||||||
1542830|NCT00415701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542831|NCT00415688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542832|NCT00415675|||Case-Only||Prospective|||||||
1542833|NCT00415662|Randomized|Single Group Assignment||||Double||||||
1542834|NCT00415649|Randomized|Parallel Assignment||Prevention||Double||||||
1542835|NCT00415636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542836|NCT00415623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542837|NCT00415610|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|Open treatment assignment was employed because it is not safe to conceal SBP measurement. Patient data routinely entered by clinical staff were used to evaluate safety.|Staged intensity levels of rapid intravenous antihypertensive control for elevated SBP in patients with intracerebral hemorrhage were implemented in 3 sequential treatment arms to assess the feasibility and tolerability (safety) of this treatment.||||
1542838|NCT00415597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542839|NCT00415584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542840|NCT00415571|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542841|NCT00415558|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542842|NCT00415545|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1542843|NCT00415532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542844|NCT00415519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542845|NCT00415506|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542846|NCT00415493|Randomized|Crossover Assignment||Diagnostic||Single|||||t|
1542847|NCT00415467|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542848|NCT00415454|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542849|NCT00415441|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1542850|NCT00415428|||Cohort||Prospective|||||||
1542851|NCT00415415|||||Prospective|||||||
1542852|NCT00415402|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1542853|NCT00415389|Randomized|Parallel Assignment||||Single|||t|||
1542854|NCT00415376||||Supportive Care||||||||
1542855|NCT00415363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542856|NCT00415350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542857|NCT00415337|||Cohort|||||||||
1542858|NCT00415324||Single Group Assignment||Treatment||None (Open Label)||||||
1542859|NCT00415311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542860|NCT00415298|Randomized|||Treatment||||||||
1542861|NCT00415285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542862|NCT00415272|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542863|NCT00415259|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1542864|NCT00415246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542865|NCT00415233|Randomized|Factorial Assignment||Treatment||Single||||||t
1542866|NCT00415220|Randomized|Crossover Assignment||Treatment||Double||||||
1542867|NCT00415207|||Cohort||Retrospective|||||||
1542868|NCT00415194|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542869|NCT00415181|||Cohort||Prospective|||||||
1542870|NCT00415168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542871|NCT00415155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542872|NCT00415142|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542873|NCT00415129|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1542874|NCT00415116||Single Group Assignment||Treatment||None (Open Label)||||||
1542875|NCT00415103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542876|NCT00415090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542877|NCT00415077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542878|NCT00415064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542879|NCT00415051||Single Group Assignment||Prevention||None (Open Label)||||||
1542880|NCT00415038|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1542881|NCT00415025||||||||||||
1542882|NCT00414999|Randomized|Parallel Assignment||Treatment||Double||||||
1542883|NCT00414986|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1542884|NCT00414973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542885|NCT00414960|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1542886|NCT00414947|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542887|NCT00414934|||Case Control||Prospective|||||||
1542888|NCT00414921|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542889|NCT00414908|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542890|NCT00414895|||Cohort||Prospective|||||||
1542891|NCT00414882|||||Prospective|||||||
1542892|NCT00414869|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1542893|NCT00414856|Randomized|Crossover Assignment||Treatment||Double||||||
1542894|NCT00414843||||||||||||
1542895|NCT00414830|||||Prospective|||||||
1542896|NCT00414817|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1542897|NCT00414804|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1542898|NCT00414778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542899|NCT00414765||Single Group Assignment||Treatment||None (Open Label)||||||
1542900|NCT00414752|Randomized|Crossover Assignment||Treatment||Double||||||
1542901|NCT00414739|Randomized|Single Group Assignment||Treatment||Double||||||
1542902|NCT00414726|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1542903|NCT00414713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542904|NCT00414700|Randomized|Parallel Assignment||Treatment||Single||||||t
1542905|NCT00414687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542906|NCT00414661|||Cohort||Prospective|||||||
1542907|NCT00414648|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1542908|NCT00414635|Randomized|Crossover Assignment||Treatment||None (Open Label)||This study is designed to compare the control and the experimental arm groups for 24 weeks of treatment. After 24 weeks, subjects on the control arm then cross over to the experimental intervention.||||
1542909|NCT00414622|Randomized|Parallel Assignment||Treatment||Double||||||
1542910|NCT00414609|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542911|NCT00414596||Single Group Assignment||Treatment||None (Open Label)||||||
1542912|NCT00414583|||Cohort||Prospective|||||||
1542913|NCT00414570|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1542914|NCT00414557|Randomized|Factorial Assignment||Treatment||Single||||||
1542915|NCT00414544|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542916|NCT00414531|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1542917|NCT00414518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542918|NCT00414505|Randomized|Parallel Assignment||Treatment||Double||||||
1542919|NCT00414492|||Case-Only||Prospective|||||||
1542920|NCT00414479|||Cohort||Prospective|||||||
1542921|NCT00414466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542922|NCT00414453|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1542923|NCT00414440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542924|NCT00414427|Randomized|Parallel Assignment||Treatment||Double||||||
1542925|NCT00414414|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1542926|NCT00414401|Randomized|Parallel Assignment||||None (Open Label)||||||
1542927|NCT00414388||Single Group Assignment||Treatment||None (Open Label)||||||
1542928|NCT00414375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542929|NCT00414362|||Other||Retrospective|||||||
1542930|NCT00414349|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542931|NCT00414336|Randomized|Parallel Assignment||Prevention||Double||||||
1542932|NCT00414323|Randomized|Crossover Assignment||Treatment||Single||||||
1542933|NCT00414310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542934|NCT00414297|Randomized|Parallel Assignment||Treatment||Single|||t|||
1542935|NCT00414284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542936|NCT00414271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542937|NCT00414258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542938|NCT00414245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542939|NCT00414232|||Case-Only||Prospective|||||||
1542940|NCT00414219|||Cohort||Prospective|||||||
1542941|NCT00414206|Randomized|Parallel Assignment||Treatment||Double||||||
1542942|NCT00414193|||Other||Retrospective|||||||
1542943|NCT00414180|Randomized|Parallel Assignment||Treatment||Double||||||
1542944|NCT00414167|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1542945|NCT00414154|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542946|NCT00414141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542947|NCT00414128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542948|NCT00414115|||Cohort||Other|||||||
1542949|NCT00414102|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542950|NCT00414089|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542951|NCT00414076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542952|NCT00414063||||||||||||
1542953|NCT00414050|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1542954|NCT00414037|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542955|NCT00414024|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542956|NCT00414011|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1542957|NCT00413998|Randomized|Parallel Assignment||Treatment||Single||||||t
1542958|NCT00413985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542959|NCT00413972|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1542960|NCT00413959||Single Group Assignment||Treatment||None (Open Label)||||||
1542961|NCT00413946|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1542962|NCT00413933|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542963|NCT00413920|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542964|NCT00413894||Single Group Assignment||Treatment||None (Open Label)||||||
1542965|NCT00413881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542966|NCT00413868|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1542967|NCT00413855|Randomized|Single Group Assignment||Treatment||Double||||||
1542968|NCT00413842||||||||||||
1542969|NCT00413829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542970|NCT00413816|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1542971|NCT00413803|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542972|NCT00413790|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1542973|NCT00413777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542974|NCT00413764|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542975|NCT00413751|||||Longitudinal, Prospective|||||||
1542976|NCT00413738|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542977|NCT00413725|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1542978|NCT00413712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542979|NCT00413699|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542980|NCT00413686|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542981|NCT00413673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542982|NCT00413660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1542983|NCT00413647||Single Group Assignment||Diagnostic||None (Open Label)||||||
1542984|NCT00413634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542985|NCT00413621||||||||||||
1542986|NCT00413608|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542987|NCT00413595|||Cohort||Prospective|||||||
1542988|NCT00413582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542989|NCT00413569|||Defined Population||Longitudinal, Retrospective|||||||
1542990|NCT00413556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1542991|NCT00413543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1542992|NCT00413517|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542993|NCT00413504|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542994|NCT00413491|Non-Randomized|Single Group Assignment||Screening||Single||||||t
1542995|NCT00413478||Single Group Assignment||Treatment||None (Open Label)||||||
1542996|NCT00413465|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1542997|NCT00413452|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1542998|NCT00413439|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1542999|NCT00413426|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543000|NCT00413413|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543001|NCT00413400|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543002|NCT00413387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543003|NCT00413374||Single Group Assignment||Treatment||None (Open Label)||||||
1543004|NCT00413361|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1543005|NCT00413348|Randomized|Parallel Assignment||Prevention||Double||||||
1543006|NCT00413335|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1543007|NCT00413322||Single Group Assignment||Treatment||None (Open Label)||||||
1543008|NCT00413309|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543009|NCT00413296|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543010|NCT00413283|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1543011|NCT00413270||||||||||||
1543012|NCT00413257|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543013|NCT00413244|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543014|NCT00413231||Single Group Assignment||Treatment||None (Open Label)||||||
1543015|NCT00413218|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543016|NCT00413205|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543017|NCT00413192||Single Group Assignment||Treatment||None (Open Label)||||||
1543018|NCT00413179|Randomized|Parallel Assignment||Treatment||Double||||||
1543019|NCT00413166|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543020|NCT00413153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543021|NCT00413140|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1543022|NCT00413127|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543023|NCT00413114||Single Group Assignment||Treatment||None (Open Label)||||||
1543024|NCT00413101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543025|NCT00413088|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543026|NCT00413075||Single Group Assignment||Treatment||None (Open Label)||||||
1543027|NCT00413062|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543028|NCT00413049|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543029|NCT00413036||Single Group Assignment||Treatment||None (Open Label)||||||
1543030|NCT00413023|Randomized|Parallel Assignment||Treatment||Double||||||
1543031|NCT00413010|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543032|NCT00412997||Single Group Assignment||Treatment||None (Open Label)||||||
1543033|NCT00412984|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1543034|NCT00412971|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1543035|NCT00412958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543036|NCT00412932|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543037|NCT00412919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543038|NCT00412906|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1543039|NCT00412893|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543040|NCT00412880||Single Group Assignment||Treatment||||||||
1543041|NCT00412867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543042|NCT00412854|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543043|NCT00412841|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1543044|NCT00412828||Single Group Assignment||Treatment||None (Open Label)||||||
1543045|NCT00412815|Randomized|Parallel Assignment||Other||Single||||||
1543046|NCT00412802|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543047|NCT00412789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543048|NCT00412776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543049|NCT00412763|Randomized|Parallel Assignment||Treatment||Double||||||
1543050|NCT00412750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543051|NCT00412737|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1543052|NCT00412724|||||Cross-Sectional|||||||
1543053|NCT00412698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543054|NCT00412685|||Case Control||Prospective|||||||
1543055|NCT00412672|||Cohort||Prospective|||||||
1543056|NCT00412659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543057|NCT00412646|Randomized|Parallel Assignment||Treatment||Double||||||
1543058|NCT00412633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543059|NCT00412620|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543060|NCT00412607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543061|NCT00412594||Single Group Assignment||Treatment||None (Open Label)||||||
1543062|NCT00412581||Single Group Assignment||Treatment||None (Open Label)||||||
1543063|NCT00412568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543064|NCT00412555|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1543065|NCT00412542||Single Group Assignment||Treatment||None (Open Label)||||||
1543066|NCT00412529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543067|NCT00412516|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1543068|NCT00412503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543069|NCT00412490|||Cohort||Prospective|||||||
1543070|NCT00412477|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1543071|NCT00412464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543072|NCT00412451|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543073|NCT00412438|||Case Control, Natural History||Cross-Sectional, Retrospective|||||||
1543074|NCT00412425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543075|NCT00412412|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543076|NCT00412399|||Natural History||Longitudinal, Prospective|||||||
1543077|NCT00412386|||Case Control||Prospective|||||||
1543078|NCT00412373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543079|NCT00412360|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543080|NCT00412347|||||Retrospective|||||||
1543081|NCT00412334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543082|NCT00412321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543083|NCT00412308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543084|NCT00412295|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1543085|NCT00412269|||Cohort||Prospective|||||||
1543086|NCT00412256|Randomized|Parallel Assignment||Treatment||Double||||||
1543087|NCT00412243||Single Group Assignment||Treatment||None (Open Label)||||||
1543088|NCT00412230|||Case Control||Retrospective|||||||
1543089|NCT00412217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543090|NCT00412204|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1543091|NCT00412191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543092|NCT00412178|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1543093|NCT00412165|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543094|NCT00412152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543095|NCT00412139|||Case-Crossover||Prospective|||||||
1543096|NCT00412126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543097|NCT00412113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543098|NCT00412100|Randomized|Parallel Assignment||Treatment||Double||||||
1543099|NCT00412087|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1543100|NCT00412074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543101|NCT00412061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543102|NCT00412048|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543103|NCT00412035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543104|NCT00412022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543105|NCT00412009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543106|NCT00411996|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543107|NCT00411983|||Cohort||Prospective|||||||
1543108|NCT00411970|Randomized|Parallel Assignment||Treatment||Single||||||
1543109|NCT00411957|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543110|NCT00411944|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1543111|NCT00411931|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543112|NCT00411905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543113|NCT00411892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543114|NCT00411879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543115|NCT00411866|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1543116|NCT00411853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543117|NCT00411840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543118|NCT00411827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543119|NCT00411814|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1543120|NCT00411801|Randomized|Parallel Assignment||Treatment||Single|||||t|
1543121|NCT00411788||Single Group Assignment||Treatment||None (Open Label)||||||
1543122|NCT00411762||Single Group Assignment||Treatment||None (Open Label)||||||
1543123|NCT00411749|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1543124|NCT00411736|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1543125|NCT00411723|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543126|NCT00411697|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1543127|NCT00411684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543128|NCT00411671||Single Group Assignment||Treatment||None (Open Label)||||||
1543129|NCT00411658||||||||||||
1543130|NCT00411645|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1543131|NCT00411632||Single Group Assignment||Treatment||None (Open Label)||||||
1543132|NCT00411619||Single Group Assignment||Treatment||None (Open Label)||||||
1543133|NCT00411606|||Case-Only||Prospective|||||||
1543134|NCT00411593||Single Group Assignment||Treatment||None (Open Label)||||||
1543135|NCT00411580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543136|NCT00411567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543137|NCT00411554|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543138|NCT00411541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543139|NCT00411528|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543140|NCT00411515|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543141|NCT00411489|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1543142|NCT00411463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543143|NCT00411450||Single Group Assignment||Treatment||None (Open Label)||||||
1543144|NCT00411437|Randomized|Parallel Assignment||Treatment||Double||||||
1543145|NCT00411424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543146|NCT00411411|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543147|NCT00411398|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543148|NCT00411385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543149|NCT00411372|Randomized|Parallel Assignment||Treatment||Double||||||
1543150|NCT00411359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543151|NCT00411346|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1543152|NCT00411333|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543153|NCT00411320|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1543154|NCT00411307|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543155|NCT00411294|||Defined Population||Longitudinal, Retrospective|||||||
1543156|NCT00411281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543157|NCT00411268|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543159|NCT00411242|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543160|NCT00411229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543161|NCT00411216|Randomized|Parallel Assignment||Treatment||Single|||t|||
1543162|NCT00411203|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543163|NCT00411190|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1543164|NCT00411177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543165|NCT00411164|Randomized|Parallel Assignment||Treatment||Double||||||
1543166|NCT00411151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543167|NCT00411138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543168|NCT00411125|Randomized|Crossover Assignment||Treatment||Double||||||
1543169|NCT00411112|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543170|NCT00411099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543171|NCT00411086||Single Group Assignment||Treatment||None (Open Label)||||||
1543172|NCT00411073|Randomized|Crossover Assignment||Treatment||Double||||||
1543173|NCT00411060|||Other||Prospective|||||||
1543174|NCT00411047||Single Group Assignment||Treatment||None (Open Label)||||||
1543175|NCT00411034|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543176|NCT00411021|Randomized|Crossover Assignment||Treatment||Single||||||
1543177|NCT00410995|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543178|NCT00410982||Single Group Assignment||Treatment||None (Open Label)||||||
1543179|NCT00410969|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543180|NCT00410956||Single Group Assignment||Treatment||None (Open Label)||||||
1543181|NCT00410943|Randomized|Parallel Assignment||Treatment||Double||||||
1543182|NCT00410930|Randomized|Parallel Assignment||Treatment||Double||||||
1543183|NCT00410904||Single Group Assignment||Treatment||None (Open Label)||||||
1543184|NCT00410891||Single Group Assignment||Other||None (Open Label)||||||
1543185|NCT00410878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543186|NCT00410865||Single Group Assignment||Treatment||None (Open Label)||||||
1543187|NCT00410852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543188|NCT00410839|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543189|NCT00410826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543190|NCT00410813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543191|NCT00410800||||||||||||
1543192|NCT00410787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543193|NCT00410774|Non-Randomized|||Treatment||None (Open Label)||||||
1543194|NCT00410761|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543195|NCT00410748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543196|NCT00410735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543197|NCT00410722|Randomized|Parallel Assignment||Treatment||Single||||||t
1543198|NCT00410709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543199|NCT00410696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543200|NCT00410683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543201|NCT00410670|||Family-Based||Retrospective|||||||
1543202|NCT00410657|Non-Randomized|||Supportive Care||None (Open Label)||||||
1543203|NCT00410644|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1543204|NCT00410631|Randomized|||Treatment||None (Open Label)||||||
1543205|NCT00410618|||Case-Only||Prospective|||||||
1543206|NCT00410605||Single Group Assignment||Treatment||None (Open Label)||||||
1543207|NCT00410592|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543208|NCT00410579|||Cohort|||||||||
1543209|NCT00410566|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543210|NCT00410553||Single Group Assignment||Treatment||None (Open Label)||||||
1543211|NCT00410540|Randomized|Parallel Assignment||Treatment||Double||||||
1543212|NCT00410527||||Treatment||||||||
1543213|NCT00410514|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543214|NCT00410501|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543215|NCT00410488|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1543216|NCT00410475|||Cohort||Prospective|||||||
1543217|NCT00410462|Randomized|||Treatment||||||||
1543218|NCT00410449|||||Prospective|||||||
1543219|NCT00410436|Randomized|Parallel Assignment||Treatment||Single||||||t
1543220|NCT00410423|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543221|NCT00410410|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543222|NCT00410397|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1543223|NCT00410384|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543224|NCT00410371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543225|NCT00410358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543226|NCT00410345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543227|NCT00410332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543228|NCT00410319|Randomized|Parallel Assignment||Treatment||Single||||||
1543229|NCT00410306|||Cohort||Prospective|||||||
1543230|NCT00410293|Randomized|Single Group Assignment||Diagnostic||Single||||||
1543231|NCT00410280|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543232|NCT00410267||||||||||||
1543233|NCT00410254|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543234|NCT00410241|||Other||Prospective|||||||
1543235|NCT00410228|Randomized|Parallel Assignment||Treatment||Double||||||
1543236|NCT00410215|Randomized|Parallel Assignment||Treatment||Single|||||t|
1543237|NCT00410202|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543238|NCT00410189||Single Group Assignment||Treatment||None (Open Label)||||||
1543239|NCT00410176|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543240|NCT00410163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543241|NCT00410150|Randomized|Parallel Assignment||Treatment||Single||||||t
1543242|NCT00410137|||Defined Population||Longitudinal, Prospective|||||||
1543243|NCT00410124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543244|NCT00410111|||Cohort||Prospective|||||||
1543245|NCT00410098|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1543246|NCT00410085|Randomized|Crossover Assignment||Basic Science||Single||||||
1543247|NCT00410072|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543248|NCT00410059||Single Group Assignment||Treatment||None (Open Label)||||||
1543249|NCT00410046|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543250|NCT00410033|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543251|NCT00410020|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543252|NCT00410007|Randomized|Crossover Assignment||Other||Double|||t||t|
1543253|NCT00409994||Single Group Assignment||Treatment||None (Open Label)||||||
1543254|NCT00409981|Randomized|Parallel Assignment||Treatment||Double||||||
1543255|NCT00409968|||Case-Only||Prospective|||||||
1543256|NCT00409955|Randomized|Parallel Assignment||Treatment||Single||||||
1543257|NCT00409942|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1543258|NCT00409929|Randomized|Parallel Assignment||Treatment||Double||||||
1543259|NCT00409916|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1543260|NCT00409903|Randomized|Crossover Assignment||||Double||||||
1543261|NCT00409890|Randomized|Parallel Assignment||Treatment||Double||||||
1543262|NCT00409864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543263|NCT00409851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543264|NCT00409838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543265|NCT00409825||Single Group Assignment||Basic Science||None (Open Label)||||||
1543266|NCT00409812|Random Sample||||Longitudinal, Prospective|||||||
1543267|NCT00409799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543268|NCT00409786|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1543269|NCT00409773|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543270|NCT00409760|Randomized|Parallel Assignment||Treatment||Double||||||
1543271|NCT00409747||Single Group Assignment||Treatment||None (Open Label)||||||
1543272|NCT00409734|||Case-Control||Retrospective|||||||
1543273|NCT00409721|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543274|NCT00409708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543275|NCT00409695|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543276|NCT00409682|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543277|NCT00409669|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543278|NCT00409656|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543279|NCT00409643|Randomized|Parallel Assignment||Treatment||Double||||||
1543280|NCT00409630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543281|NCT00409617|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543282|NCT00409604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543283|NCT00409591|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543284|NCT00409578|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543285|NCT00409565||Single Group Assignment||Treatment||None (Open Label)||||||
1543286|NCT00409552|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1543287|NCT00409539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543288|NCT00409526||Single Group Assignment||Treatment||None (Open Label)||||||
1543289|NCT00409500|Randomized|Parallel Assignment||Treatment||Double||||||
1543290|NCT00409487|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543291|NCT00409461|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1543292|NCT00409448|Randomized|Parallel Assignment||Treatment||Single||||||t
1543293|NCT00409435|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543294|NCT00409422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543295|NCT00409409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543296|NCT00409396|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543297|NCT00409383|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543298|NCT00409370|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1543299|NCT00409357|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543300|NCT00409344|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1543301|NCT00409331|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543302|NCT00409318|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543303|NCT00409305|Randomized|Single Group Assignment||Treatment||Double||||||
1543304|NCT00409292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543305|NCT00409279|Randomized|Parallel Assignment||||Single|||||t|
1543306|NCT00409266|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543307|NCT00409253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543308|NCT00409240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543309|NCT00409227|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543310|NCT00409214|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543311|NCT00409201|Randomized|Single Group Assignment||Treatment||Double||||||
1543312|NCT00409188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543313|NCT00409175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543314|NCT00409162|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543315|NCT00409149|Randomized|Parallel Assignment||Treatment||Single|||t|||
1543316|NCT00409136|||Case Control||Prospective|||||||
1543317|NCT00409123|||Case-Only||Prospective|||||||
1543318|NCT00409110|||Case-Only||Prospective|||||||
1543319|NCT00409097|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543320|NCT00409084|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543321|NCT00409071|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543322|NCT00409058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543323|NCT00409045|||||Prospective|||||||
1543324|NCT00409032|Randomized|Parallel Assignment||Treatment||Double||||||
1543325|NCT00409019|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543326|NCT00409006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543327|NCT00408993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543328|NCT00408980|Randomized|Crossover Assignment||Screening||Single||||||
1543329|NCT00408967|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543330|NCT00408954|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1543331|NCT00408941|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1543332|NCT00408928||Single Group Assignment||Treatment||None (Open Label)||||||
1543333|NCT00408915|Randomized|Parallel Assignment||Treatment||Double||||||
1543334|NCT00408902||Single Group Assignment||Treatment||None (Open Label)||||||
1543335|NCT00408889|||Cohort||Prospective|||||||
1543336|NCT00408876|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1543337|NCT00408863|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543338|NCT00408850|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543339|NCT00408824|||Case Control, Natural History||Longitudinal, Retrospective/Prospective|||||||
1543340|NCT00408798|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1543341|NCT00408785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543342|NCT00408772||Single Group Assignment||Treatment||None (Open Label)||||||
1543343|NCT00408759|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543344|NCT00408746|||Case Control||Prospective|||||||
1543345|NCT00408733|Randomized|Single Group Assignment||||Single|||||t|
1543346|NCT00408720|Random Sample|||Screening|Cross-Sectional, Retrospective|||||||
1543347|NCT00408707|Randomized|Single Group Assignment||Treatment||Double||||||
1543348|NCT00408694||Single Group Assignment||Treatment||None (Open Label)||||||
1543349|NCT00408681||Single Group Assignment||Supportive Care||None (Open Label)||||||
1543350|NCT00408668|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543351|NCT00408655||Single Group Assignment||Treatment||None (Open Label)||||||
1543352|NCT00408642|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1543353|NCT00408629|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543354|NCT00408616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543355|NCT00408603||Single Group Assignment||Treatment||None (Open Label)||||||
1543356|NCT00408590||Single Group Assignment||Treatment||None (Open Label)||||||
1543357|NCT00408577|Randomized|Parallel Assignment||Prevention||Double||||||
1543358|NCT00408564||Single Group Assignment||Treatment||None (Open Label)||||||
1543359|NCT00408551||||Treatment||None (Open Label)||||||
1543360|NCT00408538|Randomized|Parallel Assignment||Prevention||Double||||||
1543361|NCT00408525||Single Group Assignment||Health Services Research||None (Open Label)||||||
1543362|NCT00408512|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543363|NCT00408499||Single Group Assignment||Treatment||None (Open Label)||||||
1543364|NCT00408473|Randomized|Parallel Assignment||Treatment||Double||||||
1543365|NCT00408460||Single Group Assignment||Treatment||None (Open Label)||||||
1543366|NCT00408447|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543367|NCT00408434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543368|NCT00408421|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543369|NCT00408408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543370|NCT00408395|Randomized|Parallel Assignment||Prevention||Single|||t|||
1543371|NCT00408382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543372|NCT00408369|Randomized|Parallel Assignment||Prevention||Double||||||
1543373|NCT00408356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543374|NCT00408330|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543375|NCT00408317|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1543376|NCT00408304|Randomized|Parallel Assignment||Prevention||Double||||||
1543377|NCT00408291|||Cohort||Prospective|||||||
1543378|NCT00408278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543379|NCT00408265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543380|NCT00408252||Single Group Assignment||Treatment||None (Open Label)||||||
1543381|NCT00408239|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543382|NCT00408226|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543383|NCT00408213|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543384|NCT00408200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543385|NCT00408187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543386|NCT00408174|Randomized|Parallel Assignment||Treatment||Double||||||
1543387|NCT00408161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543388|NCT00408148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543389|NCT00408135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543390|NCT00408122|||Cohort||Prospective|||||||
1543391|NCT00408109|Randomized|Parallel Assignment||Prevention||Double||||||
1543392|NCT00408096|Randomized|Parallel Assignment||Treatment||Single|||t|||
1543393|NCT00408083|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1543394|NCT00408070||Single Group Assignment||Treatment||None (Open Label)||||||
1543395|NCT00408057|||Case-Only||Prospective|||||||
1543396|NCT00408044|||||Prospective|||||||
1543397|NCT00408031|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543398|NCT00408018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543399|NCT00408005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543400|NCT00407992|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543401|NCT00407979|||Case Control||Prospective|||||||
1543402|NCT00407966||Single Group Assignment||Treatment||None (Open Label)||||||
1543403|NCT00407940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543404|NCT00407927|Randomized|Parallel Assignment||Treatment||Double||||||
1543405|NCT00407914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543406|NCT00407901|||Case Control||Cross-Sectional|||||||
1543407|NCT00407888||Single Group Assignment||Treatment||None (Open Label)||||||
1543408|NCT00407875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543409|NCT00407862|Randomized|Crossover Assignment||Treatment||Double||||||
1543410|NCT00407849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543411|NCT00407836|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543412|NCT00407823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543413|NCT00407797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543414|NCT00407784|||Defined Population|Screening|Longitudinal, Prospective|||||||
1543415|NCT00407771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543416|NCT00407758||||Treatment||None (Open Label)||||||
1543417|NCT00407745|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543418|NCT00407732|Randomized|Parallel Assignment||||Single||||||t
1543419|NCT00407719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543420|NCT00407706|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1543421|NCT00407693|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543422|NCT00407680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543423|NCT00407667|Non-Randomized|Factorial Assignment||Treatment||Double|||t||t|
1543424|NCT00407654||Single Group Assignment||Treatment||None (Open Label)||||||
1543425|NCT00407641|Randomized|Parallel Assignment||Prevention||Single|||t|||
1543426|NCT00407628|||Case Control||Retrospective|||||||
1543427|NCT00407615|Randomized|Parallel Assignment||Treatment||Double||||||
1543428|NCT00407602||Single Group Assignment||Treatment||None (Open Label)||||||
1543429|NCT00407589||Single Group Assignment||Treatment||None (Open Label)||||||
1543430|NCT00407576||||Treatment||||||||
1543431|NCT00407563|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543432|NCT00407550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543433|NCT00407537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543434|NCT00407524|Randomized|Crossover Assignment||||Double||||||
1543435|NCT00407511|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543436|NCT00407498|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543437|NCT00407485||Single Group Assignment||Treatment||None (Open Label)||||||
1543438|NCT00407472|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543439|NCT00407459|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543440|NCT00407446|Randomized|Parallel Assignment||Treatment||Double||||||
1543441|NCT00407433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543442|NCT00407420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543443|NCT00407407|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543444|NCT00407394|Randomized|Parallel Assignment||Treatment||Double||||||
1543445|NCT00407381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543446|NCT00407368|||Defined Population||Longitudinal, Prospective|||||||
1543447|NCT00407355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543448|NCT00407342|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543449|NCT00407329|||Case-Only||Prospective|||||||
1543450|NCT00407316|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1543451|NCT00407303|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543452|NCT00407290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543453|NCT00407277|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1543454|NCT00407264|Randomized|Crossover Assignment||Prevention||Double||||||
1543455|NCT00407251|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543456|NCT00407238|Randomized|Crossover Assignment||Treatment||Double||||||
1543457|NCT00407225|Randomized|Parallel Assignment||Treatment||Double||||||
1543458|NCT00407212|Randomized|Parallel Assignment||Treatment||Double||||||
1543459|NCT00407199|Randomized|Crossover Assignment||Treatment||Double||||||
1543460|NCT00407186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543461|NCT00407173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543462|NCT00407160|||Cohort||Prospective|||||||
1543463|NCT00407147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543464|NCT00407134|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543465|NCT00407121|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543466|NCT00407108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543467|NCT00407095|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543468|NCT00407082|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543469|NCT00407069|||Case Control||Prospective|||||||
1543470|NCT00407056|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543471|NCT00407043|Randomized|Parallel Assignment||Treatment||Double||||||
1543472|NCT00407030|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543473|NCT00407017|Randomized|Parallel Assignment||||Double||||||
1543474|NCT00407004|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543475|NCT00406991|Randomized|Parallel Assignment||Diagnostic||Double||||||
1543476|NCT00406978|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543477|NCT00406965||||Treatment||||||||
1543478|NCT00406952|Randomized|Parallel Assignment||Treatment||Double||||||
1543479|NCT00406939|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543480|NCT00406926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543481|NCT00406913|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1543482|NCT00406900|||Defined Population|Screening|Longitudinal, Prospective|||||||
1543483|NCT00406887|Randomized|Parallel Assignment||Treatment||Double||||||
1543484|NCT00406874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543485|NCT00406861|Randomized|Parallel Assignment||Treatment||Single||||||
1543486|NCT00406848|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543487|NCT00406835|||Defined Population||Longitudinal, Prospective|||||||
1543488|NCT00406822|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543489|NCT00406809|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1543490|NCT00406796|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543491|NCT00406783|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543492|NCT00406770|Non-Randomized|Crossover Assignment||Treatment||Single|||||t|
1543493|NCT00406757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543494|NCT00406744|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543495|NCT00406731|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1543496|NCT00406718|Randomized|Parallel Assignment||Treatment||Single||||||t
1543497|NCT00406705|Randomized|Parallel Assignment||Treatment||Double||||||
1543498|NCT00406692|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543499|NCT00406679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543500|NCT00406653|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1543501|NCT00406640|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1543502|NCT00406627|||||Prospective|||||||
1543503|NCT00406614|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1543504|NCT00406601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543505|NCT00406588|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543506|NCT00406575|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543507|NCT00406562|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1543508|NCT00406549|||Defined Population|Screening|Longitudinal, Prospective|||||||
1543509|NCT00406536|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1543510|NCT00406523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543511|NCT00406510|Randomized|Parallel Assignment||||Single||||||
1543512|NCT00406497|Randomized|Parallel Assignment||Treatment||Double||||||
1543513|NCT00406484|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1543514|NCT00406471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543515|NCT00406458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543516|NCT00406445|||Case-Control||Prospective|||||||
1543517|NCT00406432|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543518|NCT00406419|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543519|NCT00406406|Randomized|Single Group Assignment||Treatment||Double||||||
1543520|NCT00406393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543521|NCT00406380|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1543522|NCT00406367|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543523|NCT00406354|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543524|NCT00406341|Randomized|Parallel Assignment||Treatment||Double||||||
1543525|NCT00406315|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543526|NCT00406302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543527|NCT00406289|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543528|NCT00406276||Single Group Assignment||Treatment||None (Open Label)||||||
1543529|NCT00406263|||Case-Only||Prospective|||||||
1543530|NCT00406250||Single Group Assignment||Treatment||None (Open Label)||||||
1543531|NCT00406237|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1543532|NCT00406224|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543533|NCT00406211|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543534|NCT00406198|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1543535|NCT00406185|||Cohort||Prospective|||||||
1543536|NCT00406172|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1543537|NCT00406159|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543538|NCT00406146|Randomized|Parallel Assignment||Treatment||Single||||||
1543539|NCT00406133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543540|NCT00406120|||Case-Only||Retrospective|||||||
1543541|NCT00406107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543542|NCT00406094|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1543543|NCT00406081|||Case Control||Cross-Sectional|||||||
1543544|NCT00406068||Single Group Assignment||Treatment||None (Open Label)||||||
1543545|NCT00406055|||||Prospective|||||||
1543546|NCT00406042|Randomized|Parallel Assignment||Treatment||Single||||||
1543547|NCT00406029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543548|NCT00406016|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543549|NCT00406003|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543550|NCT00405990|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1543551|NCT00405977|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1543552|NCT00405964|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543553|NCT00405951||Single Group Assignment||Treatment||None (Open Label)||||||
1543554|NCT00405938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543555|NCT00405925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543556|NCT00405912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543557|NCT00405899|||Cohort||Prospective|||||||
1543558|NCT00405886|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543559|NCT00405873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543560|NCT00405860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543561|NCT00405847|Randomized|Crossover Assignment||Treatment||Double||||||
1543562|NCT00405834|||||Prospective|||||||
1543563|NCT00405821|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543564|NCT00405808|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543565|NCT00405795|||Cohort||Prospective|||||||
1543566|NCT00405782|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1543567|NCT00405769|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1543568|NCT00405756|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543569|NCT00405743|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543570|NCT00405730|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1543571|NCT00405717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543572|NCT00405704|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1543573|NCT00405691|Randomized|Single Group Assignment||Treatment||Single|||t|||
1543574|NCT00405678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543575|NCT00405665|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1543576|NCT00405652|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543577|NCT00405639|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1543578|NCT00405626|Randomized|Parallel Assignment||Prevention||Double||||||
1543579|NCT00405613|Randomized|Parallel Assignment||Treatment||Double||||||
1543580|NCT00405600||Single Group Assignment||Treatment||None (Open Label)||||||
1543581|NCT00405587||Single Group Assignment||Treatment||None (Open Label)||||||
1543582|NCT00405574|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543583|NCT00405561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543584|NCT00405548|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1543585|NCT00405535|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543586|NCT00405522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543587|NCT00405509|||Cohort||Prospective|||||||
1543588|NCT00405496|Randomized|Parallel Assignment||Treatment||Double||||||
1543589|NCT00405483|Randomized|Parallel Assignment||Treatment||Single|||t|||
1543590|NCT00405470|Randomized|Parallel Assignment||Treatment||Single|||t|||
1543591|NCT00405457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543592|NCT00405444|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543593|NCT00405431|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543594|NCT00405418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543595|NCT00405405||Single Group Assignment||Treatment||None (Open Label)||||||
1543596|NCT00405392|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543597|NCT00405379|Randomized|Parallel Assignment||Treatment||Single|||t|||
1543598|NCT00405366||Single Group Assignment||Treatment||None (Open Label)||||||
1543599|NCT00405353|||||Prospective|||||||
1543600|NCT00405340||Single Group Assignment||Treatment||None (Open Label)||||||
1543601|NCT00405327||Single Group Assignment||Treatment||None (Open Label)||||||
1543602|NCT00405314|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543603|NCT00405301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543604|NCT00405288|||Case Control||Prospective|||||||
1543605|NCT00405275|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543606|NCT00405262|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543607|NCT00405249|Randomized|Single Group Assignment||Treatment||Double||||||
1543608|NCT00405236|Randomized|Parallel Assignment||Treatment||Double||||||
1543609|NCT00405210|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543610|NCT00405197|Randomized|Parallel Assignment||Prevention||Single||||||
1543611|NCT00405184||Single Group Assignment||Treatment||None (Open Label)||||||
1543612|NCT00405171|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543613|NCT00405158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543614|NCT00405145||||Screening|Longitudinal, Retrospective/Prospective|||||||
1543615|NCT00405119|Randomized|Crossover Assignment||Diagnostic||Double||||||
1543616|NCT00405106|||Defined Population||Longitudinal, Prospective|||||||
1543617|NCT00405093|||Case-Only||Retrospective|||||||
1543618|NCT00405080|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543619|NCT00405067|Randomized|Parallel Assignment||Treatment||Double||||||
1543620|NCT00405054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543621|NCT00405041|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543622|NCT00405015|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1543623|NCT00405002|||Cohort||Prospective|||||||
1543624|NCT00404989|||Cohort||Prospective|||||||
1543625|NCT00404976|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1543626|NCT00404963|Randomized|Parallel Assignment||Diagnostic||Single||||||
1543627|NCT00404950|||Case-Only||Prospective|||||||
1543628|NCT00404937|Randomized|Parallel Assignment||Treatment||Single||||||
1543629|NCT00404924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543630|NCT00404911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543631|NCT00404898|||Other||Retrospective|||||||
1543632|NCT00404885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543633|NCT00404872||||||||||||
1543634|NCT00404859|Random Sample|||Screening|Longitudinal, Prospective|||||||
1543635|NCT00404846|Randomized|Parallel Assignment||Treatment||Double||||||
1543636|NCT00404833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543637|NCT00404820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543638|NCT00404807|Randomized|Parallel Assignment||Treatment||Single||||||
1543639|NCT00404794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543640|NCT00404781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543641|NCT00404768|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543642|NCT00404755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543643|NCT00404742|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543644|NCT00404729|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543645|NCT00404716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543646|NCT00404703|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543647|NCT00404690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543648|NCT00404677|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1543649|NCT00404664|Randomized|Single Group Assignment||Educational/Counseling/Training||Single||||||
1543650|NCT00404651|Randomized|Parallel Assignment||Prevention||Single||||||t
1543651|NCT00404638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543652|NCT00404625|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1543653|NCT00404612|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543654|NCT00404599|Randomized|Parallel Assignment||Treatment||Single|||t|||
1543655|NCT00404586|Randomized|Crossover Assignment||Treatment||||||||
1543656|NCT00404573|Randomized|Parallel Assignment||Treatment||Double||||||
1543657|NCT00404560|||Other||Retrospective|||||||
1543658|NCT00404547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543659|NCT00404534|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543660|NCT00404521|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543661|NCT00404508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543662|NCT00404495||Single Group Assignment||Treatment||None (Open Label)||||||
1543663|NCT00404482|||Cohort||Retrospective|||||||
1543664|NCT00404469|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1543665|NCT00404456|Randomized|Crossover Assignment||Treatment||Double||||||
1543666|NCT00404443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543667|NCT00404430|||Cohort||Prospective|||||||
1543668|NCT00404417|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1543669|NCT00404404||||Treatment||None (Open Label)||||||
1543670|NCT00404391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543671|NCT00404378|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543672|NCT00404365|Randomized|Parallel Assignment||||Double|||t||t|
1543673|NCT00404352|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1543674|NCT00404339||Single Group Assignment||Treatment||None (Open Label)||||||
1543675|NCT00404326|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543676|NCT00404313|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543677|NCT00404300|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543678|NCT00404287|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1543679|NCT00404274|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1543680|NCT00404261|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543681|NCT00404248|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543682|NCT00404235||Single Group Assignment||Treatment||None (Open Label)||||||
1543683|NCT00404222|Randomized|Parallel Assignment||Treatment||Single||||||
1543684|NCT00404209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543685|NCT00404196|Randomized|Parallel Assignment||Treatment||Double||||||
1543686|NCT00404183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543687|NCT00404170||Single Group Assignment||||None (Open Label)||||||
1543688|NCT00404157||||Treatment||||||||
1543689|NCT00404144||Single Group Assignment||Treatment||None (Open Label)||||||
1543690|NCT00404131|Randomized|Parallel Assignment||Treatment||Double||||||
1543691|NCT00404118|||Other||Retrospective|||||||
1543692|NCT00404105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543693|NCT00404092|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543694|NCT00404079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543695|NCT00404066||Single Group Assignment||Treatment||None (Open Label)||||||
1543696|NCT00404053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543697|NCT00404040|Randomized|Crossover Assignment||Treatment||Double||||||
1543698|NCT00404027|||Cohort||Retrospective|||||||
1543699|NCT00404014|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1543700|NCT00404001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543701|NCT00403988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543702|NCT00403975|Randomized|Parallel Assignment||Treatment||Double||||||
1543703|NCT00403962|Randomized|Parallel Assignment||Treatment||Double||||||
1543704|NCT00403949|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543705|NCT00403936|Randomized|Crossover Assignment||Treatment||Single||||||
1543706|NCT00403923|||Case-Crossover||Prospective|||||||
1543707|NCT00403910|Randomized|Parallel Assignment||Diagnostic||Double||||||
1543708|NCT00403897|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543709|NCT00403884|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1543710|NCT00403871|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1543711|NCT00403858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543712|NCT00403845|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1543713|NCT00403832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543714|NCT00403819|Randomized|Crossover Assignment||Treatment||Double||||||
1543715|NCT00403806|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1543716|NCT00403793|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1543717|NCT00403780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543718|NCT00403767|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1543719|NCT00403754|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1543720|NCT00403741|Randomized|Parallel Assignment||||None (Open Label)||||||
1543721|NCT00403728|Randomized|Parallel Assignment||Treatment||Single||||||
1543722|NCT00403715|Randomized|Parallel Assignment||Treatment||Double||||||
1543723|NCT00403702|Randomized|Parallel Assignment||Treatment||Double||||||
1543724|NCT00403689|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1543725|NCT00403676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543726|NCT00403663|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1543727|NCT00403650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543728|NCT00403637|Randomized|Factorial Assignment||Treatment||Double||||||
1543729|NCT00403624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543730|NCT00403611|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1543731|NCT00403598|||||Cross-Sectional, Retrospective/Prospective|||||||
1543732|NCT00403585|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543733|NCT00403572|||Cohort||Prospective|||||||
1543734|NCT00403559|Randomized|Parallel Assignment||Treatment||Double||||||
1543735|NCT00403546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543736|NCT00403533|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543737|NCT00403520|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543738|NCT00403507|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543739|NCT00403494|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543740|NCT00403481|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543741|NCT00403455||Single Group Assignment||Treatment||None (Open Label)||||||
1543742|NCT00403442|Randomized|Parallel Assignment||Treatment||Single||||||
1543743|NCT00403429||Single Group Assignment||Treatment||None (Open Label)||||||
1543744|NCT00403416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543745|NCT00403403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543746|NCT00403390|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543747|NCT00403377|Randomized|Parallel Assignment||||None (Open Label)||||||
1543748|NCT00403364|Randomized|Parallel Assignment||Treatment||Double||||||
1543749|NCT00403351|||Cohort||Cross-Sectional|||||||
1543750|NCT00403338|||Cohort||Prospective|||||||
1543751|NCT00403325|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543752|NCT00403312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543753|NCT00403299|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1543754|NCT00403286|Randomized|Parallel Assignment||Treatment||Double||||||
1543755|NCT00403273|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543756|NCT00403260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543757|NCT00403247|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543758|NCT00403234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543759|NCT00403221|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543760|NCT00403208|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1543761|NCT00403195|||Case Control||Prospective|||||||
1543762|NCT00403182|Randomized|||Treatment||None (Open Label)||||||
1543763|NCT00403169||Single Group Assignment||Treatment||None (Open Label)||||||
1543764|NCT00403156|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543765|NCT00403143|Randomized|Parallel Assignment||Treatment||Single||||||
1543766|NCT00403130||Single Group Assignment||Treatment||None (Open Label)||||||
1543767|NCT00403117|Randomized|Single Group Assignment||Basic Science||Double|double-blind, placebo-controlled||t||t|
1543768|NCT00403104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543769|NCT00403091|Randomized|Parallel Assignment||||Single|||t|||
1543770|NCT00403078|||||Prospective|||||||
1543771|NCT00403065|Randomized|||Treatment||||||||
1543772|NCT00403052|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543773|NCT00403039||Single Group Assignment||Treatment||None (Open Label)||||||
1543774|NCT00403026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543775|NCT00403013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543776|NCT00403000||Single Group Assignment||Treatment||None (Open Label)||||||
1543777|NCT00402987|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543778|NCT00402974|Randomized|Parallel Assignment||Treatment||Double||||||
1543779|NCT00402961|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543780|NCT00402948|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543781|NCT00402935|||Cohort||Prospective|||||||
1543782|NCT00402922|||Cohort||Retrospective|||||||
1543783|NCT00402909|Randomized|Parallel Assignment||Treatment||Double||||||
1543784|NCT00402896||Single Group Assignment||Treatment||None (Open Label)||||||
1543785|NCT00402883||Single Group Assignment||Treatment||None (Open Label)||||||
1543786|NCT00402870|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1543787|NCT00402857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543788|NCT00402844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543789|NCT00402831|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543790|NCT00402818|||Cohort||Prospective|||||||
1543791|NCT00402805|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1543792|NCT00402792|Randomized|Parallel Assignment||Treatment||Double||||||
1543793|NCT00402779|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1543794|NCT00402766||Single Group Assignment||Treatment||None (Open Label)||||||
1543795|NCT00402753|Randomized|Factorial Assignment||Supportive Care||Single||||||t
1543796|NCT00402740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543797|NCT00402727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543798|NCT00402714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543799|NCT00402701|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1543800|NCT00402688|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543801|NCT00402675|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543802|NCT00402662|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543803|NCT00402649|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1543804|NCT00402636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543805|NCT00402623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543806|NCT00402610|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543807|NCT00402597|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543808|NCT00402584|Randomized|Parallel Assignment||Treatment||Double||||||
1543809|NCT00402571|Randomized|Single Group Assignment||||Double||||||
1543810|NCT00402558||Single Group Assignment||Treatment||None (Open Label)||||||
1543811|NCT00402545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543812|NCT00402532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543813|NCT00402519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543814|NCT00402506|Randomized|Parallel Assignment||Treatment||Double||||||
1543815|NCT00402493|Randomized|Crossover Assignment||Treatment||Single|||||t|
1543816|NCT00402480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543817|NCT00402467|Randomized|Parallel Assignment||Prevention||Double||||||
1543818|NCT00402454|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543819|NCT00402441|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1543820|NCT00402428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543821|NCT00402415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543822|NCT00402402|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543823|NCT00402389|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1543824|NCT00402376|Randomized|Parallel Assignment||Treatment||Single||||||
1543825|NCT00402363|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543826|NCT00402350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543827|NCT00402337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543828|NCT00402324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543829|NCT00402311|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1543830|NCT00402298|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543831|NCT00402285|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543832|NCT00402272|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543833|NCT00402259|Randomized|Parallel Assignment||Treatment||Double||||||
1543834|NCT00402246|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1543835|NCT00402233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543980|NCT00400322|Randomized|Parallel Assignment||Treatment||Double||||||
1543836|NCT00402220|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1543837|NCT00402207|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543838|NCT00402194||Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543839|NCT00402181|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543840|NCT00402168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543841|NCT00402155|||Case Control||Prospective|||||||
1543842|NCT00402142|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543843|NCT00402129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543844|NCT00402116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543845|NCT00402103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543846|NCT00402090||||Screening|Cross-Sectional, Prospective|||||||
1543847|NCT00402077|Randomized|Parallel Assignment||Treatment||Single|||t|||
1543848|NCT00402064||||||||||||
1543849|NCT00402051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543850|NCT00402038|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543851|NCT00402025||Single Group Assignment||Treatment||None (Open Label)||||||
1543852|NCT00402012|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543853|NCT00401999|||||Prospective|||||||
1543854|NCT00401986|||Cohort||Prospective|||||||
1543855|NCT00401973|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543856|NCT00401960|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543857|NCT00401947|Randomized|Single Group Assignment||Treatment||Double||||||
1543858|NCT00401934|||||Prospective|||||||
1543859|NCT00401921|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1543860|NCT00401908|||Cohort||Prospective|||||||
1543861|NCT00401895|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543862|NCT00401882|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543863|NCT00401869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543864|NCT00401856|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543865|NCT00401843|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1543866|NCT00401830|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543867|NCT00401817||Single Group Assignment||Treatment||None (Open Label)||||||
1543868|NCT00401804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543869|NCT00401791|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543870|NCT00401778|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543871|NCT00401765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543872|NCT00401752|Randomized|Parallel Assignment||Treatment||Double||||||
1543873|NCT00401739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543874|NCT00401726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543875|NCT00401713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543876|NCT00401700|||Cohort||Prospective|||||||
1543877|NCT00401687|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1543878|NCT00401674||Single Group Assignment||Treatment||None (Open Label)||||||
1543879|NCT00401661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543880|NCT00401648|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1543881|NCT00401635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543882|NCT00401622|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1543883|NCT00401609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543884|NCT00401596||||Treatment||||||||
1543885|NCT00401583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543886|NCT00401570|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543887|NCT00401557|||||Prospective|||||||
1543888|NCT00401544|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1543889|NCT00401531|Randomized|Parallel Assignment||Prevention||Single||||||t
1543890|NCT00401518|Randomized|Parallel Assignment||Treatment||Single||||||t
1543891|NCT00401505|||Cohort||Retrospective|||||||
1543892|NCT00401492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543893|NCT00401479|Randomized|Parallel Assignment||Diagnostic||Double||||||
1543894|NCT00401466|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1543895|NCT00401453|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543896|NCT00401440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543897|NCT00401427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543898|NCT00401414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543899|NCT00401401|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543900|NCT00401388|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||One treatment arm: Perifosine. Three groups related to sarcoma subtype: histologically or cytologically confirmed diagnosis of (a) chondrosarcoma, (b) alveolar soft part sarcoma and (c) extra-skeletal myxoid chondrosarcoma.||||
1543901|NCT00401375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543902|NCT00401362|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1543903|NCT00401349|||||Prospective|||||||
1543904|NCT00401336||Single Group Assignment||Diagnostic||None (Open Label)||||||
1543905|NCT00401323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543906|NCT00401310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543907|NCT00401297|||||Prospective|||||||
1543908|NCT00401284|Randomized|Parallel Assignment||Treatment||Double||||||
1543909|NCT00401271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543910|NCT00401258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543911|NCT00401245|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543912|NCT00401232|Non-Randomized|Single Group Assignment||Diagnostic||||||||
1543913|NCT00401219|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1543914|NCT00401206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543915|NCT00401193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543916|NCT00401180||Single Group Assignment||Treatment||None (Open Label)||||||
1543917|NCT00401167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543918|NCT00401154||Single Group Assignment||Treatment||Single||||||t
1543919|NCT00401141|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1543920|NCT00401128||Single Group Assignment||Treatment||None (Open Label)||||||
1543921|NCT00401115|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543922|NCT00401102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543923|NCT00401089|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1543924|NCT00401076||Single Group Assignment||Treatment||None (Open Label)||||||
1543925|NCT00401063|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543926|NCT00401050|Randomized|Parallel Assignment||Treatment||Single||||||t
1543927|NCT00401024||Single Group Assignment||Treatment||None (Open Label)||||||
1543928|NCT00401011|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||In the Phase I part, maximum tolerated dose (MTD) is determined in sequential cohorts of patients. All patients will start with perifosine and bortezomib (cf. arms and interventions). In case of progression, dexamethasone 20 mg will be added to treatment. Phase II: open-label single treatment arm.||||
1543929|NCT00400998|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1543930|NCT00400985||Single Group Assignment||Diagnostic||Double||||||
1543931|NCT00400972|Randomized|Single Group Assignment||Treatment||Single||||||
1543932|NCT00400959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543933|NCT00400946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543934|NCT00400933||Single Group Assignment||Health Services Research||None (Open Label)||||||
1543935|NCT00400907||||||||||||
1543936|NCT00400894|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1543937|NCT00400881|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1543938|NCT00400868|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1543939|NCT00400855|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1543940|NCT00400842|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543941|NCT00400829||Single Group Assignment||Treatment||None (Open Label)||||||
1543942|NCT00400816||Single Group Assignment||Treatment||None (Open Label)||||||
1543943|NCT00400803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543944|NCT00400790|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1543945|NCT00400777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543946|NCT00400764|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543947|NCT00400751|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543948|NCT00400738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543949|NCT00400725|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543950|NCT00400712|Randomized|Parallel Assignment||Treatment||Single||||||t
1543951|NCT00400699||Single Group Assignment||||None (Open Label)||||||
1543952|NCT00400686||Single Group Assignment||Supportive Care||None (Open Label)||||||
1543953|NCT00400673|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543954|NCT00400660|Randomized|Crossover Assignment||Treatment||||||||
1543955|NCT00400647|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1543956|NCT00400634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543957|NCT00400621|Randomized|Single Group Assignment||||Double||||||
1543958|NCT00400608|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543959|NCT00400595|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1543960|NCT00400582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543961|NCT00400569||Single Group Assignment||Treatment||None (Open Label)||||||
1543962|NCT00400556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543963|NCT00400543|Randomized|Parallel Assignment||Treatment||Single||||||
1543964|NCT00400530|Randomized|Crossover Assignment||Treatment||Single||||||
1543965|NCT00400517||Single Group Assignment||Treatment||None (Open Label)||||||
1543966|NCT00400504|||Defined Population|Screening|Longitudinal, Prospective|||||||
1543967|NCT00400491|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543968|NCT00400478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543969|NCT00400465|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1543970|NCT00400452|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1543971|NCT00400439|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543972|NCT00400426|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543973|NCT00400413|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1543974|NCT00400400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1543975|NCT00400387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543976|NCT00400374||Single Group Assignment||Prevention||None (Open Label)||||||
1543977|NCT00400361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543978|NCT00400348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543979|NCT00400335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543981|NCT00400309|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1543982|NCT00400296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543983|NCT00400283|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543984|NCT00400270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543985|NCT00400257|||Cohort||Prospective|||||||
1543986|NCT00400244|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543987|NCT00400231|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1543988|NCT00400218|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543989|NCT00400205||Single Group Assignment||Treatment||None (Open Label)||||||
1543990|NCT00400192|||Cohort||Prospective|||||||
1543991|NCT00400179|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1543992|NCT00400166|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1543993|NCT00400153|Randomized|Parallel Assignment||Treatment||Double||||||
1543994|NCT00400140|Randomized|Single Group Assignment||Treatment||Single|||||t|
1543995|NCT00400127|Randomized|Crossover Assignment||Treatment||Single||||||t
1543996|NCT00400114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1543997|NCT00400101|Randomized|Parallel Assignment||Prevention||Single||||||
1543998|NCT00400088|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1543999|NCT00400075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544000|NCT00400062|||Cohort||Prospective|||||||
1544001|NCT00400036|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1544002|NCT00400023|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544003|NCT00400010|Randomized|Parallel Assignment||Treatment||Single|||||t|
1544004|NCT00399997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544005|NCT00399984|Randomized|Parallel Assignment||||Single|||t|||
1544006|NCT00399971|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544007|NCT00399945|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544008|NCT00399932|||Case-Only||Prospective|||||||
1544009|NCT00399919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544010|NCT00399906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544011|NCT00399893|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544012|NCT00399880|Randomized|Parallel Assignment||Treatment||Single||||||t
1544013|NCT00399867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544014|NCT00399854|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544015|NCT00399841|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544016|NCT00399828|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544017|NCT00399815|||Case Control||Prospective|||||||
1544018|NCT00399802|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544019|NCT00399789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544020|NCT00399776|||Case Control||Retrospective|||||||
1544021|NCT00399763|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544022|NCT00399750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544023|NCT00399737|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544024|NCT00399724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544025|NCT00399711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544026|NCT00399698|Randomized|Crossover Assignment||Diagnostic||Double||||||
1544027|NCT00399685|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1544028|NCT00399672|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544029|NCT00399659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544030|NCT00399646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544031|NCT00399633|Non-Randomized|Single Group Assignment||||Single||||||
1544032|NCT00399620|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544033|NCT00399607|||Case-Only||Prospective|||||||
1544034|NCT00399594|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1544035|NCT00399581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544036|NCT00399568|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544037|NCT00399555|||Cohort||Cross-Sectional|||||||
1544038|NCT00399542|Randomized|Parallel Assignment||Treatment||Double||||||
1544039|NCT00399529||Single Group Assignment||Treatment||None (Open Label)||||||
1544040|NCT00399516|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544041|NCT00399503|||||Prospective|||||||
1544042|NCT00399490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544043|NCT00399477|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544044|NCT00399464|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544045|NCT00399451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544046|NCT00399438|Randomized|Parallel Assignment||||Double|||t||t|
1544047|NCT00399425|Randomized|Parallel Assignment||Treatment||Double||||||
1544048|NCT00399412|||Cohort||Prospective|||||||
1544049|NCT00399399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544050|NCT00399386|||Cohort||Prospective|||||||
1544051|NCT00399373|||Cohort||Prospective|||||||
1544052|NCT00399360|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1544053|NCT00399347|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1544054|NCT00399334|||Case Control||Cross-Sectional|||||||
1544055|NCT00399321|||Cohort||Prospective|||||||
1544056|NCT00399308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544653|NCT00391326|||Case Control|||||||||
1544057|NCT00399295|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544058|NCT00399282|Randomized|Factorial Assignment||Treatment||Double||||||
1544059|NCT00399269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544060|NCT00399256|Randomized|Parallel Assignment||Prevention||Double||||||
1544061|NCT00399243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544062|NCT00399230|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1544063|NCT00399217|||Cohort||Prospective|||||||
1544064|NCT00399204|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1544065|NCT00399191|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544066|NCT00399178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544067|NCT00399165|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1544068|NCT00399152|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544069|NCT00399126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544070|NCT00399113|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544071|NCT00399100|||Case-Control||Prospective|||||||
1544072|NCT00399087|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544073|NCT00399074|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1544074|NCT00399061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544075|NCT00399048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544076|NCT00399035|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544077|NCT00399022|Randomized|Parallel Assignment||Treatment||Single||||||t
1544078|NCT00399009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544079|NCT00398996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544080|NCT00398983|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1544081|NCT00398970|Randomized|Parallel Assignment||||None (Open Label)||||||
1544082|NCT00398957|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544083|NCT00398944|Randomized|Parallel Assignment||||None (Open Label)||||||
1544084|NCT00398931|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544085|NCT00398918|Non-Randomized|Crossover Assignment||Other||Double|||t||t|
1544086|NCT00398905|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1544087|NCT00398892|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1544088|NCT00398879|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544089|NCT00398866|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544090|NCT00398853|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1544091|NCT00398840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544092|NCT00398827|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544093|NCT00398814|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544094|NCT00398801|||Cohort||Prospective|||||||
1544095|NCT00398788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544096|NCT00398775|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1544097|NCT00398749|||||Prospective|||||||
1544098|NCT00398736|||Case-Only||Prospective|||||||
1544099|NCT00398723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544100|NCT00398710||Single Group Assignment||Treatment||None (Open Label)||||||
1544101|NCT00398697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544102|NCT00398684|Randomized|Parallel Assignment||Prevention||Double||||||
1544103|NCT00398671|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1544104|NCT00398658|Randomized|Parallel Assignment||||Double||||||
1544105|NCT00398645|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1544106|NCT00398632||Single Group Assignment||Treatment||None (Open Label)||||||
1544107|NCT00398619|Randomized|Parallel Assignment||Treatment||Double||||||
1544108|NCT00398606|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544109|NCT00398593|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1544110|NCT00398580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544111|NCT00398567|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544112|NCT00398554||Single Group Assignment||Treatment||None (Open Label)||||||
1544113|NCT00398541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544114|NCT00398528|||||Prospective|||||||
1544115|NCT00398515||Single Group Assignment||Treatment||None (Open Label)||||||
1544116|NCT00398502|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544117|NCT00398489||||Treatment||None (Open Label)||||||
1544118|NCT00398476|Randomized|Crossover Assignment||Treatment||||||||
1544119|NCT00398463|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1544120|NCT00398450||||Treatment||||||||
1544121|NCT00398437|Randomized|||Diagnostic||||||||
1544122|NCT00398424|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544123|NCT00398411|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1544124|NCT00398398||Single Group Assignment||Treatment||None (Open Label)||||||
1544125|NCT00398385|Randomized|||Treatment||||||||
1544126|NCT00398372|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1544127|NCT00398359|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544128|NCT00398333|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1544129|NCT00398320||Single Group Assignment||Treatment||None (Open Label)||||||
1544130|NCT00398307|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544131|NCT00398294|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544132|NCT00398281|Randomized|||Diagnostic||Double||||||
1544133|NCT00398268|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544134|NCT00398255|Randomized|Parallel Assignment||||None (Open Label)||||||
1544135|NCT00398242|Randomized|Crossover Assignment||Treatment||Single||||||
1544136|NCT00398229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544137|NCT00398216|Randomized|Parallel Assignment||Prevention||Double||||||
1544138|NCT00398203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544139|NCT00398190|Randomized|Parallel Assignment||Prevention||Single|||t|||
1544140|NCT00398177|||Cohort||Prospective|||||||
1544141|NCT00398151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544142|NCT00398138||Single Group Assignment||Treatment||None (Open Label)||||||
1544143|NCT00398125|Randomized|Parallel Assignment||Treatment||Double||||||
1544144|NCT00398112||Single Group Assignment||Treatment||None (Open Label)||||||
1544145|NCT00398099|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544146|NCT00398086|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544147|NCT00398073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544148|NCT00398060|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544149|NCT00398047||Single Group Assignment||Treatment||None (Open Label)||||||
1544150|NCT00398034|Randomized|Parallel Assignment||Treatment||Double||||||
1544151|NCT00398021|||Cohort|||||||||
1544152|NCT00398008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544153|NCT00397995|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544154|NCT00397982||Single Group Assignment||Treatment||None (Open Label)||||||
1544155|NCT00397969|Randomized|||||||||||
1544156|NCT00397956|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544157|NCT00397943|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1544158|NCT00397930|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1544159|NCT00397917|Randomized|Parallel Assignment||Prevention||Quadruple|Random number assignments||t|t|t|t
1544160|NCT00397904||Single Group Assignment||Treatment||None (Open Label)||||||
1544161|NCT00397891|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1544162|NCT00397878||Single Group Assignment||Treatment||None (Open Label)||||||
1544163|NCT00397865|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544164|NCT00397852|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544165|NCT00397839|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544166|NCT00397826||Single Group Assignment||Treatment||None (Open Label)||||||
1544167|NCT00397813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544168|NCT00397800|Non-Randomized|||Treatment||None (Open Label)||||||
1544169|NCT00397787||Single Group Assignment||Treatment||None (Open Label)||||||
1544170|NCT00397774|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1544171|NCT00397761||||Treatment||None (Open Label)||||||
1544172|NCT00397748|||||Other|||||||
1544173|NCT00397735|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544174|NCT00397722|Randomized|Parallel Assignment||Treatment||||||||
1544175|NCT00397709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544176|NCT00397696||Single Group Assignment||Diagnostic||None (Open Label)||||||
1544177|NCT00397683|Randomized|Parallel Assignment||Treatment||Double||||||
1544178|NCT00397670|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544179|NCT00397657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544180|NCT00397644|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1544181|NCT00397631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544182|NCT00397605|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1544183|NCT00397592|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1544184|NCT00397579||Single Group Assignment||Treatment||None (Open Label)||||||
1544185|NCT00397566|Randomized|Single Group Assignment||Treatment||Double||||||
1544186|NCT00397553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544187|NCT00397540|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544188|NCT00397527|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544189|NCT00397514|||Cohort||Cross-Sectional|||||||
1544190|NCT00397501|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544191|NCT00397488||Single Group Assignment||Treatment||None (Open Label)||||||
1544192|NCT00397475|Randomized|Parallel Assignment||Treatment||Double||||||
1544193|NCT00397462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544194|NCT00397449|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544195|NCT00397436||Single Group Assignment||Diagnostic||None (Open Label)||||||
1544196|NCT00397423|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1544197|NCT00397410|Randomized|||||None (Open Label)||||||
1544198|NCT00397397|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1544199|NCT00397384||Single Group Assignment||Treatment||None (Open Label)||||||
1544200|NCT00397358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544201|NCT00397345|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544202|NCT00397332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544203|NCT00397319|||Case Control||Longitudinal, Prospective|||||||
1544204|NCT00397306|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544205|NCT00397293|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544206|NCT00397280||||||||||||
1544207|NCT00397267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544208|NCT00397254|Randomized|Parallel Assignment||Treatment||Single|||||t|
1544209|NCT00397241|Randomized|Crossover Assignment||Treatment||Single|||||t|
1544210|NCT00397228||Single Group Assignment||Diagnostic||None (Open Label)||||||
1544211|NCT00397215|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544212|NCT00397202|Randomized|Parallel Assignment||||None (Open Label)||||||
1544213|NCT00397189|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544214|NCT00397176|Randomized|Single Group Assignment||Treatment||Single||||||
1544215|NCT00397163|Randomized|Single Group Assignment||Treatment||Single|||t|||
1544216|NCT00397150|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544217|NCT00397137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544218|NCT00397124|Randomized|Parallel Assignment||||None (Open Label)||||||
1544219|NCT00397111|||||Prospective|||||||
1544220|NCT00397098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544221|NCT00397072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544222|NCT00397059|Randomized|Crossover Assignment||Treatment||Double||||||
1544223|NCT00397046|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This was an open-label, phase 1, ascending single and multiple oral dose study of neratinib administered to subjects with advanced solid tumors. Each subject participated in only 1 dose group and received a single dose of neratinib. This was followed by a 1-week observation period, and the subject then received neratinib administered as a continual oral daily dose for up to 6 months (6 cycles). Daily dose administration could continue beyond 6 cycles at the same dose level after consultation with the sponsor if neratinib was well tolerated and there was no evidence of progressive disease.||||
1544224|NCT00397033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544225|NCT00397020|Randomized|Parallel Assignment||Treatment||Single||||||t
1544226|NCT00397007|Randomized|Parallel Assignment||Treatment||Single||||||
1544227|NCT00396994|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1544228|NCT00396981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544229|NCT00396968|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544230|NCT00396955|Randomized|Parallel Assignment||Treatment||Double||||||
1544231|NCT00396942||||||||||||
1544232|NCT00396929|Randomized|Parallel Assignment||Treatment||Single||||||
1544233|NCT00396916|Randomized|Single Group Assignment||||None (Open Label)||||||
1544234|NCT00396903|||||Prospective|||||||
1544235|NCT00396890||||||||||||
1544236|NCT00396877|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1544237|NCT00396864||Single Group Assignment||Treatment||None (Open Label)||||||
1544238|NCT00396851|Randomized|Parallel Assignment||Treatment||Double||||||
1544239|NCT00396838|||||Prospective|||||||
1544240|NCT00396825|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1544241|NCT00396812||Single Group Assignment||Treatment||None (Open Label)||||||
1544242|NCT00396799|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544243|NCT00396786|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1544244|NCT00396773|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1544245|NCT00396760|Randomized|Parallel Assignment||Prevention||Double||||||
1544246|NCT00396747|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544247|NCT00396734|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544248|NCT00396721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544249|NCT00396708|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544250|NCT00396695|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1544251|NCT00396682|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544252|NCT00396669||Single Group Assignment||Diagnostic||None (Open Label)||||||
1544253|NCT00396656|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544254|NCT00396643|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1544255|NCT00396630|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1544256|NCT00396617|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544257|NCT00396604|Randomized|Crossover Assignment||Treatment||Double||||||
1544258|NCT00396591|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544259|NCT00396578|Randomized|Parallel Assignment||Treatment||Double||||||
1544260|NCT00396565|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544261|NCT00396552|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544262|NCT00396539|||||Prospective|||||||
1544263|NCT00396526|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544264|NCT00396513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544265|NCT00396500|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1544266|NCT00396487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544267|NCT00396474|||Case Control||Prospective|||||||
1544268|NCT00396461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544269|NCT00396448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544270|NCT00396435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544271|NCT00396422|Randomized|Parallel Assignment||Treatment||Double||||||
1544272|NCT00396409|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1544273|NCT00396396|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1544274|NCT00396383|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544275|NCT00396370|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1544276|NCT00396357|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544277|NCT00396344|Randomized|Single Group Assignment||||Quadruple|||t|t|t|t
1544278|NCT00396331||Single Group Assignment||Treatment||None (Open Label)||||||
1544279|NCT00396318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544280|NCT00396305|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544281|NCT00396292|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544282|NCT00396279||Single Group Assignment||Treatment||None (Open Label)||||||
1544283|NCT00396266|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544284|NCT00396253||Single Group Assignment||Treatment||None (Open Label)||||||
1544285|NCT00396240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544286|NCT00396227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544287|NCT00396214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544288|NCT00396201||Single Group Assignment||Treatment||None (Open Label)||||||
1544289|NCT00396188|||Case Control||Cross-Sectional|||||||
1544290|NCT00396175|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544291|NCT00396162|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544292|NCT00396149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544293|NCT00396136||Single Group Assignment||Treatment||None (Open Label)||||||
1544294|NCT00396123|||Case-Only||Prospective|||||||
1544295|NCT00396110|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1544296|NCT00396097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544297|NCT00396084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544298|NCT00396071|Randomized|Crossover Assignment||Treatment||Double||||||
1544299|NCT00396058|Randomized|Crossover Assignment||Treatment||Double||||||
1544300|NCT00396045|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544301|NCT00396032|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544302|NCT00396019||Single Group Assignment||Treatment||None (Open Label)||||||
1544303|NCT00396006|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544304|NCT00395993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544305|NCT00395980|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544306|NCT00395967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544307|NCT00395954|||||Prospective|||||||
1544308|NCT00395941|Randomized|Parallel Assignment||Treatment||Double||||||
1544309|NCT00395928|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1544310|NCT00395915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544311|NCT00395902|||||Retrospective|||||||
1544312|NCT00395889|Randomized|Parallel Assignment||Treatment||Single||||||t
1544313|NCT00395876|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544314|NCT00395863|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1544315|NCT00395850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544316|NCT00395837|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544317|NCT00395824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544318|NCT00395811|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544319|NCT00395798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544320|NCT00395785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544321|NCT00395772|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544322|NCT00395759|Non-Randomized|Single Group Assignment||Supportive Care||Single||||||
1544323|NCT00395746|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544324|NCT00395733|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1544325|NCT00395720|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544326|NCT00395707|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544327|NCT00395694|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544328|NCT00395681|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1544329|NCT00395668|Randomized|Crossover Assignment||Treatment||Double||||||
1544330|NCT00395655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544331|NCT00395642|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544332|NCT00395629|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544333|NCT00395616|Randomized|Parallel Assignment||Treatment||Double||||||
1544334|NCT00395603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544335|NCT00395590|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1544336|NCT00395577|Randomized|Parallel Assignment||Treatment||Double||||||
1544337|NCT00395564|||Cohort||Retrospective|||||||
1544338|NCT00395551|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1544339|NCT00395538||Single Group Assignment||Treatment||None (Open Label)||||||
1544340|NCT00395512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544341|NCT00395499|||||Prospective|||||||
1544342|NCT00395486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544343|NCT00395473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544344|NCT00395460|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1544345|NCT00395447|||Cohort||Prospective|||||||
1544346|NCT00395434|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544347|NCT00395421|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544348|NCT00395408|Randomized|Parallel Assignment||Treatment||Double||||||
1544349|NCT00395395|Randomized|Crossover Assignment||Treatment||Double||||||
1544350|NCT00395382|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1544351|NCT00395369|Randomized|Single Group Assignment||||None (Open Label)||||||
1544352|NCT00395356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544353|NCT00395343|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544354|NCT00395330|||Ecologic or Community||Retrospective|||||||
1544355|NCT00395317|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544356|NCT00395304|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1544357|NCT00395291|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1544358|NCT00395278||||||||||||
1544359|NCT00395265|||Cohort||Retrospective|||||||
1544360|NCT00395252||Single Group Assignment||Treatment||None (Open Label)||||||
1544361|NCT00395239||Single Group Assignment||Treatment||None (Open Label)||||||
1544362|NCT00395226|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1544363|NCT00395213|||Cohort||Prospective|||||||
1544364|NCT00395200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544365|NCT00395187|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544366|NCT00395174|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1544367|NCT00395161|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1544368|NCT00395148|Randomized|Crossover Assignment||Treatment||Double||||||
1544369|NCT00395135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544370|NCT00395122|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1544371|NCT00395109|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544372|NCT00395096|||Cohort||Prospective|||||||
1544373|NCT00395083|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544374|NCT00395070|Randomized|Parallel Assignment||Treatment||Single||||||t
1544375|NCT00395057|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1544376|NCT00395044|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1544377|NCT00395031||Single Group Assignment||Treatment||None (Open Label)||||||
1544378|NCT00395018|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544379|NCT00395005|||Natural History||Longitudinal, Retrospective|||||||
1544380|NCT00394992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544381|NCT00394966|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1544382|NCT00394953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544383|NCT00394940|||Cohort||Prospective|||||||
1544384|NCT00394927|||Cohort|||||||||
1544385|NCT00394914|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1544386|NCT00394901|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1544387|NCT00394888|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1544388|NCT00394875|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544389|NCT00394862|Randomized|Parallel Assignment||Prevention||Double||||||
1544390|NCT00394849|Randomized|Single Group Assignment||Treatment||Single|did not tell participant which side was sutured.|sutured one tonsillar fossa. pain was compared side to side. which side was sutured was randomized|t|||
1544391|NCT00394836||Single Group Assignment||Treatment||Single||||||t
1544392|NCT00394823|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1544393|NCT00394810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544394|NCT00394797|||Cohort||Retrospective|||||||
1544395|NCT00394784|||Other||Retrospective|||||||
1544396|NCT00394771|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1544397|NCT00394758|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544398|NCT00394745|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544399|NCT00394732|Randomized|Parallel Assignment||Treatment||Single||||||t
1544400|NCT00394706|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1544401|NCT00394693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544402|NCT00394680|||Cohort||Retrospective|||||||
1544403|NCT00394667|Randomized|Parallel Assignment||Treatment||Double||||||
1544404|NCT00394654|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544405|NCT00394641|Randomized|Parallel Assignment||||Double||||||
1544406|NCT00394628|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544407|NCT00394615|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544408|NCT00394602|||Case-Control||Prospective|||||||
1544409|NCT00394589|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544410|NCT00394576|Randomized|Factorial Assignment||||None (Open Label)||||||
1544411|NCT00394563|Randomized|Parallel Assignment||Treatment||Double||||||
1544412|NCT00394550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544413|NCT00394537|Randomized|Parallel Assignment||Treatment||Double||||||
1544414|NCT00394524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544415|NCT00394511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544416|NCT00394498|Randomized|Single Group Assignment||Treatment||Double||||||
1544417|NCT00394485|Randomized|Crossover Assignment||Treatment||Double||||||
1544418|NCT00394472|Randomized|Parallel Assignment||Treatment||Double||||||
1544419|NCT00394459|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544420|NCT00394446|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544421|NCT00394433||Single Group Assignment||Treatment||None (Open Label)||||||
1544422|NCT00394420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544423|NCT00394407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544424|NCT00394394|Randomized|Parallel Assignment||Treatment||Double||||||
1544425|NCT00394381||Single Group Assignment||Treatment||None (Open Label)||||||
1544426|NCT00394368|Randomized|Parallel Assignment||Treatment||Double||||||
1544427|NCT00394355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544428|NCT00394329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544429|NCT00394316|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544430|NCT00394303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544431|NCT00394290||Single Group Assignment||Treatment||None (Open Label)||||||
1544432|NCT00394277|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1544433|NCT00394264|Randomized|Parallel Assignment||Treatment||Single||||||
1544434|NCT00394251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544435|NCT00394238|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1544436|NCT00394225|Randomized|Crossover Assignment||Treatment||Single||||||
1544437|NCT00394212|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1544438|NCT00394199|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544439|NCT00394186|Randomized|Crossover Assignment||Diagnostic||Double||||||
1544440|NCT00394173|Randomized|Parallel Assignment||Treatment||Double||||||
1544441|NCT00394160|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544442|NCT00394147|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1544443|NCT00394134||Single Group Assignment||Prevention||None (Open Label)||||||
1544444|NCT00394121|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544445|NCT00394108|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544446|NCT00394095|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1544447|NCT00394082|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544448|NCT00394069|Randomized|Parallel Assignment||Treatment||Double||||||
1544449|NCT00394056|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1544450|NCT00394043|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1544451|NCT00394030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544452|NCT00394017|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1544453|NCT00394004||||||||||||
1544454|NCT00393991|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544455|NCT00393978|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1544456|NCT00393965|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544457|NCT00393952|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544458|NCT00393939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544459|NCT00393926|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544460|NCT00393913|||Cohort||Prospective|||||||
1544461|NCT00393900|||Cohort||Prospective|||||||
1544462|NCT00393887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544463|NCT00393874|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544464|NCT00393861||Single Group Assignment||Treatment||None (Open Label)||||||
1544465|NCT00393848|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1544466|NCT00393835|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544467|NCT00393822|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1544468|NCT00393809|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544469|NCT00393796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544470|NCT00393783||Single Group Assignment||Treatment||None (Open Label)||||||
1544471|NCT00393770|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544472|NCT00393757|||||Prospective|||||||
1544473|NCT00393744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544474|NCT00393731|Randomized|Single Group Assignment||Treatment||Single||||||
1544475|NCT00393718|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544476|NCT00393705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544477|NCT00393692|||Cohort||Prospective|||||||
1544478|NCT00393679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544479|NCT00393666|||Case Control||Prospective|||||||
1544480|NCT00393653|Randomized|Single Group Assignment||Treatment||Double||||||
1544481|NCT00393640|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544482|NCT00393627|Randomized|Parallel Assignment||Treatment||Single||||||t
1544483|NCT00393614|Randomized|Crossover Assignment||Treatment||Double||||t|t|
1544484|NCT00393601|||Case Control||Retrospective|||||||
1544485|NCT00393588||||||||||||
1544486|NCT00393575||Single Group Assignment||Prevention||None (Open Label)||||||
1544487|NCT00393562|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544488|NCT00393549|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544489|NCT00393536|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1544490|NCT00393523|Randomized|Parallel Assignment||Prevention||Single|||t|||
1544491|NCT00393510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544492|NCT00393497|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544493|NCT00393484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544494|NCT00393471|Randomized|Parallel Assignment||Treatment||Double||||||
1544495|NCT00393458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544496|NCT00393445|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1544497|NCT00393432||||||||||||
1544498|NCT00393419|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1544499|NCT00393406|||||Prospective|||||||
1544500|NCT00393393|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1544501|NCT00393380||Single Group Assignment||Prevention||None (Open Label)||||||
1544502|NCT00393367|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1544503|NCT00393354|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544504|NCT00393341|||Case Control||Prospective|||||||
1544505|NCT00393328|Randomized|Crossover Assignment||||None (Open Label)||||||
1544506|NCT00393315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544507|NCT00393302|||Cohort|||||||||
1544508|NCT00393289|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1544509|NCT00393276|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544510|NCT00393263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544511|NCT00393250||||Treatment||||||||
1544512|NCT00393224|||Cohort||Other|||||||
1544513|NCT00393211|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544514|NCT00393198|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544515|NCT00393185|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544516|NCT00393172|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544517|NCT00393159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544518|NCT00393146|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1544519|NCT00393120|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1544520|NCT00393107|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544521|NCT00393094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544522|NCT00393068||Single Group Assignment||Treatment||None (Open Label)||||||
1544523|NCT00393055|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1544524|NCT00393042|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1544525|NCT00393029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544526|NCT00393003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544527|NCT00392990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544528|NCT00392977|||||Prospective|||||||
1544529|NCT00392964|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1544530|NCT00392951||Single Group Assignment||Treatment||None (Open Label)||||||
1544531|NCT00392938|||Case-Only||Prospective|||||||
1544532|NCT00392925|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544533|NCT00392912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544534|NCT00392899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544535|NCT00392886||||Treatment||||||||
1544536|NCT00392873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544537|NCT00392860|Randomized|Parallel Assignment||Prevention||Single|||t|||
1544538|NCT00392847|Randomized|Parallel Assignment||||None (Open Label)||||||
1544539|NCT00392834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544540|NCT00392821||Single Group Assignment||Treatment||None (Open Label)||||||
1544541|NCT00392808|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544542|NCT00392795|||Other||Prospective|||||||
1544543|NCT00392782||Single Group Assignment||Treatment||None (Open Label)||||||
1544544|NCT00392769||Single Group Assignment||Treatment||None (Open Label)||||||
1544545|NCT00392756|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544546|NCT00392743||||||||||||
1544547|NCT00392730|||||Prospective|||||||
1544548|NCT00392717|Randomized|Factorial Assignment||Treatment||Double||||||
1544549|NCT00392704||Single Group Assignment||Treatment||None (Open Label)||||||
1544550|NCT00392691||Single Group Assignment||Treatment||None (Open Label)||||||
1544551|NCT00392678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544552|NCT00392665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544553|NCT00392652|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1544554|NCT00392639|Randomized|Parallel Assignment||Treatment||Single||||t||
1544555|NCT00392613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544556|NCT00392587|Randomized|Parallel Assignment||Treatment||Double||||||
1544557|NCT00392574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544558|NCT00392561|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1544559|NCT00392548|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1544560|NCT00392535|Randomized|||Treatment||||||||
1544561|NCT00392522|Randomized|Parallel Assignment||Treatment||Double||||||
1544562|NCT00392509|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544563|NCT00392496|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544564|NCT00392483|||Cohort||Prospective|||||||
1544565|NCT00392470||||Treatment||||||||
1544566|NCT00392457|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1544567|NCT00392444||Single Group Assignment||Treatment||None (Open Label)||||||
1544568|NCT00392431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544569|NCT00392418|Randomized|Parallel Assignment||Treatment||Single||||||
1544570|NCT00392405|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544571|NCT00392392||Single Group Assignment||Treatment||None (Open Label)||||||
1544572|NCT00392379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544573|NCT00392366|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544574|NCT00392353||Single Group Assignment||Treatment||None (Open Label)||||||
1544575|NCT00392340||||Treatment||None (Open Label)||||||
1544576|NCT00392327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544577|NCT00392314|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544578|NCT00392301|||Other||Prospective|||||||
1544579|NCT00392288|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544580|NCT00392275|Randomized|Parallel Assignment||Treatment||Single||||||
1544581|NCT00392262|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544582|NCT00392249|Randomized|Parallel Assignment||Treatment||Single||||||
1544583|NCT00392236|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1544584|NCT00392223|Randomized|Parallel Assignment||Treatment||Double||||||
1544585|NCT00392210|Randomized|Crossover Assignment||Prevention||Single|||t|||
1544586|NCT00392197|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544587|NCT00392184||Single Group Assignment||Treatment||None (Open Label)||||||
1544588|NCT00392171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544589|NCT00392158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544590|NCT00392145|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1544591|NCT00392132|||||Other|||||||
1544592|NCT00392119|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544593|NCT00392106|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544594|NCT00392093|Randomized|Parallel Assignment||Treatment||Double||||||
1544595|NCT00392080|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544596|NCT00392067|Randomized|Parallel Assignment||Treatment||Double||||||
1544597|NCT00392054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544598|NCT00392041|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1544599|NCT00392028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544600|NCT00392015|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1544601|NCT00392002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544602|NCT00391989|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544603|NCT00391976|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544604|NCT00391963|||||Prospective|||||||
1544605|NCT00391950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544606|NCT00391937|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1544607|NCT00391924|Randomized|Parallel Assignment||Treatment||Double||||||
1544608|NCT00391911|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1544609|NCT00391898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544610|NCT00391885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544611|NCT00391872|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544612|NCT00391859|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544613|NCT00391846|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544614|NCT00391833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544615|NCT00391820|Randomized|Parallel Assignment||Treatment||Double||||||
1544616|NCT00391807|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544617|NCT00391794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544618|NCT00391781|Randomized|Single Group Assignment||Treatment||Single||||||
1544619|NCT00391768|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544620|NCT00391755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544621|NCT00391742|Randomized|Factorial Assignment||Treatment||Single||||||
1544622|NCT00391729|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1544623|NCT00391716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544624|NCT00391703|Randomized|Parallel Assignment||||None (Open Label)||||||
1544625|NCT00391690|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544626|NCT00391677|Randomized|Parallel Assignment||Treatment||Single||||||t
1544627|NCT00391664|||||Prospective|||||||
1544628|NCT00391651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544629|NCT00391638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544630|NCT00391625||Single Group Assignment||Treatment||None (Open Label)||||||
1544631|NCT00391612|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1544632|NCT00391599|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1544633|NCT00391586||Single Group Assignment||Treatment||None (Open Label)||||||
1544634|NCT00391573|Randomized|Single Group Assignment||Treatment||Single||||||
1544635|NCT00391560|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Single treatment arm. Two disease related analyses groups, i.e.: Group 1: AML, MDS, CML-BP non-lymphoid, CMML, Agnogenic Myeloid Metaplasia (AMM); Group 2: CLL, ALL, CML-BP lymphoid||||
1544636|NCT00391547|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1544637|NCT00391534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544638|NCT00391521|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544639|NCT00391508|||Case Control|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1544640|NCT00391495|||Case Control||Cross-Sectional, Prospective|||||||
1544641|NCT00391482|Randomized|Parallel Assignment||||None (Open Label)||||||
1544642|NCT00391469|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544643|NCT00391456|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1544644|NCT00391443|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544645|NCT00391430|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1544646|NCT00391417|Randomized|Parallel Assignment||Treatment||Double||||||
1544647|NCT00391404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544648|NCT00391391|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544649|NCT00391378|||||Other|||||||
1544650|NCT00391365|||Cohort||Prospective|||||||
1544651|NCT00391352|||Case Control||Prospective|||||||
1544652|NCT00391339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544654|NCT00391313|Randomized|Parallel Assignment||Treatment||Double||||||
1544655|NCT00391300||||Diagnostic||||||||
1544656|NCT00391287|||Cohort||Prospective|||||||
1544657|NCT00391274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544658|NCT00391261|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544659|NCT00391248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544660|NCT00391235|||Case Control||Prospective|||||||
1544661|NCT00391222|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544662|NCT00391209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544663|NCT00391196|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544664|NCT00391183|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1544665|NCT00391170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544666|NCT00391157|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544667|NCT00391144|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1544668|NCT00391131||Single Group Assignment||Treatment||None (Open Label)||||||
1544669|NCT00391118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544670|NCT00391105|Randomized|Parallel Assignment||Supportive Care||Double||||||
1544671|NCT00391092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544672|NCT00391079|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544673|NCT00391066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544674|NCT00391053|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1544675|NCT00391040|Randomized|Factorial Assignment||Educational/Counseling/Training||None (Open Label)||||||
1544676|NCT00391027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544677|NCT00391014|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544678|NCT00391001|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1544679|NCT00390988|||||Prospective|||||||
1544680|NCT00390975|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544681|NCT00390962|||Cohort||Prospective|||||||
1544682|NCT00390949|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544683|NCT00390936|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544684|NCT00390923|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544685|NCT00390910|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544686|NCT00390897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544687|NCT00390884|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544688|NCT00390871|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1544689|NCT00390858||Single Group Assignment||Treatment||None (Open Label)||||||
1544690|NCT00390845|Randomized|Crossover Assignment||Treatment||||||||
1544691|NCT00390832|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544692|NCT00390819|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1544693|NCT00390806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544694|NCT00390793||Single Group Assignment||Treatment||None (Open Label)||||||
1544695|NCT00390780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544696|NCT00390767||Single Group Assignment||Treatment||None (Open Label)||||||
1544697|NCT00390754|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1544698|NCT00390741|Randomized|Parallel Assignment||Treatment||Single|||||t|
1544699|NCT00390728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544700|NCT00390715|||Case-Only||Prospective|||||||
1544701|NCT00390702||Single Group Assignment||Treatment||None (Open Label)||||||
1544702|NCT00390689|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544703|NCT00390676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544704|NCT00390663|Randomized|Single Group Assignment||Treatment||Double||||||
1544705|NCT00390650|Randomized|Parallel Assignment||Treatment||Double||||||
1544706|NCT00390637|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544707|NCT00390624|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544708|NCT00390611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544709|NCT00390598|Randomized|Parallel Assignment||Treatment||Single||||||
1544710|NCT00390585|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1544711|NCT00390572|Randomized|Parallel Assignment||Treatment||Single||||||t
1544712|NCT00390559|Non-Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1544713|NCT00390546|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544714|NCT00390533|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544715|NCT00390520|Randomized|Crossover Assignment||Treatment||Double||||||
1544716|NCT00390507|Randomized|Parallel Assignment||Treatment||Single||||||
1544717|NCT00390494|||||Prospective|||||||
1544718|NCT00390481|Randomized|Parallel Assignment||Treatment||Single||||||t
1544719|NCT00390468||Single Group Assignment||Treatment||None (Open Label)||||||
1544720|NCT00390455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544721|NCT00390442|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544722|NCT00390429|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544723|NCT00390416||Single Group Assignment||Treatment||None (Open Label)||||||
1544724|NCT00390403|Non-Randomized|||Treatment||None (Open Label)||||||
1544725|NCT00390390|Randomized|Parallel Assignment||Treatment||Double||||||
1544726|NCT00390377|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1544727|NCT00390364||Single Group Assignment||Treatment||None (Open Label)||||||
1544728|NCT00390351|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1544729|NCT00390338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544730|NCT00390325||Single Group Assignment||Treatment||None (Open Label)||||||
1544731|NCT00390312|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544732|NCT00390299|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544733|NCT00390286|||Cohort||Prospective|||||||
1544734|NCT00390273|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1544735|NCT00390260|Randomized|Parallel Assignment||Treatment||Double||||||
1544736|NCT00390247|Randomized|Parallel Assignment||Treatment||Double||||||
1544737|NCT00390234||Single Group Assignment||Treatment||None (Open Label)||||||
1544738|NCT00390221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544739|NCT00390208|Randomized|Parallel Assignment||Treatment||Single||||||t
1544740|NCT00390195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544741|NCT00390182||Single Group Assignment||Treatment||None (Open Label)||||||
1544742|NCT00390169|Randomized|Parallel Assignment||||None (Open Label)||||||
1544743|NCT00390156|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544744|NCT00390143|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544745|NCT00390130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544746|NCT00390117||Single Group Assignment||Treatment||None (Open Label)||||||
1544747|NCT00390104|||Family-Based||Prospective|||||||
1544748|NCT00390091|Randomized|Parallel Assignment||Diagnostic||Single||||||
1544749|NCT00390078|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544750|NCT00390065|Randomized|Parallel Assignment||Diagnostic||Quadruple|Randomization in the neonatal period. Blinding maintained at the time of the follow-up study|This is a follow-up study, at 6 years of age, of infants randomized in the neonatal period with one other group studied as a reference group (ie 3 groups)|t|t|t|t
1544751|NCT00390052||Single Group Assignment||Treatment||None (Open Label)||||||
1544752|NCT00390039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544753|NCT00390026|Randomized|Parallel Assignment||Treatment||Double||||||
1544754|NCT00390013|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1544755|NCT00390000||Single Group Assignment||Treatment||None (Open Label)||||||
1544756|NCT00389987|Randomized|Parallel Assignment||Treatment||Double||||||
1544757|NCT00389974||Single Group Assignment||Treatment||None (Open Label)||||||
1544758|NCT00389948|Randomized|Parallel Assignment||Treatment||Double||||||
1544759|NCT00389935||Single Group Assignment||Treatment||None (Open Label)||||||
1544760|NCT00389922|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544761|NCT00389909|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1544762|NCT00389896|Randomized|Crossover Assignment||Treatment||Double||||||
1544763|NCT00389883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544764|NCT00389870|Randomized|||Treatment||None (Open Label)||||||
1544765|NCT00389857|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544766|NCT00389844|Randomized|Factorial Assignment||Treatment||Single|||||t|
1544767|NCT00389831|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544768|NCT00389818||Single Group Assignment||Treatment||None (Open Label)||||||
1544769|NCT00389805||Single Group Assignment||Treatment||None (Open Label)||||||
1544770|NCT00389792|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544771|NCT00389779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544772|NCT00389766||||Treatment||None (Open Label)||||||
1544773|NCT00389753|Randomized|Single Group Assignment||Treatment||Double||||||
1544774|NCT00389740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544775|NCT00389727|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544776|NCT00389714|Non-Randomized|Crossover Assignment||Prevention||Double||||||
1544777|NCT00389701||||Treatment||None (Open Label)||||||
1544778|NCT00389688|Randomized|||Treatment||None (Open Label)||||||
1544779|NCT00389675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544780|NCT00389662|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544781|NCT00389649|Randomized|Crossover Assignment||Treatment||Double||||||
1544782|NCT00389636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544783|NCT00389610|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544784|NCT00389597|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544785|NCT00389584||||Treatment||||||||
1544786|NCT00389558|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1544787|NCT00389545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544788|NCT00389532|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544789|NCT00389519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544790|NCT00389506|Non-Randomized|||Treatment||||||||
1544791|NCT00389493|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1544792|NCT00389480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544793|NCT00389467|Randomized|Parallel Assignment||Treatment||Single||||||t
1544794|NCT00389454|||||Prospective|||||||
1544795|NCT00389441|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1544796|NCT00389428|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544797|NCT00389415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544798|NCT00389402|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544799|NCT00389389|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544800|NCT00389376|Randomized|Parallel Assignment||Basic Science||Triple|||t||t|t
1544801|NCT00389363|Randomized|Parallel Assignment||Treatment||Double||||||
1544802|NCT00389350|Randomized|Parallel Assignment||Treatment||Double||||||
1544803|NCT00389337|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1544804|NCT00389324|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544805|NCT00389311|Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1544806|NCT00389298|Randomized|Parallel Assignment||Treatment||Double||||||
1544807|NCT00389285|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544808|NCT00389272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544809|NCT00389259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544810|NCT00389246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544811|NCT00389233|Randomized|Parallel Assignment||Treatment||Single||||||t
1544812|NCT00389220|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544813|NCT00389207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544814|NCT00389194|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544815|NCT00389181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544816|NCT00389168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544817|NCT00389155|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544818|NCT00389142|||Family-Based||Prospective|||||||
1544819|NCT00389129|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544820|NCT00389116|Randomized|Single Group Assignment||Treatment||Single|||t|||
1544821|NCT00389103|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1544822|NCT00389090||Single Group Assignment||Treatment||None (Open Label)||||||
1544823|NCT00389077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544824|NCT00389064|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544825|NCT00389051|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544826|NCT00389038|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544827|NCT00389025|Randomized|Single Group Assignment||Prevention||Double||||||
1544828|NCT00389012|Randomized|Single Group Assignment||Treatment||Single||||||
1544829|NCT00388999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544830|NCT00388986|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544831|NCT00388973|Randomized|Parallel Assignment||Treatment||Double||||||
1544832|NCT00388960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544833|NCT00388947|||Cohort||Prospective|||||||
1544834|NCT00388934|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544835|NCT00388921|Randomized|Single Group Assignment||Treatment||Double||||||
1544836|NCT00388908|Non-Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1544837|NCT00388895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544838|NCT00388882||||Treatment||||||||
1544839|NCT00388869|||Defined Population|Screening|Longitudinal, Prospective|||||||
1544840|NCT00388856|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1544841|NCT00388843|||Cohort||Prospective|||||||
1544842|NCT00388830|Randomized|Single Group Assignment||Diagnostic||Single||||||
1544843|NCT00388817|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1544844|NCT00388804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544845|NCT00388791|Randomized|Parallel Assignment||Treatment||Single||||||
1544846|NCT00388778|Randomized|Parallel Assignment||Treatment||Double||||||
1544847|NCT00388765|||||Prospective|||||||
1544848|NCT00388752|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544849|NCT00388739|Randomized|Factorial Assignment||Treatment||Single||||||
1544850|NCT00388726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544851|NCT00388713|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1544852|NCT00388700||Single Group Assignment||Treatment||None (Open Label)||||||
1544853|NCT00388687|||Defined Population||Longitudinal, Prospective|||||||
1544854|NCT00388674|||Cohort||Prospective|||||||
1544855|NCT00388661|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544856|NCT00388648|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1544857|NCT00388635|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544858|NCT00388622|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1544859|NCT00388609|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544860|NCT00388596|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544861|NCT00388583|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544862|NCT00388570|Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1544863|NCT00388557|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544864|NCT00388544|Randomized|Single Group Assignment||Diagnostic||Double||||t||t
1544865|NCT00388531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544866|NCT00388518|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544867|NCT00388505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544868|NCT00388492|||Defined Population||Longitudinal, Prospective|||||||
1544869|NCT00388479|Randomized|Parallel Assignment||Treatment||Double||||||
1544870|NCT00388466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544871|NCT00388453|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1544872|NCT00388440|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544873|NCT00388427||Single Group Assignment||Treatment||None (Open Label)||||||
1544874|NCT00388414|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1544875|NCT00388401|Randomized|Parallel Assignment||Treatment||Double||||||
1544876|NCT00388388|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544877|NCT00388375|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1544878|NCT00388362||Single Group Assignment||Treatment||None (Open Label)||||||
1544879|NCT00388349||Single Group Assignment||Treatment||None (Open Label)||||||
1544880|NCT00388336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544881|NCT00388323||Single Group Assignment||Basic Science||None (Open Label)||||||
1544882|NCT00388310|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544883|NCT00388297|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1544884|NCT00388284|Randomized|Single Group Assignment||Treatment||Double||||||
1544885|NCT00388271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544886|NCT00388258|Randomized|Parallel Assignment||Treatment||Double||||||
1544887|NCT00388245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544888|NCT00388232|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1544889|NCT00388219|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544890|NCT00388206|||Cohort||Prospective|||||||
1544891|NCT00388193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544892|NCT00388180||||||||||||
1544893|NCT00388167|||Case-Only||Prospective|||||||
1544894|NCT00388154||Single Group Assignment||Treatment||None (Open Label)||||||
1544895|NCT00388141|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1544896|NCT00388128|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1544897|NCT00388115||Single Group Assignment||Treatment||None (Open Label)||||||
1544898|NCT00388089||Single Group Assignment||Treatment||None (Open Label)||||||
1544899|NCT00388076|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544900|NCT00388063|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544901|NCT00388050|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544902|NCT00388037||Single Group Assignment||Treatment||None (Open Label)||||||
1544903|NCT00388024|||Cohort||Prospective|||||||
1544904|NCT00388011|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544905|NCT00387998|Randomized|Parallel Assignment||||Single|||||t|
1544906|NCT00387985|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544907|NCT00387972|Randomized|Parallel Assignment||Treatment||Double||||||
1544908|NCT00387959||Single Group Assignment||Treatment||None (Open Label)||||||
1544909|NCT00387946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544910|NCT00387933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544911|NCT00387920||Single Group Assignment||Treatment||None (Open Label)||||||
1544912|NCT00387907||Single Group Assignment||Treatment||None (Open Label)||||||
1544913|NCT00387894||Single Group Assignment||Treatment||None (Open Label)||||||
1544914|NCT00387881|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544915|NCT00387868|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544916|NCT00387855||Single Group Assignment||Prevention||None (Open Label)||||||
1544917|NCT00387842|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544918|NCT00387829|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1544919|NCT00387803|Randomized|Parallel Assignment||Treatment||Double||||||
1544920|NCT00387790||Single Group Assignment||Treatment||None (Open Label)||||||
1544921|NCT00387777|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544922|NCT00387764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544923|NCT00387751||Single Group Assignment||Treatment||None (Open Label)||||||
1544924|NCT00387738|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1544925|NCT00387725|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1544926|NCT00387712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544927|NCT00387699||||Treatment||None (Open Label)||||||
1544928|NCT00387686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544929|NCT00387673|Randomized|Parallel Assignment||Treatment||Single|||t|||
1544930|NCT00387660|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544931|NCT00387647||Single Group Assignment||Treatment||None (Open Label)||||||
1544932|NCT00387634|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544933|NCT00387621|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1544934|NCT00387608||||Treatment||None (Open Label)||||||
1544935|NCT00387595||||||||||||
1544936|NCT00387582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544937|NCT00387569|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1544938|NCT00387556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1544939|NCT00387543|||||Retrospective|||||||
1544940|NCT00387530||||Treatment||None (Open Label)||||||
1544941|NCT00387517|Randomized|Parallel Assignment||Treatment||Double||||||
1544942|NCT00387504||Single Group Assignment||Treatment||None (Open Label)||||||
1544943|NCT00387491|Randomized|Crossover Assignment||Treatment||Double||||||
1544944|NCT00387478|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544945|NCT00387465||Single Group Assignment||Treatment||None (Open Label)||||||
1544946|NCT00387452|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1544947|NCT00387439|Randomized|Parallel Assignment||||None (Open Label)||||||
1544948|NCT00387426||Single Group Assignment||Treatment||None (Open Label)||||||
1544949|NCT00387413|Randomized|Crossover Assignment||Treatment||||||||
1544950|NCT00387400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544951|NCT00387387|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544952|NCT00387374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544953|NCT00387361|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1544954|NCT00387348|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1544955|NCT00387335||Single Group Assignment||Treatment||None (Open Label)||||||
1544956|NCT00387322|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1544957|NCT00387309|Randomized|Parallel Assignment||Treatment||Double||||||
1544958|NCT00387296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1544959|NCT00387283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544960|NCT00387270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544961|NCT00387257|Randomized|Parallel Assignment||Diagnostic||Double||||||
1544962|NCT00387244||Single Group Assignment||Treatment||None (Open Label)||||||
1544963|NCT00387231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544964|NCT00387218|Randomized|Single Group Assignment||Treatment||Single||||||
1544965|NCT00387205||||Treatment||None (Open Label)||||||
1544966|NCT00387192|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544967|NCT00387179|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1544968|NCT00387166|||Cohort||Prospective|||||||
1544969|NCT00387153|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544970|NCT00387140|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544971|NCT00387127|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544972|NCT00387114|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1544973|NCT00387101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544974|NCT00387088||Parallel Assignment||Treatment||||||||
1544975|NCT00387075||Single Group Assignment||Diagnostic||Double|Participants and Investigators were not provided results of the University of Pennsylvania Smell Identification Test (UPSIT).||t||t|
1544976|NCT00387062|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1544977|NCT00387049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1544978|NCT00387036|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1544979|NCT00387023||Single Group Assignment||Treatment||None (Open Label)||||||
1544980|NCT00387010||Single Group Assignment||Treatment||None (Open Label)||||||
1544981|NCT00386997|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1544982|NCT00386984|Randomized|Parallel Assignment||Treatment||Double||||||
1544983|NCT00386971|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1544984|NCT00386958|Randomized|Parallel Assignment||Treatment||Double||||||
1544985|NCT00386945|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544986|NCT00386919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544987|NCT00386906||Single Group Assignment||Diagnostic||None (Open Label)||||||
1544988|NCT00386893||Single Group Assignment||Diagnostic||None (Open Label)||||||
1544989|NCT00386880|||Cohort||Prospective|||||||
1544990|NCT00386867|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544991|NCT00386854|Randomized|Crossover Assignment||Educational/Counseling/Training||None (Open Label)||||||
1544992|NCT00386841|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1544993|NCT00386828|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544994|NCT00386815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544995|NCT00386802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1544996|NCT00386789|||||Other|||||||
1544997|NCT00386776||Single Group Assignment||Diagnostic||None (Open Label)||||||
1544998|NCT00386763|Randomized|Parallel Assignment||Treatment||Single||||||
1544999|NCT00386750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545000|NCT00386737|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1545001|NCT00386724||Single Group Assignment||Treatment||None (Open Label)||||||
1545002|NCT00386711|Non-Randomized|Parallel Assignment||Prevention||Single||||||
1545003|NCT00386698|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545004|NCT00386685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545005|NCT00386672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545006|NCT00386659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545007|NCT00386646|Randomized|Parallel Assignment||Treatment||Single||||||
1545008|NCT00386633|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545009|NCT00386620|||Cohort||Prospective|||||||
1545010|NCT00386607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545011|NCT00386594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545012|NCT00386581|Randomized|Parallel Assignment||Treatment||Double||||||
1545013|NCT00386555|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545014|NCT00386542|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1545015|NCT00386529|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1545016|NCT00386516||Single Group Assignment||Treatment||None (Open Label)||||||
1545017|NCT00386503|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545018|NCT00386490|Randomized|Sequential Assignment||Basic Science||Double|double-blind|Phase 1, randomized, double-blind, placebo controlled multi-dose study|t||t|
1545019|NCT00386477|Randomized|Parallel Assignment||Prevention||Single||||||t
1545020|NCT00386464|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1545021|NCT00386451|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545022|NCT00386438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545023|NCT00386425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545024|NCT00386412|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545025|NCT00386399||Single Group Assignment||Diagnostic||None (Open Label)||||||
1545026|NCT00386386|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545027|NCT00386373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545028|NCT00386360|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1545029|NCT00386347|Randomized|Crossover Assignment||Treatment||Double||||||
1545030|NCT00386334|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545031|NCT00386321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545032|NCT00386308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545033|NCT00386282||Single Group Assignment||Treatment||None (Open Label)||||||
1545034|NCT00386269|Randomized|Parallel Assignment||||Double||||||
1545035|NCT00386256||Parallel Assignment||||None (Open Label)||||||
1545036|NCT00386243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545037|NCT00386230|Randomized|Parallel Assignment||Prevention||Double||||||
1545038|NCT00386217|||Cohort||Prospective|||||||
1545039|NCT00386204|Randomized|Single Group Assignment||Treatment||Single||||||
1545040|NCT00386191|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1545041|NCT00386178|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1545042|NCT00386165|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545043|NCT00386152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545044|NCT00386139|Randomized|Parallel Assignment||Treatment||Double||||||
1545045|NCT00386126|Randomized|Parallel Assignment||Treatment||Double||||||
1545046|NCT00386113|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545047|NCT00386100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545048|NCT00386087|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545049|NCT00386074|Randomized|Parallel Assignment||Treatment||Double||||||
1545050|NCT00386061|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545051|NCT00386048|||Case Control||Prospective|||||||
1545052|NCT00386035|||Cohort||Prospective|||||||
1545053|NCT00386022|Randomized|Sequential Assignment||Other||None (Open Label)||The study will is considered sequential as participants were studied at baseline and after one month of low-dose estrogen. Randomization refers to randomization of the order of doses of GnRH between participants.||||
1545054|NCT00386009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545055|NCT00385996||Single Group Assignment||Treatment||None (Open Label)||||||
1545056|NCT00385983|Randomized|Parallel Assignment||Treatment||Single||||||
1545057|NCT00385970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545058|NCT00385957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545059|NCT00385944|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1545060|NCT00385931|Randomized|Parallel Assignment||Treatment||Double||||||
1545061|NCT00385918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545062|NCT00385905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545063|NCT00385892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545064|NCT00385879|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1545065|NCT00385866|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545066|NCT00385853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545067|NCT00385840|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1545068|NCT00385827|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545069|NCT00385801|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545070|NCT00385788|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1545071|NCT00385775|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545072|NCT00385762|||Case-Only||Prospective|||||||
1545073|NCT00385749|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545074|NCT00385736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545075|NCT00385723|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545076|NCT00385710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545077|NCT00385697|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1545078|NCT00385684|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1545079|NCT00385671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545080|NCT00385658|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545081|NCT00385645|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545082|NCT00385632|||Cohort||Prospective|||||||
1545083|NCT00385606|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1545084|NCT00385593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545085|NCT00385580|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545086|NCT00385567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545087|NCT00385554|Randomized|Parallel Assignment||Prevention||Double||||||
1545088|NCT00385541|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545089|NCT00385528|Randomized|Parallel Assignment||Treatment||Single||||||
1545090|NCT00385515|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545091|NCT00385502|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545092|NCT00385489|Randomized|Parallel Assignment||Treatment||Double||||||
1545093|NCT00385476|||Case Control||Prospective|||||||
1545094|NCT00385463|Randomized|Parallel Assignment||Treatment||Double||||||
1545095|NCT00385450|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1545096|NCT00385437|Randomized|Parallel Assignment||Treatment||Double||||||
1545097|NCT00385411|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545098|NCT00385398|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545099|NCT00385385|Randomized|Parallel Assignment||||Double||||||
1545100|NCT00385372||||||||||||
1545101|NCT00385359|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545102|NCT00385346|Randomized|Parallel Assignment||Treatment||Single|||t|||
1545103|NCT00385333|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1545104|NCT00385320|Randomized|Parallel Assignment||Prevention||Double||||||
1545105|NCT00385307|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545106|NCT00385294|||Cohort||Prospective|||||||
1545107|NCT00385281|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545108|NCT00385268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545109|NCT00385255|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545110|NCT00385242|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1545111|NCT00385229|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545112|NCT00385216|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1545113|NCT00385203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545114|NCT00385190|Randomized|Single Group Assignment||Treatment||Double||||||
1545115|NCT00385177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545116|NCT00385164|||Cohort||Prospective|||||||
1545117|NCT00385151|||||Prospective|||||||
1545118|NCT00385138|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545119|NCT00385125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545120|NCT00385112|||Cohort||Prospective|||||||
1545121|NCT00385099|Randomized|Crossover Assignment||Treatment||||||||
1545122|NCT00385086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545123|NCT00385073|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1545124|NCT00385047|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1545125|NCT00385034|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1545126|NCT00385021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545127|NCT00385008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545128|NCT00384995|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545129|NCT00384982|Randomized|Parallel Assignment||Treatment||Single||||||t
1545130|NCT00384969|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545131|NCT00384956||Single Group Assignment||Treatment||None (Open Label)||||||
1545132|NCT00384943|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545133|NCT00384930|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545134|NCT00384917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545135|NCT00384904|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1545136|NCT00384891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545137|NCT00384878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545138|NCT00384865|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1545139|NCT00384852|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545140|NCT00384839||Single Group Assignment||Treatment||None (Open Label)||||||
1545141|NCT00384826|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545142|NCT00384813|Randomized|Parallel Assignment||Treatment||Single||||||t
1545143|NCT00384800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545144|NCT00384787|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545145|NCT00384774|Randomized|Parallel Assignment||Treatment||Double||||||
1545146|NCT00384761|||Cohort||Cross-Sectional|||||||
1545147|NCT00384748|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1545148|NCT00384735|||Cohort||Prospective|||||||
1545149|NCT00384722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545150|NCT00384709||||||||||||
1545151|NCT00384696|||Cohort||Prospective|||||||
1545152|NCT00384683|||Case-Control||Prospective|||||||
1545153|NCT00384670||Single Group Assignment||Prevention||None (Open Label)||||||
1545154|NCT00384657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545155|NCT00384644|||Cohort||Prospective|||||||
1545156|NCT00384631|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1545157|NCT00384618|Randomized|Parallel Assignment||Treatment||Double||||||
1545158|NCT00384605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545159|NCT00384592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545160|NCT00384579|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545161|NCT00384566|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545162|NCT00384553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545163|NCT00384540||Single Group Assignment||Diagnostic||None (Open Label)||||||
1545164|NCT00384527|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545165|NCT00384514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545166|NCT00384501|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545167|NCT00384488|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1545168|NCT00384475|Randomized|Parallel Assignment||Treatment||Double||||||
1545169|NCT00384462|||Cohort||Prospective|||||||
1545170|NCT00384449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545171|NCT00384436|Randomized|Parallel Assignment||Treatment||Double||||||
1545172|NCT00384423|Randomized|Parallel Assignment||Treatment||Double||||||
1545173|NCT00384410|Randomized|Crossover Assignment||Treatment||Double||||||
1545174|NCT00384397|Randomized|Parallel Assignment||Prevention||Single||||||t
1545175|NCT00384384|Randomized|Crossover Assignment||Treatment||Double||||||
1545176|NCT00384371|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545177|NCT00384358|Randomized|Parallel Assignment||Treatment||Single|||t|||
1545178|NCT00384345|Randomized|Parallel Assignment||Treatment||Double||||||
1545179|NCT00384332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545180|NCT00384319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545181|NCT00384306|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545182|NCT00384293|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545183|NCT00384280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545184|NCT00384267|||||Prospective|||||||
1545185|NCT00384254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545186|NCT00384241|||Cohort||Retrospective|||||||
1545187|NCT00384228|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545188|NCT00384215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545189|NCT00384202|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545190|NCT00384189|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545191|NCT00384176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545192|NCT00384163|||||Retrospective|||||||
1545193|NCT00384150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545194|NCT00384137|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545195|NCT00384124|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1545196|NCT00384111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545197|NCT00384098|Randomized|Parallel Assignment||Treatment||Double||||||
1545198|NCT00384085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545199|NCT00384072|Randomized|Parallel Assignment||Prevention||Double||||||
1545200|NCT00384059|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1545201|NCT00384046|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545202|NCT00384033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545203|NCT00384020|||Case-Only|||||||||
1545204|NCT00384007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545205|NCT00383994||Single Group Assignment||Treatment||None (Open Label)||||||
1545206|NCT00383981|Random Sample||||Cross-Sectional, Prospective|||||||
1545207|NCT00383968|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1545208|NCT00383955|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1545209|NCT00383942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545210|NCT00383929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545211|NCT00383916|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545212|NCT00383903|Randomized|Parallel Assignment||Prevention||Double||||||
1545213|NCT00383890|Randomized|Single Group Assignment||Treatment||Double||||||
1545214|NCT00383877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545215|NCT00383864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545216|NCT00383851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545217|NCT00383838|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545218|NCT00383825|Randomized|Parallel Assignment||Screening||Single||||||
1545219|NCT00383812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545220|NCT00383799|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545221|NCT00383786|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545222|NCT00383773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545223|NCT00383760||Single Group Assignment||Treatment||None (Open Label)||||||
1545224|NCT00383747|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1545225|NCT00383734|Randomized|Parallel Assignment||Treatment||Single|||t|||
1545226|NCT00383721|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545227|NCT00383708||Single Group Assignment||Treatment||None (Open Label)||||||
1545228|NCT00383695|Randomized|||Treatment||None (Open Label)||||||
1545229|NCT00383682|Randomized|Crossover Assignment||Treatment||Double||||||
1545230|NCT00383669|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1545231|NCT00383656||Single Group Assignment||Treatment||None (Open Label)||||||
1545232|NCT00383643|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545233|NCT00383630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545234|NCT00383617||||||||||||
1545235|NCT00383604|||Cohort||Prospective|||||||
1545236|NCT00383591|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545237|NCT00383578|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545238|NCT00383565||Single Group Assignment||Treatment||None (Open Label)||||||
1545239|NCT00383552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545240|NCT00383539|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1545241|NCT00383526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545242|NCT00383513||Single Group Assignment||Treatment||None (Open Label)||||||
1545243|NCT00383500|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545244|NCT00383487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545245|NCT00383474||Single Group Assignment||Treatment||None (Open Label)||||||
1545246|NCT00383461|Randomized|||||None (Open Label)||||||
1545247|NCT00383448||Single Group Assignment||Treatment||None (Open Label)||||||
1545248|NCT00383435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545249|NCT00383422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545250|NCT00383409|Randomized|Crossover Assignment||Treatment||Double||||||
1545251|NCT00383396|Randomized|Single Group Assignment||||None (Open Label)||||||
1545252|NCT00383383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545253|NCT00383370|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545254|NCT00383357|Randomized|Crossover Assignment||Treatment||Double||||||
1545255|NCT00383344|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1545256|NCT00383331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545257|NCT00383318|||||Prospective|||||||
1545258|NCT00383305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545259|NCT00383292||Single Group Assignment||Treatment||None (Open Label)||||||
1545260|NCT00383279||||Other||||||||
1545261|NCT00383266||Single Group Assignment||Treatment||None (Open Label)||||||
1545262|NCT00383253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545263|NCT00383240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545264|NCT00383227|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545265|NCT00383214|Randomized|Parallel Assignment||Treatment||Double||||||
1545266|NCT00383201|Randomized|Parallel Assignment||Treatment||Double||||||
1545267|NCT00383188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545268|NCT00383175|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1545269|NCT00383162|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1545270|NCT00383149|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545271|NCT00383136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545272|NCT00383123|Randomized|Parallel Assignment||Prevention||Single|||t|||
1545273|NCT00383110|||Cohort||Cross-Sectional|||||||
1545274|NCT00383097|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545275|NCT00383084|Randomized|Parallel Assignment||Treatment||Single|||t|||
1545276|NCT00383071|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1545277|NCT00383058|Randomized|Parallel Assignment||Treatment||Double||||||
1545278|NCT00383045|Randomized|Factorial Assignment||Treatment||Double||||||
1545279|NCT00383032|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545280|NCT00383019|Randomized|Parallel Assignment||Treatment||Double||||||
1545281|NCT00383006|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545282|NCT00382993|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1545283|NCT00382980|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1545284|NCT00382967|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545285|NCT00382954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545286|NCT00382941|Randomized|Parallel Assignment||Treatment||Single||||||
1545287|NCT00382928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545288|NCT00382915|||Case Control||Prospective|||||||
1545289|NCT00382902|Randomized|Parallel Assignment||Treatment||Double||||||
1545290|NCT00382889|Randomized|Parallel Assignment||Treatment||Double||||||
1545291|NCT00382876|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1545292|NCT00382863|Randomized|Parallel Assignment||Treatment||Single||||||t
1545293|NCT00382850|Randomized|Parallel Assignment||Treatment||Single||||t||
1545294|NCT00382837|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545295|NCT00382824|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1545296|NCT00382811|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545297|NCT00382798|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545298|NCT00382785|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1545299|NCT00382772|Randomized|Parallel Assignment||Prevention||Double||||||
1545300|NCT00382759|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545301|NCT00382746|||||Prospective|||||||
1545302|NCT00382733||Single Group Assignment||Treatment||None (Open Label)||||||
1545303|NCT00382720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545304|NCT00382707|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545305|NCT00382694|Randomized|Parallel Assignment||Treatment||Double||||||
1545306|NCT00382681|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545307|NCT00382668|||Cohort||Prospective|||||||
1545308|NCT00382655|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545309|NCT00382642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545310|NCT00382629|Randomized|Parallel Assignment||Treatment||Double||||||
1545311|NCT00382616|Randomized|Parallel Assignment||Treatment||Double||||||
1545312|NCT00382603|Randomized|Parallel Assignment||Treatment||Double||||||
1545313|NCT00382590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545314|NCT00382577|Randomized|Crossover Assignment||Treatment||Double||||||
1545315|NCT00382564||||||||||||
1545316|NCT00382551|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1545317|NCT00382538|Randomized|Parallel Assignment||Treatment||Double||||||
1545318|NCT00382525|||Cohort||Prospective|||||||
1545319|NCT00382512|Randomized|Parallel Assignment||Treatment||Single||||||
1545320|NCT00382499|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545321|NCT00382486|||||Prospective|||||||
1545322|NCT00382473|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1545323|NCT00382460|Randomized|Factorial Assignment||Prevention||Double||||||
1545324|NCT00382447|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1545325|NCT00382434|||||Prospective|||||||
1545326|NCT00382421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545327|NCT00382408|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1545328|NCT00382395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545329|NCT00382382|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1545330|NCT00382369|||Family-Based||Prospective|||||||
1545331|NCT00382356|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545332|NCT00382343|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545333|NCT00382330|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545334|NCT00382317|Randomized|Parallel Assignment||Diagnostic||Double||||||
1545335|NCT00382304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545336|NCT00382291|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1545337|NCT00382278|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545338|NCT00382265|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545339|NCT00382252||||Diagnostic||None (Open Label)||||||
1545340|NCT00382239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545341|NCT00382226|Randomized|Parallel Assignment||Treatment||Double||||||
1545342|NCT00382213|Randomized|Parallel Assignment||Treatment||Double||||||
1545343|NCT00382200||Single Group Assignment||Treatment||None (Open Label)||||||
1545344|NCT00382187|Randomized|Parallel Assignment||Prevention||Single|||||t|
1545345|NCT00382174|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545346|NCT00382161|Randomized|Crossover Assignment||Treatment||Double||||||
1545347|NCT00382148||Single Group Assignment||Treatment||None (Open Label)||||||
1545348|NCT00382135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545349|NCT00382122|||Cohort||Cross-Sectional|||||||
1545350|NCT00382109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545351|NCT00382096|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545352|NCT00382083|Randomized|Single Group Assignment||Treatment||Double||||||
1545353|NCT00382070|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545354|NCT00382057|Randomized|Parallel Assignment||Treatment||Double||||||
1545355|NCT00382044|||Cohort||Prospective|||||||
1545356|NCT00382031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545357|NCT00382018|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1545358|NCT00381992|||Other||Cross-Sectional|||||||
1545359|NCT00381979||Single Group Assignment||Treatment||None (Open Label)||||||
1545360|NCT00381966||Single Group Assignment||Device Feasibility||None (Open Label)||||||
1545361|NCT00381953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545362|NCT00381940||Single Group Assignment||Treatment||None (Open Label)||||||
1545363|NCT00381927|||Defined Population||Longitudinal, Prospective|||||||
1545364|NCT00381914|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545365|NCT00381901|Randomized|||Treatment||||||||
1545366|NCT00381888||Single Group Assignment||Treatment||None (Open Label)||||||
1545367|NCT00381875||||Treatment||||||||
1545368|NCT00381862||Single Group Assignment||Supportive Care||None (Open Label)||||||
1545369|NCT00381849|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1545370|NCT00381836|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1545371|NCT00381823|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1545372|NCT00381810||Single Group Assignment||Treatment||None (Open Label)||||||
1545373|NCT00381797||Single Group Assignment||Treatment||None (Open Label)||||||
1545374|NCT00381784|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545375|NCT00381771|||Case-Only||Prospective|||||||
1545376|NCT00381758|Randomized|Crossover Assignment||Treatment||Double||||||
1545377|NCT00381732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545378|NCT00381719|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545379|NCT00381706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545380|NCT00381693||||Treatment||None (Open Label)||||||
1545381|NCT00381680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545382|NCT00381667|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1545383|NCT00381654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545384|NCT00381641||Single Group Assignment||Treatment||None (Open Label)||||||
1545385|NCT00381628|||Case-Control||Prospective|||||||
1545386|NCT00381615|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545387|NCT00381602|Randomized|Crossover Assignment||Treatment||Double||||||
1545388|NCT00381589|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1545389|NCT00381576|Randomized|Crossover Assignment||||Single|||||t|
1545390|NCT00381563|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1545391|NCT00381550||Single Group Assignment||Treatment||None (Open Label)||||||
1545392|NCT00381537|Randomized|Parallel Assignment||||None (Open Label)||||||
1545393|NCT00381524|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545394|NCT00381511|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1545395|NCT00381485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545396|NCT00381472|Randomized|Parallel Assignment||Treatment||Double||||||
1545397|NCT00381446|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1545398|NCT00381433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545399|NCT00381420|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545400|NCT00381407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545473|NCT00380458|Randomized|Parallel Assignment||Treatment||Single||||||
1545401|NCT00381394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545402|NCT00381381|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545403|NCT00381368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545404|NCT00381355|Randomized|Parallel Assignment||||Single||||||
1545405|NCT00381342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545406|NCT00381329|Randomized|Factorial Assignment||Treatment||Single||||||t
1545407|NCT00381316|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1545408|NCT00381303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545409|NCT00381290|Randomized|Parallel Assignment||Treatment||Single||||||t
1545410|NCT00381277|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1545411|NCT00381264|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545412|NCT00381251|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1545413|NCT00381238|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545414|NCT00381225||Single Group Assignment||Treatment||None (Open Label)||||||
1545415|NCT00381212|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545416|NCT00381199|Randomized|Crossover Assignment||Treatment||Double||||||
1545417|NCT00381186|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545418|NCT00381173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545419|NCT00381160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545420|NCT00381147|Randomized|Parallel Assignment||Treatment||Double||||||
1545421|NCT00381134|Randomized|Parallel Assignment||Treatment||Double||||||
1545422|NCT00381121|||Cohort||Prospective|||||||
1545423|NCT00381108|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1545424|NCT00381095|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545425|NCT00381082|Randomized|Parallel Assignment||Treatment||Single||||||
1545426|NCT00381069|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545427|NCT00381056|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1545428|NCT00381043|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1545429|NCT00381030|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545430|NCT00381017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545431|NCT00381004||Single Group Assignment||Treatment||None (Open Label)||||||
1545432|NCT00380991|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545433|NCT00380978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545434|NCT00380965|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545435|NCT00380952|Randomized|Parallel Assignment||Treatment||Single||||||t
1545436|NCT00380939|Randomized|Parallel Assignment||Treatment||Double||||||
1545437|NCT00380926|Randomized|Parallel Assignment||Treatment||Double||||||
1545438|NCT00380913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545439|NCT00380900|Randomized|Factorial Assignment||Treatment||Double||||||
1545440|NCT00380887|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1545441|NCT00380874|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545442|NCT00380861|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1545443|NCT00380848|Randomized|Crossover Assignment||Treatment||Single||||||
1545444|NCT00380835|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545445|NCT00380822|Randomized|Parallel Assignment||Treatment||Double||||||
1545446|NCT00380809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545447|NCT00380796|||Case-Only||Prospective|||||||
1545448|NCT00380783|Randomized|Parallel Assignment||Treatment||Double||||||
1545449|NCT00380770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545450|NCT00380757|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1545451|NCT00380744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545452|NCT00380731|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545453|NCT00380718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545454|NCT00380705|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545455|NCT00380692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545456|NCT00380679|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545457|NCT00380666|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545458|NCT00380653|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545459|NCT00380640|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1545460|NCT00380627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545461|NCT00380614|Randomized|Parallel Assignment||Treatment||Double||||||
1545462|NCT00380601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545463|NCT00380588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545464|NCT00380575|Randomized|Parallel Assignment||Treatment||Double||||||
1545465|NCT00380562|Randomized|Parallel Assignment||Treatment||Single|||||t|
1545466|NCT00380549|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1545467|NCT00380536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545468|NCT00380523|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545469|NCT00380510|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1545470|NCT00380497|Randomized|Parallel Assignment||Treatment||Single||||||t
1545471|NCT00380484|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1545472|NCT00380471|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1545474|NCT00380445|Randomized|Crossover Assignment||Treatment||Double||||||
1545475|NCT00380419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545476|NCT00380406|Randomized|Parallel Assignment||Treatment||Double||||||
1545477|NCT00380393|Randomized|Parallel Assignment||Prevention||Double||||t||t
1545478|NCT00380380|Randomized|Crossover Assignment||Treatment||Single||||||
1545479|NCT00380367||Single Group Assignment||Prevention||None (Open Label)||||||
1545480|NCT00380354|Randomized|Crossover Assignment||Treatment||Double||||||
1545481|NCT00380341|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545482|NCT00380328|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545483|NCT00380315|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545484|NCT00380302|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545485|NCT00380289|Randomized|Crossover Assignment||Treatment||Double||||||
1545486|NCT00380276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545487|NCT00380263||||||||||||
1545488|NCT00380250|Randomized|Parallel Assignment||Treatment||Double||||||
1545489|NCT00380237|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545490|NCT00380224|Randomized|Parallel Assignment||Treatment||Double||||||
1545491|NCT00380211|Randomized|Parallel Assignment||Prevention||Double||||||
1545492|NCT00380198|Randomized|Crossover Assignment||Diagnostic||Double||||||
1545493|NCT00380185|||Case Control||Prospective|||||||
1545494|NCT00380172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545495|NCT00380159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545496|NCT00380146||Single Group Assignment||Prevention||None (Open Label)||||||
1545497|NCT00380133|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1545498|NCT00380120|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545499|NCT00380107|||||Prospective|||||||
1545500|NCT00380094|||Cohort||Prospective|||||||
1545501|NCT00380081|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1545502|NCT00380068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545503|NCT00380055|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1545504|NCT00380042|Randomized|Crossover Assignment||Treatment||Single|||t|||
1545505|NCT00380029||Single Group Assignment||Treatment||None (Open Label)||||||
1545506|NCT00380016||||Treatment||||||||
1545507|NCT00380003|Randomized|Crossover Assignment||Treatment||Double||||||
1545508|NCT00379990|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545509|NCT00379977|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545510|NCT00379964|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545511|NCT00379951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545512|NCT00379938|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1545513|NCT00379925|Randomized|Single Group Assignment||Prevention||Single||||||t
1545514|NCT00379912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545515|NCT00379899|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545516|NCT00379886|Randomized|Parallel Assignment||Treatment||Double||||||
1545517|NCT00379873|Randomized|Parallel Assignment||||None (Open Label)||||||
1545518|NCT00379860|Randomized|Single Group Assignment||Treatment||Double||||||
1545519|NCT00379847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545520|NCT00379834||Single Group Assignment||Treatment||None (Open Label)||||||
1545521|NCT00379821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545522|NCT00379808|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1545523|NCT00379795||Single Group Assignment||Treatment||None (Open Label)||||||
1545524|NCT00379782|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1545525|NCT00379769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545526|NCT00379756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545527|NCT00379743|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1545528|NCT00379730|Randomized|Parallel Assignment||Treatment||||||||
1545529|NCT00379717|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545530|NCT00379704|||Case Control||Prospective|||||||
1545531|NCT00379691|Randomized|Single Group Assignment||Prevention||Double||||||
1545532|NCT00379678|||||Prospective|||||||
1545533|NCT00379665|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545534|NCT00379652|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1545535|NCT00379639|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545536|NCT00379626||Single Group Assignment||Treatment||None (Open Label)||||||
1545537|NCT00379613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545538|NCT00379600|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545539|NCT00379587|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545540|NCT00379574||Single Group Assignment||Treatment||None (Open Label)||||||
1545541|NCT00379561|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545542|NCT00379548|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1545543|NCT00379535|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545544|NCT00379522|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1545545|NCT00379509||Single Group Assignment||Treatment||None (Open Label)||||||
1545546|NCT00379496|Randomized|Crossover Assignment||Treatment||Single||||||
1545547|NCT00379483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545624|NCT00378456|Randomized|Parallel Assignment||||Double||||||
1545548|NCT00379470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545549|NCT00379457|Randomized|||Treatment||||||||
1545550|NCT00379444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545551|NCT00379431|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545552|NCT00379418|||Cohort||Prospective|||||||
1545553|NCT00379405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545554|NCT00379392|Randomized|Crossover Assignment||Treatment||Single||||||t
1545555|NCT00379379|Randomized|Factorial Assignment||Treatment||Single||||||
1545556|NCT00379366|Randomized|Parallel Assignment||Treatment||Single||||||t
1545557|NCT00379353|Randomized|Parallel Assignment||Supportive Care||Triple|||t||t|t
1545558|NCT00379340|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545559|NCT00379327|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1545560|NCT00379314|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545561|NCT00379301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545562|NCT00379288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545563|NCT00379275||||||||||||
1545564|NCT00379262|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1545565|NCT00379249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545566|NCT00379236|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545567|NCT00379223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545568|NCT00379210|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1545569|NCT00379197||Single Group Assignment||Treatment||None (Open Label)||||||
1545570|NCT00379184|||Cohort||Cross-Sectional|||||||
1545571|NCT00379171|Randomized|Factorial Assignment||Prevention||Single||||||
1545572|NCT00379158|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1545573|NCT00379145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545574|NCT00379132|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545575|NCT00379119|||Cohort||Prospective|||||||
1545576|NCT00379106|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545577|NCT00379093|Randomized|Parallel Assignment||Prevention||Single|||t|||
1545578|NCT00379080|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545579|NCT00379067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545580|NCT00379054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545581|NCT00379041|Randomized|||Treatment||||||||
1545582|NCT00379028|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1545583|NCT00379015||Single Group Assignment||Treatment||None (Open Label)||||||
1545584|NCT00379002|||Other||Prospective|||||||
1545585|NCT00378989|Randomized|Parallel Assignment||Prevention||Single||||||t
1545586|NCT00378976|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1545587|NCT00378963|Randomized|Single Group Assignment||||None (Open Label)||||||
1545588|NCT00378950|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1545589|NCT00378937|Randomized|||Supportive Care||None (Open Label)||||||
1545590|NCT00378924|||Ecologic or Community||Cross-Sectional|||||||
1545591|NCT00378911||Single Group Assignment||Treatment||None (Open Label)||||||
1545592|NCT00378898|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1545593|NCT00378885|Randomized|Factorial Assignment||Prevention||Single||||||
1545594|NCT00378872|Randomized|Parallel Assignment||Prevention||Single||||||
1545595|NCT00378859|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545596|NCT00378846||||Diagnostic||||||||
1545597|NCT00378833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545598|NCT00378820|Randomized|Factorial Assignment||Prevention||Double||||||
1545599|NCT00378781|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1545600|NCT00378768||||Treatment||None (Open Label)||||||
1545601|NCT00378755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545602|NCT00378742|||Cohort||Prospective|||||||
1545603|NCT00378729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545604|NCT00378716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545605|NCT00378703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545606|NCT00378690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545607|NCT00378677|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545608|NCT00378664||Single Group Assignment||Treatment||None (Open Label)||||||
1545609|NCT00378651|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1545610|NCT00378638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545611|NCT00378625|Randomized|Parallel Assignment||||Double||||||
1545612|NCT00378612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545613|NCT00378599|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545614|NCT00378586|||||Prospective|||||||
1545615|NCT00378573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545616|NCT00378560|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1545617|NCT00378547|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545618|NCT00378534||Single Group Assignment||Treatment||None (Open Label)||||||
1545619|NCT00378521|Randomized|Single Group Assignment||Treatment||Double||||||
1545620|NCT00378508|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545621|NCT00378495|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545622|NCT00378482||Single Group Assignment||Treatment||None (Open Label)||||||
1545623|NCT00378469|Randomized|Crossover Assignment||||None (Open Label)||||||
1545625|NCT00378443|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545626|NCT00378430|||||Prospective|||||||
1545627|NCT00378417|Randomized|Parallel Assignment||Prevention||Double||||||
1545628|NCT00378404|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545629|NCT00378391|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1545630|NCT00378378|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545631|NCT00378365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545632|NCT00378352|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545633|NCT00378339|Randomized|Single Group Assignment||Treatment||Double||||||
1545634|NCT00378326||Single Group Assignment||Treatment||None (Open Label)||||||
1545635|NCT00378313|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545636|NCT00378300|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545637|NCT00378287|Randomized|Crossover Assignment||Treatment||Double||||||
1545638|NCT00378274|||||Prospective|||||||
1545639|NCT00378261|Randomized|Parallel Assignment||||None (Open Label)||||||
1545640|NCT00378248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545641|NCT00378235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545642|NCT00378222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545643|NCT00378209||Single Group Assignment||Treatment||None (Open Label)||||||
1545644|NCT00378196|Randomized|Parallel Assignment||Treatment||Single|||t|||
1545645|NCT00378183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545646|NCT00378170|Randomized|Parallel Assignment||Prevention||Single||||||
1545647|NCT00378157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545648|NCT00378144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545649|NCT00378131|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545650|NCT00378118|||Cohort||Prospective|||||||
1545651|NCT00378105||Single Group Assignment||Treatment||None (Open Label)||||||
1545652|NCT00378092||Single Group Assignment||Treatment||None (Open Label)||||||
1545653|NCT00378079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545654|NCT00378066||Single Group Assignment||Treatment||None (Open Label)||||||
1545655|NCT00378053|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1545656|NCT00378040|||Case-Only||Prospective|||||||
1545657|NCT00378027|||Cohort||Prospective|||||||
1545658|NCT00378014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545659|NCT00378001|Randomized|Parallel Assignment||Treatment||Double||||||
1545660|NCT00377988|||Case Control||Retrospective|||||||
1545661|NCT00377975|Randomized|Parallel Assignment||Treatment||Double||||||
1545662|NCT00377962|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545663|NCT00377949|||Case-Only||Prospective|||||||
1545664|NCT00377936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545665|NCT00377923|Randomized|Parallel Assignment||Treatment||Single||||||
1545666|NCT00377910|Randomized|Factorial Assignment||Treatment||Single|||t|||
1545667|NCT00377897|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545668|NCT00377884|||Cohort||Prospective|||||||
1545669|NCT00377871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545670|NCT00377858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545671|NCT00377845|Non-Randomized|Single Group Assignment||Screening||Single||||||
1545672|NCT00377832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545673|NCT00377819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545674|NCT00377806|Randomized|Parallel Assignment||Treatment||Double||||||
1545675|NCT00377793|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545676|NCT00377780||Single Group Assignment||Treatment||None (Open Label)||||||
1545677|NCT00377767|Randomized|Single Group Assignment||Prevention||Double||||||
1545678|NCT00377754|||||Prospective|||||||
1545679|NCT00377741|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545680|NCT00377728|Randomized|Crossover Assignment||Treatment||Double||||||
1545681|NCT00377715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545682|NCT00377702|||||Retrospective|||||||
1545683|NCT00377689|Randomized|Parallel Assignment||||Double|||t|||t
1545684|NCT00377676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545685|NCT00377663|Randomized|Parallel Assignment||Treatment||Single|||t|||
1545686|NCT00377650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545687|NCT00377637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545688|NCT00377624|Randomized|Parallel Assignment||Treatment||Double||||||
1545689|NCT00377611|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545690|NCT00377598|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545691|NCT00377585|Randomized|Parallel Assignment||Prevention||||||||
1545692|NCT00377572|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1545693|NCT00377559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545694|NCT00377546|Randomized|Parallel Assignment||||Double||||||
1545695|NCT00377533|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545696|NCT00377520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545697|NCT00377507|Randomized|Parallel Assignment||Treatment||Single|||t|||
1545698|NCT00377494|Randomized|Parallel Assignment||Prevention||Double||||||
1545699|NCT00377481|Randomized|Crossover Assignment||Treatment||Single|||t|||
1545700|NCT00377468|Randomized|Factorial Assignment||Prevention||Double||||||
1546535|NCT00366431|Randomized|Parallel Assignment||Treatment||Double||||||
1545701|NCT00377455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545702|NCT00377442|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545703|NCT00377429||Single Group Assignment||Treatment||None (Open Label)||||||
1545704|NCT00377416||Single Group Assignment||Treatment||None (Open Label)||||||
1545705|NCT00377403|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545706|NCT00377390|||Cohort||Prospective|||||||
1545707|NCT00377377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545708|NCT00377364|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545709|NCT00377351||||||||||||
1545710|NCT00377338|||Cohort||Prospective|||||||
1545711|NCT00377325|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1545712|NCT00377312||Single Group Assignment||||Single|||t|||
1545713|NCT00377299|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545714|NCT00377286|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545715|NCT00377273|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545716|NCT00377260|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545717|NCT00377247||Single Group Assignment||Treatment||None (Open Label)||||||
1545718|NCT00377234|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545719|NCT00377221|||Defined Population||Cross-Sectional, Prospective|||||||
1545720|NCT00377208|Randomized|Parallel Assignment||Health Services Research||Triple|||t|t|t|
1545721|NCT00377195|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545722|NCT00377182|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545723|NCT00377169||||||||||||
1545724|NCT00377156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545725|NCT00377143|Randomized|Parallel Assignment||Treatment||Single||||||
1545726|NCT00377130|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1545727|NCT00377117|||||Other|||||||
1545728|NCT00377104||Single Group Assignment||Treatment||None (Open Label)||||||
1545729|NCT00377091|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545730|NCT00377078|Randomized|Crossover Assignment||Prevention||Double||||||
1545731|NCT00377065||||||||||||
1545732|NCT00377052|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545733|NCT00377039|Randomized|Parallel Assignment||Treatment||Double||||||
1545734|NCT00377026|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545735|NCT00377000|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545736|NCT00376987|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545737|NCT00376974|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1545738|NCT00376961||Single Group Assignment||Treatment||None (Open Label)||||||
1545739|NCT00376948||Single Group Assignment||Treatment||None (Open Label)||||||
1545740|NCT00376935|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1545741|NCT00376922|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1545742|NCT00376909|Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1545743|NCT00376896|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1545744|NCT00376883|Randomized|Parallel Assignment||Prevention||Double||||||
1545745|NCT00376870|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545746|NCT00376857|Randomized|Parallel Assignment||Treatment||Single||||||
1545747|NCT00376844|Randomized|Parallel Assignment||Treatment||None (Open Label)||Exterbal beam radiation therapy versus vaginal brachytherapy||||
1545748|NCT00376831|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545749|NCT00376818||Single Group Assignment||Supportive Care||None (Open Label)||||||
1545750|NCT00376805||Single Group Assignment||Treatment||None (Open Label)||||||
1545751|NCT00376792|Randomized|||Treatment||None (Open Label)||||||
1545752|NCT00376779|Randomized|Parallel Assignment||Prevention||Double||||||
1545753|NCT00376766|Randomized|Parallel Assignment||Treatment||Double||||||
1545754|NCT00376753||||||||||||
1545755|NCT00376740|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545756|NCT00376727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545757|NCT00376714|Randomized|Crossover Assignment||Treatment||||||||
1545758|NCT00376701|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1545759|NCT00376688||Single Group Assignment||Treatment||None (Open Label)||||||
1545760|NCT00376675|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1545761|NCT00376662|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1545762|NCT00376649|Randomized|Parallel Assignment||||None (Open Label)||||||
1545763|NCT00376636|Randomized|Parallel Assignment||Treatment||Double||||||
1545764|NCT00376623||Parallel Assignment||Treatment||||||||
1545765|NCT00376610|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545766|NCT00376597|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1545767|NCT00376584|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545768|NCT00376571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545769|NCT00376558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545770|NCT00376545||||||||||||
1545771|NCT00376532|||Case Control||Prospective|||||||
1545772|NCT00376519||Single Group Assignment||Treatment||None (Open Label)||||||
1545773|NCT00376506|Randomized|Parallel Assignment||Treatment||Single||||||
1545774|NCT00376493|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545775|NCT00376480||||Treatment||||||||
1545776|NCT00376467|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545777|NCT00376454|Randomized|Parallel Assignment||Treatment||Double||||||
1545778|NCT00376441|||Case Control||Prospective|||||||
1545779|NCT00376428|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545780|NCT00376415|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1545781|NCT00376402|Randomized|Parallel Assignment||Prevention||Double||||||
1545782|NCT00376376|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1545783|NCT00376363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545784|NCT00376350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545785|NCT00376337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545786|NCT00376324|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545787|NCT00376311|Randomized|Parallel Assignment||Treatment||Double||||||
1545788|NCT00376298|||Case-Only||Retrospective|||||||
1545789|NCT00376285|Randomized|Parallel Assignment||Treatment||Single||||||
1545790|NCT00376272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545791|NCT00376259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545792|NCT00376246|Randomized|Crossover Assignment||Treatment||Double||||||
1545793|NCT00376233|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1545794|NCT00376220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545795|NCT00376207|Randomized|Single Group Assignment||Prevention||Single||||||
1545796|NCT00376194|Randomized|Parallel Assignment||Treatment||Double||||||
1545797|NCT00376181|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545798|NCT00376168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545799|NCT00376155|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545800|NCT00376142|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1545801|NCT00376129|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1545802|NCT00376116|||||Prospective|||||||
1545803|NCT00376103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545804|NCT00376090|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1545805|NCT00376077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545806|NCT00376064||Single Group Assignment||Treatment||None (Open Label)||||||
1545807|NCT00376051|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545808|NCT00376038|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545809|NCT00376025|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1545810|NCT00376012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545811|NCT00375999||Single Group Assignment||Treatment||None (Open Label)||||||
1545812|NCT00375986|Randomized|Single Group Assignment||||None (Open Label)||||||
1545813|NCT00375973|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545814|NCT00375960|Randomized|Crossover Assignment||Treatment||Double||||||
1545815|NCT00375947|Randomized|Crossover Assignment||Treatment||Single||||||
1545816|NCT00375934|Randomized|Parallel Assignment||Treatment||Double||||||
1545817|NCT00375921|||||Prospective|||||||
1545818|NCT00375908|||Case Control||Prospective|||||||
1545819|NCT00375895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545820|NCT00375882||Single Group Assignment||Treatment||None (Open Label)||||||
1545821|NCT00375869|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1545822|NCT00375856|Randomized|Factorial Assignment||Treatment||Single|||t|||
1545823|NCT00375843|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545824|NCT00375830||Single Group Assignment||Diagnostic||None (Open Label)||||||
1545825|NCT00375817|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1545826|NCT00375804|||Cohort||Other|||||||
1545827|NCT00375791|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1545828|NCT00375778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545829|NCT00375765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545830|NCT00375752|Randomized|Parallel Assignment||Treatment||Quadruple|Open-label, multicenter, randomized||t|t|t|t
1545831|NCT00375739|Randomized|Single Group Assignment||Treatment||Double||||||
1545832|NCT00375726|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1545833|NCT00375713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545834|NCT00375700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545835|NCT00375687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545836|NCT00375674|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545837|NCT00375661|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545838|NCT00375648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545839|NCT00375635|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1545840|NCT00375622|Randomized|Single Group Assignment||Treatment||Double||||||
1545841|NCT00375609|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545842|NCT00375596||Parallel Assignment||||||||||
1545843|NCT00375583||||Treatment||||||||
1545844|NCT00375570|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545845|NCT00375557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545846|NCT00375544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545847|NCT00375531|Randomized|Parallel Assignment||Treatment||Double||||||
1545848|NCT00375518|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1545849|NCT00375505|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1545850|NCT00375492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545851|NCT00375466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545852|NCT00375453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545853|NCT00375440|Randomized|Factorial Assignment||Treatment||Double||||||
1545854|NCT00375427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545855|NCT00375414|Randomized|Parallel Assignment||Treatment||Double||||||
1545856|NCT00375401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545857|NCT00375388|Randomized|Parallel Assignment||Treatment||Double||||||
1545858|NCT00375375|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545859|NCT00375362|Randomized|Parallel Assignment||Treatment||Double||||||
1545860|NCT00375349||||||||||||
1545861|NCT00375336|||Cohort||Prospective|||||||
1545862|NCT00375323|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1545863|NCT00375310||Single Group Assignment||Treatment||None (Open Label)||||||
1545864|NCT00375297|Randomized|Parallel Assignment||Treatment||Double||||||
1545865|NCT00375284||Parallel Assignment||Treatment||||||||
1545866|NCT00375271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545867|NCT00375258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545868|NCT00375245||Single Group Assignment||Treatment||None (Open Label)||||||
1545869|NCT00375232|Randomized|Crossover Assignment||Prevention||Double||||||
1545870|NCT00375219||Single Group Assignment||Treatment||None (Open Label)||||||
1545871|NCT00375206|Randomized|Parallel Assignment||Prevention||Double||||||
1545872|NCT00375193||Single Group Assignment||Treatment||None (Open Label)||||||
1545873|NCT00375180|||||Prospective|||||||
1545874|NCT00375167|Randomized|Single Group Assignment||Treatment||Single||||||
1545875|NCT00375154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545876|NCT00375141|Randomized|Single Group Assignment||||Single||||||
1545877|NCT00375128|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545878|NCT00375115|Randomized|Parallel Assignment||Treatment||Double||||||
1545879|NCT00375102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545880|NCT00375089|||Cohort||Prospective|||||||
1545881|NCT00375076|Randomized|Parallel Assignment||||Double||||||
1545882|NCT00375063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545883|NCT00375050|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1545884|NCT00375037|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545885|NCT00375024|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1545886|NCT00375011|||Cohort||Prospective|||||||
1545887|NCT00374998|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545888|NCT00374985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545889|NCT00374972|||||Prospective|||||||
1545890|NCT00374959|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545891|NCT00374946|||Cohort||Prospective|||||||
1545892|NCT00374933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545893|NCT00374920|Randomized|Parallel Assignment||Treatment||Double||||||
1545894|NCT00374907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545895|NCT00374894|||Defined Population|Screening|Longitudinal, Prospective|||||||
1545896|NCT00374881|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1545897|NCT00374868|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545898|NCT00374855|Randomized|Parallel Assignment||Treatment||Double||||||
1545899|NCT00374842|Randomized|Parallel Assignment||Prevention||Single|||t|||
1545900|NCT00374829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545901|NCT00374803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545902|NCT00374790|Randomized|Single Group Assignment||Prevention||Double||||||
1545903|NCT00374777|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545904|NCT00374764|Randomized|Parallel Assignment||Treatment||Double||||||
1545905|NCT00374751||Single Group Assignment||Treatment||None (Open Label)||||||
1545906|NCT00374738|Randomized|Parallel Assignment||Treatment||Single|||t|||
1545907|NCT00374725|Randomized|Parallel Assignment||Treatment||Double||||||
1545908|NCT00374712|||||Prospective|||||||
1545909|NCT00374699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545910|NCT00374686|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545911|NCT00374673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545912|NCT00374660|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545913|NCT00374647|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545914|NCT00374634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545915|NCT00374621|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545916|NCT00374608|||Case-Only||Prospective|||||||
1545917|NCT00374595|||Other||Prospective|||||||
1545918|NCT00374582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545919|NCT00374569|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1545920|NCT00374556|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1545921|NCT00374543|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545922|NCT00374530|Randomized|Crossover Assignment||||Double||||||
1545923|NCT00374517||||Treatment||||||||
1545924|NCT00374504|||Case Control||Longitudinal, Prospective|||||||
1545925|NCT00374491|||||Prospective|||||||
1545926|NCT00374478|Randomized|Crossover Assignment||Prevention||Double||||||
1545927|NCT00374465|Randomized|Parallel Assignment||Treatment||Single||||||
1545928|NCT00374452|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1545929|NCT00374439|Randomized|Parallel Assignment||Prevention||Single||||||t
1545930|NCT00374426|Randomized|Parallel Assignment||Treatment||Double||||||
1545931|NCT00374413|Randomized|Parallel Assignment||Treatment||Single|||t|||
1545932|NCT00374400|||||Prospective|||||||
1545933|NCT00374387|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1545934|NCT00374374|Randomized|Parallel Assignment||Treatment||Double||||||
1545935|NCT00374361|||Cohort||Prospective|||||||
1545936|NCT00374348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545937|NCT00374335|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1545938|NCT00374322|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545939|NCT00374309|Randomized|Parallel Assignment||Prevention||Double||||||
1545940|NCT00374296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545941|NCT00374283|||||Prospective|||||||
1545942|NCT00374270|Randomized|Single Group Assignment||Treatment||Single|||||t|
1545943|NCT00374257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545944|NCT00374244|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1545945|NCT00374231||Single Group Assignment||Treatment||None (Open Label)||||||
1545946|NCT00374218|Randomized|Crossover Assignment||Treatment||Double||||||
1545947|NCT00374205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545948|NCT00374192|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1545949|NCT00374179|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545950|NCT00374166|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545951|NCT00374153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545952|NCT00374140||Single Group Assignment||Treatment||None (Open Label)||||||
1545953|NCT00374127|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1545954|NCT00374114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545955|NCT00374101|Randomized|Parallel Assignment||Treatment||Double||||||
1545956|NCT00374088|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1545957|NCT00374075|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545958|NCT00374062|Randomized|Parallel Assignment||Treatment||Single||||||t
1545959|NCT00374049||Single Group Assignment||Treatment||None (Open Label)||||||
1545960|NCT00374036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545961|NCT00374023|Randomized|Parallel Assignment||Prevention||Double||||||
1545962|NCT00374010|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1545963|NCT00373997|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1545964|NCT00373984|||||Prospective|||||||
1545965|NCT00373971|Non-Randomized|Factorial Assignment||Prevention||Single||||||
1545966|NCT00373958|Randomized|Parallel Assignment||Prevention||Double||||||
1545967|NCT00373945|||||Retrospective|||||||
1545968|NCT00373932|Randomized|Parallel Assignment||||Single||||||t
1545969|NCT00373919|Randomized|Parallel Assignment||||Double||||||
1545970|NCT00373906|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545971|NCT00373893|Randomized|Single Group Assignment||Treatment||Double||||||
1545972|NCT00373880|Randomized|Crossover Assignment||Treatment||Double||In order to achieve steady-state concentrations, participants (n=8 men) were administered placebo and aripiprazole (15 mg/day) capsules in counter-balanced order for 21 days. A smoked cocaine dose-response curve (0, 12, 25, 50 mg) was determined twice under placebo and aripiprazole maintenance.|t||t|
1545973|NCT00373867|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1545974|NCT00373854|||Case Control||Prospective|||||||
1545975|NCT00373841|||Cohort||Other|||||||
1545976|NCT00373828|||Cohort||Prospective|||||||
1545977|NCT00373815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545978|NCT00373802|Randomized|Single Group Assignment||Treatment||Double||||||
1545979|NCT00373789|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1545980|NCT00373776|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545981|NCT00373763|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1545982|NCT00373750|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1545983|NCT00373737|||Cohort||Prospective|||||||
1545984|NCT00373724|Randomized|Crossover Assignment||Treatment||Single||||||
1545985|NCT00373711|||Cohort||Prospective|||||||
1545986|NCT00373698|Randomized|Parallel Assignment||Treatment||Single||||||t
1545987|NCT00373685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545988|NCT00373672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1545989|NCT00373659||Single Group Assignment||Treatment||None (Open Label)||||||
1545990|NCT00373646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545991|NCT00373633|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1545992|NCT00373620|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545993|NCT00373607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1545994|NCT00373594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545995|NCT00373581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1545996|NCT00373568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1545997|NCT00373555|Randomized|Parallel Assignment||Diagnostic||Single||||||
1545998|NCT00373542|Randomized|Parallel Assignment||Treatment||Double||||||
1545999|NCT00373529||Single Group Assignment||Treatment||None (Open Label)||||||
1546000|NCT00373516|Randomized|Parallel Assignment||Treatment||Double||||||
1546001|NCT00373503||Single Group Assignment||Basic Science||Double|||t||t|
1546002|NCT00373490|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546003|NCT00373477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546004|NCT00373464|Randomized|Single Group Assignment||Treatment||Double||||||
1546005|NCT00373451|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546006|NCT00373438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546007|NCT00373425|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546008|NCT00373412|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546009|NCT00373399|Randomized|Crossover Assignment||Basic Science||Double|Double-blind, placebo-controlled||t||t|
1546010|NCT00373386||Single Group Assignment||Treatment||None (Open Label)||||||
1546011|NCT00373373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546012|NCT00373360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546013|NCT00373347|||Cohort||Prospective|||||||
1546014|NCT00373334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546015|NCT00373308|||Cohort||Retrospective|||||||
1546016|NCT00373295|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1546017|NCT00373282|Randomized|Parallel Assignment||Treatment||Single||||||
1546018|NCT00373269|||Cohort||Prospective|||||||
1546019|NCT00373256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546020|NCT00373243|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546021|NCT00373230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546022|NCT00373217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546023|NCT00373204||Single Group Assignment||Treatment||None (Open Label)||||||
1546024|NCT00373191|||Cohort||Prospective|||||||
1546025|NCT00373178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546026|NCT00373165|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546027|NCT00373152||Single Group Assignment||Diagnostic||None (Open Label)||||||
1546028|NCT00373139|||Case Control||Prospective|||||||
1546029|NCT00373126|Randomized|Crossover Assignment||Treatment||Double||||||
1546030|NCT00373113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546031|NCT00373100|Randomized|Parallel Assignment||Treatment||Double||||||
1546032|NCT00373087|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1546033|NCT00373074|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546034|NCT00373061|||Cohort||Prospective|||||||
1546035|NCT00373048|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546036|NCT00373035||||||||||||
1546037|NCT00373022|Randomized|||Supportive Care||||||||
1546038|NCT00373009|Randomized|Single Group Assignment||Prevention||Single||||||t
1546039|NCT00372996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546040|NCT00372983|Randomized|Factorial Assignment||Treatment||Double||||||
1546041|NCT00372970|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546042|NCT00372957|Randomized|Parallel Assignment||Treatment||||||||
1546043|NCT00372944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546044|NCT00372931|Randomized|Parallel Assignment||Treatment||Double||||||
1546045|NCT00372918|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546046|NCT00372905||Single Group Assignment||Treatment||None (Open Label)||||||
1546047|NCT00372892|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546048|NCT00372879|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1546049|NCT00372853|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546050|NCT00372840|Randomized|Parallel Assignment||||None (Open Label)||||||
1546051|NCT00372827|Randomized|Parallel Assignment||Treatment||Double||||||
1546052|NCT00372814|Randomized|Parallel Assignment||Treatment||Single||||||t
1546053|NCT00372801|Randomized|Crossover Assignment||Treatment||Double||||||
1546054|NCT00372788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546055|NCT00372775|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546056|NCT00372762|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1546057|NCT00372749|Randomized|Crossover Assignment||Treatment||Single|||||t|
1546058|NCT00372736||Single Group Assignment||Treatment||None (Open Label)||||||
1546059|NCT00372723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546060|NCT00372710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546061|NCT00372697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546062|NCT00372684|||||Prospective|||||||
1546063|NCT00372671|Randomized|Parallel Assignment||Other||Single||||||
1546064|NCT00372658|Randomized|Parallel Assignment||Treatment||Double||||||
1546065|NCT00372645|Randomized|Parallel Assignment||||Triple|||t||t|t
1546066|NCT00372632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546067|NCT00372619|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546068|NCT00372606|Randomized|Parallel Assignment||Prevention||Single||||||
1546069|NCT00372593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546070|NCT00372580|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1546071|NCT00372567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546072|NCT00372541|Randomized|Parallel Assignment||Treatment||Double||||||
1546073|NCT00372528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546074|NCT00372515||Single Group Assignment||Treatment||None (Open Label)||||||
1546075|NCT00372502|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546076|NCT00372489||Single Group Assignment||Treatment||None (Open Label)||||||
1546077|NCT00372476||Single Group Assignment||Treatment||None (Open Label)||||||
1546078|NCT00372463|Randomized|Factorial Assignment||||None (Open Label)||||||
1546079|NCT00372450|Randomized|||Supportive Care||||||||
1546080|NCT00372437|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546081|NCT00372424|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546082|NCT00372411|Randomized|Parallel Assignment||Treatment||Single||||||t
1546083|NCT00372398|||Case Control||Cross-Sectional|||||||
1546084|NCT00372385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546085|NCT00372372|Randomized|Parallel Assignment||Treatment||Double||||||
1546086|NCT00372359|||Case-Only||Prospective|||||||
1546087|NCT00372346|Randomized|Parallel Assignment||Treatment||Double||||||
1546088|NCT00372333|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546089|NCT00372320||||Treatment||||||||
1546090|NCT00372307|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546091|NCT00372294|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546092|NCT00372281|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546093|NCT00372268|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546094|NCT00372255|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546095|NCT00372242|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546096|NCT00372229|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546097|NCT00372216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546098|NCT00372203||Single Group Assignment||Diagnostic||None (Open Label)||||||
1546099|NCT00372190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546100|NCT00372177|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546101|NCT00372164|||Case Control||Retrospective|||||||
1546102|NCT00372151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546103|NCT00372138|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546104|NCT00372125|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546105|NCT00372112|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546106|NCT00372099|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546107|NCT00372086|Randomized|Crossover Assignment||Treatment||Double||||||
1546108|NCT00372073|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546109|NCT00372060|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546110|NCT00372047|||||Retrospective|||||||
1546111|NCT00372034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546112|NCT00372021|Randomized|Parallel Assignment||Treatment||Single||||||
1546113|NCT00372008|Randomized|Crossover Assignment||||None (Open Label)||||||
1546114|NCT00371995|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546115|NCT00371982|Randomized|Parallel Assignment||Treatment||Double||||||
1546116|NCT00371969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546117|NCT00371956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546118|NCT00371943|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546119|NCT00371930|Randomized|Parallel Assignment||||Single||||||
1546120|NCT00371904|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546121|NCT00371891|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546122|NCT00371878|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546123|NCT00371865|Randomized|Parallel Assignment||Treatment||Single||||||t
1546124|NCT00371852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546125|NCT00371839|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546126|NCT00371826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546127|NCT00371813|Randomized|Parallel Assignment||Treatment||Double||||||
1546128|NCT00371800|Randomized|Parallel Assignment||Treatment||Double||||||
1546129|NCT00371787|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546130|NCT00371774|||Case-Only||Prospective|||||||
1546131|NCT00371761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546132|NCT00371748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546133|NCT00371735|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546134|NCT00371722|Randomized|Single Group Assignment||Prevention||Single||||||
1546135|NCT00371709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546136|NCT00371696|Randomized|Crossover Assignment||Health Services Research||Double||||||
1546137|NCT00371683|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546138|NCT00371670|Randomized|Parallel Assignment||Treatment||Double||||||
1546139|NCT00371657|||||Retrospective|||||||
1546140|NCT00371644|Randomized|Parallel Assignment||Treatment||Single||||||t
1546141|NCT00371631|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546142|NCT00371618|||Case-Only||Retrospective|||||||
1546143|NCT00371605|||||Prospective|||||||
1546144|NCT00371592|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1546145|NCT00371579|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546146|NCT00371566|Randomized|Parallel Assignment||Treatment||Single||||||
1546147|NCT00371553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546148|NCT00371540|Randomized|Parallel Assignment||Treatment||Single||||t||
1546149|NCT00371527|Randomized|Parallel Assignment||Treatment||Double||||||
1546150|NCT00371501|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546151|NCT00371488|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546152|NCT00371475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546153|NCT00371462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546154|NCT00371449|||Cohort||Prospective|||||||
1546155|NCT00371436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546156|NCT00371423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546157|NCT00371410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546158|NCT00371397|Randomized|Crossover Assignment||Treatment||Single|||||t|
1546159|NCT00371384|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546160|NCT00371371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546161|NCT00371345|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546162|NCT00371332|Randomized|Parallel Assignment||Treatment||Single||||||
1546163|NCT00371319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546164|NCT00371306|Randomized|Single Group Assignment||Treatment||Single||||||
1546165|NCT00371293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546166|NCT00371280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546167|NCT00371267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546168|NCT00371254|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546169|NCT00371241|||Cohort||Prospective|||||||
1546170|NCT00371228|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1546171|NCT00371215|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546172|NCT00371202|Randomized|Parallel Assignment||Treatment||Single||||||
1546173|NCT00371189|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1546174|NCT00371176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546175|NCT00371163|||Case Control||Prospective|||||||
1546176|NCT00371150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546177|NCT00371137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546178|NCT00371124|Randomized|Parallel Assignment||Treatment||Double||||||
1546179|NCT00371111|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546180|NCT00371098|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546181|NCT00371085|Randomized|Parallel Assignment||||None (Open Label)||||||
1546182|NCT00371072|Randomized|Parallel Assignment||Treatment||Single||||||
1546183|NCT00371059|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1546184|NCT00371046|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1546185|NCT00371033|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1546186|NCT00371020|Randomized|Parallel Assignment||Treatment||Double||||||
1546187|NCT00371007|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546188|NCT00370994|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1546189|NCT00370981|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546190|NCT00370968|Randomized|Parallel Assignment||Treatment||Double||||||
1546191|NCT00370955|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546192|NCT00370942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546193|NCT00370929||Single Group Assignment||Treatment||None (Open Label)||||||
1546194|NCT00370916|Non-Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1546195|NCT00370903|||||Retrospective|||||||
1546196|NCT00370890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546197|NCT00370877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546198|NCT00370864|Randomized|Parallel Assignment||Prevention||Double||||||
1546199|NCT00370851|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1546200|NCT00370838|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1546201|NCT00370825|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546202|NCT00370812|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546203|NCT00370799|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1546204|NCT00370786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546205|NCT00370773|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1546206|NCT00370760|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1546207|NCT00370747|Randomized|Parallel Assignment||Treatment||Double||||||
1546208|NCT00370734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546209|NCT00370721|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546210|NCT00370708|Randomized|Single Group Assignment||Supportive Care||Single||||||
1546211|NCT00370695||Single Group Assignment||Treatment||None (Open Label)||||||
1546212|NCT00370682|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546213|NCT00370669|Randomized|Parallel Assignment||Treatment||Single||||||
1546214|NCT00370656|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546215|NCT00370643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546216|NCT00370630|Randomized|Parallel Assignment||Treatment||Single||||||
1546217|NCT00370617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546218|NCT00370604|Randomized|Parallel Assignment||Prevention||Single||||||t
1546219|NCT00370591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546220|NCT00370578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546221|NCT00370565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546222|NCT00370552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546223|NCT00370539|Randomized|Parallel Assignment||Treatment||Single||||||
1546224|NCT00370526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546225|NCT00370513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546226|NCT00370500|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546227|NCT00370487|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1546228|NCT00370474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546229|NCT00370461|||Case-Only||Prospective|||||||
1546230|NCT00370448|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546231|NCT00370435|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546232|NCT00370422|Randomized|Parallel Assignment||Treatment||Single||||||
1546233|NCT00370409|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1546234|NCT00370396|Randomized|Parallel Assignment||Prevention||||||||
1546235|NCT00370383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546236|NCT00370370|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546237|NCT00370357|Randomized|Parallel Assignment||Prevention||Double||||||
1546238|NCT00370344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546239|NCT00370331|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546240|NCT00370318|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546241|NCT00370305||Single Group Assignment||Treatment||None (Open Label)||||||
1546242|NCT00370292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546243|NCT00370279|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546244|NCT00370266|Randomized|Parallel Assignment||Treatment||Single||||||
1546245|NCT00370253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546246|NCT00370240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546247|NCT00370227|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546248|NCT00370214|||Cohort||Prospective|||||||
1546249|NCT00370201|Randomized|Parallel Assignment||Treatment||Double||||||
1546250|NCT00370188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546251|NCT00370162|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546252|NCT00370149|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546253|NCT00370136|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1546254|NCT00370123|||Cohort||Prospective|||||||
1546255|NCT00370110|Randomized|Parallel Assignment||Treatment||Double||||||
1546256|NCT00370097|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546257|NCT00370084|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1546258|NCT00370071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546259|NCT00370058|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546260|NCT00370045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546261|NCT00370032|Randomized|Crossover Assignment||Treatment||Double||||||
1546262|NCT00370019||||Treatment||||||||
1546263|NCT00370006|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546264|NCT00369993|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546265|NCT00369980|||Defined Population|Screening|Longitudinal, Prospective|||||||
1546266|NCT00369967|Randomized|Parallel Assignment||Prevention||Single|||||t|
1546267|NCT00369954||||Treatment||||||||
1546268|NCT00369941|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546269|NCT00369928|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546270|NCT00369915|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1546271|NCT00369902|||Case-Only||Prospective|||||||
1546272|NCT00369889||Single Group Assignment||Treatment||None (Open Label)||||||
1546273|NCT00369876|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1546274|NCT00369863|Randomized|Parallel Assignment||Treatment||Single||||||
1546275|NCT00369850|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546276|NCT00369837||Single Group Assignment||Treatment||None (Open Label)||||||
1546277|NCT00369824|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546278|NCT00369811|Randomized|Parallel Assignment||Treatment||Double||||||
1546279|NCT00369798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546280|NCT00369785|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1546281|NCT00369772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546282|NCT00369759|||Cohort||Prospective|||||||
1546283|NCT00369746|||Case Control||Prospective|||||||
1546284|NCT00369733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546285|NCT00369720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546286|NCT00369707||Single Group Assignment||Treatment||None (Open Label)||||||
1546287|NCT00369694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546288|NCT00369681||Single Group Assignment||Treatment||None (Open Label)||||||
1546289|NCT00369668|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1546290|NCT00369655||Single Group Assignment||Treatment||None (Open Label)||||||
1546291|NCT00369642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546292|NCT00369629|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546293|NCT00369616|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546294|NCT00369603|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546295|NCT00369590||Single Group Assignment||Treatment||None (Open Label)||||||
1546296|NCT00369577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546297|NCT00369564|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1546298|NCT00369551||Single Group Assignment||Treatment||None (Open Label)||||||
1546299|NCT00369538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546300|NCT00369512||Single Group Assignment||Treatment||None (Open Label)||||||
1546301|NCT00369499|Randomized|Parallel Assignment||Treatment||Double||||||
1546302|NCT00369486|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546303|NCT00369473|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1546304|NCT00369460|||Cohort||Prospective|||||||
1546305|NCT00369447|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546306|NCT00369434|Randomized|Single Group Assignment||Treatment||Double||||||
1546307|NCT00369421|||Other||Prospective|||||||
1546308|NCT00369408|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546309|NCT00369395||Single Group Assignment||Treatment||None (Open Label)||||||
1546310|NCT00369382|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546311|NCT00369356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546312|NCT00369343|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546313|NCT00369330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546314|NCT00369317||Single Group Assignment||Treatment||None (Open Label)||||||
1546315|NCT00369304|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546316|NCT00369291||Single Group Assignment||Treatment||None (Open Label)||||||
1546317|NCT00369278|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546318|NCT00369265|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546319|NCT00369252|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546320|NCT00369239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546321|NCT00369226||Single Group Assignment||Prevention||None (Open Label)||||||
1546322|NCT00369213|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1546323|NCT00369200||Single Group Assignment||Treatment||None (Open Label)||||||
1546324|NCT00369187|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546325|NCT00369174||Single Group Assignment||Prevention||None (Open Label)||||||
1546326|NCT00369161|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546327|NCT00369148|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546328|NCT00369135|Randomized|Parallel Assignment||Treatment||Single|||||t|
1546329|NCT00369122||Single Group Assignment||Treatment||None (Open Label)||||||
1546330|NCT00369109||||||||||||
1546331|NCT00369096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546332|NCT00369083|Randomized|Parallel Assignment||Treatment||Single||||||
1546333|NCT00369070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546334|NCT00369057|||Cohort||Prospective|||||||
1546335|NCT00369044|Randomized|Parallel Assignment||Treatment||Double||||||
1546336|NCT00369031|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546337|NCT00369018|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546338|NCT00369005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546339|NCT00368992||Single Group Assignment||Treatment||None (Open Label)||||||
1546340|NCT00368979|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546341|NCT00368966|Randomized|Parallel Assignment||Prevention||Double||||||
1546342|NCT00368953|Randomized|Parallel Assignment||Treatment||Single||||||t
1546343|NCT00368940|Randomized|Parallel Assignment||Treatment||Single||||||t
1546344|NCT00368927|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546345|NCT00368914||||Treatment||||||||
1546346|NCT00368901|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546347|NCT00368888|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546348|NCT00368875||Single Group Assignment||Treatment||None (Open Label)||||||
1546349|NCT00368862|Randomized|Parallel Assignment||Treatment||Double||||||
1546350|NCT00368849|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1546351|NCT00368836|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1546352|NCT00368823|Randomized|Factorial Assignment||Treatment||Double||||||
1546353|NCT00368810||||||||||||
1546354|NCT00368797|Randomized|Parallel Assignment||Treatment||Double||||||
1546355|NCT00368784|||Case-Control||Prospective|||||||
1546356|NCT00368771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546357|NCT00368758|Randomized|Crossover Assignment||Treatment||Double||||||
1546358|NCT00368745|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546359|NCT00368732|||Case Control||Retrospective|||||||
1546360|NCT00368719|Randomized|Single Group Assignment||Treatment||Single|||||t|
1546361|NCT00368706|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546362|NCT00368693|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546363|NCT00368680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546364|NCT00368667|||||Prospective|||||||
1546365|NCT00368654|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546366|NCT00368641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546367|NCT00368628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546368|NCT00368615|||Case-Control||Prospective|||||||
1546369|NCT00368602|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546370|NCT00368589||||||||||||
1546371|NCT00368576|Randomized|Parallel Assignment||Diagnostic||Double||||||
1546372|NCT00368563|Randomized|Single Group Assignment||||Single||||||
1546373|NCT00368550|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546374|NCT00368537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546375|NCT00368524|Randomized|Parallel Assignment||Treatment||Single||||||
1546376|NCT00368511|Randomized|Crossover Assignment||Prevention||Double|||||t|t
1546377|NCT00368498|Randomized|Parallel Assignment||Treatment||Single||||||
1546378|NCT00368485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546379|NCT00368472||Single Group Assignment||Treatment||None (Open Label)||||||
1546380|NCT00368459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546381|NCT00368446|||||Prospective|||||||
1546382|NCT00368433||||||||||||
1546383|NCT00368420|||Cohort||Prospective|||||||
1546384|NCT00368407|Random Sample|||Screening|Longitudinal, Prospective|||||||
1546385|NCT00368394|Randomized|Crossover Assignment||Treatment||Single||||||
1546386|NCT00368381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546387|NCT00368368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546388|NCT00368355|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546389|NCT00368342|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546390|NCT00368329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546391|NCT00368316|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546392|NCT00368303|Randomized|Parallel Assignment||Treatment||Double||||||
1546393|NCT00368290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546394|NCT00368277|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546395|NCT00368264|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546396|NCT00368251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546397|NCT00368238|Randomized|Parallel Assignment||Treatment||Double||||||
1546398|NCT00368225|||||Prospective|||||||
1546399|NCT00368212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546400|NCT00368199|||Cohort||Prospective|||||||
1546401|NCT00368186|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546402|NCT00368173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546403|NCT00368160|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1546404|NCT00368147|||Cohort||Prospective|||||||
1546405|NCT00368134|Randomized|Parallel Assignment||Treatment||Double||||||
1546406|NCT00368121||Single Group Assignment||Treatment||None (Open Label)||||||
1546407|NCT00368108|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546408|NCT00368095|||Cohort||Prospective|||||||
1546409|NCT00368082||Single Group Assignment||Treatment||None (Open Label)||||||
1546410|NCT00368069|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546411|NCT00368056|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1546412|NCT00368043||||||||||||
1546413|NCT00368030|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546414|NCT00368017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546415|NCT00368004||||||||||||
1546416|NCT00367991|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546417|NCT00367978|Randomized|Parallel Assignment||Treatment||Double||||||
1546418|NCT00367965|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1546419|NCT00367952|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546420|NCT00367939|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546421|NCT00367926|Randomized|Crossover Assignment||Treatment||Double||||||
1546422|NCT00367913|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1546423|NCT00367900|||Cohort||Prospective|||||||
1546424|NCT00367887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546425|NCT00367874|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546426|NCT00367861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546427|NCT00367848|||||Prospective|||||||
1546428|NCT00367835|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546429|NCT00367822|Randomized|Parallel Assignment||Treatment||Double||||||
1546430|NCT00367809|Randomized|Parallel Assignment||||None (Open Label)||||||
1546431|NCT00367796||||||||||||
1546432|NCT00367783|Randomized|Parallel Assignment||Treatment||Single||||||
1546433|NCT00367770|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546434|NCT00367757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546435|NCT00367744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546436|NCT00367731|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1546437|NCT00367718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546438|NCT00367705|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1546439|NCT00367692|Randomized|Crossover Assignment||||Double||||||
1546440|NCT00367679|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546441|NCT00367666||Single Group Assignment||Diagnostic||None (Open Label)||||||
1546442|NCT00367653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546443|NCT00367640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546444|NCT00367627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546445|NCT00367614|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546446|NCT00367601||Single Group Assignment||Treatment||None (Open Label)||||||
1546447|NCT00367588|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546448|NCT00367575|Randomized|Parallel Assignment||Treatment||Single||||||
1546449|NCT00367562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546450|NCT00367549|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546451|NCT00367536||||||||||||
1546452|NCT00367523||||||||||||
1546453|NCT00367497|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546454|NCT00367484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546455|NCT00367471|Non-Randomized|||Treatment||None (Open Label)||||||
1546456|NCT00367458|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1546457|NCT00367445|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546458|NCT00367432||Single Group Assignment||Treatment||None (Open Label)||||||
1546459|NCT00367419|Randomized|Single Group Assignment||Treatment||Double||||||
1546460|NCT00367406|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546461|NCT00367393|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546462|NCT00367380|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1546463|NCT00367367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546464|NCT00367354|||Case Control||Prospective|||||||
1546465|NCT00367341|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546466|NCT00367328|Randomized|Parallel Assignment||Treatment||Single||||||t
1546467|NCT00367315|Randomized|Parallel Assignment||Treatment||Double||||||
1546468|NCT00367302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546469|NCT00367289|||Cohort||Prospective|||||||
1546470|NCT00367276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546471|NCT00367263|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546472|NCT00367250|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546473|NCT00367237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546474|NCT00367224||||||||||||
1546475|NCT00367211|Randomized|Parallel Assignment||Prevention||Double||||||
1546476|NCT00367198|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546477|NCT00367185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546478|NCT00367172|Randomized|Parallel Assignment||||None (Open Label)||||||
1546479|NCT00367159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546480|NCT00367146|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546481|NCT00367133|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546482|NCT00367120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546483|NCT00367107|||Cohort||Prospective|||||||
1546484|NCT00367094|Randomized|Parallel Assignment||Treatment||Double||||||
1546485|NCT00367081|Randomized|Parallel Assignment||Treatment||Single||||||
1546486|NCT00367068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546487|NCT00367055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546488|NCT00367042|Randomized|Single Group Assignment||||Single|||||t|
1546489|NCT00367029|Randomized|Parallel Assignment||Treatment||Single||||||t
1546490|NCT00367016|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1546491|NCT00367003||Single Group Assignment||Treatment||None (Open Label)||||||
1546492|NCT00366990|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546493|NCT00366977|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1546494|NCT00366964|Non-Randomized|Single Group Assignment||Treatment||Single||||||t
1546495|NCT00366951|Randomized|Single Group Assignment||Treatment||Single||||||
1546496|NCT00366938|Randomized|Parallel Assignment||Treatment||Double||||||
1546497|NCT00366925|Randomized|Parallel Assignment||||None (Open Label)||||||
1546498|NCT00366912|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546499|NCT00366899|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546500|NCT00366886|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1546501|NCT00366873|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1546502|NCT00366860|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1546503|NCT00366847|||Cohort||Retrospective|||||||
1546504|NCT00366834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546505|NCT00366821|||||Retrospective|||||||
1546506|NCT00366808|Randomized|Single Group Assignment||Treatment||Single||||||
1546507|NCT00366795|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546508|NCT00366782|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1546509|NCT00366769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546510|NCT00366756|||||Prospective|||||||
1546511|NCT00366743|Randomized|Parallel Assignment||Treatment||Double||||||
1546512|NCT00366730|Randomized|Single Group Assignment||Treatment||Double||||||
1546513|NCT00366717|||Defined Population|Screening|Longitudinal, Prospective|||||||
1546514|NCT00366704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546515|NCT00366691|Randomized|Parallel Assignment||Treatment||Double||||||
1546516|NCT00366678|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546517|NCT00366665|Randomized|Parallel Assignment||Treatment||Double||||||
1546518|NCT00366652|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546519|NCT00366639|||Cohort||Prospective|||||||
1546520|NCT00366626|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546521|NCT00366613|Randomized|Parallel Assignment||Treatment||Double||||||
1546522|NCT00366600|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546523|NCT00366587|Randomized|Parallel Assignment||Treatment||Single||||||
1546524|NCT00366574|Randomized|Parallel Assignment||Treatment||Double||||||
1546525|NCT00366561|||||Retrospective|||||||
1546526|NCT00366548|Randomized|Parallel Assignment||Prevention||Double||||||
1546527|NCT00366535|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1546528|NCT00366522|Randomized|Parallel Assignment||Treatment||Double||||||
1546529|NCT00366509|||Case-Control||Prospective|||||||
1546530|NCT00366496|Randomized|Parallel Assignment||Treatment||Double||||||
1546531|NCT00366483|Randomized|Parallel Assignment||Treatment||Double||||||
1546532|NCT00366470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546533|NCT00366457||Single Group Assignment||Treatment||None (Open Label)||||||
1546534|NCT00366444|Randomized|Parallel Assignment||Treatment||Double||||||
1546536|NCT00366418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546537|NCT00366405|||Case Control||Retrospective|||||||
1546538|NCT00366392|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546539|NCT00366379|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546540|NCT00366366|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546541|NCT00366353|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1546542|NCT00366340|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546543|NCT00366327|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546544|NCT00366314|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1546545|NCT00366301|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1546546|NCT00366288|||Cohort|||||||||
1546547|NCT00366275|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546548|NCT00366262|Randomized|Parallel Assignment||Treatment||Double||||||
1546549|NCT00366249|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546550|NCT00366236|Randomized|Single Group Assignment||Treatment||Double||||||
1546551|NCT00366223|||Other||Retrospective|||||||
1546552|NCT00366210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546553|NCT00366197|||||Prospective|||||||
1546554|NCT00366184||||||||||||
1546555|NCT00366171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546556|NCT00366158|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546557|NCT00366145|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546558|NCT00366132|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546559|NCT00366119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546560|NCT00366106||Single Group Assignment||Treatment||None (Open Label)||||||
1546561|NCT00366093|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1546562|NCT00366080|Randomized|Parallel Assignment||Treatment||Double||||||
1546563|NCT00366067|Randomized|Parallel Assignment||Treatment||Double||||||
1546564|NCT00366041|Randomized|Single Group Assignment||Treatment||Single||||||t
1546565|NCT00366028|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1546566|NCT00366015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546567|NCT00366002|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546568|NCT00365989||Single Group Assignment||Treatment||None (Open Label)||||||
1546569|NCT00365976|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546570|NCT00365963|Randomized|Factorial Assignment||||None (Open Label)||||||
1546571|NCT00365950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546572|NCT00365937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546573|NCT00365924|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1546574|NCT00365911|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546575|NCT00365898|Randomized|Parallel Assignment||Treatment||Double||||||
1546576|NCT00365885|Randomized|Factorial Assignment||Treatment||Single|||t|||
1546577|NCT00365872||Single Group Assignment||Treatment||None (Open Label)||||||
1546578|NCT00365859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546579|NCT00365846||Single Group Assignment||Prevention||None (Open Label)||||||
1546580|NCT00365833|||Cohort||Prospective|||||||
1546581|NCT00365820|Randomized|Parallel Assignment||Treatment||Double||||||
1546582|NCT00365807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546583|NCT00365794||Single Group Assignment||Treatment||None (Open Label)||||||
1546584|NCT00365781|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546585|NCT00365768|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1546586|NCT00365755|Randomized|||Treatment||||||||
1546587|NCT00365742|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546588|NCT00365729|||Case-Crossover||Prospective|||||||
1546589|NCT00365716|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546590|NCT00365703|Randomized|Parallel Assignment||||None (Open Label)||||||
1546591|NCT00365690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546592|NCT00365677|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546593|NCT00365651|Randomized|Parallel Assignment||Treatment||Double||||||
1546594|NCT00365638|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546595|NCT00365625|||||Prospective|||||||
1546596|NCT00365612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546597|NCT00365599||Single Group Assignment||Treatment||None (Open Label)||||||
1546598|NCT00365586|Randomized|Parallel Assignment||Treatment||Double||||||
1546599|NCT00365573|||Cohort||Prospective|||||||
1546600|NCT00365560|Randomized|Crossover Assignment||Treatment||Double||||||
1546601|NCT00365547||Single Group Assignment||Treatment||None (Open Label)||||||
1546602|NCT00365534|Randomized|Crossover Assignment||Diagnostic||Double||||||
1546603|NCT00365521|Randomized|Single Group Assignment||||Single||||||
1546604|NCT00365508|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1546605|NCT00365495|Randomized|Single Group Assignment||Treatment||Single||||||
1546606|NCT00365482|||Case-Only||Prospective|||||||
1546607|NCT00365469|Randomized|Parallel Assignment||Prevention||Single||||t||
1546608|NCT00365456|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546609|NCT00365443|Randomized|Parallel Assignment||Prevention||Double||||||
1546610|NCT00365430|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546611|NCT00365417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546612|NCT00365404|Randomized|Single Group Assignment||||Single||||||
1546613|NCT00365391||Single Group Assignment||Treatment||None (Open Label)||||||
1546614|NCT00365378|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546615|NCT00365365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546616|NCT00365352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546617|NCT00365339|Randomized|Parallel Assignment||||None (Open Label)||||||
1546618|NCT00365326|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546619|NCT00365313|Randomized|Parallel Assignment||Treatment||Double||||||
1546620|NCT00365300|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546621|NCT00365287||||Treatment||None (Open Label)||||||
1546622|NCT00365274||Single Group Assignment||Treatment||None (Open Label)||||||
1546623|NCT00365261|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546624|NCT00365248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546625|NCT00365235|||Family-Based||Cross-Sectional|||||||
1546626|NCT00365222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546627|NCT00365209|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546628|NCT00365196|Randomized|Factorial Assignment||Treatment||Single||||||
1546629|NCT00365183||Single Group Assignment||Treatment||None (Open Label)||||||
1546630|NCT00365170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546631|NCT00365157||Single Group Assignment||Treatment||None (Open Label)||||||
1546632|NCT00365144||Single Group Assignment||Treatment||None (Open Label)||||||
1546633|NCT00365131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546634|NCT00365118|Randomized|Single Group Assignment||Treatment||Single||||||
1546635|NCT00365105|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1546636|NCT00365092|Randomized|Parallel Assignment||Treatment||Single||||||
1546637|NCT00365053||Single Group Assignment||Treatment||None (Open Label)||||||
1546638|NCT00365040|Randomized|Parallel Assignment||Treatment||Double||||||
1546639|NCT00365027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546640|NCT00365014|||Cohort||Cross-Sectional|||||||
1546641|NCT00365001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546642|NCT00364988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546643|NCT00364975|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546644|NCT00364962|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1546645|NCT00364949|||Case Control||Prospective|||||||
1546646|NCT00364936|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546647|NCT00364923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546648|NCT00364910|Randomized|Parallel Assignment||Treatment||Single||||||t
1546649|NCT00364897|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1546650|NCT00364884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546651|NCT00364871|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1546652|NCT00364858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546653|NCT00364845|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546654|NCT00364832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546655|NCT00364819||Single Group Assignment||Treatment||None (Open Label)||||||
1546656|NCT00364806|Randomized|Parallel Assignment||Treatment||Double||||||
1546657|NCT00364793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546658|NCT00364780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546659|NCT00364767|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1546660|NCT00364754||Single Group Assignment||Treatment||None (Open Label)||||||
1546661|NCT00364741|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1546662|NCT00364728|||Case Control||Retrospective|||||||
1546663|NCT00364715|||Case Control|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1546664|NCT00364702|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1546665|NCT00364689|Randomized|Parallel Assignment||Treatment||Double||||||
1546666|NCT00364676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546667|NCT00364663|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1546668|NCT00364650|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546669|NCT00364637|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1546670|NCT00364624|||Cohort||Prospective|||||||
1546671|NCT00364611|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546672|NCT00364598|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1546673|NCT00364585|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546674|NCT00364572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546675|NCT00364559|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1546676|NCT00364546|Randomized|Parallel Assignment||Treatment||Double||||||
1546677|NCT00364533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546678|NCT00364520|||Ecologic or Community||Cross-Sectional|||||||
1546679|NCT00364507|||Case Control||Cross-Sectional, Prospective|||||||
1546680|NCT00364494|Randomized|Parallel Assignment||Prevention||Double||||||
1546681|NCT00364481|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546682|NCT00364468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546683|NCT00364455|Randomized|Parallel Assignment||Treatment||Double||||||
1546684|NCT00364442|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1546685|NCT00364429|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1546686|NCT00364416|||Cohort||Prospective|||||||
1546687|NCT00364403|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546688|NCT00364390|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546689|NCT00364377|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546690|NCT00364364|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1546691|NCT00364351|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546692|NCT00364338|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546693|NCT00364325|||Cohort||Prospective|||||||
1546694|NCT00364312|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546695|NCT00364299|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546696|NCT00364286||Single Group Assignment||Treatment||None (Open Label)||||||
1546697|NCT00364273|Randomized|Single Group Assignment||Treatment||||||||
1546698|NCT00364260|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546699|NCT00364247|Randomized|Parallel Assignment||Treatment||Double||||||
1546700|NCT00364234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546701|NCT00364221|Randomized|Parallel Assignment||Treatment||Double||||||
1546702|NCT00364195|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546703|NCT00364182|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1546704|NCT00364169|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1546705|NCT00364156|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546706|NCT00364143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546707|NCT00364130|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546708|NCT00364117|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546709|NCT00364104|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1546710|NCT00364091|Randomized|Parallel Assignment||Treatment||Double||||||
1546711|NCT00364078|||||Cross-Sectional|||||||
1546712|NCT00364065|Randomized|Parallel Assignment||Treatment||Double||||||
1546713|NCT00364052|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1546714|NCT00364039|Randomized|Parallel Assignment||||Double||||||
1546715|NCT00364026|Randomized|Parallel Assignment||Treatment||Double||||||
1546716|NCT00364013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546717|NCT00364000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546718|NCT00363987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546719|NCT00363974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546720|NCT00363961|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546721|NCT00363948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546722|NCT00363935|Randomized|Parallel Assignment||||Double||||||
1546723|NCT00363922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546724|NCT00363909|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1546725|NCT00363896|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546726|NCT00363883||Single Group Assignment||Treatment||None (Open Label)||||||
1546727|NCT00363870|Randomized|Parallel Assignment||Prevention||Double||||||
1546728|NCT00363857|Randomized|Parallel Assignment||Treatment||Double||||||
1546729|NCT00363844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546730|NCT00363831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546731|NCT00363818|||Cohort||Prospective|||||||
1546732|NCT00363805|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546733|NCT00363792|Randomized|Crossover Assignment||Educational/Counseling/Training||Double||||||
1546734|NCT00363779|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546735|NCT00363766||Single Group Assignment||Treatment||None (Open Label)||||||
1546736|NCT00363753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546737|NCT00363740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546738|NCT00363727|Randomized|Parallel Assignment||Treatment||Double||||||
1546739|NCT00363714|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546740|NCT00363701|Randomized|Parallel Assignment||Treatment||Double||||||
1546741|NCT00363688|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546742|NCT00363675|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546743|NCT00363662|||Cohort||Prospective|||||||
1546744|NCT00363649|Randomized|Crossover Assignment||Treatment||None (Open Label)||Participants were randomly assigned to Arm A or Arm B and received up to twelve months of protocol therapy. If at any point a participant progressed, relapsed, or had unacceptable toxicity, they could cross over to the other arm. Participants could only cross over once.||||
1546745|NCT00363636|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546746|NCT00363623|Randomized|Single Group Assignment||Treatment||Single||||||
1546747|NCT00363610|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546748|NCT00363597||Single Group Assignment||Diagnostic||Single||||||t
1546749|NCT00363584|Randomized|||Treatment||||||||
1546750|NCT00363571|Randomized|Crossover Assignment||Educational/Counseling/Training||Double||||||
1546751|NCT00363558|Random Sample||Natural History||Longitudinal, Retrospective|||||||
1546752|NCT00363545|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546753|NCT00363532|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1546754|NCT00363519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546755|NCT00363506|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546756|NCT00363480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546757|NCT00363467||Single Group Assignment||Other||None (Open Label)||||||
1546758|NCT00363454||Single Group Assignment||Treatment||None (Open Label)||||||
1546759|NCT00363441|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546760|NCT00363428|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1546761|NCT00363415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546762|NCT00363402|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1546763|NCT00363389|Randomized|Parallel Assignment||Treatment||Double||||||
1546764|NCT00363376|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546765|NCT00363363|Randomized|Parallel Assignment||Treatment||Single||||||t
1546766|NCT00363350|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1546767|NCT00363337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546768|NCT00363324|Randomized|Parallel Assignment||Treatment||Double||||||
1546769|NCT00363311|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546770|NCT00363298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546771|NCT00363285|Randomized|||Treatment||||||||
1546772|NCT00363272||Single Group Assignment||Treatment||None (Open Label)||||||
1546773|NCT00363259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546774|NCT00363246|||Cohort||Prospective|||||||
1546775|NCT00363233|Randomized|Crossover Assignment||Treatment||Double||||||
1546776|NCT00363220|||||Retrospective|||||||
1546777|NCT00363207|||Case-Crossover||Prospective|||||||
1546778|NCT00363194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546779|NCT00363181|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1546780|NCT00363168|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546781|NCT00363155|Randomized|Parallel Assignment||Treatment||Double||||||
1546782|NCT00363142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546783|NCT00363129|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1546784|NCT00363116|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546785|NCT00363090||||Treatment||None (Open Label)||||||
1546786|NCT00363077|Randomized|Parallel Assignment||Prevention||Single|||t|||
1546787|NCT00363051||Single Group Assignment||Treatment||None (Open Label)||||||
1546788|NCT00363038|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1546789|NCT00363025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546790|NCT00363012|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546791|NCT00362999|||||Prospective|||||||
1546792|NCT00362986|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1546793|NCT00362973|||Case-Only||Prospective|||||||
1546794|NCT00362960|Randomized|Parallel Assignment||Treatment||Double||||||
1546795|NCT00362947|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546796|NCT00362934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546797|NCT00362921||Single Group Assignment||Treatment||None (Open Label)||||||
1546798|NCT00362908|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1546799|NCT00362895|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546800|NCT00362882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546801|NCT00362869|Randomized|Parallel Assignment||||Double||||||
1546802|NCT00362856|Randomized|Parallel Assignment||Treatment||Double|double-blind|randomized, double-blind, placebo controlled, dose ranging, multicenter|t||t|
1546803|NCT00362843|||Cohort||Cross-Sectional|||||||
1546804|NCT00362830|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546805|NCT00362817||Single Group Assignment||Treatment||None (Open Label)||||||
1546806|NCT00362804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546807|NCT00362791|Randomized|Single Group Assignment||Prevention||Single||||||
1546808|NCT00362778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546809|NCT00362765|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546810|NCT00362752|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1546811|NCT00362739|||Case Control||Prospective|||||||
1546812|NCT00362726|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1546813|NCT00362713||Single Group Assignment||Treatment||None (Open Label)||||||
1546814|NCT00362700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546815|NCT00362687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546816|NCT00362674|||Cohort||Prospective|||||||
1546817|NCT00362661|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1546818|NCT00362648|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546819|NCT00362635|Randomized|Parallel Assignment||Treatment||Double||||||
1546820|NCT00362622|||Cohort||Prospective|||||||
1546821|NCT00362609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546822|NCT00362596|Randomized|Crossover Assignment||Prevention||Double||||||
1546823|NCT00362583|Randomized|Single Group Assignment||Treatment||Double||||||
1546824|NCT00362570||Single Group Assignment||Treatment||None (Open Label)||||||
1546825|NCT00362557|||Case-Only||Prospective|||||||
1546826|NCT00362544|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546827|NCT00362531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546828|NCT00362518|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1546829|NCT00362505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546830|NCT00362492|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546831|NCT00362479|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546832|NCT00362466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546833|NCT00362453|Randomized|Parallel Assignment||Treatment||Single||||||t
1546834|NCT00362440|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546835|NCT00362427|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546836|NCT00362414||Single Group Assignment||Treatment||None (Open Label)||||||
1546837|NCT00362401|||Cohort||Retrospective|||||||
1546838|NCT00362388|Randomized|Parallel Assignment||Treatment||Double||||||
1546839|NCT00362375|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546840|NCT00362362||||||||||||
1546841|NCT00362349||Single Group Assignment||Treatment||None (Open Label)||||||
1546842|NCT00362336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546843|NCT00362323|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546844|NCT00362310|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546845|NCT00362297|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1546846|NCT00362284|Randomized|Parallel Assignment||Other||Single||||||t
1546847|NCT00362271|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1546848|NCT00362258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546849|NCT00362245|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546850|NCT00362232|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1546851|NCT00362219|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1546852|NCT00362206|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546853|NCT00362193|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546854|NCT00362180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546855|NCT00362167||||||||||||
1546856|NCT00362141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546857|NCT00362128|||Ecologic or Community||Cross-Sectional|||||||
1546858|NCT00362115|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546859|NCT00362102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546860|NCT00362089|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546861|NCT00362076||||||||||||
1546862|NCT00362063|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1546863|NCT00362050|Randomized|Parallel Assignment||Treatment||Double||||||
1546864|NCT00362037|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546865|NCT00362024|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1546866|NCT00362011|Randomized|Crossover Assignment||Treatment||Single||||||
1546867|NCT00361998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546868|NCT00361985|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546869|NCT00361972|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546870|NCT00361959|Randomized|Parallel Assignment||Treatment||Double||||||
1546871|NCT00361946|||Cohort||Cross-Sectional|||||||
1546872|NCT00361933||Single Group Assignment||Treatment||None (Open Label)||||||
1546873|NCT00361920|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1546874|NCT00361907|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1546875|NCT00361894|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1546876|NCT00361881|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1546877|NCT00361868|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546878|NCT00361855|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546879|NCT00361842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546880|NCT00361829|||Ecologic or Community||Prospective|||||||
1546881|NCT00361816||||||||||||
1546882|NCT00361803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546883|NCT00361790|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1546884|NCT00361777||||||||||||
1546885|NCT00361751|Randomized|Parallel Assignment||Treatment||Double||||||
1546886|NCT00361738|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546887|NCT00361725|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1546888|NCT00361712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546889|NCT00361699|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546890|NCT00361686|Randomized|Parallel Assignment||Treatment||Double||||||
1546891|NCT00361673|||||Cross-Sectional|||||||
1546892|NCT00361660|Randomized|Parallel Assignment||Treatment||Single||||||
1546893|NCT00361647|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1546894|NCT00361634|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546895|NCT00361621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546896|NCT00361608|||Case Control||Prospective|||||||
1546897|NCT00361595||Single Group Assignment||Treatment||None (Open Label)||||||
1546898|NCT00361582|Randomized|Parallel Assignment||Treatment||Double||||||
1546899|NCT00361569|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546900|NCT00361556|Randomized|Parallel Assignment||||Double|||t||t|
1546901|NCT00361543|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546902|NCT00361530|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546903|NCT00361517|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1546904|NCT00361504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546905|NCT00361491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546906|NCT00361478|Randomized|Parallel Assignment||Prevention||Single||||||t
1546907|NCT00361465|||||Prospective|||||||
1546908|NCT00361452|Randomized|Parallel Assignment||Treatment||Double||||||
1546909|NCT00361439|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546910|NCT00361426|||Case Control||Prospective|||||||
1546911|NCT00361413|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1546912|NCT00361400|||Ecologic or Community||Prospective|||||||
1546913|NCT00361387|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1546914|NCT00361374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546915|NCT00361361|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546916|NCT00361348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546917|NCT00361335|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546918|NCT00361322|Randomized|Parallel Assignment||Treatment||Double||||||
1546919|NCT00361309|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546920|NCT00361296||Single Group Assignment||Treatment||None (Open Label)||||||
1546921|NCT00361283||Single Group Assignment||Screening||None (Open Label)||||||
1546922|NCT00361270|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546923|NCT00361257|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1546924|NCT00361244|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546925|NCT00361231||Single Group Assignment||Treatment||None (Open Label)||||||
1546926|NCT00361218||Single Group Assignment||Treatment||None (Open Label)||||||
1546927|NCT00361205|Randomized|Parallel Assignment||Treatment||Single||||||
1546928|NCT00361192|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1546929|NCT00361179|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1546930|NCT00361166|Randomized|Single Group Assignment||Treatment||Double||||||
1546931|NCT00361153|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546932|NCT00361140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546933|NCT00361127||Single Group Assignment||Prevention||None (Open Label)||||||
1546934|NCT00361114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546935|NCT00361101||Single Group Assignment||Treatment||None (Open Label)||||||
1546936|NCT00361088|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546937|NCT00361075|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1546938|NCT00361062|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1546939|NCT00361049||Single Group Assignment||Treatment||None (Open Label)||||||
1546940|NCT00361036|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1546941|NCT00361023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546942|NCT00361010|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546943|NCT00360997|Randomized|Parallel Assignment||Treatment||Single||||||t
1546944|NCT00360984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546945|NCT00360971|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1546946|NCT00360958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546947|NCT00360945|Non-Randomized|||Treatment||None (Open Label)||||||
1546948|NCT00360932|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546949|NCT00360919|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1546950|NCT00360906|Randomized|Parallel Assignment||Treatment||Double||||||
1546951|NCT00360893|||Cohort||Prospective|||||||
1546952|NCT00360867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546953|NCT00360854|Non-Randomized|||Treatment||None (Open Label)||||||
1546954|NCT00360841|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1546955|NCT00360828||Single Group Assignment||Diagnostic||None (Open Label)||||||
1546956|NCT00360815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546957|NCT00360802|Randomized|Parallel Assignment||||Double|||t||t|
1546958|NCT00360789|Randomized|Parallel Assignment||Treatment||Single||||||
1546959|NCT00360776||Single Group Assignment||Treatment||None (Open Label)||||||
1546960|NCT00360763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546961|NCT00360750|Non-Randomized|||Treatment||None (Open Label)||||||
1546962|NCT00360737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546963|NCT00360724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546964|NCT00360711||||||||||||
1546965|NCT00360698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546966|NCT00360685|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546967|NCT00360672||Single Group Assignment||Treatment||None (Open Label)||||||
1546968|NCT00360659|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1546969|NCT00360646|||Case-Control||Retrospective|||||||
1546970|NCT00360633|||Cohort||Prospective|||||||
1546971|NCT00360607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546972|NCT00360594|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1546973|NCT00360581|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546974|NCT00360568||Single Group Assignment||Treatment||None (Open Label)||||||
1546975|NCT00360555|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546976|NCT00360529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546977|NCT00360516|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1546978|NCT00360503|||Case-Only||Prospective|||||||
1546979|NCT00360490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546980|NCT00360477|Randomized|Parallel Assignment||Treatment||Single|||t|||
1546981|NCT00360464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546982|NCT00360451|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1546983|NCT00360438|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546984|NCT00360425|Randomized|Parallel Assignment||Treatment||Double||||||
1546985|NCT00360412|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546986|NCT00360399|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1546987|NCT00360386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546988|NCT00360373|||Cohort||Prospective|||||||
1546989|NCT00360360||Single Group Assignment||Treatment||None (Open Label)||||||
1546990|NCT00360347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546991|NCT00360334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1546992|NCT00360321|||Defined Population||Longitudinal, Prospective|||||||
1546993|NCT00360308|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546994|NCT00360295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1546995|NCT00360282|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1546996|NCT00360269|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546997|NCT00360256|||||Retrospective|||||||
1546998|NCT00360243|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1546999|NCT00360230|Randomized|Parallel Assignment||Prevention||Double||||t||t
1547000|NCT00360217|Randomized|Single Group Assignment||Treatment||Double||||||
1547001|NCT00360204|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547002|NCT00360191|Randomized|Single Group Assignment||Treatment||Double||||||
1547003|NCT00360178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547004|NCT00360152|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547005|NCT00360139|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547006|NCT00360126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547007|NCT00360100|Randomized|Parallel Assignment||Treatment||Double||||||
1547008|NCT00360087||||Treatment||||||||
1547009|NCT00360074|Randomized|Crossover Assignment||Treatment||Double||||||
1547010|NCT00360061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547011|NCT00360048|||||Prospective|||||||
1547012|NCT00360035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547013|NCT00360022|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1547014|NCT00360009|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547015|NCT00359996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547016|NCT00359983|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547017|NCT00359970|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547018|NCT00359957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547019|NCT00359944|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547020|NCT00359931|||Cohort||Other|||||||
1547021|NCT00359918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547022|NCT00359905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547023|NCT00359892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547024|NCT00359879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547025|NCT00359866||Single Group Assignment||Treatment||None (Open Label)||||||
1547026|NCT00359853|Randomized|Parallel Assignment||Prevention||Double||||||
1547027|NCT00359840|Randomized|Parallel Assignment||Treatment||Double||||||
1547028|NCT00359814|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547029|NCT00359801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547030|NCT00359788||Parallel Assignment||Treatment||||||||
1547031|NCT00359775|Randomized|Single Group Assignment||||None (Open Label)||||||
1547032|NCT00359762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547033|NCT00359736|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547034|NCT00359723|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1547035|NCT00359710||||||||||||
1547036|NCT00359697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547037|NCT00359684|||Cohort||Prospective|||||||
1547038|NCT00359671|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547039|NCT00359658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547040|NCT00359645|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547041|NCT00359632|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1547042|NCT00359619|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547043|NCT00359606||Single Group Assignment||Treatment||None (Open Label)||||||
1547044|NCT00359593|Randomized|Parallel Assignment||||Single||||||
1547045|NCT00359580|||Other||Retrospective|||||||
1547046|NCT00359567|Randomized|Parallel Assignment||Treatment||Double||||||
1547047|NCT00359554|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547048|NCT00359541||||||||||||
1547049|NCT00359515||||||||||||
1547050|NCT00359489|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1547051|NCT00359476|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547052|NCT00359463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547053|NCT00359450|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547054|NCT00359437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547055|NCT00359424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547056|NCT00359411||||||||||||
1547057|NCT00359398|Randomized|Parallel Assignment||Treatment||Single|||t|||
1547058|NCT00359385|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547059|NCT00359372||||||||||||
1547060|NCT00359359||Single Group Assignment||Treatment||None (Open Label)||||||
1547061|NCT00359346||||||||||||
1547062|NCT00359333|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547063|NCT00359320||Single Group Assignment||Treatment||None (Open Label)||||||
1547064|NCT00359307||||||||||||
1547141|NCT00358306|||Cohort||Cross-Sectional|||||||
1547065|NCT00359294|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547066|NCT00359281|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547067|NCT00359268||||||||||||
1547068|NCT00359255|Randomized|Parallel Assignment||Other||Single|||t|||
1547069|NCT00359242|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1547070|NCT00359229|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547071|NCT00359216|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547072|NCT00359203|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1547073|NCT00359190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547074|NCT00359177|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547075|NCT00359164|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547076|NCT00359151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547077|NCT00359138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547078|NCT00359125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547079|NCT00359112|Randomized|Parallel Assignment||Treatment||Double||||||
1547080|NCT00359099|||||Retrospective|||||||
1547081|NCT00359086|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547082|NCT00359073|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1547083|NCT00359060|Randomized|Parallel Assignment||Prevention||Single||||||
1547084|NCT00359047|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1547085|NCT00359034|||Cohort||Prospective|||||||
1547086|NCT00359021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547087|NCT00359008|||Cohort||Prospective|||||||
1547088|NCT00358995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547089|NCT00358982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547090|NCT00358969|Non-Randomized|Parallel Assignment||Treatment||Double||||||
1547091|NCT00358956||Single Group Assignment||Treatment||None (Open Label)||||||
1547092|NCT00358943|||Cohort||Prospective|||||||
1547093|NCT00358930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547094|NCT00358917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547095|NCT00358904|||Cohort||Prospective|||||||
1547096|NCT00358891|||Case Control||Longitudinal, Prospective|||||||
1547097|NCT00358878|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547098|NCT00358865|||||Prospective|||||||
1547099|NCT00358852|||Case-Only||Cross-Sectional|||||||
1547100|NCT00358839|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1547101|NCT00358826|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547102|NCT00358813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547103|NCT00358800|Randomized|Crossover Assignment||Treatment||Single||||||
1547104|NCT00358787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547105|NCT00358774|Randomized|Parallel Assignment||Prevention||Double||||||
1547106|NCT00358761||||||||||||
1547107|NCT00358748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547108|NCT00358735|Randomized|Parallel Assignment||Prevention||Single||||||t
1547109|NCT00358722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547110|NCT00358709|Randomized|Parallel Assignment||Treatment||Single||||||
1547111|NCT00358696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547112|NCT00358683|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547113|NCT00358670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547114|NCT00358657||Single Group Assignment||Treatment||None (Open Label)||||||
1547115|NCT00358644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547116|NCT00358631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547117|NCT00358618|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1547118|NCT00358605|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547119|NCT00358592|Randomized|Parallel Assignment||Treatment||Single||||||
1547120|NCT00358579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547121|NCT00358566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547122|NCT00358553|Randomized|Crossover Assignment||||None (Open Label)||||||
1547123|NCT00358540|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1547124|NCT00358527|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547125|NCT00358514|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1547126|NCT00358501|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547127|NCT00358488|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1547128|NCT00358475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547129|NCT00358462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547130|NCT00358449|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547131|NCT00358436|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547132|NCT00358423|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1547133|NCT00358410|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1547134|NCT00358397||Single Group Assignment||Treatment||None (Open Label)||||||
1547135|NCT00358384|Randomized|Parallel Assignment||Treatment||||||||
1547136|NCT00358371|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547137|NCT00358358|Randomized|Parallel Assignment||Treatment||Double||||||
1547138|NCT00358345|||Cohort||Prospective|||||||
1547139|NCT00358332|Randomized|Parallel Assignment||Prevention||Double||||||
1547140|NCT00358319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547142|NCT00358293|Randomized|Crossover Assignment||Treatment||Double||||||
1547143|NCT00358280|Randomized|Parallel Assignment||Treatment||Double||||||
1547144|NCT00358267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547145|NCT00358254|||Cohort||Cross-Sectional|||||||
1547146|NCT00358241|Randomized|Parallel Assignment||||Double||||||
1547147|NCT00358228|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547148|NCT00358215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547149|NCT00358202|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547150|NCT00358189|||||Prospective|||||||
1547151|NCT00358176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547152|NCT00358163|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547153|NCT00358150||Single Group Assignment||Treatment||None (Open Label)||||||
1547154|NCT00358137|Randomized|Parallel Assignment||Treatment||Single|||||t|
1547155|NCT00358124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547156|NCT00358111|Non-Randomized|Single Group Assignment||Diagnostic||Triple|||t|t|t|
1547157|NCT00358098|||||Prospective|||||||
1547158|NCT00358085|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547159|NCT00358072|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547160|NCT00358059|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1547161|NCT00358046|Randomized|Parallel Assignment||Treatment||Single||||||
1547162|NCT00358033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547163|NCT00358020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547164|NCT00358007||Single Group Assignment||Supportive Care||None (Open Label)||||||
1547165|NCT00357994|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547166|NCT00357981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547167|NCT00357968|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1547168|NCT00357955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547169|NCT00357942|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547170|NCT00357929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547171|NCT00357916|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547172|NCT00357903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547173|NCT00357890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547174|NCT00357877|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1547175|NCT00357864||||Screening|Longitudinal, Prospective|||||||
1547176|NCT00357851|Randomized|Single Group Assignment||Prevention||Double||||||
1547177|NCT00357838|||||Cross-Sectional, Retrospective/Prospective|||||||
1547178|NCT00357825|Randomized|Parallel Assignment||Treatment||Double||||||
1547179|NCT00357812|||||Prospective|||||||
1547180|NCT00357799|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547181|NCT00357786||Single Group Assignment||Treatment||None (Open Label)||||||
1547182|NCT00357773|Randomized|Parallel Assignment||Treatment||Single||||||
1547183|NCT00357760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547184|NCT00357747|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547185|NCT00357734||Single Group Assignment||Treatment||None (Open Label)||||||
1547186|NCT00357721|Randomized|Crossover Assignment||||None (Open Label)||||||
1547187|NCT00357708||Single Group Assignment||Treatment||None (Open Label)||||||
1547188|NCT00357695||||||||||||
1547189|NCT00357682|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1547190|NCT00357669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547191|NCT00357656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547192|NCT00357643|Randomized|Parallel Assignment||Prevention||Double||||||
1547193|NCT00357630||||Treatment||None (Open Label)||||||
1547194|NCT00357617|Non-Randomized|||Treatment||None (Open Label)||||||
1547195|NCT00357604|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1547196|NCT00357591|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547197|NCT00357578||||||||||||
1547198|NCT00357565|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547199|NCT00357552||Single Group Assignment||Treatment||None (Open Label)||||||
1547200|NCT00357539|Randomized|Parallel Assignment||Treatment||Double||||||
1547201|NCT00357526|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547202|NCT00357513||||||||||||
1547203|NCT00357500||Single Group Assignment||Treatment||None (Open Label)||||||
1547204|NCT00357487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547205|NCT00357474|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547206|NCT00357461|Randomized|||Treatment||None (Open Label)||||||
1547207|NCT00357448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547208|NCT00357435||||||||||||
1547209|NCT00357422|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547210|NCT00357409||||||||||||
1547211|NCT00357396||Single Group Assignment||Treatment||None (Open Label)||||||
1547212|NCT00357383|Randomized|Parallel Assignment||Treatment||Double||||||
1547213|NCT00357370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547214|NCT00357357|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547215|NCT00357344||||||||||||
1547216|NCT00357331|Randomized|Parallel Assignment||Treatment||Triple||Double Blind Placebo Controlled Trial|t||t|t
1547217|NCT00357318||Single Group Assignment||Treatment||None (Open Label)||||||
1547218|NCT00357305||Single Group Assignment||Treatment||None (Open Label)||||||
1547219|NCT00357292|Randomized|Parallel Assignment||Treatment||Double||||||
1547220|NCT00357279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547221|NCT00357266||||||||||||
1547222|NCT00357253||Single Group Assignment||Treatment||None (Open Label)||||||
1547223|NCT00357240|Randomized|Parallel Assignment||||None (Open Label)||||||
1547224|NCT00357227|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1547225|NCT00357214|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1547226|NCT00357201|Randomized|Parallel Assignment||Treatment||Double||||||
1547227|NCT00357188|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1547228|NCT00357162||Single Group Assignment||Treatment||None (Open Label)||||||
1547229|NCT00357149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547230|NCT00357136|||||Retrospective|||||||
1547231|NCT00357123|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1547232|NCT00357110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547233|NCT00357097|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1547234|NCT00357084||||Supportive Care||||||||
1547235|NCT00357071||||||||||||
1547236|NCT00357058||||||||||||
1547237|NCT00357045|Randomized|Parallel Assignment||||Double||||||
1547238|NCT00357032||Single Group Assignment||Treatment||None (Open Label)||||||
1547239|NCT00357019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547240|NCT00357006|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547241|NCT00356993||Single Group Assignment||Treatment||None (Open Label)||||||
1547242|NCT00356980||||Treatment||None (Open Label)||||||
1547243|NCT00356967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547244|NCT00356954|Randomized|Parallel Assignment||Prevention||Double||||||
1547245|NCT00356941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547246|NCT00356928||Single Group Assignment||Treatment||None (Open Label)||||||
1547247|NCT00356915|Randomized|Parallel Assignment||Treatment||Single|||||t|
1547248|NCT00356902|Randomized|Parallel Assignment||Treatment||Double||||||
1547249|NCT00356889||Single Group Assignment||Treatment||None (Open Label)||||||
1547250|NCT00356863|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547251|NCT00356850|Randomized|Parallel Assignment||Treatment||Double||||||
1547252|NCT00356837|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1547253|NCT00356824|||Cohort||Prospective|||||||
1547254|NCT00356811||Single Group Assignment||Treatment||None (Open Label)||||||
1547255|NCT00356798|Randomized|Factorial Assignment||Prevention||Double||||||
1547256|NCT00356785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547257|NCT00356772|Randomized|Parallel Assignment||Treatment||Single||||||
1547258|NCT00356759|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547259|NCT00356746|||Cohort||Prospective|||||||
1547260|NCT00356733|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1547261|NCT00356720|Randomized|Parallel Assignment||Treatment||Double||||||
1547262|NCT00356707|||Cohort||Prospective|||||||
1547263|NCT00356681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547264|NCT00356668|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547265|NCT00356655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547266|NCT00356642|Randomized|Parallel Assignment||Treatment||||||||
1547267|NCT00356629|||Case-Only||Prospective|||||||
1547268|NCT00356616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547269|NCT00356603|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547270|NCT00356590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547271|NCT00356564|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547272|NCT00356551|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547273|NCT00356525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547274|NCT00356512||||||||||||
1547275|NCT00356486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547276|NCT00356473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547277|NCT00356460|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547278|NCT00356447|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547279|NCT00356434|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547280|NCT00356421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547281|NCT00356408|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547282|NCT00356395|Randomized|Crossover Assignment||Treatment||Double||||||
1547283|NCT00356382|Randomized|Single Group Assignment||Prevention||Double||||||
1547284|NCT00356369|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547285|NCT00356356|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547286|NCT00356343|Randomized|Single Group Assignment||Treatment||Single||||||t
1547287|NCT00356330|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1547288|NCT00356317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547289|NCT00356304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547290|NCT00356291|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547291|NCT00356278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547292|NCT00356265|Non-Randomized|Parallel Assignment||Other||None (Open Label)||All three groups will have the same intervention||||
1547293|NCT00356252|Randomized|Single Group Assignment||Prevention||Double||||||
1547294|NCT00356239|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1547295|NCT00356226|Randomized|Factorial Assignment||Treatment||Double||||||
1547296|NCT00356213|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547297|NCT00356200|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547298|NCT00356187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547299|NCT00356174|||Cohort||Prospective|||||||
1547300|NCT00356161|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547301|NCT00356148|Randomized|Single Group Assignment||Prevention||Triple|||t|t||t
1547302|NCT00356135|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547303|NCT00356122|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547304|NCT00356109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547305|NCT00356096||Parallel Assignment||Treatment||||||||
1547306|NCT00356083||Single Group Assignment||Treatment||None (Open Label)||||||
1547307|NCT00356070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547308|NCT00356057|Randomized|Parallel Assignment||Treatment||Single||||||t
1547309|NCT00356044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547310|NCT00356031||Single Group Assignment||Treatment||None (Open Label)||||||
1547311|NCT00356018|||||Prospective|||||||
1547312|NCT00356005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547313|NCT00355992|||Cohort||Prospective|||||||
1547314|NCT00355979|Randomized|Parallel Assignment||Treatment||Double||||||
1547315|NCT00355966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547316|NCT00355953|Randomized|Parallel Assignment||Treatment||Double||||||
1547317|NCT00355940|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547318|NCT00355927|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547319|NCT00355914|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547320|NCT00355901|||||Prospective|||||||
1547321|NCT00355888||Single Group Assignment||Treatment||None (Open Label)||||||
1547322|NCT00355875|Randomized|Parallel Assignment||Prevention||Double||||||
1547323|NCT00355862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547324|NCT00355849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547325|NCT00355836|Randomized|Factorial Assignment||Treatment||Double||||||
1547326|NCT00355823|||Case-Only||Prospective|||||||
1547327|NCT00355810|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547328|NCT00355797|Randomized|Parallel Assignment||Treatment||Single|||t|||
1547329|NCT00355784|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547330|NCT00355771|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547331|NCT00355758|||Cohort||Prospective|||||||
1547332|NCT00355745|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1547333|NCT00355732|Randomized|Parallel Assignment||Treatment||Single||||||
1547334|NCT00355719|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547335|NCT00355706|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1547336|NCT00355693|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547337|NCT00355680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547338|NCT00355667|Randomized|Parallel Assignment||Treatment||Single||||||t
1547339|NCT00355654|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1547340|NCT00355641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547341|NCT00355628||Single Group Assignment||Treatment||None (Open Label)||||||
1547342|NCT00355615|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547343|NCT00355602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547344|NCT00355589|Randomized|Parallel Assignment||Treatment||Double||||||
1547345|NCT00355576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547346|NCT00355563|Randomized|Single Group Assignment||Treatment||Single||||||
1547347|NCT00355550|Randomized|Parallel Assignment||Treatment||Double||||||
1547348|NCT00355537|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1547349|NCT00355524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547350|NCT00355511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547351|NCT00355498|||Cohort||Prospective|||||||
1547352|NCT00355485||Single Group Assignment||Treatment||Single||||||t
1547353|NCT00355472||Single Group Assignment||Treatment||None (Open Label)||||||
1547354|NCT00355459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547355|NCT00355446|Randomized|Parallel Assignment||Treatment||Double||||||
1547356|NCT00355433|Randomized|Single Group Assignment||Diagnostic||Double||||||
1547357|NCT00355420|||Cohort||Prospective|||||||
1547358|NCT00355407|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547359|NCT00355394|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547360|NCT00355381|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1547361|NCT00355368|Randomized|Parallel Assignment||Treatment||Single|||t|||
1547362|NCT00355355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547363|NCT00355342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547364|NCT00355329|Randomized|Parallel Assignment||Treatment||Double||||||
1547365|NCT00355316|Non-Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1547366|NCT00355303|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547367|NCT00355290|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547368|NCT00355277|Randomized|Crossover Assignment||Treatment||Double||||||
1547369|NCT00355264|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547370|NCT00355251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547371|NCT00355238|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547753|NCT00350129|||Case Control||Prospective|||||||
1547372|NCT00355225|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1547373|NCT00355212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547374|NCT00355199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547375|NCT00355186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547376|NCT00355173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547377|NCT00355160|||Cohort||Prospective|||||||
1547378|NCT00355147|Randomized|Parallel Assignment||Health Services Research||Double|||t|||t
1547379|NCT00355134|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1547380|NCT00355121|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1547381|NCT00355108|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1547382|NCT00355095|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1547383|NCT00355082|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547384|NCT00355069|Non-Randomized|Factorial Assignment||Health Services Research||Single|||t|||
1547385|NCT00355056|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1547386|NCT00355043|Randomized|Parallel Assignment||Treatment||Double||||||
1547387|NCT00355030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547388|NCT00355017|Randomized|Parallel Assignment||||None (Open Label)||||||
1547389|NCT00355004|Randomized|||Screening||||||||
1547390|NCT00354991|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547391|NCT00354978|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547392|NCT00354965|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547393|NCT00354952|Randomized|Single Group Assignment||Diagnostic||Double||||||
1547394|NCT00354939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547395|NCT00354926||Single Group Assignment||Treatment||None (Open Label)||||||
1547396|NCT00354913||Single Group Assignment||Treatment||None (Open Label)||||||
1547397|NCT00354900|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547398|NCT00354887|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547399|NCT00354874|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1547400|NCT00354861|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1547401|NCT00354835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547402|NCT00354822|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547403|NCT00354809|Randomized|Crossover Assignment||Treatment||Double||||||
1547404|NCT00354796|||Cohort||Prospective|||||||
1547405|NCT00354783|||Case Control||Longitudinal, Prospective|||||||
1547406|NCT00354770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547407|NCT00354757|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547408|NCT00354744||Single Group Assignment||Treatment||None (Open Label)||||||
1547409|NCT00354731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547410|NCT00354705|||Case-Only||Prospective|||||||
1547411|NCT00354692|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547412|NCT00354679||Single Group Assignment||Treatment||None (Open Label)||||||
1547413|NCT00354666|Randomized|Crossover Assignment||Treatment||Double||||||
1547414|NCT00354653|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547415|NCT00354640||Single Group Assignment||Treatment||None (Open Label)||||||
1547416|NCT00354627||Single Group Assignment||Treatment||None (Open Label)||||||
1547417|NCT00354614|||Cohort||Prospective|||||||
1547418|NCT00354601||Single Group Assignment||Treatment||None (Open Label)||||||
1547419|NCT00354588|||Cohort||Prospective|||||||
1547420|NCT00354575|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1547421|NCT00354562|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547422|NCT00354549||Single Group Assignment||Treatment||None (Open Label)||||||
1547423|NCT00354536|Randomized|Parallel Assignment||Treatment||Single|||t|||
1547424|NCT00354523||Single Group Assignment||Treatment||None (Open Label)||||||
1547425|NCT00354510|Randomized|Parallel Assignment||Treatment||Double||||||
1547426|NCT00354497||||Screening||||||||
1547427|NCT00354484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547428|NCT00354471|||||Prospective|||||||
1547429|NCT00354458|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547430|NCT00354445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547431|NCT00354432|Randomized|Factorial Assignment||Supportive Care||Quadruple|||t|t|t|t
1547432|NCT00354419||Single Group Assignment||Treatment||None (Open Label)||||||
1547433|NCT00354406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547434|NCT00354393||||Treatment||None (Open Label)||||||
1547435|NCT00354380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547436|NCT00354367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547437|NCT00354354|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1547438|NCT00354341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547439|NCT00354328||||||||||||
1547440|NCT00354315|Randomized|Parallel Assignment||||None (Open Label)||||||
1547441|NCT00354302||Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1547442|NCT00354276||||Treatment||None (Open Label)||||||
1547443|NCT00354263|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1547444|NCT00354250||Single Group Assignment||Treatment||None (Open Label)||||||
1547445|NCT00354237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547446|NCT00354224||Single Group Assignment||Treatment||None (Open Label)||||||
1547447|NCT00354211|||Cohort||Prospective|||||||
1547448|NCT00354198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547449|NCT00354185||Single Group Assignment||Treatment||None (Open Label)||||||
1547450|NCT00354172||Single Group Assignment||Treatment||None (Open Label)||||||
1547451|NCT00354159|Randomized|Parallel Assignment||Treatment||Single|||t|||
1547452|NCT00354146|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547453|NCT00354133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547454|NCT00354120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547455|NCT00354107||Single Group Assignment||Treatment||None (Open Label)||||||
1547456|NCT00354094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547457|NCT00354081|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1547458|NCT00354068||||Treatment||||||||
1547459|NCT00354042|Randomized|Crossover Assignment||Treatment||Double||||||
1547460|NCT00354029|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547461|NCT00354016|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1547462|NCT00354003|||Case-Only||Prospective|||||||
1547463|NCT00353990|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1547464|NCT00353977||Single Group Assignment||Prevention||None (Open Label)||||||
1547465|NCT00353964|Randomized|Parallel Assignment||||Double||||||
1547466|NCT00353951|||Cohort||Prospective|||||||
1547467|NCT00353938|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1547468|NCT00353925||||||||||||
1547469|NCT00353912|Randomized|Parallel Assignment||Treatment||Double||||||
1547470|NCT00353899||||||||||||
1547471|NCT00353886|||Defined Population||Cross-Sectional, Retrospective|||||||
1547472|NCT00353873|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547473|NCT00353860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547474|NCT00353847|Randomized|Parallel Assignment||Treatment||Single||||||
1547475|NCT00353834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547476|NCT00353821|||||Other|||||||
1547477|NCT00353808|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547478|NCT00353795|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1547479|NCT00353782||||||||||||
1547480|NCT00353769|Randomized|Single Group Assignment||Treatment||Single||||||
1547481|NCT00353756|Randomized|Parallel Assignment||Treatment||Double||||||
1547482|NCT00353743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547483|NCT00353730|||Case-Control||Cross-Sectional|||||||
1547484|NCT00353717|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547485|NCT00353704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547486|NCT00353691|Randomized|Parallel Assignment||Treatment||Single||||||
1547487|NCT00353678|Randomized|Parallel Assignment||Prevention||Double||||||
1547488|NCT00353665|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547489|NCT00353652|Non-Randomized|Parallel Assignment||Prevention||Single|||t|||
1547490|NCT00353639|||Case-Only||Cross-Sectional|||||||
1547491|NCT00353626|||||Prospective|||||||
1547492|NCT00353613|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547493|NCT00353600||||||||||||
1547494|NCT00353587|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547495|NCT00353574|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547496|NCT00353561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547497|NCT00353548|||Case Control||Prospective|||||||
1547498|NCT00353535|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547499|NCT00353522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547500|NCT00353509|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547501|NCT00353496|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547502|NCT00353483|||Cohort||Prospective|||||||
1547503|NCT00353470|Randomized|Parallel Assignment||Treatment||Single||||||t
1547504|NCT00353457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547505|NCT00353444|||||Prospective|||||||
1547506|NCT00353431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547507|NCT00353418|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547508|NCT00353405|Randomized|Parallel Assignment||Prevention||Single||||||t
1547509|NCT00353392|Randomized|Parallel Assignment||Treatment||Single||||||
1547510|NCT00353379|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1547511|NCT00353366|||Cohort||Prospective|||||||
1547512|NCT00353353|Randomized|Parallel Assignment||Prevention||Double||||||
1547513|NCT00353340|Randomized|Parallel Assignment||Prevention||Double||||||
1547514|NCT00353327|Randomized|Parallel Assignment||Treatment||Double||||||
1547515|NCT00353301||Single Group Assignment||Treatment||None (Open Label)||||||
1547516|NCT00353288|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547517|NCT00353275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547518|NCT00353262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547519|NCT00353249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547520|NCT00353236|||Case Control||Longitudinal, Prospective|||||||
1547521|NCT00353223|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1547522|NCT00353210|||Other||Other|||||||
1547523|NCT00353197|||Other||Other|||||||
1547524|NCT00353184|Randomized|Parallel Assignment||Treatment||Double||||||
1547525|NCT00353171|||Cohort||Prospective|||||||
1547526|NCT00353158|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1547527|NCT00353145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547528|NCT00353119|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1547529|NCT00353106|||||Prospective|||||||
1547530|NCT00353093|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547531|NCT00353080|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1547532|NCT00353067|Randomized|Parallel Assignment||Prevention||Double||||||
1547533|NCT00353054|Randomized|Parallel Assignment||Treatment||Double||||||
1547534|NCT00353041|Randomized|Crossover Assignment||Educational/Counseling/Training||Double||||||
1547535|NCT00353028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547536|NCT00353015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547537|NCT00353002|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1547538|NCT00352989|Randomized|Parallel Assignment||Treatment||Double||||||
1547539|NCT00352976||Single Group Assignment||Treatment||None (Open Label)||||||
1547540|NCT00352963|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547541|NCT00352950|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547542|NCT00352937|||Cohort||Prospective|||||||
1547543|NCT00352924|||Cohort||Prospective|||||||
1547544|NCT00352911|Randomized|Parallel Assignment||Treatment||Double||||||
1547545|NCT00352898|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547546|NCT00352885|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1547547|NCT00352872|||Cohort||Prospective|||||||
1547548|NCT00352859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547549|NCT00352846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547550|NCT00352833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547551|NCT00352820|||Case-Only||Prospective|||||||
1547552|NCT00352807|Randomized|Parallel Assignment||Treatment||Double||||||
1547553|NCT00352794||Single Group Assignment||Treatment||None (Open Label)||||||
1547554|NCT00352781||Single Group Assignment||Treatment||None (Open Label)||||||
1547555|NCT00352768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547556|NCT00352755||Single Group Assignment||Treatment||None (Open Label)||||||
1547557|NCT00352742|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547558|NCT00352729|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547559|NCT00352716|Randomized|Parallel Assignment||Treatment||Double||||||
1547560|NCT00352703|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1547561|NCT00352690|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547562|NCT00352677|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547563|NCT00352664|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547564|NCT00352651|Randomized|Crossover Assignment||Treatment||Double||||||
1547565|NCT00352638|Randomized|||||||||||
1547566|NCT00352625|Randomized|Parallel Assignment||Treatment||Double||||||
1547567|NCT00352612|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1547568|NCT00352599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547569|NCT00352586||||||||||||
1547570|NCT00352573||||||||||||
1547571|NCT00352560|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547572|NCT00352547||||||||||||
1547573|NCT00352534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547574|NCT00352521||Single Group Assignment||Treatment||None (Open Label)||||||
1547575|NCT00352508|Randomized|Single Group Assignment||Educational/Counseling/Training||Double||||||
1547576|NCT00352495||Single Group Assignment||Treatment||None (Open Label)||||||
1547577|NCT00352482|Randomized|Crossover Assignment||Treatment||Double||||||
1547578|NCT00352469|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547579|NCT00352456||||||||||||
1547580|NCT00352443||Single Group Assignment||Treatment||None (Open Label)||||||
1547581|NCT00352430||||Treatment||||||||
1547582|NCT00352417|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547583|NCT00352404|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547584|NCT00352391|||Case-Only||Prospective|||||||
1547585|NCT00352378|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547586|NCT00352365||Single Group Assignment||Treatment||None (Open Label)||||||
1547587|NCT00352352|Randomized|Parallel Assignment||Treatment||Single||||||
1547588|NCT00352339|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547589|NCT00352326||Single Group Assignment||Treatment||None (Open Label)||||||
1547590|NCT00352313||||Treatment||None (Open Label)||||||
1547591|NCT00352300||Single Group Assignment||Treatment||None (Open Label)||||||
1547592|NCT00352287|Randomized|Factorial Assignment||Treatment||Double||||||
1547593|NCT00352261|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547594|NCT00352248|Randomized|Parallel Assignment||Treatment||Single||||||
1547595|NCT00352235|Randomized|Single Group Assignment||Treatment||Double||||||
1547596|NCT00352222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547597|NCT00352209||||||||||||
1547598|NCT00352196|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547599|NCT00352183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547600|NCT00352170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547601|NCT00352157|Randomized|Parallel Assignment||Treatment||Single||||||
1547602|NCT00352144|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1547603|NCT00352131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547604|NCT00352118||Single Group Assignment||Treatment||None (Open Label)||||||
1547605|NCT00352105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547606|NCT00352092|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547607|NCT00352079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547608|NCT00352066|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1547609|NCT00352053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547610|NCT00352027||Single Group Assignment||Treatment||None (Open Label)||||||
1547611|NCT00352014|||||Prospective|||||||
1547612|NCT00352001||Single Group Assignment||Treatment||None (Open Label)||||||
1547613|NCT00351988|||Other||Prospective|||||||
1547614|NCT00351975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547615|NCT00351962|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547616|NCT00351949|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547617|NCT00351936|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1547618|NCT00351923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547619|NCT00351910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547620|NCT00351897|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547621|NCT00351884|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547622|NCT00351871|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547623|NCT00351858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547624|NCT00351845|Randomized|Parallel Assignment||Treatment||Single|||t|||
1547625|NCT00351832|Randomized|Parallel Assignment||Treatment||Double||||||
1547626|NCT00351819|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547627|NCT00351806|Randomized|Parallel Assignment||Treatment||Single||||||
1547628|NCT00351793|||Case-Control||Prospective|||||||
1547629|NCT00351780|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547630|NCT00351767|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547631|NCT00351754|Randomized|Parallel Assignment||Diagnostic||Double||||||
1547632|NCT00351741|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547633|NCT00351728|||Cohort||Prospective|||||||
1547634|NCT00351715|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547635|NCT00351702|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547636|NCT00351689|Randomized|Parallel Assignment||Treatment||Double||||||
1547637|NCT00351676|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1547638|NCT00351663|Randomized|Parallel Assignment||Prevention||Single||||||t
1547639|NCT00351650||||||||||||
1547640|NCT00351637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547641|NCT00351624|Randomized|Parallel Assignment||Treatment||Double||||||
1547642|NCT00351611|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547643|NCT00351598|||Cohort||Prospective|||||||
1547644|NCT00351585|Randomized|Parallel Assignment||Treatment||Double||||||
1547645|NCT00351572|||Cohort||Prospective|||||||
1547646|NCT00351559|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547647|NCT00351546|Randomized|Crossover Assignment||Treatment||Double||||||
1547648|NCT00351533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547649|NCT00351520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547650|NCT00351507|Randomized|Crossover Assignment||Treatment||Double||||||
1547651|NCT00351494|||||Prospective|||||||
1547652|NCT00351481||||||||||||
1547653|NCT00351468||Single Group Assignment||Treatment||None (Open Label)||||||
1547654|NCT00351455|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547655|NCT00351442|||Case Control||Prospective|||||||
1547656|NCT00351429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547657|NCT00351416|Non-Randomized|Sequential Assignment||Other||None (Open Label)||This is a physiologic study designed to investigate the relative roles of estradiol and inhibin A or inhibin B in the control of FSH secretion during normal menstrual cycles using an aromatase inhibitor. Subjects serve as their own control with no intervention in cycle 1 and letrozole administration in cycle 2. Subjects are studied in the early follicular phase or the late follicular phase.||||
1547658|NCT00351403|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547659|NCT00351390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547660|NCT00351377|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547661|NCT00351364|Randomized|Parallel Assignment||Treatment||Single|||||t|
1547662|NCT00351351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547663|NCT00351338|||Defined Population||Longitudinal, Prospective|||||||
1547664|NCT00351325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547665|NCT00351312|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1547666|NCT00351299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547667|NCT00351286|Randomized|Parallel Assignment||Treatment||Double||||||
1547668|NCT00351273|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1547669|NCT00351260|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547670|NCT00351247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547671|NCT00351234|||Cohort||Retrospective|||||||
1547672|NCT00351221|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547673|NCT00351208|Randomized|Parallel Assignment||Treatment||Double||||||
1547674|NCT00351195|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547675|NCT00351182|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547676|NCT00351169|Randomized|Parallel Assignment||Treatment||Double||||||
1547677|NCT00351156||||||||||||
1547678|NCT00351143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547679|NCT00351130|Randomized|Parallel Assignment||Treatment||Double||||||
1547680|NCT00351117|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547681|NCT00351104|Randomized|Parallel Assignment||Treatment||Double||||||
1547682|NCT00351091|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547683|NCT00351078||Single Group Assignment||Treatment||None (Open Label)||||||
1547684|NCT00351065|Randomized|Parallel Assignment||Treatment||Double||||||
1547685|NCT00351052|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547686|NCT00351039||Single Group Assignment||Treatment||None (Open Label)||||||
1547687|NCT00351026|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547688|NCT00351013|Randomized|Single Group Assignment||Prevention||Double|||t|t||
1547689|NCT00351000||Single Group Assignment||Treatment||None (Open Label)||||||
1547690|NCT00350987|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1547691|NCT00350974|||Case-Control||Prospective|||||||
1547692|NCT00350961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547693|NCT00350948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547694|NCT00350935|||Case Control||Prospective|||||||
1547695|NCT00350922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547696|NCT00350909|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547697|NCT00350896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547698|NCT00350883|Randomized|Parallel Assignment||Treatment||Single||||||t
1547699|NCT00350870|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1547700|NCT00350857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547701|NCT00350844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547702|NCT00350831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547703|NCT00350818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547704|NCT00350805|||Case-Control||Prospective|||||||
1547705|NCT00350792|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547706|NCT00350779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547707|NCT00350766|Randomized|Parallel Assignment||Treatment||Quadruple|Control group received injection of saline with 5% autologous serum without the suspension of mononuclear cells.|Double Blind Randomized Controlled Trial|t|t|t|t
1547708|NCT00350753|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547709|NCT00350727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547710|NCT00350714|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1547711|NCT00350701|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1547712|NCT00350688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547713|NCT00350675|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1547714|NCT00350662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547715|NCT00350649|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547716|NCT00350636|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1547717|NCT00350623|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1547718|NCT00350610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547719|NCT00350597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547720|NCT00350584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547721|NCT00350571|Randomized|Parallel Assignment||||None (Open Label)||||||
1547722|NCT00350545||Single Group Assignment||Treatment||None (Open Label)||||||
1547723|NCT00350532|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547724|NCT00350519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547725|NCT00350506|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1547726|NCT00350493||||||||||||
1547727|NCT00350480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547728|NCT00350467|Randomized|Parallel Assignment||Treatment||Double||||||
1547729|NCT00350454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547730|NCT00350441|Randomized|Single Group Assignment||Treatment||Double||||||
1547731|NCT00350428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547732|NCT00350415|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547733|NCT00350402|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547734|NCT00350389|Randomized|Parallel Assignment||Prevention||Single||||||t
1547735|NCT00350376|||Defined Population||Cross-Sectional, Retrospective|||||||
1547736|NCT00350363|Non-Randomized|Single Group Assignment||Prevention||Single|||||t|
1547737|NCT00350350|||Cohort||Prospective|||||||
1547738|NCT00350337|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1547739|NCT00350311|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547740|NCT00350298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547741|NCT00350285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547742|NCT00350272|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547743|NCT00350259||||||||||||
1547744|NCT00350246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547745|NCT00350233|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547746|NCT00350220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547747|NCT00350207||Parallel Assignment||Treatment||||||||
1547748|NCT00350194|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1547749|NCT00350181|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1547750|NCT00350168|Randomized|Parallel Assignment||Treatment||Double||||||
1547751|NCT00350155|Randomized|Parallel Assignment||Treatment||Double||||||
1547752|NCT00350142||Single Group Assignment||Treatment||None (Open Label)||||||
1547754|NCT00350116|Randomized|Single Group Assignment||Treatment||Double||||||
1547755|NCT00350103|Randomized|Parallel Assignment||Treatment||Double||||||
1547756|NCT00350090|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547757|NCT00350077|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547758|NCT00350064|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1547759|NCT00350051|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547760|NCT00350038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547761|NCT00350025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547762|NCT00350012|||Case Control||Prospective|||||||
1547763|NCT00349999|||Cohort||Prospective|||||||
1547764|NCT00349986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547765|NCT00349973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547766|NCT00349960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547767|NCT00349947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547768|NCT00349934|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547769|NCT00349921|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1547770|NCT00349908|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547771|NCT00349895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547772|NCT00349882|Randomized|Crossover Assignment||Treatment||Double||||||
1547773|NCT00349869|Randomized|Parallel Assignment||Treatment||Single|Assessors masked to study condition|Randomized controlled trial||||t
1547774|NCT00349856|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1547775|NCT00349843|Randomized|Crossover Assignment||Treatment||Double||||||
1547776|NCT00349830|||Cohort||Prospective|||||||
1547777|NCT00349817|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1547778|NCT00349804||Single Group Assignment||Prevention||None (Open Label)||||||
1547779|NCT00349791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547780|NCT00349778||Single Group Assignment||Treatment||None (Open Label)||||||
1547781|NCT00349765|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1547782|NCT00349752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547783|NCT00349739||||||||||||
1547784|NCT00349726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547785|NCT00349713|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1547786|NCT00349700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547787|NCT00349687|Randomized|Single Group Assignment||Treatment||Single|||t|||
1547788|NCT00349674|Randomized|Parallel Assignment||||None (Open Label)||||||
1547789|NCT00349661|Randomized|Parallel Assignment||Treatment||Double||||||
1547790|NCT00349648|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547791|NCT00349635|Randomized|Parallel Assignment||Treatment||Double||||||
1547792|NCT00349622|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547793|NCT00349596||Single Group Assignment||Treatment||None (Open Label)||||||
1547794|NCT00349583|Randomized|Parallel Assignment||||Double||||||
1547795|NCT00349570|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547796|NCT00349557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547797|NCT00349544|||||Cross-Sectional|||||||
1547798|NCT00349531||Parallel Assignment||Treatment||||||||
1547799|NCT00349518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547800|NCT00349505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547801|NCT00349492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547802|NCT00349479|Randomized|Factorial Assignment||||None (Open Label)||||||
1547803|NCT00349466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547804|NCT00349453|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547805|NCT00349440|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547806|NCT00349427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547807|NCT00349414|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547808|NCT00349401|Randomized|||Treatment||Double||||||
1547809|NCT00349388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547810|NCT00349375|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547811|NCT00349362|Randomized|Parallel Assignment||Treatment||Double||||||
1547812|NCT00349349|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547813|NCT00349336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547814|NCT00349323|||||Prospective|||||||
1547815|NCT00349310||||||||||||
1547816|NCT00349297|||||Prospective|||||||
1547817|NCT00349284|Randomized|Parallel Assignment||Treatment||Double||||||
1547818|NCT00349271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547819|NCT00349258|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547820|NCT00349245|Randomized|Parallel Assignment||||Double|||t|t||
1547821|NCT00349232|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1547822|NCT00349219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547823|NCT00349206||Single Group Assignment||Treatment||None (Open Label)||||||
1547824|NCT00349193|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547825|NCT00349180|Randomized|Parallel Assignment||Prevention||Double||||||
1547826|NCT00349167||Single Group Assignment||Treatment||None (Open Label)||||||
1547827|NCT00349141|Randomized|Parallel Assignment||Prevention||Single||||||
1547828|NCT00349128|Randomized|Parallel Assignment||Treatment||Double||||||
1547829|NCT00349115|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547830|NCT00349102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547831|NCT00349089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547832|NCT00349076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547833|NCT00349063|Randomized|Crossover Assignment||Treatment||Double||||||
1547834|NCT00349050|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1547835|NCT00349037|Randomized|Parallel Assignment||Prevention||Double||||||
1547836|NCT00349024||||Supportive Care||None (Open Label)||||||
1547837|NCT00349011|Randomized|Factorial Assignment||Educational/Counseling/Training||None (Open Label)||||||
1547838|NCT00348998||||Treatment||None (Open Label)||||||
1547839|NCT00348985||Single Group Assignment||Treatment||None (Open Label)||||||
1547840|NCT00348972|Randomized|Parallel Assignment||Treatment||Double||||||
1547841|NCT00348959|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1547842|NCT00348946|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547843|NCT00348933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547844|NCT00348920|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547845|NCT00348907|Randomized|Parallel Assignment||Treatment||Single|||||t|
1547846|NCT00348894|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547847|NCT00348881|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1547848|NCT00348868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547849|NCT00348855|Randomized|Parallel Assignment||Prevention||Single|||||t|
1547850|NCT00348842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547851|NCT00348829|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1547852|NCT00348816||Single Group Assignment||Treatment||None (Open Label)||||||
1547853|NCT00348803|||Defined Population||Longitudinal, Prospective|||||||
1547854|NCT00348790||Single Group Assignment||Treatment||None (Open Label)||||||
1547855|NCT00348777|Randomized|Parallel Assignment||Treatment||Single|||t|||
1547856|NCT00348764|Randomized|Parallel Assignment||Treatment||Double||||||
1547857|NCT00348751|Randomized|Parallel Assignment||||None (Open Label)||||||
1547858|NCT00348738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547859|NCT00348725|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547860|NCT00348712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547861|NCT00348699||Single Group Assignment||Treatment||None (Open Label)||||||
1547862|NCT00348686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547863|NCT00348673|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1547864|NCT00348660|||Cohort||Prospective|||||||
1547865|NCT00348647|Randomized|Parallel Assignment||Prevention||Double||||||
1547866|NCT00348634|Randomized|Parallel Assignment||Treatment||Double||||||
1547867|NCT00348621|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1547868|NCT00348608|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1547869|NCT00348595|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547870|NCT00348582|Randomized|Parallel Assignment||||Single||||||
1547871|NCT00348569|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1547872|NCT00348556||Single Group Assignment||Treatment||None (Open Label)||||||
1547873|NCT00348543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547874|NCT00348530|Randomized|Parallel Assignment||Treatment||Single||||||
1547875|NCT00348517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547876|NCT00348504|Randomized|Parallel Assignment||Treatment||Double||||||
1547877|NCT00348491|Randomized|Parallel Assignment||Treatment||Double||||||
1547878|NCT00348478|Randomized|Parallel Assignment||Prevention||Single||||||
1547879|NCT00348465|||Cohort||Prospective|||||||
1547880|NCT00348452|Randomized|Parallel Assignment||Treatment||Double||||||
1547881|NCT00348439|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547882|NCT00348426|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1547883|NCT00348413|Randomized|Parallel Assignment||Treatment||Double||||||
1547884|NCT00348400|Randomized|Parallel Assignment||||Single||||||
1547885|NCT00348387|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547886|NCT00348374|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547887|NCT00348361|Randomized|Crossover Assignment||Diagnostic||Double||||||
1547888|NCT00348348|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1547889|NCT00348335|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547890|NCT00348322|Randomized|Parallel Assignment||Treatment||Double||||||
1547891|NCT00348309|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547892|NCT00348296|Randomized|Parallel Assignment||Treatment||Double||||||
1547893|NCT00348283|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547894|NCT00348270|Randomized|Parallel Assignment||Treatment||Single||||||
1547895|NCT00348257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547896|NCT00348244|Randomized|Parallel Assignment||||Single||||||
1547897|NCT00348231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547898|NCT00348218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547899|NCT00348205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547900|NCT00348192|Randomized|Parallel Assignment||Treatment||Double||||||
1547901|NCT00348179|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1547902|NCT00348166|Randomized|Factorial Assignment||||Double||||||
1547903|NCT00348153|Randomized|Crossover Assignment||Treatment||Single||||||t
1547904|NCT00348140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547905|NCT00348127|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547906|NCT00348114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547907|NCT00348101|Randomized|Parallel Assignment||Treatment||Single||||||
1547908|NCT00348088|||Case-Only||Prospective|||||||
1547909|NCT00348075|Randomized|Crossover Assignment||Treatment||Double||||||
1547910|NCT00348062|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1547911|NCT00348049|Randomized|Parallel Assignment||Treatment||Single||||||
1547912|NCT00348036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547913|NCT00348023|Randomized|Parallel Assignment||||Single||||||
1547914|NCT00348010|Randomized|Parallel Assignment||Treatment||Double||||||
1547915|NCT00347997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547916|NCT00347984|Randomized|Crossover Assignment||Treatment||Double||||||
1547917|NCT00347971|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547918|NCT00347958|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1547919|NCT00347945|Randomized|Single Group Assignment||Treatment||Single||||||
1547920|NCT00347932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547921|NCT00347919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547922|NCT00347906|Randomized|Parallel Assignment||||None (Open Label)||||||
1547923|NCT00347893|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1547924|NCT00347880|||Cohort||Prospective|||||||
1547925|NCT00347867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547926|NCT00347854|Randomized|Parallel Assignment||||Double|||t||t|
1547927|NCT00347841|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1547928|NCT00347828|Randomized|Single Group Assignment||Prevention||Double||||||
1547929|NCT00347815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547930|NCT00347802|Randomized|Parallel Assignment||||Single||||||
1547931|NCT00347789|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1547932|NCT00347776|Randomized|Parallel Assignment||Prevention||Single||||||t
1547933|NCT00347763|Randomized|Parallel Assignment||Prevention||Single||||||t
1547934|NCT00347750|||||Prospective|||||||
1547935|NCT00347737||Single Group Assignment||Treatment||None (Open Label)||||||
1547936|NCT00347724|Randomized|Parallel Assignment||Treatment||Double||||||
1547937|NCT00347711|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1547938|NCT00347698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547939|NCT00347685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547940|NCT00347672|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547941|NCT00347659|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547942|NCT00347646||Single Group Assignment||Treatment||None (Open Label)||||||
1547943|NCT00347620|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547944|NCT00347607|Randomized|Parallel Assignment||Treatment||Double||||||
1547945|NCT00347594|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1547946|NCT00347581|Randomized|Single Group Assignment||Treatment||Double||||||
1547947|NCT00347568|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1547948|NCT00347555|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1547949|NCT00347542|Randomized|Parallel Assignment||Prevention||Double||||||
1547950|NCT00347529|Randomized|Parallel Assignment||Prevention||Double||||||
1547951|NCT00347516|Randomized|Parallel Assignment||||Single||||||
1547952|NCT00347503|Randomized|Parallel Assignment||Treatment||Single||||||
1547953|NCT00347490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547954|NCT00347477|Randomized|Parallel Assignment||Treatment||Single||||||
1547955|NCT00347464|||Case-Only||Prospective|||||||
1547956|NCT00347451|||||Prospective|||||||
1547957|NCT00347438||Single Group Assignment||Treatment||None (Open Label)||||||
1547958|NCT00347425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547959|NCT00347412|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1547960|NCT00347399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547961|NCT00347386|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547962|NCT00347373|Randomized|Parallel Assignment||Treatment||Double||||||
1547963|NCT00347360|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547964|NCT00347347|||Cohort||Prospective|||||||
1547965|NCT00347334|||||Prospective|||||||
1547966|NCT00347321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547967|NCT00347308|||||Prospective|||||||
1547968|NCT00347295|Randomized|Parallel Assignment||Treatment||Double||||||
1547969|NCT00347282|||||Prospective|||||||
1547970|NCT00347269|Randomized|Parallel Assignment||Treatment||Single||||||t
1547971|NCT00347256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547972|NCT00347243|Randomized|Parallel Assignment||Treatment||Double||||||
1547973|NCT00347230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547974|NCT00347217|||Case-Only||Prospective|||||||
1547975|NCT00347204|Randomized|Parallel Assignment||Treatment||Double||||||
1547976|NCT00347191|||Cohort||Prospective|||||||
1547977|NCT00347178|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1547978|NCT00347165|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547979|NCT00347152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547980|NCT00347139|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1547981|NCT00347126|||Case-Only||Prospective|||||||
1547982|NCT00347113|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1547983|NCT00347100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547984|NCT00347087|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547985|NCT00347074|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1547986|NCT00347061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547987|NCT00347048|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1547988|NCT00347035|Randomized|Parallel Assignment||Treatment||Double||||||
1547989|NCT00347022|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1547990|NCT00347009|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1547991|NCT00346996|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1547992|NCT00346983|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1547993|NCT00346970|Randomized|Parallel Assignment||Treatment||Single|||t|||
1547994|NCT00346957|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1547995|NCT00346944|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1547996|NCT00346931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1547997|NCT00346918|Randomized|Parallel Assignment||Treatment||Single||||||t
1547998|NCT00346905||Single Group Assignment||Treatment||None (Open Label)||||||
1547999|NCT00346892|Randomized|Parallel Assignment||Prevention||Double||||||
1548000|NCT00346879|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548001|NCT00346866|Randomized|Parallel Assignment||Treatment||Double||||||
1548002|NCT00346853|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548003|NCT00346840|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548004|NCT00346827|Randomized|Parallel Assignment||||Double||||||
1548005|NCT00346814|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548006|NCT00346801||Single Group Assignment||Treatment||None (Open Label)||||||
1548007|NCT00346788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548008|NCT00346775|Randomized|Crossover Assignment||Treatment||Single|||t|||
1548009|NCT00346762|||Cohort||Prospective|||||||
1548010|NCT00346749|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548011|NCT00346736|Randomized|Crossover Assignment||Treatment||Double||||||
1548012|NCT00346723|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548013|NCT00346710|||Cohort||Prospective|||||||
1548014|NCT00346697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548015|NCT00346684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548016|NCT00346671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548017|NCT00346658|Randomized|Parallel Assignment||Prevention||Double||||||
1548018|NCT00346645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548019|NCT00346632||Single Group Assignment||Treatment||None (Open Label)||||||
1548020|NCT00346619|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548021|NCT00346606|Randomized|Parallel Assignment||Treatment||Double||||||
1548022|NCT00346593|Randomized|Single Group Assignment||Treatment||Double||||||
1548023|NCT00346580|Randomized|Single Group Assignment||Treatment||Double||||||
1548024|NCT00346567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548025|NCT00346554|||Cohort||Prospective|||||||
1548026|NCT00346541|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1548027|NCT00346528|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548028|NCT00346515|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1548029|NCT00346502||Single Group Assignment||Treatment||None (Open Label)||||||
1548030|NCT00346489|Randomized|Parallel Assignment||Treatment||Double||||||
1548031|NCT00346476|||Ecologic or Community||Prospective|||||||
1548032|NCT00346463|Randomized|Parallel Assignment||Treatment||Double||||||
1548033|NCT00346450|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548034|NCT00346437|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548035|NCT00346424|Randomized|Single Group Assignment||Treatment||Double||||||
1548036|NCT00346411|||Cohort||Prospective|||||||
1548037|NCT00346398|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548038|NCT00346385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548039|NCT00346372|||Cohort||Prospective|||||||
1548040|NCT00346359||||Treatment||None (Open Label)||||||
1548041|NCT00346346||||||||||||
1548042|NCT00346333|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548043|NCT00346320||Single Group Assignment||Treatment||None (Open Label)||||||
1548044|NCT00346294|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548045|NCT00346281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548046|NCT00346268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548047|NCT00346255|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548048|NCT00346242|Randomized|Parallel Assignment||Prevention||Single||||||
1548049|NCT00346229||Single Group Assignment||Treatment||None (Open Label)||||||
1548050|NCT00346216|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548051|NCT00346190|Randomized|Parallel Assignment||Prevention||Double||||||
1548052|NCT00346177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548053|NCT00346164|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548054|NCT00346151||Single Group Assignment||Treatment||None (Open Label)||||||
1548055|NCT00346138|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548056|NCT00346125|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1548057|NCT00346112|Randomized|Parallel Assignment||||None (Open Label)||||||
1548058|NCT00346099|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548059|NCT00346086|Randomized|Parallel Assignment||Treatment||Double||||||
1548060|NCT00346073|Randomized|Parallel Assignment||Prevention||Single|||t|||
1548061|NCT00346060|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1548062|NCT00346047|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548063|NCT00346034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548064|NCT00346021|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548065|NCT00346008||||||||||||
1548066|NCT00345982|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548067|NCT00345969|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548068|NCT00345956|Randomized|Parallel Assignment||Prevention||Double||||||
1548069|NCT00345943|||Case-Control||Prospective|||||||
1548070|NCT00345930|||Case-Control||Prospective|||||||
1548071|NCT00345917|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1548072|NCT00345904|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548073|NCT00345891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548074|NCT00345878|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548075|NCT00345865|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548076|NCT00345852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548077|NCT00345839|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548078|NCT00345826||Single Group Assignment||Treatment||None (Open Label)||||||
1548079|NCT00345813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548080|NCT00345800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548081|NCT00345787|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548082|NCT00345774|Randomized|Parallel Assignment||Treatment||Double||||||
1548083|NCT00345761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548084|NCT00345748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548085|NCT00345735|Randomized|Crossover Assignment||Treatment||Double||||||
1548086|NCT00345722|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548087|NCT00345709|||Case-Only|||||||||
1548088|NCT00345696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548089|NCT00345683|Randomized|Parallel Assignment||Prevention||Single||||t||
1548090|NCT00345670|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1548091|NCT00345657|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548092|NCT00345644|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548093|NCT00345631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548094|NCT00345618|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548095|NCT00345605|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1548096|NCT00345592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548097|NCT00345579|Randomized|Parallel Assignment||Prevention||Single|||t|||
1548098|NCT00345566|Non-Randomized|Crossover Assignment||Treatment||Double||||||
1548099|NCT00345553|||Cohort||Prospective|||||||
1548100|NCT00345540||Single Group Assignment||Treatment||None (Open Label)||||||
1548101|NCT00345527|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548102|NCT00345514|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1548103|NCT00345501|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1548104|NCT00345488|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1548105|NCT00345475|||||Prospective|||||||
1548106|NCT00345462|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548107|NCT00345449|Randomized|Parallel Assignment||||Single||||||
1548108|NCT00345436|||||Prospective|||||||
1548109|NCT00345410|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548110|NCT00345397||Single Group Assignment||Treatment||None (Open Label)||||||
1548111|NCT00345384|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548112|NCT00345371|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548113|NCT00345358|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548114|NCT00345345||Single Group Assignment||Treatment||None (Open Label)||||||
1548115|NCT00345332|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548116|NCT00345319|Randomized|Parallel Assignment||Prevention||Single|||t|||
1548117|NCT00345306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548118|NCT00345293||Single Group Assignment||Treatment||None (Open Label)||||||
1548119|NCT00345280|||Cohort||Prospective|||||||
1548120|NCT00345267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548121|NCT00345254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548122|NCT00345241|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548123|NCT00345228|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1548124|NCT00345215|Randomized|Crossover Assignment||||Double|||t||t|
1548125|NCT00345202|Randomized|Crossover Assignment||||Double||||||
1548126|NCT00345189|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548127|NCT00345176|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548128|NCT00345163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548129|NCT00345150|Randomized|Crossover Assignment||||Single||||||
1548130|NCT00345137|Randomized|Crossover Assignment||||Single||||||
1548131|NCT00345124|Randomized|Crossover Assignment||||Double|||t||t|
1548132|NCT00345111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548133|NCT00345098|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548134|NCT00345085||||||||||||
1548135|NCT00345072|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1548136|NCT00345059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548137|NCT00345046|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548138|NCT00345033|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548139|NCT00345020||||||||||||
1548140|NCT00345007|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1548141|NCT00344994|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548142|NCT00344981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548143|NCT00344968|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548144|NCT00344955|Randomized|Crossover Assignment||||Double||||||
1548145|NCT00344942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548146|NCT00344929|||Defined Population||Longitudinal, Prospective|||||||
1548147|NCT00344916|Randomized|Crossover Assignment||||Single||||||
1548148|NCT00344903|||Cohort||Prospective|||||||
1548149|NCT00344890|Randomized|Parallel Assignment||Treatment||Single||||||t
1548150|NCT00344877||||||||||||
1548151|NCT00344864|||Cohort||Prospective|||||||
1548152|NCT00344851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548153|NCT00344838|||Case-Only||Prospective|||||||
1548154|NCT00344825|||Cohort||Prospective|||||||
1548155|NCT00344812|Randomized|Parallel Assignment||Treatment||Double||||||
1548156|NCT00344799|||Cohort||Prospective|||||||
1548157|NCT00344786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548158|NCT00344773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548159|NCT00344760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548160|NCT00344747|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548161|NCT00344734|Randomized|Parallel Assignment||||Single||||||
1548162|NCT00344721|Randomized|Parallel Assignment||Treatment||Double|"The active ingredient and placebo softgels appear identical and are supplied in identical containers for masking purposes.~Study personnel performing study visit procedures are masked to group assignment."|Patients will be randomized to receive either omega-3 fatty acid or placebo soft-gel capsules.|t|||t
1548163|NCT00344708|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548164|NCT00344695|Randomized|Single Group Assignment||Treatment||Double||||||
1548165|NCT00344682|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548166|NCT00344669|Randomized|Parallel Assignment||Treatment||Single||||||
1548167|NCT00344656|||Cohort||Prospective|||||||
1548168|NCT00344643|Randomized|Parallel Assignment||||None (Open Label)||||||
1548169|NCT00344630|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1548170|NCT00344617|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548171|NCT00344604|||||Prospective|||||||
1548172|NCT00344591|Randomized|Parallel Assignment||||None (Open Label)||||||
1548173|NCT00344578|||Cohort||Retrospective|||||||
1548174|NCT00344565|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548175|NCT00344552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548176|NCT00344539|Randomized|Parallel Assignment||Prevention||Single|||t|||
1548177|NCT00344526|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548178|NCT00344513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548179|NCT00344500|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548180|NCT00344487||Single Group Assignment||Treatment||None (Open Label)||||||
1548181|NCT00344474|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1548182|NCT00344461||Single Group Assignment||Treatment||None (Open Label)||||||
1548183|NCT00344448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548184|NCT00344435|||Family-Based||Cross-Sectional|||||||
1548185|NCT00344422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548186|NCT00344409|Randomized|Parallel Assignment||Treatment||Double||||||
1548187|NCT00344383|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548188|NCT00344370|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548189|NCT00344344||||||||||||
1548190|NCT00344331|||Cohort||Prospective|||||||
1548191|NCT00344318|Randomized|Parallel Assignment||Prevention||Double||||t||t
1548192|NCT00344305|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548193|NCT00344292|||Case-Control||Retrospective|||||||
1548194|NCT00344279||||||||||||
1548195|NCT00344266|||Cohort||Prospective|||||||
1548196|NCT00344253|Randomized|Crossover Assignment||Treatment||Single||||||t
1548197|NCT00344240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548198|NCT00344227|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548199|NCT00344214|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548200|NCT00344201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548201|NCT00344188||||||||||||
1548202|NCT00344175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548203|NCT00344162||||||||||||
1548204|NCT00344149|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548205|NCT00344136|||||Prospective|||||||
1548206|NCT00344123||Single Group Assignment||Treatment||None (Open Label)||||||
1548207|NCT00344110|Randomized|Parallel Assignment||Treatment||Double||||||
1548208|NCT00344097|Randomized|Parallel Assignment||Treatment||Double||||||
1548209|NCT00344084||||||||||||
1548210|NCT00344071||||||||||||
1548211|NCT00344058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548212|NCT00344045|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548213|NCT00344032|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548214|NCT00344019|Randomized|Parallel Assignment||Prevention||Quadruple||randomized trial of 80 mg atorvastatin vs. placebo pre PCI|t|t|t|t
1548215|NCT00344006|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548216|NCT00343993|Randomized|Parallel Assignment||Treatment||Single||||||
1548217|NCT00343980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548218|NCT00343954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548219|NCT00343941|Randomized|Parallel Assignment||Treatment||Double||||||
1548220|NCT00343928|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1548221|NCT00343915|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548222|NCT00343902|Randomized|Parallel Assignment||Treatment||Double||||||
1548223|NCT00343889|Randomized|Parallel Assignment||Prevention||Single||||||t
1548224|NCT00343876|Randomized|Parallel Assignment||Treatment||Double||||||
1548225|NCT00343863|Non-Randomized|Sequential Assignment||Supportive Care||None (Open Label)||||||
1548226|NCT00343850|Randomized|Parallel Assignment||Prevention||Single||||||
1548227|NCT00343824|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548228|NCT00343811|Randomized|Parallel Assignment||Treatment||Double||||||
1548229|NCT00343798||Single Group Assignment||Treatment||None (Open Label)||||||
1548230|NCT00343785||Single Group Assignment||Treatment||None (Open Label)||||||
1548231|NCT00343759|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548232|NCT00343733|Randomized|||Treatment||Double||||||
1548233|NCT00343720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548234|NCT00343707|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548235|NCT00343681||Single Group Assignment||Prevention||None (Open Label)||||||
1548236|NCT00343668|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548237|NCT00343655|Randomized|Parallel Assignment||Treatment||Double||||||
1548238|NCT00343642|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1548239|NCT00343629|Randomized|||Prevention||||||||
1548240|NCT00343616|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548241|NCT00343603||||||||||||
1548242|NCT00343590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548243|NCT00343577|||||Prospective|||||||
1548244|NCT00343564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548245|NCT00343551|Randomized|Parallel Assignment||Treatment||Double||||||
1548246|NCT00343525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548247|NCT00343512|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548248|NCT00343499|Randomized|Parallel Assignment||Treatment||Double||||||
1548249|NCT00343486|Randomized|Parallel Assignment||Treatment||Double||||||
1548250|NCT00343473|||Other||Other|||||||
1548251|NCT00343460|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1548252|NCT00343447|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548253|NCT00343434||||Supportive Care||||||||
1548254|NCT00343421|Randomized|Parallel Assignment||Prevention||Single||||||t
1548255|NCT00343408||||Treatment||None (Open Label)||||||
1548256|NCT00343395|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548257|NCT00343382|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1548258|NCT00343369|Randomized|||Treatment||||||||
1548259|NCT00343356|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548260|NCT00343343|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1548261|NCT00343317|Randomized|Parallel Assignment||Prevention||Double||||||
1548262|NCT00343304|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548263|NCT00343291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548264|NCT00343278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548265|NCT00343265|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548266|NCT00343252|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548267|NCT00343239||Single Group Assignment||Treatment||None (Open Label)||||||
1548268|NCT00343226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548269|NCT00343213|Non-Randomized|Factorial Assignment||Prevention||Double||||||
1548270|NCT00343200|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548271|NCT00343187|Randomized|Parallel Assignment||Treatment||Double||||||
1548272|NCT00343174|Randomized|Parallel Assignment||||Double||||||
1548273|NCT00343161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548274|NCT00343148|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548275|NCT00343135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548276|NCT00343122|||Defined Population||Longitudinal, Prospective|||||||
1548277|NCT00343109||Single Group Assignment||Prevention||None (Open Label)||||||
1548278|NCT00343096|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1548279|NCT00343083||Single Group Assignment||Treatment||None (Open Label)||||||
1548280|NCT00343070|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548281|NCT00343057||||||||||||
1548282|NCT00343044||Single Group Assignment||Treatment||None (Open Label)||||||
1548283|NCT00343031|||Cohort||Prospective|||||||
1548284|NCT00343018||||||||||||
1548285|NCT00343005||||Treatment||||||||
1548286|NCT00342992|||Cohort||Prospective|||||||
1548287|NCT00342966||||||||||||
1548288|NCT00342953|||Cohort||Retrospective|||||||
1548289|NCT00342940|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548290|NCT00342927|||Ecologic or Community||Prospective|||||||
1548291|NCT00342888|||Case-Control||Retrospective|||||||
1548292|NCT00342875|||Case-Control||Retrospective|||||||
1548293|NCT00342862|||Cohort||Prospective|||||||
1548294|NCT00342849|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548295|NCT00342836||||Treatment||||||||
1548296|NCT00342823||||||||||||
1548297|NCT00342810|||Cohort||Retrospective|||||||
1548298|NCT00342797|||Cohort||Retrospective|||||||
1548299|NCT00342784||||||||||||
1548300|NCT00342771|||Case-Control||Retrospective|||||||
1548301|NCT00342758||||||||||||
1548302|NCT00342732|||Ecologic or Community||Cross-Sectional|||||||
1548303|NCT00342706||||Treatment||||||||
1548304|NCT00342693||||||||||||
1548305|NCT00342667||||||||||||
1548306|NCT00342654|||Cohort||Other|||||||
1548307|NCT00342641||||||||||||
1548308|NCT00342628|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548309|NCT00342602||||||||||||
1548310|NCT00342589|||Cohort||Prospective|||||||
1548311|NCT00342576|||Cohort||Prospective|||||||
1548312|NCT00342563|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548313|NCT00342550|||Cohort||Prospective|||||||
1548314|NCT00342537|||Family-Based||Other|||||||
1548315|NCT00342524||||||||||||
1548316|NCT00342511||||||||||||
1548317|NCT00342498||||||||||||
1548318|NCT00342485||||||||||||
1548319|NCT00342472|||Ecologic or Community||Cross-Sectional|||||||
1548320|NCT00342446|||Cohort||Retrospective|||||||
1548321|NCT00342433|||Case-Only||Cross-Sectional|||||||
1548322|NCT00342407|||Case-Only||Other|||||||
1548323|NCT00342394||||||||||||
1548324|NCT00342381|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1548325|NCT00342368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548326|NCT00342355|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1548327|NCT00342342|||Cohort||Other|||||||
1548328|NCT00342329||||||||||||
1548329|NCT00342316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548330|NCT00342303||||||||||||
1548331|NCT00342290||||||||||||
1548332|NCT00342277||||||||||||
1548333|NCT00342264|||Other||Retrospective|||||||
1548334|NCT00342251|||||Prospective|||||||
1548335|NCT00342225||||||||||||
1548336|NCT00342212||||||||||||
1548337|NCT00342199||||||||||||
1548338|NCT00342186|||Family-Based||Cross-Sectional|||||||
1548339|NCT00342173|||Cohort||Prospective|||||||
1548340|NCT00342160||||||||||||
1548341|NCT00342147|||Family-Based||Prospective|||||||
1548342|NCT00342134||||Treatment||||||||
1548343|NCT00342121|||Case-Control||Prospective|||||||
1548344|NCT00342108|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548345|NCT00342095||||||||||||
1548346|NCT00342082||||||||||||
1548347|NCT00342069||||||||||||
1548348|NCT00342056||||||||||||
1548349|NCT00342043||||||||||||
1548350|NCT00342030||||||||||||
1548351|NCT00342017||||||||||||
1548352|NCT00342004|||Cohort||Prospective|||||||
1548353|NCT00341991|||Other||Retrospective|||||||
1548354|NCT00341965||||||||||||
1548355|NCT00341952|||Case-Control||Retrospective|||||||
1548356|NCT00341939|||Case-Only||Retrospective|||||||
1548357|NCT00341913||||||||||||
1548358|NCT00341900|||Case-Only||Cross-Sectional|||||||
1548359|NCT00341887||||||||||||
1548360|NCT00341874|||Family-Based||Other|||||||
1548361|NCT00341861|||Case-Control||Retrospective|||||||
1548362|NCT00341848|||Case-Only||Prospective|||||||
1548363|NCT00341835|||Family-Based||Other|||||||
1548364|NCT00341822||||||||||||
1548365|NCT00341809||||||||||||
1548366|NCT00341796||||||||||||
1548367|NCT00341783||||||||||||
1548368|NCT00341770||||||||||||
1548369|NCT00341757||||||||||||
1548370|NCT00341744|||Case-Only||Prospective|||||||
1548371|NCT00341731||||||||||||
1548372|NCT00341718||||||||||||
1548373|NCT00341705||||||||||||
1548374|NCT00341692|||Other||Cross-Sectional|||||||
1548375|NCT00341679|||Cohort||Prospective|||||||
1548376|NCT00341666||||||||||||
1548377|NCT00341653|||Cohort||Cross-Sectional|||||||
1548378|NCT00341640||||Treatment||||||||
1548379|NCT00341627|||Family-Based||Retrospective|||||||
1548380|NCT00341614|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548381|NCT00341601|||Cohort||Prospective|||||||
1548382|NCT00341588|||Case-Control||Retrospective|||||||
1548383|NCT00341575||||||||||||
1548384|NCT00341562||||||||||||
1548385|NCT00341549||||||||||||
1548386|NCT00341536||||||||||||
1548387|NCT00341523|||Cohort||Prospective|||||||
1548388|NCT00341510||||||||||||
1548389|NCT00341497|||Cohort||Prospective|||||||
1548390|NCT00341484|||Other||Cross-Sectional|||||||
1548391|NCT00341471||||Treatment||||||||
1548392|NCT00341458|||Case-Control||Retrospective|||||||
1548393|NCT00341445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548394|NCT00341432||||Treatment||||||||
1548395|NCT00341419||||||||||||
1548396|NCT00341406||||||||||||
1548397|NCT00341393||||||||||||
1548398|NCT00341380|||Case-Only||Other|||||||
1548399|NCT00341367||||||||||||
1548400|NCT00341354||||Treatment||||||||
1548401|NCT00341341||||||||||||
1548402|NCT00341328|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548403|NCT00341315|||Cohort||Prospective|||||||
1548404|NCT00341302|||Cohort||Prospective|||||||
1548405|NCT00341289||||||||||||
1548406|NCT00341276|||Other||Prospective|||||||
1548407|NCT00341263|||Case-Control||Prospective|||||||
1548408|NCT00341250||||Treatment||||||||
1548409|NCT00341237|||Cohort||Cross-Sectional|||||||
1548410|NCT00341224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548411|NCT00341211||||||||||||
1548412|NCT00341198||||||||||||
1548413|NCT00341185|||Cohort||Retrospective|||||||
1548414|NCT00341172|||Case-Control||Cross-Sectional|||||||
1548415|NCT00341159||||||||||||
1548416|NCT00341146|||Family-Based||Cross-Sectional|||||||
1548417|NCT00341133||||||||||||
1548418|NCT00341120||||||||||||
1548419|NCT00341107||||||||||||
1548420|NCT00341094|||Cohort||Retrospective|||||||
1548421|NCT00341081||||||||||||
1548422|NCT00341068|||Cohort||Cross-Sectional|||||||
1548423|NCT00341055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548424|NCT00341042||||||||||||
1548425|NCT00341029||||||||||||
1548426|NCT00341016|||Case-Control||Retrospective|||||||
1548427|NCT00341003||||||||||||
1548428|NCT00340990||||||||||||
1548429|NCT00340977|||Case-Control||Retrospective|||||||
1548430|NCT00340964||||||||||||
1548431|NCT00340951||||||||||||
1548432|NCT00340938||||Treatment||||||||
1548433|NCT00340912||||||||||||
1548434|NCT00340899|||Cohort||Prospective|||||||
1548435|NCT00340886||||||||||||
1548436|NCT00340873|||Case-Control||Retrospective|||||||
1548437|NCT00340860|||Cohort||Prospective|||||||
1548438|NCT00340847||||||||||||
1548439|NCT00340834|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1548440|NCT00340821||||||||||||
1548441|NCT00340808|||Case-Only||Prospective|||||||
1548442|NCT00340795||||||||||||
1548443|NCT00340782||||||||||||
1548444|NCT00340769||||||||||||
1548445|NCT00340756||||||||||||
1548446|NCT00340743|||Other||Prospective|||||||
1548447|NCT00340730||||||||||||
1548448|NCT00340717||||||||||||
1548449|NCT00340704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548450|NCT00340691||||Treatment||||||||
1548451|NCT00340678|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548452|NCT00340665||||||||||||
1548453|NCT00340652||||||||||||
1548454|NCT00340639||||||||||||
1548455|NCT00340626||||||||||||
1548456|NCT00340613|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548457|NCT00340600|||Cohort||Prospective|||||||
1548458|NCT00340587||||||||||||
1548459|NCT00340574||||Treatment||||||||
1548460|NCT00340561||||||||||||
1548461|NCT00340548|||Cohort||Prospective|||||||
1548462|NCT00340535|||Other||Cross-Sectional|||||||
1548463|NCT00340522||||||||||||
1548464|NCT00340509||||||||||||
1548465|NCT00340496||||||||||||
1548466|NCT00340483||||Treatment||||||||
1548467|NCT00340470||||Treatment||||||||
1548468|NCT00340457|||Case-Control||Retrospective|||||||
1548469|NCT00340444||||||||||||
1548470|NCT00340431||||Treatment||||||||
1548471|NCT00340418||||||||||||
1548472|NCT00340405|||Cohort||Prospective|||||||
1548473|NCT00340392||||||||||||
1548474|NCT00340379|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548475|NCT00340366||||||||||||
1548476|NCT00340353||||||||||||
1548477|NCT00340340|||Case-Control||Retrospective|||||||
1548478|NCT00340327|Randomized|Single Group Assignment||Diagnostic||Double||||||
1548479|NCT00340314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548480|NCT00340301|||Case-Control||Retrospective|||||||
1548481|NCT00340288|||Case-Only||Prospective|||||||
1548482|NCT00340275||||||||||||
1548483|NCT00340262|||Cohort||Prospective|||||||
1548484|NCT00340249||||||||||||
1548485|NCT00340223||||||||||||
1548486|NCT00340210|||Cohort||Prospective|||||||
1548487|NCT00340184|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548488|NCT00340171||||||||||||
1548489|NCT00340158|||||Retrospective|||||||
1548490|NCT00340132||||||||||||
1548491|NCT00340119||||||||||||
1548492|NCT00340106||||Treatment||||||||
1548493|NCT00340093||||Treatment||||||||
1548494|NCT00340080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548495|NCT00340054||||||||||||
1548496|NCT00340028||||||||||||
1548497|NCT00340015|||Cohort||Prospective|||||||
1548498|NCT00340002|||Cohort||Prospective|||||||
1548499|NCT00339989|||Cohort||Cross-Sectional|||||||
1548500|NCT00339976||||||||||||
1548501|NCT00339963|||Cohort||Retrospective|||||||
1548502|NCT00339950|||Cohort||Retrospective|||||||
1548503|NCT00339937|||Case-Control||Other|||||||
1548504|NCT00339924||||||||||||
1548505|NCT00339911|||Case-Only||Cross-Sectional|||||||
1548506|NCT00339898||||||||||||
1548507|NCT00339885|||Case-Control||Other|||||||
1548508|NCT00339872|Randomized|Single Group Assignment||Diagnostic||Double||||||
1548509|NCT00339859|||Case-Control||Cross-Sectional|||||||
1548510|NCT00339846||||||||||||
1548511|NCT00339833|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548512|NCT00339807||||||||||||
1548513|NCT00339794||||||||||||
1548514|NCT00339781||||||||||||
1548515|NCT00339768|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1548516|NCT00339742|||Case-Control||Retrospective|||||||
1548517|NCT00339729||||||||||||
1548518|NCT00339716|||Cohort||Prospective|||||||
1548519|NCT00339703|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1548520|NCT00339690|Randomized|Parallel Assignment||Other||Triple|||t|t||t
1548521|NCT00339677|||Other||Prospective|||||||
1548522|NCT00339664|||Case-Only||Retrospective|||||||
1548523|NCT00339651|||Case-Control||Retrospective|||||||
1548524|NCT00339638||||||||||||
1548525|NCT00339625|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548526|NCT00339612|||Cohort||Other|||||||
1548527|NCT00339599||||||||||||
1548528|NCT00339586|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548529|NCT00339573|||Other||Cross-Sectional|||||||
1548530|NCT00339560|||Case-Control||Prospective|||||||
1548531|NCT00339547|||Case-Control||Other|||||||
1548532|NCT00339534|||Case-Control||Retrospective|||||||
1548533|NCT00339521|||Family-Based||Cross-Sectional|||||||
1548534|NCT00339508||||||||||||
1548535|NCT00339495|||Cohort||Prospective|||||||
1548536|NCT00339482||||||||||||
1548537|NCT00339469|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1548538|NCT00339456||||Treatment||||||||
1548539|NCT00339443||||||||||||
1548540|NCT00339430||||||||||||
1548541|NCT00339417||||Treatment||||||||
1548542|NCT00339404||||||||||||
1548543|NCT00339391|||Cohort||Other|||||||
1548544|NCT00339378||||||||||||
1548545|NCT00339365|Randomized|Parallel Assignment||Prevention||Single|||t|||
1548546|NCT00339352|||Other||Retrospective|||||||
1548547|NCT00339339||||||||||||
1548548|NCT00339326|||Case-Control||Other|||||||
1548549|NCT00339313||||||||||||
1548550|NCT00339300|||Case-Control||Retrospective|||||||
1548551|NCT00339287|||Other||Other|||||||
1548552|NCT00339274||||||||||||
1548553|NCT00339261||||||||||||
1548554|NCT00339248||||||||||||
1548555|NCT00339235|||Cohort||Prospective|||||||
1548556|NCT00339222|||Family-Based||Other|||||||
1548557|NCT00339209||||||||||||
1548558|NCT00339196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548559|NCT00339183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548560|NCT00339170|Randomized|Parallel Assignment||Treatment||Single||||||t
1548561|NCT00339157|Randomized|Parallel Assignment||Treatment||Double||||||
1548562|NCT00339144|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548563|NCT00339131|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1548564|NCT00339118|Randomized|Parallel Assignment||||None (Open Label)||||||
1548565|NCT00339105|||Defined Population|Screening|Longitudinal, Prospective|||||||
1548566|NCT00339092|Randomized|Parallel Assignment||||None (Open Label)||||||
1548567|NCT00339079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548568|NCT00339066|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548569|NCT00339053|Randomized|Parallel Assignment||Treatment||Double||||||
1548570|NCT00339040|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548571|NCT00339027|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1548572|NCT00339014|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548573|NCT00339001|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1548574|NCT00338988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548575|NCT00338975|Randomized|Parallel Assignment||Treatment||Single||||||t
1548576|NCT00338962|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1548577|NCT00338949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548578|NCT00338936|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548579|NCT00338923||Single Group Assignment||Treatment||None (Open Label)||||||
1548580|NCT00338910|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548581|NCT00338897|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548582|NCT00338884|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548583|NCT00338871|Randomized|Crossover Assignment||Treatment||Single||||||t
1548584|NCT00338858|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548585|NCT00338845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548586|NCT00338832|Randomized|Parallel Assignment||Treatment||Single||||||t
1548587|NCT00338819|||Defined Population||Cross-Sectional, Prospective|||||||
1548588|NCT00338806|Randomized|Parallel Assignment||Prevention||Single||||||t
1548589|NCT00338793|Randomized|Parallel Assignment||Treatment||Double||||||
1548590|NCT00338780|Randomized|Parallel Assignment||Treatment||Double||||||
1548591|NCT00338767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548592|NCT00338754|Randomized|Parallel Assignment||Treatment||Double||||||
1548593|NCT00338741|||Case Control||Prospective|||||||
1548594|NCT00338728||Single Group Assignment||Treatment||None (Open Label)||||||
1548595|NCT00338715|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1548596|NCT00338702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548597|NCT00338689|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1548598|NCT00338676|||Cohort||Prospective|||||||
1548599|NCT00338663|Randomized|Single Group Assignment||Treatment||Single||||||
1548600|NCT00338650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548601|NCT00338637|Randomized|Parallel Assignment||Treatment||Double||||||
1548602|NCT00338624|Randomized|Parallel Assignment||Treatment||Double||||||
1548603|NCT00338611|Randomized|Parallel Assignment||Treatment||Single|||t|||
1548604|NCT00338598|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548605|NCT00338585|Randomized|Parallel Assignment||Treatment||Double||||||
1548606|NCT00338572|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548607|NCT00338559|||Cohort||Prospective|||||||
1548608|NCT00338546|Randomized|Crossover Assignment||Treatment||Double||||||
1548609|NCT00338533|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548610|NCT00338520|||Cohort||Prospective|||||||
1548611|NCT00338507|Randomized|Parallel Assignment||Treatment||Double||||||
1548612|NCT00338494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548613|NCT00338481|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548614|NCT00338468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548615|NCT00338455|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548616|NCT00338442||||||||||||
1548617|NCT00338429|Randomized|Parallel Assignment||Treatment||Single||||||t
1548618|NCT00338416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548619|NCT00338403|Randomized|Crossover Assignment||||None (Open Label)||||||
1548620|NCT00338390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548621|NCT00338377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548622|NCT00338364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548623|NCT00338351|Randomized|Parallel Assignment||Prevention||Single||||||
1548624|NCT00338338|Randomized|Parallel Assignment||Treatment||Double||||||
1548625|NCT00338325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548626|NCT00338312|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548627|NCT00338299|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548628|NCT00338286|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548629|NCT00338273|Randomized|Parallel Assignment||Treatment||Double||||||
1548630|NCT00338260|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548631|NCT00338247||||||||||||
1548632|NCT00338234|||Cohort||Prospective|||||||
1548633|NCT00338221|Randomized|Parallel Assignment||Treatment||Double||||||
1548634|NCT00338208|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548635|NCT00338195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548636|NCT00338182||Single Group Assignment||Treatment||None (Open Label)||||||
1548637|NCT00338156|||Cohort||Retrospective|||||||
1548638|NCT00338143||||Treatment||||||||
1548639|NCT00338130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548640|NCT00338117|Randomized|Parallel Assignment||Treatment||Double||||||
1548641|NCT00338104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548642|NCT00338091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548643|NCT00338078|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1548644|NCT00338065|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1548645|NCT00338052|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548646|NCT00338039||Single Group Assignment||Treatment||None (Open Label)||||||
1548647|NCT00338026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548648|NCT00338013|||||Prospective|||||||
1548649|NCT00338000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548650|NCT00337987||Single Group Assignment||Treatment||None (Open Label)||||||
1548651|NCT00337974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548652|NCT00337961|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548653|NCT00337948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548654|NCT00337935|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1548655|NCT00337922|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548656|NCT00337909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548657|NCT00337896|||Case Control||Prospective|||||||
1548658|NCT00337883||||Treatment||||||||
1548659|NCT00337870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548660|NCT00337831|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548661|NCT00337818|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548662|NCT00337805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548663|NCT00337792|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1548664|NCT00337779|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548665|NCT00337766|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1548666|NCT00337753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548667|NCT00337740|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548668|NCT00337727|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548669|NCT00337714|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548670|NCT00337701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548671|NCT00337688|||Case Control||Prospective|||||||
1548672|NCT00337675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548673|NCT00337662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548674|NCT00337649|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548675|NCT00337636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548676|NCT00337623|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548677|NCT00337610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548678|NCT00337597|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548679|NCT00337584|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1548680|NCT00337571|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548681|NCT00337558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548682|NCT00337545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548683|NCT00337532|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548684|NCT00337519|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548685|NCT00337506|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548686|NCT00337493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548687|NCT00337480|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548688|NCT00337467|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548689|NCT00337454|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548690|NCT00337441|Randomized|Crossover Assignment||Treatment||Double||||||
1548691|NCT00337428|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548692|NCT00337415|Randomized|Parallel Assignment||Treatment||Double||||||
1548693|NCT00337402|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1548694|NCT00337389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548695|NCT00337376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548696|NCT00337350|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1548697|NCT00337337|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548698|NCT00337324|Randomized|Crossover Assignment||Treatment||Double||||||
1548699|NCT00337298|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1548700|NCT00337285|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548701|NCT00337272|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548702|NCT00337259||Single Group Assignment||Treatment||None (Open Label)||||||
1548703|NCT00337246|Randomized|||Treatment||None (Open Label)||||||
1548704|NCT00337233||Single Group Assignment||Supportive Care||None (Open Label)||||||
1548705|NCT00337220|||Cohort||Prospective|||||||
1548706|NCT00337207||Single Group Assignment||Treatment||None (Open Label)||||||
1548707|NCT00337194|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1548708|NCT00337181|||Cohort||Prospective|||||||
1548709|NCT00337168||Single Group Assignment||Treatment||None (Open Label)||||||
1548710|NCT00337155|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548711|NCT00337142|||Cohort||Retrospective|||||||
1548712|NCT00337129||Single Group Assignment||Treatment||None (Open Label)||||||
1548713|NCT00337116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548714|NCT00337103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548715|NCT00337090|Randomized|Parallel Assignment||Treatment||Double||||||
1548716|NCT00337077||Single Group Assignment||Treatment||None (Open Label)||||||
1548717|NCT00337064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548718|NCT00337051|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1548719|NCT00337038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1548720|NCT00337012|||||Prospective|||||||
1548721|NCT00336986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548722|NCT00336973||Single Group Assignment||Treatment||None (Open Label)||||||
1548723|NCT00336960||Single Group Assignment||Treatment||None (Open Label)||||||
1548724|NCT00336947|Randomized|||Treatment||||||||
1548725|NCT00336934|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548726|NCT00336921|Randomized|Parallel Assignment||Treatment||Double||||||
1548727|NCT00336908|Randomized|Parallel Assignment||Treatment||Double||||||
1548728|NCT00336895||Single Group Assignment||Treatment||None (Open Label)||||||
1548729|NCT00336882|Randomized|Parallel Assignment||Treatment||Single|||t|||
1548730|NCT00336869|||Cohort||Cross-Sectional|||||||
1548731|NCT00336856||Single Group Assignment||Treatment||None (Open Label)||||||
1548732|NCT00336843||Single Group Assignment||Treatment||None (Open Label)||||||
1548733|NCT00336830|Randomized|Parallel Assignment||||Single|||t|||
1548734|NCT00336817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548735|NCT00336791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548736|NCT00336778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548737|NCT00336765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548738|NCT00336752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548739|NCT00336739|Randomized|Parallel Assignment||Diagnostic||Double||||||
1548740|NCT00336726|||||Prospective|||||||
1548741|NCT00336713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548742|NCT00336700||Single Group Assignment||Treatment||None (Open Label)||||||
1548743|NCT00336687|||||Prospective|||||||
1548744|NCT00336674|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1548745|NCT00336661|Randomized|Parallel Assignment||Treatment||Single||||||
1548746|NCT00336648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548747|NCT00336635|Randomized|Single Group Assignment||Prevention||Double||||||
1548748|NCT00336622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548749|NCT00336609|||Defined Population||Longitudinal, Prospective|||||||
1548750|NCT00336596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548751|NCT00336583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548752|NCT00336570|||Ecologic or Community||Cross-Sectional|||||||
1548753|NCT00336557|||Case Control||Prospective|||||||
1548754|NCT00336544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548755|NCT00336531|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1548756|NCT00336518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548757|NCT00336505|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548758|NCT00336492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548759|NCT00336479|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548760|NCT00336466|Randomized|Single Group Assignment||Treatment||Double||||||
1548761|NCT00336453|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1548762|NCT00336427|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1548763|NCT00336414|Randomized|Parallel Assignment||Treatment||Single||||||
1548764|NCT00336401|Randomized|Parallel Assignment||||Single||||||
1548765|NCT00336388|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1548766|NCT00336375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548767|NCT00336362|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548768|NCT00336349|Randomized|Crossover Assignment||Treatment||Double||||||
1548769|NCT00336336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548770|NCT00336323|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1548771|NCT00336310|Randomized|Parallel Assignment||Treatment||Double||||||
1548772|NCT00336297|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548773|NCT00336284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548774|NCT00336271|||Defined Population||Cross-Sectional, Prospective|||||||
1548775|NCT00336258|||Case-Only||Prospective|||||||
1548776|NCT00336245|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548777|NCT00336232||Single Group Assignment||Basic Science||None (Open Label)||||||
1548778|NCT00336219|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548779|NCT00336206|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548780|NCT00336193|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1548781|NCT00336180|Randomized|Parallel Assignment||||None (Open Label)||||||
1548782|NCT00336167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548783|NCT00336154|Randomized|Crossover Assignment||Treatment||Double||||||
1548784|NCT00336141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548785|NCT00336128|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548786|NCT00336115|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548787|NCT00336102|||Case Control||Prospective|||||||
1548788|NCT00336089|Randomized|||||||||||
1548789|NCT00336076|||Cohort||Prospective|||||||
1548790|NCT00336063||Single Group Assignment||Treatment||None (Open Label)||||||
1548791|NCT00336050|||Cohort||Prospective|||||||
1548792|NCT00336024|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548793|NCT00336011|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1548794|NCT00335998||Single Group Assignment||Treatment||None (Open Label)||||||
1548795|NCT00335985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548796|NCT00335972|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1548797|NCT00335959||Single Group Assignment||Treatment||None (Open Label)||||||
1548798|NCT00335946|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548799|NCT00335933|Randomized|Factorial Assignment||Treatment||Double||||||
1548800|NCT00335920|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548801|NCT00335907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548802|NCT00335894|Randomized|Parallel Assignment||Treatment||Single||||||
1548803|NCT00335881|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548804|NCT00335868||||Treatment||None (Open Label)||||||
1548805|NCT00335855|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548806|NCT00335829||Single Group Assignment||Treatment||None (Open Label)||||||
1548807|NCT00335816|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548808|NCT00335803||||||||||||
1548809|NCT00335790|Randomized|Parallel Assignment||Treatment||Double||||||
1548810|NCT00335777|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548811|NCT00335764|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548812|NCT00335751||Single Group Assignment||Diagnostic||None (Open Label)||||||
1548813|NCT00335738|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548814|NCT00335725|Randomized|Parallel Assignment||Treatment||Single||||||
1548815|NCT00335712|Randomized|Parallel Assignment||Treatment||Double||||||
1548816|NCT00335699|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548817|NCT00335686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548818|NCT00335673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548819|NCT00335660|Randomized|Parallel Assignment||Treatment||Double||||||
1548820|NCT00335647||||Treatment||None (Open Label)||||||
1548821|NCT00335634|||Case-Only||Prospective|||||||
1548822|NCT00335621|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548823|NCT00335595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548824|NCT00335582|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1548825|NCT00335569|Randomized|Parallel Assignment||Treatment||Single||||||
1548826|NCT00335556|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548827|NCT00335543|Randomized|||Treatment||None (Open Label)||||||
1548828|NCT00335517|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548829|NCT00335504|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548830|NCT00335491|Randomized|Crossover Assignment||Supportive Care||Single|||||t|
1548831|NCT00335478||Single Group Assignment||Supportive Care||None (Open Label)||||||
1548832|NCT00335465|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548833|NCT00335452|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1548834|NCT00335439|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548835|NCT00335426|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548836|NCT00335413|Randomized|Crossover Assignment||Treatment||Double||||||
1548837|NCT00335400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548838|NCT00335374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548839|NCT00335361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548840|NCT00335348||Single Group Assignment||Treatment||None (Open Label)||||||
1548841|NCT00335335|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1548842|NCT00335322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548843|NCT00335309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548844|NCT00335296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548845|NCT00335283|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548846|NCT00335270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548847|NCT00335257|||Cohort||Prospective|||||||
1548848|NCT00335244|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1548849|NCT00335231|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548850|NCT00335218|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548851|NCT00335205|Randomized|Parallel Assignment||Treatment||Double||||||
1548852|NCT00335192|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548853|NCT00335179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548854|NCT00335166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548855|NCT00335153||Single Group Assignment||Treatment||None (Open Label)||||||
1548856|NCT00335140||Single Group Assignment||Treatment||None (Open Label)||||||
1548857|NCT00335114|Randomized|Parallel Assignment||Treatment||Double||||||
1548858|NCT00335101|Randomized|Parallel Assignment||Diagnostic||Double||||||
1548859|NCT00335088|Randomized|Parallel Assignment||Prevention||Double||||||
1548860|NCT00335075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548861|NCT00335062|||Cohort||Prospective|||||||
1548862|NCT00335049|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1548863|NCT00335036|Randomized|Parallel Assignment||Treatment||None (Open Label)|Open label|||||
1548864|NCT00335023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548865|NCT00335010|Randomized|Parallel Assignment||Prevention||Double||||||
1548866|NCT00334997|Randomized|||Treatment||||||||
1548867|NCT00334984|Randomized|||Supportive Care||Double||||||
1548868|NCT00334971|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1548869|NCT00334958|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548870|NCT00334945|||Cohort||Prospective|||||||
1548871|NCT00334932||||Treatment||||||||
1548872|NCT00334919|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548873|NCT00334906|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548874|NCT00334893||Single Group Assignment||Treatment||None (Open Label)||||||
1548875|NCT00334880|Randomized|Parallel Assignment||Treatment||Double||||||
1548876|NCT00334867|Randomized|||Treatment||||||||
1548877|NCT00334854|Non-Randomized|||Treatment||||||||
1548878|NCT00334841||||||||||||
1548879|NCT00334828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548880|NCT00334815|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548881|NCT00334802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548882|NCT00334789||Single Group Assignment||Treatment||None (Open Label)||||||
1548883|NCT00334776|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548884|NCT00334763||||Treatment||None (Open Label)||||||
1548885|NCT00334750|||Cohort||Prospective|||||||
1548886|NCT00334737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548887|NCT00334724|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1548888|NCT00334711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548889|NCT00334698|Randomized|Crossover Assignment||Treatment||Double||||||
1548890|NCT00334685|Randomized|Parallel Assignment||Treatment||Double||||||
1548891|NCT00334672||||Treatment||None (Open Label)||||||
1548892|NCT00334659|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1548893|NCT00334646|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548894|NCT00334633|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548895|NCT00334620|Randomized|Parallel Assignment||Treatment||Double||||||
1548896|NCT00334607|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548897|NCT00334594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548898|NCT00334581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548899|NCT00334568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548900|NCT00334555|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548901|NCT00334542||Single Group Assignment||Prevention||None (Open Label)||||||
1548902|NCT00334529|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548903|NCT00334516||||||||||||
1548904|NCT00334503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548905|NCT00334490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548906|NCT00334477|Randomized|Parallel Assignment||Treatment||Double||||||
1548907|NCT00334464|Randomized|Parallel Assignment||Treatment||Double||||||
1548908|NCT00334451|||Cohort||Prospective|||||||
1548909|NCT00334438||Single Group Assignment||Treatment||None (Open Label)||||||
1548910|NCT00334425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548911|NCT00334412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548912|NCT00334399|Randomized|Parallel Assignment||Treatment||Double||||||
1548913|NCT00334386|Randomized|Parallel Assignment||Treatment||Double||||||
1548914|NCT00334373|Randomized|Parallel Assignment||Treatment||Single||||||t
1548915|NCT00334360|Randomized|Crossover Assignment||Treatment||Single||||||t
1548916|NCT00334347|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1548917|NCT00334334|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548918|NCT00334321||Single Group Assignment||Treatment||None (Open Label)||||||
1548919|NCT00334308|Randomized|Crossover Assignment||Treatment||Single||||||
1548920|NCT00334295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548921|NCT00334282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548922|NCT00334269|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548923|NCT00334256|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548924|NCT00334243|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548925|NCT00334230||||||||||||
1548926|NCT00334217|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548927|NCT00334204||Single Group Assignment||Diagnostic||None (Open Label)||||||
1548928|NCT00334191|Randomized|Parallel Assignment||Prevention||Double||||||
1548929|NCT00334178|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1548930|NCT00334165|Randomized|Parallel Assignment||Treatment||Double||||||
1548931|NCT00334152|Randomized|Parallel Assignment||Prevention||Double||||||
1548932|NCT00334139||Single Group Assignment||Treatment||None (Open Label)||||||
1548933|NCT00334126|Randomized|Parallel Assignment||Treatment||Double||||||
1548934|NCT00334113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548935|NCT00334100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548936|NCT00334087|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1548937|NCT00334074||Single Group Assignment||Treatment||None (Open Label)||||||
1548938|NCT00334061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548939|NCT00334048|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1548940|NCT00334035|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1548941|NCT00334022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548942|NCT00334009|||||Prospective|||||||
1548943|NCT00333996|Randomized|Parallel Assignment||Treatment||Double||||||
1548944|NCT00333983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548945|NCT00333970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548946|NCT00333957|||||Prospective|||||||
1548947|NCT00333944|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548948|NCT00333931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548949|NCT00333918|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1548950|NCT00333905|Randomized|Parallel Assignment||Treatment||Single||||||
1548951|NCT00333892|||Cohort||Prospective|||||||
1548952|NCT00333879||Single Group Assignment||||None (Open Label)||||||
1548953|NCT00333866|Randomized|Parallel Assignment||Treatment||Double||||||
1548954|NCT00333853|Randomized|Parallel Assignment||||None (Open Label)||||||
1548955|NCT00333840|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548956|NCT00333827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548957|NCT00333814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548958|NCT00333801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548959|NCT00333788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548960|NCT00333775|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1548961|NCT00333762||Single Group Assignment||Prevention||None (Open Label)||||||
1548962|NCT00333749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1548963|NCT00333736|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548964|NCT00333723|Randomized|Parallel Assignment||Treatment||Double||||||
1548965|NCT00333710|Randomized|Parallel Assignment||||None (Open Label)||||||
1548966|NCT00333697|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1548967|NCT00333684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548968|NCT00333671||Crossover Assignment||Basic Science||None (Open Label)||||||
1548969|NCT00333658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548970|NCT00333645|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1548971|NCT00333632|Randomized|Single Group Assignment||Treatment||Double||||||
1548972|NCT00333619|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1548973|NCT00333606|Randomized|Crossover Assignment||Diagnostic||Single||||||
1548974|NCT00333593|Randomized|Crossover Assignment||Treatment||Double||||||
1548975|NCT00333580|||||Prospective|||||||
1548976|NCT00333567|Randomized|Parallel Assignment||Treatment||Double||||||
1548977|NCT00333554|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548978|NCT00333541|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1548979|NCT00333528|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1548980|NCT00333515|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1548981|NCT00333502|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548982|NCT00333489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1548983|NCT00333476|Randomized|Parallel Assignment||||None (Open Label)||||||
1548984|NCT00333463|||||Retrospective|||||||
1548985|NCT00333450|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1548986|NCT00333437||Single Group Assignment||Treatment||None (Open Label)||||||
1548987|NCT00333424|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1548988|NCT00333411|Randomized|Parallel Assignment||Treatment||Double||||||
1548989|NCT00333398|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1548990|NCT00333385|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1548991|NCT00333372|Randomized|Parallel Assignment||Treatment||Double||||||
1548992|NCT00333359||Single Group Assignment||Treatment||None (Open Label)||||||
1548993|NCT00333346|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548994|NCT00333333|||Cohort||Prospective|||||||
1548995|NCT00333320|Randomized|Parallel Assignment||Treatment||Single||||||t
1548996|NCT00333307|Randomized|Parallel Assignment||Treatment||Double||||||
1548997|NCT00333294|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1548998|NCT00333281|Randomized|Parallel Assignment||Treatment||Double||||||
1548999|NCT00333268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549000|NCT00333255|Randomized|Parallel Assignment||Treatment||Single||||||
1549001|NCT00333242|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549002|NCT00333229|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1549003|NCT00333216|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549004|NCT00333203|Randomized|Parallel Assignment||Treatment||Single||||||
1549005|NCT00333190|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549006|NCT00333177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549007|NCT00333164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549008|NCT00333151|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549009|NCT00333138|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549010|NCT00333125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549011|NCT00333112|Randomized|Parallel Assignment||Treatment||Double||||||
1549012|NCT00333099|Randomized|Parallel Assignment||||Double|||t||t|
1549013|NCT00333086||Single Group Assignment||Treatment||None (Open Label)||||||
1549014|NCT00333073||Single Group Assignment||Treatment||None (Open Label)||||||
1549015|NCT00333060|Randomized|Parallel Assignment||||Double||||||
1549016|NCT00333047|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549017|NCT00333034|Randomized|Parallel Assignment||Treatment||Double||||||
1549018|NCT00333021|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549019|NCT00333008|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549020|NCT00332995|Randomized|Parallel Assignment||Prevention||Double||||||
1549021|NCT00332982|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1549022|NCT00332969||Single Group Assignment||Treatment||None (Open Label)||||||
1549023|NCT00332956|Randomized|Parallel Assignment||||Triple|||t|t|t|
1549024|NCT00332943|Randomized|Parallel Assignment||Diagnostic||Single||||||
1549025|NCT00332930|Randomized|Parallel Assignment||Treatment||Double||||||
1549026|NCT00332917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549027|NCT00332904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549028|NCT00332891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549029|NCT00332878|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549030|NCT00332865|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549031|NCT00332852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549032|NCT00332839|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549033|NCT00332826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549034|NCT00332813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549035|NCT00332800|Randomized|Single Group Assignment||Treatment||Single||||||
1549036|NCT00332787|Randomized|Parallel Assignment||Treatment||Double||||||
1549037|NCT00332774|Randomized|Parallel Assignment||Treatment||Double||||||
1549038|NCT00332761|Randomized|Parallel Assignment||Treatment||Double||||||
1549039|NCT00332748|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549040|NCT00332735|Randomized|Parallel Assignment||Treatment||Double||||||
1549041|NCT00332722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549042|NCT00332709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549043|NCT00332696|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549044|NCT00332683|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1549045|NCT00332670|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549046|NCT00332657|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549047|NCT00332644|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1549048|NCT00332631|Randomized|Parallel Assignment||Prevention||Double||||||
1549049|NCT00332618|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1549050|NCT00332605|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549051|NCT00332592|||Cohort||Prospective|||||||
1549052|NCT00332579|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549053|NCT00332566|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549054|NCT00332553|Randomized|Parallel Assignment||Prevention||Double||||||
1549055|NCT00332540|Randomized|Parallel Assignment||Treatment||Double||||||
1549056|NCT00332514|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549057|NCT00332488|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549058|NCT00332462|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549059|NCT00332449|||Cohort||Prospective|||||||
1549060|NCT00332436|Randomized|Parallel Assignment||Treatment||Double||||||
1549061|NCT00332410|||Other||Prospective|||||||
1549062|NCT00332397|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549063|NCT00332384|Randomized|Parallel Assignment||Treatment||Double||||||
1549064|NCT00332371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549065|NCT00332345|Randomized|Parallel Assignment||Treatment||Single||||||
1549066|NCT00332332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549067|NCT00332319|Randomized|Crossover Assignment||Treatment||Double||||||
1549068|NCT00332306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549069|NCT00332293|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549070|NCT00332280||Single Group Assignment||Treatment||None (Open Label)||||||
1549071|NCT00332267|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1549072|NCT00332254|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549073|NCT00332241|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549074|NCT00332228|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1549075|NCT00332215|Randomized|Parallel Assignment||Treatment||Double||||||
1549076|NCT00332202|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1549077|NCT00332189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549078|NCT00332176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549079|NCT00332163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549080|NCT00332150|||Cohort||Prospective|||||||
1549081|NCT00332137|Randomized|Parallel Assignment||Treatment||Double||||||
1549082|NCT00332124|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549083|NCT00332111|||||Prospective|||||||
1549084|NCT00332098|Randomized|Parallel Assignment||Treatment||Single||||||t
1549085|NCT00332085|Randomized|Single Group Assignment||Treatment||Double||||||
1549086|NCT00332072|Randomized|Parallel Assignment||Treatment||Double||||||
1549087|NCT00332059|Randomized|Parallel Assignment||Treatment||Double||||||
1549088|NCT00332046|Randomized|Parallel Assignment||Diagnostic||Double||||||
1549089|NCT00332033||||Treatment||||||||
1549090|NCT00332020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549091|NCT00332007|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1549092|NCT00331994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549093|NCT00331981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549094|NCT00331955||Single Group Assignment||Treatment||None (Open Label)||||||
1549095|NCT00331942|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1549096|NCT00331929|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549097|NCT00331916|Randomized|Parallel Assignment||Treatment||Double||||||
1549098|NCT00331890|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549099|NCT00331877|Randomized|Single Group Assignment||Educational/Counseling/Training||Double||||||
1549100|NCT00331864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549101|NCT00331851|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549102|NCT00331838|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1549103|NCT00331825|Randomized|Parallel Assignment||Treatment||Single||||||
1549104|NCT00331812|||||Prospective|||||||
1549105|NCT00331799||Single Group Assignment||Treatment||None (Open Label)||||||
1549106|NCT00331786|Randomized|||Prevention||Double||||||
1549107|NCT00331773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549108|NCT00331760|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549109|NCT00331747|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549110|NCT00331721|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549111|NCT00331708||Single Group Assignment||Treatment||None (Open Label)||||||
1549112|NCT00331695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549113|NCT00331682||Single Group Assignment||Treatment||None (Open Label)||||||
1549114|NCT00331669|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1549115|NCT00331656|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549116|NCT00331643||Single Group Assignment||Treatment||None (Open Label)||||||
1549117|NCT00331630||Single Group Assignment||Treatment||None (Open Label)||||||
1549118|NCT00331604|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549119|NCT00331578|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549120|NCT00331565|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1549121|NCT00331552||Single Group Assignment||Treatment||None (Open Label)||||||
1549122|NCT00331539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549123|NCT00331526||Single Group Assignment||Treatment||None (Open Label)||||||
1549124|NCT00331513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549125|NCT00331500|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1549126|NCT00331487|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549127|NCT00331474|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549128|NCT00331448|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1549129|NCT00331435|Randomized|Parallel Assignment||Treatment||Single|||t|||
1549130|NCT00331422|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549131|NCT00331409||Single Group Assignment||Treatment||None (Open Label)||||||
1549132|NCT00331370|Randomized|Factorial Assignment||Prevention||Single||||||
1549133|NCT00331357|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1549134|NCT00331344||Sequential Assignment||Treatment||None (Open Label)||||||
1549135|NCT00331331||||||||||||
1549136|NCT00331318||||||||||||
1549137|NCT00331305|Randomized|Parallel Assignment||Treatment||Double||||||
1549138|NCT00331292|||||Prospective|||||||
1549139|NCT00331279|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1549140|NCT00331253|Randomized|Parallel Assignment||Treatment||Double||||||
1549141|NCT00331240|Randomized|Crossover Assignment||Treatment||Double||||||
1549142|NCT00331227|Randomized|Crossover Assignment||Prevention||Double||||||
1549143|NCT00331214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549144|NCT00331201|Randomized|Single Group Assignment||Treatment||Double||||||
1549145|NCT00331188|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549146|NCT00331175|Randomized|Crossover Assignment||Treatment||Single||||||
1549147|NCT00331162|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549148|NCT00331149|Randomized|Parallel Assignment||Treatment||||||||
1549149|NCT00331136|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1549150|NCT00331123|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549151|NCT00331110|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549152|NCT00331097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549153|NCT00331084|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549154|NCT00331071|||Case Control||Retrospective|||||||
1549155|NCT00331058|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1549156|NCT00331045|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549157|NCT00331032|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1549158|NCT00331019|||Cohort||Prospective|||||||
1549159|NCT00331006||Single Group Assignment||Treatment||None (Open Label)||||||
1549160|NCT00330993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549161|NCT00330980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549162|NCT00330967|||||Prospective|||||||
1549163|NCT00330954|||Case Control||Prospective|||||||
1549164|NCT00330941|Randomized|Parallel Assignment||Prevention||Double||||||
1549165|NCT00330928|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549166|NCT00330915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549167|NCT00330902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549168|NCT00330889|||||Prospective|||||||
1549169|NCT00330876|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549170|NCT00330863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549171|NCT00330850|Randomized|||Treatment||Double||||||
1549172|NCT00330837|||||Prospective|||||||
1549173|NCT00330824|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549174|NCT00330811|||Cohort||Prospective|||||||
1549175|NCT00330798|Randomized|Parallel Assignment||Treatment||Double||||||
1549176|NCT00330785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549177|NCT00330772|Randomized|Factorial Assignment||Treatment||Double||||||
1549178|NCT00330759|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1549179|NCT00330746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549180|NCT00330733|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1549181|NCT00330720|Randomized|Single Group Assignment||Treatment||Single||||||
1549182|NCT00330707|Randomized|Single Group Assignment||Treatment||Double||||||
1549183|NCT00330694|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1549184|NCT00330681|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549185|NCT00330668||Single Group Assignment||Treatment||None (Open Label)||||||
1549186|NCT00330655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549187|NCT00330642|||Cohort||Prospective|||||||
1549188|NCT00330629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549189|NCT00330616||||Treatment||None (Open Label)||||||
1549190|NCT00330603|||Cohort||Prospective|||||||
1549191|NCT00330590|||||Prospective|||||||
1549192|NCT00330577|Randomized|Crossover Assignment||Treatment||Double||||||
1549193|NCT00330564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549194|NCT00330551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549195|NCT00330538|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1549196|NCT00330525|Randomized|Parallel Assignment||Treatment||Double||||||
1549197|NCT00330512|||Cohort||Retrospective|||||||
1549198|NCT00330499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549199|NCT00330486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549200|NCT00330473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549201|NCT00330460|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549202|NCT00330447|||Cohort||Prospective|||||||
1549203|NCT00330434|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549204|NCT00330421|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549205|NCT00330408|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1549206|NCT00330395|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549207|NCT00330382|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549208|NCT00330369|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549209|NCT00330356|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1549210|NCT00330343||Single Group Assignment||Treatment||None (Open Label)||||||
1549211|NCT00330330|Randomized|Parallel Assignment||Treatment||Double||||||
1549212|NCT00330317||Single Group Assignment||Treatment||None (Open Label)||||||
1549213|NCT00330304|Randomized|Factorial Assignment||Prevention||Double||||||
1549214|NCT00330291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549215|NCT00330278|Randomized|Parallel Assignment||Prevention||Double||||||
1549216|NCT00330265|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549291|NCT00329238|Randomized|Parallel Assignment||Treatment||Double||||||
1549217|NCT00330252||Single Group Assignment||Treatment||None (Open Label)||||||
1549218|NCT00330239|Randomized|Parallel Assignment||Treatment||Double||||||
1549219|NCT00330226|||Cohort||Prospective|||||||
1549220|NCT00330213|Randomized|Crossover Assignment||Treatment||Single||||||
1549221|NCT00330200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549222|NCT00330187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549223|NCT00330174|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549224|NCT00330161||Single Group Assignment||Treatment||None (Open Label)||||||
1549225|NCT00330148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549226|NCT00330135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549227|NCT00330122|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549228|NCT00330109||Single Group Assignment||Diagnostic||None (Open Label)||||||
1549229|NCT00330096|Randomized|Parallel Assignment||Prevention||Double||||||
1549230|NCT00330083|Randomized|Single Group Assignment||Treatment||Double||||||
1549231|NCT00330070|Randomized|Parallel Assignment||Treatment||Double||||||
1549232|NCT00330044||Single Group Assignment||Treatment||None (Open Label)||||||
1549233|NCT00330018|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549234|NCT00330005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549235|NCT00329992|Randomized|Parallel Assignment||Treatment||Single||||||t
1549236|NCT00329979|||||Prospective|||||||
1549237|NCT00329966|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549238|NCT00329940||Single Group Assignment||Treatment||None (Open Label)||||||
1549239|NCT00329927|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549240|NCT00329914|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1549241|NCT00329901|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549242|NCT00329888|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1549243|NCT00329862|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549244|NCT00329849|Randomized|Parallel Assignment||Prevention||Single|||t|||
1549245|NCT00329836|||Cohort||Prospective|||||||
1549246|NCT00329823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549247|NCT00329810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549248|NCT00329797|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1549249|NCT00329784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549250|NCT00329771|||Cohort||Prospective|||||||
1549251|NCT00329758|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1549252|NCT00329745|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1549253|NCT00329732|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549254|NCT00329719|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549255|NCT00329706|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1549256|NCT00329693|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1549257|NCT00329680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549258|NCT00329667|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549259|NCT00329654|Randomized|Single Group Assignment||Treatment||Single|||t|||
1549260|NCT00329641||Single Group Assignment||Treatment||None (Open Label)||||||
1549261|NCT00329628|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549262|NCT00329615|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549263|NCT00329602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549264|NCT00329589|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549265|NCT00329576||||||||||||
1549266|NCT00329563|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549267|NCT00329550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549268|NCT00329537|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549269|NCT00329524|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1549270|NCT00329511|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549271|NCT00329498|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549272|NCT00329485|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1549273|NCT00329472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549274|NCT00329459|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549275|NCT00329446|Randomized|Parallel Assignment||Treatment||Double||||||
1549276|NCT00329433|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1549277|NCT00329420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549278|NCT00329407|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549279|NCT00329394|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1549280|NCT00329381|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549281|NCT00329368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549282|NCT00329355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549283|NCT00329342|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1549284|NCT00329329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549285|NCT00329316|Randomized|Parallel Assignment||||None (Open Label)||||||
1549286|NCT00329303|Randomized|Parallel Assignment||Treatment||Single||||||
1549287|NCT00329290|||Case-Only||Retrospective|||||||
1549288|NCT00329277|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549289|NCT00329264|Randomized|Parallel Assignment||Treatment||Double||||||
1549290|NCT00329251|Randomized|Parallel Assignment||Treatment||Double||||||
1549292|NCT00329225|Randomized|Parallel Assignment||Treatment||Double||||||
1549293|NCT00329212|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1549294|NCT00329199|Randomized|Factorial Assignment||Treatment||Single||||||
1549295|NCT00329186|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549296|NCT00329173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549297|NCT00329160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549298|NCT00329147|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549299|NCT00329134|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549300|NCT00329121|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549301|NCT00329108|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1549302|NCT00329095|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1549303|NCT00329082|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549304|NCT00329069|Randomized|Parallel Assignment||Diagnostic||Double||||||
1549305|NCT00329056|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1549306|NCT00329043||Single Group Assignment||Treatment||None (Open Label)||||||
1549307|NCT00329030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549308|NCT00329017|||Cohort||Prospective|||||||
1549309|NCT00329004|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549310|NCT00328991|Randomized|Single Group Assignment||Treatment||Double||||||
1549311|NCT00328978|Randomized|Parallel Assignment||Treatment||Double||||||
1549312|NCT00328965|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549313|NCT00328952|||Case Control||Prospective|||||||
1549314|NCT00328939|Randomized|Parallel Assignment||Prevention||Single||||||
1549315|NCT00328926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549316|NCT00328913|Randomized|Crossover Assignment||Treatment||Double||||||
1549317|NCT00328900|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1549318|NCT00328887||Single Group Assignment||Treatment||None (Open Label)||||||
1549319|NCT00328874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549320|NCT00328861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549321|NCT00328848|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1549322|NCT00328835|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1549323|NCT00328822|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549324|NCT00328809||Crossover Assignment||Treatment||None (Open Label)||||||
1549325|NCT00328796|Randomized|Parallel Assignment||Treatment||Single||||||t
1549326|NCT00328783||Single Group Assignment||Supportive Care||None (Open Label)||||||
1549327|NCT00328770||Single Group Assignment||Treatment||None (Open Label)||||||
1549328|NCT00328757|Randomized|Parallel Assignment||Treatment||Single||||||
1549329|NCT00328744|Randomized|Parallel Assignment||Treatment||Single||||||t
1549330|NCT00328731|Randomized|Parallel Assignment||Treatment||Double||||||
1549331|NCT00328718|Randomized|Parallel Assignment||Treatment||Double||||||
1549332|NCT00328705|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549333|NCT00328692|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549334|NCT00328679|Non-Randomized|Single Group Assignment||Supportive Care||Single||||||t
1549335|NCT00328666|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549336|NCT00328653|Randomized|Parallel Assignment||||Double||||||
1549337|NCT00328640|Randomized|Single Group Assignment||Prevention||Single||||||
1549338|NCT00328627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549339|NCT00328614|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549340|NCT00328601|Randomized|Parallel Assignment||Treatment||Double||||||
1549341|NCT00328588|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549342|NCT00328575||Single Group Assignment||Treatment||None (Open Label)||||||
1549343|NCT00328562||Single Group Assignment||Treatment||None (Open Label)||||||
1549344|NCT00328549|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549345|NCT00328536|Randomized|Crossover Assignment||Treatment||Double||||||
1549346|NCT00328523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549347|NCT00328510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549348|NCT00328497|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549349|NCT00328484|Randomized|Parallel Assignment||Treatment||Single|||t|||
1549350|NCT00328471||Single Group Assignment||Prevention||None (Open Label)||||||
1549351|NCT00328458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549352|NCT00328445|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549353|NCT00328432|Randomized|Parallel Assignment||Prevention||Double||||||
1549354|NCT00328419|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549355|NCT00328393|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1549356|NCT00328380|Randomized|Parallel Assignment||Prevention||Double||||||
1549357|NCT00328367|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1549358|NCT00328354|||Other||Prospective|||||||
1549359|NCT00328341|||Cohort||Prospective|||||||
1549360|NCT00328315|||Other||Prospective|||||||
1549361|NCT00328302|Randomized|Parallel Assignment||Treatment||Double||||||
1549362|NCT00328289|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549363|NCT00328276|Randomized|Parallel Assignment||Treatment||Double||||||
1549364|NCT00328263|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549365|NCT00328250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549366|NCT00328237|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549367|NCT00328224|||Case Control|||||||||
1549368|NCT00328211|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549369|NCT00328198|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549370|NCT00328185|||||Retrospective|||||||
1549371|NCT00328172|Randomized|Parallel Assignment||Treatment||Double||||||
1549372|NCT00328159|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1549373|NCT00328146|||Other||Retrospective|||||||
1549374|NCT00328133|||Cohort||Cross-Sectional|||||||
1549375|NCT00328120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549376|NCT00328107|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1549377|NCT00328094|Randomized|Parallel Assignment||Treatment||Single||||||t
1549378|NCT00328081|||Defined Population|Screening|Longitudinal, Prospective|||||||
1549379|NCT00328068|||Cohort||Prospective|||||||
1549380|NCT00328055|Randomized|Crossover Assignment||||Single||||||
1549381|NCT00328042|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1549382|NCT00328029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549383|NCT00328016|Randomized|Parallel Assignment||Treatment||Single|||t|||
1549384|NCT00327990|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549385|NCT00327977|||||Retrospective|||||||
1549386|NCT00327964|||Cohort||Prospective|||||||
1549387|NCT00327951|||||Retrospective|||||||
1549388|NCT00327938|Non-Randomized|Single Group Assignment||Treatment||Double||||||
1549389|NCT00327925|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1549390|NCT00327912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549391|NCT00327899|||||Retrospective|||||||
1549392|NCT00327886|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1549393|NCT00327873|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549394|NCT00327860|||Cohort||Prospective|||||||
1549395|NCT00327847|Randomized|Parallel Assignment||Treatment||Double||||||
1549396|NCT00327834|Randomized|Parallel Assignment||||Double||||||
1549397|NCT00327821|Randomized|Parallel Assignment||||None (Open Label)||||||
1549398|NCT00327808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549399|NCT00327795|||Case Control||Retrospective|||||||
1549400|NCT00327782|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1549401|NCT00327769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549402|NCT00327756|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1549403|NCT00327743||Single Group Assignment||Treatment||None (Open Label)||||||
1549404|NCT00327730|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549405|NCT00327717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549406|NCT00327704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549407|NCT00327691|Randomized|Parallel Assignment||Prevention||Double||||||
1549408|NCT00327678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549409|NCT00327665|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1549410|NCT00327652|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549411|NCT00327639|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1549412|NCT00327626|Randomized|Parallel Assignment||Treatment||Double||||||
1549413|NCT00327613|||Case-Only||Prospective|||||||
1549414|NCT00327600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549415|NCT00327587|Randomized|Parallel Assignment||Treatment||Double||||||
1549416|NCT00327574|Randomized|Factorial Assignment||Prevention||Single||||||
1549417|NCT00327561|Randomized|Parallel Assignment||Treatment||Double||||||
1549418|NCT00327548|Randomized|Parallel Assignment||||Double||||||
1549419|NCT00327535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549420|NCT00327522|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549421|NCT00327509|||Case Control||Prospective|||||||
1549422|NCT00327496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549423|NCT00327483|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1549424|NCT00327470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549425|NCT00327457|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1549426|NCT00327444|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549427|NCT00327431|||||Prospective|||||||
1549428|NCT00327418|Randomized|Parallel Assignment||Prevention||Double||||||
1549429|NCT00327405||||||||||||
1549430|NCT00327392|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549431|NCT00327379|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549432|NCT00327366|Non-Randomized|Crossover Assignment||Basic Science||Single||||||t
1549433|NCT00327353|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549434|NCT00327340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549435|NCT00327327|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549436|NCT00327314|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549437|NCT00327301|||Case-Only||Prospective|||||||
1549438|NCT00327288|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549439|NCT00327275|Randomized|Single Group Assignment||||None (Open Label)||||||
1549440|NCT00327262|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549441|NCT00327249|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549442|NCT00327236|||Cohort||Prospective|||||||
1549443|NCT00327223|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549444|NCT00327210|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1549445|NCT00327197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549446|NCT00327184|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549447|NCT00327171|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549448|NCT00327158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549449|NCT00327145|Randomized|Parallel Assignment||Treatment||Double||||||
1549450|NCT00327132||Single Group Assignment||Treatment||None (Open Label)||||||
1549451|NCT00327119|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549452|NCT00327106|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549453|NCT00327093|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549454|NCT00327080||||Treatment||||||||
1549455|NCT00327067|||||Prospective|||||||
1549456|NCT00327054|Randomized|Parallel Assignment||Treatment||Double||||||
1549457|NCT00327041||||||||||||
1549458|NCT00327028|Randomized|Parallel Assignment||Treatment||Double||||||
1549459|NCT00327015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549460|NCT00327002|Randomized|Parallel Assignment||Treatment||Double||||||
1549461|NCT00326989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549462|NCT00326976|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549463|NCT00326963||Single Group Assignment||Treatment||None (Open Label)||||||
1549464|NCT00326950|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549465|NCT00326924|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549466|NCT00326911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549467|NCT00326898|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549468|NCT00326885||Single Group Assignment||Treatment||None (Open Label)||||||
1549469|NCT00326872||Single Group Assignment||Treatment||None (Open Label)||||||
1549470|NCT00326859|Randomized|Crossover Assignment||Treatment||Double||||||
1549471|NCT00326833|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549472|NCT00326820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549473|NCT00326807|Randomized|||Treatment||Double||||||
1549474|NCT00326794|Randomized|Parallel Assignment||Treatment||Single||||||
1549475|NCT00326781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549476|NCT00326768|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549477|NCT00326742|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1549478|NCT00326729|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1549479|NCT00326716|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549480|NCT00326703|Randomized|Parallel Assignment||||Single||||||
1549481|NCT00326690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549482|NCT00326677|Randomized|Parallel Assignment||Prevention||Single||||||t
1549483|NCT00326664||Single Group Assignment||Treatment||None (Open Label)||||||
1549484|NCT00326651|||Natural History||Longitudinal, Retrospective/Prospective|||||||
1549485|NCT00326638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549486|NCT00326625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549487|NCT00326612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549488|NCT00326599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549489|NCT00326586|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1549490|NCT00326573|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1549491|NCT00326560|Randomized|Parallel Assignment||Treatment||Single||||||
1549492|NCT00326534|||Case Control||Prospective|||||||
1549493|NCT00326521|||Case Control||Prospective|||||||
1549494|NCT00326508||||Treatment||||||||
1549495|NCT00326495||Single Group Assignment||Treatment||None (Open Label)||||||
1549496|NCT00326482|||Cohort||Prospective|||||||
1549497|NCT00326469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549498|NCT00326456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549499|NCT00326443|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549500|NCT00326430|Randomized|Parallel Assignment||Treatment||Single||||||
1549501|NCT00326417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549502|NCT00326404|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549503|NCT00326391|Randomized|Parallel Assignment||Treatment||Double||||||
1549504|NCT00326378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549505|NCT00326365|Randomized|Parallel Assignment||Treatment||Double||||||
1549506|NCT00326352|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549507|NCT00326339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549508|NCT00326326|Randomized|Parallel Assignment||Treatment||Double||||||
1549509|NCT00326313||||||||||||
1549510|NCT00326300|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549511|NCT00326287|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549512|NCT00326274|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1549513|NCT00326261|||||Prospective|||||||
1549514|NCT00326248|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549515|NCT00326235|Randomized|Parallel Assignment||Treatment||Double||||||
1549516|NCT00326222|Randomized|Parallel Assignment||||None (Open Label)||||||
1549517|NCT00326209|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549518|NCT00326196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549519|NCT00326183|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549520|NCT00326170||Single Group Assignment||Treatment||None (Open Label)||||||
1549521|NCT00326157|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549522|NCT00326144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549523|NCT00326131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549524|NCT00326118|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549525|NCT00326105|Randomized|Parallel Assignment||Treatment||Double||||||
1549526|NCT00326092|Randomized|Parallel Assignment||Treatment||Double||||||
1549527|NCT00326079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549528|NCT00326066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549529|NCT00326053|Randomized|Parallel Assignment||Treatment||Double||||||
1549530|NCT00326040|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549531|NCT00326027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549532|NCT00326014||Single Group Assignment||Treatment||None (Open Label)||||||
1549533|NCT00326001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549534|NCT00325988||||||||||||
1549535|NCT00325975|||Cohort||Cross-Sectional|||||||
1549536|NCT00325962|Randomized|Parallel Assignment||Treatment||Double||||||
1549537|NCT00325949|Randomized|Parallel Assignment||Treatment||Double||||||
1549538|NCT00325936|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549539|NCT00325923|Randomized|Parallel Assignment||||Single||||||
1549540|NCT00325910|Randomized|Single Group Assignment||Treatment||Double||||||
1549541|NCT00325897|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1549542|NCT00325884|||Cohort||Retrospective|||||||
1549543|NCT00325871|||Case-Control||Prospective|||||||
1549544|NCT00325858|Randomized|Parallel Assignment||Treatment||Double||||||
1549545|NCT00325845|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549546|NCT00325832|Randomized|Factorial Assignment||||None (Open Label)||||||
1549547|NCT00325819|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1549548|NCT00325806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549549|NCT00325793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549550|NCT00325780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549551|NCT00325767|Randomized|Crossover Assignment||Treatment||Double||||||
1549552|NCT00325754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549553|NCT00325741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549554|NCT00325728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549555|NCT00325715|Randomized|Parallel Assignment||Prevention||Single||||||
1549556|NCT00325702|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549557|NCT00325689|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549558|NCT00325676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549559|NCT00325663|Randomized|Crossover Assignment||Treatment||Double||||||
1549560|NCT00325650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549561|NCT00325637|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549562|NCT00325624|Randomized|Single Group Assignment||||None (Open Label)||||||
1549563|NCT00325611|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549564|NCT00325598|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549565|NCT00325585||||||||||||
1549566|NCT00325572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549567|NCT00325559|Randomized|Crossover Assignment||||Single||||||
1549568|NCT00325546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549569|NCT00325533|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1549570|NCT00325520|||Cohort||Prospective|||||||
1549571|NCT00325507|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549572|NCT00325494|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549573|NCT00325481|Randomized|Single Group Assignment||Treatment||Double||||||
1549574|NCT00325468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549575|NCT00325455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549576|NCT00325442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549577|NCT00325429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549578|NCT00325416|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549579|NCT00325403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549580|NCT00325390|Randomized|Parallel Assignment||Prevention||Double||||||
1549581|NCT00325377|Randomized|Parallel Assignment||Treatment||Double||||||
1549582|NCT00325364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549583|NCT00325351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549584|NCT00325338|Randomized|Parallel Assignment||Treatment||Single||||||
1549585|NCT00325325|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549586|NCT00325312|Randomized|Parallel Assignment||Treatment||Double||||||
1549587|NCT00325299|Randomized|Parallel Assignment||Treatment||Double||||||
1549588|NCT00325286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549589|NCT00325273|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1549590|NCT00325260|Randomized|Parallel Assignment||Prevention||Double||||||
1549591|NCT00325247|Randomized|Parallel Assignment||Treatment||Double||||||
1549592|NCT00325234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549593|NCT00325221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549594|NCT00325208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549595|NCT00325195|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549596|NCT00325182|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549597|NCT00325169|Randomized|Crossover Assignment||Treatment||Double||||||
1549598|NCT00325156|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549599|NCT00325143|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549600|NCT00325130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549601|NCT00325117|Randomized|Parallel Assignment||Treatment||Double||||||
1549602|NCT00325104||||Treatment||||||||
1549603|NCT00325091||||||||||||
1549604|NCT00325078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549605|NCT00325065||||||||||||
1549606|NCT00325039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549607|NCT00325026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549608|NCT00325013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549609|NCT00325000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549610|NCT00324987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549611|NCT00324974|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549612|NCT00324961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549613|NCT00324948|Randomized|Parallel Assignment||Treatment||Double||||||
1549614|NCT00324922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549615|NCT00324909|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549616|NCT00324896|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549617|NCT00324883|||Cohort||Prospective|||||||
1549618|NCT00324870||Single Group Assignment||Treatment||None (Open Label)||||||
1549619|NCT00324857|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1549620|NCT00324831|Randomized|||Treatment||Double||||||
1549621|NCT00324818|Randomized|Factorial Assignment||Treatment||Double||||||
1549622|NCT00324805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549623|NCT00324792|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549624|NCT00324779||||Treatment||None (Open Label)||||||
1549625|NCT00324766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549626|NCT00324753|Randomized|Parallel Assignment||Prevention||Single|||t|||
1549627|NCT00324740||Single Group Assignment||Treatment||None (Open Label)||||||
1549628|NCT00324727|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549629|NCT00324714|Randomized|||Supportive Care||Double||||||
1549630|NCT00324701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549631|NCT00324688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549632|NCT00324675|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1549633|NCT00324662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549634|NCT00324649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549635|NCT00324623||Single Group Assignment||Treatment||None (Open Label)||||||
1549636|NCT00324610||||||||||||
1549637|NCT00324597||||Treatment||None (Open Label)||||||
1549638|NCT00324584|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549639|NCT00324571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549640|NCT00324558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549641|NCT00324545|Randomized|Parallel Assignment||Treatment||Double||||||
1549642|NCT00324532|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549643|NCT00324519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549644|NCT00324506|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549645|NCT00324493|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1549646|NCT00324480||Single Group Assignment||Treatment||None (Open Label)||||||
1549647|NCT00324467|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549648|NCT00324454|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549649|NCT00324441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549650|NCT00324428|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549651|NCT00324415||Single Group Assignment||Treatment||None (Open Label)||||||
1549652|NCT00324402|||Cohort||Prospective|||||||
1549653|NCT00324389|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549654|NCT00324376|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549655|NCT00324363|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549656|NCT00324350|Randomized|Factorial Assignment||Prevention||Single|||||t|
1549657|NCT00324324|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1549658|NCT00324311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549659|NCT00324298|Randomized|||Treatment||||||||
1549660|NCT00324285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549661|NCT00324272|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1549662|NCT00324259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549663|NCT00324246|||Case-Only||Retrospective|||||||
1549664|NCT00324233|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1549665|NCT00324220|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549666|NCT00324207|||Cohort||Prospective|||||||
1549667|NCT00324194|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549668|NCT00324181|||Cohort||Prospective|||||||
1549669|NCT00324168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549670|NCT00324155|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549671|NCT00324142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549672|NCT00324129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549673|NCT00324116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549674|NCT00324103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549675|NCT00324090|Randomized|Parallel Assignment||Prevention||Single||||||
1549676|NCT00324077|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549677|NCT00324064|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549678|NCT00324051|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549679|NCT00324038|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549680|NCT00324025|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549681|NCT00324012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549682|NCT00323999||||||||||||
1549683|NCT00323986|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549684|NCT00323973|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549685|NCT00323960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549686|NCT00323947|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1549687|NCT00323934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549688|NCT00323921||Parallel Assignment||Basic Science||None (Open Label)||||||
1549689|NCT00323908|||Cohort||Prospective|||||||
1549690|NCT00323895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549691|NCT00323882|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549692|NCT00323869||Single Group Assignment||Treatment||None (Open Label)||||||
1549693|NCT00323856||Single Group Assignment||Treatment||None (Open Label)||||||
1549694|NCT00323843|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549695|NCT00323830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549696|NCT00323817|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549697|NCT00323804|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549698|NCT00323791|Randomized|||Treatment||||||||
1549699|NCT00323778|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1549700|NCT00323765||||||||||||
1549701|NCT00323752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549702|NCT00323739||Single Group Assignment||Treatment||None (Open Label)||||||
1549703|NCT00323726|||||Retrospective|||||||
1549704|NCT00323713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549705|NCT00323700|||Cohort||Prospective|||||||
1549706|NCT00323687|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549707|NCT00323674|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549708|NCT00323661|Randomized|Parallel Assignment||Treatment||Single|||t|||
1549709|NCT00323648|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549710|NCT00323635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549711|NCT00323622|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549712|NCT00323609|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549713|NCT00323596||||||||||||
1549714|NCT00323583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549715|NCT00323570|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549716|NCT00323557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549717|NCT00323544|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549718|NCT00323531|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549719|NCT00323518|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1549720|NCT00323505|Randomized|Crossover Assignment||||None (Open Label)||||||
1549721|NCT00323492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549722|NCT00323479|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549723|NCT00323466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549724|NCT00323453|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1549725|NCT00323440|||Case-Control||Prospective|||||||
1549726|NCT00323427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549727|NCT00323414|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549728|NCT00323401|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1549729|NCT00323388||||||||||||
1549730|NCT00323375|Randomized|Parallel Assignment||Treatment||Double||||||
1549731|NCT00323362||Single Group Assignment||Treatment||None (Open Label)||||||
1549732|NCT00323349|Randomized|Factorial Assignment||||None (Open Label)||||||
1549733|NCT00323336|||||Prospective|||||||
1549734|NCT00323323||Single Group Assignment||Treatment||None (Open Label)||||||
1549735|NCT00323310|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549736|NCT00323297|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549737|NCT00323284|Randomized|Parallel Assignment||Treatment||Single|IOP measurement|||||t
1549738|NCT00323271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549739|NCT00323258|Randomized|Parallel Assignment||||Single||||||t
1549740|NCT00323245|Randomized|Parallel Assignment||Treatment||Single|||t|||
1549741|NCT00323232|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549742|NCT00323219|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549743|NCT00323206||Single Group Assignment||Treatment||None (Open Label)||||||
1549744|NCT00323193|Randomized|Parallel Assignment||||None (Open Label)||||||
1549745|NCT00323180|||||Prospective|||||||
1549746|NCT00323167|||Cohort||Other|||||||
1549747|NCT00323154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550277|NCT00316134|||Cohort||Prospective|||||||
1549748|NCT00323141|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549749|NCT00323128|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549750|NCT00323115||Single Group Assignment||Treatment||None (Open Label)||||||
1549751|NCT00323102|Randomized|Crossover Assignment||||Double||||||
1549752|NCT00323089||Single Group Assignment||Treatment||None (Open Label)||Preoperative CT-Guided Microcoil Localization (CTML) and Fluoroscopic-Guided Video-Assisted Thoracoscopic (VATS) Wedge Resection of Small Peripheral Pulmonary Nodules (SPPN)||||
1549753|NCT00323076||Single Group Assignment||Diagnostic||None (Open Label)||||||
1549754|NCT00323063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549755|NCT00323050|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549756|NCT00323037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549757|NCT00323024|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549758|NCT00323011|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1549759|NCT00322985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549760|NCT00322972|Randomized|Parallel Assignment||Treatment||Single||||||t
1549761|NCT00322959|||Case Control||Prospective|||||||
1549762|NCT00322946|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1549763|NCT00322933|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1549764|NCT00322920|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549765|NCT00322907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549766|NCT00322894|||Cohort||Other|||||||
1549767|NCT00322881||Single Group Assignment||Treatment||None (Open Label)||||||
1549768|NCT00322868||Single Group Assignment||Treatment||None (Open Label)|This was open-label and no one was masked.|||||
1549769|NCT00322855|||Cohort||Retrospective|||||||
1549770|NCT00322842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549771|NCT00322829|||Case-Only||Prospective|||||||
1549772|NCT00322816|||||Prospective|||||||
1549773|NCT00322803|Randomized|Crossover Assignment||Treatment||Double||||||
1549774|NCT00322790|||Cohort||Retrospective|||||||
1549775|NCT00322777|Randomized|Parallel Assignment||Treatment||Single||||||t
1549776|NCT00322764|Randomized|Parallel Assignment||Treatment||Double||||||
1549777|NCT00322751|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549778|NCT00322738|||||Prospective|||||||
1549779|NCT00322725|||Cohort||Retrospective|||||||
1549780|NCT00322712|||Cohort||Retrospective|||||||
1549781|NCT00322699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549782|NCT00322686|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1549783|NCT00322673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549784|NCT00322660|Randomized|Single Group Assignment||Prevention||Double||||||
1549785|NCT00322647|||Ecologic or Community||Retrospective|||||||
1549786|NCT00322634|||Cohort||Prospective|||||||
1549787|NCT00322621||Single Group Assignment||Treatment||None (Open Label)||||||
1549788|NCT00322608|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549789|NCT00322595|Randomized|Parallel Assignment||Treatment||Double||||||
1549790|NCT00322582|||Family-Based||Prospective|||||||
1549791|NCT00322569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549792|NCT00322556||Single Group Assignment||Treatment||None (Open Label)||||||
1549793|NCT00322543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549794|NCT00322530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549795|NCT00322517|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549796|NCT00322504|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549797|NCT00322491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549798|NCT00322478||Single Group Assignment||Supportive Care||None (Open Label)||||||
1549799|NCT00322465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549800|NCT00322452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549801|NCT00322439|||Cohort||Prospective|||||||
1549802|NCT00322426|Randomized|Crossover Assignment||Treatment||Single||||||
1549803|NCT00322413|Randomized|Parallel Assignment||Treatment||Single||||||
1549804|NCT00322400|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549805|NCT00322387|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549806|NCT00322374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549807|NCT00322361|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549808|NCT00322348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549809|NCT00322335|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549810|NCT00322322|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1549811|NCT00322309|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549812|NCT00322296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549813|NCT00322283|Non-Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1549814|NCT00322270|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549815|NCT00322257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549816|NCT00322244|Randomized|Single Group Assignment||Treatment||Double||||||
1549817|NCT00322231|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1549818|NCT00322218|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549819|NCT00322205|Randomized|Parallel Assignment||Treatment||Double||||||
1549820|NCT00322192|Randomized|Parallel Assignment||Treatment||Single||||||
1549821|NCT00322179||||||||||||
1549822|NCT00322166|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1549823|NCT00322153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549824|NCT00322140||||Treatment||||||||
1549825|NCT00322127|Non-Randomized|||Treatment||None (Open Label)||||||
1549826|NCT00322114|Randomized|||Prevention||||||||
1549827|NCT00322101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549828|NCT00322075|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549829|NCT00322062|Randomized|Parallel Assignment||Treatment||Single||||||t
1549830|NCT00322049|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1549831|NCT00322036|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549832|NCT00322023|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549833|NCT00322010|Randomized|Parallel Assignment||Treatment||Single||||||t
1549834|NCT00321997|Randomized|Parallel Assignment||Treatment||Double||||||
1549835|NCT00321984|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1549836|NCT00321971|Randomized|Parallel Assignment||Prevention||Single||||||t
1549837|NCT00321958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549838|NCT00321945|||Case-Only||Retrospective|||||||
1549839|NCT00321932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549840|NCT00321919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549841|NCT00321906|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549842|NCT00321893|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1549843|NCT00321880||Single Group Assignment||Supportive Care||None (Open Label)||||||
1549844|NCT00321867|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1549845|NCT00321854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549846|NCT00321828||Single Group Assignment||Treatment||None (Open Label)||||||
1549847|NCT00321815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549848|NCT00321802|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549849|NCT00321789|Randomized|Parallel Assignment||||Single||||||t
1549850|NCT00321763|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1549851|NCT00321750|Randomized|Parallel Assignment||Treatment||Double||||||
1549852|NCT00321737|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1549853|NCT00321724||Single Group Assignment||Treatment||None (Open Label)||||||
1549854|NCT00321711|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1549855|NCT00321698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549856|NCT00321685||Single Group Assignment||Treatment||None (Open Label)||||||
1549857|NCT00321672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549858|NCT00321659|Randomized|Parallel Assignment||Treatment||None (Open Label)||Randomized controlled trial||||
1549859|NCT00321646||Single Group Assignment||Treatment||None (Open Label)||||||
1549860|NCT00321633|Randomized|||Treatment||None (Open Label)||||||
1549861|NCT00321620|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1549862|NCT00321594||Single Group Assignment||Treatment||None (Open Label)||||||
1549863|NCT00321581||||Treatment||||||||
1549864|NCT00321568||||||||||||
1549865|NCT00321555||Single Group Assignment||Treatment||None (Open Label)||||||
1549866|NCT00321542|||Cohort||Prospective|||||||
1549867|NCT00321529|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1549868|NCT00321516|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1549869|NCT00321503|||||Prospective|||||||
1549870|NCT00321490|Randomized|Parallel Assignment||Treatment||Double||||||
1549871|NCT00321477|Randomized|Parallel Assignment||Treatment||Double||||||
1549872|NCT00321464|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1549873|NCT00321451|Randomized|Parallel Assignment||Treatment||Single|||t|||
1549874|NCT00321438|||||Prospective|||||||
1549875|NCT00321425|Randomized|Parallel Assignment||||Single||||||
1549876|NCT00321412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549877|NCT00321399|||Cohort||Prospective|||||||
1549878|NCT00321386|||Cohort||Prospective|||||||
1549879|NCT00321373|Randomized|Parallel Assignment||Prevention||Single|||t|||
1549880|NCT00321360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549881|NCT00321347|Randomized|Parallel Assignment||Treatment||Double||||||
1549882|NCT00321334||Single Group Assignment||Treatment||None (Open Label)||||||
1549883|NCT00321321|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549884|NCT00321308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549885|NCT00321295|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1549886|NCT00321282|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549887|NCT00321269|Randomized|Parallel Assignment||||Single||||||t
1549888|NCT00321256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549889|NCT00321243|Randomized|Parallel Assignment||||None (Open Label)||||||
1549890|NCT00321230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549891|NCT00321217|||Cohort||Prospective|||||||
1549892|NCT00321204||||||||||||
1549893|NCT00321191|Randomized|Crossover Assignment||||None (Open Label)||||||
1549894|NCT00321178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549895|NCT00321165|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549896|NCT00321152|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1549897|NCT00321139|||||Prospective|||||||
1549898|NCT00321126|Randomized|Single Group Assignment||Treatment||Double||||||
1549899|NCT00321113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549900|NCT00321100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549901|NCT00321087|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549902|NCT00321074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549903|NCT00321061||||Treatment||||||||
1549904|NCT00321048|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1549905|NCT00321035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549906|NCT00321022|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1549907|NCT00321009|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549908|NCT00320996|||Cohort||Prospective|||||||
1549909|NCT00320983|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549910|NCT00320970|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549911|NCT00320957|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549912|NCT00320931|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1549913|NCT00320918|||Cohort||Retrospective|||||||
1549914|NCT00320905|||||Prospective|||||||
1549915|NCT00320892|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1549916|NCT00320879|Randomized|Crossover Assignment||Treatment||Double||||||
1549917|NCT00320866|Randomized|Crossover Assignment||Treatment||Double||||||
1549918|NCT00320853|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549919|NCT00320840|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1549920|NCT00320827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549921|NCT00320814|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549922|NCT00320801|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549923|NCT00320788|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549924|NCT00320775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549925|NCT00320762|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549926|NCT00320749||Single Group Assignment||Treatment||None (Open Label)||||||
1549927|NCT00320736|Randomized|Parallel Assignment||Treatment||Double||||||
1549928|NCT00320723|Randomized|Parallel Assignment||Treatment||Double||||||
1549929|NCT00320710|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549930|NCT00320697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549931|NCT00320684|||Case Control||Prospective|||||||
1549932|NCT00320671|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549933|NCT00320658|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1549934|NCT00320632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549935|NCT00320619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549936|NCT00320606||Single Group Assignment||Treatment||None (Open Label)||Recipients of parental living-donor liver allografts will undergo gradual withdrawal as tolerated of immunosuppression with the goal of complete withdrawal.||||
1549937|NCT00320593|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1549938|NCT00320580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549939|NCT00320567|Randomized|Parallel Assignment||Treatment||Double||||||
1549940|NCT00320554||||Screening|Longitudinal, Prospective|||||||
1549941|NCT00320541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549942|NCT00320528|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549943|NCT00320515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549944|NCT00320502|Randomized|Parallel Assignment||Treatment||Double||||||
1549945|NCT00320489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549946|NCT00320476|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549947|NCT00320463|Randomized|Parallel Assignment||Prevention||Double||||||
1549948|NCT00320450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549949|NCT00320437|||Defined Population||Longitudinal, Prospective|||||||
1549950|NCT00320424|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1549951|NCT00320411|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549952|NCT00320398|Randomized|Parallel Assignment||Prevention||||||||
1549953|NCT00320385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549954|NCT00320372|||||Prospective|||||||
1549955|NCT00320359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549956|NCT00320346|Randomized|Parallel Assignment||Prevention||Double||||||
1549957|NCT00320333||||||||||||
1549958|NCT00320320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549959|NCT00320307|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1549960|NCT00320294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549961|NCT00320281|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549962|NCT00320268|Randomized|Parallel Assignment||Treatment||Double||||||
1549963|NCT00320255|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1549964|NCT00320242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549965|NCT00320229||||||||||||
1549966|NCT00320216|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549967|NCT00320203|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549968|NCT00320190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549969|NCT00320177||||||||||||
1549970|NCT00320164|||Case-Control||Prospective|||||||
1549971|NCT00320151|||Other||Other|||||||
1549972|NCT00320138|Randomized|Parallel Assignment||Treatment||Single||||t||
1549973|NCT00320125|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549974|NCT00320112|Randomized|Parallel Assignment||||None (Open Label)||||||
1549975|NCT00320099|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1549976|NCT00320086|||||Prospective|||||||
1549977|NCT00320073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549978|NCT00320060|Randomized|Parallel Assignment||Treatment||Double||||||
1549979|NCT00320047|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549980|NCT00320034|Randomized|Crossover Assignment||Treatment||Double||||||
1549981|NCT00320021|Randomized|Parallel Assignment||Treatment||Double||||||
1549982|NCT00320008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549983|NCT00319995|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1549984|NCT00319982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549985|NCT00319969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549986|NCT00319956|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1549987|NCT00319943|Randomized|Parallel Assignment||Treatment||Double||||||
1549988|NCT00319930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549989|NCT00319917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1549990|NCT00319904|||Cohort||Prospective|||||||
1549991|NCT00319891|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549992|NCT00319878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549993|NCT00319865|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1549994|NCT00319852|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1549995|NCT00319839||Single Group Assignment||Treatment||None (Open Label)||||||
1549996|NCT00319826|||Case Control||Retrospective|||||||
1549997|NCT00319813||||||||||||
1549998|NCT00319800|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1549999|NCT00319787|Randomized|Parallel Assignment||Treatment||Double||||||
1550000|NCT00319774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550001|NCT00319761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550002|NCT00319748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550003|NCT00319735||Single Group Assignment||Treatment||None (Open Label)||||||
1550004|NCT00319722|||Case Control||Prospective|||||||
1550005|NCT00319709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550006|NCT00319696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550007|NCT00319683|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550008|NCT00319670|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550009|NCT00319657||Single Group Assignment||Treatment||None (Open Label)||Combined hematopoietic stem cell and kidney transplantation||||
1550010|NCT00319644|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550011|NCT00319631|||Case-Only||Prospective|||||||
1550012|NCT00319618|Randomized|Parallel Assignment||Treatment||Double||||||
1550013|NCT00319605|||||Retrospective|||||||
1550014|NCT00319592|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1550015|NCT00319579|||Cohort||Prospective|||||||
1550016|NCT00319566|Randomized|Single Group Assignment||Prevention||Double||||||
1550017|NCT00319553|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1550018|NCT00319540|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550019|NCT00319527|||Cohort||Retrospective|||||||
1550020|NCT00319514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550021|NCT00319501|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550022|NCT00319488|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550023|NCT00319475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550024|NCT00319462|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550025|NCT00319449|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550026|NCT00319436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550027|NCT00319423|Randomized|Parallel Assignment||Treatment||Single|||||t|
1550028|NCT00319410|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550029|NCT00319397|||||Prospective|||||||
1550030|NCT00319384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550031|NCT00319371|||Case Control||Prospective|||||||
1550032|NCT00319358|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550033|NCT00319345|Randomized|Crossover Assignment||Treatment||Single||||||
1550034|NCT00319332|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550035|NCT00319319|Randomized|Parallel Assignment||Treatment||Double||||||
1550036|NCT00319306|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550037|NCT00319293|Randomized|Parallel Assignment||Treatment||Double||||||
1550038|NCT00319280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550039|NCT00319267||Single Group Assignment||Treatment||None (Open Label)||||||
1550040|NCT00319254||Single Group Assignment||Treatment||None (Open Label)||||||
1550041|NCT00319241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550042|NCT00319228||Single Group Assignment||Prevention||None (Open Label)||||||
1550043|NCT00319215|Randomized|Crossover Assignment||Prevention||Double||||||
1550044|NCT00319202|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1550045|NCT00319189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550046|NCT00319176|||Case-Only||Prospective|||||||
1550047|NCT00319163|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1550048|NCT00319150|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550049|NCT00319137|Randomized|Single Group Assignment||Treatment||Single||||||
1550050|NCT00319124|||Case Control||Cross-Sectional|||||||
1550051|NCT00319111|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550052|NCT00319098|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1550053|NCT00319085|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550054|NCT00319072|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1550055|NCT00319059|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||
1550056|NCT00319046||Single Group Assignment||Treatment||None (Open Label)||||||
1550057|NCT00319033|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550058|NCT00319020||Single Group Assignment||Treatment||None (Open Label)||||||
1550059|NCT00319007|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1550060|NCT00318994|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550061|NCT00318981|Non-Randomized|Single Group Assignment||Treatment||Double||||||
1550062|NCT00318968|Randomized|Parallel Assignment||Diagnostic||Double||||||
1550063|NCT00318955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550064|NCT00318942|Randomized|Parallel Assignment||Treatment||Single||||||t
1550065|NCT00318929||Single Group Assignment||Treatment||None (Open Label)||||||
1550066|NCT00318903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550067|NCT00318890|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550068|NCT00318877|Randomized|Parallel Assignment||Treatment||Single||||||t
1550069|NCT00318864|Randomized|Single Group Assignment||Treatment||Double||||||
1550070|NCT00318851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550071|NCT00318838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550072|NCT00318825|Randomized|Single Group Assignment||Treatment||Double||||||
1550073|NCT00318812|Randomized|Parallel Assignment||Treatment||Single|||||t|
1550074|NCT00318799|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1550075|NCT00318786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550076|NCT00318773|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1550077|NCT00318760|Randomized|Parallel Assignment||Treatment||||||||
1550078|NCT00318747|Randomized|Parallel Assignment||Treatment||Double||||||
1550079|NCT00318734|||Cohort||Prospective|||||||
1550080|NCT00318721|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550081|NCT00318708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550082|NCT00318695|Randomized|Parallel Assignment||Prevention||Double||||t|t|
1550083|NCT00318682|||Cohort||Prospective|||||||
1550084|NCT00318669|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550085|NCT00318656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550086|NCT00318643|Non-Randomized|Sequential Assignment||Prevention||None (Open Label)||||||
1550087|NCT00318630|Randomized|Crossover Assignment||Treatment||||||||
1550088|NCT00318617||||||||||||
1550089|NCT00318604|||||Longitudinal, Prospective|||||||
1550090|NCT00318591|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550091|NCT00318578|||Defined Population||Longitudinal, Prospective|||||||
1550092|NCT00318565|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550093|NCT00318552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550094|NCT00318539|Randomized|Parallel Assignment||Treatment||Double||||||
1550095|NCT00318513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550096|NCT00318500|Randomized|Parallel Assignment||Treatment||Double||||||
1550097|NCT00318487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550098|NCT00318474|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550099|NCT00318461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550100|NCT00318448|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550101|NCT00318435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550102|NCT00318422|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550103|NCT00318409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550104|NCT00318396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550105|NCT00318383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550106|NCT00318370|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550107|NCT00318357|||Cohort||Prospective|||||||
1550108|NCT00318344|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550109|NCT00318331|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1550110|NCT00318318|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550111|NCT00318305|||Case-Only||Prospective|||||||
1550112|NCT00318292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550113|NCT00318279|Randomized|Parallel Assignment||Other||Double||||||
1550114|NCT00318266|||Cohort||Prospective|||||||
1550115|NCT00318253|Randomized|Crossover Assignment||Prevention||Single|||t|||
1550116|NCT00318240|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550117|NCT00318227|Randomized|Parallel Assignment||Treatment||Single|||t|||
1550118|NCT00318214|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550119|NCT00318201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550120|NCT00318188|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1550121|NCT00318175|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550122|NCT00318162|Randomized|Crossover Assignment||Treatment||Double||||||
1550123|NCT00318149|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550124|NCT00318136|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550125|NCT00318123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550126|NCT00318110||Single Group Assignment||Treatment||None (Open Label)||||||
1550127|NCT00318097|||Case-Control||Prospective|||||||
1550128|NCT00318084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550129|NCT00318071||Single Group Assignment||Treatment||None (Open Label)||||||
1550130|NCT00318058|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550131|NCT00318045|Randomized|Crossover Assignment||Treatment||Double||||||
1550132|NCT00318032|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1550133|NCT00318019|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1550134|NCT00318006|Randomized|Parallel Assignment||||None (Open Label)||||||
1550135|NCT00317993|Randomized|Parallel Assignment||Diagnostic||Double||||||
1550136|NCT00317980|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1550137|NCT00317967|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550138|NCT00317954|Randomized|Crossover Assignment||Treatment||Double||||||
1550139|NCT00317941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550140|NCT00317928|Randomized|Crossover Assignment||Treatment||Double||||||
1550141|NCT00317915|Randomized|Parallel Assignment||Treatment||Double||||||
1550142|NCT00317902|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550143|NCT00317889|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550144|NCT00317876||||Treatment||None (Open Label)||||||
1550145|NCT00317863|||Cohort||Other|||||||
1550146|NCT00317850|Randomized|Parallel Assignment||Treatment||Double||||||
1550147|NCT00317837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550148|NCT00317811||||Treatment||None (Open Label)||||||
1550149|NCT00317798||Single Group Assignment||Treatment||None (Open Label)||||||
1550150|NCT00317785||||Treatment||None (Open Label)||||||
1550151|NCT00317772||Single Group Assignment||Treatment||None (Open Label)||||||
1550152|NCT00317759||||Treatment||None (Open Label)||||||
1550153|NCT00317746|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1550154|NCT00317733|Randomized|Parallel Assignment||Treatment||Double||||||
1550155|NCT00317720||Single Group Assignment||Treatment||None (Open Label)||||||
1550156|NCT00317707|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1550157|NCT00317694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550158|NCT00317681|Randomized|Single Group Assignment||Treatment||Double||||||
1550159|NCT00317668|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1550160|NCT00317655|Randomized|Parallel Assignment||Treatment||Double||||||
1550161|NCT00317642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550162|NCT00317629|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550163|NCT00317616|||Cohort||Prospective|||||||
1550164|NCT00317603||Single Group Assignment||Treatment||None (Open Label)||||||
1550165|NCT00317590|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550166|NCT00317577|Randomized|Parallel Assignment||Treatment||Double||||||
1550167|NCT00317564|||Cohort||Prospective|||||||
1550168|NCT00317551|Randomized|Factorial Assignment||Prevention||Double||||||
1550169|NCT00317538|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550170|NCT00317525|Randomized|Factorial Assignment||Treatment||Double||||||
1550171|NCT00317512|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1550172|NCT00317499|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1550173|NCT00317486|Randomized|Parallel Assignment||Treatment||Double||||||
1550174|NCT00317473|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1550175|NCT00317460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550176|NCT00317447|Randomized|Parallel Assignment||Treatment||Double||||||
1550177|NCT00317434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550178|NCT00317421|Randomized|Crossover Assignment||Treatment||Double||||||
1550179|NCT00317408|Non-Randomized|||Treatment||||||||
1550180|NCT00317395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550181|NCT00317382|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550182|NCT00317369|Randomized|Parallel Assignment||Treatment||Double||||||
1550183|NCT00317356|Randomized|Parallel Assignment||Treatment||Double||||||
1550184|NCT00317343|||Case-Only||Prospective|||||||
1550185|NCT00317330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550186|NCT00317317|Randomized|Parallel Assignment||Treatment||Single|||t|||
1550187|NCT00317304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550188|NCT00317291|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550189|NCT00317278|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1550190|NCT00317265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550191|NCT00317252|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550192|NCT00317239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550193|NCT00317226||Single Group Assignment||Treatment||None (Open Label)||||||
1550194|NCT00317213|Randomized|Parallel Assignment||Treatment||Double||||||
1550195|NCT00317200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550196|NCT00317187|Randomized|Parallel Assignment||Prevention||||||||
1550197|NCT00317174|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550198|NCT00317161|Randomized|Parallel Assignment||Prevention||Double||||||
1550199|NCT00317148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550200|NCT00317135|Randomized|Parallel Assignment||Prevention||||||||
1550358|NCT00315107|Randomized|Parallel Assignment||||Double||||||
1550201|NCT00317122|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550202|NCT00317109|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550203|NCT00317096|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1550204|NCT00317083|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550205|NCT00317070|Randomized|Parallel Assignment||Treatment||Single|||t|||
1550206|NCT00317057|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1550207|NCT00317044|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550208|NCT00317031|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1550209|NCT00317018|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550210|NCT00317005|Randomized|Parallel Assignment||Prevention||Double||||||
1550211|NCT00316992|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1550212|NCT00316979|Randomized|Parallel Assignment||Treatment||Double||||||
1550213|NCT00316966|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1550214|NCT00316953|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550215|NCT00316940||||Treatment||None (Open Label)||||||
1550216|NCT00316927|Randomized|||Treatment||||||||
1550217|NCT00316914|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1550218|NCT00316901||||Diagnostic||||||||
1550219|NCT00316888|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550220|NCT00316875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550221|NCT00316862||Single Group Assignment||Treatment||None (Open Label)||||||
1550222|NCT00316849||Single Group Assignment||Treatment||None (Open Label)||||||
1550223|NCT00316836|||Case-Only||Prospective|||||||
1550224|NCT00316823||||Diagnostic||None (Open Label)||||||
1550225|NCT00316810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550226|NCT00316797||Single Group Assignment||||None (Open Label)||||||
1550227|NCT00316784|Randomized|Parallel Assignment||Treatment||Double||||||
1550228|NCT00316771|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550229|NCT00316758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550230|NCT00316745|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550231|NCT00316732|||||Prospective|||||||
1550232|NCT00316719|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550233|NCT00316706|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550234|NCT00316693|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1550235|NCT00316680|Randomized|Parallel Assignment||Prevention||Double||||||
1550236|NCT00316667|||Cohort||Prospective|||||||
1550237|NCT00316654|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550238|NCT00316641|Randomized|Parallel Assignment||||Double||||||
1550239|NCT00316628|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550240|NCT00316615|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550241|NCT00316602|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550242|NCT00316589|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550243|NCT00316576|||||Prospective|||||||
1550244|NCT00316563|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1550245|NCT00316550|Randomized|Crossover Assignment||Treatment||Double||||||
1550246|NCT00316537|Randomized|Parallel Assignment||Treatment||Double||||||
1550247|NCT00316524|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1550248|NCT00316511|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550249|NCT00316498||||Treatment||||||||
1550250|NCT00316485||||||||||||
1550251|NCT00316472|Randomized|Crossover Assignment||Treatment||Double||||||
1550252|NCT00316459|Randomized|Crossover Assignment||Treatment||Double||||||
1550253|NCT00316446|||||Prospective|||||||
1550254|NCT00316433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550255|NCT00316420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550256|NCT00316407|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550257|NCT00316394|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550258|NCT00316381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550259|NCT00316368|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1550260|NCT00316355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550261|NCT00316342|Randomized|Single Group Assignment||||Single||||||
1550262|NCT00316329|Randomized|Parallel Assignment||Treatment||Single||||||
1550263|NCT00316316|Randomized|Parallel Assignment||Treatment||Single||||||t
1550264|NCT00316303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550265|NCT00316290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550266|NCT00316277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550267|NCT00316264|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1550268|NCT00316251|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550269|NCT00316238|Randomized|Parallel Assignment||Treatment||Double||||||
1550270|NCT00316225|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550271|NCT00316212|Randomized|Parallel Assignment||Prevention||Double||||||
1550272|NCT00316199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550273|NCT00316186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550274|NCT00316173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550275|NCT00316160|Randomized|Parallel Assignment||Treatment||Double||||||
1550276|NCT00316147|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550278|NCT00316121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550279|NCT00316108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550280|NCT00316095|Randomized|Factorial Assignment||Treatment||Double||||||
1550281|NCT00316082|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550282|NCT00001675||||||||||||
1550283|NCT00001673||||||||||||
1550284|NCT00316069|||Cohort||Prospective|||||||
1550285|NCT00316056||||||||||||
1550286|NCT00316043|Randomized|Factorial Assignment||||None (Open Label)||||||
1550287|NCT00316030|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550288|NCT00316017|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550289|NCT00316004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550290|NCT00315991|Randomized|Factorial Assignment||||None (Open Label)||||||
1550291|NCT00315978|Randomized|Single Group Assignment||||Single||||||
1550292|NCT00315965|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550293|NCT00315952|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550294|NCT00315939|Randomized|Crossover Assignment||||None (Open Label)||||||
1550295|NCT00315926|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1550296|NCT00315913|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550297|NCT00315900|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1550298|NCT00315887|Randomized|Parallel Assignment||Treatment||Double||||||
1550299|NCT00315874|Randomized|Parallel Assignment||Treatment||Double||||||
1550300|NCT00315861|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550301|NCT00315848|Randomized|Parallel Assignment||Treatment||Double||||||
1550302|NCT00315835|Randomized|Parallel Assignment||Treatment||Double||||||
1550303|NCT00315822|Randomized|Parallel Assignment||Other||Triple|||t||t|t
1550304|NCT00315809|||Case-Only||Prospective|||||||
1550305|NCT00315796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550306|NCT00315783|||Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1550307|NCT00315770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550308|NCT00315757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550309|NCT00315744|Randomized|Parallel Assignment||Treatment||||||||
1550310|NCT00315731||Single Group Assignment||Treatment||None (Open Label)||||||
1550311|NCT00315718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550312|NCT00315705|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550313|NCT00315692|||Cohort||Prospective|||||||
1550314|NCT00315679|Randomized|Parallel Assignment||Treatment||Double||||||
1550315|NCT00315666|Randomized|Crossover Assignment||Treatment||Double||||||
1550316|NCT00315653|||||Prospective|||||||
1550317|NCT00315640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550318|NCT00315627||Single Group Assignment||Treatment||None (Open Label)||||||
1550319|NCT00315614||Single Group Assignment||Treatment||None (Open Label)||||||
1550320|NCT00315601|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1550321|NCT00315588||Single Group Assignment||Treatment||None (Open Label)||||||
1550322|NCT00315575|||Cohort||Cross-Sectional|||||||
1550323|NCT00315562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550324|NCT00315549|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550325|NCT00315536|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1550326|NCT00315523|Randomized|Parallel Assignment||Treatment||Double||||||
1550327|NCT00315510|Randomized|Parallel Assignment||Treatment||Double||||||
1550328|NCT00315497|||Cohort||Prospective|||||||
1550329|NCT00315484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550330|NCT00315471|||Cohort||Prospective|||||||
1550331|NCT00315458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550332|NCT00315445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550333|NCT00315432|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550334|NCT00315419|||Cohort||Prospective|||||||
1550335|NCT00315406|||Cohort||Prospective|||||||
1550336|NCT00315393|||Cohort||Prospective|||||||
1550337|NCT00315380|||Cohort||Prospective|||||||
1550338|NCT00315367|Randomized|Crossover Assignment||Treatment||Double||||||
1550339|NCT00315354|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1550340|NCT00315341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550341|NCT00315328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550342|NCT00315315|||Cohort||Prospective|||||||
1550343|NCT00315302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550344|NCT00315289|||Cohort||Prospective|||||||
1550345|NCT00315276|Randomized|Parallel Assignment||Treatment||Double||||||
1550346|NCT00315263|||Case Control||Prospective|||||||
1550347|NCT00315250||Single Group Assignment||Diagnostic||None (Open Label)||||||
1550348|NCT00315237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550349|NCT00315224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550350|NCT00315211||Single Group Assignment||Treatment||None (Open Label)||||||
1550351|NCT00315198|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550352|NCT00315185|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550353|NCT00315172||||Treatment||||||||
1550354|NCT00315159||Single Group Assignment||Treatment||None (Open Label)||||||
1550355|NCT00315146|Randomized|Factorial Assignment||Treatment||Single|||t|||
1550356|NCT00315133||Single Group Assignment||Treatment||None (Open Label)||||||
1550357|NCT00315120|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1550359|NCT00315094|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1550360|NCT00315081|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550361|NCT00315068|||Defined Population|Screening|Longitudinal, Prospective|||||||
1550362|NCT00315055|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550363|NCT00315042|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550364|NCT00315029|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550365|NCT00315016|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550366|NCT00315003|Randomized|Parallel Assignment||Treatment||Double||||||
1550367|NCT00314990|Randomized|Parallel Assignment||Prevention||Double||||||
1550368|NCT00314977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550369|NCT00314964|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550370|NCT00314951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550371|NCT00314938|Randomized|Parallel Assignment||Treatment||Double||||||
1550372|NCT00314925|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550373|NCT00314912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550374|NCT00314899||||||||||||
1550375|NCT00314886|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1550376|NCT00314873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550377|NCT00314860|Randomized|Parallel Assignment||Treatment||Double||||||
1550378|NCT00314847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550379|NCT00314834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550380|NCT00314821|Randomized|Crossover Assignment||Treatment||Double||||||
1550381|NCT00314808||Single Group Assignment||Treatment||None (Open Label)||||||
1550382|NCT00314795||Single Group Assignment||Treatment||None (Open Label)||||||
1550383|NCT00314782|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550384|NCT00314769||||||||||||
1550385|NCT00314756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550386|NCT00314743|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1550387|NCT00314730|Non-Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1550388|NCT00314717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550389|NCT00314704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550390|NCT00314691|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550391|NCT00314678|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550392|NCT00314665|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550393|NCT00314652|Randomized|Parallel Assignment||Treatment||Double||||||
1550394|NCT00314639|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1550395|NCT00314626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550396|NCT00314613|Non-Randomized|||Treatment||None (Open Label)||||||
1550397|NCT00314600|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550398|NCT00314587|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550399|NCT00314574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550400|NCT00314561|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550401|NCT00314548|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550402|NCT00314535|||Case-Only||Retrospective|||||||
1550403|NCT00314522|||Case-Only||Retrospective|||||||
1550404|NCT00314509|Randomized|Parallel Assignment||Treatment||Double||||||
1550405|NCT00314496|||||Retrospective|||||||
1550406|NCT00314483|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550407|NCT00314470|||Cohort||Retrospective|||||||
1550408|NCT00314457|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550409|NCT00314444||||||||||||
1550410|NCT00314431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550411|NCT00314418|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550412|NCT00314405|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550413|NCT00314392|Randomized|Parallel Assignment||Treatment||Double||||||
1550414|NCT00314379|Randomized|Parallel Assignment||Prevention||Double||||||
1550415|NCT00314366|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1550416|NCT00314353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550417|NCT00314340|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1550418|NCT00314327||Single Group Assignment||Treatment||None (Open Label)||||||
1550419|NCT00314314|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550420|NCT00314301|Randomized|Crossover Assignment||Educational/Counseling/Training||None (Open Label)||||||
1550421|NCT00314288|Randomized|Parallel Assignment||Treatment||Double||||||
1550422|NCT00314275|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550423|NCT00314262||Single Group Assignment||Diagnostic||None (Open Label)||||||
1550424|NCT00314249|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550425|NCT00314236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550426|NCT00314223|||Case Control|Screening|Longitudinal, Prospective|||||||
1550427|NCT00314210|Randomized|Parallel Assignment||Treatment||Double||||||
1550428|NCT00314197|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1550429|NCT00314184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550430|NCT00314171|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550431|NCT00314158|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550432|NCT00314145|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1550433|NCT00314132|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1551268|NCT00302991|||||Prospective|||||||
1550434|NCT00314119|||Cohort||Prospective|||||||
1550435|NCT00314106|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550436|NCT00314093||Single Group Assignment||Treatment||Single||||||
1550437|NCT00314080||||||||||||
1550438|NCT00314067|Randomized|Parallel Assignment||||None (Open Label)||||||
1550439|NCT00314054|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550440|NCT00314041|Randomized|Parallel Assignment||Prevention||Double||||||
1550441|NCT00314028|Randomized|Parallel Assignment||Prevention||Single|||t|||
1550442|NCT00314015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550443|NCT00314002|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550444|NCT00313989|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550445|NCT00313976|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1550446|NCT00313963|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550447|NCT00313950|Randomized|Parallel Assignment||Prevention||Single||||||t
1550448|NCT00313937|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550449|NCT00313924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550450|NCT00313911|Randomized|Parallel Assignment||Prevention||Single||||||t
1550451|NCT00313898|Randomized|Crossover Assignment||Treatment||Double||||||
1550452|NCT00313885|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550453|NCT00313872|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550454|NCT00313859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550455|NCT00313846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550456|NCT00313833|Randomized|Parallel Assignment||Treatment||Double||||||
1550457|NCT00313820|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550458|NCT00313807|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1550459|NCT00313794|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550460|NCT00313781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550461|NCT00313768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550462|NCT00313755|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1550463|NCT00313742|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550464|NCT00313729||Single Group Assignment||Treatment||None (Open Label)||||||
1550465|NCT00313716|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1550466|NCT00313703|||Cohort||Prospective|||||||
1550467|NCT00313690|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550468|NCT00313677|||Cohort||Prospective|||||||
1550469|NCT00313625||||Treatment||None (Open Label)||||||
1550470|NCT00313612||Single Group Assignment||Treatment||None (Open Label)||||||
1550471|NCT00313599||Single Group Assignment||Treatment||None (Open Label)||||||
1550472|NCT00313586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550473|NCT00313573|Randomized|||||||||||
1550474|NCT00313560|Randomized|Parallel Assignment||Treatment||Single|||t|||
1550475|NCT00313547|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550476|NCT00313534||||Treatment||||||||
1550477|NCT00313521||||Treatment||None (Open Label)||||||
1550478|NCT00313508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550479|NCT00313495|||||Prospective|||||||
1550480|NCT00313482|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550481|NCT00313469|||||Prospective|||||||
1550482|NCT00313456|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550483|NCT00313443|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550484|NCT00313430|||Case Control||Cross-Sectional|||||||
1550485|NCT00313417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550486|NCT00313404||Single Group Assignment||Prevention||Single|||t|||
1550487|NCT00313391|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1550488|NCT00313378|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550489|NCT00313365|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550490|NCT00313352|||Cohort||Retrospective|||||||
1550491|NCT00313339|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1550492|NCT00313326|Randomized|Single Group Assignment||Treatment||Single|||t|||
1550493|NCT00313313|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550494|NCT00313300|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1550495|NCT00313287|Randomized|Parallel Assignment||Treatment||Double||||||
1550496|NCT00313274|Randomized|Parallel Assignment||Treatment||Double||||||
1550497|NCT00313261|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550498|NCT00313248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550499|NCT00313235||Single Group Assignment||Treatment||None (Open Label)||||||
1550500|NCT00313222|Randomized|Parallel Assignment||Treatment||Double||||||
1550501|NCT00313209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550502|NCT00313196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550503|NCT00313183|Randomized|Crossover Assignment||Treatment||Single|||t|||
1550504|NCT00313170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550505|NCT00313157|Randomized|Crossover Assignment||Treatment||Single|||||t|
1550506|NCT00313144|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550507|NCT00313131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550508|NCT00313118|||Case-Only||Prospective|||||||
1550509|NCT00313105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550510|NCT00313092|||Case-Only||Prospective|||||||
1550511|NCT00313079||Single Group Assignment||Treatment||None (Open Label)||||||
1550512|NCT00313066|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1550513|NCT00313053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550514|NCT00313040|Randomized|Parallel Assignment||Treatment||Single||||||
1550515|NCT00313027|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550516|NCT00313014|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1550517|NCT00313001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550518|NCT00312988|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550519|NCT00312975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550520|NCT00312962|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1550521|NCT00312949|Randomized|Parallel Assignment||||None (Open Label)||||||
1550522|NCT00312936|Randomized|Crossover Assignment||||None (Open Label)||||||
1550523|NCT00312923|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1550524|NCT00312910|Randomized|Parallel Assignment||Prevention||Double||||||
1550525|NCT00312897|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550526|NCT00312884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550527|NCT00312871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550528|NCT00312858|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550529|NCT00312845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550530|NCT00312832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550531|NCT00312819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550532|NCT00312806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550533|NCT00312793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550534|NCT00312780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550535|NCT00312767|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550536|NCT00312754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550537|NCT00312741|||||Prospective|||||||
1550538|NCT00312728||Single Group Assignment||Treatment||None (Open Label)||||||
1550539|NCT00312715||||||||||||
1550540|NCT00312702|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550541|NCT00312689|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1550542|NCT00312676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550543|NCT00312663|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550544|NCT00312650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550545|NCT00312637||Single Group Assignment||Diagnostic||None (Open Label)||||||
1550546|NCT00312624|||Cohort||Prospective|||||||
1550547|NCT00312611|Randomized|Parallel Assignment||Other||Double||||||
1550548|NCT00312598|||Cohort||Prospective|||||||
1550549|NCT00312585|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550550|NCT00312572|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550551|NCT00312559|Randomized|Single Group Assignment||||Single||||||
1550552|NCT00312546|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550553|NCT00312533|||||Prospective|||||||
1550554|NCT00312520|Randomized|Parallel Assignment||Treatment||Single||||||
1550555|NCT00312507|Randomized|Parallel Assignment||Treatment||Double||||||
1550556|NCT00312494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550557|NCT00312481|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550558|NCT00312468|||Cohort||Prospective|||||||
1550559|NCT00312455|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1550560|NCT00312442|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550561|NCT00312429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550562|NCT00312416|Randomized|Crossover Assignment||Treatment||Double||||||
1550563|NCT00312403|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550564|NCT00312390|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550565|NCT00312377|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550566|NCT00312364|Randomized|Parallel Assignment||Treatment||Double||||||
1550567|NCT00312351|Randomized|Parallel Assignment||Treatment||Double||||||
1550568|NCT00312338|Non-Randomized|Parallel Assignment||||Single||||||
1550569|NCT00312325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550570|NCT00312312|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550571|NCT00312299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550572|NCT00312286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550573|NCT00312273|Randomized|Parallel Assignment||Treatment||Double||||||
1550574|NCT00312260|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550575|NCT00312247|||Cohort||Prospective|||||||
1550576|NCT00312234|Randomized|Parallel Assignment||Treatment||Single||||||
1550577|NCT00312221|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550578|NCT00312208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550579|NCT00312195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550580|NCT00312182|Randomized|Crossover Assignment||Treatment||Double||||||
1550581|NCT00312169|||||Prospective|||||||
1550582|NCT00312156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550583|NCT00312143|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550584|NCT00312130|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1550585|NCT00312117|Randomized|Parallel Assignment||||None (Open Label)||||||
1550586|NCT00312104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550587|NCT00312091|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550588|NCT00312078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550589|NCT00312065||Single Group Assignment||Treatment||None (Open Label)||||||
1550590|NCT00312052|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1550591|NCT00312039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550592|NCT00312026|Randomized|Parallel Assignment||Treatment||Double||||||
1550593|NCT00312013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550594|NCT00312000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550595|NCT00311987|Randomized|Parallel Assignment||Treatment||Double||||||
1550596|NCT00311974|Randomized|Crossover Assignment||||Double||||||
1550597|NCT00311961|Randomized|Parallel Assignment||Treatment||Double||||||
1550598|NCT00311948|Randomized|Parallel Assignment||Treatment||Single|||||t|
1550599|NCT00311935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550600|NCT00311922|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1550601|NCT00311909|Randomized|Crossover Assignment||Treatment||Double||||||
1550602|NCT00311896|Randomized|Parallel Assignment||Prevention||Double||||||
1550603|NCT00311883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550604|NCT00311870|Randomized|Parallel Assignment||Treatment||Single||||||
1550605|NCT00311857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550606|NCT00311844|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1550607|NCT00311831|Non-Randomized|Parallel Assignment||Other||Single||||||t
1550608|NCT00311818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550609|NCT00311805|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550610|NCT00311792|Randomized|Parallel Assignment||||Double||||t||t
1550611|NCT00311779|Randomized|Factorial Assignment||Treatment||Single||||||
1550612|NCT00311766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550613|NCT00311753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550614|NCT00311740|Randomized|Factorial Assignment||Treatment||Double||||||
1550615|NCT00311727|Non-Randomized|||Prevention||||||||
1550616|NCT00311714|Randomized|Parallel Assignment||Prevention||Double||||||
1550617|NCT00311701|||||Retrospective|||||||
1550618|NCT00311688|||||Prospective|||||||
1550619|NCT00311675|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550620|NCT00311662|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1550621|NCT00311649|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550622|NCT00311636|Randomized|||Supportive Care||None (Open Label)||||||
1550623|NCT00311623||||Treatment||||||||
1550624|NCT00311610||Single Group Assignment||Treatment||None (Open Label)||||||
1550625|NCT00311597|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550626|NCT00311584|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550627|NCT00311571|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550628|NCT00311558||Single Group Assignment||Treatment||None (Open Label)||||||
1550629|NCT00311545||Single Group Assignment||Treatment||None (Open Label)||||||
1550630|NCT00311532|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1550631|NCT00311519|Randomized|Parallel Assignment||Treatment||Double||||||
1550632|NCT00311506|||||Prospective|||||||
1550633|NCT00311493|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1550634|NCT00311480|Randomized|Single Group Assignment||Prevention||Double||||||
1550635|NCT00311467|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550636|NCT00311454|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550637|NCT00311441|Randomized|Parallel Assignment||Prevention||Single||||||
1550638|NCT00311428|Randomized|Parallel Assignment||Prevention||Single||||||
1550639|NCT00311415|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550640|NCT00311402||Parallel Assignment||Prevention||||||||
1550641|NCT00311389|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550642|NCT00311376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550643|NCT00311363|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550644|NCT00311350|Randomized|||||Double||||||
1550645|NCT00311337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550646|NCT00311324|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550647|NCT00311311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550648|NCT00311298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550649|NCT00311285|Randomized|Single Group Assignment||||None (Open Label)||||||
1550650|NCT00311272|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1550651|NCT00311259|Random Sample||||Cross-Sectional, Prospective|||||||
1550652|NCT00311246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550653|NCT00311233|||Cohort||Prospective|||||||
1550654|NCT00311220|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550655|NCT00311207|||Case Control|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1550656|NCT00311194|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1550657|NCT00311181|Randomized|Single Group Assignment||Treatment||Single|||t|||
1550658|NCT00311168|Randomized|Crossover Assignment||Diagnostic||Single||||||
1550659|NCT00311155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550660|NCT00311142|||Cohort||Prospective|||||||
1550661|NCT00311129|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551417|NCT00300989|Randomized|Parallel Assignment||Treatment||Double||||||
1550662|NCT00311116|Randomized|Crossover Assignment||Prevention||Double||||||
1550663|NCT00311103|Randomized|Parallel Assignment||Health Services Research||Triple|||t||t|t
1550664|NCT00311090|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550665|NCT00311077|Randomized|Crossover Assignment||Treatment||Double||||||
1550666|NCT00311064|Randomized|Parallel Assignment||||Double||||||
1550667|NCT00311051|Randomized|Parallel Assignment||Treatment||Double||||||
1550668|NCT00311038|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550669|NCT00311025|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1550670|NCT00311012|Randomized|Parallel Assignment||Treatment||Double||||||
1550671|NCT00310999|Randomized|Crossover Assignment||Treatment||Single||||||
1550672|NCT00310986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550673|NCT00310973|Randomized|Factorial Assignment||Prevention||Single||||||
1550674|NCT00310960|||Cohort||Prospective|||||||
1550675|NCT00310947|Random Sample||Natural History||Longitudinal, Prospective|||||||
1550676|NCT00310934|Randomized|Parallel Assignment||Treatment||Single||||||
1550677|NCT00310921|Randomized|Crossover Assignment||Treatment||Double||||||
1550678|NCT00310908|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550679|NCT00310895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550680|NCT00310882|||Case Control||Prospective|||||||
1550681|NCT00310869||Single Group Assignment||Prevention||None (Open Label)||||||
1550682|NCT00310856|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550683|NCT00310843|||Case Control||Retrospective|||||||
1550684|NCT00310830|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550685|NCT00310817|Randomized|||Prevention||Double|||t||t|
1550686|NCT00310804|Randomized|Parallel Assignment||Prevention||Single|||t|||
1550687|NCT00310791|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550688|NCT00310778|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550689|NCT00310765|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1550690|NCT00310752|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550691|NCT00310739|||Natural History||Longitudinal, Prospective|||||||
1550692|NCT00310726|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550693|NCT00310713|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550694|NCT00310700|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550695|NCT00310687|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550696|NCT00310674|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550697|NCT00310661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550698|NCT00310648|Randomized|Parallel Assignment||Prevention||Single||||||
1550699|NCT00310635|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550700|NCT00310622|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550701|NCT00310609|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550702|NCT00310596|Randomized|Crossover Assignment||Diagnostic||Triple|||t||t|t
1550703|NCT00310583|Randomized|Parallel Assignment||Treatment||Double||||||
1550704|NCT00310570|Randomized|Parallel Assignment||Treatment||Single||||||
1550705|NCT00310557|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550706|NCT00310544|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1550707|NCT00310531|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1550708|NCT00310518|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1550709|NCT00310505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550710|NCT00310492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550711|NCT00310479||Single Group Assignment||Diagnostic||None (Open Label)||||||
1550712|NCT00310466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550713|NCT00310453|Randomized|Parallel Assignment||||Double||||||
1550714|NCT00310440|Randomized|Parallel Assignment||Treatment||Single|||t|||
1550715|NCT00310427|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550716|NCT00310414||||||||||||
1550717|NCT00310401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550718|NCT00310388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550719|NCT00310375||Single Group Assignment||Treatment||None (Open Label)||||||
1550720|NCT00310362|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1550721|NCT00310349|Randomized|Single Group Assignment||Prevention||Single||||||
1550722|NCT00310336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550723|NCT00310323|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550724|NCT00310310|Randomized|Single Group Assignment||Other||Single|||t|||
1550725|NCT00310297|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550726|NCT00310284|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550727|NCT00310271|Randomized|Factorial Assignment||Treatment||Double||||||
1550728|NCT00310258|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550729|NCT00310245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550730|NCT00310232|Randomized|Parallel Assignment||Treatment||Double||||||
1550731|NCT00310219||Single Group Assignment||Diagnostic||None (Open Label)||||||
1550732|NCT00310206|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550733|NCT00310180|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550734|NCT00310167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550735|NCT00310154|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550736|NCT00310141|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550737|NCT00310128||||Treatment||||||||
1550738|NCT00310115|||Case-Only||Prospective|||||||
1550739|NCT00310089|Randomized|||Treatment||||||||
1550740|NCT00310076||Single Group Assignment||Treatment||None (Open Label)||||||
1550741|NCT00310063|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1550742|NCT00310050||Single Group Assignment||Treatment||None (Open Label)||||||
1550743|NCT00310037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550744|NCT00310024||Single Group Assignment||Treatment||None (Open Label)||||||
1550745|NCT00310011||||Treatment||None (Open Label)||||||
1550746|NCT00309998||||Treatment||None (Open Label)||||||
1550747|NCT00309985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550748|NCT00309972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550749|NCT00309959||Single Group Assignment||Treatment||None (Open Label)||||||
1550750|NCT00309946||Single Group Assignment||Treatment||None (Open Label)||||||
1550751|NCT00309933||||||||||||
1550752|NCT00309920|Randomized|||Treatment||None (Open Label)||||||
1550753|NCT00309907||Single Group Assignment||Treatment||None (Open Label)||||||
1550754|NCT00309894|Non-Randomized|||Treatment||None (Open Label)||||||
1550755|NCT00309881||||Treatment||||||||
1550756|NCT00309868|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550757|NCT00309855|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1550758|NCT00309842||Single Group Assignment||Treatment||None (Open Label)||||||
1550759|NCT00309816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550760|NCT00309803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550761|NCT00309790|Randomized|Parallel Assignment||Treatment||Double||||||
1550762|NCT00309777|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1550763|NCT00309764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550764|NCT00309751|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550765|NCT00309738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550766|NCT00309725|Randomized|Parallel Assignment||Treatment||Double||||||
1550767|NCT00309712|Randomized|Parallel Assignment||Treatment||Double||||||
1550768|NCT00309699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550769|NCT00309686|Randomized|Parallel Assignment||Treatment||Double||||||
1550770|NCT00309673|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1550771|NCT00309660|Randomized|Parallel Assignment||Treatment||Single||||||
1550772|NCT00309647|Randomized|Parallel Assignment||Prevention||Single|||t|||
1550773|NCT00309634|Randomized|Parallel Assignment||Prevention||||||||
1550774|NCT00309621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550775|NCT00309608|Randomized|Parallel Assignment||Treatment||Double||||||
1550776|NCT00309595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550777|NCT00309582|||Defined Population||Longitudinal, Prospective|||||||
1550778|NCT00309569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550779|NCT00309556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550780|NCT00309543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550781|NCT00309530|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1550782|NCT00309517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550783|NCT00309504|||Case-Only|||||||||
1550784|NCT00309491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550785|NCT00309478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550786|NCT00309465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550787|NCT00309452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550788|NCT00309439|Randomized|Parallel Assignment||||Single||||||
1550789|NCT00309426|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1550790|NCT00309413|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1550791|NCT00309400|||||Retrospective|||||||
1550792|NCT00309387|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550793|NCT00309374|Randomized|Crossover Assignment||Treatment||Double||||||
1550794|NCT00309361|Randomized|Single Group Assignment||Treatment||Single||||||
1550795|NCT00309348|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550796|NCT00309335|Randomized|Single Group Assignment||Treatment||Single||||||
1550797|NCT00309322|Randomized|Single Group Assignment||Treatment||Single||||||
1550798|NCT00309309|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550799|NCT00309296|Randomized|Parallel Assignment||Treatment||Single||||||t
1550800|NCT00309283|Randomized|Parallel Assignment||Treatment||Single|||t|||
1550801|NCT00309270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550802|NCT00309257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550803|NCT00309244|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550804|NCT00309231|||Case-Only||Prospective|||||||
1550805|NCT00309218|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550806|NCT00309205|Randomized|Parallel Assignment||Prevention||Double||||||
1550807|NCT00309192|Randomized|Parallel Assignment||Treatment||Single||||||
1550808|NCT00309179||Single Group Assignment||Treatment||None (Open Label)||||||
1550809|NCT00309166|Randomized|Parallel Assignment||Prevention||Single|||t|||
1550810|NCT00309140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550811|NCT00309127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551570|NCT00298974|Randomized|Parallel Assignment||Treatment||Double||||||
1550812|NCT00309114|Randomized|Parallel Assignment||Prevention||Triple||Active intervention that includes bacterial interference using E. coli 83972 is compared with a placebo intervention.|t|t|t|
1550813|NCT00309101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550814|NCT00309088|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550815|NCT00309075|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550816|NCT00309062|Randomized|Parallel Assignment||Treatment||Double||||||
1550817|NCT00309049|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550818|NCT00309036|Randomized|Parallel Assignment||Treatment||Double||||||
1550819|NCT00309023|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550820|NCT00309010||||||||||||
1550821|NCT00308997|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1550822|NCT00308984|||Cohort||Prospective|||||||
1550823|NCT00308971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550824|NCT00308958|Randomized|Crossover Assignment||Treatment||Single||||||
1550825|NCT00308945|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1550826|NCT00308932|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550827|NCT00308919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550828|NCT00308906|||Case Control||Prospective|||||||
1550829|NCT00308893||Single Group Assignment||Treatment||None (Open Label)||||||
1550830|NCT00308880|Randomized|Parallel Assignment||Treatment||Double||||||
1550831|NCT00308867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550832|NCT00308854|Randomized|Parallel Assignment||Treatment||Double||||||
1550833|NCT00308841|Randomized|Single Group Assignment||Treatment||Double||||||
1550834|NCT00308828|||Cohort||Cross-Sectional|||||||
1550835|NCT00308815|Randomized|Single Group Assignment||Treatment||Single||||||
1550836|NCT00308802|||Case-Only||Prospective|||||||
1550837|NCT00308789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550838|NCT00308776|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550839|NCT00308763|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1550840|NCT00308750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550841|NCT00308737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550842|NCT00308724|Randomized|Parallel Assignment||Treatment||Single||||||t
1550843|NCT00308711|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550844|NCT00308698|||Defined Population||Longitudinal, Prospective|||||||
1550845|NCT00308685|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550846|NCT00308672|Random Sample|||Screening|Cross-Sectional, Retrospective/Prospective|||||||
1550847|NCT00308659|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550848|NCT00308646|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1550849|NCT00308633||||||||||||
1550850|NCT00308620|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1550851|NCT00308607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550852|NCT00308594|Randomized|Single Group Assignment||Treatment||Double||||||
1550853|NCT00308581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550854|NCT00308568|Randomized|Parallel Assignment||Other||Single||||||
1550855|NCT00308555||Single Group Assignment||Treatment||None (Open Label)||||||
1550856|NCT00308542|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550857|NCT00308529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550858|NCT00308516|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550859|NCT00308503|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550860|NCT00308490|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550861|NCT00308477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550862|NCT00308464|Randomized|Parallel Assignment||Treatment||Double||||||
1550863|NCT00308451|Randomized|Parallel Assignment||Treatment||Double||||||
1550864|NCT00308438||Single Group Assignment||Treatment||None (Open Label)||||||
1550865|NCT00308425|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550866|NCT00308412|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1550867|NCT00308399|Randomized|Parallel Assignment||Treatment||Double||||||
1550868|NCT00308386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550869|NCT00308373|Randomized|Parallel Assignment||Treatment||Double||||||
1550870|NCT00308360|Randomized|Parallel Assignment||Treatment||Single||||||
1550871|NCT00308347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550872|NCT00308334|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550873|NCT00308321|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550874|NCT00308308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550875|NCT00308295|Randomized|Parallel Assignment||Treatment||Double||||||
1550876|NCT00308282|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1550877|NCT00308269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550878|NCT00308256|Randomized|Parallel Assignment||||None (Open Label)||||||
1550879|NCT00308243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550880|NCT00308230|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1550881|NCT00308217|||||Prospective|||||||
1550882|NCT00308204|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550883|NCT00308191|Randomized|Parallel Assignment||Treatment||Double||||||
1550884|NCT00308178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550885|NCT00308165||Single Group Assignment||Treatment||None (Open Label)||||||
1550886|NCT00308152|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550887|NCT00308139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550888|NCT00308126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550889|NCT00308113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550890|NCT00308100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550891|NCT00308087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550892|NCT00308074||Single Group Assignment||Treatment||None (Open Label)||||||
1550893|NCT00308061|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1550894|NCT00308048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550895|NCT00308035|||Cohort||Prospective|||||||
1550896|NCT00308022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550897|NCT00308009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550898|NCT00307996|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550899|NCT00307983|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1550900|NCT00307970|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550901|NCT00307957|Randomized|Parallel Assignment||Treatment||Double||||||
1550902|NCT00307944|Randomized|Crossover Assignment||Treatment||Double||||||
1550903|NCT00307931||Single Group Assignment||Treatment||None (Open Label)||||||
1550904|NCT00307918|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550905|NCT00307905|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550906|NCT00307892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550907|NCT00307879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550908|NCT00307866|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1550909|NCT00307853|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1550910|NCT00307840|Randomized|Parallel Assignment||Treatment||Double||||||
1550911|NCT00307827|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550912|NCT00307814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550913|NCT00307801|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550914|NCT00307788||Single Group Assignment||Treatment||Single|||t|||
1550915|NCT00307775|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550916|NCT00307762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550917|NCT00307749|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1550918|NCT00307736||Single Group Assignment||Treatment||None (Open Label)||||||
1550919|NCT00307723|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1550920|NCT00307710|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1550921|NCT00307697|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1550922|NCT00307684|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1550923|NCT00307671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550924|NCT00307658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550925|NCT00307645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550926|NCT00307632|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550927|NCT00307619|Randomized|Parallel Assignment||Treatment||Double||||||
1550928|NCT00307606|Randomized|Single Group Assignment||Treatment||Single||||||
1550929|NCT00307593|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1550930|NCT00307580||||Treatment||||||||
1550931|NCT00307567|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550932|NCT00307554|Randomized|Parallel Assignment||Prevention||Double||||||
1550933|NCT00307541|Randomized|Parallel Assignment||Prevention||Single||||||
1550934|NCT00307528|Randomized|Parallel Assignment||Prevention||Single|||t|||
1550935|NCT00307515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550936|NCT00307502|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550937|NCT00307489|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1550938|NCT00307476|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550939|NCT00307463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550940|NCT00307450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550941|NCT00307437|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550942|NCT00307424|Randomized|Crossover Assignment||||None (Open Label)||||||
1550943|NCT00307411|Randomized|Parallel Assignment||Treatment||Double||||||
1550944|NCT00307398|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550945|NCT00307385||||||||||||
1550946|NCT00307346||||||||||||
1550947|NCT00307333|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1550948|NCT00307320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550949|NCT00307307|Randomized|Parallel Assignment||Treatment||Double||||||
1550950|NCT00307294||Single Group Assignment||Treatment||None (Open Label)||||||
1550951|NCT00307281|||Cohort||Other|||||||
1550952|NCT00307268|||Cohort||Prospective|||||||
1550953|NCT00307255||Single Group Assignment||Treatment||None (Open Label)||||||
1550954|NCT00307242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550955|NCT00307229|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550956|NCT00307216|Randomized|Parallel Assignment||Treatment||Single||||||t
1550957|NCT00307203|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550958|NCT00307190|||Case Control||Prospective|||||||
1550959|NCT00307177|Randomized|Parallel Assignment||Prevention||Double||||||
1550960|NCT00307164|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1550961|NCT00307151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550962|NCT00307138|Randomized|Parallel Assignment||Prevention||Double||||||
1550963|NCT00307125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550964|NCT00307112|||||Prospective|||||||
1550965|NCT00307099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550966|NCT00307086||Single Group Assignment||Treatment||None (Open Label)||||||
1550967|NCT00307073|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550968|NCT00307060|Randomized|Parallel Assignment||Treatment||Double||||||
1550969|NCT00307047|Randomized|Parallel Assignment||Treatment||Single|||t|||
1550970|NCT00307034|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550971|NCT00307021|Randomized|Parallel Assignment||Prevention||Double||||t||t
1550972|NCT00307008|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550973|NCT00306995|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550974|NCT00306982|||||Prospective|||||||
1550975|NCT00306969|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550976|NCT00306956|Randomized|Parallel Assignment||||Single||||||t
1550977|NCT00306943|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1550978|NCT00306930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550979|NCT00306917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550980|NCT00306904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550981|NCT00306891|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1550982|NCT00306878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550983|NCT00306865|||||Other|||||||
1550984|NCT00306852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550985|NCT00306839|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1550986|NCT00306826|Randomized|Parallel Assignment||Treatment||Double||||||
1550987|NCT00306813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1550988|NCT00306800|Randomized|Parallel Assignment||Treatment||Double||||||
1550989|NCT00306787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550990|NCT00306774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1550991|NCT00306761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550992|NCT00306748|Randomized|Parallel Assignment||Treatment||Double||||||
1550993|NCT00306735|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1550994|NCT00306722|Randomized|Parallel Assignment||Treatment||Double||||||
1550995|NCT00306709|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1550996|NCT00306696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550997|NCT00306683|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1550998|NCT00306670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1550999|NCT00306657|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551000|NCT00306644|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551001|NCT00306631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551002|NCT00306618|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551003|NCT00306605|||Other||Prospective|||||||
1551004|NCT00306592||Single Group Assignment||Treatment||None (Open Label)||||||
1551005|NCT00306579|||||Prospective|||||||
1551006|NCT00306566|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1551007|NCT00306553|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1551008|NCT00306540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551009|NCT00306527|Randomized|Single Group Assignment||Prevention||Single|||t|||
1551010|NCT00306514|Randomized|Parallel Assignment||||None (Open Label)||||||
1551011|NCT00306501|Randomized|Parallel Assignment||Treatment||Single||||||t
1551012|NCT00306488|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551013|NCT00306475|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551014|NCT00306462|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551015|NCT00306449|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551016|NCT00306436|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1551017|NCT00306423|Randomized|Parallel Assignment||Treatment||Single||||||t
1551018|NCT00306410|Randomized|Parallel Assignment||Treatment||Double||||||
1551019|NCT00306397|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551020|NCT00306384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551021|NCT00306371|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1551022|NCT00306358|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551023|NCT00306345|||Defined Population|Screening|Longitudinal, Prospective|||||||
1551024|NCT00306332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551025|NCT00306319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551026|NCT00306306|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551027|NCT00306293|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1551028|NCT00306280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551029|NCT00306267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551030|NCT00306254|Randomized|Parallel Assignment||Prevention||Double||||||
1551031|NCT00306241|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1551032|NCT00306228|Randomized|Parallel Assignment||Treatment||Single||||||t
1551033|NCT00306215|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1551034|NCT00306202|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551035|NCT00306189|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551036|NCT00306176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551037|NCT00306163|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551038|NCT00306150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551039|NCT00306137|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551040|NCT00306124|Randomized|Crossover Assignment||Treatment||Double||||||
1551041|NCT00306111||Single Group Assignment||Treatment||None (Open Label)||||||
1551042|NCT00306098||Single Group Assignment||Treatment||None (Open Label)||||||
1551043|NCT00306085|Non-Randomized|Single Group Assignment||Treatment||Double||||||
1551044|NCT00306072|Randomized|Crossover Assignment||Treatment||Double||||||
1551045|NCT00306059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551046|NCT00306046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551047|NCT00306033|Randomized|Single Group Assignment||Treatment||Double||||||
1551048|NCT00306020|Randomized|Crossover Assignment||Treatment||Double||||||
1551049|NCT00306007|||Cohort||Prospective|||||||
1551050|NCT00305981|||Defined Population||Cross-Sectional, Prospective|||||||
1551051|NCT00305968|Randomized|Parallel Assignment||||None (Open Label)||||||
1551052|NCT00305955|||Cohort||Prospective|||||||
1551053|NCT00305942||Single Group Assignment||Treatment||None (Open Label)||||||
1551054|NCT00305929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551055|NCT00305916|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1551056|NCT00305903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551057|NCT00305890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551058|NCT00305877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551059|NCT00305864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551060|NCT00305851|Randomized|Parallel Assignment||||Single|||t|||
1551061|NCT00305838||||Diagnostic||None (Open Label)||||||
1551062|NCT00305825||Single Group Assignment||Treatment||None (Open Label)||||||
1551063|NCT00305812|Randomized|||Treatment||None (Open Label)||||||
1551064|NCT00305799|||Cohort||Prospective|||||||
1551065|NCT00305786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551066|NCT00305773|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551067|NCT00305760|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551068|NCT00305747||Single Group Assignment||Treatment||None (Open Label)||||||
1551069|NCT00305734||Single Group Assignment||Treatment||None (Open Label)||||||
1551070|NCT00305708||||Treatment||None (Open Label)||||||
1551071|NCT00305695|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1551072|NCT00305682|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551073|NCT00305669||Single Group Assignment||Treatment||None (Open Label)||||||
1551074|NCT00305656||Single Group Assignment||Treatment||None (Open Label)||||||
1551075|NCT00305643|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1551076|NCT00305630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551077|NCT00305617|Non-Randomized|||Diagnostic||||||||
1551078|NCT00305604|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551079|NCT00305591|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551080|NCT00305578|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551081|NCT00305565|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1551082|NCT00305552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551083|NCT00305539|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551084|NCT00305526|Randomized|Parallel Assignment||Treatment||Single||||||
1551085|NCT00305513|Randomized|Parallel Assignment||Treatment||Single||||||
1551086|NCT00305500|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551087|NCT00305487|Randomized|Parallel Assignment||Treatment||Double||||||
1551088|NCT00305474|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1551089|NCT00305461|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551090|NCT00305448|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551091|NCT00305435||Single Group Assignment||Treatment||None (Open Label)||||||
1551092|NCT00305422|Randomized|Parallel Assignment||Treatment||Double||||||
1551093|NCT00305409|Randomized|Single Group Assignment||Treatment||Double||||||
1551094|NCT00305396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551095|NCT00305383|Randomized|Parallel Assignment||Treatment||Double||||||
1551096|NCT00305370|Randomized|Crossover Assignment||Treatment||Double||||||
1551097|NCT00305357|||Cohort||Prospective|||||||
1551098|NCT00305344||Single Group Assignment||Treatment||None (Open Label)||||||
1551099|NCT00305331|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1551100|NCT00305305|||Cohort||Prospective|||||||
1551101|NCT00305292|Randomized|Crossover Assignment||Health Services Research||Double||||||
1551102|NCT00305279|Randomized|Crossover Assignment||||Single|||t|||
1551103|NCT00305266|||||Prospective|||||||
1551104|NCT00305253|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551105|NCT00305240|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551106|NCT00305227|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1551107|NCT00305214|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551108|NCT00305201|Randomized|Parallel Assignment||Treatment||Double||||||
1551109|NCT00305188|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1551110|NCT00305175|||Cohort||Prospective|||||||
1551111|NCT00305162|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551112|NCT00305149|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1551113|NCT00305136|||Cohort||Prospective|||||||
1551114|NCT00305123|||Cohort||Prospective|||||||
1551115|NCT00305110||Single Group Assignment||Treatment||None (Open Label)||||||
1551116|NCT00305097|Randomized|Parallel Assignment||Prevention||Single|||||t|
1551117|NCT00305084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551118|NCT00305071|Randomized|Parallel Assignment||Treatment||Double||||||
1551119|NCT00305058|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551120|NCT00305045|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1551121|NCT00305032|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551122|NCT00305019|Randomized|Parallel Assignment||Treatment||Double||||||
1551123|NCT00305006|Randomized|Parallel Assignment||Treatment||Single||||||t
1551124|NCT00304993|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551125|NCT00304980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551126|NCT00304967||||||||||||
1551127|NCT00304954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551128|NCT00304941|||||Prospective|||||||
1551129|NCT00304915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551130|NCT00304902|||Ecologic or Community||Retrospective|||||||
1551131|NCT00304889|||Cohort||Retrospective|||||||
1551132|NCT00304876|||Cohort||Retrospective|||||||
1551133|NCT00304863|Randomized|Single Group Assignment||Treatment||Single|||t|||
1551134|NCT00304850|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1551135|NCT00304837|Randomized|Crossover Assignment||||Double||||||
1551136|NCT00304824|||Case-Only||Prospective|||||||
1551137|NCT00304811|Randomized|Parallel Assignment||||Single||||||
1551138|NCT00304798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551139|NCT00304785|Randomized|Crossover Assignment||Treatment||Double||||||
1551140|NCT00304772|Randomized|Parallel Assignment||Treatment||Single||||||t
1551141|NCT00304759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551142|NCT00304746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551143|NCT00304733|Randomized|Single Group Assignment||Treatment||Single||||||
1551144|NCT00304720|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551145|NCT00304707|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1551146|NCT00304694||||Screening|Cross-Sectional, Prospective|||||||
1551147|NCT00304681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551148|NCT00304668|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1551149|NCT00304655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551150|NCT00304642|Randomized|Parallel Assignment||Prevention||Double||||||
1551151|NCT00304629|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551152|NCT00304616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551153|NCT00304603|||Case Control||Retrospective|||||||
1551154|NCT00304590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551155|NCT00304577|||Defined Population||Longitudinal, Prospective|||||||
1551156|NCT00304564||Single Group Assignment||Screening||None (Open Label)||||||
1551157|NCT00304551|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551158|NCT00304538|Randomized|Parallel Assignment||Treatment||Single||||||
1551159|NCT00304525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551160|NCT00304512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551161|NCT00304499|Randomized|Single Group Assignment||Treatment||Double||||||
1551162|NCT00304473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551163|NCT00304460||||Treatment||||||||
1551164|NCT00304447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551165|NCT00304434|Randomized|Parallel Assignment||||None (Open Label)||||||
1551166|NCT00304421|Randomized|Crossover Assignment||Treatment||Double||||||
1551167|NCT00304408|||Cohort||Prospective|||||||
1551168|NCT00304395|||Cohort||Retrospective|||||||
1551169|NCT00304382|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1551170|NCT00304369||||||||||||
1551171|NCT00304356||Single Group Assignment||Treatment||None (Open Label)||||||
1551172|NCT00304330|||Other||Retrospective|||||||
1551173|NCT00304317|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551174|NCT00304304|Randomized|Crossover Assignment||Prevention||Single|||t|||
1551175|NCT00304291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551176|NCT00304278||Single Group Assignment||Treatment||None (Open Label)||||||
1551177|NCT00304265|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551178|NCT00304252|Randomized|Parallel Assignment||Treatment||Double||||||
1551179|NCT00304239|Randomized|Parallel Assignment||Treatment||Double||||||
1551180|NCT00304226|Randomized|Parallel Assignment||Treatment||Double||||||
1551181|NCT00304213|Randomized|Parallel Assignment||Treatment||Double||||||
1551182|NCT00304200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551183|NCT00304187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551184|NCT00304174|||Case Control||Prospective|||||||
1551185|NCT00304161|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1551186|NCT00304148|||Cohort||Prospective|||||||
1551187|NCT00304135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551188|NCT00304096|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551189|NCT00304083|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551190|NCT00304070|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551191|NCT00304031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551192|NCT00304018||Single Group Assignment||Treatment||None (Open Label)||||||
1551193|NCT00304005||||Treatment||||||||
1551194|NCT00303992||Single Group Assignment||Treatment||None (Open Label)||||||
1551195|NCT00303979|||Cohort||Prospective|||||||
1551196|NCT00303966||Single Group Assignment||Treatment||None (Open Label)||||||
1551197|NCT00303953||Single Group Assignment||Treatment||None (Open Label)||||||
1551198|NCT00303940||||Treatment||||||||
1551199|NCT00303927||||Treatment||None (Open Label)||||||
1551200|NCT00303914||||||||||||
1551201|NCT00303901||Single Group Assignment||Treatment||None (Open Label)||||||
1551202|NCT00303888|Randomized|Parallel Assignment||Treatment||Double||||||
1551203|NCT00303875|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1551204|NCT00303862||Single Group Assignment||Treatment||None (Open Label)||||||
1551205|NCT00303849||Single Group Assignment||Treatment||None (Open Label)||||||
1551206|NCT00303836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551207|NCT00303823|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1551208|NCT00303810||||Treatment||None (Open Label)||||||
1551209|NCT00303797||Single Group Assignment||Treatment||None (Open Label)||||||
1551210|NCT00303784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551211|NCT00303771|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551212|NCT00303758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551213|NCT00303745|Randomized|||Treatment||None (Open Label)||||||
1551214|NCT00303732||Single Group Assignment||Treatment||None (Open Label)||||||
1551215|NCT00303719|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551216|NCT00303706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551217|NCT00303667|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551218|NCT00303654||||Treatment||None (Open Label)||||||
1551219|NCT00303641|Randomized|Parallel Assignment||Treatment||Single||||||
1551220|NCT00303628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551221|NCT00303615|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551222|NCT00303602|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551223|NCT00303589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551224|NCT00303576|Randomized|Parallel Assignment||Prevention||Double||||||
1551225|NCT00303563|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551226|NCT00303550|Randomized|Parallel Assignment||Treatment||Double||||||
1551227|NCT00303537|Randomized|Parallel Assignment||Treatment||Double||||||
1551228|NCT00303524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551229|NCT00303511|||Cohort||Retrospective|||||||
1551230|NCT00303498|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1551231|NCT00303485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551232|NCT00303472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551233|NCT00303459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551234|NCT00303446|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551235|NCT00303433|Randomized|Parallel Assignment||Prevention||Double||||||
1551236|NCT00303420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551237|NCT00303407|||Defined Population||Longitudinal, Prospective|||||||
1551238|NCT00303394|Randomized|Factorial Assignment||Treatment||Double||||||
1551239|NCT00303381|Randomized|Parallel Assignment||Treatment||Double||||||
1551240|NCT00303368||||||||||||
1551241|NCT00303355|||||Prospective|||||||
1551242|NCT00303342|Randomized|Parallel Assignment||Treatment||Single|||t|||
1551243|NCT00303329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551244|NCT00303316|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1551245|NCT00303303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551246|NCT00303290||Single Group Assignment||Treatment||None (Open Label)||||||
1551247|NCT00303277|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1551248|NCT00303264|Randomized|Parallel Assignment||Treatment||Double||||||
1551249|NCT00303251||Single Group Assignment||Treatment||None (Open Label)||||||
1551250|NCT00303238|Randomized|Parallel Assignment||Prevention||Double||||||
1551251|NCT00303225||||Treatment||||||||
1551252|NCT00303212|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551253|NCT00303199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551254|NCT00303186|||Cohort||Prospective|||||||
1551255|NCT00303173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551256|NCT00303160|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551257|NCT00303147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551258|NCT00303134|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551259|NCT00303121|||Defined Population||Cross-Sectional, Prospective|||||||
1551260|NCT00303108||Single Group Assignment||Treatment||None (Open Label)||||||
1551261|NCT00303082|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1551262|NCT00303069|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1551263|NCT00303056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551264|NCT00303043|||Cohort||Prospective|||||||
1551265|NCT00303030|Randomized|Parallel Assignment||Treatment||Single||||||t
1551266|NCT00303017|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1551267|NCT00303004|Randomized|Crossover Assignment||Treatment||Double||||||
1551269|NCT00302978|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551270|NCT00302965|Randomized|Single Group Assignment||Treatment||Double||||||
1551271|NCT00302952|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1551272|NCT00302939|||Cohort||Prospective|||||||
1551273|NCT00302926|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1551274|NCT00302913|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551275|NCT00302900|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551276|NCT00302887|||Defined Population||Longitudinal, Prospective|||||||
1551277|NCT00302874|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1551278|NCT00302861||||||||||||
1551279|NCT00302848|||Cohort||Prospective|||||||
1551280|NCT00302835|||Case Control, Natural History||Retrospective|||||||
1551281|NCT00302822|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551282|NCT00302809|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1551283|NCT00302796|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1551284|NCT00302783|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1551285|NCT00302770|Randomized|Parallel Assignment||Treatment||Double||||||
1551286|NCT00302757|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551287|NCT00302744|Non-Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1551288|NCT00302731|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551289|NCT00302718|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1551290|NCT00302705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551291|NCT00302692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551292|NCT00302679|||Defined Population||Cross-Sectional, Prospective|||||||
1551293|NCT00302666|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551294|NCT00302653|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551295|NCT00302640|Randomized|Single Group Assignment||Treatment||Double||||||
1551296|NCT00302627||Single Group Assignment||Treatment||None (Open Label)||||||
1551297|NCT00302614|Random Sample||Natural History||Longitudinal, Retrospective|||||||
1551298|NCT00302601||Single Group Assignment||Diagnostic||None (Open Label)||||||
1551299|NCT00302588|Random Sample||Natural History||Longitudinal, Retrospective|||||||
1551300|NCT00302575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551301|NCT00302562|Random Sample||Natural History||Longitudinal, Retrospective/Prospective|||||||
1551302|NCT00302549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551303|NCT00302536||Single Group Assignment||Treatment||None (Open Label)||||||
1551304|NCT00302523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551305|NCT00302510|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551306|NCT00302497|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551307|NCT00302484|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551308|NCT00302471|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551309|NCT00302458|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1551310|NCT00302445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551311|NCT00302432|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1551312|NCT00302419|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1551313|NCT00302406|Randomized|Parallel Assignment||Treatment||Single||||||
1551314|NCT00302393|Randomized|Crossover Assignment||||None (Open Label)||||||
1551315|NCT00302380|||Case Control||Prospective|||||||
1551316|NCT00302367|Randomized|Parallel Assignment||||Single||||||
1551317|NCT00302354|Randomized|Crossover Assignment||||Double||||||
1551318|NCT00302341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551319|NCT00302328|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1551320|NCT00302315|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1551321|NCT00302302||Single Group Assignment||Prevention||Double|||t|t||
1551322|NCT00302289|Randomized|Crossover Assignment||Prevention||Double||||||
1551323|NCT00302276|Randomized|Parallel Assignment||Prevention||Double||||||
1551324|NCT00302263|Randomized|Crossover Assignment||Prevention||Double||||||
1551325|NCT00302250|Randomized|Parallel Assignment||Treatment||Double||||||
1551326|NCT00302237|||Case Control||Prospective|||||||
1551327|NCT00302224|Randomized|Parallel Assignment||Treatment||Double||||||
1551328|NCT00302211|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1551329|NCT00302198|||||Prospective|||||||
1551330|NCT00302185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551331|NCT00302172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551332|NCT00302159||Single Group Assignment||Treatment||None (Open Label)||||||
1551333|NCT00302146|||Cohort||Prospective|||||||
1551334|NCT00302133|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551335|NCT00302120|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1551336|NCT00302107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551337|NCT00302094|||Cohort||Prospective|||||||
1551338|NCT00302081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551339|NCT00302068|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551340|NCT00302055|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551341|NCT00302042|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551342|NCT00302029|||Cohort||Prospective|||||||
1551343|NCT00302016||||||||||||
1551344|NCT00302003||Single Group Assignment||Treatment||None (Open Label)||||||
1551345|NCT00301990||||Treatment||None (Open Label)||||||
1551346|NCT00301964||Single Group Assignment||Treatment||None (Open Label)||||||
1551347|NCT00301951||Single Group Assignment||Treatment||None (Open Label)||||||
1551348|NCT00301938|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551349|NCT00301925|Randomized|Factorial Assignment||Treatment||||||||
1551350|NCT00301912||||Treatment||None (Open Label)||||||
1551351|NCT00301899||||Treatment||None (Open Label)||||||
1551352|NCT00301886|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1551353|NCT00301873||Single Group Assignment||Supportive Care||None (Open Label)||||||
1551354|NCT00301860||Single Group Assignment||Treatment||None (Open Label)||||||
1551355|NCT00301847||Single Group Assignment||Treatment||None (Open Label)||||||
1551356|NCT00301834||Single Group Assignment||Treatment||None (Open Label)||||||
1551357|NCT00301821||Single Group Assignment||Treatment||None (Open Label)||||||
1551358|NCT00301808||Single Group Assignment||Treatment||None (Open Label)||||||
1551359|NCT00301795||Single Group Assignment||Treatment||None (Open Label)||||||
1551360|NCT00301782|Randomized|||Treatment||None (Open Label)||||||
1551361|NCT00301769||Single Group Assignment||Treatment||None (Open Label)||||||
1551362|NCT00301756||Single Group Assignment||Treatment||None (Open Label)||||||
1551363|NCT00301730||||Treatment||||||||
1551364|NCT00301691|Randomized|||Prevention||||||||
1551365|NCT00301678|Randomized|||Prevention||||||||
1551366|NCT00301665|Randomized|Parallel Assignment||Prevention||Double||||||
1551367|NCT00301652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551368|NCT00301639|Randomized|Crossover Assignment||||None (Open Label)||||||
1551369|NCT00301626|Randomized|Parallel Assignment||||None (Open Label)||||||
1551370|NCT00301613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551371|NCT00301600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551372|NCT00301587|Randomized|Parallel Assignment||Treatment||Double||||||
1551373|NCT00301574|Randomized|Parallel Assignment||Treatment||Double||||||
1551374|NCT00301561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551375|NCT00301548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551376|NCT00301535|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551377|NCT00301522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551378|NCT00301509|Randomized|Single Group Assignment||||None (Open Label)||||||
1551379|NCT00301496|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1551380|NCT00301483|Randomized|Crossover Assignment||Treatment||Single|||t|||
1551381|NCT00301470|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551382|NCT00301457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551383|NCT00301444|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1551384|NCT00301431|Randomized|Parallel Assignment||Treatment||Double||||||
1551385|NCT00301418||Single Group Assignment||Treatment||None (Open Label)||||||
1551386|NCT00301405||Single Group Assignment||Treatment||None (Open Label)||||||
1551387|NCT00301392|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551388|NCT00301379|||Case-Only||Prospective|||||||
1551389|NCT00301366|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551390|NCT00301353|Randomized|Parallel Assignment||Prevention||Double||||||
1551391|NCT00301340||||Treatment||||||||
1551392|NCT00301327|Randomized|Parallel Assignment||Treatment||Double||||||
1551393|NCT00301314|||||Retrospective|||||||
1551394|NCT00301301|||||Retrospective|||||||
1551395|NCT00301288|||||Retrospective|||||||
1551396|NCT00301275|Random Sample||||Longitudinal, Prospective|||||||
1551397|NCT00301262|Randomized|Parallel Assignment||Treatment||Double||||||
1551398|NCT00301249||||||||||||
1551399|NCT00301236|Randomized|Parallel Assignment||Treatment||Double||||||
1551400|NCT00301223|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551401|NCT00301210|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1551402|NCT00301197|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551403|NCT00301184|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1551404|NCT00301171|Randomized|Parallel Assignment||Diagnostic||Double||||||
1551405|NCT00301158||||Prevention||||||||
1551406|NCT00301145|Randomized|||Prevention||None (Open Label)||||||
1551407|NCT00301119|||Cohort||Prospective|||||||
1551408|NCT00301106||Single Group Assignment||Treatment||None (Open Label)||||||
1551409|NCT00301093||Single Group Assignment||Treatment||None (Open Label)||||||
1551410|NCT00301080|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1551411|NCT00301067|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||"3+3 dose escalation design study. (3) patients per dose stratum will be entered in the following cohorts:~Cohort 1 - Temozolomide and Calcitriol 0.2mcg/kg days 1 + 15~Cohort 2 - Temozolomide and Calcitriol 0.3 mcg/kg days 1 + 15~Cohort 3 - Temozolomide and Calcitriol 0.5 mcg/kg days 1 + 15~Temozolomide dose of 150 mg/m2 will be administered orally on days 2-8 and 16-22 every 28 day cycle in each cohort.~If 1 patient experiences dose limiting toxicity (DLT) at any dose, that cohort will be expanded to 6 patients. If 2 patients experience DLT in that cohort, further dose escalation will cease and the cohort immediately preceding that cohort will be considered the maximum tolerated dose (MTD). Alternatively, if no more patients experience DLT, then dose will be escalated to the next cohort."||||
1551412|NCT00301054|Randomized|Factorial Assignment||Prevention||Double||||||
1551413|NCT00301041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551414|NCT00301028||Single Group Assignment||Treatment||None (Open Label)||||||
1551415|NCT00301015|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1551416|NCT00301002|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551418|NCT00300976|Randomized|Parallel Assignment||Treatment||None (Open Label)||"(Intervention study) A multi-center, open-label, randomized controlled study, which compared the efficacy of intensive therapy and conventional therapy in type 2 diabetic patients~(Follow-up study) A prospective cohort study with a 5-year long-term follow-up period"||||
1551419|NCT00300963|Randomized|Parallel Assignment||Treatment||Double||||||
1551420|NCT00300950|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1551421|NCT00300937|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1551422|NCT00300924|Randomized|Parallel Assignment||Treatment||Double||||||
1551423|NCT00300911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551424|NCT00300898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551425|NCT00300885|Randomized|Parallel Assignment||Treatment||Double||||||
1551426|NCT00300872|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551427|NCT00300859|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1551428|NCT00300846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551429|NCT00300833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551430|NCT00300820||||||||||||
1551431|NCT00300807|Randomized|||Treatment||Double||||||
1551432|NCT00300794|Randomized|Parallel Assignment||Treatment||Double||||||
1551433|NCT00300781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551434|NCT00300768|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551435|NCT00300755|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551436|NCT00300742||Single Group Assignment||Treatment||None (Open Label)||||||
1551437|NCT00300729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551438|NCT00300716|Randomized|Parallel Assignment||Treatment||Double||||||
1551439|NCT00300703|||Cohort||Retrospective|||||||
1551440|NCT00300690|Randomized|Parallel Assignment||Treatment||Double||||||
1551441|NCT00300677|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1551442|NCT00300664|Randomized|Parallel Assignment||||Single||||||
1551443|NCT00300651|Randomized|Crossover Assignment||Treatment||Single||||||
1551444|NCT00300638|||Other||Cross-Sectional|||||||
1551445|NCT00300625|||||Prospective|||||||
1551446|NCT00300612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551447|NCT00300599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551448|NCT00300586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551449|NCT00300573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551450|NCT00300560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551451|NCT00300547|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551452|NCT00300534||Single Group Assignment||Diagnostic||None (Open Label)||||||
1551453|NCT00300521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551454|NCT00300508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551455|NCT00300495|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551456|NCT00300482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551457|NCT00300469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551458|NCT00300456|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551459|NCT00300443|Randomized|Parallel Assignment||Treatment||Double||||||
1551460|NCT00300430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551461|NCT00300417||||Treatment||||||||
1551462|NCT00300404|Randomized|Parallel Assignment||Treatment||Double||||||
1551463|NCT00300391|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551464|NCT00300378|Randomized|Parallel Assignment||Treatment||Double||||||
1551465|NCT00300365|Randomized|Parallel Assignment||Prevention||Quadruple|Pioglitazone and placebo were overencapsulated||t|t|t|t
1551466|NCT00300352|Randomized|Parallel Assignment||Prevention||Double||||||
1551467|NCT00300339|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551468|NCT00300326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551469|NCT00300313|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1551470|NCT00300300|Randomized|Factorial Assignment||Treatment||Single|||t|||
1551471|NCT00300287|Randomized|Parallel Assignment||Treatment||Double||||||
1551472|NCT00300274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551473|NCT00300261|Randomized|Single Group Assignment||||Single|||||t|
1551474|NCT00300248|||Cohort||Prospective|||||||
1551475|NCT00300235|||Cohort||Retrospective|||||||
1551476|NCT00300222|Randomized|Parallel Assignment||Treatment||Double||||||
1551477|NCT00300209|||Cohort||Prospective|||||||
1551478|NCT00300196|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551479|NCT00300183|||||Other|||||||
1551480|NCT00300170|||||Other|||||||
1551481|NCT00300157|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551482|NCT00300131|||Case-Only||Prospective|||||||
1551483|NCT00300118|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551484|NCT00300105|Randomized|Parallel Assignment||Treatment||Double||||||
1551485|NCT00300092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551486|NCT00300079|Randomized|Parallel Assignment||Treatment||Double||||||
1551487|NCT00300066|||Case-Only||Prospective|||||||
1551488|NCT00300053|Randomized|Parallel Assignment||Treatment||Double||||||
1551489|NCT00300040|Randomized|Parallel Assignment||Treatment||Single|||t|||
1551490|NCT00300027|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551491|NCT00300014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551492|NCT00300001|||Defined Population|Screening|Longitudinal, Prospective|||||||
1551493|NCT00299988|Randomized|Parallel Assignment||Treatment||Double||||||
1551494|NCT00299975|Randomized|Parallel Assignment||Treatment||Single|||t|||
1551495|NCT00299962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551496|NCT00299949|||Case-Only||Prospective|||||||
1551497|NCT00299936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551498|NCT00299923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551499|NCT00299910|Randomized|Parallel Assignment||Treatment||Double||||||
1551500|NCT00299897|Randomized|Parallel Assignment||Treatment||Double||||||
1551501|NCT00299884|||Case-Crossover||Prospective|||||||
1551502|NCT00299871|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551503|NCT00299858|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551504|NCT00299845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551505|NCT00299832|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551506|NCT00299819|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1551507|NCT00299806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551508|NCT00299793|||Defined Population||Longitudinal, Prospective|||||||
1551509|NCT00299780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551510|NCT00299767|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551511|NCT00299754|Randomized|Single Group Assignment||Treatment||Single||||||
1551512|NCT00299741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551513|NCT00299728|Randomized|||Treatment||None (Open Label)||||||
1551514|NCT00299715|Randomized|Parallel Assignment||Treatment||Double||||||
1551515|NCT00299702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551516|NCT00299689||Single Group Assignment||Treatment||None (Open Label)||||||
1551517|NCT00299676|||Cohort||Prospective|||||||
1551518|NCT00299663|||||Cross-Sectional|||||||
1551519|NCT00299650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551520|NCT00299637|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1551521|NCT00299624|||Cohort||Prospective|||||||
1551522|NCT00299611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551523|NCT00299598|||Case Control||Prospective|||||||
1551524|NCT00299585|Randomized|Parallel Assignment||Treatment||Single|||t|||
1551525|NCT00299572|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1551526|NCT00299559|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1551527|NCT00299546|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551528|NCT00299533|Randomized|Parallel Assignment||Treatment||Double||||||
1551529|NCT00299520|Randomized|Parallel Assignment||Treatment||Double||||||
1551530|NCT00299507|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551531|NCT00299494|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1551532|NCT00299481|||||Prospective|||||||
1551533|NCT00299468|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551534|NCT00299455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551535|NCT00299442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551536|NCT00299429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551537|NCT00299416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551538|NCT00299403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551539|NCT00299390||Single Group Assignment||Treatment||None (Open Label)||||||
1551540|NCT00299377|Randomized|Parallel Assignment||Treatment||Single||||||
1551541|NCT00299364|Randomized|Parallel Assignment||Treatment||Double||||||
1551542|NCT00299351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551543|NCT00299338|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551544|NCT00299325|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551545|NCT00299312|||Cohort||Prospective|||||||
1551546|NCT00299299|||||Prospective|||||||
1551547|NCT00299286|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1551548|NCT00299273||Single Group Assignment||Treatment||None (Open Label)||||||
1551549|NCT00299260|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1551550|NCT00299247|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551551|NCT00299234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551552|NCT00299221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551553|NCT00299208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551554|NCT00299195|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551555|NCT00299182|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1551556|NCT00299169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551557|NCT00299156||Single Group Assignment||Treatment||None (Open Label)||||||
1551558|NCT00299143|||Case Control||Prospective|||||||
1551559|NCT00299130|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551560|NCT00299117|Randomized|Parallel Assignment||Prevention||Single||||||t
1551561|NCT00299104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551562|NCT00299091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551563|NCT00299065|Randomized|Parallel Assignment||Treatment||Double||||||
1551564|NCT00299052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551565|NCT00299039|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551566|NCT00299026|Randomized|Parallel Assignment||Treatment||Double||||||
1551567|NCT00299013|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551568|NCT00299000|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551569|NCT00298987||Single Group Assignment||Treatment||None (Open Label)||||||
1551571|NCT00298961|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551572|NCT00298935|Randomized|Parallel Assignment||Treatment||Double||||||
1551573|NCT00298922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551574|NCT00298909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551575|NCT00298896||Single Group Assignment||Treatment||None (Open Label)||||||
1551576|NCT00298883||Single Group Assignment||Treatment||None (Open Label)||||||
1551577|NCT00298870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551578|NCT00298857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551579|NCT00298844|||Defined Population|Screening|Longitudinal, Prospective|||||||
1551580|NCT00298831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551581|NCT00298818|||Case-Only||Prospective|||||||
1551582|NCT00298805|||Case-Only||Prospective|||||||
1551583|NCT00298792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551584|NCT00298779|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1551585|NCT00298766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551586|NCT00298753|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1551587|NCT00298740||Single Group Assignment||Treatment||None (Open Label)||||||
1551588|NCT00298727|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1551589|NCT00298714|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551590|NCT00298701|Randomized|Parallel Assignment||||Double||||||
1551591|NCT00298688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551592|NCT00298675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551593|NCT00298662|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551594|NCT00298649|Randomized|Parallel Assignment||||None (Open Label)||||||
1551595|NCT00298636|Randomized|Single Group Assignment||Treatment||Double||||||
1551596|NCT00298623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551597|NCT00298610||Single Group Assignment||Treatment||None (Open Label)||||||
1551598|NCT00298597|Randomized|Parallel Assignment||Treatment||Double||||||
1551599|NCT00298584|Randomized|Parallel Assignment||Diagnostic||Double||||||
1551600|NCT00298571|Randomized|Parallel Assignment||Treatment||Double||||||
1551601|NCT00298558|Randomized|Parallel Assignment||Prevention||Single|||t|||
1551602|NCT00298545|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1551603|NCT00298532|Randomized|Single Group Assignment||Treatment||||||||
1551604|NCT00298519|||Cohort||Prospective|||||||
1551605|NCT00298506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551606|NCT00298493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551607|NCT00298480|||Case Control||Longitudinal, Prospective|||||||
1551608|NCT00298467|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551609|NCT00298454|Randomized|Parallel Assignment||Treatment||Double||||||
1551610|NCT00298441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551611|NCT00298428||Single Group Assignment||Diagnostic||None (Open Label)||||||
1551612|NCT00298415|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551613|NCT00298402|||Case Control||Prospective|||||||
1551614|NCT00298389|||Case Control||Prospective|||||||
1551615|NCT00298376|||Case Control, Natural History||Longitudinal, Prospective|||||||
1551616|NCT00298363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551617|NCT00298350|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551618|NCT00298337|Randomized|Parallel Assignment||Prevention||Double||||||
1551619|NCT00298324|Randomized|Parallel Assignment||Treatment||Double||||||
1551620|NCT00298311|Randomized|Single Group Assignment||Health Services Research||Double|||t|||t
1551621|NCT00298298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551622|NCT00298285|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551623|NCT00298272|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551624|NCT00298259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551625|NCT00298246|||Cohort||Prospective|||||||
1551626|NCT00298233|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551627|NCT00298220|Randomized|Factorial Assignment||||None (Open Label)||||||
1551628|NCT00298207|Randomized|Single Group Assignment||Educational/Counseling/Training||Single||||||
1551629|NCT00298194|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1551630|NCT00298181|||Cohort||Cross-Sectional|||||||
1551631|NCT00298168|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1551632|NCT00298155|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551633|NCT00298142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551634|NCT00298129|||Natural History||Longitudinal, Prospective|||||||
1551635|NCT00298116|||Case Control||Prospective|||||||
1551636|NCT00298103|||||Retrospective|||||||
1551637|NCT00298090|||Cohort||Prospective|||||||
1551638|NCT00298077|||Other||Retrospective|||||||
1551639|NCT00298064||||||||||||
1551640|NCT00298051|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1551641|NCT00298038|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1551642|NCT00298025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551643|NCT00298012|Randomized|Parallel Assignment||Treatment||Double||||||
1551644|NCT00297986|||Cohort||Prospective|||||||
1551645|NCT00297973|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551646|NCT00297960|Randomized|Parallel Assignment||||None (Open Label)||||||
1551647|NCT00297947|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551648|NCT00297934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551649|NCT00297921|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1551650|NCT00297908|||||Prospective|||||||
1551651|NCT00297895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551652|NCT00297882|Randomized|Parallel Assignment||Treatment||Single|||t|||
1551653|NCT00297869|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1551654|NCT00297856|||Cohort||Prospective|||||||
1551655|NCT00297843||||Screening|Cross-Sectional, Prospective|||||||
1551656|NCT00297830|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1551657|NCT00297817|Randomized|Parallel Assignment||Prevention||Single|||t|||
1551658|NCT00297804|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551659|NCT00297791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551660|NCT00297778|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551661|NCT00297765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551662|NCT00297752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551663|NCT00297739|Randomized|Parallel Assignment||Treatment||Double||||||
1551664|NCT00297726|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1551665|NCT00297713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551666|NCT00297700|Randomized|Factorial Assignment||Treatment||Single||||||
1551667|NCT00297687|Randomized|Parallel Assignment||Prevention||Double||||||
1551668|NCT00297674|Randomized|Parallel Assignment||Treatment||Double||||||
1551669|NCT00297661|Randomized|Parallel Assignment||Treatment||Single||||||
1551670|NCT00297648||Single Group Assignment||Treatment||None (Open Label)||||||
1551671|NCT00297635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551672|NCT00297609|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1551673|NCT00297596||Single Group Assignment||Treatment||None (Open Label)||||||
1551674|NCT00297583|Randomized|Crossover Assignment||Treatment||Double||||||
1551675|NCT00297570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551676|NCT00297557|||Defined Population||Cross-Sectional, Prospective|||||||
1551677|NCT00297544|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1551678|NCT00297531|Randomized|Parallel Assignment||Treatment||Single||||||
1551679|NCT00297518|Randomized|Parallel Assignment||Treatment||Single||||||
1551680|NCT00297505|Randomized|Parallel Assignment||Treatment||Double||||||
1551681|NCT00297492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551682|NCT00297479|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551683|NCT00297466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551684|NCT00297453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551685|NCT00297440|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551686|NCT00297427|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1551687|NCT00297414|||Case-Only||Retrospective|||||||
1551688|NCT00297401|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551689|NCT00297388|Randomized|Parallel Assignment||Treatment||Double||||||
1551690|NCT00297375|Randomized|Parallel Assignment||Treatment||Double||||||
1551691|NCT00297362|||||Prospective|||||||
1551692|NCT00297349|||||Prospective|||||||
1551693|NCT00297336|||||Prospective|||||||
1551694|NCT00297323|||||Prospective|||||||
1551695|NCT00297310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551696|NCT00297297|||Case-Only||Prospective|||||||
1551697|NCT00297284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551698|NCT00297271|||Cohort||Prospective|||||||
1551699|NCT00297258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551700|NCT00297245|Randomized|Parallel Assignment||Prevention||Double||||||
1551701|NCT00297232||Single Group Assignment||Treatment||None (Open Label)||||||
1551702|NCT00297219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551703|NCT00297206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551704|NCT00297193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551705|NCT00297180|Randomized|Single Group Assignment||Treatment||Double||||||
1551706|NCT00297167|Randomized|Crossover Assignment||Treatment||Double||||||
1551707|NCT00297154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551708|NCT00297141||Single Group Assignment||Treatment||None (Open Label)||||||
1551709|NCT00297128||Single Group Assignment||Treatment||None (Open Label)||||||
1551710|NCT00297115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551711|NCT00297102|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551712|NCT00297089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551713|NCT00297076|Randomized|Parallel Assignment||Treatment||Double||||||
1551714|NCT00297063|Randomized|Parallel Assignment||Treatment||||||||
1551715|NCT00297050||||Treatment||||||||
1551716|NCT00297037|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551717|NCT00297024||Single Group Assignment||Treatment||None (Open Label)||||||
1551718|NCT00297011|Randomized|Parallel Assignment||Treatment||Double||||||
1551719|NCT00296985|Randomized|Parallel Assignment||Prevention||Single||||||
1551720|NCT00296972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551721|NCT00296959|Randomized|Crossover Assignment||Treatment||Double||||||
1551722|NCT00296946|Randomized|Crossover Assignment||Treatment||Double||||||
1551723|NCT00296933|Randomized|Parallel Assignment||Treatment||Double||||||
1551724|NCT00296920|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551725|NCT00296907|Randomized|Parallel Assignment||Prevention||Single||||||t
1551726|NCT00296894|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1551727|NCT00296881|Randomized|Parallel Assignment||Treatment||Single||||||
1551728|NCT00296868|Randomized|Parallel Assignment||Prevention||Double||||||
1551729|NCT00296855|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551730|NCT00296842|Randomized|Parallel Assignment||Prevention||Single||||||t
1551731|NCT00296829|Randomized|Parallel Assignment||Prevention||Double||||||
1551732|NCT00296816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551733|NCT00296803|Randomized|Parallel Assignment||Treatment||Double||||||
1551734|NCT00296790|Randomized|Parallel Assignment||Treatment||Double||||||
1551735|NCT00296777|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1551736|NCT00296764|||Case-Only||Prospective|||||||
1551737|NCT00296751|Randomized|Parallel Assignment||||None (Open Label)||||||
1551738|NCT00296738|||Case-Only||Prospective|||||||
1551739|NCT00296725|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551740|NCT00296712||Single Group Assignment||Treatment||None (Open Label)||||||
1551741|NCT00296699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551742|NCT00296686||Single Group Assignment||Treatment||None (Open Label)||||||
1551743|NCT00296673|Randomized|Parallel Assignment||Treatment||Single||||||
1551744|NCT00296660|||Cohort||Prospective|||||||
1551745|NCT00296647|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551746|NCT00296634|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1551747|NCT00296621|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1551748|NCT00296608|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551749|NCT00296595|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551750|NCT00296582|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551751|NCT00296569|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551752|NCT00296556|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551753|NCT00296543|||Cohort||Prospective|||||||
1551754|NCT00296530|Randomized|Parallel Assignment||Treatment||Double||||||
1551755|NCT00296517|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551756|NCT00296504|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551757|NCT00296491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551758|NCT00296478|Randomized|Parallel Assignment||Treatment||Single||||||t
1551759|NCT00296465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551760|NCT00296452|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1551761|NCT00296439|Randomized|Factorial Assignment||Educational/Counseling/Training||None (Open Label)||||||
1551762|NCT00296426|Randomized|Single Group Assignment||||None (Open Label)||||||
1551763|NCT00296413|||Cohort||Prospective|||||||
1551764|NCT00296400|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551765|NCT00296387|Randomized|Parallel Assignment||Treatment||Double||||||
1551766|NCT00296374|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551767|NCT00296361|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551768|NCT00296348|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551769|NCT00296335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551770|NCT00296322|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551771|NCT00296309|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551772|NCT00296296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551773|NCT00296283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551774|NCT00296270|Randomized|Factorial Assignment||Educational/Counseling/Training||Double||||||
1551775|NCT00296257|Randomized|Parallel Assignment||Treatment||Double||||||
1551776|NCT00296244|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1551777|NCT00296231|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1551778|NCT00296218|Randomized|Factorial Assignment||Treatment||Double||||||
1551779|NCT00296205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551780|NCT00296192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551781|NCT00296179|Randomized|Parallel Assignment||Treatment||Double||||||
1551782|NCT00296166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551783|NCT00296153|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551784|NCT00296140|Randomized|Parallel Assignment||Treatment||Single||Prospective, randomized, outcome-blinded (PROBE) design. Intervention based on the Chronic Care Model||||t
1551785|NCT00296127|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1551786|NCT00296114|||Case Control||Prospective|||||||
1551787|NCT00296101|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551788|NCT00296088|||Cohort||Prospective|||||||
1551789|NCT00296062||Single Group Assignment||Treatment||None (Open Label)||||||
1551790|NCT00296049|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1551791|NCT00296036|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1551792|NCT00296023|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551793|NCT00296010|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551794|NCT00295997||||Treatment||None (Open Label)||||||
1551795|NCT00295984||||Treatment||Double||||||
1551796|NCT00295971||Single Group Assignment||Treatment||None (Open Label)||||||
1551797|NCT00295958||||Treatment||None (Open Label)||||||
1551798|NCT00295945|||Case Control||Prospective|||||||
1551799|NCT00295932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551800|NCT00295919||Single Group Assignment||Treatment||None (Open Label)||||||
1551801|NCT00295906|Randomized|||||||||||
1551802|NCT00295893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551803|NCT00295880||Single Group Assignment||Treatment||None (Open Label)||||||
1551804|NCT00295867||Single Group Assignment||||None (Open Label)||||||
1551805|NCT00295854|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1551806|NCT00295841|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551807|NCT00295828|Randomized|Parallel Assignment||Treatment||Single|||||t|
1551808|NCT00295815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551809|NCT00295802|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551810|NCT00295789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551811|NCT00295776|Randomized|Crossover Assignment||||Double||||||
1551812|NCT00295763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551813|NCT00295750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551814|NCT00295737|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1551815|NCT00295724|Randomized|Parallel Assignment||Treatment||Double||||||
1551816|NCT00295711|Randomized|Parallel Assignment||Treatment||Double||||||
1551817|NCT00295698|Randomized|Crossover Assignment||Treatment||Double||||||
1551818|NCT00295685|Randomized|Crossover Assignment||Treatment||Double||||||
1551819|NCT00295672|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551820|NCT00295659|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1551821|NCT00295646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551822|NCT00295633|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551823|NCT00295620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551824|NCT00295607|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551825|NCT00295594|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551826|NCT00295581||||Treatment||||||||
1551827|NCT00295568||||||||||||
1551828|NCT00295555|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551829|NCT00295542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551830|NCT00295529|Randomized|Parallel Assignment||||None (Open Label)||||||
1551831|NCT00295516|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1551832|NCT00295503||Single Group Assignment||Treatment||None (Open Label)||||||
1551833|NCT00295490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551834|NCT00295477|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551835|NCT00295464|Randomized|Parallel Assignment||Prevention||Double||||||
1551836|NCT00295438|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1551837|NCT00295425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551838|NCT00295412|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1551839|NCT00295399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551840|NCT00295386|Randomized|Parallel Assignment||Treatment||Double||||||
1551841|NCT00295373|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1551842|NCT00295360|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1551843|NCT00295347|Randomized|Parallel Assignment||Treatment||Double||||||
1551844|NCT00295334|Randomized|Parallel Assignment||Prevention||Single||||||
1551845|NCT00295308|Randomized|Parallel Assignment||Treatment||||||||
1551846|NCT00295295|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1551847|NCT00295282|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551848|NCT00295269|Randomized|Factorial Assignment||Treatment||Double||||||
1551849|NCT00295256|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551850|NCT00295243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551851|NCT00295230|||Case-Crossover||Prospective|||||||
1551852|NCT00295217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551853|NCT00295204|Random Sample||||Cross-Sectional, Retrospective/Prospective|||||||
1551854|NCT00295191|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1551855|NCT00295178|Randomized|Parallel Assignment||Treatment||Single||||||
1551856|NCT00295165|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551857|NCT00295152|Randomized|Factorial Assignment||Treatment||Single||||||
1551858|NCT00295139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551859|NCT00295126|Randomized|||Treatment||None (Open Label)||||||
1551860|NCT00295113|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1551861|NCT00295100|Randomized|Crossover Assignment||Prevention||Double||||||
1551862|NCT00295087|||Cohort||Cross-Sectional|||||||
1551863|NCT00295074|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551864|NCT00295061|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1551865|NCT00295048|Randomized|Single Group Assignment||Treatment||Single||||||
1551866|NCT00295035|Randomized|Single Group Assignment||Treatment||Double||||||
1551867|NCT00295022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551868|NCT00295009|Randomized|Parallel Assignment||Treatment||Single|||t|||
1551869|NCT00294996|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551870|NCT00294983|||||Retrospective|||||||
1551871|NCT00294970|||Cohort||Retrospective|||||||
1551872|NCT00294957|||||Retrospective|||||||
1551873|NCT00294944|Randomized|Parallel Assignment||||Double||||||
1551874|NCT00294931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551875|NCT00294918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551876|NCT00294905|Randomized|Parallel Assignment||Prevention||Single||||||
1551877|NCT00294892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551878|NCT00294879|Randomized|Crossover Assignment||||Single||||||
1551879|NCT00294866|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1551880|NCT00294853|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551881|NCT00294840|||Case-Only||Prospective|||||||
1551882|NCT00294827||Single Group Assignment||Treatment||None (Open Label)||||||
1551883|NCT00294814|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551884|NCT00294801|Randomized|Parallel Assignment||Treatment||Double||||||
1551885|NCT00294788|Randomized|Parallel Assignment||Prevention||Double||||||
1551886|NCT00294775|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1551887|NCT00294762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551888|NCT00294749|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551889|NCT00294736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551890|NCT00294723|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551891|NCT00294710|Randomized|Parallel Assignment||Treatment||Double||||||
1551892|NCT00294697|||Cohort||Prospective|||||||
1551893|NCT00294684|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1551894|NCT00294671|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551895|NCT00294658|Randomized|Parallel Assignment||Treatment||Single||||||t
1551896|NCT00294645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551897|NCT00294632||Single Group Assignment||Treatment||None (Open Label)||||||
1551898|NCT00294619|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551899|NCT00294606|Randomized|Crossover Assignment||||Double||||||
1551900|NCT00294593|Randomized|Parallel Assignment||Treatment||Double||||||
1551901|NCT00294580|Randomized|Single Group Assignment||Prevention||Double||||||
1551902|NCT00294567|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551903|NCT00294554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551904|NCT00294541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551905|NCT00294528|Randomized|Parallel Assignment||Treatment||Double||||||
1551906|NCT00294515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551907|NCT00294502|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1551908|NCT00294489|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1551909|NCT00294476|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551910|NCT00294463|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551911|NCT00294450||Single Group Assignment||Treatment||None (Open Label)||||||
1551912|NCT00294437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551913|NCT00294424|Randomized|Parallel Assignment||Diagnostic||Single||||||
1551914|NCT00294411|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551915|NCT00294398|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551916|NCT00294385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551917|NCT00294372|Randomized|Parallel Assignment||Treatment||Double||||||
1551918|NCT00294359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551919|NCT00294346|Randomized|Parallel Assignment||Treatment||Double||||||
1551920|NCT00294320|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1551921|NCT00294307|||Cohort||Prospective|||||||
1551922|NCT00294294|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551923|NCT00294281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551924|NCT00294268|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551925|NCT00294255||Single Group Assignment||Treatment||None (Open Label)||||||
1551926|NCT00294242|Randomized|Parallel Assignment||Treatment||Single||||||
1551927|NCT00294229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551928|NCT00294216|Randomized|Parallel Assignment||Prevention||Double||||||
1551929|NCT00294203|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551930|NCT00294190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551931|NCT00294177|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1551932|NCT00294164|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551933|NCT00294151|Randomized|Parallel Assignment||Treatment||Double||||||
1551934|NCT00294125|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1551935|NCT00294112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551936|NCT00294099|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1551937|NCT00294086|Randomized|Parallel Assignment||Treatment||Double||||||
1551938|NCT00294073|Randomized|Parallel Assignment||Treatment||Double||||||
1551939|NCT00294060|||Cohort||Prospective|||||||
1551940|NCT00294047|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1551941|NCT00294034|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1551942|NCT00294021|||Ecologic or Community||Prospective|||||||
1551943|NCT00294008|||Case-Only|||||||||
1551944|NCT00293995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551945|NCT00293982|Randomized|Single Group Assignment||||None (Open Label)||||||
1551946|NCT00293969|Randomized|Parallel Assignment||Treatment||Double||||||
1551947|NCT00293956|||Cohort||Prospective|||||||
1551948|NCT00293943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551949|NCT00293930|Randomized|Parallel Assignment||Treatment||Double||||||
1551950|NCT00293917|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1551951|NCT00293904|Randomized|Parallel Assignment||Treatment||Double||||||
1551952|NCT00293891|Randomized|Parallel Assignment||Treatment||Double||||||
1551953|NCT00293878|Randomized|Parallel Assignment||Treatment||Double||||||
1551954|NCT00293865|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1551955|NCT00293852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551956|NCT00293839|Randomized|Parallel Assignment||Treatment||Double||||||
1551957|NCT00293826|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1551958|NCT00293813|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551959|NCT00293800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551960|NCT00293787|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551961|NCT00293774|||Cohort||Prospective|||||||
1551962|NCT00293761|Randomized|Parallel Assignment||Treatment||Double||||||
1551963|NCT00293748||||||||||||
1551964|NCT00293735|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551965|NCT00293722|||Cohort||Prospective|||||||
1551966|NCT00293709|||Cohort||Prospective|||||||
1551967|NCT00293696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551968|NCT00293683|Randomized|Single Group Assignment||Treatment||Single||||||
1551969|NCT00293670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551970|NCT00293657|Randomized|Parallel Assignment||Treatment||Double||||||
1551971|NCT00293644|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551972|NCT00293631|Randomized|Parallel Assignment||Treatment||Double||||||
1551973|NCT00293618|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1551974|NCT00293605|||Case-Only||Prospective|||||||
1551975|NCT00293592|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1551976|NCT00293579||Single Group Assignment||Treatment||None (Open Label)||||||
1551977|NCT00293553|Non-Randomized|Single Group Assignment||Treatment||Double||||||
1551978|NCT00293540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551979|NCT00293527||Single Group Assignment||Treatment||None (Open Label)||||||
1551980|NCT00293514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1551981|NCT00293501||||Treatment||None (Open Label)||||||
1551982|NCT00293488|Non-Randomized|||Treatment||None (Open Label)||||||
1551983|NCT00293475||Single Group Assignment||Treatment||None (Open Label)||||||
1551984|NCT00293462|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1551985|NCT00293436||||Treatment||None (Open Label)||||||
1551986|NCT00293423||Single Group Assignment||Treatment||None (Open Label)||||||
1551987|NCT00293410||||Treatment||||||||
1551988|NCT00293397||Single Group Assignment||Treatment||None (Open Label)||||||
1551989|NCT00293384||Single Group Assignment||Supportive Care||None (Open Label)||||||
1551990|NCT00293371||||Treatment||None (Open Label)||||||
1551991|NCT00293358|Non-Randomized|||Treatment||||||||
1551992|NCT00293345||Single Group Assignment||Treatment||None (Open Label)||||||
1551993|NCT00293332||Single Group Assignment||Treatment||None (Open Label)||||||
1551994|NCT00293319||Single Group Assignment||Treatment||None (Open Label)||||||
1551995|NCT00293293|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1551996|NCT00293280||||Treatment||None (Open Label)||||||
1551997|NCT00293267|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551998|NCT00293254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1551999|NCT00293241|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552000|NCT00293228|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1552001|NCT00293215|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552002|NCT00293202|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1552003|NCT00293189|||Case Control|Screening|Longitudinal, Prospective|||||||
1552004|NCT00293176|Randomized|Parallel Assignment||Treatment||Double||||||
1552005|NCT00293163|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552006|NCT00293150|Randomized|Parallel Assignment||Treatment||Triple|Double Blind placebo vs eplerenone||t|t|t|
1552007|NCT00293137||||||||||||
1552008|NCT00293124||Single Group Assignment||Treatment||None (Open Label)||||||
1552009|NCT00293111|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552010|NCT00293098||||||||||||
1552011|NCT00293085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552012|NCT00293072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552013|NCT00293059|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552014|NCT00293046|Randomized|Parallel Assignment||||None (Open Label)||||||
1552015|NCT00293033|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1552016|NCT00293020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552017|NCT00292994|Randomized|Single Group Assignment||Treatment||Single||||||
1552018|NCT00292981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552019|NCT00292968|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552020|NCT00292955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552021|NCT00292942|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552022|NCT00292929|Randomized|Single Group Assignment||Treatment||Double||||||
1552023|NCT00292916|Randomized|Parallel Assignment||Prevention||Single||||||
1552024|NCT00292903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552025|NCT00292890|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552026|NCT00292877|Randomized|Parallel Assignment||Treatment||Double||||||
1552027|NCT00292864|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552028|NCT00292851|||Cohort||Prospective|||||||
1552029|NCT00292838|Randomized|Crossover Assignment||Treatment||Double||||||
1552030|NCT00292825|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1552031|NCT00292812|Randomized|Parallel Assignment||Prevention||Double||||||
1552032|NCT00292799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552033|NCT00292786|Randomized|Parallel Assignment||Treatment||Single||||||
1552034|NCT00292773|||||Prospective|||||||
1552035|NCT00292760|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552036|NCT00292747|Randomized|Parallel Assignment||Treatment||Double||||||
1552037|NCT00292734|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1552038|NCT00292721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552039|NCT00292708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552040|NCT00292695||Single Group Assignment||Treatment||None (Open Label)||||||
1552041|NCT00292656|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||Double||||||
1552042|NCT00292591|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552043|NCT00292578|Randomized|Single Group Assignment||Diagnostic||Double||||||
1552044|NCT00292552|||Cohort||Prospective|||||||
1552045|NCT00292539|||Cohort||Retrospective|||||||
1552046|NCT00292526||Single Group Assignment||Prevention||None (Open Label)||||||
1552047|NCT00292513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552048|NCT00292500|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552049|NCT00292487|Randomized|Parallel Assignment||Diagnostic||Double||||||
1552050|NCT00292474|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552051|NCT00292461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552052|NCT00292448|Randomized|Crossover Assignment||Treatment||Double||||||
1552053|NCT00292435|Randomized|Parallel Assignment||||Double||||||
1552054|NCT00292422|Randomized|||Treatment||Quadruple|||t|t|t|t
1552055|NCT00292409|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1552056|NCT00292396|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1552057|NCT00292383|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552058|NCT00292370|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552059|NCT00292357|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552060|NCT00292344|Randomized|Single Group Assignment||Treatment||Double||||||
1552061|NCT00292331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552062|NCT00292318|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552063|NCT00292305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552064|NCT00292292|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552065|NCT00292279|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552066|NCT00292266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552067|NCT00292253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552068|NCT00292240|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552069|NCT00292227|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1552070|NCT00292214|Randomized|Parallel Assignment||Treatment||Single||||||
1552071|NCT00292201|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552072|NCT00292188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552073|NCT00292175|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1552074|NCT00292162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552075|NCT00292136|||||Prospective|||||||
1552076|NCT00292123|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1552077|NCT00292110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552078|NCT00292097|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552079|NCT00292084|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552080|NCT00292071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552081|NCT00292058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552082|NCT00292045|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552083|NCT00292032|||Cohort||Prospective|||||||
1552084|NCT00292019|||Cohort||Prospective|||||||
1552085|NCT00292006|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552086|NCT00291993|||||Prospective|||||||
1552087|NCT00291980|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552088|NCT00291967|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552089|NCT00291954|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552090|NCT00291941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552091|NCT00291928|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552092|NCT00291915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552093|NCT00291902|Randomized|Parallel Assignment||Treatment||Double||||||
1552094|NCT00291889|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552095|NCT00291876||Single Group Assignment||Prevention||None (Open Label)||||||
1552096|NCT00291863|Randomized|Parallel Assignment||Treatment||Double||||||
1552097|NCT00291850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552098|NCT00291837|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552099|NCT00291824|Randomized|Factorial Assignment||Prevention||Double||||||
1552100|NCT00291811||||||||||||
1552101|NCT00291798|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552102|NCT00291785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552103|NCT00291772|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552104|NCT00291759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552105|NCT00291746|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1552106|NCT00291733|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1552107|NCT00291720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552108|NCT00291707|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552109|NCT00291694|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1552110|NCT00291681|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1552111|NCT00291668|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1552112|NCT00291655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552113|NCT00291642|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552114|NCT00291629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552115|NCT00291616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552116|NCT00291603|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552117|NCT00291590|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1552118|NCT00291577|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552119|NCT00291564|||||Prospective|||||||
1552120|NCT00291551|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552121|NCT00291538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552122|NCT00291525|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552123|NCT00291512|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552124|NCT00291499|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552125|NCT00291486|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552126|NCT00291473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552127|NCT00291460|Randomized|Parallel Assignment||Treatment||Single||||||
1552128|NCT00291447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552129|NCT00291434|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1552130|NCT00291421|||||Prospective|||||||
1552131|NCT00291408|Randomized|Parallel Assignment||Diagnostic||Double||||||
1552132|NCT00291395|Randomized|Crossover Assignment||||Double||||||
1552133|NCT00291382|Randomized|Parallel Assignment||Treatment||Double||||||
1552134|NCT00291369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552135|NCT00291356|Randomized|Single Group Assignment||Treatment||Double||||||
1552136|NCT00291343|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552137|NCT00291330|Randomized|Parallel Assignment||Treatment||Double||||||
1552138|NCT00291317||Single Group Assignment||Treatment||None (Open Label)||||||
1552139|NCT00291304|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1552140|NCT00291278||||||||||||
1552141|NCT00291265||||||||||||
1552142|NCT00291239|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552143|NCT00291226|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552144|NCT00291213|Randomized|Parallel Assignment||Treatment||Double||||||
1552145|NCT00291200|||Case Control||Prospective|||||||
1552146|NCT00291187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552147|NCT00291174|||Cohort||Prospective|||||||
1552148|NCT00291161|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1552149|NCT00291148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552150|NCT00291135||Single Group Assignment||Prevention||None (Open Label)||||||
1552151|NCT00291122||||||||||||
1552152|NCT00291109|||||Prospective|||||||
1552153|NCT00291096|||Cohort||Prospective|||||||
1552154|NCT00291083|||Cohort||Prospective|||||||
1552155|NCT00291070|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552156|NCT00291057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552157|NCT00291044|||Ecologic or Community||Prospective|||||||
1552158|NCT00291031|Randomized|Single Group Assignment||Treatment||Single||||||t
1552159|NCT00291018|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552160|NCT00291005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552161|NCT00290992||Parallel Assignment||Treatment||None (Open Label)||||||
1552162|NCT00290979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552163|NCT00290966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552164|NCT00290953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552165|NCT00290940|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552166|NCT00290927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552167|NCT00290914||||Treatment||||||||
1552168|NCT00290901|Randomized|Parallel Assignment||Treatment||Double||||||
1552169|NCT00290888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552170|NCT00290875|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552171|NCT00290862|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552172|NCT00290849|||Cohort||Retrospective|||||||
1552173|NCT00290836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552174|NCT00290823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552175|NCT00290810||Single Group Assignment||Treatment||None (Open Label)||||||
1552176|NCT00290771|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552177|NCT00290758|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1552178|NCT00290745|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552179|NCT00290732|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552180|NCT00290719||Single Group Assignment||Treatment||None (Open Label)||||||
1552181|NCT00290706||Single Group Assignment||Treatment||None (Open Label)||||||
1552182|NCT00290693||Single Group Assignment||Treatment||None (Open Label)||||||
1552183|NCT00290680||||Treatment||||||||
1552184|NCT00290667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552185|NCT00290654||Single Group Assignment||Treatment||None (Open Label)||||||
1552186|NCT00290641||||Treatment||None (Open Label)||||||
1552187|NCT00290628||||Treatment||None (Open Label)||||||
1552188|NCT00290615|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552189|NCT00290602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552190|NCT00290589|Randomized|Parallel Assignment||Treatment||Double||||||
1552191|NCT00290576|Randomized|Single Group Assignment||Treatment||Double||||||
1552192|NCT00290563|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552193|NCT00290550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552194|NCT00290537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552195|NCT00290524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552196|NCT00290511||Single Group Assignment||Treatment||None (Open Label)||||||
1552197|NCT00290498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552198|NCT00290485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552199|NCT00290472||Single Group Assignment||Treatment||None (Open Label)||||||
1552200|NCT00290459|||Ecologic or Community||Other|||||||
1552201|NCT00290433||Single Group Assignment||Treatment||None (Open Label)||||||
1552202|NCT00290420|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552203|NCT00290407|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552204|NCT00290394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552205|NCT00290381|Randomized|Crossover Assignment||Diagnostic||Double||||||
1552206|NCT00290368|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1552207|NCT00290355|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1552208|NCT00290342|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552209|NCT00290329|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552210|NCT00290316|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552211|NCT00290303|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552212|NCT00290290|Randomized|Single Group Assignment||Prevention||Double|||t|||t
1552213|NCT00290277|Randomized|Parallel Assignment||Prevention||Double||||||
1552214|NCT00290264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552215|NCT00290251|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552216|NCT00290238|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1552217|NCT00290225|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552218|NCT00290212|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552219|NCT00290199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552220|NCT00290186|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1552221|NCT00290173|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552222|NCT00290160|Randomized|Single Group Assignment||Prevention||Double||||||
1552223|NCT00290147|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)|Open Label|||||
1552224|NCT00290134|Randomized|Parallel Assignment||Treatment||Double||||||
1552225|NCT00290121|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552226|NCT00290108|Randomized|Single Group Assignment||Treatment||Single||||||
1552227|NCT00290095|||Case-Only||Prospective|||||||
1552228|NCT00290082|Randomized|Parallel Assignment||Treatment||Double||||t||t
1552229|NCT00290069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552230|NCT00290056|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1552231|NCT00290043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552232|NCT00290030|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552233|NCT00290017|Randomized|Single Group Assignment||Treatment||Double||||||
1552234|NCT00290004|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552235|NCT00289991|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552236|NCT00289978|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1552237|NCT00289965|Randomized|Parallel Assignment||||None (Open Label)||||||
1552238|NCT00289952|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552239|NCT00289939|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552240|NCT00289926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552241|NCT00289913|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552242|NCT00289900|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552243|NCT00289887|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552244|NCT00289874|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552245|NCT00289861|Randomized|Parallel Assignment||Treatment||Double||||||
1552246|NCT00289848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552247|NCT00289835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552248|NCT00289822|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552249|NCT00289809|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552250|NCT00289796|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1552251|NCT00289783|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1552252|NCT00289770|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552253|NCT00289757|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552254|NCT00289744|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552255|NCT00289731|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552256|NCT00289718||Single Group Assignment||Prevention||None (Open Label)||||||
1552257|NCT00289705|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552258|NCT00289679|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1552259|NCT00289666|||Case-Only||Prospective|||||||
1552260|NCT00289653||Single Group Assignment||Treatment||None (Open Label)||||||
1552261|NCT00289640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552262|NCT00289627|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552263|NCT00289614|Randomized|Parallel Assignment||||Double||||||
1552264|NCT00289601|Randomized|Single Group Assignment||Treatment||Double||||||
1552265|NCT00289588|Randomized|Parallel Assignment||Prevention||Double||||||
1552266|NCT00289575|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552267|NCT00289562||Single Group Assignment||Treatment||None (Open Label)||||||
1552268|NCT00289549|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552269|NCT00289536|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552270|NCT00289523|||Case Control||Prospective|||||||
1552271|NCT00289510|Randomized|Parallel Assignment||Prevention||Single||||||
1552272|NCT00289497|Randomized|Parallel Assignment||Prevention||Single||||||
1552273|NCT00289484|Randomized|Parallel Assignment||Treatment||Double||||||
1552274|NCT00289471|||||Cross-Sectional|||||||
1552275|NCT00289458|Randomized|Parallel Assignment||Treatment||Single||||||t
1552276|NCT00289445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552277|NCT00289432|Randomized|Parallel Assignment||||Single||||||t
1552278|NCT00289419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552279|NCT00289406|Randomized|Parallel Assignment||Treatment||Double||||||
1552280|NCT00289393|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1552281|NCT00289380|||Cohort||Prospective|||||||
1552282|NCT00289367|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1552283|NCT00289354|Randomized|Parallel Assignment||Treatment||Double||||||
1552284|NCT00289341|Randomized|Crossover Assignment||Treatment||Single|||t|||
1552285|NCT00289328|||||Prospective|||||||
1552286|NCT00289315|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552287|NCT00289302|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1552288|NCT00289289|Randomized|Crossover Assignment||Prevention||Single|||t|||
1552289|NCT00289276|Non-Randomized|Single Group Assignment||Diagnostic||Double|||t||t|
1552290|NCT00289263|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552291|NCT00289250|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552292|NCT00289237|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552293|NCT00289224|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552294|NCT00289211|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552295|NCT00289198|Randomized|Parallel Assignment||Treatment||||||||
1552296|NCT00289185|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1552297|NCT00289172|Randomized|Parallel Assignment||Prevention||||||||
1552298|NCT00289159|||Defined Population||Longitudinal, Prospective|||||||
1552299|NCT00289146|||Cohort||Prospective|||||||
1552300|NCT00289133|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552301|NCT00289120|Non-Randomized|Crossover Assignment||Health Services Research||None (Open Label)||||||
1552302|NCT00289107|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552303|NCT00289094|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552304|NCT00289081|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552305|NCT00289068|||Cohort||Prospective|||||||
1552306|NCT00289055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552307|NCT00289042|Randomized|||Treatment||None (Open Label)||||||
1552308|NCT00289029|Randomized|Parallel Assignment||||Double||||||
1552309|NCT00289016||Single Group Assignment||Treatment||None (Open Label)||||||
1552310|NCT00289003|Randomized|Parallel Assignment||Treatment||Double||||||
1552311|NCT00288990|||Case Control||Prospective|||||||
1552312|NCT00288977||Single Group Assignment||Treatment||None (Open Label)||||||
1552313|NCT00288964|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1552314|NCT00288951|Randomized|Parallel Assignment||Treatment||Double||||||
1552315|NCT00288938||||||||||||
1552316|NCT00288925|Randomized|Parallel Assignment||Treatment||Double||||||
1552317|NCT00288912|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1552318|NCT00288899|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1552319|NCT00288886|Randomized|Parallel Assignment||Treatment||Single||||||t
1552320|NCT00288873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552321|NCT00288860|Randomized|Parallel Assignment||Treatment||Single|||||t|
1552322|NCT00288847|||||Retrospective|||||||
1552323|NCT00288834|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552324|NCT00288821|||Cohort||Prospective|||||||
1552325|NCT00288808|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552326|NCT00288795|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552327|NCT00288782|Randomized|Parallel Assignment||Diagnostic||Double||||||
1552328|NCT00288769|Randomized|Single Group Assignment||Treatment||Double||||||
1552329|NCT00288756|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1552330|NCT00288743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552331|NCT00288730|Randomized|Parallel Assignment||Treatment||Double||||||
1552332|NCT00288717|Randomized|Parallel Assignment||Treatment||Single||||||
1552333|NCT00288704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552334|NCT00288691|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1552335|NCT00288678|Randomized|Parallel Assignment||||Single|||t|||
1552336|NCT00288665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552337|NCT00288652|Randomized|Parallel Assignment||Treatment||Double||||||
1552338|NCT00288639|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552339|NCT00288626||Single Group Assignment||Treatment||None (Open Label)||||||
1552340|NCT00288613|||Case-Only||Prospective|||||||
1552341|NCT00288600|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1552342|NCT00288587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552343|NCT00288574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552344|NCT00288561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552345|NCT00288548|Randomized|Parallel Assignment||Treatment||Double||||||
1552346|NCT00288535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552347|NCT00288522|Randomized|Parallel Assignment||Treatment||Double||||||
1552348|NCT00288509|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552349|NCT00288496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552350|NCT00288483|Randomized|Parallel Assignment||Treatment||Double||||||
1552351|NCT00288470||||Treatment||||||||
1552352|NCT00288457|||||Prospective|||||||
1552353|NCT00288444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552354|NCT00288431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552355|NCT00288418|Randomized|Parallel Assignment||Prevention||Single|||t|||
1552356|NCT00288405|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552357|NCT00288392|Randomized|Parallel Assignment||Treatment||Double||||||
1552358|NCT00288379|Randomized|Crossover Assignment||Treatment||Double||||||
1552359|NCT00288366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552360|NCT00288353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552361|NCT00288340|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552362|NCT00288327|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552363|NCT00288314|||Case Control||Cross-Sectional|||||||
1552364|NCT00288301|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552365|NCT00288288|||Cohort||Prospective|||||||
1552366|NCT00288275|||Case-Only||Prospective|||||||
1552367|NCT00288262|Randomized|Parallel Assignment||Treatment||Double||||||
1552368|NCT00288249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552369|NCT00288236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552370|NCT00288223|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552371|NCT00288210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552372|NCT00288197|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552373|NCT00288184|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1552374|NCT00288171|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1552375|NCT00288158|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552376|NCT00288145|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552377|NCT00288132|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1552378|NCT00288119|||Case-Control||Cross-Sectional|||||||
1552379|NCT00288106|||Cohort||Prospective|||||||
1552380|NCT00288093||Single Group Assignment||Treatment||None (Open Label)||||||
1552381|NCT00288080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552382|NCT00288067||Single Group Assignment||Treatment||None (Open Label)||||||
1552383|NCT00288054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552384|NCT00288041||Single Group Assignment||Treatment||None (Open Label)||||||
1552385|NCT00288028||Single Group Assignment||Treatment||None (Open Label)||||||
1552386|NCT00288015||Single Group Assignment||Treatment||None (Open Label)||||||
1552387|NCT00288002|Randomized|||Treatment||None (Open Label)||||||
1552388|NCT00287989|Randomized|||Treatment||None (Open Label)||||||
1552389|NCT00287976||||Treatment||None (Open Label)||||||
1552390|NCT00287963||Single Group Assignment||Treatment||None (Open Label)||||||
1552391|NCT00287950|Non-Randomized|||Treatment||None (Open Label)||||||
1552392|NCT00287937||Single Group Assignment||Treatment||None (Open Label)||||||
1552393|NCT00287924||||Treatment||None (Open Label)||||||
1552394|NCT00287911||Single Group Assignment||Treatment||None (Open Label)||||||
1552395|NCT00287898|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1552396|NCT00287885|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552397|NCT00287872||Single Group Assignment||Treatment||None (Open Label)||||||
1552398|NCT00287859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552399|NCT00287846||Single Group Assignment||Treatment||None (Open Label)||||||
1552400|NCT00287833|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1552401|NCT00287820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552402|NCT00287807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552403|NCT00287794|||Case-Only||Prospective|||||||
1552404|NCT00287781|Randomized|Single Group Assignment||Treatment||Double||||||
1552405|NCT00287768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552406|NCT00287755|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1552407|NCT00287742|Randomized|Parallel Assignment||Treatment||Double||||||
1552408|NCT00287729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552409|NCT00287716|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552410|NCT00287703|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1552411|NCT00287690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552412|NCT00287677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552413|NCT00287664|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552414|NCT00287651|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1552415|NCT00287638|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552416|NCT00287625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552417|NCT00287612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552418|NCT00287599|||Case-Only||Prospective|||||||
1552419|NCT00287586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552420|NCT00287573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552421|NCT00287560|Randomized|Parallel Assignment||Prevention||Double||||||
1552422|NCT00287547|Randomized|Parallel Assignment||Treatment||Double||||||
1552423|NCT00287534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552424|NCT00287521|Randomized|Parallel Assignment||Treatment||Double||||||
1552425|NCT00287508|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1552426|NCT00287495|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552427|NCT00287482|Randomized|Parallel Assignment||Treatment||Double||||||
1552428|NCT00287469|Randomized|Single Group Assignment||Prevention||Double||||||
1552429|NCT00287456|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552430|NCT00287443|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1552431|NCT00287430|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552432|NCT00287417|||Case-Only||Prospective|||||||
1552433|NCT00287404|||||Prospective|||||||
1552434|NCT00287391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552435|NCT00287378|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1552436|NCT00287365||Single Group Assignment||Other||None (Open Label)||||||
1552437|NCT00287352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552438|NCT00287339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552439|NCT00287326|Randomized|Parallel Assignment||Treatment||Double||||||
1552440|NCT00287313|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552441|NCT00287300|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552442|NCT00287287||Single Group Assignment||Treatment||None (Open Label)||||||
1552443|NCT00287274|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552444|NCT00287261|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552445|NCT00287248||Single Group Assignment||Diagnostic||None (Open Label)||||||
1552446|NCT00287235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552447|NCT00287222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552448|NCT00287209|Randomized|Parallel Assignment||Prevention||Double||||||
1552449|NCT00287196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552450|NCT00287183|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552451|NCT00287170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552452|NCT00287157|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1552453|NCT00287144|||Defined Population||Longitudinal, Retrospective|||||||
1552454|NCT00287131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552455|NCT00287118||Single Group Assignment||Treatment||None (Open Label)||||||
1552456|NCT00287105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552457|NCT00287092|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552458|NCT00287079||Parallel Assignment||Treatment||None (Open Label)||||||
1552459|NCT00287066|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552460|NCT00287053|Randomized|Parallel Assignment||||Triple|||t||t|t
1552461|NCT00287040|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1552462|NCT00287027|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1552463|NCT00287014|||||Prospective|||||||
1552464|NCT00287001|Non-Randomized|Single Group Assignment||||Double|||t|||t
1552465|NCT00286988|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552466|NCT00286975|Randomized|Parallel Assignment||||Single||||||
1552467|NCT00286962|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552468|NCT00286949||Single Group Assignment||Treatment||None (Open Label)||||||
1552469|NCT00286936|Randomized|Parallel Assignment||Prevention||Double||||||
1552470|NCT00286923||||||||||||
1552471|NCT00286910|||Case Control||Retrospective|||||||
1552472|NCT00286897|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552473|NCT00286884|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1552474|NCT00286871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552475|NCT00286858|||Cohort||Prospective|||||||
1552476|NCT00286845|||Case-Only||Retrospective|||||||
1552477|NCT00286832|||Case-Only||Prospective|||||||
1552478|NCT00286819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552479|NCT00286806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552480|NCT00286793||Single Group Assignment||Treatment||None (Open Label)||||||
1552481|NCT00286780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552482|NCT00286767|||Cohort||Prospective|||||||
1552483|NCT00286754|Randomized|Parallel Assignment||Treatment||Single||||||t
1552484|NCT00286741|Randomized|Parallel Assignment||Treatment||Single||||||t
1552485|NCT00286728|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552486|NCT00286702||||||||||||
1552487|NCT00286689|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552488|NCT00286676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552489|NCT00286663|||||Prospective|||||||
1552490|NCT00286650|Randomized|Crossover Assignment||Treatment||Double||||||
1552491|NCT00286637|||Other||Other|||||||
1552492|NCT00286624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552493|NCT00286611|||||Prospective|||||||
1552494|NCT00286598|Randomized|Single Group Assignment||Treatment||Single||||||t
1552495|NCT00286585|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1552496|NCT00286572|||Cohort||Prospective|||||||
1552497|NCT00286559|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1552498|NCT00286546|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1552499|NCT00286533|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552500|NCT00286520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552501|NCT00286507|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552502|NCT00286494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552503|NCT00286481|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1552504|NCT00286468|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552505|NCT00286455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552506|NCT00286442|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552507|NCT00286429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552508|NCT00286416|Randomized|Parallel Assignment||Treatment||Double||||||
1552509|NCT00286403|Randomized|Single Group Assignment||Treatment||Double||||||
1552510|NCT00286390|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1552511|NCT00286377|Randomized|Parallel Assignment||Treatment||Double||||||
1552512|NCT00286364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552513|NCT00286351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552514|NCT00286338|||||Prospective|||||||
1552515|NCT00286325||Single Group Assignment||Treatment||None (Open Label)||||||
1552516|NCT00286312|Randomized|Parallel Assignment||Treatment||Double||||||
1552517|NCT00286299|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552518|NCT00286286|Randomized|Factorial Assignment||Treatment||Double||||||
1552519|NCT00286273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552520|NCT00286260|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1552521|NCT00286247|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552522|NCT00286234|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552523|NCT00286221|Randomized|Parallel Assignment||Treatment||Single||||t||
1552524|NCT00286208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552525|NCT00286195|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552526|NCT00286182|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1552527|NCT00286169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552528|NCT00286156|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1552529|NCT00286143|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552530|NCT00286130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552531|NCT00286117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552532|NCT00286104|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552533|NCT00286091|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552534|NCT00286078|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552535|NCT00286065|Randomized|Factorial Assignment||Treatment||Double||||||
1552536|NCT00286052|Randomized|Single Group Assignment||Treatment||Double||||||
1552537|NCT00286039|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552538|NCT00286026|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1552539|NCT00286013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552540|NCT00286000|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552541|NCT00285987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552542|NCT00285974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552543|NCT00285961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552544|NCT00285948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552545|NCT00285935||Single Group Assignment||Health Services Research||None (Open Label)||||||
1552546|NCT00285922|||Defined Population|Screening|Longitudinal, Prospective|||||||
1552547|NCT00285909|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1552548|NCT00285896|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1552549|NCT00285883||||||||||||
1552550|NCT00285870|||||Prospective|||||||
1552551|NCT00285857||Single Group Assignment||Treatment||None (Open Label)||||||
1552552|NCT00285844|Randomized|Parallel Assignment||||None (Open Label)||||||
1552553|NCT00285831|||||Prospective|||||||
1552554|NCT00285818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552555|NCT00285805|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1552556|NCT00285792|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552557|NCT00285779|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1552558|NCT00285766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552559|NCT00285753|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1552560|NCT00285740|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552561|NCT00285727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552562|NCT00285714|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552563|NCT00285701|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552564|NCT00285688|||Case Control||Prospective|||||||
1552565|NCT00285675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552566|NCT00285662|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1552567|NCT00285649|Randomized|Parallel Assignment||Treatment||Single|||||t|
1552568|NCT00285636|||Case-Only||Prospective|||||||
1552569|NCT00285623|||Case-Only||Prospective|||||||
1552570|NCT00285610|||Cohort||Prospective|||||||
1552571|NCT00285597|Randomized|Crossover Assignment||Treatment||Double||||||
1552572|NCT00285584|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552573|NCT00285571|Randomized|Crossover Assignment||Prevention||Single||||||
1552574|NCT00285558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552575|NCT00285545|||Case Control||Cross-Sectional|||||||
1552576|NCT00285532|||||Prospective|||||||
1552577|NCT00285519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552578|NCT00285506|||||Cross-Sectional, Prospective|||||||
1552579|NCT00285493|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552580|NCT00285467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552581|NCT00285454|Randomized|Parallel Assignment||Treatment||Double||||||
1552582|NCT00285441|||Defined Population||Longitudinal, Prospective|||||||
1552583|NCT00285428|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552584|NCT00285415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552585|NCT00285402|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552586|NCT00285389|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552587|NCT00285376|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552588|NCT00285363|||||Cross-Sectional, Retrospective/Prospective|||||||
1552589|NCT00285350|Randomized|Parallel Assignment||Treatment||Double||||||
1552590|NCT00285337||||||||||||
1552591|NCT00285324||||||||||||
1552592|NCT00285298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552593|NCT00285285|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552594|NCT00285259|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552595|NCT00285246|||Cohort||Prospective|||||||
1552596|NCT00285233|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552597|NCT00285220|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552598|NCT00285207|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552599|NCT00285194|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552600|NCT00285181|Randomized|Parallel Assignment||Treatment||Double||||||
1552601|NCT00285168|||Cohort||Prospective|||||||
1552602|NCT00285155|Randomized|Crossover Assignment||Treatment||Double||||||
1552603|NCT00285142|Randomized|Crossover Assignment||Treatment||Double||||||
1552604|NCT00285129|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552605|NCT00285116|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552606|NCT00285103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552607|NCT00285090|Randomized|Parallel Assignment||Treatment||Double||||||
1552608|NCT00285077|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552609|NCT00285064|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1552610|NCT00285051|Randomized|Crossover Assignment||Treatment||Double||||||
1552611|NCT00285038|||Case-Only||Prospective|||||||
1552612|NCT00285025|Randomized|Parallel Assignment||Treatment||Double||||||
1552613|NCT00285012|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1552614|NCT00284999|Randomized|Crossover Assignment||Treatment||Double||||||
1552615|NCT00284986||Single Group Assignment||Treatment||None (Open Label)||||||
1552616|NCT00284973|Randomized|Parallel Assignment||Prevention||Double||||||
1552617|NCT00284960|||||Prospective|||||||
1552618|NCT00284947||Single Group Assignment||Prevention||None (Open Label)||||||
1552619|NCT00284934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552620|NCT00284921|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552621|NCT00284908|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1552622|NCT00284895|||||Prospective|||||||
1552623|NCT00284882|||||Prospective|||||||
1552624|NCT00284869|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1552625|NCT00284856|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552626|NCT00284843|||||Prospective|||||||
1552627|NCT00284830|Randomized|Parallel Assignment||Prevention||Single|||t|||
1552628|NCT00284817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552629|NCT00284804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552630|NCT00284791|Randomized|Parallel Assignment||Treatment||Double||||||
1552631|NCT00284778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552632|NCT00284765|Randomized|Parallel Assignment||||None (Open Label)||||||
1552633|NCT00284752||Single Group Assignment||Treatment||None (Open Label)||||||
1552634|NCT00284739|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552635|NCT00284726||||||||||||
1552636|NCT00284713|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552637|NCT00284700|Randomized|Parallel Assignment||Treatment||Double||||||
1552638|NCT00284687|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552639|NCT00284674|Randomized|Parallel Assignment||||None (Open Label)||||||
1552640|NCT00284661|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1552641|NCT00284648|Randomized|Parallel Assignment||Treatment||Single||||||
1552642|NCT00284635|Randomized|Parallel Assignment||||None (Open Label)||||||
1552643|NCT00284622|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1552644|NCT00284609|Randomized|Parallel Assignment||||None (Open Label)||||||
1552645|NCT00284596|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552646|NCT00284583|Randomized|Parallel Assignment||Treatment||Double||||||
1552647|NCT00284570|||Case-Only||Prospective|||||||
1552648|NCT00284557|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552649|NCT00284531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552650|NCT00284518|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552651|NCT00284505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552652|NCT00284492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552653|NCT00284479|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552654|NCT00284466|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552655|NCT00284453|||Cohort||Prospective|||||||
1552656|NCT00284440|||Case-Only||Prospective|||||||
1552657|NCT00284427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552658|NCT00284414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552659|NCT00284401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552660|NCT00284388|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552661|NCT00284375|||||Prospective|||||||
1552662|NCT00284362|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552663|NCT00284349|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552664|NCT00284336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552665|NCT00284323|Randomized|Parallel Assignment||Treatment||Double||||||
1552666|NCT00284310|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552667|NCT00284297|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552668|NCT00284284|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552669|NCT00284271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552670|NCT00284258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552671|NCT00284245|||Cohort||Prospective|||||||
1552672|NCT00284232|Randomized|Parallel Assignment||||None (Open Label)||||||
1552673|NCT00284219|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552674|NCT00284206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552675|NCT00284193||Single Group Assignment||Treatment||None (Open Label)||||||
1552676|NCT00284180|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552677|NCT00284167|Randomized|Factorial Assignment||||Single||||||
1552678|NCT00284154||Single Group Assignment||Treatment||None (Open Label)||||||
1552679|NCT00284141|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552680|NCT00284128|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552681|NCT00284115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552682|NCT00284102|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552683|NCT00284089|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552684|NCT00284076|Randomized|||Treatment||||||||
1552685|NCT00284063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552686|NCT00284050|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1552687|NCT00284037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552688|NCT00284024|Randomized|Parallel Assignment||Treatment||Double||||||
1552689|NCT00284011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552690|NCT00283998|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552691|NCT00283985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552692|NCT00283972|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1552693|NCT00283959||Single Group Assignment||Treatment||None (Open Label)||||||
1552694|NCT00283946|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552695|NCT00283933||Single Group Assignment||Treatment||None (Open Label)||||||
1552696|NCT00283920||||Treatment||||||||
1552697|NCT00283907||||||||||||
1552698|NCT00283894||||||||||||
1552699|NCT00283881||||||||||||
1552700|NCT00283868|||Cohort||Prospective|||||||
1552701|NCT00283855|Randomized|Factorial Assignment||||None (Open Label)||||||
1552702|NCT00283842|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1552703|NCT00283829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552704|NCT00283816|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552705|NCT00283803||Single Group Assignment||Treatment||None (Open Label)||||||
1552706|NCT00283790|Randomized|Crossover Assignment||Treatment||Double||||||
1552707|NCT00283777|Randomized|Parallel Assignment||Treatment||Double||||||
1552708|NCT00283764|Randomized|Parallel Assignment||Treatment||Single||||||
1552709|NCT00283751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552710|NCT00283738|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1552711|NCT00283725|||Case Control||Prospective|||||||
1552712|NCT00283712|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1553551|NCT00272441||Crossover Assignment||Treatment||||||||
1552713|NCT00283699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552714|NCT00283686|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1552715|NCT00283673|Randomized|Parallel Assignment||||Single||||||
1552716|NCT00283660|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552717|NCT00283647||||||||||||
1552718|NCT00283634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552719|NCT00283621|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552720|NCT00283608|||Cohort||Prospective|||||||
1552721|NCT00283595|Randomized|Parallel Assignment||Treatment||Single|||t|||
1552722|NCT00283582|Randomized|Crossover Assignment||Prevention||Double||||||
1552723|NCT00283569|||Case Control||Prospective|||||||
1552724|NCT00283556|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552725|NCT00283543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552726|NCT00283530|||Case-Only||Prospective|||||||
1552727|NCT00283517|||Cohort||Prospective|||||||
1552728|NCT00283504||Single Group Assignment||Diagnostic||None (Open Label)||||||
1552729|NCT00283491|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1552730|NCT00283478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552731|NCT00283465|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552732|NCT00283452|Randomized|Parallel Assignment||||None (Open Label)||||||
1552733|NCT00283439||Parallel Assignment||Supportive Care||None (Open Label)||||||
1552734|NCT00283426|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552735|NCT00283413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552736|NCT00283400|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552737|NCT00283387|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1552738|NCT00283374|||Defined Population||Longitudinal, Prospective|||||||
1552739|NCT00283361|Randomized|Parallel Assignment||Treatment||Double||||||
1552740|NCT00283348|||Cohort||Prospective|||||||
1552741|NCT00283335|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552742|NCT00283322|||Cohort||Prospective|||||||
1552743|NCT00283309|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1552744|NCT00283296||Single Group Assignment||||None (Open Label)||||||
1552745|NCT00283283|Randomized|Parallel Assignment||Prevention||Single|||t|||
1552746|NCT00283270|Randomized|Single Group Assignment||Treatment||Single||||||
1552747|NCT00283257|Randomized|Factorial Assignment||Other||None (Open Label)||||||
1552748|NCT00283244|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552749|NCT00283231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552750|NCT00283218|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552751|NCT00283205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552752|NCT00283192|Randomized|Parallel Assignment||Treatment||Double||||||
1552753|NCT00283179|Randomized|Parallel Assignment||Treatment||Double||||||
1552754|NCT00283166|Randomized|Parallel Assignment||Other||Triple||||t|t|t
1552755|NCT00283153|Randomized|Parallel Assignment||Treatment||Single||||||t
1552756|NCT00283127|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552757|NCT00283114||Single Group Assignment||Treatment||None (Open Label)||||||
1552758|NCT00283101||Single Group Assignment||Treatment||None (Open Label)||||||
1552759|NCT00283088|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1552760|NCT00283075||Single Group Assignment||Treatment||None (Open Label)||||||
1552761|NCT00283062|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1552762|NCT00283049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552763|NCT00283036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552764|NCT00283023|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1552765|NCT00283010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552766|NCT00282997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552767|NCT00282984|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1552768|NCT00282971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552769|NCT00282958|Randomized|Parallel Assignment||Treatment||Double||||||
1552770|NCT00282945|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1552771|NCT00282932|Randomized|Parallel Assignment||Treatment||Double||||||
1552772|NCT00282919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552773|NCT00282906||Single Group Assignment||Diagnostic||None (Open Label)||||||
1552774|NCT00282893|Randomized|Single Group Assignment||Prevention||Single||||||t
1552775|NCT00282867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552776|NCT00282854|||Case Control||Cross-Sectional|||||||
1552777|NCT00282841|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552778|NCT00282828|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1552779|NCT00282815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552780|NCT00282802|||Cohort||Prospective|||||||
1552781|NCT00282789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552782|NCT00282776|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1552783|NCT00282763|Randomized|Crossover Assignment||Treatment||Double||||||
1552784|NCT00282750|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552785|NCT00282724|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552786|NCT00282711|||Cohort||Prospective|||||||
1552787|NCT00282698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552788|NCT00282685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552789|NCT00282672|Randomized|Crossover Assignment||Treatment||Single|||t|||
1552790|NCT00282659|Randomized|Parallel Assignment||Treatment||Double||||||
1552791|NCT00282646|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552792|NCT00282633|Randomized|Parallel Assignment||Treatment||Single||||||t
1552793|NCT00282620|Randomized|Parallel Assignment||Treatment||Double||||||
1552794|NCT00282607|Randomized|Parallel Assignment||Treatment||Double||||||
1552795|NCT00282594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552796|NCT00282581|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1552797|NCT00282568|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552798|NCT00282555|Randomized|Parallel Assignment||Treatment||Double||||||
1552799|NCT00282542|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552800|NCT00282529|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1552801|NCT00282516|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1552802|NCT00282503|Randomized|Parallel Assignment||Treatment||Single||||||t
1552803|NCT00282490|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552804|NCT00282477|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1552805|NCT00282464|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552806|NCT00282451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552807|NCT00282438|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552808|NCT00282425||Single Group Assignment||Treatment||None (Open Label)||||||
1552809|NCT00282412||Single Group Assignment||Treatment||None (Open Label)||||||
1552810|NCT00282399|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552811|NCT00282386|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1552812|NCT00282373|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552813|NCT00282360|Randomized|Parallel Assignment||Treatment||Double||||||
1552814|NCT00282347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552815|NCT00282334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552816|NCT00282321|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552817|NCT00282308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552818|NCT00282295|Randomized|Parallel Assignment||Prevention||Single|||t|||
1552819|NCT00282282||Single Group Assignment||Treatment||None (Open Label)||||||
1552820|NCT00282269|Randomized|Single Group Assignment||Treatment||Single||||||t
1552821|NCT00282256|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552822|NCT00282243|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552823|NCT00282230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552824|NCT00282217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552825|NCT00282204|Randomized|Parallel Assignment||Prevention||Single||||||t
1552826|NCT00282191|||Ecologic or Community||Cross-Sectional|||||||
1552827|NCT00282178|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1552828|NCT00282165|Randomized|Crossover Assignment||||Triple|||t|t|t|
1552829|NCT00282152|Randomized|Parallel Assignment||Other||Single||||||t
1552830|NCT00282139|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552831|NCT00282126|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1552832|NCT00282113|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1552833|NCT00282100|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552834|NCT00282087||Single Group Assignment||Treatment||None (Open Label)||||||
1552835|NCT00282074|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1552836|NCT00282061|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1552837|NCT00282048|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552838|NCT00282035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552839|NCT00282022||||Treatment||None (Open Label)||||||
1552840|NCT00282009|Randomized|Single Group Assignment||Prevention||Single|||t|||
1552841|NCT00281996|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552842|NCT00281983||Single Group Assignment||Treatment||None (Open Label)||||||
1552843|NCT00281970||||Treatment||None (Open Label)||||||
1552844|NCT00281957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552845|NCT00281944||Single Group Assignment||Treatment||None (Open Label)||||||
1552846|NCT00281931|Non-Randomized|||Treatment||None (Open Label)||||||
1552847|NCT00281918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552848|NCT00281905||||Treatment||None (Open Label)||||||
1552849|NCT00281892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552850|NCT00281879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552851|NCT00281866|Non-Randomized|||Treatment||||||||
1552852|NCT00281853|||Cohort||Prospective|||||||
1552853|NCT00281840||Single Group Assignment||Treatment||None (Open Label)||||||
1552854|NCT00281827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552855|NCT00281814|||Cohort||Prospective|||||||
1552856|NCT00281801|||Case Control||Prospective|||||||
1552857|NCT00281788||||Treatment||None (Open Label)||||||
1552858|NCT00281762|Randomized|Crossover Assignment||||Double||||||
1552859|NCT00281749|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552860|NCT00281736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552861|NCT00281723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552862|NCT00281710|Randomized|Crossover Assignment||||Single||||||
1555672|NCT00244114|||||Prospective|||||||
1552863|NCT00281697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552864|NCT00281684|Randomized|Parallel Assignment||Treatment||||||||
1552865|NCT00281671|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1552866|NCT00281658|Randomized|||Treatment||Double|||t||t|
1552867|NCT00281645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552868|NCT00281632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552869|NCT00281619|||Cohort||Prospective|||||||
1552870|NCT00281606|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552871|NCT00281593||||Treatment||||||||
1552872|NCT00281580|Randomized|Factorial Assignment||Treatment||Double||||||
1552873|NCT00281567|Randomized|Crossover Assignment||Treatment||Double||||||
1552874|NCT00281554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552875|NCT00281541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552876|NCT00281528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552877|NCT00281515|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1552878|NCT00281502|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1552879|NCT00281489|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1552880|NCT00281476|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552881|NCT00281463||Single Group Assignment||Basic Science||None (Open Label)||||||
1552882|NCT00281450|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1552883|NCT00281437|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552884|NCT00281424|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552885|NCT00281411|||Cohort||Prospective|||||||
1552886|NCT00281398|Non-Randomized|Single Group Assignment||||Single||||||
1552887|NCT00281385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552888|NCT00281372|||Ecologic or Community||Cross-Sectional|||||||
1552889|NCT00281359|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552890|NCT00281346||Single Group Assignment||Diagnostic||None (Open Label)||||||
1552891|NCT00281333|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1552892|NCT00281320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552893|NCT00281307|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552894|NCT00281294|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552895|NCT00281281|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552896|NCT00281268||Factorial Assignment||Treatment||||||||
1552897|NCT00281255|Randomized|Parallel Assignment||Basic Science||Quadruple|||t|t|t|t
1552898|NCT00281242|||Cohort||Prospective|||||||
1552899|NCT00281229|||Case-Only||Prospective|||||||
1552900|NCT00281216|||Cohort||Prospective|||||||
1552901|NCT00281203|||Case-Only||Prospective|||||||
1552902|NCT00281190|||Case Control||Prospective|||||||
1552903|NCT00281177||||Treatment||||||||
1552904|NCT00281151|||Cohort|||||||||
1552905|NCT00281138|||Cohort||Cross-Sectional|||||||
1552906|NCT00281125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552907|NCT00281112||||||||||||
1552908|NCT00281099|Randomized|Parallel Assignment||Prevention||Single|||t|||
1552909|NCT00281086||||||||||||
1552910|NCT00281073|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552911|NCT00281060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552912|NCT00281047|Randomized|Parallel Assignment||Treatment||Double||||||
1552913|NCT00281034|||Cohort||Prospective|||||||
1552914|NCT00281021||Single Group Assignment||Treatment||None (Open Label)||||||
1552915|NCT00281008|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552916|NCT00280995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552917|NCT00280982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552918|NCT00280969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552919|NCT00280956|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1552920|NCT00280943|Randomized|Crossover Assignment||Prevention||Single||||||
1552921|NCT00280930|Randomized|Factorial Assignment||Prevention||Double||||||
1552922|NCT00280917||Parallel Assignment||Treatment||Triple|||t|t|t|
1552923|NCT00280904|||Cohort||Prospective|||||||
1552924|NCT00280891|||||Retrospective|||||||
1552925|NCT00280878|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552926|NCT00280865|Randomized|Parallel Assignment||Treatment||Double||||||
1552927|NCT00280852|||||Retrospective|||||||
1552928|NCT00280826||Single Group Assignment||Treatment||None (Open Label)||||||
1552929|NCT00280813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552930|NCT00280800|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552931|NCT00280787||Single Group Assignment||Treatment||None (Open Label)||||||
1552932|NCT00280774|Randomized|Single Group Assignment||Treatment||Double||||||
1552933|NCT00280761|||Case-Only||Prospective|||||||
1552934|NCT00280748||Single Group Assignment||Treatment||None (Open Label)||||||
1552935|NCT00280735||Single Group Assignment||Treatment||None (Open Label)||||||
1552936|NCT00280722|Randomized|||Other||||||||
1552937|NCT00280709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552938|NCT00280696|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1552939|NCT00280683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552940|NCT00280670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552941|NCT00280657|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552942|NCT00280644|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552943|NCT00280631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552944|NCT00280618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552945|NCT00280605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552946|NCT00280592|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552947|NCT00280579|||||Prospective|||||||
1552948|NCT00280566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552949|NCT00280553|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552950|NCT00280540|Randomized|Parallel Assignment||Treatment||Double||||||
1552951|NCT00280527|||Case Control||Prospective|||||||
1552952|NCT00280514|Non-Randomized|||||||||||
1552953|NCT00280501|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1552954|NCT00280488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552955|NCT00280475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552956|NCT00280462|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1552957|NCT00280449|Randomized|Parallel Assignment||Treatment||Double||||||
1552958|NCT00280436|Randomized|Crossover Assignment||Treatment||Double||||||
1552959|NCT00280423|Randomized|Parallel Assignment||Treatment||Double||||||
1552960|NCT00280410|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1552961|NCT00280397||Single Group Assignment||Treatment||None (Open Label)||||||
1552962|NCT00280384|Randomized|Parallel Assignment||Treatment||Single||||||
1552963|NCT00280371|Randomized|Parallel Assignment||Treatment||Double||||||
1552964|NCT00280358|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1552965|NCT00280345|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1552966|NCT00280332|||Case Control||Prospective|||||||
1552967|NCT00280319|Randomized|Parallel Assignment||Treatment||Single||||||t
1552968|NCT00280306|||Case Control||Cross-Sectional|||||||
1552969|NCT00280293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552970|NCT00280280|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552971|NCT00280267|Randomized|Factorial Assignment||Treatment||Double||||||
1552972|NCT00280254|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552973|NCT00280241||Single Group Assignment||Treatment||None (Open Label)||||||
1552974|NCT00280228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552975|NCT00280215|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1552976|NCT00280202|||Cohort||Prospective|||||||
1552977|NCT00280189|||Case-Only||Prospective|||||||
1552978|NCT00280176||Single Group Assignment||Treatment||None (Open Label)||||||
1552979|NCT00280163|||||Prospective|||||||
1552980|NCT00280150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552981|NCT00280137|||||Prospective|||||||
1552982|NCT00280111|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1552983|NCT00280098|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1552984|NCT00280085|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1552985|NCT00280072|Randomized|Parallel Assignment||Treatment||Double||||||
1552986|NCT00280059|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1552987|NCT00280046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552988|NCT00280033|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1552989|NCT00280020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1552990|NCT00280007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552991|NCT00279994|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1552992|NCT00279981|||||Prospective|||||||
1552993|NCT00279968|||||Prospective|||||||
1552994|NCT00279955|||Cohort||Prospective|||||||
1552995|NCT00279942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552996|NCT00279929|Randomized|Crossover Assignment||Treatment||Double||||||
1552997|NCT00279916|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1552998|NCT00279903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1552999|NCT00279890|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553000|NCT00279877|Randomized|Parallel Assignment||Treatment||Single|||t|||
1553001|NCT00279864|||||Prospective|||||||
1553002|NCT00279851|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1553003|NCT00279838|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1553004|NCT00279825|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1553005|NCT00279812|Randomized|Parallel Assignment||Other||Double|||t|t||
1553006|NCT00279799|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553007|NCT00279786|||Cohort|||||||||
1553008|NCT00279773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553009|NCT00279760|Randomized|Parallel Assignment||Treatment||Double||||||
1553010|NCT00279747|Randomized|Parallel Assignment||Treatment||Double||||||
1553011|NCT00279734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553012|NCT00279721|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553013|NCT00279708|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553014|NCT00279695|||Case Control||Prospective|||||||
1553015|NCT00279682|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553016|NCT00279669|||Case-Only||Cross-Sectional|||||||
1553017|NCT00279656|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1553018|NCT00279643|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553019|NCT00279630|Randomized|Parallel Assignment||Treatment||Single||||||t
1553020|NCT00279617|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553021|NCT00279604|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553022|NCT00279591|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1553023|NCT00279578|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553024|NCT00279565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553025|NCT00279552|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1553026|NCT00279539|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1553027|NCT00279526|Random Sample||Natural History||Cross-Sectional, Prospective|||||||
1553028|NCT00279513|Randomized|Parallel Assignment||Treatment||Double||||||
1553029|NCT00279500||Single Group Assignment||Treatment||None (Open Label)||Subjects with a confirmed history of advanced retinal degenerative disease and meeting the inclusion criteria listed will be considered as eligible participants in the study. Subjects who have a condition listed in the exclusion criteria will not be allowed to participate in the study. Eligible subjects with the above diagnoses will be recruited from the Doheny Eye Institute at the University of Southern California. Additionally, new subjects encountered in the clinic who fulfill the inclusion criteria will also be eligible to participate. Upon meeting the entry criteria, all subjects must sign an Informed Consent prior to enrollment in the study. Since the subjects are blind, an individual not associated with this study must read the informed consent to the subject. This person must sign the consent form as a witness to the informed consent process.||||
1553030|NCT00279487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553031|NCT00279474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553032|NCT00279461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553033|NCT00279448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553034|NCT00279435|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1553035|NCT00279422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553036|NCT00279409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553037|NCT00279383|||Case Control||Retrospective|||||||
1553038|NCT00279370|||Cohort||Prospective|||||||
1553039|NCT00279357|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1553040|NCT00279344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553041|NCT00279331|||||Prospective|||||||
1553042|NCT00279318|||Cohort||Prospective|||||||
1553043|NCT00279305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553044|NCT00279292|Randomized|Single Group Assignment||Treatment||Double||||||
1553045|NCT00279279|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1553046|NCT00279266|Randomized|Parallel Assignment||Treatment||Double||||||
1553047|NCT00279253|Randomized|Crossover Assignment||Treatment||Double||||||
1553048|NCT00279240|Randomized|||Prevention||None (Open Label)||||||
1553049|NCT00279227|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1553050|NCT00279214|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553051|NCT00279201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553052|NCT00279188|Randomized|Parallel Assignment||Treatment||Single||||||
1553053|NCT00279175|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553054|NCT00279162|Randomized|Parallel Assignment||Treatment||Double||||||
1553055|NCT00279149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553056|NCT00279136|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1553057|NCT00279123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553058|NCT00279110|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553059|NCT00279097|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553060|NCT00279084|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553061|NCT00279071|Randomized|Parallel Assignment||Treatment||Single|||||t|
1553062|NCT00279058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553063|NCT00279045|Randomized|Parallel Assignment||Treatment||||||||
1553064|NCT00279032|Randomized|Parallel Assignment||Treatment||Double||||||
1553065|NCT00279019|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1553066|NCT00279006|Randomized|Parallel Assignment||Treatment||Single||||||
1553067|NCT00278993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553068|NCT00278980|Randomized|Parallel Assignment||Treatment||Double||||||
1553069|NCT00278967|Randomized|Parallel Assignment||Treatment||Single||||||
1553070|NCT00278954||Single Group Assignment||Treatment||None (Open Label)||||||
1553071|NCT00278941|Randomized|Parallel Assignment||Treatment||Double||||||
1553072|NCT00278928|Randomized|Single Group Assignment||Prevention||Single||||||
1553073|NCT00278915||Single Group Assignment||Treatment||None (Open Label)||||||
1553074|NCT00278902||Single Group Assignment||Treatment||None (Open Label)||||||
1553075|NCT00278889|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553076|NCT00278876||Single Group Assignment||Treatment||None (Open Label)||||||
1553077|NCT00278863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553078|NCT00278850|||Case Control||Prospective|||||||
1553079|NCT00278837||Single Group Assignment||Supportive Care||None (Open Label)||||||
1553080|NCT00278824|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1553081|NCT00278811|Randomized|Parallel Assignment||Treatment||Single||||||
1553082|NCT00278798|||Other||Prospective|||||||
1553083|NCT00278785|Randomized|Parallel Assignment||Prevention||Single||||||t
1553084|NCT00278772|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1553085|NCT00278759|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1553086|NCT00278746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553087|NCT00278733|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1553088|NCT00278707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553089|NCT00278694||Single Group Assignment||Treatment||None (Open Label)||||||
1553090|NCT00278681||Single Group Assignment||Treatment||None (Open Label)||||||
1553091|NCT00278668|||||Prospective|||||||
1553092|NCT00278655||Single Group Assignment||Treatment||None (Open Label)||||||
1553093|NCT00278642|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553094|NCT00278629||Single Group Assignment||Treatment||None (Open Label)||||||
1553095|NCT00278616|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553096|NCT00278603|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553097|NCT00278590||Single Group Assignment||Treatment||None (Open Label)||||||
1553098|NCT00278577|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553099|NCT00278564||Single Group Assignment||Treatment||None (Open Label)||||||
1553100|NCT00278551|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553101|NCT00278538||Single Group Assignment||Treatment||None (Open Label)||||||
1553102|NCT00278525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553103|NCT00278512|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553104|NCT00278499|||Cohort||Prospective|||||||
1553105|NCT00278486|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553106|NCT00278473|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1553107|NCT00278460||Single Group Assignment||Treatment||None (Open Label)||||||
1553108|NCT00278447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553109|NCT00278434|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553110|NCT00278421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553111|NCT00278408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553112|NCT00278395||Single Group Assignment||Treatment||None (Open Label)||||||
1553113|NCT00278382||Single Group Assignment||Treatment||None (Open Label)||||||
1553114|NCT00278369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553115|NCT00278343||Single Group Assignment||Treatment||None (Open Label)||||||
1553116|NCT00278330||Single Group Assignment||Treatment||None (Open Label)||||||
1553117|NCT00278304||||Treatment||||||||
1553118|NCT00278278|Randomized|||Treatment||None (Open Label)||||||
1553119|NCT00278265||Single Group Assignment||Treatment||None (Open Label)||||||
1553120|NCT00278252||||Treatment||None (Open Label)||||||
1553121|NCT00278239||||||||||||
1553122|NCT00278226|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553123|NCT00278213||||Treatment||None (Open Label)||||||
1553124|NCT00278200|Non-Randomized|||Treatment||||||||
1553125|NCT00278187||||Treatment||None (Open Label)||||||
1553126|NCT00278174||Single Group Assignment||Treatment||None (Open Label)||||||
1553127|NCT00278161||Single Group Assignment||Treatment||None (Open Label)||||||
1553128|NCT00278148|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553129|NCT00278135|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553130|NCT00278122||||Treatment||None (Open Label)||||||
1553131|NCT00278109|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553132|NCT00278096|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553133|NCT00278083|Randomized|Parallel Assignment||Treatment||Double||||||
1553134|NCT00278070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553135|NCT00278057||||||||||||
1553136|NCT00278044|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1553137|NCT00278031|||Cohort||Retrospective|||||||
1553138|NCT00278018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553139|NCT00278005|||||Retrospective|||||||
1553140|NCT00277992|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553141|NCT00277979|||Case-Only||Retrospective|||||||
1553142|NCT00277966|||||Retrospective|||||||
1553143|NCT00277953|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553144|NCT00277940|||||Retrospective|||||||
1553145|NCT00277927|||||Retrospective|||||||
1553146|NCT00277914||Single Group Assignment||Treatment||None (Open Label)||||||
1553147|NCT00277901|||Cohort||Retrospective|||||||
1553148|NCT00277888|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553149|NCT00277875|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1553150|NCT00277862|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553151|NCT00277849||||||||||||
1553152|NCT00277836|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1553153|NCT00277823|Randomized|Parallel Assignment||Treatment||Double||||||
1553154|NCT00277810|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553155|NCT00277797|Randomized|Crossover Assignment||Treatment||Single|||t|||
1553156|NCT00277784|||Case-Only||Prospective|||||||
1553157|NCT00277771|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1553158|NCT00277758|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553159|NCT00277745|||Cohort||Prospective|||||||
1553160|NCT00277732|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553161|NCT00277706|Randomized|Parallel Assignment||Treatment||Double||||||
1553162|NCT00277693|Randomized|Parallel Assignment||Treatment||Double||||||
1553163|NCT00277680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553164|NCT00277667|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553165|NCT00277654|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553166|NCT00277641|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1553167|NCT00277615|||||Prospective|||||||
1553168|NCT00277602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553169|NCT00277589|Randomized|Parallel Assignment||Treatment||Single|||t|||
1553170|NCT00277576|Randomized|Single Group Assignment||Treatment||Double||||||
1553171|NCT00277563|Randomized|Parallel Assignment||Treatment||Double||||||
1553172|NCT00277550|Randomized|Parallel Assignment||Treatment||Double||||||
1553173|NCT00277537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553174|NCT00277524|||||Prospective|||||||
1553175|NCT00277511|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553176|NCT00277498|Randomized|Parallel Assignment||Treatment||Double||||||
1553177|NCT00277472|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553178|NCT00277446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553179|NCT00277433|||Case-Control||Retrospective|||||||
1553180|NCT00277420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553181|NCT00277407|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553182|NCT00277394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553183|NCT00277381|Randomized|Single Group Assignment||||Single||||||
1553184|NCT00277368|||Cohort||Cross-Sectional|||||||
1553185|NCT00277355|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553186|NCT00277342|Randomized|Single Group Assignment||Diagnostic||Single||||||
1553187|NCT00277329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553188|NCT00277316|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553189|NCT00277303|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553190|NCT00277290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553191|NCT00277277|Randomized|Parallel Assignment||||None (Open Label)||||||
1553192|NCT00277264|Randomized|Parallel Assignment||Treatment||Double||||||
1553193|NCT00277251|Randomized|Factorial Assignment||Treatment||Double||||||
1553194|NCT00277238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553195|NCT00277225|Randomized|Single Group Assignment||Treatment||Double||||||
1553196|NCT00277212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553197|NCT00277199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553198|NCT00277186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553199|NCT00277173|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1553200|NCT00277160|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1553201|NCT00277147||||Treatment||||||||
1553202|NCT00277121|||Case Control||Retrospective/Prospective|||||||
1553203|NCT00277108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553204|NCT00277095||Single Group Assignment||Treatment||None (Open Label)||||||
1553205|NCT00277082|||Cohort||Prospective|||||||
1553206|NCT00277069||Single Group Assignment||Treatment||None (Open Label)||||||
1553207|NCT00277056|||Cohort||Prospective|||||||
1553208|NCT00277043|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553209|NCT00277030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553210|NCT00277017||Single Group Assignment||Treatment||None (Open Label)||||||
1553211|NCT00277004|||Cohort||Prospective|||||||
1553212|NCT00276991||Single Group Assignment||Treatment||None (Open Label)||||||
1553213|NCT00276978||Single Group Assignment||Treatment||None (Open Label)||||||
1553214|NCT00276965|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553215|NCT00276952|Randomized|Single Group Assignment||Treatment||Double||||||
1553216|NCT00276939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553217|NCT00276926|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1553218|NCT00276913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553219|NCT00276900|Randomized|Factorial Assignment||Prevention||Double||||||
1553220|NCT00276887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553221|NCT00276874|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1553222|NCT00276861|Non-Randomized|||Treatment||None (Open Label)||||||
1553223|NCT00276848|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553224|NCT00276835|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553225|NCT00276822||Single Group Assignment||||None (Open Label)||||||
1553226|NCT00276809|Non-Randomized|||Treatment||None (Open Label)||||||
1553227|NCT00276796||||Treatment||None (Open Label)||||||
1553228|NCT00276783||Single Group Assignment||Treatment||None (Open Label)||||||
1553229|NCT00276770|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1553230|NCT00276757|Randomized|||Treatment||||||||
1553231|NCT00276744||Single Group Assignment||Treatment||None (Open Label)||||||
1553232|NCT00276731|Randomized|||Treatment||||||||
1553233|NCT00276718||||Treatment||None (Open Label)||||||
1553234|NCT00276705|Non-Randomized|||Treatment||None (Open Label)||||||
1553235|NCT00276692||||Treatment||None (Open Label)||||||
1553236|NCT00276679|Non-Randomized|||Treatment||None (Open Label)||||||
1553237|NCT00276666||||Treatment||None (Open Label)||||||
1553238|NCT00276640|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553239|NCT00276627|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1553240|NCT00276614||Single Group Assignment||Treatment||None (Open Label)||||||
1553241|NCT00276601||||Treatment||||||||
1553242|NCT00276588||||Treatment||None (Open Label)||||||
1553243|NCT00276575||Single Group Assignment||Treatment||None (Open Label)||||||
1553244|NCT00276549||Single Group Assignment||Treatment||None (Open Label)||||||
1553245|NCT00276536|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553246|NCT00276523|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553247|NCT00276510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553248|NCT00276497|Randomized|Parallel Assignment||Prevention||Double||||||
1553249|NCT00276484|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553250|NCT00276471|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553251|NCT00276458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553252|NCT00276445|Randomized|Crossover Assignment||Prevention||Double||||||
1553253|NCT00276432|Randomized|Parallel Assignment||Diagnostic||Double||||||
1553254|NCT00276419|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1553255|NCT00276406|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1553256|NCT00276393|Randomized|Crossover Assignment||Treatment||Single||||||
1553257|NCT00276380|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553258|NCT00276367||||||||||||
1553259|NCT00276354|Randomized|Parallel Assignment||Treatment||Single||||||
1553260|NCT00276341|Randomized|Parallel Assignment||Treatment||Double||||||
1553261|NCT00276328|Randomized|Parallel Assignment||Treatment||Double||||||
1553262|NCT00276315|Randomized|Parallel Assignment||Treatment||Single||||||
1553263|NCT00276302|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553264|NCT00276289|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553265|NCT00276276|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553266|NCT00276263|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553267|NCT00276250|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553268|NCT00276237|||||Prospective|||||||
1553269|NCT00276224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553270|NCT00276211|||Cohort||Prospective|||||||
1553271|NCT00276198|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553272|NCT00276185|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1553273|NCT00276172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553274|NCT00276159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553275|NCT00276146|Randomized|Crossover Assignment||||Double||||||
1553276|NCT00276133|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553277|NCT00276120|||Family-Based||Prospective|||||||
1553278|NCT00276107|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1553279|NCT00276094|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553280|NCT00276081|Randomized|Parallel Assignment||Treatment||Double||||||
1553281|NCT00276068|Randomized|Parallel Assignment||||Double||||||
1553282|NCT00276055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553283|NCT00276042|Randomized|Parallel Assignment||Treatment||Double||||||
1553284|NCT00276029|Randomized|Crossover Assignment||Treatment||Double||||||
1553285|NCT00276016|Randomized|Crossover Assignment||Treatment||Single|||||t|
1553286|NCT00276003|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553287|NCT00275990|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1553288|NCT00275977|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1553289|NCT00275964|||||Prospective|||||||
1553290|NCT00275951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553291|NCT00275938|Randomized|Parallel Assignment||Treatment||Double||||||
1553292|NCT00275925|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553293|NCT00275912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553294|NCT00275899|||Case Control|Screening|Cross-Sectional, Retrospective|||||||
1553295|NCT00275886|||Case Control|Screening|Cross-Sectional, Retrospective|||||||
1553296|NCT00275834|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553297|NCT00275821|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1553298|NCT00275795|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1553299|NCT00275769|Randomized|Factorial Assignment||||None (Open Label)||||||
1553300|NCT00275756|Randomized|Parallel Assignment||Basic Science||Double|||t||t|
1553301|NCT00275743|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1553302|NCT00275730|Randomized|Crossover Assignment||||Double||||||
1553303|NCT00275717|||Cohort||Prospective|||||||
1553304|NCT00275704|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553305|NCT00275691|||||Prospective|||||||
1553306|NCT00275678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553307|NCT00275665|Randomized|Parallel Assignment||Prevention||Double||||||
1553308|NCT00275652|Randomized|Parallel Assignment||Treatment||Double||||||
1553309|NCT00275639|Randomized|Parallel Assignment||Treatment||Double||||||
1553310|NCT00275613||Single Group Assignment||Treatment||None (Open Label)||||||
1553311|NCT00275600|Randomized|Parallel Assignment||Treatment||Double||||||
1553312|NCT00275587|||||Retrospective|||||||
1553313|NCT00275574||Single Group Assignment||Treatment||None (Open Label)||||||
1553314|NCT00275561|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1553315|NCT00275548|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553316|NCT00275535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553317|NCT00275522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553318|NCT00275509|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553319|NCT00275496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553320|NCT00275483|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1553321|NCT00275457|Randomized|Single Group Assignment||Treatment||Double||||||
1553322|NCT00275444|Randomized|Parallel Assignment||Treatment||Double||||||
1553323|NCT00275431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553324|NCT00275418|Randomized|Parallel Assignment||Prevention||Double||||||
1553325|NCT00275405|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553326|NCT00275392|Randomized|Parallel Assignment||Treatment||Single|||t|||
1553327|NCT00275379|Randomized|Parallel Assignment||Treatment||Double||||||
1553328|NCT00275366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553329|NCT00275353|Randomized|Parallel Assignment||Treatment||Single||||||
1553330|NCT00275340|Randomized|Single Group Assignment||Treatment||Single||||||
1553331|NCT00275327|||||Retrospective|||||||
1553332|NCT00275314|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553333|NCT00275301||Single Group Assignment||Treatment||None (Open Label)||||||
1553334|NCT00275288|||||Prospective|||||||
1553335|NCT00275275|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553336|NCT00275262|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1553337|NCT00275249|Randomized|Parallel Assignment||||Double||||||
1553338|NCT00275236|Randomized|Parallel Assignment||Treatment||Double||||||
1553339|NCT00275223|||||Prospective|||||||
1553340|NCT00275210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553341|NCT00275197|Randomized|Parallel Assignment||Treatment||Double||||||
1553342|NCT00275184|Randomized|Parallel Assignment||Diagnostic||Single||||||
1553343|NCT00275171|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553344|NCT00275158|Randomized|Parallel Assignment||Treatment||Double||||||
1553345|NCT00275145|Randomized|Parallel Assignment||Prevention||Single||||||t
1553346|NCT00275132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553347|NCT00275119||||Treatment||None (Open Label)||||||
1553348|NCT00275106|Randomized|||Treatment||||||||
1553349|NCT00275093||Single Group Assignment||Treatment||None (Open Label)||||||
1553350|NCT00275080||Single Group Assignment||Treatment||None (Open Label)||||||
1553351|NCT00275067||Single Group Assignment||Treatment||None (Open Label)||||||
1553352|NCT00275054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553353|NCT00275041||Single Group Assignment||Treatment||None (Open Label)||||||
1553354|NCT00275028||Single Group Assignment||Treatment||None (Open Label)||||||
1553355|NCT00275015||Single Group Assignment||Treatment||None (Open Label)||||||
1553356|NCT00275002||Single Group Assignment||Treatment||None (Open Label)||||||
1553357|NCT00274989||Single Group Assignment||Treatment||None (Open Label)||||||
1553358|NCT00274976||||Treatment||None (Open Label)||||||
1553359|NCT00274963|Non-Randomized|||Treatment||||||||
1553360|NCT00274950||||Treatment||None (Open Label)||||||
1553361|NCT00274937|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553362|NCT00274924|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553363|NCT00274911||||Treatment||None (Open Label)||||||
1553364|NCT00274898|Randomized|||Treatment||None (Open Label)||||||
1553365|NCT00274885|Non-Randomized|||Treatment||None (Open Label)||||||
1553366|NCT00274872|Randomized|||Treatment||None (Open Label)||||||
1553367|NCT00274859||||Treatment||None (Open Label)||||||
1553368|NCT00274846||Single Group Assignment||Treatment||None (Open Label)||||||
1553369|NCT00274833||Single Group Assignment||Treatment||None (Open Label)||||||
1553370|NCT00274820||Single Group Assignment||Treatment||None (Open Label)||||||
1553371|NCT00274807||Single Group Assignment||Treatment||None (Open Label)||||||
1553372|NCT00274794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553373|NCT00274781||Single Group Assignment||Treatment||None (Open Label)||||||
1553374|NCT00274768||Single Group Assignment||Treatment||None (Open Label)||||||
1553375|NCT00274755||||Diagnostic||None (Open Label)||||||
1553376|NCT00274742||Single Group Assignment||Treatment||None (Open Label)||||||
1553377|NCT00274729|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553378|NCT00274716|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553379|NCT00274703|Randomized|Parallel Assignment||Treatment||Double||||||
1553380|NCT00274690|Randomized|Parallel Assignment||Prevention||Double||||||
1553381|NCT00274677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553382|NCT00274664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553383|NCT00274651|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553384|NCT00274638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553385|NCT00274625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553386|NCT00274612|Randomized|Parallel Assignment||Treatment||Double||||||
1553387|NCT00274599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553388|NCT00274586|Randomized|Parallel Assignment||Treatment||Double||||||
1553389|NCT00274573|Randomized|Parallel Assignment||Treatment||Double||||||
1553390|NCT00274560|Randomized|Parallel Assignment||Treatment||Double||||||
1553391|NCT00274547|Randomized|Parallel Assignment||Treatment||Double||||||
1553392|NCT00274534|Randomized|Crossover Assignment||Treatment||Double||||||
1553393|NCT00274521|Randomized|Parallel Assignment||Treatment||Double||||||
1553394|NCT00274508|Randomized|Parallel Assignment||Treatment||Double||||||
1553395|NCT00274495|Randomized|Parallel Assignment||Treatment||Double||||||
1553396|NCT00274469|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553397|NCT00274456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553398|NCT00274443||Single Group Assignment||Treatment||None (Open Label)||||||
1553399|NCT00274430|Randomized|Parallel Assignment||Prevention||Double||||||
1553400|NCT00274417|Randomized|Parallel Assignment||Treatment||Double||||||
1553401|NCT00274404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553402|NCT00274391|Randomized|Parallel Assignment||||Double||||||
1553403|NCT00274378|Randomized|Parallel Assignment||Treatment||Double||||||
1553404|NCT00274365|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1553405|NCT00274352|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1553406|NCT00274339|Randomized|Parallel Assignment||Treatment||Double||||||
1553407|NCT00274326|Randomized|Parallel Assignment||Treatment||Double||||||
1553408|NCT00274313|Randomized|Single Group Assignment||Treatment||Double||||||
1553409|NCT00274300|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553410|NCT00274287||Single Group Assignment||Treatment||None (Open Label)||||||
1553411|NCT00274274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553412|NCT00274261|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1553413|NCT00274248|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553414|NCT00274235|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553415|NCT00274222||||||||||||
1553416|NCT00274209|||Cohort||Prospective|||||||
1553417|NCT00274196|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1553418|NCT00274183|||Cohort||Prospective|||||||
1553419|NCT00274170|Randomized|Parallel Assignment||Treatment||Double||||||
1553420|NCT00274157|||||Prospective|||||||
1553421|NCT00274144|Randomized|Parallel Assignment||Treatment||Double||||||
1553422|NCT00274131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553423|NCT00274118|Randomized|Parallel Assignment||Prevention||Double||||||
1553424|NCT00274105|Randomized|Parallel Assignment||Treatment||Double||||||
1553425|NCT00274092|Randomized|Parallel Assignment||Treatment||Double||||||
1553426|NCT00274079|Randomized|Parallel Assignment||Treatment||Double||||||
1553427|NCT00274066|Randomized|Crossover Assignment||Treatment||Double||||||
1553428|NCT00274053|Randomized|Parallel Assignment||Treatment||Double||||||
1553429|NCT00274040|Randomized|Parallel Assignment||Treatment||Double||||||
1553430|NCT00274027|Randomized|Crossover Assignment||Treatment||Double||||||
1553431|NCT00274014|Randomized|Parallel Assignment||Treatment||Double||||||
1553432|NCT00274001|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1553433|NCT00273988|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553434|NCT00273975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553435|NCT00273962|Randomized|Parallel Assignment||Treatment||Double||||||
1553436|NCT00273949|Randomized|Single Group Assignment||Prevention||Double||||||
1553437|NCT00273936|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1553438|NCT00273910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553439|NCT00273897||||Treatment||||||||
1553440|NCT00273884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553441|NCT00273871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553442|NCT00273858|||Cohort||Prospective|||||||
1553443|NCT00273845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553444|NCT00273832|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1553445|NCT00273819|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1553446|NCT00273806|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553447|NCT00273793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553448|NCT00273780|Randomized|Factorial Assignment||||None (Open Label)||||||
1553449|NCT00273767|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1553450|NCT00273754|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1553451|NCT00273741|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553452|NCT00273728|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553453|NCT00273715|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553454|NCT00273702|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553455|NCT00273689|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1553456|NCT00273676|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553457|NCT00273663|Randomized|Parallel Assignment||Treatment||Double||||||
1553458|NCT00273650|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1553459|NCT00273637|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1553460|NCT00273624|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553461|NCT00273611|Randomized|Parallel Assignment||||None (Open Label)||||||
1553462|NCT00273598|Randomized|Parallel Assignment||Treatment||Single||||||
1553463|NCT00273585|Randomized|Single Group Assignment||Prevention||Double||||||
1553464|NCT00273572|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553465|NCT00273559|||Case Control||Prospective|||||||
1553466|NCT00273546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553467|NCT00273533|Randomized|Crossover Assignment||Treatment||Double||||||
1553468|NCT00273520|Randomized|Parallel Assignment||Treatment||Double||||||
1553469|NCT00273507|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553470|NCT00273494|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553471|NCT00273481|Randomized|Crossover Assignment||Treatment||Double||||||
1553472|NCT00273468|Randomized|Parallel Assignment||Treatment||Double||||||
1553473|NCT00273455|Randomized|Crossover Assignment||Treatment||Double||||||
1553474|NCT00273442|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553475|NCT00273429|Randomized|Crossover Assignment||Treatment||Double||||||
1553476|NCT00273416|Randomized|Crossover Assignment||Treatment||Double||||||
1553477|NCT00273403|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553478|NCT00273390||||||||||||
1553479|NCT00273377|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1553480|NCT00273364|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553481|NCT00273351||Single Group Assignment||Diagnostic||None (Open Label)||||||
1553482|NCT00273338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553483|NCT00273325|||Cohort||Prospective|||||||
1553484|NCT00273312|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553485|NCT00273299|Randomized|Parallel Assignment||Treatment||Double||||||
1553486|NCT00273286|Randomized|Parallel Assignment||Prevention||Single||||||t
1553487|NCT00273273|||||Other|||||||
1553488|NCT00273260|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553489|NCT00273247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553490|NCT00273234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553491|NCT00273221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553492|NCT00273208|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1553493|NCT00273195|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553494|NCT00273182|||Cohort||Prospective|||||||
1553495|NCT00273169|||||Prospective|||||||
1553496|NCT00273156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553497|NCT00273143|||||Prospective|||||||
1553498|NCT00273130|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553499|NCT00273117|Random Sample||Natural History||Longitudinal, Prospective|||||||
1553500|NCT00273104|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553501|NCT00273091|||Cohort||Prospective|||||||
1553502|NCT00273078|||Defined Population|Screening|Longitudinal, Prospective|||||||
1553503|NCT00273065|Randomized|Single Group Assignment||Treatment||Double||||||
1553504|NCT00273052|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553505|NCT00273039|Randomized|Parallel Assignment||Treatment||Double||||||
1553506|NCT00273026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553507|NCT00273013|Randomized|Crossover Assignment||Treatment||||||||
1553508|NCT00273000|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1553509|NCT00272987||Single Group Assignment||Treatment||None (Open Label)||||||
1553510|NCT00272974|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1553511|NCT00272961|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553512|NCT00272948|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553513|NCT00272935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553514|NCT00272922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553515|NCT00272909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553516|NCT00272896|Randomized|Crossover Assignment||Diagnostic||Double||||||
1553517|NCT00272883|||Case-Only||Other|||||||
1553518|NCT00272870|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1553519|NCT00272857||Single Group Assignment||Treatment||None (Open Label)||||||
1553520|NCT00272844||Single Group Assignment||Treatment||None (Open Label)||||||
1553521|NCT00272831|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553522|NCT00272818|||Case-Only||Prospective|||||||
1553523|NCT00272805|Randomized|Parallel Assignment||Treatment||Double||||||
1553524|NCT00272792|Randomized|Parallel Assignment||Treatment||Double||||||
1553525|NCT00272779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553526|NCT00272766|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553527|NCT00272753|Randomized|Crossover Assignment||Treatment||Double||||||
1553528|NCT00272740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553529|NCT00272727|Randomized|Crossover Assignment||||None (Open Label)||||||
1553530|NCT00272714|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1553531|NCT00272701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553532|NCT00272688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553533|NCT00272675|Randomized|Parallel Assignment||Prevention||Double||||||
1553534|NCT00272662|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553535|NCT00272649|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553536|NCT00272636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553537|NCT00272623|Randomized|Parallel Assignment||Treatment||Single||||||
1553538|NCT00272610|Randomized|Single Group Assignment||Prevention||Double||||||
1553539|NCT00272597||Single Group Assignment||Treatment||None (Open Label)||||||
1553540|NCT00272584|Randomized|Parallel Assignment||Treatment||Double||||||
1553541|NCT00272571|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553542|NCT00272558|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553543|NCT00272545|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553544|NCT00272532|Randomized|Parallel Assignment||Treatment||Single||||||
1553545|NCT00272519||Single Group Assignment||Supportive Care||None (Open Label)||||||
1553546|NCT00272506||Crossover Assignment||Treatment||||||||
1553547|NCT00272493|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553548|NCT00272480|Randomized|Crossover Assignment||Treatment||Double||||||
1553549|NCT00272467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553550|NCT00272454|Randomized|Parallel Assignment||Treatment||Double||||||
1553552|NCT00272428|Randomized|Parallel Assignment||Prevention||Double||||||
1553553|NCT00272415||Single Group Assignment||Treatment||None (Open Label)||||||
1553554|NCT00272402|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1553555|NCT00272389|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1553556|NCT00272376|||Family-Based||Retrospective|||||||
1553557|NCT00272363|||Family-Based||Prospective|||||||
1553558|NCT00272350||||Treatment||||||||
1553559|NCT00272337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553560|NCT00272324|Randomized|Factorial Assignment||Prevention||Double||||||
1553561|NCT00272311|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1553562|NCT00272285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553563|NCT00272272||Single Group Assignment||Screening||None (Open Label)||||||
1553564|NCT00272259|Randomized|Parallel Assignment||||Single||||||
1553565|NCT00272246|Randomized|Parallel Assignment||Treatment||Double||||||
1553566|NCT00272233|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1553567|NCT00272220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553568|NCT00272207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553569|NCT00272194|Randomized|Parallel Assignment||||Single||||||
1553570|NCT00272181||Single Group Assignment||Treatment||None (Open Label)||||||
1553571|NCT00272168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553572|NCT00272155|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1553573|NCT00272142|Randomized|Factorial Assignment||Treatment||Double||||||
1553574|NCT00272116|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1553575|NCT00272103|Randomized|Parallel Assignment||Treatment||Double||||||
1553576|NCT00272090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553577|NCT00272077|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553578|NCT00272064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553579|NCT00272051|Randomized|Parallel Assignment||Prevention||Double||||||
1553580|NCT00272038||Single Group Assignment||Treatment||None (Open Label)||||||
1553581|NCT00272025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553582|NCT00272012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553583|NCT00271999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553584|NCT00271986|||Case Control||Prospective|||||||
1553585|NCT00271973|Randomized|Crossover Assignment||Treatment||Double||||||
1553586|NCT00271960|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553587|NCT00271947||Single Group Assignment||Treatment||None (Open Label)||||||
1553588|NCT00271934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553589|NCT00271921|||Cohort||Prospective|||||||
1553590|NCT00271908|||Cohort||Cross-Sectional|||||||
1553591|NCT00271882|||Cohort||Prospective|||||||
1553592|NCT00271869|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553593|NCT00271856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553594|NCT00271843|||||Prospective|||||||
1553595|NCT00271830|||||Prospective|||||||
1553596|NCT00271817|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553597|NCT00271804|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553598|NCT00271791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553599|NCT00271778|Randomized|Parallel Assignment||Treatment||Single||||||
1553600|NCT00271765|Randomized|Parallel Assignment||Prevention||Single||||||
1553601|NCT00271752|Randomized|Parallel Assignment||Treatment||Single|||t|||
1553602|NCT00271739|Randomized|Parallel Assignment||||None (Open Label)||||||
1553603|NCT00271726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553604|NCT00271713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553605|NCT00271700|Randomized|Parallel Assignment||Treatment||Single||||||
1553606|NCT00271687|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553607|NCT00271674|Randomized|Single Group Assignment||Treatment||Single||||||
1553608|NCT00271661|||||Retrospective|||||||
1553609|NCT00271635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553610|NCT00271622||||||||||||
1553611|NCT00271609|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553612|NCT00271596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553613|NCT00271583|Randomized|Single Group Assignment||Treatment||Double||||||
1553614|NCT00271570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553615|NCT00271557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553616|NCT00271544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553617|NCT00271531|||Cohort||Prospective|||||||
1553618|NCT00271518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553619|NCT00271505||Single Group Assignment||Treatment||None (Open Label)||||||
1553620|NCT00271492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553621|NCT00271479|Randomized|Parallel Assignment||Prevention||Single||||||
1553622|NCT00271466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553623|NCT00271453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553624|NCT00271440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553625|NCT00271427|Randomized|Crossover Assignment||Treatment||Double||||||
1553626|NCT00271414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553627|NCT00271401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553628|NCT00271388|Non-Randomized|Single Group Assignment||Device Feasibility||Single|||t|||
1553629|NCT00271375|Non-Randomized|Factorial Assignment||Health Services Research||Single||||t||
1553630|NCT00271362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553631|NCT00271349|Randomized|Parallel Assignment||Treatment||Double||||||
1553632|NCT00271336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553633|NCT00271323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553634|NCT00271310|Randomized|Parallel Assignment||Treatment||Double||||||
1553635|NCT00271297|Randomized|Parallel Assignment||Treatment||Single||||||
1553636|NCT00271284|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553637|NCT00271271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553638|NCT00271258|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553639|NCT00271245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553640|NCT00271232|Randomized|Parallel Assignment||Treatment||Double||||||
1553641|NCT00271219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553642|NCT00271206|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553643|NCT00271193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553644|NCT00271180|||Cohort||Prospective|||||||
1553645|NCT00271167|Randomized|Parallel Assignment||Prevention||Double||||||
1553646|NCT00271154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553647|NCT00271141||||Screening|Cross-Sectional, Retrospective|||||||
1553648|NCT00271128|||||Prospective|||||||
1553649|NCT00271115||Single Group Assignment||||None (Open Label)||||||
1553650|NCT00271102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553651|NCT00271089|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553652|NCT00271076|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553653|NCT00271063|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553654|NCT00271050|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553655|NCT00271037|||Cohort||Prospective|||||||
1553656|NCT00271024|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553657|NCT00271011||Single Group Assignment||Treatment||None (Open Label)||||||
1553658|NCT00270998|Randomized|Parallel Assignment||Treatment||Single||||||t
1553659|NCT00270985|Randomized|Parallel Assignment||Treatment||Single||||||t
1553660|NCT00270972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553661|NCT00270959|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1553662|NCT00270946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553663|NCT00270933|||||Prospective|||||||
1553664|NCT00270920|Randomized|Parallel Assignment||||None (Open Label)||||||
1553665|NCT00270907||Single Group Assignment||Treatment||None (Open Label)||||||
1553666|NCT00270894|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553667|NCT00270881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553668|NCT00270868|Randomized|Parallel Assignment||Treatment||Single||||||
1553669|NCT00270855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553670|NCT00270842|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553671|NCT00270829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553672|NCT00270816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553673|NCT00270803|Non-Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1553674|NCT00270790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553675|NCT00270777|Randomized|Factorial Assignment||Treatment||Double||||||
1553676|NCT00270764|||Cohort||Prospective|||||||
1553677|NCT00270751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553678|NCT00270738|Randomized|Parallel Assignment||Treatment||Single||||||t
1553679|NCT00270725|||Cohort||Retrospective|||||||
1553680|NCT00270712|||Cohort||Other|||||||
1553681|NCT00270699|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1553682|NCT00270686|||||Prospective|||||||
1553683|NCT00270673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553684|NCT00270660||||Screening|Cross-Sectional, Prospective|||||||
1553685|NCT00270647|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1553686|NCT00270634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553687|NCT00270621|Randomized|Parallel Assignment||Treatment||Single||||||t
1553688|NCT00270608|||Cohort||Prospective|||||||
1553689|NCT00270582|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553690|NCT00270569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553691|NCT00270556||||||||||||
1553692|NCT00270543|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553693|NCT00270530|Randomized|Factorial Assignment||Treatment||Double||||||
1553694|NCT00270517|Randomized|Parallel Assignment||Treatment||Double||||||
1553695|NCT00270504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553696|NCT00270491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553697|NCT00270478||||Treatment||||||||
1553698|NCT00270465||||Treatment||||||||
1553699|NCT00270452|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553700|NCT00270439|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553701|NCT00270426|Randomized|Single Group Assignment||Treatment||Double||||||
1553702|NCT00270413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553703|NCT00270400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553704|NCT00270387|Randomized|Parallel Assignment||Treatment||Double||||||
1553705|NCT00270374|Randomized|Parallel Assignment||Treatment||Double||||||
1553706|NCT00270361|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553707|NCT00270348|Randomized|Parallel Assignment||Treatment||Double||||||
1553708|NCT00270335|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1553709|NCT00270322|Randomized|Parallel Assignment||Treatment||Double||||||
1553710|NCT00270309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553711|NCT00270296|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1553712|NCT00270283|Randomized|Parallel Assignment||Treatment||Double||||||
1553713|NCT00270270|Randomized|Parallel Assignment||Treatment||Double||||||
1553714|NCT00270257|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553715|NCT00270244|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1553716|NCT00270231|Randomized|Crossover Assignment||||Triple|||t|t|t|
1553717|NCT00270218|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1553718|NCT00270205|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553719|NCT00270192|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1553720|NCT00270179|Randomized|Parallel Assignment||Treatment||Double||||||
1553721|NCT00270166|Randomized|Parallel Assignment||Treatment||Double||||||
1553722|NCT00270153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553723|NCT00270140|Randomized|Parallel Assignment||Treatment||Double||||||
1553724|NCT00270127|Randomized|Parallel Assignment||Treatment||Double||||||
1553725|NCT00270114|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553726|NCT00270101|Randomized|Parallel Assignment||Treatment||Double||||||
1553727|NCT00270088|Randomized|Parallel Assignment||Treatment||Double||||||
1553728|NCT00270075|Randomized|Parallel Assignment||Treatment||Double||||||
1553729|NCT00270062|Randomized|Parallel Assignment||Treatment||Double||||||
1553730|NCT00270049|Randomized|Parallel Assignment||Treatment||Double||||||
1553731|NCT00270036|Randomized|Parallel Assignment||Treatment||Double||||||
1553732|NCT00270023|Randomized|Parallel Assignment||Treatment||Double||||||
1553733|NCT00270010|Randomized|Parallel Assignment||Treatment||Double||||||
1553734|NCT00269997|Randomized|Parallel Assignment||Treatment||Double||||||
1553735|NCT00269984|Randomized|Parallel Assignment||Treatment||Double||||||
1553736|NCT00269971|Randomized|Parallel Assignment||Treatment||Double||||||
1553737|NCT00269958|Randomized|Parallel Assignment||Treatment||Double||||||
1553738|NCT00269945|Randomized|Parallel Assignment||Treatment||Double||||||
1553739|NCT00269932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553740|NCT00269919||Single Group Assignment||Treatment||None (Open Label)||||||
1553741|NCT00269906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553742|NCT00269893|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553743|NCT00269880|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553744|NCT00269867|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553745|NCT00269854|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553746|NCT00269841|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553747|NCT00269828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553748|NCT00269815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553749|NCT00269802|Randomized|Parallel Assignment||Treatment||Double||||||
1553750|NCT00269789|Randomized|Crossover Assignment||Treatment||Double||||||
1553751|NCT00269776|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1553752|NCT00269763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553753|NCT00269750|Randomized|Parallel Assignment||Treatment||Double||||||
1553754|NCT00269737|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553755|NCT00269724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553756|NCT00269685|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553757|NCT00269672|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553758|NCT00269659|||||Prospective|||||||
1553759|NCT00269646|Randomized|Crossover Assignment||Treatment||Single|||||t|
1553760|NCT00269633|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1553761|NCT00269620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553762|NCT00269607|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553763|NCT00269594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553764|NCT00269581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553765|NCT00269568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553766|NCT00269555|Randomized|Crossover Assignment||Treatment||Double||||||
1553767|NCT00269542|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1553768|NCT00269529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553769|NCT00269516|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553770|NCT00269503|Randomized|Factorial Assignment||Treatment||Single|||t|||
1553771|NCT00269490|||||Prospective|||||||
1553772|NCT00269477|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553773|NCT00269464|||||Retrospective|||||||
1553774|NCT00269451|||Defined Population||Longitudinal, Prospective|||||||
1553775|NCT00269438|Randomized|Single Group Assignment||Treatment||Double||||||
1553776|NCT00269425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553777|NCT00269412|Randomized|Parallel Assignment||Treatment||Double||||||
1553778|NCT00269399|Randomized|Parallel Assignment||Treatment||Double||||||
1553779|NCT00269386|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553780|NCT00269373|||Cohort||Prospective|||||||
1553781|NCT00269360|Randomized|Parallel Assignment||Treatment||Single||||||t
1553782|NCT00269347|Randomized|Parallel Assignment||Treatment||Single||||||
1553783|NCT00269334|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1553784|NCT00269321|Randomized|Parallel Assignment||Treatment||Single||||||t
1553785|NCT00269308|Randomized|Parallel Assignment||Treatment||Single||||||t
1553786|NCT00269295|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1553787|NCT00269282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553788|NCT00269269|Randomized|||Treatment||||||||
1553789|NCT00269256|||Cohort||Prospective|||||||
1553790|NCT00269243|Randomized|Parallel Assignment||||Double||||||
1553791|NCT00269230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553792|NCT00269217|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553793|NCT00269204|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553794|NCT00269191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553795|NCT00269178|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1553796|NCT00269165|Randomized|Parallel Assignment||Treatment||Double||||||
1553797|NCT00269152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553798|NCT00269139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553799|NCT00269126|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1553800|NCT00269113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553801|NCT00269100|||Defined Population|Screening|Longitudinal, Prospective|||||||
1553802|NCT00269087|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553803|NCT00269074|Randomized|Single Group Assignment||Treatment||Double||||||
1553804|NCT00269061|Randomized|Parallel Assignment||Treatment||Double||||||
1553805|NCT00269048|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1553806|NCT00269035|Randomized|Parallel Assignment||Treatment||||||||
1553807|NCT00269022|Randomized|Crossover Assignment||Treatment||Single||||||
1553808|NCT00269009|Randomized|Crossover Assignment||Educational/Counseling/Training||Double||||||
1553809|NCT00268996|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553810|NCT00268983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553811|NCT00268970|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553812|NCT00268957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553813|NCT00268944|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553814|NCT00268931|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1553815|NCT00268918||Single Group Assignment||Treatment||None (Open Label)||||||
1553816|NCT00268905|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553817|NCT00268892|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553818|NCT00268879|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553819|NCT00268866||||||||||||
1553820|NCT00268853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553821|NCT00268840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553822|NCT00268827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553823|NCT00268814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553824|NCT00268788|Randomized|Crossover Assignment||Treatment||Single||||||t
1553825|NCT00268775|Randomized|Single Group Assignment||||None (Open Label)||||||
1553826|NCT00268762||Single Group Assignment||Treatment||None (Open Label)||||||
1553827|NCT00268749||Single Group Assignment||Treatment||None (Open Label)||||||
1553828|NCT00268723|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1553829|NCT00268710|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553830|NCT00268697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553831|NCT00268684||||||||||||
1553832|NCT00268671|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553833|NCT00268658|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1553834|NCT00268645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553835|NCT00268632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553836|NCT00268619|Randomized|Parallel Assignment||Treatment||Double||||||
1553837|NCT00268606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553838|NCT00268593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553839|NCT00268580|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1553840|NCT00268567|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553841|NCT00268554|Non-Randomized|Crossover Assignment||Basic Science||None (Open Label)||||||
1553842|NCT00268541|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1553843|NCT00268528||||||||||||
1553844|NCT00268515||||Prevention||Double||||||
1553845|NCT00268502||||||||||||
1553846|NCT00268489||Single Group Assignment||Treatment||None (Open Label)||||||
1553847|NCT00268476|Randomized|Parallel Assignment||Treatment||None (Open Label)||Multi-arm Multi-Stage||||
1553848|NCT00268463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553849|NCT00268450||Single Group Assignment||Treatment||None (Open Label)||||||
1553850|NCT00268437||Single Group Assignment||Treatment||None (Open Label)||||||
1553851|NCT00268411|Randomized|||Treatment||||||||
1553852|NCT00268398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553853|NCT00268385||Single Group Assignment||Treatment||None (Open Label)||||||
1553854|NCT00268372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553855|NCT00268359||||Treatment||None (Open Label)||||||
1553856|NCT00268346||Single Group Assignment||Treatment||None (Open Label)||||||
1553857|NCT00268333|Non-Randomized|||Treatment||None (Open Label)||||||
1553858|NCT00268320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553859|NCT00268307|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1553860|NCT00268294|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553861|NCT00268281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553862|NCT00268255||Single Group Assignment||Treatment||None (Open Label)||||||
1553863|NCT00268242||Single Group Assignment||Treatment||None (Open Label)||||||
1553864|NCT00268229||Single Group Assignment||Treatment||None (Open Label)||||||
1553865|NCT00268216|Randomized|Parallel Assignment||Treatment||Double||||||
1553866|NCT00268203||||||||||||
1553867|NCT00268177|Randomized|Parallel Assignment||Treatment||Double||||||
1553868|NCT00268164|Randomized|Parallel Assignment||Treatment||Double||||||
1553869|NCT00268151|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553870|NCT00268138|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1553871|NCT00268125|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1553872|NCT00268112|||||Retrospective|||||||
1553873|NCT00268099|||||Retrospective|||||||
1553874|NCT00268086|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553875|NCT00268073|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553876|NCT00268060|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553877|NCT00268047|||||Retrospective|||||||
1553878|NCT00268034|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553879|NCT00268021|||Cohort||Retrospective|||||||
1553880|NCT00268008|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553881|NCT00267995|||||Retrospective|||||||
1553882|NCT00267982|||Cohort||Retrospective|||||||
1553883|NCT00267969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553884|NCT00267956|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1553885|NCT00267943|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553886|NCT00267930|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1553887|NCT00267917|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553888|NCT00267904|||Other||Prospective|||||||
1553889|NCT00267891||||||||||||
1553890|NCT00267865|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553891|NCT00267852|||Cohort||Prospective|||||||
1553892|NCT00267839|Randomized|Parallel Assignment||Prevention||Single|||t|||
1553893|NCT00267826|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553894|NCT00267813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553895|NCT00267800||||||||||||
1553896|NCT00267787|||Case-Only||Prospective|||||||
1553897|NCT00267774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553898|NCT00267748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553899|NCT00267735|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1553900|NCT00267722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553901|NCT00267709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553902|NCT00267696||Single Group Assignment||Treatment||None (Open Label)||||||
1553903|NCT00267683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553904|NCT00267670|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553905|NCT00267657|Randomized|Parallel Assignment||Treatment||Double||||||
1553906|NCT00267644|||Cohort||Prospective|||||||
1553907|NCT00267631|||Cohort||Prospective|||||||
1553908|NCT00267618|Randomized|Parallel Assignment||Treatment||Single||||||t
1553909|NCT00267605|Randomized|Parallel Assignment||Treatment||Single||||||t
1553910|NCT00267592||Single Group Assignment||Treatment||None (Open Label)||||||
1553911|NCT00267579|Randomized|Parallel Assignment||Treatment||Single||||||t
1553912|NCT00267566|Randomized|Parallel Assignment||Treatment||Single||||||t
1553913|NCT00267553|Randomized|Parallel Assignment||Treatment||Double||||||
1553914|NCT00267540|Randomized|Parallel Assignment||Prevention||Double||||||
1553915|NCT00267527|Randomized|Parallel Assignment||Treatment||Double||||||
1553916|NCT00267514|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1553917|NCT00267501|||||Prospective|||||||
1553918|NCT00267488|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553919|NCT00267475|||||Prospective|||||||
1553920|NCT00267462|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553921|NCT00267449|||Defined Population|Screening|Longitudinal, Prospective|||||||
1553922|NCT00267436|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1553923|NCT00267423|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553924|NCT00267410|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1553925|NCT00267397|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553926|NCT00267384|Randomized|Parallel Assignment||Treatment||Double||||||
1553927|NCT00267371|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553928|NCT00267358|Randomized|Parallel Assignment||||Double||||||
1553929|NCT00267345|||Case Control||Longitudinal, Prospective|||||||
1553930|NCT00267332|Randomized|Crossover Assignment||Treatment||Double||||||
1553931|NCT00267319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553932|NCT00267306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553933|NCT00267293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553934|NCT00267280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553935|NCT00267267|Randomized|Parallel Assignment||Treatment||Double||||||
1553936|NCT00267254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553937|NCT00267241|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1553938|NCT00267228|||Defined Population||Longitudinal, Retrospective|||||||
1553939|NCT00267215|Randomized|Parallel Assignment||Treatment||Double||||||
1553940|NCT00267202|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553941|NCT00267189|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553942|NCT00267176|Randomized|Parallel Assignment||Treatment||Double||||||
1553943|NCT00267163|Randomized|Parallel Assignment||Prevention||Double||||||
1553944|NCT00267150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553945|NCT00267137|Randomized|Parallel Assignment||Treatment||Single||||||
1553946|NCT00267124|||Case-Control||Prospective|||||||
1553947|NCT00267111|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553948|NCT00267098|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1553949|NCT00267085|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553950|NCT00267072|||Cohort||Prospective|||||||
1553951|NCT00267059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553952|NCT00267046|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1553953|NCT00267033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553954|NCT00267020|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553955|NCT00267007|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1553956|NCT00266994|||Cohort||Prospective|||||||
1553957|NCT00266981|Randomized|Parallel Assignment||Treatment||Single||||||
1553958|NCT00266968|||Cohort||Retrospective|||||||
1553959|NCT00266955|||||Retrospective|||||||
1553960|NCT00266942|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553961|NCT00266929|||Cohort||Prospective|||||||
1553962|NCT00266916|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1553963|NCT00266903|||||Retrospective|||||||
1553964|NCT00266877|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553965|NCT00266864|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553966|NCT00266851|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553967|NCT00266838|Randomized|Single Group Assignment||Prevention||Single|||||t|
1553968|NCT00266825|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553969|NCT00266812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553970|NCT00266799|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553971|NCT00266786|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553972|NCT00266773|Randomized|Parallel Assignment||Treatment||Single||||||t
1553973|NCT00266760|||Cohort||Prospective|||||||
1553974|NCT00266747|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1553975|NCT00266734|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1553976|NCT00266721|Randomized|Crossover Assignment||Treatment||Double||||||
1553977|NCT00266708|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1553978|NCT00266695||Single Group Assignment||Treatment||None (Open Label)||||||
1553979|NCT00266682|Non-Randomized|||Treatment||None (Open Label)||||||
1553980|NCT00266669|Randomized|Single Group Assignment||Treatment||Double||||||
1553981|NCT00266656|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553982|NCT00266643|Randomized|Parallel Assignment||Treatment||Double||||||
1553983|NCT00266630|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553984|NCT00266617|Randomized|Parallel Assignment||Treatment||Double||||||
1553985|NCT00266604|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1553986|NCT00266591|Randomized|Parallel Assignment||Treatment||Double||||||
1553987|NCT00266578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1553988|NCT00266565||Single Group Assignment||Treatment||None (Open Label)||||||
1553989|NCT00266552|Randomized|Parallel Assignment||Treatment||Double||||||
1553990|NCT00266539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553991|NCT00266526|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553992|NCT00266513||||||||||||
1553993|NCT00266500||||||||||||
1553994|NCT00266487|Randomized|Factorial Assignment||Treatment||Double||||||
1553995|NCT00266474|||Cohort||Cross-Sectional|||||||
1553996|NCT00266461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1553997|NCT00266448|Randomized|Parallel Assignment||Treatment||Double||||||
1553998|NCT00266435|||Cohort||Prospective|||||||
1553999|NCT00266422||||||||||||
1554000|NCT00266409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554001|NCT00266396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554002|NCT00266383|||Case Control||Longitudinal, Retrospective/Prospective|||||||
1554003|NCT00266370|||Case Control||Longitudinal, Retrospective/Prospective|||||||
1554004|NCT00266357|Randomized|Crossover Assignment||Treatment||Double||||||
1554005|NCT00266344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554006|NCT00266331|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1554007|NCT00266318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554008|NCT00266305|Randomized|Parallel Assignment||Prevention||Double||||||
1554009|NCT00266292|Randomized|Factorial Assignment||Prevention||Double||||||
1554010|NCT00266279||Single Group Assignment||Treatment||None (Open Label)||||||
1554011|NCT00266266|||Cohort||Prospective|||||||
1554012|NCT00266253|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554013|NCT00266240|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554014|NCT00266227|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554015|NCT00266214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554016|NCT00266201|||Case Control||Prospective|||||||
1554017|NCT00266188|||Cohort||Prospective|||||||
1554018|NCT00266175|||||Prospective|||||||
1554019|NCT00266162|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554020|NCT00266149|Randomized|Crossover Assignment||Treatment||Double||||||
1554021|NCT00266136|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1554022|NCT00266123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554023|NCT00266110||Single Group Assignment||Treatment||None (Open Label)||||||
1554024|NCT00266097|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554025|NCT00266084||||||||||||
1554026|NCT00266071|||Defined Population||Cross-Sectional, Prospective|||||||
1554027|NCT00266058|Randomized|Parallel Assignment||||None (Open Label)||||||
1554028|NCT00266045|||Cohort||Prospective|||||||
1554029|NCT00266032|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554030|NCT00266019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554031|NCT00266006|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1554032|NCT00265993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554033|NCT00265980|Randomized|Crossover Assignment||Treatment||Single|||t|||
1554034|NCT00265967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554035|NCT00265954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554036|NCT00265941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554037|NCT00265928||||Treatment||None (Open Label)||||||
1554038|NCT00265915||||Treatment||||||||
1554039|NCT00265902||||Diagnostic||||||||
1554040|NCT00265889|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554041|NCT00265876||Single Group Assignment||Treatment||None (Open Label)||||||
1554042|NCT00265863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554043|NCT00265850|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554044|NCT00265837|Randomized|||Treatment||None (Open Label)||||||
1554045|NCT00265824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554046|NCT00265811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554047|NCT00265798||Single Group Assignment||Treatment||None (Open Label)||||||
1554048|NCT00265785||Single Group Assignment||Treatment||None (Open Label)||||||
1554049|NCT00265772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554050|NCT00265759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554051|NCT00265746|Randomized|Parallel Assignment||Prevention||Double||||||
1554052|NCT00265733||Single Group Assignment||Treatment||None (Open Label)||||||
1554053|NCT00265720|Randomized|Factorial Assignment||||None (Open Label)||||||
1554054|NCT00265707|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1554055|NCT00265694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554056|NCT00265681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554057|NCT00265655||Single Group Assignment||Treatment||None (Open Label)||||||
1554058|NCT00265642|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554059|NCT00265629|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554060|NCT00265616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554061|NCT00265603|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554062|NCT00265590||||||||||||
1554063|NCT00265564|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1554064|NCT00265551|Randomized|Parallel Assignment||Treatment||Double||||||
1554065|NCT00265538|Randomized|Factorial Assignment||||None (Open Label)||||||
1554066|NCT00265525|Randomized|Parallel Assignment||||None (Open Label)||||||
1554067|NCT00265512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554068|NCT00265499|Randomized|Crossover Assignment||Treatment||Double||||||
1554069|NCT00265486|||Case-Only||Prospective|||||||
1554070|NCT00265473||Single Group Assignment||Treatment||None (Open Label)||||||
1554071|NCT00265460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554072|NCT00265447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554073|NCT00265434|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1554074|NCT00265421|Randomized|Parallel Assignment||Treatment||Double||||||
1554075|NCT00265408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554076|NCT00265395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554077|NCT00265382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554078|NCT00265369|Randomized|Parallel Assignment||Treatment||Double||||||
1554079|NCT00265356|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1554080|NCT00265343|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554081|NCT00265330|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554082|NCT00265317|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554083|NCT00265304|Randomized|Parallel Assignment||Treatment||Double||||||
1554084|NCT00265291|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1554085|NCT00265278|Randomized|Parallel Assignment||Treatment||Double||||||
1554086|NCT00265265|Randomized|Single Group Assignment||Treatment||Double||||||
1554087|NCT00265252|Randomized|Parallel Assignment||Prevention||Double||||||
1554088|NCT00265239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554089|NCT00265226|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554090|NCT00265213|||||Prospective|||||||
1554091|NCT00265200||Single Group Assignment||Diagnostic||None (Open Label)||||||
1554092|NCT00265187|||Cohort||Prospective|||||||
1554093|NCT00265174|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1554094|NCT00265161|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1554095|NCT00265148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554096|NCT00265135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554097|NCT00265122|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1554098|NCT00265109||Single Group Assignment||Treatment||None (Open Label)||||||
1554099|NCT00265096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554100|NCT00265083|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554101|NCT00265070|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554102|NCT00265057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554103|NCT00265044|Randomized|Single Group Assignment||||None (Open Label)||||||
1554104|NCT00265031|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1554105|NCT00265018|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1554106|NCT00265005||Single Group Assignment||Treatment||None (Open Label)||||||
1554107|NCT00264992|||||Prospective|||||||
1554108|NCT00264979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554109|NCT00264966|Randomized|Crossover Assignment||Treatment||Double||||||
1554110|NCT00264953|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1554111|NCT00264940||||||||||||
1554112|NCT00264927|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554113|NCT00264914|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554114|NCT00264901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554115|NCT00264888|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554116|NCT00264875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554117|NCT00264862|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1554118|NCT00264849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554119|NCT00264823|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554120|NCT00264810|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1554121|NCT00264797|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554122|NCT00264784|||||Prospective|||||||
1554123|NCT00264771|||||Prospective|||||||
1554124|NCT00264758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554125|NCT00264745|Randomized|Parallel Assignment||||None (Open Label)||||||
1554126|NCT00264732|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1554127|NCT00264719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554128|NCT00264706||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1554129|NCT00264693|||Cohort||Prospective|||||||
1554130|NCT00264680||||||||||||
1554131|NCT00264667|Randomized|Parallel Assignment||Treatment||Double||||||
1554132|NCT00264654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554133|NCT00264641|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1554134|NCT00264628||||||||||||
1554135|NCT00264615|Non-Randomized|Single Group Assignment||Treatment||||||||
1554136|NCT00264602||Single Group Assignment||Diagnostic||None (Open Label)|There is no masking in this study. All study subjects will receive the same intervention.|||||
1554137|NCT00264589||Single Group Assignment||||None (Open Label)||||||
1554138|NCT00264576|Randomized|Parallel Assignment||Prevention||Single|||t|||
1554139|NCT00264563|||Cohort||Prospective|||||||
1554140|NCT00264550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554141|NCT00264537|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554142|NCT00264524|Non-Randomized|||Diagnostic||None (Open Label)||||||
1554143|NCT00264511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554144|NCT00264498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554145|NCT00264485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554146|NCT00264472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554147|NCT00264459|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554148|NCT00264446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554149|NCT00264433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554150|NCT00264420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554151|NCT00264407|||Case Control, Natural History||Cross-Sectional, Retrospective|||||||
1554152|NCT00264394|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554153|NCT00264381|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554154|NCT00264368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554155|NCT00264355|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1554156|NCT00264342|||Case Control||Prospective|||||||
1554157|NCT00264329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554158|NCT00264316|Randomized|Single Group Assignment||||Double||||||
1554159|NCT00264303|Randomized|Parallel Assignment||Treatment||Double||||||
1554160|NCT00264290|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554161|NCT00264277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554162|NCT00264264|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1554163|NCT00264251|Randomized|Parallel Assignment||Treatment||Double||||||
1554164|NCT00264238||Single Group Assignment||Treatment||None (Open Label)||||||
1554165|NCT00264225|Randomized|Parallel Assignment||Treatment||Double||||||
1554166|NCT00264212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554167|NCT00264199|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1554168|NCT00264186|Randomized|Parallel Assignment||||Double||||||
1554169|NCT00264173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554170|NCT00264160||Single Group Assignment||Treatment||None (Open Label)||||||
1554171|NCT00264147|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554172|NCT00264134|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554173|NCT00264121|||||Prospective|||||||
1554174|NCT00264108|||||Prospective|||||||
1554175|NCT00264095|||||Cross-Sectional|||||||
1554176|NCT00264082|||||Other|||||||
1554177|NCT00264069|||Cohort||Prospective|||||||
1554178|NCT00264056|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554179|NCT00264043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554180|NCT00264030|Randomized|Parallel Assignment||Treatment||Single||||||
1554181|NCT00264017|||Defined Population||Longitudinal, Retrospective|||||||
1554182|NCT00264004|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1554183|NCT00263991|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1554184|NCT00263978||||||||||||
1554185|NCT00263965|Randomized|Parallel Assignment||Treatment||Double||||||
1554186|NCT00263952|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554187|NCT00263939|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1554188|NCT00263926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554189|NCT00263900|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1554190|NCT00263887|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554191|NCT00263874|Randomized|Parallel Assignment||Treatment||Double||||||
1554192|NCT00263861||Single Group Assignment||Supportive Care||None (Open Label)||||||
1554193|NCT00263835|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554194|NCT00263822|Randomized|||Treatment||None (Open Label)||||||
1554195|NCT00263809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554196|NCT00263796|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554197|NCT00263783|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554198|NCT00263770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554199|NCT00263757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554200|NCT00263744|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1554201|NCT00263731|||Case Control||Prospective|||||||
1554202|NCT00263718|Randomized|Parallel Assignment||Treatment||Double||||||
1554203|NCT00263705|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554204|NCT00263692|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1554205|NCT00263679|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1554206|NCT00263666|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1554207|NCT00263653|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554208|NCT00263640|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554209|NCT00263627|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554210|NCT00263614|||||Retrospective|||||||
1554211|NCT00263601|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554212|NCT00263588|Non-Randomized|||Treatment||None (Open Label)||||||
1554213|NCT00263575|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554214|NCT00263562|Randomized|Parallel Assignment||Treatment||Double||||||
1554215|NCT00263549|Randomized|Parallel Assignment||Treatment||Double||||||
1554216|NCT00263536||||Treatment||||||||
1554217|NCT00263523||||Treatment||||||||
1554218|NCT00263497|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554219|NCT00263484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554220|NCT00263471|Randomized|Parallel Assignment||Prevention||Double||||||
1554221|NCT00263458|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554222|NCT00263445|||Case-Only||Retrospective|||||||
1554223|NCT00263432|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554224|NCT00263419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554225|NCT00263406|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554226|NCT00263393|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1554227|NCT00263380|||Case Control|Screening|Longitudinal, Prospective|||||||
1554228|NCT00263367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554229|NCT00263354|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554230|NCT00263341|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554231|NCT00263328|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554232|NCT00263315|Randomized|Parallel Assignment||Prevention||Double||||||
1554233|NCT00263302|Randomized|Parallel Assignment||Treatment||Double||||||
1554234|NCT00263289|||||Cross-Sectional, Prospective|||||||
1554235|NCT00263276|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554236|NCT00263263|Randomized|Parallel Assignment||Treatment||Double||||||
1554237|NCT00263250|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554238|NCT00263237||||Treatment||||||||
1554239|NCT00263211|Randomized|Parallel Assignment||Treatment||Single|||t|||
1554240|NCT00263198||Single Group Assignment||Treatment||None (Open Label)||||||
1554241|NCT00263185|Randomized|Factorial Assignment||Supportive Care||Triple|||t|t|t|
1554242|NCT00263172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554243|NCT00263159|Randomized|Parallel Assignment||||None (Open Label)||||||
1554244|NCT00263146|Randomized|Parallel Assignment||Treatment||Single||||||
1554245|NCT00263133|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554246|NCT00263120|||Cohort||Cross-Sectional|||||||
1554247|NCT00263107|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1554248|NCT00263094|Randomized|Parallel Assignment||Prevention||Double||||||
1554249|NCT00263081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554250|NCT00263068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554251|NCT00263055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554252|NCT00263042|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554253|NCT00263029|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554254|NCT00263016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554255|NCT00263003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554256|NCT00262990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554257|NCT00262977|Randomized|Parallel Assignment||||None (Open Label)||||||
1554258|NCT00262964|Randomized|Factorial Assignment||Treatment||Single|||t|||
1554259|NCT00262951||Single Group Assignment||Treatment||None (Open Label)||||||
1554260|NCT00262938|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1554261|NCT00262925||Single Group Assignment||Treatment||None (Open Label)||||||
1554262|NCT00262899|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554263|NCT00262886||||Treatment||None (Open Label)||||||
1554264|NCT00262873||Single Group Assignment||Treatment||None (Open Label)||||||
1554265|NCT00262860||Single Group Assignment||Treatment||None (Open Label)||||||
1554266|NCT00262847|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554267|NCT00262834||Single Group Assignment||Treatment||None (Open Label)||Patients receive oral vorinostat twice daily on days -3 to 0. Approximately 2 hours after the final dose of vorinostat, patients undergo conventional surgical resection of the tumor on day 0. After completion of study treatment, patients are followed for 30 days.||||
1554268|NCT00262821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554269|NCT00262808||||Treatment||None (Open Label)||||||
1554270|NCT00262795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554271|NCT00262782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554272|NCT00262769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554273|NCT00262743||Single Group Assignment||Treatment||None (Open Label)||||||
1554274|NCT00262730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554275|NCT00262717|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1554276|NCT00262704|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1554277|NCT00262691|||Case Control, Natural History||Longitudinal, Prospective|||||||
1554278|NCT00262678|Randomized|Crossover Assignment||Treatment||Double||||||
1554279|NCT00262665|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1554280|NCT00262652|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554281|NCT00262639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554282|NCT00262626|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554283|NCT00262613|Randomized|Parallel Assignment||Treatment||Double||||||
1554284|NCT00262600|Randomized|Parallel Assignment||Prevention||||||||
1554285|NCT00262587|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554286|NCT00262574|Randomized|Single Group Assignment||Supportive Care||Double|||t|||t
1554287|NCT00262561|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1554288|NCT00262548|Randomized|Parallel Assignment||Treatment||Double||||||
1554289|NCT00262522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554290|NCT00262509|Randomized|Crossover Assignment||||None (Open Label)||||||
1554291|NCT00262496|Randomized|Parallel Assignment||Treatment||Double||||||
1554292|NCT00262483|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1554293|NCT00262470|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1554294|NCT00262457|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554295|NCT00262444|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554296|NCT00262431|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554297|NCT00262418|Randomized|Single Group Assignment||Treatment||Double||||||
1554298|NCT00262405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554299|NCT00262392|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554300|NCT00262379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554301|NCT00262366|Randomized|Crossover Assignment||Treatment||Double||||||
1554302|NCT00262353|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554303|NCT00262340|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1554304|NCT00262327|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554305|NCT00262314|||Cohort||Prospective|||||||
1554306|NCT00262301|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554307|NCT00262288||Single Group Assignment||Treatment||None (Open Label)||||||
1554308|NCT00262275|Randomized|Parallel Assignment||Treatment||Double||||||
1554309|NCT00262262|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1554310|NCT00262249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554311|NCT00262236|Randomized|Parallel Assignment||Treatment||Double||||||
1554312|NCT00262223|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1554313|NCT00262210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554314|NCT00262197|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1554315|NCT00262184|Randomized|Parallel Assignment||Prevention||Double||||||
1554316|NCT00262171|||Family-Based||Prospective|||||||
1554317|NCT00262158|Random Sample||||Cross-Sectional, Retrospective|||||||
1554318|NCT00262145|Randomized|Crossover Assignment||Treatment||Double||||||
1554319|NCT00262132|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1554320|NCT00262119|Randomized|Parallel Assignment||Prevention||Single|||t|||
1554321|NCT00262106|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1554322|NCT00262093|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1554323|NCT00262080|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554324|NCT00262067|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554325|NCT00262054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554326|NCT00262041|Randomized|Parallel Assignment||Prevention||Single||||||
1554327|NCT00262028|Randomized|Parallel Assignment||Prevention||Single||||||
1554328|NCT00262015|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554329|NCT00262002|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554330|NCT00261989|||||Retrospective|||||||
1554331|NCT00261976|||Cohort||Prospective|||||||
1554332|NCT00261963|Randomized|Single Group Assignment||Prevention||Single||||||
1554333|NCT00261950||Single Group Assignment||Treatment||None (Open Label)||||||
1554334|NCT00261937|Randomized|Parallel Assignment||Treatment||Double||||||
1554335|NCT00261924|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1554336|NCT00261911|Randomized|Parallel Assignment||Treatment||Double||||||
1554337|NCT00261898||||Treatment||||||||
1554338|NCT00261872||||Treatment||||||||
1554339|NCT00261859|Randomized|Factorial Assignment||||Triple|||t|t|t|
1554340|NCT00261846||Single Group Assignment||Treatment||None (Open Label)||||||
1554341|NCT00261833|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554342|NCT00261820|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554343|NCT00261807||Single Group Assignment||Treatment||None (Open Label)||||||
1554344|NCT00261794|Randomized|Single Group Assignment||Treatment||Single||||||t
1554345|NCT00261781|Randomized|Parallel Assignment||Treatment||Single||||||t
1554346|NCT00261768|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1554347|NCT00261755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554348|NCT00261742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554349|NCT00261729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554350|NCT00261716|Randomized|Parallel Assignment||Treatment||Single||||||t
1554351|NCT00261703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554352|NCT00261690|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554353|NCT00261677|Randomized|Parallel Assignment||Treatment||Double||||||
1554354|NCT00261664|Randomized|Single Group Assignment||Treatment||Single||||||
1554355|NCT00261638|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1554356|NCT00261625|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554357|NCT00261612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554358|NCT00261599|Randomized|Parallel Assignment||Treatment||Double||||||
1554359|NCT00261586|Randomized|Parallel Assignment||Treatment||Single||||||
1554360|NCT00261573|Randomized|Parallel Assignment||Treatment||Double||||||
1554361|NCT00261560|Randomized|Parallel Assignment||Treatment||Double||||||
1554362|NCT00261547|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554363|NCT00261534|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1554364|NCT00261521|Randomized|Parallel Assignment||Treatment||Double||||||
1554365|NCT00261508|Randomized|Parallel Assignment||Treatment||Double||||||
1554366|NCT00261495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554367|NCT00261482|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554368|NCT00261469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554369|NCT00261456|||Case-Control||Prospective|||||||
1554370|NCT00261443|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554371|NCT00261430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554372|NCT00261417|Randomized|Parallel Assignment||Treatment||Double||||||
1554373|NCT00261404||||||||||||
1554374|NCT00261391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554375|NCT00261378|Randomized|Parallel Assignment||Treatment||Single||||||
1554376|NCT00261365|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1554377|NCT00261352|Randomized|Parallel Assignment||Treatment||Double||||||
1554378|NCT00261339|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554379|NCT00261326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554380|NCT00261313|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554381|NCT00261300|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554382|NCT00261287|Randomized|Parallel Assignment||Treatment||Double||||||
1554383|NCT00261274|Randomized|Parallel Assignment||Treatment||Double||||||
1554384|NCT00261261|Randomized|Parallel Assignment||Treatment||Single||||||
1554385|NCT00261248|Randomized|Parallel Assignment||Prevention||Double||||||
1554386|NCT00261235|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554387|NCT00261222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554388|NCT00261209||Single Group Assignment||Treatment||None (Open Label)||||||
1554389|NCT00261196|Randomized|Single Group Assignment||Treatment||Double||||||
1554390|NCT00261183|Randomized|Crossover Assignment||Treatment||Double||||||
1554391|NCT00261170|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554392|NCT00261157|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1554393|NCT00261144||Single Group Assignment||Treatment||Double|||t||t|
1554394|NCT00261131|Randomized|Single Group Assignment||Treatment||Double||||||
1554395|NCT00261118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554396|NCT00261105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554397|NCT00261092|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554398|NCT00261079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554399|NCT00261066|||Cohort||Prospective|||||||
1554400|NCT00261053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554401|NCT00261040|Randomized|Parallel Assignment||||Single|||t|||
1554402|NCT00261027|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554403|NCT00261014|||||Prospective|||||||
1554404|NCT00261001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554405|NCT00260988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554406|NCT00260975|||Cohort||Prospective|||||||
1554407|NCT00260962|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554408|NCT00260949|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554409|NCT00260936|||Case-Control||Cross-Sectional|||||||
1554410|NCT00260923|Randomized|Parallel Assignment||Treatment||Double||||||
1554411|NCT00260910|||Family-Based||Retrospective|||||||
1554412|NCT00260897|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1554413|NCT00260884|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554414|NCT00260871|||Case Control||Prospective|||||||
1554415|NCT00260858|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554416|NCT00260832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554417|NCT00260819|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1554418|NCT00260806|||Cohort||Prospective|||||||
1554419|NCT00260793|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554420|NCT00260780|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1554421|NCT00260767|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554422|NCT00260754|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1554423|NCT00260741|Randomized|Parallel Assignment||Treatment||Double||||||
1554424|NCT00260728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554425|NCT00260715|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1554426|NCT00260702||||Treatment||||||||
1554427|NCT00260689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554428|NCT00260676|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554429|NCT00260663|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1554430|NCT00260650|Randomized|Parallel Assignment||||None (Open Label)||||||
1554431|NCT00260637|Randomized|Parallel Assignment||Treatment||Double||||||
1554432|NCT00260624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554433|NCT00260611||Single Group Assignment||Treatment||None (Open Label)||||||
1554434|NCT00260598|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1554435|NCT00260585|||Other||Prospective|||||||
1554436|NCT00260572|||Case-Only||Prospective|||||||
1554437|NCT00260559|||Case-Only||Prospective|||||||
1554438|NCT00260546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554439|NCT00260533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554440|NCT00260520||||||||||||
1554441|NCT00260494|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1554442|NCT00260481|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1554443|NCT00260468|||Case Control||Cross-Sectional|||||||
1554444|NCT00260442|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1554445|NCT00260429|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1554446|NCT00260416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554447|NCT00260403|Randomized|Parallel Assignment||Treatment||Single||||||
1554448|NCT00260390|Randomized|Parallel Assignment||Treatment||Double||||||
1554449|NCT00260377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554450|NCT00260364|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554451|NCT00260351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554452|NCT00260338|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554453|NCT00260325|Randomized|Crossover Assignment||Prevention||Double||||||
1554454|NCT00260312|Randomized|Parallel Assignment||Prevention||Double||||||
1554455|NCT00260299|||Case-Only||Prospective|||||||
1554456|NCT00260286|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1554457|NCT00260273|Randomized|Parallel Assignment||Prevention||Single||||||t
1554458|NCT00260260|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554459|NCT00260247|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554460|NCT00260234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554461|NCT00260221|Randomized|Parallel Assignment||Treatment||Single||||t||
1554462|NCT00260208|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554463|NCT00260195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554464|NCT00260182|||Cohort||Retrospective|||||||
1554465|NCT00260169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554466|NCT00260156|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554467|NCT00260143|Randomized|Parallel Assignment||Other||Quadruple|||t|t|t|t
1554468|NCT00260130|Randomized|Crossover Assignment||||None (Open Label)||||||
1554469|NCT00260117|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554470|NCT00260104|||||Retrospective|||||||
1554471|NCT00260091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554472|NCT00260078|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554473|NCT00260065|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554474|NCT00260052||Single Group Assignment||Treatment||Double|||t||t|
1554475|NCT00260039|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1554476|NCT00260026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554477|NCT00260013|Randomized|Parallel Assignment||Treatment||Single||||||
1554478|NCT00260000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554479|NCT00259987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554480|NCT00259974|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1554481|NCT00259961|||Defined Population||Longitudinal, Prospective|||||||
1554482|NCT00259948|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1554483|NCT00259935|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554484|NCT00259922|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554485|NCT00259909|||Cohort||Prospective|||||||
1554486|NCT00259896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554487|NCT00259883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554488|NCT00259870|Randomized|Parallel Assignment||Treatment||Double||||||
1554489|NCT00259857|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1554490|NCT00259844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554491|NCT00259831|Randomized|Parallel Assignment||Prevention||Double||||||
1554492|NCT00259818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554493|NCT00259805||Single Group Assignment||Treatment||None (Open Label)||||||
1554494|NCT00259792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554495|NCT00259779|Randomized|Parallel Assignment||Treatment||Double||||||
1554496|NCT00259766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554497|NCT00259753|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554498|NCT00259740||Single Group Assignment||Treatment||None (Open Label)||||||
1554499|NCT00259727||||||||||||
1554500|NCT00259714|Randomized|Crossover Assignment||Treatment||Single|||t|||
1554501|NCT00259701|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1554502|NCT00259688|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1554503|NCT00259675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554504|NCT00259662|Randomized|Parallel Assignment||||Double||||||
1554505|NCT00259649|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554506|NCT00259636|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554507|NCT00259623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554508|NCT00259610|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1554509|NCT00259597|||Cohort||Prospective|||||||
1554510|NCT00259584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554511|NCT00259571|Randomized|Parallel Assignment||Prevention||Double||||||
1554512|NCT00259558|Randomized|Parallel Assignment||Treatment||Double||||||
1554513|NCT00259545|Randomized|Parallel Assignment||Treatment||Double||||||
1554514|NCT00259532|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1554515|NCT00259519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554516|NCT00259506|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554517|NCT00259493|Randomized|Single Group Assignment||Treatment||Double||||||
1554518|NCT00259480|Randomized|Single Group Assignment||||Single|||||t|
1554519|NCT00259467|Randomized|Single Group Assignment||||Double||||||
1554520|NCT00259454|Randomized|Single Group Assignment||||None (Open Label)||||||
1554521|NCT00259441|Randomized|Parallel Assignment||Prevention||Double||||||
1554522|NCT00259428|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554523|NCT00259415|Randomized|Single Group Assignment||||Single||||||
1554524|NCT00259402|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554525|NCT00259389|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554526|NCT00259376|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554527|NCT00259363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554528|NCT00259350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554529|NCT00259337|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554530|NCT00259324|Randomized|Parallel Assignment||Treatment||Single||||||t
1554531|NCT00259311|Randomized|Parallel Assignment||Treatment||Double||||||
1554532|NCT00259298||Single Group Assignment||Treatment||None (Open Label)||||||
1554533|NCT00259285|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554534|NCT00259272||Single Group Assignment||Treatment||None (Open Label)||||||
1554535|NCT00259259|Randomized|Crossover Assignment||Prevention||Double||||||
1554536|NCT00259246|Randomized|Crossover Assignment||Treatment||Single||||||
1554537|NCT00259233|Non-Randomized|Crossover Assignment||Treatment||Single||||||
1554538|NCT00259220|Randomized|Parallel Assignment||Treatment||Single||||||t
1554539|NCT00259207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554540|NCT00259194|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554541|NCT00259181|Non-Randomized|Single Group Assignment||Prevention||Single||||||
1554542|NCT00259168|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554543|NCT00259155|Randomized|Parallel Assignment||Treatment||Double||||||
1554544|NCT00259142|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554545|NCT00259129|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1554546|NCT00259116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554547|NCT00259103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554548|NCT00259090|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554549|NCT00259077|Randomized|Parallel Assignment||Treatment||Double||||||
1554550|NCT00259064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554551|NCT00259051|Randomized|Parallel Assignment||Treatment||Double||||||
1554552|NCT00259038|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554553|NCT00259025|Randomized|Parallel Assignment||Prevention||Single|||t|||
1554554|NCT00259012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554555|NCT00258999|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1554556|NCT00258986|Randomized|Parallel Assignment||Treatment||Double||||||
1554557|NCT00258973|||||Prospective|||||||
1554558|NCT00258960|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554559|NCT00258947|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1554560|NCT00258934|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554561|NCT00258921|||||Prospective|||||||
1554562|NCT00258908|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554563|NCT00258895|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554564|NCT00258882|||Cohort||Other|||||||
1554565|NCT00258869|||Cohort||Prospective|||||||
1554566|NCT00258856|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554567|NCT00258843|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554568|NCT00258830|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554569|NCT00258817|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554570|NCT00258804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554571|NCT00258791|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1554572|NCT00258778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554573|NCT00258765|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554574|NCT00258752|Randomized|Parallel Assignment||Prevention||Single||||||t
1554575|NCT00258739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554576|NCT00258726|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554577|NCT00258713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554578|NCT00258700|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554579|NCT00258687|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554580|NCT00258674|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1554581|NCT00258661|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1554582|NCT00258635|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554583|NCT00258622|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1554584|NCT00258609|Randomized|Parallel Assignment||Prevention||Double||||||
1554585|NCT00258596|Randomized|Parallel Assignment||Treatment||Single||||||
1554586|NCT00258583|||Cohort||Other|||||||
1554587|NCT00258570|||Cohort||Other|||||||
1554588|NCT00258557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554589|NCT00258544|||Cohort||Other|||||||
1554590|NCT00258531|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1554591|NCT00258518|||Cohort||Prospective|||||||
1554592|NCT00258505|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1554593|NCT00258492|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554594|NCT00258479|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1554595|NCT00258466|Randomized|||Treatment||||||||
1554596|NCT00258453||||Diagnostic||None (Open Label)||||||
1554597|NCT00258440|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1554598|NCT00258427||Single Group Assignment||Treatment||None (Open Label)||||||
1554599|NCT00258401|Randomized|Parallel Assignment||||None (Open Label)||||||
1554600|NCT00258388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554601|NCT00258375|Non-Randomized|||Treatment||None (Open Label)||||||
1554602|NCT00258362||Single Group Assignment||Treatment||None (Open Label)||||||
1554603|NCT00258349||Single Group Assignment||Treatment||None (Open Label)||||||
1554604|NCT00258336||||Treatment||None (Open Label)||||||
1554605|NCT00258323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554606|NCT00258310||Single Group Assignment||Treatment||None (Open Label)||||||
1554607|NCT00258297||||Treatment||None (Open Label)||||||
1554608|NCT00258284||Single Group Assignment||Treatment||None (Open Label)||||||
1554609|NCT00258271||||Treatment||||||||
1554610|NCT00258258||||Treatment||None (Open Label)||||||
1554611|NCT00258245||Single Group Assignment||Treatment||None (Open Label)||||||
1554612|NCT00258232||||Treatment||None (Open Label)||||||
1554613|NCT00258206||Single Group Assignment||Treatment||None (Open Label)||||||
1554614|NCT00258193|Randomized|Parallel Assignment||Treatment||Double||||||
1554615|NCT00258180||Single Group Assignment||Supportive Care||None (Open Label)||||||
1554616|NCT00258167|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1554617|NCT00258154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554618|NCT00258141|Randomized|Crossover Assignment||Prevention||Double||||||
1554619|NCT00258128|Randomized|Parallel Assignment||||Double||||||
1554620|NCT00258115|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1554621|NCT00258102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554622|NCT00258089|Randomized|Parallel Assignment||Treatment||Double||||||
1554623|NCT00258076|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554624|NCT00258063|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554625|NCT00258050|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554626|NCT00258037|Randomized|Parallel Assignment||Treatment||Single||||||
1554627|NCT00258024|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554628|NCT00258011||Single Group Assignment||Treatment||None (Open Label)||||||
1554629|NCT00257998|Randomized|Parallel Assignment||Treatment||Single||||||t
1554630|NCT00257985|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||Single||||||
1554631|NCT00257972|Randomized|Parallel Assignment||Treatment||Double||||||
1554632|NCT00257959|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554633|NCT00257946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554634|NCT00257933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554635|NCT00257920|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554636|NCT00257907||||||||||||
1554637|NCT00257894|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1554638|NCT00257881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554639|NCT00257868|Randomized|Parallel Assignment||Prevention||Double||||||
1554640|NCT00257855|Randomized|Parallel Assignment||Treatment||Double||||||
1554641|NCT00257842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554642|NCT00257829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554643|NCT00257816||Single Group Assignment||Treatment||None (Open Label)||||||
1554644|NCT00257803|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1554645|NCT00257790|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554646|NCT00257777|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554647|NCT00257764|Randomized|Parallel Assignment||Treatment||Single||||||
1554648|NCT00257751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554649|NCT00257738|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554650|NCT00257725|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554651|NCT00257712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554652|NCT00257699|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554653|NCT00257686|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554654|NCT00257673|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1554655|NCT00257660|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554656|NCT00257647|||||Prospective|||||||
1554657|NCT00257634|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554658|NCT00257621||Single Group Assignment||Treatment||None (Open Label)||||||
1554659|NCT00257608|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554660|NCT00257595|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554661|NCT00257582|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554662|NCT00257569|Randomized|Parallel Assignment||Treatment||Double||||||
1554663|NCT00257556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554664|NCT00257543||Single Group Assignment||Treatment||None (Open Label)||||||
1554665|NCT00257530|Randomized|Parallel Assignment||Treatment||Double||||||
1554666|NCT00257517|||Cohort||Prospective|||||||
1554667|NCT00257504|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1554668|NCT00257491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554669|NCT00257478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554670|NCT00257465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554671|NCT00257452|Randomized|Crossover Assignment||Treatment||Double||||||
1554672|NCT00257439|||Cohort||Prospective|||||||
1554673|NCT00257426||Single Group Assignment||Treatment||None (Open Label)||||||
1554674|NCT00257413|Randomized|Parallel Assignment||Treatment||Single||||||
1554675|NCT00257400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554676|NCT00257387|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554677|NCT00257374|Randomized|Parallel Assignment||Treatment||Double||||||
1554678|NCT00257361|Randomized|Single Group Assignment||||None (Open Label)||||||
1554679|NCT00257348||Single Group Assignment||Treatment||None (Open Label)||||||
1554680|NCT00257335|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554681|NCT00257322||Single Group Assignment||Treatment||None (Open Label)||||||
1554682|NCT00257309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554683|NCT00257296|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1554684|NCT00257283|Randomized|Parallel Assignment||Treatment||Double||||||
1554685|NCT00257270|Non-Randomized|Crossover Assignment||Treatment||Single||||||
1554686|NCT00257257|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554687|NCT00257244|||Cohort||Prospective|||||||
1554688|NCT00257231|||Cohort||Prospective|||||||
1554689|NCT00257218|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1554690|NCT00257205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554691|NCT00257192|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554692|NCT00257179|Random Sample||Natural History||Cross-Sectional, Prospective|||||||
1554693|NCT00257166|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554694|NCT00257153|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554695|NCT00257140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554696|NCT00257127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554697|NCT00257114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554698|NCT00257101|Randomized|||Treatment||||||||
1554699|NCT00257088|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554700|NCT00257075|Randomized|Parallel Assignment||Treatment||Double||||||
1554701|NCT00257062|Randomized|Parallel Assignment||Treatment||Double||||||
1554702|NCT00257049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554703|NCT00257036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554704|NCT00257023|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554705|NCT00257010||Single Group Assignment||Treatment||None (Open Label)||||||
1554706|NCT00256997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554707|NCT00256984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554708|NCT00256971|||||Prospective|||||||
1554709|NCT00256958|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1554710|NCT00256945|Non-Randomized|Single Group Assignment||Prevention||Single||||||
1554711|NCT00256932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554712|NCT00256919|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554713|NCT00256906|||Cohort||Retrospective|||||||
1554714|NCT00256893|Randomized|Parallel Assignment||Treatment||Double||||||
1554715|NCT00256880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554716|NCT00256867|Randomized|Parallel Assignment||Treatment||||||||
1554717|NCT00256854|Randomized|Parallel Assignment||Treatment||||||||
1554718|NCT00256841|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554719|NCT00256828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554720|NCT00256815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554721|NCT00256802|Randomized|Crossover Assignment||Diagnostic||Double||||||
1554722|NCT00256789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554723|NCT00256776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554724|NCT00256750|Randomized|Parallel Assignment||Treatment||Single|||t|||
1554725|NCT00256737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554726|NCT00256724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554727|NCT00256711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554728|NCT00256698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554729|NCT00256685|Randomized|Single Group Assignment||Treatment||Double||||||
1554730|NCT00256672|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554731|NCT00256659|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554732|NCT00256646|||Cohort|||||||||
1554733|NCT00256633|||Cohort|||||||||
1554734|NCT00256620|Randomized|Factorial Assignment||Prevention||Single||||||
1554735|NCT00256607|||Cohort||Prospective|||||||
1554736|NCT00256594|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1554737|NCT00256581|||Case Control||Prospective|||||||
1554738|NCT00256568|||Cohort||Prospective|||||||
1554739|NCT00256555|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554740|NCT00256542|Randomized|Single Group Assignment||Treatment||Double||||||
1554741|NCT00256529|||||Prospective|||||||
1554742|NCT00256516|Randomized|Parallel Assignment||Treatment||Single||||||
1554743|NCT00256503|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1554744|NCT00256490|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1554745|NCT00256477|Randomized|Single Group Assignment||Educational/Counseling/Training||Single||||||
1554746|NCT00256464|Randomized|Single Group Assignment||Educational/Counseling/Training||Single||||||
1554747|NCT00256451|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1554748|NCT00256438|Randomized|Parallel Assignment||Treatment||Double||||||
1554749|NCT00256425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554750|NCT00256412|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554751|NCT00256399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554752|NCT00256386|Randomized|Parallel Assignment||Prevention||Single||||||
1554753|NCT00256373|Randomized|Parallel Assignment||Treatment||Single||||||
1554754|NCT00256360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554755|NCT00256347|Randomized|Crossover Assignment||||Double||||||
1554756|NCT00256334||Single Group Assignment||Treatment||None (Open Label)||||||
1554757|NCT00256321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554758|NCT00256308||Single Group Assignment||Treatment||None (Open Label)||||||
1554759|NCT00256295||Single Group Assignment||Treatment||None (Open Label)||||||
1554760|NCT00256282||Single Group Assignment||Treatment||None (Open Label)||||||
1554761|NCT00256269||Single Group Assignment||Treatment||None (Open Label)||||||
1554762|NCT00256256|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1554763|NCT00256243||Single Group Assignment||Treatment||None (Open Label)||||||
1554764|NCT00256230||Single Group Assignment||Treatment||None (Open Label)||||||
1554765|NCT00256217||Single Group Assignment||Treatment||None (Open Label)||||||
1554766|NCT00256204|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554767|NCT00256191|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554768|NCT00256178|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554769|NCT00256165|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1554770|NCT00256152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554771|NCT00256139|Randomized|Parallel Assignment||Treatment||Double||||||
1554772|NCT00256126|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554773|NCT00256113|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554774|NCT00256100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554775|NCT00256087|Randomized|Parallel Assignment||Prevention||Double||||||
1554776|NCT00256074|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554777|NCT00256061|||||Retrospective|||||||
1554778|NCT00256048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554779|NCT00256035|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1554780|NCT00256022|Randomized|Parallel Assignment||Prevention||Double||||||
1554781|NCT00256009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554782|NCT00255996|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554783|NCT00255983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554784|NCT00255970|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1554785|NCT00255957|Randomized|Parallel Assignment||Treatment||Double||||||
1554786|NCT00255944|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554787|NCT00255931|Randomized|Parallel Assignment||Treatment||Single||||||t
1554788|NCT00255918|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1554789|NCT00255905|Randomized|Parallel Assignment||Prevention||Single||||||
1554790|NCT00255892|||Case-Control||Cross-Sectional|||||||
1554791|NCT00255879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554792|NCT00255866|Randomized|Parallel Assignment||||None (Open Label)||||||
1554793|NCT00255840|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554794|NCT00255827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554795|NCT00255814|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554796|NCT00255801||Single Group Assignment||Treatment||None (Open Label)||||||
1554797|NCT00255788|Randomized|||Treatment||None (Open Label)||||||
1554798|NCT00255775||||Prevention||None (Open Label)||||||
1554799|NCT00255762||Single Group Assignment||Treatment||None (Open Label)||||||
1554800|NCT00255749|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1554801|NCT00255723|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554802|NCT00255710||||Supportive Care||None (Open Label)||||||
1554803|NCT00255697|||Cohort||Cross-Sectional|||||||
1554804|NCT00255684||Single Group Assignment||Treatment||None (Open Label)||||||
1554805|NCT00255671|||Case-Only||Prospective|||||||
1554806|NCT00255658||Single Group Assignment||Treatment||None (Open Label)||||||
1554807|NCT00255645|||||Prospective|||||||
1554808|NCT00255619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554809|NCT00255606|Randomized|||Treatment||||||||
1554810|NCT00255593|Randomized|Parallel Assignment||Prevention||Double||||||
1554811|NCT00255580|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1554812|NCT00255567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554813|NCT00255554|Randomized|Parallel Assignment||Treatment||Double||||||
1554814|NCT00255541|Randomized|Parallel Assignment||Treatment||Double||||||
1554815|NCT00255528|Randomized|Parallel Assignment||Treatment||Double||||||
1554816|NCT00255515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554817|NCT00255502|Randomized|Parallel Assignment||Treatment||Double||||||
1554818|NCT00255489|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554819|NCT00255476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554820|NCT00255463|Randomized|Parallel Assignment||Treatment||Double||||||
1554821|NCT00255450|Randomized|Crossover Assignment||Treatment||Double||||||
1554822|NCT00255437|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554823|NCT00255424|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554824|NCT00255411||||||||||||
1554825|NCT00255398|||Cohort||Prospective|||||||
1554826|NCT00255385|Randomized|Parallel Assignment||Prevention||Double||||||
1554827|NCT00255372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554828|NCT00255359|Randomized|Single Group Assignment||Treatment||Double||||||
1554829|NCT00255346||Single Group Assignment||Treatment||None (Open Label)||||||
1554830|NCT00255333|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554831|NCT00255320|Randomized|Crossover Assignment||Diagnostic||Double||||||
1554832|NCT00255307|Randomized|Parallel Assignment||Treatment||Double||||||
1554833|NCT00255294|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554834|NCT00255281|Randomized|Parallel Assignment||Treatment||Double||||||
1554835|NCT00255268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554836|NCT00255255|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554837|NCT00255242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554838|NCT00255229|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554839|NCT00255216|Randomized|Parallel Assignment||Treatment||Double||||||
1554840|NCT00255190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554841|NCT00255177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554842|NCT00255164|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1554843|NCT00255151|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1554844|NCT00255138|Randomized|Crossover Assignment||Treatment||Double||||||
1554845|NCT00255125|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1554846|NCT00255112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554847|NCT00255099|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554848|NCT00255086|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554849|NCT00255073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554850|NCT00255060|||Cohort||Prospective|||||||
1554851|NCT00255047|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554852|NCT00255034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554853|NCT00255021|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554854|NCT00255008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554855|NCT00254995|||Cohort|||||||||
1554856|NCT00254982|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554857|NCT00254969|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554858|NCT00254956|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554859|NCT00254930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554860|NCT00254917|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554861|NCT00254904|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554862|NCT00254891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554863|NCT00254878|Randomized|Crossover Assignment||Treatment||Double||||||
1554864|NCT00254865|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554865|NCT00254852|Randomized|Parallel Assignment||Treatment||Single|||t|||
1554866|NCT00254839|||||Cross-Sectional, Prospective|||||||
1554867|NCT00254826|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1554868|NCT00254813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554869|NCT00254800|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1554870|NCT00254787|Randomized|Parallel Assignment||Treatment||Double||||||
1554871|NCT00254774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554872|NCT00254761|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1554873|NCT00254748|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1554874|NCT00254735|Randomized|Parallel Assignment||Treatment||Double||||||
1554875|NCT00254722||Single Group Assignment||Treatment||None (Open Label)||||||
1554876|NCT00254709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554877|NCT00254696|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554878|NCT00254683|Non-Randomized|Single Group Assignment||Diagnostic||Double|||||t|t
1554879|NCT00254670|Randomized|Crossover Assignment||Treatment||Double||||||
1554880|NCT00254657|Randomized|Factorial Assignment||Treatment||Double||||||
1554881|NCT00254644|||Case Control||Prospective|||||||
1554882|NCT00254631|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1554883|NCT00254618|Randomized|Parallel Assignment||||None (Open Label)||||||
1554884|NCT00254605|||Case-Control||Prospective|||||||
1554885|NCT00254592||Single Group Assignment||Treatment||None (Open Label)||||||
1554886|NCT00254579|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554887|NCT00254566|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554888|NCT00254553|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1554889|NCT00254540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554890|NCT00254527|Random Sample|||Screening|Cross-Sectional, Retrospective/Prospective|||||||
1554891|NCT00254514|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554892|NCT00254501|Randomized|Parallel Assignment||Treatment||Single|||t|||
1554893|NCT00254488|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1554894|NCT00254475|Randomized|Single Group Assignment||Treatment||Double||||||
1554895|NCT00254462|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1554896|NCT00254449|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554897|NCT00254436|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1554898|NCT00254423|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554899|NCT00254410||Single Group Assignment||Treatment||None (Open Label)||||||
1554900|NCT00254397|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554901|NCT00254384||Single Group Assignment||Treatment||None (Open Label)||||||
1554902|NCT00254371|Randomized|Parallel Assignment||Treatment||Double||||||
1554903|NCT00254358|||Cohort||Cross-Sectional|||||||
1554904|NCT00254345|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1554905|NCT00254332|||||Prospective|||||||
1554906|NCT00254319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554907|NCT00254306|||Case Control||Cross-Sectional|||||||
1554908|NCT00254293|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554909|NCT00254280|Randomized|Parallel Assignment||||Single||||||
1554910|NCT00254267||Single Group Assignment||Treatment||None (Open Label)||||||
1554911|NCT00254254|Randomized|Crossover Assignment||Treatment||Single|||t|||
1554912|NCT00254241|Randomized|Parallel Assignment||Treatment||Single||||||
1554913|NCT00254228|Randomized|Parallel Assignment||Treatment||Double||||||
1554914|NCT00254215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554915|NCT00254202|Randomized|Parallel Assignment||Treatment||Double||||||
1554916|NCT00254189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554917|NCT00254176|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1554918|NCT00254163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554919|NCT00254150|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554920|NCT00254137|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554921|NCT00254124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554922|NCT00254111|Randomized|Single Group Assignment||Treatment||Double||||||
1554923|NCT00254085|Randomized|Crossover Assignment||Treatment||Double||||||
1554924|NCT00254072|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554925|NCT00254059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554926|NCT00254046|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554927|NCT00254033|Randomized|Crossover Assignment||Treatment||Double||||||
1554928|NCT00254020||Single Group Assignment||Treatment||None (Open Label)||||||
1554929|NCT00254007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554930|NCT00253994|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1554931|NCT00253981|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554932|NCT00253968|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554933|NCT00253955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554934|NCT00253942|Randomized|Parallel Assignment||Treatment||Double||||||
1554935|NCT00253929|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1554936|NCT00253916|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554937|NCT00253903|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1554938|NCT00253890|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554939|NCT00253877|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554940|NCT00253864|||Other||Prospective|||||||
1554941|NCT00253851|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1554942|NCT00253838|Randomized|Parallel Assignment||Treatment||Single|||t|||
1554943|NCT00253825|Randomized|Parallel Assignment||Treatment||Single||||||
1554944|NCT00253812|Non-Randomized|Crossover Assignment||Diagnostic||Single||||||
1554945|NCT00253799|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554946|NCT00253786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554947|NCT00253773|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1554948|NCT00253760|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1554949|NCT00253747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1554950|NCT00253734|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1554951|NCT00253721||Single Group Assignment||Treatment||None (Open Label)||||||
1554952|NCT00253708|Randomized|Parallel Assignment||Supportive Care||Double||The study was designed to assess the feasibility and effectiveness of massage for patients with cancer-related pain|||t|t
1554953|NCT00253695|||Case Control||Prospective|||||||
1554954|NCT00253682|||Cohort||Prospective|||||||
1554955|NCT00253669|||Case-Control||Prospective|||||||
1554956|NCT00253643|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1554957|NCT00253630||Single Group Assignment||Treatment||None (Open Label)||||||
1554958|NCT00253617||||Treatment||||||||
1554959|NCT00253591|Randomized|||Treatment||None (Open Label)||||||
1554960|NCT00253578||Single Group Assignment||Treatment||None (Open Label)||||||
1554961|NCT00253565||||Treatment||||||||
1554962|NCT00253552||||Treatment||||||||
1554963|NCT00253539|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1554964|NCT00253526||||Treatment||||||||
1554965|NCT00253513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1554966|NCT00253500||Single Group Assignment||Treatment||None (Open Label)||||||
1554967|NCT00253487||||Treatment||||||||
1554968|NCT00253474||||Treatment||||||||
1554969|NCT00253461||Single Group Assignment||Diagnostic||None (Open Label)||||||
1554970|NCT00253448||Single Group Assignment||Treatment||None (Open Label)||||||
1554971|NCT00253435||Single Group Assignment||Treatment||None (Open Label)||||||
1554972|NCT00253422|Randomized|||Treatment||Double||||||
1554973|NCT00253409|Randomized|||Treatment||||||||
1554974|NCT00253396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1554975|NCT00253383|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1554976|NCT00253370||Single Group Assignment||Treatment||None (Open Label)||||||
1554977|NCT00253357|||||Prospective|||||||
1554978|NCT00253344||Single Group Assignment||Treatment||None (Open Label)||||||
1554979|NCT00253331|Randomized|Crossover Assignment||Prevention||Double||||||
1554980|NCT00253318||Single Group Assignment||Treatment||None (Open Label)||||||
1554981|NCT00253305|Randomized|Single Group Assignment||Treatment||Double||||||
1554982|NCT00253292|||Cohort||Prospective|||||||
1554983|NCT00253279|||Case Control||Prospective|||||||
1554984|NCT00253266|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1554985|NCT00253253|||||Retrospective|||||||
1554986|NCT00253240|||||Other|||||||
1554987|NCT00253227|Randomized|Parallel Assignment||Treatment||Double||||||
1554988|NCT00253214|Randomized|Parallel Assignment||Treatment||Double||||||
1554989|NCT00253201|Randomized|Parallel Assignment||Treatment||Double||||||
1554990|NCT00253188|Randomized|Parallel Assignment||Treatment||Double||||||
1554991|NCT00253175|Randomized|Parallel Assignment||Treatment||Double||||||
1554992|NCT00253162|Randomized|Parallel Assignment||Treatment||Double||||||
1554993|NCT00253149|Randomized|Parallel Assignment||Treatment||Double||||||
1554994|NCT00253136|Randomized|Parallel Assignment||Treatment||Double||||||
1554995|NCT00253123|Randomized|Parallel Assignment||Treatment||Double||||||
1554996|NCT00253110|Randomized|Parallel Assignment||Treatment||Double||||||
1554997|NCT00253097|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1554998|NCT00253084|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1554999|NCT00253071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555000|NCT00253058|Randomized|Parallel Assignment||Treatment||Double||||||
1555001|NCT00253045|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1555002|NCT00253032||||||||||||
1555003|NCT00253019|||Cohort||Prospective|||||||
1555004|NCT00253006|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1555005|NCT00252993|Randomized|Parallel Assignment||Treatment||Double||||||
1555006|NCT00252980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555007|NCT00252967|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1555008|NCT00252954|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1555009|NCT00252941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555010|NCT00252928|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1555011|NCT00252915|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555012|NCT00252902|Randomized|Parallel Assignment||||Single||||||
1555013|NCT00252889|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555014|NCT00252876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555015|NCT00252863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555016|NCT00252850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555017|NCT00252837|Randomized|Parallel Assignment||Treatment||Double||||||
1555018|NCT00252824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555019|NCT00252811|Randomized|Parallel Assignment||Treatment||Double||||||
1555020|NCT00252798|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555021|NCT00252785|Randomized|Parallel Assignment||Treatment||Double||||||
1555022|NCT00252772|Randomized|Parallel Assignment||Treatment||Double||||||
1555023|NCT00252759|||||Prospective|||||||
1555024|NCT00252746|Randomized|Parallel Assignment||Treatment||Double||||||
1555025|NCT00252733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555026|NCT00252720|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555027|NCT00252707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555028|NCT00252694|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555029|NCT00252681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555030|NCT00252668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555031|NCT00252655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555032|NCT00252642|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555033|NCT00252629|Randomized|Parallel Assignment||Treatment||Single|||t|||
1555034|NCT00252616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555035|NCT00252603|Randomized|Single Group Assignment||Treatment||Double||||||
1555036|NCT00252590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555037|NCT00252577|||||Prospective|||||||
1555038|NCT00252564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555039|NCT00252551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555040|NCT00252538|||Cohort||Prospective|||||||
1555041|NCT00252525|||Cohort|||||||||
1555042|NCT00252512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555043|NCT00252499|Randomized|Parallel Assignment||Basic Science||Triple|||t|t|t|
1555044|NCT00252486||Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1555045|NCT00252473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555046|NCT00252460|||||Prospective|||||||
1555047|NCT00252447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555048|NCT00252434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555049|NCT00252421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555050|NCT00252408|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555051|NCT00252395|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555052|NCT00252382||Single Group Assignment||Treatment||None (Open Label)||||||
1555053|NCT00252369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555054|NCT00252356|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555055|NCT00252343|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555056|NCT00252330|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555057|NCT00252317|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555058|NCT00252304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555059|NCT00252291|Randomized|Crossover Assignment||Diagnostic||Single||||||
1555060|NCT00252278|Randomized|Parallel Assignment||Treatment||Double||||||
1555061|NCT00252252|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555062|NCT00252239|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555063|NCT00252226|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1555064|NCT00252213|Randomized|Parallel Assignment||Treatment||Single||||||
1555065|NCT00252200|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555066|NCT00252187|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555067|NCT00252174|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555068|NCT00252161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555069|NCT00252148|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555070|NCT00252135|||Cohort||Prospective|||||||
1555071|NCT00252122|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555072|NCT00252109|||||Retrospective|||||||
1555073|NCT00252096|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555074|NCT00252083||Single Group Assignment||Prevention||None (Open Label)||||||
1555075|NCT00252070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555076|NCT00252057|Randomized|Parallel Assignment||Prevention||Single||||||t
1555077|NCT00252044|Randomized|Crossover Assignment||Diagnostic||Double||||||
1555078|NCT00252031|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555079|NCT00252018|Randomized|Parallel Assignment||Prevention||Double||||||
1555080|NCT00252005|Randomized|Parallel Assignment||Treatment||Double||||||
1555081|NCT00251992|Randomized|Parallel Assignment||Treatment||Double||||||
1555082|NCT00251979|Randomized|Parallel Assignment||Prevention||Double||||||
1555083|NCT00251966|Randomized|Parallel Assignment||Prevention||Double||||||
1555084|NCT00251953|Randomized|Parallel Assignment||Treatment||Double||||||
1555085|NCT00251940|Randomized|Parallel Assignment||Treatment||Double||||||
1555086|NCT00251927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555087|NCT00251914|Randomized|Parallel Assignment||Treatment||Double||||||
1555088|NCT00251901|Randomized|Parallel Assignment||Treatment||Double||||||
1555089|NCT00251888|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555090|NCT00251875|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555091|NCT00251862|Randomized|Parallel Assignment||Prevention||Single||||t||
1555092|NCT00251849|Randomized|Parallel Assignment||Treatment||Double||||||
1555093|NCT00251836|||Cohort||Prospective|||||||
1555094|NCT00251823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555095|NCT00251810|||||Prospective|||||||
1555096|NCT00251797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555097|NCT00251784|Randomized|Crossover Assignment||Educational/Counseling/Training||Double||||||
1555098|NCT00251771|Randomized|Parallel Assignment||Treatment||Single||||||t
1555099|NCT00251758|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555100|NCT00251745|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555101|NCT00251732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555102|NCT00251719|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555103|NCT00251706|Randomized|Parallel Assignment||Prevention||Double||||||
1555104|NCT00251693|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555105|NCT00251680|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555106|NCT00251654|||||Prospective|||||||
1555107|NCT00251641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555108|NCT00251628|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555109|NCT00251615|||Cohort||Cross-Sectional|||||||
1555110|NCT00251602|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1555111|NCT00251589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555112|NCT00251576|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1555113|NCT00251563|||Case Control, Natural History||Cross-Sectional, Retrospective|||||||
1555114|NCT00251550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555115|NCT00251537|Randomized|Parallel Assignment||Treatment||Double||||||
1555116|NCT00251524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555117|NCT00251511|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555118|NCT00251498|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555119|NCT00251485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555120|NCT00251472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555121|NCT00251459||||Treatment||||||||
1555122|NCT00251446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555123|NCT00251433|Non-Randomized|||Treatment||None (Open Label)||||||
1555124|NCT00251420|Randomized|Parallel Assignment||||None (Open Label)||||||
1555125|NCT00251407|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555126|NCT00251394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555127|NCT00251381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555128|NCT00251368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555129|NCT00251355|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555130|NCT00251342|Randomized|Parallel Assignment||Diagnostic||Double||||||
1555131|NCT00251329|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555132|NCT00251316|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555133|NCT00251303|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555134|NCT00251290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555135|NCT00251277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555136|NCT00251264|Randomized|Parallel Assignment||Treatment||Single||||||t
1555137|NCT00251251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555138|NCT00251238|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1555139|NCT00251225||Single Group Assignment||Treatment||None (Open Label)||||||
1555140|NCT00251212|Randomized|Factorial Assignment||Prevention||Single||||||t
1555141|NCT00251199|Randomized|Parallel Assignment||||Double||||||
1555142|NCT00251186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555143|NCT00251173|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1555144|NCT00251160|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555145|NCT00251147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555146|NCT00251134|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555147|NCT00251121|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555148|NCT00251108|Randomized|Parallel Assignment||Treatment||Single||||||
1555149|NCT00251095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555150|NCT00251082|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555151|NCT00251069|Randomized|Parallel Assignment||Treatment||Double||||||
1555152|NCT00251056|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555153|NCT00251043|Randomized|Parallel Assignment||Treatment||Single||||||t
1555154|NCT00251030|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555155|NCT00251017||Single Group Assignment||Prevention||None (Open Label)||||||
1555156|NCT00251004|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555157|NCT00250991|Randomized|||Treatment||Double||||||
1555158|NCT00250978|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555159|NCT00250965|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555160|NCT00250952|Randomized|Single Group Assignment||Treatment||Single||||||
1555161|NCT00250939|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555162|NCT00250926||Single Group Assignment||Treatment||None (Open Label)||||||
1555163|NCT00250913|Randomized|Parallel Assignment||||None (Open Label)||||||
1555164|NCT00250900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555165|NCT00250887|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555166|NCT00250874|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555167|NCT00250861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555168|NCT00250848|||Cohort|||||||||
1555169|NCT00250835||Single Group Assignment||Treatment||None (Open Label)||||||
1555170|NCT00250822|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555171|NCT00250809|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555172|NCT00250796|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555173|NCT00250783|||Case Control||Prospective|||||||
1555174|NCT00250770|||Case Control||Prospective|||||||
1555175|NCT00250757|||Case Control||Prospective|||||||
1555176|NCT00250744|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555177|NCT00250731|Randomized|Factorial Assignment||Treatment||Single||||||t
1555178|NCT00250718||Single Group Assignment||Treatment||None (Open Label)||||||
1555179|NCT00250705||Single Group Assignment||Treatment||None (Open Label)||open label trial||||
1555180|NCT00250692|Randomized|Single Group Assignment||||Single||||||
1555181|NCT00250679|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1555182|NCT00250666|Randomized|Single Group Assignment||Diagnostic||Single||||||
1555183|NCT00250653|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555184|NCT00250640|||Cohort||Prospective|||||||
1555185|NCT00250627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555186|NCT00250614|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555187|NCT00250601|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555188|NCT00250588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555189|NCT00250575||Single Group Assignment||Treatment||None (Open Label)||||||
1555190|NCT00250562|Randomized|Parallel Assignment||Treatment||Double||||||
1555191|NCT00250549|Randomized|Parallel Assignment||Prevention||Single||||t||
1555192|NCT00250536|Randomized|Factorial Assignment||Treatment||Double||||||
1555193|NCT00250523|||Cohort||Prospective|||||||
1555194|NCT00250510|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555195|NCT00250497|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555196|NCT00250484|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1555197|NCT00250471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555198|NCT00250458|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555199|NCT00250445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555200|NCT00250432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555201|NCT00250419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555202|NCT00250406|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555203|NCT00250393|Randomized|Crossover Assignment||Treatment||Double||||||
1555204|NCT00250380|||Cohort||Prospective|||||||
1555205|NCT00250367|Randomized|Parallel Assignment||Treatment||Double||||||
1555206|NCT00250354|Randomized|Parallel Assignment||Treatment||Double||||||
1555207|NCT00250341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555208|NCT00250328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555209|NCT00250315|||||Prospective|||||||
1555210|NCT00250302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555211|NCT00250289|Randomized|Single Group Assignment||Treatment||Single||||||
1555212|NCT00250276|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555213|NCT00250263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555214|NCT00250250|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555215|NCT00250237|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1555216|NCT00250224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555217|NCT00250211|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555218|NCT00250198||||Treatment||||||||
1555219|NCT00250185||||Treatment||||||||
1555220|NCT00250172||||Treatment||||||||
1555221|NCT00250159|||Case-Only||Prospective|||||||
1555222|NCT00250146|Randomized|Parallel Assignment||Diagnostic||Double||||||
1555223|NCT00250133|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1555224|NCT00250120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555225|NCT00250094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555226|NCT00250081|Randomized|Parallel Assignment||||None (Open Label)||||||
1555227|NCT00250068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555228|NCT00250055|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555229|NCT00250042|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555230|NCT00250029|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555231|NCT00250016|||Cohort||Prospective|||||||
1555232|NCT00250003|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555233|NCT00249990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555234|NCT00249977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555235|NCT00249964||Single Group Assignment||Treatment||None (Open Label)||||||
1555236|NCT00249951|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1555237|NCT00249938|Randomized|Parallel Assignment||Treatment||Double||||||
1555238|NCT00249925|Randomized|Single Group Assignment||||Single||||||
1555239|NCT00249912|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555240|NCT00249899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555241|NCT00249886|Randomized|Parallel Assignment||Treatment||Double||||||
1555242|NCT00249873|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1555243|NCT00249860|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1555244|NCT00249847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555245|NCT00249834|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555246|NCT00249821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555247|NCT00249808||Single Group Assignment||Treatment||None (Open Label)||||||
1555248|NCT00249795|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1555249|NCT00249782|Randomized|Parallel Assignment||Treatment||Single||||||
1555250|NCT00249769|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555251|NCT00249756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555252|NCT00249743|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1555253|NCT00249730|Randomized|Parallel Assignment||Treatment||Double||||||
1555254|NCT00249717|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555255|NCT00249704|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555256|NCT00249691|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555257|NCT00249678||||Treatment||||||||
1555258|NCT00249652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555259|NCT00249639|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555260|NCT00249626|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1555261|NCT00249613|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555262|NCT00249600|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555263|NCT00249587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555264|NCT00249574|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555265|NCT00249561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555266|NCT00249548|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555267|NCT00249535|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555268|NCT00249522|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555269|NCT00249509|Randomized|Parallel Assignment||Treatment||Double||||||
1555270|NCT00249496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555271|NCT00249483|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555272|NCT00249470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555273|NCT00249457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555274|NCT00249444|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555275|NCT00249431|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1555276|NCT00249418|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555277|NCT00249405|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555278|NCT00249392||||||||||||
1555279|NCT00249379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555280|NCT00249366|Randomized|Parallel Assignment||Treatment||Single|||t|||
1555281|NCT00249353|Randomized|Parallel Assignment||Treatment||Double||||||
1555282|NCT00249340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555283|NCT00249327|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555284|NCT00249314|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1555285|NCT00249301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555286|NCT00249288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555287|NCT00249275|Randomized|Parallel Assignment||Treatment||Single||||||
1555288|NCT00249262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555289|NCT00249249|Randomized|Parallel Assignment||Treatment||Double||||||
1555290|NCT00249236|Randomized|Parallel Assignment||Treatment||Double||||||
1555291|NCT00249223|Randomized|Parallel Assignment||Treatment||Double||||||
1555292|NCT00249210|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555293|NCT00249197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555294|NCT00249171|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555295|NCT00249158|Randomized|Parallel Assignment||Treatment||Double||||||
1555296|NCT00249145|Randomized|Parallel Assignment||Treatment||Double||||||
1555297|NCT00249132|Randomized|Parallel Assignment||Treatment||Double||||||
1555298|NCT00249119|Randomized|Parallel Assignment||Treatment||Double||||||
1555299|NCT00249106|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555300|NCT00249093|Randomized|Crossover Assignment||Diagnostic||Single||||||
1555301|NCT00249080|||Cohort||Prospective|||||||
1555302|NCT00249067|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1555303|NCT00249054|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555304|NCT00249041||Single Group Assignment||Treatment||None (Open Label)||||||
1555305|NCT00249015|Randomized|Single Group Assignment||||Single|||t|||
1555306|NCT00249002||Single Group Assignment||Prevention||None (Open Label)||||||
1555307|NCT00248989|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555308|NCT00248976|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1555309|NCT00248963|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555310|NCT00248950|Non-Randomized|Single Group Assignment||||Double||||||
1555311|NCT00248937|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1555312|NCT00248924|||||Prospective|||||||
1555313|NCT00248911||Single Group Assignment||Supportive Care||None (Open Label)||||||
1555314|NCT00248898|||Cohort||Retrospective|||||||
1555315|NCT00248885|Randomized|Crossover Assignment||Prevention||Single|||t|||
1555316|NCT00248872|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555317|NCT00248859|||Cohort||Prospective|||||||
1555318|NCT00248846|Randomized|Parallel Assignment||Prevention||Single|||t|||
1555319|NCT00248833|Randomized|Single Group Assignment||Prevention||Quadruple|The first 2 cohorts were double blind, and the third cohort was not blinded. The investigator preparing the vaccine did not participate in making subsequent study assessments or subject evaluability decisions. After the vaccine was prepared, the subject's identification number was placed onto the drawn syringe. All information, vaccine dose, adjuvant dose (if applicable), and subject identification number, was recorded on the Vaccine Administration Code Form. The form was placed in an envelope. The envelope was sealed and placed in a secured location. The medical personnel who vaccinated the subjects witnessed the dilution and placement of the subject identification number on the syringe. This staff member vaccinated the subject but did not participate in subsequent study visits or the evaluation. The blind was broken after verification that all serology testing was completed.|The study was conducted as a phase 1, outpatient, dose-escalating study for the Meningococcal 44/76 MOS NOMV 5D Vaccine (lot number 1119). Two dosage levels were investigated: 25 µg with and without adjuvant and 50 µg of protein without adjuvant. Each dose was given intramuscularly at 0, 6, and 24 weeks.|t|t|t|t
1555320|NCT00248820|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555321|NCT00248807|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1555322|NCT00248794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555323|NCT00248781|Randomized|Parallel Assignment||||None (Open Label)||||||
1555324|NCT00248768|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555325|NCT00248755|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555326|NCT00248742|Randomized|Parallel Assignment||Treatment||Single||||||t
1555327|NCT00248729|Randomized|Single Group Assignment||Treatment||Double||||||
1555328|NCT00248716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555329|NCT00248703||Single Group Assignment||Treatment||None (Open Label)||||||
1555330|NCT00248690|Randomized|Parallel Assignment||||Double|||t|||t
1555331|NCT00248677|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555332|NCT00248664||||||||||||
1555333|NCT00248651|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555334|NCT00248638|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555335|NCT00248625|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555336|NCT00248612|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1555337|NCT00248586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555338|NCT00248573|||Case Control||Cross-Sectional|||||||
1555339|NCT00248560||Single Group Assignment||Treatment||None (Open Label)||||||
1555340|NCT00248547|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1555341|NCT00248534||Single Group Assignment||Treatment||None (Open Label)||||||
1555342|NCT00248521|Non-Randomized|||Treatment||None (Open Label)||||||
1555343|NCT00248495||Single Group Assignment||Treatment||None (Open Label)||||||
1555344|NCT00248482||Single Group Assignment||Treatment||None (Open Label)||||||
1555345|NCT00248469|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555346|NCT00248456|Randomized|Parallel Assignment||Treatment||Double||||||
1555347|NCT00248443|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1555348|NCT00248430||||Treatment||||||||
1555349|NCT00248404|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555350|NCT00248391|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1555351|NCT00248378|Randomized|Crossover Assignment||Treatment||Double||||||
1555352|NCT00248365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555353|NCT00248352|Randomized|Crossover Assignment||||None (Open Label)||||||
1555354|NCT00248339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555355|NCT00248326|||Case Control||Cross-Sectional|||||||
1555356|NCT00248313|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555357|NCT00248300|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1555358|NCT00248287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555359|NCT00248274|||Case-Only||Cross-Sectional|||||||
1555360|NCT00248261|||Case-Only||Prospective|||||||
1555361|NCT00248248|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555362|NCT00248235|Randomized|Parallel Assignment||Treatment||Single||||||t
1555363|NCT00248222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555364|NCT00248209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555365|NCT00248196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555366|NCT00248183|Randomized|Parallel Assignment||Treatment||Double||||||
1555367|NCT00248170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555368|NCT00248157|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555369|NCT00248144|Randomized|Parallel Assignment||Treatment||Double||||||
1555370|NCT00248131|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555371|NCT00248118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555372|NCT00248105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555373|NCT00248092|Randomized|Crossover Assignment||Treatment||Double||||||
1555374|NCT00248079|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555375|NCT00248066|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555376|NCT00248053|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1555377|NCT00248040|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555378|NCT00248027|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1555379|NCT00248014|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555380|NCT00247988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555381|NCT00247975|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555382|NCT00247962|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555383|NCT00247949|||Cohort||Prospective|||||||
1555384|NCT00247936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555385|NCT00247923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555386|NCT00247910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555387|NCT00247897|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1555388|NCT00247884|||Case Control||Prospective|||||||
1555389|NCT00247871|||Case-Only||Retrospective|||||||
1555390|NCT00247858|||Case-Only||Prospective|||||||
1555391|NCT00247845|||Case Control||Prospective|||||||
1555392|NCT00247832|Randomized|Single Group Assignment||Treatment||Single|||t|||
1555393|NCT00247819|||||Prospective|||||||
1555394|NCT00247806|||||Prospective|||||||
1555395|NCT00247793|Randomized|Parallel Assignment||Treatment||Double||||||
1555396|NCT00247780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555397|NCT00247754|Randomized|Parallel Assignment||Prevention||Single||||||
1555398|NCT00247741|Randomized|Parallel Assignment||Treatment||Double||||||
1555399|NCT00247728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555400|NCT00247715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555401|NCT00247702|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555402|NCT00247689|||||Prospective|||||||
1555403|NCT00247676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555404|NCT00247663||Single Group Assignment||Treatment||None (Open Label)||||||
1555405|NCT00247650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555406|NCT00247637|||Family-Based||Cross-Sectional|||||||
1555407|NCT00247624|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555408|NCT00247611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555409|NCT00247585|Randomized|Crossover Assignment||Prevention||Double||||||
1555410|NCT00247572|Randomized|Crossover Assignment||Treatment||Double||||||
1555411|NCT00247559|Randomized|Parallel Assignment||Treatment||Double||||||
1555412|NCT00247546|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555413|NCT00247533|Non-Randomized|Single Group Assignment||Diagnostic||Double||||||
1555414|NCT00247520|Randomized|Parallel Assignment||Prevention||Double||||||
1555415|NCT00247507|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555416|NCT00247494|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555417|NCT00247481|Randomized|Parallel Assignment||Treatment||Double||||||
1555418|NCT00247468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555419|NCT00247455|Randomized|Parallel Assignment||Prevention||Single||||||
1555420|NCT00247442|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555421|NCT00247429|||Case-Only||Prospective|||||||
1555422|NCT00247416|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555423|NCT00247403|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555424|NCT00247390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555425|NCT00247377|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555426|NCT00247364|Randomized|Crossover Assignment||Treatment||Double||||||
1555427|NCT00247351|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555428|NCT00247338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555429|NCT00247325|Randomized|Parallel Assignment||Prevention||Single||||||
1555430|NCT00247312|Randomized|Parallel Assignment||||None (Open Label)||||||
1555431|NCT00247299|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555432|NCT00247286|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1555433|NCT00247273|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555434|NCT00247260|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555435|NCT00247247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555436|NCT00247234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555437|NCT00247221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555438|NCT00247208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555439|NCT00247195|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555440|NCT00247182|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1555441|NCT00247169|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555442|NCT00247156|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555443|NCT00247143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555444|NCT00247130|Randomized|Parallel Assignment||Prevention||Single|||t|||
1555445|NCT00247117|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555446|NCT00247104|Randomized|Parallel Assignment||Prevention||Double||||||
1555447|NCT00247091|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1555448|NCT00247078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555449|NCT00247052|Randomized|Parallel Assignment||Treatment||Double||||||
1555450|NCT00247039|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1555451|NCT00247026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555452|NCT00247013|Randomized|Parallel Assignment||||Single||||||
1555453|NCT00247000|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1555454|NCT00246987|Randomized|Parallel Assignment||Treatment||Double||||||
1555455|NCT00246974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555456|NCT00246961|||||Prospective|||||||
1555457|NCT00246948|Randomized|Parallel Assignment||Treatment||Single||||||
1555458|NCT00246935|Randomized|Parallel Assignment||Treatment||Double||||||
1555459|NCT00246922|Randomized|Parallel Assignment||Treatment||Double||||||
1555460|NCT00246909|Randomized|Parallel Assignment||Treatment||Double||||||
1555461|NCT00246896|Randomized|Single Group Assignment||Treatment||Single||||||
1555462|NCT00246883||||Treatment||||||||
1555463|NCT00246870||||||||||||
1555464|NCT00246857|||Family-Based||Other|||||||
1555465|NCT00246844||||||||||||
1555466|NCT00246831||||||||||||
1555467|NCT00246818||||Treatment||||||||
1555468|NCT00246805|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1555469|NCT00246792|Non-Randomized|Crossover Assignment||Treatment||Single||||||
1555470|NCT00246779|Randomized|Parallel Assignment||Treatment||Double||||||
1555471|NCT00246766|||||Prospective|||||||
1555472|NCT00246753||Single Group Assignment||Treatment||None (Open Label)||||||
1555473|NCT00246740|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1555474|NCT00246727|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1555475|NCT00246714|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1555476|NCT00246701|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555477|NCT00246688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555478|NCT00246675|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555479|NCT00246662|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555480|NCT00246636|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555481|NCT00246623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555482|NCT00246610|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555483|NCT00246597|Randomized|Parallel Assignment||Treatment||Double||||||
1555484|NCT00246584|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555485|NCT00246571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555486|NCT00246558|||Cohort||Prospective|||||||
1555487|NCT00246545|Randomized|Parallel Assignment||||None (Open Label)||||||
1555488|NCT00246532|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1555489|NCT00246519|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555490|NCT00246506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555491|NCT00246493|||Case-Control||Prospective|||||||
1555492|NCT00246480|||||Prospective|||||||
1555493|NCT00246467|Randomized|Parallel Assignment||Prevention||Single|||t|||
1555494|NCT00246454|||Other||Other|||||||
1555495|NCT00246441|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555496|NCT00246428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555497|NCT00246415|Randomized|Parallel Assignment||Treatment||Double||||||
1555498|NCT00246402|Randomized|||Prevention||Double||||||
1555499|NCT00246389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555500|NCT00246376|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555501|NCT00246363|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555502|NCT00246350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555503|NCT00246337|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555504|NCT00246324||Single Group Assignment||Treatment||None (Open Label)||||||
1555505|NCT00246298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555506|NCT00246285|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555507|NCT00246272|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555508|NCT00246259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555509|NCT00246246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555510|NCT00246233|Randomized|Parallel Assignment||Treatment||Double||||||
1555511|NCT00246220|Randomized|Parallel Assignment||Treatment||Double||||||
1555512|NCT00246207|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555513|NCT00246194|||Cohort||Prospective|||||||
1555514|NCT00246181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555515|NCT00246168|Randomized|Parallel Assignment||Treatment||Double||||||
1555516|NCT00246155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555517|NCT00246142|Randomized|Parallel Assignment||Treatment||Double||||||
1555518|NCT00246129|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555519|NCT00246116|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1555520|NCT00246103||Single Group Assignment||Treatment||None (Open Label)||||||
1555521|NCT00246090|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555522|NCT00246077|||||Cross-Sectional, Retrospective|||||||
1555523|NCT00246064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555524|NCT00246051|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1555525|NCT00246038||Single Group Assignment||Treatment||None (Open Label)||||||
1555526|NCT00246025|Randomized|Parallel Assignment||Prevention||Double||||||
1555527|NCT00246012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555528|NCT00245986||||Treatment||||||||
1555529|NCT00245973|Randomized|Parallel Assignment||Treatment||Double||||||
1555530|NCT00245960|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555531|NCT00245947|Randomized|Parallel Assignment||Treatment||Double||||||
1555532|NCT00245934|||||Prospective|||||||
1555533|NCT00245921|Randomized|Single Group Assignment||||None (Open Label)||||||
1555534|NCT00245908|Randomized|Parallel Assignment||Treatment||Double||||||
1555535|NCT00245895|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555536|NCT00245882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555537|NCT00245869|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555538|NCT00245856|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555539|NCT00245843|Randomized|Parallel Assignment||||Single|||||t|
1555540|NCT00245830|Randomized|Single Group Assignment||Treatment||Single|||t|||
1555541|NCT00245817|Randomized|Parallel Assignment||||None (Open Label)||||||
1555542|NCT00245804|||Case Control||Prospective|||||||
1555543|NCT00245791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555544|NCT00245778|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1555545|NCT00245765|Randomized|Parallel Assignment||Treatment||Double||||||
1555546|NCT00245752|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555547|NCT00245739||||||||||||
1555548|NCT00245726|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555549|NCT00245713|Randomized|Parallel Assignment||||Double||||||
1555550|NCT00245700||||||||||||
1555551|NCT00245687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555552|NCT00245674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555553|NCT00245661|Randomized|Crossover Assignment||Treatment||Double||||||
1555554|NCT00245648|Randomized|Parallel Assignment||Treatment||Double||||||
1555555|NCT00245635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555556|NCT00245622|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1555557|NCT00245609|Randomized|Parallel Assignment||Treatment||Double||||||
1555558|NCT00245596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555559|NCT00245583|Randomized|Parallel Assignment||Treatment||Double||||||
1555560|NCT00245570|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1555561|NCT00245557|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555562|NCT00245544|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1555563|NCT00245531|||||Prospective|||||||
1555564|NCT00245518|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1555565|NCT00245505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555566|NCT00245492|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1555567|NCT00245479|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555568|NCT00245466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555569|NCT00245453|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555570|NCT00245440|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1555571|NCT00245427|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1555572|NCT00245414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555573|NCT00245401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555574|NCT00245388|Randomized|Parallel Assignment||Treatment||Double||||||
1555575|NCT00245375|Randomized|Parallel Assignment||Treatment||Double||||||
1555576|NCT00245362|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555577|NCT00245349|||Cohort||Prospective|||||||
1555578|NCT00245336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555579|NCT00245323|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555580|NCT00245310|||Cohort||Prospective|||||||
1555581|NCT00245297|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1555582|NCT00245284|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1555583|NCT00245271|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555584|NCT00245258|Randomized|Parallel Assignment||Treatment||Double||||||
1555585|NCT00245245|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555586|NCT00245232|Randomized|Parallel Assignment||Treatment||Single||||||
1555587|NCT00245219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555588|NCT00245206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555589|NCT00245193|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555590|NCT00245180||Single Group Assignment||Prevention||None (Open Label)||||||
1555591|NCT00245167||||||||||||
1555592|NCT00245154|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555593|NCT00245141||||Treatment||None (Open Label)||||||
1555594|NCT00245128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555595|NCT00245115|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555596|NCT00245102||Single Group Assignment||Treatment||None (Open Label)||||||
1555597|NCT00245089||||Treatment||None (Open Label)||||||
1555598|NCT00245076||||Prevention||None (Open Label)||||||
1555599|NCT00245063||Single Group Assignment||Treatment||None (Open Label)||||||
1555600|NCT00245050|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1555601|NCT00245037||Single Group Assignment||Treatment||None (Open Label)||||||
1555602|NCT00245024|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555603|NCT00245011||Single Group Assignment||Treatment||None (Open Label)||||||
1555604|NCT00244998||Single Group Assignment||Treatment||None (Open Label)||||||
1555605|NCT00244985||Single Group Assignment||Treatment||None (Open Label)||||||
1555606|NCT00244972||Single Group Assignment||Treatment||None (Open Label)||||||
1555607|NCT00244959||Single Group Assignment||Treatment||None (Open Label)||||||
1555608|NCT00244946||Single Group Assignment||Treatment||None (Open Label)||||||
1555609|NCT00244933||Single Group Assignment||Treatment||None (Open Label)||||||
1555610|NCT00244920|Randomized|||Treatment||None (Open Label)||||||
1555611|NCT00244907|Randomized|Crossover Assignment||Prevention||Triple|||t|t|t|
1555612|NCT00244894||Single Group Assignment||Supportive Care||None (Open Label)||||||
1555613|NCT00244881||Single Group Assignment||Treatment||None (Open Label)||||||
1555614|NCT00244868|Randomized|||||||||||
1555615|NCT00244855|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555616|NCT00244842|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555617|NCT00244829||||Treatment||None (Open Label)||||||
1555618|NCT00244816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555619|NCT00244803|||Cohort||Prospective|||||||
1555620|NCT00244790|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1555621|NCT00244777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555622|NCT00244764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555623|NCT00244751|Randomized|Parallel Assignment||Treatment||||||||
1555624|NCT00244738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555625|NCT00244725|Randomized|Single Group Assignment||Prevention||Double||||||
1555626|NCT00244712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555627|NCT00244699|Randomized|Parallel Assignment||Treatment||Single||||||
1555628|NCT00244686||||||||||||
1555629|NCT00244673|Randomized|Parallel Assignment||||None (Open Label)||||||
1555630|NCT00244660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555631|NCT00244647|Randomized|Single Group Assignment||Treatment||Single||||||
1555632|NCT00244634|Randomized|Parallel Assignment||Treatment||Double||||||
1555633|NCT00244621|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555634|NCT00244608|Randomized|Parallel Assignment||Treatment||Double||||||
1555635|NCT00244595|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555636|NCT00244582||||||||||||
1555637|NCT00244569|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555638|NCT00244556|Randomized|Parallel Assignment||Treatment||Double||||||
1555639|NCT00244543|Randomized|Parallel Assignment||Treatment||Double||||||
1555640|NCT00244530|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555641|NCT00244517|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1555642|NCT00244504|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555643|NCT00244491|Randomized|Single Group Assignment||||None (Open Label)||||||
1555644|NCT00244478|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555645|NCT00244465|||Cohort||Prospective|||||||
1555646|NCT00244452|Randomized|Parallel Assignment||Treatment||Double||||||
1555647|NCT00244439|Randomized|Parallel Assignment||Treatment||Single||||||t
1555648|NCT00244426|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1555649|NCT00244413|||Cohort||Prospective|||||||
1555650|NCT00244400|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1555651|NCT00244387|Randomized|Parallel Assignment||Treatment||Double||||||
1555652|NCT00244374|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1555653|NCT00244361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555654|NCT00244348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555655|NCT00244335|||Case Control||Prospective|||||||
1555656|NCT00244322|Randomized|Parallel Assignment||Diagnostic||Double||||||
1555657|NCT00244309|Randomized|Factorial Assignment||Treatment||Double||||||
1555658|NCT00244296|Randomized|Parallel Assignment||Treatment||Double||||||
1555659|NCT00244283|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555660|NCT00244270|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555661|NCT00244257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555662|NCT00244244|Randomized|Single Group Assignment||Treatment||Double||||||
1555663|NCT00244231|Randomized|Parallel Assignment||Treatment||Double||||||
1555664|NCT00244218|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1555665|NCT00244205|||Case Control|Screening|Longitudinal, Prospective|||||||
1555666|NCT00244192|Randomized|Parallel Assignment||Treatment||Double||||||
1555667|NCT00244179|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555668|NCT00244166|Randomized|Parallel Assignment||Treatment||Double||||||
1555669|NCT00244153|Randomized|Parallel Assignment||Treatment||Double||||||
1555670|NCT00244140|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1555671|NCT00244127|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555673|NCT00244101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555674|NCT00244088|||Case Control||Prospective|||||||
1555675|NCT00244075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555676|NCT00244062|Randomized|Parallel Assignment||||Double||||||
1555677|NCT00244049|Randomized|Single Group Assignment||||Single|||t|||
1555678|NCT00244023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555679|NCT00244010||Single Group Assignment||Treatment||None (Open Label)||||||
1555680|NCT00243997|Randomized|Parallel Assignment||Prevention||Single||||||t
1555681|NCT00243984|Randomized|Single Group Assignment||Treatment||Double||||||
1555682|NCT00243971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555683|NCT00243958|||Case Control|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1555684|NCT00243945|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555685|NCT00243932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555686|NCT00243919|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555687|NCT00243906|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555688|NCT00243893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555689|NCT00243880||Single Group Assignment||Treatment||None (Open Label)||||||
1555690|NCT00243867|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555691|NCT00243854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555692|NCT00243841|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555693|NCT00243828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555694|NCT00243815|Randomized|Single Group Assignment||Prevention||Double||||||
1555695|NCT00243802|||Case Control||Prospective|||||||
1555696|NCT00243789|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555697|NCT00243776|||Cohort||Prospective|||||||
1555698|NCT00243763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555699|NCT00243750|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555700|NCT00243737|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555701|NCT00243724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555702|NCT00243711|Randomized|Parallel Assignment||Treatment||Double||||||
1555703|NCT00243698|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555704|NCT00243685|Non-Randomized|Single Group Assignment||Treatment||Single||||t||
1555705|NCT00243672|Randomized|Parallel Assignment||Treatment||Double||||||
1555706|NCT00243659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555707|NCT00243646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555708|NCT00243633|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555709|NCT00243620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555710|NCT00243607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555711|NCT00243594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555712|NCT00243581|Randomized|Single Group Assignment||Prevention||Single||||||
1555713|NCT00243568|Randomized|Parallel Assignment||Treatment||Double||||||
1555714|NCT00243555|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1555715|NCT00243542|Randomized|Crossover Assignment||Treatment||Double||||||
1555716|NCT00243529|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555717|NCT00243516|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1555718|NCT00243503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555719|NCT00243490|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555720|NCT00243477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555721|NCT00243464|Randomized|Parallel Assignment||Treatment||Single||||||
1555722|NCT00243451|||Case Control||Prospective|||||||
1555723|NCT00243438|||Cohort||Prospective|||||||
1555724|NCT00243425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555725|NCT00243412|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555726|NCT00243399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555727|NCT00243386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555728|NCT00243373|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1555729|NCT00243360|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555730|NCT00243347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555731|NCT00243334|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1555732|NCT00243321||Single Group Assignment||Treatment||None (Open Label)||||||
1555733|NCT00243308|Randomized|Parallel Assignment||Diagnostic||Double||||||
1555734|NCT00243295|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555735|NCT00243282|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555736|NCT00243269|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1555737|NCT00243256|Randomized|Parallel Assignment||Treatment||Double||||||
1555738|NCT00243243|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555739|NCT00243230|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555740|NCT00243217|Randomized|Parallel Assignment||Treatment||Double||||||
1555741|NCT00243204|Randomized|Parallel Assignment||Treatment||Double||||||
1555742|NCT00243191|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1555743|NCT00243178|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555744|NCT00243165|Randomized|Parallel Assignment||Prevention||Double||||||
1555745|NCT00243152|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1555746|NCT00243139|Randomized|Parallel Assignment||Treatment||Single||||||
1555747|NCT00243126|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1555748|NCT00243113||||Treatment||None (Open Label)||||||
1555749|NCT00243100||Single Group Assignment||Treatment||None (Open Label)||||||
1555750|NCT00243087||||Treatment||None (Open Label)||||||
1555751|NCT00243074||Single Group Assignment||Treatment||None (Open Label)||||||
1555752|NCT00243061||Single Group Assignment||Treatment||None (Open Label)||||||
1555753|NCT00243048|Randomized|||Treatment||||||||
1555754|NCT00243035||Single Group Assignment||Treatment||None (Open Label)||||||
1555755|NCT00243022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555756|NCT00243009||Single Group Assignment||Treatment||None (Open Label)||||||
1555757|NCT00242996||||Treatment||None (Open Label)||||||
1555758|NCT00242983||||||||||||
1555759|NCT00242970|||Case Control||Prospective|||||||
1555760|NCT00242957|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555761|NCT00242944|Randomized|Parallel Assignment||Treatment||Single||||||t
1555762|NCT00242931||Single Group Assignment||Treatment||None (Open Label)||||||
1555763|NCT00242918|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555764|NCT00242905|||Cohort||Prospective|||||||
1555765|NCT00242892|Randomized|Parallel Assignment||Treatment||Single|||||t|
1555766|NCT00242879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555767|NCT00242866|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1555768|NCT00242853|||||Prospective|||||||
1555769|NCT00242840||||||||||||
1555770|NCT00242827|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555771|NCT00242814||||Treatment||||||||
1555772|NCT00242801|Randomized|Parallel Assignment||Treatment||Double||||||
1555773|NCT00242788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555774|NCT00242775|Randomized|Parallel Assignment||Treatment||Double||||||
1555775|NCT00242762|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555776|NCT00242749|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555777|NCT00242736|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555778|NCT00242723|||Cohort||Prospective|||||||
1555779|NCT00242710|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1555780|NCT00242697|Randomized|Parallel Assignment||Treatment||Double||||||
1555781|NCT00242684|||Cohort||Prospective|||||||
1555782|NCT00242671|Randomized|Parallel Assignment||Treatment||Single||||||
1555783|NCT00242658|Randomized|Parallel Assignment||||Double|||t|||t
1555784|NCT00242645|Randomized|Parallel Assignment||Prevention||Single||||||
1555785|NCT00242632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555786|NCT00242619||Single Group Assignment||Treatment||None (Open Label)||||||
1555787|NCT00242606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555788|NCT00242593|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555789|NCT00242580|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555790|NCT00242567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555791|NCT00242554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555792|NCT00242541||Single Group Assignment||Treatment||None (Open Label)||||||
1555793|NCT00242528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555794|NCT00242515|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555795|NCT00242502||Single Group Assignment||Treatment||None (Open Label)||||||
1555796|NCT00242489|Randomized|Parallel Assignment||Treatment||Double||||||
1555797|NCT00242476|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555798|NCT00242463|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1555799|NCT00242450|Randomized|Parallel Assignment||Prevention||Double||||||
1555800|NCT00242437|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1555801|NCT00242424|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555802|NCT00242411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555803|NCT00242398|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555804|NCT00242385|Randomized|Crossover Assignment||Treatment||Double||||||
1555805|NCT00242372|Randomized|Parallel Assignment||Treatment||Double||||||
1555806|NCT00242359|Randomized|Single Group Assignment||Treatment||Double||||||
1555807|NCT00242346|Randomized|Parallel Assignment||Treatment||Double||||||
1555808|NCT00242333|Randomized|Parallel Assignment||Treatment||Double||||||
1555809|NCT00242320|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555810|NCT00242307|Randomized|Parallel Assignment||Treatment||Double||||||
1555811|NCT00242294|Randomized|Parallel Assignment||Treatment||Double||||||
1555812|NCT00242281|Randomized|Parallel Assignment||Treatment||Double||||||
1555813|NCT00242268|Randomized|Parallel Assignment||Treatment||Double||||||
1555814|NCT00242255||||||||||||
1555815|NCT00242242||||||||||||
1555816|NCT00242229|Randomized|Single Group Assignment||||None (Open Label)||||||
1555817|NCT00242216|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555818|NCT00242203|Randomized|Parallel Assignment||Treatment||Single|||t|||
1555819|NCT00242190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555820|NCT00242177|Randomized|Parallel Assignment||Treatment||Double||||||
1555821|NCT00242164|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1555822|NCT00242151|||Defined Population||Longitudinal, Prospective|||||||
1555823|NCT00242138|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1555824|NCT00242125|||Defined Population||Cross-Sectional, Prospective|||||||
1555825|NCT00242112||Single Group Assignment||Diagnostic||None (Open Label)||||||
1555826|NCT00242099|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555827|NCT00242086|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555828|NCT00242073|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555829|NCT00242060|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555830|NCT00242047|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555831|NCT00242034|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1555832|NCT00242021|Randomized|Crossover Assignment||Treatment||Double||||||
1555833|NCT00242008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555834|NCT00241995|Randomized|Parallel Assignment||Treatment||Single||||||
1555835|NCT00241982|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1555836|NCT00241969|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555837|NCT00241956|||Case Control||Retrospective|||||||
1555838|NCT00241943|Randomized|Parallel Assignment||||None (Open Label)||||||
1555839|NCT00241930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555840|NCT00241917|Randomized|Parallel Assignment||||None (Open Label)||||||
1555841|NCT00241904|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555842|NCT00241891|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555843|NCT00241878|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555844|NCT00241852|Randomized|Parallel Assignment||Prevention||Single||||||t
1555845|NCT00241839|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555846|NCT00241826|||Cohort||Prospective|||||||
1555847|NCT00241813|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555848|NCT00241800|||Cohort||Retrospective|||||||
1555849|NCT00241787|||Cohort||Prospective|||||||
1555850|NCT00241774|||Cohort||Prospective|||||||
1555851|NCT00241761||||||||||||
1555852|NCT00241748|||Case Control||Retrospective|||||||
1555853|NCT00241735|||Cohort||Prospective|||||||
1555854|NCT00241722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555855|NCT00241709|||Family-Based||Retrospective|||||||
1555856|NCT00241696||||||||||||
1555857|NCT00241683|||Cohort||Retrospective|||||||
1555858|NCT00241670|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1555859|NCT00241657|Randomized|Parallel Assignment||Prevention||Single||||||
1555860|NCT00241644|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555861|NCT00241631|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555862|NCT00241618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555863|NCT00241605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555864|NCT00241592|Randomized|Crossover Assignment||Treatment||Double||||||
1555865|NCT00241579|Randomized|Crossover Assignment||Treatment||Double||||||
1555866|NCT00241566|Randomized|Crossover Assignment||Treatment||Double||||||
1555867|NCT00241553|Randomized|Parallel Assignment||Treatment||Double||||||
1555868|NCT00241540|Randomized|Parallel Assignment||Treatment||Double||||||
1555869|NCT00241527|Randomized|Parallel Assignment||Treatment||Double||||||
1555870|NCT00241514|Randomized|Parallel Assignment||Treatment||Double||||||
1555871|NCT00241501|Randomized|Parallel Assignment||Treatment||Double||||||
1555872|NCT00241488|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555873|NCT00241475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555874|NCT00241462|||Case-Only||Prospective|||||||
1555875|NCT00241449|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555876|NCT00241436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555877|NCT00241423|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555878|NCT00241410|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555879|NCT00241397|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1555880|NCT00241384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555881|NCT00241371|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555882|NCT00241358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555883|NCT00241345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555884|NCT00241332|Randomized|Single Group Assignment||Treatment||Double||||||
1555885|NCT00241319|Randomized|Parallel Assignment||Treatment||Double||||||
1555886|NCT00241306|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1555887|NCT00241293|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1555888|NCT00241280|Randomized|Parallel Assignment||||Double|||t||t|
1555889|NCT00241267|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1555890|NCT00241254|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555891|NCT00241241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555892|NCT00241228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555893|NCT00241215|Randomized|Single Group Assignment||Treatment||Double||||||
1555894|NCT00241202|Randomized|Parallel Assignment||||None (Open Label)||||||
1555895|NCT00241189|Randomized|Parallel Assignment||Treatment||Single|||||t|
1555896|NCT00241176||Single Group Assignment||Treatment||None (Open Label)||||||
1555897|NCT00241163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555898|NCT00241150|Randomized|Parallel Assignment||Treatment||Double||||||
1555899|NCT00241137|Randomized|Parallel Assignment||Treatment||Double||||||
1555900|NCT00241124|Randomized|Parallel Assignment||Treatment||Double||||||
1555901|NCT00241111|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555902|NCT00241098|Randomized|Parallel Assignment||Treatment||Double||||||
1555903|NCT00241085|Randomized|Parallel Assignment||Treatment||Double||||||
1555904|NCT00241072||Single Group Assignment||Treatment||None (Open Label)||||||
1555905|NCT00241059|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555906|NCT00241046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555907|NCT00241020||Single Group Assignment||Treatment||Triple|||t|t|t|
1555908|NCT00241007|Randomized|Parallel Assignment||Treatment||Double||||||
1555909|NCT00240994||Single Group Assignment||Prevention||None (Open Label)||||||
1555910|NCT00240981|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1555911|NCT00240968|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555912|NCT00240955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555913|NCT00240942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555914|NCT00240929|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1555915|NCT00240916|||Cohort||Prospective|||||||
1555916|NCT00240903|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555917|NCT00240877|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1555918|NCT00240864|Randomized|Parallel Assignment||Treatment||Double||||||
1555919|NCT00240851|Randomized|Parallel Assignment||Treatment||Double||||||
1555920|NCT00240838|Randomized|Parallel Assignment||Treatment||Double||||||
1555921|NCT00240825|Randomized|Parallel Assignment||Treatment||Double||||||
1555922|NCT00240812|Randomized|Parallel Assignment||Treatment||Double||||||
1555923|NCT00240799|Randomized|Parallel Assignment||Treatment||Double||||||
1555924|NCT00240786|Randomized|Parallel Assignment||Treatment||Double||||||
1555925|NCT00240773|Randomized|Parallel Assignment||Treatment||Double||||||
1555926|NCT00240760|Randomized|Parallel Assignment||Treatment||Double||||||
1555927|NCT00240747|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555928|NCT00240734|Randomized|Parallel Assignment||Treatment||Double||||||
1555929|NCT00240721|Randomized|Parallel Assignment||Treatment||Double||||||
1555930|NCT00240708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555931|NCT00240695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555932|NCT00240682||Single Group Assignment||Treatment||None (Open Label)||||||
1555933|NCT00240669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555934|NCT00240656|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555935|NCT00240643|Randomized|Parallel Assignment||Prevention||Double||||||
1555936|NCT00240630|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1555937|NCT00240617|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1555938|NCT00240604|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1555939|NCT00240591||||||||||||
1555940|NCT00240578|||Cohort||Retrospective|||||||
1555941|NCT00240565|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555942|NCT00240552||||||||||||
1555943|NCT00240539|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555944|NCT00240526|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555945|NCT00240513|Randomized|Parallel Assignment||Treatment||Single|||||t|
1555946|NCT00240500|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555947|NCT00240487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555948|NCT00240474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555949|NCT00240461|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1555950|NCT00240448|Randomized|Parallel Assignment||Treatment||Double||||||
1555951|NCT00240435|Randomized|Parallel Assignment||Treatment||Double||||||
1555952|NCT00240422|Randomized|Parallel Assignment||Treatment||Double||||||
1555953|NCT00240409|Randomized|Parallel Assignment||Treatment||Double||||||
1555954|NCT00240396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555955|NCT00240383|Randomized|Parallel Assignment||Treatment||Double||||||
1555956|NCT00240370|Randomized|Parallel Assignment||Treatment||Double||||||
1555957|NCT00240357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555958|NCT00240344|||Case-Only||Prospective|||||||
1555959|NCT00240331|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1555960|NCT00240318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555961|NCT00240305|Randomized|Crossover Assignment||Treatment||Double||||||
1555962|NCT00240292|Randomized|Parallel Assignment||Treatment||Double||||||
1555963|NCT00240279|Randomized|Parallel Assignment||Treatment||Double||||||
1555964|NCT00240266|Randomized|Crossover Assignment||Treatment||Double||||||
1555965|NCT00240253|Randomized|Parallel Assignment||Treatment||Double||||||
1555966|NCT00240227|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1555967|NCT00240214|||Cohort||Prospective|||||||
1555968|NCT00240188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555969|NCT00240175|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1555970|NCT00240162||Single Group Assignment||Treatment||None (Open Label)||||||
1555971|NCT00240149|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555972|NCT00240136|||Cohort|||||||||
1555973|NCT00240123|Randomized|Parallel Assignment||Diagnostic||Double||||||
1555974|NCT00240110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1555975|NCT00240097|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555976|NCT00240084||Single Group Assignment||Treatment||None (Open Label)||||||
1555977|NCT00240071||Single Group Assignment||Treatment||None (Open Label)||||||
1555978|NCT00240058|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1555979|NCT00240045|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555980|NCT00240032|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1555981|NCT00240019|Randomized|Crossover Assignment||Treatment||Double||||||
1555982|NCT00240006|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555983|NCT00239993|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1555984|NCT00239980|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555985|NCT00239967|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1555986|NCT00239954|Randomized|Parallel Assignment||Treatment||Double||||||
1555987|NCT00239928|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1555988|NCT00239915|Randomized|Parallel Assignment||Treatment||Double||||||
1555989|NCT00239902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555990|NCT00239889|Randomized|Parallel Assignment||Treatment||Double||||||
1555991|NCT00239876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555992|NCT00239863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555993|NCT00239850|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555994|NCT00239837|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1555995|NCT00239824|Randomized|Parallel Assignment||Treatment||Single||||||t
1555996|NCT00239811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1555997|NCT00239798|Randomized|Parallel Assignment||Treatment||Double||||||
1555998|NCT00239785|Randomized|Parallel Assignment||Treatment||Double||||||
1555999|NCT00239772|Randomized|Parallel Assignment||Treatment||Single||||||
1556000|NCT00239759||||||||||||
1556001|NCT00239746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556002|NCT00239733||Single Group Assignment||Treatment||None (Open Label)||||||
1556003|NCT00239720|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1556004|NCT00239707|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1556005|NCT00239694|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556006|NCT00239681|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1556007|NCT00239668|||Cohort||Prospective|||||||
1556008|NCT00239655|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556009|NCT00239642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556010|NCT00239629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556011|NCT00239616|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556012|NCT00239603|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1556013|NCT00239590|Randomized|Crossover Assignment||Treatment||Double||||||
1556014|NCT00239577|Randomized|Parallel Assignment||Prevention||Double||||||
1556015|NCT00239564||Single Group Assignment||Treatment||None (Open Label)||||||
1556016|NCT00239551||Single Group Assignment||Treatment||None (Open Label)||||||
1556017|NCT00239538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556018|NCT00239525||Single Group Assignment||Diagnostic||None (Open Label)||||||
1556019|NCT00239512|Randomized|Parallel Assignment||Treatment||Double||||||
1556020|NCT00239499|Randomized|Parallel Assignment||Treatment||Double||||||
1556021|NCT00239486|Randomized|Parallel Assignment||Treatment||Double||||||
1556022|NCT00239473|Randomized|Parallel Assignment||Treatment||Double||||||
1556023|NCT00239460|Randomized|Parallel Assignment||Treatment||Double||||||
1556024|NCT00239447|Randomized|Crossover Assignment||Treatment||Double||||||
1556025|NCT00239434|Randomized|Parallel Assignment||Treatment||Double||||||
1556026|NCT00239421|Randomized|Parallel Assignment||Treatment||Double||||||
1556027|NCT00239408|Randomized|Parallel Assignment||Treatment||Double||||||
1556028|NCT00239395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556029|NCT00239382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556030|NCT00239369|Randomized|Parallel Assignment||Treatment||Double||||||
1556031|NCT00239356|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556032|NCT00239343|Randomized|Parallel Assignment||Treatment||Double||||||
1556033|NCT00239330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556034|NCT00239317|Randomized|Parallel Assignment||Treatment||Double||||||
1556035|NCT00239304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556036|NCT00239291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556037|NCT00239278|Randomized|Parallel Assignment||Treatment||Double||||||
1556038|NCT00239265|Randomized|Parallel Assignment||Treatment||Double||||||
1556039|NCT00239252|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556040|NCT00239239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556041|NCT00239226|Randomized|Parallel Assignment||Prevention||Single|||t|||
1556042|NCT00239213|Randomized|Parallel Assignment||Prevention||Double||||||
1556043|NCT00239200|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556044|NCT00239187|Randomized|Single Group Assignment||Treatment||Double||||||
1556045|NCT00239174|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556046|NCT00239161|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556047|NCT00239148|Randomized|Single Group Assignment||Treatment||Double||||||
1556048|NCT00239135|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556049|NCT00239122|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556050|NCT00239109|Randomized|Parallel Assignment||Treatment||Double||||||
1556051|NCT00239096|Randomized|Parallel Assignment||Prevention||Double||||||
1556654|NCT00231010|||Family-Based||Other|||||||
1556052|NCT00239083|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556053|NCT00239070|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556054|NCT00239057|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556055|NCT00239044|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556056|NCT00239031|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556057|NCT00239018|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556058|NCT00239005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556059|NCT00238992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556060|NCT00238979|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556061|NCT00238966|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556062|NCT00238953|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556063|NCT00238940|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556064|NCT00238927|Randomized|Parallel Assignment||Treatment||Double||||||
1556065|NCT00238914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556066|NCT00238901|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556067|NCT00238888|Randomized|Parallel Assignment||Other||Single|||t|||
1556068|NCT00238875||Single Group Assignment||Treatment||None (Open Label)||||||
1556069|NCT00238862|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556070|NCT00238849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556071|NCT00238836|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556072|NCT00238823|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1556073|NCT00238810|||||Retrospective|||||||
1556074|NCT00238797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556075|NCT00238784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556076|NCT00238758|Randomized|Parallel Assignment||Treatment||Double||||||
1556077|NCT00238745|Randomized|Parallel Assignment||||Double||||||
1556078|NCT00238732|Randomized|Single Group Assignment||Diagnostic||Double||||||
1556079|NCT00238719|Randomized|Parallel Assignment||Treatment||Double||||||
1556080|NCT00238706|Randomized|Parallel Assignment||Treatment||Single||||||
1556081|NCT00238693|||Cohort||Prospective|||||||
1556082|NCT00238680|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556083|NCT00238667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556084|NCT00238654|||Cohort||Prospective|||||||
1556085|NCT00238641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556086|NCT00238628|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556087|NCT00238615||Single Group Assignment||Treatment||None (Open Label)||||||
1556088|NCT00238602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556089|NCT00238576|||||Cross-Sectional|||||||
1556090|NCT00238563|Randomized|Single Group Assignment||Treatment||Double||||||
1556091|NCT00238550|Randomized|Parallel Assignment||Treatment||Double||||||
1556092|NCT00238537|Randomized|Parallel Assignment||Treatment||Double||||||
1556093|NCT00238524|Randomized|Parallel Assignment||Treatment||Double||||||
1556094|NCT00238511|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556095|NCT00238498|Randomized|Parallel Assignment||Treatment||Double||||||
1556096|NCT00238485|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1556097|NCT00238472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556098|NCT00238459|||Case Control||Prospective|||||||
1556099|NCT00238446|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556100|NCT00238433||Single Group Assignment||Treatment||None (Open Label)||||||
1556101|NCT00238420|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556102|NCT00238407||Single Group Assignment||Treatment||None (Open Label)||||||
1556103|NCT00238394||Single Group Assignment||Treatment||None (Open Label)||||||
1556104|NCT00238381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556105|NCT00238368||||Diagnostic||||||||
1556106|NCT00238355||Single Group Assignment||Supportive Care||None (Open Label)||||||
1556107|NCT00238342||||Diagnostic||||||||
1556108|NCT00238329||||Treatment||None (Open Label)||||||
1556109|NCT00238316|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1556110|NCT00238303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556111|NCT00238290||Single Group Assignment||Treatment||None (Open Label)||||||
1556112|NCT00238277||||Treatment||None (Open Label)||||||
1556113|NCT00238264||Single Group Assignment||Treatment||None (Open Label)||||||
1556114|NCT00238251|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556115|NCT00238238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556116|NCT00238225||||Treatment||||||||
1556117|NCT00238212||Single Group Assignment||Treatment||None (Open Label)||||||
1556118|NCT00238199||Single Group Assignment||Treatment||None (Open Label)||||||
1556119|NCT00238173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556120|NCT00238160||||Treatment||||||||
1556121|NCT00238147||||Treatment||None (Open Label)||||||
1556122|NCT00238121||Single Group Assignment||Treatment||None (Open Label)||||||
1556123|NCT00238108|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556124|NCT00238082|Randomized|Parallel Assignment||Treatment||Double||||||
1556125|NCT00238069|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556126|NCT00238056|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556127|NCT00238043|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1556128|NCT00238030|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1556129|NCT00238017|Randomized|Parallel Assignment||Treatment||Double||||||
1556130|NCT00238004|Randomized|Parallel Assignment||Treatment||Double||||||
1556131|NCT00237991|||||Prospective|||||||
1556132|NCT00237978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556133|NCT00237965|Randomized|Parallel Assignment||||Single||||||
1556134|NCT00237952|Randomized|Parallel Assignment||Treatment||Single||||||
1556135|NCT00237939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556136|NCT00237926|Randomized|Parallel Assignment||||None (Open Label)||||||
1556137|NCT00237913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556138|NCT00237900|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556139|NCT00237887|Randomized|Parallel Assignment||Treatment||Double||||||
1556140|NCT00237874|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556141|NCT00237861|Randomized|Parallel Assignment||Treatment||Single||||||
1556142|NCT00237848|Randomized|Parallel Assignment||Treatment||Double||||||
1556143|NCT00237822|Randomized|Parallel Assignment||Other||Single||||||
1556144|NCT00237809|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1556145|NCT00237796|Randomized|Parallel Assignment||Treatment||Single||||||t
1556146|NCT00237783|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556147|NCT00237770|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556148|NCT00237757|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1556149|NCT00237744|Randomized|Parallel Assignment||Treatment||Single||||||t
1556150|NCT00237731|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556151|NCT00237718|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556152|NCT00237705|Randomized|Single Group Assignment||Treatment||Double||||||
1556153|NCT00237692|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1556154|NCT00237679|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556155|NCT00237666||Single Group Assignment||Treatment||None (Open Label)||||||
1556156|NCT00237653|Randomized|Parallel Assignment||Treatment||Double||||||
1556157|NCT00237640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556158|NCT00237627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556159|NCT00237614|Randomized|Parallel Assignment||Prevention||Single||||||
1556160|NCT00237601|||Cohort||Prospective|||||||
1556161|NCT00237588|Randomized|Crossover Assignment||||Double||||||
1556162|NCT00237575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556163|NCT00237562|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556164|NCT00237549|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556165|NCT00237536|Randomized|Parallel Assignment||Treatment||Double||||||
1556166|NCT00237523|Randomized|Single Group Assignment||Treatment||Double||||||
1556167|NCT00237510|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556168|NCT00237497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556169|NCT00237484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556170|NCT00237471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556171|NCT00237458||Single Group Assignment||Treatment||None (Open Label)||||||
1556172|NCT00237445|Randomized|Parallel Assignment||Treatment||Double||||||
1556173|NCT00237432|||Cohort||Prospective|||||||
1556174|NCT00237419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556175|NCT00237406|||Cohort||Prospective|||||||
1556176|NCT00237393|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556177|NCT00237380|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556178|NCT00237367|Randomized|Crossover Assignment||Treatment||Single||||||
1556179|NCT00237354|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556180|NCT00237341||||||||||||
1556181|NCT00237328|||Cohort||Prospective|||||||
1556182|NCT00237315|||Cohort||Prospective|||||||
1556183|NCT00237302|Randomized|Parallel Assignment||Prevention||Double||||||
1556184|NCT00237289|Randomized|Parallel Assignment||Treatment||Double||||||
1556185|NCT00237276|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1556186|NCT00237263|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556187|NCT00237250|Randomized|Parallel Assignment||Treatment||Double||||||
1556188|NCT00237237|Randomized|Parallel Assignment||Treatment||Double||||||
1556189|NCT00237224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556190|NCT00237211||Single Group Assignment||Treatment||None (Open Label)||||||
1556191|NCT00237198||Single Group Assignment||Treatment||None (Open Label)||||||
1556192|NCT00237185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556193|NCT00237172||Single Group Assignment||Treatment||None (Open Label)||||||
1556194|NCT00237159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556195|NCT00237146||Single Group Assignment||Treatment||None (Open Label)||||||
1556196|NCT00237133||Single Group Assignment||Treatment||None (Open Label)||||||
1556197|NCT00237120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556198|NCT00237107||Single Group Assignment||||None (Open Label)||||||
1556199|NCT00237094|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556200|NCT00237081||||||||||||
1556201|NCT00237068|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1556202|NCT00237055|||||Prospective|||||||
1556203|NCT00237042|Randomized|Parallel Assignment||Treatment||Single|||t|||
1556204|NCT00237016|Randomized|Parallel Assignment||||Double||||||
1556205|NCT00237003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556206|NCT00236990|Randomized|Parallel Assignment||Treatment||Double||||||
1556207|NCT00236977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556208|NCT00236964|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1556209|NCT00236951|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1556210|NCT00236938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556211|NCT00236925|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1556212|NCT00236912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556213|NCT00236899|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1556214|NCT00236886|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556215|NCT00236873|Randomized|Parallel Assignment||Treatment||Double||||||
1556216|NCT00236860|Randomized|Parallel Assignment||Treatment||Double||||||
1556217|NCT00236847|Randomized|Parallel Assignment||Treatment||Double||||||
1556218|NCT00236834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556219|NCT00236821|Randomized|Parallel Assignment||Treatment||Double||||||
1556220|NCT00236808|Randomized|Parallel Assignment||Treatment||Double||||||
1556221|NCT00236795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556222|NCT00236782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556223|NCT00236769|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556224|NCT00236756|Randomized|Parallel Assignment||Treatment||Double||||||
1556225|NCT00236743|Randomized|Parallel Assignment||Treatment||Double||||||
1556226|NCT00236730|Randomized|Parallel Assignment||Treatment||Double||||||
1556227|NCT00236717|Randomized|Parallel Assignment||Treatment||Double||||||
1556228|NCT00236704|Randomized|Parallel Assignment||Treatment||Double||||||
1556229|NCT00236691|Randomized|Parallel Assignment||Treatment||Double||||||
1556230|NCT00236678|Randomized|Parallel Assignment||Treatment||Double||||||
1556231|NCT00236665|Randomized|Parallel Assignment||Treatment||Double||||||
1556232|NCT00236652|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556233|NCT00236639|Randomized|Parallel Assignment||Treatment||Double||||||
1556234|NCT00236626|Randomized|Parallel Assignment||Treatment||Double||||||
1556235|NCT00236613|Randomized|Parallel Assignment||Treatment||Double||||||
1556236|NCT00236600|Randomized|Parallel Assignment||Treatment||Double||||||
1556237|NCT00236587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556238|NCT00236574|Randomized|Parallel Assignment||Treatment||Double||||||
1556239|NCT00236561|Randomized|Parallel Assignment||Treatment||Double||||||
1556240|NCT00236548|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556241|NCT00236535|Randomized|Parallel Assignment||Treatment||Double||||||
1556242|NCT00236522|Randomized|Parallel Assignment||Treatment||Double||||||
1556243|NCT00236509|Randomized|Parallel Assignment||Treatment||Double||||||
1556244|NCT00236496|Randomized|Parallel Assignment||Treatment||Double||||||
1556245|NCT00236483|Randomized|Parallel Assignment||Treatment||Double||||||
1556246|NCT00236470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556247|NCT00236457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556248|NCT00236444|Randomized|Parallel Assignment||Treatment||Double||||||
1556249|NCT00236431|Randomized|Parallel Assignment||Treatment||Double||||||
1556250|NCT00236418|Randomized|Parallel Assignment||Treatment||Double||||||
1556251|NCT00236405|Randomized|Parallel Assignment||Treatment||Double||||||
1556252|NCT00236392|Randomized|Parallel Assignment||Treatment||Double||||||
1556253|NCT00236379|Randomized|Parallel Assignment||Treatment||Double||||||
1556254|NCT00236366|Randomized|Parallel Assignment||Treatment||Double||||||
1556255|NCT00236353|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556256|NCT00236340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556257|NCT00236327|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556258|NCT00236301|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1556259|NCT00236288|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1556260|NCT00236275|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1556261|NCT00236262|Randomized|Single Group Assignment||Treatment||Single||||||
1556262|NCT00236249|Randomized|Parallel Assignment||Treatment||Single|||t|||
1556263|NCT00236236|||Defined Population||Longitudinal, Prospective|||||||
1556264|NCT00236223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556265|NCT00236210|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556266|NCT00236197|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556267|NCT00236184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556268|NCT00236171|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1556269|NCT00236158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556270|NCT00236145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556271|NCT00236132||||||||||||
1556272|NCT00236119|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556273|NCT00236106|Randomized|Crossover Assignment||||Single||||||
1556274|NCT00236093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556275|NCT00236080|Randomized|Parallel Assignment||Treatment||Double||||||
1556276|NCT00236067|Randomized|Parallel Assignment||Treatment||Double||||||
1556277|NCT00236054|Randomized|Parallel Assignment||Treatment||Double||||||
1556278|NCT00236041|Randomized|Single Group Assignment||Treatment||Double||||||
1556279|NCT00236028|Randomized|Parallel Assignment||Treatment||Double||||||
1556280|NCT00236015|Randomized|Parallel Assignment||||Double||||||
1557339|NCT00221741|||||Prospective|||||||
1556281|NCT00236002|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1556282|NCT00235989|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556283|NCT00235976|Randomized|Parallel Assignment||Treatment||Double||||||
1556284|NCT00235963|Randomized|Parallel Assignment||Treatment||Double||||||
1556285|NCT00235950|Randomized|Parallel Assignment||||Double||||||
1556286|NCT00235937|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556287|NCT00235924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556288|NCT00235911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556289|NCT00235898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556290|NCT00235885|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556291|NCT00235872|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556292|NCT00235859|Randomized|Parallel Assignment||Treatment||Double||||||
1556293|NCT00235846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556294|NCT00235833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556295|NCT00235820|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1556296|NCT00235807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556297|NCT00235794|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556298|NCT00235781|Randomized|Parallel Assignment||Treatment||Double||||||
1556299|NCT00235768|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1556300|NCT00235755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556301|NCT00235729|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1556302|NCT00235716|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1556303|NCT00235703|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1556304|NCT00235690||Single Group Assignment||Prevention||None (Open Label)||||||
1556305|NCT00235677|Randomized|Crossover Assignment||Treatment||Double||||||
1556306|NCT00235664|||||Prospective|||||||
1556307|NCT00235651|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556308|NCT00235625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556309|NCT00235599|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1556310|NCT00235586|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1556311|NCT00235573||Single Group Assignment||Diagnostic||None (Open Label)||||||
1556312|NCT00235560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556313|NCT00235547|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1556314|NCT00235534|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1556315|NCT00235521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556316|NCT00235508|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1556317|NCT00235495|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1556318|NCT00235482||Single Group Assignment||Treatment||None (Open Label)||CAVATAK||||
1556319|NCT00235469|Randomized|Parallel Assignment||Treatment||Double||||||
1556320|NCT00235456|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1556321|NCT00235443||Single Group Assignment||Treatment||None (Open Label)||||||
1556322|NCT00235417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556323|NCT00235404|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556324|NCT00235391|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556325|NCT00235378|||Cohort||Prospective|||||||
1556326|NCT00235365|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556327|NCT00235352|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556328|NCT00235339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556329|NCT00235326|||Cohort||Prospective|||||||
1556330|NCT00235313|Randomized|Parallel Assignment||Treatment||Single|||t|||
1556331|NCT00235300|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556332|NCT00235287|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556333|NCT00235274|Randomized|Parallel Assignment||Treatment||Double||||||
1556334|NCT00235261|Randomized|Parallel Assignment||Treatment||Double||||||
1556335|NCT00235248|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556336|NCT00235235|||||Prospective|||||||
1556337|NCT00235222|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556338|NCT00235209|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1556339|NCT00235196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556340|NCT00235183|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556341|NCT00235170|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556342|NCT00235157|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556343|NCT00235144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556344|NCT00235131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556345|NCT00235118|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556346|NCT00235105|Randomized|Crossover Assignment||Treatment||Double||||||
1556347|NCT00235092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556348|NCT00235079|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556349|NCT00235066|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556350|NCT00235053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556351|NCT00235040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556352|NCT00235027|Randomized|Parallel Assignment||Treatment||Single||||t||
1556353|NCT00235014|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556354|NCT00235001|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556355|NCT00234988|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556356|NCT00234975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556357|NCT00234962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556358|NCT00234949|Randomized|Parallel Assignment||Treatment||Single||||||
1556359|NCT00234936|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556360|NCT00234923|Randomized|Parallel Assignment||||Double|||t||t|
1556361|NCT00234910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556362|NCT00234897|Randomized|Parallel Assignment||Treatment||Double||||||
1556363|NCT00234884|||Cohort||Prospective|||||||
1556364|NCT00234871|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556365|NCT00234858|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556366|NCT00234845|Randomized|Parallel Assignment||Treatment||Double||||||
1556367|NCT00234832|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556368|NCT00234819|Randomized|Single Group Assignment||Treatment||Double||||||
1556369|NCT00234806|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556370|NCT00234793|Randomized|Parallel Assignment||||None (Open Label)||||||
1556371|NCT00234780|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556372|NCT00234767|||||Prospective|||||||
1556373|NCT00234754|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556374|NCT00234741|Randomized|Parallel Assignment||||Double||||||
1556375|NCT00234728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556376|NCT00234715|||Cohort||Cross-Sectional|||||||
1556377|NCT00234702|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556378|NCT00234689|Randomized|Crossover Assignment||||Double||||||
1556379|NCT00234676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556380|NCT00234663|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556381|NCT00234650|Randomized|Crossover Assignment||Diagnostic||Single||||||
1556382|NCT00234637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556383|NCT00234624|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1556384|NCT00234611|Randomized|Parallel Assignment||Treatment||Double||||||
1556385|NCT00234598|Randomized|Factorial Assignment||Prevention||Double||||t||t
1556386|NCT00234585|Randomized|Parallel Assignment||Treatment||Double||||||
1556387|NCT00234572|Randomized|Parallel Assignment||Treatment||Double||||||
1556388|NCT00234559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556389|NCT00234546|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556390|NCT00234533||Single Group Assignment||Treatment||None (Open Label)||||||
1556391|NCT00234520|||||Prospective|||||||
1556392|NCT00234507|Randomized|Parallel Assignment||Treatment||Double||||||
1556393|NCT00234494||Single Group Assignment||Treatment||None (Open Label)||||||
1556394|NCT00234481|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556395|NCT00234468|Randomized|Parallel Assignment||Treatment||Double||||||
1556396|NCT00234455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556397|NCT00234442|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556398|NCT00234429|Randomized|Single Group Assignment||Treatment||Double||||||
1556399|NCT00234416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556400|NCT00234403|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556401|NCT00234390|Randomized|Parallel Assignment||Treatment||Double||||||
1556402|NCT00234377|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556403|NCT00234364|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1556404|NCT00234338|||||Prospective|||||||
1556405|NCT00234312|Randomized|Single Group Assignment||Treatment||Single||||||
1556406|NCT00234299|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1556407|NCT00234286||Single Group Assignment||Health Services Research||None (Open Label)||||||
1556408|NCT00234273|Randomized|Parallel Assignment||||None (Open Label)||||||
1556409|NCT00234260|||||Prospective|||||||
1556410|NCT00234247|||||Prospective|||||||
1556411|NCT00234234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556412|NCT00234221|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1556413|NCT00234208|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556414|NCT00234195|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556415|NCT00234182|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556416|NCT00234169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556417|NCT00234156|Non-Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1556418|NCT00234143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556419|NCT00234130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556420|NCT00234117|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556421|NCT00234104|Randomized|Parallel Assignment||Treatment||Double||||||
1556422|NCT00234091|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556423|NCT00234078|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556424|NCT00234065|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1556425|NCT00234052||Single Group Assignment||Treatment||None (Open Label)||||||
1556426|NCT00234039||Single Group Assignment||Treatment||None (Open Label)||||||
1556427|NCT00234026||||Treatment||None (Open Label)||||||
1556428|NCT00234000||Single Group Assignment||Treatment||None (Open Label)||||||
1556429|NCT00233987||Single Group Assignment||Treatment||None (Open Label)||||||
1556430|NCT00233974|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556431|NCT00233961||||Treatment||None (Open Label)||||||
1556432|NCT00233948||Single Group Assignment||Treatment||None (Open Label)||||||
1556433|NCT00233935|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1556434|NCT00233922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556435|NCT00233909|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556436|NCT00233896|Randomized|Parallel Assignment||Treatment||Double||||||
1556437|NCT00233883|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556438|NCT00233870|||Cohort||Prospective|||||||
1556439|NCT00233857|Randomized|Parallel Assignment||Treatment||Double||||||
1556440|NCT00233844|Randomized|Crossover Assignment||Treatment||Single||||||
1556441|NCT00233831|Randomized|Parallel Assignment||Treatment||Double||||||
1556442|NCT00233818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556443|NCT00233805|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556444|NCT00233792|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556445|NCT00233779|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556446|NCT00233766|Randomized|Parallel Assignment||Treatment||Double||||||
1556447|NCT00233753|Non-Randomized|||Treatment||||||||
1556448|NCT00233740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556449|NCT00233727|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556450|NCT00233714|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556451|NCT00233701|||||Prospective|||||||
1556452|NCT00233688|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556453|NCT00233675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556454|NCT00233662|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556455|NCT00233649|||||Prospective|||||||
1556456|NCT00233636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556457|NCT00233623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556458|NCT00233610|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556459|NCT00233597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556460|NCT00233584|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556461|NCT00233571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556462|NCT00233558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556463|NCT00233545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556464|NCT00233532|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556465|NCT00233519|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556466|NCT00233506|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556467|NCT00233493|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1556468|NCT00233480|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556469|NCT00233467|||Other||Retrospective|||||||
1556470|NCT00233454||Single Group Assignment||Treatment||None (Open Label)||||||
1556471|NCT00233441|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556472|NCT00233428|||||Prospective|||||||
1556473|NCT00233415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556474|NCT00233402|Randomized|Parallel Assignment||||None (Open Label)||||||
1556475|NCT00233389|Randomized|Parallel Assignment||Treatment||Double||||||
1556476|NCT00233376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556477|NCT00233363|Randomized|Parallel Assignment||Treatment||Double||||||
1556478|NCT00233350|||Case-Only||Cross-Sectional|||||||
1556479|NCT00233337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556480|NCT00233324|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1556481|NCT00233311|||Cohort||Prospective|||||||
1556482|NCT00233298|||||Prospective|||||||
1556483|NCT00233285||||||||||||
1556484|NCT00233272|||Cohort||Other|||||||
1556485|NCT00233259|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556486|NCT00233246|Randomized|||Prevention||None (Open Label)||||||
1556487|NCT00233233|Randomized|||||||||||
1556488|NCT00233220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556489|NCT00233207|Randomized|||Treatment||Double||||||
1556490|NCT00233194|||Cohort||Prospective|||||||
1556491|NCT00233181|Randomized|||Treatment||||||||
1556492|NCT00233168|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556493|NCT00233155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556494|NCT00233142|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1556495|NCT00233129|Randomized|Parallel Assignment||Treatment||Single||||||t
1556496|NCT00233103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556497|NCT00233090|Randomized|Parallel Assignment||Treatment||Single||||||t
1556498|NCT00233077|Randomized|Parallel Assignment||||Double|||t|t||
1556499|NCT00233064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556500|NCT00233051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556501|NCT00233038|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1556502|NCT00233025|Randomized|Parallel Assignment||Treatment||Double||||||
1556503|NCT00233012||||||||||||
1556504|NCT00232999|Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1556505|NCT00232986|||Defined Population||Cross-Sectional, Retrospective|||||||
1556506|NCT00232973|Randomized|Parallel Assignment||Treatment||Double||||||
1556507|NCT00232960|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556508|NCT00232947|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1556509|NCT00232934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556510|NCT00232921|Randomized|Factorial Assignment||Treatment||Double||||||
1556511|NCT00232908|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556512|NCT00232895|Randomized|Parallel Assignment||Treatment||Double||||||
1556513|NCT00232882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556514|NCT00232869|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556515|NCT00232856|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556516|NCT00232843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556517|NCT00232830|Randomized|Parallel Assignment||Treatment||Single|||t|||
1556518|NCT00232817|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1556519|NCT00232804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556520|NCT00232791|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556521|NCT00232778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556522|NCT00232765|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556523|NCT00232752|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556524|NCT00232739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556525|NCT00232726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556526|NCT00232713|||||Prospective|||||||
1556527|NCT00232700|Randomized|Parallel Assignment||Treatment||Double||||||
1556528|NCT00232687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556529|NCT00232674|Randomized|Parallel Assignment||Treatment||Double||||||
1556530|NCT00232661|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1556531|NCT00232648|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556532|NCT00232635|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556533|NCT00232622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556534|NCT00232609|Randomized|Single Group Assignment||||None (Open Label)||||||
1556535|NCT00232596|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556536|NCT00232583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556537|NCT00232570|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1556538|NCT00232557|Randomized|Parallel Assignment||||None (Open Label)||||||
1556539|NCT00232544|Randomized|Parallel Assignment||Other||Single||||||t
1556540|NCT00232531|Randomized|Parallel Assignment||Prevention||Double||||||
1556541|NCT00232518|Randomized|Parallel Assignment||Treatment||Double||||||
1556542|NCT00232505|Randomized|Parallel Assignment||Treatment||Single||||||t
1556543|NCT00232492|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556544|NCT00232479||Single Group Assignment||Treatment||None (Open Label)||||||
1556545|NCT00232466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556546|NCT00232453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556547|NCT00232440|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556548|NCT00232427|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1556549|NCT00232414|Randomized|Single Group Assignment||Treatment||Double||||||
1556550|NCT00232401|||||Prospective|||||||
1556551|NCT00232388||||||||||||
1556552|NCT00232375|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556553|NCT00232362|Randomized|Parallel Assignment||||None (Open Label)||||||
1556554|NCT00232349|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556555|NCT00232336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556556|NCT00232323|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1556557|NCT00232310|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556558|NCT00232297|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556559|NCT00232284|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1556560|NCT00232271|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556561|NCT00232258|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556562|NCT00232245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556563|NCT00232232|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556564|NCT00232219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556565|NCT00232206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556566|NCT00232193|||Case Control||Prospective|||||||
1556567|NCT00232180|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556568|NCT00232167|Randomized|Parallel Assignment||Treatment||Double||||||
1556569|NCT00232154|Randomized|Parallel Assignment||||None (Open Label)||||||
1556570|NCT00232141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556571|NCT00232128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556572|NCT00232115|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556573|NCT00232102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556574|NCT00232089|Randomized|Parallel Assignment||Treatment||Double||||||
1556575|NCT00232076|Randomized|Single Group Assignment||Treatment||Double||||||
1556576|NCT00232063|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556577|NCT00232050|Randomized|Parallel Assignment||Treatment||Double||||||
1556578|NCT00232037|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556579|NCT00232024|Randomized|Parallel Assignment||Treatment||Double||||||
1556580|NCT00232011|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556581|NCT00231998|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556582|NCT00231985|Randomized|Parallel Assignment||Treatment||Single||||||t
1556583|NCT00231972|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556584|NCT00231959|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556585|NCT00231946|Randomized|Parallel Assignment||Treatment||Double||||||
1556586|NCT00231933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556587|NCT00231920|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556588|NCT00231907|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1556589|NCT00231894|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556590|NCT00231881|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1556591|NCT00231868|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556592|NCT00231855|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556593|NCT00231842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556594|NCT00231829|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1556595|NCT00231816|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1556596|NCT00231803|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556597|NCT00231790|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556598|NCT00231777|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1556599|NCT00231764|Randomized|Parallel Assignment||||None (Open Label)||||||
1556600|NCT00231751|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1556601|NCT00231738|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556602|NCT00231725|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1556603|NCT00231712|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1556604|NCT00231699|Randomized|Parallel Assignment||Prevention||Single||||||
1556605|NCT00231686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556606|NCT00231673|Randomized|Parallel Assignment||Treatment||Double||||||
1556607|NCT00231660|Randomized|Parallel Assignment||Treatment||Double||||||
1556608|NCT00231647|Randomized|Parallel Assignment||Treatment||Double||||||
1556609|NCT00231634|Randomized|Parallel Assignment||Treatment||Double||||||
1556610|NCT00231621|Randomized|Parallel Assignment||Treatment||Double||||||
1556611|NCT00231608|Randomized|Parallel Assignment||Treatment||Double||||||
1556612|NCT00231595|Randomized|Parallel Assignment||Treatment||Double||||||
1556613|NCT00231582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556614|NCT00231569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556615|NCT00231556|Randomized|Parallel Assignment||Treatment||Double||||||
1556616|NCT00231543|Randomized|Parallel Assignment||Treatment||Double||||||
1556617|NCT00231530|Randomized|Parallel Assignment||Treatment||Double||||||
1556618|NCT00231517|Randomized|Crossover Assignment||Treatment||Double||||||
1556619|NCT00231504|||Cohort||Prospective|||||||
1556620|NCT00231491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556621|NCT00231478|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556622|NCT00231465||Single Group Assignment||Treatment||None (Open Label)||||||
1556623|NCT00231452|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1556624|NCT00231439|Randomized|Parallel Assignment||Treatment||Double||||||
1556625|NCT00231426|Randomized|Single Group Assignment||Treatment||Single||||||
1556626|NCT00231413|Randomized|Parallel Assignment||Prevention||Double||||||
1556627|NCT00231400|||Cohort||Other|||||||
1556628|NCT00231387|Randomized|Parallel Assignment||Treatment||Double||||||
1556629|NCT00231374|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556630|NCT00231348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556631|NCT00231335|Randomized|Parallel Assignment||Treatment||Double||||||
1556632|NCT00231322|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556633|NCT00231309|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556634|NCT00231296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556635|NCT00231283|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556636|NCT00231270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556637|NCT00231257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556638|NCT00231244|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556639|NCT00231231|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556640|NCT00231218|Randomized|Parallel Assignment||Prevention||Double||||||
1556641|NCT00231205|||Case Control, Natural History||Longitudinal, Prospective|||||||
1556642|NCT00231192|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556643|NCT00231179|Randomized|Parallel Assignment||Prevention||Single||||||t
1556644|NCT00231166||Single Group Assignment||Treatment||None (Open Label)||||||
1556645|NCT00231153|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556646|NCT00231140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556647|NCT00231127|||Cohort||Cross-Sectional|||||||
1556648|NCT00231114|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1556649|NCT00231101|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1556650|NCT00231075|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556651|NCT00231062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556652|NCT00231049|Randomized|Single Group Assignment||Treatment||Single||||||
1556653|NCT00231023||||Treatment||||||||
1556655|NCT00230997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556656|NCT00230984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556657|NCT00230971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556658|NCT00230958|Randomized|Parallel Assignment||Treatment||Double||||||
1556659|NCT00230945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556660|NCT00230932|||Cohort||Cross-Sectional|||||||
1556661|NCT00230919|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556662|NCT00230906|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556663|NCT00230893|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1556664|NCT00230880|Randomized|Single Group Assignment||Health Services Research||Single||||||t
1556665|NCT00230867|Randomized|Parallel Assignment||Treatment||Double||||||
1556666|NCT00230854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556667|NCT00230841|Randomized|Parallel Assignment||Treatment||Single||||||
1556668|NCT00230828|Non-Randomized|Parallel Assignment||Treatment||Double||||||
1556669|NCT00230815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556670|NCT00230802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556671|NCT00230789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556672|NCT00230776|Randomized|Parallel Assignment||Treatment||Double||||||
1556673|NCT00230763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556674|NCT00230750|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1556675|NCT00230737|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556676|NCT00230724|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1556677|NCT00230711|Randomized|Parallel Assignment||||Single||||||
1556678|NCT00230698|Randomized|Parallel Assignment||Treatment||Double||||||
1556679|NCT00230685|||Cohort||Prospective|||||||
1556680|NCT00230672|||||Prospective|||||||
1556681|NCT00230659|||||Prospective|||||||
1556682|NCT00230646|Randomized|Parallel Assignment||||Single||||||t
1556683|NCT00230633|||||Prospective|||||||
1556684|NCT00230620|||Family-Based|||||||||
1556685|NCT00230607||Single Group Assignment||Treatment||None (Open Label)||||||
1556686|NCT00230594|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556687|NCT00230581|Randomized|Parallel Assignment||Treatment||Double||||||
1556688|NCT00230568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556689|NCT00230555|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1556690|NCT00230542||Single Group Assignment||Treatment||None (Open Label)||||||
1556691|NCT00230529|Randomized|Parallel Assignment||Treatment||Double||||||
1556692|NCT00230516|Randomized|Crossover Assignment||||None (Open Label)||||||
1556693|NCT00230503|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556694|NCT00230490|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556695|NCT00230477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556696|NCT00230464|Randomized|Crossover Assignment||Treatment||Double||||||
1556697|NCT00230451|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556698|NCT00230438|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556699|NCT00230425|||Defined Population||Cross-Sectional, Prospective|||||||
1556700|NCT00230412|||Case Control||Prospective|||||||
1556701|NCT00230399|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556702|NCT00230386|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556703|NCT00230373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556704|NCT00230360|||Defined Population|Screening|Longitudinal, Prospective|||||||
1556705|NCT00230347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556706|NCT00230334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556707|NCT00230321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556708|NCT00230308|||||Prospective|||||||
1556709|NCT00230295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556710|NCT00230282||Single Group Assignment||Treatment||None (Open Label)||||||
1556711|NCT00230269|||Cohort||Prospective|||||||
1556712|NCT00230256|||Cohort||Prospective|||||||
1556713|NCT00230243|||||Retrospective|||||||
1556714|NCT00230230|Randomized|Parallel Assignment||Treatment||Double||||||
1556715|NCT00230217|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556716|NCT00230204|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1556717|NCT00230191|Randomized|Parallel Assignment||Prevention||Double||||||
1556718|NCT00230178|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556719|NCT00230165|||Case-Control||Prospective|||||||
1556720|NCT00230152|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1556721|NCT00230139|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1556722|NCT00230126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556723|NCT00230113|Randomized|Parallel Assignment||||Triple|||t||t|t
1556724|NCT00230100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556725|NCT00230087|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556726|NCT00230074|Randomized|Parallel Assignment||Treatment||Double||||||
1556727|NCT00230061|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556728|NCT00230048|Randomized|Parallel Assignment||Treatment||Single||||||t
1556729|NCT00230035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556730|NCT00230022|Randomized|Parallel Assignment||Treatment||Single||||||t
1556731|NCT00230009|Randomized|Parallel Assignment||Prevention||Single||||||t
1556732|NCT00229996|Randomized|Parallel Assignment||Treatment||Double||||||
1556733|NCT00229983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556734|NCT00229970|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556735|NCT00229957|Randomized|Parallel Assignment||Treatment||Single||||||t
1556736|NCT00229944|Randomized|Parallel Assignment||Treatment||Double||||||
1556737|NCT00229931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556738|NCT00229918|Randomized|Parallel Assignment||Treatment||Single||||||
1556739|NCT00229905|||||Retrospective|||||||
1556740|NCT00229892|||||Retrospective|||||||
1556741|NCT00229879|||||Retrospective|||||||
1556742|NCT00229866|||||Retrospective|||||||
1556743|NCT00229853|||||Retrospective|||||||
1556744|NCT00229840|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1556745|NCT00229827|||||Retrospective|||||||
1556746|NCT00229814|||Case-Only||Retrospective|||||||
1556747|NCT00229801|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1556748|NCT00229788|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1556749|NCT00229775|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556750|NCT00229762|Randomized|Single Group Assignment||Educational/Counseling/Training||Single||||||
1556751|NCT00229749|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556752|NCT00229736|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556753|NCT00229723|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1556754|NCT00229710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556755|NCT00229697|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556756|NCT00229684|Randomized|Parallel Assignment||||None (Open Label)||||||
1556757|NCT00229671|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556758|NCT00229658|||||Prospective|||||||
1556759|NCT00229645|Randomized|Parallel Assignment||Treatment||Double||||||
1556760|NCT00229632|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1556761|NCT00229619||Single Group Assignment||Treatment||None (Open Label)||||||
1556762|NCT00229593|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1556763|NCT00229580|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556764|NCT00229567|Randomized|Parallel Assignment||Prevention||Double||||||
1556765|NCT00229554|||||Retrospective|||||||
1556766|NCT00229541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556767|NCT00229528|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556768|NCT00229515|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1556769|NCT00229502|||Cohort||Prospective|||||||
1556770|NCT00229476|Randomized|Crossover Assignment||Treatment||Double||||||
1556771|NCT00229463|||Case Control||Cross-Sectional|||||||
1556772|NCT00229450|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1556773|NCT00229437|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556774|NCT00229424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556775|NCT00229411|Non-Randomized|Crossover Assignment||Educational/Counseling/Training||None (Open Label)||||||
1556776|NCT00229398|||||Retrospective|||||||
1556777|NCT00229385|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||t
1556778|NCT00229372|Randomized|Parallel Assignment||||Single||||||
1556779|NCT00229359||||||||||||
1556780|NCT00229346|||||Retrospective|||||||
1556781|NCT00229333|Randomized|Parallel Assignment||Treatment||Double||||||
1556782|NCT00229320|Randomized|Parallel Assignment||||None (Open Label)||||||
1556783|NCT00229307|Randomized|Parallel Assignment||Treatment||Single||||||t
1556784|NCT00229294|||||Retrospective|||||||
1556785|NCT00229281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556786|NCT00229268|||Cohort||Prospective|||||||
1556787|NCT00229255|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556788|NCT00229242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556789|NCT00229229|Randomized|Parallel Assignment||Treatment||Single||||t||
1556790|NCT00229216|Randomized|Parallel Assignment||Treatment||Double||||||
1556791|NCT00229203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556792|NCT00229190|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1556793|NCT00229177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556794|NCT00229164|Randomized|Crossover Assignment||Treatment||Single||||||
1556795|NCT00229151|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556796|NCT00229138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556797|NCT00229125|Randomized|Parallel Assignment||Treatment||Double||||||
1556798|NCT00229112|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556799|NCT00229099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556800|NCT00229086||||||||||||
1556801|NCT00229073|Randomized|Parallel Assignment||Treatment||Double||||||
1556802|NCT00229060|Randomized|Parallel Assignment||Treatment||Double||||||
1556803|NCT00229047|||Cohort||Prospective|||||||
1556804|NCT00229034|||Cohort||Prospective|||||||
1556805|NCT00229021|Randomized|Parallel Assignment||Treatment||Double||||||
1556806|NCT00229008|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1556807|NCT00228995|Randomized|Parallel Assignment||Treatment||Double||||||
1556808|NCT00228982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556809|NCT00228969||||Treatment||||||||
1556810|NCT00228956|||Cohort||Prospective|||||||
1556811|NCT00228943|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1556812|NCT00228930|||Cohort||Prospective|||||||
1556813|NCT00228917|Randomized|Parallel Assignment||Prevention||Single|||t|||
1556814|NCT00228904|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1556815|NCT00228891|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1556816|NCT00228878||Single Group Assignment||Treatment||None (Open Label)||||||
1556817|NCT00228865||Single Group Assignment||Treatment||None (Open Label)||||||
1556818|NCT00228852|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1556819|NCT00228839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556820|NCT00228813||Single Group Assignment||Treatment||None (Open Label)||||||
1556821|NCT00228696|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1556822|NCT00228683|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1556823|NCT00228670|||Other||Prospective|||||||
1556824|NCT00228657|Randomized|Parallel Assignment||Diagnostic||Double||||||
1556825|NCT00228644|||Cohort||Prospective|||||||
1556826|NCT00228631|||Cohort|||||||||
1556827|NCT00228618|||Cohort||Prospective|||||||
1556828|NCT00228605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556829|NCT00228592|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556830|NCT00228579|||Cohort||Prospective|||||||
1556831|NCT00228566|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556832|NCT00228553|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1556833|NCT00228540|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1556834|NCT00228527|Randomized|Parallel Assignment||Treatment||Double||||||
1556835|NCT00228514|Randomized|Parallel Assignment||Treatment||Double||||||
1556836|NCT00228488|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556837|NCT00228475|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556838|NCT00228462|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556839|NCT00228449|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556840|NCT00228436|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556841|NCT00228423|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1556842|NCT00228410|Randomized|Parallel Assignment||Treatment||Double||||||
1556843|NCT00228397|Randomized|Parallel Assignment||Treatment||Single||||||
1556844|NCT00228384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556845|NCT00228371|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1556846|NCT00228358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556847|NCT00228345|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1556848|NCT00228332|Randomized|Single Group Assignment||Treatment||Double||||||
1556849|NCT00228319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556850|NCT00228306|Randomized|Crossover Assignment||Treatment||Single|||t|||
1556851|NCT00228293|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556852|NCT00228280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556853|NCT00228267|Randomized|Parallel Assignment||Treatment||Double||||||
1556854|NCT00228254|Randomized|Factorial Assignment||Prevention||Double||||||
1556855|NCT00228241|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556856|NCT00228228|Randomized|Parallel Assignment||Treatment||Double||||||
1556857|NCT00228215|Randomized|Parallel Assignment||Treatment||Single||||||t
1556858|NCT00228202|||Natural History||Cross-Sectional, Retrospective|||||||
1556859|NCT00228189|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556860|NCT00228176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556861|NCT00228163|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556862|NCT00228150|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1556863|NCT00228137|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1556864|NCT00228124||||Screening|Longitudinal, Retrospective/Prospective|||||||
1556865|NCT00228111|||Cohort||Prospective|||||||
1556866|NCT00228098|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1556867|NCT00228085|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1556868|NCT00228072|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556869|NCT00228059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556870|NCT00228046|Randomized|Parallel Assignment||Treatment||Double||||||
1556871|NCT00228033|Randomized|Parallel Assignment||Prevention||Double||||||
1556872|NCT00228020|Randomized|Parallel Assignment||Prevention||Double||||||
1556873|NCT00228007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556874|NCT00227994|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556875|NCT00227981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556876|NCT00227968|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556877|NCT00227955|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556878|NCT00227942|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1556879|NCT00227929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556880|NCT00227916||||Treatment||||||||
1556881|NCT00227903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556882|NCT00227890|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1556883|NCT00227877|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||In this before-/after- quasi-experimental trial, all sites first completed a treatment-as-usual phase with assessments only, followed by all sites undergoing training and completing a subsequent intervention phase.||||
1556884|NCT00227864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556885|NCT00227838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556886|NCT00227825|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556887|NCT00227812|Randomized|Single Group Assignment||Treatment||Double||||||
1556888|NCT00227786|Randomized|Single Group Assignment||Prevention||Single|||t|||
1556889|NCT00227773||||Treatment||||||||
1556890|NCT00227760||Single Group Assignment||Treatment||None (Open Label)||||||
1556891|NCT00227747|Randomized|||Treatment||||||||
1556892|NCT00227734|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556893|NCT00227721||Single Group Assignment||Treatment||None (Open Label)||||||
1556894|NCT00227708||||Treatment||None (Open Label)||||||
1556895|NCT00227695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556896|NCT00227682||Single Group Assignment||Treatment||None (Open Label)||||||
1556897|NCT00227669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556898|NCT00227656||Single Group Assignment||Treatment||None (Open Label)||||||
1556899|NCT00227630|Non-Randomized|||Treatment||||||||
1556900|NCT00227617||Single Group Assignment||Treatment||None (Open Label)||||||
1556901|NCT00227591||Single Group Assignment||Treatment||None (Open Label)||||||
1556902|NCT00227565||Single Group Assignment||Treatment||None (Open Label)||||||
1556903|NCT00227539||Single Group Assignment||Treatment||None (Open Label)||||||
1556904|NCT00227526|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1556905|NCT00227513||Single Group Assignment||Treatment||None (Open Label)||||||
1556906|NCT00227500|Randomized|Parallel Assignment||Treatment||Double||||||
1556907|NCT00227487||Single Group Assignment||Diagnostic||None (Open Label)||||||
1556908|NCT00227474||||Treatment||None (Open Label)||||||
1556909|NCT00227461|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556910|NCT00227448|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556911|NCT00227435|Randomized|Parallel Assignment||Treatment||Double||||||
1556912|NCT00227422|Randomized|Parallel Assignment||Treatment||Double||||||
1556913|NCT00227409|Randomized|Parallel Assignment||Treatment||Single||||||
1556914|NCT00227383|Randomized|Parallel Assignment||Treatment||Single||||||
1556915|NCT00227370|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1556916|NCT00227357|||||Prospective|||||||
1556917|NCT00227344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556918|NCT00227331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556919|NCT00227318|Randomized|||Prevention||Double||||||
1556920|NCT00227305||Single Group Assignment||Treatment||None (Open Label)||||||
1556921|NCT00227292|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556922|NCT00227279|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1556923|NCT00227266|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1556924|NCT00227253|||Other||Other|||||||
1556925|NCT00227240|||Cohort||Prospective|||||||
1556926|NCT00227227|||||Prospective|||||||
1556927|NCT00227214|||||Prospective|||||||
1556928|NCT00227201||||||||||||
1556929|NCT00227188|||||Prospective|||||||
1556930|NCT00227175|||||Prospective|||||||
1556931|NCT00227162|Non-Randomized|Parallel Assignment||Other||Single|||t|||
1556932|NCT00227149|||Cohort||Prospective|||||||
1556933|NCT00227136|Randomized|Crossover Assignment||Diagnostic||Double||||||
1556934|NCT00227123|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556935|NCT00227110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556936|NCT00227097|||Defined Population||Longitudinal, Prospective|||||||
1556937|NCT00227084|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556938|NCT00227071|Randomized|Crossover Assignment||Treatment||Single||||||
1556939|NCT00227058|Randomized|Parallel Assignment||Diagnostic||Double||||||
1556940|NCT00227045|||Defined Population||Cross-Sectional, Prospective|||||||
1556941|NCT00227032|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556942|NCT00227019||Single Group Assignment||Treatment||None (Open Label)||||||
1556943|NCT00227006|Randomized|Factorial Assignment||Treatment||Single||||||t
1556944|NCT00226993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556945|NCT00226980|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556946|NCT00226967|||Cohort||Prospective|||||||
1556947|NCT00226954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556948|NCT00226941|Randomized|Sequential Assignment||Treatment||None (Open Label)||Sequential design for 4 dose combinations (arms) through phase 1||||
1556949|NCT00226928||Single Group Assignment||Treatment||None (Open Label)||||||
1556950|NCT00226915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556951|NCT00226902|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1556952|NCT00226889|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556953|NCT00226876|||Cohort||Prospective|||||||
1556954|NCT00226863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556955|NCT00226850|Randomized|Parallel Assignment||||None (Open Label)||||||
1556956|NCT00226837|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1556957|NCT00226824|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556958|NCT00226811|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556959|NCT00226798|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556960|NCT00226785|Randomized|Parallel Assignment||Treatment||Double||||||
1556961|NCT00226772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556962|NCT00226759|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1556963|NCT00226746||Single Group Assignment||Treatment||None (Open Label)||"Radiation Therapy: 63.80 Gy (1.1 Gy BID X 58 fractions), Paclitaxel: 60 mg/m2 / week by 1- hour IV infusion on days 1, 8, 15, 22, 29, and 36.~Gemcitabine: 75 mg/m2 / week on days 1, 8, 15, 22, 29, and 36."||||
1556964|NCT00226733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556965|NCT00226720|Randomized|Parallel Assignment||||None (Open Label)||||||
1556966|NCT00226707|Randomized|Parallel Assignment||Treatment||Double||||||
1556967|NCT00226694|Randomized|Crossover Assignment||Basic Science||Triple|||t|t|t|
1556968|NCT00226681|Randomized|Single Group Assignment||||None (Open Label)||||||
1556969|NCT00226668|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1556970|NCT00226655|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556971|NCT00226642|Randomized|Parallel Assignment||Treatment||Double||||||
1556972|NCT00226629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556973|NCT00226616|Randomized|Parallel Assignment||Treatment||Double||||||
1556974|NCT00226603|Randomized|Parallel Assignment||Prevention||Single||||||
1556975|NCT00226590||Single Group Assignment||Treatment||None (Open Label)||||||
1556976|NCT00226577||Single Group Assignment||Treatment||None (Open Label)||||||
1556977|NCT00226564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556978|NCT00226551|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1556979|NCT00226538|Randomized|Crossover Assignment||||Double||||||
1556980|NCT00226525|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1556981|NCT00226512|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556982|NCT00226499|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1556983|NCT00226486|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1556984|NCT00226473|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556985|NCT00226460|Randomized|Single Group Assignment||Treatment||Double||||||
1556986|NCT00226447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556987|NCT00226434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556988|NCT00226421|Randomized|Parallel Assignment||Treatment||Double||||||
1556989|NCT00226408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1556990|NCT00226395|Randomized|Parallel Assignment||Treatment||Double||||||
1556991|NCT00226382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1556992|NCT00226369|Randomized|Parallel Assignment||||Double||||||
1556993|NCT00226356||Single Group Assignment||Treatment||None (Open Label)||||||
1556994|NCT00226343|Randomized|Parallel Assignment||Treatment||Double||||||
1556995|NCT00226330|Randomized|Parallel Assignment||Treatment||Double||||||
1556996|NCT00226317||Single Group Assignment||Treatment||None (Open Label)||||||
1556997|NCT00226304||||||||||||
1556998|NCT00226291|Randomized|Parallel Assignment||||None (Open Label)||||||
1556999|NCT00226278|Randomized|Single Group Assignment||Treatment||Double||||||
1557000|NCT00226265|||Case-Only||Prospective|||||||
1557001|NCT00226252|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1557002|NCT00226239||Single Group Assignment||Treatment||None (Open Label)||||||
1557003|NCT00226226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557004|NCT00226213|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557005|NCT00226200|Randomized|Single Group Assignment||Treatment||Double||||||
1557006|NCT00226187|Randomized|Parallel Assignment||Treatment||Double||||||
1557007|NCT00226174|Randomized|Parallel Assignment||Treatment||Double||||||
1557008|NCT00226161|Randomized|Parallel Assignment||Prevention||Single||||||
1557009|NCT00226148|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557010|NCT00226135|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557011|NCT00226122|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1557012|NCT00226109|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557013|NCT00226096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557014|NCT00226083|||||Prospective|||||||
1557015|NCT00226070|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1557016|NCT00226057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557017|NCT00226044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557018|NCT00226031|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557019|NCT00226018|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557020|NCT00226005||Single Group Assignment||Treatment||None (Open Label)||||||
1557021|NCT00225992|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1557022|NCT00225979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557023|NCT00225966|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557024|NCT00225927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557025|NCT00225914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557026|NCT00225901|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557027|NCT00225888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557028|NCT00225875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557029|NCT00225862|Randomized|Parallel Assignment||Treatment||Double||||||
1557030|NCT00225849|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557031|NCT00225836|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557032|NCT00225823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557033|NCT00225810|Randomized|Crossover Assignment||Prevention||Single||||||
1557034|NCT00225797|Randomized|Parallel Assignment||Treatment||Double||||||
1557035|NCT00225784||Single Group Assignment||Treatment||None (Open Label)||||||
1557036|NCT00225758||Single Group Assignment||Treatment||None (Open Label)||||||
1557037|NCT00225745|||Case Control||Retrospective|||||||
1557038|NCT00225732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557039|NCT00225719|Randomized|Parallel Assignment||Treatment||Double||||||
1557040|NCT00225706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557041|NCT00225693|Randomized|Parallel Assignment||Treatment||Double||||||
1557042|NCT00225680|Randomized|Parallel Assignment||Treatment||Double||||||
1557043|NCT00225667|Randomized|Parallel Assignment||Prevention||Double||||||
1557044|NCT00225654|Randomized|Parallel Assignment||Treatment||Double||||||
1557045|NCT00225641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557046|NCT00225628|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557047|NCT00225615|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557048|NCT00225602|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557049|NCT00225589|Randomized|Parallel Assignment||||Double||||||
1557050|NCT00225576|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1557051|NCT00225563|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1557052|NCT00225550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557053|NCT00225537|Randomized|Single Group Assignment||Treatment||Double||||||
1557054|NCT00225524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557055|NCT00225511|Non-Randomized|Parallel Assignment||Treatment||Double||||||
1557056|NCT00225498|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557057|NCT00225485|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557058|NCT00225472|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1557059|NCT00225459|||Case-Crossover||Prospective|||||||
1557060|NCT00225446|Non-Randomized|Single Group Assignment||||Double|||t|||t
1557061|NCT00225433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557062|NCT00225420||Single Group Assignment||Treatment||None (Open Label)||||||
1557063|NCT00225407|Randomized|Crossover Assignment||Prevention||Double||||||
1557064|NCT00225394|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1557065|NCT00225381|||Case-Only|||||||||
1557066|NCT00225368|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557067|NCT00225355|Randomized|Parallel Assignment||Treatment||Double||||||
1557068|NCT00225342|Randomized|Parallel Assignment||Treatment||Double||||||
1557069|NCT00225329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557070|NCT00225316|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557071|NCT00225303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557072|NCT00225290|Randomized|Parallel Assignment||Treatment||Double||||||
1557073|NCT00225277|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557074|NCT00225264|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557075|NCT00225251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557076|NCT00225238|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1557077|NCT00225225|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557078|NCT00225212||Single Group Assignment||Treatment||None (Open Label)||||||
1557079|NCT00225199|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557080|NCT00225186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557081|NCT00225173||Single Group Assignment||Treatment||None (Open Label)||||||
1557082|NCT00225160|Randomized|Parallel Assignment||Prevention||Double||||||
1557083|NCT00225147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557084|NCT00225121||||Treatment||None (Open Label)||||||
1557085|NCT00225108|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557086|NCT00225095|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1557087|NCT00225082|||Case-Only||Prospective|||||||
1557088|NCT00225069|Randomized|Single Group Assignment||Treatment||Single|||t|||
1557089|NCT00225056|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557090|NCT00225043|Randomized|Parallel Assignment||||Double||||||
1557091|NCT00225030|||Natural History||Longitudinal, Prospective|||||||
1557092|NCT00225017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557093|NCT00225004|||||Retrospective|||||||
1557094|NCT00224991|Randomized|Single Group Assignment||||None (Open Label)||||||
1557095|NCT00224978|Randomized|Single Group Assignment||Treatment||Double||||||
1557096|NCT00224965|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1557097|NCT00224952|||Case-Only||Prospective|||||||
1557098|NCT00224939|Randomized|Parallel Assignment||Prevention||Double||||||
1557099|NCT00224926|||Cohort||Prospective|||||||
1557100|NCT00224913|Randomized|Parallel Assignment||Treatment||Single||||||
1557101|NCT00224900|||Cohort||Cross-Sectional|||||||
1557102|NCT00224887|Randomized|||Prevention||||||||
1557103|NCT00224874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557104|NCT00224861|Randomized|||Treatment||||||||
1557105|NCT00224848|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557106|NCT00224835|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1557107|NCT00224822|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557108|NCT00224809|Randomized|Factorial Assignment||Prevention||||||||
1557109|NCT00224796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557110|NCT00224783|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1557111|NCT00224770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557487|NCT00219817|Randomized|Parallel Assignment||Treatment||Double||||||
1557112|NCT00224757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557113|NCT00224744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557114|NCT00224731|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1557115|NCT00224718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557116|NCT00224705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557117|NCT00224692|Randomized|Parallel Assignment||Treatment||Double||||||
1557118|NCT00224679|Randomized|Parallel Assignment||Treatment||Double||||||
1557119|NCT00224666|Randomized|Crossover Assignment||Treatment||Single||||||
1557120|NCT00224653|Randomized|Parallel Assignment||Treatment||Single||||||
1557121|NCT00224640|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557122|NCT00224627|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1557123|NCT00224614|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1557124|NCT00224601|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557125|NCT00224588|Randomized|Parallel Assignment||Treatment||Double||||||
1557126|NCT00224575||Single Group Assignment||Diagnostic||None (Open Label)||||||
1557127|NCT00224562|||Case Control, Natural History||Longitudinal, Prospective|||||||
1557128|NCT00224549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557129|NCT00224536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557130|NCT00224523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557131|NCT00224510|Randomized|Parallel Assignment||Treatment||Double||||||
1557132|NCT00224497|Randomized|Parallel Assignment||Treatment||Double||||||
1557133|NCT00224484|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1557134|NCT00224471|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1557135|NCT00224458|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557136|NCT00224445||Single Group Assignment||Treatment||None (Open Label)||||||
1557137|NCT00224432|Randomized|Parallel Assignment||Treatment||Double||||||
1557138|NCT00224419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557139|NCT00224406|Randomized|Parallel Assignment||Prevention||Double||||||
1557140|NCT00224393|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557141|NCT00224380|Randomized|Parallel Assignment||||Single||||||
1557142|NCT00224367|Randomized|Single Group Assignment||Treatment||Single||||||
1557143|NCT00224354||Single Group Assignment||Treatment||None (Open Label)||||||
1557144|NCT00280839|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1557145|NCT00224341|Randomized|Factorial Assignment||Prevention||Single||||||
1557146|NCT00224328|||Defined Population|Screening|Longitudinal, Prospective|||||||
1557147|NCT00224315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557148|NCT00224302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557149|NCT00224289||Single Group Assignment||Treatment||None (Open Label)||||||
1557150|NCT00224276|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1557151|NCT00224263|Randomized|Crossover Assignment||Treatment||Double||||||
1557152|NCT00224250|Randomized|Single Group Assignment||Treatment||Single||||||
1557153|NCT00224237|||Cohort||Prospective|||||||
1557154|NCT00224224|||||Retrospective|||||||
1557155|NCT00224211|||Case Control||Prospective|||||||
1557156|NCT00224198|||Case Control||Prospective|||||||
1557157|NCT00224185|||Case-Only||Prospective|||||||
1557158|NCT00224172||||||||||||
1557159|NCT00224159||||||||||||
1557160|NCT00224146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557161|NCT00224133||Single Group Assignment||Treatment||None (Open Label)||||||
1557162|NCT00224120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557163|NCT00224107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557164|NCT00224094|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557165|NCT00224081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557166|NCT00224068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557167|NCT00224055|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557168|NCT00224042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557169|NCT00224029|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557170|NCT00224016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557171|NCT00224003|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557172|NCT00223990|Randomized|Single Group Assignment||Prevention||Double||||||
1557173|NCT00223977|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557174|NCT00223964|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1557175|NCT00223951|Randomized|Parallel Assignment||Treatment||Double||||||
1557176|NCT00223938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557177|NCT00223925|Randomized|Parallel Assignment||Prevention||Double||||||
1557178|NCT00223912|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557179|NCT00223899|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557180|NCT00223873|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557181|NCT00223860|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557182|NCT00223847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557183|NCT00223834|Randomized|Single Group Assignment||Treatment||Single||||||t
1557184|NCT00223821|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557185|NCT00223808|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1557186|NCT00223795|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557187|NCT00223782|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557188|NCT00223769|Randomized|Single Group Assignment||Treatment||Double||||||
1557189|NCT00223756|Randomized|Single Group Assignment||Treatment||Single||||||t
1557190|NCT00223743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557191|NCT00223730|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1557192|NCT00223717|Randomized|Crossover Assignment||Treatment||Single|||t|||
1557193|NCT00223704|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1557194|NCT00223691|Randomized|Crossover Assignment||||Single|||t|||
1557195|NCT00223678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557196|NCT00223665||Single Group Assignment||Treatment||None (Open Label)||All subjects underwent androgen suppression with a two-week lead-in of Flutamide, followed by 9 monthly injections of Leuprolide Acetate. If PSA reached the appropriate nadir at by month 9, the androgen suppression was interrupted. Once the PSA reached the appropriate threshold, the subjects resumed treatment for another 9 months. These cycle continued until the patient withdrew from the study, was taken off the study due to toxicities or the decision of the investigator, or until the treatment with IAS was no longer effective in controlling the prostate cancer.||||
1557197|NCT00223652|Randomized|Parallel Assignment||Treatment||Single||||||t
1557198|NCT00223639|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1557199|NCT00223626|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1557200|NCT00223613|Randomized|Parallel Assignment||Prevention||Double||||||
1557201|NCT00223600|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557202|NCT00223587|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557203|NCT00223574|Randomized|Parallel Assignment||Treatment||Single||||||
1557204|NCT00223561|Randomized|Crossover Assignment||Prevention||Double||||||
1557205|NCT00223548|Randomized|Parallel Assignment||Prevention||Double||||||
1557206|NCT00223535|Randomized|Parallel Assignment||Treatment||Single||||||
1557207|NCT00223522|Random Sample||||Longitudinal, Prospective|||||||
1557208|NCT00223509||Single Group Assignment||Treatment||None (Open Label)||||||
1557209|NCT00223496||Single Group Assignment||Treatment||None (Open Label)||||||
1557210|NCT00223483|||Other||Prospective|||||||
1557211|NCT00223470|||Case Control||Prospective|||||||
1557212|NCT00223457|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1557213|NCT00223444|||Case Control||Prospective|||||||
1557214|NCT00223431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557215|NCT00223418|Randomized|Parallel Assignment||||None (Open Label)||||||
1557216|NCT00223405|||Cohort||Prospective|||||||
1557217|NCT00223379|Randomized|Parallel Assignment||Treatment||Single|||t|||
1557218|NCT00223366|||Case-Only||Cross-Sectional|||||||
1557219|NCT00223353||||||||||||
1557220|NCT00223340|Randomized|Factorial Assignment||||Single||||||
1557221|NCT00223327|||Cohort||Prospective|||||||
1557222|NCT00223314|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557223|NCT00223301|Randomized|Single Group Assignment||Treatment||Double||||||
1557224|NCT00223288||||||||||||
1557225|NCT00223275|Randomized|Crossover Assignment||Treatment||Double||||||
1557226|NCT00223262|Randomized|Parallel Assignment||||Double||||||
1557227|NCT00223249|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557228|NCT00223236|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557229|NCT00223223|Randomized|Parallel Assignment||Prevention||Double||||||
1557230|NCT00223210|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1557231|NCT00223197|Randomized|Parallel Assignment||Treatment||Double||||||
1557232|NCT00223184|||Cohort||Prospective|||||||
1557233|NCT00223171|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557234|NCT00223158|Randomized|Parallel Assignment||Treatment||Double||||||
1557235|NCT00223145|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557236|NCT00223132|Randomized|Single Group Assignment||||None (Open Label)||||||
1557237|NCT00223119|Randomized|Single Group Assignment||Treatment||Double||||||
1557238|NCT00223106|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557239|NCT00223093|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557240|NCT00223080|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1557241|NCT00223067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557242|NCT00223054|||||Retrospective|||||||
1557243|NCT00223041|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557244|NCT00223028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557245|NCT00223015|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557246|NCT00223002|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557247|NCT00222989||Single Group Assignment||Treatment||Double||||||
1557248|NCT00222976|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557249|NCT00222963|||||Prospective|||||||
1557250|NCT00222950|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1557251|NCT00222937|Randomized|Parallel Assignment||||None (Open Label)||||||
1557252|NCT00222924|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1557253|NCT00222911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557254|NCT00222898|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1557255|NCT00222885|||||Prospective|||||||
1557256|NCT00222872|Randomized|Parallel Assignment||Treatment||Single|||t|||
1557257|NCT00222859|||||Prospective|||||||
1557258|NCT00222846|Randomized|Parallel Assignment||||None (Open Label)||||||
1557259|NCT00222833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557260|NCT00222820|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557261|NCT00222807|||Case-Control||Prospective|||||||
1557262|NCT00222794|Randomized|Parallel Assignment||Treatment||Double||||||
1557263|NCT00222781|||||Prospective|||||||
1557264|NCT00222768|||||Prospective|||||||
1557265|NCT00222755|Randomized|Parallel Assignment||Treatment||Single||||||t
1557266|NCT00222742|Randomized|Parallel Assignment||Treatment||Single||||||t
1557267|NCT00222729||Single Group Assignment||Treatment||None (Open Label)||||||
1557268|NCT00222716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557269|NCT00222703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557270|NCT00222690|Random Sample||||Cross-Sectional, Prospective|||||||
1557271|NCT00222677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557272|NCT00222664|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557273|NCT00222651|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557274|NCT00222638|Randomized|Crossover Assignment||Treatment||Single||||||
1557275|NCT00222625|Randomized|Parallel Assignment||Treatment||Single||||||
1557276|NCT00222612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557277|NCT00222573|Randomized|Factorial Assignment||Treatment||Double||||||
1557278|NCT00222560|Randomized|Parallel Assignment||||None (Open Label)||||||
1557279|NCT00222547|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1557280|NCT00222534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557281|NCT00222521|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557282|NCT00222508|||||Prospective|||||||
1557283|NCT00222495|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557284|NCT00222482|Randomized|Parallel Assignment||Treatment||Double||||||
1557285|NCT00222469|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557286|NCT00222456|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557287|NCT00222443|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1557288|NCT00222430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557289|NCT00222417|||Case Control||Prospective|||||||
1557290|NCT00222404|||Cohort||Prospective|||||||
1557291|NCT00222391|||||Prospective|||||||
1557292|NCT00222378|||Case Control||Prospective|||||||
1557293|NCT00222365|Randomized|Parallel Assignment||Treatment||Double||||||
1557294|NCT00222352|||Cohort||Prospective|||||||
1557295|NCT00222339|Randomized|Parallel Assignment||Treatment||Single||||||
1557296|NCT00222326|Randomized|Single Group Assignment||Treatment||Single||||||t
1557297|NCT00222300|Randomized|Parallel Assignment||Treatment||Single||||||
1557298|NCT00222287|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1557299|NCT00222274|Randomized|Parallel Assignment||Treatment||Single|||t|||
1557300|NCT00222261|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557301|NCT00222248|Randomized|Parallel Assignment||Treatment||Single||||||
1557302|NCT00222235|Randomized|Parallel Assignment||Treatment||Double||||||
1557303|NCT00222222|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557304|NCT00222209|Randomized|Parallel Assignment||Diagnostic||Single||||||
1557305|NCT00222196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557306|NCT00222183|Randomized|Parallel Assignment||Treatment||Double||||||
1557307|NCT00222170|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557308|NCT00222144|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557309|NCT00222131|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1557310|NCT00222118|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557311|NCT00222105||Single Group Assignment||Treatment||None (Open Label)||||||
1557312|NCT00222092|||Cohort||Prospective|||||||
1557313|NCT00222079|Randomized|Single Group Assignment||Treatment||Double||||||
1557314|NCT00222066|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557315|NCT00222053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557316|NCT00222040|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557317|NCT00222027|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557318|NCT00222014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557319|NCT00222001|||Cohort||Prospective|||||||
1557320|NCT00221988|Randomized|Crossover Assignment||Treatment||Double||||||
1557321|NCT00221975|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1557322|NCT00221962||Single Group Assignment||Treatment||None (Open Label)||||||
1557323|NCT00221949|||||Prospective|||||||
1557324|NCT00221936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557325|NCT00221923|||Cohort||Prospective|||||||
1557326|NCT00221910|Randomized|Parallel Assignment||||Single||||||
1557327|NCT00221897|||Cohort||Prospective|||||||
1557328|NCT00221884|Randomized|Parallel Assignment||||Double||||||
1557329|NCT00221871|Randomized|Parallel Assignment||Treatment||Single||||||
1557330|NCT00221858|||||Other|||||||
1557331|NCT00221845|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557332|NCT00221832|||Family-Based||Prospective|||||||
1557333|NCT00221819|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557334|NCT00221806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557335|NCT00221793|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557336|NCT00221780|Randomized|Crossover Assignment||Treatment||Single||||||
1557337|NCT00221767|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557338|NCT00221754|Randomized|Parallel Assignment||Treatment||Double||||||
1557340|NCT00221728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557341|NCT00221715|Randomized|Parallel Assignment||Treatment||Single|||t|||
1557342|NCT00221702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557343|NCT00221689|Randomized|Parallel Assignment||Treatment||Double||||||
1557344|NCT00221676|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557345|NCT00221663|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1557346|NCT00221650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557347|NCT00221637|Randomized|Parallel Assignment||Treatment||Double||||||
1557348|NCT00221624|Randomized|Parallel Assignment||Treatment||Double||||||
1557349|NCT00221611|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557350|NCT00221598|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557351|NCT00221585|||Defined Population|Screening|Longitudinal, Prospective|||||||
1557352|NCT00221572|||||Prospective|||||||
1557353|NCT00221559|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1557354|NCT00221546|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1557355|NCT00221533|||||Prospective|||||||
1557356|NCT00221520|Randomized|Parallel Assignment||Prevention||Single||||||
1557357|NCT00221507|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557358|NCT00221494|Randomized|Single Group Assignment||Treatment||Double||||||
1557359|NCT00221481|Randomized|Single Group Assignment||Treatment||Single||||||
1557360|NCT00221468||Single Group Assignment||Treatment||Single||||||t
1557361|NCT00221455|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557362|NCT00221442|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1557363|NCT00221429|Randomized|Parallel Assignment||Treatment||Double||||||
1557364|NCT00221416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557365|NCT00221403|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1557366|NCT00221390|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557367|NCT00221377|Randomized|Parallel Assignment||Treatment||Single||||||
1557368|NCT00221364|Randomized|Single Group Assignment||Treatment||Single||||||
1557369|NCT00221351|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1557370|NCT00221338|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1557371|NCT00221325|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557372|NCT00221312|||Case Control||Prospective|||||||
1557373|NCT00221299|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1557374|NCT00221286|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1557375|NCT00221273|Randomized|Parallel Assignment||Treatment||Single|||t|||
1557376|NCT00221260|Randomized|Parallel Assignment||Treatment||Single|||t|||
1557377|NCT00221247|Randomized|Parallel Assignment||Treatment||Single||||||t
1557378|NCT00221234|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1557379|NCT00221221|Randomized|Factorial Assignment||||None (Open Label)||||||
1557380|NCT00221208|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557381|NCT00221195|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1557382|NCT00221182|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557383|NCT00221169|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557384|NCT00221156|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557385|NCT00221143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557386|NCT00221130|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557387|NCT00221117|Randomized|Parallel Assignment||Treatment||Single||||||t
1557388|NCT00221104|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557389|NCT00221091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557390|NCT00221078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557391|NCT00221065|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557392|NCT00221052|Randomized|Parallel Assignment||||Double||||||
1557393|NCT00221039||Single Group Assignment||Treatment||None (Open Label)||||||
1557394|NCT00221026|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557395|NCT00221013|Randomized|Parallel Assignment||||None (Open Label)||||||
1557396|NCT00221000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557397|NCT00220987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557398|NCT00220974|Randomized|Parallel Assignment||||Double||||||
1557399|NCT00220961|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1557400|NCT00220948|Randomized|Parallel Assignment||Diagnostic||Double||||||
1557401|NCT00220935|Randomized|Parallel Assignment||Treatment||Double||||||
1557402|NCT00220922|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1557403|NCT00220909|Randomized|Parallel Assignment||Prevention||Double||||||
1557404|NCT00220896|Randomized|Parallel Assignment||Prevention||Double||||||
1557405|NCT00220883|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1557406|NCT00220870|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557407|NCT00220857|Randomized|Parallel Assignment||Prevention||Double||||||
1557408|NCT00220844|Randomized|Crossover Assignment||Treatment||Double||||||
1557409|NCT00220831|Randomized|Parallel Assignment||Prevention||Double||||||
1557410|NCT00220818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557411|NCT00220805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557412|NCT00220792|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1557413|NCT00220779|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557414|NCT00220766|Randomized|Crossover Assignment||Treatment||Single|||t|||
1557415|NCT00220753|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1557416|NCT00220740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557417|NCT00220727|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557418|NCT00220714|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557419|NCT00220701|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557420|NCT00220688|Randomized|Parallel Assignment||Treatment||Double||||||
1557421|NCT00220675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557422|NCT00220662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557423|NCT00220649|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557424|NCT00220636||Single Group Assignment||Treatment||None (Open Label)||||||
1557425|NCT00220623|Randomized|Parallel Assignment||Treatment||Single||||||
1557426|NCT00220610|Randomized|Parallel Assignment||Treatment||Double||||||
1557427|NCT00220597|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1557428|NCT00220584||Single Group Assignment||Treatment||None (Open Label)||||||
1557429|NCT00220571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557430|NCT00220558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557431|NCT00220545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557432|NCT00220532|Randomized|Parallel Assignment||Prevention||Double||||||
1557433|NCT00220519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557434|NCT00220506|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557435|NCT00220493|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1557436|NCT00220480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557437|NCT00220467|Randomized|Parallel Assignment||Treatment||Single||||||
1557438|NCT00220454|Randomized|Parallel Assignment||Treatment||Double||||||
1557439|NCT00220441|Randomized|Parallel Assignment||Treatment||Single||||||
1557440|NCT00220428|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1557441|NCT00220415|Randomized|Parallel Assignment||Treatment||Double||||||
1557442|NCT00220402|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1557443|NCT00220389|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1557444|NCT00220376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557445|NCT00220363|Randomized|Parallel Assignment||||Double||||||
1557446|NCT00220350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557447|NCT00220337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557448|NCT00220324|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557449|NCT00220311|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557450|NCT00220298|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557451|NCT00220285|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557452|NCT00220272|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557453|NCT00220259|Randomized|Parallel Assignment||Prevention||Double||||||
1557454|NCT00220246|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1557455|NCT00220233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557456|NCT00220220|Randomized|Parallel Assignment||Treatment||Double||||||
1557457|NCT00220207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557458|NCT00220194|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557459|NCT00220181|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1557460|NCT00220168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557461|NCT00220155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557462|NCT00220142|||||Prospective|||||||
1557463|NCT00220129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557464|NCT00220116|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557465|NCT00220103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557466|NCT00220090|Randomized|Parallel Assignment||Treatment||Double||||||
1557467|NCT00220077|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1557468|NCT00220064|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557469|NCT00220051|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557470|NCT00220038|||Cohort||Prospective|||||||
1557471|NCT00220025||Single Group Assignment||Treatment||None (Open Label)||||||
1557472|NCT00220012|Non-Randomized|Single Group Assignment||Prevention||Single||||||
1557473|NCT00219999|||Case Control||Prospective|||||||
1557474|NCT00219986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557475|NCT00219973|Randomized|Parallel Assignment||Prevention||Double||||||
1557476|NCT00219960|Randomized|Crossover Assignment||Treatment||Double||||||
1557477|NCT00219947|||Other||Prospective|||||||
1557478|NCT00219934|||Cohort||Prospective|||||||
1557479|NCT00219921|Randomized|Parallel Assignment||Treatment||Double||||||
1557480|NCT00219908|Randomized|Parallel Assignment||||None (Open Label)||||||
1557481|NCT00219895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557482|NCT00219882|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557483|NCT00219869|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557484|NCT00219856|Randomized|Parallel Assignment||Treatment||Single|||t|||
1557485|NCT00219843|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557486|NCT00219830|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557488|NCT00219804|Randomized|Parallel Assignment||||Double||||||
1557489|NCT00219791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557490|NCT00219778|Randomized|Parallel Assignment||Treatment||Double||||||
1557491|NCT00219765|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557492|NCT00219752|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557493|NCT00219739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557494|NCT00219726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557495|NCT00219713|Randomized|Parallel Assignment||Prevention||Double||||||
1557496|NCT00219700|Randomized|Parallel Assignment||Treatment||Single||||||
1557497|NCT00219687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557498|NCT00219674|Randomized|Parallel Assignment||||None (Open Label)||||||
1557499|NCT00219661|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557500|NCT00219648|Randomized|Parallel Assignment||Treatment||Double||||||
1557501|NCT00219635|Randomized|Parallel Assignment||Treatment||Double||||||
1557502|NCT00219622|Randomized|Parallel Assignment||Treatment||Double||||||
1557503|NCT00219609|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557504|NCT00219596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557505|NCT00219583|Randomized|Parallel Assignment||Treatment||Double||||||
1557506|NCT00219570|Randomized|Parallel Assignment||Treatment||Single||||||
1557507|NCT00219557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557508|NCT00219544|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557509|NCT00219531|||Case-Control||Cross-Sectional|||||||
1557510|NCT00219518|||Case-Only||Prospective|||||||
1557511|NCT00219505|Randomized|Factorial Assignment||Treatment||Single||||||
1557512|NCT00219492|||||Prospective|||||||
1557513|NCT00219479|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557514|NCT00219466|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1557515|NCT00219453|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557516|NCT00219440|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557517|NCT00219427|||Case-Only||Prospective|||||||
1557518|NCT00219414|Randomized|Parallel Assignment||Treatment||Double||||||
1557519|NCT00219401|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557520|NCT00219388|Randomized|Parallel Assignment||Treatment||Double||||||
1557521|NCT00219375|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557522|NCT00219362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557523|NCT00219349||Single Group Assignment||Treatment||None (Open Label)||||||
1557524|NCT00219336|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557525|NCT00219323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557526|NCT00219310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557527|NCT00219297|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557528|NCT00219284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557529|NCT00219271||Single Group Assignment||Treatment||None (Open Label)||||||
1557530|NCT00219258|Randomized|Parallel Assignment||Treatment||Double||||||
1557531|NCT00219245|Randomized|Single Group Assignment||||None (Open Label)||||||
1557532|NCT00219232|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557533|NCT00219219|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557534|NCT00219193|Randomized|Parallel Assignment||Treatment||Double||||||
1557535|NCT00219180|Randomized|Parallel Assignment||Treatment||Double||||||
1557536|NCT00219167|Randomized|Parallel Assignment||Treatment||Double||||||
1557537|NCT00219154|Randomized|Parallel Assignment||Treatment||Double||||||
1557538|NCT00219141|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557539|NCT00219128|Randomized|Parallel Assignment||Treatment||Double||||||
1557540|NCT00219115|Randomized|Parallel Assignment||Treatment||Double||||||
1557541|NCT00219102|Randomized|Parallel Assignment||Treatment||Double||||||
1557542|NCT00219089|Randomized|Parallel Assignment||Treatment||Double||||||
1557543|NCT00219076|Randomized|Parallel Assignment||Treatment||Double||||||
1557544|NCT00219063|Randomized|Parallel Assignment||Treatment||Double||||||
1557545|NCT00219050|Randomized|Parallel Assignment||Treatment||Double||||||
1557546|NCT00219037|Randomized|Parallel Assignment||Treatment||Single||||||
1557547|NCT00219024|Randomized|Parallel Assignment||Treatment||Double||||||
1557548|NCT00219011|Randomized|Parallel Assignment||Other||Double||||||
1557549|NCT00218998|Randomized|Parallel Assignment||Prevention||Single||||||
1557550|NCT00218985|Randomized|Parallel Assignment||Basic Science||Single|||||t|
1557551|NCT00218972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557552|NCT00218959|Randomized|Parallel Assignment||Treatment||Single||||||t
1557553|NCT00218946|Randomized|Factorial Assignment||||Single||||t||
1557554|NCT00218933|Randomized|Factorial Assignment||Treatment||Single||||||t
1557555|NCT00218920|Randomized|Factorial Assignment||Treatment||Single||||||
1557556|NCT00218907|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1557557|NCT00218894|||Case-Only||Prospective|||||||
1557558|NCT00218881|Randomized|Factorial Assignment||Educational/Counseling/Training||None (Open Label)||||||
1557559|NCT00218868|||Case-Only||Prospective|||||||
1557560|NCT00218855|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557561|NCT00218842|Randomized|Parallel Assignment||Treatment||Single||||||t
1557562|NCT00218829|||Case-Only||Prospective|||||||
1557563|NCT00218816|Randomized|Parallel Assignment||||None (Open Label)||||||
1557947|NCT00213642|||||Prospective|||||||
1557564|NCT00218803|Randomized|Single Group Assignment||||None (Open Label)||||||
1557565|NCT00218790|Randomized|Parallel Assignment||Treatment||Single|||||t|
1557566|NCT00218777|Randomized|Parallel Assignment||Treatment||Double||||||
1557567|NCT00218751|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557568|NCT00218725|Randomized|Parallel Assignment||Treatment||Single||||||t
1557569|NCT00218712|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1557570|NCT00218699|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1557571|NCT00218686|Randomized|Parallel Assignment||Prevention||Single|||t|||
1557572|NCT00218673|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1557573|NCT00218660|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1557574|NCT00218634|Randomized|Parallel Assignment||Treatment||Single||||||t
1557575|NCT00218621|||Cohort||Prospective|||||||
1557576|NCT00218608|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557577|NCT00218595|Randomized|Parallel Assignment||Treatment||Single||||||t
1557578|NCT00218582|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557579|NCT00218569|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1557580|NCT00218556|Randomized|Parallel Assignment||Prevention||Single||||||t
1557581|NCT00218543||Single Group Assignment||Treatment||None (Open Label)||||||
1557582|NCT00218530|Randomized|Parallel Assignment||Treatment||Single||||||
1557583|NCT00218517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557584|NCT00218504|||Case-Only||Prospective|||||||
1557585|NCT00218491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557586|NCT00218478|||Case-Only||Prospective|||||||
1557587|NCT00218465|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1557588|NCT00218452||Single Group Assignment||Treatment||None (Open Label)||||||
1557589|NCT00218439|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1557590|NCT00218426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557591|NCT00218413|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557592|NCT00218387|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557593|NCT00218374|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1557594|NCT00218361|||Case-Only||Prospective|||||||
1557595|NCT00218348|Randomized|Parallel Assignment||Treatment||Double||||||
1557596|NCT00218335|Randomized|Parallel Assignment||Prevention||Single|||t|||
1557597|NCT00218322|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557598|NCT00218309|||||Prospective|||||||
1557599|NCT00218296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557600|NCT00218283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557601|NCT00218270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557602|NCT00218257|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1557603|NCT00218244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557604|NCT00218231|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1557605|NCT00218218|Randomized|Crossover Assignment||Basic Science||Double|||t|||t
1557606|NCT00218205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557607|NCT00218192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557608|NCT00218179|||Case-Control||Retrospective|||||||
1557609|NCT00218166|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1557610|NCT00218153|Randomized|Parallel Assignment||Treatment||Double||||||
1557611|NCT00218140|Randomized|Crossover Assignment||Treatment||Double||||||
1557612|NCT00218127|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1557613|NCT00218114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557614|NCT00218101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557615|NCT00218075|Randomized|Parallel Assignment||Treatment||Double||||||
1557616|NCT00218062|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557617|NCT00218049|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557618|NCT00218036|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557619|NCT00218023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557620|NCT00218010|||Cohort||Prospective|||||||
1557621|NCT00217997|||Cohort||Prospective|||||||
1557622|NCT00217984|Randomized|Parallel Assignment||Treatment||Single||||||t
1557623|NCT00217971|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1557624|NCT00217958|Randomized|||Treatment||||||||
1557625|NCT00217945|Randomized|||Treatment||||||||
1557626|NCT00217932|Randomized|Crossover Assignment||Treatment||Double||||||
1557627|NCT00217919|Randomized|Parallel Assignment||Treatment||Single||||||t
1557628|NCT00217906|Randomized|||Treatment||||||||
1557629|NCT00217893|Randomized|Parallel Assignment||Prevention||Single||||||t
1557630|NCT00217880||Single Group Assignment||Diagnostic||None (Open Label)||||||
1557631|NCT00217867|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557632|NCT00217854||Single Group Assignment||Diagnostic||None (Open Label)||||||
1557633|NCT00217841|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1557634|NCT00217828|Randomized|||Treatment||||||||
1557635|NCT00217815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557636|NCT00217802|Randomized|||Treatment||||||||
1557637|NCT00217789|||Case-Only||Prospective|||||||
1557638|NCT00217776|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557639|NCT00217763|Randomized|Parallel Assignment||||Double||||||
1557640|NCT00217737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557641|NCT00217724|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1557642|NCT00217711||Single Group Assignment||Treatment||None (Open Label)||||||
1557643|NCT00217698||Single Group Assignment||Treatment||None (Open Label)||||||
1557644|NCT00217672|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557645|NCT00217659||||Treatment||None (Open Label)||||||
1557646|NCT00217646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557647|NCT00217633||Single Group Assignment||Treatment||None (Open Label)||||||
1557648|NCT00217620||Single Group Assignment||Treatment||None (Open Label)||||||
1557649|NCT00217607||Single Group Assignment||Treatment||None (Open Label)||||||
1557650|NCT00217594||Single Group Assignment||Treatment||None (Open Label)||||||
1557651|NCT00217581||Single Group Assignment||Treatment||None (Open Label)||||||
1557652|NCT00217568||||Treatment||None (Open Label)||||||
1557653|NCT00217555||||Treatment||None (Open Label)||||||
1557654|NCT00217542||Single Group Assignment||Treatment||None (Open Label)||||||
1557655|NCT00217529||||Treatment||||||||
1557656|NCT00217516|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557657|NCT00217503||||Treatment||||||||
1557658|NCT00217490|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1557659|NCT00217477||Single Group Assignment||Treatment||None (Open Label)||||||
1557660|NCT00217464||Single Group Assignment||Treatment||None (Open Label)||||||
1557661|NCT00217451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557662|NCT00217438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557663|NCT00217425||Single Group Assignment||Treatment||None (Open Label)||||||
1557664|NCT00217412|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557665|NCT00217399||Single Group Assignment||Treatment||None (Open Label)||||||
1557666|NCT00217386||||Treatment||None (Open Label)||||||
1557667|NCT00217373||Single Group Assignment||Treatment||None (Open Label)||||||
1557668|NCT00217360|Randomized|Parallel Assignment||Treatment||Single||||||
1557669|NCT00217347|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557670|NCT00217334|Randomized|Parallel Assignment||Prevention||Single||||||
1557671|NCT00217321|||Ecologic or Community||Prospective|||||||
1557672|NCT00217308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557673|NCT00217295|Randomized|Parallel Assignment||Treatment||Double||||||
1557674|NCT00217282|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557675|NCT00217269|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1557676|NCT00217256|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1557677|NCT00217243|||Cohort||Prospective|||||||
1557678|NCT00217230|Randomized|Single Group Assignment||Treatment||Double||||||
1557679|NCT00217217|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1557680|NCT00217204|Randomized|Parallel Assignment||Treatment||Single||||||
1557681|NCT00217191|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1557682|NCT00217178|Randomized|Factorial Assignment||Prevention||Double||||||
1557683|NCT00217165|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1557684|NCT00217152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557685|NCT00217139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557686|NCT00217126|||Cohort||Prospective|||||||
1557687|NCT00217113|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557688|NCT00217100|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1557689|NCT00217087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557690|NCT00217074|Randomized|Single Group Assignment||Treatment||Single||||||
1557691|NCT00217061|Randomized|Parallel Assignment||||Single||||||
1557692|NCT00217048|Randomized|Parallel Assignment||Treatment||Double||||||
1557693|NCT00217035||||||||||||
1557694|NCT00217022|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557695|NCT00217009|Randomized|Single Group Assignment||Treatment||Single|||||t|
1557696|NCT00216996||||||||||||
1557697|NCT00216983|||Case-Crossover||Prospective|||||||
1557698|NCT00216970|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557699|NCT00216957|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557700|NCT00216944|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1557701|NCT00216931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557702|NCT00216918|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557703|NCT00216905|||Case-Only||Cross-Sectional|||||||
1557704|NCT00216892|Randomized|Parallel Assignment||Treatment||Double||||||
1557705|NCT00216879|Randomized|Parallel Assignment||Treatment||Double||||||
1557706|NCT00216866|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557707|NCT00216853|||Cohort||Prospective|||||||
1557708|NCT00216840|Randomized|Parallel Assignment||Treatment||Double||||||
1557709|NCT00216827|Randomized|Parallel Assignment||Treatment||Double||||||
1557710|NCT00216814|||Cohort||Prospective|||||||
1557711|NCT00216801|||Cohort||Prospective|||||||
1557712|NCT00216788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557713|NCT00216775|||Cohort||Prospective|||||||
1557714|NCT00216762|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557715|NCT00216749|||Cohort||Prospective|||||||
1557716|NCT00216736|Randomized|Single Group Assignment||Prevention||Double||||||
1557717|NCT00216723|||Ecologic or Community||Prospective|||||||
1557718|NCT00216710|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557719|NCT00216697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557720|NCT00216684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557721|NCT00216671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557722|NCT00216658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557723|NCT00216645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557724|NCT00216632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557725|NCT00216619|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557726|NCT00216606|Randomized|Parallel Assignment||Treatment||Double||||||
1557727|NCT00216593|Randomized|Parallel Assignment||Treatment||Double||||||
1557728|NCT00216580||Single Group Assignment||Treatment||None (Open Label)||||||
1557729|NCT00216567|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557730|NCT00216554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557731|NCT00216541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557732|NCT00216528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557733|NCT00216515|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557734|NCT00216502|Randomized|Parallel Assignment||Treatment||Double||||||
1557735|NCT00216489|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557736|NCT00216476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557737|NCT00216463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557738|NCT00216450|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557739|NCT00216437|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557740|NCT00216424|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557741|NCT00216411|Randomized|Parallel Assignment||Treatment||Double||||||
1557742|NCT00216398|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557743|NCT00216385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557744|NCT00216372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557745|NCT00216359|||Natural History||Longitudinal, Retrospective/Prospective|||||||
1557746|NCT00216346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557747|NCT00216333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557748|NCT00216320|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557749|NCT00216294|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1557750|NCT00216281|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557751|NCT00216268|Randomized|Parallel Assignment||Treatment||Double||||||
1557752|NCT00216255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557753|NCT00216242|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1557754|NCT00216229|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557755|NCT00216216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557756|NCT00216203||Single Group Assignment||Treatment||None (Open Label)||||||
1557757|NCT00216190|Randomized|Parallel Assignment||Treatment||Double||||||
1557758|NCT00216177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557759|NCT00216164|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557760|NCT00216151|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557761|NCT00216138|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557762|NCT00216125|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1557763|NCT00216112||Single Group Assignment||Treatment||None (Open Label)||||||
1557764|NCT00216099||Single Group Assignment||Treatment||None (Open Label)||||||
1557765|NCT00216086||Single Group Assignment||Treatment||None (Open Label)||||||
1557766|NCT00216073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557767|NCT00216060|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1557768|NCT00216047||Single Group Assignment||Treatment||None (Open Label)||||||
1557769|NCT00216034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557770|NCT00216021||Single Group Assignment||Treatment||None (Open Label)||||||
1557771|NCT00216008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557772|NCT00215995||Single Group Assignment||Treatment||None (Open Label)||||||
1557773|NCT00215982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557774|NCT00215969|||Case Control|Screening|Longitudinal, Prospective|||||||
1557775|NCT00215956||Single Group Assignment||Treatment||None (Open Label)||||||
1557776|NCT00215943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557777|NCT00215930||Single Group Assignment||Treatment||None (Open Label)||||||
1557778|NCT00215917|Randomized|Parallel Assignment||Treatment||Double||||||
1557779|NCT00215904|Randomized|Crossover Assignment||||Triple|||t|t|t|
1557780|NCT00215891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557781|NCT00215878|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1557782|NCT00215865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557783|NCT00215852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557784|NCT00215839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557785|NCT00215826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557786|NCT00215813||||||||||||
1557787|NCT00215800|Randomized|Parallel Assignment||Treatment||Double||||||
1557788|NCT00215787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557789|NCT00215774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557790|NCT00215761|||||Prospective|||||||
1557791|NCT00215748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557792|NCT00215735|Randomized|Single Group Assignment||||Single||||||
1557793|NCT00215722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557794|NCT00215709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557795|NCT00215696|Randomized|Single Group Assignment||Treatment||Double||||||
1557796|NCT00215683|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557797|NCT00215670|Randomized|Parallel Assignment||Treatment||Double||||||
1557798|NCT00215657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557799|NCT00215644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557800|NCT00215631|Randomized|Parallel Assignment||Prevention||Double||||||
1557801|NCT00215618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557802|NCT00215605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557803|NCT00215592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557804|NCT00215579|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557805|NCT00215566|Randomized|Parallel Assignment||Treatment||Double||||||
1557806|NCT00215553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557807|NCT00215540|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1557808|NCT00215527||Single Group Assignment||Treatment||None (Open Label)||||||
1557809|NCT00215514|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557810|NCT00215501|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557811|NCT00215462|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557812|NCT00215449|Randomized|Parallel Assignment||Treatment||Double||||||
1557813|NCT00215436|Randomized|Parallel Assignment||Treatment||Double||||||
1557814|NCT00215423|Randomized|Crossover Assignment||Treatment||Double||||||
1557815|NCT00215410|Randomized|Crossover Assignment||Treatment||Double||||||
1557816|NCT00215397|Randomized|Crossover Assignment||Treatment||Double||||||
1557817|NCT00215384|Randomized|Crossover Assignment||Treatment||Double||||||
1557818|NCT00215371|Randomized|Crossover Assignment||Treatment||Double||||||
1557819|NCT00215358|Randomized|Crossover Assignment||Treatment||Double||||||
1557820|NCT00215345|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557821|NCT00215332|||||Prospective|||||||
1557822|NCT00215319||Single Group Assignment||Treatment||None (Open Label)||||||
1557823|NCT00215306|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557824|NCT00215293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557825|NCT00215280|Randomized|Single Group Assignment||Treatment||Double||||||
1557826|NCT00215267|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557827|NCT00215254|Randomized|Parallel Assignment||Treatment||Double||||||
1557828|NCT00215241|Randomized|Parallel Assignment||Treatment||Double||||||
1557829|NCT00215228|Randomized|Parallel Assignment||Treatment||Double||||||
1557830|NCT00215215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557831|NCT00215202|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557832|NCT00215189|||||Prospective|||||||
1557833|NCT00215176|Randomized|Parallel Assignment||Treatment||Double||||||
1557834|NCT00215163|Randomized|Parallel Assignment||Treatment||Double||||||
1557835|NCT00215150|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1557836|NCT00215137|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1557837|NCT00215124|Randomized|Parallel Assignment||Treatment||Single||||||
1557838|NCT00215111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557839|NCT00215098|||||Retrospective|||||||
1557840|NCT00215085|||||Retrospective|||||||
1557841|NCT00215072|||||Retrospective|||||||
1557842|NCT00215059|||Cohort||Prospective|||||||
1557843|NCT00215046|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557844|NCT00215033|||||Retrospective|||||||
1557845|NCT00215020|||Case-Only||Prospective|||||||
1557846|NCT00215007|Randomized|Parallel Assignment||Prevention||Double||||||
1557847|NCT00214994|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557848|NCT00214981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557849|NCT00214968||Single Group Assignment||Treatment||None (Open Label)||||||
1557850|NCT00214955|Randomized|Factorial Assignment||Treatment||Double||||||
1557851|NCT00214942|Randomized|Factorial Assignment||Treatment||Double||||||
1557852|NCT00214929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557853|NCT00214916|Randomized|Parallel Assignment||Treatment||Single|||t|||
1557854|NCT00214903|||Cohort||Prospective|||||||
1557855|NCT00214890|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557856|NCT00214877|Randomized|Crossover Assignment||Treatment||Double||||||
1557857|NCT00214864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557858|NCT00214851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557859|NCT00214838|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557860|NCT00214825|Randomized|Crossover Assignment||Treatment||Double||||||
1557861|NCT00214812|Randomized|Crossover Assignment||Treatment||Double||||||
1557862|NCT00214786||Single Group Assignment||Treatment||None (Open Label)||||||
1557863|NCT00214773|||Cohort||Prospective|||||||
1557864|NCT00214760|Randomized|Parallel Assignment||Treatment||Single|||t|||
1557865|NCT00214747|Randomized|Single Group Assignment||Diagnostic||Double||||||
1557866|NCT00214734|||Case-Only||Prospective|||||||
1557867|NCT00214721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557868|NCT00214708|||Defined Population|Screening|Longitudinal, Prospective|||||||
1557869|NCT00214695|Randomized|Crossover Assignment||Treatment||Double||||||
1557870|NCT00214682|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1557871|NCT00214669|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1557872|NCT00214656|Randomized|Parallel Assignment||Treatment||Double||||||
1557873|NCT00214643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557874|NCT00214630|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557875|NCT00214617|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557876|NCT00214604|Randomized|Crossover Assignment||Treatment||Double||||||
1557877|NCT00214591|Randomized|Parallel Assignment||Treatment||Double||||||
1557878|NCT00214578|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557879|NCT00214565|Randomized|Parallel Assignment||Treatment||Double||||||
1557880|NCT00214552|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1557881|NCT00214539|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557882|NCT00214526|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557883|NCT00214513|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557884|NCT00214500||Single Group Assignment||Treatment||None (Open Label)||||||
1557885|NCT00214487|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1557886|NCT00214474|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1557887|NCT00214461|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1557888|NCT00214448|||Defined Population||Cross-Sectional, Prospective|||||||
1557889|NCT00214435|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557890|NCT00214422|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557891|NCT00214383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557892|NCT00214370|Randomized|Crossover Assignment||Treatment||Double||||||
1557893|NCT00214357|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557894|NCT00214344|Randomized|Single Group Assignment||||None (Open Label)||||||
1557895|NCT00214331|||Cohort||Prospective|||||||
1557896|NCT00214318|Randomized|Parallel Assignment||Treatment||Double||||||
1557897|NCT00214305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557898|NCT00214292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557899|NCT00214279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557900|NCT00214266||Single Group Assignment||Treatment||None (Open Label)||||||
1557901|NCT00214253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557902|NCT00214240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557903|NCT00214227|||Cohort||Prospective|||||||
1557904|NCT00214214|Randomized|Parallel Assignment||||None (Open Label)||||||
1557905|NCT00214201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557906|NCT00214175|||Case Control||Prospective|||||||
1557907|NCT00214162|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1557908|NCT00214149||Single Group Assignment||Treatment||None (Open Label)||||||
1557909|NCT00214136||Single Group Assignment||Treatment||None (Open Label)||||||
1557910|NCT00214123|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557911|NCT00214110|Randomized|Parallel Assignment||||Single||||||
1557912|NCT00214097||Single Group Assignment||Treatment||None (Open Label)||||||
1557913|NCT00214084|Randomized|Parallel Assignment||||Double||||||
1557914|NCT00214071|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1557915|NCT00214058|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557916|NCT00214045|Randomized|Parallel Assignment||||Single|||t|||
1557917|NCT00214032|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1557918|NCT00214019|Randomized|Crossover Assignment||Treatment||Single|||t|||
1557919|NCT00214006|||Case-Only||Prospective|||||||
1557920|NCT00213993|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557921|NCT00213980|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557922|NCT00213967|Randomized|Factorial Assignment||||Double||||||
1557923|NCT00213954|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1557924|NCT00213941|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557925|NCT00213928|Randomized|Factorial Assignment||Supportive Care||Single|||t|||
1557926|NCT00213915|Randomized|Parallel Assignment||Treatment||Double||||||
1557927|NCT00213902|||||Prospective|||||||
1557928|NCT00213889|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557929|NCT00213876|||Case-Only||Prospective|||||||
1557930|NCT00213863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557931|NCT00213850|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1557932|NCT00213837|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1557933|NCT00213824|||Case Control||Prospective|||||||
1557934|NCT00213811||||||||||||
1557935|NCT00213798|Non-Randomized|Single Group Assignment||Screening||None (Open Label)||||||
1557936|NCT00213785|||||Prospective|||||||
1557937|NCT00213772|||Case Control||Longitudinal, Prospective|||||||
1557938|NCT00213759|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1557939|NCT00213746|||||Prospective|||||||
1557940|NCT00213733|||Case-Only||Prospective|||||||
1557941|NCT00213720|||Cohort||Prospective|||||||
1557942|NCT00213707|||Cohort||Prospective|||||||
1557943|NCT00213694|||||Prospective|||||||
1557944|NCT00213681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557945|NCT00213668|Randomized|Parallel Assignment||Prevention||Double||||||
1557946|NCT00213655|||Case Control||Prospective|||||||
1557948|NCT00213629|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1557949|NCT00213616||Single Group Assignment||Treatment||None (Open Label)||||||
1557950|NCT00213603|||Cohort||Prospective|||||||
1557951|NCT00213590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557952|NCT00213577|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1557953|NCT00213564|||||Prospective|||||||
1557954|NCT00213551|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1557955|NCT00213538|||Cohort||Prospective|||||||
1557956|NCT00213525|||Case Control||Prospective|||||||
1557957|NCT00213512|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1557958|NCT00213499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557959|NCT00213486|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557960|NCT00213473|||Cohort||Prospective|||||||
1557961|NCT00213460|||||Prospective|||||||
1557962|NCT00213447|||Cohort||Prospective|||||||
1557963|NCT00213434|Randomized|Parallel Assignment||Treatment||Double||||||
1557964|NCT00213421|||Case-Only||Prospective|||||||
1557965|NCT00213408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557966|NCT00213395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557967|NCT00213382|||||Prospective|||||||
1557968|NCT00213369|||||Prospective|||||||
1557969|NCT00213356|||Cohort||Prospective|||||||
1557970|NCT00213343|||Case Control||Prospective|||||||
1557971|NCT00213330|||Case Control||Prospective|||||||
1557972|NCT00213317|||Case Control||Prospective|||||||
1557973|NCT00213304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557974|NCT00213291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557975|NCT00213278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557976|NCT00213265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1557977|NCT00213252|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1557978|NCT00213239|Randomized|Parallel Assignment||Treatment||Single||||||t
1557979|NCT00213226|Randomized|Parallel Assignment||Treatment||Double||||||
1557980|NCT00213213|Randomized|Parallel Assignment||Treatment||Double||||||
1557981|NCT00213200|Randomized|Parallel Assignment||Treatment||Double||||||
1557982|NCT00213187|Randomized|Parallel Assignment||Treatment||Single||||||
1557983|NCT00213174|Randomized|Parallel Assignment||||None (Open Label)||||||
1557984|NCT00213161|Randomized|Parallel Assignment||Treatment||Single||||||
1557985|NCT00213148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1557986|NCT00213135|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1557987|NCT00213122|Non-Randomized|Crossover Assignment||Treatment||Single||||||
1557988|NCT00213109|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1557989|NCT00213096|Randomized|Parallel Assignment||Prevention||Double||||||
1557990|NCT00213083|Randomized|Parallel Assignment||Prevention||Double||||||
1557991|NCT00213070|Randomized|Parallel Assignment||Treatment||Double||||||
1557992|NCT00213057|Randomized|Parallel Assignment||Prevention||Double||||||
1557993|NCT00213044|Randomized|Crossover Assignment||Prevention||Double||||||
1557994|NCT00213031|Randomized|Parallel Assignment||Other||Double||||||
1557995|NCT00213018|Randomized|Parallel Assignment||Prevention||Double||||||
1557996|NCT00213005|Randomized|Parallel Assignment||Diagnostic||Double||||||
1557997|NCT00212992|Randomized|Single Group Assignment||Treatment||Double||||||
1557998|NCT00212979|||||Prospective|||||||
1557999|NCT00212966||||||||||||
1558000|NCT00212953|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1558001|NCT00212940|Randomized|Parallel Assignment||||None (Open Label)||||||
1558002|NCT00212927|||||Prospective|||||||
1558003|NCT00212914|Randomized|Factorial Assignment||||None (Open Label)||||||
1558004|NCT00212901|Randomized|Crossover Assignment||||None (Open Label)||||||
1558005|NCT00212888|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1558006|NCT00212875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558007|NCT00212862|||Case-Only||Prospective|||||||
1558008|NCT00212849|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1558009|NCT00212836|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558010|NCT00212823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558011|NCT00212810|Randomized|Parallel Assignment||Treatment||Double||||||
1558012|NCT00212797|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558013|NCT00212784|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558014|NCT00212771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558015|NCT00212758|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1558016|NCT00212745|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558017|NCT00212732|Randomized|Parallel Assignment||Treatment||Double||||||
1558018|NCT00212719|Randomized|Parallel Assignment||Treatment||Double||||||
1558019|NCT00212706|Randomized|Parallel Assignment||Treatment||Double||||||
1558020|NCT00212693|Randomized|Parallel Assignment||Treatment||Double||||||
1558021|NCT00212680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558022|NCT00212667|Randomized|Parallel Assignment||Treatment||Double||||||
1558023|NCT00212654|Randomized|Parallel Assignment||Treatment||Double||||||
1558024|NCT00212641|Randomized|Parallel Assignment||Treatment||Double||||||
1558025|NCT00212628|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558026|NCT00212615|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1558550|NCT00205647|Randomized|Parallel Assignment||Treatment||Double||||||
1558027|NCT00212602|Randomized|Parallel Assignment||Prevention||Double||||||
1558028|NCT00212589|Randomized|Crossover Assignment||Treatment||Double||||||
1558029|NCT00212576|Randomized|Parallel Assignment||Prevention||Single||||||t
1558030|NCT00212550|||||Prospective|||||||
1558031|NCT00212537|||Case-Control||Other|||||||
1558032|NCT00212511|||Case-Only||Prospective|||||||
1558033|NCT00212498|||||Prospective|||||||
1558034|NCT00212485|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558035|NCT00212472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558036|NCT00212459|Randomized|Parallel Assignment||||None (Open Label)||||||
1558037|NCT00212446||Single Group Assignment||Prevention||None (Open Label)||||||
1558038|NCT00212433|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1558039|NCT00212420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558040|NCT00212407||Single Group Assignment||Treatment||None (Open Label)||||||
1558041|NCT00212394|||||Prospective|||||||
1558042|NCT00212381|Randomized|Parallel Assignment||Treatment||Quadruple|central pharmacy dispenses based on sealed randomization table|randomized double blind intervention trial|t|t|t|t
1558043|NCT00212368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558044|NCT00212355||Single Group Assignment||Treatment||None (Open Label)||||||
1558045|NCT00212342|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558046|NCT00212329|||||Prospective|||||||
1558047|NCT00212316|Randomized|Parallel Assignment||Treatment||Double||||||
1558048|NCT00212303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558049|NCT00212290|Randomized|Parallel Assignment||Treatment||Double||||||
1558050|NCT00212277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558051|NCT00212264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558052|NCT00212251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558053|NCT00212238|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558054|NCT00212225||||||||||||
1558055|NCT00212212|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1558056|NCT00212199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558057|NCT00212186|Randomized|Parallel Assignment||||Double||||||
1558058|NCT00212173|Randomized|Single Group Assignment||Treatment||Double||||||
1558059|NCT00212160|Randomized|Parallel Assignment||Basic Science||Single|||t|||
1558060|NCT00212147|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1558061|NCT00212134|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase 3 is 10.5-year follow-up study since Phase 1. There is no intervention.||||
1558062|NCT00212121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558063|NCT00212108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558064|NCT00212095|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558065|NCT00212082|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558066|NCT00212069|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558067|NCT00212056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558068|NCT00212043|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558069|NCT00212030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558070|NCT00212017|Randomized|Parallel Assignment||Prevention||Single|This is an open and blinded-endpoint study|Prospective, randomised, open, blinded-endpoint study||||t
1558071|NCT00212004|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558072|NCT00211991|Randomized|Parallel Assignment||Prevention||Double||||||
1558073|NCT00211978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558074|NCT00211965|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1558075|NCT00211952|Randomized|Parallel Assignment||Treatment||Double||||||
1558076|NCT00211939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558077|NCT00211926|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1558078|NCT00211913|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1558079|NCT00211900|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1558080|NCT00211887|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1558081|NCT00211874|Randomized|Parallel Assignment||||None (Open Label)||||||
1558082|NCT00211848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558083|NCT00211835|Randomized|Parallel Assignment||Treatment||Single||||||t
1558084|NCT00211822|||Case Control||Cross-Sectional|||||||
1558085|NCT00211809||Single Group Assignment||Treatment||None (Open Label)||||||
1558086|NCT00211796|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558087|NCT00211783|||Case Control||Prospective|||||||
1558088|NCT00211770|||Cohort||Prospective|||||||
1558089|NCT00211757|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558090|NCT00211744|Randomized|Parallel Assignment||Treatment||Double||||||
1558091|NCT00211731|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558092|NCT00211718|Randomized|Parallel Assignment||Treatment||Double||||||
1558093|NCT00211705|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558094|NCT00211692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558095|NCT00211679|Randomized|Parallel Assignment||Treatment||Double||||||
1558096|NCT00211666|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558097|NCT00211653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558098|NCT00211640||||Screening|Longitudinal, Retrospective/Prospective|||||||
1558099|NCT00211627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558100|NCT00211614|Randomized|Single Group Assignment||Treatment||Double||||||
1558101|NCT00211601|Randomized|Parallel Assignment||||None (Open Label)||||||
1558102|NCT00211588|Randomized|Parallel Assignment||Prevention||Double||||||
1558103|NCT00211575|Randomized|Parallel Assignment||||None (Open Label)||||||
1558104|NCT00211562|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1558105|NCT00211549|Randomized|Parallel Assignment||Treatment||Double||||||
1558106|NCT00211536|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558107|NCT00211523|Randomized|Parallel Assignment||Treatment||Double||||||
1558108|NCT00211510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558109|NCT00211497|Randomized|Parallel Assignment||Treatment||Double||||||
1558110|NCT00211484|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558111|NCT00211471|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558112|NCT00211458|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558113|NCT00211445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558114|NCT00211432|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558115|NCT00211419|Non-Randomized|||Treatment||None (Open Label)||||||
1558116|NCT00211406|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558117|NCT00211393|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558118|NCT00211380|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558119|NCT00211367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558120|NCT00211354|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558121|NCT00211341|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1558122|NCT00211328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558123|NCT00211315|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558124|NCT00211302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558125|NCT00211289|Randomized|Parallel Assignment||||Double||||||
1558126|NCT00211276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558127|NCT00211263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558128|NCT00211250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558129|NCT00211237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558130|NCT00211224|Randomized|Parallel Assignment||Treatment||Double||||||
1558131|NCT00211211|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1558132|NCT00211198|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558133|NCT00211185|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558134|NCT00211172|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1558135|NCT00211159|Randomized|Crossover Assignment||Treatment||Double||||||
1558136|NCT00211146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558137|NCT00211133|Randomized|Parallel Assignment||Treatment||Double||||||
1558138|NCT00211120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558139|NCT00211107|Randomized|Parallel Assignment||Treatment||Double||||||
1558140|NCT00211094|Randomized|Parallel Assignment||Treatment||Double||||||
1558141|NCT00211081|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558142|NCT00211068|||Case Control||Retrospective|||||||
1558143|NCT00211055|||||Prospective|||||||
1558144|NCT00211042|||Case-Only||Prospective|||||||
1558145|NCT00211029|||Cohort||Prospective|||||||
1558146|NCT00211016|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558147|NCT00211003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558148|NCT00210990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558149|NCT00210977|||Cohort||Prospective|||||||
1558150|NCT00210964|Randomized|Parallel Assignment||Treatment||Double||||||
1558151|NCT00210951|||Cohort||Prospective|||||||
1558152|NCT00210938|Randomized|Parallel Assignment||Treatment||Double||||||
1558153|NCT00210925|Randomized|Parallel Assignment||Treatment||Double||||||
1558154|NCT00210912|Randomized|Parallel Assignment||Prevention||Double||||||
1558155|NCT00210899|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558156|NCT00210886|Randomized|Parallel Assignment||Treatment||Double||||||
1558157|NCT00210873|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1558158|NCT00210860|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1558159|NCT00210847|Randomized|Parallel Assignment||Treatment||Double||||||
1558160|NCT00210834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558161|NCT00210821|Randomized|Parallel Assignment||Prevention||Double||||||
1558162|NCT00210808|Randomized|Parallel Assignment||Treatment||Double||||||
1558163|NCT00210795|Randomized|Parallel Assignment||Treatment||Double||||||
1558164|NCT00210782|Randomized|Parallel Assignment||Treatment||Double||||||
1558165|NCT00210769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558166|NCT00210756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558167|NCT00210743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558168|NCT00210730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558169|NCT00210717|Randomized|Parallel Assignment||Treatment||Double||||||
1558170|NCT00210704|Randomized|Parallel Assignment||Treatment||Double||||||
1558171|NCT00210691|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558172|NCT00210678|||Case Control||Prospective|||||||
1558173|NCT00210665||||||||||||
1558174|NCT00210652|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558175|NCT00210639|||Cohort||Prospective|||||||
1558176|NCT00210626|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558177|NCT00210613|Randomized|Parallel Assignment||Treatment||Double||||||
1558178|NCT00210600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558179|NCT00210587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558180|NCT00210574|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558181|NCT00210561|Randomized|Parallel Assignment||Treatment||Double||||||
1558182|NCT00210548|Randomized|Parallel Assignment||Treatment||Double||||||
1558183|NCT00210535|Randomized|Parallel Assignment||Treatment||Double||||||
1558184|NCT00210522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558185|NCT00210509|Randomized|Parallel Assignment||Treatment||Double||||||
1558186|NCT00210496|Randomized|Parallel Assignment||Treatment||Double||||||
1558187|NCT00210483|Randomized|Parallel Assignment||Treatment||Double||||||
1558188|NCT00210470||Single Group Assignment||Treatment||None (Open Label)||||||
1558189|NCT00210457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558190|NCT00210444|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558191|NCT00210431|||||Prospective|||||||
1558192|NCT00210418|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558193|NCT00210405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558194|NCT00210392|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558195|NCT00210379|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558196|NCT00210366|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558197|NCT00210353|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558198|NCT00210340|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558199|NCT00210327|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558200|NCT00210314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558201|NCT00210301|Randomized|Parallel Assignment||Treatment||Single||||||
1558202|NCT00210288|Randomized|Parallel Assignment||Prevention||Double||||||
1558203|NCT00210275|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1558204|NCT00210262|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1558205|NCT00210249||||||||||||
1558206|NCT00210236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558207|NCT00210223|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558208|NCT00210210|Randomized|Parallel Assignment||Treatment||Double||||||
1558209|NCT00210197|||||Prospective|||||||
1558210|NCT00210184|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558211|NCT00210171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558212|NCT00210158|Randomized|Parallel Assignment||Treatment||Double||||||
1558213|NCT00210145|||||Prospective|||||||
1558214|NCT00210132|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558215|NCT00210119|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558216|NCT00210106|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558217|NCT00210093|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1558218|NCT00210080|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558219|NCT00210067|Randomized|Parallel Assignment||Treatment||Double||||||
1558220|NCT00210054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558221|NCT00210041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558222|NCT00210028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558223|NCT00210015|Randomized|Parallel Assignment||Treatment||Double||||||
1558224|NCT00210002|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558225|NCT00209989|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558226|NCT00209963|Randomized|Parallel Assignment||Treatment||Double||||||
1558227|NCT00209950|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558228|NCT00209937|Randomized|Parallel Assignment||Treatment||Double||||||
1558229|NCT00209924|Randomized|Parallel Assignment||Treatment||Double||||||
1558230|NCT00209911|||Natural History||Longitudinal, Prospective|||||||
1558231|NCT00209898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558232|NCT00209885|Randomized|Parallel Assignment||Treatment||Double||||||
1558233|NCT00209872|Randomized|Parallel Assignment||Treatment||Double||||||
1558234|NCT00209859|Randomized|Parallel Assignment||Treatment||Double||||||
1558235|NCT00209846|Randomized|Parallel Assignment||Treatment||Double||||||
1558236|NCT00209833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558237|NCT00209820|Randomized|Single Group Assignment||Treatment||Single||||||
1558238|NCT00209807|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558239|NCT00209794|Randomized|Parallel Assignment||Prevention||Double||||||
1558240|NCT00209781|Randomized|Parallel Assignment||Diagnostic||Double||||||
1558241|NCT00209768|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558242|NCT00209755|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558243|NCT00209742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558244|NCT00209729|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558245|NCT00209716|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558246|NCT00209703|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558247|NCT00209690|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558248|NCT00209677|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558249|NCT00209664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558250|NCT00209651|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558251|NCT00209638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558252|NCT00209625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558253|NCT00209612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558254|NCT00209599|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558255|NCT00209586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558256|NCT00209573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558257|NCT00209560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558258|NCT00209547|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1558259|NCT00209534|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1558260|NCT00209521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558261|NCT00209508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558262|NCT00209495|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1558263|NCT00209482|Randomized|Parallel Assignment||Treatment||Double||||||
1558264|NCT00209469|Randomized|Parallel Assignment||Treatment||Double||||||
1558265|NCT00209456|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558266|NCT00209443|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558267|NCT00209430|Randomized|Parallel Assignment||Diagnostic||Double||||||
1558268|NCT00209417|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1558269|NCT00209404|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558270|NCT00209391|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558271|NCT00209378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558272|NCT00209365|Randomized|Crossover Assignment||Diagnostic||Double||||||
1558273|NCT00209352|Randomized|Parallel Assignment||||Double||||||
1558274|NCT00209339||Single Group Assignment||Treatment||None (Open Label)||||||
1558275|NCT00209326|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558276|NCT00209313|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1558277|NCT00209300|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1558278|NCT00209287|Randomized|Single Group Assignment||Treatment||Single|||t|||
1558279|NCT00209274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558280|NCT00209261|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1558281|NCT00209235||Single Group Assignment||Other||None (Open Label)||Natural history||||
1558282|NCT00209222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558283|NCT00209209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558284|NCT00209196|||Case-Only||Prospective|||||||
1558285|NCT00209170|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558286|NCT00209144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558287|NCT00209131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558288|NCT00209118|Randomized|Parallel Assignment||Prevention||Double||||||
1558289|NCT00209105|||Case-Only||Prospective|||||||
1558290|NCT00209092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558291|NCT00209079|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558292|NCT00209066|||Cohort||Prospective|||||||
1558293|NCT00209053|Randomized|Parallel Assignment||||None (Open Label)||||||
1558294|NCT00209040|||Cohort||Prospective|||||||
1558295|NCT00209027|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1558296|NCT00209014|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558297|NCT00209001|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558298|NCT00208988|Randomized|Single Group Assignment||Educational/Counseling/Training||Single||||||
1558299|NCT00208975||Single Group Assignment||Treatment||None (Open Label)||||||
1558300|NCT00208962|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558301|NCT00208949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558302|NCT00208936|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558303|NCT00208923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558304|NCT00208910|Randomized|Single Group Assignment||Treatment||Single||||||
1558305|NCT00208897|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1558306|NCT00208884|||||Retrospective|||||||
1558307|NCT00208871|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558308|NCT00208858|Randomized|Parallel Assignment||||Double||||||
1558309|NCT00208845|||Cohort||Prospective|||||||
1558310|NCT00208832|Randomized|Factorial Assignment||||Single||||||
1558311|NCT00208819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558312|NCT00208806|||Cohort||Prospective|||||||
1558313|NCT00208793|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1558314|NCT00208780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558315|NCT00208767|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1558316|NCT00208754|||||Retrospective|||||||
1558317|NCT00208741|Randomized|Single Group Assignment||Treatment||Double||||||
1558318|NCT00208728|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558319|NCT00208715|Randomized|Single Group Assignment||Treatment||Double||||||
1558320|NCT00208702|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1558321|NCT00208689||||||||||||
1558322|NCT00208676|||||Prospective|||||||
1558323|NCT00208663|||Cohort||Prospective|||||||
1558324|NCT00208650|||||Prospective|||||||
1558325|NCT00208637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558326|NCT00208624|||||Retrospective|||||||
1558327|NCT00208611||Single Group Assignment||||Quadruple|||t|t|t|t
1558328|NCT00208598|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1558329|NCT00208585|Randomized|Parallel Assignment||Treatment||Double||||||
1558330|NCT00208572|Randomized|Parallel Assignment||Treatment||Double||||||
1558331|NCT00208559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558332|NCT00208546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558333|NCT00208533||Single Group Assignment||Treatment||None (Open Label)|The care provider is unaware of the treatment arm the child is enrolled.|||||
1558334|NCT00208520|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558335|NCT00208507|Randomized|Parallel Assignment||Treatment||Single|||t|||
1558336|NCT00208494|Randomized|Parallel Assignment||Treatment||Single|||t|||
1558337|NCT00208481||||||||||||
1558338|NCT00208468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558339|NCT00208455||Single Group Assignment||Treatment||None (Open Label)||||||
1558340|NCT00208442|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558341|NCT00208429||Single Group Assignment||Treatment||None (Open Label)||||||
1558342|NCT00208416|Randomized|Parallel Assignment||Treatment||Single|||t|||
1558343|NCT00208403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558344|NCT00208390||Single Group Assignment||Treatment||None (Open Label)||||||
1558345|NCT00208377||Single Group Assignment||Treatment||None (Open Label)||||||
1558346|NCT00208364||Single Group Assignment||Treatment||None (Open Label)||||||
1558347|NCT00208351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558348|NCT00208338|Randomized|Parallel Assignment||Treatment||Single||||||t
1558349|NCT00208325|Randomized|Parallel Assignment||Treatment||Single||||||t
1558350|NCT00208312|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1558351|NCT00208299|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1558352|NCT00208286|Randomized|Parallel Assignment||Treatment||Single||||||t
1558353|NCT00208273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558354|NCT00208260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558355|NCT00208247|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1558356|NCT00208234|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558357|NCT00208221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558358|NCT00208208|Randomized|Parallel Assignment||Diagnostic||Double||||||
1558359|NCT00208195|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558360|NCT00208182|Randomized|Parallel Assignment||Prevention||Double||||||
1558361|NCT00208169|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558362|NCT00208156||Single Group Assignment||Treatment||None (Open Label)||||||
1558363|NCT00208143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558364|NCT00208130|Randomized|Parallel Assignment||Treatment||Double||||||
1558365|NCT00208117|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1558366|NCT00208104|Randomized|Parallel Assignment||||Single||||t||
1558367|NCT00208091||Single Group Assignment||Treatment||None (Open Label)||||||
1558368|NCT00208078|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558369|NCT00208065|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558370|NCT00208052|||Defined Population|Screening|Longitudinal, Prospective|||||||
1558371|NCT00208039|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558372|NCT00208026||Single Group Assignment||Treatment||None (Open Label)||||||
1558373|NCT00208013|||Case-Only||Cross-Sectional|||||||
1558374|NCT00208000|Randomized|Parallel Assignment||Treatment||Double||||||
1558375|NCT00207987|||||Prospective|||||||
1558376|NCT00207974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558377|NCT00207961|||Defined Population|Screening|Longitudinal, Prospective|||||||
1558378|NCT00207948|||Cohort||Prospective|||||||
1558379|NCT00207935|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558380|NCT00207922|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1558381|NCT00207909|||Cohort||Prospective|||||||
1558382|NCT00207896|||Cohort||Prospective|||||||
1558383|NCT00207883|||Cohort||Prospective|||||||
1558384|NCT00207870|||||Retrospective|||||||
1558385|NCT00207857|||||Prospective|||||||
1558386|NCT00207844|Randomized|Parallel Assignment||Treatment||Double||||||
1558387|NCT00207831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558388|NCT00207818||Single Group Assignment||Treatment||None (Open Label)||||||
1558389|NCT00207805|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558390|NCT00207792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558391|NCT00207779|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558392|NCT00207766|Randomized|Parallel Assignment||Treatment||Double||||||
1558393|NCT00207753|Randomized|Parallel Assignment||Treatment||Double||||||
1558394|NCT00207740|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558395|NCT00207727|Randomized|Parallel Assignment||Treatment||Double||||||
1558396|NCT00207714|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558397|NCT00207701|Randomized|Parallel Assignment||Treatment||Double||||||
1558398|NCT00207688|||Cohort||Prospective|||||||
1558399|NCT00207675|Randomized|||Treatment||Double||||||
1558400|NCT00207662|Randomized|Parallel Assignment||Treatment||Double||||||
1558401|NCT00207649|Randomized|Factorial Assignment||||None (Open Label)||||||
1558402|NCT00207636|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1558403|NCT00207623|Randomized|Crossover Assignment||Educational/Counseling/Training||None (Open Label)||||||
1558404|NCT00207610|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558405|NCT00207597|||Natural History||Longitudinal, Prospective|||||||
1558406|NCT00207584|Randomized|Parallel Assignment||||Double||||||
1558407|NCT00207571|Randomized|Parallel Assignment||Prevention||Single||||||
1558408|NCT00207558|Randomized|Parallel Assignment||Prevention||Double||||||
1558409|NCT00207532|Randomized|Parallel Assignment||Prevention||Double||||||
1558410|NCT00207519|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558411|NCT00207506|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1558412|NCT00207493|Randomized|Factorial Assignment||Prevention||Single||||||
1558413|NCT00207480|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1558414|NCT00207467|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558415|NCT00207454|Randomized|Factorial Assignment||Educational/Counseling/Training||None (Open Label)||||||
1558416|NCT00207441|Randomized|Parallel Assignment||||None (Open Label)||||||
1558417|NCT00207428|Randomized|Parallel Assignment||Treatment||Double||||||
1558418|NCT00207415|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1558419|NCT00207402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558420|NCT00207389|||Cohort||Prospective|||||||
1558421|NCT00207376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558422|NCT00207363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558423|NCT00207350||Single Group Assignment||Treatment||None (Open Label)||||||
1558424|NCT00207337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558425|NCT00207324|Randomized|Single Group Assignment||Prevention||Single||||||
1558426|NCT00207311|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1558427|NCT00207298|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558428|NCT00207285|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1558429|NCT00207272|Randomized|Parallel Assignment||Treatment||Double||||||
1558430|NCT00207259|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1558431|NCT00207233|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558432|NCT00207220|||Cohort||Prospective|||||||
1558433|NCT00207207|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558434|NCT00207194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558435|NCT00207181|||||Prospective|||||||
1558436|NCT00207168|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558437|NCT00207155||Single Group Assignment||Treatment||None (Open Label)||||||
1558438|NCT00207142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558439|NCT00207129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558440|NCT00207116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558441|NCT00207103|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558442|NCT00207090|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558443|NCT00207077|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558444|NCT00207064|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1558445|NCT00207051|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558446|NCT00207038|||Cohort||Cross-Sectional|||||||
1558447|NCT00207025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558448|NCT00207012|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558449|NCT00206999|Randomized|Crossover Assignment||Diagnostic||Quadruple|||t|t|t|t
1558450|NCT00206986|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1558451|NCT00206973||||Screening|Cross-Sectional, Prospective|||||||
1558452|NCT00206960|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1558453|NCT00206947|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558454|NCT00206934|Randomized|Single Group Assignment||Diagnostic||Triple|||t||t|t
1558455|NCT00206921|Randomized|Single Group Assignment||Treatment||Single||||||
1558456|NCT00206908|||Cohort||Retrospective|||||||
1558457|NCT00206895|Randomized|Parallel Assignment||Treatment||Single||||||
1558458|NCT00206882|Randomized|Single Group Assignment||Treatment||Double||||||
1558459|NCT00206869|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1558460|NCT00206856|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1558461|NCT00206843|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1558462|NCT00206830|Randomized|Parallel Assignment||Diagnostic||Double|||t|t||
1558463|NCT00206817|Randomized|Parallel Assignment||Diagnostic||Single||||||
1558464|NCT00206791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558465|NCT00206778|Randomized|Crossover Assignment||Treatment||Single||||||
1558466|NCT00206765|Randomized|Parallel Assignment||Treatment||Single||||||
1558467|NCT00206752||Single Group Assignment||Treatment||None (Open Label)||||||
1558468|NCT00206739|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1558469|NCT00206726||Single Group Assignment||Treatment||None (Open Label)||||||
1558470|NCT00206713|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558471|NCT00206700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558472|NCT00206687|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558473|NCT00206674|Randomized|Parallel Assignment||Treatment||Double||||||
1558474|NCT00206661|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558475|NCT00206648|Randomized|Parallel Assignment||Treatment||Single||||||t
1558476|NCT00206635|||Cohort||Cross-Sectional|||||||
1558477|NCT00206622|Randomized|Parallel Assignment||Treatment||Double||||||
1558478|NCT00206609|Randomized|Crossover Assignment||Treatment||Double||||||
1558479|NCT00206596|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558480|NCT00206583|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1558481|NCT00206570|Randomized|Parallel Assignment||Treatment||Double||||||
1558482|NCT00206557|Randomized|Parallel Assignment||Treatment||Double||||||
1558483|NCT00206544|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558484|NCT00206531|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1558485|NCT00206518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558486|NCT00206505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558487|NCT00206492||Single Group Assignment||Treatment||None (Open Label)||||||
1558488|NCT00206466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558489|NCT00206453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558490|NCT00206440|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558491|NCT00206427||Single Group Assignment||Treatment||None (Open Label)||||||
1558492|NCT00206414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558493|NCT00206401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558494|NCT00206388||Single Group Assignment||Treatment||None (Open Label)||||||
1558495|NCT00206375|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558496|NCT00206362|||Cohort||Prospective|||||||
1558497|NCT00206349|||||Retrospective|||||||
1558498|NCT00206336||Single Group Assignment||Treatment||None (Open Label)||||||
1558499|NCT00206323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558500|NCT00206310|Randomized|Parallel Assignment||Prevention||Double||||||
1558501|NCT00206297|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558502|NCT00206284|Randomized|Parallel Assignment||Treatment||Double||||||
1558503|NCT00206271|Randomized|Parallel Assignment||Treatment||Single||||||
1558504|NCT00206258|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558505|NCT00206245|Randomized|Parallel Assignment||Treatment||Double||||||
1558506|NCT00206232|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1558507|NCT00206219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558508|NCT00206206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558509|NCT00206193|||||Prospective|||||||
1558510|NCT00206180|Randomized|Parallel Assignment||||Double||||||
1558511|NCT00206167|Randomized|Parallel Assignment||Treatment||Double||||||
1558512|NCT00206154|Randomized|Parallel Assignment||Treatment||Double||||||
1558513|NCT00206141|Randomized|Parallel Assignment||Treatment||Double||||||
1558514|NCT00206128|Randomized|Parallel Assignment||Treatment||Double||||||
1558515|NCT00206115|Randomized|Parallel Assignment||Treatment||Double||||||
1558516|NCT00206102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558517|NCT00206089|Randomized|Parallel Assignment||Prevention||Double||||||
1558518|NCT00206076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558519|NCT00206063|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558520|NCT00206050|Randomized|Crossover Assignment||||None (Open Label)||||||
1558521|NCT00206037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558522|NCT00206024|Randomized|Parallel Assignment||Treatment||Double||||||
1558523|NCT00206011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558524|NCT00205998|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558525|NCT00205985|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558526|NCT00205972|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558527|NCT00205959|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558528|NCT00205946|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1558529|NCT00205933|||Cohort||Cross-Sectional|||||||
1558530|NCT00205920|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558531|NCT00205907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558532|NCT00205894|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558533|NCT00205881|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1558534|NCT00205868|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558535|NCT00205855||Single Group Assignment||Treatment||None (Open Label)||||||
1558536|NCT00205842|Randomized|Single Group Assignment||Treatment||Double||||||
1558537|NCT00205829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558538|NCT00205816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558539|NCT00205803|Randomized|Parallel Assignment||Prevention||Double||||||
1558540|NCT00205790|Randomized|Parallel Assignment||Treatment||Single||||||
1558541|NCT00205777|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1558542|NCT00205764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558543|NCT00205751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558544|NCT00205738|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558545|NCT00205725|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558546|NCT00205712|Randomized|Parallel Assignment||Treatment||Single|||t|||
1558547|NCT00205699|Randomized|Parallel Assignment||Treatment||Single||||||t
1558548|NCT00205686|Randomized|Parallel Assignment||Treatment||Double||||||
1558549|NCT00205660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558551|NCT00205634|Randomized|Crossover Assignment||Treatment||Double||||||
1558552|NCT00205621|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558553|NCT00205608|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558554|NCT00205595|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558555|NCT00205582|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558556|NCT00205569|||Cohort||Prospective|||||||
1558557|NCT00205556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558558|NCT00205543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558559|NCT00205530|||Cohort||Prospective|||||||
1558560|NCT00205517|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558561|NCT00205504|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558562|NCT00205491|Randomized|Single Group Assignment||Treatment||Double||||||
1558563|NCT00205478|Randomized|Parallel Assignment||Treatment||Double||||||
1558564|NCT00205465|Randomized|Parallel Assignment||Treatment||Double||||||
1558565|NCT00205452|||Case-Only||Prospective|||||||
1558566|NCT00205439|||Cohort|||||||||
1558567|NCT00205426|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1558568|NCT00205413||||||||||||
1558569|NCT00205400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558570|NCT00205387|||Cohort||Prospective|||||||
1558571|NCT00205374|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558572|NCT00205361|||Cohort||Prospective|||||||
1558573|NCT00205348|||Case-Only||Prospective|||||||
1558574|NCT00205335|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1558575|NCT00205322|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558576|NCT00205309|||Cohort||Prospective|||||||
1558577|NCT00205296|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558578|NCT00205283|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558579|NCT00205270|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558580|NCT00205257||||||||||||
1558581|NCT00205244|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558582|NCT00205231|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1558583|NCT00205218|||||Prospective|||||||
1558584|NCT00205205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558585|NCT00205192|||Case Control||Prospective|||||||
1558586|NCT00205179|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558587|NCT00205166|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1558588|NCT00205153|Randomized|Parallel Assignment||Treatment||Single||||||t
1558589|NCT00205140||||||||||||
1558590|NCT00205127|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558591|NCT00205114|Randomized|Single Group Assignment||||Single|||||t|
1558592|NCT00205101|||Cohort||Prospective|||||||
1558593|NCT00205088|||||Prospective|||||||
1558594|NCT00205075|||Cohort||Prospective|||||||
1558595|NCT00205062|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558596|NCT00205049||Single Group Assignment||Treatment||Double|||t||t|
1558597|NCT00205036|||||Prospective|||||||
1558598|NCT00205023||Single Group Assignment||||None (Open Label)||||||
1558599|NCT00205010|||||Prospective|||||||
1558600|NCT00204997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558601|NCT00204984|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1558602|NCT00204971|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1558603|NCT00204958|Randomized|Factorial Assignment||Prevention||Double||||||
1558604|NCT00204945|Non-Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1558605|NCT00204932|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558606|NCT00204919|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558607|NCT00204906|Non-Randomized|Single Group Assignment||Prevention||Double||||||
1558608|NCT00204893|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1558609|NCT00204880|||Case-Only||Prospective|||||||
1558610|NCT00204867|||Case Control||Prospective|||||||
1558611|NCT00204854|Randomized|Parallel Assignment||||Single||||||
1558612|NCT00204841|||Cohort||Prospective|||||||
1558613|NCT00204828|||Case-Control||Prospective|||||||
1558614|NCT00204815|||Case-Only||Prospective|||||||
1558615|NCT00204802|Randomized|Parallel Assignment||||Single||||||
1558616|NCT00204789|Randomized|Parallel Assignment||Prevention||Double||||||
1558617|NCT00204776|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1558618|NCT00204763|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1558619|NCT00204750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558620|NCT00204737|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558621|NCT00204711|||||Prospective|||||||
1558622|NCT00204698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558623|NCT00204685|Randomized|Parallel Assignment||Prevention||Double||||||
1558624|NCT00204672|Randomized|Parallel Assignment||Diagnostic||Double||||||
1558625|NCT00204659|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558626|NCT00204646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558627|NCT00204633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558628|NCT00204620|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558629|NCT00204607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558630|NCT00204594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558631|NCT00204581|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558632|NCT00204568|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558633|NCT00204555|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1558634|NCT00204542|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558635|NCT00204529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558636|NCT00204516|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558637|NCT00204503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558638|NCT00204490|Randomized|Parallel Assignment||Prevention||Quadruple|"Research pharmacist dispensed study pills according to a pre-generated randomization list and were blinded to all other aspects of the study protocol.~Subjects, research staff, investigators, and statistician all were blinded to treatment assignment."|One group received soy isoflavones (60 mg daidzein, 60 mg gensitein and 16.6 mg glycitein, all as aglycone equivalent) Another group, carbohydrate filler|t|t|t|t
1558639|NCT00204477|Randomized|Parallel Assignment||Prevention||Quadruple|"Research pharmacist dispensed blinded assigned sachets according to a pre-generated randomization list. Pharmacists were blinded to all other aspects of the research protocols.~Subjects, investigators, research staff, and statisticians were all blinded to treatment assignment."|Randomized, double-blind, placebo controlled, 2 parallel groups|t|t|t|t
1558640|NCT00204464|Randomized|Parallel Assignment||Treatment||Single||||||
1558641|NCT00204451|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558642|NCT00204438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558643|NCT00204425|Randomized|Factorial Assignment||||Quadruple|||t|t|t|t
1558644|NCT00204412|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1558645|NCT00204399|Randomized|Factorial Assignment||Prevention||Single||||||
1558646|NCT00204386|Randomized|Parallel Assignment||Treatment||Double||||||
1558647|NCT00204373||Single Group Assignment||Treatment||None (Open Label)||||||
1558648|NCT00204360|||Natural History||Longitudinal, Retrospective/Prospective|||||||
1558649|NCT00204347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558650|NCT00204334|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558651|NCT00204321|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558652|NCT00204308|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558653|NCT00204295|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558654|NCT00204282||||||||||||
1558655|NCT00204269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558656|NCT00204256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558657|NCT00204243|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558658|NCT00204230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558659|NCT00204217|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1558660|NCT00204204|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1558661|NCT00204191|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1558662|NCT00204178|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1558663|NCT00204165|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1558664|NCT00204152|Randomized|Single Group Assignment||Treatment||Single||||||
1558665|NCT00204139|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1558666|NCT00204126|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1558667|NCT00204113|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558668|NCT00204100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558669|NCT00204087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558670|NCT00204074|Randomized|Crossover Assignment||Treatment||Double||||||
1558671|NCT00204061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558672|NCT00204048|||Cohort||Cross-Sectional|||||||
1558673|NCT00204035|||Cohort||Prospective|||||||
1558674|NCT00204022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558675|NCT00204009|||Case-Only|||||||||
1558676|NCT00203996|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1558677|NCT00203970|||Cohort||Retrospective|||||||
1558678|NCT00203957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558679|NCT00203944|||Case-Only||Prospective|||||||
1558680|NCT00203931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558681|NCT00203918|||Cohort||Prospective|||||||
1558682|NCT00203905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558683|NCT00203892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558684|NCT00203879|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558685|NCT00203866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558686|NCT00203853||Factorial Assignment||Treatment||None (Open Label)||||||
1558687|NCT00203840|||Case-Only||Prospective|||||||
1558688|NCT00203827|||Cohort||Prospective|||||||
1558689|NCT00203814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558690|NCT00203801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558691|NCT00203788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558692|NCT00203775|Randomized|Parallel Assignment||Treatment||Double||||||
1558693|NCT00203762|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558694|NCT00203749|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558695|NCT00203736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558696|NCT00203723|Randomized|Parallel Assignment||Treatment||Double||||||
1558697|NCT00203710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558698|NCT00203697|Randomized|Parallel Assignment||Treatment||Double||||||
1558699|NCT00203684|Randomized|Parallel Assignment||Diagnostic||Double||||||
1558700|NCT00203671|||||Retrospective|||||||
1558701|NCT00203658|Randomized|||Treatment||None (Open Label)||||||
1558702|NCT00203645|Randomized|Factorial Assignment||Treatment||Single||||||t
1558703|NCT00203632|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558704|NCT00203619|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1558705|NCT00203606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558706|NCT00203593|Randomized|Parallel Assignment||Treatment||Single||||||
1558707|NCT00203580|Randomized|||Treatment||None (Open Label)||||||
1558708|NCT00203567|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558709|NCT00203554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558710|NCT00203541|Randomized|Parallel Assignment||||Double||||||
1558711|NCT00203528|Randomized|Single Group Assignment||Treatment||Double||||||
1558712|NCT00203515|Randomized|Parallel Assignment||Prevention||Single||||||
1558713|NCT00203502||Single Group Assignment||Treatment||None (Open Label)||||||
1558714|NCT00203489|Randomized|Parallel Assignment||Prevention||Double||||||
1558715|NCT00203476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558716|NCT00203463|Randomized|Single Group Assignment||Treatment||Double||||||
1558717|NCT00203450|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558718|NCT00203424||Single Group Assignment||Treatment||None (Open Label)||||||
1558719|NCT00203411||Single Group Assignment||Treatment||None (Open Label)||||||
1558720|NCT00203385||Single Group Assignment||Treatment||None (Open Label)|Open label|||||
1558721|NCT00203372|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558722|NCT00203359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558723|NCT00203346|||||Prospective|||||||
1558724|NCT00203333|||Cohort||Prospective|||||||
1558725|NCT00203320|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558726|NCT00203307|Randomized|Crossover Assignment||Treatment||Double||||||
1558727|NCT00203294|Randomized|Parallel Assignment||Treatment||Single|||t|||
1558728|NCT00203281|||Case-Only||Prospective|||||||
1558729|NCT00203268||Single Group Assignment||Treatment||None (Open Label)||||||
1558730|NCT00203255|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1558731|NCT00203242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558732|NCT00203229|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558733|NCT00203216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558734|NCT00203203|Randomized|Crossover Assignment||Treatment||Single|||t|||
1558735|NCT00203190|Randomized|Parallel Assignment||Treatment||Double||||||
1558736|NCT00203177|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558737|NCT00203164|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558738|NCT00203151|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558739|NCT00203138|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558740|NCT00203125|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558741|NCT00203112|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558742|NCT00203099||Single Group Assignment||Treatment||None (Open Label)||||||
1558743|NCT00203086|||Cohort||Prospective|||||||
1558744|NCT00203073|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1558745|NCT00203060|Randomized|Parallel Assignment||||Double|||t||t|
1558746|NCT00203047|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558747|NCT00203034|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558748|NCT00203021||Single Group Assignment||Treatment||None (Open Label)||||||
1558749|NCT00203008||||||||||||
1558750|NCT00202995|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558751|NCT00202982|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558752|NCT00202969|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558753|NCT00202956|Randomized|Parallel Assignment||Treatment||Double||||||
1558754|NCT00202943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558755|NCT00202930|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558756|NCT00202917||Single Group Assignment||Treatment||None (Open Label)||||||
1558757|NCT00202904|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558758|NCT00202891|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558759|NCT00202878|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558760|NCT00202865|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558761|NCT00202852|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558762|NCT00202839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558763|NCT00202826|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558764|NCT00202813|Randomized|Parallel Assignment||Treatment||Single||||||
1558765|NCT00202800|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1558766|NCT00202787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558767|NCT00202774|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558768|NCT00202761||Single Group Assignment||||None (Open Label)||||||
1558769|NCT00202748|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558770|NCT00202735|Randomized|Parallel Assignment||Treatment||Single||||||
1558771|NCT00202722||Single Group Assignment||Treatment||None (Open Label)||||||
1558772|NCT00202709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558773|NCT00202696|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558774|NCT00202683|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1558775|NCT00202670|||Cohort||Prospective|||||||
1558776|NCT00202657|||Case Control||Prospective|||||||
1558777|NCT00202644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558778|NCT00202631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558779|NCT00202618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558780|NCT00202605|Randomized|Crossover Assignment||Treatment||Double||||||
1558781|NCT00202592|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1558782|NCT00202579|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1558783|NCT00202566|Randomized|Parallel Assignment||||Double||||||
1558784|NCT00202553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558785|NCT00202540|Randomized|Parallel Assignment||||Double||||||
1558786|NCT00202527|Randomized|Parallel Assignment||Treatment||Double||||||
1558787|NCT00202514|Randomized|Parallel Assignment||Treatment||Double||||||
1558788|NCT00202501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558789|NCT00202488|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558790|NCT00202475|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558791|NCT00202462|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558792|NCT00202449|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558793|NCT00202436|Randomized|Parallel Assignment||Treatment||Single||||||t
1558794|NCT00202423|Randomized|Crossover Assignment||Treatment||Double||||||
1558795|NCT00202410|Randomized|Parallel Assignment||Treatment||Single|||t|||
1558796|NCT00202397|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1558797|NCT00202384|||Case-Only||Prospective|||||||
1558798|NCT00202371|Randomized|Parallel Assignment||Treatment||Single||||||
1558799|NCT00202358|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558800|NCT00202345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558801|NCT00202332|Randomized|Parallel Assignment||||None (Open Label)||||||
1558802|NCT00202319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558803|NCT00202306|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558804|NCT00202293|Randomized|Parallel Assignment||Treatment||Single||||||
1558805|NCT00202280|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558806|NCT00202267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558807|NCT00202254|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1558808|NCT00202241|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1558809|NCT00202228|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1558810|NCT00202215||Single Group Assignment||Treatment||None (Open Label)||||||
1558811|NCT00202202||Single Group Assignment||||None (Open Label)||||||
1558812|NCT00202189|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1558813|NCT00202176|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1558814|NCT00202163|Randomized|Parallel Assignment||Treatment||Double||||||
1558815|NCT00202150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558816|NCT00202137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558817|NCT00202124|Randomized|Parallel Assignment||Treatment||Double||||||
1558818|NCT00202111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558819|NCT00202098|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1558820|NCT00202072|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1558821|NCT00202059|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1558822|NCT00202046|||Case Control||Prospective|||||||
1558823|NCT00202033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558824|NCT00202020|Randomized|Parallel Assignment||Prevention||Double||||||
1558825|NCT00202007|Randomized|Parallel Assignment||Treatment||Double||||||
1558826|NCT00201994|Randomized|Parallel Assignment||Treatment||Double||||||
1558827|NCT00201981|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1558828|NCT00201968|Randomized|Parallel Assignment||Treatment||Single||||||t
1558829|NCT00201955|Randomized|Parallel Assignment||Treatment||Double||||||
1558830|NCT00201942|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558831|NCT00201929|Randomized|Parallel Assignment||||None (Open Label)||||||
1558832|NCT00201916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558833|NCT00201903|||||Prospective|||||||
1558834|NCT00201890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558835|NCT00201877||Single Group Assignment||Treatment||None (Open Label)||||||
1558836|NCT00201864||Single Group Assignment||Treatment||None (Open Label)||||||
1558837|NCT00201851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558838|NCT00201838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558839|NCT00201825||Single Group Assignment||Treatment||None (Open Label)||||||
1558840|NCT00201812||Single Group Assignment||Treatment||None (Open Label)||||||
1558841|NCT00201799||Single Group Assignment||Prevention||None (Open Label)||||||
1558842|NCT00201786||Single Group Assignment||Treatment||None (Open Label)||||||
1558843|NCT00201773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558844|NCT00201760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558845|NCT00201747||Single Group Assignment||Treatment||None (Open Label)||||||
1558846|NCT00201734||Single Group Assignment||Treatment||None (Open Label)||||||
1558847|NCT00201721||Single Group Assignment||Treatment||None (Open Label)||||||
1558848|NCT00201708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558849|NCT00201695||Single Group Assignment||Treatment||None (Open Label)||||||
1558850|NCT00201682||Single Group Assignment||Treatment||None (Open Label)||||||
1558851|NCT00201669||Single Group Assignment||Treatment||None (Open Label)||||||
1558852|NCT00201656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558853|NCT00201643|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1558854|NCT00201630|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558855|NCT00201617|||Case Control||Prospective|||||||
1558856|NCT00201591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558857|NCT00201578|||Case Control||Cross-Sectional, Prospective|||||||
1558858|NCT00201565|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1558859|NCT00201552|Randomized|Parallel Assignment||||None (Open Label)||||||
1558860|NCT00201539|Randomized|Single Group Assignment||Treatment||Double||||||
1558861|NCT00201526|||Case-Only||Cross-Sectional|||||||
1558862|NCT00201513|Randomized|Parallel Assignment||Treatment||Single||||||t
1558863|NCT00201500|||Case Control|||||||||
1558864|NCT00201487|||Cohort||Prospective|||||||
1558865|NCT00201474|||Case Control||Prospective|||||||
1558866|NCT00201461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558867|NCT00201448|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1558868|NCT00201435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558869|NCT00201422|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558870|NCT00201409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558871|NCT00201396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558872|NCT00201383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558873|NCT00201370|||Cohort||Retrospective|||||||
1558874|NCT00201357|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558875|NCT00201344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558876|NCT00201331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558877|NCT00201318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558878|NCT00201305|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558879|NCT00201292||||||||||||
1558880|NCT00201279|Randomized|Parallel Assignment||Prevention||Single||||||
1558881|NCT00201266|||Case Control||Prospective|||||||
1558882|NCT00201253|||Case Control||Cross-Sectional|||||||
1558883|NCT00201240||Single Group Assignment||Treatment||None (Open Label)||||||
1558884|NCT00201227|Randomized|Factorial Assignment||Health Services Research||None (Open Label)||||||
1558885|NCT00201214||Single Group Assignment||Treatment||None (Open Label)||||||
1558886|NCT00201201|Randomized|Parallel Assignment||||None (Open Label)||||||
1558887|NCT00201188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558888|NCT00201162|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1558889|NCT00201149|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1558890|NCT00201136|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1558891|NCT00201123|Randomized|Parallel Assignment||Treatment||Single|||||t|
1558892|NCT00201110|Randomized|Parallel Assignment||Treatment||Single||||||t
1558893|NCT00201084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558894|NCT00201071|||Family-Based||Prospective|||||||
1558895|NCT00201058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558896|NCT00201045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558897|NCT00201019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558898|NCT00201006|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558899|NCT00200993|Randomized|||Prevention||||||||
1558900|NCT00200980||||||||||||
1558901|NCT00200967|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1558902|NCT00200954|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1558903|NCT00200941|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1558904|NCT00200928|Randomized|Parallel Assignment||Prevention||Single||||||
1558905|NCT00200902|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1558906|NCT00200889||Single Group Assignment||Basic Science||None (Open Label)||||||
1558907|NCT00200876|Randomized|Crossover Assignment||Diagnostic||Triple||Hypertonic saline is a challenge to activate endogenous opioid systems as assessed with positron emission tomography. There is no treatment involved. Isotonic saline is the control.|t||t|t
1558908|NCT00200863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558909|NCT00200850|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558910|NCT00200837|Random Sample||Natural History||Longitudinal, Prospective|||||||
1558911|NCT00200824|Randomized|Crossover Assignment||Prevention||Double||||||
1558912|NCT00200798|||Other||Prospective|||||||
1558913|NCT00200785|Non-Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1558914|NCT00200759|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1558915|NCT00200746|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558916|NCT00200733|||||Longitudinal, Prospective|||||||
1558917|NCT00200720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558918|NCT00200707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558919|NCT00200694|Randomized|Crossover Assignment||||None (Open Label)||||||
1558920|NCT00200681|Randomized|Parallel Assignment||||None (Open Label)||||||
1558921|NCT00200668|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558922|NCT00200655|Randomized|Parallel Assignment||Treatment||Double||||||
1558923|NCT00200642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558924|NCT00200629|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1558925|NCT00200616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558926|NCT00200603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558927|NCT00200590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558928|NCT00200577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558929|NCT00200564|Randomized|Parallel Assignment||||Single||||||
1558930|NCT00200551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558931|NCT00200538|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558932|NCT00200525|Randomized|Parallel Assignment||Treatment||Double||||||
1558933|NCT00200512|Randomized|Crossover Assignment||Treatment||Double||||||
1558934|NCT00200499|Randomized|Single Group Assignment||Treatment||Double||||||
1558935|NCT00200486|||Cohort||Prospective|||||||
1558936|NCT00200473|Randomized|Parallel Assignment||Treatment||Double||||||
1558937|NCT00200460|Randomized|Parallel Assignment||Treatment||Double||||||
1558938|NCT00200447|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1558939|NCT00200434|Randomized|Parallel Assignment||Treatment||Double||||||
1558940|NCT00200421|Randomized|Parallel Assignment||Treatment||Double||||||
1558941|NCT00200408|||Case Control||Prospective|||||||
1558942|NCT00200395|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558943|NCT00200382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558944|NCT00200369|||Cohort||Prospective|||||||
1558945|NCT00200356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558946|NCT00200343|Randomized|Parallel Assignment||Treatment||Double||||||
1558947|NCT00200330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558948|NCT00200317|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558949|NCT00200304|Randomized|Factorial Assignment||Treatment||Single||||||
1558950|NCT00200291|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1558951|NCT00200278|Randomized|Single Group Assignment||Treatment||Single||||||
1558952|NCT00200265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558953|NCT00200252|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558954|NCT00200239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558955|NCT00200226|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1558956|NCT00200213|Randomized|Parallel Assignment||Treatment||Single||||||
1558957|NCT00200200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558958|NCT00200187|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1558959|NCT00200174|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558960|NCT00200161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558961|NCT00200148|Randomized|Parallel Assignment||Treatment||Single|||t|||
1558962|NCT00200135|||Case Control||Prospective|||||||
1558963|NCT00200122|Randomized|Parallel Assignment||Diagnostic||Single||||||
1558964|NCT00200109|Randomized|Parallel Assignment||||Single|||||t|
1558965|NCT00200096|Randomized|Parallel Assignment||||Single|||t|||
1558966|NCT00200083|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1558967|NCT00200070|Randomized|Parallel Assignment||||Single||||||
1558968|NCT00200057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558969|NCT00200044|Randomized|Parallel Assignment||Treatment||Single|||t|||
1558970|NCT00200031||||||||||||
1558971|NCT00200018|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1558972|NCT00200005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558973|NCT00199992|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558974|NCT00199979|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558975|NCT00199966|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558976|NCT00199953|Non-Randomized|Parallel Assignment||Diagnostic||Double||||||
1558977|NCT00199940|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558978|NCT00199927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558979|NCT00199914|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558980|NCT00199901|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1558981|NCT00199888|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558982|NCT00199875|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Patients were enrolled sequentially in cohorts of 3 to 6 patients to receive escalating doses of study treatment until determination of the MTD.||||
1558983|NCT00199862||Single Group Assignment||Diagnostic||None (Open Label)||||||
1558984|NCT00199849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558985|NCT00199836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558986|NCT00199823|Randomized|Parallel Assignment||Treatment||Single||||||
1558987|NCT00199810|||Cohort||Prospective|||||||
1558988|NCT00199797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558989|NCT00199784|Randomized|Parallel Assignment||Prevention||Double||||||
1558990|NCT00199771|Randomized|Parallel Assignment||Treatment||Double||||||
1558991|NCT00199758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558992|NCT00199745|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558993|NCT00199732|||||Prospective|||||||
1558994|NCT00199719|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1558995|NCT00199706|Randomized|Parallel Assignment||Treatment||Single||||||
1558996|NCT00199693|||Cohort||Prospective|||||||
1558997|NCT00199680|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1558998|NCT00199667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1558999|NCT00199654|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1559000|NCT00199641|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559001|NCT00199628|||Defined Population||Longitudinal, Prospective|||||||
1559002|NCT00199615|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1559003|NCT00199602|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559004|NCT00199589|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559005|NCT00199576|Randomized|Parallel Assignment||Prevention||Double||||||
1559006|NCT00199563|Randomized|Parallel Assignment||Other||Double|||t||t|
1559007|NCT00199550|Randomized|Parallel Assignment||Treatment||Single|||t|||
1559008|NCT00199537|||Cohort||Prospective|||||||
1559009|NCT00199524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559010|NCT00199511|Randomized|Parallel Assignment||Treatment||Double||||||
1559011|NCT00199498|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1559012|NCT00199485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559013|NCT00199472|||||Prospective|||||||
1559014|NCT00199459|||Case Control||Prospective|||||||
1559015|NCT00199446|Randomized|Parallel Assignment||Treatment||Double||||||
1559016|NCT00199433|Randomized|Parallel Assignment||Treatment||Double||||||
1559017|NCT00199420|Randomized|Parallel Assignment||Treatment||Double||||||
1559018|NCT00199407|Randomized|Parallel Assignment||Treatment||Double||||||
1559019|NCT00199394|Randomized|Parallel Assignment||Treatment||Double||||||
1559020|NCT00199381|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559021|NCT00199368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559022|NCT00199355|Randomized|Parallel Assignment||Treatment||Double||||||
1559023|NCT00199342|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559024|NCT00199329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559025|NCT00199316|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559026|NCT00199303|Randomized|Parallel Assignment||Treatment||Double||||||
1559027|NCT00199290|Randomized|Parallel Assignment||Treatment||Double||||||
1559028|NCT00199277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559029|NCT00199264|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559030|NCT00199251|Randomized|Parallel Assignment||Treatment||Double||||||
1559031|NCT00199238|Randomized|Parallel Assignment||Treatment||Double||||||
1559032|NCT00199225|Randomized|Parallel Assignment||Treatment||Single||||||
1559033|NCT00199212|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559034|NCT00199186|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559035|NCT00199173|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559036|NCT00199160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559037|NCT00199147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559038|NCT00199134|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559039|NCT00199121|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559040|NCT00199108|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559041|NCT00199095|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559042|NCT00199082|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559043|NCT00199069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559044|NCT00199056|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559045|NCT00199043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559046|NCT00199030|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559047|NCT00199017|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559048|NCT00199004|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559049|NCT00198991|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559050|NCT00198978|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559051|NCT00198965|Randomized|Crossover Assignment||Treatment||Double||||||
1559052|NCT00198952|Randomized|Crossover Assignment||Treatment||Double||||||
1559053|NCT00198939|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1559054|NCT00198926|Randomized|Crossover Assignment||Educational/Counseling/Training||Single||||||
1559055|NCT00198913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559056|NCT00198900|||Defined Population||Cross-Sectional, Retrospective|||||||
1559057|NCT00198887|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1559058|NCT00198874|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559059|NCT00198861|||Cohort||Prospective|||||||
1559060|NCT00198848|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559061|NCT00198835|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559062|NCT00198822|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1559063|NCT00198809|Randomized|Parallel Assignment||Treatment||Double||||||
1559064|NCT00198796||Single Group Assignment||Screening||None (Open Label)||We will initially study the effects of a 1x109 dose of H10407 (in 5 subjects) and then proceed to the dose-finding portion of the trial to study the effects of low (5x108) or higher doses (5x109) of the CS17 expressing strains (total of 20 subjects)||||
1559065|NCT00198783|||Defined Population||Longitudinal, Prospective|||||||
1559066|NCT00198770|Randomized|Crossover Assignment||Treatment||Single||||||t
1559067|NCT00198757|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559068|NCT00198744|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559069|NCT00198731|||Ecologic or Community||Prospective|||||||
1559070|NCT00198718|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1559071|NCT00198705|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559072|NCT00198692|Randomized|Single Group Assignment||||None (Open Label)||||||
1559073|NCT00198679|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559074|NCT00198666|Randomized|Parallel Assignment||Treatment||Single|||||t|
1559075|NCT00198653|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559076|NCT00198640|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1559077|NCT00198627|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559078|NCT00198614|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559079|NCT00198601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559080|NCT00198588|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559081|NCT00198575|||Defined Population|Screening|Longitudinal, Prospective|||||||
1559082|NCT00198562|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559083|NCT00198549||Single Group Assignment||Treatment||None (Open Label)||||||
1559084|NCT00198536|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559085|NCT00198523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559086|NCT00198510|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559087|NCT00198497|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559088|NCT00198484||Single Group Assignment||Treatment||None (Open Label)||||||
1559089|NCT00198471||Single Group Assignment||Treatment||None (Open Label)||||||
1559090|NCT00198458||Single Group Assignment||||None (Open Label)||||||
1559091|NCT00198445|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1559092|NCT00198432|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559093|NCT00198419||Single Group Assignment||Screening||None (Open Label)||||||
1559094|NCT00198406|||||Prospective|||||||
1559095|NCT00198393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559096|NCT00198380|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559097|NCT00198367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559098|NCT00198354|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559099|NCT00198341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559100|NCT00198328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559101|NCT00198315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559102|NCT00198302|Randomized|Parallel Assignment||||Double||||||
1559103|NCT00198289|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559104|NCT00198276||Single Group Assignment||Treatment||None (Open Label)||MedPulser Electroporation with Belomycin||||
1559105|NCT00198263||Single Group Assignment||Treatment||None (Open Label)||Medpulser electroporation with Bleomycin||||
1559106|NCT00198250|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1559107|NCT00198237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559108|NCT00198224|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1559109|NCT00198198|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559110|NCT00198185|Randomized|Single Group Assignment||Treatment||Double||||||
1559111|NCT00198172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559112|NCT00198159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559113|NCT00198146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559114|NCT00198133|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559115|NCT00198120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559116|NCT00198107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559117|NCT00198094|Randomized|Parallel Assignment||Treatment||Double||||||
1559118|NCT00198081|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559119|NCT00198068|||Case-Control||Prospective|||||||
1559120|NCT00198055||Single Group Assignment||Treatment||None (Open Label)||||||
1559121|NCT00198042||Single Group Assignment||Treatment||None (Open Label)||||||
1559122|NCT00198029|Non-Randomized|Parallel Assignment||Other||None (Open Label)||||||
1559123|NCT00198016||||||||||||
1559124|NCT00198003|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1559125|NCT00197990|||Cohort||Prospective|||||||
1559126|NCT00197977|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1559127|NCT00197964|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1559128|NCT00197951|Randomized|Parallel Assignment||Treatment||Double||||||
1559129|NCT00197938|||Cohort||Prospective|||||||
1559130|NCT00197925|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559131|NCT00197912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559132|NCT00197899|Randomized|Crossover Assignment||Diagnostic||Double||||||
1559133|NCT00197886|Randomized|Crossover Assignment||Treatment||Single||||||
1559134|NCT00197873|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1559135|NCT00197860||Single Group Assignment||Treatment||None (Open Label)||||||
1559136|NCT00197847|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1559137|NCT00197834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559138|NCT00197821|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559139|NCT00197808|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559140|NCT00197795|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559141|NCT00197782|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559142|NCT00197769|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559143|NCT00197756|||Cohort||Prospective|||||||
1559144|NCT00197743|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559145|NCT00197730|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559146|NCT00197704|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559147|NCT00197691|||Cohort||Prospective|||||||
1559148|NCT00197678|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559149|NCT00197652|||Cohort||Prospective|||||||
1559150|NCT00197639|||Cohort||Prospective|||||||
1559151|NCT00197613|Randomized|Parallel Assignment||||None (Open Label)||||||
1559152|NCT00197587|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1559153|NCT00197561|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559154|NCT00197548|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559155|NCT00197522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559156|NCT00197509|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559157|NCT00197496|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559158|NCT00197483|||Defined Population||Cross-Sectional, Prospective|||||||
1559159|NCT00197470|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559160|NCT00197457|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559161|NCT00197444|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559162|NCT00197431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559163|NCT00197418|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559164|NCT00197405|||Case Control||Retrospective|||||||
1559165|NCT00197392|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559166|NCT00197379|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559167|NCT00197366|||||Retrospective|||||||
1559168|NCT00197353|Randomized|Parallel Assignment||Prevention||Double||||||
1559169|NCT00197340|Randomized|Parallel Assignment||Treatment||Double||||||
1559170|NCT00197327|Randomized|Parallel Assignment||||Double||||||
1559171|NCT00197314|Randomized|Parallel Assignment||Treatment||Single||||||
1559172|NCT00197301|Randomized|Parallel Assignment||Prevention||Single||||||
1559173|NCT00197288|Randomized|Parallel Assignment||Prevention||Single|||t|||
1559174|NCT00197275|Randomized|Parallel Assignment||Prevention||Single||||||
1559175|NCT00197262|Randomized|Parallel Assignment||Treatment||Double||||||
1559176|NCT00197249|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559177|NCT00197236|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559178|NCT00197223|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559179|NCT00197210|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1559180|NCT00197197|Randomized|Parallel Assignment||Treatment||Single|||t|||
1559181|NCT00197184|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559182|NCT00197171|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559183|NCT00197158|Randomized|Parallel Assignment||Prevention||Single||||||
1559184|NCT00197145|Randomized|Parallel Assignment||Treatment||||||||
1559185|NCT00197132|Randomized|Crossover Assignment||Treatment||Double||||||
1559186|NCT00197119|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559187|NCT00197106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559188|NCT00197093|Randomized|Parallel Assignment||Treatment||Double||||||
1559189|NCT00197080|Randomized|Parallel Assignment||Treatment||Double||||||
1559190|NCT00197067|Randomized|Parallel Assignment||Other||||||||
1559191|NCT00197054|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559192|NCT00197041|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559193|NCT00197028|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1559194|NCT00197015|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559195|NCT00197002|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559196|NCT00196989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559197|NCT00196976|Randomized|Parallel Assignment||Prevention||Single||||t||
1559198|NCT00196963|Randomized|Parallel Assignment||Prevention||Single||||||
1559199|NCT00196950|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559200|NCT00196937|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559201|NCT00196924|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559202|NCT00196911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559203|NCT00196898|||Cohort||Prospective|||||||
1559204|NCT00196885|Randomized|Parallel Assignment||Treatment||Double||||||
1559205|NCT00196872|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559206|NCT00196859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559207|NCT00196846|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559208|NCT00196833|||Other||Other|||||||
1559209|NCT00196820|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559210|NCT00196807|Randomized|Factorial Assignment||Screening||None (Open Label)||||||
1559211|NCT00196794|Randomized|Parallel Assignment||Treatment||Double||||||
1559212|NCT00196781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559213|NCT00196768|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559214|NCT00196755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559215|NCT00196742|||Cohort||Other|||||||
1559216|NCT00196729|Randomized|Parallel Assignment||||None (Open Label)||||||
1559217|NCT00196716||Single Group Assignment||Treatment||None (Open Label)||||||
1559218|NCT00196703|Randomized|Parallel Assignment||Treatment||Double||||||
1559219|NCT00196690|Randomized|Parallel Assignment||Treatment||Double||||||
1559220|NCT00196677|Randomized|Single Group Assignment||Treatment||Double||||||
1559221|NCT00196664|Randomized|Parallel Assignment||Treatment||Double||||||
1559222|NCT00196651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559223|NCT00196638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559224|NCT00196625|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559225|NCT00196612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559226|NCT00196599|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559227|NCT00196586|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559228|NCT00196573|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1559229|NCT00196560|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559230|NCT00196547|Randomized|Single Group Assignment||Treatment||Double||||||
1559231|NCT00196534|Randomized|Parallel Assignment||||Double||||||
1559232|NCT00196521|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1559233|NCT00196508|Randomized|Parallel Assignment||||None (Open Label)||||||
1559234|NCT00196495|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559235|NCT00196482|Randomized|Crossover Assignment||Treatment||Double||||||
1559236|NCT00196469|Randomized|Parallel Assignment||Prevention||Double||||||
1559237|NCT00196456|Randomized|Parallel Assignment||Treatment||Double||||||
1559238|NCT00196443|Randomized|Parallel Assignment||Treatment||Single||||||
1559239|NCT00196430|Randomized|Crossover Assignment||Treatment||Single||||||
1559240|NCT00196417|Randomized|Parallel Assignment||Treatment||Double||||||
1559241|NCT00196404|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559242|NCT00196391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559243|NCT00196378|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559244|NCT00196365|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559245|NCT00196352|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559246|NCT00196339|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559247|NCT00196326||Single Group Assignment||Prevention||None (Open Label)||||||
1559248|NCT00196313|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559249|NCT00196300|||||Prospective|||||||
1559250|NCT00196287|||||Prospective|||||||
1559251|NCT00196274|||||Prospective|||||||
1559252|NCT00196261|||||Prospective|||||||
1559253|NCT00196248|||Defined Population|Screening|Longitudinal, Prospective|||||||
1559254|NCT00196235|||||Prospective|||||||
1559255|NCT00196222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559256|NCT00196209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559257|NCT00196196||Single Group Assignment||Treatment||None (Open Label)||||||
1559258|NCT00196183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559259|NCT00196170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559260|NCT00196157|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559261|NCT00196144|Randomized|Parallel Assignment||Prevention||Single|||t|||
1559262|NCT00196131|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1559263|NCT00196118|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1559264|NCT00196105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559265|NCT00196092|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559266|NCT00196079|Randomized|Parallel Assignment||Treatment||Double||||||
1559267|NCT00196066|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1559268|NCT00196053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559269|NCT00196040|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559270|NCT00196027|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559271|NCT00196014|||Case-Only||Prospective|||||||
1559272|NCT00196001|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1559273|NCT00195988|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559274|NCT00195975|||Case Control||Prospective|||||||
1559275|NCT00195962|||Case-Only||Prospective|||||||
1559276|NCT00195949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559277|NCT00195936|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559278|NCT00195923|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1559279|NCT00195910|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1559280|NCT00195897|||Cohort||Prospective|||||||
1559281|NCT00195884|Randomized|Factorial Assignment||Treatment||Single||||||t
1559282|NCT00195871|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559283|NCT00195858|Randomized|Factorial Assignment||Treatment||Single|||t|||
1559284|NCT00195845|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1559285|NCT00195819|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559286|NCT00195806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559287|NCT00195793|Randomized|Parallel Assignment||Treatment||Double||||||
1559288|NCT00195780|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559289|NCT00195767|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559290|NCT00195754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559291|NCT00195741|Randomized|Parallel Assignment||Treatment||Double||||||
1559292|NCT00195728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559293|NCT00195715|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559294|NCT00195702|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559295|NCT00195689|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559296|NCT00195676|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559297|NCT00195663|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559298|NCT00195650|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559299|NCT00195637||||Treatment||||||||
1559300|NCT00195624|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559301|NCT00195611|||||Prospective|||||||
1559302|NCT00195598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559303|NCT00195585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559304|NCT00195572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559305|NCT00195559|Randomized|Parallel Assignment||Prevention||Double||||||
1559306|NCT00195546|Randomized|Single Group Assignment||Treatment||Double||||||
1559307|NCT00195533|||Cohort||Prospective|||||||
1559308|NCT00195520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559309|NCT00195507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559310|NCT00195494|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1559311|NCT00195481|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559312|NCT00195468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559313|NCT00195455|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559314|NCT00195442|||Cohort||Prospective|||||||
1559315|NCT00195429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559316|NCT00195416|||Case-Only||Prospective|||||||
1559317|NCT00195403|||Case-Only||Prospective|||||||
1559318|NCT00195390|||Case-Only||Prospective|||||||
1559319|NCT00195377|||Cohort||Prospective|||||||
1559320|NCT00195364|||Cohort||Retrospective|||||||
1559321|NCT00195351|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559322|NCT00195338|||Cohort||Prospective|||||||
1559323|NCT00195325|Non-Randomized|Factorial Assignment||Educational/Counseling/Training||None (Open Label)||||||
1559324|NCT00195312|Randomized|Parallel Assignment||Treatment||Double||||||
1559325|NCT00195299|||||Prospective|||||||
1559326|NCT00195286|||Case-Only||Prospective|||||||
1559327|NCT00195273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559328|NCT00195260|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559329|NCT00195247|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559330|NCT00195234|Randomized|Parallel Assignment||Treatment||Double||||||
1559331|NCT00195221|||||Retrospective|||||||
1559332|NCT00195208|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559333|NCT00195195|||Case-Only||Prospective|||||||
1559334|NCT00195182|||Cohort||Prospective|||||||
1559335|NCT00195169|||Cohort||Prospective|||||||
1559336|NCT00195156|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559337|NCT00195143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559338|NCT00195130||||||||||||
1559339|NCT00195117|Randomized|Parallel Assignment||Other||Single|||t|||
1559340|NCT00195104||Single Group Assignment||Treatment||None (Open Label)||||||
1559341|NCT00195091||Single Group Assignment||Treatment||None (Open Label)||||||
1559342|NCT00195078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559343|NCT00195065|||||Prospective|||||||
1559344|NCT00195052|||Case-Only||Prospective|||||||
1559345|NCT00195039||Single Group Assignment||Treatment||None (Open Label)||||||
1559346|NCT00195026|||Case-Only||Prospective|||||||
1559347|NCT00195013|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559348|NCT00195000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559349|NCT00194987|Randomized|Parallel Assignment||Treatment||None (Open Label)|participants and their physicians will know if they are receiving IVIG x 2 or IVIG x1 plus prednisone|randomization between 2 groups||||
1559350|NCT00194974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559351|NCT00194961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559352|NCT00194948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559353|NCT00194935|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559354|NCT00194922|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1559355|NCT00194909|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559356|NCT00194896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559357|NCT00194883|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559358|NCT00194870||Single Group Assignment||Diagnostic||None (Open Label)||||||
1559359|NCT00194857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559360|NCT00194844|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559361|NCT00194831|||Cohort|||||||||
1559362|NCT00194818|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1559363|NCT00194805|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559364|NCT00194792||Single Group Assignment||Treatment||None (Open Label)||||||
1559365|NCT00194779||Single Group Assignment||Treatment||None (Open Label)||||||
1559366|NCT00194766||Single Group Assignment||Treatment||None (Open Label)||||||
1559367|NCT00194753||Single Group Assignment||Treatment||None (Open Label)||||||
1559368|NCT00194740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559369|NCT00194727||Single Group Assignment||Treatment||None (Open Label)||||||
1559370|NCT00194714||Single Group Assignment||Treatment||None (Open Label)||||||
1559371|NCT00194701|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559372|NCT00194688|Non-Randomized|Parallel Assignment||Diagnostic||Single||||||
1559373|NCT00194675|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559374|NCT00194649|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559375|NCT00194636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559376|NCT00194623|Randomized|Single Group Assignment||Treatment||Double||||||
1559377|NCT00194610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559378|NCT00194597|Randomized|Single Group Assignment||Treatment||Double||||||
1559379|NCT00194584|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559380|NCT00194571|Randomized|Factorial Assignment||Treatment||Single||||||t
1559381|NCT00194558|Randomized|Parallel Assignment||||None (Open Label)||||||
1559382|NCT00194545|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559383|NCT00194532|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1559384|NCT00194519|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559385|NCT00194506|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1559386|NCT00194493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559387|NCT00194480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559388|NCT00194467|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1559389|NCT00194454|Randomized|Parallel Assignment||Treatment||Single||||||t
1559390|NCT00194441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559391|NCT00194428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559392|NCT00194415|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559393|NCT00194402|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559394|NCT00194376||Single Group Assignment||Other||None (Open Label)||||||
1559395|NCT00194363|Randomized|Single Group Assignment||Other||None (Open Label)||||||
1559396|NCT00194350|||Cohort||Retrospective|||||||
1559397|NCT00194337||||Diagnostic||None (Open Label)||||||
1559398|NCT00194324|Randomized|Crossover Assignment||||None (Open Label)||||||
1559399|NCT00194311|||Cohort||Prospective|||||||
1559400|NCT00194298|||Cohort||Prospective|||||||
1559401|NCT00194285|||Cohort||Prospective|||||||
1559402|NCT00194272|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559403|NCT00194259|||Cohort||Prospective|||||||
1559404|NCT00194246|||Cohort||Prospective|||||||
1559405|NCT00194233|||Case Control||Prospective|||||||
1559406|NCT00194220|||Cohort||Prospective|||||||
1559407|NCT00194207|||Cohort||Prospective|||||||
1559408|NCT00194194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559409|NCT00194181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559410|NCT00194168|||Cohort||Prospective|||||||
1559411|NCT00194155|||Case-Only|||||||||
1559412|NCT00194142|||Cohort||Retrospective|||||||
1559413|NCT00194129|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559414|NCT00194116|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1559415|NCT00194103|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559416|NCT00194090|Randomized|Crossover Assignment||Treatment||Double||||||
1559417|NCT00194077|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559418|NCT00194064||Parallel Assignment||Treatment||None (Open Label)||||||
1559419|NCT00194051|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1559420|NCT00194038|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559421|NCT00194025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559422|NCT00194012|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559423|NCT00193999|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559424|NCT00193986|Randomized|Crossover Assignment||Prevention||Single||||||
1559425|NCT00193973||Single Group Assignment||Treatment||None (Open Label)||||||
1559426|NCT00193960|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1559427|NCT00193947|||Cohort||Prospective|||||||
1559428|NCT00193934|||Cohort||Prospective|||||||
1559429|NCT00193921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559430|NCT00193908|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559431|NCT00193895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559432|NCT00193882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559433|NCT00193869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559434|NCT00193856|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559435|NCT00193843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559436|NCT00193830|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559437|NCT00193817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559438|NCT00193804|||Cohort||Prospective|||||||
1559439|NCT00193791|Randomized|Parallel Assignment||Treatment||None (Open Label)||Concomitant chemo-radiation versus radiation alone||||
1559440|NCT00193778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559441|NCT00193765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559442|NCT00193752|||Cohort||Prospective|||||||
1559443|NCT00193739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559444|NCT00193726|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559445|NCT00193713|Randomized|Parallel Assignment||Treatment||Double||||||
1559446|NCT00193700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559447|NCT00193687|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559448|NCT00193674|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559449|NCT00193661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559450|NCT00193648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559451|NCT00193635|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559452|NCT00193622|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559453|NCT00193609||Single Group Assignment||Treatment||None (Open Label)||||||
1559454|NCT00193596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559455|NCT00193583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559456|NCT00193570|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559457|NCT00193557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559458|NCT00193544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559459|NCT00193531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559460|NCT00193518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559461|NCT00193505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559462|NCT00193492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559463|NCT00193479||Single Group Assignment||Treatment||None (Open Label)||||||
1559464|NCT00193466|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559465|NCT00193453||Single Group Assignment||Treatment||None (Open Label)||||||
1559466|NCT00193440|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559467|NCT00193427||Single Group Assignment||Treatment||None (Open Label)||||||
1559468|NCT00193414||Single Group Assignment||Treatment||None (Open Label)||||||
1559469|NCT00193401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559470|NCT00193388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559471|NCT00193375||Single Group Assignment||Treatment||None (Open Label)||||||
1559472|NCT00193362|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559473|NCT00193349|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559474|NCT00193336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559475|NCT00193323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559476|NCT00193310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559477|NCT00193297|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559478|NCT00193284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559479|NCT00193271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559480|NCT00193258||Single Group Assignment||Treatment||None (Open Label)||||||
1559481|NCT00193245|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559482|NCT00193232|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559483|NCT00193219||Single Group Assignment||Treatment||None (Open Label)||||||
1559484|NCT00193206||Single Group Assignment||Treatment||None (Open Label)||||||
1559485|NCT00193193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559486|NCT00193180||Single Group Assignment||Treatment||None (Open Label)||||||
1559487|NCT00193167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559488|NCT00193154||Single Group Assignment||Treatment||None (Open Label)||||||
1559489|NCT00193141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559490|NCT00193128|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559491|NCT00193115|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559492|NCT00193102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559493|NCT00193089|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559494|NCT00193076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559495|NCT00193063||Single Group Assignment||Treatment||None (Open Label)||||||
1559496|NCT00193050||Single Group Assignment||Treatment||None (Open Label)||||||
1559497|NCT00193037|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559498|NCT00193024|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559499|NCT00193011|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559500|NCT00192998|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1559501|NCT00192985|Randomized|Single Group Assignment||Prevention||Single||||||
1559502|NCT00192972|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1559503|NCT00192959|Randomized|Parallel Assignment||Treatment||Single||||||
1559504|NCT00192946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559505|NCT00192933|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1559506|NCT00192920|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1559507|NCT00192907|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1559508|NCT00192894|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1559509|NCT00192881|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559510|NCT00192868|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559511|NCT00192855|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1559512|NCT00192842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559513|NCT00192829||||Screening|Longitudinal, Prospective|||||||
1559514|NCT00192816|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1559586|NCT00191841|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559515|NCT00192803|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1559516|NCT00192790|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1559517|NCT00192777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559518|NCT00192764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559519|NCT00192751|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1559520|NCT00192738|||Defined Population||Longitudinal, Prospective|||||||
1559521|NCT00192725|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1559522|NCT00192712|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559523|NCT00192699|||Cohort||Retrospective|||||||
1559524|NCT00192686|||||Retrospective|||||||
1559525|NCT00192673|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559526|NCT00192660||Single Group Assignment||Diagnostic||None (Open Label)||||||
1559527|NCT00192647|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559528|NCT00192634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559529|NCT00192621||Single Group Assignment||Basic Science||None (Open Label)||||||
1559530|NCT00192608|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559531|NCT00192595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559532|NCT00192582|Randomized|Crossover Assignment||||None (Open Label)||||||
1559533|NCT00192569|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559534|NCT00192556|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1559535|NCT00192543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559536|NCT00192517|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559537|NCT00192504|Randomized|Parallel Assignment||Treatment||Double||||||
1559538|NCT00192491|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1559539|NCT00192478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559540|NCT00192465|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559541|NCT00192452|Randomized|Single Group Assignment||Treatment||Double||||||
1559542|NCT00192439|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1559543|NCT00192426|Randomized|Crossover Assignment||Prevention||Double||||||
1559544|NCT00192413|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559545|NCT00192400|Randomized|Single Group Assignment||Educational/Counseling/Training||Double||||||
1559546|NCT00192387|Randomized|Single Group Assignment||Treatment||Double||||||
1559547|NCT00192374|Randomized|Single Group Assignment||Treatment||Double||||||
1559548|NCT00192361|Randomized|Parallel Assignment||Prevention||Double||||||
1559549|NCT00192348|Randomized|Single Group Assignment||Treatment||Double||||||
1559550|NCT00192335|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1559551|NCT00192322|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559552|NCT00192309|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559553|NCT00192296|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559554|NCT00192283|Randomized|Single Group Assignment||Prevention||Double||||||
1559555|NCT00192270|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559556|NCT00192257|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559557|NCT00192244|Randomized|Single Group Assignment||Prevention||Double||||||
1559558|NCT00192231|Randomized|Parallel Assignment||Prevention||Double||||||
1559559|NCT00192218|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559560|NCT00192205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559561|NCT00192192|Randomized|Parallel Assignment||Prevention||Double||||||
1559562|NCT00192179|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559563|NCT00192166|Randomized|Single Group Assignment||Prevention||Double||||||
1559564|NCT00192153|Randomized|Parallel Assignment||Prevention||Double||||||
1559565|NCT00192140|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559566|NCT00192127|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1559567|NCT00192114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559568|NCT00192101|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559569|NCT00192088|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559570|NCT00192075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559571|NCT00192062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559572|NCT00192049|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559573|NCT00192036|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559574|NCT00192023|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559575|NCT00191997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559576|NCT00191984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559577|NCT00191971|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559578|NCT00191945|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559579|NCT00191932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559580|NCT00191919|Randomized|Parallel Assignment||Treatment||Double||||||
1559581|NCT00191906|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1559582|NCT00191893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559583|NCT00191880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559584|NCT00191867|Randomized|Parallel Assignment||Treatment||Double||||||
1559585|NCT00191854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559587|NCT00191828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559588|NCT00191815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559589|NCT00191802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559590|NCT00191789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559591|NCT00191763|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559592|NCT00191750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559593|NCT00191737|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559594|NCT00191724|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559595|NCT00191711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559596|NCT00191698|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1559597|NCT00191685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559598|NCT00191672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559599|NCT00191659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559600|NCT00191646|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559601|NCT00191633|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559602|NCT00191620|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559603|NCT00191607|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559604|NCT00191594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559605|NCT00191581|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559606|NCT00191568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559607|NCT00191555|Randomized|Parallel Assignment||Treatment||Double||||||
1559608|NCT00191542|Randomized|Parallel Assignment||Treatment||Double||||||
1559609|NCT00191529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559610|NCT00191516|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559611|NCT00191503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559612|NCT00191490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559613|NCT00191477|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559614|NCT00191464|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559615|NCT00191451|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559616|NCT00191438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559617|NCT00191425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559618|NCT00191412|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559619|NCT00191399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559620|NCT00191386|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559621|NCT00191373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559622|NCT00191360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559623|NCT00191347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559624|NCT00191334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559625|NCT00191321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559626|NCT00191308|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559627|NCT00191295|Randomized|Parallel Assignment||Treatment||Double||||||
1559628|NCT00191282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559629|NCT00191269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559630|NCT00191256|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559631|NCT00191243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559632|NCT00191230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559633|NCT00191204|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559634|NCT00191191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559635|NCT00191178|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559636|NCT00191165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559637|NCT00191152|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1559638|NCT00191139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559639|NCT00191126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559640|NCT00191113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559641|NCT00191100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559642|NCT00191087|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559643|NCT00191074|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559644|NCT00191061|Randomized|Parallel Assignment||Treatment||Double||||||
1559645|NCT00191048|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559646|NCT00191035|Randomized|Parallel Assignment||Treatment||Double||||||
1559647|NCT00191022|Randomized|Parallel Assignment||Treatment||Double||||||
1559648|NCT00191009|Randomized|Parallel Assignment||Treatment||Double||||||
1559649|NCT00190996|Randomized|Parallel Assignment||Treatment||Double||||||
1559650|NCT00190983|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559651|NCT00190970|Randomized|Parallel Assignment||Treatment||Double||||||
1559652|NCT00190957|Randomized|Parallel Assignment||Treatment||Double||||||
1559653|NCT00190944|Randomized|Parallel Assignment||Treatment||Double||||||
1559654|NCT00190931|Randomized|Parallel Assignment||Treatment||Double||||||
1559655|NCT00190918|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559656|NCT00190905|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559657|NCT00190892|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559658|NCT00190879|Randomized|Parallel Assignment||Treatment||Double||||||
1559659|NCT00190866|Randomized|Parallel Assignment||Treatment||Double||||||
1559660|NCT00190853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559661|NCT00190840|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559662|NCT00190827|Randomized|Parallel Assignment||Treatment||Double||||||
1559663|NCT00190814|Randomized|Parallel Assignment||Treatment||Double||||||
1559664|NCT00190801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559665|NCT00190788|Randomized|Parallel Assignment||Treatment||Double||||||
1559666|NCT00190775|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1559667|NCT00190762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559668|NCT00190749|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559669|NCT00190736|Randomized|Parallel Assignment||Treatment||Double||||||
1559670|NCT00190723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559671|NCT00190710|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559672|NCT00190697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559673|NCT00190684||Single Group Assignment||Treatment||None (Open Label)||||||
1559674|NCT00190671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559675|NCT00190658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559676|NCT00190645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559677|NCT00190632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559678|NCT00190619|Randomized|Parallel Assignment||Treatment||Double||||||
1559679|NCT00190606|Randomized|Parallel Assignment||Treatment||Double||||||
1559680|NCT00190593|Randomized|Parallel Assignment||Prevention||Double||||||
1559681|NCT00190580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559682|NCT00190567|Randomized|Parallel Assignment||Treatment||Double||||||
1559683|NCT00190554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559684|NCT00190541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559685|NCT00190528|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1559686|NCT00190515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559687|NCT00190502|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1559688|NCT00190489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559689|NCT00190476|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559690|NCT00190463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559691|NCT00190450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559692|NCT00190437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559693|NCT00190424|Randomized|Parallel Assignment||Treatment||Single|||t|||
1559694|NCT00190411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559695|NCT00190398|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559696|NCT00190385|Randomized|Factorial Assignment||||None (Open Label)||||||
1559697|NCT00190372|Randomized|Parallel Assignment||Health Services Research||Single||||t||
1559698|NCT00190359|||Case Control, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1559699|NCT00190346|Randomized|Parallel Assignment||||None (Open Label)||||||
1559700|NCT00190333|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559701|NCT00190320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559702|NCT00190307|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1559703|NCT00190294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559704|NCT00190281|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1559705|NCT00190268|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559706|NCT00190255|||Cohort||Prospective|||||||
1559707|NCT00190242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559708|NCT00190229|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559709|NCT00190216|Randomized|Parallel Assignment||Treatment||Double||||t|t|
1559710|NCT00190203|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559711|NCT00190190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559712|NCT00190177|||||Retrospective|||||||
1559713|NCT00190164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559714|NCT00190151|Randomized|Single Group Assignment||Treatment||Single|||||t|
1559715|NCT00190138|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559716|NCT00190125|||||Prospective|||||||
1559717|NCT00190112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559718|NCT00190099|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559719|NCT00190086|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1559720|NCT00190073|||Case Control|Screening|Cross-Sectional, Retrospective|||||||
1559721|NCT00190060|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559722|NCT00190047|Randomized|Parallel Assignment||Treatment||Double||||||
1559723|NCT00190034|Randomized|Parallel Assignment||Prevention||Double||||||
1559724|NCT00190021|Randomized|Parallel Assignment||Treatment||Double||||||
1559725|NCT00190008|Randomized|Crossover Assignment||Treatment||Double||||||
1559726|NCT00189995|Randomized|Parallel Assignment||Treatment||Double||||||
1559727|NCT00189982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559728|NCT00189969|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559729|NCT00189956|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559730|NCT00189943|Randomized|Parallel Assignment||Prevention||Double||||||
1559731|NCT00189930|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1559732|NCT00189917|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559733|NCT00189904|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559734|NCT00189878|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1559735|NCT00189852|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1559736|NCT00189839|Randomized|Parallel Assignment||Prevention||Double||||||
1559737|NCT00189826|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559738|NCT00189813|Randomized|Parallel Assignment||Treatment||Double||||||
1559739|NCT00189800|Randomized|Parallel Assignment||Treatment||Double||||||
1559740|NCT00189787|Randomized|Parallel Assignment||Treatment||Double||||||
1559741|NCT00189774|Randomized|Parallel Assignment||Treatment||Double||||||
1559742|NCT00189761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559743|NCT00189748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559744|NCT00189735|Randomized|Parallel Assignment||Treatment||Double||||||
1559745|NCT00189722|Randomized|Parallel Assignment||Treatment||Double||||||
1559746|NCT00189709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559747|NCT00189696|Randomized|Parallel Assignment||Treatment||Double||||||
1559748|NCT00189683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559749|NCT00189670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559750|NCT00189657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559751|NCT00189644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559752|NCT00189631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559753|NCT00189618|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1559754|NCT00189605|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559755|NCT00189592|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1559756|NCT00189579|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559757|NCT00189566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559758|NCT00189553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559759|NCT00189540|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559760|NCT00189527|Randomized|Crossover Assignment||Treatment||Single|||t|||
1559761|NCT00189514|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559762|NCT00189501|||||Prospective|||||||
1559763|NCT00189488|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559764|NCT00189475|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1559765|NCT00189462|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1559766|NCT00189449||||||||||||
1559767|NCT00189436|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559768|NCT00189423|Randomized|Parallel Assignment||Treatment||Single|||||t|
1559769|NCT00189410|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559770|NCT00189397|Randomized|Parallel Assignment||Treatment||Single||||||
1559771|NCT00189384|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559772|NCT00189371|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559773|NCT00189358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559774|NCT00189345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559775|NCT00189332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559776|NCT00189319|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559777|NCT00189306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559778|NCT00189293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559779|NCT00189280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559780|NCT00189267|Randomized|Parallel Assignment||Treatment||Double||||||
1559781|NCT00189254|||||Prospective|||||||
1559782|NCT00189241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559783|NCT00189228||Single Group Assignment||Basic Science||None (Open Label)||||||
1559784|NCT00189215|Randomized|Parallel Assignment||Prevention||Single||||||
1559785|NCT00189202||Single Group Assignment||Treatment||None (Open Label)||||||
1559786|NCT00189189|Non-Randomized|Parallel Assignment||Prevention||Single||||||
1559787|NCT00189176|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559788|NCT00189163|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1559789|NCT00189150|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559790|NCT00189137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559791|NCT00189124|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1559792|NCT00189111|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559793|NCT00189098|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1559794|NCT00189085|Randomized|Crossover Assignment||Treatment||Double||||||
1559795|NCT00189072|Randomized|Crossover Assignment||Treatment||Double||||||
1559796|NCT00189059|Randomized|Crossover Assignment||Treatment||Double||||||
1559797|NCT00189046|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1559798|NCT00189033|Randomized|Parallel Assignment||Treatment||Double||||||
1559799|NCT00189020|Randomized|Parallel Assignment||Prevention||Single||||||t
1559800|NCT00189007|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559801|NCT00188994|Randomized|Parallel Assignment||Treatment||Double||||||
1559802|NCT00188981|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1559803|NCT00188968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559804|NCT00188955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559805|NCT00188942|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559806|NCT00188929|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559807|NCT00188916|Random Sample||||Longitudinal, Prospective|||||||
1559808|NCT00188903|||||Prospective|||||||
1559809|NCT00188890|||Case-Control||Other|||||||
1559810|NCT00188877|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559811|NCT00188864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559812|NCT00188851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559813|NCT00188838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559814|NCT00188825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1559815|NCT00188812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559816|NCT00188799|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559817|NCT00188786|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559818|NCT00188773|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559819|NCT00188760|||Case Control||Prospective|||||||
1559820|NCT00188747|Randomized|Parallel Assignment||Treatment||Single||||||
1559821|NCT00188734|||Cohort||Prospective|||||||
1559822|NCT00188721|||Case Control||Cross-Sectional|||||||
1559823|NCT00188708||Single Group Assignment||Diagnostic||None (Open Label)||||||
1559824|NCT00188695|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559825|NCT00188682|||Cohort||Cross-Sectional|||||||
1559826|NCT00188669|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559827|NCT00188656|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559828|NCT00188643|Randomized|Parallel Assignment||Treatment||Double||||||
1559829|NCT00188630|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559830|NCT00188617||Single Group Assignment||Treatment||None (Open Label)||||||
1559831|NCT00188604|Randomized|Crossover Assignment||Treatment||Double||||||
1559832|NCT00188591|||Cohort||Cross-Sectional|||||||
1559833|NCT00188578||Single Group Assignment||Treatment||None (Open Label)||||||
1559834|NCT00188565|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559835|NCT00188552|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559836|NCT00188539||Single Group Assignment||Diagnostic||None (Open Label)||||||
1559837|NCT00188526|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559838|NCT00188513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559839|NCT00188500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559840|NCT00188487|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559841|NCT00188474|||Case-Only||Prospective|||||||
1559842|NCT00188461|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559843|NCT00188448|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559844|NCT00188435|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559845|NCT00188422|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559846|NCT00188409|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559847|NCT00188396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559848|NCT00188383|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1559849|NCT00188370|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559850|NCT00188357|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1559851|NCT00188344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559852|NCT00188331|||||Prospective|||||||
1559853|NCT00188318||Single Group Assignment||Treatment||None (Open Label)||||||
1559854|NCT00188305|Randomized|Parallel Assignment||||None (Open Label)||||||
1559855|NCT00188292|||Cohort||Prospective|||||||
1559856|NCT00188279||Single Group Assignment||Diagnostic||None (Open Label)||||||
1559857|NCT00188266||Single Group Assignment||Treatment||None (Open Label)||||||
1559858|NCT00188253|||Cohort||Prospective|||||||
1559859|NCT00188240|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559860|NCT00188227|Randomized|Parallel Assignment||Prevention||Double||||||
1559861|NCT00188214|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559862|NCT00188201|||Defined Population||Longitudinal, Prospective|||||||
1559863|NCT00188188|Randomized|Crossover Assignment||Treatment||Double||||||
1559864|NCT00188175||Single Group Assignment||Prevention||None (Open Label)||||||
1559865|NCT00188162|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559866|NCT00188149|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559867|NCT00188136|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559868|NCT00188123|||Case-Only||Cross-Sectional|||||||
1559869|NCT00188110|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559870|NCT00188097|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559871|NCT00188084|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1559872|NCT00188071|Randomized|Parallel Assignment||Treatment||Single||||||
1559873|NCT00188058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559874|NCT00188045|Randomized|Parallel Assignment||Prevention||Double||||||
1559875|NCT00188032|Randomized|Parallel Assignment||||None (Open Label)||||||
1559876|NCT00188019|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559877|NCT00188006|Randomized|Parallel Assignment||Treatment||Single||||||
1559878|NCT00187993|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1559879|NCT00187980|||Defined Population||Longitudinal, Prospective|||||||
1559880|NCT00187967|Randomized|Parallel Assignment||Treatment||Single||||||
1559881|NCT00187954|||Cohort||Prospective|||||||
1559882|NCT00187941||Single Group Assignment||Treatment||None (Open Label)||||||
1559883|NCT00187928|Randomized|Single Group Assignment||Treatment||Double||||||
1559884|NCT00187915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559885|NCT00187902|||Cohort||Cross-Sectional|||||||
1559886|NCT00187889|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559887|NCT00187876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559888|NCT00187863|||Case-Only||Prospective|||||||
1559889|NCT00187850|Randomized|Parallel Assignment||Treatment||Single||||||
1559890|NCT00187837|Randomized|Parallel Assignment||Treatment||Single|||t|||
1559891|NCT00187824|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1559892|NCT00187811|Randomized|Single Group Assignment||Treatment||Single||||||
1559893|NCT00187798||Single Group Assignment||Diagnostic||None (Open Label)||||||
1559894|NCT00187785|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1559895|NCT00187772|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559896|NCT00187759|Randomized|Single Group Assignment||Treatment||Double||||||
1559897|NCT00187746|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1559898|NCT00187733|||Cohort||Prospective|||||||
1559899|NCT00187720|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1559900|NCT00187707||Single Group Assignment||Basic Science||None (Open Label)||||||
1559901|NCT00187681|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1559902|NCT00187668|||Cohort||Prospective|||||||
1559903|NCT00187655||Single Group Assignment||Health Services Research||None (Open Label)||||||
1559904|NCT00187629|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1559905|NCT00187616|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1559906|NCT00187603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559907|NCT00187590|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559908|NCT00187577|Randomized|Parallel Assignment||Treatment||Single||||||t
1559909|NCT00187564|Randomized|Parallel Assignment||Treatment||Double||||||
1559910|NCT00187551|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559911|NCT00187538|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559912|NCT00187525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559913|NCT00187512|||Cohort||Prospective|||||||
1559914|NCT00187499|Randomized|Parallel Assignment||Treatment||Double||||||
1559915|NCT00187486||Single Group Assignment||Treatment||None (Open Label)||||||
1559916|NCT00187473|||Cohort|||||||||
1559917|NCT00187460|Randomized|Single Group Assignment||Health Services Research||None (Open Label)||||||
1559918|NCT00187447|Randomized|Single Group Assignment||Prevention||Double||||||
1559919|NCT00187434|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559920|NCT00187421|Randomized|Parallel Assignment||Prevention||Single||||||t
1559921|NCT00187408|Randomized|Parallel Assignment||Prevention||Double||||||
1559922|NCT00187395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559923|NCT00187382|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1559924|NCT00187369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559925|NCT00187356|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559926|NCT00187343|Randomized|Parallel Assignment||Treatment||Double||||||
1559927|NCT00187330|Randomized|Single Group Assignment||Prevention||Double||||||
1559928|NCT00187317|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1559929|NCT00187304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559930|NCT00187291|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1559931|NCT00187278|Randomized|Parallel Assignment||Treatment||Single|||t|||
1559932|NCT00187265|Randomized|Crossover Assignment||Treatment||Single||||||
1559933|NCT00187252|Randomized|Parallel Assignment||Treatment||Single|||t|||
1559934|NCT00187239|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559935|NCT00187226|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559936|NCT00187213|Randomized|Parallel Assignment||Treatment||Double||||||
1559937|NCT00187200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559938|NCT00187187|Randomized|Parallel Assignment||Treatment||Single|||t|||
1559939|NCT00187174||Single Group Assignment||Treatment||None (Open Label)||||||
1559940|NCT00187161|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559941|NCT00187148||Single Group Assignment||Prevention||None (Open Label)||||||
1559942|NCT00187135|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1559943|NCT00187122|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559944|NCT00187109|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559945|NCT00187096|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559946|NCT00187083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559947|NCT00187070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559948|NCT00187057|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559949|NCT00187044||Single Group Assignment||Prevention||None (Open Label)||||||
1559950|NCT00187031|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559951|NCT00187018||Single Group Assignment||Treatment||None (Open Label)||||||
1559952|NCT00187005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559953|NCT00186992||Single Group Assignment||Treatment||None (Open Label)||||||
1559954|NCT00186979||Single Group Assignment||Treatment||None (Open Label)||||||
1559955|NCT00186966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559956|NCT00186953|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1559957|NCT00186940|||Other||Prospective|||||||
1559958|NCT00186927||Single Group Assignment||Prevention||None (Open Label)||||||
1559959|NCT00186914||Single Group Assignment||Treatment||None (Open Label)||||||
1559960|NCT00186901|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1559961|NCT00186888|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559962|NCT00186875||Single Group Assignment||Treatment||None (Open Label)||||||
1559963|NCT00186862|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559964|NCT00186849|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559965|NCT00186836|Randomized|Parallel Assignment||Prevention||Single||||||
1559966|NCT00186823|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559967|NCT00186810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559968|NCT00186797|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559969|NCT00186784|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1559970|NCT00186771|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1559971|NCT00186758|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1559972|NCT00186745||Single Group Assignment||Treatment||None (Open Label)||||||
1559973|NCT00186732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559974|NCT00186719|||Cohort||Prospective|||||||
1559975|NCT00186706|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1559976|NCT00186693|||Cohort||Prospective|||||||
1559977|NCT00186680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559978|NCT00186667|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559979|NCT00186654|Randomized|Parallel Assignment||||Double||||||
1559980|NCT00186641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559981|NCT00186628||Single Group Assignment||Treatment||None (Open Label)||||||
1559982|NCT00186602|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1559983|NCT00186589|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559984|NCT00186576|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559985|NCT00186563|Randomized|Crossover Assignment||Diagnostic||Double||||||
1559986|NCT00186550||Single Group Assignment||Treatment||None (Open Label)||||||
1559987|NCT00186537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559988|NCT00186524|Randomized|Parallel Assignment||||None (Open Label)||||||
1559989|NCT00186511|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559990|NCT00186498|Randomized|Parallel Assignment||Prevention||Double||||||
1559991|NCT00186485||Single Group Assignment||Treatment||None (Open Label)||||||
1559992|NCT00186472|Randomized|Parallel Assignment||||None (Open Label)||||||
1559993|NCT00186459|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1559994|NCT00186446||Single Group Assignment||Treatment||None (Open Label)||||||
1559995|NCT00186433|||Case Control||Prospective|||||||
1559996|NCT00186420|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1559997|NCT00186407|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1559998|NCT00186394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1559999|NCT00186381|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560000|NCT00186368|||||Prospective|||||||
1560001|NCT00186355|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560002|NCT00186342|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560003|NCT00186329|Randomized|Single Group Assignment||Treatment||Double||||||
1560004|NCT00186316|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560005|NCT00186303|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560006|NCT00186290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560007|NCT00186277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560008|NCT00186264|Randomized|Parallel Assignment||Treatment||Double||||||
1560009|NCT00186251|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560010|NCT00186238|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560011|NCT00186225|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560012|NCT00186212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560013|NCT00186199|||||Prospective|||||||
1560014|NCT00186186||Single Group Assignment||Treatment||None (Open Label)||||||
1560015|NCT00186173|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1560016|NCT00186147|||Cohort||Prospective|||||||
1560017|NCT00186134|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560018|NCT00186121||Single Group Assignment||Treatment||None (Open Label)||||||
1560019|NCT00186108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560020|NCT00186095|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560021|NCT00186082|Randomized|Single Group Assignment||Prevention||Single|||t|||
1560022|NCT00186069|Randomized|Single Group Assignment||Treatment||Double|||t|||t
1560023|NCT00186056|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1560024|NCT00186043|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1560025|NCT00186030|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560026|NCT00186017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560027|NCT00186004|||Cohort||Prospective|||||||
1560028|NCT00185991|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1560029|NCT00185978|Randomized|Parallel Assignment||Prevention||Single||||||
1560030|NCT00185965|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560031|NCT00185952|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1560032|NCT00185939|Randomized|Single Group Assignment||Prevention||Double||||||
1560033|NCT00185913|||Cohort||Prospective|||||||
1560034|NCT00185900|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560035|NCT00185887|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1560036|NCT00185874|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560037|NCT00185861|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560038|NCT00185848||Single Group Assignment||Diagnostic||None (Open Label)||||||
1560039|NCT00185835|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560040|NCT00185809|||Cohort||Prospective|||||||
1560041|NCT00185796|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560042|NCT00185783|||Cohort||Prospective|||||||
1560043|NCT00185770|Randomized|Parallel Assignment||Prevention||Single||||||
1560044|NCT00185757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560045|NCT00185744|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560046|NCT00185731||Single Group Assignment||Treatment||None (Open Label)||||||
1560047|NCT00185718|||||Prospective|||||||
1560048|NCT00185705|Randomized|Single Group Assignment||Treatment||Double||||||
1560049|NCT00185692||Single Group Assignment||Treatment||None (Open Label)||||||
1560050|NCT00185679||Single Group Assignment||Treatment||None (Open Label)||||||
1560051|NCT00185666|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560052|NCT00185653|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560053|NCT00185640||Single Group Assignment||Treatment||None (Open Label)||||||
1560054|NCT00185614||Single Group Assignment||Treatment||None (Open Label)||||||
1560055|NCT00185601|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1560056|NCT00185588|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560057|NCT00185575|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560058|NCT00185562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560059|NCT00185549|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560060|NCT00185536|||Defined Population||Cross-Sectional, Prospective|||||||
1560061|NCT00185523|||Cohort||Prospective|||||||
1560062|NCT00185510|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560063|NCT00185484|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560064|NCT00185458|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560065|NCT00185445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560066|NCT00185419|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560067|NCT00185393|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560068|NCT00185380|Randomized|Parallel Assignment||Prevention||Single|||t|||
1560069|NCT00185367|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1560070|NCT00185354|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560071|NCT00185341|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560072|NCT00185328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560073|NCT00185315|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560074|NCT00185302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560075|NCT00185289|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560076|NCT00185276|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1560077|NCT00185263|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560078|NCT00185250|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1560079|NCT00185237|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560080|NCT00185224|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560081|NCT00185211|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560082|NCT00185198|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560083|NCT00185185|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560084|NCT00185172|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560085|NCT00185159|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1560086|NCT00185146|Randomized|Parallel Assignment||Treatment||Double||||||
1560087|NCT00185133|Randomized|Parallel Assignment||Treatment||Double||||||
1560088|NCT00185120|Randomized|Parallel Assignment||Treatment||Double||||||
1560089|NCT00185107|Randomized|Parallel Assignment||Treatment||Double||||||
1560090|NCT00185094|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560091|NCT00185081|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1560092|NCT00185068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560093|NCT00185055|Randomized|Crossover Assignment||Treatment||Single||||||
1560094|NCT00185042|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1560095|NCT00185029|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560096|NCT00185016|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1560097|NCT00185003|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560098|NCT00184990|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560099|NCT00184977|Randomized|Parallel Assignment||Treatment||Double||||||
1560100|NCT00184964|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560101|NCT00184951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560102|NCT00184938|Randomized|Crossover Assignment||||Double||||||
1560103|NCT00184925||Single Group Assignment||Prevention||None (Open Label)||||||
1560104|NCT00184912|Randomized|Parallel Assignment||||Double||||||
1560105|NCT00184899|Randomized|Crossover Assignment||Educational/Counseling/Training||Single||||||
1560106|NCT00184886|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560107|NCT00184873|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1560108|NCT00184860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560109|NCT00184847|Randomized|Crossover Assignment||||Double||||||
1560110|NCT00184834|||Defined Population||Longitudinal, Prospective|||||||
1560111|NCT00184821|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560112|NCT00184808|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1560113|NCT00184795|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560114|NCT00184782|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1560115|NCT00184769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560116|NCT00184756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560117|NCT00184743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560118|NCT00184730|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560119|NCT00184717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560120|NCT00184691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560121|NCT00184678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560122|NCT00184665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560123|NCT00184652|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560124|NCT00184639|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560125|NCT00184626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560126|NCT00184613|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560127|NCT00184600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560128|NCT00184587|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1560129|NCT00184574|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560130|NCT00184561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560131|NCT00184548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560132|NCT00184535|||Case-Only||Cross-Sectional|||||||
1560133|NCT00184522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560134|NCT00184509|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560135|NCT00184496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560136|NCT00184483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560137|NCT00184470|||||Retrospective|||||||
1560138|NCT00184457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560139|NCT00184444|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560140|NCT00184431|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560141|NCT00184418|||Cohort||Cross-Sectional|||||||
1560142|NCT00184405|||Cohort||Prospective|||||||
1560143|NCT00184392|Randomized|Parallel Assignment||Treatment||Single|||||t|
1560144|NCT00184379|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560145|NCT00184366|||Case-Only||Prospective|||||||
1560146|NCT00184353|||Case Control||Cross-Sectional|||||||
1560147|NCT00184340|||Case-Only||Retrospective|||||||
1560148|NCT00184327|||Cohort||Prospective|||||||
1560149|NCT00184314|||Case-Only||Retrospective|||||||
1560150|NCT00184301|Randomized|Parallel Assignment||Prevention||Single||||||t
1560151|NCT00184288|||Case-Only||Prospective|||||||
1560152|NCT00184275|||Case-Only||Prospective|||||||
1560153|NCT00184262|Randomized|Parallel Assignment||Prevention||Single||||||t
1560154|NCT00184249|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560155|NCT00184236|Randomized|Parallel Assignment||Treatment||Single||||||t
1560156|NCT00184223|Randomized|Parallel Assignment||Treatment||Single||||t||
1560157|NCT00184210|||Cohort||Cross-Sectional|||||||
1560158|NCT00184197|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1560159|NCT00184184|||||Prospective|||||||
1560160|NCT00184171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560161|NCT00184158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560162|NCT00184145|Randomized|Parallel Assignment||Treatment||Single||||||t
1560163|NCT00184132|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560164|NCT00184119|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560165|NCT00184106|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1560166|NCT00184093||Single Group Assignment||Treatment||None (Open Label)||||||
1560167|NCT00184080|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560168|NCT00184067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560169|NCT00184054||Single Group Assignment||Treatment||None (Open Label)||||||
1560170|NCT00184041||Single Group Assignment||Treatment||None (Open Label)||||||
1560171|NCT00184028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560172|NCT00184015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560173|NCT00184002||Single Group Assignment||Treatment||None (Open Label)||||||
1560174|NCT00183989|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560175|NCT00183976|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560176|NCT00183963|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560177|NCT00183950||Single Group Assignment||Treatment||None (Open Label)||||||
1560178|NCT00183937||Single Group Assignment||Treatment||None (Open Label)||||||
1560179|NCT00183924||Single Group Assignment||Treatment||None (Open Label)||||||
1560180|NCT00183911|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560181|NCT00183898||Single Group Assignment||Treatment||None (Open Label)||||||
1560182|NCT00183885||Single Group Assignment||Treatment||None (Open Label)||||||
1560183|NCT00183872||Single Group Assignment||Treatment||None (Open Label)||||||
1560184|NCT00183859||Parallel Assignment||Treatment||None (Open Label)||||||
1560185|NCT00183846||Single Group Assignment||Treatment||None (Open Label)||||||
1560186|NCT00183833||Single Group Assignment||Treatment||None (Open Label)||||||
1560187|NCT00183820||Single Group Assignment||Treatment||None (Open Label)||||||
1560188|NCT00183807||Single Group Assignment||Treatment||None (Open Label)||||||
1560189|NCT00183794|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560190|NCT00183781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560191|NCT00183768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560192|NCT00183755|||Cohort||Prospective|||||||
1560193|NCT00183742|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560194|NCT00183729|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560195|NCT00183716|Randomized|Parallel Assignment||Treatment||Single||||||t
1560196|NCT00183703|||Case-Only||Cross-Sectional|||||||
1560197|NCT00183690|Randomized|Parallel Assignment||Treatment||Single||||||t
1560198|NCT00183677||Single Group Assignment||Treatment||None (Open Label)||||||
1560199|NCT00183651|Randomized|Parallel Assignment||Treatment||Single||||||t
1560200|NCT00183638|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560201|NCT00183625|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560202|NCT00183612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560203|NCT00183599|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560204|NCT00183586|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560205|NCT00183573|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560206|NCT00183560|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1560207|NCT00183547|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560208|NCT00183521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560209|NCT00183508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560210|NCT00183495|||Case-Only||Prospective|||||||
1560211|NCT00183482|Randomized|Parallel Assignment||Prevention||Double|Investigators and outcome assessors are masked to condition of particpants.|Repeated measures ANOCA design.|||t|t
1560212|NCT00183469|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560213|NCT00183456|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1560214|NCT00183443|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1560215|NCT00183430|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560216|NCT00183417|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560217|NCT00183404||Single Group Assignment||Treatment||None (Open Label)||||||
1560218|NCT00183391|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1560219|NCT00183378|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560220|NCT00183365|Randomized|Parallel Assignment||Prevention||Single||||||t
1560221|NCT00183352|||Ecologic or Community||Prospective|||||||
1560222|NCT00183339|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560223|NCT00183326|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560224|NCT00183313|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1560225|NCT00183300|Randomized|Parallel Assignment||Treatment||Single||||||
1560226|NCT00183287|||Case-Only||Prospective|||||||
1560227|NCT00183274|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560228|NCT00183261|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1560229|NCT00183248|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560230|NCT00183235|Randomized|Factorial Assignment||Treatment||Double||||||
1560231|NCT00183222|Randomized|Factorial Assignment||Treatment||Double||||||
1560232|NCT00183209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560233|NCT00183196|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1560234|NCT00183183|Non-Randomized|Single Group Assignment||Treatment||Single|||||t|
1560235|NCT00183170|Randomized|Crossover Assignment||Prevention||Double||||||
1560236|NCT00183157|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560237|NCT00183144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560238|NCT00183131|Randomized|Parallel Assignment||Treatment||Single||||||
1560239|NCT00183118|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560240|NCT00183105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560241|NCT00183092|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560242|NCT00183079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560243|NCT00183066|||||Prospective|||||||
1560244|NCT00183053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560245|NCT00183040|Randomized|Factorial Assignment||Treatment||Double||||||
1560246|NCT00183027|Randomized|Parallel Assignment||Treatment||Double||||||
1560247|NCT00183014|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560248|NCT00183001|Randomized|Parallel Assignment||Treatment||Double||||||
1560249|NCT00182988|||||Prospective|||||||
1560250|NCT00182975|Randomized|Parallel Assignment||Treatment||Double||||||
1560251|NCT00182962|Randomized|Single Group Assignment||Treatment||Single||||||
1560252|NCT00182949|||||Prospective|||||||
1560253|NCT00182936|Randomized|Parallel Assignment||Treatment||Single||||||
1560254|NCT00182923|||||Prospective|||||||
1560255|NCT00182897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560256|NCT00182884|Randomized|Parallel Assignment||Prevention||Double||||||
1560257|NCT00182871|Randomized|Single Group Assignment||Treatment||Double||||||
1560258|NCT00182858|||||Other|||||||
1560259|NCT00182845|Randomized|Parallel Assignment||Prevention||Double||||||
1560260|NCT00182832|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1560261|NCT00182819|Randomized|||Treatment||None (Open Label)||||||
1560262|NCT00182806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560263|NCT00182793|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560264|NCT00182780|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1560265|NCT00182767||Single Group Assignment||Treatment||None (Open Label)||||||
1560266|NCT00182754|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560267|NCT00182741||Single Group Assignment||Treatment||None (Open Label)||||||
1560268|NCT00182728||Single Group Assignment||Treatment||None (Open Label)||||||
1560269|NCT00182715|Randomized|||Treatment||None (Open Label)||||||
1560270|NCT00182702||Single Group Assignment||Treatment||None (Open Label)||||||
1560271|NCT00182689||Single Group Assignment||Treatment||None (Open Label)||||||
1560272|NCT00182663||Single Group Assignment||Treatment||None (Open Label)||||||
1560273|NCT00182650|Non-Randomized|||Treatment||None (Open Label)||||||
1560274|NCT00182637||Single Group Assignment||Treatment||None (Open Label)||||||
1560275|NCT00182624||||||||||||
1560276|NCT00182611|Randomized|||Treatment||||||||
1560277|NCT00182598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560278|NCT00182585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560279|NCT00182572|Randomized|Parallel Assignment||Treatment||Double||||||
1560280|NCT00182559|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1560281|NCT00182546|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560282|NCT00182533|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560283|NCT00182520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560284|NCT00182507|Randomized|Parallel Assignment||Treatment||Double||||||
1560285|NCT00182494|Randomized|Parallel Assignment||Prevention||Double||||||
1560286|NCT00182481|Randomized|Parallel Assignment||Treatment||Single||||||
1560287|NCT00182468|Randomized|Parallel Assignment||Screening||Single||||||t
1560288|NCT00182455|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560289|NCT00182442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560290|NCT00182429|Randomized|Parallel Assignment||Treatment||Double||||||
1560291|NCT00182416|Randomized|Parallel Assignment||Treatment||Double||||||
1560292|NCT00182403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560293|NCT00182390|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560294|NCT00182377|Randomized|Single Group Assignment||Treatment||Double||||||
1560295|NCT00182364|Randomized|Parallel Assignment||Prevention||Double||||||
1560296|NCT00182351|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1560297|NCT00182338|||Cohort||Prospective|||||||
1560298|NCT00182325|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560299|NCT00182312|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1560300|NCT00182299|Randomized|Parallel Assignment||Treatment||Double||||||
1560301|NCT00182286|||Defined Population||Cross-Sectional, Prospective|||||||
1560302|NCT00182273|Randomized|Parallel Assignment||Treatment||Single||||||
1560303|NCT00182260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560304|NCT00182247|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1560305|NCT00182234|Randomized|Parallel Assignment||||None (Open Label)||||||
1560306|NCT00182221|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1560307|NCT00182208|Randomized|Crossover Assignment||Treatment||Double||||||
1560308|NCT00182195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560309|NCT00182182|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560310|NCT00182169|Randomized|Parallel Assignment||Treatment||Double||||||
1560311|NCT00182156|||Cohort||Cross-Sectional|||||||
1560312|NCT00182143|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1560313|NCT00182130|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560314|NCT00182117|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1560315|NCT00182104|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560316|NCT00182091|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560317|NCT00182078|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1560318|NCT00182065|||Natural History||Longitudinal, Prospective|||||||
1560319|NCT00182052|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1560320|NCT00182039|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1560321|NCT00182026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560322|NCT00182013|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560323|NCT00182000|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560324|NCT00181987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560325|NCT00181974|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560326|NCT00181961|Randomized|Single Group Assignment||Treatment||Double||||||
1560327|NCT00181948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560328|NCT00181935|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1560329|NCT00181922|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560330|NCT00181909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560331|NCT00181896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560332|NCT00181883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560333|NCT00181870|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560334|NCT00181857|||Family-Based||Cross-Sectional|||||||
1560335|NCT00181844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560336|NCT00181831|||Cohort||Prospective|||||||
1560337|NCT00181818|Randomized|Parallel Assignment||Treatment||Double||||||
1560338|NCT00181805|||Case Control||Retrospective|||||||
1560339|NCT00181792|||Family-Based|||||||||
1560340|NCT00181779|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560341|NCT00181766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560342|NCT00181753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560343|NCT00181740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560344|NCT00181727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560345|NCT00181714||Single Group Assignment||Prevention||None (Open Label)||||||
1560346|NCT00181701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560347|NCT00181688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560348|NCT00181675|Randomized|Parallel Assignment||Treatment||Double||||||
1560349|NCT00181662|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560350|NCT00181649|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560351|NCT00181636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560352|NCT00181623|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560353|NCT00181610|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560354|NCT00181597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560355|NCT00181584|Randomized|Factorial Assignment||Prevention||Single|||t|||
1560356|NCT00181571|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1560357|NCT00181558|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560358|NCT00181545|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560359|NCT00181532|Randomized|Parallel Assignment||Treatment||Double||||||
1560360|NCT00181506|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560361|NCT00181363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560362|NCT00181350|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560363|NCT00181311|||Defined Population||Cross-Sectional, Prospective|||||||
1560364|NCT00181298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560365|NCT00181285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560366|NCT00181272|Randomized|Crossover Assignment||Treatment||Double||||||
1560367|NCT00181259|||Other||Prospective|||||||
1560368|NCT00181246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560369|NCT00181233|||Other||Prospective|||||||
1560370|NCT00181220|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560371|NCT00181207|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1560372|NCT00181194||||||||||||
1560373|NCT00181181|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1560374|NCT00181168|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1560375|NCT00181155|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560376|NCT00181142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560377|NCT00181129|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1560378|NCT00181116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560379|NCT00181090|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560380|NCT00181077|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560381|NCT00181064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560382|NCT00181051|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560383|NCT00181038|Randomized|Parallel Assignment||Treatment||Double||||||
1560384|NCT00181025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560385|NCT00181012|Randomized|Parallel Assignment||Treatment||Double||||||
1560386|NCT00180999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560387|NCT00180986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560388|NCT00180973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560389|NCT00180960|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560390|NCT00180947|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560391|NCT00180934|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1560392|NCT00180921|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560393|NCT00180908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560394|NCT00180895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560395|NCT00180882|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560396|NCT00180869|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560547|NCT00178880|||Cohort||Prospective|||||||
1560397|NCT00180856|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560398|NCT00180843|Randomized|Single Group Assignment||Basic Science||Double|||t|||t
1560399|NCT00180830|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560400|NCT00180817|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1560401|NCT00180804|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1560402|NCT00180791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560403|NCT00180778|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560404|NCT00180765||||||||||||
1560405|NCT00180752|||Case Control||Cross-Sectional|||||||
1560406|NCT00180739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560407|NCT00180726|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560408|NCT00180713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560409|NCT00180700|Randomized|Parallel Assignment||||Single||||||
1560410|NCT00180687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560411|NCT00180674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560412|NCT00180661|||Cohort||Cross-Sectional|||||||
1560413|NCT00180648|||Case Control||Prospective|||||||
1560414|NCT00180635|Randomized|Crossover Assignment||||Double||||||
1560415|NCT00180622|||Defined Population||Longitudinal, Prospective|||||||
1560416|NCT00180609|||Cohort||Prospective|||||||
1560417|NCT00180596|Randomized|Crossover Assignment||Treatment||Single||||||
1560418|NCT00180583|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560419|NCT00180570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560420|NCT00180557|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560421|NCT00180544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560422|NCT00180531|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560423|NCT00180518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560424|NCT00180505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560425|NCT00180492|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1560426|NCT00180479|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560427|NCT00180466|||||Prospective|||||||
1560428|NCT00180453|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560429|NCT00180440|||Cohort||Prospective|||||||
1560430|NCT00180427|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1560431|NCT00180414|Randomized|Parallel Assignment||Treatment||Single||||||
1560432|NCT00180401|||Case-Control||Prospective|||||||
1560433|NCT00180388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560434|NCT00180375|||Cohort||Prospective|||||||
1560435|NCT00180362|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1560436|NCT00180349|||Cohort||Prospective|||||||
1560437|NCT00180336|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560438|NCT00180323||Single Group Assignment||Treatment||None (Open Label)||||||
1560439|NCT00180310|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560440|NCT00180297|Randomized|Parallel Assignment||Other||Single|||t|||
1560441|NCT00180284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560442|NCT00180271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560443|NCT00180258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560444|NCT00180245|||Cohort||Prospective|||||||
1560445|NCT00180232|||||Prospective|||||||
1560446|NCT00180219|||Cohort||Prospective|||||||
1560447|NCT00180206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560448|NCT00180193|||Cohort||Prospective|||||||
1560449|NCT00180180|||Cohort||Prospective|||||||
1560450|NCT00180167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560451|NCT00180154|||Cohort||Prospective|||||||
1560452|NCT00180141|Randomized|Parallel Assignment||Treatment||Double||||||
1560453|NCT00180128|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560454|NCT00180115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560455|NCT00180102|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1560456|NCT00180089|Randomized|Parallel Assignment||Prevention||Double||||||
1560457|NCT00180076|Randomized|Parallel Assignment||Treatment||Double||||||
1560458|NCT00180063|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560459|NCT00180050|Randomized|Parallel Assignment||Treatment||Double||||||
1560460|NCT00180037|Randomized|Parallel Assignment||Treatment||Double||||||
1560461|NCT00180024|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560462|NCT00180011|Non-Randomized|Single Group Assignment||Treatment||Double|||t||t|
1560463|NCT00179998|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1560464|NCT00179985|||Cohort||Prospective|||||||
1560465|NCT00179972|||Cohort||Prospective|||||||
1560466|NCT00179959|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560467|NCT00179946|||||Prospective|||||||
1560468|NCT00179933|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560469|NCT00179920|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560470|NCT00179907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560471|NCT00179894|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1560472|NCT00179881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560473|NCT00179868|||Case-Only||Prospective|||||||
1560548|NCT00178867|||Cohort||Prospective|||||||
1560474|NCT00179855|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560475|NCT00179842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560476|NCT00179829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560477|NCT00179816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560478|NCT00179803|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560479|NCT00179790|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560480|NCT00179777|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1560481|NCT00179764|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560482|NCT00179751|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1560483|NCT00179738|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560484|NCT00179725|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1560485|NCT00179712|Non-Randomized|Factorial Assignment||||None (Open Label)||||||
1560486|NCT00179699|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1560487|NCT00179686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560488|NCT00179673||Single Group Assignment||Treatment||None (Open Label)||||||
1560489|NCT00179660||Single Group Assignment||Treatment||None (Open Label)||||||
1560490|NCT00179647|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560491|NCT00179634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560492|NCT00179621|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1560493|NCT00179608|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560494|NCT00179595|Randomized|Parallel Assignment||Health Services Research||Double||||||
1560495|NCT00179582|Randomized|Parallel Assignment||Treatment||Double||||||
1560496|NCT00179569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560497|NCT00179556|Randomized|Parallel Assignment||Treatment||Double||||||
1560498|NCT00179543|Randomized|Parallel Assignment||Treatment||Double||||||
1560499|NCT00179530|Randomized|Parallel Assignment||Treatment||Single||||||t
1560500|NCT00179517|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1560501|NCT00179504|Randomized|Factorial Assignment||Treatment||Single||||||t
1560502|NCT00179491|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1560503|NCT00179478|Randomized|Parallel Assignment||Treatment||Single|Open label study: The outcome committee determined the primary outcome event (the development of Clinically definite MS) without knowledge of original treatment assignment and the central MRI reading center was not aware of original treatment assignments|||||t
1560504|NCT00179465|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1560505|NCT00179452||Single Group Assignment||Other||None (Open Label)||||||
1560506|NCT00179439||||||||||||
1560507|NCT00179426|||||Other|||||||
1560508|NCT00179413|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560509|NCT00179400|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1560510|NCT00179387|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1560511|NCT00179374|Randomized|Parallel Assignment||Other||Single||||||t
1560512|NCT00179361|||Cohort||Prospective|||||||
1560513|NCT00179348|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1560514|NCT00179335|||Case-Only||Prospective|||||||
1560515|NCT00179322||||||||||||
1560516|NCT00179309|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560517|NCT00179283|Randomized|Parallel Assignment||Treatment||Double||||||
1560518|NCT00179257|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560519|NCT00179244|Randomized|Crossover Assignment||||None (Open Label)||||||
1560520|NCT00179231|Randomized|Parallel Assignment||Treatment||Double||||||
1560521|NCT00179218|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560522|NCT00179205|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1560523|NCT00179192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560524|NCT00179179|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560525|NCT00179166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560526|NCT00179153|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560527|NCT00179140|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1560528|NCT00179127|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1560529|NCT00179114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560530|NCT00179101|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1560531|NCT00179088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560532|NCT00179075|||Case-Only||Prospective|||||||
1560533|NCT00179062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560534|NCT00179049|||Case-Only||Prospective|||||||
1560535|NCT00179036|||Case-Control||Cross-Sectional|||||||
1560536|NCT00179023|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560537|NCT00179010|Non-Randomized|Crossover Assignment||||Single|||t|||
1560538|NCT00178997|||Case-Control||Cross-Sectional|||||||
1560539|NCT00178984|||Case-Control||Cross-Sectional|||||||
1560540|NCT00178971|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560541|NCT00178958|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560542|NCT00178945|Randomized|Crossover Assignment||Treatment||Double||||||
1560543|NCT00178932|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560544|NCT00178919|Non-Randomized|Parallel Assignment||||Single||||||t
1560545|NCT00178906|||Ecologic or Community||Cross-Sectional|||||||
1560546|NCT00178893|||Ecologic or Community||Prospective|||||||
1560549|NCT00178854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560550|NCT00178841||Single Group Assignment||Treatment||None (Open Label)||||||
1560551|NCT00178828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560552|NCT00178802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560553|NCT00178789|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1560554|NCT00178776|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1560555|NCT00178763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560556|NCT00178750|Randomized|Parallel Assignment||||None (Open Label)||||||
1560557|NCT00178737|Randomized|Parallel Assignment||Health Services Research||Single||||||
1560558|NCT00178724|||Other||Prospective|||||||
1560559|NCT00178711|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1560560|NCT00178698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560561|NCT00178685|Randomized|Parallel Assignment||Treatment||Single||||||t
1560562|NCT00178672|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560563|NCT00178659|||Cohort||Prospective|||||||
1560564|NCT00178646|Randomized|Parallel Assignment||Treatment||Single||||||t
1560565|NCT00178633|||Cohort||Prospective|||||||
1560566|NCT00178620|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560567|NCT00178607|||Case-Only||Prospective|||||||
1560568|NCT00178594|||||Prospective|||||||
1560569|NCT00178581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560570|NCT00178568|||Case Control||Cross-Sectional|||||||
1560571|NCT00178555|Randomized|Parallel Assignment||||Single||||||
1560572|NCT00178542|||Case Control||Prospective|||||||
1560573|NCT00178529|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1560574|NCT00178516|||Case Control||Prospective|||||||
1560575|NCT00178503|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1560576|NCT00178490|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1560577|NCT00178477||Single Group Assignment||Treatment||None (Open Label)||||||
1560578|NCT00178464||Single Group Assignment||Treatment||None (Open Label)||||||
1560579|NCT00178451|Randomized|Single Group Assignment||||Double||||||
1560580|NCT00178438|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560581|NCT00178425|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560582|NCT00178412|Randomized|Parallel Assignment||||None (Open Label)||||||
1560583|NCT00178399||Single Group Assignment||Treatment||None (Open Label)||||||
1560584|NCT00178386|||Cohort||Retrospective|||||||
1560585|NCT00178373|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1560586|NCT00178360|Randomized|Crossover Assignment||||None (Open Label)||||||
1560587|NCT00178347|||||Retrospective|||||||
1560588|NCT00178334|||Cohort||Prospective|||||||
1560589|NCT00178321|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560590|NCT00178308|||Defined Population||Longitudinal, Prospective|||||||
1560591|NCT00178295|||Cohort||Prospective|||||||
1560592|NCT00178282|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560593|NCT00178269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560594|NCT00178256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560595|NCT00178243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560596|NCT00178230|||Cohort||Prospective|||||||
1560597|NCT00178217|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1560598|NCT00178204|||||Prospective|||||||
1560599|NCT00178191|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560600|NCT00178178|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560601|NCT00178165|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560602|NCT00178152|||Case Control||Retrospective|||||||
1560603|NCT00178139|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560604|NCT00178126|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1560605|NCT00178113|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560606|NCT00178100|Randomized|Factorial Assignment||Treatment||Double||||||
1560607|NCT00178087|||Case Control||Prospective|||||||
1560608|NCT00178074|Non-Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1560609|NCT00178061|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560610|NCT00178048|Randomized|Factorial Assignment||Treatment||Double||||||
1560611|NCT00178035|Randomized|Factorial Assignment||Treatment||Double||||||
1560612|NCT00178022|Randomized|Factorial Assignment||||Double||||||
1560613|NCT00178009|||Case Control||Prospective|||||||
1560614|NCT00177996|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1560615|NCT00177983|Randomized|Factorial Assignment||||Double||||||
1560616|NCT00177970|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1560617|NCT00177957|||Cohort||Prospective|||||||
1560618|NCT00177944|||Cohort||Prospective|||||||
1560619|NCT00177931|||Cohort||Prospective|||||||
1560620|NCT00177918|||Cohort||Prospective|||||||
1560621|NCT00177892|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1560622|NCT00177879|Randomized|Single Group Assignment||||None (Open Label)||||||
1560623|NCT00177866|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1560624|NCT00177853|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560625|NCT00177840|Randomized|Single Group Assignment||Treatment||Single||||||
1560626|NCT00177827|||Case-Only||Prospective|||||||
1560627|NCT00177814|||Other||Retrospective|||||||
1560628|NCT00177801|||||Prospective|||||||
1560630|NCT00177775|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1560631|NCT00177762|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560632|NCT00177749|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560633|NCT00177736|||||Prospective|||||||
1560634|NCT00177723|||||Prospective|||||||
1560635|NCT00177710|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560636|NCT00177697|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560637|NCT00177684|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560638|NCT00177671|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1560639|NCT00177658|||Other||Retrospective|||||||
1560640|NCT00177645||Single Group Assignment||Basic Science||None (Open Label)||||||
1560641|NCT00177632|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560642|NCT00177619|Randomized|Crossover Assignment||Treatment||Double||||||
1560643|NCT00177606|||||Prospective|||||||
1560644|NCT00177593|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560645|NCT00177580|Randomized|Parallel Assignment||Treatment||Double||||||
1560646|NCT00177567|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560647|NCT00177554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560648|NCT00177541||Single Group Assignment||Treatment||None (Open Label)||||||
1560649|NCT00177528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560650|NCT00177515|Randomized|Parallel Assignment||||Triple||||t|t|t
1560651|NCT00177502|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560652|NCT00177489|Randomized|Parallel Assignment||Treatment||Single||||||t
1560653|NCT00177476|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560654|NCT00177463|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560655|NCT00177437|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560656|NCT00177424|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1560657|NCT00177411||Single Group Assignment||Treatment||Single|||t|||
1560658|NCT00177398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560659|NCT00177385|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560660|NCT00177372|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560661|NCT00177359|Randomized|Parallel Assignment||Treatment||Single||||||
1560662|NCT00177346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560663|NCT00177333|Randomized|Parallel Assignment||Prevention||Double||||||
1560664|NCT00177320|||Cohort||Cross-Sectional|||||||
1560665|NCT00177307||Single Group Assignment||Treatment||None (Open Label)||||||
1560666|NCT00177294|Randomized|Parallel Assignment||Treatment||Single||||||t
1560667|NCT00177281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560668|NCT00177268|||Other||Prospective|||||||
1560669|NCT00177255||Single Group Assignment||Treatment||None (Open Label)||||||
1560670|NCT00177242|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560671|NCT00177229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560672|NCT00177216|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1560673|NCT00177203|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1560674|NCT00177190|||||Prospective|||||||
1560675|NCT00177177|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560676|NCT00177164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560677|NCT00177138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560678|NCT00177125|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560679|NCT00177112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560680|NCT00177099|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1560681|NCT00177086|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560682|NCT00177060|Randomized|Single Group Assignment||Treatment||Single||||||
1560683|NCT00177047||Single Group Assignment||Treatment||None (Open Label)||||||
1560684|NCT00177034|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560685|NCT00177021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560686|NCT00177008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560687|NCT00176995|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560688|NCT00176982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560689|NCT00176969|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560690|NCT00176956||||||||||||
1560691|NCT00176943|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1560692|NCT00176930||Single Group Assignment||Treatment||None (Open Label)||||||
1560693|NCT00176917||Single Group Assignment||Treatment||None (Open Label)||||||
1560694|NCT00176904|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560695|NCT00176891||Single Group Assignment||Treatment||None (Open Label)||||||
1560696|NCT00176878|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560697|NCT00176865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560698|NCT00176852|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560699|NCT00176839||Single Group Assignment||Treatment||None (Open Label)||||||
1560700|NCT00176826||Single Group Assignment||Treatment||None (Open Label)||||||
1560701|NCT00176813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560702|NCT00176800||Single Group Assignment||Treatment||None (Open Label)||||||
1560703|NCT00176787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560704|NCT00176774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560705|NCT00176761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560706|NCT00176748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560707|NCT00176735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560708|NCT00176722|||||Prospective|||||||
1560709|NCT00176696|||Cohort||Prospective|||||||
1560710|NCT00176683|||Cohort||Prospective|||||||
1560711|NCT00176670|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560712|NCT00176657|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560713|NCT00176644||Single Group Assignment||Treatment||None (Open Label)||||||
1560714|NCT00176631||Single Group Assignment||Treatment||None (Open Label)||||||
1560715|NCT00176618|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560716|NCT00176605||Single Group Assignment||Treatment||None (Open Label)||||||
1560717|NCT00176592|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1560718|NCT00176579|||Case Control||Prospective|||||||
1560719|NCT00176566|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1560720|NCT00176553|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1560721|NCT00176540||||Supportive Care||None (Open Label)||||||
1560722|NCT00176527||||Treatment||None (Open Label)||||||
1560723|NCT00176514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560724|NCT00176501||Single Group Assignment||Treatment||None (Open Label)||||||
1560725|NCT00176488||Single Group Assignment||Treatment||None (Open Label)||||||
1560726|NCT00176475||Single Group Assignment||Treatment||None (Open Label)||||||
1560727|NCT00176462|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560728|NCT00176449|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560729|NCT00176436|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560730|NCT00176423|Randomized|Parallel Assignment||Treatment||Double||||||
1560731|NCT00176410|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1560732|NCT00176397|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560733|NCT00176384|Randomized|Single Group Assignment||||None (Open Label)||||||
1560734|NCT00176371|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560735|NCT00176358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560736|NCT00176345|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560737|NCT00176332|Randomized|Single Group Assignment||Treatment||Double||||||
1560738|NCT00176319|Randomized|Single Group Assignment||||None (Open Label)||||||
1560739|NCT00176306||Single Group Assignment||Treatment||None (Open Label)||||||
1560740|NCT00176293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560741|NCT00176280|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560742|NCT00176267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560743|NCT00176254||Single Group Assignment||Treatment||None (Open Label)||||||
1560744|NCT00176241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560745|NCT00176228||Single Group Assignment||Treatment||None (Open Label)||||||
1560746|NCT00176215|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560747|NCT00176202|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1560748|NCT00176189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560749|NCT00176176|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560750|NCT00176163|Randomized|Factorial Assignment||Treatment||Double||||||
1560751|NCT00176150|||Defined Population||Cross-Sectional, Prospective|||||||
1560752|NCT00176137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560753|NCT00176124|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560754|NCT00176111|Randomized|Parallel Assignment||Treatment||Double||||||
1560755|NCT00176098|Randomized|Parallel Assignment||Treatment||Double||||||
1560756|NCT00176085|||||Prospective|||||||
1560757|NCT00176072|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560758|NCT00176059|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560759|NCT00176046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560760|NCT00176033|||||Prospective|||||||
1560761|NCT00176020||||||||||||
1560762|NCT00176007|Randomized|Crossover Assignment||Educational/Counseling/Training||Single||||||
1560763|NCT00175994|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560764|NCT00175981|Randomized|Crossover Assignment||Prevention||Double||||||
1560765|NCT00175968|Randomized|Crossover Assignment||Educational/Counseling/Training||Single||||||
1560766|NCT00175955|Randomized|Parallel Assignment||||Double||||||
1560767|NCT00175942|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1560768|NCT00175929|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560769|NCT00175916||Single Group Assignment||Treatment||None (Open Label)||||||
1560770|NCT00175903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560771|NCT00175890|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560772|NCT00175877||Single Group Assignment||Treatment||None (Open Label)||||||
1560773|NCT00175864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560774|NCT00175851|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1560775|NCT00175838|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560776|NCT00175825|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560777|NCT00175812||Single Group Assignment||Treatment||None (Open Label)||||||
1560778|NCT00175799|||Cohort|||||||||
1560779|NCT00175786|||||Prospective|||||||
1560780|NCT00175773|||Cohort||Prospective|||||||
1560781|NCT00175760|||Cohort||Prospective|||||||
1560782|NCT00175747|Randomized|Parallel Assignment||Prevention||Double||||||
1560783|NCT00175734|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560784|NCT00175721|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560785|NCT00175708|||Cohort||Prospective|||||||
1560786|NCT00175695|||Case-Only||Prospective|||||||
1560787|NCT00175682|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1560788|NCT00175669|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560789|NCT00175656|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560790|NCT00175643|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560791|NCT00175630|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560792|NCT00175617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560793|NCT00175604|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560794|NCT00175591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560795|NCT00175578|||Cohort||Prospective|||||||
1560796|NCT00175565|Randomized|Parallel Assignment||Treatment||Double||||||
1560797|NCT00175552|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1560798|NCT00175539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560799|NCT00175526|||Case-Only||Prospective|||||||
1560800|NCT00175513|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560801|NCT00175500|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560802|NCT00175487|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560803|NCT00175474|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560804|NCT00175461|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560805|NCT00175448|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560806|NCT00175435|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1560807|NCT00175422|Randomized|Parallel Assignment||||Double|||t||t|
1560808|NCT00175409|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560809|NCT00175396|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560810|NCT00175383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560811|NCT00175370|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560812|NCT00175357|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560813|NCT00175344|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560814|NCT00175318|Randomized|Single Group Assignment||||None (Open Label)||||||
1560815|NCT00175305|Randomized|Parallel Assignment||Treatment||Double||||||
1560816|NCT00175292|Randomized|Parallel Assignment||Prevention||Double||||||
1560817|NCT00175279|Randomized|Parallel Assignment||Treatment||Single||||||
1560818|NCT00175266|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560819|NCT00175253|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560820|NCT00175240|Randomized|Parallel Assignment||Prevention||Double||||||
1560821|NCT00175227|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1560822|NCT00175214|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1560823|NCT00175201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560824|NCT00175188|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560825|NCT00175175|Randomized|Parallel Assignment||Treatment||Single||||||
1560826|NCT00175162|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560827|NCT00175149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560828|NCT00175136|Randomized|Parallel Assignment||Treatment||Single|||t|||
1560829|NCT00175123|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1560830|NCT00175110|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560831|NCT00175097|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1560832|NCT00175084|Randomized|Crossover Assignment||Prevention||Single|||||t|
1560833|NCT00175071|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1560834|NCT00175058|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560835|NCT00175045|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560836|NCT00175032|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1560837|NCT00175019|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560838|NCT00175006|||||Prospective|||||||
1560839|NCT00174993|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560840|NCT00174980|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560841|NCT00174967|Randomized|Parallel Assignment||Diagnostic||Triple|||t||t|t
1560842|NCT00174954|||||Prospective|||||||
1560843|NCT00174941|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560844|NCT00174928|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560845|NCT00174915|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1560846|NCT00174902|Randomized|Factorial Assignment||Prevention||Double||||||
1560847|NCT00174889|Randomized|Parallel Assignment||Treatment||Double||||||
1560848|NCT00174876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560849|NCT00174863|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560850|NCT00174850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560851|NCT00174837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560852|NCT00174824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560853|NCT00174811|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560854|NCT00174798|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560855|NCT00174785|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1560856|NCT00174772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560857|NCT00174759|Randomized|Parallel Assignment||Treatment||Double||||||
1560858|NCT00174746|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560859|NCT00174733|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560860|NCT00174720|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1560861|NCT00174707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560862|NCT00174694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560863|NCT00174681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560864|NCT00174668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560865|NCT00174655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560866|NCT00174642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560867|NCT00174629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560868|NCT00174616|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560869|NCT00174603|Randomized|Parallel Assignment||Treatment||Double||||||
1560870|NCT00174590|Randomized|Parallel Assignment||Treatment||Double||||||
1560871|NCT00174577|Randomized|Parallel Assignment||Treatment||Double||||||
1560872|NCT00174564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560873|NCT00174551|Randomized|Crossover Assignment||Treatment||Double||||||
1560874|NCT00174538|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560875|NCT00174525|Randomized|Parallel Assignment||Treatment||Double||||||
1560876|NCT00174512|Randomized|Crossover Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560877|NCT00174499|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1560878|NCT00174486|Randomized|Parallel Assignment||Treatment||Double||||||
1560879|NCT00174473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560880|NCT00174460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560881|NCT00174447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560882|NCT00174434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560883|NCT00174421|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560884|NCT00174408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560885|NCT00174395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560886|NCT00174382|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560887|NCT00174369|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560888|NCT00174356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560889|NCT00174343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560890|NCT00174330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560891|NCT00174317|Randomized|Parallel Assignment||Treatment||Double||||||
1560892|NCT00174304|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560893|NCT00174291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560894|NCT00174278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560895|NCT00174265|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1560896|NCT00174252|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560897|NCT00174239|Randomized|Parallel Assignment||Treatment||Double||||||
1560898|NCT00174226|Randomized|Parallel Assignment||Treatment||Double||||||
1560899|NCT00174213|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1560900|NCT00174200|Randomized|Crossover Assignment||Treatment||Double||||||
1560901|NCT00174187|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560902|NCT00174174|Randomized|Crossover Assignment||Treatment||Double||||||
1560903|NCT00174161|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1560904|NCT00174148|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560905|NCT00174135|||||Cross-Sectional, Retrospective/Prospective|||||||
1560906|NCT00174122|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560907|NCT00174109|Random Sample||Natural History||Longitudinal, Prospective|||||||
1560908|NCT00174096|Random Sample||Natural History||Longitudinal, Retrospective|||||||
1560909|NCT00174083|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560910|NCT00174070|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1560911|NCT00174057|||Case Control, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1560912|NCT00174044|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1560913|NCT00174031|||Defined Population|Screening|Longitudinal, Prospective|||||||
1560914|NCT00174018|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560915|NCT00174005|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1560916|NCT00173992|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560917|NCT00173979|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560918|NCT00173966|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1560919|NCT00173953|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560920|NCT00173940||||||||||||
1560921|NCT00173927|||||Prospective|||||||
1560922|NCT00173914|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1560923|NCT00173901|Randomized|Parallel Assignment||Treatment||Single||||||
1560924|NCT00173888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560925|NCT00173875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560926|NCT00173862|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560927|NCT00173849|Random Sample||Natural History||Longitudinal, Retrospective/Prospective|||||||
1560928|NCT00173836|||Case Control||Prospective|||||||
1560929|NCT00173823|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1560930|NCT00173810|||Defined Population||Longitudinal, Prospective|||||||
1560931|NCT00173797|||Defined Population||Longitudinal, Prospective|||||||
1560932|NCT00173784|||Defined Population||Longitudinal, Prospective|||||||
1560933|NCT00173771|||Defined Population||Longitudinal, Prospective|||||||
1560934|NCT00173758|Randomized|Parallel Assignment||Treatment||Single||||||
1560935|NCT00173745|Randomized|Crossover Assignment||Treatment||Double||||||
1560936|NCT00173732|||Case Control|Screening|Longitudinal, Prospective|||||||
1560937|NCT00173719|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1560938|NCT00173706|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1560939|NCT00173693|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1560940|NCT00173680|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1560941|NCT00173667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1560942|NCT00173654|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1560943|NCT00173641|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1560944|NCT00173628|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1560945|NCT00173615||||||||||||
1560946|NCT00173602||||||||||||
1560947|NCT00173589|||Case Control||Cross-Sectional, Retrospective|||||||
1560948|NCT00173576||||Screening|Cross-Sectional, Retrospective/Prospective|||||||
1560949|NCT00173563|||||Prospective|||||||
1560950|NCT00173550|||Defined Population||Cross-Sectional, Retrospective|||||||
1560951|NCT00173537|Non-Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1560952|NCT00173524|||Cohort||Prospective|||||||
1560953|NCT00173511|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1560954|NCT00173498|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1560955|NCT00173485|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560956|NCT00173472|||Defined Population|Screening|Longitudinal, Prospective|||||||
1560957|NCT00173459|||Case Control||Longitudinal, Retrospective|||||||
1560958|NCT00173446|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1560959|NCT00173433||||||||||||
1560960|NCT00173420||||||||||||
1560961|NCT00173407||Single Group Assignment||Diagnostic||None (Open Label)||||||
1560962|NCT00173394|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1560963|NCT00173381|Random Sample||Natural History||Longitudinal, Retrospective/Prospective|||||||
1560964|NCT00173368|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1560965|NCT00173355|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1560966|NCT00173342|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560967|NCT00173329|||Defined Population||Cross-Sectional, Prospective|||||||
1560968|NCT00173316|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1560969|NCT00173303|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560970|NCT00173290||||||||||||
1560971|NCT00173277|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1560972|NCT00173264|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1560973|NCT00173251|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1560974|NCT00173238|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1560975|NCT00173225|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560976|NCT00173212|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1560977|NCT00173199|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560978|NCT00173186|||Case Control, Natural History||Longitudinal, Retrospective|||||||
1560979|NCT00173173|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1560980|NCT00173160|||Defined Population||Cross-Sectional, Retrospective/Prospective|||||||
1560981|NCT00173147|||||Retrospective|||||||
1560982|NCT00173134||||Screening|Cross-Sectional, Retrospective|||||||
1560983|NCT00173121||||Screening|Cross-Sectional, Prospective|||||||
1560984|NCT00173108|Randomized|Parallel Assignment||||Single||||||t
1560985|NCT00173095|||Case Control|Screening|Longitudinal, Retrospective/Prospective|||||||
1560986|NCT00173082|||||Prospective|||||||
1560987|NCT00173069|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1560988|NCT00173056||||||||||||
1560989|NCT00173043|||Case Control, Natural History||Longitudinal, Prospective|||||||
1560990|NCT00173030|||Case Control||Cross-Sectional, Prospective|||||||
1560991|NCT00173017|Randomized|Crossover Assignment||Diagnostic||Single||||||
1560992|NCT00173004|||Case Control||Cross-Sectional, Retrospective|||||||
1560993|NCT00172991|||Case Control||Cross-Sectional, Retrospective|||||||
1560994|NCT00172978|||Defined Population||Cross-Sectional, Retrospective|||||||
1560995|NCT00172965|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1560996|NCT00172952|||Case Control|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1560997|NCT00172939|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1560998|NCT00172926|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1560999|NCT00172913|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1561000|NCT00172900|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561001|NCT00172887|||||Prospective|||||||
1561002|NCT00172874|||Case Control||Cross-Sectional|||||||
1561003|NCT00172861|||Defined Population||Longitudinal, Prospective|||||||
1561004|NCT00172848|||Defined Population||Cross-Sectional, Retrospective|||||||
1561005|NCT00172835|Random Sample||Natural History||Cross-Sectional, Prospective|||||||
1561006|NCT00172822|||Natural History||Longitudinal, Prospective|||||||
1561007|NCT00172809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561008|NCT00172796|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1561009|NCT00172783||||Screening|Cross-Sectional, Prospective|||||||
1561010|NCT00172770|||Defined Population||Longitudinal, Retrospective|||||||
1561011|NCT00172757|||Case Control|Screening|Longitudinal, Prospective|||||||
1561012|NCT00172744|||||Prospective|||||||
1561013|NCT00172731|||Defined Population||Cross-Sectional, Retrospective|||||||
1561014|NCT00172718|||||Prospective|||||||
1561015|NCT00172705|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1561016|NCT00172692||||Screening|Cross-Sectional, Retrospective/Prospective|||||||
1561017|NCT00172679|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1561018|NCT00172666|||Case Control|Screening|Cross-Sectional, Retrospective|||||||
1561019|NCT00172653|||||Prospective|||||||
1561020|NCT00172640|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1561021|NCT00172627|||||Cross-Sectional, Retrospective|||||||
1561022|NCT00172614|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1561023|NCT00172601|Randomized|Single Group Assignment||Treatment||Single||||||
1561024|NCT00172588|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561025|NCT00172575|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1561026|NCT00172562|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561027|NCT00172549|||Defined Population||Cross-Sectional, Retrospective|||||||
1561028|NCT00172536|Randomized|Parallel Assignment||||Double|||||t|t
1561029|NCT00172523|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561030|NCT00172510|||Defined Population|Screening|Cross-Sectional, Retrospective|||||||
1561031|NCT00172497|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1561032|NCT00172484|Randomized|Parallel Assignment||||Single|||t|||
1561033|NCT00172471|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1561034|NCT00172458|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1561035|NCT00172445|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561036|NCT00172432|||Case Control, Natural History||Longitudinal, Prospective|||||||
1561037|NCT00172419||Single Group Assignment||Treatment||None (Open Label)||||||
1561038|NCT00172406|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561039|NCT00172393|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1561040|NCT00172380||Single Group Assignment||Treatment||None (Open Label)||||||
1561041|NCT00172367|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561042|NCT00172354|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561043|NCT00172341|Randomized|Parallel Assignment||Treatment||Double||||||
1561044|NCT00172328|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561045|NCT00172315|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561046|NCT00172302|Randomized|Crossover Assignment||Treatment||Double||||||
1561047|NCT00172289|||Case Control|Screening|Longitudinal, Prospective|||||||
1561048|NCT00172276|||Case Control, Natural History||Cross-Sectional, Retrospective|||||||
1561049|NCT00172263|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561050|NCT00172250|||Case Control|Screening|Cross-Sectional, Retrospective|||||||
1561051|NCT00172237|||Case Control||Cross-Sectional|||||||
1561052|NCT00172224|||Case-Only||Prospective|||||||
1561053|NCT00172211|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561054|NCT00172198|Randomized|Parallel Assignment||Treatment||Double||||||
1561055|NCT00172185|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561056|NCT00172172|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561057|NCT00172159|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561058|NCT00172146|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1561059|NCT00172133|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561060|NCT00172120|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561061|NCT00172107|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1561062|NCT00172094|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561063|NCT00172081|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561064|NCT00172068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561065|NCT00172055||Single Group Assignment||Treatment||None (Open Label)||||||
1561066|NCT00172042|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561067|NCT00172029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561068|NCT00172016|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561069|NCT00172003||Single Group Assignment||Treatment||None (Open Label)||||||
1561070|NCT00171990|Randomized|Parallel Assignment||Treatment||Double||||||
1561071|NCT00171977||Single Group Assignment||Treatment||None (Open Label)||||||
1561072|NCT00171964||Single Group Assignment||Treatment||None (Open Label)||||||
1561073|NCT00171951||Single Group Assignment||Treatment||None (Open Label)||||||
1561074|NCT00171938|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561075|NCT00171925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561076|NCT00171912||Single Group Assignment||Treatment||None (Open Label)||||||
1561077|NCT00171899||Single Group Assignment||Treatment||None (Open Label)||||||
1561078|NCT00171886|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561079|NCT00171873|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561080|NCT00171860||Single Group Assignment||Treatment||None (Open Label)||||||
1561081|NCT00171847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561082|NCT00171834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561083|NCT00171821||Single Group Assignment||Treatment||None (Open Label)||||||
1561084|NCT00171808||Single Group Assignment||Treatment||None (Open Label)||||||
1561085|NCT00171795|Randomized|Parallel Assignment||Treatment||Double||||||
1561086|NCT00171782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561087|NCT00171769|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561088|NCT00171756|Randomized|Parallel Assignment||Treatment||Double||||||
1561089|NCT00171743|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1561090|NCT00171730||Single Group Assignment||Treatment||None (Open Label)||||||
1561091|NCT00171717|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561092|NCT00171704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561093|NCT00171691|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561094|NCT00171678|Randomized|Parallel Assignment||Treatment||Double||||||
1561095|NCT00171665|Randomized|Parallel Assignment||Treatment||Double||||||
1561096|NCT00171652|Randomized|Parallel Assignment||Treatment||Double||||||
1561097|NCT00171639|Randomized|Single Group Assignment||Treatment||Double||||||
1561098|NCT00171626|Randomized|Parallel Assignment||Treatment||Double||||||
1561099|NCT00171613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561100|NCT00171600|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561101|NCT00171587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561102|NCT00171574|Randomized|Parallel Assignment||Treatment||Double||||||
1561103|NCT00171561|Randomized|Parallel Assignment||Treatment||Double||||||
1561104|NCT00171548|||||Prospective|||||||
1561105|NCT00171535|Randomized|Parallel Assignment||Treatment||Double||||||
1561106|NCT00171522|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561107|NCT00171509|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1561108|NCT00171496|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561109|NCT00171483|Randomized|Parallel Assignment||Treatment||Double||||||
1561110|NCT00171470|Randomized|Parallel Assignment||Treatment||Double||||||
1561111|NCT00171457|Randomized|Crossover Assignment||Treatment||Double||||||
1561112|NCT00171444|Randomized|Parallel Assignment||||None (Open Label)||||||
1561113|NCT00171431|Randomized|Parallel Assignment||Treatment||Double||||||
1561114|NCT00171418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561115|NCT00171405|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561116|NCT00171392|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561117|NCT00171379|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561118|NCT00171366|Randomized|Parallel Assignment||Treatment||Double||||||
1561119|NCT00171353|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561120|NCT00171340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561121|NCT00171327|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561122|NCT00171314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561123|NCT00171301|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561124|NCT00171288|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561125|NCT00171275|Randomized|Parallel Assignment||Treatment||Double||||||
1561126|NCT00171262|Randomized|Parallel Assignment||Treatment||Double||||||
1561127|NCT00171249||Single Group Assignment||Treatment||None (Open Label)||||||
1561128|NCT00171236|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561129|NCT00171223||Single Group Assignment||Treatment||None (Open Label)||||||
1561130|NCT00171210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561131|NCT00171184|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561132|NCT00171171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561133|NCT00171158||Single Group Assignment||Treatment||None (Open Label)||||||
1561134|NCT00171145|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561135|NCT00171132|Randomized|Parallel Assignment||Treatment||Double||||||
1561136|NCT00171119|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561137|NCT00171106|Randomized|Parallel Assignment||Treatment||Double||||||
1561138|NCT00171093|Randomized|Parallel Assignment||Treatment||Double||||||
1561139|NCT00171080|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561140|NCT00171067|Randomized|Parallel Assignment||Treatment||Double||||||
1561141|NCT00171054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561142|NCT00171041|Randomized|Parallel Assignment||Treatment||Double||||||
1561143|NCT00171028|Randomized|Parallel Assignment||Treatment||Double||||||
1561144|NCT00171015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561145|NCT00171002|Randomized|Parallel Assignment||Treatment||Double||||||
1561146|NCT00170989|Randomized|Parallel Assignment||Treatment||Double||||||
1561147|NCT00170976|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561148|NCT00170963|Randomized|Parallel Assignment||Treatment||Double||||||
1561149|NCT00170950|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561150|NCT00170937|Randomized|Parallel Assignment||Prevention||Double||||||
1561151|NCT00170924|Randomized|Parallel Assignment||Treatment||Double||||||
1561152|NCT00170911|Randomized|Parallel Assignment||Treatment||Double||||||
1561153|NCT00170898|Randomized|Parallel Assignment||Treatment||Double||||||
1561154|NCT00170885|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561155|NCT00170872|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561156|NCT00170859|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561157|NCT00170846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561158|NCT00170833|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561159|NCT00170820|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561160|NCT00170794|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561161|NCT00170781|Randomized|Parallel Assignment||Treatment||Double||||||
1561162|NCT00170768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561163|NCT00170755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561164|NCT00170742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561165|NCT00170729|Randomized|Parallel Assignment||Treatment||Double||||||
1561166|NCT00170716|Randomized|Parallel Assignment||Treatment||Single||||||t
1561167|NCT00170703|Randomized|Parallel Assignment||Treatment||Single||||||
1561168|NCT00170690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561169|NCT00170677|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561170|NCT00170664||Single Group Assignment||Treatment||None (Open Label)||||||
1561171|NCT00170638|||||Prospective|||||||
1561172|NCT00170625||Single Group Assignment||Treatment||None (Open Label)||||||
1561173|NCT00170612|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561174|NCT00170586|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561175|NCT00170573||Single Group Assignment||Treatment||None (Open Label)||||||
1561176|NCT00170560|||||Prospective|||||||
1561177|NCT00170547|Randomized|Parallel Assignment||Prevention||Double||||||
1561178|NCT00170534|Randomized|Parallel Assignment||Prevention||Single||||||
1561179|NCT00170521|||||Prospective|||||||
1561180|NCT00170508|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561181|NCT00170495|||Cohort||Prospective|||||||
1561182|NCT00170482|||||Prospective|||||||
1561183|NCT00170469|Randomized|Parallel Assignment||Prevention||Single|||t|||
1561184|NCT00170456|Randomized|Parallel Assignment||Prevention||Single|||t|||
1561185|NCT00170443|Randomized|Parallel Assignment||Prevention||Double||||||
1561186|NCT00170430|Randomized|Parallel Assignment||Prevention||Double||||||
1561187|NCT00170417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561188|NCT00170404|Randomized|Parallel Assignment||Treatment||Double||||||
1561189|NCT00170391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561190|NCT00170378|Randomized|Parallel Assignment||Prevention||Double||||||
1561191|NCT00170365|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561192|NCT00170352|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1561193|NCT00170339|||||Prospective|||||||
1561194|NCT00170326|Randomized|Parallel Assignment||Prevention||Single|Video tapes are provided by the central study organization and are labelled by numbers. The tapes are sent to the echocardiography core laboratory (Malaga, Spain) and are read by the Director of the Echo Core Lab (J.J. Gomez-Doblas). The echo examiner is blinded as to the point of time of the recording and assignment of treatment, although the presence of a LV lead may be adumbrated by visible artefacts.|||||t
1561195|NCT00170313|Randomized|Parallel Assignment||Treatment||Single||||||
1561196|NCT00170300|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1561197|NCT00170287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561198|NCT00170274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561199|NCT00170261|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1561200|NCT00170248|Randomized|Parallel Assignment||Treatment||Single|||t|||
1561201|NCT00170235|Randomized|Factorial Assignment||Prevention||Single||||||t
1561202|NCT00170222|Randomized|Parallel Assignment||Treatment||Double||||||
1561203|NCT00170209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561204|NCT00170196|Randomized|Parallel Assignment||Treatment||Double||||||
1561205|NCT00170183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561206|NCT00170170|||||Retrospective|||||||
1561207|NCT00170157|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561208|NCT00170144|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561209|NCT00170131|||||Prospective|||||||
1561210|NCT00170118|Randomized|Single Group Assignment||||Single||||||
1561211|NCT00170105|||||Prospective|||||||
1561212|NCT00170079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561213|NCT00170053||Single Group Assignment||Treatment||None (Open Label)||||||
1561214|NCT00170027|Non-Randomized|Single Group Assignment||Diagnostic||Double||||||
1561215|NCT00170014|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1561216|NCT00170001|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561217|NCT00169988|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1561218|NCT00169975|||Cohort||Prospective|||||||
1561219|NCT00169962|Randomized|Parallel Assignment||Treatment||Double||||||
1561220|NCT00169949|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561221|NCT00169936|Non-Randomized|Single Group Assignment||Diagnostic||Double||||||
1561222|NCT00169923|Randomized|Parallel Assignment||Treatment||Double||||||
1561223|NCT00169910|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561224|NCT00169897|Randomized|Parallel Assignment||Prevention||Single|||||t|
1561225|NCT00169884|Randomized|Parallel Assignment||Treatment||Single||||||
1561226|NCT00169871|Random Sample|||Screening|Longitudinal, Prospective|||||||
1561227|NCT00169858|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561228|NCT00169845|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1561229|NCT00169832|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1561230|NCT00169819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561231|NCT00169806||Single Group Assignment||Prevention||None (Open Label)||||||
1561232|NCT00169793|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561233|NCT00169780|||Cohort||Prospective|||||||
1561234|NCT00169767|||Cohort||Prospective|||||||
1561235|NCT00169754|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561236|NCT00169741||Single Group Assignment||Treatment||None (Open Label)||||||
1561237|NCT00169728|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561238|NCT00169715||Single Group Assignment||Prevention||None (Open Label)||||||
1561239|NCT00169702|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561240|NCT00169689|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1561241|NCT00169676|||Cohort||Prospective|||||||
1561242|NCT00169663|||Cohort||Retrospective|||||||
1561243|NCT00169650|||Cohort||Retrospective|||||||
1561244|NCT00169637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561245|NCT00169624|Randomized|Crossover Assignment||||Double||||||
1561246|NCT00169611|Randomized|Crossover Assignment||||Double||||||
1561247|NCT00169598|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1561248|NCT00169585|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1561249|NCT00169572|Randomized|Parallel Assignment||Treatment||Double||||||
1561250|NCT00169559|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561251|NCT00169546|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561252|NCT00169533|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561253|NCT00169520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561254|NCT00169507|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561255|NCT00169494|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1561256|NCT00169481|Randomized|Parallel Assignment||Prevention||Single|||t|||
1561257|NCT00169468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561258|NCT00169455|Randomized|Parallel Assignment||Prevention||Single||||||
1561259|NCT00169442|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561260|NCT00169416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561261|NCT00169403|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561262|NCT00169390|||Case Control||Prospective|||||||
1561263|NCT00169377|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1561264|NCT00169364|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1561265|NCT00169351|||Defined Population|Screening|Longitudinal, Prospective|||||||
1561266|NCT00169338|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1561267|NCT00169325|||Cohort||Prospective|||||||
1561268|NCT00169312|Randomized|||||Single||||||
1561269|NCT00169299|Randomized|Parallel Assignment||Treatment||Double||||||
1561270|NCT00169286|Randomized|Factorial Assignment||Other||Single||||||
1561271|NCT00169273|Randomized|Parallel Assignment||Treatment||Single||||||t
1561272|NCT00169260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561273|NCT00169247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561274|NCT00169234|Randomized|Single Group Assignment||Other||Single|||t|||
1561275|NCT00169221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561276|NCT00169208|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561277|NCT00169195||Single Group Assignment||Treatment||None (Open Label)||||||
1561278|NCT00169182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561279|NCT00169169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561280|NCT00169156||Single Group Assignment||Treatment||None (Open Label)||||||
1561281|NCT00169143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561282|NCT00169130|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561283|NCT00169117|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561284|NCT00169104|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561285|NCT00169091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561286|NCT00169078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561287|NCT00169065|Randomized|Parallel Assignment||Treatment||Single||||||t
1561288|NCT00169052|Randomized|Single Group Assignment||Treatment||Single||||||
1561289|NCT00169039|Randomized|Parallel Assignment||Treatment||Double||||||
1561290|NCT00169026|Randomized|Parallel Assignment||Other||Double||||||
1561291|NCT00169013|Randomized|Parallel Assignment||Treatment||Double||||||
1561292|NCT00169000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561293|NCT00168987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561294|NCT00168974|||||Prospective|||||||
1561295|NCT00168961|Randomized|Parallel Assignment||||None (Open Label)||||||
1561296|NCT00168948|Randomized|Parallel Assignment||Prevention||Double||||||
1561297|NCT00168935|Randomized|Parallel Assignment||||None (Open Label)||||||
1561298|NCT00168922|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561299|NCT00168909|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561300|NCT00168896|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561301|NCT00168883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561302|NCT00168870|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561303|NCT00168857|Randomized|Parallel Assignment||Treatment||Double||||||
1561304|NCT00168844|Randomized|Parallel Assignment||Treatment||Double||||||
1561305|NCT00168831|Randomized|Parallel Assignment||Treatment||Double||||||
1561306|NCT00168818|Randomized|Parallel Assignment||Prevention||Double||||||
1561307|NCT00168805|Randomized|Parallel Assignment||Prevention||Double||||||
1561308|NCT00168792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561309|NCT00168779||Parallel Assignment||Treatment||||||||
1561310|NCT00168766|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561311|NCT00168753|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561312|NCT00168740|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561313|NCT00168727|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561314|NCT00168714|||Cohort||Prospective|||||||
1561315|NCT00168701|Randomized|Parallel Assignment||Treatment||Double||||||
1561316|NCT00168688|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1561317|NCT00168662|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561318|NCT00168649|Randomized|Parallel Assignment||||Double||||||
1561319|NCT00168636|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561320|NCT00168623|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561321|NCT00168610|Randomized|Parallel Assignment||Prevention||Double||||||
1561322|NCT00168597|Randomized|Parallel Assignment||Prevention||Double||||||
1561323|NCT00168584|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561324|NCT00168571|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561325|NCT00168558|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561326|NCT00168545|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1561327|NCT00168532|Randomized|Parallel Assignment||Treatment||Double||||||
1561328|NCT00168519|Randomized|Crossover Assignment||Treatment||Single|||t|||
1561329|NCT00168506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561330|NCT00168493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561331|NCT00168480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561332|NCT00168467|Randomized|Parallel Assignment||Treatment||Double||||||
1561333|NCT00168454|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561334|NCT00168441|Randomized|Parallel Assignment||Treatment||Double||||||
1561335|NCT00168428|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561336|NCT00168415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561337|NCT00168402|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561338|NCT00168389|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561339|NCT00168376|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1561340|NCT00168363|Randomized|Parallel Assignment||Treatment||Double||||||
1561341|NCT00168350|Randomized|Parallel Assignment||Treatment||Double||||||
1561342|NCT00168337|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561343|NCT00168324|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561344|NCT00168311|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1561345|NCT00168298|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561346|NCT00168285|Randomized|Parallel Assignment||Treatment||Single||||||
1561347|NCT00168272|Randomized|Parallel Assignment||Treatment||Double||||||
1561348|NCT00168259|||Cohort||Prospective|||||||
1561349|NCT00168246|||Natural History||Cross-Sectional, Prospective|||||||
1561350|NCT00168233|||Cohort||Prospective|||||||
1561351|NCT00168220|||Case Control||Retrospective|||||||
1561352|NCT00168207|||Cohort||Retrospective|||||||
1561353|NCT00168194|||Cohort||Prospective|||||||
1561354|NCT00168181|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561355|NCT00168168|Randomized|Single Group Assignment||Treatment||Double||||||
1561356|NCT00168155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561357|NCT00168142|||Case-Only||Prospective|||||||
1561358|NCT00168129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561359|NCT00168116|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561360|NCT00168103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561361|NCT00168090|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561362|NCT00168077|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561363|NCT00168064|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561364|NCT00168051|Randomized|Crossover Assignment||Treatment||Double||||||
1561365|NCT00168038|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561366|NCT00168025||Single Group Assignment||Treatment||None (Open Label)||||||
1561367|NCT00168012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561368|NCT00167999|||Case Control, Natural History||Longitudinal, Prospective|||||||
1561369|NCT00167986|||Case Control, Natural History||Longitudinal, Prospective|||||||
1561370|NCT00167973|||Cohort||Prospective|||||||
1561371|NCT00167960|||Case Control, Natural History||Longitudinal, Prospective|||||||
1561372|NCT00167947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561373|NCT00167934|Randomized|Parallel Assignment||Treatment||Single|||t|||
1561374|NCT00167921|Randomized|Crossover Assignment||||None (Open Label)||||||
1561674|NCT00163930|||Defined Population||Cross-Sectional, Prospective|||||||
1561375|NCT00167908|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561376|NCT00167895|Randomized|Single Group Assignment||Prevention||Single||||||
1561377|NCT00167882|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1561378|NCT00167869|Randomized|Parallel Assignment||Prevention||Double||||||
1561379|NCT00167856|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1561380|NCT00167843|Randomized|Parallel Assignment||Prevention||Double||||||
1561381|NCT00167830||Single Group Assignment||||None (Open Label)||||||
1561382|NCT00167817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561383|NCT00167804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561384|NCT00167791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561385|NCT00167778|Randomized|Crossover Assignment||Treatment||Single|||t|||
1561386|NCT00167765|Randomized|Single Group Assignment||Treatment||Double||||||
1561387|NCT00167752|||||Prospective|||||||
1561388|NCT00167739|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561389|NCT00167726|||Case-Only||Prospective|||||||
1561390|NCT00167713|Randomized|Parallel Assignment||Treatment||Double||||||
1561391|NCT00167700|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1561392|NCT00167687|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1561393|NCT00167674|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561394|NCT00167661||Single Group Assignment||Treatment||None (Open Label)||||||
1561395|NCT00167648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561396|NCT00167635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561397|NCT00167622|Randomized|Parallel Assignment||Treatment||Single||||||t
1561398|NCT00167609|Randomized|Parallel Assignment||Treatment||Double||||||
1561399|NCT00167596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561400|NCT00167583|Randomized|Parallel Assignment||Treatment||Single||||||t
1561401|NCT00167570||||||||||||
1561402|NCT00167557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561403|NCT00167544|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1561404|NCT00167531|Randomized|Parallel Assignment||Treatment||Single||||||
1561405|NCT00167518|Randomized|Parallel Assignment||Treatment||Double||||||
1561406|NCT00167505|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561407|NCT00167492|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561408|NCT00167479|Randomized|Parallel Assignment||Treatment||Double||||||
1561409|NCT00167466|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1561410|NCT00167453|Randomized|Parallel Assignment||Treatment||Single||||||
1561411|NCT00167440|||Cohort||Prospective|||||||
1561412|NCT00167427|||Cohort||Prospective|||||||
1561413|NCT00167414||Single Group Assignment||Treatment||None (Open Label)||||||
1561414|NCT00167401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561415|NCT00167388|Randomized|Parallel Assignment||Prevention||Single|||||t|
1561416|NCT00167375|||||Prospective|||||||
1561417|NCT00167362|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561418|NCT00167349|||Cohort||Prospective|||||||
1561419|NCT00167336|||||Prospective|||||||
1561420|NCT00167323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561421|NCT00167310|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561422|NCT00167297|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561423|NCT00167284|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1561424|NCT00167271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561425|NCT00167258|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1561426|NCT00167245|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561427|NCT00167232|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1561428|NCT00167219||Single Group Assignment||Treatment||None (Open Label)||||||
1561429|NCT00167206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561430|NCT00167180|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561431|NCT00167167|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561432|NCT00167154|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561433|NCT00167141|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561434|NCT00167128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561435|NCT00167115|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561436|NCT00167102|Randomized|Parallel Assignment||Other||Triple|||t|t|t|
1561437|NCT00167089|Randomized|Parallel Assignment||||None (Open Label)||||||
1561438|NCT00167076|||Defined Population|Screening|Longitudinal, Prospective|||||||
1561439|NCT00167063|||Defined Population|Screening|Longitudinal, Prospective|||||||
1561440|NCT00167050|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561441|NCT00167037|||Case Control|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1561442|NCT00167024|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1561443|NCT00167011|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1561444|NCT00166998|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1561445|NCT00166985|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1561446|NCT00166972|||Natural History||Cross-Sectional, Retrospective|||||||
1561447|NCT00166959|||Defined Population|Screening|Longitudinal, Prospective|||||||
1561448|NCT00166946|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1561449|NCT00166933||||Screening|Cross-Sectional, Prospective|||||||
1561450|NCT00166920|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1561451|NCT00166907|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1561452|NCT00166894|Random Sample||Natural History||Cross-Sectional, Prospective|||||||
1561453|NCT00166881|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561454|NCT00166868|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561455|NCT00166855|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561456|NCT00166842|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561457|NCT00166829|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561458|NCT00166816|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561459|NCT00166803|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561460|NCT00166790||||||||||||
1561461|NCT00166777|Randomized|Crossover Assignment||Educational/Counseling/Training||Double||||||
1561462|NCT00166764|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1561463|NCT00166751|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1561464|NCT00166738|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1561465|NCT00166725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561466|NCT00166712|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561467|NCT00166699|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561468|NCT00166686|Randomized|Crossover Assignment||Treatment||Double||||||
1561469|NCT00166673|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561470|NCT00166660|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1561471|NCT00166647||||||||||||
1561472|NCT00166634|Randomized|Crossover Assignment||Diagnostic||Single||||||
1561473|NCT00166621|Randomized|Crossover Assignment||Treatment||Double||||||
1561474|NCT00166608|||||Prospective|||||||
1561475|NCT00166595||||Treatment||||||||
1561476|NCT00166582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561477|NCT00166569|||Case-Control||Prospective|||||||
1561478|NCT00166556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561479|NCT00166543|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561480|NCT00166530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561481|NCT00166517|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1561482|NCT00166504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561483|NCT00166491|Randomized|Parallel Assignment||Treatment||Single||||||
1561484|NCT00166478|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561485|NCT00166465|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561486|NCT00166452|Randomized|Crossover Assignment||Treatment||Double||||||
1561487|NCT00166439|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561488|NCT00166426|Randomized|Parallel Assignment||Prevention||Double||||||
1561489|NCT00166413|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561490|NCT00166400|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561491|NCT00166387|||Family-Based|||||||||
1561492|NCT00166374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561493|NCT00166361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561494|NCT00166348|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561495|NCT00166322|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561496|NCT00166309|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561497|NCT00166296|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1561498|NCT00166283|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1561499|NCT00166270||Single Group Assignment||Treatment||None (Open Label)||||||
1561500|NCT00166257|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561501|NCT00166244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561502|NCT00166231|||Cohort||Prospective|||||||
1561503|NCT00166218|||||Prospective|||||||
1561504|NCT00166205||Single Group Assignment||Treatment||None (Open Label)||||||
1561505|NCT00166192|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561506|NCT00166179|||Cohort||Prospective|||||||
1561507|NCT00166166|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561508|NCT00166153|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561509|NCT00166140|||||Prospective|||||||
1561510|NCT00166127|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561511|NCT00166114|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561512|NCT00166101|||Case-Only||Prospective|||||||
1561513|NCT00166088|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561514|NCT00166075|||Cohort||Cross-Sectional|||||||
1561515|NCT00166062|Randomized|Single Group Assignment||||Single||||||
1561516|NCT00166049|Randomized|Factorial Assignment||||None (Open Label)||||||
1561517|NCT00166036|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561518|NCT00166023||||||||||||
1561519|NCT00166010||Single Group Assignment||Treatment||None (Open Label)||||||
1561520|NCT00165997|||||Prospective|||||||
1561521|NCT00165984|||Cohort||Prospective|||||||
1561522|NCT00165971|Randomized|Factorial Assignment||Prevention||Double||||||
1561523|NCT00165958|Randomized|Parallel Assignment||Treatment||Single||||||t
1561524|NCT00165945|||Case-Only||Prospective|||||||
1561525|NCT00165932|||Case Control||Prospective|||||||
1561526|NCT00165919||||||||||||
1561527|NCT00165906|||||Prospective|||||||
1561528|NCT00165893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561529|NCT00165880|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561530|NCT00165867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561531|NCT00165854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561532|NCT00165841|Randomized|Parallel Assignment||Treatment||Double||||||
1561533|NCT00165828|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561534|NCT00165815|Randomized|Parallel Assignment||Treatment||Double||||||
1561535|NCT00165802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561536|NCT00165789|Randomized|Parallel Assignment||||Double||||||
1561537|NCT00165776|Randomized|Parallel Assignment||Treatment||Double||||||
1561538|NCT00165763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561539|NCT00165750|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561540|NCT00165737|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561541|NCT00165724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561542|NCT00165711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561543|NCT00165698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561544|NCT00165685|Randomized|Parallel Assignment||Treatment||Double||||||
1561545|NCT00165672|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561546|NCT00165659|Randomized|Parallel Assignment||Treatment||Double||||||
1561547|NCT00165646|Randomized|Parallel Assignment||Treatment||Double||||||
1561548|NCT00165633|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561549|NCT00165620|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1561550|NCT00165607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561551|NCT00165594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561552|NCT00165581|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561553|NCT00165568|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1561554|NCT00165555||Single Group Assignment||Treatment||None (Open Label)||||||
1561555|NCT00165542|||Case-Only||Prospective|||||||
1561556|NCT00165516||Single Group Assignment||Treatment||None (Open Label)||||||
1561557|NCT00165503||Single Group Assignment||Diagnostic||None (Open Label)||||||
1561558|NCT00165490||Single Group Assignment||Treatment||None (Open Label)||||||
1561559|NCT00165477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561560|NCT00165464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561561|NCT00165451|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561562|NCT00165438|||Case-Only||Prospective|||||||
1561563|NCT00165425||Single Group Assignment||Diagnostic||None (Open Label)||||||
1561564|NCT00165412|||Case-Only||Prospective|||||||
1561565|NCT00165399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561566|NCT00165386|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561567|NCT00165373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561568|NCT00165360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561569|NCT00165347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561570|NCT00165334|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561571|NCT00165308||Single Group Assignment||Prevention||None (Open Label)||||||
1561572|NCT00165295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561573|NCT00165282|Randomized|Parallel Assignment||||None (Open Label)||||||
1561574|NCT00165269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561575|NCT00165256||Single Group Assignment||Other||None (Open Label)||||||
1561576|NCT00165243||Single Group Assignment||Treatment||None (Open Label)||||||
1561577|NCT00165230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561578|NCT00165217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561579|NCT00165204|Randomized|Factorial Assignment||Treatment||Double||||||
1561580|NCT00165191|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561581|NCT00165178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561582|NCT00165152|Randomized|Parallel Assignment||||None (Open Label)||||||
1561583|NCT00165139|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561584|NCT00165126|||Case-Only||Prospective|||||||
1561585|NCT00165100|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561586|NCT00165087|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561587|NCT00165074|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561588|NCT00165061|Randomized|Parallel Assignment||Treatment||Single||||||
1561589|NCT00165048|Randomized|Parallel Assignment||Treatment||Double||||||
1561590|NCT00165035|Randomized|Parallel Assignment||Treatment||Single|||t|||
1561591|NCT00165022|||Cohort||Cross-Sectional|||||||
1561592|NCT00165009|Randomized|Parallel Assignment||Treatment||Single|||t|||
1561593|NCT00164996|Randomized|Parallel Assignment||Treatment||Double||||||
1561594|NCT00164970|Randomized|Parallel Assignment||Treatment||Double||||||
1561595|NCT00164957|Randomized|Parallel Assignment||Prevention||Single||||||
1561596|NCT00164944|||Case-Control||Prospective|||||||
1561597|NCT00164931|Randomized|Parallel Assignment||Treatment||Single||||||
1561598|NCT00164918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561599|NCT00164905|Randomized|Parallel Assignment||Treatment||Single|||t|||
1561600|NCT00164892|Randomized|Parallel Assignment||Treatment||Double||||||
1561901|NCT00160940|||Defined Population||Cross-Sectional, Prospective|||||||
1561601|NCT00164879|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561602|NCT00164866|Randomized|Parallel Assignment||Treatment||Double||||||
1561603|NCT00164853|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1561604|NCT00164840|Randomized|Parallel Assignment||Treatment||Double||||||
1561605|NCT00164827|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1561606|NCT00164814|||||Prospective|||||||
1561607|NCT00164801|Randomized|Parallel Assignment||Treatment||Double||||||
1561608|NCT00164788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561609|NCT00164775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561610|NCT00164762|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1561611|NCT00164749|Randomized|Parallel Assignment||Treatment||Double||||||
1561612|NCT00164736|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1561613|NCT00164723|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1561614|NCT00164710|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561615|NCT00164697|Randomized|Parallel Assignment||Prevention||Single||||||t
1561616|NCT00164684|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561617|NCT00164671|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561618|NCT00164658|Randomized|Parallel Assignment||Prevention||Single||||||
1561619|NCT00164645|Randomized|Single Group Assignment||Educational/Counseling/Training||Single||||||
1561620|NCT00164632|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561621|NCT00164619|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561622|NCT00164606|Randomized|Factorial Assignment||Prevention||||||||
1561623|NCT00164593|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561624|NCT00164580|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561625|NCT00164567|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1561626|NCT00164554|Randomized|Parallel Assignment||||Single||||||
1561627|NCT00164541|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561628|NCT00164528|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1561629|NCT00164515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561630|NCT00164502|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561631|NCT00164489|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561632|NCT00164476|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561633|NCT00164463|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561634|NCT00164450|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561635|NCT00164437|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1561636|NCT00164424|Randomized|Parallel Assignment||Treatment||Double||||||
1561637|NCT00164411|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1561638|NCT00164398|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1561639|NCT00164385|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561640|NCT00164372|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561641|NCT00164359|Randomized|Parallel Assignment||Treatment||Double||||||
1561642|NCT00164346|Randomized|Parallel Assignment||||Single||||||
1561643|NCT00164333|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1561644|NCT00164320|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1561645|NCT00164307|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1561646|NCT00164294|Randomized|Single Group Assignment||Educational/Counseling/Training||Double||||||
1561647|NCT00164281|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1561648|NCT00164268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561649|NCT00164255|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561650|NCT00164242|Randomized|Crossover Assignment||Treatment||Double||||||
1561651|NCT00164229|Randomized|Parallel Assignment||||Single||||||
1561652|NCT00164216|||||Prospective|||||||
1561653|NCT00164203|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1561654|NCT00164190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561655|NCT00164177|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561656|NCT00164164|Randomized|Parallel Assignment||||Single||||||
1561657|NCT00164151|Randomized|Factorial Assignment||||Single||||||
1561658|NCT00164138||Single Group Assignment||Treatment||None (Open Label)||||||
1561659|NCT00164125|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561660|NCT00164112|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1561661|NCT00164099|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1561662|NCT00164086|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561663|NCT00164073|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1561664|NCT00164060|||||Retrospective|||||||
1561665|NCT00164047|Randomized|Parallel Assignment||Prevention||Single||||||
1561666|NCT00164034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561667|NCT00164021|||Case Control||Prospective|||||||
1561668|NCT00164008|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561669|NCT00163995|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561670|NCT00163982|Randomized|Crossover Assignment||Treatment||Double||||||
1561671|NCT00163969|Randomized|Parallel Assignment||Treatment||Double||||||
1561672|NCT00163956|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1561673|NCT00163943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573267|NCT00001839||||Treatment||||||||
1561675|NCT00163917|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1561676|NCT00163904|Randomized|Parallel Assignment||||None (Open Label)||||||
1561677|NCT00163891|Randomized|Parallel Assignment||Treatment||Single||||||
1561678|NCT00163878|Randomized|Parallel Assignment||Treatment||Single||||||
1561679|NCT00163865|||Cohort||Cross-Sectional|||||||
1561680|NCT00163852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561681|NCT00163839|Randomized|Single Group Assignment||Treatment||Single||||||
1561682|NCT00163826|||Cohort|||||||||
1561683|NCT00163813|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561684|NCT00163800|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1561685|NCT00163787|||Natural History||Longitudinal, Retrospective/Prospective|||||||
1561686|NCT00163774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561687|NCT00163761|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561688|NCT00163748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561689|NCT00163735|Randomized|Crossover Assignment||Diagnostic||Double||||||
1561690|NCT00163722|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1561691|NCT00163709|Randomized|Parallel Assignment||Diagnostic||Single||||||
1561692|NCT00163696|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561693|NCT00163683|Randomized|Single Group Assignment||||None (Open Label)||||||
1561694|NCT00163670|||Cohort||Prospective|||||||
1561695|NCT00163657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561696|NCT00163644|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561697|NCT00163631|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1561698|NCT00163618||||||||||||
1561699|NCT00163605|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1561700|NCT00163592||||Screening|Cross-Sectional, Prospective|||||||
1561701|NCT00163579|Randomized|Parallel Assignment||Prevention||Double||||||
1561702|NCT00163566|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1561703|NCT00163553|Randomized|Single Group Assignment||Treatment||Double||||||
1561704|NCT00163540|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561705|NCT00163527|Randomized|Parallel Assignment||Treatment||Double||||||
1561706|NCT00163514|Randomized|Parallel Assignment||Prevention||Double||||||
1561707|NCT00163501|Randomized|Single Group Assignment||Treatment||Double||||||
1561708|NCT00163488|Randomized|Parallel Assignment||Treatment||Double||||||
1561709|NCT00163475|Randomized|Parallel Assignment||Treatment||Double||||||
1561710|NCT00163462|Randomized|Parallel Assignment||Treatment||Double||||||
1561711|NCT00163449|Randomized|Parallel Assignment||||Triple|||t|t|t|
1561712|NCT00163436|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561713|NCT00163423|Randomized|Parallel Assignment||Treatment||Double||||||
1561714|NCT00163410|Randomized|Parallel Assignment||Treatment||Double||||||
1561715|NCT00163397|Randomized|Parallel Assignment||Treatment||Double||||||
1561716|NCT00163384|Randomized|Parallel Assignment||Treatment||Double||||||
1561717|NCT00163371|Randomized|Crossover Assignment||Treatment||Double||||||
1561718|NCT00163358|Randomized|Parallel Assignment||Treatment||Double||||||
1561719|NCT00163345|Randomized|Parallel Assignment||Treatment||Double||||||
1561720|NCT00163332|Randomized|Crossover Assignment||Treatment||Double||||||
1561721|NCT00163319|Randomized|Parallel Assignment||Treatment||Double||||||
1561722|NCT00163306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561723|NCT00163293|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561724|NCT00163280|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1561725|NCT00163267|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561726|NCT00163254|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561727|NCT00163241|Randomized|Parallel Assignment||Prevention||Double||||||
1561728|NCT00163228|||||Prospective|||||||
1561729|NCT00163215|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561730|NCT00163202|Randomized|Parallel Assignment||Treatment||Double||||||
1561731|NCT00163189||Single Group Assignment||Treatment||None (Open Label)||||||
1561732|NCT00163176|||Cohort||Prospective|||||||
1561733|NCT00163163|Randomized|Parallel Assignment||Treatment||Double||||||
1561734|NCT00163150|Randomized|Parallel Assignment||Treatment||Double||||||
1561735|NCT00163137|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1561736|NCT00163124|Randomized|Factorial Assignment||Treatment||Single||||||
1561737|NCT00163111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561738|NCT00163098|Randomized|Parallel Assignment||Treatment||Double||||||
1561739|NCT00163085|Randomized|Crossover Assignment||Treatment||Double||||||
1561740|NCT00163072|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561741|NCT00163059|Randomized|Parallel Assignment||Treatment||Single||||||
1561742|NCT00163046|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1561743|NCT00163033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561744|NCT00163020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561745|NCT00163007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561746|NCT00162994|Randomized|Parallel Assignment||Prevention||Double||||||
1561747|NCT00162981|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561748|NCT00162968|Randomized|Crossover Assignment||Treatment||Double||||||
1561749|NCT00162955|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561750|NCT00162942|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561751|NCT00162929|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561752|NCT00162916|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1561753|NCT00162903|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1561754|NCT00162890|||Case Control||Prospective|||||||
1561755|NCT00162877|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561756|NCT00162864|Randomized|Parallel Assignment||Treatment||Double||||||
1561757|NCT00162851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561758|NCT00162838|||Defined Population||Cross-Sectional, Retrospective/Prospective|||||||
1561759|NCT00162825||||||||||||
1561760|NCT00162812|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561761|NCT00162799|Randomized|Crossover Assignment||Treatment||Double||||||
1561762|NCT00162786|Randomized|Crossover Assignment||Prevention||Double||||||
1561763|NCT00162773|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561764|NCT00162760|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561765|NCT00162747|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561766|NCT00162734||Single Group Assignment||Treatment||None (Open Label)||||||
1561767|NCT00162721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561768|NCT00162708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561769|NCT00162695|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561770|NCT00162682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561771|NCT00162669|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561772|NCT00162656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561773|NCT00162643|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561774|NCT00162630|Randomized|Single Group Assignment||Treatment||Double||||||
1561775|NCT00162617|Randomized|Parallel Assignment||Treatment||Double||||||
1561776|NCT00162604|Randomized|Parallel Assignment||Prevention||Double||||||
1561777|NCT00162591|Randomized|Parallel Assignment||Prevention||Double||||||
1561778|NCT00162578|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1561779|NCT00162565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561780|NCT00162552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561781|NCT00162539||Single Group Assignment||Prevention||None (Open Label)||||||
1561782|NCT00162526|Randomized|Single Group Assignment||Treatment||Double||||||
1561783|NCT00162513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561784|NCT00162500|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561785|NCT00162487|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561786|NCT00162474||Single Group Assignment||Other||None (Open Label)||||||
1561787|NCT00162461||Single Group Assignment||Other||None (Open Label)||||||
1561788|NCT00162448|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1561789|NCT00162435|Randomized|Parallel Assignment||Treatment||Single||||||
1561790|NCT00162422|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561791|NCT00162409|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561792|NCT00162396|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561793|NCT00162383||Single Group Assignment||Other||None (Open Label)||||||
1561794|NCT00162370||Single Group Assignment||Diagnostic||None (Open Label)||||||
1561795|NCT00162357|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561796|NCT00162344|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561797|NCT00162331|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561798|NCT00162318|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561799|NCT00162305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561800|NCT00162292|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561801|NCT00162279|Randomized|Single Group Assignment||Treatment||Double||||||
1561802|NCT00162266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561803|NCT00162253|Randomized|Parallel Assignment||Treatment||Double||||||
1561804|NCT00162240|Randomized|Parallel Assignment||Treatment||Double||||||
1561805|NCT00162227||||||||||||
1561806|NCT00162214|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561807|NCT00162201|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561808|NCT00162188||||||||||||
1561809|NCT00162175|Randomized|Parallel Assignment||Treatment||Double||||||
1561810|NCT00162149|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1561811|NCT00162136|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561812|NCT00162123|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561813|NCT00162110|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561814|NCT00162097|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561815|NCT00162084|Randomized|Parallel Assignment||Diagnostic||Double||||||
1561816|NCT00162071|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561817|NCT00162058|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561818|NCT00162045|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561819|NCT00162032|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561820|NCT00162019|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561821|NCT00162006|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561822|NCT00161993|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561823|NCT00161980|Randomized|Parallel Assignment||Treatment||Single||||||
1561824|NCT00161967|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561825|NCT00161954|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561826|NCT00161941||||||||||||
1561827|NCT00161928|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561828|NCT00161915|Randomized|Parallel Assignment||Treatment||Single||||||
1561829|NCT00161902|Randomized|Parallel Assignment||Treatment||Single||||||
1561830|NCT00161889|Randomized|Parallel Assignment||||Double||||||
1561831|NCT00161876|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561832|NCT00161863|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561833|NCT00161850|Randomized|Parallel Assignment||||Double||||||
1561834|NCT00161837|Randomized|Parallel Assignment||Prevention||Single||||||
1561835|NCT00161824|Randomized|Parallel Assignment||||Single||||||
1561836|NCT00161811|Randomized|Parallel Assignment||Prevention||Double||||||
1561837|NCT00161798|Randomized|Parallel Assignment||Prevention||Double||||||
1561838|NCT00161785|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561839|NCT00161772|Randomized|Parallel Assignment||Prevention||Double||||||
1561840|NCT00161759|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561841|NCT00161746|Randomized|Parallel Assignment||Prevention||Double||||||
1561842|NCT00161733|Randomized|Parallel Assignment||Treatment||Double||||||
1561843|NCT00161720|||||Retrospective|||||||
1561844|NCT00161707|Randomized|Crossover Assignment||Treatment||Double||||||
1561845|NCT00161694|Randomized|Crossover Assignment||Prevention||Double||||||
1561846|NCT00161681|Randomized|Parallel Assignment||Prevention||Double||||||
1561847|NCT00161668|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1561848|NCT00161655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561849|NCT00161642|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561850|NCT00161629|Randomized|Single Group Assignment||Treatment||Double||||||
1561851|NCT00161616|Randomized|Single Group Assignment||Treatment||Single||||||t
1561852|NCT00161603|||||Prospective|||||||
1561853|NCT00161590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561854|NCT00161577|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561855|NCT00161564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561856|NCT00161551|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561857|NCT00161538|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561858|NCT00161525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561859|NCT00161486|Randomized|Parallel Assignment||Treatment||Single|||t|||
1561860|NCT00161473|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561861|NCT00161460|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561862|NCT00161447|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561863|NCT00161434|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1561864|NCT00161421|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1561865|NCT00161408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561866|NCT00161395|Randomized|Single Group Assignment||||None (Open Label)||||||
1561867|NCT00161382|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561868|NCT00161369|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1561869|NCT00161356|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561870|NCT00161343|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561871|NCT00161330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561872|NCT00161317|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1561873|NCT00161304|Randomized|Parallel Assignment||Treatment||Double||||||
1561874|NCT00161291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561875|NCT00161278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561876|NCT00161265|||Cohort||Prospective|||||||
1561877|NCT00161252|||Ecologic or Community||Retrospective|||||||
1561878|NCT00161239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561879|NCT00161226|||Case-Only||Prospective|||||||
1561880|NCT00161213||Single Group Assignment||Treatment||None (Open Label)||||||
1561881|NCT00161200|Randomized|Parallel Assignment||Treatment||Double||||||
1561882|NCT00161187||Single Group Assignment||Treatment||None (Open Label)||||||
1561883|NCT00161174|||Cohort||Prospective|||||||
1561884|NCT00161161|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1561885|NCT00161148|Randomized|Crossover Assignment||Treatment||Double||||||
1561886|NCT00161135|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1561887|NCT00161122|Randomized|Parallel Assignment||||Double||||||
1561888|NCT00161109|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1561889|NCT00161096|Randomized|Parallel Assignment||Treatment||Double||||||
1561890|NCT00161083|Randomized|Parallel Assignment||Treatment||Double||||||
1561891|NCT00161070|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561892|NCT00161057|||Cohort||Prospective|||||||
1561893|NCT00161044|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561894|NCT00161031|Randomized|Parallel Assignment||Treatment||Double||||||
1561895|NCT00161018|Randomized|Parallel Assignment||Treatment||Double||||||
1561896|NCT00161005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561897|NCT00160992|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561898|NCT00160979||Single Group Assignment||Diagnostic||None (Open Label)||||||
1561899|NCT00160966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561900|NCT00160953|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1561902|NCT00160927|||Case Control, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1561903|NCT00160914|||||Prospective|||||||
1561904|NCT00160901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561905|NCT00160888|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||Double||||||
1561906|NCT00160875||Single Group Assignment||Treatment||None (Open Label)||||||
1561907|NCT00160862|Randomized|Crossover Assignment||Diagnostic||Double||||||
1561908|NCT00160849|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561909|NCT00160836|Randomized|Crossover Assignment||Diagnostic||Double||||||
1561910|NCT00160823|Randomized|Factorial Assignment||Diagnostic||Single||||||
1561911|NCT00160810|||Case-Only|||||||||
1561912|NCT00160797|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561913|NCT00160784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561914|NCT00160771|||Other||Prospective|||||||
1561915|NCT00160758|||Case-Only||Prospective|||||||
1561916|NCT00160745|Randomized|Crossover Assignment||Prevention||Double||||||
1561917|NCT00160732||Single Group Assignment||Treatment||None (Open Label)||||||
1561918|NCT00160719|||Case-Only||Prospective|||||||
1561919|NCT00160706||Single Group Assignment||Treatment||None (Open Label)||||||
1561920|NCT00160693||Single Group Assignment||Treatment||None (Open Label)||||||
1561921|NCT00160680|Randomized|Parallel Assignment||||None (Open Label)||||||
1561922|NCT00160667|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561923|NCT00160654|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561924|NCT00160641||Single Group Assignment||Treatment||None (Open Label)||||||
1561925|NCT00160628|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561926|NCT00160615|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561927|NCT00160602|Randomized|Parallel Assignment||Treatment||Double||||||
1561928|NCT00160589|Randomized|Parallel Assignment||||Double||||||
1561929|NCT00160576|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1561930|NCT00160563|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561931|NCT00160550|Randomized|Parallel Assignment||||Double||||||
1561932|NCT00160537|Randomized|Parallel Assignment||||Double||||||
1561933|NCT00160524||Single Group Assignment||Treatment||None (Open Label)||||||
1561934|NCT00160511|Randomized|Parallel Assignment||||Double||||||
1561935|NCT00160498|Randomized|Parallel Assignment||||Double||||||
1561936|NCT00160485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561937|NCT00160472|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1561938|NCT00160459|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1561939|NCT00160446|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1561940|NCT00160433|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1561941|NCT00160420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561942|NCT00160407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561943|NCT00160394|Randomized|Parallel Assignment||Treatment||Single||||||
1561944|NCT00160381|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1561945|NCT00160368|Randomized|Crossover Assignment||Treatment||Double||||||
1561946|NCT00160355||Single Group Assignment||Treatment||None (Open Label)||||||
1561947|NCT00160342|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561948|NCT00160329|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561949|NCT00160316|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561950|NCT00160303|Randomized|Single Group Assignment||Treatment||Double||||||
1561951|NCT00160290|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561952|NCT00160277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561953|NCT00160264|Randomized|Parallel Assignment||||Double||||||
1561954|NCT00160251|Randomized|Parallel Assignment||Treatment||Double||||||
1561955|NCT00160238|Randomized|Parallel Assignment||Treatment||Double||||||
1561956|NCT00160225|Randomized|Crossover Assignment||Treatment||Double||||||
1561957|NCT00160212|Randomized|Parallel Assignment||Treatment||Double||||||
1561958|NCT00160199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561959|NCT00160186|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561960|NCT00160173|Randomized|Parallel Assignment||Treatment||Double||||||
1561961|NCT00160160|Randomized|Parallel Assignment||Treatment||Double||||||
1561962|NCT00160147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561963|NCT00160134|Randomized|Parallel Assignment||Treatment||Double||||||
1561964|NCT00160121|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561965|NCT00160108|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1561966|NCT00160095|||Cohort||Prospective|||||||
1561967|NCT00160082|Randomized|Parallel Assignment||Treatment||Double||||||
1561968|NCT00160069|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561969|NCT00160056|Randomized|Crossover Assignment||Diagnostic||Single|||t|||
1561970|NCT00160043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561971|NCT00160030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561972|NCT00160017|||||Prospective|||||||
1561973|NCT00160004|Randomized|Parallel Assignment||Treatment||Single||||||
1561974|NCT00159991|Randomized|Parallel Assignment||Treatment||Single||||||t
1561975|NCT00159978|||Cohort||Prospective|||||||
1561976|NCT00159965|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1561977|NCT00159952|Randomized|Parallel Assignment||Treatment||Single|||t|||
1561978|NCT00159939|Randomized|Parallel Assignment||Treatment||Single|||t|||
1561979|NCT00159926|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561980|NCT00159913|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1561981|NCT00159900|Randomized|Parallel Assignment||Treatment||Double||||||
1561982|NCT00159887|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561983|NCT00159874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561984|NCT00159861|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1561985|NCT00159848|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1561986|NCT00159835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561987|NCT00159822|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561988|NCT00159809|Randomized|Parallel Assignment||Treatment||Double||||||
1561989|NCT00159796|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561990|NCT00159783|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561991|NCT00159770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1561992|NCT00159757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561993|NCT00159744|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1561994|NCT00159731|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1561995|NCT00159718|Randomized|Parallel Assignment||Treatment||Double||||||
1561996|NCT00159705|Randomized|Parallel Assignment||Treatment||Double||||||
1561997|NCT00159692|Randomized|Single Group Assignment||Treatment||Double||||||
1561998|NCT00159679|Randomized|Parallel Assignment||Treatment||Double||||||
1561999|NCT00159666|Randomized|Parallel Assignment||Treatment||Double||||||
1562000|NCT00159653|Randomized|Parallel Assignment||Treatment||Double||||||
1562001|NCT00159640|Randomized|Parallel Assignment||Treatment||Double||||||
1562002|NCT00159627|Randomized|Single Group Assignment||Treatment||Double||||||
1562003|NCT00159614|Randomized|Crossover Assignment||Treatment||Double||||||
1562004|NCT00159601|||Case-Control||Prospective|||||||
1562005|NCT00159588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562006|NCT00159575|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562007|NCT00159562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562008|NCT00159549|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562009|NCT00159536|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1562010|NCT00159523|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1562011|NCT00159510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562012|NCT00159497|Randomized|Parallel Assignment||Treatment||Single|||t|||
1562013|NCT00159484||Single Group Assignment||Treatment||None (Open Label)||||||
1562014|NCT00159471|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562015|NCT00159458||Single Group Assignment||Treatment||None (Open Label)||||||
1562016|NCT00159445|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562017|NCT00159432||Single Group Assignment||Treatment||None (Open Label)||||||
1562018|NCT00159419|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562019|NCT00159406|||Cohort||Prospective|||||||
1562020|NCT00159393|||Cohort||Prospective|||||||
1562021|NCT00159380|Randomized|Crossover Assignment||||Double||||||
1562022|NCT00159367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562023|NCT00159354|Randomized|Parallel Assignment||Treatment||Double||||||
1562024|NCT00159341|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1562025|NCT00159328|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562026|NCT00159315|Randomized|Crossover Assignment||||None (Open Label)||||||
1562027|NCT00159302|||Defined Population||Cross-Sectional, Prospective|||||||
1562028|NCT00159289|Randomized|Crossover Assignment||||Double|||t||t|
1562029|NCT00159276|||||Prospective|||||||
1562030|NCT00159263|Randomized|Crossover Assignment||||Double||||||
1562031|NCT00159250|Non-Randomized|Single Group Assignment||Treatment||Single|||t|||
1562032|NCT00159237|||||Prospective|||||||
1562033|NCT00159224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562034|NCT00159211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562035|NCT00159198|||Case Control||Retrospective|||||||
1562036|NCT00159185|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1562037|NCT00159172|Randomized|Crossover Assignment||Educational/Counseling/Training||Double||||||
1562038|NCT00159159|Randomized|Parallel Assignment||||None (Open Label)||||||
1562039|NCT00159146|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562040|NCT00159133|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562041|NCT00159120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562042|NCT00159107|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562043|NCT00159094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562044|NCT00159081|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562045|NCT00159068|||Other||Prospective|||||||
1562046|NCT00159055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562047|NCT00159042|||Other||Other|||||||
1562048|NCT00159029|||Other||Other|||||||
1562049|NCT00159016|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562050|NCT00159003|||Other||Prospective|||||||
1562051|NCT00158990|Randomized|Parallel Assignment||Treatment||Double||||||
1562052|NCT00158977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562053|NCT00158964|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562054|NCT00158951|Randomized|Parallel Assignment||Treatment||Double||||||
1573268|NCT00001816||||||||||||
1562055|NCT00158938|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562056|NCT00158925||Single Group Assignment||Treatment||None (Open Label)||||||
1562057|NCT00158912|Randomized|Crossover Assignment||Treatment||Single||||||
1562058|NCT00158899|Randomized|Parallel Assignment||Treatment||Double||||||
1562059|NCT00158886|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562060|NCT00158873|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1562061|NCT00158860|Randomized|Parallel Assignment||Treatment||Single|||||t|
1562062|NCT00158847|Randomized|Parallel Assignment||Treatment||Double||||||
1562063|NCT00158834|Randomized|Parallel Assignment||Treatment||Double||||||
1562064|NCT00158821||Single Group Assignment||Treatment||None (Open Label)||||||
1562065|NCT00158808|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562066|NCT00158795|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562067|NCT00158782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562068|NCT00158769|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562069|NCT00158756|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562070|NCT00158743|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562071|NCT00158730|Randomized|Single Group Assignment||Treatment||Double||||||
1562072|NCT00158717||||||||||||
1562073|NCT00158704|Non-Randomized|||Treatment||None (Open Label)||||||
1562074|NCT00158691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562075|NCT00158678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562076|NCT00158665||Single Group Assignment||Prevention||None (Open Label)||||||
1562077|NCT00158652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562078|NCT00158639|Randomized|Parallel Assignment||Treatment||Single||||||t
1562079|NCT00158626|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562080|NCT00158613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562081|NCT00158600|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562082|NCT00158587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562083|NCT00158574|Randomized|Single Group Assignment||Diagnostic||Quadruple|||t|t|t|t
1562084|NCT00158561|Randomized|Parallel Assignment||||None (Open Label)||||||
1562085|NCT00158548|Randomized|Parallel Assignment||Treatment||Single||||||
1562086|NCT00158535|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562087|NCT00158522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562088|NCT00158509|Randomized|Parallel Assignment||Prevention||Double||||||
1562089|NCT00158496|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562090|NCT00158483|Randomized|Parallel Assignment||Prevention||Double||||||
1562091|NCT00158470|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562092|NCT00158457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562093|NCT00158431|Randomized|Parallel Assignment||Treatment||Single||||||t
1562094|NCT00158418|Randomized|Parallel Assignment||Treatment||Double||||||
1562095|NCT00158405|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562096|NCT00158379||Single Group Assignment||Treatment||None (Open Label)||||||
1562097|NCT00158366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562098|NCT00158353|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562099|NCT00158340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562100|NCT00158327|Randomized|Parallel Assignment||Treatment||Single||||||t
1562101|NCT00158314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562102|NCT00158301|Randomized|Parallel Assignment||Prevention||Single||||||t
1562103|NCT00158288|Randomized|Parallel Assignment||Treatment||Double||||||
1562104|NCT00158275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562105|NCT00158262|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1562106|NCT00158249|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1562107|NCT00158236|Randomized|Crossover Assignment||Treatment||Double||||||
1562108|NCT00158223|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562109|NCT00158210|Randomized|Parallel Assignment||Treatment||Double||||||
1562110|NCT00158197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562111|NCT00158184|Non-Randomized|Parallel Assignment||Basic Science||Double|||t|||t
1562112|NCT00158171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562113|NCT00158158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562114|NCT00158145|||||Prospective|||||||
1562115|NCT00158132|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1562116|NCT00158119|Randomized|Parallel Assignment||Treatment||Single||||||
1562117|NCT00158106|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562118|NCT00158093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562119|NCT00158080|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562120|NCT00158067|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562121|NCT00158054|Randomized|Parallel Assignment||Treatment||Single||||||t
1562122|NCT00158041|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562123|NCT00158028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562124|NCT00158015|||||Prospective|||||||
1562125|NCT00158002|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562126|NCT00157989|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562127|NCT00157976|Randomized|Single Group Assignment||Treatment||Double||||||
1562128|NCT00157963|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562129|NCT00157950|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1562130|NCT00157937|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1562131|NCT00157924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562132|NCT00157911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562133|NCT00157898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562134|NCT00157885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562135|NCT00157872|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562136|NCT00157859|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562137|NCT00157846|Randomized|Crossover Assignment||Other||None (Open Label)||||||
1562138|NCT00157833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562139|NCT00157820|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562140|NCT00157807|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1562141|NCT00157794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562142|NCT00157781|Randomized|Crossover Assignment||Treatment||Single||||||
1562143|NCT00157768|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1562144|NCT00157755|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1562145|NCT00157742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562146|NCT00157729|Randomized|Crossover Assignment||Treatment||Double||||||
1562147|NCT00157716|Randomized|Parallel Assignment||Prevention||Double||||||
1562148|NCT00157703|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562149|NCT00157690|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562150|NCT00157677|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1562151|NCT00157664|||Cohort||Prospective|||||||
1562152|NCT00157651|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1562153|NCT00157638|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562154|NCT00157625|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562155|NCT00157612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562156|NCT00157599|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562157|NCT00157586|Randomized|Parallel Assignment||Diagnostic||Double||||||
1562158|NCT00157573|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1562159|NCT00157560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562160|NCT00157547|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562161|NCT00157534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562162|NCT00157521|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1562163|NCT00157508|Randomized|Crossover Assignment||Prevention||Double||||||
1562164|NCT00157482|Randomized|Parallel Assignment||Diagnostic||Double||||||
1562165|NCT00157378|Randomized|Parallel Assignment||Treatment||Double||||||
1562166|NCT00157339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562167|NCT00157326|Randomized|Parallel Assignment||Treatment||Double||||||
1562168|NCT00157313|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562169|NCT00157300|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1562170|NCT00157287|Randomized|Parallel Assignment||Treatment||Single||||||
1562171|NCT00157274|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562172|NCT00157261|Randomized|Parallel Assignment||Treatment||Double||||||
1562173|NCT00157248|Non-Randomized|||Prevention||None (Open Label)||||||
1562174|NCT00157235|Randomized|Parallel Assignment||Treatment||Double||||||
1562175|NCT00157222|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1562176|NCT00157209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562177|NCT00157196||Single Group Assignment||Treatment||None (Open Label)||||||
1562178|NCT00157183|Randomized|Crossover Assignment||Treatment||Single||||||
1562179|NCT00157170|Randomized|Single Group Assignment||Treatment||Single||||||
1562180|NCT00157157|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562181|NCT00157144|||||Retrospective|||||||
1562182|NCT00157131|Randomized|Parallel Assignment||Treatment||Single||||||t
1562183|NCT00157118|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562184|NCT00157105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562185|NCT00157092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562186|NCT00157079|Randomized|Crossover Assignment||Treatment||||||||
1562187|NCT00157066|Randomized|Parallel Assignment||||Double||||||
1562188|NCT00157053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562189|NCT00157040|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562190|NCT00157027|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562191|NCT00157014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562192|NCT00157001|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562193|NCT00156988|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562194|NCT00156975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562195|NCT00156962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562196|NCT00156949|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562197|NCT00156936|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562198|NCT00156923|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562199|NCT00156910|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562200|NCT00156897|Randomized|Parallel Assignment||Treatment||Double||||||
1562201|NCT00156884|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562202|NCT00156871|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562203|NCT00156858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562204|NCT00156845|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562205|NCT00156819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562206|NCT00156806|Randomized|Single Group Assignment||Prevention||Double||||||
1562207|NCT00156793|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562208|NCT00156780|Randomized|Crossover Assignment||Educational/Counseling/Training||Double||||||
1562209|NCT00156767||||||||||||
1562210|NCT00156741|Randomized|Crossover Assignment||Treatment||Double||||||
1562211|NCT00156728|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562212|NCT00156715|Non-Randomized|Single Group Assignment||Other||None (Open Label)||||||
1562213|NCT00156702|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562214|NCT00156689|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1562215|NCT00156676|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562216|NCT00156663|Randomized|Single Group Assignment||||None (Open Label)||||||
1562217|NCT00156650|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562218|NCT00156637|Randomized|Parallel Assignment||||None (Open Label)||||||
1562219|NCT00156624|Randomized|Parallel Assignment||Prevention||Double||||||
1562220|NCT00156611|Randomized|Parallel Assignment||Prevention||Double||||||
1562221|NCT00156598|||Cohort||Prospective|||||||
1562222|NCT00156585|||Case-Only||Prospective|||||||
1562223|NCT00156572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562224|NCT00156559|||||Prospective|||||||
1562225|NCT00156546|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562226|NCT00156533|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1562227|NCT00156520|Randomized|Single Group Assignment||||Double||||||
1562228|NCT00156507|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562229|NCT00156494|||Case Control||Cross-Sectional|||||||
1562230|NCT00156481|||||Cross-Sectional|||||||
1562231|NCT00156468|Randomized|Parallel Assignment||Prevention||Single||||||
1562232|NCT00156455|||||Prospective|||||||
1562233|NCT00156442|||||Prospective|||||||
1562234|NCT00156429|||Cohort||Prospective|||||||
1562235|NCT00156416|Randomized|Parallel Assignment||Treatment||Single|||||t|
1562236|NCT00156403|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562237|NCT00156390|Randomized|Parallel Assignment||Treatment||Single|||t|||
1562238|NCT00156377|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562239|NCT00156364|||Cohort||Prospective|||||||
1562240|NCT00156351|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562241|NCT00156338|Randomized|Factorial Assignment||Treatment||Single|||t|||
1562242|NCT00156325|Randomized|Crossover Assignment||Treatment||Double||||||
1562243|NCT00156312|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562244|NCT00156299|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562245|NCT00156286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562246|NCT00156273|||Other||Prospective|||||||
1562247|NCT00156260|||||Prospective|||||||
1562248|NCT00156247||Single Group Assignment||Treatment||None (Open Label)||||||
1562249|NCT00156234|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1562250|NCT00156221|||Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1562251|NCT00156208|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1562252|NCT00156195|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1562253|NCT00156182|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562254|NCT00156169|Randomized|Crossover Assignment||||Double||||||
1562255|NCT00156156|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1562256|NCT00156143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562257|NCT00156130|||||Prospective|||||||
1562258|NCT00156117|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562259|NCT00156104|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562260|NCT00156091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562261|NCT00156078|Randomized|Parallel Assignment||Treatment||Double||||||
1562262|NCT00156065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562263|NCT00156052|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562264|NCT00156039|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562265|NCT00156026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562266|NCT00156013||Single Group Assignment||Treatment||None (Open Label)||||||
1562267|NCT00156000|||Cohort||Prospective|||||||
1562268|NCT00155987|Randomized|Parallel Assignment||Treatment||Single||||||t
1562269|NCT00155974|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1562270|NCT00155961|Random Sample|||Screening|Cross-Sectional, Retrospective/Prospective|||||||
1562271|NCT00155948|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1562272|NCT00155935|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562273|NCT00155922|||Case Control, Natural History||Longitudinal, Prospective|||||||
1562274|NCT00155909|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1562275|NCT00155896|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1562276|NCT00155883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562277|NCT00155870|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1562278|NCT00155857|||Case Control|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1562279|NCT00155844|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1562280|NCT00155831|||Cohort||Prospective|||||||
1562281|NCT00155818|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1562282|NCT00155805|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1562283|NCT00155792|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1562284|NCT00155779|Random Sample||Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1562285|NCT00155766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562286|NCT00155753|||Case Control|||||||||
1562287|NCT00155740|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1562288|NCT00155727|Random Sample|||Screening|Longitudinal, Prospective|||||||
1562289|NCT00155714|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562290|NCT00155701|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1562291|NCT00155688|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1562292|NCT00155675|Randomized|Single Group Assignment||Treatment||Double||||||
1562293|NCT00155662|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1562294|NCT00155649|||Defined Population|Screening|Longitudinal, Retrospective/Prospective|||||||
1562295|NCT00155636|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1562296|NCT00155623|||Defined Population|Screening|Longitudinal, Prospective|||||||
1562297|NCT00155610|||||Prospective|||||||
1562298|NCT00155597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562299|NCT00155584|Random Sample||Natural History||Longitudinal, Prospective|||||||
1562300|NCT00155571|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1562301|NCT00155558|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1562302|NCT00155545|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1562303|NCT00155532|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562304|NCT00155519|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1562305|NCT00155506|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1562306|NCT00155493|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562307|NCT00155480|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562308|NCT00155467|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562309|NCT00155454|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1562310|NCT00155441|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1562311|NCT00155428|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562312|NCT00155415|Randomized|Parallel Assignment||Diagnostic||Single||||||
1562313|NCT00155402|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562314|NCT00155389||Single Group Assignment||Treatment||None (Open Label)||||||
1562315|NCT00155376|Randomized|Parallel Assignment||Diagnostic||Double||||||
1562316|NCT00155363|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1562317|NCT00155350|Randomized|Parallel Assignment||Treatment||Single||||||
1562318|NCT00155337|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562319|NCT00155324|Randomized|Parallel Assignment||Treatment||Double||||||
1562320|NCT00155311|Non-Randomized|Factorial Assignment||Treatment||Single|||||t|
1562321|NCT00155285|Randomized|Single Group Assignment||Diagnostic||Single||||||
1562322|NCT00155272|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562323|NCT00155259|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562324|NCT00155246|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562325|NCT00155233|Randomized|Parallel Assignment||Treatment||Double||||||
1562326|NCT00155220|Randomized|Parallel Assignment||Treatment||Single||||||
1562327|NCT00155207|||Defined Population||Longitudinal, Retrospective/Prospective|||||||
1562328|NCT00155194|||Defined Population|Screening|Longitudinal, Prospective|||||||
1562329|NCT00155181|||Case Control, Natural History||Cross-Sectional, Retrospective|||||||
1562330|NCT00155168|||Case Control|Screening|Longitudinal, Prospective|||||||
1562331|NCT00155155|||||Prospective|||||||
1562332|NCT00155142|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1562333|NCT00155129|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1562334|NCT00155116|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1562335|NCT00155103|||Case Control, Natural History||Longitudinal, Retrospective|||||||
1562336|NCT00155090|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1562337|NCT00155077|||Defined Population|Screening|Longitudinal, Prospective|||||||
1562338|NCT00155064|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562339|NCT00155051|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1562340|NCT00155038|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1562341|NCT00155025|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1562342|NCT00155012|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1562343|NCT00154999|Random Sample||Natural History||Longitudinal, Prospective|||||||
1562344|NCT00154986|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1562345|NCT00154973||||Screening|Longitudinal, Retrospective|||||||
1562346|NCT00154960|||Case Control|Screening|Longitudinal, Prospective|||||||
1562347|NCT00154947|||Case Control|Screening|Longitudinal, Prospective|||||||
1562348|NCT00154934|||Case Control||Prospective|||||||
1568091|NCT00002460||||Treatment||||||||
1562349|NCT00154921|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1562350|NCT00154895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562351|NCT00154882|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562352|NCT00154869|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562353|NCT00154856|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562354|NCT00154843|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562355|NCT00154830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562356|NCT00154817|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562357|NCT00154804|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562358|NCT00154791|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562359|NCT00154778|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562360|NCT00154765|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562361|NCT00154752|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562362|NCT00154739|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562363|NCT00154726|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562364|NCT00154713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562365|NCT00154700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562366|NCT00154687|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562367|NCT00154674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562368|NCT00154661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562369|NCT00154648|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1562370|NCT00154635|Randomized|Parallel Assignment||Treatment||Double||||||
1562371|NCT00154622|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1562372|NCT00154609|Randomized|Parallel Assignment||Treatment||Double||||||
1562373|NCT00154596|||Case Control||Prospective|||||||
1562374|NCT00154583|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1562375|NCT00154570|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1562376|NCT00154557|||Defined Population||Longitudinal, Retrospective|||||||
1562377|NCT00154544|||Defined Population|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1562378|NCT00154531|||Case Control|Screening|Cross-Sectional, Retrospective/Prospective|||||||
1562379|NCT00154518|Non-Randomized|Factorial Assignment||Treatment||Single||||||
1562380|NCT00154505|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562381|NCT00154492|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562382|NCT00154479|||Defined Population|Screening|Longitudinal, Prospective|||||||
1562383|NCT00154466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562384|NCT00154453|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562385|NCT00154440|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562386|NCT00154427|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562387|NCT00154414|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562388|NCT00154401|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562389|NCT00154388|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562390|NCT00154375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562391|NCT00154362|Randomized|Crossover Assignment||Treatment||Double||||||
1562392|NCT00154349|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562393|NCT00154336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562394|NCT00154323|Randomized|Parallel Assignment||Treatment||Double||||||
1562395|NCT00154310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562396|NCT00154297|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562397|NCT00154284|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562398|NCT00154271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562399|NCT00154258||Single Group Assignment||Treatment||None (Open Label)||||||
1562400|NCT00154245|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562401|NCT00154232|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562402|NCT00154219|Randomized|Parallel Assignment||Treatment||Double||||||
1562403|NCT00154206|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562404|NCT00154193|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562405|NCT00154180|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1562406|NCT00154167|Randomized|Single Group Assignment||Treatment||Double||||||
1562407|NCT00154154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562408|NCT00154141|Randomized|Parallel Assignment||||Single||||||
1562409|NCT00154128|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1562410|NCT00154115|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1562411|NCT00154102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562412|NCT00154089||Single Group Assignment||Treatment||None (Open Label)||||||
1562413|NCT00154076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562414|NCT00154063|Randomized|Parallel Assignment||Treatment||Double||||||
1562415|NCT00154050|Randomized|Parallel Assignment||Treatment||Double||||||
1562416|NCT00154037|Randomized|Parallel Assignment||Treatment||Double||||||
1562417|NCT00154024|Randomized|Crossover Assignment||Treatment||Double||||||
1562418|NCT00154011|Randomized|Parallel Assignment||Treatment||Double||||||
1562419|NCT00153998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562420|NCT00153985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562421|NCT00153972|Randomized|Parallel Assignment||Treatment||Single|||||t|
1562422|NCT00153959|Randomized|Crossover Assignment||||None (Open Label)||||||
1562423|NCT00153946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562424|NCT00153933||Single Group Assignment||Treatment||None (Open Label)||||||
1562425|NCT00153920||Single Group Assignment||Treatment||None (Open Label)||||||
1562426|NCT00153907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562427|NCT00153894|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562428|NCT00153881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562429|NCT00153868|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562430|NCT00153855|||Defined Population|Screening|Longitudinal, Prospective|||||||
1562431|NCT00153842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562432|NCT00153829|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562433|NCT00153816|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1562434|NCT00153803|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562435|NCT00153790|Randomized|Single Group Assignment||Treatment||Double||||||
1562436|NCT00153777|Randomized|Parallel Assignment||Prevention||Double||||||
1562437|NCT00153764|Randomized|Single Group Assignment||Diagnostic||Single|||||t|
1562438|NCT00153751|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1562439|NCT00153738|Randomized|Single Group Assignment||Prevention||Single||||||
1562440|NCT00153725|Randomized|Parallel Assignment||Treatment||Double||||||
1562441|NCT00153712|||Cohort||Prospective|||||||
1562442|NCT00153699|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562443|NCT00153686|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1562444|NCT00153673|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562445|NCT00153660|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562446|NCT00153647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562447|NCT00153634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562448|NCT00153621|||||Prospective|||||||
1562449|NCT00153608|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562450|NCT00153595|Randomized|Parallel Assignment||Treatment||Double||||||
1562451|NCT00153582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562452|NCT00153569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562453|NCT00153556|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562454|NCT00153543|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562455|NCT00153530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562456|NCT00153517|Randomized|Single Group Assignment||Treatment||Double||||||
1562457|NCT00153504|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562458|NCT00153491|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1562459|NCT00153478|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562460|NCT00153465|Randomized|Crossover Assignment||Treatment||Single||||||
1562461|NCT00153452|||Defined Population||Cross-Sectional, Retrospective|||||||
1562462|NCT00153439|Randomized|Factorial Assignment||Prevention||Single||||||
1562463|NCT00153426||Single Group Assignment||Prevention||None (Open Label)||||||
1562464|NCT00153413|Randomized|Parallel Assignment||Prevention||Single||||||
1562465|NCT00153400|Randomized|Parallel Assignment||Prevention||Single||||||
1562466|NCT00153387|Randomized|Parallel Assignment||Prevention||Single||||||
1562467|NCT00153374|Randomized|Parallel Assignment||Prevention||Single||||||
1562468|NCT00153361|Randomized|Parallel Assignment||Prevention||Single||||||t
1562469|NCT00153348|Randomized|Parallel Assignment||Prevention||Single||||||
1562470|NCT00153335|Randomized|Single Group Assignment||||None (Open Label)||||||
1562471|NCT00153322|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562472|NCT00153309|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562473|NCT00153296|Randomized|Parallel Assignment||Treatment||Double||||||
1562474|NCT00153283|Randomized|Parallel Assignment||Treatment||Double||||||
1562475|NCT00153270|Randomized|Parallel Assignment||Treatment||Double||||||
1562476|NCT00153257|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562477|NCT00153244|Randomized|Parallel Assignment||Treatment||Double||||||
1562478|NCT00153231|Randomized|Parallel Assignment||||None (Open Label)||||||
1562479|NCT00153218|||Case-Only||Retrospective|||||||
1562480|NCT00153205|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562481|NCT00153192|Randomized|Crossover Assignment||Treatment||Double||||||
1562482|NCT00153179|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1562483|NCT00153166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562484|NCT00153153|Randomized|Parallel Assignment||Treatment||Double||||||
1562485|NCT00153140|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562486|NCT00153127|Randomized|Parallel Assignment||||Double||||||
1562487|NCT00153114|Randomized|Parallel Assignment||Treatment||Double||||||
1562488|NCT00153101||Parallel Assignment||Prevention||||||||
1562489|NCT00153088|Randomized|Parallel Assignment||Treatment||Double||||||
1562490|NCT00153075|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1562491|NCT00153062|Randomized|Parallel Assignment||Prevention||Double||||||
1562492|NCT00153049|Randomized|Factorial Assignment||Treatment||Double||||||
1562493|NCT00153036||||Treatment||||||||
1562494|NCT00153023|Randomized|Parallel Assignment||Treatment||Double||||||
1562495|NCT00153010|Randomized|Parallel Assignment||Treatment||Double||||||
1562496|NCT00152997|Randomized|Parallel Assignment||Treatment||Double||||||
1562497|NCT00152984|Randomized|Parallel Assignment||Treatment||Double||||||
1562498|NCT00152971|Randomized|Parallel Assignment||Prevention||Double||||||
1562499|NCT00152958|Randomized|Parallel Assignment||Treatment||Double||||||
1562500|NCT00152945|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562501|NCT00152932|Randomized|Crossover Assignment||Diagnostic||Single||||||
1562502|NCT00152919|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562503|NCT00152906||Single Group Assignment||Treatment||None (Open Label)||||||
1562504|NCT00152893|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1562505|NCT00152880|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1562506|NCT00152867|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1562507|NCT00152854|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1562508|NCT00152841|Randomized|Crossover Assignment||||None (Open Label)||||||
1562509|NCT00152828||Single Group Assignment||Treatment||None (Open Label)||||||
1562510|NCT00152815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562511|NCT00152802|Randomized|Single Group Assignment||Prevention||Double||||||
1562512|NCT00152789|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562513|NCT00152776|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1562514|NCT00152763|Randomized|Factorial Assignment||Treatment||Single||||||t
1562515|NCT00152750|Randomized|Single Group Assignment||Treatment||Double||||||
1562516|NCT00152737|||Cohort||Prospective|||||||
1562517|NCT00152724|||Cohort||Prospective|||||||
1562518|NCT00152711|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1562519|NCT00152698|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1562520|NCT00152685|Randomized|Single Group Assignment||||Single||||||
1562521|NCT00152672|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1562522|NCT00152659|||||Retrospective|||||||
1562523|NCT00152646|Randomized|Crossover Assignment||Treatment||Double||||||
1562524|NCT00152633|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1562525|NCT00152620|Randomized|Single Group Assignment||Treatment||Double||||||
1562526|NCT00152607|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562527|NCT00152594|Randomized|Parallel Assignment||Prevention||Double||||||
1562528|NCT00152581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562529|NCT00152568||Single Group Assignment||Prevention||None (Open Label)||||||
1562530|NCT00152555|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562531|NCT00152542|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1562532|NCT00152529||||||||||||
1562533|NCT00152516|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562534|NCT00152503|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562535|NCT00152490|Randomized|Parallel Assignment||||Double||||||
1562536|NCT00152477|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562537|NCT00152464|Randomized|Parallel Assignment||||Double||||||
1562538|NCT00152451|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562539|NCT00152438|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562540|NCT00152425|Randomized|Parallel Assignment||||Double||||||
1562541|NCT00152412|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562542|NCT00152399|Randomized|Parallel Assignment||||Double||||||
1562543|NCT00152386|Randomized|Parallel Assignment||Treatment||Double||||||
1562544|NCT00152373|Randomized|Parallel Assignment||||Double||||||
1562545|NCT00152360||Single Group Assignment||Treatment||None (Open Label)||||||
1562546|NCT00152347|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562547|NCT00152334||Single Group Assignment||Treatment||None (Open Label)||||||
1562548|NCT00152321|Randomized|Parallel Assignment||Treatment||Triple||||t|t|t
1562549|NCT00152308|Randomized|Parallel Assignment||Treatment||Double||||||
1562550|NCT00152295|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562551|NCT00152282|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1562552|NCT00152269|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1562553|NCT00152256|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1562554|NCT00152243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562555|NCT00152230|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562556|NCT00152217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562557|NCT00152204|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562558|NCT00152191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562559|NCT00152178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562560|NCT00152165|||||Prospective|||||||
1562561|NCT00152152|||||Prospective|||||||
1562562|NCT00152139|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562563|NCT00152126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562564|NCT00152113||Single Group Assignment||Treatment||None (Open Label)||||||
1562565|NCT00152100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562566|NCT00152087|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562567|NCT00152074|Randomized|Crossover Assignment||Treatment||Double||||||
1562568|NCT00152061|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562569|NCT00152048|Randomized|Parallel Assignment||Treatment||Double||||||
1562570|NCT00152035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562571|NCT00152022|Randomized|Parallel Assignment||Treatment||Double||||||
1562572|NCT00152009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562573|NCT00151996|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562574|NCT00151983||Single Group Assignment||Treatment||None (Open Label)||||||
1562575|NCT00151970|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1562576|NCT00151957||Single Group Assignment||Treatment||None (Open Label)||||||
1562577|NCT00151944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562578|NCT00151931|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562579|NCT00151918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562580|NCT00151905|Randomized|Parallel Assignment||Treatment||Double||||||
1562581|NCT00151892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562582|NCT00151879|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562583|NCT00151866|Randomized|Single Group Assignment||Treatment||Double||||||
1562584|NCT00151853|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562585|NCT00151840|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562586|NCT00151827|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562587|NCT00151814|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562588|NCT00151801|Randomized|Parallel Assignment||Treatment||Single||||||
1562589|NCT00151788|Randomized|Parallel Assignment||Treatment||Double||||||
1562590|NCT00151775|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562591|NCT00151762|Non-Randomized|||Treatment||None (Open Label)||||||
1562592|NCT00151749|Randomized|Parallel Assignment||Treatment||Double||||||
1562593|NCT00151736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562594|NCT00151723|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562595|NCT00151710|Randomized|Crossover Assignment||||Double||||||
1562596|NCT00151697|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562597|NCT00151684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562598|NCT00151671|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1562599|NCT00151658|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562600|NCT00151645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562601|NCT00151632|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562602|NCT00151619|Randomized|Parallel Assignment||Treatment||Double||||||
1562603|NCT00151606|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562604|NCT00151593|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562605|NCT00151580|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1562606|NCT00151567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562607|NCT00151554|Randomized|Parallel Assignment||||None (Open Label)||||||
1562608|NCT00151541|Randomized|Parallel Assignment||Treatment||Double||||||
1562609|NCT00151528|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562610|NCT00151515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562611|NCT00151502|Randomized|Parallel Assignment||Treatment||Double||||||
1562612|NCT00151489|Randomized|Parallel Assignment||Treatment||Double||||||
1562613|NCT00151476|||Cohort|||||||||
1562614|NCT00151463|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562615|NCT00151450|Randomized|Parallel Assignment||Treatment||Double||||||
1562616|NCT00151437|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562617|NCT00151424|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562618|NCT00151411|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1562619|NCT00151398|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562620|NCT00151385|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1562621|NCT00151372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562622|NCT00151359|||Defined Population||Longitudinal, Prospective|||||||
1562623|NCT00151346|Randomized|Parallel Assignment||Treatment||Single|||t|||
1562624|NCT00151333|Randomized|Parallel Assignment||Treatment||Double||||||
1562625|NCT00151320||Single Group Assignment||Treatment||None (Open Label)||"Standard CHOP chemotherapy administered every 21 days (full dose) for six cycles~Rituximab administered (375 mg/m2) day 1 of each cycle (with usual premedications)~VELCADE is administered prior to rituximab and CHOP on day 1 of each cycle. The dose of VELCADE will be determined by the dose escalation schedule."||||
1562626|NCT00151307|Randomized|Parallel Assignment||Prevention||Single||||||
1562627|NCT00151294|Randomized|Parallel Assignment||Treatment||Double||||||
1562628|NCT00151281||Single Group Assignment||Treatment||None (Open Label)||||||
1562629|NCT00151268|||||Prospective|||||||
1562630|NCT00151255|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562631|NCT00151242|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562632|NCT00151229|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562633|NCT00151216|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||The study will be carried out in two populations of children with LINCL. Group A will include n= 5 children with a total disability score of 0 to 4 (the severe forms of the disease; the staging based on a modification of the scale of Steinfeld et al. Group B will include n=6 children with a total disability score of 5 to 6, a moderate stage of the disease. All of the study population of 11 children (Group A, n= 5 and Group B, n=6) will receive 3x10^12 particle units of the AAV2CUhCLN2 vector divided among 12 locations delivered through 6 burr holes (2 locations at varying depths through each hole), 3 burr holes per hemisphere. The choice of the locations for the burr holes and needle placement will be on a case-by-case basis due to the diffuse and variable nature of the disease presentation.||||
1562634|NCT00151203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562635|NCT00151190|Randomized|Parallel Assignment||||None (Open Label)||||||
1562636|NCT00151177|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562637|NCT00151164|Non-Randomized|Parallel Assignment||||Double||||||
1562638|NCT00151151|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562639|NCT00151138|Randomized|Parallel Assignment||Treatment||Double||||||
1562640|NCT00151125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562641|NCT00151112|Randomized|Parallel Assignment||Prevention||Single|||t|||
1562642|NCT00151099|Randomized|Parallel Assignment||||None (Open Label)||||||
1562643|NCT00151086||Single Group Assignment||Treatment||None (Open Label)||||||
1562644|NCT00151073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562645|NCT00151060||Single Group Assignment||Treatment||None (Open Label)||||||
1562646|NCT00151047||Single Group Assignment||Treatment||None (Open Label)||||||
1562647|NCT00151034||Single Group Assignment||Treatment||None (Open Label)||||||
1562648|NCT00151021|Randomized|Crossover Assignment||||None (Open Label)||||||
1562649|NCT00151008|Randomized|Parallel Assignment||Treatment||Double||||||
1562650|NCT00150995||Single Group Assignment||Treatment||None (Open Label)||||||
1562651|NCT00150982|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562652|NCT00150969|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1562653|NCT00150956|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562654|NCT00150943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562655|NCT00150930|Randomized|Parallel Assignment||Treatment||Single||||||
1562656|NCT00150917|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562657|NCT00150904|||Cohort||Prospective|||||||
1562658|NCT00150891|||Defined Population|Screening|Longitudinal, Prospective|||||||
1562659|NCT00150878|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562660|NCT00150865|Randomized|Single Group Assignment||Treatment||Double||||||
1562661|NCT00150852|Randomized|Parallel Assignment||Prevention||Double||||||
1562662|NCT00150839|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562663|NCT00150826|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562664|NCT00150813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562665|NCT00150800||Single Group Assignment||Treatment||None (Open Label)||||||
1562666|NCT00150787|Randomized|Parallel Assignment||||Double||||||
1562667|NCT00150774|Randomized|Parallel Assignment||Treatment||Double||||||
1562668|NCT00150761|Randomized|Crossover Assignment||||Double||||||
1562669|NCT00150748||Single Group Assignment||Treatment||None (Open Label)||||||
1562670|NCT00150735|Non-Randomized|Parallel Assignment||||Double||||||
1562671|NCT00150722|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1562672|NCT00150709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562673|NCT00150696|Randomized|Parallel Assignment||Prevention||Double||||||
1562674|NCT00150683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562675|NCT00150670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562676|NCT00150657|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562677|NCT00150644|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1562678|NCT00150631|Randomized|Parallel Assignment||||Double|||t||t|
1562679|NCT00150618|Randomized|Parallel Assignment||Treatment||Double||||||
1562680|NCT00150605|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562681|NCT00150592|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562682|NCT00150579|Randomized|Parallel Assignment||Treatment||Double||||||
1562683|NCT00150566|Randomized|Parallel Assignment||Treatment||Double||||||
1562684|NCT00150553|Randomized|Parallel Assignment||Treatment||Double||||||
1562685|NCT00150540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562686|NCT00150527|||Cohort||Prospective|||||||
1562687|NCT00150514|Randomized|Parallel Assignment||Treatment||Double||||||
1562688|NCT00150488|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562689|NCT00150475|Randomized|Crossover Assignment||Educational/Counseling/Training||Single||||||
1562690|NCT00150462|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562691|NCT00150449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562692|NCT00150436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562693|NCT00150423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562694|NCT00150410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562695|NCT00150397|Randomized|Parallel Assignment||Treatment||Double||||||
1562696|NCT00150384|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562697|NCT00150371|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562698|NCT00150358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562699|NCT00150345|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562700|NCT00150332|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562701|NCT00150319|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562702|NCT00150306|Randomized|Parallel Assignment||Treatment||Double||||||
1562703|NCT00150293|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562704|NCT00150280|Randomized|Parallel Assignment||Treatment||Double||||||
1562705|NCT00150267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562706|NCT00150254|Randomized|Parallel Assignment||Treatment||Double||||||
1562707|NCT00150241|Randomized|Parallel Assignment||Treatment||Double||||||
1562708|NCT00150228|Randomized|Parallel Assignment||Treatment||Double||||||
1562709|NCT00150215|Randomized|Crossover Assignment||Treatment||Double||||||
1562710|NCT00150202|Randomized|Parallel Assignment||Treatment||Double||||||
1562711|NCT00150189|Randomized|Parallel Assignment||Treatment||Double||||||
1562712|NCT00150176|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1562713|NCT00150163|Random Sample|||Screening|Longitudinal, Prospective|||||||
1562714|NCT00150150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562715|NCT00150137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562716|NCT00150124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562717|NCT00150111|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562718|NCT00150098|Randomized|Parallel Assignment||||None (Open Label)||||||
1562719|NCT00150085|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562720|NCT00150072||Single Group Assignment||Treatment||None (Open Label)||||||
1562721|NCT00150059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562722|NCT00150046|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562723|NCT00150033|||||Prospective|||||||
1562724|NCT00150020|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562725|NCT00150007|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562726|NCT00149994|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1562727|NCT00149981||Single Group Assignment||Treatment||None (Open Label)||||||
1562728|NCT00149968|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562729|NCT00149942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562730|NCT00149929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562731|NCT00149916|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562732|NCT00149903|Randomized|Parallel Assignment||Treatment||Double||||||
1562733|NCT00149890|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562734|NCT00149877|Randomized|Parallel Assignment||Treatment||Double||||||
1562735|NCT00149864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562736|NCT00149851|Randomized|Parallel Assignment||Treatment||Double||||||
1562737|NCT00149838|Randomized|Sequential Assignment||Treatment||Quadruple|||t|t|t|t
1562738|NCT00149825|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1562739|NCT00149812||Single Group Assignment||Prevention||None (Open Label)||||||
1562740|NCT00149799|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562741|NCT00149786|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562742|NCT00149773|Randomized|Parallel Assignment||Treatment||Single||||||t
1562743|NCT00149760|Randomized|Parallel Assignment||Treatment||Single||||||t
1562744|NCT00149747|Randomized|Parallel Assignment||Treatment||Single||||||t
1562745|NCT00149734|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1562746|NCT00149721|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562747|NCT00149708|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562748|NCT00149695|Randomized|Parallel Assignment||Prevention||Single||||||
1562749|NCT00149682|Randomized|Parallel Assignment||||None (Open Label)||||||
1562750|NCT00149669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562751|NCT00149656|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1562752|NCT00149643|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1562753|NCT00149630|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562754|NCT00149617|Randomized|Parallel Assignment||Treatment||Double||||||
1562755|NCT00149604|Randomized|Parallel Assignment||Treatment||Double||||||
1562756|NCT00149591|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562757|NCT00149578|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562758|NCT00149565|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562759|NCT00149552|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562760|NCT00149539|Randomized|Crossover Assignment||Treatment||Double||||||
1562761|NCT00149526|Randomized|||Treatment||||||||
1562762|NCT00149513|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562763|NCT00149500|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1562764|NCT00149487|Randomized|||Treatment||||||||
1562765|NCT00149474|Randomized|||||||||||
1562766|NCT00149461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562767|NCT00149448||||||||||||
1562768|NCT00149435|||Cohort||Prospective|||||||
1562769|NCT00149422|Randomized|Parallel Assignment||Diagnostic||Single||||||
1562770|NCT00149409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562771|NCT00149396||Single Group Assignment||Treatment||None (Open Label)||||||
1562772|NCT00149383|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562773|NCT00149370|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1562774|NCT00149357|||Cohort||Other|||||||
1562775|NCT00149344|Randomized|Parallel Assignment||Treatment||Single||||||t
1562776|NCT00149331|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562777|NCT00149318|||Case-Only||Prospective|||||||
1562778|NCT00149305|||Case Control||Prospective|||||||
1562779|NCT00149292|Randomized|Parallel Assignment||Treatment||Double||||||
1562780|NCT00149279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562781|NCT00149266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562782|NCT00149253|Randomized|Parallel Assignment||Treatment||Double||||||
1562783|NCT00149240|Randomized|Parallel Assignment||Treatment||Double||||||
1562784|NCT00149227|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1562785|NCT00149214|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562786|NCT00149201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562787|NCT00149188|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562788|NCT00149175|||Case Control||Prospective|||||||
1562789|NCT00149162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562790|NCT00149149|Randomized|Crossover Assignment||Prevention||Double||||||
1562791|NCT00149136|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562792|NCT00149123|Randomized|Parallel Assignment||||Double||||||
1562793|NCT00149110|Randomized|Parallel Assignment||Treatment||Single||||||t
1562794|NCT00149097|||Cohort||Cross-Sectional|||||||
1562795|NCT00149084|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1562796|NCT00149071|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1562797|NCT00149058|Randomized|Parallel Assignment||Treatment||Double||||||
1562798|NCT00149045|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1562799|NCT00149032|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562800|NCT00149019|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562801|NCT00149006|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562802|NCT00148993|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562803|NCT00148980|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562804|NCT00148967|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1562805|NCT00148954|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562806|NCT00148941|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562807|NCT00148928|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562808|NCT00148915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562809|NCT00148902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562810|NCT00148889|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1562811|NCT00148876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562812|NCT00148863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562813|NCT00148850|Randomized|Parallel Assignment||Treatment||Double||||||
1562814|NCT00148837|Randomized|Parallel Assignment||Treatment||Double||||||
1562815|NCT00148824|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562816|NCT00148798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562817|NCT00148785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562818|NCT00148772|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562819|NCT00148759|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562820|NCT00148746|Randomized|Parallel Assignment||Treatment||Single||||||
1562821|NCT00148733|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562822|NCT00148720||Single Group Assignment||Treatment||None (Open Label)||||||
1562823|NCT00148707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562824|NCT00148694||Single Group Assignment||Treatment||None (Open Label)||||||
1562825|NCT00148681|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562826|NCT00148668|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562827|NCT00148655|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562828|NCT00148642|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1562829|NCT00148629|Randomized|Single Group Assignment||||None (Open Label)||||||
1562830|NCT00148616|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1562831|NCT00148603|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1562832|NCT00148590|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1562833|NCT00148577|Random Sample||||Longitudinal, Prospective|||||||
1562834|NCT00148564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562835|NCT00148551|Randomized|Parallel Assignment||Treatment||Double||||||
1562836|NCT00148538|Randomized|Factorial Assignment||Treatment||Single|||t|||
1562837|NCT00148525|Randomized|Parallel Assignment||Prevention||Single|||t|||
1562838|NCT00148512|Randomized|Parallel Assignment||Treatment||Double||||||
1562839|NCT00148499|Randomized|Parallel Assignment||Treatment||Double||||||
1562840|NCT00148486|Randomized|Parallel Assignment||Treatment||Double||||||
1562841|NCT00148473|Randomized|Parallel Assignment||Treatment||Double||||||
1562842|NCT00148460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562843|NCT00148447|Randomized|Parallel Assignment||Treatment||Double||||||
1562844|NCT00148434|Randomized|Parallel Assignment||Prevention||Single||||||
1562845|NCT00148421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562846|NCT00148408|Randomized|Factorial Assignment||||Double||||||
1562847|NCT00148395|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562848|NCT00148382|Randomized|Parallel Assignment||Treatment||Double||||||
1562849|NCT00148369|||||Prospective|||||||
1562850|NCT00148356|Randomized|Parallel Assignment||Treatment||Single|||t|||
1562851|NCT00148343|Randomized|Parallel Assignment||Treatment||Single||||||t
1562852|NCT00148330|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562918|NCT00147459|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562919|NCT00147446|Randomized|Parallel Assignment||Prevention||Single||||||t
1562920|NCT00147433|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1562921|NCT00147420|Randomized|Parallel Assignment||Prevention||Double||||||
1562922|NCT00147394|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562923|NCT00147381|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562853|NCT00148317||Single Group Assignment||Treatment||None (Open Label)||"Consolidation: All patients will receive 2 cycles of bortezomib (VEL) and dexamethasone (DEX). Patients who achieve a complete response after 2 cycles will receive 4 additional cycles of VEL/DEX before mobilization.~Patients who do not achieve at least a partial response after 2 cycles will receive 4 more cycles of VEL/DEX plus DOXIL.~Patients who achieve a partial response after 2 cycles on VEL/DEX, will continue this combination for 2 more cycles. Patients who achieve a complete response after 4 cycles will receive 2 additional cycles of VEL/DEX before mobilization. Patients who remain with a partial response after 4 cycles of VEL/DEX will receive 2 additional cycles of the combination of VEL/DEX plus DOXIL.~Mobilization: Patients who complete 6 cycles of consolidation will proceed to mobilization. Patients will receive one cycle of VEL plus high dose CYTOXAN followed by G-CSF beginning 24 hours after CYTOXAN given for a total of 10 daily doses."||||
1562854|NCT00148304|||Cohort||Cross-Sectional|||||||
1562855|NCT00148291|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562856|NCT00148278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562857|NCT00148265|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1562858|NCT00148252|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562859|NCT00148239|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1562860|NCT00148226|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1562861|NCT00148213||||Screening|Cross-Sectional, Prospective|||||||
1562862|NCT00148200|||Case-Only||Cross-Sectional|||||||
1562863|NCT00148187|||Cohort||Prospective|||||||
1562864|NCT00148174||Single Group Assignment||Treatment||None (Open Label)||||||
1562865|NCT00148161|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1562866|NCT00148148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562867|NCT00148135|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562868|NCT00148122||Single Group Assignment||Treatment||None (Open Label)||||||
1562869|NCT00148109|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562870|NCT00148096|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562871|NCT00148083|Randomized|Factorial Assignment||Treatment||Single||||||
1562872|NCT00148070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562873|NCT00148057|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562874|NCT00148044|||||Prospective|||||||
1562875|NCT00148031|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562876|NCT00148018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562877|NCT00148005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562878|NCT00147992|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562879|NCT00147979|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562880|NCT00147966|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562881|NCT00147953|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562882|NCT00147940|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562883|NCT00147927|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562884|NCT00147914|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562885|NCT00147901||Single Group Assignment||Treatment||None (Open Label)||||||
1562886|NCT00147888|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562887|NCT00147875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562888|NCT00147862|Randomized|Parallel Assignment||Treatment||Double||||||
1562889|NCT00147849|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1562890|NCT00147836|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562891|NCT00147823|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562892|NCT00147810|Randomized|Parallel Assignment||Treatment||Single||||||
1562893|NCT00147797|||||Prospective|||||||
1562894|NCT00147784|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562895|NCT00147771|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562896|NCT00147758|Randomized|Parallel Assignment||Treatment||Double||||||
1562897|NCT00147745|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1562898|NCT00147732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562899|NCT00147719|Randomized|Parallel Assignment||Treatment||Double||||||
1562900|NCT00147706|Randomized|Parallel Assignment||||Single||||||
1562901|NCT00147693|Randomized|Factorial Assignment||Diagnostic||Single||||||t
1562902|NCT00147680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562903|NCT00147667|Randomized|Single Group Assignment||Treatment||Double||||||
1562904|NCT00147654|Randomized|Parallel Assignment||Treatment||Double||||||
1562905|NCT00147628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562906|NCT00147615|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562907|NCT00147602|Randomized|Parallel Assignment||Treatment||Double||||||
1562908|NCT00147589|Randomized|Parallel Assignment||Treatment||Double||||||
1562909|NCT00147576|Randomized|Parallel Assignment||Treatment||Double||||||
1562910|NCT00147563|Non-Randomized|Parallel Assignment||Treatment||Double||||||
1562911|NCT00147550|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562912|NCT00147537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562913|NCT00147524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562914|NCT00147511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562915|NCT00147498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562916|NCT00147485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562917|NCT00147472|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1562924|NCT00147368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562925|NCT00147355|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1562926|NCT00147342|||||Prospective|||||||
1562927|NCT00147329|Randomized|Parallel Assignment||Treatment||Double||||||
1562928|NCT00147316|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562929|NCT00147303|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1562930|NCT00147290|Randomized|Parallel Assignment||Treatment||Single|||t|||
1562931|NCT00147277|Randomized|Parallel Assignment||Treatment||Single|||t|||
1562932|NCT00147264|Randomized|Factorial Assignment||Treatment||Double||||||
1562933|NCT00147251|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562934|NCT00147238|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562935|NCT00147225|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562936|NCT00147212||Single Group Assignment||Treatment||None (Open Label)||||||
1562937|NCT00147199|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562938|NCT00147186|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562939|NCT00147160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562940|NCT00147147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562941|NCT00147134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562942|NCT00147121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562943|NCT00147108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562944|NCT00147095|||Case Control||Prospective|||||||
1562945|NCT00147082||||||||||||
1562946|NCT00147069|||Case Control||Prospective|||||||
1562947|NCT00147056||Single Group Assignment||Treatment||None (Open Label)||||||
1562948|NCT00147043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562949|NCT00147030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562950|NCT00147017|||Case-Only||Prospective|||||||
1562951|NCT00147004|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1562952|NCT00146978|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562953|NCT00146952|Non-Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1562954|NCT00146926|Randomized|Parallel Assignment||||Double||||||
1562955|NCT00146913|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1562956|NCT00146900|Randomized|Parallel Assignment||Prevention||Single||||||t
1562957|NCT00146887|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1562958|NCT00146874|||Cohort||Prospective|||||||
1562959|NCT00146861|Randomized|Parallel Assignment||||Single||||||
1562960|NCT00146848|Randomized|Parallel Assignment||Treatment||Single|||t|||
1562961|NCT00146835|||Cohort||Prospective|||||||
1562962|NCT00146822|Randomized|Parallel Assignment||||Single||||||
1562963|NCT00146809|Randomized|Parallel Assignment||Treatment||Double||||||
1562964|NCT00146796|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1562965|NCT00146783|Randomized|Single Group Assignment||Prevention||Double||||||
1562966|NCT00146770|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562967|NCT00146757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562968|NCT00146744|Randomized|Parallel Assignment||Prevention||Double||||||
1562969|NCT00146731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562970|NCT00146718|Randomized|Parallel Assignment||Treatment||Double||||||
1562971|NCT00146705|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1562972|NCT00146692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562973|NCT00146679|Randomized|Parallel Assignment||Supportive Care||Single||||||t
1562974|NCT00146666|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562975|NCT00146653|||||Prospective|||||||
1562976|NCT00146640|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562977|NCT00146627|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562978|NCT00146614|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562979|NCT00146601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562980|NCT00146588|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562981|NCT00146575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562982|NCT00146562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562983|NCT00146549|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1562984|NCT00146536|||Case-Only||Prospective|||||||
1562985|NCT00146523|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1562986|NCT00146510|Randomized|Single Group Assignment||||Single||||||
1562987|NCT00146497|Randomized|Parallel Assignment||Prevention||Double||||||
1562988|NCT00146484|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562989|NCT00146471|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1562990|NCT00146458|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1562991|NCT00146445|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1562992|NCT00146432|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1562993|NCT00146419|||Cohort||Prospective|||||||
1562994|NCT00146406|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1562995|NCT00146393|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562996|NCT00146380|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1562997|NCT00146367|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1562998|NCT00146354|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1562999|NCT00146341|Randomized|Parallel Assignment||Treatment||Double||||||
1563000|NCT00146328|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563001|NCT00146315|Randomized|Parallel Assignment||Treatment||Single||||||t
1563002|NCT00146302|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563003|NCT00146289|Randomized|Parallel Assignment||Treatment||Double||||||
1563004|NCT00146276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563005|NCT00146263|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563006|NCT00146250|Randomized|Parallel Assignment||Treatment||Single|||t|||
1563007|NCT00146237|Randomized|Parallel Assignment||Treatment||Double||||||
1563008|NCT00146224|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1563009|NCT00146211|Randomized|Parallel Assignment||Treatment||Double||||||
1563010|NCT00146198|Randomized|Parallel Assignment||Treatment||Double||||||
1563011|NCT00146185|Randomized|Parallel Assignment||Treatment||Double||||||
1563012|NCT00146172|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||This trial was an open-label, phase 1, ascending single and multiple oral dose study of HKI-272 administered to subjects with erbB-2- or erbB-1-positive tumors. Each subject participated in only 1 dose group and received a single dose of test article, followed by a 1-week observation period, and then received the test article administered once daily by mouth for up to 6 months (6 cycles). Daily dose administration could continue beyond 6 cycles at the same dose level if HKI-272 was well tolerated and there was no evidence of progressive disease.||||
1563013|NCT00146159|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563014|NCT00146146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563015|NCT00146133|Randomized|Parallel Assignment||Treatment||Single||||||
1563016|NCT00146120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563017|NCT00146107|Randomized|Parallel Assignment||Treatment||Single||||||t
1563018|NCT00146094||||Basic Science||||||||
1563019|NCT00146081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563020|NCT00146068|Randomized|Parallel Assignment||Treatment||Double||||||
1563021|NCT00146055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563022|NCT00146042|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563023|NCT00146029|||||Retrospective|||||||
1563024|NCT00146016|Randomized|Parallel Assignment||Treatment||Double||||||
1563025|NCT00146003|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563026|NCT00145990|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1563027|NCT00145977|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563028|NCT00145964|||Defined Population||Cross-Sectional, Prospective|||||||
1563029|NCT00145951|||||Prospective|||||||
1563030|NCT00145938|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563031|NCT00145925|Randomized|Factorial Assignment||Prevention||Double||||||
1563032|NCT00145912|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563033|NCT00145886||Single Group Assignment||Treatment||None (Open Label)||||||
1563034|NCT00145873|Randomized|Crossover Assignment||Treatment||Double||||||
1563035|NCT00145860|||||Prospective|||||||
1563036|NCT00145847|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563037|NCT00145834|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563038|NCT00145808|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1563039|NCT00145795|Randomized|Parallel Assignment||Treatment||Single|||t|||
1563040|NCT00145782|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1563041|NCT00145769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563042|NCT00145756|Randomized|Parallel Assignment||Prevention||Double||||||
1563043|NCT00145743|Randomized|Parallel Assignment||Treatment||Single|||t|||
1563044|NCT00145730|Randomized|Parallel Assignment||Prevention||Double||||||
1563045|NCT00145717|Randomized|Parallel Assignment||Prevention||Double||||||
1563046|NCT00145704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563047|NCT00145691|Randomized|Parallel Assignment||Treatment||Double||||||
1563048|NCT00145678|Randomized|Parallel Assignment||Treatment||Single||||||t
1563049|NCT00145665|Non-Randomized|Single Group Assignment||Diagnostic||Double|||||t|t
1563050|NCT00145652|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563051|NCT00145639|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563052|NCT00145626||Single Group Assignment||Treatment||None (Open Label)||||||
1563053|NCT00145613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563054|NCT00145600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563055|NCT00145587||Single Group Assignment||Treatment||None (Open Label)||||||
1563056|NCT00145574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563057|NCT00145561|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563058|NCT00145548|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563059|NCT00145535|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563060|NCT00145522|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563061|NCT00145509|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563062|NCT00145496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563063|NCT00145483|Randomized|Parallel Assignment||Treatment||Double||||||
1563064|NCT00145470|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563065|NCT00145457|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563066|NCT00145444|Randomized|Parallel Assignment||Treatment||Double||||||
1563067|NCT00145431|Randomized|Crossover Assignment||Treatment||Double||||||
1563368|NCT00141466|Randomized|Parallel Assignment||||Single||||||
1563068|NCT00145418||Single Group Assignment||Treatment||None (Open Label)||||||
1563069|NCT00145405|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563070|NCT00145392|||||Prospective|||||||
1563071|NCT00145379|Randomized|Crossover Assignment||Prevention||Double||||||
1563072|NCT00145366|Randomized|Crossover Assignment||Treatment||Double||||||
1563073|NCT00145353|Randomized|Crossover Assignment||Treatment||Double||||||
1563074|NCT00145340|Randomized|Parallel Assignment||Treatment||Double||||||
1563075|NCT00145327|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563076|NCT00145314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563077|NCT00145301|Randomized|Parallel Assignment||Treatment||Double||||||
1563078|NCT00145288|||Case Control, Natural History||Longitudinal, Prospective|||||||
1563079|NCT00145275|Randomized|Parallel Assignment||Treatment||Double||||||
1563080|NCT00145262|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1563081|NCT00145249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563082|NCT00145236|Randomized|Parallel Assignment||Treatment||Double||||||
1563083|NCT00145223|||||Prospective|||||||
1563084|NCT00145210|Randomized|Parallel Assignment||Treatment||Double||||||
1563085|NCT00145197||Single Group Assignment||||None (Open Label)||||||
1563086|NCT00145184|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563087|NCT00145171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563088|NCT00145158|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563089|NCT00145145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563090|NCT00145132|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1563091|NCT00145119|||Cohort||Prospective|||||||
1563092|NCT00145106|Randomized|Parallel Assignment||Treatment||Double||||||
1563093|NCT00145093|Randomized|Parallel Assignment||Treatment||Double||||||
1563094|NCT00145080|Randomized|Parallel Assignment||||None (Open Label)||||||
1563095|NCT00145067|Randomized|Parallel Assignment||||None (Open Label)||||||
1563096|NCT00145054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563097|NCT00145041||Single Group Assignment||Treatment||None (Open Label)||||||
1563098|NCT00145028|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1563099|NCT00145015|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1563100|NCT00145002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563101|NCT00144989|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563102|NCT00144976|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1563103|NCT00144963||Single Group Assignment||Treatment||None (Open Label)||||||
1563104|NCT00144950|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563105|NCT00144937|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1563106|NCT00144924|Randomized|Parallel Assignment||Supportive Care||Single|||t|||
1563107|NCT00144911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563108|NCT00144898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563109|NCT00144885|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1563110|NCT00144872|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563111|NCT00144859|Randomized|Parallel Assignment||Treatment||Double||||||
1563112|NCT00144846|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563113|NCT00144833|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563114|NCT00144820|Randomized|Parallel Assignment||Treatment||Double||||||
1563115|NCT00144807||Single Group Assignment||Treatment||None (Open Label)||||||
1563116|NCT00144794|||Cohort||Other|||||||
1563117|NCT00144781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563118|NCT00144768||Single Group Assignment||Treatment||None (Open Label)||||||
1563119|NCT00144755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563120|NCT00144729|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563121|NCT00144716|Randomized|Parallel Assignment||Diagnostic||Double||||||
1563122|NCT00144703|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563123|NCT00144690|Randomized|Parallel Assignment||Treatment||Double||||||
1563124|NCT00144677|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563125|NCT00144664|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563126|NCT00144651|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563127|NCT00144638|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1563128|NCT00144625|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563129|NCT00144612|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563130|NCT00144599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563131|NCT00144586|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563132|NCT00144573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563133|NCT00144560|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563134|NCT00144547|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563135|NCT00144534|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563136|NCT00144521|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563137|NCT00144508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563138|NCT00144495|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563139|NCT00144482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563140|NCT00144469|Randomized|Parallel Assignment||Treatment||Double||||||
1568092|NCT00084162||||||||||||
1563141|NCT00144456|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563142|NCT00144443|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1563143|NCT00144430|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563144|NCT00144417|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1563145|NCT00144404||||||||||||
1563146|NCT00144391|Randomized|Parallel Assignment||Treatment||Double|Testosterone and Placebo|Testosterone and Placebo|t||t|
1563147|NCT00144378|Randomized|Single Group Assignment||||Single||||||
1563148|NCT00144365|Randomized|Parallel Assignment||||None (Open Label)||||||
1563149|NCT00144352|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563150|NCT00144339||Parallel Assignment||Treatment||||||||
1563151|NCT00144326|Randomized|Parallel Assignment||Treatment||Double||||||
1563152|NCT00144313|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563153|NCT00144300|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1563154|NCT00144287|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563155|NCT00144274|Randomized|Parallel Assignment||Treatment||Double||||||
1563156|NCT00144261||||Prevention||||||||
1563157|NCT00144248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563158|NCT00144235|Randomized|Parallel Assignment||Treatment||Double||||||
1563159|NCT00144222|Randomized|Parallel Assignment||Treatment||Double||||||
1563160|NCT00144209|Randomized|Crossover Assignment||Treatment||Double||||||
1563161|NCT00144196|Randomized|Parallel Assignment||Treatment||Double||||||
1563162|NCT00144183|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563163|NCT00144170||Parallel Assignment||Treatment||||||||
1563164|NCT00144157|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563165|NCT00144144|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563166|NCT00144131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563167|NCT00144118|Randomized|Parallel Assignment||Treatment||Single||||||
1563168|NCT00144105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563169|NCT00144092|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563170|NCT00144079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563171|NCT00144066|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563172|NCT00144053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563173|NCT00144040|Randomized|Factorial Assignment||||None (Open Label)||||||
1563174|NCT00144027|Randomized|Parallel Assignment||||Single||||||t
1563175|NCT00144014|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563176|NCT00144001|||Cohort||Retrospective|||||||
1563177|NCT00143988|||Case-Only||Prospective|||||||
1563178|NCT00143975|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563179|NCT00143962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563180|NCT00143949|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1563181|NCT00143936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563182|NCT00143923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563183|NCT00143910|||Cohort||Prospective|||||||
1563184|NCT00143884|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1563185|NCT00143871|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563186|NCT00143858|||Ecologic or Community||Prospective|||||||
1563187|NCT00143845||Single Group Assignment||Treatment||None (Open Label)||||||
1563188|NCT00143832|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1563189|NCT00143819|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563190|NCT00143806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563191|NCT00143793|||Cohort||Prospective|||||||
1563192|NCT00143780|Randomized|Single Group Assignment||Prevention||Double||||||
1563193|NCT00143767|||Case Control, Natural History||Longitudinal, Prospective|||||||
1563194|NCT00143754|Randomized|Parallel Assignment||||Single||||||
1563195|NCT00143741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563196|NCT00143728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563197|NCT00143715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563198|NCT00143702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563199|NCT00143689|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563200|NCT00143676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563201|NCT00143663|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563202|NCT00143650|Non-Randomized|Crossover Assignment||Prevention||Double||||||
1563203|NCT00143637|Non-Randomized|Crossover Assignment||Prevention||Triple|||t||t|t
1563204|NCT00143624|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563205|NCT00143611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563206|NCT00143598|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1563207|NCT00143585|Randomized|Parallel Assignment||Treatment||Double||||||
1563208|NCT00143572||Single Group Assignment||Treatment||None (Open Label)||||||
1563209|NCT00143559|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563210|NCT00143546||||||||||||
1563211|NCT00143533||Single Group Assignment||Treatment||None (Open Label)||||||
1563212|NCT00143520|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563213|NCT00143507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563214|NCT00143494|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1563215|NCT00143481|Randomized|Parallel Assignment||Treatment||Double||||||
1568275|NCT00003976||||Treatment||||||||
1563216|NCT00143468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563217|NCT00143455|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563218|NCT00143442|Randomized|Parallel Assignment||Treatment||Double||||||
1563219|NCT00143429|Randomized|Crossover Assignment||Treatment||Single||||||
1563220|NCT00143416|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563221|NCT00143403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563222|NCT00143390|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563223|NCT00143377|Randomized|Parallel Assignment||Treatment||Double||||||
1563224|NCT00143364|Randomized|Parallel Assignment||Treatment||Double||||||
1563225|NCT00143351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563226|NCT00143338|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563227|NCT00143325|Randomized|Parallel Assignment||Treatment||Double||||||
1563228|NCT00143312|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563229|NCT00143299|Randomized|Parallel Assignment||Treatment||Double||||||
1563230|NCT00143286|Randomized|Parallel Assignment||Treatment||Double||||||
1563231|NCT00143273|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563232|NCT00143260|Randomized|Parallel Assignment||Treatment||Double||||||
1563233|NCT00143247|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563234|NCT00143234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563235|NCT00143221|Randomized|Parallel Assignment||Treatment||Double||||||
1563236|NCT00143208|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563237|NCT00143195|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563238|NCT00143182|Non-Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563239|NCT00143169|Randomized|Parallel Assignment||Treatment||Double||||||
1563240|NCT00143156|Randomized|Parallel Assignment||Treatment||Double||||||
1563241|NCT00143143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563242|NCT00143130|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563243|NCT00143117|Randomized|Parallel Assignment||Treatment||Double||||||
1563244|NCT00143104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563245|NCT00143091|Randomized|Parallel Assignment||Treatment||Double||||||
1563246|NCT00143078|||Cohort||Prospective|||||||
1563247|NCT00143065||Single Group Assignment||Treatment||None (Open Label)||||||
1563248|NCT00143052|||Case Control||Prospective|||||||
1563249|NCT00143039|||Case Control||Prospective|||||||
1563250|NCT00143026|Randomized|Parallel Assignment||Treatment||Double||||||
1563251|NCT00143013|||||Prospective|||||||
1563252|NCT00143000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563253|NCT00142987|Randomized|Parallel Assignment||Treatment||Double||||||
1563254|NCT00142974|Randomized|Parallel Assignment||||Double||||||
1563255|NCT00142961|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563256|NCT00142948|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563257|NCT00142935|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563258|NCT00142922|Randomized|Parallel Assignment||||None (Open Label)||||||
1563259|NCT00142909|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563260|NCT00142896|Randomized|Crossover Assignment||Treatment||Double||||||
1563261|NCT00142883|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1563262|NCT00142870|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563263|NCT00142844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563264|NCT00142831|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563265|NCT00142818|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563266|NCT00142805|Randomized|Parallel Assignment||Treatment||Double||||||
1563267|NCT00142792|Randomized|Parallel Assignment||Treatment||Single||||||t
1563268|NCT00142779|Randomized|Parallel Assignment||Treatment||Double||||||
1563269|NCT00142766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563270|NCT00142753|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563271|NCT00142740|||Case-Control||Prospective|||||||
1563272|NCT00142727|Randomized|Parallel Assignment||Treatment||Double||||||
1563273|NCT00142714|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1563274|NCT00142701|Randomized|||Prevention||||||||
1563275|NCT00142688|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563276|NCT00142675|Randomized|||Prevention||||||||
1563277|NCT00142662|Randomized|||Prevention||||||||
1563278|NCT00142649||||Prevention||||||||
1563279|NCT00142636|||Defined Population|Screening|Longitudinal, Prospective|||||||
1563280|NCT00142623|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563281|NCT00142610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563282|NCT00142597|Randomized|Parallel Assignment||Treatment||Single|||t|||
1563283|NCT00142584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563284|NCT00142571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563285|NCT00142558|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563286|NCT00142545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563287|NCT00142532|Randomized|Parallel Assignment||Treatment||Single|||t|||
1563288|NCT00142519|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563289|NCT00142506|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1563290|NCT00142493|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563291|NCT00142480||Single Group Assignment||Treatment||None (Open Label)||||||
1569455|NCT00003852||||Treatment||||||||
1563292|NCT00142467||Single Group Assignment||Treatment||None (Open Label)||||||
1563293|NCT00142454|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563294|NCT00142441|Randomized|Single Group Assignment||Treatment||Single||||||
1563295|NCT00142428||Single Group Assignment||Treatment||None (Open Label)||||||
1563296|NCT00142415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563297|NCT00142402|Randomized|Crossover Assignment||Treatment||Double||||||
1563298|NCT00142389|Randomized|Parallel Assignment||Prevention||Double||||||
1563299|NCT00142376|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1563300|NCT00142363|||Case Control, Natural History||Longitudinal, Prospective|||||||
1563301|NCT00142350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563302|NCT00142337|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563303|NCT00142324|Randomized|Single Group Assignment||Prevention||Double||||||
1563304|NCT00142311|||Case Control, Natural History||Longitudinal, Prospective|||||||
1563305|NCT00142298|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563306|NCT00142285|Randomized|Parallel Assignment||Treatment||Double||||||
1563307|NCT00142272|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563308|NCT00142259|Randomized|Parallel Assignment||Treatment||Double||||||
1563309|NCT00142246|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1563310|NCT00142233|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563311|NCT00142220|Randomized|Parallel Assignment||Treatment||Double||||||
1563312|NCT00142207|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1563313|NCT00142194|||Case Control||Cross-Sectional|||||||
1563314|NCT00142181|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563315|NCT00142168||Single Group Assignment||Treatment||None (Open Label)||||||
1563316|NCT00142155||||||||||||
1563317|NCT00142129|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563318|NCT00142116||Single Group Assignment||Treatment||None (Open Label)||||||
1563319|NCT00142103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563320|NCT00142090|Randomized|||Treatment||Quadruple|||t|t|t|t
1563321|NCT00142077|Randomized|Parallel Assignment||Prevention||Single||||||
1563322|NCT00142064|Randomized|Parallel Assignment||Treatment||Single||||||
1563323|NCT00142051|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563324|NCT00142038|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563325|NCT00142025|Randomized|Parallel Assignment||Treatment||Double||||||
1563326|NCT00142012|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563327|NCT00141999|||||Prospective|||||||
1563328|NCT00141986|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563329|NCT00141973|||||Prospective|||||||
1563330|NCT00141960|Randomized|Parallel Assignment||Treatment||Double||||||
1563331|NCT00141947|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563332|NCT00141934|Randomized|Parallel Assignment||Treatment||Double||||||
1563333|NCT00141921||Single Group Assignment||Treatment||None (Open Label)||||||
1563334|NCT00141908|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1563335|NCT00141895|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563336|NCT00141882|Randomized|Parallel Assignment||Treatment||Double||||||
1563337|NCT00141869||||||||||||
1563338|NCT00141856|Randomized|Parallel Assignment||||None (Open Label)||||||
1563339|NCT00141843|Randomized|Crossover Assignment||Prevention||Double||||||
1563340|NCT00141830|Randomized|Parallel Assignment||Treatment||Double||||||
1563341|NCT00141817|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563342|NCT00141804|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563343|NCT00141791|Randomized|Parallel Assignment||Treatment||Double||||||
1563344|NCT00141778|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1563345|NCT00141765||Single Group Assignment||Treatment||None (Open Label)||||||
1563346|NCT00141752|||Cohort||Prospective|||||||
1563347|NCT00141739||Single Group Assignment||Treatment||None (Open Label)||||||
1563348|NCT00141726||Single Group Assignment||Treatment||None (Open Label)||||||
1563349|NCT00141713||Single Group Assignment||Treatment||None (Open Label)||||||
1563350|NCT00141700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563351|NCT00141687|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563352|NCT00141674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563353|NCT00141661|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563354|NCT00141648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563355|NCT00141635|||Defined Population||Longitudinal, Prospective|||||||
1563356|NCT00141622|Randomized|Crossover Assignment||Prevention||Double||||||
1563357|NCT00141609|Randomized|Crossover Assignment||Treatment||Double||||||
1563358|NCT00141596|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563359|NCT00141583|Randomized|Crossover Assignment||||None (Open Label)||||||
1563360|NCT00141570|Randomized|Parallel Assignment||Treatment||Double||||||
1563361|NCT00141557|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563362|NCT00141544|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563363|NCT00141531||Single Group Assignment||Treatment||None (Open Label)||||||
1563364|NCT00141518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563365|NCT00141505|Randomized|Parallel Assignment||Treatment||Double||||||
1563366|NCT00141492|Randomized|Parallel Assignment||Treatment||Double||||||
1563367|NCT00141479|Randomized|Single Group Assignment||Treatment||Double||||||
1569456|NCT00003683||||Treatment||||||||
1563369|NCT00141453|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563370|NCT00141440|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563371|NCT00141427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563372|NCT00141414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563373|NCT00141401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563374|NCT00141388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563375|NCT00141375|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563376|NCT00141362|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563377|NCT00141349|Randomized|Parallel Assignment||Treatment||Double||||||
1563378|NCT00141336|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563379|NCT00141323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563380|NCT00141310|Randomized|Parallel Assignment||Treatment||Double||||||
1563381|NCT00141297|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563382|NCT00141284|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563383|NCT00141271|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563384|NCT00141258|Randomized|Parallel Assignment||Treatment||Double||||||
1563385|NCT00141245|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563386|NCT00141232|Randomized|Factorial Assignment||Treatment||Double||||||
1563387|NCT00141219|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563388|NCT00141206|Randomized|Parallel Assignment||Treatment||Double||||||
1563389|NCT00141193|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563390|NCT00141180|Randomized|Parallel Assignment||Treatment||Double||||||
1563391|NCT00141167|Randomized|Parallel Assignment||Treatment||Double||||||
1563392|NCT00141154|Randomized|Parallel Assignment||Treatment||Double||||||
1563393|NCT00141141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563394|NCT00141128|Randomized|Crossover Assignment||Treatment||Double||||||
1563395|NCT00141115||Single Group Assignment||Treatment||None (Open Label)||||||
1563396|NCT00141102|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1563397|NCT00141089|Randomized|Parallel Assignment||Treatment||Double||||||
1563398|NCT00141076|Randomized|Crossover Assignment||Prevention||Single||||||
1563399|NCT00141063|Randomized|Crossover Assignment||Treatment||Double||||||
1563400|NCT00141050|Randomized|Crossover Assignment||Prevention||Double||||||
1563401|NCT00141037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563402|NCT00141024|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1563403|NCT00141011|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563404|NCT00140998|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563405|NCT00140985|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563406|NCT00140972|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563407|NCT00140959|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563408|NCT00140946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563409|NCT00140933|Randomized|Parallel Assignment||Treatment||Double||||||
1563410|NCT00140920|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563411|NCT00140907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563412|NCT00140894|Randomized|Parallel Assignment||Treatment||Double||||||
1563413|NCT00140881|Randomized|Parallel Assignment||Treatment||Double||||||
1563414|NCT00140868|Randomized|Parallel Assignment||||None (Open Label)||||||
1563415|NCT00140855|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563416|NCT00140842|||Case Control||Cross-Sectional|||||||
1563417|NCT00140829|||Family-Based||Prospective|||||||
1563418|NCT00140816|Randomized|Parallel Assignment||||None (Open Label)||||||
1563419|NCT00140803|Randomized|Single Group Assignment||Treatment||Single||||||
1563420|NCT00140790|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563421|NCT00140764|Randomized|Single Group Assignment||Treatment||Double||||||
1563422|NCT00140751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563423|NCT00140738|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563424|NCT00140725|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563425|NCT00140712|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563426|NCT00140699|||Case Control|Screening|Longitudinal, Prospective|||||||
1563427|NCT00140686|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1563428|NCT00140673|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1563429|NCT00140660|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563430|NCT00140647|Randomized|Factorial Assignment||Prevention||Double||||||
1563431|NCT00140634|||Case-Only||Other|||||||
1563432|NCT00140621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563433|NCT00140608|Randomized|Parallel Assignment||Treatment||Single||||||
1563434|NCT00140595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563435|NCT00140582|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563436|NCT00140569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563437|NCT00140556||Parallel Assignment||Treatment||None (Open Label)||||||
1563438|NCT00140543|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563439|NCT00140530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563440|NCT00140517|Randomized|Single Group Assignment||Treatment||Single||||||
1563441|NCT00140504|Randomized|Single Group Assignment||Prevention||Single|||t|||
1563442|NCT00140491|Randomized|Parallel Assignment||Treatment||Double||||||
1563443|NCT00140478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563444|NCT00140465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563445|NCT00140452|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563446|NCT00140439|Randomized|Single Group Assignment||Treatment||Single||||||t
1563447|NCT00140426|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563448|NCT00140413|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563449|NCT00140400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563450|NCT00140387|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563451|NCT00140374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563452|NCT00140361|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563453|NCT00140348|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563454|NCT00140335|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563455|NCT00140322|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563456|NCT00140309|Randomized|Factorial Assignment||Treatment||Double||||||
1563457|NCT00140296|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1563458|NCT00140283|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1563459|NCT00140270|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563460|NCT00140257|Randomized|Parallel Assignment||Prevention||Double||||||
1563461|NCT00140244|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1563462|NCT00140231|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1563463|NCT00140218|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563464|NCT00140205||Single Group Assignment||Diagnostic||None (Open Label)||||||
1563465|NCT00140192|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1563466|NCT00140179|Randomized|Parallel Assignment||Treatment||Double||||||
1563467|NCT00140166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563468|NCT00140153|Randomized|Crossover Assignment||Treatment||Double||||||
1563469|NCT00140140|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563470|NCT00140114|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563471|NCT00140101|Randomized|Parallel Assignment||Prevention||Single|||t|||
1563472|NCT00140088|Randomized|Parallel Assignment||Treatment||Double||||||
1563473|NCT00140075|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563474|NCT00140062|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563475|NCT00140049|Randomized|Parallel Assignment||Treatment||Single||||||
1563476|NCT00140036|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563477|NCT00140023|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563478|NCT00140010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563479|NCT00139997|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563480|NCT00139984|Randomized|Parallel Assignment||Treatment||Single||||||
1563481|NCT00139971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563482|NCT00139958|||Case Control||Prospective|||||||
1563483|NCT00139945|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1563484|NCT00139932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563485|NCT00139919|Randomized|Single Group Assignment||Treatment||Double||||||
1563486|NCT00139906|Randomized|Single Group Assignment||Treatment||Double||||||
1563487|NCT00139893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563488|NCT00139880|Randomized|Crossover Assignment||||Double||||||
1563489|NCT00139867|Randomized|Crossover Assignment||||None (Open Label)||||||
1563490|NCT00139854|Randomized|Crossover Assignment||||None (Open Label)||||||
1563491|NCT00139841||Single Group Assignment||Treatment||None (Open Label)||||||
1563492|NCT00139828|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563493|NCT00139815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563494|NCT00139802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563495|NCT00139789|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563496|NCT00139776|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563497|NCT00139763|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1563498|NCT00139750|Randomized|Parallel Assignment||Treatment||Double||||||
1563499|NCT00139737|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563500|NCT00139724|Randomized|Parallel Assignment||Treatment||Double||||||
1563501|NCT00139711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563502|NCT00139698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563503|NCT00139685|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1563504|NCT00139672|Randomized|Parallel Assignment||Treatment||Double||||||
1563505|NCT00139659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563506|NCT00139646|Randomized|Parallel Assignment||Treatment||Single||||||
1563507|NCT00139633|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563508|NCT00139620|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563509|NCT00139607|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563510|NCT00139594||Single Group Assignment||Treatment||None (Open Label)||||||
1563511|NCT00139581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563512|NCT00139568|Randomized|Parallel Assignment||Treatment||Double||||||
1563513|NCT00139555|Randomized|Parallel Assignment||Treatment||Double||||||
1563514|NCT00139542|Randomized|Parallel Assignment||Treatment||Single||||||t
1569711|NCT00003811||||Treatment||||||||
1563515|NCT00139529|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563516|NCT00139516|Randomized|||Prevention||||||||
1563517|NCT00139490|Randomized|Parallel Assignment||Treatment||Single||||||t
1563518|NCT00139477|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563519|NCT00139451|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563520|NCT00139438|Randomized|Parallel Assignment||||None (Open Label)||||||
1563521|NCT00139425|Randomized|Parallel Assignment||||None (Open Label)||||||
1563522|NCT00139399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563523|NCT00139386|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563524|NCT00139373|Randomized|Crossover Assignment||Treatment||Double||||||
1563525|NCT00139360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563526|NCT00139347|Randomized|Parallel Assignment||Prevention||Double||||||
1563527|NCT00139334|Randomized|Parallel Assignment||Prevention||Double||||||
1563528|NCT00139321|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1563529|NCT00139308|Randomized|Crossover Assignment||Treatment||Double||||||
1563530|NCT00139295|Randomized|Parallel Assignment||Treatment||Double||||||
1563531|NCT00139282|Randomized|Parallel Assignment||Treatment||Double||||||
1563532|NCT00139269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563533|NCT00139256|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1563534|NCT00139243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563535|NCT00139230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563536|NCT00139217|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563537|NCT00139204|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1563538|NCT00139191|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1563539|NCT00139178|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563540|NCT00139165|Randomized|Parallel Assignment||Treatment||Double||||||
1563541|NCT00139152|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563542|NCT00139139|Randomized|Single Group Assignment||Prevention||Double||||||
1563543|NCT00139126|Randomized|Parallel Assignment||||Single|||t|||
1563544|NCT00139113|Randomized|Single Group Assignment||Prevention||Single|||t|||
1563545|NCT00139100|Randomized|Single Group Assignment||Prevention||Double||||||
1563546|NCT00139087|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563547|NCT00139074|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563548|NCT00139061|Randomized|Parallel Assignment||Treatment||Double||||||
1563549|NCT00139048|Randomized|Parallel Assignment||Other||Double||||||
1563550|NCT00139035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563551|NCT00139022|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563552|NCT00139009|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563553|NCT00138996|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563554|NCT00138983|Randomized|Parallel Assignment||Prevention||Double||||||
1563555|NCT00138970|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563556|NCT00138957|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563557|NCT00138944|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563558|NCT00138931|||Family-Based|||||||||
1563559|NCT00138918|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563560|NCT00138905|Randomized|Crossover Assignment||Prevention||Double||||||
1563561|NCT00138892|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1563562|NCT00138879|||Case Control, Natural History||Longitudinal, Prospective|||||||
1563563|NCT00138866|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563564|NCT00138853|Randomized|Parallel Assignment||Treatment||Single|||t|||
1563565|NCT00138840|Randomized|Parallel Assignment||Treatment||Double||||||
1563566|NCT00138827|Randomized|Parallel Assignment||Treatment||Single||||||
1563567|NCT00138814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563568|NCT00138801|Randomized|Parallel Assignment||Diagnostic||Quadruple|||t|t|t|t
1563569|NCT00138788|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563570|NCT00138775|Randomized|Parallel Assignment||Treatment||Double||||||
1563571|NCT00138762|Randomized|Parallel Assignment||Treatment||Double||||||
1563572|NCT00138749|Randomized|Parallel Assignment||Treatment||Double||||||
1563573|NCT00138736|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563574|NCT00138723|Randomized|Parallel Assignment||||Double||||||
1563575|NCT00138710|Randomized|Parallel Assignment||Treatment||Double||||||
1563576|NCT00138697|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563577|NCT00138684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563578|NCT00138671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563579|NCT00138658||Single Group Assignment||Treatment||None (Open Label)||||||
1563580|NCT00138645|Randomized|Parallel Assignment||Treatment||Single|||||t|
1563581|NCT00138632|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563582|NCT00138619|Randomized|Parallel Assignment||Treatment||Double||||||
1563583|NCT00138606|Randomized|Parallel Assignment||Treatment||Double||||||
1563584|NCT00138593|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563585|NCT00138580|Randomized|Parallel Assignment||Treatment||Double||||||
1563586|NCT00138567|Randomized|Parallel Assignment||Treatment||Double||||||
1563587|NCT00138554|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563588|NCT00138541|Randomized|Parallel Assignment||Treatment||Double||||||
1563589|NCT00138528|Randomized|Crossover Assignment||Treatment||Double||||||
1563590|NCT00138515|Randomized|Parallel Assignment||Treatment||Double||||||
1563591|NCT00138502|||||Prospective|||||||
1563592|NCT00138489|||||Prospective|||||||
1563593|NCT00138476|Randomized|Parallel Assignment||||Double|||t||t|
1563594|NCT00138463|||Cohort||Prospective|||||||
1563595|NCT00138450|||||Prospective|||||||
1563596|NCT00138437|||Cohort||Cross-Sectional|||||||
1563597|NCT00138424|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563598|NCT00138411|Randomized|Single Group Assignment||Treatment||Double||||||
1563599|NCT00138398|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563600|NCT00138385|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563601|NCT00138372|||||Prospective|||||||
1563602|NCT00138359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563603|NCT00138346|||||Prospective|||||||
1563604|NCT00138333|||||Prospective|||||||
1563605|NCT00138320|||||Prospective|||||||
1563606|NCT00138307|||||Prospective|||||||
1563607|NCT00138294|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563608|NCT00138281|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563609|NCT00138268|||||Prospective|||||||
1563610|NCT00138255|||||Prospective|||||||
1563611|NCT00138242||||Treatment||None (Open Label)||||||
1563612|NCT00138229||||Treatment||None (Open Label)||||||
1563613|NCT00138216||Single Group Assignment||Treatment||None (Open Label)||||||
1563614|NCT00138203||Single Group Assignment||Treatment||None (Open Label)||||||
1563615|NCT00138177||Single Group Assignment||Treatment||None (Open Label)||||||
1563616|NCT00138164||||Treatment||None (Open Label)||||||
1563617|NCT00138151||Single Group Assignment||Treatment||None (Open Label)||||||
1563618|NCT00138138|Randomized|Parallel Assignment||Treatment||Double||||||
1563619|NCT00138125||Single Group Assignment||Treatment||None (Open Label)||||||
1563620|NCT00138112|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563621|NCT00138099|||Defined Population|Screening|Longitudinal, Prospective|||||||
1563622|NCT00138086|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563623|NCT00138073|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1563624|NCT00138060|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563625|NCT00138047|Randomized|Single Group Assignment||Treatment||Double||||||
1563626|NCT00138034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563627|NCT00138021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563628|NCT00138008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563629|NCT00137995|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563630|NCT00137982|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563631|NCT00137969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563632|NCT00137956|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563633|NCT00137943|Randomized|Parallel Assignment||||None (Open Label)||||||
1563634|NCT00137930|Randomized|Parallel Assignment||Prevention||Double||||||
1563635|NCT00137917|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563636|NCT00137904|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1563637|NCT00137891||Parallel Assignment||Treatment||Single||||||
1563638|NCT00137878|Randomized|||Treatment||||||||
1563639|NCT00137865|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563640|NCT00137852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563641|NCT00137839||Single Group Assignment||Treatment||None (Open Label)||||||
1563642|NCT00137826|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563643|NCT00137813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563644|NCT00137800|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563645|NCT00137787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563646|NCT00137774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563647|NCT00137761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563648|NCT00137748|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563649|NCT00137735|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563650|NCT00137722|||||Retrospective|||||||
1563651|NCT00137709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563652|NCT00137696|Randomized|Single Group Assignment||Educational/Counseling/Training||Double||||||
1563653|NCT00137683|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563654|NCT00137670|Non-Randomized|Single Group Assignment||Prevention||Single||||||
1563655|NCT00137657|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1563656|NCT00137644|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563657|NCT00137631|Randomized|Parallel Assignment||||None (Open Label)||||||
1563658|NCT00137618|Randomized|Single Group Assignment||||None (Open Label)||||||
1563659|NCT00137605|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1563660|NCT00137592||Single Group Assignment||Prevention||None (Open Label)||||||
1563661|NCT00137579|Randomized|Parallel Assignment||Treatment||Single||||||
1563662|NCT00137566|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563663|NCT00137553|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563664|NCT00137540|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563665|NCT00137527|Randomized|Factorial Assignment||Prevention||Single||||||
1565084|NCT00118664|||Cohort||Prospective|||||||
1563666|NCT00137514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563667|NCT00137501|Randomized|Single Group Assignment||Treatment||Single||||||t
1563668|NCT00137488|||Case-Only||Prospective|||||||
1563669|NCT00137475||Single Group Assignment||Treatment||None (Open Label)||||||
1563670|NCT00137462|Randomized|Parallel Assignment||Treatment||Double||||||
1563671|NCT00137449|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563672|NCT00137436|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563673|NCT00137423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563674|NCT00137410|Randomized|Parallel Assignment||Treatment||Double||||||
1563675|NCT00137397|Randomized|Parallel Assignment||Treatment||Double||||||
1563676|NCT00137384|||||Prospective|||||||
1563677|NCT00137371|Randomized|Parallel Assignment||Treatment||Double||||||
1563678|NCT00137358||Single Group Assignment||Treatment||None (Open Label)||||||
1563679|NCT00137345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563680|NCT00137332|Randomized|Parallel Assignment||Treatment||Double||||||
1563681|NCT00137319|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563682|NCT00137306|Randomized|Parallel Assignment||||None (Open Label)||||||
1563683|NCT00137293|Randomized|Parallel Assignment||||Double||||||
1563684|NCT00137280|Non-Randomized|Factorial Assignment||Health Services Research||Single|research assessors had minimal contact with staff involved in implementation|||||t
1563685|NCT00137267|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563686|NCT00137254|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563687|NCT00137241||||||||||||
1563688|NCT00137228|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1563689|NCT00137215|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563690|NCT00137202|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1563691|NCT00137189|Randomized|Parallel Assignment||Treatment||Single||||||t
1563692|NCT00137176|Randomized|Parallel Assignment||||Double|||t||t|
1563693|NCT00137163|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563694|NCT00137150|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563695|NCT00137137|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563696|NCT00137124|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1563697|NCT00137111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563698|NCT00137098|||Cohort||Prospective|||||||
1563699|NCT00137085|Randomized|Parallel Assignment||Treatment||Double||||||
1563700|NCT00137072|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563701|NCT00137059|Randomized|Parallel Assignment||||Double||||||
1563702|NCT00137046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563703|NCT00137033|Randomized|Parallel Assignment||Prevention||Double||||||
1563704|NCT00137020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563705|NCT00137007|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563706|NCT00136994|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563707|NCT00136981|Randomized|Parallel Assignment||Treatment||Double||||||
1563708|NCT00136968|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1563709|NCT00136955|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563710|NCT00136942|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563711|NCT00136929|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563712|NCT00136916|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563713|NCT00136903|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563714|NCT00136890|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1563715|NCT00136877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563716|NCT00136864|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1563717|NCT00136851|Randomized|Parallel Assignment||Treatment||Double||||||
1563718|NCT00136838|Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1563719|NCT00136825|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1563720|NCT00136812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563721|NCT00136799|Randomized|Parallel Assignment||Treatment||Double||||||
1563722|NCT00136786|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1563723|NCT00136773|Randomized|Parallel Assignment||Treatment||Double||||||
1563724|NCT00136760|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1563725|NCT00136747|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1563726|NCT00136734|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563727|NCT00136721|||||Prospective|||||||
1563728|NCT00136708|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1563729|NCT00136695|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563730|NCT00136682|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563731|NCT00136669|Randomized|Parallel Assignment||Treatment||Single||||||
1563732|NCT00136656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563733|NCT00136643|Randomized|Parallel Assignment||Prevention||Double||||||
1563734|NCT00136630|||Family-Based||Prospective|||||||
1563735|NCT00136617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563736|NCT00136604|Randomized|Parallel Assignment||Prevention||Single||||t||
1563737|NCT00136591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563738|NCT00136578|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563739|NCT00136565||Single Group Assignment||Treatment||None (Open Label)||||||
1565085|NCT00118651|||||Prospective|||||||
1563740|NCT00136552|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563741|NCT00136539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563742|NCT00136526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563743|NCT00136513|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563744|NCT00136500|||Other||Prospective|||||||
1563745|NCT00136487|Randomized|Crossover Assignment||Treatment||Double||||||
1563746|NCT00136474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563747|NCT00136461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563748|NCT00136448|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1563749|NCT00136435||Single Group Assignment||Treatment||None (Open Label)||||||
1563750|NCT00136422|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563751|NCT00136409||Single Group Assignment||Treatment||None (Open Label)||||||
1563752|NCT00136396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563753|NCT00136383|Randomized|Parallel Assignment||Treatment||Double||||||
1563754|NCT00136370|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1563755|NCT00136357|Randomized|Parallel Assignment||||None (Open Label)||||||
1563756|NCT00136344|Randomized|Factorial Assignment||Prevention||Double||||||
1563757|NCT00136331|Randomized|Parallel Assignment||Prevention||Single||||||
1563758|NCT00136318|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1563759|NCT00136305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563760|NCT00136292|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1563761|NCT00136279|Randomized|Parallel Assignment||||None (Open Label)||||||
1563762|NCT00136266|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563763|NCT00136253|Randomized|Parallel Assignment||||None (Open Label)||||||
1563764|NCT00136240|Randomized|Factorial Assignment||||None (Open Label)||||||
1563765|NCT00136227||Single Group Assignment||Prevention||None (Open Label)||||||
1563766|NCT00136214|||Case-Control||Prospective|||||||
1563767|NCT00136201|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563768|NCT00136188||Single Group Assignment||Treatment||Double|||t||t|
1563769|NCT00136175|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563770|NCT00136149|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563771|NCT00136136|||Cohort||Prospective|||||||
1563772|NCT00136123|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563773|NCT00136110|Randomized|Parallel Assignment||Treatment||Double||||||
1563774|NCT00136097|Randomized|Single Group Assignment||Treatment||Double||||||
1563775|NCT00136084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563776|NCT00136071|Randomized|Parallel Assignment||Treatment||Single||||||
1563777|NCT00136058|Randomized|Parallel Assignment||||None (Open Label)||||||
1563778|NCT00136045|Randomized|Parallel Assignment||Treatment||Double||||||
1563779|NCT00136032|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1563780|NCT00136019|Randomized|Parallel Assignment||Treatment||Double||||||
1563781|NCT00136006|||Cohort||Retrospective|||||||
1563782|NCT00135993|Randomized|Parallel Assignment||Treatment||Double||||||
1563783|NCT00135980|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1563784|NCT00135967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563785|NCT00135954|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563786|NCT00135941|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563787|NCT00135928|Randomized|Parallel Assignment||||Double||||||
1563788|NCT00135915|||Case-Crossover||Prospective|||||||
1563789|NCT00135902|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1563790|NCT00135889|Randomized|Parallel Assignment||Treatment||Double||||||
1563791|NCT00135876|Randomized|Parallel Assignment||Prevention||Double||||||
1563792|NCT00135863|Randomized|Crossover Assignment||||Double||||||
1563793|NCT00135850|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563794|NCT00135837|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563795|NCT00135824|Randomized|Parallel Assignment||Treatment||Double||||||
1563796|NCT00135811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563797|NCT00135798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563798|NCT00135785|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563799|NCT00135772|||||Prospective|||||||
1563800|NCT00135759|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1563801|NCT00135746||Crossover Assignment||Treatment||Double||||||
1563802|NCT00135733|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563803|NCT00135720|Randomized|Parallel Assignment||Treatment||Double||||||
1563804|NCT00135707|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1563805|NCT00135694|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563806|NCT00135681||||Treatment||||||||
1563807|NCT00135668|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563808|NCT00135655|Randomized|Parallel Assignment||Treatment||Double||||||
1563809|NCT00135642|Randomized|Parallel Assignment||Treatment||Double||||||
1563810|NCT00135629|Randomized|Parallel Assignment||Treatment||Double||||||
1563811|NCT00135616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563812|NCT00135603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563813|NCT00135590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563814|NCT00135577|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563815|NCT00135564|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563816|NCT00135551|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563817|NCT00135538|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563818|NCT00135525|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563819|NCT00135512|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563820|NCT00135499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563821|NCT00135486|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563822|NCT00135473|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1563823|NCT00135460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563824|NCT00135447|||Cohort||Cross-Sectional|||||||
1563825|NCT00135434|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563826|NCT00135421|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563827|NCT00135408|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1563828|NCT00135395|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563829|NCT00135382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563830|NCT00135369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563831|NCT00135356|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563832|NCT00135343|Randomized|Parallel Assignment||||None (Open Label)||||||
1563833|NCT00135330|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563834|NCT00135317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563835|NCT00135304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563836|NCT00135291|Randomized|Parallel Assignment||Treatment||Double||||||
1563837|NCT00135278|Non-Randomized|Parallel Assignment||Treatment||Single|||t|||
1563838|NCT00135265|Randomized|Single Group Assignment||Prevention||Double||||t|t|
1563839|NCT00135252|Randomized|Parallel Assignment||Treatment||Single||||||
1563840|NCT00135239|Randomized|Parallel Assignment||||None (Open Label)||||||
1563841|NCT00135226|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1563842|NCT00135213|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1563843|NCT00135200||Single Group Assignment||Treatment||None (Open Label)||||||
1563844|NCT00135187|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563845|NCT00135174|||Cohort||Prospective|||||||
1563846|NCT00135161|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563847|NCT00135148||||||||||||
1563848|NCT00135135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563849|NCT00135122|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563850|NCT00135109|Randomized|Parallel Assignment||Treatment||Double||||||
1563851|NCT00135096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563852|NCT00135083|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563853|NCT00135070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563854|NCT00135057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563855|NCT00135044|Randomized|Crossover Assignment||Prevention||Double||||||
1563856|NCT00135031|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563857|NCT00135018|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563858|NCT00135005||Single Group Assignment||Treatment||None (Open Label)||||||
1563859|NCT00134992|Randomized|Crossover Assignment||Treatment||Double||||||
1563860|NCT00134979|Randomized|Parallel Assignment||Treatment||Double||||||
1563861|NCT00134966|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563862|NCT00134953|Randomized|Parallel Assignment||Treatment||Double||||||
1563863|NCT00134940|||Cohort|||||||||
1563864|NCT00134927|||Cohort||Prospective|||||||
1563865|NCT00134914|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1563866|NCT00134901|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563867|NCT00134888|Randomized|Parallel Assignment||Treatment||Double||||||
1563868|NCT00134875|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1563869|NCT00134849|||Defined Population|Screening|Longitudinal, Retrospective|||||||
1563870|NCT00134836|Randomized|Single Group Assignment||Prevention||Double|||||t|t
1563871|NCT00134823|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1563872|NCT00134810|Randomized|Parallel Assignment||Treatment||Double||||||
1563873|NCT00134797|||Defined Population|Screening|Longitudinal, Prospective|||||||
1563874|NCT00134784||Single Group Assignment||Diagnostic||None (Open Label)||||||
1563875|NCT00134771|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1563876|NCT00134758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563877|NCT00134745|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1563878|NCT00134732|Randomized|Parallel Assignment||Prevention||Double||||||
1563879|NCT00134719|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563880|NCT00134706|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563881|NCT00134693|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1563882|NCT00134680||Single Group Assignment||Treatment||None (Open Label)||||||
1563883|NCT00134667|Randomized|Parallel Assignment||Treatment||Double||||||
1563884|NCT00134654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563885|NCT00134641|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563886|NCT00134628|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1563887|NCT00134615|Non-Randomized|Parallel Assignment||Health Services Research||Single||||||t
1563888|NCT00134602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563889|NCT00134589|Randomized|Factorial Assignment||||Single||||||
1569712|NCT00003777||||Treatment||||||||
1563890|NCT00134576|Randomized|Factorial Assignment||||None (Open Label)||||||
1563891|NCT00134563|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563892|NCT00134550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563893|NCT00134537|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563894|NCT00134524|Randomized|Parallel Assignment||Treatment||Double||||||
1563895|NCT00134511|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563896|NCT00134498|Randomized|Parallel Assignment||Treatment||Double||||||
1563897|NCT00134485|Randomized|Parallel Assignment||Treatment||Double||||||
1563898|NCT00134472|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563899|NCT00134459|Randomized|Parallel Assignment||Treatment||Double||||||
1563900|NCT00134446|Randomized|Parallel Assignment||Treatment||Double||||||
1563901|NCT00134433|Randomized|Factorial Assignment||Treatment||Double||||||
1563902|NCT00134420|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1563903|NCT00134407|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1563904|NCT00134394|Randomized|Parallel Assignment||Treatment||Double||||||
1563905|NCT00134381|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563906|NCT00134368|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563907|NCT00134355||Single Group Assignment||Treatment||None (Open Label)||||||
1563908|NCT00134342|||Cohort||Prospective|||||||
1563909|NCT00134329|||||Prospective|||||||
1563910|NCT00134316|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563911|NCT00134303|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1563912|NCT00134290|Randomized|Parallel Assignment||Treatment||Double||||||
1563913|NCT00134277|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563914|NCT00134264|Randomized|Parallel Assignment||Treatment||Double||||||
1563915|NCT00134251|Randomized|Parallel Assignment||Treatment||Double||||||
1563916|NCT00134238|Randomized|Parallel Assignment||Treatment||Double||||||
1563917|NCT00134225|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1563918|NCT00134212|Randomized|Parallel Assignment||Treatment||Single||||||
1563919|NCT00134199|Randomized|Parallel Assignment||Treatment||Double||||||
1563920|NCT00134186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563921|NCT00134173|Randomized|Parallel Assignment||Treatment||Double||||||
1563922|NCT00134160|Randomized|Parallel Assignment||Prevention||Single||||||t
1563923|NCT00134147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563924|NCT00134134|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563925|NCT00134108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563926|NCT00134095||||Treatment||None (Open Label)||||||
1563927|NCT00134082||Single Group Assignment||Treatment||None (Open Label)||||||
1563928|NCT00134069||Single Group Assignment||Treatment||None (Open Label)||||||
1563929|NCT00134056|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1563930|NCT00134043||Single Group Assignment||Treatment||None (Open Label)||||||
1563931|NCT00134030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563932|NCT00134017||Single Group Assignment||Treatment||None (Open Label)||||||
1563933|NCT00134004||Single Group Assignment||Treatment||None (Open Label)||||||
1563934|NCT00133991||Single Group Assignment||Treatment||None (Open Label)||||||
1563935|NCT00133978|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1563936|NCT00133965|||Cohort||Prospective|||||||
1563937|NCT00133952|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1563938|NCT00133939|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563939|NCT00133926|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563940|NCT00133913|||Cohort||Prospective|||||||
1563941|NCT00133900|||Cohort||Prospective|||||||
1563942|NCT00133887|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563943|NCT00133874|Randomized|Single Group Assignment||Treatment||Single|||||t|
1563944|NCT00133861|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563945|NCT00133848|Randomized|||Treatment||Double||||||
1563946|NCT00133835|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1563947|NCT00133822|Randomized|Parallel Assignment||Treatment||Double||||||
1563948|NCT00133809||Single Group Assignment||Treatment||None (Open Label)||||||
1563949|NCT00133796||Single Group Assignment||Treatment||None (Open Label)||||||
1563950|NCT00133783|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1563951|NCT00133770||Single Group Assignment||Treatment||None (Open Label)||||||
1563952|NCT00133757|Randomized|Parallel Assignment||||Double||||||
1563953|NCT00133744|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1563954|NCT00133731|Randomized|Parallel Assignment||Treatment||Double||||||
1563955|NCT00133718|Randomized|Parallel Assignment||Prevention||Single|Patients were randomized to intensive care of standard care, outcomes were assessed by experts who where unaware of group allocation|||||t
1563956|NCT00133705|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563957|NCT00133692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563958|NCT00133679|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563959|NCT00133666|Randomized|Parallel Assignment||||Single|||||t|
1563960|NCT00133653|||Defined Population||Longitudinal, Prospective|||||||
1563961|NCT00133640|Randomized|Factorial Assignment||Prevention||Double||||||
1563962|NCT00133627|Randomized|Parallel Assignment||Treatment||Double||||||
1563963|NCT00133614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563964|NCT00133601|Randomized|Parallel Assignment||Treatment||Single|||t|||
1572267|NCT00019214||||Treatment||||||||
1563965|NCT00133588|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563966|NCT00133575|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1563967|NCT00133562|Randomized|Parallel Assignment||Treatment||Double||||||
1563968|NCT00133549|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1563969|NCT00133536|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1563970|NCT00133523|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1563971|NCT00133510|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1563972|NCT00133497|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1563973|NCT00133484|Randomized|Parallel Assignment||Prevention||Double||||||
1563974|NCT00133471|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1563975|NCT00133458|Randomized|Parallel Assignment||Treatment||Double||||||
1563976|NCT00133445|Randomized|Parallel Assignment||Prevention||Single||||t||
1563977|NCT00133432|Randomized|Parallel Assignment||Treatment||Double||||||
1563978|NCT00133419|Randomized|Parallel Assignment||Treatment||Double||||||
1563979|NCT00133406|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1563980|NCT00133393|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563981|NCT00133380|Randomized|Parallel Assignment||Treatment||Double||||||
1563982|NCT00133367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563983|NCT00133354|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1563984|NCT00133341|Non-Randomized|Single Group Assignment||Diagnostic||Double||||||
1563985|NCT00133328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563986|NCT00133315|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1563987|NCT00133302|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563988|NCT00133289|Randomized|Parallel Assignment||Treatment||Single||||||
1563989|NCT00133276|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1563990|NCT00133263|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1563991|NCT00133250|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563992|NCT00133237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563993|NCT00133224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563994|NCT00133211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1563995|NCT00133198|Randomized|Parallel Assignment||Treatment||Double||||||
1563996|NCT00133185|Randomized|Parallel Assignment||Treatment||Double||||||
1563997|NCT00133172|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1563998|NCT00133159|Randomized|Parallel Assignment||Treatment||Double||||||
1563999|NCT00133146|Randomized|Parallel Assignment||Treatment||Double||||||
1564000|NCT00133133|Randomized|Parallel Assignment||Treatment||Double||||||
1564001|NCT00133107|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564002|NCT00133094|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564003|NCT00133081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564004|NCT00133068|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1564005|NCT00133055|Randomized|Parallel Assignment||Treatment||Single||||||t
1564006|NCT00133042|Randomized|Crossover Assignment||Treatment||Double||||||
1564007|NCT00133029|Randomized|Parallel Assignment||||None (Open Label)||||||
1564008|NCT00133016|Randomized|Parallel Assignment||||None (Open Label)||||||
1564009|NCT00133003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564010|NCT00132990|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1564011|NCT00132977|Randomized|Parallel Assignment||Treatment||Double||||||
1564012|NCT00132964|Randomized|Parallel Assignment||Treatment||Single||||||t
1564013|NCT00132951|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564014|NCT00132938|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564015|NCT00132925|Randomized|Parallel Assignment||Treatment||Double||||||
1564016|NCT00132912|Randomized|Parallel Assignment||Prevention||Double||||||
1564017|NCT00132899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564018|NCT00132886|Randomized|Parallel Assignment||Treatment||Double||||||
1564019|NCT00132873|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1564020|NCT00132860|Randomized|Single Group Assignment||Treatment||Double||||||
1564021|NCT00132847|||Cohort||Prospective|||||||
1564022|NCT00132834|||Case Control||Prospective|||||||
1564023|NCT00132821|Randomized|Factorial Assignment||Treatment||Triple|||t||t|t
1564024|NCT00132808|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564025|NCT00132795|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564026|NCT00132782|||Case-Crossover||Prospective|||||||
1564027|NCT00132769|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564028|NCT00132756|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564029|NCT00132743|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1564030|NCT00132730|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564031|NCT00132717|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564032|NCT00132704|||Cohort||Prospective|||||||
1564033|NCT00132691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564034|NCT00132678|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564035|NCT00132665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564036|NCT00132652|Randomized|Parallel Assignment||Treatment||Double||||||
1564037|NCT00132639|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564038|NCT00132626|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1564039|NCT00132613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564040|NCT00132600|Non-Randomized|Single Group Assignment||Diagnostic||Double||||||
1564041|NCT00132587|Randomized|Parallel Assignment||Treatment||Single||||||
1564042|NCT00132574|Randomized|Parallel Assignment||Prevention||Single||||||
1564043|NCT00132561|Randomized|Single Group Assignment||Prevention||Double||||||
1564044|NCT00132548|Randomized|Single Group Assignment||Prevention||Single||||||
1564045|NCT00132535|Randomized|Single Group Assignment||Prevention||Double||||||
1564046|NCT00132522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564047|NCT00132509|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564048|NCT00132496|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564049|NCT00132483|Randomized|Parallel Assignment||Prevention||Single||||||t
1564050|NCT00132470|Randomized|Single Group Assignment||Treatment||Double||||||
1564051|NCT00132457|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564052|NCT00132444|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1564053|NCT00132431|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1564054|NCT00132418|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564055|NCT00132405|Randomized|Parallel Assignment||Treatment||Double||||||
1564056|NCT00132392|Randomized|Parallel Assignment||Treatment||Double||||||
1564057|NCT00132379||Single Group Assignment||Treatment||None (Open Label)||||||
1564058|NCT00132366||||||||||||
1564059|NCT00132353||||||||||||
1564060|NCT00132340||||Treatment||||||||
1564061|NCT00132327||||||||||||
1564062|NCT00132314|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564063|NCT00132301|Randomized|Parallel Assignment||Treatment||Single|The Endpoint Committee will adjudicate evidence for progression, metastasis, and cause of death. The committee will be blinded to the treatment assignment.|||||t
1564064|NCT00132288|Randomized|Crossover Assignment||||None (Open Label)||||||
1564065|NCT00132275|Randomized|Parallel Assignment||Treatment||Double||||||
1564066|NCT00132262|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1564067|NCT00132249|||Case-Control||Other|||||||
1564068|NCT00132236|Randomized|Parallel Assignment||Treatment||Double||||||
1564069|NCT00132223|Non-Randomized|Single Group Assignment||Diagnostic||Single||||||
1564070|NCT00132210|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564071|NCT00132197|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564072|NCT00132184|Randomized|Parallel Assignment||Treatment||Double||||||
1564073|NCT00132171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564074|NCT00132158||Single Group Assignment||Treatment||None (Open Label)||||||
1564075|NCT00132145|Randomized|Parallel Assignment||||None (Open Label)||||||
1564076|NCT00132132|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564077|NCT00132119|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564078|NCT00132106|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1564079|NCT00132093|Randomized|Parallel Assignment||Treatment||Double||||||
1564080|NCT00132080|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564081|NCT00132067||Single Group Assignment||Treatment||None (Open Label)||||||
1564082|NCT00132054||||Treatment||||||||
1564083|NCT00132041||||Treatment||None (Open Label)||||||
1564084|NCT00132028||Single Group Assignment||Treatment||None (Open Label)||||||
1564085|NCT00132015||||Treatment||None (Open Label)||||||
1564086|NCT00132002||Single Group Assignment||Treatment||None (Open Label)||||||
1564087|NCT00131989||Single Group Assignment||Treatment||None (Open Label)||||||
1564088|NCT00131963|||Cohort||Prospective|||||||
1564089|NCT00131950||||Screening||||||||
1564090|NCT00131937||Single Group Assignment||Treatment||None (Open Label)||||||
1564091|NCT00131924||||Treatment||None (Open Label)||||||
1564092|NCT00131911|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564093|NCT00131898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564094|NCT00131885|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564095|NCT00131872|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564096|NCT00131859|||Case Control||Prospective|||||||
1564097|NCT00131846|Randomized|Parallel Assignment||Prevention||Single||||||t
1564098|NCT00131833|Randomized|Single Group Assignment||Prevention||Double||||||
1564099|NCT00131820|Randomized|Single Group Assignment||Prevention||Double||||||
1564100|NCT00131807|||||Prospective|||||||
1564101|NCT00131794|Randomized|Single Group Assignment||Prevention||Single||||||
1564102|NCT00131781|Randomized|Parallel Assignment||||Single||||||
1564103|NCT00131768|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564104|NCT00131755|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564105|NCT00131742|Randomized|Parallel Assignment||Treatment||Double||||||
1564106|NCT00131729|Randomized|Parallel Assignment||Treatment||Single||||||
1564107|NCT00131716|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1564108|NCT00131703|Randomized|Parallel Assignment||Treatment||Double||||||
1564109|NCT00131690|Randomized|Parallel Assignment||Prevention||Double||||||
1564110|NCT00131677|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1564111|NCT00131664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564112|NCT00131651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564113|NCT00131638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564114|NCT00131625|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564115|NCT00131612|||Case-Only||Prospective|||||||
1564116|NCT00131599|||Case-Only||Prospective|||||||
1564117|NCT00131586|||Case-Only||Prospective|||||||
1572268|NCT00019201||||Screening||||||||
1564118|NCT00131573|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564119|NCT00131560|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564120|NCT00131547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564121|NCT00131534|||Other||Prospective|||||||
1564122|NCT00131521|Randomized|Single Group Assignment||Treatment||Double||||||
1564123|NCT00131508|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1564124|NCT00131495|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564125|NCT00131482|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564126|NCT00131469|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564127|NCT00131456|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1564128|NCT00131443|Randomized|Parallel Assignment||||Double||||||
1564129|NCT00131430|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564130|NCT00131417|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564131|NCT00131404|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564132|NCT00131391|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564133|NCT00131378|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564134|NCT00131365||Single Group Assignment||Treatment||None (Open Label)||||||
1564135|NCT00131352|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1564136|NCT00131339|Randomized|Parallel Assignment||Treatment||Double||||||
1564137|NCT00131326|Randomized|Parallel Assignment||Treatment||Double||||||
1564138|NCT00131313|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564139|NCT00131300|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564140|NCT00131287|Randomized|Parallel Assignment||Treatment||Double||||||
1564141|NCT00131274|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1564142|NCT00131261|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564143|NCT00131248|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1564144|NCT00131235|Randomized|Parallel Assignment||Prevention||Single||||||t
1564145|NCT00131222|Randomized|Parallel Assignment||Treatment||Single||||||
1564146|NCT00131209|Randomized|Parallel Assignment||Prevention||Single||||||
1564147|NCT00131196|||Cohort||Prospective|||||||
1564148|NCT00131183|Randomized|Parallel Assignment||Treatment||Double||||||
1564149|NCT00131170|Randomized|Parallel Assignment||Prevention||Double||||||
1564150|NCT00131157|Randomized|Parallel Assignment||Diagnostic||Single||||||
1564151|NCT00131144|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564152|NCT00131131|Randomized|Parallel Assignment||Prevention||Triple||||t|t|t
1564153|NCT00131118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564154|NCT00131105|Randomized|Parallel Assignment||Treatment||Single||||||
1564155|NCT00131092|Randomized|Parallel Assignment||||Single||||||
1564156|NCT00131079|Randomized|Parallel Assignment||Other||Single||||||t
1564157|NCT00131066|||Case Control||Prospective|||||||
1564158|NCT00131053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564159|NCT00131040|Randomized|Parallel Assignment||Treatment||Double||||||
1564160|NCT00131027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564161|NCT00131014|||Family-Based||Prospective|||||||
1564162|NCT00131001|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1564163|NCT00130988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564164|NCT00130975|Randomized|Parallel Assignment||Treatment||Double||||||
1564165|NCT00130962|Randomized|Parallel Assignment||Treatment||Double||||||
1564166|NCT00130949|Randomized|Parallel Assignment||Treatment||Double||||||
1564167|NCT00130936|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564168|NCT00130923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564169|NCT00130910|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564170|NCT00130897||||||||||||
1564171|NCT00130884|Randomized|Parallel Assignment||Treatment||Double||||||
1564172|NCT00130871|Randomized|Parallel Assignment||Treatment||Double||||||
1564173|NCT00130858|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564174|NCT00130845|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564175|NCT00130832|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564176|NCT00130819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564177|NCT00130806|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564178|NCT00130793|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1564179|NCT00130780|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564180|NCT00130767|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564181|NCT00130754|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564182|NCT00130741|Randomized|Parallel Assignment||Treatment||Double||||||
1564183|NCT00130728|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564184|NCT00130715|Randomized|Parallel Assignment||Treatment||Single||||||
1564185|NCT00130702||Single Group Assignment||Treatment||None (Open Label)||||||
1564186|NCT00130689||Single Group Assignment||Treatment||None (Open Label)||||||
1564187|NCT00130676|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564188|NCT00130663|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1564189|NCT00130650|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1564190|NCT00130637||Single Group Assignment||Treatment||None (Open Label)||||||
1564191|NCT00130624|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564192|NCT00130611|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1564193|NCT00130598|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564194|NCT00130585|Randomized|Parallel Assignment||Prevention||Double||||||
1564195|NCT00130572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564196|NCT00130559|Randomized|Parallel Assignment||||Single|||t|||
1564197|NCT00130546|Randomized|Single Group Assignment||Treatment||Single|||t|||
1564198|NCT00130533|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564199|NCT00130520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564200|NCT00130507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564201|NCT00130494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564202|NCT00130481|Randomized|Crossover Assignment||Prevention||Double||||||
1564203|NCT00130468|Randomized|Parallel Assignment||Treatment||Double||||||
1564204|NCT00130455|Randomized|Parallel Assignment||Treatment||Double||||||
1564205|NCT00130442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564206|NCT00130429|Randomized|Parallel Assignment||Treatment||Double||||||
1564207|NCT00130416|Randomized|Parallel Assignment||||Single||||||
1564208|NCT00130403|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564209|NCT00130390|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1564210|NCT00130377|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1564211|NCT00130364|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564212|NCT00130351|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1564213|NCT00130338|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564214|NCT00130325|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1564215|NCT00130312|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1564216|NCT00130299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564217|NCT00130286|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1564218|NCT00130273|Randomized|Parallel Assignment||Treatment||Single|||||t|
1564219|NCT00130260|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564220|NCT00130247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564221|NCT00130234|Randomized|Parallel Assignment||Treatment||Double||||||
1564222|NCT00130221|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1564223|NCT00130208|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564224|NCT00130195|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564225|NCT00130182|Randomized|Parallel Assignment||Treatment||Double||||||
1564226|NCT00130169|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564227|NCT00130156|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564228|NCT00130143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564229|NCT00130130|||Case-Only||Prospective|||||||
1564230|NCT00130117|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1564231|NCT00130104|Randomized|Single Group Assignment||Treatment||Single||||||t
1564232|NCT00130091|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564233|NCT00130078|Randomized|Parallel Assignment||Prevention||Double||||||
1564234|NCT00130065|Randomized|Parallel Assignment||Treatment||Double||||||
1564235|NCT00130039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564236|NCT00130026|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564237|NCT00130013|Randomized|Parallel Assignment||Treatment||Double||||||
1564238|NCT00130000||||Treatment||||||||
1564239|NCT00129987|Randomized|Single Group Assignment||||None (Open Label)||||||
1564240|NCT00129974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564241|NCT00129961|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564242|NCT00129948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564243|NCT00129935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564244|NCT00129922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564245|NCT00129909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564246|NCT00129896||Single Group Assignment||Treatment||None (Open Label)||||||
1564247|NCT00129883|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1564248|NCT00129870|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1564249|NCT00129857|Randomized|Parallel Assignment||Treatment||Double||||||
1564250|NCT00129844|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564251|NCT00129831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564252|NCT00129818|Randomized|Crossover Assignment||Treatment||Double||||||
1564253|NCT00129805|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564254|NCT00129792|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1564255|NCT00129779|Randomized|Single Group Assignment||||None (Open Label)||||||
1564256|NCT00129766|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564257|NCT00129753||Single Group Assignment||Treatment||None (Open Label)||||||
1564258|NCT00129740||Single Group Assignment||Treatment||None (Open Label)||||||
1564259|NCT00129727||Single Group Assignment||Treatment||None (Open Label)||||||
1564260|NCT00129714|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564261|NCT00129701|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1564262|NCT00129688|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564263|NCT00129675||Single Group Assignment||Diagnostic||Single|||t|||
1564264|NCT00129662||Single Group Assignment||Health Services Research||None (Open Label)||||||
1564265|NCT00129649|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564266|NCT00129636|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1572269|NCT00019136||||Treatment||||||||
1564267|NCT00129623|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564268|NCT00129610|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1564269|NCT00129597|Randomized|Parallel Assignment||Treatment||Double||||||
1564270|NCT00129584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564271|NCT00129571|Non-Randomized|||Treatment||None (Open Label)||||||
1564272|NCT00129558|Non-Randomized|||Treatment||None (Open Label)||||||
1564273|NCT00129545|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564274|NCT00129532|Randomized|Parallel Assignment||Prevention||Double||||||
1564275|NCT00129519|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564276|NCT00129506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564277|NCT00129493|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564278|NCT00129480|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564279|NCT00129467|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1564280|NCT00129454|Randomized|Factorial Assignment||Other||||||||
1564281|NCT00129441|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564282|NCT00129428||Single Group Assignment||Prevention||None (Open Label)||||||
1564283|NCT00129415|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564284|NCT00129402|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1564285|NCT00129389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564286|NCT00129376||Single Group Assignment||Treatment||None (Open Label)||||||
1564287|NCT00129363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564288|NCT00129350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564289|NCT00129337|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564290|NCT00129324|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1564291|NCT00129311|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1564292|NCT00129298|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564293|NCT00129285|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564294|NCT00129272|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564295|NCT00129259|Randomized|Parallel Assignment||Treatment||Single|The staff at Northwest Lipid Research Laboratory were masked to the treatment assignment since they performed the mixed-meal tolerance test (MMTT) and the HgA1C assays. All study staff including the PI were masked to the results of the MMTT. They were notified of a detectable or undetectable fasting C-peptide result to assess for continuation to the next treatment cycle.|||||t
1564296|NCT00129246|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564297|NCT00129233|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564298|NCT00129220|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564299|NCT00129207|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1564300|NCT00129194|Randomized|Single Group Assignment||Treatment||Double||||||
1564301|NCT00129181|Randomized|Parallel Assignment||Diagnostic||Single|||||t|
1564302|NCT00129168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564303|NCT00129155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564304|NCT00129142|Randomized|Factorial Assignment||Prevention||Double||||||
1564305|NCT00129129|Randomized|Parallel Assignment||Prevention||Single|||t|||
1564306|NCT00129116|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1564307|NCT00129090||Single Group Assignment||Treatment||None (Open Label)||||||
1564308|NCT00129077|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564309|NCT00129064|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1564310|NCT00129051|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564311|NCT00129038||||Treatment||||||||
1564312|NCT00129025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564313|NCT00129012||Single Group Assignment||Treatment||None (Open Label)||||||
1564314|NCT00128999|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564315|NCT00128986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564316|NCT00128973||||||||||||
1564317|NCT00128960|||Cohort||Prospective|||||||
1564318|NCT00128947||||Treatment||||||||
1564319|NCT00128934|Randomized|Parallel Assignment||Prevention||Double||||||
1564320|NCT00128921|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564321|NCT00128908|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1564322|NCT00128895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564323|NCT00128882|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564324|NCT00128869|Randomized|Single Group Assignment||Treatment||Single||||||
1564325|NCT00128856||Single Group Assignment||Treatment||None (Open Label)||||||
1564326|NCT00128843|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1564327|NCT00128830||Single Group Assignment||Treatment||None (Open Label)||||||
1564328|NCT00128817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564329|NCT00128804|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1564330|NCT00128791|Randomized|Single Group Assignment||Prevention||Double||||||
1564331|NCT00128778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564332|NCT00128765|Randomized|Parallel Assignment||||Single||||||t
1564333|NCT00128752|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1564334|NCT00128739|Randomized|Single Group Assignment||Treatment||Double||||||
1564335|NCT00128726|||Cohort||Prospective|||||||
1564336|NCT00128713|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564337|NCT00128700|Randomized|||Treatment||None (Open Label)||||||
1564338|NCT00128687|Randomized|Crossover Assignment||Prevention||Single||||||t
1564339|NCT00128661|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1564340|NCT00128635||||Treatment||None (Open Label)||||||
1564341|NCT00128622||Single Group Assignment||Treatment||None (Open Label)||||||
1564342|NCT00128596||||Treatment||None (Open Label)||||||
1564343|NCT00128583||||Treatment||None (Open Label)||||||
1564344|NCT00128570|Randomized|||Prevention||||||||
1564345|NCT00128557|Randomized|Single Group Assignment||Prevention||Double||||||
1564346|NCT00128544|Randomized|Parallel Assignment||Treatment||Double||||||
1564347|NCT00128531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564348|NCT00128518|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1564349|NCT00128505||Single Group Assignment||Treatment||None (Open Label)||||||
1564350|NCT00128492|Non-Randomized|||Treatment||None (Open Label)||||||
1564351|NCT00128479|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564352|NCT00128466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564353|NCT00128453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564354|NCT00128440|Randomized|Crossover Assignment||Treatment||Double||||||
1564355|NCT00128427|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564356|NCT00128414|Randomized|Parallel Assignment||Treatment||Double||||||
1564357|NCT00128401|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564358|NCT00128388|Randomized|Parallel Assignment||Treatment||Single||||||t
1564359|NCT00128375|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564360|NCT00128362|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1564361|NCT00128336|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564362|NCT00128323|Randomized|Parallel Assignment||Treatment||Double||||||
1564363|NCT00128310|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564364|NCT00128297|Randomized|Parallel Assignment||||None (Open Label)||||||
1564365|NCT00128284|||Case Control||Prospective|||||||
1564366|NCT00128271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564367|NCT00128258||Single Group Assignment||Treatment||None (Open Label)||||||
1564368|NCT00128245|Randomized|Parallel Assignment||Treatment||Double||||||
1564369|NCT00128232|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564370|NCT00128219|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1564371|NCT00128206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564372|NCT00128193|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1564373|NCT00128180|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564374|NCT00128167|Randomized|Single Group Assignment||Prevention||Double||||||
1564375|NCT00128154|Randomized|Parallel Assignment||Treatment||Double||||||
1564376|NCT00128141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564377|NCT00128128|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564378|NCT00128115|Randomized|Parallel Assignment||Treatment||Double||||||
1564379|NCT00128102|Randomized|Parallel Assignment||Treatment||Double||||||
1564380|NCT00128089|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564381|NCT00128076|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1564382|NCT00128063|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564383|NCT00128050|Randomized|Parallel Assignment||Treatment||Single|||||t|
1564384|NCT00128037|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564385|NCT00128024|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564386|NCT00128011|Randomized|Single Group Assignment||Prevention||Double||||||
1564387|NCT00127998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564388|NCT00127985|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564389|NCT00127972|Randomized|Single Group Assignment||||None (Open Label)||||||
1564390|NCT00127959|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564391|NCT00127946|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564392|NCT00127933|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564393|NCT00127920||Single Group Assignment||Treatment||None (Open Label)||||||
1564394|NCT00127907|Randomized|Parallel Assignment||Treatment||Double||||||
1564395|NCT00127881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564396|NCT00127868|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564397|NCT00127855|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1564398|NCT00127842||Single Group Assignment||Treatment||None (Open Label)||||||
1564399|NCT00127829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564400|NCT00127816||Single Group Assignment||Treatment||None (Open Label)||||||
1564401|NCT00127803|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1564402|NCT00127790|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564403|NCT00127777|Randomized|Single Group Assignment||Treatment||Double||||||
1564404|NCT00127764|Randomized|Parallel Assignment||Treatment||Double||||||
1564405|NCT00127751|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564406|NCT00127738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564407|NCT00127725|Randomized|Parallel Assignment||Treatment||Double||||||
1564408|NCT00127712|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564409|NCT00127699|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564410|NCT00127686|Randomized|Factorial Assignment||Treatment||Double||||||
1564411|NCT00127673|Randomized|Parallel Assignment||Treatment||Single||||||t
1564412|NCT00127660|Randomized|Factorial Assignment||Other||Single|||t|||
1564413|NCT00127647|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564414|NCT00127634|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564415|NCT00127621|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564416|NCT00127608|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564417|NCT00127595|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564418|NCT00127582|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564419|NCT00127569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564420|NCT00127556|Randomized|Factorial Assignment||||None (Open Label)||||||
1564421|NCT00127543|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1564422|NCT00127530|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564423|NCT00127517|Randomized|Parallel Assignment||Treatment||Double||||||
1564424|NCT00127504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564425|NCT00127491|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564426|NCT00127478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564427|NCT00127465|Randomized|Factorial Assignment||||None (Open Label)||||||
1564428|NCT00127452|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564429|NCT00127439|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564430|NCT00127413|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1564431|NCT00127400|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1564432|NCT00127387|Randomized|Parallel Assignment||Diagnostic||Double||||||
1564433|NCT00127374||||||||||||
1564434|NCT00127361|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564435|NCT00127348|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564436|NCT00127335|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1564437|NCT00127322|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1564438|NCT00127309|Randomized|Parallel Assignment||Treatment||Double||||||
1564439|NCT00127296|Randomized|Crossover Assignment||||None (Open Label)||||||
1564440|NCT00127283|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564441|NCT00127270|Randomized|Parallel Assignment||||None (Open Label)||||||
1564442|NCT00127257|Randomized|Parallel Assignment||Treatment||Single||||||
1564443|NCT00127244|Non-Randomized|Parallel Assignment||Treatment||Single||||||
1564444|NCT00127231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564445|NCT00127218|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564446|NCT00127205|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564447|NCT00127192|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564448|NCT00127179|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564449|NCT00127166|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1564450|NCT00127153|Randomized|Parallel Assignment||Treatment||Double||||||
1564451|NCT00127140||Single Group Assignment||Treatment||None (Open Label)||||||
1564452|NCT00127127|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564453|NCT00127114|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564454|NCT00127101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564455|NCT00127088|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564456|NCT00127075|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564457|NCT00127062|||Cohort||Prospective|||||||
1564458|NCT00127049|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564459|NCT00127036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564460|NCT00127023|Randomized|Parallel Assignment||Prevention||Double||||||
1564461|NCT00127010|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564462|NCT00126997|Randomized|Parallel Assignment||Treatment||Double||||||
1564463|NCT00126984|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564464|NCT00126971|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564465|NCT00126958|||||Prospective|||||||
1564466|NCT00126945|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564467|NCT00126932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564468|NCT00126919|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1564469|NCT00126906|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1564470|NCT00126893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564471|NCT00126880|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564472|NCT00126867|||Cohort||Prospective|||||||
1564473|NCT00126854||Single Group Assignment||Diagnostic||None (Open Label)||||||
1564474|NCT00126841|||Case-Only||Prospective|||||||
1564475|NCT00126828|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564476|NCT00126815|||Case-Only||Retrospective|||||||
1564477|NCT00126802||Single Group Assignment||Treatment||None (Open Label)||||||
1564478|NCT00126789||Single Group Assignment||Treatment||None (Open Label)||||||
1564479|NCT00126776|Randomized|Parallel Assignment||Prevention||Single||||||t
1564480|NCT00126763||Single Group Assignment||Treatment||None (Open Label)||||||
1564481|NCT00126750|Randomized|Parallel Assignment||Health Services Research||Single|||t|||
1564482|NCT00126737|Randomized|Factorial Assignment||Treatment||Single||||||t
1564483|NCT00126724|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564484|NCT00126698|Randomized|Parallel Assignment||Prevention||Double||||||
1564485|NCT00126685|Non-Randomized|||Treatment||None (Open Label)||||||
1564486|NCT00126672||||Treatment||None (Open Label)||||||
1564487|NCT00126659|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564488|NCT00126646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564489|NCT00126633|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564490|NCT00126620|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564491|NCT00126607||Single Group Assignment||Treatment||None (Open Label)||||||
1564492|NCT00126594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564493|NCT00126581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564494|NCT00126568||Single Group Assignment||Treatment||None (Open Label)||||||
1564495|NCT00126555|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564496|NCT00126542||Single Group Assignment||Treatment||None (Open Label)||||||
1564497|NCT00126516|Randomized|Parallel Assignment||Prevention||Single||||||t
1564498|NCT00126503||Single Group Assignment||Treatment||None (Open Label)||||||
1564499|NCT00126490||Single Group Assignment||Treatment||None (Open Label)||||||
1564500|NCT00126477||||||||||||
1564501|NCT00126464|Randomized|||Treatment||||||||
1564502|NCT00126451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564503|NCT00126438||Single Group Assignment||Diagnostic||None (Open Label)||||||
1564504|NCT00126425||Single Group Assignment||Diagnostic||None (Open Label)||||||
1564505|NCT00126412|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1564506|NCT00126399|Randomized|Parallel Assignment||Treatment||Double||||||
1564507|NCT00126386|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564508|NCT00126373|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564509|NCT00126360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564510|NCT00126347|Randomized|Crossover Assignment||Prevention||Double||||||
1564511|NCT00126334|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564512|NCT00126321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564513|NCT00126308|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564514|NCT00126295|Randomized|Single Group Assignment||Educational/Counseling/Training||Double||||||
1564515|NCT00126282|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564516|NCT00126269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564517|NCT00126256|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564518|NCT00126243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564519|NCT00126230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564520|NCT00126217|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564521|NCT00126204|Randomized|Parallel Assignment||Treatment||Double||||||
1564522|NCT00126191|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564523|NCT00126178|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1564524|NCT00126165|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564525|NCT00126152|Randomized|Single Group Assignment||Prevention||Single||||||
1564526|NCT00126139|Randomized|Single Group Assignment||Treatment||Double||||||
1564527|NCT00126126|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564528|NCT00126113|Randomized|Parallel Assignment||||Single|||t|||
1564529|NCT00126100|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564530|NCT00126087|Randomized|Crossover Assignment||Treatment||Double|||||t|t
1564531|NCT00126074|Randomized|Parallel Assignment||Treatment||Double||||||
1564532|NCT00126061|Randomized|Parallel Assignment||Treatment||Double||||||
1564533|NCT00126048|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1564534|NCT00126035|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1564535|NCT00126022|Randomized|Parallel Assignment||Treatment||Double||||||
1564536|NCT00126009|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564537|NCT00125996|Randomized|Parallel Assignment||Treatment||Single||||||
1564538|NCT00125983|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564539|NCT00125970|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1564540|NCT00125957|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1564541|NCT00125944|Randomized|Parallel Assignment||||Double||||||
1564542|NCT00125931||Single Group Assignment||Treatment||None (Open Label)||||||
1564543|NCT00125918|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564544|NCT00125905|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564545|NCT00125892|Randomized|Parallel Assignment||Treatment||Double||||||
1564546|NCT00125879|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564547|NCT00125866|Randomized|Parallel Assignment||Treatment||Double||||||
1564548|NCT00125853|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1564549|NCT00125840||||||||||||
1564550|NCT00125827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564551|NCT00125814|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564552|NCT00125801|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1564553|NCT00125788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564554|NCT00125775|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564555|NCT00125762||Single Group Assignment||Diagnostic||None (Open Label)|Investigator unaware of biopsy results|||||
1564556|NCT00125749||Single Group Assignment||Treatment||None (Open Label)||||||
1564557|NCT00125736|Randomized|Parallel Assignment||Treatment||Double||||||
1564558|NCT00125723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564559|NCT00125710|||Family-Based||Prospective|||||||
1564560|NCT00125697|||Cohort||Prospective|||||||
1572270|NCT00019110||||Treatment||||||||
1564561|NCT00125684|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564562|NCT00125671|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564563|NCT00125658|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1564564|NCT00125645||Single Group Assignment||Prevention||None (Open Label)||Comparison with EF||||
1564565|NCT00125632|Non-Randomized|Crossover Assignment||||Double||||||
1564566|NCT00125619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564567|NCT00125606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564568|NCT00125593|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564569|NCT00125580|Randomized|Parallel Assignment||Prevention||Single|||t|||
1564570|NCT00125567|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564571|NCT00125554|Randomized|Parallel Assignment||Treatment||Double||||||
1564572|NCT00125541|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564573|NCT00125528|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1564574|NCT00125515|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1564575|NCT00125502|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1564576|NCT00125489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564577|NCT00125476|Randomized|Parallel Assignment||||None (Open Label)||||||
1564578|NCT00125463|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564579|NCT00125450|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564580|NCT00125437|Randomized|Parallel Assignment||Treatment||Single||||||
1564581|NCT00125424|Randomized|Parallel Assignment||Treatment||Double||||||
1564582|NCT00125411||Single Group Assignment||Treatment||None (Open Label)||||||
1564583|NCT00125398|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564584|NCT00125385|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564585|NCT00125372||Single Group Assignment||Treatment||None (Open Label)||||||
1564586|NCT00125359||Single Group Assignment||Treatment||None (Open Label)||||||
1564587|NCT00125346|Randomized|||Treatment||Double||||||
1564588|NCT00125333|Randomized|Parallel Assignment||Treatment||Double||||||
1564589|NCT00125320|Randomized|Parallel Assignment||Treatment||Double||||||
1564590|NCT00125307|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564591|NCT00125294|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564592|NCT00125281|Randomized|Crossover Assignment||Treatment||Double||||||
1564593|NCT00125268|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564594|NCT00125255|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564595|NCT00125242|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564596|NCT00125229|||Case-Only||Prospective|||||||
1564597|NCT00125216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564598|NCT00125203|Randomized|Parallel Assignment||Treatment||Double||||||
1564599|NCT00125190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564600|NCT00125177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564601|NCT00125164|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564602|NCT00125151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564603|NCT00125138|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564604|NCT00125125|Randomized|Parallel Assignment||Treatment||Double||||||
1564605|NCT00125112|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564606|NCT00125099|Randomized|Parallel Assignment||Treatment||Double||||||
1564607|NCT00125086|Randomized|Single Group Assignment||Treatment||Double||||||
1564608|NCT00125073|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564609|NCT00125060|Randomized|Parallel Assignment||Prevention||Double||||||
1564610|NCT00125047|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564611|NCT00125034|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564612|NCT00125021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564613|NCT00125008|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564614|NCT00124995|Randomized|Single Group Assignment||Treatment||Double||||||
1564615|NCT00124982|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564616|NCT00124969|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564617|NCT00124956|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564618|NCT00124943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564619|NCT00124930|Randomized|Parallel Assignment||Treatment||Double||||||
1564620|NCT00124917||Single Group Assignment||Treatment||None (Open Label)||||||
1564621|NCT00124904|Randomized|Parallel Assignment||Treatment||Single||||||
1564622|NCT00124891|Randomized|Parallel Assignment||Prevention||Double||||||
1564623|NCT00124878|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564624|NCT00124865|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564625|NCT00124852|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564626|NCT00124839|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1564627|NCT00124826|Randomized|Parallel Assignment||Treatment||Single||||||
1564628|NCT00124813|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564629|NCT00124800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564630|NCT00124787|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1564631|NCT00124774|Randomized|Parallel Assignment||Treatment||Double||||||
1564632|NCT00124761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564633|NCT00124748|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565543|NCT00112567||||Treatment||None (Open Label)||||||
1564634|NCT00124735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564635|NCT00124722|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564636|NCT00124709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564637|NCT00124696|Randomized|Crossover Assignment||Treatment||Double||||||
1564638|NCT00124683|Randomized|Parallel Assignment||Treatment||Double||||||
1564639|NCT00124657||Single Group Assignment||Treatment||None (Open Label)||||||
1564640|NCT00124644||||Treatment||||||||
1564641|NCT00124618||Single Group Assignment||Treatment||None (Open Label)||||||
1564642|NCT00124605||Single Group Assignment||Treatment||None (Open Label)||||||
1564643|NCT00124579||Single Group Assignment||Treatment||None (Open Label)||||||
1564644|NCT00124566|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564645|NCT00124553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564646|NCT00124540|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1564647|NCT00124527|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564648|NCT00124514||Single Group Assignment||Diagnostic||Triple|||t|t|t|
1564649|NCT00124501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564650|NCT00124488|||Case-Only||Retrospective|||||||
1564651|NCT00124475|Randomized|Parallel Assignment||Treatment||Double||||||
1564652|NCT00124462|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1564653|NCT00124449|Randomized|Parallel Assignment||||Double|||t||t|
1564654|NCT00124436|Randomized|Parallel Assignment||||Double||||||
1564655|NCT00124423|||Case-Only||Prospective|||||||
1564656|NCT00124410|||Case-Only||Prospective|||||||
1564657|NCT00124397|Randomized|Parallel Assignment||Prevention||Double||||||
1564658|NCT00124384|Randomized|Parallel Assignment||Treatment||Single||||||
1564659|NCT00124371|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564660|NCT00124358|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564661|NCT00124345|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564662|NCT00124332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564663|NCT00124319|||Cohort||Prospective|||||||
1564664|NCT00124306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564665|NCT00124293|||Cohort||Prospective|||||||
1564666|NCT00124280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564667|NCT00124267|Randomized|Parallel Assignment||Treatment||Double||||||
1564668|NCT00124254|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564669|NCT00124241|Randomized|Parallel Assignment||Treatment||Double||||||
1564670|NCT00124228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564671|NCT00124215|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1564672|NCT00124202||Single Group Assignment||Diagnostic||Triple||||t|t|t
1564673|NCT00124189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564674|NCT00124176|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564675|NCT00124163|Random Sample|||Screening|Longitudinal, Prospective|||||||
1564676|NCT00124150|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1564677|NCT00124137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564678|NCT00124124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564679|NCT00124111|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1564680|NCT00124098|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564681|NCT00124085|Randomized|Parallel Assignment||||Single||||||
1564682|NCT00124072|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1564683|NCT00124059|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1564684|NCT00124046|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1564685|NCT00124033|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1564686|NCT00124020|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564687|NCT00124007|Randomized|Parallel Assignment||Diagnostic||Double||||||
1564688|NCT00123994|Randomized|Parallel Assignment||Treatment||Single||||||
1564689|NCT00123981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564690|NCT00123968|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1564691|NCT00123955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564692|NCT00123942|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564693|NCT00123929|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564694|NCT00123916|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564695|NCT00123903|Randomized|Parallel Assignment||Treatment||Double||||||
1564696|NCT00123890||||Diagnostic||None (Open Label)||||||
1564697|NCT00123877|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564698|NCT00123864|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564699|NCT00123851|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564700|NCT00123838||Single Group Assignment||Treatment||None (Open Label)||||||
1564701|NCT00123825|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564702|NCT00123812||||||||||||
1564703|NCT00123799||Single Group Assignment||Diagnostic||None (Open Label)||||||
1564704|NCT00123786||Single Group Assignment||Diagnostic||None (Open Label)||||||
1564705|NCT00123773||Single Group Assignment||Diagnostic||None (Open Label)||||||
1564706|NCT00123760||Single Group Assignment||Diagnostic||None (Open Label)||||||
1564707|NCT00123747||Single Group Assignment||Diagnostic||None (Open Label)||||||
1564708|NCT00123734|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1564709|NCT00123708||||||||||||
1564710|NCT00123695|||Cohort||Prospective|||||||
1564711|NCT00123682|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1564712|NCT00123669|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564713|NCT00123656|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564714|NCT00123643|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564715|NCT00123630|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564716|NCT00123617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564717|NCT00123604|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564718|NCT00123591|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564719|NCT00123578|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564720|NCT00123565|Randomized|Parallel Assignment||Treatment||Double||||||
1564721|NCT00123552|Randomized|Parallel Assignment||Treatment||Single||||t||
1564722|NCT00123539|Randomized|||Prevention||Double||||||
1564723|NCT00123526|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564724|NCT00123513|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564725|NCT00123500|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564726|NCT00123487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564727|NCT00123474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564728|NCT00123461|Randomized|Parallel Assignment||Treatment||Double||||||
1564729|NCT00123448||||||||||||
1564730|NCT00123435|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564731|NCT00123422|Randomized|Parallel Assignment||Treatment||Single||||||t
1564732|NCT00123409|Randomized|Parallel Assignment||Treatment||Single||||||t
1564733|NCT00123396|Randomized|Parallel Assignment||||Double|||t||t|
1564734|NCT00123383|Randomized|Single Group Assignment||Treatment||Double||||||
1564735|NCT00123370|Randomized|Single Group Assignment||Treatment||Double||||||
1564736|NCT00123357|||||Prospective|||||||
1564737|NCT00123344|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564738|NCT00123331|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564739|NCT00123318||Single Group Assignment||Treatment||None (Open Label)||||||
1564740|NCT00123305|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564741|NCT00123292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564742|NCT00123279|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564743|NCT00123266|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564744|NCT00123253|Randomized|Parallel Assignment||Treatment||Double||||||
1564745|NCT00123240|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564746|NCT00123227|Randomized|Single Group Assignment||Treatment||Double||||||
1564747|NCT00123214|Randomized|Parallel Assignment||Prevention||Single||||||
1564748|NCT00123201|Randomized|Parallel Assignment||Treatment||Double||||||
1564749|NCT00123188||Single Group Assignment||Diagnostic||None (Open Label)||||||
1564750|NCT00123175|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564751|NCT00123162|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564752|NCT00123149|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564753|NCT00123136|Randomized|Parallel Assignment||Treatment||Double||||||
1564754|NCT00123123|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1564755|NCT00123110|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564756|NCT00123097|Randomized|Crossover Assignment||Device Feasibility||Quadruple|||t|t|t|t
1564757|NCT00123084|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564758|NCT00123071|||Cohort||Prospective|||||||
1564759|NCT00123058|Randomized|Factorial Assignment||Treatment||Single||||||t
1564760|NCT00123045|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1564761|NCT00123032|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564762|NCT00123019|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564763|NCT00123006|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1564764|NCT00122993|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1564765|NCT00122980|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564766|NCT00122954|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1564767|NCT00122941|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564768|NCT00122928|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564769|NCT00122915|Randomized|Crossover Assignment||Treatment||Double||||||
1564770|NCT00122902|||||Longitudinal, Prospective|||||||
1564771|NCT00122889|||Case-Only||Prospective|||||||
1564772|NCT00122876|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564773|NCT00122863|Randomized|Parallel Assignment||Treatment||Double||||||
1564774|NCT00122850|Randomized|Single Group Assignment||Treatment||Double||||||
1564775|NCT00122837|Randomized|Parallel Assignment||Treatment||Double||||||
1564776|NCT00122824|Randomized|Parallel Assignment||Treatment||Double||||||
1564777|NCT00122811|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564778|NCT00122798|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1564779|NCT00122785|Randomized|Parallel Assignment||Treatment||Double||||||
1564780|NCT00122772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564781|NCT00122759|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564782|NCT00122746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564783|NCT00122733|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564784|NCT00122720|Randomized|Single Group Assignment||Treatment||Double||||||
1564785|NCT00122707|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1572271|NCT00019032||||Treatment||||||||
1564786|NCT00122694|Randomized|Crossover Assignment||Treatment||Double||||||
1564787|NCT00122681|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1564788|NCT00122668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564789|NCT00122655|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564790|NCT00122642|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564791|NCT00122629|Randomized|Parallel Assignment||Treatment||Double||||||
1564792|NCT00122616|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564793|NCT00122603|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564794|NCT00122590|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564795|NCT00122577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564796|NCT00122564|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564797|NCT00122551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564798|NCT00122538|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564799|NCT00122525|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564800|NCT00122512|Randomized|Single Group Assignment||Prevention||Double||||||
1564801|NCT00122499|Randomized|Crossover Assignment||Treatment||Double||||||
1564802|NCT00122486|Randomized|Parallel Assignment||Prevention||Double||||||
1564803|NCT00122473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564804|NCT00122460|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564805|NCT00122447|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564806|NCT00122434|Randomized|Parallel Assignment||Treatment||Double||||||
1564807|NCT00122421|Randomized|Parallel Assignment||Treatment||Single||||||t
1564808|NCT00122408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564809|NCT00122395|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564810|NCT00122382|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564811|NCT00122369|Randomized|Parallel Assignment||||None (Open Label)||||||
1564812|NCT00122356|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564813|NCT00122343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564814|NCT00122330|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1564815|NCT00122317||Single Group Assignment||Treatment||None (Open Label)||||||
1564816|NCT00122304|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564817|NCT00122291|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564818|NCT00122278|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564819|NCT00122265|||Case-Only||Retrospective|||||||
1564820|NCT00122252|||Case-Only||Prospective|||||||
1564821|NCT00122239|||Case-Only||Retrospective|||||||
1564822|NCT00122226|Randomized|Parallel Assignment||Prevention||Single||||||
1564823|NCT00122213|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564824|NCT00122187|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564825|NCT00122174|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564826|NCT00122161|Randomized|Parallel Assignment||||None (Open Label)||||||
1564827|NCT00122148|Randomized|Single Group Assignment||||None (Open Label)||||||
1564828|NCT00122135|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1564829|NCT00122122|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564830|NCT00122109|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564831|NCT00122096|Randomized|Parallel Assignment||Treatment||Double||||||
1564832|NCT00122083|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1564833|NCT00122070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564834|NCT00122057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564835|NCT00122044|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564836|NCT00122031||Single Group Assignment||Treatment||None (Open Label)||||||
1564837|NCT00122018|Randomized|Factorial Assignment||Prevention||Double||||||
1564838|NCT00122005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564839|NCT00121992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564840|NCT00121979|Randomized|Factorial Assignment||Treatment||Double||||||
1564841|NCT00121966|Randomized|Factorial Assignment||Treatment||Double||||||
1564842|NCT00121953|Randomized|Parallel Assignment||Diagnostic||Double||||||
1564843|NCT00121940|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564844|NCT00121927|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564845|NCT00121914|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564846|NCT00121901|Randomized|Parallel Assignment||Prevention||Double||||||
1564847|NCT00121888|Randomized|Parallel Assignment||Treatment||Double||||||
1564848|NCT00121875|||Case Control||Prospective|||||||
1564849|NCT00121862|Randomized|Parallel Assignment||Prevention||Double||||||
1564850|NCT00121849|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564851|NCT00121836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564852|NCT00121823|Randomized|Single Group Assignment||Prevention||Single||||||
1564853|NCT00121810|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564854|NCT00121797|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564855|NCT00121784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564856|NCT00121771|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564857|NCT00121758|Randomized|Parallel Assignment||Prevention||Double||||||
1572272|NCT00019019||||Treatment||||||||
1564858|NCT00121745|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564859|NCT00121732|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564860|NCT00121719||Single Group Assignment||Treatment||None (Open Label)||||||
1564861|NCT00121706|Randomized|Crossover Assignment||Prevention||Single||||||
1564862|NCT00121693|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564863|NCT00121680||Single Group Assignment||Treatment||None (Open Label)||||||
1564864|NCT00121667|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564865|NCT00121654|Randomized|Parallel Assignment||Treatment||Single|||t|||
1564866|NCT00121641|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564867|NCT00121628|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564868|NCT00121615|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564869|NCT00121602|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564870|NCT00121589||||Treatment||||||||
1564871|NCT00121563||||Treatment||||||||
1564872|NCT00121550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564873|NCT00121537|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564874|NCT00121524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564875|NCT00121511|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564876|NCT00121498|Randomized|Parallel Assignment||Prevention||Double||||||
1564877|NCT00121485|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564878|NCT00121472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564879|NCT00121459|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564880|NCT00121446|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564881|NCT00121433|Randomized|Crossover Assignment||Treatment||Double||||||
1564882|NCT00121420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564883|NCT00121407|Randomized|Parallel Assignment||Treatment||Double||||||
1564884|NCT00121394|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1564885|NCT00121381|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564886|NCT00121368|||||Prospective|||||||
1564887|NCT00121355|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1564888|NCT00121329|Randomized|Single Group Assignment||Treatment||Double||||||
1564889|NCT00121316|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564890|NCT00121303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564891|NCT00121290||Single Group Assignment||Treatment||None (Open Label)||||||
1564892|NCT00121277||Single Group Assignment||Treatment||None (Open Label)||||||
1564893|NCT00121264||Single Group Assignment||Treatment||None (Open Label)||||||
1564894|NCT00121251||Single Group Assignment||Treatment||None (Open Label)||||||
1564895|NCT00121238||Single Group Assignment||Treatment||None (Open Label)||||||
1564896|NCT00121225||Single Group Assignment||Treatment||None (Open Label)||||||
1564897|NCT00121212|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1564898|NCT00121199||Single Group Assignment||Treatment||None (Open Label)||||||
1564899|NCT00121186||Single Group Assignment||Treatment||None (Open Label)||||||
1564900|NCT00121173|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564901|NCT00121160|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1564902|NCT00121147|Randomized|Parallel Assignment||Treatment||Double||||||
1564903|NCT00121134|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564904|NCT00121121|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564905|NCT00121108|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1564906|NCT00121095|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564907|NCT00121069|Randomized|Parallel Assignment||Treatment||Double||||||
1564908|NCT00121056|||||Prospective|||||||
1564909|NCT00121043|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1564910|NCT00121030|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564911|NCT00121017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564912|NCT00121004|||Cohort||Prospective|||||||
1564913|NCT00120991|Randomized|Parallel Assignment||Treatment||Single||||||t
1564914|NCT00120978|Randomized|Parallel Assignment||Treatment||Double||||||
1564915|NCT00120965|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564916|NCT00120952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564917|NCT00120939|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564918|NCT00120926|Randomized|Parallel Assignment||Treatment||Double||||||
1564919|NCT00120913|Randomized|Single Group Assignment||Prevention||Double||||||
1564920|NCT00120900|Randomized|Parallel Assignment||Treatment||Double||||||
1564921|NCT00120887|Randomized|Single Group Assignment||Prevention||Double||||||
1564922|NCT00120874|Randomized|Parallel Assignment||||Single||||||t
1564923|NCT00120861|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564924|NCT00120848|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564925|NCT00120835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564926|NCT00120822|Randomized|Single Group Assignment||Prevention||Double||||||
1564927|NCT00120809|Randomized|Single Group Assignment||Prevention||Double||||||
1564928|NCT00120796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564929|NCT00120783|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564930|NCT00120770|Randomized|Parallel Assignment||Prevention||Double||||||
1564931|NCT00120757|Randomized|Parallel Assignment||Treatment||Double||||||
1565544|NCT00112554|Randomized|||Treatment||Double||||||
1564932|NCT00120744|Randomized|Parallel Assignment||Prevention||Double||||||
1564933|NCT00120731|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1564934|NCT00120718|Randomized|Crossover Assignment||Treatment||Double||||||
1564935|NCT00120705|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564936|NCT00120692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564937|NCT00120679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564938|NCT00120666||||||||||||
1564939|NCT00120653|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564940|NCT00120640|Randomized|Parallel Assignment||Treatment||Double||||||
1564941|NCT00120627|Randomized|Parallel Assignment||Treatment||Single||||||t
1564942|NCT00120614|Randomized|Parallel Assignment||||Single||||||
1564943|NCT00120601|Randomized|Parallel Assignment||Treatment||Double||||||
1564944|NCT00120588|Randomized|Parallel Assignment||Prevention||Single||||||
1564945|NCT00120575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564946|NCT00120562|||||Prospective|||||||
1564947|NCT00120549|Randomized|Parallel Assignment||Treatment||Double||||||
1564948|NCT00120536|Randomized|Parallel Assignment||Treatment||Double||||||
1564949|NCT00120523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564950|NCT00120510|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564951|NCT00120497|||Case-Crossover||Prospective|||||||
1564952|NCT00120484|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1564953|NCT00120471|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564954|NCT00120458|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1564955|NCT00120445|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564956|NCT00120432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564957|NCT00120419|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564958|NCT00120406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564959|NCT00120393|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1564960|NCT00120380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564961|NCT00120367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564962|NCT00120354||||Treatment||||||||
1564963|NCT00120341|Randomized|Factorial Assignment||Treatment||Double||||||
1564964|NCT00120328|Randomized|Parallel Assignment||Prevention||Double||||||
1564965|NCT00120315|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564966|NCT00120302|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1564967|NCT00120289|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1564968|NCT00120276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564969|NCT00120263|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564970|NCT00120250|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1564971|NCT00120237|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1564972|NCT00120224|||Defined Population|Screening|Longitudinal, Prospective|||||||
1564973|NCT00120211|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564974|NCT00120198|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564975|NCT00120185|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1564976|NCT00120172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564977|NCT00120159|||||Retrospective|||||||
1564978|NCT00120133|Randomized|Crossover Assignment||Prevention||Double||||||
1564979|NCT00120120|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1564980|NCT00120107|Randomized|Parallel Assignment||Prevention||Single||||||t
1564981|NCT00120094|||Defined Population|Screening|Longitudinal, Prospective|||||||
1564982|NCT00120081|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1564983|NCT00120068||||Prevention||None (Open Label)||||||
1564984|NCT00120055|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1564985|NCT00120042|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564986|NCT00120029|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564987|NCT00120016|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564988|NCT00120003|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1564989|NCT00119990|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1564990|NCT00119977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1564991|NCT00119964|Randomized|Parallel Assignment||||None (Open Label)||||||
1564992|NCT00119951|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1564993|NCT00119938|Randomized|Single Group Assignment||||Single||||||
1564994|NCT00119925|Randomized|Parallel Assignment||||Double|||t|t||
1564995|NCT00119912|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1564996|NCT00119899|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1564997|NCT00119886|Randomized|Single Group Assignment||Treatment||Double||||||
1564998|NCT00119873|Randomized|Parallel Assignment||Prevention||Double||||||
1564999|NCT00119847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565000|NCT00119834|||Case-Only||Other|||||||
1565001|NCT00119821|Randomized|Parallel Assignment||Prevention||Single|||||t|
1565002|NCT00119795|Randomized|Factorial Assignment||Prevention||Single||||||t
1565003|NCT00119782|Randomized|Parallel Assignment||Prevention||Single||||||t
1565004|NCT00119769|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565005|NCT00119756|Randomized|Crossover Assignment||Treatment||Double||||||
1565006|NCT00119743|Randomized|Parallel Assignment||Prevention||Double||||||
1565007|NCT00119730||Single Group Assignment||Treatment||None (Open Label)||||||
1565008|NCT00119717|Randomized|Parallel Assignment||Treatment||Single||||||t
1565009|NCT00119704|Randomized|Parallel Assignment||Treatment||Double||||||
1565010|NCT00119691|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565011|NCT00119678|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1565012|NCT00119665|Randomized|Parallel Assignment||Treatment||Double||||||
1565013|NCT00119652|Randomized|Parallel Assignment||Treatment||Double||||||
1565014|NCT00119639|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1565015|NCT00119626|Randomized|Parallel Assignment||Treatment||Double||||||
1565016|NCT00119613|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565017|NCT00119600|Randomized|Parallel Assignment||Treatment||Double||||||
1565018|NCT00119587|Randomized|Parallel Assignment||Treatment||Double||||||
1565019|NCT00119574|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1565020|NCT00119561|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565021|NCT00119548|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1565022|NCT00119535|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1565023|NCT00119522|||Cohort||Prospective|||||||
1565024|NCT00119509|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1565025|NCT00119496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565026|NCT00119483|Randomized|Parallel Assignment||Treatment||Double||||||
1565027|NCT00119470|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1565028|NCT00119457|Randomized|Parallel Assignment||Prevention||Double||||||
1565029|NCT00119444||Single Group Assignment||Treatment||None (Open Label)||||||
1565030|NCT00119431|Randomized|Crossover Assignment||Prevention||Double||||||
1565031|NCT00119418|Randomized|Parallel Assignment||Treatment||Double||||||
1565032|NCT00119405|||Cohort||Prospective|||||||
1565033|NCT00119392||Single Group Assignment||Treatment||None (Open Label)||||||
1565034|NCT00119379|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565035|NCT00119366||Single Group Assignment||Treatment||None (Open Label)||||||
1565036|NCT00119340||||Treatment||||||||
1565037|NCT00119314||||Treatment||None (Open Label)||||||
1565038|NCT00119301||||Treatment||||||||
1565039|NCT00119262|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565040|NCT00119249||Single Group Assignment||Treatment||None (Open Label)||||||
1565041|NCT00119236||Single Group Assignment||Treatment||None (Open Label)||||||
1565042|NCT00119210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565043|NCT00119197|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565044|NCT00119184|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565045|NCT00119171|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565046|NCT00119158|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565047|NCT00119145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565048|NCT00119132|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1565049|NCT00119119|Randomized|Parallel Assignment||Treatment||Double||||||
1565050|NCT00119106|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565051|NCT00119093||Parallel Assignment||Treatment||None (Open Label)||||||
1565052|NCT00119080|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565053|NCT00119067|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565054|NCT00119054|Randomized|Single Group Assignment||||None (Open Label)||||||
1565055|NCT00119041|Non-Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1565056|NCT00119028|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1565057|NCT00119015|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565058|NCT00119002|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565059|NCT00118989|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1565060|NCT00118976|Randomized|Crossover Assignment||Prevention||Double||||||
1565061|NCT00118963|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565062|NCT00118950|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1565063|NCT00118937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565064|NCT00118924|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1565065|NCT00118911|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565066|NCT00118898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565067|NCT00118885|Randomized|Parallel Assignment||Treatment||||||||
1565068|NCT00118872|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565069|NCT00118859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565070|NCT00118846|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565071|NCT00118833|Randomized|Parallel Assignment||Treatment||Double||||||
1565072|NCT00118820|Randomized|Single Group Assignment||Treatment||Double||||||
1565073|NCT00118807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565074|NCT00118794|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565075|NCT00118781|Randomized|Single Group Assignment||Prevention||Double||||||
1565076|NCT00118768|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565077|NCT00118755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565078|NCT00118742|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565079|NCT00118729|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565080|NCT00118716|Randomized|Parallel Assignment||Treatment||Double||||||
1565081|NCT00118703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565082|NCT00118690|Randomized|Parallel Assignment||Treatment||Double||||||
1565083|NCT00118677|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565086|NCT00118638|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565087|NCT00118625|Randomized|Parallel Assignment||Treatment||Double||||||
1565088|NCT00118612|Randomized|Parallel Assignment||Treatment||Double||||||
1565089|NCT00118586|||Cohort||Prospective|||||||
1565090|NCT00118573|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1565091|NCT00118560|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1565092|NCT00118547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565093|NCT00118534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565094|NCT00118521|Randomized|Parallel Assignment||Treatment||Single||||||
1565095|NCT00118508|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1565096|NCT00118495|Randomized|Parallel Assignment||Treatment||Double||||||
1565097|NCT00118482|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565098|NCT00118469|Randomized|Factorial Assignment||||None (Open Label)||||||
1565099|NCT00118456|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565100|NCT00118443|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565101|NCT00118430|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565102|NCT00118417|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1565103|NCT00118404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565104|NCT00118391|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565105|NCT00118378|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1565106|NCT00118365|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1565107|NCT00118352||Single Group Assignment||Treatment||None (Open Label)||||||
1565108|NCT00118339||||Supportive Care||||||||
1565109|NCT00118326||||Treatment||||||||
1565110|NCT00118313||||Treatment||None (Open Label)||||||
1565111|NCT00118300||Single Group Assignment||Treatment||None (Open Label)||||||
1565112|NCT00118287||Single Group Assignment||Treatment||None (Open Label)||||||
1565113|NCT00118274||||Treatment||None (Open Label)||||||
1565114|NCT00118261||Single Group Assignment||Treatment||None (Open Label)||||||
1565115|NCT00118248||Single Group Assignment||Treatment||None (Open Label)||||||
1565116|NCT00118235||Single Group Assignment||Treatment||None (Open Label)||||||
1565117|NCT00118222|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565118|NCT00118209|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565119|NCT00118196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565120|NCT00118183|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565121|NCT00118170||Single Group Assignment||Treatment||None (Open Label)||||||
1565122|NCT00118157||Single Group Assignment||Treatment||None (Open Label)||||||
1565123|NCT00118144||Single Group Assignment||Treatment||None (Open Label)||||||
1565124|NCT00118131||Single Group Assignment||Treatment||None (Open Label)||||||
1565125|NCT00118105||Single Group Assignment||Treatment||None (Open Label)||||||
1565126|NCT00118092||Single Group Assignment||Treatment||None (Open Label)||||||
1565127|NCT00118066|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565128|NCT00118053||Single Group Assignment||Treatment||None (Open Label)||||||
1565129|NCT00118040|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565130|NCT00118027|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1565131|NCT00118014|Randomized|Parallel Assignment||Treatment||Single|||t|||
1565132|NCT00118001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565133|NCT00117988||Single Group Assignment||Treatment||None (Open Label)||||||
1565134|NCT00117975||Single Group Assignment||Treatment||None (Open Label)||||||
1565135|NCT00117962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565136|NCT00117949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565137|NCT00117936|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1565138|NCT00117923|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1565139|NCT00117910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565140|NCT00117897|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565141|NCT00117884|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565142|NCT00117871|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1565143|NCT00117858||||Treatment||||||||
1565144|NCT00117845||Single Group Assignment||Treatment||None (Open Label)||||||
1565145|NCT00117832|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1565146|NCT00117819||Single Group Assignment||Diagnostic||None (Open Label)||||||
1565147|NCT00117806|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565148|NCT00117793|Randomized|Crossover Assignment||Treatment||Single|||t|||
1565149|NCT00117780|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565150|NCT00117767|Randomized|Parallel Assignment||Treatment||Single|||||t|
1565151|NCT00117754|Randomized|Single Group Assignment||Treatment||Single||||||
1565152|NCT00117741|Randomized|Parallel Assignment||Treatment||Single||||||t
1565153|NCT00117728|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565154|NCT00117715|||Case-Only||Prospective|||||||
1565155|NCT00117702|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565156|NCT00117689|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565157|NCT00117676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565158|NCT00117663|Randomized|Single Group Assignment||Diagnostic||Double||||||
1565159|NCT00117650|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565160|NCT00117637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565161|NCT00117624|Randomized|Parallel Assignment||Treatment||Double||||||
1565162|NCT00117611|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565163|NCT00117598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565164|NCT00117585||Single Group Assignment||Treatment||None (Open Label)||||||
1565165|NCT00117572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565166|NCT00117559|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565167|NCT00117546|Randomized|Crossover Assignment||Diagnostic||Double||||||
1565168|NCT00117533|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565169|NCT00117520|Randomized|Crossover Assignment||Treatment||Double||||||
1565170|NCT00117507||Single Group Assignment||Treatment||None (Open Label)||||||
1565171|NCT00117494|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565172|NCT00117481|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565173|NCT00117468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565174|NCT00117455|Randomized|Parallel Assignment||Treatment||Double||||||
1565175|NCT00117442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565176|NCT00117429|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565177|NCT00117416|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565178|NCT00117403|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565179|NCT00117390|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1565180|NCT00117377|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565181|NCT00117364|Non-Randomized|Crossover Assignment||Treatment||Single||||||
1565182|NCT00117351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565183|NCT00117338|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565184|NCT00117325|Randomized|Parallel Assignment||Treatment||||||||
1565185|NCT00117312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565186|NCT00117299|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565187|NCT00117286|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565188|NCT00117273|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565189|NCT00117260|Randomized|Parallel Assignment||Treatment||Double||||||
1565190|NCT00117247|Randomized|Parallel Assignment||Treatment||Double||||||
1565191|NCT00117234|Randomized|Parallel Assignment||Treatment||Double||||||
1565192|NCT00117221||||||||||||
1565193|NCT00117208|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565194|NCT00117195|||Case Control||Prospective|||||||
1565195|NCT00117182|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1565196|NCT00117169|Randomized|Parallel Assignment||||Double||||||
1565197|NCT00117156||Single Group Assignment||Treatment||None (Open Label)||||||
1565198|NCT00117143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565199|NCT00117130|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565200|NCT00117117|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565201|NCT00117104|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565202|NCT00117091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565203|NCT00117078|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565204|NCT00117065|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565205|NCT00117052|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565206|NCT00117039|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565207|NCT00117026|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565208|NCT00117013||||Treatment||||||||
1565209|NCT00117000|Randomized|Factorial Assignment||Treatment||Double||||||
1565210|NCT00116987|Randomized|Parallel Assignment||Treatment||Single|||t|||
1565211|NCT00116974|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1565212|NCT00116961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565213|NCT00116948|Randomized|Parallel Assignment||Treatment||Single||||||t
1565214|NCT00116935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565215|NCT00116922|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565216|NCT00116909||||Treatment||||||||
1565217|NCT00116896||||Treatment||None (Open Label)||||||
1565218|NCT00116883|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565219|NCT00116870|Randomized|Parallel Assignment||Treatment||Double||||||
1565220|NCT00116857|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565221|NCT00116844|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1565222|NCT00116831|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565223|NCT00116818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565224|NCT00116805|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565225|NCT00116792|Randomized|Single Group Assignment||Prevention||Double||||||
1565226|NCT00116779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565227|NCT00116766|Randomized|Parallel Assignment||Prevention||Single||||||
1565228|NCT00116753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565229|NCT00116740|Randomized|Parallel Assignment||Treatment||Double||||||
1565230|NCT00116727|||Cohort||Prospective|||||||
1565231|NCT00116714|||Cohort||Prospective|||||||
1565232|NCT00116701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565233|NCT00116688|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565234|NCT00116675|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1565235|NCT00116662|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1565236|NCT00116649|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565237|NCT00116636|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565238|NCT00116623|Randomized|Parallel Assignment||Prevention||Double||||||
1565239|NCT00116610|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565240|NCT00116597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565241|NCT00116584||Single Group Assignment||Treatment||Single||||||t
1565242|NCT00116571|Randomized|Parallel Assignment||Treatment||Double||||||
1565243|NCT00116558|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565244|NCT00116545|Randomized|Parallel Assignment||Treatment||Double||||||
1565245|NCT00116532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565246|NCT00116519|Randomized|Parallel Assignment||Treatment||Double||||||
1565247|NCT00116506|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565248|NCT00116493|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1565249|NCT00116480|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565250|NCT00116467|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565251|NCT00116454|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565252|NCT00116441|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565253|NCT00116428|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565254|NCT00116415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565255|NCT00116402|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565256|NCT00116389|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565257|NCT00116376|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565258|NCT00116363|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565259|NCT00116350|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565260|NCT00116337||Single Group Assignment||Treatment||None (Open Label)||||||
1565261|NCT00116324|Randomized|Crossover Assignment||Treatment||Double||||||
1565262|NCT00116311|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1565263|NCT00116298|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565264|NCT00116285|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1565265|NCT00116272|||Cohort|||||||||
1565266|NCT00116259|Randomized|Parallel Assignment||Treatment||Double||||||
1565267|NCT00116246|Randomized|Single Group Assignment||Treatment||Single||||||
1565268|NCT00116233|Randomized|Parallel Assignment||Treatment||Single||||||
1565269|NCT00116220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565270|NCT00116207|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565271|NCT00116194|Randomized|Parallel Assignment||Prevention||Single||||||
1565272|NCT00116181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565273|NCT00116168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565274|NCT00116155|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565275|NCT00116142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565276|NCT00116129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565277|NCT00116116|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565278|NCT00116103|Randomized|Parallel Assignment||Treatment||Double||||||
1565279|NCT00116090||||||||||||
1565280|NCT00116077||||||||||||
1565281|NCT00116064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565282|NCT00116051|Randomized|Parallel Assignment||Treatment||Double||||||
1565283|NCT00116038|Randomized|Parallel Assignment||Treatment||Double||||||
1565284|NCT00116025|Randomized|Crossover Assignment||Treatment||Double||||||
1565285|NCT00116012|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565286|NCT00115999|Randomized|Parallel Assignment||Treatment||Double||||||
1565287|NCT00115986|Randomized|Parallel Assignment||Prevention||Double||||||
1565288|NCT00115973|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565289|NCT00115960|Randomized|Parallel Assignment||||Double|||t|t||
1565290|NCT00115947|Randomized|Crossover Assignment||||Double||||||
1565291|NCT00115934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565292|NCT00115921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565293|NCT00115908|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565294|NCT00115895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565295|NCT00115882|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565296|NCT00115869|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565297|NCT00115856||Single Group Assignment||Diagnostic||None (Open Label)||||||
1565298|NCT00115843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565299|NCT00115830|Randomized|Parallel Assignment||Treatment||Double||||||
1565300|NCT00115817|Randomized|Factorial Assignment||Treatment||Double||||||
1565301|NCT00115804||Single Group Assignment||Treatment||None (Open Label)|Open Label|||||
1565302|NCT00115791|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565303|NCT00115778|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1565304|NCT00115765|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565305|NCT00115752||||Treatment||||||||
1565306|NCT00115739||Single Group Assignment||Treatment||None (Open Label)||||||
1565307|NCT00115726|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565308|NCT00115713|Randomized|Parallel Assignment||Treatment||Double||||||
1565309|NCT00115700|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565310|NCT00115687|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1565311|NCT00115674|||Cohort||Prospective|||||||
1565312|NCT00115661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565313|NCT00115648|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565314|NCT00115635|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565315|NCT00115622|Randomized|Parallel Assignment||Treatment||Double||||||
1565316|NCT00115609|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565317|NCT00115596|Randomized|Parallel Assignment||Other||Single||||||t
1565318|NCT00115583|Non-Randomized|Crossover Assignment||||None (Open Label)||||||
1565319|NCT00115570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565320|NCT00115557|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565321|NCT00115544|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565322|NCT00115531|Randomized|Parallel Assignment||Prevention||Double||||||
1565323|NCT00115518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565324|NCT00115505|||Case-Only||Prospective|||||||
1565325|NCT00115492|Randomized|Parallel Assignment||Treatment||Double||||||
1565326|NCT00115479|Randomized|Parallel Assignment||Treatment||Single||||||
1565327|NCT00115466|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565328|NCT00115453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565329|NCT00115440|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565330|NCT00115427|Randomized|Parallel Assignment||Treatment||Double||||||
1565331|NCT00115414|Randomized|Parallel Assignment||Treatment||Double||||||
1565332|NCT00019500||||Prevention||||||||
1565333|NCT00115401||||||||||||
1565334|NCT00115388|Randomized|Parallel Assignment||Prevention||Single||||||t
1565335|NCT00115375|Randomized|Parallel Assignment||Treatment||Double||||||
1565336|NCT00115362|Randomized|Parallel Assignment||Treatment||Double||||||
1565337|NCT00115349|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565338|NCT00115336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565339|NCT00115323|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565340|NCT00115310|Randomized|Parallel Assignment||Treatment||Double||||||
1565341|NCT00115297|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1565342|NCT00115284|Randomized|Factorial Assignment||||Single||||||
1565343|NCT00115271|Randomized|Parallel Assignment||Prevention||Double||||||
1565344|NCT00115258|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565345|NCT00115245|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565346|NCT00115232|||Cohort||Prospective|||||||
1565347|NCT00115219|Randomized|Crossover Assignment||Treatment||Double||||||
1565348|NCT00115206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565349|NCT00115193|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1565350|NCT00115180|||Cohort||Prospective|||||||
1565351|NCT00115167|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565352|NCT00115154|Randomized|Parallel Assignment||Treatment||Double||||||
1565353|NCT00115141|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1565354|NCT00115128|||Cohort||Prospective|||||||
1565355|NCT00115115|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565356|NCT00115102|Randomized|Crossover Assignment||Diagnostic||Double||||||
1565357|NCT00115089|Randomized|Parallel Assignment||Treatment||Double||||||
1565358|NCT00115076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565359|NCT00115063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565360|NCT00115050|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565361|NCT00115037|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565362|NCT00115024|Randomized|Parallel Assignment||Prevention||Double||||||
1565363|NCT00115011|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565364|NCT00114998|||Cohort||Prospective|||||||
1565365|NCT00114985|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565366|NCT00114972|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565367|NCT00114959||Single Group Assignment||Treatment||None (Open Label)||||||
1565368|NCT00114946||||Treatment||||||||
1565369|NCT00114933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565370|NCT00114920|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1565371|NCT00114907|Randomized|Single Group Assignment||Prevention||Double||||||
1565372|NCT00114894|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565373|NCT00114881|||Case-Control||Prospective|||||||
1565374|NCT00114868|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565375|NCT00114855|Randomized|Single Group Assignment||Treatment||Double||||||
1565376|NCT00114842|Randomized|Parallel Assignment||Diagnostic||Single||||||
1565377|NCT00114829|Non-Randomized|Single Group Assignment||Diagnostic||Double||||||
1565378|NCT00114816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565379|NCT00114803|Randomized|Parallel Assignment||||Double||||||
1565380|NCT00114790||Single Group Assignment||Treatment||None (Open Label)||||||
1565381|NCT00114777|Randomized|Parallel Assignment||Treatment||Single|||t|||
1565382|NCT00114764|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565383|NCT00114738|Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1565384|NCT00114725|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1565385|NCT00114712|||Cohort||Prospective|||||||
1565386|NCT00114699|Randomized|Single Group Assignment||Treatment||Single||||||
1565387|NCT00114686|Randomized|Parallel Assignment||Treatment||Double||||||
1565388|NCT00114673|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1565389|NCT00114660|Randomized|Parallel Assignment||Prevention||Double||||||
1565390|NCT00114647|||Cohort||Prospective|||||||
1565391|NCT00114634|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1565392|NCT00114621||||Treatment||||||||
1565393|NCT00114608|Randomized|Single Group Assignment||Prevention||Single||||||t
1565394|NCT00114595|Randomized|Parallel Assignment||Treatment||Double||||||
1565395|NCT00114582|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565396|NCT00114569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565397|NCT00114556|Randomized|Single Group Assignment||Prevention||Double||||||
1565398|NCT00114543|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1565399|NCT00114530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565400|NCT00114517|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565401|NCT00114504|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565402|NCT00114491|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1565403|NCT00114478|Randomized|Parallel Assignment||Treatment||Double||||||
1565404|NCT00114465|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565405|NCT00114452|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565406|NCT00114439|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565407|NCT00114426|Randomized|Parallel Assignment||Treatment||Double||||||
1565408|NCT00114413|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565409|NCT00114400|Randomized|Parallel Assignment||Treatment||Double||||||
1565410|NCT00114387|Randomized|Parallel Assignment||Prevention||Double||||||
1565411|NCT00114374|Randomized|Parallel Assignment||Prevention||Double||||||
1565412|NCT00114361|Randomized|Factorial Assignment||||Double|||t||t|
1565413|NCT00114348|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565414|NCT00114335|||Cohort||Cross-Sectional|||||||
1565415|NCT00114322|Randomized|Parallel Assignment||Treatment||Single||||||
1565416|NCT00114309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565417|NCT00114296|Randomized|||Prevention||||||||
1565418|NCT00114283||Single Group Assignment||Treatment||None (Open Label)||||||
1565419|NCT00114270|Randomized|||Prevention||Double||||||
1565420|NCT00114257||Single Group Assignment||Treatment||None (Open Label)||||||
1565421|NCT00114244|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565422|NCT00114231||Single Group Assignment||Treatment||None (Open Label)||||||
1565423|NCT00114218||Single Group Assignment||Treatment||None (Open Label)||||||
1565424|NCT00114205||||Treatment||||||||
1565425|NCT00114192||||Treatment||None (Open Label)||||||
1565426|NCT00114179||Single Group Assignment||Treatment||None (Open Label)||||||
1565427|NCT00114166|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565428|NCT00114153||||Treatment||||||||
1565429|NCT00114140||Single Group Assignment||Treatment||None (Open Label)||||||
1565430|NCT00114127|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1565431|NCT00114114|Randomized|Parallel Assignment||Diagnostic||Single|||t|||
1565432|NCT00114101|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565433|NCT00114088|Randomized|Parallel Assignment||Treatment||Single||||||
1565434|NCT00114075|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1565435|NCT00114062|Randomized|Parallel Assignment||Treatment||Double||||||
1565436|NCT00114049|Randomized|Parallel Assignment||Treatment||Double||||||
1565437|NCT00114036|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1565438|NCT00114023|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1565439|NCT00114010|Randomized|||Treatment||Single||||||
1565440|NCT00113997||||Treatment||||||||
1565441|NCT00113984||||Treatment||||||||
1565442|NCT00113971|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565443|NCT00113958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565444|NCT00113945|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565445|NCT00113932|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565446|NCT00113919||Single Group Assignment||Treatment||None (Open Label)||||||
1565447|NCT00113906|Randomized|Parallel Assignment||Treatment||Double||||||
1565448|NCT00113893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565449|NCT00113880|||Cohort||Prospective|||||||
1565450|NCT00113867||||||||||||
1565451|NCT00113854|Randomized|Parallel Assignment||Treatment||Double||||||
1565452|NCT00113841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565453|NCT00113828||Single Group Assignment||Treatment||None (Open Label)||||||
1565454|NCT00113815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565455|NCT00113802|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565456|NCT00113789|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1565457|NCT00113776|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565458|NCT00113763|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565459|NCT00113750|Randomized|Parallel Assignment||Treatment||Single||||||
1565460|NCT00113737||||Prevention||Double||||||
1565461|NCT00113724|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565462|NCT00113711|Randomized|||Prevention||||||||
1565463|NCT00113698|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565464|NCT00113685|Randomized|Parallel Assignment||Treatment||Double||||||
1565465|NCT00113672|Randomized|Parallel Assignment||Prevention||Single|||||t|
1565466|NCT00113659|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1566082|NCT00105222||||Treatment||||||||
1565467|NCT00113646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565468|NCT00113633|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1565469|NCT00113620|Randomized|Parallel Assignment||Treatment||Double||||||
1565470|NCT00113607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565471|NCT00113594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565472|NCT00113581|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565473|NCT00113568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565474|NCT00113555||Single Group Assignment||Treatment||None (Open Label)||||||
1565475|NCT00113542|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565476|NCT00113529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565477|NCT00113516|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565478|NCT00113503|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565479|NCT00113490|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565480|NCT00113477|Randomized|Single Group Assignment||Treatment||Double||||||
1565481|NCT00113464||||||||||||
1565482|NCT00113451|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1565483|NCT00113438|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565484|NCT00113425|Randomized|Single Group Assignment||Treatment||Single||||||t
1565485|NCT00113412|Randomized|Parallel Assignment||Treatment||Double||||||
1565486|NCT00113399|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565487|NCT00113386|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565488|NCT00113373||Single Group Assignment||Treatment||None (Open Label)||||||
1565489|NCT00113360|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565490|NCT00113347||Single Group Assignment||Treatment||None (Open Label)||||||
1565491|NCT00113334||Single Group Assignment||Treatment||None (Open Label)||||||
1565492|NCT00113321|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565493|NCT00113308|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1565494|NCT00113295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565495|NCT00113282|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565496|NCT00113269|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565497|NCT00113256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565498|NCT00113243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565499|NCT00113230|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565500|NCT00113217||Single Group Assignment||Treatment||None (Open Label)||||||
1565501|NCT00113204|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565502|NCT00113191|Randomized|Single Group Assignment||Prevention||Double||||||
1565503|NCT00113178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565504|NCT00113165|Randomized|Parallel Assignment||Treatment||Double||||||
1565505|NCT00113152||||||||||||
1565506|NCT00113139|Randomized|Parallel Assignment||Treatment||Single||||||t
1565507|NCT00113126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565508|NCT00113113|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565509|NCT00113100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565510|NCT00113087|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1565511|NCT00113074|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565512|NCT00113061|Randomized|Parallel Assignment||Prevention||||||||
1565513|NCT00113048|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565514|NCT00113035|||||Prospective|||||||
1565515|NCT00113022|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565516|NCT00113009|Randomized|Single Group Assignment||Treatment||Double||||||
1565517|NCT00112996|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1565518|NCT00112983|Randomized|||Prevention||Double||||||
1565519|NCT00112957||Single Group Assignment||Treatment||None (Open Label)||||||
1565520|NCT00112931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565521|NCT00112918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565522|NCT00112905||Single Group Assignment||Treatment||None (Open Label)||||||
1565523|NCT00112892||||Treatment||||||||
1565524|NCT00112879||||Treatment||||||||
1565525|NCT00112866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565526|NCT00112853||Single Group Assignment||Treatment||None (Open Label)||||||
1565527|NCT00112840||Single Group Assignment||Treatment||None (Open Label)||||||
1565528|NCT00112827||Single Group Assignment||Treatment||None (Open Label)||||||
1565529|NCT00112775||||Treatment||None (Open Label)||||||
1565530|NCT00112749||Single Group Assignment||Supportive Care||None (Open Label)||||||
1565531|NCT00112736|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565532|NCT00112723||Single Group Assignment||Treatment||None (Open Label)||||||
1565533|NCT00112710|Randomized|||Treatment||||||||
1565534|NCT00112697|Randomized|||Treatment||||||||
1565535|NCT00112684||Single Group Assignment||Treatment||None (Open Label)||||||
1565536|NCT00112671||Single Group Assignment||Treatment||None (Open Label)||||||
1565537|NCT00112658|Randomized|||Treatment||||||||
1565538|NCT00112645||||Treatment||None (Open Label)||||||
1565539|NCT00112632||||Treatment||None (Open Label)||||||
1565540|NCT00112619||Single Group Assignment||Treatment||None (Open Label)||||||
1565541|NCT00112593||Single Group Assignment||Treatment||None (Open Label)||||||
1565542|NCT00112580||||Treatment||None (Open Label)||||||
1565545|NCT00112528||Single Group Assignment||Treatment||None (Open Label)||||||
1565546|NCT00112515||||Supportive Care||||||||
1565547|NCT00112502|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1565548|NCT00112489||Single Group Assignment||Treatment||None (Open Label)||||||
1565549|NCT00112476||Single Group Assignment||Treatment||None (Open Label)||||||
1565550|NCT00112463||Single Group Assignment||Treatment||None (Open Label)||||||
1565551|NCT00112437|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565552|NCT00112424|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1565553|NCT00112411|Randomized|Crossover Assignment||Treatment||Double||||||
1565554|NCT00112398|Randomized|Parallel Assignment||Treatment||Single||||||t
1565555|NCT00112385|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565556|NCT00112372|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565557|NCT00112359|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565558|NCT00112346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565559|NCT00112333|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1565560|NCT00112320|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565561|NCT00112307|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565562|NCT00112294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565563|NCT00112281|Randomized|Parallel Assignment||Treatment||Double||||||
1565564|NCT00112268|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1565565|NCT00112255|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1565566|NCT00112242|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565567|NCT00112229|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565568|NCT00112216||Single Group Assignment||Treatment||None (Open Label)||||||
1565569|NCT00112203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565570|NCT00112190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565571|NCT00112177|Randomized|Parallel Assignment||Treatment||Double||||||
1565572|NCT00112164|Randomized|Parallel Assignment||Treatment||Double||||||
1565573|NCT00112151|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1565574|NCT00112138|Randomized|Single Group Assignment||Treatment||Double||||||
1565575|NCT00112125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565576|NCT00112112|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565577|NCT00112099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565578|NCT00112086|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565579|NCT00112073|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565580|NCT00112060|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565581|NCT00112047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565582|NCT00112034|Randomized|Factorial Assignment||||Double||||||
1565583|NCT00112021|Randomized|Parallel Assignment||Treatment||Double||||||
1565584|NCT00112008|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565585|NCT00111995|Randomized|Single Group Assignment||Prevention||Double||||||
1565586|NCT00111982||Single Group Assignment||Treatment||None (Open Label)||||||
1565587|NCT00111969|Randomized|Parallel Assignment||Treatment||Double||||||
1565588|NCT00111956|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565589|NCT00111943|Randomized|Parallel Assignment||Prevention||Double||||||
1565590|NCT00111930|Randomized|Parallel Assignment||Prevention||Double||||||
1565591|NCT00111917|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565592|NCT00111904||||Treatment||None (Open Label)||||||
1565593|NCT00111891|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565594|NCT00111878|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1565595|NCT00111865|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1565596|NCT00111852|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1565597|NCT00111839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565598|NCT00111826|Randomized|Parallel Assignment||Treatment||Double||||||
1565599|NCT00111813|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565600|NCT00111800|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565601|NCT00111787|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565602|NCT00111774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565603|NCT00111761|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565604|NCT00111748|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565605|NCT00111735|Randomized|Crossover Assignment||Treatment||Double||||||
1565606|NCT00111722|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565607|NCT00111709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565608|NCT00111696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565609|NCT00111683||Single Group Assignment||Treatment||None (Open Label)||||||
1565610|NCT00111670|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565611|NCT00111657|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565612|NCT00111644|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565613|NCT00111631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565614|NCT00111618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565615|NCT00111605|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1565616|NCT00111592|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565617|NCT00111579|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566240|NCT00102999||||||||||||
1565618|NCT00111566|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565619|NCT00111553|Randomized|Parallel Assignment||Treatment||Double||||||
1565620|NCT00111540||Single Group Assignment||Treatment||None (Open Label)||||||
1565621|NCT00111527|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565622|NCT00111514|Randomized|Parallel Assignment||Treatment||Double||||||
1565623|NCT00111501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565624|NCT00111488|Randomized|Single Group Assignment||Treatment||Single||||||
1565625|NCT00111475||||Treatment||||||||
1565626|NCT00111462|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1565627|NCT00111449|Randomized|Parallel Assignment||Treatment||Double||||||
1565628|NCT00111436|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565629|NCT00111423|Randomized|Parallel Assignment||Treatment||Double||||||
1565630|NCT00111410|Randomized|Parallel Assignment||Treatment||Double||||||
1565631|NCT00111397||||Treatment||||||||
1565632|NCT00111384|||Family-Based||Prospective|||||||
1565633|NCT00111371|Randomized|Parallel Assignment||Treatment||Double||||||
1565634|NCT00111358|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565635|NCT00111345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565636|NCT00111332|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565637|NCT00111319|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565638|NCT00111306|Randomized|Parallel Assignment||Treatment||Double||||||
1565639|NCT00111293||||||||||||
1565640|NCT00111280|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565641|NCT00111267|Randomized|Parallel Assignment||Prevention||Double||||||
1565642|NCT00111254|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565643|NCT00111241|||Cohort||Cross-Sectional|||||||
1565644|NCT00111228|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1565645|NCT00111215|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1565646|NCT00111202|||||Cross-Sectional, Retrospective/Prospective|||||||
1565647|NCT00111189|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565648|NCT00111176|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565649|NCT00111163|Randomized|Single Group Assignment||Prevention||Double||||||
1565650|NCT00111150|Randomized|Parallel Assignment||Prevention||Double||||||
1565651|NCT00111137|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565652|NCT00111124||||Treatment||||||||
1565653|NCT00111111|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1565654|NCT00111098|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565655|NCT00111085|Randomized|Parallel Assignment||Prevention||||||||
1565656|NCT00111059|||Case Control|Screening|Cross-Sectional, Prospective|||||||
1565657|NCT00111046|Randomized|Parallel Assignment||Treatment||Single||||||
1565658|NCT00111020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565659|NCT00111007|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1565660|NCT00110994|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565661|NCT00110981|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565662|NCT00110968|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565663|NCT00110955|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565664|NCT00110942|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1565665|NCT00110929|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565666|NCT00110916|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565667|NCT00110903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565668|NCT00110890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565669|NCT00111072||||Treatment||||||||
1565670|NCT00110877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565671|NCT00110864|Randomized|Parallel Assignment||Treatment||Double||||||
1565672|NCT00110851|Randomized|Parallel Assignment||Treatment||Double||||||
1565673|NCT00110838|Randomized|Parallel Assignment||Prevention||Double||||||
1565674|NCT00110825|Randomized|Factorial Assignment||Treatment||Single|||t|||
1565675|NCT00110812|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565676|NCT00110799|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565677|NCT00110786|Randomized|Parallel Assignment||Treatment||Double||||||
1565678|NCT00110773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565679|NCT00110760|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565680|NCT00110747|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565681|NCT00110734|Randomized|||Treatment||Double||||||
1565682|NCT00110721||Single Group Assignment||Treatment||None (Open Label)||||||
1565683|NCT00110708|Randomized|Parallel Assignment||Treatment||Double||||||
1565684|NCT00110695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565685|NCT00110682|Randomized|Parallel Assignment||Treatment||Double||||||
1565686|NCT00110669|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565687|NCT00110656|||||Retrospective|||||||
1565688|NCT00110643||Single Group Assignment||Treatment||Single||||||
1565689|NCT00110630|Randomized|||Treatment||None (Open Label)||||||
1565690|NCT00110617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565691|NCT00110604|Randomized|Parallel Assignment||Prevention||Double||||||
1565692|NCT00110591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565693|NCT00110578|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565694|NCT00110565|Randomized|Parallel Assignment||Treatment||Double||||||
1566391|NCT00100971||||Treatment||||||||
1565695|NCT00110552|Randomized|Parallel Assignment||Treatment||Single||||||t
1565696|NCT00110539|Randomized|Parallel Assignment||||Double||||||
1565697|NCT00110526||Single Group Assignment||Treatment||None (Open Label)||||||
1565698|NCT00110513||Single Group Assignment||Prevention||None (Open Label)||||||
1565699|NCT00110500|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1565700|NCT00110487|Randomized|Single Group Assignment||Treatment||Double||||||
1565701|NCT00110474|Randomized|Parallel Assignment||Treatment||Double||||||
1565702|NCT00110461|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565703|NCT00110448|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1565704|NCT00110435|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565705|NCT00110422|Randomized|Parallel Assignment||Treatment||Double||||||
1565706|NCT00110409|Randomized|Parallel Assignment||Treatment||Single|||t|||
1565707|NCT00110396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565708|NCT00110383|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565709|NCT00110370|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565710|NCT00110357|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1565711|NCT00110344|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565712|NCT00110331||||||||||||
1565713|NCT00110318|Randomized|Parallel Assignment||Treatment||Single||||||
1565714|NCT00110305|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565715|NCT00110292|Randomized|Factorial Assignment||Prevention||Single||||||
1565716|NCT00110279|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1565717|NCT00110266||Single Group Assignment||Treatment||None (Open Label)||||||
1565718|NCT00110253||Single Group Assignment||Treatment||None (Open Label)||||||
1565719|NCT00110240|Randomized|Parallel Assignment||Treatment||Double||||||
1565720|NCT00110227|Randomized|Parallel Assignment||Treatment||Single||||||t
1565721|NCT00110214|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565722|NCT00110201|Randomized|Parallel Assignment||Prevention||Double||||||
1565723|NCT00110188||Single Group Assignment||Treatment||None (Open Label)||||||
1565724|NCT00110175||||||||||||
1565725|NCT00110162|Randomized|||Treatment||||||||
1565726|NCT00110149||Single Group Assignment||Treatment||None (Open Label)||||||
1565727|NCT00110136||Single Group Assignment||Supportive Care||None (Open Label)||||||
1565728|NCT00110123|Randomized|||Treatment||None (Open Label)||||||
1565729|NCT00110110||Single Group Assignment||Treatment||None (Open Label)||||||
1565730|NCT00110084||Single Group Assignment||Treatment||None (Open Label)||||||
1565731|NCT00110071||Single Group Assignment||Treatment||None (Open Label)||||||
1565732|NCT00110058||||Treatment||None (Open Label)||||||
1565733|NCT00110045||||Supportive Care||None (Open Label)||||||
1565734|NCT00110032|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1565735|NCT00110019|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565736|NCT00110006||Single Group Assignment||Diagnostic||None (Open Label)||||||
1565737|NCT00109993||Single Group Assignment||Supportive Care||None (Open Label)||||||
1565738|NCT00109980|||Ecologic or Community||Cross-Sectional|||||||
1565739|NCT00109967||Single Group Assignment||Treatment||None (Open Label)||||||
1565740|NCT00109954|Randomized|||Treatment||||||||
1565741|NCT00109941||Single Group Assignment||Treatment||None (Open Label)||||||
1565742|NCT00109928||Single Group Assignment||Treatment||None (Open Label)||||||
1565743|NCT00109889||Single Group Assignment||Other||None (Open Label)||||||
1565744|NCT00109876||Single Group Assignment||Treatment||None (Open Label)||||||
1565745|NCT00109863||Single Group Assignment||Treatment||None (Open Label)||||||
1565746|NCT00109850||Single Group Assignment||Treatment||None (Open Label)||||||
1565747|NCT00109837||Single Group Assignment||Treatment||None (Open Label)||||||
1565748|NCT00109824|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565749|NCT00109811||Single Group Assignment||Treatment||None (Open Label)||||||
1565750|NCT00109798||Single Group Assignment||Treatment||None (Open Label)||||||
1565751|NCT00109785||Single Group Assignment||Diagnostic||None (Open Label)||||||
1565752|NCT00109772|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565753|NCT00109759|Randomized|Parallel Assignment||Treatment||Double||||||
1565754|NCT00109746|Randomized|Parallel Assignment||Health Services Research||Double|||t||t|
1565755|NCT00109733|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565756|NCT00109720|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565757|NCT00109707|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565758|NCT00109681|Randomized|Single Group Assignment||Treatment||Double||||||
1565759|NCT00109668|Randomized|Parallel Assignment||Treatment||Double||||||
1565760|NCT00109655|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565761|NCT00109642||||||||||||
1565762|NCT00109629||||Treatment||||||||
1565763|NCT00109616|Randomized|Parallel Assignment||Prevention||Double||||||
1565764|NCT00109603|Randomized|Parallel Assignment||Treatment||Double||||||
1565765|NCT00109590|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565766|NCT00109577|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565767|NCT00109564|Randomized|Parallel Assignment||Treatment||Double||||||
1565768|NCT00109551|Randomized|Factorial Assignment||Prevention||Double||||||
1565769|NCT00109538|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1565770|NCT00109525|||Cohort||Prospective|||||||
1565771|NCT00109512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565772|NCT00109499||||Treatment||None (Open Label)||||||
1573252|NCT00001909||||Treatment||||||||
1565773|NCT00109486|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1565774|NCT00109473|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565775|NCT00024635|||Cohort||Other|||||||
1565776|NCT00109460||Crossover Assignment||||Single||||||
1565777|NCT00109434|||||Prospective|||||||
1565778|NCT00109421|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565779|NCT00109408|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565780|NCT00109395|Randomized|Parallel Assignment||Treatment||Single||||||t
1565781|NCT00109382|Randomized|Factorial Assignment||Prevention||Double||||||
1565782|NCT00109369|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565783|NCT00109356|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565784|NCT00109343|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565785|NCT00109330|Randomized|Parallel Assignment||Prevention||Single||||||
1565786|NCT00109317|Randomized|Parallel Assignment||Treatment||Double||||||
1565787|NCT00109304|Randomized|Single Group Assignment||||Double|||t||t|
1565788|NCT00109291|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565789|NCT00109278|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1565790|NCT00109265||||Treatment||None (Open Label)||||||
1565791|NCT00109252||||Treatment||None (Open Label)||||||
1565792|NCT00109239|Randomized|||Treatment||None (Open Label)||||||
1565793|NCT00109226|Randomized|||Treatment||Double||||||
1565794|NCT00109213|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565795|NCT00109200||||Treatment||||||||
1565796|NCT00109187||||Treatment||None (Open Label)||||||
1565797|NCT00109174||||Treatment||||||||
1565798|NCT00109161|Randomized|Parallel Assignment||Treatment||Double||||||
1565799|NCT00109148|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565800|NCT00109135|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565801|NCT00109122|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1565802|NCT00109109|Non-Randomized|||Treatment||None (Open Label)||||||
1565803|NCT00109096|Randomized|Parallel Assignment||Treatment||Double||||||
1565804|NCT00109083|Randomized|Parallel Assignment||Treatment||Double||||||
1565805|NCT00109070|Randomized|||Treatment||||||||
1565806|NCT00109057||||Treatment||None (Open Label)||||||
1565807|NCT00109044|Randomized|Parallel Assignment||Treatment||Double||||||
1565808|NCT00109031|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1565809|NCT00109018||||||||||||
1565810|NCT00109005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565811|NCT00108992|Randomized|Parallel Assignment||Treatment||Double||||||
1565812|NCT00108979|Randomized|Parallel Assignment||Treatment||Double||||||
1565813|NCT00108953|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565814|NCT00108940|||Family-Based||Prospective|||||||
1565815|NCT00108927|||||Prospective|||||||
1565816|NCT00108914|Randomized|Parallel Assignment||Treatment||Double||||||
1565817|NCT00108901|Randomized|Parallel Assignment||Prevention||Single||||||t
1565818|NCT00108875|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565819|NCT00108862|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565820|NCT00108849|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565821|NCT00108836|Randomized|Parallel Assignment||Treatment||Double||||||
1565822|NCT00108823|Randomized|Parallel Assignment||Treatment||Double||||||
1565823|NCT00108810|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565824|NCT00108797|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565825|NCT00108784|Randomized|Parallel Assignment||Treatment||Single||||||
1565826|NCT00108771|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565827|NCT00108758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565828|NCT00108745|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565829|NCT00108732||Single Group Assignment||Treatment||None (Open Label)||||||
1565830|NCT00108706|Randomized|Parallel Assignment||Treatment||Double||||||
1565831|NCT00108680||||||||||||
1565832|NCT00108667||||Treatment||||||||
1565833|NCT00108654||||Treatment||||||||
1565834|NCT00108628|Randomized|Parallel Assignment||Treatment||Single||||||t
1565835|NCT00108615|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1565836|NCT00108602||Crossover Assignment||Diagnostic||Single||||||
1565837|NCT00108589|Randomized|Single Group Assignment||Treatment||Double||||||
1565838|NCT00108576|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565839|NCT00108563|Randomized|Single Group Assignment||Prevention||Double||||||
1565840|NCT00108550|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1565841|NCT00108537|Randomized|||Treatment||None (Open Label)||||||
1565842|NCT00108524|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565843|NCT00108511|Randomized|Factorial Assignment||Treatment||Double||||||
1565844|NCT00108498|Randomized|Crossover Assignment||Treatment||Double||||||
1565845|NCT00108485|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565846|NCT00108459|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565847|NCT00108446|Randomized|Crossover Assignment||Treatment||Double||||||
1565848|NCT00108433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565849|NCT00108420|Randomized|Parallel Assignment||Treatment||Double||||||
1565850|NCT00108407|Randomized|Parallel Assignment||||None (Open Label)||||||
1565851|NCT00108394|Randomized|Parallel Assignment||Treatment||Double||||||
1565852|NCT00108381|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1565853|NCT00108368|Randomized|Single Group Assignment||Treatment||Double||||||
1565854|NCT00108355|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565855|NCT00108342|Randomized|Parallel Assignment||||None (Open Label)||||||
1565856|NCT00108329|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1565857|NCT00108316|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1565858|NCT00108303|||Family-Based||Prospective|||||||
1565859|NCT00108290|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565860|NCT00108277|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565861|NCT00108264|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1565862|NCT00108251|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565863|NCT00108238|Randomized|Parallel Assignment||Prevention||Double||||||
1565864|NCT00108225|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565865|NCT00108212|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1565866|NCT00108199|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1565867|NCT00108186|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1565868|NCT00108173||Parallel Assignment||Diagnostic||None (Open Label)||||||
1565869|NCT00108160|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1565870|NCT00108147|Randomized|Parallel Assignment||||Single||||||
1565871|NCT00108134|Randomized|Parallel Assignment||Treatment||Double||||||
1565872|NCT00108121|Randomized|Parallel Assignment||Treatment||Double||||||
1565873|NCT00108108||Single Group Assignment||Treatment||None (Open Label)||||||
1565874|NCT00108095|Randomized|Parallel Assignment||Treatment||Double||||||
1565875|NCT00108082|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565876|NCT00108069|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565877|NCT00108056||||Treatment||||||||
1565878|NCT00108043|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565879|NCT00108030|Randomized|Factorial Assignment||Treatment||Single||||||
1565880|NCT00108017|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1565881|NCT00108004|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565882|NCT00107991||Single Group Assignment||Treatment||None (Open Label)||||||
1565883|NCT00107978|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565884|NCT00107965|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1565885|NCT00107952|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565886|NCT00107939|Randomized|Parallel Assignment||Treatment||Double||||||
1565887|NCT00107926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565888|NCT00107913|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565889|NCT00107900|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565890|NCT00107887|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1565891|NCT00107874|Randomized|Parallel Assignment||Prevention||Double||||||
1565892|NCT00107861|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565893|NCT00107848|Non-Randomized|Single Group Assignment||Treatment||||||||
1565894|NCT00107835||Single Group Assignment||Treatment||None (Open Label)||||||
1565895|NCT00107822|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565896|NCT00107809|Randomized|Parallel Assignment||Treatment||Double||||||
1565897|NCT00107796|Randomized|Parallel Assignment||Treatment||Double||||||
1565898|NCT00107783|Randomized|Parallel Assignment||Treatment||Single||||||t
1565899|NCT00107770|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565900|NCT00107757|Randomized|Parallel Assignment||Treatment||Double||||||
1565901|NCT00107744|Randomized|Crossover Assignment||Prevention||Triple|The randomization assignment list was generated by a computer program that could only be accessed by the study data coordinator. Apart from the data coordinator, all research personnel, including investigators, study coordinators, and BP technicians, and the study participants were unaware of treatment assignment.|The trial participants were assigned to take 40 g/d soy protein, milk protein, or carbohydrate supplementation each for 8 weeks in a random order. A 3-week washout period was implemented between the interventions.|t||t|t
1565902|NCT00107731|Randomized|Parallel Assignment||Prevention||Double||||||
1565903|NCT00107718|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565904|NCT00107705|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1565905|NCT00107692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565906|NCT00107679|||||Prospective|||||||
1565907|NCT00107666|Randomized|Parallel Assignment||Prevention||Double||||||
1565908|NCT00107653||Single Group Assignment||Treatment||None (Open Label)||||||
1565909|NCT00107640|Randomized|Parallel Assignment||Health Services Research||Single|||||t|
1565910|NCT00107627|Randomized|Parallel Assignment||||None (Open Label)||||||
1565911|NCT00107614|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565912|NCT00107601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565913|NCT00107588|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565914|NCT00107575|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1565915|NCT00107562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565916|NCT00107549||Single Group Assignment||Treatment||None (Open Label)||||||
1565917|NCT00107536||Single Group Assignment||Treatment||None (Open Label)||||||
1565918|NCT00107523||||Treatment||None (Open Label)||||||
1565919|NCT00107510||Single Group Assignment||Treatment||None (Open Label)||||||
1565920|NCT00107497|Randomized|||Treatment||||||||
1565921|NCT00107484|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1565922|NCT00107471|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573253|NCT00001906||||Treatment||||||||
1565923|NCT00107458|Randomized|Single Group Assignment||Treatment||Single|||t|||
1565924|NCT00107445||Single Group Assignment||Diagnostic||None (Open Label)||||||
1565925|NCT00107432||Single Group Assignment||Treatment||None (Open Label)||||||
1565926|NCT00107419||Single Group Assignment||Treatment||None (Open Label)||||||
1565927|NCT00107393||||Treatment||None (Open Label)||||||
1565928|NCT00107380||Single Group Assignment||Treatment||None (Open Label)||||||
1565929|NCT00107367||||Treatment||None (Open Label)||||||
1565930|NCT00107354||||Treatment||None (Open Label)||||||
1565931|NCT00107341||Single Group Assignment||Treatment||None (Open Label)||||||
1565932|NCT00107315||Single Group Assignment||Treatment||None (Open Label)||||||
1565933|NCT00107289||Single Group Assignment||Treatment||None (Open Label)||||||
1565934|NCT00107276||Single Group Assignment||Treatment||None (Open Label)||||||
1565935|NCT00107263|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1565936|NCT00107250|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565937|NCT00107237|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565938|NCT00107211||||Treatment||||||||
1565939|NCT00107198||Single Group Assignment||Treatment||None (Open Label)||||||
1565940|NCT00107185||Single Group Assignment||Treatment||None (Open Label)||||||
1565941|NCT00107172|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565942|NCT00107159||||Treatment||None (Open Label)||||||
1565943|NCT00107120|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565944|NCT00107107||Single Group Assignment||Treatment||None (Open Label)||||||
1565945|NCT00107094|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565946|NCT00107081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565947|NCT00107068|Randomized|Factorial Assignment||Treatment||Double||||||
1565948|NCT00107055|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1565949|NCT00107042|Randomized|Parallel Assignment||Prevention||Single|||t|||
1565950|NCT00107029|||Cohort||Other|||||||
1565951|NCT00107016|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1565952|NCT00107003||||Treatment||None (Open Label)||||||
1565953|NCT00106977|||||Other|||||||
1565954|NCT00106964|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565955|NCT00106951|||||Retrospective|||||||
1565956|NCT00106938|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1565957|NCT00106925|||Case-Control||Prospective|||||||
1565958|NCT00106912||||||||||||
1565959|NCT00106899|||Case Control||Prospective|||||||
1565960|NCT00106886|Randomized|Single Group Assignment||Prevention||Double||||||
1565961|NCT00106860|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565962|NCT00106847|Randomized|Parallel Assignment||Treatment||Double||||||
1565963|NCT00106834|Randomized|Crossover Assignment||Treatment||Double||||||
1565964|NCT00106821|Randomized|Parallel Assignment||Treatment||Double||||||
1565965|NCT00106808|Randomized|Parallel Assignment||Treatment||Double||||||
1565966|NCT00106795||||||||||||
1565967|NCT00106782|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1565968|NCT00106769||||Treatment||||||||
1565969|NCT00106756||||||||||||
1565970|NCT00106743|||Cohort||Prospective|||||||
1565971|NCT00106717|Randomized|Parallel Assignment||Treatment||Single||||||
1565972|NCT00106704|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1565973|NCT00106691|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1565974|NCT00106678|||Case-Control||Cross-Sectional|||||||
1565975|NCT00106665|||Cohort||Prospective|||||||
1565976|NCT00106652|||||Other|||||||
1565977|NCT00106639|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1565978|NCT00106626|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565979|NCT00106613||Single Group Assignment||Treatment||None (Open Label)||||||
1565980|NCT00106600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565981|NCT00106587|Randomized|Parallel Assignment||Treatment||Double||||||
1565982|NCT00106574|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565983|NCT00106561|Randomized|Parallel Assignment||Prevention||Double||||||
1565984|NCT00106548|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565985|NCT00106535|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565986|NCT00106522|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1565987|NCT00106509|Randomized|Parallel Assignment||Treatment||Double||||||
1565988|NCT00106496|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1565989|NCT00106483|||Cohort||Retrospective|||||||
1565990|NCT00106470|||Family-Based||Cross-Sectional|||||||
1565991|NCT00106457||||||||||||
1565992|NCT00106431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565993|NCT00106418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565994|NCT00106405||||Treatment||None (Open Label)||||||
1565995|NCT00106392|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1565996|NCT00106379|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1565997|NCT00106366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1565998|NCT00106353||Parallel Assignment||Treatment||None (Open Label)||||||
1565999|NCT00106340|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566000|NCT00106327|Randomized|Parallel Assignment||Treatment||Single||||||t
1566001|NCT00106314|Randomized|Parallel Assignment||Treatment||Double||||||
1566002|NCT00106301||Single Group Assignment||Treatment||None (Open Label)||||||
1566003|NCT00106288|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573254|NCT00001904||||||||||||
1566004|NCT00106275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566005|NCT00106262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566006|NCT00106249|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1566007|NCT00106236|Randomized|Parallel Assignment||||None (Open Label)||||||
1566008|NCT00106223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566009|NCT00106210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566010|NCT00106197|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566011|NCT00106184|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566012|NCT00106171|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566013|NCT00106158|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566014|NCT00106145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566015|NCT00106132||||Treatment||||||||
1566016|NCT00106119|Randomized|Crossover Assignment||||Triple|||t|t|t|
1566017|NCT00106106|Randomized|Parallel Assignment||||Quadruple|||t|t|t|t
1566018|NCT00106093||||||||||||
1566019|NCT00106080|Randomized|Parallel Assignment||||Double|||||t|t
1566020|NCT00106067|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1566021|NCT00106054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566022|NCT00106041|Randomized|Parallel Assignment||Treatment||Single||||||t
1566023|NCT00106028|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566024|NCT00106015|||Cohort||Prospective|||||||
1566025|NCT00106002|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566026|NCT00105989|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566027|NCT00105976|Randomized|Parallel Assignment||Treatment||Double||||||
1566028|NCT00105963|Randomized|Single Group Assignment||Prevention||Single||||||
1566029|NCT00105950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566030|NCT00105937|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566031|NCT00105911||Parallel Assignment||Treatment||Single||||||
1566032|NCT00105898|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566033|NCT00105885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566034|NCT00105872|Randomized|Parallel Assignment||Treatment||Single||||||
1566035|NCT00105859|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1566036|NCT00105846|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566037|NCT00105833|Randomized|Parallel Assignment||Treatment||Single||||||t
1566038|NCT00105820|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1566039|NCT00105807||||Treatment||||||||
1566040|NCT00105794|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1566041|NCT00105781|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566042|NCT00105768|Randomized|Parallel Assignment||Treatment||Single||||||
1566043|NCT00105755|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1566044|NCT00105742|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1566045|NCT00105729|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566046|NCT00105716|Randomized|Factorial Assignment||||None (Open Label)||||||
1566047|NCT00105703|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566048|NCT00105690|Randomized|Parallel Assignment||Treatment||Single||||||
1566049|NCT00105677||||||||||||
1566050|NCT00105664|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566051|NCT00105651|Randomized|Single Group Assignment||||None (Open Label)||||||
1566052|NCT00105638|Randomized|Single Group Assignment||||None (Open Label)||||||
1566053|NCT00105625|||||Prospective|||||||
1566054|NCT00105612|Randomized|||||||||||
1566055|NCT00105599|Randomized|Single Group Assignment||||None (Open Label)||||||
1566056|NCT00105586|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566057|NCT00105573|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566058|NCT00105560||Single Group Assignment||Treatment||None (Open Label)||||||
1566059|NCT00105547|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566060|NCT00105534|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566061|NCT00105521|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566062|NCT00105508|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566063|NCT00105495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566064|NCT00105482|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566065|NCT00105469|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1566066|NCT00105456|||Cohort||Prospective|||||||
1566067|NCT00105443|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566068|NCT00105430||||Treatment||||||||
1566069|NCT00105417||||Treatment||||||||
1566070|NCT00105404||||Treatment||||||||
1566071|NCT00105378|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1566072|NCT00105365|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566073|NCT00105352|Randomized|Crossover Assignment||Diagnostic||None (Open Label)||||||
1566074|NCT00105339|||Cohort||Prospective|||||||
1566075|NCT00105326|Randomized|Parallel Assignment||Treatment||Double||||||
1566076|NCT00105313|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566077|NCT00105300|Randomized|Parallel Assignment||Treatment||Double||||||
1566078|NCT00105287|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566079|NCT00105274||||||||||||
1566080|NCT00105248|Randomized|Parallel Assignment||||Single||||||
1566081|NCT00105235|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566083|NCT00105209|Randomized|Crossover Assignment||Treatment||Double||||||
1566084|NCT00105196|Randomized|Parallel Assignment||Diagnostic||Double|||t||t|
1566085|NCT00105183|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1566086|NCT00105170|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566087|NCT00105157|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566088|NCT00105144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566089|NCT00105131||||||||||||
1566090|NCT00105118||||||||||||
1566091|NCT00105105|Randomized|Parallel Assignment||Treatment||Double||||||
1566092|NCT00105092|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566093|NCT00105079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566094|NCT00105066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566095|NCT00105053|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566096|NCT00105040|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566097|NCT00105027|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566098|NCT00105001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566099|NCT00104988||Single Group Assignment||Treatment||None (Open Label)||||||
1566100|NCT00104975||||Treatment||||||||
1566101|NCT00104962||Single Group Assignment||Treatment||None (Open Label)||||||
1566102|NCT00104949||||Treatment||||||||
1566103|NCT00104936|Randomized|||Treatment||||||||
1566104|NCT00104923|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566105|NCT00104910||Single Group Assignment||Treatment||None (Open Label)||||||
1566106|NCT00104897||||Treatment||None (Open Label)||||||
1566107|NCT00104884||Single Group Assignment||Treatment||None (Open Label)||||||
1566108|NCT00104871||Single Group Assignment||Treatment||None (Open Label)||||||
1566109|NCT00104858||Single Group Assignment||Treatment||None (Open Label)||||||
1566110|NCT00104845|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1566111|NCT00104819||||Treatment||None (Open Label)||||||
1566112|NCT00104806|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566113|NCT00104793||||Treatment||None (Open Label)||||||
1566114|NCT00104780||||Treatment||None (Open Label)||||||
1566115|NCT00104767||Single Group Assignment||Treatment||None (Open Label)||||||
1566116|NCT00104754||||Treatment||None (Open Label)||||||
1566117|NCT00104741|Randomized|||Treatment||||||||
1566118|NCT00104728||Single Group Assignment||Treatment||None (Open Label)||||||
1566119|NCT00104715|Randomized|||Treatment||||||||
1566120|NCT00104702||Single Group Assignment||Treatment||None (Open Label)||||||
1566121|NCT00104689||||Treatment||None (Open Label)||||||
1566122|NCT00104676||||Treatment||None (Open Label)||||||
1566123|NCT00104663|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566124|NCT00104650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566125|NCT00104637|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1566126|NCT00104624||||Treatment||None (Open Label)||||||
1566127|NCT00104611|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566128|NCT00104598|Randomized|Parallel Assignment||Treatment||Single|||||t|
1566129|NCT00104585|||Family-Based||Cross-Sectional|||||||
1566130|NCT00104572|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566131|NCT00104559|Randomized|Parallel Assignment||||None (Open Label)||||||
1566132|NCT00104546|Randomized|Parallel Assignment||Treatment||Single||||||
1566133|NCT00104533|Randomized|Parallel Assignment||Treatment||Double||||||
1566134|NCT00104520|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566135|NCT00104507|Randomized|Parallel Assignment||Treatment||Double||||||
1566136|NCT00104494|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566137|NCT00104481|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566138|NCT00104468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566139|NCT00104455|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566140|NCT00104442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566141|NCT00104429|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566142|NCT00104416|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566143|NCT00104403|Randomized|Parallel Assignment||Treatment||Double||||||
1566144|NCT00104390|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1566145|NCT00104377|Randomized|Parallel Assignment||Treatment||Single||||||
1566146|NCT00104364|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566147|NCT00104338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566148|NCT00104325|||||Prospective|||||||
1566149|NCT00104312|||Cohort||Cross-Sectional|||||||
1566150|NCT00104299|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566151|NCT00104286|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566152|NCT00104273|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566153|NCT00104260|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566154|NCT00104247|Randomized|Parallel Assignment||Treatment||Double||||||
1566155|NCT00104234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566156|NCT00104195|||Case Control|||||||||
1566157|NCT00104182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566158|NCT00104169|Non-Randomized|||Treatment||||||||
1566159|NCT00104156|Randomized|Parallel Assignment||Treatment||Double||||||
1566160|NCT00104143|Randomized|Parallel Assignment||Treatment||Double||||||
1566161|NCT00104130|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573255|NCT00001903||||Treatment||||||||
1566162|NCT00104117|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566163|NCT00104104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566164|NCT00104091|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566165|NCT00104078|Randomized|Crossover Assignment||Treatment||Double||||||
1566166|NCT00104065|Randomized|Parallel Assignment||Prevention||Double||||||
1566167|NCT00104052|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566168|NCT00104039||||||||||||
1566169|NCT00104026||||||||||||
1566170|NCT00104013|Randomized|Parallel Assignment||Treatment||Double||||||
1566171|NCT00104000||||||||||||
1566172|NCT00103987||||||||||||
1566173|NCT00103974|Randomized|Crossover Assignment||Treatment||Double||||||
1566174|NCT00103961|||Cohort||Prospective|||||||
1566175|NCT00103948|Randomized|Parallel Assignment||Treatment||Double||||||
1566176|NCT00103935|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566177|NCT00103922|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566178|NCT00103896|||Ecologic or Community||Prospective|||||||
1566179|NCT00103883|||Case-Control||Cross-Sectional|||||||
1566180|NCT00103870|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566181|NCT00103857|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1566182|NCT00103844|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1566183|NCT00103831||||Treatment||||||||
1566184|NCT00103818|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566185|NCT00103805|Randomized|Crossover Assignment||Treatment||Double||||||
1566186|NCT00103792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566187|NCT00103779||Single Group Assignment||Treatment||None (Open Label)||||||
1566188|NCT00103766|Randomized|Parallel Assignment||Treatment||Double||||||
1566189|NCT00103753|Randomized|Single Group Assignment||Treatment||Double||||||
1566190|NCT00103740|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566191|NCT00103727|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566192|NCT00103714|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566193|NCT00103701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566194|NCT00103675|Non-Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1566195|NCT00103662|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566196|NCT00103649|Randomized|Parallel Assignment||Treatment||Double||||||
1566197|NCT00103636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566198|NCT00103623|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566199|NCT00103610|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566200|NCT00103597|Randomized|Crossover Assignment||Treatment||Double||||||
1566201|NCT00103584|Randomized|Parallel Assignment||Prevention||Double||||||
1566202|NCT00103571|Randomized|Parallel Assignment||Treatment||Double||||||
1566203|NCT00103558|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566204|NCT00103545|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1566205|NCT00103532|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566206|NCT00103519|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1566207|NCT00103506|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566208|NCT00103493|Randomized|Parallel Assignment||||Single||||||
1566209|NCT00103467|Randomized|Parallel Assignment||Prevention||Double||||||
1566210|NCT00103454|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566211|NCT00103428|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566212|NCT00103415|Randomized|Parallel Assignment||Treatment||Single||||||
1566213|NCT00103402|Randomized|Single Group Assignment||Treatment||Double||||||
1566214|NCT00103389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566215|NCT00103376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566216|NCT00103363||||Screening||||||||
1566217|NCT00103350|Randomized|Single Group Assignment||Treatment||Double||||||
1566218|NCT00103337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566219|NCT00103324||Single Group Assignment||Treatment||None (Open Label)||||||
1566220|NCT00103311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566221|NCT00103298||||Treatment||None (Open Label)||||||
1566222|NCT00103285|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566223|NCT00103272||Single Group Assignment||Treatment||None (Open Label)||||||
1566224|NCT00103259|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566225|NCT00103246||Single Group Assignment||Treatment||None (Open Label)||||||
1566226|NCT00103233|Randomized|||Treatment||||||||
1566227|NCT00103220||Single Group Assignment||Treatment||None (Open Label)||||||
1566228|NCT00103207||Single Group Assignment||Treatment||None (Open Label)||||||
1566229|NCT00103194||Single Group Assignment||Treatment||None (Open Label)||||||
1566230|NCT00103181|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566231|NCT00103168|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566232|NCT00103155||||Treatment||||||||
1566233|NCT00103142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566234|NCT00103116||Single Group Assignment||Treatment||None (Open Label)||||||
1566235|NCT00103103||||Treatment||None (Open Label)||||||
1566236|NCT00103051||||Treatment||None (Open Label)||||||
1566237|NCT00103038||Single Group Assignment||Diagnostic||None (Open Label)||||||
1566238|NCT00103025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566239|NCT00103012|Randomized|Crossover Assignment||||None (Open Label)||||||
1566241|NCT00102986|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566242|NCT00102973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566243|NCT00102960|Randomized|Parallel Assignment||Treatment||None (Open Label)||This study had two parts: Part A where children were enrolled with CD4% ≥ 25% and Part B where children were enrolled with CD4% < 25%. Part A had three arms: ART-Deferred, ART-40W and ART-96W where ART-40W and ART-96W were the early therapy arms for 40 and 96 weeks respectively. Part B were enrolled into two Arms: ART-40W and ART-96W. The primary efficacy analysis for CHER was based on 377 children that were enrolled in Part A in the first phase of the study. The NIH African data safety and monitoring board recommended that primary analysis be focussed on 377 children enrolled in the first phase of Part A. Additionally, all the key manuscripts have been analysed using this group. Hence all the results presented in clinicaltrials.gov will be specific to this group with three arms.||||
1566244|NCT00102947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566245|NCT00102934|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566246|NCT00102921|Randomized|Parallel Assignment||Treatment||Double||||||
1566247|NCT00102908|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1566248|NCT00102895|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566249|NCT00102882|Randomized|Parallel Assignment||Treatment||Double||||||
1566250|NCT00102869|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1566251|NCT00102856|Randomized|Parallel Assignment||Treatment||Double||||||
1566252|NCT00102843|Randomized|Crossover Assignment||Prevention||Double||||||
1566253|NCT00102830||||Treatment||||||||
1566254|NCT00102817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566255|NCT00102804|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566256|NCT00102791|Randomized|Parallel Assignment||Treatment||Double||||||
1566257|NCT00102778|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566258|NCT00102765|Randomized|Parallel Assignment||Treatment||Double||||||
1566259|NCT00102752|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566260|NCT00102739|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566261|NCT00102726|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566262|NCT00102713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566263|NCT00102700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566264|NCT00102687|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566265|NCT00102674|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566266|NCT00102661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566267|NCT00102648||Single Group Assignment||Treatment||None (Open Label)||||||
1566268|NCT00102635|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566269|NCT00102622|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566270|NCT00102609||Single Group Assignment||Treatment||None (Open Label)||||||
1566271|NCT00102596||Single Group Assignment||Treatment||None (Open Label)||||||
1566272|NCT00102583|Randomized|||Treatment||||||||
1566273|NCT00102570||||||||||||
1566274|NCT00102557||||Treatment||||||||
1566275|NCT00102544|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1566276|NCT00102531|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566277|NCT00102518||Single Group Assignment||Treatment||None (Open Label)||||||
1566278|NCT00102505|Non-Randomized|||Treatment||None (Open Label)||||||
1566279|NCT00102492|Randomized|Parallel Assignment||Treatment||Double||||||
1566280|NCT00102479|Randomized|||Treatment||None (Open Label)||||||
1566281|NCT00102466|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566282|NCT00102453|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566283|NCT00102440|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1566284|NCT00102427|Randomized|Parallel Assignment||Treatment||Single||||||
1566285|NCT00102414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566286|NCT00102401|Randomized|Parallel Assignment||Treatment||Single||||||
1566287|NCT00102388|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566288|NCT00102375|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566289|NCT00102362|Randomized|||||||||||
1566290|NCT00102349||||Prevention||||||||
1566291|NCT00102336|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566292|NCT00102323|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566293|NCT00102310|Randomized|Parallel Assignment||Treatment||Double||||||
1566294|NCT00102297|Non-Randomized|||Treatment||None (Open Label)||||||
1566295|NCT00102284|Randomized|Parallel Assignment||Treatment||Double||||||
1566296|NCT00102271||||Treatment||||||||
1566297|NCT00102258||||Treatment||||||||
1566298|NCT00102245|||Cohort||Prospective|||||||
1566299|NCT00102232|Randomized|Crossover Assignment||Prevention||Double||||||
1566300|NCT00102219|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566301|NCT00102206|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566302|NCT00102193|Randomized|Parallel Assignment||Treatment||Double||||||
1566303|NCT00102180|||Case Control||Retrospective|||||||
1566304|NCT00102167|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566305|NCT00102154|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566306|NCT00102141|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1566307|NCT00102128|Randomized|Parallel Assignment||Treatment||Double||||||
1566308|NCT00102115|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1566309|NCT00102102||||||||||||
1566310|NCT00102089||||Treatment||||||||
1566311|NCT00102076||||||||||||
1566392|NCT00100958|Randomized|||Prevention||Double||||||
1566312|NCT00102063|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566313|NCT00102050|Randomized|Parallel Assignment||Treatment||Double||||||
1566314|NCT00102037|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1566315|NCT00102024|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566316|NCT00102011|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1566317|NCT00101998|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566318|NCT00101985|Randomized|Parallel Assignment||Treatment||Double||||||
1566319|NCT00101972||Single Group Assignment||Treatment||None (Open Label)||||||
1566320|NCT00101959||||Treatment||||||||
1566321|NCT00101946|Randomized|Parallel Assignment||Treatment||Double||||||
1566322|NCT00101933|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566323|NCT00101920|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566324|NCT00101907|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566325|NCT00101894|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566326|NCT00101881|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1566327|NCT00101868|Randomized|Parallel Assignment||Health Services Research||Single||||||t
1566328|NCT00101855|Randomized|Parallel Assignment||Prevention||Single||||||
1566329|NCT00101842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566330|NCT00101829||Single Group Assignment||Treatment||None (Open Label)||||||
1566331|NCT00101816|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566332|NCT00101803|Randomized|Parallel Assignment||Treatment||Double||||||
1566333|NCT00101790|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1566334|NCT00101777||||||||||||
1566335|NCT00101764||||Treatment||||||||
1566336|NCT00101751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566337|NCT00101738|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566338|NCT00101725|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566339|NCT00101712|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566340|NCT00101699|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1566341|NCT00101686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566342|NCT00101673|Randomized|Parallel Assignment||Treatment||Double||||||
1566343|NCT00101660|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566344|NCT00101647|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566345|NCT00101634|Randomized|Parallel Assignment||Treatment||Double||||||
1566346|NCT00101621|Randomized|Factorial Assignment||Treatment||Double||||||
1566347|NCT00101608|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566348|NCT00101595|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566349|NCT00101582|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566350|NCT00101569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566351|NCT00101543|Randomized|Parallel Assignment||Treatment||Single||||||
1566352|NCT00101530|||Cohort||Prospective|||||||
1566353|NCT00101517|||Ecologic or Community||Cross-Sectional|||||||
1566354|NCT00101504||||||||||||
1566355|NCT00101491|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1566356|NCT00101478|||Case-Control||Other|||||||
1566357|NCT00101465|||Cohort||Prospective|||||||
1566358|NCT00101452|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566359|NCT00101439|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1566360|NCT00101426|Randomized|Parallel Assignment||Treatment||Double||||||
1566361|NCT00101413|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566362|NCT00101400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566363|NCT00101387|Randomized|Parallel Assignment||Treatment||Single||||||t
1566364|NCT00101374||||Treatment||||||||
1566365|NCT00101361|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566366|NCT00101348||Single Group Assignment||Treatment||None (Open Label)||||||
1566367|NCT00101335|Randomized|||Prevention||Double||||||
1566368|NCT00101309||||Treatment||||||||
1566369|NCT00101296||Single Group Assignment||Treatment||None (Open Label)||||||
1566370|NCT00101283|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566371|NCT00101270||Single Group Assignment||Treatment||None (Open Label)||||||
1566372|NCT00101257||||Treatment||||||||
1566373|NCT00101244||Single Group Assignment||Treatment||None (Open Label)||||||
1566374|NCT00101231||Single Group Assignment||Treatment||None (Open Label)||||||
1566375|NCT00101205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566376|NCT00101192||||Treatment||None (Open Label)||||||
1566377|NCT00101179||Single Group Assignment||Treatment||None (Open Label)||||||
1566378|NCT00101166||Single Group Assignment||Treatment||None (Open Label)||||||
1566379|NCT00101153||Parallel Assignment||Treatment||None (Open Label)||||||
1566380|NCT00101140||||Treatment||||||||
1566381|NCT00101127||||Treatment||None (Open Label)||||||
1566382|NCT00101114||Single Group Assignment||Treatment||None (Open Label)||||||
1566383|NCT00101101||Single Group Assignment||Treatment||None (Open Label)||||||
1566384|NCT00101088||Single Group Assignment||Treatment||None (Open Label)||||||
1566385|NCT00101075||Single Group Assignment||Treatment||None (Open Label)||||||
1566386|NCT00101062||||Treatment||None (Open Label)||||||
1566387|NCT00101036||Single Group Assignment||Treatment||None (Open Label)||||||
1566388|NCT00101010||Single Group Assignment||Treatment||None (Open Label)||||||
1566389|NCT00100997||||Treatment||None (Open Label)||||||
1566390|NCT00100984|Randomized|||Treatment||||||||
1566393|NCT00100945||Single Group Assignment||Treatment||None (Open Label)||||||
1566394|NCT00100932|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566395|NCT00100919||||||||||||
1566396|NCT00100906|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566397|NCT00100893||Single Group Assignment||Prevention||None (Open Label)||||||
1566398|NCT00100880||Single Group Assignment||Treatment||None (Open Label)||||||
1566399|NCT00100867|||Cohort||Prospective|||||||
1566400|NCT00100854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566401|NCT00100841||Single Group Assignment||Treatment||None (Open Label)||||||
1566402|NCT00100828||Single Group Assignment||Treatment||None (Open Label)||||||
1566403|NCT00100815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566404|NCT00100802||Single Group Assignment||Treatment||None (Open Label)||||||
1566405|NCT00100789||Single Group Assignment||Treatment||None (Open Label)||||||
1566406|NCT00100776|Randomized|Parallel Assignment||Treatment||Double||||||
1566407|NCT00100750||Single Group Assignment||Treatment||None (Open Label)||||||
1566408|NCT00100737|Randomized|||Treatment||None (Open Label)||||||
1566409|NCT00100724|Randomized|Parallel Assignment||Prevention||Double||||||
1566410|NCT00100711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566411|NCT00100698|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566412|NCT00100685|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566413|NCT00100672|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566414|NCT00100659|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566415|NCT00100646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566416|NCT00100633|Randomized|Parallel Assignment||Treatment||Double||||||
1566417|NCT00100620|Randomized|Parallel Assignment||Treatment||Double||||||
1566418|NCT00100607|Randomized|Parallel Assignment||Treatment||Double||||||
1566419|NCT00100594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566420|NCT00100581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566421|NCT00100568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566422|NCT00100555|Randomized|Parallel Assignment||Treatment||Double||||||
1566423|NCT00100542|||Case Control||Prospective|||||||
1566424|NCT00100529||||||||||||
1566425|NCT00100516||||||||||||
1566426|NCT00100503||||||||||||
1566427|NCT00100490|||||Prospective|||||||
1566428|NCT00100477||||||||||||
1566429|NCT00100464|Randomized|Crossover Assignment||Treatment||Double||||||
1566430|NCT00100451||||Treatment||||||||
1566431|NCT00100438||||||||||||
1566432|NCT00100425|Non-Randomized|Single Group Assignment||Diagnostic||Double||||||
1566433|NCT00100412||||Diagnostic||||||||
1566434|NCT00100399|Randomized|Crossover Assignment||Prevention||Double||||||
1566435|NCT00100386|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1566436|NCT00100373|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1566437|NCT00100360||||||||||||
1566438|NCT00100347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566439|NCT00100334|Randomized|Parallel Assignment||Treatment||Double||||||
1566440|NCT00100321||||||||||||
1566441|NCT00100308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566442|NCT00100295|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1566443|NCT00100282|Randomized|Parallel Assignment||Treatment||Double||||||
1566444|NCT00100269|Randomized|Parallel Assignment||Treatment||Double||||||
1566445|NCT00100256|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566446|NCT00100243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566447|NCT00100230|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1566448|NCT00100217||||||||||||
1566449|NCT00100204||||||||||||
1566450|NCT00100191|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566451|NCT00100178|Randomized|Parallel Assignment||||Triple|||t|t|t|
1566452|NCT00100165|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1566453|NCT00100152|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566454|NCT00100139|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1566455|NCT00100126|Randomized|Parallel Assignment||Treatment||Single||||||
1566456|NCT00100113||||Treatment||||||||
1566457|NCT00100100||||Diagnostic||||||||
1566458|NCT00100087|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566459|NCT00100074||||Diagnostic||||||||
1566460|NCT00100061|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1566461|NCT00100048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566462|NCT00100035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566463|NCT00100009||||Treatment||||||||
1566464|NCT00099996||||Treatment||||||||
1566465|NCT00099983|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566466|NCT00099970|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566467|NCT00099957|Randomized|Parallel Assignment||Treatment||Double||||||
1566468|NCT00099944|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566469|NCT00099931|Randomized|Parallel Assignment||Treatment||Double||||||
1566470|NCT00099918|Randomized|Parallel Assignment||Treatment||Double||||||
1566471|NCT00099905|Randomized|Parallel Assignment||Treatment||Double||||||
1566472|NCT00099892|Randomized|Parallel Assignment||Treatment||Double||||||
1566473|NCT00099879|Randomized|||Treatment||||||||
1566474|NCT00099866|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566475|NCT00099853|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566476|NCT00099840|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1566477|NCT00099827|Randomized|Parallel Assignment||||None (Open Label)||||||
1566478|NCT00099814|Randomized|Single Group Assignment||Treatment||Single||||||
1566479|NCT00099801|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566480|NCT00099788|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566481|NCT00099775||||Treatment||||||||
1566482|NCT00099762||||||||||||
1566483|NCT00099749|Randomized|Parallel Assignment||Treatment||Double||||||
1566484|NCT00099736|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566485|NCT00099723|Randomized|Single Group Assignment||Treatment||Double||||||
1566486|NCT00099710|Randomized|Parallel Assignment||Treatment||Double||||||
1566487|NCT00099697|Randomized|||Prevention||Double||||||
1566488|NCT00099684|Randomized|Crossover Assignment||Treatment||Double||||||
1566489|NCT00099671|Randomized|Parallel Assignment||Treatment||Double||||||
1566490|NCT00099658|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1566491|NCT00099645|Randomized|Parallel Assignment||Treatment||Double||||||
1566492|NCT00099632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566493|NCT00099619|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1566494|NCT00099606|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566495|NCT00099593|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566496|NCT00099580|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566497|NCT00099567|Random Sample||Natural History||Longitudinal, Prospective|||||||
1566498|NCT00099554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566499|NCT00099541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566500|NCT00099528|Randomized|Parallel Assignment||Treatment||Double||||||
1566501|NCT00099515|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566502|NCT00099502|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1566503|NCT00099489|Randomized|Parallel Assignment||Treatment||Double||||||
1566504|NCT00099476||||Treatment||||||||
1566505|NCT00099463||||Treatment||||||||
1566506|NCT00099450|Randomized|Single Group Assignment||Treatment||Double||||||
1566507|NCT00099437|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566508|NCT00099424|Randomized|Crossover Assignment||||Single||||||
1566509|NCT00099411|||Cohort||Prospective|||||||
1566510|NCT00099385|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1566511|NCT00099372|||Cohort||Prospective|||||||
1566512|NCT00099359|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1566513|NCT00099346|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566514|NCT00099333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566515|NCT00099320|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566516|NCT00099307||||||||||||
1566517|NCT00099294|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566518|NCT00099281|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566519|NCT00099268|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1566520|NCT00099255|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1566521|NCT00099242|Randomized|Parallel Assignment||Treatment||Double||||||
1566522|NCT00099229|Randomized|Parallel Assignment||Treatment||Double||||||
1566523|NCT00099216|Randomized|Parallel Assignment||Treatment||Double||||||
1566524|NCT00099203|Randomized|Parallel Assignment||Treatment||Double||||||
1566525|NCT00099190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566526|NCT00099177|Randomized|Parallel Assignment||Treatment||Double||||||
1566527|NCT00099164|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1566528|NCT00099151|Randomized|Parallel Assignment||Prevention||Single||||||
1566529|NCT00099138|Randomized|Parallel Assignment||Prevention||Single||||||
1566530|NCT00099125||Single Group Assignment||Treatment||None (Open Label)||||||
1566531|NCT00099112||||||||||||
1566532|NCT00099099|Randomized|Parallel Assignment||Prevention||Single||||||
1566533|NCT00099086||Single Group Assignment||Treatment||None (Open Label)||||||
1566534|NCT00099060||Single Group Assignment||Treatment||None (Open Label)||||||
1566535|NCT00099047|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1566536|NCT00099021||Single Group Assignment||Prevention||None (Open Label)||||||
1566537|NCT00099008|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1566538|NCT00098995||||Treatment||||||||
1566539|NCT00098982||||Treatment||None (Open Label)||||||
1566540|NCT00098969||||Prevention||None (Open Label)||||||
1566541|NCT00098956||Single Group Assignment||Treatment||None (Open Label)||||||
1566542|NCT00098943||||Treatment||None (Open Label)||||||
1566543|NCT00098917||||Treatment||||||||
1566544|NCT00098891||Single Group Assignment||Treatment||None (Open Label)||||||
1566545|NCT00098878|Randomized|||Treatment||||||||
1566546|NCT00098865||Single Group Assignment||Treatment||None (Open Label)||||||
1566547|NCT00098852||||Treatment||||||||
1566548|NCT00098839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566549|NCT00098826||Single Group Assignment||Treatment||None (Open Label)||||||
1566550|NCT00098813||Single Group Assignment||Treatment||None (Open Label)||||||
1566551|NCT00098800|Randomized|||Prevention||Double||||||
1566552|NCT00098787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566553|NCT00098774||Single Group Assignment||Treatment||None (Open Label)||||||
1566554|NCT00098761||Single Group Assignment||Treatment||None (Open Label)||||||
1566555|NCT00098748|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566556|NCT00098735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566557|NCT00098722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566558|NCT00098709|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1566559|NCT00098683||||Treatment||None (Open Label)||||||
1566560|NCT00098670||Single Group Assignment||Treatment||None (Open Label)||||||
1566561|NCT00098631||Single Group Assignment||Treatment||None (Open Label)||||||
1566562|NCT00098618||Single Group Assignment||Treatment||None (Open Label)||||||
1566563|NCT00098605||Single Group Assignment||Treatment||None (Open Label)||||||
1566564|NCT00098579||Single Group Assignment||Treatment||None (Open Label)||||||
1566565|NCT00098566|||Cohort||Prospective|||||||
1566566|NCT00098553||Single Group Assignment||Treatment||None (Open Label)||||||
1566567|NCT00098540||Single Group Assignment||Treatment||None (Open Label)||||||
1566568|NCT00098527||Single Group Assignment||Treatment||None (Open Label)||||||
1566569|NCT00098514||Single Group Assignment||Treatment||None (Open Label)||There were 7 potential PT523 single agent dose levels to be evaluated in this phase I study||||
1566570|NCT00098501||Single Group Assignment||Treatment||None (Open Label)||||||
1566571|NCT00098488||Single Group Assignment||Treatment||None (Open Label)||||||
1566572|NCT00098475|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566573|NCT00098462||||Treatment||None (Open Label)||||||
1566574|NCT00098436||||Treatment||None (Open Label)||||||
1566575|NCT00098423||Single Group Assignment||Treatment||None (Open Label)||||||
1566576|NCT00098397||Single Group Assignment||Treatment||None (Open Label)||||||
1566577|NCT00098384|Randomized|Parallel Assignment||Prevention||Double||||||
1566578|NCT00098371||Single Group Assignment||Treatment||None (Open Label)||||||
1566579|NCT00098358|Randomized|Parallel Assignment||Treatment||Double||||||
1566580|NCT00098345||Single Group Assignment||Treatment||None (Open Label)||||||
1566581|NCT00098332||||Treatment||None (Open Label)||||||
1566582|NCT00098319|Randomized|Parallel Assignment||Prevention||Double||||||
1566583|NCT00098306|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566584|NCT00098293|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566585|NCT00098280||||Treatment||||||||
1566586|NCT00098267||||||||||||
1566587|NCT00098254|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566588|NCT00098241|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566589|NCT00098228|Randomized|Parallel Assignment||Treatment||Double||||||
1566590|NCT00098215|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1566591|NCT00098202|Randomized|Single Group Assignment||Prevention||Double||||||
1566592|NCT00098189|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1566593|NCT00098163|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1566594|NCT00098150|||Defined Population, Natural History||Longitudinal, Retrospective|||||||
1566595|NCT00098137|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1566596|NCT00098124|Randomized|Parallel Assignment||Treatment||Double||||||
1566597|NCT00098111|Randomized|Parallel Assignment||||Triple|||t|t|t|
1566598|NCT00098098|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1566599|NCT00098085|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1566600|NCT00098072||Parallel Assignment||Diagnostic||None (Open Label)||||||
1566601|NCT00098059|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566602|NCT00098046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566603|NCT00098033|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566604|NCT00098020||Single Group Assignment||Treatment||None (Open Label)||Phase II, open-label pilot study||||
1566605|NCT00098007|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566606|NCT00097994|||Cohort||Prospective|||||||
1566607|NCT00097981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566608|NCT00097968|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1566609|NCT00097955|Randomized|Parallel Assignment||Other||Double||||||
1566610|NCT00097942|Randomized|Parallel Assignment||Treatment||Double||||||
1566611|NCT00097929|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566612|NCT00097916|Randomized|Parallel Assignment||Treatment||Double||||||
1566613|NCT00097903|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1566614|NCT00097890||||Treatment||||||||
1566615|NCT00097877|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566616|NCT00097851|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566617|NCT00097838|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1566618|NCT00097825|Randomized|Parallel Assignment||Treatment||Double||||||
1566619|NCT00097812|Randomized|Parallel Assignment||Treatment||Double||||||
1566620|NCT00097799||||||||||||
1566621|NCT00097786|Randomized|Factorial Assignment||Prevention||Double|||t||t|
1566622|NCT00097773|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1566623|NCT00097760|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1566624|NCT00097747|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566625|NCT00097734|Randomized|Parallel Assignment||Educational/Counseling/Training||None (Open Label)||||||
1566626|NCT00097721||Single Group Assignment||Treatment||None (Open Label)||||||
1566627|NCT00097708|Randomized|Parallel Assignment||Treatment||Double||||||
1566628|NCT00097695|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1566629|NCT00097682||||||||||||
1566630|NCT00097669|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1566631|NCT00097656||Single Group Assignment||Treatment||Single||||||
1566632|NCT00097643|Randomized|Factorial Assignment||Treatment||Single||||||
1566633|NCT00097630|Randomized|Parallel Assignment||Treatment||Single||||||
1566634|NCT00097617|||Cohort||Prospective|||||||
1566635|NCT00097604|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1566636|NCT00097591|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566637|NCT00097578|||Cohort||Prospective|||||||
1566638|NCT00097565|||Cohort||Prospective|||||||
1566639|NCT00097552|||Cohort||Prospective|||||||
1566640|NCT00097539|||Cohort||Prospective|||||||
1566641|NCT00097526|||Cohort||Prospective|||||||
1566642|NCT00097513|||Cohort||Prospective|||||||
1566643|NCT00097500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566644|NCT00097487|||||Prospective|||||||
1566645|NCT00097474|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566646|NCT00097461|||||Prospective|||||||
1566647|NCT00097448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566648|NCT00097435|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566649|NCT00097422|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566650|NCT00097409|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566651|NCT00097396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566652|NCT00097383|Non-Randomized|||Treatment||||||||
1566653|NCT00097370||Single Group Assignment||Treatment||None (Open Label)||||||
1566654|NCT00097357|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1566655|NCT00097344|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566656|NCT00097331|Randomized|Parallel Assignment||Treatment||Double||||||
1566657|NCT00097318||||Treatment||||||||
1566658|NCT00097305|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566659|NCT00097292|||Cohort||Prospective|||||||
1566660|NCT00097279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566661|NCT00097266|Randomized|Parallel Assignment||Treatment||Double||||||
1566662|NCT00097253|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1566663|NCT00097240|||Cohort||Prospective|||||||
1566664|NCT00097227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566665|NCT00097214|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566666|NCT00097188||||Treatment||||||||
1566667|NCT00097175||||||||||||
1566668|NCT00097162||||Treatment||||||||
1566669|NCT00097149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566670|NCT00097123|Randomized|Parallel Assignment||Prevention||Double||||||
1566671|NCT00097110|Randomized|Parallel Assignment||Prevention||Double||||||
1566672|NCT00097097|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1566673|NCT00097084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566674|NCT00097071|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566675|NCT00097058|||Cohort||Prospective|||||||
1566676|NCT00097045|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566677|NCT00097032|Randomized|Crossover Assignment||||Double||||||
1566678|NCT00097019||||Treatment||||||||
1566679|NCT00097006||||||||||||
1566680|NCT00096993|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566681|NCT00096980|Randomized|||Treatment||None (Open Label)||||||
1566682|NCT00096967||||Treatment||None (Open Label)||||||
1566683|NCT00096954|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566684|NCT00096941||Single Group Assignment||Treatment||None (Open Label)||||||
1566685|NCT00096928|||Cohort||Prospective|||||||
1566686|NCT00096915|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566687|NCT00096902||||Treatment||||||||
1566688|NCT00096876|||||Prospective|||||||
1566689|NCT00096863|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1566690|NCT00096850|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566691|NCT00096837|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566692|NCT00096824|||Cohort||Prospective|||||||
1566693|NCT00096811||||||||||||
1566694|NCT00096798|Randomized|Parallel Assignment||Treatment||Double||||||
1566695|NCT00096785|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566696|NCT00096772||||||||||||
1566697|NCT00096759|Randomized|Single Group Assignment||Treatment||Single||||||
1566698|NCT00096746|||Cohort||Prospective|||||||
1566699|NCT00096733|||Cohort||Other|||||||
1566700|NCT00096720|Randomized|Single Group Assignment||Diagnostic||Single||||||
1566701|NCT00096707|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566702|NCT00096694|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1566703|NCT00096681|||Ecologic or Community||Prospective|||||||
1566704|NCT00096668|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566705|NCT00096655|Randomized|Parallel Assignment||Treatment||Double||||||
1566706|NCT00096642|Randomized|Parallel Assignment||Treatment||Single|||t|||
1566707|NCT00096629|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1566708|NCT00096616|Randomized|Crossover Assignment||Treatment||Double||||||
1566709|NCT00096603||||Treatment||None (Open Label)||||||
1566710|NCT00096590||||||||||||
1566711|NCT00096564||||||||||||
1566712|NCT00096551||||Treatment||||||||
1566713|NCT00096538||Single Group Assignment||Treatment||None (Open Label)||||||
1566714|NCT00096525||||Treatment||None (Open Label)||||||
1566715|NCT00096512||Single Group Assignment||Treatment||None (Open Label)||||||
1566716|NCT00096499||Single Group Assignment||Treatment||None (Open Label)||||||
1567564|NCT00002535||||Treatment||||||||
1566717|NCT00096486||Single Group Assignment||Treatment||None (Open Label)||||||
1566718|NCT00096473|Randomized|Parallel Assignment||Treatment||Double||||||
1566719|NCT00096460|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566720|NCT00096447||Single Group Assignment||Treatment||None (Open Label)||||||
1566721|NCT00096434||Single Group Assignment||Treatment||None (Open Label)||||||
1566722|NCT00096421|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566723|NCT00096408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566724|NCT00096395||Single Group Assignment||Treatment||None (Open Label)||||||
1566725|NCT00096382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566726|NCT00096369|Randomized|||Prevention||Double||||||
1566727|NCT00096356|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1566728|NCT00096343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566729|NCT00096330||Single Group Assignment||Prevention||None (Open Label)||||||
1566730|NCT00096317||Single Group Assignment||Treatment||None (Open Label)||||||
1566731|NCT00096304||||Treatment||||||||
1566732|NCT00096291|Randomized|Parallel Assignment||Basic Science||None (Open Label)||||||
1566733|NCT00096278|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566734|NCT00096265|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566735|NCT00096239||||Treatment||None (Open Label)||||||
1566736|NCT00096226||Single Group Assignment||Treatment||None (Open Label)||||||
1566737|NCT00096213||Single Group Assignment||Treatment||None (Open Label)||||||
1566738|NCT00096200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566739|NCT00096187||||Treatment||None (Open Label)||||||
1566740|NCT00096174||Single Group Assignment||Treatment||None (Open Label)||||||
1566741|NCT00096161||Single Group Assignment||Treatment||None (Open Label)||||||
1566742|NCT00096148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566743|NCT00096135|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566744|NCT00096122||Single Group Assignment||Treatment||None (Open Label)||||||
1566745|NCT00096109||Single Group Assignment||Treatment||None (Open Label)||||||
1566746|NCT00096096||||Supportive Care||None (Open Label)||||||
1566747|NCT00096083||Single Group Assignment||Treatment||None (Open Label)||||||
1566748|NCT00096070||Single Group Assignment||Treatment||None (Open Label)||||||
1566749|NCT00096057||||Treatment||None (Open Label)||||||
1566750|NCT00096044||Single Group Assignment||Treatment||None (Open Label)||||||
1566751|NCT00096031||Single Group Assignment||Treatment||None (Open Label)||||||
1566752|NCT00096018||Single Group Assignment||Treatment||None (Open Label)||||||
1566753|NCT00096005||Single Group Assignment||Treatment||None (Open Label)||||||
1566754|NCT00095992|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566755|NCT00095979||Single Group Assignment||Treatment||None (Open Label)||||||
1566756|NCT00095966||Single Group Assignment||Treatment||None (Open Label)||||||
1566757|NCT00095953|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566758|NCT00095940||Single Group Assignment||Treatment||None (Open Label)||||||
1566759|NCT00095927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566760|NCT00095914||||Treatment||||||||
1566761|NCT00095901||Single Group Assignment||Treatment||None (Open Label)||||||
1566762|NCT00095888||Single Group Assignment||Treatment||None (Open Label)||||||
1566763|NCT00095875|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566764|NCT00095862||||Treatment||None (Open Label)||||||
1566765|NCT00095836||Single Group Assignment||Treatment||None (Open Label)||||||
1566766|NCT00095823|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566767|NCT00095810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566768|NCT00095797||Single Group Assignment||Treatment||None (Open Label)||||||
1566769|NCT00095784||Single Group Assignment||Treatment||None (Open Label)||||||
1566770|NCT00095771||||Treatment||||||||
1566771|NCT00095758|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566772|NCT00095745|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566773|NCT00095732|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566774|NCT00095719|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566775|NCT00095706|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566776|NCT00095693||Single Group Assignment||Treatment||None (Open Label)||||||
1566777|NCT00095680|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566778|NCT00095667||Single Group Assignment||Treatment||None (Open Label)||||||
1566779|NCT00095654|Randomized|Factorial Assignment||Prevention||Double||||||
1566780|NCT00095641||||Treatment||||||||
1566781|NCT00095628||Single Group Assignment||Treatment||None (Open Label)||||||
1566782|NCT00095589||||Diagnostic||Single||||||
1566783|NCT00095576|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1566784|NCT00095563||Single Group Assignment||Treatment||None (Open Label)||||||
1566785|NCT00095550|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566786|NCT00095537|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566787|NCT00095524|Randomized|Parallel Assignment||Treatment||Double||||||
1566788|NCT00095511|Randomized|Parallel Assignment||Prevention||Double||||||
1566789|NCT00095498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566790|NCT00095485||||||||||||
1566791|NCT00095472||||Treatment||||||||
1566792|NCT00095459||||Treatment||||||||
1566793|NCT00095446|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1566794|NCT00095433||||Treatment||None (Open Label)||||||
1566795|NCT00095420|Randomized|Parallel Assignment||||None (Open Label)||||||
1566796|NCT00095407||||||||||||
1566797|NCT00095394|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566798|NCT00095381|Non-Randomized|||Treatment||None (Open Label)||||||
1566799|NCT00095368|Randomized|Parallel Assignment||Treatment||Double||||||
1566800|NCT00095355||||Treatment||||||||
1566801|NCT00095342|Randomized|Parallel Assignment||Treatment||Double||||||
1566802|NCT00095329||Single Group Assignment||Treatment||None (Open Label)||||||
1566803|NCT00095316|Randomized|Parallel Assignment||Prevention||Double||||||
1566804|NCT00095303|Randomized|Parallel Assignment||Treatment||Single|||t|||
1566805|NCT00095290|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566806|NCT00095277|Randomized|Parallel Assignment||Treatment||Double||||||
1566807|NCT00095264|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566808|NCT00095251|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1566809|NCT00095238|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566810|NCT00095225||||Treatment||||||||
1566811|NCT00095212|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566812|NCT00095199|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566813|NCT00095186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566814|NCT00095173|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1566815|NCT00095160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566816|NCT00095147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566817|NCT00095134|Randomized|Parallel Assignment||Treatment||Double||||||
1566818|NCT00095121|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566819|NCT00095108|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566820|NCT00095095|Randomized|Parallel Assignment||Treatment||Single||||||
1566821|NCT00095082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566822|NCT00095069|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566823|NCT00095056|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566824|NCT00095043|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566825|NCT00095030|Randomized|Parallel Assignment||Treatment||Double||||||
1566826|NCT00095017|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566827|NCT00095004|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566828|NCT00094991|Randomized|Parallel Assignment||Treatment||Double||||||
1566829|NCT00094978||||Treatment||||||||
1566830|NCT00094965|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566831|NCT00094952|||||Prospective|||||||
1566832|NCT00094939|||||Prospective|||||||
1566833|NCT00094926|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566834|NCT00094913|||||Prospective|||||||
1566835|NCT00094900||Single Group Assignment||Treatment||None (Open Label)||||||
1566836|NCT00094887|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566837|NCT00094874|Randomized|Parallel Assignment||Treatment||Double||||||
1566838|NCT00094861|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566839|NCT00094848|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566840|NCT00094835|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566841|NCT00094822|||Cohort||Prospective|||||||
1566842|NCT00094809|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1566843|NCT00094796||||Treatment||||||||
1566844|NCT00094783||||Treatment||||||||
1566845|NCT00094770|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566846|NCT00094757|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566847|NCT00094744|Randomized|Parallel Assignment||Treatment||Single||||||t
1566848|NCT00094731|Randomized|||||||||||
1566849|NCT00094718|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1566850|NCT00094705|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1566851|NCT00094692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566852|NCT00094679|Randomized|Parallel Assignment||Treatment||Single||||||t
1566853|NCT00094666|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566854|NCT00094653|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566855|NCT00094640||||Treatment||||||||
1566856|NCT00094627|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566857|NCT00094614|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566858|NCT00094601||||||||||||
1566859|NCT00094575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566860|NCT00094562|Randomized|Parallel Assignment||Treatment||Double||||||
1566861|NCT00094549|Randomized|Parallel Assignment||Treatment||Double||||||
1566862|NCT00094536||Single Group Assignment||Other||None (Open Label)||||||
1566863|NCT00094523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566864|NCT00094510||||||||||||
1566865|NCT00094497|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566866|NCT00094484|Randomized|Single Group Assignment||Treatment||Double||||||
1566867|NCT00094458|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1566868|NCT00094445||Single Group Assignment||Treatment||None (Open Label)||||||
1566869|NCT00094432|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566870|NCT00094419||||||||||||
1566871|NCT00094406|Randomized|||Treatment||||||||
1566872|NCT00094393|||Case-Only||Retrospective|||||||
1566873|NCT00094380|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566874|NCT00094367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566875|NCT00094354|||||Prospective|||||||
1567824|NCT00086320|Randomized|Parallel Assignment||Treatment||Double||||||
1566876|NCT00094341|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1566877|NCT00094328||Single Group Assignment||Treatment||None (Open Label)||||||
1566878|NCT00094315||||||||||||
1566879|NCT00094302|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566880|NCT00094289||||Treatment||||||||
1566881|NCT00094276|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1566882|NCT00094263||||||||||||
1566883|NCT00094250|Randomized|Parallel Assignment||||||||||
1566884|NCT00094237|||Cohort||Prospective|||||||
1566885|NCT00094211|||Cohort||Prospective|||||||
1566886|NCT00094198||||||||||||
1566887|NCT00094185|||Cohort||Prospective|||||||
1566888|NCT00094172|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1566889|NCT00094159|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566890|NCT00094146|Randomized|Parallel Assignment||Treatment||Double||||||
1566891|NCT00094133|Randomized|||Supportive Care||||||||
1566892|NCT00094120|Randomized|Parallel Assignment||Treatment||Double||||||
1566893|NCT00094107|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566894|NCT00094094||Single Group Assignment||Treatment||None (Open Label)||||||
1566895|NCT00094081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566896|NCT00091468|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1566897|NCT00081627|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566898|NCT00094068||||||||||||
1566899|NCT00094055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566900|NCT00094042|Randomized|Parallel Assignment||Treatment||Double||||||
1566901|NCT00094029||||||||||||
1566902|NCT00094016|Randomized|Parallel Assignment||Treatment||Double||||||
1566903|NCT00094003|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566904|NCT00093990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566905|NCT00093977|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566906|NCT00093964|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566907|NCT00093951|Randomized|||Treatment||Double||||||
1566908|NCT00093938|Randomized|Parallel Assignment||Prevention||Double||||||
1566909|NCT00093925|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566910|NCT00093912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566911|NCT00093899|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566912|NCT00093886|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566913|NCT00093873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566914|NCT00093847|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1566915|NCT00093834||Single Group Assignment||Treatment||None (Open Label)||||||
1566916|NCT00093821||Single Group Assignment||Treatment||None (Open Label)||||||
1566917|NCT00093808||Single Group Assignment||Treatment||None (Open Label)||||||
1566918|NCT00093795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566919|NCT00093782||Single Group Assignment||Treatment||None (Open Label)||||||
1566920|NCT00093769||Single Group Assignment||Treatment||None (Open Label)||||||
1566921|NCT00093756||Single Group Assignment||Treatment||None (Open Label)||||||
1566922|NCT00093743||Single Group Assignment||Treatment||None (Open Label)||||||
1566923|NCT00093730||Single Group Assignment||Treatment||None (Open Label)||||||
1566924|NCT00093704||Single Group Assignment||Treatment||None (Open Label)||||||
1566925|NCT00093678|Randomized|||Supportive Care||Double||||||
1566926|NCT00093665||||Treatment||None (Open Label)||||||
1566927|NCT00093652||||Treatment||None (Open Label)||||||
1566928|NCT00093639||||Treatment||None (Open Label)||||||
1566929|NCT00093626||Single Group Assignment||Treatment||None (Open Label)||||||
1566930|NCT00093613||Single Group Assignment||Treatment||None (Open Label)||||||
1566931|NCT00093600|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566932|NCT00093587|Randomized|||Supportive Care||None (Open Label)||||||
1566933|NCT00093561||||Prevention||||||||
1566934|NCT00093548||||Treatment||||||||
1566935|NCT00093522|Randomized|||Treatment||||||||
1566936|NCT00093509||Single Group Assignment||Treatment||None (Open Label)||||||
1566937|NCT00093496||Single Group Assignment||Treatment||None (Open Label)||||||
1566938|NCT00093483||Single Group Assignment||Treatment||None (Open Label)||||||
1566939|NCT00093470|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566940|NCT00093457|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566941|NCT00093444||||Treatment||||||||
1566942|NCT00093418|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566943|NCT00093405||||Treatment||None (Open Label)||||||
1566944|NCT00093379||Single Group Assignment||Treatment||None (Open Label)||||||
1566945|NCT00093366||||Treatment||||||||
1566946|NCT00093353||||Treatment||||||||
1566947|NCT00093327|Randomized|Parallel Assignment||Treatment||Double||||||
1566948|NCT00093314|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566949|NCT00093860||||Treatment||||||||
1566950|NCT00093301|Randomized|Parallel Assignment||Treatment||Double||||||
1566951|NCT00093288|Randomized|Parallel Assignment||Treatment||Double||||||
1566952|NCT00093275|Randomized|Parallel Assignment||Treatment||Double||||||
1566953|NCT00093262|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1566954|NCT00093249|Randomized|Parallel Assignment||Treatment||Double||||||
1566955|NCT00093236|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566956|NCT00093223|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566957|NCT00093210|Randomized|Crossover Assignment||Treatment||||||||
1566958|NCT00093197|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566959|NCT00093184|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566960|NCT00093171|Non-Randomized|||Treatment||None (Open Label)||||||
1566961|NCT00093158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566962|NCT00093145|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566963|NCT00002543||||Treatment||||||||
1566964|NCT00002524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566965|NCT00093132||Single Group Assignment||Treatment||None (Open Label)||||||
1566966|NCT00093119|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566967|NCT00093093|Randomized|Parallel Assignment||Treatment||Double||||||
1566968|NCT00093080||Single Group Assignment||Treatment||None (Open Label)||||||
1566969|NCT00093067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566970|NCT00093054|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566971|NCT00093041|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566972|NCT00093028|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1566973|NCT00091520|Randomized|Parallel Assignment||Treatment||Double||||||
1566974|NCT00093015|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1566975|NCT00093002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1566976|NCT00092989|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566977|NCT00092976|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566978|NCT00092963|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566979|NCT00092924|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566980|NCT00092911|Randomized|Parallel Assignment||Treatment||Double||||||
1566981|NCT00092898|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566982|NCT00092885|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566983|NCT00092872|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566984|NCT00092859|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566985|NCT00092846|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1566986|NCT00092833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1566987|NCT00092820|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566988|NCT00092807||||Treatment||||||||
1566989|NCT00092781|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566990|NCT00092768|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566991|NCT00092755|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566992|NCT00092742|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566993|NCT00092729|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1566994|NCT00092716|Randomized|Parallel Assignment||Treatment||Double||||||
1566995|NCT00092703|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566996|NCT00092690|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566997|NCT00092677|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1566998|NCT00092664|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1566999|NCT00092651|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567000|NCT00092586|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567001|NCT00092573||||Treatment||||||||
1567002|NCT00092560||||Treatment||||||||
1567003|NCT00092547|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567004|NCT00092534|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1567005|NCT00092521|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567006|NCT00092508|Randomized|Parallel Assignment||Treatment||Double||||||
1567007|NCT00092300|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567008|NCT00092950||||Treatment||||||||
1567009|NCT00092937||||Treatment||||||||
1567010|NCT00092638|Randomized|Parallel Assignment||Treatment||Double||||||
1567011|NCT00092625|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567012|NCT00092612|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567013|NCT00092599|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567014|NCT00092495|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567015|NCT00092482|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567016|NCT00092469|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1567017|NCT00092456|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567018|NCT00092443|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567019|NCT00092430|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567020|NCT00092417|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567021|NCT00092404|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567022|NCT00092391|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1567023|NCT00092378|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567024|NCT00092365|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567025|NCT00092352|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567026|NCT00092339|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567027|NCT00092326|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567028|NCT00092313|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567029|NCT00092287|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567030|NCT00092274|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567031|NCT00092001|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567032|NCT00091650|Randomized|Parallel Assignment||Treatment||Double||||||
1567033|NCT00092209|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567034|NCT00092196|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1567035|NCT00092183|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567036|NCT00092170|Randomized|||Treatment||None (Open Label)||||||
1567037|NCT00092157|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567038|NCT00092144|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567039|NCT00092131|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1567040|NCT00092118|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567041|NCT00092105|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1567042|NCT00092092|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1567043|NCT00092079|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567044|NCT00092066|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567045|NCT00092053|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567046|NCT00092040|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567047|NCT00092027|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567048|NCT00092014|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567049|NCT00091962|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1567050|NCT00092235|||Cohort||Prospective|||||||
1567051|NCT00092222|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567052|NCT00091988|Randomized|Parallel Assignment||||Single||||||t
1567053|NCT00091975|Randomized|Parallel Assignment||Treatment||Double||||||
1567054|NCT00091949|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1567055|NCT00091923|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567056|NCT00091936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567057|NCT00091910|Randomized|Single Group Assignment||Diagnostic||Double||||||
1567058|NCT00091858|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567059|NCT00091845|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567060|NCT00091832|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1567061|NCT00091819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567062|NCT00091806|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567063|NCT00091793|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1567064|NCT00091897|Randomized|Single Group Assignment||Treatment||Double||||||
1567065|NCT00091884||||||||||||
1567066|NCT00091871|||Family-Based||Prospective|||||||
1567067|NCT00091780||||||||||||
1567068|NCT00091767||||||||||||
1567069|NCT00091754||||||||||||
1567070|NCT00091741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567071|NCT00091728|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1567072|NCT00091715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567073|NCT00091702|Randomized|Parallel Assignment||Prevention||||||||
1567074|NCT00091689|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567075|NCT00091676|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567076|NCT00091663||||Treatment||||||||
1567077|NCT00091637|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567078|NCT00004905||||Treatment||||||||
1567079|NCT00004209|Randomized|||Treatment||||||||
1567080|NCT00004195|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567081|NCT00004194||||Supportive Care||||||||
1567082|NCT00004184|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567083|NCT00004172||||Treatment||||||||
1567084|NCT00091624|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567085|NCT00091598|Randomized|Parallel Assignment||Treatment||Double||||||
1567086|NCT00091585|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567087|NCT00091572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567088|NCT00091559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567089|NCT00004089||||Treatment||||||||
1567090|NCT00004083||||Treatment||||||||
1567091|NCT00004014||Single Group Assignment||Treatment||None (Open Label)||||||
1567092|NCT00003956||||Treatment||||||||
1567093|NCT00003858||Single Group Assignment||Treatment||None (Open Label)||||||
1567094|NCT00003842||||Treatment||||||||
1567095|NCT00003780|Randomized|||Treatment||||||||
1567096|NCT00003775||||Treatment||||||||
1567097|NCT00003714||Single Group Assignment||Treatment||None (Open Label)||||||
1567098|NCT00003711||||Treatment||||||||
1567099|NCT00091611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567100|NCT00091546|||Cohort||Retrospective|||||||
1567101|NCT00091507|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567102|NCT00091494|||Cohort||Prospective|||||||
1567103|NCT00091481|Randomized|Parallel Assignment||Treatment||Double||||||
1567104|NCT00091442|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567105|NCT00004057||||Treatment||||||||
1567106|NCT00004036||||Supportive Care||||||||
1567107|NCT00004022||||Treatment||||||||
1567108|NCT00003673||||Treatment||||||||
1567109|NCT00003671||Single Group Assignment||Treatment||None (Open Label)||||||
1567110|NCT00003666|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567111|NCT00003634|Randomized|||Treatment||||||||
1567112|NCT00003625||||Treatment||None (Open Label)||||||
1567113|NCT00003599|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1567114|NCT00003591||Single Group Assignment||Treatment||None (Open Label)||||||
1567115|NCT00003587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567116|NCT00003564|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567117|NCT00003551||||Treatment||||||||
1567118|NCT00003546||Single Group Assignment||Treatment||None (Open Label)||||||
1567119|NCT00003451||Single Group Assignment||Treatment||None (Open Label)||||||
1567120|NCT00003441||Single Group Assignment||Treatment||None (Open Label)||||||
1567121|NCT00003430||||Treatment||||||||
1567122|NCT00003428|Randomized|||Treatment||||||||
1567123|NCT00003353||||Treatment||||||||
1567124|NCT00003344||||Treatment||||||||
1567125|NCT00003339|Randomized|||Treatment||||||||
1567126|NCT00003331||||Treatment||||||||
1567127|NCT00003288||Single Group Assignment||Treatment||None (Open Label)||||||
1567128|NCT00003263||Single Group Assignment||Treatment||None (Open Label)||||||
1567129|NCT00091533||||||||||||
1567130|NCT00091429|Randomized|Parallel Assignment||Treatment||Double||||||
1567131|NCT00003257||||Treatment||||||||
1567132|NCT00003252||||Supportive Care||||||||
1567133|NCT00003248|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567134|NCT00003241||||Treatment||||||||
1567135|NCT00003223||Single Group Assignment||Prevention||None (Open Label)||||||
1567136|NCT00091416|Randomized|Parallel Assignment||Prevention||Double||||||
1567137|NCT00091390||Single Group Assignment||Treatment||None (Open Label)||||||
1567138|NCT00091377|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567139|NCT00091351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567140|NCT00091338||||Treatment||||||||
1567141|NCT00091325||||Prevention||None (Open Label)||||||
1567142|NCT00091312|Randomized|||Treatment||||||||
1567143|NCT00091299||Single Group Assignment||Treatment||None (Open Label)||||||
1567144|NCT00091286||||Treatment||None (Open Label)||||||
1567145|NCT00091273||Single Group Assignment||Treatment||None (Open Label)||||||
1567146|NCT00091260||Single Group Assignment||Treatment||None (Open Label)||||||
1567147|NCT00091247|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1567148|NCT00091234|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567149|NCT00091195||Single Group Assignment||Treatment||None (Open Label)||||||
1567150|NCT00091182||Single Group Assignment||Treatment||None (Open Label)||||||
1567151|NCT00091169|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1567152|NCT00091156|Randomized|||Treatment||Double||||||
1567153|NCT00091143|Randomized|||Treatment||||||||
1567154|NCT00091130|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567155|NCT00091117||Single Group Assignment||Treatment||None (Open Label)||||||
1567156|NCT00091104||||Treatment||None (Open Label)||||||
1567157|NCT00091091|||Cohort||Prospective|||||||
1567158|NCT00091078||Single Group Assignment||Treatment||None (Open Label)||||||
1567159|NCT00091052||||Treatment||None (Open Label)||||||
1567160|NCT00091039||||Treatment||||||||
1567161|NCT00091026|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567162|NCT00090987||Single Group Assignment||Treatment||None (Open Label)||||||
1567163|NCT00090974||||||||||||
1567164|NCT00090961|Randomized|Parallel Assignment||||None (Open Label)||||||
1567165|NCT00090909||||Treatment||None (Open Label)||||||
1567166|NCT00090896||Single Group Assignment||Treatment||None (Open Label)||||||
1567167|NCT00090870||Single Group Assignment||Treatment||None (Open Label)||||||
1567168|NCT00090857|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567169|NCT00090844|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1567170|NCT00090831||||||||||||
1567171|NCT00090818||||||||||||
1567172|NCT00090779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567173|NCT00090766|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567174|NCT00090753|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567175|NCT00090740|||Case Control||Cross-Sectional|||||||
1567176|NCT00090727|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567177|NCT00090714|Randomized|Parallel Assignment||Treatment||Double||||||
1567178|NCT00090701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567179|NCT00003217||Single Group Assignment||Treatment||None (Open Label)||||||
1567180|NCT00003172||||Treatment||||||||
1567181|NCT00003170|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1567182|NCT00003139|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1567183|NCT00003134|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567184|NCT00003100||||Prevention||||||||
1567185|NCT00003088|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567186|NCT00003072||||Supportive Care||||||||
1567187|NCT00003048||Single Group Assignment||Supportive Care||None (Open Label)||||||
1567188|NCT00003039||Single Group Assignment||Treatment||None (Open Label)||||||
1567189|NCT00090688|Randomized|Parallel Assignment||Prevention||Double||||||
1567190|NCT00090675|Randomized|||Treatment||Double||||||
1567191|NCT00003005||Single Group Assignment||Treatment||None (Open Label)||||||
1567192|NCT00002993||||Treatment||||||||
1567193|NCT00002980||||Treatment||||||||
1567194|NCT00002967||||Treatment||||||||
1567195|NCT00002946||Single Group Assignment||Treatment||None (Open Label)||||||
1567196|NCT00002942|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567197|NCT00002937|Randomized|||Treatment||||||||
1567198|NCT00002932||||Treatment||||||||
1567199|NCT00002904||||Treatment||||||||
1567200|NCT00002897|Randomized|||Treatment||||||||
1567201|NCT00090662|||Cohort||Cross-Sectional|||||||
1567202|NCT00002873||||Treatment||||||||
1567203|NCT00002872|Randomized|||Supportive Care||||||||
1567204|NCT00002811|Randomized|||Prevention||Double||||||
1567205|NCT00002805||Single Group Assignment||Treatment||None (Open Label)||||||
1567206|NCT00002793|Randomized|||Treatment||||||||
1567207|NCT00002791||||Treatment||||||||
1567208|NCT00002790||||Supportive Care||||||||
1567209|NCT00002781||||Treatment||||||||
1567210|NCT00002775||||Treatment||||||||
1567211|NCT00002767|Randomized|||Treatment||||||||
1567212|NCT00090649|Randomized|Parallel Assignment||Treatment||Double||||||
1567213|NCT00090623|Randomized|||Treatment||Double||||||
1567214|NCT00002744|Randomized|Single Group Assignment||Treatment||Single||||||
1567215|NCT00002735||Single Group Assignment||Treatment||None (Open Label)||||||
1567216|NCT00002730||||Treatment||||||||
1567217|NCT00002703|Randomized|||Treatment||||||||
1567218|NCT00090610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567219|NCT00090584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567220|NCT00090532|Randomized|Parallel Assignment||Treatment||Double||||||
1567221|NCT00090519|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567222|NCT00090493||Single Group Assignment||Treatment||None (Open Label)||||||
1567223|NCT00090480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567224|NCT00002659|Randomized|||Treatment||||||||
1567225|NCT00002631|Randomized|||Treatment||||||||
1567226|NCT00002628||||Treatment||||||||
1567227|NCT00002622|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1567228|NCT00002616||||Treatment||||||||
1567229|NCT00002593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567230|NCT00002570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567231|NCT00002554||||Treatment||||||||
1567232|NCT00002527|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1567233|NCT00002509|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567234|NCT00090571|||Family-Based||Prospective|||||||
1567235|NCT00090467|||Case Control||Prospective|||||||
1567236|NCT00090454||||||||||||
1567237|NCT00090441|||Case Control||Retrospective|||||||
1567238|NCT00090376|Randomized|Parallel Assignment||Treatment||Double||||||
1567239|NCT00090363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567240|NCT00090324|Randomized|Parallel Assignment||Treatment||Double||||||
1567241|NCT00090311|Randomized|Parallel Assignment||Treatment||Double||||||
1567242|NCT00090298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567243|NCT00004915||||Treatment||||||||
1567244|NCT00004201|Randomized|||Treatment||||||||
1567245|NCT00004090||||Treatment||||||||
1567246|NCT00004029||Single Group Assignment||Treatment||None (Open Label)||||||
1567247|NCT00002489||||Treatment||||||||
1567248|NCT00002488||||Treatment||||||||
1567249|NCT00002487||||Treatment||||||||
1567250|NCT00002471||||Treatment||||||||
1567251|NCT00002458||||Treatment||||||||
1567252|NCT00090558||||Treatment||||||||
1567253|NCT00090545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567254|NCT00090506|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567255|NCT00090428|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567256|NCT00090415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567257|NCT00090285|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567258|NCT00090272|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567259|NCT00090259|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567260|NCT00090246|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567261|NCT00090233|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1567262|NCT00090220|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567263|NCT00090207|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567264|NCT00090181|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567265|NCT00090168|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567266|NCT00090155|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567267|NCT00004026|Randomized|||Treatment||||||||
1567268|NCT00004009||||Treatment||||||||
1567269|NCT00003989||||Treatment||||||||
1567270|NCT00003962||||Treatment||||||||
1567271|NCT00003778||Single Group Assignment||Treatment||None (Open Label)||||||
1567272|NCT00090402|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567273|NCT00090389|Randomized|Parallel Assignment||Treatment||Single||||||
1567274|NCT00090337|Randomized|||Supportive Care||||||||
1567275|NCT00090194|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567276|NCT00090142|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1567277|NCT00090129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567278|NCT00090116|Randomized|Parallel Assignment||Treatment||Double||||||
1567279|NCT00090103|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567280|NCT00090077|Randomized|Parallel Assignment||Treatment||Double||||||
1567281|NCT00003654||||Diagnostic||||||||
1567282|NCT00003601|Randomized|||Prevention||||||||
1567283|NCT00003588||Single Group Assignment||Treatment||None (Open Label)||||||
1567284|NCT00003519|Randomized|||Treatment||||||||
1567285|NCT00003406||||Treatment||||||||
1567286|NCT00003390||||Treatment||||||||
1567287|NCT00003378||||Treatment||||||||
1567288|NCT00003362|Randomized|||Treatment||||||||
1567289|NCT00003315|Randomized|||Supportive Care||||||||
1567290|NCT00003304||||Treatment||||||||
1567291|NCT00090090|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567292|NCT00090064|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1568087|NCT00002905||||Treatment||||||||
1567293|NCT00090051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567294|NCT00003279|Randomized|||Treatment||||||||
1567295|NCT00003260|Randomized|||Treatment||||||||
1567296|NCT00003237||||Treatment||||||||
1567297|NCT00003229|Randomized|||Treatment||||||||
1567298|NCT00003224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567299|NCT00090038|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567300|NCT00003151||||Treatment||||||||
1567301|NCT00003147||Single Group Assignment||Treatment||None (Open Label)||||||
1567302|NCT00003136||Single Group Assignment||Treatment||None (Open Label)||||||
1567303|NCT00003131||||Treatment||||||||
1567304|NCT00002969||Single Group Assignment||Treatment||None (Open Label)||||||
1567305|NCT00002960||||Treatment||||||||
1567306|NCT00002888|Randomized|||Treatment||||||||
1567307|NCT00002881|Randomized|||Treatment||||||||
1567308|NCT00002879||Single Group Assignment||Treatment||None (Open Label)||||||
1567309|NCT00002845||||Treatment||||||||
1567310|NCT00002783||||Treatment||||||||
1567311|NCT00002755|Randomized|||Treatment||||||||
1567312|NCT00002742|Randomized|||Supportive Care||||||||
1567313|NCT00002711||||Treatment||||||||
1567314|NCT00090025|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567315|NCT00090012|Randomized|Parallel Assignment||Treatment||Double||||||
1567316|NCT00089999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567317|NCT00089986|Randomized|Parallel Assignment||Treatment||||||||
1567318|NCT00005024|Randomized|||Supportive Care||||||||
1567319|NCT00004906||||Treatment||||||||
1567320|NCT00002674||||Treatment||||||||
1567321|NCT00002634||||Treatment||||||||
1567322|NCT00002579|Randomized|||Treatment||||||||
1567323|NCT00002510|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567324|NCT00002499||||Treatment||||||||
1567325|NCT00002498||||Treatment||||||||
1567326|NCT00002493||||Treatment||||||||
1567327|NCT00002479||||Treatment||||||||
1567328|NCT00089973|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567329|NCT00089960|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567330|NCT00089947|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567331|NCT00089921|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567332|NCT00004900||||Treatment||||||||
1567333|NCT00004182||||Treatment||||||||
1567334|NCT00004136|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567335|NCT00004042||||Treatment||||||||
1567336|NCT00003974||||Treatment||||||||
1567337|NCT00089908|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1567338|NCT00089895|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1567339|NCT00089882|||||Prospective|||||||
1567340|NCT00089869||||Treatment||||||||
1567341|NCT00089856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567342|NCT00003951||||Treatment||||||||
1567343|NCT00003897||||Treatment||||||||
1567344|NCT00003885||||Treatment||||||||
1567345|NCT00003776||||Treatment||||||||
1567346|NCT00003751||||Treatment||||||||
1567347|NCT00089843|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1567348|NCT00089830|Randomized|Parallel Assignment||Treatment||Double||||||
1567349|NCT00089804|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567350|NCT00003709||Single Group Assignment||Treatment||None (Open Label)||||||
1567351|NCT00003686|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1567352|NCT00003684|Randomized|||Supportive Care||||||||
1567353|NCT00003626||||Treatment||||||||
1567354|NCT00003556||Single Group Assignment||Treatment||None (Open Label)||||||
1567355|NCT00089791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567356|NCT00089752|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567357|NCT00003555||||Supportive Care||||||||
1567358|NCT00003543||||Treatment||||||||
1567359|NCT00003400||||Treatment||||||||
1567360|NCT00003395||||Treatment||||||||
1567361|NCT00003380||||Treatment||||||||
1567362|NCT00003360||||Treatment||||||||
1567363|NCT00003357||||Treatment||||||||
1567364|NCT00003348||||Treatment||||||||
1567365|NCT00003340||||Treatment||||||||
1567366|NCT00003312||||Treatment||||||||
1567367|NCT00089778|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1567368|NCT00089765||||Treatment||||||||
1567369|NCT00003294||||Treatment||||||||
1567370|NCT00003284||||Treatment||||||||
1567371|NCT00003251||||Supportive Care||||||||
1567372|NCT00003220||||Treatment||||||||
1567373|NCT00003200||Single Group Assignment||Treatment||None (Open Label)||||||
1567374|NCT00089739||||||||||||
1567375|NCT00089726|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567376|NCT00089713|Randomized|Parallel Assignment||Treatment||Double||||||
1567377|NCT00089700|Randomized|Parallel Assignment||Treatment||Double||||||
1567378|NCT00003197||||Treatment||||||||
1567379|NCT00003123||||Treatment||||||||
1567380|NCT00003115||||Supportive Care||||||||
1567381|NCT00003102||||Treatment||||||||
1567382|NCT00003058||Single Group Assignment||Treatment||None (Open Label)||||||
1567383|NCT00003044||||Treatment||||||||
1567384|NCT00003025||||Treatment||||||||
1567385|NCT00003003||||Treatment||||||||
1567386|NCT00002955||||Treatment||||||||
1567387|NCT00002933||Single Group Assignment||Treatment||None (Open Label)||||||
1567388|NCT00089687||||Treatment||||||||
1567389|NCT00089674|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567390|NCT00089661|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567391|NCT00089648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567392|NCT00089635||Single Group Assignment||Treatment||None (Open Label)||||||
1567393|NCT00002914||||Treatment||||||||
1567394|NCT00002909||Single Group Assignment||Treatment||None (Open Label)||||||
1567395|NCT00002890||||Treatment||||||||
1567396|NCT00002865|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567397|NCT00002749||||Treatment||||||||
1567398|NCT00002655||||Treatment||||||||
1567399|NCT00002635||Single Group Assignment||Treatment||||||||
1567400|NCT00002619||||Treatment||||||||
1567401|NCT00002609||||Treatment||||||||
1567402|NCT00002585||||Treatment||||||||
1567403|NCT00089596|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567404|NCT00089583|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567405|NCT00005626||Single Group Assignment||Treatment||None (Open Label)||||||
1567406|NCT00005607||||Treatment||||||||
1567407|NCT00002574||Single Group Assignment||Treatment||None (Open Label)||||||
1567408|NCT00002562||||Treatment||||||||
1567409|NCT00002507||||Treatment||||||||
1567410|NCT00089622||||Treatment||||||||
1567411|NCT00089609|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567412|NCT00089570|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567413|NCT00089557||||Treatment||None (Open Label)||||||
1567414|NCT00089544|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567415|NCT00005591||||Treatment||||||||
1567416|NCT00005076|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567417|NCT00005070||||Treatment||||||||
1567418|NCT00005057||||Treatment||||||||
1567419|NCT00005056||||Treatment||||||||
1567420|NCT00004937||||Treatment||||||||
1567421|NCT00004219|Randomized|||Supportive Care||||||||
1567422|NCT00004215|Randomized|||Supportive Care||||||||
1567423|NCT00004207||||Treatment||||||||
1567424|NCT00089531||||Treatment||||||||
1567425|NCT00089518|Randomized|Parallel Assignment||Treatment||Double||||||
1567426|NCT00089505|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567427|NCT00089492|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567428|NCT00089479|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567429|NCT00089466|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567430|NCT00089453|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567431|NCT00089440||||Treatment||||||||
1567432|NCT00089427|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567433|NCT00089414|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567434|NCT00089401||||Treatment||None (Open Label)||||||
1567435|NCT00089388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567436|NCT00089362||Single Group Assignment||Treatment||None (Open Label)||||||
1567437|NCT00089349||Single Group Assignment||Treatment||None (Open Label)||||||
1567438|NCT00089323||Single Group Assignment||Diagnostic||None (Open Label)||||||
1567439|NCT00089310||Single Group Assignment||Diagnostic||None (Open Label)||||||
1567440|NCT00089297||Single Group Assignment||Treatment||None (Open Label)||||||
1567441|NCT00089284||Single Group Assignment||Treatment||None (Open Label)||||||
1567442|NCT00089271||Single Group Assignment||Treatment||None (Open Label)||||||
1567443|NCT00089258||||Treatment||None (Open Label)||||||
1567444|NCT00089245||Single Group Assignment||Treatment||None (Open Label)||||||
1567445|NCT00089219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567446|NCT00089206||Single Group Assignment||Treatment||None (Open Label)||||||
1567447|NCT00089193|Randomized|||Treatment||None (Open Label)||||||
1567448|NCT00089180|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567449|NCT00089167||||Treatment||None (Open Label)||||||
1567450|NCT00089154||Single Group Assignment||Treatment||None (Open Label)||||||
1567451|NCT00089141|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567452|NCT00089128||Single Group Assignment||Treatment||None (Open Label)||||||
1567453|NCT00089115|Randomized|||Treatment||Double||||||
1567454|NCT00089102||Single Group Assignment||Treatment||None (Open Label)||||||
1567455|NCT00089089||Single Group Assignment||Treatment||None (Open Label)||||||
1567456|NCT00089076||Single Group Assignment||Treatment||None (Open Label)||||||
1567457|NCT00089063|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567458|NCT00089050||||Treatment||None (Open Label)||||||
1567459|NCT00089037||||Supportive Care||None (Open Label)||||||
1567460|NCT00089024||Single Group Assignment||Treatment||None (Open Label)||||||
1567461|NCT00089011|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567462|NCT00088998||Single Group Assignment||Treatment||None (Open Label)||||||
1567463|NCT00088985||Single Group Assignment||Treatment||None (Open Label)||||||
1567464|NCT00088972|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567465|NCT00088959||Single Group Assignment||Treatment||None (Open Label)||||||
1567466|NCT00088946|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567467|NCT00088933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567468|NCT00088907|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567469|NCT00088894|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567470|NCT00088881||Single Group Assignment||Treatment||None (Open Label)||||||
1567471|NCT00088868||||Treatment||||||||
1568088|NCT00002496||||Treatment||||||||
1567472|NCT00088855||Single Group Assignment||Treatment||None (Open Label)||||||
1567473|NCT00088829||Single Group Assignment||Diagnostic||None (Open Label)||||||
1567474|NCT00088816||||Treatment||None (Open Label)||||||
1567475|NCT00088803|||Case Control||Prospective|||||||
1567476|NCT00088790||||Treatment||||||||
1567477|NCT00088777|Randomized|Parallel Assignment||Treatment||Single||||||t
1567478|NCT00088764|Randomized|Factorial Assignment||||None (Open Label)||||||
1567479|NCT00004193|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567480|NCT00004187||||Treatment||||||||
1567481|NCT00004186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567482|NCT00004162|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567483|NCT00004096||||Treatment||||||||
1567484|NCT00004080||||Treatment||||||||
1567485|NCT00004064|Randomized|||Treatment||||||||
1567486|NCT00004040||||Treatment||||||||
1567487|NCT00004039||||Treatment||||||||
1567488|NCT00003957||||Treatment||||||||
1567489|NCT00003892|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567490|NCT00003828||Single Group Assignment||Treatment||None (Open Label)||||||
1567491|NCT00003821||||Treatment||||||||
1567492|NCT00003810||||Treatment||||||||
1567493|NCT00003798||||Treatment||||||||
1567494|NCT00003786||Single Group Assignment||Treatment||None (Open Label)||||||
1567495|NCT00003784||Single Group Assignment||Treatment||None (Open Label)||||||
1567496|NCT00003760||Single Group Assignment||Treatment||None (Open Label)||||||
1567497|NCT00003708||Single Group Assignment||Treatment||None (Open Label)||||||
1567498|NCT00003681||||Treatment||||||||
1567499|NCT00003663||||Treatment||||||||
1567500|NCT00003662||||Treatment||||||||
1567501|NCT00003661||Single Group Assignment||Treatment||None (Open Label)||||||
1567502|NCT00003605||||Treatment||||||||
1567503|NCT00003542||||Treatment||||||||
1567504|NCT00003539||||Treatment||||||||
1567505|NCT00003431||||Treatment||||||||
1567506|NCT00003424|Randomized|||Treatment||||||||
1567507|NCT00088673|Randomized|Parallel Assignment||Treatment||Double||||||
1567508|NCT00003416||Single Group Assignment||Treatment||None (Open Label)||||||
1567509|NCT00003415||||Treatment||||||||
1567510|NCT00003413||||Treatment||||||||
1567511|NCT00088751||||||||||||
1567512|NCT00088738||||Treatment||||||||
1567513|NCT00088712|||Cohort||Cross-Sectional|||||||
1567514|NCT00088699|Randomized|Crossover Assignment||Other||Quadruple|||t|t|t|t
1567515|NCT00088686||||Treatment||||||||
1567516|NCT00088660|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567517|NCT00088647|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1567518|NCT00088634|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1567519|NCT00088621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567520|NCT00088608||Single Group Assignment||Treatment||None (Open Label)||||||
1567521|NCT00088595|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567522|NCT00088582|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1567523|NCT00003358||||Treatment||||||||
1567524|NCT00003305||||Treatment||||||||
1567525|NCT00003259||||Treatment||||||||
1567526|NCT00003256||Single Group Assignment||Treatment||None (Open Label)||||||
1567527|NCT00003214|Randomized|||Treatment||||||||
1567528|NCT00003213|Randomized|Parallel Assignment||Supportive Care||Double||||||
1567529|NCT00003182||||Treatment||||||||
1567530|NCT00003158||Single Group Assignment||Treatment||None (Open Label)||||||
1567531|NCT00003152||||Treatment||||||||
1567532|NCT00003097||||Prevention||||||||
1567533|NCT00003090||||Treatment||||||||
1567534|NCT00003087||||Treatment||||||||
1567535|NCT00003068||||Treatment||||||||
1567536|NCT00088569||||||||||||
1567537|NCT00088556|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567538|NCT00088543|Randomized|Parallel Assignment||||None (Open Label)||||||
1567539|NCT00003055||||Treatment||||||||
1567540|NCT00003050||||Treatment||||||||
1567541|NCT00003002||Single Group Assignment||Treatment||None (Open Label)||||||
1567542|NCT00003000|||Cohort||Prospective|||||||
1567543|NCT00002984||Single Group Assignment||Treatment||None (Open Label)||||||
1567544|NCT00002921||Single Group Assignment||Treatment||None (Open Label)||||||
1567545|NCT00002833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567546|NCT00088530|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567547|NCT00002832|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567548|NCT00002831||Single Group Assignment||Treatment||None (Open Label)||||||
1567549|NCT00002824||||Treatment||||||||
1567550|NCT00002784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567551|NCT00002779||Single Group Assignment||Treatment||None (Open Label)||||||
1567552|NCT00002754||||Treatment||||||||
1567553|NCT00002753||||Treatment||||||||
1567554|NCT00002688|Randomized|||Treatment||||||||
1567555|NCT00002675||||Treatment||||||||
1567556|NCT00002665|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567557|NCT00002630||||Treatment||||||||
1567558|NCT00002627||||Treatment||||||||
1567559|NCT00002618|Randomized|||Treatment||||||||
1567560|NCT00002604||Single Group Assignment||Treatment||None (Open Label)||||||
1567561|NCT00002588||Single Group Assignment||Treatment||None (Open Label)||||||
1567562|NCT00002572||||Treatment||||||||
1567563|NCT00002542|Randomized|||Treatment||Double||||||
1567565|NCT00002529|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567566|NCT00088517||||Treatment||||||||
1567567|NCT00088504|Randomized|Parallel Assignment||Treatment||Double||||||
1567568|NCT00088491|Randomized|Parallel Assignment||Treatment||Double||||||
1567569|NCT00088478|Randomized|Parallel Assignment||Treatment||Double||||||
1567570|NCT00088465|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567571|NCT00088452|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567572|NCT00088426|||Case-Control||Prospective|||||||
1567573|NCT00088413|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1567574|NCT00088400||||Treatment||||||||
1567575|NCT00088387||||Treatment||||||||
1567576|NCT00088374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567577|NCT00088361||||||||||||
1567578|NCT00088348||||||||||||
1567579|NCT00088335||||||||||||
1567580|NCT00088309||||Treatment||||||||
1567581|NCT00088296||||Treatment||||||||
1567582|NCT00088283|Randomized|Parallel Assignment||Treatment||Double||||||
1567583|NCT00088270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567584|NCT00088257|||Cohort||Prospective|||||||
1567585|NCT00005884|Randomized|||Prevention||||||||
1567586|NCT00005852||||Treatment||||||||
1567587|NCT00005805|Randomized|||Supportive Care||||||||
1567588|NCT00005633||||Treatment||||||||
1567589|NCT00005624||Single Group Assignment||Treatment||None (Open Label)||||||
1567590|NCT00005614||Single Group Assignment||Treatment||None (Open Label)||||||
1567591|NCT00005611||||Treatment||||||||
1567592|NCT00004902||||Treatment||||||||
1567593|NCT00004901||||Treatment||||||||
1567594|NCT00004897||||Treatment||||||||
1567595|NCT00004875|||Cohort||Prospective|||||||
1567596|NCT00004265||||Treatment||||||||
1567597|NCT00004264||||Treatment||||||||
1567598|NCT00004263|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567599|NCT00004258||Single Group Assignment||Treatment||None (Open Label)||||||
1567600|NCT00004169||||Treatment||||||||
1567601|NCT00004159||||Treatment||||||||
1567602|NCT00003942||||Treatment||||||||
1567603|NCT00003936||||Treatment||||||||
1567604|NCT00003929||Single Group Assignment||Treatment||None (Open Label)||||||
1567605|NCT00002506||||Treatment||||||||
1567606|NCT00002504||||Treatment||||||||
1567607|NCT00002462|Randomized|||Treatment||||||||
1567608|NCT00088231||Single Group Assignment||Treatment||None (Open Label)||||||
1567609|NCT00088218|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1567610|NCT00088205|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567611|NCT00088179|Randomized|Parallel Assignment||Treatment||Double||||||
1567612|NCT00087997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567613|NCT00088192|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567614|NCT00088166|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567615|NCT00003884|Randomized|||Supportive Care||||||||
1567616|NCT00003812||Single Group Assignment||Treatment||None (Open Label)||||||
1567617|NCT00003808||||Treatment||||||||
1567618|NCT00003781||||Treatment||||||||
1567619|NCT00003763||||Diagnostic||||||||
1567620|NCT00003748||Single Group Assignment||Treatment||None (Open Label)||||||
1567621|NCT00003725|Randomized|||Treatment||||||||
1567622|NCT00003677|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567623|NCT00003675|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567624|NCT00003610|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1567625|NCT00003585||||Treatment||||||||
1567626|NCT00003557||Single Group Assignment||Treatment||None (Open Label)||||||
1567627|NCT00003392||Single Group Assignment||Treatment||None (Open Label)||||||
1567628|NCT00003391||||Treatment||||||||
1567629|NCT00003267|Randomized|||Supportive Care||||||||
1567630|NCT00088153|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567631|NCT00088140|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567632|NCT00088114|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567633|NCT00088101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567634|NCT00088088|Randomized|Parallel Assignment||Treatment||Double||||||
1567635|NCT00088075|Randomized|Parallel Assignment||Treatment||Double||||||
1567636|NCT00088062|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567637|NCT00088049|Randomized|Parallel Assignment||Treatment||Double||||||
1567638|NCT00088036|Randomized|Parallel Assignment||Treatment||Double||||||
1567639|NCT00003238||||Treatment||||||||
1567640|NCT00003225||Single Group Assignment||Treatment||None (Open Label)||||||
1567641|NCT00088023|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567642|NCT00088010|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567643|NCT00087984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567644|NCT00087958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567645|NCT00087945|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567646|NCT00087919||||||||||||
1567647|NCT00087906|||Case Control||Prospective|||||||
1567648|NCT00087893|||Cohort||Cross-Sectional|||||||
1567649|NCT00087880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567650|NCT00087867|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567651|NCT00005996||||Treatment||||||||
1567652|NCT00005806||||Treatment||||||||
1568089|NCT00002478||||Treatment||||||||
1567653|NCT00005632||Single Group Assignment||Treatment||None (Open Label)||||||
1567654|NCT00005619|||Cohort||Prospective|||||||
1567655|NCT00005042||||Treatment||||||||
1567656|NCT00005029||||Treatment||||||||
1567657|NCT00004199|Randomized|||Treatment||||||||
1567658|NCT00004164||||Treatment||||||||
1567659|NCT00004160|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567660|NCT00004158||||Treatment||||||||
1567661|NCT00004104|Randomized|||Treatment||||||||
1567662|NCT00004060||||Treatment||||||||
1567663|NCT00004047||||Treatment||||||||
1567664|NCT00004041||||Treatment||||||||
1567665|NCT00003881||||Treatment||||||||
1567666|NCT00003219||||Treatment||||||||
1567667|NCT00003196||Single Group Assignment||Treatment||None (Open Label)||||||
1567668|NCT00003171||||Treatment||||||||
1567669|NCT00003082||||Treatment||||||||
1567670|NCT00003057|Randomized|||Supportive Care||||||||
1567671|NCT00002998||Single Group Assignment||Treatment||None (Open Label)||||||
1567672|NCT00002994||Single Group Assignment||Treatment||None (Open Label)||||||
1567673|NCT00002956|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567674|NCT00002925|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567675|NCT00002908||||Treatment||||||||
1567676|NCT00002907||||Treatment||||||||
1567677|NCT00002862||Single Group Assignment||Treatment||None (Open Label)||||||
1567678|NCT00002763|Randomized|||Treatment||||||||
1567679|NCT00002760|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567680|NCT00002667||||Screening||||||||
1567681|NCT00002620|Randomized|||Treatment||||||||
1567682|NCT00002563|||Case-Only||Prospective|||||||
1567683|NCT00002557||||Treatment||||||||
1567684|NCT00002549|Randomized|||Treatment||||||||
1567685|NCT00002545|Randomized|||Treatment||||||||
1567686|NCT00002502||||Treatment||||||||
1567687|NCT00002495|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567688|NCT00002465||||Treatment||||||||
1567689|NCT00087932|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1567690|NCT00087854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567691|NCT00087841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567692|NCT00087828|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1567693|NCT00087815|Randomized|||Supportive Care||Single||||||
1567694|NCT00087802|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567695|NCT00087789|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567696|NCT00087776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567697|NCT00087763|Randomized|Factorial Assignment||Treatment||Double||||||
1567698|NCT00087750|Randomized|||Treatment||Double||||||
1567699|NCT00087737|Randomized|Parallel Assignment||Treatment||Double||||||
1567700|NCT00087711|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567701|NCT00087698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567702|NCT00082511|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567703|NCT00003877|Randomized|||Treatment||||||||
1567704|NCT00003874||||Treatment||||||||
1567705|NCT00003873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567706|NCT00003853||||Treatment||||||||
1567707|NCT00003805|Randomized|||Supportive Care||||||||
1567708|NCT00003804|Randomized|||Treatment||||||||
1567709|NCT00003792||||Treatment||||||||
1567710|NCT00003743|Randomized|||Treatment||||||||
1567711|NCT00003664||||Treatment||||||||
1567712|NCT00003639|Randomized|||Treatment||||||||
1567713|NCT00003604||||Treatment||||||||
1567714|NCT00003359||||Treatment||||||||
1567715|NCT00003343|Randomized|||Treatment||||||||
1567716|NCT00003328|Randomized|||Treatment||||||||
1567717|NCT00087724|Randomized|Parallel Assignment||Treatment||Double||||||
1567718|NCT00087685||Single Group Assignment||Treatment||None (Open Label)||||||
1567719|NCT00087672|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567720|NCT00087659|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567721|NCT00087646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567722|NCT00087633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567723|NCT00087620||||Treatment||||||||
1567724|NCT00087607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567725|NCT00087594|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567726|NCT00087581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567727|NCT00087568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567728|NCT00087555|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1567729|NCT00087542|Randomized|||Treatment||Double||||||
1567730|NCT00087529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567731|NCT00087516|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567732|NCT00087503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567733|NCT00087490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567734|NCT00087477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567735|NCT00087464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567736|NCT00087451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567737|NCT00086710|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1567738|NCT00086645|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567739|NCT00003589|Randomized|||Treatment||||||||
1567740|NCT00087438||Single Group Assignment||Treatment||None (Open Label)||||||
1567741|NCT00087425||||Treatment||None (Open Label)||||||
1567742|NCT00087412||Single Group Assignment||Treatment||None (Open Label)||||||
1567743|NCT00087399|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1567744|NCT00087386||Single Group Assignment||Treatment||None (Open Label)||||||
1567745|NCT00087373||Single Group Assignment||Treatment||None (Open Label)||||||
1567746|NCT00087360||||Screening||||||||
1567747|NCT00087347||||||||||||
1567748|NCT00087334||||Treatment||None (Open Label)||||||
1567749|NCT00087295||Single Group Assignment||Treatment||None (Open Label)||||||
1567750|NCT00087282||||Treatment||None (Open Label)||||||
1567751|NCT00087269||Single Group Assignment||Treatment||None (Open Label)||||||
1567752|NCT00087256|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567753|NCT00087217||Single Group Assignment||Treatment||None (Open Label)||||||
1567754|NCT00087204||Single Group Assignment||Treatment||None (Open Label)||||||
1567755|NCT00087191||Single Group Assignment||Diagnostic||None (Open Label)||||||
1567756|NCT00087178|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567757|NCT00087165||||Treatment||None (Open Label)||||||
1567758|NCT00087152||Single Group Assignment||Treatment||None (Open Label)||||||
1567759|NCT00087139||Single Group Assignment||Treatment||None (Open Label)||||||
1567760|NCT00087126||Single Group Assignment||Treatment||None (Open Label)||||||
1567761|NCT00087113||||Treatment||None (Open Label)||||||
1567762|NCT00087100||||Treatment||None (Open Label)||||||
1567763|NCT00087087||||Treatment||None (Open Label)||||||
1567764|NCT00087074||Single Group Assignment||Treatment||None (Open Label)||||||
1567765|NCT00087061||||Treatment||None (Open Label)||||||
1567766|NCT00087048||Single Group Assignment||Treatment||None (Open Label)||||||
1567767|NCT00087035||Single Group Assignment||Treatment||None (Open Label)||||||
1567768|NCT00087022|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567769|NCT00087009|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567770|NCT00086996||Single Group Assignment||Treatment||None (Open Label)||||||
1567771|NCT00086983||Single Group Assignment||Treatment||None (Open Label)||||||
1567772|NCT00086970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567773|NCT00086957||Single Group Assignment||Treatment||None (Open Label)||||||
1567774|NCT00086944||Single Group Assignment||Treatment||None (Open Label)||||||
1567775|NCT00086931||Single Group Assignment||Treatment||None (Open Label)||||||
1567776|NCT00086892||||Treatment||None (Open Label)||||||
1567777|NCT00086879|Randomized|||Treatment||None (Open Label)||||||
1567778|NCT00086866|Randomized|||Treatment||None (Open Label)||||||
1567779|NCT00086840||Single Group Assignment||Treatment||None (Open Label)||||||
1567780|NCT00086827||Single Group Assignment||Treatment||None (Open Label)||||||
1567781|NCT00086801||Single Group Assignment||Treatment||None (Open Label)||||||
1567782|NCT00086775|Randomized|||Treatment||None (Open Label)||||||
1567783|NCT00086762|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1567784|NCT00086749|||Cohort||Prospective|||||||
1567785|NCT00086736|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567786|NCT00086723||||Treatment||||||||
1567787|NCT00086684|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1567788|NCT00086671|Randomized|Parallel Assignment||||Triple|||t|t|t|
1567789|NCT00086658|Randomized|Parallel Assignment||Treatment||Double||||||
1567790|NCT00086632|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567791|NCT00086606||||Treatment||||||||
1567792|NCT00086619|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567793|NCT00086593|Randomized|Parallel Assignment||Treatment||Double||||||
1567794|NCT00086580|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567795|NCT00003297||||Treatment||||||||
1567796|NCT00003296||||Treatment||||||||
1567797|NCT00003230||||Treatment||||||||
1567798|NCT00003198||||Treatment||||||||
1567799|NCT00003109||||Treatment||||||||
1567800|NCT00086541|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567801|NCT00086528|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567802|NCT00086411|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567803|NCT00086398||Factorial Assignment||Treatment||||||||
1567804|NCT00086385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567805|NCT00003091||Single Group Assignment||Treatment||None (Open Label)||||||
1567806|NCT00002953||||Treatment||||||||
1567807|NCT00002922||||Treatment||||||||
1567808|NCT00002863||Single Group Assignment||Treatment||None (Open Label)||||||
1567809|NCT00086567|||Case-Control||Prospective|||||||
1567810|NCT00086554||||||||||||
1567811|NCT00086515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567812|NCT00086502|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567813|NCT00086489|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567814|NCT00086463|Randomized|Single Group Assignment||Treatment||Double||||||
1567815|NCT00086450|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567816|NCT00086437|||Case Control||Prospective|||||||
1567817|NCT00086424|||Cohort||Prospective|||||||
1567818|NCT00002999||||Treatment||||||||
1567819|NCT00086476||||||||||||
1567820|NCT00086346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567821|NCT00086333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567822|NCT00086372||||||||||||
1567823|NCT00086359|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1567825|NCT00086281|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1567826|NCT00086268|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1567827|NCT00002837|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567828|NCT00002804||Single Group Assignment||Treatment||None (Open Label)||||||
1567829|NCT00002751||||Treatment||||||||
1567830|NCT00002733||||Treatment||||||||
1567831|NCT00002705||Single Group Assignment||Treatment||None (Open Label)||||||
1567832|NCT00002704||Single Group Assignment||Treatment||None (Open Label)||||||
1567833|NCT00002691||||Treatment||||||||
1567834|NCT00002654|Randomized|||Treatment||||||||
1567835|NCT00086307|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567836|NCT00086294||||Treatment||||||||
1567837|NCT00086255||Parallel Assignment||Treatment||Double||||||
1567838|NCT00086216|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567839|NCT00002642||Single Group Assignment||Treatment||None (Open Label)||||||
1567840|NCT00002565|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567841|NCT00086242|Randomized|||||||||||
1567842|NCT00086229|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567843|NCT00086203|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567844|NCT00086190|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567845|NCT00086177|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1567846|NCT00086164|Randomized|Single Group Assignment||Diagnostic||Double||||||
1567847|NCT00086151|||||Retrospective|||||||
1567848|NCT00086138|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1567849|NCT00086125|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567850|NCT00086112|Randomized|Parallel Assignment||Treatment||Double||||||
1567851|NCT00006041||||Treatment||||||||
1567852|NCT00005975|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1567853|NCT00005854||||Treatment||||||||
1567854|NCT00002505||||Treatment||||||||
1567855|NCT00002482||||Treatment||||||||
1567856|NCT00086099|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567857|NCT00005613|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567858|NCT00004202||||Treatment||||||||
1567859|NCT00004197||||Treatment||||||||
1567860|NCT00004192|Randomized|||Supportive Care||||||||
1567861|NCT00003995||Single Group Assignment||Treatment||None (Open Label)||||||
1567862|NCT00003946||||Treatment||||||||
1567863|NCT00086086|Randomized|Parallel Assignment||Treatment||Double||||||
1567864|NCT00086073|||Cohort||Prospective|||||||
1567865|NCT00003762|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567866|NCT00003723||Single Group Assignment||Treatment||None (Open Label)||||||
1567867|NCT00003691|Randomized|||Treatment||||||||
1567868|NCT00003667|Randomized|||Treatment||||||||
1567869|NCT00003630||||Treatment||||||||
1567870|NCT00003549||Single Group Assignment||Treatment||None (Open Label)||||||
1567871|NCT00003369||Single Group Assignment||Treatment||None (Open Label)||||||
1567872|NCT00003317|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567873|NCT00003127||Single Group Assignment||Treatment||None (Open Label)||||||
1567874|NCT00086060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567875|NCT00086047|Randomized|Parallel Assignment||Treatment||Single|||||t|
1567876|NCT00086034|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567877|NCT00003078|Randomized|||Treatment||||||||
1567878|NCT00002844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567879|NCT00002816||||Treatment||||||||
1567880|NCT00002747|Randomized|||Treatment||||||||
1567881|NCT00002725||Single Group Assignment||Treatment||None (Open Label)||||||
1567882|NCT00086021|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567883|NCT00085969|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567884|NCT00085956|Randomized|Parallel Assignment||Prevention||Double||||||
1567885|NCT00006241||||Treatment||||||||
1567886|NCT00006235||||Treatment||||||||
1567887|NCT00006214|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1567888|NCT00006117||||Treatment||||||||
1567889|NCT00006116||||Treatment||||||||
1567890|NCT00006088||||Treatment||||||||
1567891|NCT00002717|Randomized|||Treatment||||||||
1567892|NCT00002657||Single Group Assignment||Treatment||None (Open Label)||||||
1567893|NCT00085995|||Case-Only||Prospective|||||||
1567894|NCT00085982||||Treatment||||||||
1567895|NCT00085943|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567896|NCT00085930||Single Group Assignment||Treatment||None (Open Label)||||||
1567897|NCT00006035||||Treatment||||||||
1567898|NCT00006033||||Treatment||||||||
1567899|NCT00005993||||Treatment||||||||
1567900|NCT00005968||||Treatment||||||||
1567901|NCT00085904|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567902|NCT00085891|Randomized|Parallel Assignment||Treatment||Double||||||
1567903|NCT00085878|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567904|NCT00083421|Randomized|Parallel Assignment||Treatment||Double||||||
1567905|NCT00005829||Single Group Assignment||Treatment||None (Open Label)||||||
1567906|NCT00005826||||Treatment||||||||
1567907|NCT00005616||||Treatment||||||||
1567908|NCT00005093|Randomized|||Treatment||||||||
1567909|NCT00005073|Randomized|||Treatment||||||||
1567910|NCT00005048||||Treatment||||||||
1567911|NCT00005041||||Treatment||||||||
1567912|NCT00004929||Single Group Assignment||Treatment||None (Open Label)||||||
1567913|NCT00004861|Randomized|||Treatment||||||||
1567914|NCT00004260||||Treatment||||||||
1567915|NCT00004217|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567916|NCT00085917|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567917|NCT00085852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567918|NCT00085839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567919|NCT00085826|Randomized|Parallel Assignment||Treatment||Double||||||
1567920|NCT00085813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567921|NCT00085800||||||||||||
1567922|NCT00085787||Single Group Assignment||Treatment||None (Open Label)||||||
1567923|NCT00085774|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567924|NCT00085761|Randomized|||Treatment||Double||||||
1567925|NCT00004251|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567926|NCT00004076||||Treatment||||||||
1567927|NCT00004043||Single Group Assignment||Treatment||None (Open Label)||||||
1567928|NCT00003996||Single Group Assignment||Treatment||None (Open Label)||||||
1567929|NCT00003920||||Treatment||||||||
1567930|NCT00003898|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1567931|NCT00003894||Parallel Assignment||Supportive Care||||||||
1567932|NCT00003891||||Treatment||||||||
1567933|NCT00085865||||||||||||
1567934|NCT00085748|Randomized|Parallel Assignment||Treatment||Double||||||
1567935|NCT00085735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567936|NCT00085722|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1567937|NCT00085709|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567938|NCT00085644|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1567939|NCT00003871|Randomized|||Treatment||||||||
1567940|NCT00003860||||Treatment||||||||
1567941|NCT00003847|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567942|NCT00003829||Single Group Assignment||Treatment||None (Open Label)||||||
1567943|NCT00003720||||Treatment||||||||
1567944|NCT00003624||||Supportive Care||||||||
1567945|NCT00003592|Randomized|||Treatment||||||||
1567946|NCT00003574||||Treatment||||||||
1567947|NCT00003381|||Case-Only||Prospective|||||||
1567948|NCT00003254||Single Group Assignment||Treatment||None (Open Label)||||||
1567949|NCT00003242||||Treatment||||||||
1567950|NCT00003206||||Treatment||||||||
1567951|NCT00003143|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1567952|NCT00003099|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1567953|NCT00003085||||Diagnostic||||||||
1567954|NCT00003028||||Treatment||||||||
1567955|NCT00003009||||Treatment||||||||
1567956|NCT00002973||||Treatment||||||||
1567957|NCT00002949||Single Group Assignment||Treatment||None (Open Label)||||||
1567958|NCT00002915||||Treatment||||||||
1567959|NCT00002864|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567960|NCT00002838|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567961|NCT00002785||||Treatment||||||||
1567962|NCT00002740||||Treatment||||||||
1567963|NCT00085696|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567964|NCT00085683||||||||||||
1567965|NCT00085670|||Cohort||Other|||||||
1567966|NCT00085657||||||||||||
1567967|NCT00085631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567968|NCT00085579||||Treatment||None (Open Label)||||||
1567969|NCT00085566||Single Group Assignment||Treatment||None (Open Label)||||||
1567970|NCT00085553||Single Group Assignment||Treatment||None (Open Label)||||||
1567971|NCT00085540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567972|NCT00085527||Single Group Assignment||Treatment||None (Open Label)||||||
1567973|NCT00085501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567974|NCT00085488||||Treatment||||||||
1567975|NCT00085475||||Treatment||None (Open Label)||||||
1567976|NCT00085462||||Treatment||None (Open Label)||||||
1567977|NCT00085449||Single Group Assignment||Treatment||None (Open Label)||||||
1567978|NCT00085436||Single Group Assignment||Treatment||None (Open Label)||||||
1567979|NCT00085423||Single Group Assignment||Treatment||None (Open Label)||||||
1567980|NCT00085410||Single Group Assignment||Treatment||None (Open Label)||||||
1567981|NCT00085397|Randomized|||Treatment||||||||
1567982|NCT00085384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567983|NCT00085371||Single Group Assignment||Treatment||None (Open Label)||||||
1567984|NCT00085358||Single Group Assignment||Treatment||None (Open Label)||||||
1567985|NCT00085345||||Treatment||||||||
1567986|NCT00085332||||Treatment||None (Open Label)||||||
1567987|NCT00085306|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1567988|NCT00085293||Single Group Assignment||Treatment||None (Open Label)||||||
1567989|NCT00085280||Single Group Assignment||Treatment||None (Open Label)||||||
1567990|NCT00085254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567991|NCT00085228|Randomized|||Treatment||||||||
1567992|NCT00085202|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567993|NCT00085189|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567994|NCT00085176|||||Prospective|||||||
1567995|NCT00085163|Randomized|||Treatment||Double||||||
1567996|NCT00085150||||Treatment||||||||
1567997|NCT00085124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1567998|NCT00085111||Single Group Assignment||Treatment||None (Open Label)||||||
1568090|NCT00002476||||Treatment||||||||
1567999|NCT00085098|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568000|NCT00085059||||Treatment||None (Open Label)||||||
1568001|NCT00085020||||Treatment||None (Open Label)||||||
1568002|NCT00084981||Single Group Assignment||Treatment||None (Open Label)||||||
1568003|NCT00084942||||Treatment||None (Open Label)||||||
1568004|NCT00084929||Single Group Assignment||Screening||None (Open Label)||||||
1568005|NCT00084916||Single Group Assignment||Treatment||None (Open Label)||||||
1568006|NCT00084903|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1568007|NCT00084890|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568008|NCT00084877||Single Group Assignment||Treatment||None (Open Label)||||||
1568009|NCT00084864|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568010|NCT00084838||Single Group Assignment||Treatment||None (Open Label)||||||
1568011|NCT00084825||Single Group Assignment||Treatment||None (Open Label)||||||
1568012|NCT00084812|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568013|NCT00084799||||Treatment||None (Open Label)||||||
1568014|NCT00084786||||Treatment||||||||
1568015|NCT00084773||Single Group Assignment||Treatment||None (Open Label)||||||
1568016|NCT00084747||Single Group Assignment||Treatment||None (Open Label)||||||
1568017|NCT00084734||Single Group Assignment||Treatment||None (Open Label)||||||
1568018|NCT00084721||||Treatment||||||||
1568019|NCT00084708||Single Group Assignment||Treatment||||||||
1568020|NCT00084695||||Treatment||None (Open Label)||||||
1568021|NCT00084682||Single Group Assignment||Treatment||None (Open Label)||||||
1568022|NCT00084669|Randomized|||Supportive Care||Double||||||
1568023|NCT00084656||||Treatment||None (Open Label)||||||
1568024|NCT00084643||Single Group Assignment||Treatment||None (Open Label)||||||
1568025|NCT00084630||Single Group Assignment||Treatment||None (Open Label)||||||
1568026|NCT00084617||Single Group Assignment||Treatment||None (Open Label)||||||
1568027|NCT00084604||Single Group Assignment||Treatment||None (Open Label)||||||
1568028|NCT00084591||||Treatment||||||||
1568029|NCT00084578|Randomized|||Treatment||||||||
1568030|NCT00084565||||Treatment||None (Open Label)||||||
1568031|NCT00084552|Randomized|Parallel Assignment||Treatment||Single|||t|||
1568032|NCT00084539||Single Group Assignment||Treatment||None (Open Label)||||||
1568033|NCT00084526||||Diagnostic||||||||
1568034|NCT00084513||||Treatment||||||||
1568035|NCT00084487||Single Group Assignment||Treatment||None (Open Label)||||||
1568036|NCT00084461||Single Group Assignment||Treatment||None (Open Label)||||||
1568037|NCT00084448||||Treatment||None (Open Label)||||||
1568038|NCT00084435||Single Group Assignment||Treatment||None (Open Label)||||||
1568039|NCT00084422||Single Group Assignment||Treatment||None (Open Label)||||||
1568040|NCT00084409|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1568041|NCT00084396||||Treatment||None (Open Label)||||||
1568042|NCT00084383||Single Group Assignment||Treatment||None (Open Label)||||||
1568043|NCT00084370|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1568044|NCT00084344|Randomized|||Screening||Double||||||
1568045|NCT00084318|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568046|NCT00084279|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568047|NCT00084266|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1568048|NCT00084253|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568049|NCT00084240|Randomized|Parallel Assignment||Treatment||Double||||||
1568050|NCT00084227|Randomized|Parallel Assignment||Treatment||Double||||||
1568051|NCT00084305||||||||||||
1568052|NCT00084292|||Cohort||Prospective|||||||
1568053|NCT00084214|Randomized|Parallel Assignment||Treatment||Double||||||
1568054|NCT00002682|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568055|NCT00002676||Single Group Assignment||Treatment||None (Open Label)||||||
1568056|NCT00002670|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568057|NCT00002656||Single Group Assignment||Treatment||None (Open Label)||||||
1568058|NCT00002646|Randomized|||Treatment||||||||
1568059|NCT00002637||||Treatment||||||||
1568060|NCT00002632||||Treatment||||||||
1568061|NCT00002625||Single Group Assignment||Treatment||None (Open Label)||||||
1568062|NCT00002551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568063|NCT00002538||||Treatment||||||||
1568064|NCT00084201|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1568065|NCT00084188||||Treatment||||||||
1568066|NCT00084175||||Treatment||||||||
1568067|NCT00006451|Randomized|Parallel Assignment||Treatment||||||||
1568068|NCT00006387||Single Group Assignment||Treatment||||||||
1568069|NCT00006382||||Screening||||||||
1568070|NCT00006380||||Treatment||||||||
1568071|NCT00006378||||Treatment||||||||
1568072|NCT00006374||||Treatment||||||||
1568073|NCT00006251||Single Group Assignment||Treatment||None (Open Label)||||||
1568074|NCT00005994|Randomized|||||||||||
1568075|NCT00005790||||Diagnostic||||||||
1568076|NCT00005084||||Treatment||||||||
1568077|NCT00005045||||Treatment||||||||
1568078|NCT00004236||||Treatment||||||||
1568079|NCT00003992|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568080|NCT00003859||||Treatment||||||||
1568081|NCT00003733||||Treatment||||||||
1568082|NCT00003584||||Treatment||||||||
1568083|NCT00003435||||Treatment||||||||
1568084|NCT00003410||||Diagnostic||||||||
1568085|NCT00003372||||Treatment||||||||
1568086|NCT00003236|Randomized|||Treatment||||||||
1568093|NCT00084149|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568094|NCT00084136|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568095|NCT00084123|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568096|NCT00084110|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1568097|NCT00084071|Randomized|Single Group Assignment||Treatment||Double||||||
1568098|NCT00083993|Randomized|Parallel Assignment||Treatment||Double||||||
1568099|NCT00005960||||Treatment||||||||
1568100|NCT00005641||||Treatment||||||||
1568101|NCT00005091||||Treatment||||||||
1568102|NCT00005054||||Treatment||||||||
1568103|NCT00005050||||Treatment||||||||
1568104|NCT00084097||||Treatment||||||||
1568105|NCT00084084|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568106|NCT00084058|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568107|NCT00084045|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1568108|NCT00084032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568109|NCT00084019|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568110|NCT00083980|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1568111|NCT00083967|Randomized|Parallel Assignment||Treatment||Double||||||
1568112|NCT00083954|Randomized|Single Group Assignment||Treatment||Double||||||
1568113|NCT00083941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568114|NCT00083928|Randomized|Parallel Assignment||Treatment||Double||||||
1568115|NCT00083915|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568116|NCT00083902|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568117|NCT00083889|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568118|NCT00083876|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1568119|NCT00083863|||Cohort|||||||||
1568120|NCT00083850||||||||||||
1568121|NCT00083837||||||||||||
1568122|NCT00083824|Randomized|Parallel Assignment||Health Services Research||Quadruple|||t|t|t|t
1568123|NCT00083811||||||||||||
1568124|NCT00083798|||Cohort||Prospective|||||||
1568125|NCT00005032||Single Group Assignment||Treatment||None (Open Label)||||||
1568126|NCT00005030|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568127|NCT00004979||||Treatment||||||||
1568128|NCT00004927||||Treatment||||||||
1568129|NCT00004877||||Treatment||||||||
1568130|NCT00004161|Randomized|Parallel Assignment||Prevention||Single|||t|||
1568131|NCT00004146||Single Group Assignment||Treatment||None (Open Label)||||||
1568132|NCT00004071|Randomized|||Treatment||||||||
1568133|NCT00004070|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||This is a non-randomize phase I/II where patients are directly assigned treatment.||||
1568134|NCT00004062||||Treatment||||||||
1568135|NCT00083785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568136|NCT00083772|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568137|NCT00083759|Randomized|Parallel Assignment||Treatment||Double||||||
1568138|NCT00004055||Single Group Assignment||Treatment||None (Open Label)||||||
1568139|NCT00003998|Randomized|||Treatment||||||||
1568140|NCT00003997||Single Group Assignment||Treatment||None (Open Label)||||||
1568141|NCT00003991|Randomized|||Treatment||||||||
1568142|NCT00003939||||Treatment||||||||
1568143|NCT00003856||||Treatment||||||||
1568144|NCT00003850||Single Group Assignment||Treatment||None (Open Label)||||||
1568145|NCT00003787|||Case-Control||Prospective|||||||
1568146|NCT00003773||||Treatment||||||||
1568147|NCT00003758||||Treatment||||||||
1568148|NCT00003755||||Treatment||||||||
1568149|NCT00003740||||Treatment||||||||
1568150|NCT00003443||||Treatment||||||||
1568151|NCT00003401||||Treatment||||||||
1568152|NCT00003399||||Treatment||||||||
1568153|NCT00003396||||Treatment||||||||
1568154|NCT00003293|Randomized|||Treatment||||||||
1568155|NCT00003249||Single Group Assignment||Treatment||None (Open Label)||||||
1568156|NCT00003231||||Treatment||||||||
1568157|NCT00083720|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568158|NCT00083733||||||||||||
1568159|NCT00083707|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568160|NCT00083694|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568161|NCT00083681|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1568162|NCT00083668|Randomized|Parallel Assignment||Treatment||Double||||||
1568163|NCT00083616||Single Group Assignment||Treatment||None (Open Label)||||||
1568164|NCT00083564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568165|NCT00083642||||||||||||
1568166|NCT00083629||||Treatment||||||||
1568167|NCT00083603|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1568168|NCT00083590|Randomized|Parallel Assignment||Treatment||Double||||||
1568169|NCT00083577|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568170|NCT00083551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568171|NCT00083538|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568172|NCT00083486||||Treatment||||||||
1568173|NCT00003160||||Treatment||||||||
1568174|NCT00003079|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1568175|NCT00003075|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1568176|NCT00003031|Randomized|||Supportive Care||||||||
1568177|NCT00003015||||Treatment||||||||
1568178|NCT00083525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573256|NCT00001891||||Treatment||||||||
1568179|NCT00083473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568180|NCT00083460|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568181|NCT00083447|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568182|NCT00083434||||Treatment||||||||
1568183|NCT00006877||||Treatment||||||||
1568184|NCT00006358||Single Group Assignment||Treatment||||||||
1568185|NCT00006343||||Treatment||||||||
1568186|NCT00006222||Single Group Assignment||Treatment||None (Open Label)||||||
1568187|NCT00006212||||Treatment||||||||
1568188|NCT00006083|Randomized|Parallel Assignment||Supportive Care||Double||||||
1568189|NCT00006079|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1568190|NCT00006001||Single Group Assignment||Treatment||None (Open Label)||||||
1568191|NCT00005942||Single Group Assignment||Treatment||None (Open Label)||||||
1568192|NCT00005939||||Treatment||||||||
1568193|NCT00005841||||Treatment||||||||
1568194|NCT00005645||||Treatment||||||||
1568195|NCT00005640||Single Group Assignment||Diagnostic||None (Open Label)||||||
1568196|NCT00005636|Randomized|||Treatment||||||||
1568197|NCT00005578|Randomized|Single Group Assignment||Treatment||Single||||||
1568198|NCT00005088||||Treatment||||||||
1568199|NCT00005069||||Treatment||||||||
1568200|NCT00005059||Single Group Assignment||Treatment||None (Open Label)||||||
1568201|NCT00002923||Single Group Assignment||Treatment||None (Open Label)||||||
1568202|NCT00002917||||Treatment||||||||
1568203|NCT00002911|Randomized|||Treatment||||||||
1568204|NCT00002829|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568205|NCT00002827|Randomized|Single Group Assignment||Treatment||Single|||t|||
1568206|NCT00002819|Randomized|||Treatment||||||||
1568207|NCT00002806||Single Group Assignment||Treatment||None (Open Label)||||||
1568208|NCT00002721|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568209|NCT00002639||||Treatment||||||||
1568210|NCT00002602|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568211|NCT00002555|Randomized|||Treatment||||||||
1568212|NCT00002477||||Treatment||||||||
1568213|NCT00083512|||Case-Only||Prospective|||||||
1568214|NCT00083499|||Family-Based||Cross-Sectional|||||||
1568215|NCT00083408|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568216|NCT00004881||||Treatment||||||||
1568217|NCT00004200|Randomized|||Treatment||||||||
1568218|NCT00004190||Single Group Assignment||Treatment||None (Open Label)||||||
1568219|NCT00004176||||Treatment||||||||
1568220|NCT00004139|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568221|NCT00004112|Randomized|||Treatment||||||||
1568222|NCT00004105||||Treatment||||||||
1568223|NCT00004061|Randomized|||Supportive Care||||||||
1568224|NCT00004030||||Treatment||||||||
1568225|NCT00004012||||Treatment||||||||
1568226|NCT00003985||||Treatment||||||||
1568227|NCT00003984||||Treatment||||||||
1568228|NCT00003982||||Treatment||||||||
1568229|NCT00003980||||Treatment||||||||
1568230|NCT00003944||||Treatment||||||||
1568231|NCT00003846||Single Group Assignment||Treatment||None (Open Label)||||||
1568232|NCT00003752|Randomized|||Treatment||||||||
1568233|NCT00003669||||Treatment||||||||
1568234|NCT00003580||||Supportive Care||||||||
1568235|NCT00083395||||||||||||
1568236|NCT00083382||Single Group Assignment||Treatment||None (Open Label)||||||
1568237|NCT00083369|||||Prospective|||||||
1568238|NCT00083343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568239|NCT00008229||||Treatment||||||||
1568240|NCT00008073||||Treatment||||||||
1568241|NCT00006344||Parallel Assignment||Treatment||||||||
1568242|NCT00006269||||Supportive Care||||||||
1568243|NCT00003614||||Treatment||||||||
1568244|NCT00003523||||Treatment||||||||
1568245|NCT00003518||||Treatment||||||||
1568246|NCT00003444|Randomized|||Treatment||||||||
1568247|NCT00003405||||Treatment||||||||
1568248|NCT00003403||||Treatment||||||||
1568249|NCT00003269|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1568250|NCT00003195||||Treatment||||||||
1568251|NCT00003187|Randomized|||Treatment||||||||
1568252|NCT00003098|Randomized|Parallel Assignment||Prevention||Single|||t|||
1568253|NCT00003084|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568254|NCT00003056|Randomized|Parallel Assignment||Supportive Care||||||||
1568255|NCT00003004||||Treatment||||||||
1568256|NCT00002924|||Case-Only||Prospective|||||||
1568257|NCT00002902||||Treatment||||||||
1568258|NCT00002875|Randomized|||Treatment||Single||||||
1568259|NCT00002780||||Treatment||||||||
1568260|NCT00002750||||Treatment||||||||
1568261|NCT00002734||Single Group Assignment||Treatment||None (Open Label)||||||
1568262|NCT00002671||||Treatment||||||||
1568263|NCT00002664||Single Group Assignment||Treatment||None (Open Label)||||||
1568264|NCT00002576|Randomized|||Treatment||||||||
1568265|NCT00002571||Single Group Assignment||Treatment||None (Open Label)||||||
1568266|NCT00002567||||Treatment||||||||
1568267|NCT00002552||||Treatment||||||||
1568268|NCT00002547||Single Group Assignment||Treatment||None (Open Label)||||||
1568269|NCT00083356||||Treatment||||||||
1568270|NCT00005648|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1568271|NCT00004198||||Treatment||||||||
1568272|NCT00004126||Single Group Assignment||Treatment||None (Open Label)||||||
1568273|NCT00004122||||Treatment||||||||
1568274|NCT00004113||||Treatment||||||||
1568276|NCT00003908||Single Group Assignment||Treatment||None (Open Label)||||||
1568277|NCT00003822||||Treatment||||||||
1568278|NCT00003747||||Treatment||||||||
1568279|NCT00003724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568280|NCT00003670||||Treatment||||||||
1568281|NCT00003606|Randomized|||Treatment||||||||
1568282|NCT00003562||||Treatment||||||||
1568283|NCT00003490||||Treatment||||||||
1568284|NCT00003447|Randomized|||Treatment||||||||
1568285|NCT00003365|Randomized|||Prevention||||||||
1568286|NCT00003322|Randomized|||Treatment||||||||
1568287|NCT00003289||||Treatment||||||||
1568288|NCT00003250||Single Group Assignment||Treatment||None (Open Label)||||||
1568289|NCT00003101||||Treatment||||||||
1568290|NCT00002880||Single Group Assignment||Treatment||None (Open Label)||||||
1568291|NCT00002876||||Treatment||||||||
1568292|NCT00002813||||Treatment||||||||
1568293|NCT00002787||Single Group Assignment||Treatment||None (Open Label)||||||
1568294|NCT00002707|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568295|NCT00002692|Randomized|||Treatment||||||||
1568296|NCT00002673||||Supportive Care||||||||
1568297|NCT00002599|Randomized|||Treatment||||||||
1568298|NCT00083330||||Treatment||||||||
1568299|NCT00083278|Non-Randomized|||Treatment||None (Open Label)||||||
1568300|NCT00012350||Single Group Assignment||Treatment||None (Open Label)||||||
1568301|NCT00010088||||Treatment||||||||
1568302|NCT00006220|Non-Randomized|Parallel Assignment||Treatment||||||||
1568303|NCT00005814||||Treatment||||||||
1568304|NCT00005581|Randomized|||Treatment||||||||
1568305|NCT00004880||||Treatment||||||||
1568306|NCT00004211||||Treatment||||||||
1568307|NCT00004156||Single Group Assignment||Treatment||None (Open Label)||||||
1568308|NCT00004132|Randomized|||Supportive Care||||||||
1568309|NCT00004073||||Treatment||||||||
1568310|NCT00004056||Single Group Assignment||Treatment||None (Open Label)||||||
1568311|NCT00004051||||Treatment||||||||
1568312|NCT00004038||Single Group Assignment||Treatment||None (Open Label)||||||
1568313|NCT00003924|Randomized|||Treatment||||||||
1568314|NCT00003876||||Treatment||||||||
1568315|NCT00003801||||Supportive Care||||||||
1568316|NCT00003731||||Treatment||||||||
1568317|NCT00003700|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568318|NCT00003698||||Treatment||||||||
1568319|NCT00003697||||Treatment||||||||
1568320|NCT00003685|Randomized|||Treatment||||||||
1568321|NCT00003640||||Treatment||||||||
1568322|NCT00003575||Single Group Assignment||Treatment||None (Open Label)||||||
1568323|NCT00003439||Single Group Assignment||Treatment||None (Open Label)||||||
1568324|NCT00003423||||Treatment||||||||
1568325|NCT00003330||Single Group Assignment||Treatment||None (Open Label)||||||
1568326|NCT00003326||||Treatment||||||||
1568327|NCT00003255||Single Group Assignment||Treatment||None (Open Label)||||||
1568328|NCT00002578||||Treatment||||||||
1568329|NCT00002503||||Treatment||||||||
1568330|NCT00083317||||||||||||
1568331|NCT00083304|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568332|NCT00083213||Single Group Assignment||Treatment||None (Open Label)||||||
1568333|NCT00082940||||Treatment||None (Open Label)||||||
1568334|NCT00082927|Randomized|||Supportive Care||None (Open Label)||||||
1568335|NCT00082914||||Treatment||None (Open Label)||||||
1568336|NCT00082888||Single Group Assignment||Treatment||None (Open Label)||||||
1568337|NCT00082875|Randomized|Parallel Assignment||Treatment||Double||||||
1568338|NCT00082862||||Treatment||None (Open Label)||||||
1568339|NCT00082836||||Treatment||||||||
1568340|NCT00082823||Single Group Assignment||Treatment||None (Open Label)||||||
1568341|NCT00082810||Single Group Assignment||Treatment||None (Open Label)||||||
1568342|NCT00082797||||Treatment||None (Open Label)||||||
1568343|NCT00082784||Single Group Assignment||Treatment||None (Open Label)||||||
1568344|NCT00082758|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568345|NCT00082745||||||||||||
1568346|NCT00082732|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568347|NCT00082719|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568348|NCT00082706||Single Group Assignment||Treatment||None (Open Label)||||||
1568349|NCT00082667|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1568350|NCT00082654||||||||||||
1568351|NCT00082641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568352|NCT00003186||||Diagnostic||||||||
1568353|NCT00003183||||Treatment||||||||
1568354|NCT00003154||Single Group Assignment||Treatment||None (Open Label)||||||
1568355|NCT00003118|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568356|NCT00003117|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568357|NCT00003095|||Cohort||Prospective|||||||
1568358|NCT00003020||||Treatment||||||||
1568359|NCT00002988||||Treatment||||||||
1568360|NCT00002985|Randomized|||Treatment||||||||
1568361|NCT00002961|Randomized|||Treatment||||||||
1568362|NCT00083291||||||||||||
1568363|NCT00083252|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568364|NCT00083239|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568365|NCT00083265||||||||||||
1568366|NCT00083226||Single Group Assignment||Treatment||None (Open Label)||||||
1568367|NCT00083187||||Treatment||None (Open Label)||||||
1568368|NCT00083174||Single Group Assignment||Prevention||None (Open Label)||||||
1568369|NCT00083161||Single Group Assignment||Treatment||None (Open Label)||||||
1568370|NCT00083148||Single Group Assignment||Treatment||||||||
1568371|NCT00083135||||Treatment||||||||
1568372|NCT00083122|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568373|NCT00083109||Single Group Assignment||Treatment||None (Open Label)||||||
1568374|NCT00083096||||Treatment||None (Open Label)||||||
1568375|NCT00083083||||Diagnostic||None (Open Label)||||||
1568376|NCT00083070||Single Group Assignment||Treatment||None (Open Label)||||||
1568377|NCT00083057||||Treatment||||||||
1568378|NCT00083044|||Cohort||Prospective|||||||
1568379|NCT00083031|Randomized|||Treatment||||||||
1568380|NCT00083018||||Diagnostic||||||||
1568381|NCT00083005||||Treatment||None (Open Label)||||||
1568382|NCT00082979||||Diagnostic||||||||
1568383|NCT00082966||Single Group Assignment||Treatment||None (Open Label)||||||
1568384|NCT00082628|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1568385|NCT00082602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568386|NCT00082589|Randomized|Single Group Assignment||Treatment||Double||||||
1568387|NCT00082576|Randomized|Parallel Assignment||Treatment||Double||||||
1568388|NCT00082563|Randomized|Parallel Assignment||Treatment||Double||||||
1568389|NCT00082615||||||||||||
1568390|NCT00082537|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1568391|NCT00082524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568392|NCT00002936||||Treatment||||||||
1568393|NCT00002903||||Treatment||||||||
1568394|NCT00002896|Randomized|||Treatment||||||||
1568395|NCT00002893|Randomized|||Treatment||||||||
1568396|NCT00002892|Randomized|||Treatment||||||||
1568397|NCT00082550||||||||||||
1568398|NCT00082498|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1568399|NCT00082485|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1568400|NCT00082472|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568401|NCT00082459|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568402|NCT00082420|||Case-Only|||||||||
1568403|NCT00002870|Randomized|||Treatment||||||||
1568404|NCT00002826||||Treatment||||||||
1568405|NCT00002803||||Treatment||||||||
1568406|NCT00002802|Non-Randomized|||Treatment||||||||
1568407|NCT00082446|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1568408|NCT00082433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568409|NCT00082381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568410|NCT00002788||||Treatment||||||||
1568411|NCT00002737|Randomized|||Treatment||||||||
1568412|NCT00002677||Single Group Assignment||Treatment||None (Open Label)||||||
1568413|NCT00002644|Randomized|||Prevention||Double||||||
1568414|NCT00002587||Single Group Assignment||Treatment||None (Open Label)||||||
1568415|NCT00082407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568416|NCT00082394|Randomized|Parallel Assignment||Treatment||||||||
1568417|NCT00082316|Randomized|||Treatment||None (Open Label)||||||
1568418|NCT00082368||Single Group Assignment||Diagnostic||None (Open Label)||||||
1568419|NCT00082355||Single Group Assignment||Treatment||None (Open Label)||||||
1568420|NCT00082342|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1568421|NCT00082329||Single Group Assignment||Treatment||None (Open Label)||||||
1568422|NCT00082303|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568423|NCT00082290|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1568424|NCT00082277|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1568425|NCT00082251|Randomized|Parallel Assignment||Treatment||Double||||||
1568426|NCT00082238|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1568427|NCT00082225||Single Group Assignment||Treatment||None (Open Label)||||||
1568428|NCT00082212|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568429|NCT00014651||||Supportive Care||||||||
1568430|NCT00010322||||Treatment||||||||
1568431|NCT00008255||||Diagnostic||||||||
1568432|NCT00002568|Randomized|||Treatment||||||||
1568433|NCT00002516||||Treatment||||||||
1568434|NCT00082199|Randomized|Parallel Assignment||Treatment||Double||||||
1568435|NCT00082186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568436|NCT00082173|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1568437|NCT00082160|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1568438|NCT00082134|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568439|NCT00082121|Randomized|Parallel Assignment||||Double||||||
1568440|NCT00011934||||Treatment||||||||
1568441|NCT00008242||||Treatment||||||||
1568442|NCT00008125||||Treatment||||||||
1568443|NCT00008099||Single Group Assignment||Treatment||None (Open Label)||||||
1568444|NCT00006682||||Treatment||||||||
1568445|NCT00006669||||Treatment||||||||
1568446|NCT00006342|||Case-Only||Prospective|||||||
1568447|NCT00006112||||Treatment||||||||
1568448|NCT00006097||||Treatment||||||||
1568449|NCT00006053||||Treatment||||||||
1568450|NCT00006039||||Treatment||||||||
1568451|NCT00005988||Single Group Assignment||Treatment||None (Open Label)||||||
1568452|NCT00005974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568453|NCT00005871|Randomized|||Treatment||||||||
1568454|NCT00005612||Single Group Assignment||Treatment||None (Open Label)||||||
1568455|NCT00005594||Single Group Assignment||Treatment||None (Open Label)||||||
1568456|NCT00005081||||Treatment||||||||
1568457|NCT00005055|Randomized|||Treatment||||||||
1568458|NCT00005053|Randomized|||Treatment||||||||
1568459|NCT00005021||Single Group Assignment||Treatment||None (Open Label)||||||
1568460|NCT00004893|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1568461|NCT00004892||||Treatment||||||||
1568462|NCT00004884|Randomized|||Treatment||||||||
1568463|NCT00004246|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568464|NCT00004230|Randomized|||Supportive Care||||||||
1568465|NCT00004213||||Treatment||||||||
1568466|NCT00004101||Single Group Assignment||Treatment||None (Open Label)||||||
1568467|NCT00004049||||Treatment||||||||
1568468|NCT00003972|Randomized|||Treatment||||||||
1568469|NCT00003968||Single Group Assignment||Treatment||None (Open Label)||||||
1568470|NCT00003943||Single Group Assignment||Treatment||None (Open Label)||||||
1568471|NCT00003900||Single Group Assignment||Treatment||None (Open Label)||||||
1568472|NCT00003849||Single Group Assignment||Treatment||None (Open Label)||||||
1568473|NCT00003825|Randomized|||Supportive Care||||||||
1568474|NCT00003768||Single Group Assignment||Treatment||None (Open Label)||||||
1568475|NCT00003726||Single Group Assignment||Treatment||None (Open Label)||||||
1568476|NCT00003713||||Treatment||||||||
1568477|NCT00003680|Randomized|||Treatment||||||||
1568478|NCT00003646||||Treatment||None (Open Label)||||||
1568479|NCT00003638|Randomized|||Treatment||||||||
1568480|NCT00003622||Single Group Assignment||Treatment||None (Open Label)||||||
1568481|NCT00082147||Single Group Assignment||Diagnostic||None (Open Label)||||||
1568482|NCT00082108|||Other||Prospective|||||||
1568483|NCT00082095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568484|NCT00082082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568485|NCT00082069|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1568486|NCT00081978|Randomized|||Treatment||||||||
1568487|NCT00003583||||Supportive Care||||||||
1568488|NCT00003563|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1568489|NCT00003554||||Treatment||||||||
1568490|NCT00003397||||Treatment||||||||
1568491|NCT00003394||||Treatment||||||||
1568492|NCT00003276||Single Group Assignment||Treatment||None (Open Label)||||||
1568493|NCT00003239||Single Group Assignment||Treatment||None (Open Label)||||||
1568494|NCT00003181||||Treatment||||||||
1568495|NCT00003175||||Treatment||||||||
1568496|NCT00003165||||Treatment||||||||
1568497|NCT00003133||||Treatment||||||||
1568498|NCT00003038||||Treatment||||||||
1568499|NCT00003019||Single Group Assignment||Treatment||None (Open Label)||||||
1568500|NCT00081939||Single Group Assignment||Treatment||None (Open Label)||||||
1568501|NCT00081926|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568502|NCT00014365||||Treatment||||||||
1568503|NCT00006483||Single Group Assignment||Treatment||None (Open Label)||||||
1568504|NCT00006261||Single Group Assignment||Treatment||None (Open Label)||||||
1568505|NCT00006106||||Treatment||||||||
1568506|NCT00003001||||Treatment||||||||
1568507|NCT00002977||||Treatment||||||||
1568508|NCT00002939||Single Group Assignment||Treatment||None (Open Label)||||||
1568509|NCT00002912||Single Group Assignment||Treatment||None (Open Label)||||||
1568510|NCT00002884|Randomized|||Treatment||||||||
1568511|NCT00002773||||Treatment||||||||
1568512|NCT00002719|Randomized|||Treatment||||||||
1568513|NCT00002680||||Treatment||||||||
1568514|NCT00002590||Single Group Assignment||Treatment||None (Open Label)||||||
1568515|NCT00002564|Randomized|||Treatment||||||||
1568516|NCT00002481||||Treatment||||||||
1568517|NCT00082043|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1568518|NCT00082030||||||||||||
1568519|NCT00082017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568520|NCT00081991||||||||||||
1568521|NCT00081965|Randomized|||Supportive Care||||||||
1568522|NCT00081952|Randomized|Parallel Assignment||Treatment||||||||
1568523|NCT00081913|Randomized|||Treatment||Double||||||
1568524|NCT00081900|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568525|NCT00005969||Single Group Assignment||Treatment||None (Open Label)||||||
1568526|NCT00005883||||Prevention||||||||
1568527|NCT00005796||Single Group Assignment||Treatment||None (Open Label)||||||
1568528|NCT00005649||||Treatment||||||||
1568529|NCT00004933|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568530|NCT00004923||||Treatment||||||||
1568531|NCT00004903||||Treatment||||||||
1568532|NCT00004878|Randomized|||Supportive Care||||||||
1568533|NCT00004872||||Treatment||||||||
1568534|NCT00004858||||Treatment||||||||
1568535|NCT00004604||Single Group Assignment||Treatment||None (Open Label)||||||
1568536|NCT00004249||||Treatment||||||||
1568537|NCT00004174||||Treatment||||||||
1568538|NCT00003960||||Treatment||||||||
1568539|NCT00003953||Single Group Assignment||Treatment||None (Open Label)||||||
1568540|NCT00081887|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568541|NCT00081874||Single Group Assignment||Treatment||None (Open Label)||||||
1568542|NCT00081861||Single Group Assignment||Treatment||None (Open Label)||||||
1568543|NCT00003950||Single Group Assignment||Treatment||None (Open Label)||||||
1568544|NCT00003914||||Treatment||||||||
1568545|NCT00003887||||Treatment||||||||
1568546|NCT00003835|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568547|NCT00003819|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568548|NCT00003783|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573257|NCT00001890||||Treatment||||||||
1568549|NCT00003765||Single Group Assignment||Treatment||None (Open Label)||||||
1568550|NCT00003619||||Treatment||||||||
1568551|NCT00003544||||Treatment||||||||
1568552|NCT00003434||Single Group Assignment||Treatment||None (Open Label)||||||
1568553|NCT00003427||||Treatment||||||||
1568554|NCT00003407||||Supportive Care||||||||
1568555|NCT00003398||||Treatment||||||||
1568556|NCT00003270||Single Group Assignment||Treatment||None (Open Label)||||||
1568557|NCT00003144||||Supportive Care||||||||
1568558|NCT00003094||||Prevention||||||||
1568559|NCT00003081||||Treatment||||||||
1568560|NCT00002964||||Diagnostic||||||||
1568561|NCT00002866||||Treatment||||||||
1568562|NCT00006475||||Treatment||||||||
1568563|NCT00006463||Single Group Assignment||Treatment||None (Open Label)||||||
1568564|NCT00006357||||Treatment||||||||
1568565|NCT00006216||||Treatment||||||||
1568566|NCT00006049||||Treatment||||||||
1568567|NCT00006048||||Treatment||||||||
1568568|NCT00005870|Randomized|||Treatment||||||||
1568569|NCT00005849||Single Group Assignment||Treatment||None (Open Label)||||||
1568570|NCT00005842||Single Group Assignment||Treatment||None (Open Label)||||||
1568571|NCT00005832||Single Group Assignment||Treatment||None (Open Label)||||||
1568572|NCT00002794||||Treatment||||||||
1568573|NCT00002553||||Treatment||||||||
1568574|NCT00002485||||||||||||
1568575|NCT00002466||||Treatment||||||||
1568576|NCT00002456||||Supportive Care||||||||
1568577|NCT00081822||Single Group Assignment||Treatment||None (Open Label)||||||
1568578|NCT00081809|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568579|NCT00005092||Single Group Assignment||Treatment||None (Open Label)||||||
1568580|NCT00005082||||Diagnostic||||||||
1568581|NCT00005023||||Treatment||||||||
1568582|NCT00004870||||Treatment||||||||
1568583|NCT00004254||||Treatment||||||||
1568584|NCT00004013||||Treatment||||||||
1568585|NCT00003899||||Treatment||||||||
1568586|NCT00003880|Randomized|||Treatment||||||||
1568587|NCT00003790||||||||||||
1568588|NCT00003735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568589|NCT00003715|Randomized|||Treatment||||||||
1568590|NCT00003701|Randomized|||Treatment||||||||
1568591|NCT00003621||Single Group Assignment||Treatment||None (Open Label)||||||
1568592|NCT00003445||||Treatment||||||||
1568593|NCT00003386||||Treatment||||||||
1568594|NCT00003148||||Treatment||||||||
1568595|NCT00003146||||Treatment||||||||
1568596|NCT00003076||||Prevention||||||||
1568597|NCT00003041||||Treatment||||||||
1568598|NCT00081848||||Treatment||||||||
1568599|NCT00081835||||Treatment||||||||
1568600|NCT00081796|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568601|NCT00081783|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568602|NCT00081770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568603|NCT00081757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568604|NCT00021346||||Treatment||||||||
1568605|NCT00019357||||Treatment||||||||
1568606|NCT00003018||Single Group Assignment||Treatment||None (Open Label)||||||
1568607|NCT00003017||||Treatment||||||||
1568608|NCT00002952||Single Group Assignment||Treatment||None (Open Label)||||||
1568609|NCT00002889||Single Group Assignment||Treatment||None (Open Label)||||||
1568610|NCT00002818|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568611|NCT00002800||||Treatment||||||||
1568612|NCT00002772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568613|NCT00002768||Single Group Assignment||Treatment||None (Open Label)||||||
1568614|NCT00002764|Randomized|||Treatment||||||||
1568615|NCT00002745||Single Group Assignment||Treatment||None (Open Label)||||||
1568616|NCT00002722|Randomized|||Treatment||||||||
1568617|NCT00002595||||Treatment||||||||
1568618|NCT00002583|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568619|NCT00002534||||Treatment||||||||
1568620|NCT00002519||||Treatment||||||||
1568621|NCT00002501||Single Group Assignment||Treatment||None (Open Label)||||||
1568622|NCT00002492||||Treatment||||||||
1568623|NCT00002463||Single Group Assignment||Treatment||None (Open Label)||||||
1568624|NCT00081744|Randomized|||Treatment||Double||||||
1568625|NCT00081731|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568626|NCT00081705||||||||||||
1568627|NCT00081692|||Cohort||Cross-Sectional|||||||
1568628|NCT00081679||||||||||||
1568629|NCT00081666||||||||||||
1568630|NCT00081653|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1568631|NCT00019344||||Treatment||||||||
1568632|NCT00019240||||Treatment||||||||
1568633|NCT00016900||||Treatment||||||||
1568634|NCT00010010||||Treatment||||||||
1568635|NCT00009828||||Treatment||||||||
1568636|NCT00081614|Randomized|Parallel Assignment||Treatment||Double||||||
1568637|NCT00081549|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1568638|NCT00081536|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1568639|NCT00012129||||Treatment||||||||
1568640|NCT00009815||||Treatment||||||||
1568641|NCT00005989||||Treatment||||||||
1568642|NCT00005958||||Treatment||||||||
1568643|NCT00005950||Single Group Assignment||Treatment||None (Open Label)||||||
1568644|NCT00005938||||Treatment||||||||
1568645|NCT00005828||Single Group Assignment||Treatment||None (Open Label)||||||
1568646|NCT00005827||Single Group Assignment||Treatment||None (Open Label)||||||
1568647|NCT00081640|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1568648|NCT00081601|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568649|NCT00081588|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568650|NCT00081575|Randomized|||Treatment||Double||||||
1568651|NCT00081562||||||||||||
1568652|NCT00081380|Randomized|Parallel Assignment||Prevention||Double||||||
1568653|NCT00005810||Single Group Assignment||Treatment||None (Open Label)||||||
1568654|NCT00005809||||Diagnostic||||||||
1568655|NCT00005643||||Treatment||||||||
1568656|NCT00005625||||Treatment||||||||
1568657|NCT00005608||||Treatment||||||||
1568658|NCT00005080||Single Group Assignment||Treatment||None (Open Label)||||||
1568659|NCT00005071|Randomized|||Diagnostic||||||||
1568660|NCT00004252|Randomized|||Treatment||||||||
1568661|NCT00004229||Single Group Assignment||Treatment||None (Open Label)||||||
1568662|NCT00004178||||Treatment||||||||
1568663|NCT00081510|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1568664|NCT00081497|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568665|NCT00081484|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568666|NCT00081471|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568667|NCT00004177||Single Group Assignment||Treatment||None (Open Label)||||||
1568668|NCT00004108||||Treatment||||||||
1568669|NCT00004107||Single Group Assignment||Treatment||None (Open Label)||||||
1568670|NCT00004100|Randomized|||Treatment||||||||
1568671|NCT00004087||Single Group Assignment||Treatment||None (Open Label)||||||
1568672|NCT00081523|||Case-Only||Prospective|||||||
1568673|NCT00004086||||Treatment||||||||
1568674|NCT00004085||Single Group Assignment||Treatment||None (Open Label)||||||
1568675|NCT00004084||Single Group Assignment||Treatment||None (Open Label)||||||
1568676|NCT00004048||||Treatment||||||||
1568677|NCT00004046||||Treatment||||||||
1568678|NCT00004045||||Treatment||||||||
1568679|NCT00004033||||Treatment||||||||
1568680|NCT00004016||||Treatment||||||||
1568681|NCT00004010||Single Group Assignment||Treatment||None (Open Label)||||||
1568682|NCT00003954||Single Group Assignment||Treatment||None (Open Label)||||||
1568683|NCT00081458|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1568684|NCT00003917|Randomized|Single Group Assignment||Treatment||||||||
1568685|NCT00003870||||Treatment||||||||
1568686|NCT00003834||Single Group Assignment||Treatment||None (Open Label)||||||
1568687|NCT00003824|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568688|NCT00003809|Randomized|||Treatment||||||||
1568689|NCT00003719||||Treatment||||||||
1568690|NCT00003718||||Treatment||||||||
1568691|NCT00003717||||Treatment||||||||
1568692|NCT00003674|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1568693|NCT00003493||||Treatment||||||||
1568694|NCT00003307||||Treatment||||||||
1568695|NCT00003283||||Treatment||||||||
1568696|NCT00003235|Randomized|||Treatment||||||||
1568697|NCT00003209||||Treatment||||||||
1568698|NCT00003125|Randomized|||Treatment||||||||
1568699|NCT00003080||||Treatment||||||||
1568700|NCT00003061||||Treatment||||||||
1568701|NCT00003032|Randomized|||Treatment||||||||
1568702|NCT00003010|Randomized|||Treatment||||||||
1568703|NCT00021398||Single Group Assignment||Treatment||None (Open Label)||||||
1568704|NCT00021281||||Treatment||||||||
1568705|NCT00021151||Single Group Assignment||Treatment||None (Open Label)||||||
1568706|NCT00021008||||Treatment||||||||
1568707|NCT00020774||||Treatment||||||||
1568708|NCT00019552||||Treatment||||||||
1568709|NCT00019474||||Treatment||||||||
1568710|NCT00019318||||Treatment||||||||
1568711|NCT00019123||||Treatment||||||||
1568712|NCT00014391||||Supportive Care||||||||
1568713|NCT00012311||||Treatment||||||||
1568714|NCT00010283||||Supportive Care||||||||
1568715|NCT00007943||||Treatment||||||||
1568716|NCT00006045||||Treatment||||||||
1568717|NCT00005875||||Treatment||||||||
1568718|NCT00005874||||Treatment||||||||
1568719|NCT00005873||||Treatment||||||||
1568720|NCT00002708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568721|NCT00081432||||||||||||
1568722|NCT00081419||||||||||||
1568723|NCT00081406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568724|NCT00081367|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568725|NCT00081341|||||Prospective|||||||
1568726|NCT00081328|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1568727|NCT00005872||||Treatment||||||||
1568728|NCT00005833||Single Group Assignment||Treatment||None (Open Label)||||||
1568729|NCT00005820||Single Group Assignment||Treatment||None (Open Label)||||||
1568730|NCT00005801||||Treatment||||||||
1568731|NCT00005077||||Treatment||||||||
1568732|NCT00005066||Single Group Assignment||Treatment||None (Open Label)||||||
1568733|NCT00005061||||Treatment||||||||
1568734|NCT00005058||||Diagnostic||||||||
1568735|NCT00005040||||Treatment||||||||
1568736|NCT00004885|Randomized|||Treatment||||||||
1568737|NCT00004860||||Treatment||||||||
1568738|NCT00004238||||Treatment||||||||
1568739|NCT00004166|Randomized|||Supportive Care||||||||
1568740|NCT00004137||Single Group Assignment||Treatment||None (Open Label)||||||
1568741|NCT00004102||||Treatment||||||||
1568742|NCT00004082||||Treatment||||||||
1568743|NCT00004002||||Treatment||||||||
1573258|NCT00001889||||Treatment||||||||
1568744|NCT00003911||Single Group Assignment||Treatment||None (Open Label)||||||
1568745|NCT00003840||||Treatment||||||||
1568746|NCT00081354|||Case-Control||Other|||||||
1568747|NCT00081315|Randomized|Single Group Assignment||Prevention||Double||||||
1568748|NCT00005943||||Treatment||||||||
1568749|NCT00003754||||Treatment||||||||
1568750|NCT00003710||Single Group Assignment||Treatment||None (Open Label)||||||
1568751|NCT00003692||Single Group Assignment||Treatment||None (Open Label)||||||
1568752|NCT00003642||||Treatment||||||||
1568753|NCT00003446||||Treatment||||||||
1568754|NCT00003376|Randomized|||Treatment||||||||
1568755|NCT00003316||||Treatment||||||||
1568756|NCT00003301||||Treatment||||||||
1568757|NCT00003232|Randomized|||Treatment||||||||
1568758|NCT00081302||||Treatment||None (Open Label)||||||
1568759|NCT00081289|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568760|NCT00081276||Single Group Assignment||Treatment||None (Open Label)||||||
1568761|NCT00081263|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1568762|NCT00081250|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1568763|NCT00081237||||Treatment||None (Open Label)||||||
1568764|NCT00081224||Single Group Assignment||Treatment||None (Open Label)||||||
1568765|NCT00081211||Single Group Assignment||Treatment||None (Open Label)||||||
1568766|NCT00081172||||Treatment||None (Open Label)||||||
1568767|NCT00081159|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568768|NCT00081133||||Treatment||||||||
1568769|NCT00081107||||Treatment||None (Open Label)||||||
1568770|NCT00081094||Single Group Assignment||Diagnostic||None (Open Label)||||||
1568771|NCT00081068||||Treatment||None (Open Label)||||||
1568772|NCT00081055|Randomized|||Supportive Care||Double||||||
1568773|NCT00081042||||Treatment||None (Open Label)||||||
1568774|NCT00081029|Randomized|||Treatment||||||||
1568775|NCT00081003||||Screening||||||||
1568776|NCT00080990||Single Group Assignment||Treatment||None (Open Label)||||||
1568777|NCT00080977||||Treatment||||||||
1568778|NCT00080951||Single Group Assignment||Treatment||None (Open Label)||||||
1568779|NCT00080938||Single Group Assignment||Treatment||None (Open Label)||||||
1568780|NCT00080925||||Treatment||||||||
1568781|NCT00080912|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568782|NCT00080899||Single Group Assignment||Treatment||None (Open Label)||||||
1568783|NCT00080886||Single Group Assignment||Treatment||None (Open Label)||||||
1568784|NCT00080873|Randomized|Parallel Assignment||Supportive Care||Double||||||
1568785|NCT00080860||||Diagnostic||||||||
1568786|NCT00080847|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568787|NCT00080834||||Treatment||None (Open Label)||||||
1568788|NCT00080808|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1568789|NCT00080795||Single Group Assignment||Treatment||None (Open Label)||||||
1568790|NCT00080782|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568791|NCT00080756|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1568792|NCT00080743|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1568793|NCT00080678|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1568794|NCT00080665||Single Group Assignment||Treatment||None (Open Label)||||||
1568795|NCT00080639|||Cohort||Prospective|||||||
1568796|NCT00080626||Single Group Assignment||Treatment||None (Open Label)||||||
1568797|NCT00080613||||Treatment||||||||
1568798|NCT00080600||||||||||||
1568799|NCT00080587||||||||||||
1568800|NCT00080574||||Treatment||||||||
1568801|NCT00080548||||||||||||
1568802|NCT00080535||Single Group Assignment||Treatment||None (Open Label)||||||
1568803|NCT00080522|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1568804|NCT00080509|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568805|NCT00080496|Randomized|Parallel Assignment||Treatment||Double||||||
1568806|NCT00003176||||Treatment||||||||
1568807|NCT00003156||||Treatment||||||||
1568808|NCT00003132||||Treatment||||||||
1568809|NCT00003110||Single Group Assignment||Treatment||None (Open Label)||||||
1568810|NCT00002997||||Treatment||||||||
1568811|NCT00080483|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568812|NCT00024063||||Treatment||||||||
1568813|NCT00003107||||Treatment||||||||
1568814|NCT00003103||||Treatment||||||||
1568815|NCT00003012|Randomized|||Treatment||||||||
1568816|NCT00002987||||Treatment||||||||
1568817|NCT00002814|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568818|NCT00002774|Randomized|Parallel Assignment||Treatment||||||||
1568819|NCT00002714||||Treatment||||||||
1568820|NCT00002600||||Treatment||||||||
1568821|NCT00002525|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568822|NCT00002494||Single Group Assignment||Treatment||None (Open Label)||||||
1568823|NCT00080470|Randomized|Parallel Assignment||Treatment||Single|||t|||
1568824|NCT00080457|Randomized|Parallel Assignment||Treatment||Double||||||
1568825|NCT00023816||||Treatment||||||||
1568826|NCT00022386||||Supportive Care||||||||
1568827|NCT00022256||||Treatment||||||||
1568828|NCT00020605||||Supportive Care||||||||
1568829|NCT00020540||||Treatment||||||||
1568830|NCT00019071||||Treatment||||||||
1568831|NCT00019058||||Treatment||||||||
1568832|NCT00016042||||Treatment||||||||
1568833|NCT00014573||Single Group Assignment||Treatment||None (Open Label)||||||
1568834|NCT00080444|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1568835|NCT00080418|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568836|NCT00080405|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568837|NCT00009841||||Treatment||||||||
1568838|NCT00007813||||Treatment||||||||
1568839|NCT00006487||Single Group Assignment||Treatment||None (Open Label)||||||
1568840|NCT00006458||||Treatment||||||||
1568841|NCT00006376||||Treatment||||||||
1568842|NCT00006371|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568843|NCT00006370||||Treatment||||||||
1568844|NCT00006369||||Treatment||||||||
1568845|NCT00006368||||Treatment||||||||
1568846|NCT00006052||||Treatment||||||||
1568847|NCT00006043||||Treatment||||||||
1568848|NCT00006032||||Treatment||||||||
1568849|NCT00006031|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1568850|NCT00005948||||Treatment||||||||
1568851|NCT00005860||||Treatment||||||||
1568852|NCT00005799||Single Group Assignment||Treatment||None (Open Label)||||||
1568853|NCT00005798||Single Group Assignment||Treatment||None (Open Label)||||||
1568854|NCT00005628||||Treatment||||||||
1568855|NCT00005618||||Treatment||||||||
1568856|NCT00005615||Single Group Assignment||Treatment||None (Open Label)||||||
1568857|NCT00005577||Single Group Assignment||Treatment||None (Open Label)||||||
1568858|NCT00005097|Randomized|Parallel Assignment||Prevention||Double||Subjects will have actinic keratosis on both arms and apply Polyphenon E topical ointment on one arm and placebo ointment to apply to the other arm. Subjects will serve as their own control by being unaware of which arm will have the active study drug.|t||t|
1568859|NCT00005068||||Treatment||||||||
1568860|NCT00003864||||Treatment||||||||
1568861|NCT00080431||||Treatment||||||||
1568862|NCT00005031||||Treatment||||||||
1568863|NCT00004248||Single Group Assignment||Treatment||||||||
1568864|NCT00004097||||Treatment||||||||
1568865|NCT00003967||||Treatment||||||||
1568866|NCT00003883|Randomized|||Supportive Care||||||||
1568867|NCT00003769||||Treatment||||||||
1568868|NCT00003657||Single Group Assignment||Treatment||None (Open Label)||||||
1568869|NCT00003635||||Treatment||||||||
1568870|NCT00003412||||Treatment||||||||
1568871|NCT00003402||||Treatment||||||||
1568872|NCT00080392||||Treatment||||||||
1568873|NCT00080340|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568874|NCT00080327|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1568875|NCT00080314|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1568876|NCT00080301|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568877|NCT00003345||||Treatment||||||||
1568878|NCT00003192||Single Group Assignment||Treatment||None (Open Label)||||||
1568879|NCT00003157||Single Group Assignment||Treatment||None (Open Label)||||||
1568880|NCT00003149|Randomized|||Treatment||||||||
1568881|NCT00002974||||Treatment||||||||
1568882|NCT00080366||||Treatment||||||||
1568883|NCT00080353||||Treatment||||||||
1568884|NCT00080288|Randomized|Parallel Assignment||Treatment||Double||||||
1568885|NCT00080275|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568886|NCT00080262|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568887|NCT00080236|Randomized|Parallel Assignment||Treatment||Double||||||
1568888|NCT00080223||Single Group Assignment||Other||None (Open Label)||||||
1568889|NCT00080158|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568890|NCT00012142||||Treatment||||||||
1568891|NCT00002950||||Treatment||||||||
1568892|NCT00002947||||Treatment||||||||
1568893|NCT00002887||||Treatment||||||||
1568894|NCT00002759||Single Group Assignment||Treatment||None (Open Label)||||||
1568895|NCT00002592||||Treatment||||||||
1568896|NCT00002540|Randomized|Parallel Assignment||Screening||Single|||||t|
1568897|NCT00002536||||Treatment||||||||
1568898|NCT00002461|Randomized|Parallel Assignment||Treatment||||||||
1568899|NCT00080210|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568900|NCT00080197|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568901|NCT00080184|Randomized|Single Group Assignment||Treatment||Double||||||
1568902|NCT00080171|||Cohort||Prospective|||||||
1568903|NCT00080145|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568904|NCT00080132||||Treatment||None (Open Label)||||||
1568905|NCT00080119|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1568906|NCT00080106|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1568907|NCT00010647|Randomized|||Treatment||||||||
1568908|NCT00008320||Single Group Assignment||Treatment||None (Open Label)||||||
1568909|NCT00008151||||Treatment||||||||
1568910|NCT00006348|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1568911|NCT00006345||||Supportive Care||||||||
1568912|NCT00006262||||Treatment||||||||
1568913|NCT00006090||Single Group Assignment||Treatment||None (Open Label)||||||
1568914|NCT00006084||||Treatment||||||||
1568915|NCT00006051||||Treatment||||||||
1568916|NCT00006036||||Treatment||||||||
1568917|NCT00006030||||Treatment||||||||
1568918|NCT00080093|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1568919|NCT00080080|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568920|NCT00006023||||Treatment||||||||
1568921|NCT00005992||||Treatment||||||||
1568922|NCT00005972||Single Group Assignment||Treatment||None (Open Label)||||||
1568923|NCT00005944|Randomized|||Treatment||||||||
1568924|NCT00005865|Randomized|||Treatment||||||||
1568925|NCT00080067||||||||||||
1568926|NCT00080054|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568927|NCT00080041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568928|NCT00080028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568929|NCT00080015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568930|NCT00080002|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568931|NCT00079989||||Treatment||None (Open Label)||||||
1568932|NCT00005816||||Treatment||||||||
1568933|NCT00004123|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568934|NCT00003817|Randomized|||Supportive Care||||||||
1568935|NCT00003693||Single Group Assignment||Treatment||None (Open Label)||||||
1568936|NCT00003647||||Treatment||||||||
1568937|NCT00079976|Randomized|||Treatment||Double||||||
1568938|NCT00079963|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1568939|NCT00079950|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568940|NCT00079937|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1568941|NCT00003561||||Treatment||||||||
1568942|NCT00003356||||Treatment||||||||
1568943|NCT00003327||||Treatment||||||||
1568944|NCT00003321||||||||||||
1568945|NCT00003274|Randomized|||Treatment||||||||
1568946|NCT00079924|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568947|NCT00079911|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1568948|NCT00079898|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1568949|NCT00079885|Randomized|||Treatment||Double||||||
1568950|NCT00079872|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1568951|NCT00022360||||Treatment||||||||
1568952|NCT00022165|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1568953|NCT00021138||||Prevention||||||||
1568954|NCT00003166||Single Group Assignment||Treatment||None (Open Label)||||||
1568955|NCT00002789|Randomized|||Treatment||||||||
1568956|NCT00079859|Randomized|Single Group Assignment||Treatment||Double||||||
1568957|NCT00079846|Randomized|Single Group Assignment||Treatment||Double||||||
1568958|NCT00079833|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568959|NCT00079820|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1568960|NCT00020930||||Treatment||||||||
1568961|NCT00020865||||Supportive Care||||||||
1568962|NCT00014300||||Treatment||||||||
1568963|NCT00012337||||Treatment||||||||
1568964|NCT00009737|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568965|NCT00006812||||Treatment||||||||
1568966|NCT00006708|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568967|NCT00006218||||Treatment||||||||
1568968|NCT00006215||||Treatment||||||||
1568969|NCT00006098||||Treatment||||||||
1568970|NCT00079807|Randomized|Parallel Assignment||Treatment||Double||||||
1568971|NCT00079794|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568972|NCT00079781|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1568973|NCT00079755|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568974|NCT00079742||||Treatment||||||||
1568975|NCT00079716||Single Group Assignment||Treatment||None (Open Label)||||||
1568976|NCT00006091||Single Group Assignment||Treatment||None (Open Label)||||||
1568977|NCT00006085||||Treatment||||||||
1568978|NCT00006026||||Treatment||||||||
1568979|NCT00005866|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568980|NCT00005848||Single Group Assignment||Treatment||||||||
1568981|NCT00005834|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1568982|NCT00005635|Randomized|||Treatment||||||||
1568983|NCT00005085||Single Group Assignment||Treatment||None (Open Label)||||||
1568984|NCT00005037||Single Group Assignment||Treatment||None (Open Label)||||||
1568985|NCT00004926||||Treatment||||||||
1568986|NCT00004913||||Treatment||||||||
1568987|NCT00004909|||Cohort||Retrospective|||||||
1568988|NCT00004865||||Treatment||||||||
1568989|NCT00079703||||||||||||
1568990|NCT00079690||||||||||||
1568991|NCT00004864||||Treatment||||||||
1568992|NCT00004863||||Treatment||||||||
1568993|NCT00004163||Single Group Assignment||Treatment||None (Open Label)||||||
1568994|NCT00004151||||Treatment||||||||
1568995|NCT00004142||Single Group Assignment||Treatment||None (Open Label)||||||
1568996|NCT00004109|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1568997|NCT00003959||||Treatment||||||||
1568998|NCT00003779|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1568999|NCT00003772|||Case-Only||Prospective|||||||
1569000|NCT00003742||||Treatment||||||||
1569001|NCT00003706||Single Group Assignment||Treatment||None (Open Label)||||||
1569002|NCT00003705||||Treatment||||||||
1569003|NCT00003704||Single Group Assignment||Treatment||None (Open Label)||||||
1569004|NCT00003703||||Treatment||||||||
1569005|NCT00003695|Randomized|||Treatment||||||||
1569006|NCT00079768||||Treatment||||||||
1569007|NCT00079729|||||Prospective|||||||
1569008|NCT00079677|Randomized|Parallel Assignment||Treatment||Double||||||
1569009|NCT00079664|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569010|NCT00079651|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1569011|NCT00079638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569012|NCT00078039|Randomized|Parallel Assignment||Treatment||Double||||||
1569013|NCT00003617|Randomized|||Treatment||||||||
1569014|NCT00003465||||Treatment||||||||
1569015|NCT00003421|Randomized|||Treatment||||||||
1569016|NCT00003368||||Treatment||||||||
1569017|NCT00003361||||Treatment||||||||
1569018|NCT00003338||||Diagnostic||||||||
1569019|NCT00003337||||Diagnostic||||||||
1569020|NCT00003212|Randomized|||Treatment||||||||
1569021|NCT00003021||||Treatment||||||||
1569022|NCT00003014|Randomized|||Treatment||||||||
1569023|NCT00002930||||Diagnostic||||||||
1569024|NCT00002928||||Treatment||||||||
1569025|NCT00002919||||Treatment||||||||
1569026|NCT00002901||||Treatment||||||||
1569027|NCT00002858|Randomized|||Treatment||||||||
1569028|NCT00079612|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569029|NCT00079586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569030|NCT00079508|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569031|NCT00021359||Single Group Assignment||Treatment||None (Open Label)||||||
1569032|NCT00017030||||Treatment||||||||
1569033|NCT00016978||Single Group Assignment||Treatment||None (Open Label)||||||
1569034|NCT00014547||||Treatment||||||||
1569035|NCT00007969||||Treatment||||||||
1569036|NCT00002823|Randomized|||Treatment||||||||
1569037|NCT00002650|Randomized|||Prevention||||||||
1569038|NCT00002601||Single Group Assignment||Treatment||None (Open Label)||||||
1569039|NCT00002581|Randomized|||Treatment||||||||
1569040|NCT00002580|Randomized|||Treatment||||||||
1569041|NCT00002537||Single Group Assignment||Treatment||None (Open Label)||||||
1569042|NCT00002526||Single Group Assignment||Treatment||None (Open Label)||||||
1569043|NCT00002508||||Treatment||||||||
1569044|NCT00002480||||Treatment||||||||
1569045|NCT00002459||||Treatment||||||||
1569046|NCT00079625||||Treatment||||||||
1569047|NCT00079599|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569048|NCT00079573|Randomized|Parallel Assignment||Treatment||Single||||||
1569049|NCT00079560|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1569050|NCT00079547|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569051|NCT00079534|Randomized|Parallel Assignment||Treatment||Double||||||
1569052|NCT00079521|Randomized|Factorial Assignment||Treatment||Double||||||
1569053|NCT00079495|Randomized|Parallel Assignment||Treatment||Double||||||
1569054|NCT00079482|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569055|NCT00079469|Randomized|||Prevention||||||||
1569056|NCT00079456||Single Group Assignment||Treatment||None (Open Label)||||||
1569057|NCT00079443||Single Group Assignment||Treatment||None (Open Label)||||||
1569058|NCT00079430||Single Group Assignment||Treatment||None (Open Label)||||||
1569059|NCT00079417||Single Group Assignment||Treatment||None (Open Label)||||||
1569060|NCT00079404||Single Group Assignment||Treatment||None (Open Label)||||||
1569061|NCT00079391||Single Group Assignment||Treatment||None (Open Label)||||||
1569062|NCT00079378||Single Group Assignment||Treatment||None (Open Label)||||||
1569063|NCT00079365|Randomized|||Treatment||||||||
1569064|NCT00079352||Single Group Assignment||Treatment||None (Open Label)||||||
1569065|NCT00079339||Single Group Assignment||Treatment||None (Open Label)||||||
1569066|NCT00079326||Single Group Assignment||Treatment||None (Open Label)||||||
1569067|NCT00079313|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569068|NCT00079300|Randomized|||Treatment||Double||||||
1569069|NCT00079287|Randomized|||Treatment||||||||
1569070|NCT00079274|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569071|NCT00079261|Randomized|||Treatment||None (Open Label)||||||
1569072|NCT00079248|Randomized|||Supportive Care||||||||
1569073|NCT00079235||Single Group Assignment||Treatment||None (Open Label)||||||
1569074|NCT00079222|Randomized|||Supportive Care||||||||
1569075|NCT00079183||Single Group Assignment||Supportive Care||None (Open Label)||||||
1569076|NCT00079170||||Treatment||None (Open Label)||||||
1569077|NCT00079157||||Treatment||||||||
1569078|NCT00079144||||Treatment||None (Open Label)||||||
1569079|NCT00079131||Single Group Assignment||Treatment||None (Open Label)||||||
1569080|NCT00079118||Single Group Assignment||Treatment||None (Open Label)||||||
1569081|NCT00079105|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569082|NCT00079092||||Treatment||None (Open Label)||||||
1569083|NCT00079079||||Treatment||None (Open Label)||||||
1569084|NCT00079066|Randomized|||Treatment||None (Open Label)||||||
1569085|NCT00079053||||Treatment||None (Open Label)||||||
1569086|NCT00079040||Single Group Assignment||Treatment||None (Open Label)||||||
1569087|NCT00079027|Randomized|||Treatment||||||||
1569088|NCT00079014||Single Group Assignment||Treatment||None (Open Label)||||||
1569089|NCT00079001|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569090|NCT00078988|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569091|NCT00078975||Single Group Assignment||Treatment||None (Open Label)||||||
1569092|NCT00078962||Single Group Assignment||Treatment||None (Open Label)||||||
1569093|NCT00078949|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569094|NCT00078923|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569095|NCT00078910|Non-Randomized|||Treatment||||||||
1569096|NCT00078897|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1569097|NCT00078858||Single Group Assignment||Treatment||None (Open Label)||||||
1569098|NCT00078845||Single Group Assignment||Supportive Care||None (Open Label)||||||
1569099|NCT00078832|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1569100|NCT00078819|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573259|NCT00001887||||||||||||
1569101|NCT00078806|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1569102|NCT00078793|||Cohort||Prospective|||||||
1569103|NCT00078767|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569104|NCT00078754|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569105|NCT00078741|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569106|NCT00078728|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569107|NCT00078611|Randomized|Parallel Assignment||Treatment||Double||||||
1569108|NCT00007007||Single Group Assignment||||None (Open Label)||||||
1569109|NCT00006890|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569110|NCT00006467||Single Group Assignment||Treatment||None (Open Label)||||||
1569111|NCT00006452||||Treatment||||||||
1569112|NCT00006350||||Treatment||||||||
1569113|NCT00006259||Single Group Assignment||Treatment||None (Open Label)||||||
1569114|NCT00006253|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1569115|NCT00006126||||Treatment||||||||
1569116|NCT00006115||||Treatment||||||||
1569117|NCT00006018||Single Group Assignment||Treatment||None (Open Label)||||||
1569118|NCT00078715|Randomized|Crossover Assignment||||Quadruple|||t|t|t|t
1569119|NCT00078689|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569120|NCT00078637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569121|NCT00006000||||Treatment||||||||
1569122|NCT00005965||||Treatment||||||||
1569123|NCT00005947|Randomized|||Treatment||Quadruple|||t|t|t|t
1569124|NCT00005946||||Treatment||||||||
1569125|NCT00005843||Single Group Assignment||Treatment||None (Open Label)||||||
1569126|NCT00078663||||Treatment||||||||
1569127|NCT00078624|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1569128|NCT00005595||||Treatment||||||||
1569129|NCT00005096||Single Group Assignment||Treatment||None (Open Label)||||||
1569130|NCT00005035||||Treatment||||||||
1569131|NCT00004914||||Supportive Care||||||||
1569132|NCT00078598|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569133|NCT00078585|Randomized|||Treatment||Double||||||
1569134|NCT00078572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569135|NCT00078507|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1569136|NCT00004912||||Supportive Care||||||||
1569137|NCT00004908||||Treatment||||||||
1569138|NCT00004904||||Treatment||||||||
1569139|NCT00004898||||Treatment||||||||
1569140|NCT00004235||Single Group Assignment||Treatment||None (Open Label)||||||
1569141|NCT00004175||||Treatment||||||||
1569142|NCT00078559|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569143|NCT00078546||Single Group Assignment||Treatment||None (Open Label)||||||
1569144|NCT00078533||Single Group Assignment||Treatment||None (Open Label)||||||
1569145|NCT00078520|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569146|NCT00078468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569147|NCT00078494||||Treatment||||||||
1569148|NCT00078481||||Treatment||||||||
1569149|NCT00078455|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569150|NCT00078429||||||||||||
1569151|NCT00078221|Randomized|Single Group Assignment||Treatment||Double||||||
1569152|NCT00004171||||Treatment||||||||
1569153|NCT00004091|||Cohort||Cross-Sectional|||||||
1569154|NCT00003528||Single Group Assignment||Treatment||None (Open Label)||||||
1569155|NCT00003351|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569156|NCT00003302||||Diagnostic||||||||
1569157|NCT00003264||||Treatment||||||||
1569158|NCT00003070|Randomized|Single Group Assignment||Supportive Care||Double||||||
1569159|NCT00003040||Single Group Assignment||Treatment||None (Open Label)||||||
1569160|NCT00002825||Single Group Assignment||Treatment||None (Open Label)||||||
1569161|NCT00002652||||Treatment||||||||
1569162|NCT00026429||||Treatment||||||||
1569163|NCT00025012||||Prevention||||||||
1569164|NCT00024037||||Supportive Care||||||||
1569165|NCT00022542||Single Group Assignment||Treatment||None (Open Label)||||||
1569166|NCT00022308||||Treatment||||||||
1569167|NCT00022217||||Treatment||||||||
1569168|NCT00022178||||Treatment||||||||
1569169|NCT00021996||||Supportive Care||||||||
1569170|NCT00021372||Single Group Assignment||Treatment||None (Open Label)||||||
1569171|NCT00020618||||Supportive Care||||||||
1569172|NCT00020098||||Prevention||||||||
1569173|NCT00019409|Randomized|||Treatment||||||||
1569174|NCT00017303||||Treatment||||||||
1569175|NCT00016367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569176|NCT00015990||Single Group Assignment||Treatment||None (Open Label)||||||
1569177|NCT00015964||Single Group Assignment||Treatment||None (Open Label)||||||
1569178|NCT00002597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569179|NCT00002577||||Treatment||||||||
1569180|NCT00002454||||Treatment||||||||
1569181|NCT00078442|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569182|NCT00078390|Randomized|Parallel Assignment||Treatment||None (Open Label)||"The Phase 1 part of the study will determine the tolerable dose of S-3304 in the presence of radiation and paclitaxel/carboplatin chemotherapy in a non-randomized manner.~The Phase 2 part will compare the effect combination of S-3304 in addition to chemo-irradiation therapy to the effect of radiation and paclitaxel/carboplatin chemotherapy alone on small cell lung tumors"||||
1569183|NCT00078377|Randomized|Parallel Assignment||Treatment||Double||||||
1569184|NCT00078338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569185|NCT00076687|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569186|NCT00014690||||Treatment||||||||
1569187|NCT00014339||||Treatment||||||||
1569188|NCT00012259||Single Group Assignment||Treatment||None (Open Label)||||||
1569189|NCT00010179||||Treatment||||||||
1569190|NCT00006472||||Treatment||||||||
1569191|NCT00006365||Single Group Assignment||Treatment||None (Open Label)||||||
1569192|NCT00006108||||Treatment||||||||
1569193|NCT00006037||||Treatment||||||||
1569194|NCT00006014||Single Group Assignment||Treatment||None (Open Label)||||||
1569195|NCT00078403|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569196|NCT00078325|Randomized|Parallel Assignment||Treatment||Double||||||
1569197|NCT00078312|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569198|NCT00005991||Single Group Assignment||Treatment||None (Open Label)||||||
1569199|NCT00005880|Randomized|||Prevention||||||||
1569200|NCT00005869|Randomized|||Treatment||||||||
1569201|NCT00005864||||Treatment||||||||
1569202|NCT00005593||Single Group Assignment||Treatment||None (Open Label)||||||
1569203|NCT00005075||||Treatment||||||||
1569204|NCT00005026||||Treatment||||||||
1569205|NCT00004223||||Treatment||||||||
1569206|NCT00004216||||Treatment||||||||
1569207|NCT00004183||Single Group Assignment||Treatment||None (Open Label)||||||
1569208|NCT00078364||||Treatment||||||||
1569209|NCT00078351||||Treatment||||||||
1569210|NCT00078286|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569211|NCT00078273|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569212|NCT00078260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569213|NCT00078299||||||||||||
1569214|NCT00078247|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569215|NCT00078234|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569216|NCT00078169||||Treatment||||||||
1569217|NCT00078156||||Treatment||||||||
1569218|NCT00078143||||Treatment||||||||
1569219|NCT00078208||||||||||||
1569220|NCT00078195|Randomized|Parallel Assignment||Treatment||Double||||||
1569221|NCT00078182|Randomized|Parallel Assignment||Prevention||Double||||||
1569222|NCT00078130||||Treatment||||||||
1569223|NCT00078117||||Treatment||||||||
1569224|NCT00078065|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569225|NCT00004148||Single Group Assignment||Treatment||None (Open Label)||||||
1569226|NCT00003935||Single Group Assignment||Treatment||None (Open Label)||||||
1569227|NCT00003814|Randomized|||Treatment||||||||
1569228|NCT00003766||Single Group Assignment||Treatment||None (Open Label)||||||
1569229|NCT00003623|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1569230|NCT00003615||||Treatment||||||||
1569231|NCT00003600|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1569232|NCT00003573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569233|NCT00003572||||Treatment||||||||
1569234|NCT00003548||||Treatment||||||||
1569235|NCT00003425||Single Group Assignment||Treatment||None (Open Label)||||||
1569236|NCT00003411||||Treatment||||||||
1569237|NCT00003299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569238|NCT00003240|Randomized|||Treatment||||||||
1569239|NCT00003120|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569240|NCT00078104||||Treatment||||||||
1569241|NCT00078091||||||||||||
1569242|NCT00078078|||Cohort||Prospective|||||||
1569243|NCT00078052|||Cohort||Prospective|||||||
1569244|NCT00078026|Randomized|Parallel Assignment||Treatment||Double||||||
1569245|NCT00030602||||Treatment||||||||
1569246|NCT00003089||||Treatment||||||||
1569247|NCT00003046|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569248|NCT00003035||||Treatment||||||||
1569249|NCT00078013|Randomized|Parallel Assignment||Prevention||Double||||||
1569250|NCT00078000|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569251|NCT00077987|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569252|NCT00077974|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569253|NCT00077961|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569254|NCT00077948|Randomized|Parallel Assignment||Treatment||Double||||||
1569255|NCT00077935|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569256|NCT00077844|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569257|NCT00077883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569258|NCT00077870||||Treatment||||||||
1569259|NCT00077857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569260|NCT00077831|||Case Control||Prospective|||||||
1569261|NCT00077818|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569262|NCT00077805|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569263|NCT00077792|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1569264|NCT00077779|Randomized|Parallel Assignment||Treatment||Double||||||
1569265|NCT00077766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569266|NCT00077753|Randomized|Parallel Assignment||Prevention||Double||||||
1569267|NCT00077727|Randomized|Single Group Assignment||Treatment||Double||||||
1569268|NCT00077714|Randomized|Parallel Assignment||Treatment||Double||||||
1569269|NCT00077688|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569270|NCT00076973|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569271|NCT00027924||||Treatment||||||||
1569272|NCT00023647||Single Group Assignment||Treatment||None (Open Label)||||||
1569273|NCT00021294||||Treatment||||||||
1569274|NCT00021034||||Treatment||||||||
1569275|NCT00021021||||Treatment||||||||
1569276|NCT00020917||||Treatment||||||||
1569277|NCT00020553||||||||||||
1569278|NCT00017459||||Treatment||||||||
1569279|NCT00017199||||Treatment||||||||
1569280|NCT00017056||||Treatment||||||||
1569281|NCT00016172||||Treatment||||||||
1569282|NCT00014625||||Treatment||||||||
1569283|NCT00014430|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569284|NCT00008281||||Treatment||||||||
1569285|NCT00007878||Single Group Assignment||Treatment||None (Open Label)||||||
1569286|NCT00006122||||Treatment||||||||
1569287|NCT00005795||||Treatment||||||||
1569288|NCT00005791||||Treatment||||||||
1569289|NCT00005631||||Treatment||||||||
1569290|NCT00005609||||Treatment||||||||
1569291|NCT00005089||Single Group Assignment||Treatment||None (Open Label)||||||
1569292|NCT00004152||||Diagnostic||||||||
1569293|NCT00004145||Single Group Assignment||Treatment||None (Open Label)||||||
1569294|NCT00004114||||Treatment||||||||
1569295|NCT00003916|Randomized|||Treatment||||||||
1569296|NCT00003867||||Treatment||||||||
1569297|NCT00003632||||Treatment||||||||
1569298|NCT00003582||||Treatment||||||||
1569299|NCT00003545||Single Group Assignment||Treatment||None (Open Label)||||||
1569300|NCT00003207||Single Group Assignment||Treatment||||||||
1569301|NCT00003150|Randomized|||Treatment||||||||
1569302|NCT00003066||||Treatment||||||||
1569303|NCT00003062||||Treatment||||||||
1569304|NCT00003011|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1569305|NCT00002869|Randomized|||Treatment||||||||
1569306|NCT00002868|Randomized|||Treatment||||||||
1569307|NCT00002532||||Treatment||||||||
1569308|NCT00002531||||Treatment||||||||
1569309|NCT00077922||Single Group Assignment||Treatment||None (Open Label)||||||
1569310|NCT00077909||||||||||||
1569311|NCT00077896||||Treatment||||||||
1569312|NCT00077675|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1569313|NCT00077649|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569314|NCT00077636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569315|NCT00077623|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569316|NCT00077610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569317|NCT00077662|||Cohort||Prospective|||||||
1569318|NCT00077597|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569319|NCT00077558||||Treatment||||||||
1569320|NCT00077545||Single Group Assignment||Treatment||None (Open Label)||||||
1569321|NCT00077532|Randomized|||Treatment||||||||
1569322|NCT00077519||||Treatment||||||||
1569323|NCT00077493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569324|NCT00077467||Single Group Assignment||Treatment||None (Open Label)||||||
1569325|NCT00077454||Single Group Assignment||Treatment||None (Open Label)||||||
1569326|NCT00077441||Single Group Assignment||Treatment||None (Open Label)||||||
1569327|NCT00077428||Single Group Assignment||Treatment||None (Open Label)||||||
1569328|NCT00077415||||Treatment||None (Open Label)||||||
1569329|NCT00077402||||Treatment||None (Open Label)||||||
1569330|NCT00077389||||Treatment||None (Open Label)||||||
1569331|NCT00077376||Single Group Assignment||Treatment||None (Open Label)||||||
1569332|NCT00077363||Single Group Assignment||Treatment||None (Open Label)||||||
1569333|NCT00077350||Single Group Assignment||Treatment||None (Open Label)||||||
1569334|NCT00077337||||Treatment||None (Open Label)||||||
1569335|NCT00077324|||Case-Only||Prospective|||||||
1569336|NCT00077311|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569337|NCT00007852|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569338|NCT00006786||||Treatment||||||||
1569339|NCT00006459||||Treatment||||||||
1569340|NCT00006388||Single Group Assignment||Treatment||None (Open Label)||||||
1569341|NCT00006375||||Treatment||||||||
1569342|NCT00006123||||Treatment||||||||
1569343|NCT00006047||Single Group Assignment||Treatment||None (Open Label)||||||
1569344|NCT00006038||||Treatment||||||||
1569345|NCT00005995||||Treatment||||||||
1569346|NCT00005986||||Treatment||||||||
1569347|NCT00005877||||Treatment||||||||
1569348|NCT00005862||Single Group Assignment||Treatment||None (Open Label)||||||
1569349|NCT00005610||Single Group Assignment||Treatment||None (Open Label)||||||
1569350|NCT00004919||Single Group Assignment||Treatment||None (Open Label)||||||
1569351|NCT00004889||Single Group Assignment||Treatment||None (Open Label)||||||
1569352|NCT00004203||Single Group Assignment||Treatment||None (Open Label)||||||
1569353|NCT00004157||||Treatment||||||||
1569354|NCT00004003||||Treatment||||||||
1569355|NCT00077584|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569356|NCT00077298|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569357|NCT00077285||Single Group Assignment||Treatment||None (Open Label)||||||
1569358|NCT00077259||||Treatment||None (Open Label)||||||
1569359|NCT00077246||||Treatment||None (Open Label)||||||
1569360|NCT00077233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569361|NCT00077220|Randomized|||Treatment||||||||
1569362|NCT00077207||Single Group Assignment||Treatment||None (Open Label)||||||
1569363|NCT00077194||Single Group Assignment||Treatment||None (Open Label)||||||
1569364|NCT00077181||Single Group Assignment||Treatment||None (Open Label)||||||
1569365|NCT00077168|Randomized|||Treatment||||||||
1569366|NCT00077155||Single Group Assignment||Treatment||None (Open Label)||||||
1569367|NCT00077142|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569368|NCT00077129||||Treatment||None (Open Label)||||||
1569369|NCT00077116|Randomized|||Treatment||None (Open Label)||||||
1569370|NCT00077103||Single Group Assignment||Treatment||None (Open Label)||||||
1569371|NCT00077090|Randomized|||Supportive Care||||||||
1569372|NCT00077077||||Treatment||None (Open Label)||||||
1569373|NCT00077064|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1569374|NCT00077051||Single Group Assignment||Treatment||None (Open Label)||||||
1569375|NCT00077025|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569376|NCT00077012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569377|NCT00077038||||||||||||
1569378|NCT00076999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569379|NCT00076986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569380|NCT00076960||||||||||||
1569381|NCT00076947|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1569382|NCT00076934|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569383|NCT00076921|||Ecologic or Community||Cross-Sectional|||||||
1569384|NCT00003937|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569385|NCT00003923||||Treatment||||||||
1569386|NCT00003721||Single Group Assignment||Treatment||None (Open Label)||||||
1569387|NCT00003665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569388|NCT00003616||||Treatment||||||||
1569389|NCT00003370||Single Group Assignment||Treatment||None (Open Label)||||||
1569390|NCT00003367|Randomized|||Treatment||||||||
1569391|NCT00003334||||Treatment||||||||
1569392|NCT00003222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569393|NCT00003185||||Treatment||||||||
1569394|NCT00003108||||Treatment||||||||
1569395|NCT00003086||||Treatment||||||||
1569396|NCT00076869|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569397|NCT00076856|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569398|NCT00076817|Randomized|Factorial Assignment||Prevention||Double|||t|t||
1569399|NCT00076804|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569400|NCT00076791|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569401|NCT00033592|Randomized|Crossover Assignment||Prevention||Double|||t||t|
1569402|NCT00026377||Single Group Assignment||Treatment||None (Open Label)||||||
1569403|NCT00024362||||Treatment||||||||
1569404|NCT00024011||Single Group Assignment||Treatment||None (Open Label)||||||
1569405|NCT00003320||||Treatment||||||||
1569406|NCT00003073||||Treatment||||||||
1569407|NCT00002801||||Treatment||||||||
1569408|NCT00002679||||Treatment||||||||
1569409|NCT00076843||||Treatment||||||||
1569410|NCT00076830|||Cohort||Other|||||||
1569411|NCT00076726|Randomized|Parallel Assignment||Treatment||Double||||||
1569412|NCT00076544|Non-Randomized|||Treatment||None (Open Label)||||||
1569413|NCT00076518|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569414|NCT00022373||||Supportive Care||||||||
1569415|NCT00022243||||Treatment||||||||
1569416|NCT00022204||||Supportive Care||||||||
1569417|NCT00021385||||Treatment||||||||
1569418|NCT00020696||||Treatment||||||||
1569419|NCT00017407||||Treatment||||||||
1569420|NCT00014105||||Treatment||||||||
1569421|NCT00014066||||Treatment||||||||
1569422|NCT00010244||||Treatment||||||||
1569423|NCT00076752||Single Group Assignment||Treatment||None (Open Label)||||||
1569424|NCT00076739||||||||||||
1569425|NCT00076713|||Cohort||Prospective|||||||
1569426|NCT00009997||||Treatment||||||||
1569427|NCT00009958|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569428|NCT00009906|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569429|NCT00008333||Single Group Assignment||Treatment||None (Open Label)||||||
1569430|NCT00008034||||Treatment||||||||
1569431|NCT00006460||||Treatment||||||||
1569432|NCT00006454|Randomized|||Treatment||||||||
1569433|NCT00006111||||Treatment||||||||
1569434|NCT00076700||||||||||||
1569435|NCT00006050||||Treatment||||||||
1569436|NCT00005881|||||Cross-Sectional|||||||
1569437|NCT00005792||Single Group Assignment||Treatment||None (Open Label)||||||
1569438|NCT00005064||Single Group Assignment||Treatment||None (Open Label)||||||
1569439|NCT00076648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569440|NCT00076635|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569441|NCT00076674||||Treatment||||||||
1569442|NCT00076622|||Cohort||Prospective|||||||
1569443|NCT00005022|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569444|NCT00004862||Single Group Assignment||Treatment||None (Open Label)||||||
1569445|NCT00004239||Single Group Assignment||Treatment||None (Open Label)||||||
1569446|NCT00003888|Randomized|||Treatment||||||||
1569447|NCT00076609|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569448|NCT00076557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569449|NCT00076596||||||||||||
1569450|NCT00076583||||||||||||
1569451|NCT00076570|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569452|NCT00076531||||Treatment||None (Open Label)||||||
1569453|NCT00076492|Randomized|||Treatment||Double||||||
1569454|NCT00003882||Single Group Assignment||Treatment||None (Open Label)||||||
1569457|NCT00003682|Randomized|||Treatment||||||||
1569458|NCT00003578|Randomized|||Treatment||||||||
1569459|NCT00076505||||||||||||
1569460|NCT00076453|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569461|NCT00076440|Randomized|Parallel Assignment||Treatment||Double||||||
1569462|NCT00076401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569463|NCT00076479||||||||||||
1569464|NCT00076466||||||||||||
1569465|NCT00076388|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569466|NCT00076375|Randomized|Parallel Assignment||Treatment||Double||||||
1569467|NCT00076362|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1569468|NCT00003541||||Treatment||||||||
1569469|NCT00003418|Randomized|||Treatment||||||||
1569470|NCT00003364|Randomized|||Treatment||||||||
1569471|NCT00003298||Single Group Assignment||Treatment||None (Open Label)||||||
1569472|NCT00003287|Randomized|||Treatment||||||||
1569473|NCT00076427||||||||||||
1569474|NCT00076414||||Treatment||||||||
1569475|NCT00076349||Single Group Assignment||Treatment||None (Open Label)||||||
1569476|NCT00076336|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569477|NCT00003137||Single Group Assignment||Treatment||None (Open Label)||||||
1569478|NCT00003007||||Treatment||||||||
1569479|NCT00002840|Randomized|||Treatment||||||||
1569480|NCT00002817||||Treatment||||||||
1569481|NCT00002748||||Treatment||||||||
1569482|NCT00076323|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1569483|NCT00076310||Single Group Assignment||Treatment||None (Open Label)||||||
1569484|NCT00076284||||Treatment||||||||
1569485|NCT00076271||||||||||||
1569486|NCT00076258|Randomized|Parallel Assignment||Treatment||Single||||||t
1569487|NCT00076245|Randomized|Parallel Assignment||Treatment||Single||||||
1569488|NCT00076219|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569489|NCT00076206|Randomized|Parallel Assignment||Treatment||Double||||||
1569490|NCT00076232|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1569491|NCT00076154|||Case-Only||Prospective|||||||
1569492|NCT00076141|||Cohort||Prospective|||||||
1569493|NCT00076115|Randomized|Parallel Assignment||Treatment||Double||||||
1569494|NCT00076180||Sequential Assignment||Treatment||None (Open Label)||||||
1569495|NCT00076089|Randomized|Parallel Assignment||Treatment||Double||||||
1569496|NCT00076076|Randomized|Parallel Assignment||Treatment||Double||||||
1569497|NCT00033735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569498|NCT00027508||||Treatment||||||||
1569499|NCT00024401||||Treatment||||||||
1569500|NCT00002566|Randomized|||Treatment||||||||
1569501|NCT00076102||Single Group Assignment||Treatment||None (Open Label)||||||
1569502|NCT00076063|Randomized|Factorial Assignment||Prevention||Triple|||t|t|t|
1569503|NCT00076050|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1569504|NCT00076037|Randomized|Factorial Assignment||Prevention||Double||||||
1569505|NCT00076024|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569506|NCT00076011|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569507|NCT00075998|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569508|NCT00075985|||||Prospective|||||||
1569509|NCT00075972|Randomized|Single Group Assignment||||Single||||||
1569510|NCT00075959|Randomized|Factorial Assignment||Treatment||Double||||||
1569511|NCT00075946|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569512|NCT00024388||||Treatment||||||||
1569513|NCT00022347||||Treatment||||||||
1569514|NCT00022321||||Treatment||||||||
1569515|NCT00021333||||Treatment||||||||
1569516|NCT00021307||||Treatment||||||||
1569517|NCT00075933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569518|NCT00075907|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569519|NCT00075894||||Treatment||None (Open Label)||||||
1569520|NCT00075881||Single Group Assignment||Treatment||None (Open Label)||||||
1569521|NCT00075868|Randomized|Parallel Assignment||Supportive Care||Double||||||
1569522|NCT00075855|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1569523|NCT00075842|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1569524|NCT00075829|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1569525|NCT00075816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569526|NCT00075803|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569527|NCT00075777||Single Group Assignment||Treatment||None (Open Label)||||||
1569528|NCT00075764|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569529|NCT00075751||Single Group Assignment||Treatment||None (Open Label)||||||
1569530|NCT00075738||||Treatment||None (Open Label)||||||
1569531|NCT00075725|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569532|NCT00075712|Randomized|||Treatment||||||||
1569533|NCT00075699|Randomized|||Treatment||||||||
1569534|NCT00075686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569535|NCT00075920||||||||||||
1569536|NCT00075673||Single Group Assignment||Treatment||None (Open Label)||||||
1569537|NCT00075660||||Treatment||None (Open Label)||||||
1569538|NCT00075647||Single Group Assignment||Treatment||None (Open Label)||||||
1569539|NCT00075634||Single Group Assignment||Treatment||None (Open Label)||||||
1569540|NCT00075621||Single Group Assignment||Treatment||None (Open Label)||||||
1569541|NCT00075608||Single Group Assignment||Treatment||None (Open Label)||||||
1569542|NCT00075595||||Treatment||None (Open Label)||||||
1569543|NCT00075582|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569544|NCT00075569|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||Parallel design||||
1569545|NCT00075556||||Treatment||None (Open Label)||||||
1569546|NCT00075543||||Treatment||||||||
1569547|NCT00075517||||Treatment||None (Open Label)||||||
1569548|NCT00075504||Single Group Assignment||Treatment||None (Open Label)||||||
1569549|NCT00075491|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569550|NCT00075478|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569551|NCT00075465||||Treatment||None (Open Label)||||||
1569552|NCT00075452|Randomized|||Treatment||||||||
1569553|NCT00075439||Single Group Assignment||Treatment||None (Open Label)||||||
1569554|NCT00075426||||Treatment||None (Open Label)||||||
1569555|NCT00075413||||Treatment||||||||
1569556|NCT00075400||Single Group Assignment||Treatment||None (Open Label)||||||
1569557|NCT00075387|Randomized|Parallel Assignment||Treatment||Single|||||t|
1569558|NCT00075374||Single Group Assignment||Treatment||None (Open Label)||||||
1569559|NCT00075348||||||||||||
1569560|NCT00075335||Single Group Assignment||Treatment||None (Open Label)||||||
1569561|NCT00075296||||||||||||
1569562|NCT00075283|Randomized|Parallel Assignment||Treatment||Double||||||
1569563|NCT00075270|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569564|NCT00075257|Randomized|Parallel Assignment||Treatment||Double||||||
1569565|NCT00075231|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569566|NCT00075218|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1569567|NCT00075153|||Cohort||Retrospective|||||||
1569568|NCT00020787||Single Group Assignment||Treatment||None (Open Label)||||||
1569569|NCT00017576||Single Group Assignment||Treatment||None (Open Label)||||||
1569570|NCT00017537|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569571|NCT00017433||||Treatment||||||||
1569572|NCT00075244||||Treatment||||||||
1569573|NCT00075192|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569574|NCT00017082||||Treatment||||||||
1569575|NCT00016237||||Treatment||||||||
1569576|NCT00016198||||Treatment||||||||
1569577|NCT00014404||||Prevention||||||||
1569578|NCT00014287||||Treatment||||||||
1569579|NCT00075205||||Treatment||||||||
1569580|NCT00075179||Single Group Assignment||Treatment||None (Open Label)||||||
1569581|NCT00075166||||Treatment||||||||
1569582|NCT00075140||||||||||||
1569583|NCT00075114|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569584|NCT00075101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569585|NCT00075088|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1569586|NCT00075075||||Treatment||||||||
1569587|NCT00075062|||||Prospective|||||||
1569588|NCT00075049|Randomized|Single Group Assignment||Prevention||Double||||||
1569589|NCT00014183||||Treatment||||||||
1569590|NCT00012116||Single Group Assignment||Treatment||None (Open Label)||||||
1569591|NCT00009919||Single Group Assignment||Treatment||None (Open Label)||||||
1569592|NCT00009893||Single Group Assignment||Treatment||None (Open Label)||||||
1569593|NCT00075036|||Cohort||Prospective|||||||
1569594|NCT00075023|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1569595|NCT00075010||Single Group Assignment||Treatment||None (Open Label)||||||
1569596|NCT00074997|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569597|NCT00009867||Single Group Assignment||Treatment||None (Open Label)||||||
1569598|NCT00009698||Single Group Assignment||Treatment||None (Open Label)||||||
1569599|NCT00006481||||Supportive Care||||||||
1569600|NCT00006480||||Treatment||||||||
1569601|NCT00074984|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569602|NCT00074971|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569603|NCT00074958||Single Group Assignment||Treatment||None (Open Label)||||||
1569604|NCT00074932|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569605|NCT00074919||||||||||||
1569606|NCT00074906|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1569607|NCT00074945||||||||||||
1569608|NCT00074893|Non-Randomized|Single Group Assignment||Prevention||Single||||||
1569609|NCT00074867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569610|NCT00074854|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569611|NCT00074841|Randomized|||Treatment||||||||
1569612|NCT00006384||||Treatment||||||||
1569613|NCT00006353||||Treatment||||||||
1569614|NCT00006247||||Treatment||||||||
1569615|NCT00006213||Single Group Assignment||Treatment||None (Open Label)||||||
1569616|NCT00006104||||Treatment||||||||
1569617|NCT00074880||||||||||||
1569618|NCT00074828|Randomized|Parallel Assignment||Prevention||Double||||||
1569619|NCT00074763|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1569620|NCT00074750||Single Group Assignment||Treatment||None (Open Label)||||||
1569621|NCT00074737|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569622|NCT00074724|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1569623|NCT00006099||||Diagnostic||||||||
1569624|NCT00006087||||Screening||||||||
1569625|NCT00006080||||Treatment||||||||
1569626|NCT00005978||||Treatment||||||||
1569627|NCT00005963||Single Group Assignment||Treatment||None (Open Label)||||||
1569628|NCT00074815|Randomized|Parallel Assignment||Treatment||Single||||||t
1569713|NCT00003761||Single Group Assignment||Treatment||None (Open Label)||||||
1569714|NCT00003729||||Treatment||||||||
1569715|NCT00073801||||||||||||
1569716|NCT00003734|Randomized|||Treatment||||||||
1569629|NCT00074802|Randomized|Parallel Assignment||Treatment||Single|Independent evaluators were unaware of randomized condition in the augmentation phase (Phase 2).|Open trial of paroxetine (Phase 1) followed by randomization to either continued paroxetine or continued paroxetine plus cognitive behavioral therapy (Phase 2) for patients showing partial response to paroxetine in Phase 1.||||t
1569630|NCT00074789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569631|NCT00074776|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569632|NCT00074711|Randomized|Parallel Assignment||Treatment||Single|||t|||
1569633|NCT00074698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569634|NCT00074685|||Cohort||Retrospective|||||||
1569635|NCT00074646|Randomized|||Treatment||None (Open Label)||||||
1569636|NCT00074633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569637|NCT00074620|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569638|NCT00074672||||||||||||
1569639|NCT00074607||Single Group Assignment||Treatment||None (Open Label)||||||
1569640|NCT00074581|Randomized|Parallel Assignment||Prevention||Single|||t|||
1569641|NCT00074568|||Case Control||Prospective|||||||
1569642|NCT00074555|||Cohort||Prospective|||||||
1569643|NCT00005959||||Treatment||||||||
1569644|NCT00005876||||Treatment||||||||
1569645|NCT00005646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569646|NCT00005642||Single Group Assignment||Treatment||None (Open Label)||||||
1569647|NCT00005634||||Treatment||||||||
1569648|NCT00074542|Randomized|Parallel Assignment||Treatment||Double||||||
1569649|NCT00074529|Randomized|||Treatment||Double|||t||t|
1569650|NCT00005598||||Treatment||||||||
1569651|NCT00005592||Single Group Assignment||Treatment||None (Open Label)||||||
1569652|NCT00005083||||Diagnostic||||||||
1569653|NCT00004890||||Treatment||||||||
1569654|NCT00004874|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569655|NCT00074516||||||||||||
1569656|NCT00074503||||||||||||
1569657|NCT00074490|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569658|NCT00074477|Randomized|Parallel Assignment||Treatment||Double||||||
1569659|NCT00074464|||||Cross-Sectional|||||||
1569660|NCT00074451||||||||||||
1569661|NCT00074438|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569662|NCT00074425|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1569663|NCT00074412|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1569664|NCT00074399|Randomized|Factorial Assignment||Prevention||Double|||t|t||
1569665|NCT00074386|||Cohort||Prospective|||||||
1569666|NCT00074373|||Cohort||Prospective|||||||
1569667|NCT00021983||||Treatment||||||||
1569668|NCT00008177||Single Group Assignment||Treatment||None (Open Label)||||||
1569669|NCT00074360||||||||||||
1569670|NCT00074334||||Treatment||||||||
1569671|NCT00074321||Single Group Assignment||Treatment||None (Open Label)||||||
1569672|NCT00074308||Single Group Assignment||Treatment||None (Open Label)||||||
1569673|NCT00074295||Single Group Assignment||Treatment||None (Open Label)||||||
1569674|NCT00074282||||Treatment||None (Open Label)||||||
1569675|NCT00074269||Single Group Assignment||Treatment||None (Open Label)||||||
1569676|NCT00074243||||Treatment||||||||
1569677|NCT00074230||Single Group Assignment||Treatment||None (Open Label)||||||
1569678|NCT00074204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569679|NCT00074191||||Treatment||None (Open Label)||||||
1569680|NCT00074178||Single Group Assignment||Treatment||None (Open Label)||||||
1569681|NCT00074165||Single Group Assignment||Treatment||None (Open Label)||||||
1569682|NCT00074152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569683|NCT00074139|Randomized|||Treatment||None (Open Label)||||||
1569684|NCT00074100||||Treatment||None (Open Label)||||||
1569685|NCT00074087||Single Group Assignment||Treatment||None (Open Label)||||||
1569686|NCT00074074|Randomized|||Treatment||None (Open Label)||||||
1569687|NCT00074048|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569688|NCT00074035||Single Group Assignment||Supportive Care||None (Open Label)||||||
1569689|NCT00074022||Single Group Assignment||Treatment||None (Open Label)||||||
1569690|NCT00074009||||Treatment||None (Open Label)||||||
1569691|NCT00073983||Single Group Assignment||Treatment||None (Open Label)||||||
1569692|NCT00073970||Single Group Assignment||Treatment||None (Open Label)||||||
1569693|NCT00073957||Single Group Assignment||Treatment||None (Open Label)||Standard Phase 2||||
1569694|NCT00073944||||Treatment||None (Open Label)||||||
1569695|NCT00073931||Single Group Assignment||Treatment||None (Open Label)||||||
1569696|NCT00073918||Single Group Assignment||Treatment||None (Open Label)||||||
1569697|NCT00073905||Single Group Assignment||Supportive Care||None (Open Label)||||||
1569698|NCT00073892||Single Group Assignment||Treatment||None (Open Label)||||||
1569699|NCT00073879||||Treatment||||||||
1569700|NCT00073866||||Treatment||||||||
1569701|NCT00073853|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569702|NCT00073840|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1569703|NCT00073827|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1569704|NCT00004857|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569705|NCT00004261||||Diagnostic||||||||
1569706|NCT00004242||Single Group Assignment||Treatment||None (Open Label)||||||
1569707|NCT00003927||Single Group Assignment||Treatment||None (Open Label)||||||
1569708|NCT00073814|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1569709|NCT00073788|||Case Control||Prospective|||||||
1569710|NCT00073775|||Cohort||Prospective|||||||
1569717|NCT00073762|Randomized|Parallel Assignment||Treatment||Double||||||
1569718|NCT00073749|Non-Randomized|||Treatment||None (Open Label)||||||
1569719|NCT00073736|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569720|NCT00073723|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569721|NCT00003716||||Treatment||||||||
1569722|NCT00003694||Single Group Assignment||Treatment||None (Open Label)||||||
1569723|NCT00003679|Randomized|||Treatment||||||||
1569724|NCT00003598|Randomized|||Prevention||||||||
1569725|NCT00003450||||Treatment||||||||
1569726|NCT00073710|Randomized|Crossover Assignment||Treatment||Double||||||
1569727|NCT00073697|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1569728|NCT00073684|Randomized|Parallel Assignment||Treatment||Single||||||t
1569729|NCT00073671|Randomized|Parallel Assignment||Prevention||Single|Outcome assessor were unaware of condition assignment|||||t
1569730|NCT00073658|Randomized|Parallel Assignment||Treatment||Double||||||
1569731|NCT00073645|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569732|NCT00073632|Randomized|Parallel Assignment||Treatment||Single||||||t
1569733|NCT00073619|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569734|NCT00073606||||||||||||
1569735|NCT00003426||||Treatment||||||||
1569736|NCT00003414|Randomized|||Treatment||||||||
1569737|NCT00003409||||Treatment||||||||
1569738|NCT00003388||||Treatment||||||||
1569739|NCT00073593|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569740|NCT00073580|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569741|NCT00073554|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569742|NCT00073541||||Treatment||None (Open Label)||||||
1569743|NCT00073528|Randomized|||Treatment||Quadruple|||t|t|t|t
1569744|NCT00003387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569745|NCT00003313|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1569746|NCT00003253||||Diagnostic||||||||
1569747|NCT00003202|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569748|NCT00003191||Single Group Assignment||Treatment||None (Open Label)||||||
1569749|NCT00073515|Randomized|Single Group Assignment||Treatment||Double||||||
1569750|NCT00073502||||Treatment||||||||
1569751|NCT00073489|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569752|NCT00073463|Randomized|Parallel Assignment||Treatment||Double||||||
1569753|NCT00003167||Single Group Assignment||Treatment||None (Open Label)||||||
1569754|NCT00003130||Single Group Assignment||Treatment||None (Open Label)||||||
1569755|NCT00003060||||Treatment||||||||
1569756|NCT00003037||||Treatment||||||||
1569757|NCT00002989|Randomized|||Treatment||||||||
1569758|NCT00073476|Randomized|Parallel Assignment||Treatment||Double||||||
1569759|NCT00073450|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569760|NCT00073437|Randomized|Parallel Assignment||Treatment||Double||||||
1569761|NCT00002940||||Treatment||||||||
1569762|NCT00002836|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569763|NCT00002828||||Treatment||||||||
1569764|NCT00002812|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569765|NCT00002761||||Treatment||||||||
1569766|NCT00073424|||||Prospective|||||||
1569767|NCT00073411|Randomized|Parallel Assignment||Treatment||Double||||||
1569768|NCT00073385|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569769|NCT00073372|Randomized|Parallel Assignment||Treatment||Double||||||
1569770|NCT00073359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569771|NCT00073346|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569772|NCT00073333|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569773|NCT00073320|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569774|NCT00073307|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1569775|NCT00036920||||Treatment||||||||
1569776|NCT00027521||||Treatment||||||||
1569777|NCT00025532||||Treatment||||||||
1569778|NCT00002561|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569779|NCT00073398||Single Group Assignment||Treatment||None (Open Label)||||||
1569780|NCT00073294|Non-Randomized|Single Group Assignment||Prevention||Single||||||
1569781|NCT00073281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569782|NCT00073255|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569783|NCT00073268|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1569784|NCT00073242|Non-Randomized|Single Group Assignment||Health Services Research||Single|||t|||
1569785|NCT00073229||||||||||||
1569786|NCT00073216|Randomized|Factorial Assignment||Prevention||||||||
1569787|NCT00073203|Randomized|Parallel Assignment||Treatment||Double||||||
1569788|NCT00073177|Randomized|Parallel Assignment||Treatment||Double||||||
1569789|NCT00073190|Randomized|Factorial Assignment||||Single||||||
1569790|NCT00073164|Randomized|Parallel Assignment||Treatment||Double||||||
1569791|NCT00073151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569792|NCT00073138|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569793|NCT00073125|Randomized|Parallel Assignment||Treatment||Single||||||
1569794|NCT00073112|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569795|NCT00073047|Randomized|Parallel Assignment||Treatment||Double||||||
1569796|NCT00073034|Randomized|Parallel Assignment||Treatment||Double||||||
1569797|NCT00073099||||||||||||
1569798|NCT00073086||||||||||||
1572077|NCT00025623||||Treatment||||||||
1569799|NCT00073073||Single Group Assignment||Prevention||None (Open Label)||||||
1569800|NCT00073060||||||||||||
1569801|NCT00073021|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569802|NCT00073008|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569803|NCT00072995||||Prevention||||||||
1569804|NCT00072982|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1569805|NCT00072943|Randomized|Parallel Assignment||Treatment||Double||||||
1569806|NCT00072930|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569807|NCT00072917|||Cohort||Prospective|||||||
1569808|NCT00072904|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569809|NCT00072891|Randomized|Single Group Assignment||||None (Open Label)||||||
1569810|NCT00072969||||Treatment||||||||
1569811|NCT00072956||||||||||||
1569812|NCT00072865|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569813|NCT00072852|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569814|NCT00072839|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1569815|NCT00072787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569816|NCT00072774|Randomized|Parallel Assignment||Treatment||Double||||||
1569817|NCT00072761|Randomized|Parallel Assignment||Treatment||Single|||||t|
1569818|NCT00072748|Non-Randomized|||Treatment||None (Open Label)||||||
1569819|NCT00072722|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569820|NCT00017017||||Treatment||||||||
1569821|NCT00014677||||Treatment||||||||
1569822|NCT00014638||||Treatment||||||||
1569823|NCT00014352||||Treatment||||||||
1569824|NCT00072826||||Treatment||||||||
1569825|NCT00072813||||||||||||
1569826|NCT00072800||||||||||||
1569827|NCT00072709|Randomized|Parallel Assignment||Treatment||Double||||||
1569828|NCT00072683|Randomized|Parallel Assignment||Treatment||Double||||||
1569829|NCT00072670|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569830|NCT00012090||||Treatment||||||||
1569831|NCT00010309||||Treatment||||||||
1569832|NCT00008372||||Treatment||||||||
1569833|NCT00006367||||Treatment||||||||
1569834|NCT00006224||||Treatment||||||||
1569835|NCT00072735||||Treatment||||||||
1569836|NCT00072657|Randomized|Parallel Assignment||Treatment||Single||||||t
1569837|NCT00072644||||||||||||
1569838|NCT00072631|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569839|NCT00072618|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569840|NCT00072501|Randomized|||Screening||||||||
1569841|NCT00072488||||Diagnostic||None (Open Label)||||||
1569842|NCT00072475||Single Group Assignment||Treatment||None (Open Label)||||||
1569843|NCT00072462|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1569844|NCT00072449||Single Group Assignment||Treatment||None (Open Label)||||||
1569845|NCT00072436||Single Group Assignment||Treatment||None (Open Label)||||||
1569846|NCT00072410||||Treatment||||||||
1569847|NCT00072384||Single Group Assignment||Treatment||None (Open Label)||||||
1569848|NCT00072358|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569849|NCT00072345||||Treatment||None (Open Label)||||||
1569850|NCT00072332||||Treatment||None (Open Label)||||||
1569851|NCT00072319||||Treatment||||||||
1569852|NCT00072293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569853|NCT00072280|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569854|NCT00072267||||Treatment||None (Open Label)||||||
1569855|NCT00072228||||Treatment||||||||
1569856|NCT00072215|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569857|NCT00072189||Single Group Assignment||Treatment||None (Open Label)||||||
1569858|NCT00072176||Single Group Assignment||Treatment||None (Open Label)||||||
1569859|NCT00072163||Single Group Assignment||Treatment||None (Open Label)||||||
1569860|NCT00072150||Single Group Assignment||Treatment||None (Open Label)||||||
1569861|NCT00072137||Parallel Assignment||Treatment||None (Open Label)||||||
1569862|NCT00072124|Randomized|||Treatment||||||||
1569863|NCT00072111||||Treatment||||||||
1569864|NCT00072098||Single Group Assignment||Treatment||None (Open Label)||||||
1569865|NCT00072085|Randomized|||Treatment||||||||
1569866|NCT00072072||||Treatment||||||||
1569867|NCT00072059|Randomized|||Supportive Care||None (Open Label)||||||
1569868|NCT00072046|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569869|NCT00072033||Single Group Assignment||Treatment||None (Open Label)||||||
1569870|NCT00072020|Randomized|||Treatment||None (Open Label)||||||
1569871|NCT00072007||Single Group Assignment||Treatment||None (Open Label)||||||
1569872|NCT00071994||Single Group Assignment||Treatment||None (Open Label)||||||
1569873|NCT00071981|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569874|NCT00071968|Randomized|||Treatment||None (Open Label)||||||
1569875|NCT00071955||||Treatment||None (Open Label)||||||
1569876|NCT00071942||Single Group Assignment||Treatment||None (Open Label)||||||
1569877|NCT00071929||||Treatment||None (Open Label)||||||
1569878|NCT00003141||Single Group Assignment||Treatment||None (Open Label)||||||
1569879|NCT00072605||||Treatment||||||||
1569880|NCT00072592||||Treatment||||||||
1569881|NCT00072579||||Treatment||None (Open Label)||||||
1569882|NCT00072566||Single Group Assignment||Treatment||None (Open Label)||||||
1569883|NCT00072553||||Treatment||None (Open Label)||||||
1569884|NCT00072540||||Treatment||||||||
1569885|NCT00072527||Single Group Assignment||Treatment||None (Open Label)||||||
1569886|NCT00072514||Single Group Assignment||Treatment||None (Open Label)||||||
1569887|NCT00071916|||Case Control||Prospective|||||||
1569888|NCT00071851|Randomized|Factorial Assignment||Prevention||Double||||||
1569889|NCT00071812|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569890|NCT00071799|Randomized|Parallel Assignment||||None (Open Label)||||||
1569891|NCT00006008||||Treatment||||||||
1569892|NCT00005964||Single Group Assignment||Treatment||None (Open Label)||||||
1569893|NCT00005962|Randomized|||Treatment||||||||
1569894|NCT00005576||Single Group Assignment||Treatment||None (Open Label)||||||
1569895|NCT00005094|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1569896|NCT00071903||||||||||||
1569897|NCT00071890|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569898|NCT00071877||||Treatment||||||||
1569899|NCT00005072||Single Group Assignment||Treatment||None (Open Label)||||||
1569900|NCT00005046||||Treatment||||||||
1569901|NCT00004206||||Treatment||||||||
1569902|NCT00004093||Single Group Assignment||Treatment||None (Open Label)||||||
1569903|NCT00071838||||Treatment||||||||
1569904|NCT00071773|Randomized|Parallel Assignment||Treatment||Single||||||t
1569905|NCT00071786||||||||||||
1569906|NCT00071760|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569907|NCT00071747|Randomized|Parallel Assignment||Treatment||Double||||||
1569908|NCT00071721|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569909|NCT00071708||||||||||||
1569910|NCT00071695|Randomized|Parallel Assignment||Treatment||Double||||||
1569911|NCT00071682|||||Prospective|||||||
1569912|NCT00071669|Randomized|Parallel Assignment||Treatment||Single||||||
1569913|NCT00071656|Randomized|Parallel Assignment||Treatment||||||||
1569914|NCT00071643|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1569915|NCT00071630|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569916|NCT00071617|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569917|NCT00071604|Randomized|Parallel Assignment||||Double||||||
1569918|NCT00071591|Randomized|Single Group Assignment||||Single||||||
1569919|NCT00071578|Randomized|Parallel Assignment||Treatment||Single||||||t
1569920|NCT00071734||||||||||||
1569921|NCT00071565|||Family-Based||Prospective|||||||
1569922|NCT00071552|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569923|NCT00071539|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569924|NCT00004074||Single Group Assignment||Treatment||None (Open Label)||||||
1569925|NCT00004050||Single Group Assignment||Treatment||None (Open Label)||||||
1569926|NCT00004025||||Treatment||||||||
1569927|NCT00003794||||||||||||
1569928|NCT00003648|||Case-Only||Prospective|||||||
1569929|NCT00071526|||Cohort||Prospective|||||||
1569930|NCT00071513|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1569931|NCT00071500|Randomized|Parallel Assignment||Treatment||Single||||t||
1569932|NCT00071487|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1569933|NCT00003595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569934|NCT00003266|Randomized|||Supportive Care||Double||||||
1569935|NCT00003234||||Treatment||||||||
1569936|NCT00003190|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569937|NCT00003126|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569938|NCT00071474|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569939|NCT00071461|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569940|NCT00071448|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569941|NCT00071435||||||||||||
1569942|NCT00071422|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569943|NCT00071409|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569944|NCT00071396|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569945|NCT00033527|Randomized|||Diagnostic||Double||||||
1569946|NCT00025350|Randomized|||Treatment||Double||||||
1569947|NCT00003077||Single Group Assignment||Supportive Care||None (Open Label)||||||
1569948|NCT00002935||Single Group Assignment||Treatment||None (Open Label)||||||
1569949|NCT00002723|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569950|NCT00071331|Randomized|Parallel Assignment||Treatment||Double||||||
1569951|NCT00071292|Randomized|Single Group Assignment||||None (Open Label)||||||
1569952|NCT00030420||Single Group Assignment||Treatment||None (Open Label)||||||
1569953|NCT00026260||||Treatment||||||||
1569954|NCT00024206||Single Group Assignment||Treatment||None (Open Label)||||||
1569955|NCT00024128||Single Group Assignment||Treatment||None (Open Label)||||||
1569956|NCT00023738||||Treatment||||||||
1569957|NCT00071370||||||||||||
1569958|NCT00071305||||||||||||
1569959|NCT00071279|Randomized|||||Double||||||
1569960|NCT00071266|Randomized|Parallel Assignment||Treatment||Double||||||
1569961|NCT00071253|Randomized|Parallel Assignment||Treatment||Double||||||
1569962|NCT00071240|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1569963|NCT00071214|Randomized|Parallel Assignment||Prevention||Double||||||
1569964|NCT00071201|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1569965|NCT00064428|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569966|NCT00071227||||Treatment||||||||
1569967|NCT00071188|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569968|NCT00071136|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569969|NCT00071175|||Family-Based||Retrospective|||||||
1569970|NCT00071162|||Family-Based||Retrospective|||||||
1569971|NCT00071149|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1569972|NCT00071110|Randomized|Parallel Assignment||Treatment||Single||||||
1569973|NCT00071097|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1569974|NCT00071084|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569975|NCT00071071|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569976|NCT00025467||Single Group Assignment||Treatment||None (Open Label)||||||
1569977|NCT00023725|Randomized|||Treatment||||||||
1569978|NCT00023699||||Treatment||||||||
1569979|NCT00022282||||Treatment||None (Open Label)||||||
1569980|NCT00016250|Randomized|||Treatment||None (Open Label)||||||
1569981|NCT00015912||Single Group Assignment||Treatment||None (Open Label)||||||
1569982|NCT00015886||Single Group Assignment||Treatment||None (Open Label)||||||
1569983|NCT00014144||Single Group Assignment||Treatment||None (Open Label)||||||
1569984|NCT00007917||Single Group Assignment||Treatment||None (Open Label)||||||
1569985|NCT00071383||||||||||||
1569986|NCT00071357||||||||||||
1569987|NCT00071344||||||||||||
1569988|NCT00071123||||||||||||
1569989|NCT00071032|Randomized|Parallel Assignment||Treatment||Single||||||t
1569990|NCT00071019|||Case-Control||Cross-Sectional|||||||
1569991|NCT00071006||Single Group Assignment||Treatment||None (Open Label)||||||
1569992|NCT00070993|Randomized|Factorial Assignment||Treatment||Double||||||
1569993|NCT00070980|Randomized|Factorial Assignment||Treatment||Single||||||
1569994|NCT00070967|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1569995|NCT00070954|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1569996|NCT00070941|Randomized|Factorial Assignment||Treatment||Triple|||t|t|t|
1569997|NCT00070928|Randomized|Parallel Assignment||Treatment||Double||||||
1569998|NCT00070915|Randomized|Factorial Assignment||Treatment||Single||||||
1569999|NCT00070902|Randomized|Parallel Assignment||Treatment||Double||||||
1570000|NCT00070889|||Defined Population|Screening|Longitudinal, Prospective|||||||
1570001|NCT00070850|||Defined Population|Screening|Longitudinal, Prospective|||||||
1570002|NCT00070837|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570003|NCT00070824|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1570004|NCT00070811|||Cohort||Prospective|||||||
1570005|NCT00070720|Randomized|Parallel Assignment||||None (Open Label)||||||
1570006|NCT00071058||Single Group Assignment||Treatment||None (Open Label)||||||
1570007|NCT00071045|||Case-Only||Prospective|||||||
1570008|NCT00070746|||||Prospective|||||||
1570009|NCT00070733|Randomized|Parallel Assignment||Treatment||Double||||||
1570010|NCT00070707|Randomized|||Treatment||Triple|||t|t|t|
1570011|NCT00070876|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1570012|NCT00070863|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570013|NCT00070681||||||||||||
1570014|NCT00070668||||||||||||
1570015|NCT00070655|Randomized|||Treatment||None (Open Label)||||||
1570016|NCT00069433|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570017|NCT00021099||Single Group Assignment||Treatment||None (Open Label)||||||
1570018|NCT00017368||Single Group Assignment||Treatment||None (Open Label)||||||
1570019|NCT00003907|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570020|NCT00070785||||||||||||
1570021|NCT00070759||||Treatment||||||||
1570022|NCT00070642|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570023|NCT00070629|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570024|NCT00070616|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570025|NCT00070590|Randomized|Parallel Assignment||Treatment||Double||||||
1570026|NCT00007839||||Treatment||||||||
1570027|NCT00006482||||Treatment||||||||
1570028|NCT00006466||||Treatment||||||||
1570029|NCT00006257||||Treatment||||||||
1570030|NCT00006121||||Treatment||||||||
1570031|NCT00006012||Single Group Assignment||Treatment||None (Open Label)||||||
1570032|NCT00006009||||Treatment||||||||
1570033|NCT00005998||||Treatment||||||||
1570034|NCT00005800||Single Group Assignment||Treatment||None (Open Label)||||||
1570035|NCT00005794||||Treatment||||||||
1570036|NCT00070694||||Treatment||||||||
1570037|NCT00070564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570038|NCT00070551|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570039|NCT00070538||||Treatment||None (Open Label)||||||
1570040|NCT00070525||Single Group Assignment||Treatment||None (Open Label)||||||
1570041|NCT00070499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570042|NCT00070486|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570043|NCT00070473||||Treatment||||||||
1570044|NCT00070447||||Treatment||None (Open Label)||||||
1570045|NCT00070434|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570046|NCT00070421||||||||||||
1570047|NCT00070382|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1570048|NCT00070343||||Treatment||None (Open Label)||||||
1570049|NCT00070317||Single Group Assignment||Diagnostic||None (Open Label)||||||
1570050|NCT00070304||Single Group Assignment||Treatment||None (Open Label)||||||
1570051|NCT00070291||Single Group Assignment||Treatment||None (Open Label)||||||
1570052|NCT00070278|Randomized|||Treatment||||||||
1570053|NCT00070265||Single Group Assignment||Treatment||None (Open Label)||||||
1570054|NCT00070252||Single Group Assignment||Treatment||None (Open Label)||||||
1570055|NCT00070239||Single Group Assignment||Treatment||None (Open Label)||||||
1570056|NCT00070213|Randomized|||Treatment||||||||
1570057|NCT00070200||Single Group Assignment||Treatment||None (Open Label)||||||
1570058|NCT00070187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570059|NCT00070174||||Treatment||None (Open Label)||||||
1570060|NCT00070161|Randomized|Single Group Assignment||Supportive Care||Double||||||
1570061|NCT00070148|Randomized|Factorial Assignment||Supportive Care||None (Open Label)||||||
1570062|NCT00070135||Single Group Assignment||Treatment||None (Open Label)||||||
1570063|NCT00070122|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570064|NCT00070109|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570065|NCT00070096||||Treatment||None (Open Label)||||||
1570066|NCT00070083||||Treatment||||||||
1570067|NCT00070070||||Treatment||None (Open Label)||||||
1570068|NCT00070057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570069|NCT00070031||||Treatment||None (Open Label)||||||
1570070|NCT00070018||Single Group Assignment||Treatment||None (Open Label)||||||
1570071|NCT00070005|Randomized|||Supportive Care||||||||
1570072|NCT00069992||Single Group Assignment||Treatment||None (Open Label)||||||
1570073|NCT00069966||||Treatment||None (Open Label)||||||
1570074|NCT00069953||Single Group Assignment||Treatment||None (Open Label)||||||
1570075|NCT00069940||Single Group Assignment||Treatment||None (Open Label)||||||
1570076|NCT00069927|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1570077|NCT00006034|Randomized|||Treatment||||||||
1570078|NCT00003868||||Treatment||||||||
1570079|NCT00070577||||||||||||
1570080|NCT00069901|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570081|NCT00069888|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570082|NCT00069875|Randomized|Parallel Assignment||Treatment||Double||||||
1570083|NCT00069810|||Cohort||Prospective|||||||
1570084|NCT00069797|||Cohort||Cross-Sectional|||||||
1570085|NCT00069784|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570086|NCT00069745|Randomized|Parallel Assignment||Treatment||Double||||||
1570087|NCT00069719|Randomized|Parallel Assignment||Treatment||Double||||||
1570088|NCT00069706|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570089|NCT00069914||||||||||||
1570090|NCT00069862|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1570091|NCT00069836|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570092|NCT00069823|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570093|NCT00069732|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570094|NCT00069849|Randomized|Crossover Assignment||Treatment||Double||||||
1570095|NCT00069758|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570096|NCT00069641|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570097|NCT00069524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570098|NCT00005630||||Treatment||||||||
1570099|NCT00005629|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570100|NCT00004922||||Treatment||||||||
1570101|NCT00004886||||Treatment||||||||
1570102|NCT00069693||||||||||||
1570103|NCT00069680||||||||||||
1570104|NCT00069654|Randomized|Crossover Assignment||Basic Science||Quadruple|||t|t|t|t
1570105|NCT00069628|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570106|NCT00069615|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1570107|NCT00069602|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570108|NCT00069589|||Case-Control||Prospective|||||||
1570109|NCT00069576|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570110|NCT00069563|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570111|NCT00069550|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570112|NCT00069537|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570113|NCT00069511|Randomized|Parallel Assignment||Treatment||Double||||||
1570114|NCT00069498|Randomized|Factorial Assignment||Treatment||Double||||||
1570115|NCT00069485|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1570116|NCT00004883||Single Group Assignment||Treatment||None (Open Label)||||||
1570117|NCT00004856||Single Group Assignment||Treatment||None (Open Label)||||||
1570118|NCT00003930||Single Group Assignment||Treatment||None (Open Label)||||||
1570119|NCT00003832||Single Group Assignment||Treatment||None (Open Label)||||||
1570120|NCT00069472|||Family-Based||Cross-Sectional|||||||
1570121|NCT00069459|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570122|NCT00069446||||Treatment||||||||
1570123|NCT00069368|||Case-Only||Retrospective|||||||
1570124|NCT00069420|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570125|NCT00069407|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1570126|NCT00069381|Randomized|Parallel Assignment||Treatment||Single|||t|||
1570127|NCT00003827||||Treatment||||||||
1570128|NCT00003620||Single Group Assignment||Treatment||None (Open Label)||||||
1570129|NCT00003594|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570130|NCT00003540||||Treatment||||||||
1570131|NCT00003463||||Treatment||||||||
1570132|NCT00069355||||Treatment||||||||
1570133|NCT00069342|||Cohort||Prospective|||||||
1570134|NCT00069277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570135|NCT00069264|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570136|NCT00069251|Randomized|Parallel Assignment||Treatment||Double||||||
1570137|NCT00003449||||Treatment||||||||
1570138|NCT00003281||Single Group Assignment||Treatment||None (Open Label)||||||
1570139|NCT00003280|Randomized|||Treatment||None (Open Label)||||||
1572078|NCT00025610||||Treatment||||||||
1570140|NCT00003245||Single Group Assignment||Treatment||None (Open Label)||||||
1570141|NCT00003113||Single Group Assignment||Treatment||None (Open Label)||||||
1570142|NCT00069329||Single Group Assignment||Treatment||None (Open Label)||||||
1570143|NCT00069316|Randomized|||Treatment||Double||||||
1570144|NCT00069303||||||||||||
1570145|NCT00069186|Randomized|Parallel Assignment||Treatment||Double||||||
1570146|NCT00069238||Single Group Assignment||Treatment||None (Open Label)||||||
1570147|NCT00069225||||||||||||
1570148|NCT00069212||||||||||||
1570149|NCT00069199||||||||||||
1570150|NCT00069121|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570151|NCT00069108|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570152|NCT00069095|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1570153|NCT00002638||||Treatment||||||||
1570154|NCT00002559||||Treatment||||||||
1570155|NCT00002533|Randomized|||Treatment||||||||
1570156|NCT00069173|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1570157|NCT00069134|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570158|NCT00069017|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1570159|NCT00030381||Single Group Assignment||Treatment||None (Open Label)||||||
1570160|NCT00026286|Randomized|||Supportive Care||Double||||||
1570161|NCT00025116|Randomized|||Treatment||||||||
1570162|NCT00069160|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570163|NCT00069082|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570164|NCT00069030|Randomized|Parallel Assignment||Prevention||Double||||||
1570165|NCT00069004||||||||||||
1570166|NCT00068991|Non-Randomized|Parallel Assignment||||None (Open Label)||||||
1570167|NCT00068978|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1570168|NCT00068952|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570169|NCT00069069|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1570170|NCT00069056||||Treatment||||||||
1570171|NCT00068900|||||Prospective|||||||
1570172|NCT00068887|||||Prospective|||||||
1570173|NCT00068926||||||||||||
1570174|NCT00068913|Randomized|Crossover Assignment||Treatment||Double||||||
1570175|NCT00068874|Randomized|Factorial Assignment||Treatment||Single|||||t|
1570176|NCT00068861|Randomized|Factorial Assignment||Treatment||Double||||||
1570177|NCT00068848|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1570178|NCT00068835|Randomized|Factorial Assignment||Educational/Counseling/Training||Single||||||
1570179|NCT00068822|Randomized|Crossover Assignment||Treatment||Double|||t|||t
1570180|NCT00068809|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570181|NCT00068783||Single Group Assignment||Treatment||None (Open Label)||||||
1570182|NCT00068770|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570183|NCT00068757||||Treatment||None (Open Label)||||||
1570184|NCT00068744|Randomized|||Treatment||||||||
1570185|NCT00068731||Single Group Assignment||Treatment||None (Open Label)||||||
1570186|NCT00068718||Single Group Assignment||Treatment||None (Open Label)||||||
1570187|NCT00068692|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570188|NCT00068666||Single Group Assignment||Treatment||None (Open Label)||||||
1570189|NCT00068653||Single Group Assignment||Treatment||None (Open Label)||||||
1570190|NCT00068614||||Treatment||None (Open Label)||||||
1570191|NCT00068601|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1570192|NCT00068588||Single Group Assignment||Treatment||None (Open Label)||||||
1570193|NCT00068575||Single Group Assignment||Treatment||None (Open Label)||||||
1570194|NCT00068549||Single Group Assignment||Treatment||None (Open Label)||||||
1570195|NCT00068523||Single Group Assignment||Treatment||None (Open Label)||||||
1570196|NCT00068510||Single Group Assignment||Treatment||None (Open Label)||||||
1570197|NCT00068497||Single Group Assignment||Treatment||None (Open Label)||||||
1570198|NCT00068484||Single Group Assignment||Treatment||None (Open Label)||||||
1570199|NCT00068471||||Supportive Care||None (Open Label)||||||
1570200|NCT00068458|Randomized|Parallel Assignment||Other||None (Open Label)||||||
1570201|NCT00068445|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1570202|NCT00068432||Single Group Assignment||Treatment||None (Open Label)||||||
1570203|NCT00068419||Single Group Assignment||Treatment||None (Open Label)||||||
1570204|NCT00068406||Single Group Assignment||Treatment||None (Open Label)||||||
1570205|NCT00068393||Single Group Assignment||Treatment||None (Open Label)||||||
1570206|NCT00068380||Single Group Assignment||Treatment||None (Open Label)||||||
1570207|NCT00068367||Single Group Assignment||Treatment||None (Open Label)||||||
1570208|NCT00068341|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570209|NCT00068328|||Case-Only||Prospective|||||||
1570210|NCT00068315||Single Group Assignment||Treatment||None (Open Label)||||||
1570211|NCT00068302||Single Group Assignment||Treatment||None (Open Label)||||||
1570212|NCT00068289||||Treatment||None (Open Label)||||||
1570213|NCT00068276||||Treatment||None (Open Label)||||||
1570214|NCT00068263||||Treatment||None (Open Label)||||||
1570215|NCT00068250|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1570216|NCT00068237||Single Group Assignment||Supportive Care||None (Open Label)||||||
1570217|NCT00068211|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570218|NCT00068224|||Cohort||Prospective|||||||
1570219|NCT00068198|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1570220|NCT00068185|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570221|NCT00068172|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570222|NCT00068133|Randomized|Single Group Assignment||Treatment||Double||||||
1570223|NCT00025207||Single Group Assignment||Treatment||None (Open Label)||||||
1570224|NCT00021268||||Treatment||||||||
1570225|NCT00020904||||Treatment||||||||
1570226|NCT00068159||||||||||||
1570227|NCT00068146||||||||||||
1570228|NCT00068120|||||Prospective|||||||
1570229|NCT00068094|Randomized|Parallel Assignment||Treatment||Double||||||
1570230|NCT00068081|Randomized|||Treatment||Double||||||
1570231|NCT00017043||||Treatment||||||||
1570232|NCT00016939||||Treatment||||||||
1570233|NCT00016874||||Treatment||||||||
1570234|NCT00016341|Randomized|||Treatment||||||||
1570235|NCT00068107||Single Group Assignment||Treatment||None (Open Label)||||||
1570236|NCT00068068|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570237|NCT00068055|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570238|NCT00068042|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570239|NCT00067899|Randomized|Crossover Assignment||Treatment||Double||||||
1570240|NCT00068029|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570241|NCT00067990|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1570242|NCT00067964|Randomized|||Prevention||||||||
1570243|NCT00067951||Single Group Assignment||Treatment||None (Open Label)||||||
1570244|NCT00067938|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570245|NCT00068003|||Cohort||Prospective|||||||
1570246|NCT00067925|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570247|NCT00016276|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570248|NCT00010036||||Treatment||||||||
1570249|NCT00008359|Randomized|||Supportive Care||Double||||||
1570250|NCT00008086||||Treatment||||||||
1570251|NCT00006346||||||||||||
1570252|NCT00067912|Randomized|Parallel Assignment||Treatment||Double||||||
1570253|NCT00006265|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570254|NCT00006254||||Treatment||||||||
1570255|NCT00006223|Randomized|||Treatment||||||||
1570256|NCT00006103||Single Group Assignment||Treatment||None (Open Label)||||||
1570257|NCT00006096|Randomized|||Treatment||||||||
1570258|NCT00067886|||Case Control||Cross-Sectional|||||||
1570259|NCT00067873|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570260|NCT00067860|Randomized|Parallel Assignment||Treatment||Double||||||
1570261|NCT00067847|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570262|NCT00067834|Randomized|Parallel Assignment||Treatment||Double||||||
1570263|NCT00006019||||Treatment||None (Open Label)||||||
1570264|NCT00006002|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570265|NCT00005887|Randomized|||Treatment||None (Open Label)||||||
1570266|NCT00005886|Randomized|||Treatment||Double||||||
1570267|NCT00005857||||Treatment||||||||
1570268|NCT00005845||Single Group Assignment||Treatment||None (Open Label)||||||
1570269|NCT00067821|||Cohort||Prospective|||||||
1570270|NCT00067808|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570271|NCT00067795|||||Prospective|||||||
1570272|NCT00067782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570273|NCT00067769|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570274|NCT00005804||||Treatment||||||||
1570275|NCT00005090|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570276|NCT00067756||Single Group Assignment||Treatment||None (Open Label)||||||
1570277|NCT00067743|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570278|NCT00067730||Single Group Assignment||Treatment||None (Open Label)||||||
1570279|NCT00067717|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570280|NCT00067704|Randomized|Parallel Assignment||Prevention||Single|||t|||
1570281|NCT00067691|Randomized|Single Group Assignment||Treatment||Double||||||
1570282|NCT00067678|Randomized|Parallel Assignment||Treatment||Double||||||
1570283|NCT00067665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570284|NCT00067652|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1570285|NCT00067639|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1570286|NCT00067626|Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1570287|NCT00067613|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570288|NCT00067600|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1570289|NCT00067587|||Case-Control||Prospective|||||||
1570290|NCT00067574|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570291|NCT00067561|Randomized|Parallel Assignment||Treatment||Double||||||
1570292|NCT00067548|Non-Randomized|||Treatment||None (Open Label)||||||
1570293|NCT00067535|Randomized|Parallel Assignment||Diagnostic||Triple|||t|t|t|
1570294|NCT00067522|Randomized|Factorial Assignment||Prevention||Single||||||
1570295|NCT00067509|Non-Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1570296|NCT00067470|Randomized|Parallel Assignment||Treatment||Double||||||
1570297|NCT00004256|Randomized|||Supportive Care||||||||
1570298|NCT00004233|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570299|NCT00004221||Single Group Assignment||Treatment||None (Open Label)||||||
1570300|NCT00004125|Randomized|||Treatment||||||||
1570301|NCT00004032||Single Group Assignment||Treatment||None (Open Label)||||||
1570302|NCT00067496||||Treatment||||||||
1570303|NCT00067483||||||||||||
1570304|NCT00067457|Randomized|Parallel Assignment||Treatment||Double||||||
1570305|NCT00067444|Randomized|Parallel Assignment||Treatment||Double||||||
1570306|NCT00067431|Randomized|Parallel Assignment||Treatment||Double||||||
1570307|NCT00067405|Randomized|Parallel Assignment||Treatment||Double||||||
1570308|NCT00067392|Randomized|Parallel Assignment||||Single|||t|||
1570309|NCT00067340|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1570310|NCT00004004||||Treatment||||||||
1570311|NCT00003931|||Case-Only||Prospective|||||||
1570312|NCT00003890||||Treatment||||||||
1570313|NCT00003736||||Screening||||||||
1570314|NCT00003464||||Treatment||||||||
1570315|NCT00067418||||||||||||
1570316|NCT00067379|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1570317|NCT00067366|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570318|NCT00067353|Randomized|Parallel Assignment||Treatment||Double||||||
1570319|NCT00067327|Randomized|Parallel Assignment||Treatment||Double||||||
1570320|NCT00067314|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570321|NCT00067301|Randomized|Parallel Assignment||Treatment||Double||||||
1570322|NCT00067288|Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1570323|NCT00067262|Randomized|Parallel Assignment||Treatment||Double||||||
1570324|NCT00067249|Random Sample||Natural History||Cross-Sectional, Retrospective|||||||
1570325|NCT00067275||||||||||||
1570326|NCT00067236|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570327|NCT00067223||||||||||||
1570328|NCT00067210||||Treatment||||||||
1570329|NCT00067197||||||||||||
1570330|NCT00067184|||Cohort||Prospective|||||||
1570331|NCT00067171|Randomized|||||||||||
1570332|NCT00067158||||Treatment||||||||
1570333|NCT00067145|Randomized|||Treatment||||||||
1570334|NCT00067132|Randomized|Parallel Assignment||Treatment||Double||||||
1570335|NCT00067119|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1570336|NCT00067106|||Cohort||Prospective|||||||
1570337|NCT00067093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570338|NCT00067080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570339|NCT00067041|Randomized|Parallel Assignment||Treatment||Double||||||
1570340|NCT00067028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570341|NCT00003433||||Treatment||||||||
1570342|NCT00003323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570343|NCT00003210||Single Group Assignment||Treatment||None (Open Label)||||||
1570344|NCT00003114||Single Group Assignment||Treatment||None (Open Label)||||||
1570345|NCT00003006|||Case-Only||Prospective|||||||
1570346|NCT00067067||||||||||||
1570347|NCT00067054|||Other||Prospective|||||||
1570348|NCT00067015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570349|NCT00067002|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570350|NCT00066989|Randomized|Parallel Assignment||Prevention||Double||||||
1570351|NCT00046878||||Treatment||None (Open Label)||||||
1570352|NCT00002970||Single Group Assignment||Treatment||None (Open Label)||||||
1570353|NCT00002621||Single Group Assignment||Treatment||None (Open Label)||||||
1570354|NCT00002548|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570355|NCT00002520|Randomized|Parallel Assignment||||None (Open Label)||||||
1570356|NCT00066976||||||||||||
1570357|NCT00066963|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1570358|NCT00066950|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1570359|NCT00066937|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1570360|NCT00066924|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1570361|NCT00066898|Randomized|Parallel Assignment||Prevention||Double||||||
1570362|NCT00066885|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570363|NCT00011973||||Treatment||||||||
1570364|NCT00005027||||Treatment||||||||
1570365|NCT00066911||||||||||||
1570366|NCT00066872|Randomized|||Treatment||||||||
1570367|NCT00066859|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1570368|NCT00066846||||Treatment||None (Open Label)||||||
1570369|NCT00066807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570370|NCT00066794|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570371|NCT00066781|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570372|NCT00066768|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1570373|NCT00066742||Single Group Assignment||Treatment||None (Open Label)||||||
1570374|NCT00066729||||Treatment||None (Open Label)||||||
1570375|NCT00066716||Single Group Assignment||Treatment||None (Open Label)||||||
1570376|NCT00066703|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570377|NCT00066690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570378|NCT00066677|Randomized|||Treatment||None (Open Label)||||||
1570379|NCT00066664||||Diagnostic||||||||
1570380|NCT00066651||||Treatment||None (Open Label)||||||
1570381|NCT00066638||Single Group Assignment||Treatment||None (Open Label)||||||
1570382|NCT00066625||Single Group Assignment||Treatment||None (Open Label)||||||
1570383|NCT00066612||Single Group Assignment||Treatment||None (Open Label)||||||
1570384|NCT00066599||||Supportive Care||None (Open Label)||||||
1570385|NCT00066586|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1570386|NCT00066573|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570387|NCT00066547||||Treatment||None (Open Label)||||||
1570388|NCT00066508||||Treatment||None (Open Label)||||||
1570389|NCT00066482||Single Group Assignment||Treatment||None (Open Label)||||||
1572079|NCT00025597||||Treatment||||||||
1570390|NCT00066469||Single Group Assignment||Treatment||None (Open Label)||||||
1570391|NCT00066456||Single Group Assignment||Treatment||None (Open Label)||||||
1570392|NCT00066443||Single Group Assignment||Treatment||None (Open Label)||||||
1570393|NCT00066430||Single Group Assignment||Treatment||None (Open Label)||||||
1570394|NCT00066417||||Treatment||None (Open Label)||||||
1570395|NCT00066404||||Treatment||||||||
1570396|NCT00066391||||Treatment||None (Open Label)||||||
1570397|NCT00066378|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1570398|NCT00066365|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570399|NCT00066352||||Treatment||None (Open Label)||||||
1570400|NCT00066339||||Treatment||None (Open Label)||||||
1570401|NCT00066326||||Treatment||None (Open Label)||||||
1570402|NCT00066313|Randomized|||Treatment||Double||||||
1570403|NCT00066274|Randomized|||Treatment||||||||
1570404|NCT00066248|Non-Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1570405|NCT00066222||Single Group Assignment||Treatment||None (Open Label)||||||
1570406|NCT00066196|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570407|NCT00020462||||Treatment||||||||
1570408|NCT00019721||||Treatment||||||||
1570409|NCT00019383||||Treatment||||||||
1570410|NCT00066209||||||||||||
1570411|NCT00066170|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570412|NCT00033722||||Treatment||||||||
1570413|NCT00033306||Single Group Assignment||Treatment||None (Open Label)||||||
1570414|NCT00031811|Randomized|||Supportive Care||||||||
1570415|NCT00031785||||Supportive Care||||||||
1570416|NCT00066183||||||||||||
1570417|NCT00066157|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570418|NCT00066144|Randomized|Parallel Assignment||Treatment||Double||||||
1570419|NCT00066131|Randomized|Parallel Assignment||Prevention||Single||||||t
1570420|NCT00066118|Randomized|Parallel Assignment||Treatment||Single||||||
1570421|NCT00066092|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570422|NCT00066079|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570423|NCT00066066|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570424|NCT00066053|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570425|NCT00066040|Randomized|Single Group Assignment||Treatment||Double||||||
1570426|NCT00066027|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570427|NCT00066014|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1570428|NCT00066001|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1570429|NCT00065988|Randomized|Single Group Assignment||Treatment||Single||||||
1570430|NCT00065975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570431|NCT00065962|Randomized|Factorial Assignment||Treatment||Double||||||
1570432|NCT00065949|Randomized|Parallel Assignment||Prevention||Double||||||
1570433|NCT00065936|Randomized|Parallel Assignment||Treatment||Double||||||
1570434|NCT00065923|Randomized|Crossover Assignment||Treatment||Double||||||
1570435|NCT00065910|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1570436|NCT00065897|Randomized|Factorial Assignment||Diagnostic||None (Open Label)||||||
1570437|NCT00065884|Randomized|Factorial Assignment||Treatment||Double||||||
1570438|NCT00065871|Non-Randomized|||Prevention||None (Open Label)||||||
1570439|NCT00065858|Randomized|Parallel Assignment||Prevention||Double||||||
1570440|NCT00065845|Randomized|Parallel Assignment||Prevention||Double|||t|||t
1570441|NCT00031707|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1570442|NCT00026273|Randomized|||Treatment||None (Open Label)||||||
1570443|NCT00025688|Randomized|||Treatment||||||||
1570444|NCT00024024||Single Group Assignment||Treatment||None (Open Label)||||||
1570445|NCT00022477||Single Group Assignment||Treatment||None (Open Label)||||||
1570446|NCT00065832|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570447|NCT00065819|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570448|NCT00065806|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1570449|NCT00065793|||Cohort||Prospective|||||||
1570450|NCT00065780|||Cohort||Prospective|||||||
1570451|NCT00065767|Randomized|Parallel Assignment||Treatment||Double||||||
1570452|NCT00065754|Randomized|Factorial Assignment||||Double||||||
1570453|NCT00065741|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570454|NCT00065728|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570455|NCT00065715|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570456|NCT00065702|Randomized|Crossover Assignment||Treatment||Double||||||
1570457|NCT00065689|Randomized|Crossover Assignment||Treatment||Single||||||
1570458|NCT00065676|Non-Randomized|Crossover Assignment||Basic Science||Double|||t||t|
1570459|NCT00065663|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570460|NCT00065650|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570461|NCT00065624|Randomized|Parallel Assignment||Treatment||Double||||||
1570462|NCT00065585|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1570463|NCT00065572|Randomized|Parallel Assignment||Treatment||Double||||||
1570464|NCT00065559|Randomized|Crossover Assignment||Treatment||Double||||||
1570465|NCT00065546|Randomized|Parallel Assignment||||Triple|||t||t|t
1570466|NCT00065637|Randomized|Factorial Assignment||Treatment||Double||||||
1570467|NCT00014560||||Treatment||None (Open Label)||||||
1570468|NCT00014261||||Treatment||||||||
1570469|NCT00014248||||Supportive Care||||||||
1570470|NCT00014209||||Treatment||||||||
1570471|NCT00010127||||Treatment||||||||
1573260|NCT00001886||||Treatment||||||||
1570472|NCT00065611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570473|NCT00065533|Randomized|Parallel Assignment||Treatment||Double||||||
1570474|NCT00065507|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570475|NCT00006799|Randomized|||Supportive Care||Double|||t||t|
1570476|NCT00006486|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570477|NCT00006453|Randomized|||Treatment||||||||
1570478|NCT00006352|Randomized|||Treatment||||||||
1570479|NCT00006240||||Treatment||||||||
1570480|NCT00065468|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570481|NCT00006229|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570482|NCT00006081|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570483|NCT00065455||||Treatment||||||||
1570484|NCT00065442|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570485|NCT00065429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570486|NCT00005604||Single Group Assignment||Treatment||None (Open Label)||||||
1570487|NCT00004887|Randomized|||Treatment||||||||
1570488|NCT00065416|Randomized|Parallel Assignment||Treatment||||||||
1570489|NCT00065403|Randomized|Parallel Assignment||Treatment||Double||||||
1570490|NCT00065364|Randomized|Factorial Assignment||Prevention||Double||||||
1570491|NCT00065351|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570492|NCT00065338|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1570493|NCT00065325|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570494|NCT00004253||||Treatment||||||||
1570495|NCT00065390||||Treatment||||||||
1570496|NCT00065377||||Treatment||||||||
1570497|NCT00065312||||Treatment||||||||
1570498|NCT00065299|Non-Randomized|||Treatment||None (Open Label)||||||
1570499|NCT00065286|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1570500|NCT00065273|Randomized|Crossover Assignment||Treatment||Double||||||
1570501|NCT00065247|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1570502|NCT00065234|Randomized|Parallel Assignment||Prevention||Single||||||
1570503|NCT00065221|Randomized|Parallel Assignment||Treatment||Double||||||
1570504|NCT00065208|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570505|NCT00065260|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570506|NCT00065195|Randomized|Parallel Assignment||Treatment||Single||||||
1570507|NCT00065182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570508|NCT00065169|Randomized|Parallel Assignment||Prevention||Double||||||
1570509|NCT00065156|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570510|NCT00065143|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570511|NCT00065130|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570512|NCT00065117|Randomized|Parallel Assignment||Treatment||Double||||||
1570513|NCT00065104|Randomized|Crossover Assignment||Treatment||Double||||||
1570514|NCT00065078|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570515|NCT00065065|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570516|NCT00065052|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570517|NCT00065039|Randomized|||Prevention||||||||
1570518|NCT00065026|Non-Randomized|||Prevention||None (Open Label)||||||
1570519|NCT00065013|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570520|NCT00065000||||||||||||
1570521|NCT00004204||||Treatment||||||||
1570522|NCT00004006||||Treatment||||||||
1570523|NCT00003895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570524|NCT00003795||||||||||||
1570525|NCT00003759|Randomized|||Treatment||None (Open Label)||||||
1570526|NCT00064987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570527|NCT00064974||Single Group Assignment||Treatment||None (Open Label)||||||
1570528|NCT00064961||Parallel Assignment||Prevention||Single||||||
1570529|NCT00064935|Randomized|Factorial Assignment||Diagnostic||Double||||||
1570530|NCT00064922||||Treatment||||||||
1570531|NCT00064870|||Cohort||Prospective|||||||
1570532|NCT00064857|Randomized|Parallel Assignment||Treatment||Double||||||
1570533|NCT00064909||||||||||||
1570534|NCT00064896||||Treatment||||||||
1570535|NCT00064883|||Cohort||Prospective|||||||
1570536|NCT00064844|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570537|NCT00064831|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1570538|NCT00064818|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1570539|NCT00064805|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570540|NCT00064779|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570541|NCT00064766|Randomized|Factorial Assignment||Treatment||Double||||||
1570542|NCT00064753|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570543|NCT00003712||Single Group Assignment||Treatment||None (Open Label)||||||
1570544|NCT00003707||Single Group Assignment||Treatment||None (Open Label)||||||
1570545|NCT00003645|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570546|NCT00003571|||Case-Only||Prospective|||||||
1570547|NCT00003382||||Treatment||||||||
1570548|NCT00064792|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1570549|NCT00064740|Randomized|Parallel Assignment||Treatment||Double||||||
1570550|NCT00064701|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570551|NCT00064688|||Cohort||Cross-Sectional|||||||
1570552|NCT00064675|||Cohort||Cross-Sectional|||||||
1570553|NCT00006073|||||Other|||||||
1570554|NCT00064727||||Treatment||||||||
1570555|NCT00064714|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1570556|NCT00064662|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570557|NCT00064649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570558|NCT00064636|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1570559|NCT00064623|Randomized|Parallel Assignment||Treatment||Double||||||
1570560|NCT00064610|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1570561|NCT00064597|||Defined Population|Screening|Cross-Sectional, Prospective|||||||
1570562|NCT00063726|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570563|NCT00003350|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570564|NCT00003184||||Treatment||||||||
1570565|NCT00003045||Single Group Assignment||Treatment||None (Open Label)||||||
1570566|NCT00003008||||Treatment||||||||
1570567|NCT00002965|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570568|NCT00064584|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570569|NCT00064571|Randomized|Parallel Assignment||Treatment||||||||
1570570|NCT00064558|||Cohort||Retrospective|||||||
1570571|NCT00064545|||Case Control|||||||||
1570572|NCT00064532|||Cohort||Cross-Sectional|||||||
1570573|NCT00064519|||Case Control||Cross-Sectional|||||||
1570574|NCT00064506|||Cohort||Prospective|||||||
1570575|NCT00064493||||||||||||
1570576|NCT00064480||||||||||||
1570577|NCT00064467|Randomized|Parallel Assignment||Treatment||Double||||||
1570578|NCT00064454|Randomized|Parallel Assignment||Treatment||Double||||||
1570579|NCT00064441|Randomized|Parallel Assignment||Treatment||Double||||||
1570580|NCT00064415|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570581|NCT00064402|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1570582|NCT00064389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570583|NCT00064376||||Treatment||None (Open Label)||||||
1570584|NCT00064363||||Treatment||None (Open Label)||||||
1570585|NCT00064350|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570586|NCT00064337||Single Group Assignment||Treatment||None (Open Label)||||||
1570587|NCT00064324||Single Group Assignment||Treatment||None (Open Label)||||||
1570588|NCT00064311||||Supportive Care||None (Open Label)||||||
1570589|NCT00064298|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1570590|NCT00064285|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570591|NCT00064272|Randomized|||Supportive Care||Double||||||
1570592|NCT00064259||Single Group Assignment||Treatment||None (Open Label)||||||
1570593|NCT00064246||Single Group Assignment||Treatment||None (Open Label)||||||
1570594|NCT00064233||||Treatment||None (Open Label)||||||
1570595|NCT00064220||||Treatment||None (Open Label)||||||
1570596|NCT00064207|Randomized|||Treatment||||||||
1570597|NCT00064194|Randomized|||Prevention||Double||||||
1570598|NCT00064181|Randomized|||Treatment||Double||||||
1570599|NCT00064142|Randomized|Parallel Assignment||Treatment||Double||||||
1570600|NCT00064129||Single Group Assignment||Treatment||None (Open Label)||||||
1570601|NCT00064116|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570602|NCT00064103||Single Group Assignment||Prevention||None (Open Label)||||||
1570603|NCT00064090||||Treatment||||||||
1570604|NCT00064077|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570605|NCT00064064||||Treatment||None (Open Label)||||||
1570606|NCT00064051||||Treatment||None (Open Label)||||||
1570607|NCT00064038|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570608|NCT00064025||Single Group Assignment||Treatment||None (Open Label)||||||
1570609|NCT00064012|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570610|NCT00063999|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570611|NCT00063986||Single Group Assignment||Treatment||None (Open Label)||||||
1570612|NCT00063973||Single Group Assignment||Treatment||None (Open Label)||||||
1570613|NCT00063960||Single Group Assignment||Treatment||None (Open Label)||||||
1570614|NCT00063947||Single Group Assignment||Treatment||None (Open Label)||||||
1570615|NCT00063934||Single Group Assignment||Treatment||None (Open Label)||||||
1570616|NCT00063895||Single Group Assignment||Treatment||None (Open Label)||||||
1570617|NCT00063882|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570618|NCT00063869|Randomized|Parallel Assignment||Treatment||Double||||||
1570619|NCT00023907||||Treatment||None (Open Label)||||||
1570620|NCT00005940||Single Group Assignment||Treatment||None (Open Label)||||||
1570621|NCT00003211|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1570622|NCT00002878|Randomized|||Treatment||||||||
1570623|NCT00063856|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570624|NCT00063843|Randomized|||Prevention||Double||||||
1570625|NCT00063830||||Treatment||||||||
1570626|NCT00063817||Single Group Assignment||Treatment||None (Open Label)||||||
1570627|NCT00063804|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570628|NCT00063791||||||||||||
1570629|NCT00063778|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1570630|NCT00063752|Non-Randomized|||Treatment||None (Open Label)||||||
1570631|NCT00045357||||Treatment||||||||
1570632|NCT00042900||||Treatment||||||||
1570633|NCT00040820||||Treatment||||||||
1570634|NCT00039169||||Treatment||||||||
1570635|NCT00036660||||Treatment||||||||
1570636|NCT00033384||||Treatment||||||||
1570637|NCT00002752||||Treatment||||||||
1570638|NCT00002582|Randomized|||Treatment||||||||
1570639|NCT00063765||||Treatment||||||||
1570640|NCT00063713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570641|NCT00063700||||Prevention||||||||
1570642|NCT00063687|Randomized|Parallel Assignment||Treatment||Double||||||
1570643|NCT00063674|Randomized|Parallel Assignment||Prevention||Single||||||
1570644|NCT00063648|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1570645|NCT00063635|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570646|NCT00063622|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570647|NCT00063609|Randomized|Parallel Assignment||Prevention||Double||||||
1570648|NCT00063661||||||||||||
1570649|NCT00063596|Randomized|Parallel Assignment||Treatment||Double||||||
1570650|NCT00063583|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570651|NCT00063570|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570652|NCT00063557||||||||||||
1570653|NCT00063544||||||||||||
1570654|NCT00063531|||Cohort||Prospective|||||||
1570655|NCT00063518||||||||||||
1570656|NCT00063505|||Case Control||Cross-Sectional|||||||
1570657|NCT00063492||||||||||||
1570658|NCT00063323|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570659|NCT00033319||||Prevention||||||||
1570660|NCT00031954|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570661|NCT00031889|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570662|NCT00031668|Randomized|||Treatment||||||||
1570663|NCT00028938|Randomized|||Treatment||||||||
1570664|NCT00063479|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570665|NCT00063453|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1570666|NCT00063440|||Cohort||Prospective|||||||
1570667|NCT00028925|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570668|NCT00028613||Single Group Assignment||Treatment||None (Open Label)||||||
1570669|NCT00063427|Non-Randomized|||Treatment||None (Open Label)||||||
1570670|NCT00063414||||Treatment||||||||
1570671|NCT00063401|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570672|NCT00063388|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570673|NCT00063375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570674|NCT00063362|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570675|NCT00063336|Randomized|Parallel Assignment||Treatment||||||||
1570676|NCT00030446||||Treatment||None (Open Label)||||||
1570677|NCT00028483||||Treatment||||||||
1570678|NCT00006968||||Treatment||||||||
1570679|NCT00003352||Single Group Assignment||Treatment||None (Open Label)||||||
1570680|NCT00063310|Randomized|Parallel Assignment||Treatment||Double||||||
1570681|NCT00063297|Randomized|Parallel Assignment||Treatment||Double||||||
1570682|NCT00040729||||||||||||
1570683|NCT00063284||Single Group Assignment||Treatment||None (Open Label)||||||
1570684|NCT00063258|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570685|NCT00063219|Non-Randomized|||Treatment||None (Open Label)||||||
1570686|NCT00063206||||Treatment||||||||
1570687|NCT00063193|Randomized|||Treatment||Double||||||
1570688|NCT00063154||Single Group Assignment||Treatment||None (Open Label)||||||
1570689|NCT00063141|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570690|NCT00063128|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1570691|NCT00030797|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570692|NCT00026520||||Treatment||||||||
1570693|NCT00026364||Single Group Assignment||Treatment||None (Open Label)||||||
1570694|NCT00026351||||Treatment||None (Open Label)||||||
1570695|NCT00025571||||Treatment||||||||
1570696|NCT00006013||Single Group Assignment||Treatment||None (Open Label)||||||
1570697|NCT00004037||||Treatment||||||||
1570698|NCT00003054||||Treatment||||||||
1570699|NCT00063245||||||||||||
1570700|NCT00063232||||Treatment||None (Open Label)||||||
1570701|NCT00063180||||||||||||
1570702|NCT00063102|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570703|NCT00063115||||||||||||
1570704|NCT00063089|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570705|NCT00063076|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570706|NCT00063063|||Cohort||Prospective|||||||
1570707|NCT00063050|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570708|NCT00063037|Randomized|Factorial Assignment||Prevention||Single||||||
1570709|NCT00063024|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1570710|NCT00063011|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1570711|NCT00025545||||Treatment||None (Open Label)||||||
1570712|NCT00024323||||Treatment||||||||
1570713|NCT00024310||||Treatment||||||||
1570714|NCT00024141||||Treatment||||||||
1570715|NCT00023933||Single Group Assignment||Treatment||None (Open Label)||||||
1570716|NCT00062998|||||Prospective|||||||
1570717|NCT00062985|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570718|NCT00062972|Randomized|Parallel Assignment||Treatment||Double||||||
1570719|NCT00062959|Randomized|Factorial Assignment||Prevention||Single||||||
1570720|NCT00062907|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570721|NCT00062894|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570722|NCT00062946||||Treatment||||||||
1570723|NCT00062933||||Treatment||||||||
1570724|NCT00062881|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570725|NCT00062868|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570726|NCT00062855||Single Group Assignment||Treatment||None (Open Label)||||||
1570727|NCT00062842|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570728|NCT00062829|Randomized|Factorial Assignment||Prevention||Single|||t|||
1570729|NCT00062816||||Treatment||||||||
1570730|NCT00002643||Single Group Assignment||Treatment||None (Open Label)||||||
1570731|NCT00062803|Randomized|||Treatment||None (Open Label)||||||
1570732|NCT00062790|Randomized|Parallel Assignment||Treatment||Double||||||
1570733|NCT00027612||Single Group Assignment||Treatment||None (Open Label)||||||
1570734|NCT00025376|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570735|NCT00023868|Randomized|||Treatment||||||||
1570736|NCT00022594||||Treatment||||||||
1570737|NCT00022529||Single Group Assignment||Treatment||None (Open Label)||||||
1570738|NCT00062777||||||||||||
1570739|NCT00062764||Single Group Assignment||Treatment||None (Open Label)||||||
1570740|NCT00062751|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570741|NCT00062738|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570742|NCT00062699|Randomized|Parallel Assignment||Treatment||Double||||||
1570743|NCT00062712||||Treatment||||||||
1570744|NCT00062686|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570745|NCT00062673|Randomized|Parallel Assignment||Treatment||Double||||||
1570746|NCT00062660||||||||||||
1570747|NCT00062647|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570748|NCT00062634|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1570749|NCT00062621|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570750|NCT00062608|Randomized|Single Group Assignment||Treatment||Single||||||
1570751|NCT00062595|Randomized|Single Group Assignment||Treatment||Double||||||
1570752|NCT00062569|Randomized|Parallel Assignment||||None (Open Label)||||||
1570753|NCT00062556|Randomized|Parallel Assignment||Treatment||Double||||||
1570754|NCT00062543||Single Group Assignment||Treatment||None (Open Label)||||||
1570755|NCT00062530|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570756|NCT00062504||Parallel Assignment||Treatment||||||||
1570757|NCT00062491|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570758|NCT00062478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570759|NCT00022009|Randomized|||Treatment||None (Open Label)||||||
1570760|NCT00018954||||Treatment||||||||
1570761|NCT00017446||||Treatment||||||||
1570762|NCT00017394||Single Group Assignment||Treatment||None (Open Label)||||||
1570763|NCT00017316||Single Group Assignment||Treatment||None (Open Label)||||||
1570764|NCT00062582|Randomized|Parallel Assignment||Treatment||Double||||||
1570765|NCT00016107||Single Group Assignment||Treatment||None (Open Label)||||||
1570766|NCT00014664|Randomized|||Treatment||||||||
1570767|NCT00014534|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570768|NCT00014170||Single Group Assignment||Treatment||None (Open Label)||||||
1570769|NCT00062517|||Cohort||Prospective|||||||
1570770|NCT00012155||||Treatment||||||||
1570771|NCT00062465||||Treatment||||||||
1570772|NCT00062452|||Cohort||Prospective|||||||
1570773|NCT00062439||Single Group Assignment||Treatment||None (Open Label)||||||
1570774|NCT00062426|Randomized|||Treatment||None (Open Label)||||||
1570775|NCT00062400||||||||||||
1570776|NCT00062387||Single Group Assignment||Treatment||None (Open Label)||||||
1570777|NCT00062374||Single Group Assignment||Treatment||None (Open Label)||||||
1570778|NCT00062348||||Treatment||None (Open Label)||||||
1570779|NCT00062335||||Treatment||None (Open Label)||||||
1570780|NCT00062322||||Treatment||||||||
1570781|NCT00062309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570782|NCT00062296||||Treatment||None (Open Label)||||||
1570783|NCT00062283||||Treatment||None (Open Label)||||||
1570784|NCT00062270|Randomized|||Treatment||None (Open Label)||||||
1570785|NCT00062257||||Treatment||None (Open Label)||||||
1570786|NCT00062244||Single Group Assignment||Treatment||None (Open Label)||||||
1570787|NCT00062231|Randomized|||Supportive Care||Double||||||
1570788|NCT00062205||||Treatment||None (Open Label)||||||
1570789|NCT00062179|Randomized|Parallel Assignment||Treatment||Double||||||
1570790|NCT00062166|||Cohort||Prospective|||||||
1570791|NCT00062140||||Treatment||None (Open Label)||||||
1570792|NCT00062127|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570793|NCT00062114||Single Group Assignment||Treatment||None (Open Label)||||||
1570794|NCT00062101|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570795|NCT00062075||Single Group Assignment||Treatment||None (Open Label)||||||
1570796|NCT00062062|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570797|NCT00062049||||Treatment||||||||
1570798|NCT00062036||||Treatment||None (Open Label)||||||
1570799|NCT00062023|Randomized|Single Group Assignment||Prevention||Single|||t|||
1570800|NCT00062010||Single Group Assignment||Treatment||None (Open Label)||||||
1570801|NCT00061997||||Prevention||||||||
1570802|NCT00061984|Randomized|||Treatment||None (Open Label)||||||
1570803|NCT00061958||Single Group Assignment||Treatment||None (Open Label)||||||
1570804|NCT00061945||Single Group Assignment||Treatment||None (Open Label)||||||
1570805|NCT00061932|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570806|NCT00061919|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570807|NCT00061906||Single Group Assignment||Treatment||None (Open Label)||||||
1570808|NCT00061893||Single Group Assignment||Treatment||None (Open Label)||||||
1570809|NCT00061880||||Treatment||None (Open Label)||||||
1570810|NCT00061867||||Treatment||None (Open Label)||||||
1570811|NCT00061854||||Treatment||None (Open Label)||||||
1570812|NCT00061841|Randomized|Parallel Assignment||Prevention||||||||
1570813|NCT00061828|||Cohort||Prospective|||||||
1570814|NCT00061815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570815|NCT00033462||Single Group Assignment||Treatment||None (Open Label)||||||
1570816|NCT00010231||Single Group Assignment||Treatment||None (Open Label)||||||
1570817|NCT00010114|||Cohort||Prospective|||||||
1570818|NCT00009932||||Treatment||||||||
1570819|NCT00009802||||Treatment||||||||
1570820|NCT00061802|Randomized|Parallel Assignment||Treatment||Double||||||
1570821|NCT00009789||Single Group Assignment||Treatment||None (Open Label)||||||
1570822|NCT00008424||||Treatment||||||||
1570823|NCT00008398|Randomized|||Supportive Care||Double||||||
1570824|NCT00008203|Randomized|||Treatment||||||||
1570825|NCT00008112||||Treatment||||||||
1570826|NCT00061789||||Treatment||||||||
1570827|NCT00061776|Randomized|||Treatment||Double||||||
1570828|NCT00061763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570829|NCT00061750|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570830|NCT00061737|||||Retrospective|||||||
1570831|NCT00061724|||||Prospective|||||||
1570832|NCT00061711|Randomized|||Treatment||Double||||||
1570833|NCT00061698|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570834|NCT00061672|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570835|NCT00061659|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570836|NCT00061646|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570837|NCT00051714|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570838|NCT00061633|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570839|NCT00061620|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570840|NCT00059462|Randomized|Parallel Assignment||Treatment||Double||||||
1570841|NCT00008021||||Treatment||None (Open Label)||||||
1570842|NCT00006864||||Treatment||||||||
1570843|NCT00006484|Randomized|||Treatment||||||||
1570844|NCT00061607||||||||||||
1570845|NCT00061594|Randomized|||Treatment||Double||||||
1570846|NCT00061542|Randomized|Parallel Assignment||Treatment||Double||||||
1570847|NCT00061529|Randomized|Parallel Assignment||Treatment||Double||||||
1570848|NCT00061516|Randomized|Parallel Assignment||Treatment||Double||||||
1570849|NCT00061503|Randomized|Parallel Assignment||Treatment||Double||||||
1570850|NCT00006464||||Treatment||||||||
1570851|NCT00006457|Randomized|||Prevention||Double||||||
1570852|NCT00006383||||Treatment||||||||
1570853|NCT00006377||||Treatment||||||||
1570854|NCT00006361||||Treatment||||||||
1570855|NCT00061581|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570856|NCT00061568|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570857|NCT00061490|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1570858|NCT00061477|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570859|NCT00061464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570860|NCT00061451|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570861|NCT00006349|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1570862|NCT00006341||Single Group Assignment||Supportive Care||None (Open Label)||||||
1570863|NCT00061438|Randomized|Parallel Assignment||Prevention||Double||||||
1570864|NCT00061425|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570865|NCT00061412|Randomized|Factorial Assignment||Treatment||Single||||||
1570866|NCT00061399|||||Prospective|||||||
1570867|NCT00061386|Randomized|Factorial Assignment||Prevention||Single||||||
1570868|NCT00061321|Randomized|Crossover Assignment||Prevention||None (Open Label)||||||
1570869|NCT00061308|Non-Randomized|||Treatment||None (Open Label)||||||
1570870|NCT00061295|Randomized|Factorial Assignment||Treatment||Single||||||
1570871|NCT00045149||||Treatment||None (Open Label)||||||
1570872|NCT00019734|Randomized|||Treatment||||||||
1570873|NCT00061373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570874|NCT00061360|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570875|NCT00061347||Single Group Assignment||Diagnostic||None (Open Label)||||||
1570876|NCT00061334||||||||||||
1570877|NCT00061282|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1570878|NCT00041353||||Screening||||||||
1570879|NCT00019175||||Treatment||||||||
1570880|NCT00002786||||Treatment||||||||
1570881|NCT00061269||Single Group Assignment||Treatment||None (Open Label)||||||
1570882|NCT00061256|Randomized|Parallel Assignment||Treatment||Double||||||
1570883|NCT00061243|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570884|NCT00061230|Randomized|Parallel Assignment||Treatment||Single||||||
1570885|NCT00061217|Randomized|Crossover Assignment||Treatment||Double||||||
1570886|NCT00061178|Randomized|Parallel Assignment||Treatment||Double||||||
1570887|NCT00061165|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1570888|NCT00019084||||Treatment||||||||
1570889|NCT00015821||Single Group Assignment||Treatment||None (Open Label)||||||
1570890|NCT00004868||||Treatment||||||||
1570891|NCT00003408||||Treatment||||||||
1570892|NCT00061204||||||||||||
1570893|NCT00061152||||Treatment||None (Open Label)||||||
1570894|NCT00061139|Randomized|Factorial Assignment||Treatment||Single||||||
1570895|NCT00061126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573261|NCT00001881||||||||||||
1570896|NCT00061113|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570897|NCT00061100|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570898|NCT00061087|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1570899|NCT00061074|Randomized|Single Group Assignment||Treatment||Double||||||
1570900|NCT00061061|Randomized|||Treatment||Double||||||
1570901|NCT00061035|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570902|NCT00006243|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570903|NCT00006242||Single Group Assignment||Treatment||None (Open Label)||||||
1570904|NCT00006095||Single Group Assignment||Treatment||None (Open Label)||||||
1570905|NCT00006086||||Treatment||||||||
1570906|NCT00006082||||Treatment||||||||
1570907|NCT00061048|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570908|NCT00061022|Randomized|Factorial Assignment||Treatment||Double||||||
1570909|NCT00006046||||Treatment||||||||
1570910|NCT00005999||||Treatment||||||||
1570911|NCT00005977||Single Group Assignment||Treatment||None (Open Label)||||||
1570912|NCT00005971||||Treatment||||||||
1570913|NCT00005956||Single Group Assignment||Treatment||None (Open Label)||||||
1570914|NCT00005868||||Treatment||||||||
1570915|NCT00061009||||||||||||
1570916|NCT00060996|Randomized|Parallel Assignment||Treatment||Double||||||
1570917|NCT00005813||||Treatment||||||||
1570918|NCT00060983|Randomized|Parallel Assignment||Treatment||Single||||||
1570919|NCT00060970|||Natural History||Longitudinal, Prospective|||||||
1570920|NCT00060957|Randomized|Parallel Assignment||Treatment||Double||||||
1570921|NCT00060944|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570922|NCT00005861||||Treatment||||||||
1570923|NCT00005588|Randomized|||Treatment||||||||
1570924|NCT00005587|Randomized|||Treatment||||||||
1570925|NCT00003203||Single Group Assignment||Treatment||None (Open Label)||||||
1570926|NCT00060931|Randomized|Parallel Assignment||Treatment||Double||||||
1570927|NCT00060918|Randomized|Parallel Assignment||Treatment||Double||||||
1570928|NCT00060905|Randomized|Parallel Assignment||Treatment||Double||||||
1570929|NCT00060892|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1570930|NCT00005086||Single Group Assignment||Treatment||None (Open Label)||||||
1570931|NCT00005078||||Treatment||||||||
1570932|NCT00060866||||Treatment||||||||
1570933|NCT00060840|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1570934|NCT00060827||||||||||||
1570935|NCT00060814||Single Group Assignment||Treatment||None (Open Label)||||||
1570936|NCT00060853||||||||||||
1570937|NCT00060801||||Treatment||||||||
1570938|NCT00060788|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1570939|NCT00004931|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570940|NCT00004928||||Treatment||||||||
1570941|NCT00004925||||Treatment||||||||
1570942|NCT00004916||||Treatment||||||||
1570943|NCT00004911||||Supportive Care||||||||
1570944|NCT00060775||||||||||||
1570945|NCT00060762|Randomized|Parallel Assignment||Treatment||Single||||||t
1570946|NCT00060723|||Cohort||Prospective|||||||
1570947|NCT00060710|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570948|NCT00060749||||Treatment||||||||
1570949|NCT00060736||||||||||||
1570950|NCT00060697|Randomized|Factorial Assignment||Prevention||Single||||||
1570951|NCT00060684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570952|NCT00060671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570953|NCT00060645|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570954|NCT00060632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570955|NCT00060619|Randomized|Parallel Assignment||Treatment||Single||||||
1570956|NCT00060658||||||||||||
1570957|NCT00060606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570958|NCT00060567|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1570959|NCT00004910||||Supportive Care||||||||
1570960|NCT00004895||||Supportive Care||||||||
1570961|NCT00004255|Randomized|||Treatment||None (Open Label)||||||
1570962|NCT00004232||||Supportive Care||||||||
1570963|NCT00004180|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570964|NCT00060593||||||||||||
1570965|NCT00060580||||Treatment||||||||
1570966|NCT00060554|Randomized|Parallel Assignment||Treatment||Double||||||
1570967|NCT00060515|Non-Randomized|||Treatment||||||||
1570968|NCT00060502|Randomized|Parallel Assignment||Treatment||Double||||||
1570969|NCT00060489||||Treatment||||||||
1570970|NCT00004094||||Treatment||||||||
1570971|NCT00004068||||Treatment||||||||
1570972|NCT00004059||||Treatment||||||||
1570973|NCT00004052||||Treatment||||||||
1570974|NCT00004008||||Treatment||||||||
1570975|NCT00060541||||||||||||
1570976|NCT00060528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1570977|NCT00060476|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1570978|NCT00060463|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1570979|NCT00060450|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1570980|NCT00060437||||Treatment||None (Open Label)||||||
1570981|NCT00060424||Single Group Assignment||Treatment||None (Open Label)||||||
1570982|NCT00060411||Single Group Assignment||Treatment||None (Open Label)||||||
1570983|NCT00060398|Randomized|||Supportive Care||||||||
1570984|NCT00060385|Randomized|||Treatment||||||||
1570985|NCT00060372||Single Group Assignment||Treatment||None (Open Label)||||||
1570986|NCT00060359||Single Group Assignment||Treatment||None (Open Label)||||||
1570987|NCT00060346||Single Group Assignment||Treatment||None (Open Label)||||||
1570988|NCT00060333||Single Group Assignment||Treatment||None (Open Label)||||||
1570989|NCT00060320|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1570990|NCT00060307||Single Group Assignment||Treatment||None (Open Label)||||||
1570991|NCT00060294||||Treatment||||||||
1570992|NCT00060268||Single Group Assignment||Treatment||||||||
1570993|NCT00060255||Single Group Assignment||Treatment||None (Open Label)||||||
1570994|NCT00060242||Single Group Assignment||Treatment||None (Open Label)||||||
1570995|NCT00060203||Single Group Assignment||Treatment||None (Open Label)||||||
1570996|NCT00060151||||Treatment||None (Open Label)||||||
1570997|NCT00060138|Randomized|||Supportive Care||Double||||||
1570998|NCT00060125||Single Group Assignment||Treatment||None (Open Label)||||||
1570999|NCT00060112||Single Group Assignment||Treatment||None (Open Label)||||||
1571000|NCT00060099|Randomized|||Treatment||Double||||||
1571001|NCT00060086||Single Group Assignment||Treatment||None (Open Label)||||||
1571002|NCT00060021|Randomized|||Supportive Care||Double||||||
1571003|NCT00060008||Single Group Assignment||Diagnostic||None (Open Label)||||||
1571004|NCT00059995||||Treatment||None (Open Label)||||||
1571005|NCT00059982||||Treatment||None (Open Label)||||||
1571006|NCT00059943||||Treatment||None (Open Label)||||||
1571007|NCT00059930||Single Group Assignment||Treatment||None (Open Label)||||||
1571008|NCT00059917||||Treatment||||||||
1571009|NCT00059904||||Treatment||None (Open Label)||||||
1571010|NCT00059891||Single Group Assignment||Supportive Care||None (Open Label)||||||
1571011|NCT00059878|Randomized|||Supportive Care||Double||||||
1571012|NCT00059865||Single Group Assignment||Treatment||None (Open Label)||||||
1571013|NCT00059852||Single Group Assignment||Treatment||None (Open Label)||||||
1571014|NCT00059839|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571015|NCT00059826||Single Group Assignment||Treatment||None (Open Label)||||||
1571016|NCT00059813||Single Group Assignment||Treatment||None (Open Label)||||||
1571017|NCT00059800|Non-Randomized|||Treatment||||||||
1571018|NCT00059787||Single Group Assignment||Treatment||None (Open Label)||||||
1571019|NCT00059761|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571020|NCT00059735|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571021|NCT00043108||||Treatment||None (Open Label)||||||
1571022|NCT00030667||Single Group Assignment||Treatment||None (Open Label)||||||
1571023|NCT00030524||||Treatment||None (Open Label)||||||
1571024|NCT00027599||Single Group Assignment||Treatment||None (Open Label)||||||
1571025|NCT00017134|Randomized|||Prevention||||||||
1571026|NCT00016315|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571027|NCT00006225|Randomized|||Treatment||||||||
1571028|NCT00005793||Single Group Assignment||Treatment||None (Open Label)||||||
1571029|NCT00005065||Single Group Assignment||Treatment||None (Open Label)||||||
1571030|NCT00004127||Single Group Assignment||Treatment||None (Open Label)||||||
1571031|NCT00004095||Single Group Assignment||Treatment||None (Open Label)||||||
1571032|NCT00059748||||||||||||
1571033|NCT00019435||||Treatment||||||||
1571034|NCT00002765||||Treatment||||||||
1571035|NCT00059722|Randomized|Crossover Assignment||Treatment||Double||||||
1571036|NCT00059709|Randomized|Factorial Assignment||Educational/Counseling/Training||None (Open Label)||||||
1571037|NCT00059696|Randomized|Crossover Assignment||Treatment||Single||||||
1571038|NCT00059683|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1571039|NCT00018941||||Treatment||||||||
1571040|NCT00005837||||Treatment||||||||
1571041|NCT00005818||Single Group Assignment||Treatment||None (Open Label)||||||
1571042|NCT00005025||||Treatment||||||||
1571043|NCT00002971||||Treatment||||||||
1571044|NCT00059670|Randomized|||Treatment||||||||
1571045|NCT00059657|Randomized|Parallel Assignment||Treatment||Double||||||
1571046|NCT00059644|Randomized|Parallel Assignment||Treatment||Double||||||
1571047|NCT00003933||||Diagnostic||||||||
1571048|NCT00003926|Non-Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1571049|NCT00003925||||Treatment||||||||
1571050|NCT00003802||||Treatment||||||||
1571051|NCT00003797||||Treatment||||||||
1571052|NCT00059631||Single Group Assignment||Treatment||None (Open Label)||||||
1571053|NCT00059618|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571054|NCT00059605||Single Group Assignment||Treatment||None (Open Label)||||||
1571055|NCT00059592|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571056|NCT00003757||||Treatment||None (Open Label)||||||
1571057|NCT00003649||||Treatment||||||||
1571058|NCT00003627|Randomized|||Treatment||||||||
1571059|NCT00003484||Single Group Assignment||Treatment||None (Open Label)||||||
1571060|NCT00003436|Randomized|||Treatment||||||||
1571061|NCT00059579||||||||||||
1571062|NCT00059553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571063|NCT00059540|||Cohort||Prospective|||||||
1571064|NCT00059527|Randomized|Parallel Assignment||||None (Open Label)||||||
1571065|NCT00059514|||Other||Cross-Sectional|||||||
1571066|NCT00059449|||||Prospective|||||||
1571067|NCT00005836||||Treatment||||||||
1571068|NCT00059501||||||||||||
1571069|NCT00059475|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571070|NCT00059436|Randomized|Parallel Assignment||Treatment||Single||||||
1571071|NCT00059410|||||Prospective|||||||
1573262|NCT00001879||||||||||||
1571072|NCT00059423|||Cohort||Prospective|||||||
1571073|NCT00059397|||||Prospective|||||||
1571074|NCT00003432||Single Group Assignment||Treatment||None (Open Label)||||||
1571075|NCT00003346||||Treatment||||||||
1571076|NCT00003341|Randomized|||Supportive Care||None (Open Label)||||||
1571077|NCT00003324||||Treatment||||||||
1571078|NCT00003311|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571079|NCT00059384|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571080|NCT00059371|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1571081|NCT00059358|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571082|NCT00059345|Randomized|Crossover Assignment||Treatment||Single|||t|||
1571083|NCT00059332|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571084|NCT00059319|Randomized|||Treatment||||||||
1571085|NCT00059306|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571086|NCT00059293||||||||||||
1571087|NCT00058981|Randomized|Parallel Assignment||Treatment||Double||||||
1571088|NCT00059280|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1571089|NCT00059267|||Cohort||Prospective|||||||
1571090|NCT00059254|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1571091|NCT00059241|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1571092|NCT00059215|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571093|NCT00003290|Randomized|||Treatment||||||||
1571094|NCT00003262||||Treatment||||||||
1571095|NCT00003205||||Treatment||||||||
1571096|NCT00003193||Single Group Assignment||Treatment||None (Open Label)||||||
1571097|NCT00003173||||Treatment||||||||
1571098|NCT00059228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571099|NCT00059202|Randomized|Single Group Assignment||Treatment||Double||||||
1571100|NCT00059189||||||||||||
1571101|NCT00005839||||Treatment||||||||
1571102|NCT00004220||||Treatment||||||||
1571103|NCT00059137||||||||||||
1571104|NCT00059124|||Ecologic or Community||Prospective|||||||
1571105|NCT00059111||||||||||||
1571106|NCT00059098||||||||||||
1571107|NCT00004257||||Treatment||||||||
1571108|NCT00004243||||Treatment||||||||
1571109|NCT00003597|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1571110|NCT00003163||||Treatment||||||||
1571111|NCT00003162|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1571112|NCT00003129||||Treatment||||||||
1571113|NCT00003124||||Treatment||||||||
1571114|NCT00003064||||Treatment||||||||
1571115|NCT00002972|Non-Randomized|||Treatment||None (Open Label)||||||
1571116|NCT00059046||||||||||||
1571117|NCT00059033||||||||||||
1571118|NCT00059020||||||||||||
1571119|NCT00058994|Randomized|Parallel Assignment||Treatment||Double||||||
1571120|NCT00058968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571121|NCT00058955|Non-Randomized|Crossover Assignment||Prevention||Quadruple|||t|t|t|t
1571122|NCT00058942|Randomized|Crossover Assignment||Prevention||Double||||||
1571123|NCT00058929|Randomized|Parallel Assignment||Treatment||Double||||||
1571124|NCT00058903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571125|NCT00058890|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571126|NCT00002945||Single Group Assignment||Treatment||None (Open Label)||||||
1571127|NCT00002934||Single Group Assignment||Screening||None (Open Label)||||||
1571128|NCT00002835|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571129|NCT00002822|Randomized|||Treatment||||||||
1571130|NCT00058864|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1571131|NCT00058851|Randomized|Parallel Assignment||Treatment||Single||||||
1571132|NCT00058838|Randomized|Parallel Assignment||Treatment||Double||||||
1571133|NCT00058825||Single Group Assignment||Treatment||None (Open Label)||||||
1571134|NCT00058812||Single Group Assignment||Treatment||None (Open Label)||||||
1571135|NCT00058799|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571136|NCT00058786||Single Group Assignment||Treatment||None (Open Label)||||||
1571137|NCT00058773||Single Group Assignment||Treatment||None (Open Label)||||||
1571138|NCT00058760|Randomized|Parallel Assignment||Prevention||Single||||||
1571139|NCT00058747|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571140|NCT00058734|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571141|NCT00058721||||||||||||
1571142|NCT00058695|||Case-Control||Prospective|||||||
1571143|NCT00058682||||Treatment||||||||
1571144|NCT00058669|||Cohort||Cross-Sectional|||||||
1571145|NCT00002777|Randomized|||Treatment||||||||
1571146|NCT00002701|Randomized|||Treatment||||||||
1571147|NCT00002695||||||||||||
1571148|NCT00002693||||Treatment||||||||
1571149|NCT00002669|Randomized|||Treatment||||||||
1571150|NCT00058656|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571151|NCT00002658|Randomized|||Treatment||||||||
1571152|NCT00002653|Randomized|||Treatment||||||||
1571153|NCT00002575|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571154|NCT00002550|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571155|NCT00002539|Randomized|||Treatment||||||||
1571156|NCT00058617||Single Group Assignment||Treatment||None (Open Label)||||||
1571157|NCT00058604|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571158|NCT00058591|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571159|NCT00058578|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573263|NCT00001871||||||||||||
1571160|NCT00058552||||Treatment||None (Open Label)||||||
1571161|NCT00058539|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571162|NCT00058526|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571163|NCT00058487||||Treatment||None (Open Label)||||||
1571164|NCT00058474|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571165|NCT00058461||Single Group Assignment||Treatment||None (Open Label)||||||
1571166|NCT00058448||Single Group Assignment||Treatment||None (Open Label)||||||
1571167|NCT00058435|Randomized|||Treatment||None (Open Label)||||||
1571168|NCT00058422||Single Group Assignment||Treatment||None (Open Label)||||||
1571169|NCT00058396||||Treatment||None (Open Label)||||||
1571170|NCT00058370||Single Group Assignment||Treatment||None (Open Label)||||||
1571171|NCT00058357|Randomized|Crossover Assignment||Supportive Care||Triple|||t|t|t|
1571172|NCT00058331|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1571173|NCT00058318||Single Group Assignment||Treatment||None (Open Label)||||||
1571174|NCT00058305||Single Group Assignment||Treatment||None (Open Label)||||||
1571175|NCT00058292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571176|NCT00058279||||Treatment||None (Open Label)||||||
1571177|NCT00058266|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571178|NCT00058253|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571179|NCT00058240||Single Group Assignment||Treatment||None (Open Label)||||||
1571180|NCT00058227||Single Group Assignment||Treatment||None (Open Label)||||||
1571181|NCT00058214||Single Group Assignment||Treatment||None (Open Label)||||||
1571182|NCT00058201|Randomized|||Treatment||||||||
1571183|NCT00058188|Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1571184|NCT00058149|Randomized|||Treatment||||||||
1571185|NCT00058123||Single Group Assignment||Treatment||None (Open Label)||||||
1571186|NCT00058097||Single Group Assignment||Treatment||None (Open Label)||||||
1571187|NCT00058084|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571188|NCT00058071|Randomized|||Supportive Care||||||||
1571189|NCT00058058||Single Group Assignment||Diagnostic||None (Open Label)||||||
1571190|NCT00058045||||Treatment||||||||
1571191|NCT00058032|Randomized|||Screening||||||||
1571192|NCT00058019||Single Group Assignment||Treatment||None (Open Label)||||||
1571193|NCT00058006|Randomized|||Treatment||Double||||||
1571194|NCT00057993||||Treatment||None (Open Label)||||||
1571195|NCT00057980||||Treatment||||||||
1571196|NCT00057967||Single Group Assignment||Treatment||None (Open Label)||||||
1571197|NCT00057954||Single Group Assignment||Treatment||None (Open Label)||||||
1571198|NCT00057941|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571199|NCT00057928|Randomized|||Treatment||||||||
1571200|NCT00057915||Single Group Assignment||Treatment||None (Open Label)||||||
1571201|NCT00057889||||Treatment||None (Open Label)||||||
1571202|NCT00057876|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571203|NCT00057863||Single Group Assignment||Treatment||None (Open Label)||||||
1571204|NCT00057850||Single Group Assignment||Treatment||None (Open Label)||||||
1571205|NCT00057837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571206|NCT00057811|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571207|NCT00057798||Single Group Assignment||Treatment||||||||
1571208|NCT00057785||Single Group Assignment||Treatment||None (Open Label)||||||
1571209|NCT00057759|Randomized|Crossover Assignment||Supportive Care||Quadruple|||t|t|t|t
1571210|NCT00057746|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571211|NCT00057733|Randomized|||||||||||
1571212|NCT00030368||Single Group Assignment||Treatment||None (Open Label)||||||
1571213|NCT00023673|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571214|NCT00004079||Single Group Assignment||Treatment||None (Open Label)||||||
1571215|NCT00057720|Randomized|||Treatment||None (Open Label)||||||
1571216|NCT00057707|Randomized|Crossover Assignment||Other||||||||
1571217|NCT00057694||||||||||||
1571218|NCT00057681|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571219|NCT00057668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571220|NCT00057655|||||Retrospective|||||||
1571221|NCT00057642||Single Group Assignment||Treatment||None (Open Label)||||||
1571222|NCT00057629|Randomized|Parallel Assignment||Treatment||Single||||||t
1571223|NCT00057616|Randomized|Parallel Assignment||Prevention||Double||||||
1571224|NCT00057603|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571225|NCT00057590|Randomized|Parallel Assignment||Treatment||||||||
1571226|NCT00057577|Randomized|Parallel Assignment||Prevention||Single||||||t
1571227|NCT00057564|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571228|NCT00057551|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571229|NCT00057538|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1571230|NCT00057525|Randomized|Single Group Assignment||Prevention||Double|||t||t|
1571231|NCT00057512||Single Group Assignment||Treatment||None (Open Label)||||||
1571232|NCT00057499|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571233|NCT00057486|Randomized|Parallel Assignment||Treatment||Double||||||
1571234|NCT00057473|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571235|NCT00057447|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571236|NCT00057434|Randomized|Parallel Assignment||Treatment||Double||||||
1571237|NCT00057421|Randomized|Parallel Assignment||Treatment||Double||||||
1571238|NCT00057460||||Treatment||||||||
1571239|NCT00057408|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571240|NCT00057395|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571241|NCT00057382|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571242|NCT00057369|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571243|NCT00057356|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571244|NCT00057343|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571245|NCT00057330|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1571246|NCT00057317|Randomized|||Treatment||Double||||||
1571247|NCT00057304||||Treatment||||||||
1571248|NCT00057291||Single Group Assignment||Basic Science||None (Open Label)||||||
1571249|NCT00057031|Non-Randomized|||Treatment||None (Open Label)||||||
1571250|NCT00057278|Randomized|Parallel Assignment||Treatment||Double||||||
1571251|NCT00057265|Randomized|Parallel Assignment||Treatment||Double||||||
1571252|NCT00057200|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571253|NCT00057187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571254|NCT00057252|||Other||Other|||||||
1571255|NCT00057239|Randomized|Parallel Assignment||Treatment||Double||||||
1571256|NCT00057226|Randomized|Parallel Assignment||Treatment||Double||||||
1571257|NCT00057213|Randomized|Parallel Assignment||Treatment||Double||||||
1571258|NCT00057174|Randomized|Single Group Assignment||Treatment||Single||||||
1571259|NCT00057161|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571260|NCT00057148|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571261|NCT00057135|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571262|NCT00057122|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1571263|NCT00057109|||||Prospective|||||||
1571264|NCT00057096|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571265|NCT00057083|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571266|NCT00057070|Randomized|Single Group Assignment||||Single||||||
1571267|NCT00057057|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571268|NCT00057044|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571269|NCT00057018|Randomized|Crossover Assignment||Treatment||Single||||||
1571270|NCT00057005|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571271|NCT00056992|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571272|NCT00056979||Single Group Assignment||Treatment||None (Open Label)||||||
1571273|NCT00056966|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571274|NCT00056953|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1571275|NCT00056940|Randomized|Parallel Assignment||Diagnostic||Single||||||
1571276|NCT00056927|Randomized|Parallel Assignment||Educational/Counseling/Training||Single||||||
1571277|NCT00056875|Non-Randomized|||Prevention||None (Open Label)||||||
1571278|NCT00056914||||||||||||
1571279|NCT00056901||||||||||||
1571280|NCT00056888||||||||||||
1571281|NCT00056836|Randomized|||Treatment||Double||||||
1571282|NCT00056823|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1571283|NCT00056862|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571284|NCT00056849||||||||||||
1571285|NCT00056810|Randomized|Crossover Assignment||||Double||||||
1571286|NCT00056797|Randomized|Factorial Assignment||Treatment||Single||||||
1571287|NCT00056784||||||||||||
1571288|NCT00056771|||Cohort||Prospective|||||||
1571289|NCT00056758|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571290|NCT00056745|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1571291|NCT00056693|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571292|NCT00056680|Randomized|Factorial Assignment||Prevention||Single||||||
1571293|NCT00056667|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571294|NCT00056654|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571295|NCT00056641|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571296|NCT00056719|||Cohort||Prospective|||||||
1571297|NCT00056706||||||||||||
1571298|NCT00056628|Randomized|Single Group Assignment||Treatment||Double||||||
1571299|NCT00056589|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571300|NCT00056602||||||||||||
1571301|NCT00056576|Randomized|Single Group Assignment||Treatment||Double||||||
1571302|NCT00056563|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1571303|NCT00056550||Single Group Assignment||Prevention||None (Open Label)||||||
1571304|NCT00056537||Single Group Assignment||Treatment||None (Open Label)||||||
1571305|NCT00056524|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571306|NCT00056511|Randomized|Parallel Assignment||Treatment||Double||||||
1571307|NCT00056498|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571308|NCT00056485|Randomized|Parallel Assignment||Other||None (Open Label)||This was a pilot feasibility study; the first part was a single group; the second part was a two-group randomized design.||||
1571309|NCT00056472|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571310|NCT00012454||||Treatment||||||||
1571311|NCT00056459|Randomized|Parallel Assignment||Treatment||Double||||||
1571312|NCT00056446|Randomized|Parallel Assignment||Treatment||Double||||||
1571313|NCT00056433||||Treatment||||||||
1571314|NCT00056420||||||||||||
1571315|NCT00056407|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1571316|NCT00056394|Randomized|Factorial Assignment||Other||Single||||||t
1571317|NCT00056381|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571318|NCT00056368|Randomized|Single Group Assignment||Treatment||Double||||||
1571319|NCT00056329|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571320|NCT00056355||||Treatment||||||||
1571321|NCT00056316|Randomized|Parallel Assignment||Treatment||Single||||||t
1571322|NCT00056303|Randomized|Parallel Assignment||Prevention||Triple|||t|t||t
1571323|NCT00056290|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1571324|NCT00056277|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571325|NCT00056264|Randomized|Parallel Assignment||Treatment||Double||||||
1571326|NCT00056251|Randomized|Parallel Assignment||Treatment||Double||||||
1571327|NCT00056238|Randomized|Parallel Assignment||Treatment||Double||||||
1571328|NCT00056225|Randomized|Parallel Assignment||Treatment||Double||||||
1571329|NCT00056212|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571330|NCT00056173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571331|NCT00056199||||Treatment||||||||
1571332|NCT00056186||||||||||||
1571333|NCT00056160|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571334|NCT00056147|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571335|NCT00056134||Single Group Assignment||Treatment||None (Open Label)||||||
1571336|NCT00056095|Non-Randomized|||Treatment||||||||
1571337|NCT00056082||Single Group Assignment||Prevention||None (Open Label)||||||
1571338|NCT00056069||Single Group Assignment||Treatment||None (Open Label)||||||
1571339|NCT00056056|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571340|NCT00056030||Single Group Assignment||Treatment||None (Open Label)||||||
1571341|NCT00056004|Randomized|||Prevention||Double||||||
1571342|NCT00055991|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1571343|NCT00055978|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1571344|NCT00055965|Randomized|||Treatment||||||||
1571345|NCT00055952||||Treatment||None (Open Label)||||||
1571346|NCT00055939|Non-Randomized|||Treatment||None (Open Label)||||||
1571347|NCT00055926||||Treatment||None (Open Label)||||||
1571348|NCT00055913|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571349|NCT00055887|Randomized|||Treatment||None (Open Label)||||||
1571350|NCT00055874|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571351|NCT00055861||Single Group Assignment||Treatment||None (Open Label)||||||
1571352|NCT00055848|||Case-Only||Prospective|||||||
1571353|NCT00055835||Single Group Assignment||Treatment||None (Open Label)||||||
1571354|NCT00055822||Single Group Assignment||Treatment||None (Open Label)||||||
1571355|NCT00055809|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571356|NCT00055783||||Treatment||None (Open Label)||||||
1571357|NCT00055770||Single Group Assignment||Treatment||None (Open Label)||||||
1571358|NCT00055757||Single Group Assignment||Treatment||None (Open Label)||||||
1571359|NCT00055731|Randomized|||Treatment||||||||
1571360|NCT00055718|Randomized|||Supportive Care||Double||||||
1571361|NCT00055705||||Treatment||None (Open Label)||||||
1571362|NCT00055692||Single Group Assignment||Treatment||None (Open Label)||||||
1571363|NCT00055679|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571364|NCT00055666|Non-Randomized|||Supportive Care||None (Open Label)||||||
1571365|NCT00055653||||Treatment||None (Open Label)||||||
1571366|NCT00055640||Single Group Assignment||Treatment||None (Open Label)||||||
1571367|NCT00055614||||Treatment||||||||
1571368|NCT00055601|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571369|NCT00022139||Single Group Assignment||Treatment||None (Open Label)||||||
1571370|NCT00005028||Single Group Assignment||Treatment||None (Open Label)||||||
1571371|NCT00055588||||Treatment||||||||
1571372|NCT00055575||||Treatment||||||||
1571373|NCT00055562|Randomized|Parallel Assignment||Treatment||Double||||||
1571374|NCT00055536|Randomized|Parallel Assignment||Treatment||Double||||||
1571375|NCT00055523|Randomized|Single Group Assignment||Treatment||Double||||||
1571376|NCT00055549||||Treatment||||||||
1571377|NCT00055510||||Treatment||||||||
1571378|NCT00055497|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571379|NCT00055484|Randomized|Parallel Assignment||Prevention||Double||||||
1571380|NCT00055471||||Treatment||||||||
1571381|NCT00055445|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571382|NCT00055432|Non-Randomized|||Treatment||None (Open Label)||||||
1571383|NCT00055419||Single Group Assignment||Treatment||None (Open Label)||||||
1571384|NCT00055393|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571385|NCT00055380||||Treatment||||||||
1571386|NCT00055367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571387|NCT00055354|Randomized|Parallel Assignment||Treatment||Single||||||
1571388|NCT00055341|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571389|NCT00055328|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571390|NCT00055315|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571391|NCT00055302|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571392|NCT00055263|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571393|NCT00055289||||||||||||
1571394|NCT00055250|Randomized|Parallel Assignment||Treatment||Double||||||
1571395|NCT00055237|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571396|NCT00055224||||||||||||
1571397|NCT00055198|Non-Randomized|||Treatment||None (Open Label)||||||
1571398|NCT00055185|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571399|NCT00055146|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571400|NCT00055133|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571401|NCT00055172||||||||||||
1571402|NCT00055159||||Treatment||||||||
1571403|NCT00055120|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1571404|NCT00055107|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571405|NCT00055094|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1571406|NCT00055081|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571407|NCT00055068|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571408|NCT00055055|||Case-Control||Prospective|||||||
1571409|NCT00055042||||Treatment||||||||
1571410|NCT00055029|||Family-Based||Prospective|||||||
1571411|NCT00055016||||||||||||
1571412|NCT00055003||||||||||||
1571413|NCT00054990||||||||||||
1571414|NCT00054977||Single Group Assignment||Treatment||None (Open Label)||||||
1571415|NCT00054964|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1571416|NCT00054951|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571417|NCT00054938|Randomized|Factorial Assignment||Treatment||Double||||||
1571418|NCT00054925|Randomized|Parallel Assignment||Prevention||Single||||||t
1571419|NCT00054912|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571420|NCT00054899|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571421|NCT00054886|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571422|NCT00054873||||Treatment||||||||
1571423|NCT00054860|Randomized|Parallel Assignment||Prevention||Double||||||
1571424|NCT00054847|Randomized|Parallel Assignment||Treatment||Single||||||t
1571425|NCT00054834|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571426|NCT00054821|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1571427|NCT00054808|Non-Randomized|||Treatment||None (Open Label)||||||
1571428|NCT00054795|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571429|NCT00054769|||||Prospective|||||||
1571430|NCT00054730|Randomized|Parallel Assignment||Treatment||Double||||||
1571431|NCT00054756||Single Group Assignment||Diagnostic||None (Open Label)||||||
1571432|NCT00054743||||Treatment||||||||
1571433|NCT00054717||Parallel Assignment||Treatment||||||||
1571434|NCT00054704|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1571435|NCT00054691||Single Group Assignment||Treatment||None (Open Label)||||||
1571436|NCT00054678|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571437|NCT00050531|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1571438|NCT00054665|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571439|NCT00054652||||||||||||
1571440|NCT00054639||Single Group Assignment||Treatment||None (Open Label)||||||
1571441|NCT00054626|Randomized|||Treatment||||||||
1571442|NCT00054613|Randomized|Parallel Assignment||Treatment||Single||||||
1571443|NCT00054600|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1571444|NCT00054587|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571445|NCT00054574||||Treatment||None (Open Label)||||||
1571446|NCT00054561|Randomized|||Treatment||||||||
1571447|NCT00054548||Single Group Assignment||Treatment||None (Open Label)||||||
1571448|NCT00054535||||Treatment||None (Open Label)||||||
1571449|NCT00054522||Single Group Assignment||Treatment||None (Open Label)||||||
1571450|NCT00054496||||Treatment||None (Open Label)||||||
1571451|NCT00054483||Single Group Assignment||Basic Science||None (Open Label)||||||
1571452|NCT00054470||Single Group Assignment||Treatment||None (Open Label)||||||
1571453|NCT00054457||Single Group Assignment||Treatment||None (Open Label)||||||
1571454|NCT00054444||Single Group Assignment||Treatment||None (Open Label)||||||
1571455|NCT00054431||Single Group Assignment||Treatment||None (Open Label)||||||
1571456|NCT00054418|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1571457|NCT00054405||Single Group Assignment||Treatment||None (Open Label)||||||
1571458|NCT00054392|Randomized|||Treatment||||||||
1571459|NCT00054353|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571460|NCT00054340||||Supportive Care||None (Open Label)||||||
1571461|NCT00054327|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571462|NCT00054314||||Treatment||None (Open Label)||||||
1571463|NCT00054301||Single Group Assignment||Treatment||None (Open Label)||||||
1571464|NCT00054288|Non-Randomized|||Treatment||None (Open Label)||||||
1571465|NCT00054275||Single Group Assignment||Treatment||None (Open Label)||||||
1571466|NCT00054262||||Treatment||None (Open Label)||||||
1571467|NCT00054249||||Treatment||None (Open Label)||||||
1571468|NCT00054236||Single Group Assignment||Treatment||None (Open Label)||||||
1571469|NCT00054223||||||None (Open Label)||||||
1571470|NCT00054210|Randomized|||Treatment||None (Open Label)||||||
1571471|NCT00054197|Randomized|||Treatment||None (Open Label)||||||
1571472|NCT00054184|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571473|NCT00054171|Randomized|||Treatment||||||||
1571474|NCT00054158||||Treatment||None (Open Label)||||||
1571475|NCT00054145||||Treatment||None (Open Label)||||||
1571476|NCT00054132||Single Group Assignment||Treatment||None (Open Label)||||||
1571477|NCT00054119||Single Group Assignment||Treatment||None (Open Label)||||||
1571478|NCT00054106||||Treatment||None (Open Label)||||||
1571479|NCT00054067|Randomized|||Treatment||||||||
1571480|NCT00054054||||Treatment||||||||
1571481|NCT00054041|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571482|NCT00054028||Single Group Assignment||Treatment||None (Open Label)||||||
1571483|NCT00054015||||Treatment||None (Open Label)||||||
1571484|NCT00054002||Single Group Assignment||Treatment||None (Open Label)||||||
1571485|NCT00053989||Single Group Assignment||Treatment||None (Open Label)||||||
1571486|NCT00053976|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571487|NCT00053963||Single Group Assignment||Treatment||None (Open Label)||||||
1571488|NCT00053950|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571489|NCT00053937||||Prevention||None (Open Label)||||||
1571490|NCT00053924||||Treatment||None (Open Label)||||||
1571491|NCT00053911|Randomized|||Treatment||||||||
1571492|NCT00053898|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571493|NCT00053885||Single Group Assignment||Treatment||None (Open Label)||||||
1571494|NCT00053872|Randomized|||Treatment||||||||
1571495|NCT00053846|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1571496|NCT00053833||Single Group Assignment||Treatment||None (Open Label)||||||
1571497|NCT00053820|Randomized|||Treatment||None (Open Label)||||||
1571498|NCT00053807|Randomized|||Treatment||||||||
1571499|NCT00053794||||Treatment||None (Open Label)||||||
1571500|NCT00053781||||Treatment||None (Open Label)||||||
1571501|NCT00053768|Randomized|||Treatment||None (Open Label)||||||
1571502|NCT00053716|Non-Randomized|||Treatment||None (Open Label)||||||
1571503|NCT00045123|Randomized|||Treatment||Double||||||
1571504|NCT00028678||||Treatment||||||||
1571505|NCT00017342||||Treatment||None (Open Label)||||||
1571506|NCT00053742||||Treatment||||||||
1571507|NCT00053703|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571508|NCT00053690|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571509|NCT00053677|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1571510|NCT00053651|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1571511|NCT00053638|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571512|NCT00053625|Non-Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571513|NCT00053612|Randomized|Parallel Assignment||Prevention||Double||||||
1571514|NCT00053599|Randomized|Parallel Assignment||Treatment||Double||||||
1571515|NCT00053573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571516|NCT00053560|Randomized|Parallel Assignment||Prevention||Double||||||
1571517|NCT00053547|Randomized|Single Group Assignment||Treatment||Double||||||
1571518|NCT00053534||||||||||||
1571519|NCT00053521||||||||||||
1571520|NCT00053508|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1571521|NCT00053495|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1571522|NCT00053482|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1571523|NCT00053469||||||||||||
1571524|NCT00053456||||||||||||
1571525|NCT00053443|Randomized|||Treatment||||||||
1571526|NCT00053430|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1571527|NCT00053417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571528|NCT00053404|||Cohort||Prospective|||||||
1571529|NCT00053391|Non-Randomized|||Treatment||None (Open Label)||||||
1571530|NCT00053378|Randomized|Factorial Assignment||Treatment||Double||||||
1571531|NCT00053365||Single Group Assignment||Treatment||None (Open Label)||||||
1571532|NCT00053352|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571533|NCT00053339|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571534|NCT00053326||Single Group Assignment||Treatment||None (Open Label)||||||
1571535|NCT00053300||Single Group Assignment||Treatment||None (Open Label)||||||
1571536|NCT00053287||Single Group Assignment||Treatment||None (Open Label)||||||
1571537|NCT00053261||||||||||||
1571538|NCT00053248||||Treatment||None (Open Label)||||||
1571539|NCT00053235||||||||||||
1571540|NCT00053222||Single Group Assignment||Treatment||None (Open Label)||||||
1571541|NCT00053209||Single Group Assignment||Treatment||None (Open Label)||||||
1571542|NCT00053196|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571543|NCT00053183||||Treatment||||||||
1571544|NCT00053157||||Supportive Care||||||||
1571545|NCT00053144||||Treatment||||||||
1571546|NCT00053131|Randomized|||Treatment||||||||
1571547|NCT00053118||Single Group Assignment||Treatment||None (Open Label)||||||
1571548|NCT00053105||||Treatment||||||||
1571549|NCT00053092|Randomized|||Treatment||None (Open Label)||||||
1571550|NCT00053053|Randomized|Parallel Assignment||Supportive Care||Quadruple|||t|t|t|t
1571551|NCT00053040||Single Group Assignment||Treatment||None (Open Label)||||||
1571552|NCT00053027||Single Group Assignment||Treatment||None (Open Label)||||||
1571553|NCT00053014||Single Group Assignment||Treatment||None (Open Label)||||||
1571554|NCT00053001||||Supportive Care||None (Open Label)||||||
1571555|NCT00041275|Randomized|||Treatment||Double||||||
1571556|NCT00004078||Single Group Assignment||Treatment||None (Open Label)||||||
1571557|NCT00003830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571558|NCT00052962|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571559|NCT00052949||Single Group Assignment||Treatment||None (Open Label)||||||
1571560|NCT00052936|Randomized|||Treatment||None (Open Label)||||||
1571561|NCT00052923|Randomized|||Treatment||||||||
1571562|NCT00052910|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571563|NCT00052897||Single Group Assignment||Prevention||None (Open Label)||||||
1571564|NCT00052884|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571565|NCT00052845|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571566|NCT00052832||||Treatment||None (Open Label)||||||
1573264|NCT00001867||||||||||||
1571567|NCT00052780||Single Group Assignment||Treatment||None (Open Label)||||||
1571568|NCT00052754||||Treatment||None (Open Label)||||||
1571569|NCT00052728||||Treatment||None (Open Label)||||||
1571570|NCT00052715||Single Group Assignment||Treatment||None (Open Label)||||||
1571571|NCT00052689|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1571572|NCT00052676|Randomized|||Diagnostic||||||||
1571573|NCT00052637|Non-Randomized|||Diagnostic||None (Open Label)||||||
1571574|NCT00052624||||Treatment||None (Open Label)||||||
1571575|NCT00052611||Single Group Assignment||Treatment||None (Open Label)||||||
1571576|NCT00052598||Single Group Assignment||Treatment||None (Open Label)||||||
1571577|NCT00052585||Single Group Assignment||Treatment||None (Open Label)||||||
1571578|NCT00052572||||Treatment||None (Open Label)||||||
1571579|NCT00052559||Single Group Assignment||Treatment||None (Open Label)||||||
1571580|NCT00052520||Single Group Assignment||Treatment||None (Open Label)||||||
1571581|NCT00052507||||Treatment||None (Open Label)||||||
1571582|NCT00052494||Single Group Assignment||Treatment||None (Open Label)||||||
1571583|NCT00052481|||Case-Only||Prospective|||||||
1571584|NCT00052468|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1571585|NCT00052455|Randomized|||Treatment||None (Open Label)||||||
1571586|NCT00052442||||Treatment||None (Open Label)||||||
1571587|NCT00052429||Single Group Assignment||Treatment||None (Open Label)||||||
1571588|NCT00052416||||Treatment||None (Open Label)||||||
1571589|NCT00052403||||Treatment||None (Open Label)||||||
1571590|NCT00052390||||Treatment||None (Open Label)||||||
1571591|NCT00052377||Single Group Assignment||Treatment||None (Open Label)||||||
1571592|NCT00052364||Single Group Assignment||Treatment||None (Open Label)||||||
1571593|NCT00052351|Randomized|||Treatment||||||||
1571594|NCT00052338||Single Group Assignment||Treatment||None (Open Label)||||||
1571595|NCT00052325||||Treatment||None (Open Label)||||||
1571596|NCT00052312|Randomized|||Treatment||None (Open Label)||||||
1571597|NCT00052299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571598|NCT00052286|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1571599|NCT00052273||||Treatment||||||||
1571600|NCT00052221|Randomized|Single Group Assignment||Supportive Care||Triple|||t|t|t|
1571601|NCT00052208||Single Group Assignment||Treatment||None (Open Label)||||||
1571602|NCT00052195|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1571603|NCT00052182|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1571604|NCT00052169|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571605|NCT00049712||||Treatment||||||||
1571606|NCT00049699||||Treatment||||||||
1571607|NCT00049686||||Treatment||None (Open Label)||||||
1571608|NCT00049673|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571609|NCT00049660|Randomized|||Treatment||||||||
1571610|NCT00049634||||Treatment||None (Open Label)||||||
1571611|NCT00049608||||Treatment||None (Open Label)||||||
1571612|NCT00049595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571613|NCT00049582||Single Group Assignment||Treatment||None (Open Label)||||||
1571614|NCT00049569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571615|NCT00049556||||Treatment||||||||
1571616|NCT00049543|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571617|NCT00049530||Single Group Assignment||Treatment||None (Open Label)||||||
1571618|NCT00049517|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571619|NCT00049504||Single Group Assignment||Treatment||None (Open Label)||||||
1571620|NCT00049465|Randomized|||Supportive Care||||||||
1571621|NCT00049452|Randomized|||Supportive Care||Double||||||
1571622|NCT00049439||Single Group Assignment||Treatment||None (Open Label)||||||
1571623|NCT00049413||||Treatment||None (Open Label)||||||
1571624|NCT00049400||Single Group Assignment||Treatment||None (Open Label)||||||
1571625|NCT00049387||Single Group Assignment||Treatment||None (Open Label)||||||
1571626|NCT00049374||||Treatment||None (Open Label)||||||
1571627|NCT00049361||||Treatment||None (Open Label)||||||
1571628|NCT00049348|Randomized|||Treatment||||||||
1571629|NCT00049335||Single Group Assignment||Treatment||None (Open Label)||||||
1571630|NCT00049322|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1571631|NCT00049309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571632|NCT00049296||Single Group Assignment||Treatment||None (Open Label)||||||
1571633|NCT00049283||Single Group Assignment||Treatment||None (Open Label)||||||
1571634|NCT00049257||Single Group Assignment||Treatment||None (Open Label)||||||
1571635|NCT00049244||||Treatment||||||||
1571636|NCT00049231||||Diagnostic||None (Open Label)||||||
1571637|NCT00049218||Single Group Assignment||Treatment||None (Open Label)||||||
1571638|NCT00049192||Single Group Assignment||Treatment||None (Open Label)||||||
1571639|NCT00049179|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571640|NCT00049166|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571641|NCT00049140||Single Group Assignment||Diagnostic||None (Open Label)||||||
1571642|NCT00049127|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571643|NCT00049114||Single Group Assignment||Treatment||None (Open Label)||||||
1571644|NCT00049101||||Treatment||None (Open Label)||||||
1571645|NCT00049088||Single Group Assignment||Treatment||None (Open Label)||||||
1571646|NCT00049075||||Treatment||None (Open Label)||||||
1571647|NCT00049062||||Treatment||None (Open Label)||||||
1571648|NCT00049036|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573265|NCT00001857||||Treatment||||||||
1571649|NCT00049023||Single Group Assignment||Treatment||None (Open Label)||||||
1571650|NCT00049010|Non-Randomized|||Diagnostic||||||||
1571651|NCT00048997|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571652|NCT00048984|||||Prospective|||||||
1571653|NCT00048971|||Case-Only||Prospective|||||||
1571654|NCT00048958|||Other||Prospective|||||||
1571655|NCT00047385|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1571656|NCT00047346||Single Group Assignment||Treatment||None (Open Label)||||||
1571657|NCT00047333||Single Group Assignment||Treatment||None (Open Label)||||||
1571658|NCT00047320||Single Group Assignment||Treatment||None (Open Label)||||||
1571659|NCT00047307||Single Group Assignment||Treatment||None (Open Label)||||||
1571660|NCT00047294||||Treatment||None (Open Label)||||||
1571661|NCT00047281||||Treatment||None (Open Label)||||||
1571662|NCT00047268||||Diagnostic||None (Open Label)||||||
1571663|NCT00047255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571664|NCT00047242||||Treatment||||||||
1571665|NCT00047229||Single Group Assignment||Treatment||None (Open Label)||||||
1571666|NCT00047216||||Treatment||None (Open Label)||||||
1571667|NCT00047203||Single Group Assignment||Treatment||None (Open Label)||||||
1571668|NCT00047190||Single Group Assignment||Treatment||None (Open Label)||||||
1571669|NCT00047177||||Treatment||None (Open Label)||||||
1571670|NCT00047164||||Treatment||None (Open Label)||||||
1571671|NCT00047138|Randomized|||Treatment||||||||
1571672|NCT00047125|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571673|NCT00047112|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571674|NCT00047099|Randomized|||Treatment||None (Open Label)||||||
1571675|NCT00047073|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571676|NCT00047060|Non-Randomized|||Treatment||None (Open Label)||||||
1571677|NCT00047047||Single Group Assignment||Treatment||None (Open Label)||||||
1571678|NCT00047034||Single Group Assignment||Treatment||None (Open Label)||||||
1571679|NCT00047021||Single Group Assignment||Treatment||None (Open Label)||||||
1571680|NCT00047008|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571681|NCT00046995|Randomized|||Treatment||||||||
1571682|NCT00046969|Randomized|||Supportive Care||None (Open Label)||||||
1571683|NCT00046943||||Treatment||None (Open Label)||||||
1571684|NCT00046930|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1571685|NCT00046917||Single Group Assignment||Treatment||None (Open Label)||||||
1571686|NCT00046904|Randomized|||Supportive Care||Double||||||
1571687|NCT00046891|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1571688|NCT00046865|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1571689|NCT00046852|Randomized|||Treatment||||||||
1571690|NCT00046839|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571691|NCT00046826||||Treatment||None (Open Label)||||||
1571692|NCT00045747||||Treatment||None (Open Label)||||||
1571693|NCT00045734||Single Group Assignment||Treatment||None (Open Label)||||||
1571694|NCT00045721||||Treatment||||||||
1571695|NCT00045708|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571696|NCT00045695|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571697|NCT00045682||Single Group Assignment||Treatment||None (Open Label)||||||
1571698|NCT00045669||||Treatment||None (Open Label)||||||
1571699|NCT00045630||Single Group Assignment||Treatment||None (Open Label)||||||
1571700|NCT00045617||Single Group Assignment||Treatment||None (Open Label)||||||
1571701|NCT00045604||||Treatment||||||||
1571702|NCT00045591|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1571703|NCT00045565|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571704|NCT00045539||||Treatment||None (Open Label)||||||
1571705|NCT00045526|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571706|NCT00045513||||Treatment||||||||
1571707|NCT00045500||||Treatment||||||||
1571708|NCT00045487||Single Group Assignment||Treatment||None (Open Label)||||||
1571709|NCT00045474||||Treatment||||||||
1571710|NCT00045461|Randomized|||Treatment||None (Open Label)||||||
1571711|NCT00045448||||Treatment||||||||
1571712|NCT00045435||Single Group Assignment||Treatment||None (Open Label)||||||
1571713|NCT00045422||||Treatment||None (Open Label)||||||
1571714|NCT00045396||Single Group Assignment||Treatment||None (Open Label)||||||
1571715|NCT00045370||||Treatment||||||||
1571716|NCT00045331||||Diagnostic||||||||
1571717|NCT00045318||||Treatment||||||||
1571718|NCT00045305||Single Group Assignment||Treatment||None (Open Label)||||||
1571719|NCT00045292|Randomized|||Supportive Care||Double||||||
1571720|NCT00045279||||Treatment||None (Open Label)||||||
1571721|NCT00045266||||Treatment||None (Open Label)||||||
1571722|NCT00045227|Randomized|||Treatment||||||||
1571723|NCT00045201||Single Group Assignment||Treatment||None (Open Label)||||||
1571724|NCT00045188||Single Group Assignment||Treatment||None (Open Label)||||||
1571725|NCT00045175||Single Group Assignment||Treatment||None (Open Label)||||||
1571726|NCT00045162|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571727|NCT00045136||||Treatment||||||||
1571728|NCT00045110|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571729|NCT00045097||||Treatment||None (Open Label)||||||
1571730|NCT00045045|Non-Randomized|||Diagnostic||||||||
1571731|NCT00045032|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571732|NCT00045019|||Case-Only||Prospective|||||||
1571733|NCT00045006||||Treatment||||||||
1571734|NCT00044993||||Treatment||None (Open Label)||||||
1571735|NCT00044980|Randomized|||Other||||||||
1571736|NCT00044967|||Case-Only||Prospective|||||||
1571737|NCT00044954||||Treatment||None (Open Label)||||||
1571738|NCT00043147|Randomized|||Supportive Care||Double||||||
1571739|NCT00043134|Randomized|||Treatment||None (Open Label)||||||
1571740|NCT00043121||Single Group Assignment||Treatment||None (Open Label)||||||
1571741|NCT00043095||||Treatment||||||||
1571742|NCT00043082|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571743|NCT00043069|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1571744|NCT00043043|Randomized|||Prevention||Double||||||
1571745|NCT00043030||||||||||||
1571746|NCT00043017||Single Group Assignment||Diagnostic||None (Open Label)||||||
1571747|NCT00043004|Randomized|||Treatment||None (Open Label)||||||
1571748|NCT00042991||Single Group Assignment||Treatment||None (Open Label)||||||
1571749|NCT00042978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571750|NCT00042965||Single Group Assignment||Treatment||None (Open Label)||||||
1571751|NCT00042952||Single Group Assignment||Treatment||None (Open Label)||||||
1571752|NCT00042939|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571753|NCT00042926||Single Group Assignment||Diagnostic||None (Open Label)||||||
1571754|NCT00042913|Randomized|||Treatment||||||||
1571755|NCT00042887|Randomized|||Treatment||||||||
1571756|NCT00042874||Single Group Assignment||Treatment||None (Open Label)||||||
1571757|NCT00042861||||Treatment||||||||
1571758|NCT00042848|Randomized|||Supportive Care||Double||||||
1571759|NCT00042835|Non-Randomized|Parallel Assignment||Treatment||Single|||||t|
1571760|NCT00042822||||Treatment||||||||
1571761|NCT00042809||Single Group Assignment||Treatment||None (Open Label)||||||
1571762|NCT00042796||Single Group Assignment||Treatment||None (Open Label)||||||
1571763|NCT00042783||||Treatment||None (Open Label)||||||
1571764|NCT00042770|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571765|NCT00042731|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1571766|NCT00041379||||Treatment||||||||
1571767|NCT00041340||Single Group Assignment||Treatment||None (Open Label)||||||
1571768|NCT00041327||Single Group Assignment||Treatment||None (Open Label)||||||
1571769|NCT00041314||||Treatment||||||||
1571770|NCT00041301|||Case-Only||Prospective|||||||
1571771|NCT00041288|Randomized|||Treatment||||||||
1571772|NCT00041262|Randomized|||Treatment||||||||
1571773|NCT00041249||||Treatment||||||||
1571774|NCT00041236||||Treatment||None (Open Label)||||||
1571775|NCT00041223|Randomized|||Supportive Care||Double||||||
1571776|NCT00041210|Randomized|||Treatment||||||||
1571777|NCT00041197|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571778|NCT00041171|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571779|NCT00041132||Single Group Assignment||Treatment||None (Open Label)||||||
1571780|NCT00041119|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1571781|NCT00041106||Single Group Assignment||Treatment||None (Open Label)||||||
1571782|NCT00041093||Single Group Assignment||Treatment||None (Open Label)||||||
1571783|NCT00041080|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571784|NCT00041067||Single Group Assignment||Treatment||None (Open Label)||||||
1571785|NCT00041054||Single Group Assignment||Treatment||None (Open Label)||||||
1571786|NCT00041041||Single Group Assignment||Treatment||None (Open Label)||||||
1571787|NCT00041028||||Diagnostic||||||||
1571788|NCT00041015|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571789|NCT00040989||||Treatment||||||||
1571790|NCT00040950||||Treatment||||||||
1571791|NCT00040937||Single Group Assignment||Treatment||None (Open Label)||||||
1571792|NCT00040911|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1571793|NCT00040898||||Treatment||||||||
1571794|NCT00040885|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1571795|NCT00040872||||Treatment||None (Open Label)||||||
1571796|NCT00040859||Single Group Assignment||Treatment||None (Open Label)||||||
1571797|NCT00040846||Single Group Assignment||Treatment||None (Open Label)||||||
1571798|NCT00040833||||Supportive Care||||||||
1571799|NCT00040807||||Treatment||||||||
1571800|NCT00040794|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571801|NCT00040781||Single Group Assignment||Treatment||None (Open Label)||||||
1571802|NCT00040768||Single Group Assignment||Treatment||None (Open Label)||||||
1571803|NCT00040755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571804|NCT00040742|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1571805|NCT00040690||||Treatment||None (Open Label)||||||
1571806|NCT00039611||||Treatment||None (Open Label)||||||
1571807|NCT00039585||||Treatment||None (Open Label)||||||
1571808|NCT00039572||||Treatment||||||||
1571809|NCT00039559||Single Group Assignment||Screening||None (Open Label)||||||
1571810|NCT00039546|Randomized|||Treatment||||||||
1571811|NCT00039520||Single Group Assignment||Treatment||None (Open Label)||||||
1571812|NCT00039507||||Treatment||||||||
1571813|NCT00039494||Single Group Assignment||Treatment||None (Open Label)||||||
1571814|NCT00039481||Single Group Assignment||Treatment||None (Open Label)||||||
1571815|NCT00039468|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571816|NCT00039455||Single Group Assignment||Treatment||None (Open Label)||||||
1571817|NCT00039442||Single Group Assignment||Treatment||None (Open Label)||||||
1571818|NCT00039429||||Treatment||None (Open Label)||||||
1571819|NCT00039416||Single Group Assignment||Treatment||None (Open Label)||||||
1571820|NCT00039403||Single Group Assignment||Treatment||None (Open Label)||||||
1571821|NCT00039390||Single Group Assignment||Treatment||None (Open Label)||||||
1571822|NCT00039377||Single Group Assignment||Treatment||None (Open Label)||||||
1571823|NCT00039364||||Treatment||||||||
1571824|NCT00039351||||Treatment||None (Open Label)||||||
1571825|NCT00039338|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571826|NCT00039325|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571827|NCT00039312||||Screening||||||||
1571828|NCT00039299||||Treatment||||||||
1571829|NCT00039286||Single Group Assignment||Diagnostic||None (Open Label)||||||
1571830|NCT00039273||||Treatment||||||||
1571831|NCT00039234|Randomized|||Treatment||||||||
1571832|NCT00039208|Randomized|||Treatment||||||||
1571833|NCT00039195||Single Group Assignment||Treatment||None (Open Label)||||||
1571834|NCT00039182||Single Group Assignment||Treatment||None (Open Label)||||||
1571835|NCT00039156||||Treatment||None (Open Label)||||||
1571836|NCT00039130||Single Group Assignment||Treatment||None (Open Label)||||||
1571837|NCT00039117||Single Group Assignment||Treatment||None (Open Label)||||||
1571838|NCT00039104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571839|NCT00039091||Single Group Assignment||Treatment||None (Open Label)||||||
1571840|NCT00039078||||Treatment||||||||
1571841|NCT00039052||||Treatment||||||||
1571842|NCT00039039|Randomized|||Treatment||||||||
1571843|NCT00037037|Randomized|||Treatment||None (Open Label)||||||
1571844|NCT00037024||||Other||||||||
1571845|NCT00037011||||Treatment||||||||
1571846|NCT00036998|Randomized|||Treatment||None (Open Label)||||||
1571847|NCT00036985|Randomized|||Treatment||None (Open Label)||||||
1571848|NCT00036972||||Treatment||||||||
1571849|NCT00036959||||Treatment||None (Open Label)||||||
1571850|NCT00036946||||Treatment||||||||
1571851|NCT00036933|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571852|NCT00036894||||Treatment||||||||
1571853|NCT00036881|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1571854|NCT00036868||Single Group Assignment||Treatment||None (Open Label)||||||
1571855|NCT00036855|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571856|NCT00036842||||Treatment||||||||
1571857|NCT00036829||||||||||||
1571858|NCT00036816|Randomized|||Treatment||||||||
1571859|NCT00036790||||Treatment||||||||
1571860|NCT00036777||Single Group Assignment||Treatment||None (Open Label)||||||
1571861|NCT00036764||Single Group Assignment||Treatment||None (Open Label)||||||
1571862|NCT00036751||Single Group Assignment||Treatment||None (Open Label)||||||
1571863|NCT00036738||Single Group Assignment||Treatment||None (Open Label)||||||
1571864|NCT00036712||||Supportive Care||||||||
1571865|NCT00036686|Randomized|Parallel Assignment||Treatment||Double||||||
1571866|NCT00033748|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571867|NCT00033709||||Treatment||||||||
1571868|NCT00033696||Single Group Assignment||Treatment||None (Open Label)||||||
1571869|NCT00033683|Randomized|||Treatment||||||||
1571870|NCT00033657|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571871|NCT00033644||||Treatment||||||||
1571872|NCT00033631|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571873|NCT00033618|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571874|NCT00033605|Randomized|Parallel Assignment||Supportive Care||Double|||t||t|
1571875|NCT00033566||||Treatment||||||||
1571876|NCT00033553|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571877|NCT00033540||Single Group Assignment||Treatment||None (Open Label)||||||
1571878|NCT00033514||Single Group Assignment||Treatment||None (Open Label)||||||
1571879|NCT00033488||||Screening||||||||
1571880|NCT00033475|Randomized|||Treatment||||||||
1571881|NCT00033449||Single Group Assignment||Treatment||None (Open Label)||||||
1571882|NCT00033436|Randomized|||Treatment||||||||
1571883|NCT00033423|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571884|NCT00033410||||Treatment||||||||
1571885|NCT00033397|||Cohort||Prospective|||||||
1571886|NCT00033371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1571887|NCT00033358|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1571888|NCT00033345||Single Group Assignment||Prevention||None (Open Label)||||||
1571889|NCT00033332|Randomized|||Treatment||||||||
1571890|NCT00033293|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571891|NCT00033280||Single Group Assignment||Treatment||None (Open Label)||||||
1571892|NCT00033267||Single Group Assignment||Treatment||None (Open Label)||||||
1571893|NCT00033254|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571894|NCT00033241||||Treatment||||||||
1571895|NCT00033228||Parallel Assignment||Treatment||None (Open Label)||||||
1571896|NCT00032188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571897|NCT00032175|Randomized|||Treatment||None (Open Label)||||||
1571898|NCT00032162|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571899|NCT00032149||||Treatment||||||||
1571900|NCT00032136|Randomized|||Treatment||None (Open Label)||||||
1571901|NCT00032123||||Treatment||||||||
1571902|NCT00032110||Single Group Assignment||Treatment||None (Open Label)||||||
1571903|NCT00032097||||Treatment||||||||
1571904|NCT00032084|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1571905|NCT00032058||||Diagnostic||None (Open Label)||||||
1571906|NCT00032045||||Treatment||None (Open Label)||||||
1572169|NCT00022607|Randomized|||Treatment||||||||
1571907|NCT00032032||Single Group Assignment||Treatment||None (Open Label)||||||
1571908|NCT00032019|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1571909|NCT00032006||Single Group Assignment||Treatment||None (Open Label)||||||
1571910|NCT00031993||Single Group Assignment||Treatment||None (Open Label)||||||
1571911|NCT00031980||Single Group Assignment||Supportive Care||None (Open Label)||||||
1571912|NCT00031967|Randomized|||Treatment||||||||
1571913|NCT00031941||||Treatment||||||||
1571914|NCT00031928||||Treatment||||||||
1571915|NCT00031915||||Treatment||None (Open Label)||||||
1571916|NCT00031902||||Treatment||||||||
1571917|NCT00031876||Single Group Assignment||Treatment||None (Open Label)||||||
1571918|NCT00031863|Randomized|||Treatment||Double||||||
1571919|NCT00031850||||Prevention||||||||
1571920|NCT00031837|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571921|NCT00031824|Randomized|Single Group Assignment||Supportive Care||Double||||||
1571922|NCT00031798|Randomized|||Supportive Care||Double||||||
1571923|NCT00031772|Randomized|Parallel Assignment||||None (Open Label)||||||
1571924|NCT00031759|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1571925|NCT00031746|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1571926|NCT00031733|Randomized|||Treatment||||||||
1571927|NCT00031720|Randomized|Parallel Assignment||Supportive Care||Double||||||
1571928|NCT00031694||Single Group Assignment||Treatment||None (Open Label)||||||
1571929|NCT00031681||Single Group Assignment||Treatment||None (Open Label)||||||
1571930|NCT00031655||Single Group Assignment||Treatment||None (Open Label)||||||
1571931|NCT00031642||Single Group Assignment||Treatment||None (Open Label)||||||
1571932|NCT00031629||Single Group Assignment||Treatment||None (Open Label)||||||
1571933|NCT00031616||||Treatment||||||||
1571934|NCT00031590||Single Group Assignment||Treatment||None (Open Label)||||||
1571935|NCT00031577||||Treatment||||||||
1571936|NCT00031564||Single Group Assignment||Treatment||None (Open Label)||||||
1571937|NCT00030914|Randomized|Crossover Assignment||Supportive Care||None (Open Label)||||||
1571938|NCT00030901|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1571939|NCT00030888||||Treatment||||||||
1571940|NCT00030875|Non-Randomized|||Treatment||||||||
1571941|NCT00030862||||Treatment||||||||
1571942|NCT00030849||||Treatment||||||||
1571943|NCT00030823||Single Group Assignment||Treatment||None (Open Label)||||||
1571944|NCT00030810||Single Group Assignment||Treatment||None (Open Label)||||||
1571945|NCT00030784||||Treatment||||||||
1571946|NCT00030771|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1571947|NCT00030758|Randomized|||Supportive Care||||||||
1571948|NCT00030745||Single Group Assignment||Treatment||None (Open Label)||||||
1571949|NCT00030732|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1571950|NCT00030719|Randomized|||Treatment||||||||
1571951|NCT00030706||Single Group Assignment||Treatment||None (Open Label)||||||
1571952|NCT00030693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571953|NCT00030680||||Treatment||||||||
1571954|NCT00030654|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571955|NCT00030641|Randomized|||Treatment||None (Open Label)||||||
1571956|NCT00030628|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571957|NCT00030615||Single Group Assignment||Treatment||None (Open Label)||||||
1571958|NCT00030589|Randomized|||Treatment||None (Open Label)||||||
1571959|NCT00030576||Single Group Assignment||Treatment||None (Open Label)||||||
1571960|NCT00030563||||Treatment||||||||
1571961|NCT00030550|Randomized|||Treatment||Double||||||
1571962|NCT00030537||||Treatment||||||||
1571963|NCT00030511||||Treatment||||||||
1571964|NCT00030498||Single Group Assignment||Treatment||None (Open Label)||||||
1571965|NCT00030485||||Treatment||||||||
1571966|NCT00030472||||Treatment||||||||
1571967|NCT00030459|Randomized|||Treatment||||||||
1571968|NCT00030433||Single Group Assignment||Treatment||None (Open Label)||||||
1571969|NCT00030407||Single Group Assignment||Treatment||None (Open Label)||||||
1571970|NCT00030394||Single Group Assignment||Treatment||None (Open Label)||||||
1571971|NCT00030355||||Treatment||||||||
1571972|NCT00030342||||Treatment||||||||
1571973|NCT00030303||Single Group Assignment||Treatment||None (Open Label)||||||
1571974|NCT00030290||||Treatment||||||||
1571975|NCT00030277||||Treatment||||||||
1571976|NCT00030264||Single Group Assignment||Treatment||None (Open Label)||||||
1571977|NCT00030108||||Treatment||||||||
1571978|NCT00030095||||Treatment||||||||
1571979|NCT00030082||||Treatment||||||||
1571980|NCT00029029||||Supportive Care||||||||
1571981|NCT00029003||Single Group Assignment||Treatment||None (Open Label)||||||
1571982|NCT00028990|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571983|NCT00028977||||Treatment||None (Open Label)||||||
1571984|NCT00028964|Randomized|||Supportive Care||Double||||||
1571985|NCT00028951|Randomized|||Supportive Care||||||||
1571986|NCT00028912||||Treatment||||||||
1571987|NCT00028899||||Treatment||||||||
1571988|NCT00028886|Randomized|||Treatment||||||||
1571989|NCT00028873||||Treatment||||||||
1571990|NCT00028860||||Treatment||||||||
1571991|NCT00028847||||Treatment||||||||
1571992|NCT00028834||Single Group Assignment||Treatment||None (Open Label)||||||
1571993|NCT00028821||Single Group Assignment||Treatment||None (Open Label)||||||
1571994|NCT00028795||Single Group Assignment||Treatment||None (Open Label)||||||
1572266|NCT00019227||||Treatment||||||||
1571995|NCT00028782||Single Group Assignment||Diagnostic||None (Open Label)||||||
1571996|NCT00028769||Single Group Assignment||Treatment||None (Open Label)||||||
1571997|NCT00028756|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571998|NCT00028743|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1571999|NCT00028730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572000|NCT00028717|Randomized|||Treatment||||||||
1572001|NCT00028704|Randomized|||Treatment||||||||
1572002|NCT00028691|Randomized|||Treatment||||||||
1572003|NCT00028665|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572004|NCT00028652||||Treatment||||||||
1572005|NCT00028639||||Treatment||||||||
1572006|NCT00028626||||Treatment||||||||
1572007|NCT00028600|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572008|NCT00028587|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572009|NCT00028574|Randomized|Parallel Assignment||Supportive Care||Triple|||t|t|t|
1572010|NCT00028561||Single Group Assignment||Treatment||None (Open Label)||||||
1572011|NCT00028548||Single Group Assignment||Treatment||None (Open Label)||||||
1572012|NCT00028535||Single Group Assignment||Treatment||None (Open Label)||||||
1572013|NCT00028522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572014|NCT00028509|||Cohort||Retrospective|||||||
1572015|NCT00028496||Single Group Assignment||Treatment||None (Open Label)||||||
1572016|NCT00028028|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572017|NCT00028015||||Treatment||||||||
1572018|NCT00028002||Single Group Assignment||Treatment||None (Open Label)||||||
1572019|NCT00027989||||Treatment||||||||
1572020|NCT00027976|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1572021|NCT00027963|Randomized|Crossover Assignment||Supportive Care||Double|||t||t|
1572022|NCT00027937||||Treatment||None (Open Label)||||||
1572023|NCT00027911||||Treatment||||||||
1572024|NCT00027898||Single Group Assignment||Treatment||None (Open Label)||||||
1572025|NCT00027885|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572026|NCT00027872||Single Group Assignment||Treatment||None (Open Label)||||||
1572027|NCT00027859|Randomized|||Treatment||||||||
1572028|NCT00027846|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572029|NCT00027833|Randomized|||Treatment||None (Open Label)||||||
1572030|NCT00027820||Single Group Assignment||Treatment||None (Open Label)||||||
1572031|NCT00027807||Single Group Assignment||Treatment||None (Open Label)||||||
1572032|NCT00027794||||Treatment||None (Open Label)||||||
1572033|NCT00027781||||Treatment||||||||
1572034|NCT00027768|Randomized|||Treatment||||||||
1572035|NCT00027742||||Treatment||||||||
1572036|NCT00027729||||Treatment||||||||
1572037|NCT00027716||||Treatment||None (Open Label)||||||
1572038|NCT00027703|Randomized|Parallel Assignment||Treatment||Double||||||
1572039|NCT00027690||Single Group Assignment||Treatment||None (Open Label)||||||
1572040|NCT00027677||||Treatment||||||||
1572041|NCT00027664|Randomized|||Treatment||||||||
1572042|NCT00027638||||Treatment||||||||
1572043|NCT00027625||||Treatment||||||||
1572044|NCT00027586|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572045|NCT00027573||Single Group Assignment||Treatment||None (Open Label)||||||
1572046|NCT00027560||Single Group Assignment||Treatment||None (Open Label)||||||
1572047|NCT00027547||||Treatment||None (Open Label)||||||
1572048|NCT00027534||Single Group Assignment||Treatment||None (Open Label)||||||
1572049|NCT00027495||||Prevention||||||||
1572050|NCT00026533||||Treatment||||||||
1572051|NCT00026494||Single Group Assignment||Treatment||None (Open Label)||||||
1572052|NCT00026468|Randomized|Single Group Assignment||Prevention||Double||||||
1572053|NCT00026442||||Treatment||||||||
1572054|NCT00026416||||Treatment||||||||
1572055|NCT00026403||Single Group Assignment||Treatment||None (Open Label)||||||
1572056|NCT00026338|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1572057|NCT00026312|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572058|NCT00026299|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572059|NCT00026247||||Treatment||None (Open Label)||||||
1572060|NCT00026234||Single Group Assignment||Treatment||None (Open Label)||||||
1572061|NCT00026221|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572062|NCT00026208|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||Patients with tumors 5 to 10 cm were to be assigned to concurrent radiotherapy, and participants with tumors less than 5 cm were initially planned to not receive radiotherapy.||||
1572063|NCT00026195||Single Group Assignment||Treatment||None (Open Label)||||||
1572064|NCT00026182|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572065|NCT00026169||Single Group Assignment||Treatment||None (Open Label)||||||
1572066|NCT00026156||Single Group Assignment||Treatment||None (Open Label)||||||
1572067|NCT00026143||Single Group Assignment||Treatment||None (Open Label)||||||
1572068|NCT00026130|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572069|NCT00026117|Randomized|Parallel Assignment||Treatment||Double||||||
1572070|NCT00026104|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572071|NCT00026091||Single Group Assignment||Treatment||None (Open Label)||||||
1572072|NCT00026078||||Treatment||||||||
1572073|NCT00025675|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572074|NCT00025662||Single Group Assignment||Treatment||None (Open Label)||||||
1572075|NCT00025649||||Treatment||||||||
1572076|NCT00025636|Randomized|||Treatment||||||||
1572080|NCT00025584||Single Group Assignment||Treatment||None (Open Label)||||||
1572081|NCT00025558||||Treatment||||||||
1572082|NCT00025519||||Treatment||None (Open Label)||||||
1572083|NCT00025506||Single Group Assignment||Treatment||None (Open Label)||||||
1572084|NCT00025493||Single Group Assignment||Treatment||None (Open Label)||||||
1572085|NCT00025480||||Treatment||||||||
1572086|NCT00025454||||Treatment||||||||
1572087|NCT00025441||||Treatment||||||||
1572088|NCT00025428||||Treatment||||||||
1572089|NCT00025415||Single Group Assignment||Treatment||None (Open Label)||||||
1572090|NCT00025402|Randomized|||Treatment||||||||
1572091|NCT00025389||Single Group Assignment||Treatment||None (Open Label)||||||
1572092|NCT00025363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572093|NCT00025337|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572094|NCT00025324||||Treatment||None (Open Label)||||||
1572095|NCT00025311||||Treatment||||||||
1572096|NCT00025298|Randomized|||Treatment||||||||
1572097|NCT00025285||||Treatment||||||||
1572098|NCT00025272||||Treatment||None (Open Label)||||||
1572099|NCT00025259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572100|NCT00025246||Single Group Assignment||Treatment||None (Open Label)||||||
1572101|NCT00025233||Single Group Assignment||Treatment||None (Open Label)||||||
1572102|NCT00025220||Single Group Assignment||Treatment||None (Open Label)||||||
1572103|NCT00025194|Randomized|||Treatment||||||||
1572104|NCT00025181||||Treatment||||||||
1572105|NCT00025168||||Treatment||||||||
1572106|NCT00025155||Single Group Assignment||Treatment||None (Open Label)||||||
1572107|NCT00025142||||Treatment||||||||
1572108|NCT00025129||||Treatment||||||||
1572109|NCT00025103||||Treatment||||||||
1572110|NCT00025090|Randomized|||Treatment||None (Open Label)||||||
1572111|NCT00025077||||Treatment||||||||
1572112|NCT00025064||||Treatment||||||||
1572113|NCT00025051|Randomized|||Prevention||Double||||||
1572114|NCT00025038||Single Group Assignment||Treatment||None (Open Label)||||||
1572115|NCT00025025|||Case-Only||Prospective|||||||
1572116|NCT00024466||Single Group Assignment||Treatment||None (Open Label)||||||
1572117|NCT00024453|Randomized|||Supportive Care||||||||
1572118|NCT00024440|Randomized|||Treatment||None (Open Label)||||||
1572119|NCT00024427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572120|NCT00024414||||Treatment||||||||
1572121|NCT00024375||||Treatment||||||||
1572122|NCT00024349|Randomized|||Treatment||||||||
1572123|NCT00024336||||Treatment||||||||
1572124|NCT00024297||||Supportive Care||||||||
1572125|NCT00024284||||Treatment||||||||
1572126|NCT00024271||||Treatment||||||||
1572127|NCT00024258||Single Group Assignment||Treatment||None (Open Label)||||||
1572128|NCT00024245||||Treatment||||||||
1572129|NCT00024232||||Treatment||||||||
1572130|NCT00024193||||Treatment||||||||
1572131|NCT00024180||||Treatment||||||||
1572132|NCT00024167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572133|NCT00024154||Single Group Assignment||Treatment||None (Open Label)||||||
1572134|NCT00024115||||Treatment||||||||
1572135|NCT00024102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572136|NCT00024089||Single Group Assignment||Treatment||None (Open Label)||||||
1572137|NCT00024076||Single Group Assignment||Treatment||None (Open Label)||||||
1572138|NCT00024050||||Treatment||||||||
1572139|NCT00023998||Single Group Assignment||Treatment||None (Open Label)||||||
1572140|NCT00023985||||Treatment||||||||
1572141|NCT00023972|Randomized|||Treatment||None (Open Label)||||||
1572142|NCT00023959||Single Group Assignment||Treatment||None (Open Label)||||||
1572143|NCT00023946||Single Group Assignment||Treatment||None (Open Label)||||||
1572144|NCT00023920||Single Group Assignment||Treatment||None (Open Label)||||||
1572145|NCT00023894||||Treatment||||||||
1572146|NCT00023881||Single Group Assignment||Treatment||None (Open Label)||||||
1572147|NCT00023855||||Treatment||||||||
1572148|NCT00023842|Randomized|||Treatment||None (Open Label)||||||
1572149|NCT00023829|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572150|NCT00023790||Single Group Assignment||Treatment||None (Open Label)||||||
1572151|NCT00023777|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572152|NCT00023764||Single Group Assignment||Treatment||None (Open Label)||||||
1572153|NCT00023751||Single Group Assignment||Treatment||None (Open Label)||||||
1572154|NCT00023712||Single Group Assignment||Treatment||None (Open Label)||||||
1572155|NCT00023686|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572156|NCT00023660||Single Group Assignment||Treatment||None (Open Label)||||||
1572157|NCT00023634|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572158|NCT00023621|Randomized|||Prevention||Double||||||
1572159|NCT00022737||Single Group Assignment||Treatment||None (Open Label)||||||
1572160|NCT00022724|Non-Randomized|Sequential Assignment||Treatment||||||||
1572161|NCT00022711||Single Group Assignment||Treatment||None (Open Label)||||||
1572162|NCT00022698|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572163|NCT00022685||||Treatment||None (Open Label)||||||
1572164|NCT00022672|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572165|NCT00022659||Single Group Assignment||Treatment||None (Open Label)||||||
1572166|NCT00022646|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572167|NCT00022633||Single Group Assignment||Treatment||None (Open Label)||||||
1572168|NCT00022620||||Treatment||None (Open Label)||||||
1572170|NCT00022581||Single Group Assignment||Treatment||None (Open Label)||||||
1572171|NCT00022568||||Treatment||||||||
1572172|NCT00022555||Single Group Assignment||Treatment||None (Open Label)||||||
1572173|NCT00022516|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572174|NCT00022490||Single Group Assignment||Treatment||None (Open Label)||||||
1572175|NCT00022464||||Treatment||||||||
1572176|NCT00022451||||Treatment||None (Open Label)||||||
1572177|NCT00022438|Randomized|||Treatment||None (Open Label)||||||
1572178|NCT00022425||||Prevention||||||||
1572179|NCT00022412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572180|NCT00022399|Randomized|||Prevention||Double||||||
1572181|NCT00022334||Single Group Assignment||Treatment||None (Open Label)||||||
1572182|NCT00022295||||Treatment||||||||
1572183|NCT00022230||Single Group Assignment||Treatment||None (Open Label)||||||
1572184|NCT00022191|Randomized|||Treatment||None (Open Label)||||||
1572185|NCT00022152||Single Group Assignment||Treatment||None (Open Label)||||||
1572186|NCT00022126||Single Group Assignment||Treatment||None (Open Label)||||||
1572187|NCT00022113||Single Group Assignment||Treatment||None (Open Label)||||||
1572188|NCT00022087|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1572189|NCT00022074|Randomized|||Supportive Care||None (Open Label)||||||
1572190|NCT00022048||||Treatment||||||||
1572191|NCT00022035||||Supportive Care||||||||
1572192|NCT00022022|Randomized|||Treatment||||||||
1572193|NCT00021450|Randomized|||Treatment||||||||
1572194|NCT00021424||||Treatment||||||||
1572195|NCT00021320||||Treatment||||||||
1572196|NCT00021255|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572197|NCT00021242||Single Group Assignment||Treatment||None (Open Label)||||||
1572198|NCT00021229||Single Group Assignment||Treatment||None (Open Label)||||||
1572199|NCT00021216||Single Group Assignment||Treatment||None (Open Label)||||||
1572200|NCT00021164|Randomized|||Treatment||||||||
1572201|NCT00021125||||Treatment||||||||
1572202|NCT00021112||||Treatment||||||||
1572203|NCT00021073||Single Group Assignment||Treatment||None (Open Label)||||||
1572204|NCT00021060|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572205|NCT00021047||||Treatment||||||||
1572206|NCT00020995|Randomized|||Prevention||||||||
1572207|NCT00020969||||Treatment||||||||
1572208|NCT00020943|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572209|NCT00020891||||Diagnostic||||||||
1572210|NCT00020878||Single Group Assignment||Prevention||None (Open Label)||||||
1572211|NCT00020852||||Treatment||||||||
1572212|NCT00020839|Randomized|||Treatment||||||||
1572213|NCT00020826|||Case-Only||Prospective|||||||
1572214|NCT00020800||||Treatment||||||||
1572215|NCT00020761|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572216|NCT00020748||||Treatment||||||||
1572217|NCT00020735|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1572218|NCT00020722||Single Group Assignment||Treatment||None (Open Label)||||||
1572219|NCT00020709|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1572220|NCT00020683|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572221|NCT00020670||Single Group Assignment||Treatment||None (Open Label)||||||
1572222|NCT00020657|Randomized|||Supportive Care||||||||
1572223|NCT00020644||||Treatment||||||||
1572224|NCT00020631||||Supportive Care||||||||
1572225|NCT00020579||||Treatment||None (Open Label)||||||
1572226|NCT00020566|Randomized|||Treatment||||||||
1572227|NCT00020527||||Supportive Care||||||||
1572228|NCT00020501|Randomized|||Treatment||||||||
1572229|NCT00020488||||Treatment||||||||
1572230|NCT00020449||||Treatment||None (Open Label)||||||
1572231|NCT00020410||||Treatment||||||||
1572232|NCT00020397||||Treatment||None (Open Label)||||||
1572233|NCT00020358|Randomized|||Treatment||||||||
1572234|NCT00020332||||Treatment||||||||
1572235|NCT00020254|Randomized|||Treatment||||||||
1572236|NCT00020189||||Treatment||||||||
1572237|NCT00020176||||Treatment||None (Open Label)||||||
1572238|NCT00020150||||Treatment||||||||
1572239|NCT00020124||||Treatment||||||||
1572240|NCT00020111||||Treatment||||||||
1572241|NCT00020072||||Diagnostic||||||||
1572242|NCT00020007||||Treatment||||||||
1572243|NCT00019994||||Treatment||None (Open Label)||||||
1572244|NCT00019955||||Treatment||None (Open Label)||||||
1572245|NCT00019929||||Treatment||||||||
1572246|NCT00019916|Randomized|||Treatment||||||||
1572247|NCT00019864||||Treatment||None (Open Label)||||||
1572248|NCT00019838||||Treatment||||||||
1572249|NCT00019825||||Treatment||||||||
1572250|NCT00019812||||Treatment||||||||
1572251|NCT00019786||||Treatment||None (Open Label)||||||
1572252|NCT00019773||||Treatment||||||||
1572253|NCT00019747|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1572254|NCT00019708||Single Group Assignment||Treatment||None (Open Label)||||||
1572255|NCT00019682|Randomized|Parallel Assignment||Treatment||Single|||||t|
1572256|NCT00019669||||Treatment||None (Open Label)||||||
1572257|NCT00019656||||Treatment||||||||
1572258|NCT00019604||Single Group Assignment||Treatment||None (Open Label)||||||
1572259|NCT00019591||||Treatment||||||||
1572260|NCT00019565||||Diagnostic||||||||
1572261|NCT00019513||||Treatment||||||||
1572262|NCT00019487||||Treatment||||||||
1572263|NCT00019461||||Treatment||||||||
1572264|NCT00019422||||Treatment||||||||
1572265|NCT00019331||||Treatment||||||||
1572273|NCT00018967||||Supportive Care||None (Open Label)||||||
1572274|NCT00017602|Randomized|||Treatment||None (Open Label)||||||
1572275|NCT00017589||||Treatment||||||||
1572276|NCT00017563||Single Group Assignment||Treatment||None (Open Label)||||||
1572277|NCT00017550|Randomized|||Treatment||None (Open Label)||||||
1572278|NCT00017524||||Treatment||None (Open Label)||||||
1572279|NCT00017511||||Supportive Care||||||||
1572280|NCT00017498||||Treatment||||||||
1572281|NCT00017485||Single Group Assignment||Treatment||None (Open Label)||||||
1572282|NCT00017472||Single Group Assignment||Treatment||None (Open Label)||||||
1572283|NCT00017381||Single Group Assignment||Treatment||None (Open Label)||||||
1572284|NCT00017355||||Treatment||||||||
1572285|NCT00017329||||Treatment||None (Open Label)||||||
1572286|NCT00017290|Randomized|||Treatment||Double||||||
1572287|NCT00017277|Randomized|||Treatment||Double||||||
1572288|NCT00017264||||Treatment||||||||
1572289|NCT00017251||Single Group Assignment||Treatment||None (Open Label)||||||
1572290|NCT00017238||Single Group Assignment||Treatment||None (Open Label)||||||
1572291|NCT00017225||||Treatment||||||||
1572292|NCT00017212||||Treatment||||||||
1572293|NCT00017186||Single Group Assignment||Treatment||None (Open Label)||||||
1572294|NCT00017173||Single Group Assignment||Treatment||None (Open Label)||||||
1572295|NCT00017160||||Treatment||||||||
1572296|NCT00017147|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572297|NCT00017121||Single Group Assignment||Treatment||None (Open Label)||||||
1572298|NCT00017108|Randomized|||Treatment||||||||
1572299|NCT00017095|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572300|NCT00017069||||Treatment||None (Open Label)||||||
1572301|NCT00017004|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1572302|NCT00016991||||Treatment||||||||
1572303|NCT00016965||||Treatment||||||||
1572304|NCT00016952|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572305|NCT00016926||||Treatment||||||||
1572306|NCT00016913||Single Group Assignment||Treatment||None (Open Label)||||||
1572307|NCT00016887|Randomized|||Treatment||||||||
1572308|NCT00016861||||Treatment||||||||
1572309|NCT00016432|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1572310|NCT00016419|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572311|NCT00016406|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572312|NCT00016393||||Treatment||None (Open Label)||||||
1572313|NCT00016380|Randomized|||Supportive Care||Double||||||
1572314|NCT00016354||Single Group Assignment||Treatment||None (Open Label)||||||
1572315|NCT00016328||Single Group Assignment||Treatment||None (Open Label)||||||
1572316|NCT00016302|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572317|NCT00016289||Single Group Assignment||Treatment||None (Open Label)||||||
1572318|NCT00016263|Randomized|||Treatment||None (Open Label)||||||
1572319|NCT00016224||||Treatment||||||||
1572320|NCT00016211|Randomized|||Treatment||||||||
1572321|NCT00016185||||Treatment||||||||
1572322|NCT00016159||||Treatment||||||||
1572323|NCT00016146|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572324|NCT00016133||||Treatment||||||||
1572325|NCT00016094||Single Group Assignment||Treatment||None (Open Label)||||||
1572326|NCT00016081|Randomized|||Supportive Care||||||||
1572327|NCT00016068|Randomized|||Supportive Care||Double||||||
1572328|NCT00016055||||Treatment||||||||
1572329|NCT00016029||||Diagnostic||||||||
1572330|NCT00016016||Single Group Assignment||Treatment||None (Open Label)||||||
1572331|NCT00015977||Single Group Assignment||Treatment||None (Open Label)||||||
1572332|NCT00015951||||Treatment||||||||
1572333|NCT00015938||Single Group Assignment||Treatment||None (Open Label)||||||
1572334|NCT00015925||||Treatment||||||||
1572335|NCT00015899||||Treatment||||||||
1572336|NCT00015873|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572337|NCT00015860||||Treatment||||||||
1572338|NCT00015847|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572339|NCT00015834||Single Group Assignment||Treatment||None (Open Label)||||||
1572340|NCT00014612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572341|NCT00014599||||Treatment||None (Open Label)||||||
1572342|NCT00014586|Randomized|||Treatment||||||||
1572343|NCT00014521||||Treatment||||||||
1572344|NCT00014508||||Treatment||None (Open Label)||||||
1572345|NCT00014495||Single Group Assignment||Treatment||None (Open Label)||||||
1572346|NCT00014482|Randomized|||||||||||
1572347|NCT00014469||||Treatment||||||||
1572348|NCT00014456||Single Group Assignment||Treatment||None (Open Label)||||||
1572349|NCT00014443||||Treatment||||||||
1572350|NCT00014378||Single Group Assignment||Treatment||None (Open Label)||||||
1572351|NCT00014326|Randomized|||Treatment||||||||
1572352|NCT00014313||||Treatment||None (Open Label)||||||
1572353|NCT00014274|Randomized|||Treatment||||||||
1572354|NCT00014235|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572355|NCT00014222|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572356|NCT00014196||Single Group Assignment||Treatment||None (Open Label)||||||
1572357|NCT00014131||Single Group Assignment||Treatment||None (Open Label)||||||
1572358|NCT00014118||||Treatment||None (Open Label)||||||
1572359|NCT00014092||||Treatment||||||||
1572360|NCT00014079|||Case-Only||Prospective|||||||
1572361|NCT00012389|Randomized|||Treatment||None (Open Label)||||||
1573266|NCT00001840||||||||||||
1572362|NCT00012376||Single Group Assignment||Treatment||None (Open Label)||||||
1572363|NCT00012363||Single Group Assignment||Treatment||None (Open Label)||||||
1572364|NCT00012324|Randomized|||Treatment||None (Open Label)||||||
1572365|NCT00012298||Single Group Assignment||Treatment||None (Open Label)||||||
1572366|NCT00012246|Randomized|||Treatment||||||||
1572367|NCT00012220|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572368|NCT00012207||||Treatment||None (Open Label)||||||
1572369|NCT00012194||Single Group Assignment||Treatment||None (Open Label)||||||
1572370|NCT00012181||Single Group Assignment||Treatment||None (Open Label)||||||
1572371|NCT00012168||||Diagnostic||||||||
1572372|NCT00012103||||Screening||||||||
1572373|NCT00012064|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572374|NCT00012051|Randomized|||Treatment||||||||
1572375|NCT00012038||||Treatment||||||||
1572376|NCT00012025||Single Group Assignment||Treatment||None (Open Label)||||||
1572377|NCT00012012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572378|NCT00011999||Single Group Assignment||Treatment||None (Open Label)||||||
1572379|NCT00011986|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572380|NCT00011960|Randomized|||Treatment||||||||
1572381|NCT00011921|Randomized|||Treatment||||||||
1572382|NCT00010270||||Treatment||||||||
1572383|NCT00010257||Single Group Assignment||Treatment||None (Open Label)||||||
1572384|NCT00010218||Single Group Assignment||Treatment||None (Open Label)||||||
1572385|NCT00010205||Single Group Assignment||Treatment||None (Open Label)||||||
1572386|NCT00010192||Single Group Assignment||Treatment||None (Open Label)||||||
1572387|NCT00010166||||Treatment||||||||
1572388|NCT00010153||||Treatment||||||||
1572389|NCT00010140|Randomized|||Treatment||||||||
1572390|NCT00010101|||Case-Only||Cross-Sectional|||||||
1572391|NCT00010075||||Treatment||||||||
1572392|NCT00010062||||Treatment||||||||
1572393|NCT00010049||Parallel Assignment||Treatment||||||||
1572394|NCT00010023||||Treatment||||||||
1572395|NCT00009984|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572396|NCT00009971||Single Group Assignment||Treatment||None (Open Label)||||||
1572397|NCT00009945|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1572398|NCT00009880||||Treatment||||||||
1572399|NCT00009854||||Treatment||||||||
1572400|NCT00009776||||Treatment||||||||
1572401|NCT00009763||||Treatment||||||||
1572402|NCT00009750||||Treatment||None (Open Label)||||||
1572403|NCT00009711||||||||||||
1572404|NCT00008697|Randomized|Parallel Assignment||Treatment||||||||
1572405|NCT00008437||||Treatment||||||||
1572406|NCT00008411|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572407|NCT00008385|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1572408|NCT00008346|Randomized|Parallel Assignment||Screening||None (Open Label)||||||
1572409|NCT00008307||||Treatment||||||||
1572410|NCT00008294||||Treatment||||||||
1572411|NCT00008268||||Treatment||||||||
1572412|NCT00008216|||Cohort||Prospective|||||||
1572413|NCT00008190||||Treatment||||||||
1572414|NCT00008164||||Treatment||||||||
1572415|NCT00008138||Single Group Assignment||Treatment||None (Open Label)||||||
1572416|NCT00008060|Randomized|||Treatment||None (Open Label)||||||
1572417|NCT00008047|Randomized|||Treatment||None (Open Label)||||||
1572418|NCT00008008||||Treatment||None (Open Label)||||||
1572419|NCT00007995||||Treatment||None (Open Label)||||||
1572420|NCT00007982||||Treatment||||||||
1572421|NCT00007956||||Treatment||||||||
1572422|NCT00007930||||Treatment||||||||
1572423|NCT00007904||Single Group Assignment||Treatment||None (Open Label)||||||
1572424|NCT00007891||||Treatment||||||||
1572425|NCT00007865||||Treatment||||||||
1572426|NCT00007826||||Treatment||None (Open Label)||||||
1572427|NCT00006994|Randomized|Parallel Assignment||Supportive Care||Double|||t|t||
1572428|NCT00006981||||Treatment||None (Open Label)||||||
1572429|NCT00006942||Single Group Assignment||Treatment||None (Open Label)||||||
1572430|NCT00006929||Single Group Assignment||Treatment||None (Open Label)||||||
1572431|NCT00006916||Single Group Assignment||Treatment||None (Open Label)||||||
1572432|NCT00006903||Single Group Assignment||Treatment||None (Open Label)||||||
1572433|NCT00006825||||Treatment||||||||
1572434|NCT00006773||Single Group Assignment||Treatment||None (Open Label)||||||
1572435|NCT00006760||Single Group Assignment||Treatment||None (Open Label)||||||
1572436|NCT00006747||Single Group Assignment||Treatment||None (Open Label)||||||
1572437|NCT00006734|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572438|NCT00006721|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572439|NCT00006695||Single Group Assignment||Treatment||None (Open Label)||||||
1572440|NCT00006656||||Treatment||||||||
1572441|NCT00006485|Non-Randomized|||Treatment||None (Open Label)||||||
1572442|NCT00006479||||Treatment||||||||
1572443|NCT00006478|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572444|NCT00006477||||Treatment||||||||
1572445|NCT00006476||||Treatment||||||||
1572446|NCT00006474||||Treatment||||||||
1572447|NCT00006473||Single Group Assignment||Treatment||None (Open Label)||||||
1572448|NCT00006471|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572449|NCT00006470||||Treatment||||||||
1572450|NCT00006469||||Treatment||||||||
1572451|NCT00006468|Randomized|||Treatment||None (Open Label)||||||
1572452|NCT00006465||Single Group Assignment||Treatment||None (Open Label)||||||
1572453|NCT00006462||Single Group Assignment||Treatment||None (Open Label)||||||
1572454|NCT00006461||Single Group Assignment||Treatment||None (Open Label)||||||
1572455|NCT00006456|Non-Randomized|||Treatment||None (Open Label)||||||
1572456|NCT00006455|Randomized|||Treatment||||||||
1572457|NCT00006392|Randomized|Factorial Assignment||Prevention||Quadruple|||t|t|t|t
1572458|NCT00006391||||Treatment||||||||
1572459|NCT00006390||||Treatment||None (Open Label)||||||
1572460|NCT00006389||Single Group Assignment||Treatment||None (Open Label)||||||
1572461|NCT00006386||Single Group Assignment||Treatment||None (Open Label)||||||
1572462|NCT00006385|Randomized|||Treatment||||||||
1572463|NCT00006381||||Treatment||||||||
1572464|NCT00006379||Single Group Assignment||Treatment||None (Open Label)||||||
1572465|NCT00006373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572466|NCT00006372||Single Group Assignment||Treatment||None (Open Label)||||||
1572467|NCT00006366|Randomized|||Treatment||||||||
1572468|NCT00006364||Single Group Assignment||Treatment||None (Open Label)||||||
1572469|NCT00006363|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572470|NCT00006362||||Treatment||||||||
1572471|NCT00006360||||Treatment||||||||
1572472|NCT00006359|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572473|NCT00006356|Randomized|||Treatment||||||||
1572474|NCT00006355||||Treatment||||||||
1572475|NCT00006354||||Treatment||||||||
1572476|NCT00006351||||Treatment||||||||
1572477|NCT00006347||||Treatment||||||||
1572478|NCT00006340||||Treatment||||||||
1572479|NCT00006268||||Treatment||||||||
1572480|NCT00006267||||Treatment||||||||
1572481|NCT00006264||||Treatment||||||||
1572482|NCT00006263||||Treatment||||||||
1572483|NCT00006260||Single Group Assignment||Treatment||None (Open Label)||||||
1572484|NCT00006258||||Treatment||||||||
1572485|NCT00006256||Single Group Assignment||Treatment||None (Open Label)||||||
1572486|NCT00006255||Single Group Assignment||Treatment||None (Open Label)||||||
1572487|NCT00006252|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572488|NCT00006250|Randomized|||Treatment||||||||
1572489|NCT00006249|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572490|NCT00006248||Single Group Assignment||Treatment||None (Open Label)||||||
1572491|NCT00006246||||Treatment||||||||
1572492|NCT00006245||||Treatment||||||||
1572493|NCT00006244||Single Group Assignment||Treatment||None (Open Label)||||||
1572494|NCT00006239||||Treatment||||||||
1572495|NCT00006237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572496|NCT00006234||||Treatment||||||||
1572497|NCT00006233||||Treatment||None (Open Label)||||||
1572498|NCT00006232|Randomized|||Treatment||||||||
1572499|NCT00006231||||Treatment||||||||
1572500|NCT00006230||||Treatment||||||||
1572501|NCT00006228||Single Group Assignment||Treatment||None (Open Label)||||||
1572502|NCT00006227||Single Group Assignment||Treatment||None (Open Label)||||||
1572503|NCT00006226||Single Group Assignment||Treatment||None (Open Label)||||||
1572504|NCT00006221||Single Group Assignment||Treatment||None (Open Label)||||||
1572505|NCT00006219|Randomized|||Prevention||Double||||||
1572506|NCT00006125||Single Group Assignment||Treatment||None (Open Label)||||||
1572507|NCT00006124|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1572508|NCT00006120|Randomized|||Treatment||||||||
1572509|NCT00006119||||Treatment||||||||
1572510|NCT00006118||||Treatment||||||||
1572511|NCT00006114||||Treatment||||||||
1572512|NCT00006113||||Treatment||||||||
1572513|NCT00006110|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572514|NCT00006107||Single Group Assignment||Treatment||None (Open Label)||||||
1572515|NCT00006105||Single Group Assignment||Treatment||None (Open Label)||||||
1572516|NCT00006102||Single Group Assignment||Treatment||None (Open Label)||||||
1572517|NCT00006101|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1572518|NCT00006100||||Treatment||||||||
1572519|NCT00006094||Single Group Assignment||Treatment||None (Open Label)||||||
1572520|NCT00006093||||Treatment||||||||
1572521|NCT00006092||Single Group Assignment||Treatment||None (Open Label)||||||
1572522|NCT00006089||Single Group Assignment||Treatment||None (Open Label)||||||
1572523|NCT00006078||||Prevention||||||||
1572524|NCT00006044||||Treatment||||||||
1572525|NCT00006042||||Treatment||||||||
1572526|NCT00006040||||Treatment||||||||
1572527|NCT00006029|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572528|NCT00006028||||Treatment||||||||
1572529|NCT00006027|Randomized|||Treatment||||||||
1572530|NCT00006025||Single Group Assignment||Treatment||||||||
1572531|NCT00006024||Single Group Assignment||Treatment||None (Open Label)||||||
1572532|NCT00006022|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1572533|NCT00006021|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572534|NCT00006020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572535|NCT00006017|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572536|NCT00006016||Single Group Assignment||Treatment||None (Open Label)||||||
1572537|NCT00006015|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572538|NCT00006011|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1572539|NCT00006010||Single Group Assignment||Treatment||None (Open Label)||||||
1572540|NCT00006007||Single Group Assignment||Treatment||None (Open Label)||||||
1572807|NCT00003678|Randomized|||Treatment||||||||
1572541|NCT00006006||Single Group Assignment||Treatment||None (Open Label)||||||
1572542|NCT00006005||||Treatment||||||||
1572543|NCT00006004|Randomized|||Treatment||||||||
1572544|NCT00006003||Single Group Assignment||Treatment||None (Open Label)||||||
1572545|NCT00005997||Parallel Assignment||Treatment||None (Open Label)||||||
1572546|NCT00005990||||Treatment||||||||
1572547|NCT00005987|Randomized|||Treatment||||||||
1572548|NCT00005985||||Treatment||None (Open Label)||||||
1572549|NCT00005984|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572550|NCT00005983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572551|NCT00005982||Single Group Assignment||Treatment||None (Open Label)||||||
1572552|NCT00005981||Single Group Assignment||Treatment||None (Open Label)||||||
1572553|NCT00005980|Randomized|||Treatment||||||||
1572554|NCT00005979|Randomized|||Treatment||||||||
1572555|NCT00005976|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572556|NCT00005973||Single Group Assignment||Treatment||None (Open Label)||||||
1572557|NCT00005970|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572558|NCT00005967|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572559|NCT00005966|Randomized|||Treatment||||||||
1572560|NCT00005961||Single Group Assignment||Treatment||None (Open Label)||||||
1572561|NCT00005957|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572562|NCT00005955||||Treatment||||||||
1572563|NCT00005954||||Treatment||||||||
1572564|NCT00005952||||Treatment||||||||
1572565|NCT00005951||||Treatment||||||||
1572566|NCT00005949||Single Group Assignment||Treatment||None (Open Label)||||||
1572567|NCT00005945|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572568|NCT00005941||||Treatment||None (Open Label)||||||
1572569|NCT00005879|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1572570|NCT00005878|Randomized|||Prevention||Double||||||
1572571|NCT00005867|Randomized|||Treatment||||||||
1572572|NCT00005863|Randomized|||Treatment||||||||
1572573|NCT00005859|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||||||
1572574|NCT00005858||Single Group Assignment||Treatment||None (Open Label)||||||
1572575|NCT00005856||Single Group Assignment||Treatment||None (Open Label)||||||
1572576|NCT00005855|Non-Randomized|||Treatment||None (Open Label)||||||
1572577|NCT00005853||||Treatment||||||||
1572578|NCT00005851||Single Group Assignment||Treatment||None (Open Label)||||||
1572579|NCT00005850||Single Group Assignment||Treatment||None (Open Label)||||||
1572580|NCT00005847|Randomized|||Treatment||||||||
1572581|NCT00005844||||Treatment||||||||
1572582|NCT00005840||Single Group Assignment||Treatment||None (Open Label)||||||
1572583|NCT00005838|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1572584|NCT00005835||Single Group Assignment||Treatment||None (Open Label)||||||
1572585|NCT00005831||Single Group Assignment||Treatment||None (Open Label)||||||
1572586|NCT00005830||Single Group Assignment||Treatment||None (Open Label)||||||
1572587|NCT00005825||||Treatment||||||||
1572588|NCT00005824||||Treatment||None (Open Label)||||||
1572589|NCT00005823|Randomized|||Treatment||||||||
1572590|NCT00005822||Single Group Assignment||Treatment||None (Open Label)||||||
1572591|NCT00005821||||Treatment||||||||
1572592|NCT00005819||Single Group Assignment||Treatment||None (Open Label)||||||
1572593|NCT00005817|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572594|NCT00005815||||Treatment||||||||
1572595|NCT00005812||Single Group Assignment||Treatment||None (Open Label)||||||
1572596|NCT00005811||Single Group Assignment||Treatment||None (Open Label)||||||
1572597|NCT00005808|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1572598|NCT00005807|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572599|NCT00005803||Single Group Assignment||Treatment||None (Open Label)||||||
1572600|NCT00005802||||Treatment||||||||
1572601|NCT00005797|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572602|NCT00005788||||Treatment||||||||
1572603|NCT00005787||||Supportive Care||||||||
1572604|NCT00005786||Single Group Assignment||Treatment||None (Open Label)||||||
1572605|NCT00005647||Single Group Assignment||Treatment||None (Open Label)||||||
1572606|NCT00005644||||Treatment||||||||
1572607|NCT00005639||||Treatment||||||||
1572608|NCT00005638||||Treatment||||||||
1572609|NCT00005637||||Treatment||||||||
1572610|NCT00005627||||Treatment||||||||
1572611|NCT00005623|Randomized|||Supportive Care||Double||||||
1572612|NCT00005622||Single Group Assignment||Treatment||None (Open Label)||||||
1572613|NCT00005617||||Treatment||||||||
1572614|NCT00005606||||Treatment||||||||
1572615|NCT00005605|||Cohort||Prospective|||||||
1572616|NCT00005603||||Treatment||None (Open Label)||||||
1572617|NCT00005602||||Treatment||||||||
1572618|NCT00005601||Single Group Assignment||Treatment||None (Open Label)||||||
1572619|NCT00005600|Randomized|||Supportive Care||||||||
1572620|NCT00005599||||Treatment||None (Open Label)||||||
1572621|NCT00005597||Single Group Assignment||Treatment||None (Open Label)||||||
1572622|NCT00005596|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572623|NCT00005590|Randomized|||Supportive Care||Double||||||
1572624|NCT00005589|Randomized|||Treatment||None (Open Label)||||||
1572625|NCT00005586|Randomized|||Treatment||None (Open Label)||||||
1572626|NCT00005585|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572627|NCT00005584|Randomized|||Treatment||None (Open Label)||||||
1572628|NCT00005583|Randomized|||Treatment||None (Open Label)||||||
1572629|NCT00005580|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1572630|NCT00005579||||Treatment||None (Open Label)||||||
1572631|NCT00005095|||||Prospective|||||||
1572632|NCT00005087||Single Group Assignment||Treatment||None (Open Label)||||||
1572633|NCT00005079||||Treatment||||||||
1572634|NCT00005074||||Treatment||||||||
1572635|NCT00005067||Single Group Assignment||Treatment||None (Open Label)||||||
1572636|NCT00005062|Randomized|||Treatment||||||||
1572637|NCT00005060|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1572638|NCT00005052|Randomized|||Treatment||None (Open Label)||||||
1572639|NCT00005051||||Treatment||||||||
1572640|NCT00005049||||Treatment||||||||
1572641|NCT00005047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572642|NCT00005044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572643|NCT00005039|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572644|NCT00005038|Randomized|||Treatment||None (Open Label)||||||
1572645|NCT00005036|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1572646|NCT00005033||||Treatment||||||||
1572647|NCT00004936||||Diagnostic||||||||
1572648|NCT00004935|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1572649|NCT00004934|Randomized|||Treatment||||||||
1572650|NCT00004932||Single Group Assignment||Treatment||None (Open Label)||||||
1572651|NCT00004930||||Treatment||||||||
1572652|NCT00004924||||Treatment||||||||
1572653|NCT00004921|Randomized|||Treatment||||||||
1572654|NCT00004920|Randomized|||Treatment||||||||
1572655|NCT00004918|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572656|NCT00004917|Randomized|||Treatment||||||||
1572657|NCT00004907||||Treatment||None (Open Label)||||||
1572658|NCT00004899||||Treatment||||||||
1572659|NCT00004896||||Treatment||None (Open Label)||||||
1572660|NCT00004891||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572661|NCT00004888|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572662|NCT00004879||||Treatment||None (Open Label)||||||
1572663|NCT00004876|Randomized|||Treatment||||||||
1572664|NCT00004873|Randomized|||Treatment||||||||
1572665|NCT00004871||||Treatment||||||||
1572666|NCT00004867||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572667|NCT00004866||||Treatment||||||||
1572668|NCT00004859|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572669|NCT00004262||Single Group Assignment||Treatment||None (Open Label)||||||
1572670|NCT00004259|Randomized|Parallel Assignment||Treatment||None (Open Label)||Phase I (sequential) followed by phase III (parallel)||||
1572671|NCT00004250||||Treatment||None (Open Label)||||||
1572672|NCT00004245||||Treatment||None (Open Label)||||||
1572673|NCT00004244|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572674|NCT00004241|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572675|NCT00004237|Randomized|||Treatment||None (Open Label)||||||
1572676|NCT00004234|Randomized|||Supportive Care||||||||
1572677|NCT00004231||||Treatment||||||||
1572678|NCT00004228|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572679|NCT00004227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572680|NCT00004226||||Treatment||||||||
1572681|NCT00004225||||Treatment||||||||
1572682|NCT00004224||||Treatment||||||||
1572683|NCT00004218|Randomized|||Treatment||||||||
1572684|NCT00004212||||Treatment||||||||
1572685|NCT00004210||Single Group Assignment||||None (Open Label)||||||
1572686|NCT00004208|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1572687|NCT00004205|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1572688|NCT00004196|Randomized|Parallel Assignment||Treatment||Single|||t|||
1572689|NCT00004189||Single Group Assignment||Treatment||None (Open Label)||||||
1572690|NCT00004188|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572691|NCT00004181||||Treatment||||||||
1572692|NCT00004179|Randomized|||Treatment||||||||
1572693|NCT00004173||||Treatment||||||||
1572694|NCT00004165||||Treatment||||||||
1572695|NCT00004154|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1572696|NCT00004153||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572697|NCT00004150|Randomized|||Treatment||||||||
1572698|NCT00004149||Parallel Assignment||Treatment||||||||
1572699|NCT00004147||||Treatment||||||||
1572700|NCT00004144||Single Group Assignment||Treatment||None (Open Label)||||||
1572701|NCT00004143|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572702|NCT00004141||Single Group Assignment||Treatment||None (Open Label)||||||
1572703|NCT00004138||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572704|NCT00004135||Single Group Assignment||Treatment||None (Open Label)||||||
1572705|NCT00004129||||Treatment||||||||
1572706|NCT00004128|Randomized|||Treatment||||||||
1572707|NCT00004124|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572708|NCT00004115|Randomized|||Treatment||||||||
1572709|NCT00004110||||Treatment||None (Open Label)||||||
1572710|NCT00004106|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572711|NCT00004103||||Treatment||||||||
1572712|NCT00004099|Randomized|||Treatment||None (Open Label)||||||
1572713|NCT00004092|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572714|NCT00004088||Single Group Assignment||Treatment||None (Open Label)||||||
1572715|NCT00004081||||Treatment||None (Open Label)||||||
1572716|NCT00004077||||Treatment||||||||
1572717|NCT00004075||||Treatment||||||||
1572718|NCT00004072||Single Group Assignment||Treatment||None (Open Label)||||||
1572719|NCT00004067|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572720|NCT00004066||||Treatment||||||||
1572721|NCT00004065||||Treatment||||||||
1572722|NCT00004063||||Treatment||||||||
1572723|NCT00004058||||Treatment||||||||
1572724|NCT00004054|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572725|NCT00004031|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572726|NCT00004028||||Treatment||||||||
1572727|NCT00004024||||Treatment||None (Open Label)||||||
1572728|NCT00004017||||Treatment||||||||
1572729|NCT00004015||||Treatment||||||||
1572730|NCT00004011|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572731|NCT00004005||Single Group Assignment||Treatment||None (Open Label)||||||
1572732|NCT00004001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572733|NCT00003994|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572734|NCT00003993||||Treatment||||||||
1572735|NCT00003981||||Treatment||||||||
1572736|NCT00003979||||Treatment||||||||
1572737|NCT00003977||||Treatment||||||||
1572738|NCT00003970||Single Group Assignment||Treatment||None (Open Label)||||||
1572739|NCT00003969||||Treatment||||||||
1572740|NCT00003966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572741|NCT00003963||Single Group Assignment||Treatment||None (Open Label)||||||
1572742|NCT00003961||||Treatment||None (Open Label)||||||
1572743|NCT00003958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572744|NCT00003955||||Treatment||None (Open Label)||||||
1572745|NCT00003945|Randomized|||Treatment||||||||
1572746|NCT00003941|Randomized|||Treatment||||||||
1572747|NCT00003938|Randomized|||Supportive Care||||||||
1572748|NCT00003934|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572749|NCT00003928||Single Group Assignment||Treatment||None (Open Label)||||||
1572750|NCT00003913||||Treatment||None (Open Label)||||||
1572751|NCT00003912|Randomized|||Treatment||||||||
1572752|NCT00003910||Single Group Assignment||Treatment||None (Open Label)||||||
1572753|NCT00003909||Single Group Assignment||Treatment||None (Open Label)||||||
1572754|NCT00003906|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1572755|NCT00003903||||Supportive Care||||||||
1572756|NCT00003902||||Treatment||||||||
1572757|NCT00003901||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572758|NCT00003896||Single Group Assignment||Treatment||None (Open Label)||||||
1572759|NCT00003893|Randomized|||Treatment||||||||
1572760|NCT00003878||||Treatment||||||||
1572761|NCT00003875||Single Group Assignment||Treatment||None (Open Label)||||||
1572762|NCT00003869|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1572763|NCT00003865||Single Group Assignment||Treatment||None (Open Label)||||||
1572764|NCT00003863|||Case-Only||Prospective|||||||
1572765|NCT00003862||||Treatment||None (Open Label)||||||
1572766|NCT00003861|||Case-Only||Retrospective|||||||
1572767|NCT00003857|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572768|NCT00003855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572769|NCT00003854||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572770|NCT00003851|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572771|NCT00003843||||||||||||
1572772|NCT00003838|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572773|NCT00003837||||Treatment||||||||
1572774|NCT00003833|||Case-Only||Prospective|||||||
1572775|NCT00003831|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572776|NCT00003820||Single Group Assignment||Treatment||None (Open Label)||||||
1572777|NCT00003816|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572778|NCT00003815|Randomized|||Treatment||||||||
1572779|NCT00003803|Randomized|||Treatment||||||||
1572780|NCT00003800||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572781|NCT00003799||Single Group Assignment||Treatment||None (Open Label)||||||
1572782|NCT00003796||Single Group Assignment||Treatment||None (Open Label)||||||
1572783|NCT00003793|||Cohort||Prospective|||||||
1572784|NCT00003789|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572785|NCT00003788|Randomized|||Treatment||||||||
1572786|NCT00003782|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572787|NCT00003771|Randomized|||Supportive Care||None (Open Label)||||||
1572788|NCT00003764|Randomized|||Treatment||||||||
1572789|NCT00003753||||Treatment||None (Open Label)||||||
1572790|NCT00003750||Single Group Assignment||Treatment||None (Open Label)||||||
1572791|NCT00003749|Randomized|||Treatment||||||||
1572792|NCT00003746|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1572793|NCT00003745||Single Group Assignment||Treatment||None (Open Label)||||||
1572794|NCT00003744|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572795|NCT00003741||||Treatment||None (Open Label)||||||
1572796|NCT00003739|Randomized|||Supportive Care||||||||
1572797|NCT00003737||||Treatment||||||||
1572798|NCT00003732||||Treatment||||||||
1572799|NCT00003730|Randomized|||Treatment||||||||
1572800|NCT00003728|Randomized|||Treatment||||||||
1572801|NCT00003727||||Treatment||None (Open Label)||||||
1572802|NCT00003702|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572803|NCT00003696|Randomized|||Treatment||||||||
1572804|NCT00003690||||Treatment||||||||
1572805|NCT00003688||||Treatment||||||||
1572806|NCT00003687|Randomized|||Supportive Care||Double||||||
1572808|NCT00003659||Single Group Assignment||Treatment||None (Open Label)||||||
1572809|NCT00003658||||Treatment||||||||
1572810|NCT00003656||Single Group Assignment||Treatment||None (Open Label)||||||
1572811|NCT00003653|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572812|NCT00003652|Randomized|||Treatment||||||||
1572813|NCT00003650||||Treatment||||||||
1572814|NCT00003644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572815|NCT00003643|Randomized|||Treatment||||||||
1572816|NCT00003641|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572817|NCT00003637|Randomized|||Treatment||||||||
1572818|NCT00003636|Randomized|||Treatment||||||||
1572819|NCT00003633||||Treatment||||||||
1572820|NCT00003631|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572821|NCT00003613||Single Group Assignment||Treatment||None (Open Label)||||||
1572822|NCT00003612|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572823|NCT00003611|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1572824|NCT00003607|Randomized|||Treatment||||||||
1572825|NCT00003603|Randomized|||Treatment||||||||
1572826|NCT00003602|Randomized|||Treatment||||||||
1572827|NCT00003596|Randomized|||Treatment||||||||
1572828|NCT00003593|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572829|NCT00003590||Single Group Assignment||Treatment||None (Open Label)||||||
1572830|NCT00003577|Randomized|||Treatment||||||||
1572831|NCT00003576|Randomized|||Treatment||||||||
1572832|NCT00003569||||||||||||
1572833|NCT00003568|Randomized|||Treatment||||||||
1572834|NCT00003567||Single Group Assignment||Treatment||None (Open Label)||||||
1572835|NCT00003566||Single Group Assignment||Treatment||None (Open Label)||||||
1572836|NCT00003565||Single Group Assignment||Treatment||None (Open Label)||||||
1572837|NCT00003560||||Treatment||None (Open Label)||||||
1572838|NCT00003558|Randomized|||Treatment||||||||
1572839|NCT00003553||||Treatment||None (Open Label)||||||
1572840|NCT00003538||||Supportive Care||||||||
1572841|NCT00003537||Single Group Assignment||Treatment||None (Open Label)||||||
1572842|NCT00003536||||Treatment||||||||
1572843|NCT00003535||Single Group Assignment||Treatment||None (Open Label)||||||
1572844|NCT00003534||Single Group Assignment||Treatment||None (Open Label)||||||
1572845|NCT00003533||Single Group Assignment||Treatment||None (Open Label)||||||
1572846|NCT00003532||Single Group Assignment||Treatment||None (Open Label)||||||
1572847|NCT00003531||Single Group Assignment||Treatment||None (Open Label)||||||
1572848|NCT00003530||Single Group Assignment||Treatment||None (Open Label)||||||
1572849|NCT00003526||Single Group Assignment||Treatment||None (Open Label)||||||
1572850|NCT00003525||Single Group Assignment||Treatment||None (Open Label)||||||
1572851|NCT00003524||Single Group Assignment||Treatment||None (Open Label)||||||
1572852|NCT00003522||Single Group Assignment||Treatment||None (Open Label)||||||
1572853|NCT00003521||Single Group Assignment||Treatment||None (Open Label)||||||
1572854|NCT00003520||Single Group Assignment||Treatment||None (Open Label)||||||
1572855|NCT00003517||||Treatment||||||||
1572856|NCT00003516||Single Group Assignment||Treatment||None (Open Label)||||||
1572857|NCT00003515||Single Group Assignment||Treatment||None (Open Label)||||||
1572858|NCT00003514||||Treatment||||||||
1572859|NCT00003513||Single Group Assignment||Treatment||None (Open Label)||||||
1572860|NCT00003512||Single Group Assignment||Treatment||None (Open Label)||||||
1572861|NCT00003511||Single Group Assignment||Treatment||None (Open Label)||||||
1572862|NCT00003509||Single Group Assignment||Treatment||None (Open Label)||||||
1572863|NCT00003508||||Treatment||||||||
1572864|NCT00003505||||Treatment||||||||
1572865|NCT00003502||||Treatment||||||||
1572866|NCT00003501||Single Group Assignment||Treatment||None (Open Label)||||||
1572867|NCT00003500||Single Group Assignment||Treatment||None (Open Label)||||||
1572868|NCT00003499||Single Group Assignment||Treatment||None (Open Label)||||||
1572869|NCT00003498||Single Group Assignment||Treatment||None (Open Label)||||||
1572870|NCT00003497||Single Group Assignment||Treatment||None (Open Label)||||||
1572871|NCT00003496||Single Group Assignment||Treatment||None (Open Label)||||||
1572872|NCT00003495||Single Group Assignment||Treatment||None (Open Label)||||||
1572873|NCT00003494||Single Group Assignment||Treatment||None (Open Label)||||||
1572874|NCT00003492||Single Group Assignment||Treatment||None (Open Label)||||||
1572875|NCT00003491||Single Group Assignment||Treatment||None (Open Label)||||||
1572876|NCT00003489||Single Group Assignment||Treatment||None (Open Label)||||||
1572877|NCT00003487||||Treatment||None (Open Label)||||||
1572878|NCT00003486||||Treatment||||||||
1572879|NCT00003485|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572880|NCT00003483||Single Group Assignment||Treatment||None (Open Label)||||||
1572881|NCT00003479||Single Group Assignment||Treatment||None (Open Label)||||||
1572882|NCT00003478|Randomized|||Treatment||||||||
1572883|NCT00003477||Single Group Assignment||Treatment||None (Open Label)||||||
1572884|NCT00003476||Single Group Assignment||Treatment||None (Open Label)||||||
1572885|NCT00003475||Single Group Assignment||Treatment||None (Open Label)||||||
1572886|NCT00003474||Single Group Assignment||Treatment||None (Open Label)||||||
1572887|NCT00003473||Single Group Assignment||Treatment||None (Open Label)||||||
1572888|NCT00003472||Single Group Assignment||Treatment||None (Open Label)||||||
1572889|NCT00003471||Single Group Assignment||Treatment||None (Open Label)||||||
1572890|NCT00003470||Single Group Assignment||Treatment||None (Open Label)||||||
1572891|NCT00003469||Single Group Assignment||Treatment||None (Open Label)||||||
1572892|NCT00003468||Single Group Assignment||Treatment||None (Open Label)||||||
1572893|NCT00003467||||Treatment||||||||
1572894|NCT00003466||||Treatment||||||||
1572895|NCT00003462||||Treatment||||||||
1572896|NCT00003461||||Treatment||||||||
1572897|NCT00003460||Single Group Assignment||Treatment||None (Open Label)||||||
1572898|NCT00003459||Single Group Assignment||Treatment||None (Open Label)||||||
1572899|NCT00003458||Single Group Assignment||Treatment||None (Open Label)||||||
1572900|NCT00003457||Single Group Assignment||Treatment||None (Open Label)||||||
1572901|NCT00003456||Single Group Assignment||Treatment||None (Open Label)||||||
1572902|NCT00003455||||Treatment||||||||
1572903|NCT00003454||Single Group Assignment||Treatment||None (Open Label)||||||
1572904|NCT00003453||Single Group Assignment||Treatment||None (Open Label)||||||
1572905|NCT00003452||Single Group Assignment||Treatment||None (Open Label)||||||
1572906|NCT00003440|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1572907|NCT00003437|Randomized|||Treatment||||||||
1572908|NCT00003429||||Diagnostic||||||||
1572909|NCT00003422|Randomized|||Treatment||||||||
1572910|NCT00003420|Randomized|||Diagnostic||||||||
1572911|NCT00003419||||Treatment||||||||
1572912|NCT00003417||||Treatment||||||||
1572913|NCT00003404||Single Group Assignment||Treatment||None (Open Label)||||||
1572914|NCT00003389|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572915|NCT00003385||||Treatment||||||||
1572916|NCT00003384||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572917|NCT00003379||||Treatment||||||||
1572918|NCT00003377||Single Group Assignment||Treatment||None (Open Label)||||||
1572919|NCT00003375|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572920|NCT00003354|Randomized|||Treatment||||||||
1572921|NCT00003342||||Treatment||||||||
1572922|NCT00003336||Single Group Assignment||Treatment||None (Open Label)||||||
1572923|NCT00003335||Single Group Assignment||Treatment||None (Open Label)||||||
1572924|NCT00003332||||Treatment||||||||
1572925|NCT00003329||||||||||||
1572926|NCT00003325||Single Group Assignment||Treatment||None (Open Label)||||||
1572927|NCT00003309||||Treatment||||||||
1572928|NCT00003308||||Treatment||||||||
1572929|NCT00003292||Single Group Assignment||Treatment||None (Open Label)||||||
1572930|NCT00003291|||Case-Only||Retrospective|||||||
1572931|NCT00003282||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572932|NCT00003278||Single Group Assignment||Treatment||None (Open Label)||||||
1572933|NCT00003273||||Treatment||||||||
1572934|NCT00003268||||Treatment||||||||
1572935|NCT00003261||||Treatment||||||||
1572936|NCT00003243||||Treatment||||||||
1572937|NCT00003216|Randomized|||Treatment||||||||
1572938|NCT00003215|Randomized|||Treatment||||||||
1572939|NCT00003204|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572940|NCT00003199||Single Group Assignment||Treatment||None (Open Label)||||||
1572941|NCT00003194||||Treatment||||||||
1572942|NCT00003179|Randomized|||Prevention||||||||
1572943|NCT00003178|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572944|NCT00003174||||Treatment||||||||
1572945|NCT00003159|Randomized|||Treatment||||||||
1572946|NCT00003153||||Treatment||||||||
1572947|NCT00003145||Single Group Assignment||Treatment||None (Open Label)||||||
1572948|NCT00003140|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1572949|NCT00003138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572950|NCT00003135||||Treatment||||||||
1572951|NCT00003128|Randomized|||Treatment||||||||
1572952|NCT00003122||||Treatment||||||||
1572953|NCT00003119||Single Group Assignment||Treatment||None (Open Label)||||||
1572954|NCT00003116||Single Group Assignment||Treatment||None (Open Label)||||||
1572955|NCT00003111||||Treatment||||||||
1572956|NCT00003105||||Treatment||||||||
1572957|NCT00003104||||Treatment||None (Open Label)||||||
1572958|NCT00003096||||||||||||
1572959|NCT00003093||Single Group Assignment||Treatment||None (Open Label)||||||
1572960|NCT00003092||Single Group Assignment||Treatment||None (Open Label)||||||
1572961|NCT00003067||||Treatment||||||||
1572962|NCT00003065||||Treatment||||||||
1572963|NCT00003063|Randomized|||Treatment||||||||
1572964|NCT00003053|Randomized|||Treatment||||||||
1572965|NCT00003052|Randomized|||Treatment||||||||
1572966|NCT00003049|Randomized|||Treatment||||||||
1572967|NCT00003042|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572968|NCT00003034|Randomized|||Treatment||None (Open Label)||||||
1572969|NCT00003029|Randomized|||Treatment||||||||
1572970|NCT00003027|Randomized|||Treatment||||||||
1572971|NCT00003026|Randomized|||Treatment||||||||
1572972|NCT00003023||||Treatment||||||||
1572973|NCT00003022||||Treatment||||||||
1572974|NCT00003016|Randomized|||Treatment||||||||
1572975|NCT00003013|Randomized|||Treatment||||||||
1572976|NCT00002996||||Supportive Care||||||||
1572977|NCT00002995||||Treatment||None (Open Label)||||||
1572978|NCT00002990|Randomized|||Treatment||||||||
1572979|NCT00002986||||Treatment||||||||
1572980|NCT00002982||||Treatment||||||||
1572981|NCT00002981||Single Group Assignment||Diagnostic||None (Open Label)||||||
1572982|NCT00002976|Randomized|||Treatment||||||||
1572983|NCT00002975|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572984|NCT00002968|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1572985|NCT00002963|Randomized|||Treatment||||||||
1573251|NCT00001916||||||||||||
1572986|NCT00002951||Single Group Assignment||Treatment||None (Open Label)||||||
1572987|NCT00002948||||Treatment||||||||
1572988|NCT00002944|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1572989|NCT00002943||Single Group Assignment||Treatment||None (Open Label)||||||
1572990|NCT00002941||Single Group Assignment||Treatment||None (Open Label)||||||
1572991|NCT00002938||Single Group Assignment||Treatment||None (Open Label)||||||
1572992|NCT00002931||Single Group Assignment||Treatment||None (Open Label)||||||
1572993|NCT00002926|Randomized|||Treatment||||||||
1572994|NCT00002920|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1572995|NCT00002916||||Treatment||||||||
1572996|NCT00002913||Single Group Assignment||Treatment||None (Open Label)||||||
1572997|NCT00002900|||||Prospective|||||||
1572998|NCT00002899|Randomized|||Treatment||||||||
1572999|NCT00002898|Randomized|||Treatment||||||||
1573000|NCT00002895|Randomized|||Treatment||||||||
1573001|NCT00002894|Randomized|||Treatment||||||||
1573002|NCT00002883|Randomized|||Treatment||||||||
1573003|NCT00002882|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573004|NCT00002874|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573005|NCT00002860||Single Group Assignment||Treatment||None (Open Label)||||||
1573006|NCT00002855|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573007|NCT00002854||Single Group Assignment||Treatment||None (Open Label)||||||
1573008|NCT00002852|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573009|NCT00002851|Randomized|||Treatment||||||||
1573010|NCT00002850|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1573011|NCT00002849||Single Group Assignment||Treatment||None (Open Label)||||||
1573012|NCT00002848||||||||||||
1573013|NCT00002847||||Treatment||||||||
1573014|NCT00002846||||Treatment||||||||
1573015|NCT00002842||Single Group Assignment||Treatment||None (Open Label)||||||
1573016|NCT00002839|Randomized|||Treatment||||||||
1573017|NCT00002810|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573018|NCT00002809||||Treatment||None (Open Label)||||||
1573019|NCT00002807|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573020|NCT00002798|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573021|NCT00002796||Single Group Assignment||Treatment||None (Open Label)||||||
1573022|NCT00002792||||Treatment||||||||
1573023|NCT00002778||||Treatment||None (Open Label)||||||
1573024|NCT00002771|Randomized|||Treatment||||||||
1573025|NCT00002766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573026|NCT00002762|||Case-Only||Prospective|||||||
1573027|NCT00002757|Randomized|||Treatment||||||||
1573028|NCT00002756||Single Group Assignment||Treatment||None (Open Label)||||||
1573029|NCT00002746||Single Group Assignment||Treatment||None (Open Label)||||||
1573030|NCT00002738||||Treatment||||||||
1573031|NCT00002727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573032|NCT00002720|Randomized|||Treatment||||||||
1573033|NCT00002718||Single Group Assignment||Treatment||None (Open Label)||||||
1573034|NCT00002716|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573035|NCT00002715||||Treatment||||||||
1573036|NCT00002706|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573037|NCT00002702|Randomized|||Treatment||||||||
1573038|NCT00002700|Randomized|||Treatment||||||||
1573039|NCT00002697||||Treatment||None (Open Label)||||||
1573040|NCT00002696|Randomized|||Treatment||||||||
1573041|NCT00002689||||Treatment||||||||
1573042|NCT00002687||||Treatment||||||||
1573043|NCT00002684||||Treatment||||||||
1573044|NCT00002681||||Treatment||||||||
1573045|NCT00002678|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573046|NCT00002668|Randomized|Parallel Assignment||||None (Open Label)||||||
1573047|NCT00002663||Single Group Assignment||Treatment||None (Open Label)||||||
1573048|NCT00002662|Randomized|||Treatment||None (Open Label)||||||
1573049|NCT00002651|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573050|NCT00002649|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573051|NCT00002647||||Treatment||||||||
1573052|NCT00002641|Randomized|||Treatment||||||||
1573053|NCT00002633|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573054|NCT00002624||Single Group Assignment||Treatment||None (Open Label)||||||
1573055|NCT00002623|Randomized|||Treatment||||||||
1573056|NCT00002615|Randomized|||Treatment||||||||
1573057|NCT00002611||||Treatment||||||||
1573058|NCT00002610|Non-Randomized|||Treatment||||||||
1573059|NCT00002608||||Treatment||None (Open Label)||||||
1573060|NCT00002598||||Treatment||None (Open Label)||||||
1573061|NCT00002596|Randomized|||Treatment||||||||
1573062|NCT00002594|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573063|NCT00002589||||Treatment||||||||
1573064|NCT00002586|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1573065|NCT00002569|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573066|NCT00002560||||Treatment||||||||
1573067|NCT00002558||Single Group Assignment||Treatment||None (Open Label)||||||
1573068|NCT00002556|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573069|NCT00002546|Randomized|||Treatment||||||||
1573070|NCT00002544|Randomized|||Treatment||||||||
1573071|NCT00002528|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573072|NCT00002523|Randomized|||Treatment||||||||
1573073|NCT00002522|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573074|NCT00002521|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573075|NCT00002517|Randomized|||Treatment||||||||
1573076|NCT00002515||||Treatment||||||||
1573077|NCT00002514|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573078|NCT00002511||||Treatment||||||||
1573079|NCT00002490|Randomized|||Treatment||||||||
1573080|NCT00002484||Single Group Assignment||Treatment||None (Open Label)||||||
1573081|NCT00002475||||Treatment||||||||
1573082|NCT00002474||||Treatment||None (Open Label)||||||
1573083|NCT00002473|Randomized|||Treatment||||||||
1573084|NCT00002472||||Treatment||||||||
1573085|NCT00002470||||Treatment||||||||
1573086|NCT00002455||||Treatment||||||||
1573087|NCT00052156|Randomized|Parallel Assignment||Treatment||Double||||||
1573088|NCT00052143|||Cohort||Prospective|||||||
1573089|NCT00052130|Randomized|Parallel Assignment||Treatment||Double||||||
1573090|NCT00051818|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573091|NCT00052117|Randomized|Parallel Assignment||Treatment||Double||||||
1573092|NCT00052104|Randomized|Parallel Assignment||Treatment||Single||||||
1573093|NCT00052091|Randomized|Parallel Assignment||Treatment||Single||||||t
1573094|NCT00052078|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1573095|NCT00052065|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573096|NCT00052052|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573097|NCT00052026|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573098|NCT00052039|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573099|NCT00052013|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573100|NCT00052000|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573101|NCT00051987|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573102|NCT00051974|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573103|NCT00051948|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573104|NCT00051935|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573105|NCT00051922|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1573106|NCT00051961||||||||||||
1573107|NCT00051909|Randomized|Parallel Assignment||Treatment||Double||||||
1573108|NCT00051896||||Treatment||Double||||||
1573109|NCT00051883|||||Prospective|||||||
1573110|NCT00051844|Randomized|Parallel Assignment||Treatment||Double||||||
1573111|NCT00051831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573112|NCT00051870||||||||||||
1573113|NCT00051857|||Cohort||Retrospective|||||||
1573114|NCT00051805|Randomized|Parallel Assignment||||||||||
1573115|NCT00051792|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573116|NCT00051779||||Treatment||||||||
1573117|NCT00051766|Randomized|Factorial Assignment||Educational/Counseling/Training||None (Open Label)||||||
1573118|NCT00051753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573119|NCT00051740|Randomized|Parallel Assignment||Treatment||Single|||t|||
1573120|NCT00051727|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573121|NCT00051701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573122|NCT00051688||||Treatment||||||||
1573123|NCT00051675|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573124|NCT00051662|Randomized|Single Group Assignment||Treatment||Double||||||
1573125|NCT00051636|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573126|NCT00051623|Randomized|Parallel Assignment||Treatment||Double||||||
1573127|NCT00051597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573128|NCT00051584|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573129|NCT00051571|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573130|NCT00051428|Randomized|Parallel Assignment||Treatment||Double||||||
1573131|NCT00051415|Randomized|Parallel Assignment||Treatment||Double||||||
1573132|NCT00051402|Randomized|Parallel Assignment||Treatment||Double||||||
1573133|NCT00051558|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573134|NCT00051545|Randomized|Parallel Assignment||Educational/Counseling/Training||Double||||||
1573135|NCT00051532|Randomized|||Educational/Counseling/Training||Double||||||
1573136|NCT00051506||||Treatment||||||||
1573137|NCT00051493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573138|NCT00051519||||||||||||
1573139|NCT00051480||||Treatment||||||||
1573140|NCT00051467|Randomized|||Treatment||None (Open Label)||||||
1573141|NCT00051454|Randomized|Parallel Assignment||Prevention||Double||||||
1573142|NCT00051441|Randomized|Parallel Assignment||Treatment||Double||||||
1573143|NCT00051389|Randomized|Crossover Assignment||Prevention||Double||||||
1573144|NCT00051376|Randomized|||Treatment||Double||||||
1573145|NCT00051363|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573146|NCT00051350|Randomized|Crossover Assignment||Prevention||Single|Outcome assessors were unaware of diet sequence.|Individuals were randomized to a sequence of 3 diets (CARB, UNSAT, PROTEIN)||||t
1573147|NCT00051337||||||||||||
1573148|NCT00051324|||Cohort||Prospective|||||||
1573149|NCT00051298|Randomized|Parallel Assignment||Treatment||Double||||||
1573150|NCT00051285|Randomized|Parallel Assignment||Treatment||Double||||||
1573151|NCT00051311||||Treatment||||||||
1573152|NCT00051272|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573153|NCT00051259|Randomized|Parallel Assignment||Treatment||Double||||||
1573154|NCT00051246|Randomized|Parallel Assignment||Treatment||Single||||||t
1573155|NCT00051233|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573156|NCT00051220|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1573157|NCT00051207|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573158|NCT00051194|Randomized|Parallel Assignment||Treatment||Double||||||
1573159|NCT00051181|Randomized|Parallel Assignment||Treatment||Double||||||
1573160|NCT00051168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573161|NCT00051155|Randomized|Parallel Assignment||Treatment||Double||||||
1573162|NCT00051142|Randomized|Parallel Assignment||Treatment||Double||||||
1573163|NCT00051129|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573164|NCT00051116|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573165|NCT00051103|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573166|NCT00051090|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573167|NCT00051077|Randomized|Factorial Assignment||Treatment||Double||||||
1573168|NCT00051051|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573169|NCT00051038||||Treatment||||||||
1573170|NCT00051025|Randomized|Parallel Assignment||Treatment||Double||||||
1573171|NCT00051012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573172|NCT00050999|Randomized|Parallel Assignment||Treatment||Double||||||
1573173|NCT00050986||Single Group Assignment||Treatment||None (Open Label)||||||
1573174|NCT00050973|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573175|NCT00050960|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573176|NCT00050947||||Treatment||||||||
1573177|NCT00050934||||Treatment||||||||
1573178|NCT00050921|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573179|NCT00050908|||||Prospective|||||||
1573180|NCT00050895|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573181|NCT00050882||||Treatment||||||||
1573182|NCT00050869||||||||||||
1573183|NCT00050856||||Treatment||||||||
1573184|NCT00050843|Randomized|Parallel Assignment||Treatment||Double||||||
1573185|NCT00050830|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573186|NCT00050817|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573187|NCT00050791|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573188|NCT00050778|Randomized|Parallel Assignment||Treatment||Single||||||t
1573189|NCT00050804||||Treatment||||||||
1573190|NCT00050765|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1573191|NCT00050687|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573192|NCT00050752|||Case-Only||Prospective|||||||
1573193|NCT00050726||||Treatment||||||||
1573194|NCT00050713|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573195|NCT00050700||||||||||||
1573196|NCT00050674||Single Group Assignment||Treatment||None (Open Label)||||||
1573197|NCT00050661|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573198|NCT00050648|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573199|NCT00050635|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573200|NCT00050609|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1573201|NCT00050427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573202|NCT00050622|Randomized|Crossover Assignment||Treatment||Triple|||t|t||t
1573203|NCT00050596|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1573204|NCT00050583|Randomized|Parallel Assignment||Treatment||Single||||||t
1573205|NCT00050570|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573206|NCT00050557|Randomized|Parallel Assignment||Treatment||Single||||||t
1573207|NCT00050518|Randomized|Parallel Assignment||Prevention||||||||
1573208|NCT00050505|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1573209|NCT00050492||||||||||||
1573210|NCT00050479||||Treatment||||||||
1573211|NCT00050466||||||||||||
1573212|NCT00050440||Single Group Assignment||Treatment||None (Open Label)||||||
1573213|NCT00050414||Single Group Assignment||Treatment||None (Open Label)||||||
1573214|NCT00050401|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573215|NCT00011635||||Treatment||||||||
1573216|NCT00011063||||Treatment||||||||
1573217|NCT00009542||||Treatment||||||||
1573218|NCT00006395||||Treatment||||||||
1573219|NCT00006191||||||||||||
1573220|NCT00006155||||Treatment||||||||
1573221|NCT00006071||||||||||||
1573222|NCT00006062||||Treatment||||||||
1573223|NCT00005926||||Treatment||||||||
1573224|NCT00005912||||Treatment||||||||
1573225|NCT00005783||||Treatment||||||||
1573226|NCT00005781||||||||||||
1573227|NCT00005574||||Treatment||||||||
1573228|NCT00005570||||||||||||
1573229|NCT00005111||||||||||||
1573230|NCT00005016||||||||||||
1573231|NCT00004851||||||||||||
1573232|NCT00004848||||||||||||
1573233|NCT00004576||||Treatment||||||||
1573234|NCT00004574||||||||||||
1573235|NCT00004557||||||||||||
1573236|NCT00001986||||Treatment||||||||
1573237|NCT00001982||||||||||||
1573238|NCT00001977||||||||||||
1573239|NCT00001968||||Treatment||||||||
1573240|NCT00001966||||Treatment||||||||
1573241|NCT00001965||||Treatment||||||||
1573242|NCT00001963||||Treatment||||||||
1573243|NCT00001944||||Treatment||||||||
1573244|NCT00001940||||Treatment||||||||
1573245|NCT00001937||||Treatment||||||||
1573246|NCT00001931||||Treatment||||||||
1573247|NCT00001930||||Treatment||||||||
1573248|NCT00001929||||Treatment||||||||
1573249|NCT00001928||||||||||||
1573250|NCT00001918||||||||||||
1573455|NCT00050388|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573456|NCT00050375|Randomized|Parallel Assignment||Treatment||Double||||||
1573457|NCT00050362||||Treatment||||||||
1573458|NCT00050349||Single Group Assignment||Treatment||None (Open Label)||||||
1573459|NCT00050336|Randomized|Parallel Assignment||Treatment||Single||||||
1573460|NCT00050323|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573461|NCT00050310|||||Prospective|||||||
1573462|NCT00050297|Randomized|Parallel Assignment||Treatment||Double||||||
1573463|NCT00050284|||||Prospective|||||||
1573464|NCT00050271|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573465|NCT00050245||||Treatment||||||||
1573466|NCT00050232|Randomized|Single Group Assignment||Treatment||Double||||||
1573467|NCT00050219||||||||||||
1573468|NCT00050141|Randomized|Parallel Assignment||Treatment||Double||||||
1573469|NCT00050206|Randomized|Parallel Assignment||Treatment||Double||||||
1573470|NCT00050167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573471|NCT00050193||||||||||||
1573472|NCT00050180||||Treatment||||||||
1573473|NCT00050154|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573474|NCT00050128||||Treatment||||||||
1573475|NCT00050102|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573476|NCT00050089|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1573477|NCT00050076|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573478|NCT00050063|||||Prospective|||||||
1573479|NCT00050050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573480|NCT00050037|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573481|NCT00050115|||||Prospective|||||||
1573482|NCT00050024||||||||||||
1573483|NCT00050011|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573484|NCT00049998|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573485|NCT00049985|Randomized|Parallel Assignment||Treatment||Double||||||
1573486|NCT00049972|Non-Randomized|||Treatment||None (Open Label)||||||
1573487|NCT00049959|Randomized|Parallel Assignment||Treatment||Single||||||
1573488|NCT00049946|Randomized|Parallel Assignment||Treatment||Double||||||
1573489|NCT00049933|||Cohort||Prospective|||||||
1573490|NCT00049920|||Cohort||Prospective|||||||
1573491|NCT00049907||||||||||||
1573492|NCT00049894|||||Retrospective|||||||
1573493|NCT00049881||||||||||||
1573494|NCT00049868||||||||||||
1573495|NCT00049855||||||||||||
1573496|NCT00049842|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573497|NCT00049829|Randomized|Parallel Assignment||Treatment||Double||||||
1573498|NCT00049816|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573499|NCT00049803|Randomized|Parallel Assignment||Treatment||Double||||||
1573500|NCT00049790||||Treatment||||||||
1573501|NCT00049777|Randomized|Parallel Assignment||Treatment||Double||||||
1573502|NCT00049764|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573503|NCT00049751|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573504|NCT00048945||||Treatment||||||||
1573505|NCT00049738|||Cohort||Prospective|||||||
1573506|NCT00049725||||Treatment||||||||
1573507|NCT00048932|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573508|NCT00048854|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573509|NCT00048841|Randomized|Crossover Assignment||Prevention||Double||||||
1573510|NCT00048828|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573511|NCT00048815|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573512|NCT00048802|Randomized|Parallel Assignment||Treatment||Double||||||
1573513|NCT00048581|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573514|NCT00048568|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573515|NCT00048906||||Treatment||||||||
1573516|NCT00048893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573517|NCT00048880||||Treatment||||||||
1573518|NCT00048776|Randomized|Parallel Assignment||Treatment||Double||||||
1573519|NCT00048763|Randomized|Parallel Assignment||Treatment||Double||||||
1573520|NCT00048789||Single Group Assignment||Treatment||None (Open Label)||||||
1573521|NCT00048750|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1573522|NCT00048737||Single Group Assignment||Treatment||None (Open Label)||||||
1573523|NCT00048724|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573524|NCT00048711|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573525|NCT00048698||||Treatment||||||||
1573526|NCT00048685||||||||||||
1573527|NCT00048672||Single Group Assignment||Treatment||None (Open Label)||||||
1573528|NCT00048659|Randomized|Parallel Assignment||Treatment||Double||||||
1573529|NCT00048646|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1573530|NCT00048633|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573531|NCT00048620|Randomized|Parallel Assignment||Treatment||Double||||||
1573532|NCT00048607|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573533|NCT00048594|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573534|NCT00048555|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573535|NCT00048542|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573536|NCT00048529|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573537|NCT00048516|Randomized|Parallel Assignment||Treatment||Double||||||
1573538|NCT00048503|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573621|NCT00046748|Randomized|Parallel Assignment||Treatment||Double||||||
1573539|NCT00048464|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573540|NCT00048451|Randomized|Parallel Assignment||Treatment||Double||||||
1573541|NCT00048438|Randomized|Parallel Assignment||Treatment||Double||||||
1573542|NCT00048425|Randomized|Parallel Assignment||Treatment||Double||||||
1573543|NCT00048490||||Treatment||||||||
1573544|NCT00048477||||Treatment||||||||
1573545|NCT00048412|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573546|NCT00048399|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573547|NCT00048386|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573548|NCT00048373|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573549|NCT00048360|Randomized|Parallel Assignment||Treatment||Double||||||
1573550|NCT00048321|Randomized|||Treatment||Double||||||
1573551|NCT00048308|Randomized|Parallel Assignment||Prevention||Double||||||
1573552|NCT00048347|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573553|NCT00048334||||Treatment||||||||
1573554|NCT00048295|Randomized|||Treatment||Double||||||
1573555|NCT00048282|||||Prospective|||||||
1573556|NCT00048230|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573557|NCT00048217|Randomized|||Treatment||None (Open Label)||||||
1573558|NCT00048204|Randomized|Parallel Assignment||Treatment||Double||||||
1573559|NCT00048256||||||||||||
1573560|NCT00048165|Randomized|Parallel Assignment||Treatment||Double||||||
1573561|NCT00048152|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573562|NCT00048139|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573563|NCT00048126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573564|NCT00048113|Randomized|||Treatment||Double||||||
1573565|NCT00048100||Single Group Assignment||Treatment||None (Open Label)||||||
1573566|NCT00048087|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573567|NCT00048074|Randomized|Parallel Assignment||Treatment||Double||||||
1573568|NCT00048061|Randomized|Parallel Assignment||Treatment||Double||||||
1573569|NCT00048048|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573570|NCT00048035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573571|NCT00048022||||Treatment||||||||
1573572|NCT00048009||||Treatment||||||||
1573573|NCT00047983|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573574|NCT00047970|||||Prospective|||||||
1573575|NCT00047840|Randomized|Parallel Assignment||Treatment||Double||||||
1573576|NCT00047827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573577|NCT00047814|Randomized|Crossover Assignment||Treatment||Double||||||
1573578|NCT00047957||||||||||||
1573579|NCT00047944||||||||||||
1573580|NCT00047931||||Treatment||||||||
1573581|NCT00047918||||||||||||
1573582|NCT00047905||||||||||||
1573583|NCT00047879|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573584|NCT00047866||||||||||||
1573585|NCT00047853||||||||||||
1573586|NCT00047801|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573587|NCT00047788|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573588|NCT00047775|Randomized|Single Group Assignment||Treatment||Double||||||
1573589|NCT00047762|Randomized|||Treatment||None (Open Label)||||||
1573590|NCT00047554|||Cohort||Prospective|||||||
1573591|NCT00047541|Randomized|Parallel Assignment||Treatment||Double||||||
1573592|NCT00047528|Randomized|Parallel Assignment||Treatment||Double||||||
1573593|NCT00047515|Randomized|Parallel Assignment||Treatment||Double||||||
1573594|NCT00047749|Randomized|Factorial Assignment||Treatment||Double||||||
1573595|NCT00047736|Randomized|||Treatment||Double||||||
1573596|NCT00047723|Randomized|||Treatment||Double||||||
1573597|NCT00047710||Single Group Assignment||Treatment||None (Open Label)||||||
1573598|NCT00047697|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573599|NCT00047684|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573600|NCT00047671|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573601|NCT00047658|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1573602|NCT00047645|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1573603|NCT00047632|Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1573604|NCT00047606|Randomized|Parallel Assignment||Treatment||Double||||||
1573605|NCT00047593|Randomized|Parallel Assignment||Treatment||Double||||||
1573606|NCT00047619|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1573607|NCT00047580|Randomized|||Treatment||None (Open Label)||||||
1573608|NCT00047567|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573609|NCT00046371||||Treatment||||||||
1573610|NCT00047502||Single Group Assignment||Treatment||None (Open Label)||||||
1573611|NCT00047489|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573612|NCT00047476|Randomized|Parallel Assignment||Treatment||Double||||||
1573613|NCT00047463|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573614|NCT00047450|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573615|NCT00047437|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573616|NCT00047424|Randomized|||Prevention||||||||
1573617|NCT00047411|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573618|NCT00046800|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573619|NCT00046787|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573620|NCT00046761|Randomized|Parallel Assignment||Treatment||Double||||||
1575500|NCT00000975||||Treatment||||||||
1573622|NCT00046813||||Treatment||Double||||||
1573623|NCT00046774|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573624|NCT00046735||Single Group Assignment||Treatment||None (Open Label)||||||
1573625|NCT00046722|Randomized|Parallel Assignment||Treatment||Double||||||
1573626|NCT00046527|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573627|NCT00046514|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573628|NCT00046423|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573629|NCT00046709|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573630|NCT00046696|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573631|NCT00046683|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573632|NCT00046540|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573633|NCT00046501|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573634|NCT00046488|Randomized|Single Group Assignment||||None (Open Label)||||||
1573635|NCT00046475|Randomized|Crossover Assignment||Treatment||Double||||||
1573636|NCT00046462|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573637|NCT00046449|Randomized|Parallel Assignment||Treatment||Double||||||
1573638|NCT00046670||||||||||||
1573639|NCT00046657||||||||||||
1573640|NCT00046644||||||||||||
1573641|NCT00046631|||Cohort||Prospective|||||||
1573642|NCT00046618||||||||||||
1573643|NCT00046605|||Cohort||Prospective|||||||
1573644|NCT00046592||||||||||||
1573645|NCT00046579||||||||||||
1573646|NCT00046566|Randomized|Crossover Assignment||Prevention||Triple|The randomization assignment list was generated by a computer program that could only be accessed by the study data coordinator. Apart from the data coordinator, all research personnel, including study coordinators and BP technicians, and the study participants were unaware of treatment assignment.|The trial participants were assigned to take 40 g/d soy protein, milk protein, or carbohydrate supplementation each for 8 weeks in a random order. A 3-week washout period was implemented between the interventions.|t||t|t
1573647|NCT00046553||||||||||||
1573648|NCT00046436|||||Prospective|||||||
1573649|NCT00046384||||Treatment||||||||
1573650|NCT00046410||||||||||||
1573651|NCT00046397||||Treatment||||||||
1573652|NCT00046345||||||||||||
1573653|NCT00046332|Randomized|Parallel Assignment||Treatment||Double||||||
1573654|NCT00046319|Randomized|Parallel Assignment||Treatment||Double||||||
1573655|NCT00046306|Randomized|Factorial Assignment||Prevention||Double||||||
1573656|NCT00046358||||Treatment||||||||
1573657|NCT00046293||||Treatment||||||||
1573658|NCT00046280|||Cohort||Prospective|||||||
1573659|NCT00046267|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573660|NCT00046254|Randomized|Parallel Assignment||Treatment||Double||||||
1573661|NCT00046241|Randomized|Parallel Assignment||Treatment||Double||||||
1573662|NCT00046228|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573663|NCT00046215||||||||||||
1573664|NCT00046202||||||||||||
1573665|NCT00046189|||Cohort||Prospective|||||||
1573666|NCT00046176|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573667|NCT00046163|Randomized|Parallel Assignment||Treatment||Double||||||
1573668|NCT00046150|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573669|NCT00046137||||Treatment||||||||
1573670|NCT00046124|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1573671|NCT00046111|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1573672|NCT00046085|Non-Randomized|Parallel Assignment||Treatment||Single||||||t
1573673|NCT00046072|Randomized|Single Group Assignment||Treatment||Double||||||
1573674|NCT00046059|||Cohort||Cross-Sectional|||||||
1573675|NCT00046033|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573676|NCT00046020||||Treatment||||||||
1573677|NCT00045994|Randomized|Parallel Assignment||Treatment||Double||||||
1573678|NCT00045981|Randomized|Parallel Assignment||Treatment||Double||||||
1573679|NCT00045968|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573680|NCT00045955|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573681|NCT00045942|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573682|NCT00045916|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1573683|NCT00045903|Randomized|Parallel Assignment||Treatment||Single|||t|||
1573684|NCT00044824|Randomized|Parallel Assignment||Treatment||Double||||||
1573685|NCT00044811|Randomized|Parallel Assignment||Treatment||Double||||||
1573686|NCT00045877||||Treatment||||||||
1573687|NCT00045864||||Treatment||||||||
1573688|NCT00045838||||Treatment||||||||
1573689|NCT00045812||||Treatment||||||||
1573690|NCT00045799|Randomized|Parallel Assignment||Prevention||Double||||||
1573691|NCT00045786|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573692|NCT00045773|||Case-Only||Prospective|||||||
1573693|NCT00045760||||Treatment||||||||
1573694|NCT00044928||||Treatment||||||||
1573695|NCT00044915|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573696|NCT00044902||||Treatment||||||||
1573697|NCT00044889|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573698|NCT00044863|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573699|NCT00044837||||Treatment||||||||
1573700|NCT00044876||||Treatment||||||||
1573701|NCT00044798|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1573702|NCT00044785|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573703|NCT00044772||||Treatment||||||||
1573704|NCT00044759||||Treatment||||||||
1573705|NCT00044746||||Treatment||None (Open Label)||||||
1573706|NCT00044733||||||None (Open Label)||||||
1573707|NCT00044720|Randomized|||||None (Open Label)||||||
1573708|NCT00044707|Randomized|Crossover Assignment||Treatment||Single||||||
1573709|NCT00044694|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573710|NCT00044681|Randomized|Parallel Assignment||Treatment||Double||||||
1573711|NCT00044668|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573712|NCT00044655|Randomized|Parallel Assignment||Treatment||Single||||||t
1573713|NCT00044642|Randomized|Crossover Assignment||Diagnostic||Double||||||
1573714|NCT00044629|Randomized|Parallel Assignment||Treatment||Double||||||
1573715|NCT00044616|Randomized|Parallel Assignment||Treatment||Double||||||
1573716|NCT00044603|||Cohort||Prospective|||||||
1573717|NCT00044590|||Case-Control||Other|||||||
1573718|NCT00044577|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573719|NCT00044564|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573720|NCT00044551|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573721|NCT00044538|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573722|NCT00044525|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573723|NCT00044512|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573724|NCT00044486|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573725|NCT00044473|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573726|NCT00044460|Randomized|Parallel Assignment||Treatment||Double||||||
1573727|NCT00044447|Randomized|Parallel Assignment||Treatment||Double||||||
1573728|NCT00044434|Randomized|||Treatment||Double||||||
1573729|NCT00044421|Randomized|Parallel Assignment||Treatment||Double||||||
1573730|NCT00044408|Randomized|Parallel Assignment||Treatment||Double||||||
1573731|NCT00044395|Randomized|Parallel Assignment||Treatment||Double||||||
1573732|NCT00044382|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573733|NCT00044369|||Defined Population|Screening|Longitudinal, Prospective|||||||
1573734|NCT00044356||Parallel Assignment||Treatment||None (Open Label)||||||
1573735|NCT00044343|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573736|NCT00044317|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1573737|NCT00044291|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573738|NCT00044304||Single Group Assignment||Treatment||None (Open Label)||||||
1573739|NCT00044278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573740|NCT00044265|Randomized|Crossover Assignment||Treatment||Double||||||
1573741|NCT00044252||||||||||||
1573742|NCT00044239||||||||||||
1573743|NCT00044226|Randomized|Single Group Assignment||Treatment||Double||||||
1573744|NCT00044213|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1573745|NCT00044187|Randomized|Parallel Assignment||Treatment||Double||||||
1573746|NCT00044200||||||||||||
1573747|NCT00044174||||||||||||
1573748|NCT00044148||||Treatment||||||||
1573749|NCT00044135|Randomized|Parallel Assignment||Treatment||Double||||||
1573750|NCT00044070|Randomized|||Treatment||Double||||||
1573751|NCT00044057|Randomized|||Treatment||Double||||||
1573752|NCT00044044|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1573753|NCT00044031|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573754|NCT00044018|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573755|NCT00044005|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573756|NCT00043329|||||Retrospective|||||||
1573757|NCT00044122||||||||||||
1573758|NCT00044109||||Treatment||||||||
1573759|NCT00044096||||||||||||
1573760|NCT00044083|Randomized|Crossover Assignment||Other||Triple|||t|t||t
1573761|NCT00043992|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1573762|NCT00043966|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573763|NCT00043953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573764|NCT00043888|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573765|NCT00043979|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573766|NCT00043940|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573767|NCT00043927|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573768|NCT00043914||Single Group Assignment||Treatment||None (Open Label)||||||
1573769|NCT00043901|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573770|NCT00043875|Randomized|Parallel Assignment||Treatment||Double||||||
1573771|NCT00043862|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573772|NCT00043849|Randomized|Parallel Assignment||Treatment||Double||||||
1573773|NCT00043836|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573774|NCT00043823||Single Group Assignment||Treatment||None (Open Label)||||||
1573775|NCT00043810|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573776|NCT00043797|Randomized|Parallel Assignment||Treatment||Double||||||
1573777|NCT00043784|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573778|NCT00043693|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573779|NCT00043771|Randomized|Parallel Assignment||Treatment||Double||||||
1573780|NCT00043758|Randomized|Parallel Assignment||Treatment||Double||||||
1573781|NCT00043745|Randomized|Parallel Assignment||Prevention||Triple|||t||t|t
1573782|NCT00043732|Randomized|Parallel Assignment||Treatment||Double||||||
1573783|NCT00043719|Randomized|Parallel Assignment||Prevention||Double||||||
1573784|NCT00043706||||Treatment||||||||
1573785|NCT00043602|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573786|NCT00043589|Randomized|Parallel Assignment||Treatment||Double||||||
1573787|NCT00043576|Randomized|Parallel Assignment||Treatment||Double||||||
1573788|NCT00043680||||Treatment||||||||
1573789|NCT00043667||||Treatment||||||||
1573790|NCT00043654||||Treatment||||||||
1573791|NCT00043641||||||||||||
1573792|NCT00043628||||Treatment||||||||
1573793|NCT00043615||||||||||||
1573794|NCT00043563|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573795|NCT00043550|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573796|NCT00043537|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1573797|NCT00043511||||Prevention||Double||||||
1573798|NCT00043498|||Cohort||Prospective|||||||
1573799|NCT00043459|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573800|NCT00043446|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573801|NCT00043433|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573802|NCT00043420|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573803|NCT00043407|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573804|NCT00043394|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573805|NCT00043381|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573806|NCT00043368|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573807|NCT00043355|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573808|NCT00043342|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1573809|NCT00043472|||Cohort||Other|||||||
1573810|NCT00043316|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1573811|NCT00043303|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1573812|NCT00043277|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573813|NCT00043264||Parallel Assignment||Treatment||Double||||||
1573814|NCT00043238||||||||||||
1573815|NCT00043212|Randomized|Parallel Assignment||Treatment||Double||||||
1573816|NCT00043199|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573817|NCT00043225|||Cohort||Other|||||||
1573818|NCT00043186|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573819|NCT00042718|Randomized|Parallel Assignment||Treatment||Double||||||
1573820|NCT00042705|||||Prospective|||||||
1573821|NCT00042692|||Natural History||Cross-Sectional, Prospective|||||||
1573822|NCT00042679|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573823|NCT00042666|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573824|NCT00042653|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573825|NCT00042601|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1573826|NCT00042588|Randomized|Parallel Assignment||Treatment||Double||||||
1573827|NCT00042575|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573828|NCT00042562|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573829|NCT00042549|Randomized|Parallel Assignment||Treatment||Single||||||
1573830|NCT00042627||||||||||||
1573831|NCT00042614|||Cohort||Prospective|||||||
1573832|NCT00042536||||||||||||
1573833|NCT00042523||||||||||||
1573834|NCT00042510||Single Group Assignment||Treatment||None (Open Label)||||||
1573835|NCT00042497|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573836|NCT00042484||||||||||||
1573837|NCT00042471|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1573838|NCT00042458|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1573839|NCT00042445|||Case Control, Natural History|||||||||
1573840|NCT00042432|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1573841|NCT00042419|||Natural History||Longitudinal, Prospective|||||||
1573842|NCT00042406|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573843|NCT00042393||||||||||||
1573844|NCT00042367|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573845|NCT00042354|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573846|NCT00042341|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573847|NCT00042328|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573848|NCT00042315|Randomized|||||Double||||||
1573849|NCT00042302|Randomized|||||Double||||||
1573850|NCT00042289|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573851|NCT00041483|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573852|NCT00042380||||Treatment||||||||
1573853|NCT00042276||||||||||||
1573854|NCT00042263|Random Sample||||Cross-Sectional, Retrospective|||||||
1573855|NCT00042250|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1573856|NCT00042237|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573857|NCT00042224|Randomized|Parallel Assignment||Treatment||Single||||||t
1573858|NCT00042211|Randomized|Parallel Assignment||Prevention||Single||||||t
1573859|NCT00042198|Randomized|Parallel Assignment||Treatment||Single||||||t
1573860|NCT00042185|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573861|NCT00042172|Randomized|Parallel Assignment||Treatment||Double||||||
1573862|NCT00042159|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1573863|NCT00042146|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573864|NCT00042133|||||Prospective|||||||
1573865|NCT00042120|||Case Control||Retrospective|||||||
1573866|NCT00042107||||||||||||
1573867|NCT00042094|Randomized|Parallel Assignment||Prevention||Double||||||
1573868|NCT00042081|Randomized|Single Group Assignment||Prevention||Double||||||
1573869|NCT00042068|Randomized|Parallel Assignment||||Double||||||
1573870|NCT00042055|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573871|NCT00042042|Non-Randomized|Single Group Assignment||Educational/Counseling/Training||None (Open Label)||||||
1573872|NCT00042029||||Treatment||||||||
1573873|NCT00042016|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573874|NCT00042003|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573875|NCT00041990|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573876|NCT00041977|Randomized|Single Group Assignment||Treatment||Double||||||
1573877|NCT00041964||||||||||||
1573878|NCT00041951|||Case Control||Prospective|||||||
1573879|NCT00041938|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1573880|NCT00041925|Randomized|Single Group Assignment||Prevention||Double||||||
1573881|NCT00041860||||||||||||
1573882|NCT00041847|||||Retrospective|||||||
1573883|NCT00041834|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1573884|NCT00041821|Randomized|Crossover Assignment||||Single||||||
1573885|NCT00041899||||Treatment||||||||
1573886|NCT00041886||||||||||||
1573887|NCT00041808|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573888|NCT00041795|Randomized|Parallel Assignment||Treatment||Double||||||
1573889|NCT00041782|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573890|NCT00041769|Randomized|||Treatment||None (Open Label)||||||
1573891|NCT00041756|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573892|NCT00041743|Randomized|Parallel Assignment||Treatment||||||||
1573893|NCT00041730|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573894|NCT00041717|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573895|NCT00041704|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573896|NCT00041691|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573897|NCT00041678||||Treatment||||||||
1573898|NCT00041665|Randomized|Parallel Assignment||Prevention||Double||||||
1573899|NCT00041652|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573900|NCT00041639|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573901|NCT00041626|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573902|NCT00041613|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573903|NCT00041600|||Family-Based|||||||||
1573904|NCT00041587|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573905|NCT00041509|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1573906|NCT00041496|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1573907|NCT00041574|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573908|NCT00041561|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1573909|NCT00041548|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1573910|NCT00041535||||Treatment||||||||
1573911|NCT00041470||Single Group Assignment||Treatment||None (Open Label)||||||
1573912|NCT00040677|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573913|NCT00040664|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573914|NCT00040651|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573915|NCT00041457||||||||||||
1573916|NCT00041444|||Cohort||Prospective|||||||
1573917|NCT00041431|Randomized|||||Double||||||
1573918|NCT00041418||||||||||||
1573919|NCT00041405||||||||||||
1573920|NCT00041392|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1573921|NCT00040638|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573922|NCT00040625||||||||||||
1573923|NCT00040027|Randomized|Parallel Assignment||Treatment||Double||||||
1573924|NCT00040599|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573925|NCT00040586|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573926|NCT00040573|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573927|NCT00040560|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1573928|NCT00040547|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573929|NCT00040534|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573930|NCT00040521|Randomized|||Treatment||Double||||||
1573931|NCT00040495||||Prevention||||||||
1573932|NCT00040482|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573933|NCT00040469|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573934|NCT00040456|Randomized|Crossover Assignment||Treatment||Triple|||t|t|t|
1573935|NCT00040443|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1573936|NCT00040430|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1573937|NCT00040508||||Treatment||||||||
1573938|NCT00040417|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573939|NCT00040404|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573940|NCT00040391||||Treatment||||||||
1573941|NCT00040378|||Cohort||Prospective|||||||
1573942|NCT00040365|Non-Randomized|Single Group Assignment||Supportive Care||None (Open Label)||||||
1573943|NCT00040352|||Family-Based||Other|||||||
1573944|NCT00040339|Non-Randomized|||Treatment||||||||
1573945|NCT00040326|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1573946|NCT00040313|Randomized|Parallel Assignment||Treatment||Double||||||
1573947|NCT00040300|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1573948|NCT00040287|Randomized|||Treatment||||||||
1574109|NCT00037570|Randomized|||Prevention||||||||
1573949|NCT00040274|Randomized|Crossover Assignment||Treatment||Double||||||
1573950|NCT00040183|Randomized|Parallel Assignment||Treatment||Double||||||
1573951|NCT00040170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573952|NCT00040157|Randomized|Parallel Assignment||Treatment||Double||||||
1573953|NCT00040144|Randomized|Parallel Assignment||Treatment||Double||||||
1573954|NCT00040261||||Treatment||||||||
1573955|NCT00040248||||Treatment||||||||
1573956|NCT00040235||||Treatment||||||||
1573957|NCT00040222|||Family-Based||Other|||||||
1573958|NCT00040209||||Treatment||||||||
1573959|NCT00040196||||||||||||
1573960|NCT00040131|Randomized|Single Group Assignment||Prevention||Double||||||
1573961|NCT00040105|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573962|NCT00040092|Randomized|Parallel Assignment||Treatment||Double||||||
1573963|NCT00040014|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573964|NCT00040001|Randomized|Parallel Assignment||Treatment||Double||||||
1573965|NCT00039988|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1573966|NCT00039975||||Treatment||None (Open Label)||||||
1573967|NCT00039962|Randomized|Parallel Assignment||Treatment||Double||||||
1573968|NCT00039936|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573969|NCT00040066||Parallel Assignment||Treatment||Double||||||
1573970|NCT00040053|Randomized|||Treatment||Double||||||
1573971|NCT00040040|Randomized|||Diagnostic||Double||||||
1573972|NCT00039923||||||||||||
1573973|NCT00039910|Randomized|Parallel Assignment||Prevention||Double||||||
1573974|NCT00039884|Randomized|Single Group Assignment||Treatment||Single||||||
1573975|NCT00039871|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573976|NCT00039858|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1573977|NCT00039845||||||||||||
1573978|NCT00039832||||Treatment||||||||
1573979|NCT00039793|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573980|NCT00039780|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1573981|NCT00039819||||||||||||
1573982|NCT00039754|Non-Randomized|||Treatment||None (Open Label)||||||
1573983|NCT00039741|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1573984|NCT00039767||||Treatment||||||||
1573985|NCT00039026|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573986|NCT00039013|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1573987|NCT00039000|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573988|NCT00038987|Randomized|Parallel Assignment||Prevention||Single||||||
1573989|NCT00038974||Single Group Assignment||Treatment||None (Open Label)||||||
1573990|NCT00038961|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1573991|NCT00039715||||||||||||
1573992|NCT00039702||||||||||||
1573993|NCT00039689|||Cohort||Prospective|||||||
1573994|NCT00039676|||Family-Based||Other|||||||
1573995|NCT00039663||||Treatment||||||||
1573996|NCT00039650||||||||||||
1573997|NCT00039624||Single Group Assignment||Treatment||None (Open Label)||||||
1573998|NCT00038948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1573999|NCT00038935|Randomized|Crossover Assignment||Treatment||Double||||||
1574000|NCT00038922||||Treatment||||||||
1574001|NCT00038909||||Treatment||||||||
1574002|NCT00038896||||Treatment||||||||
1574003|NCT00038883|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574004|NCT00038870||Single Group Assignment||Treatment||None (Open Label)||||||
1574005|NCT00038857||Single Group Assignment||Treatment||None (Open Label)||||||
1574006|NCT00038844|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574007|NCT00038831|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574008|NCT00038818||Single Group Assignment||Treatment||None (Open Label)||||||
1574009|NCT00038805|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574010|NCT00038792|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574011|NCT00038779|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574012|NCT00038766|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574013|NCT00038753||||Diagnostic||||||||
1574014|NCT00038727|Randomized|Parallel Assignment||Prevention||None (Open Label)|Open label phase for metformin|||||
1574015|NCT00038714|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574016|NCT00038701|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574017|NCT00038688|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1574018|NCT00038675||Single Group Assignment||Treatment||None (Open Label)||||||
1574019|NCT00038662|Randomized|Parallel Assignment||Treatment||Double||||||
1574020|NCT00038649||Single Group Assignment||Treatment||None (Open Label)||||||
1574021|NCT00038636|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574022|NCT00038623|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574023|NCT00038610||Single Group Assignment||Treatment||None (Open Label)||||||
1574024|NCT00038597|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574025|NCT00038584|Randomized|Parallel Assignment||Treatment||Single||||||
1574026|NCT00038571|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574027|NCT00038558|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574028|NCT00038545|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574029|NCT00038532|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574030|NCT00038519|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574031|NCT00038506|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574032|NCT00038493|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574033|NCT00038480|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574034|NCT00038467|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574035|NCT00038454|Randomized|Single Group Assignment||Treatment||Single||||||
1574036|NCT00038441|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574037|NCT00038428|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574038|NCT00038415|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574039|NCT00038402||Single Group Assignment||Treatment||None (Open Label)||||||
1574040|NCT00038389|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574041|NCT00038376|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574042|NCT00038363|Randomized|Factorial Assignment||Treatment||Single||||||
1574043|NCT00038350|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574044|NCT00038337|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1574045|NCT00038311|Randomized|Parallel Assignment||Prevention||Double||||||
1574046|NCT00038298|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574047|NCT00038285|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1574048|NCT00038272|Randomized|Parallel Assignment||Treatment||Double||||||
1574049|NCT00038259|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574050|NCT00038246||Single Group Assignment||Treatment||None (Open Label)||||||
1574051|NCT00038233|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574052|NCT00038220|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574053|NCT00038207|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574054|NCT00038194||Single Group Assignment||Treatment||None (Open Label)||||||
1574055|NCT00038181||Single Group Assignment||Treatment||None (Open Label)||||||
1574056|NCT00038168|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574057|NCT00038155|Randomized|Parallel Assignment||Treatment||Single||||||t
1574058|NCT00038142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574059|NCT00038129|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574060|NCT00038116|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1574061|NCT00038103|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574062|NCT00038090|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574063|NCT00038077|Randomized|||Treatment||Double||||||
1574064|NCT00038064|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574065|NCT00038051||Single Group Assignment||Treatment||None (Open Label)||||||
1574066|NCT00038038|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1574067|NCT00038025|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574068|NCT00038012|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574069|NCT00037999|Randomized|Single Group Assignment||Treatment||Double||||||
1574070|NCT00037986|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574071|NCT00037973|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574072|NCT00037960|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574073|NCT00037947|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574074|NCT00037934|Randomized|Single Group Assignment||Treatment||Single||||||t
1574075|NCT00037921|Randomized|Single Group Assignment||Treatment||Single||||||
1574076|NCT00037908|Randomized|Single Group Assignment||Treatment||Double||||||
1574077|NCT00037895|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574078|NCT00037882|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574079|NCT00037869||Single Group Assignment||Treatment||None (Open Label)||||||
1574080|NCT00037843||Single Group Assignment||Diagnostic||None (Open Label)||||||
1574081|NCT00037830|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1574082|NCT00037817|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574083|NCT00037804||||Treatment||||||||
1574084|NCT00037791|Randomized|Parallel Assignment||Prevention||Double||||||
1574085|NCT00004575||||Treatment||||||||
1574086|NCT00001908||||||||||||
1574087|NCT00001866||||Treatment||||||||
1574088|NCT00001864||||Treatment||||||||
1574089|NCT00001818||||Treatment||||||||
1574090|NCT00001688||||Treatment||||||||
1574091|NCT00001542||||Treatment||||||||
1574092|NCT00001190||||Treatment||||||||
1574093|NCT00037778|||Family-Based||Retrospective|||||||
1574094|NCT00037765|||Cohort||Prospective|||||||
1574095|NCT00037752|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1574096|NCT00037739||||||||||||
1574097|NCT00037726||||||||||||
1574098|NCT00037713|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574099|NCT00037700|Randomized|Parallel Assignment||Treatment||Double||||||
1574100|NCT00037687|Randomized|Parallel Assignment||Treatment||Double||||||
1574101|NCT00037674|Randomized|Parallel Assignment||Treatment||Double||||||
1574102|NCT00037661|Randomized|Parallel Assignment||Treatment||Double||||||
1574103|NCT00037648|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574104|NCT00037635|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1574105|NCT00037622|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574106|NCT00037609||Single Group Assignment||Treatment||None (Open Label)||||||
1574107|NCT00037596||||Treatment||||||||
1574108|NCT00037583||||Treatment||||||||
1574110|NCT00037557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574111|NCT00037544||||Treatment||||||||
1574112|NCT00037531||||||||||||
1574113|NCT00037518|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574114|NCT00037505|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1574115|NCT00037492|Randomized|||Prevention||||||||
1574116|NCT00037479|Randomized|||Treatment||||||||
1574117|NCT00037466|||Cohort||Prospective|||||||
1574118|NCT00037453||||||||||||
1574119|NCT00037440|||Ecologic or Community||Prospective|||||||
1574120|NCT00037427||||||||||||
1574121|NCT00037414||||||||||||
1574122|NCT00037401|||||Retrospective|||||||
1574123|NCT00037388|||||Retrospective|||||||
1574124|NCT00037375||||||||||||
1574125|NCT00037362||||||||||||
1574126|NCT00037349||||||||||||
1574127|NCT00037336||||||||||||
1574128|NCT00037323||||||||||||
1574129|NCT00037310||||||||||||
1574130|NCT00037297||||||||||||
1574131|NCT00037284||||||||||||
1574132|NCT00037271||||||||||||
1574133|NCT00037258||||||||||||
1574134|NCT00037245||||||||||||
1574135|NCT00037232||||||||||||
1574136|NCT00037219|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574137|NCT00037206|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574138|NCT00037193|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1574139|NCT00037180|Randomized|Parallel Assignment||Treatment||Double||||||
1574140|NCT00037167|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574141|NCT00037154|Randomized|Parallel Assignment||Treatment||Double||||||
1574142|NCT00037141|Randomized|Parallel Assignment||Treatment||||||||
1574143|NCT00037128|Randomized|Crossover Assignment||Treatment||Double||||||
1574144|NCT00037115|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574145|NCT00037102||Single Group Assignment||Treatment||None (Open Label)||||||
1574146|NCT00037089||||Treatment||||||||
1574147|NCT00037076||||||||||||
1574148|NCT00037063||||Prevention||||||||
1574149|NCT00037050|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574150|NCT00036647|Randomized|Parallel Assignment||Treatment||Double||||||
1574151|NCT00036634|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574152|NCT00036621||||Treatment||||||||
1574153|NCT00036608||||Treatment||||||||
1574154|NCT00036595||||||||||||
1574155|NCT00036582||||Treatment||||||||
1574156|NCT00036569|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574157|NCT00036556|Randomized|Parallel Assignment||Treatment||Double||||||
1574158|NCT00036543|Randomized|Parallel Assignment||Treatment||Double||||||
1574159|NCT00036517|Randomized|Crossover Assignment||Treatment||Double||||||
1574160|NCT00036504|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1574161|NCT00036491||Single Group Assignment||Treatment||None (Open Label)||||||
1574162|NCT00036478||||||||||||
1574163|NCT00036465|Randomized|Parallel Assignment||Treatment||||||||
1574164|NCT00036452|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574165|NCT00036439|Randomized|Parallel Assignment||Treatment||Double||||||
1574166|NCT00036426|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574167|NCT00036413|Randomized|Parallel Assignment||Treatment||Double||||||
1574168|NCT00036400|Randomized|Parallel Assignment||Treatment||Double||||||
1574169|NCT00036387|Randomized|Parallel Assignment||Treatment||Double||||||
1574170|NCT00036374|Randomized|Parallel Assignment||Treatment||Double||||||
1574171|NCT00036361|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574172|NCT00036348||||Treatment||||||||
1574173|NCT00036335|Randomized|Parallel Assignment||Treatment||Double||||||
1574174|NCT00036309||||Treatment||||||||
1574175|NCT00036296|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574176|NCT00036283|Randomized|Parallel Assignment||Prevention||Double||||||
1574177|NCT00036270|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574178|NCT00036257|Non-Randomized|||Treatment||None (Open Label)||||||
1574179|NCT00036244|Randomized|Single Group Assignment||Treatment||Double||||||
1574180|NCT00036231|Randomized|Single Group Assignment||Treatment||Double||||||
1574181|NCT00036218|Randomized|Parallel Assignment||Treatment||Double||||||
1574182|NCT00036205|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574183|NCT00036192|Randomized|Parallel Assignment||Treatment||Double||||||
1574184|NCT00036179|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574185|NCT00036166|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574186|NCT00036153|Randomized|Parallel Assignment||Treatment||Double||||||
1574187|NCT00036140||||Treatment||||||||
1574188|NCT00036127||||Treatment||||||||
1574189|NCT00036114||||Treatment||||||||
1574190|NCT00036101||||Treatment||||||||
1574191|NCT00036088|Randomized|Parallel Assignment||Treatment||Double||||||
1574192|NCT00036075|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574193|NCT00036062|Randomized|Parallel Assignment||Treatment||Double||||||
1574194|NCT00036036|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574195|NCT00036023|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574196|NCT00035997|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574197|NCT00035984|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574198|NCT00035971||||Treatment||||||||
1574199|NCT00035958|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574200|NCT00035945||||Treatment||||||||
1574201|NCT00035932|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574202|NCT00035919|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574203|NCT00035906|Randomized|Parallel Assignment||Treatment||||||||
1574204|NCT00035893|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574205|NCT00035880|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574206|NCT00035867|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574207|NCT00035854|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574208|NCT00035841|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574209|NCT00035828|Randomized|Parallel Assignment||Treatment||Double||||||
1574210|NCT00035815|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574211|NCT00035802|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574212|NCT00035789||||Treatment||||||||
1574213|NCT00035776||||||||||||
1574214|NCT00035763||||||||||||
1574215|NCT00035750||||||||||||
1574216|NCT00035737||||||||||||
1574217|NCT00035724||||||||||||
1574218|NCT00035711|||||Retrospective|||||||
1574219|NCT00035698|||Cohort||Cross-Sectional|||||||
1574220|NCT00035685||||||||||||
1574221|NCT00035672|||Cohort||Retrospective|||||||
1574222|NCT00035659|||Cohort||Prospective|||||||
1574223|NCT00035633||||Treatment||||||||
1574224|NCT00035620|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1574225|NCT00035607|Randomized|Parallel Assignment||Supportive Care||None (Open Label)||||||
1574226|NCT00035594|Randomized|Parallel Assignment||Prevention||Triple|||t|t|t|
1574227|NCT00035581|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574228|NCT00035568||||Treatment||||||||
1574229|NCT00035555|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1574230|NCT00035542||||Treatment||||||||
1574231|NCT00035529|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574232|NCT00035516||||Treatment||||||||
1574233|NCT00035503|Randomized|Parallel Assignment||Treatment||Double||||||
1574234|NCT00035490|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574235|NCT00035477|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574236|NCT00035464|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574237|NCT00035451|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574238|NCT00035438|Randomized|Parallel Assignment||Treatment||Double||||||
1574239|NCT00035425|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574240|NCT00035412|Randomized|Parallel Assignment||Treatment||Double||||||
1574241|NCT00035399|Randomized|Parallel Assignment||Treatment||Double||||||
1574242|NCT00035360|Randomized|Parallel Assignment||Treatment||Double||||||
1574243|NCT00035347|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574244|NCT00035386||||Treatment||||||||
1574245|NCT00035373|||Cohort||Prospective|||||||
1574246|NCT00035334|Randomized|Parallel Assignment||Treatment||Double||||||
1574247|NCT00035321|Randomized|Parallel Assignment||Treatment||Double||||||
1574248|NCT00035308|Randomized|Parallel Assignment||Treatment||Double||||||
1574249|NCT00035295|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574250|NCT00035282|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574251|NCT00035269|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574252|NCT00035256|Randomized|Parallel Assignment||Treatment||Double||||||
1574253|NCT00035243|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574254|NCT00035230|Randomized|Parallel Assignment||Treatment||Double||||||
1574255|NCT00035217|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1574256|NCT00035204|Randomized|Parallel Assignment||Treatment||Double||||||
1574257|NCT00035191|Randomized|Parallel Assignment||Treatment||Double||||||
1574258|NCT00035178|Randomized|||Treatment||None (Open Label)||||||
1574259|NCT00035165||Single Group Assignment||Treatment||None (Open Label)||||||
1574260|NCT00035152|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1574261|NCT00035139|Randomized|Crossover Assignment||Treatment||||||||
1574262|NCT00035126|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574263|NCT00035113|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574264|NCT00035100|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574265|NCT00035087|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574266|NCT00035074||Crossover Assignment||Treatment||||||||
1574267|NCT00035061||||Treatment||||||||
1574268|NCT00035048|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574269|NCT00035035|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574270|NCT00035022|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574271|NCT00035009|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574272|NCT00034983|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574273|NCT00034970|Randomized|Factorial Assignment||Educational/Counseling/Training||None (Open Label)||||||
1574274|NCT00034957||||Treatment||||||||
1574275|NCT00034944||||Treatment||Double|||t||t|
1574276|NCT00034918|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1574277|NCT00034905||||Treatment||||||||
1574278|NCT00034892|Randomized|Parallel Assignment||Treatment||Double||||||
1574279|NCT00034879|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574280|NCT00034866|Randomized|Parallel Assignment||Treatment||Double||||||
1574281|NCT00034853||Parallel Assignment||Treatment||||||||
1574282|NCT00034840|Randomized|Parallel Assignment||Treatment||Double||||||
1574642|NCT00026676||||||||||||
1574283|NCT00034827|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574284|NCT00034814||||Treatment||||||||
1574285|NCT00034801|Randomized|Parallel Assignment||Treatment||Double||||||
1574286|NCT00034788|Randomized|Parallel Assignment||Treatment||Double||||||
1574287|NCT00034775|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574288|NCT00034762|Randomized|Parallel Assignment||Treatment||Double||||||
1574289|NCT00034749|Randomized|Parallel Assignment||Treatment||Double||||||
1574290|NCT00034736|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574291|NCT00034723||||||||||||
1574292|NCT00034710|Randomized|||Treatment||Double||||||
1574293|NCT00034697|Randomized|Parallel Assignment||Treatment||Double||||||
1574294|NCT00034684|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574295|NCT00034671|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574296|NCT00034658|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574297|NCT00034645|Randomized|Parallel Assignment||Prevention||Double||||||
1574298|NCT00034632|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574299|NCT00034619||||Treatment||||||||
1574300|NCT00034606|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574301|NCT00034593||||Treatment||||||||
1574302|NCT00034580|Randomized|Parallel Assignment||Treatment||Double||||||
1574303|NCT00034567|||Defined Population|Screening|Longitudinal, Prospective|||||||
1574304|NCT00034554|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574305|NCT00034541|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574306|NCT00034528||Single Group Assignment||Treatment||None (Open Label)||||||
1574307|NCT00034515|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574308|NCT00034502||||Treatment||||||||
1574309|NCT00034489|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574310|NCT00034476|Randomized|Parallel Assignment||Treatment||Double||||||
1574311|NCT00034463||||Treatment||||||||
1574312|NCT00034450|Randomized|Crossover Assignment||Treatment||Double||||||
1574313|NCT00034437||||||||||||
1574314|NCT00034424|||Family-Based||Other|||||||
1574315|NCT00034398||||||||||||
1574316|NCT00034385||||Treatment||||||||
1574317|NCT00034372|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574318|NCT00034359|Randomized|Parallel Assignment||Treatment||Double||||||
1574319|NCT00017862||||Treatment||||||||
1574320|NCT00034346|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574321|NCT00034333|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574322|NCT00034307|Randomized|Parallel Assignment||Treatment||Double||||||
1574323|NCT00034294|Randomized|Parallel Assignment||Treatment||Double||||||
1574324|NCT00034281|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574325|NCT00034268|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574326|NCT00034255|Randomized|Single Group Assignment||Treatment||Double||||||
1574327|NCT00034203|Randomized|||Treatment||Double||||||
1574328|NCT00034190|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574329|NCT00034177|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574330|NCT00034242||||Treatment||||||||
1574331|NCT00034229||||Treatment||||||||
1574332|NCT00034216|||Cohort||Prospective|||||||
1574333|NCT00034164|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574334|NCT00034151|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574335|NCT00034138|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574336|NCT00034125|Randomized|Single Group Assignment||Treatment||Double||||||
1574337|NCT00034112|Randomized|||Treatment||||||||
1574338|NCT00034086||||Treatment||None (Open Label)||||||
1574339|NCT00034073||||||||||||
1574340|NCT00034060||||Treatment||||||||
1574341|NCT00034047|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574342|NCT00034034|Randomized|Single Group Assignment||Treatment||Single||||||
1574343|NCT00034021|Randomized|Parallel Assignment||Treatment||Double||||||
1574344|NCT00034008|Randomized|Parallel Assignment||Treatment||Single||||||
1574345|NCT00033995||||||||||||
1574346|NCT00033982||||Treatment||||||||
1574347|NCT00033969||||||||||||
1574348|NCT00033956|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1574349|NCT00033943|Randomized|Parallel Assignment||Treatment||Double||||||
1574350|NCT00033917|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1574351|NCT00033904|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574352|NCT00033891|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1574353|NCT00033878||||Treatment||||||||
1574354|NCT00033865|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574355|NCT00033852|Randomized|Parallel Assignment||Treatment||Single||||||
1574356|NCT00033839|Randomized|Parallel Assignment||Treatment||Double||||||
1574357|NCT00033826|||Case-Only||Cross-Sectional|||||||
1574358|NCT00033813|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574359|NCT00033787||||||||||||
1574360|NCT00033774|||Case-Only||Prospective|||||||
1574361|NCT00033215|Non-Randomized|Sequential Assignment||Treatment||None (Open Label)||Four dose levels were evaluated sequentially in separate groups of 6 to 8 patients: 1,600 mg/d (800 mg BID, Dose Level1 (DL1)), 3,200 mg/d (1,600 mg BID, DL2), 4,800 mg/d (2,400 mg BID, DL3), and 6,400 mg/d (3,200 mg BID, DL4). There was no intrapatient dose escalation.||||
1574362|NCT00033202|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574643|NCT00026663|||Cohort||Prospective|||||||
1574363|NCT00033189|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574364|NCT00033176|Randomized|Single Group Assignment||Treatment||Double||||||
1574365|NCT00033163|Randomized|Parallel Assignment||Treatment||||||||
1574366|NCT00033150|Randomized|Parallel Assignment||Treatment||Single||||||
1574367|NCT00033137|||Cohort||Prospective|||||||
1574368|NCT00033124||||Treatment||||||||
1574369|NCT00033111|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1574370|NCT00033098||Crossover Assignment||Treatment||Double||||||
1574371|NCT00033085|Randomized|Parallel Assignment||Treatment||Double||||||
1574372|NCT00033072|Randomized|||Treatment||Single||||||
1574373|NCT00033059|Randomized|||Treatment||Double||||||
1574374|NCT00033046||Crossover Assignment||Treatment||Double||||||
1574375|NCT00033033|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574376|NCT00033020|Randomized|||Treatment||||||||
1574377|NCT00033007|Randomized|||Treatment||||||||
1574378|NCT00032994|Randomized|||Treatment||||||||
1574379|NCT00032981|Randomized|||Treatment||||||||
1574380|NCT00032968|Randomized|||Treatment||None (Open Label)||||||
1574381|NCT00032955||||Treatment||None (Open Label)||||||
1574382|NCT00032942|Randomized|Parallel Assignment||Treatment||Double||||||
1574383|NCT00032929|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1574384|NCT00032916|Randomized|||Treatment||Double||||||
1574385|NCT00032903|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574386|NCT00032890|Randomized|Parallel Assignment||Treatment||Double||||||
1574387|NCT00032877||||||||||||
1574388|NCT00032864||||||||||||
1574389|NCT00032838||||||||||||
1574390|NCT00032825||||Treatment||||||||
1574391|NCT00032799|Randomized|Parallel Assignment||Treatment||Double||||||
1574392|NCT00032786|Randomized|Parallel Assignment||Treatment||Double||||||
1574393|NCT00032773|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574394|NCT00032812||||||||||||
1574395|NCT00032760|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1574396|NCT00032747|Randomized|Parallel Assignment||Treatment||Double||||||
1574397|NCT00032734|Randomized|Parallel Assignment||Treatment||Double||||||
1574398|NCT00032721|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1574399|NCT00032708|Randomized|Parallel Assignment||Prevention||Double||||||
1574400|NCT00032695|Randomized|||Treatment||Double||||||
1574401|NCT00032682||||||||||||
1574402|NCT00032669||||Treatment||||||||
1574403|NCT00032656|Random Sample||Natural History||Cross-Sectional, Retrospective|||||||
1574404|NCT00032643||||||Double||||||
1574405|NCT00032630|Randomized|Parallel Assignment||Treatment||Single|||t|||
1574406|NCT00032617|Randomized|Parallel Assignment||Treatment||Single|||||t|
1574407|NCT00032591|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574408|NCT00032578||||||||||||
1574409|NCT00032565|||||Cross-Sectional|||||||
1574410|NCT00032552||||||||||||
1574411|NCT00032539|||Case-Crossover||Retrospective|||||||
1574412|NCT00032526|Randomized|||Educational/Counseling/Training||Single||||||
1574413|NCT00032513||||||||||||
1574414|NCT00032500|Randomized|Parallel Assignment||Prevention||Double||||||
1574415|NCT00032487|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574416|NCT00032474|Randomized|Crossover Assignment||Treatment||Double||||||
1574417|NCT00032461|||||Retrospective|||||||
1574418|NCT00032448|Randomized|Parallel Assignment||||None (Open Label)||||||
1574419|NCT00032435||||||Double||||||
1574420|NCT00032422|Randomized|Parallel Assignment||Treatment||Single||||||
1574421|NCT00032409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574422|NCT00032396||||Treatment||||||||
1574423|NCT00032383|Randomized|Parallel Assignment||Treatment||Double||||||
1574424|NCT00032370|Randomized|Parallel Assignment||Prevention||Single||||||t
1574425|NCT00032357|Randomized|Parallel Assignment||Diagnostic||Single||||||t
1574426|NCT00032344|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1574427|NCT00032331|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1574428|NCT00032305|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574429|NCT00032292|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574430|NCT00032279|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574431|NCT00032240|Randomized|Crossover Assignment||Treatment||Double||||||
1574432|NCT00032227|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574433|NCT00032201||||||||||||
1574434|NCT00031551|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1574435|NCT00031538|||Cohort||Prospective|||||||
1574436|NCT00031512|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1574437|NCT00031499|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574438|NCT00031486|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574439|NCT00031473|Randomized|Parallel Assignment||Prevention||Single||||||
1574440|NCT00031460|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1574441|NCT00031447|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1574442|NCT00031434|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574443|NCT00031421|||Case Control||Cross-Sectional|||||||
1574444|NCT00031408|||Cohort||Prospective|||||||
1574445|NCT00031395|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574446|NCT00031382||||||||||||
1574447|NCT00031369||||||||||||
1574448|NCT00031343||||Treatment||||||||
1574449|NCT00031317||||Treatment||||||||
1574450|NCT00031304||||||||||||
1574451|NCT00031291||||||||||||
1574452|NCT00031278|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574453|NCT00031265|Randomized|||Treatment||||||||
1574454|NCT00031252||||||||||||
1574455|NCT00031239||||||||||||
1574456|NCT00031226||||||||||||
1574457|NCT00031213||||||||||||
1574458|NCT00031200||||||||||||
1574459|NCT00031187|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574460|NCT00031174|||Case-Control||Prospective|||||||
1574461|NCT00031161|Randomized|||Prevention||Double||||||
1574462|NCT00031148|Randomized|||Prevention||Double||||||
1574463|NCT00031135|Randomized|||Prevention||Double||||||
1574464|NCT00031122|||Family-Based||Retrospective|||||||
1574465|NCT00031109||||Prevention||||||||
1574466|NCT00031096|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574467|NCT00031083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574468|NCT00031070|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574469|NCT00031057||||Treatment||||||||
1574470|NCT00031044|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574471|NCT00031031|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574472|NCT00031018|Randomized|Parallel Assignment||Treatment||Double||||||
1574473|NCT00031005||||Treatment||||||||
1574474|NCT00030992||Single Group Assignment||Treatment||None (Open Label)||||||
1574475|NCT00030979||||Treatment||||||||
1574476|NCT00030966|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1574477|NCT00030953||||||||||||
1574478|NCT00030940||||||||||||
1574479|NCT00030238|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574480|NCT00030225|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574481|NCT00030212||||||||||||
1574482|NCT00030199||||||||||||
1574483|NCT00030186|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574484|NCT00030173|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574485|NCT00030160|Randomized|Parallel Assignment||Prevention||Single||||||
1574486|NCT00030147|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574487|NCT00030134||||||||||||
1574488|NCT00030121|Randomized|Parallel Assignment||Treatment||Double||||||
1574489|NCT00030069|Non-Randomized|||Treatment||None (Open Label)||||||
1574490|NCT00030056|Randomized|||Treatment||||||||
1574491|NCT00030043|Non-Randomized|||Treatment||None (Open Label)||||||
1574492|NCT00030030|Randomized|||Prevention||Double||||||
1574493|NCT00030004|Randomized|Parallel Assignment||Treatment||Double||||||
1574494|NCT00029991|Randomized|Parallel Assignment||Treatment||Double||||||
1574495|NCT00029978|||Defined Population||Cross-Sectional|||||||
1574496|NCT00029965|||Cohort||Prospective|||||||
1574497|NCT00029952||||||||||||
1574498|NCT00029939||||||||||||
1574499|NCT00029926||||||||||||
1574500|NCT00029913|||Cohort||Prospective|||||||
1574501|NCT00029900|Non-Randomized|||Treatment||None (Open Label)||||||
1574502|NCT00029874|Randomized|||Treatment||Double||||||
1574503|NCT00029861|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1574504|NCT00029848|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574505|NCT00029835|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574506|NCT00029822|Randomized|Parallel Assignment||Prevention||Double||||||
1574507|NCT00029809|Randomized|||Treatment||||||||
1574508|NCT00029796|Randomized|||Treatment||Double||||||
1574509|NCT00029783|Randomized|||Treatment||||||||
1574510|NCT00029770||||Treatment||||||||
1574511|NCT00029757|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574512|NCT00029744||||||||||||
1574513|NCT00029731|Non-Randomized|Parallel Assignment||Treatment||||||||
1574514|NCT00029718||||||||||||
1574515|NCT00029692|Randomized|||Treatment||Double||||||
1574516|NCT00029679|Randomized|||Treatment||||||||
1574517|NCT00029666||||Treatment||||||||
1574518|NCT00029653||||||||||||
1574519|NCT00029640||||||||||||
1574520|NCT00029627||||||||||||
1574521|NCT00029614|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574522|NCT00029601||||||||||||
1574523|NCT00029588|||Cohort||Cross-Sectional|||||||
1574524|NCT00029575||||Treatment||||||||
1574525|NCT00029536|Randomized|Parallel Assignment||Treatment||Quadruple||This was a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Randomization was carried out separately for women with and without catamenial epilepsy, 2:1 to progesterone or placebo.|t|t|t|t
1574526|NCT00029523|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574527|NCT00029510|Randomized|Parallel Assignment||Treatment||Double||||||
1574528|NCT00029497|Randomized|||Treatment||||||||
1574529|NCT00029484|Randomized|||||||||||
1574530|NCT00029458||||Treatment||||||||
1574531|NCT00029445|||Cohort||Prospective|||||||
1574532|NCT00029406|||Cohort||Prospective|||||||
1574533|NCT00029393||||Treatment||None (Open Label)||||||
1574534|NCT00029380||||Treatment||||||||
1574535|NCT00029341||||Treatment||None (Open Label)||||||
1574536|NCT00029328|Non-Randomized|||Treatment||None (Open Label)||||||
1574537|NCT00029315|Randomized|||Treatment||Double||||||
1574538|NCT00029302||||||||||||
1574539|NCT00029289|Randomized|Crossover Assignment||Treatment||Double||||||
1574540|NCT00029276|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574541|NCT00029263|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1574542|NCT00029250|Randomized|Parallel Assignment||Treatment||Double||||||
1574543|NCT00029237|Randomized|Crossover Assignment||Educational/Counseling/Training||None (Open Label)||||||
1574743|NCT00017784||||Treatment||||||||
1574544|NCT00029224|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574545|NCT00029211|Randomized|Parallel Assignment||Treatment||Double||||||
1574546|NCT00029198|Randomized|Factorial Assignment||Treatment||Single|||t|||
1574547|NCT00029185|Randomized|Single Group Assignment||Treatment||Double||||||
1574548|NCT00029172|Randomized|||Treatment||Single||||||t
1574549|NCT00029159|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1574550|NCT00029146|Randomized|Parallel Assignment||Treatment||Single||||||t
1574551|NCT00029133|Randomized|||Treatment||||||||
1574552|NCT00028431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574553|NCT00028418|Non-Randomized|||Treatment||None (Open Label)||||||
1574554|NCT00028405|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574555|NCT00029120||||||||||||
1574556|NCT00029107|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574557|NCT00029068||||||||||||
1574558|NCT00029042||||Treatment||||||||
1574559|NCT00028379||||||||||||
1574560|NCT00028366||Parallel Assignment||Treatment||None (Open Label)||||||
1574561|NCT00028353|Randomized|Parallel Assignment||Prevention||Double||||||
1574562|NCT00028340|||Cohort||Prospective|||||||
1574563|NCT00028327|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1574564|NCT00028314|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1574565|NCT00028301||||Treatment||None (Open Label)||||||
1574566|NCT00028288|Randomized|Parallel Assignment||Treatment||Double||||||
1574567|NCT00028275||||Treatment||||||||
1574568|NCT00028262||Single Group Assignment||Treatment||None (Open Label)||||||
1574569|NCT00028249||||||||||||
1574570|NCT00028236||||Treatment||||||||
1574571|NCT00028210||||||||||||
1574572|NCT00028197||||||||||||
1574573|NCT00028184||||||||||||
1574574|NCT00028171|Non-Randomized|||Treatment||None (Open Label)||||||
1574575|NCT00028158|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574576|NCT00028145|||Cohort||Prospective|||||||
1574577|NCT00028132||Parallel Assignment||Prevention||||||||
1574578|NCT00028119|||Cohort||Prospective|||||||
1574579|NCT00028106||||Treatment||||||||
1574580|NCT00028093|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574581|NCT00028080||||||||||||
1574582|NCT00028067||||Treatment||||||||
1574583|NCT00027482||||||||||||
1574584|NCT00027469||||Treatment||||||||
1574585|NCT00027456||||Treatment||||||||
1574586|NCT00027443|Randomized|||Treatment||None (Open Label)||||||
1574587|NCT00027430|Randomized|Parallel Assignment||Treatment||||||||
1574588|NCT00027417|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574589|NCT00027404|Randomized|Parallel Assignment||Treatment||Double||||||
1574590|NCT00027391|Randomized|||Treatment||Double||||||
1574591|NCT00027378|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1574592|NCT00027365||||Prevention||Double||||||
1574593|NCT00027352|||||Prospective|||||||
1574594|NCT00027339|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574595|NCT00027326|||Cohort||Prospective|||||||
1574596|NCT00027300|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1574597|NCT00027287||||Treatment||||||||
1574598|NCT00027274|||Family-Based||Other|||||||
1574599|NCT00027261||||Prevention||Double||||||
1574600|NCT00027248|Randomized|Single Group Assignment||Prevention||Double||||||
1574601|NCT00027235|||Defined Population, Natural History||Longitudinal|||||||
1574602|NCT00027209|Randomized|||Treatment||Double||||||
1574603|NCT00027196||||||||||||
1574604|NCT00027183||||||||||||
1574605|NCT00027170|||Case-Control||Prospective|||||||
1574606|NCT00027157||||||||||||
1574607|NCT00027144|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574608|NCT00027131|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574609|NCT00027118|||Cohort||Prospective|||||||
1574610|NCT00027105|||Cohort||Prospective|||||||
1574611|NCT00027092||||||||||||
1574612|NCT00027079|Randomized|||Treatment||Double||||||
1574613|NCT00027066|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1574614|NCT00027053|Randomized|Parallel Assignment||Treatment||Double||||||
1574615|NCT00027040||||Treatment||||||||
1574616|NCT00027027|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574617|NCT00027014|Randomized|Single Group Assignment||Diagnostic||Single||||||
1574618|NCT00027001|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574619|NCT00026988|Randomized|Parallel Assignment||Treatment||Double||||||
1574620|NCT00026975|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574621|NCT00026962||||Treatment||||||||
1574622|NCT00026949||||||||||||
1574623|NCT00026936||||Treatment||||||||
1574624|NCT00026923||||Treatment||||||||
1574625|NCT00026910||||||||||||
1574626|NCT00026897||||Treatment||||||||
1574627|NCT00026884|||Cohort||Prospective|||||||
1574628|NCT00026871||||Treatment||||||||
1574629|NCT00026858||||Treatment||||||||
1574630|NCT00026832||||||||||||
1574631|NCT00026819||||Treatment||||||||
1574632|NCT00026806||||||||||||
1574633|NCT00026793|||Cohort||Prospective|||||||
1574634|NCT00026780|||Cohort||Prospective|||||||
1574635|NCT00026767||||||||||||
1574636|NCT00026754|||Cohort||Prospective|||||||
1574637|NCT00026741||||||||||||
1574638|NCT00026728||||||||||||
1574639|NCT00026715||||||||||||
1574640|NCT00026702|||Cohort||Cross-Sectional|||||||
1574641|NCT00026689|||Case-Only||Cross-Sectional|||||||
1574644|NCT00026650|||Cohort||Prospective|||||||
1574645|NCT00026637|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574646|NCT00026624||||Treatment||None (Open Label)||||||
1574647|NCT00026611||||Prevention||Double||||||
1574648|NCT00026598||||||||||||
1574649|NCT00026585||||Treatment||||||||
1574650|NCT00026559||||||||||||
1574651|NCT00026546|||Cohort||Other|||||||
1574652|NCT00026065|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1574653|NCT00026052||||Treatment||||||||
1574654|NCT00026039|Randomized|||||Double||||||
1574655|NCT00026026||||Screening|Cross-Sectional|||||||
1574656|NCT00026013|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1574657|NCT00026000||||||||||||
1574658|NCT00025987||||Treatment||||||||
1574659|NCT00025974||||||||||||
1574660|NCT00025935||||||||||||
1574661|NCT00025922||||||||||||
1574662|NCT00025909||||Treatment||||||||
1574663|NCT00025896|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574664|NCT00027222||||Treatment||||||||
1574665|NCT00025883||Single Group Assignment||Treatment||None (Open Label)||||||
1574666|NCT00025870||||||||||||
1574667|NCT00025857||||||||||||
1574668|NCT00025844||||||||||||
1574669|NCT00025831||||||||||||
1574670|NCT00025818|Randomized|Parallel Assignment||Treatment||Double||||||
1574671|NCT00025805||||Treatment||||||||
1574672|NCT00025792||||Treatment||||||||
1574673|NCT00025779|Randomized|Crossover Assignment||Treatment||Double||||||
1574674|NCT00025766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574675|NCT00025753|Randomized|||Treatment||||||||
1574676|NCT00025740||||Treatment||||||||
1574677|NCT00025727||Parallel Assignment||Treatment||||||||
1574678|NCT00025714||||||||||||
1574679|NCT00025701||||||||||||
1574680|NCT00024999||||||||||||
1574681|NCT00024986||||Treatment||||||||
1574682|NCT00024960||||||||||||
1574683|NCT00024934||||Treatment||||||||
1574684|NCT00024921||||||||||||
1574685|NCT00024908||||||||||||
1574686|NCT00024804|||Case-Only||Prospective|||||||
1574687|NCT00024843||||||||||||
1574688|NCT00024830||||||||||||
1574689|NCT00024817||||||||||||
1574690|NCT00024791||||||||||||
1574691|NCT00024687|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574692|NCT00024674|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574693|NCT00024661|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574694|NCT00024648|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574695|NCT00024622||||||||||||
1574696|NCT00024596|||Family-Based||Cross-Sectional|||||||
1574697|NCT00024583||||||||||||
1574698|NCT00024570|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574699|NCT00024557|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574700|NCT00024544|Randomized|Parallel Assignment||Treatment||Double||||||
1574701|NCT00024531|Randomized|||Treatment||Double||||||
1574702|NCT00024518|Randomized|Parallel Assignment||Treatment||Double|||t|||t
1574703|NCT00024505|||Cohort||Prospective|||||||
1574704|NCT00024492|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574705|NCT00024479|||Cohort||Prospective|||||||
1574706|NCT00023595|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574707|NCT00023582||||||||||||
1574708|NCT00023569||||||||||||
1574709|NCT00023504||||||||||||
1574710|NCT00023465|||Defined Population||Longitudinal, Prospective|||||||
1574711|NCT00023452|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1574712|NCT00023439|||||Prospective|||||||
1574713|NCT00023426|Randomized|Parallel Assignment||Treatment||Double||||||
1574714|NCT00023413|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574715|NCT00023400|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574716|NCT00023387|Randomized|Parallel Assignment||Treatment||Double||||||
1574717|NCT00023374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574718|NCT00023361|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574719|NCT00023348|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574720|NCT00023335|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574721|NCT00023556||||||||||||
1574722|NCT00023543||Single Group Assignment||Prevention||None (Open Label)||||||
1574723|NCT00023530|Randomized|||Prevention||Double||||||
1574724|NCT00023491||||||||||||
1574725|NCT00023322||Single Group Assignment||Treatment||None (Open Label)||||||
1574726|NCT00023309|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574727|NCT00023296||||Treatment||||||||
1574728|NCT00023283|Randomized|||Treatment||||||||
1574729|NCT00023244|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1574730|NCT00023231||Single Group Assignment||Treatment||None (Open Label)||||||
1574731|NCT00023218||||Treatment||||||||
1574732|NCT00023205|Randomized|Parallel Assignment||||Double|||t|||t
1574733|NCT00022763|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1574734|NCT00021775||||||||||||
1574735|NCT00021762||||Treatment||||||||
1574736|NCT00021671||||Prevention||Double||||||
1574737|NCT00021632||||||||||||
1574738|NCT00021554||Parallel Assignment||Treatment||||||||
1574739|NCT00021489||||Treatment||Double||||||
1574740|NCT00021463||||Treatment||||||||
1574741|NCT00017992||||Treatment||||||||
1574742|NCT00017797|||Case Control, Natural History|||||||||
1574744|NCT00017771|||Case Control||Prospective|||||||
1574745|NCT00017758||||Treatment||||||||
1574746|NCT00017719|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1574747|NCT00017693|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574748|NCT00016783|||||Prospective|||||||
1574749|NCT00016718|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)|open-label|||||
1574750|NCT00016692||||Treatment||Double||||||
1574751|NCT00016601||||Treatment||||||||
1574752|NCT00016588||||Treatment||None (Open Label)||||||
1574753|NCT00016536||Crossover Assignment||Prevention||||||||
1574754|NCT00015704|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574755|NCT00015691||||Treatment||Double||||||
1574756|NCT00015652||||Treatment||||||||
1574757|NCT00014937|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1574758|NCT00014911||Single Group Assignment||Treatment||None (Open Label)||||||
1574759|NCT00014053||||||||||||
1574760|NCT00014014||Crossover Assignment||Treatment||||||||
1574761|NCT00013897||||Treatment||Double||||||
1574762|NCT00013871||||Prevention||||||||
1574763|NCT00013663||||Treatment||Double||||||
1574764|NCT00013585|Randomized|Parallel Assignment||Treatment||Double||||||
1574765|NCT00013572||||Prevention||||||||
1574766|NCT00013520||||Treatment||||||||
1574767|NCT00012519|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574768|NCT00012467||||Treatment||Double||||||
1574769|NCT00011895||||Treatment||||||||
1574770|NCT00011479||||Treatment||||||||
1574771|NCT00011128|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574772|NCT00011089||||Treatment||||||||
1574773|NCT00011050||||||||||||
1574774|NCT00011037|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1574775|NCT00011011|Randomized|Factorial Assignment||Treatment||Double||||||
1574776|NCT00009555||||Treatment||Double||||||
1574777|NCT00009061||||Treatment||||||||
1574778|NCT00008866||||Treatment||Double||||||
1574779|NCT00008853||||Prevention||Double||||||
1574780|NCT00008840||||||||||||
1574781|NCT00008554||Parallel Assignment||Treatment||||||||
1574782|NCT00008528||Parallel Assignment||Treatment||||||||
1574783|NCT00008489||||Treatment||||||||
1574784|NCT00008463||||Treatment||||||||
1574785|NCT00007787|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574786|NCT00007488||||||||||||
1574787|NCT00007449||||Treatment||||||||
1574788|NCT00007436||||Treatment||||||||
1574789|NCT00007423||||Prevention||Double||||||
1574790|NCT00007332||||Prevention||Double||||||
1574791|NCT00007319|||||Prospective|||||||
1574792|NCT00007202||||Treatment||||||||
1574793|NCT00006643||||||||||||
1574794|NCT00006630||||Treatment||||||||
1574795|NCT00006617||||Treatment||None (Open Label)||||||
1574796|NCT00006604|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574797|NCT00006591||||Treatment||||||||
1574798|NCT00006578||||Treatment||||||||
1574799|NCT00006509||||Treatment||None (Open Label)||||||
1574800|NCT00006495||||Treatment||Double||||||
1574801|NCT00006490||||||||||||
1574802|NCT00006444||||||||||||
1574803|NCT00006443||||Treatment||||||||
1574804|NCT00006442||||||||||||
1574805|NCT00006441|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574806|NCT00006440||||||||||||
1574807|NCT00006415||||||||||||
1574808|NCT00006412||||Treatment||||||||
1574809|NCT00006397||||Treatment||None (Open Label)||||||
1574810|NCT00006396||||Prevention||Double||||||
1574811|NCT00006339||||Treatment||||||||
1574812|NCT00006327||||Prevention||Double||||||
1574813|NCT00006326||||Treatment||||||||
1574814|NCT00006325||||Treatment||||||||
1574815|NCT00006324||||Treatment||||||||
1574816|NCT00006316||||||||||||
1574817|NCT00006304||||||||||||
1574818|NCT00006298||||||||||||
1574819|NCT00006291||||Treatment||Double||||||
1574820|NCT00006290||||||||||||
1574821|NCT00006279||||Prevention||||||||
1574822|NCT00006211||||Treatment||||||||
1574823|NCT00006209||||Treatment||||||||
1574824|NCT00006208||||Treatment||Double||||||
1574825|NCT00006207||||Prevention||||||||
1574826|NCT00006154|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574827|NCT00006153||||Treatment||Double||||||
1574828|NCT00006152||||Treatment||||||||
1574829|NCT00006146||||Prevention||||||||
1574830|NCT00006145||||Prevention||Double||||||
1574831|NCT00006144||||Treatment||||||||
1574832|NCT00006143||||Treatment||||||||
1574833|NCT00006075||||Prevention||||||||
1574834|NCT00006066||||Treatment||||||||
1574835|NCT00006064||||||||||||
1574836|NCT00005931||||Treatment||||||||
1574837|NCT00005921||||Treatment||None (Open Label)||||||
1574838|NCT00005920||Parallel Assignment||Treatment||||||||
1574839|NCT00005918||||Treatment||Double||||||
1574840|NCT00005915||||||||||||
1574841|NCT00005779||||Treatment||||||||
1574842|NCT00005764||||Treatment||||||||
1574843|NCT00005762||||Treatment||||||||
1574844|NCT00005758||||Treatment||Double||||||
1574845|NCT00005668||||Treatment||Double||||||
1574846|NCT00005663||||Treatment||Double||||||
1574847|NCT00005572||||||||||||
1574848|NCT00005120||||Treatment||Double||||||
1574849|NCT00005118||||Treatment||||||||
1574850|NCT00005113|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574958|NCT00002374||||Treatment||||||||
1574851|NCT00005106||Parallel Assignment||Treatment||||||||
1574852|NCT00005020||||||||||||
1574853|NCT00005018||||Treatment||||||||
1574854|NCT00005017||||Treatment||||||||
1574855|NCT00005012||||Treatment||||||||
1574856|NCT00005010|Randomized|Parallel Assignment||Treatment||Double||||||
1574857|NCT00005009||Single Group Assignment||Prevention||None (Open Label)||||||
1574858|NCT00005002||||Treatment||Double||||||
1574859|NCT00005001||||Treatment||Double||||||
1574860|NCT00005000||Crossover Assignment||Treatment||||||||
1574861|NCT00004999||||Treatment||Double||||||
1574862|NCT00004998||||Treatment||||||||
1574863|NCT00004987||||Treatment||None (Open Label)||||||
1574864|NCT00004986||||Treatment||||||||
1574865|NCT00004985||||Treatment||||||||
1574866|NCT00004981||||Treatment||||||||
1574867|NCT00004978|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574868|NCT00004855||||Treatment||||||||
1574869|NCT00004852||||Treatment||Double||||||
1574870|NCT00004736||||Treatment||||||||
1574871|NCT00004735|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574872|NCT00004585||||Treatment||||||||
1574873|NCT00004584||||Treatment||||||||
1574874|NCT00004583||||Treatment||Double||||||
1574875|NCT00004582||||Treatment||None (Open Label)||||||
1574876|NCT00004581||||Treatment||||||||
1574877|NCT00004580||||Treatment||||||||
1574878|NCT00004579||||Prevention||Double||||||
1574879|NCT00004578|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1574880|NCT00002453||||Treatment||||||||
1574881|NCT00002452||||Treatment||||||||
1574882|NCT00002451||||Treatment||||||||
1574883|NCT00002450||||Treatment||Double||||||
1574884|NCT00002449||||Treatment||||||||
1574885|NCT00002448||Parallel Assignment||Treatment||||||||
1574886|NCT00002447||||Treatment||||||||
1574887|NCT00002446||||Treatment||Double||||||
1574888|NCT00002445||||Treatment||Double||||||
1574889|NCT00002444||||Treatment||||||||
1574890|NCT00002443||||Treatment||Double||||||
1574891|NCT00002442||||Treatment||None (Open Label)||||||
1574892|NCT00002441||||Prevention||Double||||||
1574893|NCT00002440||||Treatment||||||||
1574894|NCT00002439||||Treatment||||||||
1574895|NCT00002438|Randomized|||Treatment||||||||
1574896|NCT00002437||||Treatment||||||||
1574897|NCT00002436||||Treatment||||||||
1574898|NCT00002435||||Treatment||Double||||||
1574899|NCT00002434||||Treatment||None (Open Label)||||||
1574900|NCT00002433||||Treatment||||||||
1574901|NCT00002432||||Treatment||||||||
1574902|NCT00002431||||Treatment||||||||
1574903|NCT00002430||||Treatment||||||||
1574904|NCT00002429||Parallel Assignment||Treatment||||||||
1574905|NCT00002428||||Prevention||Double||||||
1574906|NCT00002427||Factorial Assignment||Treatment||||||||
1574907|NCT00002426||||Treatment||Double||||||
1574908|NCT00002425||||Treatment||||||||
1574909|NCT00002424||||Treatment||Double||||||
1574910|NCT00002423||||Treatment||||||||
1574911|NCT00002422||||Treatment||||||||
1574912|NCT00002420||||Treatment||None (Open Label)||||||
1574913|NCT00002419||||Treatment||||||||
1574914|NCT00002418||||Treatment||||||||
1574915|NCT00002417||||Prevention||||||||
1574916|NCT00002416||||Treatment||||||||
1574917|NCT00002415||||Treatment||Double||||||
1574918|NCT00002414||||Treatment||Double||||||
1574919|NCT00002413||||Treatment||None (Open Label)||||||
1574920|NCT00002412||||Treatment||Double||||||
1574921|NCT00002411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1574922|NCT00002410||||Treatment||||||||
1574923|NCT00002409||||Treatment||||||||
1574924|NCT00002408||||Treatment||Double||||||
1574925|NCT00002407||||Treatment||||||||
1574926|NCT00002406||||Treatment||None (Open Label)||||||
1574927|NCT00002405||||Treatment||||||||
1574928|NCT00002404||||Treatment||Double||||||
1574929|NCT00002403||||Treatment||None (Open Label)||||||
1574930|NCT00002402||||Prevention||||||||
1574931|NCT00002401||||Treatment||||||||
1574932|NCT00002400||||Treatment||||||||
1574933|NCT00002399||||Treatment||Double||||||
1574934|NCT00002398||||Treatment||None (Open Label)||||||
1574935|NCT00002397||||Treatment||None (Open Label)||||||
1574936|NCT00002396||||Treatment||Double||||||
1574937|NCT00002395||||Treatment||None (Open Label)||||||
1574938|NCT00002394||Parallel Assignment||Treatment||||||||
1574939|NCT00002393||Parallel Assignment||Treatment||||||||
1574940|NCT00002392||||Treatment||||||||
1574941|NCT00002391||Parallel Assignment||Treatment||||||||
1574942|NCT00002390||||Treatment||Double||||||
1574943|NCT00002389||Parallel Assignment||Treatment||||||||
1574944|NCT00002388||||Treatment||||||||
1574945|NCT00002387||Parallel Assignment||Treatment||||||||
1574946|NCT00002386||||Treatment||||||||
1574947|NCT00002385||||Treatment||Double||||||
1574948|NCT00002384||||Treatment||||||||
1574949|NCT00002383||||Treatment||||||||
1574950|NCT00002382||||Treatment||None (Open Label)||||||
1574951|NCT00002381||||Treatment||None (Open Label)||||||
1574952|NCT00002380||||Treatment||None (Open Label)||||||
1574953|NCT00002379||||Treatment||||||||
1574954|NCT00002378||||Treatment||||||||
1574955|NCT00002377||Parallel Assignment||Treatment||||||||
1574956|NCT00002376||Parallel Assignment||Treatment||||||||
1574957|NCT00002375||Parallel Assignment||Treatment||||||||
1574959|NCT00002373||Parallel Assignment||Treatment||||||||
1574960|NCT00002372||||Treatment||None (Open Label)||||||
1574961|NCT00002371|Randomized|Parallel Assignment||Treatment||Double||||||
1574962|NCT00002370||||Treatment||||||||
1574963|NCT00002369||Parallel Assignment||Treatment||||||||
1574964|NCT00002368||Parallel Assignment||Treatment||||||||
1574965|NCT00002367||Parallel Assignment||Treatment||||||||
1574966|NCT00002366||||Treatment||||||||
1574967|NCT00002365||||Treatment||None (Open Label)||||||
1574968|NCT00002364||||Treatment||||||||
1574969|NCT00002363||||Treatment||||||||
1574970|NCT00002362||||Treatment||||||||
1574971|NCT00002361||||Treatment||||||||
1574972|NCT00002360|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1574973|NCT00002359||||Treatment||Double||||||
1574974|NCT00002358||||Treatment||None (Open Label)||||||
1574975|NCT00002357||||Treatment||Double||||||
1574976|NCT00002356||||Treatment||None (Open Label)||||||
1574977|NCT00002355||||Treatment||||||||
1574978|NCT00002354||||Treatment||Double||||||
1574979|NCT00002353||||Treatment||||||||
1574980|NCT00002352||||Treatment||||||||
1574981|NCT00002351||||Treatment||||||||
1574982|NCT00002350||||Treatment||None (Open Label)||||||
1574983|NCT00002349|Randomized|Single Group Assignment||Treatment||Double||||||
1574984|NCT00002348||||Treatment||||||||
1574985|NCT00002347||||Treatment||Double||||||
1574986|NCT00002346||||Treatment||Double||||||
1574987|NCT00002345|Randomized|||Treatment||||||||
1574988|NCT00002344||Parallel Assignment||Treatment||||||||
1574989|NCT00002343||Parallel Assignment||Treatment||||||||
1574990|NCT00002342||||Treatment||||||||
1574991|NCT00002341||||Treatment||None (Open Label)||||||
1574992|NCT00002340||||Treatment||||||||
1574993|NCT00002339||||Treatment||||||||
1574994|NCT00002338||||Treatment||||||||
1574995|NCT00002337||||Treatment||None (Open Label)||||||
1574996|NCT00002336||||Treatment||Double||||||
1574997|NCT00002335||||Treatment||||||||
1574998|NCT00002334||||Treatment||Double||||||
1574999|NCT00002333||||Treatment||Double||||||
1575000|NCT00002332||||Treatment||Double||||||
1575001|NCT00002331||||Treatment||||||||
1575002|NCT00002330||||Treatment||||||||
1575003|NCT00002329||||Treatment||Double||||||
1575004|NCT00002328||||Treatment||||||||
1575005|NCT00002327||||Treatment||||||||
1575006|NCT00002326||||Treatment||||||||
1575007|NCT00002325||Parallel Assignment||Treatment||||||||
1575008|NCT00002324||||Treatment||Double||||||
1575009|NCT00002323||||Treatment||Double||||||
1575010|NCT00002322||||Treatment||Double||||||
1575011|NCT00002321||||Treatment||||||||
1575012|NCT00002320||||Treatment||Double||||||
1575013|NCT00002319||||Treatment||None (Open Label)||||||
1575014|NCT00002318||Parallel Assignment||Treatment||||||||
1575015|NCT00002317||||Treatment||None (Open Label)||||||
1575016|NCT00002316||||Treatment||Double||||||
1575017|NCT00002315||||Treatment||Double||||||
1575018|NCT00002314||||Treatment||None (Open Label)||||||
1575019|NCT00002313||||Treatment||||||||
1575020|NCT00002312||||Treatment||None (Open Label)||||||
1575021|NCT00002311||||Treatment||||||||
1575022|NCT00002310||||Treatment||None (Open Label)||||||
1575023|NCT00002309||||Treatment||Double||||||
1575024|NCT00002308|Randomized|Single Group Assignment||Treatment||Double||||||
1575025|NCT00002307|Randomized|Single Group Assignment||Treatment||Double||||||
1575026|NCT00002306||||Treatment||||||||
1575027|NCT00002305||||Treatment||||||||
1575028|NCT00002304||||Treatment||||||||
1575029|NCT00002303||||Treatment||Double||||||
1575030|NCT00002302||||Treatment||Double||||||
1575031|NCT00002301||||Treatment||||||||
1575032|NCT00002300||||Treatment||Double||||||
1575033|NCT00002299||||Treatment||||||||
1575034|NCT00002298||||Treatment||||||||
1575035|NCT00002297||||Treatment||Double||||||
1575036|NCT00002296||||Treatment||Double||||||
1575037|NCT00002295||||Treatment||Double||||||
1575038|NCT00002294||||Treatment||Double||||||
1575039|NCT00002293||||Treatment||||||||
1575040|NCT00002292|Randomized|||Treatment||||||||
1575041|NCT00002291||||Treatment||Double||||||
1575042|NCT00002290||||Treatment||Double||||||
1575043|NCT00002289||||Treatment||Double||||||
1575044|NCT00002288||||Treatment||||||||
1575045|NCT00002287||||Treatment||||||||
1575046|NCT00002286||||Treatment||||||||
1575047|NCT00002285||||Treatment||||||||
1575048|NCT00002284||||Treatment||||||||
1575049|NCT00002283|Randomized|||Treatment||||||||
1575050|NCT00002282||||Treatment||||||||
1575051|NCT00002281||||Treatment||None (Open Label)||||||
1575052|NCT00002280||||Treatment||None (Open Label)||||||
1575053|NCT00002279||||Treatment||None (Open Label)||||||
1575054|NCT00002278||||Treatment||||||||
1575055|NCT00002277||||Treatment||||||||
1575056|NCT00002276||||Treatment||||||||
1575057|NCT00002275||||Treatment||||||||
1575058|NCT00002274||Single Group Assignment||Treatment||None (Open Label)||||||
1575059|NCT00002273||||Treatment||Double||||||
1575060|NCT00002272||||Treatment||||||||
1575061|NCT00002271||||Treatment||||||||
1575062|NCT00002270||||Treatment||||||||
1575063|NCT00002269||||Treatment||Double||||||
1575064|NCT00002268||||Treatment||||||||
1575065|NCT00002267||||Treatment||Double||||||
1575066|NCT00002266||||Treatment||None (Open Label)||||||
1575067|NCT00002265||||Treatment||None (Open Label)||||||
1575068|NCT00002264||||Treatment||||||||
1575069|NCT00002263||||Treatment||||||||
1575070|NCT00002262||||Treatment||||||||
1575071|NCT00002261||||Prevention||||||||
1575072|NCT00002260||||Treatment||None (Open Label)||||||
1575073|NCT00002259||||Treatment||||||||
1575074|NCT00002258||||Treatment||None (Open Label)||||||
1575075|NCT00002257||||Treatment||||||||
1575076|NCT00002256||||Treatment||None (Open Label)||||||
1575077|NCT00002255||||Treatment||None (Open Label)||||||
1575078|NCT00002254||||Treatment||||||||
1575079|NCT00002253||||Treatment||Double||||||
1575080|NCT00002252||||Treatment||||||||
1575081|NCT00002251||||Treatment||||||||
1575082|NCT00002250||||Treatment||||||||
1575083|NCT00002249||||Treatment||Double||||||
1575084|NCT00002248||||Treatment||Double||||||
1575085|NCT00002247|Randomized|||Treatment||||||||
1575086|NCT00002246||||Treatment||||||||
1575087|NCT00002245||||Treatment||None (Open Label)||||||
1575088|NCT00002244||||Treatment||Double||||||
1575089|NCT00002243||||Treatment||Double||||||
1575090|NCT00002241||||Treatment||||||||
1575091|NCT00002240||||Treatment||||||||
1575092|NCT00002239||||Treatment||||||||
1575093|NCT00002238||||Treatment||Double||||||
1575094|NCT00002237||||Treatment||||||||
1575095|NCT00002236||||Treatment||None (Open Label)||||||
1575096|NCT00002235||||Treatment||None (Open Label)||||||
1575097|NCT00002234||||Treatment||||||||
1575098|NCT00002233||||Treatment||None (Open Label)||||||
1575099|NCT00002232||||Prevention||Double||||||
1575100|NCT00002231||||Prevention||None (Open Label)||||||
1575101|NCT00002230||||Treatment||||||||
1575102|NCT00002229||||Treatment||None (Open Label)||||||
1575103|NCT00002228||||Treatment||||||||
1575104|NCT00002227||||Treatment||||||||
1575105|NCT00002226||||Treatment||||||||
1575106|NCT00002225||||Treatment||||||||
1575107|NCT00002224|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575108|NCT00002223||||Treatment||||||||
1575109|NCT00002222||||Treatment||None (Open Label)||||||
1575110|NCT00002221||||Treatment||||||||
1575111|NCT00002220||||Treatment||||||||
1575112|NCT00002219||||Treatment||||||||
1575113|NCT00002218||||Treatment||None (Open Label)||||||
1575114|NCT00002217||||Treatment||None (Open Label)||||||
1575115|NCT00002216||||Treatment||None (Open Label)||||||
1575116|NCT00002215||||Treatment||Double||||||
1575117|NCT00002214||||Treatment||||||||
1575118|NCT00002213||||Treatment||||||||
1575119|NCT00002212||||Treatment||||||||
1575120|NCT00002211||||Treatment||||||||
1575121|NCT00002210||||Treatment||||||||
1575122|NCT00002209||||Treatment||Double||||||
1575123|NCT00002208||||Treatment||||||||
1575124|NCT00002207|Randomized|Parallel Assignment||Treatment||Double||||||
1575125|NCT00002206||||Treatment||Double||||||
1575126|NCT00002205||||Treatment||||||||
1575127|NCT00002204||Parallel Assignment||Prevention||||||||
1575128|NCT00002203||Parallel Assignment||Treatment||||||||
1575129|NCT00002202||||Treatment||||||||
1575130|NCT00002201||||Treatment||None (Open Label)||||||
1575131|NCT00002200||||Treatment||||||||
1575132|NCT00002199||Parallel Assignment||Treatment||||||||
1575133|NCT00002198||||Treatment||None (Open Label)||||||
1575134|NCT00002197||||Treatment||None (Open Label)||||||
1575135|NCT00002196||||Treatment||||||||
1575136|NCT00002195||Parallel Assignment||Treatment||||||||
1575137|NCT00002194||Parallel Assignment||Treatment||||||||
1575138|NCT00002193||Parallel Assignment||Treatment||||||||
1575139|NCT00002192||||Treatment||||||||
1575140|NCT00002191||||Treatment||Double||||||
1575141|NCT00002190||||Treatment||||||||
1575142|NCT00002189||||Treatment||||||||
1575143|NCT00002188||||Treatment||||||||
1575144|NCT00002187||Parallel Assignment||Treatment||||||||
1575145|NCT00002186||||Treatment||Double||||||
1575146|NCT00002185||Parallel Assignment||Treatment||||||||
1575147|NCT00002184||||Treatment||Double||||||
1575148|NCT00002183||||Treatment||||||||
1575149|NCT00002182||||Treatment||Double||||||
1575150|NCT00002181||||Treatment||None (Open Label)||||||
1575151|NCT00002180||||Treatment||Double||||||
1575152|NCT00002179||||Treatment||||||||
1575153|NCT00002178||||Treatment||||||||
1575154|NCT00002177||||Treatment||None (Open Label)||||||
1575155|NCT00002176|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575156|NCT00002175||||Treatment||||||||
1575157|NCT00002174||||Treatment||Double||||||
1575158|NCT00002173||||Treatment||||||||
1575159|NCT00002172||||Treatment||None (Open Label)||||||
1575160|NCT00002171||||Treatment||||||||
1575161|NCT00002170||||Treatment||||||||
1575162|NCT00002169||||Treatment||||||||
1575163|NCT00002168||Parallel Assignment||Treatment||||||||
1575164|NCT00002167||Parallel Assignment||Treatment||||||||
1575165|NCT00002166||Parallel Assignment||Treatment||||||||
1575166|NCT00002165||||Treatment||||||||
1575167|NCT00002164||||Treatment||||||||
1575168|NCT00002163||||Treatment||Double||||||
1575169|NCT00002162||||Treatment||||||||
1575170|NCT00002161||||Treatment||Double||||||
1575171|NCT00002160||||Treatment||Double||||||
1575172|NCT00002159||||Treatment||||||||
1575173|NCT00002158||||Treatment||||||||
1575174|NCT00002157||||Treatment||None (Open Label)||||||
1575175|NCT00002156||||Treatment||None (Open Label)||||||
1575176|NCT00002155||||Treatment||Double||||||
1575177|NCT00002154||||Treatment||Double||||||
1575178|NCT00002153||||Treatment||||||||
1575179|NCT00002152||||Treatment||Double||||||
1575180|NCT00002151||||Treatment||Double||||||
1575181|NCT00002150||||Treatment||Double||||||
1575182|NCT00002149||Parallel Assignment||Treatment||||||||
1575183|NCT00002148||||Treatment||Double||||||
1575184|NCT00002147||||Treatment||None (Open Label)||||||
1575185|NCT00002146||||Treatment||Double||||||
1575186|NCT00002145||||Treatment||||||||
1575187|NCT00002144||||Treatment||||||||
1575188|NCT00002143||||Treatment||||||||
1575189|NCT00002142||||Treatment||None (Open Label)||||||
1575190|NCT00002141||||Treatment||Double||||||
1575191|NCT00002140||||Treatment||Double||||||
1575192|NCT00002139||||Treatment||None (Open Label)||||||
1575193|NCT00002138||||Treatment||||||||
1575194|NCT00002137||||Treatment||||||||
1575195|NCT00002136||||Treatment||||||||
1575196|NCT00002135||||Treatment||||||||
1575197|NCT00002134||||Treatment||||||||
1575198|NCT00002133||||Treatment||None (Open Label)||||||
1575199|NCT00002132||||Treatment||Double||||||
1575200|NCT00002131||||Treatment||None (Open Label)||||||
1575201|NCT00002130||||Treatment||None (Open Label)||||||
1575202|NCT00002129||||Treatment||None (Open Label)||||||
1575203|NCT00002128||||Treatment||||||||
1575204|NCT00002127||||Treatment||Double||||||
1575205|NCT00002126||||Treatment||||||||
1575206|NCT00002125||||Treatment||||||||
1575207|NCT00002124||||Treatment||Double||||||
1575208|NCT00002123||||Treatment||Double||||||
1575209|NCT00002122||||Treatment||Double||||||
1575210|NCT00002121||||Treatment||None (Open Label)||||||
1575211|NCT00002120||||Treatment||Double||||||
1575212|NCT00002119||||Treatment||||||||
1575213|NCT00002118||||Treatment||None (Open Label)||||||
1575214|NCT00002117||||Treatment||||||||
1575215|NCT00002116||||Treatment||Double||||||
1575216|NCT00002115||||Treatment||||||||
1575217|NCT00002114||||Treatment||Double||||||
1575218|NCT00002113|Randomized|||Treatment||||||||
1575219|NCT00002112||Parallel Assignment||Treatment||||||||
1575220|NCT00002111||||Treatment||None (Open Label)||||||
1575221|NCT00002110||||Treatment||Double||||||
1575222|NCT00002109||||Treatment||Double||||||
1575223|NCT00002108||||Treatment||None (Open Label)||||||
1575224|NCT00002107||||Treatment||||||||
1575225|NCT00002106||Parallel Assignment||Treatment||||||||
1575226|NCT00002105||Parallel Assignment||Treatment||||||||
1575227|NCT00002104||Parallel Assignment||Treatment||||||||
1575228|NCT00002103||||Treatment||None (Open Label)||||||
1575229|NCT00002102||||Treatment||None (Open Label)||||||
1575230|NCT00002101||||Treatment||Double||||||
1575231|NCT00002100||||Treatment||||||||
1575232|NCT00002099||Parallel Assignment||Treatment||||||||
1575233|NCT00002098||Parallel Assignment||Treatment||||||||
1575234|NCT00002097||||Treatment||||||||
1575235|NCT00002096||||Treatment||||||||
1575236|NCT00002095||||Treatment||Double||||||
1575237|NCT00002094||||Treatment||None (Open Label)||||||
1575238|NCT00002093|Randomized|||Treatment||||||||
1575239|NCT00002092||||Treatment||||||||
1575240|NCT00002091||||Treatment||Double||||||
1575241|NCT00002090||||Treatment||||||||
1575242|NCT00002089||||Treatment||None (Open Label)||||||
1575243|NCT00002088||||Treatment||Double||||||
1575244|NCT00002087||||Treatment||None (Open Label)||||||
1575245|NCT00002086|Randomized|||Treatment||||||||
1575246|NCT00002085||||Treatment||||||||
1575247|NCT00002084||||Treatment||||||||
1575248|NCT00002083||||Treatment||||||||
1575249|NCT00002082||||Treatment||Double||||||
1575250|NCT00002081||||Treatment||None (Open Label)||||||
1575251|NCT00002080||||Treatment||||||||
1575252|NCT00002079||||Treatment||||||||
1575253|NCT00002078||||Treatment||||||||
1575254|NCT00002077||||Treatment||None (Open Label)||||||
1575255|NCT00002076||||Treatment||||||||
1575256|NCT00002075||||Treatment||||||||
1575257|NCT00002074||||Treatment||||||||
1575258|NCT00002073||||Treatment||Double||||||
1575259|NCT00002072||||Treatment||Double||||||
1575260|NCT00002071||||Treatment||Double||||||
1575261|NCT00002070||||Treatment||||||||
1575262|NCT00002069||||Treatment||||||||
1575263|NCT00002068||||Treatment||||||||
1575264|NCT00002067||||Treatment||Double||||||
1575265|NCT00002066||||Treatment||Double||||||
1575266|NCT00002065||||Treatment||None (Open Label)||||||
1575267|NCT00002064||||Treatment||||||||
1575268|NCT00002063||||Treatment||||||||
1575269|NCT00002062||||Treatment||None (Open Label)||||||
1575270|NCT00002061||||Treatment||Double||||||
1575271|NCT00002060||||Treatment||Double||||||
1575272|NCT00002059||||Treatment||Double||||||
1575273|NCT00002058||||Treatment||||||||
1575274|NCT00002057||||Treatment||||||||
1575275|NCT00002056||||Treatment||Double||||||
1575276|NCT00002055||||Treatment||Double||||||
1575277|NCT00002054||||Treatment||Double||||||
1575278|NCT00002053||||Treatment||Double||||||
1575279|NCT00002052||||Treatment||||||||
1575280|NCT00002051||||Treatment||Double||||||
1575281|NCT00002050||||Treatment||Double||||||
1575282|NCT00002049||||Treatment||Double||||||
1575283|NCT00002048||||Treatment||||||||
1575284|NCT00002047||||Treatment||||||||
1575285|NCT00002046||||Treatment||||||||
1575286|NCT00002045||||Treatment||Double||||||
1575287|NCT00002044||||Treatment||||||||
1575288|NCT00002043||||Treatment||||||||
1575289|NCT00002042||||Treatment||Double||||||
1575290|NCT00002041|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575291|NCT00002040||||Treatment||None (Open Label)||||||
1575292|NCT00002039||||Treatment||||||||
1575293|NCT00002038||||Treatment||||||||
1575294|NCT00002037||||Treatment||None (Open Label)||||||
1575295|NCT00002036||||Treatment||||||||
1575296|NCT00002035||||Treatment||Double||||||
1575297|NCT00002034||||Treatment||||||||
1575298|NCT00002033||||Treatment||Double||||||
1575299|NCT00002032||||Treatment||Double||||||
1575300|NCT00002031||||Treatment||||||||
1575301|NCT00002030||||Treatment||None (Open Label)||||||
1575302|NCT00002029||||Treatment||||||||
1575303|NCT00002028|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575304|NCT00002027||||Treatment||||||||
1575305|NCT00002026||||Treatment||||||||
1575306|NCT00002025||||Treatment||None (Open Label)||||||
1575307|NCT00002024||||Treatment||||||||
1575308|NCT00002023||||Treatment||||||||
1575309|NCT00002022||||Treatment||||||||
1575310|NCT00002021||||Treatment||||||||
1575311|NCT00002020||||Treatment||||||||
1575312|NCT00002019||||Treatment||||||||
1575313|NCT00002018||||Treatment||Double||||||
1575314|NCT00002017||||Treatment||||||||
1575315|NCT00002016||||Treatment||||||||
1575316|NCT00002015||||Treatment||None (Open Label)||||||
1575317|NCT00002014||||Treatment||||||||
1575318|NCT00002013||||Treatment||||||||
1575319|NCT00002012||||Treatment||Double||||||
1575320|NCT00002011||||Treatment||None (Open Label)||||||
1575321|NCT00002010||||Treatment||None (Open Label)||||||
1575322|NCT00002009||||Treatment||||||||
1575323|NCT00002008||||Treatment||None (Open Label)||||||
1575324|NCT00002007||||Treatment||||||||
1575325|NCT00002006||||Treatment||||||||
1575326|NCT00002005||||Treatment||||||||
1575327|NCT00002004||||Treatment||||||||
1575328|NCT00002003||||Treatment||||||||
1575329|NCT00002002||||Treatment||Double||||||
1575330|NCT00002001||||Treatment||Double||||||
1575331|NCT00002000||||Treatment||||||||
1575332|NCT00001999||||Treatment||||||||
1575333|NCT00001998||||Treatment||||||||
1575334|NCT00001997||||Treatment||||||||
1575335|NCT00001996||||Treatment||None (Open Label)||||||
1575336|NCT00001995||||Treatment||Double||||||
1575337|NCT00001994||||Treatment||||||||
1575338|NCT00001993||||Treatment||||||||
1575339|NCT00001992||||Prevention||||||||
1575340|NCT00001991||||Treatment||None (Open Label)||||||
1575341|NCT00001990||||Treatment||None (Open Label)||||||
1575342|NCT00001989|Randomized|||Treatment||||||||
1575343|NCT00001137|||Cohort||Prospective|||||||
1575344|NCT00001136||||Prevention||||||||
1575345|NCT00001135||||Prevention||Double||||||
1575346|NCT00001133||||Treatment||||||||
1575347|NCT00001132||||Treatment||Double||||||
1575348|NCT00001131|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575349|NCT00001130||||||||||||
1575350|NCT00001129||Factorial Assignment||Treatment||||||||
1575351|NCT00001128||||Treatment||Double||||||
1575352|NCT00001127||||Prevention||None (Open Label)||||||
1575353|NCT00001126||||Treatment||Double||||||
1575354|NCT00001125||||Prevention||None (Open Label)||||||
1575355|NCT00001123||||Treatment||Double||||||
1575356|NCT00001122||Crossover Assignment||Treatment||||||||
1575357|NCT00001121||||||||||||
1575358|NCT00001120||||||||||||
1575359|NCT00001119||||Treatment||||||||
1575360|NCT00001118||||Treatment||||||||
1575361|NCT00001117||||||||||||
1575362|NCT00001116||||Treatment||||||||
1575363|NCT00001115||||Treatment||Double||||||
1575364|NCT00001114||||Treatment||||||||
1575365|NCT00001113||||Treatment||None (Open Label)||||||
1575366|NCT00001112||||Treatment||None (Open Label)||||||
1575367|NCT00001111||||Treatment||||||||
1575368|NCT00001110||||Treatment||||||||
1575369|NCT00001109||||||||||||
1575370|NCT00001108||||Treatment||||||||
1575371|NCT00001107||||Prevention||Double||||||
1575372|NCT00001106||||Treatment||None (Open Label)||||||
1575373|NCT00001105||||Treatment||||||||
1575374|NCT00001104||Parallel Assignment||Treatment||||||||
1575375|NCT00001103||||||||||||
1575376|NCT00001102||||||||||||
1575377|NCT00001101|Randomized|Parallel Assignment||Treatment||Double||||||
1575378|NCT00001100|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575379|NCT00001097||||||||||||
1575380|NCT00001096||||Prevention||Double||||||
1575381|NCT00001095||||Treatment||||||||
1575382|NCT00001094||||Treatment||None (Open Label)||||||
1575383|NCT00001093||||||||||||
1575384|NCT00001092|||Cohort||Prospective|||||||
1575385|NCT00001091||||Treatment||||||||
1575386|NCT00001090||||Prevention||Double||||||
1575387|NCT00001089|||Natural History|||||||||
1575388|NCT00001088||||Prevention||Double||||||
1575389|NCT00001087||||Treatment||Double||||||
1575390|NCT00001086||||Treatment||None (Open Label)||||||
1575391|NCT00001085||||Treatment||||||||
1575392|NCT00001084||||Treatment||Double||||||
1575393|NCT00001083||||Treatment||||||||
1575394|NCT00001082|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1575395|NCT00001081||Parallel Assignment||Treatment||||||||
1575396|NCT00001080||Parallel Assignment||Treatment||||||||
1575397|NCT00001079||Parallel Assignment||Treatment||||||||
1575398|NCT00001078||||Treatment||||||||
1575399|NCT00001077|||Cohort||Prospective|||||||
1575400|NCT00001076||||Prevention||Double||||||
1575401|NCT00001075||||Treatment||||||||
1575402|NCT00001074||||Treatment||||||||
1575403|NCT00001073||||Treatment||||||||
1575404|NCT00001072||||Prevention||Double||||||
1575405|NCT00001071||||Treatment||||||||
1575406|NCT00001070||||Treatment||||||||
1575407|NCT00001069|||Natural History|||||||||
1575408|NCT00001068|Randomized|Parallel Assignment||Treatment||||||||
1575409|NCT00001067||||Treatment||||||||
1575410|NCT00001066||||Treatment||Double||||||
1575411|NCT00001065||||Treatment||||||||
1575412|NCT00001064||||Treatment||||||||
1575413|NCT00001063||||Treatment||||||||
1575414|NCT00001062||||Treatment||||||||
1575415|NCT00001061||||Treatment||||||||
1575416|NCT00001060||||Prevention||Double||||||
1575417|NCT00001059||||Treatment||||||||
1575418|NCT00001058||||Treatment||||||||
1575419|NCT00001057||||Treatment||||||||
1575420|NCT00001056||||Prevention||Double||||||
1575421|NCT00001055||||Prevention||Double||||||
1575422|NCT00001054||||Treatment||None (Open Label)||||||
1575423|NCT00001053||||Prevention||Double||||||
1575424|NCT00001052||||Prevention||Double||||||
1575425|NCT00001050|||Natural History|||||||||
1575426|NCT00001049||||Treatment||Double||||||
1575427|NCT00001048||||Treatment||||||||
1575428|NCT00001047||||Treatment||||||||
1575429|NCT00001046||Parallel Assignment||Prevention||||||||
1575430|NCT00001045||||Treatment||||||||
1575431|NCT00001044||||Prevention||Double||||||
1575432|NCT00001043||||Prevention||||||||
1575433|NCT00001042||||Prevention||Double||||||
1575434|NCT00001041||Parallel Assignment||Prevention||||||||
1575435|NCT00001040||||Treatment||||||||
1575436|NCT00001039||||Treatment||None (Open Label)||||||
1575437|NCT00001038||||Treatment||||||||
1575438|NCT00001037||||Prevention||||||||
1575439|NCT00001036||||Treatment||||||||
1575440|NCT00001035||||Treatment||||||||
1575441|NCT00001034||Parallel Assignment||Treatment||||||||
1575442|NCT00001033||||Treatment||||||||
1575443|NCT00001032||||Treatment||||||||
1575444|NCT00001031||||Prevention||Double||||||
1575445|NCT00001030||||Treatment||||||||
1575446|NCT00001029||||Treatment||||||||
1575447|NCT00001028||||Treatment||||||||
1575448|NCT00001027||||Treatment||||||||
1575449|NCT00001026||||Prevention||Double||||||
1575450|NCT00001025||||Treatment||||||||
1575451|NCT00001024||||Treatment||||||||
1575452|NCT00001023|Randomized|||Treatment||||||||
1575453|NCT00001022||||Treatment||Double||||||
1575454|NCT00001021||||Prevention||Double||||||
1575455|NCT00001020||||Prevention||Double||||||
1575456|NCT00001019||||Prevention||Double||||||
1575457|NCT00001018||||Treatment||||||||
1575458|NCT00001017||Parallel Assignment||Treatment||||||||
1575459|NCT00001016||||Treatment||None (Open Label)||||||
1575460|NCT00001015||||Treatment||None (Open Label)||||||
1575461|NCT00001014||Parallel Assignment||Treatment||||||||
1575462|NCT00001013||Parallel Assignment||Treatment||||||||
1575463|NCT00001012||||Treatment||None (Open Label)||||||
1575464|NCT00001011||Parallel Assignment||Treatment||||||||
1575465|NCT00001010||||Treatment||None (Open Label)||||||
1575466|NCT00001009||||Treatment||None (Open Label)||||||
1575467|NCT00001008||Parallel Assignment||Treatment||||||||
1575468|NCT00001007||||Treatment||None (Open Label)||||||
1575469|NCT00001006||||Treatment||None (Open Label)||||||
1575470|NCT00001005||||Treatment||None (Open Label)||||||
1575471|NCT00001004||||Treatment||Double||||||
1575472|NCT00001003||||Treatment||||||||
1575473|NCT00001002||||Treatment||None (Open Label)||||||
1575474|NCT00001001||||Treatment||None (Open Label)||||||
1575475|NCT00001000||||Treatment||Double||||||
1575476|NCT00000999||||Treatment||None (Open Label)||||||
1575477|NCT00000998||||Treatment||||||||
1575478|NCT00000997||||Treatment||None (Open Label)||||||
1575479|NCT00000996||Parallel Assignment||Treatment||||||||
1575480|NCT00000995||||Treatment||None (Open Label)||||||
1575481|NCT00000994||||Treatment||Double||||||
1575482|NCT00000993||||Prevention||None (Open Label)||||||
1575483|NCT00000992||||Treatment||None (Open Label)||||||
1575484|NCT00000991||||Treatment||None (Open Label)||||||
1575485|NCT00000990||||Treatment||Double||||||
1575486|NCT00000989||Parallel Assignment||Treatment||||||||
1575487|NCT00000988||||Treatment||None (Open Label)||||||
1575488|NCT00000987||||Treatment||||||||
1575489|NCT00000986||||Treatment||None (Open Label)||||||
1575490|NCT00000985||Parallel Assignment||Treatment||||||||
1575491|NCT00000984||||Treatment||None (Open Label)||||||
1575492|NCT00000983||||Treatment||||||||
1575493|NCT00000982||||Treatment||||||||
1575494|NCT00000981||||Treatment||||||||
1575495|NCT00000980||||Treatment||||||||
1575496|NCT00000979||||Treatment||||||||
1575497|NCT00000978||||Treatment||||||||
1575498|NCT00000977||||Treatment||||||||
1575499|NCT00000976||||Treatment||||||||
1575501|NCT00000974||||Treatment||None (Open Label)||||||
1575502|NCT00000973||||Treatment||None (Open Label)||||||
1575503|NCT00000972|Randomized|||Prevention||||||||
1575504|NCT00000971||||Treatment||||||||
1575505|NCT00000970||||Treatment||||||||
1575506|NCT00000969||Parallel Assignment||Treatment||||||||
1575507|NCT00000968||||Prevention||Double||||||
1575508|NCT00000967||||Treatment||||||||
1575509|NCT00000966||||Treatment||||||||
1575510|NCT00000965||||Treatment||||||||
1575511|NCT00000964||||Treatment||||||||
1575512|NCT00000963||||Treatment||||||||
1575513|NCT00000962||||Treatment||||||||
1575514|NCT00000961||Parallel Assignment||Treatment||||||||
1575515|NCT00000960||||Treatment||||||||
1575516|NCT00000959||Parallel Assignment||Treatment||||||||
1575517|NCT00000958||||Treatment||||||||
1575518|NCT00000957||||Prevention||Double||||||
1575519|NCT00000956||||Prevention||Double||||||
1575520|NCT00000955||Single Group Assignment||Screening||None (Open Label)||||||
1575521|NCT00000954||||Treatment||||||||
1575522|NCT00000953||||Treatment||||||||
1575523|NCT00000952||||Treatment||||||||
1575524|NCT00000951||Parallel Assignment||Treatment||||||||
1575525|NCT00000950||||Treatment||||||||
1575526|NCT00000949||||Treatment||None (Open Label)||||||
1575527|NCT00000948|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575528|NCT00000947||Parallel Assignment||Treatment||||||||
1575529|NCT00000946||||Prevention||Double||||||
1575530|NCT00000945||||Treatment||||||||
1575531|NCT00000944||||Prevention||||||||
1575532|NCT00000943||||Treatment||||||||
1575533|NCT00000942||||Prevention||Double||||||
1575534|NCT00000941||||Treatment||None (Open Label)||||||
1575535|NCT00000940|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575536|NCT00000939||||Treatment||None (Open Label)||||||
1575537|NCT00000938|Randomized|Parallel Assignment||Treatment||Double||||||
1575538|NCT00000937|Randomized|Parallel Assignment||Treatment||Double||||||
1575539|NCT00000936|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1575540|NCT00000935|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575541|NCT00000933||||||||||||
1575542|NCT00000932|||Cohort||Prospective|||||||
1575543|NCT00000931||Parallel Assignment||Prevention||||||||
1575544|NCT00000930|||Case-Only||Prospective|||||||
1575545|NCT00000929||||Prevention||||||||
1575546|NCT00000928||Single Group Assignment||Prevention||None (Open Label)||||||
1575547|NCT00000927||||Prevention||||||||
1575548|NCT00000926||||Prevention||Double||||||
1575549|NCT00000925|Randomized|Parallel Assignment||Treatment||Double||||||
1575550|NCT00000924||||Treatment||||||||
1575551|NCT00000923||||Treatment||||||||
1575552|NCT00000922|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575553|NCT00000921||||Treatment||Double||||||
1575554|NCT00000920||||Treatment||||||||
1575555|NCT00000919||||Treatment||Double||||||
1575556|NCT00000918||||Treatment||||||||
1575557|NCT00000917||||||||||||
1575558|NCT00000916|Randomized|||Treatment||||||||
1575559|NCT00000915||||Treatment||||||||
1575560|NCT00000914||||Treatment||None (Open Label)||||||
1575561|NCT00000913||||Treatment||||||||
1575562|NCT00000912||||Treatment||||||||
1575563|NCT00000911|||Case-Only||Prospective|||||||
1575564|NCT00000910|||||Prospective|||||||
1575565|NCT00000909|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575566|NCT00000908|||Natural History|||||||||
1575567|NCT00000907||||||||||||
1575568|NCT00000906||||Treatment||||||||
1575569|NCT00000905||||||||||||
1575570|NCT00000904||||Prevention||Double||||||
1575571|NCT00000903||||Treatment||None (Open Label)||||||
1575572|NCT00000902||||Treatment||||||||
1575573|NCT00000901||||Treatment||||||||
1575574|NCT00000900|||Natural History||Longitudinal|||||||
1575575|NCT00000899||||Treatment||||||||
1575576|NCT00000898||||Treatment||||||||
1575577|NCT00000897||||Treatment||||||||
1575578|NCT00000896||||Treatment||None (Open Label)||||||
1575579|NCT00000895||||Treatment||||||||
1575580|NCT00000894||Parallel Assignment||Treatment||||||||
1575581|NCT00000893||||Treatment||||||||
1575582|NCT00000892||||Treatment||||||||
1575583|NCT00000891||||Treatment||None (Open Label)||||||
1575584|NCT00000890|||Natural History|||||||||
1575585|NCT00000889||||Treatment||||||||
1575586|NCT00000888||||Treatment||||||||
1575587|NCT00000887||||Treatment||||||||
1575588|NCT00000886||||Prevention||Double||||||
1575589|NCT00000885||||Treatment||Double||||||
1575590|NCT00000884|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1575591|NCT00000883||||Treatment||Double||||||
1575592|NCT00000882||||Treatment||||||||
1575593|NCT00000881||||Treatment||||||||
1575594|NCT00000880||||Treatment||||||||
1575595|NCT00000879||||Prevention||Double||||||
1575596|NCT00000878||||Treatment||||||||
1575597|NCT00000877||Parallel Assignment||Treatment||||||||
1575598|NCT00000876||||Treatment||None (Open Label)||||||
1575599|NCT00000875||Parallel Assignment||Treatment||||||||
1575600|NCT00000874|||Cohort||Prospective|||||||
1575601|NCT00000873||Parallel Assignment||Treatment||||||||
1575602|NCT00000872|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575603|NCT00000871||||Prevention||Double||||||
1575604|NCT00000870||||Treatment||||||||
1575605|NCT00000869||||Treatment||Double||||||
1575606|NCT00000868||||Prevention||Double||||||
1575607|NCT00000867||Parallel Assignment||Treatment||||||||
1575608|NCT00000866||||Prevention||Double||||||
1575609|NCT00000865||||Treatment||None (Open Label)||||||
1575610|NCT00000864||||Treatment||||||||
1575611|NCT00000863||||Treatment||||||||
1575612|NCT00000862||Parallel Assignment||Treatment||||||||
1575613|NCT00000861||||Treatment||Double||||||
1575614|NCT00000860|||Natural History|||||||||
1575615|NCT00000859||Parallel Assignment||Treatment||||||||
1575616|NCT00000858|||Natural History|||||||||
1575617|NCT00000857||||Treatment||Double||||||
1575618|NCT00000856||Parallel Assignment||Treatment||||||||
1575619|NCT00000855||||Treatment||None (Open Label)||||||
1575620|NCT00000854||Parallel Assignment||Treatment||||||||
1575621|NCT00000853||||Prevention||Double||||||
1575622|NCT00000852||||Treatment||||||||
1575623|NCT00000851||||Treatment||Double||||||
1575624|NCT00000850||||Treatment||||||||
1575625|NCT00000849|Randomized|||Treatment||||||||
1575626|NCT00000848||||Treatment||||||||
1575627|NCT00000847||||Prevention||Double||||||
1575628|NCT00000846||||Prevention||Double||||||
1575629|NCT00000845||||Prevention||Double||||||
1575630|NCT00000844||||Treatment||Double||||||
1575631|NCT00000843||||Treatment||None (Open Label)||||||
1575632|NCT00000842||||Treatment||Double||||||
1575633|NCT00000841||||Treatment||||||||
1575634|NCT00000840|||Natural History|||||||||
1575635|NCT00000839||||Treatment||||||||
1575636|NCT00000838||||Treatment||||||||
1575637|NCT00000837||||Prevention||||||||
1575638|NCT00000836||||Treatment||||||||
1575639|NCT00000835||||||||||||
1575640|NCT00000834|Randomized|||Treatment||||||||
1575641|NCT00000833||||Treatment||||||||
1575642|NCT00000832||||Prevention||Double||||||
1575643|NCT00000831||||Treatment||||||||
1575644|NCT00000830|||Natural History|||||||||
1575645|NCT00000829|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1575646|NCT00000828||||||||||||
1575647|NCT00000827||||Treatment||||||||
1575648|NCT00000826||||Treatment||None (Open Label)||||||
1575649|NCT00000825||||Treatment||||||||
1575650|NCT00000824||||Treatment||||||||
1575651|NCT00000823||||Treatment||||||||
1575652|NCT00000822||||Treatment||Double||||||
1575653|NCT00000821||||Treatment||||||||
1575654|NCT00000820||Parallel Assignment||Treatment||||||||
1575655|NCT00000819||||Treatment||||||||
1575656|NCT00000818||||Treatment||None (Open Label)||||||
1575657|NCT00000817|Randomized|Single Group Assignment||Treatment||Double|||t|t||
1575658|NCT00000816||||Treatment||||||||
1575659|NCT00000815|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575660|NCT00000814||||Treatment||||||||
1575661|NCT00000813||||Prevention||Double||||||
1575662|NCT00000812||||Treatment||Double||||||
1575663|NCT00000811||Parallel Assignment||Treatment||||||||
1575664|NCT00000810||||Treatment||||||||
1575665|NCT00000809||||Prevention||||||||
1575666|NCT00000808||||Treatment||||||||
1575667|NCT00000807||||Treatment||None (Open Label)||||||
1575668|NCT00000806|Randomized|||Treatment||||||||
1575669|NCT00000805||||Treatment||None (Open Label)||||||
1575670|NCT00000804|Randomized|||Treatment||||||||
1575671|NCT00000803||||Treatment||Double||||||
1575672|NCT00000802||Parallel Assignment||Treatment||||||||
1575673|NCT00000801||||Treatment||||||||
1575674|NCT00000800||||Treatment||None (Open Label)||||||
1575675|NCT00000799|Randomized|||Treatment||||||||
1575676|NCT00000798||||Prevention||Double||||||
1575677|NCT00000797|||Cohort||Prospective|||||||
1575678|NCT00000796||||Treatment||||||||
1575679|NCT00000795||||Prevention||Double||||||
1575680|NCT00000794||Parallel Assignment||Treatment||||||||
1575681|NCT00000793||||Treatment||Double||||||
1575682|NCT00000792||||Treatment||None (Open Label)||||||
1575683|NCT00000791||||Treatment||Double||||||
1575684|NCT00000790||Parallel Assignment||Treatment||||||||
1575685|NCT00000789||Parallel Assignment||Treatment||||||||
1575686|NCT00000788||Parallel Assignment||Treatment||||||||
1575687|NCT00000787||||Treatment||||||||
1575688|NCT00000785|||||Cross-Sectional|||||||
1575689|NCT00000784|||Case-Only||Prospective|||||||
1575690|NCT00000783|||Case Control||Prospective|||||||
1575691|NCT00000782||||Treatment||Double||||||
1575692|NCT00000781||||Treatment||Double||||||
1575693|NCT00000780||||||||||||
1575694|NCT00000779|Randomized|||Prevention||||||||
1575695|NCT00000778||||Treatment||||||||
1575696|NCT00000777||Parallel Assignment||Treatment||||||||
1575697|NCT00000776||||Treatment||Double||||||
1575698|NCT00000775||||Prevention||Double||||||
1575699|NCT00000774|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1575700|NCT00000773||||Prevention||None (Open Label)||||||
1575701|NCT00000772||||Treatment||None (Open Label)||||||
1575702|NCT00000771||Parallel Assignment||Treatment||||||||
1575703|NCT00000770||||Treatment||Double||||||
1575704|NCT00000769||||Treatment||None (Open Label)||||||
1575705|NCT00000768|Randomized|||Treatment||||||||
1575706|NCT00000767||||Prevention||Double||||||
1575707|NCT00000766||||Treatment||||||||
1575708|NCT00000765||Parallel Assignment||Treatment||||||||
1575709|NCT00000764|Randomized|||Treatment||||||||
1575710|NCT00000763||||Treatment||||||||
1575711|NCT00000762||||Treatment||Double||||||
1575712|NCT00000761||||Treatment||None (Open Label)||||||
1575715|NCT00000758||Parallel Assignment||Prevention||||||||
1575716|NCT00000757||||Prevention||Double||||||
1575717|NCT00000756||||Treatment||None (Open Label)||||||
1575718|NCT00000755||Parallel Assignment||Prevention||||||||
1575719|NCT00000754||||Treatment||||||||
1575720|NCT00000753||||Treatment||None (Open Label)||||||
1575721|NCT00000752||||Treatment||Double||||||
1575722|NCT00000751||Parallel Assignment||Treatment||||||||
1575723|NCT00000750||||Treatment||||||||
1575724|NCT00000749||Parallel Assignment||Prevention||||||||
1575725|NCT00000748||Parallel Assignment||Treatment||||||||
1575726|NCT00000747||||Treatment||None (Open Label)||||||
1575727|NCT00000746||||Prevention||||||||
1575728|NCT00000745||||Prevention||Double||||||
1575729|NCT00000744||||Treatment||Double||||||
1575730|NCT00000743||||Treatment||None (Open Label)||||||
1575731|NCT00000742||||Treatment||||||||
1575732|NCT00000741||Parallel Assignment||Treatment||||||||
1575733|NCT00000740||||Treatment||Double||||||
1575734|NCT00000739||Parallel Assignment||Treatment||||||||
1575735|NCT00000738||||Treatment||Double||||||
1575736|NCT00000737||||Treatment||None (Open Label)||||||
1575737|NCT00000736||||Treatment||Double||||||
1575738|NCT00000735||||Treatment||None (Open Label)||||||
1575739|NCT00000734||||Treatment||None (Open Label)||||||
1575740|NCT00000733||||Treatment||None (Open Label)||||||
1575741|NCT00000732||||Treatment||None (Open Label)||||||
1575742|NCT00000731||||Treatment||None (Open Label)||||||
1575743|NCT00000730|Randomized|||Treatment||||||||
1575744|NCT00000729|Randomized|||Treatment||||||||
1575745|NCT00000728||||Treatment||None (Open Label)||||||
1575746|NCT00000727||Parallel Assignment||Treatment||||||||
1575747|NCT00000726||||Treatment||None (Open Label)||||||
1575748|NCT00000725||||Treatment||None (Open Label)||||||
1575749|NCT00000724||||Treatment||None (Open Label)||||||
1575750|NCT00000723||||Treatment||||||||
1575751|NCT00000722||Parallel Assignment||Treatment||||||||
1575752|NCT00000721||||Treatment||None (Open Label)||||||
1575753|NCT00000720||||Treatment||Double||||||
1575754|NCT00000719||||Treatment||None (Open Label)||||||
1575755|NCT00000718||||Treatment||None (Open Label)||||||
1575756|NCT00000717||||Treatment||None (Open Label)||||||
1575757|NCT00000716||||Treatment||None (Open Label)||||||
1575758|NCT00000715||Parallel Assignment||Treatment||||||||
1575759|NCT00000714||||Treatment||None (Open Label)||||||
1575760|NCT00000713||||Treatment||||||||
1575761|NCT00000712||Parallel Assignment||Treatment||||||||
1575762|NCT00000711||||Treatment||None (Open Label)||||||
1575763|NCT00000710||||Treatment||None (Open Label)||||||
1575764|NCT00000709||||Treatment||None (Open Label)||||||
1575765|NCT00000708||Parallel Assignment||Treatment||||||||
1575766|NCT00000707||||Treatment||None (Open Label)||||||
1575767|NCT00000706||||Treatment||None (Open Label)||||||
1575768|NCT00000705||||Treatment||None (Open Label)||||||
1575769|NCT00000704||||Treatment||None (Open Label)||||||
1575770|NCT00000703||||Treatment||||||||
1575771|NCT00000702||||Treatment||Double||||||
1575772|NCT00000701||||Treatment||None (Open Label)||||||
1575773|NCT00000700||Parallel Assignment||Treatment||||||||
1575774|NCT00000699||||Treatment||None (Open Label)||||||
1575775|NCT00000698||||Treatment||None (Open Label)||||||
1575776|NCT00000697||Parallel Assignment||Treatment||||||||
1575777|NCT00000696||||Treatment||None (Open Label)||||||
1575778|NCT00000695||||Treatment||None (Open Label)||||||
1575779|NCT00000694||||Treatment||||||||
1575780|NCT00000693||||Treatment||None (Open Label)||||||
1575781|NCT00000692||||Treatment||None (Open Label)||||||
1575782|NCT00000691||||Treatment||||||||
1575783|NCT00000690||||Treatment||None (Open Label)||||||
1575784|NCT00000689||||Treatment||None (Open Label)||||||
1575785|NCT00000688||||Treatment||||||||
1575786|NCT00000687||||Treatment||None (Open Label)||||||
1575787|NCT00000686||||Treatment||None (Open Label)||||||
1575788|NCT00000685||||Treatment||None (Open Label)||||||
1575789|NCT00000684||||Treatment||None (Open Label)||||||
1575790|NCT00000683||||Prevention||Double||||||
1575791|NCT00000682|Randomized|||Treatment||||||||
1575792|NCT00000681||||Treatment||None (Open Label)||||||
1575793|NCT00000680||||Treatment||None (Open Label)||||||
1575794|NCT00000679||||Treatment||Double||||||
1575795|NCT00000678||||Treatment||None (Open Label)||||||
1575796|NCT00000677||||Treatment||None (Open Label)||||||
1575797|NCT00000676||||Prevention||||||||
1575798|NCT00000675||||Treatment||||||||
1575799|NCT00000674||||Treatment||None (Open Label)||||||
1575800|NCT00000673||||Treatment||None (Open Label)||||||
1575801|NCT00000672||||Treatment||||||||
1575802|NCT00000671||||Treatment||Double||||||
1575803|NCT00000670||||Treatment||None (Open Label)||||||
1575804|NCT00000669||||Treatment||None (Open Label)||||||
1575805|NCT00000668||||Treatment||None (Open Label)||||||
1575806|NCT00000667||||Prevention||None (Open Label)||||||
1575807|NCT00000666||Parallel Assignment||Prevention||||||||
1575808|NCT00000665||||Treatment||||||||
1575809|NCT00000664||Parallel Assignment||Treatment||||||||
1575810|NCT00000663||||Treatment||||||||
1575811|NCT00000662||||Treatment||||||||
1575812|NCT00000661||||Treatment||None (Open Label)||||||
1575813|NCT00000660||||Treatment||||||||
1575814|NCT00000659||||Treatment||None (Open Label)||||||
1575815|NCT00000658||||Treatment||None (Open Label)||||||
1575816|NCT00000657||||Treatment||Double||||||
1575817|NCT00000656||||Treatment||None (Open Label)||||||
1575818|NCT00000655||Parallel Assignment||Treatment||||||||
1575819|NCT00000654||||Treatment||||||||
1575820|NCT00000653||||Treatment||||||||
1575821|NCT00000652||Parallel Assignment||Treatment||||||||
1575822|NCT00000651||||Treatment||Double||||||
1575823|NCT00000650||||Treatment||None (Open Label)||||||
1575824|NCT00000649||||Treatment||||||||
1575825|NCT00000648||Parallel Assignment||Treatment||||||||
1575826|NCT00000647||||Treatment||None (Open Label)||||||
1575827|NCT00000646||||Treatment||||||||
1575828|NCT00000645||||Treatment||None (Open Label)||||||
1575829|NCT00000644||||Treatment||Double||||||
1575830|NCT00000643||||Prevention||Double||||||
1575831|NCT00000642||||Prevention||None (Open Label)||||||
1575832|NCT00000641||||Treatment||None (Open Label)||||||
1575833|NCT00000640||||Treatment||Double||||||
1575834|NCT00000639||||Treatment||Double||||||
1575835|NCT00000638||Parallel Assignment||Prevention||||||||
1575836|NCT00000637||||Treatment||Double||||||
1575837|NCT00000636||Parallel Assignment||Treatment||||||||
1575838|NCT00000635||||Treatment||None (Open Label)||||||
1575839|NCT00000634||||Treatment||||||||
1575840|NCT00000633||||Treatment||||||||
1575841|NCT00000632|Randomized|||Prevention||||||||
1575842|NCT00000631||||Prevention||None (Open Label)||||||
1575843|NCT00000630|Randomized|||Prevention||||||||
1575844|NCT00000629||||Treatment||None (Open Label)||||||
1575845|NCT00000628||Parallel Assignment||Treatment||||||||
1575846|NCT00000627||||Treatment||||||||
1575847|NCT00000626||||Treatment||||||||
1575848|NCT00000625||||Treatment||Double||||||
1575849|NCT00023192||||Treatment||||||||
1575850|NCT00023166|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575851|NCT00023153||||Treatment||||||||
1575852|NCT00023140|||||Prospective|||||||
1575853|NCT00023127|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1575854|NCT00023114|Random Sample|||Screening||||||||
1575855|NCT00023101|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1575856|NCT00023088||||||||||||
1575857|NCT00023075||||||||||||
1575858|NCT00023062||||||||||||
1575859|NCT00023049|||||Other|||||||
1575860|NCT00023036|||||Other|||||||
1575861|NCT00023023||||||||||||
1575862|NCT00023010||||||||||||
1575863|NCT00022997||||||||||||
1575864|NCT00022984||||||||||||
1575865|NCT00022971||Single Group Assignment||Treatment||None (Open Label)||||||
1575866|NCT00022958|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575867|NCT00022945|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575868|NCT00022932|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575869|NCT00022919||||||||||||
1575870|NCT00022906|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575871|NCT00022893|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575872|NCT00022880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575873|NCT00022867|Randomized|Parallel Assignment||Prevention||Double||||||
1575874|NCT00022854|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1575875|NCT00022841|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575876|NCT00022828||||Screening|Longitudinal, Prospective|||||||
1575877|NCT00022815|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575878|NCT00022802|Randomized|Parallel Assignment||Treatment||Single||||||
1575879|NCT00022776|Randomized|Parallel Assignment||Treatment||Single|||||t|
1575880|NCT00022789|||Cohort|||||||||
1575881|NCT00022750|Randomized|||Prevention||||||||
1575882|NCT00021970|||||Retrospective|||||||
1575883|NCT00021957|||||Retrospective|||||||
1575884|NCT00021944|||||Retrospective|||||||
1575885|NCT00021931|||||Retrospective|||||||
1575886|NCT00021918|||||Retrospective|||||||
1575887|NCT00021905||||||||||||
1575888|NCT00021892||||||||||||
1575889|NCT00021879||||||||||||
1575890|NCT00021866|||Family-Based||Prospective|||||||
1575891|NCT00021853||||Treatment||||||||
1575892|NCT00021840|||Family-Based||Cross-Sectional|||||||
1575893|NCT00021827|Randomized|||Treatment||Double||||||
1575894|NCT00021814|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1575895|NCT00021801||||Treatment||None (Open Label)||||||
1575896|NCT00021788||||Treatment||None (Open Label)||||||
1575897|NCT00021749|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575898|NCT00021736|Randomized|Parallel Assignment||Treatment||Double||||||
1575899|NCT00021723|Randomized|Parallel Assignment||Treatment||Double||||||
1575900|NCT00021710||||||||||||
1575901|NCT00021697|Randomized|Parallel Assignment||Treatment||Double||||||
1575902|NCT00021658||||Prevention||||||||
1575903|NCT00021645||||Treatment||||||||
1575904|NCT00021580|Non-Randomized|||Treatment||None (Open Label)||||||
1575905|NCT00021567||||Treatment||||||||
1575906|NCT00021541|Randomized|Crossover Assignment||Prevention||Single||||||t
1575907|NCT00021528|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575908|NCT00021502|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575909|NCT00021476|Randomized|Single Group Assignment||Prevention||Single||||||
1575910|NCT00021437|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1575911|NCT00018902|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1575912|NCT00018889|||Family-Based||Prospective|||||||
1575913|NCT00018876|Randomized|Single Group Assignment||Treatment||Double||||||
1575914|NCT00018863|Randomized|||Treatment||Double||||||
1575915|NCT00018850|Randomized|Crossover Assignment||Treatment||Double||||||
1575916|NCT00018837||Parallel Assignment||||||||||
1575917|NCT00018824|Randomized|Single Group Assignment||Treatment||Triple|||t||t|t
1575918|NCT00018811|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575919|NCT00018798|||Cohort||Prospective|||||||
1575920|NCT00018785||Parallel Assignment||Prevention||None (Open Label)||||||
1575921|NCT00018772|||||Prospective|||||||
1575922|NCT00018759|Randomized|Parallel Assignment||Treatment||Double||||||
1575923|NCT00018746|Randomized|Crossover Assignment||Treatment||Single||||||
1575924|NCT00018733|Randomized|||Treatment||Double||||||
1575925|NCT00018720|||||Prospective|||||||
1575926|NCT00018707||||||||||||
1575927|NCT00018694|Non-Randomized|||||None (Open Label)||||||
1575928|NCT00018681|||||Prospective|||||||
1575929|NCT00018668|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575930|NCT00018655|Randomized|Factorial Assignment||Treatment||Single||||||t
1575931|NCT00018642|Randomized|Parallel Assignment||Treatment||||||||
1575932|NCT00018629|Randomized|Parallel Assignment||||Single||||||
1575933|NCT00018616|Randomized|Parallel Assignment||||None (Open Label)||||||
1575934|NCT00018603|Randomized|Parallel Assignment||Treatment||Double||||||
1575935|NCT00018590||||||||||||
1575936|NCT00018577|||||Prospective|||||||
1575937|NCT00018564|Randomized|||Treatment||Double||||||
1575938|NCT00018551|Randomized|||Prevention||Double||||||
1575939|NCT00018538|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575940|NCT00018525|Randomized|||Treatment||||||||
1575941|NCT00018512|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575942|NCT00018499||||||||||||
1575943|NCT00018486||||||||||||
1575944|NCT00018473||||||||||||
1575945|NCT00018460|Randomized|Single Group Assignment||Prevention||Double||||||
1575946|NCT00018447|Randomized|||Treatment||None (Open Label)||||||
1575947|NCT00018434|||||Prospective|||||||
1575948|NCT00018421|Randomized|Parallel Assignment||Treatment||||||||
1575949|NCT00018408|||||Retrospective|||||||
1575950|NCT00018395||||||||||||
1575951|NCT00018382|Randomized|||Treatment||Double||||||
1575952|NCT00018369|||||Prospective|||||||
1575953|NCT00018356||||||||||||
1575954|NCT00018343|Randomized|Parallel Assignment||Treatment||Double||||||
1575955|NCT00018330|Non-Randomized|Single Group Assignment||Treatment||||||||
1575956|NCT00018317|Randomized|||Treatment||None (Open Label)||||||
1575957|NCT00018304||||||||||||
1575958|NCT00018291|Randomized|Single Group Assignment||Treatment||Double||||||
1575959|NCT00018278|Non-Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1575960|NCT00018265|Randomized|Single Group Assignment||Treatment||Single||||||
1575961|NCT00018252|Randomized|||||||||||
1575962|NCT00018239|Randomized|Single Group Assignment||Treatment||||||||
1575963|NCT00018226|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575964|NCT00018213|Randomized|Single Group Assignment||Treatment||Double||||||
1575965|NCT00018200|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1575966|NCT00018187|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575967|NCT00018174|Randomized|Factorial Assignment||Treatment||Double||||||
1575968|NCT00018161|Randomized|Parallel Assignment||Treatment||Double||||||
1575969|NCT00018148|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1575970|NCT00018135|Randomized|Single Group Assignment||Prevention||||||||
1575971|NCT00018122|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1575972|NCT00018109|Randomized|||Treatment||Double||||||
1575973|NCT00018096|Non-Randomized|Single Group Assignment||Basic Science||None (Open Label)||||||
1575974|NCT00018083|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575975|NCT00018070||||Treatment||||||||
1575976|NCT00018057||||||||||||
1575977|NCT00018044||||||||||||
1575978|NCT00018031||Single Group Assignment||Treatment||None (Open Label)||||||
1575979|NCT00018018||||Treatment||||||||
1575980|NCT00018005|Randomized|Parallel Assignment||Treatment||Single||||||t
1575981|NCT00017979||||||||||||
1575982|NCT00017966||||||||||||
1575983|NCT00017940||||Treatment||None (Open Label)||||||
1575984|NCT00017953|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1575985|NCT00017927||||Treatment||||||||
1575986|NCT00017914|||Cohort||Prospective|||||||
1575987|NCT00017875||||||||||||
1575988|NCT00017836||||||||||||
1575989|NCT00017823||||Treatment||None (Open Label)||||||
1575990|NCT00017810|Randomized|||Educational/Counseling/Training||Single||||||
1575991|NCT00017745||||||||||||
1575992|NCT00017732||||||||||||
1575993|NCT00017706|Randomized|||Treatment||||||||
1575994|NCT00016848||||||||||||
1575995|NCT00016835|Randomized|Parallel Assignment||Treatment||Double|Participants and examiners were unaware of the type of medication and examiners were also unaware of the type of periodontal therapy the participants receive|Study participants were randomized into 3 groups for the initial non-surgical treatment appointment. One group received supra-gingival scaling and placebo, one group received non-surgical periodontal supra- and sub-gingival scaling plus metronidazole and one group received non-surgical periodontal supra- and sub-gingival scaling plus doxycycline. All three groups received 3-month follow-up visits for 15 months and the group receiving supra-gingival scaling and placebo at the initial visit received supra- and sub-gingival scaling at the 9-month follow-up visit.|t|t||
1575996|NCT00017680|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1575997|NCT00017654||||Treatment||||||||
1575998|NCT00017641||||Treatment||||||||
1575999|NCT00017628||||Treatment||||||||
1576001|NCT00016744|Randomized|Single Group Assignment||Basic Science||Quadruple|||t|t|t|t
1576002|NCT00016731|||Case-Control||Retrospective|||||||
1576003|NCT00016679||||Treatment||||||||
1576004|NCT00016666||||Treatment||||||||
1576005|NCT00016653|Randomized|||Treatment||Double||||||
1576006|NCT00016627||||||||||||
1576007|NCT00016562||||||||||||
1576008|NCT00016549||||Treatment||||||||
1576009|NCT00016523|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1576010|NCT00016510||||||||||||
1576011|NCT00016497|Randomized|Parallel Assignment||Treatment||||||||
1576012|NCT00016471|||Defined Population, Natural History|||||||||
1576013|NCT00016458||||Treatment||||||||
1576014|NCT00016445||||Treatment||||||||
1576015|NCT00015808||||Treatment||||||||
1576016|NCT00015795||||Treatment||||||||
1576017|NCT00015782||||||||||||
1576018|NCT00015769||||Treatment||||||||
1576019|NCT00015756||||||||||||
1576020|NCT00015717||||||||||||
1576021|NCT00015678||||||||||||
1576022|NCT00015665||||Treatment||||||||
1576023|NCT00015639||||||||||||
1576024|NCT00015626|Randomized|||Treatment||Double||||||
1576025|NCT00015613|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1576026|NCT00015600|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1576027|NCT00015587|||Case Control||Prospective|||||||
1576028|NCT00015574|||Defined Population, Natural History||Longitudinal, Retrospective/Prospective|||||||
1576029|NCT00015561|||Defined Population, Natural History||Cross-Sectional, Retrospective/Prospective|||||||
1576030|NCT00015548|Randomized|Parallel Assignment||Treatment||Double||||||
1576031|NCT00015483|Random Sample|||||||||||
1576032|NCT00015470||||||||||||
1576033|NCT00015457|Randomized|Crossover Assignment||Treatment||Triple|||t||t|t
1576034|NCT00015444|||Cohort||Other|||||||
1576035|NCT00015431||||||||||||
1576036|NCT00015015|||Defined Population|Screening|Longitudinal, Prospective|||||||
1576037|NCT00015340||Single Group Assignment||Treatment||None (Open Label)||||||
1576038|NCT00015301||||Diagnostic||Double||||||
1576039|NCT00015288||||Treatment||Double||||||
1576040|NCT00015275||||Diagnostic||None (Open Label)||||||
1576041|NCT00015249||||Diagnostic||Double||||||
1576042|NCT00015236||||Prevention||None (Open Label)||||||
1576043|NCT00015223||||Treatment||Double||||||
1576044|NCT00015210|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1576045|NCT00015171||Parallel Assignment||Treatment||Double||||||
1576046|NCT00015132||Parallel Assignment||Treatment||||||||
1576047|NCT00015106||Parallel Assignment||Treatment||||||||
1576048|NCT00015080||||Treatment||||||||
1576049|NCT00015067||Crossover Assignment||Treatment||||||||
1576050|NCT00015054||||Treatment||None (Open Label)||||||
1576051|NCT00015041||||Treatment||||||||
1576052|NCT00015028||||Treatment||||||||
1576053|NCT00015002|Randomized|Single Group Assignment||Treatment||Triple|||t|t|t|
1576054|NCT00014989|Randomized|Single Group Assignment||Prevention||Triple|||t|t|t|
1576055|NCT00014976||||||||||||
1576056|NCT00014963|Random Sample|||Screening|Cross-Sectional|||||||
1576057|NCT00014950|Randomized|Single Group Assignment||Diagnostic||||||||
1576058|NCT00014898|||Case Control||Retrospective|||||||
1576059|NCT00014885|||||Retrospective|||||||
1576060|NCT00014872|||Cohort||Prospective|||||||
1576061|NCT00014859|||Case-Control||Prospective|||||||
1576062|NCT00014833|||Cohort||Retrospective|||||||
1576063|NCT00014820|||Case Control||Retrospective|||||||
1576064|NCT00014807||||Prevention||||||||
1576065|NCT00014794||||Treatment||||||||
1576066|NCT00014781||||||||||||
1576067|NCT00014768|||Natural History|||||||||
1576068|NCT00014755||||Treatment||||||||
1576069|NCT00014742|Randomized|||Treatment||||||||
1576070|NCT00014729||||Treatment||||||||
1576071|NCT00014040||||Treatment||||||||
1576072|NCT00014027||||Treatment||||||||
1576073|NCT00014001|Randomized|Crossover Assignment||Treatment||Double||||||
1576074|NCT00013975||||||||||||
1576075|NCT00013962|||Case Control, Natural History|||||||||
1576076|NCT00013949|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1576077|NCT00013936||||||||||||
1576078|NCT00013923|Randomized|Parallel Assignment||Treatment||Double||||||
1576079|NCT00013910|Randomized|Crossover Assignment||Treatment||Double||||||
1576080|NCT00013858|||||Prospective|||||||
1576081|NCT00013884||||Treatment||||||||
1576082|NCT00013845||||||||||||
1576083|NCT00013832||||||||||||
1576084|NCT00013819|||||Prospective|||||||
1576085|NCT00013806||||Treatment||||||||
1576086|NCT00013793|Randomized|||Treatment||||||||
1576087|NCT00013780|||Natural History||Cross-Sectional, Prospective|||||||
1576088|NCT00013767||||Prevention||||||||
1576089|NCT00013754||||||||||||
1576090|NCT00013741|Randomized|||||Double||||||
1576091|NCT00013728|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1576092|NCT00013715|||||Prospective|||||||
1576093|NCT00013702||||Treatment||||||||
1576094|NCT00013689||||Treatment||||||||
1576095|NCT00013650||||Treatment||||||||
1576096|NCT00013637|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1576097|NCT00013624||||Treatment||||||||
1576098|NCT00013611|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576099|NCT00013598||||Treatment||||||||
1576100|NCT00013559|||Cohort||Other|||||||
1576101|NCT00013546||||Treatment||||||||
1576102|NCT00013533||Single Group Assignment||Treatment||None (Open Label)||||||
1576186|NCT00011817||||||||||||
1576103|NCT00013507|Randomized|Crossover Assignment||||None (Open Label)||||||
1576104|NCT00013494|Randomized|Single Group Assignment||||Single||||||
1576105|NCT00013481|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576106|NCT00013468|||||Prospective|||||||
1576107|NCT00013455|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1576108|NCT00013442|||||Prospective|||||||
1576109|NCT00013429|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576110|NCT00013416|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576111|NCT00013403|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576112|NCT00013390|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576113|NCT00013377|Randomized|Single Group Assignment||||None (Open Label)||||||
1576114|NCT00013364|||||Prospective|||||||
1576115|NCT00013351|||||Prospective|||||||
1576116|NCT00013338|Randomized|Single Group Assignment||||None (Open Label)||||||
1576117|NCT00013325|||||Prospective|||||||
1576118|NCT00013312|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1576119|NCT00013299|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1576120|NCT00013286|||||Prospective|||||||
1576121|NCT00013273|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576122|NCT00013260|Randomized|Single Group Assignment||Treatment||Single||||||
1576123|NCT00013247|Randomized|Single Group Assignment||Treatment||Single||||||
1576124|NCT00013234|Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1576125|NCT00013221|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1576126|NCT00013208|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576127|NCT00013195|Randomized|Parallel Assignment||Prevention||Single||||||
1576128|NCT00013182|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1576129|NCT00013169|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576130|NCT00013156|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576131|NCT00013143|Randomized|Single Group Assignment||||Single||||||
1576132|NCT00013130|Randomized|Parallel Assignment||||None (Open Label)||||||
1576133|NCT00013117|Randomized|Single Group Assignment||||None (Open Label)||||||
1576134|NCT00013104|||||Prospective|||||||
1576135|NCT00013091||||Treatment||Single||||||
1576136|NCT00013078|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1576137|NCT00013065|||||Prospective|||||||
1576138|NCT00013052|Randomized|Factorial Assignment||||None (Open Label)||||||
1576139|NCT00013039|Randomized|Single Group Assignment||||None (Open Label)||||||
1576140|NCT00013026|Randomized|Parallel Assignment||||Single||||||
1576141|NCT00013013|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1576142|NCT00013000|Randomized|Parallel Assignment||Treatment||Single||||||
1576143|NCT00012987|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576144|NCT00012974|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1576145|NCT00012961|||||Prospective|||||||
1576146|NCT00012948|Randomized|Single Group Assignment||||None (Open Label)||||||
1576147|NCT00012935|Non-Randomized|Single Group Assignment||||None (Open Label)||||||
1576148|NCT00012922|Randomized|Single Group Assignment||||None (Open Label)||||||
1576149|NCT00012909|Randomized|Parallel Assignment||||None (Open Label)||||||
1576150|NCT00012896|Randomized|Factorial Assignment||||Single||||||
1576151|NCT00012883|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576152|NCT00012870|Randomized|Single Group Assignment||||None (Open Label)||||||
1576153|NCT00012857|Randomized|Crossover Assignment||Treatment||Double||||||
1576154|NCT00012844|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1576155|NCT00012831|||||Prospective|||||||
1576156|NCT00012818|Randomized|Parallel Assignment||||None (Open Label)||||||
1576157|NCT00012805|Randomized|Single Group Assignment||||None (Open Label)||||||
1576158|NCT00012792|Randomized|Single Group Assignment||||None (Open Label)||||||
1576159|NCT00012779|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576160|NCT00012766|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576161|NCT00012753|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576162|NCT00012740|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576163|NCT00012727|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576164|NCT00012714|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576165|NCT00012701||||||||||||
1576166|NCT00012688|Randomized|Factorial Assignment||Treatment||Single||||||
1576167|NCT00012675|||||Retrospective|||||||
1576168|NCT00012662|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1576169|NCT00012649||||||||||||
1576170|NCT00012636|Randomized|Parallel Assignment||||Single||||||
1576171|NCT00012623|||||Retrospective|||||||
1576172|NCT00012610|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576173|NCT00012597|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1576174|NCT00012584|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1576175|NCT00012558|Randomized|||Treatment||Double||||||
1576176|NCT00012545|||Case-Control||Cross-Sectional|||||||
1576177|NCT00012506||||Treatment||||||||
1576178|NCT00012493|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1576179|NCT00012480||||||||||||
1576180|NCT00012441|Non-Randomized|||Treatment||||||||
1576181|NCT00012428|||||Prospective|||||||
1576182|NCT00011908||||Treatment||||||||
1576183|NCT00011856||||||||||||
1576184|NCT00011843||||||||||||
1576185|NCT00011830||||Treatment||||||||
1576193|NCT00011726|||Natural History||Longitudinal, Prospective|||||||
1576194|NCT00011713|||Cohort||Prospective|||||||
1576195|NCT00011700||||||||||||
1576196|NCT00011687|Random Sample|||Screening|Cross-Sectional, Prospective|||||||
1576197|NCT00011674|||Defined Population||Longitudinal, Prospective|||||||
1576198|NCT00011661|Non-Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1576199|NCT00011648|||Case-Control||Prospective|||||||
1576200|NCT00011622|||Defined Population||Cross-Sectional, Prospective|||||||
1576201|NCT00011609|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576202|NCT00011596|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576203|NCT00011583|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576204|NCT00011570|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576205|NCT00011557|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576206|NCT00011544|Randomized|Single Group Assignment||||None (Open Label)||||||
1576207|NCT00011531|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576208|NCT00011518|||Case Control, Natural History||Longitudinal, Retrospective|||||||
1576209|NCT00011505||||Treatment||||||||
1576210|NCT00011492|||Cohort||Prospective|||||||
1576211|NCT00011466|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1576212|NCT00011453||||Screening|Prospective|||||||
1576213|NCT00011440|Random Sample||Natural History||Longitudinal, Prospective|||||||
1576214|NCT00011414|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576215|NCT00011388|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1576216|NCT00011375||||Treatment||||||||
1576217|NCT00011362|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1576218|NCT00011349|||Cohort||Prospective|||||||
1576219|NCT00011336||||||||||||
1576220|NCT00011323||||||||||||
1576221|NCT00011310|||Defined Population, Natural History||Longitudinal, Prospective|||||||
1576222|NCT00011297|Randomized|||Treatment||Double||||||
1576223|NCT00011284|||Case Control, Natural History||Cross-Sectional, Prospective|||||||
1576224|NCT00011258||||||||||||
1576225|NCT00011245||||||||||||
1576226|NCT00011154|||Defined Population, Natural History||Cross-Sectional, Retrospective|||||||
1576227|NCT00011141|Randomized|Single Group Assignment||Treatment||Double||||||
1576228|NCT00011206|||||Retrospective|||||||
1576229|NCT00011193|||Cohort||Prospective|||||||
1576230|NCT00011180|||Case Control||Retrospective|||||||
1576231|NCT00011167|||Case Control||Retrospective|||||||
1576232|NCT00011076||||Treatment||||||||
1576233|NCT00011115||Factorial Assignment||Treatment||||||||
1576234|NCT00011102|Randomized|||Prevention||||||||
1576235|NCT00011024|Randomized|||Treatment||||||||
1576236|NCT00010998||||Treatment||||||||
1576237|NCT00010985|Randomized|||Treatment||||||||
1576238|NCT00010972|Randomized|||Treatment||||||||
1576239|NCT00010959|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576240|NCT00010946|Randomized|||Treatment||Single||||||
1576241|NCT00010933|Randomized|||Treatment||Double||||||
1576242|NCT00010920|Randomized|||Prevention||Double||||||
1576243|NCT00010907|Randomized|||Treatment||||||||
1576244|NCT00010881||||Treatment||||||||
1576245|NCT00010868||Parallel Assignment||Treatment||Double||||||
1576246|NCT00010855|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576247|NCT00010842|Randomized|||Treatment||||||||
1576248|NCT00010829|Randomized|||Treatment||||||||
1576249|NCT00010816|Randomized|||Treatment||Double||||||
1576250|NCT00010803|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1576251|NCT00010777|Randomized|||Treatment||||||||
1576252|NCT00010764|Randomized|||Treatment||||||||
1576253|NCT00010751|Randomized|||Treatment||Single||||||
1576254|NCT00010738|Randomized|||Treatment||||||||
1576255|NCT00010725|Randomized|||Treatment||||||||
1576256|NCT00010712|Randomized|||Treatment||||||||
1576257|NCT00010699|Randomized|||Treatment||Double||||||
1576258|NCT00010686|Randomized|||Treatment||||||||
1576259|NCT00010634|Randomized|||Treatment||||||||
1576260|NCT00010621|Randomized|Parallel Assignment||Treatment||||||||
1576261|NCT00010608|Randomized|Parallel Assignment||Treatment||Single||||||
1576262|NCT00010530|Randomized|||Treatment||Single||||||
1576263|NCT00010517|Randomized|||Treatment||Double||||||
1576264|NCT00010504|Randomized|Parallel Assignment||Treatment||Single||||||
1576265|NCT00010491|Randomized|Parallel Assignment||Treatment||Double||||||
1576266|NCT00010478|Randomized|||Treatment||Double||||||
1576267|NCT00010465|Randomized|||Treatment||Double||||||
1576268|NCT00009685||||Treatment||||||||
1576269|NCT00009672||||Treatment||||||||
1576270|NCT00009659||||Treatment||||||||
1576271|NCT00009646|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1576272|NCT00009633|||Cohort||Prospective|||||||
1576273|NCT00009620|Randomized|Parallel Assignment||Prevention||Double||||||
1576274|NCT00010452||Single Group Assignment||Treatment||None (Open Label)||||||
1576275|NCT00010439|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576276|NCT00010426||||Treatment||||||||
1576277|NCT00010413||||Treatment||||||||
1576278|NCT00010400|Non-Randomized|||Treatment||||||||
1576279|NCT00010387||Single Group Assignment||Treatment||||||||
1576280|NCT00010374|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576281|NCT00010361||||Treatment||||||||
1576282|NCT00010335||Single Group Assignment||Treatment||None (Open Label)||||||
1576283|NCT00009594||||Diagnostic||||||||
1576289|NCT00009230|Randomized|||Treatment||Double||||||
1576290|NCT00009217|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1576291|NCT00009204|Randomized|||Treatment||Double||||||
1576292|NCT00009191|Randomized|Single Group Assignment||Treatment||Double||||||
1576293|NCT00009048||||Treatment||||||||
1576294|NCT00009035|||Case-Only||Prospective|||||||
1576295|NCT00009178|Randomized|Parallel Assignment||Treatment||Double||||||
1576296|NCT00009009||||Treatment||||||||
1576297|NCT00008892||||||||||||
1576298|NCT00008814|||Natural History||Cross-Sectional, Prospective|||||||
1576299|NCT00008801|Non-Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1576300|NCT00008788|||Defined Population, Natural History||Cross-Sectional|||||||
1576301|NCT00008775|Randomized|||Treatment||None (Open Label)||||||
1576302|NCT00008762|||Defined Population, Natural History||Cross-Sectional, Prospective|||||||
1576303|NCT00008749|||Case Control, Natural History|||||||||
1576304|NCT00008736|Non-Randomized|||Treatment||||||||
1576305|NCT00008827|Randomized|||Treatment||||||||
1576306|NCT00008541||||||||||||
1576307|NCT00008515||||Treatment||||||||
1576308|NCT00008502|||Family-Based||Cross-Sectional|||||||
1576309|NCT00008476||||Treatment||||||||
1576310|NCT00008450||Single Group Assignment||Treatment||None (Open Label)||||||
1576311|NCT00007800|Randomized|Parallel Assignment||Treatment||||||||
1576312|NCT00007696||||||||||||
1576313|NCT00007670|Randomized|Parallel Assignment||||Double||||||
1576314|NCT00007657|Randomized|Single Group Assignment||||None (Open Label)||||||
1576315|NCT00007774||||||Double||||||
1576316|NCT00007761||||||||||||
1576317|NCT00007748|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1576318|NCT00007735|Randomized|Parallel Assignment||||Double||||||
1576319|NCT00007722|||Case-Only||Prospective|||||||
1576320|NCT00007709||||||||||||
1576321|NCT00007683|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1576322|NCT00007644|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576323|NCT00007631|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1576324|NCT00007618||||||||||||
1576325|NCT00007605|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1576326|NCT00007592|||||Prospective|||||||
1576327|NCT00007579||||||||||||
1576328|NCT00007540||||||||||||
1576329|NCT00007527|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576330|NCT00007514||||||||||||
1576331|NCT00007501|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1576332|NCT00007475||Single Group Assignment||Treatment||None (Open Label)||||||
1576333|NCT00007410||||||||||||
1576334|NCT00007397||||||||||||
1576335|NCT00007384||||||||||||
1576336|NCT00007358|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1576337|NCT00007345|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576338|NCT00007306|Randomized|Single Group Assignment||Treatment||Double||||||
1576339|NCT00007293|Non-Randomized|Single Group Assignment||Treatment||Single||||||
1576340|NCT00007280|Randomized|Single Group Assignment||Treatment||Double|||t||t|
1576341|NCT00007267|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576342|NCT00007254|Randomized|Parallel Assignment||Treatment||Double||||||
1576343|NCT00007241|Randomized|Parallel Assignment||Treatment||Single||||||
1576344|NCT00007228||||||||||||
1576345|NCT00007215||||||||||||
1576346|NCT00007189|Randomized|Parallel Assignment||Prevention||Double||||||
1576347|NCT00007163||||Treatment||||||||
1576348|NCT00007150|||Cohort||Prospective|||||||
1576349|NCT00007137||||||||||||
1576350|NCT00007124||||||||||||
1576351|NCT00007111||||||||||||
1576352|NCT00007098|||Cohort||Prospective|||||||
1576353|NCT00007085||||Diagnostic||||||||
1576354|NCT00007059||||Treatment||||||||
1576355|NCT00007046||||Screening||||||||
1576356|NCT00007033||||Treatment||||||||
1576357|NCT00007020|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576358|NCT00006565|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1576359|NCT00007371||||||||||||
1576360|NCT00006552|||||Retrospective|||||||
1576361|NCT00006539||||||||||||
1576362|NCT00006526||||||||||||
1576363|NCT00006519||||Treatment||||||||
1576364|NCT00006518|||Cohort||Prospective|||||||
1576365|NCT00006517|Randomized|Parallel Assignment||Treatment||Single||||||t
1576366|NCT00006516|Randomized|Parallel Assignment||Treatment||Single||||||
1576367|NCT00006515||||||||||||
1576368|NCT00006514||||||||||||
1576369|NCT00006513||||||||||||
1576370|NCT00006512||||||||||||
1576371|NCT00006511||||||||||||
1576372|NCT00006510||||||||||||
1576373|NCT00006508||||Diagnostic||||||||
1576374|NCT00006505||Single Group Assignment||Treatment||None (Open Label)||||||
1576375|NCT00006504||||||||||||
1576376|NCT00006503||||||||||||
1576377|NCT00006502||||||||||||
1576378|NCT00006501|||Cohort||Prospective|||||||
1576379|NCT00006500||||||||||||
1576380|NCT00006499||||||||||||
1576381|NCT00006498||||||||||||
1576382|NCT00006497||||||||||||
1576383|NCT00006496|||Case-Control||Prospective|||||||
1576384|NCT00006494||||||||||||
1576385|NCT00006493||||Treatment||None (Open Label)||||||
1576386|NCT00006492||||||||||||
1576387|NCT00006489|Randomized|Factorial Assignment||Treatment||Triple|||t|t||t
1576388|NCT00006488||||Treatment||||||||
1576389|NCT00006450||||Treatment||||||||
1576390|NCT00006449|Randomized|||Treatment||Double||||||
1576391|NCT00006507|Randomized|Crossover Assignment||Treatment||Single||||||
1576392|NCT00006448|Randomized|Single Group Assignment||Treatment||Double||||||
1576393|NCT00006447|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576394|NCT00006446|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576395|NCT00006445|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1576396|NCT00006439||Single Group Assignment||Educational/Counseling/Training||||||||
1576397|NCT00006438|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1576398|NCT00006437||||||||||||
1576399|NCT00006436||Single Group Assignment||Treatment||None (Open Label)||||||
1576400|NCT00006435|||Cohort||Prospective|||||||
1576401|NCT00006434||||Treatment||None (Open Label)||||||
1576402|NCT00006433||||Treatment||||||||
1576403|NCT00006432|Randomized|||Treatment||Single||||||
1576404|NCT00006431||||Treatment||||||||
1576405|NCT00006430||||Treatment||||||||
1576406|NCT00006429|Randomized|Single Group Assignment||||Single||||||
1576407|NCT00006428|Randomized|Single Group Assignment||Treatment||Double||||||
1576408|NCT00006427|Randomized|Single Group Assignment||Treatment||Double||||||
1576409|NCT00006426|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576410|NCT00006425|||Cohort||Cross-Sectional|||||||
1576411|NCT00006424||||||||||||
1576412|NCT00006422||||||||||||
1576413|NCT00006421|||Cohort||Prospective|||||||
1576414|NCT00006420||||||||||||
1576415|NCT00006419||||||||||||
1576416|NCT00006418||||||||||||
1576417|NCT00006417||||Treatment||||||||
1576418|NCT00006414||||||||||||
1576419|NCT00006413||||Treatment||||||||
1576420|NCT00006411||Parallel Assignment||||Triple|||t||t|t
1576421|NCT00006409|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1576422|NCT00006408|||||Retrospective|||||||
1576423|NCT00006407||||||||||||
1576424|NCT00006406||||||||||||
1576425|NCT00006405||||||||||||
1576426|NCT00006404||||||||||||
1576427|NCT00006403||||||||||||
1576428|NCT00006402||||||||||||
1576429|NCT00006401|Randomized|Parallel Assignment||Prevention||Double|||t|t||
1576430|NCT00006400|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1576431|NCT00006398|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1576432|NCT00006394|Randomized|||Treatment||Double||||||
1576433|NCT00006393||||Screening||||||||
1576434|NCT00006337||||Treatment||||||||
1576435|NCT00006336||||||||||||
1576436|NCT00006335||||||||||||
1576437|NCT00006334||||||||||||
1576438|NCT00006333||||||||||||
1576439|NCT00006332||||Treatment||None (Open Label)||||||
1576440|NCT00006331|||Defined Population||Longitudinal|||||||
1576441|NCT00006330|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1576442|NCT00006329|Randomized|||Treatment||||||||
1576443|NCT00006328|||Natural History||Retrospective|||||||
1576444|NCT00006323||||||||||||
1576445|NCT00006322||||||||||||
1576446|NCT00006321|||Cohort||Prospective|||||||
1576447|NCT00006320||||Treatment||||||||
1576448|NCT00006319||||||||||||
1576449|NCT00006318||||||||||||
1576450|NCT00006315||||||||||||
1576451|NCT00006314||||||||||||
1576452|NCT00006313|||||Retrospective|||||||
1576453|NCT00006312||||||||||||
1576454|NCT00006311||||||||||||
1576455|NCT00006310||||||||||||
1576456|NCT00006309||||||||||||
1576457|NCT00006308||||||||||||
1576458|NCT00006307||||||||||||
1576459|NCT00006306||||||||||||
1576460|NCT00006305|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1576461|NCT00006301|||Cohort||Prospective|||||||
1576462|NCT00006300||||||||||||
1576463|NCT00006299||||Treatment||||||||
1576464|NCT00006297||||||||||||
1576465|NCT00006296||||||||||||
1576466|NCT00006295|||Family-Based||Prospective|||||||
1576467|NCT00006294|||Cohort||Prospective|||||||
1576468|NCT00006292||||Treatment||||||||
1576469|NCT00006289|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1576470|NCT00006285||||||||||||
1576471|NCT00006286|Randomized|||Treatment||Double||||||
1576472|NCT00006278||||||||||||
1576473|NCT00006276||||Treatment||||||||
1576474|NCT00006280|Randomized|||Treatment||Double||||||
1576475|NCT00006275||||Treatment||||||||
1576476|NCT00006274|||Natural History|||||||||
1576477|NCT00006273|||Natural History|||||||||
1576478|NCT00006272|||Natural History|||||||||
1576479|NCT00006271||||Screening||||||||
1576480|NCT00006270||||Screening||||||||
1576481|NCT00006206|Randomized|Factorial Assignment||Treatment||Double||||||
1576482|NCT00006205|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1576483|NCT00006204|Randomized|Parallel Assignment||Treatment||Double||||||
1576484|NCT00006203|Randomized|||Treatment||||||||
1576485|NCT00006202||||Treatment||||||||
1576486|NCT00006200||||Treatment||||||||
1576487|NCT00006199||||Treatment||||||||
1576488|NCT00006198||||Treatment||None (Open Label)||||||
1576489|NCT00006196|Randomized|||Diagnostic||Double||||||
1576490|NCT00006195||||Treatment||None (Open Label)||||||
1576491|NCT00006194|Randomized|Single Group Assignment||Treatment||||||||
1576492|NCT00006193|Randomized|||Treatment||||||||
1576493|NCT00006192||||||||||||
1576494|NCT00006190||||Diagnostic||Double||||||
1576495|NCT00006188||||||||||||
1576496|NCT00006187|Randomized|Parallel Assignment||Treatment||Double||||||
1576497|NCT00006186|Randomized|Parallel Assignment||Treatment||Single||||||
1576498|NCT00006184|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576499|NCT00006185||||Diagnostic||None (Open Label)||||||
1576892|NCT00005364||||||||||||
1576500|NCT00006183|Randomized|Parallel Assignment||Treatment||||||||
1576501|NCT00006182|Randomized|||Prevention||||||||
1576502|NCT00006399||||Treatment||Double||||||
1576503|NCT00006181|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1576504|NCT00006180||||Treatment||||||||
1576505|NCT00006178||||Treatment||||||||
1576506|NCT00006177|||Cohort||Prospective|||||||
1576507|NCT00006176||||||||||||
1576508|NCT00006175||||||||||||
1576509|NCT00006174||||Treatment||||||||
1576510|NCT00006173||||||||||||
1576511|NCT00006172|Randomized|Parallel Assignment||Treatment||Single||||||t
1576512|NCT00006171||||||||||||
1576513|NCT00006170|Randomized|Factorial Assignment||Treatment||Double|||t|||t
1576514|NCT00006156|Non-Randomized|Parallel Assignment||Diagnostic||None (Open Label)||||||
1576515|NCT00006169||||Prevention||||||||
1576516|NCT00006168|Randomized|||Treatment||Double||||||
1576517|NCT00006167||||Treatment||Double||||||
1576518|NCT00006166|Randomized|||Treatment||None (Open Label)||||||
1576519|NCT00006165||||Prevention||||||||
1576520|NCT00006164|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1576521|NCT00006163|Randomized|Factorial Assignment||||||||||
1576522|NCT00006162|Randomized|||Prevention||||||||
1576523|NCT00006161|Randomized|Parallel Assignment||Treatment||||||||
1576524|NCT00006160|Randomized|||Treatment||||||||
1576525|NCT00006159||||Treatment||||||||
1576526|NCT00006158||||Treatment||None (Open Label)||||||
1576527|NCT00006157|Randomized|||Treatment||Double||||||
1576528|NCT00006151|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1576529|NCT00006150||||||||||||
1576530|NCT00006148||||||||||||
1576531|NCT00006077||||Treatment||||||||
1576532|NCT00006142||||Prevention||||||||
1576533|NCT00006138||||Screening||||||||
1576534|NCT00006137||||Treatment||||||||
1576535|NCT00006136||||Treatment||||||||
1576536|NCT00006135|Randomized|||Treatment||Double||||||
1576537|NCT00006134||||Screening||||||||
1576538|NCT00006133|Randomized|||Treatment||Double||||||
1576539|NCT00006132||||Treatment||||||||
1576540|NCT00006131|Randomized|||Treatment||Double||||||
1576541|NCT00006130|Randomized|||Treatment||||||||
1576542|NCT00006129|Randomized|||Treatment||||||||
1576543|NCT00006128||||Screening||||||||
1576544|NCT00006127||||Treatment||||||||
1576545|NCT00006076||||||||||||
1576546|NCT00006072||||Treatment||None (Open Label)||||||
1576547|NCT00006070||||Treatment||||||||
1576548|NCT00006068|Non-Randomized|||Treatment||Single||||||
1576549|NCT00005937||Single Group Assignment||Treatment||None (Open Label)||||||
1576550|NCT00005936||||||||||||
1576551|NCT00005935||||Treatment||||||||
1576552|NCT00005934||||Treatment||||||||
1576553|NCT00006063||||Treatment||||||||
1576554|NCT00006061||||Treatment||||||||
1576555|NCT00006060||||||||||||
1576556|NCT00006059||||Screening||||||||
1576557|NCT00006058||||Screening||||||||
1576558|NCT00006057||||Screening||||||||
1576559|NCT00006056||||Treatment||||||||
1576560|NCT00006055||||Treatment||||||||
1576561|NCT00006054||||Treatment||||||||
1576562|NCT00005933||||||||||||
1576563|NCT00005928||||Treatment||||||||
1576564|NCT00005927||||||||||||
1576565|NCT00005925||||Treatment||||||||
1576566|NCT00005924||||||||||||
1576567|NCT00005923|||Natural History|||||||||
1576568|NCT00005922|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1576569|NCT00005919||||||||||||
1576570|NCT00005917|||Cohort||Prospective|||||||
1576571|NCT00005916||||Treatment||||||||
1576572|NCT00005914|||||Retrospective|||||||
1576573|NCT00005911||||||||||||
1576574|NCT00005910||||||||||||
1576575|NCT00005909|||Cohort||Prospective|||||||
1576576|NCT00005908|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576577|NCT00005907||||||||||||
1576578|NCT00005906||Single Group Assignment||Treatment||None (Open Label)||||||
1576579|NCT00005905||||Treatment||||||||
1576580|NCT00005903||||Treatment||||||||
1576581|NCT00005902||||||||||||
1576582|NCT00005901|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576583|NCT00005900||||Screening||||||||
1576584|NCT00005898||||Treatment||||||||
1576585|NCT00005896||||Treatment||||||||
1576586|NCT00005893||||Treatment||||||||
1576587|NCT00005892||||Treatment||||||||
1576588|NCT00005891||||Treatment||||||||
1576589|NCT00005890||||Diagnostic||||||||
1576590|NCT00005889||||Treatment||||||||
1576591|NCT00005888|Randomized|||Treatment||Double||||||
1576592|NCT00005785||||Treatment||||||||
1576593|NCT00005784||||||||||||
1576594|NCT00005782||||Treatment||||||||
1576595|NCT00005780||Single Group Assignment||Treatment||None (Open Label)||||||
1576596|NCT00005778|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1576597|NCT00005777|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1576598|NCT00005776|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1576599|NCT00005775|Randomized|Single Group Assignment||Treatment||Quadruple|||t|t|t|t
1576600|NCT00005774|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1576601|NCT00005773|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1576602|NCT00005772|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1576603|NCT00005771|Randomized|Parallel Assignment||Treatment||||||||
1576604|NCT00005770|||Natural History||Cross-Sectional|||||||
1576605|NCT00005769|Randomized|Parallel Assignment||Treatment||Double||||||
1576606|NCT00005768|Randomized|||Treatment||Double||||||
1576607|NCT00005767|||Natural History||Cross-Sectional|||||||
1576608|NCT00005766|Randomized|||Treatment||Double||||||
1576609|NCT00005765|||Natural History||Cross-Sectional|||||||
1576610|NCT00005761||||||||||||
1576611|NCT00005760||||||||||||
1576612|NCT00005675|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1576613|NCT00005674||||Treatment||||||||
1576614|NCT00005763||||||||||||
1576615|NCT00005757|||Case-Crossover|||||||||
1576616|NCT00005756||||||||||||
1576617|NCT00005755||||||||||||
1576618|NCT00005754|||Cohort||Prospective|||||||
1576619|NCT00005753||||||||||||
1576620|NCT00005752||||||||||||
1576621|NCT00005751||||||||||||
1576622|NCT00005750||||||||||||
1576623|NCT00005749||||||||||||
1576624|NCT00005748||||||||||||
1576625|NCT00005746||||||||||||
1576626|NCT00005745||||||||||||
1576627|NCT00005744||||||||||||
1576628|NCT00005743|Randomized|||||||||||
1576629|NCT00005742||||||||||||
1576630|NCT00005741||||||||||||
1576631|NCT00005740||||||||||||
1576632|NCT00005739|||Case Control||Prospective|||||||
1576633|NCT00005738||||||||||||
1576634|NCT00005737||||||||||||
1576635|NCT00005736|||Natural History|||||||||
1576636|NCT00005735||||||||||||
1576637|NCT00005734||||||||||||
1576638|NCT00005733||||||||||||
1576639|NCT00005732|||Natural History|||||||||
1576640|NCT00005731|||Natural History|||||||||
1576641|NCT00005730||||||||||||
1576642|NCT00005729||||||||||||
1576643|NCT00005728||||||||||||
1576644|NCT00005727|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1576645|NCT00005726||||||||||||
1576646|NCT00005725||||||||||||
1576647|NCT00005724|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1576648|NCT00005723||||||||||||
1576649|NCT00005722|||Natural History|||||||||
1576650|NCT00005721||||||||||||
1576651|NCT00005720||||||||||||
1576652|NCT00005719||||||||||||
1576653|NCT00005718||||||||||||
1576654|NCT00005717||||||||||||
1576655|NCT00005716||||||||||||
1576656|NCT00005715||||||||||||
1576657|NCT00005714||||||||||||
1576658|NCT00005713|||Cohort||Prospective|||||||
1576659|NCT00005712||||||||||||
1576660|NCT00005711|Randomized|Parallel Assignment||Treatment||Single|||||t|
1576661|NCT00005710||||||||||||
1576662|NCT00005709||||||||||||
1576663|NCT00005708||||||||||||
1576664|NCT00005707||||||||||||
1576665|NCT00005706||||||||||||
1576666|NCT00005705|||||Retrospective|||||||
1576667|NCT00005704||||||||||||
1576668|NCT00005703||||||||||||
1576669|NCT00005702||||||||||||
1576670|NCT00005701||||||||||||
1576671|NCT00005700||||||||||||
1576672|NCT00005699|||Cohort||Prospective|||||||
1576673|NCT00005698||||||||||||
1576674|NCT00005697||||||||||||
1576675|NCT00005696|||||Retrospective|||||||
1576676|NCT00005695||||||||||||
1576677|NCT00005694||||||||||||
1576678|NCT00005693||||||||||||
1576679|NCT00005692||||||||||||
1576680|NCT00005691||||||||||||
1576681|NCT00005690|||||Prospective|||||||
1576682|NCT00005689|||||Retrospective|||||||
1576683|NCT00005688||||||||||||
1576684|NCT00005687||||||||||||
1576685|NCT00005686||||||||||||
1576686|NCT00005685||||||||||||
1576687|NCT00005684|||||Retrospective|||||||
1576688|NCT00005683|||||Retrospective|||||||
1576689|NCT00005682||||||||||||
1576690|NCT00005681||||||||||||
1576691|NCT00005680||||||||||||
1576692|NCT00005679||||||||||||
1576693|NCT00005678|||Natural History|||||||||
1576694|NCT00005677|||Cohort||Prospective|||||||
1576695|NCT00005676|||Case Control||Cross-Sectional|||||||
1576696|NCT00005565||||||||||||
1576697|NCT00005564||||||||||||
1576698|NCT00005563||||||||||||
1576699|NCT00005562||||||||||||
1576700|NCT00005560||||||||||||
1576701|NCT00005559||||||||||||
1576702|NCT00005557|||Cohort||Prospective|||||||
1576703|NCT00005556||||||||||||
1576704|NCT00005555||||Prevention||||||||
1576705|NCT00005554||||||||||||
1576706|NCT00005553||||||||||||
1576707|NCT00005552||||||||||||
1576708|NCT00005551||||||||||||
1576709|NCT00005550||||||||||||
1576710|NCT00005549||||||||||||
1576711|NCT00005548||||||||||||
1576712|NCT00005547||||||||||||
1576713|NCT00005546||||||||||||
1576714|NCT00005545|||Cohort||Prospective|||||||
1576715|NCT00005544||||||||||||
1576716|NCT00005543|||||Prospective|||||||
1576717|NCT00005542||||||||||||
1576718|NCT00005541||||||||||||
1576719|NCT00005540|||Cohort||Retrospective|||||||
1576720|NCT00005539|||Cohort||Cross-Sectional|||||||
1576721|NCT00005538||||||||||||
1576722|NCT00005537||||||||||||
1576723|NCT00005536||||||||||||
1576724|NCT00005535||||||||||||
1576725|NCT00005534||||||||||||
1576726|NCT00005533|||||Prospective|||||||
1576727|NCT00005532||||||||||||
1576728|NCT00005531||||||||||||
1576729|NCT00005530||||||||||||
1576730|NCT00005529||||||||||||
1576731|NCT00005528||||||||||||
1576732|NCT00005526||||||||||||
1576733|NCT00005525||||||||||||
1576734|NCT00005524||||||||||||
1576735|NCT00005523||||||||||||
1576736|NCT00005522||||||||||||
1576737|NCT00005521|||||Retrospective|||||||
1576738|NCT00005520|||Cohort||Prospective|||||||
1576739|NCT00005519||||||||||||
1576740|NCT00005518||||||||||||
1576741|NCT00005517||||||||||||
1576742|NCT00005516||||||||||||
1576743|NCT00005515||||||||||||
1576744|NCT00005514|||Cohort||Prospective|||||||
1576745|NCT00005513||||||||||||
1576746|NCT00005512||||||||||||
1576747|NCT00005511||||||||||||
1576748|NCT00005510||||||||||||
1576749|NCT00005509||||||||||||
1576750|NCT00005508||||||||||||
1576751|NCT00005507||||||||||||
1576752|NCT00005506||||||||||||
1576753|NCT00005505||||||||||||
1576754|NCT00005504|||Cohort||Prospective|||||||
1576755|NCT00005503||||||||||||
1576756|NCT00005502|||Cohort||Prospective|||||||
1576757|NCT00005501||||||||||||
1576758|NCT00005500|||Cohort||Retrospective|||||||
1576759|NCT00005499||||||||||||
1576760|NCT00005498||||||||||||
1576761|NCT00005497||||||||||||
1576762|NCT00005496||||||||||||
1576763|NCT00005495||||||||||||
1576764|NCT00005494||||||||||||
1576765|NCT00005493||||||||||||
1576766|NCT00005492||||||||||||
1576767|NCT00005490||||||||||||
1576768|NCT00005489||||||||||||
1576769|NCT00005488||||||||||||
1576770|NCT00005487|||Cohort||Prospective|||||||
1576771|NCT00005486||||||||||||
1576772|NCT00005485|||Cohort||Prospective|||||||
1576773|NCT00005484||||||||||||
1576774|NCT00005483||||||||||||
1576775|NCT00005482||||||||||||
1576776|NCT00005481||||||||||||
1576777|NCT00005480||||||||||||
1576778|NCT00005479|||Case Control||Cross-Sectional|||||||
1576779|NCT00005478||||||||||||
1576780|NCT00005477||||||||||||
1576781|NCT00005476||||||||||||
1576782|NCT00005475||||||||||||
1576783|NCT00005474|||Cohort||Prospective|||||||
1576784|NCT00005473||||||||||||
1576785|NCT00005472||||||||||||
1576786|NCT00005471||||||||||||
1576787|NCT00005470||||||||||||
1576788|NCT00005469||||||||||||
1576789|NCT00005468||||||||||||
1576790|NCT00005467||||||||||||
1576791|NCT00005466||||||||||||
1576792|NCT00005465||||||||||||
1576793|NCT00005464||||||||||||
1576794|NCT00005463||||||||||||
1576795|NCT00005462||||||||||||
1576796|NCT00005461||||||||||||
1576797|NCT00005460||||||||||||
1576798|NCT00005459||||||||||||
1576799|NCT00005458||||||||||||
1576800|NCT00005457||||||||||||
1576801|NCT00005456||||||||||||
1576802|NCT00005455||||||||||||
1576803|NCT00005453|||||Retrospective|||||||
1576804|NCT00005452||||||||||||
1576805|NCT00005451||||||||||||
1576806|NCT00005450||||||||||||
1576807|NCT00005449||||||||||||
1576808|NCT00005448||||||||||||
1576809|NCT00005447||||||||||||
1576810|NCT00005446|||Case Control||Retrospective|||||||
1576811|NCT00005445||||||||||||
1576812|NCT00005444||||||||||||
1576813|NCT00005443||||||||||||
1576814|NCT00005442||||||||||||
1576815|NCT00005441||||||||||||
1576816|NCT00005440||||||||||||
1576817|NCT00005439||||||||||||
1576818|NCT00005438||||||||||||
1576819|NCT00005437|||Natural History|||||||||
1576820|NCT00005436||||||||||||
1576821|NCT00005435||||||||||||
1576822|NCT00005434||||||||||||
1576823|NCT00005433|||Cohort||Prospective|||||||
1576824|NCT00005432||||||||||||
1576825|NCT00005431||||||||||||
1576826|NCT00005430||||||||||||
1576827|NCT00005429||||||||||||
1576828|NCT00005428||||||||||||
1576829|NCT00005427||||||||||||
1576830|NCT00005426||||||||||||
1576831|NCT00005425||||||||||||
1576832|NCT00005424||||||||||||
1576833|NCT00005423||||||||||||
1576834|NCT00005422||||||||||||
1576835|NCT00005421||||||||||||
1576836|NCT00005420||||||||||||
1576837|NCT00005419||||||||||||
1576838|NCT00005418||||||||||||
1576839|NCT00005417||||||||||||
1576840|NCT00005416||||||||||||
1576841|NCT00005415||||||||||||
1576842|NCT00005414||||||||||||
1576843|NCT00005413||||||||||||
1576844|NCT00005412||||||||||||
1576845|NCT00005411||||||||||||
1576846|NCT00005410||||||||||||
1576847|NCT00005409||||||||||||
1576848|NCT00005408||||||||||||
1576849|NCT00005407||||||||||||
1576850|NCT00005406||||||||||||
1576851|NCT00005405||||||||||||
1576852|NCT00005404||||||||||||
1576853|NCT00005403||||||||||||
1576854|NCT00005402||||||||||||
1576855|NCT00005401||||||||||||
1576856|NCT00005400||||||||||||
1576857|NCT00005399|||Cohort||Prospective|||||||
1576858|NCT00005398|||Cohort||Prospective|||||||
1576859|NCT00005397|||Cohort||Prospective|||||||
1576860|NCT00005396||||||||||||
1576861|NCT00005395||||||||||||
1576862|NCT00005394||||||||||||
1576863|NCT00005393|||Cohort||Prospective|||||||
1576864|NCT00005392||||||||||||
1576865|NCT00005391||||||||||||
1576866|NCT00005390||||||||||||
1576867|NCT00005389||||||||||||
1576868|NCT00005388||||||||||||
1576869|NCT00005387||||||||||||
1576870|NCT00005386||||||||||||
1576871|NCT00005385||||||||||||
1576872|NCT00005384||||||||||||
1576873|NCT00005383||||||||||||
1576874|NCT00005382||||||||||||
1576875|NCT00005381|||Cohort||Prospective|||||||
1576876|NCT00005380||||||||||||
1576877|NCT00005379|||Case Control|||||||||
1576878|NCT00005378||||||||||||
1576879|NCT00005377||||||||||||
1576880|NCT00005376||||||||||||
1576881|NCT00005375||||||||||||
1576882|NCT00005374||||||||||||
1576883|NCT00005373||||||||||||
1576884|NCT00005372||||||||||||
1576885|NCT00005371||||||||||||
1576886|NCT00005370||||||||||||
1576887|NCT00005369||||||||||||
1576888|NCT00005368||||||||||||
1576889|NCT00005367||||||||||||
1576890|NCT00005366||||||||||||
1576891|NCT00005365||||||||||||
1576907|NCT00005349|||Ecologic or Community||Cross-Sectional|||||||
1576908|NCT00005348||||||||||||
1576909|NCT00005347||||||||||||
1576910|NCT00005346||||||||||||
1576911|NCT00005345||||||||||||
1576912|NCT00005344||||||||||||
1576913|NCT00005343||||||||||||
1576914|NCT00005342||||||||||||
1576915|NCT00005341||||||||||||
1576916|NCT00005340||||||||||||
1576917|NCT00005339||||||||||||
1576918|NCT00005338|||||Retrospective|||||||
1576919|NCT00005337||||||||||||
1576920|NCT00005336||||||||||||
1576921|NCT00005335||||||||||||
1576922|NCT00005334||||||||||||
1576923|NCT00005333||||||||||||
1576924|NCT00005332||||||||||||
1576925|NCT00005331||||||||||||
1576926|NCT00005330||||||||||||
1576927|NCT00005329||||||||||||
1576928|NCT00005328|||Ecologic or Community||Cross-Sectional|||||||
1576929|NCT00005327||||||||||||
1576930|NCT00005326||||||||||||
1576931|NCT00005325||||||||||||
1576932|NCT00005324||||||||||||
1576933|NCT00005323||||||||||||
1576934|NCT00005322||||||||||||
1576935|NCT00005321||||||||||||
1576936|NCT00005320||||||||||||
1576937|NCT00005319||||||||||||
1576938|NCT00005318||||||||||||
1576939|NCT00005317||||||||||||
1576940|NCT00005316||||||||||||
1576941|NCT00005315||||||||||||
1576942|NCT00005314|||Family-Based||Cross-Sectional|||||||
1576943|NCT00005313|||Family-Based|||||||||
1576944|NCT00005312||||||||||||
1576945|NCT00005311||||||||||||
1576946|NCT00005309||||||||||||
1576947|NCT00005308||||||||||||
1576948|NCT00005307||||||||||||
1576949|NCT00005306||||||||||||
1576950|NCT00005305||||||||||||
1576951|NCT00005304||||||||||||
1576952|NCT00005303|||Natural History|||||||||
1576953|NCT00005302||||||||||||
1576954|NCT00005301||||||||||||
1576955|NCT00005300||||||||||||
1576956|NCT00005299|||Cohort||Prospective|||||||
1576957|NCT00005298||||||||||||
1576958|NCT00005297||||||||||||
1576959|NCT00005296|||Cohort||Prospective|||||||
1576960|NCT00005295||||||||||||
1576961|NCT00005294||||||||||||
1576962|NCT00005293||||||||||||
1576963|NCT00005292||||||||||||
1576964|NCT00005291||||||||||||
1576965|NCT00005290||||||||||||
1576966|NCT00005289||||||||||||
1576967|NCT00005288||||||||||||
1576968|NCT00005287||||||||||||
1576969|NCT00005286||||||||||||
1576970|NCT00005285||||||||||||
1576971|NCT00005284||||||||||||
1576972|NCT00005283||||||||||||
1576973|NCT00005282||||||||||||
1576974|NCT00005281||||||||||||
1576975|NCT00005280||||||||||||
1576976|NCT00005279||||||||||||
1576977|NCT00005278||||||||||||
1576978|NCT00005277||||||||||||
1576979|NCT00005276||||||||||||
1576980|NCT00005275|||Cohort||Prospective|||||||
1576981|NCT00005274||||||||||||
1576982|NCT00005273||||||||||||
1576983|NCT00005272||||||||||||
1576984|NCT00005271|||Cohort||Cross-Sectional|||||||
1576985|NCT00005270||||||||||||
1576986|NCT00005269||||||||||||
1576987|NCT00005268||||||||||||
1576988|NCT00005267|||Family-Based||Cross-Sectional|||||||
1576989|NCT00005266||||||||||||
1576990|NCT00005265||||||||||||
1576991|NCT00005264||||||||||||
1576992|NCT00005263|||Case Control||Prospective|||||||
1576993|NCT00005262||||||||||||
1576994|NCT00005261||||||||||||
1576995|NCT00005260||||||||||||
1576996|NCT00005259||||||||||||
1576997|NCT00005258||||||||||||
1576998|NCT00005257||||||||||||
1576999|NCT00005256||||||||||||
1577000|NCT00005255||||||||||||
1577001|NCT00005254||||||||||||
1577002|NCT00005253||||||||||||
1577003|NCT00005252||||||||||||
1577004|NCT00005251||||||||||||
1577005|NCT00005250||||||||||||
1577006|NCT00005249||||||||||||
1577007|NCT00005248||||||||||||
1577008|NCT00005247||||||||||||
1577009|NCT00005246||||||||||||
1577010|NCT00005245||||||||||||
1577011|NCT00005244||||||||||||
1577012|NCT00005243||||||||||||
1577013|NCT00005242||||||||||||
1577014|NCT00005241||||||||||||
1577015|NCT00005240|||Case Control||Prospective|||||||
1577016|NCT00005239||||||||||||
1577017|NCT00005238||||||||||||
1577018|NCT00005237||||||||||||
1577019|NCT00005236||||||||||||
1577020|NCT00005235|||Cohort||Prospective|||||||
1577021|NCT00005234||||||||||||
1577022|NCT00005233||||||||||||
1577023|NCT00005232||||||||||||
1577024|NCT00005231||||||||||||
1577025|NCT00005230||||||||||||
1577026|NCT00005229||||||||||||
1577027|NCT00005228||||||||||||
1577028|NCT00005227||||||||||||
1577029|NCT00005226||||||||||||
1577030|NCT00005225||||||||||||
1577031|NCT00005224||||||||||||
1577032|NCT00005223||||||||||||
1577033|NCT00005222||||||||||||
1577034|NCT00005221|||||Cross-Sectional|||||||
1577035|NCT00005220||||||||||||
1577036|NCT00005219|||Cohort||Prospective|||||||
1577037|NCT00005218||||||||||||
1577038|NCT00005217||||||||||||
1577039|NCT00005216||||||||||||
1577040|NCT00005215||||||||||||
1577041|NCT00005214||||||||||||
1577042|NCT00005213||||||||||||
1577043|NCT00005212||||||||||||
1577044|NCT00005211||||||||||||
1577045|NCT00005210||||||||||||
1577046|NCT00005209||||||||||||
1577047|NCT00005208||||||||||||
1577048|NCT00005207||||||||||||
1577049|NCT00005206||||||||||||
1577050|NCT00005205||||||||||||
1577051|NCT00005204||||||||||||
1577052|NCT00005203||||||||||||
1577053|NCT00005202||||||||||||
1577054|NCT00005201||||||||||||
1577055|NCT00005200||||||||||||
1577073|NCT00005182|||Cohort||Prospective|||||||
1577074|NCT00005181||||||||||||
1577075|NCT00005180||||||||||||
1577076|NCT00005179||||||||||||
1577077|NCT00005178||||||||||||
1577078|NCT00005177||||||||||||
1577079|NCT00005176|||Family-Based||Prospective|||||||
1577080|NCT00005175||||||||||||
1577081|NCT00005174||||||||||||
1577082|NCT00005173||||||||||||
1577083|NCT00005172||||||||||||
1577084|NCT00005171||||||||||||
1577085|NCT00005170||||||||||||
1577086|NCT00005169||||||||||||
1577087|NCT00005168||||||||||||
1577088|NCT00005167||||||||||||
1577089|NCT00005166||||||||||||
1577090|NCT00005165||||||||||||
1577091|NCT00005164||||||||||||
1577092|NCT00005163||||||||||||
1577093|NCT00005162||||||||||||
1577094|NCT00005161||||||||||||
1577095|NCT00005160|||Cohort||Prospective|||||||
1577096|NCT00005159||||||||||||
1577097|NCT00005158||||||||||||
1577098|NCT00005157||||||||||||
1577099|NCT00005156||||||||||||
1577100|NCT00005155||||||||||||
1577101|NCT00005154||||||||||||
1577102|NCT00005153||||||||||||
1577103|NCT00005152|||Cohort||Prospective|||||||
1577104|NCT00005151||||||||||||
1577105|NCT00005150||||||||||||
1577106|NCT00005149||||||||||||
1577107|NCT00005148||||||||||||
1577108|NCT00005147||||||||||||
1577109|NCT00005146||||||||||||
1577110|NCT00005145||||||||||||
1577111|NCT00005144||||||||||||
1577112|NCT00005143||||||||||||
1577113|NCT00005142||||||||||||
1577114|NCT00005141||||||||||||
1577115|NCT00005140||||||||||||
1577116|NCT00005139||||||||||||
1577117|NCT00005138||||||||||||
1577118|NCT00005137||Single Group Assignment||Basic Science||||||||
1577119|NCT00005136||||||||||||
1577120|NCT00005135||||||||||||
1577121|NCT00005134||||||||||||
1577122|NCT00005133||||||||||||
1577123|NCT00005132||||||||||||
1577124|NCT00005131||||||||||||
1577125|NCT00005130|||Cohort||Prospective|||||||
1577126|NCT00005129|||Cohort||Prospective|||||||
1577127|NCT00005128||||||||||||
1577128|NCT00005127||||||||||||
1577129|NCT00005126||||||||||||
1577130|NCT00005125||||||||||||
1577131|NCT00005124||||||||||||
1577132|NCT00005123||||||||||||
1577133|NCT00005122||||||||||||
1577134|NCT00005121||||||||||||
1577135|NCT00005673||||Treatment||||||||
1577136|NCT00005671||||||||||||
1577137|NCT00005669|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1577138|NCT00005667|||Case Control, Natural History||Cross-Sectional, Retrospective|||||||
1577139|NCT00005666||||Treatment||None (Open Label)||||||
1577140|NCT00005665|Randomized|Parallel Assignment||Treatment||Double||||||
1577141|NCT00005664|||Other||Prospective|||||||
1577142|NCT00005660||||||||||||
1577143|NCT00005658||||Treatment||||||||
1577144|NCT00005657||||||||||||
1577145|NCT00005655||Single Group Assignment||Treatment||None (Open Label)||||||
1577146|NCT00005654|Randomized|||Treatment||Double||||||
1577147|NCT00005652||||Treatment||||||||
1577148|NCT00005650|||Natural History|||||||||
1577149|NCT00005575|Randomized|||Treatment||Single||||||
1577150|NCT00005571||||Treatment||||||||
1577151|NCT00005569||||Treatment||||||||
1577152|NCT00005567||||Educational/Counseling/Training||||||||
1577153|NCT00005566||||Diagnostic||||||||
1577154|NCT00005119||Parallel Assignment||Diagnostic||||||||
1577155|NCT00005117|Randomized|||Treatment||Double||||||
1577156|NCT00005112|Randomized|||Treatment||||||||
1577157|NCT00005116||||Diagnostic||None (Open Label)||||||
1577158|NCT00005110|Randomized|Parallel Assignment||Treatment||Double||||||
1577159|NCT00005108||||Treatment||||||||
1577160|NCT00005107||||Treatment||None (Open Label)||||||
1577161|NCT00005105||||Screening||||||||
1577162|NCT00005104|Randomized|||Treatment||Double||||||
1577163|NCT00005103||||Screening||||||||
1577164|NCT00005102|||Natural History|||||||||
1577165|NCT00005101||||Screening||||||||
1577166|NCT00005100||||Screening||||||||
1577167|NCT00005098||||Screening||||||||
1577168|NCT00005015||||Treatment||Double||||||
1577169|NCT00005014|Randomized|||Treatment||Double||||||
1577170|NCT00005013|Randomized|||Treatment||Double||||||
1577171|NCT00005011||||||||||||
1577172|NCT00005007|Randomized|Parallel Assignment||Treatment||Double||||||
1577173|NCT00005006|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577174|NCT00005005|Randomized|Parallel Assignment||Treatment||Double||||||
1577175|NCT00005004||||||||||||
1577176|NCT00005003||||||||||||
1577177|NCT00004997||||Treatment||||||||
1577178|NCT00004996||||||||||||
1577179|NCT00004994||||||||||||
1577180|NCT00004993|Randomized|||Treatment||Double||||||
1577181|NCT00004992|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1577182|NCT00004991||||||||||||
1577183|NCT00004990||||Treatment||||||||
1577184|NCT00004988||||Treatment||||||||
1577185|NCT00004984|Randomized|||Prevention||Double||||||
1577186|NCT00004983|Non-Randomized|||Prevention||||||||
1577187|NCT00004982|Randomized|||Treatment||None (Open Label)||||||
1577188|NCT00004980|Randomized|Parallel Assignment||Treatment||Triple|||t|t||t
1577189|NCT00004854||||Diagnostic||||||||
1577190|NCT00004853|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577191|NCT00004850|||Cohort||Prospective|||||||
1577192|NCT00004847||||||||||||
1577193|NCT00004846||||||||||||
1577194|NCT00004739||||Prevention||||||||
1577195|NCT00004845|Randomized|||Treatment||Double||||||
1577196|NCT00004738||||||||||||
1577197|NCT00004734|Randomized|||Prevention||Double||||||
1577198|NCT00004733|Randomized|||Treatment||Double||||||
1577199|NCT00004732|Randomized|Parallel Assignment||Prevention||Double|||||t|t
1577200|NCT00004731|Randomized|Parallel Assignment||Treatment||Double||||||
1577201|NCT00004730|Randomized|Parallel Assignment||Treatment||Double||||||
1577202|NCT00004729|Randomized|||Treatment||Double||||||
1577203|NCT00004728|Randomized|||Prevention||Double||||||
1577204|NCT00004727|Randomized|||Prevention||Double||||||
1577205|NCT00004941|Randomized|||Treatment||Double||||||
1577206|NCT00004940||||Treatment||||||||
1577207|NCT00004939|Randomized|||Treatment||Double||||||
1577208|NCT00004938|Randomized|||Treatment||||||||
1577209|NCT00004844|Randomized|||Treatment||Double||||||
1577210|NCT00004843|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577211|NCT00004842||Single Group Assignment||Treatment||None (Open Label)||||||
1577212|NCT00004840|Randomized|||Treatment||Double||||||
1577213|NCT00004838|Randomized|||Treatment||||||||
1577214|NCT00004834|Randomized|||Treatment||Double||||||
1577215|NCT00004833|Randomized|||Treatment||||||||
1577216|NCT00004832|Randomized|||Treatment||Double||||||
1577217|NCT00004831|Randomized|Crossover Assignment||Treatment||Double||||||
1577218|NCT00004829|Randomized|||Treatment||Double||||||
1577219|NCT00004828|Randomized|||Treatment||||||||
1577220|NCT00004827|Randomized|Parallel Assignment||Treatment||Double||||||
1577221|NCT00004826|Randomized|||Treatment||Double||||||
1577222|NCT00004825||||Treatment||||||||
1577223|NCT00004817||||Treatment||||||||
1577224|NCT00004816||||Treatment||None (Open Label)||||||
1577225|NCT00004815|Non-Randomized|||Treatment||||||||
1577226|NCT00004814|Randomized|||Treatment||||||||
1577227|NCT00004812||||Treatment||||||||
1577228|NCT00004811||||Treatment||||||||
1577229|NCT00004810|Randomized|||Treatment||||||||
1577230|NCT00004809||||Treatment||||||||
1577231|NCT00004808||||Treatment||||||||
1577232|NCT00004807||||Treatment||||||||
1577233|NCT00004806||||Treatment||||||||
1577234|NCT00004805||||Educational/Counseling/Training||||||||
1577235|NCT00004804||||Treatment||||||||
1577236|NCT00004802|Randomized|||Treatment||Double||||||
1577237|NCT00004801||||Treatment||||||||
1577238|NCT00004800|Randomized|||Prevention||Double||||||
1577239|NCT00004799|Randomized|||Prevention||Double||||||
1577240|NCT00004797||||Treatment||||||||
1577241|NCT00004796||||Treatment||||||||
1577242|NCT00004795|Randomized|||Treatment||Double||||||
1577243|NCT00004794||||Treatment||||||||
1577244|NCT00004793||||Screening||||||||
1577245|NCT00004791||||Screening||||||||
1577246|NCT00004789||||Treatment||||||||
1577247|NCT00004788||||Screening||||||||
1577248|NCT00004787||||Treatment||||||||
1577249|NCT00004786|Randomized|||Treatment||Double||||||
1577250|NCT00004785|Randomized|||Treatment||Double||||||
1577251|NCT00004784|Randomized|||Treatment||Double||||||
1577252|NCT00004781||||Screening||||||||
1577253|NCT00004779||||Treatment||||||||
1577254|NCT00004778|Randomized|||Treatment||Double||||||
1577255|NCT00004776|Randomized|||Treatment||Double||||||
1577256|NCT00004773||||Screening||||||||
1577257|NCT00004772|Randomized|||Treatment||Double||||||
1577258|NCT00004771||||Treatment||||||||
1577259|NCT00004770||||Treatment||||||||
1577260|NCT00004769|||Case Control||Prospective|||||||
1577261|NCT00004767||||Treatment||||||||
1577262|NCT00004763|Randomized|||Treatment||||||||
1577263|NCT00004762||||Treatment||||||||
1577264|NCT00004761|||Natural History||Longitudinal|||||||
1577265|NCT00004760||||Educational/Counseling/Training||||||||
1577266|NCT00004759|Randomized|Parallel Assignment||Treatment||Double||||||
1577267|NCT00004758|Randomized|||Treatment||||||||
1577268|NCT00004757|Randomized|||Treatment||Double||||||
1577269|NCT00004756|Randomized|||Educational/Counseling/Training||||||||
1577270|NCT00004755|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577271|NCT00004754||||Treatment||None (Open Label)||||||
1577272|NCT00004753||||Screening||||||||
1577273|NCT00004751|Randomized|||Treatment||||||||
1577274|NCT00004748|Randomized|Parallel Assignment||Treatment||Double||||||
1577275|NCT00004747|Randomized|||Treatment||Double||||||
1577276|NCT00004744|Randomized|||Treatment||Double||||||
1577277|NCT00004740|Randomized|||Prevention||None (Open Label)||||||
1577278|NCT00004705||||Treatment||||||||
1577279|NCT00004700|Randomized|||Treatment||Double||||||
1577280|NCT00004699||||Treatment||||||||
1577281|NCT00004697|Randomized|||Treatment||Double||||||
1577282|NCT00004696|Randomized|||||||||||
1577283|NCT00004695|Randomized|||Treatment||None (Open Label)||||||
1577284|NCT00004694|Randomized|Crossover Assignment||Treatment||Single||||||
1577285|NCT00004690|Randomized|||Treatment||Double||||||
1577286|NCT00004689|Randomized|||Treatment||None (Open Label)||||||
1577287|NCT00004688||||Treatment||||||||
1577288|NCT00004686|Randomized|||Treatment||Double||||||
1577289|NCT00004685|Randomized|||Treatment||Double||||||
1577290|NCT00004682|Randomized|||Treatment||||||||
1577291|NCT00004670|Randomized|||Treatment||||||||
1577292|NCT00004669||||Prevention||||||||
1577293|NCT00004667||||Treatment||||||||
1577294|NCT00004665||||Treatment||||||||
1577295|NCT00004664|Randomized|||Treatment||||||||
1577296|NCT00004663||||Screening|Longitudinal|||||||
1577297|NCT00004662|Randomized|||Treatment||Double||||||
1577299|NCT00004660|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1577300|NCT00004659|Randomized|||Treatment||||||||
1577301|NCT00004658||||Treatment||||||||
1577302|NCT00004656||||Diagnostic||||||||
1577303|NCT00004654|Randomized|Crossover Assignment||Treatment||||||||
1577304|NCT00004652|Randomized|||Treatment||||||||
1577305|NCT00004650|Randomized|||Treatment||Double||||||
1577306|NCT00004649||||Screening||||||||
1577307|NCT00004648||||Screening||||||||
1577308|NCT00004647|Randomized|||Treatment||Double||||||
1577309|NCT00004646|Randomized|||Treatment||Double||||||
1577310|NCT00004645|Randomized|||Treatment||Double||||||
1577311|NCT00004644||||Treatment||||||||
1577312|NCT00004643||||Treatment||None (Open Label)||||||
1577313|NCT00004642||||Treatment||||||||
1577314|NCT00004638||||Diagnostic||||||||
1577315|NCT00004637|Randomized|||Treatment||Double||||||
1577316|NCT00004635|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1577317|NCT00004577||||||||||||
1577318|NCT00004573||||Diagnostic||||||||
1577319|NCT00004572|||Defined Population|||||||||
1577320|NCT00004571||||||||||||
1577321|NCT00004570||||||||||||
1577322|NCT00004569||||Diagnostic||||||||
1577323|NCT00004568||||||||||||
1577324|NCT00004567||||Treatment||||||||
1577325|NCT00004566||||||||||||
1577326|NCT00004565||||||||||||
1577327|NCT00004564|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577328|NCT00004563|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1577329|NCT00004562|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577330|NCT00004561|Randomized|||Treatment||||||||
1577331|NCT00004560|Randomized|||Treatment||||||||
1577332|NCT00004559|Randomized|||Prevention||Double||||||
1577333|NCT00004558|Randomized|||Prevention||Double||||||
1577334|NCT00004556||||||||||||
1577335|NCT00004554|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1577336|NCT00004553||||||||||||
1577337|NCT00004552|Randomized|||Treatment||||||||
1577338|NCT00004551|Randomized|||Treatment||None (Open Label)||||||
1577339|NCT00004550||||||||||||
1577340|NCT00004549||||Treatment||||||||
1577341|NCT00004547|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577342|NCT00004533|Randomized|||Treatment||Double||||||
1577343|NCT00001987|||Cohort||Prospective|||||||
1577344|NCT00000436|Randomized|Single Group Assignment||Treatment||Single||||||
1577345|NCT00001985||||||||||||
1577346|NCT00001984||Single Group Assignment||Treatment||None (Open Label)||||||
1577347|NCT00001983||||||||||||
1577348|NCT00001981||||||||||||
1577349|NCT00000435|Randomized|Parallel Assignment||Treatment||Double||||||
1577350|NCT00000434|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1577351|NCT00001979|||Cohort||Other|||||||
1577352|NCT00001978||||||||||||
1577353|NCT00001976||||||||||||
1577354|NCT00001975|||Cohort||Prospective|||||||
1577355|NCT00001973||||||||||||
1577356|NCT00001972||||||||||||
1577357|NCT00001971||||||||||||
1577358|NCT00001969||||||||||||
1577359|NCT00001967||||Treatment||||||||
1577360|NCT00001964|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577361|NCT00001962||Single Group Assignment||Treatment||None (Open Label)||||||
1577362|NCT00001961||||Treatment||||||||
1577363|NCT00001960||||Treatment||||||||
1577364|NCT00001959||Single Group Assignment||Treatment||None (Open Label)||||||
1577365|NCT00001958||||Treatment||||||||
1577366|NCT00001957||||||||||||
1577367|NCT00001956||||Treatment||||||||
1577368|NCT00001955||||Treatment||||||||
1577369|NCT00001954||||Treatment||||||||
1577370|NCT00001953||||||||||||
1577371|NCT00001952||||||||||||
1577372|NCT00001951||||Treatment||||||||
1577373|NCT00001950||||||||||||
1577374|NCT00001948||||||||||||
1577375|NCT00001946||||Treatment||||||||
1577376|NCT00001941|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577377|NCT00001938|||Cohort||Prospective|||||||
1577378|NCT00000433|Randomized|Single Group Assignment||Treatment||Double||||||
1577379|NCT00000432|Randomized|||Prevention||||||||
1577380|NCT00000431|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577381|NCT00000430|Randomized|Parallel Assignment||Treatment||Double||||||
1577382|NCT00000429|Randomized|||Treatment||Double||||||
1577383|NCT00000428|Randomized|Crossover Assignment||Treatment||Quadruple|||t|t|t|t
1577384|NCT00000427|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577385|NCT00000112|||Defined Population, Natural History||Longitudinal|||||||
1577386|NCT00000111|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577387|NCT00000110||||Treatment||Single||||||
1577388|NCT00000108|Randomized|Parallel Assignment||Prevention||||||||
1577389|NCT00000107|||Case Control, Natural History|||||||||
1577390|NCT00000106|Randomized|Parallel Assignment||Treatment||||||||
1577391|NCT00000393|Non-Randomized|||Treatment||None (Open Label)||||||
1577392|NCT00000392|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1577393|NCT00000391|Non-Randomized|||Treatment||None (Open Label)||||||
1577394|NCT00000390||||Treatment||||||||
1577395|NCT00001936||||||||||||
1577396|NCT00001934||||Treatment||||||||
1577397|NCT00001933||||Treatment||||||||
1577398|NCT00001932||||||||||||
1577399|NCT00001927||||||||||||
1577400|NCT00001926||||||||||||
1577401|NCT00001925||||Treatment||||||||
1577402|NCT00001923||||Treatment||||||||
1577403|NCT00001922||||||||||||
1577419|NCT00001893|Randomized|Parallel Assignment||Treatment||Double||||||
1577420|NCT00001888|||Case-Control||Prospective|||||||
1577421|NCT00001885||||||||||||
1577422|NCT00001884||||||||||||
1577423|NCT00001883||||||||||||
1577424|NCT00001880|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577425|NCT00001878||||||||||||
1577426|NCT00001877||||Treatment||||||||
1577427|NCT00001876|||Cohort|||||||||
1577428|NCT00001874||||||||||||
1577429|NCT00001873|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577430|NCT00001872|||||Prospective|||||||
1577431|NCT00001870||||Treatment||||||||
1577432|NCT00001869||||||||||||
1577433|NCT00001865||||Treatment||||||||
1577434|NCT00001863||||Treatment||||||||
1577435|NCT00001862||||Treatment||||||||
1577436|NCT00001861||||||||||||
1577437|NCT00001860||||Treatment||||||||
1577438|NCT00001859||||||||||||
1577439|NCT00001858||||||||||||
1577440|NCT00001856||||||||||||
1577441|NCT00001854||||Treatment||||||||
1577442|NCT00001853|||Cohort||Cross-Sectional|||||||
1577443|NCT00001852||||||||||||
1577444|NCT00001851||||||||||||
1577445|NCT00001850||||||||||||
1577446|NCT00001849|Non-Randomized|Single Group Assignment||Diagnostic||None (Open Label)||||||
1577447|NCT00001848||||Treatment||||||||
1577448|NCT00001846|||Other||Prospective|||||||
1577449|NCT00001845||||||||||||
1577450|NCT00001844||||||||||||
1577451|NCT00001842||||Treatment||||||||
1577452|NCT00001841||||||||||||
1577453|NCT00001837||||||||||||
1577454|NCT00001836||||||||||||
1577455|NCT00001835||||Treatment||||||||
1577456|NCT00001832|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577457|NCT00001830||||Treatment||||||||
1577458|NCT00001827||||Treatment||None (Open Label)||||||
1577459|NCT00001826||||||||||||
1577460|NCT00001823|||Cohort||Prospective|||||||
1577461|NCT00001813|||Case-Control||Prospective|||||||
1577462|NCT00001807|||Cohort||Prospective|||||||
1577463|NCT00001806|Randomized|Parallel Assignment||Health Services Research||None (Open Label)||||||
1577464|NCT00001803|||Case-Control||Retrospective|||||||
1577465|NCT00001788||||||||||||
1577466|NCT00001785||||Treatment||||||||
1577467|NCT00001784||||Treatment||||||||
1577468|NCT00001783||||Treatment||||||||
1577469|NCT00001781||||Treatment||||||||
1577470|NCT00001780||||||||||||
1577471|NCT00001778||||||||||||
1577472|NCT00001776||||||||||||
1577473|NCT00001771||||||||||||
1577474|NCT00001770||||||||||||
1577475|NCT00001766||||Treatment||||||||
1577476|NCT00001765||||Treatment||||||||
1577477|NCT00001764||||Treatment||||||||
1577478|NCT00001762||||||||||||
1577479|NCT00001760||||||||||||
1577480|NCT00001758||||Treatment||||||||
1577481|NCT00001756|||Case-Only||Prospective|||||||
1577482|NCT00001750||||Treatment||||||||
1577483|NCT00001749||||Treatment||||||||
1577484|NCT00001746||||||||||||
1577485|NCT00001741||||Treatment||||||||
1577486|NCT00001737||||Treatment||||||||
1577487|NCT00001734||||||||||||
1577488|NCT00001733||||||||||||
1577489|NCT00001732||||||||||||
1577490|NCT00001729||||Treatment||||||||
1577491|NCT00001728||||Treatment||||||||
1577492|NCT00001727||||||||||||
1577493|NCT00001726||||||||||||
1577494|NCT00001725||||Treatment||||||||
1577495|NCT00001724||||Treatment||||||||
1577496|NCT00001723|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1577497|NCT00001722||||||||||||
1577498|NCT00001721|||Cohort||Prospective|||||||
1577499|NCT00001720||||Treatment||||||||
1577500|NCT00001719||||||||||||
1577501|NCT00001716||||Treatment||||||||
1577502|NCT00001715||||||||||||
1577503|NCT00001713||||Treatment||||||||
1577504|NCT00001712||||||||||||
1577505|NCT00001711||||||||||||
1577506|NCT00001703|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577507|NCT00001702||||||||||||
1577508|NCT00001701||||||||||||
1577509|NCT00001698||||Treatment||||||||
1577510|NCT00001695||||||||||||
1577511|NCT00001693||||Treatment||||||||
1577512|NCT00001689||||Treatment||||||||
1577513|NCT00001686|||Cohort||Prospective|||||||
1577514|NCT00001683||||Treatment||||||||
1577515|NCT00001678||||||||||||
1577516|NCT00001676||||Treatment||||||||
1577517|NCT00001671||||||||||||
1577518|NCT00001666||||||||||||
1577519|NCT00001664||||||||||||
1577520|NCT00001663||||Treatment||||||||
1577521|NCT00001662||||Treatment||||||||
1577522|NCT00001661||||||||||||
1577523|NCT00001659||||||||||||
1577524|NCT00001656|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1577525|NCT00001654||||||||||||
1577526|NCT00001652||||||||||||
1577527|NCT00001651|||||Prospective|||||||
1577528|NCT00001650||||||||||||
1577529|NCT00001649||||Treatment||||||||
1577530|NCT00001648||||||||||||
1577531|NCT00001647||||Treatment||||||||
1577532|NCT00001645|||Case-Only||Prospective|||||||
1577533|NCT00001644||||Treatment||||||||
1577534|NCT00001643||||||||||||
1577535|NCT00001641||||||||||||
1577536|NCT00001640||||||||||||
1577537|NCT00001638||||||||||||
1577538|NCT00001637|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577539|NCT00001632||||||||||||
1577540|NCT00001631||||Treatment||||||||
1577541|NCT00001630|Non-Randomized|||Treatment||None (Open Label)||||||
1577542|NCT00001627|||Cohort||Prospective|||||||
1577543|NCT00001626|Randomized|Crossover Assignment||Treatment||None (Open Label)||||||
1577544|NCT00001625||||||||||||
1577545|NCT00001623|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577546|NCT00001621|||Cohort||Prospective|||||||
1577547|NCT00001620|||Other||Other|||||||
1577548|NCT00001619||||||||||||
1577549|NCT00001618||||||||||||
1577550|NCT00001613||||||||||||
1577551|NCT00001611||||||||||||
1577552|NCT00001610||||||||||||
1577553|NCT00001609||||||||||||
1577554|NCT00001606||||||||||||
1577555|NCT00001604||||||||||||
1577556|NCT00001603||||||||||||
1577557|NCT00001602||||||||||||
1577558|NCT00001601||||||||||||
1577559|NCT00001600||||||||||||
1577560|NCT00001599||||Treatment||||||||
1577561|NCT00001598||||Treatment||||||||
1577562|NCT00001597||||||||||||
1577563|NCT00001596|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1577564|NCT00001595|||Cohort||Prospective|||||||
1577565|NCT00001594|||Cohort||Prospective|||||||
1577566|NCT00001591||||||||||||
1577567|NCT00001589||||||||||||
1577568|NCT00001586|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577569|NCT00001582|||Cohort||Prospective|||||||
1577570|NCT00001580||||||||||||
1577571|NCT00001576||||Treatment||||||||
1577572|NCT00001575||Single Group Assignment||Treatment||None (Open Label)||||||
1577573|NCT00001574|||Cohort||Prospective|||||||
1577574|NCT00001572||||Treatment||||||||
1577575|NCT00001569||||Treatment||||||||
1577576|NCT00001568||||Treatment||||||||
1577577|NCT00001567||||Treatment||||||||
1577578|NCT00001566||Single Group Assignment||Treatment||None (Open Label)||||||
1577579|NCT00001564||||Treatment||||||||
1577580|NCT00001563||Single Group Assignment||Treatment||None (Open Label)||||||
1577581|NCT00001561||||Treatment||||||||
1577582|NCT00001560||||||||||||
1577583|NCT00001552||||||||||||
1577584|NCT00001551||||||||||||
1577585|NCT00001550||||Treatment||||||||
1577586|NCT00001549||||||||||||
1577587|NCT00001548||||||||||||
1577588|NCT00001547||||||||||||
1577589|NCT00001545||||Treatment||||||||
1577590|NCT00001544||||||||||||
1577591|NCT00001543||||||||||||
1577592|NCT00001541||||||||||||
1577593|NCT00001539|||Cohort||Prospective|||||||
1577594|NCT00001535||||Treatment||||||||
1577595|NCT00001534||||||||||||
1577596|NCT00001532|||Case-Control||Prospective|||||||
1577597|NCT00001529|||Case-Only||Prospective|||||||
1577598|NCT00001526||||Treatment||||||||
1577599|NCT00001524||||Treatment||||||||
1577600|NCT00001522|||Cohort||Prospective|||||||
1577601|NCT00001521|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577602|NCT00001516||||||||||||
1577603|NCT00001515||||Treatment||||||||
1577604|NCT00001512||||Treatment||||||||
1577605|NCT00001507||||Treatment||||||||
1577606|NCT00001506|||Cohort||Prospective|||||||
1577607|NCT00001505|||Case-Only||Prospective|||||||
1577608|NCT00001504||||Treatment||||||||
1577609|NCT00001503|||Cohort||Prospective|||||||
1577610|NCT00001500||||||||||||
1577611|NCT00001496||||||||||||
1577612|NCT00001491||||||||||||
1577613|NCT00001487||||Treatment||||||||
1577614|NCT00001486||||||||||||
1577615|NCT00001483||||Treatment||||||||
1577616|NCT00001481||||||||||||
1577617|NCT00001480||||||||||||
1577618|NCT00001476||||Treatment||||||||
1577619|NCT00001475||||Treatment||||||||
1577620|NCT00001474||||Treatment||||||||
1577621|NCT00001473||||||||||||
1577622|NCT00001471|||Cohort||Prospective|||||||
1577623|NCT00001469||||||||||||
1577624|NCT00001467||||||||||||
1577625|NCT00001465|||Case-Control||Prospective|||||||
1577626|NCT00001464|||Case-Only||Prospective|||||||
1577627|NCT00001460||||||||||||
1577628|NCT00001458|||Cohort||Prospective|||||||
1577629|NCT00001457||||Treatment||||||||
1577630|NCT00001456||||||||||||
1577631|NCT00001454||||||||||||
1577632|NCT00001453||||||||||||
1577633|NCT00001452||||||||||||
1577634|NCT00001451||||||||||||
1577635|NCT00001444||||Treatment||||||||
1577636|NCT00001442||||Treatment||||||||
1577637|NCT00001440||||Treatment||||||||
1577638|NCT00001432||||||||||||
1577639|NCT00001430||||Treatment||||||||
1577640|NCT00001426||||Treatment||||||||
1577641|NCT00001420||||||||||||
1577642|NCT00001418||||||||||||
1577643|NCT00001417||||||||||||
1577644|NCT00001414||||||||||||
1577645|NCT00001413||||||||||||
1577646|NCT00001412||||||||||||
1577647|NCT00001410||||Treatment||||||||
1577648|NCT00001409||||Treatment||||||||
1577649|NCT00001408||||||||||||
1577650|NCT00001407||||Treatment||||||||
1577651|NCT00001406||||||||||||
1577652|NCT00001405|||Cohort||Prospective|||||||
1577653|NCT00001404||||||||||||
1577654|NCT00001403|||Cohort||Prospective|||||||
1577655|NCT00001400||||||||||||
1577656|NCT00001399|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577657|NCT00001398||||Treatment||||||||
1577658|NCT00001397|||Case-Only||Prospective|||||||
1577659|NCT00001396||||Treatment||||||||
1577660|NCT00001394||||||||||||
1577661|NCT00001393|||Cohort||Prospective|||||||
1577662|NCT00001392||||||||||||
1577663|NCT00001391||||||||||||
1577664|NCT00001390||||||||||||
1577665|NCT00001386||||Treatment||||||||
1577666|NCT00001379|Non-Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577667|NCT00001373|||Cohort||Prospective|||||||
1577668|NCT00001372|||Cohort||Other|||||||
1577669|NCT00001368||||Treatment||||||||
1577670|NCT00001367||||||||||||
1577671|NCT00001366||||||||||||
1577672|NCT00001364||||||||||||
1577673|NCT00001362||||||||||||
1577674|NCT00001361||||||||||||
1577675|NCT00001360||||||||||||
1577676|NCT00001359||||Treatment||||||||
1577677|NCT00001357||||Treatment||||||||
1577678|NCT00001356||||||||||||
1577679|NCT00001355||||||||||||
1577680|NCT00001354||||Treatment||||||||
1577681|NCT00001353||||||||||||
1577682|NCT00001352|||Cohort||Prospective|||||||
1577683|NCT00001351|||Case-Only||Prospective|||||||
1577684|NCT00001350|||Family-Based||Retrospective|||||||
1577685|NCT00001349||||||||||||
1577686|NCT00001347||||||||||||
1577687|NCT00001345||||||||||||
1577688|NCT00001343||||Treatment||||||||
1577689|NCT00001339||||Treatment||||||||
1577690|NCT00001337||Single Group Assignment||Treatment||None (Open Label)||||||
1577691|NCT00001336||||||||||||
1577692|NCT00001335||||Treatment||||||||
1577693|NCT00001331||||||||||||
1577694|NCT00001329||||||||||||
1577695|NCT00001328||||Treatment||||||||
1577696|NCT00001327||||||||||||
1577697|NCT00001325||||||||||||
1577698|NCT00001323||||||||||||
1577699|NCT00001322||||||||||||
1577700|NCT00001320||||||||||||
1577701|NCT00001319||||||||||||
1577702|NCT00001316|||Cohort||Prospective|||||||
1577703|NCT00001313||||||||||||
1577704|NCT00001310|||Cohort||Prospective|||||||
1577705|NCT00001309|||Cohort||Prospective|||||||
1577706|NCT00001308||||||||||||
1577707|NCT00001307||||||||||||
1577708|NCT00001306||||||||||||
1577709|NCT00001305|Non-Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1577710|NCT00001304|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577711|NCT00001303||||Treatment||||||||
1577712|NCT00001302||||Treatment||||||||
1577713|NCT00001295|||Cohort||Prospective|||||||
1577714|NCT00001294||||||||||||
1577715|NCT00001289||||||||||||
1577716|NCT00001288||||||||||||
1577717|NCT00001284|||Cohort||Prospective|||||||
1577718|NCT00001282||||Treatment||||||||
1577719|NCT00001281|||Cohort||Prospective|||||||
1577720|NCT00001277|||Cohort||Prospective|||||||
1577721|NCT00001276||||||||||||
1577722|NCT00001275||||||||||||
1577723|NCT00001266||||Treatment||||||||
1577724|NCT00001265||||||||||||
1577725|NCT00001262||Single Group Assignment||Treatment||None (Open Label)||||||
1577726|NCT00001261||||Treatment||||||||
1577727|NCT00001260||||||||||||
1577728|NCT00001259||||||||||||
1577729|NCT00001258||||||||||||
1577730|NCT00001257|||Cohort||Other|||||||
1577731|NCT00001256||||Treatment||||||||
1577732|NCT00001255||||||||||||
1577733|NCT00001254||||||||||||
1577734|NCT00001253||||Treatment||||||||
1577735|NCT00001252|||Case-Control||Prospective|||||||
1577736|NCT00001251||||Treatment||||||||
1577737|NCT00001250||||Treatment||||||||
1577738|NCT00001248|||Cohort||Prospective|||||||
1577739|NCT00001247||||||||||||
1577740|NCT00001246|||Cohort||Cross-Sectional|||||||
1577741|NCT00001245||||||||||||
1577742|NCT00001244|||Cohort||Prospective|||||||
1577743|NCT00001243||||||||||||
1577744|NCT00001242||||||||||||
1577745|NCT00001241||||||||||||
1577746|NCT00001240||||||||||||
1577747|NCT00001238|||Cohort||Prospective|||||||
1577748|NCT00001235||||||||||||
1577749|NCT00001234||||Treatment||||||||
1577750|NCT00001231||||||||||||
1577751|NCT00001230||||||||||||
1577752|NCT00001228||||Treatment||||||||
1577753|NCT00001226||||||||||||
1577754|NCT00001225||||||||||||
1577755|NCT00001224||||||||||||
1577756|NCT00001223|||Cohort||Prospective|||||||
1577757|NCT00001221||||Treatment||||||||
1577758|NCT00001220||||||||||||
1577759|NCT00001219|||Cohort||Prospective|||||||
1577760|NCT00001215||||||||||||
1577761|NCT00001214|||Case-Only||Cross-Sectional|||||||
1577762|NCT00001213||Single Group Assignment||Treatment||None (Open Label)||||||
1577763|NCT00001212||||Treatment||||||||
1577764|NCT00001208|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577765|NCT00001206||||||||||||
1577766|NCT00001205|||Cohort||Prospective|||||||
1577767|NCT00001204||||||||||||
1577768|NCT00001203||||||||||||
1577769|NCT00001202||||Treatment||||||||
1577770|NCT00001201||||||||||||
1577771|NCT00001198|||Family-Based||Prospective|||||||
1577772|NCT00001197||||Treatment||||||||
1577773|NCT00001196|||Cohort||Prospective|||||||
1577774|NCT00001195||||||||||||
1577775|NCT00001192||||||||||||
1577776|NCT00001191||||Treatment||||||||
1577777|NCT00001186|||Cohort||Prospective|||||||
1577778|NCT00001185||||||||||||
1577779|NCT00001184|||Cohort||Prospective|||||||
1577780|NCT00001183|||Case-Only||Prospective|||||||
1577781|NCT00001182||||||||||||
1577782|NCT00001181||||Treatment||||||||
1577783|NCT00001180||||||||||||
1577784|NCT00001178||||||||||||
1577785|NCT00001177||||||||||||
1577786|NCT00001176||||||||||||
1577787|NCT00001174|||Family-Based||Retrospective|||||||
1577788|NCT00001172||||||||||||
1577789|NCT00001171||||||||||||
1577790|NCT00001170||||||||||||
1577791|NCT00001168||||||||||||
1577792|NCT00001167||||||||||||
1577795|NCT00001163|||Family-Based||Other|||||||
1577796|NCT00001162|||Case-Only||Prospective|||||||
1577797|NCT00001161||||||||||||
1577798|NCT00001160|||Case-Only||Retrospective|||||||
1577799|NCT00001159|||Case-Only||Retrospective|||||||
1577800|NCT00001156||||||||||||
1577801|NCT00001155||||Treatment||||||||
1577802|NCT00001154|||Case-Only||Prospective|||||||
1577803|NCT00001151||Single Group Assignment||Treatment||None (Open Label)||||||
1577804|NCT00001150||||||||||||
1577805|NCT00001149||||||||||||
1577806|NCT00001148||||||||||||
1577807|NCT00001147||||||||||||
1577808|NCT00001146||||Treatment||||||||
1577809|NCT00001145||||Treatment||||||||
1577810|NCT00001144||||Treatment||||||||
1577811|NCT00001143||||||||||||
1577812|NCT00000426|Randomized|Parallel Assignment||Treatment||Double||||||
1577813|NCT00000425|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577814|NCT00000424|Randomized|Parallel Assignment||Treatment||Double||||||
1577815|NCT00000423|Randomized|Factorial Assignment||||None (Open Label)||||||
1577816|NCT00000422|Randomized|Single Group Assignment||Treatment||Single||||||
1577817|NCT00000421|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1577818|NCT00000420|Randomized|Single Group Assignment||Treatment||Double||||||
1577819|NCT00000419|Randomized|Single Group Assignment||Treatment||Double||||||
1577820|NCT00000418|Randomized|Parallel Assignment||Treatment||Single||||||
1577821|NCT00000417|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1577822|NCT00000416|Randomized|Single Group Assignment||Prevention||Triple|||t||t|t
1577823|NCT00000415|Randomized|Factorial Assignment||Prevention||Double||||||
1577824|NCT00000414|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577825|NCT00000413|Randomized|Parallel Assignment||Prevention||Single||||||
1577826|NCT00000412|Randomized|Parallel Assignment||Prevention||Double|||t||t|
1577827|NCT00000411|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577828|NCT00000410|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577829|NCT00000409|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577830|NCT00000408|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577831|NCT00000407|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577832|NCT00000406|Randomized|Single Group Assignment||Treatment||Single||||||
1577833|NCT00000405|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1577834|NCT00000404|Randomized|Factorial Assignment||Treatment||Single||||||
1577835|NCT00000403|Randomized|Factorial Assignment||Treatment||Double||||||
1577836|NCT00000402|Randomized|Single Group Assignment||Prevention||Double||||||
1577837|NCT00000401|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577838|NCT00000400|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577839|NCT00000399|Randomized|Single Group Assignment||Prevention||None (Open Label)||||||
1577840|NCT00000398|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577841|NCT00000397|Randomized|Parallel Assignment||Treatment||Single||||||
1577842|NCT00000396|Randomized|Single Group Assignment||||None (Open Label)||||||
1577843|NCT00000395|Randomized|Crossover Assignment||Diagnostic||Double|||t||t|
1577844|NCT00000394|Randomized|Parallel Assignment||Treatment||Double||||||
1577845|NCT00000105|||Case-Control||Prospective|||||||
1577846|NCT00000104|||Defined Population||Longitudinal|||||||
1577847|NCT00000102||Parallel Assignment||Treatment||Double||||||
1577848|NCT00000458|Randomized|||Treatment||Double||||||
1577849|NCT00000457|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1577850|NCT00000456|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577851|NCT00000455|Randomized|||Treatment||||||||
1577852|NCT00000454|Randomized|||Treatment||None (Open Label)||||||
1577853|NCT00000452|Randomized|||Treatment||Double||||||
1577854|NCT00000451|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1577855|NCT00000450|Randomized|Sequential Assignment||Treatment||Quadruple|Naltrexone and placebo were identical in appearance and packaging to preserve the double blind.|Naltrexone 50 mg was provided for 3 months to all study participants, who were masked regarding the identity of study medication. At 3 months, full and partial responders were randomized to an additional 9 months of double blind treatment with naltrexone or matched placebo. Full responders were defined as complete abstinence for the last six weeks of the acute phase. Partial responders were defined as having no more than 2 heavy drinking days in any given week and/or a 50% reduction in weekly alcohol consumption from baseline over the last six weeks of the acute phase.|t|t|t|t
1577856|NCT00000449|Randomized|Factorial Assignment||Treatment||||||||
1577857|NCT00000448|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1577858|NCT00000447|Randomized|Factorial Assignment||Treatment||Double||||||
1577859|NCT00000446|Randomized|||Treatment||Double||||||
1577860|NCT00000445|Randomized|||Treatment||None (Open Label)||||||
1577861|NCT00000444|Randomized|||Treatment||None (Open Label)||||||
1577862|NCT00000443|Randomized|||Treatment||Double||||||
1577863|NCT00000442||Parallel Assignment||Treatment||||||||
1577864|NCT00000441|Randomized|||Treatment||Double||||||
1577865|NCT00000440|Randomized|||Treatment||Double||||||
1577866|NCT00000439|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1577867|NCT00000438|Randomized|||Treatment||||||||
1577868|NCT00000437|Randomized|Parallel Assignment||Treatment||Quadruple|Double blind tablet and patch active study medications, and matched tablet and patch placebos||t|t|t|t
1577869|NCT00000389||||Treatment||Double||||||
1577870|NCT00000388|Randomized|||Treatment||||||||
1577871|NCT00000387|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577872|NCT00000386|Randomized|||Treatment||||||||
1577873|NCT00000385|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1577874|NCT00000384||||Treatment||||||||
1577875|NCT00000383|Randomized|Parallel Assignment||Treatment||Double|||||t|t
1577876|NCT00000382|Randomized|||Prevention||||||||
1577877|NCT00000381|Randomized|||Treatment||Double||||||
1577878|NCT00000380||||Treatment||||||||
1577879|NCT00000379|Randomized|||Treatment||||||||
1577880|NCT00000378|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1577881|NCT00000377|Randomized|||Treatment||||||||
1577882|NCT00000376|Randomized|||Treatment||||||||
1577883|NCT00000375|Randomized|||Treatment||Single||||||
1577884|NCT00000374|Randomized|Parallel Assignment||Treatment||Single||||||t
1577885|NCT00000373|Randomized|Crossover Assignment||Treatment||Single|||t|||
1577886|NCT00000372|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1577887|NCT00000371|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1577888|NCT00000370||||Treatment||||||||
1577889|NCT00000369|Randomized|||Treatment||||||||
1577890|NCT00000368|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577891|NCT00000367||||Prevention||||||||
1577892|NCT00000363|Randomized|||Treatment||Double||||||
1577893|NCT00000362|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1577894|NCT00000361|Randomized|Parallel Assignment||Treatment||Double||||||
1577895|NCT00000359|Randomized|||Treatment||Single||||||t
1577896|NCT00000180|Randomized|||Treatment||Double||||||
1577897|NCT00000179|Randomized|||Treatment||Double||||||
1577898|NCT00000178|Randomized|||Treatment||Double||||||
1577899|NCT00000177|Randomized|||Treatment||Double||||||
1577900|NCT00000176|Randomized|||Prevention||Double||||||
1577901|NCT00000175||Crossover Assignment||Treatment||Double||||||
1577902|NCT00000174|Randomized|||Treatment||Double||||||
1577903|NCT00000173|Randomized|Parallel Assignment||Treatment||Double||||||
1577904|NCT00000172|Randomized|Parallel Assignment||Treatment||Double||||||
1577905|NCT00000171|Randomized|Parallel Assignment||Treatment||Double||||||
1577906|NCT00000623|||||Prospective|||||||
1577907|NCT00000621||||Treatment||||||||
1577908|NCT00000620|Randomized|Factorial Assignment||Prevention||None (Open Label)||||||
1577909|NCT00000619|Randomized|||Treatment||||||||
1577910|NCT00000617|Randomized|||Prevention||Double||||||
1577911|NCT00000616|Randomized|||Prevention||||||||
1577912|NCT00000615||||Prevention||||||||
1577913|NCT00000614|Randomized|||Prevention||Double||||||
1577914|NCT00000613|Randomized|||Prevention||Double||||||
1577915|NCT00000612|Randomized|||Prevention||Double||||||
1577916|NCT00000611|Randomized|||Prevention||||||||
1577917|NCT00000610|Randomized|||Treatment||||||||
1577918|NCT00000609|Randomized|||Treatment||||||||
1577919|NCT00000608||Parallel Assignment||Prevention||||||||
1577920|NCT00000607|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577921|NCT00000606|Randomized|||Treatment||||||||
1577922|NCT00000605|Randomized|||Prevention||Double||||||
1577923|NCT00000604|Randomized|||Treatment||||||||
1577924|NCT00000603||||Treatment||||||||
1577925|NCT00000602||||Treatment||||||||
1577926|NCT00000601|Randomized|||Prevention||Double||||||
1577927|NCT00000600|Randomized|||Prevention||||||||
1577928|NCT00000599|Randomized|||Treatment||||||||
1577929|NCT00000598|Randomized|Factorial Assignment||Prevention||||||||
1577930|NCT00000597|Randomized|||Treatment||||||||
1577931|NCT00000596|Randomized|||Treatment||||||||
1577932|NCT00000595||||Treatment||||||||
1577933|NCT00000594|Randomized|||Prevention||Double||||||
1577934|NCT00000593|Randomized|||Prevention||||||||
1577935|NCT00000592|Randomized|||Prevention||||||||
1577936|NCT00000591|Randomized|||Treatment||||||||
1577937|NCT00000590|Randomized|||Prevention||Double||||||
1577938|NCT00000589|Randomized|||Prevention||Double||||||
1577939|NCT00000588||||Treatment||||||||
1577940|NCT00000587|Randomized|||Treatment||Double||||||
1577941|NCT00000586|Randomized|||Treatment||Double||||||
1577942|NCT00000585|Randomized|||Prevention||Double||||||
1577943|NCT00000584|Randomized|||Prevention||Double||||||
1577944|NCT00000583|Randomized|||Prevention||Double||||||
1577945|NCT00000582||||Treatment||Double||||||
1577946|NCT00000581|Randomized|||Prevention||||||||
1577947|NCT00000580|Randomized|||Prevention||Double||||||
1577948|NCT00000579||Factorial Assignment||Treatment||||||||
1577949|NCT00000578|Randomized|||Treatment||Double||||||
1577950|NCT00000577|Randomized|Parallel Assignment||Treatment||Double||||||
1577951|NCT00000576|Randomized|||||||||||
1577952|NCT00000575|Randomized|Parallel Assignment||Treatment||Triple|||t|t|t|
1577953|NCT00000574|Randomized|||Treatment||Double||||||
1577954|NCT00000573|Randomized|||||||||||
1577955|NCT00000572|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1577956|NCT00000571|Randomized|||Treatment||||||||
1577957|NCT00000570|Randomized|||Prevention||||||||
1577958|NCT00000569|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1577959|NCT00000568|Randomized|||Prevention||Double||||||
1577960|NCT00000567|Randomized|||Treatment||||||||
1577961|NCT00000566||||Diagnostic||||||||
1577962|NCT00000565|Randomized|||Treatment||||||||
1577963|NCT00000564|Randomized|||Treatment||||||||
1577964|NCT00000563|Randomized|||Prevention||Double||||||
1577965|NCT00000562|Randomized|||Treatment||||||||
1577966|NCT00000561|Randomized|||Treatment||||||||
1577967|NCT00000560|Randomized|||||Double||||||
1577968|NCT00000559|Randomized|||Prevention||Double||||||
1577969|NCT00000558|Randomized|||Prevention||Double||||||
1577970|NCT00000557||||Prevention||||||||
1577971|NCT00000556|Randomized|||Treatment||||||||
1577972|NCT00000555|Randomized|Factorial Assignment||Prevention||Double||||||
1577973|NCT00000554||||Diagnostic||||||||
1577974|NCT00000553|Randomized|Factorial Assignment||Prevention||||||||
1577975|NCT00000552|Randomized|||Treatment||||||||
1577976|NCT00000551|Randomized|||Prevention||||||||
1577977|NCT00000550||||Treatment||||||||
1577978|NCT00000549|Randomized|||Prevention||||||||
1577979|NCT00000548|Randomized|||Prevention||Double||||||
1577980|NCT00000547|Randomized|||Treatment||Double||||||
1577981|NCT00000546|Randomized|||Treatment||||||||
1577982|NCT00000545||||Prevention||||||||
1577983|NCT00000544|Randomized|||Treatment||||||||
1577984|NCT00000543|Randomized|||Prevention||Double||||||
1577985|NCT00000542|Randomized|||Prevention||||||||
1577986|NCT00000541|Randomized|Factorial Assignment||Prevention||||||||
1577987|NCT00000540|Randomized|||Treatment||||||||
1577988|NCT00000539|Randomized|||Treatment||||||||
1577989|NCT00000538||||Treatment||||||||
1577990|NCT00000537|Randomized|||Prevention||||||||
1577991|NCT00000536|Randomized|Crossover Assignment||Prevention||Double||||||
1577992|NCT00000535|Randomized|Factorial Assignment||Treatment||||||||
1577993|NCT00000534||||Prevention||Double||||||
1577994|NCT00000533||||||||||||
1577995|NCT00000532|Randomized|||Prevention||||||||
1577996|NCT00000531|Randomized|||Treatment||||||||
1577997|NCT00000530|Randomized|||Treatment||||||||
1577998|NCT00000529|Randomized|||Prevention||||||||
1577999|NCT00000528||Factorial Assignment||Prevention||||||||
1578000|NCT00000527|Randomized|||Prevention||Double||||||
1578001|NCT00000526|Randomized|||Prevention||Double||||||
1578002|NCT00000525|Randomized|||||Double||||||
1578003|NCT00000524|Randomized|Parallel Assignment||Treatment||||||||
1578004|NCT00000523|Randomized|||Prevention||||||||
1578005|NCT00000522|Randomized|||Treatment||||||||
1578006|NCT00000521|Randomized|Parallel Assignment||Prevention||Quadruple|||t|t|t|t
1578007|NCT00000520|Randomized|Parallel Assignment||Prevention||||||||
1578008|NCT00000519|Randomized|||Prevention||||||||
1578009|NCT00000518|Randomized|||Treatment||||||||
1578010|NCT00000517|Randomized|||Prevention||||||||
1578011|NCT00000516|Randomized|||Prevention||Double||||||
1578012|NCT00000515|Randomized|Parallel Assignment||Prevention||||||||
1578013|NCT00000514|Randomized|||Prevention||Double||||||
1578014|NCT00000513|Randomized|||Treatment||||||||
1578015|NCT00000512|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1578016|NCT00000511|Randomized|Crossover Assignment||Treatment||||||||
1578017|NCT00000510|Randomized|||Prevention||Double||||||
1578018|NCT00000509|Randomized|Parallel Assignment||Treatment||||||||
1578019|NCT00000508|Randomized|||Prevention||||||||
1578020|NCT00000507|Randomized|||Treatment||||||||
1578021|NCT00000506|Randomized|Parallel Assignment||Treatment||||||||
1578022|NCT00000505|Randomized|||Treatment||||||||
1578023|NCT00000504|Randomized|||Treatment||Double||||||
1578024|NCT00000503|Randomized|||Treatment||Double||||||
1578025|NCT00000502||Crossover Assignment||Treatment||||||||
1578026|NCT00000501|Randomized|||Prevention||||||||
1578027|NCT00000500|Randomized|||Prevention||Double||||||
1578028|NCT00000499|Randomized|||Treatment||Double||||||
1578029|NCT00000498|Randomized|||Treatment||||||||
1578030|NCT00000497|Randomized|||Treatment||||||||
1578031|NCT00000496|Randomized|||Prevention||Double||||||
1578032|NCT00000495|Randomized|Parallel Assignment||Prevention||||||||
1578033|NCT00000494|Randomized|||Treatment||Double||||||
1578034|NCT00000493|Randomized|||Prevention||Double||||||
1578035|NCT00000492|Randomized|||Prevention||Double||||||
1578036|NCT00000491|Randomized|||Prevention||Double||||||
1578037|NCT00000490|Randomized|||Prevention||||||||
1578038|NCT00000489|Randomized|||Treatment||||||||
1578039|NCT00000488|Randomized|||Prevention||Double||||||
1578040|NCT00000487|Randomized|||Prevention||||||||
1578041|NCT00000486|Randomized|||Treatment||||||||
1578042|NCT00000485|Randomized|||Prevention||||||||
1578043|NCT00000484|Randomized|||Prevention||Double||||||
1578044|NCT00000483|Randomized|||Prevention||||||||
1578045|NCT00000482|Randomized|||Prevention||Double||||||
1578046|NCT00000481|Randomized|||Prevention||||||||
1578047|NCT00000480|Randomized|||Treatment||||||||
1578048|NCT00000479|Randomized|Factorial Assignment||Prevention||Triple|||t||t|t
1578049|NCT00000478|Randomized|||Treatment||||||||
1578050|NCT00000477|Randomized|||Prevention||||||||
1578051|NCT00000476|Randomized|||Treatment||Double||||||
1578052|NCT00000475|Randomized|||Prevention||||||||
1578053|NCT00000474|Randomized|||Prevention||||||||
1578054|NCT00000473|Randomized|||Prevention||Double||||||
1578055|NCT00000472|Randomized|||Treatment||Double||||||
1578056|NCT00000471|Randomized|||Prevention||||||||
1578057|NCT00000470|Randomized|Parallel Assignment||Treatment||||||||
1578058|NCT00000469|Randomized|||Prevention||Double||||||
1578059|NCT00000468||||Treatment||||||||
1578060|NCT00000467||Parallel Assignment||Prevention||||||||
1578061|NCT00000466|Randomized|||Prevention||Double||||||
1578062|NCT00000465|Randomized|Parallel Assignment||Treatment||||||||
1578063|NCT00000464|Randomized|Parallel Assignment||Prevention||||||||
1578064|NCT00000463|Randomized|||Prevention||Double||||||
1578065|NCT00000462|Randomized|Parallel Assignment||Treatment||||||||
1578066|NCT00000461|Randomized|||Treatment||||||||
1578067|NCT00000460|||Cohort||Prospective|||||||
1578068|NCT00000459|Randomized|||Prevention||||||||
1578069|NCT00004500|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1578070|NCT00004498||||Treatment||||||||
1578071|NCT00004497|Randomized|||Treatment||Double||||||
1578072|NCT00004496||||Treatment||Double||||||
1578073|NCT00004495||||Treatment||||||||
1578074|NCT00004494||||Treatment||||||||
1578075|NCT00004493||||Treatment||||||||
1578076|NCT00004492|Randomized|||Treatment||||||||
1578077|NCT00004490|Randomized|Crossover Assignment||Treatment||Double||||||
1578078|NCT00004489||||Treatment||||||||
1578079|NCT00004488|Randomized|Single Group Assignment||Treatment||Double||||||
1578080|NCT00004487||||Treatment||||||||
1578081|NCT00004486|Randomized|Crossover Assignment||Treatment||Double||||||
1578082|NCT00004485||||Treatment||||||||
1578083|NCT00004483|||Natural History||Longitudinal|||||||
1578084|NCT00004482|Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1578085|NCT00004481|||Natural History|||||||||
1578086|NCT00004480||||Treatment||||||||
1578087|NCT00004479|Randomized|||Treatment||Double||||||
1578088|NCT00004478||||Treatment||||||||
1578089|NCT00004475|||Family-Based||Prospective|||||||
1578090|NCT00004474|Randomized|Parallel Assignment||Treatment||||||||
1578091|NCT00004471||||Treatment||||||||
1578092|NCT00004468||||Treatment||||||||
1578093|NCT00004467|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1578094|NCT00004466|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1578095|NCT00004465|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1578096|NCT00004464||||Treatment||||||||
1578097|NCT00004458||||Screening|Longitudinal|||||||
1578098|NCT00004457|||Defined Population|Screening|Prospective|||||||
1578099|NCT00004454||||Treatment||||||||
1578100|NCT00004451|Randomized|||Treatment||Double||||||
1578101|NCT00004450|Randomized|||Treatment||Double||||||
1578102|NCT00004449||Single Group Assignment||Treatment||None (Open Label)||||||
1578103|NCT00004448|Randomized|||Treatment||Double||||||
1578104|NCT00004446|Randomized|||Treatment||Double||||||
1578105|NCT00004445||Single Group Assignment||Treatment||None (Open Label)||||||
1578106|NCT00004444|Randomized|||Treatment||||||||
1578107|NCT00004443||||Treatment||||||||
1578108|NCT00004442||||Treatment||||||||
1578109|NCT00004441||||Treatment||||||||
1578110|NCT00004440|Randomized|||Treatment||None (Open Label)||||||
1578111|NCT00004438||||Treatment||||||||
1578112|NCT00004437||||Treatment||||||||
1578113|NCT00004436|Randomized|||Treatment||||||||
1578114|NCT00004433|Randomized|||Treatment||||||||
1578115|NCT00004431|Randomized|Parallel Assignment||Treatment||Double||||||
1578116|NCT00004430|Randomized|||Treatment||||||||
1578117|NCT00004429|Randomized|Crossover Assignment||Treatment||Double||||||
1578118|NCT00004428|Randomized|||Treatment||Double||||||
1578119|NCT00004426|Randomized|||Treatment||Double||||||
1578120|NCT00004424|Randomized|||Treatment||Double||||||
1578121|NCT00004423|Randomized|||Treatment||||||||
1578122|NCT00004422|Randomized|||Treatment||||||||
1578123|NCT00004421||||Treatment||||||||
1578124|NCT00004420|Randomized|Crossover Assignment||Treatment||Double||||||
1578125|NCT00004419||||Treatment||None (Open Label)||||||
1578126|NCT00004418||Single Group Assignment||Treatment||None (Open Label)||||||
1578127|NCT00004416||||Treatment||||||||
1578128|NCT00004415||||Treatment||||||||
1578129|NCT00004414|Randomized|||Treatment||Double||||||
1578130|NCT00004412|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1578131|NCT00004410|Randomized|||Treatment||||||||
1578132|NCT00004409|Randomized|||Treatment||Double||||||
1578133|NCT00004408|Randomized|||Treatment||Double||||||
1578134|NCT00004407||||Treatment||||||||
1578135|NCT00004406|Randomized|||Treatment||Double||||||
1578136|NCT00004404||||Treatment||||||||
1578137|NCT00004403|Randomized|||Treatment||Double||||||
1578138|NCT00004402||||Treatment||||||||
1578139|NCT00004401||||Treatment||None (Open Label)||||||
1578140|NCT00004400|Randomized|||Treatment||Double||||||
1578141|NCT00004399|Randomized|||Prevention||||||||
1578142|NCT00004398|Randomized|||Treatment||None (Open Label)||||||
1578143|NCT00004397||||Treatment||||||||
1578144|NCT00004396||||Treatment||||||||
1578145|NCT00004393|Randomized|Parallel Assignment||Treatment||Double||||||
1578146|NCT00004392||||Screening||||||||
1578147|NCT00004390|Randomized|Crossover Assignment||Treatment||Double||||||
1578148|NCT00004387|Randomized|||Treatment||Double||||||
1578149|NCT00004386||||Treatment||||||||
1578150|NCT00004382|Randomized|||Treatment||||||||
1578151|NCT00004381||||Treatment||||||||
1578152|NCT00004380|Non-Randomized|||Treatment||||||||
1578153|NCT00004378||||Treatment||||||||
1578154|NCT00004376||||Treatment||||||||
1578155|NCT00004375||||Treatment||||||||
1578156|NCT00004374||||Screening||||||||
1578157|NCT00004373||||Treatment||||||||
1578158|NCT00004368||||Treatment||||||||
1578159|NCT00004367||||Diagnostic||||||||
1578160|NCT00004366||||Educational/Counseling/Training||||||||
1578161|NCT00004365||||Screening||||||||
1578162|NCT00004364||||Screening||||||||
1578163|NCT00004363||||Screening||||||||
1578164|NCT00004361||||Screening||||||||
1578165|NCT00004360||||Screening||||||||
1578166|NCT00004359||||Treatment||||||||
1578167|NCT00004358||||Treatment||||||||
1578168|NCT00004357|Non-Randomized|Single Group Assignment||Treatment||None (Open Label)||||||
1578169|NCT00004356||||Screening||||||||
1578170|NCT00004354||||Screening||||||||
1578171|NCT00004353||||||||||||
1578172|NCT00004351||||Screening||||||||
1578173|NCT00004350||||Screening||||||||
1578174|NCT00004348||||Screening||||||||
1578175|NCT00004347||||Treatment||||||||
1578176|NCT00004346||||Treatment||||||||
1578177|NCT00004345||||Screening||||||||
1578178|NCT00004344||||Screening||||||||
1578179|NCT00004343||||Screening||||||||
1578180|NCT00004342|||Natural History|||||||||
1578181|NCT00004341||||Screening||||||||
1578182|NCT00004340|Randomized|||Treatment||||||||
1578183|NCT00004339|Randomized|||Treatment||Double||||||
1578184|NCT00004338||||Treatment||||||||
1578185|NCT00004336||||Screening||||||||
1578186|NCT00004335||||Screening||||||||
1578187|NCT00004334||||Screening||||||||
1578188|NCT00004333||||Treatment||||||||
1578189|NCT00004332||||Screening||||||||
1578190|NCT00004331||||Screening||||||||
1578191|NCT00004330||||Prevention||||||||
1578192|NCT00004329||||Screening||||||||
1578193|NCT00004328||||Treatment||||||||
1578194|NCT00004327||||Treatment||||||||
1578195|NCT00004326||||Screening||||||||
1578196|NCT00004325||||Screening||||||||
1578197|NCT00004324||||Screening||||||||
1578198|NCT00004323||||Treatment||||||||
1578199|NCT00004317|Randomized|Parallel Assignment||Treatment||Single||||||t
1578200|NCT00004316|Randomized|||Treatment||||||||
1578201|NCT00004315||||Treatment||||||||
1578202|NCT00004314||||Treatment||||||||
1578203|NCT00004313|Randomized|||Treatment||Double||||||
1578204|NCT00004312||||Screening||||||||
1578205|NCT00004311||||Treatment||||||||
1578206|NCT00004310|Randomized|||Treatment||Double||||||
1578207|NCT00004307||||Treatment||||||||
1578208|NCT00004306|||Cohort||Prospective|||||||
1578209|NCT00004305||||Screening||||||||
1578210|NCT00004300|Randomized|Crossover Assignment||Treatment||Double||||||
1578211|NCT00004297|Randomized|||Treatment||Double||||||
1578212|NCT00004296||||Screening|Longitudinal|||||||
1578213|NCT00004294||||Treatment||||||||
1578214|NCT00004293||||Treatment||||||||
1578215|NCT00004288||||Treatment||||||||
1578216|NCT00004287||||Treatment||||||||
1578217|NCT00004286|Randomized|||Treatment||Double||||||
1578218|NCT00004285|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1578219|NCT00004284|Randomized|||Treatment||Double||||||
1578220|NCT00004278|Randomized|||Treatment||||||||
1578221|NCT00004276|Randomized|||Treatment||Double||||||
1578222|NCT00004275||||Treatment||||||||
1578223|NCT00004274||||Treatment||||||||
1578224|NCT00004268||||Treatment||||||||
1578225|NCT00004266|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1578226|NCT00000170|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1578227|NCT00000169||||||||||||
1578228|NCT00000168|||Cohort||Prospective|||||||
1578229|NCT00000167|Randomized|Single Group Assignment||Prevention||Single||||||t
1578230|NCT00000163||||||||||||
1578231|NCT00000162|Randomized|||Treatment||||||||
1578232|NCT00000161|Randomized|Factorial Assignment||Prevention||Double||||||
1578233|NCT00000160|Randomized|||Treatment||||||||
1578234|NCT00000159|Randomized|||Treatment||Double||||||
1578235|NCT00000158|Randomized|||Treatment||||||||
1578236|NCT00000157|Randomized|||Prevention||||||||
1578237|NCT00000156|Randomized|||Treatment||Double||||||
1578238|NCT00000155|||||Prospective|||||||
1578239|NCT00000154|Randomized|||Treatment||||||||
1578240|NCT00000153|Randomized|||Treatment||||||||
1578241|NCT00000152|Randomized|||Prevention||||||||
1578242|NCT00000151|Randomized|||Treatment||||||||
1578243|NCT00000150|Randomized|||Treatment||||||||
1578244|NCT00000149|Randomized|||Treatment||||||||
1578245|NCT00000148|Randomized|||Treatment||||||||
1578246|NCT00000147||||Treatment||Single||||||
1578247|NCT00000146|Randomized|||Treatment||Single||||||
1578248|NCT00000145|Randomized|Factorial Assignment||Treatment||Quadruple|||t|t|t|t
1578249|NCT00000144|Randomized|||Treatment||||||||
1578250|NCT00000143|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1578251|NCT00000142|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1578252|NCT00000140|Randomized|||Treatment||||||||
1578253|NCT00000139|Randomized|||Treatment||||||||
1578254|NCT00000138|Randomized|||Treatment||||||||
1578255|NCT00000137|Randomized|||Treatment||Double||||||
1578256|NCT00000136|Randomized|Parallel Assignment||Treatment||Single||||||t
1578257|NCT00000135|Randomized|Parallel Assignment||Treatment||Double|||t|t||
1578258|NCT00000134|Randomized|Factorial Assignment||Treatment||Double|||t||t|
1578259|NCT00000133|Randomized|||||||||||
1578260|NCT00000132|Randomized|||Treatment||||||||
1578261|NCT00000131|Randomized|||Treatment||||||||
1578262|NCT00000130|Randomized|||Treatment||||||||
1578263|NCT00000129|Randomized|||Treatment||||||||
1578264|NCT00000128|Randomized|||Treatment||||||||
1578265|NCT00000127|Randomized|||Treatment||||||||
1578266|NCT00000126|||||Longitudinal|||||||
1578267|NCT00000125|Randomized|Parallel Assignment||Prevention||None (Open Label)||||||
1578268|NCT00000124|Randomized|||Treatment||||||||
1578269|NCT00000123|Randomized|||Treatment||Double||||||
1578270|NCT00000122|Randomized|||Treatment||Double||||||
1578271|NCT00000121|Randomized|||Treatment||||||||
1578272|NCT00000120|Randomized|||Treatment||Double||||||
1578273|NCT00000119|Randomized|||Treatment||||||||
1578274|NCT00000118|Randomized|||Treatment||||||||
1578275|NCT00000117|Randomized|||Treatment||Double||||||
1578276|NCT00000116|Randomized|Parallel Assignment||Treatment||Double||||||
1578277|NCT00000115|Randomized|Crossover Assignment||Treatment||Double||||||
1578278|NCT00000114|Randomized|Factorial Assignment||Treatment||Double||||||
1578279|NCT00000113|Randomized|Parallel Assignment||Treatment||Triple|||t||t|t
1578280|NCT00000358||||Treatment||||||||
1578281|NCT00000357||||Treatment||||||||
1578282|NCT00000356||||Treatment||||||||
1578283|NCT00000355||||Treatment||||||||
1578284|NCT00000354||||Treatment||||||||
1578285|NCT00000353||||Treatment||||||||
1578286|NCT00000352||||Treatment||||||||
1578287|NCT00000351||||||||||||
1578288|NCT00000350||||Treatment||None (Open Label)||||||
1578289|NCT00000349||||Treatment||None (Open Label)||||||
1578290|NCT00000348||||Treatment||None (Open Label)||||||
1578291|NCT00000347||Parallel Assignment||Treatment||Double||||||
1578292|NCT00000346||||Treatment||||||||
1578293|NCT00000345||||Treatment||None (Open Label)||||||
1578294|NCT00000344|Randomized|||Treatment||Double||||||
1578295|NCT00000343||||Treatment||||||||
1578296|NCT00000342||Parallel Assignment||Treatment||Double||||||
1578297|NCT00000341|Randomized|Crossover Assignment||Treatment||Double||||||
1578298|NCT00000340||||Treatment||||||||
1578299|NCT00000339||Crossover Assignment||Treatment||Single||||||
1578300|NCT00000338||||Treatment||None (Open Label)||||||
1578301|NCT00000337||||Treatment||||||||
1578302|NCT00000336||||Treatment||Double||||||
1578303|NCT00000335||||Treatment||||||||
1578304|NCT00000334||||Treatment||||||||
1578305|NCT00000333||||Treatment||||||||
1578306|NCT00000332||||Treatment||||||||
1578307|NCT00000331||||Treatment||Double||||||
1578308|NCT00000330||||Treatment||Double||||||
1578309|NCT00000329||||Treatment||Double||||||
1578310|NCT00000328|Randomized|Parallel Assignment||Treatment||Double||||||
1578311|NCT00000327||Crossover Assignment||Treatment||Double||||||
1578312|NCT00000326||Crossover Assignment||Treatment||Double||||||
1578313|NCT00000325||||Treatment||||||||
1578314|NCT00000324|Randomized|||Treatment||Double||||||
1578315|NCT00000323||||||||||||
1578316|NCT00000322|Randomized|||Treatment||Double||||||
1578317|NCT00000321||||Treatment||||||||
1578318|NCT00000320|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1578319|NCT00000319||||Treatment||||||||
1578320|NCT00000318|Randomized|Factorial Assignment||Treatment||None (Open Label)||||||
1578321|NCT00000317|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1578322|NCT00000316||||Treatment||||||||
1578323|NCT00000315||||Treatment||||||||
1578324|NCT00000314||||Treatment||||||||
1578325|NCT00000313||||Treatment||||||||
1578326|NCT00000312||||Treatment||||||||
1578327|NCT00000311|Randomized|Factorial Assignment||Treatment||Double||||||
1578328|NCT00000310|Randomized|||Treatment||Double||||||
1578329|NCT00000309|Randomized|||Treatment||Double||||||
1578330|NCT00000308|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1578331|NCT00000307||||Treatment||||||||
1578332|NCT00000306|Randomized|Single Group Assignment||Treatment||Double||||||
1578333|NCT00000305||||Treatment||||||||
1578334|NCT00000304|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
1578335|NCT00000303|Randomized|||Treatment||Double||||||
1578336|NCT00000302||||Treatment||Double||||||
1578337|NCT00000301|Randomized|||Treatment||Double||||||
1578338|NCT00000300|Randomized|||Treatment||||||||
1578339|NCT00000299|Randomized|Crossover Assignment||Treatment||Single|||t|||
1578340|NCT00000298||||Treatment||Double||||||
1578341|NCT00000297||||Treatment||Double||||||
1578342|NCT00000296||Crossover Assignment||Treatment||Double||||||
1578343|NCT00000295||Crossover Assignment||Treatment||Double||||||
1578344|NCT00000294||||Treatment||Double||||||
1578345|NCT00000293||||Treatment||Double||||||
1578346|NCT00000292||||Treatment||Double||||||
1578347|NCT00000291||||Treatment||Double||||||
1578348|NCT00000290||Crossover Assignment||Treatment||Double||||||
1578349|NCT00000289||||Treatment||Double||||||
1578350|NCT00000288||Crossover Assignment||Treatment||Double||||||
1578351|NCT00000287||||||||||||
1578352|NCT00000286||||Treatment||Double||||||
1578353|NCT00000285||Parallel Assignment||Treatment||Double||||||
1578354|NCT00000284|Randomized|||Treatment||Double||||||
1578355|NCT00000282||||Treatment||||||||
1578356|NCT00000281||||Treatment||||||||
1578357|NCT00000280||||Treatment||||||||
1578358|NCT00000279||||Treatment||||||||
1578359|NCT00000278||||Treatment||||||||
1578360|NCT00000277||||Treatment||||||||
1578361|NCT00000276||||Treatment||||||||
1578362|NCT00000275||||Treatment||||||||
1578363|NCT00000274||||Treatment||||||||
1578364|NCT00000273||Single Group Assignment||Treatment||None (Open Label)||||||
1578365|NCT00000271|Randomized|Parallel Assignment||Treatment||None (Open Label)||||||
1578366|NCT00000270||||Treatment||||||||
1578367|NCT00000269||||Treatment||||||||
1578368|NCT00000268||Single Group Assignment||Treatment||||||||
1578369|NCT00000267||||Treatment||||||||
1578370|NCT00000266||||Treatment||||||||
1578371|NCT00000265|||Cohort||Prospective|||||||
1578372|NCT00000264||Crossover Assignment||||Double|||t|t||
1578373|NCT00000263|Non-Randomized|Crossover Assignment||||Double|||t|t||
1578374|NCT00000262|Randomized|Crossover Assignment||Treatment||Double|||t|t||
1578375|NCT00000261||Single Group Assignment||||Double|||t|t||
1578376|NCT00000260||||||||||||
1578377|NCT00000259|Non-Randomized|Crossover Assignment||||Double|||t||t|
1578378|NCT00000258|Randomized|Crossover Assignment||||Double|||t||t|
1578379|NCT00000257|Non-Randomized|Crossover Assignment||||Double|||t||t|
1578380|NCT00000256|Non-Randomized|Crossover Assignment||||Double|||t||t|
1578381|NCT00000255|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1578382|NCT00000254|Randomized|Crossover Assignment||Treatment||Single|||t|||
1578383|NCT00000253|Non-Randomized|Crossover Assignment||||Double|||t||t|
1578384|NCT00000252|Randomized|Crossover Assignment||Treatment||Double|||t||t|
1578385|NCT00000251|Randomized|Crossover Assignment||Treatment||Single|||t|||
1578386|NCT00000250|Non-Randomized|Crossover Assignment||Treatment||Single|||t|||
1578387|NCT00000249|Non-Randomized|Crossover Assignment||Treatment||Double|||t||t|
1578388|NCT00000248||||Treatment||||||||
1578389|NCT00000246||||Treatment||||||||
1578390|NCT00000245||||Treatment||||||||
1578391|NCT00000244||||Treatment||Double||||||
1578392|NCT00000243|Randomized|Parallel Assignment||Treatment||Double||||||
1578393|NCT00000242||||Treatment||||||||
1578394|NCT00000241||||Treatment||||||||
1578395|NCT00000240||||Treatment||None (Open Label)||||||
1578396|NCT00000239||||Treatment||||||||
1578397|NCT00000238||||Treatment||||||||
1578398|NCT00000237||||Treatment||||||||
1578399|NCT00000236||||Treatment||||||||
1578400|NCT00000235||Crossover Assignment||Treatment||||||||
1578401|NCT00000234||Crossover Assignment||Treatment||||||||
1578402|NCT00000233||||Treatment||||||||
1578403|NCT00000232||Crossover Assignment||Treatment||Double||||||
1578404|NCT00000231||||Treatment||||||||
1578405|NCT00000230||||Treatment||||||||
1578406|NCT00000229||||Treatment||||||||
1578407|NCT00000228||||Treatment||||||||
1578408|NCT00000227||Crossover Assignment||Treatment||||||||
1578409|NCT00000226||||Treatment||||||||
1578410|NCT00000225||||Treatment||Double||||||
1578411|NCT00000224||Crossover Assignment||Treatment||Double||||||
1578412|NCT00000223||Crossover Assignment||Treatment||Double||||||
1578413|NCT00000222||Crossover Assignment||Treatment||||||||
1578414|NCT00000221||Crossover Assignment||Treatment||Double||||||
1578415|NCT00000220||||Treatment||Double||||||
1578416|NCT00000219||||Treatment||Double||||||
1578417|NCT00000218||||Treatment||||||||
1578418|NCT00000217||||Treatment||||||||
1578419|NCT00000216||||Treatment||||||||
1578420|NCT00000215||||Treatment||||||||
1578421|NCT00000214||||Treatment||||||||
1578422|NCT00000213||||Treatment||||||||
1578423|NCT00000212||||Treatment||||||||
1578424|NCT00000211||||Treatment||||||||
1578425|NCT00000210||||Treatment||||||||
1578426|NCT00000209||||Treatment||Single||||||
1578427|NCT00000208||||Treatment||None (Open Label)||||||
1578428|NCT00000207|Randomized|||Treatment||Double||||||
1578429|NCT00000206||||Treatment||Double||||||
1578430|NCT00000205||||Treatment||Double||||||
1578431|NCT00000204||||Treatment||||||||
1578432|NCT00000203||||Treatment||||||||
1578433|NCT00000202||||Treatment||||||||
1578434|NCT00000201||||Treatment||||||||
1578435|NCT00000200||Single Group Assignment||Treatment||Double|||t|t||
1578436|NCT00000199||||Treatment||||||||
1578437|NCT00000198||||Treatment||||||||
1578438|NCT00000197||||Treatment||||||||
1578439|NCT00000196||||Treatment||Double||||||
1578440|NCT00000195||Crossover Assignment||Treatment||Double||||||
1578441|NCT00000194||||Treatment||Double||||||
1578442|NCT00000193||||Treatment||Double||||||
1578443|NCT00000192||||Treatment||Double||||||
1578444|NCT00000191||||Treatment||||||||
1578445|NCT00000190||||Diagnostic||||||||
1578446|NCT00000189|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1578447|NCT00000188|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1578448|NCT00000187|Randomized|Parallel Assignment||Treatment||Double|||t||t|
1578449|NCT00004640|Randomized|Single Group Assignment||Prevention||Quadruple|||t|t|t|t
1578450|NCT00004639|Randomized|Parallel Assignment||Treatment||Quadruple|||t|t|t|t
